PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chen, Y; Li, C; Xie, H; Fan, Y; Yang, Z; Ma, J; He, D; Li, L				Chen, Y.; Li, C.; Xie, H.; Fan, Y.; Yang, Z.; Ma, J.; He, D.; Li, L.			Infiltrating mast cells promote renal cell carcinoma angiogenesis by modulating PI3K -> AKT -> GSK3 beta -> AM signaling	ONCOGENE			English	Article							PROSTATE-CANCER; MICROVESSEL DENSITY; THERAPEUTIC TARGET; TUMOR ANGIOGENESIS; ADRENOMEDULLIN; ACTIVATION; EXPRESSION; AXIS	The recruitment of vascular endothelial cells from the tumor microenvironment (TME) to promote angiogenesis plays key roles in the progression of renal cell carcinoma (RCC). The potential impact of immune cells in the TME on RCC angiogenesis, however, remains unclear. Here, we found that recruitment of mast cells resulted in increased RCC angiogenesis in both in vitro cell lines and in vivo mouse models. Mechanistic analyses revealed that RCC recruited mast cells by modulating PI3K -> AKT -> GSK3 beta -> AM signaling. A clinical survey of human RCC samples also showed that higher expression of the PI3K -> AKT -> GSK3 beta -> AM signaling pathway correlated with increased angiogenesis. Interruption of PI3K -> AKT -> GSK3 beta -> AM signaling via specific inhibitors led to decreased recruitment of mast cells, and targeting this infiltrating mast cell-related signaling via an AKT-specific inhibitor suppressed RCC angiogenesis in xenograft mouse models. Together, these results identified a novel role of infiltrating mast cells in RCC angiogenesis and metastasis and suggest a new strategy for treating RCC by targeting this newly identified signaling pathway.	[Chen, Y.; Xie, H.; Fan, Y.; Yang, Z.; Ma, J.; He, D.; Li, L.] Xi An Jiao Tong Univ, Dept Urol, Affiliated Hosp 1, 277 Yanta Wast Rd, Xian 710061, Peoples R China; [Li, C.] Chinese Acad Sci, Inst Biophys, Core Facil Prot Res, Beijing, Peoples R China; [Li, C.] Beijing Jianlan Inst Med, Beijing, Peoples R China	Xi'an Jiaotong University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Li, L (corresponding author), Xi An Jiao Tong Univ, Dept Urol, Affiliated Hosp 1, 277 Yanta Wast Rd, Xian 710061, Peoples R China.	lilydr@hotmail.com			The National High Technology Research and Development Program of China (863 Program) [SS2014AA020607]; National Natural Science Foundation of China [81072107, 81472679, 81302227, 81130041]; National Key Research and Development Program [2016YFC0902603]	The National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program	This work was supported by The National High Technology Research and Development Program of China (863 Program, NO SS2014AA020607) and National Natural Science Foundation of China grant (No. 81072107, 81472679, 81302227, 81130041), and the National Key Research and Development Program (2016YFC0902603).	Cairns P, 2011, CANCER BIOMARK, V9, P461, DOI 10.3233/CBM-2011-0176; Crivellato E, 2008, CANCER LETT, V269, P1, DOI 10.1016/j.canlet.2008.03.031; Dang Q, 2015, MOL ONCOL, V9, P1241, DOI 10.1016/j.molonc.2015.02.010; Deville JL, 2010, EXPERT OPIN THER TAR, V14, P1059, DOI 10.1517/14728222.2010.522328; Deville JL, 2009, INT J CANCER, V125, P2307, DOI 10.1002/ijc.24568; Eddy AA, 2001, KIDNEY INT, V60, P375, DOI 10.1046/j.1523-1755.2001.00811.x; Forster A, 2015, ALLERGY, V70, P764, DOI 10.1111/all.12612; Fujita Y, 2002, INT J UROL, V9, P285, DOI 10.1046/j.1442-2042.2002.00469.x; Galinsky DST, 2008, CRIT REV ONCOL HEMAT, V68, P115, DOI 10.1016/j.critrevonc.2008.06.001; Guldur ME, 2014, J PAK MED ASSOC, V64, P300; Hollins F, 2008, J IMMUNOL, V181, P2772, DOI 10.4049/jimmunol.181.4.2772; Horstmann M, 2012, ANTICANCER RES, V32, P4339; Juengel E, 2015, J CELL MOL MED, V19, P430, DOI 10.1111/jcmm.12471; Kinoshita T, 1999, BLOOD, V94, P496, DOI 10.1182/blood.V94.2.496.414k19_496_508; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; Kitamura Y, 2007, P JPN ACAD B-PHYS, V83, P164, DOI 10.2183/pjab.83.164; Kornakiewicz A, 2013, CURR SIGNAL TRANSD T, V8, P210; Li L, 2015, ONCOTARGET, V6, P14179, DOI 10.18632/oncotarget.3651; Liu XD, 2015, CANCER IMMUNOL RES, V3, P1017, DOI 10.1158/2326-6066.CIR-14-0244; Maltby S, 2009, BBA-REV CANCER, V1796, P19, DOI 10.1016/j.bbcan.2009.02.001; Mohseni MG, 2010, INT UROL NEPHROL, V42, P109, DOI 10.1007/s11255-009-9577-2; Nikitenko LL, 2006, BRIT J CANCER, V94, P1, DOI 10.1038/sj.bjc.6602832; Ning H, 2012, CHINESE MED J-PEKING, V125, P2120, DOI 10.3760/cma.j.issn.0366-6999.2012.12.008; Park JY, 2007, EXPERT REV ANTICANC, V7, P863, DOI 10.1586/14737140.7.6.863; Patel PH, 2006, BRIT J CANCER, V94, P614, DOI 10.1038/sj.bjc.6602978; PAVONE-MACALUSO M, 1960, Acta Pathol Microbiol Scand, V50, P337; Ribatti D, 2016, EUR J PHARMACOL, V778, P152, DOI 10.1016/j.ejphar.2015.02.056; Ribatti D, 2012, BBA-MOL BASIS DIS, V1822, P2, DOI 10.1016/j.bbadis.2010.11.010; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Safdari Y, 2015, PHARMACOL RES, V93, P1, DOI 10.1016/j.phrs.2014.12.004; Samayawardhena LA, 2008, J BIOL CHEM, V283, P29175, DOI 10.1074/jbc.M804077200; SARUTA T, 1977, Keio Journal of Medicine, V26, P163; Shen C, 2013, SEMIN CANCER BIOL, V23, P18, DOI 10.1016/j.semcancer.2012.06.001; Shi GP, 2013, CURR VASC PHARMACOL, V11, P314, DOI 10.2174/1570161111311030006; Siebenhaar F, 2014, EXP DERMATOL, V23, P159, DOI 10.1111/exd.12328; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Toge H, 2009, INT J UROL, V16, P801, DOI 10.1111/j.1442-2042.2009.02377.x; Trojan L, 2004, ANTICANCER RES, V24, P1651; Tuna B, 2006, EUR UROL, V50, P530, DOI 10.1016/j.eururo.2005.12.040; Watanabe S, 2012, HUM PATHOL, V43, P888, DOI 10.1016/j.humpath.2011.07.019; Wickenden JA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2558; Zhang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019144; Zhang W, 2000, CANCER RES, V60, P6757	43	38	40	2	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 18	2017	36	20					2879	2888		10.1038/onc.2016.442	http://dx.doi.org/10.1038/onc.2016.442			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EV3ZM	28114284	hybrid, Green Published			2022-12-26	WOS:000401697800010
J	Goch, W; Bal, W				Goch, Wojciech; Bal, Wojciech			Numerical Simulations Reveal Randomness of Cu(II) Induced A beta Peptide Dimerization under Conditions Present in Glutamatergic Synapses	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; METAL-IONS; SENILE PLAQUES; COPPER-BINDING; COORDINATION GEOMETRY; AGGREGATION KINETICS; CEREBROSPINAL-FLUID; FIBER FORMATION; IN-VIVO	The interactions between the A beta(1-40) molecules species and the copper ions (Cu(II)) were intensively investigated due to their potential role in the development of the Alzheimer Disease (AD). The rate and the mechanism of the Cu(II)-A beta complexes formation determines the aggregation pathway of the A beta species, starting from smaller but more cytotoxic oligomers and ending up in large A beta plaques, being the main hallmark of the AD. In our study we exploit the existing knowledge on the Cu(II)-A beta interactions and create the theoretical model of the initial phase of the copper-driven A beta aggregation mechanism. The model is based on the direct solution of the Chemical Master Equations, which capture the inherent stochastics of the considered system. In our work we argue that due to a strong Cu(II) affinity to A beta and temporal accessibility of the Cu(II) ions during normal synaptic activity the aggregation driven by Cu(II) dominates the pure A beta aggregation. We also demonstrate the dependence of the formation of different Cu(II)-A beta complexes on the concentrations of reagents and the synaptic activity. Our findings correspond to recent experimental results and give a sound hypothesis on the AD development mechanisms.	[Goch, Wojciech; Bal, Wojciech] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Goch, W (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	wojciech_goch@wp.pl		Goch, Wojciech/0000-0001-7230-7173; Bal, Wojciech/0000-0003-3780-083X	Polish National Science Centre [2015/19/N/NZ1/02021]; Foundation for Polish Science [TEAM/2009-4/1]	Polish National Science Centre; Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission)	The project was supported by the Polish National Science Centre grant Preludium10 no 2015/19/N/NZ1/02021 to WG (http://www.ncn.gov.pl/) and by the Foundation for Polish Science TEAM grant no TEAM/2009-4/1 (http://www.fnp.org.pl/). Both authors received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Agarwal R, 2012, ADV ALZHEIMERS DIS, V1, P30, DOI DOI 10.4236/aad.2012.13005; Alies B, 2013, ANAL CHEM, V85, P1501, DOI 10.1021/ac302629u; Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Arellano JI, 2007, FRONT NEUROSCI-SWITZ, V1, P131, DOI 10.3389/neuro.01.1.1.010.2007; Artells E, 2014, FEBS J, V281, P1659, DOI 10.1111/febs.12731; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Barnham KJ, 2003, J BIOL CHEM, V278, P42959, DOI 10.1074/jbc.M305494200; Bin YN, 2013, J INORG BIOCHEM, V119, P21, DOI 10.1016/j.jinorgbio.2012.10.013; Bouter Y, 2013, ACTA NEUROPATHOL, V126, P189, DOI 10.1007/s00401-013-1129-2; Branch T, 2015, ANGEW CHEM INT EDIT, V54, P1227, DOI 10.1002/anie.201408810; Capo CR, 2008, BIOMETALS, V21, P367, DOI 10.1007/s10534-007-9125-4; Chyung ASC, 1997, J CELL BIOL, V138, P671, DOI 10.1083/jcb.138.3.671; Cirrito JR, 2003, J NEUROSCI, V23, P8844; Crimins JL, 2013, AGEING RES REV, V12, P757, DOI 10.1016/j.arr.2013.03.002; Deshpande A, 2009, J NEUROSCI, V29, P4004, DOI 10.1523/JNEUROSCI.5980-08.2009; Drew SC, 2011, ACCOUNTS CHEM RES, V44, P1146, DOI 10.1021/ar200014u; Faller P, 2013, INORG CHEM, V52, P12193, DOI 10.1021/ic4003059; Fawzi NL, 2010, J AM CHEM SOC, V132, P9948, DOI 10.1021/ja1048253; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Garai K, 2013, P NATL ACAD SCI USA, V110, P3321, DOI 10.1073/pnas.1222478110; GarzonRodriguez W, 1997, J BIOL CHEM, V272, P21037, DOI 10.1074/jbc.272.34.21037; GILLESPIE DT, 1992, PHYSICA A, V188, P404, DOI 10.1016/0378-4371(92)90283-V; Gu L, 2013, J NEUROCHEM, V126, P305, DOI 10.1111/jnc.12202; Ha C, 2007, BIOCHEMISTRY-US, V46, P6118, DOI 10.1021/bi7000032; Hane F, 2014, BIOMOLECULES, V4, P101, DOI 10.3390/biom4010101; Holtta M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066381; Hopt A, 2003, J NEUROSCI METH, V128, P159, DOI 10.1016/S0165-0270(03)00173-0; Hortschansky P, 2005, PROTEIN SCI, V14, P1753, DOI 10.1110/ps.041266605; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Huang XD, 2004, J BIOL INORG CHEM, V9, P954, DOI 10.1007/s00775-004-0602-8; Hung LW, 2008, J NEUROSCI, V28, P11950, DOI 10.1523/JNEUROSCI.3916-08.2008; Hureau C, 2012, COORDIN CHEM REV, V256, P2164, DOI 10.1016/j.ccr.2012.03.037; Jiang DL, 2013, BIOCHEMISTRY-US, V52, P547, DOI 10.1021/bi301053h; Johnston I., 2012, SIGNIFICANCE, V9, P17, DOI DOI 10.1111/J.1740-9713.2012.00586.X; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; KARDOS J, 1989, NEUROSCI LETT, V103, P139, DOI 10.1016/0304-3940(89)90565-X; Karr JW, 2007, J AM CHEM SOC, V129, P3796, DOI 10.1021/ja068952d; Kepp KP, 2012, CHEM REV, V112, P5193, DOI 10.1021/cr300009x; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lewis H, 2006, NEUROPATH APPL NEURO, V32, P103, DOI 10.1111/j.1365-2990.2006.00696.x; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mccoll G, 2009, J BIOL CHEM, V284, P22697, DOI 10.1074/jbc.C109.028514; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Mital M, 2015, ANGEW CHEM INT EDIT, V54, P10460, DOI 10.1002/anie.201502644; Mo JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116802; Murphy RM, 2007, BBA-BIOMEMBRANES, V1768, P1923, DOI 10.1016/j.bbamem.2006.12.014; Nasica-Labouze J, 2015, CHEM REV, V115, P3518, DOI 10.1021/cr500638n; Neniskyte U, 2011, J BIOL CHEM, V286, P39904, DOI 10.1074/jbc.M111.267583; Nischwitz V, 2008, ANAL CHIM ACTA, V627, P258, DOI 10.1016/j.aca.2008.08.018; Nose Y, 2010, J BIOL CHEM, V285, P32385, DOI 10.1074/jbc.M110.143826; Pallitto MM, 2001, BIOPHYS J, V81, P1805, DOI 10.1016/S0006-3495(01)75831-6; Pedersen JT, 2011, J BIOL CHEM, V286, P26952, DOI 10.1074/jbc.M111.220863; Pedersen JT, 2011, ANGEW CHEM INT EDIT, V50, P2532, DOI 10.1002/anie.201006335; Pellarin R, 2006, J MOL BIOL, V360, P882, DOI 10.1016/j.jmb.2006.05.033; Roher AE, 1996, J BIOL CHEM, V271, P20631, DOI 10.1074/jbc.271.34.20631; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; Sarell CJ, 2010, J BIOL CHEM, V285, P41533, DOI 10.1074/jbc.M110.171355; Sarell CJ, 2009, BIOCHEMISTRY-US, V48, P4388, DOI 10.1021/bi900254n; Schlief ML, 2005, J NEUROSCI, V25, P239, DOI 10.1523/JNEUROSCI.3699-04.2005; Schreck JS, 2013, FIBRIL GROWTH LENGTH; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Shahrezaei V, 2008, CURR OPIN BIOTECH, V19, P369, DOI 10.1016/j.copbio.2008.06.011; Singh I, 2013, P NATL ACAD SCI USA, V110, P14771, DOI 10.1073/pnas.1302212110; Smith DP, 2007, BIOCHEMISTRY-US, V46, P2881, DOI 10.1021/bi0620961; Smith DP, 2006, J BIOL CHEM, V281, P15145, DOI 10.1074/jbc.M600417200; Syme CD, 2004, J BIOL CHEM, V279, P18169, DOI 10.1074/jbc.M313572200; Szaruga M, 2015, J EXP MED, V212, P2003, DOI 10.1084/jem.20150892; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Viles JH, 2012, COORDIN CHEM REV, V256, P2271, DOI 10.1016/j.ccr.2012.05.003; Walsh DM, 2005, J NEUROSCI, V25, P2455, DOI 10.1523/JNEUROSCI.4391-04.2005; Wang J, 1999, EXP NEUROL, V158, P328, DOI 10.1006/exnr.1999.7085; Warmlander S, 2013, CHEMBIOCHEM, V14, P1692, DOI 10.1002/cbic.201300262; Wezynfeld NE, 2016, ANGEW CHEM INT EDIT, V55, P8235, DOI 10.1002/anie.201511968; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748; Yamamoto N, 2007, J BIOL CHEM, V282, P2646, DOI 10.1074/jbc.M606202200; Yoshiike Y, 2001, J BIOL CHEM, V276, P32293, DOI 10.1074/jbc.M010706200; Young TR, 2014, METALLOMICS, V6, P505, DOI 10.1039/c4mt00001c	83	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170749	10.1371/journal.pone.0170749	http://dx.doi.org/10.1371/journal.pone.0170749			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125716	Green Submitted, gold, Green Published			2022-12-26	WOS:000396176100066
J	Lee, CW; Kwon, S; Park, SH; Kim, BY; Yoo, W; Ryu, BH; Kim, HW; Shin, SC; Kim, S; Park, H; Kim, TD; Lee, JH				Lee, Chang Woo; Kwon, Sena; Park, Sun-Ha; Kim, Boo-Young; Yoo, Wanki; Ryu, Bum Han; Kim, Han-Woo; Shin, Seung Chul; Kim, Sunghwan; Park, Hyun; Kim, T. Doohun; Lee, Jun Hyuck			Crystal Structure and Functional Characterization of an Esterase (EaEST) from Exiguobacterium antarcticum	PLOS ONE			English	Article							SALT-TOLERANT ESTERASE; COLD; ENZYMES; ACID; CLASSIFICATION; PURIFICATION; PROMISCUITY; ACTIVATION; COMPLEX	A novel microbial esterase, EaEST, from a psychrophilic bacterium Exiguobacterium antarcticum B7, was identified and characterized. To our knowledge, this is the first report describing structural analysis and biochemical characterization of an esterase isolated from the genus Exiguobacterium. Crystal structure of EaEST, determined at a resolution of 1.9 angstrom, showed that the enzyme has a canonical alpha/beta hydrolase fold with an a-helical cap domain and a catalytic triad consisting of Ser96, Asp220, and His248. Interestingly, the active site of the structure of EaEST is occupied by a peracetate molecule, which is the product of perhydrolysis of acetate. This result suggests that EaEST may have perhydrolase activity. The activity assay showed that EaEST has significant perhydrolase and esterase activity with respect to short-chain p-nitrophenyl esters (<= C8), naphthyl derivatives, phenyl acetate, and glyceryl tributyrate. However, the S96A single mutant had low esterase and perhydrolase activity. Moreover, the L27A mutant showed low levels of protein expression and solubility as well as preference for different substrates. On conducting an enantioselectivity analysis using R- and S-methyl-3-hydroxy-2-methylpropionate, a preference for R-enantiomers was observed. Surprisingly, immobilized EaEST was found to not only retain 200% of its initial activity after incubation for 1 h at 80 degrees C, but also retained more than 60% of its initial activity after 20 cycles of reutilization. This research will serve as basis for future engineering of this esterase for biotechnological and industrial applications.	[Lee, Chang Woo; Park, Sun-Ha; Kim, Han-Woo; Shin, Seung Chul; Park, Hyun; Lee, Jun Hyuck] Korea Polar Res Inst, Unit Polar Genom, Incheon, South Korea; [Lee, Chang Woo; Kim, Han-Woo; Park, Hyun; Lee, Jun Hyuck] Univ Sci & Technol, Dept Polar Sci, Incheon, South Korea; [Kwon, Sena; Kim, Boo-Young; Yoo, Wanki; Ryu, Bum Han; Kim, T. Doohun] Sookmyung Womens Univ, Dept Chem, Coll Nat Sci, Seoul, South Korea; [Kim, Sunghwan] Daegu Gyeongpuk Med Innovat Fdn, New Drug Dev Ctr, Daegu, South Korea	Korea Polar Research Institute (KOPRI); Sookmyung Women's University	Lee, JH (corresponding author), Sookmyung Womens Univ, Dept Chem, Coll Nat Sci, Seoul, South Korea.	doohunkim@sookmyung.ac.kr; junhyucklee@kopri.re.kr	kim, doohun/AAC-4528-2019		Antarctic organisms: Cold-Adaptation Mechanisms and its application grant [PE16070]; Polar Genomics 101 Project: Genome analysis of polar organisms and establishment of application platform [PE17080]; Polar Academic Program - Korea Polar Research Institute (KOPRI) [PD15010]; National Research Foundation of Korea - Korean Government (MSIP) [NRF-2016M1A5A1901770, PN16082, KOPRI]	Antarctic organisms: Cold-Adaptation Mechanisms and its application grant; Polar Genomics 101 Project: Genome analysis of polar organisms and establishment of application platform; Polar Academic Program - Korea Polar Research Institute (KOPRI); National Research Foundation of Korea - Korean Government (MSIP)	This work was supported by the Antarctic organisms: Cold-Adaptation Mechanisms and its application grant (PE16070), Polar Genomics 101 Project: Genome analysis of polar organisms and establishment of application platform (PE17080) and the Polar Academic Program (PD15010) funded by the Korea Polar Research Institute (KOPRI). This study was also supported by the National Research Foundation of Korea, which is funded by the Korean Government (MSIP), (NRF-2016M1A5A1901770) (PN16082, KOPRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Bencharit S, 2003, CHEM BIOL, V10, P341, DOI 10.1016/S1074-5521(03)00071-1; Bernhardt P., 2005, ANGEW CHEM, V117, P2802; Bornscheuer UT, 2006, HYDROLASES IN ORGANIC SYNTHESIS: REGIO- AND STEREOSELECTIVE BIOTRANSFORMATIONS, 2ND EDITION, P1; Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4; Carboni-Oerlemans C, 2006, J BIOTECHNOL, V126, P140, DOI 10.1016/j.jbiotec.2006.04.008; Carneiro AR, 2012, J BACTERIOL, V194, P6689, DOI 10.1128/JB.01791-12; De Santi C, 2016, EXTREMOPHILES, V20, P323, DOI 10.1007/s00792-016-0824-z; Elmi F, 2005, J BACTERIOL, V187, P8470, DOI 10.1128/JB.187.24.8470-8476.2005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Georlette D, 2004, FEMS MICROBIOL REV, V28, P25, DOI 10.1016/j.femsre.2003.07.003; Hajighasemi M, 2016, BIOMACROMOLECULES, V17, P2027, DOI 10.1021/acs.biomac.6b00223; Hofmann B, 1998, J MOL BIOL, V279, P889, DOI 10.1006/jmbi.1998.1802; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ileperuma NR, 2007, BIOCHEMISTRY-US, V46, P1851, DOI 10.1021/bi062046w; Jackson CJ, 2013, P NATL ACAD SCI USA, V110, P10177, DOI 10.1073/pnas.1304097110; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Lee C, 2013, APPL BIOCHEM BIOTECH, V169, P29, DOI 10.1007/s12010-012-9947-6; Legler PM, 2008, BIOCHEMISTRY-US, V47, P9592, DOI 10.1021/bi8010016; Liu P, 2007, J MOL BIOL, V367, P212, DOI 10.1016/j.jmb.2006.12.067; Lonhienne T, 2000, BBA-PROTEIN STRUCT M, V1543, P1, DOI 10.1016/S0167-4838(00)00210-7; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Novototskaya-Vlasova K, 2012, FEMS MICROBIOL ECOL, V82, P367, DOI 10.1111/j.1574-6941.2012.01385.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panda T, 2005, APPL MICROBIOL BIOT, V67, P160, DOI 10.1007/s00253-004-1840-y; Rozeboom HJ, 2014, BBA-PROTEINS PROTEOM, V1844, P567, DOI 10.1016/j.bbapap.2014.01.003; Santiago M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01408; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sharma R, 2001, BIOTECHNOL ADV, V19, P627, DOI 10.1016/S0734-9750(01)00086-6; Sharma S, 2014, SCI WORLD J, DOI 10.1155/2014/625258; Struvay C, 2012, INT J MOL SCI, V13, P11643, DOI 10.3390/ijms130911643; Tutino ML, 2009, PROTEIN PEPTIDE LETT, V16, P1172; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wu GJ, 2013, EXTREMOPHILES, V17, P809, DOI 10.1007/s00792-013-0562-4; YAMADA H, 1985, AGR BIOL CHEM TOKYO, V49, P2961, DOI 10.1080/00021369.1985.10867194; Yin DL, 2010, BIOCHEMISTRY-US, V49, P1931, DOI 10.1021/bi9021268	38	31	32	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0169540	10.1371/journal.pone.0169540	http://dx.doi.org/10.1371/journal.pone.0169540			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125606	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100137
J	Szema, AM; Forsyth, E; Ying, B; Hamidi, SA; Chen, JJ; Hwang, S; Li, JC; Dwyer, DS; Ramiro-Diaz, JM; Giermakowska, W; Bosc, LVG				Szema, Anthony M.; Forsyth, Edward; Ying, Benjamin; Hamidi, Sayyed A.; Chen, John J.; Hwang, Sonya; Li, Jonathan C.; Dwyer, Debra Sabatini; Ramiro-Diaz, Juan M.; Giermakowska, Wieslawa; Bosc, Laura V. Gonzalez			NFATc3 and VIP in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; ACTIVATED T-CELLS; CHRONIC HYPOXIA; ARTERIAL-HYPERTENSION; NUCLEAR FACTOR; SMOOTH-MUSCLE; UP-REGULATION; COPD; ANGIOGENESIS; INHIBITION	Idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD) are both debilitating lung diseases which can lead to hypoxemia and pulmonary hypertension (PH). Nuclear Factor of Activated T-cells (NFAT) is a transcription factor implicated in the etiology of vascular remodeling in hypoxic PH. We have previously shown that mice lacking the ability to generate Vasoactive Intestinal Peptide (VIP) develop spontaneous PH, pulmonary arterial remodeling and lung inflammation. Inhibition of NFAT attenuated PH in these mice suggesting a connection between NFAT and VIP. To test the hypotheses that: 1) VIP inhibits NFAT isoform c3 (NFATc3) activity in pulmonary vascular smooth muscle cells; 2) lung NFATc3 activation is associated with disease severity in IPF and COPD patients, and 3) VIP and NFATc3 expression correlate in lung tissue from IPF and COPD patients. NFAT activity was determined in isolated pulmonary arteries from NFAT-luciferase reporter mice. The% of nuclei with NFAT nuclear accumulation was determined in primary human pulmonary artery smooth muscle cell (PASMC) cultures; in lung airway epithelia and smooth muscle and pulmonary endothelia and smooth muscle from IPF and COPD patients; and in PASMC from mouse lung sections by fluorescence microscopy. Both NFAT and VIP mRNA levels were measured in lungs from IPF and COPD patients. Empirical strategies applied to test hypotheses regarding VIP, NFATc3 expression and activity, and disease type and severity. This study shows a significant negative correlation between NFAT isoform c3 protein expression levels in PASMC, activity of NFATc3 in pulmonary endothelial cells,expression and activity of NFATc3 in bronchial epithelial cells and lung function in IPF patients, supporting the concept that NFATc3 is activated in the early stages of IPF. We further show that there is a significant positive correlation between NFATc3 mRNA expression and VIP RNA expression only in lungs from IPF patients. In addition, we found that VIP inhibits NFAT nuclear translocation in primary human pulmonary artery smooth muscle cells (PASMC). Early activation of NFATc3 in IPF patients may contribute to disease progression and the increase in VIP expression could be a protective compensatory mechanism.	[Szema, Anthony M.; Dwyer, Debra Sabatini] SUNY Stony Brook, Coll Engn & Appl Sci, Dept Technol & Soc, Stony Brook, NY 11794 USA; [Szema, Anthony M.] John T Mather Mem Hosp, Stony Brook Med SUNY, Stony Brook Internal Med Residency Program, Port Jefferson, NY USA; [Szema, Anthony M.] Hofstra Univ, Dept Occupat Med Epidemiol & Prevent Med, Hofstra Northwell Sch Med, Hempstead, NY 11550 USA; [Szema, Anthony M.] Hofstra Univ, Dept Occupat Med Epidemiol & Prevent Med, Hofstra Northwell Sch Med, Manhasset, NY USA; [Szema, Anthony M.; Li, Jonathan C.] Three Village Allergy & Asthma PLLC, South Setauket, NY USA; [Szema, Anthony M.] Columbia Univ, Child Psychiat Epidemiol Grp, New York, NY USA; [Forsyth, Edward; Ying, Benjamin] SUNY Stony Brook, Sch Med, MD Scholarly Recognit Program, Stony Brook, NY 11794 USA; [Hamidi, Sayyed A.] Bronx Vet Affairs Med Ctr, Internal Med Residency Program, Dept Internal Med, Bronx, NY USA; [Chen, John J.] Univ Hawaii, Biostat & Data Management Core, John A Burns Sch Med, Honolulu, HI 96822 USA; [Hwang, Sonya] SUNY Stony Brook, Sch Med, Dept Pathol, Stony Brook, NY 11794 USA; [Ramiro-Diaz, Juan M.; Giermakowska, Wieslawa; Bosc, Laura V. Gonzalez] Univ New Mexico, Hlth Sci Ctr, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Hofstra University; Northwell Health; Hofstra University; Northwell Health; Columbia University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; University of Hawaii System; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of New Mexico; University of New Mexico's Health Sciences Center	Bosc, LVG (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA.	lgonzalezbosc@salud.unm.edu	chen, JJ/HGB-6029-2022	Forsyth, Edward/0000-0002-8974-2929; Li, Jonathan/0000-0002-0916-6678	NIH Lung Tissue Research Consortium (LTRC) [08-99-0002]; NIH [R01 HL088151-05]; Three Village Allergy Asthma, PLLC; National Institute on Minority Health and Health Disparities [U54MD007584] Funding Source: NIH RePORTER	NIH Lung Tissue Research Consortium (LTRC); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Three Village Allergy Asthma, PLLC; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	NIH Lung Tissue Research Consortium (LTRC) concept sheet number 08-99-0002. "Gene deficiency of Vasoactive Intestinal Peptide in COPD patients with pulmonary artery hypertension" to Anthony Szema, M.D (PI). NIH R01 HL088151-05 "NFATc3 in Chronic Pulmonary Hypertension" to Laura Gonzalez Bosc, Ph.D (PI). Three Village Allergy & Asthma, PLLC provided support in the form of salaries only for A.M.S., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Adir Y, 2014, CURRENT OPINION PULM, V20; Amberg GC, 2004, J BIOL CHEM, V279, P47326, DOI 10.1074/jbc.M408789200; Bahr TM, 2013, AM J RESP CELL MOL, V49, P316, DOI 10.1165/rcmb.2012-0230OC; Bierer R, 2011, AM J PHYSL LUNG CELL; Bonnet S, 2007, P NATL ACAD SCI USA, V104, P11418, DOI 10.1073/pnas.0610467104; Bosc LVG, 2005, J BIOL CHEM, V280, P26113, DOI 10.1074/jbc.M411972200; Braz JC, 2003, J CLIN INVEST, V111, P1475, DOI 10.1172/JCI200317295; Burger CD, 2009, COPD, V6, P137, DOI 10.1080/15412550902754252; Chilosi M, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-3; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; de Frutos S, 2008, AM J PHYSIOL-HEART C, V294, pH2382, DOI 10.1152/ajpheart.00132.2008; de Frutos S, 2007, J BIOL CHEM, V282, P15081, DOI 10.1074/jbc.M702679200; de Frutos S, 2011, AM J PHYSIOL-CELL PH, V301, pC441, DOI 10.1152/ajpcell.00029.2011; de Frutos S, 2009, AM J PHYSIOL-LUNG C, V297, pL475, DOI 10.1152/ajplung.00060.2009; Friedman JK, 2014, VASC PHARMACOL, V60, P17, DOI 10.1016/j.vph.2013.11.001; Grundy S, 2014, CLIN SCI, V126, P223, DOI 10.1042/CS20130152; HAMASAKI Y, 1983, J APPL PHYSIOL, V54, P1607, DOI 10.1152/jappl.1983.54.6.1607; Hamidi SA, 2008, EUR RESP SOC ANN C; Hamidi SA, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-141; Hanumegowda C, 2012, CHEST, V142, P200, DOI 10.1378/chest.11-1962; Harkness LM, 2014, PULM PHARMACOL THER, V29, P144, DOI 10.1016/j.pupt.2014.09.003; Hilaire RCS, 2009, PEPTIDES, V30, P2323, DOI 10.1016/j.peptides.2009.08.010; Hou XH, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-2; KEITH IM, 1992, EXP LUNG RES, V18, P205, DOI 10.3109/01902149209031681; Koga M, 2014, J APPL PHYSIOL, V117, P383, DOI 10.1152/japplphysiol.00861.2013; MacNee William, 2005, Proc Am Thorac Soc, V2, P258, DOI 10.1513/pats.200504-045SR; Minami T, 2013, CELL REP, V4, P709, DOI 10.1016/j.celrep.2013.07.021; NANDIWADA PA, 1985, J APPL PHYSIOL, V58, P1723, DOI 10.1152/jappl.1985.58.5.1723; Nieves-Cintron M, 2007, J BIOL CHEM, V282, P3231, DOI 10.1074/jbc.M608822200; Paulin R, 2011, CIRCULATION, V123, P1205, DOI 10.1161/CIRCULATIONAHA.110.963314; Petkov V, 2003, J CLIN INVEST, V111, P1339, DOI 10.1172/JCI200317500; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; SAGA T, 1984, T ASSOC AM PHYSICIAN, V97, P304; Said SI, 2008, ANN NY ACAD SCI, V1144, P148, DOI 10.1196/annals.1418.014; Said SI, 1998, ANN NY ACAD SCI, V865, P582, DOI 10.1111/j.1749-6632.1998.tb11240.x; Senavirathna LK, 2016, FASEB J, V30; Suehiro J, 2014, J BIOL CHEM, V289, P29044, DOI 10.1074/jbc.M114.555235; Urso K, 2011, BLOOD, V118, P795, DOI 10.1182/blood-2010-12-322701; Wolters PJ, 2014, ANNU REV PATHOL-MECH, V9, P157, DOI 10.1146/annurev-pathol-012513-104706	39	11	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170606	10.1371/journal.pone.0170606	http://dx.doi.org/10.1371/journal.pone.0170606			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125639	gold, Green Published, Green Submitted			2022-12-26	WOS:000396176100088
J	Wang, KJ; Vijay, V; Fuscoe, JC				Wang, Kejian; Vijay, Vikrant; Fuscoe, James C.			Stably Expressed Genes Involved in Basic Cellular Functions	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; MOUSE PHENOTYPING CONSORTIUM; CANCER; VARIANTS; DISEASE	Stably Expressed Genes (SEGs) whose expression varies within a narrow range may be involved in core cellular processes necessary for basic functions. To identify such genes, we re-analyzed existing RNA-Seq gene expression profiles across 11 organs at 4 developmental stages (from immature to old age) in both sexes of F344 rats (n = 4/group; 320 samples). Expression changes (calculated as the maximum expression/minimum expression for each gene) of > 19000 genes across organs, ages, and sexes ranged from 2.35 to > 10(9) fold, with a median of 165-fold. The expression of 278 SEGs was found to vary <= 4-fold and these genes were significantly involved in protein catabolism (proteasome and ubiquitination), RNA transport, protein processing, and the spliceosome. Such stability of expression was further validated in human samples where the expression variability of the homologous human SEGs was significantly lower than that of other genes in the human genome. It was also found that the homologous human SEGs were generally less subject to non-synonymous mutation than other genes, as would be expected of stably expressed genes. We also found that knockout of SEG homologs in mouse models was more likely to cause complete preweaning lethality than non-SEG homologs, corroborating the fundamental roles played by SEGs in biological development. Such stably expressed genes and pathways across life-stages suggest that tight control of these processes is important in basic cellular functions and that perturbation by endogenous (e.g., genetics) or exogenous agents (e.g., drugs, environmental factors) may cause serious adverse effects.	[Wang, Kejian; Vijay, Vikrant; Fuscoe, James C.] US FDA, Div Syst Biol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA	US Food & Drug Administration (FDA)	Fuscoe, JC (corresponding author), US FDA, Div Syst Biol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.	James.Fuscoe@fda.hhs.gov	Vijay, Vikrant/E-7651-2010	Vijay, Vikrant/0000-0001-8425-1285; Wang, Kejian/0000-0003-4221-2485				Agarwal S, 2004, ARTHRITIS RHEUM-US, V50, P3541, DOI 10.1002/art.20601; Altintas DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066278; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bradley A, 2012, MAMM GENOME, V23, P580, DOI 10.1007/s00335-012-9422-2; Brown SDM, 2012, DIS MODEL MECH, V5, P289, DOI 10.1242/dmm.009878; Chen D, 2010, CURR PROTEIN PEPT SC, V11, P459, DOI 10.2174/138920310791824057; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Escrich E, 2004, MOL CARCINOGEN, V40, P73, DOI 10.1002/mc.20028; Fang H, 2009, METHODS MOL BIOL, V563, P379, DOI 10.1007/978-1-60761-175-2_20; Hasegawa Y, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005428; Hipp MS, 2012, METHODS MOL BIOL, V832, P463, DOI 10.1007/978-1-61779-474-2_33; Itan Y, 2015, P NATL ACAD SCI USA, V112, P13615, DOI 10.1073/pnas.1518646112; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Janssens Nico, 2004, Mol Diagn, V8, P107, DOI 10.2165/00066982-200408020-00005; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kaushik S, 2015, NAT MED, V21, P1406, DOI 10.1038/nm.4001; Kleiger G, 2014, TRENDS CELL BIOL, V24, P352, DOI 10.1016/j.tcb.2013.12.003; Kleinhammer A, 2010, METHOD ENZYMOL, V477, P387, DOI 10.1016/S0076-6879(10)77020-8; Koscielny G, 2014, NUCLEIC ACIDS RES, V42, pD802, DOI 10.1093/nar/gkt977; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Liu LX, 2002, WORLD J GASTROENTERO, V8, P580, DOI 10.3748/wjg.v8.i4.580; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mar JC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002207; Mason EA, 2014, STEM CELL REP, V3, P365, DOI 10.1016/j.stemcr.2014.06.008; Myers JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145322; Onken MD, 2014, CLIN CANCER RES, V20, P2873, DOI 10.1158/1078-0432.CCR-14-0205; Peixoto A, 2004, GENOME RES, V14, P1938, DOI 10.1101/gr.2890204; Prelich G, 2012, GENETICS, V190, P841, DOI 10.1534/genetics.111.136911; Shen M, 2013, EXPERT OPIN THER TAR, V17, P1091, DOI 10.1517/14728222.2013.815728; Shen YZ, 2014, MOL MED REP, V10, P1746, DOI 10.3892/mmr.2014.2396; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Wang JS, 2006, CELL MOL IMMUNOL, V3, P255; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Yang Z, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S14; Yu Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4230	37	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170813	10.1371/journal.pone.0170813	http://dx.doi.org/10.1371/journal.pone.0170813			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125669	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100045
J	Antal, MC; Benardais, K; Samama, B; Auger, C; Schini-Kerth, V; Ghandour, S; Boehm, N				Antal, Maria Cristina; Benardais, Karelle; Samama, Brigitte; Auger, Cyril; Schini-Kerth, Valerie; Ghandour, Said; Boehm, Nelly			Adenylate Cyclase Type III Is Not a Ubiquitous Marker for All Primary Cilia during Development	PLOS ONE			English	Article							BIEDL-SYNDROME PROTEINS; CELL-CYCLE; ADIPOGENIC DIFFERENTIATION; NEURONAL CILIA; LOCALIZATION; RECEPTORS; MICE; CILIOGENESIS; DISEASE; GASTRIN	Adenylate cyclase type III (AC3) is localized in plasma membrane of neuronal primary cilium and can be used as a marker of this cilium. AC3 has also been detected in some other primary cilia such as those of fibroblasts, synoviocytes or astrocytes. Despite the presence of a cilium in almost all cell types, we show that AC3 is not a common marker of all primary cilia of different human and mouse tissues during development. In peripheral organs, AC3 is present mainly in primary cilia in cells of the mesenchymal lineage (fibroblasts, chondroblasts, osteoblasts-osteocytes, odontoblasts, muscle cells and endothelial cells). In epithelia, the apical cilium of renal and pancreatic tubules and of ductal plate in liver is AC3-negative whereas the cilium of basal cells of stratified epithelia is AC3-positive. Using fibroblasts cell culture, we show that AC3 appears at the plasma membrane of the primary cilium as soon as this organelle develops. The functional significance of AC3 localization at the cilium membrane in some cells but not others has to be investigated in relationship with cell physiology and expression at the cilium plasma membrane of specific upstream receptors.	[Antal, Maria Cristina; Benardais, Karelle; Samama, Brigitte; Boehm, Nelly] Univ Strasbourg, Hist Inst, Fac Med, Serv Cent Microscopie Elect, Strasbourg, France; [Antal, Maria Cristina; Benardais, Karelle; Samama, Brigitte; Boehm, Nelly] FMTS, Strasbourg, France; [Antal, Maria Cristina; Benardais, Karelle; Samama, Brigitte; Boehm, Nelly] Hop Univ Strasbourg, Strasbourg, France; [Antal, Maria Cristina; Benardais, Karelle; Samama, Brigitte; Ghandour, Said] ICube Lab UMR 7357, Team IMIS, Strasbourg, France; [Auger, Cyril; Schini-Kerth, Valerie] Univ Strasbourg, UMR CNRS 7213, Fac Pharm, Lab Biophoton & Pharmacol, Illkirch Graffenstaden, France; [Ghandour, Said] VCU, Anat & Neurobiol, Richmond, VA USA	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Virginia Commonwealth University	Samama, B (corresponding author), Univ Strasbourg, Hist Inst, Fac Med, Serv Cent Microscopie Elect, Strasbourg, France.; Samama, B (corresponding author), FMTS, Strasbourg, France.; Samama, B (corresponding author), Hop Univ Strasbourg, Strasbourg, France.; Samama, B (corresponding author), ICube Lab UMR 7357, Team IMIS, Strasbourg, France.	samama@unistra.fr	Auger, Cyril/N-4702-2016		Programme Hospitalier de Recherche Clinique des Hopitaux Universitaires de Strasbourg	Programme Hospitalier de Recherche Clinique des Hopitaux Universitaires de Strasbourg	Programme Hospitalier de Recherche Clinique des Hopitaux Universitaires de Strasbourg.	Anselm E, 2005, FASEB J, V19, pA1230; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Berbari NF, 2007, J NEUROSCI RES, V85, P1095, DOI 10.1002/jnr.21209; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Brailov I, 2000, BRAIN RES, V872, P271, DOI 10.1016/S0006-8993(00)02519-1; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Chen XM, 2012, J NEUROSCI, V32, P15769, DOI 10.1523/JNEUROSCI.2180-12.2012; Cortes CR, 2015, WIRES DEV BIOL, V4, P637, DOI 10.1002/wdev.199; Dalbay MT, 2015, STEM CELLS, V33, P1952, DOI 10.1002/stem.1975; Domire JS, 2011, CELL MOL LIFE SCI, V68, P2951, DOI 10.1007/s00018-010-0603-4; Forcioli-Conti N, 2015, BIOCHIMIE; Goto H, 2013, CELL MOL LIFE SCI, V70, P3893, DOI 10.1007/s00018-013-1302-8; Handel M, 1999, NEUROSCIENCE, V89, P909, DOI 10.1016/S0306-4522(98)00354-6; Hisamoto M, 2016, BIOMED RES-TOKYO, V37, P207, DOI 10.2220/biomedres.37.207; Irigoin F, 2011, CURR GENOMICS, V12, P285, DOI 10.2174/138920211795860134; Joiner AM, 2015, J NEUROSCI, V35, P13761, DOI 10.1523/JNEUROSCI.1708-15.2015; Kim S, 2011, CELL CYCLE, V10, P2683, DOI 10.4161/cc.10.16.17009; Livera G, 2005, MOL ENDOCRINOL, V19, P1277, DOI 10.1210/me.2004-0318; Lodh S, 2014, BIRTH DEFECTS RES C, V102, P139, DOI 10.1002/bdrc.21063; Marion V, 2009, P NATL ACAD SCI USA, V106, P1820, DOI 10.1073/pnas.0812518106; McGlashan SR, 2006, J HISTOCHEM CYTOCHEM, V54, P1005, DOI 10.1369/jhc.5A6866.2006; Miyoshi K, 2009, BIOCHEM BIOPH RES CO, V388, P757, DOI 10.1016/j.bbrc.2009.08.099; ONOLFO JP, 1987, ANAT REC, V218, P416, DOI 10.1002/ar.1092180409; Ou Y, 2009, EXP CELL RES, V315, P2802, DOI 10.1016/j.yexcr.2009.06.028; Pitaval A, 2010, J CELL BIOL, V191, P303, DOI 10.1083/jcb.201004003; Pitman JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110226; Saqui-Salces M, 2012, FASEB J, V26, P3127, DOI 10.1096/fj.11-197426; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Seeley ES, 2010, J CELL SCI, V123, P511, DOI 10.1242/jcs.061093; Tran PV, 2014, BIRTH DEFECTS RES C, V102, P159, DOI 10.1002/bdrc.21065; TUCKER RW, 1979, CELL, V17, P527, DOI 10.1016/0092-8674(79)90261-7; Vincze E, 2001, J PHYSIOL-PARIS, V95, P99, DOI 10.1016/S0928-4257(01)00014-6; VOROBJEV IA, 1982, J CELL BIOL, V93, P938, DOI 10.1083/jcb.93.3.938; Wang ZS, 2011, J NEUROSCI, V31, P5557, DOI 10.1523/JNEUROSCI.6561-10.2011; Wang ZS, 2011, NEUROPSYCHOPHARMACOL, V36, P772, DOI 10.1038/npp.2010.211; Wang ZS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006979; Wills ES, 2014, TRENDS MOL MED, V20, P261, DOI 10.1016/j.molmed.2014.01.003; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; Zou DJ, 2007, J NEUROSCI, V27, P6675, DOI 10.1523/JNEUROSCI.0699-07.2007	40	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0170756	10.1371/journal.pone.0170756	http://dx.doi.org/10.1371/journal.pone.0170756			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122017	gold, Green Submitted, Green Published			2022-12-26	WOS:000396167300021
J	Rodriguez-Martinez, D; Martinez-Losa, MM; Alvarez-Dolado, M				Rodriguez-Martinez, Daniel; Magdalena Martinez-Losa, Maria; Alvarez-Dolado, Manuel			Cryopreservation of GABAergic Neuronal Precursors for Cell-Based Therapy	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; RAT CEREBRAL-CORTEX; NEURAL STEM; INTERNEURON DYSFUNCTION; CORTICAL INTERNEURONS; BRAIN-TISSUE; CULTURE; LONG; DISEASE; SCHIZOPHRENIA	Cryopreservation protocols are essential for stem cells storage in order to apply them in the clinic. Here we describe a new standardized cryopreservation protocol for GABAergic neural precursors derived from the medial glanglionic eminence (MGE), a promising source of GABAergic neuronal progenitors for cell therapy against interneuron-related pathologies. We used 10% Me2SO as cryoprotectant and assessed the effects of cell culture amplification and cellular organization, as in toto explants, neurospheres, or individualized cells, on post-thaw cell viability and retrieval. We confirmed that in toto cryopreservation of MGE explants is an optimal preservation system to keep intact the interneuron precursor properties for cell transplantation, together with a high cell viability (>80%) and yield (>70%). Post-thaw proliferation and self-renewal of the cryopreserved precursors were tested in vitro. In addition, their migration capacity, acquisition of mature neuronal morphology, and potency to differentiate into multiple interneuron subtypes were also confirmed in vivo after transplantation. The results show that the cryopreserved precursor features remained intact and were similar to those immediately transplanted after their dissection from the MGE. We hope this protocol will facilitate the generation of biobanks to obtain a permanent and reliable source of GABAergic precursors for clinical application in cell-based therapies against interneuronopathies.	[Rodriguez-Martinez, Daniel; Magdalena Martinez-Losa, Maria; Alvarez-Dolado, Manuel] CSIC, Andalusian Ctr Mol Biol & Regenerat Med CABIMER, Lab Cell Based Therapy Neuropathol, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER)	Alvarez-Dolado, M (corresponding author), CSIC, Andalusian Ctr Mol Biol & Regenerat Med CABIMER, Lab Cell Based Therapy Neuropathol, Seville, Spain.	manuel.alvarez@cabimer.es	Rodriguez-Martinez, Daniel/C-2627-2017; Alvarez-Dolado, Manuel/C-2706-2017	Rodriguez-Martinez, Daniel/0000-0002-8412-4574; Alvarez-Dolado, Manuel/0000-0002-0655-8289	Ministerio de Economia y Competitividad [SAF 09-07746, 12- 36853]; Junta de Andalucia [CTS-2563]; Ramon Areces Fundation; Carlos III Health Institute	Ministerio de Economia y Competitividad(Spanish Government); Junta de Andalucia(Junta de Andalucia); Ramon Areces Fundation; Carlos III Health Institute(Instituto de Salud Carlos III)	This work was supported by the Ministerio de Economia y Competitividad (SAF 09-07746 y 12- 36853), Junta de Andalucia (CTS-2563), and Ramon Areces Fundation. DR and MM-L were respectively recipients of a Formative and a Sara Borrell fellowship from the Carlos III Health Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dolado MA, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/384216; Alvarez-Dolado M, 2006, J NEUROSCI, V26, P7380, DOI 10.1523/JNEUROSCI.1540-06.2006; Arber C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00010; Chong YK, 2009, STEM CELLS, V27, P29, DOI 10.1634/stemcells.2008-0009; COLLIER TJ, 1993, BRAIN RES, V623, P249, DOI 10.1016/0006-8993(93)91435-U; Fahy GM, 2015, METHODS MOL BIOL, V1257, P21, DOI 10.1007/978-1-4939-2193-5_2; Fuller BJ, 2004, CRYOLETTERS, V25, P375; Grandbarbe L, 2003, DEVELOPMENT, V130, P1391, DOI 10.1242/dev.00374; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Henderson KW, 2014, J NEUROSCI, V34, P13492, DOI 10.1523/JNEUROSCI.0005-14.2014; Howard MA, 2016, J NEUROPHYSIOL; Hunt RF, 2015, COLD SPRING HARB PER, V5; Jacob J, 2016, EPILEPSIA, V57, P182, DOI 10.1111/epi.13272; JENSEN S, 1987, CRYOBIOLOGY, V24, P120, DOI 10.1016/0011-2240(87)90014-9; JUN F, 1992, CRYOBIOLOGY, V29, P267, DOI 10.1016/0011-2240(92)90025-W; Karlsson JOM, 1996, BIOMATERIALS, V17, P243, DOI 10.1016/0142-9612(96)85562-1; KAWAMOTO JC, 1986, BRAIN RES, V384, P84, DOI 10.1016/0006-8993(86)91222-9; Kim TG, 2014, STEM CELLS, V32, P1789, DOI 10.1002/stem.1704; Kuleshova LL, 2009, CELL TRANSPLANT, V18, P135, DOI 10.3727/096368909788341298; Liu AG, 2015, ADV EXP MED BIOL, V864, P55, DOI 10.1007/978-3-319-20579-3_5; Ma XH, 2010, CRYOBIOLOGY, V60, P184, DOI 10.1016/j.cryobiol.2009.10.013; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; MAZUR P, 1984, AM J PHYSIOL, V247, pC125, DOI 10.1152/ajpcell.1984.247.3.C125; Milosevic J, 2005, STEM CELLS, V23, P681, DOI 10.1634/stemcells.2004-0135; Moliner A, 2008, STEM CELLS DEV, V17, P233, DOI 10.1089/scd.2007.0211; Negishi T, 2002, EXP ANIM TOKYO, V51, P383, DOI 10.1538/expanim.51.383; Paynter SJ, 2009, CRYOBIOLOGY, V58, P308, DOI 10.1016/j.cryobiol.2009.02.008; Pegg David E, 2007, Methods Mol Biol, V368, P39; PETITE D, 1995, BRAIN RES, V669, P263, DOI 10.1016/0006-8993(94)01269-N; Petite D, 1997, BRAIN RES, V747, P279, DOI 10.1016/S0006-8993(96)01287-5; Santos NC, 2003, BIOCHEM PHARMACOL, V65, P1035, DOI 10.1016/S0006-2952(03)00002-9; Scharfman HE, 2012, EPILEPSY CURR, V12, P178, DOI 10.5698/1535-7511-12.5.178; Shetty AK, 2016, BRAIN RES, V1638, P74, DOI 10.1016/j.brainres.2015.09.019; SHOLL DA, 1953, J ANAT, V87, P387; SILANI V, 1988, BRAIN RES, V473, P169, DOI 10.1016/0006-8993(88)90331-9; Southwell DG, 2012, NATURE, V491, P109, DOI 10.1038/nature11523; Takano T, 2015, DEV NEUROSCI-BASEL, V37, P467, DOI 10.1159/000434638; Taylor SF, 2015, SCHIZOPHR RES, V167, P84, DOI 10.1016/j.schres.2014.10.011; Tyson JA, 2014, TRENDS NEUROSCI, V37, P169, DOI 10.1016/j.tins.2014.01.003; Vescovi Angelo L, 2002, Methods Mol Biol, V198, P115; Woo SM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-97; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Zipancic I, 2010, CELL TRANSPLANT, V19, P549, DOI 10.3727/096368910X491383	44	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0170776	10.1371/journal.pone.0170776	http://dx.doi.org/10.1371/journal.pone.0170776			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122047	gold, Green Published, Green Submitted			2022-12-26	WOS:000396167300020
J	Saly, D; Yang, A; Triebwasser, C; Oh, J; Sun, QS; Testani, J; Parikh, CR; Bia, J; Biswas, A; Stetson, C; Chaisanguanthum, K; Wilson, FP				Saly, Danielle; Yang, Alina; Triebwasser, Corey; Oh, Janice; Sun, Qisi; Testani, Jeffrey; Parikh, Chirag R.; Bia, Joshua; Biswas, Aditya; Stetson, Chess; Chaisanguanthum, Kris; Wilson, F. Perry			Approaches to Predicting Outcomes in Patients with Acute Kidney Injury	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; RISK; MORTALITY; DIALYSIS; DISEASE; MODELS; SCORE; AKI	Despite recognition that Acute Kidney Injury (AKI) leads to substantial increases in morbidity, mortality, and length of stay, accurate prognostication of these clinical events remains difficult. It remains unclear which approaches to variable selection and model building are most robust. We used data from a randomized trial of AKI alerting to develop time-updated prognostic models using stepwise regression compared to more advanced variable selection techniques. We randomly split data into training and validation cohorts. Outcomes of interest were death within 7 days, dialysis within 7 days, and length of stay. Data elements eligible for model-building included lab values, medications and dosages, procedures, and demographics. We assessed model discrimination using the area under the receiver operator characteristic curve and r-squared values. 2241 individuals were available for analysis. Both modeling techniques created viable models with very good discrimination ability, with AUCs exceeding 0.85 for dialysis and 0.8 for death prediction. Model performance was similar across model building strategies, though the strategy employing more advanced variable selection was more parsimonious. Very good to excellent prediction of outcome events is feasible in patients with AKI. More advanced techniques may lead to more parsimonious models, which may facilitate adoption in other settings.	[Saly, Danielle; Yang, Alina; Sun, Qisi; Testani, Jeffrey; Parikh, Chirag R.; Wilson, F. Perry] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Triebwasser, Corey; Oh, Janice] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Parikh, Chirag R.; Bia, Joshua; Biswas, Aditya; Wilson, F. Perry] Yale Univ, Sch Med, Program Appl Translat Res, New Haven, CT 06520 USA; [Parikh, Chirag R.; Wilson, F. Perry] Vet Affairs Med Ctr, Clin Epidemiol Res Ctr, West Haven, CT 06516 USA; [Stetson, Chess; Chaisanguanthum, Kris] Helynx Inc, Altadena, CA USA	Yale University; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Wilson, FP (corresponding author), Yale Univ, Sch Med, New Haven, CT 06520 USA.; Wilson, FP (corresponding author), Yale Univ, Sch Med, Program Appl Translat Res, New Haven, CT 06520 USA.; Wilson, FP (corresponding author), Vet Affairs Med Ctr, Clin Epidemiol Res Ctr, West Haven, CT 06516 USA.	francis.p.wilson@yale.edu		Parikh, Chirag/0000-0001-9051-7385; Sun, Qisi/0000-0002-0024-5441; Wilson, Francis Perry/0000-0002-2633-2412	 [K23 DK097201];  [K24 DK090203];  [K23HL114868];  [L30HL115790]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL114868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK090203, K23DK097201] Funding Source: NIH RePORTER	; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by K23 DK097201 to FPW, by K24 DK090203 to CRP, and by K23HL114868, L30HL115790 to JT. Helynx, inc employs CS and KC. The funder provided support in the form of salaries for these authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; [Anonymous], 2012, KIDNEY INT SUPPL, V2, P1, DOI [10.1038/kisup.2012.1, DOI 10.1038/KISUP.2012.1]; Boessen R, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-103; Boyle JM, 2006, AM J KIDNEY DIS, V48, P787, DOI 10.1053/j.ajkd.2006.08.002; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Cerda J, 2008, CLIN J AM SOC NEPHRO, V3, P881, DOI 10.2215/CJN.04961107; Chawla LS, 2013, CRIT CARE, V17, DOI 10.1186/cc13015; Chertow GM, 2006, KIDNEY INT, V70, P1120, DOI 10.1038/sj.ki.5001579; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Demirjian S, 2011, CLIN J AM SOC NEPHRO, V6, P2114, DOI 10.2215/CJN.02900311; Frohlich B., 2012, Pattern Recognition and Image Analysis, V22, P113, DOI 10.1134/S1054661812010166; Hsieh CH, 2011, SURGERY, V149, P87, DOI 10.1016/j.surg.2010.03.023; Hsu RK, 2013, J AM SOC NEPHROL, V24, P37, DOI 10.1681/ASN.2012080800; Jackson J. E., 1991, USERS GUIDE PRINCIPA; Jensen PB, 2012, NAT REV GENET, V13, P395, DOI 10.1038/nrg3208; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group, 2013, KIDNEY INT S, V3, P1, DOI [DOI 10.1038/KISUP.2012.73, 10.1038/kisup.2012.48]; Leonard CE, 2012, PHARMACOEPIDEM DR S, V21, P1155, DOI 10.1002/pds.3329; Meng XH, 2013, KAOHSIUNG J MED SCI, V29, P93, DOI 10.1016/j.kjms.2012.08.016; Newson R, 2006, STATA J, V6, P309, DOI 10.1177/1536867X0600600302; Praga M, 2015, NEPHROL DIAL TRANSPL, V30, P1472, DOI 10.1093/ndt/gfu326; Riley RD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001380; Susantitaphong P, 2013, CLIN J AM SOC NEPHRO, V8, P1482, DOI 10.2215/CJN.00710113; Thakar CV, 2005, J AM SOC NEPHROL, V16, P162, DOI 10.1681/ASN.2004040331; Tsai TT, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001380; Uchino S, 2006, CRIT CARE MED, V34, P1913, DOI 10.1097/01.CCM.0000224227.70642.4F; Venkataraman Ramesh, 2007, J Intensive Care Med, V22, P187, DOI 10.1177/0885066607299510; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wilson FP, 2015, LANCET, V385, P1966, DOI 10.1016/S0140-6736(15)60266-5; Wilson FP, 2014, CLIN TRIALS; Wilson FP, 2012, CLIN J AM SOC NEPHRO; Wilson FP, 2013, CLIN J AM SOC NEPHRO, V8, P527, DOI 10.2215/CJN.06450612; Wu JL, 2010, MED CARE, V48, pS106, DOI 10.1097/MLR.0b013e3181de9e17; Yoo TK, 2013, YONSEI MED J, V54, P1321, DOI 10.3349/ymj.2013.54.6.1321	35	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0169305	10.1371/journal.pone.0169305	http://dx.doi.org/10.1371/journal.pone.0169305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122032	Green Submitted, gold, Green Published			2022-12-26	WOS:000396167300077
J	Donovan, KF; Hegde, M; Sullender, M; Vaimberg, EW; Johannessen, CM; Root, DE; Doench, JG				Donovan, Katherine F.; Hegde, Mudra; Sullender, Meagan; Vaimberg, Emma W.; Johannessen, Cory M.; Root, David E.; Doench, John G.			Creation of Novel Protein Variants with CRISPR/Cas9-Mediated Mut agenesis: Turning a Screening By-Product into a Discovery Tool	PLOS ONE			English	Article							MAMMALIAN-CELLS; RAF INHIBITION; CRISPR-CAS9; RESISTANCE; MUTATIONS; REPAIR; DNA	CRISPR/Cas9 screening has proven to be a versatile tool for genomics research. Based on unexpected results from a genome-wide screen, we developed a CRISPR/Cas9-mediated approach to mutagenesis, exploiting the allelic diversity generated by error-prone nonhomologous end-joining (NHEJ) to identify novel gain-of-function and drug resistant alleles of the MAPK signaling pathway genes MEK1 and BRAF. We define the parameters of a scalable technique to easily generate cell populations containing thousands of endogenous allelic variants to map gene functions. Further, these results highlight an unexpected but important phenomenon, that Cas9-induced gain-of-function alleles are an inherent by-product of normal Cas9 loss-of-function screens and should be investigated during analysis of data from large-scale positive selection screens.	[Donovan, Katherine F.; Hegde, Mudra; Sullender, Meagan; Vaimberg, Emma W.; Johannessen, Cory M.; Root, David E.; Doench, John G.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Doench, JG (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	jdoench@broadinstitute.org	Doench, John G/HCI-9570-2022; Doench, John/ABE-6251-2020	Doench, John G/0000-0002-3707-9889; Doench, John/0000-0002-3707-9889; Sullender, Meagan/0000-0001-6666-8650	Next Generation Fund at the Broad Institute of MIT and Harvard	Next Generation Fund at the Broad Institute of MIT and Harvard	This study was funded by the Next Generation Fund at the Broad Institute of MIT and Harvard (JGD, Merkin Institute Fellow). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Findlay GM, 2014, NATURE, V513, P120, DOI 10.1038/nature13695; Fischmann TO, 2009, BIOCHEMISTRY-US, V48, P2661, DOI 10.1021/bi801898e; Foster SA, 2016, CANCER CELL, V29, P477, DOI 10.1016/j.ccell.2016.02.010; Fowler DM, 2014, NAT METHODS, V11, P801, DOI [10.1038/NMETH.3027, 10.1038/nmeth.3027]; Hess GT, 2016, NAT METHODS, V13, P1036, DOI [10.1038/NMETH.4038, 10.1038/nmeth.4038]; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kitzman JO, 2015, NAT METHODS, V12, P203, DOI [10.1038/NMETH.3223, 10.1038/nmeth.3223]; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Ma YQ, 2016, NAT METHODS, V13, P1029, DOI [10.1038/NMETH.4027, 10.1038/nmeth.4027]; Melnikov A, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku511; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; van Overbeek M, 2016, MOL CELL, V63, P633, DOI 10.1016/j.molcel.2016.06.037; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]	20	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2017	12	1							e0170445	10.1371/journal.pone.0170445	http://dx.doi.org/10.1371/journal.pone.0170445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7CU	28118392	Green Published, Green Submitted, gold			2022-12-26	WOS:000396160500033
J	Raifu, AO; El-Zein, M; Sangwa-Lugoma, G; Ramanakumar, A; Walter, SD; Franco, EL				Raifu, Amidu O.; El-Zein, Mariam; Sangwa-Lugoma, Ghislain; Ramanakumar, Agnihotram; Walter, Stephen D.; Franco, Eduardo L.		Congo Screening Study Grp	Determinants of Cervical Cancer Screening Accuracy for Visual Inspection with Acetic Acid (VIA) and Lugol's Iodine (VILI) Performed by Nurse and Physician	PLOS ONE			English	Article							RISK-FACTORS; WOMEN; SPECIFICITY; SENSITIVITY; POSITIVITY; TESTS	Background Visual inspection with acetic acid (VIA) and Lugol's iodine (VILI) are used to screen women for cervical cancer in low-resource settings. Little is known about correlates of their diagnostic accuracy by healthcare provider. We examined determinants of VIA and VILI screening accuracy by examiner in a cross-sectional screening study of 1528 women aged 30 years or older in a suburb of Kinshasa, Democratic Republic of Congo. Methods We used a logistic regression model for sensitivity and specificity to estimate the diagnostic accuracy of VIA and VILI, independently performed by nurse and physician, as a function of sociodemographic and reproductive health characteristics. Results Nurses rated tests as positive more often than physicians (36.3% vs 30.2% for VIA, 26.2% vs 25.2% for VILI). Women's age was the most important determinant of performance. It was inversely associated with sensitivity (nurse's VIA: p<0.001, nurse's VILI: p = 0.018, physician's VIA: p = 0.005, physician's VILI: p = 0.006) but positively associated with specificity (all four combinations: p<0.001). Increasing parity adversely affected sensitivity and specificity, but the effects on sensitivity were significant for nurses only. The screening performance of physician's assessment was significantly better than the nurse's (difference in sensitivity: VIA = 13%, VILI = 16%; difference in specificity: VIA = 6%, VILI = 1%). Conclusions Age and parity influence the performance of visual tests for cervical cancer screening. Proper training of local healthcare providers in the conduct of these tests should take into account these factors for improved performance of VIA and VILI in detecting cervical precancerous lesions among women in limited-resource settings.	[Raifu, Amidu O.] Western Univ, Dept Epidemiol & Biostat, Hamilton, ON, Canada; [El-Zein, Mariam; Ramanakumar, Agnihotram; Franco, Eduardo L.] McGill Univ, Dept Oncol, Div Canc Epidemiol, Montreal, PQ, Canada; [Sangwa-Lugoma, Ghislain] Univ Kinshasa, Dept Obstet & Gynaecol, Kinshasa, DEM REP CONGO; [Walter, Stephen D.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	McGill University; Universite de Kinshasa; McMaster University	Franco, EL (corresponding author), McGill Univ, Dept Oncol, Div Canc Epidemiol, Montreal, PQ, Canada.	eduardo.franco@mcgill.ca	Walter, Stephen/AAB-5548-2022; Franco, Eduardo/C-6445-2014	Walter, Stephen/0000-0003-4157-8928; Franco, Eduardo/0000-0002-4409-8084	Program for Appropriate Technology in Health (PATH); International Agency for Research on Cancer Postdoctoral Fellowship; Cancer Research Society Division of Epidemiology	Program for Appropriate Technology in Health (PATH); International Agency for Research on Cancer Postdoctoral Fellowship; Cancer Research Society Division of Epidemiology	Financial support for the Congo Cervical Screening Study was provided by the Program for Appropriate Technology in Health (PATH) (Grant to Ghislain Sangwa-Lugoma), an International Agency for Research on Cancer Postdoctoral Fellowship (to Ghislain Sangwa-Lugoma), and by the Cancer Research Society Division of Epidemiology.	[Anonymous], 1962, FED PROC, V21, P58; Arbyn M, 2007, ANN ONCOL, V18, P1708, DOI 10.1093/annonc/mdm079; Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Arbyn M, 2008, INT J CANCER, V123, P153, DOI 10.1002/ijc.23489; Bhatla N, 2004, Indian J Cancer, V41, P32; Castle PE, 2014, BJOG-INT J OBSTET GY, V121, P739, DOI 10.1111/1471-0528.12646; COUGHLIN SS, 1992, J CLIN EPIDEMIOL, V45, P1, DOI 10.1016/0895-4356(92)90180-U; Cremer M, 2011, INT J GYNECOL OBSTET, V113, P68, DOI 10.1016/j.ijgo.2010.10.018; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Denny L, 2006, VACCINE, V24, P71, DOI 10.1016/j.vaccine.2006.05.121; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Franco EL, 2000, CLIN LAB MED, V20, P345; Kahesa C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1055; Mahe C, 2005, CANCER CAUSE CONTROL, V16, P657, DOI 10.1007/s10552-005-0296-4; Mahmud SM, 2012, GYNECOL ONCOL, V124, P286, DOI 10.1016/j.ygyno.2011.10.031; Ogunbowale T, 2008, AUST J RURAL HEALTH, V16, P338, DOI 10.1111/j.1440-1584.2008.01013.x; Parashari A, 2013, ASIAN PAC J CANCER P, V14, P7761, DOI 10.7314/APJCP.2013.14.12.7761; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Sangiva-Lugoma G, 2006, INT J CANCER, V119, P1389, DOI 10.1002/ijc.21972; Sangwa-Lugoma G, 2011, SEX TRANSM DIS, V38, P308, DOI 10.1097/OLQ.0b013e3181fc6ec0; Sankaranarayanan R, 2004, INT J CANCER, V110, P907, DOI 10.1002/ijc.20190; Sankaranarayanan R, 2012, BEST PRACT RES CL OB, V26, P221, DOI 10.1016/j.bpobgyn.2011.08.003; Sellors JW, 2002, OBSTET GYNECOL, V99, P635, DOI 10.1016/S0029-7844(01)01767-7; Sherigar B, 2010, ASIAN PAC J CANCER P, V11, P323; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Vedantham H, 2010, CANCER EPIDEM BIOMAR, V19, P1373, DOI 10.1158/1055-9965.EPI-09-1282; Zhou XH, 1998, J ROY STAT SOC C-APP, V47, P135, DOI 10.1111/1467-9876.00102	27	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170631	10.1371/journal.pone.0170631	http://dx.doi.org/10.1371/journal.pone.0170631			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107486	Green Submitted, Green Published, gold			2022-12-26	WOS:000392405300175
J	Moloney, EB; Hobo, B; De Winter, F; Verhaagen, J				Moloney, Elizabeth B.; Hobo, Barbara; De Winter, Fred; Verhaagen, Joost			Expression of a Mutant SEMA3A Protein with Diminished Signalling Capacity Does Not Alter ALS-Related Motor Decline, or Confer Changes in NMJ Plasticity after BotoxA-Induced Paralysis of Male Gastrocnemic Muscle	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; G93A MOUSE MODEL; NEUROMUSCULAR SYNAPSE ELIMINATION; SKELETAL-MUSCLE; AXON GUIDANCE; BOTULINUM TOXIN; GROWTH-HORMONE; SEMAPHORIN 3A; UNIT LOSS; MULTIPLE INNERVATION	Terminal Schwann cells (TSCs) are specialized cells that envelop the motor nerve terminal, and play a role in the maintenance and regeneration of neuromuscular junctions (NMJs). The chemorepulsive protein semaphorin 3A (SEMA3A) is selectively up-regulated in TSCs on fast-fatigable muscle fibers following experimental denervation of the muscle (BotoxAinduced paralysis or crush injury to the sciatic nerve) or in the motor neuron disease amyotrophic lateral sclerosis (ALS). Re-expression of SEMA3A in this subset of TSCs is thought to play a role in the selective plasticity of nerve terminals as observed in ALS and following BotoxA-induced paralysis. Using a mouse model expressing a mutant SEMA3A with diminished signaling capacity, we studied the influence of SEMA3A signaling at the NMJ with two denervation paradigms; a motor neuron disease model (the G93A-hSOD1 ALS mouse line) and an injury model (BotoxA-induced paralysis). ALS mice that either expressed 1 or 2 mutant SEMA3A alleles demonstrated no difference in ALS-induced decline in motor behavior. We also investigated the effects of BotoxA-induced paralysis on the sprouting capacity of NMJs in the K108N-SEMA3A mutant mouse, and observed no change in the differential neuronal plasticity found at NMJs on fast-fatigable or slow muscle fibers due to the presence of the SEMA3A mutant protein. Our data may be explained by the residual repulsive activity of the mutant SEMA3A, or it may imply that SEMA3A alone is not a key component of the molecular signature affecting NMJ plasticity in ALS or BotoxA-induced paralysis. Interestingly, we did observe a sex difference in motor neuron sprouting behavior after BotoxAinduced paralysis in WT mice which we speculate may be an important factor in the sex dimorphic differences seen in ALS.	[Moloney, Elizabeth B.; Hobo, Barbara; De Winter, Fred; Verhaagen, Joost] Netherlands Inst Neurosci, Dept Regenerat Sensorimotor Syst, Amsterdam, Netherlands; [De Winter, Fred] Leiden Univ, Dept Neurosurg, Med Ctr, Leiden, Netherlands; [Verhaagen, Joost] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam	Verhaagen, J (corresponding author), Netherlands Inst Neurosci, Dept Regenerat Sensorimotor Syst, Amsterdam, Netherlands.; Verhaagen, J (corresponding author), Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Amsterdam, Netherlands.	j.verhaagen@nin.knaw.nl	De Winter, Fred/AAZ-8671-2020; Verhaagen, Joost/G-4773-2012	De Winter, Fred/0000-0002-3042-2429; Moloney, Elizabeth/0000-0003-0746-5081	EU	EU(European Commission)	This work was supported by EU Seventh Framework Program (FP7) Marie Curie Actions (AxRegen) 2008-2012 to JV. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuwaijri S, 2004, ENDOCRINE, V25, P27, DOI 10.1385/ENDO:25:1:27; Alves CJ, 2011, BRAIN RES, V1394, P90, DOI 10.1016/j.brainres.2011.02.060; ANGAUTPETIT D, 1990, NEUROSCIENCE, V37, P799, DOI 10.1016/0306-4522(90)90109-H; Ball SG, 2010, BIOCHEM J, V427, P29, DOI 10.1042/BJ20091512; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Blasco H, 2012, AMYOTROPH LATERAL SC, V13, P585, DOI 10.3109/17482968.2012.706303; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; de Jong S, 2013, J NEUROL, V260, P507, DOI 10.1007/s00415-012-6665-5; De Winter F, 2006, MOL CELL NEUROSCI, V32, P102, DOI 10.1016/j.mcn.2006.03.002; DUCHEN LW, 1970, J NEUROL NEUROSUR PS, V33, P40, DOI 10.1136/jnnp.33.1.40; DUCHEN LW, 1971, J NEUROL SCI, V14, P47, DOI 10.1016/0022-510X(71)90129-8; Duplan L, 2010, J NEUROSCI, V30, P785, DOI 10.1523/JNEUROSCI.5411-09.2010; Frey D, 2000, J NEUROSCI, V20, P2534; Giacobini P, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001808; Glinka Y, 2008, J LEUKOCYTE BIOL, V84, P302, DOI 10.1189/jlb.0208090; Gluzman-Poltorak Z, 2000, J BIOL CHEM, V275, P18040, DOI 10.1074/jbc.M909259199; Good PF, 2004, J NEUROCHEM, V91, P716, DOI 10.1111/j.1471-4159.2004.02766.x; Gu CH, 2013, EXP CELL RES, V319, P1306, DOI 10.1016/j.yexcr.2013.02.003; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hadano S, 2010, NEUROSCI RES, V68, P131, DOI 10.1016/j.neures.2010.06.004; Hegedus J, 2008, J PHYSIOL-LONDON, V586, P3337, DOI 10.1113/jphysiol.2007.149286; Hegedus J, 2007, NEUROBIOL DIS, V28, P154, DOI 10.1016/j.nbd.2007.07.003; Hegedus J, 2009, MUSCLE NERVE, V39, P318, DOI 10.1002/mus.21160; Heiman-Patterson TD, 2005, J NEUROL SCI, V236, P1, DOI 10.1016/j.jns.2005.02.006; Hensley K, 2011, MOL NEUROBIOL, V43, P180, DOI 10.1007/s12035-011-8166-4; Huber AB, 2005, NEURON, V48, P949, DOI 10.1016/j.neuron.2005.12.003; JORDAN CL, 1989, J NEUROSCI, V9, P229; JORDAN CL, 1989, J NEUROSCI, V9, P239; Jun G, 2014, ANN NEUROL; Juzans P, 1996, NEUROMUSCULAR DISORD, V6, P177, DOI 10.1016/0960-8966(96)00041-7; Kanning KC, 2010, ANNU REV NEUROSCI, V33, P409, DOI 10.1146/annurev.neuro.051508.135722; Klover P, 2009, FASEB J, V23, P3140, DOI 10.1096/fj.08-128215; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Lesnick TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001449; Lin L, 2009, TRENDS NEUROSCI, V32, P142, DOI 10.1016/j.tins.2008.11.006; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Manzano R, 2011, J CELL BIOCHEM, V112, P2825, DOI 10.1002/jcb.23197; McCombe PA, 2010, GENDER MED, V7, P557, DOI 10.1016/j.genm.2010.11.010; Melcangi RC, 2005, BRAIN RES REV, V48, P328, DOI 10.1016/j.brainresrev.2004.12.021; Merte J, 2010, J NEUROSCI, V30, P5767, DOI 10.1523/JNEUROSCI.5061-09.2010; Messina Andrea, 2013, Front Endocrinol (Lausanne), V4, P133, DOI 10.3389/fendo.2013.00133; Miana-Mena FJ, 2005, AMYOTROPH LATERAL SC, V6, P55, DOI 10.1080/14660820510026162; Moloney EB, 2012, SOC NEUROSCI PROGR N; Moloney EB, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00252; Moret F, 2007, DEVELOPMENT, V134, P4491, DOI 10.1242/dev.011452; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Naumenko N, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00026; Ophoff J, 2009, ENDOCRINOLOGY, V150, P3558, DOI 10.1210/en.2008-1509; PARRY DJ, 1990, CAN J PHYSIOL PHARM, V68, P596, DOI 10.1139/y90-086; Pasterkamp RJ, 1998, J NEUROSCI, V18, P9962; Pette D, 2001, HISTOCHEM CELL BIOL, V115, P359, DOI 10.1007/s004180100268; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Rocha MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073846; Rogozhin AA, 2008, J PHYSIOL-LONDON, V586, P3163, DOI 10.1113/jphysiol.2008.153569; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Santafe MM, 2000, NEUROSCIENCE, V95, P227; Schomburg ED, 2011, MUSCLE NERVE, V43, P230, DOI 10.1002/mus.21835; Sharma A, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00028; SON YJ, 1995, NEURON, V14, P125, DOI 10.1016/0896-6273(95)90246-5; SON YJ, 1995, NEURON, V14, P133, DOI 10.1016/0896-6273(95)90247-3; Son YJ, 1996, TRENDS NEUROSCI, V19, P280, DOI 10.1016/S0166-2236(96)10032-1; Steyn FJ, 2013, ENDOCRINOLOGY, V154, P4695, DOI 10.1210/en.2013-1570; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Ustunel I, 2003, ANAT HISTOL EMBRYOL, V32, P70, DOI 10.1046/j.1439-0264.2003.00441.x; Van Battum EY, 2015, LANCET NEUROL, V14, P532, DOI 10.1016/S1474-4422(14)70257-1; Veldhuis JD, 1998, GROWTH HORM IGF RES, V8, P49, DOI 10.1016/S1096-6374(98)80024-5; Veldink JH, 2003, NEUROMUSCULAR DISORD, V13, P737, DOI 10.1016/S0960-8966(03)00104-4; Venkova K, 2014, J NEUROPATH EXP NEUR, V73, P702, DOI 10.1097/NEN.0000000000000086; Villa C, 2010, NEUROL SCI, V31, P169, DOI 10.1007/s10072-009-0200-1; Wang Y, 2012, J APPL PHYSIOL, V113, P1902, DOI 10.1152/japplphysiol.01515.2011; Weydt P, 2003, NEUROREPORT, V14, P1051, DOI 10.1097/01.wnr.0000073685.00308.89; Zhou C, 2007, AMYOTROPH LATERAL SC, V8, P366, DOI 10.1080/17482960701538759	73	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170314	10.1371/journal.pone.0170314	http://dx.doi.org/10.1371/journal.pone.0170314			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103314	Green Submitted, Green Published, gold			2022-12-26	WOS:000392381100054
J	Mercer, SW; Wang, JB; Burke, R				Mercer, Stephen W.; Wang, Jianbin; Burke, Richard			In Vivo Modeling of the Pathogenic Effect of Copper Transporter Mutations That Cause Menkes and Wilson Diseases, Motor Neuropathy, and Susceptibility to Alzheimer's Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANDIDATE GENE; MOLECULAR-BASIS; ATPASE ATP7B; MUTANT ATP7B; PROTEIN; LOCALIZATION; TRAFFICKING; DROSOPHILA; HOMEOSTASIS; ROLES	Copper is an essential biometal, and several inherited diseases are directly associated with a disruption to normal copper homeostasis. The best characterized are the copper deficiency and toxicity disorders Menkes and Wilson diseases caused by mutations in the p-type Cu-ATPase genes ATP7A and ATP7B, respectively. Missense mutations in the C-terminal portion of ATP7A have also been shown to cause distal motor neuropathy, whereas polymorphisms inATP7Bare associated with increased risk of Alzheimer's disease. We have generated a single, in vivo model for studying multiple pathogenic mutations inATP7proteins using Drosophila melanogaster, which has a single orthologue of ATP7A and ATP7B. Four pathogenic ATP7A mutations and two ATP7B mutations were introduced into a genomic ATP7 rescue construct containing an in-frame C-terminal GFP tag. Analysis of the wild type ATP7-GFP transgene confirmed that ATP7 is expressed at the basolateral membrane of larval midgut copper cells and that the transgene can rescue a normally early lethal ATP7 deletion allele to adulthood. Analysis of the gATP7-GFP transgenes containing pathogenic mutations showed that the function of ATP7 was affected, to varying degrees, by all six of the mutations investigated in this study. Of particular interest, the ATP7B(K832R) Alzheimer's disease susceptibility allele was found, for the first time, to be a loss of function allele. This in vivo system allows us to assess the severity of individual ATP7A/ B mutations in an invariant genetic background and has the potential to be used to screen for therapeutic compounds able to restore function to faulty copper transport proteins.	[Mercer, Stephen W.; Wang, Jianbin; Burke, Richard] Monash Univ, Sch Biol Sci, Wellington Rd, Clayton, Vic 3800, Australia	Monash University	Burke, R (corresponding author), Monash Univ, Sch Biol Sci, Wellington Rd, Clayton, Vic 3800, Australia.	richard.burke@monash.edu		Burke, Richard/0000-0003-0086-0767	Australian National Health and Medical Research Council Project [RB 606609]	Australian National Health and Medical Research Council Project(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian National Health and Medical Research Council Project Grant RB 606609. The authors declare that they have no conflicts of interest with the contents of this article.	Ambrosini L, 1999, HUM MOL GENET, V8, P1547, DOI 10.1093/hmg/8.8.1547; Balamurugan K, 2007, EMBO J, V26, P1035, DOI 10.1038/sj.emboj.7601543; Barnes N, 2005, J BIOL CHEM, V280, P9640, DOI 10.1074/jbc.M413840200; Braiterman LT, 2014, P NATL ACAD SCI USA, V111, pE1364, DOI 10.1073/pnas.1314161111; Bucossi S, 2012, J ALZHEIMERS DIS, V29, P913, DOI 10.3233/JAD-2012-111997; Burke R, 2008, INT J BIOCHEM CELL B, V40, P1850, DOI 10.1016/j.biocel.2008.01.021; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; de Bie P, 2007, J MED GENET, V44, P673, DOI 10.1136/jmg.2007.052746; Forbes JR, 1998, AM J HUM GENET, V63, P1663, DOI 10.1086/302163; Forbes JR, 2000, HUM MOL GENET, V9, P1927, DOI 10.1093/hmg/9.13.1927; Grimes A, 1997, HUM MOL GENET, V6, P1037, DOI 10.1093/hmg/6.7.1037; Gromadzka G, 2006, MOVEMENT DISORD, V21, P245, DOI 10.1002/mds.20671; HUNT DM, 1974, NATURE, V249, P852, DOI 10.1038/249852a0; Huster D, 2003, GASTROENTEROLOGY, V124, P335, DOI 10.1053/gast.2003.50066; Jones MWM, 2015, J BIOL INORG CHEM, V20, P979, DOI 10.1007/s00775-015-1281-3; KALER SG, 1994, NAT GENET, V8, P195, DOI 10.1038/ng1094-195; Kaler SG, 2011, NAT REV NEUROL, V7, P15, DOI 10.1038/nrneurol.2010.180; Kambe T, 2008, GENESIS, V46, P214, DOI 10.1002/dvg.20382; Kennerson ML, 2010, AM J HUM GENET, V86, P343, DOI 10.1016/j.ajhg.2010.01.027; La Fontaine S, 2010, INT J BIOCHEM CELL B, V42, P206, DOI 10.1016/j.biocel.2009.11.007; LEVINSON B, 1994, NAT GENET, V6, P369, DOI 10.1038/ng0494-369; Lutsenko S, 2002, J BIOENERG BIOMEMBR, V34, P351, DOI 10.1023/A:1021297919034; Menkes J H, 1999, Eur J Paediatr Neurol, V3, P245, DOI 10.1016/S1090-3798(99)90979-0; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; Mercer JFB, 2001, TRENDS MOL MED, V7, P64, DOI 10.1016/S1471-4914(01)01920-7; Moller LB, 2005, HUM MUTAT, V26, P84, DOI 10.1002/humu.20190; Monty JF, 2005, J NUTR, V135, P2762, DOI 10.1093/jn/135.12.2762; Norgate M, 2006, MOL BIOL CELL, V17, P475, DOI 10.1091/mbc.E05-06-0492; Nyasae L, 2007, AM J PHYSIOL-GASTR L, V292, pG1181, DOI 10.1152/ajpgi.00472.2006; Polishchuk EV, 2014, DEV CELL, V29, P686, DOI 10.1016/j.devcel.2014.04.033; Quon BS, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i859; Schaefer M, 1999, AM J PHYSIOL-GASTR L, V276, pG311, DOI 10.1152/ajpgi.1999.276.2.G311; Southon A, 2010, BIOMETALS, V23, P681, DOI 10.1007/s10534-010-9332-2; Squitti R, 2014, BIOMETALS, V27, P53, DOI 10.1007/s10534-013-9686-3; Squitti R, 2013, REJUV RES, V16, P3, DOI 10.1089/rej.2012.1357; Tang JR, 2008, MOL GENET METAB, V95, P174, DOI 10.1016/j.ymgme.2008.06.015; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; Tsivkovskii R, 2003, J BIOL CHEM, V278, P13302, DOI 10.1074/jbc.M300034200; Turski ML, 2009, J BIOL CHEM, V284, P717, DOI 10.1074/jbc.R800055200; van den Berghe PVE, 2009, HEPATOLOGY, V50, P1783, DOI 10.1002/hep.23209; van den Berghe PVE, 2009, NUTR REV, V67, P658, DOI 10.1111/j.1753-4887.2009.00250.x; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; WACHNIK A, 1988, NAHRUNG, V32, P755, DOI 10.1002/food.19880320811; YAMAGUCHI Y, 1993, BIOCHEM BIOPH RES CO, V197, P271, DOI 10.1006/bbrc.1993.2471; Yi L, 2012, HUM MOL GENET, V21, P1794, DOI 10.1093/hmg/ddr612	45	38	38	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4113	4122		10.1074/jbc.M116.756163	http://dx.doi.org/10.1074/jbc.M116.756163			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28119449	Green Published, hybrid			2022-12-26	WOS:000395837100013
J	Ryan, B; Logan, BJ; Abraham, WC; Williams, JM				Ryan, Brigid; Logan, Barbara J.; Abraham, Wickliffe C.; Williams, Joanna M.			MicroRNAs, miR-23a-3p and miR-151-3p, Are Regulated in Dentate Gyrus Neuropil following Induction of Long-Term Potentiation In Vivo	PLOS ONE			English	Article							HIPPOCAMPAL SYNAPTIC PLASTICITY; LARGE GENE LISTS; LTP MAINTENANCE; PROTEIN-SYNTHESIS; DENDRITIC SPINES; LATE-PHASE; EXPRESSION; TRAFFICKING; BRAIN; NORMALIZATION	Translation of synaptic mRNA contributes to alterations in the proteome necessary to consolidate long-term potentiation (LTP), a model of memory processes. Yet, how this process is controlled is not fully resolved. MicroRNAs are non-coding RNAs that negatively regulate gene expression by suppressing translation or promoting mRNA degradation. As specific microRNAs are synaptically located, we hypothesized that they are ideally suited to couple synaptic activation, translational regulation, and LTP persistence. The aim of this study was to identify LTP-regulated microRNAs at or near synapses. Accordingly, LTP was induced unilaterally at perforant path-dentate gyrus synapses in awake adult Sprague-Dawley rats. Five hours later, dentate gyrus middle molecular layer neuropil, containing potentiated synapses, was laser-microdissected. MicroRNA expression profiling, using TaqMan Low Density MicroRNA Microarrays (n = 4), identified eight regulated microRNAs. Subsequent individual TaqMan assays confirmed upregulation of miR-23a-3p (1.30 +/- 0.10; p = 0.015) and miR-151-3p (1.17 +/- 0.19; p = 0.045) in a second cohort (n = 7). Interestingly, bioinformatic analysis indicated that miR-151-3p and miR-23a-3p regulate synaptic reorganisation and transcription, respectively. In summary, we have demonstrated for the first time that microRNAs are regulated in isolated neuropil following LTP induction in vivo, supporting the hypothesis that synaptic, LTP-responsive microRNAs contribute to LTP persistence via regulation of the synaptic proteome.	[Ryan, Brigid; Williams, Joanna M.] Univ Otago, Dept Anat, Dunedin, New Zealand; [Ryan, Brigid; Logan, Barbara J.; Abraham, Wickliffe C.; Williams, Joanna M.] Univ Otago, Brain Hlth Res Ctr, Dunedin, New Zealand; [Ryan, Brigid; Logan, Barbara J.; Abraham, Wickliffe C.; Williams, Joanna M.] Univ Otago, Brain Res New Zealand, Rangahau Roro Aotearoa, Dunedin, New Zealand; [Logan, Barbara J.; Abraham, Wickliffe C.] Univ Otago, Dept Psychol, Dunedin, New Zealand; [Ryan, Brigid] Univ Auckland, Ctr Brain Res, Auckland, New Zealand; [Ryan, Brigid] Univ Auckland, Dept Anat Med Imaging, Auckland, New Zealand	University of Otago; University of Otago; University of Otago; University of Otago; University of Auckland; University of Auckland	Williams, JM (corresponding author), Univ Otago, Dept Anat, Dunedin, New Zealand.	joanna.williams@otago.ac.nz		Williams, Joanna/0000-0003-3936-2220	Neurological Foundation of New Zealand; New Zealand Neurological Foundation	Neurological Foundation of New Zealand; New Zealand Neurological Foundation	This work was supported by the Neurological Foundation of New Zealand, Postgraduate Scholarship, www.neurological.org.nz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; This research was supported by a Postgraduate Scholarship awarded from the New Zealand Neurological Foundation to Brigid Ryan.	Abraham WC, 2008, NEUROBIOL LEARN MEM, V89, P260, DOI 10.1016/j.nlm.2007.10.001; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bowden JB, 2012, HIPPOCAMPUS, V22, P1363, DOI 10.1002/hipo.20972; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036; Caron C, 2005, BIOESSAYS, V27, P408, DOI 10.1002/bies.20210; Finnegan EF, 2013, CRIT REV BIOCHEM MOL, V48, P51, DOI 10.3109/10409238.2012.738643; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Grooms SY, 2006, J NEUROSCI, V26, P8339, DOI 10.1523/JNEUROSCI.0472-06.2006; Gu QH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7789; HJORTHSIMONSEN A, 1972, J COMP NEUROL, V144, P215, DOI 10.1002/cne.901440206; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Joilin G, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00098; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kennard JTT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092972; Kennard JTT, 2009, NEUROPHARMACOLOGY, V56, P66, DOI 10.1016/j.neuropharm.2008.07.044; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lee K, 2012, J NEUROSCI, V32, P5678, DOI 10.1523/JNEUROSCI.6471-11.2012; Lugli G, 2005, J NEUROCHEM, V94, P896, DOI 10.1111/j.1471-4159.2005.03224.x; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mestdagh P, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr646; Nguyen PV, 1996, J NEUROSCI, V16, P3189; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Pai B, 2014, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00285; Park CS, 2009, J MOL NEUROSCI, V38, P50, DOI 10.1007/s12031-008-9158-3; Pichardo-Casas I, 2012, BRAIN RES, V1436, P20, DOI 10.1016/j.brainres.2011.12.001; Ryan B, 2016, NEUROSCI LETT; Ryan B, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00004; Ryan MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040538; Ryan MM, 2011, HIPPOCAMPUS, V21, P541, DOI 10.1002/hipo.20770; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Siegel G, 2011, CURR OPIN GENET DEV, V21, P491, DOI 10.1016/j.gde.2011.04.008; Sysi-Aho M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-93; Temesvari L, 2000, MOL BIOL CELL, V11, P2019, DOI 10.1091/mbc.11.6.2019; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wibrand K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041688; Wibrand K, 2010, EUR J NEUROSCI, V31, P636, DOI 10.1111/j.1460-9568.2010.07112.x; Williams JM, 1998, MOL BRAIN RES, V60, P21, DOI 10.1016/S0169-328X(98)00154-5; Williams JM, 2003, NEUROSCIENCE, V118, P1003, DOI 10.1016/S0306-4522(03)00028-9; Williams JM, 2007, J NEUROSCI, V27, P14171, DOI 10.1523/JNEUROSCI.2348-07.2007; Yen HJ, 2006, HUM MOL GENET, V15, P667, DOI 10.1093/hmg/ddi468; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	47	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170407	10.1371/journal.pone.0170407	http://dx.doi.org/10.1371/journal.pone.0170407			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125614	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100112
J	Seyffert, M; Glauser, DL; Schraner, EM; de Oliveira, AP; Mansilla-Soto, J; Vogt, B; Buning, H; Linden, RM; Ackermann, M; Fraefel, C				Seyffert, Michael; Glauser, Daniel L.; Schraner, Elisabeth M.; de Oliveira, Anna-Paula; Mansilla-Soto, Jorge; Vogt, Bernd; Buening, Hildegard; Linden, R. Michael; Ackermann, Mathias; Fraefel, Cornel			Novel Mutant AAV2 Rep Proteins Support AAV2 Replication without Blocking HSV-1 Helpervirus Replication	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS TYPE-2; DNA-DAMAGE RESPONSE; BACTERIAL ARTIFICIAL CHROMOSOME; GREEN FLUORESCENT PROTEIN; SITE-SPECIFIC INTEGRATION; E2A GENE-EXPRESSION; AMPLICON VECTORS; IN-VITRO; ADENOVIRUS REPLICATION; TRANSGENE EXPRESSION	As their names imply, parvoviruses of the genus Dependovirus rely for their efficient replication on the concurrent presence of a helpervirus, such as herpesvirus, adenovirus, or papilloma virus. Adeno-associated virus 2 (AAV2) is such an example, which in turn can efficiently inhibit the replication of each helpervirus by distinct mechanisms. In a previous study we have shown that expression of the AAV2 rep gene is not compatible with efficient replication of herpes simplex virus 1 (HSV-1). In particular, the combined DNA-binding and ATPase/helicase activities of the Rep68/78 proteins have been shown to exert opposite effects on the replication of AAV2 and HSV-1. While essential for AAV2 DNA replication these protein activities account for the Rep-mediated inhibition of HSV-1 replication. Here, we describe a novel Rep mutant (Rep-D371Y), which displayed an unexpected phenotype. Rep-D371Y did not block HSV-1 replication, but still supported efficient AAV2 replication, at least when a double-stranded AAV2 genome template was used. We also found that the capacity of Rep-D371Y to induce apoptosis and a Rep-specific DNA damage response was significantly reduced compared to wild-type Rep. These findings suggest that AAV2 Rep-helicase subdomains exert diverging activities, which contribute to distinct steps of the AAV2 life cycle. More important, the novel AAV2 mutant Rep-D371Y may allow deciphering yet unsolved activities of the AAV2 Rep proteins such as DNA second-strand synthesis, genomic integration or packaging, which all involve the Rep-helicase activity.	[Seyffert, Michael; Glauser, Daniel L.; Schraner, Elisabeth M.; de Oliveira, Anna-Paula; Vogt, Bernd; Ackermann, Mathias; Fraefel, Cornel] Univ Zurich, Inst Virol, Zurich, Switzerland; [Seyffert, Michael] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Schraner, Elisabeth M.] Univ Zurich, Inst Vet Anat, Zurich, Switzerland; [Mansilla-Soto, Jorge] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, 1275 York Ave, New York, NY 10021 USA; [Buening, Hildegard] Univ Cologne, Ctr Mol Med Cologne, Cologne, Germany; [Buening, Hildegard] Hannover Med Sch, Inst Expt Hematol, Hannover, Germany; [Linden, R. Michael] Kings Coll London, Dept Infect Dis, London, England; [Glauser, Daniel L.] Suisselab AG, Bern, Switzerland; [de Oliveira, Anna-Paula] Deutsch Krebsforschungszentrum, Div Tumor Virol, F010, Heidelberg, Germany	University of Zurich; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Zurich; Memorial Sloan Kettering Cancer Center; University of Cologne; Hannover Medical School; University of London; King's College London; Helmholtz Association; German Cancer Research Center (DKFZ)	Fraefel, C (corresponding author), Univ Zurich, Inst Virol, Zurich, Switzerland.	cornel.fraefel@access.uzh.ch	Buening, Hildegard/AAJ-2352-2020; Buening, Hildegard/AAV-9928-2021	Buening, Hildegard/0000-0002-3365-6933; Fraefel, Cornel/0000-0001-7221-6706; Seyffert, Michael/0000-0001-7483-2430	Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung [31003A_144094/1, 31003A_166668/1]	Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF))	This work was supported by Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung, http://www.snf.ch, No. 31003A_144094/1 and No. 31003A_166668/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AboodyGuterman KS, 1997, NEUROREPORT, V8, P3801, DOI 10.1097/00001756-199712010-00029; BECERRA SP, 1988, J VIROL, V62, P2745, DOI 10.1128/JVI.62.8.2745-2754.1988; Berthet C, 2005, P NATL ACAD SCI USA, V102, P13634, DOI 10.1073/pnas.0504583102; Boutell C, 2003, J BIOL CHEM, V278, P36596, DOI 10.1074/jbc.M300776200; BULLER RML, 1981, J VIROL, V40, P241, DOI 10.1128/JVI.40.1.241-247.1981; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; CASSINOTTI P, 1988, VIROLOGY, V167, P176, DOI 10.1016/0042-6822(88)90067-0; CHEJANOVSKY N, 1989, VIROLOGY, V173, P120, DOI 10.1016/0042-6822(89)90227-4; CHEJANOVSKY N, 1990, J VIROL, V64, P1764, DOI 10.1128/JVI.64.4.1764-1770.1990; CHIORINI JA, 1994, J VIROL, V68, P7448, DOI 10.1128/JVI.68.11.7448-7457.1994; Conway JE, 1999, GENE THER, V6, P986, DOI 10.1038/sj.gt.3300937; Davis MD, 2000, J VIROL, V74, P2936, DOI 10.1128/JVI.74.6.2936-2942.2000; Davis MD, 1999, J VIROL, V73, P2084, DOI 10.1128/JVI.73.3.2084-2093.1999; de Oliveira AP, 2008, J VIROL, V82, P4974, DOI 10.1128/JVI.02431-07; Di Pasquale G, 2003, EMBO J, V22, P1716, DOI 10.1093/emboj/cdg153; Dubielzig R, 1999, J VIROL, V73, P8989, DOI 10.1128/JVI.73.11.8989-8998.1999; Fraefel C, 2004, J VIROL, V78, P389, DOI 10.1128/JVI.78.1.389-398.2004; Fraefel C, 1996, J VIROL, V70, P7190, DOI 10.1128/JVI.70.10.7190-7197.1996; Glauser DL, 2007, J VIROL, V81, P4732, DOI 10.1128/JVI.02476-06; Glauser DL, 2010, J VIROL, V84, P3808, DOI 10.1128/JVI.01503-09; Glauser DL, 2005, J VIROL, V79, P12218, DOI 10.1128/JVI.79.19.12218-12230.2005; GORBALENYA AE, 1990, FEBS LETT, V262, P145, DOI 10.1016/0014-5793(90)80175-I; Grieger JC, 2005, J VIROL, V79, P9933, DOI 10.1128/JVI.79.15.9933-9944.2005; Grimm D, 1998, HUM GENE THER, V9, P2745, DOI 10.1089/hum.1998.9.18-2745; HEILBRONN R, 1990, J VIROL, V64, P3012, DOI 10.1128/JVI.64.6.3012-3018.1990; Heister T, 2002, J VIROL, V76, P7163, DOI 10.1128/JVI.76.14.7163-7173.2002; Hickman AB, 2002, MOL CELL, V10, P327, DOI 10.1016/S1097-2765(02)00592-0; Hickman AB, 2004, MOL CELL, V13, P403, DOI 10.1016/S1097-2765(04)00023-1; Hickman AB, 2005, CURR OPIN STRUC BIOL, V15, P77, DOI 10.1016/j.sbi.2004.12.001; HIRT B, 1969, J MOL BIOL, V40, P141, DOI 10.1016/0022-2836(69)90302-7; HOGGAN MD, 1966, P NATL ACAD SCI USA, V55, P1467, DOI 10.1073/pnas.55.6.1467; HONG G, 1992, P NATL ACAD SCI USA, V89, P4673, DOI 10.1073/pnas.89.10.4673; HORER M, 1995, J VIROL, V69, P5485; IM DS, 1990, CELL, V61, P447, DOI 10.1016/0092-8674(90)90526-K; Iyer LM, 2004, NUCLEIC ACIDS RES, V32, P5260, DOI 10.1093/nar/gkh828; James JA, 2004, P NATL ACAD SCI USA, V101, P12455, DOI 10.1073/pnas.0403454101; Jing XJ, 2001, VIROLOGY, V291, P140, DOI 10.1006/viro.2001.1192; Johnston KM, 1997, HUM GENE THER, V8, P359, DOI 10.1089/hum.1997.8.3-359; King JA, 2001, EMBO J, V20, P3282, DOI 10.1093/emboj/20.12.3282; KLEINSCHMIDT JA, 1995, VIROLOGY, V206, P254, DOI 10.1016/S0042-6822(95)80040-9; KOTIN RM, 1991, GENOMICS, V10, P831, DOI 10.1016/0888-7543(91)90470-Y; KOTIN RM, 1992, EMBO J, V11, P5071, DOI 10.1002/j.1460-2075.1992.tb05614.x; Kyostio SRM, 1996, BIOCHEM BIOPH RES CO, V220, P294, DOI 10.1006/bbrc.1996.0399; LeesMiller SP, 1996, J VIROL, V70, P7471, DOI 10.1128/JVI.70.11.7471-7477.1996; Li Z, 2003, VIROLOGY, V313, P364, DOI 10.1016/S0042-6822(03)00340-4; Lilley CE, 2005, P NATL ACAD SCI USA, V102, P5844, DOI 10.1073/pnas.0501916102; Linden RM, 2000, MOL BIOLO ADENO ASS; Lux K, 2005, J VIROL, V79, P11776, DOI 10.1128/JVI.79.18.11776-11787.2005; Mansilla-Soto J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000513; Nada S, 2002, VIROLOGY, V293, P345, DOI 10.1006/viro.2001.1286; Naumer M, 2012, J VIROL, V86, P13038, DOI 10.1128/JVI.01675-12; Parkinson J, 2000, J VIROL, V74, P10006, DOI 10.1128/JVI.74.21.10006-10017.2000; Putnam CD, 2001, J MOL BIOL, V311, P297, DOI 10.1006/jmbi.2001.4852; Saeki Y, 1998, HUM GENE THER, V9, P2787, DOI 10.1089/hum.1998.9.18-2787; Saeki Y, 2001, MOL THER, V3, P591, DOI 10.1006/mthe.2001.0294; Saudan P, 2000, EMBO J, V19, P4351, DOI 10.1093/emboj/19.16.4351; Schmidt M, 2000, J VIROL, V74, P9441, DOI 10.1128/JVI.74.20.9441-9450.2000; Schwartz RA, 2009, J VIROL, V83, P6269, DOI 10.1128/JVI.00318-09; Seyffert M, 2015, J VIROL, V89, P11150, DOI 10.1128/JVI.01370-15; Shirata N, 2005, J BIOL CHEM, V280, P30336, DOI 10.1074/jbc.M500976200; SMITH IL, 1992, VIROLOGY, V186, P74, DOI 10.1016/0042-6822(92)90062-T; Smith RH, 2000, J VIROL, V74, P3122, DOI 10.1128/JVI.74.7.3122-3129.2000; SNYDER RO, 1990, J VIROL, V64, P6204, DOI 10.1128/JVI.64.12.6204-6213.1990; Sonntag F, 2010, P NATL ACAD SCI USA, V107, P10220, DOI 10.1073/pnas.1001673107; Sourvinos G, 2002, EMBO J, V21, P4989, DOI 10.1093/emboj/cdf458; Timpe JA, 2006, J VIROL, V80, P7807, DOI 10.1128/JVI.00198-06; Tsukamoto T, 2000, NAT CELL BIOL, V2, P871, DOI 10.1038/35046510; Urabe M, 1999, J VIROL, V73, P2682, DOI 10.1128/JVI.73.4.2682-2693.1999; Vogel Rebecca, 2013, Open Virol J, V7, P98, DOI 10.2174/1874357901307010098; Vogel R, 2012, J VIROL, V86, P143, DOI 10.1128/JVI.05694-11; Walz C, 1997, J GEN VIROL, V78, P1441, DOI 10.1099/0022-1317-78-6-1441; Wang Y, 2002, J VIROL, V76, P7150, DOI 10.1128/JVI.76.14.7150-7162.2002; Weitzman MD, 1996, J VIROL, V70, P1845, DOI 10.1128/JVI.70.3.1845-1854.1996; Wilkinson DE, 2004, J VIROL, V78, P4783, DOI 10.1128/JVI.78.9.4783-4796.2004; Wilkinson DE, 2006, J CELL SCI, V119, P2695, DOI 10.1242/jcs.02981; Yoon M, 2001, J VIROL, V75, P3230, DOI 10.1128/JVI.75.7.3230-3239.2001; Yoon-Robarts M, 2004, J BIOL CHEM, V279, P50472, DOI 10.1074/jbc.M403900200; Zarate-Perez F, 2013, J VIROL, V87, P1232, DOI 10.1128/JVI.02441-12; Zarate-Perez F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002764	79	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170908	10.1371/journal.pone.0170908	http://dx.doi.org/10.1371/journal.pone.0170908			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125695	Green Published, Green Accepted, gold			2022-12-26	WOS:000396176100026
J	Chakravarti, A; Camp, K; McNabb, DS; Pinto, I				Chakravarti, Ananya; Camp, Kyle; McNabb, David S.; Pinto, Ines			The Iron-Dependent Regulation of the Candida albicans Oxidative Stress Response by the CCAAT-Binding Factor	PLOS ONE			English	Article							CONTAINING SUPEROXIDE-DISMUTASE; ACTIVATED PROTEIN-KINASE; FUNGAL PATHOGEN; TRANSCRIPTION FACTOR; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; YEAST; COMPLEX; CATALASE; ROLES	Candida albicans is the most frequently encountered fungal pathogen in humans, capable of causing mucocutaneous and systemic infections in immunocompromised individuals. C. albicans virulence is influenced by multiple factors. Importantly, iron acquisition and avoidance of the immune oxidative burst are two critical barriers for survival in the host. Prior studies using whole genome microarray expression data indicated that the CCAAT-binding factor is involved in the regulation of iron uptake/utilization and the oxidative stress response. This study examines directly the role of the CCAAT-binding factor in regulating the expression of oxidative stress genes in response to iron availability. The CCAAT-binding factor is a heterooligomeric transcription factor previously shown to regulate genes involved in respiration and iron uptake/utilization in C. albicans. Since these pathways directly influence the level of free radicals, it seemed plausible the CCAAT-binding factor regulates genes necessary for the oxidative stress response. In this study, we show the CCAAT-binding factor is involved in regulating some oxidative stress genes in response to iron availability, including CAT1, SOD4, GRX5, and TRX1. We also show that CAT1 expression and catalase activity correlate with the survival of C. albicans to oxidative stress, providing a connection between iron obtainability and the oxidative stress response. We further explore the role of the various CCAAT-binding factor subunits in the formation of distinct protein complexes that modulate the transcription of CAT1 in response to iron. We find that Hap31 and Hap32 can compensate for each other in the formation of an active transcriptional complex; however, they play distinct roles in the oxidative stress response during iron limitation. Moreover, Hap43 was found to be solely responsible for the repression observed under iron deprivation.	[Chakravarti, Ananya; Camp, Kyle; McNabb, David S.; Pinto, Ines] Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA; [Chakravarti, Ananya; McNabb, David S.; Pinto, Ines] Univ Arkansas, Cell & Mol Biol Program, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville	Pinto, I (corresponding author), Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA.; Pinto, I (corresponding author), Univ Arkansas, Cell & Mol Biol Program, Fayetteville, AR 72701 USA.	ipinto@uark.edu	Pinto, Inês/GVT-4690-2022		NIH [R01 A1051470]; Arkansas Biosciences Institute	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arkansas Biosciences Institute	This work was supported by the NIH, R01 A1051470 (http://www.niaid.nih.gov) and the Arkansas Biosciences Institute (http://arbiosciences.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrover MA, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002204; Alarco AM, 1999, J BACTERIOL, V181, P700, DOI 10.1128/JB.181.3.700-708.1999; Almeida RS, 2009, FEMS YEAST RES, V9, P1000, DOI 10.1111/j.1567-1364.2009.00570.x; Alonso-Monge R, 2003, EUKARYOT CELL, V2, P351, DOI 10.1128/EC.2.2.351-361.2003; Alonso-Monge R, 2009, MICROBIOL-SGM, V155, P413, DOI 10.1099/mic.0.023309-0; Asubel FM, 1994, CURRENT PROTOCOLS MO; Babazadeh R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04697; Baek YU, 2008, EUKARYOT CELL, V7, P1168, DOI 10.1128/EC.00108-08; Bates L, 2009, THESIS; Brown AJP, 2014, J EXP BIOL, V217, P144, DOI 10.1242/jeb.088930; Calderone RA., 2002, CANDIDA CANDIDIASIS; Chaves GM, 2007, GENET MOL RES, V6, P1051; Chaves GM, 2012, MEM I OSWALDO CRUZ, V107, P998, DOI 10.1590/S0074-02762012000800006; Chen CB, 2011, CELL HOST MICROBE, V10, P118, DOI 10.1016/j.chom.2011.07.005; Chibana H, 2005, MICROBIOL IMMUNOL, V49, P937, DOI 10.1111/j.1348-0421.2005.tb03686.x; Collette JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096203; Cuellar-Cruz M, 2014, CURR MICROBIOL, V69, P733, DOI 10.1007/s00284-014-0651-3; Cuellar-Cruz M, 2008, EUKARYOT CELL, V7, P814, DOI 10.1128/EC.00011-08; Dantas AD, 2010, MOL CELL BIOL, V30, P4550, DOI 10.1128/MCB.00313-10; Dang VD, 1996, J BACTERIOL, V178, P1842, DOI 10.1128/jb.178.7.1842-1849.1996; Dantas AD, 2015, BIOMOLECULES, V5, P142, DOI 10.3390/biom5010142; De Freitas JM, 2000, J BIOL CHEM, V275, P11645, DOI 10.1074/jbc.275.16.11645; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Enjalbert B, 2006, MOL BIOL CELL, V17, P1018, DOI 10.1091/mbc.E05-06-0501; Enjalbert B, 2003, MOL BIOL CELL, V14, P1460, DOI 10.1091/mbc.E02-08-0546; FONZI WA, 1993, GENETICS, V134, P717; FORSBURG SL, 1989, ANNU REV CELL BIOL, V5, P153, DOI 10.1146/annurev.cb.05.110189.001101; FORSBURG SL, 1989, GENE DEV, V3, P1166, DOI 10.1101/gad.3.8.1166; Frohner IE, 2009, MOL MICROBIOL, V71, P240, DOI 10.1111/j.1365-2958.2008.06528.x; Ganz T, 2009, CURR OPIN IMMUNOL, V21, P63, DOI 10.1016/j.coi.2009.01.011; Garcia MG, 2001, YEAST, V18, P301, DOI 10.1002/1097-0061(20010315)18:4&lt;301::AID-YEA672&gt;3.0.CO;2-H; Gazendam RP, 2014, BLOOD, V124, P590, DOI 10.1182/blood-2014-01-551473; Gleason JE, 2014, J BIOL INORG CHEM, V19, P595, DOI 10.1007/s00775-013-1045-x; Gleason JE, 2014, P NATL ACAD SCI USA, V111, P5866, DOI 10.1073/pnas.1400137111; Gsaller F, 2014, EMBO J, V33, P2261, DOI 10.15252/embj.201489468; Guthrie C, 1991, GUIDE YEAST GENETICS; Herrero E, 2008, BBA-GEN SUBJECTS, V1780, P1217, DOI 10.1016/j.bbagen.2007.12.004; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Homann OR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000783; Hortschansky P, 2007, EMBO J, V26, P3157, DOI 10.1038/sj.emboj.7601752; Hsu PC, 2013, EUKARYOT CELL, V12, P804, DOI 10.1128/EC.00014-13; Hsu PC, 2011, EUKARYOT CELL, V10, P207, DOI 10.1128/EC.00158-10; Hwang CS, 2003, YEAST, V20, P929, DOI 10.1002/yea.1004; Hwang CS, 2002, MICROBIOL-SGM, V148, P3705, DOI 10.1099/00221287-148-11-3705; Johnson DC, 2005, EUKARYOT CELL, V4, P1662, DOI 10.1128/EC.4.10.1662-1676.2005; Jung WH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001209; Kaloriti D, 2014, MBIO, V5, DOI 10.1128/mBio.01334-14; Kornitzer D, 2009, CURR OPIN MICROBIOL, V12, P377, DOI 10.1016/j.mib.2009.05.005; Kuznets G, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004407; Labbe S, 2013, CURR OPIN MICROBIOL, V16, P669, DOI 10.1016/j.mib.2013.07.007; Lamarre C, 2001, J BIOL CHEM, V276, P43784, DOI 10.1074/jbc.M108095200; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; McNabb DS, 2005, EUKARYOT CELL, V4, P1829, DOI 10.1128/EC.4.11.1829-1839.2005; MCNABB DS, 1995, GENE DEV, V9, P47, DOI 10.1101/gad.9.1.47; Nakamura K, 2012, MICROBIOL IMMUNOL, V56, P48, DOI 10.1111/j.1348-0421.2011.00400.x; Odds FC., 1988, CANDIDA CANDIDOSIS; Pierre JL, 2002, BIOMETALS, V15, P341, DOI 10.1023/A:1020259021641; Ratti BA, 2015, CELL IMMUNOL, V293, P22, DOI 10.1016/j.cellimm.2014.11.004; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; Schrettl M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001124; Singh RP, 2011, J BIOL CHEM, V286, P25154, DOI 10.1074/jbc.M111.233569; Srinivasan C, 2000, J BIOL CHEM, V275, P29187, DOI 10.1074/jbc.M004239200; Sutak R, 2008, TRENDS MICROBIOL, V16, P261, DOI 10.1016/j.tim.2008.03.005; Thon M, 2010, NUCLEIC ACIDS RES, V38, P1098, DOI 10.1093/nar/gkp1091; Toledano MB, 2007, FEBS LETT, V581, P3598, DOI 10.1016/j.febslet.2007.07.002; Toledano MB, 2013, ANTIOXID REDOX SIGN, V18, P1699, DOI 10.1089/ars.2012.5033; Toone WM, 1998, GENES CELLS, V3, P485, DOI 10.1046/j.1365-2443.1998.00211.x; UEDA M, 1990, METHOD ENZYMOL, V188, P463; Wang Y, 2006, WATER PRACT TECHNOL, V1, DOI 10.2166/WPT.2006048; Weinberg ED, 2009, BBA-GEN SUBJECTS, V1790, P600, DOI 10.1016/j.bbagen.2008.07.002; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Wysong DR, 1998, INFECT IMMUN, V66, P1953, DOI 10.1128/IAI.66.5.1953-1961.1998; ZITOMER RS, 1992, MICROBIOL REV, V56, P1	73	11	12	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e170649	10.1371/journal.pone.0170649	http://dx.doi.org/10.1371/journal.pone.0170649			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122000	Green Submitted, Green Published, gold			2022-12-26	WOS:000396167300031
J	Veronezi, GMB; Felisbino, MB; Gatti, MSV; Mello, MLS; Vidal, BD				Veronezi, Giovana M. B.; Felisbino, Marina Barreto; Gatti, Maria Silvia V.; Mello, Maria Luiza S.; Vidal, Benedicto de Campos			DNA Methylation Changes in Valproic Acid-Treated HeLa Cells as Assessed by Image Analysis, Immunofluorescence and Vibrational Microspectroscopy	PLOS ONE			English	Article							CHROMATIN-STRUCTURE; NUCLEAR PHENOTYPES; EPITHELIAL-CELLS; LASER-RAMAN; DEMETHYLATION; SPECTROSCOPY; CYTOSINE; TEXTURE; PROTEINS; SPECTRA	Valproic acid (VPA), a well-known histone deacetylase inhibitor, has been reported to affect the DNA methylation status in addition to inducing histone hyperacetylation in several cell types. In HeLa cells, VPA promotes histone acetylation and chromatin remodeling. However, DNA demethylation was not checked in this cell model for standing effects longer than those provided by histone acetylation, which is a rapid and transient phenomenon. Demonstration of VPA-induced DNA demethylation in HeLa cells would contribute to understanding the effect of VPA on an aggressive tumor cell line. In the present work, DNA demethylation in VPA-treated HeLa cells was assessed by image analysis of chromatin texture, the abundance of 5-methylcytosine (5mC) immunofluorescence signals and Fourier transform-infrared (FT-IR) microspectroscopy centered on spectral regions related to the vibration of-(CH3 groups. Image analysis indicated that increased chromatin unpacking promoted by a 4-htreatment with 1.0 mM VPA persisted for 24 h in the absence of the drug, suggesting the occurrence of DNA demethylation that was confirmed by decreased 5mC immunofluorescence signals. FT-IR spectra of DNA samples from 1 mM or 20 mM VPA-treated cells subjected to a peak fitting analysis of the spectral window for-CH3 stretching vibrations showed decreased vibrations and energy of these groups as a function of the decreased abundance of 5mC induced by increased VPA concentrations. Only the 20 mM-VPA treatment caused an increase in the ratio of-CH3 bending vibrations evaluated at 1375 cm(-1) in relation to inplane vibrations of overall cytosines evaluated at 1492 cm(-1). CH3 stretching vibrations showed to be more sensitive than-CH3 bending vibrations, as detected with FT-IR microspectroscopy, for studies aiming to associate vibrational spectroscopy and changes in DNA 5mC abundance.	[Veronezi, Giovana M. B.; Felisbino, Marina Barreto; Mello, Maria Luiza S.; Vidal, Benedicto de Campos] Univ Campinas Unicamp, Dept Struct & Funct Biol, Sao Paulo, Brazil; [Veronezi, Giovana M. B.; Felisbino, Marina Barreto; Mello, Maria Luiza S.; Vidal, Benedicto de Campos] Univ Campinas Unicamp, Inst Biol, Sao Paulo, Brazil; [Gatti, Maria Silvia V.] Univ Campinas Unicamp, Dept Genet Evolut & Bioagents, Inst Biol, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas	Mello, MLS (corresponding author), Univ Campinas Unicamp, Dept Struct & Funct Biol, Sao Paulo, Brazil.; Mello, MLS (corresponding author), Univ Campinas Unicamp, Inst Biol, Sao Paulo, Brazil.	mlsmello@unicamp.br	de Campos Vidal, Benedicto/ABH-6617-2020; Vidal, Benedicto/I-3227-2012; Mello, Maria Luiza Silveira/D-9158-2012; Felisbino, Marina/N-9311-2019	de Campos Vidal, Benedicto/0000-0003-0285-1653; Vidal, Benedicto/0000-0003-1629-5619; Mello, Maria Luiza Silveira/0000-0003-1629-5619; 	Fundacaao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2007/58251-8, 2014/23842-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [304668/2014-1]	Fundacaao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support: Fundacaao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP): grants no. 2007/58251-8 (recipient: BCV) and 2014/23842-0 (recipient: GMBV); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq): grant no. 304668/2014-1 (recipient: MLSM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEX S, 1989, INORG CHIM ACTA, V157, P271, DOI 10.1016/S0020-1693(00)80552-6; Banyay M, 2002, J MOL BIOL, V324, P667, DOI 10.1016/S0022-2836(02)01104-X; Banyay M, 2003, BIOPHYS CHEM, V104, P477, DOI 10.1016/S0301-4622(03)00035-8; Boudadi E, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-11; Brodie SA, 2014, CANCER PREV RES, V7, P351, DOI 10.1158/1940-6207.CAPR-13-0254; Cui Y, 2013, EPIGENETICS-US, V8, P1089, DOI 10.4161/epi.25958; Vidal BD, 2016, CYTOGENET GENOME RES, V148, P149; Detich N, 2003, J BIOL CHEM, V278, P27586, DOI 10.1074/jbc.M303740200; Eglinton G, 1970, INTRO SPECTROSCOPY M, V1, p[129, 139]; Felisbino MB, 2014, J CELL BIOCHEM, V115, P1937, DOI 10.1002/jcb.24865; Felisbino MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029144; Flett MSC, 1970, INTRO SPECTROSCOPIC, V1, P109; Fox JJ, 1940, PROC R SOC LON SER-A, V175, P0208, DOI 10.1098/rspa.1940.0053; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Gu S, 2012, ANTI-CANCER DRUG, V23, P1054, DOI 10.1097/CAD.0b013e32835739dd; Hembram KPSS, 2009, MAT SCI ENG C-BIO S, V29, P1093, DOI 10.1016/j.msec.2008.09.021; Kelly JG, 2011, J BIOPHOTONICS, V4, P345, DOI 10.1002/jbio.201000085; Kelly JG, 2009, ANAL CHEM, V81, P5314, DOI 10.1021/ac900546m; Lee JH, 2010, P NATL ACAD SCI USA, V107, P14639, DOI 10.1073/pnas.1008522107; Marchion DC, 2005, CANCER RES, V65, P3815, DOI 10.1158/0008-5472.CAN-04-2478; MATHLOUTHI M, 1986, CARBOHYD RES, V146, P1, DOI 10.1016/0008-6215(86)85019-4; Mello MLS, 2014, MICRON, V61, P49, DOI 10.1016/j.micron.2014.02.003; Mello MLS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043169; MELLO MLS, 1994, ACTA HISTOCHEM CYTOC, V27, P23, DOI 10.1267/ahc.27.23; Mello MLS, 1997, BRAZ J GENET, V20, P257; Milutinovic S, 2007, CARCINOGENESIS, V28, P560, DOI 10.1093/carcin/bgl167; MOHAN S, 1993, ASIAN J CHEM, V5, P243; Nafisi S, 2005, DNA CELL BIOL, V24, P634, DOI 10.1089/dna.2005.24.634; Palsamy P, 2014, EXP EYE RES, V121, P26, DOI 10.1016/j.exer.2014.01.021; Pavia D.L., 2009, INTRO SPECTROSCOPY; Perisic T, 2010, NEUROPSYCHOPHARMACOL, V35, P792, DOI 10.1038/npp.2009.188; Sambrook J, 2006, RAPID ISOLATION MAMM; Sami S, 2008, J BIOCHEM, V144, P357, DOI 10.1093/jb/mvn074; Shimanouchi T., 1964, ADVANCES CHEMICAL PH, V7, P435; Tabolacci E, 2008, PHARMACOGENET GENOM, V18, P738, DOI 10.1097/FPC.0b013e32830500a1; Tajmir-Riahi HA, 2012, METHODS FOR STUDYING NUCLEIC ACID/DRUG INTERACTIONS, P43; Tung EWY, 2010, TOXICOL APPL PHARM, V248, P201, DOI 10.1016/j.taap.2010.08.001; Vidal BD, 1998, EXP CELL RES, V244, P77, DOI 10.1006/excr.1998.4171; VIDAL BD, 1984, BIOL CELL, V50, P137, DOI 10.1111/j.1768-322X.1984.tb00260.x; VIDAL BDC, 1973, ACTA CYTOL, V17, P510; Vidal BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102295; Vidal BD, 2011, MICRON, V42, P283, DOI 10.1016/j.micron.2010.09.010; Walsh MJ, 2008, STEM CELLS, V26, P108, DOI 10.1634/stemcells.2007-0196; Yugami H, 1996, SOLID STATE IONICS, V85, P319, DOI 10.1016/0167-2738(96)00076-8	44	23	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170740	10.1371/journal.pone.0170740	http://dx.doi.org/10.1371/journal.pone.0170740			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114349	gold, Green Submitted, Green Published			2022-12-26	WOS:000396129000092
J	Yin, KL; Liu, YC; Chu, M; Wang, YD				Yin, Kailin; Liu, Yanchen; Chu, Ming; Wang, Yuedan			TFDP3 Regulates Epithelial-Mesenchymal Transition in Breast Cancer	PLOS ONE			English	Article							TESTIS ANTIGEN NY-ESO-1; OPEN-LABEL; TRASTUZUMAB; E2F; MULTICENTER; PROGRESSION; PERTUZUMAB; APOPTOSIS; SURVIVAL; SUBUNIT	Breast cancer remains a lethal disease to women due to lymph node metastasis, the tumor microenvironment, secondary resistance and other unknown factors. Several important transcription factors involved in this disease, such as PTEN, p53 and beta-catenin, have been identified and researched in-depth as candidates for targeted therapy in breast cancer. TFDP3 is a new, promising candidate for transcriptional regulation in breast cancer, although it was first identified in hepatocellular carcinoma. Here, we demonstrate that TFDP3 is expressed in a variety of malignancies, normal testis tissue and breast cancer cell lines and thus provide evidence that TFDP3 is a cancer-testis antigen. We illustrate that overexpression or silencing TFDP3 interferes with epithelial-mesenchymal transition but does not influence cell proliferation, indicating that the TFDP3 protein acts as a transcription factor during epithelial-mesenchymal transition. These data highlight that TFDP3 is expressed in breast cancer, that it is a member of the cancer-testis antigen family and that it functions as a regulator in epithelial-mesenchymal transition.	[Yin, Kailin; Chu, Ming; Wang, Yuedan] Peking Univ, Sch Basic Med Sci, Dept Immunol, Beijing, Peoples R China; [Liu, Yanchen] Liaoning Univ Tradit Chinese Med, Sch Pharm, Shenyang, Liaoning, Peoples R China	Peking University; Liaoning University of Traditional Chinese Medicine	Yin, KL; Wang, YD (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Immunol, Beijing, Peoples R China.	yinkailing@163.com; wangyuedan@bjmu.edu.cn			National Natural Science Foundation of China [J1030831/J0108, 81603119]; Natural Science Foundation of Beijing Municipality [7162099]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing Municipality(Beijing Natural Science Foundation)	This work was supported by the National Natural Science Foundation of China (J1030831/J0108 and 81603119) (http://www.nsfc.gov.cn/) and Natural Science Foundation of Beijing Municipality (7162099) (http://www.bjnsf.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baselga J, 2012, LANCET, V379, P633, DOI 10.1016/S0140-6736(11)61847-3; delaLuna S, 1996, J CELL SCI, V109, P2443; Finn RS, 2015, LANCET ONCOL, V16, P25, DOI 10.1016/S1470-2045(14)71159-3; Gianni L, 2012, LANCET ONCOL, V13, P25, DOI 10.1016/S1470-2045(11)70336-9; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Ingram L, 2011, CELL DEATH DIFFER, V18, P122, DOI 10.1038/cdd.2010.70; Jager E, 1998, J EXP MED, V187, P265, DOI 10.1084/jem.187.2.265; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lim SH, 2001, BLOOD, V97, P1508, DOI 10.1182/blood.V97.5.1508; Ma YY, 2014, GENE, V537, P253, DOI 10.1016/j.gene.2013.12.051; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Milton A, 2006, ONCOGENE, V25, P3212, DOI 10.1038/sj.onc.1209343; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Qiao H, 2007, J BIOL CHEM, V282, P454, DOI 10.1074/jbc.M606169200; Radisky DC, 2005, J CELL SCI, V118, P4325, DOI 10.1242/jcs.02552; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Swain SM, 2013, LANCET ONCOL, V14, P461, DOI 10.1016/S1470-2045(13)70130-X; Tian C, 2007, BIOCHEM BIOPH RES CO, V361, P20, DOI 10.1016/j.bbrc.2007.06.128; Tovar H, 2015, COMPUT BIOL CHEM, V59, P67, DOI 10.1016/j.compbiolchem.2015.08.007; Valmori D, 2000, CANCER RES, V60, P4499; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; Wang Y, 2002, J IMMUNOL, V169, P1102, DOI 10.4049/jimmunol.169.2.1102; Whitehurst AW, 2014, ANNU REV PHARMACOL, V54, P251, DOI 10.1146/annurev-pharmtox-011112-140326; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zavadil J, 2008, CANCER RES, V68, P9574, DOI 10.1158/0008-5472.CAN-08-2316	33	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170573	10.1371/journal.pone.0170573	http://dx.doi.org/10.1371/journal.pone.0170573			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114432	gold, Green Published, Green Submitted			2022-12-26	WOS:000396129000073
J	Hu, SQ; Duggavathi, R; Zadworny, D				Hu, Shenqiang; Duggavathi, Raj; Zadworny, David			Regulatory Mechanisms Underlying the Expression of Prolactin Receptor in Chicken Granulosa Cells	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; PROTEIN-KINASE-A; VASOACTIVE-INTESTINAL-PEPTIDE; MESSENGER-RNA EXPRESSION; PROGESTERONE PRODUCTION; ACTIVE IMMUNIZATION; LUTEINIZING-HORMONE; SIGNALING PATHWAYS; OVARIAN-FOLLICLES; TURKEY HENS	Prolactin (PRL) has both pro- and anti-gonadal roles in the regulation of avian ovarian functions through its interaction with the receptor (PRLR). However, neither the pattern of expression of PRLR nor its regulatory mechanisms during follicle development have been clearly defined. The objective of the present study was to investigate mechanisms of PRLR expression in chicken granulosa cells. Levels of PRLR transcript were highest in the stroma and walls of follicles < 2 mm in diameter and progressively declined with the maturation of follicles. In preovulatory follicles, PRLR was expressed at higher levels in granulosa than theca layers. FSH exerted the greatest stimulatory effect on PRLR and StAR expression in cultured granulosa cells of the 6-8 mm follicles but this effect declined as follicles matured to F1. In contrast, LH did not alter the expression of PRLR in granulosa cells of all follicular classes but increased levels of StAR in F2 and F1 granulosa cells. Both non-glycosylated(NG-) and glycosylated-(G-) PRL upregulated basal PRLR expression in granulosa cells of the 6-8 mm, F3 or F1 follicles but had little effect in F2 follicles. Furthermore, FSH-stimulated PRLR expression was reduced by the addition of either isoform of PRL especially in F2 granulosa cells. These results indicate that PRLR is differentially distributed and regulated by FSH or PRL variants independently or in combination in the follicular hierarchy. By using activators and inhibitors, we further demonstrated that multiple signaling pathways, including PKA, PKC, PI3K, mTOR and AMPK, are not only directly involved in, but they can also converge to modulate ERK2 activity to regulate FSH-mediated PRLR and StAR expression in undifferentiated granulosa cells. These data provide new insights into the regulatory mechanisms controlling the expression of PRLR in granulosa cells.	[Hu, Shenqiang; Duggavathi, Raj; Zadworny, David] McGill Univ, Dept Anim Sci, Macdonald Campus, Montreal, PQ H3A 2T5, Canada	McGill University	Zadworny, D (corresponding author), McGill Univ, Dept Anim Sci, Macdonald Campus, Montreal, PQ H3A 2T5, Canada.	david.zadworny@mcgill.ca	Duggavathi, Raj/GSJ-3503-2022		Natural Sciences and Engineering Research Council of Canada; Chinese Scholarship Council (CSC); Hector & Ada Ma Fellowship; Graduate Excellence Award of McGill University	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Chinese Scholarship Council (CSC)(China Scholarship Council); Hector & Ada Ma Fellowship; Graduate Excellence Award of McGill University	This research was supported by the Natural Sciences and Engineering Research Council of Canada. SH was supported by the Chinese Scholarship Council (CSC), Hector & Ada Ma Fellowship and Graduate Excellence Award of McGill University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliston TN, 1997, MOL ENDOCRINOL, V11, P1934, DOI 10.1210/me.11.13.1934; Bedecarrats G, 1999, GEN COMP ENDOCR, V113, P96, DOI 10.1006/gcen.1998.7187; Bu GX, 2013, MOL CELL ENDOCRINOL, V370, P149, DOI 10.1016/j.mce.2013.03.001; CAMPER PM, 1977, GEN COMP ENDOCR, V32, P72, DOI 10.1016/0016-6480(77)90083-1; Crisostomo S, 1998, THERIOGENOLOGY, V50, P675, DOI 10.1016/S0093-691X(98)00172-1; Duchene S, 2008, DOMEST ANIM ENDOCRIN, V34, P1, DOI 10.1016/j.domaniend.2006.09.002; ELHALAWANI ME, 1995, BIOL REPROD, V52, P179, DOI 10.1095/biolreprod52.1.179; Eresheim C, 2014, J BIOL CHEM, V289, P10182, DOI 10.1074/jbc.M113.533489; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; GILBERT AB, 1977, J REPROD FERTIL, V50, P179, DOI 10.1530/jrf.0.0500179; HANKS MC, 1989, J MOL ENDOCRINOL, V2, P21, DOI 10.1677/jme.0.0020021; Hiyama G, 2009, GEN COMP ENDOCR, V161, P238, DOI 10.1016/j.ygcen.2009.01.007; Hrabia A, 2004, FOLIA BIOL-KRAKOW, V52, P197, DOI 10.3409/1734916044527494; Hunzicker-Dunn M, 2006, CELL SIGNAL, V18, P1351, DOI 10.1016/j.cellsig.2006.02.011; Jin YM, 2006, PROSTAG OTH LIPID M, V81, P45, DOI 10.1016/j.prostaglandins.2006.07.002; Johnson AL, 2015, POULTRY SCI, V94, P781, DOI 10.3382/ps/peu008; Johnson AL, 2009, GEN COMP ENDOCR, V163, P12, DOI 10.1016/j.ygcen.2008.11.012; Johnson AL, 2003, ANIM REPROD SCI, V78, P185, DOI 10.1016/S0378-4320(03)00090-3; Johnson AL, 2002, BIOL REPROD, V67, P1313, DOI 10.1095/biolreprod67.4.1313; Johnson AL, 2001, ENDOCRINOLOGY, V142, P3116, DOI 10.1210/en.142.7.3116; Johnson AL, 2001, BIOL REPROD, V64, P1566, DOI 10.1095/biolreprod64.5.1566; Johnson PA, 2012, REPROD DOMEST ANIM, V47, P283, DOI 10.1111/j.1439-0531.2012.02087.x; Kansaku N, 1998, COMP BIOCHEM PHYS C, V119, P89, DOI 10.1016/S0742-8413(97)00195-3; LEA RW, 1981, J ENDOCRINOL, V91, P89, DOI 10.1677/joe.0.0910089; LEE KA, 1994, DOMEST ANIM ENDOCRIN, V11, P307, DOI 10.1016/0739-7240(94)90022-1; Li WL, 2011, DOMEST ANIM ENDOCRIN, V41, P57, DOI 10.1016/j.domaniend.2011.03.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARCH JB, 1994, J REPROD FERTIL, V101, P227, DOI 10.1530/jrf.0.1010227; Nakamura E, 2010, ENDOCRINOLOGY, V151, P5506, DOI 10.1210/en.2010-0265; OPEL H, 1980, POULTRY SCI, V59, P2550, DOI 10.3382/ps.0592550; Porter MB, 2000, FERTIL STERIL, V73, P99; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; ROZENBOIM I, 1993, BIOL REPROD, V48, P1246, DOI 10.1095/biolreprod48.6.1246; Sechman A, 2011, DOMEST ANIM ENDOCRIN, V41, P137, DOI 10.1016/j.domaniend.2011.05.007; SHARP PJ, 1988, J ENDOCRINOL, V118, P279, DOI 10.1677/joe.0.1180279; SHARP PJ, 1989, J ENDOCRINOL, V122, P5, DOI 10.1677/joe.0.1220005; Stocco DM, 2005, MOL ENDOCRINOL, V19, P2647, DOI 10.1210/me.2004-0532; Taira H, 2006, POULTRY SCI, V85, P1769, DOI 10.1093/ps/85.10.1769; TANAKA K, 1971, POULTRY SCI, V50, P63, DOI 10.3382/ps.0500063; TANAKA M, 1992, BIOCHEM BIOPH RES CO, V188, P490, DOI 10.1016/0006-291X(92)91082-2; TILLY JL, 1991, BIOL REPROD, V45, P967, DOI 10.1095/biolreprod45.6.967; TILLY JL, 1991, BIOL REPROD, V44, P305, DOI 10.1095/biolreprod44.2.305; Tosca L, 2008, DOMEST ANIM ENDOCRIN, V34, P204, DOI 10.1016/j.domaniend.2007.03.001; Tosca L, 2006, J ENDOCRINOL, V190, P85, DOI 10.1677/joe.1.06828; VELDHUIS JD, 1980, ENDOCRINOLOGY, V107, P42, DOI 10.1210/endo-107-1-42; WANG C, 1979, J BIOL CHEM, V254, P1330; Wang YJ, 2010, GEN COMP ENDOCR, V166, P200, DOI 10.1016/j.ygcen.2009.10.007; Wen R, 2015, J STEROID BIOCHEM, V149, P70, DOI 10.1016/j.jsbmb.2015.01.001; Wilkanowska A, 2014, FOLIA BIOL-KRAKOW, V62, P1, DOI 10.3409/fb62_1.1; Woods DC, 2005, BIOCHEM BIOPH RES CO, V336, P450, DOI 10.1016/j.bbrc.2005.08.107; Woods DC, 2005, BIOL REPROD, V72, P643, DOI 10.1095/biolreprod.104.033902; Woods DC, 2007, BIOL REPROD, V77, P61, DOI 10.1095/biolreprod.106.059394; Woods DC, 2007, REPRODUCTION, V133, P733, DOI 10.1530/REP-06-0261; Woods DC, 2006, ENDOCRINOLOGY, V147, P4931, DOI 10.1210/en.2006-0194; ZADWORNY D, 1989, GEN COMP ENDOCR, V74, P468, DOI 10.1016/S0016-6480(89)80044-9; Zakany R, 2002, EXP CELL RES, V275, P1, DOI 10.1006/excr.2002.5487; Zhou JF, 1996, BIOL REPROD, V55, P1081, DOI 10.1095/biolreprod55.5.1081	57	14	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170409	10.1371/journal.pone.0170409	http://dx.doi.org/10.1371/journal.pone.0170409			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107515	gold, Green Published, Green Submitted			2022-12-26	WOS:000392405300129
J	Kilian, S; Burns, JK; Seedat, S; Asmal, L; Chiliza, B; Du Plessis, S; Olivier, MR; Kidd, M; Emsley, R				Kilian, S.; Burns, J. K.; Seedat, S.; Asmal, L.; Chiliza, B.; Du Plessis, S.; Olivier, M. R.; Kidd, M.; Emsley, R.			Factors Moderating the Relationship Between Childhood Trauma and Premorbid Adjustment in First-Episode Schizophrenia	PLOS ONE			English	Article							HIGH-RISK; PSYCHOSIS; STRESS; MALTREATMENT; SYMPTOMS; DISSOCIATION; REACTIVITY; DISORDERS; INTERACT; CHILDREN	Childhood trauma is a recognised risk factor for schizophrenia. It has been proposed that childhood trauma interferes with normal neurodevelopment, thereby establishing a biological vulnerability to schizophrenia. Poor premorbid adjustment is frequently a precursor to schizophrenia, and may be a manifestation of neurodevelopmental compromise. We investigated the relationship between childhood trauma and premorbid adjustment in 77 patients with first-episode schizophrenia spectrum disorders. We also investigated possible mediating roles for other selected risk factors in the relationship. We found several significant correlations between different trauma types and both social and academic premorbid adjustment from childhood to late adolescence. There were no significant moderating effects for family history of schizophrenia or family history of psychiatric disorder. History of obstetric complications, substance abuse and poor motor coordination weakened some of the associations between childhood trauma and premorbid adjustment, while poor sequencing of motor acts strengthened the association. Our results confirm previous studies indicating an association between childhood trauma and premorbid adjustment. Results indicate a general rather than specific association, apparent with different types of trauma, and affecting both social and academic components of premorbid adjustment across childhood, early and late adolescence. Further, our results suggest a complex interplay of various risk factors, supporting the notion of different pathways to psychosis.	[Kilian, S.; Seedat, S.; Asmal, L.; Chiliza, B.; Du Plessis, S.; Olivier, M. R.; Emsley, R.] Univ Stellenbosch, Dept Psychiat, Cape Town, South Africa; [Burns, J. K.] Univ KwaZulu Natal, Dept Psychiat, Durban, South Africa; [Burns, J. K.] Univ Exeter, Inst Hlth Res, Exeter, Devon, England; [Kidd, M.] Univ Stellenbosch, Ctr Stat Consultat, Cape Town, South Africa	Stellenbosch University; University of Kwazulu Natal; University of Exeter; Stellenbosch University	Kilian, S (corresponding author), Univ Stellenbosch, Dept Psychiat, Cape Town, South Africa.	sanjak@sun.ac.za	du Plessis, Stefan/AFO-8572-2022; Chiliza, Bonga/AAD-6259-2019	du Plessis, Stefan/0000-0001-9750-5731; Kilian, Sanja/0000-0003-4649-8388; Seedat, Soraya/0000-0002-5118-786X; Chiliza, Bonginkosi/0000-0001-5417-5920	New Partnership for Africa's Development (NEPAD) grant, through the Department of Science and Technology of South Africa; Medical Research Council of South Africa; Lundbeck International	New Partnership for Africa's Development (NEPAD) grant, through the Department of Science and Technology of South Africa; Medical Research Council of South Africa(South African Medical Research Council); Lundbeck International	This study was funded by a New Partnership for Africa's Development (NEPAD) grant, through the Department of Science and Technology of South Africa, the Medical Research Council of South Africa and an unrestricted grant from Lundbeck International.	Aas M, 2011, SCHIZOPHR RES, V129, P12, DOI 10.1016/j.schres.2011.03.017; Alameda L, 2015, PSYCHOL MED, V45, P2727, DOI 10.1017/S0033291715000690; Allen DN, 2013, SCHIZOPHR RES, V146, P132, DOI 10.1016/j.schres.2013.01.032; Bendall S, 2013, EARLY INTERV PSYCHIA, V7, P1, DOI 10.1111/eip.12008; Bernstein D. P, 1998, CTQ CHILDHOOD TRAUMA; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; Braehler C, 2013, PSYCHIAT RES, V210, P36, DOI 10.1016/j.psychres.2013.05.033; Buchanan RQ, 1998, PSYCHIAT RES, V21, P335; CANNONSPOOR HE, 1982, SCHIZOPHRENIA BULL, V8, P470, DOI 10.1093/schbul/8.3.470; Conus P, 2010, J AFFECT DISORDERS, V124, P341, DOI 10.1016/j.jad.2009.12.021; Demjaha A, 2012, SCHIZOPHRENIA BULL, V38, P209, DOI 10.1093/schbul/sbr100; Fergusson DM, 2011, INT J METH PSYCH RES, V20, P93, DOI 10.1002/mpr.337; First M, 2002, COMMUNICATION; Glaser JP, 2006, J PSYCHOSOM RES, V61, P229, DOI 10.1016/j.jpsychores.2006.04.014; Gupta Swapnil, 2010, Indian J Psychiatry, V52, P21, DOI 10.4103/0019-5545.58891; Harley M, 2010, PSYCHOL MED, V40, P1627, DOI 10.1017/S0033291709991966; Houston JE, 2011, PSYCHOL MED, V41, P2339, DOI 10.1017/S0033291711000559; Jonson-Reid M, 2004, CHILD MALTREATMENT, V9, P382, DOI 10.1177/1077559504269192; Krabbendam L, 2008, PSYCHOL MED, V38, P1405, DOI 10.1017/S0033291708002705; Lowe SR, 2016, CHILD ABUSE NEGLECT, V51, P212, DOI 10.1016/j.chiabu.2015.10.007; Maguire SA, 2015, CHILD CARE HLTH DEV, V41, P641, DOI 10.1111/cch.12227; MURRAY RM, 1992, J PSYCHIAT RES, V26, P225, DOI 10.1016/0022-3956(92)90029-N; Murray Robin M, 2002, World Psychiatry, V1, P137; Myin-Germeys I, 2007, CLIN PSYCHOL REV, V27, P409, DOI 10.1016/j.cpr.2006.09.005; Norman RMG, 2005, ACTA PSYCHIAT SCAND, V112, P30, DOI 10.1111/j.1600-0447.2005.00555.x; Perzow SED, 2013, J TRAUMA DISSOCIATIO, V14, P302, DOI 10.1080/15299732.2012.736928; Petruzzelli MG, 2015, NEUROPSYCH DIS TREAT, V11, P1793, DOI 10.2147/NDT.S83904; Quee PJ, 2014, J ABNORM PSYCHOL, V123, P578, DOI 10.1037/a0037189; Ramsay CE, 2011, PSYCHIAT RES, V188, P343, DOI 10.1016/j.psychres.2011.05.019; SANDERS B, 1991, AM J PSYCHIAT, V148, P50; Schafer I, 2006, J NERV MENT DIS, V194, P135, DOI 10.1097/01.nmd.0000198199.57512.84; Schenkel LS, 2005, SCHIZOPHR RES, V76, P273, DOI 10.1016/j.schres.2005.03.003; Sideli L, 2018, EARLY INTERV PSYCHIA, V12, P135, DOI 10.1111/eip.12285; Stain HJ, 2014, SCHIZOPHRENIA BULL, V40, P1491, DOI 10.1093/schbul/sbt166; Tarbox SI, 2012, SCHIZOPHR RES, V141, P91, DOI 10.1016/j.schres.2012.07.008; Thompson AD, 2014, SCHIZOPHRENIA BULL, V40, P697, DOI 10.1093/schbul/sbt032; Tikka M, 2013, EARLY INTERV PSYCHIA, V7, P51, DOI 10.1111/j.1751-7893.2012.00391.x; Trauelsen A. M., 2016, AUST NZ J PSYCHIAT, V2016, P1, DOI DOI 10.1016/LPSYCHRES.2016.02.003; Trotta A, 2015, BJPSYCH OPEN, V1, P6, DOI 10.1192/bjpo.bp.115.000158; Ucok A, 2007, ACTA PSYCHIAT SCAND, V116, P371, DOI 10.1111/j.1600-0447.2007.01079.x; van Winkel R, 2008, SCHIZOPHRENIA BULL, V34, P1095, DOI 10.1093/schbul/sbn101; Varambally Shivarama, 2012, Indian J Psychiatry, V54, P73, DOI 10.4103/0019-5545.94653; Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050; Viola TW, 2016, CHILD ABUSE NEGLECT, V51, P1, DOI 10.1016/j.chiabu.2015.11.019; Wang Z, 2013, EARLY INTERV PSYCHIA, V7, P23, DOI 10.1111/j.1751-7893.2012.00387.x	45	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170178	10.1371/journal.pone.0170178	http://dx.doi.org/10.1371/journal.pone.0170178			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI3QC	28107388	Green Submitted, Green Published, gold			2022-12-26	WOS:000392405300081
J	Laitman, BM; Mariani, JN; Zhang, C; Sawai, S; John, GR				Laitman, Benjamin M.; Mariani, John N.; Zhang, Chi; Sawai, Setsu; John, Gareth R.			Karyopherin Alpha Proteins Regulate Oligodendrocyte Differentiation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; IMPORTIN-ALPHA; NUCLEAR IMPORT; MULTIPLE-SCLEROSIS; TRANSPORT RECEPTOR; CELLS; LOCALIZATION; EXPRESSION; TRANSLOCATION; PATHOGENESIS	Proper regulation of the coordinated transcriptional program that drives oligodendrocyte (OL) differentiation is essential for central nervous system myelin formation and repair. Nuclear import, mediated in part by a group of karyopherin alpha (Kpna) proteins, regulates transcription factor access to the genome. Understanding how canonical nuclear import functions to control genomic access in OL differentiation may aid in the creation of novel therapeutics to stimulate myelination and remyelination. Here, we show that members of the Kpna family regulate OL differentiation, and may play distinct roles downstream of different pro-myelinating stimuli. Multiple family members are expressed in OLs, and their pharmacologic inactivation dose-dependently decreases the rate of differentiation. Additionally, upon differentiation, the three major Kpna subtypes (P/alpha 2, Q/alpha 3, S/alpha 1) display differential responses to the pro-myelinating cues T3 and CNTF. Most notably, the Q/a3 karyopherin Kpna4 is strongly upregulated by CNTF treatment both compared with T3 treatment and other Kpna responses. Kpna4 inactivation results in inhibition of CNTF-induced OL differentiation, in the absence of changes in proliferation or viability. Collectively, these findings suggest that canonical nuclear import is an integral component of OL differentiation, and that specific Kpnas may serve vital and distinct functions downstream of different pro-myelinating cues.	[Laitman, Benjamin M.; Mariani, John N.; Zhang, Chi; Sawai, Setsu; John, Gareth R.] Friedman Brain Inst, New York, NY 10029 USA; [Laitman, Benjamin M.; Mariani, John N.; Zhang, Chi; Sawai, Setsu; John, Gareth R.] Corinne Goldsmith Dickinson Ctr Multiple Sclerosi, New York, NY 10029 USA; [Laitman, Benjamin M.; Mariani, John N.; Zhang, Chi; Sawai, Setsu; John, Gareth R.] Icahn Sch Med Mt Sinai, Neurol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Laitman, BM (corresponding author), Friedman Brain Inst, New York, NY 10029 USA.; Laitman, BM (corresponding author), Corinne Goldsmith Dickinson Ctr Multiple Sclerosi, New York, NY 10029 USA.; Laitman, BM (corresponding author), Icahn Sch Med Mt Sinai, Neurol, New York, NY 10029 USA.	benjamin.laitman@icahn.mssm.edu		Laitman, Benjamin/0000-0002-9582-6088	National Institutes of Health [R01NS085103, R01NS062703]; National Institutes of Health National Research Service Award Fellowship [F30NS090718]; NMSS [RG4127, RG5024]; Beker Foundation; Noto Foundation; Guthy-Jackson Charitable Foundation; National Institutes of Health/National Cancer Institute [R24CA095823]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085103] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health National Research Service Award Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NMSS(National Multiple Sclerosis Society); Beker Foundation; Noto Foundation; Guthy-Jackson Charitable Foundation; National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (http://www.nih.gov/) R01NS085103 and R01NS062703 (GRJ). BML is the recipient of a National Institutes of Health National Research Service Award Fellowship F30NS090718. This study was also supported by NMSS Research Grants RG4127 and RG5024 (GRJ), and the Beker Foundation, Noto Foundation, and Guthy-Jackson Charitable Foundation (http://www guthyjacksonfoundation.org/) (GRJ). The ISMMS Microscopy Facility is supported by National Institutes of Health/National Cancer Institute (http://www.cancer.gov/) award R24CA095823. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRES BA, 1994, DEVELOPMENT, V120, P1097; Berger J, 2001, CURR OPIN NEUROL, V14, P305, DOI 10.1097/00019052-200106000-00007; Brilli E, 2009, J NEUROSCI RES, V87, P636, DOI 10.1002/jnr.21879; Chahine MN, 2009, PHARMACOL REV, V61, P358, DOI 10.1124/pr.108.000620; Dai JX, 2015, J NEUROSCI, V35, P15875, DOI 10.1523/JNEUROSCI.0882-15.2015; Ernst M, 2004, TRENDS GENET, V20, P23, DOI 10.1016/j.tig.2003.11.003; Fancy SPJ, 2011, ANNU REV NEUROSCI, V34, P21, DOI 10.1146/annurev-neuro-061010-113629; FORAN DR, 1992, J NEUROSCI, V12, P4890; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gottle P, 2015, SOC NEUROSCIENCE, V35, P906, DOI [10.1523/JNEUROSCI.1423-14.2015, DOI 10.1523/JNEUROSCI.1423-14.2015]; Gousias K, 2012, J NEURO-ONCOL, V109, P545, DOI 10.1007/s11060-012-0924-2; Hall MN, 2011, DEV BIOL, V357, P248, DOI 10.1016/j.ydbio.2011.06.032; Hosokawa K, 2008, NEUROSCIENCE, V157, P864, DOI 10.1016/j.neuroscience.2008.09.045; Huenniger K, 2010, CELL MOL LIFE SCI, V67, P3187, DOI 10.1007/s00018-010-0378-7; Jensen JB, 2011, EUR UROL, V59, P841, DOI 10.1016/j.eururo.2011.01.048; Kau TR, 2004, NAT REV CANCER, V4, P106, DOI 10.1038/nrc1274; King FW, 2004, MOL CELL BIOL, V24, P7091, DOI 10.1128/MCB.24.16.7091-7101.2004; Kohler M, 1999, MOL CELL BIOL, V19, P7782; Kohler M, 1997, FEBS LETT, V417, P104, DOI 10.1016/S0014-5793(97)01265-9; Laitman BM, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002467; Liang HJ, 2015, J NEUROSCI RES, V93, P253, DOI 10.1002/jnr.23486; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Matte C, 2010, INFECT IMMUN, V78, P3736, DOI 10.1128/IAI.00046-10; MCDONALD WI, 1969, NATURE, V221, P182, DOI 10.1038/221182a0; Mei F, 2014, NAT MED, V20, P954, DOI 10.1038/nm.3618; Nakahara J, 2009, J CLIN INVEST, V119, P169, DOI 10.1172/JCI35440; Nitahara-Kasahara Y, 2007, J VIROL, V81, P5284, DOI 10.1128/JVI.01928-06; Pandya K, 2002, J BIOL CHEM, V277, P16304, DOI 10.1074/jbc.M200866200; Quadrini KJ, 2002, J BIOL CHEM, V277, P32243, DOI 10.1074/jbc.M205677200; Quensel C, 2004, MOL CELL BIOL, V24, P10246, DOI 10.1128/MCB.24.23.10246-10255.2004; Soderholm JF, 2011, ACS CHEM BIOL, V6, P700, DOI 10.1021/cb2000296; Stankoff B, 2002, J NEUROSCI, V22, P9221; Talcott B, 2000, J BIOL CHEM, V275, P10099, DOI 10.1074/jbc.275.14.10099; Wang R, 2013, J VIROL, V87, P5219, DOI 10.1128/JVI.02643-12; Wang RW, 2007, FEBS LETT, V581, P3164, DOI 10.1016/j.febslet.2007.05.082; Yang WJ, 2015, GLIA, V63, P684, DOI 10.1002/glia.22778; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521; Yasuhara N, 2013, DEV CELL, V26, P123, DOI 10.1016/j.devcel.2013.06.022; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	42	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170477	10.1371/journal.pone.0170477	http://dx.doi.org/10.1371/journal.pone.0170477			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107514	gold, Green Submitted, Green Published			2022-12-26	WOS:000392405300144
J	Wang, Q; Chen, Y; Cvitkovic, R; Pennini, ME; Chang, CS; Pelletier, M; Bonnell, J; Koksal, AC; Wu, H; Dall'Acqua, WF; Stover, CK; Xiao, XD				Wang, Qun; Chen, Yan; Cvitkovic, Romana; Pennini, Meghan E.; Chang, Chew Shun; Pelletier, Mark; Bonnell, Jessica; Koksal, Adem C.; Wu, Herren; Dall'Acqua, William F.; Stover, C. Kendall; Xiao, Xiaodong			Anti-MrkA Monoclonal Antibodies Reveal Distinct Structural and Antigenic Features of MrkA	PLOS ONE			English	Article							BROADLY NEUTRALIZING ANTIBODIES; KLEBSIELLA-PNEUMONIAE; BIOFILM FORMATION; TYPE-3 FIMBRIAE; IDENTIFICATION; INFECTIONS; STRAINS; TARGET	Antibody therapy against antibiotics resistant Klebsiella pneumoniae infections represents a promising strategy, the success of which depends critically on the ability to identify appropriate antibody targets. Using a target-agnostic strategy, we recently discovered MrkA as a potential antibody target and vaccine antigen. Interestingly, the anti-MrkA monoclonal antibodies isolated through phage display and hybridoma platforms all recognize an overlapping epitope, which opens up important questions including whether monoclonal antibodies targeting different MrkA epitopes can be generated and if they possess different protective profiles. In this study we generated four anti-MrkA antibodies targeting different epitopes through phage library panning against recombinant MrkA protein. These anti-MrkA antibodies elicited strong in vitro and in vivo protections against a multi-drug resistant Klebsiella pneumoniae strain. Furthermore, mutational and epitope analysis suggest that the two cysteine residues may play essential roles in maintaining a MrkA structure that is highly compacted and exposes limited antibody binding/neutralizing epitopes. These results suggest the need for further in-depth understandings of the structure of MrkA, the role of MrkA in the pathogenesis of Klebsiella pneumoniae and the protective mechanism adopted by anti-MrkA antibodies to fully explore the potential of MrkA as an efficient therapeutic target and vaccine antigen.	[Wang, Qun; Cvitkovic, Romana; Pennini, Meghan E.; Pelletier, Mark; Bonnell, Jessica; Stover, C. Kendall] MedImmune, Dept Infect Dis & Vaccines, Gaithersburg, MD USA; [Chen, Yan; Chang, Chew Shun; Koksal, Adem C.; Wu, Herren; Dall'Acqua, William F.; Xiao, Xiaodong] MedImmune, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 21703 USA	AstraZeneca; Medimmune; AstraZeneca; Medimmune	Xiao, XD (corresponding author), MedImmune, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 21703 USA.	xiaox@medimmune.com		Koksal, Adem/0000-0002-3163-7421	MedImmune; Astra-Zeneca Plc.	MedImmune(AstraZenecaMedimmune); Astra-Zeneca Plc.(AstraZeneca)	This study was funded solely by MedImmune which is a subsidiary of Astra-Zeneca Plc. MedImmune has provided support in the form of salaries for all the authors and procurement of all materials for the study, but did not have any additional role in the study design, data collection and analysis or preparation of the manuscript. It has approved the decision to publish. The specific roles of all the authors are articulated in the 'author contributions' section.	Brisse S, 2013, J CLIN MICROBIOL, V51, P4073, DOI 10.1128/JCM.01924-13; Broberg Christopher A, 2014, F1000Prime Rep, V6, P64, DOI 10.12703/P6-64; Chan CH, 2012, LANGMUIR, V28, P7428, DOI 10.1021/la300224w; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Clements A, 2008, VACCINE, V26, P5649, DOI 10.1016/j.vaccine.2008.07.100; Cross AS, 2014, VIRULENCE, V5, P219, DOI 10.4161/viru.25965; Cywes-Bentley C, 2013, P NATL ACAD SCI USA, V110, pE2209, DOI 10.1073/pnas.1303573110; DiGiandomenico A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009655; DiGiandomenico A, 2012, J EXP MED, V209, P1273, DOI 10.1084/jem.20120033; Donta ST, 1996, J INFECT DIS, V174, P537, DOI 10.1093/infdis/174.3.537; EDELMAN R, 1994, VACCINE, V12, P1288, DOI 10.1016/S0264-410X(94)80054-4; Hansen DS, 1999, J CLIN MICROBIOL, V37, P56, DOI 10.1128/JCM.37.1.56-62.1999; Jagnow J, 2003, MICROBIOL-SGM, V149, P2397, DOI 10.1099/mic.0.26434-0; Langstraat J, 2001, INFECT IMMUN, V69, P5805, DOI 10.1128/IAI.69.9.5805-5812.2001; Lillo AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027756; McKenna M, 2013, NATURE, V499, P394, DOI 10.1038/499394a; Murphy CN, 2012, FUTURE MICROBIOL, V7, P991, DOI [10.2217/fmb.12.74, 10.2217/FMB.12.74]; Newton P, 2013, J BIOMOL SCREEN, V18, P237, DOI 10.1177/1087057112469047; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; Oganesyan V, 2008, ACTA CRYSTALLOGR D, V64, P700, DOI 10.1107/S0907444908007877; Piccoli L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8375; Vaughan TJ, 1996, NAT BIOTECHNOL, V14, P309, DOI 10.1038/nbt0396-309; VOLK WA, 1984, INFECT IMMUN, V45, P604, DOI 10.1128/IAI.45.3.604-609.1984; Wang Q, 2016, J INFECT DIS, V213, P1800, DOI 10.1093/infdis/jiw021; Xiao X, 2016, HUM VACC IMMUNOTHER, V0, DOI [10.1371/journal.pone.0027756, DOI 10.1371/JOURNAL.PONE.0027756]; Xiao XD, 2016, MABS-AUSTIN, V8, P916, DOI 10.1080/19420862.2016.1170263; Xiao XD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140691; Zwick MB, 2001, J VIROL, V75, P12198, DOI 10.1128/JVI.75.24.12198-12208.2001	28	9	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170529	10.1371/journal.pone.0170529	http://dx.doi.org/10.1371/journal.pone.0170529			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107434	Green Published, gold, Green Submitted			2022-12-26	WOS:000392405300156
J	Zhang, JL; Wang, L; Li, J; Kelly, P; Price, S; Wang, CM				Zhang, Jilei; Wang, Liang; Li, Jing; Kelly, Patrick; Price, Stuart; Wang, Chengming			First Molecular Characterization of Feline Immunodeficiency Virus in Domestic Cats from Mainland China	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; TOXOPLASMA-GONDII; GENETIC DIVERSITY; LEUKEMIA-VIRUS; FIV VACCINE; SUBTYPE-C; ENV GENE; INFECTION; TAIWAN; RECOMBINATION	The feline immunodeficiency virus (FIV) is a retrovirus of the Lentivirus genus that was initially isolated from a colony of domestic cats in California in 1986 and has now been recognized as a common feline pathogen worldwide. To date, there is only one recent serology-based report on FIV in mainland China which was published in 2016. We designed this study to investigate the molecular prevalence and diversity of feline immunodeficiency virus (FIV) in domestic cats from mainland China. We studied the prevalence of FIV in whole blood samples of 615 domestic cats in five cities (Beijing, Guangzhou, Nanjing, Shanghai and Yangzhou) of mainland China and examined them using FRET-PCR (Fluorescence Resonance Energy Transfer-Polymerase Chain Reaction) and regular PCRs for the gag and env genes. Overall, 1.3% (8/615) of the cats were positive for provirus DNA with nucleotide analysis using PCRs for the gag and env sequences showing the cats were infected with FIV subtype A. This is the first molecular characterization of FIV in mainland China and the first description of subtype A in continental Asia.	[Zhang, Jilei; Wang, Liang; Li, Jing; Wang, Chengming] Yangzhou Univ, Coll Vet Med, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China; [Kelly, Patrick] Ross Univ, Sch Vet Med, Dept Clin Sci, Basseterre, St Kitts & Nevi; [Price, Stuart; Wang, Chengming] Coll Vet Med, Dept Pathobiol, Auburn, AL 36849 USA	Yangzhou University	Wang, CM (corresponding author), Yangzhou Univ, Coll Vet Med, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China.; Wang, CM (corresponding author), Coll Vet Med, Dept Pathobiol, Auburn, AL 36849 USA.	wangche@auburn.edu	Zhang, Jilei/L-8672-2019	Zhang, Jilei/0000-0002-9589-1162	National Natural Science Foundation of China [31272575, 31472225]; Priority Academic Program Development of Jiangsu Higher Education Institutions; China Scholarship Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; China Scholarship Council(China Scholarship Council)	This project was supported by grants from the National Natural Science Foundation of China (NO 31272575, 31472225), and the Priority Academic Program Development of Jiangsu Higher Education Institutions and China Scholarship Council.	Bachmann MH, 1997, J VIROL, V71, P4241, DOI 10.1128/JVI.71.6.4241-4253.1997; Beczkowski PM, 2015, VET MICROBIOL, V176, P50, DOI 10.1016/j.vetmic.2014.12.023; Beczkowski PM, 2015, VACCINE, V33, P977, DOI 10.1016/j.vaccine.2015.01.028; Brown MA, 2010, VET IMMUNOL IMMUNOP, V134, P90, DOI 10.1016/j.vetimm.2009.10.014; Cong W, 2016, PARASITOL RES, V115, P217, DOI 10.1007/s00436-015-4738-y; Crawford PC, 2005, JAVMA-J AM VET MED A, V226, P1503, DOI 10.2460/javma.2005.226.1503; De Rozieres S, 2008, J VIROL, V82, P7953, DOI 10.1128/JVI.00337-08; Duarte A, 2006, VET MICROBIOL, V114, P25, DOI 10.1016/j.vetmic.2005.11.056; Gleich SE, 2009, J FELINE MED SURG, V11, P985, DOI 10.1016/j.jfms.2009.05.019; Hayward JJ, 2007, J VIROL, V81, P2999, DOI 10.1128/JVI.02090-06; Hayward JJ, 2010, VET IMMUNOL IMMUNOP, V134, P68, DOI 10.1016/j.vetimm.2009.10.011; Hayward JJ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-76; Ikeda Y, 1999, J WILDLIFE DIS, V35, P578, DOI 10.7589/0090-3558-35.3.578; Inada G, 1997, ARCH VIROL, V142, P1459, DOI 10.1007/s007050050172; KAWAGUCHI Y, 1992, VIROLOGY, V190, P465, DOI 10.1016/0042-6822(92)91235-M; Keawcharoen J., 2006, Thai Journal of Veterinary Medicine, V36, P77; Levy JK, 2008, J VET INTERN MED, V22, P330, DOI 10.1111/j.1939-1676.2008.0078.x; Levy J, 2008, J FELINE MED SURG, V10, P300, DOI 10.1016/j.jfms.2008.03.002; LIN DS, 1990, BRIT VET J, V146, P468, DOI 10.1016/0007-1935(90)90037-4; LIN JA, 1995, J VET MED SCI, V57, P161, DOI 10.1292/jvms.57.161; Nakamura K, 2003, ARCH VIROL, V148, P783, DOI 10.1007/s00705-002-0954-8; Nishimura Y, 1998, VIRUS RES, V57, P101, DOI 10.1016/S0168-1702(98)00085-9; Pedersen NC, 2001, VET IMMUNOL IMMUNOP, V79, P53, DOI 10.1016/S0165-2427(01)00252-5; PEDERSEN NC, 1987, SCIENCE, V235, P790, DOI 10.1126/science.3643650; Perharic M, 2016, ARCH VIROL, V161, P2567, DOI 10.1007/s00705-016-2928-2; Pu RY, 2005, J FELINE MED SURG, V7, P65, DOI 10.1016/j.jfms.2004.08.005; Ravi M, 2010, CAN VET J, V51, P271; Reggeti F, 2004, J GEN VIROL, V85, P1843, DOI 10.1099/vir.0.19743-0; RIGBY MA, 1993, J GEN VIROL, V74, P425, DOI 10.1099/0022-1317-74-3-425; Sellon R., 2006, INFECT DIS DOG CAT, V3rd, P131; SODORA DL, 1994, J VIROL, V68, P2230, DOI 10.1128/JVI.68.4.2230-2238.1994; Stickney AL, 2013, VET REC, V172, P607, DOI 10.1136/vr.f101460; Troyer JL, 2005, J VIROL, V79, P8282, DOI 10.1128/JVI.79.13.8282-8294.2005; Uema M, 1999, J VET MED SCI, V61, P197, DOI 10.1292/jvms.61.197; Wang CM, 2010, J CLIN MICROBIOL, V48, P1667, DOI 10.1128/JCM.00227-10; Weaver EA, 2004, J VIROL, V78, P2158, DOI 10.1128/JVI.78.4.2158-2163.2004; Weaver EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012004; Westman ME, 2016, VACCINE, V34, P4752, DOI 10.1016/j.vaccine.2016.06.060; Yamamoto JK, 2007, AIDS, V21, P547, DOI 10.1097/QAD.0b013e328013d88a	39	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0169739	10.1371/journal.pone.0169739	http://dx.doi.org/10.1371/journal.pone.0169739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107367	Green Published, gold, Green Submitted			2022-12-26	WOS:000392405300040
J	Kononenko, O; Galatenko, V; Andersson, M; Bazov, I; Watanabe, H; Zhou, XW; Iatsyshyna, A; Mityakina, I; Yakovleva, T; Sarkisyan, D; Ponomarev, I; Krishtal, O; Marklund, N; Tonevitsky, A; Adkins, DL; Bakalkin, G				Kononenko, Olga; Galatenko, Vladimir; Andersson, Malin; Bazov, Igor; Watanabe, Hiroyuki; Zhou, Xing Wu; Iatsyshyna, Anna; Mityakina, Irina; Yakovleva, Tatiana; Sarkisyan, Daniil; Ponomarev, Igor; Krishtal, Oleg; Marklund, Niklas; Tonevitsky, Alex; Adkins, DeAnna L.; Bakalkin, Georgy			Intra- and interregional coregulation of opioid genes: broken symmetry in spinal circuits	FASEB JOURNAL			English	Article						neuropeptides; spinal cord; lateralization	CONTROLLED CORTICAL IMPACT; TRAUMATIC BRAIN-INJURY; DROPLET DIGITAL PCR; COEXPRESSION NETWORKS; POSTURAL ASYMMETRY; INDUCED ARTHRITIS; NEURAL CIRCUITS; RECEPTOR GENE; RAT; EXPRESSION	Regulation of the formation and rewiring of neural circuits by neuropeptides may require coordinated production of these signaling molecules and their receptors that may be established at the transcriptional level. Here, we address this hypothesis by comparing absolute expression levels of opioid peptides with their receptors, the largest neuropeptide family, and by characterizing coexpression (transcriptionally coordinated) patterns of these genes. We demonstrated that expression patterns of opioid genes highly correlate within and across functionally and anatomically different areas. Opioid peptide genes, compared with their receptor genes, are transcribed at much greater absolute levels, which suggests formation of a neuropeptide cloud that covers the receptor-expressed circuits. Surprisingly, we found that both expression levels and the proportion of opioid receptors are strongly lateralized in the spinal cord, interregional coexpression patterns are side specific, and intraregional coexpression profiles are affected differently by left-and right-side unilateral body injury. We propose that opioid genes are regulated as interconnected components of the same molecular system distributed between distinct anatomic regions. The striking feature of this system is its asymmetric coexpression patterns, which suggest side-specific regulation of selective neural circuits by opioid neurohormones.-Kononenko, O., Galatenko, V., Andersson, M., Bazov, I., Watanabe, H., Zhou, X. W., Iatsyshyna, A., Mityakina, I., Yakovleva, T., Sarkisyan, D., Ponomarev, I., Krishtal, O., Marklund, N., Tonevitsky, A., Adkins, D. L., Bakalkin, G. Intra-and interregional coregulation of opioid genes: broken symmetry in spinal circuits.	[Kononenko, Olga; Andersson, Malin; Bazov, Igor; Watanabe, Hiroyuki; Zhou, Xing Wu; Iatsyshyna, Anna; Yakovleva, Tatiana; Sarkisyan, Daniil; Bakalkin, Georgy] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden; [Kononenko, Olga; Krishtal, Oleg] Bogomoletz Inst Physiol, Key State Lab, Kiev, Ukraine; [Galatenko, Vladimir; Mityakina, Irina; Tonevitsky, Alex] Moscow MV Lomonosov State Univ, Moscow, Russia; [Iatsyshyna, Anna] Inst Mol Biol & Genet, Dept Human Genet, Kiev, Ukraine; [Ponomarev, Igor] Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA; [Ponomarev, Igor] Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA; [Marklund, Niklas] Uppsala Univ Hosp, Sect Neurosurg, Dept Neurosci, Uppsala, Sweden; [Adkins, DeAnna L.] Med Univ South Carolina, Coll Hlth Profess, Dept Neurosci, Coll Med, Charleston, SC USA; [Adkins, DeAnna L.] Med Univ South Carolina, Coll Hlth Profess, Dept Hlth Sci & Res, Charleston, SC USA	Uppsala University; National Academy of Sciences Ukraine; A.A. Bogomoletz Institute of Physiology; Lomonosov Moscow State University; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Uppsala University; Uppsala University Hospital; Medical University of South Carolina; Medical University of South Carolina	Bazov, I (corresponding author), Uppsala Univ, Div Biol Res Drug Dependence, Dept Pharmaceut Biosci, Husargatan 3,Box 591, S-75124 Uppsala, Sweden.	igor.bazov@farmbio.uu.se	Tonevitsky, Alexander/R-5596-2019; Galatenko, Vladimir V./E-5139-2014; Galatenko, Vladimir/ABB-7514-2020; Andersson, Malin/A-9930-2009; Iatsyshyna, Anna/M-3648-2015	Galatenko, Vladimir V./0000-0003-3029-3628; Galatenko, Vladimir/0000-0003-3029-3628; Andersson, Malin/0000-0002-1450-8046; Adkins, DeAnna L/0000-0002-3063-5731; Iatsyshyna, Anna/0000-0002-8175-6955; Bazov, Igor/0000-0003-4388-1656; Bakalkin, Georgy/0000-0002-8074-9833; Marklund, Niklas/0000-0002-9797-5626	Swedish Science Research Council (VR); Swedish Council for Working Life and Social Research (FORTE); Swedish Research Council Formas; Swedish Institute (Visby Program); European Union, Swedish Brain Foundation; Uppsala University Hospital Research Fund (ALF); U. S. National Institutes of Health National Institute of Neurological Disorders and Stroke [NS065866]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R28AA012725] Funding Source: NIH RePORTER	Swedish Science Research Council (VR)(Swedish Research Council); Swedish Council for Working Life and Social Research (FORTE); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish Institute (Visby Program); European Union, Swedish Brain Foundation; Uppsala University Hospital Research Fund (ALF); U. S. National Institutes of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in part, by grants from the Swedish Science Research Council (VR), the Swedish Council for Working Life and Social Research (FORTE), and the Swedish Research Council Formas (to G. B.); the Swedish Institute (Visby Program; to O. K. and G. B.); the European Union, Swedish Brain Foundation, and Uppsala University Hospital Research Fund (ALF; to N. M.); and U. S. National Institutes of Health National Institute of Neurological Disorders and Stroke Grant NS065866 (to D. L. A.). The authors thank Prof. Olga Korosteleva (Statistics at California State University, Long Beach, Long Beach, CA, USA) for discussion and correction of the manuscript. The authors declare no conflicts of interest.	BAKALKIN GJ, 1980, DOKL AKAD NAUK SSSR+, V252, P762; BAKALKIN GY, 1989, BRAIN RES, V480, P268, DOI 10.1016/0006-8993(89)90192-3; BAKALKIN GY, 1986, PEPTIDES, V7, P551, DOI 10.1016/0196-9781(86)90025-2; BAKALKIN GY, 1989, BRAIN RES, V480, P277, DOI 10.1016/0006-8993(89)90193-5; Bardoni R, 2014, NEURON, V81, P1312, DOI 10.1016/j.neuron.2014.01.044; Bargmann CI, 2013, NAT METHODS, V10, P483, DOI 10.1038/NMETH.2451; Bargmann CI, 2012, BIOESSAYS, V34, P458, DOI 10.1002/bies.201100185; Barrios A, 2012, NAT NEUROSCI, V15, P1675, DOI 10.1038/nn.3253; CHAMBERLAIN TJ, 1963, J NEUROPHYSIOL, V26, P662, DOI 10.1152/jn.1963.26.4.662; Chavkin C, 2013, MOL PHARMACOL, V83, P729, DOI 10.1124/mol.112.083337; CHAZOV EI, 1981, EXPERIENTIA, V37, P887, DOI 10.1007/BF01985696; Clarke RW, 2004, BRAIN RES REV, V46, P163, DOI 10.1016/j.brainresrev.2004.07.005; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Combs HL, 2016, J NEUROTRAUM, V33, P741, DOI 10.1089/neu.2015.4136; Concha ML, 2012, NAT REV NEUROSCI, V13, P832, DOI 10.1038/nrn3371; DiGiorgio A., 1942, ARCH FISIOL, V42, P25; DiGiorgio AM., 1929, ARCH FISIOL, V27, P518; Drake CT, 2007, PROG BRAIN RES, V163, P245, DOI 10.1016/S0079-6123(07)63015-5; Duan B, 2014, CELL, V159, P1417, DOI 10.1016/j.cell.2014.11.003; Duboc V, 2015, ANNU REV GENET, V49, P647, DOI 10.1146/annurev-genet-112414-055322; Ferguson SM, 2011, NAT NEUROSCI, V14, P22, DOI 10.1038/nn.2703; Francks C, 2015, ANN NY ACAD SCI, V1359, P1, DOI 10.1111/nyas.12770; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Gaiteri C, 2014, GENES BRAIN BEHAV, V13, P13, DOI 10.1111/gbb.12106; Gao CJ, 2012, NEUROSCIENCE, V202, P352, DOI 10.1016/j.neuroscience.2011.11.060; Georganta EM, 2010, NEUROPHARMACOLOGY, V59, P139, DOI 10.1016/j.neuropharm.2010.04.010; Grange P, 2014, P NATL ACAD SCI USA, V111, P5397, DOI 10.1073/pnas.1312098111; Hauser KF, 2005, FRONT BIOSCI-LANDMRK, V10, P216, DOI 10.2741/1522; Hausmann M, 2013, NEUROPSYCHOLOGIA, V51, P1734, DOI 10.1016/j.neuropsychologia.2013.05.017; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; HERKENHAM M, 1987, NEUROSCIENCE, V23, P1, DOI 10.1016/0306-4522(87)90268-5; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Hong S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086851; Hu Zhenjun, 2014, Curr Protoc Bioinformatics, V45, DOI 10.1002/0471250953.bi0808s45; Hu ZJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-17; Hussain ZM, 2012, J NEUROTRAUM, V29, P1785, DOI 10.1089/neu.2011.2286; Jefferson SC, 2016, NEUROREHAB NEURAL RE, V30, P155, DOI 10.1177/1545968315600274; JENNRICH RI, 1970, J AM STAT ASSOC, V65, P904, DOI 10.2307/2284596; Jones TA, 2012, J NEUROTRAUM, V29, P1455, DOI 10.1089/neu.2011.2207; Kim KI, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-114; Kraus J, 2001, J BIOL CHEM, V276, P43901, DOI 10.1074/jbc.M107543200; Kuzmin A, 2000, J PHARMACOL EXP THER, V295, P1031; Leinwand Sarah G, 2014, Worm, V3, pe27730, DOI 10.4161/worm.27730; LEVIN BE, 1995, BRAIN RES, V674, P307, DOI 10.1016/0006-8993(95)00032-L; Li Q, 2003, MOL BRAIN RES, V114, P46, DOI 10.1016/S0169-328X(03)00131-1; Li YP, 2015, G3-GENES GENOM GENET, V5, P1075, DOI 10.1534/g3.115.018127; Lopez-Kleine L, 2013, BRIEF FUNCT GENOMICS, V12, P457, DOI 10.1093/bfgp/elt003; Ludwig M, 2006, NAT REV NEUROSCI, V7, P126, DOI 10.1038/nrn1845; MacNeilage PF, 2009, SCI AM, V301, P60, DOI 10.1038/scientificamerican0709-60; Madsen KS, 2012, NEUROIMAGE, V63, P95, DOI 10.1016/j.neuroimage.2012.06.071; Marcoli M, 2015, REV NEUROSCIENCE, V26, P489, DOI 10.1515/revneuro-2015-0007; Marlin BJ, 2015, NATURE, V520, P499, DOI 10.1038/nature14402; MATTHEWS SG, 1995, DEV BRAIN RES, V86, P259, DOI 10.1016/0165-3806(95)00032-9; McDermott GP, 2013, ANAL CHEM, V85, P11619, DOI 10.1021/ac403061n; MORROW L, 1981, NEUROPSYCHOLOGIA, V19, P65, DOI 10.1016/0028-3932(81)90045-2; Park SW, 2008, NEUROSCIENCE, V151, P1034, DOI 10.1016/j.neuroscience.2007.12.015; PEARLSON GD, 1981, BRAIN RES, V218, P233, DOI 10.1016/0006-8993(81)91303-2; PERSSON S, 1994, NEUROSCIENCE, V63, P313, DOI 10.1016/0306-4522(94)90026-4; Remage-Healey L, 2014, HORM BEHAV, V66, P552, DOI 10.1016/j.yhbeh.2014.07.014; Reznikov K, 1999, EUR J NEUROSCI, V11, P2711, DOI 10.1046/j.1460-9568.1999.00680.x; Schaefer SY, 2009, NEUROPSYCHOLOGIA, V47, P2953, DOI 10.1016/j.neuropsychologia.2009.06.025; Schweickert A, 2008, DEV DYNAM, V237, P3557, DOI 10.1002/dvdy.21638; Steffens H, 2011, NEUROSCI RES, V70, P44, DOI 10.1016/j.neures.2011.01.011; Stoop R, 2012, NEURON, V76, P142, DOI 10.1016/j.neuron.2012.09.025; Sun T, 2006, NAT REV NEUROSCI, V7, P655, DOI 10.1038/nrn1930; THAI L, 1992, MOL BRAIN RES, V16, P150, DOI 10.1016/0169-328X(92)90205-P; Nguyen TV, 2013, CEREB CORTEX, V23, P1424, DOI 10.1093/cercor/bhs125; Ulrich JD, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.365197; van den Pol AN, 2012, NEURON, V76, P98, DOI 10.1016/j.neuron.2012.09.014; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Watanabe H, 2015, CEREB CORTEX, V25, P97, DOI 10.1093/cercor/bht204; Williams JT, 2013, PHARMACOL REV, V65, P223, DOI 10.1124/pr.112.005942; Wu YX, 2014, NEUROSCI LETT, V580, P7, DOI 10.1016/j.neulet.2013.11.055; Yuen JWF, 2004, NEUROREPORT, V15, P1431, DOI 10.1097/01.wnr.0000130433.90962.6e; Zaringhalam J, 2008, CLIN EXP PHARMACOL P, V35, P1309, DOI 10.1111/j.1440-1681.2008.05009.x; Zink CF, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.2	76	18	18	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1953	1963		10.1096/fj.201601039R	http://dx.doi.org/10.1096/fj.201601039R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28122917	Green Published			2022-12-26	WOS:000399195500017
J	Greer, YE; Gao, B; Yang, YZ; Nussenzweig, A; Rubin, JS				Greer, Yoshimi Endo; Gao, Bo; Yang, Yingzi; Nussenzweig, Andre; Rubin, Jeffrey S.			Lack of Casein Kinase 1 Delta Promotes Genomic Instability - The Accumulation of DNA Damage and Down-Regulation of Checkpoint Kinase 1	PLOS ONE			English	Article							MITOTIC SPINDLE FORMATION; BARDET-BIEDL SYNDROME; CELL-CYCLE ARREST; PROTEIN-KINASE; REPLICATION STRESS; BUDDING YEAST; PHOSPHORYLATION; CHK1; CANCER; ACTIVATION	Casein kinase 1 delta (CK1 delta) is a conserved serine/threonine protein kinase that regulates diverse cellular processes. Mice lacking CK1 delta have a perinatal lethal phenotype and typically weigh 30% less than their wild type littermates. However, the causes of death and small size are unknown. We observed cells with abnormally large nuclei in tissue from Csnk1d null embryos, and multiple centrosomes in mouse embryo fibroblasts (MEFs) deficient in CK1 delta (MEFCsnk1d null). Results from gamma-H2AX staining and the comet assay demonstrated significant DNA damage in MEFCsnk1d null cells. These cells often contain micronuclei, an indicator of genomic instability. Similarly, abrogation of CK1 delta expression in control MEFs stimulated micronuclei formation after doxorubicin treatment, suggesting that CK1 delta loss increases vulnerability to genotoxic stress. Cellular levels of total and activated checkpoint kinase 1 (Chk1), which functions in the DNA damage response and mitotic checkpoints, and its downstream effector, Cdc2/CDK1 kinase, were often decreased in MEFCsnk1d null cells as well as in control MEFs transfected with CK1 delta siRNA. Hydroxyureainduced Chk1 activation, as measured by Ser345 phosphorylation, and nuclear localization also were impaired in MEF cells following siRNA knockdown of CK1 delta. Similar results were observed in the MCF7 human breast cancer cell line. The decreases in phosphorylated Chk1 were rescued by concomitant expression of siRNA-resistant CK1 delta. Experiments with cycloheximide demonstrated that the stability of Chk1 protein was diminished in cells subjected to CK1 delta knockdown. Together, these findings suggest that CK1 delta contributes to the efficient repair of DNA damage and the proper functioning of mitotic checkpoints by maintaining appropriate levels of Chk1.	[Greer, Yoshimi Endo; Rubin, Jeffrey S.] NCI, Cellular & Mol Biol Lab, Bldg 37, Bethesda, MD 20892 USA; [Greer, Yoshimi Endo] NCI, Womens Malignancies Branch, Bethesda, MD 20892 USA; [Gao, Bo; Yang, Yingzi] NHGRI, Genet Dis Res Branch, Bethesda, MD 20892 USA; [Nussenzweig, Andre] NCI, Lab Genome Integr, Bethesda, MD 20892 USA; [Gao, Bo] Univ Hong Kong, Li Ka Shing Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Yang, Yingzi] Harvard Sch Dent Med, Dept Dev Biol, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Hong Kong; Harvard University; Harvard School of Dental Medicine	Greer, YE; Rubin, JS (corresponding author), NCI, Cellular & Mol Biol Lab, Bldg 37, Bethesda, MD 20892 USA.; Greer, YE (corresponding author), NCI, Womens Malignancies Branch, Bethesda, MD 20892 USA.	greery@mail.nih.gov; jeff535@verizon.net	Greer, Yoshimi/K-2155-2019	Gao, Bo/0000-0002-8684-5199	Intramural Research Program of the National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC010959, ZIABC010283] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute. It paid the salaries of YEG, AN and JSR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARLTROP JA, 1991, BIOORG MED CHEM LETT, V1, P611, DOI 10.1016/S0960-894X(01)81162-8; Behrend L, 2000, ONCOGENE, V19, P5303, DOI 10.1038/sj.onc.1203939; Behrend L, 2000, EUR J CELL BIOL, V79, P240, DOI 10.1078/S0171-9335(04)70027-8; Bischof J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068803; Bischof J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020857; Calvo E, 2014, INVEST NEW DRUG, V32, P955, DOI 10.1007/s10637-014-0114-5; Chen P, 2000, CELL, V100, P681, DOI 10.1016/S0092-8674(00)80704-7; Cheong JK, 2011, ONCOGENE, V30, P2558, DOI 10.1038/onc.2010.627; Cheong JK, 2011, INT J BIOCHEM CELL B, V43, P465, DOI 10.1016/j.biocel.2010.12.004; Dagon Y, 2001, ONCOGENE, V20, P8045, DOI 10.1038/sj.onc.1204945; Dai Y, 2010, CLIN CANCER RES, V16, P376, DOI 10.1158/1078-0432.CCR-09-1029; Daud AI, 2015, J CLIN ONCOL, V33, P1060, DOI 10.1200/JCO.2014.57.5027; Donzelli M, 2003, EMBO REP, V4, P671, DOI 10.1038/sj.embor.embor887; Dumaz N, 1999, FEBS LETT, V463, P312, DOI 10.1016/S0014-5793(99)01647-6; Etchegaray JP, 2009, MOL CELL BIOL, V29, P3853, DOI 10.1128/MCB.00338-09; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Filges I, 2016, HUM MUTAT, V37, P359, DOI 10.1002/humu.22960; Forsythe E, 2015, CLIN GENET, V87, P343, DOI 10.1111/cge.12373; Greer YE, 2014, MOL BIOL CELL, V25, P1629, DOI 10.1091/mbc.E13-10-0598; Greer YE, 2011, J CELL BIOL, V192, P993, DOI 10.1083/jcb.201011111; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Ho Y, 1997, P NATL ACAD SCI USA, V94, P581, DOI 10.1073/pnas.94.2.581; HOEKSTRA MF, 1991, SCIENCE, V253, P1031, DOI 10.1126/science.1887218; Honaker Y, 2010, ONCOGENE, V29, P3324, DOI 10.1038/onc.2010.96; Imhoff O, 2011, CLIN J AM SOC NEPHRO, V6, P22, DOI 10.2215/CJN.03320410; Inuzuka H, 2010, CANCER CELL, V18, P147, DOI 10.1016/j.ccr.2010.06.015; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; Jiang KC, 2003, J BIOL CHEM, V278, P25207, DOI 10.1074/jbc.M300070200; Johnson AE, 2013, CURR BIOL, V23, P1920, DOI 10.1016/j.cub.2013.07.077; Kim K., 2014, J MARKETING THOUGHT, V1, P1, DOI DOI 10.4161/15384047; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Knippschild U, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00096; Lecona E, 2014, EXP CELL RES, V329, P26, DOI 10.1016/j.yexcr.2014.09.019; Leung-Pineda V, 2009, CANCER RES, V69, P2630, DOI 10.1158/0008-5472.CAN-08-3382; Liu QH, 2000, GENE DEV, V14, P1448; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Loughery J., 2013, BIODISCOVERY, V8, pe8946, DOI [10.7750/BioDiscovery.2013.8.1, DOI 10.7750/BI0DISC0VERY.2013.8.1]; Lu XH, 2001, CLIN CANCER RES, V7, P2114; Luzhna Lidiya, 2013, Frontiers in Genetics, V4, P131, DOI 10.3389/fgene.2013.00131; Mehlgarten C, 2003, MOL GENET GENOMICS, V269, P188, DOI 10.1007/s00438-003-0807-5; Meng Z, 2011, MOL BIOL CELL, V22, P2834, DOI 10.1091/mbc.E11-01-0048; Mijaljica D, 2013, J CELL SCI, V126, P4325, DOI 10.1242/jcs.133090; Piao S, 2011, CELL CYCLE, V10, P531, DOI 10.4161/cc.10.3.14757; Probst FJ, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0291-0; Puigvert JC, 2016, FEBS J, V283, P232, DOI 10.1111/febs.13574; Sakaguchi K, 2000, J BIOL CHEM, V275, P9278, DOI 10.1074/jbc.275.13.9278; Sakurikar N, 2015, J CLIN ONCOL, V33, P1075, DOI 10.1200/JCO.2014.60.0767; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Smits VAJ, 2015, FEBS J, V282, P3681, DOI 10.1111/febs.13387; Stoter M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100090; Stoter M, 2005, ONCOGENE, V24, P7964, DOI 10.1038/sj.onc.1208941; Waters AM, 2015, J MED GENET, V52, P147, DOI 10.1136/jmedgenet-2014-102691; Willers H, 2015, SEMIN RADIAT ONCOL, V25, P237, DOI 10.1016/j.semradonc.2015.05.007; Winter M, 2004, BIOCHEMISTRY-US, V43, P16356, DOI 10.1021/bi0489255; Yoon CH, 2010, EMBO REP, V11, P393, DOI 10.1038/embor.2010.45; Zhang Y., 2012, SCI TOTAL ENVIRON, V442, P1, DOI DOI 10.1016/J.SCIT0TENV.2012.10.042; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	58	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170903	10.1371/journal.pone.0170903	http://dx.doi.org/10.1371/journal.pone.0170903			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125685	Green Published, gold, Green Submitted			2022-12-26	WOS:000396176100027
J	Guo, HY; Cheng, GH; Li, YJ; Zhang, H; Qin, KL				Guo, Haiyan; Cheng, Guohu; Li, Yongjun; Zhang, Hao; Qin, Kangle			A Screen for Key Genes and Pathways Involved in High-Quality Brush Hair in the Yangtze River Delta White Goat	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; PHOSPHATASES; RECEPTOR; MITOGEN; SKIN	The Yangtze River Delta White Goat is the only goat breed that produces high-quality brush hair, or type III hair, which is specialized for use in top-grade writing brushes. There has been little research, especially molecular research, on the traits that result in high-quality brush hair in the Yangtze River Delta White Goat. To explore the molecular mechanisms of the formation of high-quality brush hair, High-throughput RNA-Seq technology was used to compare skin samples from Yangtze River Delta White Goats that produce high-quality hair and non high-quality hair for identification of the important genes and related pathways that might influence the hair quality traits. The results showed that 295 genes were expressed differentially between the goats with higher and lower hair quality, respectively. Of those genes, 132 were up-regulated, 62 were down-regulated, and 101 were expressed exclusively in the goats with high-quality brush hair. Gene Ontology and Metabolic Pathway Significant Enrichment analyses of the differentially expressed genes indicated that the MAP3K1, DUSP1, DUSP6 and the MAPK signaling pathway might play important roles in the traits important for high-quality brush hair.	[Guo, Haiyan; Cheng, Guohu; Li, Yongjun; Zhang, Hao; Qin, Kangle] Yangzhou Univ, Key Lab Anim Genet & Mol Breeding Jiangsu Prov, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China	Yangzhou University	Li, YJ (corresponding author), Yangzhou Univ, Key Lab Anim Genet & Mol Breeding Jiangsu Prov, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China.	877201233@qq.com		Li, Yongjun/0000-0002-7913-8533	National Natural Science Foundation of China [31572355]; Priority Academic Program Development of Jiangsu Higher Education Institutions [PAPD 2011-137]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by funding from the National Natural Science Foundation of China (31572355) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD 2011-137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeev V, 2000, NAT BIOTECHNOL, V18, P43, DOI 10.1038/71901; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chang ZL, 2006, CHINA HERBIVORE SCI, P88; Chen Li, 2014, Acta Veterinaria et Zootechnica Sinica, V45, P1228; Chen WY, 2012, MOL CELL BIOCHEM, V366, P11, DOI 10.1007/s11010-012-1275-1; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; DENU JM, 1995, P NATL ACAD SCI USA, V92, P5910, DOI 10.1073/pnas.92.13.5910; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; Efimova T, 1998, J BIOL CHEM, V273, P24387, DOI 10.1074/jbc.273.38.24387; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Geng RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062704; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Huang YH, 1994, J JIANGSU AGR COLL, V16, P51; Jia ZH, 1999, ACTA ZOONUTRIMENTA S, P97; Li G Q, 2004, FOREIGN MED SCI DERM, V30, P38; Li LW, 2009, INT J CLIN EXP MED, V2, P48; Li SW, 2009, EXP DERMATOL, V18, P134, DOI 10.1111/j.1600-0625.2008.00774.x; Li WB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132621; Li Y., 2005, CHINA HERBIV, V25, P44; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Lv XY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157463; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Mills JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078480; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; National livestock and Poultry Genetic Resources Committee, 2011, CHINESE LIVESTOCK PO; Ozturk OA, 2015, CELL REP, V13, P561, DOI 10.1016/j.celrep.2015.09.015; Pan XG, 1985, CHINESE J ANIMAL SCI, P38; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Schneider MR, 2008, AM J PATHOL, V173, P14, DOI 10.2353/ajpath.2008.070942; Sheng Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143742; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; Wei B, 2015, MOL MED REP, V11, P2548, DOI 10.3892/mmr.2014.3094; [吴刘成 WU LiuCheng], 2011, [动物学杂志, Chinese Journal of Zoology], V46, P144; Xiaoyan L I, 2015, ACTA VET ZOOTECHNICA; Xu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055496; Yang B, 2015, GENET MOL RES, V14, P323, DOI 10.4238/2015.January.23.6; Yang HL, 2014, GENE, V538, P113, DOI 10.1016/j.gene.2013.12.057; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhan XL, 2001, CHEM REV, V101, P2477, DOI 10.1021/cr000245u; Zhao YZ, 2013, CHINESE SHEEP BREEDI	41	12	14	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0169820	10.1371/journal.pone.0169820	http://dx.doi.org/10.1371/journal.pone.0169820			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125615	gold, Green Published, Green Submitted			2022-12-26	WOS:000396176100134
J	Peters, ITA; van Zwet, EW; Smit, VTHBM; Liefers, GJ; Kuppen, PJK; Hilders, CGJM; Trimbos, JB				Peters, Inge T. A.; van Zwet, Erik W.; Smit, Vincent T. H. B. M.; Liefers, Gerrit Jan; Kuppen, Peter J. K.; Hilders, Carina G. J. M.; Trimbos, J. Baptist			Prevalence and Risk Factors of Ovarian Metastases in Breast Cancer Patients < 41 Years of Age in the Netherlands: A Nationwide Retrospective Cohort Study	PLOS ONE			English	Article							TISSUE; TRANSPLANTATION; AUTOTRANSPLANTATION; MECHANISMS; PATHOLOGY; CORTEX	Purpose Breast cancer is one of the primary indications for cryopreservation and subsequent autotransplantation of ovarian tissue. The safety of this fertility preservation method remains questionable, as the presence of disseminated breast tumor cells cannot yet be excluded in the ovarian autografts. We explored the prevalence of ovarian metastases among young breast cancer patients and determined risk factors for the development of ovarian metastases. Methods Using the nationwide database of the Dutch Pathology Registry (PALGA), we identified a cohort of 2648 women with primary invasive breast cancer at age < 41 years in the period 2000-2010 in the Netherlands who subsequently underwent an oophorectomy. From this source population, all cases who had histologically confirmed ovarian metastases were included. For each case of whom clinical data were available, one control without ovarian metastases who matched the time interval between breast cancer diagnosis and oophorectomy was selected. Data were collected on patient characteristics, diagnosis, treatment and follow-up. Results Ovarian metastases were found in 63 out of 2648 patients who met the inclusion criteria. The risk of developing ovarian metastases increased with time passed since breast cancer diagnosis. Multivariate logistic regression analyses showed significant association between tumor stage and the development of ovarian metastases (p = 0.024). Conclusions The prevalence of ovarian metastases was 2.4% among young breast cancer patients. Early ovary removal may reduce the risk of developing ovarian metastases. In breast cancer patients with tumors > 5 cm and/or inflammatory carcinoma, we recommend a cautious approach to ovarian tissue autotransplantation.	[Peters, Inge T. A.; Trimbos, J. Baptist] Leiden Univ, Med Ctr, Dept Gynecol, Leiden, Netherlands; [van Zwet, Erik W.] Leiden Univ, Med Ctr, Dept Med Stat, Leiden, Netherlands; [Smit, Vincent T. H. B. M.] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [Liefers, Gerrit Jan; Kuppen, Peter J. K.] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands; [Hilders, Carina G. J. M.] Reinier da Graaf Hosp, Dept Gynecol, Delft, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Peters, ITA (corresponding author), Leiden Univ, Med Ctr, Dept Gynecol, Leiden, Netherlands.	i.t.a.peters@lumc.nl	Kuppen, Peter/J-2342-2016; Smit, Vincent/AAD-1811-2022	Kuppen, Peter/0000-0002-0294-3251; Smit, Vincent/0000-0003-3730-5652; Peters, Inge/0000-0001-8665-9487	DSW Health Insurance; Zabawas Foundation	DSW Health Insurance; Zabawas Foundation	This work was supported by a grant from DSW Health Insurance (https://ww.dsw.nl) and the Zabawas Foundation (http://zabawas.nl/). These funding sources were not involved in any part of the study.	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Anderson WF, 2006, CANCER EPIDEM BIOMAR, V15, P1899, DOI 10.1158/1055-9965.EPI-06-0191; Azem F, 2010, INT J GYNECOL PATHOL, V29, P19, DOI 10.1097/PGP.0b013e3181ad1c52; Bastings L, 2013, HUM REPROD UPDATE, V19, P483, DOI 10.1093/humupd/dmt020; Bigorie V, 2010, CANCER-AM CANCER SOC, V116, P799, DOI 10.1002/cncr.24807; Casparie M, 2007, CELL ONCOL, V29, P19; Donnez J, 2015, J ASSIST REPROD GEN, V32, P1167, DOI 10.1007/s10815-015-0544-9; Donnez J, 2013, FERTIL STERIL, V99, P1503, DOI 10.1016/j.fertnstert.2013.03.030; Federa FMWV, 2011, COD PROP 2 US HUM TI; Finch APM, 2014, J CLIN ONCOL, V32, P1547, DOI 10.1200/JCO.2013.53.2820; Gamzatova Z, 2014, GYNECOL ENDOCRINOL, V30, P43, DOI 10.3109/09513590.2014.945789; Grogan TM, INTERPRETATION GUIDE; Kim SS, 2012, J ASSIST REPROD GEN, V29, P489, DOI 10.1007/s10815-012-9757-3; Luyckx V, 2013, J ASSIST REPROD GEN, V30, P1289, DOI 10.1007/s10815-013-0065-3; McCluggage WG, 2005, HISTOPATHOLOGY, V47, P231, DOI 10.1111/j.1365-2559.2005.02194.x; Morgan S, 2012, HUM REPROD UPDATE, V18, P525, DOI 10.1093/humupd/dms022; Oncoline, 2012, CANC CLIN PRACT GUID; Perrotin F, 2001, Gynecol Obstet Fertil, V29, P308, DOI 10.1016/S1297-9589(01)00131-X; Peters IT, 2016, ARCH GYNECOL OBSTET, V5; Rabban JT, 2009, AM J SURG PATHOL, V33, P1125, DOI 10.1097/PAS.0b013e31819e986a; Ridolfi RL, 2000, MODERN PATHOL, V13, P866, DOI 10.1038/modpathol.3880154; Rosendahl M, 2011, FERTIL STERIL, V95, P2158, DOI 10.1016/j.fertnstert.2010.12.019; Sanchez-Serrano M, 2009, HUM REPROD, V24, P2238, DOI 10.1093/humrep/dep196; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sosa MS, 2014, NAT REV CANCER, V14, P611, DOI 10.1038/nrc3793	25	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0168277	10.1371/journal.pone.0168277	http://dx.doi.org/10.1371/journal.pone.0168277			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125710	Green Published, gold, Green Submitted			2022-12-26	WOS:000396176100150
J	Delsett, LL; Roberts, AJ; Druckenmiller, PS; Hurum, JH				Delsett, Lene Liebe; Roberts, Aubrey J.; Druckenmiller, Patrick S.; Hurum, Jorn H.			A New Ophthalmosaurid (Ichthyosauria) from Svalbard, Norway, and Evolution of the Ichthyopterygian Pelvic Girdle	PLOS ONE			English	Article							REPTILIA ICHTHYOSAURIA; CRETACEOUS ICHTHYOSAUR; SLOTTSMOYA MEMBER; PATAGONIA; GENUS; REDESCRIPTION; ENVIRONMENTS; JANUSFJELLET; LAGERSTATTE; SPITSBERGEN	In spite of a fossil record spanning over 150 million years, pelvic girdle evolution in Ichthyopterygia is poorly known. Here, we examine pelvic girdle size relationships using quantitative methods and new ophthalmosaurid material from the Slottsmoya Member Lagerstatte of Svalbard, Norway. One of these new specimens, which preserves the most complete ichthyosaur pelvic girdle from the Cretaceous, is described herein as a new taxon, Keilhauia nui gen. et sp. nov. It represents the most complete Berriasian ichthyosaur known and the youngest yet described from the Slottsmoya Member. It is diagnosed on the basis of two autapomorphies from the pelvic girdle, including an ilium that is anteroposteriorly expanded at its dorsal end and an ischiopubis that is shorter or subequal in length to the femur, as well as a unique character combination. The Slottsmoya Member Lagerstatte ichthyosaurs are significant in that they represent a diverse assemblage of ophthalmosaurids that existed immediately preceding and across the Jurassic Cretaceous boundary. They also exhibit considerable variation in pelvic girdle morphology, and expand the known range in size variation of pelvic girdle elements in the Glade.	[Delsett, Lene Liebe; Roberts, Aubrey J.; Hurum, Jorn H.] Univ Oslo, Nat Hist Museum, Oslo, Norway; [Roberts, Aubrey J.] Univ Southampton, Dept Ocean & Earth Sci, Natl Oceanog Ctr, Southampton, Hants, England; [Druckenmiller, Patrick S.] Univ Alaska Museum, Fairbanks, AK USA; [Druckenmiller, Patrick S.] Univ Alaska Fairbanks, Dept Geosci, Fairbanks, AK USA	University of Oslo; NERC National Oceanography Centre; University of Southampton; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks	Delsett, LL (corresponding author), Univ Oslo, Nat Hist Museum, Oslo, Norway.	l.l.delsett@nhm.uio.no	Delsett, Lene Liebe/AAY-7694-2020	Liebe Delsett, Lene/0000-0002-6806-1411	Ministry of Education and Research via the Natural History Museum, University of Oslo; Tullow Oil; NERC; University of Southampton; Norwegian Research Council; National Geographic [EC0425_09, EC0435_09]; Ministry of Education and Research; Brian Snyder; Spitsbergen Travel; Exxon Mobil Norway; Fugro; OMV; PowerShop; Nexen; Norwegian Petroleum Directorate; Hydro; Bautas	Ministry of Education and Research via the Natural History Museum, University of Oslo; Tullow Oil; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); University of Southampton; Norwegian Research Council(Research Council of NorwayEuropean Commission); National Geographic(National Geographic Society); Ministry of Education and Research; Brian Snyder; Spitsbergen Travel; Exxon Mobil Norway(Exxon Mobil Corporation); Fugro; OMV; PowerShop; Nexen; Norwegian Petroleum Directorate; Hydro; Bautas	LLD is supported by a PhD grant from the Ministry of Education and Research via the Natural History Museum, University of Oslo. AJR is supported by PhD grants from Tullow Oil, NERC and the University of Southampton. Grants for the excavations were provided by the Norwegian Research Council, National Geographic (grant no. EC0425_09 and EC0435_09), the Ministry of Education and Research and Brian Snyder. Sponsors for the excavations were Spitsbergen Travel, Exxon Mobil Norway, Fugro, OMV, PowerShop, Nexen, Norwegian Petroleum Directorate, Hydro and Bautas.	Andrews CW., 1910, BASED LEEDS COLLEC 1; Arkhangelsky M. S., 2014, Trudy Zoologicheskogo Instituta, V318, P187; Arkhangelsky M.S., 2000, PALEONTOL J, V34, P549; Arkhangelsky M.S., 1997, PALEONTOL J, V31, P87; Arkhangelsky MS, 1998, PALEONTOL ZH, P87; Bardet N, 2000, J PALEONTOL, V74, P503, DOI 10.1666/0022-3360(2000)074<0503:ANIFTU>2.0.CO;2; BARDET N, 1992, TERRA NOVA, V4, P649, DOI 10.1111/j.1365-3121.1992.tb00614.x; Bauer F., 1898, Palaeontogr, Vxliv, P283; Boulenger G.A., 1904, P ZOOL SOC LOND, P424; Broili Ferdinand, 1907, Palaeontographica Stuttgart, V54; Buchholtz EA, 2001, J ZOOL, V253, P175, DOI 10.1017/S0952836901000164; Buchholtz EA, 2001, J VERTEBR PALEONTOL, V21, P61, DOI 10.1671/0272-4634(2001)021[0061:SSIJI]2.0.CO;2; Carroll RL, 1997, PATTERNS PROCESSES V; Collignon M, 2012, NORW J GEOL, V92, P89; Dal Sasso Cristiano, 1996, Paleontologia Lombarda, V4, P1; Dalseg TS, 2016, NORWEGIAN J GEOLOGY, V96; Delsett LL, 2016, GEOL SOC SPEC PUBL, V434, P165, DOI 10.1144/SP434.2; Dines JP, 2014, EVOLUTION, V68, P3296, DOI 10.1111/evo.12516; Don EK, 2013, J ANAT, V222, P114, DOI 10.1111/j.1469-7580.2012.01557.x; Druckenmiller PS, 2012, NORW J GEOL, V92, P311; Druckenmiller PS, 2010, CAN J EARTH SCI, V47, P1037, DOI 10.1139/E10-028; Druckenmiller PS, 2013, GEOL MAG; DYPVIK H, 1991, POLAR RES, V9, P21, DOI 10.1111/j.1751-8369.1991.tb00400.x; Dypvik H, 2012, NORW J GEOL, V92, P65; Efimov V.M., 1999, Paleontologicheskii Zhurnal, V1, P92; Efimov V. M., 1999, PALEONTOL J, V33, P51; Ensom PC, 2009, CRETACEOUS RES, V30, P699, DOI 10.1016/j.cretres.2008.12.005; Fernandez M, 2005, J VERTEBR PALEONTOL, V25, P583, DOI 10.1671/0272-4634(2005)025[0583:ROPHVH]2.0.CO;2; Fernandez M, 2007, J PALEONTOL, V81, P368, DOI 10.1666/0022-3360(2007)81[368:RAPPOC]2.0.CO;2; Fernandez Marta, 2007, P271; Fernandez Marta S., 2015, Asociacion Paleontologica Argentina Publicacion Electronica, V15, P20; Fernandez MS, 2014, GEOL MAG, V151, P49, DOI 10.1017/S0016756813000058; Fernandez MS, 1997, J PALEONTOL, V71, P479, DOI 10.1017/S0022336000039494; Fischer V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10825; Fischer V, 2014, ZOOL J LINN SOC-LOND, V171, P822, DOI 10.1111/zoj.12158; Fischer V, 2014, GEOL MAG, V151, P60, DOI 10.1017/S0016756812000994; Fischer V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084709; Fischer V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029234; Fischer V, 2011, J VERTEBR PALEONTOL, V31, P1010, DOI 10.1080/02724634.2011.595464; GILMORE C. W., 1905, MEM CARNEGIE MUS, V2, P77; GINGERICH PD, 1990, SCIENCE, V249, P154, DOI 10.1126/science.249.4965.154; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Green JP, 2014, P GEOLOGIST ASSOC, V125, P432, DOI 10.1016/j.pgeola.2014.08.007; Hammer O, 2012, NORW J GEOL, V92, P103; Hammer O, 2011, PALAEOGEOGR PALAEOCL, V306, P15, DOI 10.1016/j.palaeo.2011.03.019; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hulke, 1871, Q J GEOL SOC LOND, V27, P440, DOI DOI 10.1144/GSL.JGS.1871.027.01-02.52; Hurum JH, 2012, NORW J GEOL, V92, P55; Ji C, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2015.1025956; Jiang DY, 2016, SCI REP-UK, V6, DOI 10.1038/srep26232; JOHNSON R, 1977, CAN J EARTH SCI, V14, P1916, DOI 10.1139/e77-162; Kear BP, 2014, GEOL MAG, V151, P71, DOI 10.1017/S0016756813000113; Kelly DA, 2013, ANAT REC, V296, P488, DOI 10.1002/ar.22644; Kirton AM, 1983, REV BRIT UPPER UNPUB; Kolb C, 2009, PALAEONTOGR ABT A, V288, P151; LIGHTHILL MJ, 1969, ANNU REV FLUID MECH, V1, P413, DOI 10.1146/annurev.fl.01.010169.002213; Lislevand T, 2006, NATUREN, V5, P196; Lomax DR, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2014.903260; Maisch Michael W., 2000, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V298, P1; MASSARE JA, 1988, PALEOBIOLOGY, V14, P187, DOI 10.1017/S009483730001191X; Massare JA, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2016.1163264; Massare JA, 2014, GEOL MAG, V151, P21, DOI 10.1017/S0016756813000241; Maxwell EE, 2006, PALAEONTOLOGY, V49, P1043, DOI 10.1111/j.1475-4983.2006.00589.x; Maxwell EE, 2016, PAP PALAEONTOL, V2, P59, DOI 10.1002/spp2.1030; Maxwell EE, 2013, PALEOBIOLOGY, V39, P123, DOI 10.1666/0094-8373-39.1.123; Maxwell EE, 2012, J VERTEBR PALEONTOL, V32, P1207, DOI 10.1080/02724634.2012.682834; Maxwell EE, 2011, PALAEONTOL Z, V85, P457, DOI 10.1007/s12542-011-0106-0; Maxwell EE, 2010, J VERTEBR PALEONTOL, V30, P1059, DOI 10.1080/02724634.2010.483546; Maxwell EE, 2010, J VERTEBR PALEONTOL, V30, P403, DOI 10.1080/02724631003617944; McGowan C, 1996, CAN J EARTH SCI, V33, P1011, DOI 10.1139/e96-077; McGowan C., 2003, ICHTHYOPTERYGIA; Motani R, 2005, ANNU REV EARTH PL SC, V33, P395, DOI 10.1146/annurev.earth.33.092203.122707; Motani R, 1999, J VERTEBR PALEONTOL, V19, P473, DOI 10.1080/02724634.1999.10011160; Motani R, 1998, NATURE, V393, P255, DOI 10.1038/30473; Motani R, 2015, NATURE, V517, P485, DOI 10.1038/nature13866; Motani R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088640; Nagy J, 1998, MICROPALEONTOLOGY, V44, P217, DOI 10.2307/1486047; Novis LKS., 2012, TAPHONOMIC STUDY MAR; Ogg JG, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P731, DOI 10.1016/B978-0-444-59425-9.00026-3; Paparella I, 2016, GEOLOGICAL MAGAZINE, P1; Pardo-Perez Judith, 2012, Palaeobiodiversity and Palaeoenvironments, V92, P287, DOI 10.1007/s12549-012-0074-8; Roberts AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103152; Sander P. Martin, 2000, Palaeontologische Zeitschrift, V74, P1; Steel R.J., 1984, PETROLEUM GEOLOGY N, P109, DOI DOI 10.1007/978-94-009-5626-1; Thewissen J.G.M., 2009, Evolution Education and Outreach, V2, P272; Torsvik TH, 2012, EARTH-SCI REV, V114, P325, DOI 10.1016/j.earscirev.2012.06.007; Uhen MD, 2010, ANNU REV EARTH PL SC, V38, P189, DOI 10.1146/annurev-earth-040809-152453; WADE M, 1990, Memoirs of the Queensland Museum, V28, P115; Wierzbowski A, 2011, NEUES JAHRB GEOL P-A, V262, P267, DOI 10.1127/0077-7749/2011/0198; Williston S. W., 1914, WATER REPTILES PRESE; Wiman C., 1921, B U UPSALA, V18, P19; Wiman C., 1922, PALAEONTOL Z, V5, P272; Zakharov VA, 2003, STRATIGR GEO CORREL+, V11, P585; Zammit M, 2010, J VERTEBR PALEONTOL, V30, P1726, DOI 10.1080/02724634.2010.521930; Zverkov N.G., 2015, [Труды Зоологического института РАН, Trudy Zoologicheskogo instituta RAN], V319, P558; Zverkov N. G., 2015, Trudy Zoologicheskogo Instituta, V319, P81	96	26	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0169971	10.1371/journal.pone.0169971	http://dx.doi.org/10.1371/journal.pone.0169971			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28121995	Green Submitted, Green Published, gold			2022-12-26	WOS:000396167300056
J	Studwell, AJ; Hines, E; Elliott, ML; Howar, J; Holzman, B; Nur, N; Jahncke, J				Studwell, Anna J.; Hines, Ellen; Elliott, Meredith L.; Howar, Julie; Holzman, Barbara; Nur, Nadav; Jahncke, Jaime			Modeling Nonresident Seabird Foraging Distributions to Inform Ocean Zoning in Central California	PLOS ONE			English	Article							MARINE PROTECTED AREAS; TROPHIC TRANSFER; CURRENT SYSTEM; CLIMATE; BIRD; FRONTS; HOTSPOTS; AGGREGATIONS; ASSOCIATIONS; PREY	Seabird aggregations at sea have been shown to be associated with concentrations of prey. Previous research identified Central California as a highly used foraging area for seabirds, with locally breeding seabirds foraging close to their colonies on Southeast Farallon Island. Herein, we focus on nonresident (i.e. non-locally breeding) seabird species off of Central California. We hypothesized that high-use foraging areas for nonresident seabirds would be influenced by oceanographic and bathymetric factors and that spatial and temporal distributions would be similar within planktivorous and generalist foraging guilds but would differ between them. With data collected by the Applied California Current Ecosystem Studies (ACCESS) partnership during cruises between April and October from 2004-2013, we developed generalized linear models to identify high-use foraging areas for each of six nonresident seabird species. The four generalist species are Phoebastria nigripes (black-footed albatross), Ardenna griseus (sooty shearwater), Ardenna creatopus (pink-footed shearwater), and Fulmarus glacialis (northern fulmar). The two planktivorous species are Phalaropus lobatus (red-necked phalarope) and Phalaropus fulicarius (red phalarope). Sea surface temperature was significant for generalist species and sea surface salinity was important for planktivorous species. The distance to the 200-m isobath was significant in five of six models, Pacific Decadal Oscillation with a 3-month lag in four models, and sea surface fluorescence, the distance to Cordell Bank, and depth in three models. We did not find statistically significant differences between distributions of individual seabird species within a foraging guild or between guilds, with the exception of the sooty shearwater. Model results for a multi-use seabird foraging area highlighted the continental shelf break, particularly within the vicinity of Cordell Bank, as the highest use areas as did Marxan prioritization. Our research methods can be implemented elsewhere to identify critical habitat that needs protection as human development pressures continue to expand to the ocean.	[Studwell, Anna J.; Hines, Ellen] San Francisco State Univ, Romberg Tiburon Ctr Environm Studies, Tiburon, CA USA; [Studwell, Anna J.; Hines, Ellen; Holzman, Barbara] San Francisco State Univ, Dept Geog & Environm, San Francisco, CA 94132 USA; [Studwell, Anna J.; Elliott, Meredith L.; Howar, Julie; Nur, Nadav; Jahncke, Jaime] Point Blue Conservat Sci, Petaluma, CA 94954 USA	California State University System; San Francisco State University; California State University System; San Francisco State University	Jahncke, J (corresponding author), Point Blue Conservat Sci, Petaluma, CA 94954 USA.	jjahncke@pointblue.org			Bently Foundation; Boring Family Foundation; California Sea Grant; Elinor Paterson Baker Trust; Faucett Catalyst Fund; Firedoll Foundation; Hellman Family Foundation; Marisla Foundation; Moore Family Foundation; National Fish and Wildlife Foundation; Resources Legacy Fund; Wendy P. McCaw Foundation; Council on Ocean Affairs, Science, and Technology (COAST), San Francisco State University; Romberg Tiburon Center Bay Scholarship and Student Association	Bently Foundation; Boring Family Foundation; California Sea Grant; Elinor Paterson Baker Trust; Faucett Catalyst Fund; Firedoll Foundation; Hellman Family Foundation; Marisla Foundation; Moore Family Foundation; National Fish and Wildlife Foundation; Resources Legacy Fund; Wendy P. McCaw Foundation; Council on Ocean Affairs, Science, and Technology (COAST), San Francisco State University; Romberg Tiburon Center Bay Scholarship and Student Association	We thank the Bently Foundation, Boring Family Foundation, California Sea Grant, Elinor Paterson Baker Trust, Faucett Catalyst Fund, Firedoll Foundation, Hellman Family Foundation, Marisla Foundation, Moore Family Foundation, National Fish and Wildlife Foundation, Resources Legacy Fund, Wendy P. McCaw Foundation and the many Point Blue donors who have helped fund ACCESS work over the years. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The lead author thanks the Council on Ocean Affairs, Science, and Technology (COAST), San Francisco State University Robert Maxwell and University Scholarships, and the Romberg Tiburon Center Bay Scholarship and Student Association for their support.	Acha EM, 2004, J MARINE SYST, V44, P83, DOI 10.1016/j.jmarsys.2003.09.005; Ainley DG, 2010, PROG OCEANOGR, V84, P242, DOI 10.1016/j.pocean.2009.10.001; Ainley DG, 2009, MAR ECOL PROG SER, V389, P271, DOI 10.3354/meps08153; Ainley DG, 2005, DEEP-SEA RES PT II, V52, P123, DOI 10.1016/j.dsr2.2004.08.016; Alpine JE, 2007, MAR FRESHWATER RES, V58, P558, DOI 10.1071/MF06214; [Anonymous], P 14 INT JOINT C ART; Barbraud C, 2009, J AVIAN BIOL, V40, P584, DOI 10.1111/j.1600-048X.2009.04653.x; Belkin IM, 2014, DEEP-SEA RES PT II, V107, P1, DOI 10.1016/j.dsr2.2014.07.009; Briggs K.T., 1987, P279; Chen YH, 2007, J CLIMATE, V20, P3580, DOI 10.1175/JCLI4208.1; Di Lorenzo E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032838; DiGiacomo PM, 2002, J MARINE SYST, V37, P199, DOI 10.1016/S0924-7963(02)00202-6; Durant JM, 2009, CLIM RES, V39, P115, DOI 10.3354/cr00798; Fontana R., 2013, PHYS PROCESSES THEIR; Fontana RE, 2015, ENV INFLUENCE CASSIN; Fontana RE, 2015, FIELD OBSERVATIONS S; Franklin J, 2009, MAPPING SPECIES DIST; FRANKS PJS, 1992, MAR ECOL PROG SER, V82, P1, DOI 10.3354/meps082001; Game E.T., 2008, MARXAN USER MANUAL M, P127; Game ET, 2009, TRENDS ECOL EVOL, V24, P360, DOI 10.1016/j.tree.2009.01.011; Halpern BS, 2009, CONSERV LETT, V2, P138, DOI 10.1111/j.1755-263X.2009.00058.x; HAY RB, 1992, J BIOGEOGR, V19, P67, DOI 10.2307/2845621; Hazen EL, 2012, NAT CLIM CHANGE, V2, P1; Hickey BM, 2008, OCEANOGRAPHY, V21, P90, DOI 10.5670/oceanog.2008.07; Hoefer CJ, 2000, CONDOR, V102, P423, DOI 10.1650/0010-5422(2000)102[0423:MBATTF]2.0.CO;2; Hunt GL, 1998, MAR ECOL PROG SER, V167, P241, DOI 10.3354/meps167241; Hyrenbach KD, 2006, FISH OCEANOGR, V15, P95, DOI 10.1111/j.1365-2419.2005.00350.x; Hyrenbach KD, 2000, AQUAT CONSERV, V10, P437, DOI 10.1002/1099-0755(200011/12)10:6<437::AID-AQC425>3.3.CO;2-H; Jahncke J, 2008, PROG OCEANOGR, V77, P182, DOI 10.1016/j.pocean.2008.03.010; Jahncke J, 2005, MAR ECOL PROG SER, V305, P219, DOI 10.3354/meps305219; Lascelles BG, 2012, BIOL CONSERV, V156, P5, DOI 10.1016/j.biocon.2011.12.008; Loos S., 2011, BC Journal of Ecosystems and Management, V12, P88; Ludynia K, 2012, BIOL CONSERV, V156, P136, DOI 10.1016/j.biocon.2011.11.014; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; Mantua NJ, 2009, PACIFIC DECADAL OSCI, P1; Manugian S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144232; MAURER BA, 1984, WILSON BULL, V96, P380; McDonnell MD, 2002, ENVIRON MODEL ASSESS, V7, P107, DOI 10.1023/A:1015649716111; McGowan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071406; Michael PE, 2014, FISH OCEANOGR, V23, P18, DOI 10.1111/fog.12039; Michelutti N, 2011, POLAR BIOL, V34, P799, DOI 10.1007/s00300-010-0934-5; Morgan LE, 2005, COMMISSION ENV COOPE; National Resources Defense Council, 2000, PRIOR OC AR PROT MID; Natural Resources Wales, 2016, PROP NEW MAR SPEC AR; Natural Resources Wales Joint Nature Conservation Committee, 2015, PROP EXT SKOKH SKOM; Nur N, 2011, ECOL APPL, V21, P2241, DOI 10.1890/10-1460.1; Oedekoven CS, 2001, MAR ECOL PROG SER, V212, P265, DOI 10.3354/meps212265; Oppel S, 2012, BIOL CONSERV, V156, P94, DOI 10.1016/j.biocon.2011.11.013; Orians G.H., 1979, P155; Piatt John F., 2003, Marine Ornithology, V31, P141; Pichegru L, 2012, BIOL CONSERV, V156, P117, DOI 10.1016/j.biocon.2011.12.013; Possingham H. P., 2006, PRINCIPLES CONSERVAT, V3rd, P507, DOI DOI 10.1023/A:1006601319528; Reese DC, 2006, DEEP-SEA RES PT II, V53, P291, DOI 10.1016/j.dsr2.2006.01.014; Rogers P., 2015, SAN JOSE MERCURY NEW, P11; Ronconi RA, 2012, BIOL CONSERV, V156, P1, DOI 10.1016/j.biocon.2012.02.016; Rueda M, 2001, MAR ECOL PROG SER, V222, P217, DOI 10.3354/meps222217; Rufino MM, 2004, MAR ECOL PROG SER, V276, P223, DOI 10.3354/meps276223; RUSSELL RW, 1992, LANDSCAPE ECOL, V7, P195, DOI 10.1007/BF00133310; Santora JA, 2011, PROG OCEANOGR, V91, P397, DOI 10.1016/j.pocean.2011.04.002; Scales KL, 2014, J R SOC INTERFACE, P11; SCHNEIDER D, 1982, MAR ECOL PROG SER, V10, P101, DOI 10.3354/meps010101; Schorch S, 2013, DEUTER COGN LIT STUD, V16, P1; Schubel JR, 2010, ROLE PUBLIC SUPPORT; Selig ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082898; Smith MA, 2014, BIOL CONSERV, V172, P180, DOI 10.1016/j.biocon.2014.02.039; Srinivasan BV, 2008, 20 C PROB STAT ATM S, P228; Stewart RR, 2005, ENVIRON MODEL ASSESS, V10, P203, DOI 10.1007/s10666-005-9001-y; Sydeman WJ, 2013, GLOBAL CHANGE BIOL, V19, P1662, DOI 10.1111/gcb.12165; Sydeman WJ, 2012, MAR ECOL PROG SER, V454, P107, DOI 10.3354/meps09806; Sydeman WJ, 2010, J PLANKTON RES, V32, P1697, DOI 10.1093/plankt/fbq119; Syrjala SE, 1996, ECOLOGY, V77, P75, DOI 10.2307/2265656; TRENBERTH KE, 1984, MON WEATHER REV, V112, P326, DOI 10.1175/1520-0493(1984)112<0326:SVNITS>2.0.CO;2; Trenberth KE, 2001, J CLIMATE, V14, P1697, DOI 10.1175/1520-0442(2001)014<1697:LIOENO>2.0.CO;2; Vandenbosch R, 2000, WATERBIRDS, V23, P416, DOI 10.2307/1522178; Votier SC, 2008, J ANIM ECOL, V77, P974, DOI 10.1111/j.1365-2656.2008.01421.x; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Winch P., 2007, WILDLIFE SPOTLIGHT N, P1; Wynn Russell B., 2013, Seabird, V26, P87; Yen PPW, 2004, J MARINE SYST, V50, P79, DOI 10.1016/j.jmarsys.2003.09.015; Zamon JE, 2014, DEEP-SEA RES PT II, V107, P85, DOI 10.1016/j.dsr2.2013.03.031; Zuur A.F, 2012, ZERO INFLATED MODELS; Zuur Alain F., 2009, P1	83	9	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0169517	10.1371/journal.pone.0169517	http://dx.doi.org/10.1371/journal.pone.0169517			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122001	gold, Green Published, Green Submitted			2022-12-26	WOS:000396167300075
J	Mahardja, B; Farruggia, MJ; Schreier, B; Sommer, T				Mahardja, Brian; Farruggia, Mary Jade; Schreier, Brian; Sommer, Ted			Evidence of a Shift in the Littoral Fish Community of the Sacramento-San Joaquin Delta	PLOS ONE			English	Article							CLAM POTAMOCORBULA-AMURENSIS; FRANCISCO BAY CALIFORNIA; REGIME SHIFTS; REMARKABLE INVASION; LARGEMOUTH BASS; ESTUARINE FISH; PELAGIC FISHES; RIVER; ABUNDANCE; FLOW	Many estuarine and freshwater ecosystems worldwide have undergone substantial changes due to multiple anthropogenic stressors. Over the past two decades, the Sacramento-San Joaquin Delta (Delta) in California, USA, saw a severe decline in pelagic fishes, a shift in zooplankton community composition, and a rapid expansion of invasive aquatic vegetation. To evaluate whether major changes have also occurred in the littoral fish community, we analyzed a beach seine survey dataset collected from 1995 to 2015 from 26 sites within the Delta. We examined changes in the Delta fish community at three different ecological scales (species, community, and biomass), using clustering analyses, trend tests, and changepoint analyses. We found that the annual catch per effort for many introduced species and some native species have increased since 1995, while few experienced a decline. We also observed a steady pattern of change over time in annual fish community composition, driven primarily by a steady increase in non-native Centrarchid species. Lastly, we found that littoral fish biomass has essentially doubled over the 21-year study period, with Mississippi Silverside Menidia audens and fishes in the Centrarchidae family driving most of this increase. The changes in the catch per effort, fish community composition, and biomass per volume indicate that a shift has occurred in the Delta littoral fish community and that the same factors affecting the Delta's pelagic food web may have been a key driver of change.	[Mahardja, Brian; Farruggia, Mary Jade; Schreier, Brian; Sommer, Ted] Calif Dept Water Resources, Div Environm Serv, West Sacramento, CA 95691 USA		Mahardja, B (corresponding author), Calif Dept Water Resources, Div Environm Serv, West Sacramento, CA 95691 USA.	brian.mahardja@water.ca.gov	Schreier, Brian/H-5292-2013	Schreier, Brian/0000-0002-5075-3946; Farruggia, Mary/0000-0003-4234-6678; Mahardja, Brian/0000-0003-0695-3745	California Department of Water Resources; Interagency Ecological Program (IEP)	California Department of Water Resources; Interagency Ecological Program (IEP)	The authors received no specific funding for this work. Salary support was provided for all authors by the California Department of Water Resources. The California Department of Water Resources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was conducted under the auspices of the Interagency Ecological Program (IEP) for the San Francisco Estuary. We thank Jonathan Speegle, Kim Webb, Matthew Dekar, and all past and present staff of the U.S. Fish and Wildlife Survey who has taken part in the DJFMP beach seine survey. We also thank Todd Miller, Louise Conrad, Pat Brandes, and two anonymous reviewers for their suggestions and comments that substantially improved the manuscript.	Alheit J, 2005, ICES J MAR SCI, V62, P1205, DOI 10.1016/j.icesjms.2005.04.024; ALPINE AE, 1992, LIMNOL OCEANOGR, V37, P946, DOI 10.4319/lo.1992.37.5.0946; [Anonymous], 2021, LANG ENV STAT COMP; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bettoli Phillip W., 1993, North American Journal of Fisheries Management, V13, P110, DOI 10.1577/1548-8675(1993)013<0110:ROARFC>2.3.CO;2; Biggs R, 2009, P NATL ACAD SCI USA, V106, P826, DOI 10.1073/pnas.0811729106; Brooks BA, 2012, SAN FRANCISCO ESTUAR, V10, P1; Brooks ML, 2012, ESTUAR COAST, V35, P603, DOI 10.1007/s12237-011-9459-6; Brown L.R., 2006, SAN FRANC ESTUARY WA, V4, P2; Brown L.R., 2003, SAN FRANC ESTUARY WA, V1, DOI [10.15447/sfews.2003v1iss1art2, DOI 10.15447/SFEWS.2003V1ISS1ART2]; Brown LR, 2007, ESTUAR COAST, V30, P186, DOI 10.1007/BF02782979; Brown LR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146724; Brown LR, 2013, ESTUAR COAST, V36, P754, DOI 10.1007/s12237-013-9585-4; Brown LR, 2005, AM FISH S S, V45, P75; Brown LR, 2002, RIVER RES APPL, V18, P331, DOI 10.1002/rra.673; Capon SJ, 2015, SCI TOTAL ENVIRON, V534, P122, DOI 10.1016/j.scitotenv.2015.02.045; CARLTON JT, 1990, MAR ECOL PROG SER, V66, P81, DOI 10.3354/meps066081; Choi JS, 2004, CAN J FISH AQUAT SCI, V61, P505, DOI 10.1139/F04-079; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cloern JE, 2012, REV GEOPHYS, V50, DOI 10.1029/2012RG000397; Cohen AN, 1998, SCIENCE, V279, P555, DOI 10.1126/science.279.5350.555; Collie JS, 2004, PROG OCEANOGR, V60, P281, DOI 10.1016/j.pocean.2004.02.013; Conners ME, 2002, PROG OCEANOGR, V55, P209, DOI 10.1016/S0079-6611(02)00079-4; Conrad J.L., 2016, SAN FRANC ESTUARY WA, V14, P1; Conrad JL, 2016, T AM FISH SOC, V145, P249, DOI 10.1080/00028487.2015.1114521; Contamin R, 2009, ECOL APPL, V19, P799, DOI 10.1890/08-0109.1; Crepin AS, 2012, ECOL ECON, V84, P15, DOI 10.1016/j.ecolecon.2012.09.003; CROWDER LB, 1982, ECOLOGY, V63, P1802, DOI 10.2307/1940122; Feyrer F, 2005, COPEIA, P159, DOI 10.1643/CE-04-187R1; Feyrer F, 2003, ENVIRON BIOL FISH, V66, P123, DOI 10.1023/A:1023670404997; Feyrer F, 2007, CAN J FISH AQUAT SCI, V64, P723, DOI 10.1139/F07-048; Feyrer F, 2015, GLOBAL CHANGE BIOL, V21, P3608, DOI 10.1111/gcb.12969; FIELD JG, 1982, MAR ECOL PROG SER, V8, P37, DOI 10.3354/meps008037; Glibert PM, 2010, REV FISH SCI, V18, P211, DOI 10.1080/10641262.2010.492059; Grimaldo LF, 2009, N AM J FISH MANAGE, V29, P1253, DOI 10.1577/M08-062.1; Hestir EL, 2016, ESTUAR COAST, V39, P1100, DOI 10.1007/s12237-015-0055-z; HUBER ER, 2015, SAN FRANCISCO ESTUAR, V13, P2, DOI DOI 10.15447/SFEWS.2015V0L13ISS2ART3; Hughes TP, 2013, TRENDS ECOL EVOL, V28, P149, DOI 10.1016/j.tree.2012.08.022; Jiao Y, 2009, REV FISH BIOL FISHER, V19, P177, DOI 10.1007/s11160-008-9096-8; Kimmerer W, 2005, T AM FISH SOC, V134, P481, DOI 10.1577/T04-042.1; Kimmerer WJ, 2009, ESTUAR COAST, V32, P375, DOI 10.1007/s12237-008-9124-x; Kjelson M.A., 1982, ESTUARINE COMP, P393; Lund J.R., 2008, COMPARING FUTURES SA; Luoma Samuel N., 2015, San Francisco Estuary & Watershed Science, V13, P7; Mac Nally R, 2014, AUSTRAL ECOL, V39, P898, DOI 10.1111/aec.12162; Mac Nally R, 2010, ECOL APPL, V20, P1417, DOI 10.1890/09-1724.1; Mahardja Brian, 2016, San Francisco Estuary & Watershed Science, V14, P2; Mallakpour I, 2016, HYDROLOG SCI J, V61, P245, DOI 10.1080/02626667.2015.1008482; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; Marchetti MP, 2001, ECOL APPL, V11, P530, DOI 10.2307/3060907; McLeod AI, 2011, **DATA OBJECT**; Miller WJ, 2012, REV FISH SCI, V20, P1, DOI 10.1080/10641262.2011.634930; Miranda LE, 2000, HYDROBIOLOGIA, V427, P51, DOI 10.1023/A:1003999929094; Mount J., 2005, SAN FRANC ESTUARY WA, V3, DOI 10.15447/sfews.2005v3iss1art7; Moyle P.B., 2002, INLAND FISHES CALIFO; Moyle P.B., 2010, SAN FRANCISCO ESTUAR, V8, P3; NICHOLS FH, 1986, SCIENCE, V231, P567, DOI 10.1126/science.231.4738.567; NICHOLS FH, 1990, MAR ECOL PROG SER, V66, P95, DOI 10.3354/meps066095; Nobriga ML, 2016, T AM FISH SOC, V145, P44, DOI 10.1080/00028487.2015.1100136; Nobriga ML, 2006, WEST N AM NATURALIST, V66, P106, DOI 10.3398/1527-0904(2006)66[106:AOSPBI]2.0.CO;2; Nobriga ML, 2005, ESTUARIES, V28, P776, DOI 10.1007/BF02732915; Oksanen J, 2022, R PACKAGE VERSION; Pearse Devon E., 2015, San Francisco Estuary & Watershed Science, V13, P3; Pohlert T., 2016, R PACKAGE TREND NONP; Quinones Rebecca M., 2014, San Francisco Estuary & Watershed Science, V12, P3; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Santos MJ, 2011, BIOL INVASIONS, V13, P443, DOI 10.1007/s10530-010-9840-6; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; SCHNEIDER JC, 2000, MANUAL FISHERIES SUR, V0002; Schoellhamer DH, 2011, ESTUAR COAST, V34, P885, DOI 10.1007/s12237-011-9382-x; Schroeter RE, 2015, AQUATIC TROPHIC ECOL, V13, P3; Service RF, 2007, SCIENCE, V317, P442, DOI 10.1126/science.317.5837.442; Sobczak WV, 2005, ESTUARIES, V28, P124, DOI 10.1007/BF02732759; Sommer T, 2007, FISHERIES, V32, P270, DOI 10.1577/1548-8446(2007)32[270:TCOPFI]2.0.CO;2; Sommer TR, 2014, ECOL FRESHW FISH, V23, P414, DOI 10.1111/eff.12095; Tate WB, 2003, N AM J FISH MANAGE, V23, P251, DOI 10.1577/1548-8675(2003)023&lt;0251:ROALBA&gt;2.0.CO;2; Thomson JR, 2010, ECOL APPL, V20, P1431, DOI 10.1890/09-0998.1; Wagner RW, 2011, ESTUAR COAST, V34, P544, DOI 10.1007/s12237-010-9369-z; Whipple A.A., 2012, SAN FRANCISCO ESTUAR; Whitaker D, 2014, CLUSTSIG SIGNIFICANT; Winder M, 2011, ESTUAR COAST, V34, P675, DOI 10.1007/s12237-010-9342-x; Young MJ, SUBMERSED AQUATIC VE	85	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2017	12	1							e0170683	10.1371/journal.pone.0170683	http://dx.doi.org/10.1371/journal.pone.0170683			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7CU	28118393	Green Submitted, gold, Green Published			2022-12-26	WOS:000396160500014
J	Nishimura, K; Noda, T; Dabdoub, A				Nishimura, Koji; Noda, Teppei; Dabdoub, Alain			Dynamic Expression of Sox2, Gata3, and Prox1 during Primary Auditory Neuron Development in the Mammalian Cochlea	PLOS ONE			English	Article							SPIRAL GANGLION NEURONS; HAIR CELL-DIFFERENTIATION; INNER-EAR; TRANSCRIPTION FACTOR; SENSORY EPITHELIA; HDR SYNDROME; CREST CELLS; INNERVATION; PERIPHERIN; MICE	Primary auditory neurons (PANs) connect cochlear sensory hair cells in the mammalian inner ear to cochlear nucleus neurons in the brainstem. PANs develop from neuroblasts delaminated from the proneurosensory domain of the otocyst and keep maturing until the onset of hearing after birth. There are two types of PANs: type I, which innervate the inner hair cells (IHCs), and type II, which innervate the outer hair cells (OHCs). Glial cells surrounding these neurons originate from neural crest cells and migrate to the spiral ganglion. Several transcription factors are known to regulate the development and differentiation of PANs. Here we systematically examined the spatiotemporal expression of five transcription factors: Sox2, Sox10, Gata3, Mafb, and Prox1 from early delamination at embryonic day (E) 10.5 to adult. We found that Sox2 and Sox10 were initially expressed in the proneurosensory cells in the otocyst (E10.5). By E12.75 both Sox2 and Sox10 were downregulated in the developing PANs; however, Sox2 expression transiently increased in the neurons around birth. Furthermore, both Sox2 and Sox10 continued to be expressed in spiral ganglion glial cells. We also show that Gata3 and Prox1 were first expressed in all developing neurons, followed by a decrease in expression of Gata3 and Mafb in type I PANs and Prox1 in type II PANs as they matured. Moreover, we describe two subtypes of type II neurons based on Peripherin expression. These results suggest that Sox2, Gata3 and Prox1 play a role during neurogenesis as well as maturation of the PANs.	[Nishimura, Koji] Shiga Med Ctr Res Inst, Moriyama Ku, Shiga, Japan; [Noda, Teppei; Dabdoub, Alain] Sunnybrook Res Inst, Biol Sci, Toronto, ON, Canada; [Dabdoub, Alain] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada; [Dabdoub, Alain] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto	Dabdoub, A (corresponding author), Sunnybrook Res Inst, Biol Sci, Toronto, ON, Canada.; Dabdoub, A (corresponding author), Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada.; Dabdoub, A (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	Alain.Dabdoub@sri.utoronto.ca		Dabdoub, Alain/0000-0002-4259-2425	Design initiative; Canada First Research Excellence Fund; Koerner Foundation; Harry Barberian grant; Uehara Memorial Foundation; Japan Society for the Promotion of Science KAKENHI [15H06911, 16K20293]; Leave a Nest grant IKEDA SCIENTIFIC award; Sunnybrook Hearing Regeneration Initiative	Design initiative; Canada First Research Excellence Fund; Koerner Foundation; Harry Barberian grant; Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Leave a Nest grant IKEDA SCIENTIFIC award; Sunnybrook Hearing Regeneration Initiative	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research was undertaken thanks in part to funding provided to the University of Toronto Medicine by Design initiative, by the Canada First Research Excellence Fund (AD), Koerner Foundation (AD), a Harry Barberian grant (TN), Uehara Memorial Foundation (TN), Japan Society for the Promotion of Science KAKENHI Grant number 15H06911 (KN), 16K20293 (KN), Leave a Nest grant IKEDA SCIENTIFIC award (KN) and the Sunnybrook Hearing Regeneration Initiative.	Ahmed M, 2012, DEVELOPMENT, V139, P1965, DOI 10.1242/dev.071670; Appler JM, 2013, J NEUROSCI, V33, P3679, DOI 10.1523/JNEUROSCI.4703-12.2013; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Barclay M, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-33; BERGLUND AM, 1986, BRAIN RES, V383, P327, DOI 10.1016/0006-8993(86)90034-X; BERGLUND AM, 1991, J COMP NEUROL, V306, P393, DOI 10.1002/cne.903060304; Bermingham-McDonogh O, 2006, J COMP NEUROL, V496, P172, DOI 10.1002/cne.20944; Breuskin I, 2010, J NEUROCHEM, V114, P1827, DOI 10.1111/j.1471-4159.2010.06897.x; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; CACCAMO D, 1989, LAB INVEST, V60, P390; Chien WWD, 2014, OTOL NEUROTOL, V35, P577, DOI 10.1097/MAO.0000000000000238; CORDES SP, 1994, CELL, V79, P1025, DOI 10.1016/0092-8674(94)90033-7; Dabdoub A., 2016, PRIMARY AUDITORY NEU; Dabdoub A, 2008, P NATL ACAD SCI USA, V105, P18396, DOI 10.1073/pnas.0808175105; DAMICOMARTEL A, 1983, AM J ANAT, V166, P445, DOI 10.1002/aja.1001660406; Duncan JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062046; Evsen L, 2013, J NEUROSCI, V33, P3879, DOI 10.1523/JNEUROSCI.4030-12.2013; Flores EN, 2015, CURR BIOL, V25, P606, DOI 10.1016/j.cub.2015.01.009; Flores-Otero J, 2011, J COMP NEUROL, V519, P1455, DOI 10.1002/cne.22576; Freter S, 2013, DEVELOPMENT, V140, P3595, DOI 10.1242/dev.091033; Fritzsch B, 2002, J NEUROBIOL, V53, P143, DOI 10.1002/neu.10098; Fritzsch B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009377; Gu R, 2016, DEV BIOL; Hafidi A, 1998, BRAIN RES, V805, P181, DOI 10.1016/S0006-8993(98)00448-X; HAFIDI A, 1993, INT J DEV NEUROSCI, V11, P507, DOI 10.1016/0736-5748(93)90024-8; Hallworth R, 2000, HEARING RES, V139, P31, DOI 10.1016/S0378-5955(99)00165-3; Hutton SR, 2011, DEV BIOL, V352, P40, DOI 10.1016/j.ydbio.2011.01.015; Karis A, 2001, J COMP NEUROL, V429, P615, DOI 10.1002/1096-9861(20010122)429:4<615::AID-CNE8>3.0.CO;2-F; KEITHLEY EM, 1979, J COMP NEUROL, V188, P429, DOI 10.1002/cne.901880306; KIANG NYS, 1982, SCIENCE, V217, P175, DOI 10.1126/science.7089553; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kim WY, 2001, DEVELOPMENT, V128, P417; Lallemend F, 2007, NEUROSCIENCE, V150, P212, DOI 10.1016/j.neuroscience.2007.08.032; Lang HN, 2015, SCI REP-UK, V5, DOI 10.1038/srep13383; Lang HN, 2011, JARO-J ASSOC RES OTO, V12, P151, DOI 10.1007/s10162-010-0244-1; Lawoko-Kerali G, 2004, MECH DEVELOP, V121, P287, DOI 10.1016/j.mod.2003.12.006; Lawoko-Kerali G, 2002, J COMP NEUROL, V442, P378, DOI 10.1002/cne.10088; Liu W, 2010, CELL TISSUE RES, V342, P345, DOI 10.1007/s00441-010-1081-6; Liu W, 2009, ACTA OTO-LARYNGOL, V129, P608, DOI 10.1080/00016480802369294; Lu CC, 2011, J NEUROSCI, V31, P10903, DOI 10.1523/JNEUROSCI.2358-11.2011; Ma QF, 2000, JARO-J ASSOC RES OTO, V1, P129, DOI 10.1007/s101620010017; Maison S, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0207-16.2016; Mao YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094580; Muroya K, 2001, J MED GENET, V38, P374, DOI 10.1136/jmg.38.6.374; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Neves J, 2007, J COMP NEUROL, V503, P487, DOI 10.1002/cne.21299; Nishimura K, 2009, NEUROREPORT, V20, P1250, DOI 10.1097/WNR.0b013e32832ff287; Park JG, 2016, AM J HUM GENET, V98, P1220, DOI 10.1016/j.ajhg.2016.03.023; PERKINS RE, 1975, J COMP NEUROL, V163, P129, DOI 10.1002/cne.901630202; Puligilla C, 2010, J NEUROSCI, V30, P714, DOI 10.1523/JNEUROSCI.3852-09.2010; Reid MA, 2004, J NEUROSCI, V24, P733, DOI 10.1523/JNEUROSCI.3923-03.2004; Rivolta MN, 1998, J NEUROCYTOL, V27, P637, DOI 10.1023/A:1006951813063; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Sandell L. L., 2013, DEV BIOL; SPOENDLIN H, 1972, ACTA OTO-LARYNGOL, V73, P235, DOI 10.3109/00016487209138937; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Van Esch H, 2000, NATURE, V406, P419, DOI 10.1038/35019088; van Looij MAJ, 2006, AUDIOL NEURO-OTOL, V11, P373, DOI 10.1159/000095899; Vyas P, 2016, J ASS RES OTOLARYNGO; Wakaoka T, 2013, HEARING RES, V302, P17, DOI 10.1016/j.heares.2013.05.003; Whitlon DS, 2010, NEUROSCIENCE, V171, P23, DOI 10.1016/j.neuroscience.2010.08.069; Yu WM, 2013, ELIFE, V2, DOI 10.7554/eLife.01341; Zhang KD, 2016, SEMINARS CELL DEV BI	64	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2017	12	1							e0170568	10.1371/journal.pone.0170568	http://dx.doi.org/10.1371/journal.pone.0170568			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7CU	28118374	Green Submitted, Green Published, gold			2022-12-26	WOS:000396160500027
J	Nogueira, JE; Soriano, RN; Fernandez, RAR; Francescato, HDC; Saia, RS; Coimbra, TM; Antunes-Rodrigues, J; Branco, LGS				Nogueira, Jonatas E.; Soriano, Renato N.; Fernandez, Rodrigo A. R.; Francescato, Heloisa D. C.; Saia, Rafael S.; Coimbra, Terezila M.; Antunes-Rodrigues, Jose; Branco, Luiz G. S.			Effect of Physical Exercise on the Febrigenic Signaling is Modulated by Preoptic Hydrogen Sulfide Production	PLOS ONE			English	Article							CYSTATHIONINE BETA-SYNTHASE; CENTRAL-NERVOUS-SYSTEM; LOCALIZED INFLAMMATION; INTERLEUKIN (IL)-6; FEBRILE RESPONSE; GENE-EXPRESSION; INDUCED FEVER; RATS; ENDOTOXIN; LIPOPOLYSACCHARIDE	We tested the hypothesis that the neuromodulator hydrogen sulfide (H2S) in the preoptic area (POA) of the hypothalamus modulates the febrigenic signaling differently in sedentary and trained rats. Besides H2S production rate and protein expressions of H2S-related synthases cystathionine beta-synthase (CBS), 3-mercaptopyruvate sulfurtransferase (3-MPST) and cystathionine gamma-lyase (CSE) in the POA, we also measured deep body temperature (Tb), circulating plasma levels of cytokines and corticosterone in an animal model of systemic inflammation. Rats run on a treadmill before receiving an intraperitoneal injection of lipopolysaccharide (LPS, 100 mu g/kg) or saline. The magnitude of changes of Tb during the LPS-induced fever was found to be similar between sedentary and trained rats. In sedentary rats, H2S production was not affected by LPS. Conversely, in trained rats LPS caused a sharp increase in H2S production rate that was accompanied by an increased CBS expression profile, whereas 3-MPST and CSE expressions were kept relatively constant. Sedentary rats showed a significant LPS-induced release of cytokines (IL-1 beta, IL-6, and TNF-alpha) which was virtually abolished in the trained animals. Correlation between POA H2S and IL-6 as well as TNF-alpha was observed. Corticosterone levels were augmented after LPS injection in both groups. We found correlations between H2S and corticosterone, and corticosterone and IL-1 beta. These data are consistent with the notion that the responses to systemic inflammation are tightly regulated through adjustments in POA H2S production which may play an anti-inflammatory role downmodulating plasma cytokines levels and upregulating corticosterone release.	[Nogueira, Jonatas E.; Branco, Luiz G. S.] Univ Sao Paulo, Postgrad Program Rehabil & Funct Performance, Ribeirao Preto, SP, Brazil; [Nogueira, Jonatas E.] Univ Sao Paulo, Sch Phys Educ & Sports Ribeirao Preto, Ribeirao Preto, SP, Brazil; [Soriano, Renato N.] Univ Fed Juiz de Fora, Governador Valadares, MG, Brazil; [Fernandez, Rodrigo A. R.; Francescato, Heloisa D. C.; Saia, Rafael S.; Coimbra, Terezila M.; Antunes-Rodrigues, Jose] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Physiol, Ribeirao Preto, SP, Brazil; [Branco, Luiz G. S.] Univ Sao Paulo, Dent Sch Ribeirao Preto, Dept Morphol Physiol & Basic Pathol, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Juiz de Fora; Universidade de Sao Paulo; Universidade de Sao Paulo	Branco, LGS (corresponding author), Univ Sao Paulo, Postgrad Program Rehabil & Funct Performance, Ribeirao Preto, SP, Brazil.; Branco, LGS (corresponding author), Univ Sao Paulo, Dent Sch Ribeirao Preto, Dept Morphol Physiol & Basic Pathol, Ribeirao Preto, SP, Brazil.	branco@forp.usp.br	Saia, Rafael S/I-8454-2014; Branco, Luiz G S/N-6273-2014; Nogueira, Jonatas/AAE-7619-2019; Fernandez, Rodrigo/GRF-1350-2022; Francescato, Heloísa D. C./J-7389-2017; Branco, Luiz/AAH-7589-2020	Saia, Rafael S/0000-0001-5106-5988; Branco, Luiz/0000-0003-0292-4947; Evandro Nogueira, Jonatas/0000-0001-5145-9928; Saia, Rafael Simone/0000-0002-9771-7627	FAPESP [2015/24950-3]; CNPq [459747/2014-2]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funded by FAPESP 2015/24950-3 www.fapesp.br/ CNPq 459747/2014-2 www.cnpq.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Mauro F. Silva and Maria Valci Silva for excellent technical assistance, and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil, for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1996, J NEUROSCI, V16, P1066; BAGBY GJ, 1994, J APPL PHYSIOL, V77, P1542, DOI 10.1152/jappl.1994.77.3.1542; Blackstone E, 2007, SHOCK, V27, P370, DOI 10.1097/SHK.0b013e31802e27a0; Blair SN, 2001, MED SCI SPORT EXER, V33, pS379, DOI 10.1097/00005768-200106001-00007; Blatteis CM, 2006, PHARMACOL THERAPEUT, V111, P194, DOI 10.1016/j.pharmthera.2005.10.013; Bonyadi M, 2009, SAUDI MED J, V30, P1390; Branco LGS, 2014, COMPR PHYSIOL, V4, P1301, DOI 10.1002/cphy.c130053; Cartmell T, 2000, J PHYSIOL-LONDON, V526, P653, DOI 10.1111/j.1469-7793.2000.00653.x; Cartmell T, 1999, J PHYSIOL-LONDON, V518, P585, DOI 10.1111/j.1469-7793.1999.0585p.x; Chai Z, 1996, J EXP MED, V183, P311, DOI 10.1084/jem.183.1.311; Chen HI, 2007, MED SCI SPORT EXER, V39, P435, DOI 10.1249/mss.0b013e31802d11c8; Chen XL, 2004, J BIOL CHEM, V279, P52082, DOI 10.1074/jbc.C400481200; Chennaoui M, 2008, EUR CYTOKINE NETW, V19, P8, DOI 10.1684/ecn.2008.0115; COELHO MM, 1992, AM J PHYSIOL, V263, pR423, DOI 10.1152/ajpregu.1992.263.2.R423; Criswell DS, 2004, IMMUNOL LETT, V95, P213, DOI 10.1016/j.imlet.2004.07.012; Feleder C, 2004, AM J PHYSIOL-REG I, V286, pR1156, DOI 10.1152/ajpregu.00486.2003; Ferreira JCB, 2007, CLIN EXP PHARMACOL P, V34, P760, DOI 10.1111/j.1440-1681.2007.04635.x; Gil B, 1997, ENDOCRINOLOGY, V138, P1251, DOI 10.1210/en.138.3.1251; GIVALOIS L, 1994, AM J PHYSIOL, V267, pR164, DOI 10.1152/ajpregu.1994.267.1.R164; Harden LM, 2011, PSYCHONEUROENDOCRINO, V36, P608, DOI 10.1016/j.psyneuen.2010.09.003; Inoue K, 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0UMAL.P0NE.0128720; Kabil O, 2011, ANTIOXID REDOX SIGN, V15, P363, DOI 10.1089/ars.2010.3781; Kimura H, 2005, ANTIOXID REDOX SIGN, V7, P795, DOI 10.1089/ars.2005.7.795; Kimura H, 2013, NEUROCHEM INT, V63, P492, DOI 10.1016/j.neuint.2013.09.003; Kimura H, 2012, ANTIOXID REDOX SIGN, V17, P45, DOI 10.1089/ars.2011.4345; Krall CM, 2010, AM J PHYSIOL-REG I, V298, pR1512, DOI 10.1152/ajpregu.00158.2010; Kwiatkoski M, 2014, ACTA PHYSIOL, V210, P913, DOI 10.1111/apha.12177; Kwiatkoski M, 2012, NEUROSCIENCE, V201, P146, DOI 10.1016/j.neuroscience.2011.11.030; Kwiatkoski M, 2013, EXP NEUROL, V240, P88, DOI 10.1016/j.expneurol.2012.11.008; Contarteze RVL, 2008, COMP BIOCHEM PHYS A, V151, P415, DOI 10.1016/j.cbpa.2007.03.005; Lee M, 2009, NEUROBIOL AGING, V30, P1523, DOI 10.1016/j.neurobiolaging.2009.06.001; Lenczowski MJP, 1998, ANN NY ACAD SCI, V856, P139, DOI 10.1111/j.1749-6632.1998.tb08322.x; Luheshi G, 1996, AM J PHYSIOL-ENDOC M, V270, pE91, DOI 10.1152/ajpendo.1996.270.1.E91; Malm C, 2004, SPORTS MED, V34, P555, DOI 10.2165/00007256-200434090-00001; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pedersen BK, 2000, PHYSIOL REV, V80, P1055, DOI 10.1152/physrev.2000.80.3.1055; Radahmadi M, 2015, EXP BRAIN RES, V233, P2789, DOI 10.1007/s00221-015-4349-y; Rowsey PJ, 2009, BIOL RES NURS, V10, P374, DOI 10.1177/1099800408329409; Rowsey PJ, 2006, ARCH TOXICOL, V80, P81, DOI 10.1007/s00204-005-0036-2; Rowsey PJ, 2003, ENVIRON RES, V92, P27, DOI 10.1016/S0013-9351(02)00096-8; Russo C. Dello, 2000, Journal of Neuroendocrinology, V12, P225; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; Vecsei P., 1978, METHODS HORMONE RADI, P767, DOI [10.1016/B978-0-12-379260-0.50046-7, DOI 10.1016/B978-0-12-379260-0.50046-7]; Wang CN, 2014, ANTIOXID REDOX SIGN, V21, P2192, DOI 10.1089/ars.2013.5682; Wang J, 2012, ACTA PHYSIOL HUNG, V99, P261, DOI 10.1556/APhysiol.99.2012.3.3; Wrotek S, 2017, CYTOKINE, V90, P31, DOI 10.1016/j.cyto.2016.10.005	47	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2017	12	1							e0170468	10.1371/journal.pone.0170468	http://dx.doi.org/10.1371/journal.pone.0170468			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7CU	28118407	Green Submitted, Green Published, gold			2022-12-26	WOS:000396160500032
J	Ginindza, TG; Dlamini, X; Almonte, M; Herrero, R; Jolly, PE; Tsoka-Gwegweni, JM; Weiderpass, E; Broutet, N; Sartorius, B				Ginindza, Themba G.; Dlamini, Xolisile; Almonte, Maribel; Herrero, Rolando; Jolly, Pauline E.; Tsoka-Gwegweni, Joyce M.; Weiderpass, Elisabete; Broutet, Nathalie; Sartorius, Benn			Prevalence of and Associated Risk Factors for High Risk Human Papillomavirus among Sexually Active Women, Swaziland	PLOS ONE			English	Article							INVASIVE CERVICAL-CANCER; AGE-SPECIFIC PREVALENCE; HIV-NEGATIVE WOMEN; HPV INFECTION; GENOTYPE DISTRIBUTION; VIRUS-INFECTION; ABNORMALITIES; POPULATION; PATTERNS	Background High risk human papillomavirus (hr-HPV) infection and the dual burden of HIV remains a huge challenge in some low-income countries (LICs) such as Swaziland with limited or no data. We estimated the prevalence and investigated determinants of hr-HPV, including HIV infection among sexually active women in Swaziland. Methods A total of 655 women aged between 15 and 49 years from five health facilities were randomly enrolled using a cross-sectional study design. Cervical cells were tested for hr-HPV types using GeneXpert HPV Assays. Results The overall weighted hr-HPV prevalence was 46.2% (95% CI: 42.8-49.5). Of hr-HPV infected women, 12.4% (95% CI: 8.6-17.5) were HPV16-positive, 13.8% (95% CI: 12.0-15.8) were positive for HPV18/45, 26.7% (95% CI: 24.2-29.3) for HPV31/33/35/52/58, 7.6% (95% CI: 7.6-11.9) for HPV51/59 and 11.0%, (95% CI: 7.9-15.3) for HPV39/56/66/68. Prevalence of hr-HPV decreased with increasing age. Overall HIV prevalence remained high (42.7%; 95% CI: 35.7-46.2). HIV infection was associated with hr-HPV infection (Adjusted OR = 4.9, 95% CI: 3.043-7.8, p<0.001). Overall hr-HPV/HIV co-infection was 24.4% (95% CI: 20.3-29.1) which was significantly higher among younger age groups (p<0.001). Prevalence of multiple group hr-HPV infection was significantly higher in HIV-positive versus negative women (27.7% and 12.7% respectively, p<0.001). The presence, absence or unknown of history of STI with HIV did not appear to modify the relationship with hr-HPV (OR = 4.2, 95% CI: 2.6-7.1, OR = 4.6, 95% CI: 2.8-7.7, p<0.001, p<0.001 and OR = 4.1, 95% CI: 1.3-13.4, p<0.021 respectively). Conclusion The prevalence of hr-HPV infection was high and significantly associated with HIV among sexually active women. Furthermore, the study has provided essential information about the HIV link with hr-HPV infections which may explain the high prevalence among HIV infected women. This can contribute to policy development and planning of prevention strategies incorporating HPV infection prevention especially among youth and HIV infected people.	[Ginindza, Themba G.; Tsoka-Gwegweni, Joyce M.; Sartorius, Benn] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Dept Publ Hlth, Durban, South Africa; [Dlamini, Xolisile] Minist Hlth, Epidemiol Unit, Mbabane, Eswatini; [Almonte, Maribel; Herrero, Rolando] Int Agcy Res Canc IARC, Prevent & Implementat Grp, Lyon, France; [Jolly, Pauline E.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA; [Weiderpass, Elisabete] Canc Registry Norway, Inst Populat Based Canc Res, Dept Res, Oslo, Norway; [Weiderpass, Elisabete] Univ Tromso, Fac Hlth Sci, Dept Community Med, Tromso, Norway; [Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Weiderpass, Elisabete] Folkhalsan Res Ctr, Genet Epidemiol Grp, Helsinki, Finland; [Broutet, Nathalie] WHO, Dept Reprod Hlth & Res, Geneva, Switzerland	University of Kwazulu Natal; World Health Organization; International Agency for Research on Cancer (IARC); University of Alabama System; University of Alabama Birmingham; University of Oslo; UiT The Arctic University of Tromso; Karolinska Institutet; Folkhalsan Research Center; World Health Organization	Ginindza, TG (corresponding author), Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Dept Publ Hlth, Durban, South Africa.	Ginindza@ukzn.ac.za	Weiderpass, Elisabete/AAP-2747-2021; Almonte, Maribel/O-3286-2016; Weiderpass, Elisabete/M-4029-2016; Gindza, Prof. Themba G/N-5762-2013	Weiderpass, Elisabete/0000-0003-2237-0128; Weiderpass, Elisabete/0000-0003-2237-0128; , bennsartorius/0000-0001-6761-2325; Ginindza, Themba G/0000-0002-0993-8308	University of KwaZulu-Natal College of health sciences Doctoral research Scholarship grant; Health and Welfare Sector Education and Training Authority (HWASETA); Victor Daitz Information Gateway, an initiative of the Victor Daitz Foundation; University of KwaZulu-Natal; International Agency for Research on cancer (IARC); WHO Swaziland local office; Ministry of health Epidemiology Unit; Sexually Reproductive Health Unit (SRH); University of Alabama at Birmingham (Minority Health International Research Training (MHIRT) grant)	University of KwaZulu-Natal College of health sciences Doctoral research Scholarship grant; Health and Welfare Sector Education and Training Authority (HWASETA); Victor Daitz Information Gateway, an initiative of the Victor Daitz Foundation; University of KwaZulu-Natal; International Agency for Research on cancer (IARC)(World Health Organization); WHO Swaziland local office; Ministry of health Epidemiology Unit; Sexually Reproductive Health Unit (SRH); University of Alabama at Birmingham (Minority Health International Research Training (MHIRT) grant)	This work received support from a University of KwaZulu-Natal College of health sciences Doctoral research Scholarship grant and another part funding from Health and Welfare Sector Education and Training Authority (HWASETA). Open access publication of this article has been made possible through support from the Victor Daitz Information Gateway, an initiative of the Victor Daitz Foundation and the University of KwaZulu-Natal.; We thank the Kingdom of Swaziland Ministry of Health for allowing us to implement the study. We also thank the International Agency for Research on cancer (IARC), the WHO Swaziland local office, the Ministry of health Epidemiology Unit, the Sexually Reproductive Health Unit (SRH) and the University of Alabama at Birmingham (Minority Health International Research Training (MHIRT) grant) for all their support. We are so thankful for the laboratory support and capacity building from Cepheid Europe and South Africa.	Akarolo-Anthony SN, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-656; Brandao VDRAB, 2009, MEM I OSWALDO CRUZ, V104, P755, DOI 10.1590/S0074-02762009000500016; Auwal I. K., 2013, Bayero Journal of Pure and Applied Sciences, V6, P67, DOI 10.4314/bajopas.v6i1.14; Bahmanyar ER, 2012, GYNECOL ONCOL, V127, P440, DOI 10.1016/j.ygyno.2012.08.033; Belglaiaa E, 2015, INFECT AGENTS CANCER, V10, DOI 10.1186/s13027-015-0040-y; BOUVARD V, 2009, LANCET ONCOL, V10, P321, DOI [DOI 10.1016/S1470-2045(09)70096-8, 10.1016/s1470-2045(09)70096-8]; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Castellsague X, 2009, GYNECOL ONCOL, V115, pS15, DOI 10.1016/j.ygyno.2009.09.021; Clifford G, 2006, VACCINE, V24, P26, DOI 10.1016/j.vaccine.2006.05.026; Dartell M, 2013, SEX TRANSM DIS, V40, P737, DOI 10.1097/OLQ.0000000000000005; Dartell M, 2012, SEX TRANSM DIS, V39, P201, DOI 10.1097/OLQ.0b013e31823b50ad; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Dempsey AF, 2010, J ADOLESCENT HEALTH, V47, P242, DOI 10.1016/j.jadohealth.2009.12.009; Dreyer G, 2015, S AFR J GYNAECOL ONC, V5, pS21; Dunne EF, 2007, JAMA-J AM MED ASSOC, V297, P813, DOI 10.1001/jama.297.8.813; Ebrahim S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146603; Ferlay J, 2012, GLOBOCAN 2012 ESTIMA; Foliaki S, 2014, INFECT AGENTS CANCER, V9, DOI 10.1186/1750-9378-9-14; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Gage JC, 2012, INT J CANCER, V130, P2111, DOI 10.1002/ijc.26211; Giuliano AR, 1999, CANCER EPIDEM BIOMAR, V8, P615; Hoste G, 2013, OBSTET GYNECOL INT, V2013, DOI 10.1155/2013/610373; Jacobs MV, 2000, INT J CANCER, V87, P221, DOI 10.1002/1097-0215(20000715)87:2&lt;221::AID-IJC11&gt;3.0.CO;2-2; Jing LP, 2014, SEX TRANSM DIS, V41, P725, DOI 10.1097/OLQ.0000000000000201; Mbulawa ZZA, 2016, PAPILLOMAVIRUS RES, V2, P56, DOI 10.1016/j.pvr.2016.02.004; McDonald AC, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00048; Memiah P, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/953743; Meyrelles ARI, 2013, GYNECOL ONCOL, V128, P107, DOI 10.1016/j.ygyno.2012.10.003; Muula AS, 2008, CROAT MED J, V49, P423, DOI 10.3325/cmj.2008.3.423; Ng'andwe C, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-77; Niyazi M, 2016, BOSNIAN J BASIC MED; Ogembo RK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122488; Patel Parin. V., 2012, IJERT, V1, P1, DOI DOI 10.1097/0LQ; Ramjee G, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-30; Ribeiro AA, 2015, INFECT AGENTS CANCER, V10, DOI 10.1186/s13027-015-0011-3; Rocha-Brischiliari SC, 2014, INFECT AGENTS CANCER, V9, DOI 10.1186/1750-9378-9-6; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Schluterman NH, 2013, BMC WOMENS HEALTH, V13, DOI 10.1186/1472-6874-13-4; Smith-McCune KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010094; Sun XW, 1997, NEW ENGL J MED, V337, P1343, DOI 10.1056/NEJM199711063371903; Syrjanen S, 2011, Adv Dent Res, V23, P84, DOI 10.1177/0022034511399914; The Kingdom of Swaziland Gorvernment and UNFPA, 2007, SWAZ POP PROJ 2007 2; The Kingdom of Swaziland Ministry of Health, 2014, NAT GUID HIV TEST CO; van Aardt MC, 2015, INT J GYNECOL CANCER, V25, P919, DOI 10.1097/IGC.0000000000000422; Veldhuijzen NJ, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-333; Wang R, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0998-5; Winer RL, 2008, J INFECT DIS, V197, P279, DOI 10.1086/524875; World Health Organization (WHO), 2010, HUM PAP REL CANC; Zetola NM, 2007, MAYO CLIN PROC, V82, P1091, DOI 10.4065/82.9.1091; Zuma K, 2016, AJAR-AFR J AIDS RES, V15, P67, DOI 10.2989/16085906.2016.1153491	51	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170189	10.1371/journal.pone.0170189	http://dx.doi.org/10.1371/journal.pone.0170189			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114325	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129000023
J	Smirnov, MS; Evans, PR; Garrett, TR; Yan, L; Yasuda, R				Smirnov, Michael S.; Evans, Paul R.; Garrett, Tavita R.; Yan, Long; Yasuda, Ryohei			Automated Remote Focusing, Drift Correction, and Photostimulation to Evaluate Structural Plasticity in Dendritic Spines	PLOS ONE			English	Article							DIGITAL AUTOFOCUS; ACTIVATION; COMPLEXES; CAMKII	Long-term structural plasticity of dendritic spines plays a key role in synaptic plasticity, the cellular basis for learning and memory. The biochemical step is mediated by a complex network of signaling proteins in spines. Two-photon imaging techniques combined with two-photon glutamate uncaging allows researchers to induce and quantify structural plasticity in single dendritic spines. However, this method is laborious and slow, making it unsuitable for high throughput screening of factors necessary for structural plasticity. Here we introduce a MATLAB-based module built for Scanimage to automatically track, image, and stimulate multiple dendritic spines. We implemented an electrically tunable lens in combination with a drift correction algorithm to rapidly and continuously track targeted spines and correct sample movements. With a straightforward user interface to design custom multi-position experiments, we were able to adequately image and produce targeted plasticity in multiple dendritic spines using glutamate uncaging. Our methods are inexpensive, open source, and provides up to a five-fold increase in throughput for quantifying structural plasticity of dendritic spines.	[Smirnov, Michael S.; Garrett, Tavita R.; Yasuda, Ryohei] Max Planck Florida Inst Neurosci, Neuronal Signal Transduct, Jupiter, FL 33458 USA; [Evans, Paul R.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Yan, Long] Max Planck Florida Inst Neurosci, Light Microscopy Core, Jupiter, FL USA	Max Planck Society; Emory University; Max Planck Society	Smirnov, MS (corresponding author), Max Planck Florida Inst Neurosci, Neuronal Signal Transduct, Jupiter, FL 33458 USA.	Michael.Smirnov@mpfi.org		Garrett, Tavita/0000-0002-2585-4251; Yasuda, Ryohei/0000-0001-6263-9297	National Institutes of Health [DP1NS096787, 1F31NS086174]; Max Planck Florida Institute for Neuroscience and the Max Planck Society; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [DP1NS096787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Planck Florida Institute for Neuroscience and the Max Planck Society; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (DP1NS096787 to RY and 1F31NS086174 to PRE) and funding from The Max Planck Florida Institute for Neuroscience and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey CH, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a021758; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Botcherby EJ, 2012, P NATL ACAD SCI USA, V109, P2919, DOI 10.1073/pnas.1111662109; Bravo-Zanoguera ME, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2743078; Chen JL, 2013, J PHYSIOL-LONDON, V591, P4689, DOI 10.1113/jphysiol.2013.259804; Colgan LA, 2014, ANNU REV PHYSIOL, V76, P365, DOI 10.1146/annurev-physiol-021113-170400; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Eskicioglu AM, 1995, IEEE T COMMUN, V43, P2959, DOI 10.1109/26.477498; Evans Paul R, 2017, WILD TYPE CA1 AUTOMA; Fernandez E, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.27; FIRESTONE L, 1991, CYTOMETRY, V12, P195, DOI 10.1002/cyto.990120302; Fu M, 2012, NATURE, V483, P92, DOI 10.1038/nature10844; Geusebroek JM, 2000, CYTOMETRY, V39, P1; Grewe BF, 2011, BIOMED OPT EXPRESS, V2, P2035, DOI 10.1364/BOE.2.002035; Harsh Nanda R C, 2001, TECHNICAL SKETCHES C; Hayashi-Takagi A, 2015, NATURE, V525, P333, DOI 10.1038/nature15257; Helmli FS, 2001, IM SIGN PROC AN 2001; Jabbour JM, 2014, BIOMED OPT EXPRESS, V5, P645, DOI 10.1364/BOE.5.000645; Kim IH, 2014, ELIFE, V3, DOI 10.7554/eLife.02839; Kirkby PA, 2010, OPT EXPRESS, V18, P13720, DOI 10.1364/OE.18.013720; Krotkov E, 1986, ROB AUT P 1986 IEEE; Lee SY, 2009, IEEE SIGNAL PROC LET, V16, P133, DOI 10.1109/LSP.2008.2008938; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Lutz C, 2008, NAT METHODS, V5, P821, DOI 10.1038/NMETH.1241; Marks DL, 2003, APPL OPTICS, V42, P3038, DOI 10.1364/AO.42.003038; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Murakoshi H, 2011, NATURE, V472, P100, DOI 10.1038/nature09823; Murakoshi H, 2008, BRAIN CELL BIOL, V36, P31, DOI 10.1007/s11068-008-9024-9; Nayar SK, 1990, ROB AUT 1990 P 1990; Nikolenko V, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.005.2008; Pech-Pacheco JL, 2000, PATT REC 2000 P 15 I; Pertuz S, 2013, PATTERN RECOGN, V46, P1415, DOI 10.1016/j.patcog.2012.11.011; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; PRICE JH, 1994, CYTOMETRY, V16, P283, DOI 10.1002/cyto.990160402; Reddy GD, 2008, NAT NEUROSCI, V11, P713, DOI 10.1038/nn.2116; Redondo R, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.3.036008; Rex CS, 2009, J CELL BIOL, V186, P85, DOI 10.1083/jcb.200901084; Santos A, 1997, J MICROSC-OXFORD, V188, P264, DOI 10.1046/j.1365-2818.1997.2630819.x; Shen FM, 2006, METHOD ENZYMOL, V414, P620, DOI 10.1016/S0076-6879(06)14032-X; Shirvaikar M, 2004, PROCEEDINGS OF THE T; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; SUBBARAO M, 1993, OPT ENG, V32, P2824, DOI 10.1117/12.147706; Sugar JD., 2014, MICROSC TODAY, V22, P40, DOI DOI 10.1017/S1551929514000790; Thelen A, 2009, IEEE T IMAGE PROCESS, V18, P151, DOI 10.1109/TIP.2008.2007049; Wilbrecht L, 2010, J NEUROSCI, V30, P4927, DOI 10.1523/JNEUROSCI.6403-09.2010; Windsor RM, 2016, 3D SHAPE FOCUS DEPTH; Yang WJ, 2016, NEURON, V89, P269, DOI 10.1016/j.neuron.2015.12.012; Zhang Zan-Chao, 2008, Zhongguo Yi Liao Qi Xie Za Zhi, V32, P391	49	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170586	10.1371/journal.pone.0170586	http://dx.doi.org/10.1371/journal.pone.0170586			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114380	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129000075
J	Guo, DJ; Zou, J; Rensing, N; Wong, M				Guo, Dongjun; Zou, Jia; Rensing, Nicholas; Wong, Michael			In Vivo Two-Photon Imaging of Astrocytes in GFAP-GFP Transgenic Mice	PLOS ONE			English	Article							LONG-TERM; DENDRITIC INJURY; NEOCORTEX; CORTEX	Astrocytes play important roles in normal brain function and neurological diseases. In vivo two-photon excitation laser scanning microscopy has the potential to reveal rapid, dynamic structural changes in cells in a variety of physiological and pathological conditions. The type of in vivo imaging method has been shown to affect the plasticity of dendritic spines of neurons, but the optimal in vivo imaging methods of astrocytes have not been established. We compared open-skull and thinned-skull imaging methods for two-photon laser microscopy of live astrocytes in neocortex of GFAP-GFP transgenic mice. The thinned-skull method provided stable image intensity and morphological features of astrocytes in vivo over at least one week, with no evidence of astrogliosis. In contrast, the open-skull method resulted in significant changes in image intensity and induced astrogliosis. The thinned-skull method is the preferred approach for in vivo imaging of astrocytes under most conditions involving gross astrocyte modulation or causing astrogliosis.	[Wong, Michael] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Hope Ctr Neurol Disorders, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Wong, M (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	wong_m@wustl.edu			National Institutes of Health/National Institutes of Neurological Disorders and Stroke [R01 NS079321, R21 NS091047]; National Institutes of Health [R01 NS079321, R21NS091047]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079321, R21NS091047] Funding Source: NIH RePORTER	National Institutes of Health/National Institutes of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health/National Institutes of Neurological Disorders and Stroke: R01 NS079321, R21 NS091047. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Krzysztof Hyrc for his expertise and advice on two-photon microscopy. The imaging studies were performed in the Alafi Neuroimaging Laboratory of Washington University. This work was supported by the National Institutes of Health (R01 NS079321 and R21NS091047 to MW).	Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; De Pitta M., 2015, NEUROSCIENCE; Drew PJ, 2010, NAT METHODS, V7, P981, DOI 10.1038/NMETH.1530; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Guo DJ, 2012, NEUROBIOL DIS, V45, P348, DOI 10.1016/j.nbd.2011.08.020; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Holtmaat Anthony, 2012, Cold Spring Harb Protoc, V2012, P694, DOI 10.1101/pdb.prot069617; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Masamoto K, 2012, NEUROSCIENCE, V212, P190, DOI 10.1016/j.neuroscience.2012.03.034; Risher WC, 2012, GLIA, V60, P1709, DOI 10.1002/glia.22390; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Svoboda K, 2006, NEURON, V50, P823, DOI 10.1016/j.neuron.2006.05.019; Sword J, 2013, BRAIN, V136, P1446, DOI 10.1093/brain/awt026; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Verkhratsky A, 2015, NEUROCHEM RES, V40, P389, DOI 10.1007/s11064-014-1403-2; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883; Yang G, 2010, NAT PROTOC, V5, P201, DOI 10.1038/nprot.2009.222; Zeng LH, 2007, J NEUROSCI, V27, P11604, DOI 10.1523/JNEUROSCI.0983-07.2007; Zhang SX, 2005, J NEUROSCI, V25, P5333, DOI 10.1523/JNEUROSCI.1085-05.2005	20	17	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170005	10.1371/journal.pone.0170005	http://dx.doi.org/10.1371/journal.pone.0170005			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107381	Green Submitted, Green Published, gold			2022-12-26	WOS:000392405300060
J	Liu, H; Duan, HJ; Wang, C				Liu, He; Duan, Hejun; Wang, Cheng			Effects of Ambient Environmental Factors on the Stereotypic Behaviors of Giant Pandas (Ailuropoda melanoleuca)	PLOS ONE			English	Article							SPECIES-DIFFERENCES; RESPONSES; WELFARE; STRESS; BEARS; ZOO; PERFORMANCE; ENRICHMENT; CHOICE; CATS	Stereotypies are commonly observed in zoo animals, and it is necessary to better understand whether ambient environmental factors contribute to stereotypy and how to affect animal welfare in zoo settings. This study investigated the relationships between stereotypic behaviors and environmental factors including ambient temperatures, humidity, light intensity, sound intensity and number of visitors. Seven giant pandas were observed in three indoor enclosures and three outdoor enclosures. Environmental factors were measured for both indoor and outdoor enclosures and the effect they had on stereotypical behaviors was investigated. Our research found that light intensity significantly correlated with all stereotypies behaviors. Higher environmental temperature reduced the duration of pacing but increased the frequency of pacing, the duration and frequency of door-directed, meanwhile the duration of head-toss. However, we found no noticeable effect of humidity on stereotypic behaviors except for the frequency of head-toss. We also found that sound intensity was not correlated with stereotypies. Finally, the growth of visitors was negatively associated with the duration of door-directed. These results demonstrated that various environmental factors can have significant effects on stereotypic behaviors causing the expression of various stereotypies. Thus, stereotypies in zoo animals may not simply represent suboptimal welfare, but rather might be adopted as a means of coping with an aversive environment.	[Liu, He] Beijing Zoo, Giant Panda Res Ctr, Beijing Key Lab Capt Wildlife Technol, Beijing, Peoples R China; [Duan, Hejun] Beijing Ctr Dis Control & Prevent, Beijing Municipal Key Lab Food Poisoning Diag Tra, Beijing, Peoples R China; [Wang, Cheng] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Key Lab Digital Earth Sci, Beijing, Peoples R China	Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS	Liu, H (corresponding author), Beijing Zoo, Giant Panda Res Ctr, Beijing Key Lab Capt Wildlife Technol, Beijing, Peoples R China.; Duan, HJ (corresponding author), Beijing Ctr Dis Control & Prevent, Beijing Municipal Key Lab Food Poisoning Diag Tra, Beijing, Peoples R China.	liuherstar@yahoo.com; dhj@vip.163.com			Memphis Zoo Collaborative Project [MP-ES0611]; Science & Technology Project of Beijing City Park Management Center [2017]; International Science & Technology Cooperation Program of China [2013DFG21640]; Beijing Health Research and Development of Special Project [2011-1013-01]	Memphis Zoo Collaborative Project; Science & Technology Project of Beijing City Park Management Center; International Science & Technology Cooperation Program of China; Beijing Health Research and Development of Special Project	This study was financially supported by the Memphis Zoo Collaborative Project (MP-ES0611), Science & Technology Project of Beijing City Park Management Center (No.2017), the International Science & Technology Cooperation Program of China (2013DFG21640) and Beijing Health Research and Development of Special Project (No.2011-1013-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Many thanks to Prof. Qiao Huili, Dr. Zhang Meijia (China Agriculture University) and Dr. Bao Weidong (Beijing Forestry University) for collecting data. Our deep gratitude to Nathan J. P. Wintle of PDXWildlife, Dr. Carin Harrington, Mr. Christopher Baxter and Ms. May Fong Ho for correcting English. We thank two anonymous reviewers for valuable suggestions that have improved this manuscript. We would also like to thank keepers and lovely giant pandas. This study was financially supported by the Memphis Zoo Collaborative Project (MP-ES0611), Science & Technology Project of Beijing City Park Management Center (No.2017), the International Science & Technology Cooperation Program of China (2013DFG21640) and Beijing Health Research and Development of Special Project (No.2011-1013-01).	Bareham JR, 1972, WELFARE MANAGEMENT W, P90; Bashaw MJ, 2001, APPL ANIM BEHAV SCI, V73, P235, DOI 10.1016/S0168-1591(01)00137-X; BERKSON G, 1968, Developmental Psychobiology, V1, P118, DOI 10.1002/dev.420010210; Broom D M, 1991, Behav Processes, V25, P117, DOI 10.1016/0376-6357(91)90014-Q; CARLSTEAD K, 1991, International Zoo Yearbook, V30, P202; CARLSTEAD K, 1993, ZOO BIOL, V12, P321, DOI 10.1002/zoo.1430120403; Carlstead Kathy, 1996, P317; Carlstead Kathy, 1998, P172; CARO TM, 1979, BEHAVIOUR, V69, P303, DOI 10.1163/156853979X00520; Clubb R, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P58, DOI 10.1079/9780851990040.0058; Clubb R, 2004, ANIM WELFARE, V13, pS33; Cremers PWFH, 2012, P MEAS BEH 2012 8 IN, P338; DANTZER R, 1991, BEHAV PROCESS, V25, P95, DOI 10.1016/0376-6357(91)90012-O; Duncan Ian J. H., 1993, P193; Fang Jiming, 1993, Journal of Beijing Normal University (Natural Science), V29, P549; Hare B, 2003, ANIM BEHAV, V65, P131, DOI 10.1006/anbe.2002.2017; He TM, 2004, J CHINA W NORM U NAT, V25, P34; Kelly KR, 2015, J APPL ANIM WELF SCI, V18, P17, DOI 10.1080/10888705.2014.924832; Kolter Lydia, 1995, P248; Korhonen HT, 2001, CAN J ANIM SCI, V81, P189, DOI 10.4141/A00-093; Kuhar CW, 2006, ZOO BIOL, V25, P339, DOI 10.1002/zoo.20089; Lawrence AB, 1993, STEREOTYPIC ANIMAL B, P1; Lehner PN, HDB ETHOLOGICAL METH; Liu Ding-Zhen, 2002, Acta Zoologica Sinica, V48, P585; Liu DZ, 2003, ZOO BIOL, V22, P77, DOI 10.1002/zoo.10076; Lukas KE, 1999, APPL ANIM BEHAV SCI, V63, P237, DOI 10.1016/S0168-1591(98)00239-1; Lyons J, 1997, ZOO BIOL, V16, P71; Mallapur A, 2005, APPL ANIM BEHAV SCI, V91, P337, DOI 10.1016/j.applanim.2004.10.002; Mallapur A, 2002, ZOO BIOL, V21, P585, DOI 10.1002/zoo.10063; Markowitz H, 1982, BEHAV ENRICHMENT ZOO, P210; MARRINER LM, 1994, ZOO BIOL, V13, P267, DOI 10.1002/zoo.1430130308; Martin P, 1986, MEASURING BEHAV INTR, P200; Mason G, 1997, APPL ANIM BEHAV SCI, V53, P45, DOI 10.1016/S0168-1591(96)01150-1; Mason GJ, 2010, TRENDS ECOL EVOL, V25, P713, DOI 10.1016/j.tree.2010.08.011; MASON GJ, 1993, BEHAVIOUR, V127, P191, DOI 10.1163/156853993X00029; Mason GJ, 2004, ANIM WELFARE, V13, pS57; MASON GJ, 1991, ANIM BEHAV, V41, P1015, DOI 10.1016/S0003-3472(05)80640-2; Meyer-Holzapfel M., 1968, ABNORMAL BEHAV ANIMA, P476; Odberg Frank O., 1993, P173; Owen MA, 2005, ZOO BIOL, V24, P475, DOI 10.1002/zoo.20064; Owen MA, 2004, ZOO BIOL, V23, P147, DOI 10.1002/zoo.10124; Poole TB, 1995, P 2 INT C ENV ENR CO, P118; Powell DM, 2006, ZOO BIOL, V25, P391, DOI 10.1002/zoo.20098; Redbo I, 1997, APPL ANIM BEHAV SCI, V53, P193, DOI 10.1016/S0168-1591(96)01145-8; Rees PA, 2004, J THERM BIOL, V29, P37, DOI 10.1016/j.jtherbio.2003.10.004; Rees PA, 2009, ZOO BIOL, V28, P79, DOI 10.1002/Zoo.20200; Ross SR, 2006, BEHAV PROCESS, V73, P117, DOI 10.1016/j.beproc.2006.04.003; Shepherdson D, 2013, APPL ANIM BEHAV SCI, V147, P268, DOI 10.1016/j.applanim.2013.01.001; SHEPHERDSON DJ, 1993, ZOO BIOL, V12, P203, DOI 10.1002/zoo.1430120206; Steenkamp Gerhard, 2003, Veterinary Clinics of North America Exotic Animal Practice, V6, P689, DOI 10.1016/S1094-9194(03)00035-5; Swaisgood RR, 2005, ZOO BIOL, V24, P499, DOI 10.1002/zoo.20066; Swaisgood RR, 2001, ANIM BEHAV, V61, P447, DOI 10.1006/anbe.2000.1610; Tang QF, 2014, 2014 INTERNATIONAL CONFERENCE ON INTELLIGENT GREEN BUILDING AND SMART GRID (IGBSG); Tarou LR, 2005, AM J PRIMATOL, V65, P181, DOI 10.1002/ajp.20107; TERLOUW EMC, 1993, ANIM BEHAV, V46, P939, DOI 10.1006/anbe.1993.1275; Tian Hong, 2004, Zoological Research, V25, P137; van Zeeland YRA, 2009, APPL ANIM BEHAV SCI, V121, P75, DOI 10.1016/j.applanim.2009.09.006; Vickery SS, 2003, URSUS-SERIES, V14, P35; Zhang JG, 2006, PRIMARY TEACHING MAT, P184; Zhang Shuang, 2004, Acta Ecologica Sinica, V24, P1950	60	10	10	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170167	10.1371/journal.pone.0170167	http://dx.doi.org/10.1371/journal.pone.0170167			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107477	gold, Green Submitted, Green Published			2022-12-26	WOS:000392405300080
J	Nikolovska, K; Spillmann, D; Haier, J; Ladanyi, A; Stock, C; Seidler, DG				Nikolovska, Katerina; Spillmann, Dorothe; Haier, Joerg; Ladanyi, Andrea; Stock, Christian; Seidler, Daniela G.			Melanoma Cell Adhesion and Migration Is Modulated by the Uronyl 2-O Sulfotransferase	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-2; HEPARAN-SULFATE STRUCTURE; CHONDROITIN SULFATE; DERMATAN SULFATE; BREAST-CANCER; UP-REGULATION; IN-VITRO; INTEGRIN; EXPRESSION; METASTASIS	Although the vast majority of melanomas are characterized by a high metastatic potential, if detected early, melanoma can have a good prognostic outcome. However, once metastasised, the prognosis is bleak. We showed previously that uronyl-2-O sulfotransferase (Ust) and 2-O sulfation of chondroitin/dermatan sulfate (CS/DS) are involved in cell migration. To demonstrate an impact of 2-O sulfation in metastasis we knocked-down Ust in mouse melanoma cells. This significantly reduced the amount of Ust protein and enzyme activity. Furthermore, in vitro cell motility and adhesion were significantly reduced correlating with the decrease of cellular Ust protein. Single cell migration of B16V(shUst(16)) cells showed a decreased cell movement phenotype. The adhesion of B16V cells to fibronectin depended on alpha 5 beta 3 but not alpha v beta 3 integrin. Inhibition of glycosaminoglycan sulfation or blocking fibroblast growth factor receptor (FgfR) reduced alpha 5 integrin in B16V cell lines. Interestingly, FgfR1 expression and activation was reduced in Ust knock-down cells. In vivo, pulmonary metastasis of B16(VshUst) cells was prevented due to a reduction of alpha 5 integrin. As a proof of concept UST knock-down in human melanoma cells also showed a reduction in ITGa5 and adhesion. This is the first study showing that Ust, and consequently 2-O sulfation of the low affinity receptor for FgfR CS/DS, reduces Itga5 and leads to an impaired adhesion and migration of melanoma cells.	[Nikolovska, Katerina; Seidler, Daniela G.] Univ Munster, Inst Physiol Chem & Pathobiochem, Munster, Germany; [Nikolovska, Katerina; Stock, Christian; Seidler, Daniela G.] Hannover Med Sch, Ctr Internal Med, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Spillmann, Dorothe] Uppsala Univ, Biomed Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Haier, Joerg] Univ Hosp Munster, Comprehens Canc Ctr Munster, Munster, Germany; [Ladanyi, Andrea] Natl Inst Oncol, Dept Surg & Mol Pathol, Budapest, Hungary	University of Munster; Hannover Medical School; Uppsala University; University of Munster; National Institute of Oncology Hungary	Seidler, DG (corresponding author), Univ Munster, Inst Physiol Chem & Pathobiochem, Munster, Germany.; Seidler, DG (corresponding author), Hannover Med Sch, Ctr Internal Med, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany.	Seidler.Daniela@mh-hannover.de	Ladányi, Andrea/HHM-8153-2022		German Research Foundation [SE1431/3-1, GRK 1549]; German Cancer Aid [111262, 1549]	German Research Foundation(German Research Foundation (DFG)); German Cancer Aid(Deutsche Krebshilfe)	This work was financially supported by the German Research Foundation (SE1431/3-1) to DGS, German Cancer Aid (#111262) to DGS and CS, and the German Research Foundation - GRK 1549 International Research Training Group Molecular and Cellular GlycoSciences to KN.	Afratis N, 2012, FEBS J, V279, P1177, DOI 10.1111/j.1742-4658.2012.08529.x; Bartolini B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066704; Bocian C, 2013, J BIOL CHEM, V288, P12699, DOI 10.1074/jbc.M112.419366; Collo G, 1999, J CELL SCI, V112, P569; Cooney CA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2895; Denholm EM, 2001, EUR J PHARMACOL, V416, P213, DOI 10.1016/S0014-2999(01)00884-6; Dierker T, 2016, MATRIX BIOL, V49, P82, DOI 10.1016/j.matbio.2015.06.004; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fthenou E, 2009, IN VIVO, V23, P69; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; GARRIGUES HJ, 1986, J CELL BIOL, V103, P1699, DOI 10.1083/jcb.103.5.1699; Gouignard N., 2016, DIS MODEL MECH; Ishii M, 2008, J BIOL CHEM, V283, P32610, DOI 10.1074/jbc.M806331200; Jungmann O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050809; Keire PA, 2016, MATRIX BIOL, V50, P67, DOI 10.1016/j.matbio.2015.12.010; KELLER KM, 1989, BIOCHEMISTRY-US, V28, P8100, DOI 10.1021/bi00446a021; Klein S, 1996, J BIOL CHEM, V271, P22583, DOI 10.1074/jbc.271.37.22583; Kobayashi M, 1999, J BIOL CHEM, V274, P10474, DOI 10.1074/jbc.274.15.10474; Kwok JCF, 2012, INT J BIOCHEM CELL B, V44, P582, DOI 10.1016/j.biocel.2012.01.004; Ladanyi Andrea, 2001, Pathology and Oncology Research, V7, P260; Li F, 2008, J BIOL CHEM, V283, P34294, DOI 10.1074/jbc.M806015200; Loffek S, 2005, J INVEST DERMATOL, V124, P638, DOI 10.1111/j.0022-202X.2005.23629.x; Maccarana M, 2009, MOL CELL BIOL, V29, P5517, DOI 10.1128/MCB.00430-09; Malmstrom A, 2012, J HISTOCHEM CYTOCHEM, V60, P916, DOI 10.1369/0022155412459857; McKenzie JA, 2013, CARCINOGENESIS, V34, P2137, DOI 10.1093/carcin/bgt155; McKenzie JA, 2010, CANCER RES, V70, P7927, DOI 10.1158/0008-5472.CAN-10-0194; Mizumoto S, 2015, CURR OPIN STRUC BIOL, V34, P35, DOI 10.1016/j.sbi.2015.06.004; Mizumoto S, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/56319, 10.1155/2013/656319]; Mizumoto S, 2012, J BIOL CHEM, V287, P18985, DOI 10.1074/jbc.M111.313437; Morgan MR, 2009, IUBMB LIFE, V61, P731, DOI 10.1002/iub.200; Nakamura K, 2002, LIFE SCI, V70, P791, DOI 10.1016/S0024-3205(01)01454-0; Nakao M, 2000, J IMMUNOL, V164, P2565, DOI 10.4049/jimmunol.164.5.2565; Nam EH, 2015, CARCINOGENESIS, V36, P327, DOI 10.1093/carcin/bgv005; Nikolovska K, 2015, J CELL SCI, V128, P460, DOI 10.1242/jcs.152660; Nikolovska K, 2014, MATRIX BIOL, V35, P91, DOI 10.1016/j.matbio.2014.01.003; Orso F, 2016, CANCER RES, V76, P5151, DOI 10.1158/0008-5472.CAN-15-1322; Qian F, 2005, BIOCHEM BIOPH RES CO, V333, P1269, DOI 10.1016/j.bbrc.2005.06.039; Salpietro V, 2015, AM J MED GENET A, V167, P2042, DOI 10.1002/ajmg.a.37118; Schaffner Florence, 2013, Cancers (Basel), V5, P27, DOI 10.3390/cancers5010027; Seidler DG, 2012, CURR OPIN STRUC BIOL, V22, P578, DOI 10.1016/j.sbi.2012.07.012; Seidler DG, 2011, J IMMUNOL, V187, P6108, DOI 10.4049/jimmunol.1100373; Seidler DG, 2002, J BIOL CHEM, V277, P42409, DOI 10.1074/jbc.M208442200; Smetsers TFCM, 2004, J INVEST DERMATOL, V122, P707, DOI 10.1111/j.0022-202X.2004.22316.x; Stock C, 2011, J CELL PHYSIOL, V226, P2641, DOI 10.1002/jcp.22612; Su Y, 2016, P NATL ACAD SCI USA, V113, pE3872, DOI 10.1073/pnas.1605074113; SUPINO R, 1986, BRIT J CANCER, V54, P33, DOI 10.1038/bjc.1986.149; Syx D, 2015, HUM MUTAT, V36, P535, DOI 10.1002/humu.22774; Taylor KR, 2005, J BIOL CHEM, V280, P5300, DOI 10.1074/jbc.m410412200; Vahle AK, 2014, INT J ONCOL, V44, P78, DOI 10.3892/ijo.2013.2158; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANMUIJEN GNP, 1991, INT J CANCER, V48, P85; Wegrowski Y, 2006, ADV PHARMACOL, V53, P297, DOI 10.1016/S1054-3589(05)53014-X	52	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170054	10.1371/journal.pone.0170054	http://dx.doi.org/10.1371/journal.pone.0170054			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107390	Green Submitted, Green Published, gold			2022-12-26	WOS:000392405300068
J	Sundermeier, TR; Sakami, S; Sahu, B; Howell, SJ; Gao, SQ; Dong, ZQ; Golczak, M; Maeda, A; Palczewski, K				Sundermeier, Thomas R.; Sakami, Sanae; Sahu, Bhubanananda; Howell, Scott J.; Gao, Songqi; Dong, Zhiqian; Golczak, Marcin; Maeda, Akiko; Palczewski, Krzysztof			MicroRNA-processing Enzymes Are Essential for Survival and Function of Mature Retinal Pigmented Epithelial Cells in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						eye; retina; retinal degeneration; retinal metabolism; vision; ret; retina; retina metabolism	MACULAR DEGENERATION; NLRP3 INFLAMMASOME; ALU RNA; TRANSCRIPTION FACTOR; GENE-EXPRESSION; MOUSE MODEL; C-ELEGANS; MIRNAS; ROD; PHOTORECEPTORS	Age-related macular degeneration (AMD) is a major cause of irreversible vision loss. The neovascular or wet form of AMD can be treated to varying degrees with anti-angiogenic drugs, but geographic atrophy (GA) is an advanced stage of the more prevalent dry form of AMD for which there is no effective treatment. Development of GA has been linked to loss of the microRNA (miRNA)-processing enzyme DICER1 in the mature retinal pigmented epithelium (RPE). This loss results in the accumulation of toxic transcripts of Alu transposable elements, which activate the NLRP3 inflammasome and additional downstream pathways that compromise the integrity and function of the RPE. However, it remains unclear whether the loss of miRNA processing and subsequent gene regulation in the RPE due to DICER1 deficiency also contributes to RPE cell death. To clarify the role of miRNAs in RPE cells, we used two different mature RPE cell-specific Cre recombinase drivers to inactivate either Dicer1 or DiGeorge syndrome critical region 8 (Dgcr8), thus removing RPE miRNA regulatory activity in mice by disrupting two independent and essential steps of miRNA biogenesis. In contrast with prior studies, we found that the loss of each factor independently led to strikingly similar defects in the survival and function of the RPE and retina. These results suggest that the loss of miRNAs also contributes to RPE cell death and loss of visual function and could affect the pathology of dry AMD.	[Sundermeier, Thomas R.; Sakami, Sanae; Gao, Songqi; Golczak, Marcin; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Sahu, Bhubanananda; Howell, Scott J.; Maeda, Akiko] Case Western Reserve Univ, Sch Med, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Golczak, Marcin; Palczewski, Krzysztof] Case Western Reserve Univ, Cleveland Ctr Membrane & Struct Biol, Cleveland, OH 44106 USA; [Dong, Zhiqian] Polgenix Inc, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Cleveland Ctr Membrane & Struct Biol, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu		Imanishi, Sanae/0000-0001-9884-2123; DONG, ZHIQIAN/0000-0002-8748-4532	National Institutes of Health [EY022326, EY R24024864, EY022658, EY023948, P30EY011373]; Arnold and Mabel Beckman Foundation; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [R01EY023948, P30EY011373, R01EY022326, R01EY022658] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arnold and Mabel Beckman Foundation; Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported in part by National Institutes of Health Grants EY022326 and EY R24024864 (to K.P.), EY022658 (to A. M.), EY023948 (to M. G.), and P30EY011373 (from the VSRC CORE grant). This work was also supported by the Arnold and Mabel Beckman Foundation and the Foundation Fighting Blindness. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADAMUS G, 1991, VISION RES, V31, P17, DOI 10.1016/0042-6989(91)90069-H; Adijanto J, 2012, J BIOL CHEM, V287, P20491, DOI 10.1074/jbc.M112.354761; Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Ambati J, 2011, INVEST OPHTH VIS SCI, V52, P2166, DOI 10.1167/iovs.11-7328; Busskamp V, 2014, NEURON, V83, P586, DOI 10.1016/j.neuron.2014.06.020; Chappelow AV, 2008, DRUGS, V68, P1029, DOI 10.2165/00003495-200868080-00002; Chen YH, 2010, MOL INTERV, V10, P271, DOI 10.1124/mi.10.5.4; Cheung LK, 2013, PHARMACOTHERAPY, V33, P838, DOI 10.1002/phar.1264; Dai XD, 2015, PIGM CELL MELANOMA R, V28, P217, DOI 10.1111/pcmr.12334; Dong CS, 2012, RNA, V18, P1679, DOI 10.1261/rna.033977.112; Dridi S, 2012, P NATL ACAD SCI USA, V109, P13781, DOI 10.1073/pnas.1206494109; Dynoodt P, 2013, J INVEST DERMATOL, V133, P201, DOI 10.1038/jid.2012.266; Emde A, 2014, EMBO J, V33, P1428, DOI 10.15252/embj.201488142; Fabian MR, 2010, PROG MOL SUBCELL BIO, V50, P1, DOI 10.1007/978-3-642-03103-8_1; Fowler BJ, 2014, SCIENCE, V346, P1000, DOI 10.1126/science.1261754; Gelfand BD, 2015, CELL REP, V11, P1686, DOI 10.1016/j.celrep.2015.05.023; Golczak M, 2010, METHODS MOL BIOL, V652, P229, DOI 10.1007/978-1-60327-325-1_13; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Iacovelli J, 2011, INVEST OPHTH VIS SCI, V52, P1378, DOI 10.1167/iovs.10-6347; Jian Q, 2014, MOL CELL BIOL, V34, P3407, DOI 10.1128/MCB.00106-14; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Kerur N, 2013, INVEST OPHTH VIS SCI, V54, P7395, DOI 10.1167/iovs.13-12500; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Kim Y, 2014, P NATL ACAD SCI USA, V111, P16082, DOI 10.1073/pnas.1403814111; Kleinman ME, 2016, DEV OPHTHALMOL, V55, P46, DOI 10.1159/000431141; Krol J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8305; Le YZ, 2008, INVEST OPHTH VIS SCI, V49, P1248, DOI 10.1167/iovs.07-1105; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Lumayag S, 2013, P NATL ACAD SCI USA, V110, pE507, DOI 10.1073/pnas.1212655110; Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P12758, DOI 10.1073/pnas.220402097; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; Mione M, 2015, PIGM CELL MELANOMA R, V28, DOI 10.1111/pcmr.12346; Nowak JZ, 2006, PHARMACOL REP, V58, P353; Ohana R, 2015, DEVELOPMENT, V142, P2487, DOI 10.1242/dev.121533; Peden MC, 2015, OPHTHALMOLOGY, V122, P803, DOI 10.1016/j.ophtha.2014.11.018; Pelaez N, 2012, CURR TOP DEV BIOL, V99, P237, DOI 10.1016/B978-0-12-387038-4.00009-4; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; ROBISON WG, 1977, INVEST OPHTH VIS SCI, V16, P1110; Rofagha S, 2013, OPHTHALMOLOGY, V120, P2292, DOI 10.1016/j.ophtha.2013.03.046; Sakami S, 2014, HUM MOL GENET, V23, P1723, DOI 10.1093/hmg/ddt561; Sethna Saumil, 2013, Methods Mol Biol, V935, P245, DOI 10.1007/978-1-62703-080-9_17; Staurenghi G, 2014, OPHTHALMOLOGY, V121, P1572, DOI 10.1016/j.ophtha.2014.02.023; Sundermeier TR, 2016, FASEB J, V30, P23, DOI 10.1096/fj.15-279745; Sundermeier TR, 2014, FASEB J, V28, P3780, DOI 10.1096/fj.14-254292; Tajaddod M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1083-0; Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Vidigal JA, 2015, TRENDS CELL BIOL, V25, P137, DOI 10.1016/j.tcb.2014.11.004; Wang FE, 2010, FASEB J, V24, P1552, DOI 10.1096/fj.08-125856; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Yaqoob Zahid, 2005, Biotechniques, V39, pS6, DOI 10.2144/000112090; Yazdi MH, 2015, EXPERT OPIN BIOL TH, V15, P1349, DOI 10.1517/14712598.2015.1057565; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; Zhu QB, 2011, J BIOL CHEM, V286, P31749, DOI 10.1074/jbc.M111.259028	56	21	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3366	3378		10.1074/jbc.M116.770024	http://dx.doi.org/10.1074/jbc.M116.770024			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28104803	Green Published, hybrid			2022-12-26	WOS:000395538800026
J	Alberic, M; Dean, MN; Gourrier, A; Wagermaier, W; Dunlop, JWC; Staude, A; Fratzl, P; Reiche, I				Alberic, Marie; Dean, Mason N.; Gourrier, Aurelien; Wagermaier, Wolfgang; Dunlop, John W. C.; Staude, Andreas; Fratzl, Peter; Reiche, Ina			Relation between the Macroscopic Pattern of Elephant Ivory and Its Three-Dimensional Micro-Tubular Network	PLOS ONE			English	Article							SCHREGER PATTERN	Macroscopic, periodic, dark and bright patterns are observed on sections of elephant tusk, in the dentin part (ivory). The motifs-also called Schreger pattern-vary depending on the orientation in the tusk: on sections perpendicular to the tusk axis, a checkerboard pattern is present whereas on sections longitudinal to it, alternating stripes are observed. This pattern has been used to identify elephant and mammoth ivory in archeological artifacts and informs on the continuous tissue growth mechanisms of tusk. However, its origin, assumed to be related to the 3D structure of empty microtubules surrounded by the ivory matrix has yet to be characterized unequivocally. Based on 2D observations of the ivory microtubules by means of a variety of imaging techniques of three different planes (transverse, longitudinal and tangential to the tusk axis), we show that the dark areas of the macroscopic pattern are due to tubules oblique to the surface whereas bright areas are related to tubules parallel to it. The different microstructures observed in the three planes as well as the 3D data obtained by SR-mu CT analysis allow us to propose a 3D model of the microtubule network with helical tubules phase-shifted in the tangential direction. The phase shift is a combination of a continuous phase shift of pi every 1 mm with a stepwise phase shift of pi/2 every 500 mu m. By using 3D modeling, we show how the 3D helical model better represents the experimental microstructure observed in 2D planes compared to previous models in the literature. This brings new information on the origin of the unique Schreger pattern of elephant ivory, crucial for better understanding how archaeological objects were processed and for opening new routes to rethink how biological materials are built.	[Alberic, Marie; Reiche, Ina] Univ Paris 06, Sorbonne Univ, Univ Pierre & Marie Curie, UMR CNRS 8220,Lab Archeol Mol & Struct, Paris, France; [Alberic, Marie; Dean, Mason N.; Wagermaier, Wolfgang; Dunlop, John W. C.; Fratzl, Peter] Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany; [Gourrier, Aurelien] Univ Grenoble Alpes, Lab Interdisciplinaire Phys LIPHY, Grenoble, France; [Gourrier, Aurelien] CNRS, LIPHY, Grenoble, France; [Gourrier, Aurelien] European Synchrotron Radiat Facil, Grenoble, France; [Staude, Andreas] Bundesanstalt Mat Forsch & Prufung BAM, Berlin, Germany; [Reiche, Ina] Staatliche Museen Berlin, Stiftung Preuss Kulturbesitz, Rathgen Forschungslab, Berlin, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Sorbonne Universite; Max Planck Society; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); European Synchrotron Radiation Facility (ESRF); Federal Institute for Materials Research & Testing	Reiche, I (corresponding author), Univ Paris 06, Sorbonne Univ, Univ Pierre & Marie Curie, UMR CNRS 8220,Lab Archeol Mol & Struct, Paris, France.; Reiche, I (corresponding author), Staatliche Museen Berlin, Stiftung Preuss Kulturbesitz, Rathgen Forschungslab, Berlin, Germany.	ina.reiche@upmc.fr	Reiche, Ina/AAQ-3897-2020; Alberic, Marie/GYJ-8104-2022; Dean, Mason N/C-8758-2014; Dunlop, John W C/A-1997-2012; Fratzl, Peter/H-9095-2012	Dean, Mason N/0000-0002-5026-6216; Dunlop, John W C/0000-0003-2741-6383; Fratzl, Peter/0000-0003-4437-7830; Alberic, Marie/0000-0002-5322-9904; Staude, Andreas/0000-0002-4890-6691	PhD grant from the doctoral school at the University Pierre et Marie Curie [ED388]; PhD scholarship of German Academic Exchange Service (DAAD) [A1270967]; PHC Procope [28576YC]	PhD grant from the doctoral school at the University Pierre et Marie Curie; PhD scholarship of German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); PHC Procope	This study received support by the PhD grant from the doctoral school ED388 (2011-14) at the University Pierre et Marie Curie and the PhD scholarship of German Academic Exchange Service (DAAD, A1270967) for MA. The project also received funding in the framework of PHC Procope (28576YC, 2013-2014) for MA, MND, AG, WW, JWCD, PF and IR.	Abelova M, 2008, B GEOSCI, V83, P225, DOI 10.3140/bull.geosci.2008.02.225; Ball P., 1999, SELF MADE TAPESTRY P; BOYDE A, 1983, ANAT EMBRYOL, V168, P211, DOI 10.1007/BF00315817; Campbell JL, 2010, NUCL INSTRUM METH B, V268, P3356, DOI 10.1016/j.nimb.2010.07.012; Cox B, 2010, J THEOR BIOL, V262, P58, DOI 10.1016/j.jtbi.2009.09.010; CUI FZ, 1994, J MATER SCI LETT, V13, P1042; Daubenton LJM., 1764, HIST NATURELLE GEN P, V11; Espinoza E.O., 1993, J AM INST CONSERV, V32, P241, DOI DOI 10.1179/019713693806124866; Grande C, 2009, NATURE, V457, P1007, DOI 10.1038/nature07603; Jones S. J., 1984, DENTIN DENTINOGENESI, P81; KRZYSZKOWSKA O., 2000, ANCIENT EGYPTIAN MAT, P320; Locke M, 2008, J MORPHOL, V269, P423, DOI 10.1002/jmor.10585; Macho GA, 2003, J HUM EVOL, V45, P81, DOI 10.1016/S0047-2484(03)00083-6; Mann M.-J., 1992, IDENTIFICATION GUIDE; MILES AE, 1960, P ROY SOC MED, V53, P775, DOI 10.1177/003591576005300913; Miller WD, 1890, DENT COSMOS, V5, P337; Mjor I. A., 1984, DENTIN DENTINO GENES, V1, P2; Palombo M.R., 2001, TERRA ELEFANTI WORLD, P656; Pichon L, 2014, NUCL INSTRUM METH B, V318, P27, DOI 10.1016/j.nimb.2013.06.065; Pichon L, 2010, NUCL INSTRUM METH B, V268, P2028, DOI 10.1016/j.nimb.2010.02.124; Purves D, 2002, AM SCI, V90, P236; Rack A, 2008, NUCL INSTRUM METH A, V586, P327, DOI 10.1016/j.nima.2007.11.020; Raubenheimer EJ, 1998, ARCH ORAL BIOL, V43, P641, DOI 10.1016/S0003-9969(98)00051-X; Riesemeier H, 2009, J PHYS CONF SER, V186, DOI 10.1088/1742-6596/186/1/012047; Singh RR, 2006, FORENSIC SCI INT, V162, P144, DOI 10.1016/j.forsciint.2006.06.028; Su XW, 1999, MAT SCI ENG C-BIO S, V7, P19, DOI 10.1016/S0928-4931(98)00067-8; Teyssier J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7368; Trapani J, 2003, J ARCHAEOL SCI, V30, P429, DOI 10.1006/jasc.2002.0852; Virag A, 2012, J MORPHOL, V273, P1406, DOI 10.1002/jmor.20069; Wang JS, 2013, SCI REP-UK, V3, DOI 10.1038/srep03102	30	17	18	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0166671	10.1371/journal.pone.0166671	http://dx.doi.org/10.1371/journal.pone.0166671			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7IT	28125603	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100154
J	dos Santos, FC; Peixoto, MGCD; Fonseca, PAD; Pires, MDA; Ventura, RV; Rosse, IDC; Bruneli, FAT; Machado, MA; Carvalho, MRS				dos Santos, Fernanda Caroline; Campolina Diniz Peixoto, Maria Gabriela; de Souza Fonseca, Pablo Augusto; Avila Pires, Maria de Fatima; Ventura, Ricardo Vieira; Rosse, Izinara da Cruz; Tomita Bruneli, Frank Angelo; Machado, Marco Antonio; Santos Carvalho, Maria Raquel			Identification of Candidate Genes for Reactivity in Guzerat (Bos indicus) Cattle: A Genome-Wide Association Study	PLOS ONE			English	Article							BEEF-CATTLE; MILK-PRODUCTION; TEMPERAMENT TRAITS; FEED-EFFICIENCY; BEHAVIOR; VARIANTS; PIT-1; RESISTANCE; SELECTION; GENETICS	Temperament is fundamental to animal production due to its direct influence on the animalherdsman relationship. When compared to calm animals, the aggressive, anxious or fearful ones exhibit less weight gain, lower reproductive efficiency, decreased milk production and higher herd maintenance costs, all of which contribute to reduced profits. However, temperament is a trait that is complex and difficult to assess. Recently, a new quantitative system, REATEST (R), for assessing reactivity, a phenotype of temperament, was developed. Herein, we describe the results of a Genome-wide association study for reactivity, assessed using REATEST (R) with a sample of 754 females from five dual-purpose ( milk and meat production) Guzerat ( Bos indicus) herds. Genotyping was performed using a 50k SNP chip and a two-step mixed model approach ( Grammar-Gamma) with a one-by-one marker regression was used to identify QTLs. QTLs for reactivity were identified on chromosomes BTA1, BTA5, BTA14, and BTA25. Five intronic and two intergenic markers were significantly associated with reactivity. POU1F1, DRD3, VWA3A, ZBTB20, EPHA6, SNRPF and NTN4 were identified as candidate genes. Previous QTL reports for temperament traits, covering areas surrounding the SNPs/genes identified here, further corroborate these associations. The seven genes identified in the present study explain 20.5% of reactivity variance and give a better understanding of temperament biology.	[dos Santos, Fernanda Caroline; de Souza Fonseca, Pablo Augusto; Rosse, Izinara da Cruz; Santos Carvalho, Maria Raquel] Univ Fed Minas Gerais, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Campolina Diniz Peixoto, Maria Gabriela; Avila Pires, Maria de Fatima; Tomita Bruneli, Frank Angelo; Machado, Marco Antonio] Embrapa Gado Leite, Juiz De Fora, Brazil; [Ventura, Ricardo Vieira] Univ Guelph, Ctr Genet Improvement Livestock, Guelph, ON, Canada; [Ventura, Ricardo Vieira] Beef Improvement Opportun, Guelph, ON, Canada	Universidade Federal de Minas Gerais; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University of Guelph	Carvalho, MRS (corresponding author), Univ Fed Minas Gerais, Dept Biol Geral, Belo Horizonte, MG, Brazil.	ma.raquel.carvalho@gmail.com	Carvalho, Maria Raquel/C-7310-2016; Fonseca, Pablo/AAZ-2254-2021; Carvalho, Maria Raquel Santos/HHN-1690-2022; Peixoto, Maria Gabriela Campolina Diniz/A-2901-2013; Rosse, Izinara/AAQ-8008-2020	Carvalho, Maria Raquel/0000-0002-1744-448X; Carvalho, Maria Raquel Santos/0000-0002-1744-448X; Rosse, Izinara/0000-0003-2058-689X; Dos Santos, Fernanda/0000-0002-4590-5722	Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Empresa Brasileira de Pesquisa Agropecuaria (Embrapa); Fapemig [CVZ APQ 01353 e CVZ APQ 3182-5.04/07]; CNPq [307975/2010-0, 312068/2015-8, 481018/2008-5]; FAPEMIG; CAPES	Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Empresa Brasileira de Pesquisa Agropecuaria (Embrapa)(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); Fapemig(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Empresa Brasileira de Pesquisa Agropecuaria (Embrapa). Maria Gabriela Campolina Diniz Peixoto was supported by the Fapemig - CVZ APQ 01353 e CVZ APQ 3182-5.04/07. MRSC has a fellowship from the CNPq - 307975/2010-0 and was supported by CNPq - 312068/2015-8 and 481018/2008-5 projects. MGCDP, RW, and MAM have fellowships from FAPEMIG. PASF has CNPq fellowship. FCS and ICR have CAPES fellowships.	Adamczyk K, 2013, LIVEST SCI, V154, P1, DOI 10.1016/j.livsci.2013.01.016; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Barth V, 2013, J PHARMACOL EXP THER, V344, P501, DOI 10.1124/jpet.112.198895; Boldt C. R., 2008, STUDY CATTLE DISPOSI; Broucek J., 2008, SLOVAK J ANIM SCI, V41, P166, DOI DOI 10.1079/9781780642215.0234; Burrow H, 1988, NEW TECHNIQUE MEASUR, P154; Burrow HM, 2004, LIVEST PROD SCI, V86, P143, DOI 10.1016/j.livprodsci.2003.06.001; Burrow HM, 2000, AUST J AGR RES, V51, P155, DOI 10.1071/AR99053; Cooke RF, 2009, J ANIM SCI, V87, P4125, DOI 10.2527/jas.2009-2021; Deesing M.J, 2013, GENETICS BEHAV DOMES, VSecond; Dragan WL, 2012, J INDIVIDUAL DIFFERE; Elnitski L, 2003, CURRENT PROTOCOLS IN, DOI DOI 10.12.11-10.12.23; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Fordyce G, 1996, AUST J EXP AGR, V36, P9, DOI 10.1071/EA9960009; Friedrich J, 2016, ANIM GENET, V47, P12, DOI 10.1111/age.12371; Gazzin S, 2008, J COMP NEUROL, V510, P497, DOI 10.1002/cne.21808; Glenske K, 2011, ANIMAL, V5, P195, DOI 10.1017/S1751731110001801; Glenske K, 2010, ARCH TIERZUCHT, V53, P388, DOI 10.5194/aab-53-388-2010; Goldstone AP, 2004, TRENDS ENDOCRIN MET, V15, P12, DOI 10.1016/j.tem.2003.11.003; GRANDIN T, 1993, APPL ANIM BEHAV SCI, V36, P1, DOI 10.1016/0168-1591(93)90094-6; Grandin T, 2007, LIVESTOCK HANDLING AND TRANSPORT, 3RD EDITION, P44, DOI 10.1079/9781845932190.0044; Grignard L, 2001, APPL ANIM BEHAV SCI, V71, P263, DOI 10.1016/S0168-1591(00)00187-8; Haskell MJ, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00368; Heidari M, 2012, RUSS J GENET+, V48, P417, DOI 10.1134/S1022795412040060; Hoppe S, 2010, J ANIM SCI, V88, P1982, DOI 10.2527/jas.2008-1557; Hu ZL, 2016, NUCLEIC ACIDS RES, V44, pD827, DOI 10.1093/nar/gkv1233; Hurnik JF, 1985, DICT FAM ANIMAL BEHA; Institute S, 2009, SAS STAT SAS I; Kadel MJ, 2006, CROP PASTURE SCI, V57, P1029; Kadri NK, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004049; Kaimala S, 2015, GENE, V554, P75, DOI 10.1016/j.gene.2014.10.026; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Koch M, 2000, J CELL BIOL, V151, P221, DOI 10.1083/jcb.151.2.221; Kozulin P, 2009, GRADIENTS EPH A6 EXP; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; Li Y, 2012, BRAIN STRUCT FUNCT, V217, P809, DOI 10.1007/s00429-012-0383-8; Lindholm-Perry AK, 2015, ANIM GENET, V46, P60, DOI 10.1111/age.12244; Liu Y, 2004, CURR BIOL, V14, P897, DOI 10.1016/j.cub.2004.05.020; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Maffei WE, 2006, ARQ BRAS MED VET ZOO, V58, P1123, DOI 10.1590/S0102-09352006000600022; Maffei WE, 2009, REV BRAS ZOOTECN, V38, P81, DOI 10.1590/S1516-35982009001300010; Marcelli F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100096; Marchler-Bauer A, 2012, NUCL ACIDS RES; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mormede P, 2005, LIVEST PROD SCI, V93, P15, DOI 10.1016/j.livprodsci.2004.11.002; Nicolazzi EL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-123; Nielsen JV, 2007, DEVELOPMENT, V134, P1133, DOI 10.1242/dev.000265; Nkrumah JD, 2007, J ANIM SCI, V85, P2382, DOI 10.2527/jas.2006-657; Ott J, 2011, NAT REV GENET, V12, P465, DOI 10.1038/nrg2989; Ovcharenko I, 2004, GENOMICS, V84, P890, DOI 10.1016/j.ygeno.2004.07.011; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Peixoto M, 2016, LIVESTOCK RES RURAL, V28, P9; Peixoto MGCD, 2010, LIVEST SCI, V131, P168, DOI 10.1016/j.livsci.2010.03.015; Penna V, ASPECTOS TECNICOS EC, V1, P103; PFAFFLE RW, 1992, SCIENCE, V257, P1118, DOI 10.1126/science.257.5073.1118; Rauw WM, 1998, LIVEST PROD SCI, V56, P15, DOI 10.1016/S0301-6226(98)00147-X; Retz W, 2003, J NEURAL TRANSM, V110, P561, DOI 10.1007/s00702-002-0805-5; Rosenthal EH, 2012, HIPPOCAMPUS, V22, P2144, DOI 10.1002/hipo.22035; Salemi S, 2003, GROWTH HORM IGF RES, V13, P264, DOI 10.1016/S1096-6374(03)00015-7; Sant'Anna AC, 2013, LIVEST SCI, V157, P254, DOI 10.1016/j.livsci.2013.08.004; Savelieva KV, 2008, NEUROSCI LETT, V438, P205, DOI 10.1016/j.neulet.2008.04.013; Schmutz SM, 2001, J HERED, V92, P290, DOI 10.1093/jhered/92.3.290; Selvaggi M, 2011, LIVEST SCI, V138, P308, DOI 10.1016/j.livsci.2011.01.007; Stein JM, 2006, J NEUROSCI, V26, P2184, DOI 10.1523/JNEUROSCI.4437-05.2006; Sutherland MA, 2012, PHYSIOL BEHAV, V107, P329, DOI 10.1016/j.physbeh.2012.07.013; Svishcheva GR, 2012, NAT GENET, V44, P1166, DOI 10.1038/ng.2410; Taha D, 2005, HORM RES, V64, P175, DOI 10.1159/000088793; Team RC, 2014, R LANG ENV STAT COMP; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wang K, 2010, AM J HUM GENET, V86, P730, DOI 10.1016/j.ajhg.2010.04.003; Wegenhoft M. A., 2005, LOCATING QUANTITATIV; Yang Y, 2015, SCI BULL, V60, P21, DOI 10.1007/s11434-014-0695-6	73	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0169163	10.1371/journal.pone.0169163	http://dx.doi.org/10.1371/journal.pone.0169163			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125592	gold, Green Published, Green Submitted			2022-12-26	WOS:000396176100145
J	Ellis, H; Schoenberger, E				Ellis, Hugh; Schoenberger, Erica			On the Identification of Associations between Five World Health Organization Water, Sanitation and Hygiene Phenotypes and Six Predictors in Low and Middle-Income Countries	PLOS ONE			English	Article							FALSE DISCOVERY RATE; DIARRHEAL DISEASE; DRINKING-WATER; IMPACT; INTERVENTIONS; SETTINGS; BURDEN; ACCESS	Background According to the most recent estimates, 842,000 deaths in low-to middle-income countries were attributable to inadequate water, sanitation and hygiene in 2012. Despite billions of dollars and decades of effort, we still lack a sound understanding of which kinds of WASH interventions are most effective in improving public health outcomes, and an important corollary-whether the right things are being measured. The World Health Organization (WHO) has made a concerted effort to compile comprehensive data on drinking water quality and sanitation in the developing world. A recent 2014 report provides information on three phenotypes (responses): Unsafe Water Deaths, Unsafe Sanitation Deaths, Unsafe Hygiene Deaths; two grouped phenotypes: Unsafe Water and Sanitation Deaths and Unsafe Water, Sanitation and Hygiene Deaths; and six explanatory variables (predictors): Improved Sanitation, Unimproved Water Source, Piped Water To Premises, Other Improved Water Source, Filtered and Bottled Water in the Household and Handwashing. Methods and Findings Regression analyses were performed to identify statistically significant associations between these mortality responses and predictors. Good fitted-model performance required: (1) the use of population-normalized death fractions as opposed to number of deaths; (2) transformed response (logit or power); and (3) square-root predictor transformation. Given the complexity and heterogeneity of the relationships and countries being studied, these models exhibited remarkable performance and explained, for example, about 85% of the observed variance in population-normalized Unsafe Sanitation Death fraction, with a high F-statistic and highly statistically significant predictor p-values. Similar performance was found for all other responses, which was an unexpected result (the expected associations between responses and predictors-i.e., water-related with water-related, etc. did not occur). The set of statistically significant predictors remains the same across all responses. That is, Unsafe Water Source (UWS), Improved Sanitation (IS) and Filtered and Bottled Water in the Household (FBH) were the only statistically significant predictors whether the response was Unsafe Sanitation Death Fraction, Unsafe Hygiene Death Fraction or Unsafe Water Death Fraction. Moreover, the fraction of variance explained for all fitted models remained relatively high (adjusted R-2 ranges from 0.7605 to 0.8533). We find that two of the statistically significant predictors-Improved Sanitation and Unimproved Water Sources-are particularly influential. We also find that some predictors (Piped Water to Premises, Other Improved Water Sources) have very little explanatory power for predicting mortality and one (Other Improved Water Sources) has a counterintuitive effect on response (Unsafe Sanitary Death Fraction increases with increases in OIWS) and one predictor (Hand Washing) to have essentially no explanatory usefulness. Conclusions Our results suggest that a higher priority may need to be given to improved sanitation than has been the case. Nevertheless, while our focus in this paper is mortality, morbidity is a staggering consequence of inadequate water, sanitation and hygiene, and lower impact on mortality may not mean a similarly low impact on morbidity. More specifically, those predictors that we found uninfluential for predicting mortality-related responses may indeed be important when morbidity is the response.	[Ellis, Hugh; Schoenberger, Erica] Johns Hopkins Univ, Dept Geog & Environm Engn, Baltimore, MD 21218 USA	Johns Hopkins University	Ellis, H (corresponding author), Johns Hopkins Univ, Dept Geog & Environm Engn, Baltimore, MD 21218 USA.	hugh.ellis@jhu.edu						Bain R, 2014, TROP MED INT HEALTH, V19, P917, DOI 10.1111/tmi.12334; Bartram J, 2005, LANCET, V365, P810, DOI 10.1016/S0140-6736(05)71007-2; Bartram J., 2010, PLOS MED, V7; Bartram J, 2014, INT J ENV RES PUB HE, V11, P8137, DOI 10.3390/ijerph110808137; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLUM D, 1983, INT J EPIDEMIOL, V12, P357, DOI 10.1093/ije/12.3.357; Cairncross S, 2010, INT J EPIDEMIOL, V39, P193, DOI 10.1093/ije/dyq035; Clasen T, 2014, TROP MED INT HEALTH, V19, P884, DOI 10.1111/tmi.12330; Clasen TF, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004794.pub3; Cumming O, 2014, PLOS ONE, V9; Engell RE, 2013, LANCET, V381, P44; ESREY SA, 1985, B WORLD HEALTH ORGAN, V63, P757; ESREY SA, 1992, AM J EPIDEMIOL, V135, P659, DOI 10.1093/oxfordjournals.aje.a116345; ESREY SA, 1991, B WORLD HEALTH ORGAN, V69, P609; Esrey SA, 1996, AM J EPIDEMIOL, V143, P608, DOI 10.1093/oxfordjournals.aje.a008791; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Fox J., 2019, R COMPANION APPL REG, V.; Fox J., 2015, APPL REGRESSION ANAL; Freeman MC, 2014, TROP MED INT HEALTH, V19, P906, DOI 10.1111/tmi.12339; Fuller JA, 2015, TROP MED INT HEALTH, V20, P284, DOI 10.1111/tmi.12441; Godfrey S, 2011, ENVIRON MONIT ASSESS, V176, P561, DOI 10.1007/s10661-010-1604-3; HOLM S, 1979, SCAND J STAT, V6, P65; Hunter PR, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000361; Hutton G, 2007, J WATER HEALTH, V5, P481, DOI 10.2166/wh.2007.009; Jeuland MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074804; MacDonald L, 2016, HOUSEHOLD WATER TREA; Maindonald J. H., 2014, DAAG DATA ANAL GRAPH; Mosteller F., 1968, HDB SOC PSYCHOL, V2, P80; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; O'Hare BAM, 2007, J ROY SOC MED, V100, P564, DOI 10.1258/jrsm.100.12.564; Onda K, 2012, INT J ENV RES PUB HE, V9, P880, DOI 10.3390/ijerph9030880; Pruss-Ustun A, 2014, TROP MED INT HEALTH, V19, P894, DOI 10.1111/tmi.12329; Pruss A, 2002, ENVIRON HEALTH PERSP, V110, P537, DOI 10.1289/ehp.02110537; Rheingans R, 2014, TROP MED INT HEALTH, V19, P2, DOI 10.1111/tmi.12220; Saunders R. J., 1976, VILLAGE WATER SUPPLY; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Shaheed A, 2014, B WORLD HEALTH ORGAN, V92, P283, DOI 10.2471/BLT.13.119594; Stuart E., 2015, DATA REVOLUTION FIND; VANDERSLICE J, 1995, AM J EPIDEMIOL, V141, P135, DOI 10.1093/oxfordjournals.aje.a117401; Weisberg S, 2014, APPL LINEAR REGRESSI, V4th; Wolf J, 2014, TROP MED INT HEALTH, V19, P928, DOI 10.1111/tmi.12331; World Health Organization, 2014, PREVENTING DIARRHOEA; World Health Organization, 2015, PROGR SAN DRINK WAT	44	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170451	10.1371/journal.pone.0170451	http://dx.doi.org/10.1371/journal.pone.0170451			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125625	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100108
J	Ooi, DSQ; Tan, VMH; Ong, SG; Chan, YH; Heng, CK; Lee, YS				Ooi, Delicia Shu Qin; Tan, Verena Ming Hui; Ong, Siong Gim; Chan, Yiong Huak; Heng, Chew Kiat; Lee, Yung Seng			Differences in AMY1 Gene Copy Numbers Derived from Blood, Buccal Cells and Saliva Using Quantitative and Droplet Digital PCR Methods: Flagging the Pitfall	PLOS ONE			English	Article							GENOMIC DNA; COLLECTION; SAMPLES; QUALITY; OBESITY; COHORT; MAIL	Introduction The human salivary (AMY1) gene, encoding salivary a-amylase, has variable copy number variants (CNVs) in the human genome. We aimed to determine if real-time quantitative polymerase chain reaction (qPCR) and the more recently available Droplet Digital PCR (ddPCR) can provide a precise quantification of the AMY1 gene copy number in blood, buccal cells and saliva samples derived from the same individual. Methods Seven participants were recruited and DNA was extracted from the blood, buccal cells and saliva samples provided by each participant. Taqman assay real-time qPCR and ddPCR were conducted to quantify AMY1 gene copy numbers. Statistical analysis was carried out to determine the difference in AMY1 gene copy number between the different biological specimens and different assay methods. Results We found significant within-individual difference (p<0.01) in AMY1 gene copy number between different biological samples as determined by qPCR. However, there was no significant within-individual difference in AMY1 gene copy number between different biological samples as determined by ddPCR. We also found that AMY1 gene copy number of blood samples were comparable between qPCR and ddPCR, while there is a significant difference (p<0.01) between AMY1 gene copy numbers measured by qPCR and ddPCR for both buccal swab and saliva samples. Conclusions Despite buccal cells and saliva samples being possible sources of DNA, it is pertinent that ddPCR or a single biological sample, preferably blood sample, be used for determining highly polymorphic gene copy numbers like AMY1, due to the large within-individual variability between different biological samples if real time qPCR is employed.	[Ooi, Delicia Shu Qin; Tan, Verena Ming Hui; Ong, Siong Gim; Heng, Chew Kiat; Lee, Yung Seng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore, Singapore; [Ooi, Delicia Shu Qin; Tan, Verena Ming Hui; Ong, Siong Gim; Heng, Chew Kiat; Lee, Yung Seng] Natl Univ Hlth Syst, Khoo Teck Puat Natl Univ Childrens Med Inst, Natl Univ Hosp, Div Endocrinol & Diabet, Singapore, Singapore; [Tan, Verena Ming Hui; Lee, Yung Seng] ASTAR, Singapore Inst Clin Sci, Singapore, Singapore; [Chan, Yiong Huak] Natl Univ Singapore, Yong Loo Lin Sch Med, Biostat Unit, Singapore, Singapore	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); National University of Singapore	Lee, YS (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore, Singapore.; Lee, YS (corresponding author), Natl Univ Hlth Syst, Khoo Teck Puat Natl Univ Childrens Med Inst, Natl Univ Hosp, Div Endocrinol & Diabet, Singapore, Singapore.; Lee, YS (corresponding author), ASTAR, Singapore Inst Clin Sci, Singapore, Singapore.	paeleeys@nus.edu.sg	Lee, Yung Seng/F-2169-2014; Heng, Chew Kiat/A-5530-2009	Lee, Yung Seng/0000-0002-1253-0557; Heng, Chew Kiat/0000-0002-7309-9473; Ooi, Delicia Shu Qin/0000-0001-8677-0126	project: SICS [C8019]	project: SICS	Funding source of the project: SICS core funding of Yung Seng Lee (C8019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham JE, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-19; Cozier YC, 2004, ANN EPIDEMIOL, V14, P117, DOI 10.1016/S1047-2797(03)00132-7; Falchi M, 2014, NAT GENET, V46, P492, DOI 10.1038/ng.2939; Fernandez-Jimenez N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028910; Garcia-Closas M, 2001, CANCER EPIDEM BIOMAR, V10, P687; Hansen TVO, 2007, CANCER EPIDEM BIOMAR, V16, P2072, DOI 10.1158/1055-9965.EPI-07-0611; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Le Marchand L, 2001, CANCER EPIDEM BIOMAR, V10, P701; Livy A, 2012, INDIAN J CLIN BIOCHE, V27, P28, DOI 10.1007/s12291-011-0154-y; Mandel AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013352; Mandel AL, 2012, J NUTR; Marenne G, 2011, HUM MUTAT, V32, P240, DOI 10.1002/humu.21398; MEISLER MH, 1993, CRIT REV ORAL BIOL M, V4, P503, DOI 10.1177/10454411930040033501; Mejia-Bentez MA, 2015, DIABETOLOGIA, V58, P290, DOI 10.1007/s00125-014-3441-3; Mulot C, 2005, J BIOMED BIOTECHNOL, P291, DOI 10.1155/JBB.2005.291; Nunes AP, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-65; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Philibert RA, 2008, PSYCHIAT GENET, V18, P275, DOI 10.1097/YPG.0b013e3283060f81; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Piotrowski A, 2008, HUM MUTAT, V29, P1118, DOI 10.1002/humu.20815; Rogers NL, 2007, AM J HUM BIOL, V19, P319; Rylander-Rudqvist T, 2006, CANCER EPIDEM BIOMAR, V15, P1742, DOI 10.1158/1055-9965.EPI-05-0706; Satia-Abouta, 2002, CANCER EPIDEM BIOMAR, V11, P1130; Sedlackova T, 2013, BIOL PROCED ONLINE, V15, DOI 10.1186/1480-9222-15-5; Smith AK, 2015, AM J MED GENET B, V168, P36, DOI 10.1002/ajmg.b.32278; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Sun Fanyue, 2014, Oral Health Dent Manag, V13, P217; Tan VMH, 2015, BRIT J NUTR, V113, P1228, DOI 10.1017/S0007114515000586; Tan VMH, 2016, EUR J NUTR, V55, P1573, DOI 10.1007/s00394-015-0976-0; Usher CL, 2015, NAT GENET, V47, P921, DOI 10.1038/ng.3340; Viljakainen H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131883	31	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170767	10.1371/journal.pone.0170767	http://dx.doi.org/10.1371/journal.pone.0170767			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125683	Green Submitted, Green Published, gold			2022-12-26	WOS:000396176100057
J	Audeh, B; Beigbeder, M; Zimmermann, A; Jaillon, P; Bousquet, C				Audeh, Bissan; Beigbeder, Michel; Zimmermann, Antoine; Jaillon, Philippe; Bousquet, Cedric			Vigi4Med Scraper: A Framework for Web Forum Structured Data Extraction and Semantic Representation	PLOS ONE			English	Article								The extraction of information from social media is an essential yet complicated step for data analysis in multiple domains. In this paper, we present Vigi4Med Scraper, a generic open source framework for extracting structured data from web forums. Our framework is highly configurable; using a configuration file, the user can freely choose the data to extract from any web forum. The extracted data are anonymized and represented in a semantic structure using Resource Description Framework (RDF) graphs. This representation enables efficient manipulation by data analysis algorithms and allows the collected data to be directly linked to any existing semantic resource. To avoid server overload, an integrated proxy with cach-ing functionality imposes a minimal delay between sequential requests. Vigi4Med Scraper represents the first step of Vigi4Med, a project to detect adverse drug reactions (ADRs) from social networks founded by the French drug safety agency Agence Nationale de Securite du Medicament (ANSM). Vigi4Med Scraper has successfully extracted greater than 200 gigabytes of data from the web forums of over 20 different websites.	[Audeh, Bissan; Beigbeder, Michel; Zimmermann, Antoine] Univ Lyon, MINES St Etienne, CNRS, Hubert Curien Lab,UMR 5516, St Etienne, France; [Jaillon, Philippe] Ecole Natl Super Mines, St Etienne, France; [Bousquet, Cedric] LIMICS, INSERM, U1142, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite Jean Monnet; IMT - Institut Mines-Telecom; Mines Saint-Etienne; IMT - Institut Mines-Telecom; Mines Saint-Etienne; Institut National de la Sante et de la Recherche Medicale (Inserm)	Audeh, B (corresponding author), Univ Lyon, MINES St Etienne, CNRS, Hubert Curien Lab,UMR 5516, St Etienne, France.	audeh@emse.fr		Zimmermann, Antoine/0000-0003-1502-6986; Bousquet, Cedric/0000-0001-9775-2476	ANSM, French agency for drug safety (Agence nationale de securite du medicament et des produits de sante) [AAP-2013-052]	ANSM, French agency for drug safety (Agence nationale de securite du medicament et des produits de sante)	This work was supported by grant number AAP-2013-052 from the ANSM, the French agency for drug safety (Agence nationale de securite du medicament et des produits de sante). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamrah NH, 2014, INT J COMPUT APPL, V85, P17, DOI DOI 10.5120/14936-3506; Benard-Laribiere A, 2015, FUND CLIN PHARMACOL, V29, P106, DOI 10.1111/fcp.12088; Berners-Lee T., 2002, SEMANTIC WEB; BERNERSLEE T, 2001, SEMANTIC WEB; Boulos Maged N, 2002, Med Sci Monit, V8, pMT124; Breslin J. G., 2006, International Journal of Web Based Communities, V2, P133; Crescenzi V., 2001, Proceedings of the 27th International Conference on Very Large Data Bases, P109; Dwork C, 2008, LECT NOTES COMPUT SC, V4978, P1, DOI 10.1007/978-3-540-79228-4_1; El Emam K, 2008, J AM MED INFORM ASSN, V15, P627, DOI 10.1197/jamia.M2716; Eltoweissy MY, 2003, IEEE SECUR PRIV, V1, P4; Ferrara E, 2014, KNOWL-BASED SYST, V70, P301, DOI 10.1016/j.knosys.2014.07.007; Georgiou T, 2010, 2010 ACM SIGMOD C; Glez-Pena D, 2014, BRIEF BIOINFORM, V15, P788, DOI 10.1093/bib/bbt026; Gross R., 2005, P WPES 2005, P71, DOI DOI 10.1145/1102199.1102214; Guo Y, 2006, 2006 IEEE/WIC/ACM INTERNATIONAL CONFERENCE ON WEB INTELLIGENCE, (WI 2006 MAIN CONFERENCE PROCEEDINGS), P745, DOI 10.1109/WI.2006.52; JIANG J, 2013, SYSTEMS MAN CYBERN A, V25, P1293, DOI DOI 10.1109/TKDE.2012.56; Jothi TM, 2014, IJIRSET, V3, P1708; Lardon J, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4304; Lassila O., 1998, RESOURCE DESCRIPTION; McKee R, 2013, HEALTH POLICY, V110, P298, DOI 10.1016/j.healthpol.2013.02.006; Micoulaud-Franchi JA, 2011, PRESSE MED, V40, P790, DOI 10.1016/j.lpm.2011.07.001; Musiea I., 1999, Proceedings of the Third International Conference on Autonomous Agents, P190, DOI 10.1145/301136.301191; Noren GN, 2014, DRUG SAFETY, V37, P761, DOI 10.1007/s40264-014-0205-4; Robie J., 2014, XML PATH LANGUAGE XP; Softic S, 2008, 7 INT SEM WEB C CIT, P79; Sweeney L, 2002, INT J UNCERTAIN FUZZ, V10, P557, DOI 10.1142/S0218488502001648; Wang Y., 2008, P 17 INT C WORLD WID, P447, DOI DOI 10.1145/1367497.1367558; Wang Y., 2008, P 31 ANN INT ACM SIG, P459, DOI DOI 10.1145/1390334.1390413; Yang CC, 2007, LECT NOTES COMPUT SC, V4430, P21; Yang JM, 2009, PROCEEDINGS OF THE FIRST INTERNATIONAL WORKSHOP ON EDUCATION TECHNOLOGY AND COMPUTER SCIENCE, VOL III, P181, DOI 10.1109/ETCS.2009.566; Zhou B., 2008, ACM SIGKDD EXPLORATI, V10, P12, DOI DOI 10.1145/1540276.1540279; Zimmer M, 2010, ETHICS INF TECHNOL, V12, P313, DOI 10.1007/s10676-010-9227-5	32	22	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0169658	10.1371/journal.pone.0169658	http://dx.doi.org/10.1371/journal.pone.0169658			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122056	Green Submitted, gold, Green Published			2022-12-26	WOS:000396167300069
J	Baptista, SJ; Silva, MMC; Moroni, E; Meli, M; Colombo, G; Dinis, TCP; Salvador, JAR				Baptista, Salete J.; Silva, Maria M. C.; Moroni, Elisabetta; Meli, Massimiliano; Colombo, Giorgio; Dinis, Teresa C. P.; Salvador, Jorge A. R.			Novel PARP-1 Inhibitor Scaffolds Disclosed by a Dynamic Structure-Based Pharmacophore Approach	PLOS ONE			English	Article							DRUG DISCOVERY; FORCE-FIELD; POLYMERASE; CANCER; FLEXIBILITY	PARP-1 inhibition has been studied over the last decades for the treatment of various diseases. Despite the fact that several molecules act as PARP-1 inhibitors, a reduced number of compounds are used in clinical practice. To identify new compounds with a discriminatory PARP-1 inhibitory function, explicit-solvent molecular dynamics simulations using different inhibitors bound to the PARP-1 catalytic domain were performed. The representative structures obtained were used to generate structure-based pharmacophores, taking into account the dynamic features of receptor-ligand interactions. Thereafter, a virtual screening of compound databases using the pharmacophore models obtained was performed and the hits retrieved were subjected to molecular docking-based scoring. The drug-like molecules featuring the best ranking were evaluated for their PARP-1 inhibitory activity and IC50 values were calculated for the top scoring docked compounds. Altogether, three new PARP-1 inhibitor chemotypes were identified.	[Baptista, Salete J.; Silva, Maria M. C.; Salvador, Jorge A. R.] Univ Coimbra, Fac Pharm, Lab Pharmaceut Chem, Coimbra, Portugal; [Baptista, Salete J.; Silva, Maria M. C.; Dinis, Teresa C. P.; Salvador, Jorge A. R.] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Moroni, Elisabetta; Meli, Massimiliano; Colombo, Giorgio] CNR, Ist Chim Riconoscimento Mol, Milan, Italy; [Dinis, Teresa C. P.] Univ Coimbra, Fac Pharm, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); Universidade de Coimbra	Salvador, JAR (corresponding author), Univ Coimbra, Fac Pharm, Lab Pharmaceut Chem, Coimbra, Portugal.; Salvador, JAR (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal.; Colombo, G (corresponding author), CNR, Ist Chim Riconoscimento Mol, Milan, Italy.	giorgio.colombo@icrm.cnr.it; salvador@ci.uc.pt	Silva, Maria Manuel Cruz/AAF-9649-2021; Moroni, Elisabetta/ABH-7293-2020; Meli, Massimiliano/AAY-8570-2020; Colombo, Giorgio/A-2730-2012; de La Salete de Jesus Baptista, Maria/AAG-3928-2021; SALVADOR, JORGE A. R./N-7174-2017	Silva, Maria Manuel Cruz/0000-0002-1938-4150; Moroni, Elisabetta/0000-0002-7705-7457; Meli, Massimiliano/0000-0003-3304-6104; Colombo, Giorgio/0000-0002-1318-668X; de La Salete de Jesus Baptista, Maria/0000-0002-7213-5997; SALVADOR, JORGE A. R./0000-0003-0779-6083	Universidade de Coimbra; Fundacao para a Ciencia e a Tecnologia [SFRH/BD/80975/2011]; AIRC [IG 15420]; FEDER European Regional Development Fund through the COMPETE Programme; National Funds through FCT - Fundacao para a Ciencia e a Tecnologia (Portuguese Foundation for Science and Technology) [REEQ/481/QUI/2006, RECI/QEQ-QFI/0168/2012, CENTRO-07-CT62-FEDER-002012]; Rede Nacional de Ressonancia Magnetica Nuclear (RNRMN)	Universidade de Coimbra; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); AIRC(Fondazione AIRC per la ricerca sul cancro); FEDER European Regional Development Fund through the COMPETE Programme; National Funds through FCT - Fundacao para a Ciencia e a Tecnologia (Portuguese Foundation for Science and Technology); Rede Nacional de Ressonancia Magnetica Nuclear (RNRMN)	JARS thanks Universidade de Coimbra for financial support. SJB thanks Fundacao para a Ciencia e a Tecnologia for financial support (SFRH/BD/80975/2011). GC acknowledges funding from AIRC through project IG 15420. The authors gratefully acknowledge UC-NMR facility, which is supported by FEDER European Regional Development Fund through the COMPETE Programme (Operational Programme for Competitiveness), as well as by National Funds through FCT - Fundacao para a Ciencia e a Tecnologia (Portuguese Foundation for Science and Technology) through grants REEQ/481/QUI/2006, RECI/QEQ-QFI/0168/2012, CENTRO-07-CT62-FEDER-002012, and Rede Nacional de Ressonancia Magnetica Nuclear (RNRMN), for NMR data. We are also grateful to Drug Synthesis and Chemistry Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute for kindly providing the compounds screened in this study.	Bowman AL, 2007, J AM CHEM SOC, V129, P12809, DOI 10.1021/ja073687x; Carlson HA, 2000, J MED CHEM, V43, P2100, DOI 10.1021/jm990322h; Colombo G, 2010, J BIOL CHEM, V285, P8733, DOI 10.1074/jbc.M109.085605; Cozzini P, 2008, J MED CHEM, V51, P6237, DOI 10.1021/jm800562d; Curtin NJ, 2013, MOL ASPECTS MED, V34, P1217, DOI 10.1016/j.mam.2013.01.006; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Ferraris DV, 2010, J MED CHEM, V53, P4561, DOI 10.1021/jm100012m; Genoni A, 2012, RSC ADV, V2, P4268, DOI 10.1039/c2ra00911k; Hattori K, 2004, J MED CHEM, V47, P4151, DOI 10.1021/jm0499256; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Rodriguez MI, 2015, MED RES REV, V35, P678, DOI 10.1002/med.21339; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim G, 2015, CLIN CANCER RES, V21, P4257, DOI 10.1158/1078-0432.CCR-15-0887; Kinoshita T, 2004, FEBS LETT, V556, P43, DOI [10.1016/S0014-5793(03)01362-0, 10.5940/jcrsj.46.421]; Lawlor D, 2014, J PHARM SCI-US, V103, P1913, DOI 10.1002/jps.23952; Lee YR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056284, 10.1371/journal.pone.0063255]; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lupo B, 2014, BBA-REV CANCER, V1846, P201, DOI 10.1016/j.bbcan.2014.07.004; McCrudden CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118187; Meagher KL, 2004, J AM CHEM SOC, V126, P13276, DOI 10.1021/ja0469378; Meli M, 2006, J MED CHEM, V49, P7721, DOI 10.1021/jm060836y; Morales JC, 2014, CRIT REV EUKAR GENE, V24, P15, DOI 10.1615/CritRevEukaryotGeneExpr.2013006875; Passeri D, 2016, CHEMMEDCHEM, V11, P1219, DOI 10.1002/cmdc.201500391; Scott CL, 2015, J CLIN ONCOL, V33, P1397, DOI 10.1200/JCO.2014.58.8848; Sistigu A, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1053594; Sliwoski G, 2014, PHARMACOL REV, V66, P334, DOI 10.1124/pr.112.007336; Tangutoori S, 2015, MATURITAS, V81, P5, DOI 10.1016/j.maturitas.2015.01.015; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Verdone L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144287; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; [徐思伟 Xu Siwei], 2014, [宇航计测技术, Journal of Astronautic Metrology and Measurement], V34, P1	33	12	12	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0170846	10.1371/journal.pone.0170846	http://dx.doi.org/10.1371/journal.pone.0170846			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122037	Green Submitted, Green Published, gold			2022-12-26	WOS:000396167300011
J	Knowler, SP; Kiviranta, AM; McFadyen, AK; Jokinen, TS; La Ragione, RM; Rusbridge, C				Knowler, Susan P.; Kiviranta, Anna-Mariam; McFadyen, Angus K.; Jokinen, Tarja S.; La Ragione, Roberto M.; Rusbridge, Clare			Craniometric Analysis of the Hindbrain and Craniocervical Junction of Chihuahua, Affenpinscher and Cavalier King Charles Spaniel Dogs With and Without Syringomyelia Secondary to Chiari-Like Malformation	PLOS ONE			English	Article							CAUDAL CRANIAL FOSSA; OCCIPITAL HYPOPLASIA/SYRINGOMYELIA; BONE; SYRINGOHYDROMYELIA; PATHOGENESIS; PREVALENCE; MORPHOLOGY; POSITION; FEATURES; CLOSURE	Objectives To characterize and compare the phenotypic variables of the hindbrain and craniocervical junction associated with syringomyelia (SM) in the Chihuahua, Affenpinscher and Cavalier King Charles Spaniel (CKCS). Method Analysis of 273 T1-weighted mid-sagittal DICOM sequences of the hindbrain and craniocer-vical junction from 99 Chihuahuas, 42 Affenpinschers and 132 CKCSs. The study compared 22 morphometric features (11 lines, eight angles and three ratios) of dogs with and without SM using refined techniques based on previous studies of the Griffon Bruxellois (GB) using Discriminant Function Analysis and ANOVA with post-hoc corrections. Results The analysis identified 14/22 significant traits for SM in the three dog breeds, five of which were identical to those reported for the GB and suggest inclusion of a common aetiology. One ratio, caudal fossa height to the length of the skull base extended to an imaginary point of alignment between the atlas and supraoccipital bones, was common to all three breeds (p values 0.029 to < 0.001). Associated with SM were a reduced occipital crest and two acute changes in angulation i) 'sphenoid flexure' at the spheno-occipital synchondrosis ii) 'cervical flexure' at the foramen magnum allied with medulla oblongata elevation. Comparing dogs with and without SM, each breed had a unique trait: Chihuahua had a smaller angle between the dens, atlas and basioccipital bone (p value < 0.001); Affenpinschers had a smaller dis-tance from atlas to dens (p value 0.009); CKCS had a shorter distance between the spheno-occipital synchondrosis and atlas (p value 0.007). Conclusion The selected morphometries successfully characterised conformational changes in the brain and craniocervical junction that might form the basis of a diagnostic tool for all breeds. The severity of SM involved a spectrum of abnormalities, incurred by changes in both angulation and size that could alter neural parenchyma compliance and/or impede cerebrospinal fluid channels.	[Knowler, Susan P.; La Ragione, Roberto M.; Rusbridge, Clare] Univ Surrey, Fac Hlth & Med Sci, Sch Vet Med, Guildford, Surrey, England; [Kiviranta, Anna-Mariam; Jokinen, Tarja S.] Univ Helsinki, Dept Equine & Small Anim Med, FIN-00014 Helsinki, Finland; [McFadyen, Angus K.] Akm Stats, Glasgow, Lanark, Scotland; [Rusbridge, Clare] Fitzpatrick Referrals, Godalming, Surrey, England	University of Surrey; University of Helsinki	Knowler, SP (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Sch Vet Med, Guildford, Surrey, England.	s.knowler@surrey.ac.uk	Knowler, Susan P/AAL-4595-2021; Rusbridge, Clare/A-3794-2019; La Ragione, Roberto M/Q-9916-2017; Rusbridge, Clare/K-6560-2019	Knowler, Susan P/0000-0001-8727-8440; Rusbridge, Clare/0000-0002-3366-2110; La Ragione, Roberto M/0000-0001-5861-613X; Rusbridge, Clare/0000-0002-3366-2110; McFadyen, Angus/0000-0003-3081-5780; Jokinen, Tarja/0000-0001-6389-0109; Kiviranta, Anna-Mariam/0000-0002-9542-7247	Cavalier Matters Charity [1141674]; Dogs Trust Charity [227523, SC037843]; Finnish Veterinary Foundation; AbrosoftFantaMorph. Rupert's Fund; For the Love of Ollie	Cavalier Matters Charity; Dogs Trust Charity; Finnish Veterinary Foundation; AbrosoftFantaMorph. Rupert's Fund; For the Love of Ollie	Cavalier Matters Charity Reg No 1141674 http://www.cavaliermatters.org/ funded SPK's doctoral research. Dogs Trust Charity Reg. No. 227523 & SC037843, https://www.dogstrust.org.uk/ contributed towards the cost of leasing the DICOM viewing software package MIMICS 14.12 Materialise (Technologielaan 15 3001 Leuven Belgium). The Finnish Veterinary Foundation funded the costs of the imaging at the Veterinary Teaching Hospital of University of Helsinki. Henny van/der Berg donated the photo morphing software AbrosoftFantaMorph. Rupert's Fund (www.rupertsfund.com) and For the Love of Ollie (www.fortheloveofollie.com) provided financial support for health screening. AKM is an independent statistical consultant operating professionally as a sole trader under the company name of akm-stats and did not receive any salary or other remittance for his contribution in this investigation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Botelho RV, 2013, NEUROSURG REV, V36, P603, DOI 10.1007/s10143-013-0471-0; Bynevelt M, 2000, VET RADIOL ULTRASOUN, V41, P521, DOI 10.1111/j.1740-8261.2000.tb01882.x; Carrera I, 2009, AM J VET RES, V70, P340, DOI 10.2460/ajvr.70.3.340; CAWC, BREED WELF COMP AN A, P1; Cerda-Gonzalez S, 2016, VET J, V209, P133, DOI 10.1016/j.tvjl.2016.01.008; Cerda-Gonzalez S, 2015, J VET INTERN MED, V29, P882, DOI 10.1111/jvim.12605; Cerda-Gonzalez S, 2016, J VET INTERN MED; Cerda-Gonzalez S, 2009, VET RADIOL ULTRASOUN, V50, P37, DOI 10.1111/j.1740-8261.2008.01487.x; Cerda-Gonzalez S, 2010, VET CLIN N AM-SMALL, V40, P121, DOI 10.1016/j.cvsm.2009.10.001; Cerda-Gonzalez S, 2009, VET RADIOL ULTRASOUN, V50, P467, DOI 10.1111/j.1740-8261.2009.01571.x; Cerda-Gonzalez S, 2009, VET RADIOL ULTRASOUN, V50, P264, DOI 10.1111/j.1740-8261.2009.01531.x; Chern JJ, 2011, J NEUROSURG-PEDIATR, V8, P1, DOI 10.3171/2011.4.PEDS10528; Dewey CW, 2013, NZ VET J; Dixon A., 1997, FUNDAMENTALS CRANIOF; Driver CJ, 2013, VET J, V198, P551, DOI 10.1016/j.tvjl.2013.07.014; Driver CJ, 2013, VET J, V198, P88, DOI 10.1016/j.tvjl.2013.05.017; Driver CJ, 2010, J SMALL ANIM PRACT, V51, P382, DOI 10.1111/j.1748-5827.2010.00952.x; DUBRUL EL, 1961, AM J ANAT, V109, P117, DOI 10.1002/aja.1001090203; Evans HE., 2012, MILLERS ANATOMY DOG, V4; Ferreira Janio A, 2015, Surg Neurol Int, V6, P118, DOI 10.4103/2152-7806.160322; Freeman AC, 2014, J VET INTERN MED, V28, P1551, DOI 10.1111/jvim.12421; Geiger M, 2016, ANAT REC, V299, P412, DOI 10.1002/ar.23313; Giejda A.A., 2012, DEV CHIARI LIKE MALF; Harcourt-Brown TR, 2015, J VET INTERN MED, V29, P231, DOI 10.1111/jvim.12477; Henderson FC, 2010, SURG NEUROL INT; Knowler SP, 2011, VET REC, V169, P681, DOI 10.1136/vr.100062; Knowler SP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151280; Knowler SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088120; Koyabu D, 2012, P NATL ACAD SCI USA, V109, P14075, DOI 10.1073/pnas.1208693109; Kromhout K., 2014, J VET INT MED; Lemay P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089816; Lewis T, 2010, VET J, V183, P345, DOI 10.1016/j.tvjl.2009.10.022; Marino DJ, 2012, AM J VET RES, V73, P105, DOI 10.2460/ajvr.73.1.105; MATSUMURA G, 1993, J ANAT, V182, P197; McBratney-Owen B, 2008, DEV BIOL, V322, P121, DOI 10.1016/j.ydbio.2008.07.016; Mitchell Thomas J, 2014, Canine Genet Epidemiol, V1, P9, DOI 10.1186/2052-6687-1-9; Pang D, 2011, CHILD NERV SYST, V27, P523, DOI 10.1007/s00381-010-1358-9; Parker JE, 2011, VET REC, V168, DOI 10.1136/vr.d1726; Plessas IN, 2008, VET REC, V171, P501; Rusbridge C, 2006, J SMALL ANIM PRACT, V47, P603, DOI 10.1111/j.1748-5827.2006.00048.x; Rusbridge C, 2005, J HERED, V96, P745, DOI 10.1093/jhered/esi074; Rusbridge C, 2003, VET REC, V153, P107, DOI 10.1136/vr.153.4.107; Rusbridge C, 2009, J SMALL ANIM PRACT, V50, P386, DOI 10.1111/j.1748-5827.2009.00744.x; Rusbridge C, 2000, J AM ANIM HOSP ASSOC, V36, P34, DOI 10.5326/15473317-36-1-34; Rusbridge C., 2007, BRIT J NEUROSURG, V21, P468; Rusbridge C., 2013, EUR J COMPANION, V23, P70, DOI DOI 10.1111/J.1748-5827.2008.00578.X; Schmidt MJ, 2012, VET RADIOL ULTRASOUN, V53, P540, DOI 10.1111/j.1740-8261.2012.01955.x; Schmidt MJ, 2013, VET RADIOL ULTRASOUN, V54, P497, DOI 10.1111/vru.12072; Shaw TA, 2013, VET REC, V172, DOI 10.1136/vr.101082; Shaw TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033660; Smith PM, 2013, VET J, V198, P545, DOI 10.1016/j.tvjl.2013.09.072; Stalin C, 2015, VET COMP ORTHOPAED, V28, P1, DOI 10.3415/VCOT-14-05-0064; Stockard Charles Rupert, 1941, GENETIC ENDOCRINE BA; Thofner MS, 2015, J VET INTERN MED, V29, P243, DOI 10.1111/jvim.12475	54	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0169898	10.1371/journal.pone.0169898	http://dx.doi.org/10.1371/journal.pone.0169898			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28121988	Green Published, gold			2022-12-26	WOS:000396167300061
J	Giannios, I; Chatzantonaki, E; Georgatos, S				Giannios, Ioannis; Chatzantonaki, Eleftheria; Georgatos, Spyros			Dynamics and Structure-Function Relationships of the Lamin B Receptor (LBR)	PLOS ONE			English	Article							INNER NUCLEAR-MEMBRANE; PROTEIN DYNAMICS; FLUORESCENCE RECOVERY; CHROMODOMAIN PROTEINS; INTEGRAL PROTEIN; LIVING CELLS; ENVELOPE; MUTATIONS; DOMAIN; DIFFUSION	The lamin B receptor (LBR) is a multi-spanning membrane protein of the inner nuclear membrane that is often employed as a "reporter" of nuclear envelope dynamics. We show here that the diffusional mobility of full-length LBR exhibits significant regional variation along the nuclear envelope, consistent with the existence of discrete LBR microdomains and the occurrence of multiple, asymmetrically-spaced anastomoses along the nuclear envelope-endoplasmic reticulum interface. Interestingly, a commonly used fusion protein that contains the amino-terminal region and the first transmembrane domain of LBR exhibits reduced mobility at the nuclear envelope, but behaves similarly to full-length LBR in the endoplasmic reticulum. On the other hand, carboxy-terminally truncated mutants that retain the first four transmembrane domains and a part or the whole of the amino-terminal region of LBR are generally hyper-mobile. These results suggest that LBR dynamics is structure and compartment specific. They also indicate that native LBR is probably "configured" by long-range interactions that involve the loops between adjacent transmembrane domains and parts of the amino-terminal region.	[Giannios, Ioannis; Chatzantonaki, Eleftheria; Georgatos, Spyros] FORTH ITE, Inst Mol Biol & Biotechnol, Div Biomed, Stem Cell & Chromatin Grp, Iraklion, Greece; [Giannios, Ioannis; Chatzantonaki, Eleftheria; Georgatos, Spyros] Univ Ioannina, Sch Med, Biol Lab, Ioannina, Greece	University of Ioannina	Georgatos, S (corresponding author), FORTH ITE, Inst Mol Biol & Biotechnol, Div Biomed, Stem Cell & Chromatin Grp, Iraklion, Greece.; Georgatos, S (corresponding author), Univ Ioannina, Sch Med, Biol Lab, Ioannina, Greece.	sgeorgat@cc.uoi.gr		Chatzantonaki, Eleftheria/0000-0002-1850-4720	THALIS Program; European Union (ESF); Greek national funds (Education and Lifelong Learning-NSRF)	THALIS Program; European Union (ESF)(European Commission); Greek national funds (Education and Lifelong Learning-NSRF)(Greek Ministry of Development-GSRT)	This work was supported by a THALIS Program, co-financed by the European Union (ESF) and Greek national funds (Education and Lifelong Learning-NSRF). http://excellence.minedu.gov.gr/thales/.	Bates IR, 2006, BIOCHEM CELL BIOL, V84, P825, DOI 10.1139/O06-189; Best S, 2003, BRIT J HAEMATOL, V123, P542, DOI 10.1046/j.1365-2141.2003.04621.x; Boni A, 2015, J CELL BIOL, V209, P705, DOI 10.1083/jcb.201409133; Chmielewska M, 2011, CELL TISSUE RES, V344, P97, DOI 10.1007/s00441-011-1129-2; Clever M, 2012, NUCLEUS-PHILA, V3, P187, DOI 10.4161/nucl.19595; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; Feder TJ, 1996, BIOPHYS J, V70, P2767, DOI 10.1016/S0006-3495(96)79846-6; Gaudy-Marqueste C, 2010, J MED GENET, V47, P361, DOI 10.1136/jmg.2009.071696; Graunnann K, 2007, BIOL CELL, V99, P553, DOI [10.1042/BC20070013, 10.1042/BC20070033]; Guarda A, 2009, EXP CELL RES, V315, P1895, DOI 10.1016/j.yexcr.2009.01.019; Hoffmann K, 2002, NAT GENET, V31, P410, DOI 10.1038/ng925; Holmer L, 1998, GENOMICS, V54, P469, DOI 10.1006/geno.1998.5615; Holmer L, 2001, CELL MOL LIFE SCI, V58, P1741, DOI 10.1007/PL00000813; Irons SL, 2003, J EXP BOT, V54, P943, DOI 10.1093/jxb/erg102; Kourmouli N, 2000, EMBO J, V19, P6558, DOI 10.1093/emboj/19.23.6558; Lin F, 1996, HEPATOLOGY, V23, P57, DOI 10.1002/hep.510230109; Liokatis S, 2012, J BIOL CHEM, V287, P1032, DOI 10.1074/jbc.M111.281303; Lu XL, 2010, J BIOL CHEM, V285, P33281, DOI 10.1074/jbc.M110.102368; Lusk CP, 2007, NAT REV MOL CELL BIO, V8, P414, DOI 10.1038/nrm2165; Makatsori D, 2004, J BIOL CHEM, V279, P25567, DOI 10.1074/jbc.M313606200; Martins SB, 2000, J CELL SCI, V113, P3703; Mueller F, 2008, BIOPHYS J, V94, P3323, DOI 10.1529/biophysj.107.123182; Nikolakaki E, 1996, J BIOL CHEM, V271, P8365, DOI 10.1074/jbc.271.14.8365; Oosterwijk JC, 2003, J MED GENET, V40, P937, DOI 10.1136/jmg.40.12.937; Ostlund C, 2006, BIOCHEMISTRY-US, V45, P1374, DOI 10.1021/bi052156n; Owen DM, 2009, TRAFFIC, V10, P962, DOI 10.1111/j.1600-0854.2009.00908.x; Polioudaki H, 2001, EMBO REP, V2, P920, DOI 10.1093/embo-reports/kve199; Rayan G, 2010, SENSORS-BASEL, V10, P5927, DOI 10.3390/s100605927; Sbalzarini IF, 2006, BIOPHYS J, V90, P878, DOI 10.1529/biophysj.105.073809; Scott ES, 2001, J VIROL, V75, P8818, DOI 10.1128/JVI.75.18.8818-8830.2001; Shultz LD, 2003, HUM MOL GENET, V12, P61, DOI 10.1093/hmg/ddg003; SIMOS G, 1992, EMBO J, V11, P4027, DOI 10.1002/j.1460-2075.1992.tb05496.x; SMITH S, 1993, J CELL BIOL, V120, P631, DOI 10.1083/jcb.120.3.631; SOULLAM B, 1993, J CELL BIOL, V120, P1093, DOI 10.1083/jcb.120.5.1093; SOULLAM B, 1995, J CELL BIOL, V130, P15, DOI 10.1083/jcb.130.1.15; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Tian A, 2009, BIOPHYS J, V96, P2676, DOI 10.1016/j.bpj.2008.11.067; Ungricht R, 2015, J CELL BIOL, V209, P687, DOI 10.1083/jcb.201409127; Wang YN, 2010, J BIOL CHEM, V285, P38720, DOI 10.1074/jbc.M110.158659; Waterham HR, 2003, AM J HUM GENET, V72, P1013, DOI 10.1086/373938; WORMAN HJ, 1990, J CELL BIOL, V111, P1535, DOI 10.1083/jcb.111.4.1535; WORMAN HJ, 1988, P NATL ACAD SCI USA, V85, P8531, DOI 10.1073/pnas.85.22.8531; Ye Q, 1996, J BIOL CHEM, V271, P14653, DOI 10.1074/jbc.271.25.14653; YE Q, 1994, J BIOL CHEM, V269, P11306; Ye QA, 1997, J BIOL CHEM, V272, P14983, DOI 10.1074/jbc.272.23.14983; Zuleger N, 2011, J CELL BIOL, V193, P109, DOI 10.1083/jcb.201009068; Zwerger M, 2010, MOL BIOL CELL, V21, P354, DOI 10.1091/mbc.E09-08-0739	47	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2017	12	1							e0169626	10.1371/journal.pone.0169626	http://dx.doi.org/10.1371/journal.pone.0169626			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7CU	28118363	Green Published, gold, Green Submitted			2022-12-26	WOS:000396160500047
J	Silva, LA; Reis-Cunha, JL; Bartholomeu, DC; Victor, RWA				Silva, Leticia Azevedo; Reis-Cunha, Joao Luis; Bartholomeu, Daniella Castanheira; Almeida Victor, Ricardo Wagner			Genetic Polymorphisms and Phenotypic Profiles of Sulfadiazine-Resistant and Sensitive Toxoplasma gondii Isolates Obtained from Newborns with Congenital Toxoplasmosis in Minas Gerais, Brazil	PLOS ONE			English	Article							IN-VITRO; SULFONAMIDE RESISTANCE; PLASMODIUM-FALCIPARUM; MURINE TOXOPLASMOSIS; STRAINS; PYRIMETHAMINE; MUTATIONS; COMBINATION; ATOVAQUONE	Background Previous Toxoplasma gondii studies revealed that mutations in the dhps (dihydropteroate synthase) gene are associated with resistance to sulfonamides. Although Brazilian strains are genotypically different, very limited data are available regarding the susceptibility of strains obtained from human to sulfonamides. The aim of this study was to evaluate the efficacy of sulfadiazine (SDZ) against Brazilian isolates of T. gondii and verify whether isolates present polymorphisms in the dhps gene. We also investigated whether the virulence-phenotype and/or genotype were associated with the profile of susceptibility to SDZ. Methods Five T. gondii isolates obtained from newborns with congenital toxoplasmosis were used to verify susceptibility. Mice were infected with 10(4) tachyzoites and orally treated with different doses of SDZ. The mortality curve was evaluated by the Log-rank test. The presence of polymorphisms in the dhps gene was verified using sequencing. A descriptive analysis for 11 Brazilian isolates was used to assess the association between susceptibility, genotype, and virulence-phenotype. Results Statistical analysis showed that TgCTBr03, 07, 08, and 16 isolates were susceptible to SDZ, whereas TgCTBr11 isolate presented a profile of resistance to SDZ. Nineteen polymorphisms were identified in dhps exons. Seven polymorphisms corresponded to non-synonymous mutations, with four being new mutations, described for the first time in this study. No association was found between the profile of susceptibility and the virulence-phenotype or genotype of the parasite. Conclusions There is a high variability in the susceptibilities of Brazilian T. gondii strains to SDZ, with evidence of drug resistance. Despite the large number of polymorphisms identified, the profile of susceptibility to SDZ was not associated with any of the dhps variants identified in this study. Other genetic factors, not yet determined, may be associated with the resistance to SDZ; thus, further studies are needed as a basis for a more adequate toxoplasmosis treatment.	[Silva, Leticia Azevedo; Almeida Victor, Ricardo Wagner] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Lab Toxoplasmose, Belo Horizonte, MG, Brazil; [Reis-Cunha, Joao Luis; Bartholomeu, Daniella Castanheira] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Lab Genom Parasitos, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Victor, RWA (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Lab Toxoplasmose, Belo Horizonte, MG, Brazil.	ricardovitor@icb.ufmg.br	Reis-Cunha, João/AAX-6470-2020; De Almeida Vitor, Ricardo Wagner/ABH-1666-2020; Vitor, Ricardo/B-8924-2013; Bartholomeu, Daniella C./J-4714-2015	Reis-Cunha, João/0000-0003-1034-0992; De Almeida Vitor, Ricardo Wagner/0000-0002-8599-0474; Bartholomeu, Daniella C./0000-0003-0974-7357	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [150956/2014-2]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	LAS was supported by a post doctoral fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) grant 150956/2014-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carneiro ACAV, 2013, J CLIN MICROBIOL, V51, P901, DOI 10.1128/JCM.02502-12; Alves CF, 2005, PARASITE, V12, P171, DOI 10.1051/parasite/2005122171; ARAUJO FG, 1993, J INFECT DIS, V167, P494, DOI 10.1093/infdis/167.2.494; Aspinall TV, 2002, J INFECT DIS, V185, P1637, DOI 10.1086/340577; Doliwa C, 2013, EXP PARASITOL, V133, P131, DOI 10.1016/j.exppara.2012.11.019; Doliwa C, 2013, INT J PARASITOL-DRUG, V3, P35, DOI 10.1016/j.ijpddr.2012.12.002; Doliwa C, 2013, PARASITE, V20, DOI 10.1051/parasite/2013020; Dubey JP, 2012, PARASITOLOGY, V139, P1, DOI 10.1017/S0031182011001673; Dubey JP, 2010, TOXOPLASMOSIS ANIMAL, P70; Ferreira AD, 2006, INFECT GENET EVOL, V6, P22, DOI 10.1016/j.meegid.2004.12.004; Harrington D, 2005, LINEAR RANK TESTS SU; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Khan AA, 1997, ANTIMICROB AGENTS CH, V41, P893, DOI 10.1128/AAC.41.5.893; Meneceur P, 2008, ANTIMICROB AGENTS CH, V52, P1269, DOI 10.1128/AAC.01203-07; Oliveira CBS, 2016, MEM I OSWALDO CRUZ, V111, P391, DOI 10.1590/0074-02760150459; Pena HFJ, 2008, INT J PARASITOL, V38, P561, DOI 10.1016/j.ijpara.2007.09.004; Petersen E, 2007, SEMIN FETAL NEONAT M, V12, P214, DOI 10.1016/j.siny.2007.01.011; PFEFFERKORN ER, 1992, EXP PARASITOL, V74, P261, DOI 10.1016/0014-4894(92)90149-5; Pinheiro BV, 2015, EXP PARASITOL, V156, P87, DOI 10.1016/j.exppara.2015.06.002; Reynolds MG, 2001, ANTIMICROB AGENTS CH, V45, P1271, DOI 10.1128/AAC.45.4.1271-1277.2001; Schmid A, 2009, MOL BIOCHEM PARASIT, V163, P54, DOI 10.1016/j.molbiopara.2008.09.010; Silva LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090237; Triglia T, 1997, P NATL ACAD SCI USA, V94, P13944, DOI 10.1073/pnas.94.25.13944; Vasconcelos-Santos DV, 2009, OPHTHALMOLOGY, V116, P2199, DOI 10.1016/j.ophtha.2009.04.042; Wang P, 1997, MOL MICROBIOL, V23, P979, DOI 10.1046/j.1365-2958.1997.2821646.x	25	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2017	12	1							e0170689	10.1371/journal.pone.0170689	http://dx.doi.org/10.1371/journal.pone.0170689			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7CU	28118394	gold, Green Submitted, Green Published			2022-12-26	WOS:000396160500012
J	Sandler, H; Fendel, U; Busse, P; Rose, M; Boesel, R; Klapp, BF				Sandler, Hubertus; Fendel, Uta; Busse, Petra; Rose, Matthias; Boesel, Rainer; Klapp, Burghard F.			Relaxation - Induced by Vibroacoustic Stimulation via a Body Monochord and via Relaxation Music - Is Associated with a Decrease in Tonic Electrodermal Activity and an Increase of the Salivary Cortisol Level in Patients with Psychosomatic Disorders	PLOS ONE			English	Article							PROGRESSIVE MUSCLE-RELAXATION; PHYSIOLOGICAL-RESPONSES; ANXIETY; STATES; CARE; EEG; MEDITATION; THERAPY; PATTERN; THETA	Vibroacoustic stimulation by a Body Monochord can induce relaxation states of various emotional valence. The skin conductance level (SCL) of the tonic electrodermal activity is an indicator of sympathetic arousal of the autonomic nervous system and thus an indicator of the relaxation response. Salivary cortisol is considered to be a stress indicator of the HPA-axis. The effects of the treatment with a Body Monochord and listening to relaxation music (randomized chronological presentation) on SCL and salivary cortisol in relation to the emotional valence of the experience were examined in patients with psychosomatic disorders (N = 42). Salivary cortisol samples were collected immediately before and after the expositions. Subjective experience was measured via self-rating scales. Overall, both the exposure to the Body Monochord as well as the exposure to the relaxation music induced an improvement of patients' mood and caused a highly significant reduction of SCL. A more emotionally positive experience of relaxation correlated with a slightly stronger reduction of the SCL. Both treatment conditions caused a slight increase in salivary cortisol, which was significant after exposure to the first treatment. The increase of salivary cortisol during a relaxation state is contrary to previous findings. It is possible that the relaxation state was experienced as an emotional challenge, due to inner images and uncommon sensations that might have occurred.	[Sandler, Hubertus; Fendel, Uta; Busse, Petra; Rose, Matthias; Klapp, Burghard F.] Charite, Dept Gen Internal & Psychosomat Med, Berlin, Germany; [Boesel, Rainer] Int Psychoanalyt Univ Berlin, Berlin, Germany; [Boesel, Rainer] Free Univ Berlin, Dept Cognit Neurosci, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin	Sandler, H (corresponding author), Charite, Dept Gen Internal & Psychosomat Med, Berlin, Germany.	hubertus.sandler@charite.de			Universitare Forschungsforderung Charite (Universitary Research Support Charite) [11/48720]	Universitare Forschungsforderung Charite (Universitary Research Support Charite)	The study was funded by Universitare Forschungsforderung Charite (Universitary Research Support Charite, Identification: 11/48720)) in the period from 1.1.2011 to 31.12.2011 with an amount of 3.800 (three thousand eight hundred). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENSON H, 1974, PSYCHIATRY, V37, P37, DOI 10.1080/00332747.1974.11023785; Bernardi L, 2006, HEART, V92, P445, DOI 10.1136/hrt.2005.064600; Bonny H., 2002, MUSIC CONSCIOUSNESS, P43; Booij SH, 2016, PSYCHONEUROENDOCRINO, V69, P16, DOI 10.1016/j.psyneuen.2016.03.012; Bosel R, 1993, KOGNITIONSWISSENSCHA, V3, P53; Boucsein W., 2007, ELECTRODERMAL ACTIVI; Bradt J., 2009, COCHRANE DB SYST REV, V12; Bradt J, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006911.pub2, 10.1002/14651858.CD006911]; Buchanan TW, 1999, PSYCHONEUROENDOCRINO, V24, P227, DOI 10.1016/S0306-4530(98)00078-X; Cahn BR, 2006, PSYCHOL BULL, V132, P180, DOI 10.1037/0033-2909.132.2.180; Castro M, 2000, BRAZ J MED BIOL RES, V33, P1171, DOI 10.1590/S0100-879X2000001000006; Chan MF, 2009, J CLIN NURS, V18, P1250, DOI 10.1111/j.1365-2702.2008.02491.x; Chlan L L, 2000, AACN Clin Issues, V11, P128, DOI 10.1097/00044067-200002000-00014; Deiber MP, 2007, J COGNITIVE NEUROSCI, V19, P158, DOI 10.1162/jocn.2007.19.1.158; DUJARDIN K, 1993, ELECTROEN CLIN NEURO, V86, P353, DOI 10.1016/0013-4694(93)90049-2; Fendel U., UNPUB; Fendel U, 2017, UNPUB; Gingras B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102103; Han L, 2010, J CLIN NURS, V19, P978, DOI 10.1111/j.1365-2702.2009.02845.x; Harding S, 1996, Int J Nurs Pract, V2, P160, DOI 10.1111/j.1440-172X.1996.tb00043.x; Harthog T, 2001, Z MUSIK TANZ KUNSTTH, V12, P111; Hellhammer DH, 2009, PSYCHONEUROENDOCRINO, V34, P163, DOI 10.1016/j.psyneuen.2008.10.026; HORHOLD M, 1993, Z MED PSYCHOL, V2, P27; Hoyt LT, 2015, PSYCHOSOM MED, V77, P392, DOI 10.1097/PSY.0000000000000178; JEVNING R, 1978, HORM BEHAV, V10, P54, DOI 10.1016/0018-506X(78)90024-7; JIN P, 1989, J PSYCHOSOM RES, V33, P197, DOI 10.1016/0022-3999(89)90047-0; Jungaberle H, 2003, MUSIKTHER UMSCH, V24, P319; Khalfa S, 2003, ANN NY ACAD SCI, V999, P374, DOI 10.1196/annals.1284.045; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Koelsch S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00110; Kreibig SD, 2010, BIOL PSYCHOL, V84, P394, DOI 10.1016/j.biopsycho.2010.03.010; KRIEGER DT, 1971, J CLIN ENDOCR METAB, V32, P266, DOI 10.1210/jcem-32-2-266; Labbe E, 2007, APPL PSYCHOPHYS BIOF, V32, P163, DOI 10.1007/s10484-007-9043-9; Lee EJ, 2012, COMPLEMENT THER MED, V20, P409, DOI 10.1016/j.ctim.2012.07.002; Lee MS, 2004, STRESS HEALTH, V20, P243, DOI 10.1002/smi.1023; Lee OKA, 2005, J CLIN NURS, V14, P609, DOI 10.1111/j.1365-2702.2004.01103.x; MILUKKOLASA B, 1994, EXP CLIN ENDOCRINOL, V102, P118, DOI 10.1055/s-0029-1211273; MOCKEL M, 1994, EUR J APPL PHYSIOL, V68, P451, DOI 10.1007/BF00599512; Nater UM, 2006, INT J PSYCHOPHYSIOL, V62, P300, DOI 10.1016/j.ijpsycho.2006.05.011; Pawlow LA, 2005, APPL PSYCHOPHYS BIOF, V30, P375, DOI 10.1007/s10484-005-8423-2; Peeters F, 2003, PSYCHOSOM MED, V65, P836, DOI 10.1097/01.PSY.0000088594.17747.2E; Pekala RJ, 1991, QUANTIFYING CONSCIOU; PENNEKAMP P, 1994, J PSYCHOPHYSIOL, V8, P131; Putignano P, 2001, EUR J ENDOCRINOL, V145, P165, DOI 10.1530/eje.0.1450165; Rodriguez ACI, 2015, PSYCHONEUROENDOCRINO, V62, P301, DOI 10.1016/j.psyneuen.2015.08.014; Rose JP, 2008, FORSCH KOMPLEMENTMED, V15, P335, DOI 10.1159/000164268; Rux M, 2002, ERPROBUNG DEUTSCHEN; Sandler, UNPUB; Sandler H, 2015, NORDIC J MUSIC THERA; Sandler H., 2008, MUSIK TANZ KUNSTTHER, V19, P110; Sandler H, 2016, BRAIN TOPOGRAPHY; Sandstrom G.M., 2010, MUSIC MED, V2, P137, DOI [10.1177/1943862110371486, DOI 10.1177/1943862110371486]; Smith JC, 1996, BIOFEEDBACK SELF-REG, V21, P63, DOI 10.1007/BF02214150; Smyth J, 1998, PSYCHONEUROENDOCRINO, V23, P353, DOI 10.1016/S0306-4530(98)00008-0; Spitzer M, 2005, NERVENHEILKUNDE, V24, P198; SUDSUANG R, 1991, PHYSIOL BEHAV, V50, P543, DOI 10.1016/0031-9384(91)90543-W; Teut M, 2014, BMC PALLIAT CARE, V13, DOI 10.1186/1472-684X-13-18; Uedo N, 2004, HEPATO-GASTROENTEROL, V51, P451; Vaitl D, 2005, PSYCHOL BULL, V131, P98, DOI 10.1037/0033-2909.131.1.98; Vaitl D, 2000, HDB ENTSPANNUNGSVERF, P206; Warth M, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0933-8; Weeks BP, 2011, EUR J CARDIOVASC NUR, V10, P88, DOI 10.1016/j.ejcnurse.2010.07.002; WEITZMAN ED, 1971, J CLIN ENDOCR METAB, V33, P14, DOI 10.1210/jcem-33-1-14; White J M, 1999, Am J Crit Care, V8, P220; Yamamoto M., 2007, PSYCHOL MUSIC, V35, P249, DOI [10.1177/0305735607070375, DOI 10.1177/0305735607070375]	65	10	10	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170411	10.1371/journal.pone.0170411	http://dx.doi.org/10.1371/journal.pone.0170411			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6QR	28114399	Green Published, Green Submitted, gold			2022-12-26	WOS:000396129000045
J	Sato, Y; Uchida, E; Aoki, H; Hanamura, T; Nagamine, K; Kato, H; Koizumi, T; Ishigami, A				Sato, Yasunori; Uchida, Eriko; Aoki, Hitoshi; Hanamura, Takayuki; Nagamine, Kenichi; Kato, Hisanori; Koizumi, Takeshi; Ishigami, Akihito			Acerola (Malpighia emarginata DC.) Juice Intake Suppresses UVB-Induced Skin Pigmentation in SMP30/GNL Knockout Hairless Mice	PLOS ONE			English	Article							ASCORBIC-ACID DEFICIENCY; VITAMIN-C; MOUSE-TISSUES; TNF-ALPHA; CYCLIN D1; IN-VIVO; FRUIT; RADIATION; KERATINOCYTES; BIOSYNTHESIS	Background/ Aims Acerola (Malpighia emarginata DC.) is a fruit that is known to contain high amounts of ascorbic acid (AA) and various phytochemicals. We have previously reported that AA deficiency leads to ultraviolet B (UVB)-induced skin pigmentation in senescence marker protein 30 (SMP30)/gluconolactonase (GNL) knockout (KO) hairless mice. The present study was undertaken to investigate the effects of acerola juice (AJ) intake on the skin of UVB-irradiated SMP30/GNL KO mice. Research design/Principal findings Five-week old hairless mice were given drinking water containing physiologically sufficient AA (1.5 g/L) [AA (+)], no AA [AA (-)] or 1.67% acerola juice [AJ]. All mice were exposed to UVB irradiation for 6 weeks. UVB irradiation was performed three times per week. The dorsal skin color and stratum corneum water content were measured every weekly, and finally, the AA contents of the skin was determined. The skin AA and stratum corneum water content was similar between the AA (+) and AJ groups. The L* value of the AA (+) group was significantly decreased by UVB irradiation, whereas AJ intake suppressed the decrease in the L* value throughout the experiment. Moreover, in the AJ group, there was a significant decrease in the expression level of dopachrome tautomerase, an enzyme that is involved in melanin biosynthesis. Conclusion These results indicate that AJ intake is effective in suppressing UVB-induced skin pigmentation by inhibiting melanogenesis-related genes.	[Sato, Yasunori; Ishigami, Akihito] Tokyo Metropolitan Inst Gerontol, Mol Regulat Aging, Tokyo, Japan; [Uchida, Eriko; Koizumi, Takeshi] Nichirei Corp, Corp Sci Res Div, Chiba, Japan; [Aoki, Hitoshi; Hanamura, Takayuki] Nichirei Foods Corp, Div Res & Dev, Chiba, Japan; [Nagamine, Kenichi] Nichirei Biosci Corp, Ctr Res & Dev, Div Res & Dev, Tokyo, Japan; [Kato, Hisanori] Univ Tokyo, Corp Sponsored Res Program Food Life, Tokyo, Japan	Tokyo Metropolitan Institute of Gerontology; Nichirei Corporation; Nichirei Corporation; Nichirei Corporation; University of Tokyo	Ishigami, A (corresponding author), Tokyo Metropolitan Inst Gerontol, Mol Regulat Aging, Tokyo, Japan.	ishigami@tmig.or.jp		Ishigami, Akihito/0000-0001-7875-7482	Japan Society for the Promotion of Science (JSPS) KAKENHI [15H04505, 15K15104]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study is supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant (http://www.mext.go.jp/a_menu/shinkou/hoivo/main5 a5.htm) Number 15H04505 (AI) and 15K15104 (Al). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. EU and TK are current employees of Nichirei Corporation. HA and TH are current employees of Nichirei Foods Corporation. KN is current employee of Nichirei Bioscience Corporation. However, these founders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano A, 2014, EUR J NUTR, V53, P177, DOI 10.1007/s00394-013-0515-9; Amano A, 2013, J NUTR SCI VITAMINOL, V59, P489, DOI 10.3177/jnsv.59.489; de Lima VLAG, 2011, CIENCIA TECNOL ALIME, V31, P86, DOI 10.1590/S0101-20612011000100011; Bashir MM, 2009, J INVEST DERMATOL, V129, P994, DOI 10.1038/jid.2008.332; Chen HX, 2014, J INVEST DERMATOL, V134, P2080, DOI 10.1038/jid.2014.161; D'Orazio J, 2013, INT J MOL SCI, V14, P12222, DOI 10.3390/ijms140612222; Dias FM, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-24; Fernandez-Hernandez R, 2013, CELL CYCLE, V12, P2510, DOI 10.4161/cc.25590; FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7; Hanamura T, 2008, J FOOD SCI, V73, pT55, DOI 10.1111/j.1750-3841.2008.00708.x; Hanamura T, 2005, BIOSCI BIOTECH BIOCH, V69, P280, DOI 10.1271/bbb.69.280; Hanamura T, 2008, J SCI FOOD AGR, V88, P1813, DOI 10.1002/jsfa.3285; Hanamura T, 2006, BIOSCI BIOTECH BIOCH, V70, P1813, DOI 10.1271/bbb.50592; Hanamura T, 2008, BIOSCI BIOTECH BIOCH, V72, P3211, DOI 10.1271/bbb.80421; Horta RN, 2016, GENET MOL BIOL, V39, P122, DOI 10.1590/1678-4685-GMB-2015-0157; IMOKAWA G, 1995, J INVEST DERMATOL, V105, P32, DOI 10.1111/1523-1747.ep12312500; Iwama M, 2011, NUTRITION, V27, P471, DOI 10.1016/j.nut.2010.04.010; Janjetovic Z, 2014, J PINEAL RES, V57, P90, DOI 10.1111/jpi.12146; Kim JH, 2008, J INVEST DERMATOL, V128, P1227, DOI 10.1038/sj.jid.5701177; Koike K, 2014, AM J RESP CELL MOL, V50, P347, DOI 10.1165/rcmb.2013-0121OC; Koike K, 2010, AM J PHYSIOL-LUNG C, V298, pL784, DOI 10.1152/ajplung.00256.2009; Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103; Kondo Y, 2008, BIOCHEM BIOPH RES CO, V377, P291, DOI 10.1016/j.bbrc.2008.09.132; Kondo Y, 2014, J AGR FOOD CHEM, V62, P9286, DOI 10.1021/jf502587j; Lee MH, 2006, PHYTOCHEMISTRY, V67, P1262, DOI 10.1016/j.phytochem.2006.05.008; Leffa DD, 2014, MUTAT RES-FUND MOL M, V770, P144, DOI 10.1016/j.mrfmmm.2013.11.005; Linster CL, 2007, FEBS J, V274, P1, DOI 10.1111/j.1742-4658.2006.05607.x; Mitra D, 2012, NATURE, V491, P449, DOI 10.1038/nature11624; Murase D, 2015, BIOL OPEN, V4, P1213, DOI 10.1242/bio.011973; Nagamine I, 2002, J NUTR SCI VITAMINOL, V48, P69, DOI 10.3177/jnsv.48.69; Naganumaa M, 2001, J DERMATOL SCI, V25, P29, DOI 10.1016/S0923-1811(00)00098-0; NISHIKIMI M, 1991, AM J CLIN NUTR, V54, pS1203, DOI 10.1093/ajcn/54.6.1203s; Nobrega EM, 2015, J FOOD PROCESS PRES, V39, P131, DOI 10.1111/jfpp.12213; Quevedo WC, 2000, PIGM CELL RES, V13, P89, DOI 10.1034/j.1600-0749.2000.130207.x; Rijken F, 2009, J INVEST DERM SYMP P, V14, P67, DOI 10.1038/jidsymp.2009.15; Robles AI, 1996, P NATL ACAD SCI USA, V93, P7634, DOI 10.1073/pnas.93.15.7634; Sagar S.B., 2014, INT J SCI RES RAIPUR, V3, P2176; Sato T, 2006, AM J RESP CRIT CARE, V174, P530, DOI 10.1164/rccm.200511-1816OC; Sato Y, 2008, BIOCHEM BIOPH RES CO, V375, P346, DOI 10.1016/j.bbrc.2008.08.020; Sato Y, 2014, GERIATR GERONTOL INT, V14, P989, DOI 10.1111/ggi.12162; Sato Y, 2012, J INVEST DERMATOL, V132, P2112, DOI 10.1038/jid.2012.105; Sato Y, 2010, BIOL PHARM BULL, V33, P364, DOI 10.1248/bpb.33.364; Seike M, 2002, J DERMATOL SCI, V28, P135, DOI 10.1016/S0923-1811(01)00155-4; Skobowiat C, 2013, BRIT J DERMATOL, V168, P595, DOI 10.1111/bjd.12096; Slominski A, 2005, ENDOCRINE, V27, P137, DOI 10.1385/ENDO:27:2:137; Slominski A, 2005, FASEB J, V19, P176, DOI 10.1096/fj.04-2079rev; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Strickland I, 1997, J INVEST DERMATOL, V108, P763, DOI 10.1111/1523-1747.ep12292156; Tobin DJ, 2005, J INVEST DERM SYMP P, V10, P212, DOI 10.1111/j.1087-0024.2005.10108.x; Uchida E, 2011, BIOL PHARM BULL, V34, P1744, DOI 10.1248/bpb.34.1744; Vendramini AL, 2000, FOOD CHEM, V71, P195, DOI 10.1016/S0308-8146(00)00152-7; Yamada Y, 2008, J NUTR SCI VITAMINOL, V54, P117, DOI 10.3177/jnsv.54.117; Zi SX, 2009, INT J MOL MED, V23, P197, DOI 10.3892/ijmm_00000117; Zmijewski MA, 2013, EXP DERMATOL, V22, P790, DOI 10.1111/exd.12129	55	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170438	10.1371/journal.pone.0170438	http://dx.doi.org/10.1371/journal.pone.0170438			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114343	gold, Green Submitted, Green Published			2022-12-26	WOS:000396129000049
J	Stidham, RW; Wu, J; Shi, JQ; Lubman, DM; Higgins, PDR				Stidham, Ryan W.; Wu, Jing; Shi, Jiaqi; Lubman, David M.; Higgins, Peter D. R.			Serum Glycoproteome Profiles for Distinguishing Intestinal Fibrosis from Inflammation in Crohn's Disease	PLOS ONE			English	Article							HEPATOCYTE-GROWTH-FACTOR; OLIGOMERIC MATRIX PROTEIN; C-REACTIVE PROTEIN; LIVER FIBROSIS; ENTEROGRAPHY; ACTIVATION; EXPRESSION; ACCURACY; BINDING; CANCER	Background Reliable identification and quantitation of intestinal fibrosis in the setting of co-existing inflammation due to Crohn's disease (CD) is difficult. We aimed to identify serum biomarkers which distinguish inflammatory from fibrostenotic phenotypes of CD using serum glycoproteome profiles. Methods Subjects with fibrostenotic and inflammation-predominant CD phenotypes (n=20 per group) underwent comparison by quantitative serum glycoproteome profiles as part of a single tertiary care center cohort study. Following lectin elution, glycoproteins underwent liquid chromatography followed by tandem mass spectrometry. Identified candidate biomarkers of fibrosis were also measured by serum ELISA, a widely available technique. Results Five (5) glycoproteins demonstrated a >= 20% relative abundance change in >= 80% of subjects, including cartilage oligomeric matrix protein (COMP) and hepatocyte growth factor activator (HGFA). COMP (431.7 +/- 112.7 vs. 348.7 +/- 90.5 ng/mL, p = 0.012) and HGFA (152.7 +/- 66.5 vs. 107.1 +/- 38.7 ng/mL, p = 0.031) serum levels were elevated in the fibrostenotic vs. inflammatory CD groups using ELISA. Within the fibrostenotic group, intra-individual changes of candidate biomarkers revealed HGFA levels significantly declined following the resection of all diseased intestine (152.7 +/- 66.5 vs. 107.1 +/- 38.7 ng/mL, p = 0.015); COMP levels were unchanged. Immunohistochemical staining confirmed the presence of COMP in the submucosa and muscularis of resected fibrostenotic tissue. Conclusions In this biomarker discovery study, several serum glycoproteins, specifically COMP and HGFA, differ between between predominately inflammatory and fibrostenotic CD phenotypes. The development of blood-based biomarkers of fibrosis would provide an important complement to existing prognostic tools in IBD, aiding decisions on therapeutic intensity and mechanism selection, surgery, and the monitoring of future anti-fibrotic therapies for CD.	[Stidham, Ryan W.; Higgins, Peter D. R.] Univ Michigan, Div Gastroenterol & Hepatol, Dept Internal Med, Ann Arbor, MI USA; [Wu, Jing; Lubman, David M.] Univ Michigan Hlth Syst, Dept Surg, Ann Arbor, MI USA; [Shi, Jiaqi] Univ Michigan Hlth Syst, Dept Pathol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Stidham, RW (corresponding author), Univ Michigan, Div Gastroenterol & Hepatol, Dept Internal Med, Ann Arbor, MI USA.	ryanstid@med.umich.edu		Shi, Jiaqi/0000-0003-4893-1587	Broad Medical Research Program at CCFA [IBD-0385]; National Institutes of Health [K23-DK101687]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK101687] Funding Source: NIH RePORTER	Broad Medical Research Program at CCFA; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by: 1. The Broad Medical Research Program at CCFA (IBD-0385), http ://www.ccfa.org/science-and-professionals/broad/; 2. The National Institutes of Health (K23-DK101687), http://grants.nih.gov/grants/guide/contacts/parent_K23.html.	Acharya C, 2014, MATRIX BIOL, V37, P102, DOI 10.1016/j.matbio.2014.06.001; Adler J, 2012, INFLAMM BOWEL DIS, V18, P849, DOI 10.1002/ibd.21801; Agarwal P, 2013, MATRIX BIOL, V32, P325, DOI 10.1016/j.matbio.2013.02.010; Andreasson K, 2015, INFECT DIS-NOR, V47, P915, DOI 10.3109/23744235.2015.1075659; Azuma J, 2006, GENE THER, V13, P1206, DOI 10.1038/sj.gt.3302740; Benjamini Y, 2010, J R STAT SOC B, V72, P405, DOI 10.1111/j.1467-9868.2010.00746.x; Bernstein CN, 2012, INFLAMM BOWEL DIS, V18, P1498, DOI 10.1002/ibd.21878; Chiorean MV, 2007, AM J GASTROENTEROL, V102, P2541, DOI 10.1111/j.1572-0241.2007.01537.x; Crestani Bruno, 2012, Proc Am Thorac Soc, V9, P158, DOI 10.1513/pats.201202-018AW; Cui QB, 2013, J PHYSIOL SCI, V63, P163, DOI 10.1007/s12576-013-0251-1; Dai L, 2010, J PROTEOME RES, V9, P3394, DOI 10.1021/pr100231m; Dillman JR, 2015, J MAGN RESON IMAGING, V42, P801, DOI 10.1002/jmri.24815; Farina G, 2009, ANN RHEUM DIS, V68, P435, DOI 10.1136/ard.2007.086850; Filik L, 2006, ADV THER, V23, P655, DOI 10.1007/BF02850054; Happonen KE, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3694; Hou JK, 2014, DIGEST DIS SCI, V59, P2406, DOI 10.1007/s10620-014-3174-7; Huang HP, 2012, HEPATOLOGY, V55, P161, DOI 10.1002/hep.24657; Ishida K, 2013, BONE, V55, P23, DOI 10.1016/j.bone.2013.03.007; Jess T, 2007, INFLAMM BOWEL DIS, V13, P481, DOI 10.1002/ibd.20036; Kataoka H, 2010, FEBS J, V277, P2230, DOI 10.1111/j.1742-4658.2010.07640.x; Kawaguchi M, 2011, AM J PATHOL, V179, P1815, DOI 10.1016/j.ajpath.2011.06.038; Marchand-Adam S, 2006, AM J RESP CRIT CARE, V174, P58, DOI 10.1164/rccm.200507-1074OC; Mungunsukh O, 2013, MOL BIOL CELL, V24, P2088, DOI 10.1091/mbc.E13-01-0017; Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x; Nie S, 2013, ANAL CHEM, V85, P5353, DOI 10.1021/ac400838s; Norman GL, 2015, WORLD J HEPATOL, V7, P1875, DOI 10.4254/wjh.v7.i14.1875; Ordas I, 2014, GASTROENTEROLOGY, V146, P374, DOI 10.1053/j.gastro.2013.10.055; Owen KA, 2010, BIOCHEM J, V426, P219, DOI 10.1042/BJ20091448; Pariente B, 2015, GASTROENTEROLOGY, V148, P52, DOI 10.1053/j.gastro.2014.09.015; Peyrin-Biroulet L, 2012, AM J GASTROENTEROL, V107, P1693, DOI 10.1038/ajg.2012.298; Rieder F, 2013, GUT, V62, P1072, DOI 10.1136/gutjnl-2012-304353; Rieder F, 2011, INFLAMM BOWEL DIS, V17, P2000, DOI 10.1002/ibd.21627; Rimola J, 2015, AM J GASTROENTEROL, V110, P432, DOI 10.1038/ajg.2014.424; Saldova R, 2008, DIS MARKERS, V25, P219, DOI 10.1155/2008/601583; Schulz JN, 2016, J CELL SCI, V129, P706, DOI 10.1242/jcs.180216; Solem CA, 2005, INFLAMM BOWEL DIS, V11, P707, DOI 10.1097/01.MIB.0000173271.18319.53; Stidham RW, 2016, UNITED EUROPEAN GAST; Stidham RW, 2011, GASTROENTEROLOGY, V141, P819, DOI 10.1053/j.gastro.2011.07.027; Tan K, 2009, J CELL COMMUN SIGNAL, V3, P177, DOI 10.1007/s12079-009-0074-2; Vivekanandan-Giri Anuradha, 2011, Int J Proteomics, V2011, P214715, DOI 10.1155/2011/214715; Vuga LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083120; Yuan B, 2008, IN VIVO, V22, P629; Zhang YW, 2015, J PROTEOME RES, V14, P5388, DOI 10.1021/acs.jproteome.5b00792	43	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170506	10.1371/journal.pone.0170506	http://dx.doi.org/10.1371/journal.pone.0170506			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114331	Green Published, Green Submitted, gold			2022-12-26	WOS:000396129000058
J	Guo, J; Kim, NH; Cui, XS				Guo, Jing; Kim, Nam-Hyung; Cui, Xiang-Shun			Inhibition of Fatty Acid Synthase Reduces Blastocyst Hatching through Regulation of the AKT Pathway in Pigs	PLOS ONE			English	Article							ATP CONTENT; IN-VITRO; PROLIFERATION; OXIDATION; METABOLISM; ACTIVATION; MECHANISMS; EXPRESSION; PROMOTES; SURVIVAL	Fatty acid synthase (FASN) is an enzyme responsible for the de novo synthesis of long-chain fatty acids. During oncogenesis, FASN plays a role in growth and survival rather than acting within the energy storage pathways. Here, the function of FASN during early embryonic development was studied using its specific inhibitor, C75. We found that the presence of the inhibitor reduced blastocyst hatching. FASN inhibition decreased Cpt1 expression, leading to a reduction in mitochondria numbers and ATP content. This inhibition of FASN resulted in the down-regulation of the AKT pathway, thereby triggering apoptosis through the activation of the p53 pathway. Activation of the apoptotic pathway also leads to increased accumulation of reactive oxygen species and autophagy. In addition, the FASN inhibitor impaired cell proliferation, a parameter of blastocyst quality for outgrowth. The level of OCT4, an important factor in embryonic development, decreased after treatment with the FASN inhibitor. These results show that FASN exerts an effect on early embryonic development by regulating both fatty acid oxidation and the AKT pathway in pigs.	[Guo, Jing; Kim, Nam-Hyung; Cui, Xiang-Shun] Chungbuk Natl Univ, Dept Anim Sci, Chungbuk, Cheongju, South Korea	Chungbuk National University	Kim, NH; Cui, XS (corresponding author), Chungbuk Natl Univ, Dept Anim Sci, Chungbuk, Cheongju, South Korea.	nhkim@chungbuk.ac.kr; xscui@chungbuk.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2015R1D1A1A01057629]; Next Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ011126]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Next Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (No. 2015R1D1A1A01057629), and the Next Generation BioGreen 21 Program (PJ011126), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (No. 2015R1D1A1A01057629), and the Next-Generation BioGreen 21 Program (PJ011126), Rural Development Administration, Republic of Korea.	Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49; Asturias FJ, 2005, NAT STRUCT MOL BIOL, V12, P225, DOI 10.1038/nsmb899; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; Casals N, 2016, PROG LIPID RES, V61, P134, DOI 10.1016/j.plipres.2015.11.004; Chajes V, 2006, CANCER RES, V66, P5287, DOI 10.1158/0008-5472.CAN-05-1489; Chirala SS, 2003, P NATL ACAD SCI USA, V100, P6358, DOI 10.1073/pnas.0931394100; Fritz V, 2013, ONCOGENE, V32, P5101, DOI 10.1038/onc.2012.523; Gerasimovskaya EV, 2005, J BIOL CHEM, V280, P1838, DOI 10.1074/jbc.M409466200; Giordano A, 2005, CELL DEATH DIFFER, V12, P603, DOI 10.1038/sj.cdd.4401636; GUO J, 2016, J REPROD DEV; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Harris DM, 2012, METABOLOMICS, V8, P201, DOI 10.1007/s11306-011-0300-9; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kottawatta KSA, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.131334; Krawczynski K, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2172-2; Kuhajda FP, 2000, P NATL ACAD SCI USA, V97, P3450, DOI 10.1073/pnas.050582897; Larabee SM, 2015, STEM CELLS DEV, V24, P354, DOI 10.1089/scd.2014.0051; Lee SK, 2015, THERIOGENOLOGY, V83, P121, DOI 10.1016/j.theriogenology.2014.08.019; Li JN, 2001, CANCER RES, V61, P1493; Liang S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134567; Lin YJ, 2012, MOL CELL, V48, P627, DOI 10.1016/j.molcel.2012.08.030; Liu WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037039; Lupu R, 2006, CURR PHARM BIOTECHNO, V7, P483, DOI 10.2174/138920106779116928; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; McCallie B, 2010, FERTIL STERIL, V93, P2374, DOI 10.1016/j.fertnstert.2009.01.069; Menendez JA, 2005, INT J CANCER, V115, P19, DOI 10.1002/ijc.20754; Menendez JA, 2005, INT J MOL MED, V15, P33; Menendez JA, 2004, ONCOGENE, V23, P4945, DOI 10.1038/sj.onc.1207476; Menendez JA, 2004, INT J ONCOL, V24, P591; Moon JS, 2015, J CLIN INVEST, V125, P665, DOI 10.1172/JCI78253; Pike LS, 2011, BBA-BIOENERGETICS, V1807, P726, DOI 10.1016/j.bbabio.2010.10.022; Pizer ES, 1997, INT J GYNECOL PATHOL, V16, P45, DOI 10.1097/00004347-199701000-00008; QUINN P, 1973, J REPROD FERTIL, V35, P301, DOI 10.1530/jrf.0.0350301; Revel A, 2011, HUM REPROD; Riley JK, 2005, DEV BIOL, V284, P377, DOI 10.1016/j.ydbio.2005.05.033; Su T, 2014, CHINESE SCI BULL, V59, P936, DOI 10.1007/s11434-014-0131-y; Sutton-McDowall ML, 2012, THERIOGENOLOGY, V77, P1632, DOI 10.1016/j.theriogenology.2011.12.008; Tait SWG, 2014, J CELL SCI, V127, P2135, DOI 10.1242/jcs.093575; Thupari JN, 2001, BIOCHEM BIOPH RES CO, V285, P217, DOI 10.1006/bbrc.2001.5146; Van Blerkom J, 2006, REPRODUCTION, V131, P961, DOI 10.1530/rep.1.00458; VANBLERKOM J, 1995, HUM REPROD, V10, P415, DOI 10.1093/oxfordjournals.humrep.a135954; Vilella F, 2015, DEVELOPMENT, V142, P3210, DOI 10.1242/dev.124289; Yang YA, 2002, EXP CELL RES, V279, P80, DOI 10.1006/excr.2002.5600; Zhao QW, 2015, ONCOL REP, V33, P1621, DOI 10.3892/or.2015.3752	45	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170624	10.1371/journal.pone.0170624	http://dx.doi.org/10.1371/journal.pone.0170624			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107461	Green Published, Green Submitted, gold			2022-12-26	WOS:000392405300174
J	Igarashi, K; Kobayashi, J; Katsumura, T; Urushihara, Y; Hida, K; Watanabe-Asaka, T; Oota, H; Oda, S; Mitani, H				Igarashi, Kento; Kobayashi, Junya; Katsumura, Takafumi; Urushihara, Yusuke; Hida, Kyohei; Watanabe-Asaka, Tomomi; Oota, Hiroki; Oda, Shoji; Mitani, Hiroshi			An Approach to Elucidate NBS1 Function in DNA Repair Using Frequent Nonsynonymous Polymorphism in Wild Medaka (Oryzias latipes) Populations	PLOS ONE			English	Article							GEOGRAPHIC-VARIATION; STATISTICAL-METHOD; GENE-EXPRESSION; CANCER-RISK; DOMAIN; FISH; DIFFERENTIATION; SUSCEPTIBILITY; RECOMBINATION; DYNAMICS	Nbs1 is one of the genes responsible for Nijmegen breakage syndrome, which is marked with high radiosensitivity. In human NBS1 (hNBS1), Q185E polymorphism is known as the factor to cancer risks, although its DSB repair defect has not been addressed. Here we investigated the genetic variations in medaka (Oryzias latipes) wild populations, and found 40 nonsynonymous single nucleotide polymorphisms (SNPs) in medaka nbs1 (olnbs1) gene within 5 inbred strains. A mutation to histidine in Q170 residue in olNbs1, which corresponds to Q185 residue of hNBS1, was widely distributed in the closed colonies derived from the eastern Korean population of medaka. Overexpression of H170 type olNbs1 in medaka cultured cell lines resulted in the increased accumulation of olNbs1 at laser-induced DSB sites. Autophosphorylation of DNA-dependent protein kinase at T2609 was suppressed after the gamma-ray irradiation, which was followed by prolonged formation of gamma-H2AX foci and delayed DSB repair. These findings suggested that the nonsynonymous SNP (Q170H) in olnbs1, which induced DSB repair defects, is specifically distributed in the eastern Korean population of medaka. Furthermore, examination using the variation within wild populations might provide a novel method to characterize a driving force to spread the disease risk alleles.	[Igarashi, Kento; Urushihara, Yusuke; Hida, Kyohei; Watanabe-Asaka, Tomomi; Oda, Shoji; Mitani, Hiroshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan; [Kobayashi, Junya] Kyoto Univ, Ctr Radiat Biol, Dept Genome Repair Dynam, Kyoto, Japan; [Katsumura, Takafumi; Oota, Hiroki] Kitasato Univ, Sch Med, Dept Anat, Sagamihara, Kanagawa, Japan; [Katsumura, Takafumi] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama, Japan; [Urushihara, Yusuke] Natl Inst Radiol Sci, Fukushima Project Headquarters, Fukushima, Japan	University of Tokyo; Kyoto University; Kitasato University; Okayama University; National Institutes for Quantum Science & Technology	Mitani, H (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan.	mitani@k.u-tokyo.ac.jp	Kobayashi, Junya/AAX-6390-2021	Kobayashi, Junya/0000-0003-4645-7500; IGARASHI, Kento/0000-0002-9509-5107	Ministry of Education, Sports, Science and Technology (MEXT) of Japan [21221003, 25220102]; Grants-in-Aid for Scientific Research [15K12201, 26251050] Funding Source: KAKEN	Ministry of Education, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study is supported by a Grant-in-Aid for Scientific Research(s) (21221003, 25220102) from the Ministry of Education, Sports, Science and Technology (MEXT) of Japan (https://www.jsps.go.jp/english/e-grants/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloraifi F, 2015, SURG ONCOL, V24, P100, DOI 10.1016/j.suronc.2015.04.003; Auton A., 2015, NATURE, V7571, P68, DOI 10.1038/nature15393; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Becker E, 2006, BIOINFORMATICS, V22, P1289, DOI 10.1093/bioinformatics/btl075; Berardinelli F, 2013, CURR GENOMICS, V14, P425, DOI 10.2174/13892029113146660012; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Clapperton JA, 2004, NAT STRUCT MOL BIOL, V11, P512, DOI 10.1038/nsmb775; Crown KN, 2013, G3-GENES GENOM GENET, V3, P1927, DOI 10.1534/g3.113.007906; Demogines A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001169; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fachal L, 2015, CURR OPIN GENET DEV, V30, P32, DOI 10.1016/j.gde.2015.01.004; Hicks C, 2013, CANCER INFORM, V12, P1, DOI 10.4137/CIN.S10413; Hidaka M, 2010, J RADIAT RES, V51, P165, DOI 10.1269/jrr.09107; Hirayama M, 2006, J COMP PHYSIOL B, V176, P311, DOI 10.1007/s00360-005-0053-8; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Katsumura T, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.2259; Katsumura T, 2012, ANTHROPOL SCI, V120, P81, DOI 10.1537/ase.110525; Katsumura T, 2009, GENE, V443, P170, DOI 10.1016/j.gene.2009.04.017; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kobayashi J, 2002, CURR BIOL, V12, P1846, DOI 10.1016/S0960-9822(02)01259-9; Kobayashi J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049245; Konca K, 2003, MUTAT RES-GEN TOX EN, V534, P15, DOI 10.1016/S1383-5718(02)00251-6; Lafrance-Vanasse J, 2015, PROG BIOPHYS MOL BIO, V117, P182, DOI 10.1016/j.pbiomolbio.2014.12.004; Lan Q, 2005, LUNG CANCER, V49, P317, DOI 10.1016/j.lungcan.2005.04.004; Li N, 2013, MOL BIOL REP, V40, P3749, DOI 10.1007/s11033-012-2451-9; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Matsumoto Yoshifumi, 2009, BMC Res Notes, V2, P88, DOI 10.1186/1756-0500-2-88; Meek K, 2008, ADV IMMUNOL, V99, P33, DOI 10.1016/S0065-2776(08)00602-0; Nei M., 2000, MOL EVOLUTION PHYLOG; Oda S, 2010, ZOOL SCI, V27, P410, DOI 10.2108/zsj.27.410; Oota H, 2011, MEDAKA: A MODEL FOR ORGANOGENESIS, HUMAN DISEASE, AND EVOLUTION, P339, DOI 10.1007/978-4-431-92691-7_22; Saito Y, 2013, TRANSL CANCER RES, V2, P178, DOI 10.3978/j.issn.2218-676X.2013.04.05; SAKAIZUMI M, 1983, COPEIA, P311, DOI 10.2307/1444373; Sakaizumi M., 1987, Korean Journal of Limnology, V20, P13; SAKAIZUMI M, 1984, JPN J GENET, V59, P651; Sanyal S, 2004, CARCINOGENESIS, V25, P729, DOI 10.1093/carcin/bgh058; Seemanov E, 2007, JNCI-J NATL CANCER I, V99, P1875, DOI 10.1093/jnci/djm251; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Shima A, 1985, J FAC SCI U TOKYO, P27; Staszewski O, 2011, MOL CELL, V41, P232, DOI 10.1016/j.molcel.2011.01.007; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Takehana Y, 2003, ZOOL SCI, V20, P1279, DOI 10.2108/zsj.20.1279; Takehana Y, 2004, ZOOLOG SCI, V21, P3; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thirumaran RK, 2006, CARCINOGENESIS, V27, P1676, DOI 10.1093/carcin/bgi381; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; Urushihara Y, 2012, BIOCHEM BIOPH RES CO, V429, P131, DOI 10.1016/j.bbrc.2012.10.128; Varon R, 2001, CANCER RES, V61, P3570; Walter J, 2003, J MICROSC-OXFORD, V209, P71, DOI 10.1046/j.1365-2818.2003.01117.x; Williams RS, 2009, CELL, V139, P87, DOI 10.1016/j.cell.2009.07.033; Yamamoto Y, 2014, CANCER RES, V74, P3707, DOI 10.1158/0008-5472.CAN-13-3037	52	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170006	10.1371/journal.pone.0170006	http://dx.doi.org/10.1371/journal.pone.0170006			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107384	Green Submitted, Green Published, gold			2022-12-26	WOS:000392405300061
J	Kaneko, H; Asami, T; Sugita, T; Tsunekawa, T; Matsuura, T; Takayama, K; Yamamoto, K; Kachi, S; Ito, Y; Ueno, S; Nonobe, N; Kataoka, K; Suzumura, A; Iwase, T; Terasaki, H				Kaneko, Hiroki; Asami, Tetsu; Sugita, Tadasu; Tsunekawa, Taichi; Matsuura, Toshiyuki; Takayama, Kei; Yamamoto, Kentaro; Kachi, Shu; Ito, Yasuki; Ueno, Shinji; Nonobe, Norie; Kataoka, Keiko; Suzumura, Ayana; Iwase, Takeshi; Terasaki, Hiroko			Better Visual Outcome by Intraocular Lens Ejection in Geriatric Patients with Ruptured Ocular Injuries	PLOS ONE			English	Article							PENETRATING EYE INJURIES; NO LIGHT PERCEPTION; TRAUMA; GLOBE; PREVALENCE; CLASSIFICATION; VITRECTOMY; SYSTEM	Ocular trauma is one of the leading causes of visual impairment worldwide. Because of the popularity of cataract surgeries, aged individuals with ocular trauma commonly have a surgical wound in their eyes. The purpose of this study was to evaluate the visual outcome of cases that were coincident with intraocular lens (IOL) ejection in the eyes with ruptured open-globe ocular injuries. Consecutive patients with open-globe ocular injuries were first reviewed. Patients' characteristics, corrected distance visual acuities (CDVAs) over 3 years after the trauma, causes of injuries, traumatic wound patterns, and coexistence of retinal detachment were examined. The relationships between poor CDVA and the other factors, including the complications of crystalline lens and IOL ejection, were examined. A total of 105 eyes/patients [43 eyes with rupture, 33 with penetrating, 28 with intraocular foreign body (IOFB), and 1 with perforating injuries] were included. Rupture injuries were common in aged patients and were mostly caused by falls, whereas penetrating and IOFB injuries were common in young male patients. CDVAs of the eyes with rupture injuries were significantly worse than those of the eyes with penetrating or IOFB injuries. CDVA from more than 50% of the ruptured eyes resulted in no light perception or light perception to 20/500. CDVA of the ruptured eyes complicated by crystalline lens ejection was significantly worse than that of those complicated by IOL ejection. The wounds of the ruptured eyes complicated by IOL ejection were mainly located at the superior corneoscleral limbus, whereas those of the eyes complicated by crystalline lens ejection were located at the posterior sclera. There were significant correlations between poor CDVA and retinal detachment and crystalline lens ejection. These results proposed a new trend in the ocular injuries that commonly occur in aged patients; history of cataract surgery might affect the final visual outcome after open-globe ocular injuries.	[Kaneko, Hiroki; Asami, Tetsu; Sugita, Tadasu; Tsunekawa, Taichi; Matsuura, Toshiyuki; Takayama, Kei; Yamamoto, Kentaro; Kachi, Shu; Ito, Yasuki; Ueno, Shinji; Nonobe, Norie; Kataoka, Keiko; Suzumura, Ayana; Iwase, Takeshi; Terasaki, Hiroko] Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Nagoya, Aichi, Japan	Nagoya University	Kaneko, H (corresponding author), Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Nagoya, Aichi, Japan.	h-kaneko@med.nagoya-u.ac.jp	Kaneko, Hiroki/AHA-2461-2022; Ito, Yasuki/M-4876-2014; Kaneko, Hiroki/O-7695-2015; Kataoka, Keiko/B-2806-2016	Kaneko, Hiroki/0000-0003-0731-6465; Ito, Yasuki/0000-0001-9219-9261; Kaneko, Hiroki/0000-0003-0731-6465; Kataoka, Keiko/0000-0002-8795-6536; Takayama, Kei/0000-0002-1477-9014	Grants-in-Aid for Scientific Research [26462635] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Andreoli MT, 2011, OPHTHALMOLOGY, V118, P156, DOI 10.1016/j.ophtha.2010.04.034; Chou C, 2016, INJURY; ESMAELI B, 1995, OPHTHALMOLOGY, V102, P393; Feng K, 2011, AM J OPHTHALMOL, V152, P654, DOI 10.1016/j.ajo.2011.04.004; Karimi A, 2016, INJURY; KATZ J, 1993, ARCH OPHTHALMOL-CHIC, V111, P1564, DOI 10.1001/archopht.1993.01090110130038; Kuhn F, 1996, GRAEF ARCH CLIN EXP, V234, P399, DOI 10.1007/BF00190717; Kuhn Ferenc, 2002, Ophthalmol Clin North Am, V15, P163, DOI 10.1016/S0896-1549(02)00007-X; Maberley DAL, 2006, EYE, V20, P341, DOI 10.1038/sj.eye.6701879; May DR, 2000, GRAEF ARCH CLIN EXP, V238, P153, DOI 10.1007/PL00007884; Petrovic MG, 2004, CROAT MED J, V45, P299; Pieramici DJ, 1997, AM J OPHTHALMOL, V123, P820, DOI 10.1016/S0002-9394(14)71132-8; Rozga S R-P, 2004, OPHTHALMOLOGY, V45, P304; Savar A, 2009, AM J OPHTHALMOL, V147, P595, DOI 10.1016/j.ajo.2008.10.017; SCOTT IU, 1994, ARCH OPHTHALMOL-CHIC, V112, P329, DOI 10.1001/archopht.1994.01090150059023; Shams-Vahdati S, 2015, INJURY, V46, P1238, DOI 10.1016/j.injury.2014.10.056; Sobaci G, 2000, AM J OPHTHALMOL, V129, P47, DOI 10.1016/S0002-9394(99)00254-8; Soni NG, 2013, RETINA-J RET VIT DIS, V33, P380, DOI 10.1097/IAE.0b013e318263cefb; Szijarto Z, 2008, GRAEF ARCH CLIN EXP, V246, P161, DOI 10.1007/s00417-007-0650-1; WILLIAMS DF, 1990, RETINA-J RET VIT DIS, V10, pS35, DOI 10.1097/00006982-199010001-00006; Wong TY, 2000, OPHTHALMOLOGY, V107, P2196, DOI 10.1016/S0161-6420(00)00390-0; Zhu LL, 2015, INJURY, V46, P1828, DOI 10.1016/j.injury.2015.04.024	22	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170094	10.1371/journal.pone.0170094	http://dx.doi.org/10.1371/journal.pone.0170094			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107485	gold, Green Published, Green Submitted			2022-12-26	WOS:000392405300073
J	Vonk, JJ; Yeshaw, WM; Pinto, F; Faber, AIE; Lahaye, LL; Kanon, B; van der Zwaag, M; Velayos-Baeza, A; Freire, R; van IJzendoorn, SC; Grzeschik, NA; Sibon, OCM				Vonk, Jan J.; Yeshaw, Wondwossen M.; Pinto, Francesco; Faber, Anita I. E.; Lahaye, Liza L.; Kanon, Bart; van der Zwaag, Marianne; Velayos-Baeza, Antonio; Freire, Raimundo; van IJzendoorn, Sven C.; Grzeschik, Nicola A.; Sibon, Ody C. M.			Drosophila Vps13 Is Required for Protein Homeostasis in the Brain	PLOS ONE			English	Article							GOLGI MATRIX PROTEIN; CHOREA-ACANTHOCYTOSIS; COHEN-SYNDROME; MOUSE MODEL; GENE; MEMBRANE; NEURODEGENERATION; LOCALIZATION; CELLS; PHAGOCYTOSIS	Chorea-Acanthocytosis is a rare, neurodegenerative disorder characterized by progressive loss of locomotor and cognitive function. It is caused by loss of function mutations in the Vacuolar Protein Sorting 13A (VPS13A) gene, which is conserved from yeast to human. The consequences of VPS13A dysfunction in the nervous system are still largely unspecified. In order to study the consequences of VPS13A protein dysfunction in the ageing central nervous system we characterized a Drosophila melanogaster Vps13 mutant line. The Drosophila Vps13 gene encoded a protein of similar size as human VPS13A. Our data suggest that Vps13 is a peripheral membrane protein located to endosomal membranes and enriched in the fly head. Vps13 mutant flies showed a shortened life span and age associated neurodegeneration. Vps13 mutant flies were sensitive to proteotoxic stress and accumulated ubiquitylated proteins. Levels of Ref(2) P, the Drosophila orthologue of p62, were increased and protein aggregates accumulated in the central nervous system. Overexpression of the human Vps13A protein in the mutant flies partly rescued apparent phenotypes. This suggests a functional conservation of human VPS13A and Drosophila Vps13. Our results demonstrate that Vps13 is essential to maintain protein homeostasis in the larval and adult Drosophila brain. Drosophila Vps13 mutants are suitable to investigate the function of Vps13 in the brain, to identify genetic enhancers and suppressors and to screen for potential therapeutic targets for Chorea-Acanthocytosis.	[Vonk, Jan J.; Yeshaw, Wondwossen M.; Pinto, Francesco; Faber, Anita I. E.; Lahaye, Liza L.; Kanon, Bart; van der Zwaag, Marianne; van IJzendoorn, Sven C.; Grzeschik, Nicola A.; Sibon, Ody C. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Groningen, Netherlands; [Velayos-Baeza, Antonio] Wellcome Trust Ctr Human Genet, Oxford, England; [Freire, Raimundo] Hosp Univ Canarias, Inst Tecnol Biomed, Unidad Invest, Ofra S-N, Tenerife, Spain	University of Groningen; University of Oxford; Wellcome Centre for Human Genetics; Universidad de la Laguna	Sibon, OCM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Groningen, Netherlands.	o.c.m.sibon@umcg.nl	Freire, Raimundo/Q-7660-2019; Velayos-Baeza, Antonio/K-6310-2019	Freire, Raimundo/0000-0003-4473-8894; Velayos-Baeza, Antonio/0000-0002-7717-4477; Yeshaw, Wondwossen/0000-0002-3134-3458; Sibon, Ody/0000-0002-6836-6063	E-RARE programme EMINA-1; E-RARE programme EMINA-2; NWO VICI grant [865.10.012]; Wellcome Trust [090532/Z/09/Z]; Advocacy for Neuroacanthocytosis Patients; NWO [175-010-2009-023]	E-RARE programme EMINA-1; E-RARE programme EMINA-2; NWO VICI grant(Netherlands Organization for Scientific Research (NWO)); Wellcome Trust(Wellcome TrustEuropean Commission); Advocacy for Neuroacanthocytosis Patients; NWO(Netherlands Organization for Scientific Research (NWO))	This work was supported by the E-RARE programmes EMINA-1 and EMINA-2 (OCMS, JJV, NAG), by a NWO VICI grant (865.10.012) (OCMS), by the Wellcome Trust (Core Award 090532/Z/09/Z) (AVB) and the Advocacy for Neuroacanthocytosis Patients (AVB). Part of the work was performed at the UMCG Microscopy and Imaging Center (UMIC), which is sponsored by NWO grant (175-010-2009-023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the E-RARE programmes EMINA-1 and EMINA-2 to OCMS, JJV, NAG, by a Wellcome Trust grant (090532/Z/09/Z) to AVB, Advocacy for Neuroacanthocytosis Patients to AVB and by a NWO VICI grant (865.10.012) to OCMS. Part of the work was performed at the UMCG Microscopy and Imaging Center (UMIC), which is sponsored by an NWO grant (175-010-2009-023). We thank prof. Fulvio Reggiori for critical reading of the manuscript.	Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Bate M., 1993, DEV DROSOPHILA MELAN, V2; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brickner JH, 1997, J CELL BIOL, V139, P23, DOI 10.1083/jcb.139.1.23; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Cumming RC, 2008, METHOD ENZYMOL, V451, P639, DOI 10.1016/S0076-6879(08)03235-7; Dobson-Stone C, 2004, ANN NEUROL, V56, P299, DOI 10.1002/ana.20200; Holstein JD, 2013, EXP CLIN ENDOCR DIAB, V121, P54, DOI 10.1055/s-0032-1321834; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Hyttinen JMT, 2013, BBA-MOL CELL RES, V1833, P503, DOI 10.1016/j.bbamcr.2012.11.018; Ito K, 2014, NEURON, V81, P755, DOI 10.1016/j.neuron.2013.12.017; Ivan V, 2008, MOL BIOL CELL, V19, P4352, DOI 10.1091/mbc.E08-03-0246; Kolehmainen J, 2003, AM J HUM GENET, V72, P1359, DOI 10.1086/375454; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Lang AB, 2015, J CELL BIOL, V210, P883, DOI 10.1083/jcb.201502105; Lesage S, 2016, AM J HUM GENET, V98, P500, DOI 10.1016/j.ajhg.2016.01.014; Lessing D, 2009, NAT REV GENET, V10, P359, DOI 10.1038/nrg2563; Munoz-Braceras S, 2015, AUTOPHAGY, V11, P918, DOI 10.1080/15548627.2015.1034413; Nakada TA, 2015, J INNATE IMMUN, V7, P545, DOI 10.1159/000381265; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Oczypok EA, 2013, AM J PATHOL, V182, P612, DOI 10.1016/j.ajpath.2012.12.017; Park JS, 2016, MOL BIOL CELL, V27, P2435, DOI 10.1091/mbc.E16-02-0112; Park JS, 2012, J CELL SCI, V125, P3004, DOI 10.1242/jcs.105114; Prohaska R, 2012, NEUROBIOL DIS, V46, P607, DOI 10.1016/j.nbd.2012.03.006; Rampoldi L, 2001, NAT GENET, V28, P119, DOI 10.1038/88821; Redding K, 1996, MOL CELL BIOL, V16, P6208; ROSENTHAL GA, 1986, P NATL ACAD SCI USA, V83, P14, DOI 10.1073/pnas.83.1.14; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Sakimoto H, 2016, BIOCHEM BIOPH RES CO, V472, P118, DOI 10.1016/j.bbrc.2016.02.077; Samaranayake HS, 2011, EUKARYOT CELL, V10, P1207, DOI 10.1128/EC.05089-11; Seifert W, 2015, J BIOL CHEM, V290, P3349, DOI 10.1074/jbc.M114.608174; Seifert W, 2011, J BIOL CHEM, V286, P37665, DOI 10.1074/jbc.M111.267971; Silvis MR, 2009, MOL BIOL CELL, V20, P2337, DOI 10.1091/mbc.E08-01-0084; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Tanaka T, 2008, DEVELOPMENT, V135, P1107, DOI 10.1242/dev.017293; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Tomemori Y, 2005, J NEUROCHEM, V92, P759, DOI 10.1111/j.1471-4159.2004.02924.x; Ueno S, 2001, NAT GENET, V28, P121, DOI 10.1038/88825; Velayos Baeza A., 1993, GENEREVIEWS; Velayos-Baeza A, 2004, GENOMICS, V84, P536, DOI 10.1016/j.ygeno.2004.04.012; Venkatachalam K, 2008, CELL, V135, P838, DOI 10.1016/j.cell.2008.09.041; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Windholz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022101; WYERS F, 1995, J VIROL, V69, P4463, DOI 10.1128/JVI.69.7.4463-4470.1995; Yang RY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153534	46	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170106	10.1371/journal.pone.0170106	http://dx.doi.org/10.1371/journal.pone.0170106			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107480	Green Submitted, Green Published, gold			2022-12-26	WOS:000392405300076
J	Yang, L; Dai, M; Xu, CH; Zhang, G; Li, WC; Fu, F; Shi, XT; Dong, XZ				Yang, Lin; Dai, Meng; Xu, Canhua; Zhang, Ge; Li, Weichen; Fu, Feng; Shi, Xuetao; Dong, Xiuzhen			The Frequency Spectral Properties of Electrode-Skin Contact Impedance on Human Head and Its Frequency-Dependent Effects on Frequency-Difference EIT in Stroke Detection from 10Hz to 1MHz	PLOS ONE			English	Article							TIME; TOMOGRAPHY; RECONSTRUCTION; HEMORRHAGE	Frequency-difference electrical impedance tomography (fdEIT) reconstructs frequencydependent changes of a complex impedance distribution. It has a potential application in acute stroke detection because there are significant differences in impedance spectra between stroke lesions and normal brain tissues. However, fdEIT suffers from the influences of electrode-skin contact impedance since contact impedance varies greatly with frequency. When using fdEIT to detect stroke, it is critical to know the degree of measurement errors or image artifacts caused by contact impedance. To our knowledge, no study has systematically investigated the frequency spectral properties of electrode-skin contact impedance on human head and its frequency-dependent effects on fdEIT used in stroke detection within a wide frequency band (10 Hz-1 MHz). In this study, we first measured and analyzed the frequency spectral properties of electrode-skin contact impedance on 47 human subjects' heads within 10 Hz-1 MHz. Then, we quantified the frequency-dependent effects of contact impedance on fdEIT in stroke detection in terms of the current distribution beneath the electrodes and the contact impedance imbalance between two measuring electrodes. The results showed that the contact impedance at high frequencies (> 100 kHz) significantly changed the current distribution beneath the electrode, leading to nonnegligible errors in boundary voltages and artifacts in reconstructed images. The contact impedance imbalance at low frequencies (< 1 kHz) also caused significant measurement errors. We conclude that the contact impedance has critical frequency-dependent influences on fdEIT and further studies on reducing such influences are necessary to improve the application of fdEIT in stroke detection.	[Yang, Lin; Dai, Meng; Xu, Canhua; Zhang, Ge; Li, Weichen; Fu, Feng; Shi, Xuetao; Dong, Xiuzhen] Fourth Mil Med Univ, Dept Biomed Engn, Xian, Peoples R China	Air Force Military Medical University	Dong, XZ (corresponding author), Fourth Mil Med Univ, Dept Biomed Engn, Xian, Peoples R China.	dongxiuzhen@fmmu.edu.cn		Yang, Lin/0000-0003-1641-2926	National Key Technology of China [2011BAI08B13, 2012BAI20B02]; Military Program of PLA [AWS14C006]; Scientific and Technological Project of Shaanxi Province of China [2016SF-266]	National Key Technology of China; Military Program of PLA; Scientific and Technological Project of Shaanxi Province of China	This work was supported in part by the National Key Technology of China under Grant 2011BAI08B13 and 2012BAI20B02, and Military Program of PLA under Grant AWS14C006 and the Scientific and Technological Project of Shaanxi Province of China under Grant 2016SF-266.	Bayford RH, 2006, ANNU REV BIOMED ENG, V8, P63, DOI 10.1146/annurev.bioeng.8.061505.095716; Boverman G, 2016, IEEE T BIOMED ENG; Boverman G, 2009, IEEE T BIO-MED ENG, V56, P2762, DOI 10.1109/TBME.2009.2027129; Boyle A, 2011, PHYSIOL MEAS, V32, DOI 10.1088/0967-3334/32/7/S02; Dai M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055020; DALZIEL CF, 1972, IEEE SPECTRUM, V9, P41, DOI 10.1109/MSPEC.1972.5218692; Dehghani H, 2005, PHYSIOL MEAS, V26, pS185, DOI 10.1088/0967-3334/26/2/018; Demidenko E, 2011, PHYSIOL MEAS, V32, DOI 10.1088/0967-3334/32/9/008; Demidenko E, 2011, IEEE T BIO-MED ENG, V58, DOI 10.1109/TBME.2011.2125790; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Fu F, 2014, PLOS ONE, V9; Grychtol B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103045; Halter RJ, 2007, PHYSIOL MEAS, V28, pS115, DOI 10.1088/0967-3334/28/7/S09; Horesh L, 2005, P 3 EUR MED BIOL ENG, P1251; Horesh L., 2006, SOME NOVEL APPROACHE; HUA P, 1993, IEEE T BIO-MED ENG, V40, P335, DOI 10.1109/10.222326; Jang J, 2015, PHYSIOL MEAS, V36, P1179, DOI 10.1088/0967-3334/36/6/1179; Jun SC, 2009, PHYSIOL MEAS, V30, P1087, DOI 10.1088/0967-3334/30/10/009; Malone E, 2014, PHYSIOL MEAS, V35, P1051, DOI 10.1088/0967-3334/35/6/1051; Malone E, 2014, IEEE T MED IMAGING, V33, P340, DOI 10.1109/TMI.2013.2284966; McAdams ET, 1996, MED BIOL ENG COMPUT, V34, P397, DOI 10.1007/BF02523842; McEwan A, 2007, PHYSIOL MEAS, V28, pS197, DOI 10.1088/0967-3334/28/7/S15; Packham B, 2012, PHYSIOL MEAS, V33, P767, DOI 10.1088/0967-3334/33/5/767; Prausnitz MR, 1993, P NATL ACAD SCI US; Romsauerova A, 2006, PHYSIOL MEAS, V27, pS211, DOI 10.1088/0967-3334/27/5/S18; ROSELL J, 1988, IEEE T BIO-MED ENG, V35, P649, DOI 10.1109/10.4599; Rost NS, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002433; Saver JL, 2013, JAMA-J AM MED ASSOC, V309, P2480, DOI 10.1001/jama.2013.6959; Spinelli EM, 2006, IEEE T BIO-MED ENG, V53, P1451, DOI 10.1109/TBME.2006.875714; Tang C, 2008, IEEE T BIO-MED ENG, V55, P2286, DOI 10.1109/TBME.2008.923919; Vilhunen T, 2002, MEAS SCI TECHNOL, V13, P1848, DOI 10.1088/0957-0233/13/12/307; Wei X-E, J NEUROLOGICAL SCI; Xu CH, 2010, J INT MED RES, V38, P1596, DOI 10.1177/147323001003800504; Xu CH, 2011, PHYSIOL MEAS, V32, P585, DOI 10.1088/0967-3334/32/5/007; Yang B, 2014, J INT MED RES, V42, P173, DOI 10.1177/0300060513499100; Yang L, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16111942	36	13	14	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170563	10.1371/journal.pone.0170563	http://dx.doi.org/10.1371/journal.pone.0170563			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107524	Green Published, gold, Green Submitted			2022-12-26	WOS:000392405300166
J	Prange, KHM; Mandoli, A; Kuznetsova, T; Wang, SY; Sotoca, AM; Marneth, AE; van der Reijden, BA; Stunnenberg, HG; Martens, JHA				Prange, K. H. M.; Mandoli, A.; Kuznetsova, T.; Wang, S-Y; Sotoca, A. M.; Marneth, A. E.; van der Reijden, B. A.; Stunnenberg, H. G.; Martens, J. H. A.			MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in 11q23 acute myeloid leukemia	ONCOGENE			English	Article							MLL FUSION PROTEINS; H3K79 METHYLATION; TRANSCRIPTION FACTORS; HOX GENES; INHIBITION; CHROMATIN; BET; EXPRESSION; COMPLEX; MEIS1	In 11q23 leukemias, the N-terminal part of the mixed lineage leukemia (MLL) gene is fused to 460 different partner genes. In order to define a core set of MLL rearranged targets, we investigated the genome-wide binding of the MLL-AF9 and MLL-AF4 fusion proteins and associated epigenetic signatures in acute myeloid leukemia (AML) cell lines THP-1 and MV4-11. We uncovered both common as well as specific MLL-AF9 and MLL-AF4 target genes, which were all marked by H3K79me2, H3K27ac and H3K4me3. Apart from promoter binding, we also identified MLL-AF9 and MLL-AF4 binding at specific subsets of non-overlapping active distal regulatory elements. Despite this differential enhancer binding, MLL-AF9 and MLL-AF4 still direct a common gene program, which represents part of the RUNX1 gene program and constitutes of CD34(+) and monocyte-specific genes. Comparing these data sets identified several zinc finger transcription factors (TFs) as potential MLL-AF9 co-regulators. Together, these results suggest that MLL fusions collaborate with specific subsets of TFs to deregulate the RUNX1 gene program in 11q23 AMLs. Oncogene (2017)	[Prange, K. H. M.; Mandoli, A.; Kuznetsova, T.; Wang, S-Y; Sotoca, A. M.; Stunnenberg, H. G.; Martens, J. H. A.] Radboud Univ Nijmegen, Fac Sci, Radboud Inst Mol Life Sci, Dept Mol Biol, Geert Grootepl 26, NL-6500 HB Nijmegen, Netherlands; [Marneth, A. E.; van der Reijden, B. A.] Radboud Univ Nijmegen, Dept Lab Med, Lab Hematol, Med Ctr, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Martens, JHA (corresponding author), Radboud Univ Nijmegen, Fac Sci, Radboud Inst Mol Life Sci, Dept Mol Biol, Geert Grootepl 26, NL-6500 HB Nijmegen, Netherlands.	j.martens@ncmls.ru.nl	Martens, Joost/D-4966-2012; Stunnenberg, Hendrik G./D-6875-2012; van der Reijden, Bert A/A-3543-2014; Marneth, Anna/G-6236-2016	Martens, Joost/0000-0003-2008-6537; Stunnenberg, Hendrik G./0000-0002-0066-1576; Kuznetsova, Tatyana/0000-0001-7533-3334; Prange, Koen/0000-0002-9835-1735; Marneth, Anna/0000-0001-9065-0581; Wang, Shuang-Yin/0000-0001-9683-4103	Dutch Cancer Foundation [KWF KUN 2009-4527, KUN 2011-4937]; Netherlands Organization for Scientific Research (NWO-VIDI)	Dutch Cancer Foundation(KWF Kankerbestrijding); Netherlands Organization for Scientific Research (NWO-VIDI)(Netherlands Organization for Scientific Research (NWO))	We thank A Singh, A Brinkman, G Georgiou, S van Heeringen and K Francoijs for bioinformatic support. This work was supported by the Dutch Cancer Foundation (KWF KUN 2009-4527 and KUN 2011-4937) and Netherlands Organization for Scientific Research (NWO-VIDI to JHAM).	Allen BL, 2015, NAT REV MOL CELL BIO, V16, P155, DOI 10.1038/nrm3951; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Benito JM, 2015, CELL REP, V13, P2715, DOI 10.1016/j.celrep.2015.12.003; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Biswas D, 2011, P NATL ACAD SCI USA, V108, P15751, DOI 10.1073/pnas.1111498108; Bond HM, 2008, INT J BIOCHEM CELL B, V40, P848, DOI 10.1016/j.biocel.2007.04.006; Bousquet M, 2013, MOL CANCER RES, V11, P912, DOI 10.1158/1541-7786.MCR-13-0002-T; Chaidos A, 2015, THER ADV HEMATOL, V6, P128, DOI 10.1177/2040620715576662; Daigle SR, 2013, BLOOD, V122, P1017, DOI 10.1182/blood-2013-04-497644; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; de Bruijn MFTR, 2004, ONCOGENE, V23, P4238, DOI 10.1038/sj.onc.1207763; Della Gatta G, 2012, NAT MED, V18, P436, DOI 10.1038/nm.2610; Erben P, 2010, HAEMATOL-HEMATOL J, V95, P738, DOI 10.3324/haematol.2009.016345; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fong CY, 2015, NATURE, V525, P538, DOI 10.1038/nature14888; Geng HM, 2012, CANCER DISCOV, V2, P1004, DOI 10.1158/2159-8290.CD-12-0208; GOLUB TR, 1995, P NATL ACAD SCI USA, V92, P4917, DOI 10.1073/pnas.92.11.4917; Guenther MG, 2008, GENE DEV, V22, P3403, DOI 10.1101/gad.1741408; Hoffman B, 2002, ONCOGENE, V21, P3414, DOI 10.1038/sj.onc.1205400; Huang G, 2011, BLOOD, V118, P6544, DOI 10.1182/blood-2010-11-317909; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kawagoe H, 1999, LEUKEMIA, V13, P687, DOI 10.1038/sj.leu.2401410; Krivtsov AV, 2008, CANCER CELL, V14, P355, DOI 10.1016/j.ccr.2008.10.001; Kumar AR, 2009, BLOOD, V113, P1756, DOI 10.1182/blood-2008-06-163287; Kuntimaddi A, 2015, CELL REP, V11, P808, DOI 10.1016/j.celrep.2015.04.004; LANGE B, 1987, BLOOD, V70, P192; Leach BI, 2013, STRUCTURE, V21, P176, DOI 10.1016/j.str.2012.11.011; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Mandoli A, 2014, GENOM DATA, V2, P170, DOI 10.1016/j.gdata.2014.06.014; Mandoli A, 2014, LEUKEMIA, V28, P770, DOI 10.1038/leu.2013.257; Marschalek R, 2011, BRIT J HAEMATOL, V152, P141, DOI 10.1111/j.1365-2141.2010.08459.x; Martens JHA, 2012, BLOOD, V120, P4038, DOI 10.1182/blood-2012-05-429050; Mazumdar C, 2015, CELL STEM CELL, V17, P1, DOI 10.1016/j.stem.2015.09.017; Merkenschlager M, 2013, CELL, V152, P1285, DOI 10.1016/j.cell.2013.02.029; Meyer C, 2013, LEUKEMIA, V27, P2165, DOI 10.1038/leu.2013.135; Meyer C, 2009, LEUKEMIA, V23, P1490, DOI 10.1038/leu.2009.33; Mohan M, 2010, GENE DEV, V24, P574, DOI 10.1101/gad.1898410; Mueller D, 2007, BLOOD, V110, P4445, DOI 10.1182/blood-2007-05-090514; Mullican SE, 2007, NAT MED, V13, P730, DOI 10.1038/nm1579; Niebuhr B, 2013, BLOOD, V122, P413, DOI 10.1182/blood-2013-01-480244; Okuda H, 2014, NUCLEIC ACIDS RES, V42, P4241, DOI 10.1093/nar/gkt1394; Pan RQ, 2014, CANCER DISCOV, V4, P362, DOI 10.1158/2159-8290.CD-13-0609; Patel B, 2014, LEUKEMIA, V28, P349, DOI 10.1038/leu.2013.158; Pelish HE, 2015, NATURE, V526, P273, DOI 10.1038/nature14904; Pession A, 2003, ONCOGENE, V22, P8671, DOI 10.1038/sj.onc.1207125; Phillips-Cremins JE, 2013, MOL CELL, V50, P461, DOI 10.1016/j.molcel.2013.04.018; Pospisil V, 2011, EMBO J, V30, P4450, DOI 10.1038/emboj.2011.317; Ptasinska A, 2012, LEUKEMIA, V26, P1829, DOI 10.1038/leu.2012.49; Quentmeier H, 2004, LEUKEMIA LYMPHOMA, V45, P567, DOI 10.1080/10428190310001609942; Rathert P, 2015, NATURE, V525, P543, DOI 10.1038/nature14898; Renneville A, 2008, LEUKEMIA, V22, P915, DOI 10.1038/leu.2008.19; Roe JS, 2015, MOL CELL, V58, P1028, DOI 10.1016/j.molcel.2015.04.011; Rousseau M, 2013, NUCLEIC ACIDS RES, V42; Rousseau M, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-4-r60; Sotoca AM, 2016, ONCOGENE, V35, P1965, DOI 10.1038/onc.2015.261; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; van Heeringen SJ, 2011, BIOINFORMATICS, V27, P270, DOI 10.1093/bioinformatics/btq636; Wang GG, 2005, BLOOD, V106, P254, DOI 10.1182/blood-2004-12-4664; Wilkinson AC, 2013, CELL REP, V3, P116, DOI 10.1016/j.celrep.2012.12.016; Wong P, 2007, GENE DEV, V21, P2762, DOI 10.1101/gad.1602107; Yokoyama A, 2010, CANCER CELL, V17, P198, DOI 10.1016/j.ccr.2009.12.040; Zhao XiuHai, 2014, Forest Ecosystems, V1, P8, DOI 10.1186/2197-5620-1-8	65	58	58	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 8	2017	36	23					3346	3356		10.1038/onc.2016.488	http://dx.doi.org/10.1038/onc.2016.488			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EW9WJ	28114278	Green Published, hybrid			2022-12-26	WOS:000402869800013
J	Draberova, E; Sulimenko, V; Vinopal, S; Sulimenko, T; Sladkova, V; D'Agostino, L; Sobol, M; Hozak, P; Kren, L; Katsetos, CD; Draber, P				Draberova, Eduarda; Sulimenko, Vadym; Vinopal, Stanislav; Sulimenko, Tetyana; Sladkova, Vladimira; D'Agostino, Luca; Sobol, Margaryta; Hozak, Pavel; Kren, Leos; Katsetos, Christos D.; Draber, Pavel			Differential expression of human gamma-tubulin isotypes during neuronal development and oxidative stress points to a gamma-tubulin-2 prosurvival function	FASEB JOURNAL			English	Article						microtubules; mitochondria; neuroblastoma differentiation; neurons	ALPHA-BETA-TUBULIN; MICROTUBULE NUCLEATION; PROTEIN; COMPLEXES; INTERACTS; COMPONENT; GENE; ORGANIZATION; CENTROSOME; MEMBRANES	gamma-Tubulins are highly conserved members of the tubulin superfamily essential for microtubule nucleation. Humans possess 2 gamma-tubulin genes. It is thought that gamma-tubulin-1 represents aubiquitous isotype, whereas gamma-tubulin-2 is found predominantly in the brain, where it may be endowed with divergent functions beyond microtubule nucleation. The molecular basis of the purported functional differences between gamma-tubulins is unknown. We report discrimination of human gamma-tubulins according to their electrophoretic and immunochemical properties. In vitro mutagenesis revealed that the differences in electrophoretic mobility originate in the C-terminal regions of the gamma-tubulins. Using epitope mapping, we discovered mouse monoclonal antibodies that can discriminate between human gamma-tubulin isotypes. Real time quantitative RT-PCR and 2-dimensional-PAGE showed that gamma-tubulin-1 is the dominant isotype in fetal neurons. Although gamma-tubulin-2 accumulates in the adult brain, gamma-tubulin-1 remains the major isotype in various brain regions. Localization of gamma-tubulin-1 in mature neurons was confirmed by immunohistochemistry and immunofluorescence microscopy on clinical samples and tissue microarrays. Differentiation of SH-SY5Y human neuroblastoma cells by all-trans retinoic acid, or oxidative stress induced by mitochondrial inhibitors, resulted in upregulation of gamma-tubulin-2, whereas the expression of gamma-tubulin-1 was unchanged. Fractionation experiments and immunoelectron microscopy revealed an association of gamma-tubulins with mitochondrial membranes. These data indicate that in the face of predominant nu-tubulin-1 expression, the accumulation of gamma-tubulin-2 in mature neurons and neuroblastoma cells during oxidative stress may denote a prosurvival role of gamma-tubulin-2 in neurons.-Draberova, E., Sulimenko, V., Vinopal, S., Sulimenko, T., Sladkova, V., D'Agostino, L., Sobol, M., Hozak, P., Kren, L., Katsetos, C. D., Draber, P. Differential expression of human gamma-tubulin isotypes during neuronal development and oxidative stress points to gamma-tubulin-2 prosurvival function.	[Draberova, Eduarda; Sulimenko, Vadym; Vinopal, Stanislav; Sulimenko, Tetyana; Sladkova, Vladimira; Draber, Pavel] Acad Sci Czech Republ, Dept Biol Cytoskeleton, Inst Mol Genet, Videnska 1083, Prague 14220 4, Czech Republic; [Sobol, Margaryta; Hozak, Pavel] Acad Sci Czech Republ, Dept Nucleus, Inst Mol Genet, Prague, Czech Republic; [D'Agostino, Luca; Katsetos, Christos D.] Drexel Univ, Coll Med, St Christophers Hosp Children, Dept Pediat, Philadelphia, PA 19104 USA; [D'Agostino, Luca; Kren, Leos; Katsetos, Christos D.] Drexel Univ, Coll Med, St Christophers Hosp Children, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Kren, Leos] Med Coll Penn & Hahnemann Univ, Philadelphia, PA 19104 USA; Univ Hosp Brno, Dept Pathol, Brno, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Drexel University; Drexel University; Drexel University; University Hospital Brno	Draber, P (corresponding author), Acad Sci Czech Republ, Dept Biol Cytoskeleton, Inst Mol Genet, Videnska 1083, Prague 14220 4, Czech Republic.	paveldra@img.cas.cz	Sladkova, Vladimira/G-7706-2019; Sulimenko, Vadym/G-3549-2014; Vinopal, Stanislav/GLR-3200-2022; Vinopal, Stanislav/ABG-4322-2021; Hozak, Pavel/AAB-5359-2021; Draber, Pavel/C-7735-2012	Vinopal, Stanislav/0000-0001-9352-4580; Hozak, Pavel/0000-0003-1901-1394; Draber, Pavel/0000-0001-9625-5013; Sulimenko, Vadym/0000-0003-2153-4485	Ministry of Education, Youth, and Sports of the Czech Republic [LH 12050, LM 2015062]; Ministry of Health of the Czech Republic [NT14467]; Grant Agency of the Czech Republic [302/12/1673, 15-22194S, 16-25159S]; Academy of Sciences of the Czech Republic [M200521203PIP]; Technological Grant Agency of the Czech Republic [TE01020118]; Institutional Research Support Program [RVO 68378050]	Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Technological Grant Agency of the Czech Republic; Institutional Research Support Program	The authors thank Dr. B. R. Oakley (University of Kansas, Lawrence, KS, USA) for the pH3-16 vector encoding human TUBG1; Dr. R.Y. Tsien (Howard Hughes Medical Institute, University of California, San Diego, La Jolla, CA, USA) for the pcDNA3.1-TagRFP vector, and Dr. Petr Draber (Department of Signal Transduction, Institute of Molecular Genetics, Academy of Sciences of the Czech Republic) for the Ab against GST; Dr. Eleni Mahera (Department of Pathology, General Hospital of Attica KAT, Athens, Greece) and Dr. Theodoros Maraziotis (Department of Neurosurgery, University of Patras Hospital, Rion, Greece) for providing sections from existing paraffin blocks of clinical specimens used in this study; and Ivana Mlchova, Ladislav Cupak, Ivana Novakova, and Zuzana Lubovska (all from the Institute of Molecular Genetics, Academy of Sciences of the Czech Republic) for excellent technical work. The microscopic data were produced at the Institute of Molecular Genetics Microscopy Centre. This work was supported, in part, by Grants LH 12050 (to P.D.) and LM 2015062 (CzechBioImaging Large Research Infrastructure Project) from the Ministry of Education, Youth, and Sports of the Czech Republic; Grant NT14467 from the Ministry of Health of the Czech Republic (to P.D.); Grants 302/12/1673, 15-22194S, and 16-25159S from the Grant Agency of the Czech Republic (all to P.D.); Grant M200521203PIP from the Academy of Sciences of the Czech Republic (to P.D.); Grant TE01020118 from the Technological Grant Agency of the Czech Republic (to P.H.); and Institutional Research Support Program RVO 68378050. The authors declare no conflicts of interest.	Borland MK, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-21; Cabezas R, 2012, NEUROSCI RES, V74, P80, DOI 10.1016/j.neures.2012.07.008; Carre M, 2002, J BIOL CHEM, V277, P33664, DOI 10.1074/jbc.M203834200; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Diaz-Corrales FJ, 2005, NEUROSCIENCE, V133, P117, DOI 10.1016/j.neuroscience.2005.01.044; DRABER P, 1988, HISTOCHEMISTRY, V89, P485, DOI 10.1007/BF00492606; DRABER P, 1991, ELECTROPHORESIS, V12, P453, DOI 10.1002/elps.1150120617; Draberova E, 1998, HISTOCHEM CELL BIOL, V109, P231; DRABEROVA E, 1993, J CELL SCI, V106, P1263; Draberova E, 1999, FOLIA BIOL-PRAGUE, V45, P163; Draberova E, 2015, J NEUROPATH EXP NEUR, V74, P723, DOI 10.1097/NEN.0000000000000212; Drykova D, 2003, PLANT CELL, V15, P465, DOI 10.1105/tpc.007005; Hajkova Z, 2011, J IMMUNOL, V186, P913, DOI 10.4049/jimmunol.1002074; Hehnly H, 2014, DEV CELL, V28, P497, DOI 10.1016/j.devcel.2014.01.014; Horejsi B, 2012, J CELL PHYSIOL, V227, P367, DOI 10.1002/jcp.22772; Inclan YF, 2001, J CELL SCI, V114, P413; Katsetos CD, 2006, J NEUROPATH EXP NEUR, V65, P465, DOI 10.1097/01.jnen.0000229235.20995.6e; Keck JM, 2011, SCIENCE, V332, P1557, DOI 10.1126/science.1205193; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; Kubo A., 2011, MOL BIOL CELL, V22, P3555; Kukharskyy V, 2004, EXP CELL RES, V298, P218, DOI 10.1016/j.yexcr.2004.04.016; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin TC, 2015, TRENDS CELL BIOL, V25, P296, DOI 10.1016/j.tcb.2014.12.002; LINHARTOVA I, 1992, BIOCHEM J, V288, P919, DOI 10.1042/bj2880919; Macurek L, 2008, BIOCHEM J, V416, P421, DOI 10.1042/BJ20080909; McNaught KSP, 2002, EUR J NEUROSCI, V16, P2136, DOI 10.1046/j.1460-9568.2002.02301.x; MEADS T, 1995, CELL MOTIL CYTOSKEL, V32, P273, DOI 10.1002/cm.970320404; Nishimura N., 2014, BIO PROTOC, V4, pe1299; Novakova M, 1996, CELL MOTIL CYTOSKEL, V33, P38, DOI 10.1002/(SICI)1097-0169(1996)33:1<38::AID-CM5>3.0.CO;2-E; Oakley BR, 2015, MOL BIOL CELL, V26, P2957, DOI 10.1091/mbc.E14-11-1514; OAKLEY BR, 1990, CELL, V61, P1289, DOI 10.1016/0092-8674(90)90693-9; Ohashi T, 2016, FEBS LETT, V590, P1053, DOI 10.1002/1873-3468.12163; Ori-McKenney KM, 2012, NEURON, V76, P921, DOI 10.1016/j.neuron.2012.10.008; Parker AL, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00153; Remy MH, 2013, PROG MOL BIOL TRANSL, V117, P511, DOI 10.1016/B978-0-12-386931-9.00019-2; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; Samantaray S, 2007, NEUROSCIENCE, V146, P741, DOI 10.1016/j.neuroscience.2007.01.056; Schneider L, 2011, FREE RADICAL BIO MED, V51, P2007, DOI 10.1016/j.freeradbiomed.2011.08.030; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; Sobol MA, 2012, HISTOCHEM CELL BIOL, V138, P167, DOI 10.1007/s00418-012-0931-6; Starita LM, 2004, MOL CELL BIOL, V24, P8457, DOI 10.1128/MCB.24.19.8457-8466.2004; STEARNS T, 1991, CELL, V65, P825, DOI 10.1016/0092-8674(91)90390-K; Sulimenko V, 2002, BIOCHEM J, V365, P889, DOI 10.1042/BJ20020175; Sun Anyang, 2009, Int J Physiol Pathophysiol Pharmacol, V2, P29; Teixido-Travesa N, 2012, J CELL SCI, V125, P4445, DOI 10.1242/jcs.106971; Tsui-Pierchala BA, 2002, TRENDS NEUROSCI, V25, P412, DOI 10.1016/S0166-2236(02)02215-4; Tsutsumi K., 2010, MOL BIOL CELL, V21, P4299; Vinopal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029919; Vogel J, 2001, DEV CELL, V1, P621, DOI 10.1016/S1534-5807(01)00073-9; Wise DO, 2000, GENOMICS, V67, P164, DOI 10.1006/geno.2000.6247; Yonezawa S, 2015, ACTA HISTOCHEM CYTOC, V48, P145, DOI 10.1267/ahc.15023; Yuba-Kubo A, 2005, DEV BIOL, V282, P361, DOI 10.1016/j.ydbio.2005.03.031; ZHENG YX, 1991, CELL, V65, P817, DOI 10.1016/0092-8674(91)90389-G	55	20	20	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1828	1846		10.1096/fj.201600846RR	http://dx.doi.org/10.1096/fj.201600846RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28119396				2022-12-26	WOS:000399195500007
J	Borsuk, G; Ptaszynska, AA; Olszewski, K; Domaciuk, M; Krutmuang, P; Paleolog, J				Borsuk, Grzegorz; Ptaszynska, Aneta A.; Olszewski, Krzysztof; Domaciuk, Marcin; Krutmuang, Patcharin; Paleolog, Jerzy			A New Method for Quick and Easy Hemolymph Collection from Apidae Adults	PLOS ONE			English	Article							APIS-MELLIFERA; HONEYBEE HEMOLYMPH; BEES	Bio-analysis of insects is increasingly dependent on highly sensitive methods that require high quality biological material, such as hemolymph. However, it is difficult to collect fresh and uncontaminated hemolymph from adult bees since they are very active and have the potential to sting, and because hemolymph is rapidly melanized. Here we aimed to develop and test a quick and easy method for sterile and contamination-free hemolymph sampling from adult Apidae. Our novel antennae method for hemolymph sampling (AMHS), entailed the detachment of an antenna, followed by application of delicate pressure to the bee's abdomen. This resulted in the appearance of a drop of hemolymph at the base of the detached antenna, which was then aspirated using an automatic pipetter. Larger insect size corresponded to easier and faster hemolymph sampling, and to a greater sample volume. We obtained 80-100 mu L of sterile non-melanized hemolymph in 1 minute from one Bombus terrestris worker, in 6 minutes from 10 Apis mellifera workers, and in 15 minutes from 18 Apis cerana workers (+/-0.5 minutes). Compared to the most popular method of hemolymph collection, in which hemolymph is sampled by puncturing the dorsal sinus of the thorax with a capillary (TCHS), significantly fewer bees were required to collect 80-100 mu L hemolymph using our novel AMHS method. Moreover, the time required for hemolymph collection was significantly shorter using the AMHS compared to the TCHS, which protects the acquired hemolymph against melanization, thus providing the highest quality material for biological analysis.	[Borsuk, Grzegorz; Olszewski, Krzysztof] Univ Life Sci, Dept Biol Basis Anim Prod, Fac Biol Anim Sci & Bioecon, Lublin, Poland; [Ptaszynska, Aneta A.] Maria Curie Skfodowska Univ, Inst Biol & Biochem, Fac Biol & Biotechnol, Dept Bot & Mycol, Lublin, Poland; [Domaciuk, Marcin] Maria Curie Skfodowska Univ, Inst Biol & Biochem, Fac Biol & Biotechnol, Dept Plant Anat & Cytol, Lublin, Poland; [Krutmuang, Patcharin] Chang Mai Univ, Dept Entomol & Plant Pathol, Fac Agr, Chiang Mai, Thailand; [Paleolog, Jerzy] Univ Life Sci Lublin, Dept Zool Anim Ecol Wildlife Management, Fac Biol Anim Sci & Bioecon, Lublin, Poland	University of Life Sciences in Lublin	Borsuk, G (corresponding author), Univ Life Sci, Dept Biol Basis Anim Prod, Fac Biol Anim Sci & Bioecon, Lublin, Poland.	grzegorz.borsuk@up.lublin.pl	Krutmuang, Patcharin/AAN-9038-2021; Paleolog, Jerzy/U-5290-2018; Borsuk, Grzegorz/AAD-3268-2021; Ptaszynska, Aneta/AAG-7172-2021; Olszewski, Krzysztof/U-5281-2018	Krutmuang, Patcharin/0000-0003-3521-7659; Paleolog, Jerzy/0000-0002-4447-4318; Borsuk, Grzegorz/0000-0002-8407-3383; Ptaszynska, Aneta/0000-0001-6413-6028; Olszewski, Krzysztof/0000-0002-4968-4621	Ministry of Science and Higher Education [DS-2]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by the Ministry of Science and Higher Education under DS-2.	Antunez K, 2009, ENVIRON MICROBIOL, V11, P2284, DOI 10.1111/j.1462-2920.2009.01953.x; Borsuk G, 2011, J APIC SCI, V55, P53; Chan QWT, 2006, MOL CELL PROTEOMICS, V5, P2252, DOI 10.1074/mcp.M600197-MCP200; Dade HA, 2009, ANATOMY DISSECTION H, P70; Franco NH, 2014, LAB ANIM-UK, V48, P50, DOI 10.1177/0023677213498717; Garido MP, 2013, J APICULT RES, V52, P67; Kobmoo N., 2012, RES GATE, V8, P19; KOSTECKI R., 1965, J APICULT RES, V4, P49; Laughton AM, 2011, APIDOLOGIE, V42, P140, DOI 10.1051/apido/2010046; Mayack C, 2010, J INSECT PHYSIOL, V56, P1572, DOI 10.1016/j.jinsphys.2010.05.016; Mikulecky M, 1997, BRAZ J MED BIOL RES, V30, P275, DOI 10.1590/S0100-879X1997000200018; Ptaszynska AA, 2016, MED WETER, V72, P430, DOI 10.21521/mw.5534; Ptaszynska AA, 2016, PARASITOL RES, V115, P397, DOI 10.1007/s00436-015-4761-z; [Страческа А. Strachecka A.], 2014, [Биохимия, BIOCHEMISTRY (MOSCOW), Biokhimiya], V79, P1464; Strachecka A, 2014, ARCH INSECT BIOCHEM, V86, P165, DOI 10.1002/arch.21159; Szymas B, 2003, APIDOLOGIE, V34, P97, DOI 10.1051/apido:2003012	16	21	22	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170487	10.1371/journal.pone.0170487	http://dx.doi.org/10.1371/journal.pone.0170487			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125668	Green Published, gold, Green Submitted			2022-12-26	WOS:000396176100103
J	Chebaro, Y; Sirigu, S; Amal, I; Lutzing, R; Stote, RH; Rochette-Egly, C; Rochel, N; Dejaegere, A				Chebaro, Yassmine; Sirigu, Serena; Amal, Ismail; Lutzing, Regis; Stote, Roland H.; Rochette-Egly, Cecile; Rochel, Natacha; Dejaegere, Annick			Allosteric Regulation in the Ligand Binding Domain of Retinoic Acid Receptor gamma	PLOS ONE			English	Article							NUCLEAR RECEPTORS; MOLECULAR-DYNAMICS; STEM-CELLS; RAR-ALPHA; NEURONAL DIFFERENTIATION; HETERODIMERIC COMPLEX; SIGNALING PATHWAYS; CRYSTAL-STRUCTURE; PHOSPHORYLATION; PROTEINS	Retinoic acid (RA) plays key roles in cell differentiation and growth arrest through nuclear retinoic acid receptors (RARs), which are ligand-dependent transcription factors. While the main trigger of RAR activation is the binding of RA, phosphorylation of the receptors has also emerged as an important regulatory signal. Phosphorylation of the RAR. N-terminal domain (NTD) is known to play a functional role in neuronal differentiation. In this work, we investigated the phosphorylation of RAR. ligand binding domain (LBD), and present evidence that the phosphorylation status of the LBD affects the phosphorylation of the NTD region. We solved the X-ray structure of a phospho-mimetic mutant of the LBD (RAR. S371E), which we used in molecular dynamics simulations to characterize the consequences of the S371E mutation on the RAR. structural dynamics. Combined with simulations of the wild-type LBD, we show that the conformational equilibria of LBD salt bridges (notably R387-D340) are affected by the S371E mutation, which likely affects the recruitment of the kinase complex that phosphorylates the NTD. The molecular dynamics simulations also showed that a conservative mutation in this salt bridge (R387K) affects the dynamics of the LBD without inducing large conformational changes. Finally, cellular assays showed that the phosphorylation of the NTD of RAR. is differentially regulated by retinoic acid in RAR.WT and in the S371N, S371E and R387K mutants. This multidisciplinary work highlights an allosteric coupling between phosphorylations of the LBD and the NTD of RAR. and supports the importance of structural dynamics involving electrostatic interactions in the regulation of RARs activity.	[Chebaro, Yassmine; Sirigu, Serena; Amal, Ismail; Stote, Roland H.; Rochel, Natacha; Dejaegere, Annick] Univ Strasbourg, CNRS, Dept Integrat Struct Biol, IGBMC,INSERM,U964,UMR 7104, Illkirch Graffenstaden, France; [Lutzing, Regis; Rochette-Egly, Cecile] Univ Strasbourg, CNRS, Dept Funct Genom & Canc, IGBMC,INSERM,U964,UMR 7104, Illkirch Graffenstaden, France; [Sirigu, Serena] Synchrotron SOLEIL, LOrme Merisiers, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; SOLEIL Synchrotron	Dejaegere, A (corresponding author), Univ Strasbourg, CNRS, Dept Integrat Struct Biol, IGBMC,INSERM,U964,UMR 7104, Illkirch Graffenstaden, France.	annick@igbmc.fr	Chebaro, Yassmine/M-2174-2019; Rochel, Natacha/A-5718-2016	Chebaro, Yassmine/0000-0002-5970-2117; Rochel, Natacha/0000-0002-3573-5889; Regis, Lutzing/0000-0002-9927-1825	Centre National de Recherche Scientifique (CNRS), Institut National de la Sante et de la Recherche Medicale (INSERM), Universite de Strasbourg, Agence Nationale pour la Recherche [ANR-09-BLAN-0127-01]; Institut National du Cancer [INCa-PL09-194]; Instruct, part of the European Strategy Forum on Research Infrastructures (ESFRI); French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; French State fund [ANR-10-IDEX-0002-02]; project EQUIP@MESO;  [ANR-10-MABX-0030-INRT]	Centre National de Recherche Scientifique (CNRS), Institut National de la Sante et de la Recherche Medicale (INSERM), Universite de Strasbourg, Agence Nationale pour la Recherche(French National Research Agency (ANR)); Institut National du Cancer(Institut National du Cancer (INCA) France); Instruct, part of the European Strategy Forum on Research Infrastructures (ESFRI); French Infrastructure for Integrated Structural Biology (FRISBI); French State fund; project EQUIP@MESO; 	This work was supported by funds from the Centre National de Recherche Scientifique (CNRS), Institut National de la Sante et de la Recherche Medicale (INSERM), Universite de Strasbourg, Agence Nationale pour la Recherche (ANR-09-BLAN-0127-01) and the Institut National du Cancer (INCa-PL09-194), Instruct, part of the European Strategy Forum on Research Infrastructures (ESFRI) and supported by national member subscriptions, the French Infrastructure for Integrated Structural Biology (FRISBI) (Grant ANR-10-INSB-05-01). This study was also supported by the grant ANR-10-MABX-0030-INRT, a French State fund managed by the Agence Nationale de la Recherche under the frame program Investissements d'Avenir ANR-10-IDEX-0002-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Yoshiteru Sato and the beam-line staff at the ESRF (Grenoble, France) for help during data collection. Computing resources were provided by the Institut du Developpement et des Ressources en Informatique Scientifique (IDRIS), the Centre Informatique National de l'Enseignement Superieur (CINES) and the Meso-centre de Calcul de l'Universite de Strasbourg supported by the project EQUIP@MESO.	Al Tanoury Z, 2014, J CELL SCI, V127, P2095, DOI 10.1242/jcs.145979; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Bastien J, 2000, J BIOL CHEM, V275, P21896, DOI 10.1074/jbc.M001985200; Billas I, 2013, J MOL BIOL, V425, P2317, DOI 10.1016/j.jmb.2013.03.017; Bour G, 2005, P NATL ACAD SCI USA, V102, P16608, DOI 10.1073/pnas.0505556102; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; Brelivet Y, 2004, EMBO REP, V5, P423, DOI 10.1038/sj.embor.7400119; Brelivet Y, 2012, MOL CELL ENDOCRINOL, V348, P466, DOI 10.1016/j.mce.2011.08.015; Brooks BR, 2009, J COMPUT CHEM, V26, P1781; Bruck N, 2009, EMBO J, V28, P34, DOI 10.1038/emboj.2008.256; BRUNGER AT, 1988, PROTEINS, V4, P148, DOI 10.1002/prot.340040208; Burendahl S, 2012, PROTEINS, V80, P294, DOI 10.1002/prot.23209; Chebaro Y, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003012; Choi JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7968; CHOTHIA C, 1981, J MOL BIOL, V145, P215, DOI 10.1016/0022-2836(81)90341-7; Cunningham TJ, 2015, NAT REV MOL CELL BIO, V16, P110, DOI 10.1038/nrm3932; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Das BC, 2014, BIOORGAN MED CHEM, V22, P673, DOI 10.1016/j.bmc.2013.11.025; De Simone A, 2015, ELIFE, V4, DOI 10.7554/eLife.02777; Delacroix L, 2010, MOL CELL BIOL, V30, P231, DOI 10.1128/MCB.00756-09; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gaillard E, 2006, P NATL ACAD SCI USA, V103, P9548, DOI 10.1073/pnas.0509717103; Germain P, 2002, NATURE, V415, P187, DOI 10.1038/415187a; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Glass CK, 2000, GENE DEV, V14, P121; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Grosdidier S, 2012, MOL ENDOCRINOL, V26, P1078, DOI 10.1210/me.2011-1281; Hua SJ, 2009, CELL, V137, P1259, DOI 10.1016/j.cell.2009.04.043; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Janesick A, 2015, CELL MOL LIFE SCI, V72, P1559, DOI 10.1007/s00018-014-1815-9; Klaholz BP, 2000, ACTA CRYSTALLOGR D, V56, P933, DOI 10.1107/S090744490000634X; Klaholz BP, 1998, NAT STRUCT BIOL, V5, P199, DOI 10.1038/nsb0398-199; Lalevee S, 2010, FASEB J, V24, P4523, DOI 10.1096/fj.10-160572; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laudet V, 2002, THE NUCLEAR RECEPTOR; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mackinnon JAG, 2014, MOL CELL ENDOCRINOL, V393, P75, DOI 10.1016/j.mce.2014.05.017; Masunov A, 2003, J AM CHEM SOC, V125, P1722, DOI 10.1021/ja025521w; Mendoza-Parra MA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.73; Michielssens S, 2014, ANGEW CHEM INT EDIT, V53, P10367, DOI 10.1002/anie.201403102; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagy L, 1999, GENE DEV, V13, P3209, DOI 10.1101/gad.13.24.3209; Navaza J., 1994, ACTA CRYST; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pogenberg V, 2004, ACTA CRYSTALLOGR D, V60, P1170, DOI 10.1107/S0907444904009928; Rassam P, 2015, NATURE, V523, P333, DOI 10.1038/nature14461; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Rochette-Egly C, 2003, CELL SIGNAL, V15, P355, DOI 10.1016/S0898-6568(02)00115-8; Rochette-Egly C, 2015, BBA-MOL CELL BIOL L, V1851, P66, DOI 10.1016/j.bbalip.2014.04.003; Rochette-Egly Cecile, 2009, Nucl Recept Signal, V7, pe005, DOI 10.1621/nrs.07005; RochetteEgly C, 1997, CELL, V90, P97, DOI 10.1016/S0092-8674(00)80317-7; Rostkowski M, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-6; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Samarut E, 2012, MOL CELL ENDOCRINOL, V348, P348, DOI 10.1016/j.mce.2011.03.025; Samarut E, 2011, MOL BIOL EVOL, V28, P2125, DOI 10.1093/molbev/msr035; Sato Y, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012674, 10.1371/journal.pone.0015119, 10.1371/journal.pone.0013109]; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Su D, 2008, BIOCHEM PHARMACOL, V75, P1129, DOI 10.1016/j.bcp.2007.11.006; Tzeng SR, 2013, NAT CHEM BIOL, V9, P462, DOI [10.1038/NCHEMBIO.1250, 10.1038/nchembio.1250]; van Wijk SJL, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002754; WIGLEY DB, 1987, BIOCHEM BIOPH RES CO, V149, P927, DOI 10.1016/0006-291X(87)90497-9; Zhu Y, 2014, INTERNATIONAL CONFERENCE ON ENERGY AND POWER ENGINEERING (EPE 2014), P1	65	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0171043	10.1371/journal.pone.0171043	http://dx.doi.org/10.1371/journal.pone.0171043			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125680	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100009
J	Qin, MB; Zhang, JX; Xu, CY; Peng, P; Tan, L; Liu, SQ; Huang, JA				Qin, Mengbin; Zhang, Jinxiu; Xu, Chunyan; Peng, Peng; Tan, Lin; Liu, Shiquan; Huang, Jiean			Knockdown of NIK and IKK beta-Binding Protein (NIBP) Reduces Colorectal Cancer Metastasis through Down-Regulation of the Canonical NF-kB Signaling Pathway and Suppression of MAPK Signaling Mediated through ERK and JNK	PLOS ONE			English	Article							KAPPA-B PATHWAY; CELLS; ACTIVATION; ASTROCYTES; CASCADES	Background Despite the identification of many signaling pathways involved in colorectal cancer (CRC) tumorigenesis, metastatic CRC still remains one of the major causes of cancer related death. NIK and IKK beta-binding protein (NIBP) is one of the key regulators of the NF-B signaling pathway, which has been implicated in CRC metastasis. The aim of this study was to investigate the possible role of NIBP in CRC metastasis through its regulation of NF-kB and extracellular regulated kinase/c-Janus kinase (ERK/JNK) signaling pathways. Methods In this study NIBP, phosphorylated (p)-p65, p-ERK1/2, and p-JNK1/2 expression was examined in 130 CRC, and 25 adenoma tissue samples were studied by immunohistochemistry. NIBP shRNA knockdown was performed in HCT116 cells, and NF-kB and ERK/JNK pathway activity was measured after TNF-alpha stimulation in vitro and in vivo. Results We found that NIBP, p-p65, p-ERK1/2, and p-JNK1/2 expression was higher in late stages of CRC compared to early stages or adenomas. Expression of p-p65, p-IkB alpha, p-IkB beta, pERK1/ 2, and p-JNK1/2 was inhibited in TNF-alpha stimulated HCT116 cells following NIBP knockdown. Nevertheless, p-ERK1/2 expression in un-transfected and NIBP knockdown HCT116 cells remained the same in the absence of TNF-alpha stimulation. Furthermore, cell motility and invasion were reduced in HCT116 cells following NIBP knockdown even after TNF-a treatment. Finally, primary tumor weight and liver metastasis were reduced in nude mice with orthotopically transplanted NIBP knockdown of HCT116 cells. Conclusion In conclusion, we demonstrated that NIBP knockdown reduces colorectal cancer metastasis through down-regulation of canonical NF-kB signaling and suppression of ERK and JNK signaling.	[Qin, Mengbin; Zhang, Jinxiu; Xu, Chunyan; Peng, Peng; Tan, Lin; Liu, Shiquan; Huang, Jiean] Guangxi Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanning, Peoples R China	Guangxi Medical University	Huang, JA (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanning, Peoples R China.	hjagxmu@163.com			National Natural Science Foundation of China [81260365]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81260365).	Blits B, 2005, RESTOR NEUROL NEUROS, V23, P313; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Dvoriantchikova G, 2014, EUR J NEUROSCI, V40, P3171, DOI 10.1111/ejn.12710; FRIEDRICHS K, 1993, CANCER, V72, P3641, DOI 10.1002/1097-0142(19931215)72:12<3641::AID-CNCR2820721215>3.0.CO;2-8; Jeong JB, 2013, ARCH BIOCHEM BIOPHYS, V537, P168, DOI 10.1016/j.abb.2013.07.016; Kim EK, 2015, ARCH TOXICOL, V89, P867, DOI 10.1007/s00204-015-1472-2; Kim JC, 2008, WORLD J GASTROENTERO, V14, P6662, DOI 10.3748/wjg.14.6662; Kraus S, 2014, CANCER LETT, V347, P15, DOI 10.1016/j.canlet.2014.01.025; Lewis DA, 2008, J INVEST DERMATOL, V128, P1022, DOI 10.1038/sj.jid.5701127; Liu SY, 2012, SCI WORLD J, DOI 10.1100/2012/614263; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Ongchin M, 2009, J SURG RES, V156, P250, DOI 10.1016/j.jss.2009.02.002; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Qin MB, 2016, TUMOR BIOL, V37, P5979, DOI 10.1007/s13277-015-4433-8; Rajput A, 2008, J SURG RES, V147, P276, DOI 10.1016/j.jss.2007.04.021; Saha RN, 2007, J IMMUNOL, V179, P7101, DOI 10.4049/jimmunol.179.10.7101; Shao HJ, 2015, BIOMOL THER, V23, P39, DOI 10.4062/biomolther.2014.088; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Yang Z, 2009, CURR CANCER DRUG TAR, V9, P915, DOI 10.2174/156800909790192383; Zahoor MA, 2010, J GEN VIROL, V91, P1939, DOI 10.1099/vir.0.020990-0; Zhang YL, 2015, ONCOTARGET, V6, P30439, DOI 10.18632/oncotarget.5900; Zong M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029995	24	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170595	10.1371/journal.pone.0170595	http://dx.doi.org/10.1371/journal.pone.0170595			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125661	Green Submitted, Green Published, gold			2022-12-26	WOS:000396176100090
J	Yao, G; Zhang, YF; Wang, D; Yang, RR; Sang, H; Han, LL; Zhu, YX; Lu, YY; Tan, YK; Shang, ZP				Yao, Guo; Zhang, Yafang; Wang, Di; Yang, Ruirui; Sang, Hui; Han, Linlin; Zhu, Yuexia; Lu, Yanyan; Tan, Yeke; Shang, Zhanping			GDM-Induced Macrosomia Is Reversed by Cav-1 via AMPK-Mediated Fatty Acid Transport and GLUT1-Mediated Glucose Transport in Placenta	PLOS ONE			English	Article							GESTATIONAL DIABETES-MELLITUS; RANDOMIZED-CONTROLLED-TRIAL; CHINESE WOMEN; NUTRIENT TRANSPORT; FETAL MACROSOMIA; MATERNAL OBESITY; GENE-EXPRESSION; BIRTH-WEIGHT; PREDICTORS; CAVEOLIN-1	Objective To investigate if the role of Cav-1 in GDM-induced macrosomia is through regulating AMPK signaling pathway in placenta. Methods We used diagnostic criteria of gestational diabetes mellitus (GDM) and macrosomia to separate and compare placental protein and mRNA levels from GDM with macrosomia group (GDMM), GDM with normal birth weight group (GDMN) and normal glucose tolerance (NGT) with normal birth weight group (CON). Western blotting was performed to examine differentially expressed proteins of caveolin-1 (Cav-1) and Adenosine monophosphate-activated protein kinase (AMPK) signaling pathway related proteins, including phosphorylated-AMPK alpha(Thr172), AMPK alpha, phosphorylated-Acetyl-CoA carboxylase(Ser79) (p-ACC (Ser79)), ACC and glucose transporter 1 (GLUT1) in placenta between the three groups. The mRNA levels of Cav-1, AMPKa, ACC and GLUT1 in placenta were measured by real time-PCR. Results In the GDMM placenta group, both protein and mRNA levels of Cav-1 were down-regulated, while GLUT1 was up-regulated; the phosphorylation and mRNA levels of ACC and AMPKa were decreased, but total ACC protein levels were increased compared to both the GDMN (p<0.05) and CON groups (p<0.05). In GDMM placenta group, there was a significant negative correlation observed between neonatal birth weight (NBW) and protein expression levels of Cav-1, p-ACC(Ser79) and p-AMPK alpha(Thr172) (p<0.05), while positive relationship with ACC and GLUT1 protein levels. Besides, in GDMM group placental mRNA levels, NBW had a positive correlation with GLUT1 (p<0.05), while negative with Cav-1, AMPK alpha and ACC expression (p<0.05). Cav-1 protein expression was positively associated with p-AMPK and p-ACC (p<0.05), and negatively associated with GLUT1 (p<0.05). Interestingly, p-AMPK protein expression was closely related to p-ACC (p<0.05), but not with GLUT1. Conclusion GDM-induced macrosomias have more severe inhibition of Cav-1 expression in placenta. Cav-1 is associated with placental glucose and fatty acid transport via the induction of AMPK signaling pathway and the reduction of GLUT1 signaling pathway to reverse GDM-induced macrosomia.	[Yao, Guo] Shandong Univ, Dept Pediat, Qilu Hosp, Jinan, Peoples R China; [Yao, Guo; Zhang, Yafang] Taian City Cent Hosp, Dept Pediat, Tai An, Shandong, Peoples R China; [Zhang, Yafang; Yang, Ruirui; Sang, Hui; Han, Linlin; Zhu, Yuexia; Shang, Zhanping] Taishan Med Univ, Dept Pathophysiol, Tai An, Shandong, Peoples R China; [Wang, Di; Lu, Yanyan; Tan, Yeke] Taian City Cent Hosp, Tai An, Shandong, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences	Shang, ZP (corresponding author), Taishan Med Univ, Dept Pathophysiol, Tai An, Shandong, Peoples R China.	Zhpshang@126.com			National Natural Science Foundation of China [81570410]; Shandong Education Department [03k10]; Ministry of Education of the People's Republic of China [201510439120]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Education Department; Ministry of Education of the People's Republic of China(Ministry of Education, China)	This work was funded by the National Natural Science Foundation of China (81570410), the project of Shandong Education Department (03k10), and the Ministry of Education of the People's Republic of China (201510439120).	Baumann MU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106037; Brett KE, 2016, J MATERN-FETAL NEO M, V29, P1399, DOI 10.3109/14767058.2015.1049522; Brett KE, 2014, INT J MOL SCI, V15, P16153, DOI 10.3390/ijms150916153; Briley AL, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-74; Codenotti S, 2016, EUR J CELL BIOL, V95, P252, DOI 10.1016/j.ejcb.2016.04.005; Fernandez-Real JM, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-20; Gaccioli F, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109702; Hernandez TL, 2014, DIABETES CARE, V37, P1254, DOI 10.2337/dc13-2411; Holme AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117084; Huo Y, 2015, BRAZ J MED BIOL RES, V48, P273, DOI 10.1590/1414-431X20143432; Jarmuzek P, 2015, NEUROENDOCRINOL LETT, V36, P101; Javadian Pouya, 2014, Acta Med Iran, V52, P385; Karantanos T, 2016, ONCOTARGET; Kim HS, 2009, EUR J APPL PHYSIOL, V106, P173, DOI 10.1007/s00421-009-1001-1; King RG, 2003, J PERINAT MED, V31, P475, DOI 10.1515/JPM.2003.073; Larque E, 2014, ANN NUTR METAB, V64, P247, DOI 10.1159/000365028; Lee H, 2011, INT J MOL MED, V28, P65, DOI 10.3892/ijmm.2011.674; Lennon JC, 2016, INVEST NEW DRUG, V34, P663, DOI 10.1007/s10637-016-0366-3; Li J., 2015, OPEN FUEL ENERGY SCI, V8, P52, DOI [10.2174/1876973X01508010052, DOI 10.2174/1876973X01508010052]; Madiraju AK, 2016, P NATL ACAD SCI USA, V113, pE3423, DOI 10.1073/pnas.1606022113; Mai CY, 2015, INT J CLIN EXP MED, V8, P21694; Martino J, 2016, J CLIN ENDOCR METAB, V101, P58, DOI 10.1210/jc.2015-2590; Mirzamoradi Masoomeh, 2015, Acta Med Iran, V53, P97; Muir R, 2016, CLIN SCI, V130, P183, DOI 10.1042/CS20150539; Nobles C, 2015, OBSTET GYNECOL, V125, P1195, DOI 10.1097/AOG.0000000000000738; Oh YS, 2007, EXP MOL MED, V39, P395, DOI 10.1038/emm.2007.44; Palacios-Ortega S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095100; Park S, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0455-5; Peng X., 2014, IEEE GEOSCI REMOTE S, V11, P1, DOI DOI 10.1371/J0URNAL.P0NE.0113716; Penumathsa SV, 2008, J CELL MOL MED, V12, P2350, DOI 10.1111/j.1582-4934.2008.00251.x; Salis O, 2014, EUR REV MED PHARMACO, V18, P1602; Sciullo E, 1997, Early Pregnancy, V3, P172; Su RN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148399; Sun DM, 2014, INT J CLIN EXP MED, V7, P5784; Wahlberg J, 2016, DIABETES RES CLIN PR, V114, P99, DOI 10.1016/j.diabres.2015.12.017; Wilson BL, 2015, JOGNN-J OBST GYN NEO, V44, P760, DOI 10.1111/1552-6909.12754; Wysham WZ, 2016, TARGETED ONCOLOGY; Zhang Q, 2015, IEEE ENER CONV, P1, DOI 10.1109/ECCE.2015.7309661; Zhang Wei, 2015, Zhonghua Bing Li Xue Za Zhi, V44, P767; Zhu M, 2014, DIABETES-METAB RES, V30, P489, DOI 10.1002/dmrr.2544	40	24	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170490	10.1371/journal.pone.0170490	http://dx.doi.org/10.1371/journal.pone.0170490			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125642	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100102
J	Yuan, CH; Chu, CC; Yan, XJ; Bagnara, D; Chiorazzi, N; MacCarthy, T				Yuan, Chaohui; Chu, Charles C.; Yan, Xiao-Jie; Bagnara, Davide; Chiorazzi, Nicholas; MacCarthy, Thomas			The Number of Overlapping AID Hotspots in Germline IGHV Genes Is Inversely Correlated with Mutation Frequency in Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							CLASS SWITCH RECOMBINATION; B-CELL RECEPTORS; SOMATIC HYPERMUTATION; IMMUNOGLOBULIN HEAVY; ANTIGEN SELECTION; STRUCTURAL BASIS; ANTIBODIES; REARRANGEMENTS; SUBSET; HIV-1	The targeting of mutations by Activation-Induced Deaminase (AID) is a key step in generating antibody diversity at the Immunoglobulin (Ig) loci but is also implicated in B-cell malignancies such as chronic lymphocytic leukemia (CLL). AID has previously been shown to preferentially deaminate WRC (W = A/T, R = A/G) hotspots. WGCW sites, which contain an overlapping WRC hotspot on both DNA strands, mutate at much higher frequency than single hotspots. Human Ig heavy chain (IGHV) genes differ in terms ofWGCW numbers, ranging from 4 for IGHV3-48*03 to as many as 12 in IGHV1-69*01. An absence of V-region mutations in CLL patients ("IGHV unmutated", or U-CLL) is associated with a poorer prognosis compared to "IGHV mutated" (M-CLL) patients. The reasons for this difference are still unclear, but it has been noted that particular IGHV genes associate with U-CLL vs M-CLL. For example, patients with IGHV1-69 clones tend to be U-CLL with a poor prognosis, whereas patients with IGHV3-30 tend to be M-CLL and have a better prognosis. Another distinctive feature of CLL is that similar to 30% of (mostly poor prognosis) patients can be classified into " stereo-typed" subsets, each defined by HCDR3 similarity, suggesting selection, possibly for a self-antigen. We analyzed > 1000 IGHV genes from CLL patients and found a highly significant statistical relationship between the number ofWGCW hotspots in the germline V-region and the observed mutation frequency in patients. However, paradoxically, this correlation was inverse, with V-regions with moreWGCW hotspots being less likely to be mutated, i.e., more likely to be U-CLL. The number ofWGCW hotspots in particular, are more strongly correlated with mutation frequency than either non-overlapping (WRC) hotspots or more general models of mutability derived from somatic hypermutation data. Furthermore, this correlation is not observed in sequences from the B cell repertoires of normal individuals and those with autoimmune diseases.	[Yuan, Chaohui; MacCarthy, Thomas] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [Chu, Charles C.; Yan, Xiao-Jie; Bagnara, Davide; Chiorazzi, Nicholas] Northwell Hlth, Feinstein Inst Med Res, Manhasset, NY USA; [Chu, Charles C.; Chiorazzi, Nicholas] Hofstra Northwell Sch Med, Dept Med, Hempstead, NY USA; [Chu, Charles C.; Chiorazzi, Nicholas] Hofstra Northwell Sch Med, Dept Mol Med, Hempstead, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Northwell Health; Northwell Health; Northwell Health	MacCarthy, T (corresponding author), SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA.	thomas.maccarthy@stonybrook.edu	Bagnara, Davide/AAQ-4172-2021; Bagnara, Davide/S-2124-2019; Bagnara, Davide/L-2691-2016	Bagnara, Davide/0000-0001-7889-8103; Bagnara, Davide/0000-0001-7889-8103	National Institute for General Medical Sciences / NIH [1R01GM111741]; National Cancer Institute / NIH [CA081554]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111741] Funding Source: NIH RePORTER	National Institute for General Medical Sciences / NIH; National Cancer Institute / NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	TM was supported by the National Institute for General Medical Sciences / NIH (1R01GM111741), https://www.nigms.nih.gov/Pages/default.aspx. NC was supported by the National Cancer Institute / NIH (CA081554), http://www.cancer.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; Bagnara D, 2015, J IMMUNOL, V195, P3716, DOI 10.4049/jimmunol.1500753; Baliakas P, 2015, BLOOD, V125, P856, DOI 10.1182/blood-2014-09-600874; Baughn LB, 2011, MBIO, V2, DOI 10.1128/mBio.00186-11; Binder M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015992; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Chan CH, 2001, BLOOD, V97, P1023, DOI 10.1182/blood.V97.4.1023; Chan TD, 2012, IMMUNITY, V37, P893, DOI 10.1016/j.immuni.2012.07.017; Chen ZG, 2016, J IMMUNOL, V196, P2335, DOI 10.4049/jimmunol.1502184; Chen Zhiliang, 2010, Immunome Res, V6 Suppl 1, pS4, DOI 10.1186/1745-7580-6-S1-S4; Chu CC, 2008, BLOOD, V112, P5122, DOI 10.1182/blood-2008-06-162024; Dal-Bo M, 2011, BRIT J HAEMATOL, V153, P3, DOI 10.1111/j.1365-2141.2010.08440.x; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Darzentas N, 2010, LEUKEMIA, V24, P125, DOI 10.1038/leu.2009.186; Degan M, 2004, BRIT J HAEMATOL, V126, P29, DOI 10.1111/j.1365-2141.2004.04985.x; Efremov DG, 1996, J CLIN INVEST, V98, P290, DOI 10.1172/JCI118792; Fais F, 1998, J CLIN INVEST, V102, P1515, DOI 10.1172/JCI3009; Gelmez MY, 2014, LEUKEMIA LYMPHOMA, V55, P326, DOI 10.3109/10428194.2013.803225; Ghia P, 2008, J INTERN MED, V264, P549, DOI 10.1111/j.1365-2796.2008.02030.x; Ghiotto F, 2004, J CLIN INVEST, V113, P1008, DOI 10.1172/JCI200419399; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P695, DOI 10.1101/pdb.prot5633; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Han L, 2011, P NATL ACAD SCI USA, V108, P11584, DOI 10.1073/pnas.1018726108; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Herve M, 2005, J CLIN INVEST, V115, P1636, DOI 10.1172/JCI24387; Hoogeboom R, 2013, LEUKEMIA, V27, P738, DOI 10.1038/leu.2012.238; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; ICHIYOSHI Y, 1994, J EXP MED, V180, P885, DOI 10.1084/jem.180.3.885; Kasar S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9866; KIPPS TJ, 1989, P NATL ACAD SCI USA, V86, P5913, DOI 10.1073/pnas.86.15.5913; Kostareli E, 2009, LEUKEMIA, V23, P919, DOI 10.1038/leu.2008.379; Lefranc MP, 2001, NUCLEIC ACIDS RES, V29, P207, DOI 10.1093/nar/29.1.207; Lerner RA, 2011, MOL BIOSYST, V7, P1004, DOI 10.1039/c0mb00310g; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; Marantidou F, 2010, BLOOD CELL MOL DIS, V44, P262, DOI 10.1016/j.bcmd.2009.12.005; Martomo SA, 2004, J EXP MED, V200, P61, DOI 10.1084/jem.20040691; Matthews C, 2007, LEUKEMIA RES, V31, P231, DOI 10.1016/j.leukres.2006.03.028; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; Murray F, 2008, BLOOD, V111, P1524, DOI 10.1182/blood-2007-07-099564; Myhrinder AL, 2008, BLOOD, V111, P3838, DOI 10.1182/blood-2007-11-125450; Ohm-Laursen L, 2007, J IMMUNOL, V178, P4322, DOI 10.4049/jimmunol.178.7.4322; Oppezzo P, 2003, BLOOD, V101, P4029, DOI 10.1182/blood-2002-10-3175; Palacios F, 2012, MICROENVIRONMENT INT; Palacios F, 2010, BLOOD, V115, P4488, DOI 10.1182/blood-2009-12-257758; Patten PEM, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86288; Patten PEM, 2012, BLOOD, V120, P4802, DOI 10.1182/blood-2012-08-449744; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Perotti M, 2008, AUTOIMMUN REV, V7, P468, DOI 10.1016/j.autrev.2008.03.008; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Rene C, 2014, J CELL MOL MED, V18, P979, DOI 10.1111/jcmm.12215; Sabouri Z, 2014, P NATL ACAD SCI USA, V111, pE2567, DOI 10.1073/pnas.1406974111; SHLOMCHIK MJ, 1987, NATURE, V328, P805, DOI 10.1038/328805a0; Stamatopoulos K, 2007, BLOOD, V109, P259, DOI 10.1182/blood-2006-03-012948; Steininger C, 2012, BLOOD, V119, P2293, DOI 10.1182/blood-2011-08-374058; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Sutton LA, 2013, SEMIN CANCER BIOL, V23, P399, DOI 10.1016/j.semcancer.2013.07.006; Wang M, 2010, J EXP MED, V207, P141, DOI 10.1084/jem.20092238; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wei LR, 2015, P NATL ACAD SCI USA, V112, pE728, DOI 10.1073/pnas.1500788112; William J, 2002, SCIENCE, V297, P2066, DOI 10.1126/science.1073924; Yaari G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00358; Yang G, 2013, J EXP MED, V210, P241, DOI 10.1084/jem.20121977; Yeap LS, 2015, CELL, V163, P1124, DOI 10.1016/j.cell.2015.10.042; Zahn A, 2013, J IMMUNOL, V190, P5949, DOI 10.4049/jimmunol.1202711; Zwick C, 2013, BLOOD, V121, P4708, DOI 10.1182/blood-2012-08-447904	65	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0167602	10.1371/journal.pone.0167602	http://dx.doi.org/10.1371/journal.pone.0167602			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125682	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100153
J	Wei, W; Liao, HT; Xue, YM; Fang, XH; Huang, J; Liu, Y; Deng, H; Liang, YH; Liao, ZL; Liu, FZ; Lin, WD; Zhan, XZ; Wu, SL				Wei, Wei; Liao, Hongtao; Xue, Yumei; Fang, Xianhong; Huang, Jun; Liu, Yang; Deng, Hai; Liang, Yuanhong; Liao, Zili; Liu, Fangzhou; Lin, Weidong; Zhan, Xianzhang; Wu, Shulin			Long-Term Outcomes of Radio-Frequency Catheter Ablation on Ventricular Tachycardias Due to Arrhythmogenic Right Ventricular Cardiomyopathy: A Single Center Experience	PLOS ONE			English	Article							SUBSTRATE; SCAR	Aims To summarize our experience of radiofrequency catheter ablation (RFCA) for recurrent drug-refractory ventricular tachycardias (VTs) due to arrhythmogenic right ventricular car-diomyopathy (ARVC) in our center over the past 11 years and its related factors. Methods and Results We reviewed 48 adults (mean age 39.9 +/- 12.9 years, range: 14 to 65) who met the present ARVC diagnostic criteria and accepted RFCA for VTs from December 2004 to April 2016. The patients received a total of 70 procedures using two ablation approaches, the endocardial approach in 52 RFCAs, and the combined epicardial and endocardial approach (the com-bined approach) in 18 RFCAs. Kaplan-Meier survival analysis showed that the combined approach achieved better acute procedural success (p = 0.003) and better long-term out-comes (p = 0.028) than the endocardial approach. Patients who obtained acute procedural success with non-inducibility had better long-term outcomes (p < 0.001). COX regression of multivariate analysis showed that procedural success was the only factor that benefited long-term outcome, irrespective of the endocardial or the combined approach (p = 0.001). The rate of sudden cardiac death (SCD) in patients without procedural success was significantly higher than that in patients with procedural success (p = 0.005). All patients without implant-able cardioverter defibrillator (ICD) implantation who had successful final RFCA sur-vived. Conclusions The combined approach resulted in better procedural success and long-term VT-free survival compared with the endocardial approach in ARVC patients with recurrent VTs. Acute procedural success with non-inducibility was strongly related to better long-term VT-free survival and reduced SCD, irrespective of whether this was achieved by the endocardial approach or the combined approach.	[Wei, Wei; Liao, Hongtao; Xue, Yumei; Fang, Xianhong; Huang, Jun; Liu, Yang; Deng, Hai; Liang, Yuanhong; Liao, Zili; Liu, Fangzhou; Lin, Weidong; Zhan, Xianzhang; Wu, Shulin] Guangdong Cardiovasc Inst, Guangzhou, Guangdong, Peoples R China; [Wei, Wei; Liao, Hongtao; Xue, Yumei; Fang, Xianhong; Huang, Jun; Liu, Yang; Deng, Hai; Liang, Yuanhong; Liao, Zili; Liu, Fangzhou; Lin, Weidong; Zhan, Xianzhang; Wu, Shulin] Guangdong Prov Key Lab South China Struct Heart D, Guangzhou, Guangdong, Peoples R China; [Wei, Wei; Liao, Hongtao; Xue, Yumei; Fang, Xianhong; Huang, Jun; Liu, Yang; Deng, Hai; Liang, Yuanhong; Liao, Zili; Liu, Fangzhou; Lin, Weidong; Zhan, Xianzhang; Wu, Shulin] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital	Zhan, XZ; Wu, SL (corresponding author), Guangdong Cardiovasc Inst, Guangzhou, Guangdong, Peoples R China.; Zhan, XZ; Wu, SL (corresponding author), Guangdong Prov Key Lab South China Struct Heart D, Guangzhou, Guangdong, Peoples R China.; Zhan, XZ; Wu, SL (corresponding author), Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangzhou, Guangdong, Peoples R China.	gdzxz@163.com; dr_shulinwu@126.com	Liu, Fang-zhou/J-2645-2019	Liu, Fang-zhou/0000-0001-7637-1447	National Five-year Science and Technology Supportive Program of China [2011BAI11613]; Science and Technology Planning of Guangdong Province, China [2014B070705005]	National Five-year Science and Technology Supportive Program of China; Science and Technology Planning of Guangdong Province, China	This study was supported by the National Five-year Science and Technology Supportive Program of China "A study of idiopathic outflow tract originated ventricular arrhythmias" (No. 2011BAI11613) and the Science and Technology Planning of Guangdong Province, China "A study of early warning and intervention of malignant and potentially malignant ventricular arrhythmias" (No. 2014B070705005).	Bai R, 2011, CIRC-ARRHYTHMIA ELEC, V4, P478, DOI 10.1161/CIRCEP.111.963066; Basso C, 2009, LANCET, V373, P1289, DOI 10.1016/S0140-6736(09)60256-7; Berruezo A, 2012, CIRC-ARRHYTHMIA ELEC, V5, P111, DOI 10.1161/CIRCEP.110.960740; Corrado D, 2008, J AM COLL CARDIOL, V51, P731, DOI 10.1016/j.jacc.2007.11.027; Dalal D, 2007, J AM COLL CARDIOL, V50, P432, DOI 10.1016/j.jacc.2007.03.049; Ellison KE, 1998, J AM COLL CARDIOL, V32, P724, DOI 10.1016/S0735-1097(98)00292-7; Fernandez-Armenta J, 2014, HEART RHYTHM, V11, P747, DOI 10.1016/j.hrthm.2014.02.016; Haqqani HM, 2012, CIRC-ARRHYTHMIA ELEC, V5, P796, DOI 10.1161/CIRCEP.111.967935; Jais P, 2012, CIRCULATION, V125, P2184, DOI 10.1161/CIRCULATIONAHA.111.043216; Marchlinski FE, 2000, CIRCULATION, V101, P1288, DOI 10.1161/01.CIR.101.11.1288; Marchlinski FE, 2004, CIRCULATION, V110, P2293, DOI 10.1161/01.CIR.0000145154.02436.90; Marcus FI, 2010, EUR HEART J, V31, P806, DOI [10.1093/eurheartj/ehq025, 10.1161/CIRCULATIONAHA.108.840827]; Mussigbrodt A, 2015, J ELECTROCARDIOL, V48, P86, DOI 10.1016/j.jelectrocard.2014.10.013; Nair M, 2011, J INTERV CARD ELECTR, V31, P141, DOI 10.1007/s10840-011-9556-2; Pedersen CT, 2014, HEART RHYTHM, V11, pE166, DOI 10.1016/j.hrthm.2014.07.024; Philips B, 2012, CIRC-ARRHYTHMIA ELEC, V5, P499, DOI 10.1161/CIRCEP.111.968677; Sosa E, 2000, J AM COLL CARDIOL, V35, P1442, DOI 10.1016/S0735-1097(00)00606-9; Tung R, 2010, HEART RHYTHM, V7, P389, DOI 10.1016/j.hrthm.2009.11.023; Verma A, 2005, CIRCULATION, V111, P3209, DOI 10.1161/CIRCULATIONAHA.104.510503	19	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0169863	10.1371/journal.pone.0169863	http://dx.doi.org/10.1371/journal.pone.0169863			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122031	Green Submitted, gold, Green Published			2022-12-26	WOS:000396167300062
J	Caskenette, AL; McCann, KS				Caskenette, Amanda L.; McCann, Kevin S.			Biomass Reallocation between Juveniles and Adults Mediates Food Web Stability by Distributing Energy Away from Strong Interactions	PLOS ONE			English	Article							INTRAGUILD PREDATION SYSTEMS; LIFE-HISTORY OMNIVORY; STRUCTURED POPULATIONS; DEPENDENT INTERACTIONS; PRODUCTIVITY GRADIENT; COMMUNITY DYNAMICS; ONTOGENIC NICHE; SIZE; PREY; CONSEQUENCES	Ecological theory has uncovered dynamical differences between food web modules (i.e. low species food web configurations) with only species-level links and food web modules that include within-species links (e.g. non-feeding links between mature and immature individuals) and has argued that these differences ought to cause food web theory that includes within-species links to contrast with classical food web theory. It is unclear, however, if life-history will affect the observed connection between interaction strength and stability in species-level theory. We show that when the predator in a species-level food chain is split into juvenile and adult stages using a simple nested approach, stage-structure can mute potentially strong interactions through the transfer of biomass within a species. Within-species biomass transfer distributes energy away from strong interactions promoting increased system stability consistent with classical food web theory.	[Caskenette, Amanda L.; McCann, Kevin S.] Univ Guelph, Dept Integrat Biol, Guelph, ON, Canada; [Caskenette, Amanda L.] Fisheries & Oceans Canada, Winnipeg, MB, Canada	University of Guelph; Fisheries & Oceans Canada	Caskenette, AL (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON, Canada.; Caskenette, AL (corresponding author), Fisheries & Oceans Canada, Winnipeg, MB, Canada.	Amanda.Caskenette@dfo-mpo.gc.ca		Caskenette, Amanda/0000-0002-7028-3208	Natural Sciences and Engineering Research Council of Canada [400353]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Natural Sciences and Engineering Research Council of Canada Discovery Grant Funding Number: 400353, KSM; http:/www.nserc-crsng.gc.ca./Professors-Professeurs/Grants-Subs/DGIGP-PSIGP_eng.asp. "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Abrams PA, 2005, THEOR POPUL BIOL, V68, P253, DOI 10.1016/j.tpb.2005.05.004; ABRAMS PA, 1993, AM NAT, V141, P351, DOI 10.1086/285478; Abrams PA, 1996, ECOLOGY, V77, P1125, DOI 10.2307/2265581; Abrams PA, 2011, AM NAT, V178, P305, DOI 10.1086/661243; CRISP DJ, 1961, LIMNOL OCEANOGR, V6, P105, DOI 10.4319/lo.1961.6.2.0105; de Roos AM, 2007, AM NAT, V170, pE59, DOI 10.1086/520119; Duffy JE, 2005, ECOL LETT, V8, P301, DOI 10.1111/j.1461-0248.2005.00725.x; Fagan WF, 1997, AM NAT, V150, P554, DOI 10.1086/286081; Gellner G, 2012, AM NAT, V179, P22, DOI 10.1086/663191; Guill C, 2009, THEOR POPUL BIOL, V76, P168, DOI 10.1016/j.tpb.2009.06.002; Hin V, 2011, AM NAT, V178, P701, DOI 10.1086/662676; HOLT RD, 1994, AM NAT, V144, P741, DOI 10.1086/285705; Jorgensen C, 2007, SCIENCE, V318, P1247, DOI 10.1126/science.1148089; Kondoh M, 2010, ECOLOGY, V91, P3123, DOI 10.1890/09-2219.1; Lester NP, 2004, P ROY SOC B-BIOL SCI, V271, P1625, DOI 10.1098/rspb.2004.2778; May R. M., 1973, STABILITY COMPLEXITY, V6; McCann K, 1997, P ROY SOC B-BIOL SCI, V264, P1249, DOI 10.1098/rspb.1997.0172; MCCANN K, 1995, THEOR POPUL BIOL, V48, P93, DOI 10.1006/tpbi.1995.1023; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; McCann K.S., 2011, FOOD WEBS; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Miller TEX, 2011, TRENDS ECOL EVOL, V26, P457, DOI 10.1016/j.tree.2011.05.005; Mylius SD, 2001, AM NAT, V158, P259, DOI 10.1086/321321; Nakazawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014667; Persson L, 2013, POPULATION COMMUNITY; Persson L, 2013, CAN J FISH AQUAT SCI, V70, P610, DOI 10.1139/cjfas-2012-0175; Persson L, 2012, J ANIM ECOL, V81, P483, DOI 10.1111/j.1365-2656.2011.01927.x; PIMM SL, 1987, THEOR POPUL BIOL, V32, P303, DOI 10.1016/0040-5809(87)90052-9; PIMM SL, 1991, NATURE, V350, P669, DOI 10.1038/350669a0; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; Rudolf VHW, 2008, ECOLOGY, V89, P1650, DOI 10.1890/07-0709.1; Rudolf VHW, 2007, ECOLOGY, V88, P2697, DOI 10.1890/06-1266.1; Rudolf VHW, 2013, ECOLOGY, V94, P1046, DOI 10.1890/12-0378.1; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Stouffer DB, 2010, ECOL LETT, V13, P154, DOI 10.1111/j.1461-0248.2009.01407.x; Takimoto G, 2007, THEOR POPUL BIOL, V72, P264, DOI 10.1016/j.tpb.2007.04.005; van de Wolfshaar KE, 2006, AM NAT, V168, P62, DOI 10.1086/505156; Vandermeer J, 2006, J THEOR BIOL, V238, P497, DOI 10.1016/j.jtbi.2005.06.006; Walters C, 2001, CAN J FISH AQUAT SCI, V58, P39, DOI 10.1139/cjfas-58-1-39; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Wolfram Research Inc., 2010, MATHEMATICA; Yodzis Peter, 2007, P185	43	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170725	10.1371/journal.pone.0170725	http://dx.doi.org/10.1371/journal.pone.0170725			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114339	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129000089
J	Le Roux, E; Gottot, S; Aupiais, C; Girard, T; Teixeira, M; Alberti, C				Le Roux, Enora; Gottot, Serge; Aupiais, Camille; Girard, Thomas; Teixeira, Maria; Alberti, Corinne			Professional's Perspectives on Care Management of Young People with Perinatally Acquired HIV during Transition: A Qualitative Study in Adult Care Setting	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEALTH-CARE; ADOLESCENTS; MEDICINE; NETWORK; PREVALENCE; CHALLENGES	Background Increasing numbers of young people with perinatally acquired HIV are surviving to adulthood. When they come of age, they leave pediatric services in which they were followed and have to be transferred to the adult health care system. Difficulties in adaptation to adult care and the numbers of young people lost to follow up after transfer to adult care have been reported. This transition phase and their retention in adult care are crucial in maintaining the clinical status of these young with HIV in adulthood. Our study aimed to explore how HIV professionals working in adult care perceive and adapt their practices to young people in transition. Methods Qualitative interviews were conducted with 18 health and social services professionals in hospitals or patient associations in France. A thematic analysis was conducted. Results Adult care professionals were found to be making a distinction between these young people and their patients who were infected during adulthood. On the basis of the health-care teams' experience, a simplified categorization of these young people into four levels can be used: those "who have everything good"; those who have some deficiencies that must be addressed; those "who have everything bad"; and those lost to follow up. Professionals interviewed highlighted the difficulties they encountered with young people in transition. Three types of problematic situations were identified: problems of acceptance of the disease; communication problems; and problems of disorientation in the new care environment. Conclusions Despite the lack of specific training or national policy recommendations for the integration of young people with perinatally acquired HIV into adult services, all the adult healthcare teams interviewed tried to adapt their practice to this population. The results suggested that professional involvement during transition should depend on the characteristics of the patient, not be limited to a single transition model and that a dedicated structure for transition care is not appropriate for all young people.	[Le Roux, Enora; Gottot, Serge; Aupiais, Camille; Teixeira, Maria; Alberti, Corinne] Univ Paris Diderot, Sorbonne Paris Cite, ECEVE, UMRS 1123, Paris, France; [Le Roux, Enora; Gottot, Serge; Aupiais, Camille; Teixeira, Maria; Alberti, Corinne] INSERM, ECEVE U1123, Paris, France; [Le Roux, Enora; Gottot, Serge; Aupiais, Camille; Teixeira, Maria; Alberti, Corinne] CIC EC, CIC 1426, Paris, France; [Gottot, Serge; Aupiais, Camille; Teixeira, Maria; Alberti, Corinne] Hop Robert Debre, AP HP, Unite Epidemiol Clin, Paris, France; [Girard, Thomas] Hop Hotel Dieu, AP HP, Unite Guy Mocquet, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Le Roux, E (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, ECEVE, UMRS 1123, Paris, France.; Le Roux, E (corresponding author), INSERM, ECEVE U1123, Paris, France.; Le Roux, E (corresponding author), CIC EC, CIC 1426, Paris, France.	enora.le-roux@inserm.fr	Le Roux, Enora/AAN-8370-2020; aupiais, camille/J-8386-2019	aupiais, camille/0000-0001-7482-0405	Roche Foundation to our institution [2014RDB010]; French Ministry of Health (PREPS); UPMC Universite Paris 6 Sorbonne Paris Cite	Roche Foundation to our institution; French Ministry of Health (PREPS); UPMC Universite Paris 6 Sorbonne Paris Cite	This study was funded by a grant from the Roche Foundation to our institution (contract number 2014RDB010) and by the French Ministry of Health (PREPS2013). The first author was supported by a doctoral contract funded by the UPMC Universite Paris 6 Sorbonne Paris Cite for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agwu AL, 2015, J ADOLESCENT HEALTH, V56, P345, DOI 10.1016/j.jadohealth.2014.11.009; Agwu AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18579; [Anonymous], 2011, TRANSITIONING HIV IN; [Anonymous], 2014, HIV SURV REP; Arora S, 2010, MED EDUC, V44, P749, DOI 10.1111/j.1365-2923.2010.03709.x; Bennett DL, 2005, MED J AUSTRALIA, V182, P373, DOI 10.5694/j.1326-5377.2005.tb06751.x; BLUM RW, 1993, J ADOLESCENT HEALTH, V14, P570, DOI 10.1016/1054-139X(93)90143-D; Blum RW, 2002, PEDIATRICS, V110, P1301; Bodenlos JS, 2007, J ASSOC NURSE AIDS C, V18, P65, DOI 10.1016/j.jana.2007.03.002; Cadario F, 2009, CLIN ENDOCRINOL, V71, P346, DOI 10.1111/j.1365-2265.2008.03467.x; Fish R, 2014, HIV MED, V15, P239, DOI 10.1111/hiv.12091; Gilliam PP, 2011, J ASSOC NURSE AIDS C, V22, P283, DOI 10.1016/j.jana.2010.04.003; Glaser B. G., 2009, DISCOVERY GROUNDED T; Hazra R, 2010, ANNU REV MED, V61, P169, DOI 10.1146/annurev.med.050108.151127; Hersh AO, 2009, PEDIATR RHEUMATOL, V7, DOI 10.1186/1546-0096-7-13; Hill Terry E, 2010, Philos Ethics Humanit Med, V5, P11, DOI 10.1186/1747-5341-5-11; Hussen SA, 2014, FUTURE VIROL, V9, P921, DOI 10.2217/FVL.14.73; Ingersoll KS, 2005, AIDS BEHAV, V9, P89, DOI 10.1007/s10461-005-1684-1; KELLY MP, 1982, J ADV NURS, V7, P147, DOI 10.1111/j.1365-2648.1982.tb00222.x; Krebs EE, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-128; MAYER JD, 1997, MAYER SALOVEY CARUSI, V3, P34; Monaghan M, 2013, CURR DIABETES REP, V13, P900, DOI 10.1007/s11892-013-0420-x; Newman C, 2014, AIDS PATIENT CARE ST, V28, P381, DOI 10.1089/apc.2013.0346; Orban LA, 2010, AIDS CARE, V22, P420, DOI 10.1080/09540120903193724; Paille P, 2008, ANAL QUALITATIVE SCI; Sohn AH, 2013, J INT AIDS SOC, V16; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; UNAIDS, 2013, GLOBAL REPORT UNAIDS; Vaudre G, 2012, ARCH PEDIATRIE, V19, P786, DOI 10.1016/j.arcped.2012.05.003; Velter A, 2013, AIDS BEHAV, V17, P1266, DOI 10.1007/s10461-012-0303-1; Wasan AD, 2005, REGION ANESTH PAIN M, V30, P184, DOI 10.1016/j.rapm.2004.11.005; Watson AR, 2005, PEDIATR NEPHROL, V20, P113, DOI 10.1007/s00467-004-1763-y; WHO, 2013, HIV AD GUID HIV TEST; World Health organization, 2014, ADOLESCENT HIV TESTI	34	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0169782	10.1371/journal.pone.0169782	http://dx.doi.org/10.1371/journal.pone.0169782			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6QR	28114376	Green Published, Green Submitted, gold			2022-12-26	WOS:000396129000011
J	George, T; Bell, M; Chakraborty, M; Siderovski, DP; Giembycz, MA; Newton, R				George, Tresa; Bell, Matthew; Chakraborty, Mainak; Siderovski, David P.; Giembycz, Mark A.; Newton, Robert			Protective Roles for RGS2 in a Mouse Model of House Dust Mite-Induced Airway Inflammation	PLOS ONE			English	Article							PROTEINASE-ACTIVATED RECEPTOR-2; ACTING BETA(2)-ADRENOCEPTOR AGONISTS; RESPIRATORY EPITHELIAL-CELLS; SMOOTH-MUSCLE-CELLS; GLUCOCORTICOID-RECEPTOR; ALLERGIC SENSITIZATION; SIGNALING 2; PROSTAGLANDIN E-2; GM-CSF; RELEASE	The GTPase-accelerating protein, regulator of G-protein signalling 2 (RGS2) reduces signalling from G-protein-coupled receptors (GPCRs) that signal via Gaq. In humans, RGS2 expression is up-regulated by inhaled corticosteroids (ICSs) and long-acting beta(2)-adrenoceptor agonists (LABAs) such that synergy is produced in combination. This may contribute to the superior clinical efficacy of ICS/LABA therapy in asthma relative to ICS alone. In a murine model of house dust mite (HDM)-induced airways inflammation, three weeks of intranasal HDM (25 mu g, 3x/week) reduced lung function and induced granulocytic airways inflammation. Compared to wild type animals, Rgs2(-/-) mice showed airways hyperresponsiveness (increased airways resistance and reduced compliance). While HDM increased pulmonary inflammation observed on hematoxylin and eosin-stained sections, there was no difference between wild type and Rgs2(-/-) animals. HDM-induced mucus hypersecretion was also unaffected by RGS2 deficiency. However, inflammatory cell counts in the bronchoalveolar lavage fluid of Rgs2(-/-) animals were significantly increased (57%) compared to wild type animals and this correlated with increased granulocyte (neutrophil and eosinophil) numbers. Likewise, cytokine and chemokine (IL4, IL17, IL5, LIF, IL6, CSF3, CXCLI, CXCL10 and CXCL11) release was increased by HDM exposure. Compared to wild type, Rgs2(-/-) animals showed a trend towards increased expression for many cytokines/chemokines, with CCL3, CCL11, CXCL9 and CXCL10 being significantly enhanced. As RGS2 expression was unaffected by HDM exposure, these data indicate that RGS2 exerts tonic bronchoprotection in HDM-induced airways inflammation. Modest anti-inflammatory and anti-remodelling roles for RGS2 are also suggested. If translatable to humans, therapies that maximize RGS2 expression may prove advantageous.	[George, Tresa; Bell, Matthew; Giembycz, Mark A.; Newton, Robert] Univ Calgary, Snyder Inst Chron Dis, Airways Inflammat Res Grp, Calgary, AB, Canada; [Chakraborty, Mainak] Univ Calgary, Snyder Inst Chron Dis, Immunol Res Grp, Calgary, AB, Canada; [Siderovski, David P.] West Virginia Univ, Blanchette Rockefeller Neurosci Inst, Morgantown, WV 26506 USA; [Bell, Matthew] GSK Med Res Ctr, Epinova DPU Immunoinflammat Therapy Area, Stevenage, Herts, England	University of Calgary; University of Calgary; West Virginia University; GlaxoSmithKline	Newton, R (corresponding author), Univ Calgary, Snyder Inst Chron Dis, Airways Inflammat Res Grp, Calgary, AB, Canada.	rnewton@ucalgary.ca	Siderovski, David Peter/AAA-9603-2019; Newton, Robert/C-6814-2012	Siderovski, David Peter/0000-0002-0688-8210; Newton, Robert/0000-0002-4919-8498; G, Tresa/0000-0002-8647-1246	Canadian Institutes of Health Research (CIHR) [MOP 125918]; Alberta Innovates Health Solutions (Al-HS) Senior Scholar award; Alberta Lung Association scholarship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions (Al-HS) Senior Scholar award; Alberta Lung Association scholarship	This work was supported by: Canadian Institutes of Health Research (CIHR) (MOP 125918) (RN); Alberta Innovates Health Solutions (Al-HS) Senior Scholar award (RN); Alberta Lung Association scholarship (TG) and grant in aid (RN).	Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Adam E, 2006, J BIOL CHEM, V281, P6910, DOI 10.1074/jbc.M507140200; Alexander SPH, 2011, BRIT J PHARMACOL, V164, pS1, DOI 10.1111/j.1476-5381.2011.01649_1.x; Alshurafa Hashem N., 2004, BMC Pharmacology, V4, P12, DOI 10.1186/1471-2210-4-12; Ammit AJ, 2002, AM J RESP CELL MOL, V26, P465, DOI 10.1165/ajrcmb.26.4.4681; Arizmendi NG, 2011, J IMMUNOL, V186, P3164, DOI 10.4049/jimmunol.0903812; Asokananthan N, 2002, J IMMUNOL, V168, P3577, DOI 10.4049/jimmunol.168.7.3577; Asokananthan N, 2002, J IMMUNOL, V169, P4572, DOI 10.4049/jimmunol.169.8.4572; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Bosch Dustin E, 2012, Curr Protoc Pharmacol, VChapter 2, DOI 10.1002/0471141755.ph0208s56; Chivers JE, 2006, MOL PHARMACOL, V70, P2084, DOI 10.1124/mol.106.025841; Clark AR, 2008, J BIOL CHEM, V283, P25765, DOI 10.1074/jbc.R700053200; Clark AR, 2012, PHARMACOL THERAPEUT, V134, P54, DOI 10.1016/j.pharmthera.2011.12.004; Davidson CE, 2013, CLIN EXP ALLERGY, V43, P1274, DOI 10.1111/cea.12185; Ebeling C, 2007, J IMMUNOL, V179, P2910, DOI 10.4049/jimmunol.179.5.2910; Fyfe M, 2005, CYTOKINE, V31, P358, DOI 10.1016/j.cyto.2005.06.004; Gosens R, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-73; Gregory LG, 2009, CLIN EXP ALLERGY; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Heximer SP, 2004, METHOD ENZYMOL, V390, P65; Heximer SP, 2003, J CLIN INVEST, V111, P445, DOI 10.1172/JC1200315598; Holden NS, 2010, BRIT J PHARMACOL, V160, P410, DOI 10.1111/j.1476-5381.2010.00708.x; Holden NS, 2014, J PHARMACOL EXP THER, V348, P12, DOI 10.1124/jpet.113.204586; Holden NS, 2011, P NATL ACAD SCI USA, V108, P19713, DOI 10.1073/pnas.1110226108; Jacquet A, 2011, TRENDS MOL MED, V17, P604, DOI 10.1016/j.molmed.2011.05.014; Jairaman A, 2015, J IMMUNOL, V195, P2122, DOI 10.4049/jimmunol.1500396; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Kauffman Henk F, 2006, Clin Mol Allergy, V4, P5, DOI 10.1186/1476-7961-4-5; Kaur M, 2008, MOL PHARMACOL, V73, P203, DOI 10.1124/mol.107.040121; Kelly MM, 2012, BRIT J PHARMACOL, V165, P1737, DOI 10.1111/j.1476-5381.2011.01620.x; Kim JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep27615; Kimple AJ, 2009, J BIOL CHEM, V284, P19402, DOI 10.1074/jbc.M109.024711; King EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053936; KNIGHT DA, 1995, EUR J PHARMACOL, V272, P13, DOI 10.1016/0014-2999(94)00602-4; Lambrecht BN, 2014, J ALLERGY CLIN IMMUN, V134, P499, DOI 10.1016/j.jaci.2014.06.036; Leigh R, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.243; Li HJ, 2010, CELL BIOCHEM FUNCT, V28, P597, DOI 10.1002/cbf.1697; Manetsch M, 2012, BRIT J PHARMACOL, V166, P2049, DOI 10.1111/j.1476-5381.2012.01923.x; Mitchell J, 2010, CURR OPIN INVEST DR, V11, P527; Newton R, 2000, THORAX, V55, P603, DOI 10.1136/thorax.55.7.603; Newton R, 2002, EUR J PHARMACOL, V441, P193, DOI 10.1016/S0014-2999(01)01624-7; Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794; Newton R, 2016, BRIT J PHARMACOL, V173, P3405, DOI 10.1111/bph.13628; Newton R, 2014, EUR J PHARMACOL, V724, P231, DOI 10.1016/j.ejphar.2013.05.035; Newton R, 2010, PHARMACOL THERAPEUT, V125, P286, DOI 10.1016/j.pharmthera.2009.11.003; Nichols HL, 2012, P NATL ACAD SCI USA, V109, P16660, DOI 10.1073/pnas.1208881109; Nomiyama H, 2011, DEV COMP IMMUNOL, V35, P705, DOI 10.1016/j.dci.2011.01.019; Oliveira-dos-Santos AJ, 2000, P NATL ACAD SCI USA, V97, P12272, DOI 10.1073/pnas.220414397; Palikhe NS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144500; Pepperl DJ, 1998, BIOCHEM BIOPH RES CO, V243, P52, DOI 10.1006/bbrc.1997.8056; Pinart M, 2014, EUR J PHARMACOL, V744, P108, DOI 10.1016/j.ejphar.2014.10.003; Post S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091206; Pyne NJ, 1997, BIOCHEM J, V328, P689; Quante T, 2008, AM J RESP CELL MOL, V39, P208, DOI 10.1165/rcmb.2007-0014OC; Reed CE, 2004, J ALLERGY CLIN IMMUN, V114, P997, DOI 10.1016/j.jaci.2004.07.060; Rumzhum NN, 2016, CLIN EXP ALLERGY, V46, P397, DOI 10.1111/cea.12697; Ryu JH, 2013, J ALLERGY CLIN IMMUN, V131, P549, DOI 10.1016/j.jaci.2012.07.050; Saglani S, 2009, AM J RESP CELL MOL, V41, P281, DOI 10.1165/rcmb.2008-0396OC; Shalaby KH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-82; Song Y, 2010, NATURE, V468, P933, DOI 10.1038/nature09564; Southam DS, 2007, J ALLERGY CLIN IMMUN, V119, P848, DOI 10.1016/j.jaci.2006.12.623; Surjit M, 2011, CELL, V145, P224, DOI 10.1016/j.cell.2011.03.027; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Vliagoftis A, 2000, J ALLERGY CLIN IMMUN, V106, P537, DOI 10.1067/mai.2000.109058; Vliagoftis H, 2001, J ALLERGY CLIN IMMUN, V107, P679, DOI 10.1067/mai.2001.114245; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Willart MAM, 2012, J EXP MED, V209, P1505, DOI 10.1084/jem.20112691; Xie Y, 2012, J ALLERGY CLIN IMMUN, V130, P968, DOI 10.1016/j.jaci.2012.05.004; Xie ZW, 2011, J BIOL CHEM, V286, P44646, DOI 10.1074/jbc.M111.265462; Zabel BA, 2015, ANNU REV PATHOL-MECH, V10, P51, DOI 10.1146/annurev-pathol-012513-104640	71	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170269	10.1371/journal.pone.0170269	http://dx.doi.org/10.1371/journal.pone.0170269			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107494	Green Published, gold, Green Submitted			2022-12-26	WOS:000392405300097
J	Hao, JH; Lv, SS; Bhattacharya, S; Fu, JG				Hao, Jian-Hua; Lv, Shuang-Shuang; Bhattacharya, Saurav; Fu, Jian-Guo			Germination Response of Four Alien Congeneric Amaranthus Species to Environmental Factors	PLOS ONE			English	Article							SEEDLING EMERGENCE; WIDESPREAD CONGENER; ECOLOGY; TRAITS; PLANTS; BIOLOGY; GROWTH; DIFFER; WEEDS; ESTABLISHMENT	Seed germination is the key step for successful establishment, growth and further expansion of population especially for alien plants with annual life cycle. Traits like better adaptability and germination response were thought to be associated with plant invasion. However, there are not enough empirical studies correlating adaptation to environmental factors with germination response of alien invasive plants. In this study, we conducted congeneric comparisons of germination response to different environmental factors such as light, pH, NaCl, osmotic and soil burials among four alien amaranths that differ in invasiveness and have sympatric distribution in Jiangsu Province, China. The data were used to create three-parameter sigmoid and exponential decay models, which were fitted to cumulative germination and emergence curves. The results showed higher maximum Germination (G(max)), shorter time for 50% germination (G(50)) and the rapid slope (G(rate)) for Amaranthus blitum (low-invasive) and A. retroflexus (high-invasive) compare to intermediately invasive A. spinosus and A. viridis in all experimental regimes. It indicated that germination potential does not necessarily constitute a trait that can efficiently distinguish highly invasive and low invasive congeners in four Amaranthus species. However, it was showed that the germination performances of four amaranth species were more or less correlated with their worldwide distribution area. Therefore, the germination performance can be used as a reference indicator, but not an absolute trait for invasiveness. Our results also confirmed that superior germination performance in wide environmental conditions supplementing high seed productivity in highly invasive A. retroflexus might be one of the reasons for its prolific growth and wide distribution. These findings lay the foundation to develop more efficient weed management practice like deep burial of seeds by turning over soil and use of tillage agriculture to control these invasive weed species.	[Hao, Jian-Hua; Lv, Shuang-Shuang; Bhattacharya, Saurav] Changshu Inst Technol, Suzhou, Jiangsu, Peoples R China; [Fu, Jian-Guo] Jiangsu Entry Exit Inspect & Quarantine Bur, Nanjing, Jiangsu, Peoples R China	Changshu Institute of Technology	Hao, JH (corresponding author), Changshu Inst Technol, Suzhou, Jiangsu, Peoples R China.	jhhao@cslg.edu.cn	Bhattacharya, Saurav/P-1366-2019		Natural Science Foundation of Jiangsu, China [BK20131192]; National Natural Science Foundation of China [31370548]; Science and Technology Plan Project of General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China [JSCIQ_20141K013]; Suzhou Science and Technology Plan Projects [SYN201304]	Natural Science Foundation of Jiangsu, China(Natural Science Foundation of Jiangsu Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Plan Project of General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China; Suzhou Science and Technology Plan Projects	The present work received funding from following sources: 1. Natural Science Foundation of Jiangsu, China - Grant No-BK20131192; 2. National Natural Science Foundation of China Grant No.-31370548; 3. Science and Technology Plan Project of General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China. Grant No. - JSCIQ_20141K013; 4. Suzhou Science and Technology Plan Projects. Grant No- SYN201304.	Beckmann M, 2011, ECOL RES, V26, P763, DOI 10.1007/s11284-011-0834-3; Burke IC, 2003, WEED SCI, V51, P683, DOI 10.1614/0043-1745(2003)051[0683:IOEFOB]2.0.CO;2; Chauhan BS, 2006, WEED SCI, V54, P1004, DOI 10.1614/WS-06-087R.1; Chauhan BS, 2009, WEED SCI, V57, P379, DOI 10.1614/WS-08-179.1; Chrobock T, 2011, BASIC APPL ECOL, V12, P244, DOI 10.1016/j.baae.2011.03.001; Cohn Marc A., 2008, ANN BOT, V102, P877; Costea M, 2004, CAN J PLANT SCI, V84, P631, DOI 10.4141/P02-183; DREYER GD, 1987, B TORREY BOT CLUB, V114, P260, DOI 10.2307/2996463; Feng JM, 2010, BIODIVERS CONSERV, V19, P3489, DOI 10.1007/s10531-010-9909-7; FORCELLA F, 1986, WEED RES, V26, P351, DOI 10.1111/j.1365-3180.1986.tb00718.x; Ghorbani R, 1999, WEED SCI, V47, P505, DOI 10.1017/S0043174500092183; GROSS KL, 1984, J ECOL, V72, P369, DOI 10.2307/2260053; Guo PG, 2003, WEED SCI, V51, P869, DOI 10.1614/P2002-127; Holm L., 1979, GEOGRAPHICAL ATLAW; Holzmueller EJ, 2013, INVASIVE PLANT ECOLOGY, P7; Huang QQ, 2009, BIODIVERS CONSERV, V18, P305, DOI 10.1007/s10531-008-9485-2; Jose S, 2013, INVASIVE PLANT ECOLOGY, P1; Kudoh H, 2007, ECOL RES, V22, P869, DOI 10.1007/s11284-007-0417-5; Lavergne S, 2004, OIKOS, V107, P505, DOI 10.1111/j.0030-1299.2004.13423.x; Leiblein-Wild MC, 2014, OECOLOGIA, V174, P739, DOI 10.1007/s00442-013-2813-6; Li YP, 2009, WEED SCI, V57, P26, DOI 10.1614/WS-08-068.1; Ma J. S., 2013, CHECKLIST CHINESE IN; Mandak B, 2003, FLORA, V198, P45, DOI 10.1078/0367-2530-00075; Mattana E, 2010, PLANT SPEC BIOL, V25, P165, DOI 10.1111/j.1442-1984.2010.00280.x; MICHEL BE, 1983, PLANT PHYSIOL, V72, P66, DOI 10.1104/pp.72.1.66; Moravcova L, 2010, PRESLIA, V82, P365; Noe GB, 2000, AM J BOT, V87, P1679, DOI 10.2307/2656745; Novoa A, 2014, BIOL INVASIONS, V16, P429, DOI 10.1007/s10530-013-0531-y; Perglova I, 2009, PRESLIA, V81, P357; Pysek Petr, 2007, V193, P97; Radford IJ, 2000, OECOLOGIA, V125, P531, DOI 10.1007/s004420000474; Rejmanek M., 2005, Invasive alien species: a new synthesis, P161; Schlaepfer DR, 2010, NEW PHYTOL, V185, P1087, DOI 10.1111/j.1469-8137.2009.03114.x; Sellers BA, 2003, WEED SCI, V51, P329, DOI 10.1614/0043-1745(2003)051[0329:CGOSAS]2.0.CO;2; Skalova H, 2011, PERSPECT PLANT ECOL, V13, P173, DOI 10.1016/j.ppees.2011.03.005; Steckel LE, 2004, WEED SCI, V52, P217, DOI 10.1614/WS-03-012R; Thomas WE, 2006, WEED SCI, V54, P316; Tobe K, 2007, ARID LAND RES MANAG, V21, P181, DOI 10.1080/15324980701429342; Van Acker RC, 2009, WEED RES, V49, P1, DOI 10.1111/j.1365-3180.2008.00656.x; Van Kleunen M, 2007, J ECOL, V95, P674, DOI 10.1111/j.1365-2745.2007.01250.x; van Kleunen M, 2011, J BIOGEOGR, V38, P1294, DOI 10.1111/j.1365-2699.2011.02495.x; van Kleunen M, 2010, ECOL LETT, V13, P947, DOI 10.1111/j.1461-0248.2010.01503.x; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Wang Kun, 2009, Biodiversity Science, V17, P353, DOI 10.3724/SP.J.1003.2009.09055; Weber E, 2008, BIOL INVASIONS, V10, P1411, DOI 10.1007/s10530-008-9216-3; Xu HG., 2004, CATALOG INVASIVE SPE; Young AS, 2007, AM J BOT, V94, P228, DOI 10.3732/ajb.94.2.228	48	19	20	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170297	10.1371/journal.pone.0170297	http://dx.doi.org/10.1371/journal.pone.0170297			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107495	gold, Green Published, Green Submitted			2022-12-26	WOS:000392405300102
J	Tai, EL; Li, LJ; Wan-Hazabbah, WH; Wong, TY; Shatriah, I				Tai, Evelyn Li Min; Li, Ling-Jun; Wan-Hazabbah, Wan Hitam; Wong, Tien-Yin; Shatriah, Ismail			Effect of Axial Eye Length on Retinal Vessel Parameters in 6 to 12-Year-Old Malay Girls	PLOS ONE			English	Article							VASCULAR CALIBER; BLOOD-PRESSURE; MICROVASCULAR ABNORMALITIES; CARDIOVASCULAR-DISEASE; FRACTAL DIMENSION; OCULAR BIOMETRY; IMAGE-ANALYSIS; CHILDREN; RISK; ASSOCIATION	Purpose Retinal vessel analysis is affected by both systemic and ocular factors. Malays are the major ethnicity in South East Asia. Data on the retinal microvasculature in Malays is limited, especially among children. We aim to evaluate the influence of ocular biometry on retinal vessel parameters in young Malay girls. Methods This was a cross-sectional, hospital-based study involving 86 Malay girls aged 6 to 12 years old in Hospital Universiti Sains Malaysia from 2015-2016. Ocular examination, refraction, biometry, retinal photography, and anthropometric measurements were performed. The central retinal arteriolar equivalent (CRAE), central retinal venular equivalent (CRVE) and overall fractal dimension (Df) were measured using validated computer-based methods (Singapore I vessel analyzer, SIVA version 3.0, Singapore). The associations of ocular biometry and CRAE, CRVE and Df were analyzed using multivariable analysis. Results The mean CRAE, CRVE and Df in Malay girls were 171.40 (14.40) um, 248.02 (16.95) um and 1.42 (0.05) respectively. Each 1 mm increase in axial length was associated with a reduction of 4.25 um in the CRAE (p = 0.03) and a reduction of 0.02 in the Df (p = 0.02), after adjustment for age, blood pressure and body mass index. No association was observed between axial length and CRVE. Anterior chamber depth and corneal curvature had no association with CRAE, CRVE or Df. Conclusion Axial length affects retinal vessel measurements. Narrower retinal arterioles and reduced retinal fractal dimension were observed in Malay girls with longer axial lengths.	[Tai, Evelyn Li Min; Wan-Hazabbah, Wan Hitam; Shatriah, Ismail] Univ Sains Malaysia, Sch Med Sci, Dept Ophthalmol, Hlth Campus, Kubang Kerian, Kelantan, Malaysia; [Tai, Evelyn Li Min; Wan-Hazabbah, Wan Hitam; Shatriah, Ismail] Hosp Univ Sains Malaysia, Kubang Kerian, Kelantan, Malaysia; [Li, Ling-Jun; Wong, Tien-Yin] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Li, Ling-Jun; Wong, Tien-Yin] Duke NUS Sch Med, Singapore, Singapore; [Wong, Tien-Yin] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia	Universiti Sains Malaysia; Universiti Sains Malaysia; National University of Singapore; Singapore National Eye Center; Centre for Eye Research Australia; University of Melbourne	Tai, EL; Shatriah, I (corresponding author), Univ Sains Malaysia, Sch Med Sci, Dept Ophthalmol, Hlth Campus, Kubang Kerian, Kelantan, Malaysia.; Tai, EL; Shatriah, I (corresponding author), Hosp Univ Sains Malaysia, Kubang Kerian, Kelantan, Malaysia.	daileid@yahoo.com; shatriah@usm.my	Tai, Evelyn/V-1522-2018; Shatriah, Ismail/D-3637-2016; Wong, Tien Yin/AAC-9724-2020	Tai, Evelyn/0000-0001-8055-5396; Shatriah, Ismail/0000-0002-4753-4814; Wong, Tien Yin/0000-0002-8448-1264	Universiti Sains Malaysia Research Grant [304/PPSP/61313063]	Universiti Sains Malaysia Research Grant(Universiti Sains Malaysia)	This work was funded by a Universiti Sains Malaysia Research Grant, 304/PPSP/61313063 (http://www.research.usm.my/) awarded to ELMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyol N, 1996, CAN J OPHTHALMOL, V31, P113; [Anonymous], 1944, WORLD ATL INT ED; BENGTSSON B, 1992, GRAEF ARCH CLIN EXP, V230, P24, DOI 10.1007/BF00166758; Bernardes R, 2011, OPHTHALMOLOGICA, V226, P161, DOI 10.1159/000329597; Blumenbach J. F., 1865, ANTHR TREATISES JOHA; Broe R, 2015, ACTA OPHTHALMOL, V93, P1, DOI 10.1111/aos.12702; Cheung CY, 2012, AM J OPHTHALMOL, V154, P663, DOI 10.1016/j.ajo.2012.04.016; Cheung N, 2007, AM J OPHTHALMOL, V144, P658, DOI 10.1016/j.ajo.2007.07.023; Cheung N, 2007, OBESITY, V15, P209, DOI 10.1038/oby.2007.576; Cheung N, 2007, INVEST OPHTH VIS SCI, V48, P1018, DOI 10.1167/iovs.06-0978; Chew SKH, 2012, CURR HYPERTENS REP, V14, P144, DOI 10.1007/s11906-012-0252-0; Dastiridou AI, 2013, INVEST OPHTH VIS SCI, V54, P2087, DOI 10.1167/iovs.12-11576; Department of Statistics Malaysia, 2010, POPULATION DISTRIBUT; Dirani M, 2010, CLIN EXP OPHTHALMOL, V38, P577, DOI 10.1111/j.1442-9071.2010.02322.x; Gopinath B, 2013, INVEST OPHTH VIS SCI, V54, P1501, DOI 10.1167/iovs.12-11036; Gopinath B, 2012, AM J CLIN NUTR, V95, P1215, DOI 10.3945/ajcn.111.031641; Gopinath B, 2011, INT J PEDIATR OBES, V6, pE353, DOI 10.3109/17477166.2010.500390; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Kawasaki R, 2011, NEUROLOGY, V76, P1766, DOI 10.1212/WNL.0b013e31821a7d7d; Kawasaki R, 2012, STROKE, V43, P3245, DOI 10.1161/STROKEAHA.112.673335; Knudtson MD, 2003, CURR EYE RES, V27, P143, DOI 10.1076/ceyr.27.3.143.16049; Kurniawan ED, 2012, INVEST OPHTH VIS SCI, V53, P470, DOI 10.1167/iovs.11-8835; Li LJ, 2011, INVEST OPHTH VIS SCI, V52, P9561, DOI 10.1167/iovs.11-7969; Liew G, 2008, OPHTHALMOLOGY, V115, P1951, DOI 10.1016/j.ophtha.2008.05.029; Liew G, 2011, EUR HEART J, V32, P422, DOI 10.1093/eurheartj/ehq431; Lim SW, 2009, DIABETES CARE, V32, P2081, DOI 10.2337/dc09-0719; Luzhnov P V, 2015, Vestn Ross Akad Med Nauk, P372, DOI 10.15690/vramn.v70i3.1336; Masters BR, 2004, ANNU REV BIOMED ENG, V6, P427, DOI 10.1146/annurev.bioeng.6.040803.140100; Nemeth J, 2001, J GLAUCOMA, V10, P390; Patton N, 2006, PROG RETIN EYE RES, V25, P99, DOI 10.1016/j.preteyeres.2005.07.001; Patton N, 2005, J ANAT, V206, P319, DOI 10.1111/j.1469-7580.2005.00395.x; Rochtchina E, 2008, INVEST OPHTH VIS SCI, V49, P1362, DOI 10.1167/iovs.07-0150; Rosman M, 2012, CLIN EXP OPHTHALMOL, V40, P557, DOI 10.1111/j.1442-9071.2012.02763.x; Shimada N, 2004, GRAEF ARCH CLIN EXP, V242, P284, DOI 10.1007/s00417-003-0836-0; Stosic T, 2006, IEEE T MED IMAGING, V25, P1101, DOI 10.1109/TMI.2006.879316; Wong TY, 2006, ARCH INTERN MED, V166, P2388, DOI 10.1001/archinte.166.21.2388; Wong TY, 2004, AM J OPHTHALMOL, V137, P1050, DOI 10.1016/j.ajo.2004.01.035; Wong TY, 2001, SURV OPHTHALMOL, V46, P59, DOI 10.1016/S0039-6257(01)00234-X; Zhu PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106551	39	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170014	10.1371/journal.pone.0170014	http://dx.doi.org/10.1371/journal.pone.0170014			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107389	Green Published, Green Submitted, gold			2022-12-26	WOS:000392405300062
J	Wang, CX; Wang, Q; Hu, JY; Sun, HL; Pu, J; Liu, JH; Sun, YP				Wang, Chenxi; Wang, Qian; Hu, Junyi; Sun, Honglei; Pu, Juan; Liu, Jinhua; Sun, Yipeng			A Multiplex RT-PCR Assay for Detection and Differentiation of Avian-Origin Canine H3N2, Equine-Origin H3N8, Human-Origin H3N2, and H1N1/2009 Canine Influenza Viruses	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; A-VIRUS; DOGS; TRANSMISSION; INFECTION; DISEASE; CHINA; H5N1	Virological and serological surveys have documented that H1N1/2009, avian-origin canine H3N2 (cH3N2), seasonal human-origin H3N2 (hH3N2), and equine-origin H3N8 influenza viruses are consistently circulating in dogs. In the present study, a multiplex reverse-transcriptase polymerase chain reaction (mRT-PCR) assay was developed for simultaneous detection and differentiation of these influenza viruses. Four primer sets were designed to target the hemagglutinin genes of H1N1/2009, cH3N2, hH3N2, and H3N8 canine influenza viruses (CIVs). This mRT-PCR assay demonstrated high specificity and sensitivity for the four CIV subtypes. Additionally, mRT-PCR results obtained from 420 clinical samples were consistent with those obtained by the conventional virus isolation method. Our mRT-PCR assay is reliable for clinical diagnosis and rapid identification of CIVs.	[Wang, Chenxi; Wang, Qian; Hu, Junyi; Sun, Honglei; Pu, Juan; Liu, Jinhua; Sun, Yipeng] China Agr Univ, Coll Vet Med, Key Lab Anim Epidemiol & Zoonosis, Minist Agr, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Sun, YP (corresponding author), China Agr Univ, Coll Vet Med, Key Lab Anim Epidemiol & Zoonosis, Minist Agr, Beijing, Peoples R China.	sypcau@163.com			National Natural Science Foundation of China [31672573]; National Key Technology Research and Development Program [2013BAD121301]; Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) [20130008120011]; Beijing New-star Plan of Science and Technology [xx2016073]; Chang Jiang Scholars Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Research and Development Program(National Key Technology R&D Program); Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Beijing New-star Plan of Science and Technology; Chang Jiang Scholars Program(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Natural Science Foundation of China (31672573), National Key Technology Research and Development Program (2013BAD121301), Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) (20130008120011), Beijing New-star Plan of Science and Technology (xx2016073), and grants from the Chang Jiang Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belak S, 2009, REV SCI TECH OIE, V28, P233, DOI 10.20506/rst.28.1.1853; CHANG C P, 1976, International Journal of Zoonoses, V3, P61; Chen HT, 2008, VET RES COMMUN, V32, P491, DOI 10.1007/s11259-008-9052-z; Chen HT, 2009, J VIROL METHODS, V158, P58, DOI 10.1016/j.jviromet.2009.01.026; Crawford PC, 2005, SCIENCE, V310, P482, DOI 10.1126/science.1117950; Daly JM, 2008, EMERG INFECT DIS, V14, P461, DOI 10.3201/eid1403.070643; Dundon WG, 2010, EMERG INFECT DIS, V16, P2019, DOI 10.3201/eid1612.100514; Fu GH, 2010, VIRUS GENES, V41, P236, DOI 10.1007/s11262-010-0508-1; HOUSER RE, 1980, CAN J COMP MED, V44, P396; Jirjis FF, 2010, VET MICROBIOL, V144, P303, DOI 10.1016/j.vetmic.2010.02.029; KILBOURNE ED, 1976, INTERVIROLOGY, V6, P315, DOI 10.1159/000149485; Kruth SA, 2008, CAN VET J, V49, P800; Lee C, 2010, VET MICROBIOL, V143, P184, DOI 10.1016/j.vetmic.2009.11.037; Lee E, 2016, MOL CELL PROBE, V30, P56, DOI 10.1016/j.mcp.2015.12.002; Li SJ, 2010, INFECT GENET EVOL, V10, P1286, DOI 10.1016/j.meegid.2010.08.010; Lu ZC, 2010, J VET DIAGN INVEST, V22, P942, DOI 10.1177/104063871002200614; NIKITIN T, 1972, B WORLD HEALTH ORGAN, V47, P471; Oh J., 2008, EMERG INFECT DIS, V14, P741, DOI [10.3201/eid1405.071471, DOI 10.3201/eid1405.071471]; Payungporn S, 2008, EMERG INFECT DIS, V14, P902, DOI 10.3201/eid1406.071270; Pecoraro HL, 2013, J VET DIAGN INVEST, V25, P402, DOI 10.1177/1040638713480500; REED L. J., 1938, AMER JOUR HYG, V27, P493; Song D, 2009, EMERG INFECT DIS, V15, P56, DOI 10.3201/eid1501.080755; Songserm T, 2006, EMERG INFECT DIS, V12, P1744, DOI 10.3201/eid1211.060542; Sun XX, 2013, INFECT GENET EVOL, V20, P471, DOI 10.1016/j.meegid.2013.10.012; Sun Y, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/214841; Sun YP, 2013, VIROLOGY, V435, P301, DOI 10.1016/j.virol.2012.09.037; Tang QD, 2012, J VIROL METHODS, V181, P164, DOI 10.1016/j.jviromet.2012.02.003; Tao QM, 2009, J VET DIAGN INVEST, V21, P623, DOI 10.1177/104063870902100506; Wang RXE, 2010, EXPERT REV ANTI-INFE, V8, P517, DOI 10.1586/ERI.10.24; Wei HL, 2006, VIRUS GENES, V32, P261, DOI 10.1007/s11262-005-6910-4; Wei K, 2014, J VIROL, V88, P11981, DOI 10.1128/JVI.01679-14; Yoon KJ, 2005, EMERG INFECT DIS, V11, P1974	32	7	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170374	10.1371/journal.pone.0170374	http://dx.doi.org/10.1371/journal.pone.0170374			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107507	Green Published, gold, Green Submitted			2022-12-26	WOS:000392405300120
J	Yuan, Y; Feng, HJ; Wang, LF; Li, ZF; Shi, YQ; Zhao, LH; Feng, ZL; Zhu, HQ				Yuan, Yuan; Feng, Hongjie; Wang, Lingfei; Li, Zhifang; Shi, Yongqiang; Zhao, LiHong; Feng, Zili; Zhu, Heqin			Potential of Endophytic Fungi Isolated from Cotton Roots for Biological Control against Verticillium Wilt Disease	PLOS ONE			English	Article							BACTERIAL ENDOPHYTES; GOSSYPIUM-HIRSUTUM; KNOT NEMATODE; RESISTANCE; DAHLIAE; PLANTS; ACID; BIOCONTROL; MANAGEMENT; DIVERSITY	Verticillium wilt is a soil-borne disease, and severely limits the development of cotton production. To investigate the role of endophytic fungi on Verticillium wilt, CEF-818 (Penicillium simplicissimum), CEF-714 (Leptosphaeria sp.), CEF-642 (Talaromyces flavus.) and CEF-193 (Acremonium sp.) isolated from cotton roots were used to assess their effects against cotton wilt disease caused by a defoliating V. dahliae strain Vd080. In the greenhouse, all treatments significantly reduced disease incidence and disease index, with the control efficacy ranging from 26% (CEF-642) to 67% (CEF-818) at 25 days (d) after inoculation. In the disease nursery, compared to controls (with disease incidence of 33.8% and disease index of 31), CEF-818, CEF-193, CEF-714 and CEF-642 provided a protection effect of 69.5%, 69.2%, 54.6% and 45.7%, respectively. Especially, CEF-818 and CEF-714 still provided well protection against Verticillium wilt with 46.9% and 56.6% or 14.3% and 33.7% at the first peak of the disease in heavily infected field, respectively (in early July). These results indicated that these endophytes not only delayed but also reduced wilt symptoms on cotton. In the harvest, the available cotton bolls of plant treated with CEF-818 and CEF-714 increased to 13.1, and 12.2, respectively. And the seed cotton yield significantly increased after seed bacterization with CEF-818 (3442.04 kg/ha) compared to untreated control (3207.51 kg/ha) by 7.3%. Furtherly, CEF-818 and CET-714 treatment increased transcript levels for PAL, PPO, POD, which leads to the increase of cotton defense reactions. Our results indicate that seed treatment of cotton plants with CEF-818 and CET-714 can help in the biocontrol of V. dahliae and improve seed cotton yield in cotton fields. This study provided a better understanding of cotton-endophyte interactions which will aid in developing effective biocontrol agents for Verticillium wilt of cotton in futhre.	[Yuan, Yuan; Feng, Hongjie; Wang, Lingfei; Li, Zhifang; Shi, Yongqiang; Zhao, LiHong; Feng, Zili; Zhu, Heqin] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Feng, ZL; Zhu, HQ (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China.	fzlsky@126.com; heqinanyang@163.com			National Transgenic Major Projects [2014ZX0800501B-002]; Special Fund for Agro-scientific Research in the Public Interest [201503109]	National Transgenic Major Projects; Special Fund for Agro-scientific Research in the Public Interest	We appreciate the support of the National Transgenic Major Projects (Grant number 2014ZX0800501B-002) and Special Fund for Agro-scientific Research in the Public Interest (201503109).	Adams PD, 2002, PLANT SOIL, V240, P181, DOI 10.1023/A:1015840224564; Athman S.Y., 2006, HOST ENDOPHYTE PEST; Back MA, 2002, PLANT PATHOL, V51, P683, DOI 10.1046/j.1365-3059.2002.00785.x; Bogs J, 2005, PLANT PHYSIOL, V139, P652, DOI 10.1104/pp.105.064238; BROOKS DS, 1994, BIOL CONTROL, V4, P373, DOI 10.1006/bcon.1994.1047; Cai YF, 2009, AFR J BIOTECHNOL, V8, P7363; Cortesero AM, 2000, BIOL CONTROL, V17, P35, DOI 10.1006/bcon.1999.0777; Dalton DA, 2004, FEMS MICROBIOL ECOL, V49, P469, DOI 10.1016/j.femsec.2004.04.010; Erdogan O, 2010, BIOL CONTROL, V53, P39, DOI 10.1016/j.biocontrol.2009.11.011; Eynck C, 2009, PHYTOPATHOLOGY, V99, P802, DOI 10.1094/PHYTO-99-7-0802; Forchetti G, 2007, APPL MICROBIOL BIOT, V76, P1145, DOI 10.1007/s00253-007-1077-7; Fradin EF, 2006, MOL PLANT PATHOL, V7, P71, DOI [10.1111/j.1364-3703.2006.00323.x, 10.1111/J.1364-3703.2006.00323.X]; Fravel D. R., 1991, Biocontrol Science and Technology, V1, P91, DOI 10.1080/09583159109355189; Gadjev I, 2006, PLANT PHYSIOL, V141, P436, DOI 10.1104/pp.106.078717; Gao W, 2013, MOL CELL PROTEOMICS, V12, P3690, DOI 10.1074/mcp.M113.031013; Gore ME, 2009, CROP PROT, V28, P215, DOI 10.1016/j.cropro.2008.10.004; Goswami J, 2008, J ENVIRON SCI HEAL B, V43, P237, DOI 10.1080/03601230701771164; Grayston SJ, 1997, APPL SOIL ECOL, V5, P29, DOI 10.1016/S0929-1393(96)00126-6; Hallmann J, 1998, SOIL BIOL BIOCHEM, V30, P925, DOI 10.1016/S0038-0717(97)00183-1; Hallmann J, 1997, CAN J MICROBIOL, V43, P895, DOI 10.1139/m97-131; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; Hossain MM, 2007, PLANT CELL PHYSIOL, V48, P1724, DOI 10.1093/pcp/pcm144; JACKSON RM, 1995, MYCORRHIZA, V5, P165, DOI 10.1007/BF00203333; James C, 2003, CURR SCI INDIA, V84, P303; Lopez-Escudero FJ, 2011, PLANT SOIL, V344, P1, DOI 10.1007/s11104-010-0629-2; KAGEYAMA S.A., 2008, MYCORRHIZA STATE ART, P29, DOI DOI 10.1007/978-3-540-78826-3_2; Katsantonis D, 2005, PHYTOPARASITICA, V33, P215, DOI 10.1007/BF02979858; Kim DS, 2014, J EXP BOT, V65, P2295, DOI 10.1093/jxb/eru109; KIM KK, 1988, PHYTOPATHOLOGY, V78, P488, DOI 10.1094/Phyto-78-488; Klosterman SJ, 2009, ANNU REV PHYTOPATHOL, V47, P39, DOI 10.1146/annurev-phyto-080508-081748; LETACON F, 1992, MYCORRHIZAS IN ECOSYSTEMS, P119; Li AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028810; Li CH, 2012, J APPL MICROBIOL, V113, P641, DOI 10.1111/j.1365-2672.2012.05371.x; Li CH, 2010, MICROB ECOL, V59, P344, DOI 10.1007/s00248-009-9570-4; Li ZF, 2014, J MICROBIOL BIOTECHN, V24, P1149, DOI 10.4014/jmb.1402.02035; Luo Ming, 2003, Acta Genetica Sinica, V30, P175; Naraghi L, 2012, J PLANT GROWTH REGUL, V31, P471, DOI 10.1007/s00344-011-9256-2; Naraghi L, 2010, PHYTOPATHOL MEDITERR, V49, P321; Naraghi L, 2010, CROP PROT, V29, P658, DOI 10.1016/j.cropro.2010.01.011; Pomar F, 2004, NEW PHYTOL, V163, P111, DOI 10.1111/j.1469-8137.2004.01092.x; Ruby E. J., 2011, J PHARM RES, V4, P795; Sheng XF, 2008, INT BIODETER BIODEGR, V62, P88, DOI 10.1016/j.ibiod.2007.12.003; STOREY GW, 1987, PLANT PATHOL, V36, P192, DOI 10.1111/j.1365-3059.1987.tb02221.x; Tiwari R, 2010, CURR MICROBIOL, V60, P167, DOI 10.1007/s00284-009-9520-x; Van Buren AM, 1993, PHYTOPATHOLOGY, V83, P140; WILSON D, 1995, OIKOS, V73, P274, DOI 10.2307/3545919; Xu L, 2011, J EXP BOT, V62, P5607, DOI 10.1093/jxb/err245; Yan XN, 2011, J ZHEJIANG UNIV-SC B, V12, P219, DOI 10.1631/jzus.B1000165; Yang C, 2008, PLANT SCI, V174, P290, DOI 10.1016/j.plantsci.2007.11.016; Zhu HQ, 2013, J PHYTOPATHOL, V161, P70, DOI 10.1111/jph.12027	50	65	71	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170557	10.1371/journal.pone.0170557	http://dx.doi.org/10.1371/journal.pone.0170557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107448	Green Submitted, Green Published, gold			2022-12-26	WOS:000392405300163
J	Zhao, L; Ji, G; Le, X; Luo, Z; Wang, C; Feng, M; Xu, L; Zhang, Y; Lau, WB; Lau, B; Yang, Y; Lei, L; Yang, H; Xuan, Y; Chen, Y; Deng, X; Yi, T; Yao, S; Zhao, X; Wei, Y; Zhou, S				Zhao, L.; Ji, G.; Le, X.; Luo, Z.; Wang, C.; Feng, M.; Xu, L.; Zhang, Y.; Lau, W. B.; Lau, B.; Yang, Y.; Lei, L.; Yang, H.; Xuan, Y.; Chen, Y.; Deng, X.; Yi, T.; Yao, S.; Zhao, X.; Wei, Y.; Zhou, S.			An integrated analysis identifies STAT4 as a key regulator of ovarian cancer metastasis	ONCOGENE			English	Article							MESENCHYMAL STEM-CELLS; TUMOR MICROENVIRONMENT; EXPRESSION; INVASION; PROMOTES; FIBROBLASTS; GROWTH; MODEL	Epithelial ovarian cancer (EOC) is one of the most common gynecological cancers, with diagnosis often at a late stage. Metastasis is a major cause of death in patients with EOC, but the underlying molecular mechanisms remain obscure. Here, we utilized an integrated approach to find potential key transcription factors involved in ovarian cancer metastasis and identified STAT4 as a critical player in ovarian cancer metastasis. We found that activated STAT4 was overexpressed in epithelial cells of ovarian cancer and STAT4 overexpression was associated with poor outcome of ovarian cancer patients, which promoted metastasis of ovarian cancer in both in vivo and in vitro. Although STAT4 mediated EOC metastasis via inducing epithelial-to-mesenchymal transition (EMT) of ovarian cancer cells in vivo, STAT4 failed to induce EMT directly in vitro, suggesting that STAT4 might mediate EMT process via cancer-stroma interactions. Further functional analysis revealed that STAT4 overexpression induced normal omental fibroblasts and adipose- and bone marrow-derived mesenchymal stem cells to obtain cancer-associated fibroblasts (CAF)-like features via induction of tumor-derived Wnt7a. Reciprocally, increased production of CAF-induced CXCL12, IL6 and VEGFA within tumor microenvironment could enable peritoneal metastasis of ovarian cancer via induction of EMT program. In summary, our study established a model that STAT4 promotes ovarian cancer metastasis via tumor-derived Wnt7a-induced activation of CAFs.	[Zhao, L.; Ji, G.; Le, X.; Zhang, Y.; Xuan, Y.; Yi, T.; Yao, S.; Zhao, X.; Wei, Y.; Zhou, S.] Sichuan Univ, Dept Obstet & Gynecol, Key Lab Birth Defects & Related Dis Women, Chengdu 610041, Peoples R China; [Zhao, L.; Ji, G.; Le, X.; Zhang, Y.; Xuan, Y.; Yi, T.; Yao, S.; Zhao, X.; Wei, Y.; Zhou, S.] Sichuan Univ, Children Minist Educ, West China Second Hosp, Chengdu 610041, Peoples R China; [Zhao, L.; Ji, G.; Le, X.; Zhang, Y.; Xuan, Y.; Yi, T.; Yao, S.; Zhao, X.; Wei, Y.; Zhou, S.] Sichuan Univ, State Key Lab Biotherapy, Collaborat Innovat Ctr, West China Hosp, Chengdu 610041, Peoples R China; [Luo, Z.; Wang, C.] Sichuan Univ, Coll Biol Sci, Chengdu, Peoples R China; [Feng, M.; Xu, L.] Sichuan Univ, West China Second Hosp, Dept Pathol, Chengdu, Peoples R China; [Lau, W. B.] Thomas Jefferson Univ Hosp, Dept Emergency Med, Philadelphia, PA 19107 USA; [Lau, B.] Affiliate Stanford Univ, Kaiser Santa Clara Med Ctr, Dept Surg Emergency Med, Santa Clara, CA USA; [Yang, Y.; Lei, L.] Sichuan Univ, West China Sch Med, Chengdu, Peoples R China; [Yang, H.] Sichuan Univ, West China Hosp, Dept Orthoped, Chengdu, Peoples R China; [Chen, Y.; Deng, X.] Sichuan Univ, West China Hosp, Dept Surg Gastroenterol, Chengdu, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University; Sichuan University; Jefferson University; Sichuan University; Sichuan University; Sichuan University	Zhao, L (corresponding author), Sichuan Univ, Dept Obstet & Gynecol, Key Lab Birth Defects & Related Dis Women, Chengdu 610041, Peoples R China.; Zhao, L (corresponding author), Sichuan Univ, Children Minist Educ, West China Second Hosp, Chengdu 610041, Peoples R China.; Zhao, L (corresponding author), Sichuan Univ, State Key Lab Biotherapy, Collaborat Innovat Ctr, West China Hosp, Chengdu 610041, Peoples R China.	taotaovip2005@163.com		Zhang, Yaguang/0000-0002-9216-1834; Zhou, Shengtao/0000-0001-8322-5536; Lau, Wayne Bond/0000-0002-8064-8290	National Natural Science Foundation of China [81402396]; Sichuan Science-Technology Soft Sciences Project [2016ZR0086]; Yi Yao Foundation [14H0563]; West China Second Hospital, Sichuan University [KS021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Science-Technology Soft Sciences Project; Yi Yao Foundation; West China Second Hospital, Sichuan University	This work was supported by grants from the National Natural Science Foundation of China (grant #81402396), Sichuan Science-Technology Soft Sciences Project (grant #2016ZR0086), Yi Yao Foundation (grant #14H0563) and Direct Scientific Research Grants from West China Second Hospital, Sichuan University (grant #KS021).	Ao Z, 2015, CANCER RES, V75, P4681, DOI 10.1158/0008-5472.CAN-15-1633; Baumann C, 2015, P NATL ACAD SCI USA, V112, P4056, DOI 10.1073/pnas.1418549112; Charlet J, 2016, MOL CELL, V62, P422, DOI 10.1016/j.molcel.2016.03.033; Chen WJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4472; Cheng JM, 2015, J BIOL REG HOMEOS AG, V29, P85; Cordero AB, 2010, JOVE-J VIS EXP, V42, P2125, DOI DOI 10.3791/2125;42; Gandellini P, 2015, SEMIN CANCER BIOL, V35, P96, DOI 10.1016/j.semcancer.2015.08.008; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Jeon ES, 2008, STEM CELLS, V26, P789, DOI 10.1634/stemcells.2007-0742; Kenny HA, 2007, INT J CANCER, V121, P1463, DOI 10.1002/ijc.22874; Kim KW, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0197-8; King ML, 2015, ONCOGENE, V34, P3452, DOI 10.1038/onc.2014.277; Kipps E, 2013, NAT REV CANCER, V13, P273, DOI 10.1038/nrc3432; Ko SY, 2012, J CLIN INVEST, V122, P3603, DOI 10.1172/JCI62229; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Litvinov IV, 2014, CELL CYCLE, V13, P2975, DOI 10.4161/15384101.2014.947759; Luo ZY, 2016, CANCER LETT, V377, P174, DOI 10.1016/j.canlet.2016.04.038; McLean K, 2011, J CLIN INVEST, V121, P3206, DOI 10.1172/JCI45273; Nick AM, 2015, NAT REV CLIN ONCOL, V12, P239, DOI 10.1038/nrclinonc.2015.26; Peng Y, 2016, SIGNAL TRANSDUCT TAR, V1, P1; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Roider HG, 2009, BIOINFORMATICS, V25, P435, DOI 10.1093/bioinformatics/btn627; Sharon Y, 2013, JOVE-J VIS EXP, DOI 10.3791/4425; Shen HJ, 2016, CELL, V165, P331, DOI 10.1016/j.cell.2016.02.064; Tang LJ, 2015, CELL PHYSIOL BIOCHEM, V37, P143, DOI 10.1159/000430340; Thibault B, 2014, CANCER METAST REV, V33, P17, DOI 10.1007/s10555-013-9456-2; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Wubetu GY, 2014, ANN SURG ONCOL, V21, pS721, DOI 10.1245/s10434-014-3861-9; Xu XF, 2014, MOL CANCER THER, V13, P1729, DOI 10.1158/1535-7163.MCT-13-0982; Yoshioka S, 2012, MOL CANCER RES, V10, P469, DOI 10.1158/1541-7786.MCR-11-0177; Yu KH, 2016, MOL CELL PROTEOMICS, V15, P2525, DOI 10.1074/mcp.O116.059253; Zhou ST, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M112.017988; Zhou XY, 2014, CELL PHYSIOL BIOCHEM, V33, P1003, DOI 10.1159/000358671	35	50	52	2	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 15	2017	36	24					3384	3396		10.1038/onc.2016.487	http://dx.doi.org/10.1038/onc.2016.487			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EX6GL	28114283				2022-12-26	WOS:000403340700003
J	Buntgen, U; Bagi, I; Fekete, O; Molinier, V; Peter, M; Splivallo, R; Vahdatzadeh, M; Richard, F; Murat, C; Tegel, W; Stobbe, U; Martinez-Pena, F; Sproll, L; Hulsmann, L; Nievergelt, D; Meier, B; Egli, S				Buntgen, Ulf; Bagi, Istvan; Fekete, Oszkar; Molinier, Virginie; Peter, Martina; Splivallo, Richard; Vahdatzadeh, Maryam; Richard, Franck; Murat, Claude; Tegel, Willy; Stobbe, Ulrich; Martinez-Pena, Fernando; Sproll, Ludger; Hulsmann, Lisa; Nievergelt, Daniel; Meier, Barbara; Egli, Simon			New Insights into the Complex Relationship between Weight and Maturity of Burgundy Truffles ( Tuber aestivum)	PLOS ONE			English	Article							ECTOMYCORRHIZAL COMMUNITIES; UNCINATUM; VITTAD.; AROMA; CULTIVATION; DECOMPOSITION; VARIABILITY; MICROBIOME; VOLATILES	Despite an increasing demand for Burgundy truffles (Tuber aestivum), gaps remain in our understanding of the fungus' overall lifecycle and ecology. Here, we compile evidence from three independent surveys in Hungary and Switzerland. First, we measured the weight and maturity of 2,656 T. aestivum fruit bodies from a three-day harvest in August 2014 in a highly productive orchard in Hungary. All specimens ranging between 2 and 755 g were almost evenly distributed through five maturation classes. Then, we measured the weight and maturity of another 4,795 T. aestivum fruit bodies harvested on four occasions between June and October 2015 in the same truffiere. Again, different maturation stages occurred at varying fruit body size and during the entire fruiting season. Finally, the predominantly unrelated weight and maturity of 81 T. aestivum fruit bodies from four fruiting seasons between 2010 and 2013 in Switzerland confirmed the Hungarian results. The spatiotemporal coexistence of 7,532 small-ripe and large-unripe T. aestivum, which accumulate to similar to 182 kg, differs from species-specific associations between the size and ripeness that have been reported for other mushrooms. Although size-independent truffle maturation stages may possibly relate to the perpetual belowground environment, the role of mycelial connectivity, soil property, microclimatology, as well as other abiotic factors and a combination thereof, is still unclear. Despite its massive sample size and proof of concept, this study, together with existing literature, suggests consideration of a wider ecological and biogeographical range, as well as the complex symbiotic fungus-host interaction, to further illuminate the hidden development of belowground truffle fruit bodies.	[Buntgen, Ulf] Univ Cambridge, Dept Geog, Cambridge, England; [Buntgen, Ulf; Molinier, Virginie; Peter, Martina; Hulsmann, Lisa; Nievergelt, Daniel; Meier, Barbara; Egli, Simon] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Buntgen, Ulf] CzechGlobe Res Inst CAS, Brno, Czech Republic; [Buntgen, Ulf] Masaryk Univ Brno, Brno, Czech Republic; [Bagi, Istvan; Fekete, Oszkar] Truffleminers Ltd, Taksony Kinizsi, Hungary; [Splivallo, Richard; Vahdatzadeh, Maryam] Goethe Univ Frankfurt, Inst Mol Bio Sci, Frankfurt, Germany; [Splivallo, Richard; Vahdatzadeh, Maryam] Integrat Fungal Res Cluster IPF, Frankfurt, Germany; [Richard, Franck] Univ Montpellier, UMR CEFE 5175, Montpellier, France; [Murat, Claude] Univ Lorraine, Interact Arbres Microorganismes UMR1136, Vandoeuvre Les Nancy, France; [Murat, Claude] INRA, Interact Arbres Microorganismes UMR1136, Champenoux, France; [Tegel, Willy] Albert Ludwigs Univ, Chair Forest Growth, Freiburg, Germany; [Stobbe, Ulrich; Sproll, Ludger] AlbertLudwigs Univ, Chair Forest Bot, Freiburg, Germany; [Stobbe, Ulrich; Sproll, Ludger] Deutsch Truffelbaume, Radolfzell am Bodensee, Germany; [Martinez-Pena, Fernando] Agrifood Res & Technol Ctr Aragon CITA, Zaragoza, Spain; [Martinez-Pena, Fernando] European Mycol Inst EGTC EMI, Soria, Spain	University of Cambridge; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Czech Academy of Sciences; Global Change Research Centre of the Czech Academy of Sciences; Masaryk University Brno; Goethe University Frankfurt; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Universite de Lorraine; INRAE; Universite de Lorraine; University of Freiburg	Buntgen, U (corresponding author), Univ Cambridge, Dept Geog, Cambridge, England.	buentgen@wsl.ch	Hülsmann, Lisa/B-6680-2017; Simonneau, Thierry/AAI-1230-2019; Nievergelt, Daniel/J-7156-2012; Murat, Claude/AAA-5226-2020; Tegel, Willy/M-8187-2014; Peter, Martina/G-2284-2018; buentgen, ulf/J-6952-2013; MARTINEZ-PENA, FERNANDO/H-9093-2015	Hülsmann, Lisa/0000-0003-4252-2715; Nievergelt, Daniel/0000-0003-0402-9348; Murat, Claude/0000-0003-0685-7307; Peter, Martina/0000-0002-6365-6889; Tegel, Willy/0000-0003-4707-2848; MARTINEZ-PENA, FERNANDO/0000-0002-4402-4237; Splivallo, Richard/0000-0002-7567-6553	WSL-internal DITREC project; Ernst Gohner Foundation; Swiss State Secretariat for Education, Research and Innovation (SERI): COST Action [FP1203]; Ministry of Education, Youth and Sports of CR within the National Sustainability Program I (NPU I) [LO1415]; LOEWE research-funding program of the government of Hessen; German Research Foundation (DFG) [1191/4-1]; French National Research Agency (ANR) as part of the "Investissements d'Avenir program [UMR1136, ANR-11-LABX-0002-01]	WSL-internal DITREC project; Ernst Gohner Foundation; Swiss State Secretariat for Education, Research and Innovation (SERI): COST Action; Ministry of Education, Youth and Sports of CR within the National Sustainability Program I (NPU I); LOEWE research-funding program of the government of Hessen; German Research Foundation (DFG)(German Research Foundation (DFG)); French National Research Agency (ANR) as part of the "Investissements d'Avenir program(French National Research Agency (ANR))	Supported by the WSL-internal DITREC project, the Ernst Gohner Foundation, as well as the Swiss State Secretariat for Education, Research and Innovation (SERI): COST Action FP1203. Moreover, U. Buntgen received funding from the Ministry of Education, Youth and Sports of CR within the National Sustainability Program I (NPU I), grant number LO1415., whereas R. Splivallo and M. Vandatzadeh were supported by the LOEWE research-funding program of the government of Hessen, in the framework of the Integrative Fungal Research Cluster (IPF) and by the German Research Foundation (DFG) - grant number 1191/4-1. The UMR1136 is supported by a grant overseen by the French National Research Agency (ANR) as part of the "Investissements d'Avenir program (ANR-11-LABX-0002-01, Lab of Excellence ARBRE). Truffleminers Ltd provided support in the form of salaries for authors [IB, OF], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funder provided support in the form of salaries for authors [UB, RS, MV, CM, IB, OF], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Antony-Babu S, 2014, ENVIRON MICROBIOL, V16, P2831, DOI 10.1111/1462-2920.12294; Auguie B, 2017, GRIDEXTRA MISCELLANE; Benucci GMN, 2016, MICROB ECOL, V72, P4, DOI 10.1007/s00248-016-0755-3; Benucci GMN, 2012, MYCORRHIZA, V22, P383, DOI 10.1007/s00572-011-0413-z; Benucci GMN, 2011, FEMS MICROBIOL ECOL, V76, P170, DOI 10.1111/j.1574-6941.2010.01039.x; Bonito G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052765; Buntgen U, 2012, NAT CLIM CHANGE, V2, P827, DOI 10.1038/nclimate1733; Buntgen U, 2012, FRONT ECOL ENVIRON, V10, P462, DOI 10.1890/12.WB.021; Buntgen U, 2011, FRONT ECOL ENVIRON, V9, P150, DOI 10.1890/11.WB.004; Callot G., 1999, TERRE VIE; Cullere L, 2010, FOOD CHEM, V122, P300, DOI 10.1016/j.foodchem.2010.02.024; Debuchy R, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P501; Diamandis Stephanos, 2008, Acta Mycologica, V43, P139, DOI 10.5586/am.2008.017; Diaz P, 2009, FOOD SCI TECHNOL, V42, P1253; Ekblad A, 2013, PLANT SOIL, V366, P1, DOI 10.1007/s11104-013-1630-3; Fernandez CW, 2014, SOIL BIOL BIOCHEM, V77, P150, DOI 10.1016/j.soilbio.2014.06.026; Frey-Klett P, 2007, NEW PHYTOL, V176, P22, DOI 10.1111/j.1469-8137.2007.02191.x; Gogan Andrea Csorbai, 2012, Acta Mycologica, V47, P133, DOI 10.5586/am.2012.015; Gryndler M, 2011, FEMS MICROBIOL LETT, V318, P84, DOI 10.1111/j.1574-6968.2011.02243.x; Hall IR, 2003, TRENDS BIOTECHNOL, V21, P433, DOI 10.1016/S0167-7799(03)00204-X; Harki E, 2006, FOOD CHEM, V99, P394, DOI 10.1016/j.foodchem.2005.08.030; Healy RA, 2013, MOL ECOL, V22, P1717, DOI 10.1111/mec.12135; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Kues U, 2000, APPL MICROBIOL BIOT, V54, P141, DOI 10.1007/s002530000396; Le Tacon F, 2016, ANN FOREST SCI, V73, P105, DOI 10.1007/s13595-015-0461-1; Le Tacon F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064626; Martin F, 2011, NEW PHYTOL, V189, P645, DOI 10.1111/j.1469-8137.2010.03618.x; Martinez-Pena F, 2012, FOREST ECOL MANAG, V282, P63, DOI 10.1016/j.foreco.2012.06.034; Mello A, 2010, PLANT BIOSYST, V144, P323, DOI 10.1080/11263500903374724; Mello A, 2002, ENVIRON MICROBIOL, V4, P584, DOI 10.1046/j.1462-2920.2002.00343.x; Molinier V, 2013, DIVERSITY EVOL, V13, P503; Molinier V, 2015, ENVIRON MICROBIOL, V17, P3039, DOI 10.1111/1462-2920.12910; Moore D., 1998, FUNGAL MORPHOGENESIS; Moore-Kucera J, 2008, SOIL BIOL BIOCHEM, V40, P2485, DOI 10.1016/j.soilbio.2008.06.002; Pacioni G, 2014, MYCORRHIZA, V24, pS65, DOI 10.1007/s00572-014-0561-z; Pacioni G, 2015, PHYTOCHEMISTRY, V110, P104, DOI 10.1016/j.phytochem.2014.11.012; Paolocci F, 2006, APPL ENVIRON MICROB, V72, P2390, DOI 10.1128/AEM.72.4.2390-2393.2006; Paolocci F, 2004, FEMS MICROBIOL LETT, V235, P109, DOI 10.1016/femsle.2004.04.029; Rubini A, 2011, NEW PHYTOL, V189, P723, DOI 10.1111/j.1469-8137.2010.03493.x; Salerni E, 2014, FOREST SYST, V23, P329, DOI 10.5424/fs/2014232-04777; Samils N, 2008, ECON BOT, V62, P331, DOI 10.1007/s12231-008-9030-y; Shamekh S, 2014, MYCOL PROG, V13, P373, DOI 10.1007/s11557-013-0923-5; Splivallo R, 2015, ENVIRON MICROBIOL, V17, P2647, DOI 10.1111/1462-2920.12521; Splivallo R, 2015, APPL MICROBIOL BIOT, V99, P2583, DOI 10.1007/s00253-014-6360-9; Splivallo R, 2012, NEW PHYTOL, V194, P823, DOI 10.1111/j.1469-8137.2012.04077.x; Splivallo R, 2011, NEW PHYTOL, V189, P688, DOI 10.1111/j.1469-8137.2010.03523.x; Stobbe U, 2013, MYCORRHIZA, V23, P669, DOI 10.1007/s00572-013-0508-9; Stobbe U, 2013, APPL MICROBIOL BIOT, V97, P5215, DOI 10.1007/s00253-013-4956-0; Stobbe U, 2012, FUNGAL ECOL, V5, P591, DOI 10.1016/j.funeco.2012.02.001; TALOU T, 1992, RECHERCHE, V23, P30; Vahdatzadeh M, 2015, APPL ENVIRON MICROB, V81, P6946, DOI 10.1128/AEM.01098-15; Weden C, 2005, ENVIRON MICROBIOL, V7, P1535, DOI 10.1111/j.1462-2920.2005.00837.x; Weden C, 2004, MYCOL RES, V108, P304, DOI 10.1017/S0953756204009256; Weden C, 2004, MYCORRHIZA, V14, P19, DOI 10.1007/s00572-003-0271-4; Zawirska-Wojtaslak R, 2004, FOOD CHEM, V86, P113, DOI 10.1016/j.foodchem.2003.08.016; Zeppa S, 2004, RAPID COMMUN MASS SP, V18, P199, DOI 10.1002/rcm.1313	56	22	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170375	10.1371/journal.pone.0170375	http://dx.doi.org/10.1371/journal.pone.0170375			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125633	Green Published, gold, Green Submitted			2022-12-26	WOS:000396176100115
J	Rudenick, PA; Segers, P; Pineda, V; Cuellar, H; Garcia-Dorado, D; Evangelista, A; Bijnens, BH				Rudenick, Paula A.; Segers, Patrick; Pineda, Victor; Cuellar, Hug; Garcia-Dorado, David; Evangelista, Arturo; Bijnens, Bart H.			False Lumen Flow Patterns and their Relation with Morphological and Biomechanical Characteristics of Chronic Aortic Dissections. Computational Model Compared with Magnetic Resonance Imaging Measurements	PLOS ONE			English	Article							SYSTEMIC ARTERIAL TREE; IN-VITRO PHANTOM; BLOOD-FLOW; TEAR SIZE; VALIDATION; HEMODYNAMICS; SIMULATIONS; STIFFNESS; PRESSURE; LOCATION	Aortic wall stiffness, tear size and location and the presence of abdominal side branches arising from the false lumen (FL) are key properties potentially involved in FL enlargement in chronic aortic dissections (ADs). We hypothesize that temporal variations on FL flow patterns, as measured in a cross-section by phase-contrast magnetic resonance imaging (PC-MRI), could be used to infer integrated information on these features. In 33 patients with chronic descending AD, instantaneous flow profiles were quantified in the FL at diaphragm level by PC-MRI. We used a lumped-parameter model to assess the changes in flow profiles induced by wall stiffness, tear size/location, and the presence of abdominal side branches arising from the FL. Four characteristic FL flow patterns were identified in 31/33 patients (94%) based on the direction of flow in systole and diastole: B-A = systolic biphasic flow and primarily diastolic antegrade flow (n = 6); B-R = systolic biphasic flow and primarily diastolic retrograde flow (n = 14); M-A = systolic monophasic flow and primarily diastolic antegrade flow (n = 9); M-R = systolic monophasic flow and primarily diastolic retrograde flow (n = 2). In the computational model, the temporal variation of flow directions within the FL was highly dependent on the position of assessment along the aorta. FL flow patterns (especially at the level of the diaphragm) showed their characteristic patterns due to variations in the cumulative size and the spatial distribution of the communicating tears, and the incidence of visceral side branches originating from the FL. Changes in wall stiffness did not change the temporal variation of the flows whereas it importantly determined intraluminal pressures. FL flow patterns implicitly codify morphological information on key determinants of aortic expansion in ADs. This data might be taken into consideration in the imaging protocol to define the predictive value of FL flows.	[Rudenick, Paula A.; Bijnens, Bart H.] Univ Pompeu Fabra, Physense, Barcelona, Spain; [Rudenick, Paula A.; Pineda, Victor; Cuellar, Hug; Garcia-Dorado, David; Evangelista, Arturo] Univ Autonoma Barcelona, Univ Hosp & Res Inst Vall dHebron, Barcelona, Spain; [Segers, Patrick] Univ Ghent, Inst Biomed Technol, Biofluid Tissue & Solid Mech Med Applicat, Ghent, Belgium; [Bijnens, Bart H.] ICREA, Barcelona, Spain	Pompeu Fabra University; Autonomous University of Barcelona; Ghent University; ICREA	Rudenick, PA (corresponding author), Univ Pompeu Fabra, Physense, Barcelona, Spain.; Rudenick, PA (corresponding author), Univ Autonoma Barcelona, Univ Hosp & Res Inst Vall dHebron, Barcelona, Spain.	paula.rudenick@upf.edu	Bijnens, Bart/AAE-7186-2021; Bijnens, Bart H/C-2955-2008; Segers, Patrick/AAA-7844-2020; Pineda, Victor/ABC-2772-2021; Rudenick, Paula Andrea/D-8100-2014	Bijnens, Bart/0000-0003-3130-6937; Bijnens, Bart H/0000-0003-3130-6937; Segers, Patrick/0000-0003-3870-3409; Rudenick, Paula Andrea/0000-0003-0561-0193; Cuellar-Calabria, Hug/0000-0003-2197-4990	Subprograma de Proyectos de Investigacion en Salud (FIS), Instituto de Salud Carlos III, Spain [PI108/0608, PI11/01709]; Programa de ayudas destinadas a universidades, centros de investigacion y fundaciones hospitalarias para la contratacion de personal investigador novel (FI-DGR), Spain; EU FP7 for research, technological development and demonstration under grant VP2HF [611823]; ICREA Funding Source: Custom	Subprograma de Proyectos de Investigacion en Salud (FIS), Instituto de Salud Carlos III, Spain; Programa de ayudas destinadas a universidades, centros de investigacion y fundaciones hospitalarias para la contratacion de personal investigador novel (FI-DGR), Spain; EU FP7 for research, technological development and demonstration under grant VP2HF; ICREA(ICREA)	The research leading to these results has received funding from the Subprograma de Proyectos de Investigacion en Salud (FIS), Instituto de Salud Carlos III, Spain (ref. PI108/0608, PI11/01709); the Programa de ayudas destinadas a universidades, centros de investigacion y fundaciones hospitalarias para la contratacion de personal investigador novel (FI-DGR 2011), Spain; and the EU FP7 for research, technological development and demonstration under grant agreement VP2HF (no 611823). All authors have reported that they have no relationships relevant to the contents of this paper to disclose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akin I, 2009, EUR J VASC ENDOVASC, V37, P289, DOI 10.1016/j.ejvs.2008.12.004; Amano Y, 2011, MAGN RESON MED SCI, V10, P93, DOI 10.2463/mrms.10.93; Berguer R, 2015, ANN VASC SURG, V29, P167, DOI 10.1016/j.avsg.2014.10.001; Bernard Y, 2001, AM J CARDIOL, V87, P1378, DOI 10.1016/S0002-9149(01)01556-9; CHANG JM, 1991, J COMPUT ASSIST TOMO, V15, P418, DOI 10.1097/00004728-199105000-00013; Clough RE, 2012, J VASC SURG, V55, P914, DOI 10.1016/j.jvs.2011.11.005; Collette M, 2011, HYPERTENS RES, V34, P578, DOI 10.1038/hr.2010.280; Dillon-Murphy D, 2015, BIOMECH MOD IN PRESS; ERBEL R, 1993, CIRCULATION, V87, P1604, DOI 10.1161/01.CIR.87.5.1604; Evangelista A, 2006, THORACIC AORTIC DIS, P33; Evangelista A, 2012, CIRCULATION, V125, P3133, DOI 10.1161/CIRCULATIONAHA.111.090266; Francois CJ, 2013, J THORAC CARDIOV SUR, V145, P1359, DOI 10.1016/j.jtcvs.2012.07.019; Ince H, 2007, HEART, V93, P266, DOI 10.1136/hrt.2005.078550; Inoue T, 2000, JPN CIRC J, V64, P760, DOI 10.1253/jcj.64.760; JAGER GN, 1965, CIRC RES, V16, P121, DOI 10.1161/01.RES.16.2.121; Johnson DA, 2011, J BIOMECH, V44, P869, DOI 10.1016/j.jbiomech.2010.12.003; Juvonen T, 1999, J THORAC CARDIOV SUR, V117, P776, DOI 10.1016/S0022-5223(99)70299-0; LEAROYD BM, 1966, CIRC RES, V18, P278, DOI 10.1161/01.RES.18.3.278; Mensel B, 2013, ACAD RADIOL, V20, P1004, DOI 10.1016/j.acra.2013.03.014; Milisic V, 2004, ESAIM-MATH MODEL NUM, V38, P613, DOI 10.1051/m2an:2004036; Nienaber CA, 2006, ESC TXB CARDIOVASCUL, P993; Nollen GJ, 2004, EUR HEART J, V25, P1146, DOI 10.1016/j.ehj.2004.04.033; Quint LE, 2003, J ENDOVASC THER, V10, P505, DOI 10.1583/1545-1550(2003)010<0505:AITDWS>2.0.CO;2; Reymond P, 2012, ANN BIOMED ENG, V40, P742, DOI 10.1007/s10439-011-0443-x; Reymond P, 2009, AM J PHYSIOL-HEART C, V297, pH208, DOI 10.1152/ajpheart.00037.2009; Rudenick PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124011; Rudenick PA, 2013, J VASC SURG, V57, P464, DOI 10.1016/j.jvs.2012.07.008; Shi YB, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-33; Soudah E, 2015, COMPUT METHOD BIOMEC, V18, P805, DOI 10.1080/10255842.2013.847095; Strotzer M, 2000, ACTA RADIOL, V41, P594; Taylor M, 2011, MCDONALD'S BLOOD FLOW IN ARTERIES: THEORETICAL, EXPERIMENTAL AND CLINICAL PRINCIPLES, 6TH EDITION, P13; Tsai TT, 2008, J VASC SURG, V47, P844, DOI 10.1016/j.jvs.2007.11.059; Veger HTC, 2015, EUR J VASC ENDOVASC, V49, P375, DOI 10.1016/j.ejvs.2014.12.016; WESTERHOF N, 1969, J BIOMECH, V2, P121, DOI 10.1016/0021-9290(69)90024-4; Williams D M, 1993, J Vasc Interv Radiol, V4, P75, DOI 10.1016/S1051-0443(93)71824-2; ZEIHER AM, 1991, CIRCULATION, V83, P391, DOI 10.1161/01.CIR.83.2.391	36	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170888	10.1371/journal.pone.0170888	http://dx.doi.org/10.1371/journal.pone.0170888			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125720	gold, Green Published, Green Submitted			2022-12-26	WOS:000396176100031
J	Taylor, C; Cadenhead, N; Lindenmayer, DB; Wintle, BA				Taylor, Chris; Cadenhead, Natasha; Lindenmayer, David B.; Wintle, Brendan A.			Improving the Design of a Conservation Reserve for a Critically Endangered Species	PLOS ONE			English	Article							SOUTH-EASTERN AUSTRALIA; MOUNTAIN ASH FOREST; ARBOREAL MARSUPIALS; PROTECTED AREAS; BIODIVERSITY CONSERVATION; METAPOPULATION VIABILITY; LANDSCAPE CONTEXT; CENTRAL HIGHLANDS; FIRE SEVERITY; HABITAT	Setting aside protected areas is a key strategy for tackling biodiversity loss. Reserve effectiveness depends on the extent to which protected areas capture both known occurrences and areas likely to support the species. We assessed the effectiveness of the existing reserve network for Leadbeater's Possum (Gymnobelideus leadbeateri) and other forest-dependent species, and compared the existing reserve system to a set of plausible reserve expansion options based on area targets implied in a recent Population Viability Analysis (PVA). The existing Leadbeater's Reserve and surrounding reserve system captured 7.6% and 29.6% of cumulative habitat suitability, respectively, across the landscape. Expanded reserve scenarios captured 34% to 62% of cumulative habitat suitability. We found acute trade-offs between conserving Leadbeater's Possum habitat and conserving habitat of other forest-dependent species. Our analysis provides a template for systematically expanding and evaluating reserve expansion options in terms of trade-offs between priority species' needs.	[Taylor, Chris] Univ Melbourne, Melbourne Sustainable Soc Inst, Parkville, Vic, Australia; [Cadenhead, Natasha; Wintle, Brendan A.] Univ Melbourne, Sch Biosci, Parkville, Vic, Australia; [Lindenmayer, David B.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia	University of Melbourne; University of Melbourne; Australian National University	Lindenmayer, DB (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia.	david.lindenmayer@anu.edu.au	Cadenhead, Natasha/AAE-8767-2021; Lindenmayer, David B/P-7183-2017	Lindenmayer, David B/0000-0002-4766-4088; wintle, brendan/0000-0002-4234-5950; Cadenhead, Natasha/0000-0002-8274-485X	ARC Future Fellowship [FT100100819]; ARC Laureate Fellowship [FL120100108]; CSIRO; Department of the Environment, Water, Heritage and the Arts	ARC Future Fellowship(Australian Research Council); ARC Laureate Fellowship(Australian Research Council); CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Department of the Environment, Water, Heritage and the Arts	NC and BW were support by ARC Future Fellowship FT100100819. DBL was supported by ARC Laureate Fellowship FL120100108. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; NC and BW were support by ARC Future Fellowship FT100100819. DBL was supported by ARC Laureate Fellowship FL120100108. Helpful advice on modelling and data were provided by Graeme Newell, Michael Scroggie, and Matt White (Victoria's Arthur Rylah Institute). The authors would like to thank Kristen Williams at CSIRO for some of the environmental data, which was compiled as part of a Caring for Country project co-funded by CSIRO and the Department of the Environment, Water, Heritage and the Arts.	Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Blair DP, 2016, ECOL APPL, V26, P2280, DOI 10.1002/eap.1369; Burns EL, 2015, AUSTRAL ECOL, V40, P386, DOI 10.1111/aec.12200; Caro T. M, 2010, CONSERVATION PROXY I; Chen Y, 2016, DIVERS DISTRIB; Department of Environment Land Water and Planning, 2016, VICT BIOD ATL; Department of Environment Land Water and Planning, 1998, FOR MAN PLAN CENTR H; Fiorella K, 2010, BIOL CONSERV, V143, P963, DOI 10.1016/j.biocon.2010.01.005; Gibbons P., 2002, TREE HOLLOWS WILDLIF, DOI [10.1071/9780643090033, DOI 10.1071/9780643090033]; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Klein CJ, 2010, FRONT ECOL ENVIRON, V8, P349, DOI 10.1890/090047; Kujala H, 2015, BIOL CONSERV, V192, P513, DOI 10.1016/j.biocon.2015.08.017; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Lindenmayer D, 2015, MOUNTAIN ASH: FIRE, LOGGING AND THE FUTURE OF VICTORIA'S GIANT FORESTS, P1; Lindenmayer D, 2009, FOREST PATTERN AND ECOLOGICAL PROCESS: A SYNTHESIS OF 25 YEARS OF RESEARCH, P1; Lindenmayer DB, 2013, BIOL CONSERV, V167, P137, DOI 10.1016/j.biocon.2013.07.028; Lindenmayer DB, 2011, BIOL CONSERV, V144, P1663, DOI 10.1016/j.biocon.2011.02.022; Lindenmayer D.B., 2002, CONSERVING FOREST BI; Lindenmayer DB, 2006, BIODIVERS CONSERV, V15, P4079, DOI 10.1007/s10531-005-3367-7; Lindenmayer DB, 2016, FOREST ECOL MANAG, V372, P226, DOI 10.1016/j.foreco.2016.04.017; Lindenmayer David B., 2015, Pacific Conservation Biology, V21, P266, DOI 10.1071/PC15042; Lindenmayer DB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089807; Lindenmayer DB, 1999, BIOL CONSERV, V89, P83, DOI 10.1016/S0006-3207(98)00116-5; Lindenmayer DB, 2000, J MAMMAL, V81, P787, DOI 10.1644/1545-1542(2000)081<0787:HFLCAM>2.3.CO;2; LINDENMAYER DB, 1995, ECOL APPL, V5, P183, DOI 10.2307/1942062; Lumsden L.F., 2013, NEW STRATEGIC APPROA; Lutze M. T., 1999, Australian Forestry, V62, P236; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McCarthy MA, 1999, FOREST ECOL MANAG, V124, P193, DOI 10.1016/S0378-1127(99)00066-3; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Milledge D.R., 1991, P53; Moilanen A, 2005, P ROY SOC B-BIOL SCI, V272, P1885, DOI 10.1098/rspb.2005.3164; Moilanen A., 2014, SPATIAL CONSERVATION; Rodriguez JP, 2007, DIVERS DISTRIB, V13, P243, DOI 10.1111/j.1472-4642.2007.00356.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; POSSINGHAM HP, 1994, BIOL CONSERV, V70, P227, DOI 10.1016/0006-3207(94)90167-8; Rayner L, 2014, ECOGRAPHY, V37, P43, DOI 10.1111/j.1600-0587.2013.00388.x; Rodrigues ASL, 2007, ANNU REV ECOL EVOL S, V38, P713, DOI 10.1146/annurev.ecolsys.38.091206.095737; Russo D, 2015, J ZOOL, V297, P165, DOI 10.1111/jzo.12271; Sebastian-Gonzalez E, 2011, BIOL CONSERV, V144, P2354, DOI 10.1016/j.biocon.2011.06.015; Smith S., 2001, OPTIONS PERMANENT RE; Taylor AC, 2007, MOL ECOL, V16, P2655, DOI 10.1111/j.1365-294X.2007.03331.x; Taylor C, 2014, CONSERV LETT, V7, P355, DOI 10.1111/conl.12122; Todd CR, 2016, ECOL MODEL, V338, P90, DOI 10.1016/j.ecolmodel.2016.07.021; van Steenis W., 2021, IUCN RED LIST THREAT, pe.T149165436A149165446, DOI [10.2305/IUCN.UK.2021-3.RLTS.T149165436A149165446.en, DOI 10.2305/IUCN.UK.2021-1.RLTS.T49254712A49256721]; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Watson JEM, 2014, NATURE, V515, P67, DOI 10.1038/nature13947; Williams KJ, 2012, INT J GEOGR INF SCI, V26, P2009, DOI 10.1080/13658816.2012.698015; Worboys GL, 2015, PROTECTED AREA GOVERNANCE AND MANAGEMENT, P1; Xu T., 2011, ANUCLIM VERSION 6 1	51	24	26	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0169629	10.1371/journal.pone.0169629	http://dx.doi.org/10.1371/journal.pone.0169629			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28121984	Green Published, gold, Green Submitted			2022-12-26	WOS:000396167300071
J	Harati, S; Cooper, LAD; Moran, JD; Giuste, FO; Du, YH; Ivanov, AA; Johns, MA; Khuri, FR; Fu, HA; Moreno, CS				Harati, Sahar; Cooper, Lee A. D.; Moran, Josue D.; Giuste, Felipe O.; Du, Yuhong; Ivanov, Andrei A.; Johns, Margaret A.; Khuri, Fadlo R.; Fu, Haian; Moreno, Carlos S.			MEDICI: Mining Essentiality Data to Identify Critical Interactions for Cancer Drug Target Discovery and Development	PLOS ONE			English	Article							NEGATIVE BREAST-CANCER; CELL LUNG-CANCER; BETA-CATENIN; P53 PATHWAY; IN-VITRO; GROWTH; ACTIVATION; INHIBITION; SCREEN; VULNERABILITIES	Protein-protein interactions (PPIs) mediate the transmission and regulation of oncogenic signals that are essential to cellular proliferation and survival, and thus represent potential targets for anti-cancer therapeutic discovery. Despite their significance, there is no method to experimentally disrupt and interrogate the essentiality of individual endogenous PPIs. The ability to computationally predict or infer PPI essentiality would help prioritize PPIs for drug discovery and help advance understanding of cancer biology. Here we introduce a computational method (MEDICI) to predict PPI essentiality by combining gene knockdown studies with network models of protein interaction pathways in an analytic framework. Our method uses network topology to model how gene silencing can disrupt PPIs, relating the unknown essentialities of individual PPIs to experimentally observed protein essentialities. This model is then deconvolved to recover the unknown essentialities of individual PPIs. We demonstrate the validity of our approach via prediction of sensitivities to compounds based on PPI essentiality and differences in essentiality based on genetic mutations. We further show that lung cancer patients have improved overall survival when specific PPIs are no longer present, suggesting that these PPIs may be potentially new targets for therapeutic development. Software is freely available at https://github.com/cooperlab/MEDICI. Datasets are available at https://ctd2.nci.nih.gov/dataPortal.	[Harati, Sahar; Cooper, Lee A. D.; Moreno, Carlos S.] Emory Univ, Dept Biomed Informat, Atlanta, GA 30322 USA; [Harati, Sahar] Emory Univ, Grad Program Biomed Informat, Atlanta, GA 30322 USA; [Cooper, Lee A. D.; Du, Yuhong; Khuri, Fadlo R.; Fu, Haian; Moreno, Carlos S.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Cooper, Lee A. D.] Emory Univ, Dept Biomed Engn, Atlanta, GA 30322 USA; [Moran, Josue D.] Emory Univ, Grad Program Canc Biol, Atlanta, GA 30322 USA; [Moran, Josue D.; Moreno, Carlos S.] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Giuste, Felipe O.] Emory Univ, Med Sci Training Program, Atlanta, GA 30322 USA; [Du, Yuhong; Ivanov, Andrei A.; Johns, Margaret A.; Fu, Haian] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA; [Khuri, Fadlo R.] Emory Univ, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; Emory University	Moreno, CS (corresponding author), Emory Univ, Dept Biomed Informat, Atlanta, GA 30322 USA.; Moreno, CS (corresponding author), Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA.; Moreno, CS (corresponding author), Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.	cmoreno@emory.edu	Giuste, Felipe/ABH-9932-2020; Khuri, Fadlo R./AAU-4942-2020; Moreno, Carlos S/B-3863-2009	Giuste, Felipe/0000-0002-8355-3705; Khuri, Fadlo R./0000-0002-8638-7618; Moreno, Carlos S/0000-0002-5582-0028; Ivanov, Andrei A/0000-0001-7476-1329	National Cancer Institute [U01 CA168449]; National Institutes of Health [U01 CA168449]; NATIONAL CANCER INSTITUTE [U01CA168449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Cancer Institute grant U01 CA168449 to HF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Institutes of Health, [grant number U01 CA168449].	AKIYAMA T, 1992, P NATL ACAD SCI USA, V89, P7900, DOI 10.1073/pnas.89.17.7900; Bandopadhayay P, 2014, CLIN CANCER RES, V20, P912, DOI 10.1158/1078-0432.CCR-13-2281; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Benjamini Y, 2001, ANN STAT, V29, P1165; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bilir B, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-280; Brin S, 2012, COMPUT NETW, V56, P3825, DOI 10.1016/j.comnet.2012.10.007; Brummelkamp TR, 2006, NAT CHEM BIOL, V2, P202, DOI 10.1038/nchembio774; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Chesire DR, 2002, ONCOGENE, V21, P2679, DOI 10.1038/sj.onc.1205352; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Colombi M, 2011, ONCOGENE, V30, P1551, DOI 10.1038/onc.2010.539; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; De P, 2016, ONCOTARGET; Deel MD, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00190; Derksen PWB, 2004, P NATL ACAD SCI USA, V101, P6122, DOI 10.1073/pnas.0305855101; Dey N, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-537; Edlund S, 2005, MOL CELL BIOL, V25, P1475, DOI 10.1128/MCB.25.4.1475-1488.2005; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Ford CE, 2016, GYNECOL ONCOL, V140, P345, DOI 10.1016/j.ygyno.2015.09.085; Helming KC, 2014, CANCER CELL, V26, P309, DOI 10.1016/j.ccr.2014.07.018; Helming KC, 2014, NAT MED, V20, P251, DOI 10.1038/nm.3480; Ivanov AA, 2013, TRENDS PHARMACOL SCI, V34, P393, DOI 10.1016/j.tips.2013.04.007; Jeon SH, 2007, J LEUKOCYTE BIOL, V81, P557, DOI 10.1189/jlb.0806517; Jiang P, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0808-9; Jiang XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060464; Kim HS, 2013, CELL, V155, P552, DOI 10.1016/j.cell.2013.09.041; Kim SM, 2012, MOL CANCER THER, V11, P2254, DOI 10.1158/1535-7163.MCT-12-0311; Lee JH, 2013, CLIN CANCER RES, V19, P6777, DOI 10.1158/1078-0432.CCR-13-1110; Lenz HJ, 2014, CANCER SCI, V105, P1087, DOI 10.1111/cas.12471; Li Z, 2016, ONCOPPI CANC P UNPUB; Mitsopoulos C, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004597; Neal CL, 2012, ONCOGENE, V31, P897, DOI 10.1038/onc.2011.284; Newaz K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144389; Pedraza-Alva G, 2006, EMBO J, V25, P763, DOI 10.1038/sj.emboj.7600972; Pratt D, 2015, CELL SYST, V1, P302, DOI 10.1016/j.cels.2015.10.001; Rampurwala M, 2016, CLIN ADV HEMATOL ONC, V14, P186; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Sahni N, 2015, CELL, V161, P647, DOI 10.1016/j.cell.2015.04.013; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shao DD, 2013, GENOME RES, V23, P665, DOI 10.1101/gr.143586.112; Simon M, 2005, ONCOGENE, V24, P2410, DOI 10.1038/sj.onc.1208431; Stolfi C, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.49; Stuhmer T, 2005, BLOOD, V106, P3609, DOI 10.1182/blood-2005-04-1489; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; Tiemessen MM, 2013, FUTURE ONCOL, V9, P1757, DOI [10.2217/FON.13.122, 10.2217/fon.13.122]; Tsai MS, 2012, MOL CANCER THER, V11, P561, DOI 10.1158/1535-7163.MCT-11-0684; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Tu ZD, 2009, GENOME RES, V19, P1057, DOI 10.1101/gr.087890.108; Ueda Y, 2009, INT J ONCOL, V34, P689, DOI 10.3892/ijo_00000195; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wang DY, 2016, CHIN J CANCER, V35, P1, DOI 10.1186/s40880-016-0109-z; Wang L, 2009, BMC GENOMICS, V10, DOI [10.1186/1471-2164-10-220, 10.1186/1471-2164-10-S1-S1]; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Wu CC, 2010, PROTEIN CELL, V1, P573, DOI 10.1007/s13238-010-0075-1; Wyce A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072967; Yang FJ, 2002, J BIOL CHEM, V277, P11336, DOI 10.1074/jbc.M111962200; Yuan F, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/623121; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438; Zhang H, 2015, TUMOR BIOL, V36, P1613, DOI 10.1007/s13277-014-2757-4; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80	67	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2017	12	1							e0170339	10.1371/journal.pone.0170339	http://dx.doi.org/10.1371/journal.pone.0170339			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7CU	28118365	Green Submitted, Green Published, gold			2022-12-26	WOS:000396160500039
J	Artigas, MS; Wain, LV; Shrine, N; McKeever, TM; Sayers, I; Hall, IP; Tobin, MD				Artigas, Maria Soler; Wain, Louise V.; Shrine, Nick; McKeever, Tricia M.; Sayers, Ian; Hall, Ian P.; Tobin, Martin D.		UK BiLEVE	Targeted Sequencing of Lung Function Loci in Chronic Obstructive Pulmonary Disease Cases and Controls	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RARE VARIANTS; REFERENCE VALUES; HERITABILITY	Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide; smoking is the main risk factor for COPD, but genetic factors are also relevant contributors. Genome-wide association studies (GWAS) of the lung function measures used in the diagnosis of COPD have identified a number of loci, however association signals are often broad and collectively these loci only explain a small proportion of the heritability. In order to examine the association with COPD risk of genetic variants down to low allele frequencies, to aid fine-mapping of association signals and to explain more of the missing heritability, we undertook a targeted sequencing study in 300 COPD cases and 300 smoking controls for 26 loci previously reported to be associated with lung function. We used a pooled sequencing approach, with 12 pools of 25 individuals each, enabling high depth (30x) coverage per sample to be achieved. This pooled design maximised sample size and therefore power, but led to challenges during variant-calling since sequencing error rates and minor allele frequencies for rare variants can be very similar. For this reason we employed a rigorous quality control pipeline for variant detection which included the use of 3 independent calling algorithms. In order to avoid false positive associations we also developed tests to detect variants with potential batch effects and removed them before undertaking association testing. We tested for the effects of single variants and the combined effect of rare variants within a locus. We followed up the top signals with data available (only 67% of collapsing methods signals) in 4,249 COPD cases and 11,916 smoking controls from UK Biobank. We provide suggestive evidence for the combined effect of rare variants on COPD risk in TNXB and in sliding windows within MECOM and upstream of HHIP. These findings can lead to an improved understanding of the molecular pathways involved in the development of COPD.	[Artigas, Maria Soler; Wain, Louise V.; Shrine, Nick; Tobin, Martin D.] Univ Leicester, Dept Hlth Sci, Genet Epidemiol Grp, Leicester, Leics, England; [Wain, Louise V.; Tobin, Martin D.] Glenfield Hosp, Natl Inst Hlth Res, Leicester Resp Biomed Res Unit, Leicester, Leics, England; [McKeever, Tricia M.; Sayers, Ian; Hall, Ian P.] Univ Nottingham, Queens Med Ctr, Div Resp Med, Nottingham, England	University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Nottingham	Wain, LV (corresponding author), Univ Leicester, Dept Hlth Sci, Genet Epidemiol Grp, Leicester, Leics, England.	maria.soler@vhir.org; lvw1@leicester.ac.uk	; Soler Artigas, Maria/L-6529-2013	Sayers, Ian/0000-0001-5601-5410; Wain, Louise/0000-0003-4951-1867; Tobin, Martin/0000-0002-3596-7874; Shrine, Nick/0000-0003-3641-4371; Hall, Ian/0000-0001-9933-3216; Soler Artigas, Maria/0000-0002-3213-1107	National Institute for Health Research (NIHR); Medical Research Council [G0902313, G1000861]; Medical Research Council (MRC) [MC_PC_12010]; Medical Research Council [MR/N011317/1, MC_qA137853, MC_PC_12010] Funding Source: researchfish; MRC [MC_PC_12010, MR/N011317/1, G1000861, G0902313] Funding Source: UKRI	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research undertaken by M.D.T., M.S.A., L.V.W. and N.S. was partly funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. M.D.T. holds a Medical Research Council Senior Clinical Fellowship (G0902313). I.P.H. holds a Medical Research Council programme grant (G1000861). The UK BiLEVE study was funded by a Medical Research Council (MRC) strategic award to M.D.T., I.P.H., L.V.W. and David Strachan (MC_PC_12010).; The research undertaken by M.D.T., M.S.A., L.V.W. and N.S. was partly funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. M.D.T. holds a Medical Research Council Senior Clinical Fellowship (G0902313). This research used the ALICE High Performance Computing Facility at the University of Leicester. I.P.H. holds a Medical Research Council programme grant (G1000861). The UK BiLEVE study was funded by a Medical Research Council (MRC) strategic award to M.D.T., I.P.H., L.V.W. and David Strachan (MC_PC_12010). UK BiLEVE members are: Louise V Wain, Nick Shrine, Victoria E Jackson, Ioanna Ntalla, Maria Soler Artigas, Panos Deloukas, Richard Hubbard, Ian Pavord, Anna Hansell, Neil C Thomson, Eleftheria Zeggini, Andrew P Morris, Jonathan Marchini, David Strachan, Martin D Tobin, and Ian P Hall. This research has been conducted using the UK Biobank Resource under Application Number 648. This study makes use of data generated by the UK10K Consortium (www.UK10K.org). We would like to acknowledge Andrew J Wardlaw's contribution.	Abbey DE, 1998, AM J RESP CRIT CARE, V158, P289, DOI 10.1164/ajrccm.158.1.9710101; Altmann A, 2011, BIOINFORMATICS, V27, pI77, DOI 10.1093/bioinformatics/btr205; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Artigas MS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9658; Artigas MS, 2011, AM J RESP CRIT CARE, V184, P786, DOI 10.1164/rccm.201102-0192OC; Bard-Chapeau EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089397; Bei JX, 2010, NAT GENET, V42, P599, DOI 10.1038/ng.601; Castaldi PJ, 2011, AM J RESP CELL MOL B; Chen XW, 2012, GENET EPIDEMIOL, V36, P549, DOI 10.1002/gepi.21648; Cho MH, 2014, LANCET RESP MED, V2, P214, DOI 10.1016/S2213-2600(14)70002-5; Cho MH, 2010, NAT GENET, V42, P200, DOI 10.1038/ng.535; Choi YW, 2007, LUNG CANCER, V55, P43, DOI 10.1016/j.lungcan.2006.09.018; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hankinson JL, 2003, CHEST, V124, P1805, DOI 10.1378/chest.124.5.1805; Hankinson JL, 2010, CHEST, V137, P138, DOI 10.1378/chest.09-0919; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hoyt PR, 1997, MECH DEVELOP, V65, P55, DOI 10.1016/S0925-4773(97)00057-9; Hwang JY, 2013, J MED GENET, V50, P212, DOI 10.1136/jmedgenet-2012-101156; Ingebrigtsen T, 2010, RESP MED, V104, P1890, DOI 10.1016/j.rmed.2010.05.004; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Lawrence R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-527; LEWITTER FI, 1984, AM J EPIDEMIOL, V120, P518, DOI 10.1093/oxfordjournals.aje.a113912; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer TE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001045; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Okada Y, 2012, NAT GENET, V44, P904, DOI 10.1038/ng.2352; Palmer LJ, 2001, EUR RESPIR J, V17, P696, DOI 10.1183/09031936.01.17406960; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Stewart CE, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-112; Wain LV, 2015, LANCET RESP MED, V3, P769, DOI 10.1016/S2213-2600(15)00283-0; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Wei Z, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr599; Wilk JB, 2012, AM J RESP CRIT CARE, V186, P622, DOI 10.1164/rccm.201202-0366OC; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; Yokoi S, 2003, CLIN CANCER RES, V9, P4705; Yuasa H, 2005, EMBO J, V24, P1976, DOI 10.1038/sj.emboj.7600679; Zhou XB, 2012, HUM MOL GENET, V21, P1325, DOI 10.1093/hmg/ddr569	51	8	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170222	10.1371/journal.pone.0170222	http://dx.doi.org/10.1371/journal.pone.0170222			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114305	Green Published, gold			2022-12-26	WOS:000396129000027
J	Xu, ZH; Xiao, T; Li, YH; Yang, KY; Tang, Y; Bai, LQ				Xu, Zuhui; Xiao, Tao; Li, Yanhong; Yang, Kunyun; Tang, Yi; Bai, Liqiong			Reasons for Non-Enrollment in Treatment among Multi-Drug Resistant Tuberculosis Patients in Hunan Province, China	PLOS ONE			English	Article							DIAGNOSIS	In 2015, only 49% of notified multi-drug resistant tuberculosis (MDR-TB) patients in China were estimated to have initiated treatment, compared with 90% of those worldwide. A case-control study was conducted to identify the reasons for non-enrollment in treatment among MDR-TB patients in Hunan province, China. All detected MDR-TB patients registered in designated MDR-TB hospitals in Hunan province from 2011 to 2014 were included and followed until June 2015 to determine their treatment status. Approximately 33.8% (482/1425) of patients were not enrolled in standardized treatment. Factors associated with lower enrollment rate were: age greater than 60 years, living in rural area, unemployed or occupation unreported. Of those who were not enrolled in MDR-TB treatment, the primary reasons for non-enrollment included economic hardship (23.0%), out-migration for work (18.0%), concerns about work and studies (13.7%), and the belief that they were cured after undergoing drug-sensitive TB treatment (12.4%). Therefore, comprehensive strategies targeting priority populations, especially those enhancing treatment affordability and availability, need to be implemented to improve MDR-TB control.	[Xu, Zuhui; Xiao, Tao; Li, Yanhong; Tang, Yi] TB Control Inst Hunan Prov, Dept TB Control, Changsha, Hunan, Peoples R China; [Yang, Kunyun] Hunan Chest Hosp, Dept MDR TB Internal Med, Changsha, Hunan, Peoples R China; [Bai, Liqiong] TB Control Inst Hunan Prov, Dept Directors Off, Changsha, Hunan, Peoples R China		Bai, LQ (corresponding author), TB Control Inst Hunan Prov, Dept Directors Off, Changsha, Hunan, Peoples R China.	liqiong99@126.com	Xu, Zuhui/E-6888-2015	Xu, Zuhui/0000-0003-0757-2768	Medical and Health Research Project of the Hunan Province Health Bureau [132014-138]; World Health Organization County Project [CHN/10/STB/005520]	Medical and Health Research Project of the Hunan Province Health Bureau; World Health Organization County Project	The study was funded by the Medical and Health Research Project of the Hunan Province Health Bureau (132014-138) and the World Health Organization County Project (CHN/10/STB/005520). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, MULTIDRUG EXTENSIVEL; [边学峰 Bian Xuefeng], 2011, [中国公共卫生, China Public Health], V27, P385; Chen J, 2009, CHIN J ANTITUBERC, V31, P337; Chinese Antituberculosis Association, 2015, CHIN J ANTITUBERCULO, V37, P421; Kakchapati S, 2012, ASIA-PAC J PUBLIC HE, V24, P631, DOI 10.1177/1010539511408067; Lamunu D, 2012, INT J TUBERC LUNG D, V16, P480, DOI 10.5588/ijtld.11.0434; Liu CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019399; Naidoo P, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1145-0; Ramma L, 2015, INT J TUBERC LUNG D, V19, P1513, DOI 10.5588/ijtld.15.0341; Rifat M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1253-9; Ruan Y, 2014, CHIN J ANTITUBERC, V36, P308; Sharma A, 2015, INT J TUBERC LUNG D, V19, P1348, DOI 10.5588/ijtld.15.0328; Sun YN, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2327-8; Tattevin P, 2012, INT J TUBERC LUNG D, V6, P480; Wang Y., 2011, WORK PROGRAM MDR TB; Wang Y., 2011, COLLECTION 5 NATIONW, P3; World Health Organization, 2011, MAN US ROUT DAT QUAL; World Health Organization, 2014, DEF REP FRAM TUB 201; World Health Organization, 2015, WHOHTMTB201554; World Health Organization, 2009, WHOHTMTB200913; Yang K, 2012, PRACTICAL PREVENTIVE, V9, P846; Yang XJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117361; Yu L, 2013, CHIN J ANTITUBERC, V35, P370; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789	24	12	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170718	10.1371/journal.pone.0170718	http://dx.doi.org/10.1371/journal.pone.0170718			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114320	Green Submitted, Green Published, gold			2022-12-26	WOS:000396129000088
J	Yang, HS; Woo, JE; Kim, MH; Kim, DY; Yoon, YH				Yang, Hyun Seung; Woo, Jong Eun; Kim, Min-ho; Kim, Dong Yoon; Yoon, Young Hee			Co-Evaluation of Peripapillary RNFL Thickness and Retinal Thickness in Patients with Diabetic Macular Edema: RNFL Misinterpretation and Its Adjustment	PLOS ONE			English	Article							NERVE-FIBER LAYER; ENDOTHELIAL GROWTH-FACTOR; PANRETINAL PHOTOCOAGULATION; CHOROIDAL THICKNESS; RETINOPATHY; GLAUCOMA; NEURODEGENERATION; DEGENERATION; EYES	We investigated the relationship between the peripapillary retinal nerve fiber layer and peripapillary retinal thickness in patients with diabetic macular edema. Fifty eyes (group I) with non-proliferative diabetic retinopathy and diabetic macular edema receiving intravitreal anti-VEGF injection, and 90 eyes (group II) without diabetic macular edema were included in this case-control study. The peripapillary retinal nerve fiber layer thickness, peripapillary retinal thickness, and a new retinal nerve fiber layer index using a modeled relationship between the two parameters were evaluated with spectral-domain optical coherence tomography, at baseline and at the 6-month follow-up. In group I, the peripapillary retinal nerve fiber layer thickness decreased from 126.4 mu m at baseline to 117.6 mu m at 6 months (p < 0.001), while the peripapillary retinal thickness decreased from 376.0 mu m at baseline to 359.6 mu m at 6 months (p < 0.001) after intravitreal anti-VEGF injection. In group II, however, both the parameters remained stable at the 6-month follow-up (100.7 to 102.1 mu m and 311.1 to 316.2 mu m, respectively, and all p > 0.01). Analysis with the new index to adjust for retinal edema showed no significant change from baseline to 6 months in both groups (p = 0.593 and p = 0.101, respectively). The peripapillary retinal nerve fiber layer thickness is strongly affected by the peripapillary retinal thickness. Therefore, the measured changes in peripapillary retinal nerve fiber layer thickness may not represent the real gain or loss of the retinal nerve fiber layer. Therefore, the new retinal nerve fiber layer index, which corrects for the component of macula edema, could be a better means of assessing the changes of peripapillary retinal nerve fiber layer thickness in patients with diabetic macular edema.	[Yang, Hyun Seung] Seoul Shinsegae Eye Ctr, Dept Ophthalmol, Eui Jung Bu, Gyeonggi Do, South Korea; [Woo, Jong Eun] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Ophthalmol, Ulsan, South Korea; [Kim, Min-ho] Univ Ulsan, Ulsan Univ Hosp, Dept Stat, Biomed Res Ctr,Coll Med, Ulsan, South Korea; [Kim, Dong Yoon] Chungbuk Natl Univ, Coll Med, Dept Ophthalmol, Cheongju, South Korea; [Yoon, Young Hee] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Ophthalmol, Seoul, South Korea	University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital; Chungbuk National University; University of Ulsan; Asan Medical Center	Yoon, YH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Ophthalmol, Seoul, South Korea.	yhyoon@amc.seoul.kr	Yang, Hyun Seung/AAC-4319-2020; Yang, Hyun Seung/GRS-1440-2022	Yang, Hyun Seung/0000-0002-0470-676X; Kim, Min-ho/0000-0003-4909-2308	Ministry of Science, Information and Communication Technology, and Future Planning, South Korea [NRF-2013R1A2A2A01068457]	Ministry of Science, Information and Communication Technology, and Future Planning, South Korea	This study was supported by grant number NRF-2013R1A2A2A01068457 from Ministry of Science, Information and Communication Technology, and Future Planning, South Korea. The sponsor or funding organization had no role in the design or conduct of this research.	Barber AJ, 2003, PROG NEURO-PSYCHOPH, V27, P283, DOI 10.1016/S0278-5846(03)00023-X; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Howell SJ, 2013, MOL VIS, V19, P1413; Hsu Sheng-Yao, 2002, Kaohsiung Journal of Medical Sciences, V18, P397; Huang WB, 2013, BMC OPHTHALMOL, V13, DOI 10.1186/1471-2415-13-23; Hwang DJ, 2014, INVEST OPHTH VIS SCI, V55, P4213, DOI 10.1167/iovs.13-13776; Kim J, 2012, RETINA-J RET VIT DIS, V32, P2052, DOI 10.1097/IAE.0b013e3182562000; Lee SB, 2013, RETINA-J RET VIT DIS, V33, P188, DOI 10.1097/IAE.0b013e318261a710; Leung CKS, 2013, OPHTHALMOLOGY, V120, P2485, DOI 10.1016/j.ophtha.2013.07.021; Li L, 2013, AM J OPHTHALMOL, V156, P1277, DOI 10.1016/j.ajo.2013.07.011; Lim MC, 2009, ARCH OPHTHALMOL-CHIC, V127, P857, DOI 10.1001/archophthalmol.2009.135; Lung JCY, 2012, DOC OPHTHALMOL, V125, P123, DOI 10.1007/s10633-012-9343-0; Martinez-de-la-Casa JM, 2012, INVEST OPHTH VIS SCI, V53, P6214, DOI 10.1167/iovs.12-9875; Min JK, 2016, CURR EYE RES, P1; Oh Jaeryung, 2013, Korean J Ophthalmol, V27, P172, DOI 10.3341/kjo.2013.27.3.172; Oshitari T, 2009, EYE, V23, P884, DOI 10.1038/eye.2008.119; Seth RK, 2009, RETINA-J RET VIT DIS, V29, P956, DOI 10.1097/IAE.0b013e3181a91dfd; Shin HJ, 2014, INVEST OPHTH VIS SCI, V55, P2403, DOI 10.1167/iovs.13-13769; Suh W, 2014, JPN J OPHTHALMOL, V58, P62, DOI 10.1007/s10384-013-0290-4; van Dijk HW, 2012, INVEST OPHTH VIS SCI, V53, P2715, DOI 10.1167/iovs.11-8997; van Dijk HW, 2011, VISION RES, V51, P224, DOI 10.1016/j.visres.2010.08.024; Verma A, 2012, OPHTHALMIC RES, V47, P202, DOI 10.1159/000333220; Yang JH, 2013, INVEST OPHTH VIS SCI, V54, P3844, DOI 10.1167/iovs.12-11309	23	32	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e170341	10.1371/journal.pone.0170341	http://dx.doi.org/10.1371/journal.pone.0170341			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114356	gold, Green Published, Green Submitted			2022-12-26	WOS:000396129000038
J	Yoo, JE; Kim, YJ; Rhee, H; Kim, H; Ahn, EY; Choi, JS; Roncalli, M; Park, YN				Yoo, Jeong Eun; Kim, Young-Joo; Rhee, Hyungjin; Kim, Haeryoung; Ahn, Ei Yong; Choi, Jin Sub; Roncalli, Massimo; Park, Young Nyun			Progressive Enrichment of Stemness Features and Tumor Stromal Alterations in Multistep Hepatocarcinogenesis	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; LIVER-CANCER; PROMOTE; CELLS; MICROENVIRONMENT; HEPATOCYTES; EXPRESSION; NODULES; ANTIGEN	Cancer stem cells (CSCs), a subset of tumor cells, contribute to an aggressive biological behavior, which is also affected by the tumor stroma. Despite the role of CSCs and the tumor stroma in hepatocellular carcinoma (HCC), features of stemness have not yet been studied in relation to tumor stromal alterations in multistep hepatocarcinogenesis. We investigated the expression status of stemness markers and tumor stromal changes in B viral carcinogenesis, which is the main etiology of HCC in Asia. Stemness features of tumoral hepatocytes (EpCAM, K19, Oct3/4, c-KIT, c-MET, and CD133), and tumor stromal cells expressing alpha-smooth muscle actin (alpha-SMA), CD68, CD163, and IL-6 were analyzed in 36 low grade dysplastic nodules (DNs), 48 high grade DNs, 30 early HCCs (eHCCs), and 51 progressed HCCs (pHCCs) by immunohistochemistry or real-time PCR. Stemness features (EpCAM and K19 in particular) were progressively acquired during hepatocarcinogenesis in combination with enrichment of stromal cells (CAFs, TAMs, IL-6+ cells). Stemness features were seen sporadically in DNs, more consistent in eHCCs, and peaked in pHCCs. Likewise, stromal cells were discernable in DNs, showed up as consistent cell densities in eHCCs and peaked in pHCCs. The stemness features and tumor stromal alterations also peaked in less differentiated or larger HCCs. In conclusion, progression of B viral multistep hepatocarcinogenesis is characterized by an enrichment of stemness features of neoplastic hepatocytes and a parallel alteration of the tumor stroma. The modulation of neoplastic hepatocytes and stromal cells was at low levels in precancerous lesions (DNs), consistently increased in incipient cancer (eHCCs) and peaked in pHCCs. Thus, in B viral hepatocarcinogenesis, interactions between CSCs and the tumor stroma, although starting early, seem to play a major role in tumor progression.	[Yoo, Jeong Eun; Rhee, Hyungjin; Ahn, Ei Yong; Park, Young Nyun] Yonsei Univ, Dept Pathol, Coll Med, Seoul, South Korea; [Yoo, Jeong Eun; Rhee, Hyungjin; Ahn, Ei Yong; Park, Young Nyun] Yonsei Univ, Coll Med, Integrated Genom Res Ctr Metab Regulat, Seoul, South Korea; [Yoo, Jeong Eun; Park, Young Nyun] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea; [Kim, Young-Joo] Korea Inst Sci & Technol, Nat Prod Res Ctr, Kangnung, Gangwon Do, South Korea; [Kim, Young-Joo; Rhee, Hyungjin; Park, Young Nyun] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea; [Kim, Haeryoung] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Pathol, Seongnam, South Korea; [Choi, Jin Sub] Yonsei Univ, Dept Surg, Yonsei Liver Canc Special Clin, Coll Med, Seoul, South Korea; [Roncalli, Massimo] Humanitas Clin & Res Hosp, Dept Pathol, Milan, Italy; [Roncalli, Massimo] Hunimed Univ Rozzano, Milan, Italy	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Korea Institute of Science & Technology (KIST); Yonsei University; Yonsei University Health System; Seoul National University (SNU); Yonsei University; Yonsei University Health System	Park, YN (corresponding author), Yonsei Univ, Dept Pathol, Coll Med, Seoul, South Korea.; Park, YN (corresponding author), Yonsei Univ, Coll Med, Integrated Genom Res Ctr Metab Regulat, Seoul, South Korea.; Park, YN (corresponding author), Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea.; Park, YN (corresponding author), Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea.	young0608@yuhs.ac	Rhee, Hyungjin/T-7619-2019	Kim, Haeryoung/0000-0002-4205-9081; Rhee, Hyungjin/0000-0001-7759-4458; Roncalli, Massimo/0000-0002-7901-8910; Park, Young Nyun/0000-0003-0357-7967	National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2012M3A9B6055350, NRF-2011-0030086]; Korea Institute of Science and Technology Institutional Program [2Z04930]	National Research Foundation of Korea (NRF) - Korea government (MSIP); Korea Institute of Science and Technology Institutional Program	This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (grant number: NRF-2012M3A9B6055350, NRF-2011-0030086) and Korea Institute of Science and Technology Institutional Program (2Z04930). We declared that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann T, 2009, CANCER SCI, V100, P646, DOI 10.1111/j.1349-7006.2009.01087.x; Arzumanyan A, 2012, ONCOGENE, V31, P563, DOI 10.1038/onc.2011.255; Arzumanyan A, 2011, CANCER RES, V71, P3701, DOI 10.1158/0008-5472.CAN-10-3951; Chen YX, 2012, HEPATOLOGY, V55, P563, DOI 10.1002/hep.24712; Coulouarn C, 2012, CANCER RES, V72, P2533, DOI 10.1158/0008-5472.CAN-11-3317; Deng Y, 2016, ONCOGENE; Di Tommaso L, 2013, BEST PRACT RES CL GA, V27, P269, DOI 10.1016/j.bpg.2013.03.015; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Jing YY, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-29; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kim H, 2011, HEPATOLOGY, V54, P1707, DOI 10.1002/hep.24559; Kowalik MA, 2015, ONCOTARGET, V6, P38749, DOI 10.18632/oncotarget.5501; Lau EYT, 2016, CELL REP, V15, P1175, DOI 10.1016/j.celrep.2016.04.019; Marquardt JU, 2014, J HEPATOL, V60, P346, DOI 10.1016/j.jhep.2013.10.014; Mu X, 2015, J CLIN INVEST, V125, P3891, DOI 10.1172/JCI77995; Nault JC, 2014, HEPATOLOGY, V60, P1983, DOI 10.1002/hep.27372; Park YN, 1997, LIVER, V17, P271; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Sciarra A, 2015, J HEPATOL; Seok JY, 2012, HEPATOLOGY, V55, P1776, DOI 10.1002/hep.25570; Takeishi K, 2011, SURG TODAY, V41, P1016, DOI [10.1007/s00595-011-0058-8, 10.1007/s00595-010-4392-z]; Theise ND, 2010, WHO CLASSIFICATION T, V4, P205; Wan SS, 2014, GASTROENTEROLOGY, V147, P1393, DOI 10.1053/j.gastro.2014.08.039; Yang JD, 2011, SEMIN CANCER BIOL, V21, P35, DOI 10.1016/j.semcancer.2010.10.007; Yu SJ, 2016, CLIN MOL HEPATOL, V22, P7, DOI 10.3350/cmh.2016.22.1.7; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137; 2009, HEPATOLOGY, V49, P658, DOI DOI 10.1002/HEP.22709	27	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170465	10.1371/journal.pone.0170465	http://dx.doi.org/10.1371/journal.pone.0170465			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114366	Green Published, Green Submitted, gold			2022-12-26	WOS:000396129000053
J	Zainulabadeen, A; Yao, P; Zare, H				Zainulabadeen, Aamir; Yao, Philip; Zare, Habil			Underexpression of Specific Interferon Genes Is Associated with Poor Prognosis of Melanoma	PLOS ONE			English	Article							CUTANEOUS MELANOMA; MALIGNANT-MELANOMA; EXPRESSION SIGNATURES; DOWN-REGULATION; CANCER-CELLS; PROGRESSION; SURVIVAL; REVEALS; ASSAY; HETEROGENEITY	Because the prognosis of melanoma is challenging and inaccurate when using current clinical approaches, clinicians are seeking more accurate molecular markers to improve risk models. Accordingly, we performed a survival analysis on 404 samples from The Cancer Genome Atlas (TCGA) cohort of skin cutaneous melanoma. Using our recently developed gene network model, we identified biological signatures that confidently predict the prognosis of melanoma (p-value < 10(-5)). Our model predicted 38 cases as low-risk and 54 cases as high-risk. The probability of surviving at least 5 years was 64% for low-risk and 14% for high-risk cases. In particular, we found that the overexpression of specific genes in the mitotic cell cycle pathway and the underexpression of specific genes in the interferon pathway are both associated with poor prognosis. We show that our predictive model assesses the risk more accurately than the traditional Clark staging method. Therefore, our model can help clinicians design treatment strategies more effectively. Furthermore, our findings shed light on the biology of melanoma and its prognosis. This is the first in vivo study that demonstrates the association between the interferon pathway and the prognosis of melanoma.	[Zainulabadeen, Aamir; Yao, Philip; Zare, Habil] Texas State Univ, Dept Comp Sci, San Marcos, TX 78666 USA; [Zainulabadeen, Aamir] Princeton Univ, Dept Comp Sci, Princeton, NJ 08544 USA; [Yao, Philip] Univ Michigan, Elect Engn & Comp Sci, Ann Arbor, MI 48109 USA	Texas State University System; Texas State University San Marcos; Princeton University; University of Michigan System; University of Michigan	Zare, H (corresponding author), Texas State Univ, Dept Comp Sci, San Marcos, TX 78666 USA.	zare@txstate.edu	Zare, Habil/ABD-6735-2021	Zare, Habil/0000-0001-5902-6238	National Science Foundation (NSF) through the Research Experiences for Undergraduates (REU) program [CNS1358939, CRI 1305302]	National Science Foundation (NSF) through the Research Experiences for Undergraduates (REU) program(National Science Foundation (NSF))	This study was supported by the National Science Foundation (NSF) through the Research Experiences for Undergraduates (REU) program (CNS1358939), and also through the infrastructure grant (CRI 1305302).	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Anaka M, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-40; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balch CM, 2010, J CLIN ONCOL, V28, P2452, DOI 10.1200/JCO.2009.27.1627; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Belmar-Lopez C, 2008, CLIN TRANSL ONCOL, V10, P137, DOI 10.1007/s12094-008-0170-4; Berger AC, 2016, CURR MED RES OPIN, V32, P1599, DOI 10.1080/03007995.2016.1192997; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Bostick PJ, 1999, J CLIN ONCOL, V17, P3238, DOI 10.1200/JCO.1999.17.10.3238; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Brunner G, 2013, J CANCER RES CLIN, V139, P249, DOI 10.1007/s00432-012-1322-z; Brunner G, 2008, CANCER BIOTHER RADIO, V23, P451, DOI 10.1089/cbr.2008.0473; Cassarino David S, 2014, J Med Econ, V17, P782, DOI 10.3111/13696998.2014.950421; Chikina M, 2015, BIOINFORMATICS, V31, P1584, DOI 10.1093/bioinformatics/btv015; Cirenajwis H, 2015, ONCOTARGET, DOI 10.18632/oncotarget.3655; CLARK WH, 1989, JNCI-J NATL CANCER I, V81, P1893, DOI 10.1093/jnci/81.24.1893; Colman H, 2009, NEURO-ONCOLOGY; COX DR, 1972, J R STAT SOC B, V34, P187; Critchley-Thorne RJ, 2007, PLOS MED, V4, P897, DOI 10.1371/journal.pmed.0040176; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Daniel W.W., 1990, APPL NONPARAMETRIC S, P358, DOI DOI 10.2307/2347215; Deivendran S, 2014, ADV EXP MED BIOL, V816, P377, DOI 10.1007/978-3-0348-0837-8_15; Ekmekcioglu S, 2016, CLIN CANCER RES, V22, P3016, DOI 10.1158/1078-0432.CCR-15-2226; Essner R, 2004, ARCH SURG-CHICAGO, V139, P961, DOI 10.1001/archsurg.139.9.961; Ferrone CR, 2002, ANN SURG ONCOL, V9, P637, DOI 10.1245/aso.2002.9.7.637; Fischer A, 2014, CELL REP, V7, P1740, DOI 10.1016/j.celrep.2014.04.055; Francis P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-73; Gaujoux R, 2013, BIOINFORMATICS, V29, P2211, DOI 10.1093/bioinformatics/btt351; Gerami P, 2015, J AM ACAD DERMATOL, V72, P780, DOI 10.1016/j.jaad.2015.01.009; Gerami P, 2015, CLIN CANCER RES, V21, P175, DOI 10.1158/1078-0432.CCR-13-3316; Gimotty PA, 2007, J CLIN ONCOL, V25, P1129, DOI 10.1200/JCO.2006.08.1463; Gordon GJ, 2003, J NATL CANCER I, V95, P598, DOI 10.1093/jnci/95.8.598; Gui J, 2005, BIOINFORMATICS, V21, P3001, DOI 10.1093/bioinformatics/bti422; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; Hastie T, 2000, GENOME BIOL, V1, P1, DOI DOI 10.1186/GB-2000-1-2-RESEARCH0003; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Houseman EA, 2016, BIORXIV; Jaccard P, 1901, B SOC VAUD SCI NAT, V37, P547, DOI [10.5169/seals.266450, DOI 10.5169/SEALS.266450, DOI 10.5169/SEALS-266450]; Jaeger J, 2007, CLIN CANCER RES, V13, P806, DOI 10.1158/1078-0432.CCR-06-1820; Ji AL, 2016, J NATL COMPR CANC NE, V14, P475, DOI 10.6004/jnccn.2016.0052; Jiang YC, 2016, P NATL ACAD SCI USA, V113, pE5528, DOI 10.1073/pnas.1522203113; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Kalbfleisch R.L, 2011, STAT ANAL FAILURE TI; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Karjalainen JM, 1998, J CLIN ONCOL, V16, P3584, DOI 10.1200/JCO.1998.16.11.3584; Kim SH, 2002, ONCOGENE, V21, P8741, DOI 10.1038/sj.onc.1205987; Kimbrough CW, 2016, J AM COLL SURGEONS, V222, P357, DOI 10.1016/j.jamcollsurg.2015.12.042; Kolesnikov N, 2014, NUCLEIC ACIDS RES, DOI [10.1093/nar/gku1057, DOI 10.1093/NAR/GKU1057]; Kumari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050411; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee CY, 2016, PATHOLOGY, V48, P142, DOI 10.1016/j.pathol.2015.12.004; Litvin O, 2015, MOL CELL, V57, P784, DOI 10.1016/j.molcel.2014.12.030; Lu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111061; Mahar AL, 2016, ANN SURG ONCOL, V23, P2753, DOI 10.1245/s10434-016-5212-5; MANTEL N, 1959, J NATL CANCER I, V22, P719; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Marass F, 2016, ARXIV160401715; March J, 2015, J AM ACAD DERMATOL, V72, P943, DOI 10.1016/j.jaad.2015.02.1140; Matsui Y, 2016, BIORXIV; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Moerdyk-Schauwecker M, 2013, VIROLOGY, V436, P221, DOI 10.1016/j.virol.2012.11.014; Morton DL, 2006, NEW ENGL J MED, V355, P1307, DOI 10.1056/NEJMoa060992; Mukaka MM, 2012, MALAWI MED J, V24, P69; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Newman AM, 2016, CURR OPIN IMMUNOL, V41, P77, DOI 10.1016/j.coi.2016.06.006; Nsengimana J, 2015, ONCOTARGET, V6, P11683, DOI 10.18632/oncotarget.3549; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Onken MD, 2004, CANCER RES, V64, P7205, DOI 10.1158/0008-5472.CAN-04-1750; Onken MD, 2012, OPHTHALMOLOGY, V119, P1596, DOI 10.1016/j.ophtha.2012.02.017; Onken MD, 2010, J MOL DIAGN, V12, P461, DOI 10.2353/jmoldx.2010.090220; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Patro R, 2014, NAT BIOTECHNOL, V32, P462, DOI 10.1038/nbt.2862; Rautela J, 2014, CYTOKINE, V70, P25, DOI 10.1016/j.cyto.2014.07.240; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Roth A, 2014, NATURE METHODS; Scaruffi P, 2012, PEDIATR BLOOD CANCER, V59, P44, DOI 10.1002/pbc.23339; Scatolini M, 2010, INT J CANCER, V126, P1869, DOI 10.1002/ijc.24899; Schuh A, 2012, BLOOD, V120, P4191, DOI 10.1182/blood-2012-05-433540; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Simon N, 2011, J STAT SOFTW, V39, P1; Sivendran S, 2014, J INVEST DERMATOL, V134, P2202, DOI 10.1038/jid.2014.85; Smith AP, 2005, CANCER BIOL THER, V4, P1018, DOI 10.4161/cbt.4.9.2165; Somasundaram R, 2012, ADV PHARMACOL, V65, P335, DOI 10.1016/B978-0-12-397927-8.00011-7; Sondak VK, 2016, ANN SURG ONCOL, P1; Sun XX, 2015, ACTA PHARMACOL SIN, V36, P1219, DOI 10.1038/aps.2015.92; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Tanimoto T.T., 1958, ELEMENTARY MATH THEO; Therneau T.M., 2000, MODELING SURVIVAL DA; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Wan YW, 2015, BIOINFORMATICS; Wang LH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039845, 10.1371/journal.pone.0051769, 10.1371/journal.pone.0045491, 10.1371/journal.pone.0044596]; Weeraratna AT, 2004, ONCOGENE, V23, P2264, DOI 10.1038/sj.onc.1207337; Weiss SA, 2015, CANCER-AM CANCER SOC, V121, P4108, DOI 10.1002/cncr.29634; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Wrangle J, 2013, ONCOTARGET, V4, P2067, DOI 10.18632/oncotarget.1542; Zare H, 2016, PIGENGENE COMPUTING; Zare H, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003703; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zitvogel L, 2015, NAT REV IMMUNOL, V15, P405, DOI 10.1038/nri3845	102	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170025	10.1371/journal.pone.0170025	http://dx.doi.org/10.1371/journal.pone.0170025			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114321	Green Submitted, Green Published, gold			2022-12-26	WOS:000396129000018
J	Cosola, C; De Angelis, M; Rocchetti, MT; Montemurno, E; Maranzano, V; Dalfino, G; Manno, C; Zito, A; Gesualdo, M; Ciccone, MM; Gobbetti, M; Gesualdo, L				Cosola, Carmela; De Angelis, Maria; Rocchetti, Maria Teresa; Montemurno, Eustacchio; Maranzano, Valentina; Dalfino, Giuseppe; Manno, Carlo; Zito, Annapaola; Gesualdo, Michele; Ciccone, Marco Matteo; Gobbetti, Marco; Gesualdo, Loreto			Beta-Glucans Supplementation Associates with Reduction in P-Cresyl Sulfate Levels and Improved Endothelial Vascular Reactivity in Healthy Individuals	PLOS ONE			English	Article							BOUND UREMIC TOXINS; INDOXYL SULFATE; INTESTINAL MICROBIOTA; HEMODIALYSIS-PATIENTS; GUT MICROBIOME; DISEASE; PROTEIN; METABOLISM; OATS	Background Oat and barley beta-glucans are prebiotic fibers known for their cholesterol-lowering activity, but their action on the human gut microbiota metabolism is still under research. Although the induction of short-chain fatty acids (SCFA) following their ingestion has previously been reported, no study has investigated their effects on proteolytic uremic toxins p-cresyl sulfate (pCS) and indoxyl sulfate (IS) levels, while others have failed to demonstrate an effect on the endothelial function measured through flow-mediated dilation (FMD). Objective The aim of our study was to evaluate whether a nutritional intervention with a functional pasta enriched with beta-glucans could promote a saccharolytic shift on the gut microbial metabolism and improve FMD. Methods We carried out a pilot study on 26 healthy volunteers who underwent a 2-month dietary treatment including a daily administration of Granoro "Cuore Mio" pasta enriched with barley beta-glucans (3g/100g). Blood and urine routine parameters, serum pCS/IS and FMD were evaluated before and after the dietary treatment. Results The nutritional treatment significantly reduced LDL and total cholesterol, as expected. Moreover, following beta-glucans supplementation we observed a reduction of serum pCS levels and an increase of FMD, while IS serum levels remained unchanged. Conclusions We demonstrated that a beta-glucans dietary intervention in healthy volunteers correlates with a saccharolytic shift on the gut microbiota metabolism, as suggested by the decrease of pCS and the increase of SCFA, and associates with an improved endothelial reactivity. Our pilot study suggests, in addition to cholesterol, novel pCS-lowering properties of beta-glucans, worthy to be confirmed in large-scale trials and particularly in contexts where the reduction of the microbial-derived uremic toxin pCS is of critical importance, such as in chronic kidney disease.	[Cosola, Carmela; Rocchetti, Maria Teresa; Montemurno, Eustacchio; Maranzano, Valentina; Dalfino, Giuseppe; Manno, Carlo; Gesualdo, Loreto] Univ Bari Aldo Moro, Dept Emergency & Organ Transplantat, Nephrol Dialysis & Transplantat Unit, Bari, Italy; [De Angelis, Maria] Univ Bari Aldo Moro, Dept Soil Plant & Food Sci, Bari, Italy; [Zito, Annapaola; Gesualdo, Michele; Ciccone, Marco Matteo] Univ Bari Aldo Moro, Dept Emergency & Organ Transplantat, Cardiovasc Dis Unit, Bari, Italy; [Gobbetti, Marco] Free Univ Bozen, Fac Sci & Technol, Bolzano, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Free University of Bozen-Bolzano	Cosola, C (corresponding author), Univ Bari Aldo Moro, Dept Emergency & Organ Transplantat, Nephrol Dialysis & Transplantat Unit, Bari, Italy.	carmela.cosola@uniba.it	Dalfino, Giuseppe G/I-8125-2018; Rocchetti, Maria Teresa/N-2212-2018; Rocchetti, Maria Teresa/AAA-6771-2019; De Angelis, Maria/AAA-9909-2019; Gesualdo, Loreto/K-7751-2016; Rocchetti, Maria Teresa/AAQ-1881-2021; Ciccone, Marco M/C-5271-2013	Dalfino, Giuseppe G/0000-0002-6381-6985; Rocchetti, Maria Teresa/0000-0002-2397-6474; Gesualdo, Loreto/0000-0002-4861-0911; Rocchetti, Maria Teresa/0000-0002-2397-6474; Ciccone, Marco M/0000-0002-5710-4228; zito, paola cosma/0000-0003-3198-3655	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca; Fondo Europeo di Sviluppo Regionale (P.O.N. Ricerca e Competitivita per le Regioni della Convergenza) [19_PON02_00657_00186_2937475/1 - PROALIFUN]; Ministero dello Sviluppo Economico	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Fondo Europeo di Sviluppo Regionale (P.O.N. Ricerca e Competitivita per le Regioni della Convergenza); Ministero dello Sviluppo Economico(Ministry of Economic Development, Italy)	This work was funded by the Italian Ministero dell'Istruzione, dell'Universita e della Ricerca, Ministero dello Sviluppo Economico and Fondo Europeo di Sviluppo Regionale (P.O.N. Ricerca e Competitivita 2007-2013 per le Regioni della Convergenza, project code 19_PON02_00657_00186_2937475/1 - PROALIFUN), ASSE I 443-Sostegno ai mutamenti strutturali-Obiettivo Operativo: "Reti per il rafforzamento del potenziale scientifico-tecnologico delle Regioni della Convergenza"- Azione I: "Distretti di Alta Tecnologia e relative Reti"). http://www.ponrec.it/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostoni C, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2471; Agostoni C, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2207; Andersson KE, 2012, MOL NUTR FOOD RES, V56, P1003, DOI 10.1002/mnfr.201100706; Martinez-Gonzalez MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043134; Candela M, 2012, TRENDS MICROBIOL, V20, P385, DOI 10.1016/j.tim.2012.05.003; Ciccone MM, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/782137; Ciccone MM, 2011, EUR J CARDIOV PREV R, V18, P831, DOI 10.1177/1741826711398180; Ciccone MM, 2011, CLIN RES CARDIOL, V100, P515, DOI 10.1007/s00392-010-0275-y; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; De Angelis M, 2015, APPL ENVIRON MICROB, V81, P7945, DOI 10.1128/AEM.02507-15; De Angelis M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099006; Delzenne NM, 2015, DIABETOLOGIA, V58, P2206, DOI 10.1007/s00125-015-3712-7; EFSA, 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.227r; Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897; Gerritsen J, 2011, GENES NUTR, V6, P209, DOI 10.1007/s12263-011-0229-7; Guinane CM, 2013, THER ADV GASTROENTER, V6, P295, DOI 10.1177/1756283X13482996; Ito S, 2014, TOXINS, V6, P665, DOI 10.3390/toxins6020665; Itoh Y, 2012, ANAL BIOANAL CHEM, V403, P1841, DOI 10.1007/s00216-012-5929-3; Katz DL, 2001, AM J PREV MED, V20, P124, DOI 10.1016/S0749-3797(00)00287-7; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Leonel AJ, 2012, CURR OPIN CLIN NUTR, V15, P474, DOI 10.1097/MCO.0b013e32835665fa; Lin CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132589; Massy ZA, 2010, ATHEROSCLEROSIS, V211, P381, DOI 10.1016/j.atherosclerosis.2010.04.010; Meijers BKI, 2011, NEPHROL DIAL TRANSPL, V26, P759, DOI 10.1093/ndt/gfq818; Momenizadeh A, 2014, ARYA ATHEROSCLER, V10, P259; Montemurno E, 2014, KIDNEY BLOOD PRESS R, V39, P114, DOI 10.1159/000355785; Nakabayashi I, 2011, NEPHROL DIAL TRANSPL, V26, P1094, DOI 10.1093/ndt/gfq624; Nakajima K, 2011, CLIN CHIM ACTA, V412, P1306, DOI 10.1016/j.cca.2011.04.018; Nilsson AC, 2010, J NUTR, V140, P1932, DOI 10.3945/jn.110.123604; Norata GD, 2007, ATHEROSCLEROSIS, V193, P321, DOI 10.1016/j.atherosclerosis.2006.09.015; Piccolo M, 2015, MICROB ECOL, V70, P557, DOI 10.1007/s00248-015-0592-9; Puertollano E, 2014, CURR OPIN CLIN NUTR, V17, P139, DOI 10.1097/MCO.0000000000000025; Purchiaroni F, 2013, EUR REV MED PHARMACO, V17, P323; Rossi M, 2014, NUTR METAB CARDIOVAS, V24, P1035, DOI 10.1016/j.numecd.2014.04.006; Rossi M, 2016, CLIN J AM SOC NEPHRO, V11, P223, DOI 10.2215/CJN.05240515; Sun J, 2014, GENES DIS, V1, P132, DOI 10.1016/j.gendis.2014.08.001; Tabesh F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/481904; Tan J, 2014, ADV IMMUNOL, V121, P91, DOI 10.1016/B978-0-12-800100-4.00003-9; Tang WH, 2014, CLIN CHIM ACTA, V437, P25, DOI 10.1016/j.cca.2014.07.002; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vanholder R, 2014, J AM SOC NEPHROL, V25, P1897, DOI 10.1681/ASN.2013101062; Viaene L, 2013, BIOPHARM DRUG DISPOS, V34, P165, DOI 10.1002/bdd.1834; Vipperla K, 2012, NUTR CLIN PRACT, V27, P624, DOI 10.1177/0884533612452012; Wang CP, 2013, J NEPHROL, V26, P111, DOI 10.5301/jn.5000111; Witte DR, 2005, J AM COLL CARDIOL, V45, P1987, DOI 10.1016/j.jacc.2005.02.073; Wu IW, 2011, NEPHROL DIAL TRANSPL, V26, P938, DOI 10.1093/ndt/gfq580	46	44	46	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0169635	10.1371/journal.pone.0169635	http://dx.doi.org/10.1371/journal.pone.0169635			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107445	Green Submitted, Green Published, gold			2022-12-26	WOS:000392405300033
J	Pires, BRB; Mencalha, AL; Ferreira, GM; de Souza, WF; Morgado-Diaz, JA; Maia, AM; Correa, S; Abdelhay, ESFW				Pires, Bruno R. B.; Mencalha, Andre L.; Ferreira, Gerson M.; de Souza, Waldemir F.; Morgado-Diaz, Jose A.; Maia, Amanda M.; Correa, Stephany; Abdelhay, Eliana S. F. W.			NF-kappaB Is Involved in the Regulation of EMT Genes in Breast Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR SNAIL; TIME QUANTITATIVE PCR; E-CADHERIN EXPRESSION; B INHIBITOR DHMEQ; DEHYDROXYMETHYLEPOXYQUINOMICIN DHMEQ; TUMOR-CELLS; IN-VIVO; METASTASIS; TWIST	The metastatic process in breast cancer is related to the expression of the epithelial-to-mesenchymal transition transcription factors (EMT-TFs) SNAIL, SLUG, SIP1 and TWIST1. EMT-TFs and nuclear factor-kappa B (NF-kappa B) activation have been associated with aggressiveness and metastatic potential in carcinomas. Here, we sought to examine the role of NF-kappa B in the aggressive properties and regulation of EMT-TFs in human breast cancer cells. Blocking NF-kappa B/p65 activity by reducing its transcript and protein levels (through siRNA-strategy and dehydroxymethylepoxyquinomicin [DHMEQ] treatment) in the aggressive MDA-MB-231 and HCC-1954 cell lines resulted in decreased invasiveness and migration, a downregulation of SLUG, SIP1, TWIST1, MMP11 and N-cadherin transcripts and an upregulation of E-cadherin transcripts. No significant changes were observed in the less aggressive cell line MCF-7. Bioinformatics tools identified several NF-kappa B binding sites along the promoters of SNAIL, SLUG, SIP1 and TWIST1 genes. Through chromatin immunoprecipitation and luciferase reporter assays, the NF-.B/p65 binding on TWIST1, SLUG and SIP1 promoter regions was confirmed. Thus, we suggest that NF-kappa B directly regulates the transcription of EMT-TF genes in breast cancer. Our findings may contribute to a greater understanding of the metastatic process of this neoplasia and highlight NF-kappa B as a potential target for breast cancer treatment.	[Pires, Bruno R. B.; Ferreira, Gerson M.; Maia, Amanda M.; Correa, Stephany; Abdelhay, Eliana S. F. W.] Inst Nacl Canc Jose Alencar Gomes da Silva, Lab Celula Tronco, Rio De Janeiro, RJ, Brazil; [Pires, Bruno R. B.; Ferreira, Gerson M.; Maia, Amanda M.; Correa, Stephany; Abdelhay, Eliana S. F. W.] Inst Nacl Ciencia & Tecnol Controle Canc, Rio De Janeiro, RJ, Brazil; [Mencalha, Andre L.] Univ Estado Rio de Janeiro, Dept Biofis & Biometria, Rio De Janeiro, RJ, Brazil; [de Souza, Waldemir F.; Morgado-Diaz, Jose A.] Inst Nacl Canc Jose Alencar Gomes da Silva, Grp Biol Estrutural, Rio De Janeiro, RJ, Brazil	Universidade do Estado do Rio de Janeiro	Pires, BRB (corresponding author), Inst Nacl Canc Jose Alencar Gomes da Silva, Lab Celula Tronco, Rio De Janeiro, RJ, Brazil.; Pires, BRB (corresponding author), Inst Nacl Ciencia & Tecnol Controle Canc, Rio De Janeiro, RJ, Brazil.	brunoricardopires@gmail.com	Mencalha, Andre Luiz/Y-2522-2019; Corrêa, Stephany/F-8800-2018; PIRES, BRUNO/AAY-9154-2021; Maia, Amanda M/K-4880-2012; Morgado-Diaz, Jose A./A-9649-2010; Ferreira, Gerson Moura/B-4698-2017; Pires, Bruno/H-8294-2014; Mencalha, Andre/AAC-6700-2019	PIRES, BRUNO/0000-0002-0429-7871; Maia, Amanda M/0000-0002-4212-8606; Ferreira, Gerson Moura/0000-0002-3467-2580; Pires, Bruno/0000-0002-0429-7871; Mencalha, Andre Luiz/0000-0003-3229-8094	Instituto Nacional de Cancer (INCA)/Ministerio da Saude (MS); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E26/170.026/2008]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [573806/2008-0]	Instituto Nacional de Cancer (INCA)/Ministerio da Saude (MS); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was financially supported by Instituto Nacional de Cancer (INCA)/Ministerio da Saude (MS), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ): E26/170.026/2008; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq): 573806/2008-0.	Barbera MJ, 2004, ONCOGENE, V23, P7345, DOI 10.1038/sj.onc.1207990; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Blick T, 2008, CLIN EXP METASTAS, V25, P629, DOI 10.1007/s10585-008-9170-6; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Brabletz T, 2012, NAT REV CANCER, V12, P425, DOI 10.1038/nrc3265; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chung CH, 2006, CANCER RES, V66, P8210, DOI 10.1158/0008-5472.CAN-06-1213; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Furlong EEM, 2001, SCIENCE, V293, P1629, DOI 10.1126/science.1062660; Geiger TR, 2009, BBA-REV CANCER, V1796, P293, DOI 10.1016/j.bbcan.2009.07.006; Gilmore TD, 2011, CURR TOP MICROBIOL, V349, P245, DOI 10.1007/82_2010_105; Golan S, 2015, J ENDOUROL; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Hinohara K, 2012, P NATL ACAD SCI USA, V109, P6584, DOI 10.1073/pnas.1113271109; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Horiguchi Yutaka, 2003, Expert Rev Anticancer Ther, V3, P793, DOI 10.1586/14737140.3.6.793; Huber MA, 2004, CELL CYCLE, V3, P1477, DOI 10.4161/cc.3.12.1280; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; IP YT, 1992, GENE DEV, V6, P1518, DOI 10.1101/gad.6.8.1518; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Katoh M, 2009, INT J ONCOL, V34, P1737, DOI 10.3892/ijo_00000304; Kikuchi E, 2003, CANCER RES, V63, P107; Liu XL, 2009, J CELL BIOL, V184, P805, DOI 10.1083/jcb.200806074; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maier HJ, 2010, CANCER LETT, V295, P214, DOI 10.1016/j.canlet.2010.03.003; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; Matsumoto G, 2005, CLIN CANCER RES, V11, P1287; Matsumoto G, 2005, INT J ONCOL, V27, P1247; Matsumoto N, 2000, BIOORG MED CHEM LETT, V10, P865, DOI 10.1016/S0960-894X(00)00114-1; Mencalha AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048160; Narasimhan M, 2008, CANCER RES, V68, P5185, DOI 10.1158/0008-5472.CAN-07-6883; Neil RJ, 2008, CANCER RES, V68, P1462, DOI [10.1158/0008-5472.CAN-07-3094, DOI 10.1158/0008-5472.CAN-07-3094]; Ohsugi T, 2007, CANCER LETT, V257, P206, DOI 10.1016/j.canlet.2007.07.017; Pantuck AJ, 2010, CANCER RES, V70, P752, DOI 10.1158/0008-5472.CAN-09-2211; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Pham CG, 2007, MOL CELL BIOL, V27, P3920, DOI 10.1128/MCB.01219-06; Pires BR, 2013, J SENOLOGIC INT SOC, V2; Rodriguez LG, 2002, METHODS MOL BIOL, V294; Ruan HY, 2006, HEAD NECK-J SCI SPEC, V28, P158, DOI 10.1002/hed.20304; Starenki DV, 2004, CLIN CANCER RES, V10, P6821, DOI 10.1158/1078-0432.CCR-04-0463; Storci G, 2010, J CELL PHYSIOL, V225, P682, DOI 10.1002/jcp.22264; SUN SC, 1994, P NATL ACAD SCI USA, V91, P1346, DOI 10.1073/pnas.91.4.1346; Taneyhill LA, 2008, METHOD CELL BIOL, V87, P367, DOI 10.1016/S0091-679X(08)00219-7; Umezawa K, 2002, MOL CELLS, V14, P163; Umezawa K, 2006, CANCER SCI, V97, P990, DOI 10.1111/j.1349-7006.2006.00285.x; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Vesuna F, 2012, ONCOGENE, V31, P3223, DOI 10.1038/onc.2011.483; Watanabe M, 2005, INT J CANCER, V114, P32, DOI 10.1002/ijc.20688; Watanabe M, 2008, BIOCHEM BIOPH RES CO, V376, P310, DOI 10.1016/j.bbrc.2008.08.148; Xu Y, 2014, INT J BIOL SCI, V10, P396, DOI 10.7150/ijbs.8193; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zhang C, 2009, DEV BIOL, V331, P340, DOI 10.1016/j.ydbio.2009.04.016; Zhang Q, 2009, CLIN CANCER RES, V15, P3557, DOI 10.1158/1078-0432.CCR-08-1656; Zheng C, 2011, CELL RES, V21, P183, DOI 10.1038/cr.2010.171; Zhou R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030772	59	175	179	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0169622	10.1371/journal.pone.0169622	http://dx.doi.org/10.1371/journal.pone.0169622			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107418	Green Submitted, gold, Green Published			2022-12-26	WOS:000392405300032
J	Pantoja-Melendez, CA; Miranda-Duarte, A; Roque-Ramirez, B; Zenteno, JC				Pantoja-Melendez, Carlos A.; Miranda-Duarte, Antonio; Roque-Ramirez, Bladimir; Zenteno, Juan C.			Epidemiological and Molecular Characterization of a Mexican Population Isolate with High Prevalence of Limb-Girdle Muscular Dystrophy Type 2A Due to a Novel Calpain-3 Mutation	PLOS ONE			English	Article							FOUNDER MUTATION; GENE; FREQUENCY; GUIDELINE; PHENOTYPE; DIAGNOSIS; MEDICINE; LGMD2A; BASQUE; 2C	Limb-Girdle Muscular Dystrophy type 2 (LGMD2) is a group of autosomally recessive inherited disorders defined by weakness and wasting of the shoulder and pelvic girdle muscles. In the past, several population isolates with high incidence of LGMD2 arising from founder mutation effects have been identified. The aim of this work is to describe the results of clinical, epidemiologic, and molecular studies performed in a Mexican village segregating numerous cases of LGMD2. A population census was conducted in the village to identify all LGMD affected patients. Molecular analysis included genome wide homozygosity mapping using a 250K SNP Affymetrix microarray followed by PCR amplification and direct nucleotide sequencing of the candidate gene. In addition, DNA from 401 randomly selected unaffected villagers was analyzed to establish the carrier frequency of the LGMD2 causal mutation. A total of 32 LGMD2 patients were identified in the village, rendering a disease prevalence of 4.3 (CI: 2.9-5.9) cases per 1,000 habitants (1 in 232). Genome wide homozygosity mapping revealed that affected individuals shared a 6.6 Mb region of homozygosity at chromosome 15q15. The identified homozygous interval contained CAPN3, the gene responsible for LGM D2 type A (LGMD2A). Direct sequencing of this gene revealed homozygosity for a novel c.348C>A mutation (p.A1a116Asp) in DNA from all 20 affected subjects available for genetic screening, except one which was heterozygous for the mutation. In such patient, a heterozygous c.2362AG>TCATCT deletion/insertion was recognized as the second CAPN3 mutation. Western blot and autocatalytic activity analyses in protein lysates from skeletal muscle biopsy obtained from a p.A1a116Asp homozygous patient suggested that this particular mutation increased the autocatalytic activity of CAPN3. Thirty eigth heterozygotes of the p.A1a116Asp mutation were identified among 401 genotyped unaffected villagers, yielding a population carrier frequency of 1 in 11. This study demonstrates that a cluster of patients with LGMD2A in a small Mexican village arises from a novel CAPN3 founder mutation. Evidence of allelic heterogeneity is demonstrated by the recognition of an additional CAPN3 mutation in a single affected. Our study provides an additional example of genetic isolation causing a high prevalence of LGMD and of successful molecular characterization of the disease by means of homozygosity mapping. The identification of a very high carrier frequency of the LGMD2-causing mutation has implications for more rational genetic counseling in this community.	[Pantoja-Melendez, Carlos A.; Zenteno, Juan C.] Inst Ophthalmol Conde de Valenciana, Dept Genet, Res Unit, Mexico City, DF, Mexico; [Miranda-Duarte, Antonio] Inst Nacl Rehabil, Dept Genet, Mexico City, DF, Mexico; [Roque-Ramirez, Bladimir] CINVESTAV, Sede Sur, Pharmacobiol Dept, Mexico City, DF, Mexico; [Zenteno, Juan C.] Univ Nacl Autonoma Mexico, Fac Med, Dept Biochem, Mexico City, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Universidad Nacional Autonoma de Mexico		jczenteno@institutodeoftalmologia.org		Miranda-Duarte, Antonio/0000-0001-6530-4636; Roque Ramirez, Bladimir/0000-0002-1649-5568	Mexican Council for Science and Technology (CONACYT) [183084]	Mexican Council for Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was funded by the Mexican Council for Science and Technology (CONACYT), www.conacyt.mx Grant Number 183084 (JCZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckmann JS, 1996, CURR OPIN NEUROL, V9, P389, DOI 10.1097/00019052-199610000-00013; Beckmann JS, 1996, AM J HUM GENET, V59, P1400; Bushby Kate, 2009, Pract Neurol, V9, P314, DOI 10.1136/jnnp.2009.193938; Zenteno JC, 2011, AM J MED GENET A, V155A, P1001, DOI 10.1002/ajmg.a.33862; Cobo AN, 2004, HUM BIOL, V76, P731, DOI 10.1353/hub.2005.0002; El Kerch F, 2014, GENET TEST MOL BIOMA, V18, P253, DOI 10.1089/gtmb.2013.0326; Fanin M, 2005, NEUROMUSCULAR DISORD, V15, P218, DOI 10.1016/j.nmd.2004.11.003; Flanigan KM, 2012, SEMIN NEUROL, V32, P255, DOI 10.1055/s-0032-1329199; Gomez-Diaz B, 2012, MUSCLE NERVE, V45, P338, DOI 10.1002/mus.22314; Guglieri M, 2008, HUM MUTAT, V29, P258, DOI 10.1002/humu.20642; Gundesli H, 2010, AM J HUM GENET, V87, P834, DOI 10.1016/j.ajhg.2010.10.017; Kaplan JC, 2014, NEUROMUSCULAR DISORD, V24, P1123, DOI 10.1016/j.nmd.2014.11.001; Kefi M, 2003, NEUROMUSCULAR DISORD, V13, P779, DOI 10.1016/S0960-8966(03)00136-6; Liang WC, 2013, NEUROMUSCULAR DISORD, V23, P675, DOI 10.1016/j.nmd.2013.05.010; Mahmood OA, 2014, MOL MED REP, V9, P1515, DOI 10.3892/mmr.2014.2048; Mercuri E, 2013, LANCET, V381, P845, DOI 10.1016/S0140-6736(12)61897-2; Miano MG, 2000, AM J HUM GENET, V67, P1348, DOI 10.1016/S0002-9297(07)62966-8; Narayanaswami P, 2014, NEUROLOGY, V83, P1453, DOI 10.1212/WNL.0000000000000892; Nigro V, 2003, Acta Myol, V22, P35; Nigro Vincenzo, 2014, Acta Myol, V33, P1; Nigro V, 2011, CURR OPIN NEUROL, V24, P429, DOI 10.1097/WCO.0b013e32834aa38d; Norwood F, 2007, EUR J NEUROL, V14, P1305, DOI 10.1111/j.1468-1331.2007.01979.x; Norwood FLM, 2009, BRAIN, V132, P3175, DOI 10.1093/brain/awp236; Pantoja-Melendez C, 2013, MOL VIS, V19, P1866; Papic L, 2011, EUR J MED GENET, V54, P214, DOI 10.1016/j.ejmg.2010.12.003; Piluso G, 2005, J MED GENET, V42, P686, DOI 10.1136/jmg.2004.028738; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Saenz A, 2005, BRAIN, V128, P732, DOI 10.1093/brain/awh408; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Seelow D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003874; Silva-Zolezzi I, 2009, P NATL ACAD SCI USA, V106, P8611, DOI 10.1073/pnas.0903045106; Tetreault M, 2011, CAN J NEUROL SCI, V38, P747, DOI 10.1017/S0317167100054135; Torella A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063536; Urtasun M, 1998, BRAIN, V121, P1735, DOI 10.1093/brain/121.9.1735; Zlotogora J, 1996, AM J HUM GENET, V58, P241	35	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170280	10.1371/journal.pone.0170280	http://dx.doi.org/10.1371/journal.pone.0170280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103310	Green Published, Green Submitted, gold			2022-12-26	WOS:000392381100050
J	Pewsner, M; Origgi, FC; Frey, J; Ryser-Degiorgis, MP				Pewsner, Mirjam; Origgi, Francesco Carlo; Frey, Joachim; Ryser-Degiorgis, Marie-Pierre			Assessing Fifty Years of General Health Surveillance of Roe Deer in Switzerland: A Retrospective Analysis of Necropsy Reports	PLOS ONE			English	Article							CAPREOLUS-CAPREOLUS-L; FREE-RANGING CERVIDS; WILD RUMINANTS; SCHMALLENBERG VIRUS; RISK-FACTORS; PARATUBERCULOSIS; INFECTION; DISEASES; FRANCE; SPAIN	General wildlife health surveillance is a valuable source of information on the causes of mortality, disease susceptibility and pathology of the investigated hosts and it is considered to be an essential component of early warning systems. However, the representativeness of data from such surveillance programs is known to be limited by numerous biases. The roe deer (Capreolus capreolus capreolus) is the most abundant ungulate and a major game species all over Europe. Yet, internationally available literature on roe deer pathology is scarce. The aims of this study were (1) to provide an overview of the causes of mortality or morbidity observed in roe deer in Switzerland and to assess potential changes in the disease pattern over time; and (2) to evaluate the value and limitations of a long term dataset originating from general wildlife health surveillance. We compiled 1571 necropsy reports of free ranging roe deer examined at the Centre for Fish and Wildlife Health in Switzerland from 1958 to 2014. Descriptive data analysis was performed considering animal metadata, submitter, pathologist in charge, laboratory methods, morphological diagnoses and etiologies. Recurrent causes of mortality and disease pictures included pneumonia, diarrhea, meningoencephalitis, actinomycosis, blunt trauma, predation, neoplasms and anomalies. By contrast, other diagnoses such as fatal parasitic gastritis, suspected alimentary intoxication and reproductive disorders appeared only in earlier time periods. Diseases potentially relevant for other animals or humans such as caseous lymphadenitis (or pseudotuberculosis), salmonellosis, paratuberculosis and listeriosis were sporadically observed. The disease pattern in roe deer from Switzerland was largely in accordance with previous reports. The observed fluctuations were consistent with methodical and/or personnel changes and varying disease awareness. Nevertheless, despite such limitations, the compiled data provide a valuable baseline. To facilitate comparison among studies, we recommend systematically archiving all case documents and fixed tissues and to perform data analyses more regularly and in a harmonized way.	[Pewsner, Mirjam; Origgi, Francesco Carlo; Ryser-Degiorgis, Marie-Pierre] Univ Bern, Vetsuisse Fac, Ctr Fish & Wildlife Hlth, Bern, Switzerland; [Frey, Joachim] Univ Bern, Inst Vet Bacteriol, Vetsuisse Fac, Bern, Switzerland	University of Bern; University of Bern	Ryser-Degiorgis, MP (corresponding author), Univ Bern, Vetsuisse Fac, Ctr Fish & Wildlife Hlth, Bern, Switzerland.	marie-pierre.ryser@vetsuisse.unibe.ch	Ryser-Degiorgis, Marie-Pierre/AAN-5249-2020	Ryser-Degiorgis, Marie-Pierre/0000-0003-1062-870X				Aguirre AA, 1999, J WILDLIFE DIS, V35, P753, DOI 10.7589/0090-3558-35.4.753; Balseiro A, 2009, VET REC, V164, P468, DOI 10.1136/vr.164.15.468; Barlow AM, 2006, VET REC, V159, P211, DOI 10.1136/vr.159.7.211; Baumann M, 2014, JAGEN IN DER SCHWEIZ; Belser EH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120028; BLANCOU J, 1983, J WILDLIFE DIS, V19, P271, DOI 10.7589/0090-3558-19.3.271; Boadella M, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-51; Bolukbas CS, 2012, PARASITOL INT, V61, P729, DOI 10.1016/j.parint.2012.06.008; Borg K, 1956, JAGDWISS, V4, P203; Bouvier G., 1958, MALADIES RUMINANTS S; Braunschweig A, 1970, JAGDWISS, V16, P116; Breitenmoser U, 2008, GROSSRAUBTIER KULTUR; Breitenmoser Urs, 1998, Hystrix, V10, P17; Brunk R, 1965, JAGDWISS, V11, P145; Brunk R, 1960, JAGDWISS, V6, P121; Burgisser H, 1959, SCHWEIZ ARCH TIER, V112-134; Burri K., 1998, GEOGRAFISCHE BETRACH; Candela MG, 2014, RES VET SCI, V96, P254, DOI 10.1016/j.rvsc.2014.02.003; Carta T, 2013, RES VET SCI, V94, P191, DOI 10.1016/j.rvsc.2012.11.002; Casaubon J, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-166; Casaubon J, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-204; De Bosschere H, 2007, VET J, V174, P665, DOI 10.1016/j.tvjl.2006.10.015; de Jong CB, 2004, VET REC, V155, P197, DOI 10.1136/vr.155.7.197; Dedek J, 1987, MH VET MED, P784; Deplazes P., 2012, LEHRBUCH PARASITOLOG, V3rd; Eckert J, 1992, VETERINARMEDIZINISCH; Eskens U, 1991, TIERAERZTL PRAX, P52; Euzenat K, 2003, CAUSES MORTALITE CHE; Fairbrother A., 1996, NONINFECTIOUS DIS WI; Fernandez-Aguilar X, 2014, EMERG INFECT DIS, V20, P1062, DOI 10.3201/eid2006.130961; Frolich K, 2006, J WILDLIFE DIS, V42, P836, DOI 10.7589/0090-3558-42.4.836; Gaffuri A, 2006, J WILDLIFE DIS, V42, P685, DOI 10.7589/0090-3558-42.3.685; GANZINGER U, 1986, Z JAGDWISS, V32, P125; Gjerde B, 2012, PARASITOL RES, V110, P1225, DOI 10.1007/s00436-011-2619-6; Haberli R., 1995, 00 RAPS BEDINGTE KLI; Hewison AJM, 2009, ECOGRAPHY, V32, P1062, DOI 10.1111/j.1600-0587.2009.05888.x; HOFMANN W, 1984, Z JAGDWISS, V30, P259, DOI 10.1007/BF02241412; Imesch-Bebie A N, 2010, EUROPEAN UNGULATES T, P392; KEMENES F, 1983, ZBL VET MED B, V30, P258; Kleinschmidt S, 2012, J COMP PATHOL, V146, P283, DOI 10.1016/j.jcpa.2011.07.001; Kleinschmidt S, 2012, RES VET SCI, V93, P1334, DOI 10.1016/j.rvsc.2012.03.008; Krametter R, 2004, J WILDLIFE DIS, V40, P791, DOI 10.7589/0090-3558-40.4.791; Kuiken T, 2011, REV SCI TECH OIE, V30, P755; Lamarque F., 1999, Gibier Faune Sauvage, V16, P101; Larska M, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0307-3; LEIGHTON FA, 1995, REV SCI TECH OIE, V14, P819; Linden A, 2012, EMERG INFECT DIS, V18, P2006, DOI 10.3201/eid1812.121067; Linden A, 2010, EMERG INFECT DIS, V16, P833, DOI 10.3201/eid1605.091217; Linnell John D.C., 2011, P12; Liz JS, 2002, J CLIN MICROBIOL, V40, P892, DOI 10.1128/JCM.40.3.892-897.2002; Machackova M, 2004, VET MICROBIOL, V101, P225, DOI 10.1016/j.vetmic.2004.04.001; Magistrali CF, 2015, VET MICROBIOL, V180, P161, DOI 10.1016/j.vetmic.2015.08.020; Martin C, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-70; Melis C, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00099.1; MEYER P, 1979, Z JAGDWISS, V25, P239, DOI 10.1007/BF02242497; MEYER P, 1977, Z JAGDWISS, V23, P98, DOI 10.1007/BF01904977; MEYER P, 1977, Z JAGDWISS, V23, P50, DOI 10.1007/BF01904741; Meyer P., 1975, JAGDWISS, V21, P89; Michel AO, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-65; Molinari P, 2000, RAUBTIERE AM WERK HD; Montane J, 2002, J VET MED A, V49, P93, DOI 10.1046/j.1439-0442.2002.jv409.x; Morner T, 2002, REV SCI TECH OIE, V21, P67, DOI 10.20506/rst.21.1.1321; Muller T, 1997, Z JAGDWISS, V43, P166, DOI 10.1007/BF02241326; Munro R, 1996, VET REC, V138, P542, DOI 10.1136/vr.138.22.542; Panadero R, 2001, VET PARASITOL, V99, P221, DOI 10.1016/S0304-4017(01)00465-4; Panzacchi M, 2009, J ANIM ECOL, V78, P1124, DOI 10.1111/j.1365-2656.2009.01584.x; Paterson J, 2014, ZOO ANIMAL AND WILDLIFE IMMOBILIZATION AND ANESTHESIA, 2ND EDITION, P171; Pato FJ, 2013, VET PARASITOL, V196, P136, DOI 10.1016/j.vetpar.2013.01.027; Pavlik I, 2000, VET MICROBIOL, V77, P231, DOI 10.1016/S0378-1135(00)00309-6; Rajsky D, 2016, EUR J WILDLIFE RES, V62, P43, DOI 10.1007/s10344-015-0972-y; Rehbein S, 2000, Z JAGDWISS, V46, P248, DOI 10.1007/BF02241594; Robino P, 2008, EUR J WILDLIFE RES, V54, P357, DOI 10.1007/s10344-007-0141-z; Ryser-Degiorgis MP, 2015, SCHWEIZ ARCH TIERH, V157, P255, DOI 10.17236/sat00019; Ryser-Degiorgis MP, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-223; Schmidt-Posthaus H, 2002, J WILDLIFE DIS, V38, P84, DOI 10.7589/0090-3558-38.1.84; Schneider-Sliwa R., 2011, SCHWEIZ GEOGRAPHIE G; Schoning JM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054253, 10.1371/journal.pone.0060336]; Schulze C, 2005, DEUT TIERARZTL WOCH, V112, P393; Ferron ES, 2012, ECOL RES, V27, P77, DOI 10.1007/s11284-011-0872-x; Sieber V, 2010, VET MED INT VET MED, V2010; Spraker Terry R., 1993, P481; Strugnell BW, 2010, VET REC, V167, P425, DOI 10.1136/vr.c4901; Stubbe C., 1997, REHWILD BIOL OKOLOGI, Vfourth; SUNDBERG JP, 1981, CAN VET J, V22, P385; Tavernier Paul, 2015, Infection Ecology & Epidemiology, V5, P29862, DOI 10.3402/iee.v5.29862; Thorsson E., 2015, HYPERTROPHIC OSTEOAR; Tryland M, 2004, J WILDLIFE DIS, V40, P32, DOI 10.7589/0090-3558-40.1.32; Valiere N, 2003, ANIM CONSERV, V6, P83, DOI 10.1017/S1367943003003111; VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666, DOI 10.1128/JCM.34.7.1666-1671.1996; Vikoren T, 2006, J WILDLIFE DIS, V42, P797, DOI 10.7589/0090-3558-42.4.797; Wobeser G. A., 2010, DIS WILD ANIMALS INV; WURSTER K, 1983, Z JAGDWISS, V29, P74, DOI 10.1007/BF02243525; Zanoni RG, 2000, SCHWEIZ ARCH TIERH, V142, P423; Zwart P., 1987, KRANKHEITEN WILDTIER	94	21	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170338	10.1371/journal.pone.0170338	http://dx.doi.org/10.1371/journal.pone.0170338			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103325	gold, Green Published, Green Submitted			2022-12-26	WOS:000392381100056
J	Butt, HI; Yang, ZE; Chen, EY; Zhao, G; Gong, Q; Yang, ZR; Zhang, XY; Li, FG				Butt, Hamama Islam; Yang, Zhaoen; Chen, Eryong; Zhao, Ge; Gong, Qian; Yang, Zuoren; Zhang, Xueyan; Li, Fuguang			Functional Characterization of Cotton GaMYB62L, a Novel R2R3 TF in Transgenic Arabidopsis	PLOS ONE			English	Article							MYB TRANSCRIPTION FACTOR; ABIOTIC STRESS RESPONSES; PLANT ADAPTIVE RESPONSE; CIS-ACTING ELEMENTS; DNA-BINDING DOMAIN; ABSCISIC-ACID; DROUGHT TOLERANCE; GENE FAMILY; DEHYDRATION TOLERANCE; FREEZING TOLERANCE	Drought stress can trigger the production of ABA in plants, in response to adverse conditions, which induces the transcript of stress-related marker genes. The R2R3 MYB TFs are implicated in regulation of various plants developmental, metabolic and multiple environmental stress responses. Here, a R2R3-MYB cloned gene, GaMYB62L, was transformed in Arabidopsis and was functionally characterized. The GaMYB62L protein contains two SANT domains with a conserved R2R3 imperfect repeats. The GaMYB62L cDNA is 1,017 bp with a CDS of 879, encodes a 292-residue polypeptide with MW of 38.78 kD and a pl value of 8.91. Overexpressed GaMYB62L transgenic Arabidopsis have increased proline and chlorophyll content, superior seed germination rate under salt and osmotic stress, less water loss rate with reduced stomatal apertures, high drought avoidance as compared to WT on water deprivation and also significant plant survival rates at low temperature. In addition, overexpressed GaMYB62L lines were more sensitive to ABA mediated germination and root elongation assay. Moreover, ABA induced GaMYB62L overexpression, enhanced the expression of ABA stress related marker genes like RD22, COR15A, ADH1, and RD29A. Together, overexpression of GaMYB62L suggested having developed better drought, salt and cold tolerance in transgenic Arabidopsis and thus presented it as a prospective candidate gene to achieve better abiotic stress tolerance in cotton crop.	[Butt, Hamama Islam; Yang, Zhaoen; Chen, Eryong; Zhao, Ge; Gong, Qian; Yang, Zuoren; Zhang, Xueyan; Li, Fuguang] CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Zhang, XY; Li, FG (corresponding author), CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China.	Zhangxueyan_caas@126.com; aylifug@163.com	Yang, Zuoren/AAF-5040-2020	ge, xiaoyang/0000-0003-4134-4443; Qian, Gong/0000-0003-1724-4653; Yang, Zuoren/0000-0001-5898-6309	National Natural Science Foundation of China [U1303282]; Henan Province [162300410160]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Henan Province	This work was supported by the Major Program of Joint Funds (Sinkiang) of the National Natural Science Foundation of China (grant U1303282) and also supported by a grant from Henan Province (No. 162300410160).	Aasland R, 1996, TRENDS BIOCHEM SCI, V21, P87, DOI 10.1016/S0968-0004(96)30009-1; Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Chen CB, 2005, P NATL ACAD SCI USA, V102, P3459, DOI 10.1073/pnas.0407960102; Chen TZ, 2015, PLANT CELL PHYSIOL, V56, P917, DOI 10.1093/pcp/pcv019; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cominelli E, 2005, CURR BIOL, V15, P1196, DOI 10.1016/j.cub.2005.05.048; Cominelli E, 2008, PLANT J, V53, P53, DOI 10.1111/j.1365-313X.2007.03310.x; Dai XY, 2007, PLANT PHYSIOL, V143, P1739, DOI 10.1104/pp.106.094532; Denekamp M, 2003, PLANT PHYSIOL, V132, P1415, DOI 10.1104/pp.102.019273; Devaiah BN, 2009, MOL PLANT, V2, P43, DOI 10.1093/mp/ssn081; Dhanda SS, 1998, EUPHYTICA, V104, P39, DOI 10.1023/A:1018644113378; DIAZDELEON F, 1993, PLANT PHYSIOL, V101, P1117, DOI 10.1104/pp.101.3.1117; Ding ZH, 2009, J GENET GENOMICS, V36, P17, DOI 10.1016/S1673-8527(09)60003-5; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Gao S, 2014, PLANT SOIL, V376, P433, DOI 10.1007/s11104-013-1992-6; Garg B, 2012, MOL BIOL REP, V39, P10865, DOI 10.1007/s11033-012-1983-3; Hamanishi ET, 2012, J EXP BOT, V63, P4959, DOI 10.1093/jxb/ers177; He QL, 2016, SCI REP-UK, V6, DOI 10.1038/srep22980; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Hoeren FU, 1998, GENETICS, V149, P479; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Huang CJ, 2013, PHYSIOL PLANTARUM, V149, P297, DOI 10.1111/ppl.12031; Huang JY, 2012, PLOS ONE, V7; Hwang OJ, 2014, INT J PHOTOENERGY, V2014, DOI 10.1155/2014/501016; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; Jaglo-Ottosen KR, 1998, SCIENCE, P280; Jakab G, 2005, PLANT PHYSIOL, V139, P267, DOI 10.1104/pp.105.065698; Jamil M, 2006, J CENT EUR AGRIC, V7, P273; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; KISHOR PBK, 1995, PLANT PHYSIOL, V108, P1387, DOI 10.1104/pp.108.4.1387; Kranz HD, 1998, PLANT J, V16, P263, DOI 10.1046/j.1365-313x.1998.00278.x; Lee SC, 2012, PLANT CELL ENVIRON, V35, P53, DOI 10.1111/j.1365-3040.2011.02426.x; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Lippold F, 2009, PLANT PHYSIOL, V149, P1761, DOI 10.1104/pp.108.134874; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masle J, 2005, NATURE, V436, P866, DOI 10.1038/nature03835; Meissner RC, 1999, PLANT CELL, V11, P1827, DOI 10.1105/tpc.11.10.1827; Mo XM, 2005, GENE DEV, V19, P2447, DOI 10.1101/gad.355405; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; Ogata K, 1996, NAT STRUCT BIOL, V3, P178, DOI 10.1038/nsb0296-178; Osakabe Y, 2010, J BIOL CHEM, V285, P9190, DOI 10.1074/jbc.M109.051938; Parida AK, 2007, PLANT BIOTECHNOL REP, V1, P37, DOI 10.1007/s11816-006-0004-1; Pastuglia M, 1997, PLANT CELL, V9, P49, DOI 10.1105/tpc.9.1.49; Pei ZM, 1997, PLANT CELL, V9, P409, DOI 10.1105/tpc.9.3.409; Qin F, 2011, PLANT CELL PHYSIOL, V52, P1569, DOI 10.1093/pcp/pcr106; Qin YX, 2012, MOL BIOL REP, V39, P7183, DOI 10.1007/s11033-012-1550-y; Ramanjulu S, 2002, PLANT CELL ENVIRON, V25, P141, DOI 10.1046/j.0016-8025.2001.00764.x; Rouster J, 1997, PLANT J, V11, P513, DOI 10.1046/j.1365-313X.1997.11030513.x; Sabbagh E, 2014, INT J FARM ALLI SCI, V3, P988; Seki M, 2007, CURR OPIN PLANT BIOL, V10, P296, DOI 10.1016/j.pbi.2007.04.014; Seo PJ, 2011, PLANT CELL, V23, P1138, DOI 10.1105/tpc.111.083485; Simpson SD, 2003, PLANT J, V33, P259, DOI 10.1046/j.1365-313X.2003.01624.x; Smith CW, 1999, COTTON ORIGIN HIST T; Song SY, 2011, PLANTA, V234, P331, DOI 10.1007/s00425-011-1403-2; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Su LT, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1889-5; Su LT, 2014, GENE, V538, P46, DOI 10.1016/j.gene.2014.01.024; Sun X., 2012, ABST APPL ANAL, V2012, P1, DOI DOI 10.1371/J0URNAL.PGEN.1002674; Suo JF, 2003, BBA-GENE STRUCT EXPR, V1630, P25, DOI 10.1016/j.bbaexp.2003.08.009; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Szekely G, 2008, PLANT J, V53, P11, DOI 10.1111/j.1365-313X.2007.03318.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vannini C, 2004, PLANT J, V37, P115, DOI 10.1046/j.1365-313X.2003.01938.x; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; Villalobos MA, 2004, PLANT PHYSIOL, V135, P309, DOI 10.1104/pp.103.034199; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Walford SA, 2011, PLANT J, V65, P785, DOI 10.1111/j.1365-313X.2010.04464.x; Wang CX, 2011, J EXP BOT, V62, P1299, DOI 10.1093/jxb/erq377; Wang RK, 2014, PHYSIOL PLANTARUM, V150, P76, DOI 10.1111/ppl.12069; Yamaguchi K, 2007, BIOCHEM BIOPH RES CO, V352, P486, DOI 10.1016/j.bbrc.2006.11.041; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; YAMAGUCHISHINOZAKI K, 1993, PLANT PHYSIOL, V101, P1119, DOI 10.1104/pp.101.3.1119; YAMAGUCHISHINOZAKI K, 1993, MOL GEN GENET, V236, P331, DOI 10.1007/BF00277130; Yang A, 2012, J EXP BOT, V63, P2541, DOI 10.1093/jxb/err431; Yang L, 2016, J INTEGR PLANT BIOL, V58, P67, DOI 10.1111/jipb.12364; Yi SY, 2009, J PLANT BIOL, V52, P560, DOI 10.1007/s12374-009-9072-4; Yu H, 2008, PLANT CELL, V20, P1134, DOI 10.1105/tpc.108.058263; Yuan Y, 2015, PLANT CELL TISS ORG, V120, P973, DOI 10.1007/s11240-014-0686-y; Zhang LC, 2014, PLANT CELL PHYSIOL, V55, P1802, DOI 10.1093/pcp/pcu109; Zhang LN, 2016, FRONT PLANT SCI, P6; [张学清 Zhang Xueqing], 2013, [电工技术学报, Transactions of China Electrotechnical Society], V28, P28; Zhang ZY, 2012, NEW PHYTOL, V196, P1155, DOI 10.1111/j.1469-8137.2012.04353.x; Zhao FL, 2016, GENE, V576, P268, DOI 10.1016/j.gene.2015.10.042; Zhong RQ, 2009, PLANT SIGNAL BEHAV, V4, P1028, DOI 10.4161/psb.4.11.9875; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2	90	18	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170578	10.1371/journal.pone.0170578	http://dx.doi.org/10.1371/journal.pone.0170578			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125637	gold, Green Published, Green Submitted			2022-12-26	WOS:000396176100094
J	Huang, X; Shen, S; Fan, DS				Huang, Xiao; Shen, Shen; Fan, Dongsheng			No Evidence for Pathogenic Role of UBQLN2 Mutations in Sporadic Amyotrophic Lateral Sclerosis in the Mainland Chinese Population	PLOS ONE			English	Article								Mutations in the UBQLN2 gene, which encodes a member of the ubiquitin-like protein family (ubiquilin-2), have been identified in patients with dominant X-linked amyotrophic lateral sclerosis (ALS) and ALS with frontotemporal dementia (FTD). We analyzed mutations in the UBQLN2 gene in a Chinese cohort of 515 patients with sporadic ALS (sALS). A novel missense mutation (p.M392V) was detected in one sALS patient. The p. M392V mutation substitutes a highly conserved residue, has not been reported in the population databases, and previously, at the same residue, a missense mutation p. M392I was detected in two Turkey ALS patients and was considered to be pathogenic, so the M392V is a variant of uncertain significance (VOUS) for ALS. We also found a deletion mutation (p. P500_ G502del), which seems to be benign. In conclusion, our data suggest that mutations in the UBQLN2 gene are rare in Chinese sALS patients.	[Huang, Xiao; Shen, Shen; Fan, Dongsheng] Peking Univ, Dept Neurol, Hosp 3, Beijing, Peoples R China	Peking University	Fan, DS (corresponding author), Peking Univ, Dept Neurol, Hosp 3, Beijing, Peoples R China.	dsfan2010@aliyun.com			National Natural Sciences Foundation of China [81030019]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Sciences Foundation of China [81030019] (URL: http://www.nsfc.gov.cn/). No individuals employed or contracted by the funders (other than the named authors) played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Daoud H, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.03.015; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Gellera C, 2013, J NEUROL NEUROSUR PS, V84, P183, DOI 10.1136/jnnp-2012-303433; Kim HJ, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.03.001; McLaughlin RL, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.07.023; Millecamps S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.11.010; Ozoguz A, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.12.032; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Soong BW, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.05.008; van Doormaal PTC, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.02.032	11	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170943	10.1371/journal.pone.0170943	http://dx.doi.org/10.1371/journal.pone.0170943			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125704	gold, Green Published, Green Submitted			2022-12-26	WOS:000396176100017
J	Marra, F; Ceruleo, P; Pandolfi, L; Petronio, C; Rolfo, MF; Salari, L				Marra, Fabrizio; Ceruleo, Piero; Pandolfi, Luca; Petronio, Carmelo; Rolfo, Mario F.; Salari, Leonardo			The Aggradational Successions of the Aniene River Valley in Rome: Age Constraints to Early Neanderthal Presence in Europe	PLOS ONE			English	Article							MIDDLE PLEISTOCENE; TIBER RIVER; SEA-LEVEL; MONTI SABATINI; GEOCHRONOLOGY; 40AR/39AR; HISTORY; BIOCHRONOLOGY; STRATIGRAPHY; ARCHAEOLOGY	We revise the chronostratigraphy of several sedimentary successions cropping out along a 5 km-long tract of the Aniene River Valley in Rome (Italy), which yielded six hominin remains previously attributed to proto- or archaic Neanderthal individuals, as well as a large number of lithic artefacts showing intermediate characteristics somewhere between the local Acheulean and Mousterian cultures. Through a method of correlation of aggradational successions with post-glacial sea-level rises, relying on a large set of published 40Ar/(39) Ar ages of interbedded volcanic deposits, we demonstrate that deposition of the sediments hosting the human remains spans the interval 295-220 ka. This is consistent with other well constrained ages for lithic industries recovered in England, displaying transitional features from Lower to Middle Paleolithic, suggesting the appearance of Mode 3 during the MIS 9-MIS 8 transition. Moreover, the six human bone fragments recovered in the Aniene Valley should be regarded as the most precisely dated and oldest hominin remains ascribable to Neanderthal-type individuals in Europe, discovered to date. The chronostratigraphic study presented here constitutes the groundwork for addressing re-analysis of these remains and of their associated lithic industries, in the light of their well-constrained chronological picture.	[Marra, Fabrizio] Ist Nazl Geofis & Vulcanol, Via Vigna Murata, Rome, Italy; [Ceruleo, Piero] Freelance, Rome, Italy; [Pandolfi, Luca] Univ Roma Tre, Dipartimento Sci, Sez Geol, Rome, Italy; [Petronio, Carmelo; Salari, Leonardo] Univ Roma, Dipartimento Sci Terra, Piazzale Aldo Moro, Rome, Italy; [Rolfo, Mario F.] Univ Tor Vergata, Dipartimento Storia Culture & Soc, Via Columbia, Rome, Italy	Istituto Nazionale Geofisica e Vulcanologia (INGV); Roma Tre University; Sapienza University Rome; University of Rome Tor Vergata; University of Rome Tor Vergata	Marra, F (corresponding author), Ist Nazl Geofis & Vulcanol, Via Vigna Murata, Rome, Italy.	fabrizio.marra@ingv.it	Pandolfi, Luca/AAH-7964-2020; MARRA, Fabrizio/AAB-9514-2019	Pandolfi, Luca/0000-0002-4186-4126; MARRA, Fabrizio/0000-0002-4881-9563				AA VV, 1998, ROMA OLTRE MURA LINE, P35; Adler DS, 2014, SCIENCE, V345, P1609, DOI 10.1126/science.1256484; Alvarez W, 1996, GEOLOGY, V24, P751, DOI 10.1130/0091-7613(1996)024<0751:QFVSAG>2.3.CO;2; [Anonymous], 1869, B SOC GEOLOGIQUE FRA, V26, P11; Anzidei AP, 1990, 4 C IT ARCH NEW DEV; Anzidei AP, 1984, ATT 24 RIUN SCI 2 PA; BASSINOT FC, 1994, EARTH PLANET SC LETT, V126, P91, DOI 10.1016/0012-821X(94)90244-5; BIDDITTU I, 1987, Zeitschrift fuer Morphologie und Anthropologie, V77, P181; BLACKWELL B, 1986, QUATERNARY RES, V25, P215, DOI 10.1016/0033-5894(86)90058-X; Blanc AC, 1939, ATT 27 RIUN SOC IT P, P1; Blanc AC., 1948, PALEONTOGR ITALICA, V42, P3; Boeda E., 2013, PAL HIST OBJ LITH TR; Breuil H., 1935, REND R ACCAD LI SFMN, V6, P166; Bridgland D, 2008, GEOMORPHOLOGY, V98, P285, DOI 10.1016/j.geomorph.2006.12.032; Bridgland DR, 2006, P GEOLOGIST ASSOC, V117, P281, DOI 10.1016/S0016-7878(06)80036-2; Bridgland DR, 2014, BOREAS, V43, P543, DOI 10.1111/bor.12059; Bruner E., 2006, P23, DOI 10.1007/978-1-4020-5121-0_3; Caloi L., 1978, Quaternaria, V20, P315; Caloi L, 1981, B SERV GEOL ITAL, V102, P41; Catuneanu O, 2011, NEWSL STRATIGR, V44, P173, DOI 10.1127/0078-0421/2011/0011; Cosentino D, 2009, QUATERNARY RES, V72, P143, DOI 10.1016/j.yqres.2009.03.003; Di Stefano Giuseppe, 1997, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V203, P57; DIBROZOLO FR, 1981, EARTH PLANET SC LETT, V53, P445, DOI 10.1016/0012-821X(81)90049-2; Fabbri M, 2014, GEOSITI TERRITORIO R; Faccenna C, 1996, GEOPHYS J INT, V126, P781, DOI 10.1111/j.1365-246X.1996.tb04702.x; Ferranti L, 2006, QUATERN INT, V145, P30, DOI 10.1016/j.quaint.2005.07.009; Florindo F, 2007, EARTH PLANET SC LETT, V256, P61, DOI 10.1016/j.epsl.2007.01.014; Fontana F, 2013, J ANTHROPOL ARCHAEOL, V32, P478, DOI 10.1016/j.jaa.2013.08.003; Fontana F, 2009, HUMAN EVOLUTION, V24, P43; Gaeta M, 2016, LITHOS, V244, P151, DOI 10.1016/j.lithos.2015.11.034; Gamble C., 1999, PALAEOLITHIC SOC EUR; Gliozzi E, 1997, RIV ITAL PALEONTOL S, V103, P369, DOI 10.13130/2039-4942/5299; Grant KM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6076; GREEN HS, 1981, NATURE, V294, P707, DOI 10.1038/294707a0; Guipert G, 2011, CR PALEVOL, V10, P21, DOI 10.1016/j.crpv.2010.10.006; Hernandez M, 2014, J HUM EVOL, V75, P53, DOI 10.1016/j.jhevol.2014.05.010; Karner DB, 1998, GEOL SOC AM BULL, V110, P748, DOI 10.1130/0016-7606(1998)110<0748:COFASW>2.3.CO;2; Karner DB, 1998, GEOL SOC AM BULL, V110, P740, DOI 10.1130/0016-7606(1998)110<0740:AAGORV>2.3.CO;2; Karner DB, 2001, J VOLCANOL GEOTH RES, V107, P185, DOI 10.1016/S0377-0273(00)00258-4; Karner DB, 2001, EARTH PLANET SC LETT, V188, P135, DOI 10.1016/S0012-821X(01)00325-9; Klein RG, 1989, HUMAN CAREER HUMAN B; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Luberti GM, 2016, QUATERNARY INT; MALLEGNI F, 1986, ANTHROPOLOGIE, V90, P539; MANZI G, 1990, J HUM EVOL, V19, P751, DOI 10.1016/0047-2484(90)90019-8; Marra F, 2016, GEOPHYS RES LETT, V43, P6898, DOI 10.1002/2016GL069518; Marra F, 2016, EARTH PLANET SC LETT, V449, P105, DOI 10.1016/j.epsl.2016.05.037; Marra F, 2014, EARTH-SCI REV, V139, P104, DOI 10.1016/j.earscirev.2014.08.014; Marra F, 2014, QUATERNARY SCI REV, V94, P74, DOI 10.1016/j.quascirev.2014.04.010; Marra F, 2013, GLOBAL PLANET CHANGE, V107, P157, DOI 10.1016/j.gloplacha.2013.05.002; Marra F, 1998, EARTH PLANET SC LETT, V159, P147, DOI 10.1016/S0012-821X(98)00071-5; Marra F, 2004, QUATERNARIO, V17, P643; Marra F., 1995, B SOC GEOL ITAL, V114, P195; Marra F., 1995, GEOLOGIA ROMA CTR ST, VVolume 50, P49; Marra F, 2003, QUATERNARIO, V16, P121; Marra F, 2016, QUATERNARY SCI REV, V148, P85, DOI 10.1016/j.quascirev.2016.07.003; Marra F, 2015, QUATERNARY SCI REV, V129, P260, DOI 10.1016/j.quascirev.2015.10.027; Marra F, 2014, EARTH-SCI REV, V136, P1, DOI 10.1016/j.earscirev.2014.05.001; Marra F, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001543; Marra F, 2009, J VOLCANOL GEOTH RES, V179, P217, DOI 10.1016/j.jvolgeores.2008.11.009; Nomade S, 2005, CHEM GEOL, V218, P315, DOI 10.1016/j.chemgeo.2005.01.005; Palma Di Cesnola A., 2001, PALEOLITICO INFERIOR; Palombo M.R., 2004, GEOL ROMANA, V37, P143; Parotto M., 1975, STRUCT MODEL ITALY, V90, P257; Peretto C, 2015, QUATERNARY IN PRESS; Peris J Fernandez, 2007, IND LITICAS PLEISTOC, P108; Petronio C, 2011, GEODIVERSITAS, V33, P485, DOI 10.5252/g2011n3a4; Picin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076182; Piperno M, 1978, QUATERNARIA, V20, P441; Sani F, 2004, MAR PETROL GEOL, V21, P1235, DOI 10.1016/j.marpetgeo.2004.09.004; Schreve DC, 2002, QUATERNARY SCI REV, V21, P1423, DOI 10.1016/S0277-3791(01)00100-7; Segre A.G., 1948, REND SC FIS NAT ACAD, V4, P743; Segre A. G., 1983, RIV ANTROPOLOGIA S, V62S, P87; Sergi S., 1929, RIV ANTROPOL, V28, P457; Taschini M., 1967, QUATERNARIA, V9, P301; van Kolfschoten T, 2014, QUATERN INT, V326-327, P469; Villa P, 2016, PLOS ONE IN PRESS; Villa P, 2009, SOURCEBOOK OF PALEOLITHIC TRANSITIONS, P265, DOI 10.1007/978-0-387-76487-0_17; Westaway R, 2006, QUATERNARY SCI REV, V25, P2212, DOI 10.1016/j.quascirev.2005.06.005; White M, 2003, CURR ANTHROPOL, V44, P598, DOI 10.1086/377653; White M, 2011, DEV QUATER SCI, V14, P53; WYMER J, 1988, QUATERNARY SCI REV, V7, P79, DOI 10.1016/0277-3791(88)90095-9; Wymer JJ, 1999, LOWER PALAEOLITHIC O; Zecchin M, 2013, MAR PETROL GEOL, V39, P1, DOI 10.1016/j.marpetgeo.2012.08.015	84	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170434	10.1371/journal.pone.0170434	http://dx.doi.org/10.1371/journal.pone.0170434			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7IT	28125602	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100109
J	Shiao, F; Liu, LCO; Huang, N; Lai, YJJ; Barndt, RJ; Tseng, CC; Wang, JK; Jia, B; Johnson, MD; Lin, CY				Shiao, Frank; Liu, Li-Ching O.; Huang, Nanxi; Lai, Ying-Jung J.; Barndt, Robert J.; Tseng, Chun-Che; Wang, Jehng-Kang; Jia, Bailing; Johnson, Michael D.; Lin, Chen-Yong			Selective Inhibition of Prostasin in Human Enterocytes by the Integral Membrane Kunitz-Type Serine Protease Inhibitor HAI-2	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; FACTOR ACTIVATOR INHIBITOR; MATRIPTASE-ACTIVATION; EPIDERMAL DIFFERENTIATION; PLACENTAL DEVELOPMENT; PROTEOLYTIC CASCADE; SECRETORY DIARRHEA; ZYMOGEN ACTIVATION; EPITHELIAL-CELLS; HUMAN TISSUES	Mutations of hepatocyte growth factor activator inhibitor (HAI)-2 in humans cause sodium loss in the gastrointestinal (GI) tract in patients with syndromic congenital sodium diarrhea (SCSD). Aberrant regulation of HAI-2 target protease(s) was proposed as the cause of the disease. Here functional linkage of HAI-2 with two membrane-associated serine proteases, matriptase and prostasin was analyzed in Caco-2 cells and the human GI tract. Immunodepletion- immunoblot analysis showed that significant proportion of HAI-2 is in complex with activated prostasin but not matriptase. Unexpectedly, prostasin is expressed predominantly in activated forms and was also detected in complex with HAI-1, a Kunitz inhibitor highly related to HAI-2. Immunohistochemistry showed a similar tissue distribution of prostasin and HAI-2 immunoreactivity with the most intense labeling near the brush borders of villus epithelial cells. In contrast, matriptase was detected primarily at the lateral plasma membrane, where HAI-1 was also detected. The tissue distribution profiles of immunoreactivity against these proteins, when paired with the species detected suggests that prostasin is under tight control by both HAI-1 and HAI-2 and matriptase by HAI-1 in human enterocytes. Furthermore, HAI-1 is a general inhibitor of prostasin in a variety of epithelial cells. In contrast, HAI-2 was not found to be a significant inhibitor for prostasin in mammary epithelial cells or keratinocytes. The high levels of constitutive prostasin zymogen activation and the selective prostasin inhibition by HAI-2 in enterocytes suggest that dysregulated prostasin proteolysis may be particularly important in the GI tract when HAI-2 function is lost and/or dysregulated.	[Shiao, Frank; Huang, Nanxi; Lai, Ying-Jung J.; Barndt, Robert J.; Tseng, Chun-Che; Jia, Bailing; Johnson, Michael D.; Lin, Chen-Yong] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA; [Liu, Li-Ching O.] Natl Def Med Ctr, Coll Med, Taipei, Taiwan; [Wang, Jehng-Kang] Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan; [Jia, Bailing] Henan Prov Peoples Hosp, Dept Gastroenterol, Zhengzhou, Peoples R China	Georgetown University; National Defense Medical Center; National Defense Medical Center; Zhengzhou University	Lin, CY (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA.; Wang, JK (corresponding author), Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan.	jkwang@ndmctsgh.edu.tw; lincy@georgetown.edu	Lin, Chen/GRR-2799-2022	Tseng, Chun-che/0000-0001-9637-4127; Lin, Chen-Yong/0000-0002-6391-2571	National Cancer Institute (NCI) [R01 CA 123223]; Department of Defense, Taiwan [MAB104-026]; Chi-Mei Medical Center [CM NDMC10506]; Lombardi Comprehensive Cancer Center (NIH/NCI) [P30-CA051008]; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense, Taiwan(United States Department of Defense); Chi-Mei Medical Center; Lombardi Comprehensive Cancer Center (NIH/NCI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Cancer Institute (NCI) Grant R01 CA 123223 (to M. D. Johnson and C.-Y. Lin), Grant (MAB104-026) from the Department of Defense, Taiwan (to J.-K. Wang), Grant CM NDMC10506 from Chi-Mei Medical Center (to J.-K. Wang). We also acknowledge the assistance provided by the Histopathology and Tissue Shared Resource and the Microscopy and Imaging Shared Resource which are supported in part by the Lombardi Comprehensive Cancer Center support grant (NIH/NCI grant P30-CA051008).	Andreasen D, 2006, J AM SOC NEPHROL, V17, P968, DOI 10.1681/ASN.2005060637; [Anonymous], 2010, CLIN DYSMORPHOL; Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Bhatt AS, 2007, P NATL ACAD SCI USA, V104, P5771, DOI 10.1073/pnas.0606514104; BOOTH IW, 1985, LANCET, V1, P1066; Carattino MD, 2014, AM J PHYSIOL-RENAL, V307, pF1080, DOI 10.1152/ajprenal.00157.2014; Carney TJ, 2007, DEVELOPMENT, V134, P3461, DOI 10.1242/dev.004556; Chang HHD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120489; Chen CJ, 2011, AM J PHYSIOL-CELL PH, V300, pC406, DOI 10.1152/ajpcell.00403.2010; Chen LM, 2001, J BIOL CHEM, V276, P21434, DOI 10.1074/jbc.M011423200; Chen LM, 2004, PROSTATE, V59, P1, DOI 10.1002/pros.10346; Chen YW, 2014, J INVEST DERMATOL, V134, P405, DOI 10.1038/jid.2013.320; Chen YW, 2010, J BIOL CHEM, V285, P31755, DOI 10.1074/jbc.M110.150367; Chen YW, 2010, AM J PATHOL, V176, P2986, DOI 10.2353/ajpath.2010.090665; Crisante G, 2014, FASEB J, V28, P4792, DOI 10.1096/fj.14-253781; Faller N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094267; Friis S, 2016, J BIOL CHEM, V291, P2577, DOI 10.1074/jbc.C115.706721; Friis S, 2014, J BIOL CHEM, V289, P22319, DOI 10.1074/jbc.M114.574400; Friis S, 2013, J BIOL CHEM, V288, P19028, DOI 10.1074/jbc.M113.469932; Heinz-Erian P, 2009, AM J HUM GENET, V84, P188, DOI 10.1016/j.ajhg.2009.01.004; HOLMBERG C, 1985, J PEDIATR-US, V106, P56, DOI 10.1016/S0022-3476(85)80465-0; Kataoka H, 1999, J HISTOCHEM CYTOCHEM, V47, P673, DOI 10.1177/002215549904700509; Kataoka H, 2000, CANCER LETT, V148, P127, DOI 10.1016/S0304-3835(99)00322-5; Kato A, 2011, ANNU REV PHYSIOL, V73, P261, DOI 10.1146/annurev-physiol-012110-142244; Kawaguchi T, 1997, J BIOL CHEM, V272, P27558, DOI 10.1074/jbc.272.44.27558; Kirchhofer D, 2005, FEBS LETT, V579, P1945, DOI 10.1016/j.febslet.2005.01.085; Lai CH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152904; Lai YJJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132163; LAWRENCE DA, 1995, J BIOL CHEM, V270, P25309, DOI 10.1074/jbc.270.43.25309; Lee MS, 2005, AM J PHYSIOL-CELL PH, V288, pC932, DOI 10.1152/ajpcell.00497.2004; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; Lin CY, 1997, J BIOL CHEM, V272, P9147; Marlor CW, 1997, J BIOL CHEM, V272, P12202, DOI 10.1074/jbc.272.18.12202; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Shipway A, 2004, BIOCHEM BIOPH RES CO, V324, P953, DOI 10.1016/j.bbrc.2004.09.123; STAMPFER MR, 1985, P NATL ACAD SCI USA, V82, P2394, DOI 10.1073/pnas.82.8.2394; Szabo R, 2007, ONCOGENE, V26, P1546, DOI 10.1038/sj.onc.1209966; Szabo R, 2008, J BIOL CHEM, V283, P29495, DOI 10.1074/jbc.M801970200; Szabo R, 2016, DEVELOPMENT, V143, P2818, DOI 10.1242/dev.137968; Szabo R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002937; Szabo R, 2009, DEVELOPMENT, V136, P2653, DOI 10.1242/dev.038430; Szabo R, 2009, AM J PATHOL, V174, P2015, DOI 10.2353/ajpath.2009.090053; Tseng IC, 2010, J BIOL CHEM, V285, P3261, DOI 10.1074/jbc.M109.055640; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; VINCENT JP, 1976, FEBS LETT, V63, P240, DOI 10.1016/0014-5793(76)80103-2; VINCENT JP, 1972, BIOCHEMISTRY-US, V11, P2967, DOI 10.1021/bi00766a007; Xu H, 2012, AM J PHYSIOL-CELL PH, V302, pC453, DOI 10.1152/ajpcell.00344.2011; YU JX, 1995, J BIOL CHEM, V270, P13483, DOI 10.1074/jbc.270.22.13483	52	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170944	10.1371/journal.pone.0170944	http://dx.doi.org/10.1371/journal.pone.0170944			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125689	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100016
J	Pereira, LS; Keppeler, FW; Agostinho, AA; Winemiller, KO				Pereira, Larissa Strictar; Keppeler, Friedrich Wolfgang; Agostinho, Angelo Antonio; Winemiller, Kirk O.			Is There a Relationship between Fish Cannibalism and Latitude or Species Richness?	PLOS ONE			English	Article							MIXED-EFFECTS MODELS; FRESH-WATER FISH; BIOTIC HOMOGENIZATION; ARCTIC CHARR; STRUCTURED POPULATIONS; PRACTICAL GUIDE; GLOBAL PATTERNS; SIZE STRUCTURE; DIVERSITY; PREY	Cannibalism has been commonly observed in fish from northern and alpine regions and less frequently reported for subtropical and tropical fish in more diverse communities. Assuming all else being equal, cannibalism should be more common in communities with lower species richness because the probability of encountering conspecific versus heterospecific prey would be higher. A global dataset was compiled to determine if cannibalism occurrence is associated with species richness and latitude. Cannibalism occurrence, local species rich-ness and latitude were recorded for 4,100 populations of 2,314 teleost fish species. Relation-ships between cannibalism, species richness and latitude were evaluated using generalized linear mixed models. Species richness was an important predictor of cannibalism, with occurrences more frequently reported for assemblages containing fewer species. Cannibalism was positively related with latitude for both marine and freshwater ecosystems in the North-ern Hemisphere, but not in the Southern Hemisphere. The regression slope for the relationship was steeper for freshwater than marine fishes. In general, cannibalism is more frequent in communities with lower species richness, and the relationship between cannibalism and latitude is stronger in the Northern Hemisphere. In the Southern Hemisphere, weaker latitudi-nal gradients of fish species richness may account for the weak relationship between canni-balism and latitude. Cannibalism may be more common in freshwater than marine systems because freshwater habitats tend to be smaller and more closed to dispersal. Cannibalism should have greatest potential to influence fish population dynamics in freshwater systems at high northern latitudes.	[Pereira, Larissa Strictar; Agostinho, Angelo Antonio] Univ Estadual Maringa, Nupelia, Av Colombo, Maringa, Parana, Brazil; [Keppeler, Friedrich Wolfgang; Winemiller, Kirk O.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA	Universidade Estadual de Maringa; Texas A&M University System; Texas A&M University College Station	Pereira, LS (corresponding author), Univ Estadual Maringa, Nupelia, Av Colombo, Maringa, Parana, Brazil.	lari.strictar@gmail.com	Agostinho, Angelo Antonio/S-1538-2019; Pereira, Larissa/O-4325-2016; Agostini, Angelo/D-5888-2013	Agostinho, Angelo Antonio/0000-0002-4707-9444; Pereira, Larissa/0000-0002-5547-2860; Agostini, Angelo/0000-0002-4707-9444; Keppeler, Friedrich/0000-0002-5165-1298	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); Capes (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); PVE-Capes/Project [74-2013]; CNPq [306553/2011, 233691/2014-6]	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Capes (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PVE-Capes/Project; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) and Capes (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior). KOW was supported as a visiting researcher (PVE-Capes/Project 74-2013) and AAA and LSP were supported by CNPq grants (Proc. 306553/2011 and Proc. 233691/2014-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelha Milza Celi Fedatto, 2001, Acta Scientiarum Universidade Estadual de Maringa, V23, P425; AMUNDSEN PA, 1994, J FISH BIOL, V45, P181, DOI 10.1006/jfbi.1994.1222; Amundsen PA, 1999, ECOL FRESHW FISH, V8, P43, DOI 10.1111/j.1600-0633.1999.tb00051.x; Bailly D, 2014, ECOLOGY, V95, P553, DOI 10.1890/13-0483.1; Bates D.M., 2010, LME4 MIXED EFFECTS M; Bell GW, 1999, J FISH BIOL, V55, P990, DOI 10.1111/j.1095-8649.1999.tb00734.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bradbury IR, 2008, P ROY SOC B-BIOL SCI, V275, P1803, DOI 10.1098/rspb.2008.0216; Briggs JC, 2005, BIOL CONSERV, V126, P297, DOI 10.1016/j.biocon.2005.06.018; Brosse S, 2013, HYDROBIOLOGIA, V700, P343, DOI 10.1007/s10750-012-1242-6; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Bystrom P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070404; Canty A., 2015, BOOT BOOTSTRAP R S P; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Chown SL, 2004, PLOS BIOL, V2, P1701, DOI 10.1371/journal.pbio.0020406; CHRISTENSEN B, 1993, BEHAV ECOL SOCIOBIOL, V32, P1; Claessen D, 2000, AM NAT, V155, P219, DOI 10.1086/303315; Solar RRD, 2015, ECOL LETT, V18, P1108, DOI 10.1111/ele.12494; Drakou EG, 2009, ECOL FRESHW FISH, V18, P369, DOI 10.1111/j.1600-0633.2009.00354.x; Eklov P, 1997, CAN J FISH AQUAT SCI, V54, P1520, DOI 10.1139/cjfas-54-7-1520; Filgueiras BKC, 2016, DIVERS DISTRIB, V1-10; FOX LR, 1975, ANNU REV ECOL SYST, V6, P87, DOI 10.1146/annurev.es.06.110175.000511; FOX LR, 1975, ECOLOGY, V56, P933, DOI 10.2307/1936303; Fugi R, 2008, HYDROBIOLOGIA, V607, P143, DOI 10.1007/s10750-008-9384-2; Gaston K. J., 2000, PATTERNS PROCESS MAC; GRIFFITHS D, 1994, BIOL J LINN SOC, V51, P337, DOI 10.1006/bijl.1994.1028; GROSS MR, 1988, SCIENCE, V239, P1291, DOI 10.1126/science.239.4845.1291; Hardie DC, 2014, EVOL ECOL RES, V16, P569; HARRIS JGK, 1975, J CONSEIL, V36, P144; Heermann L, 2013, J APPL ICHTHYOL, V29, P549, DOI 10.1111/jai.12044; Inoue N, 2016, AQUAC RES, V47, P605, DOI 10.1111/are.12519; Kaplan MR, 2010, NATURE, V467, P194, DOI 10.1038/nature09313; Korner-Nievergelt F., 2015, BAYESIAN DATA ANAL E, DOI DOI 10.1007/S13398-014-0173-7.2; LANNOO MJ, 1989, CAN J ZOOL, V67, P1911, DOI 10.1139/z89-273; Leveque C, 2008, HYDROBIOLOGIA, V595, P545, DOI 10.1007/s10750-007-9034-0; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Lowe-McConnell R. H., 1987, ECOLOGICAL STUDIES T; Magnusson Kjartan G., 1999, Rit Fiskideildar, V16, P295; McBride MM, 2014, ICES J MAR SCI, V71, P1934, DOI 10.1093/icesjms/fsu002; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Mora C, 2005, ECOLOGY, V86, P1771, DOI 10.1890/04-0883; Mora C, 2003, NATURE, V421, P933, DOI 10.1038/nature01393; Moss, 2013, ECOLOGY FRESHWATERS; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nakazawa M., 2014, FMSB FUNCTIONS MED S; Neves MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141651; Nishimura K, 2004, J THEOR BIOL, V228, P291, DOI 10.1016/j.jtbi.2004.02.008; Nonnis Marzano F, 2001, ETHOL ECOL EVOL, V13, P385, DOI 10.1080/08927014.2001.9522769; Pellissier L, 2014, SCIENCE, V344, P1016, DOI 10.1126/science.1249853; Persson L, 2000, ECOLOGY, V81, P1058; Persson L, 2003, P NATL ACAD SCI USA, V100, P4035, DOI 10.1073/pnas.0636404100; Persson L, 1996, ECOLOGY, V77, P900, DOI 10.2307/2265510; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; POLIS GA, 1981, ANNU REV ECOL SYST, V12, P225, DOI 10.1146/annurev.es.12.110181.001301; REIST JD, 1980, CAN J ZOOL, V58, P1245, DOI 10.1139/z80-174; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Ricker WE, 1963, J FISH RES BOARD CAN, V713; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Rocha LA, 2003, J BIOGEOGR, V30, P1161, DOI 10.1046/j.1365-2699.2003.00900.x; Rudolf VHW, 2008, J ANIM ECOL, V77, P520, DOI 10.1111/j.1365-2656.2008.01368.x; Rudolf VHW, 2007, ECOLOGY, V88, P2697, DOI 10.1890/06-1266.1; Rudolf VHW, 2010, AM NAT, V175, P513, DOI 10.1086/651616; Saefken B., 2014, CAIC4 CONDITIONAL AK; Scharf FS, 2000, MAR ECOL PROG SER, V208, P229, DOI 10.3354/meps208229; Smith C., 1991, Reviews in Fish Biology and Fisheries, V1, P41, DOI 10.1007/BF00042661; Stuart-Smith RD, 2013, NATURE, V501, P539, DOI 10.1038/nature12529; Tedesco PA, 2013, GLOBAL FRESHWATER FI; TREASURER JW, 1992, ENVIRON BIOL FISH, V34, P65, DOI 10.1007/BF00004785; Trentanovi G, 2013, DIVERS DISTRIB, V19, P738, DOI 10.1111/ddi.12028; Vaida F, 2005, BIOMETRIKA, V92, P351, DOI 10.1093/biomet/92.2.351; Wagner JD, 1999, EVOL ECOL RES, V1, P375; WEBB PW, 1984, SCI AM, V251, P72, DOI 10.1038/scientificamerican0784-72; Wildy EL, 1998, J HERPETOL, V32, P286, DOI 10.2307/1565312; WINEMILLER KO, 1989, OECOLOGIA, V81, P225, DOI 10.1007/BF00379810; WOOTTON JT, 1992, ENVIRON BIOL FISH, V35, P311, DOI 10.1007/BF00001899	76	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0169813	10.1371/journal.pone.0169813	http://dx.doi.org/10.1371/journal.pone.0169813			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122040	gold, Green Published, Green Submitted			2022-12-26	WOS:000396167300066
J	Whetstone, WD; Walker, B; Trivedi, A; Lee, S; Noble-Haeusslein, LJ; Hsu, JYC				Whetstone, William D.; Walker, Breset; Trivedi, Alpa; Lee, Sangmi; Noble-Haeusslein, Linda J.; Hsu, Jung-Yu C.			Protease-Activated Receptor-1 Supports Locomotor Recovery by Biased Agonist Activated Protein C after Contusive Spinal Cord Injury	PLOS ONE			English	Article							HUMAN BRAIN ENDOTHELIUM; THROMBIN RECEPTOR; REACTIVE ASTROCYTES; FUNCTIONAL RECOVERY; SCAR FORMATION; UP-REGULATION; GLIAL SCAR; P-SELECTIN; BARRIER; RAT	Thrombin-induced secondary injury is mediated through its receptor, protease activated receptor-1 (PAR-1), by "biased agonism." Activated protein C (APC) acts through the same PAR-1 receptor but functions as an anti-coagulant and anti-inflammatory protein, which counteracts many of the effects of thrombin. Although the working mechanism of PAR-1 is becoming clear, the functional role of PAR-1 and its correlation with APC in the injured spinal cord remains to be elucidated. Here we investigated if PAR-1 and APC are determinants of long-term functional recovery after a spinal cord contusive injury using PAR-1 null and wildtype mice. We found that neutrophil infiltration and disruption of the blood-spinal cord barrier were significantly reduced in spinal cord injured PAR-1 null mice relative to the wild-type group. Both locomotor recovery and ability to descend an inclined grid were significantly improved in the PAR-1 null group 42 days after injury and this improvement was associated with greater long-term sparing of white matter and a reduction in glial scarring. Wild-type mice treated with APC acutely after injury showed a similar level of improved locomotor recovery to that of PAR-1 null mice. However, improvement of APC-treated PAR-1 null mice was indistinguishable from that of vehicle-treated PAR-1 null mice, suggesting that APC acts through PAR-1. Collectively, our findings define a detrimental role of thrombin-activated PAR-1 in wound healing and further validate APC, also acting through the PAR-1 by biased agonism, as a promising therapeutic target for spinal cord injury.	[Whetstone, William D.] Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA; [Walker, Breset; Trivedi, Alpa; Lee, Sangmi; Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Dept Phys Therapy & Rehabil Sci, San Francisco, CA 94143 USA; [Hsu, Jung-Yu C.] Natl Cheng Kung Univ, Coll Med, Dept Cell Biol & Anat, Tainan, Taiwan	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Cheng Kung University	Hsu, JYC (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Cell Biol & Anat, Tainan, Taiwan.	jungyu.hsu@gmail.com			U.S. National Institutes of Health/National Institute of Neurological Disorders and Stroke [NS39278, NS43302]; Roman Reed Fund of California; Ministry of Science and Technology, Taiwan [101-2320-B-006-008-MY3]	U.S. National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Roman Reed Fund of California; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the U.S. National Institutes of Health/National Institute of Neurological Disorders and Stroke (http://www.ninds.nih.gov) NS39278 (LN), NS43302 (WW), the Roman Reed Fund of California (http://romanreedfoundation.com/) (WW), and the Ministry of Science and Technology, Taiwan (https://www.most.gov.tw/en/public) 101-2320-B-006-008-MY3 (JYH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MN, 2011, PHARMACOL THERAPEUT, V130, P248, DOI 10.1016/j.pharmthera.2011.01.003; Alabanza LM, 2012, J NEUROIMMUNOL, V245, P48, DOI 10.1016/j.jneuroim.2012.02.004; Anwar MA, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00098; Bartha K, 2000, J CEREBR BLOOD F MET, V20, P175, DOI 10.1097/00004647-200001000-00022; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; Cheng T, 2006, NAT MED, V12, P1278, DOI 10.1038/nm1498; Citron BA, 2000, J NEUROTRAUM, V17, P1191, DOI 10.1089/neu.2000.17.1191; COLOTTA F, 1994, AM J PATHOL, V144, P975; Connolly AJ, 1996, NATURE, V381, P516, DOI 10.1038/381516a0; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Coughlin SR, 1999, P NATL ACAD SCI USA, V96, P11023, DOI 10.1073/pnas.96.20.11023; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; CUNNINGHAM DD, 1993, THROMB HAEMOSTASIS, V70, P168; de Garavilla L, 2001, BRIT J PHARMACOL, V133, P975, DOI 10.1038/sj.bjp.0704152; Domotor E, 2003, BLOOD, V101, P4797, DOI 10.1182/blood-2002-12-3680; Esmon CT, 2012, SEMIN IMMUNOPATHOL, V34, P127, DOI 10.1007/s00281-011-0284-6; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Ferrari CC, 2004, AM J PATHOL, V165, P1827, DOI 10.1016/S0002-9440(10)63438-4; Festoff BM, 2000, MOL MED, V6, P410, DOI 10.1007/BF03401784; Fiore C, 2004, J NEUROSCI RES, V75, P391, DOI 10.1002/jnr.10821; FRANCIS CW, 1983, J LAB CLIN MED, V102, P220; Geiger H, 2012, NAT MED, V18, P1123, DOI 10.1038/nm.2813; Gresele P, 1998, J CLIN INVEST, V101, P667, DOI 10.1172/JCI575; Griffin JH, 2016, THROMB RES, V141, pS62, DOI 10.1016/S0049-3848(16)30368-1; Griffin JH, 2015, BLOOD, V125, P2898, DOI 10.1182/blood-2015-02-355974; Gris D, 2004, J NEUROSCI, V24, P4043, DOI 10.1523/JNEUROSCI.5343-03.2004; Guitton C, 2011, AM J PHYSIOL-CELL PH, V300, pC833, DOI 10.1152/ajpcell.00003.2010; Guo H, 2009, EUR J NEUROSCI, V29, P1119, DOI 10.1111/j.1460-9568.2009.06664.x; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hirano Katsuya, 2003, J Atheroscler Thromb, V10, P211; Hirose K, 2000, ANN SURG, V232, P272, DOI 10.1097/00000658-200008000-00018; HIRSCHBERG DL, 1994, J NEUROIMMUNOL, V50, P9, DOI 10.1016/0165-5728(94)90209-7; Hsu JYC, 2006, J NEUROSCI, V26, P9841, DOI 10.1523/JNEUROSCI.1993-06.2006; Hsu JYC, 2008, J NEUROSCI, V28, P13467, DOI 10.1523/JNEUROSCI.2287-08.2008; Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667; Joyce DE, 2002, CRIT CARE MED, V30, pS288, DOI 10.1097/00003246-200205001-00019; Junge CE, 2003, P NATL ACAD SCI USA, V100, P13019, DOI 10.1073/pnas.2235594100; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404; Komarova Yulia A, 2007, Sci STKE, V2007, pre8; Kouklis P, 2004, CIRC RES, V94, P159, DOI 10.1161/01.RES.0000110418.38500.31; Krenzlin H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010084; Lang R, 2003, INVEST OPHTH VIS SCI, V44, P99, DOI 10.1167/iovs.02-0357; Lay AJ, 2007, BLOOD, V109, P1984, DOI 10.1182/blood-2006-07-037945; LIU CY, 1979, J BIOL CHEM, V254, P421; Liu D, 2004, NAT MED, V10, P1379, DOI 10.1038/nm1122; Loubele STBG, 2009, ARTERIOSCL THROM VAS, V29, P1087, DOI 10.1161/ATVBAHA.109.188656; Luo W, 2007, BRAIN RES REV, V56, P331, DOI 10.1016/j.brainresrev.2007.08.002; Ma L, 2012, SEMIN IMMUNOPATHOL, V34, P63, DOI 10.1007/s00281-011-0281-9; MALIK AB, 1992, SEMIN THROMB HEMOST, V18, P193, DOI 10.1055/s-2007-1002425; Mann KG., 1994, HEMOSTASIS THROMBOSI, P184; Minami T, 2004, ARTERIOSCL THROM VAS, V24, P41, DOI 10.1161/01.ATV.0000099880.09014.7D; Mosnier LO, 2014, THROMB HAEMOSTASIS, V112, P883, DOI 10.1160/TH14-05-0448; Mosnier LO, 2012, BLOOD, V120, P5237, DOI 10.1182/blood-2012-08-452169; Niclou SP, 1998, EUR J NEUROSCI, V10, P1590, DOI 10.1046/j.1460-9568.1998.00183.x; Nicole O, 2005, J NEUROSCI, V25, P4319, DOI 10.1523/JNEUROSCI.5200-04.2005; NOBLE LJ, 1989, BRAIN RES, V482, P57, DOI 10.1016/0006-8993(89)90542-8; Noble LJ, 2002, J NEUROSCI, V22, P7526; NOBLE LJ, 1985, EXP NEUROL, V88, P135, DOI 10.1016/0014-4886(85)90119-0; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Papastefanaki F, 2015, GLIA, V63, P1101, DOI 10.1002/glia.22809; Park SW, 2009, KIDNEY INT, V76, P739, DOI 10.1038/ki.2009.255; Petraglia AL, 2010, NEUROSURGERY, V66, P165, DOI 10.1227/01.NEU.0000363148.49779.68; Popovich PG, 1996, EXP NEUROL, V142, P258, DOI 10.1006/exnr.1996.0196; Radulovic M, 2016, NEUROBIOL DIS, V93, P226, DOI 10.1016/j.nbd.2016.04.010; Rhodes KE, 2003, NEUROSCIENCE, V120, P41, DOI 10.1016/S0306-4522(03)00285-9; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Russo A, 2009, P NATL ACAD SCI USA, V106, P6393, DOI 10.1073/pnas.0810687106; Schuepbach RA, 2012, J THROMB HAEMOST, V10, P1675, DOI 10.1111/j.1538-7836.2012.04825.x; Schuepbach RA, 2008, BLOOD, V111, P2667, DOI 10.1182/blood-2007-09-113076; Schuepbach RA, 2009, THROMB HAEMOSTASIS, V101, P724, DOI 10.1160/TH08-10-0632; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; SUGAMA Y, 1992, CIRC RES, V71, P1015, DOI 10.1161/01.RES.71.4.1015; Taoka Y, 2000, J NEUROTRAUM, V17, P219, DOI 10.1089/neu.2000.17.219; Thiyagarajan M, 2008, J NEUROSCI, V28, P12788, DOI 10.1523/JNEUROSCI.3485-08.2008; Traynelis SF, 2007, CURR OPIN HEMATOL, V14, P230, DOI 10.1097/MOH.0b013e3280dce568; Trivedi A, 2006, CLIN NEUROSCI RES, V6, P283, DOI 10.1016/j.cnr.2006.09.007; Tsuji K, 2005, STROKE, V36, P1954, DOI 10.1161/01.STR.0000177517.01203.eb; Vergnolle N, 1999, BRIT J PHARMACOL, V126, P1262, DOI 10.1038/sj.bjp.0702408; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Walker CT, 2010, BRAIN RES, V1347, P125, DOI 10.1016/j.brainres.2010.05.075; Wang H, 2002, AM J PHYSIOL-CELL PH, V283, pC1351, DOI 10.1152/ajpcell.00001.2002; Wang Y, 2016, NAT MED; Wang Yan-Li, 2006, Zhong Xi Yi Jie He Xue Bao, V4, P98; Wang YZ, 2013, J NANOMATER, V2013, DOI 10.1155/2013/169405; Wang YM, 2009, STROKE, V40, P1864, DOI 10.1161/STROKEAHA.108.536680; Whetstone WD, 2003, J NEUROSCI RES, V74, P227, DOI 10.1002/jnr.10759; WILNER GD, 1981, J LAB CLIN MED, V97, P403; Winkler EA, 2014, P NATL ACAD SCI USA, V111, pE1035, DOI 10.1073/pnas.1401595111; Yamauchi T, 2006, STROKE, V37, P1081, DOI 10.1161/01.STR.0000206280.30972.21; Yang CC, 2016, MOL NEUROBIOLOGY; Yoon H, 2015, GLIA, V63, P846, DOI 10.1002/glia.22788; Zhong ZH, 2009, J CLIN INVEST, V119, P3437, DOI 10.1172/JCI38476; ZIMMERMAN BJ, 1994, AM J PHYSIOL, V267, pH1049, DOI 10.1152/ajpheart.1994.267.3.H1049; Zlokovic BV, 2011, TRENDS NEUROSCI, V34, P198, DOI 10.1016/j.tins.2011.01.005	99	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0170512	10.1371/journal.pone.0170512	http://dx.doi.org/10.1371/journal.pone.0170512			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122028	Green Published, Green Submitted, gold			2022-12-26	WOS:000396167300042
J	Kastanenka, KV; Hou, SS; Shakerdge, N; Logan, R; Feng, D; Wegmann, S; Chopra, V; Hawkes, JM; Chen, XQ; Bacskai, BJ				Kastanenka, Ksenia V.; Hou, Steven S.; Shakerdge, Naomi; Logan, Robert; Feng, Danielle; Wegmann, Susanne; Chopra, Vanita; Hawkes, Jonathan M.; Chen, Xiqun; Bacskai, Brian J.			Optogenetic Restoration of Disrupted Slow Oscillations Halts Amyloid Deposition and Restores Calcium Homeostasis in an Animal Model of Alzheimer's Disease	PLOS ONE			English	Article							IN-VIVO; SYNAPSE LOSS; MOUSE MODEL; COGNITIVE IMPAIRMENT; NEOCORTICAL NEURONS; BETA-PLAQUES; SLEEP; MEMORY; ACTIVATION; PROTEIN	Slow oscillations are important for consolidation of memory during sleep, and Alzheimer's disease (AD) patients experience memory disturbances. Thus, we examined slow oscillation activity in an animal model of AD. APP mice exhibit aberrant slow oscillation activity. Aberrant inhibitory activity within the cortical circuit was responsible for slow oscillation dysfunction, since topical application of GABA restored slow oscillations in APP mice. In addition, light activation of channelrhodopsin-2 (ChR2) expressed in excitatory cortical neurons restored slow oscillations by synchronizing neuronal activity. Driving slow oscillation activity with ChR2 halted amyloid plaque deposition and prevented calcium overload associated with this pathology. Thus, targeting slow oscillatory activity in AD patients might prevent neurodegenerative phenotypes and slow disease progression.	[Kastanenka, Ksenia V.; Bacskai, Brian J.] Massachusetts Gen Hosp, MassGeneral Inst Neurodegenerat Dis, Dept Neurol, Charlestown, MA 02129 USA; Harvard Med Sch, Charlestown, MA USA	Harvard University; Massachusetts General Hospital	Bacskai, BJ (corresponding author), Massachusetts Gen Hosp, MassGeneral Inst Neurodegenerat Dis, Dept Neurol, Charlestown, MA 02129 USA.	kkastanenka@mgh.harvard.edu; bbacskai@mgh.harvard.edu	Bacskai, Brian/AAE-9583-2021		NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG044263] Funding Source: NIH RePORTER; NCRR NIH HHS [S10 RR025645] Funding Source: Medline; NIA NIH HHS [R01 AG044263] Funding Source: Medline; NIBIB NIH HHS [R01 EB000768] Funding Source: Medline; NINDS NIH HHS [P30 NS045776] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bacskai BJ, 2002, NEUROSCIENTIST, V8, P386, DOI 10.1177/107385802236963; Beltramo R, 2013, NAT NEUROSCI, V16, P227, DOI 10.1038/nn.3306; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Busche MA, 2015, NAT NEUROSCI, V18, P1623, DOI 10.1038/nn.4137; Chen JY, 2012, J PHYSIOL-LONDON, V590, P3987, DOI 10.1113/jphysiol.2012.227462; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Grienberger C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1783; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hashimoto T, 2011, J BIOL CHEM, V286, P27081, DOI 10.1074/jbc.M111.257378; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Kastanenka KV, 2013, P NATL ACAD SCI USA, V110, P17528, DOI 10.1073/pnas.1316457110; Kastanenka KV, 2010, J NEUROSCI, V30, P10575, DOI 10.1523/JNEUROSCI.2773-10.2010; Kastanenka KV, 2015, OPTICAL PROBES BIOL; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Kuchibhotla KV, 2008, NEURON, V59, P214, DOI 10.1016/j.neuron.2008.06.008; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Mander BA, 2015, NAT NEUROSCI, V18, P1051, DOI 10.1038/nn.4035; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Mohajerani MH, 2010, J NEUROSCI, V30, P3745, DOI 10.1523/JNEUROSCI.6437-09.2010; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Pihlajamaki M, 2008, AM J GERIAT PSYCHIAT, V16, P283, DOI 10.1097/JGP.0b013e318162a0a9; Pihlajamaki M, 2010, ALZ DIS ASSOC DIS, V24, P28, DOI 10.1097/WAD.0b013e3181a785c9; Ruiz-Mejias M, 2011, J NEUROPHYSIOL, V106, P2910, DOI 10.1152/jn.00440.2011; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stern EA, 2004, J NEUROSCI, V24, P4535, DOI 10.1523/JNEUROSCI.0462-04.2004; Takeda S, 2013, FASEB J, V27, P3239, DOI 10.1096/fj.13-229666; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Timofeev I, 2001, P NATL ACAD SCI USA, V98, P1924, DOI 10.1073/pnas.041430398; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006; Westerberg CE, 2012, J INT NEUROPSYCH SOC, V18, P490, DOI 10.1017/S135561771200001X; Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010; Yamamoto K, 2015, CELL REP, V11, P859, DOI 10.1016/j.celrep.2015.04.017	47	49	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e70275	10.1371/journal.pone.0170275	http://dx.doi.org/10.1371/journal.pone.0170275			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114405	Green Submitted, Green Published, gold			2022-12-26	WOS:000396129000031
J	Park, JY; Kim, BJ; Lee, EJ; Park, KS; Park, HS; Jung, SS; Kim, JO				Park, Ji Young; Kim, Bong-Joon; Lee, Eun Jung; Park, Kwi Sung; Park, Hee Sun; Jung, Sung Soo; Kim, Ju Ock			Clinical Features and Courses of Adenovirus Pneumonia in Healthy Young Adults during an Outbreak among Korean Military Personnel	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; ACUTE RESPIRATORY-DISEASE; US MILITARY; TRAINING FACILITY; SEROTYPE 14; INFECTIONS; CHINA; CAMP; IMMUNOCOMPETENT; VALIDATION	Background The number of pneumonia patients increased suddenly in Korean military hospitals in late December 2014, indicating the urgent need for an epidemic outbreak investigation. Methods We conducted a prospective study of pneumonia etiology among immunocompetent young adults admitted to Daejeon Armed Forces hospital. Patient blood and sputum samples were subjected to conventional culture, serology, and polymerase chain reaction tests for respiratory viruses and atypical pathogens. Results From January to May 2015, we enrolled 191 (189 male) adults with pneumonia; the mean age was 20.1 +/- 1.3 years. Five patients had severe pneumonia, and one died. Pathogenic human adenoviruses were most common (HAdV, 153/191 [80.1%]), indicating a HAdV pneumonia outbreak. Genotyping of 35 isolates indicated that 34 matched HAdV-55 and one matched HAdV-2. HAdV pneumonia infected recruit trainees most frequently. High and prolonged fever, nasal congestion, sore throat, and pharyngeal inflammation were significantly more common in the HAdV pneumonia group, compared to patients with other or unknown causes of pneumonia. Only 12% of HAdV pneumonia patients displayed leukocytosis, whereas febrile leukopenia (62.7%) and thrombocytopenia (41%) were commonly observed. HAdV pneumonia patient chest CT scans displayed ground glass opacity (with or without septal thickness) with consolidation in 50.0% of patients. Conclusions An outbreak of HAdV respiratory infection occurred at the Korean military training center. HAdV pneumonia exhibited specific laboratory and clinical features, and although most patients were cured without complication, some progressed to respiratory failure and fatality. Therefore, HAdV vaccine should be provided to military trainees in Korea.	[Park, Ji Young] Hallym Univ, Sacred Heart Hosp, Dept Internal Med, Div Pulm Allergy & Crit Care Med, Anyang, South Korea; [Park, Ji Young; Kim, Bong-Joon; Lee, Eun Jung] Armed Forces Daejeon Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Daejeon, South Korea; [Kim, Bong-Joon] Kosin Univ, Coll Med, Dept Internal Med, Busan, South Korea; [Park, Kwi Sung] Chungcheongnam Do Inst Hlth & Environm Res, Daejeon, South Korea; [Park, Hee Sun; Jung, Sung Soo; Kim, Ju Ock] Chungnam Natl Univ Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Daejeon, South Korea	Hallym University; Chungnam National University; Chungnam National University Hospital	Kim, JO (corresponding author), Chungnam Natl Univ Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Daejeon, South Korea.	jokim@cnu.ac.kr	Jung, Sung Soo/AAI-3008-2020	Jung, Sung Soo/0000-0001-7990-3066; Park, Hee Sun/0000-0002-9730-8524; Park, Ji Young/0000-0002-6533-4656; Kim, Bong Joon/0000-0002-5435-7449				Aujesky D, 2008, CLIN INFECT DIS, V47, pS133, DOI 10.1086/591394; Bjarnason A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046816; Broderick MP, 2008, J INFECT DIS, V198, P1420, DOI 10.1086/592711; Cao B, 2014, CHEST, V145, P79, DOI 10.1378/chest.13-1186; Cassir N., 2014, Eurosurveillance, V19, P20914, DOI 10.2807/1560-7917.ES2014.19.39.20914; Chen SP, 2013, J CLIN VIROL, V56, P7, DOI 10.1016/j.jcv.2012.08.021; Chmielewicz B, 2005, J MED VIROL, V77, P232, DOI 10.1002/jmv.20441; Chong SM, 2006, AM J ROENTGENOL, V186, P1288, DOI 10.2214/AJR.05.0128; COHEN S, 1991, NEW ENGL J MED, V325, P606, DOI 10.1056/NEJM199108293250903; Esposito DH, 2010, J INFECT DIS, V202, P214, DOI 10.1086/653498; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Gu L, 2012, J CLIN VIROL, V54, P295, DOI 10.1016/j.jcv.2012.04.018; Heo JY, 2014, EMERG INFECT DIS, V20, P875, DOI 10.3201/eid2005.131692; Jain S, 2015, NEW ENGL J MED, V373, P415, DOI [10.1056/NEJMoa1500245, 10.1056/NEJMc1511751]; Jennings LC, 2008, THORAX, V63, P42, DOI 10.1136/thx.2006.075077; Jeon K, 2007, EUR J CLIN MICROBIOL, V26, P481, DOI 10.1007/s10096-007-0312-6; Kajon AE, 2010, J CLIN MICROBIOL, V48, P1438, DOI 10.1128/JCM.01928-09; Kim SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122642; Kolavic-Gray SA, 2002, CLIN INFECT DIS, V35, P808, DOI 10.1086/342573; Li XY, 2014, INT J INFECT DIS, V28, P117, DOI 10.1016/j.ijid.2014.06.019; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Lion T, 2014, CLIN MICROBIOL REV, V27, P441, DOI 10.1128/CMR.00116-13; Lu Q, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.30; MURRAY PR, 1975, MAYO CLIN PROC, V50, P339; Okada M, 2007, ARCH VIROL, V152, P1, DOI 10.1007/s00705-006-0842-8; Pereira JM, 2012, CLIN MICROBIOL INFEC, V18, P1040, DOI 10.1111/j.1469-0691.2011.03736.x; Potter RN, 2012, EMERG INFECT DIS, V18, P507, DOI 10.3201/eid1803.111238; Rheem I, 2012, ANN LAB MED, V32, P399, DOI 10.3343/alm.2012.32.6.399; Russell KL, 2006, VACCINE, V24, P2835, DOI 10.1016/j.vaccine.2005.12.062; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Sanchez JL, 2015, CLIN MICROBIOL REV, V28, P743, DOI 10.1128/CMR.00039-14; Tate JE, 2009, J INFECT DIS, V199, P1419, DOI 10.1086/598520; Trei JS, 2010, EMERG INFECT DIS, V16, P769, DOI 10.3201/eid1605.091633; Vento TJ, 2011, J INFECT DIS, V203, P1388, DOI 10.1093/infdis/jir040; Walsh MP, 2010, J CLIN MICROBIOL, V48, P991, DOI 10.1128/JCM.01694-09; Yu PB, 2013, MICROBIOL IMMUNOL, V57, P553, DOI 10.1111/1348-0421.12074; Zhu Z, 2009, J CLIN MICROBIOL, V47, P697, DOI 10.1128/JCM.01769-08; 이미애, 2010, Annals of Clinical Microbiology, V13, P40	38	23	29	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170592	10.1371/journal.pone.0170592	http://dx.doi.org/10.1371/journal.pone.0170592			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114362	gold, Green Published, Green Submitted			2022-12-26	WOS:000396129000076
J	Yoshida, S; Shime, H; Funami, K; Takaki, H; Matsumoto, M; Kasahara, M; Seya, T				Yoshida, Sumito; Shime, Hiroaki; Funami, Kenji; Takaki, Hiromi; Matsumoto, Misako; Kasahara, Masanori; Seya, Tsukasa			The Anti-Oxidant Ergothioneine Augments the Immunomodulatory Function of TLR Agonists by Direct Action on Macrophages	PLOS ONE			English	Article							CELL-DEATH; TNF-ALPHA; POLARIZATION; ACTIVATION; TRANSPORTER; EXPRESSION; PLASTICITY; AXIS	L-Ergothioneine (EGT) is a naturally-occurring amino acid which is characterized by its antioxidant property; yet, the physiological role of EGT has yet to be established. We investigated the immune-enhancing properties of EGT, and found that it acts as a potentiator of toll-like receptor (TLR) signaling. When mouse bone marrow-derived macrophages (BMDMs) were pretreated with EGT, TLR signal-mediated cytokine production was augmented in BMDMs. The results were reproducible with TLR2, 3, 4 and 7 agonists. In particular, IL-6 and IL-12p40 were elevated further by pretreatment with EGT in BMDMs, suggesting the induction of M1 polarization. In co-culture assay with OT-II CD4(+) T cells and splenic F4/80(+) macrophages, EGT significantly induced Th17 skewing in CD4(+) T cells. Thus, EGT is an immune modifier as well as a redox controller under TLR stimulation that induces M1 macrophages and a Th17 shift in inflammation.	[Yoshida, Sumito; Shime, Hiroaki; Funami, Kenji; Takaki, Hiromi; Matsumoto, Misako; Seya, Tsukasa] Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Kita Ku, Sapporo, Hokkaido, Japan; [Yoshida, Sumito; Matsumoto, Misako; Kasahara, Masanori; Seya, Tsukasa] Hokkaido Univ, Grad Sch Med, Dept Pathol 1, Kita Ku, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Seya, T (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Kita Ku, Sapporo, Hokkaido, Japan.; Seya, T (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Pathol 1, Kita Ku, Sapporo, Hokkaido, Japan.	seya-tu@pop.med.hokudai.ac.jp	Funami, Kenji/A-4284-2012; Shime, Hiroaki/P-6454-2019; Kasahara, Masanori/G-7651-2011; Seya, Tsukasa/A-4336-2012	Shime, Hiroaki/0000-0003-0209-5034; 	MEXT; AMED from the Japanese government; Uehara Memorial Foundation; GSK Research Fund; Grants-in-Aid for Scientific Research [16K19134] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); AMED from the Japanese government; Uehara Memorial Foundation(Uehara Memorial Foundation); GSK Research Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was partly supported by the MEXT and AMED from the Japanese government, and the Uehara Memorial Foundation and GSK Research Fund (2016). The company Three B only provided financial support in the form of authors' salaries and research materials and information. The funding sources and company had no role in study design, data collection and analysis, decision to publish, or preparation of the present manuscript.	AKANMU D, 1991, ARCH BIOCHEM BIOPHYS, V288, P10, DOI 10.1016/0003-9861(91)90158-F; Alam K, 2010, J IMMUNOL, V184, P2918, DOI 10.4049/jimmunol.0900439; Aruoma OI, 1999, FOOD CHEM TOXICOL, V37, P1043, DOI 10.1016/S0278-6915(99)00098-8; Azuma M, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1188244; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Cheah IK, 2012, BBA-MOL BASIS DIS, V1822, P784, DOI 10.1016/j.bbadis.2011.09.017; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Grundemann D, 2005, P NATL ACAD SCI USA, V102, P5256, DOI 10.1073/pnas.0408624102; HANLON DP, 1971, J MED CHEM, V14, P1084, DOI 10.1021/jm00293a017; HEATH H, 1958, BIOCHEM J, V68, P204, DOI 10.1042/bj0680204; Hirata N, 2010, CELL IMMUNOL, V261, P37, DOI 10.1016/j.cellimm.2009.10.009; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Kato Y, 2010, PHARM RES-DORDR, V27, P832, DOI 10.1007/s11095-010-0076-z; KAWANO H, 1982, CHEM PHARM BULL, V30, P2611; KAWANO H, 1982, CHEM PHARM BULL, V30, P1760; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Lamhonwah AM, 2006, BIOCHEM BIOPH RES CO, V345, P1315, DOI 10.1016/j.bbrc.2006.05.026; Laurenza I, 2008, BIOFACTORS, V33, P237, DOI 10.1002/biof.5520330401; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee AJ, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.8; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Paul BD, 2010, CELL DEATH DIFFER, V17, P1134, DOI 10.1038/cdd.2009.163; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Rahim SS, 2005, IMMUNOLOGY, V114, P313, DOI 10.1111/j.1365-2567.2005.02107.x; Rahman I, 2003, BIOCHEM BIOPH RES CO, V302, P860, DOI 10.1016/S0006-291X(03)00224-9; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Shime H, 2016, CELL DEATH IN PRESS; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Srivastava MK, 2010, CANCER RES, V70, P68, DOI 10.1158/0008-5472.CAN-09-2587; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Yabu M, 2011, INT IMMUNOL, V23, P29, DOI 10.1093/intimm/dxq455	34	17	19	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0169360	10.1371/journal.pone.0169360	http://dx.doi.org/10.1371/journal.pone.0169360			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114402	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129000008
J	Chao, HY; Liu, PH; Lin, SC; Chen, CK; Chen, JC; Chan, YL; Wu, CC; Blaney, GN; Liu, ZY; Wu, CJ; Chen, KF				Chao, Hsiao-Yun; Liu, Peng-Hui; Lin, Shen-Che; Chen, Chun-Kuei; Chen, Jih-Chang; Chan, Yi-Lin; Wu, Chin-Chieh; Blaney, Gerald N.; Liu, Zhen-Ying; Wu, Cho-Ju; Chen, Kuan-Fu			Association of In-Hospital Mortality and Dysglycemia in Septic Patients	PLOS ONE			English	Article							BLOOD-GLUCOSE CONCENTRATION; CRITICALLY-ILL PATIENTS; SEVERE SEPSIS; HETEROGENEOUS POPULATION; HYPERGLYCEMIA; MANAGEMENT; SHOCK; RISK; IMPLEMENTATION; VARIABILITY	Background The associations between dysglycemia and mortality in septic patients with and without diabetes are yet to be confirmed. Our aim was to analyze the association of diabetes and sepsis mortality, and to examine how dysglycemia (hyperglycemia, hypoglycemia and glucose variability) affects in-hospital mortality of patients with suspected sepsis in emergency department (ED) and intensive care units. Methods Clinically suspected septic patients admitted to ED were included, and stratified into subgroups according to in-hospital mortality and the presence of diabetes. We analyzed patients' demographics, comorbidities, clinical and laboratory parameters, admission glucose levels and severity of sepsis. Odds ratio of mortality was assessed after adjusting for possible confounders. The correlations of admission glucose and CoV (blood glucose coefficients of variation) and mortality in diabetes and non-diabetes were also tested. Results Diabetes was present in 58.3% of the patients. Diabetic patients were older, more likely to have end-stage renal disease and undergoing hemodialysis, but had fewer malignancies, less sepsis severity (lower Mortality in Emergency Department Sepsis Score), less steroid usage in emergency department, and lower in-hospital mortality rate (aOR:0.83, 95% CI 0.65-0.99, p = 0.044). Hyperglycemia at admission (glucose >= 200 mg/dL) was associated with higher risks of in-hospital mortality among the non-diabetes patients (OR:1.83 vs. diabetes, 95% CI 1.20-2.80, p = 0.005) with the same elevated glucose levels at admission. In addition, CoV>30% resulted in higher risk of death as well (a0R:1.88 vs. CoV between 10 and 30, 95%CI 1.24-2.86 p = 0.003). Conclusions This study indicates that while diabetes mellitus seems to be a protective factor in sepsis patients, hyper- or hypoglycemia status on admission, and increased blood glucose variation during hospital stays, were independently associated with increased odds ratio of mortality.	[Chao, Hsiao-Yun; Liu, Peng-Hui; Lin, Shen-Che; Chen, Chun-Kuei; Chen, Jih-Chang; Chan, Yi-Lin; Wu, Cho-Ju] Chang Gung Mem Hosp, Dept Emergency Med, Linkou, Taiwan; [Chen, Chun-Kuei; Chen, Jih-Chang; Chan, Yi-Lin; Chen, Kuan-Fu] Chang Gung Mem Hosp, Dept Emergency Med, Keelung, Taiwan; [Chen, Kuan-Fu] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Taoyuan, Taiwan; [Chen, Kuan-Fu] Chang Gung Mem Hosp, Community Med Res Ctr, Keelung, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Chen, KF (corresponding author), Chang Gung Mem Hosp, Dept Emergency Med, Keelung, Taiwan.; Chen, KF (corresponding author), Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Taoyuan, Taiwan.; Chen, KF (corresponding author), Chang Gung Mem Hosp, Community Med Res Ctr, Keelung, Taiwan.	kfchen@cgmh.org.tw	CHEN, Chun Kuei/ABB-1653-2021	Chen, Kuan-Fu/0000-0001-7287-9497	National Science Council; Chang Gung Memorial Hospital in Taiwan [100-2314-B-182A-038-MY3, CMRPG2C0202, CMRPG2B0123, CMRPG2B0273, CIRPG2E0022, CPRPG2D0012, CMRPG2B0373]	National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital in Taiwan(Chang Gung Memorial Hospital)	The study was supported by the National Science Council and Chang Gung Memorial Hospital in Taiwan (100-2314-B-182A-038-MY3, CMRPG2C0202, CMRPG2B0123, CMRPG2B0273, CIRPG2E0022, CPRPG2D0012 and CMRPG2B0373). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beale R, 2009, INFECTION, V37, P222, DOI 10.1007/s15010-008-8203-z; Chang CM, 2012, PLASMONICS, V7, P563, DOI [10.1007/s11468-012-9343-7, 10.1371/journal.pone.0050729]; Chang CH, 2012, J FORMOS MED ASSOC, V111, P617, DOI 10.1016/j.jfma.2012.09.009; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Dugan LL, 2013, J CLIN INVEST, V123, P4888, DOI 10.1172/JCI66218; Dungan KM, 2009, LANCET, V373, P1798, DOI 10.1016/S0140-6736(09)60553-5; Egi M, 2008, CRIT CARE MED, V36, P2249, DOI 10.1097/CCM.0b013e318181039a; Egi M, 2006, ANESTHESIOLOGY, V105, P244, DOI 10.1097/00000542-200608000-00006; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Graham BB, 2010, CRIT CARE MED, V38, P16, DOI 10.1097/CCM.0b013e3181b9eaa5; Huang CT, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002136; Kortgen A, 2006, CRIT CARE MED, V34, P943, DOI 10.1097/01.CCM.0000206112.32673.D4; Krinsley JS, 2008, CRIT CARE MED, V36, P3008, DOI 10.1097/CCM.0b013e31818b38d2; Krinsley JS, 2006, SEMIN THORAC CARDIOV, V18, P317, DOI 10.1053/j.semtcvs.2006.12.003; Krinsley James Stephen, 2009, J Diabetes Sci Technol, V3, P1292; Krinsley JS, 2003, MAYO CLIN PROC, V78, P1471, DOI 10.4065/78.12.1471; Lanspa MJ, 2014, CRIT CARE, V18, DOI 10.1186/cc13851; Levy MM, 2015, CRIT CARE MED, V43, P3, DOI [10.1097/CCM.0000000000000723, 10.1007/s00134-014-3496-0]; Mackenzie IMJ, 2011, INTENS CARE MED, V37, P435, DOI 10.1007/s00134-010-2103-2; Marfella R, 2000, DIABETOLOGIA, V43, P571, DOI 10.1007/s001250051345; Marik PE, 2013, CRIT CARE, V17, DOI 10.1186/cc12514; Moss M, 2000, CRIT CARE MED, V28, P2187, DOI 10.1097/00003246-200007000-00001; Muller LMAJ, 2005, CLIN INFECT DIS, V41, P281, DOI 10.1086/431587; Nguyen HB, 2007, CRIT CARE MED, V35, P1105, DOI 10.1097/01.CCM.0000259463.33848.3D; Schuetz P, 2012, AM J MED, V125, P670, DOI 10.1016/j.amjmed.2012.03.001; Schuetz P, 2011, ANN EMERG MED, V58, P438, DOI 10.1016/j.annemergmed.2011.03.052; Schuetz P, 2011, DIABETES CARE, V34, P771, DOI 10.2337/dc10-1185; Shah BR, 2003, DIABETES CARE, V26, P510, DOI 10.2337/diacare.26.2.510; Shapiro NI, 2003, CRIT CARE MED, V31, P670, DOI 10.1097/01.CCM.0000054867.01688.D1; Shen HN, 2014, CRIT CARE MED, V42, P816, DOI 10.1097/CCM.0000000000000033; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Tsai CL, 2007, J INFECTION, V55, P27, DOI 10.1016/j.jinf.2007.01.004; Tsai MJ, 2015, INTENS CARE MED, V41, P806, DOI 10.1007/s00134-015-3760-y	34	25	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170408	10.1371/journal.pone.0170408	http://dx.doi.org/10.1371/journal.pone.0170408			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107491	Green Submitted, Green Published, gold			2022-12-26	WOS:000392405300128
J	Horikiri, T; Ohi, H; Shibata, M; Ikeya, M; Ueno, M; Sotozono, C; Kinoshita, S; Sato, T				Horikiri, Tomoko; Ohi, Hiromi; Shibata, Mitsuaki; Ikeya, Makoto; Ueno, Morio; Sotozono, Chie; Kinoshita, Shigeru; Sato, Takahiko			SOX10-Nano-Lantern Reporter Human iPS Cells; A Versatile Tool for Neural Crest Research	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; IN-VIVO; SOX10; GENE; DIFFERENTIATION; CRISPR-CAS9; EMBRYOS; VECTOR	The neural crest is a source to produce multipotent neural crest stem cells that have a potential to differentiate into diverse cell types. The transcription factor SOX10 is expressed through early neural crest progenitors and stem cells in vertebrates. Here we report the generation of SOX10-Nano-lantern (NL) reporter human induced pluripotent stem cells (hiPS) by using CRISPR/Cas9 systems, that are beneficial to investigate the generation and maintenance of neural crest progenitor cells. SOX10-NL positive cells are produced transiently from hiPS cells by treatment with TGF beta inhibitor SB431542 and GSK3 inhibitor CHIR99021. We found that all SOX10-NL-positive cells expressed an early neural crest marker NGFR, however SOX10-NL-positive cells purified from differentiated hiPS cells progressively attenuate their NL-expression under proliferation. We therefore attempted to maintain SOX10NL-positive cells with additional signaling on the plane and sphere culture conditions. These SOX10-NL cells provide us to investigate mass culture with neural crest cells for stem cell research.	[Horikiri, Tomoko; Ueno, Morio; Sotozono, Chie; Sato, Takahiko] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan; [Ohi, Hiromi] Doshisha Univ, Dept Biomed Engn, Fac Life Sci, Kyotanabe, Japan; [Shibata, Mitsuaki; Ikeya, Makoto] Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Frontier Med Sci & Technol Ophthalmol, Kyoto, Japan; [Sato, Takahiko] Doshisha Univ, Adv Biomed Engn Res Ctr, Kyotanabe, Japan	Kyoto Prefectural University of Medicine; Doshisha University; Kyoto University; Kyoto Prefectural University of Medicine; Doshisha University	Sato, T (corresponding author), Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan.; Sato, T (corresponding author), Doshisha Univ, Adv Biomed Engn Res Ctr, Kyotanabe, Japan.	takahiko@koto.kpu-m.ac.jp		Ikeya, Makoto/0000-0002-3930-8032; Sato, Takahiko/0000-0003-3836-7978	Ministry of Education, Culture, Sports, Science, and Technology [26870285]; Japan Agency for Medical Research and Development (Projects for Technology Development, Development of Cell Transplantation Methods for Refractory Muscle Diseases); Japan Agency for Medical Research and Development (Centers for Clinical Application Research on Specific Disease/Organ); Nakatomi Foundation; Grants-in-Aid for Scientific Research [16H05447] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development (Projects for Technology Development, Development of Cell Transplantation Methods for Refractory Muscle Diseases)(Japan Agency for Medical Research and Development (AMED)); Japan Agency for Medical Research and Development (Centers for Clinical Application Research on Specific Disease/Organ)(Japan Agency for Medical Research and Development (AMED)); Nakatomi Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology (26870285), the Japan Agency for Medical Research and Development (Projects for Technology Development, Development of Cell Transplantation Methods for Refractory Muscle Diseases and Centers for Clinical Application Research on Specific Disease/Organ), and the Nakatomi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DJ, 1997, TRENDS GENET, V13, P276, DOI 10.1016/S0168-9525(97)01187-6; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249; Corpening JC, 2011, GENESIS, V49, P599, DOI 10.1002/dvg.20748; Fukuta M, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0112291, DOI 10.1371/JOURNAL.PONE.0112291]; Hiramuki Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130436; Honore SM, 2003, DEV BIOL, V260, P79, DOI 10.1016/S0012-1606(03)00247-1; Ikeya M, 2005, INT J DEV BIOL, V49, P807, DOI 10.1387/ijdb.051975mi; Kawaguchi J, 2010, DEVELOPMENT, V137, P693, DOI 10.1242/dev.046896; Kelsh RN., 2006, SORTING OUT SOX10 FU; Kerosuo L, 2015, STEM CELL REP, V5, P499, DOI 10.1016/j.stemcr.2015.08.017; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Le Douarin NM, 1999, NEURAL CREST, V2; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013; Mayor R, 2013, DEVELOPMENT, V140, P2247, DOI 10.1242/dev.091751; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Nakagawa M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03594; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Saito K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2248; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Sato T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5597; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019	25	6	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170342	10.1371/journal.pone.0170342	http://dx.doi.org/10.1371/journal.pone.0170342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107504	Green Published, Green Submitted, gold			2022-12-26	WOS:000392405300115
J	Kallakuri, S; Desai, A; Feng, K; Tummala, S; Saif, T; Chen, CY; Zhang, LY; Cavanaugh, JM; King, AI				Kallakuri, Srinivasu; Desai, Alok; Feng, Ke; Tummala, Sharvani; Saif, Tal; Chen, Chaoyang; Zhang, Liying; Cavanaugh, John M.; King, Albert I.			Neuronal Injury and Glial Changes Are Hallmarks of Open Field Blast Exposure in Swine Frontal Lobe	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; INTRAAXONAL NEUROFILAMENT COMPACTION; IMPAIRED AXONAL-TRANSPORT; TIME-DEPENDENT CHANGES; EXPLOSIVE BLAST; ASTROCYTE ACTIVATION; INDUCED NEUROTRAUMA; BIOMARKER LEVELS; SERVICE MEMBERS; MOUSE MODEL	With the rapid increase in the number of blast induced traumatic brain injuries and associated neuropsychological consequences in veterans returning from the operations in Iraq and Afghanistan, the need to better understand the neuropathological sequelae following exposure to an open field blast exposure is still critical. Although a large body of experimental studies have attempted to address these pathological changes using shock tube models of blast injury, studies directed at understanding changes in a gyrencephalic brain exposed to a true open field blast are limited and thus forms the focus of this study. Anesthetized, male Yucatan swine were subjected to forward facing medium blast overpressure (peak side on overpressure 224-332 kPa; n = 7) or high blast overpressure (peak side on overpressure 350-403 kPa; n = 5) by detonating 3.6 kg of composition-4 charge. Sham animals (n = 5) were subjected to all the conditions without blast exposure. After a 3-day survival period, the brain was harvested and sections from the frontal lobes were processed for histological assessment of neuronal injury and glial reactivity changes. Significant neuronal injury in the form of beta amyloid precursor protein immunoreactive zones in the gray and white matter was observed in the frontal lobe sections from both the blast exposure groups. A significant increase in the number of astrocytes and microglia was also observed in the blast exposed sections compared to sham sections. We postulate that the observed acute injury changes may progress to chronic periods after blast and may contribute to short and long-term neuronal degeneration and glial mediated inflammation.	[Kallakuri, Srinivasu; Desai, Alok; Feng, Ke; Tummala, Sharvani; Saif, Tal; Chen, Chaoyang; Zhang, Liying; Cavanaugh, John M.; King, Albert I.] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA	Wayne State University	Kallakuri, S (corresponding author), Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA.	skallakuri@wayne.edu	Chen, Chaoyang/H-3605-2012	Chen, Chaoyang/0000-0003-0838-2245	United States Army through a Medical Research and Materials Command [W81XWH-12-2-0038]; US Army through an MRMC [W81XWH-12-2-0038]	United States Army through a Medical Research and Materials Command; US Army through an MRMC	This research was supported by the United States Army through a Medical Research and Materials Command Cooperative Agreement, Award No. W81XWH-12-2-0038 (AIK).; This research was supported by the US Army through an MRMC Cooperative Agreement, Award No. W81XWH-12-2-0038. The authors would like to extend their sincere thanks Dr. Elizabeth Dawe, DVM and Ms. Janine Mattei, from Surgical Research Services, School of Medicine, Wayne State University for their invaluable technical help in preparing the swine for blast procedures. Our special thanks to Team Wendy LLC, Cleveland, OH and ARES, Inc., Port Clinton, OH. We also wish to thank Dr. Chengpeng Zhou, Ms. Heena Purkait, Mrs. Tong Shi, Ms. Natasha Gupta, Ms. Leena Penumalee and Ms. Ramya Maramraju for their valuable technical assistance during the course of this work. We also thank Dr. Scott Millis for his valuable assistance with statistical analyses.	Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bialas AR, 2013, NAT NEUROSCI, V16, P1773, DOI 10.1038/nn.3560; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Burda JE, 2015, EXP NEUROL; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chen LLK, 2014, MIL MED, V179, P492, DOI 10.7205/MILMED-D-13-00413; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; de Lanerolle NC, 2014, ANN CLIN TRANSL NEUR, V1, P692, DOI 10.1002/acn3.98; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Garman RH, 2011, JOURNAL OF NEUROTRAU; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Gyorgy A, 2011, J NEUROTRAUM, V28, P1121, DOI 10.1089/neu.2010.1561; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Kallakuri S, 2012, BRAIN RES, V1452, P29, DOI 10.1016/j.brainres.2012.02.065; Kane MJ, 2012, NEUROSCI LETT, V522, P47, DOI 10.1016/j.neulet.2012.06.012; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Kilbourne M, 2009, J NEUROTRAUM, V26, P2233, DOI 10.1089/neu.2009.0968; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kraft AW, 2013, FASEB J, V27, P187, DOI 10.1096/fj.12-208660; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Lemke S, 2013, JAMA OPHTHALMOL, V131, P1602, DOI 10.1001/jamaophthalmol.2013.5028; Mac Donald C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055823; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Macauley SL, 2011, J NEUROSCI, V31, P15575, DOI 10.1523/JNEUROSCI.3579-11.2011; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Magone MT, 2014, J REHABIL RES DEV, V51, P71, DOI 10.1682/JRRD.2013.01.0008; Marmarou CR, 2005, J NEUROTRAUM, V22, P1066, DOI 10.1089/neu.2005.22.1066; Neipert L, 2014, BRAIN INJURY, V28, P1667, DOI 10.3109/02699052.2014.947623; Park E, 2013, NEUROBIOL DIS, V52, P150, DOI 10.1016/j.nbd.2012.12.002; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Pun Pamela B L, 2011, Front Neurol, V2, P19, DOI 10.3389/fneur.2011.00019; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Ryu J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0153-3; Sajja VSSS, 2014, NEUROSCI LETT, V570, P33, DOI 10.1016/j.neulet.2014.03.072; Sajja VSSS, 2014, MOL CELL NEUROSCI, V59, P119, DOI 10.1016/j.mcn.2014.02.004; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Saljo A, 2011, NEUROIMAGE, V54, pS83, DOI 10.1016/j.neuroimage.2010.05.050; Saljo Annette, 2001, Pathophysiology, V8, P105, DOI 10.1016/S0928-4680(01)00067-0; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Snell FI, 2010, J PSYCHOSOC NURS MEN, V48, P22, DOI [10.3928/02793695-20100108-02, 10.3928/02793695-20100107-01]; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; Suneson A, 2000, MIL MED, V165, P119, DOI 10.1093/milmed/165.2.119; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Troyanskaya M, 2015, MIL MED, V180, P285, DOI 10.7205/MILMED-D-14-00256; Turner RC, 2013, EXP NEUROL, V248, P520, DOI 10.1016/j.expneurol.2013.07.008; VandeVord PJ, 2008, NEUROSCI LETT, V434, P247, DOI 10.1016/j.neulet.2008.01.056; Vandevord PJ, 2011, ANNALS OF BIOMEDICAL; Wilkinson C, 2012, FRONT NEUROTRAUMA, V3, P11, DOI DOI 10.3389/FNEUR.2012.00011; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006	65	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0169239	10.1371/journal.pone.0169239	http://dx.doi.org/10.1371/journal.pone.0169239			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107370	Green Published, Green Submitted, gold			2022-12-26	WOS:000392405300022
J	Kim, BM; Kang, S; Ahn, DH; Kim, JH; Ahn, I; Lee, CW; Cho, JL; Min, GS; Park, H				Kim, Bo-Mi; Kang, Seunghyun; Ahn, Do-Hwan; Kim, Jin-Hyoung; Ahn, Inhye; Lee, Chi-Woo; Cho, Joo-Lae; Min, Gi-Sik; Park, Hyun			First Insights into the Subterranean Crustacean Bathynellacea Transcriptome: Transcriptionally Reduced Opsin Repertoire and Evidence of Conserved Homeostasis Regulatory Mechanisms	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; DIFFERENTIATION FACTOR 88; TOLL-LIKE RECEPTORS; GENE-EXPRESSION; MOLECULAR CHAPERONES; ERIOCHEIR-SINENSIS; MULTIPLE FUNCTIONS; SIGNALING PATHWAY; BINDING ACTIVITY; INNATE IMMUNITY	Bathynellacea (Crustacea, Syncarida, Parabathynellidae) are subterranean aquatic crustaceans that typically inhabit freshwater interstitial spaces (e.g., groundwater) and are occasionally found in caves and even hot springs. In this study, we sequenced the whole transcriptome of Allobathynella bangokensis using RNA-seq. De novo sequence assembly produced 74,866 contigs including 28,934 BLAST hits. Overall, the gene sequences were most similar to those of the waterflea Daphnia pulex. In the A. bangokensis transcriptome, no opsin or related sequences were identified, and no contig aligned to the crustacean visual opsins and non-visual opsins (i.e. arthropsins, peropsins, and melaopsins), suggesting potential regressive adaptation to the dark environment. However, A. bangokensis expressed conserved gene family sets, such as heat shock proteins and those related to key innate immunity pathways and antioxidant defense systems, at the transcriptional level, suggesting that this species has evolved adaptations involving molecular mechanisms of homeostasis. The transcriptomic information of A. bangokensis will be useful for investigating molecular adaptations and response mechanisms to subterranean environmental conditions.	[Kim, Bo-Mi; Kang, Seunghyun; Ahn, Do-Hwan; Kim, Jin-Hyoung; Ahn, Inhye; Park, Hyun] Korea Polar Res Inst, Unit Polar Genom, Incheon, South Korea; [Ahn, Inhye; Park, Hyun] Univ Sci & Technol, Polar Sci, Daejeon, South Korea; [Lee, Chi-Woo; Min, Gi-Sik] Inha Univ, Dept Biol Sci, Incheon, South Korea; [Cho, Joo-Lae] Nakdonggang Natl Inst Biol Resources, Sangju, South Korea	Korea Polar Research Institute (KOPRI); University of Science & Technology (UST); Inha University	Park, H (corresponding author), Korea Polar Res Inst, Unit Polar Genom, Incheon, South Korea.; Park, H (corresponding author), Univ Sci & Technol, Polar Sci, Daejeon, South Korea.; Min, GS (corresponding author), Inha Univ, Dept Biol Sci, Incheon, South Korea.	mingisik@inha.ac.kr; hpark@kopri.re.kr		Kim, Jin-Hyoung/0000-0001-6746-7447	Korea Polar Research Institute [PE17080]	Korea Polar Research Institute(Korea Polar Research Institute of Marine Research Placement (KOPRI))	This work was supported by a grant, entitled "Polar Genomics 101 Project (PE17080)", funded by the Korea Polar Research Institute.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Asmyhr MG, 2014, FRESHWATER BIOL, V59, P1, DOI 10.1111/fwb.12239; Bettencourt R, 1997, EUR J BIOCHEM, V250, P630, DOI 10.1111/j.1432-1033.1997.00630.x; Bolger AM, 2014, BIOINFORMATICS; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; Brites D, 2008, MOL BIOL EVOL, V25, P1429, DOI 10.1093/molbev/msn087; Carlini DB, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-89; Chao JL, 2004, DEVELOPMENT, V131, P3839, DOI 10.1242/dev.01258; Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X; Chou PH, 2009, DEV COMP IMMUNOL, V33, P1258, DOI 10.1016/j.dci.2009.07.006; Coineau N, 2000, ECOSY WORLD, V30, P189; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Coscia MR, 2011, ISJ-INVERT SURVIV J, V8, P210; Dominguez M, 2004, NAT GENET, V36, P31, DOI 10.1038/ng1281; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Friedrich M, 2011, J EXP BIOL, V214, P3532, DOI 10.1242/jeb.060368; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Gibert J, 2002, BIOSCIENCE, V52, P473, DOI 10.1641/0006-3568(2002)052[0473:SEATFB]2.0.CO;2; Gibert J, 2009, FRESHWATER BIOL, V54, P930, DOI 10.1111/j.1365-2427.2009.02201.x; Gordon A, 2010, FASTX TOOLKIT FASTQA; Hancock PJ, 2005, HYDROGEOL J, V13, P98, DOI 10.1007/s10040-004-0421-6; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hook SE, 2014, AQUAT TOXICOL, V153, P73, DOI 10.1016/j.aquatox.2013.11.022; Hooven TA, 2004, INT J DEV BIOL, V48, P731, DOI 10.1387/ijdb.041874th; Huang Y, 2014, DEV COMP IMMUNOL, V47, P298, DOI 10.1016/j.dci.2014.08.005; Humphreys WF, 2006, AUST J BOT, V54, P115, DOI 10.1071/BT04151; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Jenner RA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-21; Karig S, 2015, MAR GENOM, V24, P253, DOI 10.1016/j.margen.2015.07.012; Kim SS, 2002, STRUCTURE, V10, P787, DOI 10.1016/S0969-2126(02)00769-4; Lefebure T, 2007, MOL PHYLOGENET EVOL, V42, P676, DOI 10.1016/j.ympev.2006.08.020; Leonard PM, 2001, GENE, V269, P155, DOI 10.1016/S0378-1119(01)00444-9; Li XC, 2013, DEV COMP IMMUNOL, V39, P313, DOI 10.1016/j.dci.2012.11.011; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Malard F, 1999, FRESHWATER BIOL, V41, P1, DOI 10.1046/j.1365-2427.1999.00379.x; McTaggart SJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-175; Morimoto RI, 1997, ESSAYS BIOCHEM, V32, P17; MORIMOTO Y., 1957, PROC JAPANESE ACAD, V33, P145; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Palmer WJ, 2015, MOL BIOL EVOL, V32, P2111, DOI 10.1093/molbev/msv093; Park Jong-Geun, 2016, Journal of Species Research, V5, P49; Porter ML, 2003, TRENDS ECOL EVOL, V18, P541, DOI 10.1016/S0169-5347(03)00244-1; Porter ML, 2012, P R SOC B; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Rebay I, 2016, MOL CELL BIOL, V36, P668, DOI 10.1128/MCB.00976-15; Rivera AS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-123; Rosa RD, 2016, DEV COMP IMMUNOL, V59, P1, DOI 10.1016/j.dci.2015.12.018; Schmidt SI, 2012, LIMNOLOGICA, V42, P1, DOI 10.1016/j.limno.2011.08.002; SCHMINKE HK, 1988, J CRUSTACEAN BIOL, V8, P290, DOI 10.2307/1548321; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Smith AA, 2015, LYME DIS RECENT ADV; Stahl BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140484; Takeda K, 2004, TLR SIGN PATHW SEM I; Tierney SM, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140386; Valenzuela-Munoz V, 2014, FISH SHELLFISH IMMUN, V36, P428, DOI 10.1016/j.fsi.2013.12.019; Vandel A., 2013, BIOSPELEOLOGY BIOL C; Verbruggen B, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1667-1; Wang XW, 2013, DEV COMP IMMUNOL, V39, P27, DOI 10.1016/j.dci.2012.04.009; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Watthanasurorot A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002062; Weston DP, 2013, P NATL ACAD SCI USA, V110, P16532, DOI 10.1073/pnas.1302023110; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; Xu CJ, 2005, ARCH PHARM RES, V28, P249, DOI 10.1007/BF02977789; Yednock BK, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1739-2; Yu AQ, 2013, FISH SHELLFISH IMMUN, V35, P1282, DOI 10.1016/j.fsi.2013.07.044; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zeng V, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-581; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	70	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170424	10.1371/journal.pone.0170424	http://dx.doi.org/10.1371/journal.pone.0170424			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107438	gold, Green Published, Green Submitted			2022-12-26	WOS:000392405300132
J	Liu, C; Gaudet, D; Miller, YI				Liu, Chao; Gaudet, Daniel; Miller, Yury I.			Deficient Cholesterol Esterification in Plasma of apoc2 Knockout Zebrafish and Familial Chylomicronemia Patients	PLOS ONE			English	Article							APOLIPOPROTEIN C-II; HIGH-DENSITY-LIPOPROTEINS; HYPERTRIGLYCERIDEMIA; LIPASE; ACYLTRANSFERASE; RISK; EXPRESSION; MUTATIONS; ANGPTL4; MODEL	Hypertriglyceridemia is an independent risk factor for cardiovascular disease. Apolipoprotein C-II (APOC2) is an obligatory cofactor for lipoprotein lipase (LPL), the major enzyme catalyzing plasma triglyceride hydrolysis. We have created an apoc2 knockout zebrafish model, which mimics the familial chylomicronemia syndrome (FCS) in human patients with a defect in the APOC2 or LPL gene. In this study, we measured plasma levels of free cholesterol (FC) and cholesterol esters (CE) and found that apoc2 mutant zebrafish have a significantly higher FC to CE ratio (FC/CE), when compared to the wild type. Feeding apoc2 mutant zebrafish a low-fat diet reduced triglyceride levels but not the FC/CE ratio. In situ hybridization and qPCR results demonstrated that the hepatic expression of lecithin-cholesterol acyltransferase (lcat), the enzyme responsible for esterifying plasma FC to CE, and of apolipoprotein A-I, a major protein component of HDL, were dramatically decreased in apoc2 mutants. Furthermore, the FC/CE ratio was significantly increased in the whole plasma and in a chylomicron-depleted fraction of human FCS patients. The FCS plasma LCAT activity was significantly lower than that of healthy controls. In summary, this study, using a zebrafish model and human patient samples, reports for the first time the defect in plasma cholesterol esterification associated with LPL deficiency.	[Liu, Chao; Miller, Yury I.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Gaudet, Daniel] Univ Montreal, Dept Med, ECOGENE Clin & Translat Res Ctr 21, Chicoutimi, PQ, Canada; [Gaudet, Daniel] Univ Montreal, Lipidol Unit, Chicoutimi, PQ, Canada	University of California System; University of California San Diego; Universite de Montreal; Universite de Montreal	Miller, YI (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	yumiller@ucsd.edu			National Institutes of Health [HL124174, HL055798, HL088093]; American Heart Association [16POST27250126]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088093, P01HL055798, R01HL124174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants HL124174, HL055798 and HL088093 (YIM) from the National Institutes of Health and 16POST27250126 (CL) from the American Heart Association.; This study was supported by grants HL124174, HL055798 and HL088093 (Y.I.M.) from the National Institutes of Health and 16POST27250126 (C.L.) from the American Heart Association.	Amar MJA, 2009, METABOLISM, V58, P568, DOI 10.1016/j.metabol.2008.11.019; BAGGIO G, 1986, J CLIN INVEST, V77, P520, DOI 10.1172/JCI112332; BRECKENRIDGE WC, 1978, NEW ENGL J MED, V298, P1265, DOI 10.1056/NEJM197806082982301; COX DW, 1978, NEW ENGL J MED, V299, P1421, DOI 10.1056/NEJM197812282992601; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Dewey FF, 2016, NEW ENGL J MED, V374, P1123, DOI 10.1056/NEJMoa1510926; EISENBERG S, 1984, J CLIN INVEST, V74, P470, DOI 10.1172/JCI111444; Fang LH, 2014, TRANSL RES, V163, P99, DOI 10.1016/j.trsl.2013.09.004; FELLIN R, 1983, ATHEROSCLEROSIS, V49, P55, DOI 10.1016/0021-9150(83)90007-2; Gaudet D, 2016, CURR OPIN LIPIDOL, V27, P112, DOI 10.1097/MOL.0000000000000281; Gaudet D, 2014, NEW ENGL J MED, V371, P2200, DOI 10.1056/NEJMoa1400284; Goldberg IJ, 2001, FRONT BIOSCI-LANDMRK, V6, pD388, DOI 10.2741/Goldberg; Holtta-Vuori M, 2010, BIOCHEM J, V429, P235, DOI 10.1042/BJ20100293; JACKSON RL, 1987, ATHEROSCLEROSIS, V66, P37, DOI 10.1016/0021-9150(87)90177-8; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; Jowett T, 2001, METHODS, V23, P345, DOI 10.1006/meth.2000.1147; Kei AA, 2012, METABOLISM, V61, P906, DOI 10.1016/j.metabol.2011.12.002; Kuroda M, 2014, ARTERIOSCL THROM VAS, V34, P1756, DOI 10.1161/ATVBAHA.114.303420; Liu C, 2015, DIS MODEL MECH, V8, P989, DOI 10.1242/dmm.019836; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Otis JP, 2015, DIS MODEL MECH, V8, P295, DOI 10.1242/dmm.018754; Rashid S, 2003, CLIN BIOCHEM, V36, P421, DOI 10.1016/S0009-9120(03)00078-X; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; Rousset X, 2011, CURR ATHEROSCLER REP, V13, P249, DOI 10.1007/s11883-011-0171-6; SAKU K, 1984, AM J MED, V77, P457, DOI 10.1016/0002-9343(84)90102-5; Shamburek RD, 2016, CIRC RES, V118, P73, DOI 10.1161/CIRCRESAHA.115.306223; Stitziel NO, 2016, NEW ENGL J MED, V374, P1134, DOI 10.1056/NEJMoa1507652; Stoletov K, 2009, CIRC RES, V104, P952, DOI 10.1161/CIRCRESAHA.108.189803; van den Bogaard B, 2012, ATHEROSCLEROSIS, V225, P481, DOI 10.1016/j.atherosclerosis.2012.09.022; Watts GF, 2013, NAT REV CARDIOL, V10, P648, DOI 10.1038/nrcardio.2013.140	30	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0169939	10.1371/journal.pone.0169939	http://dx.doi.org/10.1371/journal.pone.0169939			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107429	Green Published, Green Submitted, gold			2022-12-26	WOS:000392405300052
J	Matamala, N; Aggarwal, N; Iadarola, P; Fumagalli, M; Gomez-Mariano, G; Lara, B; Martinez, MT; Cuesta, I; Stolk, J; Janciauskiene, S; Martinez-Delgado, B				Matamala, Nerea; Aggarwal, Nupur; Iadarola, Paolo; Fumagalli, Marco; Gomez-Mariano, Gema; Lara, Beatriz; Teresa Martinez, Maria; Cuesta, Isabel; Stolk, Jan; Janciauskiene, Sabina; Martinez-Delgado, Beatriz			Identification of Novel Short C-Terminal Transcripts of Human SERPINA1 Gene	PLOS ONE			English	Article							HUMAN ALPHA-1-ANTITRYPSIN GENE; SERINE PROTEINASE-INHIBITORS; PROTEASE INHIBITOR; TRANSGENIC MICE; EXPRESSION; PEPTIDE; ALPHA(1)-ANTITRYPSIN; MACROPHAGES; DEFICIENCY; 44-RESIDUE	Human SERPINA1 gene is located on chromosome 14q31-32.3 and is organized into three (IA, IB, and IC) non-coding and four (II, III, IV, V) coding exons. This gene produces a1-antitrypsin (A1AT), a prototypical member of the serpin superfamily of proteins. We demonstrate that human peripheral blood leukocytes express not only a product corresponding to the transcript coding for the full-length A1AT protein but also two short transcripts (ST1C4 and ST1C5) of A1AT. In silico sequence analysis revealed that the last exon of the short transcripts contains an Open Reading Frame (ORF) and thus putatively can produce peptides. We found ST1C4 expression across different human tissues whereas ST1C5 was mainly restricted to leukocytes, specifically neutrophils. A high up-regulation (10-fold) of short transcripts was observed in isolated human blood neutrophils after activation with lipopolysaccharide. Parallel analyses by liquid chromatography-mass spectrometry identified peptides corresponding to C-terminal region of A1AT in supernatants of activated but not naive neutrophils. Herein we report for the first time a tissue specific expression and regulation of short transcripts of SERPINA1 gene, and the presence of C-terminal peptides in supernatants from activated neutrophils, in vitro. This gives a novel insight into the studies on the transcription of SERPINA1 gene.	[Matamala, Nerea; Gomez-Mariano, Gema; Martinez-Delgado, Beatriz] Inst Salud Carlos III, IIER, Mol Genet Unit, Madrid, Spain; [Aggarwal, Nupur; Janciauskiene, Sabina] Hannover Med Sch, Dept Resp Med, Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany; [Iadarola, Paolo; Fumagalli, Marco] Univ Pavia, Dept Biol & Biotechnol, Biochem Unit, Pavia, Italy; [Lara, Beatriz] Coventry & Warwickshire Univ Hosp, Dept Resp Med, Coventry, W Midlands, England; [Teresa Martinez, Maria] Hosp 12 Octubre, Dept Pneumol, Madrid, Spain; [Cuesta, Isabel] Inst Salud Carlos III, Bioinformat Unit, Madrid, Spain; [Stolk, Jan] Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands	Instituto de Salud Carlos III; Instituto de Investigacion de Enfermedades Raras (IIER); Hannover Medical School; University of Pavia; Hospital Universitario 12 de Octubre; Instituto de Salud Carlos III; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Martinez-Delgado, B (corresponding author), Inst Salud Carlos III, IIER, Mol Genet Unit, Madrid, Spain.	bmartinezd@isciii.es	Aggarwal, Nupur/K-1296-2019; Cuesta de la Plaza, Isabel/C-1628-2018; Matamala, Nerea/AAA-5006-2020; Martinez-Delgado, Beatriz/B-6833-2013	Cuesta de la Plaza, Isabel/0000-0002-7911-9041; Martinez-Delgado, Beatriz/0000-0001-6834-350X; GOMEZ MARIANO, GEMA/0000-0003-0682-5276; Matamala, Nerea/0000-0002-3082-2414; Aggarwal, Nupur/0000-0002-7992-0023	Institute de Salud Carlos III [PI14CIII/00070]; SEPAR (Sociedad Espanola de Neumologia y Cirugia Toracica) [92/2014]	Institute de Salud Carlos III(Instituto de Salud Carlos III); SEPAR (Sociedad Espanola de Neumologia y Cirugia Toracica)	This work has been partially funded by the Institute de Salud Carlos III (www.isciii.es) grant PI14CIII/00070 (BMD) and SEPAR (Sociedad Espanola de Neumologia y Cirugia Toracica, www.separ.es) grant 92/2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBEYMOREL C, 1987, J EXP MED, V166, P1041, DOI 10.1084/jem.166.4.1041; Bartz R, 2011, BIOCHEM J, V435, P475, DOI 10.1042/BJ20101021; BILLINGSLEY GD, 1993, AM J HUM GENET, V52, P343; Blaurock N, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6129437; CARLSON JA, 1988, J CLIN INVEST, V82, P26, DOI 10.1172/JCI113580; Carninci P, 2006, TRENDS GENET, V22, P501, DOI 10.1016/j.tig.2006.07.003; CERCEK L, 1993, CANCER DETECT PREV, V17, P447; CILIBERTO G, 1985, CELL, V41, P531, DOI 10.1016/S0092-8674(85)80026-X; Clemmensen SN, 2011, EUR J HAEMATOL, V86, P517, DOI 10.1111/j.1600-0609.2011.01601.x; Dichtl Wolfgang, 2000, Molecular Cell Biology Research Communications, V4, P50, DOI 10.1006/mcbr.2000.0256; Frochaux V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109483; Galindo MI, 2007, PLOS BIOL, V5, P1052, DOI 10.1371/journal.pbio.0050106; Gerbod-Giannone MC, 2002, J BIOL CHEM, V277, P42973, DOI 10.1074/jbc.M205089200; Grosse-Holz FM, 2016, NEW PHYTOL, V210, P794, DOI 10.1111/nph.13839; HAFEEZ W, 1992, J CLIN INVEST, V89, P1214, DOI 10.1172/JCI115705; Heit C, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-22; Ingolia NT, 2014, CELL REP, V8, P1365, DOI 10.1016/j.celrep.2014.07.045; JOHANSSON J, 1992, FEBS LETT, V299, P146, DOI 10.1016/0014-5793(92)80234-8; Johnson JM, 2005, TRENDS GENET, V21, P93, DOI 10.1016/j.tig.2004.12.009; Kalsheker N, 2002, BIOCHEM SOC T, V30, P93, DOI 10.1042/bst0300093; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; KELSEY GD, 1987, GENE DEV, V1, P161, DOI 10.1101/gad.1.2.161; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kramer HB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000893; Laumont CM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10238; Marchitelli C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073020; Matamala N, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0585-y; NIEMANN MA, 1992, MATRIX, V12, P233, DOI 10.1016/S0934-8832(11)80066-1; Niemann MA, 1997, BBA-PROTEIN STRUCT M, V1340, P123, DOI 10.1016/S0167-4838(97)00034-4; Niemann MA, 1997, J CELL BIOCHEM, V66, P346, DOI 10.1002/(SICI)1097-4644(19970901)66:3<346::AID-JCB7>3.3.CO;2-U; Otlewski J, 2005, EMBO J, V24, P1303, DOI 10.1038/sj.emboj.7600611; PERLINO E, 1987, EMBO J, V6, P2767, DOI 10.1002/j.1460-2075.1987.tb02571.x; Rollini P, 2000, NUCLEIC ACIDS RES, V28, P1767, DOI 10.1093/nar/28.8.1767; Roussel BD, 2011, FEBS J, V278, P3859, DOI 10.1111/j.1742-4658.2011.08201.x; Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]; Soreq L, 2015, GENOM DATA, V3, P57, DOI 10.1016/j.gdata.2014.11.009; Subramaniyam D, 2006, INT J BIOCHEM CELL B, V38, P563, DOI 10.1016/j.biocel.2005.09.021; van Gent D, 2003, INT J BIOCHEM CELL B, V35, P1536, DOI 10.1016/S1357-2725(03)00134-1; van't Wout EFA, 2015, EUR RESPIR J, V45, P365, DOI 10.1183/09031936.00046114; WILCZYNSKA M, 1995, J BIOL CHEM, V270, P29652; Willingham AT, 2006, CELL, V125, P1215, DOI 10.1016/j.cell.2006.06.009; Wood AM, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-52; YUAN ZA, 1992, J CELL BIOCHEM, V49, P410, DOI 10.1002/jcb.240490411; Zelvyte I, 2004, CANCER CELL INT, V4, DOI 10.1186/1475-2867-4-7; Zheng DH, 2012, TRENDS MOL MED, V18, P304, DOI 10.1016/j.molmed.2012.03.006	46	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170533	10.1371/journal.pone.0170533	http://dx.doi.org/10.1371/journal.pone.0170533			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107454	gold, Green Published, Green Submitted			2022-12-26	WOS:000392405300159
J	Nydam, ML; Giesbrecht, KB; Stephenson, EE				Nydam, Marie L.; Giesbrecht, Kirsten B.; Stephenson, Emily E.			Origin and Dispersal History of Two Colonial Ascidian Clades in the Botryllus schlosseri Species Complex	PLOS ONE			English	Article							POPULATION-GENETICS; CLIMATE-CHANGE; TUNICATA POPULATIONS; INVASION PROCESSES; DNA-SEQUENCE; MARINE; BIODIVERSITY; SPECIATION; ECOSYSTEM; SOFTWARE	Human-induced global warming and species introductions are rapidly altering the composition and functioning of Earth's marine ecosystems. Ascidians (Phylum Chordata, Subphylum Tunicata, Class Ascidiacea) are likely to play an increasingly greater role in marine communities. The colonial ascidian B. schlosseri is a cryptic species complex comprising five genetically divergent clades (A-E). Clade A is a global species, and Clade E has so far been identified in European waters only. Using the largest mitochondrial cytochrome oxidase I datasets yet assembled, we determine the origin and dispersal history of these species. Nucleotide diversity and Approximate Bayesian Computation analyses support a Pacific origin for Clade A, with two likely dispersal scenarios that both show the northwestern Atlantic populations establishing early in the history of the species. Both Discrete Phylogeo-graphic Analysis and Approximate Bayesian Computation support an origin of Clade E on the French side of the English Channel. An unsampled lineage evolved from the French lineage, which reflects the conclusion from the median joining network that not all Clade E lineages have been sampled. This unsampled lineage gave rise to the haplotypes on the English side of the English Channel, which were the ancestors to the Mediterranean and Bay of Biscay populations. Clade E has a wider geographic range than previously thought, and shows evidence of recent range expansion. Both Clade A and Clade E should be considered widespread species: Clade A globally and Clade E within Europe.	[Nydam, Marie L.; Giesbrecht, Kirsten B.; Stephenson, Emily E.] Ctr Coll Danville, Div Sci & Math, Danville, KY 40422 USA		Nydam, ML (corresponding author), Ctr Coll Danville, Div Sci & Math, Danville, KY 40422 USA.	marie.nydam@centre.edu			National Science Foundation; Office of Integrative Activities [1355438] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by the National Science Foundation's Kentucky Experimental Program to Stimulate Competitive Research, http://www.kyepscor.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARON S, 1991, BIOCHEM SYST ECOL, V19, P271, DOI 10.1016/0305-1978(91)90014-Q; Bak RPM, 1996, MAR ECOL PROG SER, V133, P303, DOI 10.3354/meps133303; Bell JD, 2013, NAT CLIM CHANGE, V3, P591, DOI 10.1038/NCLIMATE1838; Ben-Shlomo R, 2001, MAR ECOL PROG SER, V209, P109, DOI 10.3354/meps209109; Ben-Shlomo R, 2006, ECOSYSTEMS, V9, P1118, DOI 10.1007/s10021-006-0141-y; Ben-Shlomo R, 2010, MAR ECOL PROG SER, V412, P85, DOI 10.3354/meps08688; Benjamini Y, 2001, ANN STAT, V29, P1165; Berrill N. J., 1950, TUNICATA ACCOUNT BRI; Bishop JDD, 2013, BIOL INVASIONS, V15, P253, DOI 10.1007/s10530-012-0286-x; Bock DG, 2012, P ROY SOC B-BIOL SCI, V279, P2377, DOI 10.1098/rspb.2011.2610; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; BOYD HC, 1990, BIOL BULL, V178, P239, DOI 10.2307/1541825; Carlton J.T., 1995, NONINDIGENOUS AQUATI; Carlton J.T., 2005, P INT INVASIVE SEA S; Cockrell ML, 2013, J EXP MAR BIOL ECOL, V440, P42, DOI 10.1016/j.jembe.2012.11.008; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Costello JH, 2012, HYDROBIOLOGIA, V690, P21, DOI 10.1007/s10750-012-1037-9; Crisp MD, 2005, TRENDS ECOL EVOL, V20, P122, DOI 10.1016/j.tree.2004.11.010; Dalby JE, 1997, OPHELIA, V47, P227, DOI 10.1080/00785236.1997.10428673; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dijkstra J, 2007, J EXP MAR BIOL ECOL, V342, P61, DOI 10.1016/j.jembe.2006.10.015; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fu YX, 1997, GENETICS, V147, P915; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Goldstien SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016755; Gribben PE, 2013, OIKOS, V122, P816, DOI 10.1111/j.1600-0706.2012.20868.x; Griggio F, 2014, GENOME BIOL EVOL, V6, P591, DOI 10.1093/gbe/evu041; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harley CDG, 2012, J PHYCOL, V48, P1064, DOI 10.1111/j.1529-8817.2012.01224.x; HARTMEYER R., 1928, FAUNA SLIDWEST AUSTRALIENS, V5, P251; Katsanevakis S, 2014, AQUAT INVASIONS, V9, P391, DOI 10.3391/ai.2014.9.4.01; Lacoursiere-Roussel A, 2012, MOL ECOL, V21, P4227, DOI 10.1111/j.1365-294X.2012.05702.x; Lambert CC, 2003, MAR ECOL PROG SER, V259, P145, DOI 10.3354/meps259145; Lambert G, 2005, J MAR BIOL ASSOC UK, V85, P1011, DOI 10.1017/S002531540501204X; Lambert G, 2007, J EXP MAR BIOL ECOL, V342, P3, DOI 10.1016/j.jembe.2006.10.009; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Lejeusne C, 2011, BIOL INVASIONS, V13, P635, DOI 10.1007/s10530-010-9854-0; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lopez-Legentil S, 2006, MOL ECOL, V15, P3957, DOI 10.1111/j.1365-294X.2006.03087.x; Lopez-Legentil S, 2006, BIOL J LINN SOC, V88, P203, DOI 10.1111/j.1095-8312.2006.00614.x; Mead A, 2011, J NAT HIST, V45, P2463, DOI 10.1080/00222933.2011.595836; Molinos JG, 2016, NAT CLIM CHANGE, V6, P83, DOI [10.1038/NCLIMATE2769, 10.1038/nclimate2769]; Naranjo SA, 1996, MAR ECOL PROG SER, V144, P119, DOI 10.3354/meps144119; Nobrega R, 2004, J EXP MAR BIOL ECOL, V303, P173, DOI 10.1016/j.jembe.2003.11.009; Nydam ML, 2007, MAR BIOL, V151, P1839, DOI 10.1007/s00227-007-0617-0; Nydam ML, 2011, EVOLUTION, V65, P429, DOI 10.1111/j.1558-5646.2010.01153.x; Ordonez V, 2015, BIOL INVASIONS, V17, P2075, DOI 10.1007/s10530-015-0861-z; Pallas P.S., 1766, ELENCHUS ZOOPHYTORUM; Paz G, 2003, MAR ECOL PROG SER, V250, P153, DOI 10.3354/meps250153; Perez-Portela R, 2013, SCI REP-UK, V3, DOI 10.1038/srep03197; Pineda MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025495; Piola RF, 2008, DIVERS DISTRIB, V14, P329, DOI 10.1111/j.1472-4642.2007.00430.x; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; R Core Team, 2021, R LANGUAGE ENV STAT; Rambaut A., 2009, FIGTREE V143; Rambaut A, 2007, TRACER V 1 4 SOFTWAR; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Reem E, 2017, MOL PHYLOGENET EVOL, V107, P221, DOI 10.1016/j.ympev.2016.10.005; Rinkevich B, 1998, MAR ECOL-P S Z N I, V19, P129, DOI 10.1111/j.1439-0485.1998.tb00458.x; Rius M, 2014, GLOBAL ECOL BIOGEOGR, V23, P76, DOI 10.1111/geb.12105; Rius M, 2012, MAR POLLUT BULL, V64, P2060, DOI 10.1016/j.marpolbul.2012.06.029; Rius M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035815; Sheets EA, 2016, ECOL EVOL, V6, P2453, DOI 10.1002/ece3.2065; Shenkar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020657; Sorte CJB, 2010, ECOLOGY, V91, P2198, DOI 10.1890/10-0238.1; Stachowicz JJ, 2002, P NATL ACAD SCI USA, V99, P15497, DOI 10.1073/pnas.242437499; Stefaniak Lauren, 2009, Aquatic Invasions, V4, P29, DOI 10.3391/ai.2009.4.1.3; Stoner DS, 2002, MAR ECOL PROG SER, V243, P93, DOI 10.3354/meps243093; TAJIMA F, 1989, GENETICS, V123, P585; Tarjuelo I, 2004, MOL ECOL, V13, P3125, DOI 10.1111/j.1365-294X.2004.02306.x; Tarjuelo I, 2001, MAR BIOL, V139, P455; Teske PR, 2014, ECOL EVOL, V4, P2848, DOI 10.1002/ece3.1129; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Tokioka T., 1953, ASCIDIANS SAGAMI BAY; Turon X, 2003, HYDROBIOLOGIA, V503, P29, DOI 10.1023/B:HYDR.0000008481.10705.c2; Van Dongen S, 2006, J THEOR BIOL, V242, P90, DOI 10.1016/j.jtbi.2006.02.002; VANNAME WG, 1945, B AM MUS NAT HIST, V84, P1; Verrill AE, 1871, AM J SCI, V1, P54, DOI DOI 10.2475/AJS.S3-1.1.54; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Yund PO, 2015, BIOL BULL-US, V228, P201, DOI 10.1086/BBLv228n3p201; Yund PO, 2002, MAR BIOL, V141, P955, DOI 10.1007/s00227-002-0894-6; Zhan AB, 2015, MAR BIOL, V162, P2449, DOI 10.1007/s00227-015-2734-5	86	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0169944	10.1371/journal.pone.0169944	http://dx.doi.org/10.1371/journal.pone.0169944			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107476	Green Published, gold, Green Submitted			2022-12-26	WOS:000392405300053
J	Hudson, DM; Weis, M; Rai, J; Joeng, KS; Dimori, M; Lee, BH; Morello, R; Eyre, DR				Hudson, David M.; Weis, MaryAnn; Rai, Jyoti; Joeng, Kyu Sang; Dimori, Milena; Lee, Brendan H.; Morello, Roy; Eyre, David R.			P3h3-null and Sc65-null Mice Phenocopy the Collagen Lysine Under-hydroxylation and Cross-linking Abnormality of Ehlers-Danlos Syndrome Type VIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone; collagen; endoplasmic reticulum (ER); mass spectrometry (MS); post-translational modification (PTM); skin; cross-links	OSTEOGENESIS IMPERFECTA; I COLLAGEN; PROLYL 3-HYDROXYLATION; BRUCK-SYNDROME; CYCLOPHILIN-B; BONE-COLLAGEN; NULL MICE; MUTATIONS; PYRIDINOLINE; LEPREL1	Tandem mass spectrometry was applied to tissues from targeted mutant mouse models to explore the collagen substrate specificities of individual members of the prolyl 3-hydroxylase (P3H) gene family. Previous studies revealed that P3h1 preferentially 3-hydroxylates proline at a single site in collagen type I chains, whereas P3h2 is responsible for 3-hydroxylating multiple proline sites in collagen types I, II, IV, and V. In screening for collagen substrate sites for the remaining members of the vertebrate P3H family, P3h3 and Sc65 knock-out mice revealed a common lysine under-hydroxylation effect at helical domain cross-linking sites in skin, bone, tendon, aorta, and cornea. No effect on prolyl 3-hydroxylation was evident on screening the spectrum of known 3-hydroxyproline sites from all major tissue collagen types. However, collagen type I extracted from both Sc65(-/-) and P3h3(-/-) skin revealed the same abnormal chain pattern on SDS-PAGE with an overabundance of a (112) cross-linked trimer. The latter proved to be from native molecules that had intramolecular aldol cross-links at each end. The lysine under-hydroxylation was shown to alter the divalent aldimine cross-link chemistry of mutant skin collagen. Furthermore, the ratio of mature HP/LP cross-links in bone of both P3h3(-/-) and Sc65(-/-) mice was reversed compared with wild type, consistent with the level of lysine under-hydroxylation seen in individual chains at cross-linking sites. The effect on cross-linking lysines was quantitatively very similar to that previously observed in EDS VIA human and Plod1(-/-) mouse tissues, suggesting that P3H3 and/or SC65 mutations may cause as yet undefined EDS variants.	[Hudson, David M.; Weis, MaryAnn; Rai, Jyoti; Eyre, David R.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA; [Joeng, Kyu Sang; Lee, Brendan H.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Dimori, Milena; Morello, Roy] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA	University of Washington; University of Washington Seattle; Baylor College of Medicine; University of Arkansas System; University of Arkansas Medical Sciences	Hudson, DM (corresponding author), Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA.	dmhudson@uw.edu			National Institute of Arthritis and Musculoskeletal and Skin Diseases and Eunice Kennedy Shriver NICHD; National Institutes of Health NIAMS [AR037318, AR036794, AR060823]; NICHD [HD070394]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR037318, R01AR036794, R01AR060823, R01AR037318, R37AR036794] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases and Eunice Kennedy Shriver NICHD; National Institutes of Health NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Institute of Arthritis and Musculoskeletal and Skin Diseases and Eunice Kennedy Shriver NICHD, National Institutes of Health NIAMS Grants AR037318 (to D. E.), AR036794 (to D. E.), AR060823 (to R. M.), and NICHD Grant HD070394 (to B. L. and D. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barnes AM, 2012, HUM MUTAT, V33, P1589, DOI 10.1002/humu.22139; Barnes AM, 2010, NEW ENGL J MED, V362, P521, DOI 10.1056/NEJMoa0907705; Basak T, 2016, J PROTEOME RES, V15, P245, DOI 10.1021/acs.jproteome.5b00767; Bella J, 2016, BIOCHEM J, V473, P1001, DOI 10.1042/BJ20151169; Cabral WA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004465; Cavazzini F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048845; EYRE D, 1987, METHOD ENZYMOL, V144, P115; Eyre DR, 2013, CALCIFIED TISSUE INT, V93, P338, DOI 10.1007/s00223-013-9723-9; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; Gjaltema RAF, 2016, P NATL ACAD SCI USA, V113, P7142, DOI 10.1073/pnas.1600074113; Gruenwald K, 2014, J BONE MINER RES, V29, P666, DOI 10.1002/jbmr.2075; Guo H, 2014, CLIN GENET, V86, P575, DOI 10.1111/cge.12309; Ha-Vinh R, 2004, AM J MED GENET A, V131A, P115, DOI 10.1002/ajmg.a.30231; Hanson DA, 1996, J BIOL CHEM, V271, P26508, DOI 10.1074/jbc.271.43.26508; Heard ME, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006002; Homan EP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004121; Hudson DM, 2015, J BIOL CHEM, V290, P8613, DOI 10.1074/jbc.M114.634915; Hudson DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093467; Hudson DM, 2013, CONNECT TISSUE RES, V54, P245, DOI 10.3109/03008207.2013.800867; Hudson DM, 2012, BIOCHEMISTRY-US, V51, P2417, DOI 10.1021/bi2019139; Ishikawa Y, 2009, J BIOL CHEM, V284, P17641, DOI 10.1074/jbc.M109.007070; Kalamajski S, 2016, J BIOL CHEM, V291, P7951, DOI 10.1074/jbc.M115.693408; Kalamajski S, 2014, J BIOL CHEM, V289, P18873, DOI 10.1074/jbc.M114.572941; Khan AO, 2015, OPHTHALMIC GENET, V36, P58, DOI 10.3109/13816810.2014.985847; Lietman CD, 2014, HUM MOL GENET, V23, P4822, DOI 10.1093/hmg/ddu197; Marini JC, 2014, CURR OPIN PEDIATR, V26, P500, DOI 10.1097/MOP.0000000000000117; Matsui Y, 2003, MATRIX BIOL, V22, P123, DOI 10.1016/S0945-053X(02)00102-6; Mordechai S, 2011, AM J HUM GENET, V89, P438, DOI 10.1016/j.ajhg.2011.08.003; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Pokidysheva E, 2014, P NATL ACAD SCI USA, V111, P161, DOI 10.1073/pnas.1307597111; Pokidysheva E, 2013, J BIOL CHEM, V288, P24742, DOI 10.1074/jbc.M113.464156; ROBINS SP, 1973, BIOCHEM J, V135, P657, DOI 10.1042/bj1350657; Schwarze U, 2013, HUM MOL GENET, V22, P1, DOI 10.1093/hmg/dds371; STEINMANN B, 1995, AM J HUM GENET, V57, P1505; Steinmann B., 2003, CONNECTIVE TISSUE IT, P431; Steinmann B., 2002, CONNECTIVE TISSUE IT, P431, DOI DOI 10.1002/0471221929.CH9; Takaluoma K, 2007, J BIOL CHEM, V282, P6588, DOI 10.1074/jbc.M608830200; TANZER ML, 1973, J BIOL CHEM, V248, P393; Terajima M, 2016, J BIOL CHEM, V291, P9501, DOI 10.1074/jbc.M115.699470; Tiainen P, 2008, J BIOL CHEM, V283, P19432, DOI 10.1074/jbc.M802973200; Weis MA, 2010, J BIOL CHEM, V285, P2580, DOI 10.1074/jbc.M109.068726; Yamauchi M, 2012, ESSAYS BIOCHEM, V52, P113, DOI DOI 10.1042/BSE0520113; Yang CX, 2012, J BIOL CHEM, V287, P40598, DOI 10.1074/jbc.M112.406850	43	16	19	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3877	3887		10.1074/jbc.M116.762245	http://dx.doi.org/10.1074/jbc.M116.762245			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28115524	Green Published, hybrid			2022-12-26	WOS:000395542500028
J	Fuentes-Ramirez, A; Jimenez-Soto, M; Castro, R; Romero-Zuniga, JJ; Dolz, G				Fuentes-Ramirez, Alicia; Jimenez-Soto, Mauricio; Castro, Ruth; Jose Romero-Zuniga, Juan; Dolz, Gaby			Molecular Detection of Plasmodium malariae/Plasmodium brasilianum in Non-Human Primates in Captivity in Costa Rica	PLOS ONE			English	Article							MALARIA PARASITES; ATLANTIC FOREST; NATURAL INFECTION; HOWLER MONKEYS; HUMANS; RESERVOIRS; KNOWLESI; REGIONS; AMAZON; SIMIUM	One hundred and fifty-two blood samples of non-human primates of thirteen rescue centers in Costa Rica were analyzed to determine the presence of species of Plasmodium using thick blood smears, semi-nested multiplex polymerase chain reaction (SnM-PCR) for species differentiation, cloning and sequencing for confirmation. Using thick blood smears, two samples were determined to contain the Plasmodium malariae parasite, with SnM-PCR, a total of five (3.3%) samples were positive to P. malariae, cloning and sequencing confirmed both smear samples as P. malariae. One sample amplified a larger and conserved region of 18S rDNA for the genus Plasmodium and sequencing confirmed the results obtained microscopically and through SnM-PCR tests. Sequencing and construction of a phylogenetic tree of this sample revealed that the P. malariae/P. brasilianum parasite (GenBank KU999995) found in a howler monkey (Alouatta palliata) is identical to that recently reported in humans in Costa Rica. The SnM-PCR detected P. malariae/P. brasilianum parasite in different nonhuman primate species in captivity and in various regions of the southern Atlantic and Pacific coast of Costa Rica. The similarity of the sequences of parasites found in humans and a monkey suggests that monkeys may be acting as reservoirs of P. malariae/P. brasilianum, for which reason it is important, to include them in control and eradication programs.	[Fuentes-Ramirez, Alicia; Castro, Ruth; Dolz, Gaby] Univ Nacl UNA, Posgrad Reg Ciencias Vet Trop PCVET, Campus Benjamin Nunez, Barreal De Heredia, Costa Rica; [Jimenez-Soto, Mauricio; Jose Romero-Zuniga, Juan; Dolz, Gaby] UNA, Escuela Med Vet, Campus Benjamin Nunez, Barreal De Heredia, Costa Rica	Universidad Nacional Costa Rica	Fuentes-Ramirez, A; Dolz, G (corresponding author), Univ Nacl UNA, Posgrad Reg Ciencias Vet Trop PCVET, Campus Benjamin Nunez, Barreal De Heredia, Costa Rica.; Dolz, G (corresponding author), UNA, Escuela Med Vet, Campus Benjamin Nunez, Barreal De Heredia, Costa Rica.	alicia.fuentes.ramirez@est.una.ac.cr; gaby.dolz.wiedner@una.cr		Dolz, Gaby/0000-0002-9566-5130	Vicerrectoria de Investigacion, Universidad Nacional; Deutscher Akademischer Austauschdienst (DAAD)	Vicerrectoria de Investigacion, Universidad Nacional; Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	Vicerrectoria de Investigacion, Universidad Nacional provided financial support for translating the article. Deutscher Akademischer Austauschdienst (DAAD) provided the scholarship granted to Alicia Fuentes-Ramirez.	Araujo MS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-180; Avila-Aguero ML, 2008, ACTA MED COSTAR, V50; Bannister LH, 2001, ENCY LIFE SCI; Calvo N., 2015, SCI POSTPRINT, V1; Chinchilla Misael, 2006, Parasitologia Latinoamericana, V61, P192; COATNEY GR, 1971, PRIMATE MALARIAS; Cormier Loretta A., 2010, Diversity, V2, P256; Costa DC, 2014, MEM I OSWALDO CRUZ, V109, P641, DOI 10.1590/0074-0276130578; de Pina-Costa A, 2014, MEM I OSWALDO CRUZ, V109, P618, DOI 10.1590/0074-0276140228; DEANE LM, 1988, AM J TROP MED HYG, V38, P223, DOI 10.4269/ajtmh.1988.38.223; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ESCALANTE AA, 1995, MOL BIOL EVOL, V12, P616; Fandeur T, 2000, PARASITOLOGY, V120, P11, DOI 10.1017/S0031182099005168; Galland G G, 2000, ILAR J, V41, P37; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Kirchgatter K, 2014, REV INST MED TROP SP, V56, P403, DOI 10.1590/S0036-46652014000500006; Lalremruata A, 2015, EBIOMEDICINE, V2, P1186, DOI 10.1016/j.ebiom.2015.07.033; Leclerc MC, 2004, PARASITOLOGY, V129, P677, DOI 10.1017/S0031182004006146; Lopez AC, 2011, REV CIENCIA TECNOLOG, V9, P68; de Alvarenga DAM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0606-6; Maeno Y, 2015, PARASIT VECT, V8, P1473; Mixson-Hayden Tonya, 2010, BMC Res Notes, V3, P88, DOI 10.1186/1756-0500-3-88; Ndao M, 2004, J CLIN MICROBIOL, V42, P2694, DOI 10.1128/JCM.42.6.2694-2700.2004; Noordhuizen JPTM., 2001, APPL QUANTITATIVE ME, V2nd; Rayner JC, 2015, EBIOMEDICINE, V2, P1023, DOI 10.1016/j.ebiom.2015.08.035; Duarte AMRD, 2008, ACTA TROP, V107, P179, DOI 10.1016/j.actatropica.2008.05.020; Rubio JM, 1999, AM J TROP MED HYG, V60, P183, DOI 10.4269/ajtmh.1999.60.183; Singh B, 2013, CLIN MICROBIOL REV, V26, P165, DOI 10.1128/CMR.00079-12; Tazi L, 2011, INFECT GENET EVOL, V11, P209, DOI 10.1016/j.meegid.2010.08.007; Verhulst NO, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00197; Vythilingam I, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P487, DOI 10.5772/54491; White NJ, 2008, CLIN INFECT DIS, V46, P172, DOI 10.1086/524889; Yamasaki T, 2011, J MED PRIMATOL, V40, P392, DOI 10.1111/j.1600-0684.2011.00498.x	33	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170704	10.1371/journal.pone.0170704	http://dx.doi.org/10.1371/journal.pone.0170704			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125696	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100071
J	Geddes, RI; Hayashi, K; Bongers, Q; Wehber, M; Anderson, IM; Jansen, AD; Nier, C; Fares, E; Farquhar, G; Kapoor, A; Ziegler, TE; VadakkadathMeethal, S; Bird, IM; Atwood, CS				Geddes, Rastafa I.; Hayashi, Kentaro; Bongers, Quinn; Wehber, Marlyse; Anderson, Icelle M.; Jansen, Alex D.; Nier, Chase; Fares, Emily; Farquhar, Gabrielle; Kapoor, Amita; Ziegler, Toni E.; VadakkadathMeethal, Sivan; Bird, Ian M.; Atwood, Craig S.			Conjugated Linoleic Acid Administration Induces Amnesia in Male Sprague Dawley Rats and Exacerbates Recovery from Functional Deficits Induced by a Controlled Cortical Impact Injury	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; PLUS-MAZE BEHAVIOR; QUALITY-OF-LIFE; CLA ISOMERS; POSTTRAUMATIC HYPOPITUITARISM; NEUROENDOCRINE DYSFUNCTION; PITUITARY INSUFFICIENCY; CELL-PROLIFERATION; GENE-EXPRESSION; MAMMARY-GLAND	Long-chain polyunsaturated fatty acids like conjugated linoleic acids (CLA) are required for normal neural development and cognitive function and have been ascribed various beneficial functions. Recently, oral CLA also has been shown to increase testosterone (T) biosynthesis, which is known to diminish traumatic brain injury (TBI)-induced neuropathology and reduce deficits induced by stroke in adult rats. To test the impact of CLA on cognitive recovery following a TBI, 5-6 month old male Sprague Dawley rats received a focal injury (craniectomy + controlled cortical impact (CCI; n = 17)) or Sham injury (craniectomy alone; n = 12) and were injected with 25 mg/kg body weight of Clarinol (R) G-80 (80% CLA in safflower oil; n = 16) or saline (n = 13) every 48 h for 4 weeks. Sham surgery decreased baseline plasma progesterone (P-4) by 64.2% (from 9.5 +/- 3.4 ng/mL to 3.4 +/- 0.5 ng/mL; p = 0.068), T by 74.6% (from 5.9 +/- 1.2 ng/mL to 1.5 +/- 0.3 ng/mL; p < 0.05), 11-deoxycorticosterone (11-DOC) by 37.5% (from 289.3 +/- 42.0 ng/mL to 180.7 +/- 3.3 ng/mL), and corticosterone by 50.8% (from 195.1 +/- 22.4 ng/mL to 95.9 +/- 2.2 ng/mL), by post-surgery day 1. CCI injury induced similar declines in P-4, T, 11-DOC and corticosterone (58.9%, 74.6%, 39.4% and 24.6%, respectively) by post-surgery day 1. These results suggest that both Sham surgery and CCI injury induce hypogonadism and hypoadrenalism in adult male rats. CLA treatment did not reverse hypogonadism in Sham (P4: 2.5 +/- 1.0 ng/mL; T: 0.9 +/- 0.2 ng/mL) or CCI-injured (P4: 2.2 +/- 0.9 ng/mL; T: 1.0 +/- 0.2 ng/mL, p > 0.05) animals by post-injury day 29, but rapidly reversed by post-injury day 1 the hypoadrenalism in Sham (11-DOC: 372.6 +/- 36.6 ng/mL; corticosterone: 202.6 +/- 15.6 ng/mL) and CCI-injured (11-DOC: 384.2 +/- 101.3 ng/mL; corticosterone: 234.6 +/- 43.8 ng/mL) animals. In Sham surgery animals, CLA did not alter body weight, but did markedly increase latency to find the hidden Morris Water Maze platform (40.3 +/- 13.0 s) compared to saline treated Sham animals (8.8 +/- 1.7 s). In CCI injured animals, CLA did not alter CCI-induced body weight loss, CCI-induced cystic infarct size, or deficits in rotarod performance. However, like Sham animals, CLA injections exacerbated the latency of CCI-injured rats to find the hidden MWM platform (66.8 +/- 10.6 s) compared to CCI-injured rats treated with saline (30.7 +/- 5.5 s, p < 0.05). These results indicate that chronic treatment of CLA at a dose of 25 mg/kg body weight in adult male rats over 1-month 1) does not reverse craniectomy-and craniectomy + CCI-induced hypogonadism, but does reverse craniectomy-and craniectomy + CCI-induced hypoadrenalism, 2) is detrimental to medium-and long-term spatial learning and memory in craniectomized uninjured rats, 3) limits cognitive recovery following a moderate-severe CCI injury, and 4) does not alter body weight.	[Geddes, Rastafa I.; Hayashi, Kentaro; Bongers, Quinn; Wehber, Marlyse; Anderson, Icelle M.; Jansen, Alex D.; Nier, Chase; Fares, Emily; Farquhar, Gabrielle; VadakkadathMeethal, Sivan; Atwood, Craig S.] Univ Wisconsin, Div Geriatr & Gerontol, Dept Med, Madison Sch Med & Publ Hlth, Madison, WI 53706 USA; [Kapoor, Amita; Ziegler, Toni E.] Univ Wisconsin, Natl Primate Res Ctr, Assay Serv Unit, Madison, WI 53706 USA; [Kapoor, Amita; Ziegler, Toni E.] Univ Wisconsin, Natl Primate Res Ctr, Inst Clin & Translat Res Core Lab, Madison, WI 53706 USA; [Bird, Ian M.] Univ Wisconsin, Madison Sch Med & Publ Hlth, Dept Obstet & Gynecol, Madison, WI 53706 USA; [Atwood, Craig S.] Vet Adm Hosp, Geriatr Res Educ & Clin Ctr, Madison, WI 53705 USA; [Atwood, Craig S.] Edith Cowan Univ, Sch Exercise Biomed & Hlth Sci, Joondalup, WA, Australia	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Geriatric Research Education & Clinical Center; Edith Cowan University	Atwood, CS (corresponding author), Univ Wisconsin, Div Geriatr & Gerontol, Dept Med, Madison Sch Med & Publ Hlth, Madison, WI 53706 USA.	csa@medicine.wisc.edu	, Craig/AAB-3963-2022		Veterans Administration Merit Review grant [1121RX001371]; National Institutes of Aging T32 training grant [5T32AG00213]; Institute for Clinical and Translational Research, UW-Madison, NIH [UL1T000427]; NATIONAL INSTITUTE ON AGING [T32AG000213, P50AG033514] Funding Source: NIH RePORTER; Veterans Affairs [I21RX001371] Funding Source: NIH RePORTER	Veterans Administration Merit Review grant(US Department of Veterans Affairs); National Institutes of Aging T32 training grant; Institute for Clinical and Translational Research, UW-Madison, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This study was funded by the Veterans Administration Merit Review grant #1121RX001371 (CSA). RIG was funded by a National Institutes of Aging T32 training grant #5T32AG00213. This material is the result of work supported with resources at the William S. Middleton Memorial Veterans Hospital, Madison, WI. The Institute for Clinical and Translational Research, UW-Madison, NIH UL1T000427 (CSA), provided support for the steroid assays. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absalon-Medina VA, 2014, J DAIRY SCI, V97, P6164, DOI 10.3168/jds.2013-7719; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Akers KG, 2007, BEHAV NEUROSCI, V121, P1426, DOI 10.1037/0735-7044.121.6.1426; ALTMAN R, 1961, ANN INTERN MED, V55, P149, DOI 10.7326/0003-4819-55-1-149; Atwood CS, 2015, HORM BEHAV, V76, P63, DOI 10.1016/j.yhbeh.2015.06.021; Atwood CS, 2015, J ALZHEIMERS DIS, V47, P33, DOI 10.3233/JAD-143210; Atwood CS, 2011, EXP GERONTOL, V46, P100, DOI 10.1016/j.exger.2010.09.007; Atwood CS, 2000, J ENDOCRINOL, V167, P39, DOI 10.1677/joe.0.1670039; Auer M, 2013, DEUT MED WOCHENSCHR, V138, P831, DOI 10.1055/s-0033-1343099; Barone R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079686; Barton DJ, 2015, J HEAD TRAUMA REHAB; Berg C, 2010, EXP CLIN ENDOCR DIAB, V118, P139, DOI 10.1055/s-0029-1225611; Berryhill GE, 2016, J DAIRY SCI, V99, P875, DOI 10.3168/jds.2015-10105; Brown JM, 2003, J LIPID RES, V44, P1287, DOI 10.1194/jlr.M300001-JLR200; Cao Y, 2009, J NUTR BIOCHEM, V20, P685, DOI 10.1016/j.jnutbio.2008.06.011; Cao ZP, 2007, NEUROSCI LETT, V418, P217, DOI 10.1016/j.neulet.2007.03.010; Carlson NE, 2009, BRAIN INJURY, V23, P336, DOI 10.1080/02699050902788535; Castaneda-Gutierrez E, 2007, J DAIRY SCI, V90, P4253, DOI 10.3168/jds.2007-0117; Centers for Disease Control, WHAT IS TRAUMATIC BR; Cepicky P, 1993, Cesk Gynekol, V58, P288; CHIN SF, 1994, J NUTR, V124, P2344, DOI 10.1093/jn/124.12.2344; Chin SF, 1994, J NUTR; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; de Deckere EAM, 1999, BRIT J NUTR, V82, P309, DOI 10.1017/S0007114599001518; Di Felice V, 2007, J STRENGTH COND RES, V21, P193, DOI 10.1519/00124278-200702000-00035; Dickinson R, 2000, ANESTHESIOLOGY, V93, P837, DOI 10.1097/00000542-200009000-00035; Doremus TL, 2006, PHARMACOL BIOCHEM BE, V83, P570, DOI 10.1016/j.pbb.2006.03.019; Doremus TL, 2004, ANN NY ACAD SCI, V1021, P427, DOI 10.1196/annals.1308.057; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Emery CA, 2005, MED SPORT SCI, V48, P179, DOI [10.1159/000085396, 10.1159/000084289]; Evans ME, 2002, J NUTR BIOCHEM, V13, P508, DOI 10.1016/S0955-2863(02)00211-5; Fa M, 2005, BBA-MOL CELL BIOL L, V1736, P61, DOI 10.1016/j.bbalip.2005.06.010; FERNANDEZCASTANER M, 1982, ANN ENDOCRINOL-PARIS, V43, P213; Fischer-Posovszky P, 2008, MMW Fortschr Med, V149 Suppl 4, P128; FLEISCHER AS, 1978, J NEUROSURG, V49, P650, DOI 10.3171/jns.1978.49.5.0650; Frye CA, 2007, NEUROBIOL LEARN MEM, V88, P208, DOI 10.1016/j.nlm.2007.04.003; Gallagher S, 2008, ARCHIVES OF PHYSICAL, V89, pe26; Gama MAS, 2015, J NEURAL TRANSM, V122, P1371, DOI 10.1007/s00702-015-1401-9; Gaullier JM, 2005, J NUTR, V135, P778; Geddes RI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146419; Geddes RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087252; Guerrero AF, 2010, MIL MED, V175, P574, DOI 10.7205/MILMED-D-09-00189; HA YL, 1987, CARCINOGENESIS, V8, P1881, DOI 10.1093/carcin/8.12.1881; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Haugen Margaretha, 2004, Tidsskr Nor Laegeforen, V124, P3051; Herrmann J, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-35; Hohl A, 2014, BRAIN INJURY, V28, P1262, DOI 10.3109/02699052.2014.915986; Hohl A, 2009, ARQ BRAS ENDOCRINOL, V53, P1012, DOI 10.1590/S0004-27302009000800016; Hunt WT, 2010, J NEUROCHEM, V115, P123, DOI 10.1111/j.1471-4159.2010.06908.x; Hutchinson I, 2011, J DAIRY RES, V78, P308, DOI 10.1017/S0022029911000422; IP C, 1991, CANCER RES, V51, P6118; IP C, 1994, CANCER RES, V54, P1212; Janssen CIF, 2014, PROG LIPID RES, V53, P1, DOI 10.1016/j.plipres.2013.10.002; Jenkins ND, 2016, EXP GERONTOL; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kelly DF, 2014, J NEUROTRAUM, V31, P1161, DOI 10.1089/neu.2013.3212; Kempermann G, 2000, NOVART FDN SYMP, V231, P220, DOI 10.1002/0470870834.ch14; Kenealy BP, 2016, ENDOCRINOLOGY, V157, P70, DOI 10.1210/en.2015-1770; Kenealy BP, 2013, J NEUROSCI, V33, P19051, DOI 10.1523/JNEUROSCI.3878-13.2013; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Kramer JKG, 1998, LIPIDS, V33, P549, DOI 10.1007/s11745-998-0239-1; Kramer JKG, 2004, AM J CLIN NUTR, V79, p1137S, DOI 10.1093/ajcn/79.6.1137S; Lee E, 2013, BBA-MOL CELL BIOL L, V1831, P709, DOI 10.1016/j.bbalip.2012.12.003; LEE SC, 1994, BRAIN INJURY, V8, P571; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Macaluso F, 2012, J STRENGTH COND RES, V26, P1667, DOI 10.1519/JSC.0b013e318231ab78; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Margulies S, 2016, J NEUROTRAUM, V33, P101, DOI 10.1089/neu.2014.3855; Marina D, 2015, EUR J ENDOCRINOL, V172, P813, DOI 10.1530/EJE-14-1152; May KCP, 2011, MOL REPROD DEV, V78, P328, DOI 10.1002/mrd.21308; MIYASAKI K, 1972, ACTA PATHOL JAPON, V22, P779; Murialdo G, 2001, J ENDOCRINOL INVEST, V24, P139, DOI 10.1007/BF03343833; Nakanishi T, 2003, NEUROSCI LETT, V341, P135, DOI 10.1016/S0304-3940(03)00189-7; Noone EJ, 2002, BRIT J NUTR, V88, P243, DOI 10.1079/BJN2002615; Pariza MW, 2001, PROG LIPID RES, V40, P283, DOI 10.1016/S0163-7827(01)00008-X; Rubin D, 2012, GENES NUTR, V7, P499, DOI 10.1007/s12263-012-0289-3; Ruggeri RM, 2010, HORM-INT J ENDOCRINO, V9, P332, DOI 10.14310/horm.2002.1285; Sato K, 2011, J NUTR SCI VITAMINOL, V57, P364, DOI 10.3177/jnsv.57.364; Schaeffer EL, 2005, PSYCHOPHARMACOLOGY, V181, P392, DOI 10.1007/s00213-005-2256-9; Schaeffer EL, 2011, J NEURAL TRANSM, V118, P1273, DOI 10.1007/s00702-011-0619-4; Schaeffer EL, 2010, PROG NEURO-PSYCHOPH, V34, P1381, DOI 10.1016/j.pnpbp.2010.08.019; Schmidt RH, 1999, J NEUROTRAUM, V16, P1139, DOI 10.1089/neu.1999.16.1139; Scranton RA, 2015, J CLIN MED, V4, P1463, DOI 10.3390/jcm4071463; Sebedio JL, 1997, BBA-LIPID LIPID MET, V1345, P5, DOI 10.1016/S0005-2760(97)00015-5; Sharma I., 2012, IJ INFORM TECHNOLOGY, V8, P1, DOI DOI 10.1530/REP-12-0079; Sikorski AM, 2008, BRAIN RES, V1213, P35, DOI 10.1016/j.brainres.2008.01.096; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Tanriverdi F, 2015, NEUROPSYCH DIS TREAT, V11, P1835, DOI 10.2147/NDT.S65814; Thijssen MAMA, 2005, LIPIDS, V40, P137, DOI 10.1007/s11745-005-1368-2; Tosetti P, 2013, J NEUROTRAUM, V30, P1211, DOI 10.1089/neu.2013.2896; Urban RJ, 2005, BRAIN INJURY, V19, P349, DOI 10.1080/02699050400004807; Wagner AK, 2012, BRAIN INJURY, V26, P1226, DOI 10.3109/02699052.2012.667594; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Wagner J, 2010, J NEUROTRAUM, V27, P1007, DOI 10.1089/neu.2009.1092; Whigham LD, 2001, AM J PHYSIOL-REG I, V280, pR908, DOI 10.1152/ajpregu.2001.280.3.R908; Wilkinson C, 2012, FRONT NEUROTRAUMA, V3, P11, DOI DOI 10.3389/FNEUR.2012.00011; WOOLF PD, 1985, J CLIN ENDOCR METAB, V60, P444, DOI 10.1210/jcem-60-3-444; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820	105	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0169494	10.1371/journal.pone.0169494	http://dx.doi.org/10.1371/journal.pone.0169494			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125600	gold, Green Published			2022-12-26	WOS:000396176100138
J	Jackson, B; Compton, J; Thornton, AL; Dimmock, JA				Jackson, Ben; Compton, Josh; Thornton, Ashleigh L.; Dimmock, James A.			Re-Thinking Anxiety: Using Inoculation Messages to Reduce and Reinterpret Public Speaking Fears	PLOS ONE			English	Article							PERFORMANCE ANXIETY; SOCIAL PHOBIA; CONFERRING RESISTANCE; STRESS INOCULATION; VIRTUAL-REALITY; COMMUNICATION; EFFICACY; ADOLESCENTS; PERSONALITY; PREVALENCE	Inoculation theory offers a framework for protecting individuals against challenges to an existing attitude, belief, or state. Despite the prevalence and damaging effects of public speaking anxiety, inoculation strategies have yet to be used to help individuals remain calm before and during public speaking. We aimed to test the effectiveness of an inoculation message for reducing the onset of public speaking anxiety, and helping presenters interpret their speech-related anxiety more positively. Participants (M-age = 20.14, SD = 2.72) received either an inoculation (n = 102) or control (n = 128) message prior to engaging a public speaking task and reported a range of anxiety-related perceptions. Accounting for personality characteristics and perceptions of task importance, and relative to control participants, those who received the inoculation message reported significantly lower pre-task anxiety, and following the task, reported that they had experienced lower somatic anxiety, and that the inoculation message had caused them to view their nerves in a less debilitating light. Inoculation messages may be an effective strategy for helping participants reframe and reduce their apprehension about public speaking, and investigating their efficacy in other stress-inducing contexts may be worthwhile.	[Jackson, Ben; Thornton, Ashleigh L.; Dimmock, James A.] Univ Western Australia, Sch Sport Sci Exercise & Hlth, Perth, WA, Australia; [Compton, Josh] Dartmouth Coll, Inst Writing & Rhetor, Hanover, NH 03755 USA	University of Western Australia; Dartmouth College	Jackson, B (corresponding author), Univ Western Australia, Sch Sport Sci Exercise & Hlth, Perth, WA, Australia.	ben.jackson@uwa.edu.au	Compton, Josh/I-6729-2019; Thornton, Ashleigh/H-5960-2014; Jackson, Ben/H-5117-2014	Compton, Josh/0000-0003-4625-3823; Dimmock, James/0000-0002-4475-8169; Thornton, Ashleigh/0000-0003-3712-3330; Jackson, Ben/0000-0003-0351-8377				ALLEN M, 1989, COMMUN EDUC, V38, P54, DOI 10.1080/03634528909378740; ALTMAIER EM, 1985, J SOC CLIN PSYCHOL, V3, P500, DOI 10.1521/jscp.1985.3.4.500; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; Amir N, 2008, J ABNORM PSYCHOL, V117, P860, DOI 10.1037/a0013445; Anderson PL, 2005, DEPRESS ANXIETY, V22, P156, DOI 10.1002/da.20090; Ayres J, 1993, J APPL COMMUN RES, V21, P132, DOI DOI 10.1080/00909889309365362; Banas JA, 2010, COMMUN MONOGR, V77, P281, DOI 10.1080/03637751003758193; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Barlow DH, 2002, ANXIETY ITS DISORDER; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BEHNKE RR, 1987, COMMUN EDUC, V36, P138, DOI 10.1080/03634528709378654; Behnke RR, 1999, COMMUN EDUC, V48, P165, DOI 10.1080/03634529909379164; Beltzer ML, 2014, EMOTION, V14, P761, DOI 10.1037/a0036326; Berko RM, 2004, COMMUNICATION SOCIAL; Bodie GD, 2010, COMMUN EDUC, V59, P70, DOI 10.1080/03634520903443849; Brooks AW, 2014, J EXP PSYCHOL GEN, V143, P1144, DOI 10.1037/a0035325; Cerin E, 2003, J APPL SPORT PSYCHOL, V15, P223, DOI 10.1080/10413200305389; Clevenger T, 1992, CONVERTING PRC UNPUB; Compton J., 2013, SAGE HDB PERSUASION, V2nd ed, P220; Compton J, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00122; COUCH JV, 1983, PSYCHOL REC, V33, P237, DOI 10.1007/BF03394841; Crum AJ, 2013, J PERS SOC PSYCHOL, V104, P716, DOI 10.1037/a0031201; Daly J. A., 1989, COMMUN Q, V37, P39, DOI [10.1080/01463378909385524, DOI 10.1080/01463378909385524]; Dillard J.P., 2012, SAGE HDB PERSUASION; Dimmock JA, J SPORT EXE IN PRESS; Draugelis S, 2014, SPORT PSYCHOL, V28, P1, DOI 10.1123/tsp.2012-0093; Furmark T, 1999, SOC PSYCH PSYCH EPID, V34, P416, DOI 10.1007/s001270050163; Furmark T, 2002, ACTA PSYCHIAT SCAND, V105, P84, DOI 10.1034/j.1600-0447.2002.1r103.x; Gilovich T, 2000, J PERS SOC PSYCHOL, V78, P211, DOI 10.1037/0022-3514.78.2.211; Godbold LC, 2000, COMMUN RES, V27, P411, DOI 10.1177/009365000027004001; Hancock AB, 2010, J VOICE, V24, P302, DOI 10.1016/j.jvoice.2008.09.007; Hanton S., 2008, INT REV SPORT EXER P, V1:1, P45, DOI [https://doi.org/10.1080/17509840701827445, DOI 10.1080/17509840701827445]; Harris SR, 2002, CYBERPSYCHOL BEHAV, V5, P543, DOI 10.1089/109493102321018187; Heimberg RG, 2014, DEPRESS ANXIETY, V31, P472, DOI 10.1002/da.22231; Hofmann SG, 2000, BEHAV THER, V31, P499, DOI 10.1016/S0005-7894(00)80027-1; Jackson B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124886; Jamieson JP, 2013, CLIN PSYCHOL SCI, V1, P363, DOI 10.1177/2167702613482119; JAREMKO ME, 1980, J CLIN PSYCHOL, V36, P735, DOI 10.1002/1097-4679(198007)36:3<735::AID-JCLP2270360322>3.0.CO;2-N; John O. P., 2008, HDB PERSONALITY THEO, V3, P114; JONES G, 1995, BRIT J PSYCHOL, V86, P449, DOI 10.1111/j.2044-8295.1995.tb02565.x; Kessler RC, 1998, AM J PSYCHIAT, V155, P613, DOI 10.1176/ajp.155.5.613; Lang P. J., 1969, BEHAV THERAPY APPRAI, P161; Lazarus R.S., 1984, EMOTION ADAPTATION; LEARY MR, 1983, J PERS ASSESS, V47, P66, DOI 10.1207/s15327752jpa4701_8; Lechner CM, 2015, PSYCHOL ASSESSMENT, V27, P1301, DOI 10.1037/pas0000151; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Lumsdaine AA, 1953, PUBLIC OPIN QUART, V17, P311, DOI 10.1086/266464; Martin KA, 2001, J APPL SOC PSYCHOL, V31, P1000, DOI 10.1111/j.1559-1816.2001.tb02659.x; MCCROSKEY JC, 1970, SPEECH MONOGR, V37, P269; MCCROSKEY JC, 1984, COMMUN MONOGR, V51, P79, DOI 10.1080/03637758409390185; MCGUIRE WJ, 1964, ADV EXP SOC PSYCHOL, V1, P191, DOI 10.1016/S0065-2601(08)60052-0; MENZEL KE, 1994, COMMUN EDUC, V43, P17, DOI 10.1080/03634529409378958; MOTLEY MT, 1990, J SOC BEHAV PERS, V5, P85; Myers ND, 2005, MEAS PHYS EDUC EXERC, V9, P135, DOI 10.1207/s15327841mpee0903_1; Parker KA, 2012, HEALTH COMMUN, V27, P223, DOI 10.1080/10410236.2011.575541; PFAU M, 1994, HUM COMMUN RES, V20, P413, DOI 10.1111/j.1468-2958.1994.tb00329.x; Pfau M, 1997, HUM COMMUN RES, V24, P187; Rammstedt B, 2007, J RES PERS, V41, P203, DOI 10.1016/j.jrp.2006.02.001; Richards AS, 2015, HEALTH COMMUN, V30, P451, DOI 10.1080/10410236.2013.867005; Savitsky K, 2003, J EXP SOC PSYCHOL, V39, P618, DOI 10.1016/S0022-1031(03)00056-8; Schoenberger NE, 1997, BEHAV THER, V28, P127, DOI 10.1016/S0005-7894(97)80038-X; Smith R.E., 1990, ANXIETY RES, V2, P263, DOI [DOI 10.1080/08917779008248733, https://doi.org/10.1080/08917779008248733]; Smith RE, 2006, J SPORT EXERCISE PSY, V28, P479, DOI 10.1123/jsep.28.4.479; Stein MB, 1996, ARCH GEN PSYCHIAT, V53, P169; Urdan TC, 2006, SELF EFFICACY BELIEF, P307; Williams S.E., 2012, SPORT EXERC PSYCHOL, V8, P4, DOI DOI 10.1016/J.IJPSYCH0.2017.04.011; Zeidner M., 2005, HDB COMPETENCE MOTIV, P141	67	10	10	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0169972	10.1371/journal.pone.0169972	http://dx.doi.org/10.1371/journal.pone.0169972			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7IT	28125618	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000396176100133
J	Kao, FC; Hsu, YC; Lin, CFJ; Lo, YY; Tu, YK				Kao, Feng-Chen; Hsu, Yao-Chun; Lin, Chien-Fu Jeff; Lo, Ying-Ying; Tu, Yuan-Kun			Corticosteroid Is Associated with Both Hip Fracture and Fracture-Unrelated Arthropathy	PLOS ONE			English	Article							HUMAN FEMORAL-HEAD; RENAL-TRANSPLANTATION; CLINICAL-IMPLICATIONS; AVASCULAR NECROSIS; INDUCED OSTEOPOROSIS; OSTEONECROSIS; BONE; THERAPY; RISK; GLUCOCORTICOIDS	Objective We aimed to investigate whether and how corticosteroid use was associated with serious hip arthropathy. Methods and Materials This population-based cohort study analyzed the Taiwan National Health Insurance Research Database and screened the one-million random sample from the entire population for eligibility. The steroid cohort consisted of 21,995 individuals who had used systemic corticosteroid for a minimum of 6 months between January 1, 1997 and December 31, 2006. They were matched 1: 1 in propensity score on the index calendar date with controls who never used steroid. All participants were followed up until occurrence of serious hip arthropathy that required arthroplasty, withdrawal from the national health insurance, or the end of 2011. Surgical indication was classified as fracture-related and -unrelated. The cumulative incidence of hip arthroplasty was estimated by the Kaplan Meier method. The association with steroid exposure was explored by the Cox proportional hazard model. Results Cumulative incidences of hip arthroplasty after 12 years of follow-up were 2.96% (95% confidence interval [CI], 2.73-3.2%) and 1.34% (95% CI, 1.2-1.51%) in the steroid users and non-users, respectively (P< 0.0001). The difference was evident in fracture-related arthroplasty with 1.89% (95% CI, 1.71-2.09%) versus 1.10% (95% CI, 0.97-1.25%), but more pronounced in fracture-unrelated surgery, 1.09% (95% CI, 0.95-1.24%) versus 0.24% (95% CI, 0.19-0.32%). Multivariate-adjusted Cox regression analysis confirmed steroid use was independently associated with both fracture-related (adjusted hazard ratio [HR], 1.65; 95% CI, 1.43-1.91) and unrelated arthroplasty (adjusted HR, 4.21; 95% CI, 3.2-5.53). Moreover, the risk for fracture-unrelated arthropathy rose with steroid dosage, as the adjusted HR increased from 3.30 (95% CI, 2.44-4.46) in the low-dose subgroup, 4.54 (95% CI, 3.05-6.77) in intermediate-dose users, to 6.54 (95% CI, 4.74-9.02) in the high-dose counterpart (P-trend<0.0001). Conclusions Corticosteroid use is associated with long-term risk of hip arthroplasty, particularly for fracture-unrelated arthropathy.	[Kao, Feng-Chen; Tu, Yuan-Kun] E Da Hosp, Dept Orthopaed, Kaohsiung, Taiwan; [Kao, Feng-Chen; Hsu, Yao-Chun; Tu, Yuan-Kun] I Shou Univ, Sch Med Int Students, Kaohsiung, Taiwan; [Hsu, Yao-Chun] E Da Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Hsu, Yao-Chun] E Da Hosp, Ctr Database Res, Kaohsiung, Taiwan; [Hsu, Yao-Chun] China Med Univ, Grad Inst Clin Med, Taichung, Taiwan; [Lin, Chien-Fu Jeff] Natl Taipei Univ, Dept Stat, Taipei, Taiwan; [Lin, Chien-Fu Jeff] Wan Fang Hosp, Dept Orthoped Surg, Taipei, Taiwan; [Lo, Ying-Ying] I Shou Univ, Dept Healthcare Adm, Kaohsiung, Taiwan	E-Da Hospital; I Shou University; E-Da Hospital; E-Da Hospital; China Medical University Taiwan; National Taipei University; Taipei Municipal WanFang Hospital; I Shou University	Tu, YK (corresponding author), E Da Hosp, Dept Orthopaed, Kaohsiung, Taiwan.; Hsu, YC; Tu, YK (corresponding author), I Shou Univ, Sch Med Int Students, Kaohsiung, Taiwan.; Hsu, YC (corresponding author), E Da Hosp, Dept Internal Med, Kaohsiung, Taiwan.; Hsu, YC (corresponding author), E Da Hosp, Ctr Database Res, Kaohsiung, Taiwan.; Hsu, YC (corresponding author), China Med Univ, Grad Inst Clin Med, Taichung, Taiwan.	holdenhsu@gamil.com; ed100130@edah.org.tw			Center for Database Research, E-Da Hospital [CFDR-B-103-1-1]	Center for Database Research, E-Da Hospital	The work was supported by the Center for Database Research, E-Da Hospital (CFDR-B-103-1-1).	Asano Takeshi, 2003, J Orthop Sci, V8, P329, DOI 10.1007/s10776-003-0646-7; Canalis E, 2007, OSTEOPOROSIS INT, V18, P1319, DOI 10.1007/s00198-007-0394-0; Colwell CW, 1996, ORTHOPEDICS, V19, P941; CRUESS RL, 1981, CAN J SURG, V24, P567; FISHER DE, 1971, J BONE JOINT SURG AM, VA 53, P859, DOI 10.2106/00004623-197153050-00002; Gebhard K L, 2001, Am J Clin Dermatol, V2, P377, DOI 10.2165/00128071-200102060-00004; GLIMCHER MJ, 1979, CLIN ORTHOP RELAT R, P273; GLIMCHER MJ, 1979, CLIN ORTHOP RELAT R, P284; GLIMCHER MJ, 1979, CLIN ORTHOP RELAT R, P283; HARRINGTON KD, 1971, J BONE JOINT SURG AM, VA 53, P203, DOI 10.2106/00004623-197153020-00001; Hsu YC, 2014, HEPATOLOGY, V59, P1293, DOI 10.1002/hep.26892; Hsu YC, 2012, HEPATOLOGY, V56, P698, DOI 10.1002/hep.25684; Hungeford DS, 2002, J ARTHROPLASTY, V17, P121, DOI 10.1054/arth.2002.33300; King KB, 2013, CLIN ORTHOP RELAT R, V471, P3049, DOI 10.1007/s11999-013-3026-3; Kubo T, 1998, TRANSPLANT P, V30, P3039, DOI 10.1016/S0041-1345(98)00920-8; LAUSTEN GS, 1988, ACTA ORTHOP SCAND, V59, P650, DOI 10.3109/17453678809149417; MCNATT LG, 1992, J STEROID BIOCHEM, V42, P687, DOI 10.1016/0960-0760(92)90109-V; Mirzai R, 1999, J ASTHMA, V36, P77, DOI 10.3109/02770909909065152; MONT MA, 1995, J BONE JOINT SURG AM, V77A, P459, DOI 10.2106/00004623-199503000-00018; O'Brien CA, 2004, ENDOCRINOLOGY, V145, P1835, DOI 10.1210/en.2003-0990; Powell ET, 1997, CLIN ORTHOP RELAT R, P181; Russell LA, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0371-x; Sakamoto M, 1997, J BONE JOINT SURG BR, V79B, P213, DOI 10.1302/0301-620X.79B2.7179; SAMBROOK PN, 1984, J RHEUMATOL, V11, P514; Solaymani-Dodaran M, 2006, GASTROENTEROLOGY, V131, P1752, DOI 10.1053/j.gastro.2006.09.012; SOLOMON L, 1981, CAN J SURG, V24, P573; Steinbuch M, 2004, OSTEOPOROSIS INT, V15, P323, DOI 10.1007/s00198-003-1548-3; Van Staa TP, 2003, ARTHRITIS RHEUM, V48, P3224, DOI 10.1002/art.11283; van Staa TP, 2002, OSTEOPOROSIS INT, V13, P777, DOI 10.1007/s001980200108; VREDEN SGS, 1991, NETH J MED, V39, P153; WANG GJ, 1977, J BONE JOINT SURG AM, V59, P729, DOI 10.2106/00004623-197759060-00003; WANG GJ, 1978, CLIN ORTHOP RELAT R, P81; Weinstein RS, 2011, NEW ENGL J MED, V365, P62, DOI 10.1056/NEJMcp1012926; Weinstein RS, 2010, AGING CELL, V9, P147, DOI 10.1111/j.1474-9726.2009.00545.x; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799	35	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0169468	10.1371/journal.pone.0169468	http://dx.doi.org/10.1371/journal.pone.0169468			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125643	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100139
J	Yang, C; Wang, Y; Xu, H				Yang, Chen; Wang, Yan; Xu, Hui			Fluoride Regulate Osteoblastic Transforming Growth Factor-beta 1 Signaling by Mediating Recycling of the Type I Receptor ALK5	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MESENCHYMAL STEM-CELLS; BONE-FORMATION; TGF-BETA; DIFFERENTIATION; EXPRESSION; PROTEIN; PATHWAYS; TURNOVER; RUNX2	This study aimed to preliminary investigate the role of activin receptor-like kinase (ALK) 5 as one of TGF-beta R1 subtypes in bone turnover and osteoblastic differentiation induced by fluoride. We analyzed bone mineral density and the expression of genes related with transforming growth factor-beta 1(TGF-beta 1) signaling and bone turnover in rats treated by different concentrations of fluoride with or without SB431542 in vivo. Moreover, MTT assay, alkaline phosphatase staining, RT-PCR, immunocytochemical analysis and western blot analysis were used to detect the influence on bone marrow stem cells (BMSC) after stimulating by varying concentration of fluoride with or without SB431542 in vitro. The in vivo study showed SB431542 treatment affected bone density and gene expression of rats, which indicated TGF-beta 1 and ALK5 might take part in fluoride-induced bone turnover and bone formation. The in vitro study showed low concentration of fluoride improved BMSC cells viability, alkaline phosphatase activity, and osteocalcin protein expression which were inhibited by high concentration of fluoride. The gene expression of Runx2 and ALK5 in cells increased after low concentration fluoride treatment which was also inhibited by high concentration of fluoride. Fluoride treatment inhibited gene and protein expression of Samd3 (except 1 mgF(-)/L). Compared with fluoride treatment alone, cells differentiation was inhibited with SB431542 treatment. Moreover, the expression of Runx2, ALK5 and Smad3 were influenced by SB431542 treatment. In conclusion, this preliminary study indicated that fluoride regulated osteoblastic TGF beta 1 signaling in bone turnover and cells differentiation via ALK5.	[Yang, Chen; Wang, Yan; Xu, Hui] Jilin Univ, Sch Pharmaceut Sci, Changchun, Peoples R China	Jilin University	Xu, H (corresponding author), Jilin Univ, Sch Pharmaceut Sci, Changchun, Peoples R China.	huixujilin@163.com			National Natural Science Foundation of China [81673111]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant for skeletal fluorosis research from National Natural Science Foundation of China (81673111).	Anastasilakis AD, 2015, METABOLISM, V64, P1291, DOI 10.1016/j.metabol.2015.06.018; Birmingham E, 2012, EUR CELLS MATER, V23, P13, DOI 10.22203/eCM.v023a02; Callahan JF, 2002, J MED CHEM, V45, P999, DOI 10.1021/jm010493y; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Driver J, 2015, J BIOL CHEM, V290, P9959, DOI 10.1074/jbc.M114.616888; Ehnert S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014073; Fang J, 2016, HISTOL HISTOPATHOL, V31, P1161, DOI 10.14670/HH-11-779; Hu Zhen-Yu, 2012, J ORAL MAXILLOFACIAL; KHOKHER MA, 1990, METABOLISM, V39, P1118, DOI 10.1016/0026-0495(90)90081-M; Lai CH, 2014, EVID-BASED COMPL ALT, V2014; Lee KS, 2002, ONCOGENE, V21, P7156, DOI 10.1038/sj.onc.1205937; Li XN, 2014, BIOL TRACE ELEM RES, V158, P113, DOI 10.1007/s12011-014-9897-7; Liu QY, 2016, BIOL TRACE ELEM RES, V171, P380, DOI 10.1007/s12011-015-0555-5; Miles FL, 2015, PROSTATE, V75, P1802, DOI 10.1002/pros.23060; Mohapatra M, 2009, J ENVIRON MANAGE, V91, P67, DOI 10.1016/j.jenvman.2009.08.015; Mousny M, 2008, BONE, V43, P1067, DOI 10.1016/j.bone.2008.07.248; Murakami T, 1998, BIOCHEM BIOPH RES CO, V252, P747, DOI 10.1006/bbrc.1998.9723; Oshimori N, 2012, CELL STEM CELL, V11, P751, DOI 10.1016/j.stem.2012.11.001; Pei J.R., 2012, ENVIRON TOXICOL, V29, P588, DOI DOI 10.1002/T0X.21784; Perumal E, 2013, TOXICOL LETT, V223, P236, DOI 10.1016/j.toxlet.2013.09.005; Quinn JMW, 2001, J BONE MINER RES, V16, P1787, DOI 10.1359/jbmr.2001.16.10.1787; Rodriguez JP, 2001, J CELL BIOCHEM, V83, P607, DOI 10.1002/jcb.1255; Sang Zhi-Cheng, 2010, Zhongguo Gu Shang, V23, P379; Selvamurugan N, 2004, J BIOL CHEM, V279, P19327, DOI 10.1074/jbc.M314048200; Song Yu-e, 2011, Environmental Health and Preventive Medicine, V16, P158, DOI 10.1007/s12199-010-0181-y; Sugiyama K, 2008, CANCER SCI, V99, P1021, DOI 10.1111/j.1349-7006.2008.00761.x; Sun F, 2014, TOXICOLOGY, V325, P52, DOI 10.1016/j.tox.2014.07.006; Suzuki M, 2014, J DENT RES, V93, P1022, DOI 10.1177/0022034514545629; Xu H, 2010, TOXICOLOGY, V277, P1, DOI 10.1016/j.tox.2010.08.006; Yang C, 2015, BIOL TRACE ELEM RES, V168, P453, DOI 10.1007/s12011-015-0374-8	30	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170674	10.1371/journal.pone.0170674	http://dx.doi.org/10.1371/journal.pone.0170674			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125630	Green Published, gold, Green Submitted			2022-12-26	WOS:000396176100077
J	Li, SH; Li, P; Gong, HH; Jiang, F; Liu, D; Cai, FQ; Pei, CG; Zhou, FQ; Zeng, XJ				Li, Shenghong; Li, Ping; Gong, Honghan; Jiang, Fei; Liu, Dan; Cai, Fengqin; Pei, Chonggang; Zhou, Fuqing; Zeng, Xianjun			Intrinsic Functional Connectivity Alterations of the Primary Visual Cortex in Primary AngleClosure Glaucoma Patients before and after Surgery: A Resting-State fMRI Study	PLOS ONE			English	Article							ANGLE-CLOSURE GLAUCOMA; LATERAL GENICULATE-NUCLEUS; GANGLION-CELL LOSS; OPTIC-NERVE; DEFAULT; ATROPHY	Purpose To investigate the altered intrinsic functional connectivity (iFC) of the primary visual cortex (V1) in primary angle-closure glaucoma (PACG) patients before and after surgery using resting-state functional MRI. Materials and Methods Twenty-five preoperative PACG (pre-PACG) patients and 25 well-matched healthy controls (HCs) were included in this study, and 9 PACG patients were assessed again at least 3 months after treatment (post-PACG). We generated the iFC maps of the seed regions in the centers of the left and right V1 and conducted group comparisons. Then, the relationships between the altered iFC coefficients and clinical variables were investigated in the prePACG patients. Results Compared with the HCs, the pre-PACG patients showed decreased iFC between the left V1 and right V2 (covering the cuneus, calcarine and lingual gyrus) and increased iFC between the left V1 and left temporal-parietal region, left frontal opercula-insula-basal ganglia region, right insula-basal ganglia region, and right inferior parietal lobule (P < 0.01, corrected). Compared with the pre-PACG patients, the post-PACG patients showed increased iFC between the left V1 and bilateral V2, and between the left V1 and left or right postcentral gyrus; in addition, they showed decreased iFC between the left V1 and the dorsal-attention and frontoparietal-control networks. In the pre-PACG patients, visual activity (VA) was positively correlated with increased iFC between the left V1 and the left temporal-parietal region or theright inferior parietal lobule. Similar patterns of alterations were observed in the right V1-iFC in both the pre-and post-PACG patients. Conclusions The primary findings have demonstrated a gradual decrease in visual information integration in the left V1-V2 pathway and VA-related functional compensation in the pre-PACG patients, generating further evidence of functional restoration in post-PACG patients.	[Li, Shenghong; Li, Ping; Gong, Honghan; Jiang, Fei; Liu, Dan; Cai, Fengqin; Zhou, Fuqing; Zeng, Xianjun] Nanchang Univ, Affiliated Hosp 1, Dept Radiol, Nanchang, Jiangxi, Peoples R China; [Gong, Honghan; Zhou, Fuqing; Zeng, Xianjun] Jiangxi Prov Med Imaging Res Inst, Nanchang, Jiangxi, Peoples R China; [Pei, Chonggang] Nanchang Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanchang, Jiangxi, Peoples R China	Nanchang University; Nanchang University	Zhou, FQ; Zeng, XJ (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Radiol, Nanchang, Jiangxi, Peoples R China.; Zhou, FQ; Zeng, XJ (corresponding author), Jiangxi Prov Med Imaging Res Inst, Nanchang, Jiangxi, Peoples R China.	fq.chou@yahoo.com; xianjun-zeng@126.com			National Natural Science Foundation of China [81360219]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant No. 81360219). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann O, 2015, CEREBELLUM, V14, P197, DOI 10.1007/s12311-014-0627-7; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Cai FQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141389; Chadick JZ, 2011, NAT NEUROSCI, V14, P830, DOI 10.1038/nn.2823; Cheng JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103222; Dai H, 2013, HUM BRAIN MAPP, V34, P2455, DOI 10.1002/hbm.22079; Desatnik H, 1996, J GLAUCOMA, V5, P46; Ding K, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/612086; Duncan RO, 2012, VISION RES, V60, P51, DOI 10.1016/j.visres.2012.03.012; Foster PJ, 2001, BRIT J OPHTHALMOL, V85, P1277, DOI 10.1136/bjo.85.11.1277; Frezzotti P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105931; Gazzard G, 2002, ARCH OPHTHALMOL-CHIC, V120, P1636; Gerente VM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126362; Gupta N, 2006, BRIT J OPHTHALMOL, V90, P674, DOI 10.1136/bjo.2005.086769; Gupta N, 2009, BRIT J OPHTHALMOL, V93, P56, DOI 10.1136/bjo.2008.138172; Hah MH, 2012, INT J OPHTHALMOL-CHI, V5, P384, DOI 10.3980/j.issn.2222-3959.2012.03.26; Harmelech T, 2015, J NEUROSCI, V35, P2588, DOI 10.1523/JNEUROSCI.3098-14.2015; Holcombe DJ, 2008, BRIT J OPHTHALMOL, V92, P683, DOI 10.1136/bjo.2007.133223; Ito Y, 2009, EXP EYE RES, V89, P246, DOI 10.1016/j.exer.2009.03.013; Jann K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012945; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Lee PJ, 2010, AM J OPHTHALMOL, V149, P817, DOI 10.1016/j.ajo.2009.12.007; Li T, 2015, INVEST OPHTH VIS SCI, V56, P322, DOI 10.1167/iovs.14-14974; Marchini J, 2004, NEUROIMAGE, V22, P1203, DOI 10.1016/j.neuroimage.2004.03.030; Morgan JE, 2000, BRIT J OPHTHALMOL, V84, P303, DOI 10.1136/bjo.84.3.303; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Sato JR, 2015, NEUROIMAGE, V104, P44, DOI 10.1016/j.neuroimage.2014.09.063; Song YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089493; Tillikainen L, 2006, NEUROIMAGE, V32, P654, DOI 10.1016/j.neuroimage.2006.03.058; Uchida H, 1999, AM J OPHTHALMOL, V127, P121, DOI 10.1016/S0002-9394(98)00318-3; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Wang K, 2008, CEREB CORTEX, V18, P697, DOI 10.1093/cercor/bhm105; Yan CG, 2016, NEUROINFORMATICS, V14, P339, DOI 10.1007/s12021-016-9299-4; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zhang QJ, 2015, INT J OPHTHALMOL-CHI, V8, P975, DOI 10.3980/j.issn.2222-3959.2015.05.22; Zhang Y., 2013, MATH PROB ENG, V2013, DOI DOI 10.4018/JIIT.2013010101	37	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e170598	10.1371/journal.pone.0170598	http://dx.doi.org/10.1371/journal.pone.0170598			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122025	Green Submitted, gold, Green Published			2022-12-26	WOS:000396167300036
J	Marsden, AE; Grudzinski, K; Ondrey, JM; DeLoney-Marino, CR; Visick, KL				Marsden, Anne E.; Grudzinski, Kevin; Ondrey, Jakob M.; DeLoney-Marino, Cindy R.; Visick, Karen L.			Impact of Salt and Nutrient Content on Biofilm Formation by Vibrio fischeri	PLOS ONE			English	Article							SYMBIOTIC COLONIZATION; RESPONSE REGULATOR; HOST COLONIZATION; LIGHT ORGAN; MOTILITY; GENES; POLYSACCHARIDE; IDENTIFICATION; FLAGELLATION; UPSTREAM	Vibrio fischeri, a marine bacterium and symbiont of the Hawaiian bobtail squid Euprymna scolopes, depends on biofilm formation for successful colonization of the squid's symbiotic light organ. Here, we investigated if culture conditions, such as nutrient and salt availability, affect biofilm formation by V. fischeri by testing the formation of wrinkled colonies on solid media. We found that V. fischeri forms colonies with more substantial wrinkling when grown on the nutrient-dense LBS medium containing NaCl relative to those formed on the more nutrient-poor, seawater-salt containing SWT medium. The presence of both tryptone and yeast extract was necessary for the production of "normal" wrinkled colonies; when grown on tryptone alone, the colonies displayed a divoting phenotype and were attached to the agar surface. We also found that the type and concentration of specific seawater salts influenced the timing of biofilm formation. Of the conditions assayed, wrinkled colony formation occurred earliest in LBS(-Tris) media containing 425 mM NaCl, 35 mM MgSO4, and 5 mM CaCl2. Pellicle formation, another measure of biofilm development, was also enhanced in these growth conditions. Therefore, both nutrient and salt availability contribute to V. fischeri biofilm formation. While growth was unaffected, these optimized conditions resulted in increased syp locus expression as measured by a PsypA-lacZ transcriptional reporter. We anticipate these studies will help us understand how the natural environment of V. fischeri affects its ability to form biofilms and, ultimately, colonize E. scolopes.	[Marsden, Anne E.; Grudzinski, Kevin; Ondrey, Jakob M.; Visick, Karen L.] Loyola Univ Chicago, Dept Microbiol & Immunol, Maywood, IL 60153 USA; [DeLoney-Marino, Cindy R.] Univ Southern Indiana, Dept Biol, 8600 Univ Blvd, Evansville, IN 47712 USA; [Grudzinski, Kevin] Loyola Univ Chicago, Dept Cell & Mol Physiol, Maywood, IL USA; [Ondrey, Jakob M.] Lurie Childrens Hosp Chicago, Special Infect Dis Sect, Chicago, IL USA	Loyola University Chicago; Loyola University Chicago; Ann & Robert H. Lurie Children's Hospital of Chicago	Visick, KL (corresponding author), Loyola Univ Chicago, Dept Microbiol & Immunol, Maywood, IL 60153 USA.	kvisick@luc.edu		Visick, Karen/0000-0002-2400-2591	NIH [R01 GM114288]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059690, R01GM114288] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant R01 GM114288 awarded to KLV. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augimeri RV, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01282; Bassis CM, 2010, J BACTERIOL, V192, P1269, DOI 10.1128/JB.01048-09; Bilecen K, 2009, ENVIRON MICROBIOL, V11, P2015, DOI 10.1111/j.1462-2920.2009.01923.x; BOETTCHER KJ, 1990, J BACTERIOL, V172, P3701, DOI 10.1128/jb.172.7.3701-3706.1990; Bogino PC, 2013, INT J MOL SCI, V14, P15838, DOI 10.3390/ijms140815838; Brooks JF, 2016, J BACTERIOL; Darnell CL, 2008, J BACTERIOL, V190, P4941, DOI 10.1128/JB.00197-08; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Geszvain K, 2008, J BACTERIOL, V190, P4437, DOI 10.1128/JB.00055-08; GRAF J, 1994, J BACTERIOL, V176, P6986, DOI 10.1128/JB.176.22.6986-6991.1994; Hussa EA, 2008, J BACTERIOL, V190, P4576, DOI 10.1128/JB.00130-08; Kierek K, 2003, P NATL ACAD SCI USA, V100, P14357, DOI 10.1073/pnas.2334614100; Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185; Le Roux F, 2007, APPL ENVIRON MICROB, V73, P777, DOI 10.1128/AEM.02147-06; Mangwani N, 2014, COLLOID SURFACE B, V114, P301, DOI 10.1016/j.colsurfb.2013.10.003; Miller JH, 1972, EXPT MOL GENETICS, Vxvi; Morris AR, 2013, MOL MICROBIOL, V87, P509, DOI 10.1111/mmi.12109; Morris AR, 2011, MOL MICROBIOL, V82, P114, DOI 10.1111/j.1365-2958.2011.07800.x; Norsworthy AN, 2015, MOL MICROBIOL, V96, P233, DOI 10.1111/mmi.12932; Nyholm SV, 2000, P NATL ACAD SCI USA, V97, P10231, DOI 10.1073/pnas.97.18.10231; O'Shea TM, 2006, J BACTERIOL, V188, P8196, DOI 10.1128/JB.00728-06; O'Shea TM, 2005, J BACTERIOL, V187, P2058, DOI 10.1128/JB.187.6.2058-2065.2005; Olsen I, 2015, EUR J CLIN MICROBIOL, V34, P877, DOI 10.1007/s10096-015-2323-z; Park JH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005192; Parker JK, 2016, ENVIRON MICROBIOL, V18, P1620, DOI 10.1111/1462-2920.13242; Pilson M.E.Q., 2013, INTRO CHEM SEA, Vsecond, P248, DOI [10.5670/oceanog.2014.31, DOI 10.5670/OCEANOG.2014.31]; Ray VA, 2015, J BACTERIOL, V197, P518, DOI 10.1128/JB.02292-14; Ray VA, 2012, MOL MICROBIOL, V86, P954, DOI 10.1111/mmi.12035; Ray VA, 2012, JOVE-J VIS EXP, DOI 10.3791/4035; RUBY EG, 1993, ARCH MICROBIOL, V159, P160, DOI 10.1007/BF00250277; Shibata S, 2012, J BACTERIOL, V194, P6736, DOI 10.1128/JB.00707-12; Singh P, 2015, APPL ENVIRON MICROB, V81, P5223, DOI 10.1128/AEM.00157-15; Stabb EV, 2002, METHOD ENZYMOL, V358, P413; Stabb EV, 2001, J BACTERIOL, V183, P309, DOI 10.1128/JB.183.1.309-317.2001; Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200; Thompson CM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00760; Visick KL, 2001, J BACTERIOL, V183, P835, DOI 10.1128/JB.183.3.835-842.2001; Williams TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114376; Yildiz FH, 2009, TRENDS MICROBIOL, V17, P109, DOI 10.1016/j.tim.2008.12.004; Yip ES, 2006, MOL MICROBIOL, V62, P1586, DOI 10.1111/j.1365-2958.2006.05475.x; Yip ES, 2005, MOL MICROBIOL, V57, P1485, DOI 10.1111/j.1365-2958.2005.04784.x	41	29	29	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0169521	10.1371/journal.pone.0169521	http://dx.doi.org/10.1371/journal.pone.0169521			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122010	gold, Green Submitted, Green Published			2022-12-26	WOS:000396167300074
J	Jang, MA; Lee, SJ; Baek, SE; Park, SY; Choi, YW; Kim, CD				Jang, Min A.; Lee, Seung Jin; Baek, Seung Eun; Park, So Youn; Choi, Young Whan; Kim, Chi Dae			alpha-Iso-Cubebene Inhibits PDGF-Induced Vascular Smooth Muscle Cell Proliferation by Suppressing Osteopontin Expression	PLOS ONE			English	Article							SCHISANDRA-CHINENSIS; UP-REGULATION; MIGRATION; DIFFERENTIATION; RELAXATION; PHENOTYPE; INCREASE; RECEPTOR; EXTRACT; GOMISIN	alpha-Iso-cubebene (ICB) is a dibenzocyclooctadiene lignin contained in Schisandra chinensis (SC), a well-known medicinal herb that ameliorates cardiovascular symptoms. Thus, we examined the effect of ICB on vascular smooth muscle cell (VSMC) proliferation, a key feature of diverse vascular diseases. When VSMCs primary cultured from rat thoracic aorta were stimulated with PDGF (1-10 ng/ml), cell proliferation and osteopontin (OPN) expression were concomitantly up-regulated, but these effects were attenuated when cells were treated with MPIIIB10, a neutralizing monoclonal antibody for OPN. In aortic tissues exposed to PDGF, sprouting VSMC numbers increased, which was attenuated in tissues from OPN-deficient mice. Furthermore, VSMC proliferation and OPN expression induced by PDGF were attenuated dose-dependently by ICB (10 or 30 mu g/ml). Reporter assays conducted using OPN promoter-luciferase constructs showed that the promoter region 538-234 bp of the transcription start site was responsible for transcriptional activity enhancement by PDGF, which was significantly inhibited by ICB. Putative binding sites for AP-1 and C/EBP beta in the indicated promoter region were suggested by TF Search, and increased binding of AP-1 and C/EBPa in PDGF-treated VSMCs was demonstrated using a ChIP assay. The increased bindings of AP-1 and C/EBP into OPN promoter were attenuated by ICB. Moreover, the PDGF-induced expression of OPN was markedly attenuated in VSMCs transfected with siRNA for AP-1 and C/EBP beta. These results indicate that ICB inhibit VSMC proliferation by inhibiting the AP-1 and C/EBP beta signaling pathways and thus downregulating OPN expression.	[Jang, Min A.; Baek, Seung Eun; Park, So Youn; Kim, Chi Dae] Pusan Natl Univ, Sch Med, Dept Pharmacol, Gyeongnam, South Korea; [Jang, Min A.; Baek, Seung Eun; Park, So Youn; Kim, Chi Dae] Pusan Natl Univ, Gene & Cell Therapy Res Ctr Vessel Associated Dis, Gyeongnam, South Korea; [Lee, Seung Jin] Pusan Natl Univ, Coll Pharm, Busan, South Korea; [Choi, Young Whan] Pusan Natl Univ, Coll Nat Resources & Life Sci, Gyeongnam, South Korea	Pusan National University; Pusan National University; Pusan National University; Pusan National University	Kim, CD (corresponding author), Pusan Natl Univ, Sch Med, Dept Pharmacol, Gyeongnam, South Korea.; Kim, CD (corresponding author), Pusan Natl Univ, Gene & Cell Therapy Res Ctr Vessel Associated Dis, Gyeongnam, South Korea.	chidkim@pusan.ac.kr	Choi, Young-Whan/AAO-4826-2021		Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning [NRF-2013R1A2A2A01067921, NRF-2016R1A2B2011509]; Medical Research Center (MRC) Program through the NRF - Korea government (MSIP) [NRF-2015R1A5A2009656]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning; Medical Research Center (MRC) Program through the NRF - Korea government (MSIP)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (NRF-2013R1A2A2A01067921 & NRF-2016R1A2B2011509). This work was also supported by the Medical Research Center (MRC) Program through the NRF grant funded by the Korea government (MSIP) (NRF-2015R1A5A2009656).	Branchetti E, 2013, CARDIOVASC RES, V100, P316, DOI 10.1093/cvr/cvt205; Bras LED, 2015, J MOL CELL CARDIOL, V85, P151, DOI 10.1016/j.yjmcc.2015.05.020; Brown XQ, 2010, J CELL PHYSIOL, V225, P115, DOI 10.1002/jcp.22202; Chen K, 1993, J Tradit Chin Med, V13, P223; Chistiakov DA, 2015, ACTA PHYSIOL, V214, P33, DOI 10.1111/apha.12466; Choi YW, 2006, J NAT PROD, V69, P356, DOI 10.1021/np0503707; Davis-Dusenbery BN, 2011, ARTERIOSCL THROM VAS, V31, P2370, DOI 10.1161/ATVBAHA.111.226670; Dong LH, 2010, CELL RES, V20, P1252, DOI 10.1038/cr.2010.111; Gao H, 2012, CELL BIOL INT, V36, P155, DOI 10.1042/CBI20100240; Gluba-Brzozka A, 2014, LIPIDS HLTH DIS, V135, P1; Huang SX, 2007, ORG LETT, V9, P2079, DOI 10.1021/ol070510z; Huby AC, 2014, J AM COLL CARDIOL, V64, P2765, DOI 10.1016/j.jacc.2014.09.071; Johnson JL, 2014, CARDIOVASC RES, V103, P452, DOI 10.1093/cvr/cvu171; Kiyan Y, 2012, ARTERIOSCL THROM VAS, V32, P110, DOI 10.1161/ATVBAHA.111.234369; Lacolley P, 2012, CARDIOVASC RES, V95, P194, DOI 10.1093/cvr/cvs135; Land WG, 2013, TRANSFUS MED HEMOTH, V40, P3, DOI 10.1159/000345688; Lee SJ, 2016, PHARMACOL RES, V108, P1, DOI 10.1016/j.phrs.2016.03.041; Lee YJ, 2009, BIOCHEM BIOPH RES CO, V379, P928, DOI 10.1016/j.bbrc.2008.12.174; Li JJ, 2007, BIOCHEM BIOPH RES CO, V356, P13, DOI 10.1016/j.bbrc.2007.02.092; Liu J, 2014, INT J MOL MED, V33, P1341, DOI 10.3892/ijmm.2014.1681; Lu Y, 2009, J CHROMATOGR A, V1216, P1980, DOI 10.1016/j.chroma.2008.09.070; Marx SO, 2011, CIRC-CARDIOVASC INTE, V4, P104, DOI 10.1161/CIRCINTERVENTIONS.110.957332; Millette E, 2005, CIRC RES, V96, P172, DOI 10.1161/01.RES.0000154595.87608.db; Moharnadpour AH, 2015, ARCH MED RES, V46, P112, DOI 10.1016/j.arcmed.2015.02.005; Mu Y, 2006, J PHARMACOL EXP THER, V316, P1369, DOI 10.1124/jpet.105.094342; Panda D, 1997, P NATL ACAD SCI USA, V94, P9308, DOI 10.1073/pnas.94.17.9308; Park JY, 2012, HYPERTENS RES, V35, P928, DOI 10.1038/hr.2012.50; Park JY, 2012, VASC PHARMACOL, V57, P124, DOI 10.1016/j.vph.2012.06.002; Park JY, 2009, J ETHNOPHARMACOL, V121, P69, DOI 10.1016/j.jep.2008.09.031; Qiu ZB, 2012, PHARMAZIE, V67, P553, DOI 10.1691/ph.2012.1123; Remus EW, 2013, ATHEROSCLEROSIS, V228, P168, DOI 10.1016/j.atherosclerosis.2013.01.037; Renault MA, 2005, J BIOL CHEM, V280, P2708, DOI 10.1074/jbc.M411786200; Rhyu MR, 2006, PHYTOMEDICINE, V13, P651, DOI 10.1016/j.phymed.2006.02.003; Schwencke C, 2005, CARDIOVASC RES, V68, P128, DOI 10.1016/j.cardiores.2005.05.004; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shi N, 2016, J CELL PHYSIOL, V231, P777, DOI 10.1002/jcp.25208; Spin JM, 2012, CARDIOVASC RES, V95, P147, DOI 10.1093/cvr/cvs098; Wolak T, 2014, ATHEROSCLEROSIS, V236, P327, DOI 10.1016/j.atherosclerosis.2014.07.004; Xu J, 2013, IEEE VEHICLE POWER, P1; Yoo SH, 2013, VASC PHARMACOL, V59, P44, DOI 10.1016/j.vph.2013.06.003; You Jyh-Sheng, 2006, Chang Gung Med J, V29, P63; Zheng Y, 2011, ARTERIOSCL THROM VAS, V31, P2781, DOI 10.1161/ATVBAHA.111.224907	42	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170699	10.1371/journal.pone.0170699	http://dx.doi.org/10.1371/journal.pone.0170699			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114367	Green Published, Green Submitted, gold			2022-12-26	WOS:000396129000085
J	Ma, L; Wang, XM; Bi, XY; Yang, JZ; Shi, B; He, XY; Ma, R; Ma, QQ; Yao, XS				Ma, Long; Wang, Xiaomei; Bi, Xiaoying; Yang, Jiezuan; Shi, Bin; He, Xiaoyan; Ma, Rui; Ma, Qingqing; Yao, Xinsheng			Characteristics Peripheral Blood IgG and IgM Heavy Chain Complementarity Determining Region 3 Repertoire before and after Immunization with Recombinant HBV Vaccine	PLOS ONE			English	Article							HEPATITIS-B VACCINATION; VIRUS SURFACE-ANTIGEN; MONOCLONAL-ANTIBODY; CELL; DIVERSITY; INFECTION; SEQUENCES; DYNAMICS; FRAGMENT; LIBRARY	Immunization with recombinant HBV vaccine induces specific immune responses in human causing B lymphocytes to produce protective HBsAb, and to form memory B lymphocytes, thereby facilitating HBV immunity in the body. However, B lymphocytes heterogeneity and characteristics are not fully elucidated. In this study, we conducted high-throughput sequencing of BCR heavy chain CDR3 repertoires in 3 healthy volunteers before and after the third immunization with recombinant HBV vaccine. We used Roche 454 Genome Sequencer FLX system to perform a comparative analysis of IgM and IgG H chain CDR3 repertoires. First, we found that the diversity of IgG H chain CDR3 repertoires was 1/6 of IgM on average. Moreover, after the third immunization with HBV vaccine, the diversity of IgG H chain CDR3 repertoires was 1/26 of IgM on average. Second, we detected relatively high levels of HBsAbs in all the healthy volunteers after immunization with HBV vaccine. The volunteers shared a small number of CDR3 sequences before and after immunization, and among each other. However, we did not find completely identical BCR H chain CDR3 amino acid sequences in these volunteers. Lastly, after immunization with recombinant HBV vaccine, the volunteers showed high frequency of IgG H chain CDR3 amino acid sequences mostly resulting from rearrangements of IGHV, IGHD and IGHJ, suggesting that the mechanism of high frequency CDR3 generation might be associated with the maturation of IgG affinity (somatic hypermutation) during the recombinant HBV vaccine-induced B lymphocyte responses. This study identified the characteristics and changes of BCR CDR3 repertoires before and after immunization with HBV vaccine, and evaluated the performance of the sequencing technology for this application. Our findings provide a basis for further research in B lymphocyte generated HBsAb heterogeneity and monitoring the maintenance of memory B lymphocytes.	[Ma, Long; Bi, Xiaoying; He, Xiaoyan; Ma, Rui; Ma, Qingqing; Yao, Xinsheng] Zunyi Med Univ, Dept Immunol, Res Ctr Med & Biol Innovat & Practice Base Grad S, Zunyi, Guizhou, Peoples R China; [Wang, Xiaomei] Hunan Univ Chinese Med, Hosp 1, Changsha, Hunan, Peoples R China; [Yang, Jiezuan] Zhejiang Univ, Affiliated Hosp 1, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Diag & Treatment Infect Dis,Coll Me, Hangzhou, Zhejiang, Peoples R China; [Shi, Bin] Zunyi Med Univ, Dept Lab Med, Zunyi, Guizhou, Peoples R China	Zunyi Medical University; Hunan University of Chinese Medicine; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Zunyi Medical University	Yao, XS (corresponding author), Zunyi Med Univ, Dept Immunol, Res Ctr Med & Biol Innovat & Practice Base Grad S, Zunyi, Guizhou, Peoples R China.; Yang, JZ (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Diag & Treatment Infect Dis,Coll Me, Hangzhou, Zhejiang, Peoples R China.	Yangsea117@126.com; immunology01@126.com			National Prophase Project on Basic Research of China (973pre-Program) [2008CB517310]; National Natural Science Foundation of China [31160195, 81441048]; Education Department of Hunan province [13C688]	National Prophase Project on Basic Research of China (973pre-Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Department of Hunan province	This study was supported by grants from the National Prophase Project on Basic Research of China (973pre-Program, 2008CB517310), the National Natural Science Foundation of China (31160195&81441048) and the Education Department of Hunan province (13C688).	Ada G, 2001, NEW ENGL J MED, V345, P1042, DOI 10.1056/NEJMra011223; Arnaout R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022365; Bose B, 2003, MOL IMMUNOL, V40, P617, DOI 10.1016/j.molimm.2003.07.002; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Chang YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep26556; Doorenspleet ME, 2014, ANN RHEUM DIS, V73, P756, DOI 10.1136/annrheumdis-2012-202861; Galson JD, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0322-z; Galson JD, 2015, EBIOMEDICINE, V2, P2070, DOI 10.1016/j.ebiom.2015.11.034; Galson JD, 2014, TRENDS IMMUNOL, V35, P319, DOI 10.1016/j.it.2014.04.005; Glanville J, 2009, P NATL ACAD SCI USA, V106, P20216, DOI 10.1073/pnas.0909775106; Jiang N, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004794; Liang XF, 2013, VACCINE, V31, pJ21, DOI 10.1016/j.vaccine.2013.08.012; Maeda F, 1999, J MED VIROL, V58, P338, DOI 10.1002/(SICI)1096-9071(199908)58:4<338::AID-JMV4>3.0.CO;2-5; Maeda F, 2005, J VIROL METHODS, V127, P141, DOI 10.1016/j.jviromet.2005.03.018; Robinson WH, 2015, NAT REV RHEUMATOL, V11, P171, DOI 10.1038/nrrheum.2014.220; Tajiri K, 2010, ANTIVIR RES, V87, P40, DOI 10.1016/j.antiviral.2010.04.006; Truck J, 2015, J IMMUNOL, V194, P252, DOI 10.4049/jimmunol.1401405; van Heijst JWJ, 2013, NAT MED, V19, P372, DOI 10.1038/nm.3100; Venturi V, 2007, J IMMUNOL METHODS, V321, P182, DOI 10.1016/j.jim.2007.01.019; Wen WH, 2007, J VIRAL HEPATITIS, V14, P512, DOI 10.1111/j.1365-2893.2007.00843.x; Yang JZ, 2014, CELL MOL IMMUNOL, V11, P332, DOI 10.1038/cmi.2014.22; Yano A, 2004, J MED VIROL, V73, P208, DOI 10.1002/jmv.20077; Yao XS, 2006, HEPATOL RES, V35, P10, DOI 10.1016/j.hepres.2006.01.006; Zhang Jian-Lin, 2006, Hepatobiliary Pancreat Dis Int, V5, P237; Zhang Yao, 2013, Chin Med Sci J, V27, P243; Zuckerman JN, 2007, J MED VIROL, V79, P919, DOI 10.1002/jmv.20816	26	9	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170479	10.1371/journal.pone.0170479	http://dx.doi.org/10.1371/journal.pone.0170479			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114326	Green Submitted, Green Published, gold			2022-12-26	WOS:000396129000055
J	Maharana, J; Pradhan, SK; De, S				Maharana, Jitendra; Pradhan, Sukanta Kumar; De, Sachinandan			NOD1(CARD) Might Be Using Multiple Interfaces for RIP2-Mediated CARD-CARD Interaction: Insights from Molecular Dynamics Simulation	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; NOD1; PROTEINS; DIAGRAMS; IMMUNITY; BINDING	The nucleotide-binding and oligomerization domain (NOD)-containing protein 1 (NOD1) plays the pivotal role in host-pathogen interface of innate immunity and triggers immune signalling pathways for the maturation and release of pro-inflammatory cytokines. Upon the recognition of iE-DAP, NOD1 self-oligomerizes in an ATP-dependent fashion and interacts with adaptor molecule receptor-interacting protein 2 (RIP2) for the propagation of innate immune signalling and initiation of pro-inflammatory immune responses. This interaction (mediated by NOD1 and RIP2) helps in transmitting the downstream signals for the activation of NF-kappa B signalling pathway, and has been arbitrated by respective caspaserecruitment domains (CARDs). The so-called CARD-CARD interaction still remained contradictory due to inconsistent results. Henceforth, to understand the mode and the nature of the interaction, structural bioinformatics approaches were employed. MD simulation of modelled 1: 1 heterodimeric complexes revealed that the type-Ia interface of NOD1 CARD and the type-Ib interface of RIP2 CARD might be the suitable interfaces for the said interaction. Moreover, we perceived three dynamically stable heterotrimeric complexes with an NOD1: RIP2 ratio of 1: 2 (two numbers) and 2: 1. Out of which, in the first trimeric complex, a type-I NOD1-RIP2 heterodimer was found interacting with an RIP2(CARD) using their type-IIa and IIIa interfaces. However, in the second and third heterotrimer, we observed type-I homodimers of NOD1 and RIP2 CARDs were interacting individually with RIP2 CARD and NOD1 CARD (in type-II and type-III interface), respectively. Overall, this study provides structural and dynamic insights into the NOD1-RIP2 oligomer formation, which will be crucial in understanding the molecular basis of NOD1-mediated CARD-CARD interaction in higher and lower eukaryotes.	[Maharana, Jitendra; Pradhan, Sukanta Kumar] Orissa Univ Agr & Technol, Dept Bioinformat, Bhubaneswar, Odisha, India; [De, Sachinandan] ICAR Natl Dairy Res Inst, Anim Biotechnol Ctr, Anim Genom Lab, Karnal, Haryana, India	Orissa University of Agriculture & Technology; Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute	Maharana, J (corresponding author), Orissa Univ Agr & Technol, Dept Bioinformat, Bhubaneswar, Odisha, India.; De, S (corresponding author), ICAR Natl Dairy Res Inst, Anim Biotechnol Ctr, Anim Genom Lab, Karnal, Haryana, India.	jitued@gmail.com; sachinandan@gmail.com	Maharana, Jitendra/B-5210-2014	Maharana, Jitendra/0000-0003-4628-5956				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Boyle JP, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140178; Boyle JP, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00317; Bryant CE, 2015, PHARMACOL REV, V67, P462, DOI 10.1124/pr.114.009928; Fridh V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034375; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Heul AMV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104017; Hu Q, 2014, P NATL ACAD SCI USA, V111, P16254, DOI 10.1073/pnas.1418000111; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hysi P, 2005, HUM MOL GENET, V14, P935, DOI 10.1093/hmg/ddi087; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kara B, 2010, CLIN EXP MED, V10, P107, DOI 10.1007/s10238-009-0077-6; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Li ZK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127355; Lin Z, 2015, ELIFE, V4, DOI 10.7554/eLife.11692; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lu A, 2016, NAT STRUCT MOL BIOL, V23, P416, DOI 10.1038/nsmb.3199; Maharana J, 2015, MOL BIOSYST, V11, P2324, DOI 10.1039/c5mb00212e; Maharana J, 2014, J MOL RECOGNIT, V27, P260, DOI 10.1002/jmr.2357; Manon F, 2007, J MOL BIOL, V365, P160, DOI 10.1016/j.jmb.2006.09.067; Mayle S, 2014, J BIOL CHEM, V289, P22900, DOI 10.1074/jbc.M114.557900; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Proell M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002119; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Todd AE, 1999, PROTEIN ENG, V12, P375, DOI 10.1093/protein/12.5.375; Wagner RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004931; Weidinger S, 2005, J ALLERGY CLIN IMMUN, V116, P177, DOI 10.1016/j.jaci.2005.02.034; Wilmanski JM, 2008, J LEUKOCYTE BIOL, V83, P13, DOI 10.1189/jlb.0607402; Wu B, 2014, MOL CELL, V55, P511, DOI 10.1016/j.molcel.2014.06.010	36	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170232	10.1371/journal.pone.0170232	http://dx.doi.org/10.1371/journal.pone.0170232			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114344	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129000028
J	Huang, SW; Li, WY; Wang, WH; Lin, YT; Chou, CH; Chen, M; Huang, HD; Chen, YH; Lu, PL; Wang, SF; Oka, S; Chen, YMA				Huang, Szu-Wei; Li, Wei-You; Wang, Wen-Hung; Lin, Yu-Ting; Chou, Chih-Hung; Chen, Marcelo; Huang, Hsien-Da; Chen, Yen-Hsu; Lu, Po-Liang; Wang, Sheng-Fan; Oka, Shinichi; Chen, Yi-Ming Arthur			Characterization of the Drug Resistance Profiles of Patients Infected with CRF07_BC Using Phenotypic Assay and Ultra-Deep Pyrosequencing	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-1 SUBTYPE B; REVERSE-TRANSCRIPTASE; MOLECULAR EPIDEMIOLOGY; IN-VITRO; ANTIRETROVIRAL THERAPY; COMBINATION THERAPIES; CLINICAL-SIGNIFICANCE; REPLICATION CAPACITY; PROTEASE INHIBITORS	The usefulness of ultra-deep pyrosequencing (UDPS) for the diagnosis of HIV-1 drug resistance (DR) remains to be determined. Previously, we reported an explosive outbreak of HIV-1 circulating recombinant form (CRF) 07_BC among injection drug users (IDUs) in Taiwan in 2004. The goal of this study was to characterize the DR of CRF07_BC strains using different assays including UDPS. Seven CRF07_BC isolates including 4 from early epidemic (collected in 2004 - 2005) and 3 from late epidemic (collected in 2008) were obtained from treatment-naive patient's peripheral blood mononuclear cells. Viral RNA was extracted directly from patient's plasma or from cultural supernatant and the pol sequences were determined using RT-PCR sequencing or UDPS. For comparison, phenotypic drug susceptibility assay using MAGIC-5 cells (in-house phenotypic assay) and Antivirogram were performed. In-house phenotypic assay showed that all the early epidemic and none of the late epidemic CRF07_BC isolates were resistant to most protease inhibitors (PIs) (4.4 - 47.3 fold). Neither genotypic assay nor Antivirogram detected any DR mutations. UDPS showed that early epidemic isolates contained 0.01 +/- 0.08% of PI DR major mutations. Furthermore, the combinations of major and accessory PI DR mutations significantly correlated with the phenotypic DR. The in-house phenotypic assay is superior to other conventional phenotypic assays in the detection of DR variants with a frequency as low as 0.01%.	[Huang, Szu-Wei; Li, Wei-You; Wang, Wen-Hung; Lin, Yu-Ting; Chen, Yen-Hsu; Lu, Po-Liang; Wang, Sheng-Fan; Chen, Yi-Ming Arthur] Kaohsiung Med Univ, CICAR, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan; [Li, Wei-You; Chen, Yen-Hsu; Lu, Po-Liang; Chen, Yi-Ming Arthur] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan; [Wang, Wen-Hung] Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Chou, Chih-Hung; Huang, Hsien-Da] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Chen, Marcelo] Mackay Mem Hosp, Dept Urol, Taipei, Taiwan; [Chen, Marcelo] Mackay Jr Coll Med Nursing & Management, Dept Cosmet Applicat & Management, Taipei, Taiwan; [Chen, Marcelo] Mackay Med Coll, Sch Med, New Taipei, Taiwan; [Huang, Hsien-Da] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Chen, Yen-Hsu] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan; [Lu, Po-Liang] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan; [Lu, Po-Liang] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Wang, Sheng-Fan] Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Oka, Shinichi] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Oka, Shinichi] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Yang Ming Chiao Tung University; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; Mackay Medical College; National Yang Ming Chiao Tung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Center for Global Health & Medicine - Japan; Kumamoto University	Chen, YMA (corresponding author), Kaohsiung Med Univ, CICAR, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan.; Chen, YMA (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan.	arthur@kmu.edu.tw	Lu, Po-Liang/D-4499-2009; Huang, Szu-Wei/AAT-1998-2020; Wang, Sheng-Fan/ABA-7842-2020; Huang, Hsien-Da/AAA-7376-2019; HUANG, SZU-WEI/AAT-5153-2021; Chou, Chih-Hung/K-9077-2015	Lu, Po-Liang/0000-0002-7423-6783; Huang, Szu-Wei/0000-0002-3813-7737; Wang, Sheng-Fan/0000-0002-8142-4707; Chou, Chih-Hung/0000-0001-5714-1718; Wang, Sheng-Fan/0000-0002-4183-3872; Chen, Yen-hsu/0000-0002-8667-4844; Wang, Wen-Hung/0000-0002-4494-1123	Kaohsiung Medical University [KMU-TP104E01, KMU-TP104E02, KMU-TP104E03, KMU-TP104E04]	Kaohsiung Medical University	This study was funded by Kaohsiung Medical University, project no. KMU-TP104E01, KMU-TP104E02, KMU-TP104E03 and KMU-TP104E04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bally F, 2000, AIDS RES HUM RETROV, V16, P1209, DOI 10.1089/08892220050116970; Campbell TB, 2005, CLIN INFECT DIS, V41, P236, DOI 10.1086/430709; Chen YJ, 2010, JAIDS-J ACQ IMM DEF, V53, P425, DOI 10.1097/QAI.0b013e3181ccba1a; Chen YMA, 2007, LANCET, V369, P623, DOI 10.1016/S0140-6736(07)60291-8; Chen YMA, 2006, EMERG INFECT DIS, V12, P703, DOI 10.3201/eid1204.050762; Church JD, 2006, J MOL DIAGN, V8, P430, DOI 10.2353/jmoldx.2006.050148; Cong ME, 2007, J VIROL, V81, P3037, DOI 10.1128/JVI.02712-06; Dam E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000345; Egger M, 1997, BMJ-BRIT MED J, V315, P1194, DOI 10.1136/bmj.315.7117.1194; Fisher R, 2012, J VIROL, V86, P6231, DOI 10.1128/JVI.06541-11; Gonzalez LMF, 2004, ANTIMICROB AGENTS CH, V48, P3552, DOI 10.1128/AAC.48.9.3552-3555.2004; Gonzalez LMF, 2003, ANTIMICROB AGENTS CH, V47, P2817, DOI 10.1128/AAC.47.9.2817-2822.2003; Hachiya A, 2003, J VIROL METHODS, V111, P43, DOI 10.1016/S0166-0934(03)00150-2; Hachiya A, 2001, ANTIMICROB AGENTS CH, V45, P495, DOI 10.1128/AAC.45.2.495-501.2001; Hanna GJ, 2001, CLIN INFECT DIS, V32, P774, DOI 10.1086/319231; Harrigan PR, 2001, AIDS, V15, P1671, DOI 10.1097/00002030-200109070-00010; Hertogs K, 1998, ANTIMICROB AGENTS CH, V42, P269, DOI 10.1093/jac/42.2.269; Hogg RS, 2006, PLOS MED, V3, P1570, DOI 10.1371/journal.pmed.0030356; Holguin A, 2006, J CLIN VIROL, V36, P264, DOI 10.1016/j.jcv.2006.05.001; Huang SC, 2014, IEEE T FUZZY SYST, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0114441; Jain V, 2011, J INFECT DIS, V203, P1174, DOI 10.1093/infdis/jiq167; Johnson JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000638; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Lan YC, 2008, J MED VIROL, V80, P183, DOI 10.1002/jmv.21065; Li JZ, 2013, CLIN INFECT DIS, V56, P1667, DOI 10.1093/cid/cit125; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Lin YT, 2007, J INFECT DIS, V195, P1283, DOI 10.1086/513437; Lisovsky I, 2010, ANTIMICROB AGENTS CH, V54, P2878, DOI 10.1128/AAC.01828-09; Lyu SY, 2012, LANCET, V379, pE28, DOI 10.1016/S0140-6736(11)60786-1; Ma LY, 2007, JAIDS-J ACQ IMM DEF, V44, P14, DOI 10.1097/01.qai.0000243049.27580.cc; Maguire M, 2002, ANTIMICROB AGENTS CH, V46, P731, DOI 10.1128/AAC.46.3.731-738.2002; Martinez-Picado J, 1999, J VIROL, V73, P3744, DOI 10.1128/JVI.73.5.3744-3752.1999; Martinez-Picado J, 2008, VIRUS RES, V134, P104, DOI 10.1016/j.virusres.2007.12.021; Metzner KJ, 2003, J INFECT DIS, V188, P1433, DOI 10.1086/379215; MEYERHANS A, 1989, CELL, V58, P901, DOI 10.1016/0092-8674(89)90942-2; Nijhuis M, 1999, AIDS, V13, P2349, DOI 10.1097/00002030-199912030-00006; Nijhuis M., 2009, V189, P299, DOI 10.1007/978-3-540-79086-0_11; Obermaier Bianca, 2003, Biol Proced Online, V5, P197, DOI 10.1251/bpo62; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Paredes R, 2007, J VIROL METHODS, V146, P136, DOI 10.1016/j.jviromet.2007.06.012; Paredes R, 2009, J VIROL, V83, P2038, DOI 10.1128/JVI.02154-08; Pattery T, 2012, INTERVIROLOGY, V55, P138, DOI 10.1159/000332013; Perno C-F, 2006, ANTIRETROVIRAL RESIS; Pingen M, 2011, J ANTIMICROB CHEMOTH, V66, P1467, DOI 10.1093/jac/dkr157; Rhee SY, 2010, ANTIMICROB AGENTS CH, V54, P4253, DOI 10.1128/AAC.00574-10; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Rowley CF, 2010, AIDS RES HUM RETROV, V26, P293, DOI 10.1089/aid.2009.0082; SABINO E, 1994, AIDS, V8, P901, DOI 10.1097/00002030-199407000-00006; Santos AFA, 2011, MEM I OSWALDO CRUZ, V106, P177, DOI 10.1590/S0074-02762011000200010; Schmit JC, 1996, AIDS, V10, P995, DOI 10.1097/00002030-199610090-00010; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Swenson LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017402; Swenson LC, 2011, J INFECT DIS, V203, P237, DOI 10.1093/infdis/jiq030; Tang MW, 2012, DRUGS, V72, pE1, DOI 10.2165/11633630-000000000-00000; Van Houtte M, 2009, J MED VIROL, V81, P1702, DOI 10.1002/jmv.21585; Van Laethem K, 1999, J ACQ IMMUN DEF SYND, V22, P107; Vermeiren H, 2007, J VIROL METHODS, V145, P47, DOI 10.1016/j.jviromet.2007.05.009; von Briesen H, 1999, AIDS, V13, P307, DOI 10.1097/00002030-199902250-00002; Youree Bryan E., 2002, AIDS Reviews, V4, P3; Zaccarelli M, 2005, AIDS, V19, P1081, DOI 10.1097/01.aids.0000174455.01369.ad; Zhang CY, 2009, INT J INFECT DIS, V13, pE212, DOI 10.1016/j.ijid.2008.12.010; Zhang FJ, 2005, CELL RES, V15, P877, DOI 10.1038/sj.cr.7290362; Zimmer JM, 2008, JAIDS-J ACQ IMM DEF, V48, P255, DOI 10.1097/QAI.0b013e318174dca6	64	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170420	10.1371/journal.pone.0170420	http://dx.doi.org/10.1371/journal.pone.0170420			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107423	Green Published, gold, Green Submitted			2022-12-26	WOS:000392405300131
J	Nien, HC; Hsu, SJ; Su, TH; Yang, PJ; Sheu, JC; Wang, JT; Chow, LP; Chen, CL; Kao, JH; Yang, WS				Nien, Hsiao-Ching; Hsu, Shih-Jer; Su, Tung-Hung; Yang, Po-Jen; Sheu, Jin-Chuan; Wang, Jin-Town; Chow, Lu-Ping; Chen, Chi-Ling; Kao, Jia-Horng; Yang, Wei-Shiung			High Serum Lipopolysaccharide-Binding Protein Level in Chronic Hepatitis C Viral Infection Is Reduced by Anti-Viral Treatments	PLOS ONE			English	Article							FATTY LIVER-DISEASE; VIRUS CHCV INFECTION; NONALCOHOLIC STEATOHEPATITIS; IMMUNE RESPONSIVENESS; PATTERN-RECOGNITION; INSULIN-RESISTANCE; INTERFERON-ALPHA; GENE-EXPRESSION; GUT MICROBIOTA; I INTERFERON	Background Lipopolysaccharide-binding protein (LBP) has been reported to associate with metabolic diseases, such as obesity, diabetes, and non-alcoholic fatty liver disease. Since chronic hepatitis C virus (HCV) infection is associated with metabolic derangements, the relationship between LBP and HCV deserves additional studies. This study aimed to determine the serum LBP level in subjects with or without HCV infection and investigate the change of its level after anti-viral treatments with or without interferon. Methods and Findings We recruited 120 non-HCV subjects, 42 and 17 HCV-infected subjects respectively treated with peginterferon alpha-2a/ribavirin and direct-acting antiviral drugs. Basic information, clinical data, serum LBP level and abdominal ultrasonography were collected. All the subjects provided written informed consent before being enrolled approved by the Research Ethics Committee of the National Taiwan University Hospital. Serum LBP level was significantly higher in HCV-infected subjects than non-HCV subjects (31.0 +/- 8.8 versus 20.0 +/- 6.4 mu g/mL; p-value <0.001). After multivariate analyses, LBP at baseline was independently associated with body mass index, hemoglobin A1c, alanine aminotransferase (ALT) and HCV infection. Moreover, the baseline LBP was only significantly positively associated with ALT and inversely with fatty liver in HCV-infected subjects. The LBP level significantly decreased at sustained virologic response (27.4 +/- 6.6 versus 34.6 +/- 7.3 mu g/mL, p-value < 0.001; 15.9 +/- 4.4 versus 22.2 +/- 5.7 mu g/mL, p-value = 0.001), regardless of interferon-based or -free therapy. Conclusions LBP, an endotoxemia associated protein might be used as an inflammatory biomarker of both infectious and non-infectious origins in HCV-infected subjects.	[Nien, Hsiao-Ching; Yang, Po-Jen; Chen, Chi-Ling; Kao, Jia-Horng; Yang, Wei-Shiung] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Nien, Hsiao-Ching; Sheu, Jin-Chuan] Liver Dis Prevent & Treatment Res Fdn, Taipei, Taiwan; [Nien, Hsiao-Ching] Natl Taiwan Univ Hosp, Dept Family Med, Taipei, Taiwan; [Hsu, Shih-Jer] Natl Taiwan Univ Hosp, Dept Internal Med, Yun Lin Branch, Yunlin, Taiwan; [Su, Tung-Hung; Sheu, Jin-Chuan; Wang, Jin-Town; Kao, Jia-Horng; Yang, Wei-Shiung] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Yang, Po-Jen] Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan; [Wang, Jin-Town] Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei, Taiwan; [Chow, Lu-Ping] Natl Taiwan Univ, Grad Inst Biochem & Mol Biol, Coll Med, Taipei, Taiwan; [Chow, Lu-Ping] Natl Taiwan Univ Hosp, Dept Med Genet, Taipei, Taiwan; [Chen, Chi-Ling] Natl Taiwan Univ, Grad Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei, Taiwan; [Kao, Jia-Horng; Yang, Wei-Shiung] Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Kao, JH; Yang, WS (corresponding author), Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan.; Kao, JH; Yang, WS (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan.; Kao, JH; Yang, WS (corresponding author), Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei, Taiwan.	kaojh@ntu.edu.tw; wsyang@ntu.edu.tw	Kao, Jia-Horng/AAB-8947-2019	Kao, Jia-Horng/0000-0002-2442-7952; SHEU, JIN-CHUAN/0000-0002-2503-7139; YANG, WEI-SHIUNG/0000-0001-5087-373X; Yang, Po-Jen/0000-0001-7247-916X; SU, TUNG-HUNG/0000-0002-6747-7941; CHOW, LU-PING/0000-0002-4420-211X	Liver Disease Prevention and Treatment Research Foundation, Taiwan [201600001]	Liver Disease Prevention and Treatment Research Foundation, Taiwan	Support was provided by the Liver Disease Prevention and Treatment Research Foundation, Taiwan, grant number: 201600001 [www.liver.org.tw]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiminstration HP, 2015, DEF BOD MASS IND AD; Amati L, 2002, CURR PHARM DESIGN, V8, P981, DOI 10.2174/1381612024607036; Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Behrendt D, 2004, ARCH DIS CHILD-FETAL, V89, pF551, DOI 10.1136/adc.2003.030049; Belardelli F, 1996, IMMUNOL TODAY, V17, P369, DOI 10.1016/0167-5699(96)10027-X; Caccavo D, 1999, INFECT IMMUN, V67, P4668, DOI 10.1128/IAI.67.9.4668-4672.1999; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; FUKUI H, 1991, J HEPATOL, V12, P162, DOI 10.1016/0168-8278(91)90933-3; Gonzalez-Quintela A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054600; GRUBE BJ, 1994, J BIOL CHEM, V269, P8477; Guo JS, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-21; Harte AL, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-15; Jenabian MA, 2016, JAIDS-J ACQ IMM DEF, V71, P254, DOI 10.1097/QAI.0000000000000859; Jirillo E, 1996, IMMUNOPHARM IMMUNOT, V18, P355; Jirillo E, 1998, IMMUNOPHARM IMMUNOT, V20, P1, DOI 10.3109/08923979809034805; Jirillo E, 2002, J ENDOTOXIN RES, V8, P319, DOI 10.1179/096805102125000641; Jirillo E, 2000, CURR PHARM DESIGN, V6, P169, DOI 10.2174/1381612003401271; JIRILLO E, 1995, IMMUNOPHARM IMMUNOT, V17, P347, DOI 10.3109/08923979509019756; JOSEPH AEA, 1991, CLIN RADIOL, V43, P26, DOI 10.1016/S0009-9260(05)80350-2; Kao JH, 2016, J FORMOS MED ASSOC, V115, P65, DOI 10.1016/j.jfma.2015.06.012; LIN DY, 1993, J CLIN ULTRASOUND, V21, P303, DOI 10.1002/jcu.1870210502; Manco M, 2010, ENDOCR REV, V31, P817, DOI 10.1210/er.2009-0030; Molle C, 2010, J IMMUNOL, V184, P1784, DOI 10.4049/jimmunol.0902005; Moreno-Navarrete JM, 2012, INT J OBESITY, V36, P1442, DOI 10.1038/ijo.2011.256; Moreno-Navarrete JM, 2011, INT J OBES LOND, V36, P1442; NEEDLEMAN L, 1986, AM J ROENTGENOL, V146, P1011, DOI 10.2214/ajr.146.5.1011; Nystrom J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118643; OESTERREICHER C, 1995, J HEPATOL, V23, P396, DOI 10.1016/0168-8278(95)80197-9; Petta S, 2011, LIVER INT, V31, P507, DOI 10.1111/j.1478-3231.2011.02453.x; Ruiz AG, 2007, OBES SURG, V17, P1374; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; SAVERYMUTTU SH, 1986, BRIT MED J, V292, P13, DOI 10.1136/bmj.292.6512.13; Schumann RR, 2011, BIOCHEM SOC T, V39, P989, DOI 10.1042/BST0390989; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Singh Divya, 2013, Indian J Endocrinol Metab, V17, P990, DOI 10.4103/2230-8210.122606; Sun LA, 2010, DIABETES CARE, V33, P1925, DOI 10.2337/dc10-0340; Umoh FI, 2016, EUR J NUTR, V55, P793, DOI 10.1007/s00394-015-0900-7; Verdam FJ, 2011, J CLIN GASTROENTEROL, V45, P149, DOI 10.1097/MCG.0b013e3181e12c24; Vespasiani-Gentilucci U, 2015, LIVER INT, V35, P569, DOI 10.1111/liv.12531; WEINSTOCKGUTTMAN B, 1995, ANN NEUROL, V37, P7, DOI 10.1002/ana.410370105; Weiss J, 2003, BIOCHEM SOC T, V31, P785, DOI 10.1042/BST0310785; Wong VWS, 2015, ALIMENT PHARM THER, V42, P731, DOI 10.1111/apt.13327; Yang PJ, 2014, SURG OBES RELAT DIS, V10, P1182, DOI 10.1016/j.soard.2014.02.022	44	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170028	10.1371/journal.pone.0170028	http://dx.doi.org/10.1371/journal.pone.0170028			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107471	Green Submitted, gold, Green Published			2022-12-26	WOS:000392405300065
J	Salehi, S; Wang, XM; Juvet, S; Scott, JA; Chow, CW				Salehi, Sepehr; Wang, Xiaomin; Juvet, Stephen; Scott, Jeremy A.; Chow, Chung-Wai			Syk Regulates Neutrophilic Airway Hyper-Responsiveness in a Chronic Mouse Model of Allergic Airways Inflammation	PLOS ONE			English	Article							CLINICAL PHENOTYPES; CLUSTER-ANALYSIS; ASTHMA; ACTIVATION; RESPONSIVENESS; VARIABILITY; INHIBITION; EXPRESSION; MIGRATION; ANTISENSE	Background Asthma is a chronic inflammatory disease characterized by airways hyper-responsiveness (AHR), reversible airway obstruction, and airway inflammation and remodeling. We previously showed that Syk modulates methacholine-induced airways contractility in naive mice and in mice with allergic airways inflammation. We hypothesize that Syk plays a role in the pathogenesis of AHR; this was evaluated in a chronic 8-week mouse model of house dust mite (HDM)-induced allergic airways inflammation. Methods We used the Syk(flox/flox)//rosa26CreER(T2) conditional Syk knock-out mice to assess the role of Syk prior to HDM exposure, and treated HDM-sensitized mice with the Syk inhibitor, GSK143, to evaluate its role in established allergic airways inflammation. Respiratory mechanics and methacholine (MCh)-responsiveness were assessed using the flexiVent (R) system. Lungs underwent bronchoalveolar lavage to isolate inflammatory cells or were frozen for determination of gene expression in tissues. Results MCh-induced AHR was observed following HDM sensitization in the Syk-intact (Syk(flox/flox)) and vehicle-treated BALB/c mice. MCh responsiveness was reduced to control levels in HDM-sensitized Syk(del/del) mice and in BALB/c and Syk(flox/flox) mice treated with GSK143. Both Syk(del/del) and GSK143-treated mice mounted appropriate immune responses to HDM, with HDM-specific IgE levels that were comparable to Syk(flox/flox) and vehicle-treated BALB/c mice. HDM-induced increases in bronchoalveolar lavage cell counts were attenuated in both Syk(del/del) and GSK143-treated mice, due primarily to decreased neutrophil recruitment. Gene expression analysis of lung tissues revealed that HDM-induced expression of IL-17 and CXCL-1 was significantly attenuated in both Syk (del/del) and GSK143-treated mice. Conclusion Syk inhibitors may play a role in the management of neutrophilic asthma.	[Salehi, Sepehr; Wang, Xiaomin; Juvet, Stephen; Chow, Chung-Wai] Univ Toronto, Fac Med, Div Respirol, Dept Med, Toronto, ON, Canada; [Juvet, Stephen] Northern Ontario Sch Med, Div Med Sci, Thunder Bay, ON, Canada; [Scott, Jeremy A.; Chow, Chung-Wai] Univ Toronto, Fac Sci Appl, Southern Ontario Ctr Atmospher Aerosol Res, Toronto, ON, Canada; [Scott, Jeremy A.; Chow, Chung-Wai] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Occupat & Environm Hlth, Toronto, ON, Canada; [Scott, Jeremy A.] Lakehead Univ, Fac Hlth & Behav Sci, Dept Hlth Sci, Thunder Bay, ON, Canada; [Chow, Chung-Wai] Univ Hlth Network, Multiorgan Transplant Programme, Toronto, ON, Canada	University of Toronto; Northern Ontario School of Medicine; University of Toronto; University of Toronto; Lakehead University; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Chow, CW (corresponding author), Univ Toronto, Fac Med, Div Respirol, Dept Med, Toronto, ON, Canada.; Chow, CW (corresponding author), Univ Toronto, Fac Sci Appl, Southern Ontario Ctr Atmospher Aerosol Res, Toronto, ON, Canada.; Chow, CW (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Div Occupat & Environm Hlth, Toronto, ON, Canada.; Chow, CW (corresponding author), Univ Hlth Network, Multiorgan Transplant Programme, Toronto, ON, Canada.	cw.chow@utoronto.ca	Scott, Jeremy A/D-2965-2009; Chow, Chung-Wai/AAP-5533-2020	Scott, Jeremy A/0000-0002-7513-6768; Chow, Chung-Wai/0000-0001-9344-8522; Juvet, Stephen/0000-0002-7243-556X	GlaxoSmithKline - Collaborative and Innovative Research Fund; Ontario Thoracic Society; Queen Elizabeth II Graduate Scholarship in Science and Technology Award	GlaxoSmithKline - Collaborative and Innovative Research Fund; Ontario Thoracic Society; Queen Elizabeth II Graduate Scholarship in Science and Technology Award	The work presented in this manuscript was supported by an investigator-initiated grant from the GlaxoSmithKline - Collaborative and Innovative Research Fund (PI: Chow) and from an Ontario Thoracic Society Grant-in-Aid (PI: Chow) and the Queen Elizabeth II Graduate Scholarship in Science and Technology Award (Salehi).	[Anonymous], 2015, GLOB STRAT ASTHM MAN; Barnes PJ, 2010, TRENDS PHARMACOL SCI, V31, P335, DOI 10.1016/j.tips.2010.04.009; Barnes PJ, 2006, PHARMACOL THERAPEUT, V109, P238, DOI 10.1016/j.pharmthera.2005.08.001; Bergquist M, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-110; Berndt A, 2011, PHYSIOL GENOMICS, V43, P1, DOI 10.1152/physiolgenomics.00108.2010; Bourdin A, 2014, J ALLERGY CLIN IMMUN, V134, P1043, DOI 10.1016/j.jaci.2014.04.038; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; Castellanos P, 2013, J ALLERGY CLIN IMMUN, V131, P512, DOI DOI 10.1016/J.JACI.2012.07.039; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Chung KF, 2015, CURR OPIN ALLERGY CL, V15, P56, DOI 10.1097/ACI.0000000000000134; Chung KF, 2013, LANCET RESP MED, V1, P639, DOI 10.1016/S2213-2600(13)70128-0; Chung Kian Fan, 2013, Ann Am Thorac Soc, V10 Suppl, pS109, DOI 10.1513/AnnalsATS.201304-087AW; Huang ZY, 2013, MOL IMMUNOL, V53, P52, DOI 10.1016/j.molimm.2012.06.011; Jacquemin B, 2012, J EPIDEMIOL COMMUN H, V66, P796, DOI 10.1136/jech.2010.130229; Just J, 2014, J PEDIATR-US, V164, P815, DOI 10.1016/j.jpeds.2013.11.037; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Lau C, 2008, J IMMUNOL, V180, P870, DOI 10.4049/jimmunol.180.2.870; Lau C, 2011, PROTEIN PEPTIDE LETT, V18, P518, DOI 10.2174/092986611794927910; Leme AS, 2010, MOL GENET GENOMICS, V283, P317, DOI 10.1007/s00438-010-0515-x; Liddle J, 2011, BIOORG MED CHEM LETT, V21, P6188, DOI 10.1016/j.bmcl.2011.07.082; Matsubara S, 2006, AM J RESP CELL MOL, V34, P426, DOI 10.1165/rcmb.2005-0298OC; Matsubara S, 2006, AM J RESP CRIT CARE, V173, P56, DOI 10.1164/rccm.200503-361OC; Matsuda Y, 2015, AM J TRANSPLANT, V10; Moore WC, 2014, J ALLERGY CLIN IMMUN, V133, P1557, DOI 10.1016/j.jaci.2013.10.011; Murphy DM, 2010, CHEST, V137, P1417, DOI 10.1378/chest.09-1895; North ML, 2009, AM J PHYSIOL-LUNG C, V296, pL911, DOI 10.1152/ajplung.00025.2009; Ordonez CL, 2000, AM J RESP CRIT CARE, V161, P1185, DOI 10.1164/ajrccm.161.4.9812061; Peters SP, 2014, J ALLER CL IMM-PRACT, V2, P650, DOI 10.1016/j.jaip.2014.09.006; Plant PJ, 2011, AM J RESP CELL MOL B; Sakagami T, 2014, J ASTHMA, V51, P113, DOI 10.3109/02770903.2013.852201; Schatz M, 2014, J ALLERGY CLIN IMMUN, V133, P1549, DOI 10.1016/j.jaci.2013.10.006; Scott JA, 2011, AM J RESP CRIT CARE, V184, P779, DOI 10.1164/rccm.201011-1810OC; Simpson JL, 2008, AM J RESP CRIT CARE, V177, P148, DOI 10.1164/rccm.200707-1134OC; Simpson JL, 2014, ASIAN PAC J ALLERGY, V32, P66, DOI 10.12932/AP0322.32.1.2014; Southam DS, 2007, J ALLERGY CLIN IMMUN, V119, P848, DOI 10.1016/j.jaci.2006.12.623; Stenton GR, 2002, J IMMUNOL, V169, P1028, DOI 10.4049/jimmunol.169.2.1028; Stenton GR, 2000, J IMMUNOL, V164, P3790, DOI 10.4049/jimmunol.164.7.3790; Wang X, 2015, ALLERGY, V70, P429, DOI 10.1111/all.12564; Wang XM, 2012, J PHARMACOL EXP THER, V340, P277, DOI 10.1124/jpet.111.186429; Wex E, 2011, EUR J IMMUNOL, V41, P3208, DOI 10.1002/eji.201141502; Wood LG, 2012, CHEST, V142, P86, DOI 10.1378/chest.11-1838	41	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0163614	10.1371/journal.pone.0163614	http://dx.doi.org/10.1371/journal.pone.0163614			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107345	Green Published, gold, Green Submitted			2022-12-26	WOS:000392405300001
J	Molino, Y; David, M; Varini, K; Jabes, F; Gaudin, N; Fortoul, A; Bakloul, K; Masse, M; Bernard, A; Drobecq, L; Lecorche, P; Temsamani, J; Jacquot, G; Khrestchatisky, M				Molino, Yves; David, Marion; Varini, Karine; Jabes, Francoise; Gaudin, Nicolas; Fortoul, Aude; Bakloul, Karima; Masse, Maxime; Bernard, Anne; Drobecq, Lucile; Lecorche, Pascaline; Temsamani, Jamal; Jacquot, Guillaume; Khrestchatisky, Michel			Use of LDL receptor-targeting peptide vectors for in vitro and in vivo cargo transport across the blood-brain barrier	FASEB JOURNAL			English	Article						receptor-mediated transcytosis; intracellular trafficking; lysosome; endosome; CNS drug delivery	LOW-DENSITY-LIPOPROTEIN; CAPILLARY ENDOTHELIAL-CELLS; CENTRAL-NERVOUS-SYSTEM; LYSOSOMAL-ENZYME; UP-REGULATION; AMYLOID-BETA; DELIVERY; TRANSCYTOSIS; TRANSFERRIN; ANTIBODIES	The blood-brain barrier (BBB) prevents the entry of many drugs into the brain and, thus, is a major obstacle in the treatment of CNS diseases. There is some evidence that the LDL receptor (LDLR) is expressed at the BBB and may participate in the transport of endogenous ligands from blood to brain, a process referred to as receptor-mediated transcytosis. We previously described a family of peptide vectors that were developed to target the LDLR. In the present study, in vitro BBB models that were derived from wild-type and LDLR-knockout animals (ldlr(-/-)) were used to validate the specific LDLR-dependent transcytosis of LDL via a nondegradative route. We next showed that LDLR-targeting peptide vectors, whether in fusion or chemically conjugated to an Ab Fc fragment, promote binding to apical LDLR and transendothelial transfer of the Fc fragment across BBB monolayers via the same route as LDL. Finally, we demonstrated in vivo that LDLR significantly contributes to the brain uptake of vectorized Fc. We thus provide further evidence that LDLR is a relevant receptor for CNS drug delivery via receptor-mediated transcytosis and that the peptide vectors we developed have the potential to transport drugs, including proteins or Ab based, across the BBB.-Molino, Y., David, M., Varini, K., Jabes, F., Gaudin, N., Fortoul, A., Bakloul, K., Masse, M., Bernard, A., Drobecq, L., Lecorche, P., Temsamani, J., Jacquot, G., Khrestchatisky, M. Use of LDL receptor-targeting peptide vectors for in vitro and in vivo cargo transport across the blood-brain barrier.	[Molino, Yves; David, Marion; Jabes, Francoise; Fortoul, Aude; Bakloul, Karima; Masse, Maxime; Drobecq, Lucile; Lecorche, Pascaline; Temsamani, Jamal; Jacquot, Guillaume] Vect Horus SAS, Fac Med, Marseille, France; [Varini, Karine; Gaudin, Nicolas; Bernard, Anne; Khrestchatisky, Michel] Aix Marseille Univ, CNRS, Neurobiol Interact Cellulaires & Neurophysiopatho, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Khrestchatisky, M (corresponding author), Fac Med Marseille, Sect Nord, Unite Mixte Rech 7259, Neurobiol Interact Cellulaires & Neurophysiopatho, 51 Bd Pierre Dramard,CS80011, F-13344 Marseille 15, France.	michel.khrestchatisky@univ-amu.fr			Centre National de la Recherche Scientifique; Aix-Marseille Universite; Fonds Unique Interministeriel; Agence Nationale de la Recherche; A*MIDEX; Vect-Horus biotechnology company; UMR7259 Laboratory	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille Universite; Fonds Unique Interministeriel; Agence Nationale de la Recherche(French National Research Agency (ANR)); A*MIDEX(French National Research Agency (ANR)); Vect-Horus biotechnology company; UMR7259 Laboratory	This work was supported by the Centre National de la Recherche Scientifique and Aix-Marseille Universite to the Unite Mixte de Recherche (UMR) 7259 Laboratory; the Fonds Unique Interministeriel to Vect-Horus for the MEDUL project; the Agence Nationale de la Recherche to the UMR7259 Laboratory, and Vect-Horus for the TIMPAD, ADHOC, PREVENTAD, VECtoBrain, VEC2Brain, NANOVECTOR collaborative projects, and to the DHUNE project supported by A*MIDEX; LECMA (to M.K.). M.K. is director of the UMR7259 Laboratory, and cofounder, shareholder, and scientific counsel of the Vect-Horus biotechnology company. The remaining authors declare no conflicts of interest.	Boado RJ, 2007, BIOTECHNOL BIOENG, V96, P381, DOI 10.1002/bit.21120; Bockenhoff A, 2014, J NEUROSCI, V34, P3122, DOI 10.1523/JNEUROSCI.4785-13.2014; Calvo D, 1997, ARTERIOSCL THROM VAS, V17, P2341, DOI 10.1161/01.ATV.17.11.2341; Camargo N, 2012, FASEB J, V26, P4302, DOI 10.1096/fj.12-205807; Candela P, 2008, ENDOTHELIUM-J ENDOTH, V15, P254, DOI 10.1080/10623320802487759; Cooper PR, 2013, BRAIN RES, V1534, P13, DOI 10.1016/j.brainres.2013.08.035; Cucullo L, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-18; Dehouck B, 1997, J CELL BIOL, V138, P877, DOI 10.1083/jcb.138.4.877; DEHOUCK B, 1994, J CELL BIOL, V126, P465, DOI 10.1083/jcb.126.2.465; Demeule M, 2008, J PHARMACOL EXP THER, V324, P1064, DOI 10.1124/jpet.107.131318; Descamps L, 1996, AM J PHYSIOL-HEART C, V270, pH1149, DOI 10.1152/ajpheart.1996.270.4.H1149; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; Duan SM, 1999, J NEUROSCI, V19, P10193; DUNN KW, 1989, J CELL BIOL, V109, P3303, DOI 10.1083/jcb.109.6.3303; Friden PM, 1996, J PHARMACOL EXP THER, V278, P1491; Georgieva Julia V, 2014, Pharmaceutics, V6, P557, DOI 10.3390/pharmaceutics6040557; Goti D, 2002, J BIOL CHEM, V277, P28537, DOI 10.1074/jbc.M203989200; Goti D, 2001, J NEUROCHEM, V76, P498, DOI 10.1046/j.1471-4159.2001.00100.x; Hussain MM, 1999, ANNU REV NUTR, V19, P141, DOI 10.1146/annurev.nutr.19.1.141; Jacquot G., 2014, US Patent, Patent No. [WO 2014/060601, 2014060601]; Jacquot G, 2016, MOL PHARMACEUT, V13, P4094, DOI 10.1021/acs.molpharmaceut.6b00687; Jefferies W. A., 2015, US Patent, Patent No. [2015/0056218, 20150056218]; Jones AR, 2007, PHARM RES-DORDR, V24, P1759, DOI 10.1007/s11095-007-9379-0; Kannan R, 1999, J NEUROCHEM, V73, P390, DOI 10.1046/j.1471-4159.1999.0730390.x; Karkan D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002469; KENAGY R, 1984, ARTERIOSCLEROSIS, V4, P365, DOI 10.1161/01.ATV.4.4.365; Khrestchatisky M, 2010, PCT patent Pub., Patent No. [WO2010046588, 2010046588, WO/2010/046588]; Macdonald JA, 2010, J NEUROSCI RES, V88, P1457, DOI 10.1002/jnr.22316; Malcor JD, 2012, J MED CHEM, V55, P2227, DOI 10.1021/jm2014919; MERESSE S, 1989, J NEUROCHEM, V53, P340, DOI 10.1111/j.1471-4159.1989.tb07340.x; Molino Y, 2014, JOVE-J VIS EXP, DOI 10.3791/51278; Niewoehner J, 2014, NEURON, V81, P49, DOI 10.1016/j.neuron.2013.10.061; O'Kane RL, 1999, J BIOL CHEM, V274, P31891, DOI 10.1074/jbc.274.45.31891; Pan WH, 2004, J CELL SCI, V117, P5071, DOI 10.1242/jcs.01381; Pardridge WM, 2012, METHOD ENZYMOL, V503, P269, DOI 10.1016/B978-0-12-396962-0.00011-2; Ramanathan A, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00136; RAUB TJ, 1991, J CELL PHYSIOL, V149, P141, DOI 10.1002/jcp.1041490118; Regina A, 2015, MOL CANCER THER, V14, P129, DOI 10.1158/1535-7163.MCT-14-0399; ROBERTS RL, 1993, J CELL SCI, V104, P521; Sade H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096340; Shamenkov DA, 2006, B EXP BIOL MED+, V142, P703, DOI 10.1007/s10517-006-0456-x; Simionescu M, 2009, CELL TISSUE RES, V335, P27, DOI 10.1007/s00441-008-0688-3; Sorrentino NC, 2013, EMBO MOL MED, V5, P675, DOI 10.1002/emmm.201202083; Spencer B, 2014, J BIOL CHEM, V289, P17917, DOI 10.1074/jbc.M114.557439; Temsamani J, 2004, DRUG DISCOV TODAY, V9, P1012, DOI 10.1016/S1359-6446(04)03279-9; Valenza M, 2010, J NEUROSCI, V30, P10844, DOI 10.1523/JNEUROSCI.0917-10.2010; Vance JE, 2012, DIS MODEL MECH, V5, P746, DOI 10.1242/dmm.010124; Vlieghe P., 2011, US Patent, Patent No. [WO 2011/131896, 2011131896]; Vlieghe P, 2013, MED RES REV, V33, P457, DOI 10.1002/med.21252; Vlieghe P, 2010, THER DELIV, V1, P489, DOI 10.4155/TDE.10.44; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Wang DR, 2013, P NATL ACAD SCI USA, V110, P2999, DOI 10.1073/pnas.1222742110; Watts RJ, 2013, CURR OPIN CHEM BIOL, V17, P393, DOI 10.1016/j.cbpa.2013.03.023; Wilhelmus MMM, 2007, AM J PATHOL, V171, P1989, DOI 10.2353/ajpath.2007.070050; Yu YJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002230; Zensi A, 2009, J CONTROL RELEASE, V137, P78, DOI 10.1016/j.jconrel.2009.03.002; Zhang B, 2013, BIOMATERIALS, V34, P9171, DOI 10.1016/j.biomaterials.2013.08.039; Zhang Y, 2004, J PHARMACOL EXP THER, V311, P449, DOI 10.1124/jpet.104.068528	58	52	52	2	32	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1807	1827		10.1096/fj.201600827R	http://dx.doi.org/10.1096/fj.201600827R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28108572				2022-12-26	WOS:000399195500006
J	Perez-Sancho, M; Vela, AI; Garcia-Seco, T; Gonzalez, S; Dominguez, L; Fernandez-Garayzabal, JF				Perez-Sancho, Marta; Vela, Ana I.; Garcia-Seco, Teresa; Gonzalez, Sergio; Dominguez, Lucas; Francisco Fernandez-Garayzabal, Jose			Usefulness of MALDI-TOF MS as a Diagnostic Tool for the Identification of Streptococcus Species Recovered from Clinical Specimens of Pigs	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; RAPID IDENTIFICATION; SP NOV.; SYSTEM; SUIS	The application of MALDI-TOF MS for identifying streptococcal isolates recovered from clinical specimens of diseased pigs was evaluated. For this proposal, the MALDI BDAL Database (Bruker Daltoniks, Germany) was supplemented with the main spectrum profiles (MSP) of the reference strains of S. porci, S. porcorum and S. plurextorum associated with pneumonia and septicemia. Although these three species showed similar MALDI profiles, several peaks were recognized that can be useful for their differentiation: S. porci (4113, 6133, 7975 and 8228 m/z Da), S. plurextorum (3979, 4078, 4665, 6164, 6491, 6812, 7959 and 9330 m/z Da) and S. porcorum (3385, 3954, 4190, 6772, 7908, and 8381 m/z Da). After adding these MSPs, an evaluation was conducted to determine the accuracy of MALDI-TOF MS for the identification of streptococci from diseased pigs using 74 field isolates. Isolates were identified as S. suis, S. porcinus, S. dysgalactiae, S. hyovaginalis, S. porcorum, S. alactolyticus, S. hyointestinalis and S. orisratti. This is the first time that the latter three species have been reported from clinical specimens of pigs. Overall, there was good concordance (95.9%) between the results obtained from MALDI-TOF MS identification (best hint) and those from genotyping. Our results demonstrate the good performance of MALDI-TOF MS (100% sensitivity and specificity) for identifying most of the species of streptococci that can frequently be isolated from diseased pigs. However, conflicting results were observed in the correct identification of some isolates of S. dysgalactiae and S. alactolyticus.	[Perez-Sancho, Marta; Vela, Ana I.; Garcia-Seco, Teresa; Gonzalez, Sergio; Dominguez, Lucas; Francisco Fernandez-Garayzabal, Jose] Univ Complutense, Ctr Vigilancia Sanitaria Vet VISAVET, Madrid, Spain; [Perez-Sancho, Marta; Dominguez, Lucas] Univ Complutense Madrid, Univ Politecn Madrid, Campus Excelencia Internac CEI Moncloa, Madrid, Spain; [Vela, Ana I.; Francisco Fernandez-Garayzabal, Jose] Univ Complutense, Fac Vet, Dept Sanidad Anim, Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid; Universidad Politecnica de Madrid; Complutense University of Madrid	Fernandez-Garayzabal, JF (corresponding author), Univ Complutense, Ctr Vigilancia Sanitaria Vet VISAVET, Madrid, Spain.; Fernandez-Garayzabal, JF (corresponding author), Univ Complutense, Fac Vet, Dept Sanidad Anim, Madrid, Spain.	garayzab@vet.ucm.es	FERNANDEZ-GARAYZABAL, JOSE FRANCISCO/K-9611-2014; Vela, Ana I/K-8015-2014; Dominguez, Sergio Gonzalez/B-9645-2014; Garcia-Seco Romero, Teresa/K-8589-2014; PEREZ-SANCHO, MARTA/L-4872-2014; Dominguez Rodriguez, Lucas/B-9668-2014	FERNANDEZ-GARAYZABAL, JOSE FRANCISCO/0000-0003-1597-0643; Vela, Ana I/0000-0001-5004-3103; Dominguez, Sergio Gonzalez/0000-0001-6867-7796; Garcia-Seco Romero, Teresa/0000-0002-6162-1025; PEREZ-SANCHO, MARTA/0000-0002-1493-8978; Dominguez Rodriguez, Lucas/0000-0001-8843-0010	Moncloa Campus of International Excellence [CEI09-0019]; Ministerio de Educacion, Cultura y Deporte [Orden PRE/1996/2009 de 20 de Julio]; Regional Government of Madrid; European Union [S2013/ABI-2747]	Moncloa Campus of International Excellence; Ministerio de Educacion, Cultura y Deporte; Regional Government of Madrid; European Union(European Commission)	Marta Perez-Sancho is recipient of a technical support staff for scientific infrastructures of the Moncloa Campus of International Excellence (Programa CEI09-0019) and Ministerio de Educacion, Cultura y Deporte (Orden PRE/1996/2009 de 20 de Julio). This study was supported by Regional Government of Madrid Structural funds and European Union S2013/ABI-2747 (TAVS-CM).	Abramson Joseph H, 2004, Epidemiol Perspect Innov, V1, P6, DOI 10.1186/1742-5573-1-6; Branda JA, 2013, J CLIN MICROBIOL, V51, P3079, DOI 10.1128/JCM.00824-13; Brigante G, 2006, J CLIN MICROBIOL, V44, P3263, DOI 10.1128/JCM.00299-06; Cherkaoui A, 2011, J CLIN MICROBIOL, V49, P3004, DOI 10.1128/JCM.00240-11; FLYNN CE, 1995, J CLIN MICROBIOL, V33, P2704, DOI 10.1128/JCM.33.10.2704-2706.1995; Gottschalk M., 2012, DIS SWINE, P841; Goyette-Desjardins G, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.45; Lau SKP, 2012, J CLIN MICROBIOL, V50, P3142, DOI 10.1128/JCM.01349-12; Lu BH, 2014, INT J INFECT DIS, V27, P44, DOI 10.1016/j.ijid.2014.06.023; Moreno LZ, 2016, DIAGN MICR INFEC DIS, V86, P178, DOI 10.1016/j.diagmicrobio.2016.07.020; Okwumabua O, 2003, FEMS MICROBIOL LETT, V218, P79, DOI 10.1111/j.1574-6968.2003.tb11501.x; Perez-Sancho M, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00202; Plagemann O, 1988, Zentralbl Veterinarmed B, V35, P770; Rettinger A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-185; Romero B, 2011, J CLIN MICROBIOL, V49, P3228, DOI 10.1128/JCM.00524-11; Schulthess B, 2013, J CLIN MICROBIOL, V51, P1834, DOI 10.1128/JCM.02654-12; Singhal N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00791; Vela AI, 2011, INT J SYST EVOL MICR, V61, P1585, DOI 10.1099/ijs.0.022657-0; Vela AI, 2010, INT J SYST EVOL MICR, V60, P104, DOI 10.1099/ijs.0.011171-0; Vela AI, 2009, INT J SYST EVOL MICR, V59, P504, DOI 10.1099/ijs.0.65636-0; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; WESSMAN GE, 1986, VET MICROBIOL, V12, P297, DOI 10.1016/0378-1135(86)90081-7; Whiley RA, 2009, BERGEYS MANUAL SYSTE, P655; Zhu H, 2000, INT J SYST EVOL MICR, V50, P55, DOI 10.1099/00207713-50-1-55	24	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170784	10.1371/journal.pone.0170784	http://dx.doi.org/10.1371/journal.pone.0170784			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125697	Green Published, gold, Green Submitted			2022-12-26	WOS:000396176100051
J	Manera, ME; Carrillo, JM; Batista, M; Rubio, M; Sopena, J; Santana, A; Vilar, JM				Manera, Maria E.; Carrillo, Jose M.; Batista, Miguel; Rubio, Monica; Sopena, Joaquin; Santana, Angelo; Vilar, Jose M.			Static Posturography: A New Perspective in the Assessment of Lameness in a Canine Model	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; FORCE PLATFORM ANALYSIS; MESENCHYMAL STEM-CELLS; INTRAARTICULAR INJECTION; VERTICAL FORCES; ELBOW DYSPLASIA; OSTEOARTHRITIC DOGS; PRESSURE MEASURES; POSTURAL CONTROL; CORONOID PROCESS	The aim of this study was to assess the static posturography in dogs as a useful tool for diagnosis of lameness by means of the use of a pressure platform. For this purpose, a series of different parameters (pressure distribution, area of support, mean pressure, maximum pressure and statokinesiograms) were obtained from five lame dogs with unilateral elbow osteoarthritis treated with plasma rich in growth factors. Data were obtained before and 3 months after treatment, and results were compared with a control group of sound dogs of similar conformation. Significant differences were found in the above mentioned parameters between sound and lame limbs. Improvement after 3 months of treatment was also detected, demonstrating that this multi-parametric technique is an effective and reliable method for the assessment of lameness in dogs.	[Manera, Maria E.; Batista, Miguel; Vilar, Jose M.] Univ Las Palmas Gran Canaria, Inst Univ Invest Biomed & Sanit, Dept Patol Anim, Arucas, Las Palmas, Spain; [Carrillo, Jose M.; Rubio, Monica; Sopena, Joaquin] Univ CEU Cardenal Herrera, Catedra Garcia Cugat, Dept Med & Cirugia Anim, Valencia, Spain; [Santana, Angelo] Univ Las Palmas Gran Canaria, Dept Matemat, Las Palmas Gran Canaria, Spain	Universidad de Las Palmas de Gran Canaria; Universidad CEU Cardenal Herrera; Universidad de Las Palmas de Gran Canaria	Vilar, JM (corresponding author), Univ Las Palmas Gran Canaria, Inst Univ Invest Biomed & Sanit, Dept Patol Anim, Arucas, Las Palmas, Spain.	jose.vilar@ulpgc.es	Batista-Arteaga, Miguel/ABC-7868-2021; Santana, Angelo/H-6012-2011; Sopena, Joaquín/AAF-7088-2019; Vilar, José Manuel/AAA-7925-2019	Santana, Angelo/0000-0002-6513-4814; Sopena, Joaquín/0000-0002-3601-9745; Vilar, José Manuel/0000-0002-2060-2274; RUBIO, MONICA/0000-0002-2689-8862; BATISTA ARTEAGA, MIGUEL/0000-0001-9753-4786				Souza ANA, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-51; Baratto L, 2002, MOTOR CONTROL, V6, P246, DOI 10.1123/mcj.6.3.246; Basher A., 1994, COMPENDIUM CONTINUIN, P1159; Besancon MF, 2003, VET COMP ORTHOPAED, V16, P153, DOI 10.1055/s-0038-1632766; Blaszczyk JW, 2016, GAIT POSTURE, V44, P1, DOI 10.1016/j.gaitpost.2015.10.014; BLASZCZYK JW, 1994, GAIT POSTURE, V2, P11, DOI 10.1016/0966-6362(94)90012-4; Bottaro A, 2005, HUM MOVEMENT SCI, V24, P588, DOI 10.1016/j.humov.2005.07.006; Buchner H H, 2001, Equine Vet J Suppl, P122; Buchner HHF., 2013, EQUINE LOCOMOTION, P251; Caron A, 2014, VET COMP ORTHOPAED, V27, P461, DOI 10.3415/VCOT-14-03-0051; Cook CR, 2009, VET SURG, V38, P144, DOI 10.1111/j.1532-950X.2008.00481.x; Cook JL, 2016, J ORTHOP RES, V34, P607, DOI 10.1002/jor.23054; Fanchon L, 2007, AM J VET RES, V68, P1089, DOI 10.2460/ajvr.68.10.1089; Fitzpatrick N, 2009, VET SURG, V38, P261, DOI 10.1111/j.1532-950X.2008.00493.x; Franklin SP, 2015, AM J VET RES, V76, P822, DOI 10.2460/ajvr.76.9.822; Gibert S, 2012, VET COMP ORTHOPAED T, pA21; Gillette RL, 2014, CANINE REHABILITATIO, P201; Hirjakova Z, 2016, PHYSIOL RES, V65, pS409, DOI 10.33549/physiolres.933437; Hornof WJ, 2000, VET CLIN N AM-SMALL, V30, P257, DOI 10.1016/S0195-5616(00)50021-7; Kim SE, 2010, VET SURG, V39, P363, DOI 10.1111/j.1532-950X.2010.00655.x; Marghitu DB, 2003, NONLINEAR DYNAM, V33, P253, DOI 10.1023/A:1026096111497; Maurer C, 2005, J NEUROPHYSIOL, V93, P189, DOI 10.1152/jn.00221.2004; Moores AP, 2008, VET SURG, V37, P390, DOI 10.1111/j.1532-950X.2008.00393.x; Moraes VY, 2014, COCHRANE DB SYST REV, P4; Oosterlinck M, 2011, VET J, V190, P71, DOI 10.1016/j.tvjl.2010.08.016; Peham C, 2001, VET REC, V148, P750, DOI 10.1136/vr.148.24.750; Pinsault N, 2009, MED ENG PHYS, V31, P276, DOI 10.1016/j.medengphy.2008.08.003; Ruhe A, 2010, GAIT POSTURE, V32, P436, DOI 10.1016/j.gaitpost.2010.09.012; Sanchez M, 2008, CLIN EXP RHEUMATOL, V26, P910; Schmid M, 2002, MED ENG PHYS, V24, P623, DOI 10.1016/S1350-4533(02)00046-2; Scivoletto G, 2008, SPINE, V33, P259, DOI 10.1097/BRS.0b013e3181626ab0; Smith TJ, 2009, VET SURG, V38, P199, DOI 10.1111/j.1532-950X.2008.00488.x; Souza ANA, 2013, VET COMP ORTHOPAED, V26, P6, DOI 10.3415/VCOT-11-07-0100; SWAIM SF, 1985, J AM ANIM HOSP ASSOC, V21, P329; Tamburella F, 2013, EUR J PHYS REHAB MED, V49, P353; Temwichitr J, 2010, VET J, V185, P123, DOI 10.1016/j.tvjl.2009.06.022; Vassalo FG, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0158-3; Vilar JM, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-143; Vilar JM, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-131; Villamonte-Chevalier A, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0556-9; Whiteside D, 2015, J SPORT SCI, V33, P675, DOI 10.1080/02640414.2014.962569; Winter DA, 1996, J NEUROPHYSIOL, V75, P2334, DOI 10.1152/jn.1996.75.6.2334	42	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170692	10.1371/journal.pone.0170692	http://dx.doi.org/10.1371/journal.pone.0170692			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114312	Green Submitted, Green Published, gold			2022-12-26	WOS:000396129000084
J	Ahlstrom, LS; Vorontsov, II; Shi, J; Miyashita, O				Ahlstrom, Logan S.; Vorontsov, Ivan I.; Shi, Jun; Miyashita, Osamu			Effect of the Crystal Environment on Side-Chain Conformational Dynamics in Cyanovirin-N Investigated through Crystal and Solution Molecular Dynamics Simulations	PLOS ONE			English	Article							LAMBDA CRO DIMER; CONFIGURATIONAL ENTROPY; FORCE-FIELD; PROTEIN; BINDING; RECOGNITION; PACKING; GP120; FORMS	Side chains in protein crystal structures are essential for understanding biochemical processes such as catalysis and molecular recognition. However, crystal packing could influence side-chain conformation and dynamics, thus complicating functional interpretations of available experimental structures. Here we investigate the effect of crystal packing on side-chain conformational dynamics with crystal and solution molecular dynamics simulations using Cyanovirin-N as a model system. Side-chain ensembles for solvent-exposed residues obtained from simulation largely reflect the conformations observed in the X-ray structure. This agreement is most striking for crystal-contacting residues during crystal simulation. Given the high level of correspondence between our simulations and the X-ray data, we compare side-chain ensembles in solution and crystal simulations. We observe large decreases in conformational entropy in the crystal for several long, polar and contacting residues on the protein surface. Such cases agree well with the average loss in conformational entropy per residue upon protein folding and are accompanied by a change in side-chain conformation. This finding supports the application of surface engineering to facilitate crystallization. Our simulation-based approach demonstrated here with Cyanovirin-N establishes a framework for quantitatively comparing side-chain ensembles in solution and in the crystal across a larger set of proteins to elucidate the effect of the crystal environment on protein conformations.	[Ahlstrom, Logan S.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Vorontsov, Ivan I.; Shi, Jun] Univ Arizona, Dept Chem & Biochem, Tucson, AZ USA; [Miyashita, Osamu] RIKEN, Adv Inst Computat Sci, Chuo Ku, Kobe, Hyogo, Japan; [Vorontsov, Ivan I.] Ventana Med Syst Inc, 1910 E Innovat Pk Dr, Tucson, AZ USA	University of Michigan System; University of Michigan; University of Arizona; RIKEN; Roche Holding; Ventana Medical Systems, Inc.	Miyashita, O (corresponding author), RIKEN, Adv Inst Computat Sci, Chuo Ku, Kobe, Hyogo, Japan.	osamu.miyashita@riken.jp			National Institutes of Health [GM084905]; Achievement Rewards for College Scientists; Japan Society for the Promotion of Science KAKENHI [25891031, 26119006]; FOCUS Establishing Supercomputing Center of Excellence	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Achievement Rewards for College Scientists; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); FOCUS Establishing Supercomputing Center of Excellence	This work was supported by the National Institutes of Health (training grant GM084905, to LSA), Achievement Rewards for College Scientists (Phoenix chapter, to LSA), Japan Society for the Promotion of Science KAKENHI (grant numbers 25891031 and 26119006, to OM) and FOCUS Establishing Supercomputing Center of Excellence (to OM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Acharya C, 2011, CURR COMPUT-AID DRUG, V7, P10, DOI 10.2174/157340911793743547; Ahlstrom LS, 2014, PROTEINS, V82, P1128, DOI 10.1002/prot.24478; Ahlstrom LS, 2013, INT J QUANTUM CHEM, V113, P518, DOI 10.1002/qua.24029; Ahlstrom LS, 2011, BIOPHYS J, V101, P2516, DOI 10.1016/j.bpj.2011.10.016; [Anonymous], 2008, AMBER 10; Balzarini Jan, 2007, Antiviral Chemistry & Chemotherapy, V18, P1; BLABER M, 1994, J MOL BIOL, V235, P600, DOI 10.1006/jmbi.1994.1016; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cerutti DS, 2009, J PHYS CHEM B, V113, P6971, DOI 10.1021/jp9010372; Chodera JD, 2013, ANNU REV BIOPHYS, V42, P121, DOI 10.1146/annurev-biophys-083012-130318; CREAMER TP, 1992, P NATL ACAD SCI USA, V89, P5937, DOI 10.1073/pnas.89.13.5937; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Derewenda ZS, 2006, ACTA CRYSTALLOGR D, V62, P116, DOI 10.1107/S0907444905035237; Derewenda ZS, 2011, ACTA CRYSTALLOGR D, V67, P243, DOI 10.1107/S0907444911007797; DOIG AJ, 1995, PROTEIN SCI, V4, P2247, DOI 10.1002/pro.5560041101; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Eyal E, 2005, J MOL BIOL, V351, P431, DOI 10.1016/j.jmb.2005.05.066; Eyal E, 2004, J COMPUT CHEM, V25, P712, DOI 10.1002/jcc.10420; FLORES TP, 1993, PROTEIN SCI, V2, P1811, DOI 10.1002/pro.5560021104; Fraser JS, 2011, P NATL ACAD SCI USA, V108, P16247, DOI 10.1073/pnas.1111325108; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; Fromme R, 2008, PROTEIN SCI, V17, P939, DOI 10.1110/ps.083472808; Fromme R, 2007, BIOCHEMISTRY-US, V46, P9199, DOI 10.1021/bi700666m; Furnham N, 2006, NAT STRUCT MOL BIOL, V13, P184, DOI 10.1038/nsmb0306-184; GELIN BR, 1979, BIOCHEMISTRY-US, V18, P1256, DOI 10.1021/bi00574a022; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; Janowski PA, 2016, PROTEIN SCI, V25, P87, DOI 10.1002/pro.2713; Juers DH, 2001, J MOL BIOL, V311, P851, DOI 10.1006/jmbi.2001.4891; KARPLUS M, 1987, BIOPHYS J, V52, P1083, DOI 10.1016/S0006-3495(87)83303-9; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; KOEHL P, 1994, J MOL BIOL, V239, P249, DOI 10.1006/jmbi.1994.1366; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Kumar S, 2000, PROTEIN SCI, V9, P10; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LEE KH, 1994, PROTEINS, V20, P68, DOI 10.1002/prot.340200108; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; PICKETT SD, 1993, J MOL BIOL, V231, P825, DOI 10.1006/jmbi.1993.1329; Reeves JD, 2005, DRUGS, V65, P1747, DOI 10.2165/00003495-200565130-00002; Reiser B, 1999, J ROY STAT SOC D-STA, V48, P413, DOI 10.1111/1467-9884.00199; Saff EB, 1997, MATH INTELL, V19, P5, DOI 10.1007/BF03024331; Terada T, 2012, J PHYS CHEM B, V116, P6810, DOI 10.1021/jp2125558; VANGUNSTEREN WF, 1984, J MOL BIOL, V176, P559, DOI 10.1016/0022-2836(84)90177-3; Vorontsov II, 2011, J COMPUT CHEM, V32, P1043, DOI 10.1002/jcc.21683; Vorontsov II, 2009, BIOPHYS J, V97, P2532, DOI 10.1016/j.bpj.2009.08.011; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; ZHANG XJ, 1995, J MOL BIOL, V250, P527, DOI 10.1006/jmbi.1995.0396	51	5	5	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170337	10.1371/journal.pone.0170337	http://dx.doi.org/10.1371/journal.pone.0170337			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107510	Green Published, gold, Green Submitted			2022-12-26	WOS:000392405300114
J	Budnik, A; Henneberg, M				Budnik, Alicja; Henneberg, Maciej			Worldwide Increase of Obesity Is Related to the Reduced Opportunity for Natural Selection	PLOS ONE			English	Article							BODY-MASS INDEX; EVOLUTIONARY ORIGINS; PREVALENCE; MUTATION; CHILDHOOD; MEDICINE	Worldwide rise of obesity may be partly related to the relaxation of natural selection in the last few generations. Accumulation of mutations affecting metabolism towards excessive fat deposition is suggested to be a result of less purging selection. Using the WHO and UN data for 159 countries there is a significant correlation (r = 0.60, p<0.01) between an index of the relaxed opportunity for selection (Biological State Index) and prevalence of obesity (percentage of individuals with BMI > 30kg/m(2)). This correlation remains significant (r = 0.32., p<0.01) when caloric intake and insufficient physical activity prevalence are kept statistically constant (partial correlation analysis, N = 82). The correlation is still significant when gross domestic product per capita is also kept constant (r = 0.24, p < 0.05, N = 81). In the last decades, prevalence of both obesity and underweight has increased in some countries despite no change in caloric intake nor in physical inactivity prevalence. Relaxed selection against genes affecting energy balance and metabolism may contribute to the increase of fatness independent from commonly considered positive energy balance. Diagnoses of individual predispositions to obesity at an early age and individual counselling on diet and behaviour may be appropriate strategies to limit further increases in body mass.	[Budnik, Alicja] Adam Mickiewicz Univ, Inst Anthropol, Poznan, Poland; [Budnik, Alicja] Cardinal Stefan Wyszynski Univ, Dept Human Biol, Warsaw, Poland; [Henneberg, Maciej] Univ Adelaide, Biol Anthropol & Comparat Anat Unit, Adelaide, SA, Australia; [Henneberg, Maciej] Univ Zurich, Inst Evolutionary Med, Zurich, Switzerland	Adam Mickiewicz University; Cardinal Stefan Wyszynski University in Warsaw; University of Adelaide; University of Zurich	Henneberg, M (corresponding author), Univ Adelaide, Biol Anthropol & Comparat Anat Unit, Adelaide, SA, Australia.; Henneberg, M (corresponding author), Univ Zurich, Inst Evolutionary Med, Zurich, Switzerland.	maciej.henneberg@iem.uzh.ch	Budnik, Alicja/K-2291-2019	Budnik, Alicja/0000-0002-9916-9775; Henneberg, Maciej/0000-0003-1941-2286	University of Adelaide	University of Adelaide	Wood Jones Bequest to the University of Adelaide. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera CM, 2013, NUTR HOSP, V28, P44, DOI 10.3305/nh.2013.28.sup5.6917; Cheng YLJ, 2013, DIABETES CARE, V36, P2690, DOI 10.2337/dc12-2074; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; CROW JF, 1958, AM ANTHROPOL, V60, P1; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Grantham JP, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-15; Henn BM, 2015, NAT REV GENET, V16, P333, DOI 10.1038/nrg3931; Henneberg M., 2011, Food and Nutrition Sciences, V2, P1054, DOI 10.4236/fns.2011.210141; HENNEBERG M, 1976, J HUM EVOL, V5, P41, DOI 10.1016/0047-2484(76)90098-1; Henneberg M, 2003, KINANTHREPORT, V16, P34; Henneberg M, 1975, ANTHROPOS ATHENS, V2, P31; Henneberg M, 1975, PRZEGLAD ANTROPOLOGI, VXLI, P191; Henneberg M, 2010, AM J HUM BIOL, V22, P83, DOI 10.1002/ajhb.20957; Koziel S, 2006, INT J OBESITY, V30, P1382, DOI 10.1038/sj.ijo.0803292; Kunej T, 2012, J GENOMICS, V1, P45; Lucas T, 2014, AM J HUM BIOL, V26, P151, DOI 10.1002/ajhb.22494; Menke A, 2014, ANN INTERN MED, V161, P328, DOI 10.7326/M14-0286; Nan C, 2012, EUR J EPIDEMIOL, V27, P247, DOI 10.1007/s10654-012-9678-6; Naukkarinen J, 2012, INT J OBESITY, V36, P1017, DOI 10.1038/ijo.2011.192; Neel JV, 1999, NUTR REV, V57, pS2, DOI 10.1111/j.1753-4887.1999.tb01782.x; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nguyen DM, 2010, GASTROENTEROL CLIN N, V39, P1, DOI 10.1016/j.gtc.2009.12.014; Pettitt DJ, 2014, DIABETES CARE, V37, P402, DOI 10.2337/dc13-1838; PIONTEK J, 1981, AM J PHYS ANTHROPOL, V54, P129, DOI 10.1002/ajpa.1330540116; Prentice AM, 2008, INT J OBESITY, V32, P1607, DOI 10.1038/ijo.2008.147; Saniotis A, 2011, MED HYPOTHESES, V77, P560, DOI 10.1016/j.mehy.2011.06.031; Sellayah D, 2014, ENDOCRINOLOGY, V155, P1573, DOI 10.1210/en.2013-2103; Speakman JR, 2008, INT J OBESITY, V32, P1611, DOI 10.1038/ijo.2008.161; Stephan CN, 2001, MED HYPOTHESES, V57, P633, DOI 10.1054/mehy.2001.1431; You WP, 2016, BMJ OPEN DIAB RES CA, V4, DOI 10.1136/bmjdrc-2015-000161	32	23	23	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170098	10.1371/journal.pone.0170098	http://dx.doi.org/10.1371/journal.pone.0170098			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107497	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000392405300074
J	Campuzano, A; Castro-Lopez, N; Wozniak, KL; Wager, CML; Wormley, FL				Campuzano, Althea; Castro-Lopez, Natalia; Wozniak, Karen L.; Wager, Chrissy M. Leopold; Wormley, Floyd L., Jr.			Dectin-3 Is Not Required for Protection against Cryptococcus neoformans Infection	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTOR; HOST-DEFENSE; BETA-GLUCAN; PULMONARY INFECTION; LECTIN RECEPTORS; MENINGITIS; IMMUNITY; ACTIVATION; CELLS; DIFFERENTIATION	C-type lectin receptors (CLRs) are diverse, trans-membrane proteins that function as pattern recognition receptors (PRRs) which are necessary for orchestrating immune responses against pathogens. CLRs have been shown to play a major role in recognition and protection against fungal pathogens. Dectin-3 (also known as MCL, Clecsf8, or Clec4d) is a myeloid cell-specific CLR that recognizes mycobacterial trehalose 6,6'-dimycolate (TDM) as well as a-mannans present in the cell wall of fungal pathogens. To date, a potential role for Dectin-3 in the mediation of protective immune responses against C. neoformans has yet to be determined. Consequently, we evaluated the impact of Dectin-3 deficiency on the development of protective immune responses against C. neoformans using an experimental murine model of pulmonary cryptococcosis. Dectin-3 deficiency did not lead to increased susceptibility of mice to experimental pulmonary C. neoformans infection. Also, no significant differences in pulmonary leukocyte recruitment and cytokine production were observed in Dectin-3 deficient mice compared to wild type infected mice. In addition, we observed no differences in uptake and anti-cryptococcal activity of Dectin-3 deficient dendritic cells and macrophages. Altogether, our studies show that Dectin-3 is dispensable for mediating protective immune responses against pulmonary C. neoformans infection.	[Campuzano, Althea; Castro-Lopez, Natalia; Wozniak, Karen L.; Wager, Chrissy M. Leopold; Wormley, Floyd L., Jr.] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA; [Campuzano, Althea; Castro-Lopez, Natalia; Wager, Chrissy M. Leopold; Wormley, Floyd L., Jr.] Univ Texas San Antonio, South Texas Ctr Emerging Infect Dis, San Antonio, TX 78249 USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA)	Wormley, FL (corresponding author), Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA.; Wormley, FL (corresponding author), Univ Texas San Antonio, South Texas Ctr Emerging Infect Dis, San Antonio, TX 78249 USA.	floyd.wormley@utsa.edu	Castro-Lopez, Natalia/ABA-7490-2020	Wozniak, Karen/0000-0003-1798-2146; Leopold Wager, Chrissy/0000-0002-3828-055X; Campuzano, Althea/0000-0003-3159-7113	National Institute on Minority Health and Health Disparities [G12MD007591]; National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) [2RO1AI071752]; Army Research Office of the Department of Defense [W911NF-11-1-0136]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060655] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Army Research Office of the Department of Defense; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by grants from the National Institute on Minority Health and Health Disparities (G12MD007591) and the National Institute of Allergy and Infectious Diseases 2RO1AI071752 (NIAID) of the National Institutes of Health (NIH) and by Army Research Office of the Department of Defense No. W911NF-11-1-0136. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora S, 2011, INFECT IMMUN, V79, P1915, DOI 10.1128/IAI.01270-10; Bicanic T, 2007, CLIN INFECT DIS, V45, P76, DOI 10.1086/518607; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Bugarcic A, 2008, GLYCOBIOLOGY, V18, P679, DOI 10.1093/glycob/cwn046; Dambuza IM, 2015, CURR OPIN IMMUNOL, V32, P21, DOI 10.1016/j.coi.2014.12.002; Doering TL, 2009, ANNU REV MICROBIOL, V63, P223, DOI 10.1146/annurev.micro.62.081307.162753; Drummond RA, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00039; Goldman DL, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e66; Gow NAR, 2007, J INFECT DIS, V196, P1565, DOI 10.1086/523110; Graham LM, 2012, J BIOL CHEM, V287, P25964, DOI 10.1074/jbc.M112.384164; Hole C, 2016, J MICROBIOL, V54, P202, DOI 10.1007/s12275-016-5625-7; Hole CR, 2012, SCI REP-UK, V2, DOI 10.1038/srep00739; HUFFNAGLE GB, 1991, J EXP MED, V173, P793, DOI 10.1084/jem.173.4.793; Husain S, 2001, EMERG INFECT DIS, V7, P375; Jarvis JN, 2014, CLIN INFECT DIS, V58, P736, DOI 10.1093/cid/cit794; Karkowska-Kuleta J, 2015, ACTA BIOCHIM POL, V62, P339, DOI 10.18388/abp.2015_1032; Kelly RM, 2005, INFECT IMMUN, V73, P592, DOI 10.1128/IAI.73.1.592-598.2005; Kerscher B, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.007; Kwon-Chung KJ, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019760; Lobato-Pascual A, 2013, EUR J IMMUNOL, V43, P3167, DOI 10.1002/eji.201343752; Mansour MK, 2006, J IMMUNOL, V176, P3053, DOI 10.4049/jimmunol.176.5.3053; Mansour MK, 2002, J IMMUNOL, V168, P2872, DOI 10.4049/jimmunol.168.6.2872; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Nakamura K, 2007, MICROBIOL IMMUNOL, V51, P1115, DOI 10.1111/j.1348-0421.2007.tb04007.x; Nakamura Y, 2015, INFECT IMMUN, V83, P671, DOI 10.1128/IAI.02835-14; O'Meara TR, 2012, CLIN MICROBIOL REV, V25, P387, DOI 10.1128/CMR.00001-12; Ostrop J, 2015, J IMMUNOL, V195, P2417, DOI 10.4049/jimmunol.1500102; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; POWDERLY WG, 1993, CLIN INFECT DIS, V17, P837, DOI 10.1093/clinids/17.5.837; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; vanderHorst CM, 1997, NEW ENGL J MED, V337, P15, DOI 10.1056/NEJM199707033370103; Wager CML, 2014, MUCOSAL IMMUNOL, V7, P1023, DOI 10.1038/mi.2014.65; Wager CML, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00105; Wager CML, 2015, INFECT IMMUN, V83, P4513, DOI 10.1128/IAI.00935-15; Wang HF, 2016, INFECT IMMUN, V84, P635, DOI 10.1128/IAI.01263-15; Wilson GJ, 2015, CELL HOST MICROBE, V17, P252, DOI 10.1016/j.chom.2015.01.004; Wozniak KL, 2006, INFECT IMMUN, V74, P3817, DOI 10.1128/IAI.00317-06; Wuthrich M, 2015, EUR J IMMUNOL, V45, P2542, DOI 10.1002/eji.201545591; Yamamoto H, 2014, INFECT IMMUN, V82, P1606, DOI 10.1128/IAI.01089-13; Zhao XQ, 2014, J BIOL CHEM, V289, P30052, DOI 10.1074/jbc.M114.588574; Zhu LL, 2013, IMMUNITY, V39, P324, DOI 10.1016/j.immuni.2013.05.017	44	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0169347	10.1371/journal.pone.0169347	http://dx.doi.org/10.1371/journal.pone.0169347			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107361	Green Submitted, Green Published, gold			2022-12-26	WOS:000392405300023
J	de Campos, LM; Martins, BM; Cabral, NL; Franco, SC; Pontes-Neto, OM; Mazin, SC; dos Reis, FI				de Campos, Livia Mizuki; Martins, Bruna Mariah; Cabral, Norberto Luiz; Franco, Selma Cristina; Pontes-Neto, Octavio Marques; Mazin, Suleimy Cristina; dos Reis, Felipe Ibiapina			How Many Patients Become Functionally Dependent after a Stroke? A 3-Year Population-Based Study in Joinville, Brazil	PLOS ONE			English	Article							MODIFIED RANKIN SCALE; ISCHEMIC-STROKE; GUIDELINES; OUTCOMES; TRENDS	The decrease in stroke mortality will increase the burden of survivors with functional dependence (FD). The aim of this study was to evaluate how many patients become functionally dependent over 3 years after an incident event in Joinville, Brazil. The proportion of FD (defined as a modified Rankin score 3 to 5) among stroke survivors from the Joinville Stroke Registry was assessed using a validated telephone interview. Incidence of FD after stroke in Joinville in one year was 23.24 per 100,000 population. The overall proportion of FD among stroke survivors at discharge was 32.7%. Of 303 patients with first-ever ischaemic stroke (IS), one-third were FD at discharge, and 12%, 9% and 8%, respectively at 1, 2 and 3 years. Among 37 patients with haemorrhagic stroke (HS), 38% were dependent at discharge, 16% after 1 and 2 years and 14% after 3. Among 27 patients with subarachnoid haemorrhage (SAH), 19% were dependent at discharge and 4% from 1 to 3 years. Among IS subtypes, cardioembolic ones had the worst risk of FD. (RR 19.8; 95% CI: 2.2 to 175.9). Our results showed that one-third of stroke survivors have FD during the first year after stroke in Brazil. Therefore, a city with half a million people might expect 120 new stroke patients with FD each year.	[de Campos, Livia Mizuki; Martins, Bruna Mariah; Cabral, Norberto Luiz; Franco, Selma Cristina; dos Reis, Felipe Ibiapina] Univ Regiao Joinville, Dept Med, Joinville, SC, Brazil; [Cabral, Norberto Luiz] Univ Regiao Joinville, Joinville Stroke Registry, Joinville, SC, Brazil; [Pontes-Neto, Octavio Marques; Mazin, Suleimy Cristina] Univ Sao Paulo, Dept Med, Ribeirao Preto, SP, Brazil	Universidade da Regiao de Joinville; Universidade da Regiao de Joinville; Universidade de Sao Paulo	Franco, SC (corresponding author), Univ Regiao Joinville, Dept Med, Joinville, SC, Brazil.	scfranco@terra.com.br	Pontes-Neto, Octavio Marques/G-4294-2012; Cabral, Norberto Luiz/N-7906-2016	Pontes-Neto, Octavio Marques/0000-0003-0317-843X; Cabral, Norberto Luiz/0000-0001-5829-9699	University of Joinville Region; Joinville Municipal Health Department; Brazilian National Council for Scientific and Technological Development (CNPq) [402396/2013-8, 402388/2013-5]	University of Joinville Region; Joinville Municipal Health Department; Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The University of Joinville Region supported providing research supplies, www.univille.edu.br; the Joinville Municipal Health Department supported with maintenance expenses of the Joinville Stroke Registry, https://saude.joinville.sc.gov.br/; the Brazilian National Council for Scientific and Technological Development (CNPq) provided grants to OMPN. Grants: 402396/2013-8 and 402388/2013-5, http://cnpq.br.	Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Asplund K, 2005, LANCET NEUROL, V4, P64, DOI 10.1016/S1474-4422(04)00967-6; Baggio JAO, 2014, CEREBROVASC DIS, V38, P297, DOI 10.1159/000367646; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Bensenor IM, 2015, ARQ NEURO-PSIQUIAT, V73, P746, DOI 10.1590/0004-282X20150115; Cabral NL, 2009, J NEUROL NEUROSUR PS, V80, P749, DOI 10.1136/jnnp.2008.164475; Cabral NL, 2016, NEUROEPIDEMIOLOGY, V46, P273, DOI 10.1159/000445060; Dobkin BH, 2005, NEW ENGL J MED, V352, P1677, DOI 10.1056/NEJMcp043511; Fang J., 2011, USING SAS PROCEDURES; Feigin VL, 2010, NEUROLOGY, V75, P1597, DOI 10.1212/WNL.0b013e3181fb44b3; Grotta JC, 2015, STROKE, V46, P1447, DOI 10.1161/STROKEAHA.115.008384; Hendricks HT, 2002, ARCH PHYS MED REHAB, V83, P1629, DOI 10.1053/apmr.2002.35473; Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI 10.1016/S2214-109X(13)70089-5; Kulesh SD, 2011, STROKE, V42, P3274, DOI 10.1161/STROKEAHA.111.625400; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Oliveira J, 2012, ARQ NEURO-PSIQUIAT, V70, P621, DOI 10.1590/S0004-282X2012000800012; Paiva GFS, CONSUMPTION AND SOCI; Rothwell PM, 1981, LANCET, V2004, P1925, DOI DOI 10.1016/S0140-6736(04); Schnitzler A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115375; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Sudlow CLM, 1996, STROKE, V27, P550, DOI 10.1161/01.STR.27.3.550; Sulter G, 1999, STROKE, V30, P1538, DOI 10.1161/01.STR.30.8.1538; Truelsen T, 2007, LANCET NEUROL, V6, P134, DOI 10.1016/S1474-4422(06)70686-X; Ullberg T, 2015, STROKE, V46, P389, DOI 10.1161/STROKEAHA.114.006538; Wolfe CDA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001033	26	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170204	10.1371/journal.pone.0170204	http://dx.doi.org/10.1371/journal.pone.0170204			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107401	Green Published, gold, Green Submitted			2022-12-26	WOS:000392405300086
J	Malo, MC; Duchemin, AL; Guglielmi, L; Patzel, E; Sel, S; Auffarth, GU; Carl, M; Poggi, L				Malo, Meret Cepero; Duchemin, Anne-Laure; Guglielmi, Luca; Patzel, Eva; Sel, Saadettin; Auffarth, Gerd U.; Carl, Matthias; Poggi, Lucia			The Zebrafish Anillin-eGFP Reporter Marks Late Dividing Retinal Precursors and Stem Cells Entering Neuronal Lineages	PLOS ONE			English	Article							IN-VIVO; MULLER GLIA; NEUROEPITHELIAL CELLS; BASAL PROCESS; DIVISIONS; REGENERATION; PROGENITORS; LOCALIZATION; EXPRESSION; CARCINOMA	Monitoring cycling behaviours of stem and somatic cells in the living animal is a powerful tool to better understand tissue development and homeostasis. The tg(anillin: anillin-eGFP) transgenic line carries the full-length zebrafish F-actin binding protein Anillin fused to eGFP from a bacterial artificial chromosome (BAC) containing Anillin cis-regulatory sequences. Here we report the suitability of the Anillin-eGFP reporter as a direct indicator of cycling cells in the late embryonic and post-embryonic retina. We show that combining the anillin: anillin-GFP with other transgenes such as ptf1a: dsRed and atoh7: gap-RFP allows obtaining spatial and temporal resolution of the mitotic potentials of specific retinal cell populations. This is exemplified by the analysis of the origin of the previously reported apically and non-apically dividing late committed precursors of the photoreceptor and horizontal cell layers.	[Malo, Meret Cepero; Duchemin, Anne-Laure; Patzel, Eva; Poggi, Lucia] Heidelberg Univ, Ctr Organismal Studies, Heidelberg, Germany; [Guglielmi, Luca; Carl, Matthias] Heidelberg Univ, Med Fac Mannheim, Dept Cell & Mol Biol, Mannheim, Germany; [Sel, Saadettin; Auffarth, Gerd U.; Poggi, Lucia] Univ Heidelberg Hosp, Dept Ophthalmol, David J Apple Ctr Vis Res, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Poggi, L (corresponding author), Heidelberg Univ, Ctr Organismal Studies, Heidelberg, Germany.; Poggi, L (corresponding author), Univ Heidelberg Hosp, Dept Ophthalmol, David J Apple Ctr Vis Res, Heidelberg, Germany.	lucia.poggi@med.uni-heidelberg.de	Duchemin, Anne-Laure/GYV-1739-2022; Guglielmi, Luca/GYD-7659-2022; Auffarth, Gerd/AAE-6805-2021; Poggi, Lucia/AAF-7911-2019	Duchemin, Anne-Laure/0000-0002-2897-0821; Auffarth, Gerd/0000-0002-6927-5251; Carl, Matthias/0000-0002-9936-5813; Sel, Prof. Dr. med. Saadettin/0000-0003-3307-3305	Deutsche Forschungsgemeinschaft (DFG) [PO 1440/1-1, SE 1995/1-1]; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing	This work was supported by a Deutsche Forschungsgemeinschaft (DFG) research grants to Lucia Poggi [PO 1440/1-1] and to Saadettin Sel [SE 1995/1-1]. We acknowledge the financial support of the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajioka I, 2007, CELL, V131, P378, DOI 10.1016/j.cell.2007.09.036; Baye LM, 2007, J NEUROSCI, V27, P10143, DOI 10.1523/JNEUROSCI.2754-07.2007; Bernardos RL, 2007, J NEUROSCI, V27, P7028, DOI 10.1523/JNEUROSCI.1624-07.2007; Boije H, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00077; Boije H, 2009, DEV BIOL, V330, P105, DOI 10.1016/j.ydbio.2009.03.013; Centanin L, 2011, CELL STEM CELL, V9, P553, DOI 10.1016/j.stem.2011.11.004; Edqvist PHD, 2004, DEVELOPMENT, V131, P1343, DOI 10.1242/dev.01018; FIELD CM, 1995, J CELL BIOL, V131, P165, DOI 10.1083/jcb.131.1.165; Fischer AJ, 2001, NAT NEUROSCI, V4, P247, DOI 10.1038/85090; Gbadegesin RA, 2014, J AM SOC NEPHROL; Godinho L, 2007, NEURON, V56, P597, DOI 10.1016/j.neuron.2007.09.036; Hamon A, 2016, DEV DYNAM, V245, P727, DOI [10.1002/DVDY.24375, 10.1002/dvdy.24375]; He J, 2012, NEURON, V75, P786, DOI 10.1016/j.neuron.2012.06.033; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hesse M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2089; Jusuf P, 2013, COLD SPRING HARB PRO, V2013; Jusuf P, 2013, COLD SPRING HARB PRO, V2013; Jusuf PR, 2012, J NEUROSCI, V32, P13929, DOI 10.1523/JNEUROSCI.2073-12.2012; Jusuf PR, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-34; Jusuf PR, 2010, IMAGING DEV BIOL LAB, p[253, 253]; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kosodo Y, 2009, DEV GROWTH DIFFER, V51, P251, DOI 10.1111/j.1440-169X.2009.01101.x; Kosodo Y, 2008, EMBO J, V27, P3151, DOI 10.1038/emboj.2008.227; Lenkowski JR, 2014, PROG RETIN EYE RES, V40, P94, DOI 10.1016/j.preteyeres.2013.12.007; Liang PI, 2015, J CLIN PATHOL, V68, P1026, DOI 10.1136/jclinpath-2015-202958; Paolini A, 2015, DEVELOPMENT, V142, P832, DOI 10.1242/dev.118612; Perron M, 2000, BIOESSAYS, V22, P685, DOI 10.1002/1521-1878(200008)22:8<685::AID-BIES1>3.0.CO;2-C; Piekny AJ, 2010, SEMIN CELL DEV BIOL, V21, P881, DOI 10.1016/j.semcdb.2010.08.002; Poche RA, 2009, DEVELOPMENT, V136, P2141, DOI 10.1242/dev.033175; Poggi L, 2005, J CELL BIOL, V171, P991, DOI 10.1083/jcb.200509098; Raymond PA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-36; Reinhardt R, 2015, EMBO J, V34, P1572, DOI 10.15252/embj.201490706; Ronkainen H, 2011, ONCOL REP, V25, P129, DOI 10.3892/or_00001051; Sharif B, 2015, GENE EXPR PATTERNS, V17, P98, DOI 10.1016/j.gep.2015.03.002; Singh D, 2014, DEV CELL, V28, P253, DOI 10.1016/j.devcel.2014.01.002; Sugiyama M, 2009, P NATL ACAD SCI USA, V106, P20812, DOI 10.1073/pnas.0906464106; Suzuki SC, 2013, P NATL ACAD SCI USA, V110, P15109, DOI 10.1073/pnas.1303551110; Tian D, 2015, CURR BIOL, P1; Wan Y, 2016, DEVELOPMENT; Wang D, 2015, CELL MOL LIFE SCI; Weber IP, 2014, CELL REP, V7, P386, DOI 10.1016/j.celrep.2014.03.014; Wullimann MF, 2000, ANAT EMBRYOL, V202, P385, DOI 10.1007/s004290000115; Zhang L, 2010, CURR BIOL, V20, pR135, DOI 10.1016/j.cub.2009.12.017; Zhou W, 2014, MOL CELL BIOCH; Zolessi FR, 2006, NEURAL DEV, V1, DOI 10.1186/1749-8104-1-2	46	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170356	10.1371/journal.pone.0170356	http://dx.doi.org/10.1371/journal.pone.0170356			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107513	Green Published, gold, Green Submitted			2022-12-26	WOS:000392405300117
J	Somanathan, H; Borges, RM; Warrant, EJ; Kelber, A				Somanathan, Hema; Borges, Renee Maria; Warrant, Eric J.; Kelber, Almut			Visual Adaptations for Mate Detection in the Male Carpenter Bee Xylocopa tenuiscapa	PLOS ONE			English	Article							FEMALE CHOICE SELECTS; SEXUAL-DIMORPHISM; COMPOUND EYES; MATING-BEHAVIOR; APIS-MELLIFERA; FUNCTIONAL-MORPHOLOGY; DRONE HONEYBEE; GENUS XYLOCOPA; EVOLUTION; HYMENOPTERA	Sexual dimorphism in eye structure is attributed to sexual selection in animals that employ vision for locating mates. In many male insects, large eyes and eye regions of higher acuity are believed to facilitate the location of females. Here, we compare various features of male and female eyes in three sympatric carpenter bee species, which include two diurnal species (Xylocopa tenuiscapa and X. leucothorax) as well as a nocturnal species (X. tranquebarica). In X. tenuiscapa, males have larger eyes than females, while in the nocturnal X. tranquebarica, males have slightly smaller eyes and in X. leucothorax, the eyes are of similar size in both sexes. X. tenuiscapa males detect females by perching near nest sites (resource defence) or along fly-ways and other open areas with good visibility. Males of the other two species search for females by patrolling. We postulate that the larger eyes of male X. tenuiscapa are beneficial to their mode of mate detection since perching males may benefit from a larger visual area of high resolution detecting moving stimuli across the sky, and which may be germane to the more social and gregarious nesting behaviour of this species, compared to the other solitary bees. We tested the performance of the eyes of male X. tenuiscapa behaviourally and find that a perching male can detect a flying female at a distance of 20 m, which darkens the visual field of a single ommatidium by just 2%. This, together with the bee's high spatial resolution permits detection of moving stimuli at least as well or even better than achieved by honey bee drones.	[Somanathan, Hema] Indian Inst Sci Educ & Res, Sch Biol, IISER TVM Ctr Res & Educ Ecol & Evolut ICREEE, Thiruvananthapuram, Kerala, India; [Borges, Renee Maria] Indian Inst Sci, Ctr Ecol Sci, Bangalore, Karnataka, India; [Warrant, Eric J.; Kelber, Almut] Lund Univ, Dept Biol, Lund Vis Grp, Lund, Sweden	Indian Institute of Science Education & Research (IISER) - Thiruvananthapuram; Indian Institute of Science (IISC) - Bangalore; Lund University	Somanathan, H (corresponding author), Indian Inst Sci Educ & Res, Sch Biol, IISER TVM Ctr Res & Educ Ecol & Evolut ICREEE, Thiruvananthapuram, Kerala, India.	hsomanathan@iisertvm.ac.in	Somanathan, Hema/S-9684-2019; Kelber, Almut/H-6216-2014	Warrant, Eric/0000-0001-7480-7016; Kelber, Almut/0000-0003-3937-2808	Swedish International Development Agency [348-2005-6058]; Swedish Research Council; Wenner-Gren	Swedish International Development Agency; Swedish Research Council(Swedish Research CouncilEuropean Commission); Wenner-Gren	This work was supported by the Swedish International Development Agency (Grant Number 348-2005-6058 to AK and RMB), the Swedish Research Council for research funds to AK and EJW and funding from Wenner-Gren to AK and HS.	ALCOCK J, 1987, J NAT HIST, V21, P319, DOI 10.1080/00222938700771041; Alcock J, 1997, J INSECT BEHAV, V10, P99, DOI 10.1007/BF02765477; ALCOCK J, 1977, AM NAT, V111, P145, DOI 10.1086/283145; ALCOCK J, 1993, BEHAVIOUR, V125, P199, DOI 10.1163/156853993X00245; ALLAN SA, 1991, CAN J ZOOL, V69, P369, DOI 10.1139/z91-057; ANDERSSON M, 1982, NATURE, V299, P818, DOI 10.1038/299818a0; ANZENBERGER G, 1977, Z TIERPSYCHOL, V44, P337; ARAK A, 1983, NATURE, V306, P261, DOI 10.1038/306261a0; Arikawa K, 2005, J NEUROSCI, V25, P5935, DOI 10.1523/JNEUROSCI.1364-05.2005; Baker RH, 2001, EVOLUTION, V55, P1373; Baudry E, 1998, P ROY SOC B-BIOL SCI, V265, P2009, DOI 10.1098/rspb.1998.0533; EICKWORT GC, 1980, ANNU REV ENTOMOL, V25, P421, DOI 10.1146/annurev.en.25.010180.002225; Eltz T, 2005, J COMP PHYSIOL A, V191, P575, DOI 10.1007/s00359-005-0603-2; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; GERLING D, 1989, ANNU REV ENTOMOL, V34, P163, DOI 10.1146/annurev.en.34.010189.001115; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; Hansson BS, 2011, NEURON, V72, P698, DOI 10.1016/j.neuron.2011.11.003; HARDIE RC, 1981, J COMP PHYSIOL, V145, P139, DOI 10.1007/BF00605029; Heubel KU, 2008, BEHAV ECOL, V19, P1080, DOI 10.1093/beheco/arn105; Hornstein EP, 2000, P ROY SOC B-BIOL SCI, V267, P2111, DOI 10.1098/rspb.2000.1257; HORRIDGE GA, 1978, PHILOS T R SOC B, V285, P1, DOI 10.1098/rstb.1978.0093; Horridge GA, 1986, P ROY SOC LOND B BIO, V200, P137; Hovorka O, 1998, J CHEM ECOL, V24, P183, DOI 10.1023/A:1022353315874; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Kelber A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021892; KIRKPATRICK M, 1982, EVOLUTION, V36, P1, DOI 10.1111/j.1558-5646.1982.tb05003.x; Kraaijeveld K, 2007, ANIM BEHAV, V74, P657, DOI 10.1016/j.anbehav.2006.12.027; Lailvaux SP, 2006, ANIM BEHAV, V72, P263, DOI 10.1016/j.anbehav.2006.02.003; LAND MF, 1985, J COMP PHYSIOL A, V156, P525, DOI 10.1007/BF00613976; LAND MF, 1974, J COMP PHYSIOL, V89, P331, DOI 10.1007/BF00695351; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; Leys R, 2000, J ZOOL, V252, P453, DOI 10.1111/j.1469-7998.2000.tb01228.x; Leys R, 2008, APIDOLOGIE, V39, P119, DOI 10.1051/apido:2007044; MENZEL JG, 1991, TISSUE CELL, V23, P525, DOI 10.1016/0040-8166(91)90010-Q; MILINSKI M, 1990, NATURE, V344, P330, DOI 10.1038/344330a0; MINCKLEY RL, 1991, J ZOOL, V224, P285, DOI 10.1111/j.1469-7998.1991.tb04805.x; Minckley RL, 1994, ZOOL J LINN SOC-LOND, V53, P291; MOLLER AP, 1988, NATURE, V332, P640, DOI 10.1038/332640a0; NOONAN KC, 1983, ANIM BEHAV, V31, P1005, DOI 10.1016/S0003-3472(83)80005-0; Nordstrom K, 2008, CURR BIOL, V18, P661, DOI 10.1016/j.cub.2008.03.061; Olsson M, 2002, EVOLUTION, V56, P1538; Osten T, 1989, STUTT BEITR NATURK A, V422, P1; PARKER GA, 1978, ANNU REV ENTOMOL, V23, P173, DOI 10.1146/annurev.en.23.010178.001133; Paxton RJ, 2005, APIDOLOGIE, V36, P145, DOI 10.1051/apido:2005007; RIBI WA, 1989, ENTOMOL GEN, V14, P233; Roubik D.W., 1990, ECOLOGY NATURAL HIST, V1st ed., P526, DOI [10.1126/science.248.4958.1026, DOI 10.1126/SCIENCE.248.4958.1026]; Rutowski RL, 2000, J ZOOL, V252, P187, DOI 10.1111/j.1469-7998.2000.tb00614.x; Rutowski RL, 2002, J COMP PHYSIOL A, V188, P1, DOI 10.1007/s00359-001-0273-7; Schluns H, 2005, ANIM BEHAV, V70, P125, DOI 10.1016/j.anbehav.2004.11.005; Seidemann K, 1999, J INSECT BEHAV, V12, P13, DOI 10.1023/A:1020920929613; Seidl R., 1980, VERHANDLUNGEN DTSCH, V1980, P367; SHAW SR, 1969, VISION RES, V9, P999, DOI 10.1016/0042-6989(69)90044-3; Sison-Mangus MP, 2006, J EXP BIOL, V209, P3079, DOI 10.1242/jeb.02360; SNYDER AW, 1977, J COMP PHYSIOL, V116, P183, DOI 10.1007/BF00605402; Somanathan H, 2001, BIOTROPICA, V33, P78, DOI 10.1111/j.1744-7429.2001.tb00159.x; Somanathan H, 2008, CURR BIOL, V18, pR996, DOI 10.1016/j.cub.2008.08.023; Somanathan H, 2008, J COMP PHYSIOL A, V194, P97, DOI 10.1007/s00359-007-0291-1; Somanathan H, 2009, J COMP PHYSIOL A, V195, P571, DOI 10.1007/s00359-009-0432-9; Straw AD, 2006, J EXP BIOL, V209, P4339, DOI 10.1242/jeb.02517; Streinzer M, 2014, ZOOL J LINN SOC-LOND, V170, P735, DOI 10.1111/zoj.12117; Streinzer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057702; VALLET AM, 1991, VISION RES, V31, P1453, DOI 10.1016/0042-6989(91)90065-D; VALLET AM, 1993, J COMP PHYSIOL A, V172, P183; WILBUR HM, 1978, EVOLUTION, V32, P264, DOI 10.1111/j.1558-5646.1978.tb00642.x; WITTMANN D, 1989, BEHAV ECOL SOCIOBIOL, V25, P387, DOI 10.1007/BF00300184; ZEIL J, 1983, J COMP PHYSIOL, V150, P379, DOI 10.1007/BF00605027	67	17	17	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0168452	10.1371/journal.pone.0168452	http://dx.doi.org/10.1371/journal.pone.0168452			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107354	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000392405300012
J	Yasin, B; Kohn, E; Peters, M; Zaguri, R; Weiss, S; Schopf, K; Katz, B; Huber, A; Minke, B				Yasin, Bushra; Kohn, Elkana; Peters, Maximilian; Zaguri, Rachel; Weiss, Shirley; Schopf, Krystina; Katz, Ben; Huber, Armin; Minke, Baruch			Ectopic Expression of Mouse Melanopsin in Drosophila Photoreceptors Reveals Fast Response Kinetics and Persistent Dark Excitation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drosophila; electrophysiology; gene expression; photoreceptor; rhodopsin; Opn4; Early Receptor Potential; single photon response	RETINAL GANGLION-CELLS; IN-VIVO; VISUAL PIGMENT; PHOSPHOLIPASE-C; G-PROTEIN; PHOTOTRANSDUCTION CASCADE; HETEROLOGOUS EXPRESSION; GENETIC DISSECTION; LIGHT RESPONSE; RHODOPSIN	The intrinsically photosensitive M1 retinal ganglion cells (ipRGC) initiate non-image-forming light-dependent activities and express the melanopsin (OPN4) photopigment. Several features of ipRGC photosensitivity are characteristic of fly photoreceptors. However, the light response kinetics of ipRGC is much slower due to unknown reasons. Here we used transgenic Drosophila, in which the mouse OPN4 replaced the native Rh1 photopigment of Drosophila R1-6 photoreceptors, resulting in deformed rhabdomeric structure. Immunocytochemistry revealed OPN4 expression at the base of the rhabdomeres, mainly at the rhabdomeral stalk. Measurements of the early receptor current, a linear manifestation of photopigment activation, indicated large expression of OPN4 in the plasma membrane. Comparing the early receptor current amplitude and action spectra between WT and the Opn4-expressing Drosophila further indicated that large quantities of a blue absorbing photopigment were expressed, having a dark stable blue intermediate state. Strikingly, the light-induced current of the Opn4-expressing fly photoreceptors was approximate to 40-fold faster than that of ipRGC. Furthermore, an intense white flash induced a small amplitude prolonged dark current composed of discrete unitary currents similar to the Drosophila single photon responses. The induction of prolonged dark currents by intense blue light could be suppressed by a following intense green light, suggesting induction and suppression of prolonged depolarizing afterpotential. This is the first demonstration of heterologous functional expression of mammalian OPN4 in the genetically emendable Drosophila photoreceptors. Moreover, the fast OPN4-activated ionic current of Drosophila photoreceptors relative to that of mouse ipRGC, indicates that the slow light response of ipRGC does not arise from an intrinsic property of melanopsin.	[Yasin, Bushra; Kohn, Elkana; Peters, Maximilian; Zaguri, Rachel; Weiss, Shirley; Katz, Ben; Minke, Baruch] Hebrew Univ Jerusalem, Dept Med Neurobiol, IMRIC, Fac Med, IL-91120 Jerusalem, Israel; [Yasin, Bushra; Kohn, Elkana; Peters, Maximilian; Zaguri, Rachel; Weiss, Shirley; Katz, Ben; Minke, Baruch] Hebrew Univ Jerusalem, Fac Med, Edmond & Lily Safra Ctr Brain Sci ELSC, IL-91120 Jerusalem, Israel; [Schopf, Krystina; Huber, Armin] Univ Hohenheim, Inst Physiol, Dept Biosensor, D-70599 Stuttgart, Germany	Hebrew University of Jerusalem; Hebrew University of Jerusalem; University Hohenheim	Minke, B (corresponding author), Hebrew Univ Jerusalem, Fac Med, Dept Med Neurobiol, IL-91120 Jerusalem, Israel.	baruchm@ekmd.huji.ac.il	Huber, Armin/GYU-6322-2022; Peters, Maximilian/AAA-3509-2020	Wagner, Krystina/0000-0001-8840-3805	Israel Science Foundation (ISF); Deutsch-Israelische Projektkooperation (DIP); US-Israel Binational Science Foundation (BSF)	Israel Science Foundation (ISF)(Israel Science Foundation); Deutsch-Israelische Projektkooperation (DIP); US-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation)	This work was supported by grants from the Israel Science Foundation (ISF), the Deutsch-Israelische Projektkooperation (DIP), and the US-Israel Binational Science Foundation (BSF). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmad ST, 2006, INVEST OPHTH VIS SCI, V47, P3722, DOI 10.1167/iovs.06-0281; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Borges R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052413; BYK T, 1993, P NATL ACAD SCI USA, V90, P1907, DOI 10.1073/pnas.90.5.1907; Cerny AC, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005578; Chorna-Ornan I, 2005, J CELL BIOL, V171, P143, DOI 10.1083/jcb.200503014; CONE RA, 1964, NATURE, V204, P736, DOI 10.1038/204736a0; Cook B, 2000, NAT CELL BIOL, V2, P296, DOI 10.1038/35010571; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; Emanuel AJ, 2015, NEURON, V85, P1043, DOI 10.1016/j.neuron.2015.02.011; Ferrer C, 2012, J NEUROSCI, V32, P17977, DOI 10.1523/JNEUROSCI.3069-12.2012; Frechter S, 2007, J NEUROSCI, V27, P5571, DOI 10.1523/JNEUROSCI.0310-07.2007; Graham DM, 2008, J NEUROPHYSIOL, V99, P2522, DOI 10.1152/jn.01066.2007; Hardie RC, 2002, NEURON, V36, P689, DOI 10.1016/S0896-6273(02)01048-6; HARDIE RC, 1995, J NEUROSCI, V15, P889; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; HARRIS WA, 1977, NATURE, V266, P648, DOI 10.1038/266648a0; Hatori M, 2010, TRENDS MOL MED, V16, P435, DOI 10.1016/j.molmed.2010.07.005; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; HILLMAN P, 1973, J GEN PHYSIOL, V62, P77, DOI 10.1085/jgp.62.1.77; HILLMAN P, 1983, PHYSIOL REV, V63, P668, DOI 10.1152/physrev.1983.63.2.668; HOCHSTEIN S, 1973, J GEN PHYSIOL, V62, P105, DOI 10.1085/jgp.62.1.105; ISONO K, 1988, J GEN PHYSIOL, V92, P587, DOI 10.1085/jgp.92.5.587; Katz B, 2012, J NEUROSCI, V32, P2722, DOI 10.1523/JNEUROSCI.5221-11.2012; Katz B, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.002.2009; KIRSCHFELD K, 1977, NATURE, V269, P386, DOI 10.1038/269386a0; Knox BE, 2003, J BIOL CHEM, V278, P40493, DOI 10.1074/jbc.M304567200; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; Liu CH, 2008, NEURON, V59, P778, DOI 10.1016/j.neuron.2008.07.007; MATSUMOTO H, 1991, BIOCHEM BIOPH RES CO, V177, P1306, DOI 10.1016/0006-291X(91)90683-X; Matsuyama T, 2012, BIOCHEMISTRY-US, V51, P5454, DOI 10.1021/bi3004999; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; MINKE B, 1973, J GEN PHYSIOL, V62, P87, DOI 10.1085/jgp.62.1.87; MINKE B, 1974, BIOPHYS J, V14, P490, DOI 10.1016/S0006-3495(74)85929-1; Minke B., 1992, SENSORY TRANSDUCTION, P202; Minke B, 2012, J NEUROGENET, V26, P106, DOI 10.3109/01677063.2012.666299; Minke B, 2010, J NEUROGENET, V24, P216, DOI 10.3109/01677063.2010.514369; Mure LS, 2007, J BIOL RHYTHM, V22, P411, DOI 10.1177/0748730407306043; Mure LS, 2016, NEURON, V90, P1016, DOI 10.1016/j.neuron.2016.04.016; Mure LS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005991; PAK WL, 1974, J GEN PHYSIOL, V63, P740, DOI 10.1085/jgp.63.6.740; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; PERETZ A, 1994, NEURON, V12, P1257, DOI 10.1016/0896-6273(94)90442-1; Pinal N, 2011, J CELL SCI, V124, P1564, DOI 10.1242/jcs.082115; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Rinaldi S, 2014, P NATL ACAD SCI USA, V111, P1714, DOI 10.1073/pnas.1309508111; Rollag MD, 2003, J BIOL RHYTHM, V18, P227, DOI [10.1177/0748730403018003005, 10.1177/0748730403253382]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott K, 1998, NATURE, V395, P805, DOI 10.1038/27448; Scott K, 1997, CELL, V91, P375, DOI 10.1016/S0092-8674(00)80421-3; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; Sekaran S, 2003, CURR BIOL, V13, P1290, DOI 10.1016/S0960-9822(03)00510-4; Sekharan S, 2011, J AM CHEM SOC, V133, P19052, DOI 10.1021/ja208789h; SELINGER Z, 1993, BIOCHIM BIOPHYS ACTA, V1179, P283, DOI 10.1016/0167-4889(93)90084-3; Sexton TJ, 2012, J BIOL CHEM, V287, P20888, DOI 10.1074/jbc.M111.325969; Shen WL, 2011, SCIENCE, V331, P1333, DOI 10.1126/science.1198904; Spoida K, 2016, CURR BIOL, V26, P1206, DOI 10.1016/j.cub.2016.03.007; Tsukamoto H, 2015, J BIOL CHEM, V290, P27176, DOI 10.1074/jbc.M115.666305; Walker MT, 2008, P NATL ACAD SCI USA, V105, P8861, DOI 10.1073/pnas.0711397105; Wang T, 2005, J NEUROSCI, V25, P5187, DOI 10.1523/JNEUROSCI.0995-05.2005; Wang XY, 2010, CURR BIOL, V20, P93, DOI 10.1016/j.cub.2009.12.022; Weiss S, 2012, J NEUROSCI, V32, P14696, DOI 10.1523/JNEUROSCI.2456-12.2012; Xue HH, 2000, J BIOCHEM, V128, P329, DOI 10.1093/oxfordjournals.jbchem.a022757; Xue T, 2011, NATURE, V479, P67, DOI 10.1038/nature10567; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029	67	4	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3624	3636		10.1074/jbc.M116.754770	http://dx.doi.org/10.1074/jbc.M116.754770			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28119450	hybrid, Green Published			2022-12-26	WOS:000395542500008
J	Degre, D; Serste, T; Lasser, L; Delwaide, J; Starkel, P; Laleman, W; Langlet, P; Reynaert, H; Bourgeois, S; Vanwolleghem, T; Dastis, SN; Gustot, T; Geerts, A; Van Steenkiste, C; De Galocsy, C; Lepida, A; Orlent, H; Moreno, C				Degre, Delphine; Serste, Thomas; Lasser, Luc; Delwaide, Jean; Starkel, Peter; Laleman, Wim; Langlet, Philippe; Reynaert, Hendrik; Bourgeois, Stefan; Vanwolleghem, Thomas; Dastis, Sergio Negrin; Gustot, Thierry; Geerts, Anja; Van Steenkiste, Christophe; De Galocsy, Chantal; Lepida, Antonia; Orlent, Hans; Moreno, Christophe			Sofosbuvir in Combination with Simeprevir plus /- Ribavirin in Genotype 4 Hepatitis C Patients with Advanced Fibrosis or Cirrhosis: A Real-World Experience from Belgium	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; ALL-CAUSE MORTALITY; OPEN-LABEL; CHRONIC HCV; VIRUS; LEDIPASVIR; INFECTION; THERAPY; MULTICENTER; NAIVE	Introduction Hepatitis C virus (HCV) is a major global health issue and successful treatment has been associated with a reduction of risk of all-cause mortality. Advancements have been made in HCV treatment through the use of interferon-free regimens. Most trials have been conducted in HCV genotype (GT) 1 and data for interferon-free regimens in GT4 patients are limited. The aim of this study was to evaluate the safety and efficacy of sofosbuvir plus simeprevir in a real-world cohort of HCV GT4 patients with advanced fibrosis. Patients and Methods Eighty-seven GT4 treatment-naive or -Interferon (IFN) ribavirin (RBV) experienced patients treated with sofosbuvir and simeprevir +/- ribavirin (RBV) were enrolled in this cohort study (41% severe fibrosis, 59% cirrhosis). Results Patients were 51.7% male, 78.2% IFN/RBV treatment-experienced, and 37.9% received RBV treatment. The overall sustained virologic response at least 12 weeks after treatment SVR12) rate was 87.4% while patients treated with and without RBV had rates of 87.9% and 87% (p = 0.593), respectively, and patients with advanced fibrosis (F3) and patients with cirrhosis had SVR12 rates of 94.4% and 82.4% (p = 0.087), respectively. SVR12 rates in treatment-naive patients and in IFN/RBV -experienced patients were 78.9% and 89.7% (p = 0.191), respectively. Treatment failure occurred most commonly in patients with cirrhosis and severe disease. The treatment was well tolerated and no patient died or discontinued treatment due to adverse events. Conclusions Sofosbuvir in combination with simeprevir +/- ribavirin in GT 4 HCV patients with advanced fibrosis achieved high SVR12 rates and was well tolerated. RBV did not appear to increase the rate of SVR12.	[Degre, Delphine; Serste, Thomas; Lepida, Antonia; Moreno, Christophe] Univ Libre Bruxelles, CUB Hop Erasme, Dept Gastroenterol Hepatopancreatol & Digest Onco, Brussels, Belgium; [Serste, Thomas] CHU St Pierre, Dept Hepatogastroenterol, Brussels, Belgium; [Lasser, Luc] Brugmann Univ Hosp, Dept Gastroenterol, Brussels, Belgium; [Delwaide, Jean] Univ Liege, Dept Hepatogastroenterol, CHU Sart Tilman, Liege, Belgium; [Starkel, Peter] Clin Univ St Luc, Dept Hepatogastroenterol, Brussels, Belgium; [Laleman, Wim] Univ Hosp Gasthuisberg, Dept Gastroenterol & Hepatol, Leuven, Belgium; [Langlet, Philippe] CHIREC, Dept Hepatogastroenterol, Brussels, Belgium; [Reynaert, Hendrik] VUB, UZ Brussels, Dept Gastroenterol & Hepatol, Brussels, Belgium; [Bourgeois, Stefan] ZNA, Dept Gastroenterol & Hepatol, Antwerp, Belgium; [Vanwolleghem, Thomas] Univ Antwerp Hosp, Dept Gastroenterol & Hepatol, Edegem, Belgium; [Vanwolleghem, Thomas] Erasmus MC, Dept Gastroenterol & Hepatol, Lab Gastroenterol & Hepatol, Rotterdam, Netherlands; [Dastis, Sergio Negrin] GHdC, Dept Gastroenterol & Hepatol, Charleroi, Belgium; [Geerts, Anja] Univ Hosp Ghent, Dept Gastroenterol & Hepatol, Ghent, Belgium; [Van Steenkiste, Christophe] AZ Maria Middelares, Dept Gastroenterol & Hepatol, Ghent, Belgium; [De Galocsy, Chantal; Lepida, Antonia] Hop IRIS sud, Dept Gastroenterol & Hepatol, Brussels, Belgium; [Orlent, Hans] AZ Bruges, Dept Gastroenterol & Hepatol, Brugge, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of Liege; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; KU Leuven; University Hospital Leuven; Vrije Universiteit Brussel; ZNA Stuivenberg; University of Antwerp; Erasmus University Rotterdam; Erasmus MC; Grand Hopital De Charleroi; Ghent University; Ghent University Hospital	Degre, D (corresponding author), Univ Libre Bruxelles, CUB Hop Erasme, Dept Gastroenterol Hepatopancreatol & Digest Onco, Brussels, Belgium.	delphine.degre@erasme.ulb.ac.be	Stärkel, Peter/AAC-6400-2019; Vanwolleghem, Thomas/AAD-4094-2022; Laleman, Wim/H-7272-2019	Laleman, Wim/0000-0002-0842-7813; Reynaert, Hendrik/0000-0002-2701-5777; Gustot, Thierry/0000-0002-5537-9607; de Galocsy, Chantal/0000-0003-2659-8859; Vanwolleghem, Thomas/0000-0002-0572-8741				Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Al Ashgar HI, 2013, SAUDI J GASTROENTERO, V19, P28, DOI 10.4103/1319-3767.105920; Aqel BA, 2015, HEPATOLOGY, V62, P1004, DOI 10.1002/hep.27937; Asselah T, 2016, LANCET GASTROENTEROL, V1, P25, DOI 10.1016/S2468-1253(16)30001-2; Asselah T, 2015, HEPATOLOGY, V62, p340A; Backus LI, 2011, CLIN GASTROENTEROL H, V9, P509, DOI 10.1016/j.cgh.2011.03.004; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Chung RT, 2015, HEPATOLOGY, V62, P932, DOI 10.1002/hep.27950; Curry MP, 2015, NEW ENGL J MED, V373, P2618, DOI 10.1056/NEJMoa1512614; Doss W, 2015, J HEPATOL, V63, P581, DOI 10.1016/j.jhep.2015.04.023; Feld JJ, 2015, NEW ENGL J MED, V373, P2599, DOI 10.1056/NEJMoa1512610; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Ferraioli G, 2012, HEPATOLOGY, V56, P2125, DOI 10.1002/hep.25936; Food and Drug Administration (FDA), 2015, DRUG SAFETY COMMUNIC; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Holmberg SD, 2013, CLIN INFECT DIS, V57, P240, DOI 10.1093/cid/cit245; Kamal SM, 2008, HEPATOLOGY, V47, P1371, DOI 10.1002/hep.22127; Kamal SM, 2009, LIVER INT, V29, P39, DOI 10.1111/j.1478-3231.2008.01930.x; Khattab MA, 2011, J HEPATOL, V54, P1250, DOI 10.1016/j.jhep.2010.11.016; Kohli A, 2015, LANCET INFECT DIS, V15, P1049, DOI 10.1016/S1473-3099(15)00157-7; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Kwo P, 2016, HEPATOLOGY; Lawitz E, 2016, HEPATOLOGY, V64, P360, DOI 10.1002/hep.28422; Lawitz E, 2014, LANCET, V384, P1756, DOI 10.1016/S0140-6736(14)61036-9; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Manns M, 2016, LANCET INFECT DIS, V16, P685, DOI 10.1016/S1473-3099(16)00052-9; Moreno C, 2015, J HEPATOL, V62, P1047, DOI 10.1016/j.jhep.2014.12.031; Nicot F, 2005, J GEN VIROL, V86, P107, DOI 10.1099/vir.0.80409-0; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Ray SC, 2000, J INFECT DIS, V182, P698, DOI 10.1086/315786; Sulkowski MS, 2016, GASTROENTEROLOGY, V150, P419, DOI 10.1053/j.gastro.2015.10.013; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Wantuck JM, 2014, ALIMENT PHARM THER, V39, P137, DOI 10.1111/apt.12551; Wehmeyer MH, 2015, DIGEST LIVER DIS, V47, P811, DOI 10.1016/j.dld.2015.05.018; Willemse SB, 2016, J VIRAL HEPATITIS, V23, P950, DOI 10.1111/jvh.12567; Wise M, 2008, HEPATOLOGY, V47, P1128, DOI 10.1002/hep.22165; Zeuzem S, 2015, ANN INTERN MED, V163, P1, DOI 10.7326/M15-0785; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561	40	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170933	10.1371/journal.pone.0170933	http://dx.doi.org/10.1371/journal.pone.0170933			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125694	Green Published, gold, Green Submitted			2022-12-26	WOS:000396176100020
J	Meyer, M; Le-Bras, L; Fernandez, P; Zanotti-Fregonara, P				Meyer, Marie; Le-Bras, Lucie; Fernandez, Philippe; Zanotti-Fregonara, Paolo			Standardized Input Function for (18) F-FDG PET Studies in Mice: A Cautionary Study	PLOS ONE			English	Article							SMALL ANIMAL PET; BETA-MICROPROBE; BRAIN PET; QUANTIFICATION; IMAGES; RATS; METHODOLOGY; VALIDATION; BINDING	Aim of the Study The aim of this study was to assess the accuracy of a standardized arterial input function (SAIF) for positron emission tomography 18 F-FDG studies in mice. In particular, we tested whether the same SAIF could be applied to populations of mice whose fasting conditions differed. Methods The SAIF was first created from a population of fasting mice (n = 11) and validated within this group using a correlation analysis and a leave-one-out procedure. Then, the SAIF was prospectively applied to a population of non-fasting mice (n = 16). The SAIFs were scaled using a single individual blood sample taken 25 min after injection. The metabolic rates of glucose (CMRglc) calculated with the SAIFs were compared with the reference values obtained by full arterial sampling (AIF). Results In both populations of mice, CMRglc values showed a very small bias but an important variability. The SAIF/AIF CMRglc ratio in the fasting mice was 0.97 +/- 0.22 (after excluding a major outlier). The SAIF/AIF CMRglc ratio in the non-fasting mice was 1.04 +/- 0.22. This variability was due to the presence of cases in which the SAIF poorly estimated the shape of the input function based on full arterial sampling. Conclusion Although SAIF allows the estimation of the 18 F-FDG mice input function with negligible bias and independently from the fasting state, errors in individual mice (as high as 30 +/- 50%) cause an important variability. Alternative techniques, such as image-derived input function, might be a better option for mice PET studies.	[Meyer, Marie; Le-Bras, Lucie; Fernandez, Philippe] Pellegrin Hosp, Dept Nucl Med, Bordeaux, France; [Meyer, Marie; Fernandez, Philippe] Univ Bordeaux, Aquitaine Inst Cognit & Integrat Neurosci, UMR 5287, Bordeaux, France; [Zanotti-Fregonara, Paolo] Houston Methodist Res Inst, Houston, TX USA	CHU Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; The Methodist Hospital System; The Methodist Hospital - Houston	Meyer, M (corresponding author), Pellegrin Hosp, Dept Nucl Med, Bordeaux, France.; Meyer, M (corresponding author), Univ Bordeaux, Aquitaine Inst Cognit & Integrat Neurosci, UMR 5287, Bordeaux, France.	marie.meye@chu-bordeaux.fr						Chen K, 1998, J CEREBR BLOOD F MET, V18, P716, DOI 10.1097/00004647-199807000-00002; Goertzen AL, 2012, J NUCL MED, V53, P1300, DOI 10.2967/jnumed.111.099382; Green LA, 1998, J NUCL MED, V39, P729; Hines CS, 2013, J NUCL MED, V54, P64, DOI 10.2967/jnumed.112.106872; Itoh T, 2010, SYNAPSE, V64, P172, DOI 10.1002/syn.20728; Kim J, 2006, J NUCL MED, V47, P330; Lanz B, 2014, J NUCL MED; Meyer PT, 2006, EUR J NUCL MED MOL I, V33, P948, DOI 10.1007/s00259-006-0121-7; Mourik JEM, 2008, NEUROIMAGE, V39, P1041, DOI 10.1016/j.neuroimage.2007.10.022; Mourik JEM, 2008, NEUROIMAGE, V43, P676, DOI 10.1016/j.neuroimage.2008.07.035; Mu W, 2014, J NUCL MED, V55; Pain F, 2004, J NUCL MED, V45, P1577; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Seike Y, 2004, ANN NUCL MED, V18, P563, DOI 10.1007/BF02984577; Simoncic U, 2015, NUCL MED COMMUN, V36, P187, DOI 10.1097/MNM.0000000000000231; TAKIKAWA S, 1994, J NUCL MED, V35, P955; TAKIKAWA S, 1993, RADIOLOGY, V188, P131, DOI 10.1148/radiology.188.1.8511286; Tantawy MN, 2010, MOL IMAGING, V9, P76, DOI 10.2310/7290.2010.0004; Toyama H, 2004, NUCL MED BIOL, V31, P251, DOI 10.1016/S0969-8051(03)00124-0; Toyama H, 2004, J NUCL MED, V45, P1398; Warnock G, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-13; Zanotti-Fregonara P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060231; Zanotti-Fregonara P, 2012, NEUROIMAGE, V63, P1532, DOI 10.1016/j.neuroimage.2012.08.007; Zanotti-Fregonara P, 2012, EUR J NUCL MED MOL I, V39, P651, DOI 10.1007/s00259-011-2004-9; Zanotti-Fregonara P, 2011, J CEREBR BLOOD F MET, V31, P1986, DOI 10.1038/jcbfm.2011.107; Zanotti-Fregonara P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017056	26	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0168667	10.1371/journal.pone.0168667	http://dx.doi.org/10.1371/journal.pone.0168667			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125579	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100149
J	Vallet-Courbin, A; Lariviere, M; Hocquellet, A; Hemadou, A; Parimala, SN; Laroche-Traineau, J; Santarelli, X; Clofent-Sanchez, G; Jacobin-Valat, MJ; Noubhani, A				Vallet-Courbin, Amelie; Lariviere, Melusine; Hocquellet, Agnes; Hemadou, Audrey; Parimala, Sarjapura-Nagaraja; Laroche-Traineau, Jeanny; Santarelli, Xavier; Clofent-Sanchez, Gisele; Jacobin-Valat, Marie-Josee; Noubhani, Abdelmajid			A Recombinant Human Anti-Platelet scFv Antibody Produced in Pichia pastoris for Atheroma Targeting	PLOS ONE			English	Article							CHAIN FV ANTIBODY; IIB-IIIA COMPLEX; MONOCLONAL-ANTIBODY; PHAGE DISPLAY; FAB FRAGMENT; HIGH-YIELD; ATHEROSCLEROSIS; PLATELETS; INFLAMMATION; EXPRESSION	Cells of the innate and adaptive immune system are key factors in the progression of atherosclerotic plaque, leading to plaque instability and rupture, potentially resulting in acute atherothrombotic events such as coronary artery disease, cerebrovascular disease and peripheral arterial disease. Here, we describe the cloning, expression, purification, and immunoreactivity assessment of a recombinant single-chain variable fragment (scFv) derived from a human anti-alpha IIb beta 3 antibody (HuAb) selected to target atheromatous lesions for the presence of platelets. Indeed, platelets within atheroma plaques have been shown to play a role in inflammation, in platelet-leucocyte aggregates and in thrombi formation and might thus be considered relevant biomarkers of atherosclerotic progression. The DNA sequence that encodes the anti-alpha IIb beta 3 TEG4 scFv previously obtained from a phage-display selection on activated platelets, was inserted into the eukaryote vector (pPICZaA) in fusion with a tag sequence encoding 2 cysteines useable for specific probes grafting experiments. The recombinant protein was expressed at high yields in Pichia pastoris (30 mg/L culture). The advantage of P.pastoris as an expression system is the production and secretion of recombinant proteins in the supernatant, ruling out the difficulties encountered when scFv are produced in the cytoplasm of bacteria (low yield, low solubility and reduced affinity). The improved conditions allowed for the recovery of highly purified and biologically active scFv fragments ready to be grafted in a site-directed way to nanoparticles for the imaging of atherosclerotic plaques involving inflammatory processes and thus at high risk of instability.	[Vallet-Courbin, Amelie; Hocquellet, Agnes; Parimala, Sarjapura-Nagaraja; Santarelli, Xavier; Noubhani, Abdelmajid] Bordeaux INP, UMR5248, CBMN, Pessac, France; [Lariviere, Melusine; Hemadou, Audrey; Laroche-Traineau, Jeanny; Clofent-Sanchez, Gisele; Jacobin-Valat, Marie-Josee] CNRS, Ctr Resonance Magnet Syst Biol, Bordeaux, France; [Lariviere, Melusine; Hemadou, Audrey; Laroche-Traineau, Jeanny; Clofent-Sanchez, Gisele; Jacobin-Valat, Marie-Josee] Univ Bordeaux, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Noubhani, A (corresponding author), Bordeaux INP, UMR5248, CBMN, Pessac, France.	noubhani@bordeaux-inp.fr	Clofent-Sanchez, Gisèle/AAL-4545-2020	SANTARELLI, Xavier/0000-0003-1530-4632	French National Research Agency Program [ANR-07-PCVI-0023 IMATHABIO]; SFR TecSan (Technology for Health) of University of Bordeaux; French National Research Agency [ANR-10-LABX-57, ANR-13-BSV5-0018]	French National Research Agency Program(French National Research Agency (ANR)); SFR TecSan (Technology for Health) of University of Bordeaux; French National Research Agency(French National Research Agency (ANR))	This study was funded by (1) the French National Research Agency Program ANR-07-PCVI-0023 IMATHABIO, (2) the SFR TecSan (Technology for Health) of University of Bordeaux and (3) a public grant from the French National Research Agency within the context of the Investments for the Future Program, referenced ANR-10-LABX-57 and named TRAIL, Grant ANR-13-BSV5-0018 French National Research Agency Program.	Ahmad ZA, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/980250; Aloui C, 2014, INT J MOL SCI, V15, P22342, DOI 10.3390/ijms151222342; Badrnya S, 2014, ARTERIOSCL THROM VAS, V34, P571, DOI 10.1161/ATVBAHA.113.302919; Burioni R, 2009, J IMMUNOL, V183, P2537, DOI 10.4049/jimmunol.0901076; Cupit PM, 1999, LETT APPL MICROBIOL, V29, P273, DOI 10.1046/j.1472-765X.1999.00600.x; Dabadie M, 2001, PLATELETS, V12, P395, DOI 10.1080/09537100120071031; Daub K, 2010, SEMIN THROMB HEMOST, V36, P146, DOI 10.1055/s-0030-1251498; Eldin P, 1997, J IMMUNOL METHODS, V201, P67, DOI 10.1016/S0022-1759(96)00213-X; Falk E, 2006, J AM COLL CARDIOL, V47, pC7, DOI 10.1016/j.jacc.2005.09.068; Fenyo IM, 2013, IMMUNOBIOLOGY, V218, P1376, DOI 10.1016/j.imbio.2013.06.005; Ferdous F, 2015, IMMUNOL LETT, V163, P32, DOI 10.1016/j.imlet.2014.11.010; Frenzel A, 2016, MABS-AUSTIN, V8, P1177, DOI 10.1080/19420862.2016.1212149; Frenzel A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00217; Freyre FM, 2000, J BIOTECHNOL, V76, P157, DOI 10.1016/S0168-1656(99)00183-2; Groves MAT, 2014, MABS-AUSTIN, V6, P236, DOI 10.4161/mabs.27261; Hagemeyer CE, 2009, THROMB HAEMOSTASIS, V101, P1012, DOI 10.1160/TH08-12-0816; Herter JM, 2014, J THROMB HAEMOST, V12, P1764, DOI 10.1111/jth.12730; Hohmann JD, 2013, BLOOD, V121, P3067, DOI 10.1182/blood-2012-08-449694; Jacobin MJ, 2002, J IMMUNOL, V168, P2035, DOI 10.4049/jimmunol.168.4.2035; Jacobin-Valat MJ, 2015, NANOMED-NANOTECHNOL, V11, P927, DOI 10.1016/j.nano.2014.12.006; Janakiraman VN, 2016, BIOTECHNOL J, V11, P117, DOI 10.1002/biot.201500245; Joosten V, 2003, MICROB CELL FACT, V2, DOI 10.1186/1475-2859-2-1; Joshi FR, 2012, EUR HEART J-CARD IMG, V13, P205, DOI 10.1093/ehjci/jer319; Kyaw T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060430; Kyaw T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029371; Kyaw T, 2010, J IMMUNOL, V185, P4410, DOI 10.4049/jimmunol.1000033; Lange S, 2001, J IMMUNOL METHODS, V255, P103, DOI 10.1016/S0022-1759(01)00351-9; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lievens D, 2010, BLOOD, V116, P4317, DOI 10.1182/blood-2010-01-261206; Morrell CN, 2014, BLOOD, V123, P2759, DOI 10.1182/blood-2013-11-462432; PIDARD D, 1983, J BIOL CHEM, V258, P2582; Reichert JM, 2016, MABS-AUSTIN, V8, P197, DOI 10.1080/19420862.2015.1125583; Robert R, 2006, INT J BIOL MACROMOL, V39, P51, DOI 10.1016/j.ijbiomac.2006.01.014; Robert R, 2005, J CHROMATOGR B, V818, P43, DOI 10.1016/j.jchromb.2004.10.038; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; Takahashi K, 2000, BIOSCI BIOTECH BIOCH, V64, P2138, DOI 10.1271/bbb.64.2138; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Wildgruber M, 2013, THERANOSTICS, V3, P865, DOI 10.7150/thno.5771	38	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170305	10.1371/journal.pone.0170305	http://dx.doi.org/10.1371/journal.pone.0170305			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125612	gold, Green Published, Green Submitted			2022-12-26	WOS:000396176100120
J	Xiao, LL; Liu, N; Zhang, GF; Zhang, H; Gao, S; Fu, Z; Wang, SZ; Yu, QX; Yu, JM; Yuan, SH				Xiao, Linlin; Liu, Ning; Zhang, Guifang; Zhang, Hui; Gao, Song; Fu, Zheng; Wang, Suzhen; Yu, Qingxi; Yu, Jinming; Yuan, Shuanghu			Late-Course Adaptive Adjustment Based on Metabolic Tumor Volume Changes during Radiotherapy May Reduce Radiation Toxicity in Patients with Non-Small Cell Lung Cancer	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CONCURRENT CHEMORADIOTHERAPY; DOSE-ESCALATION; POTENTIAL IMPACT; MEGAVOLTAGE CT; THERAPY; PET/CT; F-18-FDG	To reduce the high risk of radiation toxicity and enhance the quality of life of patients with non-small cell lung cancer (NSCLC), we quantified the metabolic tumor volumes (MTVs) from baseline to the late-course of radiotherapy (RT) by fluorodeoxyglucose positron emission tomography computerized tomography (FDG PET-CT) and discussed the potential benefit of late-course adaptive plans rather than original plans by dose volume histogram (DVH) comparisons. Seventeen patients with stage II-III NSCLC who were treated with definitive conventionally fractionated RT were eligible for this prospective study. FDG PET-CT scans were acquired within 1 week before RT (pre-RT) and at approximately two-thirds of the total dose during-RT (approximately 40 Gy). MTVs were taken as gross tumor volumes (GTVs) that included the primary tumor and any involved hilar or mediastinal lymph nodes. An original plan based on the baseline MTVs and adaptive plans based on observations during-RT MTVs were generated for each patient. The DVHs for lung, heart, esophagus and spinal cord were compared between the original plans and composite plans at 66 Gy. At the time of approximately 40 Gy during-RT, MTVs were significantly reduced in patients with NSCLC (pre-RT 136.2 +/- 82.3 ml vs. during-RT 64.7 +/- 68.0 ml, p = 0.001). The composite plan of the original plan at 40 Gy plus the adaptive plan at 26 Gy resulted in better DVHs for all the organs at risk that were evaluated compared to the original plan at 66 Gy (p<0.05), including V-5, V-10, V-15, V-20, V-25, V-30 and the mean dose of total lung, V-10, V-20, V-30, V-40, V-50, V-60 and the mean dose of heart, V-35, V-40, V-50, V-55, V-60, the maximum dose and mean dose of the esophagus, and the maximum dose of the spinal-cord. PET-MTVs were reduced significantly at the time of approximately 40 Gy during-RT. Late course adaptive radiotherapy may be an effective way to reduce the dose volume to the organs at risk, thus reducing radiation toxicity in patients with NSCLC.	[Xiao, Linlin] Univ Jinan, Shandong Acad Med Sci, Sch Med & Life Sci, Jinan, Shandong, Peoples R China; [Xiao, Linlin; Liu, Ning; Zhang, Guifang; Wang, Suzhen; Yu, Qingxi; Yu, Jinming; Yuan, Shuanghu] Shandong Univ, Shandong Canc Hosp, Dept Radiat Oncol, Jinan, Shandong, Peoples R China; [Zhang, Hui] Linyi Canc Hosp, Dept Oncol, Linyi, Shandong, Peoples R China; [Gao, Song] Jining Infect Dis Hosp, Dept Oncol, Jining, Shandong, Peoples R China; [Fu, Zheng] Shandong Univ, Shandong Canc Hosp, Dept Radiol, Jinan, Shandong, Peoples R China; [Yuan, Shuanghu] Shandong Acad Med Sci, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Yuan, SH (corresponding author), Shandong Univ, Shandong Canc Hosp, Dept Radiat Oncol, Jinan, Shandong, Peoples R China.; Yuan, SH (corresponding author), Shandong Acad Med Sci, Jinan, Shandong, Peoples R China.	yuanshuanghu@sina.com		, yuan/0000-0002-8327-2524	Natural Science Foundation of China [NSFC81172133, NSFC81372413]; Outstanding Youth Natural Science Foundation of Shandong Province [JQ201423]; projects of the Medical and Health Technology Development Program in Shandong province [2014WS0058]; Scientific Research in the Public Interest [201402011]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Youth Natural Science Foundation of Shandong Province; projects of the Medical and Health Technology Development Program in Shandong province; Scientific Research in the Public Interest	This study was supported by the Natural Science Foundation of China (NSFC81172133, NSFC81372413); the Outstanding Youth Natural Science Foundation of Shandong Province (JQ201423); and the projects of the Medical and Health Technology Development Program in Shandong province (2014WS0058), to SY. It was also supported by the special fund for Scientific Research in the Public Interest (201402011), to JY.	Auperin A, 2010, J CLIN ONCOL, V28, P2181, DOI 10.1200/JCO.2009.26.2543; Barriger RB, 2010, INT J RADIAT ONCOL, V78, P1381, DOI 10.1016/j.ijrobp.2009.09.030; Chi A, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00273; Ding XP, 2012, ASIAN PAC J CANCER P, V13, P319, DOI 10.7314/APJCP.2012.13.1.319; Ding XP, 2013, TECHNOL CANCER RES T, V12, P251, DOI 10.7785/tcrt.2012.500310; Everitt SJ, 2014, J NUCL MED, V55, P1069, DOI 10.2967/jnumed.113.131631; Feng M, 2009, INT J RADIAT ONCOL, V73, P1228, DOI 10.1016/j.ijrobp.2008.10.054; Flentje M, 2016, STRAHLENTHER ONKOL, V192, P216, DOI 10.1007/s00066-016-0941-8; Ford EC, 2009, J NUCL MED, V50, P1655, DOI 10.2967/jnumed.108.055780; Fox J, 2009, INT J RADIAT ONCOL, V74, P341, DOI 10.1016/j.ijrobp.2008.07.063; Gillham C, 2008, RADIOTHER ONCOL, V88, P335, DOI 10.1016/j.radonc.2008.05.004; Guckenberger M, 2011, INT J RADIAT ONCOL, V79, P901, DOI 10.1016/j.ijrobp.2010.04.050; Juweid ME, 2006, NEW ENGL J MED, V354, P496, DOI 10.1056/NEJMra050276; Kong FMS, 2007, J CLIN ONCOL, V25, P3116, DOI 10.1200/JCO.2006.10.3747; Kong FM, 2005, INT J RADIAT ONCOL, V63, P324, DOI 10.1016/j.ijrobp.2005.02.010; Kupelian PA, 2005, INT J RADIAT ONCOL, V63, P1024, DOI 10.1016/j.ijrobp.2005.04.046; Lee P, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00071; Lim G, 2011, J THORAC ONCOL, V6, P531, DOI 10.1097/JTO.0b013e31820b8a52; Mac MMP, 2012, SEMIN NUCL MED, V42, P308, DOI [10.1053/j.semnucimed.2012.04.003, DOI 10.1053/J.SEMNUCIMED.2012.04.003]; Mahasittiwat P, 2013, J RADIOL ONCOL, V2, P191, DOI 10.1007/s13566-013-0091-x; Marta GN, 2011, NUCL MED COMMUN, V32, P903, DOI 10.1097/MNM.0b013e32834a719a; Meng X, 2014, INT J RADIAT ONCOL, V89, P145, DOI 10.1016/j.ijrobp.2014.01.044; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Phernambucq ECJ, 2011, ANN ONCOL, V22, P132, DOI 10.1093/annonc/mdq316; Ramsey CR, 2006, INT J RADIAT ONCOL, V64, P1237, DOI 10.1016/j.ijrobp.2005.11.012; Saitoh JI, 2012, INT J RADIAT ONCOL, V82, P1791, DOI 10.1016/j.ijrobp.2011.03.007; Siker ML, 2006, INT J RADIAT ONCOL, V66, P135, DOI 10.1016/j.ijrobp.2006.03.064; Spratt DE, 2010, CLIN NUCL MED, V35, P237, DOI 10.1097/RLU.0b013e3181d18eb0; Tyldesley S, 2001, INT J RADIAT ONCOL, V49, P973, DOI 10.1016/S0360-3016(00)01401-2; Werner-Wasik M, 2011, CLIN LUNG CANCER, V12, P245, DOI 10.1016/j.cllc.2011.03.026; Yuan SG, 2012, INT J RADIAT ONCOL, V82, pE631, DOI 10.1016/j.ijrobp.2011.07.044; Zheng YD, 2014, ONCOL LETT, V7, P1015, DOI 10.3892/ol.2014.1874	32	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170901	10.1371/journal.pone.0170901	http://dx.doi.org/10.1371/journal.pone.0170901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125698	Green Submitted, gold, Green Published			2022-12-26	WOS:000396176100028
J	Kannegieter, NM; Hesselink, DA; Dieterich, M; Kraaijeveld, R; Rowshani, AT; Leenen, PJM; Baan, CC				Kannegieter, Nynke M.; Hesselink, Dennis A.; Dieterich, Marjolein; Kraaijeveld, Rens; Rowshani, Ajda T.; Leenen, Pieter J. M.; Baan, Carla C.			The Effect of Tacrolimus and Mycophenolic Acid on CD14+Monocyte Activation and Function	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; MACROPHAGE IL-12 PRODUCTION; TOLL-LIKE RECEPTORS; PROTEIN-KINASE-C; HUMAN MONOCYTES; TRANSPLANT RECIPIENTS; ALLOGRAFT DYSFUNCTION; RHEUMATOID-ARTHRITIS; FLOW-CYTOMETRY; IMMUNE CELLS	Monocytes and macrophages play key roles in many disease states, including cellular and humoral rejection after solid organ transplantation (SOT). To suppress alloimmunity after SOT, immunosuppressive drug therapy is necessary. However, little is known about the effects of the immunosuppressive drugs tacrolimus and mycophenolic acid (MPA) on monocyte activation and function. Here, the effect of these immunosuppressants on monocytes was investigated by measuring phosphorylation of three intracellular signaling proteins which all have a major role in monocyte function: p38MAPK, ERK and Akt. In addition, biological functions downstream of these signaling pathways were studied, including cytokine production, phagocytosis and differentiation into macrophages. To this end, blood samples from healthy volunteers were spiked with diverse concentrations of tacrolimus and MPA. Tacrolimus (200 ng/ml) inhibited phosphorylation of p38MAPK by 30% (mean) in CD14+ monocytes which was significantly less than in activated CD3+ T cells (max 60%; p < 0.05). This immunosuppressive agent also partly inhibited p-AKT (14%). MPA, at a therapeutic concentration showed the strongest effect on p-AKT (27% inhibition). p-ERK was inhibited with a maximum of 15% after spiking with either tacrolimus or MPA. The production of IL-1 beta and phagocytosis by monocytes were not affected by tacrolimus concentrations, whereas MPA did inhibit IL-1 beta production by 50%. Monocyte/macrophage polarization was shifted to an M2-like phenotype in the presence of tacrolimus, while MPA increased the expression of M2 surface markers, including CD163 and CD200R, on M1 macrophages. These results show that tacrolimus and MPA do not strongly affect monocyte function, apart from a change in macrophage polarization, to a clinically relevant degree.	[Kannegieter, Nynke M.; Hesselink, Dennis A.; Dieterich, Marjolein; Kraaijeveld, Rens; Rowshani, Ajda T.; Baan, Carla C.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Internal Med, Sect Transplantat & Nephrol, Rotterdam, Netherlands; [Leenen, Pieter J. M.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Immunol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Kannegieter, NM (corresponding author), Erasmus MC, Univ Med Ctr Rotterdam, Dept Internal Med, Sect Transplantat & Nephrol, Rotterdam, Netherlands.	n.kannegieter@erasmusmc.nl	Leenen, Pieter JM/I-5839-2013	Leenen, Pieter JM/0000-0001-9860-2920; Baan, Carla/0000-0003-2274-2788				Allison AC, 2000, IMMUNOPHARMACOLOGY, V47, P85, DOI 10.1016/S0162-3109(00)00188-0; Ambarus CA, 2012, J IMMUNOL METHODS, V375, P196, DOI 10.1016/j.jim.2011.10.013; Baan C, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-20; Badou A, 2000, J VIROL, V74, P10551, DOI 10.1128/JVI.74.22.10551-10562.2000; Bai LL, 2010, THROMB HAEMOSTASIS, V104, P143, DOI 10.1160/TH09-07-0502; Bilzer M, 2006, LIVER INT, V26, P1175, DOI 10.1111/j.1478-3231.2006.01342.x; Chang KT, 2016, J MICROBIOL IMMUNOL, V49, P409, DOI 10.1016/j.jmii.2014.07.006; Christie JD, 2012, J HEART LUNG TRANSPL, V31, P1073, DOI 10.1016/j.healun.2012.08.004; Clavel C, 2016, ANN RHEUM DIS, V75, P2184, DOI 10.1136/annrheumdis-2015-208887; Dall'Era M, 2011, CURR OPIN RHEUMATOL, V23, P454, DOI 10.1097/BOR.0b013e328349a1e5; Day YJ, 2005, AM J PHYSIOL-RENAL, V288, pF722, DOI 10.1152/ajprenal.00378.2004; Eckardt KU, 2009, AM J TRANSPLANT, V9, pS1, DOI 10.1111/j.1600-6143.2009.02834.x; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Feng GJ, 1999, J IMMUNOL, V163, P6403; Foey AD, 2004, IMMUNOLOGY, V112, P44, DOI 10.1111/j.1365-2567.2004.01852.x; Girlanda R, 2008, AM J TRANSPLANT, V8, P600, DOI 10.1111/j.1600-6143.2007.02109.x; Gordon S, 2014, IMMUNOL REV, V262, P36, DOI 10.1111/imr.12223; Grigoryev YA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013358; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Howell J, 2013, LIVER TRANSPLANT, V19, P1099, DOI 10.1002/lt.23712; Jasiak NM, 2016, CRIT CARE NURS Q, V39, P227, DOI 10.1097/CNQ.0000000000000117; Ju C, 2016, CELL MOL IMMUNOL, V13, P316, DOI 10.1038/cmi.2015.104; Kaufman DB, 2004, AM J TRANSPLANT, V4, P38, DOI 10.1111/j.1600-6135.2004.00397.x; Kim L, 2005, J IMMUNOL, V174, P4178, DOI 10.4049/jimmunol.174.7.4178; Komaki Y, 2016, J CROHNS COLITIS, V10, P484, DOI 10.1093/ecco-jcc/jjv221; Kraaij MD, 2014, CYTOKINE, V67, P7, DOI 10.1016/j.cyto.2014.02.001; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Li LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141909; Lodermann B, 2012, INT J RADIAT BIOL, V88, P727, DOI 10.3109/09553002.2012.689464; Luyendyk JP, 2008, J IMMUNOL, V180, P4218, DOI 10.4049/jimmunol.180.6.4218; Mannon RB, 2012, CURR OPIN ORGAN TRAN, V17, P20, DOI 10.1097/MOT.0b013e32834ee5b6; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Martins JC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009864.pub2; Matas AJ, 2013, AM J TRANSPLANT, V13, P11, DOI 10.1111/ajt.12019; Meier-Kriesche HU, 2006, CURR OPIN NEPHROL HY, V15, pS1, DOI 10.1097/01.mnh.0000236065.75007.5e; Meier-Kriesche HU, 2006, AM J TRANSPLANT, V6, P1111, DOI 10.1111/j.1600-6143.2006.01270.x; Mittelstadt PR, 2005, CELL CYCLE, V4, P1189, DOI 10.4161/cc.4.9.2043; Molnarfi N, 2007, J IMMUNOL, V178, P446, DOI 10.4049/jimmunol.178.1.446; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nagata Y, 2016, TRANSPLANTATION, V100, P1675, DOI 10.1097/TP.0000000000001222; Numazawa S, 2003, J BIOCHEM, V133, P599, DOI 10.1093/jb/mvg077; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Oberbarnscheidt MH, 2014, J CLIN INVEST, V124, P3579, DOI 10.1172/JCI74370; Okada Y, 2011, INFLAMM RES, V60, P1049, DOI 10.1007/s00011-011-0366-x; Pimienta G, 2007, CELL CYCLE, V6, P2628, DOI 10.4161/cc.6.21.4930; Puzik A, 2007, ACTA PAEDIATR, V96, P1483, DOI 10.1111/j.1651-2227.2007.00484.x; Rowshani AT, 2012, TRANSPLANTATION, V94, P309, DOI 10.1097/TP.0b013e318250c10f; Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177; Schaeffer V, 2011, J SURG RES, V171, P769, DOI 10.1016/j.jss.2010.05.035; Schmidt RE, 2005, IMMUNOL LETT, V100, P56, DOI 10.1016/j.imlet.2005.06.022; Sellares J, 2013, AM J TRANSPLANT, V13, P971, DOI 10.1111/ajt.12150; Shao K, 2016, SCAND J IMMUNOL, V83, P119, DOI 10.1111/sji.12398; Udalova IA, 2016, NAT REV RHEUMATOL, V12, P472, DOI 10.1038/nrrheum.2016.91; Vafadari R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060784; Vafadari R, 2012, TRANSPLANTATION, V93, P1245, DOI 10.1097/TP.0b013e318250fc62; van Gelder T, 2015, TRANSPL INT, V28, P508, DOI 10.1111/tri.12554; Vereyken EJF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070152; Visintin A, 2001, J IMMUNOL, V166, P249, DOI 10.4049/jimmunol.166.1.249; Wang N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00614; Wasowska BA, 2010, IMMUNOL RES, V47, P25, DOI 10.1007/s12026-009-8136-3; Weimer R, 2003, TRANSPLANTATION, V75, P2090, DOI 10.1097/01.TP.0000058808.37349.23; Zhuang Q, 2015, KIDNEY INT, V87, P712, DOI 10.1038/ki.2014.430; Ziegler-Heitbrock L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00423	65	30	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0170806	10.1371/journal.pone.0170806	http://dx.doi.org/10.1371/journal.pone.0170806			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122021	Green Published, Green Submitted, gold			2022-12-26	WOS:000396167300017
J	Montigny, C; Dieudonne, T; Orlowski, S; Vazquez-Ibar, JL; Gauron, C; Georgin, D; Lund, S; le Maire, M; Moller, JV; Champeil, P; Lenoir, G				Montigny, Cedric; Dieudonne, Thibaud; Orlowski, Stephane; Vazquez-Ibar, Jose Luis; Gauron, Carole; Georgin, Dominique; Lund, Sten; le Maire, Marc; Moller, Jesper V.; Champeil, Philippe; Lenoir, Guillaume			Slow Phospholipid Exchange between a Detergent-Solubilized Membrane Protein and Lipid-Detergent Mixed Micelles: Brominated Phospholipids as Tools to Follow Its Kinetics	PLOS ONE			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; MECHANOSENSITIVE CHANNEL; ADENOSINE-TRIPHOSPHATASE; FLUORESCENCE; BINDING; CRYSTALLIZATION; STABILIZATION; CA-2+-ATPASE; INHIBITION; MECHANISM	Membrane proteins are largely dependent for their function on the phospholipids present in their immediate environment, and when they are solubilized by detergent for further study, residual phospholipids are critical, too. Here, brominated phosphatidylcholine, a phospholipid which behaves as an unsaturated phosphatidylcholine, was used to reveal the kinetics of phospholipid exchange or transfer from detergent mixed micelles to the environment of a detergent-solubilized membrane protein, the paradigmatic P-type ATPase SERCA1a, in which Trp residues can experience fluorescence quenching by bromine atoms present on phospholipid alkyl chains in their immediate environment. Using dodecylmaltoside as the detergent, exchange of (brominated) phospholipid was found to be much slower than exchange of detergent under the same conditions, and also much slower than membrane solubilization, the latter being evidenced by light scattering changes. The kinetics of this exchange was strongly dependent on temperature. It was also dependent on the total concentration of the mixed micelles, revealing the major role for such exchange of the collision of detergent micelles with the detergent-solubilized protein. Back-transfer of the brominated phospholipid from the solubilized protein to the detergent micelle was much faster if lipid-free DDM micelles instead of mixed micelles were added for triggering dissociation of brominated phosphatidylcholine from the solubilized protein, or in the additional presence of C12E8 detergent during exchange, also emphasizing the role of the chemical nature of the micelle/protein interface. This protocol using brominated lipids appears to be valuable for revealing the possibly slow kinetics of phospholipid transfer to or from detergent-solubilized membrane proteins. Independently, continuous recording of the activity of the protein can also be used in some cases to correlate changes in activity with the exchange of a specific phospholipid, as shown here by using the Drs2p/Cdc50p complex, a lipid flippase with specific binding sites for lipids.	[Montigny, Cedric; Dieudonne, Thibaud; Orlowski, Stephane; Vazquez-Ibar, Jose Luis; Gauron, Carole; le Maire, Marc; Champeil, Philippe; Lenoir, Guillaume] Univ Paris Saclay, Univ Paris Sud, CNRS, Inst Integrat Biol Cell I2BC,CEA, Gif Sur Yvette, France; [Georgin, Dominique] CEA, iBiTec S, Serv Chim Bioorgan & Marquage, Gif Sur Yvette, France; [Lund, Sten] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, Med Res Lab, Aarhus, Denmark; [Moller, Jesper V.] Aarhus Univ, Danish Natl Res Fdn, PUMPKIN, Ctr Membrane Pumps Cells & Dis, Aarhus, Denmark; [Moller, Jesper V.] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Gauron, Carole] CIRB, CNRS UMR 7241, INSERM, U1050,Coll France, Paris, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Aarhus University; Aarhus University; Danmarks Grundforskningsfond; Aarhus University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France	Montigny, C; Lenoir, G (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, Inst Integrat Biol Cell I2BC,CEA, Gif Sur Yvette, France.	cedric.montigny@i2bc.paris-saclay.fr; guillaume.lenoir@i2bc.paris-saclay.fr	Lenoir, Guillaume/I-4002-2019; MONTIGNY, Cédric/AAH-4216-2021; Vazquez-Ibar, Jose-Luis/AAD-8827-2021	Lenoir, Guillaume/0000-0002-8759-5179; Vazquez-Ibar, Jose-Luis/0000-0002-8314-3378; Dieudonne, Thibaud/0000-0001-6988-4121; Lund, Sten/0000-0002-3805-6267	Agence Nationale de la Recherche (ANR) [ANR-14-CE09-0022]; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; Centre National de la Recherche Scientifique (CNRS)	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); French Infrastructure for Integrated Structural Biology (FRISBI); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was funded by a grant from the Agence Nationale de la Recherche (ANR, htttp://www.agence-nationale-recherche.fr) to GL ('AsymLip', ANR-14-CE09-0022) and by the French Infrastructure for Integrated Structural Biology (FRISBI, http://frisbi.eu, ANR-10-INSB-05-01). This work was also supported by the Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autzen HE, 2015, MOL MEMBR BIOL, V32, P75, DOI 10.3109/09687688.2015.1073382; Azouaoui H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112176; BAYERL TM, 1988, BIOCHEMISTRY-US, V27, P6078, DOI 10.1021/bi00416a037; Bechara C, 2015, NAT CHEM, V7, P255, DOI [10.1038/NCHEM.2172, 10.1038/nchem.2172]; BENZONAN.G, 1969, BIOCHIM BIOPHYS ACTA, V176, P836, DOI 10.1016/0005-2760(69)90265-3; Betaneli V, 2012, BIOPHYS J, V102, P523, DOI 10.1016/j.bpj.2011.12.049; Bogdanov M, 2010, P NATL ACAD SCI USA, V107, P15057, DOI 10.1073/pnas.1006286107; BOLEN EJ, 1990, BIOCHEMISTRY-US, V29, P9638, DOI 10.1021/bi00493a019; Carney J, 2006, JOHN; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; CORNELIUS F, 1991, BIOCHIM BIOPHYS ACTA, V1071, P19, DOI 10.1016/0304-4157(91)90011-K; Dalton KA, 1998, BIOCHEM J, V329, P637; de Foresta B, 1999, BIOPHYS J, V77, P3071, DOI 10.1016/S0006-3495(99)77138-9; DEFORESTA B, 1989, BIOCHEMISTRY-US, V28, P2558, DOI 10.1021/bi00432a032; DEFORESTA B, 1990, EUR J BIOCHEM, V194, P383; deForesta B, 1996, EUR J BIOCHEM, V241, P343; Drachmann ND, 2014, FEBS J, V281, P4249, DOI 10.1111/febs.12957; EAST JM, 1982, BIOCHEMISTRY-US, V21, P4144, DOI 10.1021/bi00260a035; FULLINGTON DA, 1990, BIOCHEMISTRY-US, V29, P879, DOI 10.1021/bi00456a005; Georgin D, 2001, J LABELLED COMPD RAD, V44, P575, DOI 10.1002/jlcr.485; Haviv H, 2013, J BIOL CHEM, V288, P10073, DOI 10.1074/jbc.M112.446997; JONES JD, 1990, BIOCHEMISTRY-US, V29, P1593, DOI 10.1021/bi00458a034; Laganowsky A, 2014, NATURE, V510, P172, DOI 10.1038/nature13419; le Maire M, 2000, BBA-BIOMEMBRANES, V1508, P86, DOI 10.1016/S0304-4157(00)00010-1; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Lemieux MJ, 2002, J STRUCT BIOL, V137, P322; LONDON E, 1981, BIOCHEMISTRY-US, V20, P1932, DOI 10.1021/bi00510a032; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; LUND S, 1989, J BIOL CHEM, V264, P4907; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; MOLLER JV, 1993, J BIOL CHEM, V268, P18659; Needham D, 1997, BIOPHYS J, V73, P2615, DOI 10.1016/S0006-3495(97)78291-2; NICHOLS JW, 1988, BIOCHEMISTRY-US, V27, P3925, DOI 10.1021/bi00411a006; null Aoudia, 1998, J COLLOID INTERF SCI, V206, P158, DOI [10.1006/jcis.1998.5627, DOI 10.1006/JCIS.1998.5627]; Picard M, 2006, J BIOL CHEM, V281, P3360, DOI 10.1074/jbc.M511385200; Powl AM, 2005, BIOCHEMISTRY-US, V44, P5873, DOI 10.1021/bi047439e; Powl AM, 2003, BIOCHEMISTRY-US, V42, P14306, DOI 10.1021/bi034995k; POWNALL HJ, 1991, BIOCHEMISTRY-US, V30, P5696, DOI 10.1021/bi00237a009; ROUX M, 1984, FEBS LETT, V171, P169, DOI 10.1016/0014-5793(84)80481-0; SHOEMAKER DG, 1992, BIOCHEMISTRY-US, V31, P3414, DOI 10.1021/bi00128a016; VARSANYI M, 1983, EMBO J, V2, P1543, DOI 10.1002/j.1460-2075.1983.tb01621.x; WARREN GB, 1974, BIOCHEMISTRY-US, V13, P5501, DOI 10.1021/bi00724a008; Zana R, 2006, ADV COLLOID INTERFAC, V123, P345, DOI 10.1016/j.cis.2006.05.011; Zhou XM, 2013, J BIOL CHEM, V288, P31807, DOI 10.1074/jbc.M113.481986; Zoonens M, 2007, BIOCHEMISTRY-US, V46, P10392, DOI 10.1021/bi7007596	45	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2017	12	1							e0170481	10.1371/journal.pone.0170481	http://dx.doi.org/10.1371/journal.pone.0170481			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7CU	28118404	gold, Green Published, Green Submitted			2022-12-26	WOS:000396160500031
J	Cao, ZB; Hong, RY; Ding, B; Zuo, XY; Li, H; Ding, JP; Li, YS; Huang, WP; Zhang, YH				Cao, Zubing; Hong, Renyun; Ding, Biao; Zuo, Xiaoyuan; Li, Hui; Ding, Jianping; Li, Yunsheng; Huang, Weiping; Zhang, Yunhai			TSA and BIX-01294 Induced Normal DNA and Histone Methylation and Increased Protein Expression in Porcine Somatic Cell Nuclear Transfer Embryos	PLOS ONE			English	Article							IN-VITRO DEVELOPMENT; CLONING EFFICIENCY; H3K9 DIMETHYLATION; INHIBITOR; GENOME; PIG; GENES; EHMT2; FATE; CDX2	The poor efficiency of animal cloning is mainly attributed to the defects in epigenetic reprogramming of donor cells' chromatins during early embryonic development. Previous studies indicated that inhibition of histone deacetylases or methyltransferase, such as G9A, using Trichostatin A (TSA) or BIX-01294 significantly enhanced the developmental efficiency of porcine somatic cell nuclear transfer (SCNT) embryos. However, potential mechanisms underlying the improved early developmental competence of SCNT embryos exposed to TSA and BIX-01294 are largely unclear. Here we found that 50 nM TSA or 1.0 mu M BIX-01294 treatment alone for 24 h significantly elevated the blastocyst rate (P < 0.05), while further improvement was not observed under combined treatment condition. Furthermore, co treatment or TSA treatment alone significantly reduced H3K9me2 level at the 4-cell stage, which is comparable with that in in vivo and in vitro fertilized counterparts. However, only co treatment significantly decreased the levels of 5mC and H3K9me2 in trophectoderm lineage and subsequently increased the expression of OCT4 and CDX2 associated with ICM and TE lineage differentiation. Altogether, these results demonstrate that co-treatment of TSA and BIX-01294 enhances the early developmental competence of porcine SCNT embryos via improvements in epigenetic status and protein expression.	[Cao, Zubing; Hong, Renyun; Ding, Biao; Zuo, Xiaoyuan; Li, Hui; Ding, Jianping; Li, Yunsheng; Huang, Weiping; Zhang, Yunhai] Anhui Agr Univ, Anhui Prov Lab Local Livestock & Poultry Genet Re, Coll Anim Sci & Technol, Hefei, Peoples R China	Anhui Agricultural University	Zhang, YH (corresponding author), Anhui Agr Univ, Anhui Prov Lab Local Livestock & Poultry Genet Re, Coll Anim Sci & Technol, Hefei, Peoples R China.	yunhaizhang@ahau.edu.cn	Zhang, Yunhai/O-4453-2014; ding, biao/AAR-1465-2021	Zhang, Yunhai/0000-0001-9721-5910; 	National Natural Science Foundation of China [31272442]; National Transgenic New Species Breeding Program of China [2014ZX08006-01B]; National Science Foundation of the Higher Education Institutions of Anhui Province [KJ2016A227]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Transgenic New Species Breeding Program of China; National Science Foundation of the Higher Education Institutions of Anhui Province	This work was supported by the National Natural Science Foundation of China (31272442) and National Transgenic New Species Breeding Program of China (2014ZX08006-01B) and National Science Foundation of the Higher Education Institutions of Anhui Province (KJ2016A227).	Bou G, 2016, DEV BIOL, V410, P36, DOI 10.1016/j.ydbio.2015.12.014; Cao ZB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144897; Cao ZB, 2014, THERIOGENOLOGY, V81, P496, DOI 10.1016/j.theriogenology.2013.10.025; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Cervera RP, 2009, THERIOGENOLOGY, V72, P1097, DOI 10.1016/j.theriogenology.2009.06.030; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chung YG, 2015, CELL STEM CELL, V17, P758, DOI 10.1016/j.stem.2015.10.001; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Fu L, 2012, THERIOGENOLOGY, V78, P1929, DOI 10.1016/j.theriogenology.2012.07.017; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Huan YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129803; Huang JJ, 2016, REPRODUCTION, V151, P39, DOI 10.1530/REP-15-0460; Huang YY, 2011, CELL REPROGRAM, V13, P513, DOI 10.1089/cell.2011.0032; Inoue K, 2002, SCIENCE, V295, P297, DOI 10.1126/science.295.5553.297; Kang YK, 2001, NAT GENET, V28, P173, DOI 10.1038/88903; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Kwak SS, 2012, J VET MED SCI, V74, P1095, DOI 10.1292/jvms.12-0050; Li J, 2008, THERIOGENOLOGY, V70, P800, DOI 10.1016/j.theriogenology.2008.05.046; Matoba S, 2014, CELL, V159, P884, DOI 10.1016/j.cell.2014.09.055; Matoba S, 2011, P NATL ACAD SCI USA, V108, P20621, DOI 10.1073/pnas.1112664108; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Park KE, 2012, REPROD FERT DEVELOP, V24, P813, DOI 10.1071/RD11205; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Smallwood A, 2007, GENE DEV, V21, P1169, DOI 10.1101/gad.1536807; Song YR, 2014, PROTEIN CELL, V5, P382, DOI 10.1007/s13238-014-0034-3; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Van Thuan N, 2010, J REPROD DEVELOP, V56, P20, DOI 10.1262/jrd.09-221A; Whyte JJ, 2011, MOL REPROD DEV, V78, P879, DOI 10.1002/mrd.21333; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wilmut I, 2002, NATURE, V419, P583, DOI 10.1038/nature01079; Wu LP, 2008, MOL CELL BIOL, V28, P3219, DOI 10.1128/MCB.01516-07; Zhang YH, 2007, CLONING STEM CELLS, V9, P357, DOI 10.1089/clo.2006.0090; Zhao JG, 2010, CELL REPROGRAM, V12, P75, DOI 10.1089/cell.2009.0038; Zhao JG, 2009, BIOL REPROD, V81, P525, DOI 10.1095/biolreprod.109.077016; Zhou NR, 2014, ANIM REPROD SCI, V148, P153, DOI 10.1016/j.anireprosci.2014.06.002	39	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0169092	10.1371/journal.pone.0169092	http://dx.doi.org/10.1371/journal.pone.0169092			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114389	Green Published, Green Submitted, gold			2022-12-26	WOS:000396129000007
J	Manna, D; Pust, S; Torgersen, ML; Cordara, G; Kunzier, M; Krengel, U; Sandvig, K				Manna, Dipankar; Pust, Sascha; Torgersen, Maria L.; Cordara, Gabriele; Kunzier, Markus; Krengel, Ute; Sandvig, Kirsten			Polyporus squamosus Lectin 1a (PSL1a) Exhibits Cytotoxicity in Mammalian Cells by Disruption of Focal Adhesions, Inhibition of Protein Synthesis and Induction of Apoptosis	PLOS ONE			English	Article							OREADES AGGLUTININ MOA; MARASMIUS-OREADES; RECOGNITION MOLECULES; SIALIC ACIDS; BINDING; INTEGRINS; AUTOPHAGY; DISEASE; COMPLEX; CANCER	PSL1a is a lectin from the mushroom Polyporus squamosus that binds to sialylated glycans and glycoconjugates with high specificity and selectivity. In addition to its N-terminal carbohydrate-binding domain, PSL1a possesses a Ca2+-dependent proteolytic activity in the C-terminal domain. In the present study, we demonstrate that PSL1a has cytotoxic effects on mammalian cancer cells, and we show that the cytotoxicity is dependent on the cysteine protease activity. PSL1a treatment leads to cell rounding and detachment from the substratum, concomitant with disruption of vinculin complexes in focal adhesions. We also demonstrate that PSL1a inhibits protein synthesis and induces apoptosis in HeLa cells, in a time- and concentration-dependent manner.	[Manna, Dipankar; Cordara, Gabriele; Krengel, Ute] Univ Oslo, Dept Chem, Oslo, Norway; [Manna, Dipankar; Pust, Sascha; Torgersen, Maria L.; Sandvig, Kirsten] Oslo Univ Hosp, Inst Canc Res, Dept Mol Cell Biol, Oslo, Norway; [Manna, Dipankar; Pust, Sascha; Torgersen, Maria L.; Sandvig, Kirsten] Univ Oslo, Ctr Canc Biomed, Fac Med, Oslo, Norway; [Kunzier, Markus] Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland; [Sandvig, Kirsten] Univ Oslo, Fac Math & Nat Sci, Dept Biosci, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Oslo	Krengel, U (corresponding author), Univ Oslo, Dept Chem, Oslo, Norway.; Sandvig, K (corresponding author), Oslo Univ Hosp, Inst Canc Res, Dept Mol Cell Biol, Oslo, Norway.; Sandvig, K (corresponding author), Univ Oslo, Ctr Canc Biomed, Fac Med, Oslo, Norway.; Sandvig, K (corresponding author), Univ Oslo, Fac Math & Nat Sci, Dept Biosci, Oslo, Norway.	ute.krengel@kjemi.uio.no; ksandvig@ibv.uio.no	Torgersen, Maria Lyngaas/O-6240-2019; Torgersen, Maria Lyngaas L/F-3492-2017; Pust, Sascha/M-3201-2013; Manna, Dipankar/AAP-3452-2020	Torgersen, Maria Lyngaas/0000-0003-2616-7194; Torgersen, Maria Lyngaas L/0000-0003-2616-7194; Pust, Sascha/0000-0002-0178-2206; Manna, Dipankar/0000-0002-1650-8250; Kunzler, Markus/0000-0003-1275-0629; Krengel, Ute/0000-0001-6688-8151	UiO, the Norwegian Loan Fund; BioStruct (the National Norwegian Graduate School in Structural Biology); South-Eastern Norway Regional Health Authority (Helse Sor-Ost); Norwegian Research council; Norwegian Cancer Society	UiO, the Norwegian Loan Fund; BioStruct (the National Norwegian Graduate School in Structural Biology); South-Eastern Norway Regional Health Authority (Helse Sor-Ost); Norwegian Research council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society)	This work has been supported by UiO, the Norwegian Loan Fund (stipend of D.M.), travel grants by BioStruct (the National Norwegian Graduate School in Structural Biology), the South-Eastern Norway Regional Health Authority (Helse Sor-Ost), the Norwegian Research council, and the Norwegian Cancer Society.	Anaya-Ruiz M, 2003, INT J PARASITOL, V33, P663, DOI 10.1016/S0020-7519(03)00029-8; BACIC A, 1990, EXP PARASITOL, V71, P483, DOI 10.1016/0014-4894(90)90074-M; Chen L, 2013, J VIROL, V87, P4118, DOI 10.1128/JVI.03476-12; Cordara G, 2014, BIOCHEM BIOPH RES CO, V447, P586, DOI 10.1016/j.bbrc.2014.04.043; Cordara G, 2011, BIOCHEM BIOPH RES CO, V408, P405, DOI 10.1016/j.bbrc.2011.04.031; Dam TK, 2010, ADV CARBOHYD CHEM BI, V63, P139, DOI 10.1016/S0065-2318(10)63005-3; Dam TK, 2000, J BIOL CHEM, V275, P14223, DOI 10.1074/jbc.275.19.14223; Damiano JS, 1999, BLOOD, V93, P1658, DOI 10.1182/blood.V93.5.1658; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; EGBERTS E, 1977, J VIROL, V22, P591, DOI 10.1128/JVI.22.3.591-597.1977; FIORENTINI C, 1990, INFECT IMMUN, V58, P2329, DOI 10.1128/IAI.58.7.2329-2336.1990; Fitzwalter BE, 2015, FEBS J, V282, P4279, DOI 10.1111/febs.13515; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; GOLDSTEIN IJ, 1980, NATURE, V66, P285; Grahn E, 2007, J MOL BIOL, V369, P710, DOI 10.1016/j.jmb.2007.03.016; Grahn EM, 2009, J MOL BIOL, V390, P457, DOI 10.1016/j.jmb.2009.04.074; Hassan MAA, 2015, INT J MOL SCI, V16, P7802, DOI 10.3390/ijms16047802; Jiang QL, 2015, CELL PROLIFERAT, V48, P17, DOI 10.1111/cpr.12155; JORGENSEN T, 1995, CANCER RES, V55, P1817; Juillot S, 2016, BBA-GEN SUBJECTS, V1860, P392, DOI 10.1016/j.bbagen.2015.11.002; Kadirvelraj R, 2011, GLYCOBIOLOGY, V21, P973, DOI 10.1093/glycob/cwr030; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Koles K, 2009, GLYCOCONJUGATE J, V26, P313, DOI 10.1007/s10719-008-9154-4; Lakhtin V, 2011, ANAEROBE, V17, P452, DOI 10.1016/j.anaerobe.2011.06.004; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; Marty-Detraves C, 2004, MOL CELL BIOCHEM, V258, P49, DOI 10.1023/B:MCBI.0000012835.08001.8f; Matsuda A, 2015, ANAL CHEM, V87, P7274, DOI 10.1021/acs.analchem.5b01329; Matsuda A, 2010, HEPATOLOGY, V52, P174, DOI 10.1002/hep.23654; Mo HQ, 2000, J BIOL CHEM, V275, P10623, DOI 10.1074/jbc.275.14.10623; OLSNES S, 1976, J BIOL CHEM, V251, P3985; Pust S, 2010, CELL MICROBIOL, V12, P1809, DOI 10.1111/j.1462-5822.2010.01512.x; Repnikova E, 2010, J NEUROSCI, V30, P6466, DOI 10.1523/JNEUROSCI.5253-09.2010; Rhodes JM, 1999, ANN ONCOL, V10, P118, DOI 10.1023/A:1008369626649; Sabotic J, 2016, APPL MICROBIOL BIOT, V100, P91, DOI 10.1007/s00253-015-7075-2; SHARON N, 1989, SCIENCE, V246, P227, DOI 10.1126/science.2552581; SHARON N, 1987, FEBS LETT, V217, P145, DOI 10.1016/0014-5793(87)80654-3; Sharon N, 2007, J BIOL CHEM, V282, P2753, DOI 10.1074/JBC.X600004200; Singh RS, 2011, BIOTECHNOL ADV, V29, P726, DOI 10.1016/j.biotechadv.2011.06.002; Singh RS, 2010, CRIT REV BIOTECHNOL, V30, P99, DOI 10.3109/07388550903365048; Spooner RA, 2015, TOXINS, V7, P49, DOI 10.3390/toxins7010049; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Varrot A, 2013, CURR OPIN STRUC BIOL, V23, P678, DOI 10.1016/j.sbi.2013.07.007; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Wahrenbrock MG, 2006, CANCER RES, V66, P2433, DOI 10.1158/0008-5472.CAN-05-3851; Wohlschlager T, 2011, J BIOL CHEM, V286, P30337, DOI 10.1074/jbc.M111.258202; Xu XF, 2011, BIOTECHNOL ADV, V29, P667, DOI 10.1016/j.biotechadv.2011.05.003; Yamada KM, 1997, CURR OPIN CELL BIOL, V9, P76, DOI 10.1016/S0955-0674(97)80155-X; Yamaguchi T, 2016, ANN SURG ONCOL, V23, P671, DOI 10.1245/s10434-015-4878-4	49	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170716	10.1371/journal.pone.0170716	http://dx.doi.org/10.1371/journal.pone.0170716			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114329	Green Submitted, Green Published, gold			2022-12-26	WOS:000396129000087
J	Tan, MC; Wong, WY; Ng, WL; Yeo, KS; Mohidin, TBM; Lim, YY; Lafta, F; Ali, HM; Ea, CK				Tan, Ming Cheang; Wong, Wan Ying; Ng, Wei Lun; Yeo, Kok Siong; Mohidin, Taznim Begam Mohd; Lim, Yat-Yuen; Lafta, Fadhil; Ali, Hapipah Mohd; Ea, Chee-Kwee			Identification of 5-Methoxy-2( Diformylmethylidene)-3,3-Dimethylindole as an Anti-Influenza A Virus Agent	PLOS ONE			English	Article							RIG-I; INNATE IMMUNITY; INDOLE; DERIVATIVES; RNA	Influenza virus is estimated to cause 3-5 million severe complications and about 250-500 thousand deaths per year. Different kinds of anti-influenza virus drugs have been developed. However, the emergence of drug resistant strains has presented a big challenge for efficient antiviral therapy. Indole derivatives have been shown to exhibit both antiviral and anti-inflammatory activities. In this study, we adopted a cell-based system to screen for potential anti-IAV agents. Four indole derivatives (named 525A, 526A, 527A and 528A) were subjected to the antiviral screening, of which 526A was selected for further investigation. We reported that pre-treating cells with 526A protects cells from IAV infection. Furthermore, 526A inhibits IAV replication by inhibiting the expression of IAV genes. Interestingly, 526A suppresses the activation of IRF3 and STAT1 in host cells and thus represses the production of type I interferon response and cytokines in IAV-infected cells. Importantly, 526A also partially blocks the activation of RIG-I pathway. Taken together, these results suggest that 526A may be a potential anti-influenza A virus agent.	[Tan, Ming Cheang; Wong, Wan Ying; Ng, Wei Lun; Yeo, Kok Siong; Mohidin, Taznim Begam Mohd; Lim, Yat-Yuen; Ea, Chee-Kwee] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia; [Lafta, Fadhil; Ali, Hapipah Mohd] Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur, Malaysia; [Ea, Chee-Kwee] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	Universiti Malaya; Universiti Malaya; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lim, YY; Ea, CK (corresponding author), Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia.; Ea, CK (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	yatyuen.lim@um.edu.my; Chee-Kwee.Ea@utsouthwestern.edu	Yeo, Kok Siong/AAA-8345-2019; Ng, Wei Lun/X-3337-2019; YEO, KOK SIONG/D-9910-2010; Mohidin, Taznim Begam Mohd/S-8567-2016; Lim, Yat Yuen/I-6495-2013	Yeo, Kok Siong/0000-0003-2430-2487; Lim, Yat Yuen/0000-0001-8617-6063	University of Malaya High Impact Research Grant [UM.C/625/1/HIR/MOHE/CHAN-02]; University Malaya Postgraduate Research Grant [PG136-2014B]	University of Malaya High Impact Research Grant; University Malaya Postgraduate Research Grant	This work was supported by the University of Malaya High Impact Research Grant (UM.C/625/1/HIR/MOHE/CHAN-02) and University Malaya Postgraduate Research Grant (PG136-2014B).; We thank Dr. Jesse Bloom (Fred Hutchinson Cancer Research Center, USA) for PR8-PB lflank-eGFP virus, A549-PB1 and 293T-PB1 cells; Dr. Glen N. Barber (University of Miami, USA) for VSV-GFP; Dr. Gabriel Pineda (National University, USA) for comments and critical reading of the manuscript. This work was supported by the University of Malaya High Impact Research Grant (UM.C/625/1/HIR/MOHE/CHAN-02) and University Malaya Postgraduate Research Grant (PG136-2014B).	Das K, 2010, NAT STRUCT MOL BIOL, V17, P530, DOI 10.1038/nsmb.1779; Gao QS, 2012, J VIROL, V86, P7043, DOI 10.1128/JVI.00662-12; Giampieri M, 2009, ANTIVIR RES, V83, P179, DOI 10.1016/j.antiviral.2009.05.001; Goraya MU, 2015, PROTEIN CELL, V6, P712, DOI 10.1007/s13238-015-0191-z; Goubau D, 2014, NATURE, V514, P372, DOI 10.1038/nature13590; Killip MJ, 2015, INFLUENZA VIRUS ACTI; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Mehta DS, 2005, INDIAN J CHEM B, V44, P2594; Olgen S, 2008, Z NATURFORSCH C, V63, P189; Ozdemir A, 2015, EUR J MED CHEM, V89, P304, DOI 10.1016/j.ejmech.2014.10.056; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Samji Tasleem, 2009, Yale Journal of Biology and Medicine, V82, P153; Tissari J, 2005, J IMMUNOL, V174, P4289, DOI 10.4049/jimmunol.174.7.4289; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Wong WY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08672; Xue S, 2014, ACTA PHARM SIN B, V4, P313, DOI 10.1016/j.apsb.2014.06.003; Zhang MZ, 2015, EUR J MED CHEM, V89, P421, DOI 10.1016/j.ejmech.2014.10.065; Zhao F, 2009, J BIOCHEM MOL TOXIC, V23, P273, DOI 10.1002/jbt.20289	18	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e170352	10.1371/journal.pone.0170352	http://dx.doi.org/10.1371/journal.pone.0170352			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114392	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129000039
J	Wallbillich, JJ; Josyula, S; Saini, U; Zingarelli, RA; Dorayappan, KDP; Riley, MK; Wanner, RA; Cohn, DE; Selvendiran, K				Wallbillich, John J.; Josyula, Srirama; Saini, Uksha; Zingarelli, Roman A.; Dorayappan, Kalpana Deepa Priya; Riley, Maria K.; Wanner, Ross A.; Cohn, David E.; Selvendiran, Karuppaiyah			High Glucose-Mediated STAT3 Activation in Endometrial Cancer Is Inhibited by Metformin: Therapeutic Implications for Endometrial Cancer	PLOS ONE			English	Article							GROWTH-FACTOR-I; INSULIN-RESISTANCE; DIABETES-MELLITUS; BINDING PROTEIN-1; SIGNAL TRANSDUCER; INCIDENT CANCER; DOWN-REGULATION; BREAST-CANCER; UNITED-STATES; OBESITY	Objectives STAT3 is over-expressed in endometrial cancer, and diabetes is a risk factor for the development of type 1 endometrial cancer. We therefore investigated whether glucose concentrations influence STAT3 expression in type 1 endometrial cancer, and whether such STAT3 expression might be inhibited by metformin. Methods In Ishikawa (grade 1) endometrial cancer cells subjected to media with low, normal, or high concentrations of glucose, expression of STAT3 and its target proteins was evaluated by real-time quantitative PCR (qPCR). Ishikawa cells were treated with metformin and assessed with cell proliferation, survival, migration, and ubiquitin assays, as well as Western blot and qPCR. Expression of apoptosis proteins was evaluated with Western blot in Ishikawa cells transfected with a STAT3 overexpression plasmid and treated with metformin. A xenograft tumor model was used for studying the in vivo efficacy of metformin. Results Expression of STAT3 and its target proteins was increased in Ishikawa cells cultured in high glucose media. In vitro, metformin inhibited cell proliferation, survival and migration but induced apoptosis. Metformin reduced expression levels of pSTAT3 ser727, total STAT3, and its associated cell survival and anti-apoptotic proteins. Additionally, metformin treatment was associated with increased degradation of pSTAT3 ser727. No change in apoptotic protein expression was noticed with STAT3 overexpression in Ishikawa cells. In vivo, metformin treatment led to a decrease in tumor weight as well as reductions of STAT3, pSTAT3 ser727, its target proteins. Conclusions These results suggest that STAT3 expression in type 1 endometrial cancer is stimulated by a high glucose environment and inhibited by metformin.	[Wallbillich, John J.; Josyula, Srirama; Saini, Uksha; Zingarelli, Roman A.; Dorayappan, Kalpana Deepa Priya; Riley, Maria K.; Wanner, Ross A.; Cohn, David E.; Selvendiran, Karuppaiyah] Ohio State Univ, Wexner Med Ctr, Ctr Comprehens Canc, Div Gynecol Oncol, Columbus, OH 43210 USA; [Wallbillich, John J.] Augusta Univ, Dept Obstet & Gynecol, Gynecol Oncol Sect, Augusta, GA USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Georgia; Augusta University	Selvendiran, K (corresponding author), Ohio State Univ, Wexner Med Ctr, Ctr Comprehens Canc, Div Gynecol Oncol, Columbus, OH 43210 USA.	selvendiran.karuppaiyah@osumc.edu		Wallbillich, John/0000-0001-5913-8088; Cohn, David/0000-0002-3036-6172	Division of Gynecologic Oncology Startup Fund; Ohio State University Comprehensive Cancer Center Startup Fund; Ohio State University Comprehensive Cancer Center (OSU CCC); Division of Gynecologic Oncology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD085817] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER	Division of Gynecologic Oncology Startup Fund; Ohio State University Comprehensive Cancer Center Startup Fund; Ohio State University Comprehensive Cancer Center (OSU CCC); Division of Gynecologic Oncology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the Division of Gynecologic Oncology Startup Fund and The Ohio State University Comprehensive Cancer Center Startup Fund, an internal grant from the Ohio State University Comprehensive Cancer Center (OSU CCC) to DEC, and a startup fund from the Division of Gynecologic Oncology to KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KE, 2001, CANCER EPIDEM BIOMAR, V10, P611; Ayabe T, 1997, ENDOCR J, V44, P419, DOI 10.1507/endocrj.44.419; Berger NA, 2014, ANN NY ACAD SCI, V1311, P57, DOI 10.1111/nyas.12416; Berstein LM, 2004, J CANCER RES CLIN, V130, P687, DOI 10.1007/s00432-004-0587-2; Bhardwaj A, 2007, BLOOD, V109, P2293, DOI 10.1182/blood-2006-02-003988; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Cantrell LA, 2010, GYNECOL ONCOL, V116, P92, DOI 10.1016/j.ygyno.2009.09.024; Currie CJ, 2012, DIABETES CARE, V35, P299, DOI 10.2337/dc11-1313; Deng XS, 2012, CELL CYCLE, V11, P367, DOI 10.4161/cc.11.2.18813; Duong LM, 2011, J WOMENS HEALTH, V20, P1157, DOI 10.1089/jwh.2010.2529; Eccles SA, 2005, BIOTECHNOL ANN REV, V11, P391, DOI 10.1016/S1387-2656(05)11013-8; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Feng Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.59; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; Fu AKY, 2004, P NATL ACAD SCI USA, V101, P6728, DOI 10.1073/pnas.0307606100; Hanna RK, 2012, GYNECOL ONCOL, V125, P458, DOI 10.1016/j.ygyno.2012.01.009; He L, 2016, J BIOL CHEM, V291, P10562, DOI 10.1074/jbc.M116.719666; Hirsch HA, 2013, P NATL ACAD SCI USA, V110, P972, DOI 10.1073/pnas.1221055110; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Iglesias DA, 2013, MOL CANCER THER, V12, P2847, DOI 10.1158/1535-7163.MCT-13-0439; Irons BK, 2014, DIABETES METAB SYNDR, V7, P15, DOI 10.2147/DMSO.S38753; Liao CY, 2014, GYNECOL ONCOL, V135, P163, DOI 10.1016/j.ygyno.2014.07.095; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Lopez R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079708; Malki A, 2011, ONCOL RES, V19, P275, DOI 10.3727/096504011X13021877989838; McDonnell DP, 2014, CANCER RES, V74, P4976, DOI 10.1158/0008-5472.CAN-14-1756; Menke A, 2014, ANN INTERN MED, V161, P328, DOI 10.7326/M14-0286; Pan Q, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0183-0; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Petridou E, 2003, ONCOLOGY-BASEL, V64, P341, DOI 10.1159/000070291; Priceman SJ, 2013, P NATL ACAD SCI USA, V110, P13079, DOI 10.1073/pnas.1311557110; Rath KS, 2014, CANCER RES, V74, P2316, DOI 10.1158/0008-5472.CAN-13-2433; Saini U, 2016, ONCOGENE; Selvendiran K, 2006, CANCER RES, V66, P4826, DOI 10.1158/0008-5472.CAN-05-4062; Selvendiran K, 2010, MOL CANCER RES, V8, P1188, DOI 10.1158/1541-7786.MCR-10-0201; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Soliman PT, 2006, CANCER-AM CANCER SOC, V106, P2376, DOI 10.1002/cncr.21866; Stattin P, 2007, DIABETES CARE, V30, P561, DOI 10.2337/dc06-0922; Tandon M, 2016, ONCOGENE; Tierney BJ, 2014, GYNECOL ONCOL, V135, P133, DOI 10.1016/j.ygyno.2014.07.087; Umene K, 2013, ONCOL REP, V29, P855, DOI 10.3892/or.2013.2221; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Weiderpass E, 2003, BRIT J CANCER, V89, P1697, DOI 10.1038/sj.bjc.6601312; Xu YZ, 2016, DIABETES, V65, P1040, DOI 10.2337/db15-1160; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P9623, DOI 10.1073/pnas.1121606109; Zhu MJ, 2015, ONCOL REP, V34, P129, DOI 10.3892/or.2015.3951	50	22	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e170318	10.1371/journal.pone.0170318	http://dx.doi.org/10.1371/journal.pone.0170318			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114390	gold, Green Published, Green Submitted			2022-12-26	WOS:000396129000037
J	Zhang, C; Liang, J; Yang, L; Sun, BG; Wang, CT				Zhang, Chan; Liang, Jian; Yang, Le; Sun, Baoguo; Wang, Chengtao			De Novo RNA Sequencing and Transcriptome Analysis of Monascus purpureus and Analysis of Key Genes Involved in Monacolin K Biosynthesis	PLOS ONE			English	Article							RED YEAST RICE; FUNCTIONAL ANNOTATION; FERMENTATION; METABOLITES; DERIVATIVES; LOVASTATIN; NUTRIENTS; PIGMENTS	Monascus purpureus is an important medicinal and edible microbial resource. To facilitate biological, biochemical, and molecular research on medicinal components of M. purpureus, we investigated the M. purpureus transcriptome by RNA sequencing (RNA-seq). An RNA-seq library was created using RNA extracted from a mixed sample of M. purpureus expressing different levels of monacolin K output. In total 29,713 unigenes were assembled from more than 60 million high-quality short reads. A BLAST search revealed hits for 21,331 unigenes in at least one of the protein or nucleotide databases used in this study. The 22,365 unigenes were categorized into 48 functional groups based on Gene Ontology classification. Owing to the economic and medicinal importance of M. purpureus, most studies on this organism have focused on the pharmacological activity of chemical components and the molecular function of genes involved in their biogenesis. In this study, we performed quantitative real-time PCR to detect the expression of genes related to monacolin K (mokA-mokI) at different phases (2, 5, 8, and 12 days) of M. purpureus M1 and M1-36. Our study found that mokF modulates monacolin K biogenesis in M. purpureus. Nine genes were suggested to be associated with the monacolin K biosynthesis. Studies on these genes could provide useful information on secondary metabolic processes in M. purpureus. These results indicate a detailed resource through genetic engineering of monacolin K biosynthesis in M. purpureus and related species.	[Zhang, Chan; Liang, Jian; Yang, Le; Sun, Baoguo; Wang, Chengtao] Beijing Technol & Business Univ, Sch Food & Chem Engn, Beijing, Peoples R China; [Zhang, Chan; Sun, Baoguo; Wang, Chengtao] Beijing Technol & Business Univ, Beijing Engn & Technol Res Ctr Food Addit, Beijing, Peoples R China; [Zhang, Chan; Sun, Baoguo; Wang, Chengtao] Beijing Technol & Business Univ, Beijing Key Lab Flavor Chem, Beijing, Peoples R China	Beijing Technology & Business University; Beijing Technology & Business University; Beijing Technology & Business University	Wang, CT (corresponding author), Beijing Technol & Business Univ, Sch Food & Chem Engn, Beijing, Peoples R China.	13641119958@163.com			National Natural Science Foundation of China [31301411]; Beijing Municipal Education Commission [KM201410011009]; Beijing Municipal Science and Technology Commission [Z151100001215008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Education Commission(Beijing Municipal Commission of Education); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission)	This work was supported by the National Natural Science Foundation of China (Grant No. 31301411), Beijing Municipal Education Commission (Grant No. KM201410011009), and Beijing Municipal Science and Technology Commission (Grant No. Z151100001215008).	Anandakumar S, 2016, MITOCHONDRIAL DNA A, V27, P811, DOI 10.3109/19401736.2014.919454; Ansari MP, 2013, NAT PROD RES, V27, P1848, DOI 10.1080/14786419.2013.768990; Bajetha G, 2013, ANIM BIOTECHNOL, V24, P25, DOI 10.1080/10495398.2012.737884; Bogsrud MP, 2010, SCAND CARDIOVASC J, V44, P197, DOI 10.3109/14017431003624123; Chen G, 2016, WORLD J MICROB BIOT, V32, P136, DOI 10.1007/s11274-016-2082-8; Chen HH, 2014, CYTA-J FOOD, V12, P134, DOI 10.1080/19476337.2013.805818; Chen J, 2015, HEMATOLOGY, V20, P336, DOI 10.1179/1607845414Y.0000000209; Cheng MJ, 2010, NAT PROD RES, V24, P1719, DOI 10.1080/14786410902941477; Chuang CY, 2011, J AGR FOOD CHEM, V59, P3027, DOI 10.1021/jf104239m; Dikshit R, 2015, J FOOD SCI TECH MYS, V52, P6679, DOI 10.1007/s13197-014-1678-y; Dikshit R, 2014, PREP BIOCHEM BIOTECH, V44, P68, DOI 10.1080/10826068.2013.792097; Du YF, 2016, ANIMAL BIOTECHNOLOGY; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Ferse I, 2012, NAT PROD RES, V26, P1914, DOI 10.1080/14786419.2011.639074; Feuerstein Joseph Stefon, 2012, Journal of Dietary Supplements, V9, P110, DOI 10.3109/19390211.2012.682645; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Han J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161987; Hong SY, 2011, BIOSCI BIOTECH BIOCH, V75, P1490, DOI 10.1271/bbb.110195; Hsu WH, 2014, APPL MICROBIOL BIOT, V98, P4853, DOI 10.1007/s00253-014-5716-5; Jang H, 2014, NAT PROD RES, V28, P1427, DOI 10.1080/14786419.2014.905561; Jo D, 2014, BIOTECHNOL LETT, V36, P1605, DOI 10.1007/s10529-014-1518-1; Langevin SA, 2013, RNA BIOL, V10, P502, DOI 10.4161/rna.24284; Lee CL, 2016, J MICROBIOLOGY IMMUN; Li YP, 2013, J AGR FOOD CHEM, V61, P7397, DOI 10.1021/jf400879s; Li YP, 2012, BIOTECHNOL LETT, V34, P131, DOI 10.1007/s10529-011-0745-y; Lian XJ, 2015, EUR FOOD RES TECHNOL, V240, P719, DOI 10.1007/s00217-014-2376-8; Liu MT, 2013, J ASIAN NAT PROD RES, V15, P600, DOI 10.1080/10286020.2013.790379; Lu TF, 2016, MOL GENET GENOMICS, V291, P2145, DOI 10.1007/s00438-016-1246-4; Mao SH, 2014, SYST BIOL REPROD MED, V60, P308, DOI 10.3109/19396368.2014.944318; Maurin M, 2012, EXPERT REV MOL DIAGN, V12, P731, DOI [10.1586/ERM.12.53, 10.1586/erm.12.53]; Miao L, 2016, FRONTIERS PLANT SCI; Miyake T, 2006, BIOSCI BIOTECH BIOCH, V70, P1154, DOI 10.1271/bbb.70.1154; Nie SS, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2633-2; Ning ZQ, 2017, INT J FOOD MICROBIOL, V241, P325, DOI 10.1016/j.ijfoodmicro.2016.11.004; Okada T, 2016, GENOM DATA, V10, P4, DOI 10.1016/j.gdata.2016.08.003; Park SH, 2016, BIOTECHNOLOGY LETT; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Radu N, 2012, MOL CRYST LIQ CRYST, V555, P195, DOI 10.1080/15421406.2012.635535; Sakai K, 2009, BIOTECHNOL LETT, V31, P1911, DOI 10.1007/s10529-009-0093-3; Seong J, 2016, GENES-BASEL, V7, DOI 10.3390/genes7120114; Su XH, 2016, BIOTECHNOL BIOTEC EQ, V30, P592, DOI 10.1080/13102818.2016.1146086; Tachibana S, 2007, BIOSCI BIOTECH BIOCH, V71, P2573, DOI 10.1271/bbb.70285; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Tran VDT, 2016, RNA BIOL, V13, P59, DOI 10.1080/15476286.2015.1118604; Wei Z, 2016, PEER J; Wilhelm BT, 2010, NAT PROTOC, V5, P255, DOI 10.1038/nprot.2009.229; Wilkinson B, 2005, EXPERT OPINION THERA, V13, P1579; Wu GJ, 2016, FOOD HYDROCOLLOID, V53, P16, DOI 10.1016/j.foodhyd.2015.01.019; Xiong X, 2015, CRITICAL REV FO 0713; Zhang BB, 2015, J BIOTECHNOL, V206, P60, DOI 10.1016/j.jbiotec.2015.04.011; Zhang GD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135339; Zhang L, 2016, FRONTIERS PLANT SCI; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042082; Zhu C, 2016, FRONTIERS MICROBIOLO	54	10	12	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170149	10.1371/journal.pone.0170149	http://dx.doi.org/10.1371/journal.pone.0170149			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114365	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129000021
J	Awade, M; Candia-Gallardo, C; Cornelius, C; Metzger, JP				Awade, Marcelo; Candia-Gallardo, Carlos; Cornelius, Cintia; Metzger, Jean Paul			High Emigration Propensity and Low Mortality on Transfer Drives Female-Biased Dispersal of Pyriglena leucoptera in Fragmented Landscapes	PLOS ONE			English	Article							ATLANTIC FOREST; MOVEMENT; BIRD; HABITAT; SEX; PREDATION; BEHAVIOR; CONNECTIVITY; MAMMALS; LEVEL	Dispersal is a biological process performed in three stages: emigration, transfer and immigration. Intra-specific variation on dispersal behavior, such as sex-bias, is very common in nature, particularly in birds and mammals. However, dispersal is difficult to measure in the field and many hypotheses concerning the causes of sex-biased dispersal remain without empirical confirmation. An important limitation of most empirical studies is that inferences about sex-biased dispersal are based only on emigration proneness or immigration success data. Thus, we still do not know whether sex-biased immigration in fragmented landscapes occurs during emigration, transfer or in both stages. We conducted translocation and radio tracking experiments to assess i) whether inter-patch dispersal movements of a rainforest bird (Pyriglena leucoptera) is sex-biased and ii) how dispersal stages and the perceptual range of the individuals are integrated to generate dispersal patterns. Our results showed that inter-patch dispersal is sex-biased at all stages for P. leucoptera, as females not only exhibit a higher emigration propensity but are subjected to a lower risk of predation when moving through the matrix. Moreover, our data support a perceptual range of 80 m and our results showed that dispersal success decreases considerably when inter-patch distances exceeds this perceptual range. In this case, birds have a higher probability of travelling over longer routes and, as a consequence, the risk of predation increases, specially for males. Overall, results supported that assuming dispersal as a single-stage process to describe dispersal behavior may be misleading. In this way, our study advanced our understanding of processes and patterns related to inter-patch dispersal of neotropical forest birds, shedding light on potential implications for population dynamics and for the management of fragmented landscapes.	[Awade, Marcelo; Candia-Gallardo, Carlos; Metzger, Jean Paul] Univ Sao Paulo, Inst Biosci, Dept Ecol, Sao Paulo, SP, Brazil; [Cornelius, Cintia] Fed Univ Amazonas UFAM, Inst Biol Sci, Dept Biol, Manaus, AM, Brazil	Universidade de Sao Paulo; Universidade Federal de Amazonas	Awade, M (corresponding author), Univ Sao Paulo, Inst Biosci, Dept Ecol, Sao Paulo, SP, Brazil.	awadem@gmail.com	Metzger, Jean Paul/C-2514-2012	Metzger, Jean Paul/0000-0002-0087-5240; Cornelius, Cintia/0000-0002-6690-7655; Awade, Marcelo/0000-0003-4490-8670	Coordination for the Improvement of Higher Education Personnel (CAPES) [33002010116P8]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP 2007/55642-6]; Brazilian Council for Research and Technology; Bundesministerium fur Bildung and Forschung (CNPq/BMBF) [690144/01-6]	Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Council for Research and Technology(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Bundesministerium fur Bildung and Forschung (CNPq/BMBF)(Federal Ministry of Education & Research (BMBF))	MA and CCG were granted master's scholarships (n. 33002010116P8) from the Coordination for the Improvement of Higher Education Personnel (CAPES). CC was granted a Post-Doctoral fellowship from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (grant: FAPESP 2007/55642-6). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Radio-tracking material was obtained with the financial support from the Brazilian Council for Research and Technology and by the Bundesministerium fur Bildung and Forschung, grant: 690144/01-6 (CNPq/BMBF).	ACHARYA L, 1995, ANIM BEHAV, V49, P1461, DOI 10.1016/0003-3472(95)90067-5; Aleixo A, 1999, CONDOR, V101, P537, DOI 10.2307/1370183; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Awade M, 2012, LANDSCAPE ECOL, V27, P185, DOI 10.1007/s10980-011-9667-2; Baguette M, 2007, LANDSCAPE ECOL, V22, P1117, DOI 10.1007/s10980-007-9108-4; Belisle M, 2005, ECOLOGY, V86, P1988, DOI 10.1890/04-0923; Betts MG, 2015, LANDSCAPE ECOL, V30, P585, DOI 10.1007/s10980-015-0156-x; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; Boscolo D, 2008, BIOTROPICA, V40, P273, DOI 10.1111/j.1744-7429.2008.00409.x; Boscolo D, 2011, ECOGRAPHY, V34, P1018, DOI 10.1111/j.1600-0587.2011.06763.x; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Bowler DE, 2009, J ANIM ECOL, V78, P1234, DOI 10.1111/j.1365-2656.2009.01580.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Castellon TD, 2006, CONSERV BIOL, V20, P135, DOI 10.1111/j.1523-1739.2006.00332.x; Catharino Eduardo Luís Martins, 2006, Biota Neotrop., V6, P0, DOI 10.1590/S1676-06032006000200004; Clarke AL, 1997, OIKOS, V79, P429, DOI 10.2307/3546885; Collett, 2003, MODELLING SURVIVAL D; COMINS HN, 1980, J THEOR BIOL, V82, P205, DOI 10.1016/0022-5193(80)90099-5; Costantini D, 2007, NATURWISSENSCHAFTEN, V94, P1015, DOI 10.1007/s00114-007-0284-5; Crooks K. R., 2006, CONNECTIVITY CONSERV; Dale S, 2001, OIKOS, V92, P344, DOI 10.1034/j.1600-0706.2001.920217.x; Dale S, 2006, ECOGRAPHY, V29, P886, DOI 10.1111/j.2006.0906-7590.04816.x; Desrochers A, 2011, LANDSCAPE ECOL, V26, P47, DOI 10.1007/s10980-010-9532-8; Duca C, 2006, REV BRAS ZOOL, V23, P692, DOI 10.1590/S0101-81752006000300011; Fahrig L, 2001, BIOL CONSERV, V100, P65, DOI 10.1016/S0006-3207(00)00208-1; Fahrig L, 2007, FUNCT ECOL, V21, P1003, DOI 10.1111/j.1365-2435.2007.01326.x; Forero-Medina G, 2009, J TROP ECOL, V25, P53, DOI 10.1017/S0266467408005543; Gillies CS, 2010, J APPL ECOL, V47, P182, DOI 10.1111/j.1365-2664.2009.01756.x; Gillies CS, 2008, P NATL ACAD SCI USA, V105, P19774, DOI 10.1073/pnas.0803530105; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Grimm V., 2005, INDIVIDUAL BASED MOD; HAMILTON WD, 1977, NATURE, V269, P578, DOI 10.1038/269578a0; Hansbauer MM, 2008, J TROP ECOL, V24, P291, DOI 10.1017/S0266467408005002; Hansbauer MM, 2008, REV BRAS ORNITOL, V16, P131; Huhta E, 2003, ECOLOGY, V84, P1793, DOI 10.1890/0012-9658(2003)084[1793:PBOPIP]2.0.CO;2; Ibarra-Macias A, 2011, BIOL CONSERV, V144, P703, DOI 10.1016/j.biocon.2010.08.006; Ims Rolf A., 1997, P247, DOI 10.1016/B978-012323445-2/50015-8; Kays R, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2478; Kenward RE., 2000, MANUAL WILDLIFE RADI; Kiltie RA, 2000, FUNCT ECOL, V14, P226, DOI 10.1046/j.1365-2435.2000.00404.x; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Mabry KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057980; Matthysen E, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P3; Moore RP, 2008, ECOL LETT, V11, P960, DOI 10.1111/j.1461-0248.2008.01196.x; Morrison CA, 2016, J ANIM ECOL, V85, P1298, DOI 10.1111/1365-2656.12556; Nams VO, 2006, ANIM BEHAV, V72, P1197, DOI 10.1016/j.anbehav.2006.04.005; Nathan Ran, 2001, Trends in Ecology and Evolution, V16, P481, DOI 10.1016/S0169-5347(01)02272-8; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Oliveira AT, 2000, BIOTROPICA, V32, P793, DOI 10.1646/0006-3606(2000)032[0793:POFDAA]2.0.CO;2; Ovaskainen O, 2008, THEOR POPUL BIOL, V73, P198, DOI 10.1016/j.tpb.2007.11.002; Prevedello JA, 2010, J ANIM ECOL, V79, P1315, DOI 10.1111/j.1365-2656.2010.01736.x; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; R Core Team, 2012, R LANG ENV STAT COMP; RAIM A, 1978, Bird-Banding, V49, P326; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Saura S, 2009, ENVIRON MODELL SOFTW, V24, P135, DOI 10.1016/j.envsoft.2008.05.005; Sick H., 1997, ORNITOLOGIA BRASILEI; Stenseth NC, 1992, DISPERSAL ECOLOGY EV; Travis JMJ, 2012, METHODS ECOL EVOL, V3, P628, DOI 10.1111/j.2041-210X.2012.00193.x; Trochet A, 2013, J ANIM ECOL, V82, P946, DOI 10.1111/1365-2656.12082; Uezu A, 2005, BIOL CONSERV, V123, P507, DOI 10.1016/j.biocon.2005.01.001; WILLIS EO, 1978, ANNU REV ECOL SYST, V9, P243, DOI 10.1146/annurev.es.09.110178.001331; Woltmann S, 2012, J AVIAN BIOL, V43, P33, DOI 10.1111/j.1600-048X.2011.05572.x; Zollner PA, 2005, OIKOS, V108, P219, DOI 10.1111/j.0030-1299.2005.13711.x; Zollner PA, 1999, ECOLOGY, V80, P1019, DOI 10.2307/177035; Zollner PA, 2000, LANDSCAPE ECOL, V15, P523, DOI 10.1023/A:1008154532512	66	18	18	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170493	10.1371/journal.pone.0170493	http://dx.doi.org/10.1371/journal.pone.0170493			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107517	Green Published, gold			2022-12-26	WOS:000392405300147
J	Fung-Leung, WP; Edwards, W; Liu, Y; Ngo, K; Angsana, J; Castro, G; Wu, N; Liu, XJ; Swanson, RV; Wickenden, AD				Fung-Leung, Wai-Ping; Edwards, Wilson; Liu, Yi; Ngo, Karen; Angsana, Julianty; Castro, Glenda; Wu, Nancy; Liu, Xuejun; Swanson, Ronald V.; Wickenden, Alan D.			T Cell Subset and Stimulation Strength-Dependent Modulation of T Cell Activation by Kv1.3 Blockers	PLOS ONE			English	Article							GATED POTASSIUM CHANNELS; SEA-ANEMONE TOXIN; AUTOIMMUNE-DISEASES; K+ CHANNELS; IMMUNOLOGICAL SYNAPSE; LYMPHOCYTE ACTIVATION; K(V)1.3 CHANNELS; GENE-EXPRESSION; SCORPION-VENOM; ION CHANNELS	Kv1.3 is a voltage-gated potassium channel expressed on T cells that plays an important role in T cell activation. Previous studies have shown that blocking Kv1.3 channels in human T cells during activation results in reduced calcium entry, cytokine production, and proliferation. The aim of the present study was to further explore the effects of Kv1.3 blockers on the response of different human T cell subsets under various stimulation conditions. Our studies show that, unlike the immune suppressor cyclosporine A, the inhibitory effect of Kv1.3 blockers was partial and stimulation strength dependent, with reduced inhibitory efficacy on T cells under strengthened anti-CD3/CD28 stimulations. T cell responses to allergens including house dust mites and ragweed were partially reduced by Kv1.3 blockers. The effect of Kv1.3 inhibition was dependent on T cell subsets, with stronger effects on CCR7-effector memory compared to CCR7(+) central memory CD4 T cells. Calcium entry studies also revealed a population of CD4 T cells resistant to Kv1.3 blockade. Activation of CD4 T cells was accompanied with an increase in Kv1.3 currents but Kv1.3 transcripts were found to be reduced, suggesting a posttranscriptional mechanism in the regulation of Kv1.3 activities. In summary, Kv1.3 blockers inhibit T cell activation in a manner that is highly dependent on the T cell identity and stimulation strength, These findings suggest that Kv1.3 blockers inhibit T cells in a unique, conditional manner, further refining our understanding of the therapeutic potential of Kv1.3 blockers.	[Fung-Leung, Wai-Ping; Edwards, Wilson; Liu, Yi; Ngo, Karen; Angsana, Julianty; Castro, Glenda; Wu, Nancy; Liu, Xuejun; Swanson, Ronald V.; Wickenden, Alan D.] Janssen Res & Dev LLC, San Diego, CA 92121 USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Fung-Leung, WP (corresponding author), Janssen Res & Dev LLC, San Diego, CA 92121 USA.	wleung@its.jnj.com		Fung-Leung, Wai-Ping/0000-0001-7013-8855				Abdel-Mottaleb Y, 2008, TOXICON, V51, P1424, DOI 10.1016/j.toxicon.2008.03.027; Adachi K, 2011, P NATL ACAD SCI USA, V108, P1549, DOI 10.1073/pnas.1017340108; Azam P, 2007, J INVEST DERMATOL, V127, P1419, DOI 10.1038/sj.jid.5700717; Beeton C, 2005, MOL PHARMACOL, V67, P1369, DOI 10.1124/mol.104.008193; Beeton C, 2001, J IMMUNOL, V166, P936, DOI 10.4049/jimmunol.166.2.936; Beeton C, 2008, J BIOL CHEM, V283, P988, DOI 10.1074/jbc.M706008200; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Bowlby MR, 1997, J GEN PHYSIOL, V110, P601, DOI 10.1085/jgp.110.5.601; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; CAI YC, 1992, DNA CELL BIOL, V11, P163, DOI 10.1089/dna.1992.11.163; CHANDY KG, 1984, J EXP MED, V160, P369, DOI 10.1084/jem.160.2.369; Chen R, 2012, BIOCHEMISTRY-US, V51, P1976, DOI 10.1021/bi201811j; Chen R, 2011, BIOPHYS J, V101, P2652, DOI 10.1016/j.bpj.2011.10.029; Cheng J, 2011, IMMUNOL RES, V50, P113, DOI 10.1007/s12026-011-8216-z; Chi V, 2012, TOXICON, V59, P529, DOI 10.1016/j.toxicon.2011.07.016; Conforti L, 2003, J IMMUNOL, V170, P695, DOI 10.4049/jimmunol.170.2.695; Cronin SJF, 2007, IMMUNOL REV, V220, P151, DOI 10.1111/j.1600-065X.2007.00570.x; DECOURSEY TE, 1984, NATURE, V307, P465, DOI 10.1038/307465a0; Deppong CM, 2010, EUR J IMMUNOL, V40, P1985, DOI 10.1002/eji.200940282; Edwards W, 2014, J BIOL CHEM, V289, P22704, DOI 10.1074/jbc.M114.568642; Gilhar A, 2011, J INVEST DERMATOL, V131, P118, DOI 10.1038/jid.2010.245; Grgic I, 2009, TRANSPL P, V41, P2601, DOI 10.1016/j.transproceed.2009.06.025; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Holmes TC, 1996, J NEUROSCI, V16, P1581; Hu L, 2007, J IMMUNOL, V179, P4563, DOI 10.4049/jimmunol.179.7.4563; Hyodo T, 2010, AM J PHYSIOL-RENAL, V299, pF1258, DOI 10.1152/ajprenal.00374.2010; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Kalman K, 1998, J BIOL CHEM, V273, P32697, DOI 10.1074/jbc.273.49.32697; Kerschbaum HH, 1997, J IMMUNOL, V159, P1628; Kmonickova E, 2008, EUR J PHARMACOL, V588, P85, DOI 10.1016/j.ejphar.2008.03.037; Koshy S, 2014, J BIOL CHEM, V289, P12623, DOI 10.1074/jbc.M113.517037; Lewis RS, 2003, BIOCHEM SOC T, V31, P925; LIN CS, 1993, J EXP MED, V177, P637, DOI 10.1084/jem.177.3.637; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; Mouhat S, 2005, BIOCHEM J, V385, P95, DOI 10.1042/BJ20041379; Murray JK, 2015, J MED CHEM, V58, P6784, DOI 10.1021/acs.jmedchem.5b00495; Nicolaou SA, 2007, J IMMUNOL, V179, P346, DOI 10.4049/jimmunol.179.1.346; Panyi G, 2004, P NATL ACAD SCI USA, V101, P1285, DOI 10.1073/pnas.0307421100; Pennington MW, 2009, MOL PHARMACOL, V75, P762, DOI 10.1124/mol.108.052704; Rauer H, 1999, J BIOL CHEM, V274, P21885, DOI 10.1074/jbc.274.31.21885; Ren YZR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004009; Schmitz A, 2005, MOL PHARMACOL, V68, P1254, DOI 10.1124/mol.105.015669; Sole L, 2009, J CELL SCI, V122, P3738, DOI 10.1242/jcs.056689; Szabo I, 2008, P NATL ACAD SCI USA, V105, P14861, DOI [10.1073/pnas.0804236105, 10.1073/pnas.0804236T05]; Tarcha EJ, 2012, J PHARMACOL EXP THER, V342, P642, DOI 10.1124/jpet.112.191890; WACHOLTZ MC, 1993, J IMMUNOL, V150, P5338; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Yu SP, 1998, J NEUROSCI RES, V52, P612, DOI 10.1002/(SICI)1097-4547(19980601)52:5<612::AID-JNR13>3.0.CO;2-3; Zitt C, 2004, J BIOL CHEM, V279, P12427, DOI 10.1074/jbc.M309297200	51	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170102	10.1371/journal.pone.0170102	http://dx.doi.org/10.1371/journal.pone.0170102			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107393	Green Published, gold, Green Submitted			2022-12-26	WOS:000392405300075
J	Varadi, J; Harazin, A; Fenyvesi, F; Reti-Nagy, K; Gogolak, P; Vamosi, G; Bacskay, I; Feher, P; Ujhelyi, Z; Vasvari, G; Roka, E; Haines, D; Dell, MA; Vecsernyes, M				Varadi, Judit; Harazin, Andras; Fenyvesi, Ferenc; Reti-Nagy, Katalin; Gogolak, Peter; Vamosi, Gyorgy; Bacskay, Ildiko; Feher, Palma; Ujhelyi, Zoltan; Vasvari, Gabor; Roka, Eszter; Haines, David; Dell, Maria A.; Vecsernyes, Miklos			Alpha-Melanocyte Stimulating Hormone Protects against Cytokine-Induced Barrier Damage in Caco-2 Intestinal Epithelial Monolayers	PLOS ONE			English	Article							NF-KAPPA-B; TNF-ALPHA; ENDOTHELIAL-CELLS; MSH; PERMEABILITY; ACTIVATION; MODEL; INFLAMMATION; MODULATION; MECHANISM	Alpha-melanocyte-stimulating hormone (alpha-MSH) is a potent anti-inflammatory peptide with cytoprotective effect in various tissues. The present investigation demonstrates the ability of alpha-MSH to interact with intestinal epithelial cell monolayers and mitigate inflammatory processes of the epithelial barrier. The protective effect of alpha-MSH was studied on Caco-2 human intestinal epithelial monolayers, which were disrupted by exposure to tumor necrosis factor-alpha and interleukin-1 beta. The barrier integrity was assessed by measuring transepithelial electric resistance (TEER) and permeability for marker molecules. Caco-2 monolayers were evaluated by immunohistochemistry for expression of melanocortin-1 receptor and tight junction proteins ZO-1 and claudin-4. The activation of nuclear factor kappa beta (NF-kappa B) was detected by fluorescence microscopy and inflammatory cytokine expression was assessed by flow cytometric bead array cytokine assay. Exposure of Caco-2 monolayers to proinflammatory cytokines lowered TEER and increased permeability for fluorescein and albumin, which was accompanied by changes in ZO-1 and claudin-4 immunostaining. alpha MSH was able to prevent inflammation-associated decrease of TEER in a dose-dependent manner and reduce the increased permeability for paracellular marker fluorescein. Further immunohistochemistry analysis revealed proinflammatory cytokine induced translocation of the NF-kappa B p65 subunit into Caco-2 cell nuclei, which was inhibited by alpha-MSH. As a result the IL-6 and IL-8 production of Caco-2 monolayers were also decreased with different patterns by the addition of alpha-MSH to the culture medium. In conclusion, Caco-2 cells showed a positive immunostaining for melanocortin-1 receptor and alpha-MSH protected Caco-2 cells against inflammatory barrier dysfunction and inflammatory activation induced by tumor necrosis factor-alpha and interleukin-1 beta cytokines.	[Varadi, Judit; Fenyvesi, Ferenc; Reti-Nagy, Katalin; Bacskay, Ildiko; Feher, Palma; Ujhelyi, Zoltan; Vasvari, Gabor; Roka, Eszter; Haines, David; Vecsernyes, Miklos] Univ Debrecen, Fac Pharm, Dept Pharmaceut Technol, Debrecen, Hungary; [Harazin, Andras; Dell, Maria A.] Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, Szeged, Hungary; [Gogolak, Peter] Univ Debrecen, Fac Med, Dept Immunol, Debrecen, Hungary; [Vamosi, Gyorgy] Univ Debrecen, Fac Med, Dept Biophys & Cell Biol, Debrecen, Hungary; [Haines, David] Univ Debrecen, Fac Pharm, Dept Pharmacol, Debrecen, Hungary	University of Debrecen; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Debrecen; University of Debrecen; University of Debrecen	Varadi, J (corresponding author), Univ Debrecen, Fac Pharm, Dept Pharmaceut Technol, Debrecen, Hungary.	varadi.judit@pharm.unideb.hu	Deli, Mária A./I-2885-2019; Harazin, András/AAR-4286-2020; Ujhelyi, Zoltan/AAF-7036-2021; Réti-Nagy, Katalin/AAR-7341-2021	Deli, Mária A./0000-0001-6084-6524; Harazin, András/0000-0002-0904-5606; Ujhelyi, Zoltan/0000-0001-9724-0614; Fenyvesi, Ferenc/0000-0003-2890-0783; Varadi, Judit/0000-0003-1885-164X; Vamosi, Gyorgy/0000-0002-7940-2787	Janos Bolyai Research Scolarship of the Hungarian Academy of Sciences [BO/00290/16/5]	Janos Bolyai Research Scolarship of the Hungarian Academy of Sciences	FF was supported by Janos Bolyai Research Scolarship of the Hungarian Academy of Sciences (BO/00290/16/5). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sadi R, 2013, AM J PATHOL, V183, P1871, DOI 10.1016/j.ajpath.2013.09.001; Al-Sadi R, 2012, J INTERF CYTOK RES, V32, P474, DOI 10.1089/jir.2012.0031; Al-Sadi R, 2010, AM J PATHOL, V177, P2310, DOI 10.2353/ajpath.2010.100371; Artursson P, 2001, ADV DRUG DELIVER REV, V46, P27, DOI 10.1016/S0169-409X(00)00128-9; Bettenworth D, 2011, AM J PATHOL, V179, P1230, DOI 10.1016/j.ajpath.2011.05.013; Bijuklic K, 2007, AM J PHYSIOL-CELL PH, V293, pC486, DOI 10.1152/ajpcell.00419.2006; Bocsik A, 2016, J PHARM SCI-US, V105, P754, DOI 10.1016/j.xphs.2015.11.018; Brzoska T, 2008, ENDOCR REV, V29, P581, DOI 10.1210/er.2007-0027; Capaldo CT, 2014, MOL BIOL CELL, V25, P2710, DOI 10.1091/mbc.E14-02-0773; Choi HJ, 2012, TOXICOL LETT, V211, P289, DOI 10.1016/j.toxlet.2012.04.012; Dalmasso G, 2008, GASTROENTEROLOGY, V134, P166, DOI 10.1053/j.gastro.2007.10.026; Fenyvesi F, 2011, J PHARM SCI-US, V100, P4734, DOI 10.1002/jps.22666; Hassoun HT, 2002, AM J PHYSIOL-GASTR L, V282, pG1059, DOI 10.1152/ajpgi.00073.2001; Joosten EAJ, 1996, BRAIN RES, V736, P91; Kalden DH, 1999, ANN NY ACAD SCI, V885, P254; Kiss T, 2010, EUR J PHARM SCI, V40, P376, DOI 10.1016/j.ejps.2010.04.014; Kongsuphol P, 2016, BIOMED MICRODEVICES, V18, DOI 10.1007/s10544-016-0117-4; Kovacs J, 2001, PEPTIDES, V22, P1049, DOI 10.1016/S0196-9781(01)00440-5; Kurti L, 2013, CYTOTECHNOLOGY, V65, P395, DOI 10.1007/s10616-012-9493-7; Laroui H, 2010, GASTROENTEROLOGY, V138, P843, DOI 10.1053/j.gastro.2009.11.003; Lee SH, 2015, INTEST RES, V13, P11, DOI 10.5217/ir.2015.13.1.11; Lin JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031686; Luger TA, 2007, ANN RHEUM DIS, V66, P52, DOI 10.1136/ard.2007.079780; Maaser C, 2006, GUT, V55, P1415, DOI 10.1136/gut.2005.083634; Magnoni S, 2003, J NEUROTRAUM, V20, P251, DOI 10.1089/089771503321532833; Mako V, 2010, CYTOM PART A, V77A, P962, DOI 10.1002/cyto.a.20952; Oktar BK, 2000, PEPTIDES, V21, P1271, DOI 10.1016/S0196-9781(00)00269-2; Oshima T, 2008, J GASTROEN HEPATOL, V23, pS146, DOI 10.1111/j.1440-1746.2008.05405.x; Rajora N, 1997, PEPTIDES, V18, P381, DOI 10.1016/S0196-9781(96)00345-2; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; Sonnier DI, 2010, J GASTROINTEST SURG, V14, P1592, DOI 10.1007/s11605-010-1321-9; Susewind J, 2016, NANOTOXICOLOGY, V10, P53, DOI 10.3109/17435390.2015.1008065; Van De Walle J, 2010, TOXICOL IN VITRO, V24, P1441, DOI 10.1016/j.tiv.2010.04.002; Varga B, 2013, J MOL NEUROSCI, V50, P558, DOI 10.1007/s12031-013-9998-3; Vecsernyes M, 2003, EUR J PHARMACOL, V470, P177, DOI 10.1016/S0014-2999(03)01780-1; Wang J, 2009, CYTOKINE, V47, P69, DOI 10.1016/j.cyto.2009.05.001; Wang LX, 2003, J IMMUNOL, V171, P3194, DOI 10.4049/jimmunol.171.6.3194; Ye DM, 2006, AM J PHYSIOL-GASTR L, V290, pG496, DOI 10.1152/ajpgi.00318.2005; Zou L, 2004, SHOCK, V22, P453, DOI 10.1097/01.shk.0000142255.15759.de; Zou L, 2003, SHOCK, V20, P469, DOI 10.1097/01.shk.0000091205.08003.fd	40	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170537	10.1371/journal.pone.0170537	http://dx.doi.org/10.1371/journal.pone.0170537			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103316	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000392381100071
J	Lord, MS; Cheng, B; Farrugia, BL; McCarthy, S; Whitelock, JM				Lord, Megan S.; Cheng, Bill; Farrugia, Brooke L.; McCarthy, Simon; Whitelock, John M.			Platelet Factor 4 Binds to Vascular Proteoglycans and Controls Both Growth Factor Activities and Platelet Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-IV; SERGLYCIN PROTEOGLYCAN; ENDOTHELIAL-CELLS; IN-VITRO; HEPARIN; PERLECAN; ANGIOGENESIS; RECEPTOR; ENDOREPELLIN; INHIBITION	Platelet factor 4 (PF4) is produced by platelets with roles in both inflammation and wound healing. PF4 is stored in platelet alpha-granules bound to the glycosaminoglycan (GAG) chains of serglycin. This study revealed that platelet serglycin is decorated with chondroitin/dermatan sulfate and that PF4 binds to these GAG chains. Additionally, PF4 had a higher affinity for endo-thelial- derived perlecan heparan sulfate chains than serglycin GAG chains. The binding of PF4 to perlecan was found to inhibit both FGF2 signaling and platelet activation. This study revealed additional insight into the ways in which PF4 interacts with components of the vasculature to modulate cellular events.	[Lord, Megan S.; Cheng, Bill; Farrugia, Brooke L.; Whitelock, John M.] Univ New South Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia; [McCarthy, Simon] Tricol Biomed, Portland, OR 97205 USA; [Cheng, Bill] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan	University of New South Wales Sydney; Academia Sinica - Taiwan	Lord, MS (corresponding author), Univ New South Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.	m.lord@unsw.edu.au	Lord, Megan/D-4673-2013; Farrugia, Brooke/J-1292-2012	Lord, Megan/0000-0002-0506-9811; Farrugia, Brooke/0000-0003-1303-4165; Whitelock, John/0000-0003-1835-802X; Cheng, Bill/0000-0002-0692-4349	Australian Research Council Linkage Project [LP0776293]	Australian Research Council Linkage Project(Australian Research Council)	This work was supported by Australian Research Council Linkage Project LP0776293. The authors declare that they have no conflicts of interest with the contents of this article.	Aidoudi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002657; Baroletti SA, 2006, CIRCULATION, V114, pE355, DOI 10.1161/CIRCULATIONAHA.106.632653; Bix G, 2007, BLOOD, V109, P3745, DOI 10.1182/blood-2006-08-039925; CAPITANIO AM, 1985, BIOCHIM BIOPHYS ACTA, V839, P161, DOI 10.1016/0304-4165(85)90033-9; DAWES J, 1982, THROMB RES, V27, P65, DOI 10.1016/0049-3848(82)90279-1; Dudek AZ, 1997, J BIOL CHEM, V272, P31785, DOI 10.1074/jbc.272.50.31785; GENGRINOVITCH S, 1995, J BIOL CHEM, V270, P15059, DOI 10.1074/jbc.270.25.15059; GOLDBERG ID, 1980, SCIENCE, V209, P611, DOI 10.1126/science.6994228; HANDIN RI, 1976, J BIOL CHEM, V251, P4273; HANSELL P, 1995, AM J PHYSIOL-HEART C, V269, pH829, DOI 10.1152/ajpheart.1995.269.3.H829; IBEL K, 1986, BIOCHIM BIOPHYS ACTA, V870, P58, DOI 10.1016/0167-4838(86)90008-7; Ito Y, 2005, GLYCOBIOLOGY, V15, P593, DOI 10.1093/glycob/cwi036; Jouan V, 1999, BLOOD, V94, P984, DOI 10.1182/blood.V94.3.984.415k31_984_993; Jung M, 2013, J BIOL CHEM, V288, P3289, DOI 10.1074/jbc.M112.387811; Knox S, 2001, PROTEOMICS, V1, P1534, DOI 10.1002/1615-9861(200111)1:12<1534::AID-PROT1534>3.0.CO;2-A; Kolset SO, 2008, CELL MOL LIFE SCI, V65, P1073, DOI 10.1007/s00018-007-7455-6; Kolset SO, 1996, J LEUKOCYTE BIOL, V59, P545, DOI 10.1002/jlb.59.4.545; KOLSET SO, 1990, BIOCHIM BIOPHYS ACTA, V1032, P191, DOI 10.1016/0304-419X(90)90004-K; Kolset SO, 2011, J IMMUNOL, V187, P4927, DOI 10.4049/jimmunol.1100806; LANE DA, 1984, BIOCHEM J, V218, P725, DOI 10.1042/bj2180725; Lemire JM, 2007, J CELL BIOCHEM, V101, P753, DOI 10.1002/jcb.21235; Lord MS, 2016, METAB ENG, V38, P105, DOI 10.1016/j.ymben.2016.07.006; Lord MS, 2011, BIOMATERIALS, V32, P6655, DOI 10.1016/j.biomaterials.2011.05.062; Lord MS, 2009, BIOMATERIALS, V30, P4898, DOI 10.1016/j.biomaterials.2009.05.063; MAIONE TE, 1990, SCIENCE, V247, P77, DOI 10.1126/science.1688470; MAYO KH, 1995, BIOCHEM J, V312, P357, DOI 10.1042/bj3120357; Melrose J, 2001, Methods Mol Biol, V171, P53; Melrose J, 2006, J BIOL CHEM, V281, P36905, DOI 10.1074/jbc.M608462200; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Petersen F, 1999, J BIOL CHEM, V274, P12376, DOI 10.1074/jbc.274.18.12376; SATO Y, 1990, BIOCHEM BIOPH RES CO, V172, P595, DOI 10.1016/0006-291X(90)90715-Y; Schick BP, 2001, BLOOD, V97, P449, DOI 10.1182/blood.V97.2.449; Stringer SE, 1997, J BIOL CHEM, V272, P20508, DOI 10.1074/jbc.272.33.20508; Theocharis AD, 2006, J BIOL CHEM, V281, P35116, DOI 10.1074/jbc.M601061200; Vandercappellen J, 2011, CYTOKINE GROWTH F R, V22, P1, DOI 10.1016/j.cytogfr.2010.10.011; Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079; Whitelock JM, 1999, MATRIX BIOL, V18, P163, DOI 10.1016/S0945-053X(99)00014-1; Woulfe DS, 2008, BLOOD, V111, P3458, DOI 10.1182/blood-2007-07-104703; Zoeller JJ, 2009, MATRIX BIOL, V28, P284, DOI 10.1016/j.matbio.2009.04.010	40	34	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4054	4063		10.1074/jbc.M116.760660	http://dx.doi.org/10.1074/jbc.M116.760660			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28115521	Green Published, hybrid			2022-12-26	WOS:000395837100009
J	Castro, JM; Amorim, MCP; Oliveira, AP; Goncalves, EJ; Munday, PL; Simpson, SD; Faria, AM				Castro, Joana M.; Amorim, M. Clara P.; Oliveira, Ana P.; Goncalves, Emanuel J.; Munday, Philip L.; Simpson, Stephen D.; Faria, Ana M.			Painted Goby Larvae under High-CO2 Fail to Recognize Reef Sounds	PLOS ONE			English	Article							CO2-DRIVEN OCEAN ACIDIFICATION; MARINE ANIMAL BEHAVIOR; PELAGIC LARVAE; CARBON-DIOXIDE; CLIMATE-CHANGE; ELEVATED CO2; FISH LARVAE; MOOREA ISLAND; IN-SITU; SETTLEMENT	Atmospheric CO2 levels have been increasing at an unprecedented rate due to anthropogenic activity. Consequently, ocean pCO(2) is increasing and pH decreasing, affecting marine life, including fish. For many coastal marine fishes, selection of the adult habitat occurs at the end of the pelagic larval phase. Fish larvae use a range of sensory cues, including sound, for locating settlement habitat. This study tested the effect of elevated CO2 on the ability of settlement-stage temperate fish to use auditory cues from adult coastal reef habitats. Wild late larval stages of painted goby (Pomatoschistus pictus) were exposed to control pCO(2) (532 mu atm, pH 8.06) and high pCO(2) (1503 mu atm, pH 7.66) conditions, likely to occur in nearshore regions subjected to upwelling events by the end of the century, and tested in an auditory choice chamber for their preference or avoidance to nighttime reef recordings. Fish reared in control pCO(2) conditions discriminated reef soundscapes and were attracted by reef recordings. This behaviour changed in fish reared in the high CO2 conditions, with settlement- stage larvae strongly avoiding reef recordings. This study provides evidence that ocean acidification might affect the auditory responses of larval stages of temperate reef fish species, with potentially significant impacts on their survival.	[Castro, Joana M.; Amorim, M. Clara P.; Goncalves, Emanuel J.; Faria, Ana M.] ISPA Inst Univ, MARE Marine & Environm Sci Ctr, Lisbon, Portugal; [Oliveira, Ana P.] IPMA, Alges, Portugal; [Munday, Philip L.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [Simpson, Stephen D.] Univ Exeter, Coll Life & Environm Sci, Biosci, Exeter, Devon, England	Instituto Superior Psicologia Aplicada (ISPA); Instituto Portugues do Mar e da Atmosfera; James Cook University; University of Exeter	Faria, AM (corresponding author), ISPA Inst Univ, MARE Marine & Environm Sci Ctr, Lisbon, Portugal.	afaria@ispa.pt	Munday, Philip L/F-5443-2011; Amorim, M. Clara P./K-1889-2012	Munday, Philip L/0000-0001-9725-2498; Amorim, M. Clara P./0000-0002-2453-6999; Faria, Ana M./0000-0001-7969-3177; Simpson, Stephen/0000-0002-4856-6164; Goncalves, Emanuel/0000-0002-3918-6215; Eugenio de Oliveira, Ana Paula/0000-0003-0152-8141	Fundacao para a Ciencia e a Tecnologia through the project ACIDLARVAE [PTDC/MAR-EST/4627/2012, SFRH/BPD/68673/2010, UID/MAR/04292/2013]; NERC [NE/J500616/2, NE/P001572/1] Funding Source: UKRI; Natural Environment Research Council [NE/J500616/2, NE/P001572/1] Funding Source: researchfish; Fundação para a Ciência e a Tecnologia [PTDC/MAR-EST/4627/2012] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia through the project ACIDLARVAE; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Fundação para a Ciência e a Tecnologia	This study was funded by Fundacao para a Ciencia e a Tecnologia through the project ACIDLARVAE (PTDC/MAR-EST/4627/2012), a post-doc grant to AF (SFRH/BPD/68673/2010), and through the strategic project UID/MAR/04292/2013 granted to MARE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu T, 2002, J ACOUST SOC AM, V112, P3073, DOI 10.1121/1.1515799; Allan BJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058520; Baumann H, 2012, NAT CLIM CHANGE, V2, P38, DOI 10.1038/NCLIMATE1291; Bertucci F, 2016, SCI REP-UK, V6, DOI 10.1038/srep33326; Bignami S, 2013, P NATL ACAD SCI USA, V110, P7366, DOI 10.1073/pnas.1301365110; Bolgan M, 2012, ADV EXP MED BIOL, V730, P109, DOI 10.1007/978-1-4419-7311-5_24; Briffa M, 2012, MAR POLLUT BULL, V64, P1519, DOI 10.1016/j.marpolbul.2012.05.032; Cabec adas L., 2005, J NANNOPLANKT RES, V27, P141; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Cato D, 1992, ACOUST AUST, V20, P76; CATO DH, 1978, J ACOUST SOC AM, V64, P736, DOI 10.1121/1.382038; Checkley DM, 2009, SCIENCE, V324, P1683, DOI 10.1126/science.1169806; Chung WS, 2014, J EXP BIOL, V217, P323, DOI 10.1242/jeb.092478; Clements JC, 2015, MAR ECOL PROG SER, V536, P259, DOI 10.3354/meps11426; Dickson A.G., 2007, GUIDE BEST PRACTICES; Dixson DL, 2010, ECOL LETT, V13, P68, DOI 10.1111/j.1461-0248.2009.01400.x; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; DUFOUR V, 1993, MAR ECOL PROG SER, V102, P143, DOI 10.3354/meps102143; Dupont S, 2008, MAR ECOL PROG SER, V373, P285, DOI 10.3354/meps07800; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Ferrari MCO, 2012, FUNCT ECOL, V26, P553, DOI 10.1111/j.1365-2435.2011.01951.x; Ferrari MCO, 2011, GLOBAL CHANGE BIOL, V17, P2980, DOI 10.1111/j.1365-2486.2011.02439.x; Ferrari MCO, 2012, PLOS ONE, V7; Frommel AY, 2012, NAT CLIM CHANGE, V2, P42, DOI 10.1038/nclimate1324; Hamilton TJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2509; Heenan A, 2009, P 11 INT COR REEF S, P554; Heuer RM, 2014, AM J PHYSIOL-REG I, V307, pR1061, DOI 10.1152/ajpregu.00064.2014; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hofmann GE, 2010, ANNU REV ECOL EVOL S, V41, P127, DOI 10.1146/annurev.ecolsys.110308.120227; Huijbers CM, 2012, ECOLOGY, V93, P46, DOI 10.1890/10-2236.1; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Irisson JO, 2008, J FISH BIOL, V72, P2707, DOI 10.1111/j.1095-8649.2008.01868.x; Jutfelt F, 2015, FRONT ZOOL, V12, DOI 10.1186/s12983-015-0104-2; Kennedy EV, 2010, J EXP MAR BIOL ECOL, V395, P85, DOI 10.1016/j.jembe.2010.08.017; Kenyon TN, 1998, J COMP PHYSIOL A, V182, P307, DOI 10.1007/s003590050181; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Lai F, 2015, CONSERV PHYSIOL, V3, DOI 10.1093/conphys/cov018; Lebour ML, 1920, J MAR BIOL ASSOC UK, V12, P253; Leis JM, 2011, INTEGR COMP BIOL, V51, P826, DOI 10.1093/icb/icr004; Leis JM, 2005, B MAR SCI, V76, P715; Leis JM, 1996, MAR FRESHWATER RES, V47, P401, DOI 10.1071/MF9960401; Leis JM, 2003, J FISH BIOL, V63, P724, DOI 10.1046/j.1095-8649.2003.00182.x; Leis JM, 2003, MAR ECOL PROG SER, V252, P239, DOI 10.3354/meps252239; Leis JM, 2002, MAR ECOL PROG SER, V232, P259, DOI 10.3354/meps232259; Lillis A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079337; McCauley RD, 2000, PHILOS T ROY SOC B, V355, P1289, DOI 10.1098/rstb.2000.0686; Millar RB, 2004, FISH RES, V70, P397, DOI 10.1016/j.fishres.2004.08.016; Miller GM, 2012, NAT CLIM CHANGE, V2, P858, DOI 10.1038/NCLIMATE1599; Miller P.J., 1986, P1019; Millero FJ, 2006, MAR CHEM, V100, P80, DOI 10.1016/j.marchem.2005.12.001; Montgomery JC, 2006, ADV MAR BIOL, V51, P143, DOI 10.1016/S0065-2881(06)51003-X; Munday PL, 2011, BIOGEOSCIENCES, V8, P1631, DOI 10.5194/bg-8-1631-2011; Munday PL, 2016, PEERJ, V4, DOI 10.7717/peerj.2501; Munday PL, 2014, NAT CLIM CHANGE, V4, P487, DOI [10.1038/nclimate2195, 10.1038/NCLIMATE2195]; Munday PL, 2011, MAR ECOL PROG SER, V423, P211, DOI 10.3354/meps08990; Munday PL, 2010, P NATL ACAD SCI USA, V107, P12930, DOI 10.1073/pnas.1004519107; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; Murray CS, 2014, MAR ECOL PROG SER, V504, P1, DOI 10.3354/meps10791; Nagelkerken I, 2016, GLOBAL CHANGE BIOL, V22, P974, DOI 10.1111/gcb.13167; Nagelkerken I, 2015, P NATL ACAD SCI USA, V112, P13272, DOI 10.1073/pnas.1510856112; Nedelec SL, 2015, MAR ECOL PROG SER, V524, P125, DOI 10.3354/meps11175; Nilsson GE, 2012, NAT CLIM CHANGE, V2, P201, DOI [10.1038/nclimate1352, 10.1038/NCLIMATE1352]; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Parmentier E, 2015, J FISH BIOL, V86, P1507, DOI 10.1111/jfb.12651; Parvulescu A., 1967, MARINE BIOACOUSTICS, P7, DOI DOI 10.3354/MEPS331243.; Petersen CGJ, 1919, REP DAN BIOL STN, V26, P47; Piercy JJB, 2014, MAR ECOL PROG SER, V516, P35, DOI 10.3354/meps10986; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner HO, 2004, J OCEANOGR, V60, P705, DOI 10.1007/s10872-004-5763-0; Radford CA, 2011, CORAL REEFS, V30, P295, DOI 10.1007/s00338-010-0710-6; Radford CA, 2010, MAR ECOL PROG SER, V401, P21, DOI 10.3354/meps08451; Radford C, 2008, MAR ECOL PROG SER, V362, P37, DOI 10.3354/meps07444; Radford CA, 2008, OECOLOGIA, V156, P921, DOI 10.1007/s00442-008-1041-y; Reum JCP, 2015, ICES J MAR SCI, P528; ROBERTSON DR, 1988, ECOLOGY, V69, P370, DOI 10.2307/1940435; Rossi T, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.3046; Rossi T, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0937; Rossi T, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1954; Simpson SD, 2008, ANIM BEHAV, V75, P1861, DOI 10.1016/j.anbehav.2007.11.004; Simpson SD, 2008, CORAL REEFS, V27, P97, DOI 10.1007/s00338-007-0294-y; Simpson SD, 2005, SCIENCE, V308, P221, DOI 10.1126/science.1107406; Simpson SD, 2005, MAR ECOL PROG SER, V287, P201, DOI 10.3354/meps287201; Simpson SD, 2004, MAR ECOL PROG SER, V276, P263, DOI 10.3354/meps276263; Simpson SD, 2011, BIOL LETTERS, V7, P917, DOI 10.1098/rsbl.2011.0293; Smith ME, 2004, J EXP MAR BIOL ECOL, V302, P17, DOI 10.1016/j.jembe.2003.09.021; Stanley JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028572; Stanley JA, 2010, BEHAV ECOL, V21, P113, DOI 10.1093/beheco/arp159; Tolimieri N, 2000, MAR ECOL PROG SER, V207, P219, DOI 10.3354/meps207219; Tolimieri Nicholas, 2002, Bioacoustics, V12, P214; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Weiss R.F., 1974, MAR CHEM, V2, P203, DOI DOI 10.1016/0304-4203(74)90015-2; Welch MJ, 2014, NAT CLIM CHANGE, V4, P1086, DOI 10.1038/NCLIMATE2400; WILLIAMS DM, 1983, MAR ECOL PROG SER, V10, P231, DOI 10.3354/meps010231; Wright KJ, 2011, MAR ECOL PROG SER, V424, P1, DOI 10.3354/meps09004; Wright KJ, 2005, MAR BIOL, V147, P1425, DOI 10.1007/s00227-005-0028-z	95	10	11	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170838	10.1371/journal.pone.0170838	http://dx.doi.org/10.1371/journal.pone.0170838			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125690	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000396176100038
J	Ferri, M; Graen-Heedfeld, J; Bretz, K; Guillon, F; Michelini, E; Calabretta, MM; Lamborghini, M; Gruarin, N; Roda, A; Kraft, A; Tassoni, A				Ferri, Maura; Graen-Heedfeld, Jurgen; Bretz, Karlheinz; Guillon, Fabien; Michelini, Elisa; Calabretta, Maria Maddalena; Lamborghini, Matteo; Gruarin, Nicolo; Roda, Aldo; Kraft, Axel; Tassoni, Annalisa			Peptide Fractions Obtained from Rice By-Products by Means of an Environment-Friendly Process Show In Vitro Health-Related Bioactivities	PLOS ONE			English	Article							TYROSINASE INHIBITOR; ANTIOXIDANT PEPTIDES; CONVERTING-ENZYME; BRAN PROTEIN; IDENTIFICATION; POLYPHENOLS; ASSAY	Recently, the isolation of new health-related bioactive molecules derived from agro-food industrial by-products by means of environment-friendly extraction processes has become of particular interest. In the present study, a protein by-product from the rice starch industry was hydrolysed with five commercial proteolytic enzymes, avoiding the use of solvents or chemicals. The digestion processes were optimised, and the digestates were separated in fractions with four different molecular weight ranges by using a cross-flow membrane filtration technique. Total hydrolysates and fractions were tested in vitro for a wide range of biological activities. For the first time rice-derived peptides were assayed for anti-tyrosinase, anti-inflammatory, cytotoxicity and irritation capacities. Antioxidant and anti-hypertensive activities were also evaluated. Protamex, Alcalase and Neutrase treatments produced peptide fractions with valuable bioactivities without resulting cytotoxic or irritant. Highest levels of bioactivity were detected in Protamex-derived samples, followed by samples treated with Alcalase. Based on the present results, a future direct exploitation of isolated peptide fractions in the nutraceutical, functional food and cosmetic industrial fields may be foreseen.	[Ferri, Maura; Gruarin, Nicolo; Tassoni, Annalisa] Univ Bologna, Dept Biol Geol & Environm Sci, Bologna, Italy; [Graen-Heedfeld, Jurgen; Bretz, Karlheinz; Kraft, Axel] Fraunhofer Inst Environm Safety & Energy Technol, Oberhausen, Germany; [Guillon, Fabien] Sterlab, Cell Culture Lab, Vallauris, France; [Michelini, Elisa; Calabretta, Maria Maddalena; Roda, Aldo] Univ Bologna, Dept Chem G Ciamician, Bologna, Italy; [Lamborghini, Matteo] Carminia Snc, Bologna, Italy	University of Bologna; Fraunhofer Gesellschaft; University of Bologna	Tassoni, A (corresponding author), Univ Bologna, Dept Biol Geol & Environm Sci, Bologna, Italy.	annalisa.tassoni2@unibo.it	Michelini, Elisa/ABD-9692-2020; TASSONI, ANNALISA/G-3981-2012	FERRI, MAURA/0000-0001-5428-4369; Bretz, Karlheinz/0000-0001-5419-5040; CALABRETTA, Maria Maddalena/0000-0002-5673-3073; TASSONI, ANNALISA/0000-0002-3541-4030; Roda, Aldo/0000-0001-7649-4797; Michelini, Elisa/0000-0002-8651-0575	European Union [605285]	European Union(European Commission)	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) managed by REA-Research Executive Agency (http://ec.europa.eu/research/rea) under the grant agreement number 605285, project FP7-SME-2013 BIORICE (www.biorice.eu). Sterlab Laboratories and Carminia snc provided support in the form of salaries for authors [FG] and [ML], and actively took part in the research activities in the frame of the BIORICE project but did not have any role in the study design and decision to publish. Additionally, Sterlab took part in the data collection and analysis and in the preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Branchini BR, 2010, ANAL BIOCHEM, V396, P290, DOI 10.1016/j.ab.2009.09.009; Cavazos A, 2013, COMPR REV FOOD SCI F, V12, P364, DOI 10.1111/1541-4337.12017; Cho JG, 2015, NAT PROD RES, V29, P1052, DOI 10.1080/14786419.2014.968155; CUSHMAN DW, 1971, BIOCHEM PHARMACOL, V20, P1637, DOI 10.1016/0006-2952(71)90292-9; Dei Piu L, 2014, FOOD CHEM, V155, P199, DOI 10.1016/j.foodchem.2014.01.055; Erdmann K, 2008, J NUTR BIOCHEM, V19, P643, DOI 10.1016/j.jnutbio.2007.11.010; Ferri M, 2016, NEW BIOTECHNOL, V33, P338, DOI 10.1016/j.nbt.2015.12.004; Ferri M, 2013, J FOOD COMPOS ANAL, V30, P94, DOI 10.1016/j.jfca.2013.02.004; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemes AC, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060950; Li GH, 2007, ASIA PAC J CLIN NUTR, V16, P275; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maack A, 2016, FITOTERAPIA, V111, P95, DOI 10.1016/j.fitote.2016.04.001; Maestri E, 2016, J PROTEOMICS, V147, P140, DOI 10.1016/j.jprot.2016.03.048; MASAMOTO Y, 1980, PLANTA MED, V40, P361, DOI 10.1055/s-2008-1074986; Miyazawa M, 2003, J AGR FOOD CHEM, V51, P6953, DOI 10.1021/jf030388s; Qiu J, 2016, INT J COSMET SCI; Shih FF, 2012, J AM OIL CHEM SOC, V89, P1, DOI 10.1007/s11746-011-1941-6; Tuntipopipat S, 2015, FOOD FUNCT, V6, P1480, DOI [10.1039/C4FO01194E, 10.1039/c4fo01194e]; Uraipong C, 2016, J SCI FOOD AGR, V96, P1101, DOI 10.1002/jsfa.7182; Van der Borght A, 2006, J CEREAL SCI, V44, P68, DOI 10.1016/j.jcs.2006.03.005; Wattanasiritham L, 2016, FOOD CHEM, V192, P156, DOI 10.1016/j.foodchem.2015.06.057; Zhang JH, 2010, FOOD CHEM, V119, P226, DOI 10.1016/j.foodchem.2009.06.015; Zhao Q, 2012, FOOD CHEM, V134, P1360, DOI 10.1016/j.foodchem.2012.03.033; Zou TB, 2016, MOLECULES, V21, DOI 10.3390/molecules21010072	26	27	30	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170954	10.1371/journal.pone.0170954	http://dx.doi.org/10.1371/journal.pone.0170954			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125712	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000396176100015
J	Fu, YR; Xu, XQ; Xue, JF; Duan, WP; Yi, ZJ				Fu, Yurong; Xu, Xianqin; Xue, Junfang; Duan, Wenping; Yi, Zhengjun			Deregulated lncRNAs in B Cells from Patients with Active Tuberculosis	PLOS ONE			English	Article							LONG NONCODING RNAS; MYCOBACTERIUM-TUBERCULOSIS; EXPRESSION PROFILES; IMMUNE-RESPONSES; GENE-REGULATION; GASTRIC-CANCER; T-CELLS; SOCS3; MACROPHAGES; INFECTION	Role of lncRNAs in human adaptive immune response to TB infection is largely unexplored. To address this issue, here we characterized lncRNA expression profile in primary human B cell response to TB infection using microarray assay. Several lncRNAs and mRNAs were chosen for RT-qPCR validation. Bioinformatics prediction was applied to delineate function of the deregulated mRNAs. We found that 844 lncRNAs and 597 mRNAs were differentially expressed between B cell samples from individuals with or without TB. KEGG pathway analysis for the deregulated mRNAs indicated a number of pathways, such as TB, TLR signaling pathway and antigen processing and presentation. Moreover, corresponding to the dysregulation of many lncRNAs, we also found that their adjacent protein-coding genes were also deregulated. Functional annotation for the corresponding mRNAs showed that these lncRNAs were mainly associated with TLR signaling, TGF-beta signaling. Interestingly, SOCS3, which is a critical negative regulator of cytokine response to TB infection and its nearby lncRNA XLOC_012582, were highly expressed in active TB B cells. Subsequent RT-qPCR results confirmed the changes. Whether upregulated XLOC_012582 causes SOCS3 overexpression and is eventually involved in the context of exacerbations of active TB represents an interesting issue that deserves to be further explored. Taken together, for the first time, we identified a set of deregulated lncRNAs in active TB B cells and their functions were predicted. Such findings provided novel insight into the pathogenesis of TB and further studies should focus on the function and pathogenic mechanisms of the lncRNAs involved in active TB.	[Fu, Yurong] Weifang Med Univ, Clin Med Coll, Dept Med Microbiol, Weifang, Shandong, Peoples R China; [Fu, Yurong; Yi, Zhengjun] Weifang Med Univ, Key Lab Clin Lab Diagnost Univ Shandong, Dept Lab Med, Weifang, Shandong, Peoples R China; [Xu, Xianqin] Weifang Med Univ, Clin Med Coll, Dept Clin Skill Lab, Weifang, Shandong, Peoples R China; [Xue, Junfang] Gaomi City Peoples Hosp, Dept Surg, Weifang, Shandong, Peoples R China; [Duan, Wenping] Weifang Med Univ, Dept Nursing, Affiliated Hosp, Weifang, Shandong, Peoples R China	Weifang Medical University; Weifang Medical University; Weifang Medical University; Weifang Medical University	Fu, YR (corresponding author), Weifang Med Univ, Clin Med Coll, Dept Med Microbiol, Weifang, Shandong, Peoples R China.; Fu, YR; Yi, ZJ (corresponding author), Weifang Med Univ, Key Lab Clin Lab Diagnost Univ Shandong, Dept Lab Med, Weifang, Shandong, Peoples R China.	yifuyurong@163.com; fuyizhengjun@163.com			National Natural Science Foundation of China [81100006, 81470001]; Natural Science Foundation of Shandong Province of China [ZR2016HM09]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province of China(Natural Science Foundation of Shandong Province)	This research was financially supported by the grants from the National Natural Science Foundation of China (Grant No. 81100006, 81470001) and the Natural Science Foundation of Shandong Province of China (Grant No. ZR2016HM09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achkar JM, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a018432; Alam-Faruque Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027541; Ashenafi S, 2014, CLIN IMMUNOL, V151, P84, DOI 10.1016/j.clim.2014.01.010; Baer CE, 2015, IMMUNOL REV, V264, P327, DOI 10.1111/imr.12267; Booty MG, 2016, J IMMUNOL, V196, P1822, DOI 10.4049/jimmunol.1502206; Dang Y, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0706-3; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Goovaerts O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133924; He Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep27051; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Hu P, 2014, CELL SIGNAL, V26, P83, DOI 10.1016/j.cellsig.2013.10.001; Huang X, 2016, J ASSIST REPROD GEN, V33, P111, DOI 10.1007/s10815-015-0630-z; Imam H, 2015, SCI REP-UK, V5, DOI 10.1038/srep08639; Jiang TT, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1436-y; Kazemzadeh M, 2015, J GENET, V94, P771, DOI 10.1007/s12041-015-0561-6; Kleinsteuber K, 2012, BLOOD, V120, P4374, DOI 10.1182/blood-2011-11-392738; Lin XC, 2014, INT J ONCOL, V45, P619, DOI 10.3892/ijo.2014.2431; Narayana Y, 2008, J BIOL CHEM, V283, P12501, DOI 10.1074/jbc.M709960200; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Parida SK, 2015, CLIN INFECT DIS, V61, pS217, DOI 10.1093/cid/civ615; Pawar K, 2016, SCI REP-UK, V6, DOI 10.1038/srep19416; Pollock KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146905; Rao M, 2015, CLIN INFECT DIS, V61, pS225, DOI 10.1093/cid/civ614; Rottenberg ME, 2014, SEMIN IMMUNOL, V26, P518, DOI 10.1016/j.smim.2014.10.004; Sebina I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106796; Torrado E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061681; Uchida S, 2015, CIRC RES, V116, P737, DOI 10.1161/CIRCRESAHA.116.302521; Ueta M, 2012, J ALLERGY CLIN IMMUN, V129, P1413, DOI 10.1016/j.jaci.2012.01.069; Wang NT, 2015, CLIN CANCER RES, V21, P4676, DOI 10.1158/1078-0432.CCR-14-3163; Wang Y, 2015, P NATL ACAD SCI USA, V112, pE3883, DOI 10.1073/pnas.1501662112; Weymouth KS, 2016, CLIN ORTHOP RELAT R, V474, P1726, DOI 10.1007/s11999-016-4788-1; Yang XF, 2016, SCI REP-UK, V6, DOI 10.1038/srep38963; Yao YL, 2014, INT J MOL SCI, V15, P18985, DOI 10.3390/ijms151018985; Yi ZJ, 2014, J INFECTION, V69, P558, DOI 10.1016/j.jinf.2014.06.016; Zheng L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126018; Zhu Q, 2016, IMMUNOBIOLOGY, V221, P558, DOI 10.1016/j.imbio.2015.12.003	36	17	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170712	10.1371/journal.pone.0170712	http://dx.doi.org/10.1371/journal.pone.0170712			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125665	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100068
J	Melo, ATO; Guthrie, RS; Hale, I				Melo, Arthur T. O.; Guthrie, Robert S.; Hale, Iago			GBS-Based Deconvolution of the Surviving North American Collection of Cold-Hardy Kiwifruit (Actinidia spp.) Germplasm	PLOS ONE			English	Article							GENETIC DIVERSITY; POPULATION; ARGUTA; SIMILARITY	Plant germplasm collections can be invaluable resources to plant breeders, provided they are well-characterized. After 140 years of acquisition and curation efforts by a wide and largely non-coordinated array of private and institutional actors, the current US collection of cold-hardy kiwifruit (Actinidia spp.) is rife with misclassifications, misnomers, and mix-ups. To facilitate the systematic improvement and resource-efficient curation of these species of long-recognized horticultural potential, we used genotyping-by-sequencing (GBS) data to deconvolute this historic collection. Evaluation of a total of 138 accessions (103 A. arguta, 28 A. kolomikta, and 7 A. polygama) with an interspecific set of 1,040 high-quality SNPs resulted in clear resolution of the three species. Intraspecific analysis (2,964 SNPs) within A. arguta revealed a significant level of redundancy (41.7%; only 60 unique genotypes out of 103 analyzed) and a sub-population structure reflecting likely geographic provenance, phenotypic classes, and hybrid pedigree. For A. kolomikta (3,425 SNPs), the level of accession redundancy was even higher (53.6%; 13 unique genotypes out of 28 analyzed); but no sub-structure was detected. Numerous instances were discovered of distinct genotypes sharing a common name, different names assigned to the same genotype, mistaken species assignments, and incorrect gender records, all critical information for both breeders and curators. In terms of method, this study demonstrates the practical and cost-effective use of GBS data to characterize plant genetic resources, despite ploidy differences and the lack of reference genomes. With the recent prohibition on further imports of Actinidia plant material into the country and with the active eradication of historic vines looming, this analysis of the US cold-hardy kiwifruit germplasm collection provides a timely assessment of the genetic resource base of an emerging, high-value specialty crop.	[Melo, Arthur T. O.; Hale, Iago] Univ New Hampshire, Coll Life Sci & Agr, Dept Biol Sci, Durham, NH 03824 USA; [Guthrie, Robert S.] Univ Minnesota, Minnesota Landscape Arboretum Hort Res Ctr, Chanhassen, MN USA	University System Of New Hampshire; University of New Hampshire; University of Minnesota System	Hale, I (corresponding author), Univ New Hampshire, Coll Life Sci & Agr, Dept Biol Sci, Durham, NH 03824 USA.	iago.hale@unh.edu	Melo, Arthur/J-2187-2018	Hale, Iago/0000-0002-8558-7861	New Hampshire Agricultural Experiment Station; USDA National Institute of Food and Agriculture Multi-State Hatch Project [233561]	New Hampshire Agricultural Experiment Station; USDA National Institute of Food and Agriculture Multi-State Hatch Project	Partial funding was provided by the New Hampshire Agricultural Experiment Station. This is Scientific Contribution Number 2687. This work is supported by the USDA National Institute of Food and Agriculture Multi-State Hatch Project 233561. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, CASAVA 1 8 2 QUICK R; Bonman JM, 2015, CROP SCI, V55, P1243, DOI 10.2135/cropsci2014.09.0621; Brown C, 2003, AM J ALTERNATIVE AGR, V18, P213, DOI 10.1079/AJAA200353; Darrow GM, 1937, YB AGR, V1, P545; EVREINOFF V. -A., 1949, Revue horticole, V121, P155; Fairchild D, 1927, J HERED, V18, P49, DOI 10.1093/oxfordjournals.jhered.a102803; Fairchild D, 1906, SCIENCE, V24, P498, DOI 10.1126/science.24.616.498-a; Fairchild D., 1913, SOME ASIATIC ACTINID; Farrand B., 1954, REEF POINT GARDENS B, V1, P2; Ferguson A. R., 2008, P235, DOI 10.1007/978-1-4020-6907-9_8; Ferguson AR, 2016, THE KIWIFRUIT GENOME, P55; FERGUSON AR, 1990, KIWIFRUIT SCI MANAGE, P165; Fisk CL, 2006, J FOOD SCI; FLATH RA, 1978, J AGR FOOD CHEM, V26, P835, DOI 10.1021/jf60218a053; Goodale GL, 1891, USEFUL PLANTS FUTURE; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Huang S, 2013, NATURE COMMUNICATION; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Kataoka I, 2010, SCI HORTIC-AMSTERDAM, V124, P409, DOI 10.1016/j.scienta.2010.01.016; Kaufman Lois., 1990, ROUSSEEUW FINDING GR; Keefer JS, 2010, NPSERMNNRR2010196 NA; Kolbasina EI, 2000, BERRY BEARING VINES; Li ZZ, 2013, SCI HORTIC-AMSTERDAM, V161, P259, DOI 10.1016/j.scienta.2013.07.008; Long Island Botanical Society, 2014, Q NEWSL, V24, P7; MCQUITTY LL, 1966, EDUC PSYCHOL MEAS, V26, P825, DOI 10.1177/001316446602600402; Meirmans PG, 2012, J HERED, V103, P744, DOI 10.1093/jhered/ess047; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Melo ATO, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0879-y; Michurin IV., 1949, SELECTED WORKS; Mizugami T, 2007, ACTA HORTIC, P199, DOI 10.17660/ActaHortic.2007.753.22; Murtagh F, 2014, J CLASSIF, V31, P274, DOI 10.1007/s00357-014-9161-z; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; NPGS GRIN, 2016, NATL PLANT GERMPL SY; Odong TL, 2013, THEOR APPL GENET, V289, P305, DOI DOI 10.1007/S00122-012-1971-Y; Orpet E. O., 1892, GARD FOR, V5, P320; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Pollack S, 2001, MARKET TRADE B; Smith RL., 1970, LASCA LEAVES, V20, P8; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Start MA, 2007, ACTA HORT, V753; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Whealy K., 1989, FRUIT BERRY NUT INVE; Yoshida K, 2013, ELIFE, V2, DOI 10.7554/eLife.00731	46	12	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170580	10.1371/journal.pone.0170580	http://dx.doi.org/10.1371/journal.pone.0170580			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125645	Green Published, gold			2022-12-26	WOS:000396176100093
J	Murayama, C; Kawaguchi, AT; Kamijo, A; Naito, K; Kanazawa, M; Tsukada, H				Murayama, Chieko; Kawaguchi, Akira T.; Kamijo, Akemi; Naito, Katsuko; Kanazawa, Masakatsu; Tsukada, Hideo			Monitoring Mitochondrial Complex-I Activity Using Novel PET Probe F-18-BCPP-EF Allows Early Detection of Radiotherapy Effect in Murine Squamous Cell Carcinoma	PLOS ONE			English	Article							OXYGEN SPECIES PRODUCTION; TUMORS	Objectives Aerobic glycolysis, the main pathway of energy production in tumors (Warburg effect) allows detection of tumors by positron emission tomography (PET) using F-18-fluoro-2-deoxy-D-glucose (F-18-FDG). Since ionizing radiation (IR) is reported to switch aerobic glycolysis to mitochondrial oxidative phosphorylation, radiotherapeutic efficacy was monitored by the activity of mitochondrial complex I (MC-I), using a new PET probe F-18-BCPP-EF, F-18-2-tert-butyl-4-chloro-5-{6-[2-(2-fluoro-ethoxy)-ethoxy]-pyridine-3-ylmethoxy}-2H-pyridazin-3-one, compared with F-18-FDG uptake and the apoptosis index. Methods Tumor uptake of F-18-BCPP-EF or F-18-FDG was examined in C3H/HeN mice inoculated with murine squamous cell carcinoma SCCVII at various time points after a single dose of x-ray irradiation at 0, 6, 15, or 30 Gy. Apoptosis incidence was determined by TUNEL staining in excised tumor tissue. Results Tumor growth suppression was dose-dependent; tumor grew 10-fold (0 Gy), 5-fold (6 Gy), 2-fold (15 Gy), and reduced to half in its volume (30 Gy) 14 days after treatment. F-18-BCPPEF uptake was significantly increased as early as 3 days after 15 Gy or 30 Gy, when tumor size and apoptosis index showed no difference among radiation doses. In contrast, F-18-FDG uptake was initially increased dose-dependently, remained elevated up to 7 days, and eventually decreased 10 days after 30 Gy and also 14 days after 15 Gy when tumor size was already reduced. Apoptosis index was increased after irradiation but failed to correlate with tumor response. Conclusion Tumor uptake of F-18-BCPP-EF was increased dose-dependently early after effective doses of IR when F-18-FDG uptake as well as apoptosis incidence were not indicative of tumor response. The results suggest that F-18-BCPP-EF is a promising "positive" MC-I imaging PET probe for early detection of efficacy of tumor radiotherapy.	[Murayama, Chieko] Tokai Univ, Sch Med, Dept Clin Pharmacol, Isehara, Kanagawa, Japan; [Murayama, Chieko] Tokai Univ, Sch Med, Dept Radiat Oncol, Isehara, Kanagawa, Japan; [Kawaguchi, Akira T.] Tokai Univ, Sch Med, Dept Cell Transplantat & Regenerat Med, Isehara, Kanagawa, Japan; [Kamijo, Akemi; Naito, Katsuko] Tokai Univ, Support Ctr Med Res & Educ, Isehara, Kanagawa, Japan; [Kanazawa, Masakatsu; Tsukada, Hideo] Hamamatsu Photon KK, Cent Res Lab, Hamamatsu, Shizuoka, Japan	Tokai University; Tokai University; Tokai University; Tokai University; Hamamatsu Photonics	Kawaguchi, AT (corresponding author), Tokai Univ, Sch Med, Dept Cell Transplantat & Regenerat Med, Isehara, Kanagawa, Japan.	akira@is.icc.u-tokai.ac.jp		Kanazawa, Masakatsu/0000-0002-1444-2630	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP24249086, JP26461871, JP15H2569]; Tokai University School of Medicine Research Aid	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Tokai University School of Medicine Research Aid	This work was supported in part by Japan Society for the Promotion of Science (JSPS) KAKENHI grant numbers JP24249086, JP26461871, JP15H2569, and 2014 Tokai University School of Medicine Research Aid. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study. MK and HT are employees for Hamamatsu Photonics K.K. This did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials. CM, ATK, AK and KN were researchers belonging to Tokai University at the time of the study. They all were involved in animal care, data collection and discussion to summarize the results and prepare and develop the work for publication. MK and HT were employed by Hamamatsu Photonics K.K. PET probe syntheses and PET measurements of this study were performed by MK and HT, respectively. The funder provided support in the form of salaries for authors [MK and HT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzam EI, 2012, CANCER LETT, V327, P48, DOI 10.1016/j.canlet.2011.12.012; Chen HJ, 2015, STRAHLENTHER ONKOL, V191, P141, DOI 10.1007/s00066-014-0744-8; Choi KM, 2007, ONCOL REP, V17, P1183; FU KK, 1984, INT J RADIAT ONCOL, V10, P1473, DOI 10.1016/0360-3016(84)90371-7; Guppy M, 2002, BIOCHEM BIOPH RES CO, V299, P676, DOI 10.1016/S0006-291X(02)02710-9; Harada N, 2013, J LABELLED COMPD RAD, V56, P553, DOI 10.1002/jlcr.3056; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Kitajima K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096999; Kobashigawa S, 2011, BIOCHEM BIOPH RES CO, V414, P795, DOI 10.1016/j.bbrc.2011.10.006; Leach JK, 2001, CANCER RES, V61, P3894; Masunaga S, 2001, INT J RADIAT ONCOL, V49, P1361, DOI 10.1016/S0360-3016(00)01535-2; Motoori S, 2001, CANCER RES, V61, P5382; MURAYAMA C, 1993, INT J RADIAT ONCOL, V26, P433, DOI 10.1016/0360-3016(93)90961-T; Murayama C, 2009, J NUCL MED, V50, P290, DOI 10.2967/jnumed.108.057091; Nakano T, 2010, J RADIAT RES, V51, P1, DOI 10.1269/jrr.09132; Nishida N, 2014, J RADIAT RES, V55, P455, DOI 10.1093/jrr/rrt142; Salto K, 2015, CLIN CANCER RES, V21, P5073, DOI [10.1158/1078-0432.CCR-14-1717, DOI 10.1158/1078-0432.CCR-14-1717]; Tsukada H, 2014, J CEREBR BLOOD F MET, V34, P708, DOI 10.1038/jcbfm.2014.5; Tsukada H, 2014, EUR J NUCL MED MOL I, V41, P755, DOI 10.1007/s00259-013-2628-z; Tsukada H, 2014, J NUCL MED, V55, P473, DOI 10.2967/jnumed.113.125328; Yamamori T, 2012, FREE RADICAL BIO MED, V53, P260, DOI 10.1016/j.freeradbiomed.2012.04.033	21	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170911	10.1371/journal.pone.0170911	http://dx.doi.org/10.1371/journal.pone.0170911			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125711	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100025
J	Gong, XQ; Wei, L; Yu, X; Li, SY; Sun, XY; Wang, XY				Gong, Xiaoqiang; Wei, Le; Yu, Xin; Li, Suyan; Sun, Xiangyang; Wang, Xinyu			Effects of Rhamnolipid and Microbial Inoculants on the Vermicomposting of Green Waste with Eisenia fetida	PLOS ONE			English	Article							ORGANIC WASTES; ENZYMATIC-ACTIVITIES; RICE STRAW; COMPOST; CARBON; DEGRADATION; EARTHWORMS; EVOLUTION; NITROGEN; QUALITY	The effects of adding the biosurfactant rhamnolipid, the lignolytic and cellulolytic fungus Phanerochete chrysosporium, and the free-living nitrogen-fixing bacterium Azotobacter chrococcum on vermicomposting of green waste with Eisenia fetida was investigated. The addition of rhamnolipid and/or either microorganism alone or in all combinations significantly increased E. fetida growth rate, the number of E. fetida juveniles and cocoons, the population densities of cellulolytic fungi and Azotobacter bacteria, and cellulase and urease activities in the vermicomposts. The quality of the final vermicompost (in terms of electrical conductivity, nutrient content, C/N ratio, humic acid content, lignin and cellulose contents, and phytotoxicity to germinating seeds) was enhanced by addition of rhamnolipid and/or microorganisms. The physical characteristics of vermicomposts produced with rhamnolipid and/or microorganisms were acceptable for agricultural application. The best quality vermicompost was obtained with the combined addition of P. chrysosporium, A. chrococcum, and rhamnolipid.	[Gong, Xiaoqiang; Wei, Le; Yu, Xin; Li, Suyan; Sun, Xiangyang; Wang, Xinyu] Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China	Beijing Forestry University	Yu, X; Li, SY (corresponding author), Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China.	bjfuyuxin@bjfu.edu.cn; lisuyan@bjfu.edu.cn			Fundamental Research Funds for the Central Universities [YX2013-39]; National Forestry Public Welfare Industry Research Project "Development and Application of Technology of Converting Forestry Waste into Growing Media" [201504205]; Graduate Training and Development Program of Beijing Municipal Commission of Education [BLCXY201603]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Forestry Public Welfare Industry Research Project "Development and Application of Technology of Converting Forestry Waste into Growing Media"; Graduate Training and Development Program of Beijing Municipal Commission of Education	This research was supported by the Fundamental Research Funds for the Central Universities (Grant No. YX2013-39); the National Forestry Public Welfare Industry Research Project "Development and Application of Technology of Converting Forestry Waste into Growing Media". (Grant No. 201504205); and the Graduate Training and Development Program of Beijing Municipal Commission of Education (Grant No. BLCXY201603). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad M, 2005, HORTSCIENCE, V40, P2138, DOI 10.21273/HORTSCI.40.7.2138; Aira M, 2007, SCI TOTAL ENVIRON, V385, P252, DOI 10.1016/j.scitotenv.2007.06.031; Aulinas-Maso M, 2008, BIORESOURCE TECHNOL, V99, P5120, DOI 10.1016/j.biortech.2007.09.083; Barrington S, 2002, BIORESOURCE TECHNOL, V83, P189, DOI 10.1016/S0960-8524(01)00229-2; Benitez E, 2005, BIORESOURCE TECHNOL, V96, P785, DOI 10.1016/j.biortech.2004.08.010; Bonkowski M, 2000, PEDOBIOLOGIA, V44, P666, DOI 10.1078/S0031-4056(04)70080-3; Cai H, 2010, SCI HORTIC-AMSTERDAM, V124, P381, DOI 10.1016/j.scienta.2010.01.009; Chan YC, 2011, WASTE MANAGE RES, V29, P540, DOI 10.1177/0734242X10375587; Clifford JS, 2007, J COLLOID INTERF SCI, V305, P361, DOI 10.1016/j.jcis.2006.10.026; Das D, 2016, ECOL ENG, V86, P154, DOI 10.1016/j.ecoleng.2015.11.012; El-Haddad M. E., 2014, Annals of Agricultural Science (Cairo), V59, P243; Fornes F, 2012, BIORESOURCE TECHNOL, V118, P296, DOI 10.1016/j.biortech.2012.05.028; Frederickson J, 1997, SOIL BIOL BIOCHEM, V29, P725, DOI 10.1016/S0038-0717(96)00025-9; Fu HY, 2007, COLLOID SURFACE B, V58, P91, DOI 10.1016/j.colsurfb.2007.02.012; Gabhane J, 2012, BIORESOURCE TECHNOL, V114, P382, DOI 10.1016/j.biortech.2012.02.040; Gomez-Brandon M, 2014, CRIT REV ENV SCI TEC, V44, P1289, DOI 10.1080/10643389.2013.763588; Gong XQ, 2016, ENVIRON TECHNOL, P1; Haddadin MSY, 2009, BIORESOURCE TECHNOL, V100, P4773, DOI 10.1016/j.biortech.2009.04.047; Hait S, 2011, WASTE MANAGE, V31, P502, DOI 10.1016/j.wasman.2010.11.004; Jahanshah G, 2013, ANN MICROBIOL, V63, P91, DOI 10.1007/s13213-012-0448-1; Molina MJ, 2013, BIORESOURCE TECHNOL, V137, P88, DOI 10.1016/j.biortech.2013.03.029; Jurado MM, 2014, J ENVIRON MANAGE, V133, P355, DOI 10.1016/j.jenvman.2013.12.020; Kim Y, 2011, ENZYME MICROB TECH, V48, P408, DOI 10.1016/j.enzmictec.2011.01.007; Kumar R, 2011, BIORESOURCE TECHNOL, V102, P1475, DOI 10.1016/j.biortech.2010.09.090; Kumar V, 2001, BIORESOURCE TECHNOL, V76, P173, DOI 10.1016/S0960-8524(00)00061-4; Li ZL, 2013, ENVIRON SCI TECHNOL, V47, P1534, DOI 10.1021/es303784f; Liang YS, 2010, BIODEGRADATION, V21, P615, DOI 10.1007/s10532-010-9329-0; LIU S, 2004, ANAL MEASUREMENT PAP; Pramanik P, 2007, BIORESOURCE TECHNOL, V98, P2485, DOI 10.1016/j.biortech.2006.09.017; Pramanik P, 2009, WASTE MANAGE, V29, P574, DOI 10.1016/j.wasman.2008.06.015; Pratibha G, 2013, ECOL ENG, V61, P235, DOI 10.1016/j.ecoleng.2013.09.013; Shi JG, 2006, WORLD J MICROB BIOT, V22, P1121, DOI 10.1007/s11274-006-9152-2; Shi Y, 2013, RENEW SUST ENERG REV, V22, P432, DOI 10.1016/j.rser.2013.02.003; Singh A, 2002, BIORESOURCE TECHNOL, V85, P107, DOI 10.1016/S0960-8524(02)00095-0; Slizovskiy IB, 2011, ENVIRON TOXICOL CHEM, V30, P112, DOI 10.1002/etc.357; Subramanian S, 2010, J HAZARD MATER, V179, P318, DOI 10.1016/j.jhazmat.2010.03.007; Tian Y, 2012, SCI HORTIC-AMSTERDAM, V143, P15, DOI 10.1016/j.scienta.2012.05.018; van Heerden I, 2002, BIORESOURCE TECHNOL, V81, P71, DOI 10.1016/S0960-8524(01)00058-X; Varma V, 2015, ENVIRON SCI POLLUT R, V22, P7851, DOI 10.1007/s11356-014-3989-y; Wang HY, 2011, BIORESOURCE TECHNOL, V102, P6515, DOI 10.1016/j.biortech.2011.02.102; Wang JZ, 2014, WASTE MANAGE, V34, P1546, DOI 10.1016/j.wasman.2014.04.010; Xi BD, 2005, J ENVIRON SCI-CHINA, V17, P409; YEOMANS JC, 1988, COMMUN SOIL SCI PLAN, V19, P1467, DOI 10.1080/00103628809368027; Zhang FB, 2011, WASTE MANAGE, V31, P1333, DOI 10.1016/j.wasman.2011.02.002; Zhang L, 2014, BIORESOURCE TECHNOL, V171, P274, DOI 10.1016/j.biortech.2014.08.079; Zhang L, 2014, BIORESOURCE TECHNOL, V163, P112, DOI 10.1016/j.biortech.2014.04.041; Zhang L, 2013, BIORESOURCE TECHNOL, V131, P68, DOI 10.1016/j.biortech.2012.10.059; Zhang QZ, 2008, J ENVIRON SCI-CHINA, V20, P975, DOI 10.1016/S1001-0742(08)62196-8; ZUCCONI F, 1981, BIOCYCLE, V22, P27	49	16	22	7	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0170820	10.1371/journal.pone.0170820	http://dx.doi.org/10.1371/journal.pone.0170820			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122059	Green Published, Green Submitted, gold			2022-12-26	WOS:000396167300015
J	Hwang, J; Park, SY; Park, M; Lee, S; Lee, TK				Hwang, Jinik; Park, So Yun; Park, Mirye; Lee, Sukchan; Lee, Taek-Kyun			Seasonal Dynamics and Metagenomic Characterization of Marine Viruses in Goseong Bay, Korea	PLOS ONE			English	Article							SEALS HALICHOERUS-GRYPUS; BACTERIAL-GROWTH RATE; MICROBIAL COMMUNITIES; MORTALITY; INFECTION; ABUNDANCE; DISEASES; ECOLOGY; OSHV-1	Viruses are the most abundant biological entities in the oceans, and account for a significant amount of the genetic diversity of marine ecosystems. However, there is little detailed information about the biodiversity of viruses in marine environments. Rapid advances in metagenomics have enabled the identification of previously unknown marine viruses. We performed metagenomic profiling of seawater samples collected at 6 sites in Goseong Bay (South Sea, Korea) during the spring, summer, autumn, and winter of 2014. The results in-dicated the presence of highly diverse virus communities. The DNA libraries from samples collected during four seasons were sequenced using Illumina HiSeq 2000. The number of viral reads was 136,850 during March, 70,651 during June, 66,165 during September, and 111,778 during December. Species identification indicated that Pelagibacter phage HTVC010P, Ostreococcus lucimarinus OIV5 and OIV1, and Roseobacter phage SIO1 were the most common species in all samples. For viruses with at least 10 reads, there were 204 species during March, 189 during June, 170 during September, and 173 during December. Analysis of virus families indicated that the Myoviridae was the most common during all four seasons, and viruses in the Polyomaviridae were only present during March. Viruses in the Iridoviridae were only present during three seasons. Additionally, viruses in the Iridoviridae, Herpesviridae, and Poxviridae, which may affect fish and marine animals, appeared during different seasons. These results suggest that seasonal changes in temperature contribute to the dynamic structure of the viral community in the study area. The information presented here will be useful for comparative analyses with other marine viral communities.	[Hwang, Jinik; Park, So Yun; Park, Mirye; Lee, Taek-Kyun] Korea Inst Ocean Sci & Technol, South Sea Environm Res Dept, Geoje, South Korea; [Hwang, Jinik; Park, Mirye; Lee, Taek-Kyun] Korea Univ Sci & Technol, Marine Environm Sci, Daejeon, South Korea; [Lee, Sukchan] Sungkyunkwan Univ, Dept Genet Engn, Suwon, South Korea	Korea Institute of Ocean Science & Technology (KIOST); University of Science & Technology (UST); Sungkyunkwan University (SKKU)	Lee, TK (corresponding author), Korea Inst Ocean Sci & Technol, South Sea Environm Res Dept, Geoje, South Korea.	tklee@kiost.ac.kr			Korea Institute of Ocean Science Technology [PE99441]	Korea Institute of Ocean Science Technology	This work was supported by grants from the Korea Institute of Ocean Science & Technology (No. PE99441).	Adams HE, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00250; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Bench SR, 2007, APPL ENVIRON MICROB, V73, P7629, DOI 10.1128/AEM.00938-07; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Brum JR, 2015, SCIENCE, V348, DOI 10.1126/science.1261498; Brum JR, 2013, ISME J, V7, P1738, DOI 10.1038/ismej.2013.67; Carreira C, 2015, APPL ENVIRON MICROB, V81, P2149, DOI 10.1128/AEM.02863-14; Chow CET, 2015, ANNU REV VIROL, V2, P41, DOI 10.1146/annurev-virology-031413-085540; Danovaro R, 2001, APPL ENVIRON MICROB, V67, P1384, DOI 10.1128/AEM.67.3.1384-1387.2001; Davison AJ, 2005, J GEN VIROL, V86, P41, DOI 10.1099/vir.0.80382-0; Davison AJ, 2010, VET MICROBIOL, V143, P52, DOI 10.1016/j.vetmic.2010.02.014; Degremont L, 2013, AQUACULTURE, V416, P129, DOI 10.1016/j.aquaculture.2013.09.011; Diaz-Munoz SL, 2014, ADV APPL MICROBIOL, V89, P135, DOI 10.1016/B978-0-12-800259-9.00004-4; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Fuhrman JA, 2015, NAT REV MICROBIOL, V13, P133, DOI 10.1038/nrmicro3417; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; He JG, 2002, AQUACULTURE, V204, P11, DOI 10.1016/S0044-8486(01)00639-1; Hewson I, 2012, APPL ENVIRON MICROB, V78, P6583, DOI 10.1128/AEM.01705-12; HICKS BD, 1987, J WILDLIFE DIS, V23, P1, DOI 10.7589/0090-3558-23.1.1; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Hyatt AD, 2000, ARCH VIROL, V145, P301, DOI 10.1007/s007050050025; Ilouze M, 2011, ECOL RES, V26, P885, DOI 10.1007/s11284-010-0694-2; John SG, 2011, ENV MICROBIOL REP, V3, P195, DOI 10.1111/j.1758-2229.2010.00208.x; Kawakami H, 2002, FISH PATHOL, V37, P45, DOI 10.3147/jsfp.37.45; Kristensen DM, 2010, TRENDS MICROBIOL, V18, P11, DOI 10.1016/j.tim.2009.11.003; Labonte JM, 2015, ISME J, V9, P2386, DOI 10.1038/ismej.2015.48; Lara E, 2013, AQUAT MICROB ECOL, V70, P17, DOI 10.3354/ame01636; Lim YW, 2013, J CYST FIBROS, V12, P154, DOI 10.1016/j.jcf.2012.07.009; Sanmartin ML, 2016, VIRUS RES, V217, P55, DOI 10.1016/j.virusres.2016.01.023; Lutze W, 1990, NATURE, V347, P4; Middelboe M, 2000, MICROBIAL ECOL, V40, P114; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Proctor LM, 1990, VIRAL MORTALITY OF M; Rohwer F, 2009, NATURE, V459, P207, DOI 10.1038/nature08060; Rosario K, 2009, J GEN VIROL, V90, P2418, DOI 10.1099/vir.0.012955-0; Shi C, 2004, J FISHERY SCI CHINA, V12, P588; SIMPSON VR, 1994, VET REC, V134, P292, DOI 10.1136/vr.134.12.292; SUTTLE CA, 1994, MICROBIAL ECOL, V28, P237, DOI 10.1007/BF00166813; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Thingstad TF, 1997, AQUAT MICROB ECOL, V13, P19, DOI 10.3354/ame013019; Thurber RLV, 2008, P NATL ACAD SCI USA, V105, P18413, DOI 10.1073/pnas.0808985105; Tripp HJ, 2008, NATURE, V452, P741, DOI 10.1038/nature06776; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; Weitz Joshua S, 2012, F1000 Biol Rep, V4, P17; Willner D, 2013, BIOESSAYS, V35, P436, DOI 10.1002/bies.201200174; Wright EP, 2015, VET OPHTHALMOL, V18, P148, DOI 10.1111/vop.12235; Yu Donghyeon, 2013, Genomics & Informatics, V11, P200, DOI 10.5808/GI.2013.11.4.200; Zhu BT, 2005, WATER RES, V39, P5153, DOI 10.1016/j.watres.2005.09.035	50	15	15	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0169841	10.1371/journal.pone.0169841	http://dx.doi.org/10.1371/journal.pone.0169841			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122030	Green Published, gold, Green Submitted			2022-12-26	WOS:000396167300064
J	Yee, JY; Nurjono, M; Teo, SR; Lee, TS; Lee, J				Yee, Jie Yin; Nurjono, Milawaty; Teo, Stephanie Ruth; Lee, Tih-Shih; Lee, Jimmy			GAD1 Gene Expression in Blood of Patients with First-Episode Psychosis	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; MESSENGER-RNA EXPRESSION; PREFRONTAL CORTEX; SCHIZOPHRENIA; BRAIN; NEURONS; HALOPERIDOL; BIOMARKERS; CLOZAPINE; DECREASE	gamma-Aminobutyric acid (GABA), the primary inhibitory neurotransmitter, has often been studied in relation to its role in the pathophysiology of schizophrenia. GABA is synthesized from glutamate by glutamic acid decarboxylase (GAD), derived from two genes, GAD1 and GAD2. GAD1 is expressed as both GAD67 and GAD25 mRNA transcripts with the former reported to have a lower expression level in schizophrenia compared to healthy controls and latter was reported to be predominantly expressed fetally, suggesting a role in developmental process. In this study, GAD67 and GAD25 mRNA levels were measured by quantitative PCR (qPCR) in peripheral blood of subjects with first-episode psychosis (FEP) and from healthy controls. We observed low GAD25 and GAD67 gene expression levels in human peripheral blood. There was no difference in GAD25 and GAD67 gene expression level, and GAD25/GAD67 ratio between patients with FEP and healthy controls. PANSS negative symptoms were associated with levels of GAD25 mRNA transcripts in patients with FEP. While the current study provides information on GAD25 and GAD67 mRNA transcript levels in whole blood of FEP patients, further correlation and validation work between brain regions, cerebrospinal fluid and peripheral blood expression profiling are required to provide a better understanding of GAD25 and GAD67.	[Yee, Jie Yin; Lee, Jimmy] Inst Mental Hlth, Div Res, Singapore, Singapore; [Nurjono, Milawaty] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Teo, Stephanie Ruth; Lee, Tih-Shih] Duke NUS Med Sch, Neurosci & Behav Disorders, Singapore, Singapore; [Lee, Jimmy] Inst Mental Hlth, Dept Gen Psychiat 1, Singapore, Singapore	National University of Singapore; National University of Singapore	Yee, JY (corresponding author), Inst Mental Hlth, Div Res, Singapore, Singapore.	jie_yin_yee@imh.com.sg	Lee, Jimmy/ABB-2919-2020	Lee, Jimmy/0000-0002-7724-7445	Singapore Ministry of Health's National Medical Research Council under the Centre Grant Programme [NMRC/CG/004/2013]	Singapore Ministry of Health's National Medical Research Council under the Centre Grant Programme	This study was funded by the Singapore Ministry of Healths National Medical Research Council under the Centre Grant Programme (Grant No.: NMRC/CG/004/2013). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington AM, 2005, MOL PSYCHIATR, V10, P581, DOI 10.1038/sj.mp.4001599; AKBARIAN S, 1995, ARCH GEN PSYCHIAT, V52, P258, DOI 10.1001/archpsyc.1995.03950160008002; Akbarian S, 2006, BRAIN RES REV, V52, P293, DOI 10.1016/j.brainresrev.2006.04.001; Belforte JE, 2010, NAT NEUROSCI, V13, P76, DOI 10.1038/nn.2447; Chertkow Y, 2006, INT J NEUROPSYCHOPH, V9, P287, DOI 10.1017/S1461145705005626; Curley AA, 2011, AM J PSYCHIAT; Dracheva S, 2004, J NEUROSCI RES, V76, P581, DOI 10.1002/jnr.20122; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Hashimoto T, 2005, J NEUROSCI, V25, P372, DOI 10.1523/JNEUROSCI.4035-04.2005; Hashimoto T, 2003, J NEUROSCI, V23, P6315; Huang HS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000809; Huhman KL, 1996, J BIOL RHYTHM, V11, P311, DOI 10.1177/074873049601100404; Hyde TM, 2011, J NEUROSCI, V31, P11088, DOI 10.1523/JNEUROSCI.1234-11.2011; Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718; Jiang JD, 2013, SCHIZOPHR RES, V143, P38, DOI 10.1016/j.schres.2012.10.019; Lee J, 2012, PSYCHIAT RES, V200, P52, DOI 10.1016/j.psychres.2012.03.021; Lipska BK, 2003, EUR J NEUROSCI, V18, P3097, DOI 10.1111/j.1460-9568.2003.03047.x; Mirzakhanian H, 2014, BIOMARK MED, V8, P51, DOI 10.2217/bmm.13.134; Mitchell AC, 2015, SCHIZOPHR RES, V167, P28, DOI 10.1016/j.schres.2014.10.020; Prata D, 2014, NEUROSCI BIOBEHAV R, V45, P134, DOI 10.1016/j.neubiorev.2014.05.010; RUPNIAK NMJ, 1987, J NEURAL TRANSM, V68, P113, DOI 10.1007/BF01244643; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Trifonov S, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-114; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Volk DW, 2000, ARCH GEN PSYCHIAT, V57, P237, DOI 10.1001/archpsyc.57.3.237	26	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0170805	10.1371/journal.pone.0170805	http://dx.doi.org/10.1371/journal.pone.0170805			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122016	Green Published, Green Submitted, gold			2022-12-26	WOS:000396167300018
J	Lee, E; Khurana, MS; Whiteley, AS; Monis, PT; Bath, A; Gordon, C; Ryan, UM; Paparini, A				Lee, Elvina; Khurana, Maninder S.; Whiteley, Andrew S.; Monis, Paul T.; Bath, Andrew; Gordon, Cameron; Ryan, Una M.; Paparini, Andrea			Novel Primer Sets for Next Generation Sequencing-Based Analyses of Water Quality	PLOS ONE			English	Article							RIBOSOMAL-RNA; PCR PRIMERS; CYANOBACTERIA; DIVERSITY; IDENTIFICATION; PHYLOGENY; DNA; PROTEOBACTERIA; BIODIVERSITY; COMMUNITIES	Next generation sequencing (NGS) has rapidly become an invaluable tool for the detection, identification and relative quantification of environmental microorganisms. Here, we demonstrate two new 16S rDNA primer sets, which are compatible with NGS approaches and are primarily for use in water quality studies. Compared to 16S rRNA gene based universal primers, in silico and experimental analyses demonstrated that the new primers showed increased specificity for the Cyanobacteria and Proteobacteria phyla, allowing increased sensitivity for the detection, identification and relative quantification of toxic bloom-forming microalgae, microbial water quality bioindicators and common pathogens. Significantly, Cyanobacterial and Proteobacterial sequences accounted for ca. 95% of all sequences obtained within NGS runs (when compared to ca. 50% with standard universal NGS primers), providing higher sensitivity and greater phylogenetic resolution of key water quality microbial groups. The increased selectivity of the new primers allow the parallel sequencing of more samples through reduced sequence retrieval levels required to detect target groups, potentially reducing NGS costs by 50% but still guaranteeing optimal coverage and species discrimination.	[Lee, Elvina; Khurana, Maninder S.; Ryan, Una M.; Paparini, Andrea] Murdoch Univ, Sch Vet & Life Sci, Vector & Water Borne Pathogen Res Lab, Perth, WA, Australia; [Whiteley, Andrew S.] Univ Western Australia, Sch Earth & Environm, Crawley, WA, Australia; [Monis, Paul T.] South Australian Water Corp, Australian Water Qual Ctr, Adelaide, SA, Australia; [Bath, Andrew; Gordon, Cameron] Water Corp, Drinking Water Qual Branch, Leederville, WA, Australia	Murdoch University; University of Western Australia	Paparini, A (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Vector & Water Borne Pathogen Res Lab, Perth, WA, Australia.	a.paparini@murdoch.edu.au	Paparini, Andrea/T-8057-2019; Monis, Paul T/B-8539-2011	Monis, Paul T/0000-0002-9052-4742; Whiteley, Andrew/0000-0001-7762-1575; Paparini, Andrea/0000-0002-1105-5184; Ryan, Una/0000-0003-2710-9324	Murdoch University; Australian Research Council [LP100100160]; Bayer Healthcare; Bayer Australia Ltd.; Western Australia Water Corporation; WaterRA	Murdoch University; Australian Research Council(Australian Research Council); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Bayer Australia Ltd.; Western Australia Water Corporation; WaterRA	Resources of the Pawsey Supercomputing Centre (BLAST on MAGNUS) were used during some steps of the data analysis under an existing project (The microbiome of Australia's source water). Partial financial support for this study was indirectly provided by Murdoch University, the Australian Research Council (LP100100160), Bayer Healthcare, Bayer Australia Ltd., Western Australia Water Corporation, WaterRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Tebrineh J, 2011, TOXICON, V57, P546, DOI 10.1016/j.toxicon.2010.12.018; Apprill A, 2015, AQUAT MICROB ECOL, V75, P129, DOI 10.3354/ame01753; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; Dall'Agnol LT, 2012, J PLANKTON RES, V34, P245, DOI 10.1093/plankt/fbr109; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eiler A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053516; Fergusson KM, 2000, APPL ENVIRON MICROB, V66, P4145, DOI 10.1128/AEM.66.9.4145-4148.2000; Gaget V, 2011, INT J SYST EVOL MICR, V61, P170, DOI 10.1099/ijs.0.019018-0; Gofton AW, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0958-3; Gupta RS, 2000, FEMS MICROBIOL REV, V24, P367, DOI 10.1111/j.1574-6976.2000.tb00547.x; Hadziavdic K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087624; Hajibabaei M, 2012, TRENDS GENET, V28, P535, DOI 10.1016/j.tig.2012.08.001; Holscher HD, 2015, AM J CLIN NUTR, V101, P55, DOI 10.3945/ajcn.114.092064; Hong SH, 2009, ISME J, V3, P1365, DOI 10.1038/ismej.2009.89; Humpage A, 2012, WATER RES, V46, P1576, DOI 10.1016/j.watres.2011.11.019; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; IMHOFF JF, 2001, BERGEYS MANUAL SYSTE, V1, P631; Kataoka T, 2013, HARMFUL ALGAE, V23, P46, DOI 10.1016/j.hal.2012.12.003; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kermarrec L, 2013, MOL ECOL RESOUR, V13, P607, DOI 10.1111/1755-0998.12105; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kolmakova OV, 2014, FEMS MICROBIOL ECOL, V89, P442, DOI 10.1111/1574-6941.12355; Lanzen A, 2011, FEMS MICROBIOL ECOL, V77, P577, DOI 10.1111/j.1574-6941.2011.01138.x; Lee E, 2014, WATER RES, V59, P248, DOI 10.1016/j.watres.2014.04.023; Machida RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046180; Man-Aharonovich D, 2007, ENVIRON MICROBIOL, V9, P2354, DOI 10.1111/j.1462-2920.2007.01353.x; Manen JF, 2002, INT J SYST EVOL MICR, V52, P861, DOI [10.1099/ijs.0.01981-0, 10.1099/00207713-52-3-861]; Menchaca AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067129; Milani C, 2014, FEMS MICROBIOL ECOL, V90, P493, DOI 10.1111/1574-6941.12410; Mizrahi-Man O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053608; Morotomi M., 2014, PROKARYOTES ALPHAPRO, P1005; NEILAN BA, 1995, APPL ENVIRON MICROB, V61, P3875, DOI 10.1128/AEM.61.11.3875-3883.1995; Paerl HW, 2013, MICROB ECOL, V65, P995, DOI 10.1007/s00248-012-0159-y; Paparini A, 2015, EXP PARASITOL, V151, P21, DOI 10.1016/j.exppara.2015.02.001; Parte AC, 2014, NUCLEIC ACIDS RES, V42, pD613, DOI 10.1093/nar/gkt1111; Rasmussen JP, 2008, J APPL MICROBIOL, V104, P1503, DOI 10.1111/j.1365-2672.2007.03676.x; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Shih PM, 2013, P NATL ACAD SCI USA, V110, P1053, DOI 10.1073/pnas.1217107110; Sinclair L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116955; Soo RM, 2014, GENOME BIOL EVOL, V6, P1031, DOI 10.1093/gbe/evu073; STACKEBRANDT E, 1988, INT J SYST BACTERIOL, V38, P321, DOI 10.1099/00207713-38-3-321; Su C, 2012, APPL MICROBIOL BIOT, V93, P993, DOI 10.1007/s00253-011-3800-7; Takahashi S., 2014, PLOS ONE, V9; Tan B, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01027; Tissot-Dupont H, 2008, INFECT DIS CLIN N AM, V22, P505, DOI 10.1016/j.idc.2008.03.002; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Valerio E, 2009, MICROBIOL-SGM, V155, P642, DOI 10.1099/mic.0.022848-0; Welker M, 2006, FEMS MICROBIOL REV, V30, P530, DOI 10.1111/j.1574-6976.2006.00022.x; Whiteley AS, 2012, J MICROBIOL METH, V91, P80, DOI 10.1016/j.mimet.2012.07.008; Wood SA, 2013, NEW ZEAL J MAR FRESH, V47, P90, DOI 10.1080/00288330.2012.745885	59	14	14	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2017	12	1							e0170008	10.1371/journal.pone.0170008	http://dx.doi.org/10.1371/journal.pone.0170008			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7CU	28118368	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000396160500042
J	Quan, Q; Hong, L; Chang, B; Liu, RX; Zhu, Y; Peng, J; Zhao, Q; Lu, SB				Quan, Qi; Hong, Lei; Chang, Biao; Liu, Ruoxi; Zhu, Yun; Peng, Jiang; Zhao, Qing; Lu, Shibi			The Scaphoid Safe Zone: A Radiographic Simulation Study to Prevent Cortical Perforation Arising from Different Views	PLOS ONE			English	Article							COMPUTATIONAL APPROACH; FRACTURES; SCREW; FIXATION; PLACEMENT; PATTERNS; WAIST	Purpose The purpose of this study was to simulate and calculate the probability of iatrogenic perforation of the scaphoid cortical bone when internal fixation appeared to be safe on radiographs. The results will assist surgeons in determining proper screw placement. Methods Thirty scaphoids were reconstructed using computed tomography data and image-processing software. Different central axes were determined by the software to simulate the surgical views. The safe zone (SZ) and risk zone (RZ) were identified on the axial projection radiographs by comparing the scaphoid bone stenosis measured by the fluoroscopic radiographs with a three-dimensional reconstruction of the scaphoid stenosis. Each original axial projection radiograph was zoomed and compiled to match a calculated average image. The RZ, SZ, and probability of perforations in various quadrants were calculated. Results Using a volar view (approach), the mean risks of cortical perforation were 25% with screws and 36% with k-wires. Using a dorsal view (approach), the mean risks of cortical perforation were 18% with screws and 30% with k-wires. A high risk of perforation was detected at the ulnar-dorsal zone. Conclusion Surgeons should be wary of screws that appear to lie close to the scaphoid cortex on both anteroposterior (AP) and lateral radiographs, particularly in the ulnar-dorsal and radial-dorsal quadrants, because such screws are likely to perforate the cortex. The position of the internal fixator should be assessed using a diagram outlining the various SZs. Therapeutic, Level III.	[Quan, Qi; Chang, Biao; Liu, Ruoxi; Peng, Jiang; Lu, Shibi] Chinese Peoples Liberat Army Gen Hosp, Dept Orthoped Surg, Key Lab Musculoskeletal Trauma & War Injuries PLA, Beijing Key Lab Regenerat Med Orthoped, Beijing, Peoples R China; [Hong, Lei; Zhao, Qing] Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Orthoped Surg, Beijing, Peoples R China; [Zhu, Yun] Univ Hong Kong HKU, Sch Biomed Sci, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; University of Hong Kong	Lu, SB (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Orthoped Surg, Key Lab Musculoskeletal Trauma & War Injuries PLA, Beijing Key Lab Regenerat Med Orthoped, Beijing, Peoples R China.; Zhao, Q (corresponding author), Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Orthoped Surg, Beijing, Peoples R China.	zqmd304@126.com; lushibi301@126.com		Zhang, Ying-Qi/0000-0002-4616-6888	973 grant [2014CB542201, 2012CB518106]; Special Project of the "Thirteenth Five-year Plan" for medical Science Development of PLA grant [BWS13C029]; Special Project of the "Twelfth Five-year Plan" for medical Science Development of PLA [BWS11J025]; Chinese PLA General Hospital MiaoPu project [16KMM37]	973 grant(National Basic Research Program of China); Special Project of the "Thirteenth Five-year Plan" for medical Science Development of PLA grant; Special Project of the "Twelfth Five-year Plan" for medical Science Development of PLA; Chinese PLA General Hospital MiaoPu project	This work was supported by 973 grant number (2014CB542201 and No.2012CB518106); the Special Project of the "Thirteenth Five-year Plan" for medical Science Development of PLA grant number (BWS13C029) and the Special Project of the "Twelfth Five-year Plan" for medical Science Development of PLA grant number (BWS11J025); Chinese PLA General Hospital MiaoPu project grant number (NO. 16KMM37).	Chan KW, 2004, J HAND SURG-AM, V29A, P74, DOI 10.1016/j.jhsa.2003.09.002; DIAS JJ, 1989, J BONE JOINT SURG BR, V71, P307, DOI 10.1302/0301-620X.71B2.2925752; Duckworth AD, 2011, J TRAUMA; Geissler WB, 2012, J BONE JOINT SURG AM, V94A, P169, DOI 10.2106/JBJS.942icl; Gruszka D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145949; Guo Y, 2014, INT ORTHOP, V38, P95, DOI 10.1007/s00264-013-2089-9; Kawamura K, 2008, J HAND SURG-AM, V33A, P988, DOI 10.1016/j.jhsa.2008.04.026; Kumar AJS, 2007, INJURY, V38, P792, DOI 10.1016/j.injury.2006.12.002; Leventhal EL, 2009, J HAND SURG-AM, V34A, P677, DOI 10.1016/j.jhsa.2009.01.011; McCallister WV, 2003, J BONE JOINT SURG AM, V85A, P72, DOI 10.2106/00004623-200301000-00012; Segalman KA, J AM SOC SURG HAND, V4, P233; ten Berg PWL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/547250; Trumble TE, 2000, J BONE JOINT SURG AM, V82A, P633, DOI 10.2106/00004623-200005000-00004; Welling RD, 2008, AM J ROENTGENOL, V190, P10, DOI 10.2214/AJR.07.2699; Zhang YQ, 2015, J ORTHOP TRAUMA, V29, pE178, DOI 10.1097/BOT.0000000000000239	15	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170677	10.1371/journal.pone.0170677	http://dx.doi.org/10.1371/journal.pone.0170677			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114317	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129000083
J	Zhu, YJ; Zheng, GY; Wang, HC; Jia, YD; Zhang, Y; Tang, YF; Li, WL; Fan, YA; Zhang, XD; Liu, YW; Liu, SH				Zhu, Yingjie; Zheng, Guangyong; Wang, Huichao; Jia, Yudong; Zhang, Ying; Tang, Yanfeng; Li, Wenlong; Fan, Yanan; Zhang, Xiaodong; Liu, Youwen; Liu, Sanhong			Downregulated miR-29a/b/c during Contact Inhibition Stage Promote 3T3-L1 Adipogenesis by Targeting DNMT3A	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HUMAN ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; UP-REGULATION; MICRORNAS; ROLES; RATS	Differentiation of 3T3-L1 cells into adipocytes involves a highly-orchestrated series of events including contact inhibition (CI), clonal expansion, growth arrest, and terminal differentiation. Recent study demonstrated that 3T3-L1 preadipocytes will not be differentiated into mature adipocytes without CI stage, which indicated that CI stage plays an important role during 3T3-L1 adipogenesis. However, the molecular mechanism is not yet fully understood. In the present study, we found that the expression level of miR-29a/b/c was decreased and the expression of DNMT3A was up-regulated during CI stage, respectively. Furthermore, overexpression of miR-29a/b/c during CI stage inhibits adipogenesis significantly but not at other stages. In addition, miR-29a/b/c repressed DNMT3A expression by directly targeting its 3' untranslated region (3' UTR). Our data reveal a novel mechanism of miR-29a/b/c in the regulation of adipogenesis.	[Zhu, Yingjie; Wang, Huichao; Jia, Yudong; Zhang, Ying; Tang, Yanfeng; Li, Wenlong; Fan, Yanan; Zhang, Xiaodong; Liu, Youwen] Henan Prov Orthoped Hosp, Henan Prov Luoyang Orthoped Traumatol Hosp, Luoyang, Henan, Peoples R China; [Zheng, Guangyong] Chinese Acad Sci, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China; [Liu, Sanhong] ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; ShanghaiTech University	Liu, SH (corresponding author), Henan Prov Orthoped Hosp, Henan Prov Luoyang Orthoped Traumatol Hosp, Luoyang, Henan, Peoples R China.	sgkyyzxd@163.com; liuyouwendr@sina.com; liush@shanghaitech.edu.cn		Liu, Sanhong/0000-0002-8695-0343	National Natural Science Foundation of China [81473704]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81473704), [http://www.nsfc.gov.cn/] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Natural Science Foundation of China (81473704).	Alexander R, 2011, EXPERT OPIN THER TAR, V15, P623, DOI 10.1517/14728222.2011.561317; Arner P, 2015, NAT REV ENDOCRINOL, V11, P276, DOI 10.1038/nrendo.2015.25; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benoit C, 2013, J ENDOCRINOL, V218, P35, DOI 10.1530/JOE-12-0561; Deiuliis JA, 2016, INT J OBESITY, V40, P88, DOI 10.1038/ijo.2015.170; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Guo W, 2009, CELL RES, V19, P216, DOI 10.1038/cr.2008.319; He AB, 2007, MOL ENDOCRINOL, V21, P2785, DOI 10.1210/me.2007-0167; Hilton C, 2013, INT J OBESITY, V37, P325, DOI 10.1038/ijo.2012.59; Huang S, 2012, STEM CELLS DEV, V21, P2531, DOI 10.1089/scd.2012.0014; Kajimoto K, 2006, RNA, V12, P1626, DOI 10.1261/rna.7228806; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; Kim SY, 2010, BIOCHEM BIOPH RES CO, V392, P323, DOI 10.1016/j.bbrc.2010.01.012; Kim YJ, 2009, STEM CELLS, V27, P3093, DOI 10.1002/stem.235; Lee EK, 2011, BIOLOGY, V31, P626, DOI [10.1128/MCB.00894-10, DOI 10.1128/MCB.00894-10]; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Li HL, 2013, STEM CELL RES, V10, P313, DOI 10.1016/j.scr.2012.11.007; Ling HY, 2013, BIOCHEM CELL BIOL, V91, P195, DOI 10.1139/bcb-2012-0053; Liu SH, 2011, BIOCHEM BIOPH RES CO, V414, P618, DOI 10.1016/j.bbrc.2011.09.131; McGregor RA, 2011, CURR MOL MED, V11, P304; Oskowitz AZ, 2008, P NATL ACAD SCI USA, V105, P18372, DOI 10.1073/pnas.0809807105; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Peng YD, 2014, CELL SIGNAL, V26, P1888, DOI 10.1016/j.cellsig.2014.05.006; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Skarn M, 2012, STEM CELLS DEV, V21, P873, DOI 10.1089/scd.2010.0503; Son YH, 2014, ENDOCRINOL METAB, V29, P122, DOI 10.3803/EnM.2014.29.2.122; Sun TW, 2009, MOL ENDOCRINOL, V23, P925, DOI 10.1210/me.2008-0298; Wei JF, 2014, STEM CELLS DEV, V23, P1452, DOI 10.1089/scd.2013.0600; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Zhu YJ, 2014, ACTA BIOCH BIOPH SIN, V46, P590, DOI 10.1093/abbs/gmu036; Zhuang GQ, 2012, CIRCULATION, V125, P2892, DOI 10.1161/CIRCULATIONAHA.111.087817	33	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170636	10.1371/journal.pone.0170636	http://dx.doi.org/10.1371/journal.pone.0170636			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114345	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129000081
J	Dalm, SU; Schrijver, WAME; Sieuwerts, AM; Look, MP; Ziel-van der Made, ACJ; de Weerd, V; Martens, JW; van Diest, PJ; de Jong, M; van Deurzen, CHM				Dalm, Simone U.; Schrijver, Willemijne A. M. E.; Sieuwerts, Anieta M.; Look, Maxime P.; Ziel-van der Made, Angelique C. J.; de Weerd, Vanja; Martens, John W.; van Diest, Paul J.; de Jong, Marion; van Deurzen, Carolien H. M.			Prospects of Targeting the Gastrin Releasing Peptide Receptor and Somatostatin Receptor 2 for Nuclear Imaging and Therapy in Metastatic Breast Cancer	PLOS ONE			English	Article							EXPRESSION; SUBTYPES	Background The gastrin releasing peptide receptor (GRPR) and the somatostatin receptor 2 (SSTR2) are overexpressed on primary breast cancer (BC), making them ideal candidates for receptor- mediated nuclear imaging and therapy. The aim of this study was to determine whether these receptors are also suitable targets for metastatic BC. Methods mRNA expression of human BC samples were studied by in vitro autoradiography and associated with radioligand binding. Next, GRPR and SSTR2 mRNA levels of 60 paired primary BCs and metastases from different sites were measured by quantitative reverse transcriptase polymerase chain reaction. Receptor mRNA expression levels were associated with clinico-pathological factors and expression levels of primary tumors and corresponding metastases were compared. Results Binding of GRPR and SSTR radioligands to tumor tissue correlated significantly with receptor mRNA expression. High GRPR and SSTR2 mRNA levels were associated with estrogen receptor (ESR1)-positive tumors (p< 0.001 for both receptors). There was no significant difference in GRPR mRNA expression of primary tumors versus paired metastases. Regarding SSTR2 mRNA expression, there was also no significant difference in the majority of cases, apart from liver and ovarian metastases which showed a significantly lower expression compared to the corresponding primary tumors (p = 0.02 and p = 0.03, respectively). Conclusion Targeting the GRPR and SSTR2 for nuclear imaging and/ or treatment has the potential to improve BC care in primary as well as metastatic disease.	[Dalm, Simone U.; de Jong, Marion] Erasmus MC, Dept Radiol & Nucl Med, Rotterdam, Netherlands; [Schrijver, Willemijne A. M. E.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Look, Maxime P.; Martens, John W.] Erasmus MC, Erasmus MC Canc Inst, Dept Med Oncol & Canc Genom Netherlands, Rotterdam, Netherlands; [Ziel-van der Made, Angelique C. J.; van Deurzen, Carolien H. M.] Erasmus MC, Dept Pathol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC	Dalm, SU (corresponding author), Erasmus MC, Dept Radiol & Nucl Med, Rotterdam, Netherlands.	s.dalm@erasmusmc.nl		Dalm, Simone/0000-0002-6393-6901	Erasmus MC grant "The Application of Radiolabeled Peptides in Breast Cancer"	Erasmus MC grant "The Application of Radiolabeled Peptides in Breast Cancer"	This study was supported by the Erasmus MC grant "The Application of Radiolabeled Peptides in Breast Cancer".	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Bison SM, 2014, CLIN TRANSL IMAGING, V2, P55, DOI 10.1007/s40336-014-0054-2; BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; Dalm SU, 2015, J NUCL MED, V56, P1487, DOI 10.2967/jnumed.115.160739; Dalm SU, 2015, J NUCL MED, V56, P752, DOI 10.2967/jnumed.114.153023; De Blois E, 2013, Q J NUCL MED MOL IMA; de Blois E, 2012, CURR TOP MED CHEM, V12, P2677; Hindie E, 2011, J NUCL MED, V52, P405, DOI 10.2967/jnumed.110.081711; Hoefnagel LDC, 2013, ANN ONCOL, V24, P3017, DOI 10.1093/annonc/mdt390; IACR, 2015, GLOBOCAN 2012 EST CA; Korner M, 2012, AM J SURG PATHOL, V36, P242, DOI 10.1097/PAS.0b013e31823d07f3; Kumar U, 2005, BREAST CANCER RES TR, V92, P175, DOI 10.1007/s10549-005-2414-0; Vercher-Conejero JL, 2015, DIAGNOSTICS, V5, P61, DOI 10.3390/diagnostics5010061; Mariani G, 2004, J SURG ONCOL, V85, P112, DOI 10.1002/jso.20023; Marsouvanidis PJ, 2013, J MED CHEM, V56, P2374, DOI 10.1021/jm301692p; Nagasaki S, 2012, NEOPLASMA, V59, P224, DOI 10.4149/neo_2012_029; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prignon A, 2015, NUCL MED BIOL, V42, P92, DOI 10.1016/j.nucmedbio.2014.10.003; Schrijver WAME, 2015, BREAST CANCER RES TR, V151, P41, DOI 10.1007/s10549-015-3362-y; Skanberg J, 2002, BREAST CANCER RES TR, V74, P101, DOI 10.1023/A:1016120529858; Stoykow C, 2015, ANN C EUR ASS NUCL M; Van Den Bossche B, 2006, J NUCL MED, V47, P6; Van den Bossche B, 2004, EUR J NUCL MED MOL I, V31, P1022, DOI 10.1007/s00259-004-1500-6; Yersal O, 2014, WORLD J CLIN ONCOL, V5, P412, DOI 10.5306/wjco.v5.i3.412	24	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170536	10.1371/journal.pone.0170536	http://dx.doi.org/10.1371/journal.pone.0170536			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107508	Green Published, Green Submitted, gold			2022-12-26	WOS:000392405300160
J	He, HJ; Lv, F; Zhang, NNY; Wu, ZY; Liao, QH; Chang, ZJ; Li, Y; Xu, HF; OuYang, L; Huan, XP; Yang, J				He, Huijing; Lv, Fan; Zhang, Nanci Nanyi; Wu, Zunyou; Liao, Qinghua; Chang, Zhanjun; Li, Yi; Xu, Huifang; OuYang, Lin; Huan, Xiping; Yang, Juan			Look into the HIV Epidemic of Gay Community with a Socio-Cultural Perspective: A Qualitative Study in China, 2015-2016	PLOS ONE			English	Article							UNPROTECTED ANAL INTERCOURSE; CROSS-SECTIONAL SURVEY; SEXUAL HEALTH; RISK-FACTORS; MEN; PREVALENCE; ATTITUDES; SYPHILIS; PROVINCE; MSM	Background Current Chinese studies continue to view male homosexuality through a disease focused lens which pays limited attention to socio-cultural aspects of sexual behavior and HIV transmission. This qualitative study aimed to investigate how socio-cultural factors influence gay men's sexual beliefs and behaviors in contemporary China, and their implications for HIV epidemic. Methods and Findings Qualitative methodology was used in this study. During 2015 - 2016, in-depth interviews were conducted with 61 self identified gay men in Jiangxi, Henan, Heilongjiang, Guangdong, Jiangsu provinces and Chongqing municipality of China. Our study revealed that: 1) influenced by Chinese traditional culture, gay men have conflicts on self-identity, which led to low self-acceptance and negative attitude on sex, and huge socio-psychological stress; 2) a generational differences within gay community was observed, reflected in varied sexual attitudes and practices as well as way for approaching new friends, both of which have implications and challenges on HIV control and prevention; 3) socio-cultural barriers, including open minds towards casual sex and nonmonogamous relationship, and low priority of health demands were widely observed and led to negative coping with AIDS among gay community. Conclusions It is essential to take a holistic view into gay men's HIV epidemic in China. Socio-cultural barriers for HIV control and prevention found in this study call for serious and imperative consideration on integrated measures, including targeted efforts towards effective sex education and further inclusion of socio-cultural perspectives in HIV/AIDS interventions for gay men.	[He, Huijing; Lv, Fan; Zhang, Nanci Nanyi; Wu, Zunyou; Yang, Juan] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Liao, Qinghua] Jiangxi Prov Ctr Dis Control & Prevent, Nanchang, Jiangxi, Peoples R China; [Chang, Zhanjun] Zhengzhou Ctr Dis Control & Prevent, Zhengzhou, Herts, Peoples R China; [Li, Yi] Heilongjiang Prov Ctr Dis Control & Prevent, Harbin, Heilongjiang, Peoples R China; [Xu, Huifang] Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [OuYang, Lin] Chongqing Ctr Dis Control & Prevent, Chongqing, Peoples R China; [Huan, Xiping] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Jiangsu Provincial Center for Disease Control & Prevention	Lv, F (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	fanlv@chinaaids.cn	He, Huijing/ABB-1408-2021		National Natural Science Foundation of China [71473234]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by The National Natural Science Foundation of China(NO. 71473234). No specific funds were sought for the research and no funding sources had influence on study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, J SEX RES, V47, P269, DOI [10.1080/00224490903062241, DOI 10.1080/00224490903062241]; [Anonymous], 2014, YOUTH RES, P79; Belkin A, 2015, NEW ENGL J MED, V373, P1089, DOI 10.1056/NEJMp1509230; Bien CH, 2015, AIDS BEHAV, V19, P941, DOI 10.1007/s10461-014-0994-6; Chen Z. Y., 2011, S CHINA J PREVENTIVE, V37, P23; Cheng WB, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0696-8; Choi KH, 2016, ARCH SEX BEHAV, V45, P1483, DOI 10.1007/s10508-015-0640-z; Chow EPF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/607261; Chow EPF, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-549; Chow EPF, 2013, SEX HEALTH, V10, P533, DOI 10.1071/SH13097; Ding J, 2012, JIANGSU PREVENTIVE M, V23, P34; Feng YL, 2012, J ADOLESCENT HEALTH, V50, pS52, DOI 10.1016/j.jadohealth.2011.12.008; Feng YJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS98, DOI 10.1097/QAI.0b013e3181c7df71; Han XX, 2015, SCI REP-UK, V5, DOI 10.1038/srep18147; He Q, 2011, SE ASIAN J TROP MED, V42, P616; Hou LJ, 2015, ARCH VIROL, V160, P2051, DOI 10.1007/s00705-015-2481-4; Hu C., 2009, INT C CHIN TRANSP PR, P1; Huebner DM, 2012, INT J STD AIDS, V23, P182, DOI 10.1258/ijsa.2009.009318; Jing J, 2012, OPEN TIME, P106; Kail BL, 2015, AM J PUBLIC HEALTH, V105, P1101, DOI 10.2105/AJPH.2015.302589; Khawcharoenporn T, 2016, AIDS CARE, P1; Koo FK, 2014, CULT HEALTH SEX, V16, P302, DOI 10.1080/13691058.2014.883643; Kwok DK, 2015, INT REV PSYCHIATR, V27, P444, DOI 10.3109/09540261.2015.1083950; Lau JTF, 2011, PUBLIC HEALTH, V125, P260, DOI 10.1016/j.puhe.2011.01.007; Lau JTF, 2013, J SEX MED, V10, P642, DOI 10.1111/j.1743-6109.2012.02956.x; Lee SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031072; Li HC, 2010, AIDS CARE, V22, P1481, DOI 10.1080/09540121.2010.482121; Li HC, 2010, CULT HEALTH SEX, V12, P401, DOI 10.1080/13691050903551721; Li XS, 2016, SCI REP-UK, V6, DOI 10.1038/srep34729; Li XF, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000124; Li XF, 2012, SEX TRANSM INFECT, V88, P187, DOI 10.1136/sextrans-2011-050248; Li Y., 1992, YOUTH STUDY, V10, P43; Liu H, 2006, SEX TRANSM DIS, V33, P68, DOI 10.1097/01.olq.0000187266.29927.11; Liu J., 2015, THESIS; Liu J, 2015, SOFT SCI HLTH, V29, P576; Liu JX, 2006, AIDS BEHAV, V10, pS25, DOI 10.1007/s10461-006-9123-5; Liu WL, 2011, INT J SEX HEALTH, V23, P224, DOI 10.1080/19317611.2011.596256; Liu Y, 2016, AIDS PATIENT CARE ST, V30, P70, DOI 10.1089/apc.2015.0296; Lu HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072747; Luo Y, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006791; Lyons A, 2014, ARCH SEX BEHAV, V43, P1621, DOI 10.1007/s10508-014-0315-1; Ma Yanmin, 2015, Zhonghua Liu Xing Bing Xue Za Zhi, V36, P158; Macapagal K, 2016, ARCH SEX BEHAV, V45, P1513, DOI 10.1007/s10508-016-0698-2; Mi GD, 2016, CLIN INFECT DIS, V62, P1443, DOI 10.1093/cid/ciw167; Moskowitz DA, 2013, ARCH SEX BEHAV, V42, P775, DOI 10.1007/s10508-013-0095-z; Prestage G, 2015, AIDS BEHAV, V19, P2224, DOI 10.1007/s10461-015-1027-9; Pyun T, 2014, ASIA-PAC J PUBLIC HE, V26, P118, DOI 10.1177/1010539514524434; Qu L, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3809-z; Quidley-Rodriguez N, 2015, AM J MENS HLTH; Shao B, 2014, J INFECTION, V68, P273, DOI 10.1016/j.jinf.2013.10.014; Shi LE, 2016, LGBT HEALTH, V3, P238, DOI 10.1089/lgbt.2014.0129; Solomon Sunil S, 2010, J Int AIDS Soc, V13 Suppl 2, pS7, DOI 10.1186/1758-2652-13-S2-S7; Steward WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071778; Tang J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-917; Uwah C., 2012, WORLD J AIDS, V2, P17, DOI https://doi.org/10.4236/wja.2012.21003; Wang HX, 2015, INT J CLIN EXP MED, V8, P16414; Wang KL, 2012, INT J EPIDEMIOL, V41, P423, DOI 10.1093/ije/dyr182; Wang L, 2012, CHINESE MED J-PEKING, V125, P1857, DOI 10.3760/cma.j.issn.0366-6999.2012.11.003; Wei CY, 2016, JAIDS-J ACQ IMM DEF, V71, P87, DOI 10.1097/QAI.0000000000000815; Wei CY, 2011, SEX TRANSM INFECT, V87, P225, DOI 10.1136/sti.2010.047407; Wu ZY, 2013, CLIN INFECT DIS, V57, P298, DOI 10.1093/cid/cit210; Wu ZY, 2010, INT J EPIDEMIOL, V39, pII1, DOI 10.1093/ije/dyq220; Xu JJ, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0178-x; Yan HM, 2014, SEX HEALTH, V11, P285, DOI 10.1071/SH14017; Ye SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050873; Young SD, 2011, AIDS BEHAV, V15, P253, DOI 10.1007/s10461-010-9810-0; Yu Y, 2011, J HOMOSEXUAL, V58, P263, DOI 10.1080/00918369.2011.540182; Zhang B, 2008, CHINJ HUM SEX, V17, P6; ZHANG B, 2008, CHINESE J AIDS STD, V14, P541; Zhang K, 1999, AIDS CARE, V11, P581, DOI 10.1080/09540129947730; Zhao YJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000534; Zhou YQR, 2006, CULT HEALTH SEX, V8, P487, DOI 10.1080/13691050600847455	72	13	15	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170457	10.1371/journal.pone.0170457	http://dx.doi.org/10.1371/journal.pone.0170457			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI3QC	28107523	gold, Green Submitted, Green Published			2022-12-26	WOS:000392405300138
J	Huang, YQ; Liu, YH; Zheng, CY; Shen, C				Huang, Yaqing; Liu, Yuehong; Zheng, Congyi; Shen, Chao			Investigation of Cross-Contamination and Misidentification of 278 Widely Used Tumor Cell Lines	PLOS ONE			English	Article							GENETIC PROFILING REVEALS; MICROSATELLITE INSTABILITY; NEOPLASTIC TRANSFORMATION; EPITHELIAL-CELLS; AUTHENTICATION; IDENTIFICATION; ANGIOGENESIS; CULTURES; ECV304; MODEL	In recent years, biological research involving human cell lines has been rapidly developing in China. However, some of the cell lines are not authenticated before use. Therefore, misidentified and/or cross-contaminated cell lines are unfortunately commonplace. In this study, we present a comprehensive investigation of cross-contamination and misidentification for a panel of 278 cell lines from 28 institutes in China by using short tandem repeat profiling method. By comparing the DNA profiles with the cell bank databases of ATCC and DSMZ, a total of 46.0% (128/278) cases with cross-contamination/misidentification were uncovered coming from 22 institutes. Notably, 73.2% (52 out of 71) of the cell lines established by the Chinese researchers were misidentified and accounted for 40.6% of total misidentification (52/128). Further, 67.3% (35/52) of the misidentified cell lines established in laboratories of China were HeLa cells or a possible hybrid of HeLa with another kind of cell line. Furthermore, the bile duct cancer cell line HCCC-9810 and degenerative lung cancer Calu-6 exhibited 88.9% match in the ATCC database (9-loci), indicating that they were from the same origin. However, when we used 21-loci to compare these two cell lines with the same algorithm, the percent match was only 48.2%, indicating that these two cell lines were different. The SNP profiles of HCCC-9810 and Calu-6 also revealed that they were different cell lines. 150 cell lines with unique profiles demonstrated a wide range of in vitro phenotypes. This panel of 150 genomically validated cancer cell lines represents a valuable resource for the cancer research community and will advance our understanding of the disease by providing a standard reference for cell lines that can be used for biological as well as preclinical studies.	[Huang, Yaqing; Liu, Yuehong; Zheng, Congyi; Shen, Chao] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Hunan, Peoples R China; [Zheng, Congyi; Shen, Chao] China Ctr Type Culture Collect, Wuhan, Hubei, Peoples R China	Wuhan University	Zheng, CY; Shen, C (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Hunan, Peoples R China.; Zheng, CY; Shen, C (corresponding author), China Ctr Type Culture Collect, Wuhan, Hubei, Peoples R China.	cctcc202@whu.edu.cn; shenchao@whu.edu.cn			National Natural Sciences Foundation of China [31370185]; National Basic Research Program of China [NSTI-CR14, NSTI-CR15]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Natural Sciences Foundation of China (No.31370185) and the National Basic Research Program of China (No. NSTI-CR14, NSTI-CR15). The funder's websites are [http://www.nsfc.gov.cn/publish/portal1/] and [http://www.most.gov.cn/eng/programmes1/200610/t20061009_36223.htm]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adem C, 2003, INT J CANCER, V107, P580, DOI 10.1002/ijc.11442; Azari S, 2007, BIOLOGICALS, V35, P195, DOI 10.1016/j.biologicals.2006.10.001; Bhagat R, 2014, GENOMICS, V104, P257, DOI DOI 10.1016/J.YGENO.2014.08.016; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Castro F, 2013, INT J CANCER, V132, P308, DOI 10.1002/ijc.27675; Chan SYY, 2008, INT J CANCER, V122, P2169, DOI 10.1002/ijc.23374; Chen Xu-Dong, 2012, Shengli Xuebao, V64, P617; Cooper JK, 2007, IN VITRO CELL DEV-AN, V43, P344, DOI 10.1007/s11626-007-9060-2; Craig P. Giacomini, 2015, AM ASS CANC RES, V65, P9200; Drexler HG, 2002, IN VITRO CELL DEV-AN, V38, P185; Elisia I, 2013, AM J PHYSIOL-GASTR L, V305, pG940, DOI 10.1152/ajpgi.00269.2013; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; GARTLER SM, 1968, NATURE, V217, P750, DOI 10.1038/217750a0; Hughes SE, 1996, EXP CELL RES, V225, P171, DOI 10.1006/excr.1996.0168; Hukku B, 1984, CELL CHARACTERIZATIO, P13; Johnen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064139; Kniss DA, 2014, REPROD SCI, V21, P1015, DOI 10.1177/1933719114522518; Liang-Chu MMY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116218; Lorenzi PL, 2009, MOL CANCER THER, V8, P713, DOI 10.1158/1535-7163.MCT-08-0921; Markovic O, 1998, IN VITRO CELL DEV-AN, V34, P1; Masters JR, 2012, NATURE, V492, P186, DOI 10.1038/492186a; Masters JRW, 2010, NAT REV CANCER, V10, P441, DOI 10.1038/nrc2852; Masters JR, 2001, P NATL ACAD SCI USA, V98, P8012, DOI 10.1073/pnas.121616198; Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775; Nabarra B, 2005, INT J EXP PATHOL, V86, P397, DOI 10.1111/j.0959-9673.2005.00451.x; Nardone RM, 2007, CELL BIOL TOXICOL, V23, P367, DOI 10.1007/s10565-007-9019-9; Parson W, 2005, FASEB J, V19, P434, DOI 10.1096/fj.04-3062fje; Phuchareon J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006040; Ramya R, 2009, CYTOTECHNOLOGY, V61, P81, DOI 10.1007/s10616-009-9245-5; REZNIKOFF CA, 1988, CARCINOGENESIS, V9, P1427, DOI 10.1093/carcin/9.8.1427; SIDDIQUI KM, 1984, IN VITRO CELL DEV B, V20, P859; Valletta E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147414; Yamamoto H, 2015, ARCH TOXICOL, V89, P899, DOI 10.1007/s00204-015-1474-0; Yang J, 2005, CANCER GENET CYTOGEN, V158, P180, DOI 10.1016/j.cancergencyto.2004.05.010; Yao Y, 2004, LAB INVEST, V84, P915, DOI 10.1038/labinvest.3700117; Ye F, 2015, FASEB J, V29, P4268, DOI 10.1096/fj.14-266718; Yoshino Kaori, 2006, Hum Cell, V19, P43, DOI 10.1111/j.1749-0774.2005.00007.x; Zou CY, 2008, ACTA PHARMACOL SIN, V29, P325, DOI 10.1111/j.1745-7254.2008.00756.x	38	37	41	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170384	10.1371/journal.pone.0170384	http://dx.doi.org/10.1371/journal.pone.0170384			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107433	Green Published, gold, Green Submitted			2022-12-26	WOS:000392405300123
J	Kammers, K; Taub, MA; Ruczinski, I; Martin, J; Yanek, LR; Frazee, A; Gao, YX; Hoyle, D; Faraday, N; Becker, DM; Cheng, LZ; Wang, ZZ; Leek, JT; Becker, LC; Mathias, RA				Kammers, Kai; Taub, Margaret A.; Ruczinski, Ingo; Martin, Joshua; Yanek, Lisa R.; Frazee, Alyssa; Gao, Yongxing; Hoyle, Dixie; Faraday, Nauder; Becker, Diane M.; Cheng, Linzhao; Wang, Zack Z.; Leek, Jeff T.; Becker, Lewis C.; Mathias, Rasika A.			Integrity of Induced Pluripotent Stem Cell (iPSC) Derived Megakaryocytes as Assessed by Genetic and Transcriptomic Analysis	PLOS ONE			English	Article							COPY NUMBER; GENOMIC INSTABILITY; HERITABILITY; AGGREGATION; ACTIVATION; ASPIRIN; VARIANT; TOOL	Previously, we have described our feeder-free, xeno-free approach to generate megakaryo-cytes (MKs) in culture from human induced pluripotent stem cells (iPSCs). Here, we focus specifically on the integrity of these MKs using: (1) genotype discordance between parent cell DNA to iPSC cell DNA and onward to the differentiated MK DNA; (2) genomic structural integrity using copy number variation (CNV); and (3) transcriptomic signatures of the derived MK lines compared to the iPSC lines. We detected a very low rate of genotype discordance; estimates were 0.0001%-0.01%, well below the genotyping error rate for our assay (0.37%). No CNVs were generated in the iPSCs that were subsequently passed on to the MKs. Finally, we observed highly biologically relevant gene sets as being upregulated in MKs relative to the iPSCs: platelet activation, blood coagulation, megakaryocyte development, platelet formation, platelet degranulation, and platelet aggregation. These data strongly support the integrity of the derived MK lines.	[Kammers, Kai] Johns Hopkins Univ, Sch Med, Dept Oncol, Div Biostat & Bioinformat,Sidney Kimmel Comprehen, Baltimore, MD 21205 USA; [Kammers, Kai; Taub, Margaret A.; Ruczinski, Ingo; Frazee, Alyssa; Leek, Jeff T.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Martin, Joshua; Yanek, Lisa R.; Faraday, Nauder; Becker, Diane M.; Becker, Lewis C.; Mathias, Rasika A.] Johns Hopkins Sch Med, GeneSTAR Res Program, Baltimore, MD 21205 USA; [Gao, Yongxing; Hoyle, Dixie; Cheng, Linzhao; Wang, Zack Z.] Johns Hopkins Sch Med, Div Hematol, Baltimore, MD USA; [Gao, Yongxing; Hoyle, Dixie; Cheng, Linzhao; Wang, Zack Z.] Johns Hopkins Sch Med, Inst Cell Engn, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Becker, LC (corresponding author), Johns Hopkins Sch Med, GeneSTAR Res Program, Baltimore, MD 21205 USA.	lbecker@jhmi.edu			NHLBI [U01 HL72518-05, U01 HL107446, R01HL112064]; German Research Foundation [KA 3884/1-1];  [R01 GM105705]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107446, R01HL112064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105705] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); German Research Foundation(German Research Foundation (DFG)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NHLBI projects U01 HL72518-05, U01 HL107446 and R01HL112064. KK and MAT were supported from R01 GM105705. KK was also partly supported by the German Research Foundation (KA 3884/1-1).	Adrian A., 2010, TOPGO ENRICHMENT ANA; Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Becker DM, 2006, JAMA-J AM MED ASSOC, V295, P1420, DOI 10.1001/jama.295.12.1420; Ben-David U, 2011, CELL STEM CELL, V9, P97, DOI 10.1016/j.stem.2011.06.013; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Bray PF, 2007, J THROMB HAEMOST, V5, P1617, DOI 10.1111/j.1538-7836.2007.02618.x; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Ecker JR, 2012, NATURE, V489, P52, DOI 10.1038/489052a; Faraday N, 2007, CIRCULATION, V115, P2490, DOI 10.1161/CIRCULATIONAHA.106.667584; Faraday N, 2011, BLOOD, V118, P3367, DOI 10.1182/blood-2010-11-320788; Faraday N, 2009, THROMB RES, V124, P311, DOI 10.1016/j.thromres.2008.12.031; Frazee AC, 2015, NAT BIOTECHNOL, V33, P243, DOI 10.1038/nbt.3172; Garitaonandia I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118307; Goring HHH, 2012, NAT GENET, V44, P1077, DOI 10.1038/ng.2420; Herrera-Galeano JE, 2008, ARTERIOSCL THROM VAS, V28, P1484, DOI 10.1161/ATVBAHA.108.168971; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Johnson AD, 2010, NAT GENET, V42, P608, DOI 10.1038/ng.604; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Liu YF, 2015, STEM CELL TRANSL MED, V4, P309, DOI 10.5966/sctm.2014-0183; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Moreau T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11208; Muers M, 2011, NAT REV GENET, V12, P230, DOI 10.1038/nrg2975; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Oliveira PH, 2014, STEM CELLS, V32, P2824, DOI 10.1002/stem.1796; Pera MF, 2011, NATURE, V471, P46, DOI 10.1038/471046a; Peterson SE, 2014, J BIOL CHEM, V289, P4578, DOI 10.1074/jbc.R113.516419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Scharpf RB, 2008, ANN APPL STAT, V2, P687, DOI 10.1214/07-AOAS155; Scharpf RB, 2011, J STAT SOFTW, V40, P1; Scharpf RB, 2011, BIOSTATISTICS, V12, P33, DOI 10.1093/biostatistics/kxq043; Schubert P, 2010, VOX SANG, V99, P112, DOI 10.1111/j.1423-0410.2010.01333.x; Skylaki S, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks663; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Taapken SM, 2011, NAT BIOTECHNOL, V29, P313, DOI 10.1038/nbt.1835; Team RC, 2015, LANG ENV STAT COMP; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016	42	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0167794	10.1371/journal.pone.0167794	http://dx.doi.org/10.1371/journal.pone.0167794			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107356	Green Submitted, Green Published, gold			2022-12-26	WOS:000392405300007
J	Marianno, P; Abrahao, KP; Camarini, R				Marianno, Priscila; Abrahao, Karina Possa; Camarini, Rosana			Environmental Enrichment Blunts Ethanol Consumption after Restraint Stress in C57BL/6 Mice	PLOS ONE			English	Article							ALCOHOL DEPRIVATION; SOCIAL-ISOLATION; RATS; COCAINE; MODEL; EXPERIENCE; DRINKING; BEHAVIOR; ANXIETY; IMPACT	Elevated alcohol intake after abstinence is a key feature of the addiction process. Some studies have shown that environmental enrichment (EE) affects ethanol intake and other reinforcing effects. However, different EE protocols may vary in their ability to influence alcohol consumption and stress-induced intake. The present study evaluated whether short (3 h) or continuous (24 h) EE protocols affect ethanol consumption after periods of withdrawal. Mice were challenged with stressful stimuli (24 h isolation and restraint stress) to evaluate the effects of stress on drinking. Male C57BL/6 mice were subjected to a two-bottle choice drinking-in-the-dark paradigm for 15 days (20% ethanol and water, 2 h/day, acquisition phase). Control mice were housed under standard conditions (SC). In the first experiment, one group of mice was housed under EE conditions 24 h/day (EE24h). In the second experiment, the exposure to EE was reduced to 3 h/day (EE3h). After the acquisition phase, the animals were deprived of ethanol for 6 days, followed by 2 h ethanol access once a week. Animals were tested in the elevated plus maze (EPM) during ethanol withdrawal. During the last 2 weeks, the mice were exposed to 24 h ethanol access. A 1-h restraint stress test was performed immediately before the last ethanol exposure. EE24h but not EE3h increased anxiety-like behavior during withdrawal compared to controls. Neither EE24h nor EE3h affected ethanol consumption during the 2 h weekly exposure periods. However, EE24h and EE3h mice that were exposed to acute restraint stress consumed less ethanol than controls during a 24 h ethanol access. These results showed that EE reduces alcohol intake after an acute restraint stress.	[Marianno, Priscila; Abrahao, Karina Possa; Camarini, Rosana] Univ Sao Paulo, Inst Ciencias Biomed, Dept Farmacol, Sao Paulo, SP, Brazil; [Abrahao, Karina Possa] NIAAA, Lab Integrat Neurosci, Div Intramural Clin & Biol Res, NIH, Bethesda, MD USA	Universidade de Sao Paulo; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Camarini, R (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Farmacol, Sao Paulo, SP, Brazil.	camarini@icb.usp.br	Abrahao, Karina/R-3267-2017; Marianno, Priscila/GMW-8102-2022; Camarini, Rosana/D-2251-2012	Abrahao, Karina/0000-0002-4528-2430; Camarini, Rosana/0000-0002-8131-6108; Marianno, Priscila/0000-0003-3746-6309	FAPESP (Sao Paulo Research Foundation) [2015/02397-0, 2011/08280-0]; CNPq (National Council for Scientific and Technological Development) [470070/2012-9]; CAPES (Coordination for the Improvement of Higher Education Personnel)	FAPESP (Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordination for the Improvement of Higher Education Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors thank FAPESP (Sao Paulo Research Foundation) for the research funding (grant # 2015/02397-0) and for scholarship to KPA (grant # 2011/08280-0), CNPq (National Council for Scientific and Technological Development) for the research funding (grant # 470070/2012-9) and CAPES (Coordination for the Improvement of Higher Education Personnel) for the scholarship to PM. RC is research fellow of CNPq.	Becker HC, 2011, PSYCHOPHARMACOLOGY, V218, P131, DOI 10.1007/s00213-011-2443-9; Bremner JD, 1996, SYNAPSE, V23, P28, DOI 10.1002/(SICI)1098-2396(199605)23:1<28::AID-SYN4>3.0.CO;2-J; Chauvet C, 2009, NEUROPSYCHOPHARMACOL, V34, P2767, DOI 10.1038/npp.2009.127; Cox BR, 2013, ALCOHOL CLIN EXP RES, V37, P1688, DOI 10.1111/acer.12145; Cozzoli DK, 2014, ALCOHOL, V48, P741, DOI 10.1016/j.alcohol.2014.07.015; Crabbe JC, 2009, BIOL PSYCHIAT, V65, P662, DOI 10.1016/j.biopsych.2008.11.002; Crofton EJ, 2015, NEUROSCI BIOBEHAV R, V49, P19, DOI 10.1016/j.neubiorev.2014.11.017; de Carvalho CR, 2010, BEHAV BRAIN RES, V208, P231, DOI 10.1016/j.bbr.2009.11.043; Deehan GA, 2011, BEHAV NEUROSCI, V125, P184, DOI 10.1037/a0022627; Fox C, 2006, BEHAV BRAIN RES, V175, P1, DOI 10.1016/j.bbr.2006.08.016; Francis DD, 2002, J NEUROSCI, V22, P7840; Goeders NE, 2002, J PHARMACOL EXP THER, V301, P785, DOI 10.1124/jpet.301.3.785; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; Green TA, 2002, PSYCHOPHARMACOLOGY, V162, P373, DOI 10.1007/s00213-002-1134-y; Hellemans KGC, 2005, BEHAV BRAIN RES, V159, P207, DOI 10.1016/j.bbr.2004.10.018; Keyes KM, 2012, ALCOHOL RES-CURR REV, V34, P391; Khisti RT, 2006, ALCOHOL, V40, P119, DOI 10.1016/j.alcohol.2006.12.003; Knapp CM, 2007, PHARMACOL BIOCHEM BE, V87, P65, DOI 10.1016/j.pbb.2007.04.001; Konkle ATM, 2010, J AM ASSOC LAB ANIM, V49, P427; Koob G, 2000, NEUROBIOL DIS, V7, P543, DOI 10.1006/nbdi.2000.0351; Koob GF, 2008, ANNU REV PSYCHOL, V59, P29, DOI 10.1146/annurev.psych.59.103006.093548; Le AD, 1998, PSYCHOPHARMACOLOGY, V135, P169, DOI 10.1007/s002130050498; Lehmann ML, 2013, J NEUROSCI, V33, P2961, DOI 10.1523/JNEUROSCI.3878-12.2013; Lehmann ML, 2011, J NEUROSCI, V31, P6159, DOI 10.1523/JNEUROSCI.0577-11.2011; Li XM, 2015, ACCIDENT ANAL PREV, V77, P91, DOI 10.1016/j.aap.2015.01.022; Rueda AVL, 2012, ADDICT BIOL, V17, P736, DOI 10.1111/j.1369-1600.2011.00408.x; Lopez MF, 2015, PHYSIOL BEHAV, V148, P151, DOI 10.1016/j.physbeh.2014.11.012; Matsumoto K, 2007, STRESS, V10, P3, DOI 10.1080/10253890701200997; McKinley MJ, 2004, NEWS PHYSIOL SCI, V19, P1, DOI 10.1152/nips.01470.2003; Melendez RI, 2006, ALCOHOL CLIN EXP RES, V30, P2017, DOI 10.1111/j.1530-0277.2006.00248.x; MICHAJLOVSKIJ N, 1988, ENDOCRINOL EXP, V22, P143; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Novaes LS, 2017, NEUROPHARMACOLOGY, V113, P457, DOI 10.1016/j.neuropharm.2016.10.026; Ostroumov A, 2016, NEURON, V92, P493, DOI 10.1016/j.neuron.2016.09.029; Perry JL, 2008, BEHAV BRAIN RES, V193, P48, DOI 10.1016/j.bbr.2008.04.019; Puhl MD, 2012, BEHAV PHARMACOL, V23, P43, DOI 10.1097/FBP.0b013e32834eb060; Rhodes JS, 2007, GENES BRAIN BEHAV, V6, P1, DOI 10.1111/j.1601-183X.2006.00210.x; Rhodes JS, 2005, PHYSIOL BEHAV, V84, P53, DOI 10.1016/j.physbeh.2004.10.007; ROCKMAN GE, 1989, PHARMACOL BIOCHEM BE, V34, P487, DOI 10.1016/0091-3057(89)90545-5; Rodd-Henricks ZA, 2000, ALCOHOL CLIN EXP RES, V24, P8, DOI 10.1111/j.1530-0277.2000.tb04546.x; Sanchis-Segura C, 2006, ADDICT BIOL, V11, P2, DOI 10.1111/j.1369-1600.2006.00012.x; SELYE H, 1973, AM SCI, V61, P692; Simpson J, 2011, BEHAV BRAIN RES, V222, P246, DOI 10.1016/j.bbr.2011.04.002; Solinas M, 2008, P NATL ACAD SCI USA, V105, P17145, DOI 10.1073/pnas.0806889105; Spanagel R, 1999, ALCOHOL ALCOHOLISM, V34, P231, DOI 10.1093/alcalc/34.2.231; Spanagel R, 2009, PHYSIOL REV, V89, P649, DOI 10.1152/physrev.00013.2008; Stairs DJ, 2009, PHARMACOL BIOCHEM BE, V92, P377, DOI 10.1016/j.pbb.2009.01.016; Sztainberg Y, 2010, MOL PSYCHIATR, V15, P905, DOI 10.1038/mp.2009.151; Toth LA, 2011, COMPARATIVE MED, V61, P314; Varlinskaya EI, 2012, PHARMACOL BIOCHEM BE, V100, P440, DOI 10.1016/j.pbb.2011.10.010; Varman DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127945; Vengeliene V, 2014, ALCOHOL, V48, P313, DOI 10.1016/j.alcohol.2014.03.002; Zimmermann A, 2001, BEHAV BRAIN RES, V121, P11, DOI 10.1016/S0166-4328(00)00377-6	53	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170317	10.1371/journal.pone.0170317	http://dx.doi.org/10.1371/journal.pone.0170317			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107511	Green Submitted, Green Published, gold			2022-12-26	WOS:000392405300106
J	Thorvaldsen, TE; Pedersen, NM; Wenzel, EM; Stenmark, H				Thorvaldsen, Tor Espen; Pedersen, Nina Marie; Wenzel, Eva Maria; Stenmark, Harald			Differential Roles of AXIN1 and AXIN2 in Tankyrase Inhibitor-Induced Formation of Degradasomes and beta-Catenin Degradation	PLOS ONE			English	Article							RIBOSE POLYMERASE TANKYRASE; COLON-CANCER; APC; PATHWAY; POLYMERIZATION; ACTIVATION; CELLS	Inhibition of the tankyrase enzymes (TNKS1 and TNKS2) has recently been shown to induce highly dynamic assemblies of beta-catenin destruction complex components known as degradasomes, which promote degradation of beta-catenin and reduced Wnt signaling activity in colorectal cancer cells. AXIN1 and AXIN2/Conductin, the rate-limiting factors for the stability and function of endogenous destruction complexes, are stabilized upon TNKS inhibition due to abrogated degradation of AXIN by the proteasome. Since the role of AXIN1 versus AXIN2 as scaffolding proteins in the Wnt signaling pathway still remains incompletely understood, we sought to elucidate their relative contribution in the formation of degradasomes, as these protein assemblies most likely represent the morphological and functional correlates of endogenous beta-catenin destruction complexes. In SW480 colorectal cancer cells treated with the tankyrase inhibitor (TNKSi) G007-LK we found that AXIN1 was not required for degradasome formation. In contrast, the formation of degradasomes as well as their capacity to degrade beta-catenin were considerably impaired in G007-LK-treated cells depleted of AXIN2. These findings give novel insights into differential functional roles of AXIN1 versus AXIN2 in the beta-catenin destruction complex.	[Thorvaldsen, Tor Espen; Pedersen, Nina Marie; Wenzel, Eva Maria; Stenmark, Harald] Oslo Univ Hosp, Fac Med, Ctr Canc Biomed, Oslo, Norway; [Thorvaldsen, Tor Espen; Pedersen, Nina Marie; Wenzel, Eva Maria; Stenmark, Harald] Oslo Univ Hosp, Inst Canc Res, Dept Mol Cell Biol, Oslo, Norway	University of Oslo; University of Oslo	Wenzel, EM; Stenmark, H (corresponding author), Oslo Univ Hosp, Fac Med, Ctr Canc Biomed, Oslo, Norway.; Wenzel, EM; Stenmark, H (corresponding author), Oslo Univ Hosp, Inst Canc Res, Dept Mol Cell Biol, Oslo, Norway.	eva.wenzel@rr-research.no; stenmark@ulrik.uio.no	Stenmark, Harald/B-8868-2008	Wenzel, Eva Maria/0000-0002-5561-3344	Norwegian Cancer Society [4541899145315]; South-Eastern Norway Regional Health Authority [2015014]; Norwegian Cancer Society; Research Council of Norway [179571]	Norwegian Cancer Society(Norwegian Cancer Society); South-Eastern Norway Regional Health Authority; Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway)	TET is a PhD student of the South-Eastern Norway Regional Health Authority (http://www.helse-sorost.no/). NMP is a postdoctoral fellow of the Norwegian Cancer Society (Grant number 4541899145315, https://kreftforeningen.no/en/). EMW is a senior research fellow of the South-Eastern Norway Regional Health Authority (Grant number 2015014). HS has been supported by the Norwegian Cancer Society. This work was partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 179571 (http://www.forskningsradet.no/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanda A Riccio, 2016, STRUCTURE, V24, P1573, DOI [10.1016/j.str.2016.06.022, DOI 10.1016/J.STR.2016.06.022]; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bernkopf DB, 2015, J CELL SCI, V128, P33, DOI 10.1242/jcs.159145; Bienz M, 2014, TRENDS BIOCHEM SCI, V39, P487, DOI 10.1016/j.tibs.2014.08.006; Chia IV, 2005, MOL CELL BIOL, V25, P4371, DOI 10.1128/MCB.25.11.4371-4376.2005; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Croy HE, 2016, J BIOL CHEM; de la Roche M, 2014, CANCER RES, V74, P1495, DOI 10.1158/0008-5472.CAN-13-2682; Fiedler M, 2011, P NATL ACAD SCI USA, V108, P1937, DOI 10.1073/pnas.1017063108; Hadjihannas MV, 2006, P NATL ACAD SCI USA, V103, P10747, DOI 10.1073/pnas.0604206103; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Lehtio L, 2013, FEBS J, V280, P3576, DOI 10.1111/febs.12320; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mariotti L, 2016, MOL CELL, V63, P498, DOI 10.1016/j.molcel.2016.06.019; Martino-Echarri E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150484; Mendoza-Topaz C, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110013; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Pedersen NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160507; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Tanneberger K, 2011, J BIOL CHEM, V286, P19204, DOI 10.1074/jbc.M111.224881; Thorvaldsen TE, 2015, MOL CANCER RES, V13, P1487, DOI 10.1158/1541-7786.MCR-15-0125; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Voronkov A, 2013, J MED CHEM, V56, P3012, DOI 10.1021/jm4000566; Waaler J, 2012, CANCER RES, V72, P2822, DOI 10.1158/0008-5472.CAN-11-3336; Wang ZH, 2016, DEVELOPMENT, V143, P1710, DOI 10.1242/dev.127647; Wang ZH, 2016, GENETICS, V203, P269, DOI 10.1534/genetics.115.183244; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	31	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170508	10.1371/journal.pone.0170508	http://dx.doi.org/10.1371/journal.pone.0170508			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107521	gold, Green Published			2022-12-26	WOS:000392405300152
J	Zhao, PZ; Tang, SY; Wang, C; Zhang, Y; Best, J; Tangthanasup, TM; Huang, SJ; Yang, B; Wei, CY; Tucker, JD; Tang, WM				Zhao, Peizhen; Tang, Songyuan; Wang, Cheng; Zhang, Ye; Best, John; Tangthanasup, Thitikarn May; Huang, Shujie; Yang, Bin; Wei, Chongyi; Tucker, Joseph D.; Tang, Weiming			Recreational Drug Use among Chinese MSM and Transgender Individuals: Results from a National Online Cross-Sectional Study	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; INJECT DRUGS; GROUP SEX; MEN MSM; HIV; CHALLENGES; SYPHILIS; BEHAVIOR; PEOPLE; GAY	Background Recreational drug use has increased considerably among Chinese men who have sex with men (MSM). The phenomenon has the potentially to increase HIV transmission among Chinese MSM. The aims of this study were: 1) to investigate the prevalence of recreational drug use among Chinese MSM, and 2) to explore the correlation between gay smartphone based sex-seeking applications (gay apps), HIV/STIs testing, group sex, commercial sex, sexual roles and poppers use among Chinese MSM. Methods MSM who were born biologically male, were at least 16 years of age and had engaged in anal sex with a man at least once were recruited through a nation-wide online survey in 2014. Information regarding socio-demographics, risk behaviors, recreational drug use, HIV and other STIs testing history and gay app use were collected. Univariate and multivariate analysis were used to determine factors associated with recreational drug use among Chinese MSM. Results Among 1424 participating MSM, 1100 (77.3%) reported ever using recreational drugs in their lifetime. In the last 12 months, 303 (21.3%) used poppers, 34 (2.4%) used crystal meth and 15 (1.0%) used ecstasy. The mean age of respondents was 25.6 +/- 6.8 years, 72.9% identified as gay, 41.3% were students, and 83.8% had never been married. Multiple logistic regression models revealed that compared with non-popper users, popper users were more likely to have been tested for HIV (adjusted OR (aOR) = 1.50, 95% CI: 1.15-1.96) and other STIs (aOR = 1.65, 95% CI: 1.26-2.17). In addition, popper users were more likely to engage in group sex (aOR = 2.63, 95% CI: 1.80-3.86), commercial sex (aOR = 1.86, 95% CI: 1.13-3.06) and used gay mobile apps to seek sexual partners (aOR = 2.10, 95% CI: 1.58-2.80). Conclusion Chinese MSM has a high rate of recreational drug use, including poppers. Public health programs serving MSM may consider integrating intervention programs to decrease recreational drug use related harms.	[Zhao, Peizhen; Wang, Cheng; Zhang, Ye; Huang, Shujie; Yang, Bin; Tang, Weiming] Guangdong Ctr Skin Dis & STI Control, Guangzhou, Guangdong, Peoples R China; [Tang, Songyuan; Zhang, Ye; Tangthanasup, Thitikarn May; Tucker, Joseph D.; Tang, Weiming] Univ North Carolina Chapel Hill Project China, Guangzhou, Guangdong, Peoples R China; [Tang, Songyuan; Zhang, Ye; Tangthanasup, Thitikarn May; Tucker, Joseph D.; Tang, Weiming] Univ North Carolina Chapel Hill, SESH Study Grp, Guangzhou, Guangdong, Peoples R China; [Tang, Songyuan] Kunming Med Univ, Kunming, Peoples R China; [Best, John; Wei, Chongyi] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Tucker, Joseph D.; Tang, Weiming] Univ North Carolina Chapel Hill, Sch Med, Chapel Hill, NC USA	Kunming Medical University; University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Tang, WM (corresponding author), Guangdong Ctr Skin Dis & STI Control, Guangzhou, Guangdong, Peoples R China.; Tang, WM (corresponding author), Univ North Carolina Chapel Hill Project China, Guangzhou, Guangdong, Peoples R China.; Tang, WM (corresponding author), Univ North Carolina Chapel Hill, SESH Study Grp, Guangzhou, Guangdong, Peoples R China.; Tang, WM (corresponding author), Univ North Carolina Chapel Hill, Sch Med, Chapel Hill, NC USA.	weimingtangscience@gmail.com		Zhang, Ye/0000-0001-6159-7427; Tucker, Joseph/0000-0003-2804-1181	National Institutes of Health [National Institute of Allergy and Infectious Diseases] [1R01AI114310]; UNC-South China STD Research Training Centre [Fogarty International Centre] [1D43TW009532]; UNC Center for AIDS Research [National Institute of Allergy and Infectious Diseases] [5P30AI050410]; University of California San Francisco Centre for AIDS Research [National Institute of Allergy and Infectious Diseases ] [P30 AI027763]; National Institute of Mental Health [R00MH093201]; UNC Chapel Hill, Johns Hopkins University, Morehead School of Medicine and Tulane University (UJMT) Fogarty Fellowship [FIC R25TW0093]; Doris Duke International Clinical Research Fellowship; National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health [UL1TR001111]; FOGARTY INTERNATIONAL CENTER [R25TW009340, D43TW009532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114310, P30AI050410] Funding Source: NIH RePORTER	National Institutes of Health [National Institute of Allergy and Infectious Diseases](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UNC-South China STD Research Training Centre [Fogarty International Centre]; UNC Center for AIDS Research [National Institute of Allergy and Infectious Diseases]; University of California San Francisco Centre for AIDS Research [National Institute of Allergy and Infectious Diseases ]; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); UNC Chapel Hill, Johns Hopkins University, Morehead School of Medicine and Tulane University (UJMT) Fogarty Fellowship; Doris Duke International Clinical Research Fellowship; National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health [National Institute of Allergy and Infectious Diseases 1R01AI114310]; UNC-South China STD Research Training Centre [Fogarty International Centre 1D43TW009532 to JT]; UNC Center for AIDS Research [National Institute of Allergy and Infectious Diseases 5P30AI050410]; University of California San Francisco Centre for AIDS Research [National Institute of Allergy and Infectious Diseases P30 AI027763 to CWei]; National Institute of Mental Health [R00MH093201 ]; the UNC Chapel Hill, Johns Hopkins University, Morehead School of Medicine and Tulane University (UJMT) Fogarty Fellowship [FIC R25TW0093]; and the Doris Duke International Clinical Research Fellowship. This publication was also supported by Grant Number UL1TR001111 from the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health.	[Anonymous], 2013, UNAIDS REP GLOB AIDS; Bien CH, 2015, AIDS BEHAV, V19, P941, DOI 10.1007/s10461-014-0994-6; Breyer BN, 2012, UROLOGY, V79, P188, DOI 10.1016/j.urology.2011.07.1412; Buttram ME, 2015, SEX HEALTH, V12, P560, DOI 10.1071/SH15071; Celentano DD, 2006, SEX TRANSM DIS; Chua AC, 2013, ANN ACAD MED SINGAP, V42, P350; Darrow WW, 2005, J URBAN HEALTH, V82, P601, DOI 10.1093/jurban/jti122; Daskalopoulou M, 2014, LANCET HIV, V1, pE22, DOI 10.1016/S2352-3018(14)70001-3; European Centre for Disease Prevention and Control, 2015, UND IMP SMARTPH APPL; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; Holloway IW, 2015, ARCH SEX BEHAV, V44, P1799, DOI 10.1007/s10508-015-0581-6; Hull P, 2016, SEX TRANSM INFECT, P2015; Hunter LJ, 2014, POSTGRAD MED J, V90, P133, DOI 10.1136/postgradmedj-2012-131428; Jia Y, 2014, BIOMED RES INT, V2014, P1; Juan S, 2015, CHINA DAILY US; Kurka T, 2015, SEX TRANSM INFECT, V91, P394, DOI 10.1136/sextrans-2015-052218; Li Y, 2012, AIDS BEHAV, V16, P491, DOI 10.1007/s10461-012-0157-6; MacArthur GJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5945; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Parra LWAA, 2014, US NEWS; Pattanasin S, 2016, INT J STD AIDS, V27, P196, DOI 10.1177/0956462415578954; Plankey MW, 2007, JAIDS-J ACQ IMM DEF, V45, P85, DOI 10.1097/QAI.0b013e3180417c99; Rice CE, 2016, ARCH SEX BEHAV, V45, P1411, DOI 10.1007/s10508-015-0554-9; Ruan YH, 2013, SEX TRANSM DIS, V40, P323, DOI 10.1097/OLQ.0b013e31827fd4d4; Saw YM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002747; Tang W, 2015, PLOS ONE, V10; Thurtle N, 2015, INT J STD AIDS; UNAIDS, 2014, UNAIDS GAP REP; Ward C, 2014, J INT AIDS SOC, V17, P69, DOI 10.7448/IAS.17.4.19591; World Health Organization, 2014, 90 90 90 AMB TREATM; Xu J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/269305; Xu JJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0642-9; Zuckerman MD, 2012, CURR OPIN PEDIATR, V24, P219, DOI 10.1097/MOP.0b013e32834faa9b	33	30	36	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170024	10.1371/journal.pone.0170024	http://dx.doi.org/10.1371/journal.pone.0170024			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI3QC	28107391	Green Published, Green Submitted, gold			2022-12-26	WOS:000392405300063
J	Arellano, P; Tansey, K; Balzter, H; Tellkamp, M				Arellano, Paul; Tansey, Kevin; Balzter, Heiko; Tellkamp, Markus			Plant Family-Specific Impacts of Petroleum Pollution on Biodiversity and Leaf Chlorophyll Content in the Amazon Rainforest of Ecuador	PLOS ONE			English	Article							PHYLOGENETIC NICHE CONSERVATISM; HYDROCARBON; EVOLUTIONARY; REFLECTANCE; ECOLOGY; BASIN; SOIL; GAS	In recent decades petroleum pollution in the tropical rainforest has caused significant environmental damage in vast areas of the Amazon region. At present the extent of this damage is not entirely clear. Little is known about the specific impacts of petroleum pollution on tropical vegetation. In a field expedition to the Ecuadorian Amazon over 1100 leaf samples were collected from tropical trees in polluted and unpolluted sites. Plant families were identified for 739 of the leaf samples and compared between sites. Plant biodiversity indices show a reduction of the plant biodiversity when the site was affected by petroleum pollution. In addition, reflectance and transmittance were measured with a field spectroradiometer for every leaf sample and leaf chlorophyll content was estimated using reflectance model inversion with the radiative tranfer model PROSPECT. Four of the 15 plant families that are most representative of the ecoregion (Melastomataceae, Fabaceae, Rubiaceae and Euphorbiaceae) had significantly lower leaf chlorophyll content in the polluted areas compared to the unpolluted areas. This suggests that these families are more sensitive to petroleum pollution. The polluted site is dominated by Melastomataceae and Rubiaceae, suggesting that these plant families are particularly competitive in the presence of pollution. This study provides evidence of a decrease of plant diversity and richness caused by petroleum pollution and of a plant family-specific response of leaf chlorophyll content to petroleum pollution in the Ecuadorian Amazon using information from field spectroscopy and radiative transfer modelling.	[Arellano, Paul] Yachay Tech Univ, Sch Geol Sci & Engn, Hacienda San Jose, Urcuqui Imbabur, Ecuador; [Arellano, Paul] Yachay Tech Univ, Sch Geol Sci & Engn, CEO, Hacienda San Jose, Urcuqui Imbabur, Ecuador; [Arellano, Paul; Tansey, Kevin; Balzter, Heiko] Univ Leicester, Dept Geog, Ctr Landscape & Climate Res, Univ Rd, Leicester, Leics, England; [Balzter, Heiko] Univ Leicester, Natl Ctr Earth Observat, Univ Rd, Leicester, Leics, England; [Tellkamp, Markus] Yachay Tech Univ, Sch Biol Sci & Engn, Hacienda San Jose, Urcuqui Imbabur, Ecuador	University of Leicester; University of Leicester	Arellano, P (corresponding author), Yachay Tech Univ, Sch Geol Sci & Engn, Hacienda San Jose, Urcuqui Imbabur, Ecuador.; Arellano, P (corresponding author), Yachay Tech Univ, Sch Geol Sci & Engn, CEO, Hacienda San Jose, Urcuqui Imbabur, Ecuador.; Arellano, P (corresponding author), Univ Leicester, Dept Geog, Ctr Landscape & Climate Res, Univ Rd, Leicester, Leics, England.	pa134@le.ac.uk	Arellano, Paul/AAE-1566-2019; Balzter, Heiko/B-5976-2008	Arellano, Paul/0000-0003-2548-4550; Balzter, Heiko/0000-0002-9053-4684	SENESCYT-Ecuador (National Secretariat for Science and Technology of Ecuador); Royal Society Wolfson Research Merit Award [2011/R3]; NERC National Centre for Earth Observation; SENESCYT-Ecuador; Natural Environment Research Council [nceo020005] Funding Source: researchfish; NERC [nceo020005] Funding Source: UKRI	SENESCYT-Ecuador (National Secretariat for Science and Technology of Ecuador); Royal Society Wolfson Research Merit Award(Royal Society of London); NERC National Centre for Earth Observation(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); SENESCYT-Ecuador; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research has been funded by the principal author and had an important contribution of the SENESCYT (National Secretariat for Science and Technology of Ecuador). SENESCYT-Ecuador granted a scholarship to Paul Arellano for his doctoral studies. H. Balzter was supported by the Royal Society Wolfson Research Merit Award, 2011/R3 and the NERC National Centre for Earth Observation.	Arellano P, 2016, CHALLENGES MAINTAINI, P51; Arellano P, 2015, ENVIRON POLLUT, V205, P225, DOI 10.1016/j.envpol.2015.05.041; BAKER J. M., 1970, Environmental Pollution, V1, P27, DOI 10.1016/0013-9327(70)90004-2; Bernal AM, 2011, NEW POLIT SCI, V33, P143, DOI 10.1080/07393148.2011.570078; Blackburn GA, 2007, J EXP BOT, V58, P855, DOI 10.1093/jxb/erl123; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Colwell RK, 2014, ECOGRAPHY, V37, P609, DOI 10.1111/ecog.00814; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Crisp MD, 2012, NEW PHYTOL, V196, P681, DOI 10.1111/j.1469-8137.2012.04298.x; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; Dawson TP, 1998, REMOTE SENS ENVIRON, V65, P50, DOI 10.1016/S0034-4257(98)00007-8; Feret JB, 2008, REMOTE SENS ENVIRON, V112, P3030, DOI 10.1016/j.rse.2008.02.012; Hall J, 2011, INT J PHYTOREMEDIAT, V13, P317, DOI 10.1080/15226514.2010.495143; Higley D.K., 2001, USGS DIGITAL DATA SE, P40, DOI DOI 10.3133/DS63; Hurtig AK, 2005, INT J EPIDEMIOL, V34, P1170, DOI 10.1093/ije/dyi151; International Standard Organization-ISO, 2012, 228912012E ISO; Jacquemoud S, 2012, COMMUNICATION; Jacquemoud S, 2009, REMOTE SENS ENVIRON, V113, pS56, DOI 10.1016/j.rse.2008.01.026; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jost Lou, 2011, P66; Kimerling Judith, 2006, NYU J INT LAW POLIT, V43, P413; Kumar L., 2006, IMAGING SPECTROMETRY, P111, DOI DOI 10.1007/0-306-47578-2_5; Lichtenthaler HK, 1996, J PLANT PHYSIOL, V148, P4, DOI 10.1016/S0176-1617(96)80287-2; Liu H, 2015, SCI REP-UK, V5, DOI 10.1038/srep12246; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Malhi Y, 2006, GLOBAL CHANGE BIOL, V12, P1107, DOI 10.1111/j.1365-2486.2006.01120.x; Maurer Brian A., 2011, P55; Noomen MF, 2009, INT J REMOTE SENS, V30, P481, DOI 10.1080/01431160802339431; Noomen M.F., 2007, HYPERSPECTRAL REFLEC; Noomen MF, 2006, REMOTE SENS ENVIRON, V105, P262, DOI 10.1016/j.rse.2006.07.009; Noomen MF, 2012, ECOL INFORM, V8, P55, DOI 10.1016/j.ecoinf.2012.01.001; Olson PE, 2007, J ENVIRON QUAL, V36, P1461, DOI 10.2134/jeq2006.0371; Patterson TB, 2002, EVOLUTION, V56, P233, DOI 10.1111/j.0014-3820.2002.tb01334.x; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Prasad MNV, 2003, ELECTRON J BIOTECHN, V6, P285, DOI 10.2225/vol6-issue3-fulltext-6; Prinzing A, 2001, P ROY SOC B-BIOL SCI, V268, P2383, DOI 10.1098/rspb.2001.1801; Robson DB, 2004, CAN J BOT, V82, P22, DOI [10.1139/b03-138, 10.1139/B03-138]; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schafer RW, 2011, IEEE SIGNAL PROC MAG, V28, P111, DOI 10.1109/MSP.2011.941097; Smith KL, 2005, INT J REMOTE SENS, V26, P4067, DOI 10.1080/01431160500165625; Smith KL, 2005, FACILITY INVESTIGATE, P75; van der Meer F, 2006, IMAGING SPECTROMETRY, P35; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Yang H, 1999, INT J REMOTE SENS, V20, P807, DOI 10.1080/014311699213226; Yang H, 2000, INT J REMOTE SENS, V21, P197, DOI 10.1080/014311600211091	46	30	31	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0169867	10.1371/journal.pone.0169867	http://dx.doi.org/10.1371/journal.pone.0169867			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103307	Green Submitted, Green Published, gold			2022-12-26	WOS:000392381100025
J	Heffernan, C; Jain, MR; Liu, T; Kim, H; Barretto, K; Li, H; Maurel, P				Heffernan, Corey; Jain, Mohit R.; Liu, Tong; Kim, Hyosung; Barretto, Kevin; Li, Hong; Maurel, Patrice			Nectin-like 4 Complexes with Choline Transporter-like Protein-1 and Regulates Schwann Cell Choline Homeostasis and Lipid Biogenesis in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN BASIC-PROTEIN; PHOSPHATIDIC-ACID; PLASMA-MEMBRANE; SPHINGOMYELIN SYNTHASE; STATISTICAL-MODEL; MAMMALIAN-CELLS; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLCHOLINE; NEUROPATHY; SYSTEM	Nectin-like 4 (NECL4, CADM4) is a Schwann cell-specific cell adhesion molecule that promotes axo-glial interactions. In vitro and in vivo studies have shown that NECL4 is necessary for proper peripheral nerve myelination. However, the molecular mechanisms that are regulated by NECL4 and affect peripheral myelination currently remain unclear. We used an in vitro approach to begin identifying some of the mechanisms that could explain NECL4 function. Using mass spectrometry and Western blotting techniques, we have identified choline transporter-like 1 (CTL1) as a putative complexing partner with NECL4. We show that intracellular choline levels are significantly elevated in NECL4-deficient Schwann cells. The analysis of extracellular d(9)-choline uptake revealed a deficit in the amount of d(9)-choline found inside NECL4-deficient Schwann cells, suggestive of either reduced transport capabilities or increased metabolization of transported choline. An extensive lipidomic screen of choline derivatives showed that total phosphatidylcholine and phosphatidylinositol (but not diacylglycerol or sphingomyelin) are significantly elevated in NECL4deficient Schwann cells, particularly specific subspecies of phosphatidylcholine carrying very long polyunsaturated fatty acid chains. Finally, CTL1-deficient Schwann cells are significantly impaired in their ability to myelinate neurites in vitro. To our knowledge, this is the first demonstration of a bona fide cell adhesion molecule, NECL4, regulating choline homeostasis and lipid biogenesis. Phosphatidylcholines are major myelin phospholipids, and several phosphorylated phosphatidylinositol species are known to regulate key aspects of peripheral myelination. Furthermore, the biophysical properties imparted to plasma membranes are regulated by fatty acid chain profiles. Therefore, it will be important to translate these in vitro observations to in vivo studies of NECL4 and CTL1-deficient mice.	[Heffernan, Corey; Kim, Hyosung; Barretto, Kevin; Maurel, Patrice] Rutgers State Univ, Dept Biol Sci, Boyden Hall,Rm 206,195 Univ Ave, Newark, NJ 07102 USA; [Jain, Mohit R.; Liu, Tong; Li, Hong] Univ Med & Dent New Jersey, Ctr Adv Prote Res, Newark, NJ 07103 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Maurel, P (corresponding author), Rutgers State Univ, Dept Biol Sci, Boyden Hall,Rm 206,195 Univ Ave, Newark, NJ 07102 USA.	maurep01@andromeda.rutgers.edu	Maurel, Patrice/E-9559-2017	Li, Hong/0000-0001-5731-5335	National Institutes of Health from NINDS [P30 NS046593]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS046593, R21NS090305, R01NS065218] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Haesun Kim for helpful discussion. We thank Dr. Baichen Zhang at LipoSpectrum Inc. for lipidomic mass spectrometry and Drs. Haiyan Zheng and Caifeng Zhao (Rutgers University) for help with MALDI-TOF mass spectrometry. Operation of the Center for Advanced Proteomics was supported by National Institutes of Health Grant P30 NS046593 from NINDS (to H. L.).	Apparsundaram S, 2000, BIOCHEM BIOPH RES CO, V276, P862, DOI 10.1006/bbrc.2000.3561; Athenstaedt K, 1999, EUR J BIOCHEM, V266, P1, DOI 10.1046/j.1432-1327.1999.00822.x; Baykal AT, 2008, METABOLOMICS, V4, P347, DOI 10.1007/s11306-008-0125-3; Bazalakova MH, 2006, HANDB EXP PHARM, V175, P525; Berger P, 2011, J CELL MOL MED, V15, P307, DOI 10.1111/j.1582-4934.2009.00967.x; BLUSZTAJN JK, 1985, BIOCHEM J, V232, P505, DOI 10.1042/bj2320505; Bolis A, 2005, J NEUROSCI, V25, P8567, DOI 10.1523/JNEUROSCI.2493-05.2005; BREMER J, 1961, BIOCHIM BIOPHYS ACTA, V46, P205, DOI 10.1016/0006-3002(61)90745-4; BUNGE RP, 1989, J CELL BIOL, V109, P273, DOI 10.1083/jcb.109.1.273; Campagnoni A.T., 2004, MYELIN BIOL DISORDER, P387, DOI DOI 10.1016/B978-012439510-7/50068-1; Clarke CJ, 2006, BBA-BIOMEMBRANES, V1758, P1893, DOI 10.1016/j.bbamem.2006.06.025; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; Cotter L, 2010, SCIENCE, V328, P1415, DOI 10.1126/science.1187735; Craig R, 2003, RAPID COMMUN MASS SP, V17, P2310, DOI 10.1002/rcm.1198; Cui Z, 1996, J BIOL CHEM, V271, P2839, DOI 10.1074/jbc.271.5.2839; Dangata YY, 1996, J ANAT, V189, P117; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Estrada V, 2006, METABOLISM, V55, P940, DOI 10.1016/j.metabol.2006.02.024; Fitzner D, 2006, EMBO J, V25, P5037, DOI 10.1038/sj.emboj.7601376; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Fujita E, 2007, AM J PATHOL, V171, P1800, DOI 10.2353/ajpath.2007.070261; Goebbels S, 2012, EMBO MOL MED, V4, P486, DOI 10.1002/emmm.201200227; Golan N, 2013, J NEUROSCI, V33, P10950, DOI 10.1523/JNEUROSCI.0571-13.2013; GOULD RM, 1977, J CELL BIOL, V75, P326, DOI 10.1083/jcb.75.2.326; Ho C S, 2003, Clin Biochem Rev, V24, P3; Hudson L. D., 2004, MYELIN BIOL DISORDER; Jang WH, 2014, BIOSCI BIOTECH BIOCH, V78, P644, DOI 10.1080/09168451.2014.890031; Kakunaga S, 2005, J CELL SCI, V118, P1267, DOI 10.1242/jcs.01656; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kim HA, 2010, SPRINGER PROTOC HAND, P253, DOI 10.1007/978-1-60761-292-6_15; Kim T, 1999, J NEUROCYTOL, V28, P281, DOI 10.1023/A:1007001427597; Kirschner D. A., 2004, MYELIN BIOL DISORDER, V1, P523; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; LASSEGUE B, 1993, BIOCHEM J, V292, P509, DOI 10.1042/bj2920509; MACALA LJ, 1983, J LIPID RES, V24, P1243; Maurel P, 2007, J CELL BIOL, V178, P861, DOI 10.1083/jcb.200705132; McGrath C, 2016, CLIN ANAT, V29, P547, DOI 10.1002/ca.22653; Meunier FM, 2002, NEUROREPORT, V13, P1617, DOI 10.1097/00001756-200209160-00009; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Musse AA, 2008, BIOCHEMISTRY-US, V47, P10372, DOI 10.1021/bi801302b; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Nawaz S, 2009, J NEUROSCI, V29, P4794, DOI 10.1523/JNEUROSCI.3955-08.2009; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; O'Regan S, 2000, P NATL ACAD SCI USA, V97, P1835, DOI 10.1073/pnas.030339697; OWENS GC, 1990, GLIA, V3, P118, DOI 10.1002/glia.440030205; Pertusa M, 2007, J BIOL CHEM, V282, P28768, DOI 10.1074/jbc.M701878200; RIDGWAY ND, 1988, J BIOL CHEM, V263, P16856; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; Simons M, 2000, J CELL BIOL, V151, P143, DOI 10.1083/jcb.151.1.143; Smith AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016206; Spiegel I, 2007, NAT NEUROSCI, V10, P861, DOI 10.1038/nn1915; Stahelin RV, 2014, CHEM PHYS LIPIDS, V182, P3, DOI 10.1016/j.chemphyslip.2014.02.002; STURROCK RR, 1980, NEUROPATH APPL NEURO, V6, P415, DOI 10.1111/j.1365-2990.1980.tb00219.x; Szule JA, 2002, BIOPHYS J, V83, P977, DOI 10.1016/S0006-3495(02)75223-5; Tafesse FG, 2006, J BIOL CHEM, V281, P29421, DOI 10.1074/jbc.R600021200; Talbot WA, 1997, BIOCHEMISTRY-US, V36, P5827, DOI 10.1021/bi962437i; TANFORD C, 1978, SCIENCE, V200, P1012, DOI 10.1126/science.653353; TASHIRO S-I, 1983, Tohoku Journal of Experimental Medicine, V141, P485; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Traiffort E, 2005, J NEUROCHEM, V92, P1116, DOI 10.1111/j.1471-4159.2004.02962.x; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vaccari I, 2015, HUM MOL GENET, V24, P383, DOI 10.1093/hmg/ddu451; VAN HELVOORT A, 1994, J BIOL CHEM, V269, P1763; Vance DE, 2014, BBA-BIOMEMBRANES, V1838, P1477, DOI 10.1016/j.bbamem.2013.10.018; Verheijen MHG, 2009, P NATL ACAD SCI USA, V106, P21383, DOI 10.1073/pnas.0905633106; Verkade P, 1997, HISTOCHEM CELL BIOL, V108, P211, DOI 10.1007/s004180050161; WEBSTER HD, 1971, J CELL BIOL, V48, P348, DOI 10.1083/jcb.48.2.348; Yageta M, 2002, CANCER RES, V62, P5129; Yuan ZF, 2006, PHYSIOL GENOMICS, V26, P76, DOI 10.1152/physiolgenomics.00107.2005; Zacchetti D, 1995, FEBS LETT, V377, P465, DOI 10.1016/0014-5793(95)01396-2; Zhou Y, 2005, BBA-BIOMEMBRANES, V1669, P142, DOI 10.1016/j.bbamem.2005.01.013	74	9	10	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4484	4498		10.1074/jbc.M116.747816	http://dx.doi.org/10.1074/jbc.M116.747816			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28119456	Green Published, hybrid			2022-12-26	WOS:000397585100009
J	Castellanos, LR; Donado-Godoy, P; Leon, M; Clavijo, V; Arevalo, A; Bernal, JF; Timmerman, AJ; Mevius, DJ; Wagenaar, JA; Hordijk, J				Castellanos, Luis Ricardo; Donado-Godoy, Pilar; Leon, Maribel; Clavijo, Viviana; Arevalo, Alejandra; Bernal, Johan F.; Timmerman, Arjen J.; Mevius, Dik J.; Wagenaar, Jaap A.; Hordijk, Joost			High Heterogeneity of Escherichia coli Sequence Types Harbouring ESBL/AmpC Genes on IncI1 Plasmids in the Colombian Poultry Chain	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; URINARY-TRACT-INFECTIONS; FOOD-PRODUCING ANIMALS; EXTENDED-SPECTRUM; ANTIMICROBIAL RESISTANCE; KLEBSIELLA-PNEUMONIAE; SALMONELLA-ENTERICA; CTX-M; BROILER FARMS; CHICKEN MEAT	Background Escherichia coli producing ESBL/AmpC enzymes are unwanted in animal production chains as they may pose a risk to human and animal health. Molecular characterization of plasmids and strains carrying genes that encode these enzymes is essential to understand their local and global spread. Objectives To investigate the diversity of genes, plasmids and strains in ESBL/AmpC-producing E. coli from the Colombian poultry chain isolated within the Colombian Integrated Program for Antimicrobial Resistance Surveillance (Coipars). Methods A total of 541 non-clinical E. coli strains from epidemiologically independent samples and randomly isolated between 2008 and 2013 within the Coipars program were tested for antimicrobial susceptibility. Poultry isolates resistant to cefotaxime (MIC >= 4 mg/L) were screened for ESBL/AmpC genes including bla(CTX-M), bla(SHV), bla(TEM), bla(CMY) and bla(OXA). Plasmid and strain characterization was performed for a selection of the ESBL/AmpC-producing isolates. Plasmids were purified and transformed into E. coli DH10B cells or transferred by conjugation to E. coli W3110. When applicable, PCR Based Replicon Typing (PBRT), plasmid Multi Locus Sequence Typing (pMLST), plasmid Double Locus Sequence Typing (pDLST) and/or plasmid Replicon Sequence Typing (pRST) was performed on resulting transformants and conjugants. Multi Locus Sequence Typing (MLST) was used for strain characterization. Results In total, 132 of 541 isolates were resistant to cefotaxime and 122 were found to carry ESBL/AmpC genes. Ninety-two harboured bla(CMY-2) (75%), fourteen bla(SHV-12) (11%), three bla(SHV-5) (2%), five bla(CTX-M-2) (4%), one bla(CTX-M-15) (1%), one bla(CTX-M-8) (1%), four a combination of bla(CMY-2) and bla(SHV-12) (4%) and two a combination of bla(CMY-2) and bla(SHV-5) (2%). A selection of 39 ESBL/AmpC-producing isolates was characterized at the plasmid and strain level. ESBL/AmpC genes from 36 isolates were transferable by transformation or conjugation of which 22 were located on IncI1 plasmids. These IncI1 plasmids harboured predominantly blaCMY-2 (16/22), and to a lesser extend bla(SHV-12) (5/22) and bla(CTX-M-8) (1/22). Other plasmid families associated with ESBL/AmpC-genes were IncK (4/33), IncHI2 (3/33), IncA/C (2/33), Inc./O (1/33) and a non-typeable replicon (1/33). Subtyping of IncI1 and IncHI2 demonstrated IncI1/ST12 was predominantly associated with bla(CMY-2) (12/16) and IncHI2/ST7 with bla(CTX-M-2) (2/3). Finally, 31 different STs were detected among the 39 selected isolates. Conclusions Resistance to extended spectrum cephalosporins in E. coli from Colombian poultry is mainly caused by bla(CMY-2) and bla(SHV-12). The high diversity of strain Sequence Types and the dissemination of homogeneous IncI1/ST12 plasmids suggest that spread of the resistance is mainly mediated by horizontal gene transfer.	[Castellanos, Luis Ricardo; Timmerman, Arjen J.; Mevius, Dik J.; Wagenaar, Jaap A.; Hordijk, Joost] Univ Utrecht, Dept Infect Dis & Immunol, Fac Vet Med, Utrecht, Netherlands; [Castellanos, Luis Ricardo; Donado-Godoy, Pilar; Clavijo, Viviana; Arevalo, Alejandra; Bernal, Johan F.] Corp Colombiana Invest Agr Corp, Colombian Integrated Program Antimicrobial Resist, Cundinamarca, Colombia; [Leon, Maribel] ICA, Bogota, Colombia; [Clavijo, Viviana] Univ Los Andes, Dept Biol Sci, Bogota, Colombia; [Mevius, Dik J.; Wagenaar, Jaap A.] Wageningen Biovet Res, Wageningen, Netherlands	Utrecht University; Corporacion Colombiana de Investigacion Agropecuaria, AGROSAVIA; Universidad de los Andes (Colombia); Wageningen University & Research	Hordijk, J (corresponding author), Univ Utrecht, Dept Infect Dis & Immunol, Fac Vet Med, Utrecht, Netherlands.	j.hordijk@uu.nl		Clavijo, Viviana/0000-0003-1442-9791; Castellanos, Luis Ricardo/0000-0003-3580-2719				Aarestrup FM, 2010, MICROB DRUG RESIST, V16, P253, DOI 10.1089/mdr.2010.0036; Abreu R, 2014, FOODBORNE PATHOG DIS, V11, P868, DOI 10.1089/fpd.2014.1796; Agerso Y, 2014, FOODBORNE PATHOG DIS, V11, P740, DOI 10.1089/fpd.2014.1742; Botelho LAB, 2015, MEM I OSWALDO CRUZ, V110, P249, DOI 10.1590/0074-02760140389; Ben Sallem R, 2014, MICROB DRUG RESIST, V20, P495, DOI 10.1089/mdr.2013.0224; Blanco VM, 2016, ENFERM INFECC MICROB; Borjesson S, 2013, CLIN MICROBIOL INFEC, V19, pE309, DOI 10.1111/1469-0691.12192; Braun SD, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01020; Canadian Integrated program for Antimicrobial Resistance Surveillance (CIPARS), 2008, ANN REPORT; CLSI, 2013, PERFORMANCE STANDARD; Correia S, 2012, DIAGN MICR INFEC DIS, V74, P423, DOI 10.1016/j.diagmicrobio.2012.08.017; Dahmen S, 2013, J ANTIMICROB CHEMOTH, V68, P2797, DOI 10.1093/jac/dkt291; de Been M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004776; Dierikx CM, 2012, J ANTIMICROB CHEMOTH, V67, P1368, DOI 10.1093/jac/dks049; Dierikx C, 2013, J ANTIMICROB CHEMOTH, V68, P60, DOI 10.1093/jac/dks349; Dierikx C, 2010, VET MICROBIOL, V145, P273, DOI 10.1016/j.vetmic.2010.03.019; Dierikx CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079005; Doi Y, 2010, CLIN MICROBIOL INFEC, V16, P33, DOI 10.1111/j.1469-0691.2009.03001.x; Donado-Godoy P, 2015, ZOONOSES PUBLIC HLTH, V62, P58, DOI 10.1111/zph.12192; Donado-Godoy P, 2012, J FOOD PROTECT, V75, P874, DOI 10.4315/0362-028X.JFP-11-458; El-Jade MR, 2016, PLOS ONE, P1; Ellis C, 2013, DIAGN MICR INFEC DIS, V76, P399, DOI 10.1016/j.diagmicrobio.2013.04.017; Espinal P, 2010, J CHEMOTHERAPY, V22, P160, DOI 10.1179/joc.2010.22.3.160; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Fadlelmula A, 2016, TROP ANIM HEALTH PRO, V48, P427, DOI 10.1007/s11250-015-0970-9; Ferreira JC, 2014, CLIN MICROBIOL INFEC, V20, pO623, DOI 10.1111/1469-0691.12531; Ferreira JC, 2016, DIAGN MICROBIOL INFE; Ferreira JC, 2014, DIAGN MICR INFEC DIS, V80, P304, DOI 10.1016/j.diagmicrobio.2014.09.012; Garcia-Fernandez A, 2008, J ANTIMICROB CHEMOTH, V61, P1229, DOI 10.1093/jac/dkn131; Garcia-Fernandez A, 2010, J ANTIMICROB CHEMOTH, V65, P1155, DOI 10.1093/jac/dkq101; Glenn LM, 2012, MICROB DRUG RESIST, V18, P453, DOI 10.1089/mdr.2011.0224; Guo YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102718; Hasman H, 2005, J ANTIMICROB CHEMOTH, V56, P115, DOI 10.1093/jac/dki190; Hordijk J, 2013, J ANTIMICROB CHEMOTH, V68, P2468, DOI 10.1093/jac/dkt219; Huijbers PMC, 2014, J ANTIMICROB CHEMOTH, V69, P2669, DOI 10.1093/jac/dku178; Jacoby GA, 1996, J CLIN MICROBIOL, V34, P908, DOI 10.1128/JCM.34.4.908-911.1996; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Jean SS, 2014, INT J ANTIMICROB AG, V44, P222, DOI 10.1016/j.ijantimicag.2014.05.018; Kluytmans JAJW, 2013, CLIN INFECT DIS, V56, P478, DOI 10.1093/cid/cis929; Koga VL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/618752; Koga VL, 2015, FOODBORNE PATHOG DIS, V12, P479, DOI 10.1089/fpd.2014.1888; Lazarus B, 2015, CLIN INFECT DIS, V60, P439, DOI 10.1093/cid/ciu785; Leistner R, 2014, INFECTION, V42; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Leverstein-van Hall MA, 2002, J CLIN MICROBIOL, V40, P3703, DOI 10.1128/JCM.40.10.3703-3711.2002; Leverstein-van Hall MA, 2013, J ANTIMICROB CHEMOTH, V68, P2636, DOI 10.1093/jac/dkt218; Leal AL, 2013, ENFERM INFEC MICR CL, V31, P298, DOI 10.1016/j.eimc.2012.04.007; MacVane SH, 2014, J HOSP MED, V9, P232, DOI 10.1002/jhm.2157; Martinez P, 2012, BRAZ J INFECT DIS, V16, P420, DOI 10.1016/j.bjid.2012.05.001; Meunier D, 2006, INT J ANTIMICROB AG, V28, P402, DOI 10.1016/j.ijantimicag.2006.08.016; Mollenkopf DF, 2014, FOODBORNE PATHOG DIS, V11, P920, DOI 10.1089/fpd.2014.1808; Nilsson O, 2014, J ANTIMICROB CHEMOTH, V69, P1497, DOI 10.1093/jac/dku030; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Park YS, 2012, EMERG INFECT DIS, V18, P515, DOI 10.3201/eid1803.111434; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P4914, DOI 10.1128/AAC.00878-10; Potron A, 2013, EUROSURVEILLANCE, V18, P9, DOI 10.2807/1560-7917.ES2013.18.31.20549; Ruiz SJ, 2011, J CLIN MICROBIOL, V49, P1993, DOI 10.1128/JCM.00045-11; Sheikh AA, 2012, FOODBORNE PATHOG DIS, V9, P625, DOI 10.1089/fpd.2011.1078; Smith H, 2015, ANTIMICROB AGENTS CH, V59, P5357, DOI 10.1128/AAC.05006-14; Teshager T, 2000, ANTIMICROB AGENTS CH, V44, P3483, DOI 10.1128/AAC.44.12.3483-3484.2000; Thomson KS, 2007, J CLIN MICROBIOL, V45, P2380, DOI 10.1128/JCM.00776-07; Villa L, 2010, J ANTIMICROB CHEMOTH, V65, P2518, DOI 10.1093/jac/dkq347; Villegas MV, 2004, DIAGN MICR INFEC DIS, V49, P217, DOI 10.1016/j.diagmicrobio.2004.03.001; Voets GM, 2013, INT J FOOD MICROBIOL, V167, P359, DOI 10.1016/j.ijfoodmicro.2013.10.001; Vogt D, 2014, MICROB DRUG RESIST, V20, P485, DOI 10.1089/mdr.2013.0210; Wang J, 2014, J ANTIMICROB CHEMOTH, V69, P2658, DOI 10.1093/jac/dku206; Winstanley T, 2011, CLIN MICROBIOL REV, V24, P515, DOI 10.1128/CMR.00061-10; Zhao S, 2012, APPL ENVIRON MICROB, V78, P1701, DOI 10.1128/AEM.07522-11; Zurfluh K, 2015, APPL ENVIRON MICROB, V81, P3115, DOI 10.1128/AEM.00258-15	69	48	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170777	10.1371/journal.pone.0170777	http://dx.doi.org/10.1371/journal.pone.0170777			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125687	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100054
J	Jeffery, ND; Barker, AK; Alcott, CJ; Levine, JM; Meren, I; Wengert, J; Jergens, AE; Suchodolski, JS				Jeffery, Nick D.; Barker, Andrew K.; Alcott, Cody J.; Levine, Jon M.; Meren, Ilyssa; Wengert, Jane; Jergens, Albert E.; Suchodolski, Jan S.			The Association of Specific Constituents of the Fecal Microbiota with Immune-Mediated Brain Disease in Dogs	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GUT MICROBIOTA; NECROTIZING MENINGOENCEPHALITIS; MULTIPLE-SCLEROSIS; GRANULOMATOUS MENINGOENCEPHALOMYELITIS; VITAMIN-D; RISK; OPPORTUNITY; POPULATION; INDUCTION	Meningoencephalomyelitis of unknown origin (MUO) is a common, naturally-occurring, clinical disease of pet dogs. It is an immune-mediated condition that has many similarities with experimental autoimmune encephalitis (EAE) in rodents and so investigation of its pathogenesis may aid in understanding factors that contribute to development of multiple sclerosis in people. Gut microbiota are known to modulate immune responses that influence susceptibility to immune-mediated brain disease. In this study we aimed to compare abundance of specific constituents of the fecal microbiota, namely Faecalibacterium prausnitzii and Prevotellaceae, between dogs diagnosed with MUO and matched controls. Fecal samples were obtained from 20 dogs diagnosed with MUO and 20 control dogs matched for breed, age and gender. Bacterial abundance was measured using qPCR and 16S rRNA sequencing. We found that Prevotellaceae were significantly less abundant in cases compared with controls (p = 0.003) but there was no difference in abundance of F. prausnitzii. There was no evidence of other differences in gut microbiota between groups. These data, derived from this naturally-occurring canine clinical model, provide strong corroborative evidence that high abundance of Prevotellaceae in the gut is associated with reduced risk for developing immune-mediated brain disease.	[Jeffery, Nick D.; Barker, Andrew K.; Alcott, Cody J.; Meren, Ilyssa; Wengert, Jane; Jergens, Albert E.] Iowa State Univ, Coll Vet Med, Dept Vet Clin Studies, Ames, IA 50011 USA; [Jeffery, Nick D.; Levine, Jon M.; Suchodolski, Jan S.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, College Stn, TX 77843 USA; [Barker, Andrew K.] Toronto Vet Emergency Hosp, Scarborough, ON, Canada; [Alcott, Cody J.] Vet Specialty Ctr Tucson, Tucson, AZ USA	Iowa State University; Texas A&M University System; Texas A&M University College Station	Jeffery, ND (corresponding author), Iowa State Univ, Coll Vet Med, Dept Vet Clin Studies, Ames, IA 50011 USA.; Jeffery, ND (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, College Stn, TX 77843 USA.	njeffery@cvm.tamu.edu	Fiumefreddo, Andrea/T-2977-2019; Alcott, Cody/N-4006-2019	Alcott, Cody/0000-0002-5782-8533; Jeffery, Nick/0000-0002-9812-1788	American Kennel Club [01731]	American Kennel Club	This study was sponsored by the American Kennel Club, grant #01731, awarded to NDJ, JS and AJ. http://www.akcchf.org/research/? referrer=https://www.google.com/. The sponsor provided the funding based on a grant proposal designed by the applicants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Ascherio A, 2010, LANCET NEUROL, V9, P599, DOI 10.1016/S1474-4422(10)70086-7; Barber RM, 2012, J VET INTERN MED, V26, P962, DOI 10.1111/j.1939-1676.2012.00954.x; Barber RM, 2011, J HERED, V102, pS40, DOI 10.1093/jhered/esr048; Barragan-Martinez C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051506; Bell ET, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108729; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Buscarinu MC, 2016, MULT SCLER; Cantarel BL, 2015, J INVEST MED, V63, P729, DOI 10.1097/JIM.0000000000000192; Coates JR, 2014, VET CLIN N AM-SMALL, V44, P1157, DOI 10.1016/j.cvsm.2014.07.009; Confavreux C, 2001, NEW ENGL J MED, V344, P319, DOI 10.1056/NEJM200102013440501; Constantinescu CS, 2011, BRIT J PHARMACOL, V164, P1079, DOI 10.1111/j.1476-5381.2011.01302.x; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Galland L, 2014, J MED FOOD, V17, P1261, DOI 10.1089/jmf.2014.7000; Granger N, 2010, VET J, V184, P290, DOI 10.1016/j.tvjl.2009.03.031; Greer KA, 2009, RES VET SCI, V86, P438, DOI 10.1016/j.rvsc.2008.10.002; Grimes DA, 2005, LANCET, V365, P1429, DOI 10.1016/S0140-6736(05)66379-9; Hansen AK, 2014, WORLD J GASTROENTERO, V20, P17727, DOI 10.3748/wjg.v20.i47.17727; Holodniy M, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014764, 10.1371/journal.pone.0025792]; HOW KL, 1994, GEN COMP ENDOCR, V96, P12, DOI 10.1006/gcen.1994.1154; Jeffery ND, 2006, SPINAL CORD, V44, P584, DOI 10.1038/sj.sc.3101912; Jun SM, 2005, J IMMUNOL, V175, P6733, DOI 10.4049/jimmunol.175.10.6733; Knapp DW, 1997, MOL MED TODAY, V3, P8, DOI 10.1016/S1357-4310(96)20031-0; Kwon HK, 2013, CLIN IMMUNOL, V146, P217, DOI 10.1016/j.clim.2013.01.001; Langer-Gould A, 2014, JAMA NEUROL, V71, P1506, DOI 10.1001/jamaneurol.2014.2633; Lassmann H, 2016, ACTA NEUROPATHOL; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Levine JM, 2011, J NEUROTRAUM, V28, P675, DOI 10.1089/neu.2010.1645; Malli C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124064; Mellanby RJ, 2013, VET J, V196, P92, DOI 10.1016/j.tvjl.2012.08.009; Miyake S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137429; Nouri M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106335; Ochoa-Reparaz J, 2010, GUT MICROBES, V1, P103, DOI 10.4161/gmic.1.2.11515; Park ES, 2012, VET PATHOL, V49, P682, DOI 10.1177/0300985811429311; Robinson AP, 2014, HAND CLINIC, V122, P173, DOI 10.1016/B978-0-444-52001-2.00008-X; Rogers MAM, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.10.003; Safra N, 2011, VET J, V189, P220, DOI 10.1016/j.tvjl.2011.06.023; Scheperjans F, 2015, MOVEMENT DISORD, V30, P350, DOI 10.1002/mds.26069; Schrauwen I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112755; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Talarico LR, 2010, J SMALL ANIM PRACT, V51, P138, DOI 10.1111/j.1748-5827.2009.00823.x; Tipold A, 2012, INFECT DIS DOG CAT, P856; Velasquez-Manoff M, 2015, NATURE, V518, pS3, DOI 10.1038/518S3a	43	19	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170589	10.1371/journal.pone.0170589	http://dx.doi.org/10.1371/journal.pone.0170589			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125651	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100091
J	Kolumam, G; Wu, XM; Lee, WP; Hackney, JA; Zavala-Solorio, J; Gandham, V; Danilenko, DM; Arora, P; Wang, XT; Ouyang, WJ				Kolumam, Ganesh; Wu, Xiumin; Lee, Wyne P.; Hackney, Jason A.; Zavala-Solorio, Jose; Gandham, Vineela; Danilenko, Dimitry M.; Arora, Puneet; Wang, Xiaoting; Ouyang, Wenjun			IL-22R Ligands IL-20, IL-22, and IL-24 Promote Wound Healing in Diabetic db/db Mice	PLOS ONE			English	Article							HOST-DEFENSE; FOOT ULCERS; CYTOKINES; EXPRESSION; SKIN; DIFFERENTIATION; KERATINOCYTES; HOMEOSTASIS; PSORIASIS; SUBFAMILY	Diabetic foot ulcers (DFU) are one of the major complications in type II diabetes patients and can result in amputation and morbidity. Although multiple approaches are used clinically to help wound closure, many patients still lack adequate treatment. Here we show that IL-20 subfamily cytokines are upregulated during normal wound healing. While there is a redundant role for each individual cytokine in this subfamily in wound healing, mice deficient in IL22R, the common receptor chain for IL-20, IL-22, and IL-24, display a significant delay in wound healing. Furthermore, IL-20, IL-22 and IL-24 are all able to promote wound healing in type II diabetic db/db mice. Mechanistically, when compared to other growth factors such as VEGF and PDGF that accelerate wound healing in this model, IL-22 uniquely induced genes involved in reepithelialization, tissue remodeling and innate host defense mechanisms from wounded skin. Interestingly, IL-22 treatment showed superior efficacy compared to PDGF or VEGF in an infectious diabetic wound model. Taken together, our data suggest that IL-20 subfamily cytokines, particularly IL-20, IL-22, and IL-24, might provide therapeutic benefit for patients with DFU.	[Kolumam, Ganesh; Gandham, Vineela] Genentech Inc, Dept Biomed Imaging, San Francisco, CA USA; [Wu, Xiumin; Lee, Wyne P.; Wang, Xiaoting; Ouyang, Wenjun] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Hackney, Jason A.] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA USA; [Zavala-Solorio, Jose] Genentech Inc, Dept Mol Biol, San Francisco, CA USA; [Danilenko, Dimitry M.] Genentech Inc, Dept Safety Assessment Pathol, San Francisco, CA USA; [Arora, Puneet] Genentech Inc, Dept Early Clin Dev, San Francisco, CA USA; [Kolumam, Ganesh] Calico, Dept Res, San Francisco, CA USA; [Wang, Xiaoting] Amgen Inc, Dept Comparat Biol & Safety Sci, San Francisco, CA 94080 USA; [Ouyang, Wenjun] Amgen Inc, Dept Inflammat & Oncol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Amgen; Amgen	Wang, XT; Ouyang, WJ (corresponding author), Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA.; Wang, XT (corresponding author), Amgen Inc, Dept Comparat Biol & Safety Sci, San Francisco, CA 94080 USA.; Ouyang, WJ (corresponding author), Amgen Inc, Dept Inflammat & Oncol, San Francisco, CA 94080 USA.	xiaoting@amgen.com; wouyang@amgen.com	Ouyang, Wenjun/ABA-8763-2020	Hackney, Jason/0000-0002-5922-563X; Ouyang, Wenjun/0000-0002-1811-5864; Danilenko, Dimitry/0000-0002-8326-1921	Genentech	Genentech(Roche HoldingGenentech)	Other than all the authors, Genentech had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received support in the form of salaries. Genentech has reviewed the manuscript, and may potentially file patents and develop therapies based on part of the data in the manuscript.	Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Avitabile S, 2015, J INVESTIGATIVE DERM; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Cavanagh PR, 2005, LANCET, V366, P1725, DOI 10.1016/S0140-6736(05)67699-4; Devalaraja RM, 2000, J INVEST DERMATOL, V115, P234, DOI 10.1046/j.1523-1747.2000.00034.x; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Dumoutier L, 2001, J IMMUNOLOGY, V167; Dworkin S, 2011, ORGANOGENESIS, V7, P202, DOI 10.4161/org.7.3.18431; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fang RC, 2008, BIOL-TARGETS THER, V2, P1; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; GREENHALGH DG, 1990, AM J PATHOL, V136, P1235; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jeffcoate WJ, 2003, LANCET, V361, P1545, DOI 10.1016/S0140-6736(03)13169-8; Kavitha KV, 2014, WORLD J DIABETES, V5, P546, DOI 10.4239/wjd.v5.i4.546; Kishibe M, 2012, J INVEST DERMATOL, V132, P1717, DOI 10.1038/jid.2012.18; LeGrand EK, 1998, AM J SURG, V176, p48S, DOI 10.1016/S0002-9610(98)00177-9; Leung PC, 2007, SURG-J R COLL SURG E, V5, P219, DOI 10.1016/S1479-666X(07)80007-2; [黎继子 LI Jizi], 2007, [系统工程, Systems Engineering], V25, P25; Mcgee HM, 2013, J INVEST DERMATOL, V133, P1321, DOI 10.1038/jid.2012.463; Michaels J, 2007, WOUND REPAIR REGEN, V15, P665, DOI 10.1111/j.1524-475X.2007.00273.x; Monaco JL, 2003, CLIN PLAST SURG, V30, P1, DOI 10.1016/S0094-1298(02)00070-6; Novak JP, 2002, J BIOL CHEM, V277, P47517, DOI 10.1074/jbc.M205114200; Ota N, 2011, NAT IMMUNOL, V12, P941, DOI 10.1038/ni.2089; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Perera GK, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007217; Rutz S, 2014, NAT REV IMMUNOL, V14, P783, DOI 10.1038/nri3766; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Saaristo A, 2006, AM J PATHOL, V169, P1080, DOI 10.2353/ajpath.2006.051251; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Sun DP, 2013, CYTOKINE, V62, P360, DOI 10.1016/j.cyto.2013.03.017; Wang M, 2002, J BIOL CHEM, V277, P7341, DOI 10.1074/jbc.M106043200; Wang XT, 2014, NATURE, V514, P237, DOI 10.1038/nature13564; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Wong V, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/969618; Wu AL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002669; Xie MH, 2000, J BIOL CHEM, V275, P31335, DOI 10.1074/jbc.M005304200; Yazdanpanah L, 2015, WORLD J DIABETES, V6, P37, DOI 10.4239/wjd.v6.i1.37; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	50	39	44	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170639	10.1371/journal.pone.0170639	http://dx.doi.org/10.1371/journal.pone.0170639			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125663	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100083
J	Le Luherne, E; Le Pape, O; Murillo, L; Randon, M; Lebot, C; Reveillac, E				Le Luherne, Emilie; Le Pape, Olivier; Murillo, Laurence; Randon, Marine; Lebot, Clement; Reveillac, Elodie			Influence of Green Tides in Coastal Nursery Grounds on the Habitat Selection and Individual Performance of Juvenile Fish	PLOS ONE			English	Article							PLAICE PLEURONECTES-PLATESSA; BASS DICENTRARCHUS-LABRAX; SPRAT SPRATTUS-SPRATTUS; FOOD-WEB INTERACTIONS; SOLE SOLEA-SOLEA; OTOLITH MICROSTRUCTURE; MACROALGAL BLOOMS; SEA-BASS; SUBSTRATUM SELECTION; COMMUNITY STRUCTURE	Coastal ecosystems, which provide numerous essential ecological functions for fish, are threatened by the proliferation of green macroalgae that significantly modify habitat conditions in intertidal areas. Understanding the influence of green tides on the nursery function of these ecosystems is essential to determine their potential effects on fish recruitment success. In this study, the influence of green tides on juvenile fish was examined in an intertidal sandy beach area, the Bay of Saint-Brieuc (Northwestern France), during two annual cycles of green tides with varying levels of intensity. The responses of three nursery-dependent fish species, the pelagic Sprattus sprattus (L.), the demersal Dicentrarchus labrax (L.) and the benthic Pleuronectes platessa L., were analysed to determine the effects of green tides according to species-specific habitat niche and behaviour. The responses to this perturbation were investigated based on habitat selection and a comparison of individual performance between a control and an impacted site. Several indices on different integrative scales were examined to evaluate these responses (antioxidant defence capacity, muscle total lipid, morphometric condition and growth). Based on these analyses, green tides affect juvenile fish differently according to macroalgal density and species-specific tolerance, which is linked to their capacity to move and to their distribution in the water column. A decreasing gradient of sensitivity was observed from benthic to demersal and pelagic fish species. At low densities of green macroalgae, the three species stayed at the impacted site and the growth of plaice was reduced. At medium macroalgal densities, plaice disappeared from the impacted site and the growth of sea bass and the muscle total lipid content of sprat were reduced. Finally, when high macroalgal densities were reached, none of the studied species were captured at the impacted site. Hence, sites affected by green tides are less favourable nursery grounds for all the studied species, with species-specific effects related to macroalgal density.	[Le Luherne, Emilie; Le Pape, Olivier; Randon, Marine; Lebot, Clement; Reveillac, Elodie] INRA, Agrocampus Ouest, ESE, Ecol & Ecosyst Hlth, Rennes, France; [Murillo, Laurence] Univ La Rochelle, LIttoral ENvironm & Soc LIENSs, UMR CNRS 7266, Inst Littoral & Environm, 2 Rue Olympe Gouges, La Rochelle, France	INRAE; Institut Agro; Agrocampus Ouest; La Rochelle Universite	Le Luherne, E (corresponding author), INRA, Agrocampus Ouest, ESE, Ecol & Ecosyst Hlth, Rennes, France.	emilie.leluherne@agrocampus-ouest.fr	Gonse, Marine/GRO-2323-2022; Randon, Marine/AAG-5286-2021	Randon, Marine/0000-0002-5378-8482; Reveillac, Elodie/0000-0002-1121-638X; Le Pape, Olivier/0000-0002-7233-7951; MURILLO, Laurence/0000-0002-0934-4227	France Filiere Peche; Loire-Bretagne Water Agency; Normand-Breton Marine Natural Park Review Study Group (French agency for marine protected areas)	France Filiere Peche; Loire-Bretagne Water Agency; Normand-Breton Marine Natural Park Review Study Group (French agency for marine protected areas)	This work was supported by (all French) the fisheries organisation France Filiere Peche, the Loire-Bretagne Water Agency and the Normand-Breton Marine Natural Park Review Study Group (French agency for marine protected areas). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S. M., 2002, BIOL INDICATORS AQUA; Aguilera B, 2009, SCI MAR, V73, P173, DOI 10.3989/scimar.2009.73n1173; ALLIOT E, 1984, BIOCHEM SYST ECOL, V12, P209, DOI 10.1016/0305-1978(84)90038-3; Amara R, 2003, ENVIRON BIOL FISH, V67, P191, DOI 10.1023/A:1025646622066; [Anonymous], 2014, CONDITION HLTH INDIC; [Anonymous], 1992, CAN SPEC PUBL FISH A; Arts MJTJ, 2004, FOOD CHEM, V88, P567, DOI 10.1016/j.foodchem.2004.02.008; Barton BA, 2002, BIOLOGICAL INDICATORS OF AQUATIC ECOSYSTEM STRESS, P111; Baumann H, 2005, MAR FRESHWATER RES, V56, P539, DOI 10.1071/MF04140; Baumann H, 2006, FISH OCEANOGR, V15, P465, DOI 10.1111/j.1365-2419.2005.00395.x; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Buchheister A, 2010, CAN J FISH AQUAT SCI, V67, P445, DOI 10.1139/F09-196; Burrows MT, 2004, J FISH BIOL, V65, P620, DOI 10.1111/j.0022-1112.2004.00467.x; Campana SE, 2001, J FISH BIOL, V59, P197, DOI [10.1111/j.1095-8649.2001.tb00127.x, 10.1006/jfbi.2001.1668]; Carl JD, 2008, J FISH BIOL, V72, P2570, DOI 10.1111/j.1095-8649.2008.01866.x; Charlier Roger H., 2007, Environmental Research, Engineering and Management, V41, P52; Chouvelon T, 2014, J SEA RES, V85, P277, DOI 10.1016/j.seares.2013.05.011; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1977, SCIENCE, V197, P261, DOI 10.1126/science.327543; Deudero S, 2004, MAR BIOL, V145, P971, DOI 10.1007/s00227-004-1374-y; Elliott M., 1995, Netherlands Journal of Aquatic Ecology, V29, P397, DOI 10.1007/BF02084239; Engstrom-Ost J, 2006, J EXP MAR BIOL ECOL, V335, P227, DOI 10.1016/j.jembe.2006.03.007; FECHHELM RG, 1995, T AM FISH SOC, V124, P508, DOI 10.1577/1548-8659(1995)124<0508:IAICIT>2.3.CO;2; Fletcher RL., 1996, MARINE BENTHIC VEGET, P7, DOI [10.1007/978-3-642-61398-2_2, DOI 10.1007/978-3-642-61398-2_2]; GIBSON RN, 1994, NETH J SEA RES, V32, P191, DOI 10.1016/0077-7579(94)90040-X; Gilliers C, 2006, ESTUAR COAST SHELF S, V69, P96, DOI 10.1016/j.ecss.2006.02.006; Green BC, 2012, OECOLOGIA, V168, P245, DOI 10.1007/s00442-011-2077-y; Growth J., 1994, MAR BIOL, V119, P169; Guelinckx J, 2007, MAR ECOL PROG SER, V341, P205, DOI 10.3354/meps341205; Guelinckx J, 2006, ESTUAR COAST SHELF S, V66, P612, DOI 10.1016/j.ecss.2005.11.007; Gunther CC, 2012, CAN J FISH AQUAT SCI, V69, P1214, DOI 10.1139/F2012-054; HAINES EB, 1979, ECOLOGY, V60, P48, DOI 10.2307/1936467; HAKANSON JL, 1994, ICES J MAR SCI, V51, P147, DOI 10.1006/jmsc.1994.1016; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hansson S, 1997, ECOLOGY, V78, P2249, DOI 10.2307/2265961; Harder T, 2004, MAR ECOL PROG SER, V274, P133, DOI 10.3354/meps274133; HOVENKAMP F, 1990, MAR ECOL PROG SER, V58, P205; HULL SC, 1987, ESTUAR COAST SHELF S, V25, P519, DOI 10.1016/0272-7714(87)90112-0; ISAKSSON I, 1992, NETH J SEA RES, V30, P131, DOI 10.1016/0077-7579(92)90052-G; ISAKSSON I, 1994, J EXP MAR BIOL ECOL, V177, P203, DOI 10.1016/0022-0981(94)90237-2; JOHNSON DA, 1985, J EXP MAR BIOL ECOL, V86, P73, DOI 10.1016/0022-0981(85)90043-7; JOHNSTON IA, 1981, CELL TISSUE RES, V214, P369; Jokinen H, 2016, J SEA RES, V107, P67, DOI 10.1016/j.seares.2015.06.002; Jokinen H, 2015, J SEA RES, V105, P1, DOI 10.1016/j.seares.2015.08.001; Kamimura Y, 2013, ESTUAR COAST SHELF S, V129, P86, DOI 10.1016/j.ecss.2013.05.028; KARAKIRI M, 1989, MAR ECOL PROG SER, V55, P15, DOI 10.3354/meps055015; Kostecki C, 2010, J SEA RES, V64, P54, DOI 10.1016/j.seares.2009.07.006; Arroyo NL, 2012, J EXP MAR BIOL ECOL, V420, P77, DOI 10.1016/j.jembe.2012.03.020; Le Luherne E, 2016, ESTUAR COAST SHELF S, V175, P79, DOI 10.1016/j.ecss.2016.03.031; Le Pape O, 2016, J SEA RES, V107, P43, DOI 10.1016/j.seares.2015.06.001; Le Pape O, 2015, FISH FISH, V16, P373, DOI 10.1111/faf.12063; Leakey CDB, 2009, J SEA RES, V61, P268, DOI 10.1016/j.seares.2008.12.002; Little EE, 2002, BIOLOGICAL INDICATORS OF AQUATIC ECOSYSTEM STRESS, P431; Logan JM, 2008, J ANIM ECOL, V77, P838, DOI 10.1111/j.1365-2656.2008.01394.x; Lyons DA, 2014, GLOBAL CHANGE BIOL, V20, P2712, DOI 10.1111/gcb.12644; Madeira D, 2013, COMP BIOCHEM PHYS A, V166, P237, DOI 10.1016/j.cbpa.2013.06.008; Merceron M, 2007, SCI TOTAL ENVIRON, V384, P293, DOI 10.1016/j.scitotenv.2007.05.007; Modin J, 1996, ICES J MAR SCI, V53, P745, DOI 10.1006/jmsc.1996.0094; Neilan RM, 2014, J THEOR BIOL, V343, P54, DOI 10.1016/j.jtbi.2013.11.004; Nordstrom M, 2007, J SEA RES, V58, P335, DOI 10.1016/j.seares.2007.08.001; Peck MA, 2015, J EXP MAR BIOL ECOL, V471, P217, DOI 10.1016/j.jembe.2015.06.011; Perrot T, 2014, J MARINE SYST, V132, P38, DOI 10.1016/j.jmarsys.2013.12.010; PETERSEN JK, 1995, ENVIRON BIOL FISH, V43, P311, DOI 10.1007/BF00005864; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Pihl L, 2005, CAN J FISH AQUAT SCI, V62, P1184, DOI 10.1139/F05-023; Pihl L., 1995, Netherlands Journal of Aquatic Ecology, V29, P349, DOI 10.1007/BF02084234; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post JR, 2001, ECOLOGY, V82, P1040, DOI 10.1890/0012-9658(2001)082[1040:EASIYF]2.0.CO;2; Quillien N, 2016, J EXP MAR BIOL ECOL, V477, P92, DOI 10.1016/j.jembe.2016.01.010; Quillien N, 2015, MAR ECOL PROG SER, V522, P97, DOI 10.3354/meps11151; R Development Core Team, 2012, R LANG ENV STAT COMP; Raffaelli D, 2000, HELGOLAND MAR RES, V54, P71, DOI 10.1007/s101520050004; Raffaelli DG, 1998, OCEANOGR MAR BIOL<D>, V36, P97; Reglero P, 2007, MAR ECOL PROG SER, V330, P223, DOI 10.3354/meps330223; ROBERTSON AI, 1984, J EXP MAR BIOL ECOL, V84, P265, DOI 10.1016/0022-0981(84)90185-0; Rochette S, 2012, FISH OCEANOGR, V21, P229, DOI 10.1111/j.1365-2419.2012.00621.x; Seitz RD, 2014, ICES J MAR SCI, V71, P648, DOI 10.1093/icesjms/fst152; Selleslagh J, 2013, J MAR BIOL ASSOC UK, V93, P479, DOI 10.1017/S0025315412000483; SFRISO A, 1992, ESTUARIES, V15, P517, DOI 10.2307/1352394; Shields RJ., 1989, STUDIES GROWTH NUTR; Smetacek V, 2013, NATURE, V504, P84, DOI 10.1038/nature12860; SOGARD SM, 1991, ESTUAR COAST SHELF S, V33, P501, DOI 10.1016/0272-7714(91)90087-R; Solidoro C, 1997, ECOL MODEL, V102, P259, DOI 10.1016/S0304-3800(97)00060-4; Stoner AW, 2001, MAR ECOL PROG SER, V213, P253, DOI 10.3354/meps213253; Suzuki KW, 2005, CAN J FISH AQUAT SCI, V62, P671, DOI 10.1139/F04-231; Svensson E, 2014, J EXP MAR BIOL ECOL, V457, P173, DOI 10.1016/j.jembe.2014.04.014; Thillart G. V. D., 2002, FISH PHYSIOL BIOCHEM, V27, P189; Vasconcelos RP, 2014, ICES J MAR SCI, V71, P638, DOI 10.1093/icesjms/fst136; Vinagre C, 2008, ESTUAR COAST SHELF S, V76, P255, DOI 10.1016/j.ecss.2007.07.006; Vinagre C, 2014, MAR ENVIRON RES, V97, P10, DOI 10.1016/j.marenvres.2014.01.007; Wang C, 2011, CHIN J OCEANOL LIMN, V29, P541, DOI 10.1007/s00343-011-0126-3; WENNHAGE H, 1994, NETH J SEA RES, V32, P343, DOI 10.1016/0077-7579(94)90011-6; Wennhage H, 2007, MAR ECOL PROG SER, V335, P187, DOI 10.3354/meps335187; Wetzel MA, 2002, MAR BIOL, V141, P679, DOI 10.1007/s00227-002-0863-0; Ye NH, 2011, ECOL RES, V26, P477, DOI 10.1007/s11284-011-0821-8	97	15	16	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e170110	10.1371/journal.pone.0170110	http://dx.doi.org/10.1371/journal.pone.0170110			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125605	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100128
J	Luo, M; Zhang, X; Zhang, SC; Zhang, HP; Yang, W; Zhu, ZL; Chen, K; Bai, L; Wei, J; Huang, AL; Wang, DQ				Luo, Miao; Zhang, Xiang; Zhang, Shaocheng; Zhang, Hongpeng; Yang, Wei; Zhu, Zhongliang; Chen, Ke; Bai, Lei; Wei, Jie; Huang, Ailong; Wang, Deqiang			Crystal Structure of an Invasivity-Associated Domain of SdrE in S-aureus	PLOS ONE			English	Article							LIGAND-BINDING MECHANISM; SURFACE-PROTEINS; MSCRAMM; ADHERENCE; REVEAL	The surface protein SdrE, a microbial surface components recognizing adhesive matrix molecule (MSCRAMM) family protein expressed on the surface of Staphylococcus aureus (S. aureus), can recognize human complement regulator Factor H and C4BP, thus making it a potentially promising vaccine candidate. In this study, SdrE(278-591) was found to directly affect S. aureus host cell invasion. Additionally, the crystal structure of SdrE(278-591) at a resolution of 1.25 angstrom was established, with the three-dimensional structure revealing N2-N3 domains which fold in a manner similar to an IgG fold. Furthermore, a putative ligand binding site located at a conserved charged groove formed by the interface between N2 and N3 domains was identified, with beta 2 suspected to occupy the ligand recognizing site and undergo a structural rearrangement to allow ligand binding. Overall, these findings have further contributed to the understanding of SdrE as a key factor for S. aureus invasivity and will enable a better understanding of bacterial infection processes.	[Luo, Miao; Zhang, Xiang; Zhang, Hongpeng; Chen, Ke; Bai, Lei; Wei, Jie; Huang, Ailong; Wang, Deqiang] Chongqing Med Univ, Affiliated Hosp 2, Key Lab Mol Biol Infect Dis, Minist Educ,Inst Viral Hepatitis,Dept Infect Dis, Chongqing, Peoples R China; [Luo, Miao] Peoples Hosp YuBei Dist, Dept Lab Med, Chongqing, Peoples R China; [Zhang, Shaocheng; Wang, Deqiang] Chongqing Med Univ, Dept Lab Med, YixueYuanlu 1, Chongqing, Peoples R China; [Yang, Wei] Hosp Zhejiang, Dept Lab Med, Hangzhou, Zhejiang, Peoples R China; [Zhu, Zhongliang] Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wang, DQ (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Key Lab Mol Biol Infect Dis, Minist Educ,Inst Viral Hepatitis,Dept Infect Dis, Chongqing, Peoples R China.; Wang, DQ (corresponding author), Chongqing Med Univ, Dept Lab Med, YixueYuanlu 1, Chongqing, Peoples R China.	wangdq@cqmu.edu.cn	Shaocheng, Zhang/GXF-7437-2022; Yang, Wei/HIA-0360-2022; Yang, Wei/GWV-4107-2022		National Science and Technology Major Projects [2013ZX10002002-003-002]; Chinese National Natural Science Foundation [81301395]; Chongqing Natural Science Foundation [cstc2015jcyjA10003]	National Science and Technology Major Projects; Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chongqing Natural Science Foundation(Natural Science Foundation of Chongqing)	This research was supported by a grant (2013ZX10002002-003-002) from the National Science and Technology Major Projects, a grant (81301395) from the Chinese National Natural Science Foundation and a grant (cstc2015jcyjA10003) from the Chongqing Natural Science Foundation.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Barbu EM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000726; Bartlett John G, 2008, Top HIV Med, V16, P151; Becherelli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074718; Bowden MG, 2008, J BIOL CHEM, V283, P638, DOI 10.1074/jbc.M706252200; Corrigan RM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-22; Deivanayagam CCS, 2002, EMBO J, V21, P6660, DOI 10.1093/emboj/cdf619; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Hair Pamela S, 2013, Results Immunol, V3, P114, DOI 10.1016/j.rinim.2013.10.004; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jensen SO, 2009, FUTURE MICROBIOL, V4, P565, DOI 10.2217/FMB.09.30; Josefsson E, 1998, MICROBIOL-UK, V144, P3387, DOI 10.1099/00221287-144-12-3387; Kaplan SL, 2005, CLIN INFECT DIS, V40, P1785, DOI 10.1086/430312; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Sharp JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038407; Stranger-Jones YK, 2006, P NATL ACAD SCI USA, V103, P16942, DOI 10.1073/pnas.0606863103; Tenover FC, 2006, J CLIN MICROBIOL, V44, P108, DOI 10.1128/JCM.44.1.108-118.2006; Wang X, 2013, PROTEIN CELL, V4, P277, DOI 10.1007/s13238-013-3009-x; Yang Junshu, 2014, Methods Mol Biol, V1085, P187, DOI 10.1007/978-1-62703-664-1_11; Zhang XY, 2015, PROTEIN CELL, V6, P757, DOI 10.1007/s13238-015-0205-x	20	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0168814	10.1371/journal.pone.0168814	http://dx.doi.org/10.1371/journal.pone.0168814			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125581	Green Published, gold, Green Submitted			2022-12-26	WOS:000396176100148
J	Liu, PL; Wen, J; Duan, L; Arslan, E; Ertugrul, K; Chang, ZY				Liu, Pei-Liang; Wen, Jun; Duan, Lei; Arslan, Emine; Ertugrul, Kuddisi; Chang, Zhao-Yang			Hedysarum L. ( Fabaceae: Hedysareae) Is Not Monophyletic - Evidence from Phylogenetic Analyses Based on Five Nuclear and Five Plastid Sequences	PLOS ONE			English	Article							CHLOROPLAST CAPTURE; MOLECULAR SYSTEMATICS; NONCODING REGIONS; GENOME SEQUENCES; DNA-SEQUENCES; SPECIES TREES; GENE TREES; TRNL-F; UTILITY; CONCORDANCE	The legume family (Fabaceae) exhibits a high level of species diversity and evolutionary success worldwide. Previous phylogenetic studies of the genus Hedysarum L. (Fabaceae: Hedysareae) showed that the nuclear and the plastid topologies might be incongruent, and the systematic position of the Hedysarum sect. Stracheya clade was uncertain. In this study, phylogenetic relationships of Hedysarum were investigated based on the nuclear ITS, ETS, PGDH, SQD1, TRPT and the plastid psbA-trnH, trnC-petN, trnL-trnF, trnS-trnG, petN-psbM sequences. Both nuclear and plastid data support two major lineages in Hedysarum: the Hedysarum s. s. clade and the Sartoria clade. In the nuclear tree, Hedysarum is biphyletic with the Hedysarum s. s. clade sister to the Corethrodendron + Eversmannia + Greuteria + Onobrychis clade (the CEGO clade), whereas the Sartoria clade is sister to the genus Taverniera DC. In the plastid tree, Hedysarum is monophyletic and sister to Taverniera. The incongruent position of the Hedysarum s. s. clade between the nuclear and plastid trees may be best explained by a chloroplast capture hypothesis via introgression. The Hedysarum sect. Stracheya clade is resolved as sister to the H. sect. Hedysarum clade in both nuclear and plastid trees, and our analyses support merging Stracheya into Hedysarum. Based on our new evidence from multiple sequences, Hedysarum is not monophyletic, and its generic delimitation needs to be reconsidered.	[Liu, Pei-Liang; Chang, Zhao-Yang] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Wen, Jun] Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, Washington, DC 20560 USA; [Duan, Lei] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Arslan, Emine; Ertugrul, Kuddisi] Selcuk Univ, Fac Sci, Dept Biol, Konya, Turkey	Northwest A&F University - China; Smithsonian Institution; Smithsonian National Museum of Natural History; Chinese Academy of Sciences; South China Botanical Garden, CAS; Selcuk University	Chang, ZY (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.; Wen, J (corresponding author), Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, Washington, DC 20560 USA.	wenj@si.edu; czybbg@nwsuaf.edu.cn	Ertugrul, Kuddisi/A-1122-2016; ARSLAN, Emine/DTP-7013-2022; Duan, Lei/HGT-9132-2022; Duan, Lei/HGT-9055-2022	Ertugrul, Kuddisi/0000-0002-6463-2918; ARSLAN, Emine/0000-0002-0782-506X; Duan, Lei/0000-0001-6152-5458	National Natural Science Foundation of China [30270106, 30870155]; China Scholarship Council [201406300108]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This work was supported by the National Natural Science Foundation of China (www.nsfc.gov.cn, grant numbers 30270106, 30870155, to ZYC) and China Scholarship Council (www.csc.edu.cn, grant number 201406300108, to PLL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta MC, 2010, MOL PHYLOGENET EVOL, V54, P235, DOI 10.1016/j.ympev.2009.08.008; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Amirahmadi A, 2014, PLANT SYST EVOL, V300, P729, DOI 10.1007/s00606-013-0916-5; Ane C, 2007, MOL BIOL EVOL, V24, P412; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Babineau M, 2013, S AFR J BOT, V89, P94, DOI 10.1016/j.sajb.2013.06.018; Baldwin BG, 1998, MOL PHYLOGENET EVOL, V10, P449, DOI 10.1006/mpev.1998.0545; Baum DA, 2007, TAXON, V56, P417, DOI 10.1002/tax.562013; Bentham G., 1853, HOOKERS J BOT KEW GA, V5, P304; Blattner FR, 2004, MOL PHYLOGENET EVOL, V33, P289, DOI 10.1016/j.ympev.2004.05.012; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Bruneau A, 2013, TAXON, V62, P217, DOI 10.12705/622.8; Choi BH, 2003, TAXON, V52, P567, DOI 10.2307/3647455; Choi HK, 2006, MOL GENET GENOMICS, V276, P56, DOI 10.1007/s00438-006-0118-8; Cunningham CW, 1997, MOL BIOL EVOL, V14, P733, DOI 10.1093/oxfordjournals.molbev.a025813; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Deng T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117171; DOYLE JJ, 1992, SYST BOT, V17, P144, DOI 10.2307/2419070; Doyle JJ, 2012, POLYPLOIDY GENOME EV, P147, DOI [DOI 10.1007/978-3-642-31442-1_9, DOI 10.1007/978-3-642-31442-1-9]; Duan Lei, 2016, PhytoKeys, P111; Duan L, 2015, TAXON, V64, P49, DOI 10.12705/641.26; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Farris JS, 1995, CLADISTICS, V10, P315, DOI [DOI 10.1111/J.1096-0031.1994.TB00181.X, DOI 10.1111/J.1096-0031.1996.TB00196.X]; Farruggia FT, 2011, BRITTONIA, V63, P489, DOI 10.1007/s12228-011-9189-x; Fedtschenko B., 1948, FLORA USSR, V13, P259; Fedtschenko B., 1902, ACTA HORTI PETROP, V19, P183; Fehrer J, 2007, MOL PHYLOGENET EVOL, V42, P347, DOI 10.1016/j.ympev.2006.07.004; Goldblatt P., 1981, Advances in legume systematics. Part 2 [Polhill, R.M.; Raven, P.H. (Editors)], P427; Hager M, 1999, EMBO J, V18, P5834, DOI 10.1093/emboj/18.21.5834; Hedge IC, 1970, FLORA TURKEY E AEGEA, V3, P549; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; HIRAISHI A, 1995, J FERMENT BIOENG, V79, P523, DOI 10.1016/0922-338X(95)94742-A; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jarvis C. E., 2007, ORDER OUT CHAOS LINN; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Larget BR, 2010, BIOINFORMATICS, V26, P2910, DOI 10.1093/bioinformatics/btq539; Lee C, 2004, MOL PHYLOGENET EVOL, V31, P894, DOI 10.1016/j.ympev.2003.10.009; Lee MSY, 2001, MOL BIOL EVOL, V18, P676, DOI 10.1093/oxfordjournals.molbev.a003848; Li MG, 2008, CLADISTICS, V24, P727, DOI 10.1111/j.1096-0031.2008.00207.x; Linnaeus C, 1753, SPECIES PLANTARUM, DOI DOI 10.5962/BHL.TITLE.669; Maureira-Butler IJ, 2008, SYST BIOL, V57, P466, DOI 10.1080/10635150802172168; Meng HH, 2015, J SYST EVOL, V53, P33, DOI 10.1111/jse.12088; Mironov Ye. M., 2000, Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody Otdel Biologicheskii, V105, P50; Muller Kai, 2005, Appl Bioinformatics, V4, P65; Okuyama Y, 2005, MOL BIOL EVOL, V22, P285, DOI 10.1093/molbev/msi016; RIESEBERG LH, 1991, EVOL TREND PLANT, V5, P65; Ronquist F., 2011, MRBAYES VERSION 3 2; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Sang T, 2000, SYST BIOL, V49, P422, DOI 10.1080/10635159950127321; Schwarz EN, 2015, J SYST EVOL, V53, P458, DOI 10.1111/jse.12179; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; SOLTIS DE, 1995, EVOLUTION, V49, P727, DOI 10.1111/j.1558-5646.1995.tb02309.x; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stanford AM, 2000, AM J BOT, V87, P872, DOI 10.2307/2656895; Stegemann S, 2012, P NATL ACAD SCI USA, V109, P2434, DOI 10.1073/pnas.1114076109; Sultanov B., 1970, FLORA KIRGHIZ SSR SU, V2, P31; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THULIN M, 1985, Acta Universitatis Upsaliensis Symbolae Botanicae Upsalienses, V25, P43; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Valdes B, 2000, FLORA IBERICA, V7, P943; Wen J, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00004; Wendel J.F., 1998, MOL SYSTEMATICS PLAN, P265, DOI 10.1007/978-1-4615-5419-6_10; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; WOLFE AD, 1995, SYST BOT, V20, P395, DOI 10.2307/2419800; Xu B, 2012, MOL PHYLOGENET EVOL, V62, P346, DOI 10.1016/j.ympev.2011.10.007; XU L R, 2010, FLORA CHINA, V10, P514; Xu L.-R., 1985, ACTA BOT BOREALI-OCC, V4, P275; Xu L-R., 1998, FLORA REIPUBLICAE PO, V42, P176; Yi TS, 2015, MOL PHYLOGENET EVOL, V85, P10, DOI 10.1016/j.ympev.2014.09.028; YOKOTA Y, 1989, J MOL EVOL, V29, P294, DOI 10.1007/BF02103617; Zimmer EA, 2012, MOL PHYLOGENET EVOL, V65, P774, DOI 10.1016/j.ympev.2012.07.015; Zou XH, 2008, J SYST EVOL, V46, P795, DOI 10.3724/SP.J.1002.2008.08081	80	17	22	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e170596	10.1371/journal.pone.0170596	http://dx.doi.org/10.1371/journal.pone.0170596			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122062	Green Submitted, Green Published, gold			2022-12-26	WOS:000396167300037
J	Mei, YJ; Yu, JW; Xue, AL; Fan, SL; Song, MZ; Pang, CY; Pei, WF; Yu, SX; Zhu, J				Mei, Yongjun; Yu, Jiwen; Xue, Angli; Fan, Shuli; Song, Meizhen; Pang, Chaoyou; Pei, Wenfeng; Yu, Shuxun; Zhu, Jun			Dissecting Genetic Network of Fruit Branch Traits in Upland Cotton by Association Mapping Using SSR Markers	PLOS ONE			English	Article							PLANT ARCHITECTURE TRAITS; LOCI; IDENTIFICATION; QUALITY; YIELD	Genetic architecture of branch traits has large influences on the morphological structure, photosynthetic capacity, planting density, and yield of Upland cotton (Gossypium hirsutum L.). This research aims to reveal the genetic effects of six branch traits, including bottom fruit branch node number (BFBNN), bottom fruit branch length (BFBL), middle fruit branch node number (MFBNN), middle fruit branch length (MFBL), upper fruit branch node number (UFBNN), and upper fruit branch length (UFBL). Association mapping was conducted for these traits of 39 lines and their 178 F-1 hybrids in three environments. There were 20 highly significant Quantitative Trait SSRs (QTSs) detected by mixed linear model approach analyzing a full genetic model with genetic effects of additive, dominance, epistasis and their environment interaction. The phenotypic variation explained by genetic effects ranged from 32.64 similar to 91.61%, suggesting these branch traits largely influenced by genetic factors.	[Mei, Yongjun] Tarim Univ, Coll Plant Sci, Alar, Xinjiang, Peoples R China; [Yu, Jiwen; Fan, Shuli; Song, Meizhen; Pang, Chaoyou; Pei, Wenfeng; Yu, Shuxun] Chinese Acad Agr Sci, Inst Cotton Res, Minist Agr, Key Lab Cotton Genet Improvement,State Key Lab Co, Anyang, Henan, Peoples R China; [Xue, Angli; Zhu, Jun] Zhejiang Univ, Key Lab Crop Germplasm Resource Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China	Tarim University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Ministry of Agriculture & Rural Affairs; Zhejiang University	Mei, YJ (corresponding author), Tarim Univ, Coll Plant Sci, Alar, Xinjiang, Peoples R China.; Yu, SX (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, Minist Agr, Key Lab Cotton Genet Improvement,State Key Lab Co, Anyang, Henan, Peoples R China.; Zhu, J (corresponding author), Zhejiang Univ, Key Lab Crop Germplasm Resource Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China.	xnmeiyj@126.com; yu@cricaas.com.cn; jzhu@zju.edu.cn	Xue, Angli/L-4843-2016	Xue, Angli/0000-0002-0285-0426	National High Technology Research Development 863 Plan [2009AA101104]; National Basic Research Program of China [2011CB109306]; National Cotton Industry Technology System [CARS-18]; Scientific Research Program of the Higher Education Institution of Xinjiang, China [XJEdu 2006159]	National High Technology Research Development 863 Plan; National Basic Research Program of China(National Basic Research Program of China); National Cotton Industry Technology System; Scientific Research Program of the Higher Education Institution of Xinjiang, China	This study was supported by the National High Technology Research Development 863 Plan (2009AA101104), the National Basic Research Program of China (973) (2011CB109306), the National Cotton Industry Technology System (CARS-18), and the Scientific Research Program of the Higher Education Institution of Xinjiang, China (XJEdu 2006159). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurakhmonov IY, 2008, GENOMICS, V92, P478, DOI 10.1016/j.ygeno.2008.07.013; Bednarz CW, 2006, CROP SCI, V46, P2076, DOI 10.2135/cropsci2005.12.0493; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Casa AM, 2008, CROP SCI, V48, P30, DOI 10.2135/cropsci2007.02.0080; Chen W, 2015, THEOR APPL GENET, V128, P539, DOI 10.1007/s00122-014-2452-2; Jia YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095882; Kraakman ATW, 2004, GENETICS, V168, P435, DOI 10.1534/genetics.104.026831; Li C, 2014, J AGR SCI-CAMBRIDGE, V152, P275, DOI 10.1017/S0021859613000063; Li CQ, 2014, PLANT BREEDING, V133, P390, DOI 10.1111/pbr.12161; Malagouda Patil, 2013, Current Biotica, V7, P16; Malosetti M, 2007, GENETICS, V175, P879, DOI 10.1534/genetics.105.054932; Parisseaux B, 2004, THEOR APPL GENET, V109, P508, DOI 10.1007/S00122-004-1666-0; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Rong JK, 2005, THEOR APPL GENET, V111, P1137, DOI 10.1007/s00122-005-0041-0; Said JI, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-776; Searle SR., 2009, VARIANCE COMPONENTS; Song XL, 2009, PLANT SCI, V177, P317, DOI 10.1016/j.plantsci.2009.05.015; Tan ZY, 2015, EUPHYTICA, V203, P615, DOI 10.1007/s10681-014-1288-9; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Yang J, 2005, THEOR APPL GENET, V110, P1268, DOI 10.1007/s00122-005-1963-2; Yang J, 2007, BIOINFORMATICS, V23, P1527, DOI 10.1093/bioinformatics/btm143; Yao J, 2009, GENETICA, V137, P67, DOI 10.1007/s10709-009-9351-5; Zhang FT, 2015, SCI REP-UK, V5, DOI 10.1038/srep10298; Zhang K, 2012, MOL BREEDING, V29, P335, DOI 10.1007/s11032-011-9549-y; Zhang N, 2005, THEOR APPL GENET, V110, P721, DOI 10.1007/s00122-004-1898-z; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	26	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0162815	10.1371/journal.pone.0162815	http://dx.doi.org/10.1371/journal.pone.0162815			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28121983	gold, Green Submitted, Green Published			2022-12-26	WOS:000396167300083
J	Stayte, S; Rentsch, P; Troscher, AR; Bamberger, M; Li, KM; Vissel, B				Stayte, Sandy; Rentsch, Peggy; Troscher, Anna R.; Bamberger, Maximilian; Li, Kong M.; Vissel, Bryce			Activin A Inhibits MPTP and LPS-Induced Increases in Inflammatory Cell Populations and Loss of Dopamine Neurons in the Mouse Midbrain In Vivo	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; PARKINSONS-DISEASE; TYROSINE-HYDROXYLASE; SUBSTANTIA-NIGRA; RAT MODEL; NEURODEGENERATIVE DISEASES; DIFFERENTIAL REGULATION; NIGROSTRIATAL PATHWAY; NEUROTROPHIC FACTOR; GENE-EXPRESSION	Parkinson's disease is a chronic neurodegenerative disease characterized by a significant loss of dopaminergic neurons within the substantia nigra pars compacta region and a subsequent loss of dopamine within the striatum. A promising avenue of research has been the administration of growth factors to promote the survival of remaining midbrain neurons, although the mechanism by which they provide neuroprotection is not understood. Activin A, a member of the transforming growth factor beta superfamily, has been shown to be a potent anti-inflammatory following acute brain injury and has been demonstrated to play a role in the neuroprotection of midbrain neurons against MPP+-induced degeneration in vitro. We hypothesized that activin A may offer similar anti-inflammatory and neuroprotective effects in in vivo mouse models of Parkinson's disease. We found that activin A significantly attenuated the inflammatory response induced by both MPTP and intranigral administration of lipopolysaccharide in C57BL/6 mice. We found that administration of activin A promoted survival of dopaminergic and total neuron populations in the pars compacta region both 8 days and 8 weeks after MPTP-induced degeneration. Surprisingly, no corresponding protection of striatal dopamine levels was found. Furthermore, activin A failed to protect against loss of striatal dopamine transporter expression in the striatum, suggesting the neuroprotective action of activin A may be localized to the substantia nigra. Together, these results provide the first evidence that activin A exerts potent neuroprotection and anti-inflammatory effects in the MPTP and lipopolysaccharide mouse models of Parkinson's disease.	[Stayte, Sandy; Rentsch, Peggy; Vissel, Bryce] Garvan Inst Med Res, Dept Neurosci, Sydney, NSW, Australia; [Troscher, Anna R.; Bamberger, Maximilian] FH Krems Univ Appl Sci, Krems, Austria; [Li, Kong M.] Univ Sydney, Sydney Med Sch, Bosch Inst, Dept Pharmacol, Sydney, NSW, Australia; [Vissel, Bryce] Univ Technol Sydney, Sch Life Sci, Sydney, NSW, Australia	Garvan Institute of Medical Research; University of Sydney; University of Technology Sydney	Vissel, B (corresponding author), Garvan Inst Med Res, Dept Neurosci, Sydney, NSW, Australia.	brycevissel@gmail.com	Stayte, Sandy/AAC-5457-2019; Li, Kong M./R-4655-2019	Stayte, Sandy/0000-0002-6518-1979; Vissel, Bryce/0000-0001-8860-8050; Troscher, Anna/0000-0003-3003-4677; Rentsch, Peggy/0000-0002-2108-3568; Li, Kong/0000-0003-2709-0344	Parkinson's NSW grant [2257]; Patricia A. Quick Foundation; David King, Doug Battersby, Iain S. Gray Foundation; Amadeus Energy Ltd.; Mason Foundation; SpinalCure Australia	Parkinson's NSW grant; Patricia A. Quick Foundation; David King, Doug Battersby, Iain S. Gray Foundation; Amadeus Energy Ltd.; Mason Foundation; SpinalCure Australia	Funding provided by Parkinson's NSW under grant number 2257 (www.parkinsonsnsw.org.au), Bill Gruy, The Boyarsky family, Stanley and John Roth, David and Helen Baffsky, Patricia A. Quick Foundation, David King, Doug Battersby, Iain S. Gray Foundation in memory of Kylie, FIVEX in memory of Marco Berger (www.fivex.com.au), Tony and Vivian Howland-Rose, Walter and Edith Sheldon in memory of Walter Sheldon, Gleneagle Securities (www.gleneagle.com.au), Geoffrey Towner, Amadeus Energy Ltd., Nick and Melanie Kell, J. O. and J. R. Wicking Trust, The Mason Foundation and SpinalCure Australia (www.spinalcure.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdipranoto-Cowley A, 2009, STEM CELLS, V27, P1330, DOI 10.1002/stem.80; Agid Y, 1987, MOVEMENT DISORD, V1, P166; AMGEN, 2005, FOLL COMPL REV PHAS; Appel E, 1997, NEUROREPORT, V8, P3309, DOI 10.1097/00001756-199710200-00023; Archer T, 2006, J NEURAL TRANSM, V113, P1119, DOI 10.1007/s00702-005-0402-5; Barcia C, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.17; Barkholt P, 2012, NEUROSCIENCE, V208, P85, DOI 10.1016/j.neuroscience.2012.02.004; Barnum CJ, 2012, PHARMACOL BIOCHEM BE, V100, P607, DOI 10.1016/j.pbb.2011.09.009; Bartus RT, 2013, NEUROLOGY, V80, P1698, DOI 10.1212/WNL.0b013e3182904faa; Bartus RT, 2011, MOVEMENT DISORD, V26, P27, DOI 10.1002/mds.23442; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Bezard E, 2001, J NEUROSCI, V21, P6853, DOI 10.1523/JNEUROSCI.21-17-06853.2001; Castano A, 1998, J NEUROCHEM, V70, P1584; Ceregene, 2013, CER REP DAT PARK DIS; Chen LW, 2006, J COMP NEUROL, V497, P898, DOI 10.1002/cne.21014; Chen PC, 2009, P NATL ACAD SCI USA, V106, P2933, DOI 10.1073/pnas.0813361106; Czlonkowska A, 1996, NEURODEGENERATION, V5, P137, DOI 10.1006/neur.1996.0020; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; Eberling JL, 2009, HUM GENE THER, V20, P511, DOI 10.1089/hum.2008.201; Eslamboli A, 2003, EXP NEUROL, V184, P536, DOI 10.1016/j.expneurol.2003.08.007; Feng Z, 2002, CARSOLOGICA SIN, V2, P3; Fornai F, 1997, J PHARMACOL EXP THER, V283, P100; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; German DC, 2000, NEUROSCIENCE, V101, P1063, DOI 10.1016/S0306-4522(00)00385-7; Gesi M, 2000, NEUROSCI BIOBEHAV R, V24, P655, DOI 10.1016/S0149-7634(00)00028-2; Grunblatt E, 2001, J NEUROCHEM, V78, P1, DOI 10.1046/j.1471-4159.2001.00397.x; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; HALLMAN H, 1984, EUR J PHARMACOL, V97, P133, DOI 10.1016/0014-2999(84)90521-1; HEIKKILA RE, 1992, NEUROCHEM INT, V20, pS299; Henry B, 1998, EXP NEUROL, V151, P334, DOI 10.1006/exnr.1998.6819; Herzog CD, 2013, NEUROBIOL DIS, V58, P38, DOI 10.1016/j.nbd.2013.04.011; Hill MP, 1999, BRIT J PHARMACOL, V128, P1577, DOI 10.1038/sj.bjp.0702943; Hoban DB, 2015, NEUROSCIENCE, V303, P402, DOI 10.1016/j.neuroscience.2015.07.014; Hughes PE, 1999, PROG NEUROBIOL, V57, P421, DOI 10.1016/S0301-0082(98)00057-4; Jaber M, 1999, EUR J NEUROSCI, V11, P3499, DOI 10.1046/j.1460-9568.1999.00764.x; JACKSONLEWIS V, 1995, NEURODEGENERATION, V4, P257, DOI 10.1016/1055-8330(95)90015-2; Johnston LC, 2009, HUM GENE THER, V20, P497, DOI 10.1089/hum.2008.137; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; KASTNER A, 1994, ANN NEUROL, V36, P206, DOI 10.1002/ana.410360213; Kirik D, 2000, EUR J NEUROSCI, V12, P3871, DOI 10.1046/j.1460-9568.2000.00274.x; Kohutnicka M, 1998, IMMUNOPHARMACOLOGY, V39, P167, DOI 10.1016/S0162-3109(98)00022-8; Kordower JH, 2013, MOVEMENT DISORD, V28, P96, DOI 10.1002/mds.25344; Kordower JH, 1999, ANN NEUROL, V46, P419, DOI 10.1002/1531-8249(199909)46:3<419::AID-ANA21>3.0.CO;2-Q; Kozina EA, 2014, J NEUROL SCI, V340, P198, DOI 10.1016/j.jns.2014.03.028; KRIEGLSTEIN K, 1995, EMBO J, V14, P736, DOI 10.1002/j.1460-2075.1995.tb07052.x; Kupershmidt L, 2007, J NEUROCHEM, V103, P962, DOI 10.1111/j.1471-4159.2007.04785.x; Li N, 2013, BIOCHEM BIOPH RES CO, V435, P222, DOI 10.1016/j.bbrc.2013.04.077; McGeer PL, 2003, ANN NEUROL, V54, P599, DOI 10.1002/ana.10728; Meiser J, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-34; Mogi M, 1999, NEUROSCI LETT, V270, P45, DOI 10.1016/S0304-3940(99)00463-2; NUSING RM, 1995, EUR J BIOCHEM, V227, P130, DOI 10.1111/j.1432-1033.1995.tb20368.x; Paxinos G., 2001, THE MOUSE BRAIN IN S, DOI DOI 10.1084/JEM.20081588; Rommelfanger KS, 2007, BIOCHEM PHARMACOL, V74, P177, DOI 10.1016/j.bcp.2007.01.036; Sanchez-Guajardo V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008784; Sedelis M, 2001, BEHAV BRAIN RES, V125, P109, DOI 10.1016/S0166-4328(01)00309-6; Stayte S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124325; Suh HS, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-37; Tretter YP, 2000, NAT MED, V6, P812, DOI 10.1038/77548; VALE W, 1986, NATURE, V321, P776, DOI 10.1038/321776a0; Vaughan RA, 2013, TRENDS PHARMACOL SCI, V34, P489, DOI 10.1016/j.tips.2013.07.005; Wachter B, 2010, CELL TISSUE RES, V342, P147, DOI 10.1007/s00441-010-1061-x; Wang L, 2002, GENE THER, V9, P381, DOI 10.1038/sj.gt.3301682; Wang SY, 2008, CYTOKINE, V42, P85, DOI 10.1016/j.cyto.2008.01.010; WILLIS GL, 1987, BRAIN RES, V402, P269, DOI 10.1016/0006-8993(87)90033-3; Xu Z, 2005, SYNAPSE, V55, P45, DOI 10.1002/syn.20089; Yang TT, 2013, BRAIN STRUCT FUNCT, V218, P1051, DOI 10.1007/s00429-012-0446-x; Yasuda Y, 2008, J NEUROIMMUNOL, V204, P43, DOI 10.1016/j.jneuroim.2008.08.003	67	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0167211	10.1371/journal.pone.0167211	http://dx.doi.org/10.1371/journal.pone.0167211			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28121982	gold, Green Published, Green Submitted			2022-12-26	WOS:000396167300082
J	Asiedu, MN; Han, CY; Dib-Hajj, SD; Waxman, SG; Price, TJ; Dussor, G				Asiedu, Marina N.; Han, Chongyang; Dib-Hajj, Sulayman D.; Waxman, Stephen G.; Price, Theodore J.; Dussor, Gregory			The AMPK Activator A769662 Blocks Voltage-Gated Sodium Channels: Discovery of a Novel Pharmacophore with Potential Utility for Analgesic Development	PLOS ONE			English	Article							BENZAZEPINONE NA(V)1.7 BLOCKERS; CLOSED-STATE INACTIVATION; OF-FUNCTION MUTATION; PROTEIN-KINASE; INTRAVENOUS LIDOCAINE; NEUROPATHIC PAIN; RESVERATROL; NOCICEPTION; ALLODYNIA; NEURONS	Voltage-gated sodium channels (VGSC) regulate neuronal excitability by governing action potential (AP) generation and propagation. Recent studies have revealed that AMP-activated protein kinase (AMPK) activators decrease sensory neuron excitability, potentially by preventing sodium (Na+) channel phosphorylation by kinases such as ERK or via modulation of translation regulation pathways. The direct positive allosteric modulator A769662 displays substantially greater efficacy than other AMPK activators in decreasing sensory neuron excitability suggesting additional mechanisms of action. Here, we show that A769662 acutely inhibits AP firing stimulated by ramp current injection in rat trigeminal ganglion (TG) neurons. PT1, a structurally dissimilar AMPK activator that reduces nerve growth factor (NGF) -induced hyperexcitability, has no influence on AP firing in TG neurons upon acute application. In voltage-clamp recordings, application of A769662 reduces VGSC current amplitudes. These findings, based on acute A769662 application, suggest a direct channel blocking effect. Indeed, A769662 dose-dependently blocks VGSC in rat TG neurons and in Na(v)1.7-transfected cells with an IC50 of similar to 10 mu M. A769662 neither displayed use-dependent inhibition nor interacted with the local anesthetic (LA) binding site. Popliteal fossa administration of A769662 decreased noxious thermal responses with a peak effect at 5 mins demonstrating an analgesic effect. These data indicate that in addition to AMPK activation, A769662 acts as a direct blocker/modulator of VGSCs, a potential mechanism enhancing the analgesic property of this compound.	[Asiedu, Marina N.; Price, Theodore J.; Dussor, Gregory] Univ Arizona, Dept Pharmacol, Tucson, AZ USA; [Asiedu, Marina N.; Price, Theodore J.; Dussor, Gregory] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA; [Han, Chongyang; Dib-Hajj, Sulayman D.; Waxman, Stephen G.] Yale Sch Med, Dept Neurol, Ctr Neurosci & Regenerat, West Haven, CT USA; [Han, Chongyang; Dib-Hajj, Sulayman D.; Waxman, Stephen G.] Vet Adm Connecticut Healthcare Syst, Rehabil Res Ctr, West Haven, CT USA	University of Arizona; University of Texas System; University of Texas Dallas; Yale University	Dussor, G (corresponding author), Univ Arizona, Dept Pharmacol, Tucson, AZ USA.; Dussor, G (corresponding author), Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA.	gregory.dussor1@utdallas.edu	Waxman, Stephen/Z-2507-2019; Price, Theodore/M-3810-2018	Waxman, Stephen/0000-0001-5718-7177; Price, Theodore/0000-0002-6971-6221	NIH [R01GM102575]; University of Texas; Medical Research Service and Rehabilitation Research Service, Dept. of Veterans Affairs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102575] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas; Medical Research Service and Rehabilitation Research Service, Dept. of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant: R01GM102575 (TJP and GD) and The University of Texas STARS program research supports grant (TJP and GD), and by the Medical Research Service and Rehabilitation Research Service, Dept. of Veterans Affairs (SGW and SDH). The authors declare no conflicts of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2007, HUM MOL GENET, V16, P2114, DOI 10.1093/hmg/ddm160; Alexandrou AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152405; Araujo MC, 2003, PAIN, V103, P21, DOI 10.1016/S0304-3959(02)00350-0; Asiedu M, 2010, PAIN, V148, P302, DOI 10.1016/j.pain.2009.11.015; Bazzo KO, 2013, J NAT PROD, V76, P13, DOI 10.1021/np300529x; BESSOU P, 1969, J NEUROPHYSIOL, V32, P1025, DOI 10.1152/jn.1969.32.6.1025; Bullon P, 2015, ANTIOXID REDOX SIGNA; Cao LS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7653; Carling D, 2012, BIOCHEM J, V445, P11, DOI 10.1042/BJ20120546; CHAPLAN SR, 1995, ANESTHESIOLOGY, V83, P775, DOI 10.1097/00000542-199510000-00017; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cummins TR, 2007, PAIN, V131, P243, DOI 10.1016/j.pain.2007.07.026; Cummins TR, 1998, J NEUROSCI, V18, P9607; Dib-Hajj SD, 2005, BRAIN, V128, P1847, DOI 10.1093/brain/awh514; Dib-Hajj SD, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-37; Dib-Hajj SD, 2015, NAT REV NEUROSCI, V16, P511, DOI 10.1038/nrn3977; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Dib-Hajj SD, 2008, ADV GENET, V63, P85, DOI 10.1016/S0065-2660(08)01004-3; Dib-Hajj SD, 2009, BRAIN RES REV, V60, P65, DOI 10.1016/j.brainresrev.2008.12.005; Eijkelkamp N, 2012, BRAIN, V135, P2585, DOI 10.1093/brain/aws225; Estacion M, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-35; Faber CG, 2012, ANN NEUROL, V71, P26, DOI 10.1002/ana.22485; Fischer TZ, 2009, ANN NEUROL, V65, P733, DOI 10.1002/ana.21678; Geha P, 2016, JAMA NEUROL, V73, P659, DOI 10.1001/jamaneurol.2016.0389; Gentilli M, 2001, LIFE SCI, V68, P1317, DOI 10.1016/S0024-3205(00)01018-3; Gingras J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105895; Goldberg YP, 2007, CLIN GENET, V71, P311, DOI 10.1111/j.1399-0004.2007.00790.x; Han CY, 2016, NEUROLOGY, V86, P473, DOI 10.1212/WNL.0000000000002333; Han CY, 2006, ANN NEUROL, V59, P553, DOI 10.1002/ana.20776; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Herzog RI, 2003, J PHYSIOL-LONDON, V551, P741, DOI 10.1113/jphysiol.2003.047357; Hoeijmakers JGJ, 2015, NEUROSCI LETT, V596, P51, DOI 10.1016/j.neulet.2014.12.056; Hoyt SB, 2007, BIOORG MED CHEM LETT, V17, P6172, DOI 10.1016/j.bmcl.2007.09.032; Hoyt SB, 2007, BIOORG MED CHEM LETT, V17, P4630, DOI 10.1016/j.bmcl.2007.05.076; Jarvis MF, 2007, P NATL ACAD SCI USA, V104, P8520, DOI 10.1073/pnas.0611364104; Kim HI, 2005, BRAIN RES, V1045, P134, DOI 10.1016/j.brainres.2005.03.019; Ma JX, 2015, EUR J PHARMACOL, V764, P599, DOI 10.1016/j.ejphar.2015.06.010; Maixner DW, 2015, ANESTHESIOLOGY, V122, P1401, DOI 10.1097/ALN.0000000000000619; Mao-Ying QL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100701; McCormack K, 2013, P NATL ACAD SCI USA, V110, pE2724, DOI 10.1073/pnas.1220844110; Melemedjian OK, 2013, PAIN, V154, P1080, DOI 10.1016/j.pain.2013.03.021; Melemedjian OK, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-70; Minett MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104458; Minett MS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1795; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Pang T, 2008, J BIOL CHEM, V283, P16051, DOI 10.1074/jbc.M710114200; Panigel J, 2011, J NEUROGENET, V25, P134, DOI 10.3109/01677063.2011.629702; Perl E R, 1976, Prog Brain Res, V43, P263; Rush AM, 2007, J PHYSIOL-LONDON, V579, P1, DOI 10.1113/jphysiol.2006.121483; Schmalhofer WA, 2008, MOL PHARMACOL, V74, P1476, DOI 10.1124/mol.108.047670; Sinnott CJ, 1999, PAIN, V80, P521, DOI 10.1016/S0304-3959(98)00245-0; Smith LJ, 2002, PAIN, V97, P267, DOI 10.1016/S0304-3959(02)00028-3; Song H., 2015, ANESTHESIOLOGY; Stamboulian S, 2010, J NEUROSCI, V30, P1637, DOI 10.1523/JNEUROSCI.4872-09.2010; Theile JW, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00054; Tillu DV, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-5; Tyagarajan S, 2010, BIOORG MED CHEM LETT, V20, P5480, DOI 10.1016/j.bmcl.2010.07.080; Vasylyev DV, 2012, J NEUROPHYSIOL, V108, P729, DOI 10.1152/jn.00091.2012; Vijayaragavan K, 2001, J NEUROSCI, V21, P7909, DOI 10.1523/JNEUROSCI.21-20-07909.2001; Williams BS, 2007, BIOCHEMISTRY-US, V46, P14693, DOI 10.1021/bi7018207; Yang Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2184; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	63	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2017	12	1							e0169882	10.1371/journal.pone.0169882	http://dx.doi.org/10.1371/journal.pone.0169882			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7CU	28118359	Green Submitted, Green Published, gold			2022-12-26	WOS:000396160500044
J	Eberhardt, C; Thillai, M; Parker, R; Siddiqui, N; Potiphar, L; Goldin, R; Timms, JF; Wells, AU; Kon, OM; Wickremasinghe, M; Mitchell, D; Weeks, ME; Lalvani, A				Eberhardt, Christian; Thillai, Muhunthan; Parker, Robert; Siddiqui, Nazneen; Potiphar, Lee; Goldin, Rob; Timms, John F.; Wells, Athol U.; Kon, Onn M.; Wickremasinghe, Melissa; Mitchell, Donald; Weeks, Mark E.; Lalvani, Ajit			Proteomic Analysis of Kveim Reagent Identifies Targets of Cellular Immunity in Sarcoidosis	PLOS ONE			English	Article							MYCOBACTERIAL CATALASE-PEROXIDASE; T-CELLS; CITRULLINATED VIMENTIN; RESPONSES; ANTIGENS; TUBERCULOSIS; PEPTIDES; BODIES	Background Kveim-reagent (Kv) skin testing was a historical method of diagnosing sarcoidosis. Intradermal injection of treated sarcoidosis spleen tissue resulted in a granuloma response at injection site by 4-6 weeks. Previous work indicates proteins as the possible trigger of this reaction. We aimed to identify Kv-specific proteins and characterise the ex vivo response of Peripheral Blood Mononuclear Cells (PBMCs) from sarcoidosis, tuberculosis and healthy control patients when stimulated with both Kv and selected Kv-specific proteins. Methods Kv extracts were separated by 1D-SDS-PAGE and 2D-DIGE and then underwent mass spectrometric analysis for protein identification. Sarcoidosis and control PBMCs were first stimulated with Kv and then with three selected recombinant protein candidates which were identified from the proteomic analysis. PBMC secreted cytokines were subsequently measured by Multiplex Cytokine Assay. Results We observed significantly increased IFN-Y and TNF-alpha secretion from Kv-stimulated PBMCs of sarcoidosis patients vs. PBMCs from healthy volunteers (IFN-.: 207.2 pg/mL vs. 3.86 pg/mL, p = 0.0018; TNF-alpha: 2375 pg/mL vs. 42.82 pg/mL, p = 0.0003). Through proteomic approaches we then identified 74 sarcoidosis tissue-specific proteins. Of these, 3 proteins (vimentin, tubulin and alpha-actinin-4) were identified using both 1D-SDS-PAGE and 2D-DIGE. Dataare available via ProteomeXchange with identifier PXD005150. Increased cytokine secretion was subsequently observed with vimentin stimulation of sarcoidosis PBMCs vs. tuberculosis PBMCs (IFN-alpha:396.6pg/mL vs 0.1 pg/mL, p = 0.0009; TNF-alpha: 1139 pg/mL vs 0.1 pg/mL, p< 0.0001). This finding was also observed in vimentin stimulation of sarcoidosis PBMCs compared to PBMCs from healthy controls (IFN-Y: 396.6 pg/mL vs. 0.1 pg/mL, p = 0.014; TNF-a: 1139 pg/mL vs 42.29 pg/mL, p = 0.027). No difference was found in cytokine secretion between sarcoidosis and control PBMCs when stimulated with either tubulin or alpha-actinin-4. Conclusions Stimulation with both Kveim reagent and vimentin induces a specific pro-inflammatory cytokine secretion from sarcoidosis PBMCs. Further investigation of cellular immune responses to Kveim-specific proteins may identify novel biomarkers to assist the diagnosis of sarcoidosis.	[Eberhardt, Christian; Parker, Robert; Siddiqui, Nazneen; Potiphar, Lee; Mitchell, Donald; Lalvani, Ajit] Imperial Coll London, Natl Heart & Lung Inst, TB Res Unit, London, England; [Thillai, Muhunthan] Papworth NHS Trust, Cambridge Interstitial Lung Dis Grp, Cambridge, England; [Goldin, Rob] Imperial Coll London, Dept Med, Ctr Pathol, London, England; [Timms, John F.] UCL, Inst Womens Hlth, Fac Populat Hlth Sci, London, England; [Wells, Athol U.] Imperial Coll London NHS Healthcare Trust, Royal Brompton Hosp, Interstitial Lung Unit, London, England; [Kon, Onn M.; Wickremasinghe, Melissa] Imperial Coll London NHS Healthcare Trust, St Marys Hosp London, Dept Resp Med, London, England; [Weeks, Mark E.] Queen Mary Univ London, John Vane Sci Ctr, Barts Canc Inst, Charterhouse Sq, London EC1M 6BQ, England	Imperial College London; Papworth Hospital; Imperial College London; University of London; University College London; Royal Brompton Hospital; Imperial College London; University of London; Queen Mary University London	Eberhardt, C (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, TB Res Unit, London, England.	Christian.Eberhardt@usz.ch	/C-2531-2011; weeks, Mark/AAT-7258-2021; Timms, John/A-1556-2010	/0000-0002-6576-8809; Timms, John/0000-0002-4507-835X; Goldin, Robert/0000-0001-5184-4519; Parker, Robert/0000-0003-3989-8893; Lalvani, Ajit/0000-0002-2396-246X	Wellcome Trust [085275/Z/08/Z]; Medical Research Council [G0801620/1]; MRC [G0801620] Funding Source: UKRI; Medical Research Council [G0801620] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10155, NF-SI-0508-10179] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by the following sponsors: 1) The Wellcome Trust (Research Training Fellowship to support MT, grant number 085275/Z/08/Z), https://www.wellcome.ac.uk; 2) Medical Research Council (Project grant awarded to AL to support the study, grant number: G0801620/1), https://www.mrc.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzai H, 2012, RESP MED, V106, P701, DOI 10.1016/j.rmed.2012.01.012; Alete DE, 2006, FEBS J, V273, P4668, DOI 10.1111/j.1742-4658.2006.05471.x; Ang SC, 1996, HISTOL HISTOPATHOL, V11, P125; [Anonymous], 1999, Am J Respir Crit Care Med, V160, P736; BRESNITZ EA, 1983, EPIDEMIOL REV, V5, P124, DOI 10.1093/oxfordjournals.epirev.a036255; CAIN H, 1983, VIRCHOWS ARCH B, V42, P213, DOI 10.1007/BF02890384; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; CHASE MW, 1961, AM REV RESPIR DIS, V84, P86; Chen ES, 2010, AM J RESP CRIT CARE, V181, P360, DOI 10.1164/rccm.200905-0696OC; Chen ES, 2008, J IMMUNOL, V181, P8784, DOI 10.4049/jimmunol.181.12.8784; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; Feitsma AL, 2010, ARTHRITIS RHEUM-US, V62, P117, DOI 10.1002/art.25059; Grunewald J, 2016, EUR RESPIR J, V47, P898, DOI 10.1183/13993003.01209-2015; Grunewald J, 2010, SEMIN RESP CRIT CARE, V31, P380, DOI 10.1055/s-0030-1262206; Humphryes PC, 2012, CLIN VACCINE IMMUNOL, V19, P587, DOI 10.1128/CVI.05622-11; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Kaarteenaho-Wiik R, 2007, HUM PATHOL, V38, P147, DOI 10.1016/j.humpath.2006.07.001; KATARIA YP, 1986, ANN NY ACAD SCI, V465, P221, DOI 10.1111/j.1749-6632.1986.tb18498.x; KLEIN JT, 1995, J IMMUNOL, V154, P1450; LYONS DJ, 1992, RESPIRATION, V59, P22; Newman LS, 2004, AM J RESP CRIT CARE, V170, P1324, DOI 10.1164/rccm.200402-249OC; PARKES SA, 1985, THORAX, V40, P284, DOI 10.1136/thx.40.4.284; Segal JL, 2012, AM J THER, V19, P317, DOI 10.1097/MJT.0b013e3182204fd9; SILTZBACH L, 1961, JAMA-J AM MED ASSOC, V178, P476, DOI 10.1001/jama.1961.03040440028006; SILTZBACH LE, 1954, AM J MED, V16, P790, DOI 10.1016/0002-9343(54)90443-X; Snir O, 2011, ARTHRITIS RHEUM-US, V63, P2873, DOI 10.1002/art.30445; Song ZM, 2005, J EXP MED, V201, P755, DOI 10.1084/jem.20040429; Thillai M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038083; Vizcaino JA, 2016, NUCL ACIDS RES; Wahlstom J, 2007, J CLIN INVEST, V117, P3576, DOI 10.1172/JCI32401; Wahlstrom J, 2009, CLIN IMMUNOL, V133, P353, DOI 10.1016/j.clim.2009.08.008; Weeks ME, 2006, PROTEOMICS, V6, P2772, DOI 10.1002/pmic.200500741; Zissel G, 2016, EUR RESPIR J, V47, P707, DOI 10.1183/13993003.01791-2015; Zissel G, 2010, SEMIN RESP CRIT CARE, V31, P390, DOI 10.1055/s-0030-1262208	36	32	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e170285	10.1371/journal.pone.0170285	http://dx.doi.org/10.1371/journal.pone.0170285			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114394	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000396129000033
J	Handschuh, H; Ryan, MP; O'Dwyer, J; Adley, CC				Handschuh, Harald; Ryan, Michael P.; O'Dwyer, Jean; Adley, Catherine C.			Assessment of the Bacterial Diversity of Aircraft Water: Identification of the Frequent Fliers	PLOS ONE			English	Article							DRINKING-WATER; PHYLOGENETIC DIVERSITY; SYSTEM; COMMUNITIES; ALIGNMENT; BIOFILM; COMPLEX; SAFETY	The aim of this study was to determine and identify bacteria inhabiting the supply chain of an airline's drinking water using phenotypic and 16S rDNA sequence-based analysis. Water samples (n = 184) were sourced from long-haul and short-haul aircraft, the airline water source and a water service vehicle. In total, 308 isolates were characterised and their identity determined, which produced 82 identified bacterial species belonging to eight classes: y-Proteobacteria; beta-Proteobacteria; alpha-Proteobacteria; Bacilli; Actinobacteria; Flavobacteria; Sphingobacteria and Cytophaga. Statistical differences in bacterial diversity were found to exist across sampling locations (X-2 = 39.220, p = 0.009) and furthermore, differences were observed (X-2 = 15.475, p = 0.030) across aircraft type (long- or short-haul). This study demonstrates the diverse nature of microorganisms within the aircraft drinking water supply chain. To the best of our knowledge, this is the most extensive study undertaken to date of microbial diversity in aircraft drinking water.	[Handschuh, Harald; Adley, Catherine C.] Univ Limerick, Sch Nat Sci, Dept Chem Sci, Microbiol Lab, Limerick, Ireland; [Ryan, Michael P.] Univ Limerick, Sch Nat Sci, Dept Chem Sci, Ind Biochem Programme, Limerick, Ireland; [O'Dwyer, Jean] Univ Limerick, Sch Nat Sci, Dept Biol Sci, Limerick, Ireland	University of Limerick; University of Limerick; University of Limerick	Ryan, MP (corresponding author), Univ Limerick, Sch Nat Sci, Dept Chem Sci, Ind Biochem Programme, Limerick, Ireland.	michael.p.ryan@ul.ie	Ryan, Michael/A-6565-2011; O'Dwyer, Jean/B-2532-2017	Ryan, Michael/0000-0002-0489-0579; O'Dwyer, Jean/0000-0001-7852-4662				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2010, 5667212010 BS ISO; [Anonymous], 2006, 566752006 BS ISO; Bartram J., 2009, WATER SAFETY PLAN MA; Berry D, 2006, CURR OPIN BIOTECH, V17, P297, DOI 10.1016/j.copbio.2006.05.007; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; Calderon Gema, 2011, J Med Case Rep, V5, P10, DOI 10.1186/1752-1947-5-10; Coughlan A, 2011, J MATER SCI, V46, P285, DOI 10.1007/s10853-010-4945-y; Daly B, 1998, MICROBIOS, V96, P7; de Bentzmann Sophie, 2011, Environ Microbiol, V13, P1655, DOI 10.1111/j.1462-2920.2011.02469.x; Eichler S, 2006, APPL ENVIRON MICROB, V72, P1858, DOI 10.1128/AEM.72.3.1858-1872.2006; Falcone-Dias MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121284; Fenchel T., 2001, BACTERIAL ECOLOGY; Folescu TW, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0148-2; Guillot E, 2010, WATERBORNE PATHOGENS; Handschuh H, 2015, INT J ENV RES PUB HE, V12, P13938, DOI 10.3390/ijerph121113938; Harbison I., 2013, AIRLINES KEEP IT CLE; Harrigan WF, 1998, LAB METHODS FOOD MIC, P298; LECHEVALLIER MW, 1987, APPL ENVIRON MICROB, V53, P2714, DOI 10.1128/AEM.53.12.2714-2724.1987; Levenson M, 2010, CATASTROPHIC RUPTURE; Limmathurotsakul D, 2014, EMERG INFECT DIS, V20, P265, DOI 10.3201/eid2002.121891; Lo HH, 2014, DIAGN MICR INFEC DIS, V79, P298, DOI 10.1016/j.diagmicrobio.2014.01.027; Lu PP, 2013, BIOTECHNOL BIOPROC E, V18, P119, DOI 10.1007/s12257-012-0230-z; Mangili A, 2005, LANCET, V365, P989, DOI 10.1016/S0140-6736(05)71089-8; McCoy ST, 2012, J ENVIRON ENG, V138, P786, DOI 10.1061/(ASCE)EE.1943-7870.0000539; Mouchtouri VA, 2012, SCI TOTAL ENVIRON, V429, P199, DOI 10.1016/j.scitotenv.2012.04.018; Palumbo F, 2008, DETECTION METHODS AL; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Pinhassi J, 2003, APPL ENVIRON MICROB, V69, P199, DOI 10.1128/AEM.69.1.199-211.2003; Poitelon JB, 2010, J IND MICROBIOL BIOT, V37, P117, DOI 10.1007/s10295-009-0653-5; Poitelon JB, 2009, WATER RES, V43, P4197, DOI 10.1016/j.watres.2009.07.020; Public Health Laboratory Service and the Association of Port Health Authorities, 2003, MICR QUAL WAT ONB AI; RIDGWAY HF, 1982, APPL ENVIRON MICROB, V44, P972, DOI 10.1128/AEM.44.4.972-987.1982; Ryan MP, 2014, EUR J CLIN MICROBIOL, V33, P291, DOI 10.1007/s10096-013-1975-9; Ryan MP, 2010, J HOSP INFECT, V75, P153, DOI 10.1016/j.jhin.2010.03.007; Ryan M.P., 2013, MICROBIAL PATHOGENS, VVolume 4, P736; Ryan MP, 2006, J HOSP INFECT, V62, P278, DOI 10.1016/j.jhin.2005.08.015; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scales BS, 2014, CLIN MICROBIOL REV, V27, P927, DOI 10.1128/CMR.00044-14; Szewzyk U, 2000, ANNU REV MICROBIOL, V54, P81, DOI 10.1146/annurev.micro.54.1.81; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Williams MM, 2004, J APPL MICROBIOL, V96, P954, DOI 10.1111/j.1365-2672.2004.02229.x; World Health Organisation (WHO), 2011, MOD TRAV HLTH CONS I, P14; Zhang Y, 2013, WATER SCI TECH-W SUP, V13, P358, DOI 10.2166/ws.2013.037	45	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170567	10.1371/journal.pone.0170567	http://dx.doi.org/10.1371/journal.pone.0170567			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114359	Green Published, Green Submitted, gold			2022-12-26	WOS:000396129000070
J	Loturco, I; Pereira, LA; Moraes, JE; Kitamura, K; Abad, CCC; Kobal, R; Nakamura, FY				Loturco, Irineu; Pereira, Lucas A.; Moraes, Jose E.; Kitamura, Katia; Cal Abad, Cesar C.; Kobal, Ronaldo; Nakamura, Fabio Y.			Jump-Squat and Half-Squat Exercises: Selective Influences on Speed-Power Performance of Elite Rugby Sevens Players	PLOS ONE			English	Article							SPRINT PERFORMANCE; DIRECTION PERFORMANCE; STRENGTH; TESTS; AGILITY	The aim of this study was to evaluate the relation between the maximum mean propulsive power (MPP) obtained in the loaded jump squat (JS) and half squat (HS) exercises and functional performances in vertical jumps, 40m linear speed (VEL) and change-of-direction (COD) tests, using the median split technique. Twenty-two male rugby sevens players from the Brazilian National Olympic Team (Rio-2016) performed vertical jumping tests (squat and countermovement jumps [SJ and CMJ]), JS and HS exercises, COD speed test and sprinting velocity in 40 m, in this order. Based on the results of the MPP in the JS and HS exercises the participants were divided, using the median split, into four groups as follows: higher JS, lower JS, higher HS, and lower HS. Between-group differences in the functional tasks were detected via magnitude-based inferences. The athletes with higher MPP in the JS were capable of jumping higher and sprinting faster (including the COD speed test) than their weaker counterparts. This pattern was not observed in the HS exercise. To conclude, JS was shown to be more connected to sprinting, COD speed and jumping abilities than HS in elite rugby sevens players and should be preferred for assessing and possibly training elite athletes needing to improve speed-power related abilities.	[Loturco, Irineu; Pereira, Lucas A.; Kitamura, Katia; Cal Abad, Cesar C.; Kobal, Ronaldo; Nakamura, Fabio Y.] NAR Nucleus High Performance Sport, Sao Paulo, SP, Brazil; [Moraes, Jose E.] CBRu Brazilian Rugby Confederat, Sao Paulo, SP, Brazil; [Nakamura, Fabio Y.] Univ Estadual Londrina, Londrina, PR, Brazil	Universidade Estadual de Londrina	Loturco, I (corresponding author), NAR Nucleus High Performance Sport, Sao Paulo, SP, Brazil.	irineu.loturco@terra.com.br	Nakamura, Fábio Yuzo/AAC-3069-2020; Kobal, Ronaldo/AAU-8415-2021; Loturco, Irineu/AAH-4916-2019; PEREIRA, LUCAS/HHZ-5877-2022; Pereira, Lucas/S-3110-2019	Nakamura, Fábio Yuzo/0000-0002-5336-3652; Kobal, Ronaldo/0000-0003-0243-2133; Loturco, Irineu/0000-0003-1309-2568; Pereira, Lucas/0000-0003-1079-2446				Aagaard P, 2003, EXERC SPORT SCI REV, V31, P61, DOI 10.1097/00003677-200304000-00002; Aagaard P, 2002, J APPL PHYSIOL, V93, P1318, DOI 10.1152/japplphysiol.00283.2002; Argus CK, 2012, INT J SPORT PHYSIOL, V7, P68, DOI 10.1123/ijspp.7.1.68; Baker D, 1999, J STRENGTH COND RES, V13, P224, DOI 10.1519/00124278-199908000-00008; Barnes C, 2014, INT J SPORTS MED, V35, P1095, DOI 10.1055/s-0034-1375695; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Bloomfield J, 2007, J SPORT SCI MED, V6, P63; Chelly MS, 2009, J STRENGTH COND RES, V23, P2241, DOI 10.1519/JSC.0b013e3181b86c40; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cormie P, 2007, MED SCI SPORT EXER, V39, P340, DOI 10.1249/01.mss.0000246993.71599.bf; Cormie P, 2011, SPORTS MED, V41, P125, DOI 10.2165/11538500-000000000-00000; COSTILL DL, 1968, RES QUART, V39, P785, DOI 10.1080/10671188.1968.10616615; Cronin JB, 2005, J STRENGTH COND RES, V19, P349; Faude O, 2012, J SPORT SCI, V30, P625, DOI 10.1080/02640414.2012.665940; Hewit JK, 2012, INT J SPORTS SCI COA, V7, P503, DOI 10.1260/1747-9541.7.3.503; Hori N, 2008, J STRENGTH COND RES, V22, P54, DOI 10.1519/JSC.0b013e31815ef052; Iacobucci D, 2015, J CONSUM PSYCHOL, V25, P690, DOI 10.1016/j.jcps.2015.06.014; Kraemer, 1994, STRENGTH COND, V16, P20, DOI DOI 10.1519/1073-6840(1994)016<0020:DEMPIF>2.3.CO;2; Kumagai K, 2000, J APPL PHYSIOL, V88, P811, DOI 10.1152/jappl.2000.88.3.811; Little T, 2005, J STRENGTH COND RES, V19, P76; Loturco I, 2016, INT J SPORTS MED, V37, P211, DOI 10.1055/s-0035-1559694; Loturco I, 2015, INT J SPORT IN PRESS; Loturco I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153958; Loturco I, 2016, J STRENGTH COND RES, V30, P109, DOI 10.1519/JSC.0000000000001075; Loturco I, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00323; Loturco I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140102; Loturco I, 2015, J STRENGTH COND RES, V29, P2771, DOI 10.1519/JSC.0000000000000951; Loturco I, 2015, J STRENGTH COND RES, V29, P1966, DOI 10.1519/JSC.0000000000000849; Loturco I, 2015, J SPORT SCI, V33, P1283, DOI 10.1080/02640414.2015.1022574; Loturco I, 2015, J STRENGTH COND RES, V29, P758, DOI 10.1519/JSC.0000000000000660; Loturco I, 2013, J SPORT SCI MED, V12, P109; Loturco I, 2013, J STRENGTH COND RES, V27, P188, DOI 10.1519/JSC.0b013e3182503807; McBride JM, 2005, J STRENGTH COND RES, V19, P893, DOI 10.1519/00124278-200511000-00029; McBride JM, 2002, J STRENGTH COND RES, V16, P75, DOI 10.1519/00124278-200202000-00011; Newton RU, 1996, J APPL BIOMECH, V12, P31, DOI 10.1123/jab.12.1.31; Nibali ML, 2013, J STRENGTH COND RES, V27, P388, DOI 10.1519/JSC.0b013e3182576feb; Nimphius S, 2012, J STRENGTH COND RES, V26, P2655, DOI 10.1519/JSC.0b013e318269f81e; Nimphius S, 2010, J STRENGTH COND RES, V24, P885, DOI 10.1519/JSC.0b013e3181d4d41d; Rampinini E, 2007, INT J SPORTS MED, V28, P228, DOI 10.1055/s-2006-924340; Rhea MR, 2004, J STRENGTH COND RES, V18, P918, DOI 10.1519/00124278-200411000-00040; Sanchez-Medina L, 2010, INT J SPORTS MED, V31, P123, DOI 10.1055/s-0029-1242815; Sheppard JM, 2006, J SPORT SCI, V24, P919, DOI 10.1080/02640410500457109; Stone MH, 2006, STRENGTH COND J, V28, P44, DOI 10.1519/1533-4295(2006)28[44:MSASTR]2.0.CO;2; VIITASALO JT, 1978, EUR J APPL PHYSIOL O, V40, P7, DOI 10.1007/BF00420984; Wisloff U, 2004, BRIT J SPORT MED, V38, P285, DOI 10.1136/bjsm.2002.002071; Young W, 2006, STRENGTH COND J, V28, P24, DOI 10.1519/1533-4295(2006)28[24:AROAPA]2.0.CO;2	46	28	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170627	10.1371/journal.pone.0170627	http://dx.doi.org/10.1371/journal.pone.0170627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114431	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129000078
J	Martin-Vilchez, S; Whitmore, L; Asmussen, H; Zareno, J; Horwitz, R; Newell-Litwa, K				Martin-Vilchez, Samuel; Whitmore, Leanna; Asmussen, Hannelore; Zareno, Jessica; Horwitz, Rick; Newell-Litwa, Karen			RhoGTPase Regulators Orchestrate Distinct Stages of Synaptic Development	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; LINKED MENTAL-RETARDATION; DENDRITIC SPINE MORPHOLOGY; COPY NUMBER VARIANTS; AUTISM SPECTRUM DISORDERS; RHO GTPASES; ARRAY CGH; INTELLECTUAL DISABILITY; CHROMOSOMAL MICROARRAY; FOCAL ADHESIONS	Small RhoGTPases regulate changes in post-synaptic spine morphology and density that support learning and memory. They are also major targets of synaptic disorders, including Autism. Here we sought to determine whether upstream RhoGTPase regulators, including GEFs,GAPs, and GDIs, sculpt specific stages of synaptic development. The majority of examined molecules uniquely regulate either early spine precursor formation or later maturation. Specifically, an activator of actin polymerization, the Rac1 GEF beta-PIX, drives spine precursor formation, whereas both FRABIN, a Cdc42 GEF, and OLIGOPHRENIN-1, a RhoA GAP, regulate spine precursor elongation. However, in later development, a novel Rac1 GAP, ARHGAP23, and RhoGDIs inactivate actomyosin dynamics to stabilize mature synapses. Our observations demonstrate that specific combinations of RhoGTPase regulatory proteins temporally balance RhoGTPase activity during post-synaptic spine development.	[Martin-Vilchez, Samuel; Whitmore, Leanna; Asmussen, Hannelore; Zareno, Jessica; Horwitz, Rick; Newell-Litwa, Karen] Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA; [Newell-Litwa, Karen] East Carolina Univ, Dept Anat & Cell Biol, Brody Sch Med, Greenville, NC 27858 USA	University of Virginia; University of North Carolina; East Carolina University	Newell-Litwa, K (corresponding author), Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA.	litwak16@ecu.edu	Litwa, Karen/J-3815-2019; Martin-Vilchez, Samuel/AFV-2112-2022	Litwa, Karen/0000-0002-6180-3486; Martin-Vilchez, Samuel/0000-0003-0557-7653	NIGMS grant [GM23244]; Howard Hughes Institute Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM023244, R01GM023244] Funding Source: NIH RePORTER	NIGMS grant; Howard Hughes Institute Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The laboratory of R. Horwitz is supported by an NIGMS grant (GM23244) and K. Newell-Litwa was supported by a Howard Hughes Institute Fellowship administered by the Life Sciences Research Foundation and Hartwell Foundation Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by an NIGMS grant (GM23244) to R. Horwitz and a Howard Hughes Institute Fellowship administered by the Life Sciences Research Foundation and Hart-well Foundation Fellowship to K. Newell-Litwa.	Abe K, 2000, J BIOL CHEM, V275, P10141, DOI 10.1074/jbc.275.14.10141; Ahnert-Hilger G, 2004, J NEUROCHEM, V90, P9, DOI 10.1111/j.1471-4159.2004.02475.x; Al-Qattan SM, 2014, GENET MED; Ba W, 2016, CELL REP, V14, P1355, DOI 10.1016/j.celrep.2016.01.037; Battaglia A, 2013, EUR J PAEDIATR NEURO, V17, P589, DOI 10.1016/j.ejpn.2013.04.010; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Celestino-Soper PBS, 2011, HUM MOL GENET, V20, P4360, DOI 10.1093/hmg/ddr363; CHEN Hui, 2006, VEHICLE POWER TECHNO, V1, P1, DOI DOI 10.1093/GLYC0B/CWJ115; Chong WWS, 2014, MOL CYTOGENET, V7, DOI 10.1186/1755-8166-7-34; Coba MP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000102; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Dasouki M, 2014, EUR J MED GENET, V57, P76, DOI 10.1016/j.ejmg.2013.12.007; Delague V, 2007, AM J HUM GENET, V81, P1, DOI 10.1086/518428; Dimassi S, 2013, AM J MED GENET A, V161, P2564, DOI 10.1002/ajmg.a.36079; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Fortin DA, 2010, J NEUROSCI, V30, P11565, DOI 10.1523/JNEUROSCI.1746-10.2010; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Girirajan S, 2012, NEW ENGL J MED, V367, P1321, DOI 10.1056/NEJMoa1200395; Girirajan S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002334; Govek EE, 2004, NAT NEUROSCI, V7, P364, DOI 10.1038/nn1210; Gupta IR, 2013, J MED GENET, V50, P330, DOI 10.1136/jmedgenet-2012-101442; Hale CF, 2011, J NEUROSCI, V31, P12426, DOI 10.1523/JNEUROSCI.0685-11.2011; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hedrick NG, 2016, NAT PUBL GR, P538; Hodges JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024149; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Huesa G, 2010, J ALZHEIMERS DIS, V19, P37, DOI 10.3233/JAD-2010-1203; Iourov IY, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-46; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jordan BA, 2004, MOL CELL PROTEOMICS, V3, P857, DOI 10.1074/mcp.M400045-MCP200; Kaminsky EB, 2011, GENET MED, V13, P777, DOI 10.1097/GIM.0b013e31822c79f9; Kasri NN, 2009, GENE DEV, V23, P1289, DOI 10.1101/gad.1783809; Katoh K, 2007, GENES CELLS, V12, P623, DOI 10.1111/j.1365-2443.2007.01073.x; Katoh M, 2004, INT J ONCOL, V25, P535; Kaya N, 2012, ANN NEUROL, V71, P498, DOI 10.1002/ana.22673; Korobova F, 2010, MOL BIOL CELL, V21, P165, DOI 10.1091/mbc.E09-07-0596; Krumm N, 2015, NAT GENET, V47, P582, DOI 10.1038/ng.3303; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; Labandeira-Garcia J.L., 2014, NEUROSCIENTIST; Lamb AN, 2012, HUM MUTAT, V33, P728, DOI 10.1002/humu.22037; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Lionel AC, 2014, HUM MOL GENET, V23, P2752, DOI 10.1093/hmg/ddt669; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Marco EJ, 2008, J MED GENET, V45, P100, DOI 10.1136/jmg.2007.052324; Moon MS, 2010, MOL CELL NEUROSCI, V44, P118, DOI 10.1016/j.mcn.2010.03.001; Murata T, 2006, J NEUROSCI, V26, P12397, DOI 10.1523/JNEUROSCI.3981-06.2006; Nakano-Kobayashi A, 2014, J NEUROSCI, V34, P8665, DOI 10.1523/JNEUROSCI.0894-14.2014; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nakazawa T, 2008, J NEUROCHEM, V105, P1384, DOI 10.1111/j.1471-4159.2008.05335.x; Newell-Litwa KA, 2015, J CELL BIOL, V210, P225, DOI 10.1083/jcb.201504046; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Nguyen LS, 2013, HUM MOL GENET, V22, P1816, DOI 10.1093/hmg/ddt035; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; PAPA M, 1995, J NEUROSCI, V15, P1; Park E, 2003, J BIOL CHEM, V278, P19220, DOI 10.1074/jbc.M301052200; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Petratos S, 2008, BRAIN, V131, P90, DOI 10.1093/brain/awm260; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Poultney CS, 2013, AM J HUM GENET, V93, P607, DOI 10.1016/j.ajhg.2013.09.001; Reddy-Alla S, 2010, EUR J NEUROSCI, V31, P1173, DOI 10.1111/j.1460-9568.2010.07149.x; Reid T, 1999, J BIOL CHEM, V274, P33587, DOI 10.1074/jbc.274.47.33587; Rex CS, 2009, J CELL BIOL, V186, P85, DOI 10.1083/jcb.200901084; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Ryu JB, 2006, NEURON, V49, P175, DOI 10.1016/j.neuron.2005.12.017; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shimojima K, 2011, J HUM GENET, V56, P561, DOI 10.1038/jhg.2011.58; Soysal Y, 2011, AM J MED GENET A, V155A, P1745, DOI 10.1002/ajmg.a.34101; Stendel C, 2007, AM J HUM GENET, V81, P158, DOI 10.1086/518770; Sun Y, 2011, J NEUROSCI, V31, P17123, DOI 10.1523/JNEUROSCI.2359-11.2011; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Tashiro A, 2004, MOL CELL NEUROSCI, V26, P429, DOI 10.1016/j.mcn.2004.04.001; Tyagarajan SK, 2011, J CELL SCI, V124, P2786, DOI 10.1242/jcs.086199; Tzetis M, 2012, EXPERT REV MOL DIAGN, V12, P449, DOI [10.1586/erm.12.40, 10.1586/ERM.12.40]; Um K, 2014, DEV CELL, V29, P701, DOI 10.1016/j.devcel.2014.05.011; Umikawa M, 1999, J BIOL CHEM, V274, P25197, DOI 10.1074/jbc.274.36.25197; Vadodaria KC, 2013, J NEUROSCI, V33, P1179, DOI 10.1523/JNEUROSCI.2103-12.2013; Walker S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-499; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yatsenko SA, 2012, HUM GENET, V131, P1895, DOI 10.1007/s00439-012-1216-9; Yoshimura Y, 2004, J NEUROCHEM, V88, P759, DOI 10.1046/j.1471-4159.2003.02136.x; Zhang HY, 2003, J CELL BIOL, V161, P131, DOI 10.1083/jcb.200211002; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhao Z., 2014, MOL PSYCHIAT; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	93	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170464	10.1371/journal.pone.0170464	http://dx.doi.org/10.1371/journal.pone.0170464			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114311	Green Submitted, Green Published, gold			2022-12-26	WOS:000396129000052
J	Tan, LY; Walker, SM; Lonergan, T; Lima, NE; Todd, AV; Mokany, E				Tan, Lit Yeen; Walker, Samantha Michelle; Lonergan, Tina; Lima, Nicole Elizabeth; Todd, Alison Velyian; Mokany, Elisa			Superior Multiplexing Capacity of PlexPrimers Enables Sensitive and Specific Detection of SNPs and Clustered Mutations in qPCR	PLOS ONE			English	Article							PARAFFIN-EMBEDDED TISSUE; GROWTH-FACTOR RECEPTOR; LUNG-CANCER; DRUG-RESISTANCE; POINT MUTATION; PLASMA DNA; AMPLIFICATION; GENE; PCR; SPECIMENS	Background Whilst qPCR provides an extremely powerful tool for genetic analysis, some applications such as multiplexing variant alleles (eg SNPs, point mutations or deletions), remain challenging using current primer/probe systems. The novel design features of PlexPrimers allow sensitive, multiplexed analysis of variant alleles even when these are tightly clustered. Method PlexPrimers were combined with PlexZymes in qPCR assays for the detection of SNPs in human absorption, distribution, metabolism, and excretion (ADME) genes; clustered mutations in the 23S rRNA gene which confer antibiotic resistance to Mycoplasma genitalium; and deletions within the human epidermal growth factor receptor (EGFR) gene. Results The combination of PlexPrimers and PlexZymes allowed robust multiplexing of targets which resulted in 100% concordance with results obtained using hydrolysis probe kits for 14 SNPs in the ADME genes. A 7-plex qPCR assay targeting M. genitalium, 5 clustered mutations associated with macrolide resistance and an internal control, allowed efficient amplification of all targets, with all 5 mutations detected in a single channel. Finally, the strategy was employed to analyse common EGFR mutants with high sensitivity, detecting deletions present at only 0.01%. Conclusion PlexPrime is a novel technology for the detection of genetic variants. Unlike previous strategies, the combination of PlexPrimers with PlexZymes enables both allele-specific detection and allele-specific amplification in qPCR. The study demonstrated highly sensitive and specific detection of mutations and SNPs, and superior multiplexing capacity. The ability to multiplex clustered genetic variants reduces the time to result providing more actionable information.	[Tan, Lit Yeen; Walker, Samantha Michelle; Lonergan, Tina; Lima, Nicole Elizabeth; Todd, Alison Velyian; Mokany, Elisa] SpeeDx Pty Ltd, Eveleigh, NSW, Australia		Mokany, E (corresponding author), SpeeDx Pty Ltd, Eveleigh, NSW, Australia.	elisam@speedx.com.au			SpeeDx PTY LTD	SpeeDx PTY LTD	SpeeDx PTY LTD provided support in the form of salaries and research materials for the authors EM, AT, LT, TL, SW and NL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bissessor M, 2015, CLIN INFECT DIS, V60, P1228, DOI 10.1093/cid/ciu1162; Board RE, 2008, CLIN CHEM, V54, P757, DOI 10.1373/clinchem.2007.098376; Burrell RA, 2014, MOL ONCOL, V8, P1095, DOI 10.1016/j.molonc.2014.06.005; Cha R S, 1992, PCR Methods Appl, V2, P14; Chen X, 2003, PHARMACOGENOMICS J, V3, P77, DOI 10.1038/sj.tpj.6500167; Chun JY, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm051; Clayton SJ, 2000, CLIN CHEM, V46, P1929; Crowley E, 2013, NAT REV CLIN ONCOL, V10, P472, DOI 10.1038/nrclinonc.2013.110; De Luca C., 2016, J CLIN PATHOL; Jensen JS, 2012, METHODS MOL BIOL, V903, P129, DOI 10.1007/978-1-61779-937-2_8; Laosinchai-Wolf W, 2011, J CLIN PATHOL, V64, P30, DOI 10.1136/jcp.2010.081539; Li BH, 2004, GENOMICS, V83, P311, DOI 10.1016/j.ygeno.2003.08.005; Malkki Mari, 2012, Methods Mol Biol, V882, P173, DOI 10.1007/978-1-61779-842-9_10; Melchior L, 2015, EXP MOL PATHOL, V99, P485, DOI 10.1016/j.yexmp.2015.09.004; Milbury CA, 2009, CLIN CHEM, V55, P632, DOI 10.1373/clinchem.2008.113035; Mitsudomi T, 2010, FEBS J, V277, P301, DOI 10.1111/j.1742-4658.2009.07448.x; Mokany E, 2013, CLIN CHEM, V59, P419, DOI 10.1373/clinchem.2012.192930; Mokany E, 2010, J AM CHEM SOC, V132, P1051, DOI 10.1021/ja9076777; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Oxnard GR, 2014, CLIN CANCER RES, V20, P1698, DOI 10.1158/1078-0432.CCR-13-2482; Piatek AS, 1998, NAT BIOTECHNOL, V16, P359, DOI 10.1038/nbt0498-359; Qiagen, 2012, QIAPREP MIN HDB, P1; Sorensen BS, 2014, CANCER-AM CANCER SOC, V120, P3896, DOI 10.1002/cncr.28964; Tabrizi SN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156740; Twin J, 2012, PLOS ONE, V7, P1; Vandenbroucke I, AACR 2014; Vargas DY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156546; Vossen RHAM, 2009, HUM MUTAT, V30, P860, DOI 10.1002/humu.21019	28	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170087	10.1371/journal.pone.0170087	http://dx.doi.org/10.1371/journal.pone.0170087			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114309	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129000020
J	Htoo, HH; Limsuvan, S; Thamsermsang, O; Hernandez, JF; Checler, F; Govitrapong, P; Pakaprot, N; Akarasereenont, P; Vincent, B				Htoo, Htut Htut; Limsuvan, Suveerawan; Thamsermsang, Onusa; Hernandez, Jean-Francois; Checler, Frederic; Govitrapong, Piyarat; Pakaprot, Narawut; Akarasereenont, Pravit; Vincent, Bruno			The Polyherbal Wattana Formula Displays Anti-Amyloidogenic Properties by Increasing alpha-Secretase Activities	PLOS ONE			English	Article							ACETYLCHOLINESTERASE INHIBITORY-ACTIVITY; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; GALLIC ACID; CENTELLA-ASIATICA; HUMAN-CELLS; EXTRACT; IDENTIFICATION; DISINTEGRIN; TOXICITY	Alzheimer's disease is characterized by the deposition of insoluble amyloid-beta peptides produced from the beta-amyloid precursor protein (beta APP). Because a-secretase cleavage by ADAM10 and ADAM17 takes place in the middle of A beta, its activation is considered as a promising anti-AD therapeutic track. Here we establish that the polyherbal Wattana formula (WNF) stimulates sAPP alpha production in cells of neuronal and non-neuronal origins through an increase of both ADAM10 and ADAM17 catalytic activities with no modification of BACE1 activity and expression. This effect is blocked by specific inhibition or genetic depletion of these disintegrins and we show that WNF up-regulates ADAM10 transcription and ADAM17 maturation. In addition, WNF reduces A beta 40 and A beta 42 generation in human cell lines. Altogether, WNF presents all the characteristics of a potent preventive anti-Alzheimer formula. Importantly, this natural recipe, currently prescribed to patients for the treatment of other symptoms without any secondary effect, can be tested immediately for further clinical studies.	[Htoo, Htut Htut; Govitrapong, Piyarat; Vincent, Bruno] Mahidol Univ, Inst Mol Biosci, Nakhon Pathom, Thailand; [Limsuvan, Suveerawan; Thamsermsang, Onusa; Akarasereenont, Pravit] Mahidol Univ, Siriraj Hosp, Ctr Appl Thai Tradit Med, Fac Med, Bangkok, Thailand; [Hernandez, Jean-Francois] Univ Montpellier, ENSCM, CNRS UMR5247, Inst Biomol Max Mousseron,Fac Pharm, Montpellier, France; [Checler, Frederic] Univ Cote Azur, INSERM, CNRS, IPMC,Lab Excellence DistALZ, Valbonne, France; [Govitrapong, Piyarat] Mahidol Univ, Fac Sci, Ctr Neurosci, Bangkok, Thailand; [Govitrapong, Piyarat] Mahidol Univ, Fac Sci, Dept Pharmacol, Bangkok, Thailand; [Govitrapong, Piyarat; Vincent, Bruno] Mahidol Univ, Inst Mol Biosci, Res Ctr Neurosci, Nakhon Pathom, Thailand; [Pakaprot, Narawut] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Physiol, Bangkok, Thailand; [Akarasereenont, Pravit] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Pharmacol, Bangkok, Thailand; [Vincent, Bruno] CNRS, Paris, France	Mahidol University; Mahidol University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Mahidol University; Mahidol University; Mahidol University; Mahidol University; Mahidol University; Centre National de la Recherche Scientifique (CNRS)	Vincent, B (corresponding author), Mahidol Univ, Inst Mol Biosci, Nakhon Pathom, Thailand.; Vincent, B (corresponding author), Mahidol Univ, Inst Mol Biosci, Res Ctr Neurosci, Nakhon Pathom, Thailand.; Vincent, B (corresponding author), CNRS, Paris, France.	bruno.vin@mahidol.ac.th	Checler, Frederic/C-1241-2009	Checler, Frederic/0000-0003-2098-1750; Htoo, Htut Htut/0000-0002-3284-0608; Thamsermsang, Onusa/0000-0002-7566-8238; Vincent, Bruno/0000-0003-3876-2118	National Science and Technology Development Agency (NSTDA) [P-10-11285, P-11-00783]; Thailand Research Fund (TRF) [IRG 5780009]; Mahidol University	National Science and Technology Development Agency (NSTDA); Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); Mahidol University	This work was supported by the National Science and Technology Development Agency (NSTDA) grant number P-10-11285 (PG, BV) and grant number P-11-00783 (BV); http://www.nstda.or.th/eng/index.php; the Thailand Research Fund (TRF) grant number IRG 5780009 (BV); http://www.trf.or.th/eng/index.php; and Mahidol University budget grant 2014 (BV); https://www.mahidol.ac.th/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrau D, 2003, J BIOL CHEM, V278, P25859, DOI 10.1074/jbc.M302622200; Asaduzzaman M, 2014, PSYCHOGERIATRICS, V14, P1, DOI 10.1111/psyg.12031; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Borchelt DR, 1996, NEURON, P17; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bunnan K., 2012, Siriraj Medical Journal, V64, P89; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Chonpathompikunlert P, 2010, FOOD CHEM TOXICOL, V48, P798, DOI 10.1016/j.fct.2009.12.009; Cisse MA, 2006, BIOCHEM BIOPH RES CO, V347, P254, DOI 10.1016/j.bbrc.2006.06.065; Claasen AM, 2009, NEUROSCI LETT, V460, P92, DOI 10.1016/j.neulet.2009.05.040; Dhanasekaran M, 2009, PHYTOTHER RES, V23, P14, DOI 10.1002/ptr.2405; Duangsa-Ard S., 2013, Siriraj Medical Journal, V65, P73; Essa MM, 2012, NEUROCHEM RES, V37, P1829, DOI 10.1007/s11064-012-0799-9; Furukawa K, 1996, J NEUROCHEM, V67, P1882, DOI 10.1046/j.1471-4159.1996.67051882.x; Hajipour S, 2016, BASIC CLIN NEUROSCI, V7, P97, DOI 10.15412/J.BCN.03070203; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Holcomb LA, 2006, J ALZHEIMERS DIS, V9, P243; Ingkaninan K, 2003, J ETHNOPHARMACOL, V89, P261, DOI 10.1016/j.jep.2003.08.008; Kim JH, 2015, NUTR RES PRACT, V9, P480, DOI 10.4162/nrp.2015.9.5.480; Kim MJ, 2011, MOL NUTR FOOD RES, V55, P1798, DOI 10.1002/mnfr.201100262; Kumar MHV, 2003, CLIN EXP PHARMACOL P, V30, P336, DOI 10.1046/j.1440-1681.2003.03842.x; Lin YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079299; Liu YQ, 2013, BIOORG MED CHEM LETT, V23, P6336, DOI 10.1016/j.bmcl.2013.09.071; Marambaud P, 1997, J NEUROCHEM, V68, P698; Mathew M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086804; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Meziane H, 1998, P NATL ACAD SCI USA, V95, P12683, DOI 10.1073/pnas.95.21.12683; Mori T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055774; Panich U, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-159; Pengkhum Thanyaporn, 2012, Journal of the Medical Association of Thailand, V95, P452; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Rao RV, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt125; Sehgal N, 2012, P NATL ACAD SCI USA, V109, P3510, DOI 10.1073/pnas.1112209109; Shukla M, 2015, J PINEAL RES, V58, P151, DOI 10.1111/jpi.12200; Uabundit N, 2010, J ETHNOPHARMACOL, V127, P26, DOI 10.1016/j.jep.2009.09.056; Vincent B, 2000, J BIOL CHEM, V275, P35612, DOI 10.1074/jbc.M004628200; Vincent B, 2012, CURR ALZHEIMER RES, V9, P140, DOI 10.2174/156720512799361646; Vincent B, 2011, J ALZHEIMERS DIS, V24, P75, DOI 10.3233/JAD-2011-110218; Vingtdeux V, 2012, J NEUROCHEM, V120, P34, DOI 10.1111/j.1471-4159.2011.07477.x; Wollen KA, 2010, ALTERN MED REV, V15, P223; Woo HN, 2011, BIOCHEM BIOPH RES CO, V404, P10, DOI 10.1016/j.bbrc.2010.11.132; Yan JJ, 2013, BIOL PHARM BULL, V36, P140, DOI 10.1248/bpb.b12-00798; Yan JJ, 2001, BRIT J PHARMACOL, V133, P89, DOI 10.1038/sj.bjp.0704047; Yoon JH, 2014, J AGR FOOD CHEM, V62, P4911, DOI 10.1021/jf501314g; Zhang H, 2012, J NEUROCHEM, V120, P9, DOI 10.1111/j.1471-4159.2011.07519.x	46	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170360	10.1371/journal.pone.0170360	http://dx.doi.org/10.1371/journal.pone.0170360			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107420	gold, Green Published, Green Submitted			2022-12-26	WOS:000392405300118
J	Jacobs, C; Lambourne, L; Xia, Y; Segre, D				Jacobs, Christopher; Lambourne, Luke; Xia, Yu; Segre, Daniel			Upon Accounting for the Impact of Isoenzyme Loss, Gene Deletion Costs Anticorrelate with Their Evolutionary Rates	PLOS ONE			English	Article							METABOLIC NETWORK; SACCHAROMYCES; YEAST; GENOME; DISPENSABILITY; EPISTASIS; BACKUP	System-level metabolic network models enable the computation of growth and metabolic phenotypes from an organism's genome. In particular, flux balance approaches have been used to estimate the contribution of individual metabolic genes to organismal fitness, offering the opportunity to test whether such contributions carry information about the evolutionary pressure on the corresponding genes. Previous failure to identify the expected negative correlation between such computed gene-loss cost and sequence-derived evolutionary rates in Saccharomyces cerevisiae has been ascribed to a real biological gap between a gene's fitness contribution to an organism "here and now" and the same gene's historical importance as evidenced by its accumulated mutations over millions of years of evolution. Here we show that this negative correlation does exist, and can be exposed by revisiting a broadly employed assumption of flux balance models. In particular, we introduce a new metric that we call "function-loss cost", which estimates the cost of a gene loss event as the total potential functional impairment caused by that loss. This new metric displays significant negative correlation with evolutionary rate, across several thousand minimal environments. We demonstrate that the improvement gained using function-loss cost over gene-loss cost is explained by replacing the base assumption that isoenzymes provide unlimited capacity for backup with the assumption that isoenzymes are completely non-redundant. We further show that this change of the assumption regarding isoenzymes increases the recall of epistatic interactions predicted by the flux balance model at the cost of a reduction in the precision of the predictions. In addition to suggesting that the gene-to-reaction mapping in genome-scale flux balance models should be used with caution, our analysis provides new evidence that evolutionary gene importance captures much more than strict essentiality.	[Jacobs, Christopher; Lambourne, Luke; Xia, Yu; Segre, Daniel] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Lambourne, Luke; Xia, Yu] McGill Univ, Fac Engn, Dept Bioengn, Montreal, PQ, Canada; [Segre, Daniel] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA; [Segre, Daniel] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Boston University; McGill University; Boston University; Boston University	Segre, D (corresponding author), Boston Univ, Bioinformat Program, Boston, MA 02215 USA.; Segre, D (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.; Segre, D (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.	dsegre@bu.edu	Lambourne, Luke/AAG-7298-2020; Xia, Yu/W-6150-2019; Segre, Daniel/A-1993-2009	Lambourne, Luke/0000-0002-7001-7575; Xia, Yu/0000-0002-5596-5518; Segre, Daniel/0000-0003-4859-1914	National Science Foundation [CCF-1219007]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-03892]; National Institute of Health [5R01GM089978, 5R01GM103502]; Army Research Office - Multidisciplinary University Research Initiative [W911NF-12-1-0390]; US Department of Energy [DE-SC0012627]; Canada Research Chairs Program	National Science Foundation(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Office - Multidisciplinary University Research Initiative(MURI); US Department of Energy(United States Department of Energy (DOE)); Canada Research Chairs Program(Canada Research Chairs)	This work was supported by the National Science Foundation, grant CCF-1219007 to YX; the Natural Sciences and Engineering Research Council of Canada, grant RGPIN-2014-03892 to YX; the National Institute of Health, grants 5R01GM089978 and 5R01GM103502 to DS; the Army Research Office - Multidisciplinary University Research Initiative, grant W911NF-12-1-0390 to DS; the US Department of Energy, grant DE-SC0012627 to DS; and by the Canada Research Chairs Program (YX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aung Hnin W, 2013, Ind Biotechnol (New Rochelle N Y), V9, P215; Burgard AP, 2004, GENOME RES, V14, P301, DOI 10.1101/gr.1926504; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Covert MW, 2001, J THEOR BIOL, V213, P73, DOI 10.1006/jtbi.2001.2405; DeLuna A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000347; Environments D., 2010, PLOS COMPUT BIOL, V6, DOI [10.1371/journal.pcbi.1001002, DOI 10.1371/JOURNAL.PCBI.1001002]; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Harrison R, 2007, P NATL ACAD SCI USA, V104, P2307, DOI 10.1073/pnas.0607153104; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Heavner BD, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat059; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hirsh AE, 2005, MOL BIOL EVOL, V22, P174, DOI 10.1093/molbev/msh265; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Ihmels J, 2004, NAT BIOTECHNOL, V22, P86, DOI 10.1038/nbt918; Ihmels J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100127; Kafri R, 2005, NAT GENET, V37, P295, DOI 10.1038/ng1523; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kuepfer L, 2005, GENOME RES, V15, P1421, DOI 10.1101/gr.3992505; Kurtzman CP, 2003, FEMS YEAST RES, V4, P233, DOI 10.1016/S1567-1356(03)00175-2; Mo ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-37; Organization D., 2012, EVOLUTIONARY SYSTEMS, P53; Orr HA, 2009, NAT REV GENET, V10, P531, DOI 10.1038/nrg2603; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Poelwijk FJ, 2011, J THEOR BIOL, V272, P141, DOI 10.1016/j.jtbi.2010.12.015; Raman K, 2009, BRIEF BIOINFORM, V10, P435, DOI 10.1093/bib/bbp011; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Shlomi T, 2007, GENOME RES, V17, P1626, DOI 10.1101/gr.6678707; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Szappanos B, 2011, NAT GENET, V43, P656, DOI 10.1038/ng.846; Wang Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000329; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xia Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000413; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7	38	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170164	10.1371/journal.pone.0170164	http://dx.doi.org/10.1371/journal.pone.0170164			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107392	Green Published, gold, Green Submitted			2022-12-26	WOS:000392405300078
J	Khandoker, AH; Al-Angari, HM; Khalaf, K; Lee, S; Almahmeed, W; Al Safar, HS; Jelinek, HF				Khandoker, Ahsan H.; Al-Angari, Haitham M.; Khalaf, Kinda; Lee, Sungmun; Almahmeed, Wael; Al Safar, Habiba S.; Jelinek, Herbert F.			Association of Diabetes Related Complications with Heart Rate Variability among a Diabetic Population in the UAE	PLOS ONE			English	Article							CARDIAC AUTONOMIC NEUROPATHY; SYMPATHOVAGAL BALANCE; CARDIOVASCULAR EVENTS; PERIPHERAL NEUROPATHY; RISK-FACTORS; RETINOPATHY; PREVALENCE; DYSFUNCTION; MELLITUS; FEATURES	Microvascular, macrovascular and neurological complications are the key causes of morbidity and mortality among type II diabetes mellitus (T2DM) patients. The aim of this study was to investigate the alterations of cardiac autonomic function of diabetic patients in relation to three types of diabetes-related complications. ECG recordings were collected and analyzed from 169 T2DM patients in supine position who were diagnosed with nephropathy (n = 55), peripheral neuropathy (n = 64) and retinopathy (n = 106) at two hospitals in the UAE. Comparison between combinations of patients with complications and a control diabetic group (CONT) with no complication (n = 34) was performed using time, frequency and multi-lag entropy measures of heart rate variability (HRV). The results show that these measures decreased significantly (p<0.05) depending on the presence and type of diabetic complications. Entropy, (median, 1 st-3 rd interquartile range) for the group combining all complications (1.74,1.37-2.09) was significantly lower than the corresponding values for the CONT group (1.77, 1.39-2.24) with lag-1 for sequential beat-to-beat changes. Odds ratios (OR) from the entropy analysis further demonstrated a significantly higher association with the combination of retinopathy and peripheral neuropathy versus CONT (OR: 1.42 at lag 8) and an even OR for the combination of retinopathy and nephropathy (OR: 2.46 at lag 8) compared to the other groups with complications. Also, the OR of low frequency power to high frequency power ratio (LF/HF) showed a higher association with these diabetic-related complications compared to CONT, especially for the patient group combining all complications (OR: 4.92). This study confirms that the type of microvascular or peripheral neuropathy complication present in T2DM patients have different effects on heart rate entropy, implying disorders of multi-organ connectivity are directly associated with autonomic nervous system dysfunction. Clinical practice may benefit from including multi-lag entropy for cardiac rhythm analysis in conjunction with traditional screening methods in patients with diabetic complications to ensure better preventive and treatment outcomes in the Emirati Arab population.	[Khandoker, Ahsan H.; Khalaf, Kinda; Lee, Sungmun; Al Safar, Habiba S.] Khalifa Univ, Dept Biomed Engn, Abu Dhabi, U Arab Emirates; [Al-Angari, Haitham M.; Al Safar, Habiba S.] Khalifa Univ, Ctr Biotechnol, Abu Dhabi, U Arab Emirates; [Almahmeed, Wael] Sheikh Khalifa Med City, Inst Cardiac Sci, Abu Dhabi, U Arab Emirates; [Almahmeed, Wael] Cleveland Clin, Inst Heart & Vasc, Abu Dhabi, U Arab Emirates; [Jelinek, Herbert F.] Charles Sturt Univ, Sch Community Hlth, Albury, NSW, Australia; [Jelinek, Herbert F.] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW, Australia	Khalifa University of Science & Technology; Khalifa University of Science & Technology; Cleveland Clinic Foundation; Charles Sturt University; Macquarie University	Al Safar, HS (corresponding author), Khalifa Univ, Dept Biomed Engn, Abu Dhabi, U Arab Emirates.; Al Safar, HS (corresponding author), Khalifa Univ, Ctr Biotechnol, Abu Dhabi, U Arab Emirates.; Jelinek, HF (corresponding author), Charles Sturt Univ, Sch Community Hlth, Albury, NSW, Australia.; Jelinek, HF (corresponding author), Macquarie Univ, Australian Sch Adv Med, Sydney, NSW, Australia.	habiba.alsafar@kustar.ac.ae; hjelinek@csu.edu.au	Jelinek, Herbert F/S-6779-2019; Khandoker, Ahsan Habib/B-3754-2013; Jelinek, Herbert/AAQ-6825-2020; Alsafar, Habiba/P-2003-2016	Jelinek, Herbert F/0000-0001-5457-6193; Khandoker, Ahsan Habib/0000-0002-0636-1646; /0000-0002-0405-516X; Khalaf, Kinda/0000-0002-3878-2621; Alsafar, Habiba/0000-0001-7141-1438	Khalifa University of Science, Technology and Research	Khalifa University of Science, Technology and Research	This work was funded by Khalifa University of Science, Technology and Research, www.kustar.ac.ae.	Amano M, 2005, EUR J APPL PHYSIOL, V94, P602, DOI 10.1007/s00421-005-1364-x; Aring AM, 2005, AM FAM PHYSICIAN, V71, P2123; BELLAVERE F, 1992, DIABETES, V41, P633, DOI 10.2337/diabetes.41.5.633; Brennan E, 2013, GENES-BASEL, V4, P596, DOI 10.3390/genes4040596; Brennan M, 2001, IEEE T BIO-MED ENG, V48, P1342, DOI 10.1109/10.959330; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cade WT, 2008, PHYS THER, V88, P1322, DOI 10.2522/ptj.20080008; Camm AJ, 1996, CIRCULATION, V93, P1043; Christensen JH, 1999, ATHEROSCLEROSIS, V145, P181, DOI 10.1016/S0021-9150(99)00052-0; Dabby R, 2007, J PERIPHER NERV SYST, V12, P98, DOI 10.1111/j.1529-8027.2007.00128.x; Drummond KN, 2003, DIABETES, V52, P1818, DOI 10.2337/diabetes.52.7.1818; El-Asrar AMA, 1998, INT OPHTHALMOL, V22, P155, DOI 10.1023/A:1006240928938; EWING DJ, 1981, DIABETOLOGIA, V21, P18, DOI 10.1007/BF03216217; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Fowler MJ, 2008, CLIN DIABETES, V26, P77, DOI [DOI 10.2337/DIACLIN.26.2.77, 10.2337/diaclin.26.2.77]; Herman WH, 1998, DIABETIC MED, V15, P1045, DOI 10.1002/(SICI)1096-9136(1998120)15:12<1045::AID-DIA696>3.0.CO;2-L; HUSSEIN MM, 1994, NEPHROL DIAL TRANSPL, V9, P1072, DOI 10.1093/ndt/9.8.1072; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jbour AS, 2003, SAUDI MED J, V24, P761; Jelinek HF, 2010, COMPUT CARDIOL CONF, V37, P955; Jelinek HF, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00186; Jelinek HF, 2010, AUTOMATED IMAGE DETECTION OF RETINAL PATHOLOGY, P1; Jelinek HJ, 2014, 2014 8TH CONFERENCE OF THE EUROPEAN STUDY GROUP ON CARDIOVASCULAR OSCILLATIONS (ESGCO), P3, DOI 10.1109/ESGCO.2014.6847490; Karmakar CK, 2013, MED BIOL ENG COMPUT, V51, P537, DOI 10.1007/s11517-012-1022-5; Khandekar R, 2003, BRIT J OPHTHALMOL, V87, P1061, DOI 10.1136/bjo.87.9.1061; Khandoker AH, 2015, COMPUTING CARDIOLOGY; Khandoker AH, 2010, COMPUT CARDIOL CONF, V37, P69; Khandoker AH, 2010, MED ENG PHYS, V32, P161, DOI 10.1016/j.medengphy.2009.11.005; Khandoker AH, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-3; Klein R, 2005, DIABETES, V54, P527, DOI 10.2337/diabetes.54.2.527; Krishnan AV, 2007, MUSCLE NERVE, V35, P273, DOI 10.1002/mus.20713; KROLEWSKI AS, 1992, DIABETES, V41, P430, DOI 10.2337/diabetes.41.4.430; Lerma C, 2003, CLIN PHYSIOL FUNCT I, V23, P72; Marzbanrad F, 2016, IEEE J BIOMED HEALTH, V20, P55, DOI 10.1109/JBHI.2015.2480778; Maxwell S.E., 1993, APPL ANAL VARIANCE B, P63; McCarty CA, 2001, CLIN EXP OPHTHALMOL, V29, P52, DOI 10.1046/j.1442-9071.2001.00376.x; Nielsen JV, 1998, DIABETES RES CLIN PR, V41, P63; Oida E, 1997, J APPL PHYSIOL, V82, P1794, DOI 10.1152/jappl.1997.82.6.1794; PAISEY RB, 1984, DIABETES CARE, V7, P428, DOI 10.2337/diacare.7.5.428; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; Penno G, 2012, DIABETES CARE, V35, P2317, DOI 10.2337/dc12-0628; QUADE D, 1967, J AM STAT ASSOC, V62, P1187, DOI 10.2307/2283769; Sasso FC, 2012, NEPHROL DIAL TRANSPL, V27, P2269, DOI 10.1093/ndt/gfr644; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Singer W, 2004, NEUROLOGY, V62, P612, DOI 10.1212/01.WNL.0000110313.39239.82; SMITH SE, 1981, DIABETOLOGIA, V21, P525; Stein PK, 2005, J CARDIOVASC ELECTR, V16, P13, DOI 10.1046/j.1540-8167.2005.04358.x; Targher G, 2008, DIABETIC MED, V25, P45, DOI 10.1111/j.1464-5491.2007.02327.x; Tarvainen MP, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00130; Vinik A, 2007, US ENDOCR DIS, V2, P66, DOI [10.1161/CIRCULATIONAHA.106.634949, DOI 10.1161/CIRCULATIONAHA.106.634949]; Vinik AI, 2007, CIRCULATION, V115, P387, DOI 10.1161/CIRCULATIONAHA.106.634949; Vinik AI, 2004, MED CLIN N AM, V88, P947, DOI [10.1016/j.mcna.2004.04.009, 10.1212/01.CON.0000455884.29545.d2]; Vinik AI, 2003, DIABETES CARE, V26, P1553, DOI 10.2337/diacare.26.5.1553; Wang DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106935; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Wilson NM, 2012, J DIABETES METAB, V3, DOI 10.4172/2155-6156.S5-004; YOUNG MJ, 1993, DIABETOLOGIA, V36, P150, DOI 10.1007/BF00400697	58	16	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0168584	10.1371/journal.pone.0168584	http://dx.doi.org/10.1371/journal.pone.0168584			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107340	Green Published, gold			2022-12-26	WOS:000392405300013
J	Uecker, FC; Olze, H; Kunte, H; Gerz, C; Goktas, O; Harms, L; Schmidt, FA				Uecker, Florian Cornelius; Olze, Heidi; Kunte, Hagen; Gerz, Christian; Goektas, Oender; Harms, Lutz; Schmidt, Felix Alexander			Longitudinal Testing of Olfactory and Gustatory Function in Patients with Multiple Sclerosis	PLOS ONE			English	Article							BULB VOLUME; DYSFUNCTION; PATHOLOGY; IDENTIFICATION	Background The aim of the study was to investigate changes of the olfactory and gustatory capacity in patients with multiple sclerosis (MS). Methodology 20 MS patients were tested longitudinally for 3 years after initial testing. The Threshold Discrimination Identification test (TDI) was used for subjective olfactometry. Objective olfactometry was performed by registering olfactory evoked potentials (OEP) by EEG. The Taste Strip Test (TST) was used for gustatory testing. Results 45% of the patients showed olfactory dysfunction in the follow-up TDI test and 50% showed delayed OEP's. 20% of the patients showed gustatory dysfunction on follow-up visit. The patients showed mild disease activity with 0,3 0,5 relapses over the testing period and no significant change of their olfactory and gustatory capacity. The olfactory capacity for the discrimination of odors correlated inversely with the number of relapses (r = -0.5, p <= 0.05). The patients were aware of their olfactory deficit. Conclusions Olfactory and gustatory dysfunction is a symptom in MS patients and may be a useful parameter to estimate disease progression in MS patients. As the discrimination of odors is processed in higher central regions of the central nervous system (CNS), the results suggest that olfactory dysfunction could be due to CNS damage.	[Uecker, Florian Cornelius; Olze, Heidi; Gerz, Christian; Goektas, Oender] Charite, Dept Otorhinolaryngol, Berlin, Germany; [Kunte, Hagen; Harms, Lutz; Schmidt, Felix Alexander] Charite, Dept Neurol, Clin & Expt Multiple Sclerosis Res Ctr, Berlin, Germany; [Kunte, Hagen] MSB, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schmidt, FA (corresponding author), Charite, Dept Neurol, Clin & Expt Multiple Sclerosis Res Ctr, Berlin, Germany.	felix.schmidt@charite.de		Olze, Heidi/0000-0001-9987-6392				Abolmaali N, 2008, NEUROIMAG CLIN N AM, V18, P233, DOI 10.1016/j.nic.2007.10.002; Barresi M, 2012, J NEUROL SCI, V323, P16, DOI 10.1016/j.jns.2012.08.028; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Benatru I, 2003, REV NEUROL-FRANCE, V159, P287; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Caminiti F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103151; DeLuca GC, 2015, BRAIN PATHOL, V25, P543, DOI 10.1111/bpa.12209; Doty RL, 1999, NEUROLOGY, V53, P880, DOI 10.1212/WNL.53.4.880; Doty RL, 1998, ANN NY ACAD SCI, V855, P781, DOI 10.1111/j.1749-6632.1998.tb10658.x; Fleiner F, 2010, AM J RHINOL ALLERGY, V24, pE93, DOI 10.2500/ajra.2010.24.3506; Goektas O, 2011, RHINOLOGY, V49, P221, DOI 10.4193/Rhino10.136; Hahner A, 2010, HNO, V58, P644, DOI 10.1007/s00106-010-2122-x; Hawkes CH, 1997, J NEUROL NEUROSUR PS, V63, P145, DOI 10.1136/jnnp.63.2.145; Heilmann S, 2004, LARYNGO RHINO OTOL, V83, P729, DOI 10.1055/s-2004-825676; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 2000, HNO, V48, P481, DOI 10.1007/s001060050602; Hummel T, 2008, RIECH SCHMECKSTORUNG; Hummel T, 2015, J NEUROL, V262, P1046, DOI 10.1007/s00415-015-7691-x; Kunte H, 2015, AUSTIN J MULT SCLER, V2, P1010; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Landis BN, 2009, J NEUROL, V256, P242, DOI 10.1007/s00415-009-0088-y; Lublin FD, 2014, NEUROLOGY, V83, P278, DOI 10.1212/WNL.0000000000000560; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ponsen MM, 2004, ANN NEUROL, V56, P173, DOI 10.1002/ana.20160; Rollin H, 1976, Laryngol Rhinol Otol (Stuttg), V55, P678; Rombaux P, 2009, RHINOLOGY, V47, P3; Schmidt FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019702; Silva AM, 2012, MULT SCLER J, V18, P616, DOI 10.1177/1352458511427156; Zorzon M, 2000, MULT SCLER J, V6, P386, DOI 10.1191/135245800701566368	29	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170492	10.1371/journal.pone.0170492	http://dx.doi.org/10.1371/journal.pone.0170492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107525	Green Published, Green Submitted, gold			2022-12-26	WOS:000392405300146
J	Malami, I; Abdul, AB; Abdullah, R; Kassim, NKB; Rosli, R; Yeap, SK; Waziri, P; Etti, IC; Bello, MB				Malami, Ibrahim; Abdul, Ahmad Bustamam; Abdullah, Rasedee; Kassim, Nur Kartinee Bt; Rosli, Rozita; Yeap, Swee Keong; Waziri, Peter; Etti, Imaobong Christopher; Bello, Muhammad Bashir			Crude Extracts, Flavokawain B and Alpinetin Compounds from the Rhizome of Alpinia mutica Induce Cell Death via UCK2 Enzyme Inhibition and in Turn Reduce 18S rRNA Biosynthesis in HT-29 Cells	PLOS ONE			English	Article							MOLECULAR-WEIGHT COMPOUND; TUMOR-SUPPRESSOR FUNCTION; HUMAN CANCER-CELLS; MUTANT P53; BINDS P53; WILD-TYPE; IN-VITRO; APOPTOSIS; PATHWAY; GROWTH	Uridine-cytidine kinase 2 is an enzyme that is overexpressed in abnormal cell growth and its implication is considered a hallmark of cancer. Due to the selective expression of UCK2 in cancer cells, a selective inhibition of this key enzyme necessitates the discovery of its potential inhibitors for cancer chemotherapy. The present study was carried out to demonstrate the potentials of natural phytochemicals from the rhizome of Alpinia mutica to inhibit UCK2 useful for colorectal cancer. Here, we employed the used of in vitro to investigate the effectiveness of natural UCK2 inhibitors to cause HT-29 cell death. Extracts, flavokawain B, and alpinetin compound from the rhizome of Alpinia mutica was used in the study. The study demonstrated that the expression of UCK2 mRNA were substantially reduced in treated HT 29 cells. In addition, downregulation in expression of 18S ribosomal RNA was also observed in all treated HT-29 cells. This was confirmed by fluorescence imaging to measure the level of expression of 18S ribosomal RNA in live cell images. The study suggests the possibility of MDM2 protein was downregulated and its suppression subsequently activates the expression of p53 during inhibition of UCK2 enzyme. The expression of p53 is directly linked to a blockage of cell cycle progression at G0/G1 phase and upregulates Bax, cytochrome c, and caspase 3 while Bcl2 was deregulated. In this respect, apoptosis induction and DNA fragmentation were observed in treated HT-29 cells. Initial results from in vitro studies have shown the ability of the bioactive compounds of flavokawain B and alpinetin to target UCK2 enzyme specifically, inducing cell cycle arrest and subsequently leading to cancer cell death, possibly through interfering the MDM2-p53 signalling pathway. These phenomena have proven that the bioactive compounds could be useful for future therapeutic use in colon cancer.	[Malami, Ibrahim; Abdul, Ahmad Bustamam; Rosli, Rozita; Waziri, Peter] Univ Putra Malaysia Serdang, Lab MAKNA Canc Res, Inst Biosci, Selangor, Malaysia; [Malami, Ibrahim] Usmanu Danfodiyo Univ, Fac Pharmaceut Sci, Dept Pharmacognosy & Ethnopharm, Sokoto, Nigeria; [Malami, Ibrahim; Abdul, Ahmad Bustamam; Rosli, Rozita] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Biomed Sci, Serdang, Malaysia; [Abdullah, Rasedee] Univ Putra Malaysia Serdang, Dept Vet Pathol & Microbiol, Fac Vet Med, Selangor, Malaysia; [Kassim, Nur Kartinee Bt] Univ Putra Malaysia Serdang, Fac Sci, Dept Chem, Selangor, Malaysia; [Yeap, Swee Keong] Univ Putra Malaysia Serdang, Lab Vaccine & Immunotherapeut, Inst Biosci, Selangor, Malaysia; [Etti, Imaobong Christopher; Bello, Muhammad Bashir] Univ Putra Malaysia Serdang, Dept Pharmacol & Toxicol, Fac Med & Hlth Sci, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia		keepibinformed@yahoo.co.uk; zer2crystals@gmail.com	Bello, Muhammad Bashir/AAZ-9569-2020; Malami, Ibrahim/C-4513-2019; Yeap, Swee Keong/H-9285-2013; Rasedee, Abdullah/E-9119-2013; Etti, Imaobong/AAE-4969-2022; Mohan, Syam/A-1231-2011	Bello, Muhammad Bashir/0000-0001-8986-8188; Malami, Ibrahim/0000-0001-9271-6927; Yeap, Swee Keong/0000-0002-4736-0674; Rasedee, Abdullah/0000-0001-6625-508X; 	TETFund; Universiti Putra Malaysia GP-IPS [9457100]	TETFund; Universiti Putra Malaysia GP-IPS	This study was co-supported by TETFund and Universiti Putra Malaysia GP-IPS (Vote No.: 9457100). The authors gratefully acknowledge the costs of publication covered by the Research Management Centre at the Universiti Putra Malaysia.	Abu N, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1046-8; Alexandrova EM, 2015, NATURE, V523, P352, DOI 10.1038/nature14430; Ayroldi E, 2015, CELL DEATH DIFFER, V22, P118, DOI 10.1038/cdd.2014.129; Benchimol S, 2001, CELL DEATH DIFFER, V8, P1049, DOI 10.1038/sj.cdd.4400918; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Burmakin M, 2013, CLIN CANCER RES, V19, P5092, DOI 10.1158/1078-0432.CCR-12-2211; Bykov VJN, 2005, J BIOL CHEM, V280, P30384, DOI 10.1074/jbc.M501664200; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Deisenroth C, 2010, ONCOGENE, V29, P4253, DOI 10.1038/onc.2010.189; Demma M, 2010, J BIOL CHEM, V285, P10198, DOI 10.1074/jbc.M109.083469; Donati G, 2012, CANCER RES, V72, P1602, DOI 10.1158/0008-5472.CAN-11-3992; Eskander RN, 2012, J OBSTET GYNAECOL RE, V38, P1086, DOI 10.1111/j.1447-0756.2011.01841.x; Fumagalli S, 2012, GENE DEV, V26, P1028, DOI 10.1101/gad.189951.112; GRUMMT I, 1976, CELL, V7, P447, DOI 10.1016/0092-8674(76)90175-6; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Hayashi Y, 2014, PLOS ONE, V9; Holzel M, 2010, J BIOL CHEM, V285, P6364, DOI 10.1074/jbc.M109.054734; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Huang M, 2008, LEUKEMIA RES, V32, P131, DOI 10.1016/j.leukres.2007.03.025; Ji T, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-55; Kadohira M, 2004, ABSTRACT, V32, P1178; Kaeser MD, 2004, J BIOL CHEM, V279, P7598, DOI 10.1074/jbc.M311732200; Kerr E, 2012, CELL DEATH DIFFER, V19, P1317, DOI 10.1038/cdd.2012.8; Kim TH, 2014, ONCOTARGET, V5, P860, DOI 10.18632/oncotarget.1784; Kuo YF, 2010, FREE RADICAL BIO MED, V49, P214, DOI 10.1016/j.freeradbiomed.2010.04.005; Lai CY, 2012, PLOS ONE, V7; Lambert JMR, 2010, ONCOGENE, V29, P1329, DOI 10.1038/onc.2009.425; Lambert JMR, 2009, CANCER CELL, V15, P376, DOI 10.1016/j.ccr.2009.03.003; Lane AN, 2015, NUCLEIC ACIDS RES, V43, P2466, DOI 10.1093/nar/gkv047; Li D, 2011, MOL CANCER RES, V9, P577, DOI 10.1158/1541-7786.MCR-10-0534; Ma Yongxian, 2000, Molecular Cell Biology Research Communications, V3, P122, DOI 10.1006/mcbr.2000.0201; Malami I, 2016, MOLECULES, V21, DOI 10.3390/molecules21040417; Malek NA, 2011, MOLECULES, V16, P583, DOI 10.3390/molecules16010583; Moll UM, 2006, ONCOGENE, V25, P4725, DOI 10.1038/sj.onc.1209601; Robledo S, 2008, RNA, V14, P1918, DOI 10.1261/rna.1132008; Rong JJ, 2009, CANCER LETT, V284, P102, DOI 10.1016/j.canlet.2009.04.011; SCHWARTZ EL, 1988, J CELL PHYSIOL, V136, P526, DOI 10.1002/jcp.1041360319; Shimamoto Y., 2002, CELLULAR BIOCHEMICAL, P445, DOI 10.1016/j.bbadis.2016.05.012; Smith AJT, 2009, ORG BIOMOL CHEM, V7, P2716, DOI 10.1039/b901429b; Soengas MS, 1999, SCIENCE, V284, P156, DOI 10.1126/science.284.5411.156; Stelzl U, 2001, ENCY LIFE SCI, V2001, P1; Tang XW, 2007, J CLIN INVEST, V117, P3753, DOI 10.1172/JCI32481; Toshiyuki M, 1995, CELL, V80, P293, DOI DOI 10.1016/0092-8674(95)90412-3; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Vakifahmetoglu-Norberg H, 2013, GENE DEV, V27, P1718, DOI 10.1101/gad.220897.113; Wang J, 2011, J CELL BIOCHEM, V112, P509, DOI 10.1002/jcb.22941; Weinmann L, 2008, CELL DEATH DIFFER, V15, P718, DOI 10.1038/sj.cdd.4402301; Yan WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086041; Yi Y., 2013, J SELECTED AREAS MIC, V3, P1; Zache N, 2008, MOL ONCOL, V2, P70, DOI 10.1016/j.molonc.2008.02.004; Zhang SL, 2015, CANCER RES, V75, P3842, DOI 10.1158/0008-5472.CAN-13-1079; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P6544, DOI 10.1093/nar/gkq536; Zhao CY, 2010, CELL CYCLE, V9, P1847, DOI 10.4161/cc.9.9.11545; Zhou P, 2010, FASEB J, V24, P4722, DOI 10.1096/fj.10-163311	56	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170233	10.1371/journal.pone.0170233	http://dx.doi.org/10.1371/journal.pone.0170233			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103302	Green Published, gold			2022-12-26	WOS:000392381100045
J	Lazaro, AMP; Cristobal, C; Franco-Pelaez, JA; Tarin, N; Acena, A; Carda, R; Huelmos, A; Martin-Mariscal, ML; Fuentes-Antras, J; Martinez-Milla, J; Alonso, J; Lorenzo, O; Egido, J; Lopez-Bescos, L; Tunon, J				Pello Lazaro, Ana Maria; Cristobal, Carmen; Antonio Franco-Pelaez, Juan; Tarin, Nieves; Acena, Alvaro; Carda, Rocio; Huelmos, Ana; Luisa Martin-Mariscal, Maria; Fuentes-Antras, Jesus; Martinez-Milla, Juan; Alonso, Joaquin; Lorenzo, Oscar; Egido, Jesus; Lopez-Bescos, Lorenzo; Tunon, Jose			Use of Proton-Pump Inhibitors Predicts Heart Failure and Death in Patients with Coronary Artery Disease	PLOS ONE			English	Article							NEGATIVE INOTROPY; CONCOMITANT USE; CLOPIDOGREL; RISK; OMEPRAZOLE; THERAPY; PANTOPRAZOLE; OUTCOMES; HYPOMAGNESEMIA; MORTALITY	Objectives Proton-pump inhibitors (PPIs) seem to increase the incidence of cardiovascular events in patients with coronary artery disease (CAD), mainly in those using clopidogrel. We analysed the impact of PPIs on the prognosis of patients with stable CAD. Methods We followed 706 patients with CAD. Primary outcome was the combination of secondary outcomes. Secondary outcomes were 1) acute ischaemic events (any acute coronary syndrome, stroke, or transient ischaemic attack) and 2) heart failure (HF) or death. Results Patients on PPIs were older [62.0 (53.0-73.0) vs. 58.0 (50.0-70.0) years; p = 0.003] and had a more frequent history of stroke (4.9% vs. 1.1%; p = 0.004) than those from the nonPPI group, and presented no differences in any other clinical variable, including cardiovascular risk factors, ejection fraction, and therapy with aspirin and clopidogrel. Follow-up was 2.2 0.99 years. Seventy-eight patients met the primary outcome, 53 developed acute ischaemic events, and 33 HF or death. PPI use was an independent predictor of the primary outcome [hazard ratio (HR) = 2.281 (1.244-4.183); p = 0.008], along with hypertension, body-mass index, glomerular filtration rate, atrial fibrillation, and nitrate use. PPI use was also an independent predictor of HF/death [HR = 5.713 (1.628-20.043); p = 0.007], but not of acute ischaemic events. A propensity score showed similar results. Conclusions In patients with CAD, PPI use is independently associated with an increased incidence of HF and death but not with a high rate of acute ischaemic events. Further studies are needed to confirm these findings.	[Pello Lazaro, Ana Maria; Antonio Franco-Pelaez, Juan; Acena, Alvaro; Carda, Rocio; Luisa Martin-Mariscal, Maria; Fuentes-Antras, Jesus; Martinez-Milla, Juan; Tunon, Jose] Fdn Jimenez Diaz, IIS, Dept Cardiol, Madrid, Spain; [Cristobal, Carmen] Hosp Fuenlabrada, Dept Cardiol, Madrid, Spain; [Cristobal, Carmen; Alonso, Joaquin; Lopez-Bescos, Lorenzo] Rey Juan Carlos Univ, Madrid, Spain; [Tarin, Nieves] Hosp Univ Mostoles, Dept Cardiol, Madrid, Spain; [Huelmos, Ana] Hosp Univ Fdn Alcorcon, Dept Cardiol, Madrid, Spain; [Alonso, Joaquin] Hosp Getafe, Dept Cardiol, Madrid, Spain; [Lorenzo, Oscar; Egido, Jesus; Tunon, Jose] Univ Autonoma Madrid, Madrid, Spain; [Lorenzo, Oscar; Egido, Jesus; Tunon, Jose] Fdn Jimenez Diaz, IIS, Lab Vasc Pathol, Madrid, Spain; [Egido, Jesus] CIBERDEM, Madrid, Spain	Fundacion Jimenez Diaz; Hospital Universitario Fuenlabrada; Universidad Rey Juan Carlos; Alcorcon Foundation University Hospital; Hospital Universitario de Getafe; Autonomous University of Madrid; Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Lazaro, AMP (corresponding author), Fdn Jimenez Diaz, IIS, Dept Cardiol, Madrid, Spain.	ampello@fjd.es	Milla, Juan Martínez/AAY-9158-2020; Tunon, Jose/ABA-8847-2020; Lorenzo, Oscar/L-2526-2013; Tuñón, José L/R-3037-2016; Tarin-Vicente, Nieves/O-6345-2015; Acena, Alvaro/AAG-4539-2021	Lorenzo, Oscar/0000-0001-5515-6078; Tuñón, José L/0000-0003-2220-180X; Tarin-Vicente, Nieves/0000-0002-7335-418X; Tunon, Jose/0000-0002-1373-0999; Alonso, Joaquin J/0000-0003-4360-5897; FUENTES-ANTRAS, JESUS/0000-0001-5805-2362; FRANCO PELAEZ, JUAN ANTONIO/0000-0001-5360-7066	Fondo de Investigaciones Sanitarias [PI 14/1567, PI13/00047, PIE13/00051]; ISCIII-RETIC REDinREN [RD12/0021]; Comunidad de Madrid [sGEN/0247/2006, S2010/BMD-2378]; Spanish Society of Cardiology; Spanish Heart Foundation; RECAVA [RD06/0014/0035]; Institute de Salud Carlos III FEDER [FJD biobank] [RD09/0076/00101]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); ISCIII-RETIC REDinREN; Comunidad de Madrid(Comunidad de Madrid); Spanish Society of Cardiology; Spanish Heart Foundation; RECAVA; Institute de Salud Carlos III FEDER [FJD biobank]	This work was supported by grants from Fondo de Investigaciones Sanitarias [grant numbers PI 14/1567, PI13/00047, PIE13/00051], ISCIII-RETIC REDinREN RD12/0021, Comunidad de Madrid [sGEN/0247/2006, S2010/BMD-2378], Spanish Society of Cardiology; Spanish Heart Foundation; RECAVA [grant number RD06/0014/0035]; Institute de Salud Carlos III FEDER [FJD biobank grant number RD09/0076/00101]. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abraham NS, 2010, AM J GASTROENTEROL, V105, P2533, DOI 10.1038/ajg.2010.445; [Anonymous], RES C DE DRUG SAF IN; [Anonymous], RES C DE POSTM DRUG; Beisvag V, 2003, ACTA PHYSIOL SCAND, V179, P251, DOI 10.1046/j.0001-6772.2003.01191.x; Bell JS, 2010, ARCH INTERN MED, V170, P1604, DOI 10.1001/archinternmed.2010.304; Bhatt DL, 2010, NEW ENGL J MED, V363, P1909, DOI 10.1056/NEJMoa1007964; Blomstrom-lundqvist C, 2003, ACC AHA ESC PRACTICE; Charlot M, 2010, ANN INTERN MED, V153, P378, DOI 10.7326/0003-4819-153-6-201009210-00005; Cunningham R, 2003, J HOSP INFECT, V54, P243, DOI 10.1016/S0195-6701(03)00088-4; Drepper MD, 2012, WORLD J GASTROENTERO, V18, P2161, DOI 10.3748/wjg.v18.i18.2161; Gilard M, 2008, J AM COLL CARDIOL, V51, P256, DOI 10.1016/j.jacc.2007.06.064; Giraud MN, 1997, ALIMENT PHARM THERAP, V11, P899, DOI 10.1046/j.1365-2036.1997.00216.x; Gulmez SE, 2007, ARCH INTERN MED, V167, P950, DOI 10.1001/archinte.167.9.950; Harjai KJ, 2011, CIRC-CARDIOVASC INTE, V4, P162, DOI 10.1161/CIRCINTERVENTIONS.110.958884; Ho PM, 2009, JAMA-J AM MED ASSOC, V301, P937, DOI 10.1001/jama.2009.261; Ishizaki T, 1999, ALIMENT PHARM THERAP, V13, P27; Kuipers MT, 2009, NETH J MED, V67, P169; Lodato F, 2010, BEST PRACT RES CL GA, V24, P193, DOI 10.1016/j.bpg.2009.11.004; Mackay JD, 2010, QJM-INT J MED, V103, P387, DOI 10.1093/qjmed/hcq021; Madanick RD, 2011, CLEV CLIN J MED, V78, P39, DOI 10.3949/ccjm.77a.10087; Maggio M, 2013, JAMA INTERN MED, V173, P518, DOI 10.1001/jamainternmed.2013.2851; MARCUARD SP, 1994, ANN INTERN MED, V120, P211, DOI 10.7326/0003-4819-120-3-199402010-00006; McCarthy DM, 2010, CURR OPIN GASTROEN, V26, P624, DOI 10.1097/MOG.0b013e32833ea9d9; Ng FH, 2010, GASTROENTEROLOGY, V138, P82, DOI 10.1053/j.gastro.2009.09.063; Oudit GY, 2011, EUR J HEART FAIL, V13, P1211, DOI 10.1093/eurjhf/hfr104; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Priori SG., 2015, EUR HEART J, V36, P2793, DOI 10.1093/eurheartj/ehv316; Rassen JA, 2009, CIRCULATION, V120, P2322, DOI 10.1161/CIRCULATIONAHA.109.873497; Ray WA, 2010, ANN INTERN MED, V152, P337, DOI 10.7326/0003-4819-152-6-201003160-00003; Schillinger W, 2007, CIRCULATION, V116, P57, DOI 10.1161/CIRCULATIONAHA.106.666008; Schillinger W, 2009, CLIN RES CARDIOL, V98, P391, DOI 10.1007/s00392-009-0012-6; Sossalla S, 2011, J CARDIOVASC SURG, V52, P437; Tanaka S, 2008, J CARDIOL, V52, P39, DOI 10.1016/j.jjcc.2008.05.004; Tantry US, 2011, JACC-CARDIOVASC INTE, V4, P365, DOI 10.1016/j.jcin.2010.12.009; Teramura-Gronblad M, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2012.03.003; Tunon J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095402; Tunon J, 2014, AM J CARDIOL, V113, P434, DOI 10.1016/j.amjcard.2013.10.012; Yang YX, 2006, JAMA-J AM MED ASSOC, V296, P2947, DOI 10.1001/jama.296.24.2947	38	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0169826	10.1371/journal.pone.0169826	http://dx.doi.org/10.1371/journal.pone.0169826			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103324	Green Published, Green Submitted, gold			2022-12-26	WOS:000392381100024
J	Gueguinou, M; Crottes, D; Chantome, A; Rapetti-Mauss, R; Potier-Cartereau, M; Clarysse, L; Girault, A; Fourbon, Y; Jezequel, P; Guerin-Charbonnel, C; Fromont, G; Martin, P; Pellissier, B; Schiappa, R; Chamorey, E; Mignen, O; Uguen, A; Borgese, F; Vandier, C; Soriani, O				Gueguinou, M.; Crottes, D.; Chantome, A.; Rapetti-Mauss, R.; Potier-Cartereau, M.; Clarysse, L.; Girault, A.; Fourbon, Y.; Jezequel, P.; Guerin-Charbonnel, C.; Fromont, G.; Martin, P.; Pellissier, B.; Schiappa, R.; Chamorey, E.; Mignen, O.; Uguen, A.; Borgese, F.; Vandier, C.; Soriani, O.			The SigmaR1 chaperone drives breast and colorectal cancer cell migration by tuning SK3-dependent Ca2+ homeostasis	ONCOGENE			English	Article							ELECTRICAL-ACTIVITY; RECEPTOR; CHANNEL; PLASTICITY; ROLES; INHIBITION; MECHANISM; RESPONSES; MEMBRANE; COMPLEX	The remodeling of calcium homeostasis contributes to the cancer hallmarks and the molecular mechanisms involved in calcium channel regulation in tumors remain to be characterized. Here, we report that SigmaR1, a stress-activated chaperone, is required to increase calcium influx by triggering the coupling between SK3, a Ca2+-activated K+ channel (KCNN3) and the voltage- independent calcium channel Orai1. We show that SigmaR1 physically binds SK3 in BC cells. Inhibition of SigmaR1 activity, either by molecular silencing or by the use of sigma ligand (igmesine), decreased SK3 current and Ca2+ entry in breast cancer (BC) and colorectal cancer (CRC) cells. Interestingly, SigmaR1 inhibition diminished SK3 and/or Orai1 levels in lipid nanodomains isolated from BC cells. Analyses of tissue microarray from CRC patients showed higher SigmaR1 expression levels in cancer samples and a correlation with tumor grade. Moreover, the exploration of a cohort of 4937 BC patients indicated that high expression of SigmaR1 and Orai1 channels was significantly correlated to a lower overall survival. As the SK3/Orai1 tandem drives invasive process in CRC and bone metastasis progression in BC, our results may inaugurate innovative therapeutic approaches targeting SigmaR1 to control the remodeling of Ca2+ homeostasis in epithelial cancers.	[Gueguinou, M.; Chantome, A.; Potier-Cartereau, M.; Clarysse, L.; Girault, A.; Fourbon, Y.; Fromont, G.; Vandier, C.] Univ Tours, INSERM, U1069, Nutr Croissance & Canc, Tours, France; [Crottes, D.; Rapetti-Mauss, R.; Martin, P.; Pellissier, B.; Borgese, F.; Soriani, O.] Univ Cote Azur, INSERM, CNRS, iBV, Nice, France; [Jezequel, P.; Guerin-Charbonnel, C.] INSERM, UMR 892, Ctr Rech Cancerol, Unit Bioinfom,Inst Cancerol Ouest Rene Gauducheau, St Herblain, France; [Fromont, G.] CHRU Tours, Hop Bretonneau, Serv Anat Pathol, Tours, France; [Schiappa, R.; Chamorey, E.] Ctr Antoine Lacassagne, UEB, Nice, France; [Mignen, O.; Uguen, A.] Brest Univ Hosp, INSERM, U1078, Dept Pathol, Brest, France; [Gueguinou, M.; Chantome, A.; Potier-Cartereau, M.; Clarysse, L.; Girault, A.; Fourbon, Y.; Fromont, G.; Mignen, O.; Vandier, C.] Ion Channels & Canc Canceropole Grand Ouest IC CG, Brest, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut de Cancerologie de l'Ouest (ICO); CHU Tours; UNICANCER; Centre Antoine Lacassagne; CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale	Vandier, C; Soriani, O (corresponding author), Univ Nice Sophia Antipolis, Inst Biol Valrose, UFR Sci, iBV, Batiment Sci Nat,Parc Valrose,28 Ave Valrose, F-06108 Nice 2, France.	christophe.vandier@univ-tours.fr; soriani@unice.fr	MIGNEN, Olivier/M-3258-2019; Rapetti-Mauss, Raphael/P-3437-2016; Chamorey, Emmanuel/AGO-9982-2022; Girault, Alban/AAB-3323-2020; Girault, Alban/AAF-7808-2019; Crottès, David/AAC-2180-2022; Uguen, Arnaud/ABF-7583-2020; fromont, gaelle/N-8708-2016; Vandier, Christophe/AAC-1900-2022; SCHIAPPA, Renaud/K-8192-2019; Potier-Cartereau, marie/AAC-4510-2022	MIGNEN, Olivier/0000-0001-7913-6119; Girault, Alban/0000-0001-5478-9340; Crottès, David/0000-0002-4038-6345; Vandier, Christophe/0000-0003-2559-0660; Potier-Cartereau, marie/0000-0002-1361-3397; soriani, olivier/0000-0001-9485-3992; BORGESE, Franck/0000-0001-7718-2111; RAPETTI-MAUSS, Raphael/0000-0002-3518-4845; Gueguinou, Maxime/0000-0002-5793-2082	Universite Cote d'Azur; CNRS; La Ligue contre le Cancer; Region Centre; INSERM; Canceropole Grand Ouest; association 'CANCEN' and Tours' Hospital oncology association 'ACORT'; Association TiToine Normandie	Universite Cote d'Azur; CNRS(Centre National de la Recherche Scientifique (CNRS)); La Ligue contre le Cancer(Ligue nationale contre le cancer); Region Centre(Region Centre-Val de Loire); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Canceropole Grand Ouest; association 'CANCEN' and Tours' Hospital oncology association 'ACORT'; Association TiToine Normandie	The study was supported by Universite Cote d'Azur, CNRS, La Ligue contre le Cancer, Region Centre (LIPIDS project of ARD2020-Biomedicaments), INSERM, Canceropole Grand Ouest, the association 'CANCEN' and Tours' Hospital oncology association 'ACORT', Association TiToine Normandie. DC is a doctoral fellow with CNRS, Region PACA and Fondation ARC. RR-M is a post-doctoral fellow of La Ligue contre le Cancer and Fondation de France. The microscopy was carried out in the Prism facility, 'Plateforme Universite Cote d'Azur, CNRS, Inserm, iBV, France. MG and LC are respectively doctoral fellows of Region Centre and Region Centre/INSERM. Local tumor tissue biobank BB-0033-00037 ('CRB Sante/Tumorotheque de Brest').	Abou-lovergne A, 2011, CELL CALCIUM, V50, P62, DOI 10.1016/j.ceca.2011.05.008; Balasuriya D, 2014, J BIOL CHEM, V289, P32353, DOI 10.1074/jbc.M114.603506; Balasuriya D, 2012, J BIOL CHEM, V287, P37021, DOI 10.1074/jbc.M112.382077; Calaghan S, 2008, J MOL CELL CARDIOL, V45, P88, DOI 10.1016/j.yjmcc.2008.04.004; Chantome A, 2013, CANCER RES, V73, P4852, DOI 10.1158/0008-5472.CAN-12-4572; Chantome A, 2009, EXP CELL RES, V315, P3620, DOI 10.1016/j.yexcr.2009.07.021; Chu UB, 2016, MOL PHARMACOL, V89, P142, DOI 10.1124/mol.115.101170; Clarysse L, 2014, PFLUG ARCH EUR J PHY, V466, P1921, DOI 10.1007/s00424-013-1435-5; Crottes D, 2016, CANCER RES, V76, P607, DOI 10.1158/0008-5472.CAN-15-1465; Crottes D, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00175; Crottes D, 2011, J BIOL CHEM, V286, P27947, DOI 10.1074/jbc.M111.226738; Dubois C, 2014, CANCER CELL, V26, P19, DOI 10.1016/j.ccr.2014.04.025; Girault A, 2011, CURR CANCER DRUG TAR, V11, P1111, DOI 10.2174/156800911798073069; Gueguinou M, 2016, ONCOTARGET, V7, P36168, DOI 10.18632/oncotarget.8786; Gueguinou M, 2014, BBA-MOL CELL RES, V1843, P2322, DOI 10.1016/j.bbamcr.2014.02.019; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayashi T, 2004, P NATL ACAD SCI USA, V101, P14949, DOI 10.1073/pnas.0402890101; Hayashi T, 2001, P NATL ACAD SCI USA, V98, P491, DOI 10.1073/pnas.021413698; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hayashi T, 2015, J PHARMACOL SCI, V127, P2, DOI 10.1016/j.jphs.2014.07.001; Hayashi T, 2010, SUBCELL BIOCHEM, V51, P381, DOI 10.1007/978-90-481-8622-8_13; Jezequel P, 2012, BREAST CANCER RES TR, V131, P765, DOI 10.1007/s10549-011-1457-7; Kondratska K, 2014, BBA-MOL CELL RES, V1843, P2263, DOI 10.1016/j.bbamcr.2014.02.012; Kourrich S, 2013, CELL, V152, P236, DOI 10.1016/j.cell.2012.12.004; Kourrich S, 2012, TRENDS NEUROSCI, V35, P762, DOI 10.1016/j.tins.2012.09.007; Martina M, 2007, J PHYSIOL-LONDON, V578, P143, DOI 10.1113/jphysiol.2006.116178; Maurice T, 2009, PHARMACOL THERAPEUT, V124, P195, DOI 10.1016/j.pharmthera.2009.07.001; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Pal A, 2007, MOL PHARMACOL, V72, P921, DOI 10.1124/mol.107.038307; Prause J, 2013, HUM MOL GENET, V22, P1581, DOI 10.1093/hmg/ddt008; Prevarskaya N, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0097; Prevarskaya N, 2010, TRENDS MOL MED, V16, P107, DOI 10.1016/j.molmed.2010.01.005; Raphael M, 2014, P NATL ACAD SCI USA, V111, pE3870, DOI 10.1073/pnas.1413409111; Renaudo A, 2007, J BIOL CHEM, V282, P2259, DOI 10.1074/jbc.M607915200; ROMAN FJ, 1990, J PHARM PHARMACOL, V42, P439, DOI 10.1111/j.2042-7158.1990.tb06588.x; Ruscher K, 2011, BRAIN, V134, P732, DOI 10.1093/brain/awq367; Soriani O, 1998, J PHARMACOL EXP THER, V286, P163; Srivats S, 2016, J CELL BIOL, V213, P65, DOI 10.1083/jcb.201506022; Su TP, 2016, TRENDS PHARMACOL SCI, V37, P262, DOI 10.1016/j.tips.2016.01.003; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; van Waarde A., 2014, BIOCHIM BIOPHYS ACTA, V1848, P2703; Vollrath JT, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.243; Wu ZP, 2008, J BIOL CHEM, V283, P28198, DOI 10.1074/jbc.M802099200	43	63	63	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 22	2017	36	25					3640	3647		10.1038/onc.2016.501	http://dx.doi.org/10.1038/onc.2016.501			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY3NL	28114279				2022-12-26	WOS:000403878600013
J	Nakano, N; Tsuchiya, Y; Kako, K; Umezaki, K; Sano, K; Ikeno, S; Otsuka, E; Shigeta, M; Nakagawa, A; Sakata, N; Itoh, F; Nakano, Y; Iemura, S; van Dinther, M; Natsume, T; ten Dijke, P; Itoh, S				Nakano, Naoko; Tsuchiya, Yuki; Kako, Kenro; Umezaki, Kenryu; Sano, Keigo; Ikeno, Souichi; Otsuka, Eri; Shigeta, Masashi; Nakagawa, Ai; Sakata, Nobuo; Itoh, Fumiko; Nakano, Yota; Iemura, Shun-ichiro; van Dinther, Maarten; Natsume, Tohru; ten Dijke, Peter; Itoh, Susumu			TMED10 Protein Interferes with Transforming Growth Factor (TGF)-beta Signaling by Disrupting TGF-beta Receptor Complex Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMAD PROTEINS; I RECEPTORS; NEGATIVE REGULATION; FAMILY; CELLS; TMP21; ACTIVATION; TRAFFICKING; PATHWAYS; DISEASE	The intensity and duration of TGF-beta signaling determine the cellular biological response. How this is negatively regulated is not well understood. Here, we identified a novel negative regulator of TGF-beta signaling, transmembrane p24-trafficking protein 10 (TMED10). TMED10 disrupts the complex formation between TGF-beta type I (also termed ALK5) and type II receptors (T beta RII). Misexpression studies revealed that TMED10 attenuated TGF-beta-mediated signaling. A 20-amino acid-long region from Thr(91) to Glu(110) within the extracellular region of TMED10 was found to be crucial for TMED 10 interaction with both ALK5 and T beta RII. Synthetic peptides corresponding to this region inhibit both TGF-beta-induced Smad2 phosphorylation and Smad-dependent transcriptional reporter activity. In a xenograft cancer model, where previously TGF-beta was shown to elicit tumor-promoting effects, gain-of-function and loss-of-function studies for TMED10 revealed a decrease and increase in the tumor size, respectively. Thus, we determined herein that TMED10 expression levels are the key determinant for efficiency of TGF-beta receptor complex formation and signaling.	[Nakano, Naoko; Tsuchiya, Yuki; Kako, Kenro; Umezaki, Kenryu; Sano, Keigo; Ikeno, Souichi; Otsuka, Eri; Shigeta, Masashi; Nakagawa, Ai; Sakata, Nobuo; Nakano, Yota; Itoh, Susumu] Showa Pharmaceut Univ, Lab Biochem, 3-3165 Higashi Tamagawagakuen, Machida, Tokyo 1948543, Japan; [Itoh, Fumiko] Tokyo Univ Pharm & Life Sci, Lab Cardiovasc Med, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan; [Iemura, Shun-ichiro] Fukushima Med Univ, Translat Res Ctr, 11-25 Sakaemachi, Fukushima, Fukushima 9608031, Japan; [van Dinther, Maarten; ten Dijke, Peter] Leiden Univ, Med Ctr, Canc Genom Ctr Netherlands, Dept Mol Cell Biol, S-1-P, NL-2300 RC Leiden, Netherlands; [Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery Molprof, Koto Ku, 2-4-7 Aomi, Tokyo 1350064, Japan; [ten Dijke, Peter] Uppsala Univ, Ludwig Inst Canc Res, Sci Life Lab, SE-75124 Uppsala, Sweden	Showa Pharmaceutical University; Tokyo University of Pharmacy & Life Sciences; Fukushima Medical University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; National Institute of Advanced Industrial Science & Technology (AIST); Ludwig Institute for Cancer Research; Uppsala University	Itoh, S (corresponding author), Showa Pharmaceut Univ, Lab Biochem, 3-3165 Higashi Tamagawagakuen, Machida, Tokyo 1948543, Japan.	sitoh@ac.shoyaku.ac.jp	Dijke, Peter ten/AAG-4660-2021; Natsume, Tohru/M-7627-2018; Sakata, Nobuo/L-9753-2015	Dijke, Peter ten/0000-0002-7234-342X; Natsume, Tohru/0000-0002-1510-2582; Sakata, Nobuo/0000-0001-9967-8409; Itoh, Fumiko/0000-0002-6134-5331; Itoh, Susumu/0000-0002-7967-0730	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation; Smoking Research Foundation; Daiichi-Sankyo Foundation of Life Science; Naito Foundation; Vehicle Racing Commemorative Foundation; MEXT; Showa Pharmaceutical University; Medical Research Institute, Tokyo Medical and Dental University; Japan Society for the Promotion of Science;  [15K18866]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Smoking Research Foundation; Daiichi-Sankyo Foundation of Life Science; Naito Foundation(Naito Memorial Foundation); Vehicle Racing Commemorative Foundation; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Showa Pharmaceutical University; Medical Research Institute, Tokyo Medical and Dental University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This research was supported by Grant-in-aid for Young Scientists (B) 15K18866 (to N.N.); the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to S. Itoh); the Takeda Science Foundation (to S. Itoh); the Smoking Research Foundation (to S. Itoh); the Daiichi-Sankyo Foundation of Life Science (to S. Itoh); the Naito Foundation (to S. Itoh); the Vehicle Racing Commemorative Foundation (to S. Itoh); Grant 2013-2017 from the MEXT-supported Program for the Strategic Research Foundation at Private Universities (to N. N. and S. Itoh); and a Grant-in-aid for Young Scientists from Showa Pharmaceutical University (to N. N.). This research also was supported by the Joint Usage/Research Program of the Medical Research Institute, Tokyo Medical and Dental University, and the Japan Society for the Promotion of Science Core-to-Core Program, "Cooperative International Framework in TGF-beta Family Signaling." The authors declare that they have no conflicts of interest with the contents of this article.	ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; Azuma H, 2005, JNCI-J NATL CANCER I, V97, P1734, DOI 10.1093/jnci/dji399; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Blum R, 1999, J CELL SCI, V112, P537; Blum R, 1996, J BIOL CHEM, V271, P17183, DOI 10.1074/jbc.271.29.17183; Blum R, 2008, TRAFFIC, V9, P1530, DOI 10.1111/j.1600-0854.2008.00784.x; Bromley-Brits K, 2012, CURR ALZHEIMER RES, V9, P411, DOI 10.2174/156720512800492521; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Derynck R, 2007, NAT CELL BIOL, V9, P1000, DOI 10.1038/ncb434; Derynck Rik, 2008, P29; Ehata S, 2007, CANCER RES, V67, P9694, DOI 10.1158/0008-5472.CAN-07-1522; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; FROLIK CA, 1984, J BIOL CHEM, V259, P995; Fucini RV, 2002, MOL BIOL CELL, V13, P621, DOI 10.1091/mbc.01-11-0547; Gaarenstroom T, 2014, SEMIN CELL DEV BIOL, V32, P107, DOI 10.1016/j.semcdb.2014.01.009; Goldman LA, 1996, BIOTECHNIQUES, V21, P1013; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Hoover LL, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.146pe48; Ikushima H, 2010, CANCER SCI, V101, P306, DOI 10.1111/j.1349-7006.2009.01441.x; Itoh F, 2001, EMBO J, V20, P4132, DOI 10.1093/emboj/20.15.4132; Itoh S, 2003, J BIOL CHEM, V278, P3751, DOI 10.1074/jbc.M208258200; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Itoh S, 2011, GROWTH FACTORS, V29, P163, DOI 10.3109/08977194.2011.614236; Jin W, 2005, P NATL ACAD SCI USA, V102, P16239, DOI 10.1073/pnas.0503137102; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Jun Y, 2011, BMB REP, V44, P369, DOI 10.5483/BMBRep.2011.44.6.369; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Kawabata M, 1998, EMBO J, V17, P4056, DOI 10.1093/emboj/17.14.4056; Macias MJ, 2015, TRENDS BIOCHEM SCI, V40, P296, DOI 10.1016/j.tibs.2015.03.012; Majoul I, 2001, DEV CELL, V1, P139, DOI 10.1016/S1534-5807(01)00004-1; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Morikawa M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021873; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Nakano N, 2014, J BIOL CHEM, V289, P12680, DOI 10.1074/jbc.M114.558981; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Nickel W, 1997, P NATL ACAD SCI USA, V94, P11393, DOI 10.1073/pnas.94.21.11393; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Orlova VV, 2011, HISTOL HISTOPATHOL, V26, P1219, DOI 10.14670/HH-26.1219; Pardossi-Piquard R, 2009, J BIOL CHEM, V284, P28634, DOI 10.1074/jbc.M109.059345; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Robertson IB, 2013, CYTOKINE GROWTH F R, V24, P355, DOI 10.1016/j.cytogfr.2013.06.003; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Souchelnytskyi S, 1998, J BIOL CHEM, V273, P25364, DOI 10.1074/jbc.273.39.25364; Strating JRPM, 2009, BIOL CELL, V101, P495, DOI 10.1042/BC20080233; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Wang HB, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227991; Wang HB, 2010, MOL BIOL CELL, V21, P1398, DOI 10.1091/mbc.E09-08-0735; Watanabe Y, 2010, MOL CELL, V37, P123, DOI 10.1016/j.molcel.2009.10.028; Weiss A, 2013, WIRES DEV BIOL, V2, P47, DOI 10.1002/wdev.86; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Xu XB, 2015, INT J CLIN EXP PATHO, V8, P10824; YAMASHITA H, 1994, J BIOL CHEM, V269, P20172; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhao B, 2014, SCI CAIRO, V2014; Zhao LY, 1999, J BIOL CHEM, V274, P14198, DOI 10.1074/jbc.274.20.14198; Zhou FF, 2011, MOL BIOL CELL, V22, P3533, DOI 10.1091/mbc.E11-06-0483	68	13	13	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	10					4099	4112		10.1074/jbc.M116.769109	http://dx.doi.org/10.1074/jbc.M116.769109			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ4GV	28115518	Green Published, hybrid			2022-12-26	WOS:000404672500001
J	Gazarian, KG; Ramirez-Garcia, LR				Gazarian, Karlen G.; Ramirez-Garcia, Luis R.			Human Deciduous Teeth Stem Cells (SHED) Display Neural Crest Signature Characters	PLOS ONE			English	Article							HUMAN DENTAL-PULP; PERIODONTAL-LIGAMENT; IN-VITRO; DIRECTED DIFFERENTIATION; GROWTH-FACTORS; IDENTIFICATION; TRANSITION; MIGRATION	Human dental tissues are sources of neural crest origin multipotent stem cells whose regenerative potential is a focus of extensive studies. Rational programming of clinical applications requires a more detailed knowledge of the characters inherited from neural crest. Investigation of neural crest cells generated from human pluripotent stem cells provided opportunity for their comparison with the postnatal dental cells. The purpose of this study was to investigate the role of the culture conditions in the expression by dental cells of neural crest characters. The results of the study demonstrate that specific neural crest cells requirements, serum-free, active WNT signaling and inactive SMAD 2/3, are needed for the activity of the neural crest characters in dental cells. Specifically, the decreasing concentration of fetal bovine serum (FBS) from regularly used for dental cells 10% to 2% and below, or using serum-free medium, led to emergence of a subset of epithelial-like cells expressing the two key neural crest markers, p75 and HNK-1. Further, the serum-free medium supplemented with neural crest signaling requirements (WNT inducer BIO and TGF-beta inhibitor REPSOX), induced epithelial-like phenotype, upregulated the p75, Sox10 and E-Cadherin and downregulated the mesenchymal genes (SNAIL1, ZEB1, TWIST). An expansion medium containing 2% FBS allowed to obtain an epithelial/mesenchymal SHED population showing high proliferation, clonogenic, multi-lineage differentiation capacities. Future experiments will be required to determine the effects of these features on regenerative potential of this novel SHED population.	[Gazarian, Karlen G.; Ramirez-Garcia, Luis R.] Mexican Natl Autonomous Univ, Dept Med Genom & Environm Tox, Inst Biomed Res, Univ Campus, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico	Gazarian, KG (corresponding author), Mexican Natl Autonomous Univ, Dept Med Genom & Environm Tox, Inst Biomed Res, Univ Campus, Mexico City, DF, Mexico.	karlen@unam.mx			Mexican Autonomous National University Fund D.G.A.P.A. [IT200313]	Mexican Autonomous National University Fund D.G.A.P.A.	This work was supported by Mexican Autonomous National University Fund D.G.A.P.A. (Grant # IT200313). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez R, 2015, INT J ORAL SCI, V7, P213, DOI 10.1038/ijos.2015.42; Alvarez R, 2015, INT J ORAL SCI, V7, P205, DOI 10.1038/ijos.2015.29; Baggiolini A, 2015, CELL STEM CELL, V16, P314, DOI 10.1016/j.stem.2015.02.017; Ballini A, 2007, INT J IMMUNOPATH PH, V20, P9, DOI 10.1177/039463200702000102; Betters E, 2010, DEV BIOL, V344, P578, DOI 10.1016/j.ydbio.2010.05.012; Briana DD, 2012, CYTOKINE, V60, P157, DOI 10.1016/j.cyto.2012.06.005; BRONNERFRASER M, 1986, DEV BIOL, V115, P44, DOI 10.1016/0012-1606(86)90226-5; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chen FM, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0288-1; Cimadamore F, 2011, CELL STEM CELL, V8, P538, DOI 10.1016/j.stem.2011.03.011; Cordero DR, 2011, AM J MED GENET A, V155A, P270, DOI 10.1002/ajmg.a.33702; Curchoe CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013890; d'Aquino R, 2008, STEM CELL REV, V4, P21, DOI 10.1007/s12015-008-9013-5; d'Aquino R, 2011, EUR CELLS MATER, V21, P304, DOI 10.22203/eCM.v021a23; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dupin E, 2003, P NATL ACAD SCI USA, V100, P5229, DOI 10.1073/pnas.0831229100; Dupin E, 2007, CR BIOL, V330, P521, DOI 10.1016/j.crvi.2007.04.004; Dupin Elisabeth, 2011, Biologie Aujourd hui, V205, P53, DOI 10.1051/jbio/2011008; Estrela Carlos, 2011, Braz. Dent. J., V22, P91, DOI 10.1590/S0103-64402011000200001; Giovannone D, 2015, ACTA HISTOCHEM, V117, P255, DOI 10.1016/j.acthis.2015.03.002; Gong SG, 2014, EXP CELL RES, V325, P90, DOI 10.1016/j.yexcr.2014.03.015; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Hynes K, 2014, STEM CELLS DEV, V23, P1084, DOI 10.1089/scd.2013.0111; Iwata K, 2012, BIOMATERIALS, V33, P444, DOI 10.1016/j.biomaterials.2011.09.056; Jaroonwitchawan T, 2016, BIOCHEM BIOPH RES CO, V481, P176, DOI 10.1016/j.bbrc.2016.10.147; Jeon M, 2014, ARCH ORAL BIOL, V59, P1013, DOI 10.1016/j.archoralbio.2014.06.002; Kaku M, 2012, ARCH ORAL BIOL, V57, P1668, DOI 10.1016/j.archoralbio.2012.04.022; Kashyap R, 2015, J CLIN DIAGN RES, V9, pZE07, DOI 10.7860/JCDR/2015/9871.5636; Kelsh RN, 2006, BIOESSAYS, V28, P788, DOI 10.1002/bies.20445; La Noce M, 2014, EUR CELLS MATER, V28, P348, DOI 10.22203/eCM.v028a24; Le Douarin NM, 2008, CELL CYCLE, V7, P1013, DOI 10.4161/cc.7.8.5641; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Lee RTH, 2013, DEVELOPMENT, V140, P4890, DOI 10.1242/dev.094680; Liu JJ, 2015, STEM CELLS, V33, P627, DOI 10.1002/stem.1909; Lu H, 2016, FEBS J, V283, P3771, DOI 10.1111/febs.13842; Martens W, 2012, CELLS TISSUES ORGANS, V196, P490, DOI 10.1159/000338654; Meeker RB, 2015, NEURAL REGEN RES, V10, P721, DOI 10.4103/1673-5374.156967; Menendez L, 2013, NAT PROTOC, V8, P203, DOI 10.1038/nprot.2012.156; Menendez L, 2011, P NATL ACAD SCI USA, V108, P19240, DOI 10.1073/pnas.1113746108; Mikami Y, 2011, STEM CELLS DEV, V20, P901, DOI 10.1089/scd.2010.0299; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Nam H, 2009, BIOCHEM BIOPH RES CO, V386, P135, DOI 10.1016/j.bbrc.2009.05.141; O'Rahilly R, 2007, J ANAT, V211, P335, DOI 10.1111/j.1469-7580.2007.00773.x; Paino F, 2010, EUR CELLS MATER, V20, P295; Pirozzi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021548; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Tirino Virginia, 2012, Methods Mol Biol, V879, P443, DOI 10.1007/978-1-61779-815-3_26; Verma Kavita, 2014, Dent Res J (Isfahan), V11, P302	49	23	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170321	10.1371/journal.pone.0170321	http://dx.doi.org/10.1371/journal.pone.0170321			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125654	Green Published, gold, Green Submitted			2022-12-26	WOS:000396176100119
J	Jaddi, NS; Abdullah, S; Malek, MA				Jaddi, Najmeh Sadat; Abdullah, Salwani; Malek, Marlinda Abdul			Master-Leader-Slave Cuckoo Search with Parameter Control for ANN Optimization and Its Real-World Application to Water Quality Prediction	PLOS ONE			English	Article							POLYNOMIAL NEURAL-NETWORKS; PARTICLE SWARM OPTIMIZATION; COOPERATIVE APPROACH; ALGORITHM; MODEL	Artificial neural networks (ANNs) have been employed to solve a broad variety of tasks. The selection of an ANN model with appropriate weights is important in achieving accurate results. This paper presents an optimization strategy for ANN model selection based on the cuckoo search (CS) algorithm, which is rooted in the obligate brood parasitic actions of some cuckoo species. In order to enhance the convergence ability of basic CS, some modifications are proposed. The fraction P-a of the n nests replaced by new nests is a fixed parameter in basic CS. As the selection of Pa is a challenging issue and has a direct effect on exploration and therefore on convergence ability, in this work the Pa is set to a maximum value at initialization to achieve more exploration in early iterations and it is decreased during the search to achieve more exploitation in later iterations until it reaches the minimum value in the final iteration. In addition, a novel master-leader-slave multi-population strategy is used where the slaves employ the best fitness function among all slaves, which is selected by the leader under a certain condition. This fitness function is used for subsequent Levy flights. In each iteration a copy of the best solution of each slave is migrated to the master and then the best solution is found by the master. The method is tested on benchmark classification and time series prediction problems and the statistical analysis proves the ability of the method. This method is also applied to a real-world water quality prediction problem with promising results.	[Jaddi, Najmeh Sadat; Abdullah, Salwani] Univ Kebangsaan Malaysia, Data Min & Optimizat Res Grp DMO, Ctr Artificial Intelligence Technol, Fac Informat Sci & Technol, Bangi, Selangor, Malaysia; [Malek, Marlinda Abdul] Univ Tenaga Nas, Dept Civil Engn, Coll Engn, Jalan IKRAM UNITEN, Kajang, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Tenaga Nasional	Abdullah, S (corresponding author), Univ Kebangsaan Malaysia, Data Min & Optimizat Res Grp DMO, Ctr Artificial Intelligence Technol, Fac Informat Sci & Technol, Bangi, Selangor, Malaysia.	salwani@ukm.edu.my	abdullah, salwani/M-1679-2019		Ministry of Higher Education, Malaysia [FRGS/1/2015/ICT02/UKM/01/2]; Universiti Kebangsaan Malaysia [DIP-2016-024]	Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia); Universiti Kebangsaan Malaysia	This work was supported by the Ministry of Higher Education, Malaysia (FRGS/1/2015/ICT02/UKM/01/2) and the Universiti Kebangsaan Malaysia (DIP-2016-024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari R, 2011, J INF SCI ENG, V27, P799; Blake CL, 1998, UCI REPOSITORY MACHI; Civicioglu P, 2013, ARTIF INTELL REV, V39, P315, DOI 10.1007/s10462-011-9276-0; Curry Bruce, 2010, International Journal of Metaheuristics, V1, P181, DOI 10.1504/IJMHEUR.2010.034205; Du W-B, 2016, HETEROGENEOUS STRATE; Du WB, 2015, APPL MATH COMPUT, V268, P832, DOI 10.1016/j.amc.2015.06.062; El-Abd M, 2010, SWARM INTELL-US, V4, P57, DOI 10.1007/s11721-009-0037-5; Gandomi AH, 2013, ENG COMPUT-GERMANY, V29, P17, DOI 10.1007/s00366-011-0241-y; Gazzaz NM, 2012, MAR POLLUT BULL, V64, P2409, DOI 10.1016/j.marpolbul.2012.08.005; Goh CK, 2008, IEEE T NEURAL NETWOR, V19, P1531, DOI 10.1109/TNN.2008.2000444; Guo YN, 2012, LECT N BIOINFORMAT, V6840, P199; Huang DS, 2008, IEEE T NEURAL NETWOR, V19, P2099, DOI 10.1109/TNN.2008.2004370; Islam MM, 2009, IEEE T SYST MAN CY B, V39, P705, DOI 10.1109/TSMCB.2008.2008724; Jaddi NS, 2015, APPL SOFT COMPUT, V37, P71, DOI 10.1016/j.asoc.2015.08.002; Jaddi NS, 2015, INFORM SCIENCES, V294, P628, DOI 10.1016/j.ins.2014.08.050; Jaddi NS, 2013, 2013 INTERNATIONAL CONFERENCE ON INFORMATICS AND CREATIVE MULTIMEDIA (ICICM), P278, DOI 10.1109/ICICM.2013.54; Karlik B., 2010, INT J ARTIF INTELL E, V1, P111; Kaylani A, 2009, NEUROCOMPUTING, V72, P2079, DOI 10.1016/j.neucom.2008.09.016; Kaylani A, 2010, IEEE T NEURAL NETWOR, V21, P529, DOI 10.1109/TNN.2009.2037813; Ludermir TB, 2006, IEEE T NEURAL NETWOR, V17, P1452, DOI 10.1109/TNN.2006.881047; Mantzaris D, 2011, NEURAL NETWORKS, V24, P831, DOI 10.1016/j.neunet.2011.06.003; Masutti TAS, 2009, NEUROCOMPUTING, V72, P2189, DOI 10.1016/j.neucom.2008.07.015; Niu B, 2005, LECT NOTES ARTIF INT, V3630, P874; Niu B, 2005, ADV ARTIFICIAL LIFE; Oh SK, 2005, PHYS LETT A, V345, P88, DOI 10.1016/j.physleta.2005.06.100; Oh SK, 2003, COMPUT ELECTR ENG, V29, P703, DOI 10.1016/S0045-7906(02)00045-9; Oh SK, 2009, APPL SOFT COMPUT, V9, P1068, DOI 10.1016/j.asoc.2009.02.007; Ouaarab A, 2014, NEURAL COMPUT APPL, V24, P1659, DOI 10.1007/s00521-013-1402-2; Park HS, 2004, INT J CONTROL AUTOM, V2, P423; Valian E., 2011, INT J ARTIFICIAL INT, V2, P36, DOI DOI 10.5121/IJAIA.2011.2304; Valian E, 2013, COMPUT IND ENG, V64, P459, DOI 10.1016/j.cie.2012.07.011; van den Bergh F, 2004, IEEE T EVOLUT COMPUT, V8, P225, DOI [10.1109/TEVC.2004.826069, 10.1109/tevc.2004.826069]; Walton S, 2011, CHAOS SOLITON FRACT, V44, P710, DOI 10.1016/j.chaos.2011.06.004; Xin-She Y, 2009, NAT BIOL INSP COMP 2; Xin-She Yang, 2010, International Journal of Mathematical Modelling and Numerical Optimisation, V1, P330, DOI 10.1504/IJMMNO.2010.035430; Yang SH, 2012, NEUROCOMPUTING, V86, P140, DOI 10.1016/j.neucom.2012.01.024; Yen GG, 2006, EV COMP 2006 CEC 200; Zanchettin C, 2011, IEEE T SYST MAN CY B, V41, P1097, DOI 10.1109/TSMCB.2011.2107035; Zhan ZH, 2009, LECT NOTES COMPUT SC, V5574, P490, DOI 10.1007/978-3-642-03095-6_47; Zhang H, 2010, ADV COMP THEOR ENG I; Zhao L, 2009, EXPERT SYST APPL, V36, P2805, DOI 10.1016/j.eswa.2008.01.061	41	10	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170372	10.1371/journal.pone.0170372	http://dx.doi.org/10.1371/journal.pone.0170372			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125609	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100116
J	Sigley, J; Jarzen, J; Scarpinato, K; Guthold, M; Pu, T; Nelli, D; Low, J; Bonin, K				Sigley, Justin; Jarzen, John; Scarpinato, Karin; Guthold, Martin; Pu, Tracey; Nelli, Daniel; Low, Josiah; Bonin, Keith			Diffusion and Binding of Mismatch Repair Protein, MSH2, in Breast Cancer Cells at Different Stages of Neoplastic Transformation	PLOS ONE			English	Article							LASER-SCANNING MICROSCOPES; ATOMIC-FORCE MICROSCOPY; FLUORESCENCE RECOVERY; LIVING CELLS; CORRELATION SPECTROSCOPY; MECHANICAL-PROPERTIES; CARCINOMA CELLS; DISEASE STATES; SINGLE-CELL; DNA	The interior of cells is a highly complex medium, containing numerous organelles, a matrix of different fibers and a viscous, aqueous fluid of proteins and small molecules. The interior of cells is also a highly dynamic medium, in which many components move, either by active transport or passive diffusion. The mobility and localization of proteins inside cells can provide important insights into protein function and also general cellular properties, such as viscosity. Neoplastic transformation affects numerous cellular properties, and our goal was to investigate the diffusional and binding behavior of the important mismatch repair ( MMR) protein MSH2 in live human cells at various stages of neoplastic transformation. Toward this end, noncancerous, immortal, tumorigenic, and metastatic mammary epithelial cells were transfected with EGFP and EGFP-tagged MSH2. MSH2 forms two MMR proteins (MutSa and MutS beta) and we assume MSH2 is in the complex MutSa, though our results are similar in either case. Unlike the MutS complexes that bind to nuclear DNA, EGFP diffuses freely. EGFP and MutS alpha- EGFP diffusion coefficients were determined in the cytoplasm and nucleus of each cell type using fluorescence recovery after photobleaching. Diffusion coefficients were 14-24 mu m(2) /s for EGFP and 3-7 mu m(2) /s for MutSa-EGFP. EGFP diffusion increased in going from noncancerous to immortal cells, indicating a decrease in viscosity, with smaller changes in subsequent stages. MutSa produces an effective diffusion coefficient that, coupled with the free EGFP diffusion measurements, can be used to extract a pure diffusion coefficient and a pseudo-equilibrium constant K*. The MutSa nuclear K* increased sixfold in the first stage of cancer and then decreased in the more advanced stages. The ratio of nuclear to cytoplasmic K* for MutSa increased almost two orders of magnitude in going from noncancerous to immortal cells, suggesting that this quantity may be a sensitive metric for recognizing the onset of cancer.	[Sigley, Justin; Guthold, Martin; Pu, Tracey; Nelli, Daniel; Low, Josiah; Bonin, Keith] Wake Forest Univ, Dept Phys, Winston Salem, NC 27109 USA; [Jarzen, John] Med Univ South Carolina, Dept Microbiol & Immunol, Charleston, SC USA; [Scarpinato, Karin] Univ Miami, OVPR, Miami, FL USA	Wake Forest University; Medical University of South Carolina; University of Miami	Bonin, K (corresponding author), Wake Forest Univ, Dept Phys, Winston Salem, NC 27109 USA.	bonin@wfu.edu	Bonin, Keith/A-3207-2014; , Guthold/AAU-9371-2021	Bonin, Keith/0000-0002-7594-823X; Guthold, Martin/0000-0003-4177-6115	National Science Foundation [1106105]	National Science Foundation(National Science Foundation (NSF))	This material is based upon work supported by the National Science Foundation under Grant Number 1106105 (KB, MG, and KS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attolini CSO, 2009, ANN NY ACAD SCI, V1168, P23, DOI 10.1111/j.1749-6632.2009.04880.x; Beil M, 2003, NAT CELL BIOL, V5, P803, DOI 10.1038/ncb1037; Braga J, 2004, MOL BIOL CELL, V15, P4749, DOI 10.1091/mbc.E04-06-0496; Brown CM, 2008, J MICROSC-OXFORD, V229, P78, DOI 10.1111/j.1365-2818.2007.01871.x; Chen Z, 2016, MOL CELL PROTEOMICS, V15, P1299, DOI [10.1074/mcp.M115.056093, 10.1074/mcp.M115.056093 ]; Cheng NS, 2008, IND ENG CHEM RES, V47, P3285, DOI 10.1021/ie071349z; Cho WK, 2012, STRUCTURE, V20, P1264, DOI 10.1016/j.str.2012.04.017; Christmann M, 2000, J BIOL CHEM, V275, P36256, DOI 10.1074/jbc.M005377200; Debes JD, 2005, CANCER RES, V65, P708; Dey P., 2009, CANC NUCLEUS MORPHOL; Digman MA, 2005, BIOPHYS J, V89, P1317, DOI 10.1529/biophysj.105.062836; Edelbrock MA, 2013, MUTAT RES-FUND MOL M, V743, P53, DOI 10.1016/j.mrfmmm.2012.12.008; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Guo XY, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/10/105002; HALL A, 1992, MOL BIOL CELL, V3, P475, DOI 10.1091/mbc.3.5.475; Hochmuth RM, 2000, J BIOMECH, V33, P15, DOI 10.1016/S0021-9290(99)00175-X; Hong Sungmin, 2010, J Biomater Nanobiotechnol, V1, P31, DOI 10.4236/jbnb.2010.11004; Hughes I., 2010, MEASUREMENTS THEIR U; HUGUET EL, 1994, CANCER RES, V54, P2615; Igawa S, 2004, CANCER SCI, V95, P342, DOI 10.1111/j.1349-7006.2004.tb03213.x; Kang M, 2012, TRAFFIC, V13, P1589, DOI 10.1111/tra.12008; Kang M, 2009, BIOPHYS J, V97, P1501, DOI 10.1016/j.bpj.2009.06.017; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Knudsen NO, 2007, NUCLEIC ACIDS RES, V35, P2609, DOI 10.1093/nar/gkl1166; Kuimova MK, 2009, NAT CHEM, V1, P69, DOI [10.1038/nchem.120, 10.1038/NCHEM.120]; Lam WA, 2007, BLOOD, V109, P3505, DOI 10.1182/blood-2006-08-043570; Lekka M, 1999, EUR BIOPHYS J BIOPHY, V28, P312, DOI 10.1007/s002490050213; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Mastrocola AS, 2010, HUM MUTAT, V31, pE1699, DOI 10.1002/humu.21333; McNally JG, QUANTITATIVE FRAP AN, P329; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Moeendarbary E, 2013, NAT MATER, V12, P253, DOI [10.1038/NMAT3517, 10.1038/nmat3517]; Mostowy S, 2012, NAT REV MOL CELL BIO; Mueller F, 2008, BIOPHYS J, V94, P3323, DOI 10.1529/biophysj.107.123182; Nishio K, 2005, HISTOCHEM CELL BIOL, V123, P263, DOI 10.1007/s00418-005-0766-5; Park S, 2005, BIOPHYS J, V89, P4330, DOI 10.1529/biophysj.104.053462; Partlin MM, 2003, ONCOGENE, V22, P819, DOI DOI 10.1038/SJ.0NC.1206252; Petrasek Z, 2008, BIOPHYS J, V94, P1437, DOI 10.1529/biophysj.107.108811; Pincet F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158457; Plodinec M, 2012, NAT NANOTECHNOL, V7, P757, DOI [10.1038/nnano.2012.167, 10.1038/NNANO.2012.167]; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Rosenbluth MJ, 2006, BIOPHYS J, V90, P2994, DOI 10.1529/biophysj.105.067496; Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8; Salsbury FR, 2006, NUCLEIC ACIDS RES, V34, P2173, DOI 10.1093/nar/gkl238; SEGUR JB, 1951, IND ENG CHEM, V43, P2117, DOI 10.1021/ie50501a040; Smelser AM, 2015, BIOMECH MODEL MECHAN, V14, P1335, DOI 10.1007/s10237-015-0677-x; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Suresh S, 2005, ACTA BIOMATER, V1, P15, DOI 10.1016/j.actbio.2004.09.001; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Thoumine O, 1999, J BIOCHEM BIOPH METH, V39, P47, DOI 10.1016/S0165-022X(98)00052-9; Vargas-Pinto R, 2013, BIOPHYS J, V105, P300, DOI 10.1016/j.bpj.2013.05.034; Wang Y, 2000, GENE DEV, V14, P927; Weinberg RA, 2014, BIOLOGY OF CANCER, SECOND EDITION, P1; Wirtz D, 2009, ANNU REV BIOPHYS, V38, P301, DOI 10.1146/annurev.biophys.050708.133724; Wu SK, 2014, EUR J CELL BIOL, V93, P396, DOI 10.1016/j.ejcb.2014.09.001; Yanagisawa J, 1996, CANCER RES, V56, P457; Yao WJ, 2003, CELL MOTIL CYTOSKEL, V56, P1, DOI 10.1002/cm.10129; Zhang G, 2002, WORLD J GASTROENTERO, V8, P243, DOI 10.3748/wjg.v8.i2.243; Zhang YY, 2011, CELL BIOCHEM BIOPHYS, V61, P595, DOI 10.1007/s12013-011-9242-0	64	1	1	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170414	10.1371/journal.pone.0170414	http://dx.doi.org/10.1371/journal.pone.0170414			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125613	Green Submitted, Green Published, gold			2022-12-26	WOS:000396176100111
J	Yang, Y; Xiao, Y; Li, M; Ji, FN; Hu, CW; Cui, YB				Yang, Yang; Xiao, Yao; Li, Mei; Ji, Funian; Hu, Changwei; Cui, Yibin			Evaluation of Complex Toxicity of Canbon Nanotubes and Sodium Pentachlorophenol Based on Earthworm Coelomocytes Test	PLOS ONE			English	Article							WALLED CARBON NANOTUBES; EISENIA-FOETIDA; DNA-DAMAGE; OXIDATIVE STRESS; BIOMARKER RESPONSES; LIPID-PEROXIDATION; ENDOTHELIAL-CELLS; PRIMARY CULTURES; APOPTOSIS; SOIL	As a standard testing organism in soil ecosystems, the earthworm Eisenia fetida has been used widely in toxicity studies. However, tests at the individual level are time-and animalconsuming, with limited sensitivity. Earthworm coelomocytes are important for the assimilation and elimination of exogenous compounds and play a key role in the processes of phagocytosis and inflammation. In this study, we explored an optimal condition to culture coelomocytes of E. fetida in vitro and investigated the cytotoxicity of multiwalled carbon nanotubes (MWCNTs) and sodium pentachlorophenol (PCP-Na) using coelomocytes via evaluating lethal toxicity, oxidative stress, membrane damage, and DNA damage. The results showed that coelomocytes can be successfully cultured in vitro in primary under the RPMI-1640 medium with 2-4x10 (4) cells/well (1-2x10(5) cells/mL) in 96-well plates at 25 E degrees C without CO2. Both MWCNTs and PCP-Na could cause oxidative damage and produce ROS, an evidence for lipid peroxidation with MDA generation and SOD and CAT activity inhibition at high stress. The two chemicals could separately damage the cell membrane structure, increasing permeability and inhibiting mitochondrial membrane potential (MMP). In addition, our results indicate that PCP-Na may be adsorbed onto MWCNTs and its toxicity on earthworm was accordingly alleviated, while a synergetic effect was revealed when PCP-Na and MWCNTs were added separately. In summary, coelomocyte toxicity in in vitro analysis is a sensitive method for detecting the adverse effects of carbon nanotubes combined with various pollutants.	[Yang, Yang; Xiao, Yao; Li, Mei; Ji, Funian] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing, Jiangsu, Peoples R China; [Hu, Changwei] Linyi Univ, Shandong Prov Key Lab Water & Soil Conservat & En, Linyi, Peoples R China; [Cui, Yibin] Minist Environm Protect, Nanjing Inst Environm Sci, Nanjing, Jiangsu, Peoples R China	Nanjing University; Linyi University	Li, M (corresponding author), Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing, Jiangsu, Peoples R China.	meili@nju.edu.cn	Hu, Changwei/K-9818-2013	Hu, Changwei/0000-0001-7511-0739	National Natural Science Foundation of China [41571468, 21077052]; Science and Technology Support Program of Jiangsu Province [BE2016172, BE2012737]; Shandong Provincial Natural Science Foundation of China [ZR2015CM023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Support Program of Jiangsu Province; Shandong Provincial Natural Science Foundation of China(Natural Science Foundation of Shandong Province)	This research was supported by National Natural Science Foundation of China (No. 41571468, 21077052), the Science and Technology Support Program of Jiangsu Province (No.BE2016172, BE2012737), and the Shandong Provincial Natural Science Foundation of China (No. ZR2015CM023).	Ali D, 2014, CHEMOSPHERE, V104, P134, DOI 10.1016/j.chemosphere.2013.10.081; [Anonymous], 2012, 8503100 OCSPP ESEPA; Chang JC, 2010, WORLD J CARDIOL, V2, P150, DOI 10.4330/wjc.v2.i6.150; Chen SZ, 2014, MAT SCI ENG C-MATER, V43, P330, DOI 10.1016/j.msec.2014.07.029; Cigerci IH, 2016, CHEMOSPHERE, V144, P754, DOI 10.1016/j.chemosphere.2015.09.053; COLLINS AR, 1995, MUTAT RES-DNA REPAIR, V336, P69, DOI 10.1016/0921-8777(94)00043-6; Cui XY, 2009, J SOIL SEDIMENT, V9, P604, DOI 10.1007/s11368-009-0124-7; De Volder MFL, 2013, SCIENCE, V339, P535, DOI 10.1126/science.1222453; Dong YL, 2009, COMP BIOCHEM PHYS C, V150, P179, DOI 10.1016/j.cbpc.2009.04.010; Du L, 2015, ENVIRON SCI POLLUT R, V22, P4660, DOI 10.1007/s11356-014-3716-8; EYAMBE GS, 1991, LAB ANIM, V25, P61, DOI 10.1258/002367791780808095; Garza KM, 2008, INT J NANOMED, V3, P83; Han YN, 2014, ECOTOX ENVIRON SAFE, V107, P214, DOI 10.1016/j.ecoenv.2014.06.006; Hayashi Y, 2013, ENVIRON SCI TECHNOL, V47, P14367, DOI 10.1021/es404132w; Heggelund LR, 2014, NANOTOXICOLOGY, V8, P559, DOI 10.3109/17435390.2013.809808; Hu CW, 2014, SOIL BIOL BIOCHEM, V70, P123, DOI 10.1016/j.soilbio.2013.12.018; Irizar A, 2015, ARCH ENVIRON CON TOX, V68, P181, DOI 10.1007/s00244-014-0060-4; Irizar A, 2015, ECOTOXICOLOGY, V24, P1004, DOI 10.1007/s10646-015-1441-9; Irizar A, 2014, ECOTOXICOLOGY, V23, P1326, DOI 10.1007/s10646-014-1275-x; Jin IK, 2014, ENVIRON RES, V134, P118, DOI [10.1016/j.envres.2014.07.014, DOI 10.1016/J.ENVRES.2014.07.014]; Jin WL, 2016, AQUAT TOXICOL, V171, P9; Kunzmann A, 2011, BBA-GEN SUBJECTS, V1810, P361, DOI 10.1016/j.bbagen.2010.04.007; Lee JW, 2016, AQUAT TOXICOL, V171, P9, DOI 10.1016/j.aquatox.2015.12.005; Li PC, 2015, CARDIOVASC TOXICOL, V15, P172, DOI 10.1007/s12012-014-9281-z; Liu L, 2013, EUR REV MED PHARMACO, V17, P88; Lowe CN, 2005, PEDOBIOLOGIA, V49, P401, DOI 10.1016/j.pedobi.2005.04.005; OECD, 2004, EARTHW REPR TEST; OECD (Organisation for Economic Co-operation and Development), 1984, EARTHW AC TOX TESTS; Martin AP, 2013, EUPHROSYNE, V41, P47; Pereira MM, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/1477-3155-12-15; Petersen EJ, 2009, ENVIRON SCI TECHNOL, V43, P4181, DOI 10.1021/es803023a; Plytycz B, 2011, PEDOBIOLOGIA, V54, pS203, DOI 10.1016/j.pedobi.2011.06.002; Plytycz B, 2010, CHEMOSPHERE, V81, P199, DOI 10.1016/j.chemosphere.2010.06.056; Reinardy HC, 2015, MUTAGENESIS, V30, P829, DOI 10.1093/mutage/gev052; Sabatini SE, 2009, ECOTOX ENVIRON SAFE, V72, P1200, DOI 10.1016/j.ecoenv.2009.01.003; Saez G, 2015, ENVIRON TOXICOL, V30, P918, DOI 10.1002/tox.21966; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Spurgeon DJ, 2000, ENVIRON TOXICOL CHEM, V19, P1800, DOI [10.1897/1551-5028(2000)019&lt;1800:RSOLCA&gt;2.3.CO;2, 10.1002/etc.5620190714]; STOMMER P, 1990, PANCREAS, V5, P114; Sun JH, 2013, BEIJING GONGYE DAXUE, V39, P624; Towell MG, 2011, ENVIRON POLLUT, V159, P706, DOI 10.1016/j.envpol.2010.11.040; Tripathi G, 2010, PESTIC BIOCHEM PHYS, V98, P333, DOI 10.1016/j.pestbp.2010.07.005; Ursini CL, 2012, TOXICOL IN VITRO, V26, P831, DOI 10.1016/j.tiv.2012.05.001; Wei Z, 2014, ENV TOXICOL PHAR, V38, P297; Yang Y, 2016, CHEMOSPHERE, V144, P2476, DOI 10.1016/j.chemosphere.2015.11.023; Zhang FQ, 2007, CHEMOSPHERE, V67, P44, DOI 10.1016/j.chemosphere.2006.10.007; Zhang LJ, 2014, ECOTOX ENVIRON SAFE, V103, P29, DOI 10.1016/j.ecoenv.2014.01.041; Zhang QM, 2015, CHEMOSPHERE, V139, P138, DOI 10.1016/j.chemosphere.2015.05.091; Zhang QM, 2013, ENVIRON SCI POLLUT R, V20, P201, DOI 10.1007/s11356-012-0962-5; Zhou CF, 2013, ENVIRON POLLUT, V180, P71, DOI 10.1016/j.envpol.2013.05.016	50	10	11	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e170092	10.1371/journal.pone.0170092	http://dx.doi.org/10.1371/journal.pone.0170092			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125623	Green Published, gold, Green Submitted			2022-12-26	WOS:000396176100129
J	Croome, KP; Lee, DD; Harnois, D; Taner, CB				Croome, Kristopher P.; Lee, David D.; Harnois, Denise; Taner, C. Burcin			Effects of the Share 35 Rule on Waitlist and Liver Transplantation Outcomes for Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							DISEASE SCORE; MODEL; RISK; ALLOGRAFT	Introduction Several studies have investigated the effects following the implementation of the "Share 35" policy; however none have investigated what effect this policy change has had on waitlist and liver transplantation (LT) outcomes for hepatocellular carcinoma(HCC). Methods Data were obtained from the UNOS database and a comparison of the 2 years post-Share 35 with data from the 2 years pre-Share 35 was performed. Results In the pre-Share35 era, 23% of LT were performed for HCC exceptions compared to 22% of LT in the post-Share35 era (p = 0.21). No difference in wait-time for HCC patients was seen in any of the UNOS regions between the 2 eras. Competing risk analysis demonstrated that HCC candidates in post-Share 35 era were more likely to die or be delisted for "too sick" while waiting (7.2% vs. 5.3%; p = 0.005) within 15 months. A higher proportion of ECD (p<0.001) and DCD (p<0.001) livers were used for patients transplanted for HCC, while lower DRI organs were used for those patients transplanted with a MELD >= 35 between the 2 eras (p = 0.007). Conclusion No significant change to wait-time for patients listed for HCC was seen following implementation of "Share 35". Transplant program behavior has changed resulting use of higher proportion of ECD and DCD liver grafts for patients with HCC. A higher rate of wait list mortality was observed in patients with HCC in the post-Share 35 era.	[Croome, Kristopher P.; Lee, David D.; Harnois, Denise; Taner, C. Burcin] Mayo Clin Florida, Dept Transplant, Jacksonville, FL 32224 USA	Mayo Clinic	Croome, KP (corresponding author), Mayo Clin Florida, Dept Transplant, Jacksonville, FL 32224 USA.	croome.kristopher@mayo.edu	Lee, David/ABH-1406-2021; Croome, Kristopher/ABB-3908-2020	Lee, David/0000-0002-2086-0150; Croome, Kristopher/0000-0001-7725-703X				Chapman WC, 2016, LIVER TRANSPLANT, V22, P393, DOI 10.1002/lt.24420; Croome KP, 2015, AM J TRANSPLANT, V15, P2704, DOI 10.1111/ajt.13306; Croome KP, 2012, TRANSPL P, V44, P1303, DOI 10.1016/j.transproceed.2012.01.115; Edwards EB, 2016, LIVER TRANSPLANT, V22, P399, DOI 10.1002/lt.24418; Feng S, 2010, LIVER TRANSPLANT, V16, pS60, DOI 10.1002/lt.22142; Freeman RB, 2006, AM J TRANSPLANT, V6, P1416, DOI 10.1111/j.1600-6143.2006.01321.x; Goldberg D, 2012, LIVER TRANSPLANT, V18; Heimbach JK, 2015, HEPATOLOGY, V61, P1643, DOI 10.1002/hep.27704; Maluf DG, 2006, TRANSPLANTATION, V82, P1653, DOI 10.1097/01.tp.0000250571.41361.21; Massie AB, 2015, AM J TRANSPLANT, V15, P659, DOI 10.1111/ajt.13099; Massie AB, 2011, AM J TRANSPLANT, V11; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Patel MS, 2015, J AM COLL SURGEONS, V220, P1001, DOI 10.1016/j.jamcollsurg.2014.12.050; Pomfret EA, 2010, LIVER TRANSPLANT, V16; Sharma P, 2012, HEPATOLOGY, V55, P192, DOI 10.1002/hep.24632; Washburn K, 2010, AM J TRANSPLANT, V10, P1643, DOI 10.1111/j.1600-6143.2010.03127.x	16	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0170673	10.1371/journal.pone.0170673	http://dx.doi.org/10.1371/journal.pone.0170673			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122003	Green Published, Green Submitted, gold			2022-12-26	WOS:000396167300029
J	Kingston, S; Rose, M; Cohen-Serrins, J; Knight, E				Kingston, Sharon; Rose, Maya; Cohen-Serrins, Julian; Knight, Emily			A Qualitative Study of the Context of Child and Adolescent Substance Use Initiation and Patterns of Use in the First Year for Early and Later Initiators	PLOS ONE			English	Article							ALCOHOL-USE INITIATION; MAJOR DEPRESSIVE DISORDER; DRINKING ONSET; BINGE DRINKING; RISK-FACTORS; UNINTENTIONAL INJURY; EMERGING ADULTHOOD; SUICIDE IDEATION; YOUNG-ADULTS; DRUG-USE	Individuals who initiate substance use before high school are at higher risk of negative outcomes. Eighty-six young adults between the ages of 18 and 28 participated in semi-structured qualitative interviews focused on the circumstances surrounding participants' first use of substances and their pattern of use in the year following initiation in order to investigate similarities and differences between early versus later initiators. Initiation and use among early initiators were more likely to be encouraged by poor parental monitoring or active facilitation of use by parents. Early initiators were more likely to report risky patterns of use such as daily use and using alone. The data suggest that interventions targeting this population should focus on improving parental monitoring and decreasing positive parental attitudes toward adolescent substance use and efforts to increase identification and intervention by middle school staff to reach youth from high-risk families.	[Kingston, Sharon; Rose, Maya; Cohen-Serrins, Julian; Knight, Emily] Dickinson Coll, Dept Psychol, Carlisle, PA 17013 USA	Dickinson College	Kingston, S (corresponding author), Dickinson Coll, Dept Psychol, Carlisle, PA 17013 USA.	kingstos@dickinson.edu		Kingston, Sharon/0000-0002-0706-3915; Rose, Maya/0000-0002-4078-2137; Cohen-Serrins, Julian/0000-0002-4401-2658	Dickinson College Research and Development Committee	Dickinson College Research and Development Committee	The authors received funding from the Dickinson College Research and Development Committee. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bossarte RM, 2011, ADDICT BEHAV, V36, P532, DOI 10.1016/j.addbeh.2010.12.031; Botvin G J, 2001, Prev Sci, V2, P1, DOI 10.1023/A:1010025311161; Botvin GJ, 2000, ADDICT BEHAV, V25, P887, DOI 10.1016/S0306-4603(00)00119-2; Botvin GJ, 2000, ALCOHOL RES HEALTH, V24, P250; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brook DW, 2002, ARCH GEN PSYCHIAT, V59, P1039, DOI 10.1001/archpsyc.59.11.1039; Chassin L, 2002, J CONSULT CLIN PSYCH, V70, P67, DOI 10.1037//0022-006X.70.1.67; Cho H, 2007, ADDICT BEHAV, V32, P1628, DOI 10.1016/j.addbeh.2006.11.017; DeHaan L, 2010, J CHILD ADOLES SUBST, V19, P223, DOI 10.1080/1067828X.2010.488960; DeWit DJ, 2000, PREV MED, V31, P455, DOI 10.1006/pmed.2000.0738; Donovan JE, 2011, J STUD ALCOHOL DRUGS, V72, P741, DOI 10.15288/jsad.2011.72.741; Ellickson PL, 2004, PREV MED, V39, P976, DOI 10.1016/j.ypmed.2004.04.013; Flory K, 2004, DEV PSYCHOPATHOL, V16, P193, DOI 10.1017/S0954579404044475; Galera C, 2010, EUR PSYCHIAT, V25, P402, DOI 10.1016/j.eurpsy.2010.06.002; Gibbons F. X., 1997, HLTH COPING WELL BEI, P63; Gibbons FX, 2003, BLACKW SER HLTH PSYC, P107; Gruber E, 1996, PREV MED, V25, P293, DOI 10.1006/pmed.1996.0059; Haggerty KP, 2008, ADDICTION, V103, P2008, DOI 10.1111/j.1360-0443.2008.02360.x; Harrison PA, 1997, CHILD ABUSE NEGLECT, V21, P529, DOI 10.1016/S0145-2134(97)00013-6; Hartman C, 2013, AM J ADDICTION, V22, P246, DOI 10.1111/j.1521-0391.2012.12010.x; Hawkins JD, 1997, J STUD ALCOHOL, V58, P280, DOI 10.15288/jsa.1997.58.280; Hayatbakhsh MR, 2008, AUST NZ J PSYCHIAT, V42, P720, DOI 10.1080/00048670802206346; Hayatbakhsh R, 2013, DRUG ALCOHOL REV, V32, P232, DOI 10.1111/j.1465-3362.2012.00520.x; Hermos JA, 2008, J ADDICT MED, V2, P22, DOI 10.1097/ADM.0b013e3181565e14; Hill KG, 2000, ALCOHOL CLIN EXP RES, V24, P892, DOI 10.1111/j.1530-0277.2000.tb02071.x; Hingson R, 2003, J STUD ALCOHOL, V64, P23, DOI 10.15288/jsa.2003.64.23; Hingson R, 2002, ACCIDENT ANAL PREV, V34, P85, DOI 10.1016/S0001-4575(01)00002-1; Hingson RW, 2008, J STUD ALCOHOL DRUGS, V69, P192, DOI 10.15288/jsad.2008.69.192; Hingson RW, 2009, ALCOHOL CLIN EXP RES, V33, P783, DOI 10.1111/j.1530-0277.2009.00896.x; Hingson RW, 2000, JAMA-J AM MED ASSOC, V284, P1527, DOI 10.1001/jama.284.12.1527; Kingston S, 2015, J ADDICT DIS, V34, P311, DOI 10.1080/10550887.2015.1074506; Kosterman R, 2000, AM J PUBLIC HEALTH, V90, P360, DOI 10.2105/AJPH.90.3.360; Kumpfer KL, 2010, GROUP DYN-THEOR RES, V14, P211, DOI 10.1037/a0020602; Lynskey MT, 2004, ARCH GEN PSYCHIAT, V61, P1026, DOI 10.1001/archpsyc.61.10.1026; McCarty CA, 2012, PSYCHOL ADDICT BEHAV, V26, P351, DOI 10.1037/a0025630; Rohde P, 2004, NICOTINE TOB RES, V6, P119, DOI 10.1080/14622200310001656948; Scheier LM, 1997, PSYCHOL ADDICT BEHAV, V11, P48, DOI 10.1037/0893-164X.11.1.48; Stueve A, 2005, AM J PUBLIC HEALTH, V95, P887, DOI 10.2105/AJPH.2003.026567; Swahn MH, 2008, PEDIATRICS, V121, P297, DOI 10.1542/peds.2006-2348; Swahn MH, 2007, J ADOLESCENT HEALTH, V41, P175, DOI 10.1016/j.jadohealth.2007.03.003; Swahn MH, 2012, INT J PUBLIC HEALTH, V57, P95, DOI 10.1007/s00038-011-0255-7; Swahn MH, 2010, ADDICT BEHAV, V35, P452, DOI 10.1016/j.addbeh.2009.12.017; Tucker JS, 2005, J DRUG ISSUES, V35, P307, DOI 10.1177/002204260503500205	43	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0170794	10.1371/journal.pone.0170794	http://dx.doi.org/10.1371/journal.pone.0170794			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7FK	28122018	Green Published, Green Submitted, gold			2022-12-26	WOS:000396167300019
J	Usai, D; Maritan, L; Dal Sasso, G; Artioli, G; Salvatori, S; Jakob, T; Salviato, T				Usai, Donatella; Maritan, Lara; Dal Sasso, Gregorio; Artioli, Gilberto; Salvatori, Sandro; Jakob, Tina; Salviato, Tiziana			Late Pleistocene/Early Holocene Evidence of Prostatic Stones at Al Khiday Cemetery, Central Sudan	PLOS ONE			English	Article							CALCULI	The recovery of three stone-like ovoid objects within the burial of a pre-Mesolithic (Late Pleistocene/ Early Holocene) individual at Al Khiday cemetery (Central Sudan) raises the question of the nature and origin of these objects. The position in which the objects were found in relation to the human skeleton suggested a pathological condition affecting the individual, possibly urinary bladder, kidney stones or gallstones. To solve this issue, a multianalytical approach, consisting of tomographic, microstructural and compositional analyses, was therefore performed. Based on their microstructure and mineralogical composition, consisting of hydroxylapatite and whitlockite, the investigated stones were identified as primary (endogenous) prostatic calculi. In addition, the occurrence of bacterial imprints also indicates on-going infectious processes in the individual. This discovery of the earliest known case of lithiasis extends the appearance of prostatic stones into the Late Pleistocene/ Early Holocene, a disease which therefore can no longer be considered exclusive to the modern era, but which also affected prehistoric individuals, whose lifestyle and diet were significantly different to our own.	[Usai, Donatella; Salvatori, Sandro] CSSeS, Treviso, Italy; [Maritan, Lara; Dal Sasso, Gregorio; Artioli, Gilberto] Univ Padua, Dept Geosci, Padua, Italy; [Jakob, Tina] Univ Durham, Dept Archaeol, Durham, England; [Salviato, Tiziana] Univ Trieste, Dept Pathol, Trieste, Italy	University of Padua; Durham University; University of Trieste	Usai, D (corresponding author), CSSeS, Treviso, Italy.	donatellausaisalvatori@gmail.com	Usai, Donatella/AAY-4536-2020; Artioli, Gilberto/F-2149-2015; Dal Sasso, Gregorio/J-5074-2017	Usai, Donatella/0000-0001-9379-9015; Artioli, Gilberto/0000-0002-8693-7392; Dal Sasso, Gregorio/0000-0002-2176-5446; salviato, tiziana/0000-0003-3492-1644	Centro Studi Sudanesi e Sub-Sahariani; University of Padova; "Ministero degli Affari Esteri" (MAE) of the Italian Government; "Centro Studi Sudanesi e Sub-Sahariani" (CSSeS)	Centro Studi Sudanesi e Sub-Sahariani; University of Padova; "Ministero degli Affari Esteri" (MAE) of the Italian Government; "Centro Studi Sudanesi e Sub-Sahariani" (CSSeS)	Italian Minister of Foreign Affairs and Centro Studi Sudanesi e Sub-Sahariani funded fieldwork in Sudan, and University of Padova funded analytical work.; We thank the "National Corporation for Antiquities and Museums", Khartoum (Sudan), in particular the General Director Abdelrahman Ali Mohamed, for authorising the study of archaeological bones; "Ministero degli Affari Esteri" (MAE) of the Italian Government and "Centro Studi Sudanesi e Sub-Sahariani" (CSSeS) for funding the archaeological research. The INES beamline staff (Antonella Scherillo) is thanked for test beamtime and help in data collection. We thank Stefano Castelli for the technical support for digital photogrammetry. We are grateful to the editor and two anonymous reviewers for their suggestions, which improved the manuscript, and Julie Dunne for revising the English text.	Adler CJ, 2013, NAT GENET, V45, P450, DOI 10.1038/ng.2536; Aguilar-Ruiz J, 2012, ULTRASTRUCT PATHOL, V36, P367, DOI 10.3109/01913123.2012.729879; Alvarez UM, 2011, CLIN MANAGEMENT COMP; Brothwell DR., 1967, DIS ANTIQUITY, P349; Collado-Vazquez S, 2014, NEUROLOGIA, V29, P433, DOI 10.1016/j.nrl.2011.05.012; D'Alessio A, 2005, ARCHAEOMETRY, V47, P127, DOI 10.1111/j.1475-4754.2005.00192.x; Dal Sasso G, 2015, THESIS; Dal Sasso G, 2014, PALAEOGEOGR PALAEOCL, V416, P30, DOI 10.1016/j.palaeo.2014.06.034; Dastugue J., 1959, B MEM SOC ANTHRO PAR, V10, P357; Dessombz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051691; GOPAL R, 1972, NATURE-PHYS SCI, V237, P30, DOI 10.1038/physci237030a0; Hardy K, 2012, NATURWISSENSCHAFTEN, V99, P617, DOI 10.1007/s00114-012-0942-0; Iacumin P, 2016, AM J PHYS ANTHROPOL, V160, P498, DOI 10.1002/ajpa.22987; Imberti S, 2008, MEAS SCI TECHNOL, V19, DOI 10.1088/0957-0233/19/3/034003; Jakob T., 2014, 4 CATARACT, P271; KLIMAS R, 1985, PROSTATE, V7, P91, DOI 10.1002/pros.2990070110; Kodaka T, 2008, J ELECTRON MICROSC, V57, P133, DOI 10.1093/jmicro/dfn013; Larson A.C, 2000, GEN STRUCTURE ANAL S; Lutterotti L, 2010, NUCL INSTRUM METH B, V268, P334, DOI 10.1016/j.nimb.2009.09.053; MARKGRAF SA, 1985, AM MINERAL, V70, P590; Mazzoli S, 2010, FEMS IMMUNOL MED MIC, V59, P337, DOI 10.1111/j.1574-695X.2010.00659.x; Moran, 2014, UROLITHIASIS COMPREH; Najoui M, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.69.2376; Ozdemir K, 2015, INT J OSTEOARCHAEOL, V25, P827, DOI 10.1002/oa.2349; Park B, 2016, ASIAN J ANDROL; RAMIREZ CT, 1980, J UROLOGY, V124, P840, DOI 10.1016/S0022-5347(17)55691-8; Salvatori S., 2014, P 12 INT C NUB STUD, P243; Salvatori S, 2011, AFR ARCHAEOL REV, V28, P177, DOI 10.1007/s10437-011-9095-3; Sfanos KS, 2009, P NATL ACAD SCI USA, V106, P3443, DOI 10.1073/pnas.0810473106; Shah J, 2002, BJU INT, V89, P801, DOI 10.1046/j.1464-410X.2002.02769.x; Steinbock R. T., 1989, J PALEOPATHOL, V3, P35; SUDARSANAN K, 1969, ACTA CRYSTALL B-STRU, VB 25, P1534, DOI 10.1107/S0567740869004298; SUTOR DJ, 1974, BRIT J UROL, V46, P533, DOI 10.1111/j.1464-410X.1974.tb03852.x; SUTOR DJ, 1971, GUT, V12, P55, DOI 10.1136/gut.12.1.55; Tefekli A, 2013, SCI WORLD J; Tonolini M, 2016, INSIGHTS IMAGING, P1; Usai D., 2010, ANTIQUITY, V84, P323; Usai D, 2014, J AFR ARCHAEOL, V12, P183, DOI 10.3213/2191-5784-10254; Venyo AK, 2012, UROLOGY, V3, P3463; Wendorf F, 1986, WADI KUBBANIYA SKELE; Williams MAJ, 2009, GLOBAL PLANET CHANGE, V69, P1, DOI 10.1016/j.gloplacha.2009.07.005	41	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0169524	10.1371/journal.pone.0169524	http://dx.doi.org/10.1371/journal.pone.0169524			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7FK	28122013	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000396167300073
J	Ishikawa, A				Ishikawa, Akira			Identification of a Putative Quantitative Trait Gene for Resistance to Obesity in Mice Using Transcriptome Analysis and Causal Inference Tests	PLOS ONE			English	Article							PHILIPPINE WILD MICE; BODY-WEIGHT; EXPRESSION ANALYSIS; POSTNATAL-GROWTH; DENDRITIC CELLS; STRAIN ANALYSIS; COMPLEX TRAITS; C57BL/6J MICE; MOUSE; LOCI	It is still challenging to identify causal genes governing obesity. Pbwg1.5, a quantitative trait locus (QTL) for resistance to obesity, was previously discovered from wild Mus musculus castaneus mice and was fine-mapped to a 2.1-Mb genomic region of mouse chromosome 2, where no known gene with an effect on white adipose tissue (WAT) has been reported. The aim of this study was to identify a strong candidate gene for Pbwg1.5 by an integration approach of transcriptome analysis (RNA-sequencing followed by real-time PCR analysis) and the causal inference test (CIT), a statistical method to infer causal relationships between diplotypes, gene expression and trait values. Body weight, body composition and biochemical traits were measured in F-2 mice obtained from an intercross between the C57BL/6JJcl strain and a congenic strain carrying Pbwg1.5 on the C57BL/6JJcl background. The F-2 mice showed significant diplotype differences in 12 traits including body weight, WAT weight and serum cholesterol/triglyceride levels. The transcriptome analysis revealed that Ly75, Pla2r1, Fap and Gca genes were differentially expressed in the liver and that Fap, Ifih1 and Grb14 were differentially expressed in WAT. However, CITs indicated statistical evidence that only the liver Ly75 gene mediated between genotype and WAT. Ly75 expression was negatively associated with WAT weight. The results suggested that Ly75 is a putative quantitative trait gene for the obesity-resistant Pbwg1.5 QTL discovered from the wild M. m. castaneus mouse. The finding provides a novel insight into a better understanding of the genetic basis for prevention of obesity.	[Ishikawa, Akira] Nagoya Univ, Grad Sch Bioagr Sci, Lab Anim Genet, Nagoya, Aichi, Japan	Nagoya University	Ishikawa, A (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Lab Anim Genet, Nagoya, Aichi, Japan.	ishikawa@agr.nagoya-u.ac.jp	Ishikawa, Akira/I-6856-2014	Ishikawa, Akira/0000-0002-8275-4230	Japan Society for the Promotion of Science [22380149, 16H04680]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by Grants in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/) (Nos. 22380149 and 16H04680). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Bunger L, 2005, MOUSE IN ANIMAL GENETICS AND BREEDING RESEARCH, P131, DOI 10.1142/9781860947162_0007; Caspar-Bauguil S, 2005, FEBS LETT, V579, P3487, DOI 10.1016/j.febslet.2005.05.031; Cheverud JM, 2010, J LIPID RES, V51, P907, DOI 10.1194/jlr.M900128; Christians JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056260; Darvasi A, 2005, TRENDS GENET, V21, P373, DOI 10.1016/j.tig.2005.05.003; Eppig JT, 2015, NUCLEIC ACIDS RES, V43, pD726, DOI 10.1093/nar/gku967; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Greenawalt DM, 2012, AM J EPIDEMIOL, V176, P423, DOI 10.1093/aje/kws123; Guo M, 2000, HUM IMMUNOL, V61, P729, DOI 10.1016/S0198-8859(00)00144-0; Ishikawa A, 2000, MAMM GENOME, V11, P824, DOI 10.1007/s003350010145; Ishikawa A, 2005, GENET RES, V85, P127, DOI 10.1017/S001667230500738X; Ishikawa A, 2004, GENES GENET SYST, V79, P27, DOI 10.1266/ggs.79.27; Ishikawa A, 2007, MAMM GENOME, V18, P229, DOI 10.1007/s00335-007-9009-5; Ishikawa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113233; Ishikawa A, 2009, J HERED, V100, P501, DOI 10.1093/jhered/esp004; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Manteniotis S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079523; Millstein J, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-23; Mollah MBR, 2011, MAMM GENOME, V22, P282, DOI 10.1007/s00335-011-9323-9; Mollah MBR, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-84; Mollah MBR, 2013, ANIM SCI J, V84, P296, DOI 10.1111/asj.12004; Morton NM, 2016, NAT MED, V22, P771, DOI 10.1038/nm.4115; Okazaki M, 2016, J OLEO SCI, V65, P265, DOI 10.5650/jos.ess16020; Partridge CG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-99; Radonjic M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006646; Rikke BA, 1998, MAMM GENOME, V9, P963, DOI 10.1007/s003359900907; Roux PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111299; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Tomida S, 2009, NAT GENET, V41, P688, DOI 10.1038/ng.344; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Usui S, 2002, J LIPID RES, V43, P805; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450; Yazdani N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005713	36	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170652	10.1371/journal.pone.0170652	http://dx.doi.org/10.1371/journal.pone.0170652			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114323	gold, Green Published			2022-12-26	WOS:000396129000082
J	Lin, CC; Hung, YY; Tsai, MC; Huang, TL				Lin, Chin-Chuen; Hung, Yi-Yung; Tsai, Meng-Chang; Huang, Tiao-Lai			The Lorazepam and Diazepam Protocol for Catatonia Due to General Medical Condition and Substance in Liaison Psychiatry	PLOS ONE			English	Article							BLOOD-FLOW CHANGES; ELECTROCONVULSIVE-THERAPY; DIFFERENTIAL-DIAGNOSIS; ALCOHOL-WITHDRAWAL; SCHIZOPHRENIA; FEATURES; ECT; COMPLICATIONS; PATIENT	Objective The lorazepam-diazepam protocol had been proved to rapidly and effectively relieve catatonia in patients with schizophrenia or mood disorder. This study aims to investigate the efficacy of lorazepam-diazepam protocol in catatonia due to general medical conditions (GMC) and substance. Method Patients with catatonia that required psychiatric intervention in various settings of a medical center were included. The lorazepam-diazepam protocol had been used to treat the catatonia due to GMC or substance according to DSM-IV criteria. The treatment response had been assessed by two psychiatrists. Results Eighteen (85.7%) of 21 catatonic patients due to GMC or substance became free of catatonia after the lorazepam-diazepam protocol. Five (23.8%) of the 21 patients had passed away with various causes of death and wide range of time periods after catatonia. Conclusion Our results showed that the lorazepam-diazepam protocol could rapidly and effectively relieve catatonia due to GMC and substance.	[Huang, Tiao-Lai] Kaohsiung Chang Gung Mem Hosp, Dept Psychiat, Kaohsiung, Taiwan; Chang Gung Univ, Coll Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Huang, TL (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Psychiat, Kaohsiung, Taiwan.	a540520@adm.cgmh.org.tw			Kaohsiung Chang Gung Memorial Hospital in Taiwan [CMRPG8D0571];  [CMRPG840521];  [CMRPG8054];  [CMRPG850491];  [CMRPG870951];  [CMRPG870952];  [CMRPG8C0831];  [NSC 99-2628-B-182-002-MY2];  [NSC 94-2314-B-182A-208];  [NSC 95-2314-B-182A-191];  [NSC 96-2314-B-182A091]	Kaohsiung Chang Gung Memorial Hospital in Taiwan; ; ; ; ; ; ; ; ; ; 	This work was supported by a clinical research grant No. CMRPG8D0571 from Kaohsiung Chang Gung Memorial Hospital in Taiwan. Some of the patients of catatonia were evaluated during the support of research grants No. CMRPG840521, CMRPG850491, CMRPG8054, CMRPG850491, CMRPG870951, CMRPG870952, CMRPG8C0831, NSC 99-2628-B-182-002-MY2, NSC 94-2314-B-182A-208, NSC 95-2314-B-182A-191, and NSC 96-2314-B-182A091.	Basu A, 2014, J PHARMACOL PHARMACO, V5, P261, DOI 10.4103/0976-500X.142449; Bush G, 1996, ACTA PSYCHIAT SCAND, V93, P137, DOI 10.1111/j.1600-0447.1996.tb09815.x; Carroll B, 2005, CURR PSYCHIAT, V4, P56; Carroll BT, 1996, J CLIN PSYCHIAT, V57, P95; Ene-Stroescu V, 2014, J NEUROPSYCH CLIN N, V26, pE43, DOI 10.1176/appi.neuropsych.13020038; Escobar R, 2000, J PSYCHOSOM RES, V49, P423, DOI 10.1016/S0022-3999(00)00190-2; Fink M, 2001, J NEURAL TRANSM, V108, P637, DOI 10.1007/s007020170041; Fink M, 2009, ARCH GEN PSYCHIAT, V66, P1173, DOI 10.1001/archgenpsychiatry.2009.141; Galynker II, 1997, J NUCL MED, V38, P251; Geoffroy PA, 2012, ALCOHOL ALCOHOLISM, V47, P288, DOI 10.1093/alcalc/agr170; Gross Anne F, 2008, Prim Care Companion J Clin Psychiatry, V10, P153; Hawkins JM, 1995, INT J PSYCHIAT MED, V25, P345, DOI 10.2190/X0FF-VU7G-QQP7-L5V7; Hsieh MH, 2011, PSYCHOSOMATICS, V52, P475, DOI 10.1016/j.psym.2011.01.024; Huang Chao-En, 2010, Chang Gung Med J, V33, P106; Huang TL, 2006, J PSYCHIATR RES, V40, P664, DOI 10.1016/j.jpsychires.2005.11.004; Huang TL, 2009, PROG NEURO-PSYCHOPH, V33, P158, DOI 10.1016/j.pnpbp.2008.10.016; Huang TL, 2005, PSYCHIAT CLIN NEUROS, V59, P52, DOI 10.1111/j.1440-1819.2005.01331.x; Huang TL, 1999, PSYCHIAT CLIN NEUROS, V53, P63, DOI 10.1046/j.1440-1819.1999.00472.x; Huang Yu-Chi, 2013, Biomed J, V36, P35, DOI 10.4103/2319-4170.107162; Hung YY, 2007, PROG NEURO-PSYCHOPH, V31, P1537, DOI 10.1016/j.pnpbp.2007.06.016; Hung YY, 2006, CLIN NEUROPHARMACOL, V29, P144, DOI 10.1097/01.WNF.0000221908.56361.C7; Ignatowski Michael, 2007, Psychiatry (Edgmont), V4, P51; Jankovic J., 2014, J NEUROL NEUROSURG P; Kleinhaus K, 2012, SCHIZOPHRENIA BULL, V38, P331, DOI 10.1093/schbul/sbq087; Lachner C, 2003, PSYCHOSOMATICS, V44, P512, DOI 10.1176/appi.psy.44.6.512; Lai JY, 2004, PSYCHIAT CLIN NEUROS, V58, P157, DOI 10.1111/j.1440-1819.2003.01210.x; Lin CC, 2016, COMPR PSYCHIAT, V66, P157, DOI 10.1016/j.comppsych.2016.01.011; Lin CC, 2013, COMPR PSYCHIAT, V54, P1210, DOI 10.1016/j.comppsych.2013.06.003; MCCALL WV, 1995, J CLIN PSYCHIAT, V56, P21; Narayanaswamy JC, 2011, PSYCHOPATHOLOGY, V44, P136, DOI 10.1159/000319849; Northoff G, 2002, BEHAV BRAIN SCI, V25, P555; Petrides G, 1997, BIOL PSYCHIAT, V42, P375, DOI 10.1016/S0006-3223(96)00378-2; Polyakova M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141564; Praharaj SK, 2013, J NEUROPSYCH CLIN N, V25, pE8, DOI 10.1176/appi.neuropsych.12010002; Rosebush PI, 2010, SCHIZOPHRENIA BULL, V36, P239, DOI 10.1093/schbul/sbp141; Rosebush PI, 2006, CUR CLIN NEUROL, P81; Smith Derek Leroux, 2014, Minn Med, V97, P38; Swartz CM, 2001, J ECT, V17, P180, DOI 10.1097/00124509-200109000-00006; Taylor MA, 2003, AM J PSYCHIAT, V160, P1233, DOI 10.1176/appi.ajp.160.7.1233; Thomas C, 2005, AM J PSYCHIAT, V162, P626, DOI 10.1176/appi.ajp.162.3.626; Tsai MC, 2010, PROG NEURO-PSYCHOPH, V34, P423, DOI 10.1016/j.pnpbp.2009.12.015; Tsujino N, 2011, PSYCHIAT CLIN NEUROS, V65, P600, DOI 10.1111/j.1440-1819.2011.02257.x	42	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170452	10.1371/journal.pone.0170452	http://dx.doi.org/10.1371/journal.pone.0170452			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6QR	28114315	Green Published, Green Submitted, gold			2022-12-26	WOS:000396129000051
J	Rodrigues, ME; Lopes, SP; Pereira, CR; Azevedo, NF; Lourenco, A; Henriques, M; Pereira, MO				Rodrigues, Maria E.; Lopes, Susana P.; Pereira, Claudia R.; Azevedo, Nuno F.; Lourenco, Anlia; Henriques, Mariana; Pereira, Maria O.			Polymicrobial Ventilator-Associated Pneumonia: Fighting In Vitro Candida albicans- Pseudomonas aeruginosa Biofilms with Antifungal-Antibacterial Combination Therapy	PLOS ONE			English	Article							INADEQUATE ANTIMICROBIAL TREATMENT; POLYMYXIN-B; TIME-KILL; CYSTIC-FIBROSIS; ACINETOBACTER-BAUMANNII; ANTIBIOTIC-RESISTANCE; ASPERGILLUS-FUMIGATUS; BACTERIAL-RESISTANCE; RESPIRATORY-TRACT; CRITICALLY-ILL	The polymicrobial nature of ventilator-associated pneumonia (VAP) is now evident, with mixed bacterial-fungal biofilms colonizing the VAP endotracheal tube (ETT) surface. The microbial interplay within this infection may contribute for enhanced pathogenesis and exert impact towards antimicrobial therapy. Consequently, the high mortality/ morbidity rates associated to VAP and the worldwide increase in antibiotic resistance has promoted the search for novel therapeutic strategies to fight VAP polymicrobial infections. Under this scope, this work aimed to assess the activity of mono-vs combinational antimicrobial therapy using one antibiotic (Polymyxin B; PolyB) and one antifungal (Amphotericin B; AmB) agent against polymicrobial biofilms of Pseudomonas aeruginosa and Candida albicans. The action of isolated antimicrobials was firstly evaluated in single-and polymicrobial cultures, with AmB being more effective against C. albicans and PolyB against P. aeruginosa. Mixed planktonic cultures required equal or higher antimicrobial concentrations. In biofilms, only PolyB at relatively high concentrations could reduce P. aeruginosa in both monospecies and polymicrobial populations, with C. albicans displaying only punctual disturbances. PolyB and AmB exhibited a synergistic effect against P. aeruginosa and C. albicans mixed planktonic cultures, but only high doses (256 mg L (-1)) of PolyB were able to eradicate polymicrobial biofilms, with P. aeruginosa showing loss of cultivability (but not viability) at 2 h posttreatment, whilst C. albicans only started to be inhibited after 14 h. In conclusion, combination therapy involving an antibiotic and an antifungal agent holds an attractive therapeutic option to treat severe bacterial-fungal polymicrobial infections. Nevertheless, optimization of antimicrobial doses and further clinical pharmacokinetics/ pharmacodynamics and toxicodynamics studies underpinning the optimal use of these drugs are urgently required to improve therapy effectiveness and avoid reinfection.	[Rodrigues, Maria E.; Lopes, Susana P.; Pereira, Claudia R.; Henriques, Mariana; Pereira, Maria O.] Univ Minho, Ctr Biol Engn, LIBRO, Campus Gualtar, Braga, Portugal; [Azevedo, Nuno F.] Univ Porto, Fac Engn, Dept Chem Engn, LEPABE, Rua Dr Roberto Frias, Oporto, Portugal; [Lourenco, Anlia] Univ Vigo, ESEI Escuela Super Ingn Informat, Dept Informat, Edificio Politecn,Campus Univ As Lagoas, Orense, Spain; [Lourenco, Anlia] Univ Minho, Ctr Biol Engn, Campus Gualtar, Braga, Portugal	Universidade do Minho; Universidade do Porto; Universidade de Vigo; Universidade do Minho	Rodrigues, ME (corresponding author), Univ Minho, Ctr Biol Engn, LIBRO, Campus Gualtar, Braga, Portugal.	elisarodrigues@deb.uminho.pt	Lourenço, Anália/G-8879-2013; da Costa Rodrigues, Maria Elisa/F-2350-2010; Lopes, Susana Patrícia Peixoto/B-3901-2017; Henriques, Mariana/A-2117-2013; Henriques, Mariana/S-2990-2019; Lourenço, Anália/Y-9447-2019; Pereira, Maria Olivia/O-4859-2015	Lourenço, Anália/0000-0001-8401-5362; da Costa Rodrigues, Maria Elisa/0000-0001-8823-9494; Lopes, Susana Patrícia Peixoto/0000-0002-8183-1695; Henriques, Mariana/0000-0003-0317-4877; Henriques, Mariana/0000-0003-0317-4877; Lourenço, Anália/0000-0001-8401-5362; Pereira, Claudia/0000-0003-4208-1163; Pereira, Maria Olivia/0000-0002-4307-3985; Azevedo, Nuno/0000-0001-5864-3250	European Society of Clinical Microbiology and Infectious Diseases (ESCMID); Portuguese Foundation for Science and Technology (FCT) [UlD/B10/04469/2013, UID/EQU/00511/2013]; FCT; European Community fund FEDER, through Program COMPETE [RECI/BBB-EBI/0179/2012, FCOMP-01-0124-FEDER-027462];  [POCI-01-0145-FEDER-006684];  [POCI-01-0145-FEDER-006939];  [SFRH/BPD/95616/2013];  [SFRH/BPD/95401/2013]	European Society of Clinical Microbiology and Infectious Diseases (ESCMID); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); European Community fund FEDER, through Program COMPETE; ; ; ; 	Support was provided by: ESCMID Research Grant 2014, named "Reconstruction of polymicrobial interactions in infections: the case of Pseudomonas aeruginosa and Candida albicans cross talk in ventilator-associated pneumonia" and funded by European Society of Clinical Microbiology and Infectious Diseases (ESCMID) [https://www.escmid.org/profession_career/ awards_grants/research_grants/previous_ awardees/awardees_2014/] (to AL); Portuguese Foundation for Science and Technology (FCT), COMPETE2020, FEDER and P2020, under the scope of the strategic funding of UlD/B10/04469/2013 (URL: http://www.ceb.uminho.pt/Projects/Details/2590) (CEB, UMinho) and UID/EQU/00511/2013 units. (URL:https://sigarra.up.ptispup/pt/ noticias_geral.ver_noticia?p_nr=17725) (LEPABE, FEUP); Project POCI-01-0145-FEDER-006684 (URL: http://www.ceb.uminho.pt/Projects/Details/ 2590) (CEB, Uminho) and POCI-01-0145-FEDER-006939 (URL: https://sigarra.up.pt/feup/pt/ noticias_geral.ver_noticia?p_nr=50509) (LEPABE, FEUP), financed by COMPETE2020, FEDER and National Funds; FCT and the European Community fund FEDER, through Program COMPETE, under the scope of project RECI/BBB-EBI/0179/2012 (FCOMP-01-0124-FEDER-027462) (URL: http// www.ceb.uminho.pt/Projects/Details/1505) (Manuel Mota, CEB, Uminho); and Post-doc grants of the author SPL (SFRH/BPD/95616/2013) and MER (SFRH/BPD/95401/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the ESCMID Research Grant 2014, funded by European Society of Clinical Microbiology and Infectious Diseases (ESCMID). They also thanks to the Portuguese Foundation for Science and Technology (FCT), under the scope of the strategic funding of UID/BIO/04469/2013 and UID/EQU/00511/2013 units and COMPETE 2020 (POCI-01-0145-FEDER-006684 and POCI-01-0145-FEDER-006939), and by FCT and the European Community fund FEDER, through Program COMPETE, under the scope of project RECI/BBB-EBI/0179/2012 (FCOMP-01-0124-FEDER-027462). The authors also acknowledge the post-doc grants of the authors S.P.Lopes (SFRH/BPD/95616/2013) and M.E.Rodrigues (SFRH/BPD/95401/2013).	Ader F, 2008, PATHOL BIOL, V56, P164, DOI 10.1016/j.patbio.2007.06.002; Ader F, 2011, CRITICAL CARE, V15, P1; Agnolucci M, 2010, INT J FOOD MICROBIOL, V143, P76, DOI 10.1016/j.ijfoodmicro.2010.07.022; Andes D, 2004, INFECT IMMUN, V72, P6023, DOI 10.1128/IAI.72.10.6023-6031.2004; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Azoulay E, 2006, CHEST, V129, P110, DOI 10.1378/chest.129.1.110; Bandara HMHN, 2013, MOL ORAL MICROBIOL, V28, P54, DOI 10.1111/omi.12006; Berra L, 2012, CRIT CARE MED, V40, P119, DOI 10.1097/CCM.0b013e31822e9fe3; Bhat AS, 2007, TOXICOL MECH METHOD, V17, P441, DOI 10.1080/15376510601177654; Bianchi SM, 2008, AM J RESP CRIT CARE, V177, P35, DOI 10.1164/rccm.200612-1804OC; Biel MA, 2011, LASER SURG MED, V43, P586, DOI 10.1002/lsm.21103; Brand A, 2008, FEMS MICROBIOL LETT, V287, P48, DOI 10.1111/j.1574-6968.2008.01301.x; Brogden KA, 2005, LANCET, V365, P253, DOI 10.1016/S0140-6736(05)70155-0; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bruzual I, 2007, J ANTIMICROB CHEMOTH, V59, P441, DOI 10.1093/jac/dkl521; Ceri H, 1999, J CLIN MICROBIOL, V37, P1771, DOI 10.1128/JCM.37.6.1771-1776.1999; Chamot E, 2003, ANTIMICROB AGENTS CH, V47, P2756, DOI 10.1128/AAC.47.9.2756-2764.2003; Chen AI, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004480; Cugini C, 2010, MICROBIOL-SGM, V156, P3096, DOI 10.1099/mic.0.037911-0; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Delgado-Silva Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086270; Deray G, 2002, J ANTIMICROB CHEMOTH, V49, P37, DOI 10.1093/jac/49.suppl_1.37; Dimopoulos G, 2013, CHEST, V144, P1759, DOI 10.1378/chest.13-0076; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; ElEbiary M, 1997, AM J RESP CRIT CARE, V156, P583, DOI 10.1164/ajrccm.156.2.9612023; EUCAST ECfAST, 2014, EUFAST ECFAST ANTIFU; EUCAST ECoAST, 2015, EUCAST ECOAST BREAKP; Falla TJ, 1996, J BIOL CHEM, V271, P19298, DOI 10.1074/jbc.271.32.19298; Flevari A, 2013, CLIN INTERV AGING, V8, P1199, DOI 10.2147/CIA.S39120; Fourie R, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00064; Gales AC, 2011, J ANTIMICROB CHEMOTH, V66, P2070, DOI 10.1093/jac/dkr239; Garibotto FM, 2010, BIOORGAN MED CHEM, V18, P158, DOI 10.1016/j.bmc.2009.11.009; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Gil-Bona A, 2015, J PROTEOMICS, V127, P340, DOI 10.1016/j.jprot.2015.06.006; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Hamet M, 2012, INTENS CARE MED, V38, P1272, DOI 10.1007/s00134-012-2584-2; Hargarten JC, 2015, INFECT IMMUN, V83, P3857, DOI 10.1128/IAI.00886-15; Herriott MM, 2011, TRENDS MICROBIOL, V19, P557, DOI 10.1016/j.tim.2011.07.004; Hoiby N, 2011, INT J ORAL SCI, V3, P55, DOI 10.4248/IJOS11026; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; HSUCHEN CC, 1973, BIOCHEMISTRY-US, V12, P2105, DOI 10.1021/bi00735a014; Hyle EP, 2005, ARCH INTERN MED, V165, P1375, DOI 10.1001/archinte.165.12.1375; Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146; ISO, 2006, CLIN LAB TEST IN VIT; Khan MSA, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-54; Kohler T, 2010, THORAX, V65, P703, DOI 10.1136/thx.2009.133082; Kollef MH, 2008, JAMA-J AM MED ASSOC, V300, P805, DOI 10.1001/jama.300.7.805; Kollef MH, 2000, CLIN INFECT DIS, V31, pS131, DOI 10.1086/314079; Kollef MH, 1999, CHEST, V115, P462, DOI 10.1378/chest.115.2.462; Kumar SN, 2014, MED MYCOL, V52, P480, DOI 10.1093/mmy/myu012; Kuti EL, 2008, J CRIT CARE, V23, P91, DOI 10.1016/j.jcrc.2007.08.007; Landman D, 2008, CLIN MICROBIOL REV, V21, P449, DOI 10.1128/CMR.00006-08; Laniado-Laborin R, 2009, REV IBEROAM MICOL, V26, P223, DOI 10.1016/j.riam.2009.06.003; Liao HM, 2010, INT J FOOD MICROBIOL, V137, P81, DOI 10.1016/j.ijfoodmicro.2009.10.004; Lindsay AK, 2014, FUNGAL BIOL REV, V28, P85, DOI 10.1016/j.fbr.2014.10.002; Liu WJ, 2013, PEDIATR CRIT CARE ME, V14, pE338, DOI 10.1097/PCC.0b013e31828aa5d6; Lopes SP, 2016, BIOTECHNOL BIOENG; Lopes SP, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/678301; Lopes SP, 2012, INT J ANTIMICROB AG, V40, P260, DOI 10.1016/j.ijantimicag.2012.04.020; Lopez-Medina E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005129; Magalhaes AP, 2016, APPL MICROBIOL BIOT, V100, P1163, DOI 10.1007/s00253-015-7177-x; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Mason AJ, 2007, BIOPHYS J, V93, P4289, DOI 10.1529/biophysj.107.116681; Mathe L, 2013, CURR GENET, V59, P251, DOI 10.1007/s00294-013-0400-3; McAlester G, 2008, J MED MICROBIOL, V57, P563, DOI 10.1099/jmm.0.47705-0; Meletiadis J, 2010, ANTIMICROB AGENTS CH, V54, P602, DOI 10.1128/AAC.00999-09; Mietto C, 2013, RESP CARE, V58, P990, DOI 10.4187/respcare.02380; Mohan R, 2015, RSC ADV, V5, P35211, DOI 10.1039/c5ra04092b; Mulcahy LR, 2014, MICROB ECOL, V68, P1, DOI 10.1007/s00248-013-0297-x; NICHOLLS MW, 1970, J MED MICROBIOL, V3, P529, DOI 10.1099/00222615-3-3-529; Ogita A, 2007, J ANTIBIOT, V60, P511, DOI 10.1038/ja.2007.65; Ogita A, 2009, J ANTIBIOT, V62, P81, DOI 10.1038/ja.2008.13; Orhan G, 2005, J CLIN MICROBIOL, V43, P140, DOI 10.1128/JCM.43.1.140-143.2005; Ovchinnikova ES, 2012, SOFT MATTER, V8, P6454, DOI 10.1039/c2sm25100k; Pankey G, 2014, ANTIMICROB AGENTS CH, V58, P5795, DOI 10.1128/AAC.03035-14; Pasquaroli S, 2013, J ANTIMICROB CHEMOTH, V68, P1812, DOI 10.1093/jac/dkt086; Patrone V, 2013, ANTON LEEUW INT J G, V103, P979, DOI 10.1007/s10482-013-9877-5; Pawlowski DR, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017585, 10.1371/journal.pone.0018169]; Penesyan A, 2015, MOLECULES, V20, P5286, DOI 10.3390/molecules20045286; Peters BM, 2012, CLIN MICROBIOL REV, V25, P193, DOI 10.1128/CMR.00013-11; Phelan VV, 2014, J BACTERIOL, V196, P1683, DOI 10.1128/JB.01258-13; Pierce GE, 2005, J IND MICROBIOL BIOT, V32, P309, DOI 10.1007/s10295-005-0225-2; Pinto D, 2015, CRIT REV MICROBIOL, V41, P61, DOI 10.3109/1040841X.2013.794127; Rahman I, 1996, APPL ENVIRON MICROB, V62, P115, DOI 10.1128/AEM.62.1.115-120.1996; Ramage G, 2002, ANTIMICROB AGENTS CH, V46, P3634, DOI 10.1128/AAC.46.11.3634-3636.2002; Rigatto MH, 2013, INFECTION, V41, P321, DOI 10.1007/s15010-012-0349-z; Rossato L, 2016, J MED MICROBIOL; Roux D, 2013, CRIT CARE MED, V41, pE191, DOI 10.1097/CCM.0b013e31828a25d6; Saiman L, 2007, PAEDIATR RESPIR REV, V8, P249, DOI 10.1016/j.prrv.2007.04.006; Sarria JC, 2004, EUR J CLIN MICROBIOL, V23, P340, DOI 10.1007/s10096-004-1106-8; Schnabel RM, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu026; SCHWARTZ SN, 1972, ANTIMICROB AGENTS CH, V2, P36, DOI 10.1128/AAC.2.1.36; Sopirala MM, 2010, ANTIMICROB AGENTS CH, V54, P4678, DOI 10.1128/AAC.00497-10; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Stergiopoulou T, 2009, J ANTIMICROB CHEMOTH, V63, P343, DOI 10.1093/jac/dkn473; Tablan OC, 2004, MMWR RECOMMENDATIONS, V53; Taff HT, 2013, FUTURE MICROBIOL, V8, P1325, DOI 10.2217/fmb.13.101; Taylor PK, 2014, J BIOTECHNOL, V191, P121, DOI 10.1016/j.jbiotec.2014.09.003; Torres A, 2009, INTENS CARE MED, V35, P9, DOI 10.1007/s00134-008-1336-9; Trejo-Hernandez A, 2014, ISME J, V8, P1974, DOI 10.1038/ismej.2014.53; Uppuluri P, 2011, ANTIMICROB AGENTS CH, V55, P3591, DOI 10.1128/AAC.01701-10; van Delden C, 2007, INT J ANTIMICROB AG, V30, pS71, DOI 10.1016/j.ijantimicag.2007.06.015; Vidal F, 1996, ARCH INTERN MED, V156, P2121, DOI 10.1001/archinte.156.18.2121; Walkey AJ, 2011, CHEST, V139, P1148, DOI 10.1378/chest.10-1556; Wang HZ, 2012, ANTIMICROB AGENTS CH, V56, P2683, DOI 10.1128/AAC.06486-11; Wang HZ, 2011, ANTIMICROB AGENTS CH, V55, P4469, DOI 10.1128/AAC.00126-11; Waters B, 2015, CURR INFECT DIS REP, V17, DOI 10.1007/s11908-015-0496-3; White RL, 1996, ANTIMICROB AGENTS CH, V40, P1914, DOI 10.1128/AAC.40.8.1914; Wilke M, 2014, INFECT DRUG RESIST, V7, P1, DOI 10.2147/IDR.S25985; Wilkins M, 2014, J INFECTION, V69, pS47, DOI 10.1016/j.jinf.2014.07.014; Zavascki AP, 2007, J ANTIMICROB CHEMOTH, V60, P1206, DOI 10.1093/jac/dkm357; Zhai B, 2010, J ANTIMICROB CHEMOTH, V65, P931, DOI 10.1093/jac/dkq046	113	23	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170433	10.1371/journal.pone.0170433	http://dx.doi.org/10.1371/journal.pone.0170433			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114348	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129000048
J	Wylon, K; Drozdenko, G; Krannich, A; Heine, G; Dolle, S; Worm, M				Wylon, Katharina; Drozdenko, Gennadiy; Krannich, Alexander; Heine, Guido; Doelle, Sabine; Worm, Margitta			Pharmacokinetic Evaluation of a Single Intramuscular High Dose versus an Oral Long-Term Supplementation of Cholecalciferol	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; LIFE-STYLE; D-RECEPTOR; SAFETY; ADULTS; WOMEN; FALLS; IU	Background and Objectives Vitamin D deficiency is frequent during the winter and occurs throughout the year in the elderly or patients suffering from autoimmune diseases. The objective of this study was to evaluate the pharmacokinetic properties of oral supplementation versus a single intramuscular injection of cholecalciferol in healthy individuals. Research design and methods Up to 8,000 I.U. oral cholecalciferol was administered daily for 84 days in a 4 week dose escalation setting to vitamin D deficient individuals. In another cohort, a single intramuscular injection of 100,000 I.U. cholecalciferol was given. In both cohorts, individuals without vitamin D intake served as the comparison group. 25-hydroxyvitamin D (25(OH)D) concentrations were measured in all individuals at defined time points throughout the studies. Results The mean 25(OH)D serum concentration increased significantly after oral cholecalciferol intake compared to the control group (day 28: 83.4 nmol/l and 42.5 nmol/l; day 56: 127.4 nmol/l and 37.3 nmol/l; day 84: 159.7 nmol/l and 30.0 nmol/l). In individuals receiving 100,000 I.U. cholecalciferol intramuscular, the mean 25(OH)D serum concentration peaked after 4 weeks measuring 70.9 nmol/l compared to 32.7 nmol/l in the placebo group (p = 0.002). The increase of 25(OH)D serum concentrations after 28 days was comparable between both routes of administration (p = 0.264). Conclusions Oral and intramuscular cholecalciferol supplementation effectively increased serum 25(OH) D concentrations.	[Wylon, Katharina; Drozdenko, Gennadiy; Heine, Guido; Doelle, Sabine; Worm, Margitta] Charite Univ Med Berlin, Klin Dermatol Venerol & Allergol, Berlin, Germany; [Krannich, Alexander] Charite Univ Med Berlin, Koordinierungszentrum Klin Studien, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Worm, M (corresponding author), Charite Univ Med Berlin, Klin Dermatol Venerol & Allergol, Berlin, Germany.	Margitta.worm@charite.de	Krannich, Alexander/AAR-1285-2021; Heine, Guido/G-1656-2018	Krannich, Alexander/0000-0002-4025-6495; Heine, Guido/0000-0003-1467-9862; Dolle-Bierke, Sabine/0000-0002-3339-0709; Worm, Margitta/0000-0002-3449-1245	Deutsche Forschungsgemeinschaft (DFG) [SFB650/TP5]; Heyl Chemisch-pharmazeutische Fabrik GmbH Co. KG	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Heyl Chemisch-pharmazeutische Fabrik GmbH Co. KG	The clinical trials were supported by the Deutsche Forschungsgemeinschaft (DFG - SFB650/TP5) (oral study) and by Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG (i.m. study).	Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Brown J, 2013, EUR J NUTR, V52, P1733, DOI 10.1007/s00394-012-0477-3; Cipriani C, 2010, J CLIN ENDOCR METAB, V95, P4771, DOI 10.1210/jc.2010-0502; Diamond TH, 2005, MED J AUSTRALIA, V183, P10, DOI 10.5694/j.1326-5377.2005.tb06879.x; Drozdenko G, 2014, EXP DERMATOL, V23, P107, DOI 10.1111/exd.12300; Dusso AS, 2005, AM J PHYSIOL-RENAL, V289, pF8, DOI 10.1152/ajprenal.00336.2004; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Giusti A, 2010, J AM GERIATR SOC, V58, P1489, DOI 10.1111/j.1532-5415.2010.02970.x; Haussler MR, 2008, NUTR REV, V66, pS98, DOI 10.1111/j.1753-4887.2008.00093.x; Heaney RP, 2003, AM J CLIN NUTR, V77, P204, DOI 10.1093/ajcn/77.1.204; Holick MF, 2003, J CELL BIOCHEM, V88, P296, DOI 10.1002/jcb.10338; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2009, ANN EPIDEMIOL, V19, P73, DOI 10.1016/j.annepidem.2007.12.001; Huh SY, 2008, REV ENDOCR METAB DIS, V9, P161, DOI 10.1007/s11154-007-9072-y; Hypponen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860; Janssen HCJP, 2002, AM J CLIN NUTR, V75, P611, DOI 10.1093/ajcn/75.4.611; Jones G, 2008, AM J CLIN NUTR, V88, p582S, DOI 10.1093/ajcn/88.2.582S; Khan AH, 2012, JCPSP-J COLL PHYSICI, V22, P207, DOI 04.2012/JCPSP.207212; Prentice A, 2008, NUTR REV, V66, pS153, DOI 10.1111/j.1753-4887.2008.00100.x; Ross AC, 2011, CLIN ENDOCRINOL META, V96, P53, DOI DOI 10.1210/JC.2010-2704; Sanders KM, 2010, JAMA-J AM MED ASSOC, V303, P1815, DOI 10.1001/jama.2010.594; Terrier B, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4060; Tonnesen R, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3042-9; Vieth R, 1999, AM J CLIN NUTR, V69, P842; Vieth R, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-8; von Restorff C, 2009, BONE, V45, P747, DOI 10.1016/j.bone.2009.06.012; WHYTE MP, 1979, J CLIN ENDOCR METAB, V48, P906, DOI 10.1210/jcem-48-6-906	27	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0169620	10.1371/journal.pone.0169620	http://dx.doi.org/10.1371/journal.pone.0169620			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114352	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129000010
J	Zhai, NC; Li, HJ; Song, HX; Yang, Y; Cui, A; Li, TY; Niu, JQ; Crispe, IN; Su, LS; Tu, ZK				Zhai, Naicui; Li, Haijun; Song, Hongxiao; Yang, Yang; Cui, An; Li, Tianyang; Niu, Junqi; Crispe, Ian Nicholas; Su, Lishan; Tu, Zhengkun			Hepatitis C Virus Induces MDSCs-Like Monocytes through TLR2/PI3K/AKT/STAT3 Signaling	PLOS ONE			English	Article							T-CELL PROLIFERATION; SUPPRESSOR-CELLS; INDOLEAMINE 2,3-DIOXYGENASE; IMMUNE SUPPRESSION; DENDRITIC CELLS; UP-REGULATION; CORE; ACTIVATION; RESPONSES; EXPRESSION	Background and Aims Recent studies reveal the accumulation of myeloid derived suppressor cells (MDSCs) in human peripheral blood mononuclear cells (PBMCs) following HCV infection, which may facilitate and maintain HCV persistent infection. The mechanisms by which HCV induces MDSCs are poorly understood. In the present study, we investigated the mechanisms by which HCV induces MDSCs that lead to suppression of T cell proliferation and expansion of CD4(+)Foxp3(+) regulatory T cells. Methods Purified monocytes from healthy donors were cultured with HCV core protein (HCVc) or cell culture-derived HCV virions (HCVcc), and characterized the phenotype and function of these monocytes by flow cytometry, quantitative PCR, ELISA and western blot assays. In addition, peripheral blood from healthy donors and chronic HCV infected patients was collected, and MDSCs and CD4(+)CD25(+)CD127(-) regulatory T cells were analyzed by flow cytometry. Results Both HCVc and HCVcc induced expression of IDO1, PD-L1 and IL-10, and significantly down-regulated HLA-DR expression in human monocytes. HCVc-treated monocytes triggered CD4(+)Foxp3(+) Tregs expansion, and inhibited autologous CD4(+) T cell activation in an IDO1-dependent fashion. Our results showed that HCV virions or HCV core proteins induced MDSC-like suppressive monocytes via the TLR2/PI3K/AKT/STAT3 signaling pathway. Monocytes derived from patients with chronic HCV infection displayed MDSCs characteristics. Moreover, the percentages of CD14(+) MDSCs and CD4(+)CD25(+)CD127(-) Tregs in chronic HCV infected patients were significantly higher than healthy individuals, and the frequency of MDSCs correlated with CD4(+) CD25(+) CD127(-) Tregs. Conclusions HCV induced MDSC-like suppressive monocytes through TLR2/PI3K/AKT/STAT3 signaling pathway to induce CD4(+) Foxp3(+) regulatory T cells and inhibit autologous CD4(+) T cell activation. It will be of interest to test whether antagonizing suppressive functions of MDSCs could enhance immune responses and virus control in chronic HCV infection.	[Zhai, Naicui; Li, Haijun; Song, Hongxiao; Yang, Yang; Cui, An; Li, Tianyang; Crispe, Ian Nicholas; Su, Lishan; Tu, Zhengkun] Jilin Univ, Hosp 1, Inst Translat Med, Changchun, Peoples R China; [Niu, Junqi; Tu, Zhengkun] Jilin Univ, Hosp 1, Dept Hepatobiliary & Pancreat Dis, Changchun, Peoples R China; [Crispe, Ian Nicholas] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Su, Lishan] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA	Jilin University; Jilin University; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Tu, ZK (corresponding author), Jilin Univ, Hosp 1, Inst Translat Med, Changchun, Peoples R China.; Tu, ZK (corresponding author), Jilin Univ, Hosp 1, Dept Hepatobiliary & Pancreat Dis, Changchun, Peoples R China.	tuzhengkun@hotmail.com		Tu, Zhengkun/0000-0001-6803-2015	National Natural Science Foundation of China [81373143, 81571535, 81501370]; National Institutes of Health [A1095097, CM 64029]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095097] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Natural Science Foundation of China (81373143, 81571535, to ZT; 81501370, to NZ, https://isisn.nsfc.gov.cn/egrantweb/), and by National Institutes of Health (A1095097 and CM 64029 to LS, https://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Boasso A, 2007, BLOOD, V109, P3351, DOI 10.1182/blood-2006-07-034785; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Brusa D, 2013, HAEMATOLOGICA, V98, P953, DOI 10.3324/haematol.2012.077537; Ding Q, 2013, J HEPATOL, V59, P52, DOI 10.1016/j.jhep.2013.03.019; Dolganiuc A, 2007, GASTROENTEROLOGY, V133, P1627, DOI 10.1053/j.gastro.2007.08.003; Eisen-Vandervelde AL, 2004, J BIOL CHEM, V279, P43479, DOI 10.1074/jbc.M407640200; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Higashitani K, 2013, J GASTROENTEROL, V48, P660, DOI 10.1007/s00535-012-0667-z; Hosomura N, 2011, DIGEST DIS SCI, V56, P1057, DOI 10.1007/s10620-010-1395-y; Ifrim DC, 2014, CLIN VACCINE IMMUNOL, V21, P534, DOI 10.1128/CVI.00688-13; Ino K, 1996, CANCER IMMUNOL IMMUN, V43, P206, DOI 10.1007/s002620050323; Jeong HY, 2008, J LEUKOCYTE BIOL, V83, P755, DOI 10.1189/jlb.0307168; Jitschin R, 2014, BLOOD, V124, P750, DOI 10.1182/blood-2013-12-546416; Jurgens B, 2009, BLOOD, V114, P3235, DOI 10.1182/blood-2008-12-195073; Kortylewski M, 2008, CURR OPIN IMMUNOL, V20, P228, DOI 10.1016/j.coi.2008.03.010; Larrea E, 2007, J VIROL, V81, P3662, DOI 10.1128/JVI.02248-06; Lin WY, 2006, J VIROL, V80, P9226, DOI 10.1128/JVI.00459-06; Liu Y, 2014, INT J CLIN EXP MED, V7, P998; Maillard P, 2001, J VIROL, V75, P8240, DOI 10.1128/JVI.75.17.8240-8250.2001; Masalova OV, 1998, J MED VIROL, V55, P1, DOI 10.1002/(SICI)1096-9071(199805)55:1&lt;1::AID-JMV1&gt;3.0.CO;2-7; Mellor AL, 2003, ADV EXP MED BIOL, V527, P27; Mielcarek M, 1997, BLOOD, V89, P1629, DOI 10.1182/blood.V89.5.1629; Mounayar M, 2015, STEM CELLS, V33, P1892, DOI 10.1002/stem.1986; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; Nagaraj S, 2012, CANCER RES, V72, P928, DOI 10.1158/0008-5472.CAN-11-2863; Pang XL, 2016, CLIN IMMUNOL, V164, P57, DOI 10.1016/j.clim.2016.01.014; Pawlotsky JM, 2014, GASTROENTEROLOGY, V146, P1176, DOI 10.1053/j.gastro.2014.03.003; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; Schulz S, 2015, CLIN EXP IMMUNOL, V180, P484, DOI 10.1111/cei.12586; Shi F, 2011, INT J CANCER, V128, P887, DOI 10.1002/ijc.25397; Shi L, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-74; Soguero C, 2002, J VIROL, V76, P9345, DOI 10.1128/JVI.76.18.9345-9354.2002; Sundstrom S, 2005, J VIROL, V79, P2230, DOI 10.1128/JVI.79.4.2230-2239.2005; Tacke RS, 2012, HEPATOLOGY, V55, P343, DOI 10.1002/hep.24700; Tacke RS, 2011, J BIOL CHEM, V286, P10847, DOI 10.1074/jbc.M110.217653; Talmadge JE, 2013, NAT REV CANCER, V13, P739, DOI 10.1038/nrc3581; Tu ZK, 2012, INT IMMUNOL, V24, P97, DOI 10.1093/intimm/dxr104; Tu Z, 2010, GASTROENTEROLOGY, V138, P305, DOI 10.1053/j.gastro.2009.09.009; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Vasquez-Dunddel D, 2013, J CLIN INVEST, V123, P1580, DOI 10.1172/JCI60083; Waggoner SN, 2005, J IMMUNOL, V175, P4706, DOI 10.4049/jimmunol.175.7.4706; Wu J, 2015, J LEUKOCYTE BIOL, V97, P191, DOI 10.1189/jlb.5A1113-626RR; YASUI H, 1986, P NATL ACAD SCI USA, V83, P6622, DOI 10.1073/pnas.83.17.6622; Zeng QL, 2014, MOL CELLS, V37, P66, DOI 10.14348/molcells.2014.2282; Zhai NC, 2015, CELL MOL IMMUNOL, V12, P743, DOI 10.1038/cmi.2014.119; Zheng JJ, 2014, CELL MOL IMMUNOL, V11, P294, DOI 10.1038/cmi.2013.70; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	50	36	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170516	10.1371/journal.pone.0170516	http://dx.doi.org/10.1371/journal.pone.0170516			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114346	Green Published, Green Submitted, gold			2022-12-26	WOS:000396129000060
J	Beheshti, A; Vanderburg, C; McDonald, JT; Ramkumar, C; Kadungure, T; Zhang, H; Gartenhaus, RB; Evens, AM				Beheshti, Afshin; Vanderburg, Charles; McDonald, J. Tyson; Ramkumar, Charusheila; Kadungure, Tatenda; Zhang, Hong; Gartenhaus, Ronald B.; Evens, Andrew M.			A Circulating microRNA Signature Predicts Age-Based Development of Lymphoma	PLOS ONE			English	Article							B-CELL LYMPHOMA; DOWN-REGULATION; EXPRESSION; DIAGNOSIS; SURVIVAL; PATHOGENESIS; REVEALS; CANCER; PROLIFERATION; ACCUMULATION	Extensive epidemiological data have demonstrated an exponential rise in the incidence of non-Hodgkin lymphoma (NHL) that is associated with increasing age. The molecular etiology of this remains largely unknown, which impacts the effectiveness of treatment for patients. We proposed that age-dependent circulating microRNA (miRNA) signatures in the host influence diffuse large B cell lymphoma (DLBCL) development. Our objective was to examine tumor development in an age-based DLBCL system using an inventive systems biology approach. We harnessed a novel murine model of spontaneous DLBCL initiation (Smurf2-deficient) at two age groups: 3 and 15 months old. All Smurf2-deficient mice develop visible DLBCL tumor starting at 15 months of age. Total miRNA was isolated from serum, bone marrow and spleen and were collected for all age groups for Smurf2-deficient mice and age-matched wild-type C57BL/6 mice. Using systems biology techniques, we identified a list of 10 circulating miRNAs being regulated in both the spleen and bone marrow that were present in DLBCL forming mice starting at 3 months of age that were not present in the control mice. Furthermore, this miRNA signature was found to occur circulating in the blood and it strongly impacted JUN and MYC oncogenic signaling. In addition, quantification of the miRNA signature was performed via Droplet Digital PCR technology. It was discovered that a key miRNA signature circulates throughout a host prior to the formation of a tumor starting at 3 months old, which becomes further modulated by age and yielded calculation of a ` carcinogenic risk score'. This novel age-based circulating miRNA signature may potentially be leveraged as a DLBCL risk profile at a young age to predict future lymphoma development or disease progression as well as for potential innovative miRNA-based targeted therapeutic strategies in lymphoma.	[Beheshti, Afshin; Evens, Andrew M.] Tufts Med Ctr, Mol Oncol Res Inst, Div Hematol Oncol, Boston, MA 02111 USA; [Vanderburg, Charles] Massachusetts Gen Hosp, Harvard NeuroDiscovery Ctr, Boston, MA USA; [McDonald, J. Tyson] Hampton Univ, Canc Res Ctr, Hampton, VA 23668 USA; [Ramkumar, Charusheila; Kadungure, Tatenda; Zhang, Hong] Univ Massachusetts, Sch Med, Dept Cell Biol & Dev, Worcester, MA 01605 USA; [Gartenhaus, Ronald B.] Univ Maryland, Marlene & Stewart Greenebaum Canc Ctr, Dept Med, Baltimore, MD 21201 USA	Tufts Medical Center; Harvard University; Massachusetts General Hospital; Hampton University; University of Massachusetts System; University of Massachusetts Worcester; University System of Maryland; University of Maryland Baltimore	Evens, AM (corresponding author), Tufts Med Ctr, Mol Oncol Res Inst, Div Hematol Oncol, Boston, MA 02111 USA.	AEvens@tuftsmedicalcenter.org	Beheshti, Afshin/AAH-7267-2019; Vanderburg, Charles/C-4516-2013; Beheshti, Afshin/N-2241-2014	Vanderburg, Charles/0000-0001-8979-5054; Evens, Andrew/0000-0002-6900-1824; Beheshti, Afshin/0000-0003-4643-531X; McDonald, John/0000-0003-4300-6827	 [R01 CA164311]; NATIONAL CANCER INSTITUTE [R01CA164311] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002990] Funding Source: NIH RePORTER	; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This research was supported in part by R01 CA164311. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Advani RH, 2010, BRIT J HAEMATOL, V151, P143, DOI 10.1111/j.1365-2141.2010.08331.x; Ameling S, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0136-7; Beheshti A, 2015, CANCER INFORM, V14, P141, DOI 10.4137/CIN.S34144; Beheshti A, 2015, ONCOTARGET, V6, P35419, DOI 10.18632/oncotarget.6214; Beheshti A, 2015, CANCER RES, V75, P1134, DOI 10.1158/0008-5472.CAN-14-1053; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Blonska M, 2015, BLOOD, V125, P981, DOI 10.1182/blood-2014-04-568188; Cai QQ, 2015, ONCOTARGET, V6, P38591, DOI 10.18632/oncotarget.5774; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Caramuta S, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.49; Christopher Ajay Francis, 2016, Perspect Clin Res, V7, P68, DOI 10.4103/2229-3485.179431; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cubillos-Ruiz JR, 2012, CANCER RES, V72, P1683, DOI 10.1158/0008-5472.CAN-11-3160; Di Lisio L, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2012.1; Doi H, 2015, ENVIRON SCI TECHNOL, V49, P5601, DOI 10.1021/acs.est.5b00253; Due H, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9513037; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Fang C, 2012, ANN HEMATOL, V91, P553, DOI 10.1007/s00277-011-1350-9; Gallamini A, 2014, CURR TREAT OPTION ON, V15, P248, DOI 10.1007/s11864-014-0278-4; Gururajan M, 2005, BLOOD, V106, P1382, DOI 10.1182/blood-2004-10-3819; Harries LW, 2014, GENES-BASEL, V5, P656, DOI 10.3390/genes5030656; Hatse S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110644; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Inada K., 2015, OPEN J BLOOD DIS, V5, P48, DOI [DOI 10.4236/ojbd.2015.54008, 10.4236/OJBD.2015.54008, DOI 10.4236/OJBD.2015.54008]; Jardin F, 2013, CURR OPIN ONCOL, V25, P480, DOI 10.1097/CCO.0b013e328363def2; Jasinski-Bergner S, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju257; Jorgensen LK, 2015, DAN MED J, V62; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Kim D. H., 2016, ONCOTARGET; Klapper W, 2012, BLOOD, V119, P1882, DOI 10.1182/blood-2011-10-388470; Kozloski GA, 2016, BLOOD, V127, P2856, DOI 10.1182/blood-2015-11-680462; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lawrie CH, 2009, J CELL MOL MED, V13, P1248, DOI 10.1111/j.1582-4934.2008.00628.x; Li Y, 2012, ANAL BIOCHEM, V431, P69, DOI 10.1016/j.ab.2012.09.007; Lim EL, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0568-y; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; Makino K, 2013, J IMMUNOL, V190, P3905, DOI 10.4049/jimmunol.1200822; Martelli M, 2013, CRIT REV ONCOL HEMAT, V87, P146, DOI 10.1016/j.critrevonc.2012.12.009; Mazan-Mamczarz K, 2013, LEUKEMIA RES, V37, P1420, DOI 10.1016/j.leukres.2013.08.020; Metzler M, 2004, GENE CHROMOSOME CANC, V39, P167, DOI 10.1002/gcc.10316; Michael MZ, 2003, MOL CANCER RES, V1, P882; Nie K, 2010, AM J PATHOL, V177, P1470, DOI 10.2353/ajpath.2010.091291; Noren Hooten N, 2013, AGING-US, V5, P725, DOI 10.18632/aging.100603; Puvvada S, 2013, CANCER GENET-NY, V206, P257, DOI 10.1016/j.cancergen.2013.07.003; Raisch J, 2013, WORLD J GASTROENTERO, V19, P2985, DOI 10.3748/wjg.v19.i20.2985; Ramkumar C, 2014, AGING CELL, V13, P478, DOI 10.1111/acel.12195; Ramkumar C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3598; Ramkumar C, 2012, CANCER RES, V72, P2714, DOI 10.1158/0008-5472.CAN-11-3773; Sandhu Sukhinder K, 2011, Adv Hematol, V2011, P347137, DOI 10.1155/2011/347137; Sarkozy C, 2013, CLIN CANCER RES, V19, P1660, DOI 10.1158/1078-0432.CCR-12-2837; Schwarzenbach H, 2014, NAT REV CLIN ONCOL, V11, P145, DOI 10.1038/nrclinonc.2014.5; Skrabek P, 2013, TRANSFUS APHER SCI, V49, P133, DOI 10.1016/j.transci.2013.07.014; Stankova M, 2015, EXPERIENTIA SUPPL, V106, P123, DOI 10.1007/978-3-0348-0955-9_5; Suzuki H, 2012, MOL ONCOL, V6, P567, DOI 10.1016/j.molonc.2012.07.007; Tang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051702; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; Troppan K, 2015, INT J MOL SCI, V16, P18077, DOI 10.3390/ijms160818077; Troppan K, 2014, ANTICANCER RES, V34, P557; Wang WT, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0086-0; Wang XR, 2012, ONCOL LETT, V3, P955, DOI 10.3892/ol.2012.609; Witwer KW, 2015, CLIN CHEM, V61, P56, DOI 10.1373/clinchem.2014.221341; Yuan WX, 2016, ONCOL LETT, V11, P423, DOI 10.3892/ol.2015.3866; Zhang J, 2013, P NATL ACAD SCI USA, V110, P1398, DOI 10.1073/pnas.1205299110; Zheng RL, 2014, INT J CLIN EXP MED, V7, P3818; Zhou KG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095020	65	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170521	10.1371/journal.pone.0170521	http://dx.doi.org/10.1371/journal.pone.0170521			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107482	Green Submitted, gold, Green Published			2022-12-26	WOS:000392405300153
J	Bellad, MB; Vidler, M; Honnungar, NV; Mallapur, A; Ramadurg, U; Charanthimath, U; Katageri, G; Bannale, S; Kavi, A; Karadiguddi, C; Sharma, S; Lee, T; Li, J; Payne, B; Magee, L; von Dadelszen, P; Derman, R; Goudar, SS				Bellad, Mrutynjaya B.; Vidler, Marianne; Honnungar, Narayan V.; Mallapur, Ashalata; Ramadurg, Umesh; Charanthimath, Umesh; Katageri, Geetanjali; Bannale, Shashidhar; Kavi, Avinash; Karadiguddi, Chandrashekhar; Sharma, Sumedha; Lee, Tang; Li, Jing; Payne, Beth; Magee, Laura; von Dadelszen, Peter; Derman, Richard; Goudar, Shivaprasad S.		CLIP Working Grp	Maternal and Newborn Health in Karnataka State, India: The Community Level Interventions for Pre-Eclampsia (CLIP) Trial's Baseline Study Results	PLOS ONE			English	Article							ANTENATAL CARE; REGISTRY; WOMEN	Existing vital health statistics registries in India have been unable to provide reliable estimates of maternal and newborn mortality and morbidity, and region-specific health estimates are essential to the planning and monitoring of health interventions. This study was designed to assess baseline rates as the precursor to a community-based cluster randomized control trial (cRCT)-Community Level Interventions for Pre-eclampsia (CLIP) Trial (NCT01911494; CTRI/2014/01/004352). The objective was to describe baseline demographics and health outcomes prior to initiation of the CLIP trial and to improve knowledge of population-level health, in particular of maternal and neonatal outcomes related to hypertensive disorders of pregnancy, in northern districts the state of Karnataka, India. The prospective population-based survey was conducted in eight clusters in Belgaum and Bagalkot districts in Karnataka State from 2013-2014. Data collection was undertaken by adapting the Maternal and Newborn Health registry platform, developed by the Global Network for Women's and Child Health Studies. Descriptive statistics were completed using SAS and R. During the period of 2013-2014, prospective data was collected on 5,469 pregnant women with an average age of 23.2 (+/-3.3) years. Delivery outcomes were collected from 5,448 completed pregnancies. A majority of the women reported institutional deliveries (96.0%), largely attended by skilled birth attendants. The maternal mortality ratio of 103 (per 100,000 livebirths) was observed during this study, neonatal mortality ratio was 25 per 1,000 livebirths, and perinatal mortality ratio was 50 per 1,000 livebirths. Despite a high number of institutional deliveries, rates of stillbirth were 2.86%. Early enrollment and close follow-up and monitoring procedures established by the Maternal and Newborn Health registry allowed for negligible lost to follow-up. This population-level study provides regional rates of maternal and newborn health in Belgaum and Bagalkot in Karnataka over 2013-14. The mortality ratios and morbidity information can be used in planning interventions and monitoring indicators of effectiveness to inform policy and practice. Comprehensive regional epidemiologic data, such as that provided here, is essential to gauge improvements and challenges in maternal health, as well as track disparities found in rural areas.	[Bellad, Mrutynjaya B.; Honnungar, Narayan V.; Charanthimath, Umesh; Bannale, Shashidhar; Kavi, Avinash; Karadiguddi, Chandrashekhar; Goudar, Shivaprasad S.] KLEs Jawaharlal Nehru Med Coll, Womens & Childrens Hlth Res Unit, Belgaum, Karnataka, India; [Vidler, Marianne; Sharma, Sumedha; Lee, Tang; Li, Jing; Payne, Beth] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC, Canada; [Mallapur, Ashalata; Ramadurg, Umesh; Katageri, Geetanjali] S Nijalingappa Med Coll, Balgalkot, Karnataka, India; [Magee, Laura; von Dadelszen, Peter] St Georges Univ London, Mol & Clin Sci Res Inst, London, England; [Magee, Laura; von Dadelszen, Peter] St Georges Univ Hosp NHS Fdn Trust, Dept Obstet & Gynaecol, London, England; [Derman, Richard] Thomas Jefferson Univ, Dept Obstet & Gynaecol, Philadelphia, PA 19107 USA; [Derman, Richard] Thomas Jefferson Univ, Global Hlth Res, Philadelphia, PA 19107 USA	K.L.E. Academy of Higher Education & Research; Jawaharlal Nehru Medical College, Belgaum; University of British Columbia; St Georges University London; Jefferson University; Jefferson University	Bellad, MB (corresponding author), KLEs Jawaharlal Nehru Med Coll, Womens & Childrens Hlth Res Unit, Belgaum, Karnataka, India.	mbbellad@hotmail.com	von Dadelszen, Peter/AAP-7480-2021; Kavi, Avinash/Q-1950-2019; GOUDAR, SHIVAPRASAD S/S-1217-2019; Charanthimath, Umesh/AAH-2968-2020	Kavi, Avinash/0000-0002-2176-4697; GOUDAR, SHIVAPRASAD S/0000-0002-8680-7053; Vidler, Marianne/0000-0002-7633-8812; CHARANTIMATH, UMESH/0000-0003-1726-2798; von Dadelszen, Peter/0000-0003-4136-3070; Derman, Richard/0000-0003-1148-1594; Katageri, Geetanjali/0000-0001-6893-1504; Bellad, Mrutyunjaya/0000-0003-0460-1439	Bill & Melinda Gates foundation [OPP1017337]	Bill & Melinda Gates foundation(Bill & Melinda Gates Foundation)	The study was funded by the Bill & Melinda Gates foundation under the grant number OPP1017337.	Abalos E, 2016, BJOG-INT J OBSTET GY, V123, P519, DOI 10.1111/1471-0528.13820; Abalos E, 2014, BJOG-INT J OBSTET GY, V121, P14, DOI 10.1111/1471-0528.12629; Adamson PC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-30; Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; Carroli G, 2001, LANCET, V357, P1565, DOI 10.1016/S0140-6736(00)04723-1; Evans CL, 2009, INT J GYNECOL OBSTET, V107, P277, DOI 10.1016/j.ijgo.2009.09.006; Goudar SS, 2015, REPROD HEALTH, V12, DOI [10.1186/1742-4755-12-S2-S2, 10.1186/1742-4755-12-S2-S13]; Goudar SS, 2012, INT J GYNECOL OBSTET, V118, P190, DOI 10.1016/j.ijgo.2012.04.022; Government of India. Office of The Registrar General & Census Commissioner, 2011, CENS 2011 OUR CENS O; International Institute for Population Sciences, 2012, DISTR LEV HOUS FAC S; Kodkany BS, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S2-S3; Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5; Ministry of Health and Family Welfare Government of India. National Health Mission, 2013, STAT WIS INF; Payne B, 2018, LANCET; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Sharma Arun Kumar, 2009, Indian J Community Med, V34, P175, DOI 10.4103/0970-0218.55268; World Health Organization, 2005, SEARO REG IMPR MAT N	17	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0166623	10.1371/journal.pone.0166623	http://dx.doi.org/10.1371/journal.pone.0166623			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107350	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000392405300003
J	Eibach, D; Nagel, M; Hogan, B; Azuure, C; Krumkamp, R; Dekker, D; Gajdiss, M; Brunke, M; Sarpong, N; Owusu-Dabo, E; May, J				Eibach, Daniel; Nagel, Michael; Hogan, Benedikt; Azuure, Clinton; Krumkamp, Ralf; Dekker, Denise; Gajdiss, Mike; Brunke, Melanie; Sarpong, Nimako; Owusu-Dabo, Ellis; May, Juergen			Nasal Carriage of Staphylococcus aureus among Children in the Ashanti Region of Ghana	PLOS ONE			English	Article							HEALTH-CARE WORKERS; METHICILLIN-RESISTANT; STREPTOCOCCUS-PNEUMONIAE; MOLECULAR EPIDEMIOLOGY; POPULATION-STRUCTURE; CENTRAL-AFRICA; COLONIZATION; INFECTIONS; EMERGENCE; STRAINS	Background Nasal carriage with Staphylococcus aureus is a common risk factor for invasive infections, indicating the necessity to monitor prevalent strains, particularly in the vulnerable paediatric population. This surveillance study aims to identify carriage rates, subtypes, antimicrobial susceptibilities and virulence markers of nasal S. aureus isolates collected from children living in the Ashanti region of Ghana. Methods Nasal swabs were obtained from children < 15 years of age on admission to the Agogo Presbyterian Hospital between April 2014 and January 2015. S. aureus isolates were characterized by their antimicrobial susceptibility, the presence of genes encoding for Panton-Valentine leukocidin (PVL) and toxic shock syndrome toxin-1 (TSST-1) and further differentiated by spa-typing and multi-locus-sequence-typing. Results Out of 544 children 120 (22.1%) were colonized with S. aureus, with highest carriage rates during the rainy seasons (27.2%; p = 0.007), in females aged 6-8 years (43.7%) and males aged 8-10 years (35.2%). The 123 isolates belonged to 35 different spa-types and 19 sequence types (ST) with the three most prevalent spa-types being t355 (n = 25), t84 (n = 18), t939 (n = 13), corresponding to ST152, ST15 and ST45. Two (2%) isolates were methicillin-resistant S. aureus (MRSA), classified as t1096 (ST152) and t4454 (ST45), and 16 (13%) were resistant to three or more different antimicrobial classes. PVL and TSST-1 were detected in 71 (58%) and 17 (14%) isolates respectively. Conclusion S. aureus carriage among Ghanaian children seems to depend on age, sex and seasonality. While MRSA rates are low, the high prevalence of PVL is of serious concern as these strains might serve not only as a source for severe invasive infections but may also transfer genes, leading to highly virulent MRSA clones.	[Eibach, Daniel; Hogan, Benedikt; Krumkamp, Ralf; Dekker, Denise; May, Juergen] Bernhard Nocht Inst Trop Med, Infect Dis Epidemiol, Hamburg, Germany; [Nagel, Michael] Deutsch Gesell Int Zusammenarbeit GIZ, Bonn, Germany; [Hogan, Benedikt; Krumkamp, Ralf; Dekker, Denise; Sarpong, Nimako; May, Juergen] German Ctr Infect Res DZIF, Hamburg, Germany; [Azuure, Clinton; Owusu-Dabo, Ellis] Kumasi Ctr Collaborat Res Trop Med KCCR, Kumasi, Ghana; [Gajdiss, Mike] Univ Clin Bonn, Inst Med Microbiol Immunol & Parasitol, Bonn, Germany; [Brunke, Melanie] Univ Bonn, Inst Pharmaceut Microbiol, Bonn, Germany	Bernhard Nocht Institut fur Tropenmedizin; German Center for Infection Research; Kumasi Center for Collaborative Research; University of Bonn; University of Bonn	Eibach, D (corresponding author), Bernhard Nocht Inst Trop Med, Infect Dis Epidemiol, Hamburg, Germany.	eibach@bnitm.de		May, Jurgen/0000-0001-7831-8420	German Center for Infection Research (Deutsches Zentrum fur Infektionsforschung, DZIF)	German Center for Infection Research (Deutsches Zentrum fur Infektionsforschung, DZIF)	This work was supported by the German Center for Infection Research (Deutsches Zentrum fur Infektionsforschung, DZIF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulgader SM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00348; Amissah NA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003421; Annan A, 2015, CLIN MICROBIOL INFEC; Ayepola OO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137531; Becker K, 1998, J CLIN MICROBIOL, V36, P2548, DOI 10.1128/JCM.36.9.2548-2553.1998; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Breurec S, 2011, CLIN MICROBIOL INFEC, V17, P160, DOI 10.1111/j.1469-0691.2010.03219.x; Campbell SJ, 2008, J CLIN MICROBIOL, V46, P678, DOI 10.1128/JCM.01822-07; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Conceicao T, 2014, MICROB DRUG RESIST, V20, P441, DOI 10.1089/mdr.2014.0007; Conceicao T, 2014, MICROB DRUG RESIST, V20, P57, DOI 10.1089/mdr.2013.0136; Cuny C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024360; De Boeck H, 2015, EUR J CLIN MICROBIOL, V34, P1567, DOI 10.1007/s10096-015-2387-9; Ebruke C, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0661-3; Egyir B, 2014, PLOS ONE, V9, P1; Egyir B, 2014, PLOS ONE, V9, P3; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fall C, 2014, CLIN MICROBIOL INFEC, V20, pO239, DOI 10.1111/1469-0691.12385; Fitzgibbon MM, 2007, J CLIN MICROBIOL, V45, P3263, DOI 10.1128/JCM.00836-07; Ghaznavi-Rad E, 2010, J MED MICROBIOL, V59, P1135, DOI 10.1099/jmm.0.021956-0; Ghebremedhin B, 2009, J CLIN MICROBIOL, V47, P2975, DOI 10.1128/JCM.00648-09; Harrison LM, 1999, FEMS IMMUNOL MED MIC, V25, P19, DOI 10.1111/j.1574-695X.1999.tb01323.x; Koreen L, 2004, J CLIN MICROBIOL, V42, P792, DOI 10.1128/JCM.42.2.792-799.2004; Kuehnert MJ, 2006, J INFECT DIS, V193, P172, DOI 10.1086/499632; Kwambana BA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-175; Lebon A, 2008, J CLIN MICROBIOL, V46, P3517, DOI 10.1128/JCM.00641-08; Lewnard JA, 2016, J INFECT DIS, V213, P1596, DOI 10.1093/infdis/jiv761; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mollema FPN, 2010, J CLIN MICROBIOL, V48, P202, DOI 10.1128/JCM.01499-09; Nagel M, 2013, CLIN MICROBIOL INFEC, V19, P1072, DOI 10.1111/1469-0691.12119; Ngoa UA, 2012, ACTA TROP, V124, P42, DOI 10.1016/j.actatropica.2012.06.005; Nilsson P, 2006, J CLIN MICROBIOL, V44, P3334, DOI 10.1128/JCM.00880-06; Schaumburg F, 2014, CLIN MICROBIOL INFEC, V20, P589, DOI 10.1111/1469-0691.12690; Schaumburg F, 2013, CLIN MICROBIOL INFEC, P1; Schaumburg F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001150; Shittu AO, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-92; Sollid JUE, 2014, INFECT GENET EVOL, V21, P531, DOI 10.1016/j.meegid.2013.03.020; van Duijkeren E, 2008, VET MICROBIOLOGY; Watson K, 2006, PEDIATR INFECT DIS J, V25, P782, DOI 10.1097/01.inf.0000232705.49634.68; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wertheim HFL, LANCET LONDON ENGLAN, V364, P703	41	26	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170320	10.1371/journal.pone.0170320	http://dx.doi.org/10.1371/journal.pone.0170320			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107412	Green Published, Green Submitted, gold			2022-12-26	WOS:000392405300107
J	Ghatak, A; Bharatham, N; Shanbhag, AP; Datta, S; Venkatraman, J				Ghatak, Arindam; Bharatham, Nagakumar; Shanbhag, Anirudh P.; Datta, Santanu; Venkatraman, Janani			Delineating Substrate Diversity of Disparate Short-Chain Dehydrogenase Reductase from Debaryomyces hansenii	PLOS ONE			English	Article							CARBONYL REDUCTASE; FINGERPRINT METHODS; CRYSTAL-STRUCTURE; PURIFICATION; ENZYMES; IDENTIFICATION; KETOREDUCTASE; BIOCATALYSIS; FLUORESCENCE; ADAPTATION	Short-chain dehydrogenase reductases (SDRs) have been utilized for catalyzing the reduction of many aromatic/aliphatic prochiral ketones to their respective alcohols. However, there is a paucity of data that elucidates their innate biological role and diverse substrate space. In this study, we executed an in-depth biochemical characterization and substrate space mapping (with 278 prochiral ketones) of an unannotated SDR (DHK) from Debaryomyces hansenii and compared it with structurally and functionally characterized SDR Synechococcus elongatus. PCC 7942 FabG to delineate its industrial significance. It was observed that DHK was significantly more efficient than FabG, reducing a diverse set of ketones albeit at higher conversion rates. Comparison of the FabG structure with a homology model of DHK and a docking of substrate to both structures revealed the presence of additional flexible loops near the substrate binding site of DHK. The comparative elasticity of the cofactor and substrate binding site of FabG and DHK was experimentally substantiated using differential scanning fluorimetry. It is postulated that the loop flexibility may account for the superior catalytic efficiency of DHK although the positioning of the catalytic triad is conserved.	[Ghatak, Arindam; Venkatraman, Janani] Biomoneta Res Private Ltd, Bangalore, Karnataka, India; [Bharatham, Nagakumar] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Ctr Cellular & Mol Platforms C CAMP, Bangalore, Karnataka, India; [Shanbhag, Anirudh P.; Datta, Santanu] Bugworks Res India Private Ltd, Bangalore, Karnataka, India; [Shanbhag, Anirudh P.] Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, Kolkata, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Calcutta	Ghatak, A (corresponding author), Biomoneta Res Private Ltd, Bangalore, Karnataka, India.; Datta, S (corresponding author), Bugworks Res India Private Ltd, Bangalore, Karnataka, India.	arindam@biomoneta.com; santanu@bugworksresearch.com		Ghatak, Arindam/0000-0003-1387-4703	Biotechnology Industrial Research Assistance Council (BIRAC) Department of Biotechnology (DBT), Government of India [BIRAC/CCAMP/BIG - 04/14]	Biotechnology Industrial Research Assistance Council (BIRAC) Department of Biotechnology (DBT), Government of India	This work was funded by Biotechnology Industrial Research Assistance Council (BIRAC) Department of Biotechnology (DBT), Government of India for the Biotechnology Ignition Grant (BIRAC/CCAMP/BIG - 04/14). The funder did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharatham N, 2014, J CHEM INF MODEL, V54, P648, DOI 10.1021/ci4004656; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breuer U, 2006, YEAST, V23, P415, DOI 10.1002/yea.1374; Chen IJ, 2010, J CHEM INF MODEL, V50, P822, DOI 10.1021/ci100026x; Cheng WH, 2002, PLANT CELL, V14, P2723, DOI 10.1105/tpc.006494; Copeland R. A., 2004, ENZYMES PRACTICAL IN; Duan JX, 2010, J MOL GRAPH MODEL, V29, P157, DOI 10.1016/j.jmgm.2010.05.008; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Dutta D, 2013, BIOCHEM J, V450, P127, DOI 10.1042/BJ20121107; Dutta D, 2012, PROTEINS, V80, P1250, DOI 10.1002/prot.24024; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Guo PC, 2014, BBA-PROTEINS PROTEOM, V1844, P1486, DOI 10.1016/j.bbapap.2014.05.008; Hammes GG, 2008, J BIOL CHEM, V283, P22337, DOI 10.1074/jbc.X800005200; Holsch K, 2008, APPL ENVIRON MICROB, V74, P6697, DOI 10.1128/AEM.00925-08; Hou J., 2013, CRYSTAL STRUCTURE 3; Hou J, 2016, J BACTERIOL, V198, P463, DOI 10.1128/JB.00360-15; Huisman GW, 2010, CURR OPIN CHEM BIOL, V14, P122, DOI 10.1016/j.cbpa.2009.12.003; Jornvall H, 1999, FEBS LETT, V445, P261, DOI 10.1016/S0014-5793(99)00130-1; Kallberg Y, 2002, EUR J BIOCHEM, V269, P4409, DOI 10.1046/j.1432-1033.2002.03130.x; Kita K, 1999, J MOL CATAL B-ENZYM, V6, P305, DOI 10.1016/S1381-1177(98)00108-8; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; Pereira JH, 2013, APPL ENVIRON MICROB, V80, P497, DOI [10.1128/AEM.03194.13, DOI 10.1128/AEM.03194.13]; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; Sastry M, 2010, J CHEM INF MODEL, V50, P771, DOI 10.1021/ci100062n; Sheldon RA, 2012, CHEMINFORM, V43; Somero GN, 2004, COMP BIOCHEM PHYS B, V139, P321, DOI 10.1016/j.cbpc.2004.05.003; Soni P, 2007, PROCESS BIOCHEM, V42, P1632, DOI 10.1016/j.procbio.2007.09.007; Stankeviciute J, 2015, PEERJ, V3, DOI 10.7717/peerj.1387; Wada M, 1999, J MOL CATAL B-ENZYM, V6, P333, DOI 10.1016/S1381-1177(98)00111-8; Wang QY, 2012, BIORESOURCE TECHNOL, V123, P690, DOI 10.1016/j.biortech.2012.07.060; Wells A, 2014, CHEMCATCHEM, V6, P918, DOI 10.1002/cctc.201402065; Wirz B, 2010, CHIMIA, V64, P780, DOI 10.2533/chimia.2010.780; Yamamoto H, 2004, BIOSCI BIOTECH BIOCH, V68, P638, DOI 10.1271/bbb.68.638; Ye Q, 2009, BIORESOURCE TECHNOL, V100, P6022, DOI 10.1016/j.biortech.2009.06.014; Zavodszky P, 1998, P NATL ACAD SCI USA, V95, P7406, DOI 10.1073/pnas.95.13.7406; Zhou Y, 2015, PLANT MOL BIOL REP, V33, P253, DOI 10.1007/s11105-014-0751-z	39	4	4	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170202	10.1371/journal.pone.0170202	http://dx.doi.org/10.1371/journal.pone.0170202			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107498	Green Published, Green Submitted, gold			2022-12-26	WOS:000392405300085
J	Kopp, DM; Rosenberg, NE; Stuart, GS; Miller, WC; Hosseinipour, MC; Bonongwe, P; Mwale, M; Tang, JH				Kopp, Dawn M.; Rosenberg, Nora E.; Stuart, Gretchen S.; Miller, William C.; Hosseinipour, Mina C.; Bonongwe, Phylos; Mwale, Mwawi; Tang, Jennifer H.			Patterns of Contraceptive Adoption, Continuation, and Switching after Delivery among Malawian Women	PLOS ONE			English	Article							MISSED OPPORTUNITIES; POSTPARTUM WOMEN; DISCONTINUATION	Women who report use of postpartum family planning may not continue their initial method or use it consistently. Understanding the patterns of method uptake, discontinuation, and switching among women after delivery is important to promote uptake and continuation of effective methods of contraception. This is a secondary analysis of 634 Malawian women enrolled into a prospective cohort study after delivery. They completed baseline surveys upon enrollment and follow-up telephone surveys 3, 6, and 12 months post-delivery. Women were included in this analysis if they had completed at least the 3- and 6-month post-delivery surveys. Descriptive statistics were used to assess contraceptive method mix and patterns of switching, whereas Pearson's chi(2) tests were used for bivariable analyses to compare characteristics of women who continued and discontinued their initial post-delivery contraceptive method. Among the 479 women included in this analysis, the use of abstinence/traditional methods decreased and the use of long-acting and permanent methods (LAPM) increased over time. Almost half (47%) discontinued the contraceptive method reported at 3-months post-delivery; women using injectables or LAPM at 3-months post delivery were significantly more likely to continue their method than those using non-modern methods (p<0.001). Of the 216 women who switched methods, 82% switched to a more or equally effective method. The change in contraceptive method mix and high rate of contraceptive switching in the first 12 months postpartum highlights a need to assist women in accessing effective contraceptives soon after delivery.	[Kopp, Dawn M.; Rosenberg, Nora E.; Hosseinipour, Mina C.; Tang, Jennifer H.] UNC Project Malawi, Lilongwe, Malawi; [Kopp, Dawn M.; Stuart, Gretchen S.; Tang, Jennifer H.] UNC Dept Obstet & Gynecol, Chapel Hill, NC USA; [Rosenberg, Nora E.] UNC Dept Epidemiol, Chapel Hill, NC USA; [Miller, William C.] Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43210 USA; [Hosseinipour, Mina C.] UNC Dept Med, Chapel Hill, NC USA; [Bonongwe, Phylos] Malawi Coll Med, Dept Obstet & Gynaecol, Blantyre, Malawi; [Mwale, Mwawi] Bwaila Hosp, Lilongwe Dist Hlth Off, Lilongwe, Malawi	University System of Ohio; Ohio State University; University of Malawi	Kopp, DM (corresponding author), UNC Project Malawi, Lilongwe, Malawi.; Kopp, DM (corresponding author), UNC Dept Obstet & Gynecol, Chapel Hill, NC USA.	dawn.m.kopp@gmail.com	Miller, William C/H-4800-2014; Kopp, Dawn/A-3764-2017	Miller, William C/0000-0002-1934-7827; Kopp, Dawn/0000-0003-4065-0625	Fogarty International Center; Office of Research on Women's Health (National Institutes of Health) [5R25TW009340-01]; University of North Carolina Center for AIDS Research (National Institute of Health) [P30-AI50410-14]; University of North Carolina at Chapel Hill National Institute of Child Health and Human Development [5T32 HD075731-01]; National Institutes of Health [K99-MH104154]; National Institutes of Health-Fogarty International Center [1K01-TW009657-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD075731] Funding Source: NIH RePORTER	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Office of Research on Women's Health (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); University of North Carolina Center for AIDS Research (National Institute of Health); University of North Carolina at Chapel Hill National Institute of Child Health and Human Development; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health-Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by: (1) Fogarty International Center and the Office of Research on Womens Health (National Institutes of Health 5R25TW009340-01 http://www.fic.nih.gov/Pages/Default.aspx; PI: Charles van der Horst, JHT received this funding); The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. (2) University of North Carolina Center for AIDS Research (National Institute of Health P30-AI50410-14, http://unccfar.org/; PI: Ronald Swanstrom, JHT received this funding); The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. (3) University of North Carolina at Chapel Hill National Institute of Child Health and Human Development training grant 5T32 HD075731-01; https://www.nichd.nih.gov/grants-funding/Pages/default.aspx; PI: Dr. Ben Chi, DMK received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. (4) National Institutes of Health, K99-MH104154, Nora E. Rosenberg. (5) National Institutes of Health-Fogarty International Center, 1K01-TW009657-01, Jennifer H. Tang.	Ali M., 2012, CAUSES CONSEQUENCES; Ali MM, 2010, CONTRACEPTION, V81, P22, DOI 10.1016/j.contraception.2009.06.009; Ali MM, 2014, CONTRACEPTION, V90, P47, DOI 10.1016/j.contraception.2014.03.008; Barden-O'Fallon J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1018; Barden-O'Fallon J, 2011, INT PERSPECT SEX R H, V37, P16, DOI 10.1363/3701611; Bolam A, 1998, BRIT MED J, V316, P805, DOI 10.1136/bmj.316.7134.805; Dasgupta ANZ, 2016, CONTRACEPTION, V94, P499, DOI 10.1016/j.contraception.2016.05.007; Hounton S, 2015, GLOBAL HEALTH ACTION, V8, P64, DOI 10.3402/gha.v8.29738; KENNEDY KI, 1995, STUD FAMILY PLANN, V26, P107, DOI 10.2307/2137936; Maman S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097092; MDHS, 2011, MAL DEM HLTH SURV 20; Moore Z, 2015, CONTRACEPTION, V92, P31, DOI 10.1016/j.contraception.2015.03.007; Mumah JN, 2015, STUD FAMILY PLANN, V46, P369, DOI 10.1111/j.1728-4465.2015.00038.x; O'Shea MS, 2014, AIDS CARE, P1; Thiel de Bocanegra H, 2014, AM J OBSTET GYNECOL, pe311, DOI DOI 10.1016/J.AJ0G.2013.12.020; Trussell J, 2011, CONTRACEPTION, V83, P397, DOI 10.1016/j.contraception.2011.01.021; White K, 2015, OBSTET GYNECOL, V125, P1471, DOI 10.1097/AOG.0000000000000841	17	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170284	10.1371/journal.pone.0170284	http://dx.doi.org/10.1371/journal.pone.0170284			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI3QC	28107404	Green Published, gold, Green Submitted			2022-12-26	WOS:000392405300099
J	Schroeder, EC; Welk, GJ; Franke, WD; Lee, DC				Schroeder, Elizabeth C.; Welk, Gregory J.; Franke, Warren D.; Lee, Duck-chul			Associations of Health Club Membership with Physical Activity and Cardiovascular Health	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; ALL-CAUSE MORTALITY; CARDIORESPIRATORY FITNESS; HEART-RATE; US ADULTS; DISEASE; RISK; WOMEN; TIME; MEN	Introduction This study evaluates whether a health club membership is associated with meeting the US physical activity (PA) guidelines and/or favorable cardiovascular health. Methods Using cross-sectional data of health club members (n = 204) and non-members (n = 201) from April to August 2013, this is the first study to our knowledge to examine a health club membership in relation to objectively measured cardiovascular health indicators including resting blood pressure, resting heart rate, body mass index, waist circumference, and cardiorespiratory fitness based on a non-exercise test algorithm. To determine the total PA and sedentary time, this study used a comprehensive PA questionnaire about both aerobic and resistance activities at the health club, as well as lifestyle activities in other settings, which was developed based on the International Physical Activity Questionnaire (IPAQ). Results The odds ratios (95% confidence interval) of meeting either the aerobic, resistance, or both aerobic and resistance PA guidelines for members compared to non-members were 16.5 (9.8-27.6), 10.1 (6.2-16.3), and 13.8 (8.5-22.4), respectively. Significant associations of health club membership with more favorable cardiovascular health outcomes and sedentary behavior were observed for resting heart rate (B: -4.8 b/min, p<0.001), cardiorespiratory fitness (B: 2.1 ml/kg/min, p<0.001), and sedentary time (B: -1.4 hours, p<0.001). Participants with a health club membership of >1 year had more favorable health outcomes, with a smaller waist circumference (men, B: -4.0 cm, p = 0.04; women, B: -3.4 cm, p = 0.06), compared to non-members. Conclusions Health club membership is associated with significantly increased aerobic and resistance physical activity levels and more favorable cardiovascular health outcomes compared to non-members. However, longitudinal, randomized controlled trials would be clearly warranted as cross-sectional data prohibits causal inferences.	[Schroeder, Elizabeth C.] Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL USA; [Welk, Gregory J.; Franke, Warren D.; Lee, Duck-chul] Iowa State Univ, Dept Kinesiol, Ames, IA 50011 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Iowa State University	Lee, DC (corresponding author), Iowa State Univ, Dept Kinesiol, Ames, IA 50011 USA.	dclee@iastate.edu		(Schroeder) Lefferts, Elizabeth/0000-0002-7538-8228	Iowa State University College of Human Sciences	Iowa State University College of Human Sciences	This work was supported by Iowa State University College of Human Sciences seed grant.	Allen MS, 2015, PREV MED, V78, P101, DOI 10.1016/j.ypmed.2015.07.014; Artero EG, 2014, J AM COLL CARDIOL, V63, P2289, DOI 10.1016/j.jacc.2014.03.008; Benetos A, 1999, HYPERTENSION, V33, P44, DOI 10.1161/01.HYP.33.1.44; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; Braith RW, 2006, CIRCULATION, V113, P2642, DOI 10.1161/CIRCULATIONAHA.105.584060; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-98; Eime RM, 2010, MED SCI SPORT EXER, V42, P1022, DOI 10.1249/MSS.0b013e3181c3adaa; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; International Health Racquet & Sportsclub Association, 2014, IHRSA HLTH CLUB CONS; International Health Racquet & Sportsclub Association, 2015, INT HLTH RACQ SPORTS; Jackson AS, 2012, AM J PREV MED, V43, P512, DOI 10.1016/j.amepre.2012.06.032; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Lee DC, 2012, J AM COLL CARDIOL, V59, P665, DOI 10.1016/j.jacc.2011.11.013; NHLBI Obesity Education Initiative Expert Panel on the Identification Evaluation and Treatment of Obesity in Adults (US), 1998, CLIN GUID ID EV TREA; NIAAA, MOD BING DRINK; Patel AV, 2010, AM J EPIDEMIOL, V172, P419, DOI 10.1093/aje/kwq155; Petersen CB, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-13; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Ready AE, 2005, J SPORT MED PHYS FIT, V45, P199; Saxena A, 2013, MAYO CLIN PROC, V88, P1420, DOI 10.1016/j.mayocp.2013.09.011; Sui XM, 2007, JAMA-J AM MED ASSOC, V298, P2507, DOI 10.1001/jama.298.21.2507; The Kaiser Family Foundation and Health Research Educational Trust, 2014, 2014 EMPL HLTH BEN S; Tucker JM, 2011, AM J PREV MED, V40, P454, DOI 10.1016/j.amepre.2010.12.016; U.S. Department of Health and Human Services, 2012, HLTH PEOPL 2020; U.S. Department of Health and Human Services National Institute of Health National Heart Lung and Blood Institute, 2004, 7 US DEP HLTH HUM SE; US Department of Health and Human Services, 2008, PHYS ACT GUID AM; US Department of Health and Human Services CDC National Center for Chronic Disease Prevention and Health Promotion Division of Nutrition Physical Activity and Obesity, 2015, NUTR PHYS ACT OB DAT; Wijndaele K, 2011, INT J EPIDEMIOL, V40, P150, DOI 10.1093/ije/dyq105; World Health Organization, 2008, WAIST CIRCUMFERENCE	32	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170471	10.1371/journal.pone.0170471	http://dx.doi.org/10.1371/journal.pone.0170471			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107459	Green Published, Green Submitted, gold			2022-12-26	WOS:000392405300143
J	Tsutsumi, T; Okushin, K; Enooku, K; Fujinaga, H; Moriya, K; Yotsuyanagi, H; Aizaki, H; Suzuki, T; Matsuura, Y; Koike, K				Tsutsumi, Takeya; Okushin, Kazuya; Enooku, Kenichiro; Fujinaga, Hidetaka; Moriya, Kyoji; Yotsuyanagi, Hiroshi; Aizaki, Hideki; Suzuki, Tetsuro; Matsuura, Yoshiharu; Koike, Kazuhiko			Nonstructural 5A Protein of Hepatitis C Virus Interferes with Toll-Like Receptor Signaling and Suppresses the Interferon Response in Mouse Liver	PLOS ONE			English	Article							TRANSGENIC MICE; HEPATOCELLULAR-CARCINOMA; GUT MICROBIOTA; CORE PROTEIN; CELL-LINES; NS5A; PHOSPHORYLATION; DISEASE; AXIS; HCV	The hepatitis C virus nonstructural protein NS5A is involved in resistance to the host immune response, as well as the viral lifecycle such as replication and maturation. Here, we established transgenic mice expressing NS5A protein in the liver and examined innate immune responses against lipopolysaccharide (LPS) in vivo. Intrahepatic gene expression levels of cytokines such as interleukin-6, tumor necrosis factor-a, and interferon-. were significantly suppressed after LPS injection in the transgenic mouse liver. Induction of the C-C motif chemokine ligand 2, 4, and 5 was also suppressed. Phosphorylation of the signal transducer and activator of transcription 3, which is activated by cytokines, was also reduced, and expression levels of interferon-stimulated genes, 2'-5' oligoadenylate synthase, interferon-inducible double- stranded RNA-activated protein kinase, and myxovirus resistance 1 were similarly suppressed. Since LPS binds to toll-like receptor 4 and stimulates the downstream pathway leading to induction of these genes, we examined the extracellular signal-regulated kinase and I kappa B-alpha. The phosphorylation levels of these molecules were reduced in transgenic mouse liver, indicating that the pathway upstream of the molecules was disrupted by NS5A. Further analyses revealed that the interaction between interleukin-1 receptor-associated kinase-1 and tumor necrosis factor receptor associated factor-6 was dispersed in transgenic mice, suggesting that NS5A may interfere with this interaction via myeloid differentiation primary response gene 88, which was shown to interact with NS5A. Since the gut microbiota, a source of LPS, is known to be associated with pathological conditions in liver diseases, our results suggest the involvement of NS5A in the pathogenesis of HCV infected-liver via the suppression of innate immunity.	[Tsutsumi, Takeya; Okushin, Kazuya; Enooku, Kenichiro; Fujinaga, Hidetaka; Moriya, Kyoji; Yotsuyanagi, Hiroshi; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Internal Med, Tokyo, Japan; [Aizaki, Hideki] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Suzuki, Tetsuro] Hamamatsu Univ Sch Med, Dept Infect Dis, Hamamatsu, Shizuoka, Japan; [Matsuura, Yoshiharu] Osaka Univ, Microbial Dis Res Inst, Dept Mol Virol, Osaka, Japan	University of Tokyo; National Institute of Infectious Diseases (NIID); Hamamatsu University School of Medicine; Osaka University	Tsutsumi, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Internal Med, Tokyo, Japan.	tsutsumi-tky@umin.ac.jp			Ministry of Health, Labor, and Welfare of Japan (Research on Hepatitis); Ministry of Education, Culture, Sports, Science and Technology; Japan Agency for Medical Research and Development, AMED	Ministry of Health, Labor, and Welfare of Japan (Research on Hepatitis); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	Support was provided by Health Sciences Research Grants from the Ministry of Health, Labor, and Welfare of Japan (Research on Hepatitis), from the Ministry of Education, Culture, Sports, Science and Technology; the Research Program on Hepatitis from Japan Agency for Medical Research and Development, AMED.	Abe T, 2007, J VIROL, V81, P8953, DOI 10.1128/JVI.00649-07; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Chassaing B, 2014, HEPATOLOGY, V59, P328, DOI 10.1002/hep.26494; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; Frasinariu OE, 2013, DIGEST LIVER DIS, V45, P543, DOI 10.1016/j.dld.2012.11.010; Gale M, 1998, MOL CELL BIOL, V18, P5208, DOI 10.1128/MCB.18.9.5208; Heim MH, 2013, J HEPATOL, V58, P564, DOI 10.1016/j.jhep.2012.10.005; Huang Y, 2007, VIROLOGY, V364, P1, DOI 10.1016/j.virol.2007.01.042; Kanda T, 2009, J VIROL, V83, P8463, DOI 10.1128/JVI.00751-09; Kriegs M, 2009, J BIOL CHEM, V284, P28343, DOI 10.1074/jbc.M109.038877; Lan KH, 2007, J HEPATOL, V46, P759, DOI 10.1016/j.jhep.2006.11.013; Leung C, 2016, NAT REV GASTRO HEPAT, V13, P412, DOI 10.1038/nrgastro.2016.85; Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562; Machida K, 2009, P NATL ACAD SCI USA, V106, P1548, DOI 10.1073/pnas.0807390106; Majumder M, 2002, VIROLOGY, V294, P94, DOI 10.1006/viro.2001.1309; Minemura M, 2015, WORLD J GASTROENTERO, V21, P1691, DOI 10.3748/wjg.v21.i6.1691; Moriya K, 1997, J GEN VIROL, V78, P1527, DOI 10.1099/0022-1317-78-7-1527; Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053; Polyak SJ, 2001, J VIROL, V75, P6095, DOI 10.1128/JVI.75.13.6095-6106.2001; Ross-Thriepland D, 2015, J GEN VIROL, V96, P727, DOI 10.1099/jgv.0.000009; Rowell DL, 1997, AM J PHYSIOL-GASTR L, V273, pG322, DOI 10.1152/ajpgi.1997.273.2.G322; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Sarcar B, 2004, VIROLOGY, V322, P51, DOI 10.1016/j.virol.2004.01.008; Szabo G, 2015, GASTROENTEROLOGY, V148, P30, DOI 10.1053/j.gastro.2014.10.042; Szabo G, 2010, WORLD J GASTROENTERO, V16, P1321, DOI 10.3748/wjg.v16.i11.1321; TANJI Y, 1995, J VIROL, V69, P3980, DOI 10.1128/JVI.69.7.3980-3986.1995; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Tsuge M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023856; Walters KA, 2006, PLOS PATHOG, V2, P591, DOI 10.1371/journal.ppat.0020059; Wang AG, 2009, J PATHOL, V219, P253, DOI 10.1002/path.2592	30	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170461	10.1371/journal.pone.0170461	http://dx.doi.org/10.1371/journal.pone.0170461			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107512	Green Published, gold, Green Submitted			2022-12-26	WOS:000392405300140
J	Song, H; Lin, CW; Yao, E; Zhang, KA; Li, XL; Wu, QZ; Chuang, PT				Song, Hai; Lin, Chuwen; Yao, Erica; Zhang, Kuan; Li, Xiaoling; Wu, Qingzhe; Chuang, Pao-Tien			Selective Ablation of Tumor Suppressors in Parafollicular C Cells Elicits Medullary Thyroid Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; gene knock-out; genomics; mouse genetics; tumor suppressor gene; CGRP; calcitonin; medullary thyroid carcinoma; parafollicular C cells	RET PROTOONCOGENE; TARGETED THERAPIES; MOLECULAR PATHOGENESIS; CANCER; INACTIVATION; MUTATIONS; RB; EXPRESSION; MANAGEMENT; PATHWAY	Among the four different types of thyroid cancer, treatment of medullary thyroid carcinoma poses a major challenge because of its propensity of early metastasis. To further investigate the molecular mechanisms of medullary thyroid carcinoma and discover candidates for targeted therapies, we developed a new mouse model of medullary thyroid carcinoma based on our CGRP(CreER) mouse line. This system enables gene manipulation in parafollicular C cells in the thyroid, the purported cells of origin of medullary thyroid carcinoma. Selective inactivation of tumor suppressors, such as p53, Rb, and Pten, in mature parafollicular C cells via an inducible Cre recombinase from CGRP(CreER) led to development of murine medullary thyroid carcinoma. Loss of Pten accelerated p53/Rb-induced medullary thyroid carcinoma, indicating interactions between pathways controlled by tumor suppressors. Moreover, labeling differentiated parafollicular C cells by CGRP(CreER) allows us to follow their fate during malignant transformation to medullary thyroid tumor. Our findings support a model in which mutational events in differentiated parafollicular C cells result in medullary thyroid carcinoma. Through expression analysis including RNA-Seq, we uncovered major signaling pathways and networks that are perturbed following the removal of tumor suppressors. Taken together, these studies not only increase our molecular understanding of medullary thyroid carcinoma but also offer new candidates for designing targeted therapies or other treatment modalities.	[Song, Hai; Li, Xiaoling; Wu, Qingzhe] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Song, Hai; Li, Xiaoling; Wu, Qingzhe] Zhejiang Univ, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China; [Song, Hai; Lin, Chuwen; Yao, Erica; Zhang, Kuan; Chuang, Pao-Tien] Univ Calif San Francisco, Cardiovasc Res Inst, 555 Mission Bay Blvd S, San Francisco, CA 94158 USA	Zhejiang University; Zhejiang University; University of California System; University of California San Francisco	Chuang, PT (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, 555 Mission Bay Blvd S, San Francisco, CA 94158 USA.	pao-tien.chuang@ucsf.edu	Lin, Chuwen/I-3287-2018	Zhang, Kuan/0000-0002-9723-1328; Li, Xiaoling/0000-0002-1554-1569	National Natural Science Foundation of China [31471368]; Zhejiang Provincial Natural Science Foundation of China [LR16C120001]; National Institutes of Health [U01 HL111054, R01 HL115207]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL111054, R01HL115207] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Natural Science Foundation of China Grant 31471368 and Zhejiang Provincial Natural Science Foundation of China Grant LR16C120001 (to H. S.) and National Institutes of Health Grants U01 HL111054 and R01 HL115207 (to P.-T.C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akeno N, 2015, ONCOGENE, V34, P589, DOI 10.1038/onc.2013.589; Almeida MQ, 2012, CURR OPIN ONCOL, V24, P229, DOI 10.1097/CCO.0b013e328351c71a; Arciuch VGA, 2011, ONCOTARGET, V2, P1109, DOI 10.18632/oncotarget.380; Bikas A, 2016, EXPERT REV CLIN PHAR, V9, P1299, DOI 10.1080/17512433.2016.1204230; Cabanillas ME, 2016, LANCET, V388, P2783, DOI 10.1016/S0140-6736(16)30172-6; Cerrato A, 2009, J MOL ENDOCRINOL, V43, P143, DOI 10.1677/JME-09-0024; Champa D, 2015, HORM CANCER-US, V6, P37, DOI 10.1007/s12672-014-0208-8; Coxon AB, 1998, ONCOGENE, V17, P1625, DOI 10.1038/sj.onc.1202381; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; DONISKELLER H, 1993, HUM MOL GENET, V2, P851, DOI 10.1093/hmg/2.7.851; Elisei R, 2007, J CLIN ENDOCR METAB, V92, P4725, DOI 10.1210/jc.2007-1005; Ernani V, 2016, CANCER TREAT REV, V50, P89, DOI 10.1016/j.ctrv.2016.09.006; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Gujral TS, 2008, CANCER RES, V68, P1338, DOI 10.1158/0008-5472.CAN-07-6052; HARVEY M, 1995, CANCER RES, V55, P1146; Jaskula-Sztul R, 2011, J SURG RES, V171, P23, DOI 10.1016/j.jss.2011.03.035; Joyner AL, 2000, GENE TARGETING PRACT; Kim EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018472; Krampitz GW, 2014, CANCER-AM CANCER SOC, V120, P1920, DOI 10.1002/cncr.28661; Kucherlapati MH, 2006, CANCER RES, V66, P3576, DOI 10.1158/0008-5472.CAN-05-2699; Maliszewska A, 2013, AM J PATHOL, V182, P350, DOI 10.1016/j.ajpath.2012.10.025; Marino S, 2000, GENE DEV, V14, P994; Matias-Guiu X, 2014, ENDOCR PATHOL, V25, P21, DOI 10.1007/s12022-013-9287-2; Maxwell JE, 2014, CANCER-AM CANCER SOC, V120, P3287, DOI 10.1002/cncr.28858; Michiels FM, 1997, P NATL ACAD SCI USA, V94, P3330, DOI 10.1073/pnas.94.7.3330; MULLIGAN LM, 1993, NATURE, V363, P458, DOI 10.1038/363458a0; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nagy A., 2003, MANIPULATING MOUSE E; Nikiforov YE, 2016, NAT REV ENDOCRINOL, V12, P67, DOI 10.1038/nrendo.2015.217; Nilsson M, 2016, EUR THYROID J, V5, P79, DOI 10.1159/000447333; Pozo K, 2016, TRENDS CANCER, V2, P606, DOI 10.1016/j.trecan.2016.09.001; Pozo K, 2013, CANCER CELL, V24, P499, DOI 10.1016/j.ccr.2013.08.027; Robbins HL, 2016, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00188; Romei C, 2016, NAT REV ENDOCRINOL, V12, P192, DOI 10.1038/nrendo.2016.11; Russo A, 2015, ONCOTARGET, V6, P26814, DOI 10.18632/oncotarget.4254; Sastre-Perona Ana, 2012, Front Endocrinol (Lausanne), V3, P31, DOI 10.3389/fendo.2012.00031; Song H, 2012, P NATL ACAD SCI USA, V109, P17531, DOI 10.1073/pnas.1207238109; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spitzweg C, 2016, ENDOCR-RELAT CANCER, V23, pR287, DOI 10.1530/ERC-16-0104; Viola D, 2016, ENDOCR-RELAT CANCER, V23, pR185, DOI 10.1530/ERC-15-0555; Vitale G, 2017, ENDOCR-RELAT CANCER, V24, pR1, DOI 10.1530/ERC-16-0399; Wells SA, 2015, THYROID, V25, P567, DOI 10.1089/thy.2014.0335; WILLIAMS BO, 1994, NAT GENET, V7, P480, DOI 10.1038/ng0894-480; Xing MZ, 2013, NAT REV CANCER, V13, P184, DOI 10.1038/nrc3431; Yu XM, 2013, CANCER-AM CANCER SOC, V119, P774, DOI 10.1002/cncr.27742	45	11	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3888	3899		10.1074/jbc.M116.765727	http://dx.doi.org/10.1074/jbc.M116.765727			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28119454	hybrid, Green Published			2022-12-26	WOS:000395542500029
J	Demonte, AM; Diez, MDA; Naleway, C; Iglesias, AA; Ballicora, MA				Demonte, Ana M.; Asencion Diez, Matias D.; Naleway, Conrad; Iglesias, Alberto A.; Ballicora, Miguel A.			Monofluorophosphate Blocks Internal Polysaccharide Synthesis in Streptococcus mutans	PLOS ONE			English	Article							ADP-GLUCOSE PYROPHOSPHORYLASE; IODOPHILIC POLYSACCHARIDE; BIOFILM FORMATION; INTRACELLULAR POLYSACCHARIDE; SODIUM MONOFLUOROPHOSPHATE; GLYCOGEN BIOSYNTHESIS; REGULATORY ENZYME; ORAL STREPTOCOCCI; ESCHERICHIA-COLI; ACID PRODUCTION	Streptococcus mutans is the leading cause of dental caries worldwide by accumulating a glycogen-like internal polysaccharide (IPS) that contributes to cariogenicity when sugars are in excess. Sodium monofluorophosphate (MFP) is an active anticariogenic compound in toothpastes. Herein, we show that MFP inhibits (with an I-0.5 of 1.5 mM) the S. mutans ADPglucose pyrophosphorylase (EC 2.7.7.27), which catalyzes the key step in IPS biosynthesis. Enzyme inhibition by MFP is similar to orthophosphate (Pi), except that the effect caused by MFP is not reverted by fructose-1,6-bisP, as occurs with Pi. Inhibition was correlated with a decrease in acidogenesis and IPS accumulation in S. mutans cells cultured with 2 mM sodium MFP. These effects were not mimicked by sodium fluoride. Considering that glycogen synthesis occurs by different pathways in mammals and bacteria, ADP-glucose pyrophosphorylase could be visualized as a molecular target for controlling S. mutans virulence. Our results strongly suggest that MFP is a suitable compound to affect such a target, inducing an anticariogenic effect primarily by inhibiting a key step in IPS synthesis.	[Demonte, Ana M.; Asencion Diez, Matias D.; Iglesias, Alberto A.] UNL, CONICET, Lab Enzimol Mol, Inst Agrobiotecnol Litoral, Santa Fe, Argentina; [Naleway, Conrad; Ballicora, Miguel A.] Loyola Univ Chicago, Dept Chem & Biochem, Chicago, IL 60611 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the Littoral; Loyola University Chicago	Ballicora, MA (corresponding author), Loyola Univ Chicago, Dept Chem & Biochem, Chicago, IL 60611 USA.	mballic@luc.edu		Asencion Diez, Matias Damian/0000-0001-6495-387X; Ballicora, Miguel/0000-0002-5324-0724; Iglesias, Alberto/0000-0001-9729-7338	Colgate Research Funds; UNL [CAI+D]; ANPCyT [PICT'14 3256, PICT'14 3362]; National Science Foundation [MCB 1024945]	Colgate Research Funds; UNL [CAI+D]; ANPCyT(ANPCyT); National Science Foundation(National Science Foundation (NSF))	This work was supported by Colgate Research Funds (CN) and by grants to AAI from UNL [CAI+D], ANPCyT [PICT'14 3256] and to MDAD [PICT'14 3362] and to MAB from the National Science Foundation [MCB 1024945]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MDAD and AAI are members of the Research Career from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold Wolfgang H, 2007, BMC Oral Health, V7, P14, DOI 10.1186/1472-6831-7-14; Ballicora MA, 2004, PHOTOSYNTH RES, V79, P1, DOI 10.1023/B:PRES.0000011916.67519.58; Ballicora MA, 2003, MICROBIOL MOL BIOL R, V67, P213, DOI 10.1128/MMBR.67.2.213-225.2003; Ballicora MA, 2007, J BACTERIOL, V189, P5325, DOI 10.1128/JB.00481-07; Bonafonte MA, 2000, FEMS MICROBIOL LETT, V191, P31, DOI 10.1016/S0378-1097(00)00366-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Busuioc M, 2009, J BACTERIOL, V191, P7315, DOI 10.1128/JB.00425-09; BUTTERWORTH PJ, 1972, BIOCHIM BIOPHYS ACTA, V289, P251, DOI 10.1016/0005-2744(72)90074-5; CURRAN TM, 1994, FEMS MICROBIOL LETT, V119, P283; Diez MD, 2013, MOL MICROBIOL; DIPERSIO JR, 1974, INFECT IMMUN, V10, P597, DOI 10.1128/IAI.10.3.597-604.1974; ELBEIN AD, 1973, J BACTERIOL, V113, P863, DOI 10.1128/JB.113.2.863-873.1973; HANDELMAN SL, 1973, J DENT RES, V52, P651, DOI 10.1177/00220345730520040301; Hernandez MA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-600; Jackson DW, 2002, J BACTERIOL, V184, P290, DOI 10.1128/JB.184.1.290-301.2002; KAUFMANN M, 1992, CARIES RES, V26, P110, DOI 10.1159/000261494; KIEL JAKW, 1994, MOL MICROBIOL, V11, P203, DOI 10.1111/j.1365-2958.1994.tb00301.x; Klein MI, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00010; Klimek J, 1997, ARCH ORAL BIOL, V42, P181, DOI 10.1016/S0003-9969(96)00118-5; Krzysciak W, 2014, EUR J CLIN MICROBIOL, V33, P499, DOI 10.1007/s10096-013-1993-7; Leme AFP, 2006, J DENT RES, V85, P878, DOI 10.1177/154405910608501002; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; MARQUIS RE, 1995, CAN J MICROBIOL, V41, P955, DOI 10.1139/m95-133; Marquis RE, 2003, FEMS MICROBIOL REV, V26, P493, DOI 10.1111/j.1574-6976.2003.tb00627.x; Pearce Ei D G H, 1995, J DENT RES, V74, P691; Ren Z, 2016, J ORAL MICROBIOL, V8, DOI 10.3402/jom.v8.31095; Saporito RA, 2000, AM J DENT, V13, P221; SPATAFORA G, 1995, INFECT IMMUN, V63, P2556, DOI 10.1128/IAI.63.7.2556-2563.1995; Takahashi N, 2011, J DENT RES, V90, P294, DOI 10.1177/0022034510379602; Takata H, 1997, J BACTERIOL, V179, P4689, DOI 10.1128/jb.179.15.4689-4698.1997; Trinder P., 1969, ANN CLIN BIOCHEM, V6, p24?27, DOI DOI 10.1177/000456326900600108; VANHOUTE J, 1969, ARCH ORAL BIOL, V14, P45, DOI 10.1016/0003-9969(69)90020-X; VANHOUTE J, 1970, ARCH ORAL BIOL, V15, P263, DOI 10.1016/0003-9969(70)90084-1; WEGMAN MR, 1984, J DENT RES, V63, P1126, DOI 10.1177/00220345840630090601; Wiegand A, 2007, DENT MATER, V23, P343, DOI 10.1016/j.dental.2006.01.022; Yep A, 2004, ANAL BIOCHEM, V324, P52, DOI 10.1016/j.ab.2003.09.024	36	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170483	10.1371/journal.pone.0170483	http://dx.doi.org/10.1371/journal.pone.0170483			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125652	Green Published, gold, Green Submitted			2022-12-26	WOS:000396176100104
J	Geiger, M; Bonnyaud, C; Fery, YA; Bussel, B; Roche, N				Geiger, Maxime; Bonnyaud, Celine; Fery, Yves-Andre; Bussel, Bernard; Roche, Nicolas			Evaluating the Effect of Cognitive Dysfunction on Mental Imagery in Patients with Stroke Using Temporal Congruence and the Imagined 'Timed Up and Go' Test (iTUG)	PLOS ONE			English	Article							MOTOR IMAGERY; FUNCTIONAL MOBILITY; GAIT; REHABILITATION; IMPAIRMENTS; SIMULATION; AGREEMENT; MOVEMENT; PEOPLE; LEVEL	Background Motor imagery (MI) capacity may be altered following stroke. MI is evaluated by measuring temporal congruence between the timed performance of an imagined and an executed task. Temporal congruence between imagined and physical gait-related activities has not been evaluated following stroke. Moreover, the effect of cognitive dysfunction on temporal congruence is not known. Objective To assess temporal congruence between the Timed Up and Go test (TUG) and the imagined TUG (iTUG) tests in patients with stroke and to investigate the role played by cognitive dysfunctions in changes in temporal congruence. Methods TUG and iTUG performance were recorded and compared in twenty patients with chronic stroke and 20 controls. Cognitive function was measured using the Montreal Cognitive Assessment (MOCA), the Frontal Assessment Battery at Bedside (FAB) and the Bells Test. Results The temporal congruence of the patients with stroke was significantly altered compared to the controls, indicating a loss of MI capacity (respectively 45.11 +/- 35.11 vs 24.36 +/- 17.91, p = 0.02). Furthermore, iTUG test results were positively correlated with pathological scores on the Bells Test (r = 0.085, p = 0.013), likely suggesting that impairment of attention was a contributing factor. Conclusion These results highlight the importance of evaluating potential attention disorder in patients with stroke to optimise the use of MI for rehabilitation and recovery. However further study is needed to determine how MI should be used in the case of cognitive dysfunction.	[Geiger, Maxime; Bonnyaud, Celine; Bussel, Bernard; Roche, Nicolas] Raymond Poincare Teaching Hosp, AP HP, Team Technol & Innovat Therapies Appl Neuromuscul, Inserm,U1179,UVSQ,CIC 805,Physiol Funct Testing W, Garches, France; [Fery, Yves-Andre] Versailles Univ St Quentin En Yvelines, STAPS Dept Versailles, St Quentin En Yvelines, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Geiger, M (corresponding author), Raymond Poincare Teaching Hosp, AP HP, Team Technol & Innovat Therapies Appl Neuromuscul, Inserm,U1179,UVSQ,CIC 805,Physiol Funct Testing W, Garches, France.	maxime.geiger@u-psud.fr	roche, nicolas/R-6080-2018; Roche, Nicolas/AAE-9206-2021; Bonnyaud, Celine/AGK-7246-2022		Fondation Garches; Allergan	Fondation Garches; Allergan(AbbVieAllergan)	The work was generously supported by Fondation Garches and Allergan.	Allali G, 2012, EUR NEUROL, V67, P116, DOI 10.1159/000334394; Ayan C, 2013, ARCH GERONTOL GERIAT, V56, P44, DOI 10.1016/j.archger.2012.06.002; Barker-Collo SL, 2010, TOP STROKE REHABIL, V17, P463, DOI 10.1310/tsr1706-463; Beauchet O, 2010, J NEUROL SCI, V294, P102, DOI 10.1016/j.jns.2010.03.021; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Faria CDCD, 2009, TOP STROKE REHABIL, V16, P196, DOI 10.1310/tsr1603-196; Dartinet V, 2005, NPG NEUROLOGIE PSYCH, P43; de Seze M, 2001, ARCH PHYS MED REHAB, V82, P793, DOI 10.1053/apmr.2001.0820793; DECETY J, 1989, BEHAV BRAIN RES, V34, P35, DOI 10.1016/S0166-4328(89)80088-9; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; DECETY J, 1990, EUR ARCH PSY CLIN N, V240, P39, DOI 10.1007/BF02190091; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Flansbjer U-B, 2005, J REHABILITATION MED; Fusco A, 2016, RESTOR NEUROL NEUROS; Fusco A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00760; Gauggel S, 2000, J HEAD TRAUMA REHAB, V15, P710, DOI 10.1097/00001199-200002000-00009; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; Gregg M, 2010, EVID-BASED COMPL ALT, V7, P249, DOI 10.1093/ecam/nem170; Guillot A, 2005, BRAIN RES REV, V50, P387, DOI 10.1016/j.brainresrev.2005.09.004; Guillot A, 2005, J MOTOR BEHAV, V37, P10, DOI 10.3200/JMBR.37.1.10-20; Guillot A, 2009, HUM BRAIN MAPP, V30, P2157, DOI 10.1002/hbm.20658; Hall C. R., 1997, J MENTAL IMAG, V21, P143, DOI DOI 10.1037/T07979-000; Jeannerod M, 1995, CURR OPIN NEUROBIOL, V5, P727, DOI 10.1016/0959-4388(95)80099-9; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Journois D, 2004, REV MAL RESPIR, V21, P127, DOI 10.1016/S0761-8425(04)71243-7; Loison B., 2013, Annals of Physical and Rehabilitation Medicine, V56, P157, DOI 10.1016/j.rehab.2013.01.001; Malouin F, 2004, NEUROREPORT, V15, P1349, DOI 10.1097/01.wnr.0000127465.94899.72; Malouin F, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/297217; Munzert J, 2009, BRAIN RES REV, V60, P306, DOI 10.1016/j.brainresrev.2008.12.024; Nadeau S, 1999, CLIN BIOMECHANICS; Ng SS, 2005, ARCH PHYS MED REHAB, V86, P1641, DOI 10.1016/j.apmr.2005.01.011; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Schuster C, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/503190; Sirigu A, 1996, SCIENCE, V273, P1564, DOI 10.1126/science.273.5281.1564; Taylor ME, 2014, J GERONTOL A-BIOL, V69, P987, DOI 10.1093/gerona/glt166; van Iersel MB, 2004, Z GERONTOL GERIATR, V37, P27, DOI 10.1007/s00391-004-0176-7; Wu AJ, 2010, AM J OCCUP THER, V64, P929, DOI 10.5014/ajot.2010.09005; Zimmermann-Schlatter A, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-8	39	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170400	10.1371/journal.pone.0170400	http://dx.doi.org/10.1371/journal.pone.0170400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7IT	28125616	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100113
J	Faupel-Badger, JM; Nelson, DE; Izmirlian, G				Faupel-Badger, Jessica M.; Nelson, David E.; Izmirlian, Grant			Career Satisfaction and Perceived Salary Competitiveness among Individuals Who Completed Postdoctoral Research Training in Cancer Prevention	PLOS ONE			English	Article							BIOMEDICAL-RESEARCH ENTERPRISE; JOB-SATISFACTION; PUBLIC-HEALTH; OUTCOMES; SCIENCES; FACULTY; RECOMMENDATIONS; SCIENTISTS; PREDICTORS; ENGINEERS	Studies examining career satisfaction of biomedical scientists are limited, especially in the context of prior postdoctoral training. Here we focused on career satisfaction defined as sat-isfaction with one's career trajectory and perceived salary competitiveness among a predominantly Ph. D.-trained population of scientists who completed cancer prevention-related postdoctoral training between 1987-2011. National Cancer Institute (NCI) Cancer Preven-tion Fellowship Program (CPFP) alumni (n = 114), and previous recipients of NCI-spon-sored Ruth L. Kirschstein National Research Service Award (NRSA/F32) postdoctoral fellowships (n = 140) completed online surveys. Associations of career satisfaction and perception of salary competitiveness with demographic, training, and employment-related factors were examined using logistic regression. Overall, 61% reported high levels of satis-faction with their career trajectory to-date. Higher salary (odds ratio [OR] = 2.86, 95% confidence interval [95% CI]: 1.07-7.69) and having more leadership roles (OR = 2.26, 95% CI: 1.04-4.90) were independently associated with higher career satisfaction. Persons with race/ethnicity other than white (OR = 0.40, 95% CI: 0.20-0.82) or age >= 50 (OR = 0.40, 95% CI: 0.17-0.94) had lower career satisfaction levels. There were no statistically signifi-cant differences in career satisfaction levels by gender, scientific discipline, or employment sector. 74% perceived their current salary as competitive, but persons with 5-9, or >= 10 years in their current position reported lower levels (OR = 0.31, 95% CI: 0.15-0.65; and OR = 0.37, 95% CI: 0.16-0.87, respectively), as did individuals in government positions (OR = 0.33, 95% CI: 0.11-0.98). These data add to the understanding of career satisfaction of those with advanced training in biomedical research by examining these measures in rela-tion to prior postdoctoral research training and across multiple career sectors.	[Faupel-Badger, Jessica M.] NIGMS, Bethesda, MD 20892 USA; [Nelson, David E.; Izmirlian, Grant] NCI, Canc Prevent Div, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Faupel-Badger, JM (corresponding author), NIGMS, Bethesda, MD 20892 USA.	badgerje@mail.nih.gov		Faupel-Badger, Jessica/0000-0001-9729-3660	NIH Evaluation Set-Aside program; NCI CPFP alumni; NRSA/F32 award	NIH Evaluation Set-Aside program; NCI CPFP alumni; NRSA/F32 award	Authors do not have additional grant funding. This work was funded by the NIH Evaluation Set-Aside program. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank all of the NCI CPFP alumni and NRSA/F32 award recipients who took the time to complete the online survey. We also thank employees of Westat, Inc (Kimberley Raue, Sophia Tsakraklides, Atsushi Miyaoka, Maura Spiegelman) for their involvement in design of the survey, collection of data, and preparation of summary report. This work was supported by the NIH Evaluation Set-Aside program award to the NCI Cancer Prevention Fellowship Program, Division of Cancer Prevention and subsequent contract to Westat, Inc.	Advisory Committee to the Director of the National Institutes of Health, 2012, BIOM RES WORKF WORK; Alberts B, 2015, P NATL ACAD SCI USA, V112, P1912, DOI 10.1073/pnas.1500969112; August L, 2004, RES HIGH EDUC, V45, P177, DOI 10.1023/B:RIHE.0000015694.14358.ed; Austin Jim, 2006, Science, V314, P842, DOI 10.1126/science.314.5800.842; Bender KA, 2006, SCOT J POLIT ECON, V53, P253, DOI 10.1111/j.1467-9485.2006.00379.x; Clark A, 1996, J OCCUP ORGAN PSYCH, V69, P57, DOI 10.1111/j.2044-8325.1996.tb00600.x; Cole S, 2010, J PUBLIC HEALTH MAN, V16, pE1, DOI 10.1097/PHH.0b013e3181b83460; Corley EA, 2007, RES HIGH EDUC, V48, P909, DOI 10.1007/s11162-007-9055-6; Cumbey DA, 1998, J NURS ADMIN, V28, P39, DOI 10.1097/00005110-199805000-00007; DesRoches CM, 2010, ACAD MED, V85, P631, DOI 10.1097/ACM.0b013e3181d2b095; Diamantopoulos A, 2012, J ACAD MARKET SCI, V40, P434, DOI 10.1007/s11747-011-0300-3; Dolbier CL, 2005, AM J HEALTH PROMOT, V19, P194, DOI 10.4278/0890-1171-19.3.194; Faupel-Badger J, 2013, J CANCER EDUC, V28, P18, DOI 10.1007/s13187-012-0437-x; Faupel-Badger JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144880; Frank E, 1999, ARCH INTERN MED, V159, P1417, DOI 10.1001/archinte.159.13.1417; Fuhrmann CN, 2011, CBE-LIFE SCI EDUC, V10, P239, DOI 10.1187/cbe.11-02-0013; Gibbs KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114736; Gibbs KD, 2013, CBE-LIFE SCI EDUC, V12, P711, DOI 10.1187/cbe.13-02-0021; GREENHAUS JH, 1990, ACAD MANAGE J, V33, P64, DOI 10.2307/256352; Husten C G, 1993, J Cancer Educ, V8, P281; Jagsi R, 2011, ACAD MED, V86, P1415, DOI 10.1097/ACM.0b013e3182305aa6; Jagsi R, 2009, ANN INTERN MED, V151, P804, DOI 10.7326/0003-4819-151-11-200912010-00009; JUDGE TA, 1995, PERS PSYCHOL, V48, P485, DOI 10.1111/j.1744-6570.1995.tb01767.x; JUHL N, 1993, PUBLIC HEALTH NURS, V10, P42, DOI 10.1111/j.1525-1446.1993.tb00019.x; Keeton K, 2007, OBSTET GYNECOL, V109, P949, DOI 10.1097/01.AOG.0000258299.45979.37; Landon BE, 2003, JAMA-J AM MED ASSOC, V289, DOI [10.1001/jama.289.4.442, DOI 10.1001/JAMA.289.4.442]; Manfreda KL, 2008, INT J MARKET RES, V50, P79, DOI 10.1177/147078530805000107; Mason JL, 2013, J CANCER EDUC, V28, P9, DOI 10.1007/s13187-012-0444-y; Mathews K., 2014, PERSPECTIVES MIDCARE; McDowell Gary S, 2014, F1000Res, V3, P291, DOI 10.12688/f1000research.5878.2; Millar MM, 2011, PUBLIC OPIN QUART, V75, P249, DOI 10.1093/poq/nfr003; National Academy of Sciences National Academy of Engineering and Institute of Medicine, 2014, POSTD EXP REV; National Institutes of Health Office of the Director, 2006, CAR ACH NAT RES SERV; Pickett CL, 2015, P NATL ACAD SCI USA, V112, P10832, DOI 10.1073/pnas.1509901112; Pion G, 2003, ACAD MED, V78, P177, DOI 10.1097/00001888-200302000-00012; Polka JK, 2015, MOL BIOL CELL, V26, P1413, DOI 10.1091/mbc.E14-10-1432; Polka JK, 2014, SCIENCE, V346, P1422, DOI 10.1126/science.346.6215.1422; R Computing Team, 2014, R LANG ENV STAT COMP; Russo G, 2010, NATURE, V467, P1143, DOI 10.1038/nj7319-1143a; Sabharwal M, 2011, RES POLICY, V40, P853, DOI 10.1016/j.respol.2011.04.002; Sabharwal M, 2009, SOC SCI J, V46, P539, DOI 10.1016/j.soscij.2009.04.015; Salive ME, 1997, AM J PREV MED, V13, P303, DOI 10.1016/S0749-3797(18)30180-6; Sauermann H, 2016, SCIENCE, V352, P663, DOI 10.1126/science.aaf2061; Spiegelman M, 2014, EVALUATION NCIS CANC; Stephan P., 2012, EC SHAPES SCI; Stephan P, 2012, NATURE, V484, P29, DOI 10.1038/484029a; Streiner D. L., 2015, HLTH MEASUREMENT SCA, V5<feminine, DOI [10.1093/med/9780199685219.001.0001, DOI 10.1093/MED/9780199685219.001.0001, 10.1093/MED/9780199685219.001.0001]; Varma R, 2004, ASIAN J SOC SCI, V32, P290, DOI DOI 10.1163/1568531041705103.VENKATESH; Wilson R., 2012, CHRONICAL HIGHE 0603; Zolas N, 2015, SCIENCE, V350, P1367, DOI 10.1126/science.aac5949	50	6	6	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0169859	10.1371/journal.pone.0169859	http://dx.doi.org/10.1371/journal.pone.0169859			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7FK	28121985	Green Published, gold, Green Submitted			2022-12-26	WOS:000396167300063
J	Kekic, M; McClelland, J; Bartholdy, S; Boysen, E; Musiat, P; Dalton, B; Tiza, M; David, AS; Campbell, IC; Schmidt, U				Kekic, Maria; McClelland, Jessica; Bartholdy, Savani; Boysen, Elena; Musiat, Peter; Dalton, Bethan; Tiza, Meyzi; David, Anthony S.; Campbell, Iain C.; Schmidt, Ulrike			Single-Session Transcranial Direct Current Stimulation Temporarily Improves Symptoms, Mood, and Self-Regulatory Control in Bulimia Nervosa: A Randomised Controlled Trial	PLOS ONE			English	Article							ANORECTIC COGNITIONS QUESTIONNAIRE; EATING-DISORDERS; ANOREXIA-NERVOSA; MAGNETIC STIMULATION; NEGATIVE AFFECT; BEHAVIORAL THERAPY; COMMUNITY SAMPLE; DECISION-MAKING; MORTALITY-RATES; FOOD CRAVINGS	Background Evidence suggests that pathological eating behaviours in bulimia nervosa (BN) are underpinned by alterations in reward processing and self-regulatory control, and by functional changes in neurocircuitry encompassing the dorsolateral prefrontal cortex (DLPFC). Manipulation of this region with transcranial direct current stimulation (tDCS) may therefore alleviate symptoms of the disorder. Objective This double-blind sham-controlled proof-of-principle trial investigated the effects of bilateral tDCS over the DLPFC in adults with BN. Methods Thirty-nine participants (two males) received three sessions of tDCS in a randomised and counterbalanced order: anode right/cathode left (AR/CL), anode left/cathode right (AL/CR), and sham. A battery of psychological/neurocognitive measures was completed before and after each session and the frequency of bulimic behaviours during the following 24-hours was recorded. Results AR/CL tDCS reduced eating disorder cognitions (indexed by the Mizes Eating Disorder Cognitions Questionnaire-Revised) when compared to AL/CR and sham tDCS. Both active conditions suppressed the self-reported urge to binge-eat and increased self-regulatory control during a temporal discounting task. Compared to sham stimulation, mood (assessed with the Profile of Mood States) improved after AR/CL but not AL/CR tDCS. Lastly, the three tDCS sessions had comparable effects on the wanting/liking of food and on bulimic behaviours during the 24 hours post-stimulation. Conclusions These data suggest that single-session tDCS transiently improves symptoms of BN. They also help to elucidate possible mechanisms of action and highlight the importance of selecting the optimal electrode montage. Multi-session trials are needed to determine whether tDCS has potential for development as a treatment for adult BN.	[Kekic, Maria; McClelland, Jessica; Bartholdy, Savani; Boysen, Elena; Musiat, Peter; Dalton, Bethan; Tiza, Meyzi; Campbell, Iain C.; Schmidt, Ulrike] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol Med, Sect Eating Disorders, London, England; [David, Anthony S.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychosis Studies, London, England; [Boysen, Elena] Med Univ Hosp Tubingen, Dept Psychosomat Med & Psychotherapy, Osianderstr 5, D-72076 Tubingen, Germany	University of London; King's College London; University of London; King's College London; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Kekic, M (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol Med, Sect Eating Disorders, London, England.	maria.kekic@kcl.ac.uk	David, Anthony S/C-1315-2011; David, Anthony/O-1750-2019; Dalton, Bethan/AAQ-6779-2020	David, Anthony S/0000-0003-0967-774X; David, Anthony/0000-0003-0967-774X; Schwarz, Elena/0000-0002-1010-9734; Dalton, Bethan/0000-0003-0898-1926	Medical Research Council/Institute of Psychiatry, Psychology & Neuroscience Excellence studentship; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London	Medical Research Council/Institute of Psychiatry, Psychology & Neuroscience Excellence studentship; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London	This research was funded by a Medical Research Council/Institute of Psychiatry, Psychology & Neuroscience Excellence studentship, awarded to Maria Kekic in 2012. Ulrike Schmidt, Iain Campbell, and Anthony David receive salary support from the National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. Open access for this article was funded by King's College London. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alonso M, 2007, JAMA-J AM MED ASSOC, V297, P1819, DOI 10.1001/jama.297.16.1819; Alonzo A, 2012, BRAIN STIMUL, V5, P208, DOI 10.1016/j.brs.2011.04.006; Arcelus J, 2011, ARCH GEN PSYCHIAT, V68, P724, DOI 10.1001/archgenpsychiatry.2011.74; Bartholdy S, 2016, NEUROSCI BIOBEHAV R, V64, P35, DOI 10.1016/j.neubiorev.2016.02.010; Beam W, 2009, BRAIN STIMUL, V2, P50, DOI 10.1016/j.brs.2008.09.006; Berg KC, 2013, J ABNORM PSYCHOL, V122, P111, DOI 10.1037/a0029703; Berner LA, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00395; Bohon C, 2012, APPETITE, V58, P964, DOI 10.1016/j.appet.2012.02.051; Brunoni AR, 2012, BRAIN STIMUL, V5, P175, DOI 10.1016/j.brs.2011.03.002; Burgess E. E., 2016, INT J EAT DISORD; Cowdrey FA, 2013, AM J CLIN NUTR, V97, P463, DOI 10.3945/ajcn.112.046011; Diana Marco, 2011, Front Psychiatry, V2, P64, DOI 10.3389/fpsyt.2011.00064; Fairburn C.G., 2008, COGNITIVE BEHAV THER, P265, DOI DOI 10.1037/T03975-000; Farmer RF, 2001, J BEHAV THER EXP PSY, V32, P211, DOI 10.1016/S0005-7916(01)00036-2; Fregni F, 2008, APPETITE, V51, P34, DOI 10.1016/j.appet.2007.09.016; Friederich HC, 2013, INT J EAT DISORDER, V46, P425, DOI 10.1002/eat.22099; Garcia-Garcia I, 2013, EUR EAT DISORD REV, V21, P89, DOI 10.1002/erv.2216; Gluck ME, 2015, OBESITY, V23, P2149, DOI 10.1002/oby.21313; Goldman RL, 2011, APPETITE, V56, P741, DOI 10.1016/j.appet.2011.02.013; Gray JC, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01104; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Hausmann A, 2004, INT J NEUROPSYCHOPH, V7, P371, DOI 10.1017/S1461145704004420; Heatherton TF, 2011, TRENDS COGN SCI, V15, P132, DOI 10.1016/j.tics.2010.12.005; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Kekic M, 2016, INT J EAT D IN PRESS; Kekic M, 2016, J PSYCHIATR RES, V74, P70, DOI 10.1016/j.jpsychires.2015.12.018; Kekic M, 2014, APPETITE, V78, P55, DOI 10.1016/j.appet.2014.03.010; Khedr EM, 2014, RESTOR NEUROL NEUROS, V32, P789, DOI 10.3233/RNN-140392; Koffarnus MN, 2013, J EXP ANAL BEHAV, V99, P32, DOI 10.1002/jeab.2; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; Loxton NJ, 2001, INT J EAT DISORDER, V29, P455, DOI 10.1002/eat.1042; Macedo IC, 2016, APPETITE, V103, P29, DOI 10.1016/j.appet.2016.03.014; Marsh R, 2011, AM J PSYCHIAT, V168, P1210, DOI 10.1176/appi.ajp.2011.11010094; Marsh R, 2009, ARCH GEN PSYCHIAT, V66, P51, DOI 10.1001/archgenpsychiatry.2008.504; Marsh-Richard DM, 2009, BEHAV RES METHODS, V41, P99, DOI 10.3758/BRM.41.1.99; Mauler BI, 2006, J ABNORM PSYCHOL, V115, P567, DOI 10.1037/0021-843X.115.3.567; McClelland J, 2016, NEUROSCI BIOBEHAV R, V71, P506, DOI 10.1016/j.neubiorev.2016.09.024; McClelland J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148606; McClelland J, 2016, EUR EAT DISORD REV, V24, P157, DOI 10.1002/erv.2414; McClelland J, 2013, EUR EAT DISORD REV, V21, P436, DOI 10.1002/erv.2256; McNair D.M., 1971, MANUAL PROFILES MOOD; Meron D, 2015, NEUROSCI BIOBEHAV R, V57, P46, DOI 10.1016/j.neubiorev.2015.07.012; Mizes JS, 2000, INT J EAT DISORDER, V28, P415, DOI 10.1002/1098-108X(200012)28:4<415::AID-EAT9>3.3.CO;2-Q; Monte-Silva K, 2013, BRAIN STIMUL, V6, P424, DOI 10.1016/j.brs.2012.04.011; National Institute for Health and Care Excellence, 2004, EATING DISORDERS COR; O'Brien KM, 2003, CLIN PSYCHOL REV, V23, P57, DOI 10.1016/S0272-7358(02)00201-5; Ochner CN, 2009, APPETITE, V53, P44, DOI 10.1016/j.appet.2009.04.220; Peak NJ, 2012, EAT BEHAV, V13, P94, DOI 10.1016/j.eatbeh.2011.12.004; Penas-Lledo E, 2013, PSYCHOTHER PSYCHOSOM, V82, P125, DOI 10.1159/000339620; Poulsen S, 2014, AM J PSYCHIAT, V171, P109, DOI 10.1176/appi.ajp.2013.12121511; Read D, 2001, J RISK UNCERTAINTY, V23, P5, DOI 10.1023/A:1011198414683; Ro O, 2012, EAT BEHAV, V13, P158, DOI 10.1016/j.eatbeh.2011.12.001; Sauvaget A, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00349; Smink FRE, 2012, CURR PSYCHIAT REP, V14, P406, DOI 10.1007/s11920-012-0282-y; Steinglass JE, 2012, J INT NEUROPSYCH SOC, V18, P773, DOI 10.1017/S1355617712000446; Stice E, 2000, PSYCHOL ASSESSMENT, V12, P123, DOI 10.1037//1040-3590.12.2.123; Stice E, 2013, J ABNORM PSYCHOL, V122, P445, DOI 10.1037/a0030679; Uher R, 2005, BIOL PSYCHIAT, V58, P840, DOI 10.1016/j.biopsych.2005.05.043; Van den Eynde F, 2012, EUR PSYCHIAT, V27, P290, DOI 10.1016/j.eurpsy.2010.08.015; Van den Eynde F., 2011, EUROPEAN PSYCHIAT, V28, P98; Van den Eynde F, 2010, BIOL PSYCHIAT, V67, P793, DOI 10.1016/j.biopsych.2009.11.023; Wagner DD, 2012, J COGNITIVE NEUROSCI, V24, P1625, DOI 10.1162/jocn_a_00238; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Weber EU, 2007, PSYCHOL SCI, V18, P516, DOI 10.1111/j.1467-9280.2007.01932.x; WEINGARTEN HP, 1990, APPETITE, V15, P231, DOI 10.1016/0195-6663(90)90023-2; Wierenga CE, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00410; Wu MD, 2016, NEUROSCI BIOBEHAV R, V61, P177, DOI 10.1016/j.neubiorev.2015.11.017	67	46	49	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0167606	10.1371/journal.pone.0167606	http://dx.doi.org/10.1371/journal.pone.0167606			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28121991	Green Published, gold, Green Submitted			2022-12-26	WOS:000396167300081
J	Sun, YN; Harley, D; Vally, H; Sleigh, A				Sun, Yanni; Harley, David; Vally, Hassan; Sleigh, Adrian			Impact of Multidrug Resistance on Tuberculosis Recurrence and Long-Term Outcome in China	PLOS ONE			English	Article							DRUG-RESISTANCE; PROVINCE; TRANSMISSION; SURVIVAL; SHANGHAI; MDR	Little is known about the impact of drug resistance on recurrence in TB. We conducted a cohort study to measure the impact of multi-drug resistance (MDR) on TB recurrence over nine years in Henan Province China. We reviewed medical records and conducted field interviews of 100 MDR and 150 non-MDR TB patients who were treated between 2001 and 2002. We compared long-term recurrence rates, risk factors, and outcomes in 2010 for 234 individuals who could be followed up. About one third (29.5%, 69/234) suffered recurrence after completion of treatment. The overall recurrence rate was 35/1,000 patient-years (PY), with a much higher rate (65/1,000 PY) among MDR-TB patients. MDR (HR: 2.75; CI: 1.58-4.79) and patient annual household income less than 10,000 Yuan (HR: 2.05; CI 1.11-3.80) were associated with recurrence. The mean time for recurrence among MDR-TB patients was 5.7 years, compared to 7.2 years among non-MDR-TB patients. Among the recurrence group members, 61.3% died, and 18.8% had failed treatments. We believe that the high TB recurrence rate after 9 years suggests that a high cure rate cannot accurately predict long-term outcome. We recommend that TB surveillance and control should be strengthened with a focus on MDR-TB and directly observed treatment, to reduce TB recurrence and transmission of MDR-TB.	[Sun, Yanni; Harley, David; Sleigh, Adrian] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Res Sch Populat Hlth, ANU Coll Med Biol & Environm, Canberra, ACT, Australia; [Vally, Hassan] La Trobe Univ, Sch Publ Hlth & Human Biosci, Melbourne, Vic, Australia	Australian National University; La Trobe University	Sun, YN (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Res Sch Populat Hlth, ANU Coll Med Biol & Environm, Canberra, ACT, Australia.	sunyanni72@hotmail.com	Vally, Hassan/AAG-1307-2022; Harley, David/B-4910-2017; sleigh, adrian/J-4540-2019; Vally, Hassan/AFK-2936-2022	Vally, Hassan/0000-0001-5281-7459; Harley, David/0000-0001-6691-5420; sleigh, adrian/0000-0001-8443-7864; Vally, Hassan/0000-0001-5281-7459	Centre for Epidemiology and Population Health, Australian National University	Centre for Epidemiology and Population Health, Australian National University	The Funding for the study was partially provided by the Centre for Epidemiology and Population Health, Australian National University, as the PhD study project for Yanni Sun, a PhD candidate at the Centre. Yanni Sun also paid in part for the study as the internal budget was insufficient. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, MULTIDRUG EXTENSIVEL; Avendano M, 2000, CAN RESP J, V7; Chen M., 2015, GLOBAL FUND MDR TB C; Chiang CY, 2006, EUR RESPIR J, V28, P980, DOI 10.1183/09031936.06.00125705; Cox H, 2006, PLOS MED, V3, P1836, DOI 10.1371/journal.pmed.0030384; Du CM, 2006, J CHINESE ANTITUBERC, V28; Geerligs WA, 2000, INT J TUBERC LUNG D, V4, P758; Gilpin CM, 2008, MED J AUSTRALIA, V188, P148, DOI 10.5694/j.1326-5377.2008.tb01557.x; He GX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010799; Henan Statistics Bureau, 2012, HEN STAT YB 2011; Kim DH, 2010, AM J RESP CRIT CARE, V182, P113, DOI 10.1164/rccm.200911-1656OC; Kirkwood BR, 2003, ESSENTIAL MED STAT; Millet JP, 2009, J EPIDEMIOL COMMUN H, V63, P799, DOI 10.1136/jech.2008.077560; Panjabi R, 2007, INT J TUBERC LUNG D, V11, P828; Paramasivan CN, 2004, INDIAN J MED RES, V120, P377; Salaniponi FM, 2003, INT J TUBERC LUNG D, V7, P948; Shen GM, 2006, EMERG INFECT DIS, V12, P1776, DOI 10.3201/eid1211.051207; Sun XY, 2009, HEALTH ECON, V18, P103, DOI 10.1002/hec.1346; Sun YN, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2327-8; Valadas E, 2005, EUR J RADIOL, V55, P154, DOI 10.1016/j.ejrad.2005.04.013; Vree M, 2007, INT J TUBERC LUNG D, V11, P392; Wang Guo-jie, 2006, Zhonghua Jiehe He Huxi Zazhi, V29, P527; WHO, 2011, WHO GLOBAL TUBERCULO; World Health Organization, 2008, WHOHTMTB2008402; World Health Organization, 2015, GLOB TUB REP 2015; World Health Organization (WHO), 2009, WHOHTMTB2009420; Xiao DL, 2008, GUIDELINES IMPLEMENT; Zhao M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004370	28	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2017	12	1							e0168865	10.1371/journal.pone.0168865	http://dx.doi.org/10.1371/journal.pone.0168865			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7CU	28118372	Green Published, gold, Green Submitted			2022-12-26	WOS:000396160500052
J	Zhang, J; Lin, W; Lin, HC; Wang, ZY; Dong, HM				Zhang, Ji; Lin, Wei; Lin, Hancheng; Wang, Zhenyuan; Dong, Hongmei			Identification of Skin Electrical Injury Using Infrared Imaging: A Possible Complementary Tool for Histological Examination	PLOS ONE			English	Article							SECONDARY STRUCTURE; CURRENT MARKS; SPECTROSCOPY; MICROSPECTROSCOPY; DENATURATION; LESIONS	In forensic practice, determination of electrocution as a cause of death usually depends on the conventional histological examination of electrical mark in the body skin, but the limitation of this method includes subjective bias by different forensic pathologists, especially for identifying suspicious electrical mark. The aim of our work is to introduce Fourier transform infrared (FTIR) spectroscopy in combination with chemometrics as a complementary tool for providing an relatively objective diagnosis. The results of principle component analysis (PCA) showed that there were significant differences of protein structural profile between electrical mark and normal skin in terms of a-helix, antiparallel beta-sheet and beta-sheet content. Then a partial least square (PLS) model was established based on this spectral dataset and used to discriminate electrical mark from normal skin areas in independent tissue sections as revealed by color-coded digital maps, making the visualization of electrical injury more intuitively. Our pilot study demonstrates the potential of FTIR spectroscopy as a complementary tool for diagnosis of electrical mark.	[Zhang, Ji; Lin, Hancheng; Wang, Zhenyuan] Xi An Jiao Tong Univ, Coll Forens Med, Dept Forens Pathol, Xian, Shaanxi, Peoples R China; [Lin, Wei; Dong, Hongmei] Huazhong Univ Sci & Technol, Dept Forens Med, Tongji Med Coll, Wuhan, Hubei Province, Peoples R China	Xi'an Jiaotong University; Huazhong University of Science & Technology	Wang, ZY; Dong, HM (corresponding author), Xi An Jiao Tong Univ, Coll Forens Med, Dept Forens Pathol, Xian, Shaanxi, Peoples R China.; Dong, HM (corresponding author), Huazhong Univ Sci & Technol, Dept Forens Med, Tongji Med Coll, Wuhan, Hubei Province, Peoples R China.	wzy218@xjtu.edu.cn; hongmeidong1@hotmail.com	wang, zhenyuan/AAB-4874-2021		National Science Foundation of China [81273335, 81471819, 81471821]; China Postdoctoral Science Foundation [2016M592801]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The work is funded by the National Science Foundation of China (No.81273335, 81471819, 81471821) and China Postdoctoral Science Foundation Grant (No.2016M592801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquah GE, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16091375; Ali K, 2008, INT J MOL MED, V21, P297; Anders S, 2003, J FORENSIC SCI, V48, P640; Anders S, 2001, AM J FOREN MED PATH, V22, P370, DOI 10.1097/00000433-200112000-00007; Beekes M, 2007, VET MICROBIOL, V123, P305, DOI 10.1016/j.vetmic.2007.04.010; Bergholt MS, 2016, ACS CENTRAL SCI, V2, P885, DOI 10.1021/acscentsci.6b00222; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Danielsen L, 2003, FORENSIC SCI INT, V134, P134, DOI 10.1016/S0379-0738(03)00140-3; Jacobsen H, 1997, FORENSIC SCI INT, V90, P85, DOI 10.1016/S0379-0738(97)00151-5; Jakubeniene M, 2006, FORENSIC SCI INT, V161, P36, DOI 10.1016/j.forsciint.2005.10.019; Kinoshita Hiroshi, 2004, Leg Med (Tokyo), V6, P55, DOI 10.1016/j.legalmed.2003.08.006; Kretlow A, 2006, BBA-BIOMEMBRANES, V1758, P948, DOI 10.1016/j.bbamem.2006.05.026; Li SY, 2014, SCI JUSTICE, V54, P98, DOI 10.1016/j.scijus.2013.07.005; LOMBARDERO M, 1990, J IMMUNOL, V144, P1353; Lu R, 2015, ANALYST, V140, P765, DOI 10.1039/c4an01495b; Mistek E, 2015, ANAL BIOANAL CHEM, V407, P7435, DOI 10.1007/s00216-015-8909-6; Nunes KM, 2016, FOOD CHEM, V205, P14, DOI 10.1016/j.foodchem.2016.02.158; Shtein Roni M, 2016, Trans Am Ophthalmol Soc, V114, pT4; Takamiya M, 2001, INT J LEGAL MED, V115, P152, DOI 10.1007/s004140100250; Tanaka N, 2013, LEGAL MED-TOKYO, V15, P283, DOI 10.1016/j.legalmed.2013.06.004; Tiwari S, 2016, ANAL CHEM, V88, P10183, DOI 10.1021/acs.analchem.6b02754; Tong PL, 2013, BRIT J DERMATOL, V169, P869, DOI 10.1111/bjd.12430; Uzun I, 2008, FORENSIC SCI INT, V178, P157, DOI 10.1016/j.forsciint.2008.03.012; Verdonck M, 2016, ANALYST, V141, P606, DOI 10.1039/c5an01512j; Xiang WZ, 2017, LASER MED SCI, V32, P211, DOI 10.1007/s10103-016-2104-7; XU XH, 1995, FORENSIC SCI INT, V73, P197; Zhang J, 2015, J FORENSIC SCI; Zhang J, 2017, SPECTROCHIM ACTA A, V173, P733, DOI 10.1016/j.saa.2016.10.041; Zhang J, 2015, J FORENSIC SCI, V60, P759, DOI 10.1111/1556-4029.12743	29	4	5	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2017	12	1							e0170844	10.1371/journal.pone.0170844	http://dx.doi.org/10.1371/journal.pone.0170844			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7CU	28118398	Green Published, gold, Green Submitted			2022-12-26	WOS:000396160500003
J	Calabrese, A; Liu, TT; Legge, GE				Calabrese, Aurelie; Liu, Tingting; Legge, Gordon E.			Does Vertical Reading Help People with Macular Degeneration: An Exploratory Study	PLOS ONE			English	Article							RETINAL LOCI RELATIONSHIP; PERIPHERAL-VISION; EYE-MOVEMENTS; VISUAL SPAN; PSYCHOPHYSICS; SPEED; SCOTOMAS; LOCATIONS; TEXT; DISEASE	Individuals with macular degeneration often develop a Preferred Retinal Locus (PRL) used in place of the impaired fovea. It is known that many people adopt a PRL left of the scotoma, which is likely to affect reading by occluding text to the right of fixation. For such individuals, we examined the possibility that reading vertical text, in which words are rotated 90 E with respect to the normal horizontal orientation, would be beneficial for reading. Vertically oriented words would be tangential to the scotoma instead of being partially occluded by it. Here we report the results of an exploratory study that aimed at investigating this hypothesis. We trained individuals with macular degeneration who had PRLs left of their scotoma to read text rotated 90 E clockwise and presented using rapid serial visual presentation (RSVP). Although training resulted in improved reading of vertical text, the training did not result in reading speeds that appreciably exceeded reading speeds following training with horizontal text. These results do not support the hypothesis that people with left PRLs read faster with vertical text.	[Calabrese, Aurelie; Legge, Gordon E.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Liu, Tingting] Fudan Univ, Dept Ophthalmol & Vis Sci, Eye & ENT Hosp, Shanghai, Peoples R China	University of Minnesota System; University of Minnesota Twin Cities; Fudan University	Calabrese, A (corresponding author), Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA.	acalabre@umn.edu	liu, ting/GZM-3326-2022	Legge, Gordon/0000-0002-3742-1680; Calabrese, Aurelie/0000-0002-7078-3595	National Institute of Health (NIH) [EY002934]; NATIONAL EYE INSTITUTE [R01EY002934] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by the National Institute of Health (NIH) grant EY002934 [https://grants.nih.gov/grants/oer.htm].	Abrams J, 2012, VISION RES, V52, P70, DOI 10.1016/j.visres.2011.10.016; Bowers AR, 2004, OPTOMETRY VISION SCI, V81, P205, DOI 10.1097/00006324-200403000-00013; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Calabrese A, 2014, INVEST OPHTH VIS SCI, V55, P3638, DOI 10.1167/iovs.13-13408; Calabrese A, 2011, INVEST OPHTH VIS SCI, V52, P2417, DOI 10.1167/iovs.09-5056; Cheong AMY, 2008, VISION RES, V48, P577, DOI 10.1016/j.visres.2007.11.022; Chung STL, 1998, VISION RES, V38, P2949, DOI 10.1016/S0042-6989(98)00072-8; Chung STL, 2011, INVEST OPHTH VIS SCI, V52, P1164, DOI 10.1167/iovs.10-6034; Crossland MD, 2002, OPTOMETRY VISION SCI, V79, P735, DOI 10.1097/00006324-200211000-00011; Crossland MD, 2005, OPHTHALMOLOGY, V112, P1579, DOI 10.1016/j.ophtha.2005.03.027; Crossland MD, 2009, RETINA-J RET VIT DIS, V29, P651, DOI 10.1097/IAE.0b013e318196bd65; CUMMINGS RW, 1985, AM J OPTOM PHYS OPT, V62, P833; Elliott DB, 1997, INVEST OPHTH VIS SCI, V38, P2566; FERRIS FL, 1982, AM J OPHTHALMOL, V94, P91, DOI 10.1016/0002-9394(82)90197-0; Fine EM, 1999, VISION RES, V39, P1039, DOI 10.1016/S0042-6989(98)00208-9; Fletcher DC, 1997, OPHTHALMOLOGY, V104, P632, DOI 10.1016/S0161-6420(97)30260-7; Fletcher DC, 1999, J REHABIL RES DEV, V36, P356; GIBSON EJ, 1963, ANNU REV PSYCHOL, V14, P29, DOI 10.1146/annurev.ps.14.020163.000333; He YC, 2013, J VISION, V13, DOI 10.1167/13.7.14; Kleiner M, 2007, PERCEPTION, V36, P14; Lee HW, 2010, J VISION, V10, DOI 10.1167/10.6.18; Legge GE, 1997, VISION RES, V37, P1999, DOI 10.1016/S0042-6989(97)00017-5; LEGGE GE, 1989, OPTOMETRY VISION SCI, V66, P843, DOI 10.1097/00006324-198912000-00008; Legge GE, 2001, VISION RES, V41, P725, DOI 10.1016/S0042-6989(00)00295-9; Mansfield JS, 1993, OPT SOC AM TECHNOL D, V3, P232; Mansfield JS, 2007, PSYCHOPHYSICS READIN; Matsumoto Y, 2005, JPN J OPHTHALMOL, V49, P462, DOI 10.1007/s10384-005-0242-8; Miller JW, 2013, AM J OPHTHALMOL, V155, P1, DOI 10.1016/j.ajo.2012.10.018; PELI E, 1986, AM J OPTOM PHYS OPT, V63, P113; PELLI DG, 1988, CLIN VISION SCI, V2, P187; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Petre KL, 2000, OPTOMETRY VISION SCI, V77, P34, DOI 10.1097/00006324-200001000-00011; Rubin GS, 2009, NEURO-OPHTHALMOLOGY, V33, P120, DOI 10.1080/01658100902998732; Schoessow KA, 2012, J VISUAL IMPAIR BLIN, V106, P745, DOI 10.1177/0145482X1210601105; STEINMAN RM, 1965, J OPT SOC AM, V55, P1158, DOI 10.1364/JOSA.55.001158; Subramanian A, 2014, OPTOMETRY VISION SCI, V91, P1097, DOI 10.1097/OPX.0000000000000344; Tanaka E, 2001, AM AC OPHTH M NEW OR, P248; Tarita-Nistor L, 2015, OPTOMETRY VISION SCI, V92, P863, DOI 10.1097/OPX.0000000000000641; Tarita-Nistor L, 2011, INVEST OPHTH VIS SCI, V52, P1887, DOI 10.1167/iovs.10-6059; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Yu DY, 2010, J VISION, V10, DOI 10.1167/10.2.21; Yu DY, 2010, VISION RES, V50, P36, DOI 10.1016/j.visres.2009.10.005	42	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170743	10.1371/journal.pone.0170743	http://dx.doi.org/10.1371/journal.pone.0170743			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6QR	28114373	gold, Green Published, Green Submitted			2022-12-26	WOS:000396129000093
J	Huhns, M; Erbersdobler, A; Obliers, A; Ropenack, P				Huehns, Maja; Erbersdobler, Andreas; Obliers, Annette; Roepenack, Paula			Identification of HPV Types and Mycobacterium Tuberculosis Complex in Historical Long-Term Preserved Formalin Fixed Tissues in Different Human Organs	PLOS ONE			English	Article							PARAFFIN-EMBEDDED TISSUES; HUMAN-PAPILLOMAVIRUS; CERVICAL-CANCER; DNA EXTRACTION; NUCLEIC-ACIDS; ARTIFACTS; SKELETAL; DISEASE	University anatomical-pathological collections represent huge sources of human tissues and preparations from a variety of different diseases. With the help of modern genetic and histological methods, preserved fixed tissues from pathological collections can be used to re-evaluate former diagnoses. We analysed 25 specimens from our pathological collection with ages ranging from 78 to 112 years. The tissues originated from the oral cavity, lip, tongue, lung, bone, kidney, spleen, thymus, larynx, lymph node, penis and uterine cervix with an original diagnosis of epithelial cancers or tuberculosis. Amplifiable DNA was extracted and in epithelial cancers, potential HPV infection was investigated. Specimens with an original diagnosis of tuberculosis were examined for mycobacterial infection. The tissues were also examined using modern histological methods. Our data showed that in 24/25 specimens the histological structure was preserved and in 10/11 specimens the diagnosis of squamous cell carcinoma could be confirmed. Additionally, HPV type 16 was detected in 8 specimens. The histological pattern of tuberculosis was found in 11/14 specimens and the Mycobacterium tuberculosis complex was ascertained in four specimens. Our study showed that pathogens such as HPV or Mycobacterium tuberculosis can be detected in historical pathological preparations, and that these collections are suitable for further epidemiological research.	[Huehns, Maja; Erbersdobler, Andreas; Obliers, Annette; Roepenack, Paula] Univ Med Rostock, Inst Pathol, Rostock, Germany	University of Rostock	Huhns, M (corresponding author), Univ Med Rostock, Inst Pathol, Rostock, Germany.	maja.huehns@med.uni-rostock.de		Rocktaschel, Paula/0000-0001-6069-476X				[Anonymous], 2014, Wkly Epidemiol Rec, V89, P465; Arend SM, 2009, CURR OPIN PULM MED, V15, P201, DOI 10.1097/MCP.0b013e3283292679; Baker O, 2015, TUBERCULOSIS, V95, pS4, DOI 10.1016/j.tube.2015.02.001; Barnes I, 2006, P ROY SOC B-BIOL SCI, V273, P645, DOI 10.1098/rspb.2005.3339; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Bouwman AS, 2012, P NATL ACAD SCI USA, V109, P18511, DOI 10.1073/pnas.1209444109; Buchwald G., 2004, DECLINE TUBERCULOSIS; Chaturvedi AK, 2008, J CLIN ONCOL, V26, P612, DOI 10.1200/JCO.2007.14.1713; Coombs N., 1999, NUCL ACIDS RES, V27; Crubezy E, 1998, CR ACAD SCI III-VIE, V321, P941, DOI 10.1016/S0764-4469(99)80009-2; Damaraju D, 2013, INT J TUBERC LUNG D, V17, P676, DOI 10.5588/ijtld.12.0684; Do HD, 2012, ONCOTARGET, V3, P546; Donoghue HD, 1998, LETT APPL MICROBIOL, V27, P265; Donoghue HD, 2010, P R SOC B, V277, P51, DOI 10.1098/rspb.2009.1484; Duval K, 2010, FORENSIC SCI INT-GEN, V4, P80, DOI 10.1016/j.fsigen.2009.06.003; Fornaciari G, 2003, LANCET, V362, P1160, DOI 10.1016/S0140-6736(03)14487-X; Gebhard Paul H., 1979, KINSEY DATA MARGINAL; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000537; Gilbert MTP, 2003, AM J HUM GENET, V72, P32, DOI 10.1086/345378; Haas CJ, 2000, AM J PHYS ANTHROPOL, V113, P293, DOI 10.1002/1096-8644(200011)113:3<293::AID-AJPA2>3.0.CO;2-6; Hardin NJ, 2000, CURR DIAGN PATHOL, DOI [10.1054/cdip.2000.0021., DOI 10.1054/CDIP.2000.0021]; HAUSEN HZ, 1989, CANCER RES, V49, P4677; Herbenick D, 2010, J SEX MED, V7, P255, DOI 10.1111/j.1743-6109.2010.02012.x; Hershkovitz I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003426; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Huhns M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135297; Hunermund G, 2006, Pneumologie, V60, P772, DOI 10.1055/s-2006-944284; Johnson MM, 2014, J THORAC DIS, V6, P210, DOI 10.3978/j.issn.2072-1439.2013.12.24; Kappel TJ, 1996, HUM PATHOL, V27, P1361, DOI 10.1016/S0046-8177(96)90351-2; Kay GL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7717; Klaus HD, 2010, J ARCHAEOL SCI, V37, P2587, DOI 10.1016/j.jas.2010.05.019; Lee SH, 2014, CANCERS, V6, P2072, DOI 10.3390/cancers6042072; MANOS MM, 1989, CANCER CEL, V7, P209; Mays S, 2001, AM J PHYS ANTHROPOL, V114, P298, DOI 10.1002/ajpa.1042; Mehanna H, 2013, HEAD NECK-J SCI SPEC, V35, P747, DOI 10.1002/hed.22015; Moser I, 2014, TUBERKULOSE RINDES U, V42, P242; Nasman A, 2009, INT J CANCER, V125, P362, DOI 10.1002/ijc.24339; Okello JBA, 2010, ANAL BIOCHEM, V400, P110, DOI 10.1016/j.ab.2010.01.014; Paireder S, 2013, ANAL BIOCHEM, V439, P152, DOI 10.1016/j.ab.2013.04.006; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Proctor RN, 2012, TOB CONTROL, V21, P87, DOI 10.1136/tobaccocontrol-2011-050338; SALO WL, 1994, P NATL ACAD SCI USA, V91, P2091, DOI 10.1073/pnas.91.6.2091; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santos MCLG, 2008, PATHOL RES PRACT, V204, P633, DOI 10.1016/j.prp.2008.04.005; Schulze A, 2006, ADDICTION, V101, P1051, DOI 10.1111/j.1360-0443.2006.01458.x; Shi SR, 2004, HISTOCHEM CELL BIOL, V122, P211, DOI 10.1007/s00418-004-0693-x; Spositto FLE, 2014, BRAZ J MICROBIOL, V45, P841, DOI 10.1590/S1517-83822014000300012; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Taylor GM, 1996, J ARCHAEOL SCI, V23, P789; Tsangaras K, 2012, ANN ANAT, V194, P58, DOI 10.1016/j.aanat.2011.04.003; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Young DB, 1998, NATURE, V393, P515, DOI 10.1038/31095; Zink A, 2001, J MED MICROBIOL, V50, P355, DOI 10.1099/0022-1317-50-4-355	53	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e17035	10.1371/journal.pone.0170353	http://dx.doi.org/10.1371/journal.pone.0170353			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6QR	28114406	Green Submitted, Green Published, gold			2022-12-26	WOS:000396129000040
J	Faggion, CM; Apaza, K; Ariza-Fritas, T; Malaga, L; Giannakopoulos, NN; Alarcon, MA				Faggion, Clovis Mariano, Jr.; Apaza, Karol; Ariza-Fritas, Tania; Malaga, Lilian; Giannakopoulos, Nikolaos Nikitas; Antonio Alarcon, Marco			Methodological Quality of Consensus Guidelines in Implant Dentistry	PLOS ONE			English	Article							AGREE II; APPRAISAL	Background Consensus guidelines are useful to improve clinical decision making. Therefore, the methodological evaluation of these guidelines is of paramount importance. Low quality information may guide to inadequate or harmful clinical decisions. Objective To evaluate the methodological quality of consensus guidelines published in implant dentistry using a validated methodological instrument. Methods The six implant dentistry journals with impact factors were scrutinised for consensus guidelines related to implant dentistry. Two assessors independently selected consensus guidelines, and four assessors independently evaluated their methodological quality using the Appraisal of Guidelines for Research & Evaluation (AGREE) II instrument. Disagreements in the selection and evaluation of guidelines were resolved by consensus. First, the consensus guidelines were analysed alone. Then, systematic reviews conducted to support the guidelines were included in the analysis. Non-parametric statistics for dependent variables (Wilcoxon signed rank test) was used to compare both groups. Results Of 258 initially retrieved articles, 27 consensus guidelines were selected. Median scores in four domains (applicability, rigour of development, stakeholder involvement, and editorial independence), expressed as percentages of maximum possible domain scores, were below 50% (median, 26%, 30.70%, 41.70%, and 41.70%, respectively). The consensus guidelines and consensus guidelines + systematic reviews data sets could be compared for 19 guidelines, and the results showed significant improvements in all domain scores (p < 0.05). Conclusions Methodological improvement of consensus guidelines published in major implant dentistry journals is needed. The findings of the present study may help researchers to better develop consensus guidelines in implant dentistry, which will improve the quality and trust of information needed to make proper clinical decisions.	[Faggion, Clovis Mariano, Jr.] Univ Munster, Fac Dent, Dept Periodontol & Operat Dent, Munster, Germany; [Apaza, Karol] Cayetano Heredia Peruvian Univ, Acad Dept Clin Stomatol, Sect Integral Oral Implantol, Lima, Peru; [Ariza-Fritas, Tania; Malaga, Lilian; Antonio Alarcon, Marco] Cayetano Heredia Peruvian Univ, Acad Dept Clin Stomatol, Sect Periodontol & Implants, Lima, Peru; [Giannakopoulos, Nikolaos Nikitas] Univ Wurzburg, Fac Med, Dept Prosthodont, Wurzburg, Germany	University of Munster; Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; University of Wurzburg	Faggion, CM (corresponding author), Univ Munster, Fac Dent, Dept Periodontol & Operat Dent, Munster, Germany.	clovisfaggion@yahoo.com	Giannakopoulos, Nikolaos/Q-7658-2017; Faggion, Clóvis Mariano/V-1987-2019; Apaza Alccayhuaman, Karol Ali/AAD-3583-2022	Apaza Alccayhuaman, Karol Ali/0000-0003-4565-5222; Giannakopoulos, Nikolaos Nikitas/0000-0002-2887-8857; Malaga Figueroa, Lilian Teresa/0000-0002-6873-9018				Barriocanal AM, 2016, J VASC SURG, V63, P1091, DOI 10.1016/j.jvs.2015.12.040; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE472, DOI 10.1503/cmaj.091716; Brouwers MC, 2010, CAN MED ASSOC J, V182, P1045, DOI 10.1503/cmaj.091714; Deng W, 2016, J EVID BASED MED; Faggion Clovis Mariano Jr, 2008, J Evid Based Dent Pract, V8, P1, DOI 10.1016/j.jebdp.2007.10.001; Glenny AM, 2009, EUR J ORAL IMPLANTOL, V2, P135; Guo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106762; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P1049, DOI 10.1136/bmj.39493.646875.AE; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Horner K, 2015, DENTOMAXILLOFAC RAD, V44, DOI 10.1259/dmfr.20140225; JACOBS C, 2014, PLOS ONE, V0009; Lopez-Olivo MA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1625, DOI 10.1002/art.24207; Nagler EV, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0231-1; Nuzzo R, 2014, NATURE, V506, P150, DOI 10.1038/506150a; Parnell C, 2009, EUR ARCH PAEDIATR DE, V10, P141, DOI 10.1007/BF03262675; San Martin-Galindo I, 2015, INT J DENT HYG; Shah P, 2011, PEDIATR DENT, V33, P120; Shawyer AC, 2015, PEDIATR SURG INT, V31, P61, DOI 10.1007/s00383-014-3623-6; Van Diermen DE, 2009, ORAL SURG ORAL MED O, V107, P616, DOI 10.1016/j.tripleo.2009.01.038; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013	22	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170262	10.1371/journal.pone.0170262	http://dx.doi.org/10.1371/journal.pone.0170262			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107405	Green Published, gold, Green Submitted			2022-12-26	WOS:000392405300095
J	Nunome, M; Nakano, M; Tadano, R; Kawahara-Miki, R; Kono, T; Takahashi, S; Kawashima, T; Fujiwara, A; Nirasawa, K; Mizutani, M; Matsuda, Y				Nunome, Mitsuo; Nakano, Mikiharu; Tadano, Ryo; Kawahara-Miki, Ryoka; Kono, Tomohiro; Takahashi, Shinji; Kawashima, Takaharu; Fujiwara, Akira; Nirasawa, Keijiro; Mizutani, Makoto; Matsuda, Yoichi			Genetic Divergence in Domestic Japanese Quail Inferred from Mitochondrial DNA D-Loop and Microsatellite Markers	PLOS ONE			English	Article							COTURNIX-JAPONICA; CHICKEN BREEDS; SOFTWARE; SAMPLES; MUTANT	To assess the genetic diversity of domestic Japanese quail (Coturnix japonica) populations, and their genetic relationships, we examined mitochondrial DNA (mtDNA) D-loop sequences and microsatellite markers for 19 Japanese quail populations. The populations included nine laboratory lines established in Japan (LWC, Quv, RWN, WE, AWE, AMRP, rb-TKP, NIES-L, and W), six meat-type quail lines reimported from Western countries (JD, JW, Estonia, NIES-Br, NIES-Fr, and NIES-Hn), one commercial population in Japan, and three wild quail populations collected from three Asian areas. The phylogenetic tree of mtDNA D-loop sequences revealed two distinct haplotype groups, Dloop-Group1 and Dloop-Group2. Dloop-Group1 included a dominant haplotype representing most of the quail populations, including wild quail. Dloop-Group2 was composed of minor haplotypes found in several laboratory lines, two meat-type lines, and a few individuals in commercial and wild quail populations. Taking the breeding histories of domestic populations into consideration, these results suggest that domestic quail populations may have derived from two sources, i.e., domestic populations established before and after World War II in Japan. A discriminant analysis of principal components and a Bayesian clustering analysis with microsatellite markers indicated that the domestic populations are clustered into four genetic groups. The two major groups were Microsat-Group1, which contained WE, and four WE-derived laboratory lines (LWC, Quv, RWN, and AWE), and Microsat-Group2 consisting of NIES-L, JD, JW, Estonia, NIES-Br, NIES-Fr, NIES-Hn, W, and commercial and wild populations. The remaining two lines (AMRP and rb-TKP) were each clustered into a separate clade. This hierarchical genetic difference between domestic quail populations is attributed to the genetic background derived from two different genetic sources D the pre-war and post-war populations D which is well supported by their breeding histories.	[Nunome, Mitsuo; Nakano, Mikiharu; Mizutani, Makoto; Matsuda, Yoichi] Nagoya Univ, Grad Sch Bioagr Sci, Avian Biosci Res Ctr, Nagoya, Aichi, Japan; [Tadano, Ryo] Gifu Univ, Fac Appl Biol Sci, Gifu, Japan; [Kawahara-Miki, Ryoka] Tokyo Univ Agr, NODAI Res Inst, Genome Res Ctr, Tokyo, Japan; [Kono, Tomohiro] Tokyo Univ Agr, Dept Biosci, Tokyo, Japan; [Takahashi, Shinji] Natl Inst Environm Studies, Dept Gen Affairs, Tsukuba, Ibaraki, Japan; [Kawashima, Takaharu] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki 3058506, Japan; [Fujiwara, Akira] Nippon Inst Biol Sci, Lab Anim Res Stn, Hokuto, Japan; [Nirasawa, Keijiro] NARO Inst Livestock & Grassland Sci, Anim Breeding & Reprod Res Div, Tsukuba, Ibaraki, Japan; [Matsuda, Yoichi] Nagoya Univ, Grad Sch Bioagr Sci, Lab Anim Genet, Nagoya, Aichi, Japan	Nagoya University; Gifu University; Tokyo University of Agriculture; Tokyo University of Agriculture; National Institute for Environmental Studies - Japan; National Institute for Environmental Studies - Japan; National Agriculture & Food Research Organization - Japan; Nagoya University	Matsuda, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Avian Biosci Res Ctr, Nagoya, Aichi, Japan.; Matsuda, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Lab Anim Genet, Nagoya, Aichi, Japan.	yoimatsu@nuagr1.agr.nagoya-u.ac.jp	Nunome, Mitsuo/V-3077-2018; Miki, Ryoka/E-7857-2017	Nunome, Mitsuo/0000-0003-2742-720X; Miki, Ryoka/0000-0003-2072-8851	National BioResource Project (NBRP) Chicken/Quail; Ministry of Education, Culture, Sports, Science and Technology, Japan [23113004]	National BioResource Project (NBRP) Chicken/Quail; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was partially supported by the National BioResource Project (NBRP) Chicken/Quail and a Grant-in-Aid for Scientific Research on Innovative Areas (No. 23113004) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Akagi K, 1918, UZURA SHIYOHO NIJUNE; [Anonymous], 2014, TRACER V1 6; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barilani M, 2005, BIOL CONSERV, V126, P445, DOI 10.1016/j.biocon.2005.06.027; Boogert NJ, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1088; Crawford R. D., 1990, POULTRY BREEDING GEN, P1; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; EMBLEY TM, 1991, LETT APPL MICROBIOL, V13, P171, DOI 10.1111/j.1472-765X.1991.tb00600.x; Emrani H, 2011, AFR J BIOTECHNOL, V10, P4289; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Filatov DA, 2002, MOL ECOL NOTES, V2, P621, DOI 10.1046/j.1471-8286.2002.00313.x; Genchev A., 2012, Trakia Journal of Sciences, V10, P91; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hinshaw BR, 1969, COTURNIX COTURNIX JA; Huo JL, 2014, GENET MOL RES, V13, P3371, DOI 10.4238/2014.April.29.16; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Kawahara T., 1978, TORI BULLETIN OF THE ORNITHOLOGICAL SOCIETY OF JAPAN, V27, P105; Kawahara-Miki R, 2013, GENOMICS, V101, P345, DOI 10.1016/j.ygeno.2013.03.006; KIMURA M, 1989, Japanese Poultry Science, V26, P245; Kinoshita K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086361; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Kovach JK, 1974, APPL ANIM ETHOL, V1, P77, DOI DOI 10.1016/0304-3762(74)90010-8; KUSUKAWA N, 1990, BIOTECHNIQUES, V9, P66; Mills AD, 1997, NEUROSCI BIOBEHAV R, V21, P261, DOI 10.1016/S0149-7634(96)00028-0; Minvielle F, 2004, WORLD POULTRY SCI J, V60, P500, DOI 10.1079/WPS200433; Miwa M, 2007, ANIM GENET, V38, P103, DOI 10.1111/j.1365-2052.2007.01568.x; Mizutani M., 1974, Experimental Animals, V23, P59; Mizutani M, 2003, RELATIONSHIP INDIGEN, P143; Murakami H, 1980, EXP ANIM TOKYO, V29, P475; NUNOYA T, 1983, LAB ANIM, V17, P138, DOI 10.1258/002367783780959439; Okuliarova M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112817; PADGETT CA, 1959, SCIENCE, V129, P267, DOI 10.1126/science.129.3344.267; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Porras-Hurtado Liliana, 2013, Frontiers in Genetics, V4, P98, DOI 10.3389/fgene.2013.00098; Pritchard JK, 2000, GENETICS, V155, P945; Rajkumar U, 2008, ASIAN AUSTRAL J ANIM, V21, P1710, DOI 10.5713/ajas.2008.80299; Sanchez-Donoso I, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00015; Sano Akiko, 1995, Japanese Poultry Science, V32, P177; Sano Akiko, 1994, Japanese Poultry Science, V31, P276; Sartore S, 2016, BRIT POULTRY SCI, V57, P435, DOI 10.1080/00071668.2016.1187714; Sefc KM, 2003, AUK, V120, P982, DOI 10.1642/0004-8038(2003)120[0982:MAFMFS]2.0.CO;2; Shen Xiang-Jun, 2000, Animal Science Journal, V71, P123; Smith O, 2014, MOL ECOL RESOUR, V14, P1011, DOI 10.1111/1755-0998.12250; Somes JRG, 1988, INT REGISTRY POULTRY; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Tadano R, 2014, ANIM GENET, V45, P881, DOI 10.1111/age.12227; TAKAHASHI S, 1984, POULTRY SCI, V63, P595, DOI 10.3382/ps.0630595; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsudzuki M, 2008, J POULT SCI, V45, P159, DOI 10.2141/jpsa.45.159; Ueda S, 1982, OBUCHIZAWA 15 NEN AY; Vali N., 2008, International Journal of Poultry Science, V7, P925; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wakasugi N, 1984, EVOLUTION DOMESTICAT, P319; Woodard AE, 1973, JAPANESE QUAIL HUSBA; YAMASAKI H, 1991, ACTA NEUROPATHOL, V82, P427, DOI 10.1007/BF00293376; Yamashina Y., 1961, Journal of the Bombay Natural History Society, V58, P216	62	9	9	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0169978	10.1371/journal.pone.0169978	http://dx.doi.org/10.1371/journal.pone.0169978			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107483	gold, Green Submitted, Green Published			2022-12-26	WOS:000392405300058
J	Yang, J; Yin, YY; Svob, C; Long, J; He, XF; Zhang, YQ; Xu, Z; Li, L; Liu, J; Dong, J; Zhang, ZP; Wang, ZS; Yuan, YG				Yang, Jie; Yin, Yingying; Svob, Connie; Long, Jun; He, Xiaofu; Zhang, Yuqun; Xu, Zhi; Li, Lei; Liu, Jie; Dong, Jian; Zhang, Zuping; Wang, Zhishun; Yuan, Yonggui			Amygdala Atrophy and Its Functional Disconnection with the Cortico-Striatal-Pallidal-Thalamic Circuit in Major Depressive Disorder in Females	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; SEX-DIFFERENCES; GENDER-DIFFERENCES; COGNITIVE-CONTROL; CORTEX; BRAIN; CONNECTIVITY; HIPPOCAMPUS; ANXIETY; FMRI	Background Major depressive disorder (MDD) is approximately twice as common in females than males. Furthermore, female patients with MDD tend to manifest comorbid anxiety. Few studies have explored the potential anatomical and functional brain changes associated with MDD in females. Therefore, the purpose of the present study was to investigate the anatomical and functional changes underlying MDD in females, especially within the context of comorbid anxiety. Methods In this study, we recruited antidepressant-free females with MDD (N = 35) and healthy female controls (HC; N = 23). The severity of depression and anxiety were evaluated by the Hamilton Depression Rating Scale (HAM-D) and the Hamilton Anxiety Rating Scale (HAM-A), respectively. Structural and resting-state functional images were acquired on a Siemens 3.0 Tesla scanner. We compared the structural volumetric differences between patients and HC with voxel-based morphometry (VBM) analyses. Seed-based voxel-wise correlative analyses were used to identify abnormal functional connectivity. Regions with structural deficits showed a significant correlation between gray matter (GM) volume and clinical variables that were selected as seeds. Furthermore, voxel-wise functional connectivity analyses were applied to identify the abnormal connectivity relevant to seed in the MDD group. Results Decreased GM volume in patients was observed in the insula, putamen, amygdala, lingual gyrus, and cerebellum. The right amygdala was selected as a seed to perform connectivity analyses, since its GM volume exhibited a significant correlation with the clinical anxiety scores. We detected regions with disrupted connectivity relevant to seed primarily within the cortico-striatal-pallidal-thalamic circuit. Conclusions Amygdaloid atrophy, as well as decreased functional connectivity between the amygdala and the cortico-striatal-pallidal-thalamic circuit, appears to play a role in female MDD, especially in relation to comorbid anxiety.	[Yang, Jie; Long, Jun; Dong, Jian; Zhang, Zuping] Cent S Univ, Sch Informat Sci & Engn, Changsha, Hunan, Peoples R China; [Yin, Yingying; Zhang, Yuqun; Xu, Zhi; Li, Lei; Yuan, Yonggui] Southeast Univ, ZhongDa Hosp, Sch Med, Dept Psychosomat & Psychiat, Nanjing, Jiangsu, Peoples R China; [Yin, Yingying; Zhang, Yuqun; Xu, Zhi; Li, Lei; Yuan, Yonggui] Southeast Univ, Sch Med, Inst Psychosomat, Nanjing, Jiangsu, Peoples R China; [Svob, Connie; He, Xiaofu; Liu, Jie; Wang, Zhishun] Columbia Univ, Dept Psychiat, Coll Phys & Surg, New York, NY USA	Central South University; Southeast University - China; Southeast University - China; Columbia University	Zhang, ZP (corresponding author), Cent S Univ, Sch Informat Sci & Engn, Changsha, Hunan, Peoples R China.; Yuan, YG (corresponding author), Southeast Univ, ZhongDa Hosp, Sch Med, Dept Psychosomat & Psychiat, Nanjing, Jiangsu, Peoples R China.; Yuan, YG (corresponding author), Southeast Univ, Sch Med, Inst Psychosomat, Nanjing, Jiangsu, Peoples R China.; Wang, ZS (corresponding author), Columbia Univ, Dept Psychiat, Coll Phys & Surg, New York, NY USA.	zpzhang@csu.edu.cn; zw2105@cumc.columbia.edu; yygylh2000@sina.com	Yuan, Yonggui/AFA-0807-2022	Yuan, Yonggui/0000-0001-6496-3998; Yang, Jie/0000-0001-7561-9076	Natural Science Foundation of China [81371488, 61379109]; Fundamental Research Funds for the Central Universities [2242016K41053]; Research Fund for the Doctoral Program of Higher Education of China [20120162110077]; Scientific research innovation project of Hunan Province [71380100010]; China Scholarship Council [201406370107]; Brain & Behavior Research Foundation	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Scientific research innovation project of Hunan Province; China Scholarship Council(China Scholarship Council); Brain & Behavior Research Foundation(NARSAD)	81371488 Natural Science Foundation of China (http://www.nsfc.gov.cn/) YONGGUI YUAN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 2242016K41053 Fundamental Research Funds for the Central Universities (http://kcb.rcswu.cq.cn/) YONGGUI YUAN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 61379109 Natural Science Foundation of China (http://www.nsfc.gov.cn/) ZUPING ZHANG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 20120162110077 Research Fund for the Doctoral Program of Higher Education of China (http://www.cutech.edu.cn/cn/) ZUPING ZHANG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 71380100010 Scientific research innovation project of Hunan Province (http://www.hnst.gov.cn/) JIE YANG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 201406370107 China Scholarship Council (http://en.csc.edu.cn/) JIE YANG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation (https://bbrfoundation.org/yi) XIAOFU HE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Beevers CG, 2010, NEUROSCIENCE, V167, P97, DOI 10.1016/j.neuroscience.2010.01.047; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bora E, 2012, PSYCHOL MED, V42, P671, DOI 10.1017/S0033291711001668; Campbell S, 2004, J PSYCHIATR NEUROSCI, V29, P417; Cerliani L, 2012, HUM BRAIN MAPP, V33, P2005, DOI 10.1002/hbm.21338; Chantiluke K, 2012, EUR NEUROPSYCHOPHARM, V22, pS121, DOI 10.1016/S0924-977X(12)70136-0; Fales CL, 2008, BIOL PSYCHIAT, V63, P377, DOI 10.1016/j.biopsych.2007.06.012; Frodl T, 2002, BIOL PSYCHIAT, V51, P708, DOI 10.1016/S0006-3223(01)01359-2; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Harvey PO, 2005, NEUROIMAGE, V26, P860, DOI 10.1016/j.neuroimage.2005.02.048; Hastings RS, 2004, NEUROPSYCHOPHARMACOL, V29, P952, DOI 10.1038/sj.npp.1300371; Johnstone T, 2007, J NEUROSCI, V27, P8877, DOI 10.1523/JNEUROSCI.2063-07.2007; Keedwell PA, 2005, BIOL PSYCHIAT, V58, P843, DOI 10.1016/j.biopsych.2005.05.019; Kim AJ, 2008, PSYCHIAT RES-NEUROIM, V164, P114, DOI 10.1016/j.pscychresns.2007.12.020; KITA H, 1990, J COMP NEUROL, V298, P40, DOI 10.1002/cne.902980104; Kong LT, 2013, J PSYCHIATR RES, V47, P733, DOI 10.1016/j.jpsychires.2013.02.003; Kornstein SG, 2000, J AFFECT DISORDERS, V60, P1, DOI 10.1016/S0165-0327(99)00158-5; KRETTEK JE, 1978, J COMP NEUROL, V178, P255, DOI 10.1002/cne.901780205; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Liu CH, 2014, NEUROSCIENCE, V262, P190, DOI 10.1016/j.neuroscience.2013.12.058; Liu ZF, 2010, PSYCHIAT RES-NEUROIM, V182, P211, DOI 10.1016/j.pscychresns.2010.03.004; Lui S, 2011, AM J PSYCHIAT, V168, P642, DOI 10.1176/appi.ajp.2010.10101419; Marcus SM, 2005, J AFFECT DISORDERS, V87, P141, DOI 10.1016/j.jad.2004.09.008; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; McHugh SB, 2004, BEHAV NEUROSCI, V118, P63, DOI 10.1037/0735-7044.118.1.63; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Obeso I, 2013, FRONTIERS IN HUMAN N, V7; Ozalay O, 2016, PSYCHIAT RES-NEUROIM, V252, P1, DOI 10.1016/j.pscychresns.2016.04.004; Peng J, 2011, EUR J RADIOL, V80, P395, DOI 10.1016/j.ejrad.2010.04.006; Phelps EA, 1997, CURR BIOL, V7, pR311, DOI 10.1016/S0960-9822(06)00146-1; Price JL, 2005, J COMP NEUROL, V493, P132, DOI 10.1002/cne.20750; Ramasubbu R, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00017; Schnitzler A, 2000, J CLIN NEUROPHYSIOL, V17, P592, DOI 10.1097/00004691-200011000-00005; Sheline YI, 2001, BIOL PSYCHIAT, V50, P651, DOI 10.1016/S0006-3223(01)01263-X; Siegle GJ, 2007, BIOL PSYCHIAT, V61, P198, DOI 10.1016/j.biopsych.2006.05.048; Stein MB, 2007, AM J PSYCHIAT, V164, P318, DOI 10.1176/appi.ajp.164.2.318; Stieglitz RD, 2000, Z KLIN PSYCHOL-FORSC, V29, P63, DOI 10.1026//0084-5345.29.1.63; Sturm W, 2001, NEUROIMAGE, V14, pS76, DOI 10.1006/nimg.2001.0839; Surguladze S, 2005, BIOL PSYCHIAT, V57, P201, DOI 10.1016/j.biopsych.2004.10.028; Wang ZS, 2016, PSYCHIAT RES-NEUROIM, V249, P76, DOI 10.1016/j.pscychresns.2015.07.008; WEISSMAN MM, 1977, ARCH GEN PSYCHIAT, V34, P98; WEISSMAN MM, 1993, J AFFECT DISORDERS, V29, P77, DOI 10.1016/0165-0327(93)90025-F; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wu XP, 2016, J AFFECT DISORDERS, V200, P275, DOI 10.1016/j.jad.2016.04.046; Young KA, 2004, AM J PSYCHIAT, V161, P1270, DOI 10.1176/appi.ajp.161.7.1270; Zhang B, 2016, BRAIN IMAGING BEHAV, V10, P920, DOI 10.1007/s11682-015-9457-6; Zuo CS, 2015, NEUROIMAGE-CLIN, V9, P348, DOI 10.1016/j.nicl.2015.08.020	51	26	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0168239	10.1371/journal.pone.0168239	http://dx.doi.org/10.1371/journal.pone.0168239			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI3QC	28107446	Green Published, gold, Green Submitted			2022-12-26	WOS:000392405300010
J	Yi, H; Geng, L; Black, A; Talmon, G; Berim, L; Wang, J				Yi, H.; Geng, L.; Black, A.; Talmon, G.; Berim, L.; Wang, J.			The miR-487b-3p/GRM3/TGF beta signaling axis is an important regulator of colon cancer tumorigenesis	ONCOGENE			English	Article							GROWTH-FACTOR-BETA; METABOTROPIC GLUTAMATE RECEPTORS; CONFERS DRUG-RESISTANCE; COLORECTAL-CANCER; PHARMACOLOGICAL BLOCKADE; CARCINOMA; EXPRESSION; CELLS; METASTASIS; PROLIFERATION	Molecular targeting is an import strategy to treat advanced colon cancer. The current study demonstrates that expression of GRM3, a metabotropic glutamate receptor mainly expressed in mammalian central nervous system, is significantly upregulated in majority of human colonic adenocarcinomas tested and colon cancer cell lines. Knockdown of GRM3 expression or inhibition of GRM3 activation in colon cancer cells reduces cell survival and anchorage-independent growth in vitro and inhibits tumor growth in vivo. Mechanistically, GRM3 antagonizes TGF beta-mediated activation of protein kinase A and inhibition of Protein kinase B (AKT). In addition, TGF beta signaling increases GRM3 protein stability and knockdown of GRM3 enhances TGF beta-mediated tumor suppressor function. Further studies indicate that miR-487b-3p directly targets GRM3. Overexpression of miR-487b-3p mimics the effects of GRM3 knockdown and suppresses the tumorigenicity of colon cancer cells in vivo. Expression of miR-487b-3p is decreased in colon adenocarcinomas and inversely correlates with GRM3 expression. Taken together, these studies indicate that upregulation of GRM3 expression is a functionally important molecular event in colon cancer, and that GRM3 is a promising molecular target for colon cancer treatment. This is particularly interesting and important from a therapeutic standpoint because numerous metabotropic glutamate receptor antagonists are available, many of which have been found unsuitable for treatment of neuropsychiatric disorders for reasons such as inability to readily penetrate blood brain barriers. As GRM3 is upregulated in colon cancer, but rarely expressed in normal peripheral tissues, targeting GRM3 with such agents would not likely cause adverse neurological or peripheral side effects, making GRM3 an attractive and specific molecular target for colon cancer treatment.	[Yi, H.; Wang, J.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA; [Geng, L.; Black, A.; Wang, J.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Talmon, G.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA; [Berim, L.] Univ Nebraska Med Ctr, Dept Internal Med Oncol Hematol, Omaha, NE USA; [Wang, J.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Wang, J (corresponding author), Univ Nebraska Med Ctr, 985950 Nebraska Med Ctr, Omaha, NE 68198 USA.	jjwang@unmc.edu			Chinese Scholar Council;  [NIH/NCI R01CA140988-01]	Chinese Scholar Council; 	This work was supported by NIH/NCI R01CA140988-01 to JW. HY was partially supported by Chinese Scholar Council.	ARAMORI I, 1992, NEURON, V8, P757, DOI 10.1016/0896-6273(92)90096-V; Arcella A, 2005, NEURO-ONCOLOGY, V7, P236, DOI 10.1215/S1152851704000961; Bacman D, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-156; Banerjee A, 2011, BIOMED PHARMACOTHER, V65, P293, DOI 10.1016/j.biopha.2011.03.009; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; BOYD DD, 1988, CANCER RES, V48, P2469; Bu PC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7879; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Cha JHJ, 1998, P NATL ACAD SCI USA, V95, P6480, DOI 10.1073/pnas.95.11.6480; Chang HJ, 2005, CLIN CANCER RES, V11, P3288, DOI 10.1158/1078-0432.CCR-04-1912; Chowdhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019335; Chowdhury SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068818; Ciceroni C, 2008, NEUROPHARMACOLOGY, V55, P568, DOI 10.1016/j.neuropharm.2008.06.064; CURTIS DR, 1959, NATURE, V183, P611, DOI 10.1038/183611a0; D'Onofrio M, 2003, J NEUROCHEM, V84, P1288, DOI 10.1046/j.1471-4159.2003.01633.x; da Costa LT, 1999, ONCOGENE, V18, P5010, DOI 10.1038/sj.onc.1202872; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Forrester E, 2005, CANCER RES, V65, P2296, DOI 10.1158/0008-5472.CAN-04-3272; Geng L, 2014, ONCOGENE, V33, P5332, DOI 10.1038/onc.2013.478; Geng LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059918; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gulubova M, 2010, INT J COLORECTAL DIS, V25, P591, DOI 10.1007/s00384-010-0906-9; Hamamoto T, 2002, CANCER RES, V62, P5955; HAYASHI TAKASHI, 1952, JAPANESE JOUR PHYSIOL, V3, P46; Hoogduijn MJ, 2006, PIGM CELL RES, V19, P58, DOI 10.1111/j.1600-0749.2005.00284.x; Kim MS, 2008, ONCOGENE, V27, P2045, DOI 10.1038/sj.onc.1210842; Kingston AE, 1998, NEUROPHARMACOLOGY, V37, P1, DOI 10.1016/S0028-3908(97)00191-3; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Martino JJ, 2013, ONCOGENE, V32, P4366, DOI 10.1038/onc.2012.471; Minoshima T, 1999, J BIOCHEM-TOKYO, V126, P889, DOI 10.1093/oxfordjournals.jbchem.a022531; Munoz NM, 2006, CANCER RES, V66, P9837, DOI 10.1158/0008-5472.CAN-06-0890; Neto FL, 2000, MOL BRAIN RES, V81, P140; Neto FL, 2001, J NEUROSCI RES, V63, P356, DOI 10.1002/1097-4547(20010215)63:4<356::AID-JNR1030>3.0.CO;2-3; Prickett TD, 2011, NAT GENET, V43, P1119, DOI 10.1038/ng.950; Roig AI, 2010, GASTROENTEROLOGY, V138, P1012, DOI 10.1053/j.gastro.2009.11.052; Schoepp DD, 1999, NEUROPHARMACOLOGY, V38, P1431, DOI 10.1016/S0028-3908(99)00092-1; Simms NAK, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-221; Skerry TM, 2001, TRENDS PHARMACOL SCI, V22, P174, DOI 10.1016/S0165-6147(00)01642-4; Sodir NM, 2006, CANCER RES, V66, P8430, DOI 10.1158/0008-5472.CAN-06-1437; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; TANABE Y, 1992, NEURON, V8, P169, DOI 10.1016/0896-6273(92)90118-W; Tong QC, 2002, AM J PHYSIOL-ENDOC M, V282, pE1324, DOI 10.1152/ajpendo.00460.2001; Veenendaal LM, 2008, CELL ONCOL, V30, P1; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Wang J, 1996, J BIOL CHEM, V271, P17366, DOI 10.1074/jbc.271.29.17366; WANG J, 1995, J BIOL CHEM, V270, P22044, DOI 10.1074/jbc.270.37.22044; Wang J, 2008, CANCER RES, V68, P3152, DOI 10.1158/0008-5472.CAN-07-5348; Woodford-Richens KL, 2001, P NATL ACAD SCI USA, V98, P9719, DOI 10.1073/pnas.171321498; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Ye SC, 1999, CANCER RES, V59, P4725; Zeng QH, 2009, CANCER RES, V69, P678, DOI 10.1158/0008-5472.CAN-08-3980; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.200; Zhang Y, 2015, J BIOL CHEM, V290, P6215, DOI 10.1074/jbc.M114.620252; Zhou K, 2014, CELL BIOL INT, V38, P426, DOI 10.1002/cbin.10207	57	26	28	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 15	2017	36	24					3477	3489		10.1038/onc.2016.499	http://dx.doi.org/10.1038/onc.2016.499			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EX6GL	28114282	Green Accepted			2022-12-26	WOS:000403340700011
J	Niazy, N; Temme, S; Bocuk, D; Giesen, C; Konig, A; Temme, N; Ziegfeld, A; Gregers, TF; Bakke, O; Lang, T; Eis-Hubinger, AM; Koch, N				Niazy, Naima; Temme, Sebastian; Bocuk, Derya; Giesen, Carmen; Koenig, Angelika; Temme, Nadine; Ziegfeld, Angelique; Gregers, Tone F.; Bakke, Oddmund; Lang, Thorsten; Eis-Huebinger, Anna M.; Koch, Norbert			Misdirection of endosomal trafficking mediated by herpes simplex virus-encoded glycoprotein B	FASEB JOURNAL			English	Article						HSV-1; giant endosomal vesicles; HLA class II; antigen processing compartments; signal sequences	MHC CLASS-II; RAB5 EFFECTOR EEA1; CELL-CELL FUSION; 1 GB CYTODOMAIN; CYTOPLASMIC TAIL; MONOCLONAL-ANTIBODIES; ANTIGEN PRESENTATION; TYPE-1 GB; WILD-TYPE; HLA-DM	Herpes simplex virus (HSV)-encoded glycoprotein B (gB) is the most abundant protein in the viral envelope and promotes fusion of the virus with the cellular membrane. In the present study, we found that gB impacts on the major histocompatibility complex (MHC)-II pathway of antigen presentation by fostering homotypic fusion of early endosomes and trapping MHC-II molecules in these altered endosomes. By using an overexpression approach, we demonstrated that transient expression of gB induces giant vesicles of early endosomal origin, which contained Rab5, early endosomal antigen 1 (EEA1), and large amounts of MHC-II molecules [human leukocyte antigen (HLA)-DR, and HLA-DM], but no CD63. In HSV-1-infected and stably transfected cell lines that expressed lower amounts of gB, giant endosomes were not observed, but strongly increased amounts of HLA-DR and HLA-DM were found in EEA1(+) early endosomes. We used these giant vesicles as a model system and revealed that gB interacts with Rab5 and EEA1, and that gB-induced homotypic fusion of early endosomes to giant endosomes requires phosphatidylinositol 3-phosphate, the activity of soluble N-ethylmaleimide-sensitive factor attachment protein receptors, and the cytosolic gB sequence 889YTQVPN894 We conclude that gB expression alters trafficking of molecules of the HLA-II processing pathway, which leads to increased retention of MHC-II molecules in early endosomal compartments, thereby intercepting antigen presentation.-Niazy, N., Temme, S., Bocuk, D., Giesen, C., Konig, A., Temme, N., Ziegfeld, A., Gregers, T. F., Bakke, O., Lang, T., Eis-Hubinger, A. M., Koch, N. Misdirection of endosomal trafficking mediated by herpes simplex virus-encoded glycoprotein B.	[Niazy, Naima; Temme, Sebastian; Bocuk, Derya; Giesen, Carmen; Koenig, Angelika; Temme, Nadine; Ziegfeld, Angelique; Koch, Norbert] Univ Bonn, Med Ctr, Sect Immunobiol, Inst Genet, Bonn, Germany; [Lang, Thorsten] Univ Bonn, Med Ctr, Membrane Biochem, Life & Med Sci Inst, Bonn, Germany; [Eis-Huebinger, Anna M.] Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany; [Gregers, Tone F.] Univ Oslo, Dept Biosci, Oslo, Norway; [Temme, Sebastian] Univ Dusseldorf, Dept Mol Cardiol, Moorenstr 5, D-40225 Dusseldorf, Germany	University of Bonn; University of Bonn; University of Bonn; University of Oslo; Heinrich Heine University Dusseldorf	Temme, S (corresponding author), Univ Dusseldorf, Dept Mol Cardiol, Moorenstr 5, D-40225 Dusseldorf, Germany.	sebastian.Temme@uni-duesseldorf.de		Bakke, Oddmund/0000-0003-4843-7626	Deutsche Forschungsgemeinschaft [KO 810/8-1]; Research Council of Norway through its Centre of Excellence [179573/V40]; University of Bonn	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Research Council of Norway through its Centre of Excellence(Research Council of Norway); University of Bonn	This work was supported by the Deutsche Forschungsgemeinschaft (KO 810/8-1) and, in part, by the Research Council of Norway through its Centre of Excellence funding scheme (Project 179573/V40). The authors thank Dr. W. Witke (University of Bonn) for support, Dr. P. Gleeson (University of Melbourne, Melbourne, Australia) for helpful discussion, and Dr. G. Moldenhauer (German Cancer Research Center, Heidelberg, Germany) for providing cells and reagents. The authors declare no conflicts of interest.	Atanasiu D, 2013, MBIO, V4, DOI 10.1128/mBio.00046-13; Avitabile E, 2004, J VIROL, V78, P8015, DOI 10.1128/JVI.78.15.8015-8025.2004; BAGHIAN A, 1993, J VIROL, V67, P2396, DOI 10.1128/JVI.67.4.2396-2401.1993; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; Barcy S, 2001, J IMMUNOL, V166, P6242, DOI 10.4049/jimmunol.166.10.6242; Bergeland T, 2008, EMBO REP, V9, P171, DOI 10.1038/sj.embor.7401152; BZIK DJ, 1984, VIROLOGY, V133, P301, DOI 10.1016/0042-6822(84)90397-0; Calistri A, 2007, J VIROL, V81, P11468, DOI 10.1128/JVI.01364-07; Carpp LN, 2006, J CELL BIOL, V173, P927, DOI 10.1083/jcb.200512024; Chotard L, 2010, MOL BIOL CELL, V21, P2285, DOI 10.1091/mbc.E09-11-0947; Chowdary TK, 2010, J VIROL, V84, P4923, DOI 10.1128/JVI.00206-10; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Corey L, 2009, NEW ENGL J MED, V361, P1376, DOI 10.1056/NEJMra0807633; de Zarate IBO, 2004, J VIROL, V78, P1540, DOI 10.1128/JVI.78.3.1540-1551-2004; de Zarate IBO, 2007, J VIROL, V81, P13889, DOI 10.1128/JVI.01231-07; Duclos S, 2000, J CELL SCI, V113, P3531; Eathiraj S, 2005, NATURE, V436, P415, DOI 10.1038/nature03798; Edgar JR, 2014, TRAFFIC, V15, P197, DOI 10.1111/tra.12139; Egan KP, 2013, J NEUROVIROL, V19, P328, DOI 10.1007/s13365-013-0189-3; Eisenberg RJ, 2012, VIRUSES-BASEL, V4, P800, DOI 10.3390/v4050800; EISHUBINGER AM, 1993, J GEN VIROL, V74, P379, DOI 10.1099/0022-1317-74-3-379; Engering AJ, 1998, INT IMMUNOL, V10, P1713, DOI 10.1093/intimm/10.11.1713; Fan ZH, 2002, J VIROL, V76, P9271, DOI 10.1128/JVI.76.18.9271-9283.2002; Fatahzadeh M, 2007, J AM ACAD DERMATOL, V57, P737, DOI 10.1016/j.jaad.2007.06.027; Favoreel HW, 2002, J VIROL, V76, P6845, DOI 10.1128/JVI.76.13.6845-6851.2002; Ferrante A, 2013, IMMUNOLOGY, V138, P85, DOI 10.1111/imm.12030; Gallagher JR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004373; Garcia NJ, 2013, MBIO, V4, DOI 10.1128/mBio.00571-12; Gianni T, 2004, J VIROL, V78, P12268, DOI 10.1128/JVI.78.22.12268-12276.2004; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Heineman TC, 2004, VIROLOGY, V328, P131, DOI 10.1016/j.virol.2004.07.011; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Herget GW, 2005, PATHOL RES PRACT, V201, P123, DOI 10.1016/j.prp.2004.12.003; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Jiang Y, 2016, ADV MECH ENG, V8, DOI 10.1177/1687814016636796; Johnson DC, 2011, J VIROL, V85, P4910, DOI 10.1128/JVI.00011-11; Kennedy PGE, 2005, J NEUROL, V252, P268, DOI 10.1007/s00415-005-0770-7; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kummel D, 2014, CURR OPIN CELL BIOL, V29, P61, DOI 10.1016/j.ceb.2014.04.007; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Landsverk OJB, 2009, SCAND J IMMUNOL, V70, P184, DOI 10.1111/j.1365-3083.2009.02301.x; Landsverk OJB, 2011, IMMUNOL CELL BIOL, V89, P619, DOI 10.1038/icb.2010.143; LANIER LL, 1982, HYBRIDOMA, V1, P125, DOI 10.1089/hyb.1.1982.1.125; Liu XQ, 2015, VIROLOGY, V479, P568, DOI 10.1016/j.virol.2015.02.040; LOPEZ C, 1977, J IMMUNOL, V118, P895; Navaroli DM, 2012, P NATL ACAD SCI USA, V109, pE471, DOI 10.1073/pnas.1115495109; Neumann J, 2003, J IMMUNOL, V171, P3075, DOI 10.4049/jimmunol.171.6.3075; Nicola AV, 2004, J VIROL, V78, P7508, DOI 10.1128/JVI.78.14.7508-7517.2004; Nicola AV, 2003, J VIROL, V77, P5324, DOI 10.1128/JVI.77.9.5324-5332.2003; Nielsen E, 2000, J CELL BIOL, V151, P601, DOI 10.1083/jcb.151.3.601; Nordeng TW, 2002, MOL BIOL CELL, V13, P1846, DOI 10.1091/mbc.01-10-0478; PELLETT PE, 1985, J VIROL, V53, P243, DOI 10.1128/JVI.53.1.243-253.1985; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Progida C, 2010, J CELL SCI, V123, P1480, DOI 10.1242/jcs.051474; QUARANTA V, 1984, J IMMUNOL, V132, P1900; Rahajeng J, 2010, EXP CELL RES, V316, P859, DOI 10.1016/j.yexcr.2009.11.007; Rajasagi NK, 2009, J VIROL, V83, P5256, DOI 10.1128/JVI.01997-08; Ramachandra L, 2000, J IMMUNOL, V164, P5103, DOI 10.4049/jimmunol.164.10.5103; Ramanathan HN, 2012, CELL RES, V22, P346, DOI 10.1038/cr.2011.80; Rao P, 2011, J VIROL, V85, P8093, DOI 10.1128/JVI.02689-10; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rogalin HB, 2015, J VIROL, V89, P12262, DOI 10.1128/JVI.02391-15; Sanderson F, 1996, IMMUNITY, V4, P87, DOI 10.1016/S1074-7613(00)80301-5; Schnatwinkel C, 2004, PLOS BIOL, V2, P1363, DOI 10.1371/journal.pbio.0020261; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; SIEGAL FP, 1981, NEW ENGL J MED, V305, P1439, DOI 10.1056/NEJM198112103052403; Sievers E, 2002, IMMUNOLOGY, V107, P129, DOI 10.1046/j.1365-2567.2002.01472.x; Sievers E., 2002, THESIS; Silverman JL, 2012, J VIROL, V86, P8171, DOI 10.1128/JVI.00932-12; Simonsen A, 1999, J BIOL CHEM, V274, P28857, DOI 10.1074/jbc.274.41.28857; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Skjeldal FM, 2012, J CELL SCI, V125, P1910, DOI 10.1242/jcs.092569; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; STAM NJ, 1990, INT IMMUNOL, V2, P113, DOI 10.1093/intimm/2.2.113; Stang E, 1997, EXP CELL RES, V235, P79, DOI 10.1006/excr.1997.3617; Steiner I, 1996, IMMUNOL REV, V152, P157, DOI 10.1111/j.1600-065X.1996.tb00915.x; Stern LJ, 2006, CURR OPIN IMMUNOL, V18, P64, DOI 10.1016/j.coi.2005.11.005; Suazo PA, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/593757; Temme S, 2010, J IMMUNOL, V184, P236, DOI 10.4049/jimmunol.0902192; Tiwari A, 2011, J BIOL CHEM, V286, P36749, DOI 10.1074/jbc.M111.260828; Trgovcich J, 2002, J VIROL, V76, P6974, DOI 10.1128/JVI.76.14.6974-6986.2002; Wang TL, 2011, CELL SIGNAL, V23, P516, DOI 10.1016/j.cellsig.2010.09.012; WATANABE M, 1983, TRANSPLANTATION, V36, P712, DOI 10.1097/00007890-198336060-00025; Whitley RJ, 2006, ANTIVIR RES, V71, P141, DOI 10.1016/j.antiviral.2006.04.002; Whitley RJ, 2001, LANCET, V357, P1513, DOI 10.1016/S0140-6736(00)04638-9; Yuan WM, 2006, NAT IMMUNOL, V7, P835, DOI 10.1038/ni1364; Zeigerer A, 2012, NATURE, V485, P465, DOI 10.1038/nature11133; Zuo JM, 2012, VIRUSES-BASEL, V4, P1335, DOI 10.3390/v4081335	89	11	11	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1650	1667		10.1096/fj.201600521R	http://dx.doi.org/10.1096/fj.201600521R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28119397				2022-12-26	WOS:000398504300030
J	Chen, MY; Lo, YC; Chen, WC; Wang, KF; Chan, PC				Chen, Meng-Yu; Lo, Yi-Chun; Chen, Wan-Chin; Wang, Kwei-Feng; Chan, Pei-Chun			Recurrence after Successful Treatment of Multidrug-Resistant Tuberculosis in Taiwan	PLOS ONE			English	Article							TREATMENT OUTCOMES; RISK-FACTORS; TB PATIENTS; FOLLOW-UP; IMPACT; REINFECTION; REGIMEN; RELAPSE; COHORT	Recurrence after successful treatment for multidrug-resistant tuberculosis (MDR-TB) is challenging because of limited retreatment options. This study aimed to determine rates and predictors of MDR-TB recurrence after successful treatment in Taiwan. Recurrence rates were analyzed by time from treatment completion in 295 M DR-TB patients in a national cohort. Factors associated with MDR-TB recurrence were examined using a multivariate Cox regression analysis. Ten (3%) patients experienced MDR-TB recurrence during a median follow-up of 4.8 years. The overall recurrence rate was 0.6 cases per 1000 person-months. Cavitation on chest radiography was an independent predictor of recurrence (adjusted hazard ratio [aHR] = 6.3; 95% CI, 1.2-34). When the analysis was restricted to 215 patients (73%) tested for second-line drug susceptibility, cavitation (aHR = 10.2; 95% CI, 1.2-89) and resistance patterns of extensively drug-resistant TB (XDR-TB) or pre-XDR-TB (aHR = 7.3; 95% CI, 1.2-44) were associated with increased risk of MDR-TB recurrence. In Taiwan, MDR-TB patients with cavitary lesions and resistance patterns of XDR-TB or pre-XDR-TB are at the highest risk of recurrence. These have important implications for MDR-TB programs aiming to optimize post-treatment follow-up and early detection of recurrent MDR-TB.	[Chen, Meng-Yu; Lo, Yi-Chun; Chen, Wan-Chin] Ctr Dis Control, Off Prevent Med, Taipei, Taiwan; [Wang, Kwei-Feng; Chan, Pei-Chun] Ctr Dis Control, Div Chron Infect, Taipei, Taiwan; [Chan, Pei-Chun] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei, Taiwan; [Chan, Pei-Chun] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Pediat, Coll Med,Div Pediat Infect Dis, Taipei, Taiwan	Centers For Disease Control - Taiwan; Centers For Disease Control - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Chan, PC (corresponding author), Ctr Dis Control, Div Chron Infect, Taipei, Taiwan.; Chan, PC (corresponding author), Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei, Taiwan.; Chan, PC (corresponding author), Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Pediat, Coll Med,Div Pediat Infect Dis, Taipei, Taiwan.	pcanita.tw@cdc.gov.tw		Chen, Wan-Chin/0000-0002-2278-6193; CHEN, MENG-YU/0000-0001-7391-4581				Anderson LF, 2013, EURO SURVEILL, V18; Aung KJM, 2014, INT J TUBERC LUNG D, V18, P1180, DOI 10.5588/ijtld.14.0100; Becerra MC, 2010, CLIN INFECT DIS, V51, P709, DOI 10.1086/655892; Benator D, 2002, LANCET, V360, P528, DOI 10.1016/S0140-6736(02)09742-8; Blondal K, 2012, INT J TUBERC LUNG D, V16, P1228, DOI 10.5588/ijtld.12.0037; Brigden G, 2015, INFECT DRUG RESIST, V8, P367, DOI 10.2147/IDR.S68351; Burgos M, 2005, CLIN INFECT DIS, V40, P968, DOI 10.1086/428582; Caminero JA, 2013, EUR RESPIR J, V42, P5, DOI 10.1183/09031936.00206712; Chan PC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057719; Chiang CY, 2006, EUR RESPIR J, V28, P980, DOI 10.1183/09031936.06.00125705; Chiang CY, 2002, INT J TUBERC LUNG D, V6, P974; Corbett EL, 1999, AM J RESP CRIT CARE, V159, P94, DOI 10.1164/ajrccm.159.1.9803048; Falzon D, 2013, EUR RESPIR J, V42, P156, DOI 10.1183/09031936.00134712; Franke MF, 2013, CLIN INFECT DIS, V56, P770, DOI 10.1093/cid/cis1008; Gelmanova IY, 2015, INT J TUBERC LUNG D, V19, P399, DOI 10.5588/ijtld.14.0415; Golub JE, 2006, INT J TUBERC LUNG D, V10, P24; Guerra-Assuncao JA, 2015, J INFECT DIS, V211, P1154, DOI 10.1093/infdis/jiu574; Huang SH, 2012, TAIWAN EPIDEMIOL B, V28, P269; Jacobson KR, 2010, CLIN INFECT DIS, V51, P6, DOI 10.1086/653115; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Karagoz T, 2009, TUBERK TORAK, V57, P383; Kim DH, 2010, AM J RESP CRIT CARE, V182, P113, DOI 10.1164/rccm.200911-1656OC; Kuaban C, 2015, INT J TUBERC LUNG D, V19, P517, DOI 10.5588/ijtld.14.0535; Kwak N, 2015, INT J TUBERC LUNG D, V19, P525, DOI 10.5588/ijtld.14.0739; Lambert ML, 2003, LANCET INFECT DIS, V3, P282, DOI 10.1016/S1473-3099(03)00607-8; Lange C, 2014, EUR RESPIR J, V44, P23, DOI 10.1183/09031936.00188313; Lee J, 2011, INT J TUBERC LUNG D, V15, P1331, DOI [10.5588/ijtld.11.0098, DOI 10.5588/IJTLD.11.0098]; Leung ECC, 2011, EUR RESPIR J, V38, P227, DOI 10.1183/09031936.00186310; Panjabi R, 2007, INT J TUBERC LUNG D, V11, P828; Piubello A, 2014, INT J TUBERC LUNG D, V18, P1188, DOI 10.5588/ijtld.13.0075; Taiwan Centers for Disease Control, 2014, TAIW TUB CONTR REP 2; Taiwan Centers for Disease Control, 2013, TAIW GUID TB DIAGN T; World Health Organization, 2008, GUDI PROGR MAN DRUG; World Health Organization, 2006, GUID PROGR MAN DRUG; World Health Organization, 2004, TOM TUB CAS DET TREA; Wu MH, 2015, 46 UN WORLD C LUNG H, pS505; Yang CH, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-304; Yim JJ, 2015, INT J TUBERC LUNG D, V19, P371, DOI 10.5588/ijtld.15.0117; Yoshiyama T, 2014, T ROY SOC TROP MED H, V108, P589, DOI 10.1093/trstmh/tru080	39	25	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170980	10.1371/journal.pone.0170980	http://dx.doi.org/10.1371/journal.pone.0170980			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125692	gold, Green Submitted, Green Published			2022-12-26	WOS:000396176100011
J	Adnan, AI; Hanapi, ZM; Othman, M; Zukarnain, ZA				Adnan, Ali Idarous; Hanapi, Zurina Mohd; Othman, Mohamed; Zukarnain, Zuriati Ahmad			A Secure Region-Based Geographic Routing Protocol (SRBGR) for Wireless Sensor Networks	PLOS ONE			English	Article							SYBIL ATTACKS; COVERAGE; ISSUES	Due to the lack of dependency for routing initiation and an inadequate allocated sextant on responding messages, the secure geographic routing protocols for Wireless Sensor Networks (WSNs) have attracted considerable attention. However, the existing protocols are more likely to drop packets when legitimate nodes fail to respond to the routing initiation messages while attackers in the allocated sextant manage to respond. Furthermore, these protocols are designed with inefficient collection window and inadequate verification criteria which may lead to a high number of attacker selections. To prevent the failure to find an appropriate relay node and undesirable packet retransmission, this paper presents Secure Region-Based Geographic Routing Protocol (SRBGR) to increase the probability of selecting the appropriate relay node. By extending the allocated sextant and applying different message contention priorities more legitimate nodes can be admitted in the routing process. Moreover, the paper also proposed the bound collection window for a sufficient collection time and verification cost for both attacker identification and isolation. Extensive simulation experiments have been performed to evaluate the performance of the proposed protocol in comparison with other existing protocols. The results demonstrate that SRBGR increases network performance in terms of the packet delivery ratio and isolates attacks such as Sybil and Black hole.	[Adnan, Ali Idarous; Hanapi, Zurina Mohd; Othman, Mohamed; Zukarnain, Zuriati Ahmad] Univ Putra Malaysia, Dept Commun Technol & Networks, Fac Comp Sci & Informat Technol, Upm 43300, Selangor, Malaysia	Universiti Putra Malaysia	Adnan, AI; Hanapi, ZM (corresponding author), Univ Putra Malaysia, Dept Commun Technol & Networks, Fac Comp Sci & Informat Technol, Upm 43300, Selangor, Malaysia.	aliadnn@gmail.com; zurinahm@upm.edu.my	Hanapi, Zurina Mohd/AAF-5345-2020; Zukarnain, Zuriati Ahmad/B-4336-2016; Othman, Mohamed/N-6888-2015	Hanapi, Zurina Mohd/0000-0002-8079-1791; Zukarnain, Zuriati Ahmad/0000-0003-2408-6956; 	 [UPM-FRGS-08-02-13-1364FR]		This work was supported by research grant UPM-FRGS-08-02-13-1364FR.	Ahmadi A, 2014, J SUPERCOMPUT, V68, P599, DOI 10.1007/s11227-013-1054-0; Akyildiz IF, 2002, COMPUT NETW, V38, P393, DOI 10.1016/S1389-1286(01)00302-4; Alcaraz C, 2010, IEEE T SYST MAN CY C, V40, P419, DOI 10.1109/TSMCC.2010.2045373; Anita X, 2013, INT J DISTRIB SENS N, DOI 10.1155/2013/952905; Bear GS, 2016, IEEE ACCESS, V4, P3182, DOI 10.1109/ACCESS.2016.2576475; Cardei M, 2006, COMPUT COMMUN, V29, P413, DOI 10.1016/j.comcom.2004.12.025; Chen D, 2005, IEEE WCNC, P1818; Chen XQ, 2009, IEEE COMMUN SURV TUT, V11, P52, DOI 10.1109/SURV.2009.090205; Deng HM, 2002, IEEE COMMUN MAG, V40, P70, DOI 10.1109/MCOM.2002.1039859; Hanapi ZM, 2009, INT C WIR COMM SENS; Hanapi ZM, 2014, IET INFORM SECUR, V8, P80, DOI 10.1049/iet-ifs.2012.0202; Hu Y.-C., 2003, P 2 ACM WORKSH WIR S, P30, DOI DOI 10.1145/941311.941317; Karlof C., 2004, P 2 INT C EMB NETW S, V3, P162; Krawczyk H., 1997, 2104 IETF RFC; Kumar P, 2012, SENSORS-BASEL, V12, P55, DOI 10.3390/s120100055; Lee J, 2015, SENSORS-BASEL, V15, P13222, DOI 10.3390/s150613222; Li J, 2000, P 6 ANN INT C MOB CO, P120, DOI DOI 10.1145/345910.345931; Lv SH, 2008, 2008 INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE AND SECURITY, VOLS 1 AND 2, PROCEEDINGS, P442, DOI 10.1109/CIS.2008.69; Lyu C, 2015, COMPUT COMMUN, V59, P37, DOI 10.1016/j.comcom.2015.01.003; Maarouf I, 2009, IET COMMUN, V3, P846, DOI 10.1049/iet-com.2008.0324; Marin-Perez R., 2011, 2011 IEEE 8th International Conference on Mobile Ad-Hoc and Sensor Systems, P610, DOI 10.1109/MASS.2011.144; Mehmood A, 2015, ADHOC SENSOR WIRELE, V28; Mostafaei H, 2015, WIRELESS PERS COMMUN, V82, P723, DOI 10.1007/s11277-014-2249-2; Naranjo PGV, 2017, J SUPERCOMPUT, V73, P733, DOI 10.1007/s11227-016-1785-9; Ng HS, 2006, BT TECHNOL J, V24, P138, DOI 10.1007/s10550-006-0051-8; Perrig A, 2004, COMMUN ACM, V47, P53, DOI 10.1145/990680.990707; Perrig A, 2002, WIREL NETW, V8, P521, DOI 10.1023/A:1016598314198; Perrig A, 2000, TESLA MULTICAST SOUR, P1; Son S, 2003, IGF STATE FREE ROBUS; Song JH, 2007, AD HOC NETW, V5, P76, DOI 10.1016/j.adhoc.2006.05.010; Sookhak M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115324; Ssu KF, 2009, COMPUT NETW, V53, P3042, DOI 10.1016/j.comnet.2009.07.013; Tanachaiwiwat S, 2004, IEEE IPCCC, P463; Tang D, 2015, IEEE T PARALL DISTR, V26, P960, DOI 10.1109/TPDS.2014.2318296; Umar MM, 2016, SECUR COMMUN NETW, V9, P3378, DOI 10.1002/sec.1544; Wood AD, 2006, P 4 ACM WORKSH SEC A, P35; Wu B, 2007, SIGNALS COMMUN TECHN, P103, DOI 10.1007/978-0-387-33112-6_5; Yang J, 2009, IEEE INFOCOM SER, P666, DOI 10.1109/INFCOM.2009.5061974; Zahariadis T, 2009, WSEAS INT C APPL INF; Zhang GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077488	40	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0170273	10.1371/journal.pone.0170273	http://dx.doi.org/10.1371/journal.pone.0170273			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28121992	Green Submitted, gold, Green Published			2022-12-26	WOS:000396167300048
J	Ahmed, AS; Li, J; Abdul, AMD; Ahmed, M; Ostenson, CG; Salo, PT; Hewitt, C; Hart, DA; Ackermann, PW				Ahmed, Aisha S.; Li, Jian; Abdul, Alim M. D.; Ahmed, Mahmood; Ostenson, Claes-Goran; Salo, Paul T.; Hewitt, Carolyn; Hart, David A.; Ackermann, Paul W.			Compromised Neurotrophic and Angiogenic Regenerative Capability during Tendon Healing in a Rat Model of Type-II Diabetes	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; ISCHEMIC BRAIN-INJURY; SUBSTANCE-P; ACHILLES-TENDON; CONNECTIVE TISSUES; EXPRESSION; REPAIR; CELLS; INFLAMMATION; TENOMODULIN	Metabolic diseases such as diabetes mellitus type-II (DM-II) may increase the risk of suffering painful connective tissue disorders and tendon ruptures. The pathomechanisms, however, by which diabetes adversely affects connective tissue matrix metabolism and regeneration, still need better definition. Our aim was to study the effect of DM-II on expressional changes of neuro-and angiotrophic mediators and receptors in intact and healing Achilles tendon. The right Achilles tendon was transected in 5 male DM-II Goto-Kakizaki (GK) and 4 age-matched Wistar control rats. The left Achilles tendons were left intact. At week 2 post-injury, NGF, BDNF, TSP, and receptors TrkA, TrkB and Nk1 gene expression was studied by quantitative RT-PCR (qRT-PCR) and their protein distribution by immunohistochemistry in intact and injured tendons. The expression of tendon-related markers, Scleraxis (SCX) and Tenomodulin (TNMD), was evaluated by qRT-PCR in intact and injured tendons. Injured tendons of diabetic GK rats exhibited significantly down-regulated Ngf and Tsp1 mRNA and corresponding protein levels, and down-regulated Trka gene expression compared to injured Wistar controls. Intact tendons of DM-II GK rats displayed reduced mRNA levels for Ngf, Tsp1 and Trkb compared to corresponding intact non-diabetic tendons. Up-regulated Scx and Tnmd gene expression was observed in injured tendons of normal and diabetic GK rats compared to intact Wistar controls. However, these molecules were not up-regulated in injured DM-II GK rats compared to their corresponding controls. Our results suggest that DM-II has detrimental effects on neuro-and angiotrophic pathways, and such effects may reflect the compromised repair seen in diabetic Achilles tendon. Thus, novel approaches for regeneration of injured, including tendinopathic, and surgically repaired diabetic tendons may include therapeutic molecular modulation of neurotrophic pathways such as NGF and its receptors.	[Ahmed, Aisha S.] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Li, Jian; Abdul, Alim M. D.; Ostenson, Claes-Goran; Ackermann, Paul W.] Karolinska Inst, Dept Mol Med & Surg, Karolinska Univ Hosp, Stockholm, Sweden; [Ahmed, Mahmood] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Ctr Family & Community Med CeFAM, Huddinge, Sweden; [Salo, Paul T.; Hewitt, Carolyn; Hart, David A.] Univ Calgary, McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Calgary	Ackermann, PW (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Karolinska Univ Hosp, Stockholm, Sweden.	paul.ackermann@karolinska.se	Ahmed, Aisha S/J-4619-2012; W, Ackermann P/B-9714-2008	W, Ackermann P/0000-0002-5520-169X; Ahmed, Aisha/0000-0002-8483-5309; Alim, Dr. Md Abdul/0000-0002-6631-6249	Stockholm County Council (ALF) [SLL20100168]; Swedish National Centre for Sports Research, a COREF-Sweden grant; Alberta Innovates Health Solutions OA Team Grant; Swedish Research Council [2012-3510]	Stockholm County Council (ALF)(Stockholm County Council); Swedish National Centre for Sports Research, a COREF-Sweden grant; Alberta Innovates Health Solutions OA Team Grant; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by Stockholm County Council (ALF),project no. SLL20100168, PA; the Swedish National Centre for Sports Research, a COREF-Sweden grant, PA, PA; Alberta Innovates Health Solutions OA Team Grant, DAH and CH. The Swedish Research Council grant, project no. 2012-3510, PA.	Ackermann PW, 2013, INT J EXP PATHOL, V94, P271, DOI 10.1111/iep.12028; Ackermann PW, 2009, FRONT BIOSCI-LANDMRK, V14, P5165, DOI 10.2741/3593; Ackermann PW, 2002, J ORTHOP RES, V20, P849, DOI 10.1016/S0736-0266(01)00159-0; Ahmad T, 2004, REGUL PEPTIDES, V119, P61, DOI 10.1016/j.regpep.2003.12.008; Ahmed AS, 2014, CELL TISSUE RES, V357, P109, DOI 10.1007/s00441-014-1871-3; Ahmed AS, 2012, J APPL PHYSIOL, V113, P1784, DOI 10.1152/japplphysiol.00767.2012; Bagge J, 2009, HISTOL HISTOPATHOL, V24, P839, DOI 10.14670/HH-24.839; Bernardi S, 2012, EXP DIABETES RES, DOI 10.1155/2012/872504; Boivin Gregory P, 2014, Muscles Ligaments Tendons J, V4, P280; Bring D, 2010, SCAND J MED SCI SPOR, V20, P411, DOI 10.1111/j.1600-0838.2009.00954.x; Cagliero E, 2002, AM J MED, V112, P487, DOI 10.1016/S0002-9343(02)01045-8; Chaldakov GN, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00130; Chen A, 2013, BIOMED REP, V1, P167, DOI 10.3892/br.2012.48; Chiaretti A, 2008, NEUROL RES, V30, P223, DOI 10.1179/016164107X247948; Connizzo BK, 2014, ANN BIOMED ENG, V42, P1880, DOI 10.1007/s10439-014-1031-7; Dahm LM, 1996, P NATL ACAD SCI USA, V93, P1276, DOI 10.1073/pnas.93.3.1276; Dex S, 2016, GENE, V587, P1, DOI 10.1016/j.gene.2016.04.051; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; FARADJI V, 1990, ACTA NEUROL SCAND, V81, P402; Goto Y, 1988, Adv Exp Med Biol, V246, P29; Graiani G, 2004, DIABETOLOGIA, V47, P1047, DOI 10.1007/s00125-004-1414-7; Hart DA, 2010, BRIT J SPORT MED, V44, P867, DOI 10.1136/bjsm.2008.054296; Hong HS, 2009, NAT MED, V15, P425, DOI 10.1038/nm.1909; Hou Y, 2009, MATRIX BIOL, V28, P324, DOI 10.1016/j.matbio.2009.04.007; LEWIN GR, 1993, TRENDS NEUROSCI, V16, P353, DOI 10.1016/0166-2236(93)90092-Z; Liu LS, 2011, J PANCREAS, V12, P389; Mammoto T, 2008, J ORTHOP RES, V26, P957, DOI 10.1002/jor.20615; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Pradhan L, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000945; Reno C, 1997, BIOTECHNIQUES, V22, P1082, DOI 10.2144/97226bm16; Rosenbloom AL, 1996, ENDOCRIN METAB CLIN, V25, P473, DOI 10.1016/S0889-8529(05)70335-2; Scott A, 2011, J ORTHOP RES, V29, P289, DOI 10.1002/jor.21220; Seegers HC, 2003, J PHARMACOL EXP THER, V306, P8, DOI 10.1124/jpet.103.050013; Shukunami C, 2005, BIOCHEM BIOPH RES CO, V333, P299, DOI 10.1016/j.bbrc.2005.05.133; Skoff AM, 2006, EXP NEUROL, V197, P430, DOI 10.1016/j.expneurol.2005.10.006	35	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0170748	10.1371/journal.pone.0170748	http://dx.doi.org/10.1371/journal.pone.0170748			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122008	gold, Green Published, Green Submitted			2022-12-26	WOS:000396167300024
J	Bayan-Bravo, A; Perez-Tasigchana, RF; Sayon-Orea, C; Martinez-Gomez, D; Lopez-Garcia, E; Rodriguez-Artalejo, F; Guallar-Castillon, P				Bayan-Bravo, Ana; Perez-Tasigchana, Raul F.; Sayon-Orea, Carmen; Martinez-Gomez, David; Lopez-Garcia, Esther; Rodriguez-Artalejo, Fernando; Guallar-Castillon, Pilar			Combined Impact of Traditional and Non-Traditional Healthy Behaviors on Health-Related Quality of Life: A Prospective Study in Older Adults	PLOS ONE			English	Article							FOOD-FREQUENCY QUESTIONNAIRE; PHYSICAL-ACTIVITY; SLEEP DURATION; PROSPECTIVE COHORT; FUNCTIONAL STATUS; SPANISH VERSION; MENTAL-HEALTH; RATED HEALTH; RISK-FACTORS; SURVEY SF-36	Combined exposure to several healthy behaviors (HB) is associated with reduced mortality in older adults but its impact on health-related quality of life (HRQL) is uncertain. This is a cohort study of 2,388 individuals aged >= 60 recruited in 2000-2001, whose data were updated in 2003 and 2009. At baseline, participants reported both traditional HB (non-smoking, being very or moderately active, healthy diet) and non-traditional HB (sleeping 7-8 h/d, being seated <8 h/d, and seeing friends every day). HRQL was measured with the SF-36 questionnaire at baseline, in 2003 (short-term) and in 2009 (long-term); a higher score on the SF-36 represents better HRQL. Linear regression models were used to assess the association between HB at baseline and HRQL in 2003 and 2009, with adjustment for the main confounders including baseline HRQL. In the short-term, being physically active, sleeping 7-8 h/d, and being seated <8 h/d was associated with better HRQL. Compared to having <= 1 of these HB, the beta (95% confidence interval) for the score on the physical component summary of the SF-36 in 2003 was 1.42 (0.52-2.33) for 2 HB, and 2.06 (1.09-3.03) for 3 HB, p-trend <0.001. Corresponding figures for the mental component summary score were 1.89 (0.58-3.21) for 2 HB and 3.35 (1.95-4.76) for 3 HB, p-trend <0.001. Non-smoking, a healthy diet or seeing friends did not show an association with HRQL. In the long-term, being physically active was the only HB associated with better physical HRQL. As a conclusion, a greater number of HB, particularly more physical activity, adequate sleep duration, and sitting less, were associated with better short-term HRQL in older adults. However, in the long-term, being physically active was the only HB associated with better physical HRQL.	[Bayan-Bravo, Ana; Perez-Tasigchana, Raul F.; Lopez-Garcia, Esther; Rodriguez-Artalejo, Fernando; Guallar-Castillon, Pilar] Univ Autonoma Madrid, IdiPaz, CIBER Epidemiol & Publ Hlth CIBERESP, Dept Prevent Med & Publ Hlth,Sch Med, Madrid, Spain; [Bayan-Bravo, Ana] Hosp 12 Octubre, Nefrol Dept, Madrid, Spain; [Perez-Tasigchana, Raul F.] Univ San Francisco Quito, Sch Med, Quito, Ecuador; [Sayon-Orea, Carmen] Complejo Hosp Navarra, Pamplona, Spain; [Martinez-Gomez, David] Univ Autonoma Madrid, Dept Phys Educ Sports & Human Movement, Madrid, Spain	Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Universitario 12 de Octubre; Servicio Navarro de Salud - Osasunbidea; Autonomous University of Madrid	Guallar-Castillon, P (corresponding author), Univ Autonoma Madrid, IdiPaz, CIBER Epidemiol & Publ Hlth CIBERESP, Dept Prevent Med & Publ Hlth,Sch Med, Madrid, Spain.	mpilar.guallar@uam.es	Guallar-Castillon, Pilar/F-1533-2016; Lopez-Garcia, Esther/A-8894-2019; Sayon-Orea, Carmen/A-9828-2017; Bayan Bravo, Ana/R-2552-2016	Guallar-Castillon, Pilar/0000-0003-4759-6713; Sayon-Orea, Carmen/0000-0002-4137-3263; Bayan Bravo, Ana/0000-0002-4281-5844; Perez Tasigchana, Raul Francisco/0000-0001-5718-6879	FIS [09/1626, PI12/1166, PI13/0288]; Spanish Ministry of Economy and Competitiveness [DEP2013-47786-R]; Catedra UAM de Epidemiologia y Control del Riesgo Cardiovascular; National Government of Ecuador through the National Institution of Higher Education, Science, Technology and Innovation-SENESCYT	FIS(Instituto de Salud Carlos III); Spanish Ministry of Economy and Competitiveness(Spanish Government); Catedra UAM de Epidemiologia y Control del Riesgo Cardiovascular; National Government of Ecuador through the National Institution of Higher Education, Science, Technology and Innovation-SENESCYT	This work was funded by FIS grants 09/1626, PI12/1166 and PI13/0288 (State Secretary of R+D and FEDER/FSE) grants, by the Spanish Ministry of Economy and Competitiveness DEP2013-47786-R grant and by the Catedra UAM de Epidemiologia y Control del Riesgo Cardiovascular. RFP-T received a grant from the National Government of Ecuador through the National Institution of Higher Education, Science, Technology and Innovation-SENESCYT.	Agahi N, 2013, PREV MED, V57, P107, DOI 10.1016/j.ypmed.2013.04.016; ALONSO J, 1995, MED CLIN-BARCELONA, V104, P771; Alonso J, 1998, MED CLIN-BARCELONA, V111, P410; [Anonymous], 2015, WORD REP AG ADN HLTH; Balboa-Castillo T, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-47; Balboa-Castillo T, 2011, AM J PREV MED, V40, P39, DOI 10.1016/j.amepre.2010.10.005; Banegas JR, 2002, J HYPERTENS, V20, P2157, DOI 10.1097/00004872-200211000-00014; Buman MP, 2010, AM J EPIDEMIOL, V172, P1155, DOI 10.1093/aje/kwq249; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Conry MC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-692; Davies CA, 2012, PREV MED, V55, P46, DOI 10.1016/j.ypmed.2012.05.003; Duncan MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094184; Eng PM, 2002, AM J EPIDEMIOL, V155, P700, DOI 10.1093/aje/155.8.700; Mesas AE, 2010, J AM GERIATR SOC, V58, P1870, DOI 10.1111/j.1532-5415.2010.03071.x; Faubel R, 2009, SLEEP, V32, P1059; Fernandez-Ballarth JD, 2010, BRIT J NUTR, V103, P1808, DOI 10.1017/S0007114509993837; Ferrer M, 1998, AGE AGEING, V27, P755, DOI 10.1093/ageing/27.6.755; Forsen L, 2010, SPORTS MED, V40, P601, DOI 10.2165/11531350-000000000-00000; Galan I, 2006, PREV MED, V42, P343, DOI 10.1016/j.ypmed.2006.01.018; Garcia EL, 2005, QUAL LIFE RES, V14, P511, DOI 10.1007/s11136-004-5329-z; Gopinath B, 2014, J ACAD NUTR DIET, V114, P220, DOI 10.1016/j.jand.2013.09.001; Guallar-Castillon P, 2005, SOC SCI MED, V60, P1229, DOI 10.1016/j.socscimed.2004.07.003; Guallar-Castillon P, 2004, MED CLIN-BARCELONA, V123, P606, DOI 10.1157/13068435; Guallar-Castillon P, 2001, J EPIDEMIOL COMMUN H, V55, P648, DOI 10.1136/jech.55.9.648; Guedes DP, 2012, J AGING HEALTH, V24, P212, DOI 10.1177/0898264311410693; Gutierrez-Fisac JL, 2004, OBES RES, V12, P710, DOI 10.1038/oby.2004.83; Heesch KC, 2012, J EPIDEMIOL COMMUN H, V66, P670, DOI 10.1136/jech-2011-200850; Sanchez PH, 2012, EUR J CLIN NUTR, V66, P360, DOI 10.1038/ejcn.2011.146; Hickey A, 2005, PHARMACOECONOMICS, V23, P971, DOI 10.2165/00019053-200523100-00002; Holahan CK, 2013, NICOTINE TOB RES, V15, P662, DOI 10.1093/ntr/nts182; Hutchinson AF, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0260-2; Lachman ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013297; Leon-Munoz LM, 2005, INT J OBESITY, V29, P1385, DOI 10.1038/sj.ijo.0803049; Magee CA, 2011, SLEEP MED, V12, P346, DOI 10.1016/j.sleep.2010.09.013; Martinez-Gomez D, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-47; MARTINMORENO JM, 1993, INT J EPIDEMIOL, V22, P512, DOI 10.1093/ije/22.3.512; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Ostbye T, 2004, HEALTH SERV RES, V39, P531, DOI 10.1111/j.1475-6773.2004.00243.x; Ostbye T, 2002, PREV MED, V34, P334, DOI 10.1006/pmed.2001.0991; Otero-Rodriguez A, 2010, QUAL LIFE RES, V19, P15, DOI 10.1007/s11136-009-9561-4; Owen N, 2009, BRIT J SPORT MED, V43, P81, DOI 10.1136/bjsm.2008.055269; Plaisted CS, 1999, J AM DIET ASSOC, V99, pS84, DOI 10.1016/S0002-8223(99)00421-6; Pronk NP, 2004, AM J PREV MED, V27, P25, DOI 10.1016/j.amepre.2004.04.022; Sarna L, 2008, QUAL LIFE RES, V17, P1217, DOI 10.1007/s11136-008-9404-8; Shi Y, 2010, ANESTHESIOLOGY, V113, P977, DOI 10.1097/ALN.0b013e3181ebdaf9; Strandberg AY, 2008, ARCH INTERN MED, V168, P1968, DOI 10.1001/archinte.168.18.1968; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Virta JJ, 2013, SLEEP, V36, P1533, DOI 10.5665/sleep.3052; White AM, 2009, AM J PUBLIC HEALTH, V99, P1872, DOI 10.2105/AJPH.2008.146894; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Windle G, 2010, AGING MENT HEALTH, V14, P652, DOI 10.1080/13607861003713232; World Health Organization, 2003, POL REC SMOK CESS TE; World Health Organization, 2004, GLOB STRAT DIET PHYS; Yokoyama E, 2008, SLEEP MED, V9, P157, DOI 10.1016/j.sleep.2007.02.007	54	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0170513	10.1371/journal.pone.0170513	http://dx.doi.org/10.1371/journal.pone.0170513			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7FK	28122033	gold, Green Published, Green Submitted			2022-12-26	WOS:000396167300041
J	Gormley, E; Bhuachalla, DN; O'Keeffe, J; Murphy, D; Aldwell, FE; Fitzsimons, T; Stanley, P; Tratalos, JA; McGrath, G; Fogarty, N; Kenny, K; More, SJ; Messam, LLM; Corner, LAL				Gormley, Eamonn; Bhuachalla, Deirdre Ni; O'Keeffe, James; Murphy, Denise; Aldwell, Frank E.; Fitzsimons, Tara; Stanley, Paul; Tratalos, Jamie A.; McGrath, Guy; Fogarty, Naomi; Kenny, Kevin; More, Simon J.; Messam, Locksley L. McV.; Corner, Leigh A. L.			Oral Vaccination of Free-Living Badgers (Meles meles) with Bacille Calmette Guerin (BCG) Vaccine Confers Protection against Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS INFECTION; FORMULATION INDUCES RESISTANCE; REAL-TIME PCR; ENDOBRONCHIAL CHALLENGE; PULMONARY TUBERCULOSIS; CONTROL STRATEGIES; WILDLIFE; IMMUNITY; CATTLE; RESPONSES	A field trial was conducted to investigate the impact of oral vaccination of free-living badgers against natural-transmitted Mycobacterium bovis infection. For a period of three years badgers were captured over seven sweeps in three zones and assigned for oral vaccination with a lipid-encapsulated BCG vaccine (Liporale-BCG) or with placebo. Badgers enrolled in Zone A were administered placebo while all badgers enrolled in Zone C were vaccinated with BCG. Badgers enrolled in the middle area, Zone B, were randomly assigned 50: 50 for treatment with vaccine or placebo. Treatment in each zone remained blinded until the end of the study period. The outcome of interest was incident cases of tuberculosis measured as time to seroconversion events using the BrockTB Stat-Pak lateral flow serology test, supplemented with post-mortem examination. Among the vaccinated badgers that seroconverted, the median time to seroconversion (413 days) was significantly longer (p = 0.04) when compared with non-vaccinated animals (230 days). Survival analysis (modelling time to seroconversion) revealed that there was a significant difference in the rate of seroconversion between vaccinated and non-vaccinated badgers in Zones A and C throughout the trial period (p = 0.015). For badgers enrolled during sweeps 1-2 the Vaccine Efficacy (VE) determined from hazard rate ratios was 36% (95% CI: -62%-75%). For badgers enrolled in these zones during sweeps 3-6, the VE was 84% (95% CI: 29%-97%). This indicated that VE increased with the level of vaccine coverage. Post-mortem examination of badgers at the end of the trial also revealed a significant difference in the proportion of animals presenting with M. bovis culture confirmed lesions in vaccinated Zone C (9%) compared with non-vaccinated Zone A (26%). These results demonstrate that oral BCG vaccination confers protection to badgers and could be used to reduce incident rates in tuberculosis-infected populations of badgers.	[Gormley, Eamonn; Bhuachalla, Deirdre Ni; Murphy, Denise; Fitzsimons, Tara; Stanley, Paul; Messam, Locksley L. McV.; Corner, Leigh A. L.] UCD, Sch Vet Med, Dublin, Ireland; [O'Keeffe, James] Dept Agr Food & Marine, Wildlife Unit, Agr House, Dublin, Ireland; [Aldwell, Frank E.] Univ Otago, Ctr Innovat, Immune Solut Ltd, Dunedin, New Zealand; [Tratalos, Jamie A.; McGrath, Guy; More, Simon J.] UCD, CVERA, Sch Vet Med, Dublin, Ireland; [Fogarty, Naomi; Kenny, Kevin] Cent Vet Res Lab, Backweston, Kildare, Ireland	University College Dublin; University of Otago; University College Dublin	Gormley, E (corresponding author), UCD, Sch Vet Med, Dublin, Ireland.	egormley@ucd.ie		More, Simon/0000-0002-4270-0385; McGrath, Guy/0000-0002-8545-396X; Messam, Locksley L. McV./0000-0001-5791-555X	Department of Agriculture, Food and the Marine (DAFM), Ireland [UCD/2552/ R9762]; Immune Solutions Ltd	Department of Agriculture, Food and the Marine (DAFM), Ireland; Immune Solutions Ltd	EG: This badger vaccine study was funded by the Department of Agriculture, Food and the Marine (DAFM), Ireland, (Grant No: UCD/2552/ R9762), www.agriculture.gov.ie. DAFM had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JO'K was involved with project administration. Immune Solutions Ltd provided support in the form of salaries for authors (FEA) and commercially provided Liporale-BCG for the study, but did not have any additional role in the study design, data collection and analysis, decision to publish. FEA was involved in reviewing and editing manuscript.	Abdou M, 2016, PREV VET MED, V125, P19, DOI 10.1016/j.prevetmed.2015.12.012; Aldwell FE, 2003, VACCINE, V22, P70, DOI 10.1016/S0264-410X(03)00539-5; Aldwell FE, 2003, INFECT IMMUN, V71, P101, DOI 10.1128/IAI.71.1.101-108.2003; Ancelet LR, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045888, DOI 10.1371/J0URNAL.P0NE.0045888]; Aznar I, 2011, VET MICROBIOL, V151, P104, DOI 10.1016/j.vetmic.2011.02.032; Buddle BM, 2013, TRANSBOUND EMERG DIS, V60, P136, DOI 10.1111/tbed.12092; Buddle BM, 2005, VACCINE, V23, P3581, DOI 10.1016/j.vaccine.2005.01.150; Buzdugan SN, 2016, EPIDEMIOL INFECT, P1; Byrne AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050807; Carter SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049833; Chambers MA, 2008, J CLIN MICROBIOL, V46, P1498, DOI 10.1128/JCM.02117-07; Chambers MA, 2011, P ROY SOC B-BIOL SCI, V278, P1913, DOI 10.1098/rspb.2010.1953; Chambers MA, 2010, CLIN VACCINE IMMUNOL, V17, P408, DOI 10.1128/CVI.00424-09; Corner LAL, 2011, J COMP PATHOL, V144, P1, DOI 10.1016/j.jcpa.2010.10.003; Corner LAL, 2009, J WILDLIFE DIS, V45, P1042, DOI 10.7589/0090-3558-45.4.1042; Corner LAL, 2010, VACCINE, V28, P6265, DOI 10.1016/j.vaccine.2010.06.120; Corner LAL, 2008, TUBERCULOSIS, V88, P601, DOI 10.1016/j.tube.2008.03.002; Davison KE, 2007, VET ANAESTH ANALG, V34, P394, DOI 10.1111/j.1467-2995.2006.00339.x; Dohoo L, 2003, VET EPIDEMIOLOGIC RE; Garrido JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024905; Gavier-Widen D, 2001, VET REC, V148, P299, DOI 10.1136/vr.148.10.299; Gormley E, 2013, TRANSBOUND EMERG DIS, V60, P128, DOI 10.1111/tbed.12095; Gormley E, 2000, TUBERCLE LUNG DIS, V80, P229, DOI 10.1054/tuld.2000.0250; Gormley E, 2011, VET J, V189, P239, DOI 10.1016/j.tvjl.2011.03.007; Gortazar C, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-96; Greenwald R, 2003, DIAGN MICR INFEC DIS, V46, P197, DOI 10.1016/S0732-8893(03)00046-4; Halloran ME, 1999, EPIDEMIOL REV, V21, P73, DOI 10.1093/oxfordjournals.epirev.a017990; Halse TA, 2011, J CLIN MICROBIOL, V49, P2562, DOI 10.1128/JCM.00467-11; Hardstaff JL, 2013, EPIDEMIOL INFECT, V141, P1417, DOI 10.1017/S0950268813000642; Lesellier S, 2009, VACCINE, V27, P402, DOI 10.1016/j.vaccine.2008.10.068; Lesellier S, 2011, VACCINE, V29, P3782, DOI 10.1016/j.vaccine.2011.03.028; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Murphy D, 2014, VET J, V200, P362, DOI 10.1016/j.tvjl.2014.02.031; Nol P, 2008, J WILDLIFE DIS, V44, P247, DOI 10.7589/0090-3558-44.2.247; Smith GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039250; Tompkins DM, 2009, P ROY SOC B-BIOL SCI, V276, P2987, DOI 10.1098/rspb.2009.0414; Torvinen E, 2010, J MICROBIOL METH, V82, P78, DOI 10.1016/j.mimet.2010.04.007	37	50	50	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0168851	10.1371/journal.pone.0168851	http://dx.doi.org/10.1371/journal.pone.0168851			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28121981	Green Published, Green Submitted, gold			2022-12-26	WOS:000396167300080
J	Matsumoto, M; Ooga, T; Kibe, R; Aiba, Y; Koga, Y; Benno, Y				Matsumoto, Mitsuharu; Ooga, Takushi; Kibe, Ryoko; Aiba, Yuji; Koga, Yasuhiro; Benno, Yoshimi			Colonic Absorption of Low-Molecular-Weight Metabolites Influenced by the Intestinal Microbiome: A Pilot Study	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; GUT MICROBIOTA; IN-VIVO; MICROFLORA; SYSTEM	Low-molecular-weight metabolites produced by the intestinal microbiome play a direct role in health and disease. However, little is known about the ability of the colon to absorb these metabolites. It is also unclear whether these metabolites are bioavailable. Here, metabolomics techniques (capillary electrophoresis with time-of-flight mass spectrometry, CETOFMS), germ-free (GF) mice, and colonized (Ex-GF) mice were used to identify the colonic luminal metabolites transported to colonic tissue and/or blood. We focused on the differences in each metabolite between GF and Ex-GF mice to determine the identities of metabolites that are transported to the colon and/or blood. CE-TOFMS identified 170, 246, 166, and 193 metabolites in the colonic feces, colonic tissue, portal plasma, and cardiac plasma, respectively. We classified the metabolites according to the following influencing factors: (i) the membrane transport system of the colonocytes, (ii) metabolism during transcellular transport, and (iii) hepatic metabolism based on the similarity in the ratio of each metabolite between GF and Ex-GF mice and found 62 and 22 metabolites that appeared to be absorbed from the colonic lumen to colonocytes and blood, respectively. For example, 11 basic amino acids were transported to the systemic circulation from the colonic lumen. Furthermore, many low-molecular-weight metabolites influenced by the intestinal microbiome are bioavailable. The present study is the first to report the transportation of metabolites from the colonic lumen to colonocytes and somatic blood in vivo, and the present findings are critical for clarifying host-intestinal bacterial interactions.	[Matsumoto, Mitsuharu] Kyodo Milk Ind Co Ltd, Dairy Sci & Technol Inst, Tokyo, Japan; [Matsumoto, Mitsuharu; Kibe, Ryoko; Benno, Yoshimi] RIKEN, Innovat Ctr, Benno Lab, Wako, Saitama, Japan; [Ooga, Takushi] Human Metabolome Technol Inc, Tsuruoka, Yamagata, Japan; [Aiba, Yuji; Koga, Yasuhiro] Tokai Univ, Sch Med, Dept Infect Dis, Isehara, Kanagawa, Japan; [Kibe, Ryoko] Nippon Vet & Life Sci Univ, Dept Vet Pathobiol, Sch Vet Med, Musashino, Tokyo, Japan	RIKEN; Tokai University; Nippon Veterinary & Life Science University	Matsumoto, M (corresponding author), Kyodo Milk Ind Co Ltd, Dairy Sci & Technol Inst, Tokyo, Japan.; Matsumoto, M (corresponding author), RIKEN, Innovat Ctr, Benno Lab, Wako, Saitama, Japan.	m-matumoto@meito.co.jp	Matsumoto, Mitsuharu/AHB-4023-2022	Matsumoto, Mitsuharu/0000-0002-0378-3077	Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry by Bio-oriented Technology Research Advancement Institution (BRAIN), Japan; Kyodo Milk Industry Co. Ltd.; Human Metabolome Technologies, Inc.	Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry by Bio-oriented Technology Research Advancement Institution (BRAIN), Japan; Kyodo Milk Industry Co. Ltd.; Human Metabolome Technologies, Inc.	This work was in part supported by the Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry by the Bio-oriented Technology Research Advancement Institution (BRAIN), Japan, and by Kyodo Milk Industry Co. Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Kyodo Milk Industry Co. Ltd. and Human Metabolome Technologies, Inc. provided support in the form of salaries for authors MM and TO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Cabre E, 2005, AM J CLIN NUTR, V81, P692; Cresci GA, 2010, J GASTROINTEST SURG, V14, P449, DOI 10.1007/s11605-009-1045-x; CUMMINGS JH, 1975, GUT, V16, P323, DOI 10.1136/gut.16.4.323; Daniel H, 2004, ANNU REV PHYSIOL, V66, P361, DOI 10.1146/annurev.physiol.66.032102.144149; Fitch MD, 1999, AM J PHYSIOL-GASTR L, V277, pG31, DOI 10.1152/ajpgi.1999.277.1.G31; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Hague A, 1997, GASTROENTEROLOGY, V112, P1036, DOI 10.1053/gast.1997.v112.agast971036; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; HOFMANN AF, 1962, FED PROC, V21, P43; Jakobsdottir G, 2013, BRIT J NUTR, V110, P1565, DOI 10.1017/S0007114513000809; Jandacek RJ, 2009, AM J PHYSIOL-GASTR L, V296, pG226, DOI 10.1152/ajpgi.90517.2008; Jorgensen JR, 2001, GASTROENTEROLOGY, V120, P1152, DOI 10.1053/gast.2001.23259; Kibe R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04548; Kim Chang H, 2014, Immune Netw, V14, P277, DOI 10.4110/in.2014.14.6.277; Kirjavainen PV, 2002, GUT, V51, P51, DOI 10.1136/gut.51.1.51; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Matsumoto M, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00009; Matsumoto M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00233; Matsumoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023652; Monton MRN, 2007, J CHROMATOGR A, V1168, P237, DOI 10.1016/j.chroma.2007.02.065; Mortensen PB, 1996, SCAND J GASTROENTERO, V31, P132, DOI 10.3109/00365529609094568; Ooga T, 2011, MOL BIOSYST, V7, P1217, DOI 10.1039/c0mb00141d; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Said HM, 2006, CURR OPIN GASTROEN, V22, P140, DOI 10.1097/01.mog.0000203870.22706.52; Singh K, 2012, AM J PHYSIOL-GASTR L, V302, pG1061, DOI 10.1152/ajpgi.00544.2011; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Tannock GW, 2008, MUCOSAL IMMUNOL, V1, pS15, DOI 10.1038/mi.2008.54; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Ugawa S, 2001, AM J PHYSIOL-GASTR L, V281, pG365, DOI 10.1152/ajpgi.2001.281.2.G365; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Wuensch T, 2013, AM J PHYSIOL-GASTR L, V305, pG66, DOI 10.1152/ajpgi.00491.2012	34	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0169207	10.1371/journal.pone.0169207	http://dx.doi.org/10.1371/journal.pone.0169207			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28121990	gold, Green Published, Green Submitted			2022-12-26	WOS:000396167300079
J	Endrich, O; Rimle, C; Zwahlen, M; Triep, K; Raio, L; Nelle, M				Endrich, Olga; Rimle, Carole; Zwahlen, Marcel; Triep, Karen; Raio, Luigi; Nelle, Mathias			Asphyxia in the Newborn: Evaluating the Accuracy of ICD Coding, Clinical Diagnosis and Reimbursement: Observational Study at a Swiss Tertiary Care Center on Routinely Collected Health Data from 2012-2015	PLOS ONE			English	Article							HYPOXIC-ISCHEMIC ENCEPHALOPATHY; NEONATAL ENCEPHALOPATHY; THERAPEUTIC HYPOTHERMIA; SYSTEMIC HYPOTHERMIA; RANDOMIZED-TRIAL; CEREBRAL-PALSY; BIRTH ASPHYXIA; INTERNATIONAL CLASSIFICATION; NEURODEVELOPMENTAL OUTCOMES; PERINATAL ASPHYXIA	Background The ICD-10 categories of the diagnosis "perinatal asphyxia" are defined by clinical signs and a 1-minute Apgar score value. However, the modern conception is more complex and considers metabolic values related to the clinical state. A lack of consistency between the former clinical and the latter encoded diagnosis poses questions over the validity of the data. Our aim was to establish a refined classification which is able to distinctly separate cases according to clinical criteria and financial resource consumption. The hypothesis of the study is that outdated ICD-10 definitions result in differences between the encoded diagnosis asphyxia and the medical diagnosis referring to the clinical context. Methods Routinely collected health data (encoding and financial data) of the University Hospital of Bern were used. The study population was chosen by selected ICD codes, the encoded and the clinical diagnosis were analyzed and each case was reevaluated. The new method categorizes the diagnoses of perinatal asphyxia into the following groups: mild, moderate and severe asphyxia, metabolic acidosis and normal clinical findings. The differences of total costs per case were determined by using one-way analysis of variance. Results The study population included 622 cases (P20 "intrauterine hypoxia" 399, P21 "birth asphyxia" 233). By applying the new method, the diagnosis asphyxia could be ruled out with a high probability in 47% of cases and the variance of case related costs (one-way ANOVA: F (5, 616) = 55.84, p < 0.001, multiple R-squared = 0.312, p < 0.001) could be best explained. The classification of the severity of asphyxia could clearly be linked to the complexity of cases. Conclusion The refined coding method provides clearly defined diagnoses groups and has the strongest effect on the distribution of costs. It improves the diagnosis accuracy of perinatal asphyxia concerning clinical practice, research and reimbursement.	[Endrich, Olga; Triep, Karen] Univ Hosp Bern, Inselspital, Bern, Switzerland; [Rimle, Carole] Univ Bern, Fac Med, Bern, Switzerland; [Zwahlen, Marcel] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Raio, Luigi] Univ Hosp Bern, Dept Obstet & Gynecol, Bern, Switzerland; [Nelle, Mathias] Univ Hosp Bern, Inselspital, Div Neonatol, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Geneva; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Endrich, O (corresponding author), Univ Hosp Bern, Inselspital, Bern, Switzerland.	olga.endrich@insel.ch	Zwahlen, Marcel/AFF-8559-2022	Zwahlen, Marcel/0000-0002-6772-6346; Triep, Karen/0000-0002-2345-3155; Endrich, Olga/0000-0003-0839-9821				Akisu M, 2003, PROSTAG LEUKOTR ESS, V69, P45, DOI 10.1016/S0952-3278(03)00055-3; American College of Obstetricians and Gynecologists, 2005, OBSTET GYNECOL, V106, P1469, DOI DOI 10.1097/00006250-200512000-00056; [Anonymous], 2014, Obstet Gynecol, V123, P896, DOI 10.1097/01.AOG.0000445580.65983.d2; [Anonymous], 2013, HDB REKOLE BETRIEBLI; APGAR V, 1953, Curr Res Anesth Analg, V32, P260; Azzopardi D, 2015, LANCET NEUROL; Bhutta ZA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S7; Brotschi B, 2015, EARLY HUM DEV, V91, P277, DOI 10.1016/j.earlhumdev.2015.02.009; Bundesamt fur Statistik SE, 2016, MED KOD; Chalak LF, 2012, J PEDIATR-US, V160, P388, DOI 10.1016/j.jpeds.2011.09.001; Cheong JLY, 2012, ARCH PEDIAT ADOL MED, V166, P634, DOI 10.1001/archpediatrics.2012.284; Daetwyler K, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13767; DIMDI GIoMDaI, 2014, INT STAT KLASS KRANK; Dixon J, 1998, J PUBLIC HEALTH MED, V20, P63, DOI 10.1093/oxfordjournals.pubmed.a024721; Dzakpasu S, 2009, PEDIATRICS, V123, pE668, DOI 10.1542/peds.2008-2579; Eicher DJ, 2005, PEDIATR NEUROL, V32, P11, DOI 10.1016/j.pediatrneurol.2004.06.014; Fahey J, 2005, J MIDWIFERY WOM HEAL, V50, P498, DOI 10.1016/j.jmwh.2005.08.007; Gancia P, 2012, J MATERN-FETAL NEO M, V25, P94, DOI 10.3109/14767058.2012.715023; Getahun D, 2013, PEDIATRICS, V131, pE53, DOI 10.1542/peds.2012-1298; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; GOLDABER KG, 1991, OBSTET GYNECOL, V78, P1103; Graham EM, 2014, OBSTET GYNECOL, V124, P507, DOI 10.1097/AOG.0000000000000424; Grass B, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0395-7; Gunn AJ, 1998, PEDIATRICS, V102, P885, DOI 10.1542/peds.102.4.885; Hagmann CF, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13145; Hankins GDV, 2011, CLIN OBSTET GYNECOL, V54, P3, DOI 10.1097/GRF.0b013e31820a015b; Higgins RD, 2011, J PEDIATR-US, V159, P851, DOI 10.1016/j.jpeds.2011.08.004; Ibrahim I, 2012, CRIT CARE RESUSC, V14, P112; Inder TE, 2004, J PEDIATR-US, V145, P835, DOI 10.1016/j.jpeds.2004.07.034; Irvine B, 2015, HEALTH PROMOT CHRON, V35, P23, DOI 10.24095/hpcdp.35.1.05; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Jacobs SE, 2011, ARCH PEDIAT ADOL MED, V165, P692, DOI 10.1001/archpediatrics.2011.43; Kottke TE, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.120009; Kwon JM, 2011, J CHILD NEUROL, V26, P322, DOI 10.1177/0883073810380915; Laura F, 2012, J MATERN-FETAL NEO M, V25, P125, DOI 10.3109/14767058.2012.663172; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Lee ACC, 2013, PEDIATR RES, V74, P50, DOI 10.1038/pr.2013.206; Logitharajah P, 2009, PEDIATR RES, V66, P222, DOI 10.1203/PDR.0b013e3181a9ef34; Lorence Daniel P, 2003, J Health Care Finance, V29, P29; MacLennan A, 1999, BMJ-BRIT MED J, V319, P1054, DOI 10.1136/bmj.319.7216.1054; McGuire W, 2007, BMJ CLIN EVID, V2007, P320; Mcintyre S, 2015, DEV MED CHILD NEUROL, V57, P2, DOI 10.1111/dmcn.12725; Mehra T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140874; Memon S, 2012, J PAK MED ASSOC, V62, P1277; Mir N A, 1989, Asia Oceania J Obstet Gynaecol, V15, P351; Moxon SG, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/1471-2393-15-S2-S8; Mwaniki MK, 2012, LANCET, V379, P445, DOI 10.1016/S0140-6736(11)61577-8; Natarajan G, 2012, PEDIATR RES, V72, P414, DOI 10.1038/pr.2012.103; Nelson KB, 1996, NEW ENGL J MED, V334, P613, DOI 10.1056/NEJM199603073341001; Nicholls SG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125620; Oh W, 1996, PEDIATRICS, V98, P141; Perlman JM, 1996, PEDIATRICS, V97, P456; Pfister RH, 2010, J PERINATOL, V30, pS82, DOI 10.1038/jp.2010.91; Ramos G, 2013, EARLY HUM DEV, V89, P159, DOI 10.1016/j.earlhumdev.2012.09.021; Reddihough DS, 2003, AUST J PHYSIOTHER, V49, P7, DOI 10.1016/S0004-9514(14)60183-5; Rochefort CM, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-014-0197-6; Ruegger C, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-17; RUTH VJ, 1988, BRIT MED J, V297, P24, DOI 10.1136/bmj.297.6640.24; Salhab WA, 2005, PEDIATR NEUROL, V32, P25, DOI 10.1016/j.pediatrneurol.2004.06.016; Sarnat HB, 2013, J CHILD NEUROL, V28, P60, DOI 10.1177/0883073812439752; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Sehdev HM, 1997, AM J OBSTET GYNECOL, V177, P1030, DOI 10.1016/S0002-9378(97)70008-5; Shankaran S, 2014, JAMA-J AM MED ASSOC, V312, P2629, DOI 10.1001/jama.2014.16058; Simbruner G, 2010, PEDIATRICS, V126, pE771, DOI 10.1542/peds.2009-2441; Spasic I, 2005, BIOINFORMATICS, V21, P2748, DOI 10.1093/bioinformatics/bti338; Tomashek KM, 2007, J PEDIATR-US, V151, P450, DOI 10.1016/j.jpeds.2007.05.002; Tomashek KM, 2006, PAEDIATR PERINAT EP, V20, P24, DOI 10.1111/j.1365-3016.2006.00690.x; Truttmann A, 2012, PAEDIATRICA, V23, P25; Vance GA, 2011, GYNECOL OBSTET INVES, V71, P202, DOI 10.1159/000318204; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; World Health Organisation, 2016, ICD 10 VERS 2016; World Health Organisation, 1999, BAS NEWB RES PRACT G; Wu YW, 2004, PEDIATRICS, V114, P1584, DOI 10.1542/peds.2004-0708	75	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2017	12	1							e0170691	10.1371/journal.pone.0170691	http://dx.doi.org/10.1371/journal.pone.0170691			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7CU	28118380	Green Published, gold			2022-12-26	WOS:000396160500011
J	Kaji, K; Mizukoshi, E; Yamashita, T; Arai, K; Sunagozaka, H; Fushimi, K; Nakagawa, H; Yamada, K; Terashima, T; Kitahara, M; Kaneko, S				Kaji, Kiichiro; Mizukoshi, Eishiro; Yamashita, Tatsuya; Arai, Kuniaki; Sunagozaka, Hajime; Fushimi, Kazumi; Nakagawa, Hidetoshi; Yamada, Kazutoshi; Terashima, Takeshi; Kitahara, Masaaki; Kaneko, Shuichi			Cellular Immune Responses for Squamous Cell Carcinoma Antigen Recognized by T Cells 3 in Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							PEPTIDE VACCINATION; ALPHA-FETOPROTEIN; PROSTATE-CANCER; CTL EPITOPES; IDENTIFICATION; IMMUNOTHERAPY; LYMPHOCYTES; TRIAL; EXPRESSION; VACCINES	Background & Aims Squamous cell carcinoma antigen recognized by T cells 3 (SART3), a tumor-associated antigen expressed in many cancers, functions in tumor rejection. In this study, we investigated its usefulness as an immunotherapeutic target in hepatocellular carcinoma (HCC). Methods The expression of SART3 in hepatoma cell lines and HCC tissues was investigated by immunofluorescence and immunohistochemical analyses. Two peptides derived from SART3 (SART3(109) and SART3(315)) were used for immunological analysis. T-cell responses were investigated by interferon-gamma (IFN-Y) enzyme-linked immunospot and cytotoxic T lymphocyte (CTL) assays using peripheral blood mononuclear cells (PBMCs) in 47 patients, and tumor-infiltrating lymphocytes in 8 of 47 patients with HCC. The safety of immunotherapy using a SART3-derived peptide was investigated by vaccinations of SART3109 in 12 patients with HCC (trial registration: UMIN000005677). Results The immunofluorescence and immunohistochemical analyses showed that SART3 was expressed in six HCC cell lines, and in HCC tissues including of alpha-fetoprotein-negative individuals. SART3-specific CTLs were generated by stimulating PBMCs with the peptides, and they showed cytotoxicity against HCC cells expressing the protein. Of the 47 HCC patients, 25.5% and 10.6% showed significant responses to SART3109 and SART3315, respectively. The infiltration of SART3109-specific IFN-Y-producing CTLs into the tumor site was confirmed. In the vaccination study, no severe adverse events were observed, and the peptide-specific CTLs were newly induced in four of five patients tested. Conclusions SART3 is an immunotherapeutic candidate, and peptides from this antigen may be applied in HCC immunotherapy.	[Kaji, Kiichiro; Mizukoshi, Eishiro; Yamashita, Tatsuya; Arai, Kuniaki; Sunagozaka, Hajime; Fushimi, Kazumi; Nakagawa, Hidetoshi; Yamada, Kazutoshi; Terashima, Takeshi; Kitahara, Masaaki; Kaneko, Shuichi] Kanazawa Univ, Grad Sch Med, Dept Gastroenterol, Kanazawa, Ishikawa, Japan	Kanazawa University	Mizukoshi, E (corresponding author), Kanazawa Univ, Grad Sch Med, Dept Gastroenterol, Kanazawa, Ishikawa, Japan.	eishirom@m-kanazawa.jp	Terashima, Takeshi/AHC-9917-2022; Yamashita, Tatsuya/K-8648-2015	Yamashita, Tatsuya/0000-0002-3602-8086; Fushimi, Kazumi/0000-0002-1158-4211	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22590723]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by research grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (No. 22590723). The URL is https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-22590723/.	ARAKI T, 1980, AM J ROENTGENOL, V135, P1037, DOI 10.2214/ajr.135.5.1037; Bell M, 2002, EMBO J, V21, P2724, DOI 10.1093/emboj/21.11.2724; Butterfield LH, 2006, CLIN CANCER RES, V12, P2817, DOI 10.1158/1078-0432.CCR-05-2856; Butterfield LH, 2003, CLIN CANCER RES, V9, P5902; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Greten TF, 2006, J HEPATOL, V45, P868, DOI 10.1016/j.jhep.2006.09.004; Greten TF, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-209; Ikeda-Moore Y, 1997, J IMMUNOL, V159, P6242; Itoh K, 2006, CANCER SCI, V97, P970, DOI 10.1111/j.1349-7006.2006.00272.x; Komohara Y, 2006, INT J ONCOL, V29, P1555; Komori H, 2006, CLIN CANCER RES, V12, P2689, DOI 10.1158/1078-0432.CCR-05-2267; Korangy F, 2004, CLIN CANCER RES, V10, P4332, DOI 10.1158/1078-0432.CCR-04-0181; Kuzushima K, 2001, BLOOD, V98, P1872, DOI 10.1182/blood.V98.6.1872; Liver Cancer Study Group of Japan, 2010, GEN RUL CLIN PATH ST; Minami T, 2007, CANCER IMMUNOL IMMUN, V56, P689, DOI 10.1007/s00262-006-0216-9; Mizukoshi E, 2006, INT J CANCER, V118, P1194, DOI 10.1002/ijc.21468; Mizukoshi E, 2006, HEPATOLOGY, V43, P1284, DOI 10.1002/hep.21203; Mizukoshi E, 2012, LIVER INT, V32, P1516, DOI 10.1111/j.1478-3231.2012.02853.x; Mizukoshi E, 2011, HEPATOLOGY, V53, P1206, DOI 10.1002/hep.24149; Mizukoshi E, 2008, J HEPATOL, V49, P946, DOI 10.1016/j.jhep.2008.05.012; Nakao M, 2000, J IMMUNOL, V164, P2565, DOI 10.4049/jimmunol.164.5.2565; Nobuoka D, 2013, HUM VACC IMMUNOTHER, V9, P210, DOI 10.4161/hv.22473; Noguchi M, 2007, PROSTATE, V67, P933, DOI 10.1002/pros.20572; Sawada Y, 2012, CLIN CANCER RES, V18, P3686, DOI 10.1158/1078-0432.CCR-11-3044; Yang D, 1999, CANCER RES, V59, P4056; Zerbini A, 2004, J HEPATOL, V40, P102, DOI 10.1016/S0168-8278(03)00484-7	29	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e170291	10.1371/journal.pone.0170291	http://dx.doi.org/10.1371/journal.pone.0170291			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114424	gold, Green Published, Green Submitted			2022-12-26	WOS:000396129000034
J	Wang, S; Willenberg, I; Krohn, M; Hecker, T; Meckelmann, S; Li, C; Pan, YJ; Schebb, NH; Steinberg, P; Empl, MT				Wang, Shan; Willenberg, Ina; Krohn, Michael; Hecker, Tanja; Meckelmann, Sven; Li, Chang; Pan, Yuanjiang; Schebb, Nils Helge; Steinberg, Pablo; Empl, Michael Telamon			Growth-Inhibiting Activity of Resveratrol Imine Analogs on Tumor Cells In Vitro	PLOS ONE			English	Article							CHEMOPREVENTIVE AGENT RESVERATROL; CYCLE ARREST; BIOLOGICAL EVALUATION; DOWN-REGULATION; CANCER; APOPTOSIS; PROLIFERATION; COX-2; CYCLOOXYGENASE-2; BIOAVAILABILITY	Although resveratrol exerts manifold antitumorigenic effects in vitro, its efficacy against malignancies in vivo seems limited. This has been increasingly recognized in recent years and has prompted scientists to search for structurally related compounds with more promising anticarcinogenic and/or pharmacokinetic properties. A class of structurally modified resveratrol derivatives, so-called resveratrol imine analogs (IRA's), might meet these requirements. Therefore, the biological activity of five of these compounds was examined and compared to that of resveratrol. Firstly, the antiproliferative potency of all five IRA's was investigated using the p53 wildtype-carrying colorectal carcinoma cell line HCT-116 (wt). Then, using the former and a panel of various other tumor cell lines (including the p53 knockout variant HCT-116(p53-/-)), the growth-inhibiting and cell cycle-disturbing effects of the most potent IRA (IRA 5,2-[[(2-hydroxyphenyl)methylene]amino]-phenol) were studied as was its influence on cyclooxygenase-2 expression and activity. Finally, rat liver microsomes were used to determine the metabolic stability of that compound. IRA 5 was clearly the most potent compound in HCT-116(wt) cells, with an unusually high IC50-value of 0.6 mu M. However, in the other five cell lines used, the antiproliferative activity was mostly similar to resveratrol and the effects on the cell cycle were heterogeneous. Although all cell lines were affected by treatment with IRA 5, cells expressing functional p53 seemed to react more sensitively, suggesting that this protein plays a modulating role in the induction of IRA 5-mediated biological effects. Lastly, IRA 5 led to contradictory effects on cyclooxygenase-2 expression and activity and was less glucuronidated than resveratrol. As IRA 5 is approximately 50 times more toxic towards HCT-116(wt) cells, exerts different effects on the cyclooxygenase-2 and is metabolized to a lesser extent, it shows certain advantages over resveratrol and could therefore serve as basis for additional chemical modifications, potentially yielding compounds with more favorable biological and pharmacokinetic features.	[Wang, Shan; Willenberg, Ina; Schebb, Nils Helge; Steinberg, Pablo; Empl, Michael Telamon] Univ Vet Med Hannover, Inst Food Toxicol & Analyt Chem, Hannover, Germany; [Krohn, Michael; Hecker, Tanja; Meckelmann, Sven; Schebb, Nils Helge] Univ Wuppertal, Inst Food Chem, Wuppertal, Germany; [Li, Chang; Pan, Yuanjiang] Zhejiang Univ, Dept Chem, Hangzhou, Zhejiang, Peoples R China	University of Veterinary Medicine Hannover, Foundation; University of Wuppertal; Zhejiang University	Empl, MT (corresponding author), Univ Vet Med Hannover, Inst Food Toxicol & Analyt Chem, Hannover, Germany.	michael.empl@tiho-hannover.de	Li, Chang/AAP-7203-2020; Empl, Michael T./H-8908-2019	Schebb, Nils Helge/0000-0003-1299-6629; Empl, Michael/0000-0002-5652-5258; Li, Chang/0000-0003-4681-0191	China Scholarship Council [201206170045]; SW; Fonds der Chemischen Industrie; Sino-German Center for Research Promotion [GZ 689]; YP; PS; Deutsche Forschungsgemeinschaft [SCHE 1801]; NHS	China Scholarship Council(China Scholarship Council); SW; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Sino-German Center for Research Promotion; YP; PS; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NHS	This work was funded by: China Scholarship Council (grant nr. 201206170045; httpl://en.csc.edu.cn/), SW; Fonds der Chemischen Industrie (https://vmw.vci.deifondsistartseite.jsp), IW; Sino-German Center for Research Promotion (grant nr. GZ 689; http://Avvmt.sinogermanscience.org.cn/de/index.html), YP and PS; and Deutsche Forschungsgemeinschaft (grant nr. SCHE 1801; http://www.dfg.de/), NHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; Ahmad N, 2001, CLIN CANCER RES, V7, P1466; Baines A, 2002, CANCER BIOL THER, V1, P370; Brown VA, 2010, CANCER RES, V70, P9003, DOI 10.1158/0008-5472.CAN-10-2364; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Carter LG, 2014, ENDOCR-RELAT CANCER, V21, pR209, DOI 10.1530/ERC-13-0171; Cheng LX, 2010, BIOORG MED CHEM LETT, V20, P2417, DOI 10.1016/j.bmcl.2010.03.039; Empl MT, 2014, VET COMP ONCOL, V12, P149, DOI 10.1111/j.1476-5829.2012.00349.x; Empl MT, 2015, PHYTOTHER RES, V29, P1640, DOI 10.1002/ptr.5443; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Fouad MA, 2013, HUM EXP TOXICOL, V32, P1067, DOI 10.1177/0960327113475679; Fulda S, 2010, DRUG DISCOV TODAY, V15, P757, DOI 10.1016/j.drudis.2010.07.005; Gayet J, 2001, ONCOGENE, V20, P5025, DOI 10.1038/sj.onc.1204611; Harper KA, 2008, BIOCHEM SOC T, V36, P543, DOI 10.1042/BST0360543; Howells LM, 2011, CANCER PREV RES, V4, P1419, DOI 10.1158/1940-6207.CAPR-11-0148; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Kim AL, 2006, EXP DERMATOL, V15, P538, DOI 10.1111/j.1600-0625.2006.00445.x; Kondratyuk TP, 2011, MOL NUTR FOOD RES, V55, P1249, DOI 10.1002/mnfr.201100122; Kotora P, 2016, MOLECULES, V21, DOI 10.3390/molecules21010127; Li C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101455; Li SY, 2014, EUR J MED CHEM, V71, P36, DOI 10.1016/j.ejmech.2013.10.068; Lin SJ, 2008, BIOORGAN MED CHEM, V16, P2697, DOI 10.1016/j.bmc.2007.11.033; Liu B, 2014, MOL MED REP, V10, P1697, DOI 10.3892/mmr.2014.2406; Liu Y, 2006, P NATL ACAD SCI USA, V103, P976, DOI 10.1073/pnas.0510146103; Lu J, 2012, BIOORG MED CHEM LETT, V22, P5744, DOI 10.1016/j.bmcl.2012.06.026; Luo Z, 2015, HYPERTENSION S1, V66, pA122; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Mahyar-Roemer M, 2001, INT J CANCER, V94, P615, DOI 10.1002/ijc.1516; Muller C, 2011, J MED FOOD, V14, P34, DOI 10.1089/jmf.2010.0022; Nguyen Anthony V, 2009, Cancer Manag Res, V1, P25; Ogas T, 2013, ANN NY ACAD SCI, V1290, P21, DOI 10.1111/nyas.12196; Oi N, 2015, ONCOGENE, V34, P2660, DOI 10.1038/onc.2014.194; Park EJ, 2015, BBA-MOL BASIS DIS, V1852, P1071, DOI 10.1016/j.bbadis.2015.01.014; Patel KR, 2010, CANCER RES, V70, P7392, DOI 10.1158/0008-5472.CAN-10-2027; Pezzuto JM, 2011, ANN NY ACAD SCI, V1215, P123, DOI 10.1111/j.1749-6632.2010.05849.x; Polonini HC, 2013, BIOORGAN MED CHEM, V21, P964, DOI 10.1016/j.bmc.2012.11.052; Popat R, 2013, BRIT J HAEMATOL, V160, P714, DOI 10.1111/bjh.12154; Rasband W., 2006, IMAGEJ; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Sale S, 2005, INT J CANCER, V115, P194, DOI 10.1002/ijc.20884; Sale S, 2004, BRIT J CANCER, V90, P736, DOI 10.1038/sj.bjc.6601568; Schneider Y, 2000, CANCER LETT, V158, P85, DOI 10.1016/S0304-3835(00)00511-5; Shao JY, 2000, J BIOL CHEM, V275, P33951, DOI 10.1074/jbc.M002324200; Sheng HM, 1997, J CLIN INVEST, V99, P2254, DOI 10.1172/JCI119400; Siddiqui A, 2013, BIOORG MED CHEM LETT, V23, P635, DOI 10.1016/j.bmcl.2012.12.002; Sobolewski Cyril, 2010, Int J Cell Biol, V2010, P215158, DOI 10.1155/2010/215158; Song SH, 2010, BIOMOL THER, V18, P402, DOI 10.4062/biomolther.2010.18.4.402; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Tome-Carneiro J, 2013, CURR PHARM DESIGN, V19, P6064, DOI 10.2174/13816128113199990407; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Walle T, 2011, ANN NY ACAD SCI, V1215, P9, DOI 10.1111/j.1749-6632.2010.05842.x; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Wang DZ, 2005, CANCER RES, V65, P1822, DOI 10.1158/0008-5472.CAN-04-3671; WATSON JV, 1987, CYTOMETRY, V8, P1, DOI 10.1002/cyto.990080101; Wenzel E, 2005, MOL NUTR FOOD RES, V49, P472, DOI 10.1002/mnfr.200500010; Willenberg I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139147; Willenberg I, 2015, J CHROMATOGR A, V1391, P40, DOI 10.1016/j.chroma.2015.02.059; Willenberg I, 2015, FOOD CHEM, V167, P245, DOI 10.1016/j.foodchem.2014.06.103; Willenberg I, 2012, J AGR FOOD CHEM, V60, P7844, DOI 10.1021/jf302136t; Wolter F, 2001, J NUTR, V131, P2197, DOI 10.1093/jn/131.8.2197; Wu BJ, 2011, J PHARM SCI-US, V100, P3655, DOI 10.1002/jps.22568; Zhao F, 2009, J PHYS ORG CHEM, V22, P791, DOI 10.1002/poc.1517; Zykova TA, 2008, MOL CARCINOGEN, V47, P797, DOI 10.1002/mc.20437	64	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170502	10.1371/journal.pone.0170502	http://dx.doi.org/10.1371/journal.pone.0170502			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114318	Green Published, Green Submitted, gold			2022-12-26	WOS:000396129000056
J	Akhvlediani, T; Bautista, CT; Garuchava, N; Sanodze, L; Kokaia, N; Malania, L; Chitadze, N; Sidamonidze, K; Rivard, RG; Hepburn, MJ; Nikolich, MP; Imnadze, P; Trapaidze, N				Akhvlediani, Tamar; Bautista, Christian T.; Garuchava, Natalia; Sanodze, Lia; Kokaia, Nora; Malania, Lile; Chitadze, Nazibrola; Sidamonidze, Ketevan; Rivard, Robert G.; Hepburn, Matthew J.; Nikolich, Mikeljon P.; Imnadze, Paata; Trapaidze, Nino			Epidemiological and Clinical Features of Brucellosis in the Country of Georgia	PLOS ONE			English	Article							NEIGHBORING COMMUNITY MEMBERS; DIAGNOSIS; MANIFESTATIONS; EGYPT; TESTS; PCR	Background Brucellosis is an endemic disease in the country of Georgia. According to the National Center for Disease Control and Public Health of Georgia (NCDC), the average annual number of brucellosis cases was 161 during 2008-2012. However, the true number of cases is thought to be higher due to underreporting. The aim of this study was to provide current epidemiological and clinical information and evaluate diagnostic methods used for brucellosis in Georgia. Methodology Adult patients were eligible for participation if they met the suspected or probable case definition for brucellosis. After consent participants were interviewed using a standardized questionnaire to collect information on socio-demographic characteristics, epidemiology, history of present illness, and clinical manifestation. For the diagnosis of brucellosis, culture and serological tests were used. Results A total of 81 participants were enrolled, of which 70 (86%) were from rural areas. Seventy-four percent of participants reported consuming unpasteurized milk products and 62% consuming undercooked meat products before symptom onset. Forty-one participants were positive by the Wright test and 33 (41%) were positive by blood culture. There was perfect agreement between the Huddelston and Wright tests (k = 1.0). Compared with blood culture (the diagnostic gold standard), ELISA IgG and total ELISA (IgG + IgM), the Wright test had fair (k = 0.12), fair (k = 0.24), and moderate (k = 0.52) agreement, respectively. Conclusions Consumption of unpasteurized milk products and undercooked meat were among the most common risk factors in brucellosis cases. We found poor agreement between ELISA tests and culture results. This report also serves as an initial indication that the suspected case definition for brucellosis surveillance purposes needs revision. Further research is needed to characterize the epidemiology and evaluate the performance of the diagnostic methods for brucellosis in Georgia.	[Akhvlediani, Tamar; Nikolich, Mikeljon P.; Trapaidze, Nino] USAMRD G, Tbilisi, Georgia; [Bautista, Christian T.; Nikolich, Mikeljon P.] WRAIR, Silver Spring, MD USA; [Garuchava, Natalia; Sanodze, Lia; Malania, Lile; Chitadze, Nazibrola; Sidamonidze, Ketevan; Imnadze, Paata; Trapaidze, Nino] Natl Ctr Dis Control & Publ Hlth, Tbilisi, Georgia; [Kokaia, Nora] Virsaladze Sci Res Inst Med Parasitol & Trop Med, Tbilisi, Georgia; [Sidamonidze, Ketevan] I Javakhishvili Tbilisi State Univ, Tbilisi, Georgia; [Rivard, Robert G.; Hepburn, Matthew J.] US Army, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA	Walter Reed Army Institute of Research (WRAIR); National Center for Disease Control & Public Health - Georgia; Ivane Javakhishvili Tbilisi State University	Akhvlediani, T (corresponding author), USAMRD G, Tbilisi, Georgia.	t_akhvlediani@yahoo.com	Nikolich, Mikeljon/ABD-5270-2020; Nikolich, Mikeljon P/ABC-9871-2021	Nikolich, Mikeljon P/0000-0001-5770-8980; Sanodze, Lia/0000-0002-8876-4392; Bautista, Christian/0000-0002-1228-0754	Defense Threat Reduction Agency (DTRA) through the Cooperative Biological Engagement Program [CBEP-CBR-GG17]	Defense Threat Reduction Agency (DTRA) through the Cooperative Biological Engagement Program	This study was funded by the Defense Threat Reduction Agency (DTRA) through the Cooperative Biological Engagement Program (CBEP-CBR-GG17). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhvlediani T, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-346; Al Dahouk Sascha, 2003, Clin Lab, V49, P487; Al Dahouk Sascha, 2003, Clin Lab, V49, P577; Alsayed Y, 2012, J INFECT DEV COUNTR, V6, P495, DOI 10.3855/jidc.2453; Asaad Ahmed Morad, 2012, J Infect Public Health, V5, P189, DOI 10.1016/j.jiph.2012.02.001; BRICKER BJ, 1994, J CLIN MICROBIOL, V32, P2660, DOI 10.1128/JCM.32.11.2660-2666.1994; Daz R, 1976, Bull World Health Organ, V53, P417; Fadeel MA, 2006, SAUDI MED J, V27, P975; Havas KA, 2013, EPIDEMIOL INFECT, V141, P45, DOI 10.1017/S0950268812000313; Havas KA, 2012, PREV VET MED, V105, P10, DOI 10.1016/j.prevetmed.2012.02.013; Hekmatimoghaddam Seyedhosssein, 2013, Pak J Biol Sci, V16, P1589, DOI 10.3923/pjbs.2013.1589.1592; Ismayilova R, 2013, AM J TROP MED HYG, V88, P929, DOI 10.4269/ajtmh.12-0381; Marei A, 2011, J INFECT DEV COUNTR, V5, P786, DOI 10.3855/jidc.1538; Maruashvili G, 1983, BRUCELLOSIS TBILISI; Memish Z, 2000, J INFECTION, V40, P59, DOI 10.1053/jinf.1999.0586; Memish ZA, 2004, J TRAVEL MED, V11, P49, DOI 10.2310/7060.2004.13551; Olsen SC, 2014, VET PATHOL, V51, P1076, DOI 10.1177/0300985814540545; Pabuccuoglu O, 2011, JPN J INFECT DIS, V64, P272; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Rubach MP, 2013, CURR OPIN INFECT DIS, V26, P404, DOI 10.1097/QCO.0b013e3283638104; Ruiz J, 1997, J CLIN MICROBIOL, V35, P2417, DOI 10.1128/JCM.35.9.2417-2418.1997; Sanodze L, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1761-y; Seleem MN, 2010, VET MICROBIOL, V140, P392, DOI 10.1016/j.vetmic.2009.06.021; Shehata GA, 2010, J NEUROVIROL, V16, P48, DOI 10.3109/13550280903586386; Tan SY, 2011, SINGAP MED J, V52, P138; Tu YK, 2005, BRIT DENT J, V199, P457, DOI 10.1038/sj.bdj.4812743	26	32	32	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170376	10.1371/journal.pone.0170376	http://dx.doi.org/10.1371/journal.pone.0170376			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107444	gold, Green Published, Green Submitted			2022-12-26	WOS:000392405300121
J	Domenis, R; Cesselli, D; Toffoletto, B; Bourkoula, E; Caponnetto, F; Manini, I; Beltrami, AP; Ius, T; Skrap, M; Di Loreto, C; Gri, G				Domenis, Rossana; Cesselli, Daniela; Toffoletto, Barbara; Bourkoula, Evgenia; Caponnetto, Federica; Manini, Ivana; Beltrami, Antonio Paolo; Ius, Tamara; Skrap, Miran; Di Loreto, Carla; Gri, Giorgia			Systemic T Cells Immunosuppression of Glioma Stem Cell-Derived Exosomes Is Mediated by Monocytic Myeloid-Derived Suppressor Cells	PLOS ONE			English	Article							IMMUNE DEFECTS; TUMOR-GROWTH; GLIOBLASTOMA; EXPRESSION; RNA; MECHANISMS; SECRETION; PROGNOSIS; MICRORNA; CULTURE	A major contributing factor to glioma development and progression is its ability to evade the immune system. Nano-meter sized vesicles, exosomes, secreted by glioma-stem cells (GSC) can act as mediators of intercellular communication to promote tumor immune escape. Here, we investigated the immunomodulatory properties of GCS-derived exosomes on different peripheral immune cell populations. Healthy donor peripheral blood mononuclear cells (PBMCs) stimulated with anti-CD3, anti-CD28 and IL-2, were treated with GSC-derived exosomes. Phenotypic characterization, cell proliferation, Th1/Th2 cytokine secretion and intracellular cytokine production were analysed by distinguishing among effector T cells, regulatory T cells and monocytes. In unfractionated PBMCs, GSC-derived exosomes inhibited T cell activation (CD25 and CD69 expression), proliferation and Th1 cytokine production, and did not affect cell viability or regulatory T-cell suppression ability. Furthermore, exosomes were able to enhance proliferation of purified CD4+ T cells. In PBMCs culture, glioma-derived exosomes directly promoted IL-10 and arginase-1 production and downregulation of HLA-DR by unstimulated CD14+ monocytic cells, that displayed an immunophenotype resembling that of monocytic myeloid-derived suppressor cells (Mo-MDSCs). Importantly, the removal of CD14+ monocytic cell fraction from PBMCs restored T-cell proliferation. The same results were observed with exosomes purified from plasma of glioblastoma patients. Our results indicate that glioma-derived exosomes suppress T-cell immune response by acting on monocyte maturation rather than on direct interaction with T cells. Selective targeting of Mo-MDSC to treat glioma should be considered with regard to how immune cells allow the acquirement of effector functions and therefore counteracting tumor progression.	[Domenis, Rossana; Cesselli, Daniela; Toffoletto, Barbara; Bourkoula, Evgenia; Caponnetto, Federica; Manini, Ivana; Beltrami, Antonio Paolo; Di Loreto, Carla; Gri, Giorgia] Univ Udine, Dept Med & Biol Sci, Udine, Italy; [Ius, Tamara; Skrap, Miran] Univ Hosp Udine, Dept Neurosurg, Udine, Italy	University of Udine; Hospital Santa Maria della Misericordia; University of Udine; University Hospital of Udine	Gri, G (corresponding author), Univ Udine, Dept Med & Biol Sci, Udine, Italy.	giorgia.gri@uniud.it	caponnetto, federica/AAC-7806-2022; skrap, miran/AAB-1708-2022; Beltrami, Antonio/C-5291-2008; ius, tamara/F-1084-2018	caponnetto, federica/0000-0002-4485-648X; skrap, miran/0000-0002-6592-6416; Beltrami, Antonio/0000-0002-0679-2710; ius, tamara/0000-0003-3741-0639; Cesselli, Daniela/0000-0002-0562-7852; GRI, Giorgia/0000-0002-2826-0459	Futuro in Ricerca (FIRB) [RBAP11Z4Z9, RBAP11ETKA]; Interreg Italia-Slovenia, GLIOMA; ERC [269051]	Futuro in Ricerca (FIRB); Interreg Italia-Slovenia, GLIOMA; ERC(European Research Council (ERC)European Commission)	This work was supported by Futuro in Ricerca (FIRB) 2011, Pr. RBAP11Z4Z9, 2012-2014; Futuro in Ricerca (FIRB) 2011, Pr. RBAP11ETKA, 2012-2015 to APB; Interreg Italia-Slovenia, GLIOMA, 2007-2013; Project ERC-7FP SP 2 IDEAS QUIDPROQUO G.A. n. 269051, 2011-2016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez ML, 2012, KIDNEY INT, V82, P1024, DOI 10.1038/ki.2012.256; Basso M, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00127; Bourkoula E, 2014, STEM CELLS, V32, P1239, DOI 10.1002/stem.1605; BROOKS WH, 1981, J NEUROSURG, V54, P331, DOI 10.3171/jns.1981.54.3.0331; Bullerdiek J, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-27; Carlsson A, 2010, PROTEOM CLIN APPL, V4, P591, DOI 10.1002/prca.200900173; Chistiakov DA, 2014, TUMOR BIOL, V35, P8425, DOI 10.1007/s13277-014-2262-9; Clayton A, 2007, CANCER RES, V67, P7458, DOI 10.1158/0008-5472.CAN-06-3456; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; de Vrij J, 2015, INT J CANCER, V137, P1630, DOI 10.1002/ijc.29521; Dix AR, 1999, J NEUROIMMUNOL, V100, P216, DOI 10.1016/S0165-5728(99)00203-9; Fecci PE, 2006, CANCER RES, V66, P3294, DOI 10.1158/0008-5472.CAN-05-3773; Filipazzi P, 2012, SEMIN CANCER BIOL, V22, P342, DOI 10.1016/j.semcancer.2012.02.005; Goswami S, 1998, J NEUROCHEM, V71, P1837; Graner MW, 2009, FASEB J, V23, P1541, DOI 10.1096/fj.08-122184; Gustafson MP, 2010, NEURO-ONCOLOGY, V12, P631, DOI 10.1093/neuonc/noq001; Harshyne LA, 2015, NEUROONCOL; Hatiboglu MA, 2010, TARGET ONCOL, V5, P217, DOI 10.1007/s11523-010-0151-8; Hellwinkel JE, 2016, NEURO-ONCOLOGY, V18, P497, DOI 10.1093/neuonc/nov170; Huettner C, 1997, ANTICANCER RES, V17, P3217; Iorgulescu JB, 2016, J NEUROIMMUNOL, V290, P103, DOI 10.1016/j.jneuroim.2015.11.025; Katakowski M, 2016, CELL MOL NEUROBIOL, V36, P343, DOI 10.1007/s10571-015-0280-9; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; Lathia JD, 2015, GENE DEV, V29, P1203, DOI 10.1101/gad.261982.115; Liu ZM, 2013, ASIAN PAC J CANCER P, V14, P309, DOI 10.7314/APJCP.2013.14.1.309; Lo Cicero A, 2015, CURR OPIN CELL BIOL, V35, P69, DOI 10.1016/j.ceb.2015.04.013; Lobb RJ, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27031; Muller L, 2016, SCI REP-UK, V6, DOI 10.1038/srep20254; Parney IF, 2012, ADV EXP MED BIOL, V746, P42, DOI 10.1007/978-1-4614-3146-6_4; Peterson MF, 2015, METHODS, V87, P31, DOI 10.1016/j.ymeth.2015.04.015; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Redzic JS, 2014, PHARMACOGEN PERS MED, V7, P65, DOI 10.2147/PGPM.S39768; Rodrigues JC, 2010, NEURO-ONCOLOGY, V12, P351, DOI 10.1093/neuonc/nop023; Rolle CE, 2012, ADV EXP MED BIOL, V746, P53, DOI 10.1007/978-1-4614-3146-6_5; Saenz-Cuesta M, 2015, FRONT IMMUNOL, V6; Saidi A, 2009, INT J CANCER, V125, P1054, DOI 10.1002/ijc.24380; Samaras V, 2007, MOL CELL BIOCHEM, V304, P343, DOI 10.1007/s11010-007-9517-3; Schreiner B, 2003, GLIA, V44, P296, DOI 10.1002/glia.10291; Shibahara I, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0307-3; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Solito S, 2014, ANN NY ACAD SCI, V1319, P47, DOI 10.1111/nyas.12469; Taylor DD, 2015, METHODS, V87, P3, DOI 10.1016/j.ymeth.2015.02.019; Tchirkov A, 2001, BRIT J CANCER, V85, P518, DOI 10.1054/bjoc.2001.1942; Trikha P, 2014, BBA-REV CANCER, V1846, P55, DOI 10.1016/j.bbcan.2014.04.003; van der Vos KE, 2016, NEURO-ONCOLOGY, V18, P58, DOI 10.1093/neuonc/nov244; Van Deun J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24858; Waziri A, 2010, NEUROSURG CLIN N AM, V21, P31, DOI 10.1016/j.nec.2009.08.005; Wei J, 2010, CLIN CANCER RES, V16, P461, DOI 10.1158/1078-0432.CCR-09-1983; Weissenberger J, 2004, ONCOGENE, V23, P3308, DOI 10.1038/sj.onc.1207455; Wieckowski EU, 2009, J IMMUNOL, V183, P3720, DOI 10.4049/jimmunol.0900970; Wu A, 2010, NEURO-ONCOLOGY, V12, P1113, DOI 10.1093/neuonc/noq082; Zhu VF, 2012, CANCER LETT, V316, P139, DOI 10.1016/j.canlet.2011.11.001; Zou JP, 1999, J IMMUNOL, V162, P4882	53	96	103	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0169932	10.1371/journal.pone.0169932	http://dx.doi.org/10.1371/journal.pone.0169932			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107450	Green Published, gold, Green Submitted			2022-12-26	WOS:000392405300051
J	Kettunen, A; Daverdin, M; Helfjord, T; Berg, P				Kettunen, Anne; Daverdin, Marc; Helfjord, Turid; Berg, Peer			Cross-Breeding Is Inevitable to Conserve the Highly Inbred Population of Puffin Hunter: The Norwegian Lundehund	PLOS ONE			English	Article							GENETIC DIVERSITY; DOG BREEDS; PEDIGREE ANALYSIS; SIZE; MANAGEMENT	The Norwegian Lundehund is a highly endangered native dog breed. Low fertility and high frequency predisposition to intestinal disorder imply inbreeding depression. We assessed the genetic diversity of the Lundehund population from pedigree data and evaluated the potential of optimal contribution selection and cross-breeding in the long-term management of the Lundehund population. The current Norwegian Lundehund population is highly inbred and has lost 38.8% of the genetic diversity in the base population. Effective population size estimates varied between 13 and 82 depending on the method used. Optimal contribution selection alone facilitates no improvement in the current situation in the Lundehund due to the extremely high relatedness of the whole population. Addition of (replacement with) 10 breeding candidates of foreign breed to 30 Lundehund breeders reduced the parental additive genetic relationship by 40-42% (48-53%). Immediate actions are needed to increase the genetic diversity in the current Lundehund population. The only option to secure the conservation of this rare breed is to introduce individuals from foreign breeds as breeding candidates.	[Kettunen, Anne; Berg, Peer] NordGen, Nord Genet Resource Ctr, As, Norway; [Daverdin, Marc] Norwegian Univ Sci & Technol, NTNU Museum, Trondheim, Norway; [Helfjord, Turid] Norsk Hestesenter, Lena, Norway	Norwegian University of Science & Technology (NTNU)	Kettunen, A (corresponding author), NordGen, Nord Genet Resource Ctr, As, Norway.	anne.kettunen@nordgen.org						Boichard D, 1997, GENET SEL EVOL, V29, P5, DOI 10.1051/gse:19970101; Caballero A, 2000, GENET RES, V75, P331, DOI 10.1017/S0016672399004449; Calboli FCF, 2008, GENETICS, V179, P593, DOI 10.1534/genetics.107.084954; Cervantes I, 2011, J ANIM BREED GENET, V128, P56, DOI 10.1111/j.1439-0388.2010.00881.x; Espelien I, 2013, J INT SOC PRESERV PR, P37; Espelien I.S., 2013, LUNDEHUND NYTT, V2, P51; Ghafouri-Kesbi F, 2010, GENET MOL BIOL, V33, P657, DOI 10.1590/S1415-47572010000400011; Glazewska I., 2008, LIVEST SCI, V113, P296; Gutierrez JP, 2009, J ANIM BREED GENET, V126, P327, DOI 10.1111/j.1439-0388.2009.00810.x; Gutierrez JP, 2005, J ANIM BREED GENET, V122, P172, DOI 10.1111/j.1439-0388.2005.00512.x; Gutierrez JP, 2003, GENET SEL EVOL, V35, P43, DOI 10.1051/gse:2002035; Gutierrez JP, 2008, GENET SEL EVOL, V40, P359, DOI 10.1051/gse:2008008; Henryon M, 2006, GENET SEL EVOL; Jansson M, 2014, J ANIM BREED GENET, V131, P153, DOI 10.1111/jbg.12060; Kropatsch R, 2015, J HERED, V106, P403, DOI 10.1093/jhered/esv031; LACY RC, 1989, ZOO BIOL, V8, P111, DOI 10.1002/zoo.1430080203; Lacy RC, 1995, ZOO BIOL, V14, P565, DOI 10.1002/zoo.1430140609; LANDSVERK T, 1984, ACTA PATH MICRO IM A, V92, P353; Leroy G, 2006, J ANIM BREED GENET, V123, P1, DOI 10.1111/j.1439-0388.2006.00565.x; Leroy G, 2009, ANIM GENET, V40, P323, DOI 10.1111/j.1365-2052.2008.01842.x; Lewis TW, 2015, CANINE GENET EPIDEMI, P2; MACCLUER JW, 1983, J HERED, V74, P394, DOI 10.1093/oxfordjournals.jhered.a109824; Maki K, 2010, J ANIM BREED GENET, V127, P318, DOI 10.1111/j.1439-0388.2010.00851.x; Melis C, 2013, ANIM GENET, V44, P348, DOI 10.1111/age.12000; Olafsdottir GA, 2008, CONSERV GENET, V9, P1639, DOI 10.1007/s10592-008-9526-0; PerezEnciso M, 1995, J ANIM BREED GENET, V112, P327, DOI 10.1111/j.1439-0388.1995.tb00574.x; Pertoldi C, 2013, J ANIM SCI, V91, P5122, DOI 10.2527/jas.2013-6617; Pfahler S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122680; Pfahler S, 2014, ANIM GENET, V45, P154, DOI 10.1111/age.12084; Wijnrocx K, 2016, J ANIM BREED GENET, P1	30	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170039	10.1371/journal.pone.0170039	http://dx.doi.org/10.1371/journal.pone.0170039			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107382	Green Submitted, Green Published, gold			2022-12-26	WOS:000392405300067
J	Pang, LJ; Kennedy, D; Wei, QL; Lv, LX; Gao, JS; Li, H; Quan, MN; Li, X; Yang, YF; Fan, XD; Song, XQ				Pang, Lijuan; Kennedy, David; Wei, Qinling; Lv, Luxian; Gao, Jinsong; Li, Hong; Quan, Meina; Li, Xue; Yang, Yongfeng; Fan, Xiaoduo; Song, Xueqin			Decreased Functional Connectivity of Insular Cortex in Drug Naive First Episode Schizophrenia: In Relation to Symptom Severity	PLOS ONE			English	Article							SCALE BRAIN NETWORKS; 1ST-EPISODE SCHIZOPHRENIA; CAUDATE-NUCLEUS; STRUCTURAL CONNECTIVITY; PLANUM TEMPORALE; SALIENCE NETWORK; ANTERIOR INSULA; HESCHL GYRUS; VOLUME; GRAY	Background This study was to examine the insular cortical functional connectivity in drug naive patients with first episode schizophrenia and to explore the relationship between the connectivity and the severity of clinical symptoms. Methods Thirty-seven drug naive patients with schizophrenia and 25 healthy controls were enrolled in this study. A seed-based approach was used to analyze the resting-state functional imaging data. Insular cortical connectivity maps were bilaterally extracted for group comparison and validated by voxel-based morphometry (VBM) analysis. Clinical symptoms were measured using the Positive and Negative Syndrome Scale (PANSS). Results There were significant reductions in the right insular cortical connectivity with the Heschl's gyrus, anterior cingulate cortex (ACC), and caudate (p's<0.001) in the patient group compared with the healthy control (HC) group. Reduced right insular cortical connectivity with the Heschl's gyrus was further confirmed in the VBM analysis (FDR corrected p<0.05). Within the patient group, there was a significant positive relationship between the right insula-Heschl's connectivity and PANSS general psychopathology scores (r = 0.384, p = 0.019). Conclusion Reduced insula-Heschl's functional connectivity is present in drug naive patients with first episode schizophrenia, which might be related to the manifestation of clinical symptoms.	[Pang, Lijuan; Gao, Jinsong; Li, Hong; Li, Xue; Song, Xueqin] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China; [Kennedy, David; Quan, Meina; Fan, Xiaoduo] Univ Massachusetts, Sch Med, Dept Psychiat, Worcester, MA 01655 USA; [Wei, Qinling] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Psychiat, Guangzhou, Guangdong, Peoples R China; [Lv, Luxian; Yang, Yongfeng] Xinxiang Med Univ, Henan Prov Biol Psychiat Key Lab, Xinxiang, Peoples R China; [Lv, Luxian; Yang, Yongfeng] Xinxiang Med Univ, Affiliated Hosp 2, Henan Prov Mental Hosp, Xinxiang, Peoples R China	Zhengzhou University; University of Massachusetts System; University of Massachusetts Worcester; Sun Yat Sen University; Xinxiang Medical University; Xinxiang Medical University	Song, XQ (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China.	sxqzhll@126.com	zhang, xu/GRX-9733-2022; Sui, Yanwei/AAH-9928-2021; Fan, Xiaoduo/AAV-1268-2020; zhang, xu/GYE-3558-2022	Fan, Xiaoduo/0000-0003-4299-8924; 	National Natural Science Foundation of China [81571318, 81371472, 81401110]; Science and Technology Planning Project of Health and Family Planning Commission [201501015]; International Science and Technology Cooperation Program of Henan [162102410061]; Science and Technology Planning Project of Guangdong Province [2013B021800085]; Fundamental Research Funds for the Central University [14ykpy28]; Youth Fund of the First Affiliated Hospital of Zhengzhou University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Health and Family Planning Commission; International Science and Technology Cooperation Program of Henan; Science and Technology Planning Project of Guangdong Province; Fundamental Research Funds for the Central University; Youth Fund of the First Affiliated Hospital of Zhengzhou University	Funding for this study was provided by the National Natural Science Foundation of China (No. 81571318 to X-QS; No. 81371472 to L-XL; No. 81401110 to XL), Science and Technology Planning Project of Health and Family Planning Commission (No. 201501015 to X-QS), International Science and Technology Cooperation Program of Henan (No. 162102410061 to X-QS), Science and Technology Planning Project of Guangdong Province (No. 2013B021800085 to Q-LW), the Fundamental Research Funds for the Central University (No. 14ykpy28 to Q-LW) and the Youth Fund of the First Affiliated Hospital of Zhengzhou University (to XL, L-JP).	Antonius D, 2011, SCHIZOPHR RES, V128, P76, DOI 10.1016/j.schres.2011.02.020; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Cascella NG, 2011, SCHIZOPHR RES, V133, P77, DOI 10.1016/j.schres.2011.08.004; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; Chan RCK, 2011, SCHIZOPHRENIA BULL, V37, P177, DOI 10.1093/schbul/sbp073; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Crespo-Facorro B, 2007, SCHIZOPHR RES, V91, P87, DOI 10.1016/j.schres.2006.12.015; Friston KJ, 1999, ACTA PSYCHIAT SCAND, V99, P68, DOI 10.1111/j.1600-0447.1999.tb05985.x; Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004; Hadley JA, 2014, NEUROPSYCHOPHARMACOL, V39, P1020, DOI 10.1038/npp.2013.305; Hirayasu Y, 2000, ARCH GEN PSYCHIAT, V57, P692, DOI 10.1001/archpsyc.57.7.692; Hoekert M, 2007, SCHIZOPHR RES, V96, P135, DOI 10.1016/j.schres.2007.07.023; Iwabuchi SJ, 2015, EUR ARCH PSY CLIN N, V265, P163, DOI 10.1007/s00406-014-0547-z; Kasai K, 2003, ARCH GEN PSYCHIAT, V60, P766, DOI 10.1001/archpsyc.60.8.766; Kasparek T, 2013, HUM BRAIN MAPP, V34, P726, DOI 10.1002/hbm.21469; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Konrad A, 2008, SCHIZOPHRENIA BULL, V34, P72, DOI 10.1093/schbul/sbm034; Lee SH, 2016, SCHIZOPHRENIA BULL, V42, P790, DOI 10.1093/schbul/sbv177; Lee SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090792; Leitman DI, 2007, AM J PSYCHIAT, V164, P474, DOI 10.1176/appi.ajp.164.3.474; Linnman C, 2013, SCHIZOPHR RES, V143, P150, DOI 10.1016/j.schres.2012.10.038; Manoliu A, 2014, SCHIZOPHRENIA BULL, V40, P428, DOI 10.1093/schbul/sbt037; Manoliu A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00216; Markostamou I, 2015, NEUROCASE, V21, P148, DOI 10.1080/13554794.2013.878725; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Moran LV, 2013, BIOL PSYCHIAT, V74, P467, DOI 10.1016/j.biopsych.2013.02.029; Moriya J, 2010, SCHIZOPHR RES, V116, P196, DOI 10.1016/j.schres.2009.10.002; Mucci A, 2015, PSYCHOL MED, V45, P1765, DOI 10.1017/S0033291714002943; Mueller S, 2015, JAMA PSYCHIAT, V72, P552, DOI 10.1001/jamapsychiatry.2014.3176; Nekovarova T, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00171; Nelson SM, 2010, BRAIN STRUCT FUNCT, V214, P669, DOI 10.1007/s00429-010-0260-2; Northoff G, 2014, CLIN PSYCHOPHARM NEU, V12, P189, DOI 10.9758/cpn.2014.12.3.189; Orliac F, 2013, SCHIZOPHR RES, V148, P74, DOI 10.1016/j.schres.2013.05.007; Palaniyappan L, 2011, PSYCHOL MED, V41, P1701, DOI 10.1017/S0033291710002205; Palaniyappan L, 2012, J PSYCHIATR NEUROSCI, V37, P17, DOI 10.1503/jpn.100176; Palaniyappan L, 2011, PROG NEURO-PSYCHOPH, V35, P523, DOI 10.1016/j.pnpbp.2010.12.008; RADEMACHER J, 1992, J COGNITIVE NEUROSCI, V4, P352, DOI 10.1162/jocn.1992.4.4.352; Rajarethinam R, 2007, BRIT J PSYCHIAT, V191, P258, DOI 10.1192/bjp.bp.106.029017; Sarpal DK, 2016, AM J PSYCHIAT, V173, P69, DOI 10.1176/appi.ajp.2015.14121571; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Simon V, 2009, EUR PSYCHIAT, V24, P239, DOI 10.1016/j.eurpsy.2008.10.004; Stefanovics EA, 2014, PSYCHIAT RES, V219, P283, DOI 10.1016/j.psychres.2014.04.041; Takahashi T, 2009, ARCH GEN PSYCHIAT, V66, P366, DOI 10.1001/archgenpsychiatry.2009.12; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Tyszka JM, 2014, CEREB CORTEX, V24, P1894, DOI 10.1093/cercor/bht040; Wylie KP, 2010, SCHIZOPHR RES, V123, P93, DOI 10.1016/j.schres.2010.08.027; Xie CM, 2012, NEUROIMAGE, V63, P320, DOI 10.1016/j.neuroimage.2012.06.062	48	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0167242	10.1371/journal.pone.0167242	http://dx.doi.org/10.1371/journal.pone.0167242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI3QC	28107346	Green Published, Green Submitted, gold			2022-12-26	WOS:000392405300004
J	Tsuboi, M; Watanabe, M; Nibe, K; Yoshimi, N; Kato, A; Sakaguchi, M; Yamato, O; Tanaka, M; Kuwamura, M; Kushida, K; Ishikura, T; Harada, T; Chambers, JK; Sugano, S; Uchida, K; Nakayama, H				Tsuboi, Masaya; Watanabe, Manabu; Nibe, Kazumi; Yoshimi, Natsuko; Kato, Akihisa; Sakaguchi, Masahiro; Yamato, Osamu; Tanaka, Miyuu; Kuwamura, Mitsuru; Kushida, Kazuya; Ishikura, Takashi; Harada, Tomoyuki; Chambers, James Kenn; Sugano, Sumio; Uchida, Kazuyuki; Nakayama, Hiroyuki			Identification of the PLA2G6 c. 1579G > A Missense Mutation in Papillon Dog Neuroaxonal Dystrophy Using Whole Exome Sequencing Analysis	PLOS ONE			English	Article							CEREBELLAR CORTICAL ABIOTROPHY; PHOSPHOLIPASE A(2); MOUSE MODEL; ACCUMULATION; ROTTWEILER; FEATURES; DEFICIENCY; PROTEINS; SYSTEM; AXONS	Whole exome sequencing (WES) has become a common tool for identifying genetic causes of human inherited disorders, and it has also recently been applied to canine genome research. We conducted WES analysis of neuroaxonal dystrophy (NAD), a neurodegenerative disease that sporadically occurs worldwide in Papillon dogs. The disease is considered an autosomal recessive monogenic disease, which is histopathologically characterized by severe axonal swelling, known as "spheroids," throughout the nervous system. By sequencing all eleven DNA samples from one NAD-affected Papillon dog and her parents, two unrelated NAD-affected Papillon dogs, and six unaffected control Papillon dogs, we identified 10 candidate mutations. Among them, three candidates were determined to be "deleterious" by in silico pathogenesis evaluation. By subsequent massive screening by TaqMan genotyping analysis, only the PLA2G6 c. 1579G>A mutation had an association with the presence or absence of the disease, suggesting that it may be a causal mutation of canine NAD. As a human homologue of this gene is a causative gene for infantile neuroaxonal dystrophy, this canine phenotype may serve as a good animal model for human disease. The results of this study also indicate that WES analysis is a powerful tool for exploring canine hereditary diseases, especially in rare monogenic hereditary diseases.	[Tsuboi, Masaya; Harada, Tomoyuki; Chambers, James Kenn; Uchida, Kazuyuki; Nakayama, Hiroyuki] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Vet Pathol, Tokyo, Japan; [Watanabe, Manabu; Sugano, Sumio] Univ Tokyo, Grad Sch Frontier Sci, Lab Funct Genom, Tokyo, Japan; [Nibe, Kazumi] Japan Anim Referral Med Ctr, Kawasaki, Kanagawa, Japan; [Yoshimi, Natsuko; Kato, Akihisa] D&C Vet Clin, Ibaraki, Japan; [Sakaguchi, Masahiro] Azabu Univ, Sch Vet Med, Lab Vet Microbiol 1, Sagamihara, Kanagawa, Japan; [Yamato, Osamu] Kagoshima Univ, Joint Fac Vet Med, Clin Pathol Lab, Kagoshima, Japan; [Tanaka, Miyuu; Kuwamura, Mitsuru] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Lab Vet Pathol, Osaka, Japan; [Ishikura, Takashi] Life Technol Japan Ltd, Thermo Fisher Sci, Tokyo, Japan	University of Tokyo; University of Tokyo; Azabu University; Kagoshima University; Osaka Metropolitan University; Thermo Fisher Scientific	Uchida, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Lab Vet Pathol, Tokyo, Japan.	auchidak@mail.ecc.u-tokyo.ac.jp		Chambers, James/0000-0001-5273-7221; Yamato, Osamu/0000-0002-4430-5645	JSPS KAKENHI [20721963]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for JSPS KAKENHI (http://www.jsps.go.jp/english/e-grants/index.html) 20721963 (to M. Tsuboi). One of our authors (TI) is employed by a commercial company (Thermo Fisher Scientific, Life Technologies Japan Ltd.). The funder provided support in the form of salary, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of the author is articulated in the author contributions section.	AICARDI J, 1979, BRAIN, V102, P727, DOI 10.1093/brain/102.4.727; Aleman M, 2011, JAVMA-J AM VET MED A, V239, P823, DOI 10.2460/javma.239.6.823; Beck G, 2011, J NEUROSCI, V31, P11411, DOI 10.1523/JNEUROSCI.0345-11.2011; BEECH J, 1984, VET PATHOL, V21, P384, DOI 10.1177/030098588402100404; Bennnett PF, 1997, AUST VET J, V75, P784, DOI 10.1111/j.1751-0813.1997.tb15650.x; Bouley DM, 2006, J COMP PATHOL, V134, P161, DOI 10.1016/j.jcpa.2005.10.002; Broeckx BJG, 2014, SCI REP-UK, V4, DOI 10.1038/srep05597; Brosnahan MM, 2009, J VET INTERN MED, V23, P1303, DOI 10.1111/j.1939-1676.2009.0379.x; CARMICHAEL KP, 1993, J VET DIAGN INVEST, V5, P585, DOI 10.1177/104063879300500414; Chambers JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046452; Chambers JK, 2011, AMYLOID, V18, P63, DOI 10.3109/13506129.2011.570385; CHRISMAN CL, 1984, J AM VET MED ASSOC, V184, P464; CLARK RG, 1982, NEW ZEAL VET J, V30, P102, DOI 10.1080/00480169.1982.34897; CORDY DR, 1967, ACTA NEUROPATHOL, V8, P133, DOI 10.1007/BF00687690; COWEN D, 1963, J NEUROPATH EXP NEUR, V22, P175, DOI 10.1097/00005072-196304000-00001; Diaz JV, 2007, J VET INTERN MED, V21, P531, DOI 10.1892/0891-6640(2007)21[531:NDIDCR]2.0.CO;2; Engel LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012897; Evans JM, 2016, MAMM GENOME, V27, P495, DOI 10.1007/s00335-016-9644-9; FRANKLIN RJM, 1995, J SMALL ANIM PRACT, V36, P441, DOI 10.1111/j.1748-5827.1995.tb02774.x; Fyfe JC, 2010, J COMP NEUROL, V518, P3771, DOI 10.1002/cne.22423; Gregory A, 2008, NEUROLOGY, V71, P1402, DOI 10.1212/01.wnl.0000327094.67726.28; Gregory A, 2009, J MED GENET, V46, P73, DOI 10.1136/jmg.2008.061929; Hahn K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141824; Hanshaw DM, 2015, AUST VET J, V93, P283, DOI 10.1111/avj.12346; HARPER P, 1991, AUST VET J, V68, P152, DOI 10.1111/j.1751-0813.1991.tb03162.x; Kessell AE, 2012, J COMP PATHOL, V147, P62, DOI 10.1016/j.jcpa.2011.09.006; Khateeb S, 2006, AM J HUM GENET, V79, P942, DOI 10.1086/508572; Kropatsch Regina, 2016, Canine Genet Epidemiol, V3, P7, DOI 10.1186/s40575-016-0037-x; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Malik I, 2008, AM J PATHOL, V172, P406, DOI 10.2353/ajpath.2008.070823; Matsushima Y, 2005, MAMM GENOME, V16, P73, DOI 10.1007/s00335-004-3017-5; Molloy GY, 1998, NEUROSCI LETT, V258, P139, DOI 10.1016/S0304-3940(98)00838-6; Morgan NV, 2006, NAT GENET, V38, P752, DOI 10.1038/ng1826; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nibe K, 2009, VET PATHOL, V46, P474, DOI 10.1354/vp.08-VP-0156-U-FL; Nibe K, 2007, J VET MED SCI, V69, P1047, DOI 10.1292/jvms.69.1047; Ong WY, 2005, J NEUROCYTOL, V34, P447, DOI 10.1007/s11068-006-8730-4; Paisan-Ruiz C, 2012, NEUROBIOL AGING, V33, P814, DOI 10.1016/j.neurobiolaging.2010.05.009; Pintus D, 2016, ACTA VET SCAND, V58, DOI 10.1186/s13028-016-0218-3; Rabbani B, 2012, J HUM GENET, V57, P621, DOI 10.1038/jhg.2012.91; Resibois A, 2004, ACTA NEUROPATHOL, V107, P553, DOI 10.1007/s00401-004-0846-y; SACRE BJ, 1993, CORNELL VET, V83, P133; Sato J, 2012, VET PATHOL, V49, P621, DOI 10.1177/0300985811402840; Shinzawa K, 2008, J NEUROSCI, V28, P2212, DOI 10.1523/JNEUROSCI.4354-07.2008; Shirai Y, 2004, J NEUROCYTOL, V33, P297, DOI 10.1023/B:NEUR.0000044191.83858.f7; Siso S, 2001, ACTA NEUROPATHOL, V102, P501; TAKEUCHI IK, 1994, ACTA NEUROPATHOL, V87, P628; Tamura S, 2007, J SMALL ANIM PRACT, V48, P458, DOI 10.1111/j.1748-5827.2006.00304.x; Tonelli A, 2010, CLIN GENET, V78, P432, DOI 10.1111/j.1399-0004.2010.01417.x; Wada H, 2009, AM J PATHOL, V175, P2257, DOI 10.2353/ajpath.2009.090343	50	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0169002	10.1371/journal.pone.0169002	http://dx.doi.org/10.1371/journal.pone.0169002			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107443	Green Published, Green Submitted, gold			2022-12-26	WOS:000392405300018
J	Wendt, A; Mollet, IG; Knutsson, A; Bolmgren, VS; Hultgardh-Nilsson, A; Gomez, MF; Eliasson, L				Wendt, Anna; Mollet, Ines G.; Knutsson, Anki; Bolmgren, Victor S.; Hultgardh-Nilsson, Anna; Gomez, Maria F.; Eliasson, Lena			Osteopontin Affects Insulin Vesicle Localization and Ca2+ Homeostasis in Pancreatic Beta Cells from Female Mice	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; ADIPOSE-TISSUE; NITRIC-OXIDE; SECRETION; ISLETS; RESISTANCE; MECHANISMS; EXOCYTOSIS; EXPRESSION; LANGERHANS	Type 2 diabetic patients suffer from insulin resistance and reduced insulin secretion. Osteopontin (OPN), a versatile protein expressed in several tissues throughout the body including the islets of Langerhans, has previously been implicated in the development of insulin resistance. Here we have investigated the role of OPN in insulin secretion using an OPN knock out mouse model (OPN-/-). Ultra-structural analyzes of islets from OPN-/- and WT mice indicated weaker cell-cell connections between the islet cells in the OPN-/-mouse compared to WT. Analysis of the insulin granule distribution in the beta cells showed that although OPN-/- and WT beta cells have the same number of insulin granules OPN-/-beta cells have significantly fewer docked granules. Both OPN-/- and WT islets displayed synchronized Ca2+ oscillations indicative of an intact beta cell communication. OPN-/- islets displayed higher intracellular Ca2+ concentrations when stimulated with 16.7 mM glucose than WT islets and the initial dip upon elevated glucose concentrations (which is associated with Ca2+ uptake into ER) was significantly lower in these islets. Glucose-induced insulin secretion was similar in OPN-/- and WT islets. Likewise, non-fasted blood glucose levels were the same in both groups. In summary, deletion of OPN results in several minor beta-cell defects that can be compensated for in a healthy system.	[Wendt, Anna; Mollet, Ines G.; Eliasson, Lena] Lund Univ, Dept Clin Sci Malmo, Ctr Diabet, Clin Res Ctr,Unit Islet Cell Exocytosis, Malmo, Sweden; [Knutsson, Anki; Bolmgren, Victor S.; Hultgardh-Nilsson, Anna] Lund Univ, Dept Expt Med Sci, Biomed Ctr, Vessel Wall Biol, Lund, Sweden; [Gomez, Maria F.] Lund Univ, Dept Clin Sci Malmo, Ctr Diabet, Unit Vasc Excitat Transcript ET Coupling,Clin Res, Malmo, Sweden	Lund University; Lund University; Lund University; Pfizer	Wendt, A (corresponding author), Lund Univ, Dept Clin Sci Malmo, Ctr Diabet, Clin Res Ctr,Unit Islet Cell Exocytosis, Malmo, Sweden.	anna.wendt@med.lu.se	Eliasson, Lena/E-9294-2012; Gomez, Maria F/D-3696-2014; Mollet, Ines Guerra/H-8526-2019	Eliasson, Lena/0000-0002-6467-5029; Gomez, Maria F/0000-0001-6210-3142; Mollet, Ines Guerra/0000-0002-1422-1336; Wendt, Anna/0000-0001-8807-5979	Albert Pahlssons Foundation; Swedish Research Council [K2012-55X-13147-14-5, 2014-3352]; ERC [GA 269045]; Region Skane-ALF; Swedish Diabetes Foundation; Knut & Alice Wallenberg Foundation	Albert Pahlssons Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); ERC(European Research Council (ERC)European Commission); Region Skane-ALF(Region Auvergne-Rhone-AlpesRegion Bourgogne-Franche-ComteRegion Hauts-de-FranceRegion Nouvelle-Aquitaine); Swedish Diabetes Foundation; Knut & Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This study was supported by Albert Pahlssons Foundation (AW), Swedish Research Council (Grant number K2012-55X-13147-14-5 for LE and 2014-3352 for M.F.G, strategic research grant to Exodiab), ERC Advanced researcher grant (GA 269045; PI Leif Groop), Region Skane-ALF (LE), The Swedish Diabetes Foundation (LE), and Knut & Alice Wallenberg Foundation. The funders had no role in the study design, data Collection and analysis, decision to publish, or preparation of the manuscript.	Ahlqvist E, 2013, DIABETES, V62, P2088, DOI 10.2337/db12-0976; Arafat HA, 2007, ENDOCRINOLOGY, V148, P575, DOI 10.1210/en.2006-0970; Arredouani A, 2002, DIABETES, V51, P3245, DOI 10.2337/diabetes.51.11.3245; ASHCROFT FM, 1994, J CELL BIOCHEM, V55, P54, DOI 10.1002/jcb.240550007; Aspord C, 2004, J AUTOIMMUN, V23, P27, DOI 10.1016/j.jaut.2004.03.007; Barchetta I, 2016, EUR J ENDOCRINOL, V174, P187, DOI 10.1530/EJE-15-0791; Berglund LM, 2016, DIABETES, V65, P239, DOI 10.2337/db15-0122; Chapman J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013959; Chen YC, 2013, MOL ENDOCRINOL, V27, P162, DOI 10.1210/me.2012-1174; DEHOFF RT, 1961, T METALL SOC AIME, V221, P975; Eraly SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097734; Fox PD, 2013, MOL BIOL CELL, V24, P2703, DOI 10.1091/mbc.E12-12-0895; FRANZEN A, 1985, BIOCHEM J, V232, P715, DOI 10.1042/bj2320715; Franzen A, 2008, J ORTHOP RES, V26, P721, DOI 10.1002/jor.20544; Gandasi NR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4914; Gilon P, 2014, CELL CALCIUM, V56, P340, DOI 10.1016/j.ceca.2014.09.001; Gong QK, 2009, ISLETS, V1, P34, DOI 10.4161/isl.1.1.8629; Gordin D, 2014, DIABETES CARE, V37, P2593, DOI 10.2337/dc14-0065; Inoue M, 2011, IMMUNOL RES, V49, P160, DOI 10.1007/s12026-010-8179-5; Ivarsson R, 2005, TRAFFIC, V6, P1027, DOI 10.1111/j.1600-0854.2005.00342.x; Katakam AK, 2005, J ENDOCRINOL, V187, P237, DOI 10.1677/joe.1.06411; Kiefer FW, 2010, DIABETES, V59, P935, DOI 10.2337/db09-0404; Kong MY, 2005, GEOL SOC AM BULL, V117, P244, DOI 10.1130/B25000.1; Kwan EP, 2007, DIABETES OBES METAB, V9, P99, DOI 10.1111/j.1463-1326.2007.00788.x; Lancha A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098398; Lyssenko V, 2011, DIABETES, V60, P2424, DOI 10.2337/db10-1532; MacDonald PE, 2011, AM J PHYSIOL-ENDOC M, V301, pE1065, DOI 10.1152/ajpendo.00426.2011; MEDA P, 1980, AM J PHYSIOL, V238, pC114, DOI 10.1152/ajpcell.1980.238.3.C114; Miura Y, 1997, J PHYSIOL-LONDON, V503, P387, DOI 10.1111/j.1469-7793.1997.387bh.x; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Oh E, 2012, J BIOL CHEM, V287, P25821, DOI 10.1074/jbc.M112.361501; Olofsson CS, 2002, PFLUG ARCH EUR J PHY, V444, P43, DOI 10.1007/s00424-002-0781-5; Orci L, 2009, P NATL ACAD SCI USA, V106, P19358, DOI 10.1073/pnas.0911280106; Ravier MA, 2005, DIABETES, V54, P1798, DOI 10.2337/diabetes.54.6.1798; Rizzuto R, 2003, ONCOGENE, V22, P8619, DOI 10.1038/sj.onc.1207105; Salehi A, 1999, J PHYSIOL-LONDON, V514, P579, DOI 10.1111/j.1469-7793.1999.579ae.x; Sun SY, 2014, P NATL ACAD SCI USA, V111, pE582, DOI 10.1073/pnas.1318114111; Uede T, 2011, PATHOL INT, V61, P265, DOI 10.1111/j.1440-1827.2011.02649.x; Varadi A, 1996, BIOCHEM J, V319, P521, DOI 10.1042/bj3190521; Zhang Q, 2008, PHILOS T R SOC A, V366, P3503, DOI 10.1098/rsta.2008.0110	40	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170498	10.1371/journal.pone.0170498	http://dx.doi.org/10.1371/journal.pone.0170498			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107503	gold, Green Published, Green Submitted			2022-12-26	WOS:000392405300148
J	Marcel, V; Catez, F; Berger, CM; Perrial, E; Plesa, A; Thomas, X; Mattei, E; Hayette, S; Saintigny, P; Bouvet, P; Diaz, JJ; Dumontet, C				Marcel, Virginie; Catez, Frederic; Berger, Caroline M.; Perrial, Emeline; Plesa, Adriana; Thomas, Xavier; Mattei, Eve; Hayette, Sandrine; Saintigny, Pierre; Bouvet, Philippe; Diaz, Jean-Jacques; Dumontet, Charles			Expression Profiling of Ribosome Biogenesis Factors Reveals Nucleolin as a Novel Potential Marker to Predict Outcome in AML Patients	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; RNA-POLYMERASE I; GENE-EXPRESSION; RISK CLASSIFICATION; MYC; OVEREXPRESSION; METHYLATION; SURVIVAL; ADULTS	Acute myeloid leukemia (AML) is a heterogeneous disease. Prognosis is mainly influenced by patient age at diagnosis and cytogenetic alterations, two of the main factors currently used in AML patient risk stratification. However, additional criteria are required to improve the current risk classification and better adapt patient care. In neoplastic cells, ribosome biogenesis is increased to sustain the high proliferation rate and ribosome composition is altered to modulate specific gene expression driving tumorigenesis. Here, we investigated the usage of ribosome biogenesis factors as clinical markers in adult patients with AML. We showed that nucleoli, the nucleus compartments where ribosome production takes place, are modified in AML by analyzing a panel of AML and healthy donor cells using immunofluorescence staining. Using four AML series, including the TCGA dataset, altogether representing a total of about 270 samples, we showed that not all factors involved in ribosome biogenesis have clinical values although ribosome biogenesis is increased in AML. Interestingly, we identified the regulator of ribosome production nucleolin (NCL) as over-expressed in AML blasts. Moreover, we found in two series that high NCL m RNA expression level was associated with a poor overall survival, particular in elderly patients. Multivariate analyses taking into account age and cytogenetic risk indicated that NCL expression in blast cells is an independent marker of reduced survival. Our study identifies NCL as a potential novel prognostic factor in AML. Altogether, our results suggest that the ribosome biogenesis pathway may be of interest as clinical markers in AML.	[Marcel, Virginie; Catez, Frederic; Berger, Caroline M.; Perrial, Emeline; Saintigny, Pierre; Bouvet, Philippe; Diaz, Jean-Jacques; Dumontet, Charles] Ctr Leon Berard, Canc Res Ctr Lyon, UMR INSERM CNRS 5286 1052, Lyon, France; [Marcel, Virginie; Catez, Frederic; Berger, Caroline M.; Perrial, Emeline; Saintigny, Pierre; Bouvet, Philippe; Diaz, Jean-Jacques; Dumontet, Charles] Univ Lyon 1, Lyon, France; [Marcel, Virginie; Catez, Frederic; Berger, Caroline M.; Bouvet, Philippe; Diaz, Jean-Jacques] Canc Cell Plast Dept, Nucl Domains & Pathol Team, Lyon, France; [Perrial, Emeline; Dumontet, Charles] Microenvironm & Virus Dept, Anticanc Antibodies Team, Immun, Lyon, France; [Plesa, Adriana; Mattei, Eve; Hayette, Sandrine] Ctr Hosp Lyon Sud, Dept Biol, Hosp Civils Lyon, Pierre Benite, France; [Thomas, Xavier] Ctr Hosp Lyon Sud, Dept Hematol, Hosp Civils Lyon, Pierre Benite, France; [Saintigny, Pierre] Ctr Leon Berard, Dept Med, Lyon, France; [Bouvet, Philippe] Ecole Normale Super Lyon, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; CHU Lyon; UNICANCER; Centre Leon Berard; Ecole Normale Superieure de Lyon (ENS de LYON)	Diaz, JJ; Dumontet, C (corresponding author), Ctr Leon Berard, Canc Res Ctr Lyon, UMR INSERM CNRS 5286 1052, Lyon, France.; Diaz, JJ; Dumontet, C (corresponding author), Univ Lyon 1, Lyon, France.; Diaz, JJ (corresponding author), Canc Cell Plast Dept, Nucl Domains & Pathol Team, Lyon, France.; Dumontet, C (corresponding author), Microenvironm & Virus Dept, Anticanc Antibodies Team, Immun, Lyon, France.	jean-jacques.diaz@lyon.unicancer.fr; charles.dumontet@chu-lyon.fr	, Bouvet/AAC-8779-2020; DIAZ, Jean-Jacques/H-3018-2014; DIAZ, Jean-Jacques/AAT-3846-2021; Marcel, Virginie/H-3037-2011; MARCEL, Virginie/ABF-1904-2020; CATEZ, Frédéric/GQP-7328-2022; HAYETTE, sandrine/Z-2283-2019	DIAZ, Jean-Jacques/0000-0002-7914-4319; DIAZ, Jean-Jacques/0000-0002-7914-4319; Marcel, Virginie/0000-0002-9557-8221; MARCEL, Virginie/0000-0002-9557-8221; Bouvet, Philippe/0000-0003-4524-2233; Dumontet, Charles/0000-0003-1875-134X; Saintigny, Pierre/0000-0002-8090-9323	Ligue Nationale Contre le Cancer Comite Rhone [13-763C]; Comite Allier; Comite Saone-et-Loire; CNRS; INSERM; Universite Claude Bernard Lyon-1; Centre Leon Berard	Ligue Nationale Contre le Cancer Comite Rhone(Ligue nationale contre le cancer); Comite Allier; Comite Saone-et-Loire; CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Claude Bernard Lyon-1; Centre Leon Berard	This study was supported by Ligue Nationale Contre le Cancer Comite Rhone (no 13-763C, 2014), Comite Allier (2016) and Comite Saone-et-Loire (2016), CNRS, INSERM, Universite Claude Bernard Lyon-1, Centre Leon Berard. VM was a recipient of a postdoctoral fellowship from Centre Leon Berard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALITALO K, 1985, LANCET, V2, P1035; Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Bellodi C, 2013, CELL REP, V3, P1493, DOI 10.1016/j.celrep.2013.04.030; Bullinger L, 2010, BLOOD, V115, P636, DOI 10.1182/blood-2009-03-211003; Burger K, 2010, J BIOL CHEM, V285, P12416, DOI 10.1074/jbc.M109.074211; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; Chan M, 2011, J MOL DIAGN, V13, P305, DOI 10.1016/j.jmoldx.2010.12.001; Chen SJ, 2013, NAT GENET, V45, P586, DOI 10.1038/ng.2651; Colovic M, 2012, ANN HEMATOL, V91, P1363, DOI 10.1007/s00277-012-1478-2; Cong R, 2012, NUCLEIC ACIDS RES, V40, P9441, DOI 10.1093/nar/gks720; Cowling VH, 2013, ONCOGENE, P1; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Federici L, 2013, PROTEIN SCI, V22, P545, DOI 10.1002/pro.2240; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Gattoni-Celli S, 2009, AM J HEMATOL, V84, P535, DOI 10.1002/ajh.21461; Grinstein E, 2007, J BIOL CHEM, V282, P12439, DOI 10.1074/jbc.M608068200; Klobusicka M, 1996, NEOPLASMA, V43, P397; Lafontaine DLJ, 2015, NAT STRUCT MOL BIOL, V22, P11, DOI 10.1038/nsmb.2939; Lapinaite A, 2013, NATURE, V502, P519, DOI 10.1038/nature12581; Larramendy ML, 2002, HAEMATOLOGICA, V87, P569; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Li ZJ, 2013, J CLIN ONCOL, V31, P1172, DOI 10.1200/JCO.2012.44.3184; Liersch R, 2014, BRIT J HAEMATOL, V165, P17, DOI 10.1111/bjh.12750; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mamdani H, 2016, J AM MED DIR ASSOC, V17, P581, DOI 10.1016/j.jamda.2016.03.001; Marcel V, 2013, ONCOTARGET, V4, P1554, DOI 10.18632/oncotarget.1511; Marcel V, 2013, CANCER CELL, V24, P318, DOI 10.1016/j.ccr.2013.08.013; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; Mrozek K, 2012, J CLIN ONCOL, V30, P4515, DOI 10.1200/JCO.2012.43.4738; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; NIKICICZ EP, 1990, J CLIN PATHOL, V43, P723, DOI 10.1136/jcp.43.9.723; Peltonen K, 2014, CANCER CELL, V25, P77, DOI 10.1016/j.ccr.2013.12.009; Pich A, 1998, J CLIN ONCOL, V16, P1512, DOI 10.1200/JCO.1998.16.4.1512; Pinto A, 2001, CRIT REV ONCOL HEMAT, V39, P275, DOI 10.1016/S1040-8428(00)00122-0; Rollig C, 2011, J CLIN ONCOL, V29, P2758, DOI 10.1200/JCO.2010.32.8500; Ruggero D, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012336; Ruggero D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003477; SCHUMACHER HR, 1973, AM J PATHOL, V73, P27; Shen N, 2014, ONCOTARGET, V5, P5494, DOI 10.18632/oncotarget.2131; Shivarov V, 2014, EXPT HEMATOLOGY, P1; Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035; SLOVAK ML, 1994, GENE CHROMOSOME CANC, V9, P62, DOI 10.1002/gcc.2870090111; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Tessarz P, 2014, NATURE, V505, P564, DOI 10.1038/nature12819; Valleron W, 2012, BLOOD, V120, P3997, DOI 10.1182/blood-2012-06-438135; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622	46	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170160	10.1371/journal.pone.0170160	http://dx.doi.org/10.1371/journal.pone.0170160			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103300	Green Published, gold, Green Submitted			2022-12-26	WOS:000392381100041
J	Yang, Z; Li, J; Feng, GX; Gao, S; Wang, Y; Zhang, SQ; Liu, YX; Ye, LH; Li, YG; Zhang, XD				Yang, Zhe; Li, Jiong; Feng, Guoxing; Gao, Shan; Wang, Yuan; Zhang, Shuqin; Liu, Yunxia; Ye, Lihong; Li, Yueguo; Zhang, Xiaodong			MicroRNA-145 Modulates N-6-Methyladenosine Levels by Targeting the 3 '-Untranslated mRNA Region of the N-6-Methyladenosine Binding YTH Domain Family 2 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microRNA (miRNA); microRNA mechanism; mRNA decay; RNA methylation; RNA modification; N6-methyladenosine (m6A); YTH domain family 2 (YTHDF2); mRNA degradation; miR-145	BREAST-CANCER CELLS; HEPATOCELLULAR-CARCINOMA; INHIBITS PROLIFERATION; HEPATOMA-CELLS; MIR-145; GROWTH; N6-METHYLADENOSINE; BIOGENESIS; M(6)A; METHYLATION	N-6-Methyladenosine (m(6)A) is a prevalent modification present in the mRNAs of higher eukaryotes. YTH domain family 2 (YTHDF2), an m(6)A reader protein, can recognize mRNA m(6)A sites to mediate mRNA degradation. However, the regulatory mechanism of YTHDF2 is poorly understood. To this end, we investigated the post-transcriptional regulation of YTHDF2. Bioinformatics analysis suggested that the microRNA miR-145 might target the 3-untranslated region (3-UTR) of YTHDF2 mRNA. The levels of miR-145 were negatively correlated with those of YTHDF2 mRNA in clinical hepatocellular carcinoma (HCC) tissues, and immunohistochemical staining revealed that YTHDF2 was closely associated with malignancy of HCC. Interestingly, miR-145 decreased the luciferase activities of 3-UTR of YTHDF2 mRNA. Mutation of predicted miR-145 binding sites in the 3-UTR of YTHDF2 mRNA abolished the miR-145-induced decrease in luciferase activity. Overexpression of miR-145 dose-dependently down-regulated YTHDF2 expression in HCC cells at the levels of both mRNA and protein. Conversely, inhibition of miR-145 resulted in the up-regulation of YTHDF2 in the cells. Dot blot analysis and immunofluorescence staining revealed that the overexpression of miR-145 strongly increased m(6)A levels relative to those in control HCC cells, and this increase could be blocked by YTHDF2 overexpression. Moreover, miR-145 inhibition strongly decreased m(6)A levels, which were rescued by treatment with a small interfering RNA-based YTHDF2 knockdown. Thus, we conclude that miR-145 modulates m(6)A levels by targeting the 3-UTR of YTHDF2 mRNA in HCC cells.	[Yang, Zhe; Li, Jiong; Feng, Guoxing; Gao, Shan; Wang, Yuan; Zhang, Shuqin; Liu, Yunxia; Zhang, Xiaodong] Nankai Univ, Dept Canc Res, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Ye, Lihong] Nankai Univ, Dept Biochem, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Li, Yueguo] Tianjin Med Univ, Dept Clin Lab, Natl Clin Res Ctr Canc, Canc Inst & Hosp,Key Lab Canc Prevent & Therapy, Tianjin 300060, Peoples R China	Nankai University; Nankai University; Tianjin Medical University	Zhang, XD (corresponding author), Nankai Univ, Dept Canc Res, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.; Li, YG (corresponding author), Tianjin Med Univ, Dept Clin Lab, Natl Clin Res Ctr Canc, Canc Inst & Hosp,Key Lab Canc Prevent & Therapy, Tianjin 300060, Peoples R China.	yli08@tmu.edu.cn; zhangxd@nankai.edu.cn	Feng, Guoxing/AAD-6163-2019; wangwangwang, yuanyaun/HHN-6432-2022; Lv, Yuanjie/AER-0767-2022; Wang, Yuan/HHC-1520-2022		National Natural Scientific Foundation of China [81272218, 81372186, 31470756]; National Basic Research Program of China [2015CB553703]; Tianjin Natural Scientific Foundation [14JCZDJC32800]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Tianjin Natural Scientific Foundation	This work was supported by the National Natural Scientific Foundation of China (81272218, 81372186, 31470756), the National Basic Research Program of China (2015CB553703), and Tianjin Natural Scientific Foundation (14JCZDJC32800). The authors declare that they have no conflicts of interest with the contents of this article.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Ben-Haim MS, 2015, CELL RES, V25, P3, DOI 10.1038/cr.2014.162; Cardelli M, 2006, J GERONTOL A-BIOL, V61, P547, DOI 10.1093/gerona/61.6.547; Caruso P, 2012, CIRC RES, V111, P290, DOI 10.1161/CIRCRESAHA.112.267591; Chandola U, 2015, BRIEF FUNCT GENOMICS, V14, P169, DOI 10.1093/bfgp/elu039; Chen JP, 2015, J PHYSIOL BIOCHEM, V71, P405, DOI 10.1007/s13105-015-0420-1; Chiyomaru T, 2011, PROSTATE, V71, P1559, DOI 10.1002/pros.21372; Ding W, 2016, TUMOR BIOL, V37, P6255, DOI 10.1007/s13277-015-4462-3; Dong RF, 2014, ONCOTARGET, V5, P10816, DOI 10.18632/oncotarget.2522; Du H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12626; Dynoodt P, 2013, J INVEST DERMATOL, V133, P201, DOI 10.1038/jid.2012.266; Eades G, 2015, MOL CANCER RES, V13, P330, DOI 10.1158/1541-7786.MCR-14-0251; Finnegan EF, 2013, CRIT REV BIOCHEM MOL, V48, P51, DOI 10.3109/10409238.2012.738643; Gregory Richard I., 2006, V342, P33, DOI 10.1385/1-59745-123-1:33; Gurtan AM, 2013, J MOL BIOL, V425, P3582, DOI 10.1016/j.jmb.2013.03.007; Hastings MH, 2013, CELL, V155, P740, DOI 10.1016/j.cell.2013.10.028; Ji LY, 2013, PHARMAZIE, V68, P387, DOI 10.1691/ph.2013.2716; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Law PTY, 2012, CARCINOGENESIS, V33, P1134, DOI 10.1093/carcin/bgs130; Li S, 2014, ANNU REV GENOM HUM G, V15, P127, DOI 10.1146/annurev-genom-090413-025405; Liu H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9494; Liu SP, 2012, J BIOL CHEM, V287, P30228, DOI 10.1074/jbc.M112.343947; Lu RJ, 2014, J CANCER RES CLIN, V140, P387, DOI 10.1007/s00432-013-1577-z; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Niu Yamei, 2013, Genomics Proteomics & Bioinformatics, V11, P8, DOI 10.1016/j.gpb.2012.12.002; Ozen M, 2015, CANCER INVEST, V33, P251, DOI 10.3109/07357907.2015.1025407; Pan T, 2013, TRENDS BIOCHEM SCI, V38, P204, DOI 10.1016/j.tibs.2012.12.006; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Saletore Y, 2013, RNA BIOL, V10, P342, DOI 10.4161/rna.23812; Shan CL, 2011, CARCINOGENESIS, V32, P1190, DOI 10.1093/carcin/bgr106; Shan CL, 2010, CELL RES, V20, P563, DOI 10.1038/cr.2010.49; Sibbritt T, 2013, WIRES RNA, V4, P397, DOI 10.1002/wrna.1166; Soifer HS, 2007, MOL THER, V15, P2070, DOI 10.1038/sj.mt.6300311; Todorova T, 2015, TRENDS MOL MED, V21, P373, DOI 10.1016/j.molmed.2015.03.002; Wang F, 2013, ONKOLOGIE, V36, P754, DOI 10.1159/000356978; Wang GH, 2015, DIGEST DIS SCI, V60, P3044, DOI 10.1007/s10620-015-3706-9; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang YS, 2014, J MOL CELL CARDIOL, V66, P94, DOI 10.1016/j.yjmcc.2013.08.007; Wang YL, 2014, BIOCHEM BIOPH RES CO, V446, P1255, DOI 10.1016/j.bbrc.2014.03.107; Wang ZG, 2012, BIOCHEM BIOPH RES CO, V427, P444, DOI 10.1016/j.bbrc.2012.06.123; Wu HJ, 2013, BIOCHEM BIOPH RES CO, V441, P693, DOI 10.1016/j.bbrc.2013.10.053; Yang JS, 2011, MOL CELL, V43, P892, DOI 10.1016/j.molcel.2011.07.024; You XN, 2013, CARCINOGENESIS, V34, P1644, DOI 10.1093/carcin/bgt089; Zhang S, 2013, FEBS LETT, V587, P645, DOI 10.1016/j.febslet.2013.01.019; Zhang T, 2012, HEPATOLOGY, V56, P2051, DOI 10.1002/hep.25899; Zhang YY, 2013, J BIOL CHEM, V288, P18961, DOI 10.1074/jbc.M113.458638; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377	51	170	186	6	72	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3614	3623		10.1074/jbc.M116.749689	http://dx.doi.org/10.1074/jbc.M116.749689			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28104805	Green Published, hybrid			2022-12-26	WOS:000395542500007
J	Amico, F; O'Hanlon, E; Kraft, D; Oertel-Knochel, V; Clarke, M; Kelleher, I; Higgins, N; Coughlan, H; Creegan, D; Heneghan, M; Power, E; Power, L; Ryan, J; Frodl, T; Cannon, M				Amico, Francesco; O'Hanlon, Erik; Kraft, Dominik; Oertel-Knoechel, Viola; Clarke, Mary; Kelleher, Ian; Higgins, Niamh; Coughlan, Helen; Creegan, Daniel; Heneghan, Mark; Power, Emmet; Power, Lucy; Ryan, Jessica; Frodl, Thomas; Cannon, Mary			Functional Connectivity Anomalies in Adolescents with Psychotic Symptoms	PLOS ONE			English	Article							ULTRA-HIGH-RISK; DEFAULT-MODE NETWORK; AUDITORY VERBAL HALLUCINATIONS; MATTER VOLUME ABNORMALITIES; RESTING-STATE CONNECTIVITY; ANTERIOR CINGULATE CORTEX; DRUG-NAIVE SCHIZOPHRENIA; SALIENCE NETWORK; SYNDROME ASSOCIATIONS; CORTICAL THICKNESS	Background Previous magnetic resonance imaging (MRI) research suggests that, prior to the onset of psychosis, high risk youths already exhibit brain abnormalities similar to those present in patients with schizophrenia. Objectives The goal of the present study was to describe the functional organization of endogenous activation in young adolescents who report auditory verbal hallucinations (AVH) in view of the " distributed network " hypothesis of psychosis. We recruited 20 young people aged 13 - 16 years who reported AVHs and 20 healthy controls matched for age, gender and handedness from local schools. Methods Each participant underwent a semi-structured clinical interview and a resting state (RS) neuroimaging protocol. We explored functional connectivity (FC) involving three different networks: 1) default mode network (DMN) 2) salience network (SN) and 3) central executive network (CEN). In line with previous findings on the role of the auditory cortex in AVHs as reported by young adolescents, we also investigated FC anomalies involving both the primary and secondary auditory cortices (A1 and A2, respectively). Further, we explored between-group inter-hemispheric FC differences (laterality) for both A1 and A2. Compared to the healthy control group, the AVH group exhibited FC differences in all three networks investigated. Moreover, FC anomalies were found in a neural network including both A1 and A2. The laterality analysis revealed no between-group, inter-hemispheric differences. Conclusions The present study suggests that young adolescents with subclinical psychotic symptoms exhibit functional connectivity anomalies directly and indirectly involving the DMN, SN, CEN and also a neural network including both primary and secondary auditory cortical regions.	[Amico, Francesco; O'Hanlon, Erik; Clarke, Mary; Kelleher, Ian; Higgins, Niamh; Coughlan, Helen; Creegan, Daniel; Heneghan, Mark; Power, Emmet; Power, Lucy; Ryan, Jessica; Cannon, Mary] Royal Coll Surgeons Ireland, Dept Psychiat, Dublin, Ireland; [O'Hanlon, Erik] Trinity Coll Dublin, Trinity Coll, Inst Neurosci, Dublin, Ireland; [Kraft, Dominik; Oertel-Knoechel, Viola; Frodl, Thomas] Goethe Univ, Lab Neuroimaging, Dept Psychiat Psychosomat Med & Psychotherapy, Frankfurt, Germany; [Clarke, Mary] Royal Coll Surgeons Ireland, Div Populat Hlth Sci, Dept Psychol, Dublin, Ireland	Royal College of Surgeons - Ireland; Trinity College Dublin; Goethe University Frankfurt; Royal College of Surgeons - Ireland; University College Dublin	Cannon, M (corresponding author), Royal Coll Surgeons Ireland, Dept Psychiat, Dublin, Ireland.	amicof@gmail.com; marycannon@rcsi.ie	Coughlan, Helen/P-3462-2014; Frodl, Thomas Stefan/GQZ-9107-2022; Frodl, Thomas/D-8118-2012; Cannon, Mary/D-8227-2012	Coughlan, Helen/0000-0002-8494-2884; Frodl, Thomas Stefan/0000-0002-8113-6959; Frodl, Thomas/0000-0002-8113-6959; Cannon, Mary/0000-0002-0910-299X; Ryan, Jessica/0000-0001-6161-9630; Amico, Francesco/0000-0003-0837-2100; Kelleher, Ian/0000-0003-1484-651X	Health Research Board (Ireland) [HRA-PHR-2015-1323]	Health Research Board (Ireland)	This study was funded by a Health Research Award to M. Cannon from the Health Research Board (Ireland) (grant code: HRA-PHR-2015-1323). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Solis A, 2012, SCHIZOPHR RES, V139, P13, DOI 10.1016/j.schres.2012.05.005; Amad A, 2014, MOL PSYCHIATR, V19, P184, DOI 10.1038/mp.2012.181; Andreou C, 2015, SCHIZOPHRENIA BULL, V41, P930, DOI 10.1093/schbul/sbu121; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Borgwardt SJ, 2007, BIOL PSYCHIAT, V61, P1148, DOI 10.1016/j.biopsych.2006.08.009; Brandt GN, 2008, WIEN MED WOCHENSCHR, V158, P84, DOI 10.1007/s10354-007-0478-7; Brewer WJ, 2001, AM J PSYCHIAT, V158, P107, DOI 10.1176/appi.ajp.158.1.107; Cannon TD, 2015, BIOL PSYCHIAT, V77, P147, DOI 10.1016/j.biopsych.2014.05.023; Carballedo A, 2011, J AFFECT DISORDERS, V134, P272, DOI 10.1016/j.jad.2011.06.021; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Chang X, 2015, SCI REP-UK, V5, DOI 10.1038/srep11218; Chen Q, 2016, NEUROSCI LETT, V627, P178, DOI 10.1016/j.neulet.2016.05.035; Choi JS, 2008, PROG NEURO-PSYCHOPH, V32, P1326, DOI 10.1016/j.pnpbp.2008.04.011; Copolov DL, 2003, PSYCHIAT RES-NEUROIM, V122, P139, DOI 10.1016/S0925-4927(02)00121-X; Cressman VL, 2015, NPJ SCHIZOPHR, V1, DOI 10.1038/npjschz.2015.20; Debbane M, 2012, SCHIZOPHR RES, V139, P33, DOI 10.1016/j.schres.2012.05.021; Diederen KMJ, 2012, SCHIZOPHRENIA BULL, V38, P1074, DOI 10.1093/schbul/sbr033; Diederen KMJ, 2010, AM J PSYCHIAT, V167, P427, DOI 10.1176/appi.ajp.2009.09040456; Farid Faisal, 2009, J Med Case Rep, V3, P7337, DOI 10.4076/1752-1947-3-7337; Ford JM, 2009, SCHIZOPHRENIA BULL, V35, P58, DOI 10.1093/schbul/sbn140; Fornito A, 2008, BIOL PSYCHIAT, V64, P758, DOI 10.1016/j.biopsych.2008.05.032; Frodl T, 2010, BIOL PSYCHIAT, V67, P161, DOI 10.1016/j.biopsych.2009.08.022; Gavrilescu M, 2010, PSYCHOL MED, V40, P1149, DOI 10.1017/S0033291709991632; Gueguin M, 2007, CEREB CORTEX, V17, P304, DOI 10.1093/cercor/bhj148; Guo WB, 2014, PROG NEURO-PSYCHOPH, V49, P16, DOI 10.1016/j.pnpbp.2013.10.021; Heinz A, 2010, SCHIZOPHRENIA BULL, V36, P472, DOI 10.1093/schbul/sbq031; Hunter MD, 2006, P NATL ACAD SCI USA, V103, P189, DOI 10.1073/pnas.0506268103; Jakab A, 2012, BRAIN TOPOGR, V25, P264, DOI 10.1007/s10548-011-0205-y; Jardri R, 2013, ENCEPHALE, V39, pS93, DOI 10.1016/S0013-7006(13)70102-7; Jardri R, 2013, CEREB CORTEX, V23, P1108, DOI 10.1093/cercor/bhs082; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Karbasforoushan H, 2012, CURR TOP MED CHEM, V12, P2404, DOI 10.2174/156802612805289863; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kelleher I, 2012, PSYCHOL MED, V42, P1857, DOI 10.1017/S0033291711002960; Kelleher I, 2012, BRIT J PSYCHIAT, V201, P26, DOI 10.1192/bjp.bp.111.101543; Kelleher I, 2013, SCHIZOPHRENIA BULL, V39, P1018, DOI 10.1093/schbul/sbs086; Kelleher I, 2013, COGN NEUROPSYCHIATRY, V18, P9, DOI 10.1080/13546805.2012.682363; Kelleher I, 2012, SCHIZOPHRENIA BULL, V38, P239, DOI 10.1093/schbul/sbr164; Kelleher I, 2011, SCHIZOPHRENIA BULL, V37, P362, DOI 10.1093/schbul/sbp057; Kompus K, 2011, NEUROPSYCHOLOGIA, V49, P3361, DOI 10.1016/j.neuropsychologia.2011.08.010; Lagioia A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00035; Li XB, 2012, PSYCHIAT RES-NEUROIM, V201, P182, DOI 10.1016/j.pscychresns.2011.07.017; Linden DEJ, 2011, CEREB CORTEX, V21, P330, DOI 10.1093/cercor/bhq097; Lisiecka D, 2011, INT J NEUROPSYCHOPH, V14, P521, DOI 10.1017/S1461145710001513; Manoliu A, 2014, SCHIZOPHRENIA BULL, V40, P428, DOI 10.1093/schbul/sbt037; McCarthy H, 2013, JAMA PSYCHIAT, V70, P1329, DOI 10.1001/jamapsychiatry.2013.2174; McEwen SCJ, 2014, ACTA PSYCHIAT SCAND, V129, P134, DOI 10.1111/acps.12141; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Mesulam M., 2000, PRINCIPLES BEHAV COG; Miller TJ, 2002, AM J PSYCHIAT, V159, P863, DOI 10.1176/appi.ajp.159.5.863; Modinos G, 2011, NEUROPSYCHOLOGY, V25, P295, DOI 10.1037/a0021747; Moller P, 2000, SCHIZOPHRENIA BULL, V26, P217, DOI 10.1093/oxfordjournals.schbul.a033442; Northoff G, 2011, SCHIZOPHR RES, V127, P202, DOI 10.1016/j.schres.2010.11.009; O'Hanlon E, 2015, JAMA PSYCHIAT, V72, P668, DOI 10.1001/jamapsychiatry.2015.0137; O'Neill A, 2015, PSYCHIAT RES-NEUROIM, V231, P25, DOI 10.1016/j.pscychresns.2014.11.002; Oertel-Knochel V, 2014, SCHIZOPHR RES, V160, P35, DOI 10.1016/j.schres.2014.10.036; Onitsuka T, 2004, AM J PSYCHIAT, V161, P1603, DOI 10.1176/appi.ajp.161.9.1603; Orliac F, 2013, SCHIZOPHR RES, V148, P74, DOI 10.1016/j.schres.2013.05.007; Palaniyappan L, 2013, NEURON, V79, P814, DOI 10.1016/j.neuron.2013.06.027; Palaniyappan L, 2012, J PSYCHIATR NEUROSCI, V37, P17, DOI 10.1503/jpn.100176; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Ritsner MS, 2011, HANDBOOK OF SCHIZOPH, VI; Rotarska-Jagiela A, 2010, SCHIZOPHR RES, V117, P21, DOI 10.1016/j.schres.2010.01.001; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seubert J, 2009, CHEM SENSES, V34, P77, DOI 10.1093/chemse/bjn054; Shim G, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-58; Shin KS, 2009, BIOL PSYCHIAT, V65, P1071, DOI 10.1016/j.biopsych.2008.12.024; Shinn AK, 2013, SCHIZOPHR RES, V143, P260, DOI 10.1016/j.schres.2012.11.037; Sommer IEC, 2007, SCHIZOPHR RES, V93, P406, DOI 10.1016/j.schres.2007.03.020; Sommer IE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043516; Sommer IEC, 2008, BRAIN, V131, P3169, DOI 10.1093/brain/awn251; Sprooten E, 2013, SCHIZOPHR RES, V151, P259, DOI 10.1016/j.schres.2013.09.024; Tamminga Carol A, 2002, Dialogues Clin Neurosci, V4, P432; Tang YQ, 2015, SCHIZOPHR RES, V168, P360, DOI 10.1016/j.schres.2015.07.025; Tohid H, 2015, NEUROSCIENCES, V20, P213, DOI 10.17712/nsj.2015.3.20140757; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Rijn S, 2011, PSYCHOL MED, V41, P1815, DOI 10.1017/S0033291710002576; van Tol MJ, 2014, NEUROIMAGE-CLIN, V4, P249, DOI 10.1016/j.nicl.2013.12.008; Wang HL, 2016, SCI REP-UK, V6, DOI 10.1038/srep26124; Weber ST, 2008, CHEM SENSES, V33, P441, DOI 10.1093/chemse/bjn011; Weinberg D, 2016, JAMA PSYCHIAT; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Williamson P, 2011, HUMAN ILLNESSES NEUR; Williamson PC, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00184; Wotruba D, 2014, SCHIZOPHRENIA BULL, V40, P1095, DOI 10.1093/schbul/sbt161; Yucel M, 2003, BRIT J PSYCHIAT, V182, P518, DOI 10.1192/bjp.182.6.518; Yung AR, 2005, AUST NZ J PSYCHIAT, V39, P964, DOI 10.1080/j.1440-1614.2005.01714.x; Zhou Bing, 2010, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V35, P17, DOI 10.3969/j.issn.1672-7347.2010.01.003	89	14	16	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0169364	10.1371/journal.pone.0169364	http://dx.doi.org/10.1371/journal.pone.0169364			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7IT	28125578	Green Published, gold, Green Submitted			2022-12-26	WOS:000396176100141
J	Escoriza, D; Ben Hassine, J				Escoriza, Daniel; Ben Hassine, Jihene			Diversity of Guilds of Amphibian Larvae in North-Western Africa	PLOS ONE			English	Article							FUNCTIONAL DIVERSITY; SPECIES RICHNESS; PHYLOGENETIC-RELATIONSHIPS; AGRICULTURAL LANDSCAPE; ECOLOGICAL DATA; HABITAT; CLIMATE; PONDS; FROG; BIODIVERSITY	The composition and diversity of biotic assemblages is regulated by a complex interplay of environmental features. We investigated the influence of climate and the aquatic habitat conditions on the larval traits and the structure of amphibian larval guilds in north-western Africa. We classified the species into morphological groups, based on external traits: body shape, size, and the relative positions of the eyes and oral apparatus. We characterized the guild diversity based on species richness and interspecific phylogenetic/functional relationships. The larvae of the urodeles were classified as typical of either the stream or pond type, and the anurans as typical of either the lentic-benthic or lentic-nektonic type. The variations in the body shapes of both urodeles and anurans were associated with the type of aquatic habitat (lentic vs lotic) and the types of predators present. Most of the urodele guilds (98.9%) contained a single species, whereas the anuran guilds were usually more diverse. Both the phylogenetic and functional diversity of the anuran guilds were positively influenced by the size of the aquatic habitat and negatively by aridity. In anurans, the benthic and nektonic morphological types frequently co-occurred, possibly influenced by their opportunistic breeding strategies.	[Escoriza, Daniel] Univ Girona, Inst Aquat Ecol, GRECO, Campus Montilivi, Girona, Spain; [Ben Hassine, Jihene] Univ Tunis El Manar, Fac Sci Tunis, Tunis, Tunisia; [Ben Hassine, Jihene] Univ Abdelmalek Essaadi, Fac Sci Tetouan, Lab Ecol Biodivers & Environm, El Mhannech II, Tetouan, Morocco	Universitat de Girona; Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); Abdelmalek Essaadi University of Tetouan	Escoriza, D (corresponding author), Univ Girona, Inst Aquat Ecol, GRECO, Campus Montilivi, Girona, Spain.	daniel_escoriza@hotmail.com	Escoriza, Daniel/AAP-9813-2021	Escoriza, Daniel/0000-0002-6853-0134	Mohamed Bin Zayed Conservation funding [140510038]	Mohamed Bin Zayed Conservation funding	The authors received a Mohamed Bin Zayed Conservation funding (project number= 140510038) for this work.	ALTIG R, 1989, HERPETOL MONOGR, V3, P81, DOI [DOI 10.2307/1466987, 10.2307/1466987]; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2010, SALAMANDERS US CANAD; Azeroual A., 2003, THESIS; Babbitt KJ, 2003, CAN J ZOOL, V81, P1539, DOI 10.1139/Z03-131; Beja P, 2003, BIOL CONSERV, V114, P317, DOI 10.1016/S0006-3207(03)00051-X; Ben Hassine Jihene, 2014, Herpetological Bulletin, P22; Ben Hassine Jihene, 2014, Herpetological Review, V45, P193; Ben Hassine J, 2012, REV ECOL-TERRE VIE, V67, P437; Bons J., 1996, AMPHIBIANS REPTILES; Both C, 2009, HYDROBIOLOGIA, V624, P125, DOI 10.1007/s10750-008-9685-5; Buisson L, 2013, GLOBAL CHANGE BIOL, V19, P387, DOI 10.1111/gcb.12056; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cadotte MW, 2012, ECOLOGY, V93, pS223, DOI 10.1890/11-0426.1; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Cantonati M, 2006, HYDROBIOLOGIA, V562, P59, DOI 10.1007/s10750-005-1806-9; Caut S, 2013, OECOLOGIA, V173, P95, DOI 10.1007/s00442-012-2428-3; Cheddadi R, 1998, CLIM DYNAM, V14, P883, DOI 10.1007/s003820050262; Cox N, 1996, STATUS DISTRIBUTION; Cruz MJ, 2005, AMPHIBIA-REPTILIA, V26, P293, DOI 10.1163/156853805774408577; Davidson C, 2001, ECOL APPL, V11, P464, DOI 10.1890/1051-0761(2001)011[0464:DOTCRL]2.0.CO;2; Della Bella V, 2008, HYDROBIOLOGIA, V597, P85, DOI 10.1007/s10750-007-9216-9; DIAZ-PANIAGUA C, 1988, Amphibia-Reptilia, V9, P15, DOI 10.1163/156853888X00161; Doledec S, 2000, ECOLOGY, V81, P2914, DOI 10.1890/0012-9658(2000)081[2914:NSICAA]2.0.CO;2; Dray S., 2007, R NEWS, V7, P47; El Garouani A, 2006, IAHS-AISH P, V308, P447; El Qoraychy Ikram, 2015, AACL Bioflux, V8, P751; Ernst R, 2006, BIOL CONSERV, V133, P143, DOI 10.1016/j.biocon.2006.05.028; Escoriza D, 2006, AMPHIBIA-REPTILIA, V27, P448, DOI 10.1163/156853806778190042; Escoriza D., 2015, THESIS; ESCORIZA D, 2013, THE HERPETOLOGICAL B, V125, P10; Escoriza D, 2016, CONSERV GENET, V17, P1445, DOI 10.1007/s10592-016-0875-9; Escoriza D, 2015, J HERPETOL, V49, P276, DOI 10.1670/13-151; Escoriza D, 2014, AFR J HERPETOL, V63, P152, DOI 10.1080/21564574.2014.948079; Escoriza D, 2014, BIOL CONSERV, V176, P252, DOI 10.1016/j.biocon.2014.05.030; Eterovick PC, 2000, AMPHIBIA-REPTILIA, V21, P439, DOI 10.1163/156853800300059331; Fauth JE, 1996, AM NAT, V147, P282, DOI 10.1086/285850; FOX BJ, 1981, ECOLOGY, V62, P1415, DOI 10.2307/1941497; GALLIEN L., 1957, BULL BIOL FRANCE ET BELGIQUE, V91, P97; Gasc J. P., 1997, ATLAS AMPHIBIANS REP; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; Gorley C.K., 2006, GETTING STARTED PRIM; Gosner K. L., 1960, Herpetologica, V16, P183; Graham CH, 2006, P NATL ACAD SCI USA, V103, P632, DOI 10.1073/pnas.0505754103; GRILLITSCH B, 1989, Amphibia-Reptilia, V10, P215, DOI 10.1163/156853889X00395; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hazell D, 2001, BIOL CONSERV, V102, P155, DOI 10.1016/S0006-3207(01)00096-9; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hedges SB, 2015, MOL BIOL EVOL, V32, P835, DOI 10.1093/molbev/msv037; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Iwata H, 2002, J HERED, V93, P384, DOI 10.1093/jhered/93.5.384; Iwata H., 2002, SHAPE VERSION 1 3; Kerr JT, 1997, NATURE, V385, P252, DOI 10.1038/385252a0; Kulkarni SS, 2011, J EVOLUTION BIOL, V24, P2445, DOI 10.1111/j.1420-9101.2011.02370.x; Laliberte E, 2010, ECOL LETT, V13, P76, DOI 10.1111/j.1461-0248.2009.01403.x; Lanza B, 2007, FAUNA DLTALIA; Lardner B, 2000, OIKOS, V88, P169, DOI 10.1034/j.1600-0706.2000.880119.x; Legendre P, 1997, ECOLOGY, V78, P547; Martinez-Solano I, 2004, J BIOGEOGR, V31, P603, DOI 10.1046/j.1365-2699.2003.01033.x; McCollum SA, 1997, OECOLOGIA, V109, P615, DOI 10.1007/s004420050124; McDiarmid R. W., 1999, TADPOLES BIOL ANURAN; Morgan L. A., 1996, Australian Zoologist, V30, P143; NASA (National Aeronautics and Space Administration), 2016, ADV SPAC THERM EM RE; NEWMAN RA, 1988, EVOLUTION, V42, P774, DOI 10.1111/j.1558-5646.1988.tb02495.x; Pavoine S, 2008, THEOR POPUL BIOL, V73, P79, DOI 10.1016/j.tpb.2007.10.001; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Peltzer PM, 2006, BIODIVERS CONSERV, V15, P3499, DOI 10.1007/s10531-004-2940-9; Peltzer PM, 2004, BIODIVERS CONSERV, V13, P1833, DOI 10.1023/B:BIOC.0000035870.36495.fc; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rasband WS., 2015, IMAGEJ VS 1 50; RCore Team, 2020, R LANG ENV STAT COMP; Recuero E, 2012, MOL PHYLOGENET EVOL, V62, P71, DOI 10.1016/j.ympev.2011.09.008; Recuero E, 2007, J BIOGEOGR, V34, P1207, DOI 10.1111/j.1365-2699.2007.01688.x; Rhazi L, 2009, HYDROBIOLOGIA, V634, P185, DOI 10.1007/s10750-009-9893-7; Rodriguez-Sanchez F, 2008, GLOBAL ECOL BIOGEOGR, V17, P685, DOI 10.1111/j.1466-8238.2008.00410.x; ROSENZWEIG ML, 1970, ECOLOGY, V51, P217, DOI 10.2307/1933657; Sandel B, 2011, SCIENCE, V334, P660, DOI 10.1126/science.1210173; SCHLEICH H. H., 1996, AMPHIBIANS REPTILES; Schleuter D, 2010, ECOL MONOGR, V80, P469, DOI 10.1890/08-2225.1; Skelly DK, 1997, AM SCI, V85, P36; Srivastava DS, 2012, ECOL LETT, V15, P637, DOI 10.1111/j.1461-0248.2012.01795.x; Strauss Axel, 2010, BMC Ecology, V10, P12, DOI 10.1186/1472-6785-10-12; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Suzuki R., 2016, PVCLUST HIERARCHICAL; Tachet H., 2010, INVERTEBRES EAU DOUC, V15; Tingley R, 2009, J BIOGEOGR, V36, P1656, DOI 10.1111/j.1365-2699.2009.02117.x; Trabucco A, 2015, GLOBAL INDEX ARIDITY; USSEGLIOPOLATERA P, 1994, FRESHWATER BIOL, V31, P417, DOI 10.1111/j.1365-2427.1994.tb01749.x; Valentine B. D., 1964, Copeia, V1964, P196, DOI 10.2307/1440850; Van Buskirk J, 2009, ECOL MONOGR, V79, P681, DOI 10.1890/08-1692.1; WARINGER-LOSCHENKOHL A, 1988, Amphibia-Reptilia, V9, P219, DOI 10.1163/156853888X00314; Wassens S, 2013, HYDROBIOLOGIA, V708, P69, DOI 10.1007/s10750-011-0955-2; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; Wells K.D., 2007, ECOLOGY BEHAV AMPHIB, DOI 10.7208/chicago/9780226893334.001.0001; Werner EE, 2007, OIKOS, V116, P1697, DOI 10.1111/j.2007.0030-1299.15935.x; Williams P, 2004, BIOL CONSERV, V115, P329, DOI 10.1016/S0006-3207(03)00153-8; Wilson RS, 2000, PHYSIOL BIOCHEM ZOOL, V73, P142, DOI 10.1086/316730	97	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170763	10.1371/journal.pone.0170763	http://dx.doi.org/10.1371/journal.pone.0170763			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125660	Green Published, gold, Green Submitted			2022-12-26	WOS:000396176100059
J	Gordoa, A; Carreras, G; Sanz, N; Vinas, J				Gordoa, Ana; Carreras, Gustavo; Sanz, Nuria; Vinas, Jordi			Tuna Species Substitution in the Spanish Commercial Chain: A Knock-On Effect	PLOS ONE			English	Article							BLUEFIN TUNA; GENETIC IDENTIFICATION; DNA; FISH; SEAFOOD; HAKE; METHODOLOGY; TECHNOLOGY; PRODUCTS; ATLANTIC	Intentional mislabelling of seafood is a widespread problem, particularly with high-value species like tuna. In this study we examine tuna mislabelling, deliberate species substitution, types of substitution and its impact on prices. The survey covered the commercial chain, from Merca-Barna to fishmongers and restaurants in the Spanish Autonomous Community of Catalonia. To understand the geographic extent of the problem we also sampled Merca-Madrid, Europe's biggest fish market, and Merca-Malaga for its proximity to the bluefin tuna migratory route and trap fishery. Monthly surveys were carried out over one year. The results showed a high deficiency in labelling: 75% of points of sale and 83% of restaurants did not specify the species, and in those cases the name of the species had to be asked. A total of 375 samples were analysed genetically, the largest dataset gathered in Europe so far. The identified species were Thunnus albacares, Thunnus thynnus and Thunnus obesus. Species substitution began at suppliers, with 40% of observed cases, increasing to 58% at fishmongers and 62% at restaurants. The substitution was mainly on bluefin tuna (T. thynnus), 73% of cases. At restaurants, only during the bluefin fishing season, we observed a decrease of Bluefin tuna substitution and an increase of reverse substitution revealing some illegal fishing. The effect of species substitution on species prices was relevant: T. obesus increased its price by around sic 12 kg(-1) when it was sold as bluefin. In view of the deficiency of labelling, the abuse of generic names and the lack of the bluefin catch document, we conclude that the Spanish regulations are ineffective, highlighting the need for policy execution, and the urgent need for information campaigns to Spanish consumers.	[Gordoa, Ana; Carreras, Gustavo] CSIC, Ctr Estudios Avanzados Blanes, Dept Marine Ecol, Blanes, Girona, Spain; [Sanz, Nuria; Vinas, Jordi] Univ Girona, Fac Sci, Dept Biol, Lab Genet Ichthyol, Girona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Universitat de Girona	Gordoa, A (corresponding author), CSIC, Ctr Estudios Avanzados Blanes, Dept Marine Ecol, Blanes, Girona, Spain.	gordoa@ceab.csic.es	Sanz, Nuria/L-3074-2014; Viñas, Jordi/A-5397-2010	Sanz, Nuria/0000-0001-5274-1917; Viñas, Jordi/0000-0003-0193-1141	Balfego Group; Blanes Centre for Advanced Study (CEAB - CSIC)	Balfego Group; Blanes Centre for Advanced Study (CEAB - CSIC)	The study was funded by the Balfego Group under a programme of scientific cooperation with the Blanes Centre for Advanced Study (CEAB - CSIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2013, OFFICIAL J EUROPEAN; [Anonymous], 2001, GLOB COMM UPD TUN; Asensio L, 2008, FOOD ADDIT CONTAM A, V25, P677, DOI 10.1080/02652030701765731; Barbuto M, 2010, FOOD RES INT, V43, P376, DOI 10.1016/j.foodres.2009.10.009; BARTLETT SE, 1992, BIOTECHNIQUES, V12, P408; Becker S, 2011, MITOCHONDR DNA, V22, P3, DOI 10.3109/19401736.2010.535528; Benard-Capelle J, 2015, PEERJ, V2, DOI 10.7717/peerj.714; BOSE S, 1996, MARINE RESOURCE EC, V11, P143, DOI DOI 10.1086/MRE.11.3.42629157; Bostock T, 1985, PESCA UTILIZACION TI; Chow S, 2006, J FISH BIOL, V68, P24, DOI 10.1111/j.0022-1112.2006.00945.x; Cohen NJ, 2009, J FOOD PROTECT, V72, P810, DOI 10.4315/0362-028X-72.4.810; Collette BB, 2011, SCIENCE, V333, P291, DOI 10.1126/science.1208730; Crego-Prieto V, 2010, MISLABELLING MEGRIMS; Curran K, 2009, CHANDOS INTERNET SER, P261; DARBY MR, 1973, J LAW ECON, V16, P67, DOI 10.1086/466756; FAO, 2010, GLOB TUN CATCH STOCK; FAO, 2016, CONTRIBUTING FOOD SE; Filonzi L, 2010, FOOD RES INT, V43, P1383, DOI 10.1016/j.foodres.2010.04.016; Galimberti A, 2013, FOOD RES INT, V50, P55, DOI 10.1016/j.foodres.2012.09.036; Garcia-Vazquez E, 2011, J AGR FOOD CHEM, V59, P475, DOI 10.1021/jf103754r; Garcia-Vazquez E, 2009, T AM FISH SOC, V138, P790, DOI 10.1577/T08-169.1; Garrett A, 2010, YELLOWFIN TUNA GLOBA; Holmes BH, 2009, FISH RES, V95, P280, DOI 10.1016/j.fishres.2008.09.036; HSIEH YHP, 1995, J FOOD QUALITY, V18, P131, DOI 10.1111/j.1745-4557.1995.tb00368.x; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Jacquet JL, 2008, MAR POLICY, V32, P309, DOI 10.1016/j.marpol.2007.06.007; Jennings S, 2016, FISH FISH, V17, P893, DOI 10.1111/faf.12152; Johannes RE, 1998, TRENDS ECOL EVOL, V13, P243, DOI 10.1016/S0169-5347(98)01384-6; Khaksar R, 2015, FOOD CONTROL, V56, P71, DOI 10.1016/j.foodcont.2015.03.007; Lamendin R, 2015, FOOD CONTROL, V47, P436, DOI 10.1016/j.foodcont.2014.07.039; Ling MP, 2009, B ENVIRON CONTAM TOX, V83, P558, DOI 10.1007/s00128-009-9829-y; Lowenstein JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007866; Machado-Schiaffino G, 2008, J AGR FOOD CHEM, V56, P5091, DOI 10.1021/jf800207t; Marko PB, 2004, NATURE, V430, P309, DOI 10.1038/430309b; Mejuto J, 2014, IND PESQUERAS REV MA, P36; Miller DD, 2010, FRONT ECOL ENVIRON, V8, P517, DOI 10.1890/090212; Paquotte P., 2003, Cahiers Options Mediterraneennes, V60, P159; Pascoal A, 2008, ELECTROPHORESIS, V29, P499, DOI 10.1002/elps.200700406; Perez J, 2004, J FOOD PROTECT, V67, P2792, DOI 10.4315/0362-028X-67.12.2792; Rasmussen RS, 2009, COMPR REV FOOD SCI F, V8, P118, DOI 10.1111/j.1541-4337.2009.00073.x; Ravier C, 2001, ICES J MAR SCI, V58, P1299, DOI 10.1006/jmsc.2001.1119; Reglero P, 2013, SCI MAR, V77, P585, DOI 10.3989/scimar.03759.28A; Rodriguez-Roda J., 1967, INVETIGACION PESQUER, V31, P11; Rooker JR, 2008, MAR ECOL PROG SER, V368, P231, DOI 10.3354/meps07602; Smith PJ, 2008, J FISH BIOL, V72, P464, DOI 10.1111/j.1095-8649.2007.01745.x; Steinke D, 2009, MAR BIOL, V156, P2641, DOI 10.1007/s00227-009-1284-0; Streicher-Porte M., 2011, GREENING CHINAS FISH; Vinas J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007606; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Warner K., 2013, OCEANA STUDY REVEALS; Wen J, 2011, FOOD CONTROL, V22, P72, DOI 10.1016/j.foodcont.2010.06.010; Wong EHK, 2008, FOOD RES INT, V41, P828, DOI 10.1016/j.foodres.2008.07.005; Woolfe M, 2004, TRENDS BIOTECHNOL, V22, P222, DOI 10.1016/j.tibtech.2004.03.010; Xiong X, 2016, FOOD CONTROL, V60, P519, DOI 10.1016/j.foodcont.2015.08.028	55	28	28	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170809	10.1371/journal.pone.0170809	http://dx.doi.org/10.1371/journal.pone.0170809			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125686	Green Submitted, Green Published, gold			2022-12-26	WOS:000396176100046
J	Makker, PGS; Duffy, SS; Lees, JG; Perera, CJ; Tonkin, RS; Butovsky, O; Park, SB; Goldstein, D; Moalem-Taylor, G				Makker, Preet G. S.; Duffy, Samuel S.; Lees, Justin G.; Perera, Chamini J.; Tonkin, Ryan S.; Butovsky, Oleg; Park, Susanna B.; Goldstein, David; Moalem-Taylor, Gila			Characterisation of Immune and Neuroinflammatory Changes Associated with Chemotherapy-Induced Peripheral Neuropathy	PLOS ONE			English	Article							REGULATORY T-CELLS; DORSAL-ROOT GANGLIA; INDUCED MECHANICAL ALLODYNIA; SATELLITE GLIAL-CELLS; NERVE INJURY; SPINAL-CORD; SENSORY NEURONS; MACROPHAGE INFILTRATION; PACLITAXEL; PAIN	Chemotherapy-induced peripheral neuropathy (CIPN) and associated neuropathic pain is a debilitating adverse effect of cancer treatment. Current understanding of the mechanisms underpinning CIPN is limited and there are no effective treatment strategies. In this study, we treated male C57BL/6J mice with 4 cycles of either Paclitaxel (PTX) or Oxaliplatin (OXA) over a week and tested pain hypersensitivity and changes in peripheral immune responses and neuroinflammation on days 7 and 13 post 1 st injection. We found that both PTX and OXA caused significant mechanical allodynia. In the periphery, PTX and OXA significantly increased circulating CD4+ and CD8+ T-cell populations. OXA caused a significant increase in the percentage of interleukin-4+ lymphocytes in the spleen and significant down-regulation of regulatory T (T-reg) cells in the inguinal lymph nodes. However, conditional depletion of T-reg cells in OXA-treated transgenic DEREG mice had no additional effect on pain sensitivity. Furthermore, there was no leukocyte infiltration into the nervous system of OXA-or PTX-treated mice. In the peripheral nervous system, PTX induced expression of the neuronal injury marker activating transcription factor-3 in IB4+ and NF200+sensory neurons as well as an increase in the chemokines CCL2 and CCL3 in the lumbar dorsal root ganglion. In the central nervous system, PTX induced significant astrocyte activation in the spinal cord dorsal horn, and both PTX and OXA caused reduction of P2ry12+homeostatic microglia, with no measurable changes in IBA-1+ microglia/macrophages in the dorsal and ventral horns. We also found that PTX induced up-regulation of several inflammatory cytokines and chemokines (TNF-alpha, IFN-beta, CCL11, CCL4, CCL3, IL-12p70 and GM-CSF) in the spinal cord. Overall, these findings suggest that PTX and OXA cause distinct pathological changes in the periphery and nervous system, which may contribute to chemotherapy-induced neuropathic pain.	[Makker, Preet G. S.; Duffy, Samuel S.; Lees, Justin G.; Perera, Chamini J.; Tonkin, Ryan S.; Moalem-Taylor, Gila] Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia; [Butovsky, Oleg] Harvard Med Sch, Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, Boston, MA USA; [Park, Susanna B.] Univ Sydney, Sydney Med Sch, Brain & Mind Ctr, Sydney, NSW, Australia; [Goldstein, David] Prince Wales Hosp, Dept Med Oncol, Randwick, NSW, Australia	University of New South Wales Sydney; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Sydney	Moalem-Taylor, G (corresponding author), Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia.	gila@unsw.edu.au	Moalem-Taylor, Gila/C-3116-2008; goldstein, david/J-6711-2012; Butovsky, Oleg/ABG-9086-2020	Moalem-Taylor, Gila/0000-0003-3828-9527; Butovsky, Oleg/0000-0003-0186-8867; Lees, Justin/0000-0002-0874-2856	Cancer Institute NSW Translational Program Grant Chemotherapy-induced Peripheral Neuropathy: Assessment strategies, Treatment and Risk Factors [14/TPG/1-05]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088137] Funding Source: NIH RePORTER	Cancer Institute NSW Translational Program Grant Chemotherapy-induced Peripheral Neuropathy: Assessment strategies, Treatment and Risk Factors; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the Cancer Institute NSW Translational Program Grant Chemotherapy-induced Peripheral Neuropathy: Assessment strategies, Treatment and Risk Factors (ID # 14/TPG/1-05; http://www.cancerinstitute.org.au) awarded to DG, SP and GMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcindor T, 2011, CURR ONCOL, V18, P18; ALOISI F, 1995, INT J DEV NEUROSCI, V13, P265, DOI 10.1016/0736-5748(94)00071-A; Argyriou AA, 2014, CANCER MANAG RES, V6, P135, DOI 10.2147/CMAR.S44261; Austin PJ, 2012, PAIN, V153, P1916, DOI 10.1016/j.pain.2012.06.005; Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; Boyette-Davis JA, 2013, CANCER CHEMOTH PHARM, V71, P619, DOI 10.1007/s00280-012-2047-z; Braz JM, 2010, PAIN, V150, P290, DOI 10.1016/j.pain.2010.05.005; Butovsky O, 2015, ANN NEUROL, V77, P75, DOI 10.1002/ana.24304; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Cook DN, 1996, J LEUKOCYTE BIOL, V59, P61, DOI 10.1002/jlb.59.1.61; Costigan M, 2009, J NEUROSCI, V29, P14415, DOI 10.1523/JNEUROSCI.4569-09.2009; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; DIXON WJ, 1965, J AM STAT ASSOC, V60, P967, DOI 10.2307/2283398; Dougherty PM, 2004, PAIN, V109, P132, DOI 10.1016/j.pain.2004.01.021; Elson K, 2003, J GEN VIROL, V84, P1079, DOI 10.1099/vir.0.19035-0; Fehrenbacher JC, 2015, PROG MOL BIOL TRANSL, V131, P471, DOI 10.1016/bs.pmbts.2014.12.002; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gornstein E, 2014, NEUROPHARMACOLOGY, V76, P175, DOI 10.1016/j.neuropharm.2013.08.016; GREGG RW, 1992, J CLIN ONCOL, V10, P795, DOI 10.1200/JCO.1992.10.5.795; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Jamieson SMF, 2007, NEUROTOXICOLOGY, V28, P1092, DOI 10.1016/j.neuro.2007.04.009; Janes K, 2015, BRAIN BEHAV IMMUN, V44, P91, DOI 10.1016/j.bbi.2014.08.010; Janes K, 2014, PAIN, V155, P2560, DOI 10.1016/j.pain.2014.09.016; Jin XC, 2006, J NEUROSCI, V26, P246, DOI 10.1523/JNEUROSCI.3858-05.2006; Kiguchi N, 2010, NEUROSCI LETT, V484, P17, DOI 10.1016/j.neulet.2010.07.085; Kim CF, 2011, BRAIN RES, V1405, P95, DOI 10.1016/j.brainres.2011.06.022; Kim D, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-74; Knerlich-Lukoschus F, 2011, J NEUROSURG-SPINE, V14, P583, DOI 10.3171/2010.12.SPINE10480; Krishnan AV, 2005, MUSCLE NERVE, V32, P51, DOI 10.1002/mus.20340; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Ledeboer A, 2007, BRAIN BEHAV IMMUN, V21, P686, DOI 10.1016/j.bbi.2006.10.012; Lees JG, 2015, CYTOKINE, V71, P207, DOI 10.1016/j.cyto.2014.10.028; Li Y, 2015, BRAIN BEHAV IMMUN, V49, P255, DOI 10.1016/j.bbi.2015.06.003; Li YJ, 2014, SUSTAIN ENERGY TECHN, V6, P25, DOI 10.1016/j.seta.2014.01.003; Liaw WJ, 2005, PAIN, V115, P60, DOI 10.1016/j.pain.2005.02.006; Liu FY, 2012, BRAIN RES, V1427, P65, DOI 10.1016/j.brainres.2011.10.016; Liu N, 2011, INT IMMUNOPHARMACOL, V11, P212, DOI 10.1016/j.intimp.2010.11.021; Liu XJ, 2014, CELL RES, V24, P1374, DOI 10.1038/cr.2014.106; Mannelli LD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128080; Mannelli LD, 2013, J PAIN, V14, P1585, DOI 10.1016/j.jpain.2013.08.002; McWhinney SR, 2009, MOL CANCER THER, V8, P10, DOI 10.1158/1535-7163.MCT-08-0840; Menten P, 2002, CYTOKINE GROWTH F R, V13, P455, DOI 10.1016/S1359-6101(02)00045-X; Mika J, 2013, EUR J PHARMACOL, V716, P106, DOI 10.1016/j.ejphar.2013.01.072; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Moalem G, 2004, NEUROSCIENCE, V129, P767, DOI 10.1016/j.neuroscience.2004.08.035; Moalem G, 2006, BRAIN RES REV, V51, P240, DOI 10.1016/j.brainresrev.2005.11.004; Nie H, 2009, J NEUROPHYSIOL, V101, P2041, DOI 10.1152/jn.91138.2008; Ochi-ishi R, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-53; Park SB, 2013, CA-CANCER J CLIN, V63, P419, DOI 10.3322/caac.21204; Peters CM, 2007, BRAIN RES, V1168, P46, DOI 10.1016/j.brainres.2007.06.066; Peters CM, 2007, EXP NEUROL, V203, P42, DOI 10.1016/j.expneurol.2006.07.022; Robinson CR, 2014, NEUROSCIENCE, V274, P308, DOI 10.1016/j.neuroscience.2014.05.051; SAHENK Z, 1994, ARCH NEUROL-CHICAGO, V51, P726, DOI 10.1001/archneur.1994.00540190110024; Saika F, 2012, EUR J PAIN, V16, P1271, DOI 10.1002/j.1532-2149.2012.00146.x; Sandireddy R, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/674987; Seretny M, 2014, PAIN, V155, P2461, DOI 10.1016/j.pain.2014.09.020; Smith SB, 2004, LIFE SCI, V74, P2593, DOI 10.1016/j.lfs.2004.01.002; Ta LE, 2006, NEUROTOXICOLOGY, V27, P992, DOI 10.1016/j.neuro.2006.04.010; Takahashi T, 2003, CURR MOL MED, V3, P693, DOI 10.2174/1566524033479429; Takeda M, 2007, PAIN, V129, P155, DOI 10.1016/j.pain.2006.10.007; Wang XM, 2012, CYTOKINE, V59, P3, DOI 10.1016/j.cyto.2012.03.027; Warwick RA, 2013, EUR J PAIN, V17, P571, DOI 10.1002/j.1532-2149.2012.00219.x; Weir Genevieve M, 2011, Cancers (Basel), V3, P3114, DOI 10.3390/cancers3033114; Whitehead KJ, 2010, BRAIN BEHAV IMMUN, V24, P569, DOI 10.1016/j.bbi.2009.12.007; Wolf S, 2008, EUR J CANCER, V44, P1507, DOI 10.1016/j.ejca.2008.04.018; Xiao WH, 2012, NEUROSCIENCE, V203, P194, DOI 10.1016/j.neuroscience.2011.12.023; Yoon SY, 2013, J PAIN, V14, P205, DOI 10.1016/j.jpain.2012.11.002; Zhang H, 2016, J PAIN OFFICIAL J AM; Zhang H, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-182; Zhang H, 2012, J NANOMATER, V2012, DOI [10.1155/2012/217412, 10.1186/2049-1891-3-26]; Zhang L, 2008, CLIN IMMUNOL, V129, P219, DOI 10.1016/j.clim.2008.07.013; Zhu Y, 2011, SCAND J IMMUNOL, V73, P301, DOI 10.1111/j.1365-3083.2011.02514.x	73	132	141	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170814	10.1371/journal.pone.0170814	http://dx.doi.org/10.1371/journal.pone.0170814			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125674	Green Published, gold			2022-12-26	WOS:000396176100044
J	Skuhrovec, J; Stejskal, R; Trnka, F; di Giulio, A				Skuhrovec, Jiri; Stejskal, Robert; Trnka, Filip; di Giulio, Andrea			Velcro-Like System Used to Fix a Protective Faecal Shield on Weevil Larvae	PLOS ONE			English	Article							IMMATURE STAGES; PHYLOGENETIC RECONSTRUCTION; BIOLOGY COLEOPTERA; MATURE LARVAE; BIONOMIC DATA; LEAF BEETLES; CURCULIONIDAE; CHRYSOMELIDAE; MORPHOLOGY; GENUS	The last instar larva and pupa of Eucoeliodes mirabilis (A. Villa & G.B. Villa, 1835) (Curculionidae: Ceutorhynchini) are described using drawings and SEM images and are compared and keyed with already described larvae of 58 other ceutorhynchinae taxa. The larval body has an effective combination of morphological adaptations that assist a unique biological defensive strategy. All larval stages of E. mirabilis feed ectophytically on leaves of Euonymus europaeus L. (Celastraceae), and the larval body is covered with a thick faecal shield. The fixation of this protective shield on the larval back is performed by a peculiar dorsal microsculpture composed of a dense carpet of microtrichia on the thorax and abdomen, which serves effectively as a velcro system. Because of this strategy, macrosetae on the larval and pupal body of E. mirabilis are completely reduced. Larvae of E. mirabilis also have distinct morphological adaptations for protecting the spiracles against intrusion of faeces and avoiding occlusion of the tracheal system: a) microtrichia around spiracles are slightly shorter, distinctly stronger and are arranged with high-density and in clusters and b) spiracles are protected by an external safety valve. This strategy of E. mirabilis larvae is unique, although somewhat similar to that of Criocerinae and Blepharida-group leave beetles (Galerucinae) (both Coleoptera: Chrysomelidae), but with distinctly different morphological adaptations.	[Skuhrovec, Jiri] Crop Res Inst, Grp Funct Invertebrate & Plant Biodivers Agroecos, Prague 6, Ruzyne, Czech Republic; [Stejskal, Robert] Adm Podyji Natl Pk, Znojmo, Czech Republic; [Trnka, Filip] Palacky Univ, Dept Ecol & Environm Sci, Fac Sci, Olomouc, Czech Republic; [di Giulio, Andrea] Univ Rome Tre, Dept Sci, Rome, Italy	Czech Crop Research Institute (CRI); Palacky University Olomouc; Italfarmaco; Roma Tre University	Skuhrovec, J (corresponding author), Crop Res Inst, Grp Funct Invertebrate & Plant Biodivers Agroecos, Prague 6, Ruzyne, Czech Republic.	jirislavskuhrovec@gmail.com	Skuhrovec, Jiri/E-9699-2016	Skuhrovec, Jiri/0000-0002-7691-5990	Czech Ministry of Agriculture (Mze OR) [R00416]; Palacky University in Olomouc [IGA_PrF_2015008]	Czech Ministry of Agriculture (Mze OR); Palacky University in Olomouc	A grant from the Czech Ministry of Agriculture (Mze OR) R00416 (JS) and a grant from Palacky University in Olomouc (IGA_PrF_2015008) (FT) supported this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrain FA, 2015, ZOOKEYS, P133, DOI 10.3897/zookeys.547.6098; Aiello A, 2006, J NEW YORK ENTOMOL S, V114, P144, DOI 10.1664/0028-7199(2007)114[144:OPTHSL]2.0.CO;2; ANDERSON DM, 1970, ANN ENTOMOL SOC AM, V63, P296, DOI 10.1093/aesa/63.1.296; Anderson DM, 1992, IMMATURE INSECTS, V2, P594; Borowiec L, 2014, HDB ZOOLOGY ARTHROPO, V3, P198; Chaboo CS, 2008, ZOOL J LINN SOC-LOND, V152, P315, DOI 10.1111/j.1096-3642.2007.00343.x; Chaboo CS, 2007, COLEOPTS BULL, V61, P297, DOI 10.1649/0010-065X(2007)61[297:FEILBN]2.0.CO;2; Chaboo CS, 2016, P ENTOMOL SOC WASH, V118, P150, DOI 10.4289/0013-8797.118.1.150; Chamorro ML, 2014, HBK ZOOL, P230; Chamorro ML, 2014, HBK ZOOL, P226; Colonnelli E., 2013, P176; Colonnelli E., 2004, Catalogue of Ceutorhynchinae of the world, with a key to genera. (Insecta: Coleoptera: Curculionidae); Costa JT, 2004, ETHOLOGY, V110, P515, DOI 10.1111/j.1439-0310.2004.00999.x; Cunningham P., 1980, Entomologist's Monthly Magazine, V115, P243; DAMMAN H, 1991, ECOL ENTOMOL, V16, P163, DOI 10.1111/j.1365-2311.1991.tb00205.x; DIECKMANN L, 1972, Beitraege zur Entomologie, V22, P3; EISNER T, 1967, SCIENCE, V158, P1471, DOI 10.1126/science.158.3807.1471; Gosik R, 2016, ZOOTAXA, V4108, P1, DOI 10.11646/zootaxa.4108.1.1; Gosik R, 2010, DEUT ENTOMOL Z, V57, P203, DOI 10.1002/mmnd.201000017; Gosik Rafal, 2009, Genus (Wroclaw), V20, P137; Gosik Rafal, 2008, Genus (Wroclaw), V19, P103; Gunter NL, 2016, AUSTRAL ENTOMOL, V55, P217, DOI 10.1111/aen.12173; Keefover-Ring K, 2013, CHEMOECOLOGY, V23, P1, DOI 10.1007/s00049-012-0117-7; Lawson FA, 1992, IMMATURE INSECTS, V2, P568; Lee CY, 1996, J FAC AGR KYUSHU U, V40, P307; Lohse GA, 1983, KAFER MITTELEUROPAS, V11, P180; Marvaldi Adriana F., 1999, Acta Zoologica Lilloana, V45, P7; Marvaldi AE, 1998, ENTOMOL SCAND, V29, P89; Marvaldi AE, 2003, REV CHIL HIST NAT, V76, P603; Marvaldi AE, 2002, SYST BIOL, V51, P761, DOI 10.1080/10635150290102465; Marvaldi AE, 2014, HDB ZOOLOGY ARTHROPO, V3, P503; May B.M., 1994, AUSTR WEEVILS COLEOP, V2, P533; MAY BM, 1977, J ROY SOC NEW ZEAL, V7, P189, DOI 10.1080/03036758.1977.10427160; May Brenda M., 1993, Fauna of New Zealand, V28, P1; Morton TC, 1998, J CHEM ECOL, V24, P765, DOI 10.1023/A:1022382931766; Nikulina O. N., 2008, ENTOMOLOGICAL REV, V88, P867, DOI DOI 10.1134/S0013873808070117; Nogueira de Sa Flavia, 2004, Chrysomela, V43.2, P8; Nogueira-de-Sa F, 2005, J TROP ECOL, V21, P189, DOI 10.1017/S0266467404002147; Nogueira-de-Sa F, 2002, ENTOMOL EXP APPL, V104, P203, DOI 10.1023/A:1021217719030; Oberprieler RG, 2014, HDB ZOOLOGY ARTHROPO, P483; Oberprieler RG, 2014, HDB ZOOLOGY ARTHROPO, P452; Oberprieler RG, 2014, HBK ZOOL, P285; Oberprieler RG, 2007, ZOOTAXA, P491; Olmstead KL, 1994, NOVEL ASPECTS BIOL C, P311; Orlova-Bienkowskaya M. Ja., 2005, Russian Entomological Journal, V14, P61; Prathapan KD, 2011, ZOOKEYS, P95, DOI 10.3897/zookeys.157.1472; Prena J, 2014, HBK ZOOL, P577; Price P.W., 2011, P1; Rather M., 1989, Bonner Zoologische Beitraege, V40, P109; Root R.B., 1983, Psyche (Cambridge), V90, P67, DOI 10.1155/1983/47471; Ruxton G. D., 2004, AVOIDING ATTACK; Scherf H., 1964, Abhandlungen der Senckenbergischen Naturforschenden Gesellschaft, V506, P1; Skuhrovec J, 2016, ZOOKEYS, P123, DOI 10.3897/zookeys.589.7847; Skuhrovec J, 2015, ZOOTAXA, V3955, P151, DOI 10.11646/zootaxa.3955.2.1; Skuhrovec J, 2014, ZOOTAXA, V3839, P1, DOI 10.11646/zootaxa.3839.1.1; Smreczynski S, 1974, PODRODZINY CURCULION; Stejskal R, 2014, ACTA ENT MUS NAT PRA, V54, P337; Stuben PE, 2013, SNUDEBILLER, V14, P1; Trnka F, 2015, ZOOTAXA, V4021, P433, DOI 10.11646/zootaxa.4021.3.3; Tzanakakis M. E., 1969, Zeitschrift fuer Angewandte Entomologie, V64, P266; VAYSSIERES J-F, 1986, Nouvelle Revue d'Entomologie, V3, P325; VENCL F. V., 2014, HDB ZOOLOGY ARTHROPO, P237; Vencl FV, 2009, J CHEM ECOL, V35, P281, DOI 10.1007/s10886-008-9577-1; Vencl FV, 1999, ADVANCES IN CHRYSOMELIDAE BIOLOGY 1, P217; Vencl FV, 2005, OECOLOGIA, V145, P404, DOI 10.1007/s00442-005-0138-9; Vig K, 1996, NATURAL HIST ORSEG L, VII, P203; Wanat M., 2011, WEEVIL NEWS, V67, P1; Weiss MR, 2006, ANNU REV ENTOMOL, V51, P635, DOI 10.1146/annurev.ento.49.061802.123212	68	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170800	10.1371/journal.pone.0170800	http://dx.doi.org/10.1371/journal.pone.0170800			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125664	Green Published, gold, Green Submitted			2022-12-26	WOS:000396176100048
J	Jensen, H; Kiljunen, M; Knudsen, R; Amundsen, PA				Jensen, Hallvard; Kiljunen, Mikko; Knudsen, Rune; Amundsen, Per-Arne			Resource Partitioning in Food, Space and Time between Arctic Charr (Salvelinus alpinus), Brown Trout (Salmo trutta) and European Whitefish (Coregonus lavaretus) at the Southern Edge of Their Continuous Coexistence	PLOS ONE			English	Article							ISOTOPE MIXING MODELS; NICHE SEGREGATION; TROPHIC POSITION; CLIMATE-CHANGE; LAKE; PISCIVORY; PREDATOR; PREFERENCE; DELTA-C-13; MORTALITY	Arctic charr and European whitefish are considered to be strong competitors in lakes, with the latter usually being the superior species. However, high niche plasticity and lake morphometry may suggestively facilitate resource partitioning and coexistence between charr and whitefish. Here, we explore the trophic niche utilization (diet and habitat use) of charr and whitefish co-occurring with brown trout in the deep and oligotrophic Lake Fyresvatnet, southern Norway (59 (-) 05' N, 8 E 10' E). Using CPUE, stomach contents and stable isotope analyses, a distinct resource partitioning was revealed between brown trout and the other two species. Brown trout typically occupied the littoral zone, feeding on benthic invertebrates, surface insects and small-sized whitefish. In contrast, charr and whitefish were predominantly zooplanktivorous, but diverged somewhat in habitat utilization as charr shifted seasonally between the profundal and the littoral zone, whereas whitefish were found in the upper water layers (littoral and pelagic habitats). Accordingly, the stable isotope values of carbon (delta(13) C) reflected a pelagic orientated prey resource use for both charr and whitefish, whereas brown trout had elevated carbon and nitrogen (delta(15) N) signatures that reflected their benthivore and piscivore diet, respectively. The findings suggest that charr may not rely upon the profundal zone as a feeding habitat but as a refuge area, and may coexist with whitefish if a third competitive and predatory species like brown trout co-occur in the lake. The study indicates that a general high habitat plasticity of Arctic charr may be essential in the presently observed coexistence with a competitively superior fish species like whitefish, and that a third fish species like brown trout may facilitate this particular fish community structure.	[Jensen, Hallvard] Norwegian Inst Bioecon Res, Dept Nat Resources & Rural Dev, Tromso, Norway; [Kiljunen, Mikko] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Knudsen, Rune; Amundsen, Per-Arne] UiT Arctic Univ Norway, Dept Arctic & Marine Biol, Tromso, Norway	Norwegian Institute of Bioeconomy Research; University of Jyvaskyla; UiT The Arctic University of Tromso	Jensen, H (corresponding author), Norwegian Inst Bioecon Res, Dept Nat Resources & Rural Dev, Tromso, Norway.	hallvard.jensen@nibio.no		Amundsen, Per-Arne/0000-0002-2203-8216; Jensen, Hallvard/0000-0002-8322-7248	Norwegian Institute of Bioeconomy Research [2004/00256]	Norwegian Institute of Bioeconomy Research	HJ was supported by a grant from the Norwegian Institute of Bioeconomy Research (Grant 2004/00256, www.nibio.no). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2009, ECOLOGY, V90, P812, DOI 10.1890/08-0446.1; AMUNDSEN PA, 1994, J FISH BIOL, V45, P181, DOI 10.1006/jfbi.1994.1222; Amundsen PA, 1996, J FISH BIOL, V48, P607, DOI 10.1111/j.1095-8649.1996.tb01455.x; Amundsen PA, 2010, HYDROBIOLOGIA, V650, P3, DOI 10.1007/s10750-009-0054-9; Amundsen PA, 2009, AQUAT ECOL, V43, P765, DOI 10.1007/s10452-009-9261-8; [Anonymous], THESIS; Bohn T, 2008, BIOL INVASIONS, V10, P359, DOI 10.1007/s10530-007-9135-8; Clarke K.R., 2015, GETTING STARTED PRIM; Corrigan LJ, 2011, ECOL FRESHW FISH, V20, P5, DOI 10.1111/j.1600-0633.2010.00446.x; Elliott JM, 2010, J FISH BIOL, V77, P1793, DOI 10.1111/j.1095-8649.2010.02762.x; Eloranta AP, 2015, ECOL EVOL, V5, P1664, DOI 10.1002/ece3.1464; Eloranta AP, 2013, FRESHWATER BIOL, V58, P207, DOI 10.1111/fwb.12052; Eloranta AP, 2011, ECOL FRESHW FISH, V20, P558, DOI 10.1111/j.1600-0633.2011.00504.x; Finstad AG, 2011, GLOBAL CHANGE BIOL, V17, P1703, DOI 10.1111/j.1365-2486.2010.02335.x; Fry B, 2007, RAPID COMMUN MASS SP, V21, P750, DOI 10.1002/rcm.2892; Fry B, 2013, MAR ECOL PROG SER, V472, P1, DOI 10.3354/meps10168; Gause G. F., 1934, STRUGGLE EXISTENCE; Gerdeaux D, 2011, HYDROBIOLOGIA, V660, P69, DOI 10.1007/s10750-010-0412-7; Graham CT, 2009, J FISH BIOL, V74, P1143, DOI 10.1111/j.1095-8649.2009.02180.x; HINDAR A, 2006, KALK VANN VASSDRAG, P2; Inger R, 2010, SIAR V4 STABLE ISOTO; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jansen PA, 2002, CAN J FISH AQUAT SCI, V59, P6, DOI 10.1139/F01-184; Jensen H, 2012, J FISH BIOL, V80, P2448, DOI 10.1111/j.1095-8649.2012.03294.x; Jensen H, 2008, CAN J FISH AQUAT SCI, V65, P1831, DOI 10.1139/F08-096; Jeppesen E, 2012, HYDROBIOLOGIA, V694, P1, DOI 10.1007/s10750-012-1182-1; Jonsson B, 2008, OECOLOGIA, V157, P553, DOI 10.1007/s00442-008-1103-1; Kahilainen K, 2003, J FISH BIOL, V63, P659, DOI 10.1046/j.1095-8649.2003.00179.x; Kahilainen K, 2001, FISHERIES MANAG ECOL, V8, P83, DOI 10.1046/j.1365-2400.2001.00240.x; Kiljunen M, 2006, J APPL ECOL, V43, P1213, DOI 10.1111/j.1365-2664.2006.01224.x; Klemetsen A, 2003, ECOL FRESHW FISH, V12, P1, DOI 10.1034/j.1600-0633.2003.00010.x; Knudsen R, 2006, P ROY SOC B-BIOL SCI, V273, P2291, DOI 10.1098/rspb.2006.3582; Knudsen R, 2010, J ANIM ECOL, V79, P161, DOI 10.1111/j.1365-2656.2009.01625.x; LABEELUND JH, 1992, J FISH BIOL, V41, P91, DOI 10.1111/j.1095-8649.1992.tb03172.x; LANGELAND A, 1991, J ANIM ECOL, V60, P895, DOI 10.2307/5420; Larsson S, 2005, ENVIRON BIOL FISH, V73, P89, DOI 10.1007/s10641-004-5353-4; Lehtiniemi M, 2009, MAR BIOL, V156, P619, DOI 10.1007/s00227-008-1113-x; Murdoch A, 2013, FISHERIES MANAG ECOL, V20, P302, DOI 10.1111/fme.12012; Museth J, 2003, J FISH BIOL, V62, P692, DOI 10.1046/j.1095-8649.2003.00059.x; Museth J, 2007, ADV LIMNOL, V60, P343; Nilsson N.A., 1967, BIOL BASIS FRESHWATE, P295; NILSSON NILS-ARVID, 1963, TRANS AMER FISH SOC, V92, P276, DOI 10.1577/1548-8659(1963)92[276:IBTACI]2.0.CO;2; Persson L, 2007, SCIENCE, V316, P1743, DOI 10.1126/science.1141412; Phillips DL, 2002, OECOLOGIA, V130, P114, DOI 10.1007/s004420100786; Pianka E. R., 2000, EVOLUTIONARY ECOLOGY; Polito MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026642; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Sandlund OT, 2010, HYDROBIOLOGIA, V650, P27, DOI 10.1007/s10750-009-0075-4; SANDLUND OT, 2000, FISK FERSKVANN, P109; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Siikavuopio SI, 2014, AQUAT ECOL, V48, P313, DOI 10.1007/s10452-014-9485-0; Siikavuopio SI, 2010, HYDROBIOLOGIA, V650, P255, DOI 10.1007/s10750-010-0192-0; Svardson G., 1976, REPORT I FRESH WATER, V56, P144; Vander Zanden MJ, 1999, ECOLOGY, V80, P1395; WALLACE RK, 1981, T AM FISH SOC, V110, P72, DOI 10.1577/1548-8659(1981)110&lt;72:AAODI&gt;2.0.CO;2; Winfield IJ, 2010, J APPL ICHTHYOL, V26, P60, DOI 10.1111/j.1439-0426.2010.01504.x; Wootton R.J., 1998, ECOLOGY TELEOST FISH	57	15	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e170582	10.1371/journal.pone.0170582	http://dx.doi.org/10.1371/journal.pone.0170582			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122061	Green Submitted, Green Accepted, gold, Green Published			2022-12-26	WOS:000396167300038
J	Melcer, T; Walker, J; Bhatnagar, V; Richard, E; Sechriest, VF; Galarneau, M				Melcer, Ted; Walker, Jay; Bhatnagar, Vibha; Richard, Erin; Sechriest, V. Franklin, II; Galarneau, Michael			A Comparison of Four-Year Health Outcomes following Combat Amputation and Limb Salvage	PLOS ONE			English	Article							INJURY SEVERITY SCORE; MILITARY; IRAQ; AFGHANISTAN; TRAUMA; PREVALENCE; VETERANS	Little research has described the long-term health outcomes of patients who had combatrelated amputations or leg-threatening injuries. We conducted retrospective analysis of Department of Defense and Department of Veterans Affairs health data for lower extremity combat-injured patients with (1) unilateral amputation within 90 days postinjury (early amputation, n = 440), (2) unilateral amputation more than 90 days postinjury (late amputation, n = 78), or (3) leg-threatening injuries without amputation (limb salvage, n = 107). Patient medical records were analyzed for four years postinjury. After adjusting for group differences, early amputation was generally associated with a lower or similar prevalence for adverse physical and psychological diagnoses (e. g., pain, osteoarthritis, posttraumatic stress disorder) versus late amputation and/or limb salvage. By contrast, early amputation was associated with an increased likelihood of osteoporosis during the first year postinjury. The prevalence of posttraumatic stress disorder increased for all patient groups over four years postinjury, particularly in the second year. The different clinical outcomes among combat extremity injured patients treated with early amputation, late amputation, or limb salvage highlight their different healthcare requirements. These findings can inform and optimize the specific treatment pathways that address the physical and psychological healthcare needs of such patients over time.	[Melcer, Ted; Walker, Jay; Bhatnagar, Vibha; Richard, Erin; Galarneau, Michael] Naval Hlth Res Ctr, Dept Med Modeling Simulat & Mission Support, San Diego, CA 92152 USA; [Bhatnagar, Vibha; Richard, Erin] VA San Diego Healthcare Syst, San Diego, CA USA; [Bhatnagar, Vibha; Richard, Erin] Univ Calif San Diego, Dept Family Med & Publ Hlth, San Diego, CA 92103 USA; [Sechriest, V. Franklin, II] VA Minneapolis Healthcare Syst, Minneapolis, MN USA	United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC); US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	Melcer, T (corresponding author), Naval Hlth Res Ctr, Dept Med Modeling Simulat & Mission Support, San Diego, CA 92152 USA.	ted.melcer.civ@mail.mil		Melcer, Ted/0000-0001-8330-6985	Navy Bureau of Medicine and Surgery under Wounded III and Injured Program [201]; Extremity Trauma and Amputation Center of Excellence	Navy Bureau of Medicine and Surgery under Wounded III and Injured Program; Extremity Trauma and Amputation Center of Excellence	Support was provided by the Navy Bureau of Medicine and Surgery under the Wounded III and Injured Program-Project 201; and the Extremity Trauma and Amputation Center of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andersen RC, 2014, J AM ACAD ORTHOP SUR, V22, P57, DOI 10.5435/JAAOS-22-01-57; Armed Forces Health Surveillance Center (AFHSC), 2015, MSMR, V22, P18; Bevevino AJ, 2013, CLIN ORTHOP RELAT RE; Bosse MJ, 2002, NEW ENGL J MED, V347, P1924, DOI 10.1056/NEJMoa012604; Bremner Luke F, 2010, J Surg Orthop Adv, V19, P77; Cameron KL, 2011, ARTHRITIS RHEUM-US, V63, P2974, DOI 10.1002/art.30498; Copeland LA, 2011, J AFFECT DISORDERS, V130, P226, DOI 10.1016/j.jad.2010.10.017; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Covey Dana C, 2008, Instr Course Lect, V57, P65; Doucet JJ, 2011, J TRAUMA, V70, P1241, DOI 10.1097/TA.0b013e3182095b52; Doukas WC, 2013, J BONE JOINT SURG AM, V95A, P138, DOI 10.2106/JBJS.K.00734; Eastridge BJ, 2006, J TRAUMA, V61, P1366, DOI 10.1097/01.ta.0000245894.78941.90; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Fischer H., 2014, CONGR RES SERV REP C; Flint LJ, J ORTHOP TRAUMA; Gailey R, 2008, J REHABIL RES DEV, V45, P15, DOI 10.1682/JRRD.2006.11.0147; Galarneau MR, 2006, MIL MED, V171, P691, DOI 10.7205/MILMED.171.8.691; Granado NS, 2009, HYPERTENSION, V54, P966, DOI 10.1161/HYPERTENSIONAHA.109.132555; Gunderson EKE, 2005, MIL MED, V170, P172; Helgeson MD, 2010, ORTHOPEDICS, V33, P1; Horesh D, 2011, SOC PSYCH PSYCH EPID, V46, P863, DOI 10.1007/s00127-010-0255-6; Kim PH, 2012, CLIN ORTHOP RELAT R, V470, P3624, DOI 10.1007/s11999-012-2642-7; Kim PH, 2012, CLIN ORTHOP RELAT R, V470, P3270, DOI 10.1007/s11999-012-2376-6; Krueger CA, 2012, J TRAUMA ACUTE CARE, V73, pS438, DOI 10.1097/TA.0b013e318275469c; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; MacKenzie EJ, 2005, J BONE JOINT SURG AM, V87A, P1801, DOI 10.2106/JBJS.E.00032; MACKENZIE EJ, 1985, MED CARE, V23, P823, DOI 10.1097/00005650-198506000-00008; Maynard C, 2010, J REHABIL RES DEV, V47, P403, DOI 10.1682/JRRD.2009.02.0016; Melcer T, 2014, J REHABIL R IN PRESS; Melcer T, 2013, J TRAUMA ACUTE CARE, V75, pS247, DOI 10.1097/TA.0b013e318299d95e; Melcer T, 2010, MIL MED, V175, P147, DOI 10.7205/MILMED-D-09-00120; Murray CK, 2008, J TRAUMA, V64, pS239, DOI 10.1097/TA.0b013e318163cd14; Nolan L, 2003, GAIT POSTURE, V17, P142, DOI 10.1016/S0966-6362(02)00066-8; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Pasquina PF, 2009, CARE COMBAT AMPUTEE, P265; Patzkowski JC, 2012, J BONE JOINT SURG AM, V94A, P507, DOI 10.2106/JBJS.K.00254; Stinner DJ, 2010, MIL MED, V175, P1027, DOI 10.7205/MILMED-D-10-00102; Tohira H, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-63; VA Information Resource Center, 2012, VIREC RESOURCE GUIDE; Woodruff SI, 2014, MIL MED, V179, P265, DOI 10.7205/MILMED-D-13-00444; Yun HC, 2008, J TRAUMA, V64, pS163, DOI 10.1097/TA.0b013e318160868c	43	19	20	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e170569	10.1371/journal.pone.0170569	http://dx.doi.org/10.1371/journal.pone.0170569			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7FK	28122002	gold, Green Submitted, Green Published			2022-12-26	WOS:000396167300039
J	Roobthaisong, A; Aikawa, C; Nozawa, T; Maruyama, F; Nakagawa, I				Roobthaisong, Amonrattana; Aikawa, Chihiro; Nozawa, Takashi; Maruyama, Fumito; Nakagawa, Ichiro			YvqE and CovRS of Group A Streptococcus Play a Pivotal Role in Viability and Phenotypic Adaptations to Multiple Environmental Stresses	PLOS ONE			English	Article							2-COMPONENT SIGNAL-TRANSDUCTION; HYALURONIC-ACID CAPSULE; GRAM-POSITIVE BACTERIA; BIOFILM FORMATION; STAPHYLOCOCCUS-AUREUS; BACILLUS-SUBTILIS; RESPONSE REGULATOR; ESCHERICHIA-COLI; EPITHELIAL-CELLS; PYOGENES	Streptococcus pyogenes (group A Streptococcus, or GAS) is a human pathogen that causes a wide range of diseases. For successful colonization within a variety of host niches, GAS utilizes TCSs to sense and respond to environmental changes and adapts its pathogenic traits accordingly; however, many GAS TCSs and their interactions remain uncharacterized. Here, we elucidated the roles of a poorly characterized TCS, YvqEC, and a wellstudied TCS, CovRS, in 2 different GAS strain SSI-1 and JRS4, respectively. Deletion of yvqE and yvqC in JRS4 resulted in lower cell viability and abnormality of cell division when compared to the wild-type strain under standard culture conditions, demonstrating an important role for YvqEC. Furthermore, a double-deletion of yvqEC and covRS in SSI-1 and JRS4 resulted in a significantly impaired ability to survive under various stress conditions, as well as an increased sensitivity to cell wall-targeting antibiotics compared to that observed in either single mutant or wild-type strains suggesting synergistic interactions. Our findings provide new insights into the impact of poorly characterized TCS (YvqEC) and potential synergistic interactions between YvqEC and CovRS and reveal their potential role as novel therapeutic targets against GAS infection.	[Roobthaisong, Amonrattana] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Mol Craniofacial Embryol, Tokyo, Japan; [Roobthaisong, Amonrattana; Aikawa, Chihiro; Nozawa, Takashi; Maruyama, Fumito; Nakagawa, Ichiro] Kyoto Univ, Grad Sch Med, Dept Microbiol, Kyoto, Japan	Tokyo Medical & Dental University (TMDU); Kyoto University	Nakagawa, I (corresponding author), Kyoto Univ, Grad Sch Med, Dept Microbiol, Kyoto, Japan.	nakagawa.ichiro.7w@kyoto-u.ac.jp	Maruyama, Fumito/AAK-5928-2020	Maruyama, Fumito/0000-0003-2347-616X	Japanese Ministry of Education, Culture, Sports, Science and Technology [25293370, 15K15130, 16H05188, 15K15675, 25713060, 23117002]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (25293370, 15K15130, and 16H05188 to IN, 15K15675, 25713060, 23117002 to FM).The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2011, J BIOL CHEM, V286, P41368, DOI 10.1074/jbc.M111.286690; Baldassarri L, 2006, J CLIN MICROBIOL, V44, P2721, DOI 10.1128/JCM.00512-06; Belcheva A, 2008, J BIOL CHEM, V283, P12354, DOI 10.1074/jbc.M710010200; Boyle-Vavra S, 2006, FEMS MICROBIOL LETT, V262, P163, DOI 10.1111/j.1574-6968.2006.00384.x; Churchward G, 2007, MOL MICROBIOL, V64, P34, DOI 10.1111/j.1365-2958.2007.05649.x; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dalton TL, 2004, J BACTERIOL, V186, P3928, DOI 10.1128/JB.186.12.3928-3937.2004; Daniel RA, 1998, MOL MICROBIOL, V29, P593, DOI 10.1046/j.1365-2958.1998.00954.x; Dubrac S, 2007, J BACTERIOL, V189, P8257, DOI 10.1128/JB.00645-07; Eldholm V, 2010, J BACTERIOL, V192, P1761, DOI 10.1128/JB.01489-09; Fabret C, 1998, J BACTERIOL, V180, P6375; Federle MJ, 1999, J BACTERIOL, V181, P3649, DOI 10.1128/JB.181.12.3649-3657.1999; Frick IM, 2000, MOL MICROBIOL, V37, P1232, DOI 10.1046/j.1365-2958.2000.02084.x; Fritsch F, 2011, MICROBIOL-SGM, V157, P373, DOI 10.1099/mic.0.044776-0; Gotoh Y, 2010, CURR OPIN MICROBIOL, V13, P232, DOI 10.1016/j.mib.2010.01.008; Graham MR, 2005, AM J PATHOL, V166, P455, DOI 10.1016/S0002-9440(10)62268-7; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; GUZMAN LM, 1992, J BACTERIOL, V174, P7716, DOI 10.1128/JB.174.23.7717-7728.1992; Ichikawa M, 2011, MICROBIOL-SGM, V157, P3187, DOI 10.1099/mic.0.050534-0; Jordan S, 2008, FEMS MICROBIOL REV, V32, P107, DOI 10.1111/j.1574-6976.2007.00091.x; Jordan S, 2006, J BACTERIOL, V188, P5153, DOI 10.1128/JB.00310-06; Kazmierczak MJ, 2005, MICROBIOL MOL BIOL R, V69, P527, DOI 10.1128/MMBR.69.4.527-543.2005; Kimura KR, 2012, J BACTERIOL, V194, P804, DOI 10.1128/JB.06283-11; Klinzing DC, 2013, MICROBIOL-SGM, V159, P1521, DOI 10.1099/mic.0.064444-0; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Kuroda M, 2003, MOL MICROBIOL, V49, P807, DOI 10.1046/j.1365-2958.2003.03599.x; LANCEFIELD RC, 1962, J IMMUNOL, V89, P307; Le Breton Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep09838; Liu MY, 2006, MICROBIOL-SGM, V152, P967, DOI 10.1099/mic.0.28706-0; Martinez B, 2007, MOL MICROBIOL, V64, P473, DOI 10.1111/j.1365-2958.2007.05668.x; Mascher T, 2004, ANTIMICROB AGENTS CH, V48, P2888, DOI 10.1128/AAC.48.8.2888-2896.2004; Nakagawa I, 2001, CELL MICROBIOL, V3, P395, DOI 10.1046/j.1462-5822.2001.00122.x; Nakagawa I, 2003, GENOME RES, V13, P1042, DOI 10.1101/gr.1096703; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; Noirclerc-Savoye M, 2005, MOL MICROBIOL, V55, P413, DOI 10.1111/j.1365-2958.2004.04408.x; Ogawa T, 2011, MICROB PATHOGENESIS, V51, P58, DOI 10.1016/j.micpath.2011.03.009; Oliver-Kozup HA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-262; Opdyke JA, 2001, MOL MICROBIOL, V42, P495, DOI 10.1046/j.1365-2958.2001.02657.x; Sakurai A, 2010, J BIOL CHEM, V285, P22666, DOI 10.1074/jbc.M109.100131; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schrager HM, 1996, J CLIN INVEST, V98, P1954, DOI 10.1172/JCI118998; SCOTT JR, 1986, J EXP MED, V164, P1641, DOI 10.1084/jem.164.5.1641; Senadheera MD, 2005, J BACTERIOL, V187, P4064, DOI 10.1128/JB.187.12.4064-4076.2005; Sitkiewicz I, 2006, INFECT IMMUN, V74, P1339, DOI 10.1128/IAI.74.2.1339-1351.2006; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Suntharalingam P, 2009, J BACTERIOL, V191, P2973, DOI 10.1128/JB.01563-08; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; Tatsuno Ichiro, 2014, BMC Res Notes, V7, P189, DOI 10.1186/1756-0500-7-189; TRIEUCUOT P, 1991, GENE, V102, P99, DOI 10.1016/0378-1119(91)90546-N; Voyich JM, 2004, J IMMUNOL, V173, P1194, DOI 10.4049/jimmunol.173.2.1194; Wagner C, 2002, INFECT IMMUN, V70, P6121, DOI 10.1128/IAI.70.11.6121-6128.2002; WESSELS MR, 1991, P NATL ACAD SCI USA, V88, P8317, DOI 10.1073/pnas.88.19.8317; Zhang JQ, 2009, MICROBIOL-SGM, V155, P61, DOI 10.1099/mic.0.023077-0; Zhang SM, 2015, ANTON LEEUW INT J G, V108, P365, DOI 10.1007/s10482-015-0489-0	54	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e170612	10.1371/journal.pone.0170612	http://dx.doi.org/10.1371/journal.pone.0170612			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122066	gold, Green Published, Green Submitted			2022-12-26	WOS:000396167300035
J	Wang, YY; Ryu, AR; Jin, S; Jeon, YM; Lee, MY				Wang, Yoon-Young; Ryu, A-Reum; Jin, Solee; Jeon, Yu-Mi; Lee, Mi-Young			Chlorin e6-Mediated Photodynamic Therapy Suppresses P. acnes-Induced Inflammatory Response via NF kappa B and MAPKs Signaling Pathway	PLOS ONE			English	Article							PROPIONIBACTERIUM-ACNES; TRANSCRIPTION FACTORS; IN-VITRO; ACTIVATION; EXPRESSION; INNATE; CANCER; FAMILY; CELLS; LIGHT	Photodynamic therapy (PDT), consisting of photosensitizer, light, and oxygen has been used for the treatment of various diseases including cancers, microbial infections and skin disorders. In this study, we examined the anti-inflammatory effect of chlorin e6-mediated PDT in P. acnes-infected HaCaT cells using photosensitizer chlorin e6 (Ce6) and halogen light. The live and heat-killed P. acnes triggered an upregulation of inflammatory molecules such as iNOS, NO, and inflammatory cytokine in HaCaT cells and mouse model. Ce6-mediated PDT notably downregulated the expression of these inflammatory molecules in vitro and in vivo. Similarly, chlorin e6-mediated PDT was capable of regulating inflammatory response in both live and heat killed S. epidermidis exposed HaCaT cells. Moreover, phosphorylation of p38, JNK, and ERK were reduced by Ce6-mediated PDT. Ce6-mediated PDT also reduced the phosphorylation of IKK alpha/beta, IB alpha and NF kappa B p65 in P. acnes-stimulated HaCaT cells. In addition, the dramatic increase in the nuclear translocation of NF kappa B p65 observed upon stimulation with P. acnes was markedly impaired by Ce6-based PDT. This is the first suggestion that Ce6-mediated PDT suppresses P. acnes-induced inflammation through modulating NF kappa B and MAPKs signaling pathways.	[Wang, Yoon-Young; Ryu, A-Reum; Jin, Solee; Jeon, Yu-Mi; Lee, Mi-Young] Soonchunhyang Univ, Dept Med Sci, Coll Med Sci, Asan, Chungnam, South Korea; [Jeon, Yu-Mi] Korea Brain Res Inst, Div Res, Daegu, South Korea; [Lee, Mi-Young] Soonchunhyang Univ, Dept Med Biotechnol, Coll Med Sci, Asan, Chungnam, South Korea	Soonchunhyang University; Korea Brain Research Institute (KBRI); Soonchunhyang University	Lee, MY (corresponding author), Soonchunhyang Univ, Dept Med Sci, Coll Med Sci, Asan, Chungnam, South Korea.; Lee, MY (corresponding author), Soonchunhyang Univ, Dept Med Biotechnol, Coll Med Sci, Asan, Chungnam, South Korea.	miyoung@sch.ac.kr		Ryu, A-Reum/0000-0002-0330-8620	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HN12C0059]; Soonchunhyang University	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea; Soonchunhyang University	This study was supported by a grant received from Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea. (Grant No.: HN12C0059). This study was also supported in part by Soonchunhyang University.	Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Caamano J, 2002, CLIN MICROBIOL REV, V15, P414, DOI 10.1128/CMR.15.3.414-429.2002; Chin WWL, 2006, J PHOTOCH PHOTOBIO B, V84, P103, DOI 10.1016/j.jphotobiol.2006.02.002; Eady EA, 2003, DERMATOLOGY, V206, P54, DOI 10.1159/000067822; Grange PA, 2009, J DERMATOL SCI, V56, P106, DOI 10.1016/j.jdermsci.2009.08.001; Guo QZ, 2016, MOL MED REP, V14, P544, DOI 10.3892/mmr.2016.5248; Hay RJ, 2014, J INVEST DERMATOL, V134, P1527, DOI 10.1038/jid.2013.446; Hayashi N, 2015, MOL CANCER THER, V14, P452, DOI 10.1158/1535-7163.MCT-14-0348; Hongcharu W, 2000, J INVEST DERMATOL, V115, P183, DOI 10.1046/j.1523-1747.2000.00046.x; Jeon YM, 2015, LIFE SCI, V124, P56, DOI 10.1016/j.lfs.2014.12.029; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kang S, 2005, AM J PATHOL, V166, P1691, DOI 10.1016/S0002-9440(10)62479-0; Kim J, 2005, DERMATOLOGY, V211, P193, DOI 10.1159/000087011; Kim JH, 2006, BIOCHEM PHARMACOL, V71, P1198, DOI 10.1016/j.bcp.2005.12.031; Kim SF, 2005, SCIENCE, V310, P1966, DOI 10.1126/science.1119407; Ko JW, 2016, MOL CELL TOXICOL, V12, P185, DOI 10.1007/s13273-016-0023-0; Lee WR, 2014, J INVEST DERMATOL, V134, P1922, DOI 10.1038/jid.2014.75; Lee YJ, 2015, MOL CELL TOXICOL, V11, P295, DOI 10.1007/s13273-015-0029-z; Lehmann P, 2007, BRIT J DERMATOL, V156, P793, DOI 10.1111/j.1365-2133.2007.07833.x; Lin C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056499, 10.1371/journal.pone.0080883, 10.1371/journal.pone.0065734, 10.1371/journal.pone.0070187]; Malina L, 2016, TOXICOL IN VITRO, V34, P246, DOI 10.1016/j.tiv.2016.04.010; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Nakatsuji T, 2009, J INVEST DERMATOL, V129, P2480, DOI 10.1038/jid.2009.93; Nishijima S, 2000, J Dermatol, V27, P318; Ozog DM, 2016, DERMATOL SURG, V42, P804, DOI 10.1097/DSS.0000000000000800; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Ryu AR, 2014, MOL CELL TOXICOL, V10, P423, DOI 10.1007/s13273-014-0047-2; Saklatvala J, 2004, CURR OPIN PHARMACOL, V4, P372, DOI 10.1016/j.coph.2004.03.009; Shan JH, 2009, INT IMMUNOPHARMACOL, V9, P1042, DOI 10.1016/j.intimp.2009.04.011; Shibata M, 2009, J INVEST DERMATOL, V129, P375, DOI 10.1038/jid.2008.237; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Tanghetti Emil A, 2013, J Clin Aesthet Dermatol, V6, P27; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wang C, 2011, BIOMATERIALS, V32, P6145, DOI 10.1016/j.biomaterials.2011.05.007; Yao R, 2015, MOL CELL TOXICOL, V11, P247, DOI 10.1007/s13273-015-0024-4; Zaenglein AL, 2016, J AM ACAD DERMATOL, V74, P945, DOI 10.1016/j.jaad.2015.12.037	39	34	35	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2017	12	1							e0170599	10.1371/journal.pone.0170599	http://dx.doi.org/10.1371/journal.pone.0170599			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7CU	28118375	Green Published, Green Submitted, gold			2022-12-26	WOS:000396160500025
J	Moisi, JC; Makawa, MS; Tall, H; Agbenoko, K; Njanpop-Lafourcade, BM; Tamekloe, S; Amidou, M; Mueller, JE; Gessner, BD				Moisi, Jennifer C.; Makawa, Makawa-Sy; Tall, Haoua; Agbenoko, Kodjo; Njanpop-Lafourcade, Berthe-Marie; Tamekloe, Stanislas; Amidou, Moussa; Mueller, Judith E.; Gessner, Bradford D.			Burden of Pneumococcal Disease in Northern Togo before the Introduction of Pneumococcal Conjugate Vaccine	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CHILDREN; SURVEILLANCE; EFFICACY; TRIAL; KENYA; MENINGITIS; INFECTIONS; CHILDHOOD; CARRIAGE	Background S. pneumoniae is a leading cause of meningitis morbidity and mortality in the African meningitis belt, but little is known of its contribution to the burden of pneumonia in the region. We aimed to estimate the incidence of pneumococcal disease in children and adults in northern Togo, before the introduction of pneumococcal conjugate vaccine (PCV). Methods and findings From May 1st 2010 to April 30th 2013, we systematically enrolled all hospitalized patients meeting a case definition of suspected meningitis or clinical pneumonia, residing in Tone or Cinkasse districts, northern Togo and providing informed consent. We collected clinical data and tested biological specimens according to standardized procedures, including bacteriology and PCR testing of cerebro-spinal fluid for meningitis patients and blood cultures and whole blood lytA PCR for pneumonia patients. Chest X-rays (CXR) were interpreted using the WHO methodology. We included 404 patients with meningitis (104 <5 years of age) and 1550 with pneumonia (251 <5 years) over the study period. Of these, 78 (19%) had pneumococcal meningitis (13 <5 years), 574 (37%) had radiologically-confirmed pneumonia (83 <5 years) and 73 (5%) had culture-confirmed pneumococcal pneumonia (2 <5 years). PCV13 serotypes caused 79% (54/ 68) of laboratory-confirmed pneumococcal meningitis and 83% (29/35) of culture-confirmed pneumococcal pneumonia. Serotype 1 predominated in meningitis (n = 33) but not in pneumonia patients (n = 1). The incidence of pneumococcal disease was 7.5 per 100,000 among children <5 years of age and 14.8 in persons 5 years of age and above in the study area. When considering CXR-confirmed and blood PCR-positive pneumonia cases as likely pneumococcal, incidence estimates increased to 43.7 and 66.0 per 100,000 in each of these age groups, respectively. Incidence was at least 3-fold higher when we restricted the analysis to the urban area immediately around the study hospitals. Conclusions Our findings highlight the important role of S. pneumoniae as a meningitis and pneumoniacausing pathogen in the African meningitis belt. Pneumococcal disease incidence in our population was substantially lower than expected from global models; we hypothesize that poor access to hospital care led us to substantially underestimate the burden of disease. Surveillance is ongoing and will enable an evaluation of PCV impact, providing novel, high quality data from the region.	[Moisi, Jennifer C.; Njanpop-Lafourcade, Berthe-Marie; Mueller, Judith E.; Gessner, Bradford D.] Agence Med Prevent, Paris, France; [Makawa, Makawa-Sy; Agbenoko, Kodjo; Tamekloe, Stanislas; Amidou, Moussa] Minist Hlth, LomeDapaong, Togo; [Tall, Haoua] Agence Med Prevent, Ouagadougou, Burkina Faso; [Mueller, Judith E.] Sorbonne Paris Cite, Ecole Hautes Etud Sante Publ, Paris, France; [Mueller, Judith E.] Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France	Agence de Medecine Preventive; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Moisi, JC (corresponding author), Agence Med Prevent, Paris, France.	jennifer.moisi@polytechnique.org			Pfizer [WS951939]; GSK	Pfizer(Pfizer); GSK(GlaxoSmithKline)	This study was funded by an Investigator Initiated Research grant from Pfizer (WS951939). BG, HT, BMNL, JCM work for AMP and receive research funding from Pfizer and GSK, manufacturers of pneumococcal conjugate vaccines. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This study was funded by an Investigator-Initiated Research grant from Pfizer.	[Anonymous], 2005, MMWR MORB MORTAL WKL, V54, P893; [Anonymous], 2015, DEMOGRAPHIC HLTH SUR; Azzari C, 2011, J MED MICROBIOL, V60, P710, DOI 10.1099/jmm.0.028357-0; Ben-Shimol S, 2015, CLIN INFECT DIS, V60, P1384, DOI 10.1093/cid/civ023; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Bunker A, 2016, EBIOMEDICINE, V6, P258, DOI 10.1016/j.ebiom.2016.02.034; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Deloria-Knoll M, PLOS MED, V7; English M, 1996, T ROY SOC TROP MED H, V90, P658, DOI 10.1016/S0035-9203(96)90423-X; Etyang AO, 2014, LANCET GLOB HEALTH, V2, pE216, DOI 10.1016/S2214-109X(14)70023-3; Gessner B., 2008, CLIN INFECT DIS, V47; Givon-Lavi N, 2003, PEDIATR INFECT DIS J, V22, P524, DOI 10.1097/00006454-200306000-00008; Griffin MR, 2013, NEW ENGL J MED, V369, P155, DOI 10.1056/NEJMoa1209165; Isaacman D, 1996, J PEDIATR-US, V128, P190, DOI 10.1016/S0022-3476(96)70388-8; Kim J, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13020213; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Kwambana-Adams BA, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1914-3; Lafourcade BMN, 2010, J CLIN MICROBIOL, V48, P612, DOI 10.1128/JCM.01402-09; LAPEYSSONNIE L, 1963, Bull World Health Organ, V28 Suppl, P1; Leimkugel J, 2005, J INFECT DIS, V192, P192, DOI 10.1086/431151; Messaoudi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151428; Millar EV, 2008, CLIN INFECT DIS, V47, P989, DOI 10.1086/591966; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Moisi JC, 2011, B WORLD HEALTH ORGAN, V89, P102, DOI 10.2471/BLT.10.080796; Mueller JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052464; Mueller JE, 2010, INT J INFECT DIS, V14, pE553, DOI 10.1016/j.ijid.2009.08.013; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2003, LANCET, V362, P355, DOI 10.1016/S0140-6736(03)14022-6; Parent dC I, 2005, CLIN INFECT DIS, V40, P17, DOI DOI 10.1086/426436; Rouphael N, 2011, DIAGN MICR INFEC DIS, V70, P452, DOI 10.1016/j.diagmicrobio.2010.09.006; Said MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060273; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; Tornheim JA, 2007, INT J INFECT DIS, V11, P536, DOI 10.1016/j.ijid.2007.03.006; Traore Y, 2009, CLIN INFECT DIS, V48, pS181, DOI 10.1086/596498; UNICEF, 2014, STAT WORLDS CHILDR 2; Weinberger DM, 2014, CLIN INFECT DIS, V58, P188, DOI 10.1093/cid/cit721; WHO Centers for Disease C Prevention, LAB METH DIAGN MEN C; Yaro S, 2006, CLIN INFECT DIS, V43, P693, DOI 10.1086/506940	40	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170412	10.1371/journal.pone.0170412	http://dx.doi.org/10.1371/journal.pone.0170412			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114427	Green Published, Green Submitted, gold			2022-12-26	WOS:000396129000046
J	Nuytten, A; Behal, H; Duhamel, A; Jarreau, PH; Mazela, J; Milligan, D; Gortner, L; Piedvache, A; Zeitlin, J; Truffert, P				Nuytten, Alexandra; Behal, Helene; Duhamel, Alain; Jarreau, Pierre-Henri; Mazela, Jan; Milligan, David; Gortner, Ludwig; Piedvache, Aurelie; Zeitlin, Jennifer; Truffert, Patrick		EPICE Effective Perinatal	Evidence-Based Neonatal Unit Practices and Determinants of Postnatal Corticosteroid-Use in Preterm Births below 30 Weeks GA in Europe. A Population-Based Cohort Study	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; CHRONIC LUNG-DISEASE; BRONCHOPULMONARY DYSPLASIA; DEXAMETHASONE TREATMENT; CONSENSUS GUIDELINES; INFANTS BORN; 1ST WEEK; RISK; HYDROCORTISONE; MANAGEMENT	Background Postnatal corticosteroids (PNC) were widely used to treat and prevent bronchopulmonary dysplasia in preterm infants until studies showed increased risk of cerebral palsy and neuro-developmental impairment. We aimed to describe PNC use in Europe and evaluate the determinants of their use, including neonatal characteristics and adherence to evidence-based practices in neonatal intensive care units (NICUs). Methods 3917/4096 (95,6%) infants born between 24 and 29 weeks gestational age in 19 regions of 11 European countries of the EPICE cohort we included. We examined neonatal characteristics associated with PNC use. The cohort was divided by tertiles of probability of PNC use determined by logistic regression analysis. We also evaluated the impact of the neonatal unit's reported adherence to European recommendations for respiratory management and a stated policy of reduced PNC use. Results PNC were prescribed for 545/3917 (13.9%) infants (regional range 3.1-49.4%) and for 29.7% of infants in the highest risk tertile (regional range 5.4-72.4%). After adjustment, independent predictors of PNC use were a low gestational age, small for gestational age, male sex, mechanical ventilation, use of non-steroidal anti-inflammatory drugs to treat persistent ductus arteriosus and region. A stated NICU policy reduced PNC use (odds ratio 0.29 [95% CI 0.17; 0.50]). Conclusion PNC are frequently used in Europe, but with wide regional variation that was unexplained by neonatal characteristics. Even for infants at highest risk for PNC use, some regions only rarely prescribed PNC. A stated policy of reduced PNC use was associated with observed practice and is recommended.	[Nuytten, Alexandra; Truffert, Patrick] CHRU Lille, Jeanne de Flandre Hosp, Dept Neonatol, Lille, France; [Nuytten, Alexandra; Behal, Helene; Duhamel, Alain; Truffert, Patrick] Univ Lille, CHRU Lille, EA 2694 Lille, Dept Biostat, Lille, France; [Jarreau, Pierre-Henri] Univ Paris V Rene Descartes, Paris, France; [Jarreau, Pierre-Henri] Hop Univ Paris, AP HP, Ctr Site Cochin, Serv Med & Reanimat Neonat Port Royal, Paris, France; [Mazela, Jan] Poznan Univ Med Sci, Dept Neonatol, Poznan, Poland; [Milligan, David] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England; [Gortner, Ludwig] Univ Saarland, Univ Hosp, Children s Hosp, Homburg, Germany; [Piedvache, Aurelie; Zeitlin, Jennifer] Paris Descartes Univ, Obstet Perinatal & Pediat Epidemiol Res Team Epop, Inserm UMR 1153, Ctr Epidemiol & Stat,Sorbonne Paris Cite,DHU Risk, Paris, France	Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Poznan University of Medical Sciences; Newcastle University - UK; Saarland University; Universitatsklinikum des Saarlandes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Nuytten, A (corresponding author), CHRU Lille, Jeanne de Flandre Hosp, Dept Neonatol, Lille, France.; Nuytten, A (corresponding author), Univ Lille, CHRU Lille, EA 2694 Lille, Dept Biostat, Lille, France.	anuytten@gmail.com	Zeitlin, Jennifer/G-4973-2017; Manktelow, Bradley/G-2794-2011; Boyle, Elaine/I-6298-2018; Draper, Elizabeth/I-6304-2018	Zeitlin, Jennifer/0000-0002-9568-2969; PIEDVACHE, AURELIE/0000-0002-2737-0461; Diegues Rodrigues, Carina Eduarda/0000-0003-1720-2808; Manktelow, Bradley/0000-0002-3264-0323; Gadzinowski, Janusz/0000-0001-8397-6989; Boyle, Elaine/0000-0002-5038-3148; Draper, Elizabeth/0000-0001-9340-8176	European Union [259882]; French Institute of Public Health Research/Institute of Public Health and its partners the French Health Ministry; National Institute of Health and Medical Research; National Institute of Cancer; National Solidarity Fund for Autonomy; National Research Agency through the French Equipex Program of Investments in the Future [ANR-11-EQPX-0038]; Prem Up Foundation; Polish Ministry of Science and Higher Education; Stockholm County Council; Karolinska Institutet; Department of Neonatal Medicine, Karolinska University Hospital; Neonatal Networks for East Midlands and Yorkshire Humber regions	European Union(European Commission); French Institute of Public Health Research/Institute of Public Health and its partners the French Health Ministry; National Institute of Health and Medical Research; National Institute of Cancer; National Solidarity Fund for Autonomy; National Research Agency through the French Equipex Program of Investments in the Future; Prem Up Foundation; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Department of Neonatal Medicine, Karolinska University Hospital; Neonatal Networks for East Midlands and Yorkshire Humber regions	The research leading to these results received funding from the European Union's Seventh Framework Programme ([FP7/2007-2013]) under grant agreement no259882. Additional funding in some countries: France (French Institute of Public Health Research/Institute of Public Health and its partners the French Health Ministry, the National Institute of Health and Medical Research, the National Institute of Cancer, and the National Solidarity Fund for Autonomy; grant ANR-11-EQPX-0038 from the National Research Agency through the French Equipex Program of Investments in the Future; and the Prem Up Foundation); Poland (2012-2015 allocation of funds for international projects from the Polish Ministry of Science and Higher Education); Sweden (regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet, and by the Department of Neonatal Medicine, Karolinska University Hospital). UK (funding for The Neonatal Survey from Neonatal Networks for East Midlands and Yorkshire & Humber regions).	Ancel PY, 2015, JAMA PEDIAT; [Anonymous], 2010, PEDIATRICS, V126, P800, DOI [10.1542/peds.2010-1534, DOI 10.1542/PEDS.2010-1534]; Barrington K J, 2001, BMC Pediatr, V1, P1, DOI 10.1186/1471-2431-1-1; Baud O, 1999, NEW ENGL J MED, V341, P1190, DOI 10.1056/NEJM199910143411604; Baud O, 2016, LANCET, V387, P1827, DOI 10.1016/S0140-6736(16)00202-6; Bhandari V, 2014, BIRTH DEFECTS RES A, V100, P189, DOI 10.1002/bdra.23220; Blackmon LR, 2002, PEDIATRICS, V109, P330; Doyle LW, 2014, J PEDIATR-US, V165, P1258, DOI 10.1016/j.jpeds.2014.07.049; Doyle LW, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001146.pub4; Doyle LW, 2010, NEONATOLOGY, V98, P289, DOI 10.1159/000286212; Doyle LW, 2010, NEONATOLOGY, V98, P217, DOI 10.1159/000286210; Doyle LW, 2010, NEONATOLOGY, V98, P111, DOI 10.1159/000279992; Egreteau L, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e26; Finer NN, 2010, NEW ENGL J MED, V362, P1970, DOI 10.1056/NEJMoa0911783; Gortner L, 2011, NEONATOLOGY, V99, P112, DOI 10.1159/000313024; Halliday HL, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001146.pub3; Halliday HL, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001145.pub2, 10.1002/14651858.CD001146.pub2]; Halliday HL, 2001, ACTA PAEDIATR, V90, P116, DOI 10.1080/080352501300049145; Jarreau PH, 2010, ARCH PEDIATRIE, V17, P1480, DOI 10.1016/j.arcped.2010.07.013; Jefferies AL, 2012, PAED CHILD HEALT-CAN, V17, P573, DOI 10.1093/pch/17.10.573; Kaempf JW, 2003, PEDIATRICS, V111; Kinsella JP, 2006, LANCET, V367, P1421, DOI 10.1016/S0140-6736(06)68615-7; Morton SC, 2015, J CLIN EPIDEMIOL; Romagnoli C, 1999, INTENS CARE MED, V25, P717, DOI 10.1007/s001340050935; Sackett D, 2007, CLIN ORTHOP RELAT R, V455, P3, DOI DOI 10.1136/BMJ.312.7023.71; Sandri F, 2010, PEDIATRICS, V125, pE1402, DOI 10.1542/peds.2009-2131; SHENNAN AT, 1988, PEDIATRICS, V82, P527; Shinwell ES, 2007, ARCH DIS CHILD-FETAL, V92, pF30, DOI 10.1136/adc.2006.094474; Sweet DG, 2013, NEONATOLOGY, V103, P353, DOI 10.1159/000349928; Sweet DG, 2010, NEONATOLOGY, V97, P402, DOI 10.1159/000297773; Walsh MC, 2006, PEDIATRICS, V118, pE1328, DOI 10.1542/peds.2006-0359; Yoder BA, 2009, PEDIATRICS, V124, P673, DOI 10.1542/peds.2008-2793; Zeitlin J, 2010, J PEDIATR-US, V157, P733, DOI 10.1016/j.jpeds.2010.05.002	33	16	17	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170234	10.1371/journal.pone.0170234	http://dx.doi.org/10.1371/journal.pone.0170234			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114369	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129000029
J	Arredondo-Hernandez, LJR; Diaz-Avalos, C; Lopez-Vidal, Y; Castillo-Rojas, G; Mazari-Hiriart, M				Rene Arredondo-Hernandez, Luis Jose; Diaz-Avalos, Carlos; Lopez-Vidal, Yolanda; Castillo-Rojas, Gonzalo; Mazari-Hiriart, Marisa			FRNA Bacteriophages as Viral Indicators of Faecal Contamination in Mexican Tropical Aquatic Systems	PLOS ONE			English	Article							HUMAN ENTERIC VIRUSES; TIME PCR DETECTION; RAW WASTE-WATER; DRINKING-WATER; SURFACE WATERS; FRESH-WATER; EXTREME PRECIPITATION; ENVIRONMENTAL WATERS; HUMAN ADENOVIRUSES; QUANTITATIVE PCR	A particular challenge to water safety in populous intertropical regions is the lack of reliable faecal indicators to detect microbiological contamination of water, while the numerical relationships of specific viral indicators remain largely unexplored. The aim of this study was to investigate the numerical relationships of FRNA-bacteriophage genotypes, adenovirus 41, and human adenoviruses (HADV) in Mexican surface water systems to assess sewage contamination. We studied the presence of HADV, HADV41 and FRNA bacteriophage genotypes in water samples and quantified by qPCR and RT-qPCR. Virus and water quality indicator variances, as analyzed by principal component analysis and partial least squared regression, followed along the major percentiles of water faecal enterococci. FRNA bacteriophages adequately deciphered viral and point source water contamination. The strongest correlation for HADV was with FRNA bacteriophage type II, in water samples higher than the 50 th percentiles of faecal enterococci, thus indicating urban pollution. FRNA bacteriophage genotypes I and III virus indicator performances were assisted by their associations with electrical conductivity and faecal enterococci. In combination, our methods are useful for inferring water quality degradation caused by sewage contamination. The methods used have potential for determining source contamination in water and, specifically, the presence of enteric viruses where clean and contaminated water have mixed.	[Rene Arredondo-Hernandez, Luis Jose; Mazari-Hiriart, Marisa] Univ Nacl Autonoma Mexico, Inst Ecol, Lab Nacl Ciencias Sostenibilidad, Mexico City, DF, Mexico; [Diaz-Avalos, Carlos] Univ Nacl Autonoma Mexico, Inst Invest Matemat Aplicadas & Sistemas, Dept Probabilidad & Estat, Mexico City, DF, Mexico; [Lopez-Vidal, Yolanda; Castillo-Rojas, Gonzalo] Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Programa Inmunol Mol Microbiana, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Arredondo-Hernandez, LJR (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Lab Nacl Ciencias Sostenibilidad, Mexico City, DF, Mexico.	ljrene@gmail.com	López-Vidal, Yolanda/ABE-9501-2021	López-Vidal, Yolanda/0000-0001-7111-8813; Arredondo-Hernandez, Luis Jose Rene/0000-0002-1631-8713	CONACYT and DGAPA [I0110/193/10]; CONACYT DFG [CB83441, C0009-2014-02-239182, SALUD2009-001-112588]; DGAPA/PAPIIT [IN215910, IG-200213]	CONACYT and DGAPA; CONACYT DFG; DGAPA/PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT))	This research was supported by the CONACYT and DGAPA, through projects:I0110/193/10 CONACYT DFG and CB83441 to MMH, C0009-2014-02-239182 to YLV, SALUD2009-001-112588 to GCR, DGAPA/PAPIIT IN215910 and DGAPA/PAPIIT IG-200213 to MMH. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aslan A, 2011, J APPL MICROBIOL, V111, P1250, DOI 10.1111/j.1365-2672.2011.05130.x; Chavez A, 2004, WATER SCI TECHNOL, V50, P179, DOI 10.2166/wst.2004.0119; Cole D, 2003, APPL ENVIRON MICROB, V69, P6507, DOI 10.1128/AEM.69.11.6507-6514.2003; Colford JM, 2007, EPIDEMIOLOGY, V18, P27, DOI 10.1097/01.ede.0000249425.32990.b9; Curriero FC, 2001, AM J PUBLIC HEALTH, V91, P1194, DOI 10.2105/AJPH.91.8.1194; de Anda J, 2008, PUBLIC WORKS MANAG P, V12, P590, DOI 10.1177/1087724X08317256; Dorevitch S, 2012, ENVIRON HEALTH PERSP, V120, P192, DOI 10.1289/ehp.1103934; Eaton A. D., 2005, STANDARD METHODS EXA; Ferrer A, 2012, ECOHEALTH, V9, P49, DOI 10.1007/s10393-012-0746-x; Flannery J, 2013, WATER RES, V47, P5222, DOI 10.1016/j.watres.2013.06.008; Fleisher JM, 2010, INT J EPIDEMIOL, V39, P1291, DOI 10.1093/ije/dyq084; Fons-Castells J, 2016, J ENV RADIOACT; Hanjra MA, 2012, INT J HYG ENVIR HEAL, V215, P255, DOI 10.1016/j.ijheh.2011.10.003; HAVELAAR AH, 1993, APPL ENVIRON MICROB, V59, P2956, DOI 10.1128/AEM.59.9.2956-2962.1993; HEJKAL TW, 1981, APPL ENVIRON MICROB, V41, P628, DOI 10.1128/AEM.41.3.628-634.1981; Herrador BRG, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0014-y; Hill VR, 2005, APPL ENVIRON MICROB, V71, P6878, DOI 10.1128/AEM.71.11.6878-6884.2005; Jang J, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv127; Jiang S, 2005, CAN J MICROBIOL, V51, P393, DOI 10.1139/W05-016; Jothikumar N, 2005, APPL ENVIRON MICROB, V71, P3131, DOI 10.1128/AEM.71.6.3131-3136.2005; King CE, 2009, BIOTECHNIQUES, V47, P941, DOI 10.2144/000113244; Kiulia NM, 2015, PATHOGENS, V4, P229, DOI 10.3390/pathogens4020229; Kumar T, 2015, MMWR-MORBID MORTAL W, V64, P758, DOI 10.15585/mmwr.mm6428a3; Lata P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-140; Levy K, 2012, AM J TROP MED HYG, V86, P499, DOI 10.4269/ajtmh.2012.11-0263; Line DE, 2013, ENVIRON MONIT ASSESS, V185, P6277, DOI 10.1007/s10661-012-3024-z; Lodder WJ, 2010, APPL ENVIRON MICROB, V76, P5965, DOI 10.1128/AEM.00245-10; Lucas FS, 2014, ENVIRON SCI POLLUT R, V21, P5318, DOI 10.1007/s11356-013-2361-y; Maurer CP, 2015, J WATER HEALTH, V13, P1123, DOI 10.2166/wh.2015.277; Mazari-Hiriart M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102081; Mazari-Hiriart M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002305; Mena KD, 2009, REV ENVIRON CONTAM T, V198, P133, DOI 10.1007/978-0-387-09647-6_4; Ogorzaly L, 2007, J VIROL METHODS, V143, P122, DOI 10.1016/j.jviromet.2007.02.002; Ogorzaly L, 2006, J VIROL METHODS, V138, P131, DOI 10.1016/j.jviromet.2006.08.004; Ogorzaly L, 2009, WATER RES, V43, P1257, DOI 10.1016/j.watres.2008.12.011; Okoh AI, 2010, INT J ENV RES PUB HE, V7, P2620, DOI 10.3390/ijerph7062620; Passerat J, 2011, WATER RES, V45, P893, DOI 10.1016/j.watres.2010.09.024; Pruss-Ustun A, 2014, TROP MED INT HEALTH, V19, P894, DOI 10.1111/tmi.12329; Ramani S, 2009, CURR OPIN INFECT DIS, V22, P477, DOI 10.1097/QCO.0b013e328330662f; Reynolds KA, 2008, REV ENVIRON CONTAM T, V192, P117, DOI 10.1007/978-0-387-71724-1_4; Rodriguez RA, 2012, J VIROL METHODS, V181, P43, DOI 10.1016/j.jviromet.2012.01.009; Sanchez-Azofeifa GA, 2009, FOREST ECOL MANAG, V258, P907, DOI 10.1016/j.foreco.2008.10.030; Simmons FJ, 2011, WATER RES, V45, P3590, DOI 10.1016/j.watres.2011.04.001; Sinclair RG, 2009, J APPL MICROBIOL, V107, P1769, DOI 10.1111/j.1365-2672.2009.04367.x; Vergara GGRV, 2015, WATER RES, V79, P39, DOI 10.1016/j.watres.2015.04.022; Wallace J, 2016, WATER RES, V96, P155, DOI 10.1016/j.watres.2016.03.046; Wolf S, 2010, APPL ENVIRON MICROB, V76, P1388, DOI 10.1128/AEM.02249-09; Wong K, 2012, ENVIRON INT, V45, P151, DOI 10.1016/j.envint.2012.02.009; Xagoraraki I, 2007, APPL ENVIRON MICROB, V73, P7874, DOI 10.1128/AEM.01239-07; Ye XY, 2012, CURR MICROBIOL, V65, P244, DOI 10.1007/s00284-012-0152-1	50	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170399	10.1371/journal.pone.0170399	http://dx.doi.org/10.1371/journal.pone.0170399			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114378	Green Submitted, Green Published, gold			2022-12-26	WOS:000396129000043
J	Viola, MG; LaBreck, CJ; Conti, J; Camberg, JL				Viola, Marissa G.; LaBreck, Christopher J.; Conti, Joseph; Camberg, Jodi L.			Proteolysis-Dependent Remodeling of the Tubulin Homolog FtsZ at the Division Septum in Escherichia coli	PLOS ONE			English	Article							CELL-DIVISION; PROTEIN FTSZ; CYTOSKELETAL PROTEIN; REGULATES DYNAMICS; ASSEMBLY DYNAMICS; GTP-BINDING; MIN SYSTEM; RING; CLPXP; ZIPA	During bacterial cell division a dynamic protein structure called the Z-ring assembles at the septum. The major protein in the Z-ring in Escherichia coli is FtsZ, a tubulin homolog that polymerizes with GTP. FtsZ is degraded by the two-component ATP-dependent protease ClpXP. Two regions of FtsZ, located outside of the polymerization domain in the unstructured linker and at the C-terminus, are important for specific recognition and degradation by ClpXP. We engineered a synthetic substrate containing green fluorescent protein (Gfp) fused to an extended FtsZ C-terminal tail (residues 317-383), including the unstructured linker and the C-terminal conserved region, but not the polymerization domain, and showed that it is sufficient to target a non-native substrate for degradation in vitro. To determine if FtsZ degradation regulates Z-ring assembly during division, we expressed a full length Gfp-FtsZ fusion protein in wild type and clp deficient strains and monitored fluorescent Z-rings. In cells deleted for clpX or clpP, or cells expressing protease-defective mutant protein ClpP (S97A), Z-rings appear normal; however, after photobleaching a region of the Z-ring, fluorescence recovers similar to 70% more slowly in cells without functional ClpXP than in wild type cells. Gfp-FtsZ(R379E), which is defective for degradation by ClpXP, also assembles into Z-rings that recover fluorescence similar to 2-fold more slowly than Z-rings containing Gfp-FtsZ. In vitro, ClpXP cooperatively degrades and disassembles FtsZ polymers. These results demonstrate that ClpXP is a regulator of Z-ring dynamics and that the regulation is proteolysis-dependent. Our results further show that FtsZ-interacting proteins in E. coli fine-tune Z-ring dynamics.	[Viola, Marissa G.; LaBreck, Christopher J.; Conti, Joseph; Camberg, Jodi L.] Univ Rhode Isl, Dept Cell & Mol Biol, Kingston, RI 02881 USA	University of Rhode Island	Camberg, JL (corresponding author), Univ Rhode Isl, Dept Cell & Mol Biol, Kingston, RI 02881 USA.	cambergj@uri.edu	Camberg, Jodi/AAX-3737-2020		USDA National Institute of Food and Agriculture [R100H-4007]; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P2OGM103430]; University of Rhode Island (Enhancement of Graduate Research); National Science Foundation under EPSCoR [0554548, EPS-1004057]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103430] Funding Source: NIH RePORTER; Office of Integrative Activities [1004057] Funding Source: National Science Foundation	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health; University of Rhode Island (Enhancement of Graduate Research); National Science Foundation under EPSCoR; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was funded by the USDA National Institute of Food and Agriculture (Hatch project #R100H-4007 to J. Camberg) and in part by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health (#P2OGM103430 to J. Camberg) and the University of Rhode Island (Enhancement of Graduate Research Award to M. Viola). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; We thank Shannon May, Erin Pelton and Eric DiBiasio for helpful discussions, Anthony Velasquez for technical assistance, Barry Wanner for pKD267, Piet de Boer for XCH151, Matt Chenoweth for strain construction, and Paul Johnson and Janet Atoyan for microscopy and sequencing assistance. Sequencing and microscopy were performed at the Rhode Island Genomics and Sequencing Center, which is supported in part by the National Science Foundation under EPSCoR Grants Nos. 0554548 & EPS-1004057.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Anderson DE, 2004, J BACTERIOL, V186, P5775, DOI 10.1128/JB.186.17.5775-5781.2004; Arjes HA, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0544-z; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; Bernhardt TG, 2004, MOL MICROBIOL, V52, P1255, DOI 10.1111/j.1365-2958.2004.04063.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BRAMHILL D, 1994, P NATL ACAD SCI USA, V91, P5813, DOI 10.1073/pnas.91.13.5813; Buczek MS, 2016, MICROBIOL-SGM, V162, P909, DOI 10.1099/mic.0.000278; Buske PJ, 2012, J BIOL CHEM, V287, P10945, DOI 10.1074/jbc.M111.330324; Buss J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005128; Buss J, 2013, MOL MICROBIOL, V89, P1099, DOI 10.1111/mmi.12331; Camberg JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094964; Camberg JL, 2011, J BACTERIOL, V193, P1911, DOI 10.1128/JB.01317-10; Camberg JL, 2009, P NATL ACAD SCI USA, V106, P10614, DOI 10.1073/pnas.0904886106; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Cho HB, 2011, P NATL ACAD SCI USA, V108, P3773, DOI 10.1073/pnas.1018674108; DAI K, 1993, J BACTERIOL, V175, P3790, DOI 10.1128/JB.175.12.3790-3797.1993; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DEBOER P, 1992, NATURE, V359, P254, DOI 10.1038/359254a0; Du SS, 2015, MOL MICROBIOL, V95, P173, DOI 10.1111/mmi.12854; Dziedzic R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011058; Eckert T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050161; Egan AJF, 2013, ANN NY ACAD SCI, V1277, P8, DOI 10.1111/j.1749-6632.2012.06818.x; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Galli E, 2012, J BACTERIOL, V194, P292, DOI 10.1128/JB.05821-11; Geissler B, 2007, MICROBIOL-SGM, V153, P814, DOI 10.1099/mic.0.2006/001834-0; Gonzalez JM, 2003, J BIOL CHEM, V278, P37664, DOI 10.1074/jbc.M305230200; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; Guo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012680; Haeusser DP, 2009, J BACTERIOL, V191, P1986, DOI 10.1128/JB.01606-07; Hale CA, 1997, CELL, V88, P175, DOI 10.1016/S0092-8674(00)81838-3; Hale CA, 1999, J BACTERIOL, V181, P167, DOI 10.1128/JB.181.1.167-176.1999; Holden SJ, 2014, P NATL ACAD SCI USA, V111, P4566, DOI 10.1073/pnas.1313368111; Jacq M, 2015, MBIO, V6, DOI 10.1128/mBio.01108-15; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Ling L, 2015, J MOL BIOL, V427, P2966, DOI 10.1016/j.jmb.2015.03.008; Liu Z, 1999, MOL MICROBIOL, V31, P1853, DOI 10.1046/j.1365-2958.1999.01322.x; Lu C, 2001, BMC Microbiol, V1, P7, DOI 10.1186/1471-2180-1-7; Ma XL, 1999, J BACTERIOL, V181, P7531, DOI 10.1128/JB.181.24.7531-7544.1999; Marteyn BS, 2014, MBIO, V5, DOI 10.1128/mBio.00022-14; MAURIZI MR, 1994, METHOD ENZYMOL, V244, P314; MAURIZI MR, 1990, J BIOL CHEM, V265, P12546; Monroe N, 2016, J MOL BIOL, V428, P1897, DOI 10.1016/j.jmb.2015.11.004; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Ortiz C, 2016, FEMS MICROBIOL REV, V40, P57, DOI 10.1093/femsre/fuv040; Pazos M, 2013, J BIOL CHEM, V288, P3219, DOI 10.1074/jbc.M112.434944; Pichoff S, 2002, EMBO J, V21, P685, DOI 10.1093/emboj/21.4.685; RAYCHAUDHURI D, 1992, NATURE, V359, P251, DOI 10.1038/359251a0; Redick SD, 2005, J BACTERIOL, V187, P2727, DOI 10.1128/JB.187.8.2727-2736.2005; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Roll-Mecak A, 2006, J CELL BIOL, V175, P849, DOI 10.1083/jcb.200611149; Sharma N, 2007, J CELL BIOL, V178, P1065, DOI 10.1083/jcb.200704021; Shen B, 2010, MOL MICROBIOL, V75, P1285, DOI 10.1111/j.1365-2958.2010.07055.x; Shen B, 2009, MOL MICROBIOL, V72, P410, DOI 10.1111/j.1365-2958.2009.06651.x; Shih YL, 2013, ENVIRON MICROBIOL, V15, P3229, DOI 10.1111/1462-2920.12119; Small E, 2007, J MOL BIOL, V369, P210, DOI 10.1016/j.jmb.2007.03.025; Smith SC, 2014, P NATL ACAD SCI USA, V111, P14229, DOI 10.1073/pnas.1407862111; Soderstrom B, 2016, MOL MICROBIOL; Soderstrom B, 2014, MOL MICROBIOL, V92, P1, DOI 10.1111/mmi.12534; Strauss MP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001389; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; Sugimoto S, 2010, J BIOL CHEM, V285, P6648, DOI 10.1074/jbc.M109.080739; Szwedziak P, 2014, ELIFE, V3, DOI 10.7554/eLife.04601; Szwedziak P, 2012, EMBO J, V31, P2249, DOI 10.1038/emboj.2012.76; TEATHER RM, 1974, J BACTERIOL, V118, P407, DOI 10.1128/JB.118.2.407-413.1974; Tonthat NK, 2011, EMBO J, V30, P154, DOI 10.1038/emboj.2010.288; Weart RB, 2005, MOL MICROBIOL, V57, P238, DOI 10.1111/j.1365-2958.2005.04673.x; Williams B, 2014, MOL MICROBIOL, V93, P853, DOI 10.1111/mmi.12698; Yu XC, 1999, MOL MICROBIOL, V32, P315, DOI 10.1046/j.1365-2958.1999.01351.x	74	14	14	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170505	10.1371/journal.pone.0170505	http://dx.doi.org/10.1371/journal.pone.0170505			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114338	Green Published, Green Submitted, gold			2022-12-26	WOS:000396129000057
J	Gilhodes, JC; Jule, Y; Kreuz, S; Stierstorfer, B; Stiller, D; Wollin, L				Gilhodes, Jean-Claude; Jule, Yvon; Kreuz, Sebastian; Stierstorfer, Birgit; Stiller, Detlef; Wollin, Lutz			Quantification of Pulmonary Fibrosis in a Bleomycin Mouse Model Using Automated Histological Image Analysis	PLOS ONE			English	Article							MICRO-COMPUTED TOMOGRAPHY; MURINE LUNG; QUANTITATIVE ASSESSMENT; ANIMAL-MODEL; IN-VIVO; PIRFENIDONE; NINTEDANIB; DAMAGE; CT	Current literature on pulmonary fibrosis induced in animal models highlights the need of an accurate, reliable and reproducible histological quantitative analysis. One of the major limits of histological scoring concerns the fact that it is observer-dependent and consequently subject to variability, which may preclude comparative studies between different laboratories. To achieve a reliable and observer-independent quantification of lung fibrosis we developed an automated software histological image analysis performed from digital image of entire lung sections. This automated analysis was compared to standard evaluation methods with regard to its validation as an end-point measure of fibrosis. Lung fibrosis was induced in mice by intratracheal administration of bleomycin (BLM) at 0.25, 0.5, 0.75 and 1 mg/kg. A detailed characterization of BLM-induced fibrosis was performed 14 days after BLM administration using lung function testing, micro-computed tomography and Ashcroft scoring analysis. Quantification of fibrosis by automated analysis was assessed based on pulmonary tissue density measured from thousands of micro-tiles processed from digital images of entire lung sections. Prior to analysis, large bronchi and vessels were manually excluded from the original images. Measurement of fibrosis has been expressed by two indexes: the mean pulmonary tissue density and the high pulmonary tissue density frequency. We showed that tissue density indexes gave access to a very accurate and reliable quantification of morphological changes induced by BLM even for the lowest concentration used (0.25 mg/kg). A reconstructed 2D-image of the entire lung section at high resolution (3.6 mu m/pixel) has been performed from tissue density values allowing the visualization of their distribution throughout fibrotic and non-fibrotic regions. A significant correlation (p< 0.0001) was found between automated analysis and the above standard evaluation methods. This correlation establishes automated analysis as a novel end-point measure of BLM-induced lung fibrosis in mice, which will be very valuable for future preclinical drug explorations.	[Gilhodes, Jean-Claude; Jule, Yvon] Biocellvia, Marseille, France; [Kreuz, Sebastian; Stierstorfer, Birgit; Stiller, Detlef; Wollin, Lutz] Boehringer Ingelheim Pharma GmbH & Co KG, Immunol & Resp, Biberach, Germany	Boehringer Ingelheim	Jule, Y (corresponding author), Biocellvia, Marseille, France.	yvon.jule@biocellvia.com						Artaechevarria X, 2010, EUR RADIOL, V20, P2600, DOI 10.1007/s00330-010-1853-0; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Ask K, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-16; Babin AL, 2012, MAGN RESON MED, V67, P499, DOI 10.1002/mrm.23009; Bei YH, 2016, EXP LUNG RES, V42, P44, DOI 10.3109/01902148.2016.1141263; Borzone G, 2001, AM J RESP CRIT CARE, V163, P1648, DOI 10.1164/ajrccm.163.7.2006132; Cavanaugh D, 2006, ACAD RADIOL, V13, P1505, DOI 10.1016/j.acra.2006.08.011; Chow LN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151765; Cicko S, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0264-9; De Langhe E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043123; Decologne N, 2010, EUR RESPIR J, V35, P176, DOI 10.1183/09031936.00181808; Egger C, 2014, AM J PHYSIOL-LUNG C, V306, pL1064, DOI 10.1152/ajplung.00027.2014; Egger C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063432; Fernandez IE, 2016, AM J PHYSIOL-LUNG C, V310, pL919, DOI 10.1152/ajplung.00183.2015; Ford NL, 2009, PHYS MED BIOL, V54, P2121, DOI 10.1088/0031-9155/54/7/018; Gammon ST, 2014, AM J PHYSIOL-LUNG C, V306, pL897, DOI 10.1152/ajplung.00007.2014; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Hubner R, 2008, BIOTECHNIQUES, V299, pL439; Izumo T, 2009, EUR RESPIR J, V34, P1444, DOI 10.1183/09031936.00143708; Jarman ER, 2014, AM J RESP CELL MOL, V50, P158, DOI 10.1165/rcmb.2013-0174OC; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Manali ED, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-33; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Phillips JE, 2012, PULM PHARMACOL THER, V25, P281, DOI 10.1016/j.pupt.2011.10.001; PICKERING JG, 1991, AM J PATHOL, V138, P1225; Raghu G, 2015, AM J RESP CRIT CARE, V192, pE3, DOI 10.1164/rccm.201506-1063ST; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Rodt T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-181; Rydell-Tormanen K, 2012, LAB INVEST, V92, P917, DOI 10.1038/labinvest.2012.57; Schaefer CJ, 2011, EUR RESPIR REV, V20, P85, DOI 10.1183/09059180.00001111; Scotton CJ, 2013, EUR RESPIR J, V42, P1633, DOI 10.1183/09031936.00182412; Scotton CJ, 2010, AM J PHYSIOL-LUNG C, V299, pL439, DOI 10.1152/ajplung.00258.2010; Stumm CL, 2011, AM J PHYSIOL-LUNG C, V301, pL636, DOI 10.1152/ajplung.00158.2011; Thiesse J, 2010, J APPL PHYSIOL, V109, P1960, DOI 10.1152/japplphysiol.01322.2009; Vande Velde G, 2014, INVEST RADIOL, V49, P691, DOI DOI 10.1097/RLI.0000000000000071; Vande Velde G, 2016, DIS MODEL MECH, V9, P91, DOI 10.1242/dmm.020321; Vasilescu DM, 2012, J APPL PHYSIOL, V112, P159, DOI 10.1152/japplphysiol.00550.2011; Weng TT, 2014, AM J RESP CRIT CARE, V190, P1402, DOI 10.1164/rccm.201404-0744OC; Wollin L, 2014, J PHARMACOL EXP THER, V349, P209, DOI 10.1124/jpet.113.208223	39	37	37	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170561	10.1371/journal.pone.0170561	http://dx.doi.org/10.1371/journal.pone.0170561			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107543	Green Submitted, Green Published, gold			2022-12-26	WOS:000392405300165
J	Koussis, K; Goulielmaki, E; Chalari, A; Withers-Martinez, C; Siden-Kiamos, I; Matuschewski, K; Loukeris, TG				Koussis, Konstantinos; Goulielmaki, Evi; Chalari, Anna; Withers-Martinez, Chrislaine; Siden-Kiamos, Inga; Matuschewski, Kai; Loukeris, Thanasis G.			Targeted Deletion of a Plasmodium Site-2 Protease Impairs Life Cycle Progression in the Mammalian Host	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; SIGNAL PEPTIDE PEPTIDASE; MALARIA PARASITE; INTRAMEMBRANE PROTEOLYSIS; ER STRESS; TRANSCRIPTION FACTOR; ESCHERICHIA-COLI; GENE-EXPRESSION; FALCIPARUM; CLEAVAGE	Site-2 proteases (S2P) belong to the M50 family of metalloproteases, which typically perform essential roles by mediating activation of membrane bound transcription factors through regulated intramembrane proteolysis (RIP). Protease-dependent liberation of dormant transcription factors triggers diverse cellular responses, such as sterol regulation, Notch signalling and the unfolded protein response. Plasmodium parasites rely on regulated proteolysis for controlling essential pathways throughout the life cycle. In this study we examine the Plasmodium-encoded S2P in a murine malaria model and show that it is expressed in all stages of Plasmodium development. Localisation studies by endogenous gene tagging revealed that in all invasive stages the protein is in close proximity to the nucleus. Ablation of PbS2P by reverse genetics leads to reduced growth rates during liver and blood infection and, hence, virulence attenuation. Strikingly, absence of PbS2P was compatible with parasite life cycle progression in the mosquito and mammalian hosts under physiological conditions, suggesting redundant or dispensable roles in vivo.	[Koussis, Konstantinos; Goulielmaki, Evi; Chalari, Anna; Siden-Kiamos, Inga; Loukeris, Thanasis G.] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Greece; [Koussis, Konstantinos; Matuschewski, Kai] Max Planck Inst Infect Biol, Parasitol Unit, Berlin, Germany; [Koussis, Konstantinos; Withers-Martinez, Chrislaine] Francis Crick Inst, Malaria Biochem Lab, London, England; [Chalari, Anna] Univ Crete, Dept Biol, Iraklion, Greece; [Matuschewski, Kai] Humboldt Univ, Inst Biol, Berlin, Germany	Foundation for Research & Technology - Hellas (FORTH); Max Planck Society; Francis Crick Institute; University of Crete; Humboldt University of Berlin	Koussis, K (corresponding author), Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Greece.; Koussis, K (corresponding author), Max Planck Inst Infect Biol, Parasitol Unit, Berlin, Germany.; Koussis, K (corresponding author), Francis Crick Inst, Malaria Biochem Lab, London, England.	konstantinos.kousis@crick.ac.uk	Kousis, Konstantinos/K-7371-2019	Kousis, Konstantinos/0000-0002-6737-8724; Matuschewski, Kai/0000-0001-6147-8591	Hellenic General Secretariat of Research and Technology [AP5243, LS6-158/AP883]; European Social Fund (ESF); Greek State; General Secretariat for Research and Technology, Ministry of Education, Greece [MIS-448301 (2013SE01380036)]; European Regional Development Fund, NSRF/European Commission; Max Planck Society; EviMalaR network	Hellenic General Secretariat of Research and Technology(Greek Ministry of Development-GSRT); European Social Fund (ESF)(European Social Fund (ESF)); Greek State; General Secretariat for Research and Technology, Ministry of Education, Greece; European Regional Development Fund, NSRF/European Commission; Max Planck Society(Max Planck SocietyFoundation CELLEX); EviMalaR network	This work was supported by grant AP5243 of the Hellenic General Secretariat of Research and Technology to Konstantinos Koussis ("Supporting Postdoctoral Researchers-Research project PROTEOMAL LS6-158/AP883" of the Operational Program "Education and Lifelong Learning" (Action's Beneficiary: General Secretariat for Research and Technology), co-financed by the European Social Fund (ESF) and the Greek State). This work was performed in the framework of the BIOSYS research project, Action KRIPIS, project No MIS-448301 (2013SE01380036) funded by the General Secretariat for Research and Technology, Ministry of Education, Greece and the European Regional Development Fund (Sectoral Operational Programme: Competitiveness and Entrepreneurship, NSRF 2007-2013)/European Commission and in part by the Max Planck Society and the EviMalaR network. The funders had no role in study design, data collection and interpretation.	Abraham EG, 2005, P NATL ACAD SCI USA, V102, P16327, DOI 10.1073/pnas.0508335102; Adam Z, 2015, BBA-BIOENERGETICS, V1847, P910, DOI 10.1016/j.bbabio.2014.12.006; Akiyama Y, 2004, EMBO J, V23, P4434, DOI 10.1038/sj.emboj.7600449; Amarneh B, 2009, J BIOL CHEM, V284, P9674, DOI 10.1074/jbc.M900346200; Baker RP, 2006, PLOS PATHOG, V2, P922, DOI 10.1371/journal.ppat.0020113; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Baldwin M, 2014, BIOCHEM BIOPH RES CO, V450, P1427, DOI 10.1016/j.bbrc.2014.07.013; Bien CM, 2009, MOL MICROBIOL, V74, P672, DOI 10.1111/j.1365-2958.2009.06895.x; Blackman MJ, 2008, CELL MICROBIOL, V10, P1925, DOI 10.1111/j.1462-5822.2008.01176.x; Chaubey S, 2014, J BIOL CHEM, V289, P16662, DOI 10.1074/jbc.M114.551549; Chen X, 2002, J BIOL CHEM, V277, P13045, DOI 10.1074/jbc.M110636200; Ejigiri I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002725; ELMENDORF HG, 1993, EMBO J, V12, P4763, DOI 10.1002/j.1460-2075.1993.tb06165.x; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Frank KL, 2012, INFECT IMMUN, V80, P539, DOI 10.1128/IAI.05964-11; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Friesen J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001058; Gissot M, 2005, J MOL BIOL, V346, P29, DOI 10.1016/j.jmb.2004.11.045; Godiska R, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1181; Gu Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06268; Harbut MB, 2012, P NATL ACAD SCI USA, V109, P21486, DOI 10.1073/pnas.1216016110; Inacio P, 2015, EMBO REP, V16, P955, DOI 10.15252/embr.201439979; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kinch LN, 2006, PROTEIN SCI, V15, P84, DOI 10.1110/ps.051766506; Komaki-Yasuda K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074701; Lackner P, 2006, NEUROPATH APPL NEURO, V32, P177, DOI 10.1111/j.1365-2990.2006.00706.x; Lasonder E, 2012, J PROTEOME RES, V11, P5323, DOI 10.1021/pr300557m; Lewis AP, 1999, PROTEIN SCI, V8, P439; Li H, 2012, BBA-PROTEINS PROTEOM, V1824, P177, DOI 10.1016/j.bbapap.2011.06.002; Lin JW, 2013, MOL MICROBIOL, V88, P318, DOI 10.1111/mmi.12187; Makinoshima H, 2005, NATURE, V436, P406, DOI 10.1038/nature03713; Marapana DS, 2012, TRAFFIC, V13, P1457, DOI 10.1111/j.1600-0854.2012.01402.x; Matson JS, 2005, P NATL ACAD SCI USA, V102, P16403, DOI 10.1073/pnas.0505818102; Matz JM, 2015, EUKARYOT CELL, V14, P528, DOI 10.1128/EC.00276-14; Michel K, 2005, EMBO REP, V6, P891, DOI 10.1038/sj.embor.7400478; Murakami T, 2006, J NEUROCHEM, V96, P1090, DOI 10.1111/j.1471-4159.2005.03596.x; O'Donnell RA, 2006, J CELL BIOL, V174, P1023, DOI 10.1083/jcb.200604136; Otto TD, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0086-0; Pfander C, 2011, NAT METHODS, V8, P1078, DOI [10.1038/NMETH.1742, 10.1038/nmeth.1742]; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Schneider JS, 2014, J BACTERIOL, V196, P2638, DOI 10.1128/JB.01537-14; Schneider JS, 2013, BBA-BIOMEMBRANES, V1828, P2808, DOI 10.1016/j.bbamem.2013.04.019; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Sibley LD, 2013, BBA-BIOMEMBRANES, V1828, P2908, DOI 10.1016/j.bbamem.2013.04.017; Silvie O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000086; SINDEN RE, 1985, PARASITOLOGY, V91, P227, DOI 10.1017/S0031182000057334; Sklar JG, 2010, MOL MICROBIOL, V77, P605, DOI 10.1111/j.1365-2958.2010.07232.x; Srinivasan P, 2008, CELL MICROBIOL, V10, P1304, DOI 10.1111/j.1462-5822.2008.01127.x; Tampaki Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121379; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; Wegscheid-Gerlach C, 2010, CURR TOP MED CHEM, V10, P346, DOI 10.2174/156802610790725461; WINGER LA, 1988, PARASITE IMMUNOL, V10, P193, DOI 10.1111/j.1365-3024.1988.tb00214.x; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	59	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170260	10.1371/journal.pone.0170260	http://dx.doi.org/10.1371/journal.pone.0170260			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107409	Green Published, Green Submitted, gold			2022-12-26	WOS:000392405300094
J	Luria, N; Smith, E; Reingold, V; Bekelman, I; Lapidot, M; Levin, I; Elad, N; Tam, Y; Sela, N; Abu-Ras, A; Ezra, N; Haberman, A; Yitzhak, L; Lachman, O; Dombrovsky, A				Luria, Neta; Smith, Elisheva; Reingold, Victoria; Bekelman, Ilana; Lapidot, Moshe; Levin, Ilan; Elad, Nadav; Tam, Yehudit; Sela, Noa; Abu-Ras, Ahmad; Ezra, Nadav; Haberman, Ami; Yitzhak, Liron; Lachman, Oded; Dombrovsky, Aviv			A New Israeli Tobamovirus Isolate Infects Tomato Plants Harboring Tm-2(2) Resistance Genes	PLOS ONE			English	Article							TOBACCO-MOSAIC-VIRUS; MOVEMENT PROTEIN; EPIDEMIOLOGY; PERFORMANCE; ALGORITHMS; OVERCOME	An outbreak of a new disease infecting tomatoes occurred in October-November 2014 at the Ohad village in Southern Israel. Symptomatic plants showed a mosaic pattern on leaves accompanied occasionally by narrowing of leaves and yellow spotted fruit. The disease spread mechanically and rapidly reminiscent of tobamovirus infection. Epidemiological studies showed the spread of the disease in various growing areas, in the South and towards the Southeast and Northern parts of the country within a year. Transmission electron microscope (TEM) analysis showed a single rod-like form characteristic to the Tobamovirus genus. We confirmed Koch's postulates for the disease followed by partial host range determination and revealed that tomato cultivars certified to harbor the Tm-2(2) resistance gene are susceptible to the new viral disease. We further characterized the viral source of the disease using a range of antisera for serological detection and analyzed various virus genera and families for cross-reactivity with the virus. In addition, next generation sequencing of total small RNA was performed on two cultivars grown in two different locations. In samples collected from commercial cultivars across Israel, we found a single virus that caused the disease. The complete genome sequence of the new Israeli tobamovirus showed high sequence identity to the Jordanian isolate of tomato brown rugose fruit virus.	[Luria, Neta; Smith, Elisheva; Reingold, Victoria; Bekelman, Ilana; Tam, Yehudit; Sela, Noa; Yitzhak, Liron; Lachman, Oded; Dombrovsky, Aviv] ARO, Volcani Ctr, Dept Plant Pathol, Rishon Leziyyon, Israel; [Lapidot, Moshe; Levin, Ilan] ARO, Volcani Ctr, Dept Vegetables & Field Crops, Rishon Leziyyon, Israel; [Elad, Nadav] Weizmann Inst Sci, Dept Chem Res Support, Electron Microscopy Unit, Rehovot, Israel; [Abu-Ras, Ahmad; Ezra, Nadav; Haberman, Ami] Plant Protect & Inspect Serv, Bet Dagan, Israel; [Yitzhak, Liron] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Plant Sci, Tel Aviv, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Weizmann Institute of Science; Tel Aviv University	Dombrovsky, A (corresponding author), ARO, Volcani Ctr, Dept Plant Pathol, Rishon Leziyyon, Israel.	aviv@volcani.agri.gov.il	Sela, Noa/C-5133-2008	Sela, Noa/0000-0002-8282-215X; reingold, victoria/0000-0003-3967-9287; Elad, Nadav/0000-0001-6222-2280; Lapidot, Moshe/0000-0002-1227-4434	Israel Ministry of Agriculture [261-1159]	Israel Ministry of Agriculture	This work was supported by the Chief Scientist, Israel Ministry of Agriculture, Management of Tm-22 Tobamo breaker in tomato plants, initiative project number 261-1159.	Adams MJ, 2009, ARCH VIROL, V154, P1967, DOI 10.1007/s00705-009-0506-6; Allen JE, PLANT HLTH PROG; Ambros S, 2016, SPAIN; BROADBENT L, 1976, ANNU REV PHYTOPATHOL, V14, P75, DOI 10.1146/annurev.py.14.090176.000451; BROADBENT L, 1963, ANN APPL BIOL, V52, P233, DOI 10.1111/j.1744-7348.1963.tb03747.x; CALDER VL, 1992, J GEN VIROL, V73, P165, DOI 10.1099/0022-1317-73-1-165; CASTELLO JD, 1992, PLANT DIS, V76, P696, DOI 10.1094/PD-76-0696; Chavan RR, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0487-5; Cohen J, 2000, PHYTOPATHOLOGY, V90, P340, DOI 10.1094/PHYTO.2000.90.4.340; de Ronde D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00307; Dombrovsky A, 2013, PLANT PATHOL, V62, P750, DOI 10.1111/ppa.12004; Dombrovsky A, 2007, J GEN VIROL, V88, P1602, DOI 10.1099/vir.0.82769-0; Dombrovsky A, 2009, PHYTOPARASITICA, V37, P477, DOI 10.1007/s12600-009-0058-z; DORNAI D, 1993, APPL ENVIRON MICROB, V59, P3123, DOI 10.1128/AEM.59.9.3123-3125.1993; Folkes L, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks277; Friedman M, 2002, J AGR FOOD CHEM, V50, P5751, DOI 10.1021/jf020560c; George B, 2004, FOOD CHEM, V84, P45, DOI 10.1016/S0308-8146(03)00165-1; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HALL TJ, 1980, EUPHYTICA, V29, P189, DOI 10.1007/BF00037266; Hanssen IM, 2010, MOL PLANT MICROBE IN, V23, P539, DOI 10.1094/MPMI-23-5-0539; He M, 2012, VIRUS RES, V163, P374, DOI 10.1016/j.virusres.2011.09.006; Hou H.Q., 2007, CHIN AGR SCIBULL, V23, P406, DOI [10.3969/j.issn.1000-6850.2007.09.087, DOI 10.3969/J.ISSN.1000-6850.2007.09.087]; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; King AM, 2012, 9 REPORT INT COMMITT, P770; Kubota K, 2012, J GEN PLANT PATHOL, V78, P43, DOI 10.1007/s10327-011-0345-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lanfermeijer FC, 2005, J EXP BOT, V56, P2925, DOI 10.1093/jxb/eri288; Lanfermeijer FC, 2004, PLANT SCI, V167, P687, DOI 10.1016/j.plantsci.2004.04.027; Lapidot M, 2014, ADV VIRUS RES, V90, P147, DOI 10.1016/B978-0-12-801246-8.00003-2; Li RH, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/743716; Li YY, 2014, PLANT DIS, V98, P1447, DOI 10.1094/PDIS-03-14-0317-PDN; Ling K-S, 2016, ACTA HORTICULTURAE; Mayer A, 1942, MOSAIC DIS TOBACCO L, P451; MESHI T, 1989, PLANT CELL, V1, P515, DOI 10.1105/tpc.1.5.515; Moreira SR, FITOPATOLOGIA BRASIL; Padmanabhan C, 2015, GENOME ANNOUNCEMENTS, V3; PELHAM J, 1972, ANN APPL BIOL, V71, P219, DOI 10.1111/j.1744-7348.1972.tb05085.x; PELHAM J, 1966, EUPHYTICA, V15, P258, DOI 10.1007/BF00022331; Polston JE, 2007, MANAGEMENT TOMATO YE, P251; Reingold V, 2016, ANN APPL BIOL, V168, P29, DOI 10.1111/aab.12238; ROSNER A, 1983, J GEN VIROL, V64, P1757, DOI 10.1099/0022-1317-64-8-1757; Salem N, 2016, ARCH VIROL, V161, P503, DOI 10.1007/s00705-015-2677-7; Sastry K. S., 2014, PLANT VIRUS VIROID D, P149, DOI DOI 10.1007/978-94-007-7820-7_2; Sosnowski MR, 2009, PLANT PATHOL, V58, P621, DOI 10.1111/j.1365-3059.2009.02042.x; Strasser M, 2007, ARCH VIROL, V152, P903, DOI 10.1007/s00705-006-0915-8; Turina M, 2016, NEW DIS REP, V33; Weber H, 1998, MOL PLANT MICROBE IN, V11, P498, DOI 10.1094/MPMI.1998.11.6.498; WEBER H, 1993, J VIROL, V67, P6432, DOI 10.1128/JVI.67.11.6432-6438.1993; Webster CG, 2014, PLANT HLTH PROG, V15, P2; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	50	93	113	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170429	10.1371/journal.pone.0170429	http://dx.doi.org/10.1371/journal.pone.0170429			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107419	Green Published, Green Submitted, gold			2022-12-26	WOS:000392405300135
J	Segovia, KM; Stallknecht, DE; Kapczynski, DR; Stabler, L; Berghaus, RD; Fotjik, A; Latorre-Margalef, N; Franca, MS				Segovia, Karen M.; Stallknecht, David E.; Kapczynski, Darrell R.; Stabler, Lisa; Berghaus, Roy D.; Fotjik, Alinde; Latorre-Margalef, Neus; Franca, Monique S.			Adaptive Heterosubtypic Immunity to Low Pathogenic Avian Influenza Viruses in Experimentally Infected Mallards	PLOS ONE			English	Article							NORTH-AMERICA; A VIRUSES; WILD DUCKS; RT-PCR; SUBTYPES; HEMAGGLUTININ; WATERFOWL; PATTERNS; PARAMYXOVIRUSES; PROTECTION	Mallards are widely recognized as reservoirs for Influenza A viruses (IAV); however, host factors that might prompt seasonality and trends in subtype diversity of IAV such as adaptive heterosubtypic immunity (HSI) are not well understood. To investigate this, we inoculated mallards with a prevailing H3N8 low pathogenic avian influenza virus (LPAIV) subtype in waterfowl to determine if prior infection with this virus would be protective against heterosubtypic infections with the H4N6, H10N7 and H14N5 LPAIV subtypes after one, two and three months, respectively. Also, we investigated the effect of cumulative immunity after sequential inoculation of mallards with these viruses in one-month intervals. Humoral immunity was assessed by microneutralization assays using a subset of representative LPAIV subtypes as antigens. Our results indicate that prior inoculation with the H3N8 virus confers partial protective immunity against subsequent heterosubtypic infections with the robustness of HSI related to the phylogenetic similarity of the HA protein of the strains used. Furthermore, induced HSI was boosted and followed by repeated exposure to more than one LPAIV subtype. Our findings provide further information on the contributions of HSI and its role in the dynamics of IAV subtype diversity in mallards.	[Segovia, Karen M.; Stabler, Lisa; Franca, Monique S.] Univ Georgia, Poultry Diagnost & Res Ctr, Athens, GA 30602 USA; [Stallknecht, David E.; Fotjik, Alinde; Latorre-Margalef, Neus] Univ Georgia, Coll Vet Med, Dept Populat Hlth, Southeastern Cooperat Wildlife Dis Study, Athens, GA USA; [Kapczynski, Darrell R.] ARS, Southeast Poultry Res Lab, USDA, Athens, GA USA; [Berghaus, Roy D.] Univ Georgia, Dept Populat Hlth, Coll Vet Med, Athens, GA USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; United States Department of Agriculture (USDA); University System of Georgia; University of Georgia	Franca, MS (corresponding author), Univ Georgia, Poultry Diagnost & Res Ctr, Athens, GA 30602 USA.	mfranca@uga.edu	Berghaus, Roy/GPX-7566-2022; Franca, Monique/J-3927-2019	Berghaus, Roy/0000-0002-8813-3056; 	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272201400006C]	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under contract HHSN272201400006C. The funding agencies were not involved in the design, implementation, or publishing of this study and the research presented herein represents the opinions of the authors, but not necessarily the opinions of the funding agencies.	Chaise C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105189; Costa TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015987; Costa TP, 2010, AVIAN DIS, V54, P1286, DOI 10.1637/9480-072210-Reg.1; Das A, 2009, J VET DIAGN INVEST, V21, P771, DOI 10.1177/104063870902100603; Fereidouni SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006706; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; Gog JR, 2002, P NATL ACAD SCI USA, V99, P17209, DOI 10.1073/pnas.252512799; Hanson BA, 2003, AVIAN DIS, V47, P867, DOI 10.1637/0005-2086-47.s3.867; HINSHAW VS, 1980, CAN J MICROBIOL, V26, P622, DOI 10.1139/m80-108; HINSHAW VS, 1985, B WORLD HEALTH ORGAN, V63, P711; Jourdain E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008935; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Kreijtz JHCM, 2011, VIRUS RES, V162, P19, DOI 10.1016/j.virusres.2011.09.022; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; Latorre-Margalef N, 2015, EMERG INFECT DIS, V21, P2257, DOI 10.3201/eid2112.150413; Latorre-Margalef N, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0098; Latorre-Margalef N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003443; Lau YF, 2011, J VIROL, V85, P76, DOI 10.1128/JVI.01564-10; Laursen NS, 2013, ANTIVIR RES, V98, P476, DOI 10.1016/j.antiviral.2013.03.021; Lee CW, 2006, CLIN VACCINE IMMUNOL, V13, P395, DOI 10.1128/CVI.13.3.395-402.2006; Lee MS, 2001, J VIROL METHODS, V97, P13, DOI 10.1016/S0166-0934(01)00301-9; Magor KE, 2011, DEV COMP IMMUNOL, V35, P1008, DOI 10.1016/j.dci.2011.02.011; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Muth JP., 2012, VIRAL SHEDDING ANTIB; OKUNO Y, 1990, J CLIN MICROBIOL, V28, P1308, DOI 10.1128/JCM.28.6.1308-1313.1990; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pearce JM, 2011, MOL ECOL, V20, P1015, DOI 10.1111/j.1365-294X.2010.04908.x; Pepin KM, 2012, J GEN VIROL, V93, P2575, DOI 10.1099/vir.0.045427-0; Quan FS, 2012, VIROLOGY, V430, P127, DOI 10.1016/j.virol.2012.05.006; Ramey AM, 2014, J WILDLIFE DIS, V50, P916, DOI 10.7589/2013-09-232; Ramey AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095620; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Seo SH, 2001, J VIROL, V75, P2516, DOI 10.1128/JVI.75.6.2516-2525.2001; Sharp GB, 1997, J VIROL, V71, P6128, DOI 10.1128/JVI.71.8.6128-6135.1997; SHARP GB, 1993, EPIDEMIOL INFECT, V110, P161, DOI 10.1017/S0950268800050780; Spackman E, 2003, AVIAN DIS, V47, P1079, DOI 10.1637/0005-2086-47.s3.1079; Tsukamoto K, 2008, J CLIN MICROBIOL, V46, P3048, DOI 10.1128/JCM.02386-07; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Webster R.G., 2002, WHO MAN AN INFL DIAG; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wong JK, AVIAN DIS S, V60, P330; Wu Y, 2014, TRENDS MICROBIOL, V22, P183, DOI 10.1016/j.tim.2014.01.010	42	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170335	10.1371/journal.pone.0170335	http://dx.doi.org/10.1371/journal.pone.0170335			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107403	gold, Green Submitted, Green Published			2022-12-26	WOS:000392405300113
J	Hermanns, C; Hampl, V; Holzer, K; Aigner, A; Penkava, J; Frank, N; Martin, DE; Maier, KC; Waldburger, N; Roessler, S; Goppelt-Struebe, M; Akrap, I; Thavamani, A; Singer, S; Nordheim, A; Gudermann, T; Muehlich, S				Hermanns, C.; Hampl, V.; Holzer, K.; Aigner, A.; Penkava, J.; Frank, N.; Martin, D. E.; Maier, K. C.; Waldburger, N.; Roessler, S.; Goppelt-Struebe, M.; Akrap, I.; Thavamani, A.; Singer, S.; Nordheim, A.; Gudermann, T.; Muehlich, S.			The novel MKL target gene myoferlin modulates expansion and senescence of hepatocellular carcinoma	ONCOGENE			English	Article							SERUM RESPONSE FACTOR; TRANSCRIPTIONAL RESPONSE; TUMOR-SUPPRESSOR; ACTIN DYNAMICS; FACTOR SRF; GROWTH; COACTIVATOR; LOCALIZATION; RESISTANCE; REGULATOR	Megakaryoblastic Leukemia 1 and 2 (MKL1/2) are transcriptional coactivators of Serum Response Factor (SRF) with an essential role for hepatocellular carcinoma (HCC) growth and oncogene-induced senescence. In this report, we identified myoferlin as a novel MKL/SRF target gene by gene expression profiling and verification in vivo in HCC xenografts. Myoferlin was overexpressed in human and murine HCCs triggered by conditional expression of constitutively active SRF-VP16 protein in hepatocytes. Furthermore, myoferlin was required for HCC cell invasion, proliferation and anchorage-independent cell growth. We provide evidence that myoferlin is a crucial gene target of MKL1/2 mediating its effect on oncogene-induced senescence by modulating the activation state of the EGFR and downstream MAPK and p16-/Rb pathways. Depletion of myoferlin in tumour cells from SRF-VP16-derived murine HCCs induced a senescence phenotype. These findings identify MKL1/2 and myoferlin as novel therapeutic targets to treat human HCC by a senescence-inducing strategy.	[Hermanns, C.; Hampl, V.; Penkava, J.; Frank, N.; Gudermann, T.; Muehlich, S.] Ludwig Maximilians Univ Munchen, Walther Straub Inst Pharmacol & Toxicol, Goethestr 33, D-80336 Munich, Germany; [Holzer, K.; Waldburger, N.; Roessler, S.; Singer, S.] Univ Hosp Heidelberg, Inst Pathol, Heidelberg, Germany; [Aigner, A.] Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, Clin Pharmacol, Leipzig, Germany; [Martin, D. E.; Maier, K. C.] Ludwig Maximilians Univ Munchen, Dept Chem & Pharm, Gene Ctr, Munich, Germany; [Goppelt-Struebe, M.] Friedrich Alexander Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, Erlangen, Germany; [Akrap, I.; Thavamani, A.; Nordheim, A.] Tuebingen Univ, Interfac Inst Cell Biol, Tubingen, Germany; [Nordheim, A.] German Canc Consortium DKTK, Heidelberg, Germany; [Nordheim, A.] DKFZ, Heidelberg, Germany	University of Munich; Ruprecht Karls University Heidelberg; Leipzig University; University of Munich; University of Erlangen Nuremberg; Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Muehlich, S (corresponding author), Ludwig Maximilians Univ Munchen, Walther Straub Inst Pharmacol & Toxicol, Goethestr 33, D-80336 Munich, Germany.	susanne.muehlich@lrz.uni-muenchen.de	Aigner, Achim/R-4429-2017; Thavamani, Abhishek/I-3207-2018; Roessler, Stephanie/J-8432-2019	Aigner, Achim/0000-0002-2778-6256; Thavamani, Abhishek/0000-0001-7187-9188; Roessler, Stephanie/0000-0002-5333-5942	NCT; Deutsche Forschungsgemeinschaft [MU 2737/2-2]; Deutsche Krebshilfe [109886]; DKTK (German Cancer Consortium); DFG [Si 1487/3-1]; HRCMM (Heidelberg Research Center for Molecular Medicine) Career Development Fellowship	NCT; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); DKTK (German Cancer Consortium); DFG(German Research Foundation (DFG)); HRCMM (Heidelberg Research Center for Molecular Medicine) Career Development Fellowship	We thank Elizabeth McNally and Alexis Demonbreun for the myoferlin promoter construct, and Veronika Geissler and Esther Herpel from the NCT tissue bank in Heidelberg for their support. Funded by grant MU 2737/2-2 of the Deutsche Forschungsgemeinschaft. Alfred Nordheim was supported by the Deutsche Krebshilfe (grant 109886) and DKTK (German Cancer Consortium). Stephan Singer was supported by DFG (grant Si 1487/3-1), and by an HRCMM (Heidelberg Research Center for Molecular Medicine) Career Development Fellowship.	Bae JS, 2014, INT J ONCOL, V44, P129, DOI 10.3892/ijo.2013.2154; Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Descot A, 2009, MOL CELL, V35, P291, DOI 10.1016/j.molcel.2009.07.015; Esnault C, 2014, GENE DEV, V28, P943, DOI 10.1101/gad.239327.114; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Giehl K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121589; Hampl V, 2013, EMBO MOL MED, V5, P1367, DOI 10.1002/emmm.201202406; Hobel S, 2010, J GENE MED, V12, P287, DOI 10.1002/jgm.1431; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; JOHANSEN FE, 1995, BBA-REV CANCER, V1242, P1, DOI 10.1016/0304-419X(94)00014-S; Kircher P, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aad2959; Kwon CY, 2010, INT J ONCOL, V37, P837, DOI 10.3892/ijo_00000734; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Muehlich S, 2012, ONCOGENE, V31, P3913, DOI 10.1038/onc.2011.560; Muehlich S, 2007, AM J PHYSIOL-CELL PH, V292, pC1732, DOI 10.1152/ajpcell.00552.2006; Ohrnberger S, 2015, HEPATOLOGY, V61, P979, DOI 10.1002/hep.27539; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Park MY, 2007, INT J ONCOL, V31, P1309; Reschke M, 2010, HEPATOLOGY, V51, P1383, DOI 10.1002/hep.23428; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121; TAKEDA S, 1992, J BIOL CHEM, V267, P16957; TREISMAN R, 1986, CELL, V46, P567, DOI 10.1016/0092-8674(86)90882-2; Turtoi A, 2013, CANCER RES, V73, P5438, DOI 10.1158/0008-5472.CAN-13-1142; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Winkler J, 2014, HEPATOLOGY, V60, P884, DOI 10.1002/hep.27207; Xue W, 2008, GENE DEV, V22, P1439, DOI 10.1101/gad.1672608; Yuan BZ, 1998, CANCER RES, V58, P2196	34	24	24	0	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 15	2017	36	24					3464	3476		10.1038/onc.2016.496	http://dx.doi.org/10.1038/onc.2016.496			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EX6GL	28114277				2022-12-26	WOS:000403340700010
J	Yu, SQ; Wang, YW; Yuan, HJ; Zhao, HW; Lv, W; Chen, J; Wan, FC; Liu, DF; Gao, ZL; Wu, JT				Yu, Shengqiang; Wang, Yanwei; Yuan, Hejia; Zhao, Hongwei; Lv, Wei; Chen, Jian; Wan, Fengchun; Liu, Dongfu; Gao, Zhenli; Wu, Jitao			Knockdown of Mediator Complex Subunit 19 Suppresses the Growth and Invasion of Prostate Cancer Cells	PLOS ONE			English	Article							ANDROGEN RECEPTOR; MED19; PROLIFERATION; EXPRESSION; TUMORIGENESIS; METASTASIS; INHIBITOR; CARCINOMA; THERAPY; SHRNA	Prostate cancer (PCa) is one of the most common cancers in elderly men. Mediator Complex Subunit 19 (Med19) is overexpressed and plays promotional roles in many cancers. However, the roles of Med19 in PCa are still obscure. In this study, by using immunohistochemical staining, we found higher expression level of Med19 in PCa tissues than in adjacent benign prostate tissues. We then knocked down the Med19 expression in PCa cell lines LNCaP and PC3 by using lentivirus siRNA. Cell proliferation, anchor-independent growth, migration, and invasion were suppressed in Med19 knockdown PCa cells. In nude mice xenograft model, we found that Med19 knockdown PCa cells formed smaller tumors with lower proliferation index than did control cells. In the mechanism study, we found that Med19 could regulate genes involved in cell proliferation, cell cycle, and epithelial-mesenchymal transition, including P27, pAKT, pPI3K, IGF1R, E-Cadherin, N-Cadherin, Vimentin, ZEB2, Snail-1 and Snail-2. Targeting Med19 in PCa cells could inhibit the PCa growth and metastasis, and might be a therapeutic option for PCa in the future.	[Yu, Shengqiang; Yuan, Hejia; Zhao, Hongwei; Wan, Fengchun; Liu, Dongfu; Gao, Zhenli; Wu, Jitao] Qingdao Univ, Affiliated Yantai Yuhuangding Hosp, Dept Urol, Yantai, Shandong, Peoples R China; [Wang, Yanwei; Chen, Jian] Qingdao Univ, Affiliated Yantai Yuhuangding Hosp, Cent Lab, Yantai, Shandong, Peoples R China; [Lv, Wei] Qingdao Univ, Affiliated Yantai Yuhuangding Hosp, Dept Nephrol, Yantai, Shandong, Peoples R China	Qingdao University; Qingdao University; Qingdao University	Wu, JT (corresponding author), Qingdao Univ, Affiliated Yantai Yuhuangding Hosp, Dept Urol, Yantai, Shandong, Peoples R China.	agourodman@163.com; jtwu1006@163.com	yu, shengqiang/AAT-4994-2020	Yu, Shengqiang/0000-0003-4654-5340	National Natural Science Foundation of China [81302234, 81572835]; Shandong Provincial Natural Science Foundation [ZR2013HL070]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province)	This study was supported by National Natural Science Foundation of China (81302234, http://www.nsfc.gov.cn/); National Natural Science Foundation of China (81572835, http://www.nsfc.gov.cn/); and Shandong Provincial Natural Science Foundation (ZR2013HL070, http://www.sdnsf.gov.cn/portal/).	Botrel TEA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157660; Broster SA, 2015, FUTURE ONCOL, V11, P3197, DOI 10.2217/fon.15.253; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Cui XG, 2011, BMB REP, V44, P547, DOI 10.5483/BMBRep.2011.44.8.547; Ding XF, 2012, GENE, V504, P262, DOI 10.1016/j.gene.2012.04.033; Golabek T, 2016, CENT EUR J UROL, V69, P131, DOI 10.5173/ceju.2016.812; Imberg-Kazdan K, 2013, GENOME RES, V23, P581, DOI 10.1101/gr.144774.112; King D, 2015, J PEDIAT HEMATOL ONC, V37, P245, DOI 10.1097/MPH.0000000000000329; Li XH, 2011, CANCER BIOTHER RADIO, V26, P495, DOI 10.1089/cbr.2010.0863; Liu YT, 2012, MOL MED REP, V6, P1050, DOI 10.3892/mmr.2012.1065; Myers LC, 1998, GENE DEV, V12, P45, DOI 10.1101/gad.12.1.45; Paller Channing J, 2013, Clin Adv Hematol Oncol, V11, P14; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Singh P, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0805-3; Sun M, 2011, MOL CELL BIOCHEM, V355, P27, DOI 10.1007/s11010-011-0835-0; van Duijn PW, 2006, PROSTATE, V66, P749, DOI 10.1002/pros.20398; Wang TJ, 2011, ONCOL RES, V19, P193, DOI 10.3727/096504011X12970940207760; Wei Ling, 2015, Asian Pac J Cancer Prev, V16, P875; Wen H, 2013, ANN DIAGN PATHOL, V17, P259, DOI 10.1016/j.anndiagpath.2012.11.004; Wong MC, 2016, EUR UROL; Xu LL, 2012, ASIAN PAC J CANCER P, V13, P3695, DOI 10.7314/APJCP.2012.13.8.3695; Yu SQ, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0674-9; Zhang H, 2012, UROL ONCOL-SEMIN ORI, V30, P920, DOI 10.1016/j.urolonc.2010.10.003; Zhang XZ, 2016, PROCEEDINGS 2016 IEEE INTERNATIONAL CONFERENCE ON INDUSTRIAL TECHNOLOGY (ICIT), P2016, DOI 10.1109/ICIT.2016.7475077; Zou SW, 2011, ACTA PHARMACOL SIN, V32, P354, DOI 10.1038/aps.2010.223	26	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0171134	10.1371/journal.pone.0171134	http://dx.doi.org/10.1371/journal.pone.0171134			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125713	Green Published, gold, Green Submitted			2022-12-26	WOS:000396176100006
J	Zheng, XB; Fan, JB; Xu, L; Zhou, J				Zheng, Xuebo; Fan, Jianbo; Xu, Lei; Zhou, Jing			Effects of Combined Application of Biogas Slurry and Chemical Fertilizer on Soil Aggregation and C/N Distribution in an Ultisol	PLOS ONE			English	Article							LONG-TERM-FERTILIZATION; ORGANIC-MATTER; PHYSICAL-PROPERTIES; CARBON SEQUESTRATION; MANURE APPLICATION; NO-TILLAGE; STABILITY; NITROGEN; MANAGEMENT; RESIDUES	Unreasonable use of chemical fertilizer (CF) on agricultural soil leads to massive losses of soil organic carbon (SOC) and total nitrogen (TN) in tropical and subtropical areas, where soil conditions are unfavorable for aggregate formation. This study evaluated the effects of combined application of biogas slurry (BS) plus CF on soil aggregation and aggregate-associated C/N concentration and storage in an Ultisol. Six treatments included: no fertilizer (T1), CF only (T2), partial (15% (T3), 30% (T4) and 45% (T5)) substitution of TN with BS and BS only (T6). Soil mechanical-stable aggregates (MSAs) formation and stability as well as MSAs D associated C/N concentration and storage were observed in different aggregate sizes (>5, 5-2, 2-1, 1.0-0.5, 0.50-0.25 and < 0.25 mm). The proportion of MSAs >5 mm significantly increased with BS substitution (T5), while the proportions of MSAs 1.0-0.5 mm, MSAs 0.50-0.25 mm and MSAs <0.25 mm significantly decreased. Both mean weight diameter and geometric mean diameter were highest in T5, which improved soil aggregation stability as well as resulted in significantly higher SOC and TN concentrations and storage in MSAs >0.5 mm that constituted 72-82% of MSAs. Stepwise regression analysis showed that MSAs >5 mm, SOC in MSAs >5 mm and TN in MSAs >5 mm were the dominant variables affecting aggregate stability. Meanwhile SOC in MSAs <0.25 mm and TN in MSAs 2-1 mm were independent variables affecting SOC and TN concentrations in bulk soils. Therefore, certain rate of combined application of BS plus CF is an effective, eco-friendly way to improve soil quality in an Ultisol.	[Zheng, Xuebo; Fan, Jianbo; Xu, Lei; Zhou, Jing] Chinese Acad Sci, Inst Soil Sci, Nanjing, Jiangsu, Peoples R China; [Zheng, Xuebo; Xu, Lei; Zhou, Jing] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhou, Jing] Chinese Acad Sci, Natl Engn Res & Technol Ctr Red Soil Improvement, Red Soil Ecol Expt Stn, Yingtan, Peoples R China; [Zhou, Jing] Jiangxi Acad Sci, Inst Biol Resource, Nanchang, Jiangxi, Peoples R China	Chinese Academy of Sciences; Institute of Soil Science, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences	Fan, JB (corresponding author), Chinese Acad Sci, Inst Soil Sci, Nanjing, Jiangsu, Peoples R China.	jbfan@issas.ac.cn		Zheng, Xuebo/0000-0001-8043-0067; zhou, jing/0000-0002-3426-1300	National Natural Science Foundation of China (NSFC) [41471237]; Key Laboratory of Bio-organic Fertilizer Creation, Ministry of Agriculture, P.R. China [233400]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Key Laboratory of Bio-organic Fertilizer Creation, Ministry of Agriculture, P.R. China	This study was financially supported (partially supported) by National Natural Science Foundation of China (NSFC) General Projects (41471237), and the Open Project Program of Key Laboratory of Bio-organic Fertilizer Creation, Ministry of Agriculture, P.R. China (233400).	Abubaker J, 2012, APPL ENERG, V99, P126, DOI 10.1016/j.apenergy.2012.04.050; Alagoz Z, 2009, SOIL TILL RES, V103, P419, DOI 10.1016/j.still.2008.12.006; Alburquerque JA, 2012, EUR J AGRON, V43, P119, DOI 10.1016/j.eja.2012.06.001; ANGERS DA, 1991, BIOL FERT SOILS, V11, P79, DOI 10.1007/BF00335840; Angers DA, 1998, SOIL TILL RES, V47, P91, DOI 10.1016/S0167-1987(98)00077-4; Alburquerque JA, 2012, BIOMASS BIOENERG, V40, P181, DOI 10.1016/j.biombioe.2012.02.018; Arai M, 2014, GEODERMA, V221, P50, DOI 10.1016/j.geoderma.2014.01.022; Bai WenBo, 2010, Transactions of the Chinese Society of Agricultural Engineering, V26, P69; Benbi DK, 2010, NUTR CYCL AGROECOSYS, V87, P233, DOI 10.1007/s10705-009-9331-2; Bin Z, 2006, PEDOSPHERE, V16, P699, DOI 10.1016/S1002-0160(06)60105-7; Bossuyt H, 2001, APPL SOIL ECOL, V16, P195, DOI 10.1016/S0929-1393(00)00116-5; CHEPIL W. S., 1962, SOIL SCI SOC AMER PROC, V26, P4; Emerson W. W., 1986, Interactions of soil minerals with natural organics and microbes, P521; Focht DD, 1981, SOIL SCI, V132, P317; FORTUN A, 1990, J SOIL SCI, V41, P563, DOI 10.1111/j.1365-2389.1990.tb00226.x; Galvez A, 2012, AGR ECOSYST ENVIRON, V160, P3, DOI 10.1016/j.agee.2011.06.015; Grandy AS, 2002, SOIL SCI SOC AM J, V66, P1311, DOI 10.2136/sssaj2002.1311; GUPTA VVSR, 1988, SOIL BIOL BIOCHEM, V20, P777, DOI 10.1016/0038-0717(88)90082-X; HAYNES RJ, 1990, J SOIL SCI, V41, P73, DOI 10.1111/j.1365-2389.1990.tb00046.x; Haynes RJ, 1998, NUTR CYCL AGROECOSYS, V51, P123, DOI 10.1023/A:1009738307837; Huang S, 2010, GEODERMA, V154, P364, DOI 10.1016/j.geoderma.2009.11.009; Kemper WD, AGGREGATE STABILITY; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R, 2009, FOOD SECUR, V1, P45, DOI 10.1007/s12571-009-0009-z; Marriott EE, 2006, SOIL SCI SOC AM J, V70, P950, DOI 10.2136/sssaj2005.0241; McLean E., 1983, METHODS SOIL ANAL PA, V9, P199, DOI DOI 10.2134/AGRONMONOGR9.2.2ED.C12; Meng QF, 2014, J SOIL SEDIMENT, V14, P1041, DOI 10.1007/s11368-014-0859-7; Naveed M, 2014, GEODERMA, V217, P181, DOI 10.1016/j.geoderma.2013.12.001; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; NWADIALO B E, 1991, Soil Technology, V4, P343, DOI 10.1016/0933-3630(91)90012-C; OADES JM, 1991, AUST J SOIL RES, V29, P815, DOI 10.1071/SR9910815; PAINULI DK, 1990, AGROCHIMICA, V34, P117; Piccolo A, 1999, SOIL SCI SOC AM J, V63, P1801, DOI 10.2136/sssaj1999.6361801x; PUGET P, 1995, EUR J SOIL SCI, V46, P449, DOI 10.1111/j.1365-2389.1995.tb01341.x; Purakayastha TJ, 2008, GEODERMA, V144, P370, DOI 10.1016/j.geoderma.2007.12.006; Rasool R, 2008, SOIL TILL RES, V101, P31, DOI 10.1016/j.still.2008.05.015; Simansky V, 2008, SOIL TILL RES, V100, P125, DOI 10.1016/j.still.2008.05.008; Six J, 2006, SOIL SCI SOC AM J, V70, P555, DOI 10.2136/sssaj2004.0347; Six J, 2000, SOIL BIOL BIOCHEM, V32, P2099, DOI 10.1016/S0038-0717(00)00179-6; Six J, 2000, SOIL SCI SOC AM J, V64, P1042, DOI 10.2136/sssaj2000.6431042x; SOMMER SG, 1992, ACTA AGR SCAND B-S P, V42, P146, DOI 10.1080/09064719209417969; Song ZW, 2015, J AGR SCI-CAMBRIDGE, V153, P236, DOI 10.1017/S0021859614000100; Spohn M, 2011, SOIL BIOL BIOCHEM, V43, P1081, DOI 10.1016/j.soilbio.2011.01.029; TISDALL JM, 1982, J SOIL SCI, V33, P141, DOI 10.1111/j.1365-2389.1982.tb01755.x; Verhulst N, 2011, PLANT SOIL, V340, P453, DOI 10.1007/s11104-010-0618-5; Yang XY, 2011, J PLANT NUTR SOIL SC, V174, P775, DOI 10.1002/jpln.201000134; Yilmaz E, 2014, J ENVIRON MANAGE, V144, P93, DOI 10.1016/j.jenvman.2014.05.023; Zhang B, 2001, GEODERMA, V99, P123, DOI 10.1016/S0016-7061(00)00069-0; Zhang MingKui, 1997, Acta Pedologica Sinica, V34, P359; Zheng XB, 2016, J SOIL SEDIMENT, V16, P449, DOI 10.1007/s11368-015-1254-8; Zheng XueBo, 2015, Transactions of the Chinese Society of Agricultural Engineering, V31, P142; [郑学博 Zheng Xuebo], 2015, [中国农业科学, Scientia Agricultura Sinica], V48, P3201; Zhou H, 2013, GEODERMA, V195, P23, DOI 10.1016/j.geoderma.2012.11.003; Zirkler D, 2014, BIOMASS BIOENERG, V67, P89, DOI 10.1016/j.biombioe.2014.04.021	54	16	17	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170491	10.1371/journal.pone.0170491	http://dx.doi.org/10.1371/journal.pone.0170491			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125647	gold, Green Published, Green Submitted			2022-12-26	WOS:000396176100101
J	Cha, S; Srinivasan, S; Jang, JH; Lee, D; Lim, S; Kim, KS; Jheong, W; Lee, DW; Park, ER; Chung, HM; Choe, J; Kim, MK; Seo, T				Cha, Seho; Srinivasan, Sathiyaraj; Jang, Jun Hyeong; Lee, Dongwook; Lim, Sora; Kim, Kyung Sang; Jheong, Weonhwa; Lee, Dong-Won; Park, Eung-Roh; Chung, Hyun-Mi; Choe, Joonho; Kim, Myung Kyum; Seo, Taegun			Metagenomic Analysis of Airborne Bacterial Community and Diversity in Seoul, Korea, during December 2014, Asian Dust Event	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; BACILLUS-CEREUS; NORTHERN CHINA; TRANSPORT; SOIL; ARTHROBACTER; DISPERSION; AEROSOL; SAND	Asian dust or yellow sand events in East Asia are a major issue of environmental contamination and human health, causing increasing concern. A high amount of dust particles, especially called as particulate matter 10 (PM10), is transported by the wind from the arid and semi-arid tracks to the Korean peninsula, bringing a bacterial population that alters the terrestrial and atmospheric microbial communities. In this study, we aimed to explore the bacterial populations of Asian dust samples collected during November-December 2014. The dust samples were collected using the impinger method, and the hypervariable regions of the 16S rRNA gene were amplified using PCR followed by pyrosequencing. Analysis of the sequencing data were performed using Mothur software. The data showed that the number of operational taxonomic units and diversity index during Asian dust events were higher than those during non-Asian dust events. At the phylum level, the proportions of Proteobacteria, Actinobacteria, and Firmicutes were different between Asian dust and non-Asian dust samples. At the genus level, the proportions of the genus Bacillus (6.9%), Arthrobacter (3.6%), Blastocatella (2%), Planomicrobium (1.4%) were increased during Asian dust compared to those in non-Asian dust samples. This study showed that the significant relationship between bacterial populations of Asian dust samples and non-Asian dust samples in Korea, which could significantly affect the microbial population in the environment.	[Cha, Seho; Jang, Jun Hyeong; Lee, Dongwook; Lim, Sora; Seo, Taegun] Dongguk Univ Seoul, Dept Life Sci, Goyang, South Korea; [Srinivasan, Sathiyaraj; Kim, Kyung Sang; Kim, Myung Kyum] Seoul Womens Univ, Coll Nat Sci, Div Environm & Life Sci, Dept Bio & Environm Technol, Seoul, South Korea; [Jheong, Weonhwa] Natl Inst Environm Res, Environm Hlth Res Dept, Biosafety Res Team, Incheon, South Korea; [Lee, Dong-Won] Natl Inst Environm Res, Air Qual Res Div, Climate & Air Qual Res Dept, Incheon, South Korea; [Park, Eung-Roh; Chung, Hyun-Mi] Natl Inst Environm Res, Water Supply & Sewerage Res Div, Environm Infrastruct Res Dept, Incheon, South Korea; [Choe, Joonho] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon, South Korea	Dongguk University; Seoul Women's University; National Institute of Environmental Research (NIER), Republic of Korea; National Institute of Environmental Research (NIER), Republic of Korea; National Institute of Environmental Research (NIER), Republic of Korea; Korea Advanced Institute of Science & Technology (KAIST)	Seo, T (corresponding author), Seoul Womens Univ, Coll Nat Sci, Div Environm & Life Sci, Dept Bio & Environm Technol, Seoul, South Korea.	biotech@swu.ac.kr; tseo@dongguk.edu	Choe, Joonho/F-3066-2011	Weon-Hwa, Jheong/0000-0001-8752-607X; Srinivasan, Sathiyaraj/0000-0001-6019-7421	National Institute of Environmental Research, Republic of Korea	National Institute of Environmental Research, Republic of Korea	This work was supported by the National Institute of Environmental Research, Republic of Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alebouyeh M, 2011, IRAN J MICROBIOL, V3, P156; Bernasconi E, 2004, CLIN INFECT DIS, V38, pE27, DOI 10.1086/381436; Bory AJM, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016446; CHAO A, 1984, SCAND J STAT, V11, P265; Cheng TT, 2005, ATMOS ENVIRON, V39, P2903, DOI 10.1016/j.atmosenv.2004.12.045; Choi DS, 1997, J MICROBIOL, V35, P1; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Dixon TC, 2000, CELL MICROBIOL, V2, P453, DOI 10.1046/j.1462-5822.2000.00067.x; Draxier RR, 1998, AUST METEOROL MAG, V47, P295; Draxler RR, 2006, WEATHER FORECAST, V21, P383, DOI 10.1175/WAF926.1; DUCE RA, 1980, SCIENCE, V209, P1522, DOI 10.1126/science.209.4464.1522; Ehling-Schulz M, 2004, MOL NUTR FOOD RES, V48, P479, DOI 10.1002/mnfr.200400055; Foesel BU, 2013, SYST APPL MICROBIOL, V36, P82, DOI 10.1016/j.syapm.2012.11.002; Funke G, 1996, J CLIN MICROBIOL, V34, P2356, DOI 10.1128/JCM.34.10.2356-2363.1996; Guinebretiere MH, 2002, J CLIN MICROBIOL, V40, P3053, DOI 10.1128/JCM.40.8.3053-3056.2002; He M, 2010, INHAL TOXICOL, V22, P1012, DOI 10.3109/08958378.2010.510151; Islam MR, 2012, SAUDI J BIOL SCI, V19, DOI 10.1016/j.sjbs.2012.04.001; Jeon EM, 2011, ATMOS ENVIRON, V45, P4313, DOI 10.1016/j.atmosenv.2010.11.054; Kar A, 2004, J ARID ENVIRON, V59, P167, DOI 10.1016/j.jaridenv.2004.01.010; Kellogg CA, 2006, TRENDS ECOL EVOL, V21, P638, DOI 10.1016/j.tree.2006.07.004; Kellogg Christina A., 2004, Aerobiologia, V20, P99, DOI 10.1023/B:AERO.0000032947.88335.bb; Kim KH, 2003, ATMOS ENVIRON, V37, P753, DOI 10.1016/S1352-2310(02)00954-8; Kim KH, 2003, CHEMOSPHERE, V51, P707, DOI 10.1016/S0045-6535(03)00036-5; Kim MY, 2001, J KOREAN EARTH SCI S, V22, P480; Kim YH, 2003, J BIOSCIENCES, V28, P77, DOI 10.1007/BF02970135; Kwaasi AAA, 1998, ALLERGY, V53, P255, DOI 10.1111/j.1398-9995.1998.tb03885.x; Kwon HJ, 2000, EPIDEMIOLOGY, V11, pS88; Lee S, 2009, SCI TOTAL ENVIRON, V407, P5308, DOI 10.1016/j.scitotenv.2009.06.052; LOGAN NA, 1985, J CLIN PATHOL, V38, P838, DOI 10.1136/jcp.38.7.838; Maki T, 2014, SCI TOTAL ENVIRON, V488, P75, DOI 10.1016/j.scitotenv.2014.04.044; Mori I, 2003, ATMOS ENVIRON, V37, P4253, DOI 10.1016/S1352-2310(03)00535-1; Nakano T, 2004, ATMOS ENVIRON, V38, P3061, DOI 10.1016/j.atmosenv.2004.02.016; Hua NP, 2007, AEROBIOLOGIA, V23, P291, DOI 10.1007/s10453-007-9076-9; Pritchard RJ, 1996, INHAL TOXICOL, V8, P457, DOI 10.3109/08958379609005440; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; REICHHARDT T, 1995, ENVIRON SCI TECHNOL, V29, pA360, DOI 10.1021/es00008a744; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; SNEATH R. R., 1973, NUMERICAL TAXONOMY; Sun JM, 2000, GEOPHYS RES LETT, V27, P2105, DOI 10.1029/1999GL010814; Vasileiadis S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042671; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Whon TW, 2012, J VIROL, V86, P8221, DOI 10.1128/JVI.00293-12; Yamaguchi N, 2012, SCI REP-UK, P2; Yamaguchi N, 2014, MICROBES ENVIRON, V29, P82, DOI 10.1264/jsme2.ME13080	45	21	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0170693	10.1371/journal.pone.0170693	http://dx.doi.org/10.1371/journal.pone.0170693			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122054	Green Published, Green Submitted, gold			2022-12-26	WOS:000396167300028
J	Shin, SC; Ahn, IH; Ahn, DH; Lee, YM; Lee, J; Lee, JH; Kim, HW; Park, H				Shin, Seung Chul; Ahn, In Hye; Ahn, Do Hwan; Lee, Yung Mi; Lee, Jungeun; Lee, Jun Hyuck; Kim, Han-Woo; Park, Hyun			Characterization of Two Antimicrobial Peptides from Antarctic Fishes (Notothenia coriiceps and Parachaenichthys charcoti)	PLOS ONE			English	Article							ANTIBACTERIAL PEPTIDES; GENE; DISCOVERY	We identified two antimicrobial peptides (AMPs) with similarity to moronecidin in Antarctic fishes. The characteristics of both AMPs were determined using moronecidin as a control. Moronecidin, which was first isolated from hybrid striped bass, is highly salt-resistant, and possesses broad-spectrum activity against various microbes. The moronecidin-like peptide from Notothenia coriiceps exhibited a narrower spectrum of activity and a higher salt sensitivity than moronecidin. The AMP from Parachaenichthys charcoti exhibited similar antimicrobial activity to moronecidin, and similar salt sensitivity. In an experiment to identify toxic effects, both of the moronecidin-like peptides from the Antarctic fishes exhibited lower hemolytic activity than moronecidin. In spite of its low toxicity, the AMP from N. coriiceps is unlikely to be considered as a candidate for antibiotic development, owing to its narrow spectrum of activity and high salt sensitivity. In contrast, the high salt resistance and broad-spectrum activity of the AMP from P. charcoti could be more advantageous for clinical use than moronecidin, since it could kill bacteria under physiological conditions with low toxicity. A further comparison of these two AMPs from Antarctic fishes with other AMPs could help to reduce the toxicity of AMPs for clinical use.	[Shin, Seung Chul; Ahn, In Hye; Ahn, Do Hwan; Lee, Yung Mi; Lee, Jungeun; Lee, Jun Hyuck; Kim, Han-Woo; Park, Hyun] Korea Polar Res Inst KOPRI, Unit Polar Genom, Incheon, South Korea; [Ahn, In Hye; Lee, Jun Hyuck; Kim, Han-Woo; Park, Hyun] Korea Univ Sci & Technol, Dept Polar Sci, Incheon, South Korea	Korea Polar Research Institute (KOPRI)	Park, H (corresponding author), Korea Polar Res Inst KOPRI, Unit Polar Genom, Incheon, South Korea.	ssc@kopri.re.kr; hwkim@kopri.re.kr; hpark@kopri.re.kr			Functional Genomics on Polar Organisms [PE16070]; 'Polar Genomics 101 Project' grant - Korea Polar Research Institute (KOPRI) [PE17080]; Korea Polar Research Institute (KOPRI)	Functional Genomics on Polar Organisms; 'Polar Genomics 101 Project' grant - Korea Polar Research Institute (KOPRI); Korea Polar Research Institute (KOPRI)	This work was supported by a Functional Genomics on Polar Organisms grant (PE16070) and a 'Polar Genomics 101 Project' grant (PE17080) funded by the Korea Polar Research Institute (KOPRI).	Aoki W, 2013, PHARMACEUTICALS-BASE, V6, P1055, DOI 10.3390/ph6081055; Bao BL, 2005, DEV COMP IMMUNOL, V29, P939, DOI 10.1016/j.dci.2005.03.006; Bowdish DME, 2005, CURR PROTEIN PEPT SC, V6, P35, DOI 10.2174/1389203053027494; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Buonocore F, 2012, FISH SHELLFISH IMMUN, V33, P1183, DOI 10.1016/j.fsi.2012.09.005; Cezard C, 2011, SCI MICROBIAL PATHOG; Chinchar VG, 2004, VIROLOGY, V323, P268, DOI 10.1016/j.virol.2004.02.029; CLARKE A, 1992, PHILOS T ROY SOC B, V338, P299, DOI 10.1098/rstb.1992.0150; Deslouches B, 2005, ANTIMICROB AGENTS CH, V49, P3208, DOI 10.1128/AAC.49.8.3208-3216.2005; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Giuliani A, 2007, CENT EUR J BIOL, V2, P1, DOI 10.2478/s11535-007-0010-5; Gordon YJ, 2005, CURR EYE RES, V30, P505, DOI 10.1080/02713680590968637; Guilhelmelli F, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00353; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Hancock REW, 2000, EXPERT OPIN INV DRUG, V9, P1723, DOI 10.1517/13543784.9.8.1723; Kim SJ, 2012, J BACTERIOL, V194, P2403, DOI 10.1128/JB.00234-12; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Lauth X, 2002, J BIOL CHEM, V277, P5030, DOI 10.1074/jbc.M109173200; Lee YM, 2014, ANTON LEEUW INT J G, V106, P527, DOI 10.1007/s10482-014-0221-5; Lin H, 2012, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2012-69; Maier VH, 2008, MOL IMMUNOL, V45, P3723, DOI 10.1016/j.molimm.2008.06.002; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; Masso-Silva JA, 2014, PHARMACEUTICALS-BASE, V7, P265, DOI 10.3390/ph7030265; Noga EJ, 2011, COMP BIOCHEM PHYS D, V6, P44, DOI 10.1016/j.cbd.2010.06.001; Oren Z, 1996, EUR J BIOCHEM, V237, P303, DOI 10.1111/j.1432-1033.1996.0303n.x; Otvos Laszlo, 2007, V386, P309, DOI 10.1007/978-1-59745-430-8_12; Otvos L, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00062; Park CB, 1997, FEBS LETT, V411, P173, DOI 10.1016/S0014-5793(97)00684-4; Park SC, 2011, INT J MOL SCI, V12, P5971, DOI 10.3390/ijms12095971; Rajanbabu V, 2011, PEPTIDES, V32, P415, DOI 10.1016/j.peptides.2010.11.005; Silphaduang U, 2001, NATURE, V414, P268, DOI 10.1038/35104690; Tam JP, 2002, J BIOL CHEM, V277, P50450, DOI 10.1074/jbc.M208429200; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teixeira V, 2012, PROG LIPID RES, V51, P149, DOI 10.1016/j.plipres.2011.12.005; Uzzell T, 2003, PEPTIDES, V24, P1655, DOI 10.1016/j.peptides.2003.08.024; Wang Q, 2006, FISH SHELLFISH IMMUN, V20, P419, DOI 10.1016/j.fsi.2005.05.005; Zou J, 2007, MOL IMMUNOL, V44, P638, DOI 10.1016/j.molimm.2006.01.012	37	16	18	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0170821	10.1371/journal.pone.0170821	http://dx.doi.org/10.1371/journal.pone.0170821			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122029	Green Submitted, Green Published, gold			2022-12-26	WOS:000396167300014
J	Gao, YJ; Katz, DF				Gao, Yajing; Katz, David F.			Multicompartmental Pharmacokinetic Model of Tenofovir Delivery to the Rectal Mucosa by an Enema	PLOS ONE			English	Article							MICROBICIDE GEL FORMULATION; INTRAVAGINAL RING; DRUG-DELIVERY; HIV-INFECTION; PREVENTION; SAFETY; SURROGATES; TRANSPORT; COLON	Rectal enemas that contain prophylactic levels of anti-HIV microbicides such as tenofovir have emerged as a promising dosage form to prevent sexually transmitted HIV infections. The enema vehicle is promising due to its likely ability to deliver a large amount of drug along the length of the rectal canal. Computational models of microbicide drug delivery by enemas can help their design process by determining key factors governing drug transport and, more specifically, the time history and degree of protection. They can also inform interpretations of experimental pharmacokinetic measures such as drug concentrations in biopsies. The present work begins rectal microbicide PK modeling, for enema vehicles. Results here show that a paramount factor in drug transport is the time of enema retention; direct connectivity between enema fluid and the fluid within rectal crypts is also important. Computations of the percentage of stromal volume protected by a single enema dose indicate that even with only a minute of enema retention, protection of 100% can be achieved after around 14 minutes post dose. Concentrations in biopsies are dependent on biopsy thickness; and control and/or knowledge of thickness could improve accuracy and decrease variability in biopsy measurements. Results here provide evidence that enemas are a promising dosage form for rectal microbicide delivery, and offer insights into their rational design.	[Gao, Yajing; Katz, David F.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Katz, David F.] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Durham, NC 27710 USA	Duke University; Duke University	Katz, DF (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	dkatz@duke.edu			National Institute of Health [R01 HD 072702, U19 Al 077289]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077289, U19AI113127] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study is funded by National Institute of Health grants R01 HD 072702 and U19 Al 077289. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037410; BILLICH CO, 1969, J CLIN INVEST, V48, P1336, DOI 10.1172/JCI106100; Cao YJ, 2012, BRIT J CLIN PHARMACO, V74, P1013, DOI 10.1111/j.1365-2125.2012.04267.x; Chuchuen O., 2015, DEV APPL RAMAN SPECT; Chuchuen O, 2014, AIDS RES HUM RETROV, V30, pA59, DOI 10.1089/aid.2014.5106.abstract; Clark Meredith R, 2014, Pharmaceutics, V6, P616; das Neves J., 2014, DRUG DELIVERY DEV AN; Dezzutti CS, 2012, J ANTIMICROB CHEMOTH, V67, P2139, DOI 10.1093/jac/dks173; Gao Y, 2015, DRUG DELIV TRANSL RE, P1; Gao YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074404; Geonnotti AR, 2010, J PHARM SCI-US, V99, P3514, DOI 10.1002/jps.22120; Ham AS, 2015, ANTIVIR RES, V120, P153, DOI 10.1016/j.antiviral.2015.06.010; Ham AS, 2012, J PHARM SCI-US, V101, P1423, DOI 10.1002/jps.23026; Hawkins T, 2005, JAIDS-J ACQ IMM DEF, V39, P406, DOI 10.1097/01.qai.0000167155.44980.e8; Hendrix C, 2008, CLIN PHARMACOL THER, V83, P97, DOI 10.1038/sj.clpt.6100236; Hendrix CW, 2009, ANNU REV PHARMACOL, V49, P349, DOI 10.1146/annurev.pharmtox.48.113006.094906; Howett MK, 2005, CURR PHARM DESIGN, V11, P3731, DOI 10.2174/138161205774580633; Jarrett AM, 2016, J PHARM SCI-US, V105, P1772, DOI 10.1016/j.xphs.2016.02.015; Katz DF, 2015, ADV DRUG DELIVERY RE; Kearney BP, 2004, CLIN PHARMACOKINET, V43, P595, DOI 10.2165/00003088-200443090-00003; Kiser PF, 2012, AIDS REV, V14, P62; Klijn AJ, 2004, J UROLOGY, V172, P1986, DOI 10.1097/01.ju.0000142686.09532.46; LERICHE M, 1978, DIS COLON RECTUM, V21, P227, DOI 10.1007/BF02586697; Leyva FJ, 2013, AIDS RES HUM RETROV, V29, P1487, DOI [10.1089/AID.2013.0189, 10.1089/aid.2013.0189]; Mahalingam A, 2010, PHARM RES-DORDR, V27, P2478, DOI 10.1007/s11095-010-0244-1; Maisel K, 2015, J CONTROL RELEASE, V209, P280, DOI 10.1016/j.jconrel.2015.04.040; Mathworks, 2010, MATLAB 7 11 0; Nel A, 2009, JAIDS-J ACQ IMM DEF, V51, P416, DOI 10.1097/QAI.0b013e3181acb536; NIVATVONGS S, 1981, DIS COLON RECTUM, V24, P600, DOI 10.1007/BF02605754; Ovalle W. K., 2013, NETTERS ESSENTIAL HI; Rohan LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009310; Schwartz JL, 2009, INT J STD AIDS, V20, P384, DOI 10.1258/ijsa.2008.008309; Slomianka L, 2009, BLUE HIST; Stone A, 2002, NAT REV DRUG DISCOV, V1, P977, DOI 10.1038/nrd959; Tanaka E, 2012, MED MOL MORPHOL, V45, P72, DOI 10.1007/s00795-011-0541-8; Yang KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106196	36	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0167696	10.1371/journal.pone.0167696	http://dx.doi.org/10.1371/journal.pone.0167696			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114388	gold, Green Published, Green Submitted			2022-12-26	WOS:000396129000001
J	Jahny, E; Yang, H; Liu, B; Jahnke, B; Lademann, F; Knoesel, T; Rummele, P; Grutzmann, R; Aust, DE; Pilarsky, C; Denz, A				Jahny, Elisabeth; Yang, Hai; Liu, Bin; Jahnke, Beatrix; Lademann, Franziska; Knoesel, Thomas; Ruemmele, Petra; Gruetzmann, Robert; Aust, Daniela E.; Pilarsky, Christian; Denz, Axel			The G Protein-Coupled Receptor RAI3 Is an Independent Prognostic Factor for Pancreatic Cancer Survival and Regulates Proliferation via STAT3 Phosphorylation	PLOS ONE			English	Article							CARCINOMA-CELL-LINES; GENE-EXPRESSION; GPRC5A; IDENTIFICATION; P53	Pancreatic Ductal Adenocarcinoma (PDAC) is one of the deadliest tumors worldwide. Understanding the function of gene expression alterations is a prerequisite for developing new strategies in diagnostic and therapy. GPRC5A (RAI3), coding for a seven transmembrane G protein-coupled receptor is known to be overexpressed in pancreatic cancer and might be an interesting candidate for therapeutic intervention. Expression levels of RAI3 were compared using a tissue microarray of 435 resected patients with pancreatic cancer as well as 209 samples from chronic pancreatitis (CP), intra-ductal papillary mucinous neoplasm (IPMN) and normal pancreatic tissue. To elucidate the function of RAI3 overexpression, siRNA based knock-down was used and transfected cells were analyzed using proliferation and migration assays. Pancreatic cancer patients showed a statistically significant overexpression of RAI3 in comparison to normal and chronic pancreatitis tissue. Especially the loss of apical RAI3 expression represents an independent prognostic parameter for overall survival of patients with pancreatic cancer. Suppression of GPRC5a results in decreased cell growth, proliferation and migration in pancreatic cancer cell lines via a STAT3 modulated pathway, independent from ERK activation.	[Jahny, Elisabeth; Jahnke, Beatrix; Lademann, Franziska] Tech Univ Dresden, Dept Surg, Fetscherstr 74, Dresden, Germany; [Yang, Hai; Liu, Bin; Gruetzmann, Robert; Pilarsky, Christian; Denz, Axel] Univ Klinikum Erlangen, Dept Surg, Krankenhausstr 12, Erlangen, Germany; [Knoesel, Thomas] Ludwig Maximilians Univ Munchen, Inst Pathol, Munich, Germany; [Ruemmele, Petra] Univ Klinikum Erlangen, Inst Pathol, Krankenhausstr 8-10, Erlangen, Germany; [Aust, Daniela E.] Tech Univ Dresden, Inst Pathol, Fetscherstr 74, Dresden, Germany	Technische Universitat Dresden; University of Erlangen Nuremberg; University of Munich; University of Erlangen Nuremberg; Technische Universitat Dresden	Pilarsky, C (corresponding author), Univ Klinikum Erlangen, Dept Surg, Krankenhausstr 12, Erlangen, Germany.	christian.pilarsky@uk-erlangen.de		Lademann, Franziska/0000-0003-1059-5506; Pilarsky, Christian/0000-0002-7968-3283	Wilhelm Sander Stiftung [2009.039.1/2]	Wilhelm Sander Stiftung	This study was supported by the Wilhelm Sander Stiftung (2009.039.1/2). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The HDPE cell line was obtained from M. Tsao, Toronto, Canada. This study was supported by the Wilhelm Sander Stiftung (2009.039.1/2). The Microarray dataset from reference 11 can be found at ArrayExpress E-MEXP 1121 and E-MEXP-950.	Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Cheng L, 2012, CANCER LETT, V326, P105, DOI 10.1016/j.canlet.2012.07.031; Cheng YJ, 1998, J BIOL CHEM, V273, P35008, DOI 10.1074/jbc.273.52.35008; Fujimoto J, 2012, J THORAC ONCOL, V7, P1747, DOI 10.1097/JTO.0b013e31826bb1ff; Grutzmann R, 2004, NEOPLASIA, V6, P611, DOI 10.1593/neo.04295; Grutzmann R, 2004, BRIT J CANCER, V90, P1053, DOI 10.1038/sj.bjc.6601645; Hanel W, 2013, CELL DEATH DIFFER, V20, P898, DOI 10.1038/cdd.2013.17; Harborth J, 2001, J CELL SCI, V114, P4557; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Jorissen H, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-200; Liu SL, 2013, J ORAL PATHOL MED, V42, P761, DOI 10.1111/jop.12077; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma T, 2016, ONCOL REP; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Moore PS, 2001, VIRCHOWS ARCH, V439, P798, DOI 10.1007/s004280100474; Nagahata T, 2005, ENDOCR-RELAT CANCER, V12, P65, DOI 10.1677/erc.1.00890; Ruckert F, 2012, J SURG RES, V172, P29, DOI 10.1016/j.jss.2011.04.021; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sipos B, 2003, VIRCHOWS ARCH, V442, P444, DOI 10.1007/s00428-003-0784-4; Wang J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11795; Wolfgang CL, 2013, CA-CANCER J CLIN, V63, P318, DOI 10.3322/caac.21190; Wu Q, 2005, J BIOL CHEM, V280, P12935, DOI 10.1074/jbc.M409901200; Zheng J, 2014, CLIN TRANSL ONCOL, V16, P57, DOI 10.1007/s12094-013-1040-2; Zhou H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.169; Zhou Honglei, 2014, Oncoscience, V1, P765; Zougman A, 2013, EUR J CANCER, V49, P531, DOI 10.1016/j.ejca.2012.07.031	26	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170390	10.1371/journal.pone.0170390	http://dx.doi.org/10.1371/journal.pone.0170390			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114355	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129000042
J	Bulakhov, AG; Volkov, PV; Rozhkova, AM; Gusakov, AV; Nemashkalov, VA; Satrutdinov, AD; Sinitsyn, AP				Bulakhov, Alexander G.; Volkov, Pavel V.; Rozhkova, Aleksandra M.; Gusakov, Alexander V.; Nemashkalov, Vitaly A.; Satrutdinov, Aidar D.; Sinitsyn, Arkady P.			Using an Inducible Promoter of a Gene Encoding Penicillium verruculosum Glucoamylase for Production of Enzyme Preparations with Enhanced Cellulase Performance	PLOS ONE			English	Article							TRICHODERMA-REESEI; EXPRESSION SYSTEM; HYDROLYSIS; CANESCENS; STRAINS; ABILITY; CLONING; FUNGUS	Background Penicillium verruculosum is an efficient producer of highly active cellulase multienzyme system. One of the approaches for enhancing cellulase performance in hydrolysis of cellulosic substrates is to enrich the reaction system with beta-glucosidase and/or accessory enzymes, such as lytic polysaccharide monooxygenases (LPMO) displaying a synergism with cellulases. Results Genes bgII, encoding beta-glucosidase from Aspergillus niger (AnBGL), and egIIV, encoding LPMO (formerly endoglucanase IV) from Trichoderma reesei (TrLPMO), were cloned and expressed by P. verruculosum B1-537 strain under the control of the inducible gla1 gene promoter. Content of the heterologous AnBGL in the secreted multienzyme cocktails (hBGL1, hBGL2 and hBGL3) varied from 4 to 10% of the total protein, while the content of TrLPMO in the hLPMO sample was similar to 3%. The glucose yields in 48-h hydrolysis of Avicel and milled aspen wood by the hBGL1, hBGL2 and hBGL3 preparations increased by up to 99 and 80%, respectively, relative to control enzyme preparations without the heterologous AnBGL (at protein loading 5 mg/g substrate for all enzyme samples). The heterologous TrLPMO in the hLPMO preparation boosted the conversion of the lignocellulosic substrate by 10-43%; however, in hydrolysis of Avicel the hLPMO sample was less effective than the control preparations. The highest product yield in hydrolysis of aspen wood was obtained when the hBGL2 and hLPMO preparations were used at the ratio 1:1. Conclusions The enzyme preparations produced by recombinant P. verruculosum strains, expressing the heterologous AnBGL or TrLPMO under the control of the gla1 gene promoter in a starch-containing medium, proved to be more effective in hydrolysis of a lignocellulosic substrate than control enzyme preparations without the heterologous enzymes. The enzyme composition containing both AnBGL and TrLPMO demonstrated the highest performance in lignocellulose hydrolysis, providing a background for developing a fungal strain capable to express both heterologous enzymes simultaneously.	[Bulakhov, Alexander G.; Volkov, Pavel V.; Rozhkova, Aleksandra M.; Gusakov, Alexander V.; Satrutdinov, Aidar D.; Sinitsyn, Arkady P.] Russian Acad Sci, Fdn Biotechnol, Fed Res Ctr, Moscow, Russia; [Rozhkova, Aleksandra M.; Gusakov, Alexander V.; Sinitsyn, Arkady P.] Moscow MV Lomonosov State Univ, Dept Chem, Moscow, Russia; [Nemashkalov, Vitaly A.] Russian Acad Sci, GK Skryabin Inst Biochem & Physiol Microorganism, Moscow, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences; Lomonosov Moscow State University; Russian Academy of Sciences	Rozhkova, AM (corresponding author), Russian Acad Sci, Fdn Biotechnol, Fed Res Ctr, Moscow, Russia.; Rozhkova, AM (corresponding author), Moscow MV Lomonosov State Univ, Dept Chem, Moscow, Russia.	amrojkova@mail.ru	Rozhkova, Alexandra/E-5607-2014; Gusakov, Alexander V/B-7783-2013; Volkov, Pavel/E-5809-2014	Rozhkova, Alexandra/0000-0003-4901-4705; Gusakov, Alexander V/0000-0002-5234-4863; Volkov, Pavel/0000-0002-3564-2674	Russian Science Foundation [14-14-00881]	Russian Science Foundation(Russian Science Foundation (RSF))	Support was provided by the Russian Science Foundation, Grant 14-14-00881, [http://grant.rscf.ru]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEKSENKO AY, 1995, CURR GENET, V28, P474, DOI 10.1007/BF00310818; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Berlin A, 2005, ENZYME MICROB TECH, V37, P175, DOI 10.1016/j.enzmictec.2005.01.039; Bulakhov AG, 2016, BIOCHEMISTRY-MOSCOW+, V81, P530, DOI 10.1134/S0006297916050102; Dashtban M, 2009, INT J BIOL SCI, V5, P578, DOI 10.7150/ijbs.5.578; Do H., 2014, BIOTECHNOL BIOENG, V111, P59, DOI [10.1002/bit.25098, DOI 10.1002/BIT.25098]; Dotsenko GS, 2015, PROCESS BIOCHEM, V50, P1258, DOI 10.1016/j.procbio.2015.05.008; Gruno M, 2004, BIOTECHNOL BIOENG, V86, P503, DOI 10.1002/bit.10838; Gusakov AV, 2012, BIOFUELS-UK, V3, P463, DOI [10.4155/bfs.12.41, 10.4155/BFS.12.41]; Gusakov AV, 2011, TRENDS BIOTECHNOL, V29, P419, DOI 10.1016/j.tibtech.2011.04.004; Gusakov AV, 2005, ENZYME MICROB TECH, V36, P57, DOI 10.1016/j.enzmictec.2004.03.025; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Inoue H, 2013, J IND MICROBIOL BIOT, V40, P823, DOI 10.1007/s10295-013-1286-2; Kameshwar AKS, 2016, INT J BIOL SCI, V12, P156, DOI 10.7150/ijbs.13537; Karnaouri A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00281; Korotkova OG, 2009, BIOCHEMISTRY-MOSCOW+, V74, P569, DOI 10.1134/S0006297909050137; Kumar R, 2009, BIOTECHNOL BIOENG, V102, P457, DOI 10.1002/bit.22068; Merzlov DA, 2015, BIOCHEMISTRY-MOSCOW+, V80, P473, DOI 10.1134/S0006297915040112; Morozova VV, 2010, BIOTECHNOL J, V5, P871, DOI 10.1002/biot.201000050; Nelson N, 1944, J BIOL CHEM, V153, P375; Osipov DO, 2011, CATAL IND, V3, P34, DOI 10.1134/S2070050411010090; Petersen KL, 1999, MOL GEN GENET, V262, P668, DOI 10.1007/s004380051129; PETERSON GL, 1979, ANAL BIOCHEM, V100, P201, DOI 10.1016/0003-2697(79)90222-7; Proskurina OV, 2015, APPL BIOCHEM MICRO+, V51, P667, DOI 10.1134/S0003683815060125; Rappsilber J, 2003, INT J MASS SPECTROM, V226, P223, DOI 10.1016/S1387-3806(02)00976-4; Rozhkova AM, 2011, APPL BIOCHEM MICRO+, V47, P279, DOI 10.1134/S0003683811030124; Sambrook J., 2001, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sinitsyn A.P., 2015, MICROORGANISMS BIORE, P1, DOI [10.1007/978-3-662-45209-7_1., DOI 10.1007/978-3-662-45209-7_1]; Sinitsyna OA, 2003, BIOCHEMISTRY-MOSCOW+, V68, P1200, DOI 10.1023/B:BIRY.0000009134.48246.7e; Smith B.J., 1997, PROTEIN SEQUENCING P; Song W, 2016, PROTEOMIC ANAL BIOMA, V9, P1; Tiwari P, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/203735; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Volkov PV, 2013, BIOCHEMISTRY-MOSCOW+, V78, P1180, DOI 10.1134/S0006297913100131; Volkov PV, 2012, APPL BIOCHEM MICRO+, V48, P58, DOI 10.1134/S000368381201019X; Westereng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027807	38	22	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170404	10.1371/journal.pone.0170404	http://dx.doi.org/10.1371/journal.pone.0170404			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107425	gold, Green Published, Green Submitted			2022-12-26	WOS:000392405300127
J	Liu, JH; Liang, PP; Yin, LL; Shu, N; Zhao, TD; Xing, Y; Li, FY; Zhao, ZL; Li, KC; Han, Y				Liu, Jianghong; Liang, Peipeng; Yin, Linlin; Shu, Ni; Zhao, Tengda; Xing, Yi; Li, Fangyu; Zhao, Zhilian; Li, Kuncheng; Han, Ying			White Matter Abnormalities in Two Different Subtypes of Amnestic Mild Cognitive Impairment	PLOS ONE			English	Article							DIFFUSION TENSOR TRACTOGRAPHY; EARLY ALZHEIMERS-DISEASE; UNCINATE FASCICULUS; ARCUATE FASCICULUS; BRAIN-DAMAGE; TRACT; DEMENTIA; LANGUAGE; APHASIA; INDIVIDUALS	White matter (WM) degeneration has been found during the course of cognitive decline in both Alzheimer's disease (AD) and amnestic mild cognitive impairment (aMCI), however, it is unclear whether there are different WM microstructural abnormalities between two sub-types of aMCI, including single domain aMCI (aMCI-s) and multiple domain aMCI (aMCI-m). Thirty-two patients of aMCI single-domain (aMCI-s), twenty-three patients of aMCI multipledomain (aMCI-m) and twenty-three healthy normal controls (NC) participated in this study. Neuropsychological measures and diffusion tensor imaging (DTI) data were acquired from each subject and tract-based spatial statistics (TBSS) was implemented. It was found that both aMCI groups showed significantly reduced fractional anisotropy (FA) in the right superior longitudinal fasciculus (SLF) than NC. It was also identified that, as compared to aMCI-m, aMCI-s showed significantly decreased FA in the left SLF, left uncinate fasciculus (UF) and left inferior longitudinal fasciculus (ILF), while significantly increased FA in the left anterior thalamic radiation (ATR). The correlation analysis showed that FA values in the regions with group difference were significantly correlated with cognitive functions as measured by Boston naming test and trail making test. These results suggested that the variations of aMCI may be differentiated by FA indexes and DTI may help to understand why specific signs and symptoms occur in patients.	[Liu, Jianghong; Xing, Yi; Li, Fangyu; Han, Ying] Capital Med Univ, Xuan Wu Hosp, Dept Neurol, Beijing, Peoples R China; [Liang, Peipeng; Zhao, Zhilian; Li, Kuncheng] Capital Med Univ, Xuan Wu Hosp, Dept Radiol, Beijing, Peoples R China; [Liang, Peipeng; Li, Kuncheng] Beijing Key Lab MRI & Brain Informat, Beijing, Peoples R China; [Yin, Linlin] Capital Med Univ, Beijing Geriatr Med Res Ctr, Xuan Wu Hosp, Key Lab Neurodegenerat Dis,Minist Educ,Dept Pharm, Beijing, Peoples R China; [Shu, Ni; Zhao, Tengda] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China; [Han, Ying] Beijing Inst Brain Disorders, Ctr Alzheimers Dis, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; Beijing Normal University	Han, Y (corresponding author), Capital Med Univ, Xuan Wu Hosp, Dept Neurol, Beijing, Peoples R China.; Liang, PP; Li, KC (corresponding author), Capital Med Univ, Xuan Wu Hosp, Dept Radiol, Beijing, Peoples R China.; Liang, PP; Li, KC (corresponding author), Beijing Key Lab MRI & Brain Informat, Beijing, Peoples R China.; Han, Y (corresponding author), Beijing Inst Brain Disorders, Ctr Alzheimers Dis, Beijing, Peoples R China.	ppliang1979@gmail.com; lkc1955@gmail.com; sophiehanying@gmail.com	Han, Ying/H-7111-2017		National Natural Science Foundation of China [81301208, 81341088, 61473196, 31371007, 81430037]; Specialized Research Fund for Doctoral Program of Higher Education [20131107120002]; Foundation of Clinical and basic cooperation of Capital Medical University [13JL70]; Beijing Nova Program [Z12111000250000, Z131107000413120]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Foundation of Clinical and basic cooperation of Capital Medical University; Beijing Nova Program(Beijing Municipal Science & Technology Commission)	This article was supported by National Natural Science Foundation of China (Grant Nos. 81301208, 81341088, 61473196, 31371007, 81430037), the Specialized Research Fund for the Doctoral Program of Higher Education (20131107120002), Foundation of Clinical and Basic Cooperation of Capital Medical University (No. 13JL70), and Beijing Nova Program (Z12111000250000, Z131107000413120). The funders had no role in study design, data collectionThis article was supported by National Natural Science Foundation of China (Grant Nos. 81301208, 81341088, 61473196, 31371007, 81430037), the Specialized Research Fund for the Doctoral Program of Higher Education (20131107120002), Foundation of Clinical and basic cooperation of Capital Medical University (No. 13JL70). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Brueggen K, 2015, J ALZHEIMERS DIS, V48, P197, DOI 10.3233/JAD-150063; BRUN A, 1986, ANN NEUROL, V19, P253, DOI 10.1002/ana.410190306; Catani M, 2003, ANN NEUROL, V53, P242, DOI 10.1002/ana.10445; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Catani M, 2008, CORTEX, V44, P953, DOI 10.1016/j.cortex.2008.04.002; Chanraud S, 2010, NEUROPSYCHOL REV, V20, P209, DOI 10.1007/s11065-010-9129-7; Cheung RW, 2004, J INT NEUROPSYCH SOC, V10, P46, DOI 10.1017/S1355617704101069; Davis SW, 2009, NEUROIMAGE, V46, P530, DOI 10.1016/j.neuroimage.2009.01.068; Delbeuck X, 2007, NEUROPSYCHOLOGIA, V45, P3315, DOI 10.1016/j.neuropsychologia.2007.05.001; Duering M, 2011, BRAIN, V134, P2366, DOI 10.1093/brain/awr169; ENGLUND E, 1988, BRAIN, V111, P1425, DOI 10.1093/brain/111.6.1425; Fellgiebel A, 2008, NEUROPSYCHOLOGIA, V46, P1698, DOI 10.1016/j.neuropsychologia.2007.12.010; Floresco SB, 2003, J NEUROSCI, V23, P3930; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Geldmacher DS, 2007, NEUROLOGY, V69, P321, DOI 10.1212/01.wnl.0000275278.38229.7b; Gmitrowicz A, 1994, Psychiatr Pol, V28, P509; Guo QH, 2009, ALZ DIS ASSOC DIS, V23, P253, DOI 10.1097/WAD.0b013e3181999e92; Hiyoshi-Taniguchi K, 2015, J NEUROIMAGING, V25, P748, DOI 10.1111/jon.12196; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Ito K, 2015, PSYCHIAT RES-NEUROIM, V231, P346, DOI 10.1016/j.pscychresns.2015.01.020; Kiuchi K, 2009, BRAIN RES, V1287, P184, DOI 10.1016/j.brainres.2009.06.052; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Liang PP, 2015, SCI REP-UK, V5, DOI 10.1038/srep18216; Liang PP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088476; Liang PP, 2012, J ALZHEIMERS DIS, V30, P475, DOI 10.3233/JAD-2012-111721; Liang PP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022153; Lu J, 2011, J GERIATR PSYCH NEUR, V24, P184, DOI 10.1177/0891988711422528; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nishioka C, 2015, J ALZHEIMERS DIS, V45, P97, DOI 10.3233/JAD-141239; Nowrangi MA, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00001; Oishi Kenichi, 2011, Front Neurol, V2, P54, DOI 10.3389/fneur.2011.00054; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Petersen RC, 2008, CNS SPECTRUMS, V13, P45, DOI 10.1017/S1092852900016151; Pievani M, 2010, HUM BRAIN MAPP, V31, P1862, DOI 10.1002/hbm.20978; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Rose SE, 2008, J MAGN RESON IMAGING, V27, P20, DOI 10.1002/jmri.21231; Schmahmann JD, 2008, ANN NY ACAD SCI, V1142, P266, DOI 10.1196/annals.1444.017; Shinoura N, 2007, NEUROCASE, V13, P127, DOI 10.1080/13554790701399254; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; SUNDERLAND T, 1989, J AM GERIATR SOC, V37, P725, DOI 10.1111/j.1532-5415.1989.tb02233.x; Taoka T, 2006, AM J NEURORADIOL, V27, P1040; Van Der Werf YD, 2003, CORTEX, V39, P1047, DOI 10.1016/S0010-9452(08)70877-3; Von Der Heide RJ, 2013, BRAIN, V136, P1692, DOI 10.1093/brain/awt094; Winston GP, 2015, QUANT IMAGING MED SU, V5, P279, DOI 10.3978/j.issn.2223-4292.2015.02.03; Wise RJS, 2003, BRIT MED BULL, V65, P95, DOI 10.1093/bmb/65.1.95; Xie YY, 2015, J ALZHEIMERS DIS, V47, P509, DOI 10.3233/JAD-150184; Yasmin H, 2008, NEURORADIOLOGY, V50, P293, DOI 10.1007/s00234-007-0353-7	52	14	17	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170185	10.1371/journal.pone.0170185	http://dx.doi.org/10.1371/journal.pone.0170185			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI3QC	28107493	Green Published, gold, Green Submitted			2022-12-26	WOS:000392405300082
J	Navas, VH; Cuche, C; Alcover, A; Di Bartolo, V				Navas, Victor H.; Cuche, Celine; Alcover, Andres; Di Bartolo, Vincenzo			Serine Phosphorylation of SLP76 Is Dispensable for T Cell Development but Modulates Helper T Cell Function	PLOS ONE			English	Article							ADAPTER PROTEIN; CBL-B; ACTIVATION; RECEPTOR; LAT; LINKER; PLC-GAMMA-1; RESISTANT; SUBSTRATE; SLP-76	The adapter protein SLP76 is a key orchestrator of T cell receptor (TCR) signal transduction. We previously identified a negative feedback loop that modulates T cell activation, involving phosphorylation of Ser376 of SLP76 by the hematopoietic progenitor kinase 1 (HPK1). However, the physiological relevance of this regulatory mechanism was still unknown. To address this question, we generated a SLP76-S376A-expressing knock-in mouse strain and investigated the effects of Ser376 mutation on T cell development and function. We report here that SLP76-S376A-expressing mice exhibit normal thymocyte development and no detectable phenotypic alterations in mature T cell subsets or other lymphoid and myeloid cell lineages. Biochemical analyses revealed that mutant T cells were hypersensitive to TCR stimulation. Indeed, phosphorylation of several signaling proteins, including SLP76 itself, phospholipase Cy1 and the protein kinases AKT and ERK1/2, was increased. These modifications correlated with increased Th1-type and decreased Th2-type cytokine production by SLP76-S376A T cells, but did not result in significant changes of proliferative capacity nor activation-induced cell death susceptibility. Hence, our results reveal that SLP76-Ser376 phosphorylation does not mediate all HPK1-dependent regulatory effects in T cells but it fine-tunes helper T cell responses.	[Navas, Victor H.; Cuche, Celine; Alcover, Andres; Di Bartolo, Vincenzo] Inst Pasteur, Lymphocyte Cell Biol Unit, Paris, France; [Navas, Victor H.; Cuche, Celine; Alcover, Andres; Di Bartolo, Vincenzo] CNRS, URA 1961, Paris, France; [Navas, Victor H.] Univ Paris 06, Paris, France; [Cuche, Celine; Alcover, Andres; Di Bartolo, Vincenzo] INSERM, U1221, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Di Bartolo, V (corresponding author), Inst Pasteur, Lymphocyte Cell Biol Unit, Paris, France.; Di Bartolo, V (corresponding author), CNRS, URA 1961, Paris, France.; Di Bartolo, V (corresponding author), INSERM, U1221, Paris, France.	vincenzo.di-bartolo@pasteur.fr	Di Bartolo, Vincenzo/AAL-6834-2020	Di Bartolo, Vincenzo/0000-0002-5453-947X; Alcover, Andres/0000-0002-9507-3450	French Ministry of Higher Education and Research; Institut Pasteur; French National Center for Scientific Research; Ligue Contre le Cancer - Comite de Paris [RS12/75-107, RS13/75-30]; Agence National de la Recherche [ANR-11-BSV3-0025]	French Ministry of Higher Education and Research; Institut Pasteur(European Commission); French National Center for Scientific Research(Centre National de la Recherche Scientifique (CNRS)); Ligue Contre le Cancer - Comite de Paris(Ligue nationale contre le cancer); Agence National de la Recherche(French National Research Agency (ANR))	V.N. was funded by a doctoral contract of the French Ministry of Higher Education and Research. This work was funded by grants from the Institut Pasteur (www.pasteur.fr), the French National Center for Scientific Research (www.cnrs.fr), the Ligue Contre le Cancer - Comite de Paris (www.ligue-cancer.net; grants nr. RS12/75-107 and RS13/75-30 to V.D.B.), the Agence National de la Recherche (www.agence-nationale-recherche.fr; grant nr. ANR-11-BSV3-0025 to A.A). French National Institute of Health and Medical Research (Inserm); website: www.inserm.fr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzabin S, 2010, CANCER IMMUNOL IMMUN, V59, P419, DOI 10.1007/s00262-009-0761-0; Balagopalan L, 2011, P NATL ACAD SCI USA, V108, P2885, DOI 10.1073/pnas.1007098108; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; Di Bartolo V, 2007, J EXP MED, V204, P681, DOI 10.1084/jem.20062066; Ebinu JO, 2000, BLOOD, V95, P3199; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; Kuhne MR, 2003, J IMMUNOL, V171, P860, DOI 10.4049/jimmunol.171.2.860; Lasserre R, 2011, J CELL BIOL, V195, P839, DOI 10.1083/jcb.201103105; Liu SK, 1998, ONCOGENE, V17, P3073, DOI 10.1038/sj.onc.1202337; Lorenz U, 2009, IMMUNOL REV, V228, P342, DOI 10.1111/j.1600-065X.2008.00760.x; Michie AM, 1999, J EXP MED, V190, P1647, DOI 10.1084/jem.190.11.1647; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Rodriguez-Pena AB, 2015, GENE THER, V22, P781, DOI 10.1038/gt.2015.48; Sauer K, 2001, J BIOL CHEM, V276, P45207, DOI 10.1074/jbc.M106811200; Shui JW, 2007, NAT IMMUNOL, V8, P84, DOI 10.1038/ni1416; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Stromnes IM, 2010, J CLIN INVEST, V120, P3722, DOI 10.1172/JCI41991; Thien CBF, 2005, BIOCHEM J, V391, P153, DOI 10.1042/BJ20050892; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yamane H, 2013, IMMUNOL REV, V252, P12, DOI 10.1111/imr.12032; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zhou PH, 2014, NATURE, V506, P52, DOI 10.1038/nature12988	27	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170396	10.1371/journal.pone.0170396	http://dx.doi.org/10.1371/journal.pone.0170396			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107427	Green Published, gold, Green Submitted			2022-12-26	WOS:000392405300126
J	Ziv, E; Tice, JA; Sprague, B; Vachon, CM; Cummings, SR; Kerlikowske, K				Ziv, Elad; Tice, Jeffrey A.; Sprague, Brian; Vachon, Celine M.; Cummings, Steven R.; Kerlikowske, Karla			Using Breast Cancer Risk Associated Polymorphisms to Identify Women for Breast Cancer Chemoprevention	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; POSTMENOPAUSAL WOMEN; COMMON VARIANT; PREDICTION; TAMOXIFEN; PREVENTION; RALOXIFENE; DENSITY; REDUCTION	Background Breast cancer can be prevented with selective estrogen receptor modifiers (SERMs) and aromatase inhibitors (AIs). The US Preventive Services Task Force recommends that women with a 5-year breast cancer risk >= 3% consider chemoprevention for breast cancer. More than 70 single nucleotide polymorphisms (SNPs) have been associated with breast cancer. We sought to determine how to best integrate risk information from SNPs with other risk factors to risk stratify women for chemoprevention. Methods We used the risk distribution among women ages 35 -69 estimated by the Breast Cancer Surveillance Consortium (BCSC) risk model. We modeled the effect of adding 70 SNPs to the BCSC model and examined how this would affect how many women are reclassified above and below the threshold for chemoprevention. Results We found that most of the benefit of SNP testing a population is achieved by testing a modest fraction of the population. For example, if women with a 5-year BCSC risk of >2.0% are tested (similar to 21% of all women), similar to 75% of the benefit of testing all women (shifting women above or below 3% 5-year risk) would be derived. If women with a 5-year risk of > 1.5% are tested (similar to 36% of all women), similar to 90% of the benefit of testing all women would be derived. Conclusion SNP testing is effective for reclassification of women for chemoprevention, but is unlikely to reclassify women with <1.5% 5-year risk. These results can be used to implement an efficient two-step testing approach to identify high risk women who may benefit from chemoprevention.	[Ziv, Elad; Tice, Jeffrey A.; Kerlikowske, Karla] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Ziv, Elad] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Ziv, Elad] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Tice, Jeffrey A.; Kerlikowske, Karla] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Sprague, Brian] Univ Vermont, Dept Surg, Burlington, VT 05405 USA; [Sprague, Brian] Univ Vermont, Ctr Canc, Burlington, VT USA; [Vachon, Celine M.] Mayo Clin, Coll Med, Dept Hlth Sci Res, Div Epidemiol, Rochester, MN USA; [Cummings, Steven R.] Calif Pacific Med Ctr, Res Inst, San Francisco Coordinating Ctr, San Francisco, CA USA; [Kerlikowske, Karla] Univ Calif San Francisco, Gen Internal Med Sect, Dept Vet Affairs, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Vermont; University of Vermont; Mayo Clinic; California Pacific Medical Center; California Pacific Medical Center Research Institute; University of California System; University of California San Francisco	Ziv, E (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Ziv, E (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.; Ziv, E (corresponding author), Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA.	elad.ziv@ucsf.edu		Tice, Jeffrey/0000-0002-9857-2028	National Cancer Institute [P01 CA154292, HHSN261201100031C, U54 CA163303, K24CA169004]; NATIONAL CANCER INSTITUTE [K24CA169004, P01CA154292, U54CA163303] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute-funded Breast Cancer Surveillance Consortium (P01 CA154292 and HHSN261201100031C) and additional grants from the National Cancer Institute U54 CA163303 and K24CA169004. The National Cancer Institute URL is www.cancer.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Antoniou AC, 2010, NAT GENET, V42, P885, DOI 10.1038/ng.669; Bambhroliya A, 2015, J NATL COMPR CANC NE, V13, P927, DOI 10.6004/jnccn.2015.0107; Bojesen SE, 2013, NAT GENET, V45, P371, DOI 10.1038/ng.2566; Brentnall AR, 2014, BRIT J CANCER, V110, P827, DOI 10.1038/bjc.2013.747; Cai QY, 2014, NAT GENET, V46, P886, DOI 10.1038/ng.3041; Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189; Cummings SR, 2009, JNCI-J NATL CANCER I, V101, P384, DOI 10.1093/jnci/djp018; Darabi H, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3110; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Fejerman L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6260; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gail MH, 2009, J NATL CANCER I, V101, P959, DOI 10.1093/jnci/djp130; Garcia-Closas M, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju305; Garcia-Closas M, 2013, NAT GENET, V45, P392, DOI 10.1038/ng.2561; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Goss PE, 2011, NEW ENGL J MED, V364, P2381, DOI 10.1056/NEJMoa1103507; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; Kaplan CP, 2012, BREAST CANCER RES TR, V133, P357, DOI 10.1007/s10549-012-1960-5; Lindstrom S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6303; Long JR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002532; Lu Q, 2008, AM J HUM GENET, V82, P641, DOI 10.1016/j.ajhg.2007.12.025; Lu Q, 2010, BIOMETRICS, V66, P586, DOI 10.1111/j.1541-0420.2009.01278.x; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Mavaddat N, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv036; Michailidou K, 2015, NAT GENET, V47, P373, DOI 10.1038/ng.3242; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Milne RL, 2014, HUM MOL GENET, V23, P1934, DOI 10.1093/hmg/ddt581; Moyer VA, 2013, ANN INTERN MED, V159, P698, DOI [10.7326/0003-4819-159-10-201311190-00717, 10.7326/0003-4819-159-10-201311190-00718]; Orr N, 2012, NAT GENET, V44, P1182, DOI 10.1038/ng.2417; Padhukasahasram B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014338; Shieh Y, 2016, BREAST CANCER RES TR, V159, P513, DOI 10.1007/s10549-016-3953-2; Siddiq A, 2012, HUM MOL GENET, V21, P5373, DOI 10.1093/hmg/dds381; So HC, 2011, AM J HUM GENET, V88, P548, DOI 10.1016/j.ajhg.2011.04.001; Tice JA, 2008, ANN INTERN MED, V148, P337, DOI 10.7326/0003-4819-148-5-200803040-00004; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Tyrer J, 2004, STAT MED, V23, P1111, DOI 10.1002/sim.1668; Vachon CM, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju397; Vachon CM, 2015, BREAST CANCER RES TR, V149, P517, DOI 10.1007/s10549-014-3175-4; Wacholder S, 2010, NEW ENGL J MED, V362, P986, DOI 10.1056/NEJMoa0907727; Waters EA, 2012, BREAST CANCER RES TR, V134, P875, DOI 10.1007/s10549-012-2089-2; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	43	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0168601	10.1371/journal.pone.0168601	http://dx.doi.org/10.1371/journal.pone.0168601			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107349	Green Published, gold, Green Submitted			2022-12-26	WOS:000392405300014
J	Harrison, RL; Rowley, DL; Mowery, J; Bauchan, GR; Theilmann, DA; Rohrmann, GF; Erlandson, MA				Harrison, Robert L.; Rowley, Daniel L.; Mowery, Joseph; Bauchan, Gary R.; Theilmann, David A.; Rohrmann, George F.; Erlandson, Martin A.			The Complete Genome Sequence of a Second Distinct Betabaculovirus from the True Armyworm, Mythimna unipuncta	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; POLYMERASE-CHAIN-REACTION; PHYLOGENETIC ANALYSIS; BACULOVIRUS; DNA; GENE; PROTEIN; IDENTIFICATION; EVOLUTION; ENHANCIN	The betabaculovirus originally called Pseudaletia (Mythimna) sp. granulovirus #8 (MyspGV#8) was examined by electron microscopy, host barcoding PCR, and determination of the nucleotide sequence of its genome. Scanning and transmission electron microscopy revealed that the occlusion bodies of MyspGV#8 possessed the characteristic size range and morphology of betabaculovirus granules. Barcoding PCR using cytochrome oxidase I primers with DNA from the MyspGV#8 collection sample confirmed that it had been isolated from the true army worm, Mythimna unipuncta (Lepidoptera: Noctuidae) and therefore was renamed MyunGV#8. The MyunGV#8 genome was found to be 144,673 bp in size with a nucleotide distribution of 49.9% G+C, which was significantly smaller and more GC-rich than the genome of Pseudaletia unipuncta granulovirus H (PsunGV-H), another M. unipuncta betabaculovirus. A phylogeny based on concatenated baculovirus core gene amino acid sequence alignments placed MyunGV#8 in Glade a of genus Betabaculovirus. Kimura-2-parameter nucleotide distances suggested that MyunGV#8 represents a virus species different and distinct from other species of Betabaculovirus. Among the 153 ORFs annotated in the MyunGV#8 genome, four ORFs appeared to have been obtained from or donated to the alphabaculovirus lineage represented by Leucania separata nucleopolyhedrovirus AH1 (LeseNPV-AH1) during co-infection of Mythimna sp. larvae. A set of 33 ORFs was identified that appears only in other Glade a betabaculovirus isolates. This Glade a-specific set includes an ORF that encodes a polypeptide sequence containing a CIDE_N domain, which is found in caspase-activated DNAse/DNA fragmentation factor (CAD/DFF) proteins. CAD/DFF proteins are involved in digesting DNA during apoptosis.	[Harrison, Robert L.; Rowley, Daniel L.] ARS, Invas Insect Biocontrol & Behav Lab, Beltsville Agr Res Ctr, USDA, Beltsville, MD 20705 USA; [Mowery, Joseph; Bauchan, Gary R.] ARS, Electron & Confocal Microscopy Unit, Beltsville Agr Res Ctr, USDA, Beltsville, MD USA; [Theilmann, David A.] Agr & Agri Food Canada, Summerland Res & Dev Ctr, Summerland, BC, Canada; [Rohrmann, George F.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Erlandson, Martin A.] Agr & Agri Food Canada, Saskatoon Res & Dev Ctr, Saskatoon, SK, Canada	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Agriculture & Agri Food Canada; Oregon State University; Agriculture & Agri Food Canada	Harrison, RL (corresponding author), ARS, Invas Insect Biocontrol & Behav Lab, Beltsville Agr Res Ctr, USDA, Beltsville, MD 20705 USA.	Robert.L.Harrison@ars.usda.gov	Theilmann, David A/N-6024-2017; Bauchan, Gary/ABH-3800-2020	Theilmann, David A/0000-0002-4910-3057; Harrison, Robert/0000-0002-8348-3874; Rowley, Daniel/0000-0002-1255-8330; Bauchan, Gary/0000-0003-3060-7666				Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Ardisson-Araujo DMP, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2408-9; Baldo AM, 1999, J VIROL, V73, P7710, DOI 10.1128/JVI.73.9.7710-7721.1999; Bideshi DK, 2003, J GEN VIROL, V84, P2531, DOI 10.1099/vir.0.19256-0; Bolton SJ, 2014, J NAT HIST, V48, P1359, DOI 10.1080/00222933.2013.859318; Byers NM, 2016, J VIROL, V90, P533, DOI 10.1128/JVI.02320-15; Cuartas PE, 2015, VIRUSES-BASEL, V7, P394, DOI 10.3390/v7010394; Eckhart L, 2007, BIOCHEM BIOPH RES CO, V356, P293, DOI 10.1016/j.bbrc.2007.02.122; Fukushima K, 2002, J MOL BIOL, V321, P317, DOI 10.1016/S0022-2836(02)00588-0; Greenstone MH, 2005, MOL ECOL, V14, P3247, DOI 10.1111/j.1365-294X.2005.02628.x; GUARINO LA, 1986, J VIROL, V60, P215, DOI 10.1128/JVI.60.1.215-223.1986; Guo FB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-9; Harrison RL, 2008, J GEN VIROL, V89, P775, DOI 10.1099/vir.0.83566-0; Harrison RL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160389; Harrison RL, 2014, J INVERTEBR PATHOL, V116, P27, DOI 10.1016/j.jip.2013.12.005; Harrison RL, 2009, VIRUS GENES, V38, P155, DOI 10.1007/s11262-008-0297-y; Hayakawa T, 1999, VIROLOGY, V262, P277, DOI 10.1006/viro.1999.9894; Herniou EA, 2012, VIRUS TAXONOMY, P163; Hilton S, 2008, ARCH VIROL, V153, P1527, DOI 10.1007/s00705-008-0148-0; Hilton S, 2007, J GEN VIROL, V88, P1496, DOI 10.1099/vir.0.82760-0; Hu ZH, 1998, J GEN VIROL, V79, P2841, DOI 10.1099/0022-1317-79-11-2841; IGNOFFO C M, 1968, Bulletin of the Entomological Society of America, V14, P265; Iyer LM, 2002, GENOME BIOL, V3; Garavaglia MJ, 2012, J VIROL, V86, P12069, DOI 10.1128/JVI.01873-12; Jehle JA, 2006, VIROLOGY, V346, P180, DOI 10.1016/j.virol.2005.10.032; Keathley CP, 2012, BIOL CONTROL, V61, P147, DOI 10.1016/j.biocontrol.2012.01.013; Lacey LA, 2015, J INVERTEBR PATHOL, V132, P1, DOI 10.1016/j.jip.2015.07.009; Lapointe R, 2004, J VIROL, V78, P6439, DOI 10.1128/JVI.78.12.6439-6448.2004; Lepore LS, 1996, J INVERTEBR PATHOL, V68, P131, DOI 10.1006/jipa.1996.0070; Li JZ, 2007, DIABETES, V56, P2523, DOI 10.2337/db07-0040; Li LL, 2002, VIROLOGY, V297, P226, DOI 10.1006/viro.2002.1411; Lugovskoy AA, 1999, CELL, V99, P747, DOI 10.1016/S0092-8674(00)81672-4; Luque T, 2001, J GEN VIROL, V82, P2531, DOI 10.1099/0022-1317-82-10-2531; Magni G, 2004, CELL MOL LIFE SCI, V61, P19, DOI 10.1007/s00018-003-3161-1; Miele Solange Ana Belen, 2011, Int J Evol Biol, V2011, P379424, DOI 10.4061/2011/379424; Mukawa S, 2008, J GEN VIROL, V89, P915, DOI 10.1099/vir.0.83365-0; Nagamine T, 2008, J VIROL, V82, P6409, DOI 10.1128/JVI.00490-08; Peng JX, 1999, J INSECT PHYSIOL, V45, P159, DOI 10.1016/S0022-1910(98)00110-3; Ardisson-Araujo DMP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-856; Possee RD, 1997, BACULOVIRUSES, P109; ROELVINK PW, 1995, J GEN VIROL, V76, P2693, DOI 10.1099/0022-1317-76-11-2693; Rohrmann GF, 2013, VIRUS GENES, V47, P357, DOI 10.1007/s11262-013-0951-x; Rohrmann GF, 2013, J INVERTEBR PATHOL, V114, P61, DOI 10.1016/j.jip.2013.04.005; Rohrmann GF, 2013, BACULOVIRUS MOL BIOL, V3rd; Rohrmann GF, 2015, GENOME ANNOUNC, V3; Rohrmann GF, 2014, GENOME ANNOUNC, V2; Samejima K, 1998, J CELL BIOL, V143, P225, DOI 10.1083/jcb.143.1.225; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Suetake T, 2000, J BIOL CHEM, V275, P17929, DOI 10.1074/jbc.C000184200; SUMMERS MD, 1987, TX AG EXPT STN B, V1555; Szewczyk B, 2011, PESTICIDES - FORMULATIONS, EFFECTS, FATE, P25; TANADA Y, 1985, J INVERTEBR PATHOL, V45, P125, DOI 10.1016/0022-2011(85)90001-1; TANADA Y., 1959, JOUR INSECT PATHOL, V1, P197; THEILMANN DA, 1992, VIROLOGY, V187, P97, DOI 10.1016/0042-6822(92)90298-4; Theze J, 2015, VIRUSES-BASEL, V7, P1960, DOI 10.3390/v7041960; Trupkiewicz JG, 2016, VET PARASITOL, V216, P52, DOI 10.1016/j.vetpar.2015.11.008; van Oers MM, 2007, CURR DRUG TARGETS, V8, P1051, DOI 10.2174/138945007782151333; van Oers MM, 2015, J GEN VIROL, V96, P6, DOI 10.1099/vir.0.067108-0; Wang P, 1997, P NATL ACAD SCI USA, V94, P6977, DOI 10.1073/pnas.94.13.6977; Widlak P, 2009, CELL MOL LIFE SCI, V66, P263, DOI 10.1007/s00018-008-8472-9; Wu CY, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-159	62	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170510	10.1371/journal.pone.0170510	http://dx.doi.org/10.1371/journal.pone.0170510			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103323	Green Published, Green Submitted, gold			2022-12-26	WOS:000392381100070
J	Lomonosova, AV; Ulitin, AB; Kazakov, AS; Mirzabekov, TA; Permyakov, EA; Permyakov, SE				Lomonosova, Anna V.; Ulitin, Andrei B.; Kazakov, Alexei S.; Mirzabekov, Tajib A.; Permyakov, Eugene A.; Permyakov, Sergei E.			Derivative of Extremophilic 50S Ribosomal Protein L35Ae as an Alternative Protein Scaffold	PLOS ONE			English	Article							BINDING-PROTEINS; MOLECULAR RECOGNITION; ANTIBODIES; STABILITY; AFFINITY; DARPINS; IDENTIFICATION; THERAPEUTICS; GENERATION; DISCOVERY	Small antibody mimetics, or alternative binding proteins (ABPs), extend and complement antibody functionality with numerous applications in research, diagnostics and therapeutics. Given the superiority of ABPs, the last two decades have witnessed development of dozens of alternative protein scaffolds (APSs) for the design of ABPs. Proteins from extremophiles with their high structural stability are especially favorable for APS design. Here, a 10X mutant of the 50S ribosomal protein L35Ae from hyperthermophilic archaea Pyrococcus horikoshii has been probed as an APS. A phage display library of L35Ae 10X was generated by randomization of its three CDR-like loop regions (repertoire size of 2x10(8)). Two L35Ae 10X variants specific to a model target, the hen egg-white lysozyme (HEL), were isolated from the resulting library using phage display. The affinity of these variants (L4 and L7) to HEL ranges from 0.10 mu M to 1.6 mu M, according to surface plasmon resonance data. While L4 has 1-2 orders of magnitude lower affinity to HEL homologue, bovine a-lactalbumin (BLA), L7 is equally specific to HEL and BLA. The reference L35Ae 10X is non-specific to both HEL and BLA. L4 and L7 are more resistant to denaturation by guanidine hydrochloride compared to the reference L35Ae 10X (mid-transition concentration is higher by 0.1-0.5 M). Chemical crosslinking experiments reveal an increased propensity of L4 and L7 to multimerization. Overall, the CDR-like loop regions of L35Ae 10X represent a proper interface for generation of functional ABPs. Hence, L35Ae is shown to extend the growing family of protein scaffolds dedicated to the design of novel binding proteins.	[Lomonosova, Anna V.; Kazakov, Alexei S.; Permyakov, Eugene A.; Permyakov, Sergei E.] Russian Acad Sci, Inst Biol Instrumentat, Pushchino, Moscow Region, Russia; [Ulitin, Andrei B.; Mirzabekov, Tajib A.] Antherix, Pushchino, Moscow Region, Russia; [Mirzabekov, Tajib A.] Biomirex Inc, Watertown, MA USA	Russian Academy of Sciences		Permyakov.S@gmail.com	Permyakov, Sergei/O-1386-2019; Permyakov, Sergei E./B-8156-2011; Lomonosova, Anna/M-9201-2014; Kazakov, Alexey S./M-9129-2014	Permyakov, Sergei/0000-0003-4086-3137; Permyakov, Sergei E./0000-0003-4086-3137; Kazakov, Alexey S./0000-0002-1586-7649; Lomonosova, Anna/0000-0003-2134-0277; Ulitin, Andrey/0000-0001-8467-4472	Program of the Russian Academy of Sciences Fundamental science for medicine (SEP); Russian Foundation for Basic Research [14-44-03604]; Ministry of Investments and Innovations of the Moscow region (SEP)	Program of the Russian Academy of Sciences Fundamental science for medicine (SEP); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Ministry of Investments and Innovations of the Moscow region (SEP)	This work was supported by a grant from the Program of the Russian Academy of Sciences Fundamental science for medicine (SEP) and grant 14-44-03604 from the Russian Foundation for Basic Research and the Ministry of Investments and Innovations of the Moscow region (SEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of	[Anonymous], 1985, BIOCH J, V229, P281; Baloch AR, 2016, CRIT REV BIOTECHNOL, V36, P268, DOI 10.3109/07388551.2014.958431; BEATTY JD, 1987, J IMMUNOL METHODS, V100, P173, DOI 10.1016/0022-1759(87)90187-6; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Beehar G, 2013, PROTEIN ENG DES SEL, V26, P267, DOI 10.1093/protein/gzs106; Beste G, 1999, P NATL ACAD SCI USA, V96, P1898, DOI 10.1073/pnas.96.5.1898; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Clark MA., 2002, STANDARD PROTOCOLS C; Correa A., 2014, PLOS ONE, V9; Farrar JE, 2008, BLOOD, V112, P1582, DOI 10.1182/blood-2008-02-140012; Friedman M, 2009, BIOTECHNOL APPL BIOC, V53, P1, DOI 10.1042/BA20080287; Galan A, 2016, MOL BIOSYST; Gebauer M, 2015, AAPS ADV PHARM SCI, V19, P221, DOI 10.1007/978-1-4939-2543-8_13; Gebauer M, 2009, CURR OPIN CHEM BIOL, V13, P245, DOI 10.1016/j.cbpa.2009.04.627; Gera N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048928; Gera N, 2011, J MOL BIOL, V409, P601, DOI 10.1016/j.jmb.2011.04.020; Hey T, 2005, TRENDS BIOTECHNOL, V23, P514, DOI 10.1016/j.tibtech.2005.07.007; Hosse RJ, 2006, PROTEIN SCI, V15, P14, DOI 10.1110/ps.051817606; HOZUMI N, 1993, CANCER INVEST, V11, P714, DOI 10.3109/07357909309046945; Jost C, 2014, CURR OPIN STRUC BIOL, V27, P102, DOI 10.1016/j.sbi.2014.05.011; Kawarabayasi Y, 1998, DNA Res, V5, P55, DOI 10.1093/dnares/5.2.55; Koide A, 1998, J MOL BIOL, V284, P1141, DOI 10.1006/jmbi.1998.2238; Ladenstein R, 1998, Adv Biochem Eng Biotechnol, V61, P37; Lipovsek D, 2011, PROTEIN ENG DES SEL, V24, P3, DOI 10.1093/protein/gzq097; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Lomonosova AV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134906; Lopez CD, 2002, CANCER LETT, V180, P195, DOI 10.1016/S0304-3835(02)00024-1; Luke KA, 2007, FEBS J, V274, P4023, DOI 10.1111/j.1742-4658.2007.05955.x; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Mouratou B, 2007, P NATL ACAD SCI USA, V104, P17983, DOI 10.1073/pnas.0702963104; Nygren PA, 2004, J IMMUNOL METHODS, V290, P3, DOI 10.1016/j.jim.2004.04.006; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Parizek P, 2012, ACS CHEM BIOL, V7, P1356, DOI 10.1021/cb3001167; Pluckthun A, 2015, ANNU REV PHARMACOL, V55, P489, DOI 10.1146/annurev-pharmtox-010611-134654; Qasba PK, 1997, CRIT REV BIOCHEM MOL, V32, P255, DOI 10.3109/10409239709082574; Ribatti D, 2014, IMMUNOL LETT, V161, P96, DOI 10.1016/j.imlet.2014.05.010; Richter A, 2014, FEBS LETT, V588, P213, DOI 10.1016/j.febslet.2013.11.006; Saerens D, 2008, CURR OPIN PHARMACOL, V8, P600, DOI 10.1016/j.coph.2008.07.006; Skerra A, 2000, BBA-PROTEIN STRUCT M, V1482, P337, DOI 10.1016/S0167-4838(00)00145-X; Skerra A, 2000, J MOL RECOGNIT, V13, P167, DOI 10.1002/1099-1352(200007/08)13:4<167::AID-JMR502>3.3.CO;2-0; Skerra A, 2007, CURR OPIN BIOTECH, V18, P295, DOI 10.1016/j.copbio.2007.04.010; Snyder DA, 2012, PROTEINS, V80, P1901, DOI 10.1002/prot.24071; Souriau C, 2003, EXPERT OPIN BIOL TH, V3, P305, DOI 10.1517/eobt.3.2.305.21159; Tsibane T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003067; ULBRICH N, 1980, J BIOL CHEM, V255, P7010; *UNIPROT CONS, 2010, NUCL ACIDS RES, V0038; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weidle UH, 2013, CANCER GENOM PROTEOM, V10, P155; Worn A, 1999, BIOCHEMISTRY-US, V38, P8739, DOI 10.1021/bi9902079; Wurch T, 2012, TRENDS BIOTECHNOL, V30, P575, DOI 10.1016/j.tibtech.2012.07.006	52	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170349	10.1371/journal.pone.0170349	http://dx.doi.org/10.1371/journal.pone.0170349			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103321	Green Submitted, gold, Green Published			2022-12-26	WOS:000392381100057
J	Huerga, H; Ferlazzo, G; Bevilacqua, P; Kirubi, B; Ardizzoni, E; Wanjala, S; Sitienei, J; Bonnet, M				Huerga, Helena; Ferlazzo, Gabriella; Bevilacqua, Paolo; Kirubi, Beatrice; Ardizzoni, Elisa; Wanjala, Stephen; Sitienei, Joseph; Bonnet, Maryline			Incremental Yield of Including Determine-TB LAM Assay in Diagnostic Algorithms for Hospitalized and Ambulatory HIV-Positive Patients in Kenya	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; LIPOARABINOMANNAN LAM; INFECTED ADULTS; XPERT MTB/RIF; URINE; CARE; PERFORMANCE; IMPACT	Background Determine-TB LAM assay is a urine point-of-care test useful for TB diagnosis in HIV-positive patients. We assessed the incremental diagnostic yield of adding LAM to algorithms based on clinical signs, sputum smear-microscopy, chest X-ray and Xpert MTB/RIF in HIV-positive patients with symptoms of pulmonary TB (PTB). Methods Prospective observational cohort of ambulatory (either severely ill or CD4< 200cells/mu l or with Body Mass Index<17Kg/m(2)) and hospitalized symptomatic HIV-positive adults in Kenya. Incremental diagnostic yield of adding LAM was the difference in the proportion of confirmed TB patients (positive Xpert or MTB culture) diagnosed by the algorithm with LAM compared to the algorithm without LAM. The multivariable mortality model was adjusted for age, sex, clinical severity, BMI, CD4, ART initiation, LAM result and TB confirmation. Results Among 474 patients included, 44.1% were severely ill, 69.6% had CD4< 200cells/mu l, 59.9% had initiated ART, 23.2% could not produce sputum. LAM, smear-microscopy, Xpert and culture in sputum were positive in 39.0% (185/474), 21.6% (76/352), 29.1% (102/350) and 39.7% (92/232) of the patients tested, respectively. Of 156 patients with confirmed TB, 65.4% were LAM positive. Of those classified as non-TB, 84.0% were LAM negative. Adding LAM increased the diagnostic yield of the algorithms by 36.6%, from 47.4% (95% CI: 39.4- 55.6) to 84.0% (95% CI: 77.3-89.4%), when using clinical signs and X-ray; by 19.9%, from 62.2% (95% CI: 54.1-69.8) to 82.1% (95% CI: 75.1-87.7), when using clinical signs and microscopy; and by 13.4%, from 74.4% (95% CI: 66.8-81.0) to 87.8% (95% CI: 81.6-92.5), when using clinical signs and Xpert. LAM positive patients had an increased risk of 2-months mortality (aOR: 2.7; 95% CI: 1.5-4.9). Conclusion LAM should be included in TB diagnostic algorithms in parallel to microscopy or Xpert request for HIV-positive patients either ambulatory (severely ill or CD4<200cells/mu l) or hospitalized. LAM allows same day treatment initiation in patients at higher risk of death and in those not able to produce sputum.	[Huerga, Helena; Bevilacqua, Paolo; Bonnet, Maryline] Epictr, Paris, France; [Ferlazzo, Gabriella; Ardizzoni, Elisa] Medecins Sans Frontieres, Paris, France; [Kirubi, Beatrice; Ardizzoni, Elisa] Inst Trop Med, Antwerp, Belgium; [Wanjala, Stephen] Medecins Sans Frontieres, Nairobi, Kenya; [Sitienei, Joseph] Minist Hlth, Nairobi, Kenya; [Bonnet, Maryline] INSERM, U1175, IRD UMI TransVIHMI 233, UM, Montpellier, France	Doctors Without Borders; Institute of Tropical Medicine (ITM); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Huerga, H (corresponding author), Epictr, Paris, France.	helena.huerga@epicentre.msf.org	Kirubi, Beatrice/HHS-5040-2022	Kirubi, Beatrice/0000-0002-6195-1876; Wanjala, Stephen/0000-0002-7001-0605	Medecins Sans Frontieres	Medecins Sans Frontieres	This study was funded by Medecins Sans Frontieres. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, ANN REP 2014; Bjerrum S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1151-1; Davis JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009859; Drain PK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006833; Drain PK, 2015, JAIDS-J ACQ IMM DEF, V68, P274, DOI 10.1097/QAI.0000000000000436; Gupta RK, 2015, AIDS, V29, P1987, DOI 10.1097/QAD.0000000000000802; Gupta-Wright A, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0603-9; Huerga H, 2010, INT J TUBERC LUNG D, V14, P611; Kerkhoff AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103285; Lawn SD, 2015, T ROY SOC TROP MED H, P180; Lawn SD, 2015, JAIDS-J ACQ IMM DEF, V69, pE144, DOI 10.1097/QAI.0000000000000672; Lawn SD, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-407; Lawn SD, 2013, LANCET INFECT DIS, V13, P349, DOI 10.1016/S1473-3099(13)70008-2; Lawn SD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-103; Lawn SD, 2012, CLIN INFECT DIS, V54, P1071, DOI 10.1093/cid/cir1039; Manabe YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101459; Mejia GI, 1999, INT J TUBERC LUNG D, V3, P138; Ministry of Health, 2014, KEN HIV EST; Nakiyingi L, 2014, J ACQUIR IMMUNE DEFI; Nakiyingi L, 2014, JAIDS-J ACQ IMM DEF, V66, P270, DOI 10.1097/QAI.0000000000000151; Peter JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054875; Peter J, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0967-z; Peter JG, 2016, LANCET, V387, P1187, DOI 10.1016/S0140-6736(15)01092-2; Shah M, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011420.pub2; Shah M, 2014, AIDS, V28, P1307, DOI 10.1097/QAD.0000000000000264; Talbot E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032876; van Cleeff MRA, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-111; World Health Organisation, 2015, THE USE OF LATERAL F, P74; World Health Organization, 2016, CONSOLIDATED GUIDELI, P480	29	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170976	10.1371/journal.pone.0170976	http://dx.doi.org/10.1371/journal.pone.0170976			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125693	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100013
J	Mansouri, S; Agartz, I; Ogren, SO; Patrone, C; Lundberg, M				Mansouri, Shiva; Agartz, Ingrid; Ogren, Sven-Oveo; Patrone, Cesare; Lundberg, Mathias			PACAP Protects Adult Neural Stem Cells from the Neurotoxic Effect of Ketamine Associated with Decreased Apoptosis, ER Stress and mTOR Pathway Activation	PLOS ONE			English	Article							POLYPEPTIDE PACAP; NEURODEGENERATIVE DISEASES; SUBVENTRICULAR ZONE; IN-VIVO; HIPPOCAMPAL-NEURONS; ALZHEIMERS-DISEASE; PROGENITOR CELLS; ANIMAL-MODEL; NEUROGENESIS; BRAIN	Ketamine administration is a well-established approach to mimic experimentally some aspects of schizophrenia. Adult neurogenesis dysregulation is associated with psychiatric disorders, including schizophrenia. The potential role of neurogenesis in the ketamineinduced phenotype is largely unknown. Recent results from human genetic studies have shown the pituitary adenylate cyclase-activating polypeptide (PACAP) gene is a risk factor for schizophrenia. Its potential role on the regulation of neurogenesis in experimental model of schizophrenia remains to be investigated. We aimed to determine whether ketamine affects the viability of adult neural stem cells (NSC). We also investigated whether the detrimental effect mediated by ketamine could be counteracted by PACAP. NSCs were isolated from the subventricular zone of the mouse and exposed to ketamine with/without PACAP. After 24 hours, cell viability, potential involvement of apoptosis, endoplasmic reticulum (ER) stress, mTOR and AMPA pathway activation were assessed by quantitative RT-PCR and Western blot analysis. We show that ketamine impairs NSC viability in correlation with increased apoptosis, ER stress and mTOR activation. The results also suggest that the effect of ketamine occurs via AMPA receptor activation. Finally, we show that PACAP counteracted the decreased NSC viability induced by ketamine via the specific activation of the PAC-1 receptor subtype. Our study shows that the NSC viability may be negatively affected by ketamine with putative importance for the development of a schizophrenia phenotype in the ketamine induced animal model of schizophrenia. The neuroprotective effect via PAC-1 activation suggests a potentially novel pharmacological target for the treatment of schizophrenia, via neurogenesis normalization.	[Mansouri, Shiva; Lundberg, Mathias] Karolinska Inst, Soder Sjukhuset, Dept Clin Sci & Educ, Stockholm, Sweden; [Agartz, Ingrid] Diakonhjemmet Hosp, Dept Psychiat Res, Oslo, Norway; [Agartz, Ingrid] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Agartz, Ingrid] Univ Oslo, Oslo Univ Hosp, NORMENT, Div Mental Hlth & Addict,KG Jebsen Ctr Psychosis, N-0316 Oslo, Norway; [Agartz, Ingrid] Univ Oslo, Inst Clin Med, N-0316 Oslo, Norway; [Agartz, Ingrid; Lundberg, Mathias] Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res, Stockholm, Sweden; [Ogren, Sven-Oveo] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Patrone, Cesare] Karolinska Inst, Soder Sjukhuset, Internal Med, Dept Clin Sci & Educ, Stockholm, Sweden	Karolinska Institutet; Sodersjukhuset Hospital; Diakonhjemmet Hospital; Karolinska Institutet; University of Oslo; University of Oslo; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Sodersjukhuset Hospital	Mansouri, S (corresponding author), Karolinska Inst, Soder Sjukhuset, Dept Clin Sci & Educ, Stockholm, Sweden.	shiva.mansouri@ki.se			Anders Paulssons gavor fond [D0042]; Swedish research council FORMAS	Anders Paulssons gavor fond; Swedish research council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	Support was provided by: 1) Anders Paulssons gavor fond [Grant number: D0042]; 2) "Swedish research council FORMAS". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous D.N., 2015, COLD SPRING HARB PER, V7; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Ayalew M, 2012, MOL PSYCHIATR, V17, P887, DOI 10.1038/mp.2012.37; Becker A, 2003, PROG NEURO-PSYCHOPH, V27, P687, DOI 10.1016/S0278-5846(03)00080-0; Bertilsson G, 2008, J NEUROSCI RES, V86, P326, DOI 10.1002/jnr.21483; Bosnjak ZJ, 2012, CURR DRUG SAF, V7, P106, DOI 10.2174/157488612802715663; Bourgault S, 2009, CURR MED CHEM, V16, P4462, DOI 10.2174/092986709789712899; Braun SMG, 2014, DEVELOPMENT, V141, P1983, DOI 10.1242/dev.104596; Brenneman DE, 2007, PEPTIDES, V28, P1720, DOI 10.1016/j.peptides.2007.04.002; Cadet JL, 2005, NEUROTOX RES, V8, P199, DOI 10.1007/BF03033973; COHEN ML, 1973, ANESTHESIOLOGY, V39, P370, DOI 10.1097/00000542-197310000-00003; Costa L, 2009, HIPPOCAMPUS, V19, P99, DOI 10.1002/hipo.20488; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; Curtis MA, 2007, NAT REV NEUROSCI, V8, P712, DOI 10.1038/nrn2216; Dickerson J, 2006, NEUROPSYCHOPHARMACOL, V31, P1420, DOI 10.1038/sj.npp.1300878; Dong CX, 2014, BIRTH DEFECTS RES B, V101, P355, DOI 10.1002/bdrb.21119; Dong CX, 2012, CRIT CARE MED, V40, P2407, DOI 10.1097/CCM.0b013e318253563c; Duncan EJ, 2001, NEUROPSYCHOPHARMACOL, V25, P72, DOI 10.1016/S0893-133X(00)00240-2; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; Ettinger U, 2015, SCHIZOPHRENIA BULL, V41, pS417, DOI 10.1093/schbul/sbu190; GARTHWAITE G, 1991, EUR J NEUROSCI, V3, P715, DOI 10.1111/j.1460-9568.1991.tb01668.x; Gilda JE, 2013, ANAL BIOCHEM, V440, P186, DOI 10.1016/j.ab.2013.05.027; Hashimoto H, 2001, P NATL ACAD SCI USA, V98, P13355, DOI 10.1073/pnas.231094498; Hashimoto R, 2007, MOL PSYCHIATR, V12, P1026, DOI 10.1038/sj.mp.4001982; Heckers S, 2002, J NEURAL TRANSM, V109, P891, DOI 10.1007/s007020200073; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Keilhoff G, 2004, NEUROSCIENCE, V126, P591, DOI 10.1016/j.neuroscience.2004.03.039; Kempermann G, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018812; Koga M, 2010, PSYCHIAT GENET, V20, P123, DOI 10.1097/YPG.0b013e32833a1f52; Lamine A, 2016, NEUROPHARMACOLOGY, V108, P440, DOI 10.1016/j.neuropharm.2015.05.014; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Mak YT, 2010, MICROSC RES TECHNIQ, V73, P195, DOI 10.1002/jemt.20774; Makela J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011091; Mansouri S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156867; Mansouri S, 2013, J NEUROCHEM, V127, P209, DOI 10.1111/jnc.12396; Mansouri S, 2012, J NEUROSCI RES, V90, P759, DOI 10.1002/jnr.22803; Matsttzaki S, 2008, EXPERT OPIN THER TAR, V12, P1097, DOI [10.1517/14728220802321783, 10.1517/14728222.12.9.1097 ]; Matsuyama S, 2003, NEUROREPORT, V14, P2095, DOI 10.1097/00001756-200311140-00017; Matus S, 2011, CURR OPIN CELL BIOL, V23, P239, DOI 10.1016/j.ceb.2011.01.003; Mercer A, 2004, J NEUROSCI RES, V76, P205, DOI 10.1002/jnr.20038; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Miyamoto S, 2001, BRAIN RES, V894, P167, DOI 10.1016/S0006-8993(01)01991-6; Moberg PJ, 1999, NEUROPSYCHOPHARMACOL, V21, P325, DOI 10.1016/S0893-133X(99)00019-6; Nicot A, 2004, J NEUROSCI, V24, P8786, DOI 10.1523/JNEUROSCI.1910-04.2004; Ohta S, 2006, J NEUROSCI RES, V84, P1177, DOI 10.1002/jnr.21026; Ohtaki H, 2008, J MOL NEUROSCI, V36, P16, DOI 10.1007/s12031-008-9077-3; Otto C, 2001, MOL BRAIN RES, V92, P78, DOI 10.1016/S0169-328X(01)00153-X; Park SW, 2014, INT J NEUROPSYCHOPH, V17, P1831, DOI 10.1017/S1461145714000534; Reglodi D, 2011, CURR PHARM DESIGN, V17, P962, DOI 10.2174/138161211795589355; Rodriguez JJ, 2009, NEUROREPORT, V20, P907, DOI 10.1097/WNR.0b013e32832be77d; Ruan L, 2013, PROG NEUROBIOL; Schobel SA, 2013, NEURON, V78, P81, DOI 10.1016/j.neuron.2013.02.011; Schoenfeld TJ, 2014, NEUROPSYCHOPHARMACOL; Shiva D V Mansouri, 2014, J DIABETES, V5; Soares MBP, 1998, J IMMUNOL, V160, P1811; Tanaka K, 2006, J NEUROSCI, V26, P5091, DOI 10.1523/JNEUROSCI.4376-05.2006; Tang GM, 2014, NEURON, V83, P1131, DOI 10.1016/j.neuron.2014.07.040; Toro CT, 2007, SCHIZOPHR RES, V90, P1, DOI 10.1016/j.schres.2006.09.030; TSAI GC, 1995, ARCH GEN PSYCHIAT, V52, P829; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Vranken JH, 2005, PAIN, V117, P231, DOI 10.1016/j.pain.2005.06.014; Yaksh TL, 2008, ANESTHESIOLOGY, V108, P938, DOI 10.1097/ALN.0b013e31816c902a; Ziabreva I, 2006, J PSYCHOSOM RES, V61, P311, DOI 10.1016/j.jpsychores.2006.07.017	67	21	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170496	10.1371/journal.pone.0170496	http://dx.doi.org/10.1371/journal.pone.0170496			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125634	gold, Green Published			2022-12-26	WOS:000396176100100
J	Martinez, CM; Duplisea, DE; Cerrato, RM; Frisk, MG				Martinez, Christopher M.; Duplisea, Daniel E.; Cerrato, Robert M.; Frisk, Michael G.			Exploration of Trends in Interspecific Abundance-Occupancy Relationships Using Empirically Derived Simulated Communities	PLOS ONE			English	Article							POSITIVE RELATIONSHIP; LOCAL ABUNDANCE; CLIMATE-CHANGE; MARINE	The interspecific abundance-occupancy relationship (AOR) is a widely used tool that describes patterns of habitat utilization and, when evaluated over time, may be used to identify large-scale changes in community structure. Our primary goal for this research was to validate the utility of AORs as temporal indicators of community state. We used long-term survey data in four regions of the northwest Atlantic coastal shelf (NWACS) to estimate the diversity of spatial behaviors in each community, which we modeled with negative binomial (NB) distributions. NB parameters were used to generate time series data for simulated communities, from which AORs were then estimated and evaluated for temporal trends. We found that AORs from simulated communities were similar in year-to-year variation to empirical relationships. In order to further understand the role of spatial diversity in the generation of AOR trends, we did additional simulations where NB parameters were manually manipulated. In one instance, we ran simulations while holding species' parameters constant over time. This treatment effectively removed trends, suggesting that temporal change in community relationships was the result of genuine variation in intraspecific spatial use. In another set of simulations, we conducted a case study to evaluate the impact of a select group of schooling and spatially aggregating species on an especially rapid shift in AORs in the Gulf of Maine from 1973 to 1983. Removals of these species reduced the magnitudes of most trends, demonstrating their importance to observed community changes. This research directly links variation in AORs to distribution and density-related processes and provides a potentially powerful framework to identify community-level change and to test ecological and mechanistic hypotheses.	[Martinez, Christopher M.; Cerrato, Robert M.; Frisk, Michael G.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Duplisea, Daniel E.] Fisheries & Oceans Canada, Inst Maurice Lamontagne, Mont Joli, PQ, Canada; [Martinez, Christopher M.] Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Fisheries & Oceans Canada; University of California System; University of California Davis	Martinez, CM (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA.; Martinez, CM (corresponding author), Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA.	cmimartinez@ucdavis.edu		Duplisea, Daniel/0000-0002-0844-359X	National Science Foundation-National Oceanic and Atmospheric Administration Comparative Analysis of Marine Ecosystem Organization (CAMEO) [1041716]	National Science Foundation-National Oceanic and Atmospheric Administration Comparative Analysis of Marine Ecosystem Organization (CAMEO)	This work was supported by a joint National Science Foundation-National Oceanic and Atmospheric Administration Comparative Analysis of Marine Ecosystem Organization (CAMEO) grant, #1041716. Data for this research comes from a long term survey by NOAA's Northeast Fisheries Science Center. The funders had no role in the study design, data analysis, decision to publish, or preparation of the manuscript.	Borregaard MK, 2010, Q REV BIOL, V85, P3, DOI 10.1086/650265; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Buckley HL, 2010, J ECOL, V98, P645, DOI 10.1111/j.1365-2745.2010.01650.x; Christensen V, 2003, FISH FISH, V4, P1, DOI 10.1046/j.1467-2979.2003.00103.x; Cowley MJR, 2001, J ANIM ECOL, V70, P426, DOI 10.1046/j.1365-2656.2001.00509.x; Dulvy NK, 2008, J APPL ECOL, V45, P1029, DOI 10.1111/j.1365-2664.2008.01488.x; Faulks L, 2015, AM NAT, V186, P272, DOI 10.1086/682004; Fisher JAD, 2004, MAR ECOL PROG SER, V279, P201, DOI 10.3354/meps279201; Frisk MG, 2011, ECOL APPL, V21, P227, DOI 10.1890/09-1698.1; Gaston KJ, 2003, GLOBAL ECOL BIOGEOGR, V12, P373, DOI 10.1046/j.1466-822X.2003.00054.x; Gaston KJ, 1998, J ANIM ECOL, V67, P995, DOI 10.1046/j.1365-2656.1998.6760995.x; Gaston KJ, 1997, J ANIM ECOL, V66, P579, DOI 10.2307/5951; Gaston KJ, 1997, OECOLOGIA, V112, P112, DOI 10.1007/s004420050290; Guedo DD, 2013, J VEG SCI, V24, P607, DOI 10.1111/jvs.12006; Hartley S, 1998, J ANIM ECOL, V67, P992, DOI 10.1046/j.1365-2656.1998.6760992.x; Heino J, 2005, ECOGRAPHY, V28, P345, DOI 10.1111/j.0906-7590.2005.04151.x; Holt AR, 2004, J ANIM ECOL, V73, P841, DOI 10.1111/j.0021-8790.2004.00862.x; Holt AR, 2002, BASIC APPL ECOL, V3, P1, DOI 10.1078/1439-1791-00083; Hoye TT, 2012, ECOL INDIC, V20, P221, DOI 10.1016/j.ecolind.2012.01.017; Lear W.H., 1998, J NW ATLANTIC FISHER, V23, P41, DOI [DOI 10.2960/J.V23.A4, 10.2960/J.v23.a4]; Lucey SM, 2010, MAR ECOL PROG SER, V415, P23, DOI 10.3354/meps08743; McLeod A.I., 2011, PACKAGE KENDALL KEND; Miller TJ, 2010, 1005 NEFSC US DEP CO; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Pauly D, 2005, B MAR SCI, V76, P197; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; R Core Team, 2021, R LANGUAGE ENV STAT; Rindorf A, 2012, CAN J FISH AQUAT SCI, V69, P382, DOI 10.1139/F2011-153; Sosebee KA, 2006, 0605 NEFSC DEP COMM; Storch D, 2004, BASIC APPL ECOL, V5, P389, DOI 10.1016/j.baae.2004.08.001; Topping CJ, 2015, SCI TOTAL ENVIRON, V537, P159, DOI 10.1016/j.scitotenv.2015.07.152; Venables WN., 2002, MODERN APPL STAT S 4; Webb TJ, 2012, GLOBAL ECOL BIOGEOGR, V21, P952, DOI 10.1111/j.1466-8238.2011.00736.x; Webb TJ, 2007, J ECOL, V76, P23; Wilson PD, 2008, GLOBAL ECOL BIOGEOGR, V17, P457, DOI 10.1111/j.1466-8238.2008.00385.x; Wilson PD, 2011, GLOBAL ECOL BIOGEOGR, V20, P193, DOI 10.1111/j.1466-8238.2010.00569.x; WRIGHT DH, 1991, J BIOGEOGR, V18, P463, DOI 10.2307/2845487	41	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170816	10.1371/journal.pone.0170816	http://dx.doi.org/10.1371/journal.pone.0170816			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125670	Green Submitted, Green Published, gold			2022-12-26	WOS:000396176100043
J	Rosenwald, M; Efthymiou, V; Opitz, L; Wolfrum, C				Rosenwald, Matthias; Efthymiou, Vissarion; Opitz, Lennart; Wolfrum, Christian			SRF and MKL1 Independently Inhibit Brown Adipogenesis	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; ADIPOSE-TISSUE; PPAR-GAMMA; TRANSCRIPTION FACTOR; INSULIN SENSITIVITY; ACTIN CYTOSKELETON; GENE-EXPRESSION; ACTIVATION; MYOCARDIN; ADIPOCYTES	Active brown adipose tissue is responsible for non-shivering thermogenesis in mammals which affects energy homeostasis. The molecular mechanisms underlying this activation as well as the formation and activation of brite adipocytes have gained increasing interest in recent years as they might be utilized to regulate systemic metabolism. We show here that the transcriptional regulators SRF and MKL1 both act as repressors of brown adipogenesis. Loss-of-function of these transcription factors leads to a significant induction of brown adipocyte differentiation, increased levels of UCP1 and other thermogenic genes as well as increased respiratory function, while SRF induction exerts the opposite effects. Interestingly, we observed that knockdown of MKL1 does not lead to a reduced expression of typical SRF target genes and that the SRF/MKL1 inhibitor CCG-1423 had no significant effects on brown adipocyte differentiation. Contrary, knockdown of MKL1 induces a significant increase in the transcriptional activity of PPAR. target genes and MKL1 interacts with PPAR., suggesting that SRF and MKL1 independently inhibit brown adipogenesis and that MKL1 exerts its effect mainly by modulating PPAR. activity.	[Rosenwald, Matthias; Efthymiou, Vissarion; Opitz, Lennart; Wolfrum, Christian] Swiss Fed Inst Technol, Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Schwerzenbach, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Wolfrum, C (corresponding author), Swiss Fed Inst Technol, Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Schwerzenbach, Switzerland.	christian-wolfrum@ethz.ch		Wolfrum, Christian/0000-0002-3862-6805; Efthymiou, Vissarion/0000-0003-4327-7977	Swiss National Funding Agency (SNF) [31003A_162887]; Swiss National Funding Agency [SNF 31003A_162887]	Swiss National Funding Agency (SNF); Swiss National Funding Agency	This work was supported by Swiss National Funding Agency (SNF) 31003A_162887.; We gratefully acknowledge Matthias Geiger for assisting with cell culture and Elke Kiehlmann for tissue microscopy. The work was supported by the Swiss National Funding Agency (SNF 31003A_162887, CW).	Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Balza RO, 2006, J BIOL CHEM, V281, P6498, DOI 10.1074/jbc.M509487200; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bell JL, 2013, BEILSTEIN J ORG CHEM, V9, P966, DOI 10.3762/bjoc.9.111; Chondronikola M, 2014, DIABETES, V63, P4089, DOI 10.2337/db14-0746; Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; Evelyn CR, 2007, MOL CANCER THER, V6, P2249, DOI 10.1158/1535-7163.MCT-06-0782; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Gineitis D, 2001, J BIOL CHEM, V276, P24531, DOI 10.1074/jbc.M102678200; Huang JH, 2012, J CLIN INVEST, V122, P3678, DOI 10.1172/JCI63635; Klein J, 2002, BIOESSAYS, V24, P382, DOI 10.1002/bies.10058; Koh YJ, 2009, EXP MOL MED, V41, P880, DOI 10.3858/emm.2009.41.12.094; Kovsan J, 2009, AM J PHYSIOL-ENDOC M, V296, pE315, DOI 10.1152/ajpendo.90486.2008; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Lefterova MI, 2014, TRENDS ENDOCRIN MET, V25, P293, DOI 10.1016/j.tem.2014.04.001; Li SJ, 2006, MOL CELL BIOL, V26, P5797, DOI 10.1128/MCB.00211-06; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Lichtenbelt WDV, 2011, AM J PHYSIOL-REG I, V301, pR285, DOI 10.1152/ajpregu.00652.2010; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; McDonald ME, 2015, CELL, V160, P105, DOI 10.1016/j.cell.2014.12.005; Meissburger B, 2011, EMBO MOL MED, V3, P637, DOI 10.1002/emmm.201100172; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Miano JM, 2010, LAB INVEST, V90, P1274, DOI 10.1038/labinvest.2010.104; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Nguyen GH, 2004, CELL SIGNAL, V16, P1141, DOI 10.1016/j.cellsig.2004.03.006; Nobusue H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4368; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Sidossis LS, 2015, CELL METAB, V22, P219, DOI 10.1016/j.cmet.2015.06.022; Vasudevan HN, 2014, DEV CELL, V31, P332, DOI 10.1016/j.devcel.2014.10.005; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang FF, 2013, P NATL ACAD SCI USA, V110, P18656, DOI 10.1073/pnas.1314863110; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	45	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170643	10.1371/journal.pone.0170643	http://dx.doi.org/10.1371/journal.pone.0170643			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125644	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000396176100081
J	Sho, SN; Court, CM; Kim, S; Braxton, DR; Hou, S; Muthusamy, VR; Watson, RR; Sedarat, A; Tseng, HR; Tomlinson, JS				Sho, Shonan; Court, Colin M.; Kim, Stephen; Braxton, David R.; Hou, Shuang; Muthusamy, V. Raman; Watson, Rabindra R.; Sedarat, Alireza; Tseng, Hsian-Rong; Tomlinson, James S.			Digital PCR Improves Mutation Analysis in Pancreas Fine Needle Aspiration Biopsy Specimens	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; RAS GENE MUTATION; DIFFERENTIAL-DIAGNOSIS; CANCER; KRAS; SUBTYPE; NUMBER	Applications of precision oncology strategies rely on accurate tumor genotyping from clinically available specimens. Fine needle aspirations (FNA) are frequently obtained in cancer management and often represent the only source of tumor tissues for patients with metastatic or locally advanced diseases. However, FNAs obtained from pancreas ductal adenocarcinoma (PDAC) are often limited in cellularity and/or tumor cell purity, precluding accurate tumor genotyping in many cases. Digital PCR (dPCR) is a technology with exceptional sensitivity and low DNA template requirement, characteristics that are necessary for analyzing PDAC FNA samples. In the current study, we sought to evaluate dPCR as a mutation analysis tool for pancreas FNA specimens. To this end, we analyzed alterations in the KRAS gene in pancreas FNAs using dPCR. The sensitivity of dPCR mutation analysis was first determined using serial dilution cell spiking studies. Single-cell laser-microdissection (LMD) was then utilized to identify the minimal number of tumor cells needed for mutation detection. Lastly, dPCR mutation analysis was performed on 44 pancreas FNAs (34 formalin-fixed paraffin-embedded (FFPE) and 10 fresh (non-fixed)), including samples highly limited in cellularity (100 cells) and tumor cell purity (1%). We found dPCR to detect mutations with allele frequencies as low as 0.17%. Additionally, a single tumor cell could be detected within an abundance of normal cells. Using clinical FNA samples, dPCR mutation analysis was successful in all preoperative FNA biopsies tested, and its accuracy was confirmed via comparison with resected tumor specimens. Moreover, dPCR revealed additional KRAS mutations representing minor subclones within a tumor that were not detected by the current clinical gold standard method of Sanger sequencing. In conclusion, dPCR performs sensitive and accurate mutation analysis in pancreas FNAs, detecting not only the dominant mutation subtype, but also the additional rare mutation subtypes representing tumor heterogeneity.	[Sho, Shonan; Court, Colin M.; Tomlinson, James S.] Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90024 USA; [Sho, Shonan; Court, Colin M.; Tomlinson, James S.] Greater Los Angeles Vet Affairs Adm, Dept Surg, Los Angeles, CA 90073 USA; [Court, Colin M.; Hou, Shuang; Tseng, Hsian-Rong] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA; [Kim, Stephen; Muthusamy, V. Raman; Watson, Rabindra R.; Sedarat, Alireza; Tomlinson, James S.] Univ Calif Los Angeles, UCLA Ctr Pancreat Dis, Los Angeles, CA USA; [Kim, Stephen; Muthusamy, V. Raman; Watson, Rabindra R.; Sedarat, Alireza] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Los Angeles, CA 90095 USA; [Braxton, David R.] Univ Calif Los Angeles, Dept Pathol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Sho, SN (corresponding author), Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90024 USA.	ssho@mednet.ucla.edu	Hou, Shuang/G-1247-2018; Hou, Shuang/AAM-5055-2021	Hou, Shuang/0000-0001-5487-2427; Hou, Shuang/0000-0001-5487-2427; Tseng, Hsian-Rong/0000-0003-0942-5905; Court, Colin/0000-0002-9357-8957	UCLA Jonsson comprehensive cancer center research grant; NATIONAL CANCER INSTITUTE [U01CA198900, R44CA180482] Funding Source: NIH RePORTER	UCLA Jonsson comprehensive cancer center research grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the UCLA Jonsson comprehensive cancer center research grant to JT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankeny JS, 2016, BRIT J CANCER, V114, P1367, DOI 10.1038/bjc.2016.121; Arvanitakis M, 2004, ENDOSCOPY, V36, P535, DOI 10.1055/s-2004-814401; Azuara D, 2012, CLIN CHEM, V58, P1332, DOI 10.1373/clinchem.2012.186577; Bidshahri R, 2016, J MOL DIAGN, V18, P190, DOI 10.1016/j.jmoldx.2015.09.003; Bournet B, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.18; Bournet B, 2016, EUR J CANCER, V54, P75, DOI 10.1016/j.ejca.2015.11.012; Bournet B, 2014, WORLD J GASTROENTERO, V20, P10758, DOI 10.3748/wjg.v20.i31.10758; Bryant KL, 2014, TRENDS BIOCHEM SCI, V39, P91, DOI 10.1016/j.tibs.2013.12.004; Court CM, 2016, THE JOURNAL OF MOLEC; Court CM, 2015, EXPERT REV MOL DIAGN, V15, P1491, DOI 10.1586/14737159.2015.1091311; de Biase D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087651; de Castro DG, 2012, BRIT J CANCER, V107, P345, DOI 10.1038/bjc.2012.259; Fuccio L, 2013, GASTROINTEST ENDOSC, V78, P596, DOI 10.1016/j.gie.2013.04.162; Garraway LA, 2013, J CLIN ONCOL, V31, P1803, DOI 10.1200/JCO.2013.49.4799; Graham JS, 2015, CLIN GENET, V88, P213, DOI 10.1111/cge.12536; Hamidi H, 2014, BRIT J CANCER, V111, P1788, DOI 10.1038/bjc.2014.475; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huggett JF, 2015, CLIN CHEM, V61, P79, DOI 10.1373/clinchem.2014.221366; Kanagal-Shamanna R, 2014, MODERN PATHOL, V27, P314, DOI 10.1038/modpathol.2013.122; Kinugasa H, 2015, CANCER-AM CANCER SOC, V121, P2271, DOI 10.1002/cncr.29364; Lamy PJ, 2015, J MOL DIAGN, V17, P366, DOI 10.1016/j.jmoldx.2015.02.004; LeBlanc JK, 2004, GASTROINTEST ENDOSC, V59, P475, DOI 10.1016/S0016-5107(03)02863-3; Li J, 2008, NAT MED, V14, P579, DOI 10.1038/nm1708; Lito P, 2016, SCIENCE, V351, P604, DOI 10.1126/science.aad6204; Nikiforova MN, 2013, MODERN PATHOL, V26, P1478, DOI 10.1038/modpathol.2013.91; Ogura T, 2013, J GASTROENTEROL, V48, P640, DOI 10.1007/s00535-012-0664-2; Ogura T, 2012, GASTROINTEST ENDOSC, V75, P769, DOI 10.1016/j.gie.2011.11.012; Perincheri S, 2015, EXPERT REV MOL DIAGN, V15, P375, DOI 10.1586/14737159.2015.986102; Takahashi K, 2005, GASTROINTEST ENDOSC, V61, P76, DOI 10.1016/S0016-5107(04)02224-2; Valero V, 2016, ANN SURG, V263, P153, DOI 10.1097/SLA.0000000000001156	30	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170897	10.1371/journal.pone.0170897	http://dx.doi.org/10.1371/journal.pone.0170897			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125707	gold, Green Published, Green Submitted			2022-12-26	WOS:000396176100029
J	Zanus, C; Battistutta, S; Aliverti, R; Montico, M; Cremaschi, S; Ronfani, L; Monasta, L; Carrozzi, M				Zanus, Caterina; Battistutta, Sara; Aliverti, Renata; Montico, Marcella; Cremaschi, Silvana; Ronfani, Luca; Monasta, Lorenzo; Carrozzi, Marco			Adolescent Admissions to Emergency Departments for Self-Injurious Thoughts and Behaviors	PLOS ONE			English	Article							ATTEMPTED-SUICIDE; YOUNG-PEOPLE; INFLICTED INJURY; COMMUNITY SAMPLE; HARM; CARE; CHILDREN; VISITS; EPIDEMIOLOGY; MULTICENTER	The objective of the present study was to describe the incidence and the characteristics of Self-Injurious Thoughts and Behaviors (SITBs), among adolescents aged 11-18 admitted, over a two year period, to all the Emergency Departments of a Region of North-eastern Italy through a comprehensive analysis of medical records. A two-step search was performed in the regional ED electronic database. First, we identified the cases that had been clearly diagnosed as SITBs by an Emergency Department physician. Secondly, suspect cases were detected through a keyword search of the database, and the medical records of these cases were hand screened to identify SITBs. The mean annual incidence rate of SITBs was 90 per 100,000 adolescents aged 11-18 years. Events were more frequent in females. Drug poisoning was the most frequently adopted method (54%). In 42% of cases a diagnosis of SITB was not explicitly reported by the physician. In 65% of cases adolescents were discharged within hours of admission. Only 9% of patients started a psychiatric assessment and treatment program during hospital stay. This research confirms the high incidence of SITBs among adolescents and highlights the difficulty in their proper diagnosis and management. Such difficulty is confirmed by the fact that only a few patients, even among those with a clear diagnosis, were sent for psychiatric assessment. Correct identification and management of SITB patients needs to be improved, since SITBs are an important public health problem in adolescence and one of the main risk factors for suicide.	[Zanus, Caterina; Battistutta, Sara; Aliverti, Renata; Montico, Marcella; Ronfani, Luca; Monasta, Lorenzo; Carrozzi, Marco] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy; [Cremaschi, Silvana] ASS4 Medio Friuli, Child & Adolescent Neuropsychiat Serv, Udine, Italy	IRCCS Burlo Garofolo	Monasta, L (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy.	lorenzo.monasta@burlo.trieste.it	Ronfani, Luca/B-6668-2013; Monasta, Lorenzo/B-1388-2012; Montico, Marcella/B-5290-2013	Ronfani, Luca/0000-0001-5710-3914; Monasta, Lorenzo/0000-0001-7774-548X; Montico, Marcella/0000-0003-0377-8232; Carrozzi, Marco/0000-0001-6282-4417				Aydin A, 2013, INT J PSYCHIAT CLIN, V17, P110, DOI 10.3109/13651501.2012.697565; Babeva K, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0738-6; Ballard ED, 2016, PREV SCI; Bennewith O, 2005, J AFFECT DISORDERS, V89, P91, DOI 10.1016/j.jad.2005.08.011; Bethell Jennifer, 2009, Health Rep, V20, P35; Betz ME, 2013, DEPRESS ANXIETY, V30, P1005, DOI 10.1002/da.22071; Bossuyt N, 2007, INT J PUBLIC HEALTH, V52, P153, DOI 10.1007/s00038-007-5060-y; Bridge JA, 2012, J AM ACAD CHILD PSY, V51, P213, DOI 10.1016/j.jaac.2011.11.002; Brunner R, 2014, J CHILD PSYCHOL PSYC, V55, P337, DOI 10.1111/jcpp.12166; Chun TH, 2016, PEDIATRICS, V138; Chun TH, 2015, CHILD ADOL PSYCH CL, V24, P21, DOI 10.1016/j.chc.2014.09.003; Clerici CA, 2016, J FORENSIC LEG MED, V37, P15, DOI 10.1016/j.jflm.2015.09.016; Colman Ian, 2004, CJEM, V6, P313; Cooper J, 2005, AM J PSYCHIAT, V162, P297, DOI 10.1176/appi.ajp.162.2.297; Cotter P, 2015, SOC PSYCH PSYCH EPID, V50, P973, DOI 10.1007/s00127-015-1016-3; Cutler GJ, 2015, PEDIATRICS, V136, P28, DOI 10.1542/peds.2014-3573; Di Napoli Wilma Angela, 2015, Psychiatr Danub, V27 Suppl 1, pS279; Dieppe C, 2009, EMERG MED J, V26, P418, DOI 10.1136/emj.2008.062463; Doshi A, 2005, ANN EMERG MED, V46, P369, DOI 10.1016/j.annemergmed.2005.04.018; Ferrara P, 2014, ITAL J PEDIATR, V40, DOI 10.1186/s13052-014-0069-3; Fox KR, 2016, PSYCHIAT RES, V244, P235, DOI 10.1016/j.psychres.2016.07.052; Glenn CR, 2015, J CLIN CHILD ADOLESC, V44, P1, DOI 10.1080/15374416.2014.945211; Hawton K, 2000, J ADOLESCENCE, V23, P47, DOI 10.1006/jado.1999.0290; Hawton K., 2008, RUTTERS CHILD ADOLES, V5th ed, P648; Hawton K, 2007, J CLIN PSYCHIAT, V68, P1574, DOI 10.4088/JCP.v68n1017; Hawton K, 2012, LANCET, V379, P2373, DOI 10.1016/S0140-6736(12)60322-5; Hooley JM, 2008, APPL PREV PSYCHOL, V12, P155, DOI 10.1016/j.appsy.2008.08.001; Horowitz LM, 2012, ARCH PEDIAT ADOL MED, V166, P1170, DOI 10.1001/archpediatrics.2012.1276; Horowitz LM, 2009, CURR OPIN PEDIATR, V21, P620, DOI 10.1097/MOP.0b013e3283307a89; Janssens A, 2013, PEDIATR EMERG CARE, V29, P1041, DOI 10.1097/PEC.0b013e3182a393e7; Jessen G, 1999, ARCH SUICIDE RES, V5, P57, DOI 10.1023/A:1009693123399; Klonsky ED, 2016, ANNU REV CLIN PSYCHO, V12, P307, DOI 10.1146/annurev-clinpsy-021815-093204; Kolves K, 2011, SOC PSYCH PSYCH EPID, V46, P805, DOI 10.1007/s00127-010-0251-x; Larkin GL, 2010, CRISIS, V31, P1, DOI 10.1027/0227-5910/a000001; Levine LJ, 2005, ARCH PEDIAT ADOL MED, V159, P860, DOI 10.1001/archpedi.159.9.860; Madge N, 2008, J CHILD PSYCHOL PSYC, V49, P667, DOI 10.1111/j.1469-7610.2008.01879.x; Mergl R, 2010, EUR ARCH PSY CLIN N, V260, P393, DOI 10.1007/s00406-009-0086-1; Mitchell AJ, 2006, EMERG MED J, V23, P251, DOI 10.1136/emj.2005.027250; Nock MK, 2008, BRIT J PSYCHIAT, V192, P98, DOI 10.1192/bjp.bp.107.040113; Nock MK, 2010, ANNU REV CLIN PSYCHO, V6, P339, DOI 10.1146/annurev.clinpsy.121208.131258; Olfson M, 2005, ARCH GEN PSYCHIAT, V62, P1122, DOI 10.1001/archpsyc.62.10.1122; Olfson M, 2014, JAMA-J AM MED ASSOC, V311, P1107, DOI 10.1001/jama.2014.501; Perry IJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031663; Petrik ML, 2015, GEN HOSP PSYCHIAT, V37, P581, DOI 10.1016/j.genhosppsych.2015.06.018; Polewka Andrzej, 2004, Przegl Lek, V61, P269; Pompili M, 2009, EUR CHILD ADOLES PSY, V18, P525, DOI 10.1007/s00787-009-0007-x; Preti A, 2001, J AFFECT DISORDERS, V65, P253, DOI 10.1016/S0165-0327(00)00232-9; Ribeiro JD, 2016, PSYCHOL MED, V46, P225, DOI 10.1017/S0033291715001804; Rodham K, 2004, J AM ACAD CHILD PSY, V43, P80, DOI 10.1097/00004583-200401000-00017; Rosychuk RJ, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0941-3; Swanepoel A, 2016, ARCH DIS CHILDHOOD-E, V101, P287, DOI 10.1136/archdischild-2016-310782; Ting SA, 2012, GEN HOSP PSYCHIAT, V34, P557, DOI 10.1016/j.genhosppsych.2012.03.020; Ting SA, 2012, ACAD EMERG MED, V19, P239, DOI 10.1111/j.1553-2712.2011.01272.x; Victor SE, 2014, CLIN PSYCHOL REV, V34, P282, DOI 10.1016/j.cpr.2014.03.005; World Health Organization, 2015, MANT HLTH SUIC DAT	55	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170979	10.1371/journal.pone.0170979	http://dx.doi.org/10.1371/journal.pone.0170979			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7IT	28125701	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100012
J	Zhu, J; Wen, H; Ju, XZ; Bi, R; Zuo, WJ; Wu, XH				Zhu, Jun; Wen, Hao; Ju, Xingzhu; Bi, Rui; Zuo, Wenjia; Wu, Xiaohua			Clinical Significance of Programmed Death Ligand-1 and Intra-Tumoral CD8(+) T Lymphocytes in Ovarian Carcinosarcoma	PLOS ONE			English	Article							CELL LUNG-CANCER; PD-L1 EXPRESSION; INFILTRATING LYMPHOCYTES; PLATINUM; IMMUNOTHERAPY; CHEMOTHERAPY; PROGNOSIS; CARCINOMA; APOPTOSIS; ANTI-PD-1	Ovarian carcinosarcoma (OCS) accounts for high mortality and lacks effective therapeutic methods. So far, we lack reliable biomarkers capable of predicting the risk of aggressive course of the disease. Programmed death ligand-1 (PD-L1) is expressed in various tumors, and antibodies targeting its receptor programmed cell death 1 (PD-1) are emerging cancer therapeutics. This study was designed to evaluate the expression of PD-L1 and intratumoral CD8+ T lymphocytes by immunohistochemistry from 19 OCS patients who underwent primary surgery at Fudan University Shanghai Cancer Center. The correlations between PD-L1 expression and CD8+ T lymphocytes as well as the patients' clinicopathologic characteristics were integrated and statistically analyzed. PD-L1-positive expression was observed in 52.6% of intraepithelial tissues and 47.4% of mesenchymal tissues (p = 0.370). Meanwhile, intraepithelial and mesenchymal CD8+ T lymphocytes were positive in 36.8% and 84.2% of OCS, respectively (p = 0.628). A significantly negative correlation was found between mesenchymal CD8+ T lymphocytes and PD-L1 expression (r = -0.630, p = 0.011). Intraepithelial PD-L1-positive expression was associated only with positive ascitic fluid (p = 0.008). Mesenchymal PD-L1-positive patients had a poorer survival than those with negative expression (p = 0.036). Meanwhile, intraepithelial PD-L1-positive patients had a better survival trend than PD-L1-negative patients, though no statistical significance was found (p = 0.061). There was a better postoperative survival noted in mesenchymal CD8-positive patients (p = 0.024), and allthough a better trend of OS was observed in intraepithelial CD8-positive patients, no statistical significance was found (p = 0.382). Positive tumoral CD8+ T lymphocytes and mesenchymal PD-L1-negative expression seem to be associated with better survival in OCS. It is possible that immunotherapy targeting PD-L1 pathway could be used in OCS.	[Zhu, Jun; Wen, Hao; Ju, Xingzhu; Wu, Xiaohua] Fudan Univ, Shanghai Canc Ctr, Dept Gynecol Oncol, Shanghai, Peoples R China; [Bi, Rui] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai, Peoples R China; [Zuo, Wenjia] Fudan Univ, Shanghai Canc Ctr, Dept Breast Canc, Shanghai, Peoples R China; [Wu, Xiaohua] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Wu, XH (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Gynecol Oncol, Shanghai, Peoples R China.; Wu, XH (corresponding author), Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai, Peoples R China.	docwuxh@yahoo.com		Zhu, Jun/0000-0003-1224-2771	Science and Technology Commission of Shanghai Municipality [12411950300]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the Science and Technology Commission of Shanghai Municipality (Grant No.12411950300). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiko K, 2013, CLIN CANCER RES, V19, P1363, DOI 10.1158/1078-0432.CCR-12-2199; Amant F, 2003, GYNECOL ONCOL, V90, P372, DOI 10.1016/S0090-8258(03)00326-3; Beckers R. K., 2015, HISTOPATHOLOGY; Bernhard H, 2005, METH MOLEC MED, V109, P175; Bindea G, 2010, CURR OPIN IMMUNOL, V22, P215, DOI 10.1016/j.coi.2010.02.006; Bocker W, 2002, VERH DEUT G, V86, P116; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Chen BJ, 2013, CLIN CANCER RES, V19, P3462, DOI 10.1158/1078-0432.CCR-13-0855; Chen YB, 2012, TUMORI, V98, P751, DOI 10.1700/1217.13499; Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863; Darb-Esfahani S, 2016, ONCOTARGET, V7, P1486, DOI 10.18632/oncotarget.6429; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Duraiswamy J, 2013, CANCER RES, V73, P6900, DOI 10.1158/0008-5472.CAN-13-1550; Faraj SF, 2015, UROLOGY, V85, DOI 10.1016/j.urology.2014.10.020; Farghaly S.A., 2014, ADV DIAGNOSIS MANAGE; GEORGE E, 1991, HUM PATHOL, V22, P215, DOI 10.1016/0046-8177(91)90153-G; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Hamanishi J, 2015, J CLIN ONCOL, V33, P4015, DOI 10.1200/JCO.2015.62.3397; Hwang WT, 2012, GYNECOL ONCOL, V124, P192, DOI 10.1016/j.ygyno.2011.09.039; Inthasorn P, 2003, AUST NZ J OBSTET GYN, V43, P61, DOI 10.1046/j.0004-8666.2003.00003.x; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; Kluger HM, 2015, CLIN CANCER RES, V21, P3052, DOI 10.1158/1078-0432.CCR-14-3073; Leiser AL, 2007, GYNECOL ONCOL, V105, P657, DOI 10.1016/j.ygyno.2007.01.037; Lipson EJ, 2013, CANCER IMMUNOL RES, V1, P54, DOI 10.1158/2326-6066.CIR-13-0034; Loizzi V, 2011, ONCOLOGY-BASEL, V80, P102, DOI 10.1159/000328794; Muhlbauer M, 2006, J HEPATOL, V45, P520, DOI 10.1016/j.jhep.2006.05.007; Muenst S, 2014, BREAST CANCER RES TR, V146, P15, DOI 10.1007/s10549-014-2988-5; Nomi T, 2007, CLIN CANCER RES, V13, P2151, DOI 10.1158/1078-0432.CCR-06-2746; Okazaki T, 2007, INT IMMUNOL, V19, P813, DOI 10.1093/intimm/dxm057; Philips GK, 2015, INT IMMUNOL, V27, P39, DOI 10.1093/intimm/dxu095; Phillips T, 2015, APPL IMMUNOHISTO M M, V23, P541, DOI 10.1097/PAI.0000000000000256; Rauh-Hain JA, 2011, GYNECOL ONCOL, V121, P477, DOI 10.1016/j.ygyno.2011.02.023; Rauh-Hain JA, 2016, GYNECOL ONCOL; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Schmidt LH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136023; Shen J, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.2; Shi SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076012; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sit ASY, 2000, GYNECOL ONCOL, V79, P196, DOI 10.1006/gyno.2000.5956; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689	40	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170879	10.1371/journal.pone.0170879	http://dx.doi.org/10.1371/journal.pone.0170879			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125702	Green Published, gold, Green Submitted			2022-12-26	WOS:000396176100033
J	Holvoet, P; Vanhaverbeke, M; Geeraert, B; De Keyzer, D; Hulsmans, M; Janssens, S				Holvoet, Paul; Vanhaverbeke, Maarten; Geeraert, Benjamine; De Keyzer, Dieuwke; Hulsmans, Maarten; Janssens, Stefan			Low Cytochrome Oxidase 1 Links Mitochondrial Dysfunction to Atherosclerosis in Mice and Pigs	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; C-OXIDASE; OXIDATIVE STRESS; EXPRESSION; METABOLISM; OBESITY; GENE	Background Cytochrome oxidase IV complex regulates energy production in mitochondria. Therefore, we determined the relation of COX genes with atherosclerosis in mice and pigs. Methods and results First, we compared atherosclerosis in the aortic arch of age-matched (24 weeks) C57BL/6J control (n = 10), LDL-receptor deficient (n = 8), leptin-deficient ob/ob (n = 10), and double knock-out (lacking LDL-receptor and leptin) mice (n = 12). Low aortic mitochondria-encoded cytochrome oxidase 1 in obese diabetic double knock-out mice was associated with a larger plaque area and higher propensity of M1 macrophages and oxidized LDL. Caloric restriction increased mitochondria-encoded cytochrome oxidase 1 and reduced plaque area and oxidized LDL. This was associated with a reduction of titer of anti-oxidized LDL antibodies, a proxy of systemic oxidative stress. Low of mitochondria-encoded cytochrome oxidase 1 was related to low expression of peroxisome proliferative activated receptors alpha, delta, and gamma and of peroxisome proliferative activated receptor, gamma, co-activator 1 alpha reflecting mitochondrial dysfunction. Caloric restriction increased them. To investigate if there was a diabetic/obesity requirement for mitochondria-encoded cytochrome oxidase 1 to be down-regulated, we then studied atherosclerosis in LAD of hypercholesterolemic pigs (n = 37). Pigs at the end of the study were divided in three groups based on increasing LAD plaque complexity according to Stary (Stary I: n = 12; Stary II: n = 13; Stary III: n = 12). Low mitochondria-encoded cytochrome oxidase 1 in isolated plaque macrophages was associated with more complex coronary plaques and oxidized LDL. Nucleus-encoded cytochrome oxidase 4I1 and cytochrome oxidase 10 did not correlate with plaque complexity and oxidative stress. In mice and pigs, MT-COI was inversely related to insulin resistance. Conclusions Low MT-COI is related to mitochondrial dysfunction, oxidative stress and atherosclerosis and plaque complexity.	[Holvoet, Paul; Geeraert, Benjamine; De Keyzer, Dieuwke; Hulsmans, Maarten] Katholieke Univ Leuven, Atherosclerosis & Metab Unit, Dept Cardiovasc Sci, Leuven, Belgium; [Vanhaverbeke, Maarten; Janssens, Stefan] Dept Clin Cardiol, Leuven, Belgium	KU Leuven	Holvoet, P (corresponding author), Katholieke Univ Leuven, Atherosclerosis & Metab Unit, Dept Cardiovasc Sci, Leuven, Belgium.	paul.holvoet@kuleuven.be	HOLVOET, PAUL/T-8434-2017; Vanhaverbeke, Maarten/ADP-6196-2022; Hulsmans, Maarten/AAI-9547-2020	HOLVOET, PAUL/0000-0001-9201-0772; Vanhaverbeke, Maarten/0000-0002-4385-7069; Hulsmans, Maarten/0000-0003-1009-658X	Bijzonder Onderzoeksfonds of the KU Leuven [PF/10/014]; Interdisciplinair Ontwikkelingsfonds - Kennisplatform [KP/12/009]; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen [G0846.11]	Bijzonder Onderzoeksfonds of the KU Leuven; Interdisciplinair Ontwikkelingsfonds - Kennisplatform; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen(FWO)	This work was funded by the Bijzonder Onderzoeksfonds of the KU Leuven (PF/10/014; Centre of Excellence), by the Interdisciplinair Ontwikkelingsfonds - Kennisplatform (Centre of Excellence KP/12/009), and by the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (G0846.11, and Vascular Biology Network). M.H. is a post-doctoral fellow of the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2003, HUM MOL GENET, V12, P329, DOI 10.1093/hmg/ddg021; Arnold S, 2012, ADV EXP MED BIOL, V748, P305, DOI 10.1007/978-1-4614-3573-0_13; Arnold S, 2012, MITOCHONDRION, V12, P46, DOI 10.1016/j.mito.2011.05.003; Boyle KE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106872; Braun M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119416; CAPALDI RA, 1990, ARCH BIOCHEM BIOPHYS, V280, P252, DOI 10.1016/0003-9861(90)90327-U; Dauwe DF, 2014, EUR HEART J-CARD IMG, V15, P900, DOI 10.1093/ehjci/jeu019; De Keyzer D, 2009, ARTERIOSCL THROM VAS, V29, P2041, DOI 10.1161/ATVBAHA.109.196592; Diaz F, 2005, HUM MOL GENET, V14, P2737, DOI 10.1093/hmg/ddi307; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Geeraert B, 2007, J THROMB HAEMOST, V5, P2529, DOI 10.1111/j.1538-7836.2007.02786.x; Goto M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-76; Hemmeryckx B, 2016, J CARDIOVASC PHARM, V68, P374, DOI 10.1097/FJC.0000000000000423; Holvoet P, 2008, JAMA-J AM MED ASSOC, V299, P2287, DOI 10.1001/jama.299.19.2287; Holvoet P, 2006, ARTERIOSCL THROM VAS, V26, P1558, DOI 10.1161/01.ATV.0000226553.01555.02; Holvoet P, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004207; Johri A, 2013, FREE RADICAL BIO MED, V62, P37, DOI 10.1016/j.freeradbiomed.2013.04.016; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Koentges C, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0495-4; Liao XD, 2015, J CLIN INVEST, V125, P3461, DOI 10.1172/JCI79964; MacNeil LG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109189; Mertens A, 2003, CIRCULATION, V107, P1640, DOI 10.1161/01.CIR.0000056523.08033.9F; Palacin M, MITOCHONDRIAL DNA TF; Parikh NI, 2015, ATHEROSCLEROSIS, V239, P50, DOI 10.1016/j.atherosclerosis.2014.12.005; Van der Schueren B, 2015, INT J OBESITY, V39, P1254, DOI 10.1038/ijo.2015.58; van der Veen JN, 2014, DIABETES, V63, P2620, DOI 10.2337/db13-0993; Verreth W, 2006, ARTERIOSCL THROM VAS, V26, P922, DOI 10.1161/01.ATV.0000207318.42066.bb; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang Y, 2014, CIRC RES, V114, P421, DOI 10.1161/CIRCRESAHA.114.302153; Williams SL, 2004, J BIOL CHEM, V279, P7462, DOI 10.1074/jbc.M309232200; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177; Yoshida T, 2005, ATHEROSCLEROSIS, V178, P39, DOI 10.1016/j.atherosclerosis.2004.08.029; Youn JY, 2014, DIABETES, V63, P2344, DOI 10.2337/db13-0719; Yue RC, 2015, J CELL PHYSIOL, V230, P2128, DOI 10.1002/jcp.24941; ZEVIANI M, 1987, GENE, V55, P205, DOI 10.1016/0378-1119(87)90281-2	35	7	9	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0170307	10.1371/journal.pone.0170307	http://dx.doi.org/10.1371/journal.pone.0170307			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122051	gold, Green Published, Green Submitted			2022-12-26	WOS:000396167300047
J	Leroi, C; Balestre, E; Messou, E; Minga, A; Sawadogo, A; Drabo, J; Maiga, M; Zannou, M; Seydi, M; Dabis, F; Jaquet, A				Leroi, Charline; Balestre, Eric; Messou, Eugene; Minga, Albert; Sawadogo, Adrien; Drabo, Joseph; Maiga, Moussa; Zannou, Marcel; Seydi, Moussa; Dabis, Francois; Jaquet, Antoine		IeDEA West Africa Collaboration	Incidence of Severe Neutropenia in HIV-Infected People Starting Antiretroviral Therapy in West Africa	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; COTE-DIVOIRE; ABIDJAN; ADULTS; COTRIMOXAZOLE; ZIDOVUDINE; BACTEREMIA; COHORT; TRIAL; AIDS	Background In sub-Saharan Africa, antiretroviral therapy (ART) including drugs with potential toxicity such as Zidovudine (ZDV) are routinely prescribed. This study aimed at estimating the incidence of severe neutropenia and associated factors after ART initiation in five West African countries. Methods A retrospective cohort analysis was conducted within the international epidemiologic database to evaluate AIDS (IeDEA) collaboration in West Africa. All HIV-infected adults, initiating ART between 2002 and 2014, with a baseline and at least one follow-up absolute neutrophil count (ANC) measurement were eligible. Incidence of severe neutropenia (ANC <750 cells/mm(3)) was estimated with 95% confidence interval (CI) according to age, gender, HIV clinic, hemoglobin, CD4 count, clinical stage, and ART duration. A Cox proportional hazard model was used to identify factors associated with severe neutropenia, expressed with their adjusted hazard ratios (aHR). Results Between 2002 and 2014, 9,426 HIV-infected adults were enrolled. The crude incidence rate of a first severe neutropenia was 9.1 per 100 person-years (95% CI: 8.6-9.8). Factors associated with severe neutropenia were exposure to ZDV <6 months (aHR = 2.2; 95% CI: 1.8-2.6), >= 6-12 months (aHR = 2.1; 95% CI: 1.6-2.8) and >= 12 months (aHR = 1.6; 95% CI: 1.2-2.2) [Ref. no ZDV exposure], CD4 count <350 cells/mm(3) (aHR = 1.3; 95% CI: 1.1-1.5) and advanced clinical stage at ART initiation ( aHR = 1.2; 95% CI: 1.0-1.4). Conclusion The incidence of severe neutropenia after ART initiation in West Africa is high and associated with ZDV exposure and advanced HIV disease. In this context, efforts are needed to scale-up access to less toxic first-line ART drugs and to promote early ART initiation.	[Leroi, Charline; Balestre, Eric; Dabis, Francois; Jaquet, Antoine] Bordeaux Univ, Sch Publ Hlth ISPED, Ctr INSERM Epidemiol Biostat U1219, Bordeaux, France; [Leroi, Charline; Balestre, Eric; Dabis, Francois; Jaquet, Antoine] INSERM, ISPED, Ctr INSERM Epidemiol Biostat Bordeaux U1219, Bordeaux, France; [Messou, Eugene] CHU Treichville, Programme PAC CI, Abidjan, Cote Ivoire; [Messou, Eugene] Hop Yopougon Attie, Ctr Prise Charge Rech & Format, Abidjan, Cote Ivoire; [Minga, Albert] Ctr Med Suivi Donneurs Sang CNTS PRIMO CI, Abidjan, Cote Ivoire; [Sawadogo, Adrien] CHU Souro Sanou, Dept Malad Infect, Bobo Dioulasso, Burkina Faso; [Drabo, Joseph] CHU Yalgado Ouedraogo, Serv Med Interne, Ouagadougou, Burkina Faso; [Maiga, Moussa] Hop Gabriel Toure, Serv Hepatogastroenterol, Bamako, Mali; [Zannou, Marcel] CNHU, Ctr Prise Charge Personnes Vivant Avec VIH, Cotonou, Benin; [Seydi, Moussa] CHU Fann, CRCF, Serv Malad Infect & Trop, Dakar, Senegal	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Leroi, C (corresponding author), Bordeaux Univ, Sch Publ Hlth ISPED, Ctr INSERM Epidemiol Biostat U1219, Bordeaux, France.; Leroi, C (corresponding author), INSERM, ISPED, Ctr INSERM Epidemiol Biostat Bordeaux U1219, Bordeaux, France.	charlineleroi.bx@gmail.com	DABIS, FRANCOIS/S-9298-2019; Jaquet, Antoine/T-2794-2019	DABIS, FRANCOIS/0000-0002-1614-8857; Jaquet, Antoine/0000-0002-3426-9492	National Cancer Institute (NCI); Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institute of Allergy and Infectious Diseases (NIAID) [5U01AI069919]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069919] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partly funded by the following institutes: the National Cancer Institute (NCI), the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), the National Institute of Allergy and Infectious Diseases (NIAID) (grant no 5U01AI069919). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; Braitstein P, 2010, JAIDS-J ACQ IMM DEF, V53, P254, DOI 10.1097/QAI.0b013e3181b8f26e; Caperna J, 1998, EPIDEMIOL INFECT, V120, P71, DOI 10.1017/S095026889700842X; Division of AIDS, 2004, DIV AIDS TABL GRAD S; Egger M, 2012, INT J EPIDEMIOL, V41, P1256, DOI 10.1093/ije/dyr080; Firnhaber C, 2010, INT J INFECT DIS, V14, pE1088, DOI 10.1016/j.ijid.2010.08.002; Hermans P, 1999, J Hematother Stem Cell Res, V8 Suppl 1, pS23; Hoffmann CJ, 2008, AIDS, V22, P67, DOI 10.1097/QAD.0b013e3282f2306e; Jaquet A, 2011, PHARMACOEPIDEM DR S, V20, P1303, DOI 10.1002/pds.2182; Keiser P, 1996, AM J MED SCI, V312, P118, DOI 10.1097/00000441-199609000-00004; Levine AM, 2006, ARCH INTERN MED, V166, P405, DOI 10.1001/.405; Moh R, 2005, ANTIVIR THER, V10, P615; Moore DAJ, 2001, CLIN INFECT DIS, V32, P469, DOI 10.1086/318495; MOORE RD, 1995, ARCH INTERN MED, V155, P1965, DOI 10.1001/archinte.155.18.1965; Nacoulma E W C, 2007, Bull Soc Pathol Exot, V100, P271; Ortega M, 2008, EUR J CLIN MICROBIOL, V27, P969, DOI 10.1007/s10096-008-0531-5; RICHMAN DD, 1987, NEW ENGL J MED, V317, P192, DOI 10.1056/NEJM198707233170402; Toure S, 2006, T ROY SOC TROP MED H, V100, P785, DOI 10.1016/j.trstmh.2005.11.008; UNAIDS, 2020, UNAIDS 2020 GLOB REP; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2013, CPMS GUID US ANT DRU	21	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0170753	10.1371/journal.pone.0170753	http://dx.doi.org/10.1371/journal.pone.0170753			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122041	gold, Green Submitted, Green Published			2022-12-26	WOS:000396167300022
J	Stokes, A; Preston, SH				Stokes, Andrew; Preston, Samuel H.			Deaths Attributable to Diabetes in the United States: Comparison of Data Sources and Estimation Approaches	PLOS ONE			English	Article							US ADULTS; TRENDS; PREVALENCE; MORTALITY; BURDEN; POPULATION; STATISTICS; AGE	Objective The goal of this research was to identify the fraction of deaths attributable to diabetes in the United States. Research Design and Methods We estimated population attributable fractions (PAF) for cohorts aged 30-84 who were surveyed in the National Health Interview Survey (NHIS) between 1997 and 2009 (N = 282,322) and in the National Health and Nutrition Examination Survey (NHANES) between 1999 and 2010 (N = 21,814). Cohort members were followed prospectively for mortality through 2011. We identified diabetes status using self-reported diagnoses in both NHIS and NHANES and using HbA1c in NHANES. Hazard ratios associated with diabetes were estimated using Cox model adjusted for age, sex, race/ethnicity, educational attainment, and smoking status. Results We found a high degree of consistency between data sets and definitions of diabetes in the hazard ratios, estimates of diabetes prevalence, and estimates of the proportion of deaths attributable to diabetes. The proportion of deaths attributable to diabetes was estimated to be 11.5% using self-reports in NHIS, 11.7% using self-reports in NHANES, and 11.8% using HbA1c in NHANES. Among the sub-groups that we examined, the PAF was highest among obese persons at 19.4%. The proportion of deaths in which diabetes was assigned as the underlying cause of death (3.3-3.7%) severely understated the contribution of diabetes to mortality in the United States. Conclusion Diabetes may represent a more prominent factor in American mortality than is commonly appreciated, reinforcing the need for robust population-level interventions aimed at diabetes prevention and care.	[Stokes, Andrew] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA 02215 USA; [Stokes, Andrew] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Preston, Samuel H.] Univ Penn, Dept Sociol, Philadelphia, PA 19104 USA; [Preston, Samuel H.] Univ Penn, Ctr Populat Studies, Philadelphia, PA 19104 USA	Boston University; Boston University; University of Pennsylvania; University of Pennsylvania	Stokes, A (corresponding author), Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA 02215 USA.; Stokes, A (corresponding author), Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA 02215 USA.	acstokes@bu.edu		Stokes, Andrew/0000-0002-8502-3636	National Institute on Aging at the National Institutes of Health [R01AG040212]; National Center for Health Statistics [R03SH000037]; NATIONAL CENTER FOR HEALTH STATISTICS [R03SH000037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040212, R03AG055724] Funding Source: NIH RePORTER	National Institute on Aging at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Health Statistics(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR HEALTH STATISTICS(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was funded by Grant Number R01AG040212 from the National Institute on Aging at the National Institutes of Health and Grant Number R03SH000037 from the National Center for Health Statistics.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Borch-Johnsen K, 1999, LANCET, V354, P617; CDC Wonder, 2016, UND CAUS DEATH 1999; Centers for Disease Control, 2020, NATL DIABETES STAT R; Cheng YLJ, 2013, DIABETES CARE, V36, P2690, DOI 10.2337/dc12-2074; Cowie CC, 2010, DIABETES CARE, V33, P562, DOI 10.2337/dc09-1524; de Vegt F, 1999, DIABETOLOGIA, V42, P926, DOI 10.1007/s001250051249; Delgado-Rodriguez M, 2004, J EPIDEMIOL COMMUN H, V58, P635, DOI 10.1136/jech.2003.008466; Engelgau MM, 2004, ANN INTERN MED, V140, P945, DOI 10.7326/0003-4819-140-11-200406010-00035; Geiss LS, 2014, JAMA-J AM MED ASSOC, V312, P1218, DOI 10.1001/jama.2014.11494; Gregg EW, 2007, ANN INTERN MED, V147, P149, DOI 10.7326/0003-4819-147-3-200708070-00167; Gregg EW, 2012, DIABETES CARE, V35, P1252, DOI 10.2337/dc11-1162; Heron M, 2013, NATL VITAL STAT REP, V62, P1; IDF Diabet Atlas Grp, 2015, DIABETES RES CLIN PR, V109, P461, DOI 10.1016/j.diabres.2015.05.037; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; Minnesota Population Center and State Health Access Data Assistance Center, 2015, INT HLTH INT SER VER; Mulnier HE, 2006, DIABETIC MED, V23, P516, DOI 10.1111/j.1464-5491.2006.01838.x; Murray CJL, 2008, DIABETES CARE, V31, P451, DOI 10.2337/dc07-1370; Newson R, 2013, PUNAFCC STATA MODULE; Preston SH, 2015, ANN EPIDEMIOL, V25, P907, DOI 10.1016/j.annepidem.2015.07.012; Rawlings AM, 2014, ANN INTERN MED, V161, P785, DOI 10.7326/M14-0737; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Roglic G, 2005, DIABETES CARE, V28, P2130, DOI 10.2337/diacare.28.9.2130; Saydah SH, 2004, ANN EPIDEMIOL, V14, P507, DOI 10.1016/j.annepidem.2003.09.016; Saydah SH, 2002, AM J EPIDEMIOL, V156, P714, DOI 10.1093/aje/kwf111; Saydah SH, 2011, DIABETES PUBLIC HLTH, P267; Selvin E, 2014, ANN INTERN MED, V160, P517, DOI 10.7326/M13-2411; Steenland K, 2006, EPIDEMIOLOGY, V17, P512, DOI 10.1097/01.ede.0000229155.05644.43; Tuomilehto J, 2003, DIABETES CARE, V26, P1770; WHO, 2016, HLTH STAT INF SYST; Zhang XP, 2008, DIABETES CARE, V31, P1748, DOI 10.2337/dc08-0572; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	32	90	93	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0170219	10.1371/journal.pone.0170219	http://dx.doi.org/10.1371/journal.pone.0170219			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28121997	gold, Green Published, Green Submitted			2022-12-26	WOS:000396167300051
J	Bae, K; Cho, K; Kang, SW; Kim, SJ; Kim, JM				Bae, Kunho; Cho, Kyuyeon; Kang, Se Woong; Kim, Sang Jin; Kim, Jong Min			Peripheral Reticular Pigmentary Degeneration and Choroidal Vascular Insufficiency, Studied by Ultra Wide-Field Fluorescein Angiography	PLOS ONE			English	Article							MACULAR DEGENERATION; FUNDUS APPEARANCE; CIRCULATION; EPITHELIUM; DYSTROPHY; DRUSEN	Purpose To explore the pathogenesis of peripheral reticular pigmentary degeneration (PRPD) and its clinical significance. Methods This cross-sectional, observational study (conducted between January 2010 and May 2015) enrolled 441 eyes of 229 subjects, including 35 eyes with PRPD and 406 eyes without PRPD, which was identified by ultra-wide-field fluorescein angiography (UWFA). The distribution and angiographic circulation time of PRPD were assessed by UWFA. The frequencies of systemic and ophthalmologic comorbidities were compared between groups. Univariate and multivariate generalized estimation equation methods were used to determine the risk factors for PRPD. Results The patients with PRPD had a mean age of 75.7 +/- 8.5 years (range, 59-93 years), whereas the patients without PRPD had a mean age of 60.1 +/- 14.9 years (range, 9-92 years). All eyes with PRPD manifested the lesion in the superior nasal periphery with or without circumferential extension. Among those, only 16 eyes (45.7%) in the PRPD group showed distinctive features in the same location on fundus photographs. There was significant choroidal filling delay in the PRPD group when compared with the control group (1.42 +/- 1.22 vs.-0.02 +/- 1.05 seconds, P < 0.001). Multivariate regression analysis revealed that older age (P < 0.001), stroke (P= 0.018), ischemic optic neuropathy (P < 0.001), and age-related macular degeneration (P = 0.022) were significantly associated with PRPD. Conclusions UWFA may enhance the diagnostic sensitivity of PRPD. Choroidal vascular insufficiency with compromised systemic circulation in the elderly was related to the manifestation of PRPD. These results help to better understand the pathophysiology of PRPD. Co-existence of systemic and ophthalmic circulatory disorders should be considered in patients with PRPD.	[Bae, Kunho; Cho, Kyuyeon; Kang, Se Woong; Kim, Sang Jin; Kim, Jong Min] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Kang, SW (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea.	swkang@skku.edu						BASTEK JV, 1981, AM J OPHTHALMOL, V92, P621, DOI 10.1016/S0002-9394(14)74652-5; BASTEK JV, 1982, OPHTHALMOLOGY, V89, P1455; Battaglia Parodi Maurizio, 2004, Semin Ophthalmol, V19, P114; Coleman DJ, 2013, BRIT J OPHTHALMOL, V97, P1020, DOI 10.1136/bjophthalmol-2013-303143; DEUTMAN AF, 1969, ARCH OPHTHALMOL-CHIC, V82, P4, DOI 10.1001/archopht.1969.00990020006002; DUGAN J D JR, 1991, Eye (London), V5, P226; Feigl B, 2009, PROG RETIN EYE RES, V28, P63, DOI 10.1016/j.preteyeres.2008.11.004; FEKE GT, 1989, INVEST OPHTH VIS SCI, V30, P58; Friberg TR, 2008, OPHTHAL SURG LAS IM, V39, P304, DOI 10.3928/15428877-20080701-06; GASS JDM, 1973, ARCH OPHTHALMOL-CHIC, V90, P206; HAYREH SS, 1981, OPHTHALMOLOGICA, V183, P11; HAYREH SS, 1990, EYE, V4, P273, DOI 10.1038/eye.1990.39; HICKAM JB, 1966, CIRCULATION, V33, P302, DOI 10.1161/01.CIR.33.2.302; HUMPHREY WT, 1984, AM J OPHTHALMOL, V98, P717, DOI 10.1016/0002-9394(84)90686-X; Kanski J J, 1975, Mod Probl Ophthalmol, V15, P103; Kim JH, 2013, AM J OPHTHALMOL, V155, P743, DOI 10.1016/j.ajo.2012.11.001; LEWIS H, 1985, OPHTHALMOLOGY, V92, P1485; Manivannan A, 2005, AM J OPHTHALMOL, V140, P525, DOI 10.1016/j.ajo.2005.02.055; McGimpsey SJ, 2007, ARCH OPHTHALMOL-CHIC, V125, P850, DOI 10.1001/archopht.125.6.850; Nishiyama Y, 2001, RETINA-J RET VIT DIS, V21, P237, DOI 10.1097/00006982-200106000-00007; Patel M, 2014, CURR OPIN OPHTHALMOL, V25, P213, DOI 10.1097/ICU.0000000000000042; RABB MF, 1978, SURV OPHTHALMOL, V22, P387, DOI 10.1016/0039-6257(78)90134-0; RUTNIN U, 1967, AM J OPHTHALMOL, V64, P1040, DOI 10.1016/0002-9394(67)93056-5; RUTNIN U, 1967, AM J OPHTHALMOL, V64, P840; Schauwvlieghe PP, 2013, RETINA-J RET VIT DIS, V33, P2118, DOI 10.1097/IAE.0b013e3182899274; Shuler RK, 2008, OPHTHALMOLOGY, V115, P520, DOI 10.1016/j.ophtha.2007.06.021; STRAATSMA BR, 1985, AM J OPHTHALMOL, V100, P202, DOI 10.1016/S0002-9394(14)75007-X; Takahashi K, 1996, OPHTHALMOLOGY, V103, P336; WEITER JJ, 1974, AM J OPHTHALMOL, V78, P583, DOI 10.1016/S0002-9394(14)76294-4; WYBAR KC, 1954, J ANAT, V88, P94	30	10	10	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170526	10.1371/journal.pone.0170526	http://dx.doi.org/10.1371/journal.pone.0170526			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114409	Green Submitted, Green Published, gold			2022-12-26	WOS:000396129000063
J	Ryu, JA; Park, TK; Chung, CR; Cho, YH; Sung, K; Suh, GY; Lee, TR; Sim, MS; Yang, JH				Ryu, Jeong-Am; Park, Taek Kyu; Chung, Chi Ryang; Cho, Yang Hyun; Sung, Kiick; Suh, Gee Young; Lee, Tae Rim; Sim, Min Seob; Yang, Jeong Hoon			Association between Body Temperature Patterns and Neurological Outcomes after Extracorporeal Cardiopulmonary Resuscitation	PLOS ONE			English	Article							HOSPITAL CARDIAC-ARREST; AMERICAN-HEART-ASSOCIATION; LIFE-SUPPORT; BRAIN TEMPERATURE; THERAPEUTIC HYPOTHERMIA; HYPERTHERMIA; GUIDELINES; MANAGEMENT; SURVIVAL; ADULTS	We evaluated the association of body temperature patterns with neurological outcomes after extracorporeal cardiopulmonary resuscitation (ECPR). Between December 2013 and December 2015, we enrolled 48 patients with cardiac arrest who survived for at least 24 hours after ECPR. Based on their body temperature patterns and the intention to control fever, we divided the patients into those in whom fever was actively controlled (N = 25), those with normothermia (N = 17), and those with unintended hypothermia (N = 6). The primary outcome was the Cerebral Performance Categories (CPC) scale at discharge. Of the 48 ECPR patients, 23 patients (47.9%) had good neurological outcomes (CPC 1 and 2) and 27 patients (56.3%) survived to discharge. The normothermia group showed a pattern of higher temperatures compared with the other groups during 48 hours after ECPR. Not only poor neurological outcomes but also intensive care unit (ICU) mortality occurred more often in the unintended hypothermia group than in the other two groups, regardless of the fever control strategy (p = 0.023 and p = 0.002, respectively). There were no differences in neurological outcomes and ICU mortality between the actively controlled fever group and the normothermia group (p = 0.845 and p = 0.616, respectively). Unintentionally sustained hypothermia may be associated with poor neurological outcomes after ECPR. These findings suggest that patients who are unable to generate a fever following ECPR may incur severe hypoxic brain injury.	[Ryu, Jeong-Am; Chung, Chi Ryang; Suh, Gee Young; Yang, Jeong Hoon] Sungkyunkwan Univ, Dept Crit Care Med, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Park, Taek Kyu; Yang, Jeong Hoon] Sungkyunkwan Univ, Div Cardiol, Samsung Med Ctr, Dept Med,Sch Med, Seoul, South Korea; [Cho, Yang Hyun; Sung, Kiick] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac & Cardiovasc Surg, Seoul, South Korea; [Suh, Gee Young] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med,Sch Med, Seoul, South Korea; [Lee, Tae Rim; Sim, Min Seob] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Emergency Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Yang, JH (corresponding author), Sungkyunkwan Univ, Dept Crit Care Med, Samsung Med Ctr, Sch Med, Seoul, South Korea.; Yang, JH (corresponding author), Sungkyunkwan Univ, Div Cardiol, Samsung Med Ctr, Dept Med,Sch Med, Seoul, South Korea.	jhysmc@gmail.com	Suh, Gee Young/O-3676-2019	Suh, Gee Young/0000-0001-5473-1712				Adrie Christophe, 2004, Curr Opin Crit Care, V10, P208, DOI 10.1097/01.ccx.0000126090.06275.fe; [Anonymous], AM HEART ASS CIRC, DOI DOI 10.1161/01.CIR.95.8.2213; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bro-Jeppesen J, 2013, RESUSCITATION, V84, P1734, DOI 10.1016/j.resuscitation.2013.07.023; Cabanac M, 2006, J APPL PHYSIOL, V100, P1338, DOI 10.1152/japplphysiol.01021.2005; Chen YS, 2008, LANCET, V372, P554, DOI 10.1016/S0140-6736(08)60958-7; Childs C, 2008, BRIT J NEUROSURG, V22, P486, DOI 10.1080/02688690802245541; Choi DH, 2016, CLIN EXP EMERG MED, V3, P132, DOI 10.15441/ceem.16.145; Cronberg T, 2015, JAMA NEUROL, V72, P634, DOI 10.1001/jamaneurol.2015.0169; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; Fountas KN, 2003, J NEUROSURG ANESTH, V15, P87, DOI 10.1097/00008506-200304000-00004; Gebhardt K, 2013, RESUSCITATION, V84, P1062, DOI 10.1016/j.resuscitation.2013.03.038; GINSBERG MD, 1992, CEREBROVAS BRAIN MET, V4, P189; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Ha T.S., 2016, EMERG MED J; Hickey RW, 2003, CRIT CARE MED, V31, P531, DOI 10.1097/01.CCM.0000050323.84293.11; Holzer M, 2002, NEW ENGL J MED, V346, P549; Howes D, 2016, RESUSCITATION, V98, P48, DOI 10.1016/j.resuscitation.2015.07.052; Kang MJ, 2014, J KOREAN MED SCI, V29, P1301, DOI 10.3346/jkms.2014.29.9.1301; Kim F, 2014, JAMA-J AM MED ASSOC, V311, P45, DOI 10.1001/jama.2013.282173; Langhelle A, 2003, RESUSCITATION, V56, P247, DOI 10.1016/S0300-9572(02)00409-4; Le Guen M, 2011, CRIT CARE, V15, DOI 10.1186/cc9976; Leary M, 2013, RESUSCITATION, V84, P1056, DOI 10.1016/j.resuscitation.2012.11.003; Link MS, 2015, CIRCULATION, V132, pS444, DOI 10.1161/CIR.0000000000000261; Massetti M, 2005, ANN THORAC SURG, V79, P178, DOI 10.1016/j.athoracsur.2004.06.095; Megarbane B, 2007, INTENS CARE MED, V33, P758, DOI 10.1007/s00134-007-0568-4; Megarbane B, 2011, RESUSCITATION, V82, P1154, DOI 10.1016/j.resuscitation.2011.05.007; Morimura N, 2011, RESUSCITATION, V82, P10, DOI 10.1016/j.resuscitation.2010.08.032; Morrison SF, 2011, FRONT BIOSCI-LANDMRK, V16, P74, DOI 10.2741/3677; Mrozek S, 2012, ANESTHESIOL RES PRAC, V2012, DOI 10.1155/2012/989487; Nagao K, 2010, CIRC J, V74, P77, DOI 10.1253/circj.CJ-09-0502; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Park SB, 2014, INT J CARDIOL, V177, P1031, DOI 10.1016/j.ijcard.2014.09.124; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Romanovsky AA, 2007, AM J PHYSIOL-REG I, V292, pR37, DOI 10.1152/ajpregu.00668.2006; Ryu JA, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0002-3; Sakamoto T, 2014, RESUSCITATION, V85, P762, DOI 10.1016/j.resuscitation.2014.01.031; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Takasu A, 2001, RESUSCITATION, V49, P273, DOI 10.1016/S0300-9572(00)00360-9; TAKINO M, 1991, INTENS CARE MED, V17, P419, DOI 10.1007/BF01720680; Zeiner A, 2001, ARCH INTERN MED, V161, P2007, DOI 10.1001/archinte.161.16.2007	41	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170711	10.1371/journal.pone.0170711	http://dx.doi.org/10.1371/journal.pone.0170711			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114337	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129000086
J	Zhai, J; Wang, Z; Shi, P; Long, C				Zhai, Jian; Wang, Zhu; Shi, Peng; Long, Chao			Microbial Community in a Biofilter for Removal of Low Load Nitrobenzene Waste Gas	PLOS ONE			English	Article							AIR-POLLUTION CONTROL; BACTERIAL DIVERSITY; WATER TREATMENT; ACTIVATED CARBON; BIOFILTRATION; TOLUENE; BIODEGRADATION; DEGRADATION; RHODOCOCCUS; VAPORS	To improve biofilter performance, the microbial community of a biofilter must be clearly defined. In this study, the performance of a lab-scale polyurethane biofilter for treating waste gas with low loads of nitrobenzene (NB) (< 20 g m(-3) h(-1)) was investigated when using different empty bed residence times (EBRT) (64, 55.4 and 34 s, respectively). In addition, the variations of the bacterial community in the biofilm on the longitudinal distribution of the biofilters were analysed by using Illumina MiSeq high-throughput sequencing. The results showed that NB waste gas was successfully degraded in the biofilter. High-throughput sequencing data suggested that the phylum Actinobacteria and genus Rhodococcus played important roles in the degradation of NB. The variations of the microbial community were attributed to the different intermediate degradation products of NB in each layer. The strains identified in this study were potential candidates for purifying waste gas effluents containing NB.	[Zhai, Jian; Wang, Zhu; Shi, Peng; Long, Chao] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resources Reuse, Nanjing, Jiangsu, Peoples R China; [Zhai, Jian] Nanjing Polytech Inst, Dept Appl Chem, Nanjing, Jiangsu, Peoples R China	Nanjing University	Long, C (corresponding author), Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resources Reuse, Nanjing, Jiangsu, Peoples R China.	clong@nju.edu.cn	Zhu, Wang/AAT-1740-2021; 王, 铸/I-3824-2016; Peng, Shi/AAP-7926-2021	王, 铸/0000-0002-6763-8194; Peng, Shi/0000-0002-3333-0458	Natural Science Foundation of Nanjing Polytechnic Institute [NHKY-2016-02]; Jiangsu Provincial Science and Technology Plan Project [BY2015060-03]	Natural Science Foundation of Nanjing Polytechnic Institute; Jiangsu Provincial Science and Technology Plan Project	This study was financially supported by Natural Science Foundation of Nanjing Polytechnic Institute (Grant No. NHKY-2016-02, PI: JZ, URL: http://menhu.njcc.edu.cn/); Jiangsu Provincial Science and Technology Plan Project (No. BY2015060-03). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizpuru A, 2005, J ENVIRON ENG, V131, P396, DOI 10.1061/(ASCE)0733-9372(2005)131:3(396); Arnold M, 1997, APPL MICROBIOL BIOT, V48, P738, DOI 10.1007/s002530051126; Auria R, 1998, J AIR WASTE MANAGE, V48, P65, DOI 10.1080/10473289.1998.10463667; Babbitt CW, 2009, BIORESOURCE TECHNOL, V100, P6207, DOI 10.1016/j.biortech.2009.06.110; Cheng Y, 2016, BIOTECHNOL ADV, V34, P1091, DOI 10.1016/j.biotechadv.2016.06.007; Chou MS, 1997, J AIR WASTE MANAGE, V47, P58, DOI 10.1080/10473289.1997.10464408; ERGAS SJ, 1994, BIOTECHNOL BIOENG, V44, P1048, DOI 10.1002/bit.260440905; Estrada JM, 2011, ENVIRON SCI TECHNOL, V45, P1100, DOI 10.1021/es103478j; Friedrich U, 2002, ENVIRON MICROBIOL, V4, P721, DOI 10.1046/j.1462-2920.2002.00349.x; Green SJ, 2012, APPL ENVIRON MICROB, V78, P1039, DOI 10.1128/AEM.06435-11; Guo XC, 2015, BIORESOURCE TECHNOL, V197, P99, DOI 10.1016/j.biortech.2015.08.049; He ZQ, 1999, ARCH MICROBIOL, V171, P309, DOI 10.1007/s002030050715; Heuvel RNVD, 2010, ENVIRON MICROBIOL, V12, P3264, DOI [10.1111/j.1462-2920.2010.02301.x, DOI 10.1111/J.1462-2920.2010.02301.X]; Jorio H, 1998, J CHEM TECHNOL BIOT, V73, P183, DOI 10.1002/(SICI)1097-4660(1998110)73:3<183::AID-JCTB943>3.0.CO;2-7; Kennes C, 1996, J CHEM TECHNOL BIOT, V66, P300, DOI 10.1002/(SICI)1097-4660(199607)66:3<300::AID-JCTB495>3.3.CO;2-0; Kennes C, 2009, J CHEM TECHNOL BIOT, V84, P1419, DOI 10.1002/jctb.2216; Li GW, 2002, ENVIRON TECHNOL, V23, P467, DOI 10.1080/09593332508618407; Li T, 2014, MAR POLLUT BULL, V89, P384, DOI 10.1016/j.marpolbul.2014.09.028; Lim JH, 2009, INT J SYST EVOL MICR, V59, P2394, DOI 10.1099/ijs.0.009480-0; Lin H, 2011, J BASIC MICROB, V51, P397, DOI 10.1002/jobm.200900429; Liu N, 2013, WORLD J MICROB BIOT, V29, P1859, DOI 10.1007/s11274-013-1348-7; Ministry of Environmental Protection the People's Republic of China, 1987, 7493 GB MIN ENV PROT, V7493; Morgenroth E, 1996, J AIR WASTE MANAGE, V46, P300, DOI 10.1080/10473289.1996.10467464; Oh YS, 1997, J IND MICROBIOL BIOT, V18, P293, DOI 10.1038/sj.jim.2900384; Qi B, 2005, J ENVIRON ENG-ASCE, V131, P180, DOI 10.1061/(ASCE)0733-9372(2005)131:2(180); Sanz JL, 2007, PROCESS BIOCHEM, V42, P119, DOI 10.1016/j.procbio.2006.10.003; SHAREEFDEEN Z, 1994, CHEM ENG SCI, V49, P4347, DOI 10.1016/S0009-2509(05)80026-0; Shen JY, 2009, J HAZARD MATER, V163, P1199, DOI 10.1016/j.jhazmat.2008.07.086; Smet E, 1997, BIODEGRADATION, V8, P53, DOI 10.1023/A:1008201412862; Tang HM, 1996, J AIR WASTE MANAGE, V46, P349, DOI 10.1080/10473289.1996.10467470; Van Groenestijn Johan W., 1993, Biodegradation, V4, P283, DOI 10.1007/BF00695975; Wang XH, 2012, APPL ENVIRON MICROB, V78, P7042, DOI 10.1128/AEM.01617-12; Wang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113603; WARHURST AM, 1994, CRIT REV BIOTECHNOL, V14, P29, DOI 10.1080/0738855031874407; Wen Y, 2015, POL J ENVIRON STUD, V24, P1809, DOI 10.15244/pjoes/38456; Xie B, 2009, BIORESOURCE TECHNOL, V100, P2204, DOI 10.1016/j.biortech.2008.10.035; Yang CP, 2010, BIOTECHNOL ADV, V28, P531, DOI 10.1016/j.biotechadv.2010.04.002; ZILLI M, 1993, BIOTECHNOL BIOENG, V41, P693, DOI 10.1002/bit.260410703	38	31	31	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170417	10.1371/journal.pone.0170417	http://dx.doi.org/10.1371/journal.pone.0170417			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114416	Green Published, Green Submitted, gold			2022-12-26	WOS:000396129000047
J	Cho, YE; Lee, MH; Song, BJ				Cho, Young-Eun; Lee, Myoung-Hwa; Song, Byoung-Joon			Neuronal Cell Death and Degeneration through Increased Nitroxidative Stress and Tau Phosphorylation in HIV-1 Transgenic Rats	PLOS ONE			English	Article							VIRUS-ASSOCIATED DEMENTIA; CENTRAL-NERVOUS-SYSTEM; OXIDATIVE STRESS; NEUROCOGNITIVE DISORDERS; ALZHEIMERS-DISEASE; MEDIATED NEURODEGENERATION; MITOCHONDRIAL DYSFUNCTION; CEREBROSPINAL-FLUID; PARKINSONS-DISEASE; EVOLVING DISEASE	The underlying mechanisms for increased neurodegeneration and neurocognitive deficits in HIV-infected people are unclear. Therefore, this study was aimed to investigate the mechanisms of increased neurodegeneration in 5-month old male HIV-1 Transgenic (Tg) rats compared to the age-and gender-matched wild-type (WT) by evaluating histological changes and biochemical parameters of the key proteins involved in the cell death signaling and apoptosis. Histological and immunohistochemical analyses revealed decreased neuronal cells with elevated astrogliosis in HIV-1 Tg rats compared to WT. Mechanistic studies revealed that increased levels of nitroxidative stress marker proteins such as NADPH-oxidase, cytochrome P450-2E1 (CYP2E1), inducible nitric oxide synthase (iNOS), the stress-activated mitogen-activated protein kinases such as JNK and p38K, activated cell-cycle dependent CDK5, hypoxia-inducible protein-1 alpha, nitrated proteins, hyperphosphorylated tau, and amyloid plaques in HIV-Tg rats were consistently observed in HIV-1 Tg rats. Confocal microscopy and cell viability analyses showed that treatment with an antioxidant N-acetylcysteine or a specific inhibitor of iNOS 1400W significantly prevented the increased apoptosis of neuro-2A cells by HIV-1 Tat or gp120 protein, demonstrating the causal role of HIV-1 mediated nitroxidative stress and protein nitration in promoting neuronal cell death. Immunoprecipitation and immunoblot analysis confirmed nitration of Hsp90, evaluated as an example of nitrated proteins, suggesting possible involvement of nitrated proteins in neuronal damage. Further, activated p-JNK directly binds tau and phosphorylates multiple amino acids, suggesting an important role of p-JNK in tau hyperphosphorylation and tauopathy. These changes were accompanied with elevated levels of many apoptosis-related proteins Bax and cleaved (activated) caspase-3 as well as proinflammatory cytokines including TNF-alpha, IL-6 and MCP-1. Collectively, these results indicate that raised nitroxidative stress accompanied by elevated inflammation, cell death signaling pathway including activated p-JNK, C-terminal C99 amyloid fragment formation and tau hyperphosphorylation are responsible for increased apoptosis of neuronal cells and neurodegeneration in 5-month old HIV-Tg rats.	[Cho, Young-Eun; Song, Byoung-Joon] NIAAA, Sect Mol Pharmacol & Toxicol, Lab Membrane Biochem & Biophys, Bethesda, MD 20892 USA; [Lee, Myoung-Hwa] NINDS, Off Clin Director, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Song, BJ (corresponding author), NIAAA, Sect Mol Pharmacol & Toxicol, Lab Membrane Biochem & Biophys, Bethesda, MD 20892 USA.	bj.song@nih.gov			Intramural Program of the National Institute on Alcohol Abuse and Alcoholism; National Institute of Neurological Disorders and Stroke; Korea Research Institute of Bioscience and Biotechnology, Republic of Korea (KRIBB) Research Initiative Program (Korean Biomedical Scientist Fellowship Program); Korean Biomedical Scientist Fellowship Program; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000036] Funding Source: NIH RePORTER	Intramural Program of the National Institute on Alcohol Abuse and Alcoholism; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Korea Research Institute of Bioscience and Biotechnology, Republic of Korea (KRIBB) Research Initiative Program (Korean Biomedical Scientist Fellowship Program); Korean Biomedical Scientist Fellowship Program; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by the Intramural Program of the National Institute on Alcohol Abuse and Alcoholism and the National Institute of Neurological Disorders and Stroke. Young-Eun Cho was supported by a grant from the Korea Research Institute of Bioscience and Biotechnology, Republic of Korea (KRIBB) Research Initiative Program (Korean Biomedical Scientist Fellowship Program). Drs. Lee and Song are US Government employees and have received our salaries from the National Institutes of Health, while Dr. Cho's salary was provided by the Korean Biomedical Scientist Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Intramural Program of the National Institute on Alcohol Abuse and Alcoholism and the National Institute of Neurological Disorders and Stroke. Young-Eun Cho was supported by a grant from the Korea Research Institute of Bioscience and Biotechnology, Republic of Korea (KRIBB) Research Initiative Program (Korean Biomedical Scientist Fellowship Program). Drs. Lee and Song are US Government employees and have received salaries from the National Institutes of Health, while Dr. Cho's salary was provided by the Korean Biomedical Scientist Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors are grateful to the NIH AIDS Reagent Program for providing the recombinant HIV-1 Tat and gp120 proteins. The authors also like to thank Drs. Klaus Gawrisch and Avindra Nath for the support of this project.	Abdelmegeed M. A., 2014, OXID MED CELL LONGEV, V2014, DOI DOI 10.1155/2014/149627; Abdelmegeed MA, 2016, FREE RADICAL BIO MED, V91, P188, DOI 10.1016/j.freeradbiomed.2015.12.016; Adamson DC, 1996, SCIENCE, V274, P1917, DOI 10.1126/science.274.5294.1917; Adamson DC, 1999, MOL MED, V5, P98, DOI 10.1007/BF03402144; Agrawal L, 2012, NEUROBIOL DIS, V45, P657, DOI 10.1016/j.nbd.2011.10.005; Akbar M, 2016, BRAIN RES; Alfahad TB, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0387-7; Anderson JM, 2010, ACTA NEUROPATHOL, V119, P591, DOI 10.1007/s00401-010-0671-4; Anthony IC, 2006, ACTA NEUROPATHOL, V111, P529, DOI 10.1007/s00401-006-0037-0; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Banerjee A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140498; Baumann K, 1993, FEBS LETT, V336; Becker JT, 2009, NEUROLOGY, V73, P1292, DOI 10.1212/WNL.0b013e3181bd10e7; Blanchard HC, 2015, PROSTAG LEUKOTR ESS, V96, P25, DOI 10.1016/j.plefa.2015.01.002; Brew BJ, 2005, NEUROLOGY, V65, P1490, DOI 10.1212/01.wnl.0000183293.95787.b7; Brier MR, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2362; Brown LAM, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-40; Busceti CL, 2008, J NEUROSCI, V28, P3234, DOI 10.1523/JNEUROSCI.0159-08.2008; Caro AA, 2004, ANNU REV PHARMACOL, V44, P27, DOI 10.1146/annurev.pharmtox.44.101802.121704; Churchill MJ, 2015, J NEUROVIROL, V21, P290, DOI 10.1007/s13365-014-0271-5; Clifford DB, 2009, NEUROLOGY, V73, P1982, DOI 10.1212/WNL.0b013e3181c5b445; Compta Y, 2009, MOVEMENT DISORD, V24, P2203, DOI 10.1002/mds.22594; EVERALL IP, 1991, LANCET, V337, P1119, DOI 10.1016/0140-6736(91)92786-2; EVERALL IP, 1993, J NEUROL NEUROSUR PS, V56, P481, DOI 10.1136/jnnp.56.5.481; Fan X, 2013, AM J PHYSIOL-LUNG C, V305, P1267, DOI 10.1152/ajplung.00288.2012; Franco MC, 2013, P NATL ACAD SCI USA, V110, pE1102, DOI 10.1073/pnas.1215177110; Garcia-Osta A, 2016, METHODS MOL BIOL, V1303, P117, DOI 10.1007/978-1-4939-2627-5_5; Garden GA, 2002, J NEUROSCI, V22, P4015, DOI 10.1523/JNEUROSCI.22-10-04015.2002; Gendron TF, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-13; GRAZIOSI C, 1993, AIDS, V7, pS53, DOI 10.1097/00002030-199311002-00012; Green AJE, 2000, SEX TRANSM INFECT, V76, P443, DOI 10.1136/sti.76.6.443; HAMPL V, 1995, EUR RESPIR J, V8, P515; He T, 2007, PATHOBIOLOGY, V74, P336, DOI 10.1159/000110027; Husain M, 2009, J BIOL CHEM, V284, P16648, DOI 10.1074/jbc.M109.008482; Ioannou GN, 2013, HEPATOLOGY, V57, P249, DOI 10.1002/hep.25800; Jang S, 2015, REDOX BIOL, V6, P552, DOI 10.1016/j.redox.2015.09.040; Kang YJ, 2010, ANN NEUROL, V68, P342, DOI 10.1002/ana.22070; Kaul M, 2005, CELL DEATH DIFFER, V12, P878, DOI 10.1038/sj.cdd.4401623; Kelder W, 1998, ANN NEUROL, V44, P831, DOI 10.1002/ana.410440521; Kim BO, 2003, AM J PATHOL, V162, P1693, DOI 10.1016/S0002-9440(10)64304-0; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; Kim EK, 2015, ARCH TOXICOL, V89, P867, DOI 10.1007/s00204-015-1472-2; Kim SH, 2015, AM J TRANSL RES, V7, P328; KIMURA T, 1993, FEBS LETT, V326, P232, DOI 10.1016/0014-5793(93)81797-4; Kline ER, 2008, AM J PHYSIOL-HEART C, V294, pH2792, DOI 10.1152/ajpheart.91447.2007; Klotman PE, 1999, KIDNEY INT, V56, P1161, DOI 10.1046/j.1523-1755.1999.00748.x; Lashomb AL, 2009, J NEUROVIROL, V15, P14, DOI 10.1080/13550280802232996; Lassiter Coy, 2009, AIDS Res Ther, V6, P1, DOI 10.1186/1742-6405-6-1; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; Lee DC, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-56; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Masliah E, 1996, AM J PATHOL, V149, P745; Masliah E, 1996, CRIT REV NEUROBIOL, V10, P57, DOI 10.1615/CritRevNeurobiol.v10.i1.30; Mattson MP, 2000, ANN NY ACAD SCI, V924, P153; McArthur JC, 2003, J NEUROVIROL, V9, P205, DOI 10.1080/13550280390194109; McArthur JC, 2004, J NEUROIMMUNOL, V157, P3, DOI 10.1016/j.jneuroim.2004.08.042; Mookherjee P, 2001, BRAIN RES, V921, P31, DOI 10.1016/S0006-8993(01)03074-8; Mootsikapun Piroon, 1996, Journal of the Medical Association of Thailand, V79, P477; Muntane G, 2008, NEUROSCIENCE, V152, P913, DOI 10.1016/j.neuroscience.2008.01.030; Nakamura H, 2002, ANTIOXID REDOX SIGN, V4, P455, DOI 10.1089/15230860260196245; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Ozdener H, 2005, J BIOSCIENCES, V30, P391, DOI 10.1007/BF02703676; Patel RC, 1996, MED CLIN N AM, V80, P1493, DOI 10.1016/S0025-7125(05)70500-9; Patrick C, 2011, AM J PATHOL, V178, P1646, DOI 10.1016/j.ajpath.2010.12.033; Price RW, 1996, LANCET, V348, P445, DOI 10.1016/S0140-6736(95)11035-6; Ramage SN, 2005, NEUROPATH APPL NEURO, V31, P439, DOI 10.1111/j.1365-2990.2005.00670.x; Reddy PVB, 2012, NEUROCHEM RES, V37, P1697, DOI 10.1007/s11064-012-0779-0; Reid W, 2001, P NATL ACAD SCI USA, V98, P9271, DOI 10.1073/pnas.161290298; Robertson Graham, 2001, American Journal of Physiology, V281, pG1135; Royal W, 2012, J NEUROIMMUNOL, V247, P16, DOI 10.1016/j.jneuroim.2012.03.015; Rudrabhatla P, 2011, FASEB J, V25, P3896, DOI 10.1096/fj.11-181297; Shah A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.374; Song BJ, 2014, REDOX BIOL, V3, P109, DOI 10.1016/j.redox.2014.10.004; Steinbrink F, 2013, EUR J NEUROL, V20, P420, DOI 10.1111/ene.12006; Suh SK, 2004, PROTEOMICS, V4, P3401, DOI 10.1002/pmic.200400971; Sy M, 2011, AM J PATHOL, V178, P2811, DOI 10.1016/j.ajpath.2011.02.012; Tang FR, 2005, EUR J NEUROSCI, V21, P2361, DOI 10.1111/j.1460-9568.2005.04071.x; Vigorito M, 2007, J NEUROIMMUNE PHARM, V2, P319, DOI 10.1007/s11481-007-9078-y; Wang JZ, 2013, J ALZHEIMERS DIS, V33, pS123, DOI 10.3233/JAD-2012-129031; Williams R, 2010, GLIA, V58, P611, DOI 10.1002/glia.20949; Yao HH, 2009, J NEUROVIROL, V15, P164, DOI 10.1080/13550280902755375; Yun JW, 2014, FREE RADICAL BIO MED, V77, P183, DOI 10.1016/j.freeradbiomed.2014.08.030; Zhang QG, 2013, BRAIN, V136, P1432, DOI 10.1093/brain/awt046	83	32	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0169945	10.1371/journal.pone.0169945	http://dx.doi.org/10.1371/journal.pone.0169945			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107387	gold, Green Published, Green Submitted			2022-12-26	WOS:000392405300054
J	Kaurilind, E; Brosche, M				Kaurilind, Eve; Brosche, Mikael			Stress Marker Signatures in Lesion Mimic Single and Double Mutants Identify a Crucial Leaf Age-Dependent Salicylic Acid Related Defense Signal	PLOS ONE			English	Article							HYPERSENSITIVE CELL-DEATH; OXIDATIVE STRESS; TRANSCRIPTION FACTOR; MORPHOGENIC RESPONSES; ESSENTIAL COMPONENT; MONOOXYGENASE FMO1; HYDROGEN-PEROXIDE; PLANT DEVELOPMENT; GENE-EXPRESSION; ARABIDOPSIS	Plants are exposed to abiotic and biotic stress conditions throughout their lifespans that activates various defense programs. Programmed cell death (PCD) is an extreme defense strategy the plant uses to manage unfavorable environments as well as during developmentally induced senescence. Here we investigated the role of leaf age on the regulation of defense gene expression in Arabidopsis thaliana. Two lesion mimic mutants with misregulated cell death, catalase2 (cat2) and defense no death1 (dnd1) were used together with several double mutants to dissect signaling pathways regulating defense gene expression associated with cell death and leaf age. PCD marker genes showed leaf age dependent expression, with the highest expression in old leaves. The salicylic acid (SA) biosynthesis mutant salicylic acid induction deficient2 (sid2) had reduced expression of PCD marker genes in the cat2 sid2 double mutant demonstrating the importance of SA biosynthesis in regulation of defense gene expression. While the auxin-and jasmonic acid (JA)-insensitive auxin resistant1 (axr1) double mutant cat2 axr1 also led to decreased expression of PCD markers; the expression of several marker genes for SA signaling (ISOCHORISMATE SYNTHASE 1, PR1 and PR2) were additionally decreased in cat2 axr1 compared to cat2. The reduced expression of these SA markers genes in cat2 axr1 implicates AXR1 as a regulator of SA signaling in addition to its known role in auxin and JA signaling. Overall, the current study reinforces the important role of SA signaling in regulation of leaf age-related transcript signatures.	[Kaurilind, Eve] Univ Tartu, Inst Ecol & Earth Sci, Tartu, Estonia; [Kaurilind, Eve] Estonian Univ Life Sci, Inst Agr & Environm Sci, Tartu, Estonia; [Brosche, Mikael] Univ Helsinki, Viikki Plant Sci Ctr, Dept Biosci, Div Plant Biol, Helsinki, Finland; [Brosche, Mikael] Univ Tartu, Inst Technol, Tartu, Estonia	University of Tartu; Tartu University Institute of Ecology & Earth Sciences; Estonian University of Life Sciences; University of Helsinki; University of Tartu	Kaurilind, E (corresponding author), Univ Tartu, Inst Ecol & Earth Sci, Tartu, Estonia.; Kaurilind, E (corresponding author), Estonian Univ Life Sci, Inst Agr & Environm Sci, Tartu, Estonia.	eve.kaurilind@ut.ee	Brosché, Mikael/H-2260-2015	Brosché, Mikael/0000-0002-1135-2496; Kaurilind, Eve/0000-0001-7605-349X; Kaurilind, Eve/0000-0002-0762-3484	European Social Fund [MJD115]; European Commission through the European Regional Fund (Center of Excellence in Environmental Adaptation) [F11100PKTF]; Academy of Finland Centre of Excellence in the Molecular Biology of Primary Producers [271832]	European Social Fund(European Social Fund (ESF)); European Commission through the European Regional Fund (Center of Excellence in Environmental Adaptation); Academy of Finland Centre of Excellence in the Molecular Biology of Primary Producers	This work was supported by European Social Fund (Mobilitas Post-doc grant MJD115), the European Commission through the European Regional Fund (Center of Excellence in Environmental Adaptation F11100PKTF) and the Academy of Finland Centre of Excellence in the Molecular Biology of Primary Producers (2014-2019) (decision #271832).	Ali R, 2007, PLANT CELL, V19, P1081, DOI 10.1105/tpc.106.045096; Allahverdiyeva Y, 2015, NEW PHYTOL, V208, P647, DOI 10.1111/nph.13549; Bailey-Serres J, 2013, ANNU REV PLANT BIOL, V64, P293, DOI 10.1146/annurev-arplant-050312-120035; Balbi V, 2008, NEW PHYTOL, V177, P301, DOI 10.1111/j.1469-8137.2007.02292.x; Bartsch M, 2006, PLANT CELL, V18, P1038, DOI 10.1105/tpc.105.039982; Baxter A, 2014, J EXP BOT, V65, P1229, DOI 10.1093/jxb/ert375; Blomster T, 2011, PLANT PHYSIOL, V157, P1866, DOI 10.1104/pp.111.181883; Bruggeman Q, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00024; Carella P, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00775; Chaouch S, 2010, PLANT PHYSIOL, V153, P1692, DOI 10.1104/pp.110.153957; Clough SJ, 2000, P NATL ACAD SCI USA, V97, P9323, DOI 10.1073/pnas.150005697; Conrath U, 2015, ANNU REV PHYTOPATHOL, V53, P97, DOI 10.1146/annurev-phyto-080614-120132; Coupe SA, 2006, J EXP BOT, V57, P329, DOI 10.1093/jxb/erj033; Cutler S, 1996, SCIENCE, V273, P1239, DOI 10.1126/science.273.5279.1239; Dharmasiri N, 2007, PLANT J, V52, P114, DOI 10.1111/j.1365-313X.2007.03211.x; Encinas-Villarejo S, 2009, J EXP BOT, V60, P3043, DOI 10.1093/jxb/erp152; Falk A, 1999, P NATL ACAD SCI USA, V96, P3292, DOI 10.1073/pnas.96.6.3292; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; Foyer CH, 2009, ANTIOXID REDOX SIGN, V11, P861, DOI 10.1089/ars.2008.2177; Gao QM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00228; Gao X, 2014, PLANT CELL ENVIRON, V37, P175, DOI 10.1111/pce.12144; Gordon MJ, 2013, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00303; Gou MY, 2009, PLANT J, V60, P757, DOI 10.1111/j.1365-313X.2009.03995.x; Han Y, 2013, PLANT CELL ENVIRON, V36, P1135, DOI 10.1111/pce.12048; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Inze A, 2012, PLANT CELL ENVIRON, V35, P308, DOI 10.1111/j.1365-3040.2011.02323.x; Kaurilind E, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1964-8; Kazan K, 2009, TRENDS PLANT SCI, V14, P373, DOI 10.1016/j.tplants.2009.04.005; Kerchev P, 2016, PLANT PHYSIOL, V171, P1704, DOI 10.1104/pp.16.00359; Kerchev P, 2015, PLANT CELL ENVIRON, V38, P253, DOI 10.1111/pce.12250; Khan M, 2014, GERONTOLOGY, V60, P49, DOI 10.1159/000354334; Kus JV, 2002, PLANT CELL, V14, P479, DOI 10.1105/tpc.010481; La Camera S, 2005, PLANT J, V44, P810, DOI 10.1111/j.1365-313X.2005.02578.x; La Camera S, 2009, MOL PLANT MICROBE IN, V22, P469, DOI 10.1094/MPMI-22-4-0469; Lake JA, 2002, J EXP BOT, V53, P183, DOI 10.1093/jexbot/53.367.183; Lake JA, 2001, NATURE, V411, P154, DOI 10.1038/35075660; Li YS, 2013, PLANT PHYSIOL, V163, P1059, DOI 10.1104/pp.113.225805; Ljung K, 2015, CURR OPIN PLANT BIOL, V25, P130, DOI 10.1016/j.pbi.2015.05.022; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Lorrain S, 2003, TRENDS PLANT SCI, V8, P263, DOI 10.1016/S1360-1385(03)00108-0; Mishina TE, 2006, PLANT PHYSIOL, V141, P1666, DOI 10.1104/pp.106.081257; Mittler R, 2015, PLANT CELL, V27, P64, DOI 10.1105/tpc.114.133090; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Mullineaux PM, 2010, PLANT PHYSIOL, V154, P521, DOI 10.1104/pp.110.161406; Nurmberg PL, 2007, P NATL ACAD SCI USA, V104, P18795, DOI 10.1073/pnas.0705586104; Overmyer K, 2003, TRENDS PLANT SCI, V8, P335, DOI 10.1016/S1360-1385(03)00135-3; Park JH, 2002, PLANT J, V31, P1, DOI 10.1046/j.1365-313X.2002.01328.x; Petersen NHT, 2008, FEBS J, V275, P4378, DOI 10.1111/j.1742-4658.2008.06584.x; Pieterse CMJ, 2014, ANNU REV PHYTOPATHOL, V52, P347, DOI 10.1146/annurev-phyto-082712-102340; Potters G, 2009, PLANT CELL ENVIRON, V32, P158, DOI 10.1111/j.1365-3040.2008.01908.x; Potters G, 2007, TRENDS PLANT SCI, V12, P98, DOI 10.1016/j.tplants.2007.01.004; Queval G, 2007, PLANT J, V52, P640, DOI 10.1111/j.1365-313X.2007.03263.x; Raffaele S, 2008, PLANT CELL, V20, P752, DOI 10.1105/tpc.107.054858; Sadanandom A, 2012, NEW PHYTOL, V196, P13, DOI 10.1111/j.1469-8137.2012.04266.x; Schmiesing A, 2016, PLANT PHYSIOL, P00031, DOI DOI 10.1104/PP.16.00031; Simanshu DK, 2014, CELL REP, V6, P388, DOI 10.1016/j.celrep.2013.12.023; Suzuki N, 2011, CURR OPIN PLANT BIOL, V14, P691, DOI 10.1016/j.pbi.2011.07.014; Tiryaki I, 2002, PLANT PHYSIOL, V130, P887, DOI 10.1104/pp.005272; Van Hautegem T, 2015, TRENDS PLANT SCI, V20, P102, DOI 10.1016/j.tplants.2014.10.003; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Waszczak C, 2016, PLANT CELL, V28, P1844, DOI 10.1105/tpc.16.00038; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Willekens H, 1997, EMBO J, V16, P4806, DOI 10.1093/emboj/16.16.4806; Xia XJ, 2015, J EXP BOT, V66, P2839, DOI 10.1093/jxb/erv089; Xu EJ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-155; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x	66	7	8	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170532	10.1371/journal.pone.0170532	http://dx.doi.org/10.1371/journal.pone.0170532			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107453	Green Published, Green Submitted, gold			2022-12-26	WOS:000392405300158
J	Nwuche, CO; Ujam, OT; Ibezim, A; Ujam, IB				Nwuche, Charles O.; Ujam, Oguejiofo T.; Ibezim, Akachukwu; Ujam, Ifeoma B.			Experimental and In-Silico Investigation of Anti-Microbial Activity of 1-Chloro-2-Isocyanatoethane Derivatives of Thiomorpholine, Piperazine and Morpholine	PLOS ONE			English	Article							ANTIBIOTICS; FRAGMENT	The Antibiogram properties of 1-chloro-2-isocyanatoethane derivatives of thiomorpholine (CTC), piperazine (CPC) and morpholine (CMC) were evaluated by the approved agar well diffusion, the minimum inhibitory concentration (MIC) and in silico techniques. A total of fourteen microbial cultures consisting of ten bacteria and four yeast strains were used in the biological study while affinity of the compounds for DNA gyrase, a validated antibacterial drug target, was investigated by docking method. Results indicate that both thiomorpholine and piperazine had zero activity against the Gram negative organisms tested. With morpholine, similar result was obtained except that cultures of Escherichia coli (ATCC 15442) and Salmonella typhi (ATCC 6539) presented with weak sensitivity (7-8 mm) as shown by the inhibition zone diameter (IZD) measurement. The Gram positive organisms were more sensitive to morpholine than the other compounds. The highest IZD values of 15-18 mm were achieved except for Streptococcus pneumoniae (ATCC 49619) in which mobility of the compound stopped after 12 mm. S. pneumoniae was resistant to both thiomorpholine and piperazine. The yeast strains were not sensitive to any of the studied compounds investigated. The MIC tests evaluated against a reference antibiotic show that while morpholine was most active at 4 mu g.ml(-1) against both B. cereus ATCC (14579) and B. subtilis, the least active compound was thiomorpholine which inhibited S. aureus (ATCC 25923) at 64 mu g.ml(-1). The three compounds demonstrated high affinity for the target protein (DNA gyrase) ranging from -4.63 to -5.64 Kcal/mol and even showed better ligand efficiencies than three known antibiotics; chlorobiocin, ciprofloxacin and tetracycline. This study identified the studied compounds as potential antibiotic leads with acceptable physicochemical properties and gave the molecular basis for the observed interactions between the compounds and the target protein which can be harnessed in structural optimization process.	[Nwuche, Charles O.] Univ Nigeria, Dept Microbiol, Nsukka, Enugu State, Nigeria; [Nwuche, Charles O.; Ujam, Oguejiofo T.] Japan Int Res Ctr Agr Sci, Tsukuba, Ibaraki, Japan; [Ujam, Oguejiofo T.] Univ Nigeria, Dept Pure & Ind Chem, Nsukka, Enugu State, Nigeria; [Ibezim, Akachukwu] Univ Nigeria, Dept Pharmaceut & Med Chem, Nsukka, Enugu State, Nigeria; [Ujam, Ifeoma B.] Univ Nigeria, Dept Pharmacognosy, Nsukka, Enugu State, Nigeria	University of Nigeria; Japan International Research Center for Agricultural Sciences; University of Nigeria; University of Nigeria; University of Nigeria	Ujam, OT (corresponding author), Univ Nigeria, Dept Pure & Ind Chem, Nsukka, Enugu State, Nigeria.; Ibezim, A (corresponding author), Univ Nigeria, Dept Pharmaceut & Med Chem, Nsukka, Enugu State, Nigeria.	oguejiofo.ujam@unn.edu.ng; akachukwu.ibezim@unn.edu.ng	Ujam, Oguejiofo T./F-6706-2012	Ujam, Oguejiofo T./0000-0002-5628-209X				Al-Habib A, 2010, J TOXICOL SCI, V35, P357, DOI 10.2131/jts.35.357; Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Amani AM, 2015, DRUG RES, V65, P5, DOI 10.1055/s-0033-1364001; [Anonymous], 2010, Drug Discov Today Technol, V7, pe147, DOI 10.1016/j.ddtec.2010.11.003; [Anonymous], 2012, TURK J CHEM, V36, P35; [Anonymous], 2014, DISC STUD VIS SOFTW; [Anonymous], 2010, MOL OP ENV MOE SOFTW; Basoglu S, 2013, ACTA POL PHARM, V70, P229; Battula K, 2016, J SERB CHEM SOC, V81, P233, DOI 10.2298/JSC150818088B; Bektas H, 2013, MED CHEM RES, V22, P3629, DOI 10.1007/s00044-012-0318-1; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bollenbach T, 2015, CURR OPIN MICROBIOL, V27, P1, DOI 10.1016/j.mib.2015.05.008; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Cushnie TPT, 2011, INT J ANTIMICROB AG, V38, P99, DOI 10.1016/j.ijantimicag.2011.02.014; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; DeLano W. L, 2013, PYMOL MOL GRAPHICS S; Ehmann DE, 2014, CURR OPIN PHARMACOL, V18, P76, DOI 10.1016/j.coph.2014.09.007; Ertl P, 2000, J MED CHEM, V43, P3714, DOI 10.1021/jm000942e; Faist J, 2012, EUR J MED CHEM, V47, P510, DOI 10.1016/j.ejmech.2011.11.022; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Hawkey PM, 2008, J ANTIMICROB CHEMOTH, V62, pI1, DOI 10.1093/jac/dkn241; Ibezim A., 2015, J APPL PHARM SCI, V5, P133; Ibezim A, 2016, J CHEMINFORM S1, V8, P1; Kardile DP, 2010, INT J APP BIO PHARM, V1, P1021; Larson E, 2007, ANNU REV PUBL HEALTH, V28, P435, DOI 10.1146/annurev.publhealth.28.021406.144020; Lovering F, 2013, MEDCHEMCOMM, V4, P515, DOI 10.1039/c2md20347b; Metuge JA, 2015, MED CHEM RES, V24, P2127, DOI 10.1007/s00044-014-1280-x; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Ntie-Kang F, 2014, J CHEM INF MODEL, V54, P2433, DOI 10.1021/ci5003697; Ozoemena CP, 2015, THESIS; Poole K, 2002, J APPL MICROBIOL, V92, p55S, DOI 10.1046/j.1365-2672.92.5s1.8.x; Rajeev Kharb, 2012, Der Pharma Chemica, V4, P2470; Ray K, 2012, NAT REV GASTRO HEPAT, V9, P615, DOI DOI 10.1038/NRGASTRO.2012.175; Ritchie TJ, 2012, MEDCHEMCOMM, V3, P1062, DOI 10.1039/c2md20111a; Seelolla G, 2014, MED CHEM, V4, P778, DOI DOI 10.4172/2161-0444.1000229; Slama TG, 2005, AM J MED, V118, P1, DOI 10.1016/j.amjmed.2005.05.007; Smullen J, 2007, CARIES RES, V41, P342, DOI 10.1159/000104791; Somashekhar M, 2013, AM J PHARMTECH RES, V3, P640; TAGG JR, 1971, APPL MICROBIOL, V21, P943, DOI 10.1128/AEM.21.5.943-943.1971; Taylor RD, 2014, J MED CHEM, V57, P5845, DOI 10.1021/jm4017625; Ujam OT, 2014, ACTA CRYSTALLOGR E, V70, pO463, DOI 10.1107/S1600536814005832; Ujam OT, 2010, INORG CHIM ACTA, V363, P3558, DOI 10.1016/j.ica.2010.07.011; Vitaku E, 2014, J MED CHEM, V57, P10257, DOI 10.1021/jm501100b; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0	48	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170150	10.1371/journal.pone.0170150	http://dx.doi.org/10.1371/journal.pone.0170150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107379	gold, Green Published, Green Submitted			2022-12-26	WOS:000392405300077
J	Guo, A; Lu, P; Lee, J; Zhen, C; Chiosis, G; Wang, YL				Guo, A.; Lu, P.; Lee, J.; Zhen, C.; Chiosis, G.; Wang, Y. L.			HSP90 stabilizes B-cell receptor kinases in a multi-client interactome: PU-H71 induces CLL apoptosis in a cytoprotective microenvironment	ONCOGENE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; IBRUTINIB RESISTANCE; INHIBITOR IBRUTINIB; ANTITUMOR-ACTIVITY; LYMPHOMA; MECHANISMS; MUTATIONS; PROTEINS; TARGETS; BTK	Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of B cells in the hematopoietic system and lymphoid tissues. Although inhibitors targeting the B-cell receptor (BCR) pathway have been successful in the treatment of the disease, the underlying mechanisms leading to BCR over-activity in CLL are not fully understood. In this study, we found that HSP90, a highly conserved molecular chaperone, is overexpressed in CLL compared with resting B cells. HSP90 overexpression is accompanied by the overexpression of several BCR kinases including LYN, spleen tyrosine kinase, Bruton tyrosine kinase and AKT. Chemical and immune-precipitation demonstrated that these BCR constituents are present in a multi-client chaperone complex with HSP90. Inhibition of HSP90 with PU-H71 destabilized the BCR kinases and caused apoptosis of CLL cells through the mitochondrial apoptotic pathway. Further, PU-H71 induced apoptosis in the presence of stromal co-culture or cytoprotective survival signals. Finally, genetic knockdown of HSP90 and its client AKT, but not BTK, reduced CLL viability. Overall, our study suggests that the chaperone function of HSP90 contributes to the over-activity of the BCR signaling in CLL and inhibition of HSP90 has the potential to achieve a multi-targeting effect. Thus, HSP90 inhibition may be explored to prevent or overcome drug resistance to single targeting agents.	[Guo, A.; Lu, P.; Lee, J.; Zhen, C.; Wang, Y. L.] Univ Chicago, Dept Pathol, Div Genom & Mol Pathol, Chicago, IL 60637 USA; [Chiosis, G.] Mem Sloan Kettering Canc Ctr, Program Chem Biol, 1275 York Ave, New York, NY 10021 USA; [Chiosis, G.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA	University of Chicago; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Wang, YL (corresponding author), Univ Chicago, Dept Pathol, MC1089,N316,5841 South Maryland Ave, Chicago, IL 60637 USA.	ylwang@bsd.uchicago.edu	Wang, Y. Lynn/GRF-6667-2022	Wang, Y. Lynn/0000-0003-0773-1212; Lee, Justine C./0000-0002-8943-0837; Lee, Jimmy/0000-0002-5547-4858	NATIONAL CANCER INSTITUTE [P30CA008748, P50CA192937, R01CA172546, P01CA186866, R21CA158609] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000459] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH076499] Funding Source: NIH RePORTER; NCATS NIH HHS [TL1 TR000459] Funding Source: Medline; NCI NIH HHS [R21 CA158609, P50 CA192937, R01 CA172546, P01 CA186866, P30 CA008748] Funding Source: Medline; NCRR NIH HHS [UL1 RR024996] Funding Source: Medline; NIMH NIH HHS [R03 MH076499] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Advani RH, 2013, J CLIN ONCOL, V31, P88, DOI 10.1200/JCO.2012.42.7906; Andersen OS, 2013, NAT CHEM BIOL, V9, P667, DOI 10.1038/nchembio.1368; Balakrishnan K, 2009, BLOOD, V113, P149, DOI 10.1182/blood-2008-02-138560; Burger JA, 2011, HEMATOL-AM SOC HEMAT, P96, DOI 10.1182/asheducation-2011.1.96; Byrd JC, 2013, NEW ENGL J MED, V369, P32, DOI 10.1056/NEJMoa1215637; Cheng S, 2015, LEUKEMIA, V29, P895, DOI 10.1038/leu.2014.263; Cheng S, 2014, LEUKEMIA, V28, P649, DOI 10.1038/leu.2013.358; Cheng SH, 2011, BLOOD, V118, P6342, DOI 10.1182/blood-2011-02-333773; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Duhren-von Minden M, 2012, NATURE, V489, P309, DOI 10.1038/nature11309; Furman RR, 2014, NEW ENGL J MED, V370, P2352, DOI 10.1056/NEJMc1402716; Furman RR, 2014, NEW ENGL J MED, V370, P997, DOI 10.1056/NEJMoa1315226; Gerecitano JF, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.15_suppl.2537; Goldstein RL, 2015, J CLIN INVEST, V125, P4559, DOI 10.1172/JCI80714; Grzybowska-Izydorczyk O, 2010, EUR J CANCER, V46, P800, DOI 10.1016/j.ejca.2009.11.023; Guo AL, 2016, ONCOTARGET, V7, P4598, DOI 10.18632/oncotarget.6727; Haerzschel A, 2016, ANN HEMATOL, V95, P1979, DOI 10.1007/s00277-016-2788-6; Hayden RE, 2012, LEUKEMIA LYMPHOMA, V53, P537, DOI 10.3109/10428194.2011.610014; Hertlein E, 2010, BLOOD, V116, P45, DOI 10.1182/blood-2010-01-263756; Kitada S, 1998, BLOOD, V91, P3379, DOI 10.1182/blood.V91.9.3379; Landau DA, 2015, NATURE, V526, P525, DOI 10.1038/nature15395; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Liu TM, 2015, BLOOD, V126, P61, DOI 10.1182/blood-2015-02-626846; Lu P, 2009, LEUKEMIA, V23, P807, DOI 10.1038/leu.2008.304; Ma J, 2015, ONCOTARGET, V6, P43881, DOI 10.18632/oncotarget.6316; Morton LM, 2006, BLOOD, V107, P265, DOI 10.1182/blood-2005-06-2508; Moulick K, 2011, NAT CHEM BIOL, V7, P818, DOI 10.1038/nchembio.670; Puente XS, 2015, NATURE, V526, P519, DOI 10.1038/nature14666; Rai KR, 2016, AM J HEMATOL, V91, P330, DOI 10.1002/ajh.24282; Robertson LE, 1996, LEUKEMIA, V10, P456; Scaltriti M, 2012, CLIN CANCER RES, V18, P4508, DOI 10.1158/1078-0432.CCR-11-2138; Sharman J, 2015, BLOOD, V125, P2336, DOI 10.1182/blood-2014-08-595934; Shrestha L, 2016, CELL CHEM BIOL, V23, P158, DOI 10.1016/j.chembiol.2015.12.006; Song ZB, 2010, CLIN CANCER RES, V16, P587, DOI 10.1158/1078-0432.CCR-09-1519; Taldone T, 2014, TRENDS PHARMACOL SCI, V35, P48, DOI 10.1016/j.tips.2014.09.001; Trentin L, 2008, BLOOD, V112, P4665, DOI 10.1182/blood-2008-02-139139; Walsby E, 2012, ONCOTARGET, V3, P525; Woyach JA, 2014, NEW ENGL J MED, V370, P2286, DOI 10.1056/NEJMoa1400029; Yang C, 2008, LEUKEMIA, V22, P1755, DOI 10.1038/leu.2008.163; Zong HL, 2015, CELL REP, V13, P2159, DOI 10.1016/j.celrep.2015.10.073	41	15	15	2	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 15	2017	36	24					3441	3449		10.1038/onc.2016.494	http://dx.doi.org/10.1038/onc.2016.494			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EX6GL	28114285	Green Accepted			2022-12-26	WOS:000403340700008
J	Chen, RY; Zhang, Q; Duan, XY; York, P; Chen, GD; Yin, PC; Zhu, HJ; Xu, MC; Chen, PL; Wu, QH; Li, DL; Samarut, J; Xu, GL; Zhang, PM; Cao, XH; Li, JW; Wong, JM				Chen, Ruoyu; Zhang, Qiao; Duan, Xiaoya; York, Philippe; Chen, Guo-Dong; Yin, Pengcheng; Zhu, Haijun; Xu, Meichen; Chen, Peilin; Wu, Qihan; Li, Dali; Samarut, Jacques; Xu, Guoliang; Zhang, Pumin; Cao, Xiaohua; Li, Jiwen; Wong, Jiemin			The 5-Hydroxymethylcytosine (5hmC) Reader UHRF2 Is Required for Normal Levels of 5hmC in Mouse Adult Brain and Spatial Learning and Memory	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLGLUCOSAMINE TRANSFERASE OGT; EMBRYONIC STEM-CELLS; DNA METHYLATION; BASE-RESOLUTION; MAMMALIAN DNA; TET PROTEINS; 5-METHYLCYTOSINE; DNMT1; CHROMATIN; 5-CARBOXYLCYTOSINE	UHRF2 has been implicated as a novel regulator for both DNA methylation (5mC) and hydroxymethylation (5hmC), but its physiological function and role in DNA methylation/ hydroxymethylation are unknown. Here we show that in mice, UHRF2 is more abundantly expressed in the brain and a few other tissues. Uhrf2 knock-out mice are viable and fertile and exhibit no gross defect. Although there is no significant change of DNA methylation, the Uhrf2 null mice exhibit a reduction of 5hmC in the brain, including the cortex and hippocampus. Furthermore, the Uhrf2 null mice exhibit a partial impairment in spatial memory acquisition and retention. Consistent with the phenotype, gene expression profiling uncovers a role for UHRF2 in regulating neuron-related gene expression. Finally, we provide evidence that UHRF2 binds 5hmC in cells but does not appear to affect the TET1 enzymatic activity. Together, our study supports UHRF2 as a bona fide 5hmC reader and further demonstrates a role for 5hmC in neuronal function.	[Chen, Ruoyu; Zhang, Qiao; Duan, Xiaoya; Zhu, Haijun; Chen, Peilin; Wu, Qihan; Li, Dali; Li, Jiwen; Wong, Jiemin] East China Normal Univ, Inst Biomed Sci & Sch Life Sci, Shanghai Key Lab Regulatory Biol, 500 Dongchuan Rd, Shanghai 200241, Peoples R China; [York, Philippe; Zhang, Pumin] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Chen, Guo-Dong] Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Yin, Pengcheng; Xu, Meichen; Cao, Xiaohua] China Normal Univ, Shanghai Key Lab Brain Funct Genom, Key Lab Brain Funct Genom, Minist Educ, Shanghai 200062, Peoples R China; [Samarut, Jacques] Univ Lyon 1, CNRS, UMR5242, Inst Genom Fonctionnelle Lyon, F-69007 Lyon, France; [Wong, Jiemin] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Peoples R China	East China Normal University; Baylor College of Medicine; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; East China Normal University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Sun Yat Sen University	Li, JW; Wong, JM (corresponding author), East China Normal Univ, Inst Biomed Sci & Sch Life Sci, Shanghai Key Lab Regulatory Biol, 500 Dongchuan Rd, Shanghai 200241, Peoples R China.	jwli@bio.ecnu.edu.cn; jmweng@bio.ecnu.edu.cn	Samarut, Jacques/AAD-2587-2019	Wong, Jiemin/0000-0002-5311-842X	National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" of China [2014ZX09507002-002]; Ministry of Science and Technology of China [2015CB910402, 2015CB856200]; National Natural Science Foundation of China [91419303, 91219202, 31525013]; Science and Technology Commission of Shanghai Municipality [14XD1401700, 11DZ2260300]; NATIONAL CANCER INSTITUTE [R01CA116097, R01CA122623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK070214] Funding Source: NIH RePORTER	National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" of China; Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" of China Grant 2014ZX09507002-002, Ministry of Science and Technology of China Grant 2015CB910402, National Natural Science Foundation of China Grant 91419303, and Science and Technology Commission of Shanghai Municipality Grants 14XD1401700 and 11DZ2260300 (to J. W.) and National Natural Science Foundation of China Grants 91219202 and 31525013 and Ministry of Science and Technology of China Grant 2015CB856200 (to G. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Bachman M, 2014, NAT CHEM, V6, P1049, DOI [10.1038/nchem.2064, 10.1038/NCHEM.2064]; Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Day JJ, 2010, NAT NEUROSCI, V13, P1319, DOI 10.1038/nn.2666; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jia YH, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.7; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kaas GA, 2013, NEURON, V79, P1086, DOI 10.1016/j.neuron.2013.08.032; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019133; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Liu XL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2562; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Moore CB, 2010, METHODS MOL BIOL, V629, P139, DOI 10.1007/978-1-60761-657-3_10; Mori T, 2004, FEBS LETT, V557, P209, DOI 10.1016/S0014-5793(03)01495-9; Mori T, 2002, BIOCHEM BIOPH RES CO, V296, P530, DOI 10.1016/S0006-291X(02)00890-2; Mori T, 2012, FEBS LETT, V586, P1570, DOI 10.1016/j.febslet.2012.04.038; Nye AC, 2002, MOL CELL BIOL, V22, P3437, DOI 10.1128/MCB.22.10.3437-3449.2002; Papait R, 2008, MOL BIOL CELL, V19, P3554, DOI 10.1091/mbc.E07-10-1059; Pichler G, 2011, J CELL BIOCHEM, V112, P2585, DOI 10.1002/jcb.23185; Rudenko A, 2013, NEURON, V79, P1109, DOI 10.1016/j.neuron.2013.08.003; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Shen L, 2014, ANNU REV BIOCHEM, V83, P585, DOI 10.1146/annurev-biochem-060713-035513; Shi FT, 2013, J BIOL CHEM, V288, P20776, DOI 10.1074/jbc.M113.460386; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Vella P, 2013, MOL CELL, V49, P645, DOI 10.1016/j.molcel.2012.12.019; Walker DL, 2008, LEARN MEMORY, V15, P67, DOI 10.1101/lm.798908; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Zhang JQ, 2011, CELL RES, V21, P1723, DOI 10.1038/cr.2011.176; Zhang Q, 2014, J BIOL CHEM, V289, P5986, DOI 10.1074/jbc.M113.524140; Zhang RR, 2013, CELL STEM CELL, V13, P237, DOI 10.1016/j.stem.2013.05.006; Zhou T, 2014, MOL CELL, V54, P879, DOI 10.1016/j.molcel.2014.04.003	39	28	28	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4533	4543		10.1074/jbc.M116.754580	http://dx.doi.org/10.1074/jbc.M116.754580			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28115522	hybrid, Green Published			2022-12-26	WOS:000397585100012
J	Alsharari, ZD; Riserus, U; Leander, K; Sjogren, P; Carlsson, AC; Vikstrom, M; Laguzzi, F; Gigante, B; Cederholm, T; De Faire, U; Hellenius, ML; Marklund, M				Alsharari, Zayed D.; Riserus, Ulf; Leander, Karin; Sjogren, Per; Carlsson, Axel C.; Vikstrom, Max; Laguzzi, Federica; Gigante, Bruna; Cederholm, Tommy; De Faire, Ulf; Hellenius, Mai-Lis; Marklund, Matti			Serum Fatty Acids, Desaturase Activities and Abdominal Obesity - A Population-Based Study of 60-Year Old Men and Women	PLOS ONE			English	Article							ANTHROPOMETRIC MEASURES; WAIST CIRCUMFERENCE; SEX-DIFFERENCES; ADIPOSE-TISSUE; SATURATED FAT; LIVER FAT; PLASMA; ADULTS; BLOOD; RISK	Abdominal obesity is a key contributor of metabolic disease. Recent trials suggest that dietary fat quality affects abdominal fat content, where palmitic acid and linoleic acid influence abdominal obesity differently, while effects of n-3 polyunsaturated fatty acids are less studied. Also, fatty acid desaturation may be altered in abdominal obesity. We aimed to investigate cross-sectional associations of serum fatty acids and desaturases with abdominal obesity prevalence in a population-based cohort study. Serum cholesteryl ester fatty acids composition was measured by gas chromatography in 60-year old men (n = 1883) and women (n = 2015). Cross-sectional associations of fatty acids with abdominal obesity prevalence and anthropometric measures (e.g., sagittal abdominal diameter) were evaluated in multivariable-adjusted logistic and linear regression models, respectively. Similar models were employed to investigate relations between desaturase activities (estimated by fatty acid ratios) and abdominal obesity. In logistic regression analyses, palmitic acid, stearoyl-CoA- desaturase and Delta 6-desaturase indices were associated with abdominal obesity; multivariable-adjusted odds ratios (95% confidence intervals) for highest versus lowest quartiles were 1.45 (1.19-1.76), 4.06 (3.27-5.05), and 3.07 (2.51-3.75), respectively. Linoleic acid, alpha-linolenic acid, docohexaenoic acid, and Delta 5-desaturase were inversely associated with abdominal obesity; multivariable-adjusted odds ratios (95% confidence intervals): 0.39 (0.32-0.48), 0.74 (0.61-0.89), 0.76 (0.62-0.93), and 0.40 (0.33-0.49), respectively. Eicosapentaenoic acid was not associated with abdominal obesity. Similar results were obtained from linear regression models evaluating associations with different anthropometric measures. Sex-specific and linear associations were mainly observed for n3-polyunsaturated fatty acids, while associations of the other exposures were generally non-linear and similar across sexes. In accordance with findings from short-term trials, abdominal obesity was more common among individuals with relatively high proportions of palmitic acid, whilst the contrary was true for linoleic acid. Further trials should examine the potential role of linoleic acid and its main dietary source, vegetable oils, in abdominal obesity prevention.	[Alsharari, Zayed D.; Riserus, Ulf; Sjogren, Per; Cederholm, Tommy; Marklund, Matti] Uppsala Univ, Dept Publ Hlth & Caring Sci, Clin Nutr & Metab, Uppsala, Sweden; [Leander, Karin; Vikstrom, Max; Laguzzi, Federica; Gigante, Bruna; De Faire, Ulf] Karolinska Inst, Inst Environm Med, Unit Cardiovasc Epidemiol, Stockholm, Sweden; [Carlsson, Axel C.] Karolinska Inst, Div Family Med, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Gigante, Bruna] Karolinska Inst, Danderyds Hosp, Div Cardiovasc Med, Dept Clin Sci, Stockholm, Sweden; [De Faire, Ulf; Hellenius, Mai-Lis] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Cardiol Unit, Stockholm, Sweden	Uppsala University; Karolinska Institutet; Karolinska Institutet; Danderyds Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Marklund, M (corresponding author), Uppsala Univ, Dept Publ Hlth & Caring Sci, Clin Nutr & Metab, Uppsala, Sweden.	matti.marklund@pubcare.uu.se	Sjogren, Per/N-5923-2014; Leander, Karin/C-7261-2017; Marklund, Matti/ABC-3674-2021; Gigante, Bruna/I-9252-2012	Leander, Karin/0000-0002-1404-9222; Marklund, Matti/0000-0002-3320-796X; Sjogren, Per/0000-0003-1824-3193; Gigante, Bruna/0000-0003-4508-7990; Carlsson, Axel C/0000-0001-6113-0472	Stockholm County Council; Swedish Heart and Lung Foundation; Swedish Research Council [09533]; Swedish Research Council for Health, Working Life and Welfare; Excellence of Diabetes Research in Swedish (EXODIAB)	Stockholm County Council(Stockholm County Council); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Excellence of Diabetes Research in Swedish (EXODIAB)	This work was supported by Stockholm County Council, Swedish Heart and Lung Foundation, the Swedish Research Council (grant nr 09533), and the Swedish Research Council for Health, Working Life and Welfare, and Excellence of Diabetes Research in Swedish (EXODIAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aune D, 2012, ANN ONCOL, V23, P843, DOI 10.1093/annonc/mdr398; Becker W, 2002, RIKSMATEN 1997 98 KO; Bjermo H, 2012, AM J CLIN NUTR, V95, P1003, DOI 10.3945/ajcn.111.030114; Bjermo H, 2010, CURR OPIN CLIN NUTR, V13, P703, DOI 10.1097/MCO.0b013e32833ec41b; BOBERG M, 1985, CLIN SCI, V68, P581, DOI 10.1042/cs0680581; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; Carlsson AC, 2013, INT J OBESITY, V37, P1579, DOI 10.1038/ijo.2013.46; Carlsson AC, 2008, AM J HYPERTENS, V21, P771, DOI 10.1038/ajh.2008.167; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; DeLany JP, 2000, AM J CLIN NUTR, V72, P905; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Fekete K, 2015, OBES REV, V16, P488, DOI 10.1111/obr.12280; Ford ES, 2014, JAMA-J AM MED ASSOC, V312, P1151, DOI 10.1001/jama.2014.8362; Freedman DS, 2015, AM J CLIN NUTR, V101, P425, DOI 10.3945/ajcn.114.094672; Gillingham LG, 2013, AM J CLIN NUTR, V97, P195, DOI 10.3945/ajcn.112.043117; Han YY, 2012, BONE, V51, P1000, DOI 10.1016/j.bone.2012.08.127; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Laguzzi F, 2015, J HUMAN NUTR DIETETI; Lee JJ, 2014, J OBES, V2014, DOI 10.1155/2014/697264; Marklund M, 2015, CIRCULATION; Marklund M, 2016, CIRCULATION, V133; Marks KA, 2013, GENES NUTR, V8, P317, DOI 10.1007/s12263-012-0325-3; Ohrvall M, 2000, INT J OBESITY, V24, P497, DOI 10.1038/sj.ijo.0801186; Ohrvall M, 1996, EUR J CLIN NUTR, V50, P381; Pan DA, 1995, J CLIN INVEST, V96, P2802, DOI 10.1172/JCI118350; Petersson H, 2010, DIABETES RES CLIN PR, V87, P379, DOI 10.1016/j.diabres.2009.11.019; Petit JM, 2012, CLIN NUTR, V31, P520, DOI 10.1016/j.clnu.2011.12.007; Petrus P, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0042-1; Rosqvist F, 2014, DIABETES, V63, P2356, DOI 10.2337/db13-1622; Song M, 2015, INT J EPIDEMIOL; Song X, 2015, NUTR METAB CARDIOVAS, V25, P295, DOI 10.1016/j.numecd.2014.09.004; Summers LKM, 2002, DIABETOLOGIA, V45, P369, DOI 10.1007/s00125-001-0768-3; Tran C, 2010, BRIT J NUTR, V104, P1139, DOI 10.1017/S000711451000190X; Vessby B, 2002, ANN NY ACAD SCI, V967, P183; Vinknes KJ, 2013, OBESITY, V21, P20011; Wandell PE, 2011, NUTR METAB CARDIOVAS, V21, P173, DOI 10.1016/j.numecd.2009.09.007; Warensjo E, 2006, NUTR METAB CARDIOVAS, V16, P128, DOI 10.1016/j.numecd.2005.06.001; Warensjo E, 2007, OBESITY, V15, P1732, DOI 10.1038/oby.2007.206; Wikner C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061763; Williams CM, 2004, P NUTR SOC, V63, P153, DOI 10.1079/PNS2003314; Zak A, 2002, ANN NY ACAD SCI, V967, P522; Zheng ZJ, 1999, AM J EPIDEMIOL, V150, P492, DOI 10.1093/oxfordjournals.aje.a010038	42	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170684	10.1371/journal.pone.0170684	http://dx.doi.org/10.1371/journal.pone.0170684			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125662	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100074
J	Tsuruta, S; Ebina, M; Kobayashi, M; Takahashi, W				Tsuruta, Shin-ichi; Ebina, Masumi; Kobayashi, Makoto; Takahashi, Wataru			Complete Chloroplast Genomes of Erianthus arundinaceus and Miscanthus sinensis: Comparative Genomics and Evolution of the Saccharum Complex	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; GENETIC DIVERSITY; DNA-SEQUENCES; RIBOSOMAL DNA; ANDROPOGONEAE; GRASSES; POACEAE; MARKERS; ORIGIN; DIVERSIFICATION	The genera Erianthus and Miscanthus, both members of the Saccharum complex, are of interest as potential resources for sugarcane improvement and as bioenergy crops. Recent studies have mainly focused on the conservation and use of wild accessions of these genera as breeding materials. However, the sequence data are limited, which hampers the studies of phylogenetic relationships, population structure, and evolution of these grasses. Here, we determined the complete chloroplast genome sequences of Erianthus arundinaceus and Miscanthus sinensis by using 454 GS FLX pyrosequencing and Sanger sequencing. Alignment of the E. arundinaceus and M. sinensis chloroplast genome sequences with the known sequence of Saccharum officinarum demonstrated a high degree of conservation in gene content and order. Using the data sets of 76 chloroplast protein-coding genes, we performed phylogenetic analysis in 40 taxa including E. arundinaceus and M. sinensis. Our results show that S. officinarum is more closely related to M. sinensis than to E. arundinaceus. We estimated that E. arundinaceus diverged from the subtribe Sorghinae before the divergence of Sorghum bicolor and the common ancestor of S. officinarum and M. sinensis. This is the first report of the phylogenetic and evolutionary relationships inferred from maternally inherited variation in the Saccharum complex. Our study provides an important framework for understanding the phylogenetic relatedness of the economically important genera Erianthus, Miscanthus, and Saccharum.	[Tsuruta, Shin-ichi] Japan Int Res Ctr Agr Sci, Trop Agr Res Front JIRCAS TARF, Okinawa, Japan; [Ebina, Masumi; Kobayashi, Makoto; Takahashi, Wataru] Natl Agr & Food Res Org, Inst Livestock & Grassland Sci NARO ILGS, Nasushiobara, Tochigi, Japan	Japan International Research Center for Agricultural Sciences; National Agriculture & Food Research Organization - Japan	Tsuruta, S (corresponding author), Japan Int Res Ctr Agr Sci, Trop Agr Res Front JIRCAS TARF, Okinawa, Japan.	stsuru@affrc.go.jp			National Agriculture and Food Research Organization [220a0]; Japan International Research Center of Agricultural Science [001750]	National Agriculture and Food Research Organization; Japan International Research Center of Agricultural Science	This work was supported by research grants from the National Agriculture and Food Research Organization (#220a0) and the Japan International Research Center of Agricultural Science (#001750). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix K, 1999, THEOR APPL GENET, V99, P962, DOI 10.1007/s001220051403; ALJANABI SM, 1994, THEOR APPL GENET, V88, P933, DOI 10.1007/BF00220799; Amalraj VA, 2006, GENET RESOUR CROP EV, V53, P35, DOI 10.1007/s10722-004-0581-1; Asano T, 2004, DNA RES, V11, P93, DOI 10.1093/dnares/11.2.93; Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; Berding N, 1987, SUGARCANE IMPROVEMEN, P143, DOI DOI 10.1016/B978-0-444-42769-4.50009-6; Besse P, 1996, THEOR APPL GENET, V92, P733, DOI 10.1007/BF00226096; Besse P, 1997, EUPHYTICA, V93, P283, DOI 10.1023/A:1002940701171; Besse P, 1998, GENETICA, V104, P143, DOI 10.1023/A:1003436403678; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Burner DM, 2009, BIOMASS BIOENERG, V33, P610, DOI 10.1016/j.biombioe.2008.10.002; Cai Q, 2005, PLANT SCI, V169, P976, DOI 10.1016/j.plantsci.2005.07.002; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; Clark LV, 2015, J EXP BOT, V66, P4213, DOI 10.1093/jxb/eru511; Clayton W. D., 1986, Kew Bulletin Additional Series, V13; Clifton-Brown JC, 2004, GLOBAL CHANGE BIOL, V10, P509, DOI 10.1111/j.1529-8817.2003.00749.x; Clifton-Brown John, 2008, P273, DOI 10.1007/978-0-387-70805-8_10; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Daniels SJ, 1987, SUGARCANE IMPROVEMEN, V11, P7, DOI DOI 10.1016/B978-0-444-42769-4.50007-2; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Cesare M, 2010, MOL BREEDING, V26, P539, DOI 10.1007/s11032-010-9451-z; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duvall Melvin R., 2007, Aliso, V23, P237; Estep MC, 2014, P NATL ACAD SCI USA, V111, P15149, DOI 10.1073/pnas.1404177111; Estep MC, 2012, AM J BOT, V99, pE443, DOI 10.3732/ajb.1200186; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gao G, 2014, BIOCHEM SYST ECOL, V57, P102, DOI 10.1016/j.bse.2014.07.004; Guisinger MM, 2010, J MOL EVOL, V70, P149, DOI 10.1007/s00239-009-9317-3; Hand ML, 2013, G3-GENES GENOM GENET, V3, P607, DOI 10.1534/g3.112.005264; Hodkinson TR, 2002, J PLANT RES, V115, P381, DOI 10.1007/s10265-002-0049-3; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; JACKSON P, 2011, WILD CROP RELATIVES, P97, DOI DOI 10.1007/978-3-642-21102-7_5; Junior TC, 2004, CURR GENET, V46, P366, DOI 10.1007/s00294-004-0542-4; Kim C, 2014, PLANT CELL, V26, P2420, DOI 10.1105/tpc.114.125583; Li LQ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031057, 10.1371/journal.pone.0045115]; Liu Yang, 2013, Biomed Res Int, V2013, P839683, DOI 10.1155/2013/839683; Loman NJ, 2012, NAT REV MICROBIOL, V10, P599, DOI 10.1038/nrmicro2850; Lozsa R, 2015, GENET RESOUR CROP EV, V62, P419, DOI 10.1007/s10722-014-0169-3; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Moore MJ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-17; MUKHERJEE SUNIL KUMAR, 1957, BOT GAZ, V119, P55, DOI 10.1086/335962; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nah G, 2016, MITOCHONDRIAL DNA A, V27, P4359, DOI 10.3109/19401736.2015.1089500; Nair N. V., 2005, Sugar Tech, V7, P55, DOI 10.1007/BF02942418; Nakagawa H, 2011, BIOFUEL'S ENGINEERING PROCESS TECHNOLOGY, P715; NECKERMANN K, 1994, GENE, V146, P177, DOI 10.1016/0378-1119(94)90290-9; Ni Y, 2011, BIOL PLANTARUM, V55, P68, DOI 10.1007/s10535-011-0009-7; Piperidis N, 2010, GENOME, V53, P331, DOI [10.1139/G10-010, 10.1139/g10-010]; Prasad V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1482; Provan J, 2001, TRENDS ECOL EVOL, V16, P142, DOI 10.1016/S0169-5347(00)02097-8; Rambaut A, 2014, FIGTREE V 1 4 2 2014; Rambaut A, TRACER V 1 6 2014; Raubeson LA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-174; Sanchez-Ken JG, 2007, SYST BOT, V32, P71, DOI 10.1600/036364407780360102; Saski C, 2007, THEOR APPL GENET, V115, P571, DOI 10.1007/s00122-007-0595-0; Schwerdt Julian G, 2015, Plant Physiol, V168, P968, DOI 10.1104/pp.15.00140; Selvi A, 2006, GENET RESOUR CROP EV, V53, P831, DOI 10.1007/s10722-004-6376-6; SOBRAL BWS, 1994, THEOR APPL GENET, V87, P843, DOI 10.1007/BF00221137; Suman A, 2012, BIOENERG RES, V5, P197, DOI 10.1007/s12155-011-9123-9; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vicentini A, 2008, GLOBAL CHANGE BIOL, V14, P2963, DOI 10.1111/j.1365-2486.2008.01688.x; Wang XY, 2012, ANN SAUDI MED, V32, P642, DOI 10.5144/0256-4947.2012.01.7.1530; Welker CAD, 2015, AM J BOT, V102, P248, DOI 10.3732/ajb.1400397; Wheeler GL, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1400059; Wu ZQ, 2012, MOL PHYLOGENET EVOL, V62, P573, DOI 10.1016/j.ympev.2011.10.019; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xu B, 2013, MOL BIOL EVOL, V30, P2723, DOI 10.1093/molbev/mst179; Yook MJ, 2014, BIOMASS BIOENERG, V66, P81, DOI 10.1016/j.biombioe.2014.01.025; Young HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023980; Zhang JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080388	75	23	24	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0169992	10.1371/journal.pone.0169992	http://dx.doi.org/10.1371/journal.pone.0169992			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125648	Green Submitted, gold, Green Published			2022-12-26	WOS:000396176100131
J	Sonner, MJ; Walters, MC; Ladle, DR				Sonner, Martha J.; Walters, Marie C.; Ladle, David R.			Analysis of Proprioceptive Sensory Innervation of the Mouse Soleus: A Whole-Mount Muscle Approach	PLOS ONE			English	Article							GOLGI TENDON ORGANS; SPINDLE AFFERENTS; SKELETAL-MUSCLE; NERVE-ENDINGS; NEUROTROPHIN-3; MICE; RAT; EXPRESSION; NEURONS; FIBERS	Muscle proprioceptive afferents provide feedback critical for successful execution of motor tasks via specialized mechanoreceptors housed within skeletal muscles: muscle spindles, supplied by group Ia and group II afferents, and Golgi tendon organs, supplied by group Ib afferents. The morphology of these proprioceptors and their associated afferents has been studied extensively in the cat soleus, and to a lesser degree, in the rat; however, quantitative analyses of proprioceptive innervation in the mouse soleus are comparatively limited. The present study employed genetically-encoded fluorescent reporting systems to label and analyze muscle spindles, Golgi tendon organs, and the proprioceptive sensory neuron subpopulations supplying them within the intact mouse soleus muscle using high magnification confocal microscopy. Total proprioceptive receptors numbered 11.3 +/- 0.4 and 5.2 +/- 0.2 for muscle spindles and Golgi tendon organs, respectively, and these receptor counts varied independently (n = 27 muscles). Analogous to findings in the rat, muscle spindles analyzed were most frequently supplied by two proprioceptive afferents, and in the majority of instances, both were classified as primary endings using established morphological criteria. Secondary endings were most frequently observed when spindle associated afferents totaled three or more. The mean diameter of primary and secondary afferent axons differed significantly, but the distributions overlap more than previously observed in cat and rat studies.	[Sonner, Martha J.; Walters, Marie C.; Ladle, David R.] Wright State Univ, Dept Neurosci Cell Biol & Physiol, Dayton, OH 45435 USA	University System of Ohio; Wright State University Dayton	Ladle, DR (corresponding author), Wright State Univ, Dept Neurosci Cell Biol & Physiol, Dayton, OH 45435 USA.	david.ladle@wright.edu			NIH/NINDS [NSO72454]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072454] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH/NINDS grant NSO72454 to DRL, http://www.ninds.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Banks R, 2005, PERIPHERAL NEUROPATH, P131, DOI 10.1002/mus.880070818; Banks RW, 2009, J ANAT, V214, P859, DOI 10.1111/j.1469-7580.2009.01072.x; BANKS RW, 1982, PHILOS T ROY SOC B, V299, P329, DOI 10.1098/rstb.1982.0136; BOYD IA, 1980, TRENDS NEUROSCI, V3, P258, DOI 10.1016/0166-2236(80)90096-X; BOYD IA, 1962, PHILOS T ROY SOC B, V245, P81, DOI 10.1098/rstb.1962.0007; CELIO MR, 1982, NATURE, V297, P504, DOI 10.1038/297504a0; COPRAY JCVM, 1994, DEV BRAIN RES, V81, P57, DOI 10.1016/0165-3806(94)90068-X; de Nooij JC, 2013, NEURON, V77, P1055, DOI 10.1016/j.neuron.2013.01.015; De-Doncker L, 2003, J NEUROPHYSIOL, V89, P442, DOI 10.1152/jn.00153.2002; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Hasegawa H, 2007, J NEUROSCI, V27, P14404, DOI 10.1523/JNEUROSCI.4908-07.2007; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; HONDA CN, 1995, NEUROSCIENCE, V68, P883, DOI 10.1016/0306-4522(95)00180-Q; HOUK JC, 1971, J NEUROPHYSIOL, V34, P1051, DOI 10.1152/jn.1971.34.6.1051; HUNT CC, 1990, PHYSIOL REV, V70, P643, DOI 10.1152/physrev.1990.70.3.643; HUNT CC, 1954, J GEN PHYSIOL, V38, P117, DOI 10.1085/jgp.38.1.117; JAMI L, 1992, PHYSIOL REV, V72, P623, DOI 10.1152/physrev.1992.72.3.623; JANSEN JKS, 1962, ACTA PHYSIOL SCAND, V55, P376, DOI 10.1111/j.1748-1716.1962.tb02451.x; JOHNSON MI, 1986, AM J ANAT, V175, P413, DOI 10.1002/aja.1001750403; KOZEKA K, 1981, DEV BIOL, V87, P133, DOI 10.1016/0012-1606(81)90067-1; KUCERA J, 1988, AM J ANAT, V183, P344, DOI 10.1002/aja.1001830408; Kucera J, 2002, DEV DYNAM, V223, P389, DOI 10.1002/dvdy.10066; Lionikas A, 2013, J ANAT, V223, P289, DOI 10.1111/joa.12076; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; Masri R, 2006, ARCH ORAL BIOL, V51, P740, DOI 10.1016/j.archoralbio.2006.03.006; MATTHEWS PBC, 1981, J PHYSIOL-LONDON, V320, P1; Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7; PierrotDeseilligny E, 2005, CIRCUITRY OF THE HUMAN SPINAL CORD: ITS ROLE IN MOTOR CONTROL AND MOVEMENT DISORDERS, P1, DOI 10.1017/CBO9780511545047; SCHOULTZ TW, 1972, J NEUROCYTOL, V1, P1, DOI 10.1007/BF01098642; Scott JJA, 2005, PERIPHERAL NEUROPATH, P151; STACEY MJ, 1969, J ANAT, V105, P231; Taylor MD, 2001, J COMP NEUROL, V432, P244, DOI 10.1002/cne.1100; Taylor MD, 2001, SOMATOSENS MOT RES, V18, P286; Tourtellotte WG, 2001, DEV BIOL, V232, P388, DOI 10.1006/dbio.2001.0202; von Steyern FV, 1999, EUR J NEUROSCI, V11, P2093, DOI 10.1046/j.1460-9568.1999.00631.x; WALRO JM, 1987, BRAIN RES, V425, P311, DOI 10.1016/0006-8993(87)90514-2; Wang Z, 2007, J NEUROSCI, V27, P3686, DOI 10.1523/JNEUROSCI.0197-07.2007; Windhorst U, 2007, BRAIN RES BULL, V73, P155, DOI 10.1016/j.brainresbull.2007.03.010; Wright DE, 1997, NEURON, V19, P503, DOI 10.1016/S0896-6273(00)80367-0; Wu SX, 2004, BRAIN RES, V1011, P247, DOI 10.1016/brainres.2004.03.047; YELLIN H, 1974, EXPERIENTIA, V30, P286, DOI 10.1007/BF01934831; Zelena J, 1994, NERVES MECHANORECEPT	44	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0170751	10.1371/journal.pone.0170751	http://dx.doi.org/10.1371/journal.pone.0170751			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122055	Green Published, Green Submitted, gold			2022-12-26	WOS:000396167300023
J	Ahn, HJ; Song, MJ; Jang, JW; Bae, SH; Choi, JY; Yoon, SK				Ahn, Hyo Jun; Song, Myeong Jun; Jang, Jeong Won; Bae, Si Hyun; Choi, Jong Young; Yoon, Seung Kew			Treatment Efficacy and Safety of Tenofovir-Based Therapy in Chronic Hepatitis B: A Real Life Cohort Study in Korea	PLOS ONE			English	Article							LONG-TERM EFFICACY; DISOPROXIL FUMARATE; RESCUE THERAPY; LAMIVUDINE; ADEFOVIR; FAILURE; VIRUS; MONOTHERAPY; RISK; EMTRICITABINE	Background & Aims We evaluated the efficacy and safety of Tenofovir disoproxil fumarate (TDF)-based therapy in naive and treatment-experienced chronic hepatitis B (CHB) patients for 96 weeks in Korean real life practice. Methods A total of 209 CHB patients with a prescription for TDF at the Seoul and Daejeon St. Mary's hospitals were enrolled from December 2012 to October 2014. We compared the virological responses and evaluated the renal safety of treatment-naive and treatment-experienced patients. Results An overall complete virological response (CVR) was achieved in 80.4% and 84.6% of patients at weeks 48 and 96, respectively. In a subgroup analysis, CVR at week 96 was present in 88.4%, 75.0%, 75.5%, and 83.3% of participants in the lamivudine-resistant (LAM-R) group, adefovir-resistant (ADV-R) group, multidrug-resistant (MDR) group, and suboptimal response group, respectively. In a multivariate analysis, ADV-R, MDR, hepatitis B virus DNA, and hepatitis B e antigen were independent predictors for CVR. With regard to renal safety, diabetes mellitus, cirrhosis, and an initial low estimated glomerular filtration rate were independent factors affecting creatinine elevation (>= 0.5 mg/dL). Moreover, two patients with DM and cirrhosis experienced TDF-related Fanconi syndrome. Conclusions TDF-based therapy demonstrated sustained viral suppression and favorable safety during a 2-year treatment period. The LAM-R and suboptimal response groups showed comparable efficacy to the naive group, while the ADV-R and MDR groups were significantly associated with a low CVR. Close monitoring of renal safety should be mandatory when treating CHB patients receiving TDF, particularly those with DM and cirrhosis.	[Ahn, Hyo Jun; Song, Myeong Jun; Jang, Jeong Won; Bae, Si Hyun; Choi, Jong Young; Yoon, Seung Kew] Catholic Univ Korea, Div Gastroenterol & Hepatol, Coll Med, Dept Internal Med, Seoul, South Korea	Catholic University of Korea	Song, MJ (corresponding author), Catholic Univ Korea, Div Gastroenterol & Hepatol, Coll Med, Dept Internal Med, Seoul, South Korea.	mjsong95@gmail.com			Catholic Medical Center Research Foundation [5-2014-60001-00176]	Catholic Medical Center Research Foundation	This work was supported by the Catholic Medical Center Research Foundation program in 2014, grant number 5-2014-60001-00176, and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SS, 2014, CLIN MOL HEPATOL, V20, P261, DOI 10.3350/cmh.2014.20.3.261; Bae SH, 2005, J KOREAN MED SCI, V20, P816, DOI 10.3346/jkms.2005.20.5.816; Baran B, 2013, ANTIMICROB AGENTS CH, V57, P1790, DOI 10.1128/AAC.02600-12; Berg T, 2014, J HEPATOL, V60, P715, DOI 10.1016/j.jhep.2013.11.024; Buti M, 2015, DIGEST DIS SCI, V60, P1457, DOI 10.1007/s10620-014-3486-7; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Cho HJ, 2015, J MED VIROL, V87, P1532, DOI 10.1002/jmv.24201; Fung S, 2014, GASTROENTEROLOGY, V146, P980, DOI 10.1053/j.gastro.2013.12.028; Ha NB, 2009, HEPATOLOGY, V50, P727, DOI 10.1002/hep.23044; Heathcote EJ, 2011, GASTROENTEROLOGY, V140, P132, DOI 10.1053/j.gastro.2010.10.011; Hongthanakorn C, 2011, HEPATOLOGY, V53, P1854, DOI 10.1002/hep.24318; Hwang HS, 2015, HEPATOLOGY, V62, P1318, DOI 10.1002/hep.27730; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; Jung SK, 2015, CLIN MOL HEPATOL, V21, P41, DOI 10.3350/cmh.2015.21.1.41; Kim HJ, 2015, KOREAN J INTERN MED, V30, P32, DOI 10.3904/kjim.2015.30.1.32; Kim JH, 2015, INT J CLIN PHARM-NET, V37, P1228, DOI 10.1007/s11096-015-0193-1; Lee S, 2015, J MED VIROL; Lee YB, 2014, ANTIMICROB AGENTS CH, V58, P6710, DOI 10.1128/AAC.03845-14; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Lim YS, 2016, GUT, V65, P1042, DOI 10.1136/gutjnl-2014-308435; Marcellin P, 2016, DIG DIS SCI; Pan CQ, 2012, J VIRAL HEPATITIS, V19, P213, DOI 10.1111/j.1365-2893.2011.01533.x; Pan CQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089789; Pan CQ, 2013, ANTIVIR THER, V18, P841, DOI 10.3851/IMP2481; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Park JH, 2015, CLIN THER, V37, P1433, DOI 10.1016/j.clinthera.2015.04.007; Park JY, 2016, LIVER INT; Patterson SJ, 2011, GUT, V60, P247, DOI 10.1136/gut.2010.223206; Petersen J, 2015, DIG DIS SCI; Safioleas M, 2007, HEPATO-GASTROENTEROL, V54, P545; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Shin JY, 2016, MEDICINE, V95, DOI [10.1097/MD.0000000000004072, 10.1097/MD.0000000000002400]; van Bommel F, 2010, HEPATOLOGY, V51, P73, DOI 10.1002/hep.23246; Wang HM, 2016, J GASTROENTEROL HEPA; Yang DH, 2015, WORLD J GASTROENTERO, V21, P2746, DOI 10.3748/wjg.v21.i9.2746	35	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170362	10.1371/journal.pone.0170362	http://dx.doi.org/10.1371/journal.pone.0170362			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114428	gold, Green Submitted, Green Published			2022-12-26	WOS:000396129000041
J	Anovazzi, G; de Medeiros, MC; Pigossi, SC; Finoti, LS; Mayer, MPA; Rossa, C; Scarel-Caminaga, RM				Anovazzi, Giovana; de Medeiros, Marcell Costa; Pigossi, Suzane Cristina; Finoti, Livia Sertori; Alves Mayer, Marcia Pinto; Rossa Junior, Carlos; Scarel-Caminaga, Raquel Mantuaneli			Functional Haplotypes in Interleukin 4 Gene Associated with Periodontitis	PLOS ONE			English	Article							REGULATORY T-CELLS; AGGREGATIBACTER-ACTINOMYCETEMCOMITANS; PORPHYROMONAS-GINGIVALIS; POLYMORPHISMS; INFECTION; DISEASE; SUSCEPTIBILITY; INDIVIDUALS; PROGRESSION; POPULATION	Chronic periodontitis (CP) is an infectious inflammatory disease that affects tooth-supporting structures and in which dental plaque bacteria, immune mechanisms and genetic predisposition play important roles. Interleukin 4 (IL-4) is a key anti-inflammatory cytokine with relevant action in imbalances in inflamed periodontal tissue. Individuals carrying the TCI/CCI genotype (S-haplotype) of the IL-4 gene are 5 times more susceptible to CP, whereas the CTI/TTD genotype (P-haplotype) confers protection against CP. Compared with the S-haplotype, subjects with the P-haplotype produce higher levels of the IL-4 protein after non-surgical periodontal therapy. The present in vitro study aimed to investigate the functionality of IL-4 haplotypes in immune cells to obtain insight into the influence of these genetic variations in regulating immune responses to CP-associated bacteria. Peripheral blood was collected from 6 subjects carrying each haplotype, and their immune cells were challenged with periodontopathogens to compare responses of the different haplotypes with regard to gene expression, protein secretion and the immunophenotype of T helper responses. We found higher IL-4 mRNA and protein levels in the P-haplotype, which also presented higher levels of anti-inflammatory cytokines. In contrast, cells from S-haplotype subjects responded with higher levels of pro-inflammatory cytokines. S-haplotype individuals exhibited significantly greater polarization toward the Th1 phenotype, whereas the Phaplotype was associated with an attenuated response to periodontopathogens, with suggestive skewing toward Th2/M2 phenotypes. In conclusion, IL-4 genetic variations associated with susceptibility to or protection against chronic periodontitis are directly associated with influencing the response of immune cells to periodontopathogens.	[Anovazzi, Giovana; de Medeiros, Marcell Costa; Pigossi, Suzane Cristina; Finoti, Livia Sertori; Rossa Junior, Carlos] UNESP Univ Estadual Paulista, Sch Dent Araraquara, Dept Oral Diag & Surg, Sao Paulo, Brazil; [Anovazzi, Giovana; Pigossi, Suzane Cristina; Finoti, Livia Sertori; Scarel-Caminaga, Raquel Mantuaneli] UNESP Univ Estadual Paulista, Sch Dent Araraquara, Dept Morphol, Sao Paulo, Brazil; [Alves Mayer, Marcia Pinto] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade de Sao Paulo	Scarel-Caminaga, RM (corresponding author), UNESP Univ Estadual Paulista, Sch Dent Araraquara, Dept Morphol, Sao Paulo, Brazil.	raquel@foar.unesp.br	Scarel-Caminaga, Raquel M./E-8888-2012; de Medeiros, Marcell Costa/AAI-2036-2019; Scarel-Caminaga, Raquel Mantuaneli/AAG-9095-2019; Rossa, Carlos/D-8328-2012; de Medeiros, Marcell Costa/J-8223-2012; Mayer, Marcia/D-4645-2012; Pigossi, Suzane/AAI-8992-2020; Pigossi, Suzane/I-8058-2012	Scarel-Caminaga, Raquel M./0000-0001-5068-0268; de Medeiros, Marcell Costa/0000-0002-6168-2012; Rossa, Carlos/0000-0003-1705-5481; Mayer, Marcia/0000-0002-5910-8433; Anovazzi, Giovana/0000-0003-0164-0141; Pigossi, Suzane/0000-0001-7067-6119	Sao Paulo Research Foundation (FAPESP) [2013/17887-8, 2014/04638-2]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by Sao Paulo Research Foundation (FAPESP) Grant 2013/17887-8 and Scholar ship 2014/04638-2.	Anovazzi G, 2013, HUM IMMUNOL, V74, P1688, DOI 10.1016/j.humimm.2013.08.286; Anovazzi G, 2010, J PERIODONTOL, V81, P392, DOI 10.1902/jop.2009.090392; BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; Bartova J, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/185757; Boyce Brendan F., 2005, Keio Journal of Medicine, V54, P127, DOI 10.2302/kjm.54.127; Byrne SJ, 2009, ORAL MICROBIOL IMMUN, V24, P469, DOI 10.1111/j.1399-302X.2009.00544.x; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Diaz-Zuniga J, 2015, J PERIODONTAL RES, V50, P824, DOI 10.1111/jre.12270; Du RJ, 2014, J LEUKOCYTE BIOL, V96, P39, DOI 10.1189/jlb.1RU0114-010RR; Finoti LS, 2013, EUR J CLIN MICROBIOL, V32, P1501, DOI 10.1007/s10096-013-1903-z; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Gelani V, 2009, J PERIODONTOL, V80, P2010, DOI 10.1902/jop.2009.090198; Gemmell E, 2002, CRIT REV ORAL BIOL M, V13, P17, DOI 10.1177/154411130201300104; Grifka-Walk HM, 2015, EUR J IMMUNOL, V45, P2780, DOI 10.1002/eji.201545800; Heitz-Mayfield LJA, 2005, J CLIN PERIODONTOL, V32, P196, DOI 10.1111/j.1600-051X.2005.00803.x; Laine ML, 2001, J DENT RES, V80, P1695, DOI 10.1177/00220345010800080301; Lima HR, 2010, J CLIN PERIODONTOL, V37, P248, DOI 10.1111/j.1600-051X.2009.01531.x; Loos BG, 2005, J CLIN PERIODONTOL, V32, P159, DOI 10.1111/j.1600-051X.2005.00806.x; Mahanonda R, 2007, PERIODONTOL 2000, V43, P41, DOI 10.1111/j.1600-0757.2006.00179.x; Michalowicz B S, 1994, Compendium, V15, ppassim; Michalowicz BS, 1994, COMPENDIUM, V15, P40; Michalowicz BS, 1994, COMPENDIUM, V15, P8; Moutsopoulos NM, 2012, J AUTOIMMUN, V39, P294, DOI 10.1016/j.jaut.2012.03.003; Nakamura H, 2008, ORAL MICROBIOL IMMUN, V23, P190, DOI 10.1111/j.1399-302X.2007.00410.x; Nakashima H, 2002, GENES IMMUN, V3, P107, DOI 10.1038/sj.gene.6363830; Parachuru VPB, 2014, J PERIODONTAL RES, V49, P817, DOI 10.1111/jre.12169; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Shapira L, 2005, J CLIN PERIODONTOL, V32, P72, DOI 10.1111/j.1600-051X.2005.00810.x; Stern DL, 2000, NATURE, V408, P529, DOI 10.1038/35046183; Vandenbroeck K, 2003, TRENDS PHARMACOL SCI, V24, P284, DOI 10.1016/S0165-6147(03)00131-7; Wajant H, 1998, CYTOKINE GROWTH F R, V9, P297	31	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0169870	10.1371/journal.pone.0169870	http://dx.doi.org/10.1371/journal.pone.0169870			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114408	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129000014
J	Banerjee, J; Sorrell, ME; Celnik, PA; Pelled, G				Banerjee, Jineta; Sorrell, Mary E.; Celnik, Pablo A.; Pelled, Galit			Immediate Effects of Repetitive Magnetic Stimulation on Single Cortical Pyramidal Neurons	PLOS ONE			English	Article							PREFRONTAL CORTEX; CALCIUM-CHANNELS; RAT-BRAIN; NEUROTROPHIC FACTOR; DOPAMINE RELEASE; CONTROLLED TRIAL; CEREBRAL-CORTEX; VISUAL-CORTEX; C-FOS; TMS	Repetitive Transcranial Magnetic Stimulation (rTMS) has been successfully used as a noninvasive therapeutic intervention for several neurological disorders in the clinic as well as an investigative tool for basic neuroscience. rTMS has been shown to induce long-term changes in neuronal circuits in vivo. Such long-term effects of rTMS have been investigated using behavioral, imaging, electrophysiological, and molecular approaches, but there is limited understanding of the immediate effects of TMS on neurons. We investigated the immediate effects of high frequency (20 Hz) rTMS on the activity of cortical neurons in an effort to understand the underlying cellular mechanisms activated by rTMS. We used whole-cell patch clamp recordings in acute rat brain slices and calcium imaging of cultured primary neurons to examine changes in neuronal activity and intracellular calcium respectively. Our results indicate that each TMS pulse caused an immediate and transient activation of voltage gated sodium channels (9.6 +/- 1.8 nA at-45 mV, p value < 0.01) in neurons. Short 500 ms 20 Hz rTMS stimulation induced action potentials in a subpopulation of neurons, and significantly increased the steady state current of the neurons at near threshold voltages (at-45 mV: before TMS: I = 130 +/- 17 pA, during TMS: I = 215 +/- 23 pA, p value = 0.001). rTMS stimulation also led to a delayed increase in intracellular calcium (153.88 +/- 61.94% increase from baseline). These results show that rTMS has an immediate and cumulative effect on neuronal activity and intracellular calcium levels, and suggest that rTMS may enhance neuronal responses when combined with an additional motor, sensory or cognitive stimulus. Thus, these results could be translated to optimize rTMS protocols for clinical as well as basic science applications.	[Banerjee, Jineta; Sorrell, Mary E.; Pelled, Galit] Kennedy Krieger Inst, FM Kirby Res Ctr Funct Brain Imaging, Baltimore, MD 21205 USA; [Banerjee, Jineta; Sorrell, Mary E.; Pelled, Galit] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA; [Celnik, Pablo A.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA	Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins University	Pelled, G (corresponding author), Kennedy Krieger Inst, FM Kirby Res Ctr Funct Brain Imaging, Baltimore, MD 21205 USA.; Pelled, G (corresponding author), Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA.	Pelled@kennedykrieger.org	Banerjee, Jineta/AAD-3671-2022	Banerjee, Jineta/0000-0002-1775-3645	National Institutes of Health, NINDS [R01NS072171]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072171] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health, NINDS, R01NS072171. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMASSIAN VE, 1992, ELECTROEN CLIN NEURO, V85, P291, DOI 10.1016/0168-5597(92)90105-K; Aydin-Abidin S, 2008, EXP BRAIN RES, V188, P249, DOI 10.1007/s00221-008-1356-2; Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BOHNING DE, 2000, TRANSCRANIAL MAGNETI, P13; Cantarero G, J NEUROSCI, V33, P4634, DOI [10.1016/j.neuron.2007.06.026, DOI 10.1016/J.NEURON.2007.06.026]; Cantarero G, 2013, J NEUROSCI, V33, P12862, DOI 10.1523/JNEUROSCI.1399-13.2013; Cantello R, 2007, EPILEPSIA, V48, P366, DOI 10.1111/j.1528-1167.2006.00938.x; Cho SS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006725; Cho SI, 2012, BIOELECTROMAGNETICS, V33, P568, DOI 10.1002/bem.21715; Fournier M, SPIE MED IMAGING; Fujiki M, 2003, J NEUROSURG, V99, P1063, DOI 10.3171/jns.2003.99.6.1063; George MS, 2000, BIOL PSYCHIAT, V48, P962, DOI 10.1016/S0006-3223(00)01048-9; Gersner R, 2011, J NEUROSCI, V31, P7521, DOI 10.1523/JNEUROSCI.6751-10.2011; Giesel FL, 2012, EUR J RADIOL, V81, P1273, DOI 10.1016/j.ejrad.2011.03.002; Gothe J, 2002, BRAIN, V125, P479, DOI 10.1093/brain/awf045; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Helton TD, 2005, J NEUROSCI, V25, P10247, DOI 10.1523/JNEUROSCI.1089-05.2005; Herbsman T, 2009, HUM BRAIN MAPP, V30, P2044, DOI 10.1002/hbm.20649; Hoogendam JM, 2010, BRAIN STIMUL, V3, P95, DOI 10.1016/j.brs.2009.10.005; Hoyer EH, 2011, RESTOR NEUROL NEUROS, V29, P395, DOI 10.3233/RNN-2011-0611; Huang YZ, 2007, CLIN NEUROPHYSIOL, V118, P1028, DOI 10.1016/j.clinph.2007.01.021; JALINOUS R, 1991, J CLIN NEUROPHYSIOL, V8, P10, DOI 10.1097/00004691-199101000-00004; Ji RR, 1998, P NATL ACAD SCI USA, V95, P15635, DOI 10.1073/pnas.95.26.15635; Kanno M, 2004, J NEUROL SCI, V217, P73, DOI 10.1016/j.jns.2003.08.013; Kapur A, 1998, J NEUROPHYSIOL, V79, P2181, DOI 10.1152/jn.1998.79.4.2181; KOLBINGER HM, 1995, HUM PSYCHOPHARM CLIN, V10, P305, DOI 10.1002/hup.470100408; Kozyrev V, P NATL ACAD SCI, V111, P13553; Lee SH, 2005, NEUROSCI LETT, V376, P177, DOI 10.1016/j.neulet.2004.11.048; Lee SW, 2014 36 ANN INT C IE; Lee SW, 2015 7 INT IEEE EMBS; Lefaucheur JP, 2014, CLIN NEUROPHYSIOL, V125, P2150, DOI 10.1016/j.clinph.2014.05.021; Lenz M, 2015, BRAIN STRUCT FUNCT, V220, P3323, DOI 10.1007/s00429-014-0859-9; Li W, 2007, BRAIN RES BULL, V71, P493, DOI 10.1016/j.brainresbull.2006.11.002; Lipton RB, 2010, LANCET NEUROL, V9, P373, DOI 10.1016/S1474-4422(10)70054-5; Lisanby SH, 2000, DEPRESS ANXIETY, V12, P178, DOI 10.1002/1520-6394(2000)12:3<178::AID-DA10>3.0.CO;2-N; Lu H, SCI REPORTS, V5; Lynnerup N, 2005, HEAD FACE MED, V1, P1, DOI DOI 10.1186/1746-160X-1-13; MACCABEE PJ, 1993, J PHYSIOL-LONDON, V460, P201, DOI 10.1113/jphysiol.1993.sp019467; Mally J, 1999, J NEUROSCI RES, V57, P935, DOI 10.1002/(SICI)1097-4547(19990915)57:6<935::AID-JNR19>3.0.CO;2-8; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Muller MB, 2000, NEUROPSYCHOPHARMACOL, V23, P205, DOI 10.1016/S0893-133X(00)00099-3; Muller-Dahlhaus F, FRONTIERS MOL NEUROS, V6; Murphy SC, ELIFE, V5, DOI [10.7554/eLife.13598, DOI 10.7554/ELIFE.13598PMID]; Nahas Z, 2001, J NEUROPSYCH CLIN N, V13, P459, DOI 10.1176/appi.neuropsych.13.4.459; Okatan M, 2000, NEURAL NETWORKS, V13, P699, DOI 10.1016/S0893-6080(00)00036-8; Pashut T, FRONTIERS CELLULAR N, V8; Pasley BN, 2009, NEURON, V62, P291, DOI 10.1016/j.neuron.2009.03.012; Pitcher D, 2008, J NEUROSCI, V28, P8929, DOI 10.1523/JNEUROSCI.1450-08.2008; Sachdev PS, 2002, BIOL PSYCHIAT, V51, P474, DOI 10.1016/S0006-3223(01)01298-7; Speer AM, 2009, J AFFECT DISORDERS, V115, P386, DOI 10.1016/j.jad.2008.10.006; Speer AM, 2000, BIOL PSYCHIAT, V48, P1133, DOI 10.1016/S0006-3223(00)01065-9; Strafella AP, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-15-j0003.2001; Sun P, 2011, J NEUROSCI, V31, P16464, DOI 10.1523/JNEUROSCI.1542-11.2011; Tang A, NEUROSCIENTIST; Theodore WH, 2002, NEUROLOGY, V59, P560, DOI 10.1212/WNL.59.4.560; Valiullina F, 2016, FRONT NEURAL CIRCUIT, V10, DOI [10.3389/fncir.2016.00001, 10.3389/Thcir2016.00001]; Vlachos A, 2012, J NEUROSCI, V32, P17514, DOI 10.1523/JNEUROSCI.0409-12.2012; Wagner T, 2009, CORTEX, V45, P1025, DOI 10.1016/j.cortex.2008.10.002; Wu D, 2001, J VIS, V1, P198; Zangen A, 2002, NEUROREPORT, V13, P2401, DOI 10.1097/00001756-200212200-00005; Zhang XQ, 2007, J HUAZHONG U SCI-MED, V27, P415, DOI 10.1007/s11596-007-0416-3	62	37	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170528	10.1371/journal.pone.0170528	http://dx.doi.org/10.1371/journal.pone.0170528			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114421	Green Submitted, Green Published, gold			2022-12-26	WOS:000396129000064
J	Dunietz, GL; Holzman, C; Zhang, YJ; Talge, NM; Li, CX; Todem, D; Boulet, SL; McKane, P; Kissin, DM; Copeland, G; Bernson, D; Diamond, MP				Dunietz, Galit Levi; Holzman, Claudia; Zhang, Yujia; Talge, Nicole M.; Li, Chenxi; Todem, David; Boulet, Sheree L.; McKane, Patricia; Kissin, Dmitry M.; Copeland, Glenn; Bernson, Dana; Diamond, Michael P.			Assisted Reproductive Technology and Newborn Size in Singletons Resulting from Fresh and Cryopreserved Embryos Transfer	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; LOW-BIRTH-WEIGHT; PERINATAL OUTCOMES; UNITED-STATES; GESTATIONAL-AGE; MATERNAL FACTORS; PREGNANCIES; RISK; INFERTILITY; FROZEN	Objectives and Study Design The aim of this study was two-fold: to investigate the association of Assisted Reproductive Technology (ART) and small newborn size, using standardized measures; and to examine within strata of fresh and cryopreserved embryos transfer, whether this association is influenced by parental infertility diagnoses. We used a population-based retrospective cohort from Michigan (2000-2009), Florida and Massachusetts (2000-2010). Our sample included 28,946 ART singletons conceived with non-donor oocytes and 4,263,846 non-ART singletons. Methods Regression models were used to examine the association of ART and newborn size, measured as small for gestational age (SGA) and birth-weight-z-score, among four mutually exclusive infertility groups: female infertility only, male infertility only, combined female and male infertility, and unexplained infertility, stratified by fresh and cryopreserved embryos transfer. Results We found increased SGA odds among ART singletons from fresh embryos transfer compared with non-ART singletons, with little difference by infertility source [adjusted odds-ratio for SGA among female infertility only: 1.18 (95% CI 1.10, 1.26), male infertility only: 1.20 (95% CI 1.10, 1.32), male and female infertility: 1.18 (95% CI 1.06, 1.31) and unexplained infertility: 1.24 (95% CI 1.10, 1.38)]. Conversely, ART singletons, born following cryopreserved embryos transfer, had lower SGA odds compared with non-ART singletons, with mild variation by infertility source [adjusted odds-ratio for SGA among female infertility only: 0.56 (95% CI 0.45, 0.71), male infertility only: 0.64 (95% CI 0.47, 0.86), male and female infertility: 0.52 (95% CI 0.36, 0.77) and unexplained infertility: 0.71 (95% CI 0.47, 1.06)]. Birth-weight-z-score was significantly lower for ART singletons born following fresh embryos transfer than non-ART singletons, regardless of infertility diagnoses.	[Dunietz, Galit Levi] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Dunietz, Galit Levi; Holzman, Claudia; Talge, Nicole M.; Li, Chenxi; Todem, David] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Zhang, Yujia; Boulet, Sheree L.; Kissin, Dmitry M.] Ctr Dis Control & Prevent, Div Reprod Hlth, Atlanta, GA USA; [McKane, Patricia] Michigan Dept Hlth & Human Serv, Maternal & Child Hlth Epidemiol Sect, Lansing, MI USA; [Copeland, Glenn] Michigan Dept Hlth & Human Serv, Div Vital Records & Hlth Stat, Lansing, MI USA; [Bernson, Dana] Massachusetts Dept Publ Hlth, Boston, MA USA; [Diamond, Michael P.] Augusta Univ, Dept Obstet & Gynecol, Augusta, GA USA	University of Michigan System; University of Michigan; Michigan State University; Centers for Disease Control & Prevention - USA; MDHHS - Michigan Department of Health & Human Services; MDHHS - Michigan Department of Health & Human Services; Massachusetts Department of Public Health; University System of Georgia; Augusta University	Dunietz, GL (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA.; Dunietz, GL (corresponding author), Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA.	gldt@med.umich.edu		Boulet, Sheree/0000-0002-7638-7374; Dunietz, Galit Levi/0000-0002-7240-4923	T32 Grant from the Eunice Kennedy Shriver National Institute of Child Health & Human Development [T32-HD046377]; NIH/NICHD Cooperative Reproductive Medicine Network; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD046377] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007222] Funding Source: NIH RePORTER	T32 Grant from the Eunice Kennedy Shriver National Institute of Child Health & Human Development; NIH/NICHD Cooperative Reproductive Medicine Network; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	GLD was partially supported by a T32 Grant from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (T32-HD046377). URL:www.nichd.nih.gov/Pages/index.aspx. MPD is a stock holder in and on the board of directors of Advanced Reproductive Care, and has received a grant from the NIH/NICHD Cooperative Reproductive Medicine Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; Allen AM, 2008, PUBLIC HEALTH REP, V123, P586, DOI 10.1177/003335490812300508; Ananth CV, 2004, EPIDEMIOLOGY, V15, P28, DOI 10.1097/01.ede.0000100288.37475.19; Barsky M, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.06.002; Basso O, 2010, EPIDEMIOLOGY, V21, P521, DOI 10.1097/EDE.0b013e3181debe5e; BERKOWITZ GS, 1993, EPIDEMIOL REV, V15, P414, DOI 10.1093/oxfordjournals.epirev.a036128; Chang J, 2016, FERTIL STERIL, V105, P394, DOI 10.1016/j.fertnstert.2015.10.018; D'Angelo DV, 2011, FERTIL STERIL, V96, P314, DOI 10.1016/j.fertnstert.2011.05.073; Delbaere I, 2007, HUM REPROD, V22, P2080, DOI 10.1093/humrep/dem151; Fujii M, 2010, FERTIL STERIL, V94, P2113, DOI 10.1016/j.fertnstert.2009.12.031; Hayashi M, 2012, FERTIL STERIL, V98, P922, DOI 10.1016/j.fertnstert.2012.05.049; Helmerhorst FM, 2004, BRIT MED J, V328, P261, DOI 10.1136/bmj.37957.560278.EE; Jackson RA, 2004, OBSTET GYNECOL, V103, P551, DOI 10.1097/01.AOG.0000114989.84822.51; Kondapalli LA, 2013, FERTIL STERIL, V99, P303, DOI 10.1016/j.fertnstert.2012.12.035; Koudstaal J, 2000, HUM REPROD, V15, P1819, DOI 10.1093/humrep/15.8.1819; Kramer MS, 2013, NESTLE NUTR WORKS SE, V74, P1, DOI 10.1159/000348382; Land JA, 2006, HUM REPROD, V21, P2638, DOI 10.1093/humrep/del246; Luke B, 2009, FERTIL STERIL, V91, P2578, DOI 10.1016/j.fertnstert.2008.03.068; Maheshwari A, 2012, FERTIL STERIL, V98, P368, DOI 10.1016/j.fertnstert.2012.05.019; Marino JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0080398; McDonald SD, 2009, EUR J OBSTET GYN R B, V146, P138, DOI 10.1016/j.ejogrb.2009.05.035; McGovern PG, 2004, FERTIL STERIL, V82, P1514, DOI 10.1016/j.fertnstert.2004.06.038; Mneimneh AS, 2013, J WOMENS HEALTH, V22, P571, DOI 10.1089/jwh.2013.4452; Nakashima A, 2013, FERTIL STERIL, V99, P450, DOI 10.1016/j.fertnstert.2012.09.027; Northam S, 2006, JOGNN-J OBST GYN NEO, V35, P3, DOI 10.1111/J.1552-6909.2006.00016.x; Opdahl S, 2015, HUM REPROD, V30, P1724, DOI 10.1093/humrep/dev090; Pandey S, 2012, HUM REPROD UPDATE, V18, P485, DOI 10.1093/humupd/dms018; Pelkonen S, 2010, HUM REPROD, V25, P914, DOI 10.1093/humrep/dep477; Pinborg A, 2005, HUM REPROD, V20, P2821, DOI 10.1093/humrep/dei142; Pinborg A, 2014, HUM REPROD, V29, P618, DOI 10.1093/humrep/det440; Pinborg A, 2013, HUM REPROD UPDATE, V19, P87, DOI 10.1093/humupd/dms044; Reddy UM, 2007, OBSTET GYNECOL, V109, P967, DOI 10.1097/01.AOG.0000259316.04136.30; Ruiz M, 2015, J EPIDEMIOL COMMUNIT; Sazonova A, 2012, HUM REPROD, V27, P1343, DOI 10.1093/humrep/des036; Schieve LA, 2002, NEW ENGL J MED, V346, P731, DOI 10.1056/NEJMoa010806; Shih W, 2008, HUM REPROD, V23, P1644, DOI 10.1093/humrep/den150; Sunderam S, 2014, MMWR SURVEILL SUMM, V63, P1; Talge NM, 2014, PEDIATRICS, V133, P844, DOI 10.1542/peds.2013-3285; Urquia ML, 2012, J EPIDEMIOL COMMUN H, V66, P971, DOI 10.1136/jech-2011-200772; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233; WILCOX AJ, 1993, AM J EPIDEMIOL, V137, P1098, DOI 10.1093/oxfordjournals.aje.a116613; Wisborg K, 2010, FERTIL STERIL, V94, P2102, DOI 10.1016/j.fertnstert.2010.01.014; Zhang YJ, 2012, MATERN CHILD HLTH J, V16, P1703, DOI 10.1007/s10995-011-0877-7; Zhu JL, 2007, OBSTET GYNECOL, V110, P1326, DOI 10.1097/01.AOG.0000290330.80256.97	44	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0169869	10.1371/journal.pone.0169869	http://dx.doi.org/10.1371/journal.pone.0169869			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114395	gold, Green Submitted, Green Published			2022-12-26	WOS:000396129000013
J	Wozniak, KL; Mayfield, BL; Duray, AM; Tembo, M; Beleny, DO; Napolitano, MA; Sauer, ML; Wisner, BW; Carlson, AE				Wozniak, Katherine L.; Mayfield, Brianna L.; Duray, Alexis M.; Tembo, Maiwase; Beleny, David O.; Napolitano, Marc A.; Sauer, Monica L.; Wisner, Bennett W.; Carlson, Anne E.			Extracellular Ca2+ Is Required for Fertilization in the African Clawed Frog, Xenopus laevis	PLOS ONE			English	Article							CALCIUM-SENSING RECEPTOR; SEA-URCHIN SPERM; ACROSOME REACTION; EGG ACTIVATION; MOTILITY; ENTRY; ZINC; SPERMATOZOA; INDICATORS; CATSPER1	Background The necessity of extracellular Ca2+ for fertilization and early embryonic development in the African clawed frog, Xenopus laevis, is controversial. Ca2+ entry into X. laevis sperm is reportedly required for the acrosome reaction, yet fertilization and embryonic development have been documented to occur in high concentrations of the Ca2+ chelator BAPTA. Here we sought to resolve this controversy. Methodology/ principal finding Using the appearance of cleavage furrows as an indicator of embryonic development, we found that X. laevis eggs inseminated in a solution lacking added divalent cations developed normally. By contrast, eggs inseminated in millimolar concentrations of BAPTA or EGTA failed to develop. Transferring embryos to varying solutions after sperm addition, we found that extracellular Ca2+ is specifically required for events occurring within the first 30 minutes after sperm addition, but not after. We found that the fluorescently stained sperm were not able to penetrate the envelope of eggs inseminated in high BAPTA, whereas several had penetrated the vitelline envelope of eggs inseminated without a Ca2+ chelator, or with BAPTA and saturating CaCl2. Together these results indicate that fertilization does not occur in high concentrations of Ca2+ chelators. Finally, we found that the jelly coat includes >5mM of readily diffusible Ca2+. Conclusions/ Significance Taken together, these data are consistent with requirement of extracellular Ca2+ for fertilization. Based on our findings, we hypothesize that the jelly coat surrounding the egg acts as a reserve of readily available Ca2+ ions to foster fertilization in changing extracellular milieu.	[Wozniak, Katherine L.; Mayfield, Brianna L.; Duray, Alexis M.; Tembo, Maiwase; Beleny, David O.; Napolitano, Marc A.; Sauer, Monica L.; Wisner, Bennett W.; Carlson, Anne E.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Carlson, AE (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	acarlson@pitt.edu	Carlson, Anne/I-9495-2019	Carlson, Anne/0000-0003-2724-1325; Duray, Alexis/0000-0002-1658-3701; Wisner, Bennett/0000-0002-7475-0934; Sauer, Monica/0000-0003-2928-1048; Wozniak, Katherine/0000-0002-3797-2116	NICHD [R00HD069410]; Howard Hughes Institute Science Education [52008122]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD069410] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Howard Hughes Institute Science Education; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Support was provided by R00HD069410 from the NICHD [http://www.,nichd.nih.gov/Pagps/ index.aspx] to AEC; Undergraduate summer research fellowship from Howard Hughes Institute Science Education Grant #52008122 to provide stipend for AMD.	Bates RC, 2014, DEV BIOL, V386, P165, DOI 10.1016/j.ydbio.2013.11.006; Bedu-Addo K, 2007, DEV BIOL, V302, P324, DOI 10.1016/j.ydbio.2006.09.040; Beltran C, 2016, ADV ANAT EMBRYOL CEL, V220, P35, DOI 10.1007/978-3-319-30567-7_3; BEMENT WM, 1990, CELL REGUL, V1, P315, DOI 10.1091/mbc.1.3.315; BERNARDINI G, 1988, GAMETE RES, V20, P165, DOI 10.1002/mrd.1120200207; Bers DM, 2010, METHOD CELL BIOL, V99, P1, DOI [10.1016/S0091-679X(10)99001-8, 10.1016/B978-0-12-374841-6.00001-3]; Britigan BE, 1998, BIOCHEM PHARMACOL, V55, P287, DOI 10.1016/S0006-2952(97)00463-2; Carlson AE, 2005, J BIOL CHEM, V280, P32238, DOI 10.1074/jbc.M501430200; Carlson AE, 2003, P NATL ACAD SCI USA, V100, P14864, DOI 10.1073/pnas.2536658100; Carlson AE, 2007, DEV BIOL, V312, P183, DOI 10.1016/j.ydbio.2007.09.017; CSERMELY P, 1989, BIOCHEM BIOPH RES CO, V165, P838, DOI 10.1016/S0006-291X(89)80042-7; Deguchi R, 2015, INT J DEV BIOL, V59, P271, DOI 10.1387/ijdb.150239ss; Medina MF, 2010, ZYGOTE, V18, P69, DOI 10.1017/S0967199409990037; Florman HM, 2015, KNOBIL NEILLS PHYSL, V1, P149; Fontanilla RA, 1998, BIOPHYS J, V75, P2079, DOI 10.1016/S0006-3495(98)77650-7; GREY RD, 1976, DEV BIOL, V54, P52, DOI 10.1016/0012-1606(76)90285-2; GREY RD, 1974, DEV BIOL, V36, P44, DOI 10.1016/0012-1606(74)90189-4; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HEASMAN J, 1991, METHOD CELL BIOL, V36, P213; Ho HC, 2001, REPRODUCTION, V122, P519, DOI 10.1530/rep.0.1220519; Iwao Y, 2014, MECH DEVELOP, V134, P80, DOI 10.1016/j.mod.2014.09.005; KLINE D, 1988, DEV BIOL, V126, P346, DOI 10.1016/0012-1606(88)90145-5; Kong BY, 2015, DEV DYNAM, V244, P935, DOI 10.1002/dvdy.24285; Macias-Garcia B, 2016, MOL REPROD DEV, V83, P236, DOI 10.1002/mrd.22615; Mendoza FJ, 2011, J ANDROL, V33, P96, DOI 10.2164/jandrol.110.011254; Miwa N, 2010, J BIOL CHEM, V285, P15627, DOI 10.1074/jbc.M109.079483; Que EL, 2015, NAT CHEM, V7, P130, DOI [10.1038/NCHEM.2133, 10.1038/nchem.2133]; Runft LL, 2002, DEV BIOL, V245, P237, DOI 10.1006/dbio.2002.0600; Seifert R, 2015, EMBO J, V34, P379, DOI 10.15252/embj.201489376; Stricker SA, 1999, DEV BIOL, V211, P157, DOI 10.1006/dbio.1999.9340; Tholl N, 2011, BIOL BULL-US, V220, P174, DOI 10.1086/BBLv220n3p174; Townley IK, 2006, SEMIN CELL DEV BIOL, V17, P293, DOI 10.1016/j.semcdb.2006.02.006; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; Ueda Y, 2002, DEV BIOL, V243, P55, DOI 10.1006/dbio.2001.0541; Wagner J, 2004, CELL CALCIUM, V35, P433, DOI 10.1016/j.ceca.2003.10.009; Whitaker M, 2006, PHYSIOL REV, V86, P25, DOI 10.1152/physrev.00023.2005; Wilkinson NC, 1998, J MEMBRANE BIOL, V165, P161, DOI 10.1007/s002329900430; Wood CD, 2005, J CELL BIOL, V169, P725, DOI 10.1083/jcb.200411001; Yanagimachi R., 1994, P189	39	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170405	10.1371/journal.pone.0170405	http://dx.doi.org/10.1371/journal.pone.0170405			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114360	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000396129000044
J	Yu, XH; Xu, JJ; Huang, GY; Zhang, K; Qing, L; Liu, WW; Xu, WG				Yu, Xuhua; Xu, Jiajun; Huang, Guoyang; Zhang, Kun; Qing, Long; Liu, Wenwu; Xu, Weigang			Bubble-Induced Endothelial Microparticles Promote Endothelial Dysfunction	PLOS ONE			English	Article							NEUTROPHIL ACTIVATION; IN-VITRO; INTRAVASCULAR BUBBLES; DECOMPRESSION ILLNESS; CELLS; AIR; INFLAMMATION; OXYGEN	Decompression sickness is a systemic pathophysiological process caused by bubbles and endothelial microparticles (EMPs) are established markers reflecting competency of endothelial function and vascular biology. Here, we investigated the effects of bubble induced EMPs on endothelial cells in vitro and vivo. Rat pulmonary microvascular endothelial cells (PMVECs) were isolated and stimulated by bubbles and bubble-induced EMPs were collected and incubated with normal PMVECs in vitro. Cell viability and apoptosis were detected using Cell Counting Kit-8 assay and Annexin V FITC/PI double staining, respectively. Cell permeability and pro-inflammatory cytokines were determined by electric cell substrate impedance sensing and enzyme-linked immunosorbent assay, respectively. Intracellular nitric oxide and reactive oxygen species production were analyzed microscopically. In vivo study, bubble-induced EMPs were intravenously injected to the rats and soluble thrombomodulin, intercellular adhesion molecule 1, and vascullar adhesion molecule 1 were involved in evaluating endothelial dysfunction. In our study, bubble stimulus resulted in a significant increase of EMPs release by 3 fold. Bubble-induced EMPs significantly decreased cell viability and increased cell apoptosis. Moreover, bubble-induced EMPs induced abnormal increase of cell permeability and over-expression of pro-inflammatory cytokines. Intracellular ROS production increased while NO production decreased. These negative effects caused by bubble-induced EMPs were remarkably suppressed when EMPs pretreated with surfactant FSN-100. Finally, intravenous injection of bubble-induced EMPs caused elevations of soluble thrombomodulin and pro-inflammatory cytokines in the circulation. Altogether, our results demonstrated that bubble-induced EMPs can mediate endothelial dysfunction in vitro and vivo, which can be attenuated by EMPs abatement strategy. These data expanded our horizon of the detrimental effects of bubble-induced EMPs, which may be of great concern in DCS.	[Yu, Xuhua; Xu, Jiajun; Huang, Guoyang; Zhang, Kun; Qing, Long; Liu, Wenwu; Xu, Weigang] Second Mil Med Univ, Dept Diving & Hyperbar Med, Fac Naval Med, Shanghai, Peoples R China	Naval Medical University	Xu, WG (corresponding author), Second Mil Med Univ, Dept Diving & Hyperbar Med, Fac Naval Med, Shanghai, Peoples R China.	wg_hsu@163.com	xu, wei/HHD-2891-2022		National Natural Science Foundation of China [81501624]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81501624) to JX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brodsky SV, 2004, AM J PHYSIOL-HEART C, V286, pH1910, DOI 10.1152/ajpheart.01172.2003; Brodsky SV, 2002, CIRCULATION, V106, P2372, DOI 10.1161/01.CIR.0000033972.90653.AF; Brubakk AO, 2005, J PHYSIOL-LONDON, V566, P901, DOI 10.1113/jphysiol.2005.089862; Cabrera-Benitez NE, 2015, CRIT CARE MED, V43, pE551, DOI 10.1097/CCM.0000000000001280; Conway EM, 2012, SEMIN IMMUNOPATHOL, V34, P107, DOI 10.1007/s00281-011-0282-8; Gelderman MP, 2008, METHODS MOL BIOL, V484, P79, DOI 10.1007/978-1-59745-398-1_6; Gunnett CA, 2005, ARTERIOSCL THROM VAS, V25, P1617, DOI 10.1161/01.ATV.0000172626.00296.ba; Han WQ, 2015, CARDIOLOGY, V132, P252, DOI 10.1159/000438782; Helbing T, 2014, WORLD J CARDIOL, V6, P1135, DOI 10.4330/wjc.v6.i11.1135; Jung C, 2015, CLIN HEMORHEOL MICRO, V61, P549, DOI 10.3233/CH-151956; Klinger AL, 2011, INTEGR BIOL-UK, V3, P1033, DOI 10.1039/c1ib00017a; Klinkner DB, 2006, SHOCK, V25, P575, DOI 10.1097/01.shk.0000209558.69575.80; Kobayashi S, 2011, UNDERSEA HYPERBAR M, V38, P27; Kondo Y, 2012, EMERG MED AUSTRALAS, V24, P460, DOI 10.1111/j.1742-6723.2012.01582.x; Lee SK, 2014, THROMB HAEMOSTASIS, V112, P580, DOI 10.1160/TH13-11-0975; Madden LA, 2010, AVIAT SPACE ENVIR MD, V81, P41, DOI 10.3357/ASEM.2610.2010; MAGEE JC, 1994, AM J PHYSIOL-LUNG C, V267, pL433, DOI 10.1152/ajplung.1994.267.4.L433; Mallat Z, 2000, CIRCULATION, V101, P841, DOI 10.1161/01.CIR.101.8.841; Mazur A, 2014, INT J SPORTS MED, V35, P551, DOI 10.1055/s-0033-1358472; Mezentsev A, 2005, AM J PHYSIOL-HEART C, V289, pH1106, DOI 10.1152/ajpheart.00265.2005; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Serne EH, 2007, HYPERTENSION, V50, P204, DOI 10.1161/HYPERTENSIONAHA.107.089680; Sobolewski P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047254; Sobolewski P, 2011, AM J PHYSIOL-CELL PH, V301, pC679, DOI 10.1152/ajpcell.00046.2011; Thom SR, 2013, J APPL PHYSIOL, V114, P1396, DOI 10.1152/japplphysiol.00106.2013; Thom SR, 2012, J APPL PHYSIOL, V112, P1268, DOI 10.1152/japplphysiol.01305.2011; Thom SR, 2011, J APPL PHYSIOL, V110, P340, DOI 10.1152/japplphysiol.00811.2010; Vann RD, 2011, LANCET, V377, P153, DOI 10.1016/S0140-6736(10)61085-9; VanWijk MJ, 2002, AM J OBSTET GYNECOL, V187, P1686, DOI 10.1067/mob.2002.127905; Venable AS, 2014, J IMMUNOL METHODS, V406, P117, DOI 10.1016/j.jim.2014.02.010; Wang Q, 2015, J APPL PHYSIOL, V119, P1355, DOI 10.1152/japplphysiol.00167.2015; Zhang Y, 2016, SHOCK, V45, P299, DOI 10.1097/SHK.0000000000000509	32	17	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0168881	10.1371/journal.pone.0168881	http://dx.doi.org/10.1371/journal.pone.0168881			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114372	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129000004
J	Kenkel, D; Varga, Z; Heuer, H; Dedes, KJ; Berger, N; Filli, L; Boss, A				Kenkel, David; Varga, Zsuzsanna; Heuer, Heike; Dedes, Konstantin J.; Berger, Nicole; Filli, Lukas; Boss, Andreas			A Micro CT Study in Patients with Breast Microcalcifications Using a Mathematical Algorithm to Assess 3D Structure	PLOS ONE			English	Article							CLUSTERED MICROCALCIFICATIONS; COST-EFFECTIVENESS; MAMMOGRAPHY; CALCIFICATIONS; CLASSIFICATION; SEGMENTATION	Purpose The aim of this study was to evaluate the relevance of the three-dimensional (3D) structure of breast microcalcifications (MC) as a predictor of malignancy using highly resolved microcomputed tomography (micro-CT) datasets of biopsy samples. Material and Methods The study included 28 women with suspicious MC in their mammogram undergoing vacuum-assisted biopsy. Directly after the intervention, the specimens were scanned in a micro-CT with an isometric spatial resolution of 9 mu m. Datasets were analysed regarding the number, volume and morphology of suspicious non-monomorphic MC (fl-fine linear, fp-fine pleomorphic, ch-coarse heterogeneous) and the structure model index (SMI). Histological evaluation was performed according to the B-classification: normal tissue or benign (group A: B1, B2), unclear malignant potential or suspicious of malignancy (group B: B3, B4) and malignant lesions (group C: B5). Results In all groups, suspicious non-monomorphic MC were found: group A exhibited fp MC in 38.5% of samples, no fl/ch; group B: fl 14.3%, fp 28.6%, ch 14.3%; group C always had at least one type of suspicious non-monomorphic MC (fl (57.1%) or fp (57.1%)) in each sample. The different histologic groups showed a similar mean SMI (benign: 2.97 +/- 0.31, malignant: 3.02 +/- 0.10, unclear: 2.90 +/- 0.28). Between the three groups, no significant differences were found regarding number, volume or SMI value of MC. Conclusion 3D structure based on the SMI of MC analysed with highest spatial resolution is not significantly associated with the B-classification of breast lesions. Thus, magnification views of MC may be omitted in the analysis of MC detected in mammograms.	[Kenkel, David; Berger, Nicole; Filli, Lukas; Boss, Andreas] Univ Zurich, Univ Zurich Hosp, Dept Diagnost & Intervent Radiol, Zurich, Switzerland; [Varga, Zsuzsanna] Univ Zurich Hosp, Dept Pathol & Mol Pathol, Zurich, Switzerland; [Heuer, Heike; Dedes, Konstantin J.] Univ Zurich Hosp, Dept Gynecol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Kenkel, D (corresponding author), Univ Zurich, Univ Zurich Hosp, Dept Diagnost & Intervent Radiol, Zurich, Switzerland.	david.kenkel@usz.ch	Dedes, Konstantin/AAK-1281-2021	Berger, Nicole/0000-0002-7936-5808				Burnside ES, 2007, RADIOLOGY, V242, P388, DOI 10.1148/radiol.2422052130; Chen Y, 2014, IEEE T MED IMAGING, V33, P2271, DOI 10.1109/TMI.2014.2336860; Chen Y, 2013, PHYS MED BIOL, V58, P5803, DOI 10.1088/0031-9155/58/16/5803; Chen Y, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/9/2667; Chen Y, 2011, EUR J RADIOL, V80, pE42, DOI 10.1016/j.ejrad.2010.07.003; Chen Y, 2009, COMPUT MED IMAG GRAP, V33, P495, DOI 10.1016/j.compmedimag.2008.12.007; Diekmann F, 2002, ROFO-FORTSCHR RONTG, V174, P297, DOI 10.1055/s-2002-20603; Ellis IO, 2004, J CLIN PATHOL, V57, P897, DOI 10.1136/jcp.2003.010983; Fallenberg EM, 2014, ROFO-FORTSCHR RONTG, V186, P274, DOI 10.1055/s-0033-1350572; Feig S, 2010, RADIOL CLIN N AM, V48, P879, DOI 10.1016/j.rcl.2010.06.002; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Geller BM, 2005, J CLIN EPIDEMIOL, V58, P942, DOI 10.1016/j.jclinepi.2005.02.009; Grunert JH, 2004, ROFO-FORTSCHR RONTG, V176, P1759, DOI 10.1055/s-2004-813651; Grunert JH, 2000, ROFO-FORTSCHR RONTG, V172, P68, DOI 10.1055/s-2000-280; Grunert JH, 1999, ROFO-FORTSCHR RONTG, V171, P302, DOI 10.1055/s-1999-253; Grunert JH, 2001, EUR RADIOL, V11, P284, DOI 10.1007/s003300000605; Hee N Sang, 1998, 1998 P 20 ANN INT C; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; Hizukuri A, 2012, J DIGIT IMAGING, V25, P377, DOI 10.1007/s10278-011-9420-z; Law J, 2005, BRIT J RADIOL, V78, P816, DOI 10.1259/bjr/52648102; Marmot MG, 2013, BRIT J CANCER, V108, P2205, DOI 10.1038/bjc.2013.177; Morel JC, 2014, CLIN RADIOL, V69, P1112, DOI 10.1016/j.crad.2014.06.005; Moritz JD, 2000, BRIT J RADIOL, V73, P1170, DOI 10.1259/bjr.73.875.11144794; Murray PJ, 2015, POSTREPRODUCTIVE HLT; Muttarak M, 2009, SINGAP MED J, V50, P907; Nakayama R, 2006, ACAD RADIOL, V13, P1219, DOI 10.1016/j.acra.2006.07.005; Rageth CJ, 2016, BREAST CANCER RES TR, V159, P203, DOI 10.1007/s10549-016-3935-4; Rominger M, 2012, ROFO-FORTSCHR RONTG, V184, P1144, DOI 10.1055/s-0032-1313102; Sankatsing VDV, 2015, INT J CANCER, V137, P1990, DOI 10.1002/ijc.29572; Slanetz P J, 2001, Breast J, V7, P417, DOI 10.1046/j.1524-4741.2001.07607.x; Weigel S, 2010, RADIOLOGY, V255, P738, DOI 10.1148/radiol.10091173; Will BP, 2000, EUR J CANCER, V36, P724, DOI 10.1016/S0959-8049(99)00340-8; Willekens I, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-9; Zelle SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082575; Zhang Y, 2016, SIMULATION	35	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0169349	10.1371/journal.pone.0169349	http://dx.doi.org/10.1371/journal.pone.0169349			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107436	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000392405300024
J	Lau, BK; Ruggles, DR; Katyal, S; Engel, SA; Oxenham, AJ				Lau, Bonnie K.; Ruggles, Dorea R.; Katyal, Sucharit; Engel, Stephen A.; Oxenham, Andrew J.			Sustained Cortical and Subcortical Measures of Auditory and Visual Plasticity following Short-Term Perceptual Learning	PLOS ONE			English	Article							PITCH DISCRIMINATION; AMPLITUDE-MODULATION; NON-MUSICIANS; SPEECH; CORTEX; FREQUENCY; SOUND; TASK; REPRESENTATION; DYNAMICS	Short-term training can lead to improvements in behavioral discrimination of auditory and visual stimuli, as well as enhanced EEG responses to those stimuli. In the auditory domain, fluency with tonal languages and musical training has been associated with long-term cortical and subcortical plasticity, but less is known about the effects of shorter-term training. This study combined electroencephalography (EEG) and behavioral measures to investigate short-term learning and neural plasticity in both auditory and visual domains. Forty adult participants were divided into four groups. Three groups trained on one of three tasks, involving discrimination of auditory fundamental frequency (F0), auditory amplitude modulation rate (AM), or visual orientation (VIS). The fourth (control) group received no training. Pre- and post-training tests, as well as retention tests 30 days after training, involved behavioral discrimination thresholds, steady-state visually evoked potentials (SSVEP) to the flicker frequencies of visual stimuli, and auditory envelope-following responses simultaneously evoked and measured in response to rapid stimulus F0 (EFR), thought to reflect subcortical generators, and slow amplitude modulation (ASSR), thought to reflect cortical generators. Enhancement of the ASSR was observed in both auditory-trained groups, not specific to the AM-trained group, whereas enhancement of the SSVEP was found only in the visually-trained group. No evidence was found for changes in the EFR. The results suggest that some aspects of neural plasticity can develop rapidly and may generalize across tasks but not across modalities. Behaviorally, the pattern of learning was complex, with significant cross-task and cross-modal learning effects.	[Lau, Bonnie K.; Ruggles, Dorea R.; Katyal, Sucharit; Engel, Stephen A.; Oxenham, Andrew J.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Lau, Bonnie K.] Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle	Lau, BK (corresponding author), Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA.; Lau, BK (corresponding author), Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA.	blau@uw.edu		Oxenham, Andrew/0000-0002-9365-1157; Lau, Bonnie/0000-0002-0576-5470; , Sucharit Katyal/0000-0002-0390-9311	National Institute of Health [R01 DC0005216]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institute of Health R01 DC0005216 to AJO.	Atienza M, 2002, LEARN MEMORY, V9, P138, DOI 10.1101/lm.46502; BACON SP, 1989, J ACOUST SOC AM, V85, P2575, DOI 10.1121/1.397751; Bao M, 2010, J NEUROSCI, V30, P15080, DOI 10.1523/JNEUROSCI.5703-09.2010; Bernstein JG, 2003, J ACOUST SOC AM, V113, P3323, DOI 10.1121/1.1572146; Bharadwaj HM, 2015, J NEUROSCI, V35, P2161, DOI 10.1523/JNEUROSCI.3915-14.2015; Bharadwaj HM, 2014, CLIN NEUROPHYSIOL, V125, P1878, DOI 10.1016/j.clinph.2014.01.011; Bidet-Caulet A, 2007, J NEUROSCI, V27, P9252, DOI 10.1523/JNEUROSCI.1402-07.2007; Boebinger D, 2015, J ACOUST SOC AM, V137, P378, DOI 10.1121/1.4904537; Bosnyak DJ, 2004, CEREB CORTEX, V14, P1088, DOI 10.1093/cercor/bhh068; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carcagno S, 2011, JARO-J ASSOC RES OTO, V12, P89, DOI 10.1007/s10162-010-0236-1; Coffey EBJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11070; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dosher BA, 1998, P NATL ACAD SCI USA, V95, P13988, DOI 10.1073/pnas.95.23.13988; DRULLMAN R, 1994, J ACOUST SOC AM, V95, P1053, DOI 10.1121/1.408467; Fitzgerald MB, 2011, J ACOUST SOC AM, V129, P898, DOI 10.1121/1.3531841; Gaudrain D, 2016, J ACOUST SOC AM, V139, pEL51, DOI [10.1121/1.4942628, DOI 10.1121/1.4942628]; HOUTSMA AJM, 1990, J ACOUST SOC AM, V87, P304, DOI 10.1121/1.399297; Kingsbury BED, 1998, SPEECH COMMUN, V25, P117, DOI 10.1016/S0167-6393(98)00032-6; Kleiner M, 2007, PERCEPTION, V36, P14; KRAUS N, 1995, J COGNITIVE NEUROSCI, V7, P25, DOI 10.1162/jocn.1995.7.1.25; Lalonde K, 2016, J ACOUST SOC AM, V139, P1713, DOI 10.1121/1.4945590; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Liebe S, 2004, VISION SCIENCES SOCI; McTeague LM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8823; Micheyl C, 2006, HEARING RES, V219, P36, DOI 10.1016/j.heares.2006.05.004; Moore BCJ, 2000, BRIT J AUDIOL, V34, P205, DOI 10.3109/03005364000000131; Muller N, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.001.2009; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Petrov AA, 2005, PSYCHOL REV, V112, P715, DOI 10.1037/0033-295X.112.4.715; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Riecke L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108045; Rutkowski RG, 2005, P NATL ACAD SCI USA, V102, P13664, DOI 10.1073/pnas.0506838102; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Stone MA, 2012, J ACOUST SOC AM, V132, P317, DOI 10.1121/1.4725766; Tremblay K, 2001, EAR HEARING, V22, P79, DOI 10.1097/00003446-200104000-00001; Wright BA, 2001, P NATL ACAD SCI USA, V98, P12307, DOI 10.1073/pnas.211220498; YOST WA, 1989, J ACOUST SOC AM, V86, P2138, DOI 10.1121/1.398474	40	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0168858	10.1371/journal.pone.0168858	http://dx.doi.org/10.1371/journal.pone.0168858			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI3QC	28107359	Green Published, Green Submitted, gold			2022-12-26	WOS:000392405300016
J	Liu, L; Meng, F; He, Y; Zhu, M; Shen, Y; Zhang, Z				Liu, Lei; Meng, Fen; He, Yonggang; Zhu, Menghao; Shen, Yanhao; Zhang, Zhihong			Fine Mapping and Candidate Gene Analysis of the Tiller Suppression Gene ts1 in Rice	PLOS ONE			English	Article							PLANT ARCHITECTURE; AXILLARY BUDS; OUTGROWTH; ORTHOLOG; REQUIRES; MUTATION; MUTANTS; WUSCHEL; OSSPL14; PROTEIN	Tiller number is one of the key factors that influences rice plant type and yield components. In this study, an EMS-induced rice tiller suppression mutant ts1 was characterized. Morphological and histological observations revealed that, in the ts1 plants, the tiller buds were abnormally formed and therefore cannot outgrow into tillers. With an F2 population derived from a cross between ts1 and an indica cultivar Wushansimiao, a major gene, tiller suppression 1 (ts1) was fine-mapped to a 108.5 kb genomic region between markers ID8378 and SSR6884 on the short arm of rice chromosome 2. Candidate gene analysis identified nineteen putative genes. Among them, ORF4 (LOC_Os02g01610) is a PPR gene which harbored a point mutation c.+ 733/C -> T in ts1 mutant plants. A co-dominant SNP marker cd733C/ T was subsequently developed and the SNP assay demonstrated that the point mutation co-segregated with tiller suppression phenotype. Quantitative RT-PCR analysis showed that the expression level of ORF4 in ts1 plants was significantly lower than that in their wild plants, and the expression of rice tillering regulators MOC1 and HTD1 was also significantly decreased in ts1 plants. Our data indicated that ORF4 was a strong candidate gene for ts1 and ts1 might play a role in regulating rice tillering through MOC1 and HTD1 associated pathway. The results above provide a basis for further functional characterization of ts1 and will shed light on molecular mechanism of rice tillering. The informative SNP marker cd-733C/T will facilitate marker-assisted selection of ts1 in rice plant type breeding.	[Liu, Lei; Meng, Fen; He, Yonggang; Zhu, Menghao; Shen, Yanhao; Zhang, Zhihong] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan, Peoples R China	Wuhan University	Zhang, Z (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan, Peoples R China.	zzh@whu.edu.cn		He, Yonggang/0000-0002-3856-4077	Special Transgenic Program of Chinese Ministry of Agriculture [2014ZX0800902B-002, 2016ZX08001004-002]	Special Transgenic Program of Chinese Ministry of Agriculture	This research was supported by grants from the Special Transgenic Program of Chinese Ministry of Agriculture (No. 2014ZX0800902B-002 and No. 2016ZX08001004-002). The funders had no roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arite T, 2007, PLANT J, V51, P1019, DOI 10.1111/j.1365-313X.2007.03210.x; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; EDWARDS MD, 1987, GENETICS, V116, P113; Falconer D.S., 1960, INTRO QUANTITATIVE G, P1, DOI [10.2307/2985722, DOI 10.2307/2985722]; Fujita D, 2010, THEOR APPL GENET, V120, P1233, DOI 10.1007/s00122-009-1251-7; Hua JP, 2002, GENETICS, V162, P1885; Ishikawa S, 2005, PLANT CELL PHYSIOL, V46, P79, DOI 10.1093/pcp/pci022; Jeon JS, 2011, J PLANT BIOL, V54, P1, DOI 10.1007/s12374-011-9144-0; Jiang H, 2006, J INTEGR PLANT BIOL, V48, P341, DOI 10.1111/j.1744-7909.2006.00224.x; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Khush G. S., 1995, Geojournal, V35, P329, DOI 10.1007/BF00989140; Koumoto T, 2013, PLANT BIOTECHNOL-NAR, V30, P47, DOI 10.5511/plantbiotechnology.12.1210a; Kulkarni KP, 2014, J GENET, V93, P389, DOI 10.1007/s12041-014-0389-5; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Liang Y, 2005, CHIN AGR SCI B, V21, P47; Lu Z, 2015, J GENET GENOMICS, V42, P71, DOI 10.1016/j.jgg.2014.12.005; Minakuchi K, 2010, PLANT CELL PHYSIOL, V51, P1127, DOI 10.1093/pcp/pcq083; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Takeda T, 2003, PLANT J, V33, P513, DOI 10.1046/j.1365-313X.2003.01648.x; Tan JJ, 2014, MOL PLANT, V7, P1329, DOI 10.1093/mp/ssu054; Tanaka W, 2015, PLANT CELL, V27, P1173, DOI 10.1105/tpc.15.00074; Wang DL, 1999, THEOR APPL GENET, V99, P1255, DOI 10.1007/s001220051331; Wang YH, 2005, PLANT MOL BIOL, V59, P75, DOI 10.1007/s11103-004-4038-x; Wang YH, 2011, CURR OPIN PLANT BIOL, V14, P94, DOI 10.1016/j.pbi.2010.11.002; Yasuno N, 2009, NEW PHYTOL, V182, P91, DOI 10.1111/j.1469-8137.2008.02724.x; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88; ZHANG QF, 1994, P NATL ACAD SCI USA, V91, P8675, DOI 10.1073/pnas.91.18.8675; Zhu JY, 2011, MOL BREEDING, V27, P171, DOI 10.1007/s11032-010-9420-6; Zou JH, 2006, PLANT J, V48, P687, DOI 10.1111/j.1365-313X.2006.02916.x	31	3	3	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170574	10.1371/journal.pone.0170574	http://dx.doi.org/10.1371/journal.pone.0170574			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107441	Green Submitted, gold, Green Published			2022-12-26	WOS:000392405300167
J	Makoveichuk, E; Ruge, T; Nilsson, S; Sodergren, A; Olivecrona, G				Makoveichuk, Elena; Ruge, Toralph; Nilsson, Solveig; Sodergren, Anna; Olivecrona, Gunilla			High Concentrations of Angiopoietin-Like Protein 4 Detected in Serum from Patients with Rheumatoid Arthritis Can Be Explained by Non-Specific Antibody Reactivity	PLOS ONE			English	Article							LIPOPROTEIN-LIPASE; ADIPOSE-TISSUE; RICH LIPOPROTEINS; FATTY-ACIDS; ANGPTL4; PLASMA; ATHEROSCLEROSIS; INACTIVATION	Angiopoietin-like protein 4 (ANGPTL4) is suggested to be a master regulator of plasma triglyceride metabolism. Our aim was to study whether the previously reported high levels of ANGPTL4 detected in serum from patients with rheumatoid arthritis (RA) by ELISA was due to any specific molecular form of this protein (oligomers, monomers or fragments). ANGPTL4 levels were first determined in serum from 68 RA patients and 43 age and sex matched control subjects and the mean values differed by a factor of 5.0. Then, ANGPTL4 was analyzed after size exclusion chromatography (SEC) of serum samples. With serum from one of the RA patients with high levels of ANGPTL4, the dominant reactivity was found in fractions corresponding to high-molecular weight proteins. In addition, a minor peak of reactivity eluting late from the column was found both in the patient and in controls. By the use of Hetero-Block r, and by careful selection of antibodies, we documented non-specific reactions for ANGPTL4 in 39% of samples from the RA patients, most likely due to cross-reactivity of the antibodies with rheumatoid factor (RF). The corresponding figure for control subjects was 6.3%. After corrections for non-specific reactions, the mean level of ANGPTL4 in serum from RA patients was still significantly higher than in control individuals (mean levels were 101 +/- 62 and 67 +/- 39 ng/ml respectively, P = 0.02). We re-analyzed samples from our previously published studies on ANGPL4 levels in patients on hemodialysis and patients with diabetes type 2. These samples did not show false positive reactions. The levels of ANGPTL4 were comparable to those detected previously.	[Makoveichuk, Elena; Nilsson, Solveig; Olivecrona, Gunilla] Umea Univ, Dept Med Biosci Physiol Chem, Umea, Sweden; [Ruge, Toralph] Umea Univ, Dept Surg & Perioperat Sci Acute Med, Umea, Sweden; [Sodergren, Anna] Umea Univ, Dept Publ Hlth & Clin Med Rheumatol, Umea, Sweden	Umea University; Umea University; Umea University	Olivecrona, G (corresponding author), Umea Univ, Dept Med Biosci Physiol Chem, Umea, Sweden.	gunilla.olivecrona@umu.se	Olivecrona, Gunilla/D-2127-2018; Ruge, Toralph/Q-4289-2017; Södergren, Anna/L-8116-2019	Olivecrona, Gunilla/0000-0002-8876-6048; Ruge, Toralph/0000-0002-1170-5183; Södergren, Anna/0000-0002-7436-7900	Swedish Research Council VR-MH [2015-02942]; Swedish Heart and Lung Foundation [20130684]	Swedish Research Council VR-MH(Swedish Research Council); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation)	This work was supported by grants from the Swedish Research Council VR-MH (2015-02942) and the Swedish Heart and Lung Foundation (20130684). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baranowski T, 2011, HORM METAB RES, V43, P117, DOI 10.1055/s-0030-1267917; Dijk W, 2016, CURR OPIN LIPIDOL, V27, P249, DOI 10.1097/MOL.0000000000000290; Dijk W, 2014, TRENDS ENDOCRIN MET, V25, P146, DOI 10.1016/j.tem.2013.12.005; Eriksson JW, 2003, ATHEROSCLEROSIS, V166, P359, DOI 10.1016/S0021-9150(02)00366-0; Ge HF, 2005, J LIPID RES, V46, P1484, DOI 10.1194/jlr.M500005-JLR200; Ge HF, 2004, J BIOL CHEM, V279, P2038, DOI 10.1074/jbc.M307583200; Georgiadi A, 2010, CIRC RES, V106, P1712, DOI 10.1161/CIRCRESAHA.110.217380; GIOUDPAQUET M, 1987, ANN RHEUM DIS, V46, P65, DOI 10.1136/ard.46.1.65; KATO K, 1979, FEBS LETT, V102, P253, DOI 10.1016/0014-5793(79)80012-5; Kersten S, 2009, ARTERIOSCL THROM VAS, V29, P969, DOI 10.1161/ATVBAHA.108.182147; Kim I, 2000, BIOCHEM J, V346, P603, DOI 10.1042/0264-6021:3460603; Kroupa Olessia, 2012, BMC Physiology, V12, P13, DOI 10.1186/1472-6793-12-13; LINDGREN FT, 1972, LIPIDS, V7, P194, DOI 10.1007/BF02533063; Mahmood D, 2014, INT J ARTIF ORGANS, V37, P13, DOI 10.5301/ijao.5000252; Makoveichuk E, 2012, BIOCHEM BIOPH RES CO, V425, P138, DOI 10.1016/j.bbrc.2012.07.048; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Mandard S, 2004, J BIOL CHEM, V279, P34411, DOI 10.1074/jbc.M403058200; Nilsson SK, 2012, BBA-MOL CELL BIOL L, V1821, P1370, DOI 10.1016/j.bbalip.2012.06.003; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Ruge T, 2012, METABOLISM, V61, P652, DOI 10.1016/j.metabol.2011.09.014; Santulli G, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00004; Smart-Halajko MC, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-89; Sodergren A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/673018; Sodergren A, 2015, J RHEUMATOL, V42, P935, DOI 10.3899/jrheum.140694; Sodergren A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3116; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; Swales C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109524; Tjeerdema N, 2014, BMJ OPEN DIAB RES CA, V2, DOI 10.1136/bmjdrc-2014-000034; Todd DJ, 2011, ARTHRITIS RHEUM-US, V63, P894, DOI 10.1002/art.30213; van Boekel MAM, 2002, ARTHRITIS RES, V4, P87, DOI 10.1186/ar395; VILELLA E, 1993, J LIPID RES, V34, P1555; Yang YH, 2008, ARTERIOSCL THROM VAS, V28, P835, DOI 10.1161/ATVBAHA.107.157776	33	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0168922	10.1371/journal.pone.0168922	http://dx.doi.org/10.1371/journal.pone.0168922			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107351	Green Published, gold, Green Submitted			2022-12-26	WOS:000392405300017
J	Neuchel, C; Furst, D; Niederwieser, D; Bunjes, D; Tsamadou, C; Wulf, G; Pfreundschuh, M; Wagner, E; Stuhler, G; Einsele, H; Schrezenmeier, H; Mytilineos, J				Neuchel, Christine; Fuerst, Daniel; Niederwieser, Dietger; Bunjes, Donald; Tsamadou, Chrysanthi; Wulf, Gerald; Pfreundschuh, Michael; Wagner, Eva; Stuhler, Gernot; Einsele, Hermann; Schrezenmeier, Hubert; Mytilineos, Joannis			Impact of Donor Activating KIR Genes on HSCT Outcome in C1-Ligand Negative Myeloid Disease Patients Transplanted with Unrelated Donors-A Retrospective Study	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; NATURAL-KILLER-CELLS; HLA CLASS-I; LIGAND INCOMPATIBILITY; LEUKEMIA PATIENTS; DOWN-REGULATION; NK CELLS; RECEPTORS; MARROW; MOLECULES	Natural Killer cells (NK) are lymphocytes with the potential to recognize and lyse cells which escaped T-cell mediated lysis due to their aberrant HLA expression profiles. Killer cell immunoglobulin-like receptors (KIR) influence NK-cell activity by mediation of activating or inhibitory signals upon interaction with HLA-C (C1, C2) ligands. Therefore, absence of ligands for donor inhibitory KIRs following hematopoietic stem cell transplantation (HSCT) may have an influence on its outcome. Previous studies showed that C1 negative patients have a decreased HSCT outcome. Our study, based on a cohort of 200 C1-negative patients, confirmed these findings for the endpoints: overall survival (OS: HR = 1.41, CI = 1.14-1.74, p = 0.0012), disease free survival (DFS: HR = 1.27, CI = 1.05-1.53, p = 0.015), treatment related mortality (TRM: HR = 1.41, CI = 1.01-1.96, p = 0.04), and relapse incidence (RI: HR = 1.33, CI = 1.01-1.75, p = 0.04) all being inferior when compared to C1-positive patients (n = 1246). Subsequent analysis showed that these findings applied for patients with myeloid malignancies but not for patients with lymphoproliferative diseases (OS: myeloid: HR = 1.51, CI = 1.15-1.99, p = 0.003; lymphoblastic: HR = 1.26, CI = 0.91-1.75, p = 0.16; DFS: myeloid: HR = 1.31, CI = 1.01-1.70, p = 0.04; lymphoblastic: HR = 1.21, CI = 0.90-1.61, p = 0.21; RI: myeloid: HR = 1.31, CI = 1.01-1.70, p = 0.04; lymphoblastic: HR = 1.21, CI = 0.90-1.61, p = 0.21). Interestingly, within the C1-negative patient group, transplantation with KIR2DS2 resulted in better OS (9/ 10 matched: HR = 0.24, CI = 0.08-0.67, p = 0.007) as well as DFS (9/10 matched: HR = 0,26, CI = 0.11-0.60, p = 0.002), and transplantation with KIR2DS1 positive donors was associated with a decreased RI (HR = 0.30, CI = 0.13-0.69, p = 0.005). TRM was increased when the donor was positive for KIR2DS1 (HR = 2.61, CI = 1.26-5.41, p = 0.001). Our findings suggest that inclusion of KIR2DS1/2/5 and KIR3DS1-genotyping in the unrelated donor search algorithm of C1-ligand negative patients with myeloid malignancies may prove to be of clinical relevance.	[Neuchel, Christine; Fuerst, Daniel; Tsamadou, Chrysanthi; Schrezenmeier, Hubert; Mytilineos, Joannis] Baden Wuerttenberg Hessen & Univ Hosp Ulm, German Red Cross Blood Transfus Serv, Inst Clin Transfus Med & Immunogenet Ulm, Ulm, Germany; [Neuchel, Christine; Fuerst, Daniel; Tsamadou, Chrysanthi; Schrezenmeier, Hubert; Mytilineos, Joannis] Univ Ulm, Inst Transfus Med, Ulm, Germany; [Niederwieser, Dietger] Univ Leipzig, Dept Hematol Oncol, Leipzig, Germany; [Bunjes, Donald] Univ Clin Ulm, Dept Hematol Oncol, Ulm, Germany; [Wulf, Gerald] Georg August Univ Gottingen, Dept Hematol Oncol, Gottingen, Germany; [Pfreundschuh, Michael] Univ Klinikum Saarlandes, Dept Internal Med 1, Homburg, Germany; [Wagner, Eva] Johannes Gutenberg Univ Mainz, Dept Med 3, Mainz, Germany; [Stuhler, Gernot] Deutsch Klin Diagnost, Ctr Bone Marrow & Blood Stem Cell Transplantat, Wiesbaden, Germany; [Einsele, Hermann] Univ Hosp Wurzburg, Dept Med 2, Wurzburg, Germany; [Mytilineos, Joannis] DRST German Registry Stem Cell Transplantat, Essen, Germany	Ulm University; Leipzig University; Ulm University; University of Gottingen; Universitatsklinikum des Saarlandes; Johannes Gutenberg University of Mainz; University of Wurzburg	Mytilineos, J (corresponding author), Baden Wuerttenberg Hessen & Univ Hosp Ulm, German Red Cross Blood Transfus Serv, Inst Clin Transfus Med & Immunogenet Ulm, Ulm, Germany.; Mytilineos, J (corresponding author), Univ Ulm, Inst Transfus Med, Ulm, Germany.; Mytilineos, J (corresponding author), DRST German Registry Stem Cell Transplantat, Essen, Germany.	j.mytilineos@blutspende.de			Deutsche Jose Carreras Leukamie-Stiftung e.V. [DJCLS 11/10]; German Red Cross Blood Transfusion Service, Baden-Wuerttemberg - Hessen; German Red Cross Blood Transfusion Service, Baden-Wuerttemberg-Hessen	Deutsche Jose Carreras Leukamie-Stiftung e.V.; German Red Cross Blood Transfusion Service, Baden-Wuerttemberg - Hessen; German Red Cross Blood Transfusion Service, Baden-Wuerttemberg-Hessen	This work was funded by the Deutsche Jose Carreras Leukamie-Stiftung e.V. (Grant No. DJCLS 11/10) (https://www.carreras-stiftung.de) and the German Red Cross Blood Transfusion Service, Baden-Wuerttemberg - Hessen (http://www.blutspende.de/en/home/home.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Deutsche Jose Carreras Leukamie-Stiftung e.V. (Grant No. DJCLS 11/10), and the German Red Cross Blood Transfusion Service, Baden-Wuerttemberg-Hessen.	Ahlenstiel G, 2008, J CLIN INVEST, V118, P1017, DOI 10.1172/JCI32400; Alter G, 2007, J EXP MED, V204, P3027, DOI 10.1084/jem.20070695; Asai O, 1998, J CLIN INVEST, V101, P1835, DOI 10.1172/JCI1268; Bacigalupo A, 2009, BIOL BLOOD MARROW TR, V15, P1628, DOI 10.1016/j.bbmt.2009.07.004; Barrett AJ, 2010, EXPERT REV HEMATOL, V3, P429, DOI 10.1586/EHM.10.32; BIASSONI R, 1995, J EXP MED, V182, P605, DOI 10.1084/jem.182.2.605; Bonagura VR, 2010, HUM IMMUNOL, V71, P212, DOI 10.1016/j.humimm.2009.10.009; Brouwer RE, 2002, HUM IMMUNOL, V63, P200, DOI 10.1016/S0198-8859(01)00381-0; Chewning JH, 2007, J IMMUNOL, V179, P854, DOI 10.4049/jimmunol.179.2.854; Cooley S, 2014, J IMMUNOL, V192, P4592, DOI 10.4049/jimmunol.1302517; Cooley S, 2009, BLOOD, V113, P726, DOI 10.1182/blood-2008-07-171926; David G, 2013, J IMMUNOL, V191, P4778, DOI 10.4049/jimmunol.1301580; Davies SM, 2002, BLOOD, V100, P3825, DOI 10.1182/blood-2002-04-1197; Demanet C, 2004, BLOOD, V103, P3122, DOI 10.1182/blood-2003-07-2500; Deol A, 2010, CANCER TREAT REV, V36, P528, DOI 10.1016/j.ctrv.2010.03.004; Farag SS, 2006, BIOL BLOOD MARROW TR, V12, P876, DOI 10.1016/j.bbmt.2006.05.007; Fischer JC, 2007, J IMMUNOL, V178, P3918, DOI 10.4049/jimmunol.178.6.3918; Fischer JC, 2012, IMMUNOGENETICS, V64, P879, DOI 10.1007/s00251-012-0648-7; Furst D, 2015, BIOL BLOOD MARROW TR, V21, pS31; Giebel S, 2005, BRIT J HAEMATOL, V131, P483, DOI 10.1111/j.1365-2141.2005.05797.x; Glidden DV, 2004, STAT MED, V23, P369, DOI 10.1002/sim.1599; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Gratwohl A, 2012, BONE MARROW TRANSPL, V47, P749, DOI 10.1038/bmt.2011.110; Gratwohl A, 2009, CANCER-AM CANCER SOC, V115, P4715, DOI 10.1002/cncr.24531; HOROWITZ MM, 1990, BLOOD, V75, P555; Hsu KC, 2005, BLOOD, V105, P4878, DOI 10.1182/blood-2004-12-4825; Iacobelli S, 2013, BONE MARROW TRANSPL, V48, pS1, DOI 10.1038/bmt.2012.282; Jamil KM, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/298348; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Knorr DA, 2016, BIOL BLOOD MARROW TR; LABOPIN M, STAT GUIDELINES EBMT; Liu JX, 2014, P NATL ACAD SCI USA, V111, P2662, DOI 10.1073/pnas.1322052111; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Maki G, 2008, LEUKEMIA, V22, P998, DOI 10.1038/leu.2008.15; Middleton D, 2010, IMMUNOLOGY, V129, P8, DOI 10.1111/j.1365-2567.2009.03208.x; Moesta AK, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00336; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; MORETTA A, 1990, J EXP MED, V172, P1589, DOI 10.1084/jem.172.6.1589; Morishima Y, 2007, BIOL BLOOD MARROW TR, V13, P315, DOI 10.1016/j.bbmt.2006.10.027; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Riemersma SA, 2000, BLOOD, V96, P3569, DOI 10.1182/blood.V96.10.3569.h8003569_3569_3577; Robinson J, 2015, NUCLEIC ACIDS RES, V43, pD423, DOI 10.1093/nar/gku1161; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Ruggeri L, 2005, TRANSPL IMMUNOL, V14, P203, DOI 10.1016/j.trim.2005.03.008; Sivori S, 2011, BLOOD, V117, P4284, DOI 10.1182/blood-2010-10-316125; Therneau T, PACKAGE SURVIVAL ANA; Tittle TV, 1997, BLOOD, V89, P4652, DOI 10.1182/blood.V89.12.4652; Uhrberg M, 1997, IMMUNITY, V7, P753, DOI 10.1016/S1074-7613(00)80394-5; Vales-Gomez M, 2000, CRIT REV IMMUNOL, V20, P223; Venstrom JM, 2012, NEW ENGL J MED, V367, P805, DOI 10.1056/NEJMoa1200503; Vitale M, 1996, P NATL ACAD SCI USA, V93, P1453, DOI 10.1073/pnas.93.4.1453; Wagtmann N, 1995, IMMUNITY, V3, P801, DOI 10.1016/1074-7613(95)90069-1; Wilson MJ, 1997, TISSUE ANTIGENS, V49, P574, DOI 10.1111/j.1399-0039.1997.tb02804.x; Yu JL, 2009, BLOOD, V113, P3875, DOI 10.1182/blood-2008-09-177055; Zhou HF, 2014, BIOL BLOOD MARROW TR, V20, P98, DOI 10.1016/j.bbmt.2013.10.017; Zingoni A, 2005, MOL IMMUNOL, V42, P451, DOI 10.1016/j.molimm.2004.07.025; Zinkernagel RM, 1996, ANNU REV IMMUNOL, V14, P333, DOI 10.1146/annurev.immunol.14.1.333	57	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0169512	10.1371/journal.pone.0169512	http://dx.doi.org/10.1371/journal.pone.0169512			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107369	Green Submitted, gold, Green Published			2022-12-26	WOS:000392405300029
J	Sun, HM; Xue, GH; Yan, C; Li, SL; Zhao, HQ; Feng, YL; Wang, LQ				Sun, Hongmei; Xue, Guanhua; Yan, Chao; Li, Shaoli; Zhao, Hanqing; Feng, Yanling; Wang, Liqiong			Changes in Molecular Characteristics of Mycoplasma pneumoniae in Clinical Specimens from Children in Beijing between 2003 and 2015	PLOS ONE			English	Article							TANDEM-REPEAT ANALYSIS; UNITED-STATES; SURVEILLANCE; INFECTIONS; STRAINS; JAPAN; CHINA	The molecular characteristics of 480 Mycoplasma pneumoniae polymerase chain reaction positive specimens (331 were previously reported and 149 were newly reported) collected from pediatric patients in Beijing, China, between 2003 and 2015 were analyzed. Genotype M4-5-7-2/P1 were the most prevalent across the 13-year study period, although the isolation and mutation rates for this genotype varied between the periods 2003-2007, 2008-2013, and 2014-2015. In addition, there was a close association between the M4-5-7-2 genotype and macrolide resistance.	[Sun, Hongmei; Xue, Guanhua; Yan, Chao; Li, Shaoli; Zhao, Hanqing; Feng, Yanling; Wang, Liqiong] Capital Inst Pediat, Dept Bacteriol, Beijing, Peoples R China	Capital Institute of Pediatrics (CIP)	Sun, HM (corresponding author), Capital Inst Pediat, Dept Bacteriol, Beijing, Peoples R China.	s.hongmei@263.net	Sun, Hongmei/CAF-0999-2022		National Nature Science Foundation [81672062]; Beijing Natural Science Foundation [7152025]	National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the National Nature Science Foundation (81672062) and the Beijing Natural Science Foundation (7152025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benitez AJ, 2012, J CLIN MICROBIOL, V50, P3620, DOI 10.1128/JCM.01755-12; Brown RJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00157; Brown RJ, 2015, J CLIN MICROBIOL, V53, P3195, DOI 10.1128/JCM.01301-15; Chalker V. J., 2015, New Microbes and New Infections, V7, P37, DOI 10.1016/j.nmni.2015.05.005; Cousin-Allery A, 2000, EPIDEMIOL INFECT, V124, P103, DOI 10.1017/S0950268899003313; Dumke R, 2007, J CLIN MICROBIOL, V45, P2726, DOI 10.1128/JCM.00321-07; Dumke R, 2011, J MICROBIOL METH, V86, P393, DOI 10.1016/j.mimet.2011.06.008; Kawai Y, 2013, ANTIMICROB AGENTS CH, V57, P4046, DOI 10.1128/AAC.00663-13; Kenri T, 2008, J MED MICROBIOL, V57, P469, DOI 10.1099/jmm.0.47634-0; Lenglet A, 2012, EUROSURVEILLANCE, V17, P2; Lin CY, 2010, J CLIN MICROBIOL, V48, P4567, DOI 10.1128/JCM.00400-10; Qu JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082174; Sun HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064607; Waites Ken B, 2009, Curr Infect Dis Rep, V11, P198, DOI 10.1007/s11908-009-0030-6; Xue GH, 2014, J CLIN MICROBIOL, V52, P1478, DOI 10.1128/JCM.03366-13; Yamada M, 2012, PEDIATR INFECT DIS J, V31, P409, DOI 10.1097/INF.0b013e318247f3e0; Yamazaki T, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00693; Yan C, 2014, J CLIN MICROBIOL; Yan C, 2016, J CLIN MICROBIOL, V54, P1400, DOI 10.1128/JCM.00184-16; Yan C, 2015, J CLIN MICROBIOL, V53, P3891, DOI 10.1128/JCM.02468-15	20	18	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170253	10.1371/journal.pone.0170253	http://dx.doi.org/10.1371/journal.pone.0170253			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107399	Green Submitted, gold, Green Published			2022-12-26	WOS:000392405300093
J	Symington, B; Mapanga, RF; Norton, GR; Essop, MF				Symington, Burger; Mapanga, Rudo F.; Norton, Gavin R.; Essop, M. Faadiel			Resveratrol Co-Treatment Attenuates the Effects of HIV Protease Inhibitors on Rat Body Weight and Enhances Cardiac Mitochondrial Respiration	PLOS ONE			English	Article							INFECTED PATIENTS; CARDIOVASCULAR-DISEASE; ANTIRETROVIRAL THERAPY; POSITIVE ADULTS; DATA-COLLECTION; DYSFUNCTION; LOPINAVIR/RITONAVIR; MECHANISMS; RISK; CARDIOMYOPATHY	Since the early 1990s human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) emerged as a global health pandemic, with sub-Saharan Africa the hardest hit. While the successful roll-out of antiretroviral (ARV) therapy provided significant relief to HIV-positive individuals, such treatment can also elicit damaging side-effects. Here especially HIV protease inhibitors (PIs) are implicated in the onset of cardio-metabolic complications such as type-2 diabetes and coronary heart disease. As there is a paucity of data regarding suitable co-treatments within this context, this preclinical study investigated whether resveratrol (RSV), aspirin (ASP) or vitamin C (VitC) co-treatment is able to blunt side-effects in a rat model of chronic PI exposure (Lopinavir/Ritonavir treatment for 4 months). Body weights and weight gain, blood metabolite levels (total cholesterol, HDL, LDL, triglycerides), echocardiography and cardiac mitochondrial respiration were assessed in PI-treated rats + various co-treatments. Our data reveal that PI treatment significantly lowered body weight and cardiac respiratory function while no significant changes were found for heart function and blood metabolite levels. Moreover, all co-treatments ameliorated the PI-induced decrease in body weight after 4 months of PI treatment, while RSV co-treatment enhanced cardiac mitochondrial respiratory capacity in PI-treated rats. This pilot study therefore provides novel hypotheses regarding RSV co-treatment that should be further assessed in greater detail.	[Symington, Burger; Mapanga, Rudo F.; Essop, M. Faadiel] Univ Stellenbosch, Dept Physiol Sci, Cardiometab Res Grp CMRG, Stellenbosch, South Africa; [Norton, Gavin R.] Univ Witwatersrand, Sch Physiol, Cardiovasc Pathophysiol & Genom Res Unit, Fac Hlth Sci, Johannesburg, South Africa	Stellenbosch University; University of Witwatersrand	Essop, MF (corresponding author), Univ Stellenbosch, Dept Physiol Sci, Cardiometab Res Grp CMRG, Stellenbosch, South Africa.	mfessop@sun.ac.za		Norton, Gavin/0000-0001-6416-6104; Essop, Faadiel/0000-0002-8434-4294	National Research Foundation of South Africa [78768]; Stellenbosch University	National Research Foundation of South Africa(National Research Foundation - South Africa); Stellenbosch University	This work was supported by the National Research Foundation of South Africa, Grant #: 78768, and Stellenbosch University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the National Research Foundation of South Africa and Stellenbosch University for providing us with financial support.	[Anonymous], GLOBAL HIV AIDS RESP; Arenas-Pinto A, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0889-9; Arzi A, 2004, PHARMACOL RES, V49, P249, DOI 10.1016/j.phrs.2003.10.004; Bacchetti P, 2005, JAIDS-J ACQ IMM DEF, V40, P121, DOI 10.1097/01.qai.0000182230.47819.aa; Badiou S, 2003, ATHEROSCLEROSIS, V168, P107, DOI 10.1016/S0021-9150(03)00058-3; Beaudoin MS, 2014, J PHYSIOL-LONDON, V592, P2519, DOI 10.1113/jphysiol.2013.270538; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cote HCF, 2007, CURR OPIN HIV AIDS, V2, P253, DOI 10.1097/COH.0b013e3281df3410; Cummins NW, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.77; Essop MF, 2004, BIOCHEM BIOPH RES CO, V314, P561, DOI 10.1016/j.bbrc.2003.12.121; Estabrook R. W., 1967, METHODS ENZYMOLOGY, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4; Fisher SD, 2005, AM HEART J, V150, P439, DOI 10.1016/j.ahj.2005.06.012; Freitas P, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-246; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Friis-Moller N, 2007, CLIN INFECT DIS, V45, P1082, DOI 10.1086/521936; Friis-Moller N, 2010, EUR J CARDIOV PREV R, V17, P491, DOI 10.1097/HJR.0b013e328336a150; Gitau SC, 2015, FRONT MED-PRC, V9, P444, DOI 10.1007/s11684-015-0421-z; Grundy SM., 2011, ATLAS ATHEROSCLEROSI; GUPTA MB, 1969, EUR J PHARMACOL, V6, P67, DOI 10.1016/0014-2999(69)90067-3; Ho JE, 2009, HEART, V95, P1193, DOI 10.1136/hrt.2008.161463; Johri MK, 2011, EXPERT OPIN BIOL TH, V11, P269, DOI 10.1517/14712598.2011.546339; Kamble P, 2013, EUR J PHARMACOL, V699, P55, DOI 10.1016/j.ejphar.2012.11.051; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Meng QY, 2002, J ACQ IMMUN DEF SYND, V30, P306, DOI [10.1097/00126334-200207010-00006, 10.1097/01.QAI.0000017995.56638.F8]; Mondy KE, 2011, CLIN INFECT DIS, V52, P378, DOI 10.1093/cid/ciq066; Norton GR, 2008, AM J PHYSIOL-HEART C, V294, pH372, DOI 10.1152/ajpheart.01024.2007; Ortblad KF, 2013, AIDS, V27, P2003, DOI 10.1097/QAD.0b013e328362ba67; PALMER JW, 1977, J BIOL CHEM, V252, P8731; Phenix BN, 2001, BLOOD, V98, P1078, DOI 10.1182/blood.V98.4.1078; Pistell PJ, 2010, ANTIVIR RES, V88, P334, DOI 10.1016/j.antiviral.2010.10.006; Porter KM, 2012, FREE RADICAL BIO MED, V53, P143, DOI 10.1016/j.freeradbiomed.2012.03.019; Prot M, 2006, ANTIMICROB AGENTS CH, V50, P3998, DOI 10.1128/AAC.00625-06; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reyskens KMSE, 2014, BBA-MOL BASIS DIS, V1842, P256, DOI 10.1016/j.bbadis.2013.11.019; Reyskens KMSE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073347; Reyskens KMSE, 2013, INT J CARDIOL, V168, P3047, DOI 10.1016/j.ijcard.2013.04.128; Rosas S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-442; Sierra S, 2005, J CLIN VIROL, V34, P233, DOI 10.1016/j.jcv.2005.09.004; Spector AA, 2006, ARTERIOSCL THROM VAS, V26, P7, DOI 10.1161/01.ATV.0000198749.28422.29; Srinivasa S, 2014, EUR J ENDOCRINOL, V170, pR185, DOI 10.1530/EJE-13-0967; Stein JH, 2001, CIRCULATION, V104, P257, DOI 10.1161/01.CIR.104.3.257; UNAIDS/World Health Organisation (WHO), 2016, FACT SHEET END AIDS; White AJ, 2001, SEX TRANSM INFECT, V77, P158, DOI 10.1136/sti.77.3.158; World Health Organisation (WHO) & UNICEF, 2008, EP FACTS SHEET HIV A; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897; Zhou HP, 2005, MOL PHARMACOL, V68, P690, DOI 10.1124/mol.105.012898; Zhou HP, 2006, AM J PHYSIOL-GASTR L, V291, pG1071, DOI 10.1152/ajpgi.00182.2006; Zungu M, 2008, MOL CELL BIOCHEM, V318, P175, DOI 10.1007/s11010-008-9867-5	48	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170344	10.1371/journal.pone.0170344	http://dx.doi.org/10.1371/journal.pone.0170344			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107484	Green Published, Green Submitted, gold			2022-12-26	WOS:000392405300116
J	Muroi, D; Hiroi, Y; Koshiba, T; Suzuki, Y; Kawaki, M; Higuchi, T				Muroi, Daisuke; Hiroi, Yasuhiro; Koshiba, Teruaki; Suzuki, Yohei; Kawaki, Masahiro; Higuchi, Takahiro			Walking through Apertures in Individuals with Stroke	PLOS ONE			English	Article							OLDER-ADULTS; VISUAL INFORMATION; FALLS; LOCOMOTION; PEOPLE; BODY; GAIT; ADAPTATION; PERCEPTION; STRATEGIES	Objective Walking through a narrow aperture requires unique postural configurations, i.e., body rotation in the yaw dimension. Stroke individuals may have difficulty performing the body rotations due to motor paralysis on one side of their body. The present study was therefore designed to investigate how successfully such individuals walk through apertures and how they perform body rotation behavior. Method Stroke fallers (n = 10), stroke non-fallers (n = 13), and healthy controls (n = 23) participated. In the main task, participants walked for 4 m and passed through apertures of various widths (0.9-1.3 times the participant's shoulder width). Accidental contact with the frame of an aperture and kinematic characteristics at the moment of aperture crossing were measured. Participants also performed a perceptual judgment task to measure the accuracy of their perceived aperture passability. Results and Discussion Stroke fallers made frequent contacts on their paretic side; however, the contacts were not frequent when they penetrated apertures from their paretic side. Stroke fallers and non-fallers rotated their body with multiple steps, rather than a single step, to deal with their motor paralysis. Although the minimum passable width was greater for stroke fallers, the body rotation angle was comparable among groups. This suggests that frequent contact in stroke fallers was due to insufficient body rotation. The fact that there was no significant group difference in the perceived aperture passability suggested that contact occurred mainly due to locomotor factors rather than perceptual factors. Two possible explanations (availability of vision and/or attention) were provided as to why accidental contact on the paretic side did not occur frequently when stroke fallers penetrated the apertures from their paretic side.	[Muroi, Daisuke; Higuchi, Takahiro] Tokyo Metropolitan Univ, Dept Hlth Promot Sci, Tokyo, Japan; [Muroi, Daisuke; Hiroi, Yasuhiro; Koshiba, Teruaki; Suzuki, Yohei; Kawaki, Masahiro] Kameda Med Ctr, Dept Rehabil, Chiba, Japan	Tokyo Metropolitan University	Higuchi, T (corresponding author), Tokyo Metropolitan Univ, Dept Hlth Promot Sci, Tokyo, Japan.	higuchit@tmu.ac.jp			Japan Society for the Promotion of Science (JSPS) [24680068]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science (JSPS, 24680068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind G, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-38; Bonnyaud C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149757; Cinelli ME, 2008, GAIT POSTURE, V27, P595, DOI 10.1016/j.gaitpost.2007.08.002; Cinelli ME, 2008, HUM MOVEMENT SCI, V27, P513, DOI 10.1016/j.humov.2007.10.001; CLARK RD, 1993, GERONTOLOGY, V39, P117; Cowie D, 2010, NEUROPSYCHOLOGIA, V48, P2750, DOI 10.1016/j.neuropsychologia.2010.05.022; Dennis A, 2009, BRAIN RES, V1287, P104, DOI 10.1016/j.brainres.2009.06.023; Dite W, 2002, ARCH PHYS MED REHAB, V83, P1566, DOI 10.1053/apmr.2002.35469; Franchak JM, 2014, ATTEN PERCEPT PSYCHO, V76, P460, DOI 10.3758/s13414-013-0578-y; Franchak JM, 2012, EXP BRAIN RES, V223, P301, DOI 10.1007/s00221-012-3261-y; Geruschat DR, 2003, OPTOMETRY VISION SCI, V80, P515, DOI 10.1097/00006324-200307000-00013; Hackney AL, 2015, ACTA PSYCHOL, V162, P62, DOI 10.1016/j.actpsy.2015.10.007; Hackney AL, 2015, HUM MOVEMENT SCI, V41, P295, DOI 10.1016/j.humov.2015.04.002; Hackney AL, 2014, J MOTOR BEHAV, V46, P319, DOI 10.1080/00222895.2014.913002; Hackney AL, 2013, GAIT POSTURE, V37, P93, DOI 10.1016/j.gaitpost.2012.06.020; Hackney AL, 2011, GAIT POSTURE, V33, P733, DOI 10.1016/j.gaitpost.2011.02.019; Harris JE, 2005, PHYS THER, V85, P150, DOI 10.1093/ptj/85.2.150; Higuchi T, 2004, J EXP PSYCHOL-APPL, V10, P55, DOI 10.1037/1076-898X.10.1.55; Higuchi T, 2012, PLOS ONE, V7; Higuchi T, 2006, EXP BRAIN RES, V175, P50, DOI 10.1007/s00221-006-0525-4; Higuchi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048123; Higuchi T, 2011, HUM MOVEMENT SCI, V30, P534, DOI 10.1016/j.humov.2010.08.003; Higuchi T, 2009, HUM MOVEMENT SCI, V28, P760, DOI 10.1016/j.humov.2009.07.012; Hollands KL, 2010, EXP BRAIN RES, V202, P591, DOI 10.1007/s00221-010-2162-1; Hollands KL, 2010, NEUROREHAB NEURAL RE, V24, P358, DOI 10.1177/1545968309348508; Holsinger T, 2007, JAMA-J AM MED ASSOC, V297, P2391, DOI 10.1001/jama.297.21.2391; Hyndman D, 2002, ARCH PHYS MED REHAB, V83, P165, DOI 10.1053/apmr.2002.28030; Isho T, 2015, J STROKE CEREBROVASC, V24, P1305, DOI 10.1016/j.jstrokecerebrovasdis.2015.02.004; Jorgensen L, 2000, BONE, V27, P701, DOI 10.1016/S8756-3282(00)00374-4; Kim CM, 2003, GAIT POSTURE, V18, P23, DOI 10.1016/S0966-6362(02)00122-4; Lamontagne A, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-22; Lamontagne A, 2010, NEUROREHAB NEURAL RE, V24, P457, DOI 10.1177/1545968309355985; Lamontagne A, 2009, NEUROREHAB NEURAL RE, V23, P256, DOI 10.1177/1545968308324549; Marigold DS, 2008, EXP BRAIN RES, V188, P23, DOI 10.1007/s00221-008-1335-7; Menant JC, 2010, J GERONTOL A-BIOL, V65, P751, DOI 10.1093/gerona/glq015; Otter A, 2005, EXP BRAIN RES, V161, P180, DOI 10.1007/s00221-004-2057-0; Patterson KK, 2008, ARCH PHYS MED REHAB, V89, P304, DOI 10.1016/j.apmr.2007.08.142; Rietdyk S, 2006, EXP BRAIN RES, V169, P272, DOI 10.1007/s00221-005-0345-y; Simpson LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019431; Takatori K, 2009, CLIN REHABIL, V23, P568, DOI 10.1177/0269215509102957; Thigpen MT, 2000, PHYS THER, V80, P1174, DOI 10.1093/ptj/80.12.1174; Tinetti ME, 2010, JAMA-J AM MED ASSOC, V303, P258, DOI 10.1001/jama.2009.2024; WARREN WH, 1987, J EXP PSYCHOL HUMAN, V13, P371, DOI 10.1037/0096-1523.13.3.371	43	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170119	10.1371/journal.pone.0170119	http://dx.doi.org/10.1371/journal.pone.0170119			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI3HP	28103299	Green Published, Green Submitted, gold			2022-12-26	WOS:000392381100039
J	Lee, MB; Martin, JA				Lee, Myung-Bok; Martin, James A.			Avian Species and Functional Diversity in Agricultural Landscapes: Does Landscape Heterogeneity Matter?	PLOS ONE			English	Article							LAND-USE INTENSIFICATION; PHYLOGENETIC DIVERSITY; HABITAT HETEROGENEITY; RICHNESS; CONSERVATION; BIODIVERSITY; FRAGMENTATION; COMMUNITIES; DISTURBANCE; MANAGEMENT	While the positive relationship between avian diversity and habitat heterogeneity is widely accepted, it is primarily based on observed species richness without accounting for imperfect detection. Other facets of diversity such as functional diversity are also rarely explored. We investigated the avian diversity-landscape heterogeneity relationship in agricultural landscapes by considering two aspects of diversity: taxonomic diversity (species richness) estimated from a multi-species dynamic occupancy model, and functional diversity (functional evenness [FEve] and divergence [FDiv]) based on traits of occurring species. We also assessed how agricultural lands enrolled in a conservation program managed on behalf of declining early successional bird species (hereafter CP38 fields, an agri-environment scheme) influenced avian diversity. We analyzed breeding bird data collected at CP38 fields in Mississippi, USA, during 2010-2012, and two principal components of environmental variables: a gradient of heterogeneity (Shannon's landscape diversity index) and of the amount of CP38 fields (percent cover of CP38 fields; CP38). FEve did not show significant responses to environmental variables, whereas FDiv responded positively to heterogeneity and negatively to CP38. However, most FDiv values did not significantly differ from random expectations along an environmental gradient. When there was a significant difference, FDiv was lower than that expected. Unlike functional diversity, species richness showed a clear pattern. Species richness increased with increasing landscape heterogeneity but decreased with increasing amounts of CP38 fields. Only one species responded negatively to heterogeneity and positively to CP38. Our results suggest that the relationships between avian diversity and landscape heterogeneity may vary depending on the aspect of diversity considered: strong positive effects of heterogeneity on taxonomic diversity, but weakly positive or non-significant effects on functional diversity. Our results also indicate that effectiveness of CP38 in conserving avian diversity, particularly, taxonomic diversity, could be limited without the consideration of landscape heterogeneity.	[Lee, Myung-Bok] Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Mississippi State, MS 39762 USA; [Martin, James A.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Savannah River Ecol Lab, Athens, GA 30602 USA; [Lee, Myung-Bok] Guangxi Univ, Coll Forestry, Nanning, Guangxi, Peoples R China	Mississippi State University; United States Department of Energy (DOE); Savannah River Ecology Laboratory; University System of Georgia; University of Georgia; Guangxi University	Lee, MB (corresponding author), Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Mississippi State, MS 39762 USA.; Lee, MB (corresponding author), Guangxi Univ, Coll Forestry, Nanning, Guangxi, Peoples R China.	bok.ecology@outlook.com			Wildlife Mississippi; Mississippi Wildlife Federation; Mississippi State University's Forest and Wildlife Research Center; Mississippi Agriculture and Forestry Experimental Station	Wildlife Mississippi; Mississippi Wildlife Federation; Mississippi State University's Forest and Wildlife Research Center; Mississippi Agriculture and Forestry Experimental Station	The work was funded by Wildlife Mississippi (http://www.wildlifemiss.org/), Mississippi Wildlife Federation, Mississippi State University's Forest and Wildlife Research Center, and Mississippi Agriculture and Forestry Experimental Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche O, 2012, P NATL ACAD SCI USA, V109, P17495, DOI 10.1073/pnas.1208652109; [Anonymous], 1988, BIRDERS HDB FIELD GU; Bar-Massada A, 2014, ECOGRAPHY, V37, P528, DOI 10.1111/j.1600-0587.2013.00590.x; Barragan F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017976; Bennett AF, 2006, BIOL CONSERV, V133, P250, DOI 10.1016/j.biocon.2006.06.008; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Best LB, 1997, WILDLIFE SOC B, V25, P864; Brennan JM, 2002, CAM STU LAN, P68, DOI 10.1017/CBO9780511613654.006; Buler JJ, 2007, ECOLOGY, V88, P1789, DOI 10.1890/06-1871.1; Burton AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038007; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Calba S, 2014, GLOBAL ECOL BIOGEOGR, V23, P669, DOI 10.1111/geb.12148; Casanoves F, 2011, METHODS ECOL EVOL, V2, P233, DOI 10.1111/j.2041-210X.2010.00082.x; CODY ML, 1981, BIOSCIENCE, V31, P107, DOI 10.2307/1308252; Coppedge BR, 2001, ECOL APPL, V11, P47, DOI 10.1890/1051-0761(2001)011[0047:ARTLCI]2.0.CO;2; Devictor V, 2007, AGR ECOSYST ENVIRON, V120, P179, DOI 10.1016/j.agee.2006.08.013; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Ding ZF, 2013, J ANIM ECOL, V82, P781, DOI 10.1111/1365-2656.12046; Dorazio RM, 2006, ECOLOGY, V87, P842, DOI 10.1890/0012-9658(2006)87[842:ESRAAB]2.0.CO;2; Duflot R, 2014, ACTA OECOL, V56, P19, DOI 10.1016/j.actao.2014.01.004; Dunning J., 2008, CRC HDB AVIAN BODY M, V2nd; Ekroos J, 2013, ECOL INDIC, V34, P528, DOI 10.1016/j.ecolind.2013.06.015; Elton C.S., 2000, ECOLOGY INVASIONS AN; Evans KO, 2014, CONSERV BIOL, V28, P892, DOI 10.1111/cobi.12311; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Gagic V, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2620; Gotelli NJ, 2002, ECOL LETT, V5, P86, DOI 10.1046/j.1461-0248.2002.00288.x; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Hervia V, 2015, OECOLOGICA; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Kadmon R, 2007, AM NAT, V170, P443, DOI 10.1086/519853; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kleijn D, 2011, TRENDS ECOL EVOL, V26, P474, DOI 10.1016/j.tree.2011.05.009; Laliberte E, 2013, J VEG SCI, V24, P834, DOI 10.1111/jvs.12044; Linden DW, 2012, FOREST ECOL MANAG, V284, P174, DOI 10.1016/j.foreco.2012.08.002; Luck GW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063671; Luck GW, 2012, J ANIM ECOL, V81, P1065, DOI 10.1111/j.1365-2656.2012.01974.x; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Maire E, 2015, GLOBAL ECOL BIOGEOGR, V24, P728, DOI 10.1111/geb.12299; Mason NWH, 2008, J ANIM ECOL, V77, P285, DOI 10.1111/j.1365-2656.2007.01350.x; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; Mayfield MM, 2010, GLOBAL ECOL BIOGEOGR, V19, P423, DOI 10.1111/j.1466-8238.2010.00532.x; Mendez V, 2012, DIVERS DISTRIB, V18, P356, DOI 10.1111/j.1472-4642.2011.00868.x; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Pakeman RJ, 2011, J ECOL, V99, P1143, DOI 10.1111/j.1365-2745.2011.01853.x; Pavoine S, 2011, BIOL REV, V86, P792, DOI 10.1111/j.1469-185X.2010.00171.x; Petchey OL, 2004, ECOLOGY, V85, P847, DOI 10.1890/03-0226; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Pickett SRA, 2011, ECOGRAPHY, V34, P955, DOI 10.1111/j.1600-0587.2011.06608.x; Pla L., 2012, QUANTIFYING FUNCTION; Poole A, 2005, BIRDS N AM ONLINE DA; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Riffell S, 2008, ENVIRON MONIT ASSESS, V146, P309, DOI 10.1007/s10661-007-0082-8; Robledo C., 2018, INFOSTAT VERSION 201; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle JA, 2007, ECOLOGY, V88, P1813, DOI 10.1890/06-0669.1; Russell RE, 2009, ECOL APPL, V19, P1253, DOI 10.1890/08-0910.1; Sitters H, 2016, ECOL APPL, V26, P115, DOI 10.1890/14-1562; Smith AC, 2011, ECOGRAPHY, V34, P103, DOI 10.1111/j.1600-0587.2010.06201.x; Swenson NG, 2014, USE R, P1, DOI 10.1007/978-1-4614-9542-0; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Thornton DH, 2011, LANDSCAPE ECOL, V26, P7, DOI 10.1007/s10980-010-9549-z; Tilman D, 2001, ENCY BIODIVERSITY, V3, P109, DOI [DOI 10.1016/B0-12-226865-2/00132-2, 10.1006/rwbd.1999.0154]; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Van Meerbeek K, 2014, BIODIVERS CONSERV, V23, P2259, DOI 10.1007/s10531-014-0720-8; Vandewalle M, 2010, BIODIVERS CONSERV, V19, P2921, DOI 10.1007/s10531-010-9798-9; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Zipkin EF, 2010, BIOL CONSERV, V143, P479, DOI 10.1016/j.biocon.2009.11.016; Zipkin EF, 2009, J APPL ECOL, V46, P815, DOI 10.1111/j.1365-2664.2009.01664.x	74	40	43	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170540	10.1371/journal.pone.0170540	http://dx.doi.org/10.1371/journal.pone.0170540			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125653	Green Submitted, Green Published, gold			2022-12-26	WOS:000396176100097
J	Mugo, PM; Micheni, M; Shangala, J; Hussein, MH; Graham, SM; de Wit, TFR; Sanders, EJ				Mugo, Peter M.; Micheni, Murugi; Shangala, Jimmy; Hussein, Mohamed H.; Graham, Susan M.; de Wit, Tobias F. Rinke; Sanders, Eduard J.			Uptake and Acceptability of Oral HIV Self-Testing among Community Pharmacy Clients in Kenya: A Feasibility Study	PLOS ONE			English	Article							COASTAL KENYA; PERSPECTIVES	Background While HIV testing and counselling is a key entry point for treatment as prevention, over half of HIV-infected adults in Kenya are unaware they are infected. Offering HIV self-testing (HST) at community pharmacies may enhance detection of undiagnosed infections. We assessed the feasibility of pharmacy-based HST in Coastal Kenya. Methods Staff at five pharmacies, supported by on-site research assistants, recruited adult clients (>= 18 years) seeking services indicative of HIV risk. Participants were offered oral HST kits (OraQuick (R)) at US$ 1 per test. Within one week of buying a test, participants were contacted for post-test data collection and counselling. The primary outcome was test uptake, defined as the proportion of invited clients who bought tests. Views of participating pharmacy staff were solicited in feedback sessions during and after the study. Results Between November 2015 and April 2016, 463 clients were invited to participate; 174 (38%) were enrolled; and 161 (35% [95% Confidence Interval (CI) 31-39%]) bought a test. Uptake was higher among clients seeking HIV testing compared to those seeking other services (84% vs. 11%, adjusted risk ratio 6.9 [95% CI 4.9-9.8]). Only4% of non-testers (11/302) stated inability to pay as the reason they did not take up the test. All but one tester reported the process was easy (29%) or very easy (70%). Demand for HST kits persisted after the study and participating service providers expressed interest in continuing to offer the service. Conclusions Pharmacy HST is feasible in Kenya and may be in high demand. The uptake pattern observed suggests that a client-initiated approach is more feasible compared to pharmacy-initiated testing. Price is unlikely to be a barrier if set at about US$ 1 per test. Further implementation research is required to assess uptake, yield, and linkage to care on a larger scale.	[Mugo, Peter M.; Micheni, Murugi; Shangala, Jimmy; Graham, Susan M.; Sanders, Eduard J.] Kemri Wellcome Trust Res Programme, Kilifi, Kenya; [Hussein, Mohamed H.] Minist Hlth, Mombasa, Kenya; [Graham, Susan M.] Univ Washington, Seattle, WA 98195 USA; [de Wit, Tobias F. Rinke; Sanders, Eduard J.] Univ Amsterdam, Amsterdam, Netherlands; [Sanders, Eduard J.] Univ Oxford, Headington, England	University of Washington; University of Washington Seattle; University of Amsterdam; University of Oxford	Mugo, PM (corresponding author), Kemri Wellcome Trust Res Programme, Kilifi, Kenya.	PMugo@kemri-wellcome.org		Mugo, Bernard/0000-0002-6373-1893	Wellcome Trust [077092]; NIH [1R34MH099946-01]; University of Washington Center for AIDS Research (CFAR); American people through the United States Agency for International Development (USAID); NATIONAL INSTITUTE OF MENTAL HEALTH [R34MH099946] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Center for AIDS Research (CFAR); American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the International AIDS Vaccine Initiative (IAVI) for funding this study. IAVIs work is made possible by generous support from many donors, www.iavi.org. The KWTRP at the Centre for Geographical Medicine Research-Kilifi is supported by core funding from the Wellcome Trust (#077092). SMG was supported by NIH grant 1R34MH099946-01 and the University of Washington Center for AIDS Research (CFAR). This study is made possible by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of the study authors and do not necessarily reflect the views of USAID, the NIH, or the United States Government. This report was published with permission from KEMRI.	Abuya TO, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-57; [Anonymous], 2016, DAILY NATION NEWSPAP; [Anonymous], 2015, KENY GUID HIV TEST S; Bigogo G, 2010, INT J INFECT DIS, V14, pE967, DOI 10.1016/j.ijid.2010.05.016; Calderon Y, 2013, AIDS PATIENT CARE ST, V27, P467, DOI 10.1089/apc.2013.0076; Cohen MS, 2013, LANCET, V382, P1515, DOI 10.1016/S0140-6736(13)61998-4; Cummings P, 2009, STATA J, V9, P175, DOI 10.1177/1536867X0900900201; Darin KM, 2015, J AM PHARM ASSOC, V55, P81, DOI 10.1331/JAPhA.2015.14070; Darin KM, 2015, J AM PHARM ASSOC, V55, P67, DOI 10.1331/JAPhA.2015.14069; Deas C, 2010, J AM PHARM ASSOC, V50, P411, DOI 10.1331/JAPhA.2010.09039; Gichangi A., 2016, 21 INT AIDS C DURB S; Government of Kenya, 2015, KENY DEM HLTH SURV 2; Heard AC, 2016, AIDS CARE, V28, P1528, DOI 10.1080/09540121.2016.1191602; IGUN UA, 1987, SOC SCI MED, V24, P689, DOI 10.1016/0277-9536(87)90312-1; Kenya Pharmaceutical Association, 2016, PHARMN; Kurth A, 2014, ACCURACY ORAL HIV SE; Msiska R, 1997, HEALTH POLICY PLANN, V12, P248, DOI 10.1093/heapol/12.3.248; Mugo PM, 2015, SEX TRANSM INFECT, V91, P257, DOI 10.1136/sextrans-2014-051751; Mugo PM, 2013, SEX TRANSM INFECT, V89, P583, DOI 10.1136/sextrans-2012-050979; National AIDS and STI Control Programme (NASCOP),, 2014, KENY AIDS IND SURV 2; National Aids and STI Control Programme (NASCOP) Ministry of Health, 2010, KENY NAT GUID HIV TE; Ng'ang'a A, 2014, JAIDS-J ACQ IMM DEF, V66, pS27, DOI 10.1097/QAI.0000000000000102; Ngure K, 2014, AIDS RES HUM RETROV, V30, pA70, DOI 10.1089/aid.2014.5128.abstract; Ochako R, 2014, INSIGHTS POTENTIAL U; Onwujekwe O, 2011, TROP MED INT HEALTH, V16, P1087, DOI 10.1111/j.1365-3156.2011.02821.x; Oqua D, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-525; Pharmaceutical Society of Kenya, 2016, GREEN CROSS; Reniers G, 2011, AIDS BEHAV, V15, P1, DOI 10.1007/s10461-010-9774-0; Rosenberg NE, 2013, JAIDS-J ACQ IMM DEF, V62, P226, DOI 10.1097/QAI.0b013e31827971ca; Ryder PT, 2013, J AM PHARM ASSOC, V53, P595, DOI 10.1331/JAPhA.2013.12240; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; Stergachis A, 2014, J AM PHARM ASSOC, V54, P476, DOI 10.1331/JAPhA.2014.14539; Thirumurthy H, 2016, LANCET HIV; Viberg N, 2007, PHARM WORLD SCI, V29, P25, DOI 10.1007/s11096-005-4801-3; Wafula FN, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-223; Weidle PJ, 2014, J AM PHARM ASSOC, V54, P486, DOI 10.1331/JAPhA.2014.14045; Wood BR, 2014, HIV AIDS-RES PALLIAT, V6, P117, DOI 10.2147/HIV.S49083	37	56	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170868	10.1371/journal.pone.0170868	http://dx.doi.org/10.1371/journal.pone.0170868			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7IT	28125699	Green Published, gold, Green Submitted			2022-12-26	WOS:000396176100034
J	Patel, B; Ismahil, MA; Hamid, T; Bansal, SS; Prabhu, SD				Patel, Bindiya; Ismahil, Mohamed Ameen; Hamid, Tariq; Bansal, Shyam S.; Prabhu, Sumanth D.			Mononuclear Phagocytes Are Dispensable for Cardiac Remodeling in Established Pressure-Overload Heart Failure	PLOS ONE			English	Article							GENE-EXPRESSION; DENDRITIC CELLS; STEADY-STATE; MACROPHAGES; MONOCYTES; IDENTIFICATION; INFLAMMATION; HYPERTROPHY; DYSFUNCTION; DIVERGENT	Background Although cardiac and splenic mononuclear phagocytes (MPs), i.e., monocytes, macrophages and dendritic cells (DCs), are key contributors to cardiac remodeling after myocardial infarction, their role in pressure-overload remodeling is unclear. We tested the hypothesis that these immune cells are required for the progression of remodeling in pressure-overload heart failure (HF), and that MP depletion would ameliorate remodeling. Methods and Results C57BL/6 mice were subjected to transverse aortic constriction (TAC) or sham operation, and assessed for alterations in MPs. As compared with sham, TAC mice exhibited expansion of circulating LyC6(hi) monocytes and pro-inflammatory CD206(-) cardiac macrophages early (1 w) after pressure-overload, prior to significant hypertrophy and systolic dysfunction, with subsequent resolution during chronic HF. In contrast, classical DCs were expanded in the heart in a biphasic manner, with peaks both early, analogous to macrophages, and late (8 w), during established HF. There was no significant expansion of circulating DCs, or Ly6C(+) monocytes and DCs in the spleen. Periodic systemic MP depletion from 2 to 16 w after TAC in macrophage Fas-induced apoptosis (MaFIA) transgenic mice did not alter cardiac remodeling progression, nor did splenectomy in mice with established HF after TAC. Lastly, adoptive transfer of splenocytes from TAC HF mice into naive recipients did not induce immediate or long-term cardiac dysfunction in recipient mice. Conclusions Mononuclear phagocytes populations expand in a phasic manner in the heart during pressure-overload. However, they are dispensable for the progression of remodeling and failure once significant hypertrophy is evident and blood monocytosis has normalized.	[Patel, Bindiya; Ismahil, Mohamed Ameen; Hamid, Tariq; Bansal, Shyam S.; Prabhu, Sumanth D.] Univ Alabama Birmingham, Div Cardiovasc Dis, Birmingham, AL 35294 USA; [Patel, Bindiya; Ismahil, Mohamed Ameen; Hamid, Tariq; Bansal, Shyam S.; Prabhu, Sumanth D.] Univ Alabama Birmingham, Comprehens Cardiovasc Ctr, Birmingham, AL 35233 USA; [Prabhu, Sumanth D.] Birmingham VA Med Ctr, Med Serv, Birmingham, AL 35233 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Prabhu, SD (corresponding author), Univ Alabama Birmingham, Div Cardiovasc Dis, Birmingham, AL 35294 USA.; Prabhu, SD (corresponding author), Univ Alabama Birmingham, Comprehens Cardiovasc Ctr, Birmingham, AL 35233 USA.; Prabhu, SD (corresponding author), Birmingham VA Med Ctr, Med Serv, Birmingham, AL 35233 USA.	sprabhu@uab.edu		Hamid, Tariq/0000-0002-4588-3754	National Institutes of Health [1R01HL125735]; VA Merit Award [I01BX002706]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125735] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002706] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health grant 1R01HL125735 and a VA Merit Award I01BX002706 (both to SDP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzai A, 2012, CIRCULATION, V125, P1234, DOI 10.1161/CIRCULATIONAHA.111.052126; Arnold CE, 2015, IMMUNOBIOLOGY, V220, P10, DOI 10.1016/j.imbio.2014.09.022; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Burnett SH, 2004, J LEUKOCYTE BIOL, V75, P612, DOI 10.1189/jlb.0903442; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ghassabeh GH, 2006, BLOOD, V108, P575, DOI 10.1182/blood-2005-04-1485; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hamid T, 2009, CIRCULATION, V119, P1386, DOI 10.1161/CIRCULATIONAHA.108.802918; Heidt T, 2014, CIRC RES, V115, P284, DOI 10.1161/CIRCRESAHA.115.303567; Heymans S, 2005, CIRCULATION, V112, P1136, DOI 10.1161/CIRCULATIONAHA.104.516963; Houser SR, 2012, CIRC RES, V111, P131, DOI 10.1161/RES.0b013e3182582523; Ismahil MA, 2014, CIRC RES, V114, P266, DOI 10.1161/CIRCRESAHA.113.301720; Kanellakis P, 2012, CARDIOVASC RES, V95, P77, DOI 10.1093/cvr/cvs142; Kushwah R, 2011, IMMUNOLOGY, V133, P409, DOI 10.1111/j.1365-2567.2011.03457.x; Laroumanie F, 2014, CIRCULATION, V129, P2111, DOI 10.1161/CIRCULATIONAHA.113.007101; Lavine KJ, 2014, P NATL ACAD SCI USA, V111, P16029, DOI 10.1073/pnas.1406508111; Li C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110950; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nevers T, 2015, CIRC-HEART FAIL, V8, P776, DOI 10.1161/CIRCHEARTFAILURE.115.002225; Pelayo R, 2005, BLOOD, V105, P4407, DOI 10.1182/blood-2004-07-2529; Pinto AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043093; Prabhu SD, 2016, CIRC RES, V119, P91, DOI 10.1161/CIRCRESAHA.116.303577; Sansbury BE, 2014, CIRC-HEART FAIL, V7, P634, DOI 10.1161/CIRCHEARTFAILURE.114.001151; Schilling JD, 2012, AM J PHYSIOL-HEART C, V303, pH1366, DOI 10.1152/ajpheart.00111.2012; Seifert HA, 2012, J NEUROIMMUNE PHARM, V7, P1017, DOI 10.1007/s11481-012-9406-8; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Sun M, 2007, CIRCULATION, V115, P1398, DOI 10.1161/CIRCULATIONAHA.106.643585; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Taegtmeyer H, 2010, ANN NY ACAD SCI, V1188, P191, DOI 10.1111/j.1749-6632.2009.05100.x; Usher MG, 2010, J CLIN INVEST, V120, P3350, DOI 10.1172/JCI41080; van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547; Vanderheyden M, 2005, HEART, V91, P926, DOI 10.1136/hrt.2004.035733; Wang G, 2010, ADV INTEL SYS RES, V12, P1; Weisheit C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112710; Xia Y, 2009, HISTOCHEM CELL BIOL, V131, P471, DOI 10.1007/s00418-008-0541-5; Zhao L, 2016, CIRC RES, V118, P1918, DOI 10.1161/CIRCRESAHA.116.308688	37	39	40	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170781	10.1371/journal.pone.0170781	http://dx.doi.org/10.1371/journal.pone.0170781			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125666	Green Published, gold, Green Submitted			2022-12-26	WOS:000396176100052
J	Totzeck, F; Andrade-Navarro, MA; Mier, P				Totzeck, Franziska; Andrade-Navarro, Miguel A.; Mier, Pablo			The Protein Structure Context of PolyQ Regions	PLOS ONE			English	Article							POLYGLUTAMINE AGGREGATION; COILED COILS; HUNTINGTIN; LENGTH; CONFORMATION; EVOLUTION; TOXICITY; REPEATS; DOMAIN	Proteins containing glutamine repeats (polyQ) are known to be structurally unstable. Abnormal expansion of polyQ in some proteins exceeding a certain threshold leads to neurode-generative disease, a symptom of which are protein aggregates. This has led to extensive research of the structure of polyQ stretches. However, the accumulation of contradictory results suggests that protein context might be of importance. Here we aimed to evaluate the structural context of polyQ regions in proteins by analysing the secondary structure of polyQ proteins and their homologs. The results revealed that the secondary structure in polyQ vicinity is predominantly random coil or helix. Importantly, the regions surrounding the polyQ are often not solved in 3D structures. In the few cases where the point of insertion of the polyQ was mapped to a full protein, we observed that these are always located in the surface of the protein. The findings support the hypothesis that polyQ might serve to extend coiled coils at their C-terminus in highly disordered regions involved in protein-protein interactions.	[Totzeck, Franziska; Andrade-Navarro, Miguel A.; Mier, Pablo] Johannes Gutenberg Univ Mainz, Fac Biol, Gresemundweg 2, Mainz, Germany; [Andrade-Navarro, Miguel A.; Mier, Pablo] Inst Mol Biol, Ackermannweg 4, Mainz, Germany	Johannes Gutenberg University of Mainz; Institute of Molecular Biology (IMB)	Mier, P (corresponding author), Johannes Gutenberg Univ Mainz, Fac Biol, Gresemundweg 2, Mainz, Germany.; Mier, P (corresponding author), Inst Mol Biol, Ackermannweg 4, Mainz, Germany.	munoz@uni-mainz.de	Mier, Pablo/P-8916-2019	Mier, Pablo/0000-0003-3663-2352	COST Association (Cost Action) [BM1405]	COST Association (Cost Action)	The authors thank all members of the CBDM group for helpful and constructive discussions. We gratefully acknowledge the support of the COST Association (Cost Action BM1405).	Albrecht M, 2004, EUR J BIOCHEM, V271, P3155, DOI 10.1111/j.1432-1033.2004.04245.x; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Chen S, 2001, J MOL BIOL, V311, P173, DOI 10.1006/jmbi.2001.4850; Davies P, 2008, J MOL ENDOCRINOL, V41, P301, DOI 10.1677/JME-08-0042; de Chiara C, 2005, J MOL BIOL, V354, P883, DOI 10.1016/j.jmb.2005.09.083; Faux NG, 2005, GENOME RES, V15, P537, DOI 10.1101/gr.3096505; Fiumara F, 2010, CELL, V143, P1121, DOI 10.1016/j.cell.2010.11.042; Hands S, 2008, BBA-GENE REGUL MECH, V1779, P507, DOI 10.1016/j.bbagrm.2008.05.008; Hands SL, 2010, ACTA NEUROPATHOL, V120, P419, DOI 10.1007/s00401-010-0703-0; Hildebrandt A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-531; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Klein FAC, 2007, J MOL BIOL, V371, P235, DOI 10.1016/j.jmb.2007.05.028; Kokona B, 2014, BIOCHEMISTRY-US, V53, P6738, DOI 10.1021/bi500449a; Kokona B, 2014, BIOCHEMISTRY-US, V53, P6747, DOI 10.1021/bi501066q; Masino L, 2004, PROTEIN PEPTIDE LETT, V11, P239, DOI 10.2174/0929866043407147; Mier P, 2016, J COMPUT BIOL, V23, P270, DOI 10.1089/cmb.2015.0191; Oma Y, 2007, PROTEIN SCI, V16, P2195, DOI 10.1110/ps.072955307; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Papaleo E, 2011, CURR COMPUT-AID DRUG, V7, P23, DOI 10.2174/157340911793743574; Pelassa I, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00345; Pelassa I, 2014, HUM MOL GENET, V23, P3402, DOI 10.1093/hmg/ddu049; Petrakis S, 2013, BIOESSAYS, V35, P503, DOI 10.1002/bies.201300001; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poirier MA, 2005, HUM MOL GENET, V14, P765, DOI 10.1093/hmg/ddi071; Robertson AL, 2008, BIOPHYS J, V95, P5922, DOI 10.1529/biophysj.108.138487; Ross CA, 2003, P NATL ACAD SCI USA, V100, P1, DOI 10.1073/pnas.0237018100; Ruff KM, 2014, BIOPHYS J, V107, P1226, DOI 10.1016/j.bpj.2014.07.019; Sahoo B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155747; Saunders HM, 2011, PROTEIN SCI, V20, P1675, DOI 10.1002/pro.698; Schaefer MH, 2012, NUCLEIC ACIDS RES, V40, P4273, DOI 10.1093/nar/gks011; Schulte Joost, 2011, Curr Trends Neurol, V5, P65; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Walters RH, 2009, J MOL BIOL, V393, P978, DOI 10.1016/j.jmb.2009.08.034; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	38	26	26	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170801	10.1371/journal.pone.0170801	http://dx.doi.org/10.1371/journal.pone.0170801			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125688	gold, Green Submitted, Green Published			2022-12-26	WOS:000396176100047
J	Valanejad, L; Nadolny, C; Shiffka, S; Chen, Y; You, SM; Deng, RT				Valanejad, Leila; Nadolny, Christina; Shiffka, Stephanie; Chen, Yuan; You, Sangmin; Deng, Ruitang			Differential Feedback Regulation of Delta(4)-3-Oxosteroid 5 beta-Reductase Expression by Bile Acids	PLOS ONE			English	Article							SALT EXPORT PUMP; CHOLESTEROL 7-ALPHA-HYDROXYLASE GENE; PRIMARY RAT HEPATOCYTES; FARNESOID-X-RECEPTOR; NUCLEAR RECEPTOR; STEROID-METABOLISM; LIVER-DISEASE; DELTA-4-3-KETOSTEROID 5-BETA-REDUCTASE; MESSENGER-RNA; INBORN ERROR	Delta(4)-3-oxosteroid 5 beta-reductase is member D1 of the aldo-keto reductase family 1 (AKR1D1), which catalyzes 5 beta-reduction of molecules with a 3-oxo-4-ene structure. Bile acid intermediates and most of the steroid hormones carry the 3-oxo-4-ene structure. Therefore, AKR1D1 plays critical roles in both bile acid synthesis and steroid hormone metabolism. Currently our understanding on transcriptional regulation of AKR1D1 under physiological and pathological conditions is very limited. In this study, we investigated the regulatory effects of primary bile acids, chenodeoxycholic acid (CDCA) and cholic acid (CA), on AKR1D1 expression. The expression levels of AKR1D1 mRNA and protein in vitro and in vivo following bile acid treatments were determined by real-time PCR and Western blotting. We found that CDCA markedly repressed AKR1D1 expression in vitro in human hepatoma HepG2 cells and in vivo in mice. On the contrary, CA significantly upregulated AKR1D1 expression in HepG2 cells and in mice. Further mechanistic investigations revealed that the farnesoid x receptor (FXR) signaling pathway was not involved in regulating AKR1D1 by bile acids. Instead, CDCA and CA regulated AKR1D1 through the mitogen-activated protein kinases/c-Jun N-terminal kinases (MAPK/JNK) signaling pathway. Inhibition of the MAPK/JNK pathway effectively abolished CDCA and CA-mediated regulation of AKR1D1. It was thus determined that AKR1D1 expression was regulated by CDCA and CA through modulating the MAPK/JNK signaling pathway. In conclusion, AKR1D1 expression was differentially regulated by primary bile acids through negative and positive feedback mechanisms. The findings indicated that both bile acid concentrations and compositions play important roles in regulating AKR1D1 expression, and consequently bile acid synthesis and steroid hormone metabolism.	[Valanejad, Leila; Nadolny, Christina; Shiffka, Stephanie; Chen, Yuan; You, Sangmin; Deng, Ruitang] Univ Rhode Isl, Coll Pharm, Dept Biomed & Pharmaceut Sci, Ctr Pharmacogen & Mol Therapy, Kingston, RI 02881 USA	University of Rhode Island	Deng, RT (corresponding author), Univ Rhode Isl, Coll Pharm, Dept Biomed & Pharmaceut Sci, Ctr Pharmacogen & Mol Therapy, Kingston, RI 02881 USA.	dengr@uri.edu	CHEN, YUAN/AAD-6189-2022; Chen, Yuan/AAD-7053-2022	Chen, Yuan/0000-0001-8676-0913	National Institutes of Health [R01DK087755]; American Foundation for Pharmaceutical Education; Institutional Development Award (IDeA) from the National Institutes of General Medical Sciences of the National Institutes of Health [P20 GM103430-13]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Foundation for Pharmaceutical Education; Institutional Development Award (IDeA) from the National Institutes of General Medical Sciences of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grant R01DK087755 (RD). CN is partially supported by the pre-doctoral fellowship from American Foundation for Pharmaceutical Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Institutes of Health Grant R01DK087755. C.N. is partially supported by the pre-doctoral fellowship from American Foundation for Pharmaceutical Education. We thank Dr. Bingfang Yan, University of Rhode Island, for sharing instruments and reagents in his laboratory with us. Instrumental supports from the RI-INBRE Core Facility in the College of Pharmacy, University of Rhode Island are greatly appreciated, which is supported by an Institutional Development Award (IDeA) from the National Institutes of General Medical Sciences of the National Institutes of Health under grant P20 GM103430-13.	Allen K, 2010, TOXICOL APPL PHARM, V243, P63, DOI 10.1016/j.taap.2009.11.013; Ananthanarayanan M, 2001, J BIOL CHEM, V276, P28857, DOI 10.1074/jbc.M011610200; Azer SA, 1996, J GASTROEN HEPATOL, V11, P208, DOI 10.1111/j.1440-1746.1996.tb00064.x; Bauman DR, 2004, DRUG NEWS PERSPECT, V17, P563, DOI 10.1358/dnp.2004.17.9.872570; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Centuori SM, 2014, DIGEST DIS SCI, V59, P2367, DOI 10.1007/s10620-014-3190-7; Chen M, 2014, STEROIDS, V83, P17, DOI 10.1016/j.steroids.2014.01.013; Chen Y, 2015, MOL ENDOCRINOL, V29, P613, DOI 10.1210/me.2015-1014; Chen Y, 2013, HEPATOLOGY, V57, P1530, DOI 10.1002/hep.26187; CLAYTON PT, 1988, LANCET, V1, P1283; DAUGHERTY CC, 1993, HEPATOLOGY, V18, P1096, DOI 10.1016/0270-9139(93)90463-W; De Fabiani E, 2001, J BIOL CHEM, V276, P30708, DOI 10.1074/jbc.M103270200; Deng RT, 2006, J PHARMACOL EXP THER, V317, P317, DOI 10.1124/jpet.105.097758; Deng RT, 2007, J PHARMACOL EXP THER, V320, P1153, DOI 10.1124/jpet.106.113837; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Gupta S, 2001, J BIOL CHEM, V276, P15816, DOI 10.1074/jbc.M010878200; Haeusler RA, 2013, DIABETES, V62, P4184, DOI 10.2337/db13-0639; Houten SM, 2006, EMBO J, V25, P1419, DOI 10.1038/sj.emboj.7601049; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Jin Y, 2014, BIOCHEM J, V462, P163, DOI 10.1042/BJ20140220; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; KONDO KH, 1994, EUR J BIOCHEM, V219, P357, DOI 10.1111/j.1432-1033.1994.tb19947.x; Kullak-Ublick GA, 2004, GASTROENTEROLOGY, V126, P322, DOI 10.1053/j.gastro.2003.06.005; LEISS O, 1984, GASTROENTEROLOGY, V87, P144; Lemonde HA, 2003, GUT, V52, P1494, DOI 10.1136/gut.52.10.1494; Li TG, 2006, HEPATOLOGY, V43, P1202, DOI 10.1002/hep.21183; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; McNeilly AD, 2010, J HEPATOL, V52, P705, DOI 10.1016/j.jhep.2009.10.037; Meier PJ, 2002, ANNU REV PHYSIOL, V64, P635, DOI 10.1146/annurev.physiol.64.082201.100300; Nakahara M, 2002, J BIOL CHEM, V277, P37229, DOI 10.1074/jbc.M206749200; OKUDA A, 1984, J BIOL CHEM, V259, P7519; OKUDA H, 1984, HEPATO-GASTROENTEROL, V31, P168; ONISHI Y, 1991, FEBS LETT, V283, P215, DOI 10.1016/0014-5793(91)80591-P; Palermo M, 2008, STEROIDS, V73, P417, DOI 10.1016/j.steroids.2007.12.001; Pandak WM, 2001, GASTROENTEROLOGY, V120, P1801, DOI 10.1053/gast.2001.24833; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Plass JRM, 2002, HEPATOLOGY, V35, P589, DOI 10.1053/jhep.2002.31724; PONZDELEON M, 1978, AM J DIG DIS, V23, P710, DOI 10.1007/BF01072357; PONZDELEON M, 1979, GASTROENTEROLOGY, V77, P223; Rao YP, 2002, HEPATOLOGY, V35, P307, DOI 10.1053/jhep.2002.31104; REYNIER MO, 1981, J LIPID RES, V22, P467; Rizner TL, 2014, STEROIDS, V79, P49, DOI 10.1016/j.steroids.2013.10.012; Rosales R, 2013, BIOCHEM PHARMACOL, V85, P829, DOI 10.1016/j.bcp.2013.01.001; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; SETCHELL KDR, 1988, J CLIN INVEST, V82, P2148, DOI 10.1172/JCI113837; SHNEIDER BL, 1994, J PEDIATR-US, V124, P234, DOI 10.1016/S0022-3476(94)70310-8; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Song KH, 2009, HEPATOLOGY, V49, P297, DOI 10.1002/hep.22627; Song XL, 2008, J LIPID RES, V49, P973, DOI 10.1194/jlr.M700417-JLR200; Song XL, 2014, HEPATOLOGY, V60, P1993, DOI 10.1002/hep.27171; Song XL, 2013, J LIPID RES, V54, P3030, DOI 10.1194/jlr.M038323; Talukdar S, 2007, J LIPID RES, V48, P2647, DOI 10.1194/jlr.M700189-JLR200; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Vlahcevic ZR, 2000, GASTROENTEROLOGY, V118, P599, DOI 10.1016/S0016-5085(00)70267-8; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Woollett LA, 2004, GASTROENTEROLOGY, V126, P724, DOI 10.1053/j.gastro.2003.11.058; Yashiro T, 2011, BIOCHEM BIOPH RES CO, V409, P155, DOI 10.1016/j.bbrc.2011.04.006	58	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170960	10.1371/journal.pone.0170960	http://dx.doi.org/10.1371/journal.pone.0170960			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125709	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100014
J	Yotova, I; Hsu, E; Do, C; Gaba, A; Sczabolcs, M; Dekan, S; Kenner, L; Wenzl, R; Tycko, B				Yotova, Iveta; Hsu, Emily; Do, Catherine; Gaba, Aulona; Sczabolcs, Matthias; Dekan, Sabine; Kenner, Lukas; Wenzl, Rene; Tycko, Benjamin			Epigenetic Alterations Affecting Transcription Factors and Signaling Pathways in Stromal Cells of Endometriosis	PLOS ONE			English	Article							STEROIDOGENIC-FACTOR-I; EPITHELIAL-MESENCHYMAL TRANSITION; DNA METHYLATION; EUTOPIC ENDOMETRIUM; NEUROTROPHIC FACTOR; GENE; EXPRESSION; RECEPTOR; KINASE; GROWTH	Endometriosis is characterized by growth of endometrial-like tissue outside the uterine cavity. Since its pathogenesis may involve epigenetic changes, we used Illumina 450K Methylation Beadchips to profile CpG methylation in endometriosis stromal cells compared to stromal cells from normal endometrium. We validated and extended the Beadchip data using bisulfite sequencing (bis-seq), and analyzed differential methylation (DM) at the CpG-level and by an element-level classification for groups of CpGs in chromatin domains. Genes found to have DM included examples encoding transporters (SLC22A23), signaling components (BDNF, DAPK1, ROR1, and WNT5A) and transcription factors (GATA family, HAND2, HOXA cluster, NR5A1, OSR2, TBX3). Intriguingly, among the TF genes with DM we also found JAZF1, a proto-oncogene affected by chromosomal translocations in endometrial stromal tumors. Using RNA-Seq we identified a subset of the DM genes showing differential expression (DE), with the likelihood of DE increasing with the extent of the DM and its location in enhancer elements. Supporting functional relevance, treatment of stromal cells with the hypomethylating drug 5aza-dC led to activation of DAPK1 and SLC22A23 and repression of HAND2, JAZF1, OSR2, and ROR1 mRNA expression. We found that global 5hmC is decreased in endometriotic versus normal epithelial but not stroma cells, and for JAZF1 and BDNF examined by oxidative bis-seq, found that when 5hmC is detected, patterns of 5hmC paralleled those of 5mC. Together with prior studies, these results define a consistent epigenetic signature in endometriosis stromal cells and nominate specific transcriptional and signaling pathways as therapeutic targets.	[Yotova, Iveta; Hsu, Emily; Do, Catherine; Tycko, Benjamin] Columbia Univ, Med Ctr, Inst Canc Genet, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Yotova, Iveta; Gaba, Aulona; Wenzl, Rene] Med Univ Vienna, Univ Clin Obstet & Gynecol, Dept Gynecol & Gynecol Oncol, Vienna, Austria; [Sczabolcs, Matthias; Tycko, Benjamin] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, Dept Pathol & Cell Biol, New York, NY USA; [Dekan, Sabine; Kenner, Lukas] Med Univ Vienna, Univ Clin Obstet & Gynecol, Dept Expt Pathol, Clin Inst Pathol, Vienna, Austria; [Kenner, Lukas] Univ Vet Med Vienna, Pathol Lab Anim Pathol, Vienna, Austria; [Kenner, Lukas] Ludwig Boltzmann Inst Canc Res, Vienna, Austria	Columbia University; Medical University of Vienna; Columbia University; Medical University of Vienna; University of Veterinary Medicine Vienna; Ludwig Boltzmann Institute	Yotova, I (corresponding author), Columbia Univ, Med Ctr, Inst Canc Genet, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA.; Yotova, I (corresponding author), Med Univ Vienna, Univ Clin Obstet & Gynecol, Dept Gynecol & Gynecol Oncol, Vienna, Austria.	iveta.yotova@meduniwien.ac.at	Gaba, Aulona/R-2633-2019; Gaba, Aulona/Q-7871-2018	Gaba, Aulona/0000-0003-1305-764X; Gaba, Aulona/0000-0003-1305-764X; Yotova, Iveta/0000-0003-1810-4951; Kenner, Lukas/0000-0003-2184-1338; do, catherine/0000-0002-9796-4345	Schaefer Scholar Award at Columbia University of New York; NIH [U54 CA163111]; Department of Obstetrics and Gynecology, Medical University of Vienna	Schaefer Scholar Award at Columbia University of New York; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Obstetrics and Gynecology, Medical University of Vienna	This work was supported by a grant from Schaefer Scholar Award at Columbia University of New York, to IY and BT, NIH grant to BT (U54 CA163111) and by institutional support to IY, AG and RW from Department of Obstetrics and Gynecology, Medical University of Vienna.	Ace Christopher I, 2004, Reprod Biol Endocrinol, V2, P54, DOI 10.1186/1477-7827-2-54; Achermann JC, 1999, NAT GENET, V22, P125, DOI 10.1038/9629; Aghajanova L, 2010, SEMIN REPROD MED, V28, P51, DOI 10.1055/s-0029-1242994; Ahn SH, 2015, J IMMUNOL, V195, P2591, DOI 10.4049/jimmunol.1501138; Aran D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r21; Borghese B, 2010, MOL ENDOCRINOL, V24, P1872, DOI 10.1210/me.2010-0160; Browne AS, 2012, FERTIL STERIL, V98, P713, DOI 10.1016/j.fertnstert.2012.05.027; Bulun SE, 2009, MOL CELL ENDOCRINOL, V300, P104, DOI 10.1016/j.mce.2008.12.012; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Burney RO, 2012, FERTIL STERIL, V98, P511, DOI 10.1016/j.fertnstert.2012.06.029; Capo-Chichi CD, 2003, CANCER RES, V63, P4967; Chuang M, 2014, APOPTOSIS, V19, P392, DOI 10.1007/s10495-013-0943-2; Cloke B, 2008, ENDOCRINOLOGY, V149, P4462, DOI 10.1210/en.2008-0356; Conklin CMJ, 2014, ADV ANAT PATHOL, V21, P383, DOI 10.1097/PAP.0000000000000046; Crispi S, 2013, J CELL PHYSIOL, V228, P1927, DOI 10.1002/jcp.24358; Cui B, 2013, CANCER RES, V73, P3649, DOI 10.1158/0008-5472.CAN-12-3832; de Arellano MLB, 2011, REPROD SCI, V18, P1202, DOI 10.1177/1933719111410711; DEISS LP, 1995, GENE DEV, V9, P15, DOI 10.1101/gad.9.1.15; Do C, 2016, AM J HUM GENET, V98, P934, DOI 10.1016/j.ajhg.2016.03.027; Du H, 2015, COLD SPRING HARB PER, V6; Dyson MT, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004158; Eggers S, 2012, CHROMOSOME RES, V20, P215, DOI 10.1007/s10577-012-9274-3; Ernfors P, 1995, INT J DEV BIOL, V39, P799; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Gizard F, 2005, MOL CELL BIOL, V25, P4335, DOI 10.1128/MCB.25.11.4335-4348.2005; Gizard F, 2006, MOL CELL BIOL, V26, P7632, DOI 10.1128/MCB.00326-06; Grum-Schwensen B, 2005, CANCER RES, V65, P3772, DOI 10.1158/0008-5472.CAN-04-4510; Haffner MC, 2011, ONCOTARGET, V2, P627; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hevir N, 2013, MOL CELL ENDOCRINOL, V367, P74, DOI 10.1016/j.mce.2012.12.019; Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109; Hoivik EA, 2010, MOL CELL ENDOCRINOL, V315, P27, DOI 10.1016/j.mce.2009.07.003; Houshdaran S, 2016, BIOL REPROD, DOI [10.1371/journal.pone.0083612, DOI 10.1371/JOURNAL.PONE.0083612]; HSIEHLI HM, 1995, DEVELOPMENT, V121, P1373; Hu MH, 2013, J SURG ONCOL, V108, P192, DOI 10.1002/jso.23367; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hudelist G, 2005, HUM REPROD, V20, P1695, DOI 10.1093/humrep/deh794; Huyen DV, 2011, REPRODUCTION, V142, P353, DOI 10.1530/REP-11-0060; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Ito K, 2009, AM J PATHOL, V175, P2508, DOI 10.2353/ajpath.2009.090347; Izawa M, 2008, FERTIL STERIL, V89, P1390, DOI 10.1016/j.fertnstert.2007.03.078; Jones A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001551; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kiewisz J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/854056; Kobayashi H, 2014, MOL MED REP, V9, P1483, DOI 10.3892/mmr.2014.2057; Koontz JI, 2001, P NATL ACAD SCI USA, V98, P6348, DOI 10.1073/pnas.101132598; Krizsan-Agbas D, 2003, EUR J NEUROSCI, V18, P2760, DOI 10.1111/j.1460-9568.2003.03029.x; Kyama Cleophas M, 2003, Reprod Biol Endocrinol, V1, P123, DOI 10.1186/1477-7827-1-123; Lan Y, 2004, DEVELOPMENT, V131, P3207, DOI 10.1242/dev.01175; Li H, 2008, SCIENCE, V321, P1357, DOI 10.1126/science.1156725; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li QL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002320; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuoka A, 2010, J CLIN ENDOCR METAB, V95, pE291, DOI 10.1210/jc.2010-0619; Mendioroz M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0827-6; Michie AM, 2010, FEBS J, V277, P74, DOI 10.1111/j.1742-4658.2009.07414.x; Minami Y, 2010, DEV DYNAM, V239, P1, DOI 10.1002/dvdy.21991; Ming GF, 2014, BIOCHEM BIOPH RES CO, V445, P673, DOI 10.1016/j.bbrc.2014.02.088; Monsivais D, 2014, MOL ENDOCRINOL, V28, P1304, DOI 10.1210/me.2013-1421; Monsivais D, 2016, FERTIL STERIL, V105, P1266, DOI 10.1016/j.fertnstert.2016.01.012; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Naqvi H, 2014, REPROD SCI, V21, P1237, DOI 10.1177/1933719114532841; Nassif J, 2013, Minerva Ginecol, V65, P167; Nasu K, 2011, J OBSTET GYNAECOL RE, V37, P683, DOI 10.1111/j.1447-0756.2011.01663.x; Omwandho COA, 2010, HUM REPROD, V25, P101, DOI 10.1093/humrep/dep382; Page A, 2016, J HEPATOL, V64, P661, DOI 10.1016/j.jhep.2015.11.024; Podlasek CA, 1999, DEV DYNAM, V214, P1, DOI 10.1002/(SICI)1097-0177(199901)214:1<1::AID-DVDY1>3.0.CO;2-2; Saare M, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-015-0168-z; Salker MS, 2011, NAT MED, V17, P1509, DOI 10.1038/nm.2498; Shakya R, 2013, CANCER RES, V73, P885, DOI 10.1158/0008-5472.CAN-12-1880; Spitzer TLB, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095885; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tabibzadeh S, 1996, MOL HUM REPROD, V2, P77, DOI 10.1093/molehr/2.2.77; Tang YX, 2009, BLOOD, V113, P744, DOI 10.1182/blood-2008-03-145219; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tulac S, 2006, J CLIN ENDOCR METAB, V91, P1453, DOI 10.1210/jc.2005-0769; Wang DB, 2012, EUR J MED RES, V17, DOI 10.1186/2047-783X-17-12; Wijetunga NA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6195; Xie R, 2009, LAB INVEST, V89, P937, DOI 10.1038/labinvest.2009.52; Xue Q, 2007, BIOL REPROD, V77, P681, DOI 10.1095/biolreprod.107.061804; Xue Q, 2007, J CLIN ENDOCR METAB, V92, P3261, DOI 10.1210/jc.2007-0494; Yamagata Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083612; Yamaguchi T, 2012, CANCER CELL, V21, P348, DOI 10.1016/j.ccr.2012.02.008; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yotova IY, 2011, HUM REPROD, V26, P885, DOI 10.1093/humrep/der010; Yuan L, 2002, DEVELOPMENT, V129, P4797; Zhang QY, 2012, HUM REPROD, V27, P1668, DOI 10.1093/humrep/des094; Zhang S, 2012, AM J PATHOL, V181, P937, DOI 10.1016/j.ajpath.2012.05.035; Zhang SM, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/761637; Zhao ZZ, 2011, MOL HUM REPROD, V17, P92, DOI 10.1093/molehr/gaq084; Zoubina EV, 2001, NEUROSCIENCE, V103, P237, DOI 10.1016/S0306-4522(00)00549-2	95	32	34	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170859	10.1371/journal.pone.0170859	http://dx.doi.org/10.1371/journal.pone.0170859			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125717	Green Published, gold, Green Submitted			2022-12-26	WOS:000396176100035
J	Callbeck, CM; Lavik, G; Stramma, L; Kuypers, MMM; Bristow, LA				Callbeck, Cameron M.; Lavik, Gaute; Stramma, Lothar; Kuypers, Marcel M. M.; Bristow, Laura A.			Enhanced Nitrogen Loss by Eddy-Induced Vertical Transport in the Offshore Peruvian Oxygen Minimum Zone	PLOS ONE			English	Article							ANAEROBIC AMMONIUM OXIDATION; EASTERN SOUTH-PACIFIC; MESOSCALE EDDIES; SATELLITE-OBSERVATIONS; ANTICYCLONIC EDDIES; FIXED NITROGEN; NORTH-ATLANTIC; ANAMMOX; OCEAN; SEA	The eastern tropical South Pacific (ETSP) upwelling region is one of the ocean's largest sinks of fixed nitrogen, which is lost as N-2 via the anaerobic processes of anammox and denitrification. One-third of nitrogen loss occurs in productive shelf waters stimulated by organic matter export as a result of eastern boundary upwelling. Offshore, nitrogen loss rates are lower, but due to its sheer size this area accounts for similar to 70% of ETSP nitrogen loss. How nitrogen loss and primary production are regulated in the offshore ETSP region where coastal upwelling is less influential remains unclear. Mesoscale eddies, ubiquitous in the ETSP region, have been suggested to enhance vertical nutrient transport and thereby regulate primary productivity and hence organic matter export. Here, we investigated the impact of mesoscale eddies on anammox and denitrification activity using N-15-labelled in situ incubation experiments. Anammox was shown to be the dominant nitrogen loss process, but varied across the eddy, whereas denitrification was below detection at all stations. Anammox rates at the eddy periphery were greater than at the center. Similarly, depth-integrated chlorophyll paralleled anammox activity, increasing at the periphery relative to the eddy center; suggestive of enhanced organic matter export along the periphery supporting nitrogen loss. This can be attributed to enhanced vertical nutrient transport caused by an eddy-driven submesoscale mechanism operating at the eddy periphery. In the ETSP region, the widespread distribution of eddies and the large heterogeneity observed in anammox rates from a compilation of stations suggests that eddy-driven vertical nutrient transport may regulate offshore primary production and thereby nitrogen loss.	[Callbeck, Cameron M.; Lavik, Gaute; Kuypers, Marcel M. M.; Bristow, Laura A.] Max Planck Inst Marine Microbiol, Dept Biogeochem, Bremen, Germany; [Stramma, Lothar] GEOMAR Helmholtz Ctr Ocean Res Kiel, Dept Phys Oceanog, Schleswig Holstein, Germany	Max Planck Society; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel	Callbeck, CM (corresponding author), Max Planck Inst Marine Microbiol, Dept Biogeochem, Bremen, Germany.	ccallbec@mpi-bremen.de	Callbeck, Cameron M./AAP-1076-2021; Callbeck, Cameron/O-9769-2018	Callbeck, Cameron M./0000-0001-7602-3338; Callbeck, Cameron/0000-0001-7602-3338; Bristow, Laura/0000-0003-4865-070X; Stramma, Lothar/0000-0003-1391-4808	DFG [Sonderforschungsbereich 754]	DFG(German Research Foundation (DFG))	CMC, GL, LS, MMMK, LAB: DFG-funded Sonderforschungsbereich 754 "Climate-Biogeochemistry Interactions in the Tropical Ocean" (www.sfb754.de); CMC, GL, MMMK, LAB: Max Planck Society (www.mpg.de); CMC: Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altabet MA, 2012, BIOGEOSCIENCES, V9, P4897, DOI 10.5194/bg-9-4897-2012; Arevalo-Martinez DL, 2016, BIOGEOSCIENCES, V13, P1105, DOI 10.5194/bg-13-1105-2016; Bourbonnais A, 2015, GLOBAL BIOGEOCHEM CY, V29, P793, DOI 10.1002/2014GB005001; Brannigan L, 2016, GEOPHYS RES LETT, V43, P3360, DOI 10.1002/2016GL067926; Brunner B, 2013, P NATL ACAD SCI USA, V110, P18994, DOI 10.1073/pnas.1310488110; Chaigneau A, 2009, PROG OCEANOGR, V83, P117, DOI 10.1016/j.pocean.2009.07.012; Chaigneau A, 2008, PROG OCEANOGR, V79, P106, DOI 10.1016/j.pocean.2008.10.013; Chelton DB, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030812; Codispoti LA, 2001, SCI MAR, V65, P85, DOI 10.3989/scimar.2001.65s285; Dalsgaard T, 2014, MBIO, V5, DOI 10.1128/mBio.01966-14; Dalsgaard T, 2012, LIMNOL OCEANOGR, V57, P1331, DOI 10.4319/lo.2012.57.5.1331; De Brabandere L, 2014, ENVIRON MICROBIOL, V16, P3041, DOI 10.1111/1462-2920.12255; De Brabandere L, 2012, J MICROBIOL METH, V88, P147, DOI 10.1016/j.mimet.2011.11.001; Fielding S, 2001, J MARINE SYST, V30, P287, DOI 10.1016/S0924-7963(01)00063-X; Galan A, 2009, DEEP-SEA RES PT II, V56, P1125, DOI 10.1016/j.dsr2.2008.09.016; Gaube P, 2013, J GEOPHYS RES-OCEANS, V118, P6349, DOI 10.1002/2013JC009027; Gaube P, 2015, J PHYS OCEANOGR, V45, P104, DOI 10.1175/JPO-D-14-0032.1; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Gruber N, 2011, NAT GEOSCI, V4, P787, DOI [10.1038/NGEO1273, 10.1038/ngeo1273]; Hamersley MR, 2007, LIMNOL OCEANOGR, V52, P923, DOI 10.4319/lo.2007.52.3.0923; Holtappels M, 2011, METHOD ENZYMOL, V486, P223, DOI [10.1016/S0076-6879(11)86010-6, 10.1016/B978-0-12-381294-0.00010-9]; Jensen MM, 2011, ISME J, V5, P1660, DOI 10.1038/ismej.2011.44; Johannessen JA, 1996, J GEOPHYS RES-OCEANS, V101, P6651, DOI 10.1029/95JC02962; Kahru M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030430; Kalvelage T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133526; Kalvelage T, 2013, NAT GEOSCI, V6, P228, DOI [10.1038/ngeo1739, 10.1038/NGEO1739]; Kalvelage T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029299; Karstensen J, 2008, PROG OCEANOGR, V77, P331, DOI 10.1016/j.pocean.2007.05.009; Klein P, 2009, ANNU REV MAR SCI, V1, P351, DOI 10.1146/annurev.marine.010908.163704; Kuypers MMM, 2005, P NATL ACAD SCI USA, V102, P6478, DOI 10.1073/pnas.0502088102; Lam P, 2011, BIOGEOSCIENCES, V8, P1565, DOI 10.5194/bg-8-1565-2011; Lam P, 2011, ANNU REV MAR SCI, V3, P317, DOI 10.1146/annurev-marine-120709-142814; Lam P, 2009, P NATL ACAD SCI USA, V106, P4752, DOI 10.1073/pnas.0812444106; Lapeyre G, 2006, J MAR RES, V64, P835, DOI 10.1357/002224006779698369; Ledwell JR, 2008, DEEP-SEA RES PT II, V55, P1139, DOI 10.1016/j.dsr2.2008.02.005; Levy ML, 2004, P ROY SOC A-MATH PHY, V460, P1673, DOI 10.1098/rspa.2003.1219; Li JM, 2014, J MARINE SYST, V132, P150, DOI 10.1016/j.jmarsys.2014.02.002; Loscher CR, 2016, BIOGEOSCIENCES, V13, P2889, DOI 10.5194/bg-13-2889-2016; Mahadevan A, 2008, SCIENCE, V320, DOI 10.1126/science.1152111; Mahadevan A, 2016, ANNU REV MAR SCI, V8, P161, DOI 10.1146/annurev-marine-010814-015912; Martin AP, 2001, DEEP-SEA RES PT II, V48, P757, DOI 10.1016/S0967-0645(00)00096-5; McGillicuddy DJ, 2007, SCIENCE, V316, P1021, DOI 10.1126/science.1136256; McGillicuddy DJ, 2016, ANNU REV MAR SCI, V8, P125, DOI 10.1146/annurev-marine-010814-015606; McGillicuddy DJ, 1998, NATURE, V394, P263, DOI 10.1038/28367; McGillicuddy DJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001987; Mizobata K, 2002, PROG OCEANOGR, V55, P65, DOI 10.1016/S0079-6611(02)00070-8; Nagai T, 2015, J GEOPHYS RES-OCEANS, V120, P5318, DOI 10.1002/2015JC010889; NIILER PP, 1969, J GEOPHYS RES, V74, P7048, DOI 10.1029/JC074i028p07048; Omand MM, 2015, SCIENCE, V348, P222, DOI 10.1126/science.1260062; Stramma L, 2013, BIOGEOSCIENCES, V10, P7293, DOI 10.5194/bg-10-7293-2013; STRASS VH, 1992, DEEP-SEA RES, V39, P75, DOI 10.1016/0198-0149(92)90021-K; Thamdrup B, 2002, APPL ENVIRON MICROB, V68, P1312, DOI 10.1128/AEM.68.3.1312-1318.2002; Thamdrup B, 2006, LIMNOL OCEANOGR, V51, P2145, DOI 10.4319/lo.2006.51.5.2145; Thamdrup B, 2012, DEEP-SEA RES PT I, V65, P36, DOI 10.1016/j.dsr.2012.03.001; Thomsen S, 2016, GEOPHYS RES LETT, V43, P8133, DOI 10.1002/2016GL070548; Thomsen S, 2016, J GEOPHYS RES-OCEANS, V121, P476, DOI 10.1002/2015JC010878; Tiano L, 2014, DEEP-SEA RES PT I, V94, P173, DOI 10.1016/j.dsr.2014.10.001; Ulloa O, 2012, P NATL ACAD SCI USA, V109, P15996, DOI 10.1073/pnas.1205009109; Winkler, 1888, BER DTSCH CHEM GES, V21, P2843, DOI [10.1002/cber.188802102122, DOI 10.1002/CBER.188802102122]	59	15	15	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0170059	10.1371/journal.pone.0170059	http://dx.doi.org/10.1371/journal.pone.0170059			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122044	Green Published, gold, Green Accepted			2022-12-26	WOS:000396167300055
J	Regaieg, M; McDougall, SR; Bondino, I; Hamon, G				Regaieg, Mohamed; McDougall, Steven Robert; Bondino, Igor; Hamon, Gerald			Finger Thickening during Extra-Heavy Oil Waterflooding: Simulation and Interpretation Using Pore-Scale Modelling	PLOS ONE			English	Article							IMMISCIBLE DISPLACEMENTS; FLUID; NETWORK; INSTABILITY; LIQUID; SURFACTANT	Although thermal methods have been popular and successfully applied in heavy oil recov-ery, they are often found to be uneconomic or impractical. Therefore, alternative production protocols are being actively pursued and interesting options include water injection and poly-mer flooding. Indeed, such techniques have been successfully tested in recent laboratory investigations, where X-ray scans performed on homogeneous rock slabs during water flooding experiments have shown evidence of an interesting new phenomenon-post-break-through, highly dendritic water fingers have been observed to thicken and coalesce, forming braided water channels that improve sweep efficiency. However, these experimental studies involve displacement mechanisms that are still poorly understood, and so the optimization of this process for eventual field application is still somewhat problematic. Ideally, a combi-nation of two-phase flow experiments and simulations should be put in place to help under-stand this process more fully. To this end, a fully dynamic network model is described and used to investigate finger thickening during water flooding of extra-heavy oils. The displace-ment physics has been implemented at the pore scale and this is followed by a successful benchmarking exercise of the numerical simulations against the groundbreaking micromo-del experiments reported by Lenormand and co-workers in the 1980s. A range of slab-scale simulations has also been carried out and compared with the corresponding experimental observations. We show that the model is able to replicate finger architectures similar to those observed in the experiments and go on to reproduce and interpret, for the first time to our knowledge, finger thickening following water breakthrough. We note that this phenome-non has been observed here in homogeneous (i. e. un-fractured) media: the presence of fractures could be expected to exacerbate such fingering still further. Finally, we examine the impact of several system parameters, including core length, wettability and injection rate, on the extent and efficiency of the finger swelling phenomenon.	[Regaieg, Mohamed; McDougall, Steven Robert] Heriot Watt Univ, Inst Petr Engn, Edinburgh, Midlothian, Scotland; [Regaieg, Mohamed] Total E&P, Geosci Res Ctr, Aberdeen, Scotland; [Bondino, Igor; Hamon, Gerald] Total E&P, Pau, France	Heriot Watt University; Total SA; Total SA	Regaieg, M (corresponding author), Heriot Watt Univ, Inst Petr Engn, Edinburgh, Midlothian, Scotland.; Regaieg, M (corresponding author), Total E&P, Geosci Res Ctr, Aberdeen, Scotland.	mohamed.regaieg@total.com		Regaieg, Mohamed/0000-0001-9601-3882	Total EP	Total EP	Total E&P (http://www.total.com/en/). Total E&P, a commercial company, provided support in the form of salaries for authors MR, IB and GH. Total E&P provided technical assistance and permission to publish the paper, but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. Total E&P also provided research funds to Herriot Watt University. These funds were used to fund a research project in which SM and MR were involved (during the PhD of MR at Heriot Watt University). The specific roles of these authors are articulated in the 'author contributions' section.	Aker E, 1998, TRANSPORT POROUS MED, V32, P163, DOI 10.1023/A:1006510106194; Arabloo M, 2015, CHEM ENG RES DES, V96, P23, DOI 10.1016/j.cherd.2015.01.009; Bogoyavlenskiy VA, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.066303; Bondino I, 2009, J PETROL SCI ENG, V65, P14, DOI 10.1016/j.petrol.2008.12.010; Bondino I., 2011, INT S SOC COR AN AUS; Chen S, 1998, ANNU REV FLUID MECH, V30, P329, DOI 10.1146/annurev.fluid.30.1.329; CHUOKE RL, 1959, T AM I MIN MET ENG, V216, P188; Clemens T, 2013, SPE RESERV EVAL ENG, V16, P144, DOI 10.2118/154169-PA; Dong B, 2011, TRANSPORT POROUS MED, V88, P293, DOI 10.1007/s11242-011-9740-y; Doorwar S, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.013028; Ferer M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.016303; Hammond PS, 2012, TRANSPORT POROUS MED, V92, P789, DOI 10.1007/s11242-011-9933-4; Haugen A, 2010, ENERG FUEL, V24, P3020, DOI 10.1021/ef1000453; Huang HB, 2014, COMPUT FLUIDS, V93, P164, DOI 10.1016/j.compfluid.2014.01.025; LENORMAND R, 1983, J FLUID MECH, V135, P337, DOI 10.1017/S0022112083003110; LENORMAND R, 1988, J FLUID MECH, V189, P165, DOI 10.1017/S0022112088000953; Liu HH, 2015, PHYS FLUIDS, V27, DOI 10.1063/1.4921611; Liu HH, 2014, ADV WATER RESOUR, V73, P144, DOI 10.1016/j.advwatres.2014.07.010; Liu HH, 2013, TRANSPORT POROUS MED, V99, P555, DOI 10.1007/s11242-013-0200-8; McDougall SR, 1993, SPE ANN TECHN C EXH; Neumann SP, 1996, WATER RESOUR RES, V32, P1891, DOI 10.1029/96WR00789; PETERS EJ, 1981, SOC PETROL ENG J, V21, P249, DOI 10.2118/8371-PA; Regaieg M, 2014, WORLD HEAV OIL C NEW; Riaz A, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.036305; SAFFMAN PG, 1958, PROC R SOC LON SER-A, V245, P312, DOI 10.1098/rspa.1958.0085; Singh M, 2003, CHEM ENG SCI, V58, P1, DOI 10.1016/S0009-2509(02)00438-4; Skauge A, 2012, SPE IMPR OIL REC S T; Skauge A, 2013, IOR 2013 FROM FUNDAM; Valvatne PH, 2004, WATER RESOUR RES, V40, DOI 10.1029/2003WR002627; Zendehboudi S, 2011, J CANADIAN PETROLEUM, V50; Zhang L, 2015, SCI CHINA TECHNOL SC, V58, P1375, DOI 10.1007/s11431-015-5842-z	31	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0169727	10.1371/journal.pone.0169727	http://dx.doi.org/10.1371/journal.pone.0169727			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122011	Green Published, Green Submitted, gold			2022-12-26	WOS:000396167300068
J	Awad, SF; Sgaier, SK; Lau, FK; Mohamoud, YA; Tambatamba, BC; Kripke, KE; Thomas, AG; Bock, N; Reed, JB; Njeuhmeli, E; Abu-Raddad, LJ				Awad, Susanne F.; Sgaier, Sema K.; Lau, Fiona K.; Mohamoud, Yousra A.; Tambatamba, Bushimbwa C.; Kripke, Katharine E.; Thomas, Anne G.; Bock, Naomi; Reed, Jason B.; Njeuhmeli, Emmanuel; Abu-Raddad, Laith J.			Could Circumcision of HIV-Positive Males Benefit Voluntary Medical Male Circumcision Programs in Africa? Mathematical Modeling Analysis	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; RANDOMIZED CONTROLLED-TRIAL; TRANSMISSION; RISK; INFECTION; UGANDA; IMPACT; WOMEN; MEN; PREVENTION	Background The epidemiological and programmatic implications of inclusivity of HIV-positive males in voluntary medical male circumcision (VMMC) programs are uncertain. We modeled these implications using Zambia as an illustrative example. Methods and Findings We used the Age-Structured Mathematical (ASM) model to evaluate, over an intermediate horizon (2010-2025), the effectiveness (number of VMMCs needed to avert one HIV infection) of VMMC scale-up scenarios with varying proportions of HIV-positive males. The model was calibrated by fitting to HIV prevalence time trend data from 1990 to 2014. We assumed that inclusivity of HIV positive males may benefit VMMC programs by increasing VMMC uptake among higher risk males, or by circumcision reducing HIV male-to-female transmission risk. All analyses were generated assuming no further antiretroviral therapy (ART) scale-up. The number of VMMCs needed to avert one HIV infection was projected to increase from 12.2 VMMCs per HIV infection averted, in a program that circumcises only HIV-negative males, to 14.0, in a program that includes HIV-positive males. The proportion of HIV-positive males was based on their representation in the population (e.g. 12.6% of those circumcised in 2010 would be HIV-positive based on HIV prevalence among males of 12.6% in 2010). However, if a program that only reaches out to HIV-negative males is associated with 20% lower uptake among higher-risk males, the effectiveness would be 13.2 VMMCs per infection averted. If improved inclusivity of HIV-positive males is associated with 20% higher uptake among higher-risk males, the effectiveness would be 12.4. As the assumed VMMC efficacy against male-to-female HIV transmission was increased from 0% to 20% and 46%, the effectiveness of circumcising regardless of HIV status improved from 14.0 to 11.5 and 9.1, respectively. The reduction in the HIV incidence rate among females increased accordingly, from 24.7% to 34.8% and 50.4%, respectively. Conclusion Improving inclusivity of males in VMMC programs regardless of HIV status increases VMMC effectiveness, if there is moderate increase in VMMC uptake among higher-risk males and/or if there is moderate efficacy for VMMC against male-to-female transmission. In these circumstances, VMMC programs can reduce the HIV incidence rate in males by nearly as much as expected by some ART programs, and additionally, females can benefit from the intervention nearly as much as males.	[Awad, Susanne F.; Mohamoud, Yousra A.; Abu-Raddad, Laith J.] Cornell Univ, Weill Cornell Med Coll Qatar, Qatar Fdn, Infect Dis Epidemiol Grp, Doha, Qatar; [Sgaier, Sema K.; Lau, Fiona K.] Surgo Fdn, Washington, DC USA; [Sgaier, Sema K.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA; [Sgaier, Sema K.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Tambatamba, Bushimbwa C.] Minist Community Dev & Mother & Child Hlth, Lusaka, Zambia; [Kripke, Katharine E.] Avenir Hlth, Hlth Policy Initiat, Washington, DC USA; [Thomas, Anne G.] US Dept Def, Naval Hlth Res Ctr, San Diego, CA USA; [Bock, Naomi] Ctr Dis Control & Prevent, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA USA; [Reed, Jason B.] Jhpiego, Washington, DC USA; [Njeuhmeli, Emmanuel] US Agcy Int Dev, Washington, DC 20523 USA; [Abu-Raddad, Laith J.] Cornell Univ, Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY 10021 USA; [Abu-Raddad, Laith J.] Hamad bin Khalifa Univ, Qatar Fdn, Coll Publ Hlth, Doha, Qatar	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Harvard University; Harvard T.H. Chan School of Public Health; University of Washington; University of Washington Seattle; United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC); Centers for Disease Control & Prevention - USA; Jhpiego; United States Agency for International Development (USAID); Cornell University; Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar	Abu-Raddad, LJ (corresponding author), Cornell Univ, Weill Cornell Med Coll Qatar, Qatar Fdn, Infect Dis Epidemiol Grp, Doha, Qatar.; Abu-Raddad, LJ (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY 10021 USA.; Abu-Raddad, LJ (corresponding author), Hamad bin Khalifa Univ, Qatar Fdn, Coll Publ Hlth, Doha, Qatar.	lja2002@qatar-med.cornell.edu	Kripke, Katharine/J-2146-2019; Abu-Raddad, Laith J/AAY-1441-2020	Kripke, Katharine/0000-0001-8228-4577; Abu-Raddad, Laith J/0000-0003-0790-0506	Bill & Melinda Gates Foundation; Health Policy Project [AID-OAA-A-10-00067]; U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through USAID	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Health Policy Project; U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through USAID(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This publication is based on research funded by the Bill & Melinda Gates Foundation. K. Kripke acknowledges the support provided by the Health Policy Project, Agreement No. AID-OAA-A-10-00067, with funding from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through USAID. One of the funders, USAID, represented by E. Njeuhmeli, study co-author, had a role in study design and manuscript preparation.	Abu-Raddad LJ, 2008, AIDS, V22, P1055, DOI 10.1097/QAD.0b013e3282f8af84; Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; ALLEN S, 1991, JAMA-J AM MED ASSOC, V266, P1657, DOI 10.1001/jama.266.12.1657; Alsallaq RA, 2009, EPIDEMICS-NETH, V1, P139, DOI 10.1016/j.epidem.2009.08.001; [Anonymous], 2009, ZAMB DEM HLTH SURV 2; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B., 2014, COMMUNICATION; Awad SF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145729; Awad SF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140818; Awad SF, 2014, EPIDEMICS-NETH, V8, P9, DOI 10.1016/j.epidem.2014.06.001; Baeten JM, 2010, AIDS, V24, P737, DOI 10.1097/QAD.0b013e32833616e0; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; Central Statistical Office MoH University of Zambia Lusaka Zambia Tropical Diseases Research Centre Ndola Zambia and Macro International Inc. Calverton Maryland USA Zambia DHS, 2007, 2007 FIN REP; CHAO A, 1994, INT J EPIDEMIOL, V23, P371, DOI 10.1093/ije/23.2.371; Chemaitelly H, 2014, EPIDEMICS-NETH, V6, P1, DOI 10.1016/j.epidem.2013.11.001; Chemaitelly H, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18765; Chemaitelly H, 2012, SEX TRANSM INFECT, V88, P51, DOI 10.1136/sextrans-2011-050114; Cuadros DF, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-216; Dokubo EK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106760; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; George G, 2014, AJAR-AFR J AIDS RES, V13, P179, DOI 10.2989/16085906.2014.943253; Gray R, 2006, 2006 C RETR OPP INF; Gray RH, 2000, AIDS, V14, P2371, DOI 10.1097/00002030-200010200-00019; Gray RH, 2007, AIDS, V21, P845, DOI 10.1097/QAD.0b013e3280187544; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gregson S, 2002, LANCET, V359, P1896, DOI 10.1016/S0140-6736(02)08780-9; Hallett TB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002212; Hallett TB, 2011, SEX TRANSM INFECT, V87, P88, DOI 10.1136/sti.2010.043372; Hamilton DT, 2008, SEX TRANSM DIS, V35, P30, DOI 10.1097/OLQ.0b013e3181453a84; Handcock MS, 2004, THEOR POPUL BIOL, V65, P413, DOI 10.1016/j.tpb.2003.09.006; Hatzold K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085051; Herman-Roloff A, 2012, AIDS BEHAV, V16, P1173, DOI 10.1007/s10461-011-0073-1; Hewett PC, 2012, AIDS, V26, P749, DOI 10.1097/QAD.0b013e32835097ff; Kamath V, 2015, AIDS CARE, P1; Kapiga SH, 1998, AIDS, V12, P75, DOI 10.1097/00002030-199801000-00009; Kigozi G, 2008, PLOS MED, V5, P911, DOI 10.1371/journal.pmed.0050116; Kikaya V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083614; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; Layer EH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104961; Malamba SS, 2005, JAIDS-J ACQ IMM DEF, V39, P576; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Mehta SD, 2009, AIDS, V23, P1557, DOI 10.1097/QAD.0b013e32832afe95; Nagelkerke NJD, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-16; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Omori R, 2015, SEX TRANSM INFECT, V91, P451, DOI 10.1136/sextrans-2014-051925; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Republic of Mozambique National AIDS Control Council 2012, 2012, GLOB AIDS RESP PROGR; Republic of Zambia Ministry of Health, 2012, COUNTR OP PLAN SCAL; Rosario IJ, 2013, CURR UROL REP, V14, P285, DOI 10.1007/s11934-013-0343-8; Sgaier SK, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001641; Sgaier SK, 2014, PERFORMED VOLUNTARY; The MathWorks Inc, 2015, MATLAB LANG TECHN CO; Tobian AAR, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001820; Turner AN, 2007, AIDS, V21, P1779, DOI 10.1097/QAD.0b013e32827b144c; UNAIDS, 2012, GLOBAL REPORT UNAIDS; UNAIDS, 2011, POL DECL HIV AIDS IN; UNAIDS, 2013, EP DAT HIV EST 1990; UNAIDS, 2014, END AIDS EP 2030 RED; United Nations - Department of Economic and Social Affairs - Population Division, 2012, WORLD POP PROSP 2012; Wawer MJ, 2009, LANCET, V374, P229, DOI 10.1016/S0140-6736(09)60998-3; Weiser SD, 2006, PLOS MED, V3, P1013, DOI 10.1371/journal.pmed.0030261; Weiss HA, 2009, LANCET INFECT DIS, V9, P669, DOI 10.1016/S1473-3099(09)70235-X; Westercamp N, 2014, AIDS BEHAV, V18, P1764, DOI 10.1007/s10461-014-0846-4; White RG, 2008, AIDS, V22, P1841, DOI 10.1097/QAD.0b013e32830e0137; WHO/ UNAIDS, 2007, WHO UNAIDS TECHN CON; WHO & UNAIDS, 2011, JOINT STRAT ACT FRAM; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262	68	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2017	12	1							e0170641	10.1371/journal.pone.0170641	http://dx.doi.org/10.1371/journal.pone.0170641			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7CU	28118387	gold, Green Published, Green Submitted			2022-12-26	WOS:000396160500019
J	Baur, R; Sigel, E				Baur, Roland; Sigel, Erwin			Low Expression in Xenopus Oocytes and Unusual Functional Properties of alpha(1)beta(2)gamma(2) GABA(A) Receptors with Non-Conventional Subunit Arrangement	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; A RECEPTORS; STOICHIOMETRY; MODULATION	The major subunit isoform of GABA(A) receptors is alpha(1)beta(2)gamma(2). The subunits are thought to surround an ion pore with the counterclockwise arrangement alpha(1)gamma(2)beta(2)alpha(1)beta(2) as seen from the outside of the neuron. These receptors have two agonist sites and one high affinity drug binding site specific for benzodiazepines. Recently, this receptor was postulated to assume alternative subunit stoichiometries and arrangements resulting in only one agonist site and one or even two sites for benzodiazepines. In order to force a defined subunit arrangement we expressed a combination of triple and dual concatenated subunits. Here we report that these unconventional receptors express only small current amplitudes in Xenopus oocytes. We determined agonist properties and modulation by diazepam of two of these receptors that resulted in currents large enough for a characterization, that is, beta(2)-alpha(1)-gamma(2)/alpha(1)-gamma(2) and beta(2)-alpha(1)-gamma(2)/beta(2)-gamma(2). The first pentamer predicted to have two benzodiazepine binding sites shows similar response to diazepam as the standard receptor. As expected for both receptors with a single predicted agonist site the concentration response curves for GABA were characterized by a Hill coefficient <1. beta(2)-alpha(1)-gamma(2)/beta(2)-gamma(2) displayed a mM apparent GABA affinity for channel opening instead of the expected mu M affinity. Based on their subunit and binding site stoichiometry, that contradicts all previous observations, their unusual functional properties and their very low expression levels in oocytes, we consider it unlikely that these unconventional receptors are expressed in neurons to an appreciable extent.	[Baur, Roland; Sigel, Erwin] Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland	University of Bern	Sigel, E (corresponding author), Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland.	sigel@ibmm.unibe.ch			Swiss National Science Foundation [315230_156929/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation, grant 315230_156929/1 (http://www.snf.ch). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Baumann SW, 2001, J BIOL CHEM, V276, P36275, DOI 10.1074/jbc.M105240200; Baur R, 2006, FEBS LETT, V580, P1616, DOI 10.1016/j.febslet.2006.02.002; Baur R, 2010, J BIOL CHEM, V285, P17398, DOI 10.1074/jbc.M110.108670; Baur R, 2009, J NEUROCHEM, V111, P1172, DOI 10.1111/j.1471-4159.2009.06387.x; Bollan KA, 2008, MOL CELL NEUROSCI, V37, P610, DOI 10.1016/j.mcn.2007.12.011; Botzolakis EJ, 2016, J BIOL CHEM, V291, P20440, DOI 10.1074/jbc.M115.698860; Chang YC, 1996, J NEUROSCI, V16, P5415; Farrar SJ, 1999, J BIOL CHEM, V274, P10100, DOI 10.1074/jbc.274.15.10100; Kaur KH, 2009, J BIOL CHEM, V284, P7889, DOI 10.1074/jbc.M806484200; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Minier F, 2004, P NATL ACAD SCI USA, V101, P7769, DOI 10.1073/pnas.0400220101; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Sigel E, 2005, MOL NUTR FOOD RES, V49, P228, DOI 10.1002/mnfr.200400104; SIGEL E, 1984, J BIOL CHEM, V259, P7219; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Teissere JA, 2001, J NEUROSCI, V21, P4977, DOI 10.1523/JNEUROSCI.21-14-04977.2001; Tretter V, 1997, J NEUROSCI, V17, P2728; Wongsamitkul N, 2016, J BIOL CHEM, V291, P18474, DOI 10.1074/jbc.M116.738906	19	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170572	10.1371/journal.pone.0170572	http://dx.doi.org/10.1371/journal.pone.0170572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114407	gold, Green Submitted, Green Published			2022-12-26	WOS:000396129000072
J	Cong, L; Cheng, Y; Cawley, NX; Murthy, SRK; Loh, YP				Cong, Lin; Cheng, Yong; Cawley, Niamh X.; Murthy, Saravana R. K.; Loh, Y. Peng			A Novel Single Nucleotide T980C Polymorphism in the Human Carboxypeptidase E Gene Results in Loss of Neuroprotective Function	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; OBESITY; DISEASE; STRESS; DEGENERATION; DEFICITS; MOUSE; DEATH	Report of a human with a homozygous truncating null mutation of the Carboxypeptidase E (CPE) gene with endocrinological and neurological deficits prompted us to search for other mutations in the human CPE gene that might be linked to disease. We searched an EST database and identified from a small population of patients, a novel T to C single nucleotide polymorphism (SNP) in the CPE gene at bp980 of exon 4, herein called TC-CPE. This introduces a tryptophan to arginine (W235R) mutation in the catalytic domain of human CPE protein. Over-expression of TC-CPE in N2A cells, a neuroendocrine cell line, showed that it was synthesized, but was found in lesser amounts compared to over-expressed WT-CPE in these cells. Furthermore, TC-CPE was secreted poorly from these N2A cells. The levels of TC-CPE were significantly increased after the N2A cells were treated with MG132 (a proteasome inhibitor), suggesting that TC-CPE was targeted to proteasomes for degradation in N2A cells. In addition, TC-CPE induced ER stress as demonstrated by the increased expression of CHOP in N2A cells. Double labeling of CPE and calnexin (and ER marker) suggested the accumulation of TC-CPE in the ER, and the accumulation appears to be enhanced by the treatment of MG132 in the cells. Moreover, the secreted levels of TC-CPE were not affected by the treatment of MG132 in the cells. Over-expression studies revealed that while N2A cells transfected with WT-CPE showed reduced cytotoxicity when challenged with H2O2 compared to cells expressing an empty vector, cells transfected with TC-CPE had no effect. Furthermore, WT-CPE condition medium showed protective effect against oxidative stress, but not TC-CPE condition medium. Although co-expression of WT-CPE and TC-CPE in N2A cells resulted in the reduction in secretion of WT-CPE, co-expression of WT-CPE and TC-CPE did not significantly affect the protective effect of WT-CPE. Taken together, we have identified a novel SNP in the CPE gene which results in the loss of its neuroprotective function in cells and may confer neurological disorders in humans.	[Cong, Lin] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gen Surg, Beijing, Peoples R China; [Cong, Lin] Peking Union Med Coll, Beijing, Peoples R China; [Cong, Lin; Cheng, Yong; Cawley, Niamh X.; Murthy, Saravana R. K.; Loh, Y. Peng] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cellular Neurobiol Sect, NIH, Bethesda, MD 20892 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Loh, YP (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cellular Neurobiol Sect, NIH, Bethesda, MD 20892 USA.	lohp@mail.nih.gov		Cheng, Yong/0000-0002-7529-4408	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health, USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000056] Funding Source: NIH RePORTER	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health, USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health, USA.	Alsters SIM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131417; Cawley NX, 2012, ENDOCR REV, V33, P216, DOI 10.1210/er.2011-1039; Cawley NX, 2004, ENDOCRINOLOGY, V145, P5807, DOI 10.1210/en.2004-0847; Chen H, 2001, HUM MUTAT, V18, P120, DOI 10.1002/humu.1161; Chen YX, 2014, NEUROSCI BULL, V30, P282, DOI 10.1007/s12264-013-1408-x; Cheng Y, 2015, MOL PSYCHIATR, V20, P744, DOI 10.1038/mp.2014.136; Cheng YC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054262, 10.1371/journal.pone.0060503]; Choquet H, 2011, CURR GENOMICS, V12, P169, DOI 10.2174/138920211795677895; Cooper DN, 2010, HUM MUTAT, V31, P631, DOI 10.1002/humu.21260; FRICKER LD, 1982, P NATL ACAD SCI-BIOL, V79, P3886, DOI 10.1073/pnas.79.12.3886; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; HOOK VYH, 1982, NATURE, V295, P341, DOI 10.1038/295341a0; Jia EZ, 2009, MOL BIOL REP, V36, P245, DOI 10.1007/s11033-007-9173-4; Lee C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050501; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; Piaceri Irene, 2013, Front Biosci (Elite Ed), V5, P167; Pla V, 2013, BRAIN PATHOL, V23, P274, DOI 10.1111/j.1750-3639.2012.00644.x; Rao KR, 2014, INDIAN J MED RES, V140, P589; Selvaraj P, 2015, MOL CELL NEUROSCI, V68, P222, DOI 10.1016/j.mcn.2015.08.005; Skalka N, 2013, ONCOGENE, V32, P2836, DOI 10.1038/onc.2012.308; Van Cauwenberghe C, 2015, GENET MED; Wang J.-R., 2008, INFRARED, V29, P29, DOI DOI 10.1111/J.1745-7254.2008.00798.X; Woronowicz A, 2008, HIPPOCAMPUS, V18, P1051, DOI 10.1002/hipo.20462; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yazdi FT, 2015, PEERJ, V3, DOI 10.7717/peerj.856	27	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170169	10.1371/journal.pone.0170169	http://dx.doi.org/10.1371/journal.pone.0170169			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114332	Green Submitted, Green Published, gold			2022-12-26	WOS:000396129000022
J	Gallique, M; Decoin, V; Barbey, C; Rosay, T; Feuilloley, MGJ; Orange, N; Merieau, A				Gallique, Mathias; Decoin, Victorien; Barbey, Corinne; Rosay, Thibaut; Feuilloley, Marc G. J.; Orange, Nicole; Merieau, Annabelle			Contribution of the Pseudomonas fluorescens MFE01 Type VI Secretion System to Biofilm Formation	PLOS ONE			English	Article							N-ACYLHOMOSERINE LACTONES; PECTOBACTERIUM-ATROSEPTICUM; BACTERIAL BIOFILMS; AERUGINOSA PAO1; WOUND MODEL; PROTEIN; COMPETITION; INFECTION; EFFECTORS; BINDING	Type VI secretion systems (T6SSs) are widespread in Gram- negative bacteria, including Pseudomonas. These macromolecular machineries inject toxins directly into prokaryotic or eukaryotic prey cells. Hcp proteins are structural components of the extracellular part of this machinery. We recently reported that MFE01, an avirulent strain of Pseudomonas fluorescens, possesses at least two hcp genes, hcp1 and hcp2, encoding proteins playing important roles in interbacterial interactions. Indeed, P. fluorescens MFE01 can immobilise and kill diverse bacteria of various origins through the action of the Hcp1 or Hcp2 proteins of the T6SS. We show here that another Hcp protein, Hcp3, is involved in killing prey cells during co- culture on solid medium. Even after the mutation of hcp1, hcp2, or hcp3, MFE01 impaired biofilm formation by MFP05, a P. fluorescens strain isolated from human skin. These mutations did not reduce P. fluorescens MFE01 biofilm formation, but the three Hcp proteins were required for the completion of biofilm maturation. Moreover, a mutant with a disruption of one of the unique core component genes, MFE01.tssC, was unable to produce its own biofilm or inhibit MFP05 biofilm formation. Finally, MFE01 did not produce detectable Nacyl-homoserine lactones for quorum sensing, a phenomenon reported for many other P. fluorescens strains. Our results suggest a role for the T6SS in communication between bacterial cells, in this strain, under biofilm conditions.	[Gallique, Mathias; Decoin, Victorien; Barbey, Corinne; Rosay, Thibaut; Feuilloley, Marc G. J.; Orange, Nicole; Merieau, Annabelle] Normandy Univ, Univ Rouen, LMSM, UT Evreux,EA 4312, Evreux, France; [Barbey, Corinne] SIPRE, Achicourt, France	Universite de Rouen Normandie	Merieau, A (corresponding author), Normandy Univ, Univ Rouen, LMSM, UT Evreux,EA 4312, Evreux, France.	annabelle.merieau@univ-rouen.fr		FEUILLOLEY, Marc G.J./0000-0001-6467-4336; merieau, annabelle/0000-0003-4320-6562	GRR CBS Sesa grant from the Region Haute-Normandie, GEA (grand Evreux agglomeration) funds; FEDER funds	GRR CBS Sesa grant from the Region Haute-Normandie, GEA (grand Evreux agglomeration) funds(Region Normandie); FEDER funds(European Commission)	This study was supported by a GRR CBS Sesa grant from the Region Haute-Normandie, GEA (grand Evreux agglomeration) funds, and FEDER funds.	Allison DG, 1998, FEMS MICROBIOL LETT, V167, P179, DOI 10.1016/S0378-1097(98)00386-3; Aubert DF, 2013, ENVIRON MICROBIOL, V15, P372, DOI 10.1111/j.1462-2920.2012.02828.x; Bernard CS, 2010, J BACTERIOL, V192, P3850, DOI 10.1128/JB.00370-10; Bonemann G, 2010, MOL MICROBIOL, V76, P815, DOI 10.1111/j.1365-2958.2010.07171.x; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Bondage DD, 2016, P NATL ACAD SCI USA, V113, pE3931, DOI 10.1073/pnas.1600428113; Brachkova MI, 2011, J HOSP INFECT, V79, P375, DOI 10.1016/j.jhin.2011.09.003; Brunet YR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005545; Brunet YR, 2014, EMBO REP, V15, P315, DOI 10.1002/embr.201337936; Brunet YR, 2013, CELL REP, V3, P36, DOI 10.1016/j.celrep.2012.11.027; Cascales E, 2012, PHILOS T R SOC B, V367, P1102, DOI 10.1098/rstb.2011.0209; Cha C, 1998, MOL PLANT MICROBE IN, V11, P1119, DOI 10.1094/MPMI.1998.11.11.1119; Chan C, 2005, J PEPT RES, V65, P343, DOI 10.1111/j.1399-3011.2005.00217.x; Chapalain A, 2008, CAN J MICROBIOL, V54, P19, DOI [10.1139/W07-110, 10.1139/w07-110]; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; Coulthurst SJ, 2013, RES MICROBIOL, V164, P640, DOI 10.1016/j.resmic.2013.03.017; Cui SL, 2016, ARCH MICROBIOL, V198, P653, DOI 10.1007/s00203-016-1226-4; Dagorn A, 2013, INT J MOL SCI, V14, P12186, DOI 10.3390/ijms140612186; Davey ME, 2003, J BACTERIOL, V185, P1027, DOI 10.1128/JB.185.3.1027-1036.2003; de Bruijn I, 2009, APPL ENVIRON MICROB, V75, P4753, DOI 10.1128/AEM.00575-09; de Pace F, 2011, MICROBIOL-SGM, V157, P2954, DOI 10.1099/mic.0.050005-0; Decker EM, 2014, INT J ORAL SCI, V6, P195, DOI 10.1038/ijos.2014.38; Decoin V, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0405-9; Decoin V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089411; Dheilly A, 2010, APPL ENVIRON MICROB, V76, P3452, DOI 10.1128/AEM.02632-09; Diniz JA, 2015, J BACTERIOL, V197, P2350, DOI 10.1128/JB.00199-15; Duong-Ly KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064241; El-Sayed AK, 2001, MICROBIOL-SGM, V147, P2127, DOI 10.1099/00221287-147-8-2127; Farrand SK, 1996, J BACTERIOL, V178, P4233, DOI 10.1128/jb.178.14.4233-4247.1996; Fazli M, 2014, ENVIRON MICROBIOL, V16, P1961, DOI 10.1111/1462-2920.12448; Flaugnatti N, 2016, MOL MICROBIOL, V99, P1099, DOI 10.1111/mmi.13292; Gjermansen M, 2010, MOL MICROBIOL, V75, P815, DOI 10.1111/j.1365-2958.2009.06793.x; Hachani A, 2016, CURR OPIN MICROBIOL, V29, P81, DOI 10.1016/j.mib.2015.11.006; Hachani A, 2014, J BIOL CHEM, V289, P17872, DOI 10.1074/jbc.M114.563429; HANCOCK REW, 1979, J BACTERIOL, V140, P902, DOI 10.1128/JB.140.3.902-910.1979; Hinsa SM, 2003, MOL MICROBIOL, V49, P905, DOI 10.1046/j.1365-2958.2003.03615.x; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Kanamaru S, 2009, P NATL ACAD SCI USA, V106, P4067, DOI 10.1073/pnas.0901205106; Kapitein N, 2013, CURR OPIN MICROBIOL, V16, P52, DOI 10.1016/j.mib.2012.11.009; Khan SR, 2005, J BACTERIOL, V187, P6517, DOI 10.1128/JB.187.18.6517-6527.2005; Kudryashev M, 2015, CELL, V160, P952, DOI 10.1016/j.cell.2015.01.037; Kyrpides NC, 1998, P NATL ACAD SCI USA, V95, P224, DOI 10.1073/pnas.95.1.224; Latour X, 2007, APPL ENVIRON MICROB, V73, P4078, DOI 10.1128/AEM.02681-06; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Liang XY, 2015, P NATL ACAD SCI USA, V112, P9106, DOI 10.1073/pnas.1505317112; Lin JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067647; Lin JS, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00070; Liu M, 2007, J APPL MICROBIOL, V103, P2174, DOI 10.1111/j.1365-2672.2007.03488.x; Liu Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0106787, 10.1371/journal.pone.0098157, 10.1371/journal.pone.0085323]; Lossi NS, 2013, J BIOL CHEM, V288, P7536, DOI 10.1074/jbc.M112.439273; Martins ML, 2014, BRAZ J MICROBIOL, V45, P1039, DOI 10.1590/S1517-83822014000300037; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; MCMANUS AT, 1985, EUR J CLIN MICROBIOL, V4, P219, DOI 10.1007/BF02013601; Mcvay CS, 2007, ANTIMICROB AGENTS CH, V51, P1934, DOI 10.1128/AAC.01028-06; Moscoso JA, 2011, ENVIRON MICROBIOL, V13, P3128, DOI 10.1111/j.1462-2920.2011.02595.x; Pamp SJ, 2007, J BACTERIOL, V189, P2531, DOI 10.1128/JB.01515-06; Poole K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00065; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Sheng LL, 2013, VET MICROBIOL, V162, P652, DOI 10.1016/j.vetmic.2012.09.009; Silverman JM, 2013, MOL CELL, V51, P584, DOI 10.1016/j.molcel.2013.07.025; Silverman JM, 2011, MOL MICROBIOL, V82, P1277, DOI 10.1111/j.1365-2958.2011.07889.x; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Smadja B, 2004, MOL PLANT MICROBE IN, V17, P1269, DOI 10.1094/MPMI.2004.17.11.1269; Tashiro Y, 2013, MICROBES ENVIRON, V28, P13, DOI 10.1264/jsme2.ME12167; Tian YL, 2015, MOL PLANT PATHOL, V16, P38, DOI 10.1111/mpp.12159; Trostrup H, 2013, WOUND REPAIR REGEN, V21, P292, DOI 10.1111/wrr.12016; Unterweger D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4549; Vettiger A, 2016, CELL, V167, P99, DOI 10.1016/j.cell.2016.08.023; Weber BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055142; Wei HL, 2006, ANTON LEEUW INT J G, V89, P267, DOI 10.1007/s10482-005-9028-8; Wei Q, 2013, INT J MOL SCI, V14, P20983, DOI 10.3390/ijms141020983; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x; Zoued A, 2014, BBA-MOL CELL RES, V1843, P1664, DOI 10.1016/j.bbamcr.2014.03.018	76	39	43	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170770	10.1371/journal.pone.0170770	http://dx.doi.org/10.1371/journal.pone.0170770			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114423	Green Submitted, gold, Green Published			2022-12-26	WOS:000396129000094
J	Blyton, MDJ; Gordon, DM				Blyton, Michaela D. J.; Gordon, David M.			Genetic Attributes of E. coli Isolates from Chlorinated Drinking Water	PLOS ONE			English	Article							PHYLOGENETIC GROUP B2; ESCHERICHIA-COLI; VIRULENCE; STRAINS; OUTBREAK; SEX	Escherichia coli, is intimately associated with both human health and water sanitation. E. coli isolates from water can either be (i) host associated commensals, indicating recent faecal contamination; (ii) diarrheal pathogens or (iii) extra-intestinal pathogens that pose a direct health risk; or (iv) free-living. In this study we genetically characterised 28 E. coli isolates obtained from treated drinking water in south eastern Australia to ascertain their likely source. We used full genome sequencing to assign the isolates to their phylogenetic group and multi-locus sequence type. The isolates were also screened in silico for several virulence genes and genes involved in acquired antibiotic resistance. The genetic characteristics of the isolates indicated that four isolates were likely human pathogens. However, these isolates were not detected in sufficient numbers to present a health risk to the public. An additional isolate was a human associated strain. Nine isolates were water associated free-living strains that were unlikely to pose a health risk. Only 14% of the isolates belonged to the host associated phylogenetic group (B2) and only a single isolate had any antibiotic resistance genes. This suggests that the primary source of the drinking water E. coli isolates may not have been recent human faecal contamination.	[Blyton, Michaela D. J.; Gordon, David M.] Australian Natl Univ, Res Sch Biol, Evolut Ecol & Genet, Acton, ACT, Australia; [Blyton, Michaela D. J.] Univ Western Sydney, Hawkesbury Inst Environm, Richmond, NSW, Australia	Australian National University; Western Sydney University	Blyton, MDJ (corresponding author), Australian Natl Univ, Res Sch Biol, Evolut Ecol & Genet, Acton, ACT, Australia.; Blyton, MDJ (corresponding author), Univ Western Sydney, Hawkesbury Inst Environm, Richmond, NSW, Australia.	M.blyton@westernsydney.edu.au	Blyton, Michaela/ABA-4463-2021; Gordon, David/N-1395-2019; Gordon, David M/C-9298-2009	Gordon, David/0000-0002-2880-3003; 	Australian Research Council [LP120100327]; Melbourne Water Organisation; Water Corporation of WA; Queensland Bulk Water Authority; Hunter Water Corporation; South East Water; Yarra Valley Water; City West Water; Sydney Water Corporation; South Australian Water Corporation; Sydney Catchment Authority; Fitzroy River Water; Victorian Department of Health	Australian Research Council(Australian Research Council); Melbourne Water Organisation; Water Corporation of WA; Queensland Bulk Water Authority; Hunter Water Corporation; South East Water; Yarra Valley Water; City West Water; Sydney Water Corporation; South Australian Water Corporation; Sydney Catchment Authority; Fitzroy River Water; Victorian Department of Health	This study was funded by an Australian Research Council Linkage Grant (LP120100327) as well as Melbourne Water Organisation, Water Corporation of WA, Queensland Bulk Water Authority, Hunter Water Corporation, South East Water, Yarra Valley Water, City West Water, Sydney Water Corporation, South Australian Water Corporation, Sydney Catchment Authority, Fitzroy River Water and Victorian Department of Health. The water authorities collected E. coli isolates for analysis. The funders had no other role in study design, data analysis or decision to publish. The water authorities received and approved a draft manuscript before submission.	Alm EW, 2011, POPULTION GENETICS B; Banerjee R, 2014, ANTIMICROBIAL AGENTS; Bergholz PW, 2011, APPL ENVIRON MICROB, V77, P211, DOI 10.1128/AEM.01880-10; Berthe T, 2013, APPL ENVIRON MICROB, V79, P4684, DOI 10.1128/AEM.00698-13; BESSER RE, 1993, JAMA-J AM MED ASSOC, V269, P2217, DOI 10.1001/jama.269.17.2217; Blyton MDJ, 2014, ENV MICROBIOL REP, V6, P605, DOI 10.1111/1758-2229.12168; Clermont O, 2014, J MICROBIOL METH, V101, P24, DOI 10.1016/j.mimet.2014.03.008; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; DoHH Service, 2015, ANN REP DRINK WAT QU; E. coli MLST Database at UoW, 2015, E COL MLST DAT UOW; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Johnson JR, 2003, ANTIMICROB AGENTS CH, V47, P2161, DOI 10.1128/AAC.47.7.2161-2168.2003; Johnson JR, 2002, J INFECT DIS, V185, P774, DOI 10.1086/339343; Johnson JR, 2011, POPULTION GENETICS B; Johnson JR, 2011, GLOBAL DISTRIBUTION, DOI [10.3201/eid1711.110488, DOI 10.3201/EID1711.110488]; Kothary MH, 2001, J FOOD SAFETY, V21, P49, DOI 10.1111/j.1745-4565.2001.tb00307.x; Larsen MV, 2012, J CLIN MICROBIOLOGY; Nei M., 2000, MOL EVOLUTION PHYLOG; Nowrouzian FL, 2005, J INFECT DIS, V191, P1078, DOI 10.1086/427996; Nowrouzian FL, 2006, MICROBES INFECT, V8, P834, DOI 10.1016/j.micinf.2005.10.011; Power ML, 2005, ENVIRON MICROBIOL, V7, P631, DOI 10.1111/j.1462-2920.2005.00729.x; Robins-Browne RM, 2004, EMERG INFECT DIS, V10, P1797, DOI 10.3201/eid1010.031086; Russo TA, 2000, J INFECT DIS, V181, P1753, DOI 10.1086/315418; Sahl JW, 2013, ESCHERICHIA COLI: PATHOTYPES AND PRINCIPLES OF PATHOGENESIS, 2ND EDITION, P21, DOI 10.1016/B978-0-12-397048-0.00002-4; Spurbeck RR, 2012, INFECT IMMUN, V80, P4115, DOI 10.1128/IAI.00752-12; Spurbeck RR, 2011, INFECT IMMUN, V79, P4753, DOI 10.1128/IAI.05621-11; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Yates MV, 2007, WATER ENVIRON RES, V79, P279, DOI 10.2175/106143006X123085; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	32	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0169445	10.1371/journal.pone.0169445	http://dx.doi.org/10.1371/journal.pone.0169445			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107364	gold, Green Submitted, Green Published			2022-12-26	WOS:000392405300028
J	Cariani, A; Messinetti, S; Ferrari, A; Arculeo, M; Bonello, JJ; Bonnici, L; Cannas, R; Carbonara, P; Cau, A; Charilaou, C; El Ouamari, N; Fiorentino, F; Follesa, MC; Garofalo, G; Golani, D; Guarniero, I; Hanner, R; Hemida, F; Kada, O; Lo Brutto, S; Mancusi, C; Morey, G; Schembri, PJ; Serena, F; Sion, L; Stagioni, M; Tursi, A; Vrgoc, N; Steinke, D; Tinti, F				Cariani, Alessia; Messinetti, Silvia; Ferrari, Alice; Arculeo, Marco; Bonello, Juan J.; Bonnici, Leanne; Cannas, Rita; Carbonara, Pierluigi; Cau, Alessandro; Charilaou, Charis; El Ouamari, Najib; Fiorentino, Fabio; Follesa, Maria Cristina; Garofalo, Germana; Golani, Daniel; Guarniero, Ilaria; Hanner, Robert; Hemida, Farid; Kada, Omar; Lo Brutto, Sabrina; Mancusi, Cecilia; Morey, Gabriel; Schembri, Patrick J.; Serena, Fabrizio; Sion, Letizia; Stagioni, Marco; Tursi, Angelo; Vrgoc, Nedo; Steinke, Dirk; Tinti, Fausto			Improving the Conservation of Mediterranean Chondrichthyans: The ELASMOMED DNA Barcode Reference Library	PLOS ONE			English	Article							SKATES CHONDRICHTHYES; COMMUNITY STRUCTURE; ENVIRONMENTAL DNA; IDENTIFICATION; BIODIVERSITY; DIVERSITY; FISH; ATLANTIC; RAJIDAE; SHARKS	Cartilaginous fish are particularly vulnerable to anthropogenic stressors and environmental change because of their K-selected reproductive strategy. Accurate data from scientific surveys and landings are essential to assess conservation status and to develop robust protection and management plans. Currently available data are often incomplete or incorrect as a result of inaccurate species identifications, due to a high level of morphological stasis, especially among closely related taxa. Moreover, several diagnostic characters clearly visible in adult specimens are less evident in juveniles. Here we present results generated by the ELASMOMED Consortium, a regional network aiming to sample and DNA-barcode the Mediterranean Chondrichthyans with the ultimate goal to provide a comprehensive DNA barcode reference library. This library will support and improve the molecular taxonomy of this group and the effectiveness of management and conservation measures. We successfully barcoded 882 individuals belonging to 42 species (17 sharks, 24 batoids and one chimaera), including four endemic and several threatened ones. Morphological misidentifications were found across most orders, further confirming the need for a comprehensive DNA barcoding library as a valuable tool for the reliable identification of specimens in support of taxonomist who are reviewing current identification keys. Despite low intraspecific variation among their barcode sequences and reduced samples size, five species showed preliminary evidence of phylogeographic structure. Overall, the ELASMOMED initiative further emphasizes the key role accurate DNA barcoding libraries play in establishing reliable diagnostic species specific features in otherwise taxonomically problematic groups for biodiversity management and conservation actions.	[Cariani, Alessia; Messinetti, Silvia; Ferrari, Alice; Stagioni, Marco; Tinti, Fausto] Univ Bologna, Dept Biol Geol & Environm Sci, Ravenna, Italy; [Arculeo, Marco; Lo Brutto, Sabrina] Univ Palermo, Dept STEBICEF, Palermo, Italy; [Bonello, Juan J.; Bonnici, Leanne; Schembri, Patrick J.] Univ Malta, Msida, Malta; [Cannas, Rita; Cau, Alessandro; Follesa, Maria Cristina] Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy; [Carbonara, Pierluigi] COISPA Technol & Res, Bari, Italy; [Charilaou, Charis] Minist Agr Rural Dev & Environm, Dept Fisheries & Marine Res, Nicosia, Cyprus; [El Ouamari, Najib; Kada, Omar] Inst Natl Rech Halieut, Ctr Reg, Nador, Morocco; [Fiorentino, Fabio; Garofalo, Germana] CNR, IAMC, Inst Coastal Marine Environm, Mazara Del Vallo, Italy; [Golani, Daniel] Hebrew Univ Jerusalem, Dept Evolut Systemat & Ecol, Jerusalem, Israel; [Guarniero, Ilaria] Univ Bologna, Dept DIMEVET, Ozzano Dellemilia, Italy; [Hanner, Robert; Steinke, Dirk] Univ Guelph, Ctr Biodivers Genom, Biodivers Inst Ontario, Guelph, ON, Canada; [Hemida, Farid] Ecole Natl Super Sci Mer & Amenagement Littoral, Campus Univ Dely Ibrahim, Algiers, Algeria; [Mancusi, Cecilia; Serena, Fabrizio] ARPAT, Reg Agcy Environm Protect Toscana, Livorno, Italy; [Morey, Gabriel] Asociac Ondine, Palma De Mallorca, Spain; [Sion, Letizia; Tursi, Angelo] Univ Bari Aldo Moro, Dept Biol, Bari, Italy; [Vrgoc, Nedo] Inst Oceanog & Fisheries, Split, Croatia; [Messinetti, Silvia] Univ Milan, Dept Biosci, Milan, Italy	University of Bologna; University of Palermo; University of Malta; University of Cagliari; Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); Hebrew University of Jerusalem; University of Bologna; University of Guelph; Ecole Nationale Superieure des Sciences de la Mer et Amenagement du Littoral (ENSSMAL); Regional Environmental Protection Agency - Italy; Universita degli Studi di Bari Aldo Moro; Croatian Institute of Oceanography & Fisheries (IZOR); University of Milan	Messinetti, S (corresponding author), Univ Bologna, Dept Biol Geol & Environm Sci, Ravenna, Italy.	silvia.messinetti@unimi.it	FERRARI, ALICE/AAF-6643-2021; Carbonara, Pierluigi/A-9231-2018; Fiorentino, Fabio/AAX-2883-2020; Stagioni, Marco/ABE-4925-2020; SION, LETIZIA/E-4205-2015; Tinti, Fausto/D-4847-2012; Ferrari, Alice/T-1410-2018; Cariani, Alessia/L-3459-2016; Lo Brutto, Sabrina/G-4322-2010; Cau, Alessandro/G-9537-2014	FERRARI, ALICE/0000-0002-3499-8396; Carbonara, Pierluigi/0000-0002-2529-2535; Fiorentino, Fabio/0000-0002-6302-649X; Stagioni, Marco/0000-0002-8819-0413; SION, LETIZIA/0000-0002-0308-1841; Tinti, Fausto/0000-0002-8649-5387; Ferrari, Alice/0000-0002-3499-8396; Cariani, Alessia/0000-0002-5513-0086; Lo Brutto, Sabrina/0000-0002-9964-904X; Cau, Alessandro/0000-0003-4082-7531; Cannas, Rita/0000-0001-6627-4053; Messinetti, Silvia/0000-0001-9677-1595; Bonello, Juan Jose/0000-0002-2052-6160; GUARNIERO, ILARIA/0000-0002-3038-3925; Tursi, Angelo Raffaele/0000-0002-7776-2738	University of Bologna; Canadian Centre for DNA Barcoding - government of Canada through Genome Canada; Biodiversity Institute of Ontario - government of Canada through Genome Canada; Autonomous Region of Sardinia (RAS) [L.R.7 CRP-25321]; Alfred P Sloan Foundation; Ontario Genomics Institute	University of Bologna; Canadian Centre for DNA Barcoding - government of Canada through Genome Canada; Biodiversity Institute of Ontario - government of Canada through Genome Canada; Autonomous Region of Sardinia (RAS)(Russian Academy of Sciences); Alfred P Sloan Foundation(Alfred P. Sloan Foundation); Ontario Genomics Institute	This research work was supported by the University of Bologna, the Canadian Centre for DNA Barcoding, and the Biodiversity Institute of Ontario both supported by the government of Canada through Genome Canada and the Ontario Genomics Institute. Rita Cannas, Maria Cristina Follesa and Alessandro Cau were funded by the Autonomous Region of Sardinia (RAS) grant no L.R.7 CRP-25321. Dirk Steinke was funded by the Alfred P Sloan Foundation. These latter funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2004, Q REV BIOL, V79, P161, DOI 10.1086/383542; Andrews KR, 2016, MOL PHYLOGENET EVOL, V100, P361, DOI 10.1016/j.ympev.2016.04.004; Ashton TJ, 2016, J MAR BIOL ASSOC UK, P1; Barbieri M, 2014, FISH RES, V154, P11, DOI 10.1016/j.fishres.2014.01.021; Becker S, 2011, MITOCHONDR DNA, V22, P3, DOI 10.3109/19401736.2010.535528; Ben Souissi J, 2007, CAH BIOL MAR, V48, P67; Bertrand JA, 2002, SCI MAR, V66, P9, DOI 10.3989/scimar.2002.66s29; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bonello J, 2015, J MAR BIOL ASSOC UK, P1; Bradai MN, 2012, ELASMOBRANCHS MEDITE; Camperi M, 2007, PLOS COMPUT BIOL, V3, P1083, DOI 10.1371/journal.pcbi.0030113; Cannas R, 2008, BIOL MAR MEDITERR, V15, P188; Cannas R, 2010, MAR BIOL RES, V6, P341, DOI 10.1080/17451000903428496; Cariani A, 2010, COMMUNICATION AT 14T; Carolan JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029251; Chevolot M, 2006, MOL ECOL, V15, P3693, DOI 10.1111/j.1365-294X.2006.03043.x; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Compagno L.J.V., 2001, FOOD AGR ORG SPECIES, V1, P1; Compagno LJV, 1999, SHARKS, SKATES, AND RAYS, P1; Costa FO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035858; Coulson MW, 2011, MOL ECOL RESOUR, V11, P968, DOI 10.1111/j.1755-0998.2011.03034.x; Crozier RH, 2005, EVOL BIOINFORM, V1, P11; DAUGHERTY CH, 1994, NEW ZEAL J ZOOL, V21, P317, DOI 10.1080/03014223.1994.9518002; DAUGHERTY CH, 1990, NATURE, V347, P177, DOI 10.1038/347177a0; Dulvy NK, 2009, NATURE, V462, P417, DOI 10.1038/462417a; Dulvy NK, 2000, CONSERV BIOL, V14, P283, DOI 10.1046/j.1523-1739.2000.98540.x; Ebert DA, 2007, ENVIRON BIOL FISH, V80, P111, DOI 10.1007/s10641-007-9247-0; Eschmeyer W. N., 2015, CATALOG FISHES GENER; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Follesa MC, 2012, CYBIUM, V36, P473; Frodella N, 2016, MAR ECOL PROG SER, V554, P99, DOI 10.3354/meps11799; Golani D., 2002, FISHES, V1, P1; Griffiths AM, 2011, CONSERV GENET, V12, P577, DOI 10.1007/s10592-010-0127-3; Griffiths AM, 2010, P ROY SOC B-BIOL SCI, V277, P1497, DOI 10.1098/rspb.2009.2111; Hamlett WC, 1999, SHARKS SKATES RAYS B; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Iglesias SP, 2010, AQUAT CONSERV, V20, P319, DOI 10.1002/aqc.1083; Kelly RP, 2014, SCIENCE, V344, P1455, DOI 10.1126/science.1251156; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; King M, 2013, FISHERIES BIOL ASSES; Klimley AP, 2013, BIOL SHARKS RAYS; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Kousteni V, 2015, HEREDITY, V114, P333, DOI 10.1038/hdy.2014.107; Landi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106135; Lim KC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120518; Lindenmayer D, 2005, PRACTICAL CONSERVATI; Lynghammar A, 2014, ZOOL SCR, V43, P485, DOI 10.1111/zsc.12064; Mahon AR, 2016, METHODS MOL BIOL, V1452, P131, DOI 10.1007/978-1-4939-3774-5_8; Marino IAM, 2015, J HERED, V106, P123, DOI 10.1093/jhered/esu064; Marouani S, 2012, SCI MAR, V76, P97, DOI 10.3989/scimar.03440.22B; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; MCEACHRAN JD, 1989, COPEIA, P629; MCEACHRAN JD, 1990, NOAA TECH REP, V90, P305; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Moftah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027001; Murphy RW, 2013, MOL ECOL RESOUR, V13, P161, DOI 10.1111/1755-0998.12050; Nieto A., 2015, EUROPEAN RED LIST MA; Ovenden JR, 2010, MAR FRESHWATER RES, V61, P253, DOI 10.1071/MF09151; Pasolini P, 2011, MAR BIOL, V158, P2173, DOI 10.1007/s00227-011-1722-7; Pegg GG, 2006, SCI MAR, V70, P7, DOI 10.3989/scimar.2006.70s27; Pfenninger M, 2007, MOL ECOL, V16, P1957, DOI 10.1111/j.1365-294X.2006.03136.x; Plass-Johnson JG, 2016, MAR FRESHWATER RES, V67, P671, DOI 10.1071/MF14248; Poortvliet M, 2015, MOL PHYLOGENET EVOL, V83, P72, DOI 10.1016/j.ympev.2014.10.012; Psomadakis PN, 2012, ZOOTAXA, P1; Puncher GN, 2015, REV FISH BIOL FISHER, V25, P485, DOI 10.1007/s11160-015-9390-1; Quattro JM, 2006, MAR BIOL, V148, P1143, DOI 10.1007/s00227-005-0151-x; Ragonese S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074865; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sandoval-Castillo J, 2004, MAR BIOL, V145, P983, DOI 10.1007/s00227-004-1378-7; Saunders GW, 2005, PHILOS T R SOC B, V360, P1879, DOI 10.1098/rstb.2005.1719; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Serena F, 2010, BIOL MARINA MEDIT S2, V17; Serena F, 2005, DEEP SEA 2003 C WORK, V2, P395; Serena F, 2014, STATUS ELASMOBRANCHI; Serena F., 2005, FIELD IDENTIFICATION, P97; Serra-Pereira B, 2011, ZOOL SCR, V40, P76, DOI 10.1111/j.1463-6409.2010.00461.x; Simpfendorfer CA, 2016, ENDANGER SPECIES RES, V30, P109, DOI 10.3354/esr00731; Sisneros JA, 2002, J PHYSIOL-PARIS, V96, P379, DOI 10.1016/S0928-4257(03)00016-0; Smith PJ, 2008, J FISH BIOL, V73, P1170, DOI 10.1111/j.1095-8649.2008.01957.x; Spies IB, 2006, J FISH BIOL, V69, P283, DOI 10.1111/j.1095-8649.2006.01286.x; Stehmann M.F.W., 1984, FISHES N W ATLANTIC, VVolume I, P163; Steinke D, 2016, LINKING ADULTS IMMAT; Steinke D, 2009, MAR BIOL, V156, P2641, DOI 10.1007/s00227-009-1284-0; Straube N, 2011, ZOOL SCR, V40, P61, DOI 10.1111/j.1463-6409.2010.00455.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomsen PF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165252; Tinti F, 2003, J EXP MAR BIOL ECOL, V288, P149, DOI 10.1016/S0022-0981(03)00021-2; Tobuni I, MAR BIODIVERS REC; Trontelj P, 2009, SYST BIODIVERS, V7, P1, DOI 10.1017/S1477200008002909; Valentini A, 2016, MOL ECOL, V25, P929, DOI 10.1111/mec.13428; Vences M, 2005, PHILOS T R SOC B, V360, P1859, DOI 10.1098/rstb.2005.1717; Verissimo A, 2014, ZOOL J LINN SOC; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2008, MAR FRESHWATER RES, V59, P57, DOI 10.1071/MF07148; Ward Robert D, 2012, Methods Mol Biol, V858, P423, DOI 10.1007/978-1-61779-591-6_21; White WT, 2013, ZOOTAXA, V 3752, P35, DOI 10.11646/zootaxa.3752.1.5; Wienerroither RM, 2015, J FISH BIOL, V86, P834, DOI 10.1111/jfb.12602; Zenetos A, 2012, MEDITERR MAR SCI, V13, P328, DOI 10.12681/mms.327; Zenetos A, 2011, MEDITERR MAR SCI, V12, P509, DOI 10.12681/mms.49; Zhang JX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039076, 10.1371/journal.pone.0030621]; Zimmer RK, 2016, ECOLOGY, V97, P2232, DOI 10.1002/ecy.1455	106	41	43	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170244	10.1371/journal.pone.0170244	http://dx.doi.org/10.1371/journal.pone.0170244			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107413	Green Published, gold, Green Submitted			2022-12-26	WOS:000392405300091
J	Destrempes, FEO; Cardinal, MHR; Saijo, Y; Finet, G; Tardif, JC; Cloutier, G				Destrempes, Francois; Cardinal, Marie-Helene Roy; Saijo, Yoshifumi; Finet, Gerard; Tardif, Jean-Claude; Cloutier, Guy			Assessment of Inter-Expert Variability and of an Automated Segmentation Method of 40 and 60 MHz IVUS Images of Coronary Arteries	PLOS ONE			English	Article							INTRAVASCULAR ULTRASOUND; CONSENSUS DOCUMENT; ANGIOGRAPHY; ACQUISITION; STANDARDS; DIAMETER; LUMEN; VIVO	The objectives were to compare the performance of a segmentation algorithm, based on the minimization of an uncertainty function, to delineate contours of external elastic membrane and lumen of human coronary arteries imaged with 40 and 60 MHz IVUS, and to use values of this function to delineate portions of contours with highest uncertainty. For 8 patients, 40 and 60 MHz IVUS coronary data acquired pre- and post-interventions were used, for a total of 68,516 images. Manual segmentations of contours (on 2312 images) performed by experts at three core laboratories were the gold-standards. Inter-expert variability was highest on contour points with largest values of the uncertainty function (p < 0.001). Inter-expert variability was lower at 60 than 40 MHz for external elastic membrane (p = 0.013) and lumen (p = 0.024). Average differences in plaque (and atheroma) burden between algorithmic contours and experts' contours were within inter-expert variability (p < 0.001).	[Destrempes, Francois; Cardinal, Marie-Helene Roy; Cloutier, Guy] Univ Montreal Hosp Res Ctr CRCHUM, Lab Biorheol & Med Ultrason, Montreal, PQ, Canada; [Saijo, Yoshifumi] Tohoku Univ, Dept Biomed Engn & Cardiol, Sendai, Miyagi, Japan; [Finet, Gerard] Hosp Civils Lyon, Dept Hemodynam & Intervent Cardiol, Lyon, France; [Finet, Gerard] Claude Bernard Univ Lyon 1, INSERM, Unit 886, Lyon, France; [Tardif, Jean-Claude] Montreal Heart Inst, Dept Cardiol, Montreal, PQ, Canada; [Tardif, Jean-Claude] Montreal Heart Inst, Res Ctr, Montreal, PQ, Canada; [Cloutier, Guy] Univ Montreal, Dept Radiol Radiooncol & Nucl Med, Montreal, PQ, Canada; [Cloutier, Guy] Univ Montreal, Inst Biomed Engn, Montreal, PQ, Canada	Universite de Montreal; Tohoku University; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Cloutier, G (corresponding author), Univ Montreal Hosp Res Ctr CRCHUM, Lab Biorheol & Med Ultrason, Montreal, PQ, Canada.; Cloutier, G (corresponding author), Univ Montreal, Dept Radiol Radiooncol & Nucl Med, Montreal, PQ, Canada.; Cloutier, G (corresponding author), Univ Montreal, Inst Biomed Engn, Montreal, PQ, Canada.	guy.cloutier@umontreal.ca	Carmen, Team3/Y-7384-2019	Carmen, Team3/0000-0002-3614-0924; Lab, Carmen/0000-0002-5935-3236; Roy Cardinal, Marie-Helene/0000-0001-9590-1167; Cloutier, Guy/0000-0002-4957-4844	Acist Medical Systems, Eden Prairie, Minnesota, USA; Natural Sciences and Engineering Research Council of Canada [138570-11]	Acist Medical Systems, Eden Prairie, Minnesota, USA; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Financial support for this project was provided by a research contract from Acist Medical Systems, Eden Prairie, Minnesota, USA; and an operating Discovery grant from the Natural Sciences and Engineering Research Council of Canada (#138570-11).	Arbab-Zadeh A, 1999, AM HEART J, V138, P865, DOI 10.1016/S0002-8703(99)70011-6; Balocco S, 2014, COMPUT MED IMAG GRAP, V38, P70, DOI 10.1016/j.compmedimag.2013.07.001; Brassard G., 1996, FUNDAMENTALS ALGORIT; Cardinal MHR, 2010, MED PHYS, V37, P3633, DOI 10.1118/1.3438476; DAUGMAN JG, 1985, J OPT SOC AM A, V2, P1160, DOI 10.1364/JOSAA.2.001160; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Destrempes F, 2014, COMPUT MED IMAG GRAP, V38, P91, DOI 10.1016/j.compmedimag.2013.09.004; Destrempes F, 2009, IEEE T MED IMAGING, V28, P215, DOI 10.1109/TMI.2008.929098; DODGE JT, 1992, CIRCULATION, V86, P232, DOI 10.1161/01.CIR.86.1.232; Fujii K, 2015, JACC-CARDIOVASC IMAG, V8, P451, DOI 10.1016/j.jcmg.2014.10.015; Funabashi N, 2003, RADIOLOGY, V226, P263, DOI 10.1148/radiol.2261011211; HUTTENLOCHER DP, 1993, IEEE T PATTERN ANAL, V15, P850, DOI 10.1109/34.232073; JAIN AK, 1991, PATTERN RECOGN, V24, P1167, DOI 10.1016/0031-3203(91)90143-S; Kobayashi Y, 2014, J AM COLL CARDIOL, V64, pB105, DOI 10.1016/j.jacc.2014.07.410; Ma T, 2015, IEEE T ULTRASON FERR, V62, P97, DOI 10.1109/TUFFC.2014.006679; Meier DS, 1997, AM HEART J, V133, P681, DOI 10.1016/S0002-8703(97)70170-4; Mintz GS, 2011, EUROINTERVENTION, V6, P1123, DOI 10.4244/EIJV6I9A195; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Nissen SE, 2001, CIRCULATION, V103, P604, DOI 10.1161/01.CIR.103.4.604; Sethian JA, 1996, P NATL ACAD SCI USA, V93, P1591, DOI 10.1073/pnas.93.4.1591; vonBirgelen C, 1996, AM HEART J, V132, P516, DOI 10.1016/S0002-8703(96)90233-1; Waters K. R., 2011, 2011 IEEE International Ultrasonics Symposium (IUS), P1762, DOI 10.1109/ULTSYM.2011.0440	22	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0168332	10.1371/journal.pone.0168332	http://dx.doi.org/10.1371/journal.pone.0168332			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107355	Green Submitted, gold, Green Published			2022-12-26	WOS:000392405300011
J	Haske, D; Beckers, SK; Hofmann, M; Lefering, R; Gliwitzky, B; Wolfl, CC; Grutzner, P; Stockle, U; Dieroff, M; Munzberg, M				Haeske, David; Beckers, Stefan K.; Hofmann, Marzellus; Lefering, Rolf; Gliwitzky, Bernhard; Woelfl, Christoph C.; Gruetzner, Paul; Stoeckle, Ulrich; Dieroff, Marc; Muenzberg, Matthias			Quality of Documentation as a Surrogate Marker for Awareness and Training Effectiveness of PHTLS-Courses. Part of the Prospective Longitudinal Mixed-Methods EPPTC-Trial	PLOS ONE			English	Article							LIFE-SUPPORT PROGRAM; AMBULANCE CAREGIVERS; END-POINTS; TRAUMA; IMPACT; ERROR; PERFORMANCE; MANAGEMENT; INJURY	Objective Care for severely injured patients requires multidisciplinary teamwork. A decrease in the number of accident victims ultimately affects the routine and skills. PHTLS ("Pre-Hospital Trauma Life Support") courses are established two-day courses for medical and non-medical rescue service personnel, aimed at improving the pre-hospital care of trauma patients worldwide. The study aims the examination of the quality of documentation before and after PHTLS courses as a surrogate endpoint of training effectiveness and awareness. Methods This was a prospective pre-post intervention trial and was part of the mixed-method longitudinal EPPTC (Effect of Paramedic Training on Pre-Hospital Trauma Care) study, evaluating subjective and objective changes among participants and real patient care, as a result of PHTLS courses. The courses provide an overview of the SAMPLE approach for interrogation of anamnestic information, which is believed to be responsible for patient safety as relevant, among others, "Allergies," "Medication," and "Patient History" (AMP). The focus of the course is not the documentation. Results In total, 320 protocols were analyzed before and after the training. The PHTLS course led to a significant increase (p < 0.001) in the "AMP" information in the documentation. The subgroups analysis of "allergies" (+47.2%), "drugs" (+38.1%), and "medical history" (+27.8%) before and after the PHTLS course showed a significant increase in the information content. Conclusion In summary, we showed that PHTLS training improves documentation quality, which we used as a surrogate endpoint for learning effectiveness and awareness. In this regard, we demonstrated that participants use certain parts of training in real life, thereby suggesting that the learning methods of PHTLS training are effective. These results, however, do not indicate whether patient care has changed.	[Haeske, David] Eberhard Karls Univ Tubingen, Fac Med, Tubingen, Germany; [Beckers, Stefan K.] Univ Hosp RWTH, Dept Anesthesiol, Aachen, Germany; [Beckers, Stefan K.] Emergency Med Serv, Fire Dept, Aachen, Germany; [Hofmann, Marzellus] Univ Witten Herdecke, Fac Hlth, Witten, Germany; [Lefering, Rolf] Univ Witten Herdecke, Inst Res Operat Med, Cologne, Germany; [Gliwitzky, Bernhard] Megamed Emergency Management GbR, Annweiler, Germany; [Woelfl, Christoph C.] Hosp Hetzelstift, Dept Orthoped Trauma Surg & Sports Traumatol, Neustadt, Germany; [Gruetzner, Paul; Muenzberg, Matthias] BG Trauma Ctr Ludwigshafen, Dept Trauma & Orthoped Surg, Ludwigshafen, Germany; [Stoeckle, Ulrich] BG Hosp Tuebingen, Dept Traumatol & Reconstruct Surg, Tubingen, Germany; [Dieroff, Marc] Fire Serv Emergency Preparedness & Crisis Managem, Wiesbaden, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Witten Herdecke University; Witten Herdecke University	Munzberg, M (corresponding author), BG Trauma Ctr Ludwigshafen, Dept Trauma & Orthoped Surg, Ludwigshafen, Germany.	matthias.muenzberg@bgu-ludwigshafen.de	Häske, David/B-6250-2017; Beckers, Stefan K./O-2943-2019; Häske, David/O-6358-2019	Häske, David/0000-0001-5190-3937; Beckers, Stefan K./0000-0002-2896-7948; Häske, David/0000-0001-5190-3937; stockle, ulrich/0000-0002-6419-2203	German Association of Emergency Medical Technicians (Deutscher Berufsverband Rettungsdienst e.V. DBRD) [2013-Hae_01]	German Association of Emergency Medical Technicians (Deutscher Berufsverband Rettungsdienst e.V. DBRD)	The German Association of Emergency Medical Technicians (Deutscher Berufsverband Rettungsdienst e.V. DBRD) funded the study in form of research materials (www.dbrd.de) (Funding-Account: 2013-Hae_01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Ali J, 1997, J TRAUMA, V42, P1018, DOI 10.1097/00005373-199706000-00005; Ali J, 1998, WORLD J SURG, V22, P1192, DOI 10.1007/s002689900543; Ali J, 1998, W INDIAN MED J, V47, P102; [Anonymous], 2015, GLOB HLTH OBS IND ES; [Anonymous], 2015, BERICHTE BUNDESANSTA; Arreola-Risa C, 2000, J TRAUMA, V48, P119, DOI 10.1097/00005373-200001000-00020; Bergrath S, 2011, ANAESTHESIST, V60, P221, DOI 10.1007/s00101-010-1790-y; Bernhard M, 2006, ANAESTHESIST, V55, P1157, DOI 10.1007/s00101-006-1106-4; Blomberg H, 2013, J AM COLL SURGEONS, V217, P1010, DOI 10.1016/j.jamcollsurg.2013.08.002; Buyse M, 2010, NAT REV CLIN ONCOL, V7, P309, DOI 10.1038/nrclinonc.2010.43; CAMPBELL JP, 1995, ANN EMERG MED, V26, P590, DOI 10.1016/S0196-0644(95)70009-9; de Haes H, 2009, PATIENT EDUC COUNS, V74, P287, DOI 10.1016/j.pec.2008.12.006; Enke N, 2009, SCHNITTSTELLEN NOTFA; Francis RCE, 2010, EMERG MED J, V27, P350, DOI 10.1136/emj.2008.070284; French SC, 2006, PREHOSP EMERG CARE, V10, P71, DOI 10.1080/10903120500366086; Guldner S, 2011, NOTFALL RETTUNGSMED, V14, P351, DOI 10.1007/s10049-011-1439-7; Haske D, 2014, ANAESTHESIST, V63, P209, DOI 10.1007/s00101-014-2301-3; Haske D, 2013, Z EVIDENZ FORTBILD Q, V107, P484, DOI 10.1016/j.zefq.2013.06.007; Haske D, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-32; Haske D, 2016, J TRAUMA ACUTE CARE; Hohn EA, 2015, J SURG EDUC, V72, P47, DOI 10.1016/j.jsurg.2014.06.005; Jarodzka H, 2015, MED EDUC, V49, P854, DOI 10.1111/medu.12791; Johansson J, 2012, RESUSCITATION, V83, P1259, DOI 10.1016/j.resuscitation.2012.02.018; Kim YS, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-2; Li ZB, 2014, ACCIDENT ANAL PREV, V64, P52, DOI 10.1016/j.aap.2013.11.003; Loftus T, 2015, CUREUS, V7, DOI 10.7759/cureus.283; Menditto VG, 2012, ANN EMERG MED, V59, P451, DOI 10.1016/j.annemergmed.2011.12.003; NAEMT, 2011, PRAKL TRAUM PREH TRA; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Peschanski N, 2015, EMERGENCY MED J; Renard D, 2002, BIOMETRICAL J, V44, P921, DOI 10.1002/bimj.200290004; Schiff GD, 2009, ARCH INTERN MED, V169, P1881, DOI 10.1001/archinternmed.2009.333; Schlechtriemen, 2005, NOTFALL RETTUNGSMED, V8, P391, DOI [DOI 10.1007/s10049-005-0756-0, 10.1007/s10049-005-0756-0]; Statistisches Bundesamt, 2015, VERL BEI VERK; Statistisches Bundesamt (Destatis), 2015, VERK; Stewart M, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-19; Ulitsky A, 2012, ANN EMERG MED, V60, pS96, DOI 10.1016/j.annemergmed.2012.06.247; Waydhas C, 2003, NOTFALL RETTUNGSMED, V6, P33, DOI DOI 10.1007/S10049-002-0524-3; Westli HK, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-47	39	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170004	10.1371/journal.pone.0170004	http://dx.doi.org/10.1371/journal.pone.0170004			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107394	gold, Green Submitted, Green Published			2022-12-26	WOS:000392405300059
J	MacFadden, BJ; Jones, DS; Jud, NA; Moreno-Bernal, JW; Morgan, GS; Portell, RW; Perez, VJ; Moran, SM; Wood, AR				MacFadden, Bruce J.; Jones, Douglas S.; Jud, Nathan A.; Moreno-Bernal, Jorge W.; Morgan, Gary S.; Portell, Roger W.; Perez, Victor J.; Moran, Sean M.; Wood, Aaron R.			Integrated Chronology, Flora and Faunas, and Paleoecology of the Alajuela Formation, Late Miocene of Panama	PLOS ONE			English	Article							NEOTROPICAL PALEOBOTANY; CUCARACHA FORMATION; GATUN FORMATION; SOUTH-AMERICA; FOSSIL RECORD; WOOD ANATOMY; COMMUNITIES; INSIDEWOOD; HISTORY; GEOLOGY	The late Miocene was an important time to understand the geological, climatic, and biotic evolution of the ancient New World tropics and the context for the Great American Biotic Interchange (GABI). Despite this importance, upper Miocene deposits containing diverse faunas and floras and their associated geological context are rare in Central America. We present an integrated study of the geological and paleontological context and age of a new locality from Lago Alajuela in northern Panama (Caribbean side) containing late Miocene marine and terrestrial fossils (plants, invertebrates, and vertebrates) from the Alajuela Formation. These taxa indicate predominantly estuarine and shallow marine paleoenvironments, along with terrestrial influences based on the occurrence of land mammals. Srisotope ratio analyses of in situ scallop shells indicate an age for the Alajuela Formation of 9.77 +/- 0.22 Ma, which also equates to a latest Clarendonian (Cl3) North American Land Mammal Age. Along with the roughly contemporaneous late Miocene Gatun and Lago Bayano faunas in Panama, we now have the opportunity to reconstruct the dynamics of the Central America seaway that existed before final closure coincident with formation of the Isthmus of Panama.	[MacFadden, Bruce J.; Jones, Douglas S.; Jud, Nathan A.; Portell, Roger W.; Perez, Victor J.; Moran, Sean M.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Moreno-Bernal, Jorge W.] Smithsonian Trop Res Inst, Ancon, Panama; [Morgan, Gary S.] New Mexico Museum Nat Hist, Albuquerque, NM USA; [Perez, Victor J.] Univ Florida, Dept Geol Sci, Gainesville, FL USA; [Moran, Sean M.] Univ Florida, Dept Biol, Gainesville, FL USA; [Wood, Aaron R.] Iowa State Univ, Dept Geol & Atmospher Sci, Ames, IA USA	State University System of Florida; University of Florida; Smithsonian Institution; Smithsonian Tropical Research Institute; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Iowa State University	MacFadden, BJ (corresponding author), Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA.	bmacfadd@flmnh.ufl.edu	Jud, Nathan/AAI-2384-2020	Jud, Nathan/0000-0001-6100-9779; , Victor/0000-0002-0041-7151; Moreno-Bernal, Jorge W./0000-0002-9603-7195	NSF [0966884, 1358919]; Directorate For Geosciences [1358919] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by NSF 0966884 and NSF 1358919.	Aguilera Socorro Orangel Antonio, 2011, Swiss Journal of Palaeontology, V130, P217, DOI 10.1007/s13358-011-0020-9; Bloch JI, 2016, NATURE; Bourque JR, 2016, TURTLES LAT IN PRESS; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Burnham RJ, 2014, PHILOS T R SOC B, V359, P1595; Campbell Matthew R., 1997, Tulane Studies in Geology and Paleontology, V30, P159; Cappetta H., 1987, CHONDRICHTHYES; Carvalho MR, 2007, COLLECTION FAUNE FLO, V42, P148; Coates AG, 2004, GEOL SOC AM BULL, V116, P1327, DOI 10.1130/B25275.1; Coates Anthony G., 1996, P21; Compagno Leonard, 2005, P1; Compagno LJV., 1984, FAO FISH SYNOP, P20; DALRYMPLE RW, 1992, J SEDIMENT PETROL, V62, P1130, DOI 10.1306/D4267A69-2B26-11D7-8648000102C1865D; DICKISON W C, 1989, Aliso, V12, P555; Domning DP, 2001, PALAEOGEOGR PALAEOCL, V166, P27, DOI 10.1016/S0031-0182(00)00200-5; Emig C.C., 1997, TREATISE INVERTEBR H, V1, P473; Fichtler E, 2012, IAWA J, V33, P119, DOI 10.1163/22941932-90000084; GENTRY AH, 1982, ANN MO BOT GARD, V69, P557, DOI 10.2307/2399084; GRAHAM A, 1985, ANN MO BOT GARD, V72, P504, DOI 10.2307/2399101; GRAHAM A, 1988, ANN MO BOT GARD, V75, P1467, DOI 10.2307/2399296; GRAHAM A, 1989, ANN MO BOT GARD, V76, P50, DOI 10.2307/2399342; Hass H., 1999, FOSSIL PLANTS SPORES, P76; Hastings AK, 2013, J VERTEBR PALEONTOL, V33, P239, DOI 10.1080/02724634.2012.713814; Henderek RL, 2014, GEOL SOC AM ANN M VA, V56-8; Hendy AJW, 2013, PALAIOS, V28, P210, DOI 10.2110/palo.2012.p12-024r; HERRERA F, 2014, PALEOBOTANY BIOGEOGR, P124; Herrera F, 2010, INT J PLANT SCI, V171, P392, DOI 10.1086/651229; Jaramillo C.A., 2014, PALEOBOTANY BIOGEOGR, P124; Jud NA, 2016, AM J BOT, V103, P277, DOI 10.3732/ajb.1500425; Kent B. W., 1994, FOSSIL SHARKS CHESAP; Kirby MX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002791; Laurito CA, 2010, MUS NAC COSTA RICA; Laurito Cesar A., 2008, Revista Geologica de America Central, V39, P107; Lucas S.G., 2011, REV GEOL AM CENT, V42, P9; Lucas Spencer G., 2014, Revista Geologica de America Central, V50, P139; MacFadden BJ, 2015, J GEOL, V123, P491, DOI 10.1086/684006; MacFadden BJ, 2015, J PALEONTOL, V89, P360, DOI 10.1017/jpa.2014.31; MacFadden BJ, 2014, J GEOL, V122, P113, DOI 10.1086/675244; McArthur JM, 2001, J GEOL, V109, P155, DOI 10.1086/319243; Metcalfe C.R., 1950, ANATOMY DICOTYLEDONS, pe1; Metcalfe C.R., 1950, ANATOMY DICOTYLEDONS, V2; Montes C, 2015, SCIENCE, V348, P226, DOI 10.1126/science.aaa2815; MORTON ES, 1977, AUK, V94, P97; Naylor Gavin J.P., 1994, American Museum Novitates, V3109, P1; Olson ME, 2014, ECOL LETT, V17, P988, DOI 10.1111/ele.12302; Perez V, 2016, J PALEONTOL IN PRESS; Pimiento C, 2013, J PALEONTOL, V87, P755, DOI 10.1666/12-117; POLLARD JE, 1993, J GEOL SOC LONDON, V150, P149, DOI 10.1144/gsjgs.150.1.0149; Rodriguez-Reyes O, 2014, REV PALAEOBOT PALYNO, V209, P11, DOI 10.1016/j.revpalbo.2014.05.006; Seret B., 2003, COLLECTION FAUNE FLO, P78; STERN WL, 1963, SCIENCE, V140, P1214, DOI 10.1126/science.140.3572.1214; Tedford Richard H., 2004, P169; Thomas R, 2015, BOT J LINN SOC, V178, P467, DOI 10.1111/boj.12274; Trueman CN, 1997, GEOLOGY, V25, P263, DOI 10.1130/0091-7613(1997)025<0263:AGMTTT>2.3.CO;2; WEBB SD, 1981, AM J SCI, V281, P513, DOI 10.2475/ajs.281.5.513; Wheeler EA, 2007, IAWA J, V28, P229, DOI 10.1163/22941932-90001638; WHEELER EA, 1991, IAWA BULL, V12, P275, DOI 10.1163/22941932-90001256; Wheeler EA, 2011, IAWA J, V32, P199, DOI 10.1163/22941932-90000051; Woodring W., 1980, GEOLOGIC MAP PANAMA; Woodring WP, 1957, GEOLOGICAL SURVEY A, P1	60	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170300	10.1371/journal.pone.0170300	http://dx.doi.org/10.1371/journal.pone.0170300			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107398	Green Submitted, Green Published, gold			2022-12-26	WOS:000392405300103
J	Marigil, M; Martinez-Velez, N; Dominguez, PD; Idoate, MA; Xipell, E; Patino-Garcia, A; Gonzalez-Huarriz, M; Garcia-Moure, M; Junier, MP; Chneiweiss, H; El-Habr, E; Diez-Valle, R; Tejada-Solis, S; Alonso, MM				Marigil, Miguel; Martinez-Velez, Naiara; Dominguez, Pablo D.; Angel Idoate, Miguel; Xipell, Enric; Patino-Garcia, Ana; Gonzalez-Huarriz, Marisol; Garcia-Moure, Marc; Junier, Marie-Pierre; Chneiweiss, Herve; El-Habr, Elias; Diez-Valle, Ricardo; Tejada-Solis, Sonia; Alonso, Marta M.			Development of a DIPG Orthotopic Model in Mice Using an Implantable Guide-Screw System	PLOS ONE			English	Article							INTRINSIC PONTINE GLIOMA; MOUSE MODEL; BRAIN	Objective In this work we set to develop and to validate a new in vivo frameless orthotopic Diffuse Intrinsic Pontine Glioma (DIPG) model based in the implantation of a guide-screw system. Methods It consisted of a guide-screw also called bolt, a Hamilton syringe with a 26-gauge needle and an insulin-like 15-gauge needle. The guide screw is 2.6 mm in length and harbors a 0.5 mm central hole which accepts the needle of the Hamilton syringe avoiding a theoretical displacement during insertion. The guide-screw is fixed on the mouse skull according to the coordinates: 1 mm right to and 0.8 mm posterior to lambda. To reach the pons the Hamilton syringe is adjusted to a 6.5 mm depth using a cuff that serves as a stopper. This system allows delivering not only cells but also any kind of intratumoral chemotherapy, antibodies or gene/viral therapies. Results The guide-screw was successfully implanted in 10 immunodeficient mice and the animals were inoculated with DIPG human cell lines during the same anesthetic period. All the mice developed severe neurologic symptoms and had a median overall survival of 95 days ranging the time of death from 81 to 116 days. Histopathological analysis confirmed tumor into the pons in all animals confirming the validity of this model. Conclusion Here we presented a reproducible and frameless DIPG model that allows for rapid evaluation of tumorigenicity and efficacy of chemotherapeutic or gene therapy products delivered intratumorally to the pons.	[Marigil, Miguel; Martinez-Velez, Naiara; Dominguez, Pablo D.; Angel Idoate, Miguel; Xipell, Enric; Patino-Garcia, Ana; Gonzalez-Huarriz, Marisol; Garcia-Moure, Marc; Diez-Valle, Ricardo; Tejada-Solis, Sonia; Alonso, Marta M.] Hlth Res Inst Navarra IDISNA, Pamplona, Spain; [Marigil, Miguel; Martinez-Velez, Naiara; Dominguez, Pablo D.; Angel Idoate, Miguel; Xipell, Enric; Patino-Garcia, Ana; Gonzalez-Huarriz, Marisol; Garcia-Moure, Marc; Diez-Valle, Ricardo; Tejada-Solis, Sonia; Alonso, Marta M.] Fdn Appl Med Res, Program Solid Tumors & Biomarkers, Pamplona, Spain; [Marigil, Miguel; Diez-Valle, Ricardo; Tejada-Solis, Sonia] Univ Navarra Clin, Dept Neurosurg, Pamplona, Spain; [Martinez-Velez, Naiara; Xipell, Enric; Patino-Garcia, Ana; Gonzalez-Huarriz, Marisol; Garcia-Moure, Marc; Alonso, Marta M.] Univ Hosp Navarra, Dept Pediat, Pamplona, Spain; [Dominguez, Pablo D.] Univ Hosp Navarra, Dept Radiol, Pamplona, Spain; [Angel Idoate, Miguel] Univ Hosp Navarra, Dept Pathol, Pamplona, Spain; [Junier, Marie-Pierre; Chneiweiss, Herve; El-Habr, Elias] Sorbonne Univ, UPMC, Neurosci Paris Seine IBPS, CNRS UMR8246,Inserm U1130, Paris, France	University of Navarra; Servicio Navarro de Salud - Osasunbidea; University of Navarra; Servicio Navarro de Salud - Osasunbidea; University of Navarra; Servicio Navarro de Salud - Osasunbidea; University of Navarra; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Alonso, MM (corresponding author), Hlth Res Inst Navarra IDISNA, Pamplona, Spain.; Alonso, MM (corresponding author), Fdn Appl Med Res, Program Solid Tumors & Biomarkers, Pamplona, Spain.; Alonso, MM (corresponding author), Univ Hosp Navarra, Dept Pediat, Pamplona, Spain.	mmalonso@unav.es	Dominguez, Pablo D./K-9067-2014; Alonso, Marta M/AAI-9457-2020; Idoate, Miguel-Ángel/D-8502-2019; El-Habr, Elias/H-5511-2019; Patiño-Garcia, Ana/I-4299-2012; herve, chneiweiss/Q-6818-2019	Dominguez, Pablo D./0000-0002-9692-3808; Alonso, Marta M/0000-0002-7520-7351; Idoate, Miguel-Ángel/0000-0002-1596-1192; El-Habr, Elias/0000-0002-4531-9707; Patiño-Garcia, Ana/0000-0002-4066-8203; herve, chneiweiss/0000-0001-7675-5061; Garcia-Moure, Marc/0000-0002-4365-7753; gonzalez-huarriz, marisol/0000-0002-0438-0077; Martinez-Velez, Naiara/0000-0003-2248-7692	European Union [IRG270459]; Institute de Salud Carlos III y los Fondos Feder Europeos [PI13/125]; Spanish Ministry of Economy and competitiveness [IEDI-2015-00638]; L'OREAL-Unesco Foundation; Department of Health of the Government of Navarra [22/2015]; Basque Foundation for Health Research (BIOEF) [BI013/CI/005]; Fundacion Caja Navarra (Convocatoria de Ayudas)	European Union(European Commission); Institute de Salud Carlos III y los Fondos Feder Europeos; Spanish Ministry of Economy and competitiveness(Spanish Government); L'OREAL-Unesco Foundation(L'Oreal Group); Department of Health of the Government of Navarra; Basque Foundation for Health Research (BIOEF); Fundacion Caja Navarra (Convocatoria de Ayudas)	This work was supported by the European Union (Marie Curie IRG270459 to MMA), the Institute de Salud Carlos III y los Fondos Feder Europeos (PI13/125 to MMA), the Spanish Ministry of Economy and competitiveness (IEDI-2015-00638 to MMA), The L'OREAL-Unesco Foundation (to MMA), The Department of Health of the Government of Navarra 22/2015 (to MMA), The Basque Foundation for Health Research (BIOEF, BI013/CI/005) and Fundacion Caja Navarra (Convocatoria de Ayudas 2015 to MMA).	Aoki Y, 2012, J NEURO-ONCOL, V108, P29, DOI 10.1007/s11060-011-0796-x; Becher OJ, 2010, CANCER RES, V70, P2548, DOI 10.1158/0008-5472.CAN-09-2503; Caretti V, 2011, BRAIN PATHOL, V21, P441, DOI 10.1111/j.1750-3639.2010.00468.x; Cohen KJ, 2011, NEURO-ONCOLOGY, V13, P410, DOI 10.1093/neuonc/noq205; Goodwin CR, 2016, CLIN NEUROL NEUROSUR, V142, P120, DOI 10.1016/j.clineuro.2016.01.007; Grasso CS, 2015, NAT MED, V21, P555, DOI 10.1038/nm.3855; Halvorson KG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118926; Hennika T, 2015, J CHILD NEUROL; Kamiya-Matsuoka C, 2014, NEURO-ONCOL PRACT, V1, P184, DOI 10.1093/nop/npu024; Kaye Erica C, 2014, CNS Oncol, V3, P421, DOI 10.2217/cns.14.47; Lal S, 2000, J NEUROSURG, V92, P326, DOI 10.3171/jns.2000.92.2.0326; Misuraca KL, 2016, NEOPLASIA, V18, P60, DOI 10.1016/j.neo.2015.12.002; Misuraca KL, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00172; Nowinski WL, 2015, J NEUROSCI METH, V246, P65, DOI 10.1016/j.jneumeth.2015.02.012; Schroeder KM, 2014, PEDIATR RES, V75, P205, DOI 10.1038/pr.2013.194; Thirant C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016375	16	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170501	10.1371/journal.pone.0170501	http://dx.doi.org/10.1371/journal.pone.0170501			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107439	Green Published, gold, Green Submitted			2022-12-26	WOS:000392405300150
J	Schimo, S; Wittig, I; Pos, KM; Ludwig, B				Schimo, Sonja; Wittig, Ilka; Pos, Klaas M.; Ludwig, Bernd			Cytochrome c Oxidase Biogenesis and Metallochaperone Interactions: Steps in the Assembly Pathway of a Bacterial Complex	PLOS ONE			English	Article							PARACOCCUS-DENITRIFICANS MUTANTS; B SITE FORMATION; CU(I)-BINDING PROTEIN; COX1 MATURATION; YEAST SCO1; SUBUNIT-I; HEME-O; SURF1; MUTATIONS; BIOSYNTHESIS	Biogenesis of mitochondrial cytochrome c oxidase (COX) is a complex process involving the coordinate expression and assembly of numerous subunits (SU) of dual genetic origin. Moreover, several auxiliary factors are required to recruit and insert the redox-active metal compounds, which in most cases are buried in their protein scaffold deep inside the membrane. Here we used a combination of gel electrophoresis and pull-down assay techniques in conjunction with immunostaining as well as complexome profiling to identify and analyze the composition of assembly intermediates in solubilized membranes of the bacterium Paracoccus denitrificans. Our results show that the central SUI passes through at least three intermediate complexes with distinct subunit and cofactor composition before formation of the holoenzyme and its subsequent integration into supercomplexes. We propose a model for COX biogenesis in which maturation of newly translated COX SUI is initially assisted by CtaG, a chaperone implicated in Cu-B site metallation, followed by the interaction with the heme chaperone Surf1c to populate the redox-active metal-heme centers in SUI. Only then the remaining smaller subunits are recruited to form the mature enzyme which ultimately associates with respiratory complexes I and III into supercomplexes.	[Schimo, Sonja; Pos, Klaas M.] Goethe Univ, Inst Biochem Membrane Transport Machineries, Frankfurt, Germany; [Wittig, Ilka] Goethe Univ, Fac Med, SFB Core Unity 815, Funct Prote, Frankfurt, Germany; [Ludwig, Bernd] Goethe Univ, Inst Biochem, Mol Genet, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Pos, KM (corresponding author), Goethe Univ, Inst Biochem Membrane Transport Machineries, Frankfurt, Germany.; Ludwig, B (corresponding author), Goethe Univ, Inst Biochem, Mol Genet, Frankfurt, Germany.	pos@em.uni-frankfurt.de; ludwig@em.uni-frankfurt.de			Deutsche Forschungsgemeinschaft (DFG) [LU 318/5-1, SFB815, Z1, PO 1344/3-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The project was funded by Deutsche Forschungsgemeinschaft (DFG, www.dfg.de) DFG Grant numbers LU 318/5-1: to BL, SFB815, project Z1: to IW, PO 1344/3-1) to KMP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abajian C, 2006, J BIOL INORG CHEM, V11, P459, DOI 10.1007/s00775-006-0096-7; Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284; Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489; Banci L, 2004, J BIOL CHEM, V279, P34833, DOI 10.1074/jbc.M403655200; Bareth B, 2013, MOL CELL BIOL, V33, P4128, DOI 10.1128/MCB.00747-13; Barrientos A, 2009, BBA-MOL CELL RES, V1793, P97, DOI 10.1016/j.bbamcr.2008.05.003; Barros MH, 2001, FEBS LETT, V492, P133, DOI 10.1016/S0014-5793(01)02249-9; Bourens M, 2014, HUM MOL GENET, V23, P2901, DOI 10.1093/hmg/ddu003; Bundschuh FA, 2008, BBA-BIOENERGETICS, V1777, P1336, DOI 10.1016/j.bbabio.2008.05.448; Bundschuh FA, 2009, J BIOL CHEM, V284, P25735, DOI 10.1074/jbc.M109.040295; Carr HS, 2003, ACCOUNTS CHEM RES, V36, P309, DOI 10.1021/ar0200807; Carr HS, 2002, J BIOL CHEM, V277, P31237, DOI 10.1074/jbc.M204854200; CASTRESANA J, 1994, EMBO J, V13, P2516, DOI 10.1002/j.1460-2075.1994.tb06541.x; Dash BP, 2015, BBA-BIOENERGETICS, V1847, P202, DOI 10.1016/j.bbabio.2014.11.001; Dennerlein S, 2015, J CELL SCI, V128, P833, DOI 10.1242/jcs.161729; DEVRIES GE, 1989, ARCH MICROBIOL, V152, P52, DOI 10.1007/BF00447011; Giese H, 2015, BIOINFORMATICS, V31, P440, DOI 10.1093/bioinformatics/btu623; Greiner P, 2008, BBA-BIOENERGETICS, V1777, P904, DOI 10.1016/j.bbabio.2008.04.003; Gurumoorthy P, 2015, FEBS J, V282, P537, DOI 10.1111/febs.13160; Hannappel A, 2011, INDIAN J CHEM A, V50, P374; Hannappel A, 2012, BBA-BIOENERGETICS, V1817, P928, DOI 10.1016/j.bbabio.2011.09.007; Hannappel A, 2011, FEBS J, V278, P1769, DOI 10.1111/j.1742-4658.2011.08101.x; Hederstedt L, 2012, BBA-BIOENERGETICS, V1817, P920, DOI 10.1016/j.bbabio.2012.03.025; Heide H, 2012, CELL METAB, V16, P538, DOI 10.1016/j.cmet.2012.08.009; Hiser L, 2000, J BIOL CHEM, V275, P619, DOI 10.1074/jbc.275.1.619; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Kaila VRI, 2010, CHEM REV, V110, P7062, DOI 10.1021/cr1002003; Kaila VRI, 2011, BBA-BIOENERGETICS, V1807, P80, DOI 10.1016/j.bbabio.2010.08.014; Khalimonchuk E, 2005, MITOCHONDRION, V5, P363, DOI 10.1016/j.mito.2005.08.002; Khalimonchuk O, 2005, CURR GENET, V47, P223, DOI 10.1007/s00294-005-0569-1; Khalimonchuk O, 2010, MOL CELL BIOL, V30, P1004, DOI 10.1128/MCB.00640-09; Leary SC, 2009, HUM MOL GENET, V18, P2230, DOI 10.1093/hmg/ddp158; LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216; Lode A, 2000, FEBS LETT, V485, P19, DOI 10.1016/S0014-5793(00)02176-1; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; McStay GP, 2013, J BIOL CHEM, V288, P26546, DOI 10.1074/jbc.M113.498592; McStay GP, 2013, MOL BIOL CELL, V24, P440, DOI 10.1091/mbc.E12-10-0749; Mick DU, 2007, EMBO J, V26, P4347, DOI 10.1038/sj.emboj.7601862; Mick DU, 2011, NAT REV MOL CELL BIO, V12, P14, DOI 10.1038/nrm3029; MOGI T, 1994, MOL MICROBIOL, V14, P391, DOI 10.1111/j.1365-2958.1994.tb02174.x; Nijtmans LGJ, 2001, FEBS LETT, V498, P46, DOI 10.1016/S0014-5793(01)02447-4; Nittis T, 2001, J BIOL CHEM, V276, P42520, DOI 10.1074/jbc.M107077200; RAITIO M, 1994, BBA-BIOENERGETICS, V1186, P100, DOI 10.1016/0005-2728(94)90140-6; Richter O.-M.H., 2013, ENCY METALLOPROTEINS, P939; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Smith D, 2005, J BIOL CHEM, V280, P17652, DOI 10.1074/jbc.C500061200; Soto IC, 2012, BBA-BIOENERGETICS, V1817, P883, DOI 10.1016/j.bbabio.2011.09.005; Sousa FL, 2012, BBA-BIOENERGETICS, V1817, P629, DOI 10.1016/j.bbabio.2011.09.020; STEINRUCKE P, 1991, J BIOL CHEM, V266, P7676; Stiburek L, 2009, AM J PHYSIOL-CELL PH, V296, pC1218, DOI 10.1152/ajpcell.00564.2008; Strecker V, 2016, BBA-MOL CELL RES, V1863, P1643, DOI 10.1016/j.bbamcr.2016.04.012; Stroh A, 2004, J BIOL CHEM, V279, P5000, DOI 10.1074/jbc.M309505200; Swenson S, 2016, J BIOL CHEM, V291, P10411, DOI 10.1074/jbc.M115.707539; Thompson AK, 2012, BBA-BIOENERGETICS, V1817, P955, DOI 10.1016/j.bbabio.2012.01.003; Thompson AK, 2010, BIOCHEMISTRY-US, V49, P5651, DOI 10.1021/bi1003876; Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150; Williams SL, 2004, J BIOL CHEM, V279, P7462, DOI 10.1074/jbc.M309232200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wittig I, 2010, MOL CELL PROTEOMICS, V9, P2149, DOI 10.1074/mcp.M900526-MCP200; Zee JM, 2006, BIOCHEM CELL BIOL, V84, P859, DOI 10.1139/O06-201; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804	62	14	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170037	10.1371/journal.pone.0170037	http://dx.doi.org/10.1371/journal.pone.0170037			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107462	Green Submitted, gold, Green Published			2022-12-26	WOS:000392405300066
J	Walshe, C; Roberts, D; Appleton, L; Calman, L; Large, P; Lloyd-Williams, M; Grande, G				Walshe, Catherine; Roberts, Diane; Appleton, Lynda; Calman, Lynn; Large, Paul; Lloyd-Williams, Mari; Grande, Gunn			Coping Well with Advanced Cancer: A Serial Qualitative Interview Study with Patients and Family Carers	PLOS ONE			English	Article							PEER-SUPPORT PROGRAMS; PALLIATIVE CARE; LIFE CARE; PSYCHOLOGICAL RESPONSES; PROSTATE-CANCER; OF-LIFE; EXPERIENCE; HEALTH; PREDICTORS; STRATEGIES	Objectives To understand successful strategies used by people to cope well when living with advanced cancer; to explore how professionals can support effective coping strategies; to understand how to support development of effective coping strategies for patients and family carers. Design Qualitative serial (4-12 week intervals) interview study with people with advanced cancer and their informal carers followed by focus groups. The iterative design had a novel focus on positive coping strategies. Interview analysis focused on patients and carers as individuals and pairs, exploring multiple dimensions of their coping experiences. Focus group analysis explored strategies for intervention development. Participants 26 people with advanced (stage 3-4) breast, prostate, lung or colorectal cancer, or in receipt of palliative care, and 24 paired nominated informal/family carers. Setting Participants recruited through outpatient clinics at two tertiary cancer centres in Merseyside and Manchester, UK, between June 2012 and July 2013. Results 45 patient and 41 carer interviews were conducted plus 4 focus groups (16 participants). People with advanced cancer and their informal/family carers develop coping strategies which enable effective management of psychological wellbeing. People draw from pre-diagnosis coping strategies, but these develop through responding to the experience of living with advanced cancer. Strategies include being realistic, indulgence, support, and learning from others, which enabled participants to regain a sense of wellbeing after emotional challenge. Learning from peers emerged as particularly important in promoting psychological wellbeing through the development of effective 'everyday', non-clinical coping strategies. Conclusions Our findings challenge current models of providing psychological support for those with advanced cancer which focus on professional intervention. It is important to recognise, enable and support peoples' own resources and coping strategies. Peer support may have potential, and could be a patient-centred, cost effective way of managing the needs of a growing population of those living with advanced cancer.	[Walshe, Catherine] Univ Lancaster, Int Observ End Life Care, Lancaster, England; [Roberts, Diane; Grande, Gunn] Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester, Lancs, England; [Appleton, Lynda] Clatterbridge Canc Ctr NHS Fdn Trust, Wirral, Merseyside, England; [Calman, Lynn] Univ Southampton, Fac Hlth Sci, Southampton, Hants, England; [Large, Paul] User Representat, Liverpool, Merseyside, England; [Lloyd-Williams, Mari] Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool, Merseyside, England	Lancaster University; University of Manchester; University of Southampton; University of Liverpool	Walshe, C (corresponding author), Univ Lancaster, Int Observ End Life Care, Lancaster, England.	c.walshe@lancaster.ac.uk		Calman, Lynn/0000-0002-9964-6017; Walshe, Catherine/0000-0002-4531-8608; Appleton, Lynda/0000-0001-8368-3000	Dimbleby Cancer Care	Dimbleby Cancer Care	This research was funded by Dimbleby Cancer Care http://www.dimblebycancercare.org/research/funded-research-projects-past-and-present through a grant awarded to CW, LA, LC, PL, MLW and GG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbour R., 2007, DOING FOCUS GROUPS; Best M, 2015, PALLIATIVE MED, V29, P885, DOI 10.1177/0269216315581538; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Buyukasik-Colak C, 2012, J PSYCHOL, V146, P471, DOI 10.1080/00223980.2012.654520; Calman L, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-14; Campbell HS, 2004, PATIENT EDUC COUNS, V55, P3, DOI 10.1016/j.pec.2003.10.001; Carolan CM, 2015, PALLIATIVE MED, V29, P605, DOI 10.1177/0269216315575680; Chen PY, 2012, EUR J ONCOL NURS, V16, P10, DOI 10.1016/j.ejon.2011.01.002; Chittem M, 2014, J CANCER RES THER, V10, P6, DOI 10.4103/0973-1482.131328; CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593; Couper JW, 2010, MED J AUSTRALIA, V193, pS58; Czerw A, 2015, BREAST CANCER-TOKYO, DOI [10.1002/pon.3343, DOI 10.1002/PON.3343]; Dale JR, 2012, DIABETIC MED, V29, P1361, DOI 10.1111/j.1464-5491.2012.03749.x; De Faye Barbara J, 2006, Palliat Support Care, V4, P239; Dempster M, 2015, J PSYCHOSOM RES, V79, P506, DOI 10.1016/j.jpsychores.2015.10.006; Drageset S, 2015, EUROPEAN J ONCOLOGY; Ellis J, 2013, EUR J CANCER CARE, V22, P97, DOI 10.1111/ecc.12003; Folkman S, 2000, PSYCHO-ONCOL, V9, P11, DOI 10.1002/(SICI)1099-1611(200001/02)9:1<11::AID-PON424>3.3.CO;2-Q; Germeni E, 2014, PSYCHO-ONCOLOGY, V23, P1373, DOI 10.1002/pon.3575; Grande G, 2009, PALLIATIVE MED, V23, P339, DOI 10.1177/0269216309104875; Griffiths KM, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1270; Hack TF, 2010, PSYCHO-ONCOLOGY, V19, P626, DOI 10.1002/pon.1592; Hartzler A, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1728; Higginson IJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-111; Hill EM, 2015, PSYCHOL HEALTH MED, P1; Hoey LM, 2008, PATIENT EDUC COUNS, V70, P315, DOI 10.1016/j.pec.2007.11.016; Hotopf M, 2002, PALLIATIVE MED, V16, P81, DOI 10.1191/02169216302pm507oa; Hou WK, 2015, PSYCHO-ONCOLOGY; Hund B, 2016, DEPRESS ANXIETY, V33, P153, DOI 10.1002/da.22441; Islam KM, 2015, JOURNAL OF CANCER ED; Jolly K, 2012, BMJ-BRIT MED J, V344; Jordhoy MS, 1999, PALLIATIVE MED, V13, P299, DOI 10.1191/026921699668963873; Kasparian NA, 2009, ARCH DERMATOL, V145, P1415, DOI 10.1001/archdermatol.2009.308; Kinnane NA, 2010, SUPPORT CARE CANCER, V18, P1123, DOI 10.1007/s00520-010-0863-4; Klemm P, 2003, CIN-COMPUT INFORM NU, V21, P136, DOI 10.1097/00024665-200305000-00010; Lambert SD, 2016, SUPPORT CARE CANCER, V24, P711, DOI 10.1007/s00520-015-2833-3; Lang HD, 2013, PSYCHO-ONCOLOGY, V22, P2648, DOI 10.1002/pon.3343; Lazarus R.S., 1984, EMOTION ADAPTATION; Lee SW, 2011, J SEX MED, V8, P5; Levy A, 2015, PSYCHOL HEALTH, V30, P1164, DOI 10.1080/08870446.2015.1040016; Lloyd-Williams M, 2013, QJM-INT J MED, V106, P995, DOI 10.1093/qjmed/hct133; Luker K., 2012, BMJ SUPPORT PALLIAT, V2, pA2, DOI DOI 10.1136/BMJSPCARE-2012-000196.6; Macvean ML, 2008, PATIENT EDUC COUNS, V70, P10, DOI 10.1016/j.pec.2007.08.005; Mitchell AJ, 2011, LANCET ONCOL, V12, P160, DOI 10.1016/S1470-2045(11)70002-X; Moss AH, 2009, J CLIN ONCOL, V27; Murray SA, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3702; National Institute for Health and Care Excellence (NICE), 2004, IMPR SUPP PALL CAR A; Paredes T, 2012, EUR J CANCER CARE, V21, P41, DOI 10.1111/j.1365-2354.2011.01269.x; Pascoe EC, 2015, CANC NURS; Paterson C, 2015, EUROPEAN J ONCOLOGY; Pitt Veronica, 2013, Cochrane Database Syst Rev, pCD004807, DOI 10.1002/14651858.CD004807.pub2; Price A, 2006, J ROY SOC MED, V99, P637, DOI 10.1258/jrsm.99.12.637; Rand KL, 2012, SUPPORT CARE CANCER, V20, P1719, DOI 10.1007/s00520-011-1265-y; Rayner L, 2011, PALLIATIVE MED, V25, P229, DOI 10.1177/0269216310387458; Roberts D, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003046; Roussi P, 2014, J BEHAV MED, V37, P931, DOI 10.1007/s10865-014-9553-x; Sallnow L, 2016, PALLIATIVE MED, V30, P200, DOI 10.1177/0269216315599869; Schreiber JA, 2012, J CANCER SURVIV, V6, P82, DOI 10.1007/s11764-011-0193-7; Scrignaro M, 2011, PSYCHO-ONCOLOGY, V20, P823, DOI 10.1002/pon.1782; Semple C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009441.pub2; Shakeri J, 2015, INDIAN J PALLIAT CAR, V21, P298, DOI 10.4103/0973-1075.164890; Small N, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-533; Stephen JE, 2011, PSYCHO-ONCOLOGY, V20, P832, DOI 10.1002/pon.1791; Team NCA, 2010, NAT CANC PEER REV PR; Thomsen TG, 2010, J CLIN NURS, V19, P3410, DOI 10.1111/j.1365-2702.2009.03154.x; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Willis K, 2015, HEALTH CARE WOMEN IN, V36, P514, DOI 10.1080/07399332.2014.896364; Zabalegui A, 2013, J RES NURS, V18, P409, DOI 10.1177/1744987111424560; Zamanian Hadi, 2015, Asian Pac J Cancer Prev, V16, P7721	69	54	55	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0169071	10.1371/journal.pone.0169071	http://dx.doi.org/10.1371/journal.pone.0169071			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI3QC	28107352	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000392405300019
J	Zhang, D; Xia, XY; Wang, XX; Zhang, P; Lu, WL; Yu, YM; Deng, S; Yang, HS; Zhu, HX; Xu, NZ; Liang, SF				Zhang, Dan; Xia, Xiangying; Wang, Xixi; Zhang, Peng; Lu, Weiliang; Yu, Yamei; Deng, Shi; Yang, Hanshuo; Zhu, Hongxia; Xu, Ningzhi; Liang, Shufang			PGRMC1 Is a Novel Potential Tumor Biomarker of Human Renal Cell Carcinoma Based on Quantitative Proteomic and Integrative Biological Assessments	PLOS ONE			English	Article							MEMBRANE COMPONENT 1; ESTROGEN-RECEPTOR; 14-3-3 EPSILON; KIDNEY CANCER; AMINO-ACIDS; PROGESTERONE; PROTEIN; EXPRESSION; DISCOVERY	Progesterone receptor membrane component 1 (PGRMC1) is widely observed with an elevated level in multiple human cancers. However, the roles of PGRMC1 in renal cancer are not clear and merit further study. In this report, we made a systematic, integrative biological assessment for PGRMC1 in renal cell carcinoma (RCC) by a quantitative proteomic identification, immunohistochemical detection, and its clinic pathologic significance analysis. We found that PGRMC1 abundance is increased by 3.91-fold in RCC tissues compared with its autologous para-cancerous tissues by a quantitative proteome identification. To validate the proteomic result with more confidence, 135 clinic RCC tissues were recruited to measure PGRMC1 abundance by immunohistochemical staining, and 63.7% RCC samples (n = 86) showed a higher abundance of PGRMC1 than the noncancerous counterparts. And the elevated PGRMC1 level was related to the tumor malignancy degree and overall survival of RCC patients. Meanwhile the average serum PGRMC1 concentration for RCC patients (n = 18) was significantly increased by 1.67 fold compared with healthy persons. Moreover an exogenous elevated abundance of PGRMC1 by plasmid transfections significantly enhanced cell proliferation of renal cancer cells in vitro. Our findings demonstrate PGRMC1, which promotes RCC progression phenotypes in vitro and in vivo, is a novel potential biomarker and therapeutic target for RCC.	[Zhang, Dan; Xia, Xiangying; Wang, Xixi; Lu, Weiliang; Yu, Yamei; Yang, Hanshuo; Xu, Ningzhi; Liang, Shufang] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Peoples R China; [Zhang, Dan; Xia, Xiangying; Wang, Xixi; Lu, Weiliang; Yu, Yamei; Yang, Hanshuo; Xu, Ningzhi; Liang, Shufang] Sichuan Univ, West China Hosp, Ctr Canc, Chengdu, Peoples R China; [Zhang, Dan; Xia, Xiangying; Wang, Xixi; Lu, Weiliang; Yu, Yamei; Yang, Hanshuo; Xu, Ningzhi; Liang, Shufang] Collaborat Innovat Ctr Biotherapy, Chengdu, Peoples R China; [Zhang, Peng; Deng, Shi] Sichuan Univ, West China Hosp, West China Med Sch, Dept Urinary Surg, Chengdu, Peoples R China; [Zhu, Hongxia; Xu, Ningzhi] Chinese Acad Med Sci, Lab Cell & Mol Biol, Beijing, Peoples R China; [Zhu, Hongxia; Xu, Ningzhi] Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing, Peoples R China; [Zhu, Hongxia; Xu, Ningzhi] Chinese Acad Med Sci, Canc Hosp, Beijing, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Liang, SF (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Peoples R China.; Liang, SF (corresponding author), Sichuan Univ, West China Hosp, Ctr Canc, Chengdu, Peoples R China.; Liang, SF (corresponding author), Collaborat Innovat Ctr Biotherapy, Chengdu, Peoples R China.	zizi2006@scu.edu.cn	Liang, Shufang/AAW-8143-2021		National 863 High Tech Foundation [2014AA020608]; National Key Basic Research Program of China [2013CB911303, 2011CB910703]; National Natural Sciences Foundation of China [31470810, 31071235, 30970654]; Doctoral Program of Higher Education [20120181110025]	National 863 High Tech Foundation(National High Technology Research and Development Program of China); National Key Basic Research Program of China(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was financially supported by the grants from the National 863 High Tech Foundation (2014AA020608, www.most.gov.cn), National Key Basic Research Program of China 2013CB911303, 2011CB910703, www.most.gov.cn), National Natural Sciences Foundation of China (31470810, 31071235, 30970654, www.nsfc.gov.cn), and the Doctoral Program of Higher Education (20120181110025, www.moe.gov.cn). SL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed IS, 2010, J BIOL CHEM, V285, P24775, DOI 10.1074/jbc.M110.134585; Ahmed IS, 2010, J PHARMACOL EXP THER, V333, P564, DOI 10.1124/jpet.109.164210; Cahill MA, 2007, J STEROID BIOCHEM, V105, P16, DOI 10.1016/j.jsbmb.2007.02.002; Craven R.J, United States Patent, Patent No. [20140106375 A1, 20140106375]; Craven RA, 2013, CLIN BIOCHEM, V46, P456, DOI 10.1016/j.clinbiochem.2012.11.029; Craven RJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2191; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Edge SB, 2010, AJCC CANC STAGING MA; Engwegen JYMN, 2007, LAB INVEST, V87, P161, DOI 10.1038/labinvest.3700503; Gong F, 2008, J PROTEOM BIOINFORM, V1, P250; Jin XW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133770; Krebs CJ, 2000, P NATL ACAD SCI USA, V97, P12816, DOI 10.1073/pnas.97.23.12816; Li HB, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-146; Liang SF, 2008, IUBMB LIFE, V60, P534, DOI 10.1002/iub.75; Liang SF, 2012, COMB CHEM HIGH T SCR, V15, P221, DOI 10.2174/138620712799218635; Liang SF, 2009, ELECTROPHORESIS, V30, P4152, DOI 10.1002/elps.200900249; Liang SF, 2009, PROTEOM CLIN APPL, V3, P743, DOI 10.1002/prca.200800198; Liang SF, 2009, J CHROMATOGR B, V877, P627, DOI 10.1016/j.jchromb.2009.01.023; Losel RM, 2008, STEROIDS, V73, P929, DOI 10.1016/j.steroids.2007.12.017; Mallory JC, 2005, MOL PHARMACOL, V68, P1747, DOI 10.1124/mol.105.016519; Mir SUR, 2012, INT J CANCER, V131, pE1, DOI 10.1002/ijc.26432; Neubauer H, 2013, CLIMACTERIC, V16, P509, DOI 10.3109/13697137.2013.800038; Neubauer H, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2155; Peluso JJ, 2006, ENDOCRINOLOGY, V147, P3133, DOI 10.1210/en.2006-0114; Peluso JJ, 2008, J CLIN ENDOCR METAB, V93, P1592, DOI 10.1210/jc.2007-2771; Peluso JJ, 2008, ENDOCRINOLOGY, V149, P534, DOI 10.1210/en.2007-1050; Perroud B, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-64; Rohe HJ, 2009, PHARMACOL THERAPEUT, V121, P14, DOI 10.1016/j.pharmthera.2008.09.006; Seliger B, 2007, PROTEOMICS, V7, P4601, DOI 10.1002/pmic.200700415; Siu KWM, 2009, J PROTEOME RES, V8, P3797, DOI 10.1021/pr800389e; Suwaki N, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002004; Unwin RD, 2003, PROTEOMICS, V3, P1620, DOI 10.1002/pmic.200300464; Vasudev NS, 2008, PROTEOMICS, V8, P5074, DOI 10.1002/pmic.200800497; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Weiss RH, 2006, KIDNEY INT, V69, P224, DOI 10.1038/sj.ki.5000065; White N.M, 2014, ONCOTARGET, V5, P493; Xu G, 2009, CANCER LETT, V282, P205, DOI 10.1016/j.canlet.2009.03.017; Xu G, 2009, TECHNOL CANCER RES T, V8, P225, DOI 10.1177/153303460900800307; Xu JH, 2013, ADV METEOROL, V2013, DOI 10.1155/2013/272715; Xu YH, 2009, BIOTECHNOL APPL BIOC, V54, P11, DOI 10.1042/BA20090007; Xu ZZ, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-46; Zisman A, 2001, J CLIN ONCOL, V19, P1649, DOI 10.1200/JCO.2001.19.6.1649	43	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170453	10.1371/journal.pone.0170453	http://dx.doi.org/10.1371/journal.pone.0170453			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107520	Green Published, gold, Green Submitted			2022-12-26	WOS:000392405300137
J	Zhao, JX; Zhai, F; Cheng, J; He, Q; Luo, JW; Yang, XP; Shao, JH; Xing, HC				Zhao, Jingxin; Zhai, Fei; Cheng, Jun; He, Qiong; Luo, Jianwen; Yang, Xueping; Shao, Jinhua; Xing, Huichun			Evaluating the Significance of Viscoelasticity in Diagnosing Early-Stage Liver Fibrosis with Transient Elastography	PLOS ONE			English	Article							STIFFNESS MEASUREMENT; HEPATITIS; REPRODUCIBILITY; BIOPSY; SIZE	Transient elastography quantifies the propagation of a mechanically generated shear wave within a soft tissue, which can be used to characterize the elasticity and viscosity parameters of the tissue. The aim of our study was to combine numerical simulation and clinical assessment to define a viscoelastic index of liver tissue to improve the quality of early diagnosis of liver fibrosis. This is clinically relevant, as early fibrosis is reversible. We developed an idealized two-dimensional axisymmetric finite element model of the liver to evaluate the effects of different viscoelastic values on the propagation characteristics of the shear wave. The diagnostic value of the identified viscoelastic index was verified against the clinical data of 99 patients who had undergone biopsy and routine blood tests for staging of liver disease resulting from chronic hepatitis B infection. Liver stiffness measurement (LSM) and the shear wave attenuation fitting coefficient (AFC) were calculated from the ultrasound data obtained by performing transient elastography. Receiver operating curve analysis was used to evaluate the reliability and diagnostic accuracy of LSM and AFC. Compared to LSM, the AFC provided a higher diagnostic accuracy to differentiate early stages of liver fibrosis, namely F1 and F2 stages, with an overall specificity of 81.48%, sensitivity of 83.33% and diagnostic accuracy of 81.82%. AFC was influenced by the level of LSM, ALT. However, there are no correlation between AFC and Age, BMI, TBIL or DBIL. Quantification of the viscoelasticity of liver tissue provides reliable measurement to identify and differentiate early stages of liver fibrosis.	[Zhao, Jingxin; Cheng, Jun; Yang, Xueping; Xing, Huichun] Capital Med Univ, Beijing Ditan Hosp, Beijing, Peoples R China; [Zhai, Fei; Shao, Jinhua] Hisky Med Technol Co Ltd, Beijing, Peoples R China; [He, Qiong; Luo, Jianwen] Tsinghua Univ, Dept Biomed Engn, Beijing, Peoples R China	Capital Medical University; Tsinghua University	Xing, HC (corresponding author), Capital Med Univ, Beijing Ditan Hosp, Beijing, Peoples R China.; Shao, JH (corresponding author), Hisky Med Technol Co Ltd, Beijing, Peoples R China.	shaojinhua@gmail.com; huichunxing@126.com	Luo, Jianwen/D-5612-2011	Luo, Jianwen/0000-0001-9215-5568; Xing, Huichun/0000-0002-9111-9669	National Natural Science Foundation of China [81271617]; National Science and Technology Support Program [2012BAI23B00]; National Science and Technology Major Project of China [2014ZX10005001]; Beijing Municipal Science and Technology Project of Traditional Chinese Medicine [JJ2014-25]; Jiangsu Province Scientific and Technological Achievements Transformation Special Fund [BA2015080]; Collaborative Innovation Center of Infectious diseases	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program; National Science and Technology Major Project of China; Beijing Municipal Science and Technology Project of Traditional Chinese Medicine; Jiangsu Province Scientific and Technological Achievements Transformation Special Fund; Collaborative Innovation Center of Infectious diseases	This work was supported by the National Natural Science Foundation of China under Grant No. 81271617; National Science and Technology Support Program under Grant No. 2012BAI23B00; National Science and Technology Major Project of China under Grant No. 2014ZX10005001; Beijing Municipal Science and Technology Project of Traditional Chinese Medicine under Grant No. JJ2014-25; Jiangsu Province Scientific and Technological Achievements Transformation Special Fund under Grant No. BA2015080; Collaborative Innovation Center of Infectious diseases.	Arena U, 2008, HEPATOLOGY, V47, P380, DOI 10.1002/hep.22007; Catheline S, 2004, J ACOUST SOC AM, V116, P3734, DOI 10.1121/1.1815075; Chen NL, 2010, J GASTROENTEROLEPATO, V19, P1; Chen SG, 2009, IEEE T ULTRASON FERR, V56, P55, DOI 10.1109/TUFFC.2009.1005; Chinese Society of Hepatology and Chinese Society of Infectious Diseases, 2011, ZHONGHUA SHIYAN HE L, V29, P65; Deffieux T, 2015, J HEPATOL, V62, P317, DOI 10.1016/j.jhep.2014.09.020; Dienstag JL, 2002, HEPATOLOGY, V36, pS152, DOI 10.1053/jhep.2002.36381; Dowman JK, 2011, ALIMENT PHARM THER, V33, P525, DOI 10.1111/j.1365-2036.2010.04556.x; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fattovich G, 1997, GASTROENTEROLOGY, V112, P463, DOI 10.1053/gast.1997.v112.pm9024300; Foucher J, 2006, EUR J GASTROEN HEPAT, V18, P411, DOI 10.1097/00042737-200604000-00015; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HOLUND B, 1980, SCAND J GASTROENTERO, V15, P329, DOI 10.3109/00365528009181479; Lewin M, 2007, HEPATOLOGY, V46, P658, DOI 10.1002/hep.21747; Liaw YF, 2008, HEPATOL INT, V25, P472; Marcellin P, 2009, LIVER INT, V29, P242, DOI 10.1111/j.1478-3231.2008.01802.x; Muller M, 2009, ULTRASOUND MED BIOL, V35, P219, DOI 10.1016/j.ultrasmedbio.2008.08.018; Poynard Thierry, 2011, Curr Hepat Rep, V10, P87, DOI 10.1007/s11901-011-0096-0; Salameh N, 2009, RADIOLOGY, V253, P90, DOI 10.1148/radiol.2523081817; SCHLICHTING P, 1983, SCAND J GASTROENTERO, V18, P27, DOI 10.3109/00365528309181554; Soresi M, 2014, WORLD J GASTROENTERO, V20, P18131, DOI 10.3748/wjg.v20.i48.18131; Standish RA, 2006, GUT, V55, P569, DOI 10.1136/gut.2005.084475; Wong GLH, 2014, CLIN MOL HEPATOL, V20, P228, DOI 10.3350/cmh.2014.20.3.228; Wong GLH, 2013, WORLD J HEPATOL, V5, P264, DOI 10.4254/wjh.v5.i5.264; Yeh CL, 2014, IEEE INT ULTRA SYM, P1140, DOI 10.1109/ULTSYM.2014.0280	25	15	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170073	10.1371/journal.pone.0170073	http://dx.doi.org/10.1371/journal.pone.0170073			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107385	Green Submitted, Green Published, gold			2022-12-26	WOS:000392405300071
J	Kern, C; Erdem, FA; El-Kasaby, A; Sandtner, W; Freissmuth, M; Sucic, S				Kern, Carina; Erdem, Fatma Asli; El-Kasaby, Ali; Sandtner, Walter; Freissmuth, Michael; Sucic, Sonja			The N Terminus Specifies the Switch between Transport Modes of the Human Serotonin Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neurotransmitter release; neurotransmitter transport; patch clamp; serotonin; serotonin transporter	OSMOREGULATED BETAINE TRANSPORTER; DOPAMINE TRANSPORTER; AMPHETAMINE ACTION; C-TERMINUS; BINDING; PHOSPHORYLATION; INHIBITION; DYNAMICS; IBOGAINE; STATE	The serotonin transporter (SERT) and other monoamine transporters operate in either a forward transport mode where the transporter undergoes a full transport cycle or an exchange mode where the transporter seesaws through half-cycles. Amphetamines trigger the exchange mode, leading to substrate efflux. This efflux was proposed to rely on the N terminus, which was suggested to adopt different conformations in the inward facing, outward facing and amphetamine-bound states. This prediction was verified by tryptic digestion of SERT-expressing membranes: in the absence of Na+, the N terminus was rapidly digested. Amphetamine conferred protection against cleavage, suggesting a relay between the conformational states of the hydrophobic core and the N terminus. We searched for a candidate segment that supported the conformational switch by serial truncation removing 22 (N22), 32 (N32), or 42 (N42) N-terminal residues. This did not affect surface expression, inhibitor binding, and substrate influx. However, amphetamine-induced efflux by SERT-N32 or SERT-N42 (but not by SERT-N22) was markedly diminished. We examined the individual steps in the transport cycle by recording transporter-associated currents: the recovery rate of capacitive peak, but not of steady state, currents was significantly lower for SERT-N32 than that of wild type SERT and SERT-N22. Thus, the exchange mode of SERT-N32 was selectively impaired. Our observations show that the N terminus affords the switch between transport modes. The findings are consistent with a model where the N terminus acts as a lever to support amphetamine-induced efflux by SERT.	[Kern, Carina; Erdem, Fatma Asli; El-Kasaby, Ali; Sandtner, Walter; Freissmuth, Michael; Sucic, Sonja] Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria	Medical University of Vienna	Sucic, S (corresponding author), Inst Pharmacol, Dept Physiol & Pharmacol, Waehringerstr 13a, A-1090 Vienna, Austria.	sonja.sucic@meduniwien.ac.at		Freissmuth, Michael/0000-0001-9398-1765; Erdem, Fatma A./0000-0003-1381-5009; Sucic, Sonja/0000-0001-5136-8022	Austrian Science Fund/FWF [P27518-B27, P28090, F3510]	Austrian Science Fund/FWF(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund/FWF Project P27518-B27 (to S. S.), Project P28090 (to W. S.), and Project Program Grant SFB35 (F3510 to M. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Binda F, 2008, MOL PHARMACOL, V74, P1101, DOI 10.1124/mol.108.048447; Buchmayer F, 2013, P NATL ACAD SCI USA, V110, P11642, DOI 10.1073/pnas.1220552110; Bulling S, 2012, J BIOL CHEM, V287, P18524, DOI 10.1074/jbc.M112.343681; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; Erreger K, 2008, J NEUROSCI, V28, P976, DOI 10.1523/JNEUROSCI.2796-07.2008; FISCHER JF, 1979, J PHARMACOL EXP THER, V208, P203; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Foster JD, 2012, J BIOL CHEM, V287, P29702, DOI 10.1074/jbc.M112.367706; Ge L, 2011, P NATL ACAD SCI USA, V108, pE890, DOI 10.1073/pnas.1109597108; Gnegy ME, 2003, EUR J PHARMACOL, V479, P83, DOI 10.1016/j.ejphar.2003.08.059; Guler G, 2016, J BIOL CHEM, V291, P4295, DOI 10.1074/jbc.M114.621979; Hamilton PJ, 2014, NAT CHEM BIOL, V10, P582, DOI [10.1038/NCHEMBIO.1545, 10.1038/nchembio.1545]; Hasenhuetl PS, 2016, J BIOL CHEM, V291, P25864, DOI 10.1074/jbc.M116.753319; Hasenhuetl PS, 2015, MOL PHARMACOL, V88, P12, DOI 10.1124/mol.115.099036; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; Khelashvili G, 2016, J BIOL CHEM, V291, P19786, DOI 10.1074/jbc.M116.731455; Khelashvili G, 2015, ACS CHEM NEUROSCI, V6, P1825, DOI 10.1021/acschemneuro.5b00179; Khoshbouei H, 2004, PLOS BIOL, V2, P387, DOI 10.1371/journal.pbio.0020078; Koban F, 2015, J BIOL CHEM, V290, P13263, DOI 10.1074/jbc.M115.641357; Korkhov VM, 2006, J BIOL CHEM, V281, P13439, DOI 10.1074/jbc.M511382200; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Montgomery TR, 2014, J NEUROSCI, V34, P6344, DOI 10.1523/JNEUROSCI.2991-13.2014; Ott V, 2008, BIOCHEMISTRY-US, V47, P12208, DOI 10.1021/bi801325r; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Perez C, 2011, EMBO REP, V12, P804, DOI 10.1038/embor.2011.102; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Sandtner W, 2014, BRIT J PHARMACOL, V171, P1007, DOI 10.1111/bph.12520; Schicker K, 2012, J BIOL CHEM, V287, P438, DOI 10.1074/jbc.M111.304261; Seidel S, 2005, MOL PHARMACOL, V67, P140, DOI 10.1124/mol.67.1.140; Sitte HH, 2015, TRENDS PHARMACOL SCI, V36, P41, DOI 10.1016/j.tips.2014.11.006; Steinkellner T, 2015, J NEUROSCI, V35, P8258, DOI 10.1523/JNEUROSCI.4034-14.2015; Steinkellner T, 2014, NEUROPSYCHOPHARMACOL, V39, P2681, DOI 10.1038/npp.2014.124; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Sweeney CG, 2017, J BIOL CHEM, V292, P1302, DOI 10.1074/jbc.M116.762872; Yuan LX, 2013, PLANT CELL, V25, P974, DOI 10.1105/tpc.112.108027; Zestos AG, 2016, ACS CHEM NEUROSCI, V7, P757, DOI 10.1021/acschemneuro.6b00028	37	16	16	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3603	3613		10.1074/jbc.M116.771360	http://dx.doi.org/10.1074/jbc.M116.771360			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28104804	Green Published, hybrid			2022-12-26	WOS:000395542500006
J	Chu, ND; Smith, MB; Perrotta, AR; Kassam, Z; Alm, EJ				Chu, Nathaniel D.; Smith, Mark B.; Perrotta, Allison R.; Kassam, Zain; Alm, Eric J.			Profiling Living Bacteria Informs Preparation of Fecal Microbiota Transplantations	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CLOSTRIDIUM-DIFFICILE INFECTION; ULCERATIVE-COLITIS; FROZEN INOCULUM; SEQUENCES; SAMPLES; BACTERIOTHERAPY; COMMUNITIES; EFFICACY; TAXONOMY	Fecal microbiota transplantation is a compelling treatment for recurrent Clostridium difficile infections, with potential applications against other diseases associated with changes in gut microbiota. But variability in fecal bacterial communities-believed to be the therapeutic agent-can complicate or undermine treatment efficacy. To understand the effects of transplant preparation methods on living fecal microbial communities, we applied a DNA-sequencing method (PMA-seq) that uses propidium monoazide (PMA) to differentiate between living and dead fecal microbes, and we created an analysis pipeline to identify individual bacteria that change in abundance between samples. We found that oxygen exposure degraded fecal bacterial communities, whereas freeze-thaw cycles and lag time between donor defecation and transplant preparation had much smaller effects. Notably, the abundance of Faecalibacterium prausnitzii-an anti-inflammatory commensal bacterium whose absence is linked to inflammatory bowel disease-decreased with oxygen exposure. Our results indicate that some current practices for preparing microbiota transplant material adversely affect living fecal microbial content and highlight PMA-seq as a valuable tool to inform best practices and evaluate the suitability of clinical fecal material.	[Chu, Nathaniel D.] MIT, Microbiol Grad Program, Cambridge, MA 02139 USA; [Chu, Nathaniel D.; Smith, Mark B.; Perrotta, Allison R.; Kassam, Zain; Alm, Eric J.] MIT, Ctr Microbiome Informat & Therapeut, Cambridge, MA 02139 USA; [Smith, Mark B.; Kassam, Zain; Alm, Eric J.] OpenBiome, Medford, MA USA; [Smith, Mark B.; Alm, Eric J.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Perrotta, Allison R.; Alm, Eric J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Alm, EJ (corresponding author), MIT, Ctr Microbiome Informat & Therapeut, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ejalm@mit.edu			Center for Microbiome Informatics and Therapeutics at MIT	Center for Microbiome Informatics and Therapeutics at MIT	This project is supported in part by a grant from the Center for Microbiome Informatics and Therapeutics at MIT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Vercoe E, 2012, CAN J GASTROENTEROL, V26, P457, DOI 10.1155/2012/213828; Anderson JL, 2012, ALIMENT PHARM THER, V36, P503, DOI 10.1111/j.1365-2036.2012.05220.x; Baughn AD, 2004, NATURE, V427, P441, DOI 10.1038/nature02285; Borody TJ, 2008, GASTROENTEROLOGY, V134, pA361; Borody TJ, 2012, NAT REV GASTRO HEPAT, V9, P88, DOI 10.1038/nrgastro.2011.244; BORODY TJ, 1989, MED J AUSTRALIA, V150, P604, DOI 10.5694/j.1326-5377.1989.tb136704.x; Borody TJ, 2004, J CLIN GASTROENTEROL, V38, P475, DOI 10.1097/01.mcg.0000128988.13808.dc; Borody TJ, 2003, J CLIN GASTROENTEROL, V37, P42, DOI 10.1097/00004836-200307000-00012; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carini P., 2016, BIORXIV; Colman RJ, 2014, J CROHNS COLITIS, V8, P1569, DOI 10.1016/j.crohns.2014.08.006; Cui BT, 2015, J GASTROEN HEPATOL, V30, P51, DOI 10.1111/jgh.12727; David LA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-7-r89; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Exterkate RAM, 2015, CLIN ORAL INVEST, V19, P813, DOI 10.1007/s00784-014-1297-z; Gorzelak MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134802; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamilton MJ, 2013, GUT MICROBES, V4, P125, DOI 10.4161/gmic.23571; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kelly CR, 2015, GASTROENTEROLOGY, V149, P223, DOI 10.1053/j.gastro.2015.05.008; Khoruts A, 2015, CLIN GASTROENTEROL H, V13, P246, DOI 10.1016/j.cgh.2014.11.014; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Li SS, 2016, SCIENCE, V352, P586, DOI 10.1126/science.aad8852; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Miquel S, 2013, CURR OPIN MICROBIOL, V16, P255, DOI 10.1016/j.mib.2013.06.003; Moayyedi P, 2015, GASTROENTEROLOGY, V149, P102, DOI 10.1053/j.gastro.2015.04.001; Nocker A, 2010, INT MICROBIOL, V13, P59, DOI 10.2436/20.1501.01.111; Olesen SW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154804; Ott SJ, 2004, DIAGN MICR INFEC DIS, V50, P237, DOI 10.1016/j.diagmicrobio.2004.08.012; Preheim SP, 2013, APPL ENVIRON MICROB, V79, P6593, DOI 10.1128/AEM.00342-13; ROEDIGER WEW, 1980, GUT, V21, P793, DOI 10.1136/gut.21.9.793; Roesch Luiz F W, 2009, Open Microbiol J, V3, P40, DOI 10.2174/1874285800903010040; Satokari R, 2015, ALIMENT PHARM THER, V41, P46, DOI 10.1111/apt.13009; SHAH HN, 1982, ZBL BAKT MIK HYG I C, V3, P394; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Smits LP, 2013, GASTROENTEROLOGY, V145, P946, DOI 10.1053/j.gastro.2013.08.058; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; van Nood E, 2014, CURR OPIN GASTROEN, V30, P34, DOI 10.1097/MOG.0000000000000024; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206; Youngster I, 2014, CLIN INFECT DIS, V58, P1515, DOI 10.1093/cid/ciu135; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071108	48	54	69	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170922	10.1371/journal.pone.0170922	http://dx.doi.org/10.1371/journal.pone.0170922			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125667	Green Submitted, Green Published, gold			2022-12-26	WOS:000396176100024
J	Stadelmann, D; Torgler, B				Stadelmann, David; Torgler, Benno			Voting on Embryonic Stem Cell Research: Citizens More Supportive than Politicians	PLOS ONE			English	Article							DEBATE	As the public debate over stem cell research continues, the observable voting behaviour in Switzerland offers a unique opportunity to compare the voting behaviour of politicians with that of voters. By analysing the outcomes of a referendum on a liberal new bill regulating such research, we reveal an about 10 percentage point lower conditional probability of the bill being accepted by politicians than by voters. Whereas the behaviour of politicians is driven almost entirely by party affiliation, citizen votes are driven not only by party attachment but also by church attendance. Seldom or never attending church increases the probability of bill acceptance by over 15 percentage points, while supporting the Liberal Party and the Social Democratic Party instead of the Christian Democratic Party makes supporting the bill more likely for voters, suggesting that religious observance is important. The observance of these tendencies in Switzerland-an environment that promotes discussion through direct democratic rights-strongly suggests that citizens see the benefits of stem cell research.	[Stadelmann, David] Univ Bayreuth, Bayreuth, Germany; [Torgler, Benno] Queensland Univ Technol, Brisbane, Qld, Australia	University of Bayreuth; Queensland University of Technology (QUT)	Stadelmann, D (corresponding author), Univ Bayreuth, Bayreuth, Germany.	david.stadelmann@uni-bayreuth.de	Stadelmann, David/I-1116-2019; Torgler, Benno/W-4556-2019; Torgler, Benno/J-1140-2012	Stadelmann, David/0000-0002-1211-9936; Torgler, Benno/0000-0002-9809-963X; Torgler, Benno/0000-0002-9809-963X	Australian Research Council [FT110100463]; German Research Foundation (DFG); University of Bayreuth	Australian Research Council(Australian Research Council); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Bayreuth	The authors acknowledge financial support from the Australian Research Council (FT110100463). This publication was funded by the German Research Foundation (DFG) and the University of Bayreuth in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, NAT MED, V19, P820; [Anonymous], 2014, NATURE, V508, P287; Blow N, 2008, NATURE, V451, P855, DOI 10.1038/451855a; Borgelt EL, 2013, CELL STEM CELL, V12, P652, DOI 10.1016/j.stem.2013.05.007; Check E., 2004, NATURE NEWS BLOG; Check E., 2011, NATURE NEWS BLOG; Cyranoski D, 2015, NATURE, V520, P593, DOI 10.1038/520593a; Cyranoski D, 2014, NATURE, V516, P162, DOI 10.1038/516162a; Daley GQ, 2007, SCIENCE, V315, P603, DOI 10.1126/science.1139337; Dasgupta I, 2014, CELL STEM CELL, V14, P9, DOI 10.1016/j.stem.2013.12.006; Gutmann J, 2015, KYKLOS, V68, P153, DOI 10.1111/kykl.12078; Hayden EC, 2014, NATURE, V511, P19, DOI 10.1038/511019a; Hessami Z, 2016, KYKLOS, V69, P263, DOI 10.1111/kykl.12111; Holden C, 2008, SCIENCE, V319, P560, DOI 10.1126/science.319.5863.560; Holden C, 2007, SCIENCE, V315, P315; Hyun I, 2014, NATURE, V509, P27, DOI 10.1038/509027a; Kamenova K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010496; Levine AD, 2011, CELL STEM CELL, V8, P132, DOI 10.1016/j.stem.2011.01.002; Lovell-Badge R, 2001, NATURE, V414, P88, DOI 10.1038/35102150; Moon S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086395; Nisbet M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088473; Nisbet MC, 2003, HARV INT J PRESS-POL, V8, P36, DOI 10.1177/1081180X02251047; Stadelmann D., 2014, J EXPT POLITIC SCI, V1, P16, DOI DOI 10.1017/XPS.2014.1; Stadelmann D, 2013, J COMP ECON, V41, P170, DOI 10.1016/j.jce.2012.05.005; Torgler B, 2006, J ECON BEHAV ORGAN, V61, P81, DOI 10.1016/j.jebo.2004.10.007; Vakili K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120052; Wadman M, 2011, NATURE, V476, P14, DOI 10.1038/476014a; Williams C, 2003, SOCIOL HEALTH ILL, V25, P793, DOI 10.1046/j.1467-9566.2003.00370.x	28	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170656	10.1371/journal.pone.0170656	http://dx.doi.org/10.1371/journal.pone.0170656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7IT	28125626	Green Submitted, Green Published, gold			2022-12-26	WOS:000396176100078
J	Walker, M; Ciraolo, M; Dewald, A; Sinnett, S				Walker, Maegen; Ciraolo, Margeaux; Dewald, Andrew; Sinnett, Scott			Differential Processing for Actively Ignored Pictures and Words	PLOS ONE			English	Article							SERIAL VERBAL REACTIONS; INATTENTIONAL BLINDNESS; STIMULI; TASK; RECOGNITION; DISTRACTOR; PERCEPTION; AMNESIA	Previous work suggests that, when attended, pictures may be processed more readily than words. The current study extends this research to assess potential differences in processing between these stimulus types when they are actively ignored. In a dual-task paradigm, facilitated recognition for previously ignored words was found provided that they appeared frequently with an attended target. When adapting the same paradigm here, previously unattended pictures were recognized at high rates regardless of how they were paired with items during the primary task, whereas unattended words were later recognized at higher rates only if they had previously been aligned with primary task targets. Implicit learning effects obtained by aligning unattended items with attended task-targets may apply only to conceptually abstract stimulus types, such as words. Pictures, on the other hand, may maintain direct access to semantic information, and are therefore processed more readily than words, even when being actively ignored.	[Walker, Maegen; Ciraolo, Margeaux; Dewald, Andrew; Sinnett, Scott] Univ Hawaii Manoa, Dept Psychol, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Walker, M (corresponding author), Univ Hawaii Manoa, Dept Psychol, Honolulu, HI 96822 USA.	maegenw@hawaii.edu						Amit E, 2009, J EXP PSYCHOL GEN, V138, P400, DOI 10.1037/a0015835; Bles M, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-20; Bright P, 2004, BRAIN LANG, V89, P417, DOI 10.1016/j.bandl.2004.01.010; CARR TH, 1982, J EXP PSYCHOL HUMAN, V8, P757, DOI 10.1037/0096-1523.8.6.757; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; de Zubicaray G, 2006, NEUROIMAGE, V33, P383, DOI 10.1016/j.neuroimage.2006.06.024; Deacon D, 2000, COGNITIVE BRAIN RES, V9, P137, DOI 10.1016/S0926-6410(99)00050-6; Dewald AD, 2011, P 33 ANN C COGN SCI, P1164; Dewald AD, 2013, P 35 ANN C COGN SCI, P2183; Dewald AD, 2012, P 34 ANN C COGN SCI, P294; Dewald AD, 2013, J EXP PSYCHOL HUMAN, V39, P1304, DOI 10.1037/a0031210; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Grill-Spector K, 2005, PSYCHOL SCI, V16, P152, DOI 10.1111/j.0956-7976.2005.00796.x; HOGABOAM TW, 1978, MEM COGNITION, V6, P189, DOI 10.3758/BF03197445; Humphreys G. W., 2001, BEHAV BRAIN SCI, V24, P476; Rees G, 1999, SCIENCE, V286, P2504, DOI 10.1126/science.286.5449.2504; Ruz M, 2005, NEUROIMAGE, V27, P852, DOI 10.1016/j.neuroimage.2005.05.031; Ruz M, 2005, J COGNITIVE NEUROSCI, V17, P768, DOI 10.1162/0898929053747685; Seitz A, 2005, TRENDS COGN SCI, V9, P329, DOI 10.1016/j.tics.2005.05.010; Seitz AR, 2009, NEURON, V61, P700, DOI 10.1016/j.neuron.2009.01.016; Seitz AR, 2003, NATURE, V422, P36, DOI 10.1038/422036a; Sinnett S, 2006, Q J EXP PSYCHOL, V59, P1425, DOI 10.1080/17470210500298948; SMITH MC, 1980, J EXP PSYCHOL GEN, V109, P373, DOI 10.1037/0096-3445.109.4.373; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Stroop JR, 1938, PSYCHOL MONOGR, V50, P38, DOI 10.1037/h0093516; STROOP JR, 1992, J EXP PSYCHOL GEN, V121, P15; Swallow KM, 2011, ATTEN PERCEPT PSYCHO, V73, P389, DOI 10.3758/s13414-010-0045-y; Swallow KM, 2010, COGNITION, V115, P118, DOI 10.1016/j.cognition.2009.12.003; TIPPER SP, 1988, MEM COGNITION, V16, P64, DOI 10.3758/BF03197746; TIPPER SP, 1985, Q J EXP PSYCHOL-A, V37, P571, DOI 10.1080/14640748508400920; Tsushima Y, 2008, CURR BIOL, V18, pR516, DOI 10.1016/j.cub.2008.04.029; Tsushima Y, 2006, SCIENCE, V314, P1786, DOI 10.1126/science.1133197; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; Walker M., 2014, P 36 ANN C COGN SCI, P1736; Watanabe T, 2001, NATURE, V413, P844, DOI 10.1038/35101601; WILSON M, 1988, BEHAV RES METH INSTR, V20, P6, DOI 10.3758/BF03202594	36	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e170520	10.1371/journal.pone.0170520	http://dx.doi.org/10.1371/journal.pone.0170520			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7FK	28122022	Green Published, Green Submitted, gold			2022-12-26	WOS:000396167300040
J	Gandolfi, A; Crestanello, B; Fagotti, A; Simoncelli, F; Chiesa, S; Girardi, M; Giovagnoli, E; Marangoni, C; Di Rosa, I; Lucentini, L				Gandolfi, Andrea; Crestanello, Barbara; Fagotti, Anna; Simoncelli, Francesca; Chiesa, Stefania; Girardi, Matteo; Giovagnoli, Eleonora; Marangoni, Carla; Di Rosa, Ines; Lucentini, Livia			New Evidences of Mitochondrial DNA Heteroplasmy by Putative Paternal Leakage between the Rock Partridge (Alectoris graeca) and the Chukar Partridge (Alectoris chukar)	PLOS ONE			English	Article							NATURAL-POPULATIONS; GALLIFORMES POPULATIONS; GENETIC-STRUCTURE; MTDNA; RUFA; HYBRIDIZATION; INHERITANCE; RECOMBINATION; MARKERS; BIRDS	The rock partridge, Alectoris graeca, is a polytypic species declining in Italy mostly due to anthropogenic causes, including the massive releases of the closely related allochthonous chukar partridge Alectoris chukar which produced the formation of hybrids. Molecular approaches are fundamental for the identification of evolutionary units in the perspective of conservation and management, and to correctly select individuals to be used in restocking campaigns. We analyzed a Cytochrome oxidase I (COI) fragment of contemporary and historical A. graeca and A. chukar samples, using duplicated analyses to confirm results and nuclear DNA microsatellites to exclude possible sample cross-contamination. In two contemporary specimens of A. graeca, collected from an anthropogenic hybrid zone, we found evidence of the presence of mtDNA heteroplasmy possibly associated to paternal leakage and suggesting hybridization with captive-bred exotic A. chukar. These results underline significant limitations in the reliability of mtDNA barcoding-based species identification and could have relevant evolutionary and ecological implications that should be accounted for when interpreting data aimed to support conservation actions.	[Gandolfi, Andrea; Crestanello, Barbara; Girardi, Matteo] FEM, Res & Innovat Ctr, Dept Biodivers & Mol Ecol, San Michele All Adige, Italy; [Fagotti, Anna; Simoncelli, Francesca; Giovagnoli, Eleonora; Di Rosa, Ines; Lucentini, Livia] Univ Perugia, Dept Chem Biol & Biotechnol, Perugia, Italy; [Chiesa, Stefania] Univ Aveiro, Dept Biol, Aveiro, Portugal; [Chiesa, Stefania] Univ Aveiro, CESAM, Aveiro, Portugal; [Marangoni, Carla] Civ Museum Zool, Rome, Italy	Fondazione Edmund Mach; University of Perugia; Universidade de Aveiro; Universidade de Aveiro	Lucentini, L (corresponding author), Univ Perugia, Dept Chem Biol & Biotechnol, Perugia, Italy.	livia.lucentini@unipg.it	Gandolfi, Andrea/A-3428-2012; lucentini, livia/AAW-7479-2020	Gandolfi, Andrea/0000-0002-7961-1431; lucentini, livia/0000-0001-5051-610X; Girardi, Matteo/0000-0002-1176-0764; Crestanello, Barbara/0000-0003-1610-8692				Amaral AJ, 2007, FOLIA ZOOL, V56, P285; Barbanera F, 2005, BIOL CONSERV, V122, P275, DOI 10.1016/j.biocon.2004.07.017; Barbanera F, 2010, BIOL CONSERV, V143, P1259, DOI 10.1016/j.biocon.2010.02.035; Barilani M, 2007, BIOL CONSERV, V137, P57, DOI 10.1016/j.biocon.2007.01.014; Barilani M, 2007, CONSERV GENET, V8, P343, DOI 10.1007/s10592-006-9174-1; Barr CM, 2005, NEW PHYTOL, V168, P39, DOI 10.1111/j.1469-8137.2005.01492.x; BirdLife International, 2015, IUCN RED LIST THREAT; Cramp S., 1985, HDB BIRDS EUROPE MID, VII; Gemmell NJ, 2004, TRENDS ECOL EVOL, V19, P238, DOI 10.1016/j.tree.2004.02.002; Gonzalez EG, 2005, MOL ECOL NOTES, V5, P449, DOI 10.1111/j.1471-8286.2005.00960.x; Guerrini M., 2007, Animal Biodiversity and Conservation, V30, P105; Kerr KCR, 2007, MOL ECOL NOTES, V7, P535, DOI 10.1111/j.1471-8286.2006.01670.x; Kvist L, 2003, MOL BIOL EVOL, V20, P243, DOI 10.1093/molbev/msg025; Lever C., 2005, NATURALISED BIRDS WO; Lucentini L, 2010, CONSERV GENET RESOUR, V2, P381, DOI 10.1007/s12686-010-9264-8; Lucentini L, 2014, BIOCHEM SYST ECOL, V56, P281, DOI 10.1016/j.bse.2014.07.005; McCauley DE, 2008, EVOLUTION, V62, P1013, DOI 10.1111/j.1558-5646.2008.00363.x; Negri A, 2013, EUR J WILDLIFE RES, V59, P407, DOI 10.1007/s10344-012-0686-3; Nunes MDS, 2013, MOL ECOL, V22, P2106, DOI 10.1111/mec.12256; Pearl SA, 2009, MOL BIOL EVOL, V26, P537, DOI 10.1093/molbev/msn273; Pereira SL, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-17; Randi E., 2006, ACTA ZOOL SINICA, V52, P370; Robison GA, 2015, J MED ENTOMOL, V52, P734, DOI 10.1093/jme/tjv055; Rokas A, 2003, TRENDS ECOL EVOL, V18, P411, DOI 10.1016/S0169-5347(03)00125-3; Rondinini C., 2013, LISTA ROSSA IUCN VER; Sorenson MD, 1998, AUK, V115, P214, DOI 10.2307/4089130; Sun J, 2012, INFORM TECHNOLOGY AG; Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466; Tsaousis AD, 2005, MOL BIOL EVOL, V22, P925, DOI 10.1093/molbev/msi084; White DJ, 2008, MOL ECOL, V17, P4925, DOI 10.1111/j.1365-294X.2008.03982.x; Wolff JN, 2013, HEREDITY, V110, P57, DOI 10.1038/hdy.2012.60; Xiang H, 2014, P NATL ACAD SCI USA, V111, P17564, DOI 10.1073/pnas.1411882111	32	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170507	10.1371/journal.pone.0170507	http://dx.doi.org/10.1371/journal.pone.0170507			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114306	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129000059
J	Morello, N; Plicato, O; Piludu, MA; Poddighe, L; Serra, MP; Quartu, M; Corda, MG; Giorgi, O; Giustetto, M				Morello, Noemi; Plicato, Ornella; Piludu, Maria Antonietta; Poddighe, Laura; Serra, Maria Pina; Quartu, Marina; Corda, Maria Giuseppa; Giorgi, Osvaldo; Giustetto, Maurizio			Effects of Forced Swimming Stress on ERK and Histone H3 Phosphorylation in Limbic Areas of Roman High- and Low-Avoidance Rats	PLOS ONE			English	Article							REGULATED KINASE PHOSPHORYLATION; GYRUS GRANULE NEURONS; DENTATE GYRUS; NUCLEUS-ACCUMBENS; EPIGENETIC MECHANISMS; PREFRONTAL CORTEX; DOPAMINE RELEASE; ACTIVATION; RESPONSES; LINES	Stressful events evoke molecular adaptations of neural circuits through chromatin remodeling and regulation of gene expression. However, the identity of the molecular pathways activated by stress in experimental models of depression is not fully understood. We investigated the effect of acute forced swimming (FS) on the phosphorylation of the extracellular signal-regulated kinase (ERK) 1/2 (pERK) and histone H3 (pH3) in limbic brain areas of genetic models of vulnerability (RLA, Roman low-avoidance rats) and resistance (RHA, Roman high-avoidance rats) to stress-induced depression-like behavior. We demonstrate that FS markedly increased the density of pERK-positive neurons in the infralimbic (ILCx) and the prelimbic area (PrLCx) of the prefrontal cortex (PFCx), the nucleus accumbens, and the dorsal blade of the hippocampal dentate gyrus to the same extent in RLA and RHA rats. In addition, FS induced a significant increase in the intensity of pERK immunoreactivity (IR) in neurons of the PFCx in both rat lines. However, RHA rats showed stronger pERK-IR than RLA rats in the ILCx both under basal and stressed conditions. Moreover, the density of pH3-positive neurons was equally increased by FS in the PFCx of both rat lines. Interestingly, pH3-IR was higher in RHA than RLA rats in PrLCx and ILCx, either under basal conditions or upon FS. Finally, colocalization analysis showed that in the PFCx of both rat lines, almost all pERK-positive cells express pH3, whereas only 50% of the pH3-positive neurons is also pERK-positive. Moreover, FS increased the percentage of neurons that express exclusively pH3, but reduced the percentage of cells expressing exclusively pERK. These results suggest that (i) the distinctive patterns of FS-induced ERK and H3 phosphorylation in the PFCx of RHA and RLA rats may represent molecular signatures of the behavioural traits that distinguish the two lines and (ii) FS-induced H3 phosphorylation is, at least in part, ERK-independent.	[Morello, Noemi; Plicato, Ornella; Giustetto, Maurizio] Univ Turin, Dept Neurosci, Turin, Italy; [Piludu, Maria Antonietta; Corda, Maria Giuseppa; Giorgi, Osvaldo] Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy; [Poddighe, Laura; Serra, Maria Pina; Quartu, Marina] Univ Cagliari, Dept Biomed Sci, Monserrato, CA, Italy; [Giustetto, Maurizio] Natl Inst Neurosci Italy, Turin, Italy	University of Turin; University of Cagliari; University of Cagliari	Giustetto, M (corresponding author), Univ Turin, Dept Neurosci, Turin, Italy.; Giorgi, O (corresponding author), Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy.; Giustetto, M (corresponding author), Natl Inst Neurosci Italy, Turin, Italy.	giorgi@unica.it; maurizio.giustetto@unito.it	giustetto, maurizio/D-6606-2011; Giorgi, Osvaldo/L-2871-2017; Serra, Maria Pina/AAG-3721-2021; Giorgi, Osvaldo/AAG-6331-2021; QUARTU, MARINA/F-9652-2012	giustetto, maurizio/0000-0003-1323-4060; Giorgi, Osvaldo/0000-0003-4610-8183; Serra, Maria Pina/0000-0002-3343-7861; Giorgi, Osvaldo/0000-0003-4610-8183; QUARTU, MARINA/0000-0002-1884-3597	ARS (Autonomous Region of Sardinia) [L. R. 7/2007, CRP-59842]; Compagnia di San Paolo, Progetto d'Ateneo, Universita degli Studi di Torino [811M33N]; ARS [CRP-59842]; AIRETT; Albero di Greta; Rettsyndrome.org; IFCR; Telethon Foundation	ARS (Autonomous Region of Sardinia)(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Compagnia di San Paolo, Progetto d'Ateneo, Universita degli Studi di Torino(Compagnia di San Paolo); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); AIRETT; Albero di Greta; Rettsyndrome.org; IFCR; Telethon Foundation(Fondazione Telethon)	This work was supported by a grant to OG from ARS (Autonomous Region of Sardinia, L. R. 7/2007, Project Code No. CRP-59842) and to MG from the Compagnia di San Paolo, Progetto d'Ateneo, Universita degli Studi di Torino 2011 No. 811M33N. NM and MAP were recipients of fellowships from ARS (Project Code No. CRP-59842). MG would also like to acknowledge the generous support from AIRETT, Albero di Greta, Rettsyndrome.org, IFCR and Telethon Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Alessando Ciccarelli for helpful discussion while preparing this MS and Dr. Marianna Boi for her skillful technical assistance. This work was partially supported by a grant to O.G. from ARS (Autonomous Region of Sardinia, L.R. 7/2007, Project Code No. CRP-59842) and to M.G. from the Compagnia di San Paolo, Progetto d'Ateneo, Universita degli Studi di Torino 2011 No. 811M33N. NM and MAP were recipients of fellowships from ARS (Project Code No. CRP-59842). MG would like to acknowledge the generous support from AIRETT, Albero di Greta, Rettsyndrome.org, IFCR and Telethon Foundation.	ABERCROMBIE ED, 1989, J NEUROCHEM, V52, P1655, DOI 10.1111/j.1471-4159.1989.tb09224.x; Acquas E, 2007, J NEUROCHEM, V102, P121, DOI 10.1111/j.1471-4159.2007.04451.x; Bilang-Bleuel A, 2005, EUR J NEUROSCI, V22, P1691, DOI 10.1111/j.1460-9568.2005.04358.x; BROADHURST PL, 1965, BEHAV RES THER, V2, P273; Chandramohan Y, 2008, EUR J NEUROSCI, V27, P2701, DOI 10.1111/j.1460-9568.2008.06230.x; Chawla MK, 2005, HIPPOCAMPUS, V15, P579, DOI 10.1002/hipo.20091; Ciccarelli A, 2014, NEUROPHARMACOLOGY, V80, P34, DOI 10.1016/j.neuropharm.2014.01.039; Ciccarelli A, 2013, NEUROPHARMACOLOGY, V70, P168, DOI 10.1016/j.neuropharm.2012.12.010; Coppens CM, 2013, BEHAV GENET, V43, P220, DOI 10.1007/s10519-013-9588-8; Davis S, 2006, GENES BRAIN BEHAV, V5, P61, DOI 10.1111/j.1601-183X.2006.00230.x; Diaz-Moran S, 2012, BEHAV BRAIN RES, V228, P203, DOI 10.1016/j.bbr.2011.12.002; Driscoll  P., 1982, GENETICS BRAIN; Fa MX, 2014, NEUROBIOL LEARN MEM, V112, P53, DOI 10.1016/j.nlm.2014.04.008; Ferland CL, 2014, ENDOCRINOLOGY, V155, P2942, DOI 10.1210/en.2013-1918; Fernandez-Teruel A, 2002, GENOME RES, V12, P618, DOI [10.1101/gr.203402, 10.1101/gr.203402. Article published online before print in March ]; Gallitano AL, 2016, SYNAPSE, V70, P277, DOI 10.1002/syn.21900; Giorgi O, 2003, EUR J NEUROSCI, V17, P2716, DOI 10.1046/j.1460-9568.2003.02689.x; Giorgi O, 2007, NEUROSCI BIOBEHAV R, V31, P148, DOI 10.1016/j.neubiorev.2006.07.008; Giorgi O, 2015, J NEUROSCI RES, V93, P714, DOI 10.1002/jnr.23526; Goto Y, 2008, TRENDS NEUROSCI, V31, P552, DOI 10.1016/j.tins.2008.08.002; Gutierrez-Mecinas M, 2011, P NATL ACAD SCI USA, V108, P13806, DOI 10.1073/pnas.1104383108; Mifsud KR, 2011, BRAIN BEHAV IMMUN, V25, P1305, DOI 10.1016/j.bbi.2011.06.005; Piras G., 2006, SOC NEUR M; Piras G, 2014, PSYCHOPHARMACOLOGY, V231, P43, DOI 10.1007/s00213-013-3205-7; Piras G, 2010, PSYCHOPHARMACOLOGY, V211, P403, DOI 10.1007/s00213-010-1904-x; Pognetto M, 2007, PLOS ONE, V2, pe604, DOI [10.1371/journal.pone.0000604, DOI 10.1371/JOURNAL.PONE.0000604]; Radley JJ, 2006, J NEUROSCI, V26, P12967, DOI 10.1523/JNEUROSCI.4297-06.2006; Reul JMHM, 2007, PSYCHONEUROENDOCRINO, V32, pS21, DOI 10.1016/j.psyneuen.2007.03.016; Saunderson EA, 2016, P NATL ACAD SCI USA, V113, P4830, DOI 10.1073/pnas.1524857113; SERESS L, 1981, J ANAT, V133, P181; Shen CP, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-36; Stankiewicz AM, 2013, BRAIN RES BULL, V98, P76, DOI 10.1016/j.brainresbull.2013.07.003; Steimer T, 2005, NEUROSCI BIOBEHAV R, V29, P99, DOI 10.1016/j.neubiorev.2004.07.002; Steimer T, 2003, STRESS, V6, P87, DOI 10.1080/1025389031000111320; Vaijent E, 2004, EUR J NEUROSCI, V19, P1826, DOI [10.1111/j.1460-9568.2004.03278.x, DOI 10.1111/J.1460-9568.2004.03278.X]; Vara H, 2009, P NATL ACAD SCI USA, V106, P9872, DOI 10.1073/pnas.0900077106; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279	37	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170093	10.1371/journal.pone.0170093	http://dx.doi.org/10.1371/journal.pone.0170093			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107383	Green Published, Green Submitted, gold			2022-12-26	WOS:000392405300072
J	Hasanov, E; Chen, G; Chowdhury, P; Weldon, J; Ding, Z; Jonasch, E; Sen, S; Walker, CL; Dere, R				Hasanov, E.; Chen, G.; Chowdhury, P.; Weldon, J.; Ding, Z.; Jonasch, E.; Sen, S.; Walker, C. L.; Dere, R.			Ubiquitination and regulation of AURKA identifies a hypoxia-independent E3 ligase activity of VHL	ONCOGENE			English	Article							VON-HIPPEL-LINDAU; TUMOR-SUPPRESSOR PROTEIN; RENAL-CELL CARCINOMA; RNA-POLYMERASE-II; SKELETAL-MUSCLE PROGENITORS; AURORA-A KINASE; PROLINE HYDROXYLATION; PROLYL HYDROXYLATION; CANCER GENOMICS; PRIMARY CILIUM	The hypoxia-regulated tumor-suppressor von Hippel-Lindau (VHL) is an E3 ligase that recognizes its substrates as part of an oxygen-dependent prolyl hydroxylase (PHD) reaction, with hypoxia-inducible factor a (HIF alpha) being its most notable substrate. Here we report that VHL has an equally important function distinct from its hypoxia-regulated activity. We find that Aurora kinase A (AURKA) is a novel, hypoxia-independent target for VHL ubiquitination. In contrast to its hypoxia-regulated activity, VHL mono-, rather than poly-ubiquitinates AURKA, in a PHD-independent reaction targeting AURKA for degradation in quiescent cells, where degradation of AURKA is required to maintain the primary cilium. Tumor-associated variants of VHL differentiate between these two functions, as a pathogenic VHL mutant that retains intrinsic ability to ubiquitinate HIFa is unable to ubiquitinate AURKA. Together, these data identify VHL as an E3 ligase with important cellular functions under both normoxic and hypoxic conditions.	[Hasanov, E.; Chen, G.; Chowdhury, P.; Weldon, J.; Walker, C. L.; Dere, R.] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Translat Canc Res, Houston, TX USA; [Hasanov, E.] Hacettepe Univ, Dept Basic Oncol, Canc Inst, Ankara, Turkey; [Chowdhury, P.; Walker, C. L.; Dere, R.] Baylor Coll Med, Ctr Precis Environm Hlth, One Baylor Plaza,BCM130, Houston, TX 77030 USA; [Ding, Z.] UT MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX USA; [Jonasch, E.] UT MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX USA; [Sen, S.] UT MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Hacettepe University; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Dere, R (corresponding author), Baylor Coll Med, Ctr Precis Environm Hlth, One Baylor Plaza,BCM130, Houston, TX 77030 USA.	ruhee.dere@bcm.edu	Hasanov, Elshad/AAO-8340-2021	Hasanov, Elshad/0000-0002-7195-0842	Robert A Welch Endowed Chair in Chemistry [BE-0023]; NATIONAL CANCER INSTITUTE [R01CA143811] Funding Source: NIH RePORTER	Robert A Welch Endowed Chair in Chemistry; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to thank T Berry and S Bai for technical assistance. This work was supported by a Robert A Welch Endowed Chair in Chemistry (BE-0023) to CLW.	Anderson K, 2011, J BIOL CHEM, V286, P42027, DOI 10.1074/jbc.M111.303222; Basten Sander G, 2013, Cilia, V2, P6, DOI 10.1186/2046-2530-2-6; Basten Sander G, 2013, Cilia, V2, P2, DOI 10.1186/2046-2530-2-2; Boutet SC, 2007, CELL, V130, P349, DOI 10.1016/j.cell.2007.05.044; Boutet SC, 2010, MOL CELL, V40, P749, DOI 10.1016/j.molcel.2010.09.029; Carvallo L, 2010, J BIOL CHEM, V285, P29546, DOI 10.1074/jbc.M110.155812; Castro A, 2002, EMBO REP, V3, P457, DOI 10.1093/embo-reports/kvf095; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Clifford SC, 2001, HUM MOL GENET, V10, P1029, DOI 10.1093/hmg/10.10.1029; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Coon TA, 2012, CELL CYCLE, V11, P721, DOI 10.4161/cc.11.4.19171; Dere R, 2015, J AM SOC NEPHROL, V26, P553, DOI 10.1681/ASN.2013090984; Ding ZY, 2014, CANCER RES, V74, P3127, DOI 10.1158/0008-5472.CAN-13-3213; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Ferchichi I, 2012, DIS MARKERS, V33, P333, DOI [10.1155/2012/804708, 10.3233/DMA-2012-00942]; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hamano K, 2002, J UROLOGY, V167, P713, DOI 10.1016/S0022-5347(01)69132-8; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Izawa Ichiro, 2015, Cilia, V4, P12, DOI 10.1186/s13630-015-0021-1; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kasap E, 2016, TUMOR BIOL, V37, P3071, DOI 10.1007/s13277-015-4131-6; Kuehn EW, 2007, CANCER RES, V67, P4537, DOI 10.1158/0008-5472.CAN-07-0391; Kuznetsova AV, 2003, P NATL ACAD SCI USA, V100, P2706, DOI 10.1073/pnas.0436037100; Lai YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016975; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Lim SK, 2007, BIOCHEM J, V403, P119, DOI 10.1042/BJ20061272; Lolkema MP, 2008, EUR J HUM GENET, V16, P73, DOI 10.1038/sj.ejhg.5201930; Lolkema MP, 2007, FEBS LETT, V581, P4571, DOI 10.1016/j.febslet.2007.08.050; Martin B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067071; Mikhaylova O, 2008, MOL CELL BIOL, V28, P2701, DOI 10.1128/MCB.01231-07; Na X, 2003, EMBO J, V22, P4249, DOI 10.1093/emboj/cdg410; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Okuda H, 2001, J BIOL CHEM, V276, P43611, DOI 10.1074/jbc.M107880200; Perera AD, 2000, CLIN CANCER RES, V6, P1518; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Randall JM, 2014, CANCER METAST REV, V33, P1109, DOI 10.1007/s10555-014-9533-1; Romain CV, 2014, ANTICANCER RES, V34, P2269; Sadowski M, 2012, IUBMB LIFE, V64, P136, DOI 10.1002/iub.589; Schodel J, 2016, EUR UROL, V69, P646, DOI 10.1016/j.eururo.2015.08.007; Schoenfeld A, 1998, P NATL ACAD SCI USA, V95, P8817, DOI 10.1073/pnas.95.15.8817; Seeger-Nukpezah Tamina, 2013, Drug Discov Today Dis Mech, V10, pe135; Shabek N, 2012, MOL CELL, V48, P87, DOI 10.1016/j.molcel.2012.07.011; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Thoma CR, 2007, NAT CELL BIOL, V9, P588, DOI 10.1038/ncb1579; Thoma CR, 2009, NAT CELL BIOL, V11, P994, DOI 10.1038/ncb1912; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Xie L, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000444; Xue J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035848; Zhou L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023936	53	28	28	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 15	2017	36	24					3450	3463		10.1038/onc.2016.495	http://dx.doi.org/10.1038/onc.2016.495			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EX6GL	28114281	hybrid, Green Published			2022-12-26	WOS:000403340700009
J	Yang, N; Wang, C; Wang, Z; Zona, S; Lin, SX; Wang, X; Yan, M; Zheng, FM; Li, SS; Xu, B; Bella, L; Yong, JS; Lam, EWF; Liu, Q				Yang, N.; Wang, C.; Wang, Z.; Zona, S.; Lin, S-X; Wang, X.; Yan, M.; Zheng, F-M; Li, S-S; Xu, B.; Bella, L.; Yong, J-S; Lam, E. W-F; Liu, Q.			FOXM1 recruits nuclear Aurora kinase A to participate in a positive feedback loop essential for the self-renewal of breast cancer stem cells	ONCOGENE			English	Article							TRANSCRIPTION FACTOR; SELECTIVE AURORA; EXPRESSION; INHIBITOR; FOXO3A; CARCINOMA; PROTEINS; MLN8237	Substantial evidence suggests that breast cancer initiation, recurrence and drug resistance is supported by breast cancer stem cells (BCSCs). Recently, we reported a novel role of Aurora kinase A (AURKA) in BCSCs, as a transactivating co-factor in the induction of the c-Myc oncoprotein. However, the mode of action and transcriptional network of nuclear AURKA in BCSCs remain unknown. Here, we report that nuclear AURKA can be recruited by Forkhead box subclass M1 (FOXM1) as a co-factor to transactivate FOXM1 target genes in a kinase-independent manner. In addition, we show that AURKA and FOXM1 participate in a tightly coupled positive feedback loop to enhance BCSC phenotype. Indeed, kinase-dead AURKA can effectively transactivate the FOXM1 promoter through a Forkhead response element, whereas FOXM1 can activate AURKA expression at the transcriptional level in a similar manner. Consistently, breast cancer patient samples portrayed a strong and significant correlation between the expression levels of FOXM1 and AURKA. Moreover, both FOXM1 and AURKA were essential for maintaining the BCSC population. Finally, we demonstrated that the AURKA inhibitor AKI603 and FOXM1 inhibitor thiostrepton acted synergistically to inhibit cytoplasmic AURKA activity and disrupt the nuclear AURKA/FOXM1-positive feedback loop, respectively, resulting in a more effective inhibition of the tumorigenicity and self-renewal ability of BCSCs. Collectively, our study uncovers a previously unknown tightly coupled positive feedback signalling loop between AURKA and FOXM1, crucial for BCSC self-renewal. Remarkably, our data reveal a novel potential therapeutic strategy for targeting both the cytoplasmic and nuclear AURKA function to effectively eliminate BCSCs, so as to overcome both breast cancer and drug resistance.	[Yang, N.; Wang, C.; Wang, Z.; Lin, S-X; Wang, X.; Yan, M.; Li, S-S; Liu, Q.] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Canc Ctr, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Yang, N.; Wang, C.; Wang, Z.; Lin, S-X; Wang, X.; Yan, M.; Li, S-S; Liu, Q.] Dalian Med Univ, Inst Canc Stem Cell, Dalian, Peoples R China; [Yang, N.; Xu, B.] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Lab Med, Guangzhou, Guangdong, Peoples R China; [Zona, S.; Bella, L.; Yong, J-S; Lam, E. W-F] Imperial Coll London, Hammersmith Hosp, Dept Surg & Canc, London, England; [Zheng, F-M] Sun Yat Sen Univ, Eastern Hosp, Affiliated Hosp 1, Dept Med Oncol, Guangzhou, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Dalian Medical University; Guangzhou Medical University; Imperial College London; Sun Yat Sen University	Liu, Q (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Univ Canc Ctr, 651 Dongfeng Rd East, Guangzhou, Guangdong, Peoples R China.; Lam, EWF (corresponding author), Imperial Coll London, Dept Surg & Canc, Hammersmith Hosp Campus,Du Cane Rd, London W12 0NN, England.; Liu, Q (corresponding author), Dalian Med Univ, Inst Canc Stem Cell, Dalian, Peoples R China.	eric.lam@imperial.ac.uk; liuq9@mail.sysu.edu.cn	Lam, Eric W-F/AAW-8566-2020	Lam, Eric W-F/0000-0003-1274-3576	National Basic Research Program of China (973 Program) [2012CB967000]; National Natural Science Foundation of China [81630005, 81130040, 81573025, 81301734, 81602434]; Program for Innovative Research Team in University [IRT13049]; Liaoning [NSF2014029102]; Natural Science Foundation of Guangdong [2016A030311038]; Cancer Now [2012MayPR070, 2012NovPhD016]; CRUK [A12011]; Breast Cancer Now [2012MayPR070, 2012NovPhD016]; Imperial College London; MRC [MR/N012097/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/03785] Funding Source: researchfish; Cancer Research UK [12011] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1234732] Funding Source: researchfish; Medical Research Council [MR/N012097/1] Funding Source: researchfish	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Innovative Research Team in University; Liaoning; Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); Cancer Now; CRUK(Cancer Research UK); Breast Cancer Now; Imperial College London(General Electric); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Quentin Liu's lab members for their critical commends and technical support. This work is supported by the National Basic Research Program of China (973 Program; no. 2012CB967000 to Q Liu), National Natural Science Foundation of China (no. 81630005, 81130040 and 81573025 to Q Liu; no. 81301734 to Z Wang; no. 81602434 to N Yang), Program for Innovative Research Team in University (IRT13049 to Q Liu), Liaoning (NSF2014029102 to Q Liu) and Natural Science Foundation of Guangdong (2016A030311038 to Q.L.). Eric W-F Lam's work is supported by Cancer Now (2012MayPR070 and 2012NovPhD016) and CRUK (A12011) and Breast. Stefania Zona and Laura Bella are supported by Breast Cancer Now (2012MayPR070 and 2012NovPhD016, respectively). Jay-Sze Yong is supported by an Imperial College London studentship.	Bella L, 2014, SEMIN CANCER BIOL, V29, P32, DOI 10.1016/j.semcancer.2014.07.008; Bijnsdorp IV, 2011, METHODS MOL BIOL, V731, P421, DOI 10.1007/978-1-61779-080-5_34; Burum-Auensen E, 2007, J HISTOCHEM CYTOCHEM, V55, P477, DOI 10.1369/jhc.6A7077.2007; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Cervantes A, 2012, CLIN CANCER RES, V18, P4764, DOI 10.1158/1078-0432.CCR-12-0571; Chen X, 2013, MOL CELL BIOL, V33, P227, DOI 10.1128/MCB.00881-12; Cheng C, 2012, MOL PHARMACEUT, V9, P1971, DOI 10.1021/mp2006714; Cheung CH, 2014, EXPERT OPIN THER PAT, V24, P1021; CHOU TC, 1994, JNCI-J NATL CANCER I, V86, P1517, DOI 10.1093/jnci/86.20.1517; Consolaro F, 2015, INT J ONCOL, V47, P1230, DOI 10.3892/ijo.2015.3139; Costa RH, 2005, NAT CELL BIOL, V7, P108, DOI 10.1038/ncb0205-108; de Moraes GN, 2015, CELL SIGNAL, V27, P2496, DOI 10.1016/j.cellsig.2015.09.013; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Friedberg JW, 2014, J CLIN ONCOL, V32, P44, DOI 10.1200/JCO.2012.46.8793; Gomes AR, 2013, CHIN J CANCER, V32, P365, DOI 10.5732/cjc.012.10277; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hay AE, 2015, LEUKEMIA LYMPHOMA, V2015, P1; Huang XF, 2008, BLOOD, V111, P2854, DOI 10.1182/blood-2007-07-099325; Karadedou CT, 2012, ONCOGENE, V31, P1845, DOI 10.1038/onc.2011.368; Katayama Hiroshi, 2003, Cancer and Metastasis Reviews, V22, P451, DOI 10.1023/A:1023789416385; Khongkow P, 2016, ONCOGENE, V35, P990, DOI 10.1038/onc.2015.152; Khongkow P, 2014, ONCOGENE, V33, P4144, DOI 10.1038/onc.2013.457; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kollareddy M, 2012, INVEST NEW DRUG, V30, P2411, DOI 10.1007/s10637-012-9798-6; Koo CY, 2012, BBA-GENE REGUL MECH, V1819, P28, DOI 10.1016/j.bbagrm.2011.09.004; Kristeleit R, 2009, J CLIN ONCOL, P27; Kwok JMM, 2008, MOL CANCER THER, V7, P2022, DOI 10.1158/1535-7163.MCT-08-0188; Liu Q, 2006, P NATL ACAD SCI USA, V103, P5811, DOI 10.1073/pnas.0601425103; McGovern UB, 2009, MOL CANCER THER, V8, P582, DOI 10.1158/1535-7163.MCT-08-0805; Millour J, 2011, MOL CANCER THER, V10, P1046, DOI 10.1158/1535-7163.MCT-11-0024; Miyoshi Y, 2001, INT J CANCER, V92, P370, DOI 10.1002/ijc.1200; Monteiro LJ, 2013, ONCOGENE, V32, P4634, DOI 10.1038/onc.2012.491; Mosse YP, 2012, CLIN CANCER RES, V18, P6058, DOI 10.1158/1078-0432.CCR-11-3251; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; da Silva VCP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0103480, 10.1371/journal.pone.0093049, 10.1371/journal.pone.0105072, 10.1371/journal.pone.0087588, 10.1371/journal.pone.0103267, 10.1371/journal.pone.0091910, 10.1371/journal.pone.0107196, 10.1371/journal.pone.0110033, 10.1371/journal.pone.0096514, 10.1371/journal.pone.0087348, 10.1371/journal.pone.0103535, 10.1371/journal.pone.0095536, 10.1371/journal.pone.0099366, 10.1371/journal.pone.0113637, 10.1371/journal.pone.0095422]; Piazzolla D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5226; Qu Hongzhu, 2013, Genomics Proteomics Bioinformatics, V11, P135, DOI 10.1016/j.gpb.2013.05.001; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Tamotsu K, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1329-3; Tanaka E, 2005, CLIN CANCER RES, V11, P1827, DOI 10.1158/1078-0432.CCR-04-1627; Tanaka T, 1999, CANCER RES, V59, P2041; Velasco-Velazquez MA, 2012, INT J BIOCHEM CELL B, V44, P573, DOI 10.1016/j.biocel.2011.12.020; Wan XB, 2008, CARCINOGENESIS, V29, P1930, DOI 10.1093/carcin/bgn176; Zheng FM, 2014, MOL CANCER THER, V13, P1991, DOI 10.1158/1535-7163.MCT-13-1029; Zheng FM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10180; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	48	59	59	2	13	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 15	2017	36	24					3428	3440		10.1038/onc.2016.490	http://dx.doi.org/10.1038/onc.2016.490			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EX6GL	28114286	Green Published, hybrid			2022-12-26	WOS:000403340700007
J	Appelman, MD; Chakraborty, A; Protzer, U; McKeating, JA; van de Graaf, SFJ				Appelman, Monique D.; Chakraborty, Anindita; Protzer, Ulrike; McKeating, Jane A.; van de Graaf, Stan F. J.			N-Glycosylation of the Na plus - Taurocholate Cotransporting Polypeptide (NTCP) Determines Its Trafficking and Stability and Is Required for Hepatitis B Virus Infection	PLOS ONE			English	Article							CO-TRANSPORTING POLYPEPTIDE; BILE-ACID COTRANSPORTER; INHIBITOR MYRCLUDEX-B; PROTEASOMAL DEGRADATION; PROTEIN GLYCOSYLATION; LINKED GLYCOSYLATION; ENTRY; MEMBRANE; HEPATOCYTES; BINDING	The sodium/bile acid cotransporter NTCP was recently identified as a receptor for hepatitis B virus (HBV). NTCP is glycosylated and the role of glycans in protein trafficking or viral receptor activity is not known. NTCP contains two N-linked glycosylation sites and asparagine amino acid residues N5 and N11 were mutated to a glutamine to generate NTCP with a single glycan (NTCP- N5Q or NTCP- N11Q) or no glycans (NTCP- N5,11Q). HepG2 cells expressing NTCP with a single glycan supported HBV infection at a comparable level to NTCP-WT. The physiological function of NTCP, the uptake of bile acids, was also not affected in cells expressing these single glycosylation variants, consistent with their trafficking to the plasma membrane. However, glycosylation-deficient NTCP (NTCP- N5,11Q) failed to support HBV infection, showed minimal cellular expression and was degraded in the lysosome. This affected the physiological bile acid transporter function of NTCP- N5,11Q in a similar fashion. In conclusion, N-glycosylation is required for efficient NTCP localization at the plasma membrane and subsequent HBV infection and these characteristics are preserved in NTCP carrying a single carbohydrate moiety.	[Appelman, Monique D.; van de Graaf, Stan F. J.] Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, Amsterdam, Netherlands; [Chakraborty, Anindita; Protzer, Ulrike] Tech Univ Munich, Inst Virol, Helmholtz Zentrum Munchen, Munich, Germany; [Chakraborty, Anindita; Protzer, Ulrike; McKeating, Jane A.] Tech Univ Munich, Inst Adv Study, Munich, Germany; [McKeating, Jane A.] Univ Birmingham, Ctr Human Virol, Birmingham, W Midlands, England; [van de Graaf, Stan F. J.] Acad Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; University of Birmingham; University of Amsterdam; Academic Medical Center Amsterdam	van de Graaf, SFJ (corresponding author), Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, Amsterdam, Netherlands.; van de Graaf, SFJ (corresponding author), Acad Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands.	k.f.vandegraaf@amc.uva.nl	Protzer, Ulrike/D-5915-2015	Protzer, Ulrike/0000-0002-9421-1911; McKeating, Jane/0000-0002-7229-5886; van de Graaf, Stan/0000-0003-4238-4359	Netherlands Organization for Scientific Research [VIDI 91713319]; European Research Council [337479]; MRC; EU; H2020 grant Hep-CAR; German research Foundation (DFG) [TRR179]; Institute for Advanced Study; Technische Universitat Munchen via the German Excellence Initiative; EU 7th Framework Programme [291763]; BBSRC [BB/N008553/2, BB/N008553/1] Funding Source: UKRI; MRC [MR/K01532X/1, G0400802, MC_PC_16056, G1100247, G0801976] Funding Source: UKRI	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU(European Commission); H2020 grant Hep-CAR; German research Foundation (DFG)(German Research Foundation (DFG)); Institute for Advanced Study(Institute for Advanced Study); Technische Universitat Munchen via the German Excellence Initiative; EU 7th Framework Programme; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	SF JvdG is supported by the Netherlands Organization for Scientific Research (VIDI 91713319) and the European Research Council (Starting grant 337479). Research in the McKeating laboratory is funded by the MRC, EU FP7 PathCO and H2020 grant Hep-CAR. Research in the Protzer laboratory was funded by the H2020 grant Hep-CAR and by the German research Foundation (DFG; TRR179). AC and collaborative work between McKeating and Protrer laboratories is funded by the Institute for Advanced Study with the support of the Technische Universitat Munchen via the German Excellence Initiative and EU 7th Framework Programme under grant agreement number 291763.	Pereira IVA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117152; Beers MF, 2013, AM J PHYSIOL-LUNG C, V305, pL970, DOI 10.1152/ajplung.00184.2013; Bijsmans ITGW, 2012, BIOCHEM J, V441, P1007, DOI 10.1042/BJ20111234; Blank A, 2016, J HEPATOL, V65, P483, DOI 10.1016/j.jhep.2016.04.013; Christiansen MN, 2014, PROTEOMICS, V14, P525, DOI 10.1002/pmic.201300387; Console L, 2015, BBA-MOL CELL RES, V1853, P1636, DOI 10.1016/j.bbamcr.2015.03.017; Craddock AL, 1998, AM J PHYSIOL-GASTR L, V274, pG157, DOI 10.1152/ajpgi.1998.274.1.G157; HAGENBUCH B, 1994, J CLIN INVEST, V93, P1326, DOI 10.1172/JCI117091; Hallen S, 2002, BIOCHEMISTRY-US, V41, P7253, DOI 10.1021/bi012152s; Jost S, 2007, J VIROL, V81, P10588, DOI 10.1128/JVI.02489-06; Konig A, 2014, J HEPATOL, V61, P867, DOI 10.1016/j.jhep.2014.05.018; LIS H, 1993, EUR J BIOCHEM, V218, P1, DOI 10.1111/j.1432-1033.1993.tb18347.x; Meredith LW, 2016, J GEN VIROL, V97, P121, DOI 10.1099/jgv.0.000317; Ni Y, 2014, GASTROENTEROLOGY, V146, P1070, DOI 10.1053/j.gastro.2013.12.024; Petersen J, 2008, NAT BIOTECHNOL, V26, P335, DOI 10.1038/nbt1389; Protzer U, 2007, GASTROENTEROLOGY, V133, P1156, DOI 10.1053/j.gastro.2007.07.021; Schulze A, 2007, HEPATOLOGY, V46, P1759, DOI 10.1002/hep.21896; Slijepcevic D, 2015, HEPATOLOGY; Stelzl T, 2016, AM J PHYSIOL-GASTR L, V310, pG128, DOI 10.1152/ajpgi.00350.2015; Sun AQ, 2001, AM J PHYSIOL-GASTR L, V280, pG1305, DOI 10.1152/ajpgi.2001.280.6.G1305; Urban S, 2014, GASTROENTEROLOGY, V147, P48, DOI 10.1053/j.gastro.2014.04.030; Vaz FM, 2015, HEPATOLOGY, V61, P260, DOI 10.1002/hep.27240; Verrier ER, 2016, HEPATOLOGY, V63, P35, DOI 10.1002/hep.28013; Volz T, 2013, J HEPATOL, V58, P861, DOI 10.1016/j.jhep.2012.12.008; Yan H, 2014, J VIROL, V88, P3273, DOI 10.1128/JVI.03478-13; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhao NN, 2014, P NATL ACAD SCI USA, V111, P9175, DOI 10.1073/pnas.1405355111	28	30	31	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170419	10.1371/journal.pone.0170419	http://dx.doi.org/10.1371/journal.pone.0170419			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125599	Green Published, gold, Green Submitted			2022-12-26	WOS:000396176100110
J	Hendricks, KE; Christman, MC; Roberts, PD				Hendricks, Katherine E.; Christman, Mary C.; Roberts, Pamela D.			A Statistical Evaluation of Methods of In-Vitro Growth Assessment for Phyllosticta citricarpa: Average Colony Diameter vs. Area	PLOS ONE			English	Article							GUIGNARDIA-CITRICARPA; FUNGAL GROWTH; CITRUS; FUNGICIDES; ENDOPHYTE; PLANTS; ASSAY	Fungal growth inhibition on solid media has been historically measured and calculated based on the average of perpendicular diameter measurements of growth on fungicide amended media. We investigated the sensitivity of the calculated area (DA) and the measured area ( MA) for assessing fungicide growth inhibition of the ascomycete, Phyllosticta citricarpa on solid media. Both the calculated, DA and the actual measured area, MA were adequate for distinguishing significant treatment effects of fungicide on fungal growth, however MA was more sensitive at identifying significant differences between the controls and fungicide concentrations below 5 ppm.	[Hendricks, Katherine E.; Roberts, Pamela D.] Univ Florida, Dept Plant Pathol, Immokalee, FL 34142 USA; [Christman, Mary C.] Univ Florida, Dept Stat, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Hendricks, KE (corresponding author), Univ Florida, Dept Plant Pathol, Immokalee, FL 34142 USA.	jinxkat@ufl.edu		Hendricks, Katherine/0000-0003-1125-4658	Florida Specialty Crop Block Grant [22915]	Florida Specialty Crop Block Grant	Florida Specialty Crop Block Grant #22915, Title: Production and Postharvest Treatments to Control Citrus Black Spot (Guignardia citricarpa) on Florida Citrus. Authors: Mark Ritenour, Associate Professor; Pamela D. Roberts, Professor; Jan Narciso, Research Microbiologist. URL: http://www.freshfromflorida.com/Business-Services/Grant-Opportunities/2016-Florida-Specialty-Crop-Block-Grant-Program-Farm-Bill-SCBGP-FB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	As'wad AWM, 2011, CROP PROT, V30, P1438, DOI 10.1016/j.cropro.2011.07.004; Baayen RP, 2002, PHYTOPATHOLOGY, V92, P464, DOI 10.1094/PHYTO.2002.92.5.464; Baldassari RB, 2008, EUR J PLANT PATHOL, V120, P103, DOI 10.1007/s10658-007-9182-0; Bertelsen JR, 2001, PLANT PATHOL, V50, P190, DOI 10.1046/j.1365-3059.2001.00545.x; BRANCATO FP, 1953, MYCOLOGIA, V45, P848, DOI 10.1080/00275514.1953.12024321; BROEKAERT WF, 1990, FEMS MICROBIOL LETT, V69, P55, DOI [10.1111/j.1574-6968.1990.tb04174.x, 10.1016/S0378-1097(98)00477-7]; Feliziani E, 2013, POSTHARVEST BIOL TEC, V78, P133, DOI 10.1016/j.postharvbio.2012.12.004; Flores FJ, 2013, DOSE-RESPONSE, V11, P361, DOI 10.2203/dose-response.12-026.Garzon; Glienke C, 2011, PERSOONIA, V26, P47, DOI 10.3767/003158511X569169; Hendricks K. E. M., 2013, American Journal of Plant Sciences, V4, P282, DOI 10.4236/ajps.2013.42037; Hincapie M, 2014, PLANT DIS, V98, P780, DOI 10.1094/PDIS-03-13-0335-RE; Iacomi-Vasilescu B, 2004, CROP PROT, V23, P481, DOI 10.1016/j.cropro.2003.10.003; KERBS S, 1978, CAN J MICROBIOL, V24, P574, DOI 10.1139/m78-093; Langvad F, 1999, J MICROBIOL METH, V37, P97, DOI 10.1016/S0167-7012(99)00053-6; MAJCHROWICZ I, 1993, BIOCONTROL SCI TECHN, V3, P321, DOI 10.1080/09583159309355287; MATCHAM SE, 1984, APPL BIOCHEM BIOTECH, V9, P387, DOI 10.1007/BF02798989; Meyer L, 2006, PLANT DIS, V90, P97, DOI 10.1094/PD-90-0097; Meyer L, 2001, S AFR J SCI, V97, P191; Mohammedi Z., 2013, Australian Journal of Crop Science, V7, P293; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Taniwaki MH, 2006, ADV EXP MED BIOL, V571, P49, DOI 10.1007/0-387-28391-9_3; Teichert A, 2008, J NAT PROD, V71, P1092, DOI 10.1021/np8000859; TRINCI APJ, 1969, J GEN MICROBIOL, V57, P11, DOI 10.1099/00221287-57-1-11; van Kuijk SJA, 2015, ANIM FEED SCI TECH, V209, P40, DOI 10.1016/j.anifeedsci.2015.07.026; VANDERAA HA, 1973, STUD MYCOL, V5, P1; WAGER V. A., 1952, Science Bulletin. Department of Agriculture and Forestry, Union of South Africa, V303; Wang NY, 2016, PHYTOPATHOLOGY, V106, P1300, DOI 10.1094/PHYTO-12-15-0316-R	27	16	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170755	10.1371/journal.pone.0170755	http://dx.doi.org/10.1371/journal.pone.0170755			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125679	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100065
J	Marrano, A; Birolo, G; Prazzoli, ML; Lorenzi, S; Valle, G; Grando, MS				Marrano, Annarita; Birolo, Giovanni; Prazzoli, Maria Lucia; Lorenzi, Silvia; Valle, Giorgio; Grando, Maria Stella			SNP-Discovery by RAD-Sequencing in a Germplasm Collection of Wild and Cultivated Grapevines ( V-vinifera L.)	PLOS ONE			English	Article							WHOLE-GENOME ASSOCIATION; GENETIC DIVERSITY; LINKAGE DISEQUILIBRIUM; MARKERS; IDENTIFICATION; SELECTION; PATTERNS; ORIGINS; PLINK; ARRAY	Whole-genome comparisons of Vitis vinifera subsp. sativa and V. vinifera subsp. sylvestris are expected to provide a better estimate of the valuable genetic diversity still present in grapevine, and help to reconstruct the evolutionary history of a major crop worldwide. To this aim, the increase of molecular marker density across the grapevine genome is fundamental. Here we describe the SNP discovery in a grapevine germplasm collection of 51 cultivars and 44 wild accessions through a novel protocol of restriction-site associated DNA (RAD) sequencing. By resequencing 1.1% of the grapevine genome at a high coverage, we recovered 34K BamHI unique restriction sites, of which 6.8% were absent in the 'PN40024' reference genome. Moreover, we identified 37,748 single nucleotide polymorphisms (SNPs), 93% of which belonged to the 19 assembled chromosomes with an average of 1.8K SNPs per chromosome. Nearly half of the SNPs fell in genic regions mostly assigned to the functional categories of metabolism and regulation, whereas some nonsynonymous variants were identified in genes related with the detection and response to environmental stimuli. SNP validation was carried-out, showing the ability of RAD-seq to accurately determine genotypes in a highly heterozygous species. To test the usefulness of our SNP panel, the main diversity statistics were evaluated, highlighting how the wild grapevine retained less genetic variability than the cultivated form. Furthermore, the analysis of Linkage Disequilibrium (LD) in the two subspecies separately revealed how the LD decays faster within the domesticated grapevine compared to its wild relative. Being the first application of RAD-seq in a diverse grapevine germplasm collection, our approach holds great promise for exploiting the genetic resources available in one of the most economically important fruit crops.	[Marrano, Annarita; Prazzoli, Maria Lucia; Lorenzi, Silvia; Grando, Maria Stella] Fdn Edmund Mach, Res & Innovat Ctr, Grapevine Genet & Breeding, Dept Genom & Biol Fruit Crops, San Michele All Adige, Trentino, Italy; [Birolo, Giovanni; Valle, Giorgio] Univ Padua, CRIBI Biotechnol Ctr, Padua, Italy; [Valle, Giorgio] Univ Padua, Dept Biol, Padua, Italy	Fondazione Edmund Mach; University of Padua; University of Padua	Marrano, A (corresponding author), Fdn Edmund Mach, Res & Innovat Ctr, Grapevine Genet & Breeding, Dept Genom & Biol Fruit Crops, San Michele All Adige, Trentino, Italy.	marrano.annarita@gmail.com	Birolo, Giovanni/ABB-6326-2020; Grando, Maria Stella/D-5448-2011	Birolo, Giovanni/0000-0003-0160-9312; Grando, Maria Stella/0000-0002-6889-1968; Marrano, Annarita/0000-0001-9560-2706	autonomous province of Trento (Italy); GMPF PhD program	autonomous province of Trento (Italy)(Autonomous Province of Trento); GMPF PhD program	This study was funded by the autonomous province of Trento (Italy) and the GMPF PhD program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam-Blondon A-F, 2011, GENETICS GENOMICS BR; Aradhya M, 2013, PLANT SYST EVOL, V299, P317, DOI 10.1007/s00606-012-0723-4; Garcia RAA, 2013, MEDITERRANEAN GENETIC CODE - GRAPEVINE AND OLIVE, P51, DOI 10.5772/52933; Arroyo-Garcia R, 2006, MOL ECOL, V15, P3707, DOI 10.1111/j.1365-294X.2006.03049.x; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bajaj D, 2015, SCI REP-UK, V5, DOI 10.1038/srep12468; Barba P, 2014, THEOR APPL GENET, V127, P73, DOI 10.1007/s00122-013-2202-x; Barchi L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-304; Barnaud A, 2006, THEOR APPL GENET, V112, P708, DOI 10.1007/s00122-005-0174-1; Bodor P, 2015, VITIS, V54, P213; Boursiquot J.M., 2013, P 9 INT S GRAP PHYS, P123; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Buffer S, FRAGMENT LIB PREPARA, V5500, P1; Castaneda-Alvarez NP, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.22, 10.1038/nplants.2016.22]; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen J, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0428-2; Chin C-S, 2016, PHASED DIPLOID GENOM, P56887; Corso M, 2015, J EXP BOT, V66, P5739, DOI 10.1093/jxb/erv274; Da Silva C, 2013, PLANT CELL, V25, P4777, DOI 10.1105/tpc.113.118810; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Davey JL, 2010, BRIEF FUNCT GENOMICS, V9, P416, DOI 10.1093/bfgp/elq031; Davey JW, 2013, MOL ECOL, V22, P3151, DOI 10.1111/mec.12084; De Andres MT, 2012, MOL ECOL, V21, P800, DOI 10.1111/j.1365-294X.2011.05395.x; De Lorenzis G, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0510-9; Deschamps Stephane, 2012, Biology (Basel), V1, P460, DOI 10.3390/biology1030460; Development Core Team R, 2011, R LANG ENV STAT COMP; Di Genova A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-7; Di Vecchi-Staraz M, 2009, J HERED, V100, P66, DOI 10.1093/jhered/esn084; Drori E, 2015, VITIS, V54, P107; Elshire RJ, 2012, GENOTYPING SEQUENCIN; Emanuelli F, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-39; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Grassi F, 2006, CONSERV GENET, V7, P837, DOI 10.1007/s10592-006-9118-9; Grimplet Jerome, 2012, BMC Res Notes, V5, P213, DOI 10.1186/1756-0500-5-213; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; Hamilton M.B., 2009, POPULATION GENETICS; Heywood V.H., 1995, FLORA MEDITERRANEAN, V5, P375; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Homer N, 2009, PLOS ONE, V4; Ilut DC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/675158; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Kumar S., 2012, INT J PLANT GENOMICS, V2012; Li Y, 2011, GENOME RES, V21, P940, DOI 10.1101/gr.117259.110; Lijavetzky D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-424; Mammadov J, 2012, INT J PLANT GENOMICS, V2012; Marrano A, 2015, VITIS, V54, P233; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Money D, 2015, G3 GENES GENOMES GEN, V5; Morgante M, 2007, CURR OPIN PLANT BIOL, V10, P149, DOI 10.1016/j.pbi.2007.02.001; Myles S, 2013, TRENDS GENET, V29, P190, DOI 10.1016/j.tig.2013.01.006; Myles S, 2011, P NATL ACAD SCI USA, V108, P3530, DOI 10.1073/pnas.1009363108; Myles S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008219; NCBI, VIT VIN CHLOR COMPL; NCBI, VIT VIN MIT COMPL GE; Nelson JC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-352; Nicolas SD, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0754-z; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Prazzoli ML, 2016, 10 INT S GRAP PHYS B; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; This P, 2006, TRENDS GENET, V22, P511, DOI 10.1016/j.tig.2006.07.008; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Vitti JJ, 2013, ANNU REV GENET, V47, P97, DOI 10.1146/annurev-genet-111212-133526; Vitulo N, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-99; Wales N, 2016, J ARCHAEOL SCI, V72, P57, DOI 10.1016/j.jas.2016.05.014; Wang N, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-148; Wang S, 2012, NAT METHODS, V9, P808, DOI [10.1038/nmeth.2023, 10.1038/NMETH.2023]; Wang Y, 2012, MOL ECOL, V21, P974, DOI 10.1111/j.1365-294X.2011.05413.x; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xin HP, 2013, TREE GENET GENOMES, V9, P1343, DOI 10.1007/s11295-013-0643-7; ZOHARY D, 1995, ORIGINS ANCIENT HIST, P23; Zohary D, 2000, DOMESTICATION PLANTS, DOI DOI 10.1006/ANBO.2001.1505	76	31	31	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170655	10.1371/journal.pone.0170655	http://dx.doi.org/10.1371/journal.pone.0170655			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125640	Green Published, gold, Green Submitted			2022-12-26	WOS:000396176100079
J	Zheng, JP; Zhai, WL; Li, Q; Jia, QX; Lin, DS				Zheng, Jiapeng; Zhai, Wenliang; Li, Qiang; Jia, Qianxin; Lin, Dasheng			A Special Tear Pattern of Anterior Horn of the Lateral Meniscus: Macerated Tear	PLOS ONE			English	Article							ARTHROSCOPIC PARTIAL MENISCECTOMY; DEGENERATIVE TEARS; PHYSICAL-THERAPY; SURGERY; OSTEOARTHRITIS; KNEE; REPAIRS	Background We describe a special, interesting phenomenon found in the anterior horn of the lateral meniscus (AHLM): most tear patterns in the AHLM are distinctive, with loose fibers in injured region and circumferential fiber bundles were separated. We name it as macerated tear. The goal of this study was to bring forward a new type of meniscal tear in the AHLM and investigate its clinical value. Materials and Methods AHLM tears underwent arthroscopic surgery from January 2012 to December 2014 were included. Data regarding the integrity of AHLM were prospectively recorded in a data registry. Tear morphology and treatment received were subsequently extracted by 2 independent reviewers from operative notes and arthroscopic surgical photos. Results A total of 60 AHLM tears in 60 patients (mean age 27.1 years) were grouped into horizontal tears (n = 15, 25%), vertical tears (n = 14, 23%), complex tears (n = 6, 10%), and macerated tears (n = 25, 42%). There were 6 patients with AHLM cysts in macerated tear group and one patient in vertical tear group. 60 patients were performed arthroscopic meniscus repairs and were followed-up with averaged 18.7 months. Each group had significant postoperative improvement in Lysholm and IKDC scores (p < 0.05). However, the macerated tear group showed least functional recovery of Lysholm and IKDC scores compared to other groups (p < 0.05). In addition, there were no differences in postoperative range of motion, return to work, or return to sport/other baseline activities between the four groups (p > 0.05). Conclusions This study demonstrated that the macerated tear is common in the tear pattern of AHLM. However, feasibility of the treatment of this type of meniscal tear, especially the meniscus repairs still requires further study.	[Zheng, Jiapeng; Zhai, Wenliang; Li, Qiang; Lin, Dasheng] Xiamen Univ, Affiliated Southeast Hosp, Dept Orthopaed Surg, Zhangzhou, Peoples R China; [Jia, Qianxin] Xiamen Univ, Affiliated Southeast Hosp, Dept Radiol, Zhangzhou, Peoples R China; [Lin, Dasheng] Ludwig Maximilians Univ Munchen, Dept Surg, Expt Surg & Regenerat Med, Munich, Germany	Xiamen University; Xiamen University; University of Munich	Lin, DS (corresponding author), Xiamen Univ, Affiliated Southeast Hosp, Dept Orthopaed Surg, Zhangzhou, Peoples R China.; Lin, DS (corresponding author), Ludwig Maximilians Univ Munchen, Dept Surg, Expt Surg & Regenerat Med, Munich, Germany.	linds@xmu.edu.cn						Andrews SHJ, 2014, J ANAT, V224, P531, DOI 10.1111/joa.12170; Anz AW, 2014, AM J SPORT MED, V42, P2699, DOI 10.1177/0363546514549445; Barber-Westin SD, 2014, ARTHROSCOPY, V30, P134, DOI 10.1016/j.arthro.2013.10.003; Bhatia S, 2014, AM J SPORT MED, V42, P3016, DOI 10.1177/0363546514524162; Buchbinder R, 2016, BRIT J SPORT MED, V50, P1413, DOI 10.1136/bmj.h2212; Cucchiarini M, 2016, OSTEOARTHR CARTILAGE, V24, P1330, DOI 10.1016/j.joca.2016.03.018; England E, 2015, SKELETAL RADIOL, V44, P369, DOI 10.1007/s00256-014-2043-y; Englund M, 2016, OSTEOARTHR CARTILAGE, V24, P270, DOI 10.1016/j.joca.2015.08.005; Gundle KR, 2010, J BONE JOINT SURG AM, V92A, P2452, DOI 10.2106/JBJS.I.01369; Hutchinson ID, 2014, AM J SPORT MED, V42, P987, DOI 10.1177/0363546513498503; Katz JN, 2014, OSTEOARTHR CARTILAGE, V22, P1749, DOI 10.1016/j.joca.2014.07.016; Katz JN, 2013, NEW ENGL J MED, V369, P677, DOI 10.1056/NEJMc1307177; Katz JN, 2013, NEW ENGL J MED, V368, P1675, DOI 10.1056/NEJMoa1301408; Khan M, 2014, CAN MED ASSOC J, V186, P1057, DOI 10.1503/cmaj.140433; Kise NJ, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3740; Krych AJ, 2014, NEW ENGL J MED, V370, P1259, DOI 10.1056/NEJMc1401128; LaPrade CM, 2014, AM J SPORT MED, V42, P2386, DOI 10.1177/0363546514544678; LaPrade CM, 2014, J BONE JOINT SURG AM, V96A, P471, DOI 10.2106/JBJS.L.01252; Losina E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130256; McDermott I, 2011, BRIT J SPORT MED, V45, P292, DOI 10.1136/bjsm.2010.081257; Monk P, 2016, AM J SPORTS MED; Price A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2382; Rongen JJ, 2015, OSTEOARTHR CARTILAGE, V23, P1242, DOI 10.1016/j.joca.2015.04.025; Sihvonen R, 2016, OSTEOARTHR CARTILAGE, V24, P1367, DOI 10.1016/j.joca.2016.03.013; Sihvonen R, 2013, NEW ENGL J MED, V369, P2515, DOI 10.1056/NEJMoa1305189; Steineman BD, 2016, AM J SPORTS MED; Szarmach A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159156; Thorlund JB, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-h2747rep; Van der Straeten C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156183; Vrancken ACT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133138	30	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170710	10.1371/journal.pone.0170710	http://dx.doi.org/10.1371/journal.pone.0170710			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125675	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100069
J	Bellizzi, S; Bassat, Q; Ali, MM; Sobel, HL; Temmerman, M				Bellizzi, Saverio; Bassat, Quique; Ali, Mohamed M.; Sobel, Howard L.; Temmerman, Marleen			Effect of Puerperal Infections on Early Neonatal Mortality: A Secondary Analysis of Six Demographic and Health Surveys	PLOS ONE			English	Article							OBSTETRIC COMPLICATIONS; SEPSIS; RISK; PREVALENCE; VALIDATION; PROGRESS; RECALL; AREAS; CARE	Background Around 1.5 million annual neonatal deaths occur in the first week of life, and infections represent one of the major causes in developing countries. Neonatal sepsis is often strictly connected to infection of the maternal genital tract during labour. Methods The association between signs suggestive of puerperal infection and early neonatal mortality (<7 days of life) was performed using Demographic and Health Surveys (DHS) data of six countries, conducted between 2010 and 2013. The population attributable fraction (PAF) was generated using the estimates on early neonatal mortality of a 1990-2013 systematic analysis for the Global Burden of Disease Study. Results Signs of puerperal infection ranged from 0.7% in the Philippines to 16.4% in Honduras. Infection was associated with a 2.1 adjusted Risk Ratio (95% CI: 1.4-3.2) of early neonatal mortality. Around five percent of all deaths in the first week of life were attributable to signs suggestive of puerperal infections and varied from 13.9% (95% CI: 1.0-26.6) in Honduras to 3.6% (95% CI: 1.0-8.5) in Indonesia. Conclusions Targeted interventions should be addressed to contain the burden of puerperal infections on early neonatal mortality. Consideration of the PAF will help in the discussion of the benefits of antenatal and perinatal measures.	[Bellizzi, Saverio; Ali, Mohamed M.] WHO, Dept Reprod Hlth & Res, Geneva, Switzerland; [Bassat, Quique] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Bassat, Quique] CISM, Maputo, Mozambique; [Bassat, Quique] ICREA, Barcelona, Spain; [Sobel, Howard L.] WHO, Western Pacific Reg Off, Manila, Philippines; [Temmerman, Marleen] Univ Ghent, Dept Obstet & Gynaecol, Ghent, Belgium	World Health Organization; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Centro de Investigacao em Saude de Manhica; ICREA; WHO Western Pacific Regional Office; World Health Organization; Ghent University	Ali, MM (corresponding author), WHO, Dept Reprod Hlth & Res, Geneva, Switzerland.	alim@who.int	Sobel, Howard L/M-8800-2018; Bassat, Quique/P-2341-2016	Bassat, Quique/0000-0003-0875-7596; Bellizzi, Saverio/0000-0002-4119-0803	program Miguel Servet of the ISCIII [CP11/00269]; ICREA Funding Source: Custom	program Miguel Servet of the ISCIII; ICREA(ICREA)	QB has a fellowship from the program Miguel Servet of the ISCIII (Plan Nacional de 414 I+D+I 2008-2011, grant number: CP11/00269). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, HLTH DIMENSIONS SEX; BAKER CJ, 1974, JAMA-J AM MED ASSOC, V230, P1158, DOI 10.1001/jama.230.8.1158; Ben Hamida Nouaili Emira, 2008, Tunis Med, V86, P136; Bhutta ZA, 1997, AM J PERINAT, V14, P577, DOI 10.1055/s-2007-994338; Bomela HN, 2001, SAMJ S AFR MED J, V91, P858; Buddeberg BS, 2015, POSTGRAD MED J, V91, P572, DOI 10.1136/postgradmedj-2015-133475; Camacho-Gonzalez A, 2013, PEDIATR CLIN N AM, V60, P367, DOI 10.1016/j.pcl.2012.12.003; Curtis S., OCCASIONAL PAPERS, V3; Dare FO, 1998, TROP DOCT, V28, P92, DOI 10.1177/004947559802800212; Dietz P, 2014, MATERN CHILD HLTH J, V18, P2489, DOI 10.1007/s10995-014-1487-y; Dolea C, 2003, GLOBAL BURDEN MATERN; DONNER A, 1994, AM J EPIDEMIOL, V140, P279, DOI 10.1093/oxfordjournals.aje.a117247; Ganatra HA, 2010, CLIN PERINATOL, V37, P501, DOI 10.1016/j.clp.2010.02.004; Johnson K., 2009, FIELDWORK RELATED FA; Khaskheli MN, 2013, PAK J MED SCI, V29, P972, DOI 10.12669/pjms.294.3389; Koenig MA, 2007, INT FAM PLAN PERSPEC, V33, P75, DOI 10.1363/3307507; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2008, EARLY HUM DEV, V84, P809, DOI 10.1016/j.earlhumdev.2008.09.009; LEE J, 1994, INT J EPIDEMIOL, V23, P201, DOI 10.1093/ije/23.1.201; Liu J., 2013, ADV MECH ENG, V2013, P16, DOI DOI 10.1016/J.ACTBI0.2013.08.016; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Masukume G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122729; Midhet F, 2007, INT J HEALTH SCI-IJH, V1, P243; Neal S., 2012, 25 ESRC CTR POP CHAN; Newton O, 2007, T ROY SOC TROP MED H, V101, P959, DOI 10.1016/j.trstmh.2007.05.005; Ojukwu JU, 2006, J PERINAT MED, V34, P166, DOI 10.1515/JPM.2006.030; Souza JP, 2007, REV PANAM SALUD PUBL, V21, P396, DOI 10.1590/S1020-49892007000500008; Ronsmans C, 1997, STUD FAMILY PLANN, V28, P203, DOI 10.2307/2137888; Rustein SO, 2003, GUIDE DHS STAT; Salam RA, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S1-S3; Seale AC, 2009, LANCET INFECT DIS, V9, P428, DOI 10.1016/S1473-3099(09)70172-0; Sebitloane HM, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.053; Stata Corp, 2008, STAT SOFTW REL 10SE; STEWART MK, 1995, INT J GYNECOL OBSTET, V48, pS53, DOI 10.1016/0020-7292(95)02320-C; VERKUYL DAA, 1995, LANCET, V346, P293, DOI 10.1016/S0140-6736(95)92171-0; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; Winani S, 2007, J MIDWIFERY WOM HEAL, V98, P252; World Health Organization, 2003, GLOB BURD MAT SEPS Y; World Health Organization, 2009, MAN PUERP SEP	40	9	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0170856	10.1371/journal.pone.0170856	http://dx.doi.org/10.1371/journal.pone.0170856			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7FK	28122046	Green Published, gold			2022-12-26	WOS:000396167300009
J	Guo, ZH; Rajput, SK; Folger, JK; Liu, D; Knott, JG; Smith, GW				Guo Zhenhua; Rajput, Sandeep K.; Folger, Joseph K.; Liu Di; Knott, Jason G.; Smith, George W.			Pre- and Peri-/Post-Compaction Follistatin Treatment Increases In Vitro Production of Cattle Embryos	PLOS ONE			English	Article							OOCYTE COMPETENCE; GENE-EXPRESSION; SMAD PROTEINS; TGF-BETA; BOVINE; VIVO; TRANSITION; ABUNDANCE; ACTIVIN; BINDING	Our previous studies demonstrated that maternal (oocyte derived) follistatin (FST) expression is positively associated with bovine oocyte competence and exogenous follistatin treatment during the pre-compaction period of development (d 1-3 post insemination) is stimulatory to bovine early embryogenesis in vitro [blastocyst rates and cell numbers/allocation to trophectoderm (TE)]. In the present study, bovine embryos were treated with exogenous follistatin during d 1-3, d 4-7 and d 1-7 post insemination to test the hypothesis that embryotropic effects of exogenous follistatin are specific to the pre-compaction period (d 1-3) of early embryogenesis. Follistatin treatment during d 4-7 (peri-/post-compaction period) of embryo culture increased proportion of embryos reaching blastocyst and expanded blastocyst stage and total cell numbers compared to controls, but blastocyst rates and total cell numbers were lower than observed following d 1-3 (pre-compaction) follistatin treatment. Follistatin supplementation during d 1-7 of embryo culture increased development to blastocyst and expanded blastocyst stages and blastocyst total cell numbers compared to d 1-3 and d 4-7 follistatin treatment and untreated controls. A similar increase in blastocyst CDX2 mRNA and protein (TE cell marker) was observed in response to d 1-3, d 4-7 and d 1-7 follistatin treatment. However, an elevation in blastocyst BMP4 protein (TE cell regulator) was observed in response to d 1-3 and d 1-7, but not d 4-7 (peri-/post-compaction) follistatin treatment. In summary, our study revealed the potential utility of follistatin treatment for increasing the success rate of in vitro embryo production in cattle. Such results also expand our understanding of the embryotropic actions of follistatin and demonstrate that follistatin actions on blastocyst development and cell allocation to the TE layer are not specific to the pre-compaction period.	[Guo Zhenhua; Liu Di] HAAS, Anim Husb Res Inst, Harbin, Peoples R China; [Guo Zhenhua; Rajput, Sandeep K.; Folger, Joseph K.; Liu Di; Smith, George W.] Michigan State Univ, Lab Mammalian Reprod Biol & Genom, E Lansing, MI 48824 USA; [Rajput, Sandeep K.; Folger, Joseph K.; Knott, Jason G.; Smith, George W.] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA; [Knott, Jason G.] Michigan State Univ, Dev Epigenet Lab, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Smith, GW (corresponding author), Michigan State Univ, Lab Mammalian Reprod Biol & Genom, E Lansing, MI 48824 USA.	smithge7@msu.edu	Rajput, Sandeep K/F-8857-2015	Rajput, Sandeep K/0000-0001-6450-7773	National Institute of Child Health and Human Development of the National Institutes of Health [R01HD072972]; Michigan State University AgBioResearch; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072972] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Michigan State University AgBioResearch; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the National Institute of Child Health and Human Development of the National Institutes of Health under award number R01HD072972 and by Michigan State University AgBioResearch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABALOLA GO, 1995, MOL REPROD DEV, V41, P133, DOI 10.1002/mrd.1080410203; Berg DK, 2011, DEV CELL, V20, P244, DOI 10.1016/j.devcel.2011.01.003; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Bettegowda A, 2006, MOL REPROD DEV, V73, P267, DOI 10.1002/mrd.20333; Bettegowda A, 2008, BIOL REPROD, V79, P301, DOI 10.1095/biolreprod.107.067223; Bettegowda A, 2008, REPROD FERT DEVELOP, V20, P45, DOI 10.1071/RD07156; El-Sayed A, 2006, PHYSIOL GENOMICS, V28, P84, DOI 10.1152/physiolgenomics.00111.2006; Garcia SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119463; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Iemura S, 1998, P NATL ACAD SCI USA, V95, P9337, DOI 10.1073/pnas.95.16.9337; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; Kocabas AM, 2006, P NATL ACAD SCI USA, V103, P14027, DOI 10.1073/pnas.0603227103; KOYAMA H, 1994, BIOL REPROD, V50, P163, DOI 10.1095/biolreprod50.1.163; Kues WA, 2008, P NATL ACAD SCI USA, V105, P19768, DOI 10.1073/pnas.0805616105; Lechniak D, 2008, REPROD BIOLOGY, V8, P23, DOI 10.1016/S1642-431X(12)60002-3; Lee KB, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.120105; Lee KB, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-67; Lee KB, 2009, ENDOCRINOLOGY, V150, P2463, DOI 10.1210/en.2008-1574; Lee MT, 2014, ANNU REV CELL DEV BI, V30, P581, DOI 10.1146/annurev-cellbio-100913-013027; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machaty Z, 1998, BIOL REPROD, V59, P451, DOI 10.1095/biolreprod59.2.451; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; Nganvongpanit K, 2006, MOL REPROD DEV, V73, P153, DOI 10.1002/mrd.20406; Patel OV, 2007, REPRODUCTION, V133, P95, DOI 10.1530/rep.1.01123; Rajput SK, 2014, REPROD FERT DEVELOP, V26, P37, DOI 10.1071/RD13282; ROBERTSON DM, 1987, BIOCHEM BIOPH RES CO, V149, P744, DOI 10.1016/0006-291X(87)90430-X; Sakaki-Yumoto M, 2013, J BIOL CHEM, V288, P18546, DOI 10.1074/jbc.M112.446591; SHIMONAKA M, 1991, ENDOCRINOLOGY, V128, P3313, DOI 10.1210/endo-128-6-3313; Sirard MA, 2006, THERIOGENOLOGY, V65, P126, DOI 10.1016/j.theriogenology.2005.09.020; VanSoom A, 1997, BIOL REPROD, V57, P1041, DOI 10.1095/biolreprod57.5.1041; WATSON AJ, 1992, MOL REPROD DEV, V33, P492, DOI 10.1002/mrd.1080330417; Zhang K, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.130278	33	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0170808	10.1371/journal.pone.0170808	http://dx.doi.org/10.1371/journal.pone.0170808			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122009	Green Published, Green Submitted, gold			2022-12-26	WOS:000396167300016
J	Affatato, S; Zanini, F; Carmignato, S				Affatato, Saverio; Zanini, Filippo; Carmignato, Simone			Micro X-Ray Computed Tomography Mass Loss Assessment of Different UHMWPE: A Hip Joint Simulator Study on Standard vs. Cross-Linked Polyethylene	PLOS ONE			English	Article							MICROCOMPUTED TOMOGRAPHY; WEAR; REPLACEMENT	More than 60.000 hip arthroplasty are performed every year in Italy. Although Ultra-High Molecular-Weight-Polyethylene remains the most used material as acetabular cup, wear of this material induces over time in vivo a foreign-body response and consequently osteolysis, pain, and the need of implant revision. Furthermore, oxidative wear of the polyethylene provoke several and severe failures. To solve these problems, highly cross-linked polyethylene and Vitamin-E-stabilized polyethylene were introduced in the last years. In in vitro experiments, various efforts have been made to compare the wear behavior of standard PE and vitamin-E infused liners. In this study we compared the in vitro wear behavior of two different configurations of cross-linked polyethylene (with and without the add of Vitamin E) vs. the standard polyethylene acetabular cups. The aim of the present study was to validate a micro X-ray computed tomography technique to assess the wear of different commercially available, polyethylene's acetabular cups after wear simulation; in particular, the gravimetric method was used to provide reference wear values. The agreement between the two methods is documented in this paper.	[Affatato, Saverio] Rizzoli Orthopaed Inst, Med Technol Lab, Bologna, Italy; [Zanini, Filippo; Carmignato, Simone] Univ Padua, Dept Management & Engn, Vicenza, Italy	IRCCS Istituto Ortopedico Rizzoli; University of Padua	Affatato, S (corresponding author), Rizzoli Orthopaed Inst, Med Technol Lab, Bologna, Italy.	affatato@tecno.ior.it	Affatato, Saverio/N-5106-2019; Carmignato, Simone/ABA-2380-2021; Affatato, Saverio/C-6976-2019	Affatato, Saverio/0000-0003-3615-6085; Carmignato, Simone/0000-0001-6135-6834; Affatato, Saverio/0000-0003-3615-6085				Affatato S, 2008, TRIBOL INT, V41, P813, DOI 10.1016/j.triboint.2008.02.006; Affatato S, 2010, TRIBOL INT, V43, P22, DOI 10.1016/j.triboint.2009.04.049; Affatato S, 2016, J MECH BEHAV BIOMED, V53, P40, DOI 10.1016/j.jmbbm.2015.08.001; Affatato S, 2012, J BIOMED MATER RES A, V100A, P554, DOI 10.1002/jbm.a.33297; Affatato S, 2010, ARTIF ORGANS, V34, P319, DOI 10.1111/j.1525-1594.2009.00854.x; [Anonymous], 2012, MEAS SCI TECHNOL; Bills P, 2007, WEAR, V263, P1133, DOI 10.1016/j.wear.2007.01.054; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Bowden AE, 2005, J BIOMED MATER RES B, V75B, P205, DOI 10.1002/jbm.b.30318; Carmignato S, 2011, CIRP ANN-MANUF TECHN, V60, P519, DOI 10.1016/j.cirp.2011.03.061; Carmignato S, 2011, WEAR, V270, P584, DOI 10.1016/j.wear.2011.01.012; Carmignato S, 2012, CIRP ANN-MANUF TECHN, V61, P491, DOI 10.1016/j.cirp.2012.03.021; Chang JD, 2014, CLIN ORTHOP SURG, V6, P110, DOI 10.4055/cios.2014.6.1.110; Dumbleton JH, 2006, CLIN ORTHOP RELAT R, P265, DOI 10.1097/01.blo.0000238856.61862.7d; Engh CA, 2013, CLIN ORTHOP RELAT R, V471, P86, DOI 10.1007/s11999-012-2513-2; Gigante A, 2015, J FUNCT BIOMATER, V6, P889, DOI 10.3390/jfb6030889; Grillini L, 2013, HIP INT, V23, P233, DOI 10.5301/hipint.5000003; Knight SR, 2011, ORTHOP REV PAVIA; Kruth JP, 2011, CIRP ANN-MANUF TECHN, V60, P821, DOI 10.1016/j.cirp.2011.05.006; Kurtz S, 2008, CURR ORTHOPAED, V22, P392, DOI 10.1016/j.cuor.2008.10.011; Parrilli A, 2014, J MICROSC-OXFORD, V255, P20, DOI 10.1111/jmi.12132; Parrilli A, 2016, IS MICROCOMPUTED TOM; RIPO, 2012, ANN REPORT; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Spinelli M, 2009, WEAR, V267, P753, DOI 10.1016/j.wear.2008.12.049; Teeter MG, 2011, CLIN ORTHOP RELAT R, V469, P107, DOI 10.1007/s11999-010-1490-6; Teeter MG, 2010, J ARTHROPLASTY, V25, P330, DOI 10.1016/j.arth.2009.11.001	27	9	9	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170263	10.1371/journal.pone.0170263	http://dx.doi.org/10.1371/journal.pone.0170263			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107468	Green Published, Green Submitted, gold			2022-12-26	WOS:000392405300096
J	Kulkarni, SS; Dosdall, LM; Spence, JR; Willenborg, CJ				Kulkarni, Sharavari S.; Dosdall, Lloyd M.; Spence, John R.; Willenborg, Christian J.			Seed Detection and Discrimination by Ground Beetles (Coleoptera: Carabidae) Are Associated with Olfactory Cues	PLOS ONE			English	Article							PTEROSTICHUS-MELANARIUS; HARPALUS-PENSYLVANICUS; PREDATION; PREFERENCES; RESPONSES; BEHAVIOR; SELECTION; INSECTS; PREY	Olfactory ability is an element of fitness in many animals, guiding choices among alternatives such as mating partners or food. Ground beetles (Coleoptera; Carabidae), exhibit preferences for prey, and some species are well-known weed seed predators. We used olfactometer-based bioassays to determine if olfactory stimuli are associated with detection of Brassica napus L., Sinapis arvensis L., and Thlaspi arvense L. seeds by ground beetles characteristic of agroecosystems, and whether behavioural responses to seed odors depended on seed physiological state (imbibed or unimbibed). Imbibed B. napus seeds were preferred over other weed species by two of the three carabid species tested. Only A. littoralis responded significantly to unimbibed seeds of B. napus. Sensitivity to olfactory cues appeared to be highly specific as all carabid species discriminated between the olfactory cues of imbibed brassicaceous weed seeds, but did not discriminate between weed seeds that were unimbibed. Overall, our data suggest that depending on seed physiological state, odours can play an important role in the ability of carabids to find and recognize seeds of particular weed species.	[Kulkarni, Sharavari S.; Dosdall, Lloyd M.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Spence, John R.] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [Willenborg, Christian J.] Univ Saskatchewan, Coll Agr & Bioresources, Dept Plant Sci, Saskatoon, SK, Canada	University of Alberta; University of Alberta; University of Saskatchewan	Willenborg, CJ (corresponding author), Univ Saskatchewan, Coll Agr & Bioresources, Dept Plant Sci, Saskatoon, SK, Canada.	chris.willenborg@usask.ca	Willenborg, Christian/AAH-9360-2021	Kulkarni, Sharavari/0000-0002-9929-5608; Willenborg, Christian/0000-0001-9733-2252	Natural Sciences and Engineering Research Council (NSERC) of Canada; Alberta Canola Producers Commission; NSERC	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Canola Producers Commission; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded in part by the Natural Sciences and Engineering Research Council (NSERC) of Canada received by CJW and LMD and the Alberta Canola Producers Commission received by LMD. NSERC provided a graduate student stipend for lead author SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the Alberta Canola Producers Commission and the Natural Sciences and Engineering Research Council (NSERC) of Canada for their generous funding of this project. One of the authors, Dr. Lloyd M. Dosdall passed away before the submission of the final version of this manuscript.	Allema AB, 2012, J APPL ENTOMOL, V136, P793, DOI 10.1111/j.1439-0418.2012.01728.x; Bohan DA, 2011, J APPL ECOL, V48, P888, DOI 10.1111/j.1365-2664.2011.02008.x; Crawley M. J., 2000, Seeds: the ecology of regeneration in plant communities, P167, DOI 10.1079/9780851994321.0167; Cromar HE, 1999, WEED SCI, V47, P184, DOI 10.1017/S0043174500091608; Dalling JW, 2011, J ECOL, V99, P89, DOI 10.1111/j.1365-2745.2010.01739.x; Harper J. L, 1977, POPULATION BIOL PLAN; Harrison SK, 2012, ACTA OECOL, V12; Honek A, 2003, EUR J ENTOMOL, V100, P531, DOI 10.14411/eje.2003.081; Honek A, 2007, BASIC APPL ECOL, V8, P343, DOI 10.1016/j.baae.2006.07.002; Jorgensen EE, 2001, AM MIDL NAT, V145, P419, DOI 10.1674/0003-0031(2001)145[0419:EOVCBS]2.0.CO;2; Kielty JP, 1996, J INSECT BEHAV, V9, P237, DOI 10.1007/BF02213868; Kulkarni SS, 2016, WEED SCI, V64, P294, DOI 10.1614/WS-D-15-00069.1; Kulkarni SS, 2015, WEED SCI, V63, P910, DOI 10.1614/WS-D-15-00080.1; Kulkarni SS, 2015, WEED SCI, V63, P355, DOI 10.1614/WS-D-14-00067.1; Law JJ, 2015, APPL SOIL ECOL, V87, P118, DOI 10.1016/j.apsoil.2014.11.015; Lee PC., 2001, J NEW SEED, V2, P59, DOI [10.1300/J153v02n01_04, DOI 10.1300/J153V02N01_04]; Leeson JY., 2005, WEED SURVEY SERIES P, V5; Lovei GL, 1996, ANNU REV ENTOMOL, V41, P231, DOI 10.1146/annurev.en.41.010196.001311; Lundgren JG, 2009, RELATIONSHIPS NATURA; Lundgren JG, 2007, ARTHROPOD-PLANT INTE, V1, P93, DOI 10.1007/s11829-007-9008-1; Mundy CA, 2000, J APPL ENTOMOL, V124, P349, DOI 10.1046/j.1439-0418.2000.00491.x; Oster M, 2014, ARTHROPOD-PLANT INTE, V8, P429, DOI 10.1007/s11829-014-9322-3; SAS Institute, 2010, PROC US MAN VERS 9 2; Schapers A, 2015, J INSECT BEHAV, V28, P77, DOI 10.1007/s10905-014-9482-0; Thiele H, 1977, CARABID BEETLES THEI; Toft S, 2002, AGROECOLOGY OF CARABID BEETLES, P81; TOKUMASU S, 1990, SCI HORTIC-AMSTERDAM, V42, P1, DOI 10.1016/0304-4238(90)90142-2; Trefas H, 2001, AGR FOREST ENTOMOL, V3, P71, DOI 10.1046/j.1461-9563.2001.00089.x; Trefas H, 2008, B INSECTOL, V61, P225; VET LEM, 1983, PHYSIOL ENTOMOL, V8, P97, DOI 10.1111/j.1365-3032.1983.tb00338.x; Ward MJ, 2014, WEED SCI, V62, P555, DOI 10.1614/WS-D-14-00010.1; Westerman PR, 2006, WEED SCI, V54, P566, DOI 10.1614/WS-05-067R.1; White SS, 2007, WEED SCI, V55, P606, DOI 10.1614/WS-06-162.1; Zhang J, 1997, USDA TECHNICAL B, V163	34	7	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170593	10.1371/journal.pone.0170593	http://dx.doi.org/10.1371/journal.pone.0170593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107464	Green Submitted, Green Published, gold			2022-12-26	WOS:000392405300171
J	Morabito, MV; Ravussin, Y; Mueller, BR; Skowronski, AA; Watanabe, K; Foo, KS; Lee, SX; Lehmann, A; Hjorth, S; Zeltser, LM; LeDuc, CA; Leibel, RL				Morabito, Michael V.; Ravussin, Yann; Mueller, Bridget R.; Skowronski, Alicja A.; Watanabe, Kazuhisa; Foo, Kylie S.; Lee, Samuel X.; Lehmann, Anders; Hjorth, Stephan; Zeltser, Lori M.; LeDuc, Charles A.; Leibel, Rudolph L.			Weight Perturbation Alters Leptin Signal Transduction in a Region-Specific Manner throughout the Brain	PLOS ONE			English	Article							REDUCED BODY-WEIGHT; INDUCED OBESE MICE; ENERGY-EXPENDITURE; HYPOTHALAMIC PROOPIOMELANOCORTIN; MESSENGER-RNA; MAINTENANCE; HOMEOSTASIS; EXPRESSION; RESPONSES; INSULIN	Diet-induced obesity (DIO) resulting from consumption of a high fat diet (HFD) attenuates normal neuronal responses to leptin and may contribute to the metabolic defense of an acquired higher body weight in humans; the molecular bases for the persistence of this defense are unknown. We measured the responses of 23 brain regions to exogenous leptin in 4 different groups of weight-and/or diet-perturbed mice. Responses to leptin were assessed by quantifying pSTAT3 levels in brain nuclei 30 minutes following 3 mg/kg intraperitoneal leptin. HFD attenuated leptin sensing throughout the brain, but weight loss did not restore central leptin signaling to control levels in several brain regions important in energy homeostasis, including the arcuate and dorsomedial hypothalamic nuclei. Effects of diet on leptin signaling varied by brain region, with results dependent on the method of weight loss (restriction of calories of HFD, ad lib intake of standard mouse chow). High fat diet attenuates leptin signaling throughout the brain, but some brain regions maintain their ability to sense leptin. Weight loss restores leptin sensing to some degree in most (but not all) brain regions, while other brain regions display hypersensitivity to leptin following weight loss. Normal leptin sensing was restored in several brain regions, with the pattern of restoration dependent on the method of weight loss.	[Morabito, Michael V.; Ravussin, Yann; Mueller, Bridget R.; Skowronski, Alicja A.; Watanabe, Kazuhisa; Foo, Kylie S.; Lee, Samuel X.; Zeltser, Lori M.; LeDuc, Charles A.; Leibel, Rudolph L.] Columbia Univ, Dept Pediat, Div Mol Genet, Coll Phys & Surg, New York, NY 10027 USA; [Lehmann, Anders; Hjorth, Stephan] AstraZeneca, R&D Dis Area Diabet Obes, Molndal, Sweden; [Mueller, Bridget R.] NYU, Sch Med, New York, NY USA; [Watanabe, Kazuhisa] Jichi Med Univ, Ctr Mol Med, Div Human Genet, Shimotsuke, Tochigi, Japan; [Foo, Kylie S.] Karolinska Inst, Dept Med, Huddinge, Sweden; [Lehmann, Anders] Gothenburg Univ, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden; [Hjorth, Stephan] Gothenburg Univ, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden	Columbia University; AstraZeneca; New York University; Jichi Medical University; Karolinska Institutet; University of Gothenburg; University of Gothenburg	Morabito, MV; Leibel, RL (corresponding author), Columbia Univ, Dept Pediat, Div Mol Genet, Coll Phys & Surg, New York, NY 10027 USA.	morabito42@gmail.com; rl232@cumc.columbia.edu	Hjorth, Stephan/AAO-4298-2021; Ravussin, Yann/ABE-8061-2021; Watanabe, Kazuhisa/ABY-2241-2022; Ravussin, Yann/AAE-1440-2020	Hjorth, Stephan/0000-0002-6980-3691; Ravussin, Yann/0000-0002-6699-3944; LeDuc, Charles/0000-0002-2073-5050; Watanabe, Kazuhisa/0000-0002-5640-0818	AstraZeneca; CUMC Diabetes and Endocrinology Research Center [NIH P30DK063608]; New York City Obesity Research Center [NIH P30DK026687]; New York University Langone Medical Center Histopathology Core [NIH P30CA016087]; NIH [RO1DK52431]; Institute of Human Nutrition [NIH T32DK007647-23]; Russell Berrie Foundation; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063608, T32DK007647, P30DK026687, R01DK052431] Funding Source: NIH RePORTER	AstraZeneca(AstraZeneca); CUMC Diabetes and Endocrinology Research Center; New York City Obesity Research Center; New York University Langone Medical Center Histopathology Core; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of Human Nutrition; Russell Berrie Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported (in part) by a research grant from AstraZeneca ("Molecular and cell physiology of responses to weight perturbation in mice." AstraZeneca scientists participated in aspects of these studies; their roles are described in the Role of Funders and Author Contributions); the CUMC Diabetes and Endocrinology Research Center (NIH P30DK063608); the New York City Obesity Research Center (NIH P30DK026687); the New York University Langone Medical Center Histopathology Core (NIH P30CA016087); NIH RO1DK52431; the Institute of Human Nutrition training grant (NIH T32DK007647-23); and the Russell Berrie Foundation. Role of Funders: The grant from AstraZeneca provided support for a collaborative effort between Columbia University and AstraZeneca scientists to study the metabolic and behavioral consequences of weight perturbation in mice. The funding partially supported a graduate student, postdoctoral fellows, animal and reagent costs for the studies reported in this manuscript. AstraZeneca scientists participated in aspects of the design and data analysis, and read and commented on the manuscript. Their specific roles are enumerated in the authors' contributions section. AstraZeneca scientists did not direct the data analyses and had no editorial control over the manuscript. The study was conducted entirely at Columbia, solely by Columbia personnel.	Ahima RS, 1999, ENDOCRINOLOGY, V140, P4923, DOI 10.1210/en.140.11.4923; Belgardt BF, 2010, ANN NY ACAD SCI, V1212, P97, DOI 10.1111/j.1749-6632.2010.05799.x; Berkseth KE, 2014, ENDOCRINOLOGY, V155, P2858, DOI 10.1210/en.2014-1121; Czupryn A, 2011, SCIENCE, V334, P1133, DOI 10.1126/science.1209870; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Franz Marion J, 2006, Diabetes Forecast, V59, P41; Franz MJ, 2006, DIABETES FORECAST, V59, P4; FREDERICH RC, 1995, J CLIN INVEST, V96, P1658, DOI 10.1172/JCI118206; Fujita N, 2003, EXP BIOL MED, V228, P1156, DOI 10.1177/153537020322801009; Gautron L, 2011, J CLIN INVEST, V121, P2087, DOI 10.1172/JCI45888; Halldorsdottir Solveig, 2009, Int J Body Compos Res, V7, P147; Hinkle W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059114; Korner J, 2001, J NEUROENDOCRINOL, V13, P959, DOI 10.1046/j.1365-2826.2001.00716.x; Korner J, 1999, NEUROENDOCRINOLOGY, V70, P377, DOI 10.1159/000054499; Kraschnewski JL, 2010, INT J OBESITY, V34, P1644, DOI 10.1038/ijo.2010.94; Leibel RL, 2002, NUTR REV, V60, pS15, DOI 10.1301/002966402320634788; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Lutter M, 2009, J NUTR, V139, P629, DOI 10.3945/jn.108.097618; Matheny M, 2011, NEUROPHARMACOLOGY, V60, P480, DOI 10.1016/j.neuropharm.2010.11.002; McNay DEG, 2013, MOL METAB, V2, P103, DOI 10.1016/j.molmet.2012.10.003; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Munzberg H, 2003, ENDOCRINOLOGY, V144, P2121, DOI 10.1210/en.2002-221037; Ottaway N, 2015, CELL METABOLISM; Patterson CM, 2011, BRAIN RES, V1378, P18, DOI 10.1016/j.brainres.2011.01.010; Ravussin Y, 2011, AM J PHYSIOL-REG I, V300, pR1352, DOI 10.1152/ajpregu.00429.2010; Ravussin Y, 2014, MOL METAB; Ravussin Y, 2014, CELL METAB, V20, P565, DOI 10.1016/j.cmet.2014.09.002; Ravussin Y, 2012, AM J PHYSIOL-REG I, V303, pR438, DOI 10.1152/ajpregu.00092.2012; Rosenbaum M, 1997, J CLIN ENDOCR METAB, V82, P3647, DOI 10.1210/jc.82.11.3647; Rosenbaum M, 2002, J CLIN ENDOCR METAB, V87, P2391, DOI 10.1210/jc.87.5.2391; Rosenbaum M, 2005, J CLIN INVEST, V115, P3579, DOI 10.1172/JCI25977; Rosenbaum M, 2008, J CLIN INVEST, V118, P2583, DOI 10.1172/JCI35055; Rosenbaum M, 2014, J ENDOCRINOL, V223, pT83, DOI 10.1530/JOE-14-0358; Rosenbaum M, 2013, MOL METAB, V2, P58, DOI 10.1016/j.molmet.2013.01.005; Rosenbaum M, 2010, BRAIN RES, V1350, P95, DOI 10.1016/j.brainres.2010.05.062; Scott MM, 2009, J COMP NEUROL, V514, P518, DOI 10.1002/cne.22025; Siso S, 2010, ACTA NEUROPATHOL, V120, P689, DOI 10.1007/s00401-010-0743-5; Skowronski AA, 2014, OBESITY, V22, P1287, DOI 10.1002/oby.20678; Smith PM, 2009, AM J PHYSIOL-REG I, V296, pR512, DOI 10.1152/ajpregu.90858.2008; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Velloso LA, 2011, INT J OBESITY, V35, P1455, DOI 10.1038/ijo.2011.56; Wunderlich Claudia M, 2013, JAKSTAT, V2, pe23878, DOI 10.4161/jkst.23878; Yu YH, 2015, OBES REV, V16, P234, DOI 10.1111/obr.12246; Zhang Y, EATING DISO IN PRESS, P15	47	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0168226	10.1371/journal.pone.0168226	http://dx.doi.org/10.1371/journal.pone.0168226			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107353	Green Published, Green Submitted, gold			2022-12-26	WOS:000392405300009
J	Nagata, Y; Yamamoto, T; Hayashi, M; Hayashi, S; Kadowaki, M				Nagata, Yuka; Yamamoto, Takeshi; Hayashi, Michie; Hayashi, Shusaku; Kadowaki, Makoto			Improvement of Therapeutic Efficacy of Oral Immunotherapy in Combination with Regulatory T Cell-Inducer Kakkonto in a Murine Food Allergy Model	PLOS ONE			English	Article							RETINOIC-ACID; IMMUNE TOLERANCE; GM-CSF; EPICUTANEOUS IMMUNOTHERAPY; MOUSE MODEL; INDUCTION; CHILDREN; MECHANISMS; INFLAMMATION; PATHOGENESIS	Oral immunotherapy (OIT) has been considered a promising approach for food allergies (FAs). However, the current OIT strategy is limited in terms of the long-term efficacy and safety. We have previously demonstrated that kakkonto, a traditional Japanese herbal medicine, suppresses the occurrence of allergic symptoms in a murine model of ovalbumin (OVA)-induced FA, which is attributed to the induction of the Foxp3(+) CD4(+) regulatory T cells. In this study, we established an OIT model using the FA mice with already established allergic symptoms and determined whether kakkonto could improve the efficacy of OIT. The OIT method consisted of initially administrating a very small amount of OVA and slowly increasing the amount. Allergic symptoms decreased in the OIT-treated FA mice. OIT significantly downregulated Th2 immune response-related gene expression in the FA mouse colon, and decreased the level of mouse mast cell protease-1, a marker of mast cell degranulation in the FA mouse plasma. Moreover, the concomitant use of kakkonto significantly enhanced the effectiveness of OIT on the allergic symptoms, and the combination therapy further suppressed the Th2 immune responses and the mast cell degranulation. In addition, OIT significantly increased the population of Foxp3(+) CD4(+) regulatory T cells in the FA mouse colon, and this population was further increased by OIT in combination with kakkonto. Furthermore, the combined therapy with kakkonto reduced the expression of RA-degrading enzyme CYP26B1 mRNA in the FA mouse colon. These findings indicated that the combination of OIT with kakkonto represents a promising approach for FA treatment.	[Nagata, Yuka; Yamamoto, Takeshi; Hayashi, Michie; Hayashi, Shusaku; Kadowaki, Makoto] Toyama Univ, Inst Nat Med, Div Gastrointestinal Pathophysiol, Toyama, Japan	University of Toyama	Yamamoto, T (corresponding author), Toyama Univ, Inst Nat Med, Div Gastrointestinal Pathophysiol, Toyama, Japan.	ty@inm.u-toyama.ac.jp	Hayashi, Shusaku/AAP-1185-2020	Hayashi, Shusaku/0000-0002-8304-7255; YAMAMOTO, Takeshi/0000-0002-4383-6954	Ministry of Education, Culture, Sports, Science and Technology of Japan [JP16K09234]; Joint Usage/Research Center (Joint Usage/Research Center for Science-Based Natural Medicine) Institute of Natural Medicine, University of Toyama	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Joint Usage/Research Center (Joint Usage/Research Center for Science-Based Natural Medicine) Institute of Natural Medicine, University of Toyama	This research was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan to T. Yamamoto (No. JP16K09234) (https://www.jsps.go.jp/j-grantsinaid/index.html) and by a Grant-in-Aid for the Cooperative Research Project from Joint Usage/Research Center (Joint Usage/Research Center for Science-Based Natural Medicine) Institute of Natural Medicine, University of Toyama in 2015 and 2012 to T. Yamamoto (http://www.inm.u-toyama.ac.jp/jp/collabo/hub_index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akase T., 2002, Journal of Traditional Medicines, V19, P58; Akdis CA, 2012, NAT MED, V18, P736, DOI 10.1038/nm.2754; Akdis M, 2014, J ALLERGY CLIN IMMUN, V133, P621, DOI 10.1016/j.jaci.2013.12.1088; Bailey M, 2005, P NUTR SOC, V64, P451, DOI 10.1079/PNS2005452; Bauer RN, 2015, J ALLERGY CLIN IMMUN, V135, P312, DOI 10.1016/j.jaci.2014.12.1908; Bhattacharya P, 2015, CYTOKINE, V75, P261, DOI 10.1016/j.cyto.2015.05.030; Bhattacharya P, 2015, J INTERF CYTOK RES, V35, P585, DOI 10.1089/jir.2014.0149; Bischoff S, 2004, CURR OPIN GASTROEN, V20, P156, DOI 10.1097/00001574-200403000-00018; Bischoff S, 2005, GASTROENTEROLOGY, V128, P1089, DOI 10.1053/j.gastro.2004.08.015; Bohm L, 2015, J IMMUNOL, V194, P887, DOI 10.4049/jimmunol.1401612; Buchanan AD, 2007, J ALLERGY CLIN IMMUN, V119, P199, DOI 10.1016/j.jaci.2006.09.016; Burton OT, 2014, IMMUNITY, V41, P141, DOI 10.1016/j.immuni.2014.05.017; Casale TB, 2014, J ALLERGY CLIN IMMUN, V133, P612, DOI 10.1016/j.jaci.2014.01.007; Chenery A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072308; Clark AT, 2009, ALLERGY, V64, P1218, DOI 10.1111/j.1398-9995.2009.01982.x; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Demoly P, 2016, J ALLERGY CLIN IMMUN, V137, P444, DOI 10.1016/j.jaci.2015.06.036; Di Bona D, 2012, J ALLERGY CLIN IMMUN, V130, P1097, DOI 10.1016/j.jaci.2012.08.012; Dupont C, 2010, J ALLERGY CLIN IMMUN, V125, P1165, DOI 10.1016/j.jaci.2010.02.029; Egea L, 2010, EXPERT REV GASTROENT, V4, P723, DOI [10.1586/egh.10.73, 10.1586/EGH.10.73]; Elshabrawy HA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050366; Farooq SM, 2014, BRAIN BEHAV IMMUN, V42, P118, DOI 10.1016/j.bbi.2014.06.010; Farooq SM, 2014, J CELL MOL MED, V18, P2512, DOI 10.1111/jcmm.12376; Farooq SM, 2014, BRAIN BEHAV IMMUN, V35, P64, DOI 10.1016/j.bbi.2013.09.016; Farooq SM, 2013, CNS NEUROSCI THER, V19, P503, DOI 10.1111/cns.12087; Farooq SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048635; Ganeshan K, 2012, J IMMUNOL, V188, P594, DOI 10.4049/jimmunol.1102389; Gathungu G, 2013, INFLAMM BOWEL DIS, V19, P1671, DOI 10.1097/MIB.0b013e318281f506; Gill N, 2010, NAT IMMUNOL, V11, P558, DOI 10.1038/ni0710-558; Haddad CS, 2016, AUTOIMMUNITY, V49, P298, DOI 10.1080/08916934.2016.1183657; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hofmann AM, 2009, J ALLERGY CLIN IMMUN, V124, P286, DOI 10.1016/j.jaci.2009.03.045; Jones SM, 2012, NEW ENGL J MED, V367, P233, DOI [10.1056/NEJMoa1200435, DOI 10.1056/NEJMOA1200435]; Jones SM, 2014, J ALLERGY CLIN IMMUN, V133, P318, DOI 10.1016/j.jaci.2013.12.1040; Jutel M, 2015, J ALLERGY CLIN IMMUN, V136, P556, DOI 10.1016/j.jaci.2015.04.047; Jutel M, 2013, ALLERGOL INT, V62, P425, DOI 10.2332/allergolint.13-RAI-0608; Kageyama-Yahara N, 2010, FEBS LETT, V584, P111, DOI 10.1016/j.febslet.2009.11.007; Kang SG, 2007, J IMMUNOL, V179, P3724, DOI 10.4049/jimmunol.179.6.3724; Kerstan A, 2011, J ALLERGY CLIN IMMUN, V127, P495, DOI 10.1016/j.jaci.2010.11.025; Kim SJ, 2016, ARTHRITIS RHEUMATOL, V68, P1099, DOI 10.1002/art.39544; Kim SJ, 2016, ANN RHEUM D IN PRESS; Kurokawa M, 2002, ANTIVIR RES, V56, P183, DOI 10.1016/S0166-3542(02)00104-3; Larange A, 2016, ANNU REV IMMUNOL, V34, P369, DOI 10.1146/annurev-immunol-041015-055427; Longo G, 2008, J ALLERGY CLIN IMMUN, V121, P343, DOI 10.1016/j.jaci.2007.10.029; Maazi H, 2012, CLIN EXP ALLERGY, V42, P1519, DOI 10.1111/j.1365-2222.2012.04064.x; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Medeiros SR, 2015, NUTRITION, V31, P1260, DOI 10.1016/j.nut.2015.03.004; Meglio P, 2004, ALLERGY, V59, P980, DOI 10.1111/j.1398-9995.2004.00542.x; Mondoulet L, 2015, J ALLERGY CLIN IMMUN, V135, P1546, DOI 10.1016/j.jaci.2014.11.028; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nelson CH, 2013, CURR TOP MED CHEM, V13, P1402; Nolting J, 2009, J EXP MED, V206, P2131, DOI 10.1084/jem.20090639; Nowak-Wegrzyn A, 2015, CLIN EXP ALLERGY, V45, P368, DOI 10.1111/cea.12382; Okubo Kimihiro, 2011, Allergology International, V60, P171, DOI [10.2332/allergolint.11-RAI-0334, 10.2332/allergolint. 11-RAI-0334]; Oyoshi MK, 2014, J ALLERGY CLIN IMMUN, V133, P309, DOI 10.1016/j.jaci.2013.12.1045; Pastore S, 2006, EUR J DERMATOL, V16, P125; Peric A, 2016, INT ARCH OTORHINOLAR, V20, P364, DOI 10.1055/s-0035-1570746; Pesek RD, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0610-0; Ross AC, 2011, ANNU REV NUTR, V31, P65, DOI 10.1146/annurev-nutr-072610-145127; Rowin J, 2012, MUSCLE NERVE, V46, P449, DOI 10.1002/mus.23488; Rupa P, 2012, ALLERGY, V67, P74, DOI 10.1111/j.1398-9995.2011.02724.x; Sampson HA, 2005, J ALLERGY CLIN IMMUN, V115, P139, DOI 10.1016/j.jaci.2004.11.003; Sato S, 2014, INT ARCH ALLERGY IMM, V164, P1, DOI 10.1159/000361025; Shershakova N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135070; Sicherer SH, 2014, J ALLERGY CLIN IMMUN, V133, P291, DOI 10.1016/j.jaci.2013.11.020; Siebeneicher S, 2015, ALLERGY, V70, P1559, DOI 10.1111/all.12732; Syed A, 2014, J ALLERGY CLIN IMMUN, V133, P500, DOI 10.1016/j.jaci.2013.12.1037; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016089; Terasawa K, 2004, EVID-BASED COMPL ALT, V1, P119, DOI 10.1093/ecam/neh022; Wood RA, 2016, J ALLERGY CLIN IMMUN, V137, P973, DOI 10.1016/j.jaci.2016.01.001; Yamamoto T, 2009, INT ARCH ALLERGY IMM, V148, P175, DOI 10.1159/000161578; Yamamoto T, 2016, INT ARCH ALLERGY IMM, V169, P146, DOI 10.1159/000445433; Yamamoto T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085888; Yamamoto T, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/721085; Yanagida N, 2016, ALLERGOL INT, V65, P135, DOI 10.1016/j.alit.2015.10.010; Zhou YX, 2014, PHYTOTHER RES, V28, P961, DOI 10.1002/ptr.5083	76	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170577	10.1371/journal.pone.0170577	http://dx.doi.org/10.1371/journal.pone.0170577			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107533	Green Submitted, gold, Green Published			2022-12-26	WOS:000392405300169
J	Nattenmuller, J; Wochner, R; Muley, T; Steins, M; Hummler, S; Teucher, B; Wiskemann, J; Kauczor, HU; Wielputz, MO; Heussel, CP				Nattenmueller, Johanna; Wochner, Raoul; Muley, Thomas; Steins, Martin; Hummler, Simone; Teucher, Birgit; Wiskemann, Joachim; Kauczor, Hans-Ulrich; Wielpuetz, Mark Oliver; Heussel, Claus Peter			Prognostic Impact of CT-Quantified Muscle and Fat Distribution before and after First-Line-Chemotherapy in Lung Cancer Patients	PLOS ONE			English	Article							BODY-COMPOSITION; WEIGHT-LOSS; CHEMOTHERAPY; SARCOPENIA; OBESITY; PREVALENCE; CACHEXIA; TOXICITY; ADIPOSE; TISSUE	Introduction Cachexia and sarcopenia are associated with poor outcome and increased chemotherapy-induced toxicity in lung cancer patients. However, the complex interplay of obesity, sarcopenia and cachexia, and its impact on survival in the context of first-line-chemotherapy is not yet understood. Methods In 200 consecutively recruited lung cancer patients (70 female, mean age 62y; mean BMI 25 kg/m(2); median follow-up 15.97 months) with routine staging-CT before and after chemotherapy (CTX, mean interval: 4.3 months), densitometric quantification of total (TFA), visceral (VFA), and subcutaneous-fat-area (SFA), inter-muscular-fat-area (IMFA), muscle-density (MD), muscle-area (MA) and skeletal-muscle-index (SMI) was performed retrospectively to evaluate changes under chemotherapy and the impact on survival. Results We observed increases in TFA, VFA, SFA, VFA/SFA, and IMFA (p<0.05-0.001), while there were decreases in MA, MD and BMI (p<0.05-0.001) after chemotherapy. High pre-therapeutic VFA/SFA was a predictive factor for poor survival (HR = 1.272; p = 0.008), high pre-therapeutic MD for improved survival (HR = 0.93; p<0.05). Decrease in BMI (HR = 1.303; p<0.001), weight (HR = 1.067; p<0.001) and SMI (HR = 1.063; p<0.001) after chemotherapy were associated with poor survival. Patients with >= 4 CTX-cycles showed increased survival (17.6 vs. 9.1months), less muscle depletion (SMIdifference: p<0.05) and no BMI loss (BMIdifference: p<0.001). Conclusions After chemotherapy, patients exhibited sarcopenia with decreased muscle and increased adipose tissue compartments, which was not adequately mirrored by BMI and weight loss but by imaging. Particularly sarcopenic patients received less CTX-cycles and had poorer survival. As loss of BMI, weight and muscle were associated with poor survival, early detection (via imaging) and prevention (via physical exercise and nutrition) of sarcopenia may potentially improve outcome and reduce chemotherapy-induced toxicity.	[Nattenmueller, Johanna; Kauczor, Hans-Ulrich; Wielpuetz, Mark Oliver; Heussel, Claus Peter] Univ Heidelberg Hosp, Dept Diagnost & Intervent Radiol, Heidelberg, Germany; [Nattenmueller, Johanna; Wochner, Raoul; Muley, Thomas; Steins, Martin; Hummler, Simone; Teucher, Birgit; Kauczor, Hans-Ulrich; Wielpuetz, Mark Oliver; Heussel, Claus Peter] German Ctr Lung Res DZL, Translat Lung Res Ctr Heidelberg TLRC, Heidelberg, Germany; [Nattenmueller, Johanna; Wochner, Raoul; Kauczor, Hans-Ulrich; Wielpuetz, Mark Oliver; Heussel, Claus Peter] Heidelberg Univ, Thoraxklin, Dept Diagnost & Intervent Radiol Nucl Med, Amalienstr, Heidelberg, Germany; [Muley, Thomas] Heidelberg Univ, Thoraxklin, Translat Res Unit STF, Amalienstr, Heidelberg, Germany; [Steins, Martin; Hummler, Simone] Heidelberg Univ, Thoraxklin, Dept Thorac Oncol, Amalienstr, Heidelberg, Germany; [Hummler, Simone] Heidelberg Univ, Thoraxklin, Dept Pneumol & Resp Crit Care Med, Amalienstr, Heidelberg, Germany; [Wiskemann, Joachim] Natl Ctr Tumor Dis NCT, Div Med Oncol, Heidelberg, Germany; [Wiskemann, Joachim] Univ Heidelberg Hosp, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Nattenmuller, J (corresponding author), Univ Heidelberg Hosp, Dept Diagnost & Intervent Radiol, Heidelberg, Germany.; Nattenmuller, J (corresponding author), German Ctr Lung Res DZL, Translat Lung Res Ctr Heidelberg TLRC, Heidelberg, Germany.; Nattenmuller, J (corresponding author), Heidelberg Univ, Thoraxklin, Dept Diagnost & Intervent Radiol Nucl Med, Amalienstr, Heidelberg, Germany.	Johanna.nattenmueller@med.uni-heidelberg.de	Kauczor, HU/AAX-6033-2021; Wiskemann, Joachim/AAF-6862-2020; Teucher, Birgit/J-6380-2015; Wielpütz, Mark Oliver/ADP-0499-2022; Wielpuetz, Mark/ABE-1790-2020; Kauczor, Hans-Ulrich/AAU-5955-2021; Muley, Thomas/AAY-9200-2020	Wielpütz, Mark Oliver/0000-0001-6962-037X; Wielpuetz, Mark/0000-0001-6962-037X; Nattenmueller, Johanna/0000-0003-4032-378X	Medical Faculty of the University of Heidelberg	Medical Faculty of the University of Heidelberg	Johanna Nattenmuller was supported by a grant from the Medical Faculty of the University of Heidelberg.	Baracos VE, 2010, AM J CLIN NUTR, V91, p1133S, DOI 10.3945/ajcn.2010.28608C; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Baumgartner RN, 2000, ANN NY ACAD SCI, V904, P437; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; Di Sebastiano KM, 2012, APPL PHYSIOL NUTR ME, V37, P811, DOI [10.1139/h2012-079, 10.1139/H2012-079]; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fukushima H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115895; George SM, 2014, BREAST CANCER RES TR, V146, P647, DOI 10.1007/s10549-014-3048-x; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Irlbeck T, 2010, INT J OBESITY, V34, P781, DOI 10.1038/ijo.2009.279; Kim EY, 2015, J THORAC ONCOL; Kimura M, 2015, SUPPORT CARE CANCER, V23, P1699, DOI 10.1007/s00520-014-2534-3; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; Mitsiopoulos N., 1985, J APPL PHYSIOL, V1998, P115; Nattenmueller J, 2016, EUR RADIOL; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Organization WH. International Agency for Research on Cancer, 2014, WORLD CANC REPORT 20; Prado CM, 2013, AM J CLIN NUTR, V98, P1012, DOI 10.3945/ajcn.113.060228; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Prado CMM, 2009, CLIN CANCER RES, V15, P2920, DOI 10.1158/1078-0432.CCR-08-2242; Rickles AS, 2013, J GASTROINTEST SURG, V17, P133, DOI 10.1007/s11605-012-2045-9; Robert-Koch-Institut, 2013, KREBS DEUTSCHL 2009, P56; Ross PJ, 2004, BRIT J CANCER, V90, P1905, DOI 10.1038/sj.bjc.6601781; Sjoblom B, 2016, CLIN NUTR; Stene GB, 2015, ACTA ONCOL, V54, P340, DOI 10.3109/0284186X.2014.953259; Tamandl D, 2015, EUR RADIOL; Tan BHL, 2015, EJSO-EUR J SURG ONC, V41, P333, DOI 10.1016/j.ejso.2014.11.040; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Travis WD., 2004, TRAVIS WB WHO CLASSI; Villasenor A, 2012, J CANCER SURVIV, V6, P398, DOI 10.1007/s11764-012-0234-x; von Haehling S, 2010, J CACHEXIA SARCOPENI, V1, P129, DOI 10.1007/s13539-010-0014-2; Yoshizumi T, 1999, RADIOLOGY, V211, P283, DOI 10.1148/radiology.211.1.r99ap15283	32	73	75	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0169136	10.1371/journal.pone.0169136	http://dx.doi.org/10.1371/journal.pone.0169136			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107410	gold, Green Published, Green Submitted			2022-12-26	WOS:000392405300020
J	Perez-Losada, M; Alamri, L; Crandall, KA; Freishtat, RJ				Perez-Losada, Marcos; Alamri, Lamia; Crandall, Keith A.; Freishtat, Robert J.			Nasopharyngeal Microbiome Diversity Changes over Time in Children with Asthma	PLOS ONE			English	Article							HEALTH; COLONIZATION; COMMUNITIES; CARRIAGE; IMPACT	Background The nasopharynx is a reservoir for pathogens associated with respiratory illnesses such as asthma. Next-generation sequencing (NGS) has been used to characterize the nasopharyngeal microbiome of infants and adults during health and disease; less is known, however, about the composition and temporal dynamics (i. e., longitudinal variation) of microbiotas from children and adolescents. Here we use NGS technology to characterize the nasopharyngeal microbiomes of asthmatic children and adolescents (6 to 18 years) and determine their stability over time. Methods Two nasopharyngeal washes collected 5.5 to 6.5 months apart were taken from 40 children and adolescents with asthma living in the Washington D. C. area. Sequence data from the 16S-V4 rRNA gene region (similar to 250 bp) were collected from the samples using the MiSeq platform. Raw data were processed in mothur (SILVA123 reference database) and Operational Taxonomic Units (OTU)-based alpha-and beta-diversity metrics were estimated. Relatedness among samples was assessed using PCoA ordination and Procrustes analyses. Differences in microbial diversity and taxon mean relative proportions were assessed using linear mixed effects models. Core microbiome analyses were also performed to identify stable and consistent microbes of the nasopharynx. Results and Discussion A total of 2,096,584 clean 16S sequences corresponding to an average of 167 OTUs per sample were generated. Representatives of Moraxella*, Staphylococcus*, Dolosigranulum, Corynebacterium, Prevotella, Streptococcus*, Haemophilus*, Fusobacterium* and a Neisseriaceae genus accounted for 86% of the total reads. These nine genera have been previously found in the nasopharynxes of both infants and adults, but in different proportions. OTUs from the five genera highlighted (*) above defined the nasopharyngeal core microbiome at the 95% level. No significant differences in alpha-and beta-diversity were observed between seasons, but bacterial mean relative proportions of Haemophilus, Moraxella, Staphylococcus and Corynebacterium varied significantly between summer-fall and age groups (inter-patient variation). Additionally, OTUs varied significantly within patients between time points in 35 of the 40 patients analyzed. Future cross-sectional studies should be mindful of the temporal dynamics of the nasopharyngeal microbiota.	[Perez-Losada, Marcos; Crandall, Keith A.] George Washington Univ, Computat Biol Inst, Ashburn, VA 20052 USA; [Perez-Losada, Marcos; Alamri, Lamia; Freishtat, Robert J.] Childrens Natl Med Ctr, Div Emergency Med, Washington, DC 20010 USA; [Perez-Losada, Marcos] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO InBIO, Campus Agrario Vairao, Vairao, Portugal	George Washington University; Children's National Health System; Universidade do Porto	Perez-Losada, M (corresponding author), George Washington Univ, Computat Biol Inst, Ashburn, VA 20052 USA.; Perez-Losada, M (corresponding author), Childrens Natl Med Ctr, Div Emergency Med, Washington, DC 20010 USA.; Perez-Losada, M (corresponding author), Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO InBIO, Campus Agrario Vairao, Vairao, Portugal.	mlosada@gwu.edu	Crandall, Keith A./H-2789-2019; Perez-Losada, Marcos/I-4407-2013	Crandall, Keith A./0000-0002-0836-3389; Perez-Losada, Marcos/0000-0002-2585-4657; Freishtat, Robert/0000-0002-7411-2342	K12 Career Development Program [K12HL119994]; NIH National Center for Advancing Translational Sciences [UL1TR001876, KL2TR001877, R01MD007075, UL1TR000075]; Clark Charitable Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL119994] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007075] Funding Source: NIH RePORTER	K12 Career Development Program; NIH National Center for Advancing Translational Sciences; Clark Charitable Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	MP-L was funded in part by a K12 Career Development Program K12HL119994 award and by Award Numbers UL1TR001876 and KL2TR001877 from the NIH National Center for Advancing Translational Sciences. The AsthMaP2 project was supported by Award Numbers R01MD007075 to RJF and UL1TR000075 from the NIH National Center for Advancing Translational Sciences (RJF, KAC), in addition to funding to RJF from the Clark Charitable Foundation. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Center for Advancing Translational Sciences or the National Institutes of Health.	Allen EK, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-22; [Anonymous], 2007, J ALLERGY CLIN IMMUN, V120, pS94, DOI 10.1016/j.jaci.2007.09.029; Backhed F, 2012, CELL HOST MICROBE, V12, P611, DOI 10.1016/j.chom.2012.10.012; Benton AS, 2010, J ASTHMA, V47, P728, DOI 10.3109/02770903.2010.491142; Biesbroek G, 2014, AM J RESP CRIT CARE, V190, P1283, DOI 10.1164/rccm.201407-1240OC; Biesbroek G, 2014, AM J RESP CRIT CARE, V190, P298, DOI 10.1164/rccm.201401-0073OC; Biesbroek G, 2014, EMERG INFECT DIS, V20, P201, DOI 10.3201/eid2002.131220; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Bisgaard H, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4978; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bogaert D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017035; Brar T, 2012, CURR OPIN PULM MED, V18, P14, DOI 10.1097/MCP.0b013e32834dccc0; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardenas PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046803; Castro-Nallar E, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0121-1; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cremers AJH, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-44; Dickson RP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004923; Dickson RP, 2013, EXPERT REV RESP MED, V7, P245, DOI [10.1586/ers.13.24, 10.1586/ERS.13.24]; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Feazel LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128064; Garcia-Rodriguez JA, 2002, J ANTIMICROB CHEMOTH, V50, P59, DOI 10.1093/jac/dkf506; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Huang YJ, 2015, J ALLERGY CLIN IMMUN, V135, P25, DOI 10.1016/j.jaci.2014.11.011; Huang Yvonne J, 2014, Ann Am Thorac Soc, V11 Suppl 1, pS48, DOI 10.1513/AnnalsATS.201306-187MG; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Jounio U, 2010, CLIN RESPIR J, V4, P222, DOI 10.1111/j.1752-699X.2009.00179.x; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Mackenzie GA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-304; Marchesi JR, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0094-5; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Perez-Losada M, 2016, MICROBIOME IN PRESS; Perez-Losada M, 2016, AIMS MICROBIOL, V2, P108, DOI 10.3934/microbiol.2016.2.108; Perez-Losada M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131819; Prevaes SM, 2015, AM J RESP CRITICAL C; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; RStudio Team, 2015, RSTUDIO INT DEV R; Sakwinska O, 2014, J CLIN MICROBIOL, V52, P1590, DOI 10.1128/JCM.03280-13; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x; Shafquat A, 2014, TRENDS MICROBIOL, V22, P261, DOI 10.1016/j.tim.2014.01.011; Teo SM, 2015, CELL HOST MICROBE, V17, P704, DOI 10.1016/j.chom.2015.03.008; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	50	37	38	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170543	10.1371/journal.pone.0170543	http://dx.doi.org/10.1371/journal.pone.0170543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107528	gold, Green Published, Green Submitted			2022-12-26	WOS:000392405300161
J	Santos, GD; Barros, AL; de Oliveira, CAF; da Luz, LL; da Silva, FF; Demets, GJF; Alves, S				Santos, Guilherme de C.; Barros, Amanda L.; de Oliveira, Carlos A. F.; da Luz, Leonis L.; da Silva, Fausthon F.; Demets, Gregoire J. -F.; Alves Junior, Severino			New Composites LnBDC@AC and CB[6]@AC: From Design toward Selective Adsorption of Methylene Blue or Methyl Orange	PLOS ONE			English	Article							METAL-ORGANIC FRAMEWORK; ACTIVATED CARBON; COORDINATION POLYMERS; SURFACE-CHEMISTRY; AQUEOUS-SOLUTION; CUCURBITURIL; DYES; PH; SEPARATION; HOMOLOGS	New porous composites LnBDC@AC (AC = Activated carbon, Ln = Eu and Gd and BDC = 1,4-benzenedicaboxylate) and CB[6]@AC (CB[6] = Cucurbit[6] uril) were obtained using hydrothermal route. The LnBDC and CB[B] are located inside the pore of the carbon materials as was observed in SEM-EDS, XRPD and FT-IR analysis. Porosimetry analysis showed values typically between AC and LnBDC material, with pore size and surface area, respectively, 29,56 A an353.98 m(2)g(-1) for LnBDC@ AC and 35,53 A and 353.98 m(2)g(-1) for CB[6] @AC. Both materials showed good absorptive capacity of metil orange (MO) and methylene blue (MB) with selectivity as a function of pH. For acid pH, both materials present selectivity by MB and alkaline pH for MO, with notable performance for CB[6]@AC. Additionally, europium luminescence was used as structural probe to investigate the coordination environment of Eu3+ ions in the EuBDC@AC composite after adsorption experiment.	[Santos, Guilherme de C.; Barros, Amanda L.; de Oliveira, Carlos A. F.; da Luz, Leonis L.; Alves Junior, Severino] Univ Fed Pernambuco, Dept Quim Fundamental, Recife, PE, Brazil; [da Silva, Fausthon F.] Univ Fed Paraiba, Dept Quim, Joao Pessoa, Paraiba, Brazil; [Demets, Gregoire J. -F.] Univ Sao Paulo, Dept Quim, Ribeirao Preto, SP, Brazil	Universidade Federal de Pernambuco; Universidade Federal da Paraiba; Universidade de Sao Paulo	Alves, S (corresponding author), Univ Fed Pernambuco, Dept Quim Fundamental, Recife, PE, Brazil.	salvesjr@ufpe.br	da Silva, Fausthon F./L-9963-2015; da Luz, Leonis L./J-2395-2016; Demets, Grégoire JF/A-5152-2008; Alves, Severino/L-8963-2013; da Luz, Leonis/N-3546-2017	Demets, Grégoire JF/0000-0001-7152-1266; Junior, Severino/0000-0002-8092-4224; da Silva, fausthon/0000-0002-6095-512X; Fernandes de Oliveira, Carlos Alberto/0000-0001-8795-2685; da Luz, Leonis/0000-0003-2556-3961	Development Agency for Research-CNPq	Development Agency for Research-CNPq	This work was supported by the Development Agency for Research-CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo B, 2015, J COLLOID INTERF SCI, V459, P189, DOI 10.1016/j.jcis.2015.07.068; Binnemans K, 2015, COORDIN CHEM REV, V295, P1, DOI 10.1016/j.ccr.2015.02.015; Cao MN, 2011, J HAZARD MATER, V186, P948, DOI 10.1016/j.jhazmat.2010.10.119; Chen R-h, 2015, ENV PROG SUSTAIN ENE, P34; Choi JG, 2001, IND ENG CHEM RES, V40, P4005, DOI 10.1021/ie010195z; Choy KKH, 2000, J CHEM ENG DATA, V45, P575, DOI 10.1021/je9902894; Daiguebonne C, 2008, INORG CHEM, V47, P3700, DOI 10.1021/ic702325m; David B, 2011, CRYST GROWTH DES, V11, P5598; Day A, 2001, J ORG CHEM, V66, P8094, DOI 10.1021/jo015897c; de Oliveira CAF, 2013, CHEM COMMUN, V49, P6486, DOI 10.1039/c3cc40449h; Gurbuz S, 2015, ORG BIOMOL CHEM, V13, P330, DOI 10.1039/c4ob02065k; Haque E, 2011, J HAZARD MATER, V185, P507, DOI 10.1016/j.jhazmat.2010.09.035; Haque E, 2010, J HAZARD MATER, V181, P535, DOI 10.1016/j.jhazmat.2010.05.047; He SH, 2016, J MOL STRUCT, V1107, P182, DOI 10.1016/j.molstruc.2015.11.039; Huang W.-H., 2008, MODERN SUPRAMOLECULA, P113; Huo SH, 2012, J MATER CHEM, V22, P7449, DOI 10.1039/c2jm16513a; Ikezoe Y, 2012, NAT MATER, V11, P1081, DOI [10.1038/nmat3461, 10.1038/NMAT3461]; Demets GJF, 2008, J NANOSCI NANOTECHNO, V8, P432, DOI 10.1166/jnn.2008.051; Karcher S, 2001, WATER RES, V35, P3309, DOI 10.1016/S0043-1354(01)00038-0; Lee J, 2009, CHEM SOC REV, V38, P1450, DOI 10.1039/b807080f; Lee JW, 2003, ACCOUNTS CHEM RES, V36, P621, DOI 10.1021/ar020254k; Lillo-Rodenas MA, 2003, CARBON, V41, P267, DOI 10.1016/S0008-6223(02)00279-8; Liu B, 2012, J MATER CHEM, V22, P10094, DOI 10.1039/c2jm15827b; Liu JW, 2014, CHEM SOC REV, V43, P6011, DOI 10.1039/c4cs00094c; Malhis LD, 2015, COMPUT THEOR CHEM, V1066, P104, DOI 10.1016/j.comptc.2015.05.010; Martins A, 2015, J CHEM EDUC, V92, P143, DOI 10.1021/ed500055v; Masson E, 2012, RSC ADV, V2, P1213, DOI 10.1039/c1ra00768h; Naderi M, 2014, PROGR FILTRATION SEP, P585; Pachfule P, 2012, CHEM COMMUN, V48, P2009, DOI 10.1039/c2cc16877d; Reineke TM, 1999, J AM CHEM SOC, V121, P1651, DOI 10.1021/ja983577d; Sarkar C, 2014, IND ENG CHEM RES, V53, P16148, DOI 10.1021/ie502653t; Schettino MA, 2007, QUIM NOVA, V30, P1663, DOI 10.1590/S0100-40422007000700031; Schnorr JM, 2011, CHEM MATER, V23, P646, DOI 10.1021/cm102406h; Silva FD, 2014, INORG CHEM FRONT, V1, P495, DOI 10.1039/c4qi00069b; Sorokhaibam LG, 2015, IND ENG CHEM RES, V54, P11844, DOI 10.1021/acs.iecr.5b02945; Souza AP, 2010, J LUMIN, V130, P181, DOI 10.1016/j.jlumin.2009.08.009; Tong MM, 2013, J MATER CHEM A, V1, P8534, DOI 10.1039/c3ta11807j; Valix M, 2006, LANGMUIR, V22, P4574, DOI 10.1021/la051711j; Vijayakumar G., 2012, J MAT ENV SCI, V3, P157; Wanderley KA, 2011, QUIM NOVA, V34, P434, DOI 10.1590/S0100-40422011000300013; Wang LH, 2016, DALTON T, V45, P4541, DOI 10.1039/c5dt04260g; Wei W, 2015, J MATER CHEM A, V3, P4314, DOI 10.1039/c4ta06444e; Zhong SL, 2013, MATER LETT, V96, P125, DOI 10.1016/j.matlet.2013.01.035; Zhou Y, 2016, CHEM COMMUN, V52, P2265, DOI 10.1039/c5cc09029f; Zhu YW, 2011, SCIENCE, V332, P1537, DOI 10.1126/science.1200770	45	9	11	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170026	10.1371/journal.pone.0170026	http://dx.doi.org/10.1371/journal.pone.0170026			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107440	Green Submitted, Green Published, gold			2022-12-26	WOS:000392405300064
J	Cheng, XC; Shao, ZY; Li, CB; Yu, LJ; Raja, MA; Liu, CG				Cheng, Xiaochen; Shao, Ziyu; Li, Chengbo; Yu, Lejun; Raja, Mazhar Ali; Liu, Chenguang			Isolation, Characterization and Evaluation of Collagen from Jellyfish Rhopilema esculentum Kishinouye for Use in Hemostatic Applications	PLOS ONE			English	Article							PEPSIN-SOLUBILIZED COLLAGEN; CUCUMBER STICHOPUS-JAPONICUS; SNAPPER PRIACANTHUS-TAYENUS; ACID-SOLUBLE COLLAGEN; FIBRIN SEALANTS; IN-VITRO; BIOMEDICAL APPLICATIONS; OXIDIZED CELLULOSE; RANDOMIZED-TRIAL; MOLECULAR-WEIGHT	Hemostat has been a crucial focus since human body is unable to control massive blood loss, and collagen proves to be an effective hemostat in previous studies. In this study, collagen was isolated from the mesoglea of jellyfish Rhopilema esculentum Kishinouye and its hemostatic property was studied. The yields of acid-soluble collagen (ASC) and pepsin-soluble (PSC) were 0.12% and 0.28% respectively. The SDS-PAGE patterns indicated that the collagen extracted from jellyfish mesoglea was type I collagen. The lyophilized jellyfish collagen sponges were cross-linked with EDC and interconnected networks in the sponges were revealed by scanning electron microscope (SEM). Collagen sponges exhibited higher water absorption rates than medical gauze and EDC/NHS cross-linking method could improve the stability of the collagen sponges. Compared with medical gauze groups, the blood clotting indexes (BCIs) of collagen sponges were significantly decreased (P< 0.05) and the concentration of collagen also had an influence on the hemostatic property (P< 0.05). Collagen sponges had an improved hemostatic ability compared to the gauze control in tail amputation rat models. Hemostatic mechanism studies showed that hemocytes and platelets could adhere and aggregate on the surface of collagen sponge. All properties make jellyfish collagen sponge to be a suitable candidate used as hemostatic material and for wound healing applications.	[Cheng, Xiaochen; Shao, Ziyu; Li, Chengbo; Yu, Lejun; Raja, Mazhar Ali; Liu, Chenguang] Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China	Ocean University of China	Liu, CG (corresponding author), Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China.	liucg@ouc.edu.cn						ABE Y, 1972, BIOPOLYMERS, V11, P1817, DOI 10.1002/bip.1972.360110905; Achneck HE, 2010, ANN SURG, V251, P217, DOI 10.1097/SLA.0b013e3181c3bcca; Addad S, 2011, MAR DRUGS, V9, P967, DOI 10.3390/md9060967; Akturk O, 2011, J BIOSCI BIOENG, V112, P279, DOI 10.1016/j.jbiosc.2011.05.014; Beck K, 1998, J STRUCT BIOL, V122, P17, DOI 10.1006/jsbi.1998.3965; Beck K, 2000, P NATL ACAD SCI USA, V97, P4273, DOI 10.1073/pnas.070050097; Behrens AM, 2014, ACTA BIOMATER, V10, P701, DOI 10.1016/j.actbio.2013.10.029; Boucher BA, 2007, PHARMACOTHERAPY, V27, P1394, DOI 10.1592/phco.27.10.1394; Bouten PJM, 2014, PROG POLYM SCI, V39, P1375, DOI 10.1016/j.progpolymsci.2014.02.001; Busuttil RW, 2003, J AM COLL SURGEONS, V197, P1021, DOI 10.1016/j.jamcollsurg.2003.07.002; Chang MC, 2002, BIOMATERIALS, V23, P4811, DOI 10.1016/S0142-9612(02)00232-6; Cole DJ, 1999, SURGERY, V126, P510, DOI 10.1016/S0039-6060(99)70092-9; Damink LHHO, 1996, BIOMATERIALS, V17, P679, DOI 10.1016/0142-9612(96)86737-8; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Diaz-Guemes I, 2015, J SURG RES, V194, P312, DOI 10.1016/j.jss.2014.10.017; Dickneite G, 2003, THROMB RES, V112, P73, DOI 10.1016/j.thromres.2003.10.010; Duan R, 2012, CHEM PAP, V66, P636, DOI 10.2478/s11696-012-0172-0; Emilia M, 2011, TRANSFUS APHER SCI, V45, P305, DOI 10.1016/j.transci.2011.10.013; Exposito JY, 2008, J BIOL CHEM, V283, P28226, DOI 10.1074/jbc.M804573200; Farndale RW, 2004, J THROMB HAEMOST, V2, P561, DOI 10.1111/j.1538-7836.2004.00665.x; Fennema, 1996, FOOD CHEM, P879; Fleck Cynthia Ann, 2010, J Am Col Certif Wound Spec, V2, P50, DOI 10.1016/j.jcws.2010.12.003; Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4; Gu JP, 1985, CHIN J MAR DRUGS, V4, P47; Gu RL, 2010, BIOMATERIALS, V31, P1270, DOI 10.1016/j.biomaterials.2009.10.023; HEMKER HC, 1983, BLOOD CELLS, V9, P303; Hino M, 2000, BRIT J HAEMATOL, V108, P194, DOI 10.1046/j.1365-2141.2000.01818.x; Horowitz B, 2008, TRANSFUSION, V48, P1739, DOI 10.1111/j.1537-2995.2008.01717.x; HSIEH YHP, 1994, TRENDS FOOD SCI TECH, V5, P225, DOI 10.1016/0924-2244(94)90253-4; Hsieh YHP, 2001, HYDROBIOLOGIA, V451, P11, DOI 10.1023/A:1011875720415; Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005; Jeong SI, 2007, BIOMATERIALS, V28, P1115, DOI 10.1016/j.biomaterials.2006.10.025; Kabiri M, 2011, CURR APPL PHYS, V11, P457, DOI 10.1016/j.cap.2010.08.031; KIMURA S, 1993, COMP BIOCHEM PHYS B, V104, P663, DOI 10.1016/0305-0491(93)90194-A; Kittiphattanabawon P, 2005, FOOD CHEM, V89, P363, DOI 10.1016/j.foodchem.2004.02.042; Knott L, 1998, BONE, V22, P181, DOI 10.1016/S8756-3282(97)00279-2; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Krishnan LK, 2004, BIOMATERIALS, V25, P5557, DOI 10.1016/j.biomaterials.2004.01.013; LAZAREV YA, 1992, BIOPOLYMERS, V32, P189, DOI 10.1002/bip.360320209; Lee CH, 2001, INT J PHARMACEUT, V221, P1, DOI 10.1016/S0378-5173(01)00691-3; Li, 2014, BIOMED PREV NUTR, V4, P399, DOI [10.1016/j.bionut.2014.04.007, DOI 10.1016/J.BI0NUT.2014.04.007, DOI 10.1016/J.BIONUT.2014.04.007]; Li H, 2004, FOOD CHEM, V84, P65, DOI 10.1016/S0308-8146(03)00167-5; Liu H, 2007, FOOD CHEM, V101, P621, DOI 10.1016/j.foodchem.2006.01.059; Liu WT, 2009, J FOOD BIOCHEM, V33, P20, DOI 10.1111/j.1745-4514.2008.00207.x; Liu X, 2013, FOOD RES INT, V50, P339, DOI 10.1016/j.foodres.2012.11.002; Liu ZY, 2010, J AGR FOOD CHEM, V58, P1270, DOI 10.1021/jf9032415; Marchac D, 2005, PLAST RECONSTR SURG, V115, P911, DOI 10.1097/01.PRS.0000153219.32665.D5; Matmaroh K, 2011, FOOD CHEM, V129, P1179, DOI 10.1016/j.foodchem.2011.05.099; MATTHEWS TW, 1991, J OTOLARYNGOL, V20, P276; McManus JG, 2007, J TRAUMA, V62, pS14, DOI 10.1097/TA.0b013e3180653b6d; Mizuno K, 2014, SPINE J, V14, P2141, DOI 10.1016/j.spinee.2014.01.050; Nagai T, 1999, J SCI FOOD AGR, V79, P855, DOI 10.1002/(SICI)1097-0010(19990501)79:6<855::AID-JSFA299>3.3.CO;2-E; Nalinanon S, 2007, FOOD CHEM, V104, P593, DOI 10.1016/j.foodchem.2006.12.035; Neuffer MC, 2004, MIL MED, V169, P716, DOI 10.7205/MILMED.169.9.716; Ogawa M, 2004, FOOD CHEM, V88, P495, DOI 10.1016/j.foodchem.2004.02.006; Ohta S, 2015, J BIOSCI BIOENG, V119, P718, DOI 10.1016/j.jbiosc.2014.10.026; Omura Y, 1996, COMP BIOCHEM PHYS B, V115, P63, DOI 10.1016/0305-0491(96)00085-5; Park SY, 2012, FOOD CHEM, V132, P487, DOI 10.1016/j.foodchem.2011.11.032; Patel MJ, 2006, LARYNGOSCOPE, V116, P1708, DOI 10.1097/01.mlg.0000231785.96955.c8; PAYNE KJ, 1988, BIOPOLYMERS, V27, P1749, DOI 10.1002/bip.360271105; Prabhakaran MP, 2014, J BIOMED MATER RES B, V102, P447, DOI 10.1002/jbm.b.33022; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Qerimi B, 2013, AM J SURG, V205, P636, DOI 10.1016/j.amjsurg.2012.05.033; ROBERTS WS, 1989, SOUTHERN MED J, V82, P607; Ruozi B, 2009, INT J PHARMACEUT, V378, P108, DOI 10.1016/j.ijpharm.2009.05.049; Sai KP, 2001, COMP BIOCHEM PHYS B, V128, P81; Saito M, 2002, J FOOD SCI, V67, P1319, DOI 10.1111/j.1365-2621.2002.tb10281.x; Samudrala Srinath, 2008, AORN J, V88, pS2, DOI 10.1016/S0001-2092(08)00586-3; Schonauer C, 2004, EUR SPINE J, V13, pS89, DOI 10.1007/s00586-004-0727-z; Singh P, 2011, FOOD CHEM, V124, P97, DOI 10.1016/j.foodchem.2010.05.111; Sixma JJ, 1997, THROMB HAEMOSTASIS, V78, P434; Song E, 2006, BIOMATERIALS, V27, P2951, DOI 10.1016/j.biomaterials.2006.01.015; Spotnitz WD, 2008, TRANSFUSION, V48, P1502, DOI 10.1111/j.1537-2995.2008.01703.x; SUGAR O, 1984, SURG NEUROL, V21, P521, DOI 10.1016/0090-3019(84)90462-2; TIMKOVICH R, 1977, ANAL BIOCHEM, V79, P135, DOI 10.1016/0003-2697(77)90387-6; Usha R, 2012, COLLOID SURFACE B, V90, P83, DOI 10.1016/j.colsurfb.2011.10.002; Wang L, 2008, FOOD CHEM, V108, P616, DOI 10.1016/j.foodchem.2007.11.017; WEBER K, 1969, J BIOL CHEM, V244, P4406; Witono JR, 2014, CARBOHYD POLYM, V103, P325, DOI 10.1016/j.carbpol.2013.12.056; Yu HH, 2006, FOOD CHEM, V95, P123, DOI 10.1016/j.foodchem.2004.12.025; Zange R, 1998, J CONTROL RELEASE, V56, P249, DOI 10.1016/S0168-3659(98)00093-5; Zeng SK, 2012, FOOD CHEM, V135, P1975, DOI 10.1016/j.foodchem.2012.06.086; Zhang JJ, 2010, J FOOD BIOCHEM, V34, P1343, DOI 10.1111/j.1745-4514.2010.00439.x	83	78	86	11	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0169731	10.1371/journal.pone.0169731	http://dx.doi.org/10.1371/journal.pone.0169731			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103327	Green Published, gold, Green Submitted			2022-12-26	WOS:000392381100021
J	Wang, JB; Su, CX; Liu, R; Liu, BX; Khan, IU; Xie, J; Zhu, NS				Wang, Jingbo; Su, Caixia; Liu, Rui; Liu, Baoxiu; Khan, Inam Ullah; Xie, Jun; Zhu, Naishuo			A Pre-Clinical Safety Evaluation of SBP (HBsAg-Binding Protein) Adjuvant for Hepatitis B Vaccine	PLOS ONE			English	Article							NONCLINICAL SAFETY; IMMUNOGENICITY; ALUMINUM; COMBINATION; EFFICACY	Although adjuvants are a common component of many vaccines, there are few adjuvants licensed for use in humans due to concerns about their toxic effects. There is a need to develop new and safe adjuvants, because some existing vaccines have low immunogenicity among certain patient groups. In this study, SBP, a hepatitis B surface antigen binding protein that was discovered through screening a human liver cDNA expression library, was introduced into hepatitis B vaccine. A good laboratory practice, non-clinical safety evaluation was performed to identify the side effects of both SBP and SBP-adjuvanted hepatitis B vaccine. The results indicate that SBP could enhance the HBsAg-specific immune response, thus increasing the protection provided by the hepatitis B vaccine. The safety data obtained here warrant further investigation of SBP as a vaccine adjuvant.	[Wang, Jingbo; Su, Caixia; Liu, Rui; Liu, Baoxiu; Khan, Inam Ullah; Xie, Jun; Zhu, Naishuo] Fudan Univ, Inst Biomed Sci, State Key Lab Genet Engn, Lab Mol Immunol,Sch Life Sci, Shanghai, Peoples R China	Fudan University	Xie, J; Zhu, NS (corresponding author), Fudan Univ, Inst Biomed Sci, State Key Lab Genet Engn, Lab Mol Immunol,Sch Life Sci, Shanghai, Peoples R China.	xiejun@fudan.edu.cn; nzhu@fudan.edu.cn		wang, jingbo/0000-0001-5941-3131	National Major Scientific and Technological Special Project [2012ZX10002006-002-003]; National High Technology Research and Development Program of China [2011AA02A114]; National Natural Science Foundation of China [31370927, 30571650]; Science and Technology Innovation Action Plan of Shanghai [13431900602]	National Major Scientific and Technological Special Project; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Innovation Action Plan of Shanghai	This work was supported by the National Major Scientific and Technological Special Project (2012ZX10002006-002-003, http://www.nrnp.gov.cnizxisizdxy/201012/120101208_2128 htm), the National High Technology Research and Development Program of China (2011AA02A114, http://program.most.gov.cn/), the National Natural Science Foundation of China (31370927 and 30571650, http://www.nsfc.gov.cn/) and the Science and Technology Innovation Action Plan of Shanghai (13431900602, http://www.dragon-star.eu/callishanghai-2013-st-innovation-action-planintemationakooperation-programme/).; This work was supported by the National Major Scientific and Technological Special Project (2012ZX10002006-002-003), the National High Technology Research and Development Program of China (2011AA02A114), the National Natural Science Foundation of China (31370927 and 30571650) and the Science and Technology Innovation Action Plan of Shanghai (13431900602).	Agmon-Levin N, 2014, J AUTOIMMUN, V54, P21, DOI 10.1016/j.jaut.2014.06.006; Belafsky PC, 2016, LARYNGOSCOPE, V126, P108, DOI 10.1002/lary.25467; Ben Azoun S, 2016, BIOCHEM ENG J, V113, P77, DOI 10.1016/j.bej.2016.05.013; Block TM, 2015, ANTIVIR RES, V121, P69, DOI 10.1016/j.antiviral.2015.06.014; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Ghatan PH, 2014, CONTACT DERMATITIS, V71, P371, DOI 10.1111/cod.12305; Hall S, 2015, FOOD RES INT, V76, P626, DOI 10.1016/j.foodres.2015.07.027; Janssen JM, 2015, VACCINE, V33, P3614, DOI 10.1016/j.vaccine.2015.05.070; Jensen-Jarolim E, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-015-0060-5; Kimber I, 2014, TOXICOLOGY, V318, P32, DOI 10.1016/j.tox.2014.02.001; Krawczyk A, 2014, VACCINE, V32, P5077, DOI 10.1016/j.vaccine.2014.06.076; Lee MSJ, 2016, VACCINE, V34, P2055, DOI 10.1016/j.vaccine.2016.02.064; Leroux-Roels G, 2016, CLIN IMMUNOL, V169, P16, DOI 10.1016/j.clim.2016.05.007; Li XR, 2015, J CONTROL RELEASE, V204, P38, DOI 10.1016/j.jconrel.2015.02.035; Minhinnick A, 2016, VACCINE, V34, P1412, DOI 10.1016/j.vaccine.2016.01.062; Moon SH, 2015, VACCINE, V33, P4762, DOI 10.1016/j.vaccine.2015.08.006; Nakaya HI, 2016, P NATL ACAD SCI USA, V113, P1853, DOI 10.1073/pnas.1519690113; Pane JA, 2016, SCI REP-UK, V6, DOI 10.1038/srep29697; PERSSON GR, 1994, ORAL MICROBIOL IMMUN, V9, P104, DOI 10.1111/j.1399-302X.1994.tb00043.x; Pujol JL, 2015, J THORAC ONCOL, V10, P1458, DOI 10.1097/JTO.0000000000000653; Segal L, 2015, J APPL TOXICOL, V35, P1577, DOI 10.1002/jat.3131; Segal L, 2015, J APPL TOXICOL, V35, P1564, DOI 10.1002/jat.3130; Wei MJ, 2015, INT IMMUNOPHARMACOL, V27, P238, DOI 10.1016/j.intimp.2015.06.019; Yam KK, 2016, VACCINE, V34, P1444, DOI 10.1016/j.vaccine.2016.02.012; Zhai SQ, 2014, CELL BIOCHEM BIOPHYS, V70, P1813, DOI 10.1007/s12013-014-0134-y; Zhang CW, 2013, MOL IMMUNOL, V53, P60, DOI 10.1016/j.molimm.2012.06.014	26	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170313	10.1371/journal.pone.0170313	http://dx.doi.org/10.1371/journal.pone.0170313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103328	Green Published, gold, Green Submitted			2022-12-26	WOS:000392381100053
J	Abe, S; Nagai, T; Masukawa, M; Okumoto, K; Homma, Y; Fujiki, Y; Mizuno, K				Abe, Shoko; Nagai, Tomoaki; Masukawa, Moe; Okumoto, Kanji; Homma, Yuta; Fujiki, Yukio; Mizuno, Kensaku			Localization of Protein Kinase NDR2 to Peroxisomes and Its Role in Ciliogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OVARY CELL MUTANT; TARGETING SIGNAL; BIOGENESIS; CILIA; TRIPEPTIDE; COMPLEX; RABIN8; PEX5P; IDENTIFICATION; TRAFFICKING	Nuclear Dbf2-related (NDR) kinases, comprising NDR1 and NDR2, are serine/threonine kinases that play crucial roles in the control of cell proliferation, apoptosis, and morphogenesis. We recently showed that NDR2, but not NDR1, is involved in primary cilium formation; however, the mechanism underlying their functional difference in ciliogenesis is unknown. To address this issue, we examined their subcellular localization. Despite their close sequence similarity, NDR2 exhibited punctate localization in the cytoplasm, whereas NDR1 was diffusely distributed within the cell. Notably, NDR2 puncta mostly co-localized with the peroxisome marker proteins, catalase and CFPSKL (cyan fluorescent protein carrying the C-terminal typical peroxisome-targeting signal type-1 (PTS1) sequence, Ser-LysLeu). NDR2 contains the PTS1-like sequence, Gly-Lys-Leu, at the C-terminal end, whereas the C-terminal end ofNDR1is AlaLys. An NDR2 mutant lacking the C-terminal Leu, NDR2(Delta L), exhibited almost diffuse distribution in cells. Additionally, NDR2, but neither NDR1 nor NDR2(Delta L), bound to the PTS1 receptor Pex5p. Together, these findings indicate that NDR2 localizes to the peroxisome by using the C-terminal GKL sequence. Intriguingly, topology analysis of NDR2 suggests that NDR2 is exposed to the cytosolic surface of the peroxisome. The expression of wild-type NDR2, but not NDR2(Delta L), recovered the suppressive effect of NDR2 knockdown on ciliogenesis. Furthermore, knockdown of peroxisome biogenesis factor genes (PEX1 or PEX3) partially suppressed ciliogenesis. These results suggest that the peroxisomal localization of NDR2 is implicated in its function to promote primary cilium formation.	[Abe, Shoko; Nagai, Tomoaki; Masukawa, Moe; Homma, Yuta; Mizuno, Kensaku] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan; [Okumoto, Kanji] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 8190395, Japan; [Fujiki, Yukio] Kyushu Univ, Med Inst Bioregulat, Maidashi, Fukuoka 8128582, Japan	Tohoku University; Kyushu University; Kyushu University	Mizuno, K (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan.	kmizuno@biology.tohoku.ac.jp	Nagai, Tomoaki/N-8924-2017; Homma, Yuta/T-3089-2018; Homma, Yuta/O-1029-2019	Nagai, Tomoaki/0000-0002-9577-9314; Homma, Yuta/0000-0002-3676-6089; Homma, Yuta/0000-0002-3676-6089	Ministry of Education, Culture, Science, Sports, and Technology of Japan Grants for Scientific Research [15H04347, 15H01197, 24247038, 26116007]; Grants-in-Aid for Scientific Research [15K14511, 26440032] Funding Source: KAKEN	Ministry of Education, Culture, Science, Sports, and Technology of Japan Grants for Scientific Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Ministry of Education, Culture, Science, Sports, and Technology of Japan Grants for Scientific Research 15H04347 and 15H01197 (to K. M.) and 24247038 and 26116007 (to Y. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Abiko H, 2015, J CELL SCI, V128, P1683, DOI 10.1242/jcs.157503; Berta AI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024074; Cajanek L, 2014, P NATL ACAD SCI USA, V111, pE2841, DOI 10.1073/pnas.1401777111; Chiba S, 2013, EMBO J, V32, P874, DOI 10.1038/emboj.2013.32; Chiba S, 2009, CURR BIOL, V19, P675, DOI 10.1016/j.cub.2009.02.054; Cornils H, 2011, MOL CELL BIOL, V31, P1382, DOI 10.1128/MCB.01216-10; Cornils H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000681; Devroe E, 2004, J BIOL CHEM, V279, P24444, DOI 10.1074/jbc.M401999200; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Elgersma Y, 1996, J BIOL CHEM, V271, P26375, DOI 10.1074/jbc.271.42.26375; Emoto K, 2011, J BIOCHEM, V150, P133, DOI 10.1093/jb/mvr080; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Fujiki Y, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00307; Goetz SC, 2012, CELL, V151, P847, DOI 10.1016/j.cell.2012.10.010; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Goldstein O, 2010, GENOMICS, V96, P362, DOI 10.1016/j.ygeno.2010.09.003; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Gouveia AMM, 2000, J BIOL CHEM, V275, P32444, DOI 10.1074/jbc.M004366200; Harano T, 2001, BIOCHEM J, V357, P157, DOI 10.1042/0264-6021:3570157; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Hergovich A, 2007, MOL CELL, V25, P625, DOI 10.1016/j.molcel.2007.01.020; Hergovich A, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-32; Hettema EH, 2014, CURR OPIN CELL BIOL, V29, P25, DOI 10.1016/j.ceb.2014.02.002; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Lazarow PB, 2011, CURR OPIN MICROBIOL, V14, P458, DOI 10.1016/j.mib.2011.07.009; Ma CL, 2011, J CELL BIOL, V193, P7, DOI 10.1083/jcb.201010022; Martin CA, 2014, NAT GENET, V46, P1283, DOI 10.1038/ng.3122; Mast FD, 2015, CURR OPIN CELL BIOL, V35, P131, DOI 10.1016/j.ceb.2015.05.002; Matsumura T, 2000, J BIOL CHEM, V275, P21715, DOI 10.1074/jbc.M000721200; MIURA S, 1992, J BIOL CHEM, V267, P14405; Mohan KVK, 2002, J VIROL, V76, P2543, DOI 10.1128/JVI.76.5.2543-2547.2002; Nagai T, 2014, J BIOCHEM, V155, P137, DOI 10.1093/jb/mvu001; Oda T, 2014, GENES CELLS, V19, P927, DOI 10.1111/gtc.12191; Otera H, 1998, MOL CELL BIOL, V18, P388, DOI 10.1128/MCB.18.1.388; Shimizu N, 1999, J BIOL CHEM, V274, P12593, DOI 10.1074/jbc.274.18.12593; Smith JJ, 2013, NAT REV MOL CELL BIO, V14, P803, DOI 10.1038/nrm3700; Sung CH, 2013, NAT CELL BIOL, V15, P1387, DOI 10.1038/ncb2888; SWINKELS BW, 1992, FEBS LETT, V305, P133, DOI 10.1016/0014-5793(92)80880-P; Ultanir SK, 2012, NEURON, V73, P1127, DOI 10.1016/j.neuron.2012.01.019; Vichalkovski A, 2008, CURR BIOL, V18, P1889, DOI 10.1016/j.cub.2008.10.060; Waterham HR, 2016, BBA-MOL CELL RES, V1863, P922, DOI 10.1016/j.bbamcr.2015.11.015; Watters D, 1999, J BIOL CHEM, V274, P34277, DOI 10.1074/jbc.274.48.34277; Westlake CJ, 2011, P NATL ACAD SCI USA, V108, P2759, DOI 10.1073/pnas.1018823108; Zaki MS, 2016, HUM MUTAT, V37, P170, DOI 10.1002/humu.22934; Zhang JW, 2015, NAT CELL BIOL, V17, P1259, DOI 10.1038/ncb3230; Zhang JW, 2013, NAT CELL BIOL, V15, P1186, DOI 10.1038/ncb2822; Zhang L, 2015, CURR BIOL, V25, P296, DOI 10.1016/j.cub.2014.11.054	47	8	9	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4089	4098		10.1074/jbc.M117.775916	http://dx.doi.org/10.1074/jbc.M117.775916			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28122914	Green Published, hybrid			2022-12-26	WOS:000395837100012
J	Engel, N; Adamus, A; Schauer, N; Kuhn, J; Nebe, B; Seitz, G; Kraft, K				Engel, Nadja; Adamus, Anna; Schauer, Nicolas; Kuehn, Juliane; Nebe, Barbara; Seitz, Guido; Kraft, Karin			Synergistic Action of Genistein and Calcitriol in Immature Osteosarcoma MG-63 Cells by SGPL1 Up-Regulation	PLOS ONE			English	Article							BREAST-CANCER; VITAMIN-D; SPHINGOSINE-1-PHOSPHATE LYASE; PROSTATE-CANCER; PLANT-EXTRACTS; GROWTH; MORTALITY; MCF-7; LINES	Background Phytoestrogens such as genistein, the most prominent isoflavone from soy, show concentration-dependent anti-estrogenic or estrogenic effects. High genistein concentrations (>10 mu M) also promote proliferation of bone cancer cells in vitro. On the other hand, the most active component of the vitamin D family, calcitriol, has been shown to be tumor protective in vitro and in vivo. The purpose of this study was to examine a putative synergism of genistein and calcitriol in two osteosarcoma cell lines MG-63 (early osteoblast), Saos-2 (mature osteoblast) and primary osteoblasts. Methods Thus, an initial screening based on cell cycle phase alterations, estrogen (ER) and vitamin D receptor (VDR) expression, live cell metabolic monitoring, and metabolomics were performed. Results Exposure to the combination of 100 mu M genistein and 10 nM calcitriol reduced the number of proliferative cells to control levels, increased ER beta and VDR expression, and reduced extracellular acidification (40%) as well as respiratory activity (70%), primarily in MG-63 cells. In order to identify the underlying cellular mechanisms in the MG-63 cell line, metabolic profiling via GC/MS technology was conducted. Combined treatment significantly influenced lipids and amino acids preferably, whereas metabolites of the energy metabolism were not altered. The comparative analysis of the log2-ratios revealed that after combined treatment only the metabolite ethanolamine was highly up-regulated. This is the result: a strong overexpression (350%) of the enzyme sphingosine-1-phosphate lyase (SGPL1), which irreversibly degrades sphingosine-1-phosphate (S1P), thereby, generating ethanolamine. S1P production and secretion is associated with an increased capability of migration and invasion of cancer cells. Conclusion From these results can be concluded that the tumor promoting effect of high concentrations of genistein in immature osteosarcoma cells is reduced by the co-administration of calcitriol, primarily by the breakdown of S1P. It should be tested whether this anti-metastatic pathway can be stimulated by combined treatment also in metastatic xenograft mice models.	[Engel, Nadja; Adamus, Anna; Seitz, Guido] Univ Hosp Marburg, Dept Pediat Surg, Marburg, Germany; [Engel, Nadja; Adamus, Anna; Kuehn, Juliane; Nebe, Barbara] Univ Rostock, Med Ctr, Dept Cell Biol, Rostock, Germany; [Schauer, Nicolas] Metabol Discoveries GmbH, Potsdam, Germany; [Kraft, Karin] Univ Rostock, Med Ctr, Complementary Med, Ctr Internal Med, Rostock, Germany	University Hospital of Giessen & Marburg; University of Rostock; University of Rostock	Engel, N (corresponding author), Univ Hosp Marburg, Dept Pediat Surg, Marburg, Germany.	nadja.engel-lutz@gmx.de	Seitz, Guido/AAH-5460-2019	Adamus, Anna/0000-0001-9938-8903; Seitz, Prof. Dr. Guido/0000-0001-9280-1451	Federal Ministry of Education and Research Germany (Women Professors Program); FORUN program of the University Medical Center Rostock [889025]; Women Professors Program	Federal Ministry of Education and Research Germany (Women Professors Program); FORUN program of the University Medical Center Rostock; Women Professors Program	This work is supported by fund from Federal Ministry of Education and Research Germany (Women Professors Program) and FORUN program of the University Medical Center Rostock (no. 889025). Women Professors Program provided the salary for author [NE]. Metabolomic Discoveries GmbH, a commercial company, provided support by measuring the metabolomics samples, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bandhuvula P, 2007, TRENDS MOL MED, V13, P210, DOI 10.1016/j.molmed.2007.03.005; Begagne E, 2014, J CLIN INVEST, V124, P5368, DOI 10.1172/JCI74188; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Engel N, 2011, J ETHNOPHARMACOL, V137, P1003, DOI 10.1016/j.jep.2011.07.023; Engel N, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-334; Engel N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047833; Grant WB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2862; Grant WB, 2011, SCAND J PUBLIC HEALT, V39, P70, DOI 10.1177/1403494810382473; Hilakivi-Clarke L, 2010, J NUTR, V140, p2326S, DOI 10.3945/jn.110.124230; Hsieh CY, 1998, CANCER RES, V58, P3833; Hutchinson MS, 2010, EUR J ENDOCRINOL, V162, P935, DOI 10.1530/EJE-09-1041; Jarvinen T, AMERICAN JOURNAL OF, V156, P29; Kaelin WG, 2010, NATURE, V465, P562, DOI 10.1038/465562a; Keum N, 2014, BRIT J CANCER, V111, P976, DOI 10.1038/bjc.2014.294; Krishnan AV, 2007, NUTR REV, V65, pS121, DOI 10.1111/j.1753-4887.2007.tb00338.x; Kumar A, 2009, EXPERT OPIN THER TAR, V13, P1013, DOI 10.1517/14728220903039722; Lamartiniere CA, 1998, P SOC EXP BIOL MED, V217, P358, DOI 10.3181/00379727-217-44245; Lappe J, 2013, EUR J NUTR, V52, P203, DOI 10.1007/s00394-012-0304-x; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Martinez-Montemayor MM, 2010, CLIN EXP METASTAS, V27, P465, DOI 10.1007/s10585-010-9336-x; Murphy LC, 2002, BIOMED PHARMACOTHER, V56, P65, DOI 10.1016/S0753-3322(01)00157-3; PAGLIACCI MC, 1994, EUR J CANCER, V30A, P1675, DOI 10.1016/0959-8049(94)00262-4; Rao A, 2002, J NUTR, V132, P3191, DOI 10.1093/jn/131.10.3191; Schmitt J, 2014, BRIT J CANCER, V111, P1646, DOI 10.1038/bjc.2014.457; Sirtori CR, 2005, ANN MED, V37, P423, DOI 10.1080/07853890510044586; Swami S., 2005, MOL CELL ENDOCRINOL, V12, P12; Van Veldhoven PP, 2000, BBA-MOL CELL BIOL L, V1487, P128, DOI 10.1016/S1388-1981(00)00079-2; Vuolo Laura, 2012, Front Endocrinol (Lausanne), V3, P58, DOI 10.3389/fendo.2012.00058; Wang D, 2008, MOL CANCER THER, V7, P1993, DOI 10.1158/1535-7163.MCT-08-0088; Warsow G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081784; Yang XJ, 2015, CLIN EXP METASTAS, V32, P323, DOI 10.1007/s10585-015-9709-2	32	14	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0169742	10.1371/journal.pone.0169742	http://dx.doi.org/10.1371/journal.pone.0169742			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125641	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100135
J	Finnicum, CT; Dolan, CV; Willemsen, G; Weber, ZM; Petersen, JL; Beck, JJ; Codd, V; Boomsma, DI; Davies, GE; Ehli, EA				Finnicum, Casey T.; Dolan, Conor V.; Willemsen, Gonneke; Weber, Zachary M.; Petersen, Jason L.; Beck, Jeffrey J.; Codd, Veryan; Boomsma, Dorret I.; Davies, Gareth E.; Ehli, Erik A.			Relative Telomere Repeat Mass in Buccal and Leukocyte-Derived DNA	PLOS ONE			English	Article							NETHERLANDS TWIN REGISTER; EXTRACTION METHOD IMPLICATIONS; LENGTH VARIES; STEM-CELLS; BIOLOGY; IDENTIFICATION; METAANALYSIS; ASSOCIATION; PARAMETERS; DYNAMICS	Telomere length has garnered interest due to the potential role it may play as a biomarker for the cellular aging process. Telomere measurements obtained from blood-derived DNA are often used in epidemiological studies. However, the invasive nature of blood draws severely limits sample collection, particularly with children. Buccal cells are commonly sampled for DNA isolation and thus may present a non-invasive alternative for telomere measurement. Buccal and leukocyte derived DNA obtained from samples collected at the same time period were analyzed for telomere repeat mass (TRM). TRM was measured in buccal-derived DNA samples from individuals for whom previous TRM data from blood samples existed. TRM measurement was performed by qPCR and was normalized to the single copy 36B4 gene relative to a reference DNA sample (K562). Correlations between TRM from blood and buccal DNA were obtained and also between the same blood DNA samples measured in separate laboratories. Using the classical twin design, TRM heritability was estimated (N = 1892, MZ = 1044, DZ = 775). Buccal samples measured for TRM showed a significant correlation with the blood-1 (R = 0.39, p < 0.01) and blood-2 (R = 0.36, p < 0.01) samples. Sex and age effects were observed within the buccal samples as is the norm within blood-derived DNA. The buccal, blood-1, and blood-2 measurements generated heritability estimates of 23.3%, 47.6% and 22.2%, respectively. Buccal derived DNA provides a valid source for the determination of TRM, paving the way for non-invasive projects, such as longitudinal studies in children.	[Finnicum, Casey T.; Weber, Zachary M.; Petersen, Jason L.; Beck, Jeffrey J.; Boomsma, Dorret I.; Davies, Gareth E.; Ehli, Erik A.] Avera McKennan Hosp & Univ Hlth Ctr, Avera Inst Human Genet, Sioux Falls, SD 57105 USA; [Dolan, Conor V.; Willemsen, Gonneke; Boomsma, Dorret I.; Davies, Gareth E.] Vrije Univ, Dept Biol Psychol, Amsterdam, Netherlands; [Codd, Veryan] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England	Vrije Universiteit Amsterdam; University of Leicester	Finnicum, CT (corresponding author), Avera McKennan Hosp & Univ Hlth Ctr, Avera Inst Human Genet, Sioux Falls, SD 57105 USA.	Casey.Finnicum@avera.org; di.boomsma@vu.nl	Beck, Jeffrey/AAP-2742-2021; Boomsma, Dorret I/AAX-4470-2020	Beck, Jeffrey/0000-0002-1152-9968; Willemsen, Gonneke/0000-0003-3755-0236; Finnicum, Casey/0000-0001-5959-3961; Codd, Veryan/0000-0002-9430-8254				ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Andrew T, 2006, AM J HUM GENET, V78, P480, DOI 10.1086/500052; Aviv A, 2006, INT J EPIDEMIOL, V35, P1424, DOI 10.1093/ije/dyl169; Bakaysa SL, 2007, AGING CELL, V6, P769, DOI 10.1111/j.1474-9726.2007.00340.x; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Beekman M, 2001, GENET RES, V77, P129, DOI 10.1017/S001667230100492X; Blackburn EH, 2015, SCIENCE, V350, P1193, DOI 10.1126/science.aab3389; Boker S, 2011, PSYCHOMETRIKA, V76, P306, DOI 10.1007/s11336-010-9200-6; Boomsma DI, 2006, TWIN RES HUM GENET, V9, P849, DOI 10.1375/183242706779462426; Broer L, 2013, EUR J HUM GENET, V21, P1163, DOI 10.1038/ejhg.2012.303; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Cunningham JM, 2013, CANCER EPIDEM BIOMAR, V22, P2047, DOI 10.1158/1055-9965.EPI-13-0409; Dalgard C, 2015, INT J EPIDEMIOL, V44, P1688, DOI 10.1093/ije/dyv165; Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602; Deelen J, 2014, INT J EPIDEMIOL, V43, P878, DOI 10.1093/ije/dyt267; Dobson AJ, 2008, AN INTRODUCTION TO G; Falconer D. S., 1996, Introduction to quantitative genetics.; Friedrich U, 2000, MECH AGEING DEV, V119, P89, DOI 10.1016/S0047-6374(00)00173-1; Gardner JP, 2007, J GERONTOL A-BIOL, V62, P367, DOI 10.1093/gerona/62.4.367; Gomes NMV, 2011, AGING CELL, V10, P761, DOI 10.1111/j.1474-9726.2011.00718.x; Heidinger BJ, 2012, P NATL ACAD SCI USA, V109, P1743, DOI 10.1073/pnas.1113306109; Hofmann JN, 2014, CANCER EPIDEM BIOMAR, V23, P1129, DOI 10.1158/1055-9965.EPI-14-0145; Keller MC, 2010, BEHAV GENET, V40, P377, DOI 10.1007/s10519-009-9320-x; MARTIN NG, 1977, HEREDITY, V38, P79, DOI 10.1038/hdy.1977.9; MARTIN NG, 1978, HEREDITY, V40, P97, DOI 10.1038/hdy.1978.10; Martin-Ruiz CM, 2015, INT J EPIDEMIOL, V44, P1673, DOI 10.1093/ije/dyu191; Mathur MB, 2016, BRAIN BEHAV IMMUN, V54, P158, DOI 10.1016/j.bbi.2016.02.002; MEULENBELT I, 1995, AM J HUM GENET, V57, P1252; Min JL, 2006, TWIN RES HUM GENET, V9, P501, DOI 10.1375/twin.9.4.501; Minica CC, 2015, EUR J HUM GENET, V23, P388, DOI 10.1038/ejhg.2014.94; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Oliveira BS, 2016, AGEING RES REV, V26, P37, DOI 10.1016/j.arr.2015.12.006; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Plomin R., 2008, BEHAV GENET; Purcell S, 2002, TWIN RES, V5, P554, DOI 10.1375/136905202762342026; Rizvi Saliha, 2014, Curr Aging Sci, V7, P161; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Scheet P, 2012, TWIN RES HUM GENET, V15, P737, DOI 10.1017/thg.2012.61; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Slieker RC, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-26; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846; Willemsen G, 2013, TWIN RES HUM GENET, V16, P271, DOI 10.1017/thg.2012.140; Willemsen G, 2010, TWIN RES HUM GENET, V13, P231, DOI 10.1375/twin.13.3.231	48	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170765	10.1371/journal.pone.0170765	http://dx.doi.org/10.1371/journal.pone.0170765			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125671	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100058
J	Tebbett, SB; Goatley, CHR; Bellwood, DR				Tebbett, Sterling B.; Goatley, Christopher H. R.; Bellwood, David R.			Algal Turf Sediments and Sediment Production by Parrotfishes across the Continental Shelf of the Northern Great Barrier Reef	PLOS ONE			English	Article							LIMITED FUNCTIONAL REDUNDANCY; INSHORE TURBID REEFS; CORAL-REEFS; INNER-SHELF; COMMUNITY STRUCTURE; SUSPENDED SEDIMENT; EPILITHIC ALGAL; FAMILY SCARIDAE; TERRIGENOUS SEDIMENT; TERRESTRIAL RUNOFF	Sediments are found in the epilithic algal matrix (EAM) of all coral reefs and play important roles in ecological processes. Although we have some understanding of patterns of EAM sediments across individual reefs, our knowledge of patterns across broader spatial scales is limited. We used an underwater vacuum sampler to quantify patterns in two of the most ecologically relevant factors of EAM sediments across the Great Barrier Reef: total load and grain size distribution. We compare these patterns with rates of sediment production and reworking by parrotfishes to gain insights into the potential contribution of parrotfishes to EAM sediments. Inner-shelf reef EAMs had the highest sediment loads with a mean of 864.1 g m(-2), compared to 126.8 g m(-2) and 287.4 g m(-2) on mid-and outer-shelf reefs, respectively. High sediment loads were expected on inner-shelf reefs due to their proximity to the mainland, however, terrigenous siliceous sediments only accounted for 13-24% of total mass. On inner-shelf reef crests parrotfishes would take three months to produce the equivalent mass of sediment found in the EAM. On the outer-shelf it would take just three days, suggesting that inner-shelf EAMs are characterised by low rates of sediment turnover. By contrast, on-reef sediment production by parrotfishes is high on outer-shelf crests. However, exposure to oceanic swells means that much of this production is likely to be lost. Hydrodynamic activity also appears to structure sediment patterns at within-reef scales, with coarser sediments (> 250 mu m) typifying exposed reef crest EAMs, and finer sediments (< 250 mu m) typifying sheltered back-reef EAMs. As both the load and grain size of EAM sediments mediate a number of important ecological processes on coral reefs, the observed sediment gradients are likely to play a key role in the structure and function of the associated coral reef communities.	[Tebbett, Sterling B.] James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia; James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia	James Cook University; James Cook University	Tebbett, SB (corresponding author), James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia.	sterling.tebbett@my.jcu.edu.au	Tebbett, Sterling B./J-9420-2019; Goatley, Christopher/C-1492-2016	Tebbett, Sterling B./0000-0002-9372-7617; Goatley, Christopher/0000-0002-2930-5591	Australian Museum, through a Lizard Island Doctoral Fellowship; Australian Research Council [DP140100122, CE140100020]	Australian Museum, through a Lizard Island Doctoral Fellowship; Australian Research Council(Australian Research Council)	This study was funded by the Australian Museum, through a Lizard Island Doctoral Fellowship (CHRG. URL: http://australiarimuseum.net.au/) and the Australian Research Council (DRB: grant numbers DP140100122 and CE140100020. URL: http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold SN, 2010, MAR ECOL PROG SER, V414, P91, DOI 10.3354/meps08724; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BELLWOOD DR, 1995, MAR ECOL PROG SER, V117, P127, DOI 10.3354/meps117127; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; BELLWOOD DR, 1990, ENVIRON BIOL FISH, V28, P189, DOI 10.1007/BF00751035; Bellwood DR, 1996, MAR BIOL, V125, P795, DOI 10.1007/BF00349262; BELLWOOD DR, 1995, MAR BIOL, V121, P419, DOI 10.1007/BF00349451; Bellwood DR, 2001, CORAL REEFS, V20, P139, DOI 10.1007/s003380100156; Birrell CL, 2005, MAR POLLUT BULL, V51, P408, DOI 10.1016/j.marpolbul.2004.10.022; Bonaldo RM, 2011, CORAL REEFS, V30, P381, DOI 10.1007/s00338-010-0704-4; Bonaldo RM, 2014, OCEANOGR MAR BIOL, V52, P81; Brodie JE, 2012, MAR POLLUT BULL, V65, P81, DOI 10.1016/j.marpolbul.2011.12.012; Brodie J, 2012, ESTUAR COAST SHELF S, V104, P1, DOI 10.1016/j.ecss.2012.03.012; Brown-Saracino J, 2007, CORAL REEFS, V26, P71, DOI 10.1007/s00338-006-0159-9; Browne NK, 2013, MAR GEOL, V346, P101, DOI 10.1016/j.margeo.2013.08.011; Browne NK, 2013, CORAL REEFS, V32, P195, DOI 10.1007/s00338-012-0965-1; Browne NK, 2012, EARTH-SCI REV, V115, P1, DOI 10.1016/j.earscirev.2012.06.006; Browne NK, 2015, J EXP MAR BIOL ECOL, V466, P98, DOI 10.1016/j.jembe.2015.02.010; CARPENTER RC, 1993, LIMNOL OCEANOGR, V38, P687, DOI 10.4319/lo.1993.38.3.0687; Cheal A, 2012, MAR BIOL, V159, P1143, DOI 10.1007/s00227-012-1893-x; CHOAT JH, 1985, MAR BIOL, V89, P221, DOI 10.1007/BF00393655; Clarke K.R., 2006, PRIMER V6 USER MANUA; Clausing RJ, 2014, MAR ECOL PROG SER, V517, P121, DOI 10.3354/meps11029; Crossman DJ, 2001, LIMNOL OCEANOGR, V46, P1596, DOI 10.4319/lo.2001.46.7.1596; Dickens LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018965; Dyer K.R., 1986, COASTAL ESTUARINE SE; Erftemeijer PLA, 2012, MAR POLLUT BULL, V64, P1737, DOI 10.1016/j.marpolbul.2012.05.008; Fabricius K, 2005, MAR POLLUT BULL, V51, P384, DOI 10.1016/j.marpolbul.2004.10.041; Fabricius K, 2001, CORAL REEFS, V19, P303, DOI 10.1007/s003380000120; Fabricius KE, 2016, ESTUAR COAST SHELF S, V173, pA1, DOI 10.1016/j.ecss.2016.03.001; Fabricius KE, 2014, MAR POLLUT BULL, V84, P191, DOI 10.1016/j.marpolbul.2014.05.012; Fabricius KE, 2013, ESTUAR COAST SHELF S, V116, P57, DOI 10.1016/j.ecss.2012.03.010; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Flores F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037795; Fujita K, 2009, CORAL REEFS, V28, P29, DOI 10.1007/s00338-008-0441-0; Fulton CJ, 2013, CORAL REEFS, V32, P685, DOI 10.1007/s00338-013-1039-8; Fulton CJ, 2005, LIMNOL OCEANOGR, V50, P255, DOI 10.4319/lo.2005.50.1.0255; Glynn Peter W., 1997, P68; Goatley CHR, 2016, MAR ECOL PROG SER, V544, P271, DOI 10.3354/meps11614; Goatley CHR, 2016, ECOL SOC, V21, DOI 10.5751/ES-08334-210129; Goatley CHR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077737; Goatley CHR, 2012, BIOL LETTERS, V8, P1016, DOI 10.1098/rsbl.2012.0770; Goatley CHR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039979; Goatley CHR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027307; Goatley CHR, 2010, MAR ECOL PROG SER, V415, P237, DOI 10.3354/meps08761; Gordon SE, 2016, MAR POLLUT BULL, V111, P178, DOI 10.1016/j.marpolbul.2016.07.013; Gordon SE, 2016, CORAL REEFS, V35, P285, DOI 10.1007/s00338-015-1374-z; Hess S, 2015, SCI REP-UK, V5, DOI 10.1038/srep10561; HODGSON G, 1990, CORAL REEFS, V9, P41, DOI 10.1007/BF00686720; Hoey AS, 2010, CORAL REEFS, V29, P499, DOI 10.1007/s00338-010-0605-6; Hoey J, 2007, CORAL REEFS, V26, P603, DOI 10.1007/s00338-007-0246-6; Hopley D, 2007, GEOMORPHOLOGY OF THE GREAT BARRIER REEF: DEVELOPMENT, DIVERSITY, AND CHANGE, P1, DOI 10.1017/CBO9780511535543; Hughes TP, 2015, NAT CLIM CHANGE, V5, P508, DOI 10.1038/nclimate2604; HUTCHINGS PA, 1986, CORAL REEFS, V4, P239, DOI 10.1007/BF00298083; Hutchings Pat, 2011, P139; Johansson CL, 2013, CORAL REEFS, V32, P963, DOI 10.1007/s00338-013-1044-y; Kench PS, 2006, J COASTAL RES, V22, P209, DOI 10.2112/05A-0016.1; KENDRICK GA, 1991, J EXP MAR BIOL ECOL, V147, P47, DOI 10.1016/0022-0981(91)90036-V; KIENE WE, 1994, CORAL REEFS, V13, P91, DOI 10.1007/BF00300767; Kramer MJ, 2014, MAR BIOL, V161, P2183, DOI 10.1007/s00227-014-2495-6; Kramer MJ, 2012, CORAL REEFS, V31, P1007, DOI 10.1007/s00338-012-0924-x; Kroon FJ, 2012, MAR POLLUT BULL, V65, P167, DOI 10.1016/j.marpolbul.2011.10.018; Larcombe P, 2004, QUATERNARY SCI REV, V23, P107, DOI 10.1016/j.quascirev.2003.10.003; LARCOMBE P, 1995, CORAL REEFS, V14, P163, DOI 10.1007/BF00367235; Mallela J, 2007, J FISH BIOL, V70, P523, DOI 10.1111/j.1095-8649.2007.01323.x; Mallela J, 2004, CARIBB J SCI, V40, P299; Mazerolle MJ, 2015, AICCMODAVG MODEL SEL; McCulloch M, 2003, NATURE, V421, P727, DOI 10.1038/nature01361; Morgan KM, 2016, SEDIMENT GEOL, V341, P50, DOI 10.1016/j.sedgeo.2016.05.011; Neil DT, 2002, MAR FRESHWATER RES, V53, P733, DOI 10.1071/MF00151; Orpin AR, 2012, CONT SHELF RES, V47, P55, DOI 10.1016/j.csr.2012.06.013; Orpin AR, 2004, MAR POLLUT BULL, V49, P602, DOI 10.1016/j.marpolbul.2004.03.020; Orpin AR, 1999, AUST J EARTH SCI, V46, P883, DOI 10.1046/j.1440-0952.1999.00751.x; Osorno A, 2005, CORAL REEFS, V24, P292, DOI 10.1007/s00338-005-0478-2; Perez K, 2014, PEERJ, V2, DOI 10.7717/peerj.387; Perry CT, 2015, GEOLOGY, V43, P503, DOI 10.1130/G36623.1; Perry CT, 2012, GEOLOGY, V40, P719, DOI 10.1130/G33261.1; Perry CT, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.2018; Purcell SW, 2001, CORAL REEFS, V20, P117, DOI 10.1007/s003380100150; Purcell SW, 2000, B MAR SCI, V66, P199; Purcell SW, 1996, CORAL REEFS, V15, P211, DOI 10.1007/BF01787453; R Core Team, 2021, R LANGUAGE ENV STAT; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; RUSS G, 1984, MAR ECOL PROG SER, V20, P23, DOI 10.3354/meps020023; SAMMARCO PW, 1990, MAR ECOL PROG SER, V59, P145, DOI 10.3354/meps059145; SCOFFIN TP, 1992, CORAL REEFS, V11, P57, DOI 10.1007/BF00357423; Smithers SG, 2006, J COASTAL RES, V22, P175, DOI 10.2112/05A-0013.1; Steneck R., 1997, P 8 INT COR REEF S, P695; Tebbett SB, 2016, MAR POLLUT B; Tebbett SB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169479; Thibaut LM, 2013, ECOL LETT, V16, P140, DOI 10.1111/ele.12019; Uthicke S, 2012, ECOLOGY, V93, P111, DOI 10.1890/11-0665.1; Wenger AS, 2011, CORAL REEFS, V30, P879, DOI 10.1007/s00338-011-0773-z; Wilson S, 1997, MAR ECOL PROG SER, V153, P299, DOI 10.3354/meps153299; Wismer S, 2009, MAR ECOL PROG SER, V376, P45, DOI 10.3354/meps07790; Wolanski E, 2008, ESTUAR COAST SHELF S, V77, P755, DOI 10.1016/j.ecss.2007.10.014	96	30	30	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0170854	10.1371/journal.pone.0170854	http://dx.doi.org/10.1371/journal.pone.0170854			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122042	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000396167300010
J	Badalato, N; Guillot, A; Sabarly, V; Dubois, M; Pourette, N; Pontoire, B; Robert, P; Bridier, A; Monnet, V; Sousa, DZ; Durand, S; Mazeas, L; Buleon, A; Bouchez, T; Mortha, G; Bize, A				Badalato, Nelly; Guillot, Alain; Sabarly, Victor; Dubois, Marc; Pourette, Nina; Pontoire, Bruno; Robert, Paul; Bridier, Arnaud; Monnet, Veronique; Sousa, Diana Z.; Durand, Sylvie; Mazeas, Laurent; Buleon, Alain; Bouchez, Theodore; Mortha, Gerard; Bize, Ariane			Whole Proteome Analyses on Ruminiclostridium cellulolyticum Show a Modulation of the Cellulolysis Machinery in Response to Cellulosic Materials with Subtle Differences in Chemical and Structural Properties	PLOS ONE			English	Article							CLOSTRIDIUM-CELLULOLYTICUM; ENZYMATIC-HYDROLYSIS; WASTE; METABOLISM; MICROBES; IMPACT; BATCH; PART	Lignocellulosic materials from municipal solid waste emerge as attractive resources for anaerobic digestion biorefinery. To increase the knowledge required for establishing efficient bioprocesses, dynamics of batch fermentation by the cellulolytic bacterium Ruminiclostridium cellulolyticum were compared using three cellulosic materials, paper handkerchief, cotton discs and Whatman filter paper. Fermentation of paper handkerchief occurred the fastest and resulted in a specific metabolic profile: it resulted in the lowest acetate-to-lactate and acetate-to-ethanol ratios. By shotgun proteomic analyses of paper handkerchief and Whatman paper incubations, 151 proteins with significantly different levels were detected, including 20 of the 65 cellulosomal components, 8 non-cellulosomal CAZymes and 44 distinct extracytoplasmic proteins. Consistent with the specific metabolic profile observed, many enzymes from the central carbon catabolic pathways had higher levels in paper handkerchief incubations. Among the quantified CAZymes and cellulosomal components, 10 endoglucanases mainly from the GH9 families and 7 other cellulosomal subunits had lower levels in paper handkerchief incubations. An in-depth characterization of the materials used showed that the lower levels of endoglucanases in paper handkerchief incubations could hypothetically result from its lower crystallinity index (50%) and degree of polymerization (970). By contrast, the higher hemicellulose rate in paper handkerchief (13.87%) did not result in the enhanced expression of enzyme with xylanase as primary activity, including enzymes from the "xyl-doc" cluster. It suggests the absence, in this material, of molecular structures that specifically lead to xylanase induction. The integrated approach developed in this work shows that subtle differences among cellulosic materials regarding chemical and structural characteristics have significant effects on expressed bacterial functions, in particular the cellulolysis machinery, resulting in different metabolic patterns and degradation dynamics.	[Badalato, Nelly; Pourette, Nina; Bridier, Arnaud; Mazeas, Laurent; Bouchez, Theodore; Bize, Ariane] Irstea, UR HBAN, Antony, France; [Guillot, Alain; Monnet, Veronique] INRA, PAPPSO, UMR MICALIS 1319, Jouy En Josas, France; [Sabarly, Victor; Dubois, Marc] Omics Serv, Paris, France; [Pontoire, Bruno; Robert, Paul; Durand, Sylvie; Buleon, Alain] INRA, UR BIA 1268, Nantes, France; [Sousa, Diana Z.] Univ Minho, Ctr Biol Engn, Braga, Portugal; [Sousa, Diana Z.] Wageningen Univ, Microbiol Lab, Wageningen, Netherlands; [Mortha, Gerard] Grenoble INP Pagora, UMR CNRS 5518, LGP2, St Martin Dheres, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Universidade do Minho; Wageningen University & Research; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Centre National de la Recherche Scientifique (CNRS)	Bize, A (corresponding author), Irstea, UR HBAN, Antony, France.	ariane.bize@irstea.fr	BOUCHEZ, Théodore/AAC-4652-2021; Bize, Ariane/L-8447-2018; Sousa, Diana Z/K-5558-2012; Monnet, Veronique/E-9022-2014	BOUCHEZ, Théodore/0000-0002-2236-8282; Bize, Ariane/0000-0003-4023-8665; Sousa, Diana Z/0000-0003-3569-1545; Badalato, Nelly/0000-0002-1994-5894; Monnet, Veronique/0000-0001-7438-5618; MORTHA, Gerard/0000-0002-5944-8489; Bridier, Arnaud/0000-0002-7221-8944	Conseil Regional d'Ile-de-France through DIM R2DS programs [R2DS 2010-08]; Omics Services	Conseil Regional d'Ile-de-France through DIM R2DS programs(Region Ile-de-France); Omics Services	This work was supported by a grant [R2DS 2010-08] from Conseil Regional d'Ile-de-France through DIM R2DS programs (http://www.r2ds-ile-de-france.com/). Irstea (www.irstea.fr/) contributed to the funding of a PhD grant for the first author. The funders provided support in the form of salaries for author [NB], funding for consumables and laboratory equipment, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Omics Services provided support in the form of salaries for authors [VS, MD], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors [NB, VS, MD] are articulated in the 'author contributions' section.	Artzi L, 2015, MBIO, V6, DOI 10.1128/mBio.00411-15; Barinov A, 2009, PROTEOMICS, V9, P61, DOI 10.1002/pmic.200800195; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blouzard JC, 2010, PROTEOMICS, V10, P541, DOI 10.1002/pmic.200900311; Buruiana CT, 2013, ANN UNIV DUNAREA JOS, V37, P25; Chu KH, 2013, PROCESS SAF ENVIRON, V91, P123, DOI 10.1016/j.psep.2011.12.003; Desvaux M, 2005, FEMS MICROBIOL REV, V29, P741, DOI 10.1016/j.femsre.2004.11.003; Desvaux M, 2004, J MICROBIOL BIOTECHN, V14, P1200; Desvaux M, 2001, MICROBIOL-SGM, V147, P1461, DOI 10.1099/00221287-147-6-1461; Desvaux M, 2000, APPL ENVIRON MICROB, V66, P2461, DOI 10.1128/AEM.66.6.2461-2470.2000; Desvaux M, 2006, BIOTECHNOL PROGR, V22, P1229, DOI 10.1021/bp060016e; Gehin A, 1996, J APPL BACTERIOL, V80, P187, DOI 10.1111/j.1365-2672.1996.tb03208.x; GELHAYE E, 1993, APPL ENVIRON MICROB, V59, P3154, DOI 10.1128/AEM.59.9.3154-3156.1993; Hanreich A, 2012, CAN J MICROBIOL, V58, P917, DOI [10.1139/W2012-058, 10.1139/w2012-058]; Hansen MAT, 2011, BIORESOURCE TECHNOL, V102, P2804, DOI 10.1016/j.biortech.2010.10.030; Hasunuma T, 2013, BIORESOURCE TECHNOL, V135, P513, DOI 10.1016/j.biortech.2012.10.047; HEIDELBERGER P, 1983, OPER RES, V31, P1109, DOI 10.1287/opre.31.6.1109; Henniges U, 2007, CELLULOSE, V14, P497, DOI 10.1007/s10570-007-9130-3; Higashide W, 2011, APPL ENVIRON MICROB, V77, P2727, DOI 10.1128/AEM.02454-10; Himmel ME, 2009, CURR OPIN BIOTECH, V20, P316, DOI 10.1016/j.copbio.2009.05.005; Junker J, 2012, J PROTEOME RES, V11, P3914, DOI 10.1021/pr300187f; Kalogo Y, 2007, ENVIRON SCI TECHNOL, V41, P35, DOI 10.1021/es061117b; Kataeva IA, 2002, APPL ENVIRON MICROB, V68, P4292, DOI 10.1128/AEM.68.9.4292-4300.2002; Krassig HA, 1993, CELLULOSE STRUCTURE, P6; Li TL, 2009, ENVIRON MICROBIOL, V11, P889, DOI 10.1111/j.1462-2920.2008.01810.x; Lima D, 2014, BMC P; Lu F, 2014, ISME J, V8, P88, DOI 10.1038/ismej.2013.120; Marshall CW, 2013, CURR OPIN BIOTECH, V24, P391, DOI 10.1016/j.copbio.2013.03.016; Martin AD, 2011, J STAT SOFTW, V42, P1; Mottet A, 2010, CHEM ENG J, V160, P488, DOI 10.1016/j.cej.2010.03.059; Munir RI, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0711-x; Ogeda TL, 2012, J BIOTECHNOL, V157, P246, DOI 10.1016/j.jbiotec.2011.11.018; Olson DG, 2012, CURR OPIN BIOTECH, V23, P396, DOI 10.1016/j.copbio.2011.11.026; Peng XW, 2014, BIORESOURCE TECHNOL, V152, P567, DOI 10.1016/j.biortech.2013.11.067; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Raman B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005271; Ravachol J, 2016, SCI REP-UK, V6, DOI 10.1038/srep22770; Ravachol J, 2014, J BIOL CHEM, V289, P7335, DOI 10.1074/jbc.M113.545046; Renier S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042982; Sangkharak K, 2011, WASTE MANAGE RES, V29, P1134, DOI 10.1177/0734242X10387656; STAMS AJM, 1993, APPL ENVIRON MICROB, V59, P1114, DOI 10.1128/AEM.59.4.1114-1119.1993; Sturm M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-163; WAKELIN JH, 1959, J APPL PHYS, V30, P1654, DOI 10.1063/1.1735031; Xu CG, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-73	44	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170524	10.1371/journal.pone.0170524	http://dx.doi.org/10.1371/journal.pone.0170524			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114419	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129000062
J	Liu, TY; Iavarone, AT; Doudna, JA				Liu, Tina Y.; Iavarone, Anthony T.; Doudna, Jennifer A.			RNA and DNA Targeting by a Reconstituted Thermus thermophilus Type III-A CRISPR-Cas System	PLOS ONE			English	Article							IN-VITRO RECONSTITUTION; STREPTOCOCCUS-THERMOPHILUS; STRUCTURAL BASIS; TRANSCRIPTION ELONGATION; CRYSTAL-STRUCTURE; IMMUNE-SYSTEM; CSM COMPLEX; CLEAVAGE; CASCADE; RECOGNITION	CRISPR-Cas (clustered regularly interspaced short palindromic repeats-CRISPR-associated) systems are RNA-guided adaptive immunity pathways used by bacteria and archaea to defend against phages and plasmids. Type III-A systems use a multisubunit interference complex called Csm, containing Cas proteins and a CRISPR RNA (crRNA) to target cognate nucleic acids. The Csm complex is intriguing in that it mediates RNA-guided targeting of both RNA and transcriptionally active DNA, but the mechanism is not well understood. Here, we overexpressed the five components of the Thermus thermophilus (T. thermophilus) Type III-A Csm complex (TthCsm) with a defined crRNA sequence, and purified intact TthCsm complexes from E. coli cells. The complexes were thermophilic, targeting complementary ssRNA more efficiently at 65 degrees C than at 37 degrees C. Sequence-independent, endonucleolytic cleavage of single-stranded DNA (ssDNA) by TthCsm was triggered by recognition of a complementary ssRNA, and required a lack of complementarity between the first 8 nucleotides (5' tag) of the crRNA and the 3' flanking region of the ssRNA. Mutation of the histidine-aspartate (HD) nuclease domain of the TthCsm subunit, Cas10/Csm1, abolished DNA cleavage. Activation of DNA cleavage was dependent on RNA binding but not cleavage. This leads to a model in which binding of an ssRNA target to the Csm complex would stimulate cleavage of exposed ssDNA in the cell, such as could occur when the RNA polymerase unwinds double-stranded DNA (dsDNA) during transcription. Our findings establish an amenable, thermostable system for more in-depth investigation of the targeting mechanism using structural biology methods, such as cryoelectron microscopy and x-ray crystallography.	[Liu, Tina Y.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Liu, Tina Y.; Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Iavarone, Anthony T.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Innovat Genom Initiat, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Lawrence Berkeley Natl Lab, MBIB Div, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Innovat Genom Initiat, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Lawrence Berkeley Natl Lab, MBIB Div, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA.	doudna@berkeley.edu		Liu, Tina/0000-0003-1297-7102	Howard Hughes Medical Institute (HHMI); NIH S10 Instrumentation Grant [S10RR025622]	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); NIH S10 Instrumentation Grant	This work is supported by the Howard Hughes Medical Institute (HHMI). Jennifer A. Doudna is an HHMI Investigator. Tina Y. Liu is an HHMI Postdoctoral Associate. This work used the Vincent J. Proteomics/Mass Spectrometry Laboratory at UC Berkeley, supported in part by NIH S10 Instrumentation Grant S10RR025622.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Carte J, 2010, RNA, V16, P2181, DOI 10.1261/rna.2230110; Deng LX, 2013, J CONTROL SCI ENG, V2013, DOI 10.1155/2013/416715; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Elmore J, 2015, NUCLEIC ACIDS RES, V43; Elmore JR, 2016, GENE DEV, V30, P447, DOI 10.1101/gad.272153.115; Estrella MA, 2016, GENE DEV, V30, P460, DOI 10.1101/gad.273722.115; Gleditzsch D, 2016, NUCLEIC ACIDS RES, V44, P5872, DOI 10.1093/nar/gkw469; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hatoum-Aslan A, 2014, J BACTERIOL, V196, P310, DOI 10.1128/JB.01130-13; Hochstrasser ML, 2015, TRENDS BIOCHEM SCI, V40, P58, DOI 10.1016/j.tibs.2014.10.007; Jackson RN, 2015, MOL CELL, V58, P722, DOI 10.1016/j.molcel.2015.05.023; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Jung TY, 2015, STRUCTURE, V23, P782, DOI 10.1016/j.str.2015.01.021; Kazlauskiene M, 2016, MOL CELL, V62, P295, DOI 10.1016/j.molcel.2016.03.024; Kuznedelov K, 2016, NUCLEIC ACIDS RES, V44, P10849, DOI 10.1093/nar/gkw914; Luo ML, 2016, NUCLEIC ACIDS RES, V44; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Mulepati S, 2013, J BIOL CHEM, V288, P22184, DOI 10.1074/jbc.M113.472233; Niewoehner O, 2016, RNA, V22, P318, DOI 10.1261/rna.054098.115; Niewoehner O, 2014, NUCLEIC ACIDS RES, V42, P1341, DOI 10.1093/nar/gkt922; Osawa T, 2015, MOL CELL, V58, P418, DOI 10.1016/j.molcel.2015.03.018; RADKEMITCHELL LC, 1986, J DAIRY SCI, V69, P2558, DOI 10.3168/jds.S0022-0302(86)80701-9; Ramia NF, 2014, NUCLEIC ACIDS RES, V42, P1129, DOI 10.1093/nar/gkt914; Rouillon C, 2013, MOL CELL, V52, P124, DOI 10.1016/j.molcel.2013.08.020; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Sinkunas T, 2013, EMBO J, V32, P385, DOI 10.1038/emboj.2012.352; Staals RHJ, 2014, MOL CELL, V56, P518, DOI 10.1016/j.molcel.2014.10.005; Staals RHJ, 2013, MOL CELL, V52, P135, DOI 10.1016/j.molcel.2013.09.013; Szychowska M, 2016, ACTA BIOCHIM POL, V63, P377, DOI 10.18388/abp.2016_1261; Tamulaitis G, 2016, TRENDS MICROBIOL, Vxx, P1; Tamulaitis G, 2014, MOL CELL, V56, P506, DOI 10.1016/j.molcel.2014.09.027; Taylor DW, 2015, SCIENCE, V348, P581, DOI 10.1126/science.aaa4535; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Wang DG, 1997, J BIOL CHEM, V272, P5989, DOI 10.1074/jbc.272.9.5989; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Zetsche B, 2015, CELL, P1; Zhang J, 2016, NUCLEIC ACIDS RES, V44, P1789, DOI 10.1093/nar/gkw020; Zuo YH, 2015, MOL CELL, V58, P534, DOI 10.1016/j.molcel.2015.03.010	48	42	44	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170552	10.1371/journal.pone.0170552	http://dx.doi.org/10.1371/journal.pone.0170552			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114398	Green Published, Green Submitted, gold			2022-12-26	WOS:000396129000065
J	Dutz, S; Hayden, ME; Hafell, UO				Dutz, S.; Hayden, M. E.; Hafell, U. O.			Fractionation of Magnetic Microspheres in a Microfluidic Spiral: Interplay between Magnetic and Hydrodynamic Forces	PLOS ONE			English	Article							INERTIAL MIGRATION; SPHERICAL-PARTICLE; CELL-SEPARATION; RIGID SPHERE; FLOW; NANOPARTICLES; MANIPULATION; FILTRATION; SYSTEMS; FLUID	Magnetic forces and curvature-induced hydrodynamic drag have both been studied and employed in continuous microfluidic particle separation and enrichment schemes. Here we combine the two. We investigate consequences of applying an outwardly directed magnetic force to a dilute suspension of magnetic microspheres circulating in a spiral microfluidic channel. This force is realized with an array of permanent magnets arranged to produce a magnetic field with octupolar symmetry about the spiral axis. At low flow rates particles cluster around an apparent streamline of the flow near the outer wall of the turn. At high flow rates this equilibrium is disrupted by the induced secondary (Dean) flow and a new equilibrium is established near the inner wall of the turn. A model incorporating key forces involved in establishing these equilibria is described, and is used to extract quantitative information about the magnitude of local Dean drag forces from experimental data. Steady-state fractionation of suspensions by particle size under the combined influence of magnetic and hydrodynamic forces is demonstrated. Extensions of this work could lead to new continuous microscale particle sorting and enrichment processes with improved fidelity and specificity.	[Dutz, S.; Hafell, U. O.] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada; [Dutz, S.] Tech Univ Ilmenau, Inst Biomed Engn & Informat BMTI, Ilmenau, Germany; [Hayden, M. E.] Simon Fraser Univ, Dept Phys, Burnaby, BC, Canada	University of British Columbia; Technische Universitat Ilmenau; Simon Fraser University	Dutz, S (corresponding author), Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada.; Dutz, S (corresponding author), Tech Univ Ilmenau, Inst Biomed Engn & Informat BMTI, Ilmenau, Germany.	silvio.dutz@tu-ilmenau.de	Dutz, Silvio/E-3865-2010	Hafeli, Urs/0000-0003-0671-4509	Postdoc-Programme of the German Academic Exchange Service (DAAD); Canadian Foundation for Innovation (CFI); Natural Sciences and Engineering Research Council of Canada; British Columbia Innovation Council (BCIC); German Research Foundation (DFG); Open Access Publication Fund of the Technische Universitat Ilmenau	Postdoc-Programme of the German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); British Columbia Innovation Council (BCIC); German Research Foundation (DFG)(German Research Foundation (DFG)); Open Access Publication Fund of the Technische Universitat Ilmenau	This work was funded by a fellowship within the "Postdoc-Programme of the German Academic Exchange Service (DAAD)". The authors also acknowledge funding from the Canadian Foundation for Innovation (CFI), the Natural Sciences and Engineering Research Council of Canada, and the British Columbia Innovation Council (BCIC). We acknowledge support for the Article Processing Charge by the German Research Foundation (DFG) and the Open Access Publication Fund of the Technische Universitat Ilmenau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz M., 1972, HDB MATH FUNCTIONS F; Adams JD, 2009, JALA-J LAB AUTOM, V14, P331, DOI 10.1016/j.jala.2009.06.003; Amini H, 2014, LAB CHIP, V14, P2739, DOI 10.1039/c4lc00128a; Andrae W., 2007, HDB MAGNETISM ADV MA, P2536; [Anonymous], 1961, INTRO ELLIPTIC FUNCT; Asmolov ES, 1999, J FLUID MECH, V381, P63, DOI 10.1017/S0022112098003474; Berret JF, 2007, LANGMUIR, V23, P2993, DOI 10.1021/la061958w; Bhagat AAS, 2008, LAB CHIP, V8, P1906, DOI 10.1039/b807107a; Bolinder CJ, 1996, J FLUID MECH, V314, P113, DOI 10.1017/S0022112096000250; Cabral B., 1993, Computer Graphics Proceedings, P263, DOI 10.1145/166117.166151; Cao QL, 2014, LAB CHIP, V14, P2762, DOI 10.1039/c4lc00367e; Carpino F, 2007, J MAGN MAGN MATER, V311, P383, DOI 10.1016/j.jmmm.2006.11.162; Chanteau B, 2009, LANGMUIR, V25, P9064, DOI 10.1021/la900833v; Chatterjee A, 2011, PROC SPIE, V7929, DOI 10.1117/12.875774; Chatterjee J, 2003, J MAGN MAGN MATER, V257, P113, DOI 10.1016/S0304-8853(02)01066-1; Chuang HS, 2010, MICROFLUID NANOFLUID, V9, P743, DOI 10.1007/s10404-010-0589-0; Dean WR, 1928, PHILOS MAG, V5, P673; Dean WR, 1927, PHILOS MAG, V4, P208; Di Carlo D, 2007, P NATL ACAD SCI USA, V104, P18892, DOI 10.1073/pnas.0704958104; Di Carlo D, 2009, LAB CHIP, V9, P3038, DOI 10.1039/b912547g; Di Carlo D, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.094503; Dutz S, 2012, J MAGN MAGN MATER, V324, P3791, DOI 10.1016/j.jmmm.2012.06.014; Dutz S, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/35/355701; Dutz S, 2009, J MAGN MAGN MATER, V321, P1501, DOI 10.1016/j.jmmm.2009.02.073; Eichhorn R., 1964, J FLUID MECH, V20, P513; GERBER R, 1984, IEEE T MAGN, V20, P1159, DOI 10.1109/TMAG.1984.1063234; Glockl G, 2006, J PHYS-CONDENS MAT, V18, pS2935, DOI 10.1088/0953-8984/18/38/S27; Gossett DR, 2010, ANAL BIOANAL CHEM, V397, P3249, DOI 10.1007/s00216-010-3721-9; Gossett DR, 2009, ANAL CHEM, V81, P8459, DOI 10.1021/ac901306y; Hafeli UO, 2006, SMART NANOPARTICLES, V8, P77; Hayden ME, 2006, J PHYS-CONDENS MAT, V18, pS2877, DOI 10.1088/0953-8984/18/38/S23; HO BP, 1974, J FLUID MECH, V65, P365, DOI 10.1017/S0022112074001431; Hood K, 2015, J FLUID MECH, V765, P452, DOI 10.1017/jfm.2014.739; Huh D, 2007, ANAL CHEM, V79, P1369, DOI 10.1021/ac061542n; Ijiri Y, 2013, IEEE T MAGN, V49, P3449, DOI 10.1109/TMAG.2013.2244577; Kuntaegowdanahalli SS, 2009, LAB CHIP, V9, P2973, DOI 10.1039/b908271a; Laurell T, 2007, CHEM SOC REV, V36, P492, DOI 10.1039/b601326k; Lohrke J, 2008, NANOMEDICINE-UK, V3, P437, DOI 10.2217/17435889.3.4.437; Martel JM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03340; Matas JP, 2009, J FLUID MECH, V621, P59, DOI 10.1017/S0022112008004977; Milne G, 2007, OPT LETT, V32, P1144, DOI 10.1364/OL.32.001144; Mustin B, 2010, MICROFLUID NANOFLUID, V9, P905, DOI 10.1007/s10404-010-0613-4; Pamme N, 2007, LAB CHIP, V7, P1644, DOI 10.1039/b712784g; Pamme N, 2006, J MAGN MAGN MATER, V307, P237, DOI 10.1016/j.jmmm.2006.04.008; Rosensweig RE, 1998, FERROHYDRODYNAMICS; Sajeesh P, 2014, MICROFLUID NANOFLUID, V17, P1, DOI 10.1007/s10404-013-1291-9; SCHONBERG JA, 1989, J FLUID MECH, V203, P517, DOI 10.1017/S0022112089001564; Seo J, 2007, J CHROMATOGR A, V1162, P126, DOI 10.1016/j.chroma.2007.05.110; Shields CW, 2015, LAB CHIP, V15, P1230, DOI 10.1039/c4lc01246a; Smistrup K, 2005, J MAGN MAGN MATER, V293, P597, DOI 10.1016/j.jmmm.2005.01.079; Sollier E, 2009, SENSOR ACTUAT B-CHEM, V141, P617, DOI 10.1016/j.snb.2009.05.023; Thurm S, 2002, J MAGN MAGN MATER, V252, P247, DOI 10.1016/S0304-8853(02)00679-0; TORCHILIN VP, 1988, HAEMOSTASIS, V18, P113; Torno MD, 2008, THROMB RES, V121, P799, DOI 10.1016/j.thromres.2007.08.017; VASSEUR P, 1976, J FLUID MECH, V78, P385, DOI 10.1017/S0022112076002498; Willmott N, 1994, MICROSPHERES REGIONA; Yamada M, 2005, LAB CHIP, V5, P1233, DOI 10.1039/b509386d; Zborowski M, 1999, J MAGN MAGN MATER, V194, P224, DOI 10.1016/S0304-8853(98)00581-2; Zborowski M, 2009, MAGNETIC CELL SEPARA; Zeng L, 2011, DRUG DELIV; Zhao Hong, 2007, Biomagn Res Technol, V5, P2, DOI 10.1186/1477-044X-5-2; Zhou J, 2013, LAB CHIP, V13, P1121, DOI 10.1039/c2lc41248a	62	6	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0169919	10.1371/journal.pone.0169919	http://dx.doi.org/10.1371/journal.pone.0169919			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107472	Green Published, gold, Green Submitted			2022-12-26	WOS:000392405300050
J	Kishikawa, H; Kimura, K; Ito, A; Arahata, K; Takarabe, S; Kaida, S; Kanai, T; Miura, S; Nishida, J				Kishikawa, Hiroshi; Kimura, Kayoko; Ito, Asako; Arahata, Kyoko; Takarabe, Sakiko; Kaida, Shogo; Kanai, Takanori; Miura, Soichiro; Nishida, Jiro			Association between Increased Gastric Juice Acidity and Sliding Hiatal Hernia Development in Humans	PLOS ONE			English	Article							HELICOBACTER-PYLORI; ESOPHAGITIS; PREDICTORS	Objectives Several clinical factors; overweight, male gender and increasing age, have been implicated as the etiology of hiatal hernia. Esophageal shortening due to acid perfusion in the lower esophagus has been suggested as the etiological mechanism. However, little is known about the correlation between gastric acidity and sliding hiatus hernia formation. This study examined whether increased gastric acid secretion is associated with an endoscopic diagnosis of hiatal hernia. Methods A total of 286 consecutive asymptomatic patients (64 were diagnosed as having a hiatal hernia) who underwent upper gastrointestinal endoscopy were studied. Clinical findings including fasting gastric juice pH as an indicator of acid secretion, age, sex, body mass index, and Helicobacter pylori infection status determined by both Helicobacter pylori serology and pepsinogen status, were evaluated to identify predictors in subjects with hiatal hernia. Results Male gender, obesity with a body mass index >25, and fasting gastric juice pH were significantly different between subjects with and without hiatal hernia. The cut-off point of fasting gastric juice pH determined by receiver operating curve analysis was 2.1. Multivariate regression analyses using these variables, and age, which is known to be associated with hiatal hernia, revealed that increased gastric acid secretion with fasting gastric juice pH <2.1 (OR = 2.60, 95% CI: 1.38-4.90) was independently associated with hiatal hernia. Moreover, previously reported risk factors including male gender (OR = 2.32, 95% CI: 1.23-4.35), body mass index >25 (OR = 3.49, 95% CI: 1.77-6.91) and age >65 years (OR = 1.86, 95% CI: 1.00-3.45), were also significantly associated with hiatal hernia. Conclusions This study suggests that increased gastric acid secretion independently induces the development of hiatal hernia in humans. These results are in accordance with the previously reported hypothesis that high gastric acid itself induces hiatal hernia development.	[Kishikawa, Hiroshi; Kimura, Kayoko; Ito, Asako; Arahata, Kyoko; Takarabe, Sakiko; Kaida, Shogo; Nishida, Jiro] Ichikawa Gen Hosp, Tokyo Dent Coll, Dept Gastroenterol, Chiba, Japan; [Kanai, Takanori; Miura, Soichiro] Keio Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Shinjyuku Ku, Keio, Japan	Tokyo Dental College; Keio University	Kishikawa, H (corresponding author), Ichikawa Gen Hosp, Tokyo Dent Coll, Dept Gastroenterol, Chiba, Japan.	kisikawa@tdc.ac.jp	Kishikawa, Hiroshi/AAU-5977-2021	Kanai, Takanori/0000-0002-1466-4532				Ayazi S, 2009, SURG ENDOSC, V23, P1968, DOI 10.1007/s00464-008-0218-0; DeMeester TR, 1989, SUGICAL TREATMENT DI; Dent J, 2008, NEUROGASTROENT MOTIL, V20, P91, DOI 10.1111/j.1365-2982.2008.01096.x; Dunne DP, 2000, CAN J GASTROENTEROL, V14, P847, DOI 10.1155/2000/438981; Gastal OL, 1999, ARCH SURG-CHICAGO, V134, P633, DOI 10.1001/archsurg.134.6.633; Gordon C, 2004, ALIMENT PHARM THER, V20, P719, DOI 10.1111/j.1365-2036.2004.02149.x; Hill LD, 1996, GASTROINTEST ENDOSC, V44, P541, DOI 10.1016/S0016-5107(96)70006-8; Itoh T, 2015, JPN J RADIOL, V33, P636, DOI 10.1007/s11604-015-0469-3; Iwakiri K, 2007, J GASTROEN HEPATOL, V22, P2212, DOI 10.1111/j.1440-1746.2006.04726.x; Kahrilas PJ, 2008, BEST PRACT RES CL GA, V22, P601, DOI 10.1016/j.bpg.2007.12.007; Kishikawa H, 2015, ANTICANCER RES, V35, P6765; Kishikawa H, 2015, DIS MARKERS, V2015, P1, DOI 10.1155/2015/156719; Kishikawa H, 2014, CLIN RES HEPATOL GAS, V38, P505, DOI 10.1016/j.clinre.2014.01.008; Kishikawa H, 2011, HELICOBACTER, V16, P427, DOI 10.1111/j.1523-5378.2011.00868.x; Lee YY, 2014, GUT, V63, P1053, DOI 10.1136/gutjnl-2013-305803; Lundell LR, 1999, GUT, V45, P172, DOI 10.1136/gut.45.2.172; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; Menon S, 2011, EUR J GASTROEN HEPAT, V23, P133, DOI 10.1097/MEG.0b013e3283426f57; Mittal RK, 1987, GASTROENTEROLOGY, V92, P130, DOI 10.1016/0016-5085(87)90849-3; Pandolfino JE, 2008, GASTROENTEROL CLIN N, V37, P827, DOI 10.1016/j.gtc.2008.09.009; PATERSON WG, 1994, GASTROENTEROLOGY, V107, P1736, DOI 10.1016/0016-5085(94)90814-1; Swanstrom LL, 1996, AM J SURG, V171, P477, DOI 10.1016/S0002-9610(96)00008-6; Tucci A, 2007, GASTROINTEST ENDOSC, V66, P881, DOI 10.1016/j.gie.2007.03.1052; Ueda J, 2014, HELICOBACTER, V19, P105, DOI 10.1111/hel.12110; Yamamichi N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111359	25	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170416	10.1371/journal.pone.0170416	http://dx.doi.org/10.1371/journal.pone.0170416			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107506	Green Submitted, gold, Green Published			2022-12-26	WOS:000392405300130
J	Mechtensimer, S; Toor, GS				Mechtensimer, Sara; Toor, Gurpal S.			Septic Systems Contribution to Phosphorus in Shallow Groundwater: Field-Scale Studies Using Conventional Drainfield Designs	PLOS ONE			English	Article							GRASSLAND SOIL; WATER; SEDIMENTS; AQUIFERS; PLUMES	Septic systems can be a potential source of phosphorus (P) in groundwater and contribute to eutrophication in aquatic systems. Our objective was to investigate P transport from two conventional septic systems (drip dispersal and gravel trench) to shallow groundwater. Two new in-situ drainfields (6.1 m long by 0.61 m wide) with a 3.72 m(2) infiltrative surface were constructed. The drip dispersal drainfield was constructed by placing 30.5 cm commercial sand on top of natural soil and the gravel trench drainfield was constructed by placing 30.5 cm of gravel on top of 30.5 cm commercial sand and natural soil. Suction cup lysimeters were installed in the drainfields (at 30.5, 61, 106.7 cm below infiltrative surface) and piezometers were installed in the groundwater (>300 cm below infiltrative surface) to capture P dynamics from the continuum of unsaturated to saturated zones in the septic systems. Septic tank effluent (STE), soil-water, and groundwater samples were collected for 64 events (May 2012-Dec 2013) at 2 to 3 days (n = 13), weekly (n = 29), biweekly (n = 17), and monthly (n = 5) intervals. One piezometer was installed up-gradient of the drainfields to monitor background groundwater (n = 15). Samples were analyzed for total P (TP), orthophosphate- P (PO4-P), and other-P (TP D PO4-P). The gravel trench drainfield removed significantly (p<0.0001) greater TP (similar to 20%) than the drip dispersal in the first 30.5 cm of the drainfield. However, when STE reached >300 cm in the groundwater, both systems had similar TP reductions of >97%. After 18 months of STE application, there was no significant increase in groundwater TP concentrations in both systems. We conclude that both drainfield designs are effective at reducing P transport to shallow groundwater.	[Mechtensimer, Sara; Toor, Gurpal S.] Univ Florida, Soil & Water Qual Lab, Gulf Coast Res & Educ Ctr, Inst Food & Agr Sci, Wimauma, FL 33598 USA	State University System of Florida; University of Florida	Toor, GS (corresponding author), Univ Florida, Soil & Water Qual Lab, Gulf Coast Res & Educ Ctr, Inst Food & Agr Sci, Wimauma, FL 33598 USA.	gstoor@ufl.edu			Florida Department of Health via Hazen; Sawyer Inc; Soil and Water Quality Laboratory located at the Gulf Coast Research and Education Center of the University of Florida-Institute of Food and Agricultural Sciences	Florida Department of Health via Hazen; Sawyer Inc; Soil and Water Quality Laboratory located at the Gulf Coast Research and Education Center of the University of Florida-Institute of Food and Agricultural Sciences	Funding for the construction of drainfields was provided by Florida Department of Health via Hazen and Sawyer Inc and the Soil and Water Quality Laboratory located at the Gulf Coast Research and Education Center of the University of Florida-Institute of Food and Agricultural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter ouradherence to PLOS ONE policies on sharing data and materials. The specific roles of these authors are articulated in the authors contribution section.; Funding for the construction of drainfields was provided by Florida Department of Health via Hazen and Sawyer Inc. We thank Hazen and Sawyer Inc. personnel for their cooperation and support. Funding for the research work was provided by Soil & Water Quality Laboratory located at the Gulf Coast Research and Education of the University of Florida-IFAS.	CAPONE DG, 1990, BIOGEOCHEMISTRY, V10, P277; CHAUHAN BS, 1981, CAN J SOIL SCI, V61, P373, DOI 10.4141/cjss81-041; De M, 2015, VADOSE ZONE J, V14, DOI 10.2136/vzj2015.07.0096; EBINA J, 1983, WATER RES, V17, P1721, DOI 10.1016/0043-1354(83)90192-6; EPA, 1980, DES MAN ONS WAST TRE; FDOH, 2013, FDOH CHAPT 64E 6 FAC; Hall P, 2009, FLORIDA STA IN PRESS; Lapointe BE, 2015, HARMFUL ALGAE, V43, P82, DOI 10.1016/j.hal.2015.01.004; LOMBARDO P., 2006, PHOSPHORUS GEOCHEMIS; Mechtensimer S, 2016, CHEMOSPHERE, V159, P153, DOI 10.1016/j.chemosphere.2016.05.084; Meeroff DE, 2008, WATER AIR SOIL POLL, V192, P11, DOI 10.1007/s11270-008-9630-2; Meinikmann K, 2015, HYDROLOGY, V524, P214; Ouyang Y, 2012, WATER AIR SOIL POLL, V223, P3181, DOI 10.1007/s11270-012-1100-1; Robertson WD, 2008, GROUND WATER, V46, P51, DOI 10.1111/j.1745-6584.2007.00389.x; Robertson WD, 2012, J ENVIRON QUAL, V41, P1437, DOI 10.2134/jeq2011.0427; ROBERTSON WD, 1991, GROUND WATER, V29, P82, DOI 10.1111/j.1745-6584.1991.tb00500.x; Robertson WD, 1998, GROUND WATER, V36, P1000, DOI 10.1111/j.1745-6584.1998.tb02107.x; SFWMD, 2016, WEATH WAT S FLOR WAT; Toor GS, 2005, EUR J SOIL SCI, V56, P155, DOI 10.1111/j.1365-2389.2004.00656.x; Toor GS, 2003, SOIL BIOL BIOCHEM, V35, P1317, DOI 10.1016/S0038-0717(03)00202-5; Toor GS, 2016, ADV AGRON, V89, P1; Toor GS, 2016, J ENVIRON QUAL, V45, P1; Wilhelm SR, 1996, GROUND WATER, V34, P853, DOI 10.1111/j.1745-6584.1996.tb02080.x; Zanini L, 1998, J CONTAM HYDROL, V33, P405, DOI 10.1016/S0169-7722(98)00082-5	24	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170304	10.1371/journal.pone.0170304	http://dx.doi.org/10.1371/journal.pone.0170304			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107505	Green Published, gold			2022-12-26	WOS:000392405300105
J	Mpakou, V; Papadavid, E; Kontsioti, F; Konsta, E; Vikentiou, M; Spathis, A; Papageorgiou, S; Vasilatou, D; Gkontopoulos, K; Mpazani, E; Karakitsos, P; Rigopoulos, D; Dimitriadis, G; Pappa, V				Mpakou, Vassiliki; Papadavid, Evangelia; Kontsioti, Frieda; Konsta, Eugene; Vikentiou, Miriam; Spathis, Aris; Papageorgiou, Sotiris; Vasilatou, Diamantina; Gkontopoulos, Konstantinos; Mpazani, Efthimia; Karakitsos, Petros; Rigopoulos, Dimitrios; Dimitriadis, George; Pappa, Vasiliki			Apoptosis Induction and Gene Expression Profile Alterations of Cutaneous T-Cell Lymphoma Cells following Their Exposure to Bortezomib and Methotrexate	PLOS ONE			English	Article							LOW-DOSE METHOTREXATE; PROTEASOME INHIBITOR BORTEZOMIB; PHASE-II TRIAL; MYCOSIS-FUNGOIDES; SEZARY-SYNDROME; CANCER; SURVIVAL; PATHWAY; PROLIFERATION; SENSITIVITY	Mycosis fungoides (MF) and its leukemic variant Sezary syndrome (SS) comprise the majority of CTCL, a heterogenous group of non-Hodgkins lymphomas involving the skin. The CTCL's resistance to chemotherapy and the lack of full understanding of their pathogenesis request further investigation. With the view of a more targeted therapy, we evaluated in vitro the effectiveness of bortezomib and methotrexate, as well as their combination in CTCL cell lines, regarding apoptosis induction. Our data are of clinical value and indicate that the bortezomib/methotrexate combinational therapy has an inferior impact on the apoptosis of CTCL compared to monotherapy, with bortezomib presenting as the most efficient treatment option for SS and methotrexate for MF. Using PCR arrays technology, we also investigated the alterations in the expression profile of genes related to DNA repair pathways in CTCL cell lines after treatment with bortezomib or methotrexate. We found that both agents, but mostly bortezomib, significantly deregulate a large number of genes in SS and MF cell lines, suggesting another pathway through which these agents could induce apoptosis in CTCL. Finally, we show that SS and MF respond differently to treatment, verifying their distinct nature and further emphasizing the need for discrete treatment approaches.	[Mpakou, Vassiliki; Kontsioti, Frieda; Konsta, Eugene; Vikentiou, Miriam; Papageorgiou, Sotiris; Vasilatou, Diamantina; Gkontopoulos, Konstantinos; Mpazani, Efthimia; Dimitriadis, George; Pappa, Vasiliki] Attikon Univ Gen Hosp, Dept Internal Med 2, Rimini 1, Athens, Greece; [Mpakou, Vassiliki; Kontsioti, Frieda; Konsta, Eugene; Vikentiou, Miriam; Papageorgiou, Sotiris; Vasilatou, Diamantina; Gkontopoulos, Konstantinos; Mpazani, Efthimia; Dimitriadis, George; Pappa, Vasiliki] Attikon Univ Gen Hosp, Res Inst, Rimini 1, Athens, Greece; [Papadavid, Evangelia; Rigopoulos, Dimitrios] Attikon Univ Gen Hosp, Dept Dermatol 2, Rimini 1, Athens, Greece; [Papadavid, Evangelia] Univ Athens, Sch Med, A Syggros Univ Hosp, Dept Dermatol 1, GR-10679 Athens, Greece; [Spathis, Aris; Karakitsos, Petros] Attikon Univ Gen Hosp, Dept Cytopathol, Athens, Greece	University Hospital Attikon; University Hospital Attikon; University Hospital Attikon; Athens Medical School; National & Kapodistrian University of Athens; University Hospital Attikon	Pappa, V (corresponding author), Attikon Univ Gen Hosp, Dept Internal Med 2, Rimini 1, Athens, Greece.; Pappa, V (corresponding author), Attikon Univ Gen Hosp, Res Inst, Rimini 1, Athens, Greece.	vas_pappa@yahoo.com	Spathis, Aris T/A-2442-2015; Papadavid, Evangelia/A-9211-2015; rigopoulos, dimitrios/AAG-3052-2020; Papageorgiou, Sotirios G./AAL-4906-2021	Spathis, Aris T/0000-0001-8867-3661; Papageorgiou, Sotirios G./0000-0002-3376-837X; Mpakou, Vassiliki/0000-0002-8850-884X	European Union (European Social Fund - ESF); Greek national funds through the Operational Program [MIS: 377177]	European Union (European Social Fund - ESF)(European Social Fund (ESF)); Greek national funds through the Operational Program	This work is co-financed by the European Union (European Social Fund - ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) Research Funding Program: THALIS - UOA-'Analysis of genotoxic resistance mechanisms of breast cancer stem cells: applications in prognosis, diagnosis & treatment', MIS: 377177.	Aviles A, 2007, CANCER BIOTHER RADIO, V22, P836, DOI 10.1089/cbr.2007.0402; Aviles A, 2015, HEMATOLOGY, V20, P538, DOI 10.1179/1607845415Y.0000000002; Barnhart K, 2001, Expert Opin Pharmacother, V2, P409, DOI 10.1517/14656566.2.3.409; Biskup E, 2013, BRIT J DERMATOL, V168, P504, DOI 10.1111/bjd.12071; Boudjarane J, 2015, EXP DERMATOL, V24, P60, DOI 10.1111/exd.12567; Buac D, 2013, CURR PHARM DESIGN, V19, P4025, DOI 10.2174/1381612811319220012; Campbell JJ, 2010, BLOOD, V116, P767, DOI 10.1182/blood-2009-11-251926; Chang TP, 2015, J IMMUNOL, V194, P2942, DOI 10.4049/jimmunol.1402610; Chang TP, 2014, BBA-MOL CELL RES, V1843, P2620, DOI 10.1016/j.bbamcr.2014.07.012; Chung CG, 2015, CURR HEMATOL MALIG R, V10, P468, DOI 10.1007/s11899-015-0293-y; Devata S, 2016, AM J CLIN DERMATOL; Drews RE, 2012, J CLIN ONCOL, V30, P4064, DOI 10.1200/JCO.2012.44.5650; Du LQ, 2012, J CANCER RES CLIN, V138, P811, DOI 10.1007/s00432-011-1132-8; Gibson RJ, 2005, CLIN EXP MED, V4, P188, DOI 10.1007/s10238-004-0055-y; Girardi M, 2004, NEW ENGL J MED, V350, P1978, DOI 10.1056/NEJMra032810; Heider U, 2009, EUR J HAEMATOL, V82, P440, DOI 10.1111/j.1600-0609.2009.01239.x; Hideshima T, 2001, CANCER RES, V61, P3071; Holkova B, 2012, BEST PRACT RES CL HA, V25, P133, DOI 10.1016/j.beha.2012.04.007; Horwitz SM, 2008, CLIN LYMPHOMA MYELOM, V8, pS187, DOI 10.3816/CLM.2008.s.015; Howard SM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004943; Huang WY, 2011, BIOCHEM PHARMACOL, V81, P510, DOI 10.1016/j.bcp.2010.11.014; Hughes CFM, 2015, BLOOD, V125, P71, DOI 10.1182/blood-2014-07-588236; Jacquemont C, 2007, CANCER RES, V67, P7395, DOI 10.1158/0008-5472.CAN-07-1015; Jain S, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-24; Juvekar A, 2011, MOL CANCER RES, V9, P183, DOI 10.1158/1541-7786.MCR-10-0368; Kannangara AP, 2009, J DERMATOL TREAT, V20, P169, DOI 10.1080/09546630802562427; Kim SJ, 2012, EUR J CANCER, V48, P3223, DOI 10.1016/j.ejca.2012.06.003; Kim YH, 2003, ARCH DERMATOL, V139, P857, DOI 10.1001/archderm.139.7.857; Kozuch PS, 2008, J CLIN ONCOL, V26, P2320, DOI 10.1200/JCO.2007.14.0152; Krogan NJ, 2004, MOL CELL, V16, P1027, DOI 10.1016/j.molcel.2004.11.033; Kruiswijk F, 2015, NAT REV MOL CELL BIO, V16, P393, DOI 10.1038/nrm4007; Li Janet Y, 2012, Cancer Manag Res, V4, P75, DOI 10.2147/CMAR.S9660; Lopes UG, 1997, J BIOL CHEM, V272, P12893, DOI 10.1074/jbc.272.20.12893; LORICO A, 1988, CANCER RES, V48, P2036; Manfe V, 2012, J INVEST DERMATOL, V132, P1487, DOI 10.1038/jid.2012.10; Morales C, 2009, MOL CANCER THER, V8, P424, DOI 10.1158/1535-7163.MCT-08-0759; Morris MJ, 2007, J UROLOGY, V178, P2378, DOI 10.1016/j.juro.2007.08.015; Motegi A, 2009, CANCER LETT, V283, P1, DOI 10.1016/j.canlet.2008.12.030; Mpakou VE, 2013, LEUKEMIA RES, V37, P175, DOI 10.1016/j.leukres.2012.10.011; Navi D, 2011, ARCH DERMATOL, V147, P561, DOI 10.1001/archdermatol.2011.98; OLSEN EA, 1991, J AM ACAD DERMATOL, V25, P306, DOI 10.1016/0190-9622(91)70199-C; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schmid P, 2008, ANN ONCOL, V19, P871, DOI 10.1093/annonc/mdm569; Shah JJ, 2009, LEUKEMIA, V23, P1964, DOI 10.1038/leu.2009.173; Sors A, 2006, BLOOD, V107, P2354, DOI 10.1182/blood-2005-06-2536; Takeshita T, 2009, CANCER CHEMOTH PHARM, V64, P1039, DOI 10.1007/s00280-009-0961-5; van Doorn R, 2005, J CLIN ONCOL, V23, P3886, DOI 10.1200/JCO.2005.11.353; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Willemze R, 2005, BLOOD, V105, P3768, DOI 10.1182/blood-2004-09-3502; Woollard WJ, 2016, BLOOD, V1015; WRIGHT JC, 1964, CANCER, V17, P1045, DOI 10.1002/1097-0142(196408)17:8<1045::AID-CNCR2820170811>3.0.CO;2-S; Wu JQ, 2011, ARCH DERMATOL, V147, P443, DOI 10.1001/archdermatol.2010.376; Wu JQ, 2009, J INVEST DERMATOL, V129, P1165, DOI 10.1038/jid.2008.309; Yerlikaya A, 2015, J PROTEOMICS, V113, P315, DOI 10.1016/j.jprot.2014.09.010; Yerlikaya A, 2012, TUMOR BIOL, V33, P1385, DOI 10.1007/s13277-012-0386-3; Zackheim HS, 1996, J AM ACAD DERMATOL, V34, P626, DOI 10.1016/S0190-9622(96)80062-4; Zackheim HS, 2003, J AM ACAD DERMATOL, V49, P873, DOI 10.1016/S0190-9622(03)01591-3; Zinzani PL, 2007, J CLIN ONCOL, V25, P4293, DOI 10.1200/JCO.2007.11.4207	60	5	5	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170186	10.1371/journal.pone.0170186	http://dx.doi.org/10.1371/journal.pone.0170186			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107479	gold, Green Submitted, Green Published			2022-12-26	WOS:000392405300083
J	Soo, HC; Chung, FFL; Lim, KH; Yap, VA; Bradshaw, TD; Hii, LW; Tan, SH; See, SJ; Tan, YF; Leong, CO; Mai, CW				Soo, Hsien-Chuen; Chung, Felicia Fei-Lei; Lim, Kuan-Hon; Yap, Veronica Alicia; Bradshaw, Tracey D.; Hii, Ling-Wei; Tan, Si-Hoey; See, Sze-Jia; Tan, Yuen-Fen; Leong, Chee-Onn; Mai, Chun-Wai			Cudraflavone C Induces Tumor-Specific Apoptosis in Colorectal Cancer Cells through Inhibition of the Phosphoinositide 3-Kinase (PI3K)-AKT Pathway	PLOS ONE			English	Article							ROOT BARK; CYCLIN B1; LUNG-CANCER; ISOPRENYLATED FLAVONES; CUDRANIA-TRICUSPIDATA; CLINICAL-SIGNIFICANCE; CONNECTIVITY MAP; PI3K/AKT PATHWAY; GENE-EXPRESSION; HUMAN BREAST	Cudraflavone C (Cud C) is a naturally-occurring flavonol with reported anti-proliferative activities. However, the mechanisms by which Cud C induced cytotoxicity have yet to be fully elucidated. Here, we investigated the effects of Cud C on cell proliferation, caspase activation andapoptosis induction in colorectal cancer cells (CRC). We show that Cud C inhibits cell proliferation in KM12, Caco-2, HT29, HCC2998, HCT116 and SW48 CRC but not in the non-transformed colorectal epithelial cells, CCD CoN 841. Cud C induces tumorselective apoptosis via mitochondrial depolarization and activation of the intrinsic caspase pathway. Gene expression profiling by microarray analyses revealed that tumor suppressor genes EGR1, HUWE1 and SMG1 were significantly up-regulated while oncogenes such as MYB1, CCNB1 and GPX2 were down-regulated following treatment with Cud C. Further analyses using Connectivity Map revealed that Cud C induced a gene signature highly similar to that of protein synthesis inhibitors and phosphoinositide 3-kinase (PI3K)-AKT inhibitors, suggesting that Cud C might inhibit PI3K-AKT signaling. A luminescent cell free PI3K lipid kinase assay revealed that Cud C significantly inhibited p110 beta/p85 alpha PI3K activity, followed by p120 gamma, p110 delta/p85 alpha, and p110 alpha/p85 alpha PI3K activities. The inhibition by Cud C on p110 beta/p85 alpha PI3K activity was comparable to LY-294002, a known PI3K inhibitor. Cud C also inhibited phosphorylation of AKT independent of NF kappa B activity in CRC cells, while ectopic expression of myristoylated AKT completely abrogated the anti-proliferative effects, and apoptosis induced by Cud C in CRC. These findings demonstrate that Cud C induces tumor-selective cytotoxicity by targeting the PI3K-AKT pathway. These findings provide novel insights into the mechanism of action of Cud C, and indicate that Cud C further development of Cud C derivatives as potential therapeutic agents is warranted.	[Soo, Hsien-Chuen] Int Med Univ, Sch Med, Kuala Lumpur, Malaysia; [Chung, Felicia Fei-Lei; See, Sze-Jia; Leong, Chee-Onn] Int Med Univ, Ctr Canc & Stem Cell Res, Kuala Lumpur, Malaysia; [Lim, Kuan-Hon; Yap, Veronica Alicia] Univ Nottingham, Sch Pharm, Malaysia Campus,Jalan Broga, Semenyih, Selangor, Malaysia; [Bradshaw, Tracey D.] Univ Nottingham, Ctr Biomol Sci, Sch Pharm, Univ Pk, Nottingham, England; [Hii, Ling-Wei; Tan, Si-Hoey; Tan, Yuen-Fen] Int Med Univ, Sch Postgrad Studies, Kuala Lumpur, Malaysia; [Mai, Chun-Wai] Int Med Univ, Sch Pharm, Kuala Lumpur, Malaysia	International Medical University Malaysia; International Medical University Malaysia; University of Nottingham Malaysia; University of Nottingham; International Medical University Malaysia; International Medical University Malaysia	Mai, CW (corresponding author), Int Med Univ, Sch Pharm, Kuala Lumpur, Malaysia.	chunwai_mai@imu.edu.my	Leong, Chee-Onn/C-9779-2013; Hii, Ling-Wei/J-8926-2015; Chung, Felicia FL/E-5846-2016; Lim, Kuan-Hon/AAD-5807-2020; Mai, Chun Wai/M-3972-2013	Leong, Chee-Onn/0000-0002-6353-9703; Hii, Ling-Wei/0000-0003-0537-3693; Chung, Felicia FL/0000-0003-1043-4948; Lim, Kuan-Hon/0000-0003-1462-3324; Mai, Chun Wai/0000-0001-6532-184X	IMU BMedSci Research Training Program [BMS I01/2015]; University of Nottingham [A2RHF1]; Ministry of Higher Education, Malaysia	IMU BMedSci Research Training Program; University of Nottingham; Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia)	We express sincere gratitude to researchers of the International Medical University (IMU) (http://www.imu.edu.my/imu/) Institute for Research, Development and Innovation (IRDI) especially to Center for Cancer and Stem Cell Research for the insightful scientific discussions. This work was funded by the IMU BMedSci Research Training Program (BMS I01/2015) for HCS. KHL was granted an Early Career Research and Knowledge Transfer Award provided by the University of Nottingham in 2011 (A2RHF1) (http://www.nottingham.edu.my/index.aspx), which supported the plant collection, extraction and isolation work. VAY was a recipient of the postgraduate scholarship from the Ministry of Higher Education, Malaysia from 2013-2015 (https://www.mohe.gov.my/en/).	Aaltonen K, 2009, BRIT J CANCER, V100, P1055, DOI 10.1038/sj.bjc.6604874; Adi S, 2001, ENDOCRINOLOGY, V142, P498, DOI 10.1210/en.142.1.498; Agarwal E, 2013, CELL SIGNAL, V25, P1711, DOI 10.1016/j.cellsig.2013.03.025; Akca H, 2011, LUNG CANCER, V73, P302, DOI 10.1016/j.lungcan.2011.01.012; Alexander Walter, 2011, P T, V36, P225; Ali K, 2014, NATURE, V510, P407, DOI 10.1038/nature13444; Arnold M., 2016, GUT; Arung ET, 2011, NAT PROD COMMUN, V6, P1397; Arung ET, 2010, FITOTERAPIA, V81, P120, DOI 10.1016/j.fitote.2009.08.001; Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Brognard J, 2001, CANCER RES, V61, P3986; Chen ZH, 2014, MOL CELL BIOCHEM, V385, P169, DOI 10.1007/s11010-013-1825-1; Cheung HH, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.25; Cho EJ, 2003, PHYTOMEDICINE, V10, P544, DOI 10.1078/094471103322331520; Chung FFL, 2016, CURR CANCER DRUG TAR, V16, P71, DOI 10.2174/1568009616888151112095948; Danielsen SA, 2015, BBA-REV CANCER, V1855, P104, DOI 10.1016/j.bbcan.2014.09.008; Eichenmuller M, 2009, INT J ONCOL, V35, P873, DOI 10.3892/ijo_00000402; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; FUJIMOTO T, 1984, PLANTA MED, V50, P161, DOI 10.1055/s-2007-969660; Gfeller D, 2014, NUCLEIC ACIDS RES, V42, pW32, DOI 10.1093/nar/gku293; Gfeller D, 2013, BIOINFORMATICS, V29, P3073, DOI 10.1093/bioinformatics/btt540; Graff JR, 2000, J BIOL CHEM, V275, P24500, DOI 10.1074/jbc.M003145200; HANO Y, 1990, HETEROCYCLES, V31, P1339; Hao Y, 2016, NATURE COMMUNICATION, V7; Hassan KA, 2002, CANCER RES, V62, P6414; Hassan KA, 2001, CLIN CANCER RES, V7, P2458; Hemmings Brian A, 2012, COLD SPRING HARB PER; Hwang JH, 2007, J NAT PROD, V70, P1207, DOI 10.1021/np070059k; Islam MR, 2014, EXP HEMATOL ONCOL, V3, DOI 10.1186/2162-3619-3-25; Jhawer M, 2008, CANCER RES, V68, P1953, DOI 10.1158/0008-5472.CAN-07-5659; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Jin KS, 2014, FOOD CHEM TOXICOL, V68, P38, DOI 10.1016/j.fct.2014.03.001; Kang S, 2012, APOPTOSIS, V17, P989, DOI 10.1007/s10495-012-0717-2; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lan WC, 2013, PHYTOCHEMISTRY, V89, P78, DOI 10.1016/j.phytochem.2013.01.011; Laurent-Puig P, 2009, J CLIN ONCOL, V27, P5924, DOI 10.1200/JCO.2008.21.6796; Lee BW, 2005, BIOORG MED CHEM LETT, V15, P5548, DOI 10.1016/j.bmcl.2005.08.099; Lee HJ, 2013, PLANTA MED, V79, P1298, DOI 10.1055/s-0033-1350619; Leonard R, 2001, J CLIN ONCOL, V19, P4150, DOI 10.1200/JCO.2001.19.21.4150; Low SY, 2012, CANCER LETT, V314, P166, DOI 10.1016/j.canlet.2011.09.025; Ma JP, 2010, J ASIAN NAT PROD RES, V12, P586, DOI 10.1080/10286020.2010.485932; Mai CW, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00007; Mai CW, 2014, EUR J MED CHEM, V77, P378, DOI 10.1016/j.ejmech.2014.03.002; Manegold PC, 2008, CLIN CANCER RES, V14, P892, DOI 10.1158/1078-0432.CCR-07-0955; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martin-Fernandez C, 2009, MOL CANCER RES, V7, P955, DOI 10.1158/1541-7786.MCR-08-0445; Martini M, 2013, FRONT ONCOL, P3; Mayer IA, 2016, ANNU REV MED, V67, P11, DOI 10.1146/annurev-med-062913-051343; Meuillet EJ, 2004, ONCOL RES, V14, P513, DOI 10.3727/0965040042380487; Miller TW, 2009, CANCER RES, V69, P4192, DOI 10.1158/0008-5472.CAN-09-0042; Min KJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.35; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Naiki T, 2014, CARCINOGENESIS, V35, P1962, DOI 10.1093/carcin/bgu048; Naiki-Ito A, 2007, CANCER RES, V67, P11353, DOI 10.1158/0008-5472.CAN-07-2226; Ni J, 2012, CANCER DISCOV, V2, P425, DOI 10.1158/2159-8290.CD-12-0003; Palles C, 2013, NAT GENET, V45, P136, DOI 10.1038/ng.2503; Pan Y, 2015, INVEST NEW DRUG, V33, P271, DOI 10.1007/s10637-014-0190-6; Porta C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00064; Raja VJ, 2014, INVEST NEW DRUG, V32, P838, DOI 10.1007/s10637-014-0126-1; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Rodon J, 2013, NAT REV CLIN ONCOL, V10, P143, DOI 10.1038/nrclinonc.2013.10; Roseweir A. K., 2016, ONCOTARGET; Roy HK, 2002, CARCINOGENESIS, V23, P201, DOI 10.1093/carcin/23.1.201; Sawai H, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-56; Schlieman MG, 2003, BRIT J CANCER, V89, P2110, DOI 10.1038/sj.bjc.6601396; Shen XL, 2007, REGUL PEPTIDES, V141, P61, DOI 10.1016/j.regpep.2006.12.017; Shuttleworth SJ, 2015, BLOOD, V126, DOI 10.1182/blood.V126.23.2052.2052; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Soo JS-S, 2015, ADV HEALTH SCI EDUC, P1; Soria JC, 2000, CANCER RES, V60, P4000; Sritularak B, 2013, NAT PROD COMMUN, V8, P1079; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Tan BS, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.191; Tan BS, 2013, CANCER LETT, V336, P127, DOI 10.1016/j.canlet.2013.04.014; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tsurutani J, 2006, J CLIN ONCOL, V24, P306, DOI 10.1200/JCO.2005.02.4133; Urban BC, 2015, GUT; Vaish V, 2013, MOL CELL BIOCHEM, V378, P47, DOI 10.1007/s11010-013-1593-y; Vukelja S, 2009, J CLIN ONCOL S, V27, P4081; Wang GL, 2004, GENE DEV, V18, P912, DOI 10.1101/gad.1183304; Wilson CL, 2006, ENDOCR-RELAT CANCER, V13, P617, DOI 10.1677/erc.1.01165; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu Q, 2009, J HUAZHONG U SCI-MED, V29, P451, DOI 10.1007/s11596-009-0412-x; Yi J, 2015, NUCL ACIDS RES; Yoshida T, 2004, ANN ONCOL, V15, P252, DOI 10.1093/annonc/mdh073; Yu MH, 2012, CHEM BIODIVERS, V9, P394, DOI 10.1002/cbdv.201100072; Zhang J, 2011, GASTROENTEROLOGY, V141, P50, DOI 10.1053/j.gastro.2011.05.010; Zheng ZP, 2012, FITOTERAPIA, V83, P1008, DOI 10.1016/j.fitote.2012.06.001	89	50	50	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170551	10.1371/journal.pone.0170551	http://dx.doi.org/10.1371/journal.pone.0170551			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107519	Green Published, gold			2022-12-26	WOS:000392405300162
J	Castano, E; Caviedes, L; Hirsch, S; Llanos, M; Iniguez, G; Ronco, AM				Castano, Erika; Caviedes, Lorena; Hirsch, Sandra; Llanos, Miguel; Iniguez, German; Maria Ronco, Ana			Folate Transporters in Placentas from Preterm Newborns and Their Relation to Cord Blood Folate and Vitamin B12 Levels	PLOS ONE			English	Article							FETAL-GROWTH RESTRICTION; NEURAL-TUBE DEFECTS; MATERNAL FOLATE; FOLIC-ACID; INSULIN-RESISTANCE; COBALAMIN STATUS; PREGNANCY; EXPRESSION; DEFICIENCY; BIRTH	Folate deficiency during pregnancy has been related to low birth weight, preterm (PT) birth and other health risks in the offspring; however, it is unknown whether prematurity is related to low folate transport through the placenta due to altered expression of specific folate transporters. We determined placental expression (mRNA and protein concentrations by RTqPCR and WB respectively) of specific folate transporters: RFC, PCFT/HCP1 and FOLR1 in chorionic (fetal) and basal (maternal) plates of placentas of PT pregnancies (PT, 32-36 weeks, n = 51). Term placentas were used as controls (T, 37-41 weeks, n = 47). Folates and vitamin B12 levels were measured by electrochemiluminescence in umbilical cord blood of newborns. FOLR1 mRNA expression was lower and protein concentration higher in PT placentas (both plates) relative to the control group (p < 0.05). In addition, gestational age was positively correlated with mRNA expression (Rho = 0.7), and negatively with protein concentration (Rho = -0.7 for chorionic and -0.43 for basal plate). PCFT/HCP1 mRNA was lower in PT placentas, without changes in protein levels. RFC did not differ in PT placentas compared to controls. PT newborns presented higher cord blood folate level (p = 0.049) along with lower vitamin B12 concentration compared to controls (p = 0.037). In conclusion, placental FOLR1 mRNA was positively associated with gestational age. Conversely, FOLR1 protein concentrations along with folate/vitamin B12 ratio in cord blood were negatively associated with gestational age. Placental FOLR1 is likely the main placental folate transporter to the fetus in newborns.	[Castano, Erika; Caviedes, Lorena; Hirsch, Sandra; Llanos, Miguel; Maria Ronco, Ana] Univ Chile, Inst Nutr & Food Technol, Dr Fernando Monckeberg Barros INTA, Lab Nutr & Metab Regulat,Human Nutr Unit, Santiago, Chile; [Iniguez, German] Univ Chile, Mother & Child Res Inst, Sch Med, Div Med Sci, Santiago, Chile	Universidad de Chile; Universidad de Chile	Ronco, AM (corresponding author), Univ Chile, Inst Nutr & Food Technol, Dr Fernando Monckeberg Barros INTA, Lab Nutr & Metab Regulat,Human Nutr Unit, Santiago, Chile.	amronco@inta.uchile.cl	Castano-Moreno, Erika/AAD-7536-2021; Ronco, Ana M/F-9393-2015; Hirsch, Sandra/R-2431-2016; Llanos, Miguel/M-9595-2017; Castaño-Moreno, Erika/AFM-1776-2022; Hirsch, Shaye/F-2008-2018	Castaño-Moreno, Erika/0000-0002-0338-0761; Hirsch, Shaye/0000-0003-1214-4258	Fondo Nacional de Ciencia y Tecnologia (FONDECYT), Gobierno de Chile [1130188]	Fondo Nacional de Ciencia y Tecnologia (FONDECYT), Gobierno de Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This study was funded by Fondo Nacional de Ciencia y Tecnologia (FONDECYT # 1130188 to AMR), Gobierno de Chile.; This study was funded by Fondo Nacional de Ciencia y Tecnologia (FONDECYT #1130188 to AMR), Gobierno de Chile. We are very grateful to all mothers who donated their placentas for this study. We thank Mrs. Paulina Hidalgo for her contribution in some measurements and Mrs. Valeska Castillo for her supervision and support in the measurements. EC thanks the program: "Enlaza Mundos-Sapiencia-Alcaldia de Medellin, Colombia", for having made possible the realization of a Master's Degree.	[Anonymous], 2010, INF PROGR FORT HAR; [Anonymous], [No title captured]; Antony AC, 2007, AM J CLIN NUTR, V85, p598S, DOI 10.1093/ajcn/85.2.598S; Bailey LB, 2015, J NUTR, V145, P1636, DOI 10.3945/jn.114.206599; BAKER H, 1981, AM J OBSTET GYNECOL, V141, P792, DOI 10.1016/0002-9378(81)90706-7; Bisseling TM, 2004, PLACENTA, V25, P588, DOI 10.1016/j.placenta.2003.11.010; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caviedes L, 2016, PLACENTA, V38, P24, DOI 10.1016/j.placenta.2015.12.007; Cherukad J, 2012, PLACENTA, V33, P440, DOI 10.1016/j.placenta.2012.02.005; Cortes F, 2001, REV MED CHILE, V129, P277; Dunstan JA, 2012, ALLERGY, V67, P50, DOI 10.1111/j.1398-9995.2011.02714.x; Duong MC, 2015, J NUTR, V145, P1541, DOI 10.3945/jn.115.211391; Fekete K, 2010, MATERN CHILD NUTR, V6, P23, DOI 10.1111/j.1740-8709.2010.00261.x; Furness D, 2013, MATERN CHILD NUTR, V9, P155, DOI 10.1111/j.1740-8709.2011.00364.x; Gille D, 2015, NUTR REV, V73, P106, DOI 10.1093/nutrit/nuu011; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gueant JL, 2013, TRENDS ENDOCRIN MET, V24, P279, DOI 10.1016/j.tem.2013.01.010; Hannibal L, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00027; Hay G, 2008, AM J CLIN NUTR, V88, P105, DOI 10.1093/ajcn/88.1.105; Hertrampf E, 2003, J NUTR, V133, P3166, DOI 10.1093/jn/133.10.3166; Hertrampf E, 2008, FOOD NUTR BULL, V29, pS231, DOI 10.1177/15648265080292S128; Hoffbrand AV, 2014, BRIT J HAEMATOL, V164, P496, DOI 10.1111/bjh.12654; Hou Z, 2014, BIOSCI REP, V34; Hure AJ, 2012, MATERN CHILD HLTH J, V16, P792, DOI 10.1007/s10995-011-0782-0; Institute of Medicine, 1998, DIET REF INT THIAM R; Kim HW, 2011, NUTR RES PRACT, V5, P112, DOI 10.4162/nrp.2011.5.2.112; Krishnaveni GV, 2014, DIABETOLOGIA, V57, P110, DOI 10.1007/s00125-013-3086-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mantovani E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/481914; McCormick MC, 2011, ANNU REV PUBL HEALTH, V32, P367, DOI 10.1146/annurev-publhealth-090810-182459; Milad M, 2010, REV CHIL PEDIATR-CHI, V81, P264; Monsen ALB, 2001, PEDIATRICS, V108, P624, DOI 10.1542/peds.108.3.624; Murthi P, 2008, PLACENTA, V29, P798, DOI 10.1016/j.placenta.2008.06.007; Park Bo-hyun, 2005, J Prev Med Public Health, V38, P437; Qiu A, 2007, AM J PHYSIOL-CELL PH, V293, pC1669, DOI 10.1152/ajpcell.00202.2007; Relton CL, 2005, BRIT J NUTR, V93, P593, DOI 10.1079/BJN20041395; Said HM, 2000, AM J PHYSIOL-CELL PH, V279, pC1889, DOI 10.1152/ajpcell.2000.279.6.C1889; Sandovici I, 2012, REPROD BIOMED ONLINE, V25, P68, DOI 10.1016/j.rbmo.2012.03.017; Scott JM, 1999, P NUTR SOC, V58, P441, DOI 10.1017/S0029665199000580; Scott J, 1994, ESSAYS BIOCHEM, V28, P63; Solanky N, 2010, PLACENTA, V31, P134, DOI 10.1016/j.placenta.2009.11.017; Sukumar N, 2016, AM J CLIN NUTR; Takimoto H, 2011, J NUTR SCI VITAMINOL, V57, P130, DOI 10.3177/jnsv.57.130; Tamura T, 2006, AM J CLIN NUTR, V83, P993, DOI 10.1093/ajcn/83.5.993; Tang ZH, 2013, AM J REPROD IMMUNOL, V70, P104, DOI 10.1111/aji.12112; Villalpando S, 2008, FOOD NUTR BULL, V29, pS112, DOI 10.1177/15648265080292S115; Vo HD, 2015, NUTRITION, V31, P1224, DOI 10.1016/j.nut.2015.04.008; Wani NA, 2012, INDIAN J MED RES, V136, P758; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Xie RH, 2016, INT J OBESITY, V40, P1, DOI 10.1038/ijo.2015.189; Yajnik CS, 2008, DIABETOLOGIA, V51, P29, DOI 10.1007/s00125-007-0793-y; Yasuda S, 2008, BIOSCI BIOTECH BIOCH, V72, P2277, DOI 10.1271/bbb.80112; Zhang S, 2015, NUTRIENTS, V7, P360, DOI 10.3390/nu7010360; Zhao RB, 2011, ANNU REV NUTR, V31, P177, DOI 10.1146/annurev-nutr-072610-145133	54	19	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2017	12	1							e0170389	10.1371/journal.pone.0170389	http://dx.doi.org/10.1371/journal.pone.0170389			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3HP	28103309	gold, Green Published, Green Submitted			2022-12-26	WOS:000392381100060
J	Sun, GY; Larsen, CN; Baumgarth, N; Klem, EB; Scheuermann, RH				Sun, Guangyu; Larsen, Christopher N.; Baumgarth, Nicole; Klem, Edward B.; Scheuermann, Richard H.			Comprehensive Annotation of Mature Peptides and Genotypes for Zika Virus	PLOS ONE			English	Article							HEPATITIS-C VIRUS; CLEAVAGE; CLASSIFICATION; INHIBITORS; PROTEASE	The rapid spread of Zika virus (ZIKV) has caused much concern in the global health community, due in part to a link to fetal microcephaly and other neurological illnesses. While an increasing amount of ZIKV genomic sequence data is being generated, an understanding of the virus molecular biology is still greatly lacking. A significant step towards establishing ZIKV proteomics would be the compilation of all proteins produced by the virus, and the resultant virus genotypes. Here we report for the first time such data, using new computational methods for the annotation of mature peptide proteins, genotypes, and recombination events for all ZIKV genomes.	[Sun, Guangyu; Larsen, Christopher N.] Vecna Technol Inc, Greenbelt, MD 20770 USA; [Baumgarth, Nicole] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Baumgarth, Nicole] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Klem, Edward B.] Northrop Grumman Hlth Solut, Rockville, MD USA; [Scheuermann, Richard H.] J Craig Venter Inst, La Jolla, CA USA; [Scheuermann, Richard H.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Scheuermann, Richard H.] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; J. Craig Venter Institute; University of California System; University of California San Diego; La Jolla Institute for Immunology	Larsen, CN (corresponding author), Vecna Technol Inc, Greenbelt, MD 20770 USA.	clarsen@vecna.com	Baumgarth, Nicole/AAI-6949-2020	Larsen, Christopher N/0000-0002-1051-5767	National Institute of Allergy and Infectious Diseases (NIAID) as part of the National Institutes of Health (NIH); USA Department of Health and Human Services (DHHS) [HHSN272201400028C]	National Institute of Allergy and Infectious Diseases (NIAID) as part of the National Institutes of Health (NIH); USA Department of Health and Human Services (DHHS)	This project is funded by the National Institute of Allergy and Infectious Diseases (NIAID) as part of the National Institutes of Health (NIH), USA Department of Health and Human Services (DHHS), under Contract No. HHSN272201400028C and is a collaboration between Northrop Grumman Health IT (Prime), J. Craig Venter Institute (RHS - PI), and Vecna Technologies, Inc. (GS, CNL). NB is a Co-PI. Vecna is an independent privately held woman owned small business, subcontracting along with the J. Craig Venter Institute to the Northrop Grumman corporation under this contracted funding vehicle. The funder provided support in the form of salary support for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Addis SNK, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0375-4; [Anonymous], 2016, CDC DIV VECT BORN DI; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Elshuber S, 2005, J VIROL, V79, P11813, DOI 10.1128/JVI.79.18.11813-11823.2005; Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9; Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636; Hraber P, 2008, J GEN VIROL, V89, P2098, DOI 10.1099/vir.0.83657-0; Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z; Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065; Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419; Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9; SCHECHTER I, 1968, BIOCHEM BIOPH RES CO, V32, P898, DOI 10.1016/0006-291X(68)90326-4; Shiryaev SA, 2006, BIOCHEM J, V393, P503, DOI 10.1042/BJ20051374; Shrinet J, 2016, B WHO; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Stocks CE, 1998, J VIROL, V72, P2141, DOI 10.1128/JVI.72.3.2141-2149.1998; Zhang Y, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6236	19	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170462	10.1371/journal.pone.0170462	http://dx.doi.org/10.1371/journal.pone.0170462			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125631	Green Published, gold, Green Submitted			2022-12-26	WOS:000396176100106
J	Deng, J; Yang, MC; Jiang, R; An, N; Wang, XS; Liu, B				Deng, Jia; Yang, Mengchang; Jiang, Rong; An, Ning; Wang, Xiaoshan; Liu, Bin			Long Non-Coding RNA HOTAIR Regulates the Proliferation, Self-Renewal Capacity, Tumor Formation and Migration of the Cancer Stem-Like Cell (CSC) Subpopulation Enriched from Breast Cancer Cells	PLOS ONE			English	Article							CARCINOMA-CELLS; ENDOMETRIAL CARCINOMA; POOR-PROGNOSIS; GASTRIC-CANCER; IN-VITRO; EXPRESSION; INVASION; MICRORNAS; SURVIVAL; PROMOTE	Purpose Long non-coding RNAs (lncRNAs) play important roles in the malignant behavior of cancer. HOTAIR, a well-studied lncRNA, contributes to breast cancer development, and overexpression of HOTAIR predicts a poor prognosis. However, the regulatory role of HOTAIR in the cancer stem-like cell (CSC) subpopulation remains largely unknown. Our goal was to determine the regulatory functions of HOTAIR in the processes of self-renewal capacity, tumor formation and proliferation of CSCs derived from breast cancer. Methods We first enriched and incubated the CSC population derived from breast cancer cell line MCF7 (CSC-MCF7) or MDA-MB-231 (MB231, CSC-MB231). Self-renewal capacity and tumor formation were assessed in vitro and in vivo to determine the stemness of CSCs. We assessed the impact on ectopically upregulated or downregulated expression of HOTAIR in CSCs by soft agar, self-renewal capacity and CCK-8 assays. The functional domain of HOTAIR was determined by truncation. RT-qPCR and semiquantitative Western blotting were performed to detect the expression levels of genes of interest. Chromatin IP (ChIP) was employed to detect the transcriptional regulatory activity of p53 on its target gene. Results After the identification of CSC properties, RT-qPCR analysis revealed that HOTAIR, but not other cancer-associated lncRNAs, is highly upregulated in both CSC-MCF7 and CSCMB231 populations compared with MCF7 and MB231 populations. By modulating the level of HOTAIR expression, we showed that HOTAIR tightly regulates the proliferation, colony formation, migration and self-renewal capacity of CSCs. Moreover, full-length HOTAIR transcriptionally inhibits miR-34a specifically, leading to upregulation of Sox2, which is targeted by miR-34a. Ectopic introduction of miR-34a mimics reverses the effects of HOTAIR on the physiological processes of CSCs, indicating that HOTAIR affects these processes, including self-renewal capacity; these effects are dependent on the regulation of Sox2 via miR-34a. Interestingly, tight transcriptional regulation of p53 by HOTAIR was found; accordingly, p21 is indirectly regulated by HOTAIR, resulting in cell cycle entry. Conclusion These results suggest that HOTAIR is a key regulator of proliferation, colony formation, invasion and self-renewal capacity in breast CSCs, which occurs in part through regulation of Sox2 and p53.	[Deng, Jia; Liu, Bin] Sichuan Univ, West China Hosp, Dept Anesthesiol, Chengdu, Sichuan, Peoples R China; [Deng, Jia; Yang, Mengchang; Jiang, Rong] Sichuan Acad Med Sci, Dept Anesthesiol, Chengdu, Sichuan, Peoples R China; [Deng, Jia; Yang, Mengchang; Jiang, Rong; An, Ning; Wang, Xiaoshan] Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China; [An, Ning; Wang, Xiaoshan] Sichuan Acad Med Sci, Dept Oncol, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Liu, B (corresponding author), Sichuan Univ, West China Hosp, Dept Anesthesiol, Chengdu, Sichuan, Peoples R China.	liubinhxyy@163.com			National Natural Science Foundation of China [30571785]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant number: 30571785).; The authors would like to thank Mrs. Huimin Shi for outstanding assistance in English editing. This work was supported by the National Natural Science Foundation of China (grant number: 30571785).	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Cai B, 2014, NEOPLASMA, V61, P379, DOI 10.4149/neo_2014_075; Chiyomaru T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070372; Choi YJ, 2011, NAT CELL BIOL, V13, P1353, DOI 10.1038/ncb2366; Ding CF, 2014, INT J MOL SCI, V15, P4060, DOI 10.3390/ijms15034060; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Ge XS, 2013, CANCER SCI, V104, P1675, DOI 10.1111/cas.12296; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Gutschner T, 2013, J MOL MED, V91, P791, DOI 10.1007/s00109-013-1028-y; He XY, 2014, INT J MOL MED, V33, P325, DOI 10.3892/ijmm.2013.1570; Hermann PC, 2009, EXPERT OPIN BIOL TH, V9, P1271, DOI 10.1517/14712590903246362; Huang JM, 2014, INT J GYNECOL CANCER, V24, P635, DOI 10.1097/IGC.0000000000000121; Huang Y, 2005, CANCER BIOL THER, V4, P1006, DOI 10.4161/cbt.4.9.1970; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; Kim K, 2013, ONCOGENE, V32, P1616, DOI 10.1038/onc.2012.193; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Lee CJ, 2008, J CLIN ONCOL, V26, P2806, DOI 10.1200/JCO.2008.16.6702; Liu XH, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-92; Liu YW, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.150; Lu Jing, 2009, Cancer Res, V69, P4951, DOI 10.1158/0008-5472.CAN-09-0099; Mercer TR, 2013, NAT STRUCT MOL BIOL, V20, P300, DOI 10.1038/nsmb.2480; Nakagawa T, 2013, BIOCHEM BIOPH RES CO, V436, P319, DOI 10.1016/j.bbrc.2013.05.101; Pei CS, 2014, ASIAN PAC J CANCER P, V15, P4239, DOI 10.7314/APJCP.2014.15.10.4239; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sorensen KP, 2007, BREAST CANC RES TREA, V142, P529; Wang YC, 2015, MOL MED REP, V11, P2534, DOI 10.3892/mmr.2014.3024; Yoon JH, 2013, J MOL BIOL, V425, P3723, DOI 10.1016/j.jmb.2012.11.024; Zhang JX, 2013, NEURO-ONCOLOGY, V15, P1595, DOI 10.1093/neuonc/not131; Zhao ZY, 2014, BIOCHEM BIOPH RES CO, V445, P388, DOI 10.1016/j.bbrc.2014.02.006	32	94	102	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0170860	10.1371/journal.pone.0170860	http://dx.doi.org/10.1371/journal.pone.0170860			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122024	Green Published, gold, Green Submitted			2022-12-26	WOS:000396167300007
J	Dadashzadeh, B; Esmaeili, M; Macnab, C				Dadashzadeh, Behnam; Esmaeili, Mohammad; Macnab, Chris			Arbitrary Symmetric Running Gait Generation for an Underactuated Biped Model	PLOS ONE			English	Article							LEGGED LOCOMOTION; DYNAMICS	This paper investigates generating symmetric trajectories for an underactuated biped during the stance phase of running. We use a point mass biped (PMB) model for gait analysis that consists of a prismatic force actuator on a massless leg. The significance of this model is its ability to generate more general and versatile running gaits than the spring-loaded inverted pendulum (SLIP) model, making it more suitable as a template for real robots. The algorithm plans the necessary leg actuator force to cause the robot center of mass to undergo arbitrary trajectories in stance with any arbitrary attack angle and velocity angle. The necessary actuator forces follow from the inverse kinematics and dynamics. Then these calculated forces become the control input to the dynamic model. We compare various center-of-mass trajectories, including a circular arc and polynomials of the degrees 2, 4 and 6. The cost of transport and maximum leg force are calculated for various attack angles and velocity angles. The results show that choosing the velocity angle as small as possible is beneficial, but the angle of attack has an optimum value. We also find a new result: there exist biped running gaits with double-hump ground reaction force profiles which result in less maximum leg force than single-hump profiles.	[Dadashzadeh, Behnam; Esmaeili, Mohammad] Univ Tabriz, Sch Engn Emerging Technol, Dept Mechatron Engn, Tabriz, Iran; [Macnab, Chris] Univ Calgary, Dept Elect & Comp Engn, Calgary, AB, Canada	University of Tabriz; University of Calgary	Dadashzadeh, B (corresponding author), Univ Tabriz, Sch Engn Emerging Technol, Dept Mechatron Engn, Tabriz, Iran.	b.dadashzadeh@tabrizu.ac.ir		Dadashzadeh, Behnam/0000-0002-9666-4535				Ankarali MM, 2010, CHAOS, V20, DOI 10.1063/1.3486803; BLICKHAN R, 1993, J COMP PHYSIOL A, V173, P509; BLICKHAN R, 1989, J BIOMECH, V22, P1217, DOI 10.1016/0021-9290(89)90224-8; Dadashzadeh B, 2014, IEEE INT C INT ROBOT, P2566, DOI 10.1109/IROS.2014.6942912; Dadashzadeh B, 2014, ADV ROBOTICS, V28, P231, DOI 10.1080/01691864.2013.865299; Full RJ, 1999, J EXP BIOL, V202, P3325; Geyer H, 2005, J THEOR BIOL, V232, P315, DOI 10.1016/j.jtbi.2004.08.015; Geyer H, 2006, P R SOC B, V273, P2861, DOI 10.1098/rspb.2006.3637; Ghigliazza RM, 2003, SIAM J APPL DYN SYST, V2, P187, DOI 10.1137/S1111111102408311; Grimes J., 2012, INT C CLIMB WALK ROB; Grizzle JW, 2009, P C AM CONTR C ACC 0; Holmes P, 2006, SIAM REV, V48, P207, DOI 10.1137/S0036144504445133; Piovan G, 2015, INT J ROBOT RES, V34, P270, DOI 10.1177/0278364914552112; Poulakakis I, 2009, IEEE T AUTOMAT CONTR, V54, P1779, DOI 10.1109/TAC.2009.2024565; Raibert MH., 1986, IEEE INTELL SYST APP, DOI [10.1109/MEX.1986.4307016, DOI 10.1109/MEX.1986.4307016]; Rebula JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117384; Schmitt J, 2009, BIOINSPIR BIOMIM, V4, DOI 10.1088/1748-3182/4/4/046005; Seipel J, 2007, REGUL CHAOTIC DYN, V12, P502, DOI 10.1134/S1560354707050048; Seyfarth A, 2002, CLIMBING AND WALKING ROBOTS, P81; Seyfarth A, 2002, J BIOMECH, V35, P649, DOI 10.1016/S0021-9290(01)00245-7; Seyfarth A, 2003, J EXP BIOL, V206, P2547, DOI 10.1242/jeb.00463; Srinivasan M, 2006, NATURE, V439, P72, DOI 10.1038/nature04113; Tamaddoni SH, 2010, INT J HUM ROBOT, V7, P263, DOI 10.1142/S0219843610002106; Vejdani HR, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/4/046006; Vleugels A, 2011, UNITED ACAD MAGAZINE; Wensing PM, 2014, IEEE INT C INT ROBOT, P4008, DOI 10.1109/IROS.2014.6943126	26	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2017	12	1							e0170122	10.1371/journal.pone.0170122	http://dx.doi.org/10.1371/journal.pone.0170122			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7CU	28118401	Green Published, Green Submitted, gold			2022-12-26	WOS:000396160500041
J	Kus, A; Kwasniewska, J; Hasterok, R				Kus, Arita; Kwasniewska, Jolanta; Hasterok, Robert			Brachypodium distachyon - A Useful Model in the Qualification of Mutagen-Induced Micronuclei Using Multicolor FISH	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; IN-SITU HYBRIDIZATION; METHYL-N-NITROSOUREA; MALEIC HYDRAZIDE; CHROMOSOME-ABERRATIONS; INSITU HYBRIDIZATION; ARABIDOPSIS-THALIANA; CYTOGENETIC ANALYSIS; LOLIUM-MULTIFLORUM; PLANT-SYSTEMS	Brachypodium distachyon (Brachypodium) is now intensively utilized as a model grass species in various biological studies. Its favorable cytological features create a unique foundation for a convenient system in mutagenesis, thereby potentially enabling the 'hot spots' and 'cold spots' of DNA damage in its genome to be analyzed. The aim of this study was to analyze the involvement of 5S rDNA, 25S rDNA, the Arabidopsis-type (TTTAGGG)n telomeric sequence and the Brachypodium-originated centromeric BAC clone CB33J12 in the micronuclei formation in Brachypodium root tip cells that were subjected to the chemical clastogenic agent maleic hydrazide (MH). To the best of our knowledge, this is the first use of a multicolor fluorescence in situ hybridization (mFISH) with four different DNA probes being used simultaneously to study plant mutagenesis. A quantitative analysis allowed ten types of micronuclei, which were characterized by the presence or absence of specific FISH signal(s), to be distinguished, thus enabling some specific rules governing the composition of the MH-induced micronuclei with the majority of them originating from the terminal regions of chromosomes, to be identified. The application of rDNA sequences as probes showed that 5S rDNA-bearing chromosomes are involved in micronuclei formation more frequently than the 25S rDNA-bearing chromosomes. These findings demonstrate the promising potential of Brachypodium to be a useful model organism to analyze the effects of various genotoxic agents on the plant nuclear genome stability, especially when the complex FISH-based and chromosome-specific approaches such as chromosome barcoding and chromosome painting will be applied in future studies.	[Kus, Arita; Kwasniewska, Jolanta; Hasterok, Robert] Univ Silesia Katowice, Fac Biol & Environm Protect, Dept Plant Anat & Cytol, Katowice, Poland	University of Silesia in Katowice	Hasterok, R (corresponding author), Univ Silesia Katowice, Fac Biol & Environm Protect, Dept Plant Anat & Cytol, Katowice, Poland.	robert.hasterok@us.edu.pl	Kwasniewska, Jolanta/ABF-1547-2020; Hasterok, Robert/A-1629-2008	Kwasniewska, Jolanta/0000-0002-8965-8727; Hasterok, Robert/0000-0001-6667-2721	National Science Centre, Poland [DEC-2012/04/A/NZ3/00572]	National Science Centre, Poland(National Science Centre, Poland)	The authors gratefully acknowledge the financial support from the National Science Centre, Poland [grant no. DEC-2012/04/A/NZ3/00572]. Funder's website: http://ncn.gov.pl/?language=en. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves SC, 2009, NAT PROTOC, V4, P638, DOI 10.1038/nprot.2009.30; Betekhtin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115108; Bustamante FO, 2014, CROP SCI, V54, P617, DOI 10.2135/cropsci2013.05.0325; Catalan P, 2014, TRENDS PLANT SCI, V19, P414, DOI 10.1016/j.tplants.2014.05.002; CONSTANTIN MJ, 1982, MUTAT RES, V99, P1, DOI 10.1016/0165-1110(82)90027-6; Dalmais M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065503; Derbyshire P, 2013, PLANT PHYSIOL, V161, P1291, DOI 10.1104/pp.112.212340; dos Reis GB, 2016, CHROMOSOME RES, V24, P285, DOI 10.1007/s10577-016-9521-0; ENGVILD KC, 2005, MUTAGENESIS MODEL GR; Farrar K, 2007, NAT PROTOC, V2, P1661, DOI 10.1038/nprot.2007.204; Flores LER, 2003, LIFE SCI, V72, P1345, DOI 10.1016/S0024-3205(02)02412-8; Foltete AS, 2011, CHEMOSPHERE, V85, P1624, DOI 10.1016/j.chemosphere.2011.08.026; GERLACH WL, 1980, NUCLEIC ACIDS RES, V8, P4851, DOI 10.1093/nar/8.21.4851; GICHNER T, 1994, MUTAT RES-FUND MOL M, V310, P249, DOI 10.1016/0027-5107(94)90117-1; GRANT WF, 1994, MUTAT RES-FUND MOL M, V310, P187, DOI 10.1016/0027-5107(94)90113-9; Hajdera I, 2003, THEOR APPL GENET, V107, P988, DOI 10.1007/s00122-003-1303-3; Hasterok R, 2002, FOLIA HISTOCHEM CYTO, V40, P319; Hasterok R, 2004, CHROMOSOME RES, V12, P397, DOI 10.1023/B:CHRO.0000034130.35983.99; Hasterok R, 2006, GENETICS, V173, P349, DOI 10.1534/genetics.105.049726; HESLOPHARRISON JS, 1992, TRENDS GENET, V8, P372, DOI 10.1016/0168-9525(92)90162-W; Huang J, 2008, PLOS ONE, V3; Idziak D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093503; Idziak D, 2011, CHROMOSOMA, V120, P469, DOI 10.1007/s00412-011-0326-9; Jenkins G, 2007, NAT PROTOC, V2, P88, DOI 10.1038/nprot.2006.490; Jovtchev G, 2002, MUTAT RES-GEN TOX EN, V517, P47, DOI 10.1016/S1383-5718(02)00038-4; Juchimiuk J, 2007, J APPL GENET, V48, P99, DOI 10.1007/BF03194666; Juchimiuk-Kwasniewska J, 2011, J APPL GENET, V52, P23, DOI 10.1007/s13353-010-0017-x; Kwasniewska J, 2012, ENVIRON MOL MUTAGEN, V53, P369, DOI 10.1002/em.21699; Lee ManBo, 2013, Journal of Crop Science and Biotechnology, V16, P105, DOI 10.1007/s12892-013-0022-9; Lysak MA, 2006, P NATL ACAD SCI USA, V103, P5224, DOI 10.1073/pnas.0510791103; Ma TH, 1999, MUTAT RES-REV MUTAT, V437, P97; Maluszynska J, 2003, FOLIA HISTOCHEM CYTO, V41, P101; Marcano L, 2004, ENVIRON RES, V94, P221, DOI 10.1016/S0013-9351(03)00121-X; Marshall RR, 1996, MUTAT RES-FUND MOL M, V372, P233, DOI 10.1016/S0027-5107(96)00143-1; Natarajan A, 2003, MUTAT RES-REV MUTAT, V544, P299, DOI 10.1016/j.mrrev.2003.09.005; NEDERLOF PM, 1989, CYTOMETRY, V10, P20, DOI 10.1002/cyto.990100105; Pacurar DI, 2008, TRANSGENIC RES, V17, P965, DOI 10.1007/s11248-007-9159-y; Pecinka A, 2004, CHROMOSOMA, V113, P258, DOI 10.1007/s00412-004-0316-2; Plewa MJ DP, 1983, MAIZE GEN COOP NEWSL, V57, P47; Rank J, 2002, HEREDITAS, V136, P13, DOI 10.1034/j.1601-5223.2002.1360103.x; Rank J, 1997, MUTAT RES-GEN TOX EN, V390, P121, DOI 10.1016/S0165-1218(97)00008-6; Robaszkiewicz E, 2016, J EXP BOT; Rocha LC, 2016, MOL BIOL REP, V43, P659, DOI 10.1007/s11033-016-4003-1; Schubert I, 2004, CYTOGENET GENOME RES, V104, P104, DOI 10.1159/000077473; Siroky J, 2003, CHROMOSOMA, V112, P116, DOI 10.1007/s00412-003-0251-7; Tchurikov NA, 2015, J MOL CELL BIOL, V7, P366, DOI 10.1093/jmcb/mju038; The International Barley Genome Sequencing Consortium, 2012, Nature (London), V491, P711; Tkacz MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160303; UNFRIED I, 1990, NUCLEIC ACIDS RES, V18, P4011, DOI 10.1093/nar/18.13.4011; Vain P, 2008, PLANT BIOTECHNOL J, V6, P236, DOI 10.1111/j.1467-7652.2007.00308.x; Vogel J, 2008, PLANT CELL REP, V27, P471, DOI 10.1007/s00299-007-0472-y; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Vogel JP, 2015, GENETICS GENOMICS BR, P353; Wolny E, 2011, CHROMOSOMA, V120, P199, DOI 10.1007/s00412-010-0303-8; Wolny E, 2009, ANN BOT-LONDON, V104, P873, DOI 10.1093/aob/mcp179	55	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2017	12	1							e0170618	10.1371/journal.pone.0170618	http://dx.doi.org/10.1371/journal.pone.0170618			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7CU	28118403	gold, Green Published, Green Submitted			2022-12-26	WOS:000396160500023
J	He, JN; Lu, LN; He, XG; Xu, X; Du, X; Zhang, B; Zhao, HJ; Sha, JD; Zhu, JF; Zou, HD; Xu, X				He, Jiangnan; Lu, Lina; He, Xiangui; Xu, Xian; Du, Xuan; Zhang, Bo; Zhao, Huijuan; Sha, Jida; Zhu, Jianfeng; Zou, Haidong; Xu, Xun			The Relationship between Crystalline Lens Power and Refractive Error in Older Chinese Adults: The Shanghai Eye Study	PLOS ONE			English	Article							OCULAR BIOMETRY; INDEX DISTRIBUTION; AGE; POPULATION; ACCOMMODATION; CURVATURE; SINGAPORE; CHILDREN; INFANTS; GROWTH	Purpose To report calculated crystalline lens power and describe the distribution of ocular biometry and its association with refractive error in older Chinese adults. Methods Random clustering sampling was used to identify adults aged 50 years and above in Xuhui and Baoshan districts of Shanghai. Refraction was determined by subjective refraction that achieved the best corrected vision based on monocular measurement. Ocular biometry was measured by IOL Master. The crystalline lens power of right eyes was calculated using modified Bennett-Rabbetts formula. Results We analyzed 6099 normal phakic right eyes. The mean crystalline lens power was 20.34 +/- 2.24D (range: 13.40 +/- 36.08). Lens power, spherical equivalent, and anterior chamber depth changed linearly with age; however, axial length, corneal power and AL/CR ratio did not vary with age. The overall prevalence of hyperopia, myopia, and high myopia was 48.48% (95% CI: 47.23%-49.74%), 22.82% (95% CI: 21.77%-23.88%), and 4.57% (95% CI: 4.05-5.10), respectively. The prevalence of hyperopia increased linearly with age while lens power decreased with age. In multivariate models, refractive error was strongly correlated with axial length, lens power, corneal power, and anterior chamber depth; refractive error was slightly correlated with best corrected visual acuity, age and sex. Conclusion Lens power, hyperopia, and spherical equivalent changed linearly with age; Moreover, the continuous loss of lens power produced hyperopic shifts in refraction in subjects aged more than 50 years.	[He, Jiangnan; Lu, Lina; He, Xiangui; Xu, Xian; Zhang, Bo; Zhu, Jianfeng; Zou, Haidong; Xu, Xun] Shanghai Eye Dis Prevent & Treatment Ctr, Dept Preventat Ophthalmol, Shanghai, Peoples R China; [Xu, Xian; Du, Xuan; Zou, Haidong; Xu, Xun] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Ophthalmol, Shanghai, Peoples R China; [Zhao, Huijuan] Ctr Dis Control & Prevent Baoshan Dist, Shanghai, Peoples R China; [Sha, Jida] Ctr Dis Control & Prevent Xuhui Dist, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention	Zhu, JF (corresponding author), Shanghai Eye Dis Prevent & Treatment Ctr, Dept Preventat Ophthalmol, Shanghai, Peoples R China.	jfzhu1974@hotmail.com	He, Jiang/AAF-5303-2020	He, Jiang/0000-0002-8286-9652; Zou, Haidong/0000-0002-6831-7560	Shanghai Shenkang Hospital Development Center Project [SHDC12012123]; Shanghai health and family planning commission youth Project [20144Y0210]; Novartis Foundation [CRFB002ACN03T]	Shanghai Shenkang Hospital Development Center Project; Shanghai health and family planning commission youth Project; Novartis Foundation(Novartis)	This study was funded by Shanghai Shenkang Hospital Development Center Project (project number SHDC12012123), Shanghai health and family planning commission youth Project (project number 20144Y0210) and Novartis Foundation (project number CRFB002ACN03T). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, BENNETT RABBETTS CLI, p[223, 412, 425]; Augusteyn RC, 2010, EXP EYE RES, V90, P643, DOI 10.1016/j.exer.2010.01.013; BROWN N, 1974, EXP EYE RES, V19, P175, DOI 10.1016/0014-4835(74)90034-7; Brown NP, 1999, EYE, V13, P83, DOI 10.1038/eye.1999.16; Dubbelman M, 2005, VISION RES, V45, P117, DOI 10.1016/j.visres.2004.07.032; Dubbelman M, 2001, VISION RES, V41, P1867, DOI 10.1016/S0042-6989(01)00057-8; GARNER L. F., 1992, OPTOMETRY VISION SCI, V69, P63; Glasser A, 1998, VISION RES, V38, P209, DOI 10.1016/S0042-6989(97)00102-8; Hashemi H, 2010, BRIT J OPHTHALMOL, V94, P20, DOI 10.1136/bjo.2009.160465; He MG, 2009, INVEST OPHTH VIS SCI, V50, P5130, DOI 10.1167/iovs.09-3455; HEMENGER RP, 1995, INVEST OPHTH VIS SCI, V36, P703; Iribarren R, 2015, PROG RETIN EYE RES, V47, P86, DOI 10.1016/j.preteyeres.2015.02.002; Iribarren R, 2014, INVEST OPHTH VIS SCI, V55, P1031, DOI 10.1167/iovs.13-13575; Iribarren R, 2012, INVEST OPHTH VIS SCI, V53, P5124, DOI 10.1167/iovs.12-9637; Iribarren R, 2012, INVEST OPHTH VIS SCI, V53, P543, DOI 10.1167/iovs.11-8523; Kasthurirangan S, 2008, INVEST OPHTH VIS SCI, V49, P2531, DOI 10.1167/iovs.07-1443; KORETZ JF, 1988, SCI AM, V259, P92, DOI 10.1038/scientificamerican0788-92; Mayer DL, 2001, ARCH OPHTHALMOL-CHIC, V119, P1625; Moffat BA, 2002, VISION RES, V42, P1683, DOI 10.1016/S0042-6989(02)00078-0; Mutti DO, 2005, INVEST OPHTH VIS SCI, V46, P3074, DOI 10.1167/iovs.04-1040; Nangia V, 2010, OPHTHALMOLOGY, V117, P1360, DOI 10.1016/j.ophtha.2009.11.040; Olsen T, 2007, ACTA OPHTHALMOL SCAN, V85, P361, DOI 10.1111/j.1600-0420.2006.00847.x; Pennie FC, 2001, VISION RES, V41, P2799, DOI 10.1016/S0042-6989(01)00169-9; Rozema JJ, 2011, INVEST OPHTH VIS SCI, V52, P7937, DOI 10.1167/iovs.11-7899; Shufelt C, 2005, INVEST OPHTH VIS SCI, V46, P4450, DOI 10.1167/iovs.05-0435; Warrier S, 2008, BRIT J OPHTHALMOL, V92, P1591, DOI 10.1136/bjo.2008.144477; Wong TY, 2001, INVEST OPHTH VIS SCI, V42, P73; Yin G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043172; Zhao JL, 2010, OPHTHALMOLOGY, V117, P409, DOI 10.1016/j.ophtha.2009.11.023	29	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170030	10.1371/journal.pone.0170030	http://dx.doi.org/10.1371/journal.pone.0170030			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114313	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129000019
J	Hube, L; Dohrn, MF; Karsai, G; Hirshman, S; Van Damme, P; Schulz, JB; Weis, J; Hornemann, T; Claeys, KG				Hube, Larissa; Dohrn, Maike F.; Karsai, Gergely; Hirshman, Sarah; Van Damme, Philip; Schulz, Jorg B.; Weis, Joachim; Hornemann, Thorsten; Claeys, Kristl G.			Metabolic Syndrome, Neurotoxic 1-Deoxysphingolipids and Nervous Tissue Inflammation in Chronic Idiopathic Axonal Polyneuropathy (CIAP)	PLOS ONE			English	Article							PERIPHERAL NEUROPATHY; GLUCOSE-TOLERANCE; SURAL NERVE; SCALE; SEVERITY	Aim Chronic idiopathic axonal polyneuropathy (CIAP) is a slowly progressive, predominantly sensory, axonal polyneuropathy, with no aetiology being identified despite extensive investigations. We studied the potential role of the metabolic syndrome, neurotoxic 1-deoxysphingolipids (1-deoxySLs), microangiopathy and inflammation in sural nerve biopsies. Methods We included 30 CIAP-patients, 28 with diabetic distal symmetrical polyneuropathy (DSPN) and 31 healthy controls. We assessed standardised scales, tested for the metabolic syndrome, measured 1-deoxySLs in plasma, performed electroneurography and studied 17 sural nerve biopsies (10 CIAP; 7 DSPN). Results One third of the CIAP-patients had a metabolic syndrome, significantly less frequent than DSPN-patients (89%). Although the metabolic syndrome was not significantly more prevalent in CIAP compared to healthy controls, hypercholesterolemia did occur significantly more frequent. 1-deoxySLs were significantly and equally elevated in both patient groups compared to healthy controls. Mean basal lamina thickness of small endoneurial vessels and the number of CD68- or CD8-positive cells in biopsies of CIAP- and DSPN-patients did not differ significantly. However, the number of leucocyte-common-antigen positive cells was significantly increased in CIAP. Conclusions A non-significant trend towards a higher occurrence of the metabolic syndrome in CIAP-patients compared to healthy controls was found. 1-deoxySLs were significantly increased in plasma of CIAP-patients. Microangiopathy and an inflammatory component were present in CIAP-biopsies.	[Hube, Larissa; Dohrn, Maike F.; Hirshman, Sarah; Schulz, Jorg B.; Claeys, Kristl G.] Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany; [Hube, Larissa; Weis, Joachim; Claeys, Kristl G.] Rhein Westfal TH Aachen, Inst Neuropathol, Aachen, Germany; [Karsai, Gergely; Hornemann, Thorsten] Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland; [Karsai, Gergely; Hornemann, Thorsten] Univ Zurich Hosp, Inst Clin Chem, Zurich, Switzerland; [Van Damme, Philip] Univ Hosp Leuven, Dept Neurol, Leuven, Belgium; [Van Damme, Philip] Univ Leuven KU Leuven, Dept Neurosci, Expt Neurol, Leuven, Belgium; [Van Damme, Philip] VIB, Vesalius Res Ctr, Neurobiol Lab, Leuven, Belgium; [Schulz, Jorg B.] Forschungszentrum Julich, JARA Inst Mol Neurosci & Neuroimaging, Aachen, Germany; [Schulz, Jorg B.] Rhein Westfal TH Aachen, Aachen, Germany; [Claeys, Kristl G.] Univ Leuven KU Leuven, Lab Muscle Dis & Neuropathies, Dept Neurosci, Expt Neurol, Leuven, Belgium	RWTH Aachen University; RWTH Aachen University; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University Zurich Hospital; KU Leuven; University Hospital Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; Helmholtz Association; Research Center Julich; RWTH Aachen University; KU Leuven	Claeys, KG (corresponding author), Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany.	Kristl.Claeys@uzleuven.be	Van Damme, Philip/A-6464-2009; Weis, Joachim/G-1984-2014; Schulz, Jörg B/D-9786-2012	Van Damme, Philip/0000-0002-4010-2357; Weis, Joachim/0000-0003-3280-6773; Schulz, Jörg B/0000-0002-8903-0593; Karsai, Gergely/0000-0002-6840-682X; Claeys, Kristl/0000-0001-9937-443X	7th Framework Program of the European Commission [305707]; Swiss National Foundation SNF [31003A_153390/1]; Dr. Wilhelm Hurka Stiftung; Novartis Foundation; Rare Disease Initiative Zurich; Deutsche Diabetes Gesellschaft; Deutsche Gesellschaft fur Muskelkranke	7th Framework Program of the European Commission(European Commission); Swiss National Foundation SNF(Swiss National Science Foundation (SNSF)); Dr. Wilhelm Hurka Stiftung; Novartis Foundation(Novartis); Rare Disease Initiative Zurich; Deutsche Diabetes Gesellschaft; Deutsche Gesellschaft fur Muskelkranke	The authors received no specific funding for this work. TH received grants prior to this work from the 7th Framework Program of the European Commission (RESOLVE, Project number 305707; https://ec.europa.eu/research/fp7/index_en.cfm), the Swiss National Foundation SNF (Project 31003A_153390/1; http://www.snf.ch/en/Pages/default.aspx); the Dr. Wilhelm Hurka Stiftung (http://www.bvs.zh.ch/files/zh_stiftungen_20160606-k.pdf), the Novartis Foundation (http://www.novartisfoundation.org/) and the Rare Disease Initiative Zurich (radiz, Clinical Research Priority Program for Rare Diseases, University of Zurich; http://www.radiz.uzh.ch/de.html). KGC received a grant from the Deutsche Diabetes Gesellschaft (http://www.deutsche-diabetes-gesellschaft.de/home.html), as well as grants from the Deutsche Gesellschaft fur Muskelkranke (https://www.dgm.org/) for projects unrelated to this work. PVD holds a senior clinical investigatorship from Fonds Wetenschappelijk Onderzoek-Vlaanderen (http://www.fwo.be/).	Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Bertea M, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-84; Dohrn MF, 2015, EUR J NEUROL, V22, P806, DOI 10.1111/ene.12663; Dyck PJ, 2011, DIABETES-METAB RES, V27, P620, DOI 10.1002/dmrr.1226; Farhad K, 2016, MUSCLE NERVE, V53, P856, DOI 10.1002/mus.24969; FELIG P, 1974, J CLIN INVEST, V53, P582, DOI 10.1172/JCI107593; Garofalo K, 2011, J CLIN INVEST, V121, P4735, DOI 10.1172/JCI57549; GIANNINI C, 1994, ANN NEUROL, V36, P408, DOI 10.1002/ana.410360312; Gore M, 2005, J PAIN SYMPTOM MANAG, V30, P374, DOI 10.1016/j.jpainsymman.2005.04.009; Graham RC, 2006, J NEUROL NEUROSUR PS, V77, P973, DOI 10.1136/jnnp.2005.081547; HEIMANS JJ, 1986, J NEUROL SCI, V74, P1, DOI 10.1016/0022-510X(86)90186-3; Heuss D, 2012, KOMMISSION LEITLINIE, V5, P578; Hoffman-Snyder C, 2006, ARCH NEUROL-CHICAGO, V63, P1075, DOI 10.1001/archneur.63.8.noc50336; Hughes RAC, 2004, BRAIN, V127, P1723, DOI 10.1093/brain/awh192; JACOBS JM, 1985, BRAIN, V108, P897, DOI 10.1093/brain/108.4.897; Korei AE, 2016, ANGIOLOGY, V67, P49, DOI 10.1177/0003319715583595; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; MALIK RA, 1992, J NEUROL NEUROSUR PS, V55, P557, DOI 10.1136/jnnp.55.7.557; Martin Hautzinger F K, 2006, BDI 2 BECK DEPRESSIO; Merkies ISJ, 2000, NEUROLOGY, V54, P943, DOI 10.1212/WNL.54.4.943; Othman A, 2012, DIABETOLOGIA, V55, P421, DOI 10.1007/s00125-011-2384-1; Othman A, 2015, DIABETES, V64, P1035, DOI 10.2337/db14-1325; Penno A, 2010, J BIOL CHEM, V285, P11178, DOI 10.1074/jbc.M109.092973; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Rotthier A, 2010, AM J HUM GENET, V87, P513, DOI 10.1016/j.ajhg.2010.09.010; Samuelsson K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163427; Singleton JR, 2001, DIABETES CARE, V24, P1448, DOI 10.2337/diacare.24.8.1448; Smith AG, 2008, J NEUROL SCI, V273, P25, DOI 10.1016/j.jns.2008.06.005; Smith AG, 2004, ARCH INTERN MED, V164, P1021, DOI 10.1001/archinte.164.9.1021; Sommer C, 2008, NEUROMUSCULAR DISORD, V18, P90, DOI DOI 10.1016/J.NMD.2007.08.010; Teunissen LL, 2000, ACTA NEUROPATHOL, V100, P445, DOI 10.1007/s004010000193; Visser NA, 2013, DIABETES CARE, V36, P817, DOI 10.2337/dc12-0469; WHO / IDF, 2006, DEF DIAGN DIAB MELL; Wolfe GI, 1999, ARCH NEUROL-CHICAGO, V56, P540, DOI 10.1001/archneur.56.5.540	34	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170583	10.1371/journal.pone.0170583	http://dx.doi.org/10.1371/journal.pone.0170583			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114358	gold, Green Published, Green Accepted			2022-12-26	WOS:000396129000074
J	Hutten, SJ; Hamers, DS; den Toorn, MA; van Esse, W; Nolles, A; Bucherl, CA; de Vries, SC; Hohlbein, J; Borst, JW				Hutten, Stefan J.; Hamers, Danny S.; den Toorn, Marije Aan; van Esse, Wilma; Nolles, Antsje; Bucherl, Christoph A.; de Vries, Sacco C.; Hohlbein, Johannes; Borst, Jan Willem			Visualization of BRI1 and SERK3/BAK1 Nanoclusters in Arabidopsis Roots	PLOS ONE			English	Article							REFLECTION FLUORESCENCE MICROSCOPY; RECEPTOR-KINASE; SIGNAL-TRANSDUCTION; NEGATIVE REGULATOR; ENDOCYTOSIS; ACTIVATION; DYNAMICS; PROTEINS; GROWTH; CELLS	Brassinosteroids (BRs) are plant hormones that are perceived at the plasma membrane (PM) by the ligand binding receptor BRASSINOSTEROID-INSENSITIVE1 (BRI1) and the co-receptor SOMATIC EMBRYOGENESIS RECEPTOR LIKE KINASE 3/BRI1 ASSOCIATED KINASE 1 (SERK3/BAK1). To visualize BRI1-GFP and SERK3/BAK1-mCherry in the plane of the PM, variable-angle epifluorescence microscopy (VAEM) was employed, which allows selective illumination of a thin surface layer. VAEM revealed an inhomogeneous distribution of BRI1-GFP and SERK3/BAK1-mCherry at the PM, which we attribute to the presence of distinct nanoclusters. Neither the BRI1 nor the SERK3/BAK1 nanocluster density is affected by depletion of endogenous ligands or application of exogenous ligands. To reveal interacting populations of receptor complexes, we utilized selective-surface observation-fluorescence lifetime imaging microscopy (SSO-FLIM) for the detection of Foerster resonance energy transfer (FRET). Using this approach, we observed hetero-oligomerisation of BRI1 and SERK3 in the nanoclusters, which did not change upon depletion of endogenous ligand or signal activation. Upon ligand application, however, the number of BRI1-SERK3 /BAK1 hetero-oligomers was reduced, possibly due to endocytosis of active signalling units of BRI1-SERK3/BAK1 residing in the PM. We propose that formation of nanoclusters in the plant PM is subjected to biophysical restraints, while the stoichiometry of receptors inside these nanoclusters is variable and important for signal transduction.	[Hutten, Stefan J.; Hamers, Danny S.; den Toorn, Marije Aan; van Esse, Wilma; Nolles, Antsje; Bucherl, Christoph A.; de Vries, Sacco C.; Borst, Jan Willem] Wageningen Univ & Res, Biochem Lab, Stippeneng 4, Wageningen, Netherlands; [Hohlbein, Johannes] Wageningen Univ & Res, Biophys Lab, Stippeneng 4, Wageningen, Netherlands; [Hohlbein, Johannes; Borst, Jan Willem] Wageningen Univ & Res, Microspect Ctr, Stippeneng 4, Wageningen, Netherlands; [van Esse, Wilma] Max Planck Inst Plant Breeding Res, Dept Plant Breeding & Genet, Carl von Linne Weg 10, Cologne, Germany; [Bucherl, Christoph A.] Sainsbury Lab, Norwich Res Pk, Norwich, Norfolk, England	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Max Planck Society; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Borst, JW (corresponding author), Wageningen Univ & Res, Biochem Lab, Stippeneng 4, Wageningen, Netherlands.; Borst, JW (corresponding author), Wageningen Univ & Res, Microspect Ctr, Stippeneng 4, Wageningen, Netherlands.	JanWillem.Borst@wur.nl	Borst, Jan Willem/B-1259-2011; Hohlbein, Johannes/D-9512-2011; van Esse, Wilma/AAN-2145-2020	Hohlbein, Johannes/0000-0001-7436-2221; van Esse, Wilma/0000-0001-5012-2346; Hutten, Stefan/0000-0001-5395-8392; Nolles, Antsje/0000-0001-6780-7237	Graduate School VLAG (Wageningen, The Netherlands); FP7-PEOPLE-CIG - Marie-Curie Action [630992]; NWO Middelgroot Investment Grant [721.011.004]; Netherlands Organization for Scientific Research (NWO) [ALW 821.02.003]	Graduate School VLAG (Wageningen, The Netherlands)(Netherlands Government); FP7-PEOPLE-CIG - Marie-Curie Action; NWO Middelgroot Investment Grant; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Financial support from the Graduate School VLAG (Wageningen, The Netherlands) is gratefully acknowledged. J. H. acknowledges support from FP7-PEOPLE-2013-CIG - Marie-Curie Action: "Career Integration Grants" (grant ID 630992). The FRET-FLIM experiments were performed on a multimode confocal microscope supported by a NWO Middelgroot Investment Grant (721.011.004; J.W.B.). D.S.H. was supported by Netherlands Organization for Scientific Research (NWO; ALW 821.02.003).	Albrecht C, 2008, PLANT PHYSIOL, V148, P611, DOI 10.1104/pp.108.123216; Ariotti N, 2010, MOL CELL BIOL, V30, P3795, DOI 10.1128/MCB.01615-09; Asami T, 2000, PLANT PHYSIOL, V123, P93, DOI 10.1104/pp.123.1.93; AXELROD D, 1983, J MICROSC-OXFORD, V129, P19, DOI 10.1111/j.1365-2818.1983.tb04158.x; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Boutte Y, 2010, EMBO J, V29, P546, DOI 10.1038/emboj.2009.363; Bucherl C.A., 2013, PLANT PHYSL; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Clouse S, 2001, CURR BIOL, V11, pR904, DOI 10.1016/S0960-9822(01)00549-8; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Ebine K, 2011, NAT CELL BIOL, V13, P853, DOI 10.1038/ncb2270; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Farooq S, 2015, PHYS CHEM CHEM PHYS, V17, P27862, DOI 10.1039/c5cp04137f; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; Fujioka S, 1997, PLANT CELL, V9, P1951, DOI 10.1105/tpc.9.11.1951; Gao MH, 2009, CELL HOST MICROBE, V6, P34, DOI 10.1016/j.chom.2009.05.019; Geldner N, 2007, GENE DEV, V21, P1598, DOI 10.1101/gad.1561307; Geldner N, 2009, PLANT J, V59, P169, DOI 10.1111/j.1365-313X.2009.03851.x; Gonzalez-Garcia MP, 2011, DEVELOPMENT, V138, P849, DOI 10.1242/dev.057331; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Gou XP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002452; Hacham Y, 2011, DEVELOPMENT, V138, P839, DOI 10.1242/dev.061804; Halter T, 2014, CURR BIOL, V24, P134, DOI 10.1016/j.cub.2013.11.047; Hao HQ, 2014, PLANT CELL, V26, P1729, DOI 10.1105/tpc.113.122358; Harding A, 2008, CELL CYCLE, V7, P127, DOI 10.4161/cc.7.2.5237; Irani NG, 2012, NAT CHEM BIOL, V8, P583, DOI [10.1038/nchembio.958, 10.1038/NCHEMBIO.958]; Jaillais Y, 2016, CURR OPIN PLANT BIOL, V33, P92, DOI 10.1016/j.pbi.2016.06.014; Jaillais Y, 2011, GENE DEV, V25, P232, DOI 10.1101/gad.2001911; Jaqaman K, 2012, TRENDS CELL BIOL, V22, P515, DOI 10.1016/j.tcb.2012.07.006; Jarsch IK, 2014, PLANT CELL, V26, P1698, DOI 10.1105/tpc.114.124446; Karlova R, 2006, PLANT CELL, V18, P626, DOI 10.1105/tpc.105.039412; Kenworthy AK, 2007, NAT CELL BIOL, V9; Kim TW, 2011, MOL CELL, V43, P561, DOI 10.1016/j.molcel.2011.05.037; Kleine-Vehn J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.72; Konopka CA, 2008, PLANT J, V53, P186, DOI 10.1111/j.1365-313X.2007.03306.x; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Martiniere A, 2012, P NATL ACAD SCI USA, V109, P12805, DOI 10.1073/pnas.1202040109; Orr G, 2005, BIOPHYS J, V89, P1362, DOI 10.1529/biophysj.104.056192; Plowman SJ, 2008, MOL CELL BIOL, V28, P4377, DOI 10.1128/MCB.00050-08; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Santiago J, 2013, SCIENCE, V341, P889, DOI 10.1126/science.1242468; Savaldi-Goldstein S, 2007, NATURE, V446, P199, DOI 10.1038/nature05618; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shaw SL, 2006, PLANT J, V45, P573, DOI 10.1111/j.1365-313X.2006.02653.x; Somssich M, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab0598; Tang WQ, 2008, SCIENCE, V321, P557, DOI 10.1126/science.1156973; Ueda T, 2004, PLANT J, V40, P783, DOI 10.1111/j.1365-313X.2004.02249.x; van Esse GW, 2012, PLANT PHYSIOL, V160, P523, DOI 10.1104/pp.112.200105; van Esse GW, 2011, PLANT PHYSIOL, V156, P1691, DOI 10.1104/pp.111.179309; Vizcay-Barrena G, 2011, J EXP BOT, V62, P5419, DOI 10.1093/jxb/err212; Wan YL, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-27; Wang L, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500463; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang XL, 2006, SCIENCE, V313, P1118, DOI 10.1126/science.1127593; Wang Y, 2014, CELL RES, V24, P959, DOI 10.1038/cr.2014.89; Webb SED, 2006, OPT LETT, V31, P2157, DOI 10.1364/OL.31.002157; Wilson BS, 2011, ADV EXP MED BIOL, V716, P91, DOI 10.1007/978-1-4419-9533-9_6	60	23	23	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0169905	10.1371/journal.pone.0169905	http://dx.doi.org/10.1371/journal.pone.0169905			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114413	Green Submitted, Green Published, gold			2022-12-26	WOS:000396129000015
J	Kadochova, S; Frouz, J; Roces, F				Kadochova, Stepanka; Frouz, Jan; Roces, Flavio			Sun Basking in Red Wood Ants Formica polyctena (Hymenoptera, Formicidae): Individual Behaviour and Temperature-Dependent Respiration Rates	PLOS ONE			English	Article							FORAGING ACTIVITY; NEST MOISTURE; RUFA GROUP; THERMOREGULATION; COLONIES; CLIMATE; MOUND; BEES	In early spring, red wood ants Formica polyctena are often observed clustering on the nest surface in large numbers basking in the sun. It has been hypothesized that sun-basking behaviour may contribute to nest heating because of both heat carriage into the nest by sun-basking workers, and catabolic heat production from the mobilization of the workers' lipid reserves. We investigated sun-basking behaviour in laboratory colonies of F. polyctena exposed to an artificial heat source. Observations on identified individuals revealed that not all ants bask in the sun. Sun-basking and non-sun-basking workers did not differ in body size nor in respiration rates. The number of sun-basking ants and the number of their visits to the hot spot depended on the temperature of both the air and the hot spot. To investigate whether sun basking leads to a physiological activation linked with increased lipolysis, we measured respiration rates of individual workers as a function of temperature, and compared respiration rates of sun-basking workers before and two days after they were allowed to expose themselves to a heat source over 10 days, at self-determined intervals. As expected for ectothermic animals, respiration rates increased with increasing temperatures in the range 5 to 35 degrees C. However, the respiration rates of sun-basking workers measured two days after a long-term exposure to the heat source were similar to those before sun basking, providing no evidence for a sustained increase of the basal metabolic rates after prolonged sun basking. Based on our measurements, we argue that self-heating of the nest mound in early spring has therefore to rely on alternative heat sources, and speculate that physical transport of heat in the ant bodies may have a significant effect.	[Kadochova, Stepanka; Roces, Flavio] Univ Wurzburg, Bioctr, Dept Behav Physiol & Sociobiol, Wurzburg, Germany; [Kadochova, Stepanka] Charles Univ Prague, Fac Sci, Dept Ecol, Prague, Czech Republic; [Frouz, Jan] Charles Univ Prague, Fac Sci, Inst Environm Studies, Prague, Czech Republic	University of Wurzburg; Charles University Prague; Charles University Prague	Kadochova, S (corresponding author), Univ Wurzburg, Bioctr, Dept Behav Physiol & Sociobiol, Wurzburg, Germany.; Kadochova, S (corresponding author), Charles Univ Prague, Fac Sci, Dept Ecol, Prague, Czech Republic.	stepanka.kadochova@natur.cuni.cz	Frouz, Jan/P-4388-2016; Kadochova, Stepanka/Q-5664-2017	Frouz, Jan/0000-0002-0908-8606; Kadochova, Stepanka/0000-0003-1369-3929; Roces, Flavio/0000-0001-9258-3079	Annual Scholarship Program of the Free State of Bavaria (Jahresstipendien-Program des Freistaates Bayern fur Hochschulabsolventen aus Mittel- und sudosteuropa); German Research Foundation (DFG) [SFB 1047 TP C1]; German Research Foundation (DFG); University of Wurzburg	Annual Scholarship Program of the Free State of Bavaria (Jahresstipendien-Program des Freistaates Bayern fur Hochschulabsolventen aus Mittel- und sudosteuropa); German Research Foundation (DFG)(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wurzburg	SK was supported by an Annual Scholarship Program of the Free State of Bavaria (Jahresstipendien-Program des Freistaates Bayern fur Hochschulabsolventen aus Mittel- und sudosteuropa; www.uni-regensburg.de/bayhost/). The experimental work was partially supported by a grant of the German Research Foundation (DFG, SFB 1047 TP C1) to FR. This publication was funded by the German Research Foundation (DFG) and the University of Wurzburg in the funding program Open Access Publishing.	[Anonymous], 1971, INSECT SOC; Auguie B, 2017, GRIDEXTRA MISCELLANE; Bausenwein F, 1960, CAS CESKOSL SPOLEC E, V57, P31; Bollazzi M, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.13701; BRANDT DC, 1980, OECOLOGIA, V44, P281, DOI 10.1007/BF00572691; Bujok B, 2002, NATURWISSENSCHAFTEN, V89, P299, DOI 10.1007/s00114-002-0338-7; Coenen-Stass D., 1985, Verhandlungen der Deutschen Zoologischen Gesellschaft, V78, P204; COENENSTASS D, 1980, ECOLOGY, V61, P238, DOI 10.2307/1935180; Domisch T, 2009, ECOL ENTOMOL, V34, P369, DOI 10.1111/j.1365-2311.2009.01086.x; Engels W, 1995, STUD NEOTROP FAUNA E, V30, P193, DOI 10.1080/01650529509360958; ESCH H, 1960, Z VERGL PHYSIOL, V43, P305, DOI 10.1007/BF00298066; Frouz J, 1996, BIOLOGIA, V51, P541; Frouz J, 2000, INSECT SOC, V47, P229, DOI 10.1007/PL00001708; Frouz J, 2007, INSECT SOC, V54, P251, DOI 10.1007/s00040-007-0939-4; GALLE L JR, 1978, Acta Universitatis Szegediensis Acta Biologica, V24, P111; Gordon DM, 1996, NATURE, V380, P121, DOI 10.1038/380121a0; Gosswald K, 1964, WALDHYGIENE, V4, P199; Heinrich B., 1993, HOT BLOODED INSECTS; Heinrich B., 1981, INSECT THERMOREGULAT, P159; HOLT SJ, 1955, J ANIM ECOL, V24, P1, DOI 10.2307/1877; HORSTMANN K, 1990, Zoologische Beitraege, V33, P105; Jilkova V, 2015, SOIL BIOL BIOCHEM, V86, P50, DOI 10.1016/j.soilbio.2015.03.024; Jilkova V, 2014, EUR J SOIL BIOL, V60, P44, DOI 10.1016/j.ejsobi.2013.11.003; Jones JC, 2007, ADV INSECT PHYSIOL, V33, P153, DOI 10.1016/S0065-2806(06)33003-2; Kadochova S, 2014, INSECT SOC, V61, P297, DOI 10.1007/s00040-014-0356-4; Kadochova Stepanka, 2013, F1000Res, V2, P280, DOI 10.12688/f1000research.2-280.v1; Kasimova RG, 2014, J THEOR BIOL, V355, P21, DOI 10.1016/j.jtbi.2014.01.038; KIPYATKOV VE, 1990, ZOOL ZH, V69, P40; Kirchner W, 1964, ZOOL JB PHYSL, V70, P1; Kleinhenz M, 2003, J EXP BIOL, V206, P4217, DOI 10.1242/jeb.00680; Kneitz G., 1965, P 5 C INT IUSSI, P278; Kneitz G., 1964, THESIS; LINDAUER M, 1954, Z VERGL PHYSIOL, V36, P391, DOI 10.1007/BF00345028; LUESCHER M, 1961, SCI AM, V205, P138, DOI 10.1038/scientificamerican0761-138; MABELIS AA, 1979, NETH J ZOOL, V29, P451, DOI 10.1163/002829679X00016; Martin A-JA, 1980, IZV AKAD NAUK ESTON, V29, P188; Mildner S, 2017, PLOS ONE IN PRESS; Muth M., 2012, THESIS; Otto D., 1958, ARBEITSTEILUNG STAAT, P1; Rosengren R, 1978, ANN ZOOL FENN, V24, P147; Schilman PE, 2005, PHYSIOL ENTOMOL, V30, P332, DOI 10.1111/j.1365-3032.2005.00464.x; Schmidt GH, 1968, ZOOL BEITR, V15, P171; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; Stabentheiner A., 1987, Thermology, V2, P563; Weidenmuller A, 2004, BEHAV ECOL, V15, P120, DOI 10.1093/beheco/arg101; Weidenmuller A, 2002, ANIM BEHAV, V63, P1065, DOI 10.1006/anbe.2002.3020; Zahn M., 1958, Zoologische Beitraege Berlin (NS), V3, P127	47	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170570	10.1371/journal.pone.0170570	http://dx.doi.org/10.1371/journal.pone.0170570			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114396	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129000071
J	Aiyegbo, MS; Shmelkov, E; Dominguez, L; Goger, M; Battacharya, S; deCamp, AC; Gilbert, PB; Berman, PW; Cardozo, T				Aiyegbo, Mohammed S.; Shmelkov, Evgeny; Dominguez, Lorenzo; Goger, Michael; Battacharya, Shibani; deCamp, Allan C.; Gilbert, Peter B.; Berman, Phillip W.; Cardozo, Timothy			Peptide Targeted by Human Antibodies Associated with HIV Vaccine-Associated Protection Assumes a Dynamic alpha-Helical Structure	PLOS ONE			English	Article							EFFICACY TRIAL; DOUBLE-BLIND; V3 LOOP; PROTEIN; RECOGNITION; THAILAND	The only evidence of vaccine-induced protection from HIV acquisition in humans was obtained in the RV144 HIV vaccine clinical trial. One immune correlate of risk in RV144 was observed to be higher titers of vaccine-induced antibodies (Abs) reacting with a 23-mer non-glycosylated peptide with the same amino acid sequence as a segment in the second variable (V2) loop of the MN strain of HIV. We used NMR to analyze the dynamic 3D structure of this peptide. Distance restraints between spatially proximate inter-residue protons were calculated from NOE cross peak intensities and used to constrain a thorough search of all possible conformations of the peptide. alpha-helical folding was strongly preferred by part of the peptide. A high-throughput structure prediction of this segment in all circulating HIV strains demonstrated that alpha-helical conformations are preferred by this segment almost universally across all subtypes. Notably, alpha-helical conformations of this segment of the V2 loop cluster cross-subtype-conserved amino acids on one face of the helix and the variable amino acid positions on the other in a semblance of an amphipathic alpha-helix. Accordingly, some Abs that protected against HIV in RV144 may have targeted a specific, conserved alpha-helical peptide epitope in the V2 loop of HIV's surface envelope glycoprotein.	[Aiyegbo, Mohammed S.; Shmelkov, Evgeny; Dominguez, Lorenzo; Cardozo, Timothy] NYU, Dept Biochem & Mol Pharmacol, New York, NY 10003 USA; [Goger, Michael; Battacharya, Shibani] New York Struct Biol Ctr, New York, NY USA; [deCamp, Allan C.; Gilbert, Peter B.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Gilbert, Peter B.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Berman, Phillip W.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA	New York University; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of California System; University of California Santa Cruz	Cardozo, T (corresponding author), NYU, Dept Biochem & Mol Pharmacol, New York, NY 10003 USA.	timothy.cardozo@nyumc.org			National Institute of Health [DP1DA036478, R01AI084119]; NYSTAR; ORIP/NIH [CO6RR015495]; NIH [P41GM066354]; Keck Foundation; New York State Assembly; U.S. Department of Defense; Henry Jackson Foundation; Henry Jackson Foundation [792087]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI106501, UM1AI068635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA036478] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTAR; ORIP/NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation(W.M. Keck Foundation); New York State Assembly; U.S. Department of Defense(United States Department of Defense); Henry Jackson Foundation; Henry Jackson Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute of Health grants DP1DA036478 and R01AI084119 (to T.C.). The NMR work was designed and conducted at The New York Structural Biology Center, which was made possible by a grant from NYSTAR and ORIP/NIH facility improvement grant CO6RR015495. The 900 MHz NMR spectrometers were purchased with funds from NIH grant P41GM066354, the Keck Foundation, New York State Assembly, and U.S. Department of Defense. Antibody binding assays were supported by funding to P.B. provided by the Henry Jackson Foundation. This research was partially supported by contract 792087 from the Henry Jackson Foundation to the Statistical Center for HIV/AIDS Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Abagyan RA, 1999, J COMPUT PHYS, V151, P402, DOI 10.1006/jcph.1999.6233; Almond David, 2010, J Vis Exp, DOI 10.3791/2118; Almond D, 2012, ADV VIROL, V2012, DOI 10.1155/2012/803535; Almond D, 2010, AIDS RES HUM RETROV, V26, P717, DOI 10.1089/aid.2009.0254; Cardozo T, 2016, BIOL TREAT SUBSTANCE, P75; Excler JL, 2014, CLIN VACCINE IMMUNOL, V21, P1023, DOI 10.1128/CVI.00230-14; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Gartland AJ, 2014, J VIROL, V88, P8242, DOI 10.1128/JVI.01164-14; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Keller R., 2004, THESIS; Kim JH, 2010, CURR OPIN HIV AIDS, V5, P428, DOI 10.1097/COH.0b013e32833d17ac; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Pancera M, 2013, NAT STRUCT MOL BIOL, V20, P804, DOI 10.1038/nsmb.2600; Pitisuttithum P, 2004, JAIDS-J ACQ IMM DEF, V37, P1160, DOI 10.1097/01.qai.0000136091.72955.4b; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Rosen O, 2005, BIOCHEMISTRY-US, V44, P7250, DOI 10.1021/bi047387t; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Tassaneetrithep B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108446; Totrov M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094002; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zolla-Pazner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087572; Zolla-Pazner S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053629	31	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170530	10.1371/journal.pone.0170530	http://dx.doi.org/10.1371/journal.pone.0170530			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107435	Green Submitted, Green Published, gold			2022-12-26	WOS:000392405300157
J	Antonieto, ACC; Pedersoli, WR; Castro, LD; Santos, RD; Cruz, AHD; Nogueira, KMV; Silva-Rocha, R; Rossi, A; Silva, RN				Campos Antonieto, Amanda Cristina; Pedersoli, Wellington Ramos; Castro, Lilian dos Santos; Santos, Rodrigo da Silva; da Silva Cruz, Aline Helena; Vieira Nogueira, Karoline Maria; Silva-Rocha, Rafael; Rossi, Antonio; Silva, Roberto Nascimento			Deletion of pH Regulator pac-3 Affects Cellulase and Xylanase Activity during Sugarcane Bagasse Degradation by Neurospora crassa	PLOS ONE			English	Article							ASPERGILLUS-NIDULANS; GENE-EXPRESSION; AMBIENT PH; TRANSCRIPTIONAL REGULATION; TRICHODERMA-REESEI; CARBON SOURCE; FUNGI; MECHANISMS; SEQUENCE	Microorganisms play a vital role in bioethanol production whose usage as fuel energy is increasing worldwide. The filamentous fungus Neurospora crassa synthesize and secrete the major enzymes involved in plant cell wall deconstruction. The production of cellulases and hemicellulases is known to be affected by the environmental pH; however, the regulatory mechanisms of this process are still poorly understood. In this study, we investigated the role of the pH regulator PAC-3 in N. crassa during their growth on sugarcane bagasse at different pH conditions. Our data indicate that secretion of cellulolytic enzymes is reduced in the mutant Delta pac-3 at alkaline pH, whereas xylanases are positively regulated by PAC-3 in acidic (pH 5.0), neutral (pH 7.0), and alkaline (pH 10.0) medium. Gene expression profiles, evaluated by real-time qPCR, revealed that genes encoding cellulases and hemicellulases are also subject to PAC-3 control. Moreover, deletion of pac-3 affects the expression of transcription factor-encoding genes. Together, the results suggest that the regulation of holocellulase genes by PAC-3 can occur as directly as in indirect manner. Our study helps improve the understanding of holocellulolytic performance in response to PAC-3 and should thereby contribute to the better use of N. crassa in the biotechnology industry.	[Campos Antonieto, Amanda Cristina; Castro, Lilian dos Santos; Vieira Nogueira, Karoline Maria; Silva, Roberto Nascimento] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Biochem & Immunol, Ribeirao Preto, SP, Brazil; [Pedersoli, Wellington Ramos; Santos, Rodrigo da Silva; da Silva Cruz, Aline Helena; Rossi, Antonio] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, Ribeirao Preto, SP, Brazil; [Silva-Rocha, Rafael] Univ Sao Paulo, Ribeirao Preto Med Sch, Syst & Synthet Biol Lab, Dept Cell & Mol Biol, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Silva, RN (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Biochem & Immunol, Ribeirao Preto, SP, Brazil.	rsilva@fmrp.usp.br	Antoniêto, Amanda Cristina/E-3463-2018; Silva-Rocha, Rafael/H-4929-2012; Silva, Roberto/F-3897-2012	Silva-Rocha, Rafael/0000-0001-6319-631X; Silva, Roberto/0000-0002-8992-7130; Ramos Pedersoli, Wellington/0000-0002-3982-0626; da Silva Santos, Rodrigo/0000-0002-9480-4362; Rossi, Antonio/0000-0003-1951-4741; da Silva Cruz, Aline Helena/0000-0002-9943-5797	Sao Paulo Research Foundation (FAPESP) [2014/09493-2, 2014/03847-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [304222/2013-5]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Apoio ao Ensino, Pesquisa e Assistencia (FAEPA)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Apoio ao Ensino, Pesquisa e Assistencia (FAEPA)	This work was supported by grants from the Brazilian Funding Agencies: Sao Paulo Research Foundation (FAPESP), (Grant No 2014/09493-2, ACCA) (Grant No 2014/03847-7; AR, RSS, AHSC), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), (Grant No 304222/2013-5), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Apoio ao Ensino, Pesquisa e Assistencia (FAEPA).	Alkan N, 2013, MOL PLANT MICROBE IN, V26, P1345, DOI 10.1094/MPMI-03-13-0080-R; Castro LD, 2014, GENE EXPR PATTERNS, V14, P88, DOI 10.1016/j.gep.2014.01.003; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Coradetti ST, 2012, P NATL ACAD SCI USA, V109, P7397, DOI 10.1073/pnas.1200785109; Craig JP, 2015, MBIO, V6, DOI 10.1128/mBio.01452-15; Cupertino FB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044258; Dogaris I, 2013, APPL MICROBIOL BIOT, V97, P1457, DOI 10.1007/s00253-012-4655-2; EBERHART BM, 1977, J BACTERIOL, V130, P181, DOI 10.1128/JB.130.1.181-186.1977; Eshel D, 2002, MOL PLANT MICROBE IN, V15, P774, DOI 10.1094/MPMI.2002.15.8.774; Ferreira SMP, 2009, ELECTRON J BIOTECHN, V12, DOI 10.2225/vol12-issue3-fulltext-6; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Gutierrez-Rojas I, 2015, REV IBEROAM MICOL, V32, P1, DOI 10.1016/j.riam.2013.10.009; Hakkinen M, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0247-z; He RL, 2014, ENZYME MICROB TECH, V67, P17, DOI 10.1016/j.enzmictec.2014.08.013; Kubicek CP, 2013, J BIOTECHNOL, V163, P133, DOI 10.1016/j.jbiotec.2012.05.020; Kunitake E, 2016, APPL MICROBIOL BIOT, V100, P3621, DOI 10.1007/s00253-016-7409-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacCabe AP, 1998, J BACTERIOL, V180, P1331, DOI 10.1128/JB.180.5.1331-1333.1998; McCluskey K, 2003, ADV APPL MICROBIOL, V52, P245, DOI 10.1016/S0065-2164(03)01010-4; Mello-de-Sousa TM, 2011, ENZYME MICROB TECH, V48, P19, DOI 10.1016/j.enzmictec.2010.08.007; Pandit A, 1996, J BIOSCIENCE, V21, P57, DOI 10.1007/BF02716813; Penalva MA, 2008, TRENDS MICROBIOL, V16, P291, DOI 10.1016/j.tim.2008.03.006; Perez-Gonzalez J, 1998, APPL ENVIRON MICROB, V64, P1412; PERKINS DD, 1976, EVOLUTION, V30, P281, DOI 10.1111/j.1558-5646.1976.tb00910.x; Rossi A, 2013, IUBMB LIFE, V65, P930, DOI 10.1002/iub.1217; Segato F, 2014, MICROBIOL MOL BIOL R, V78, P588, DOI 10.1128/MMBR.00019-14; STEWART JC, 1981, J GEN MICROBIOL, V125, P33; Sun JP, 2012, EUKARYOT CELL, V11, P482, DOI 10.1128/EC.05327-11; Sun JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025654; Tian CG, 2009, P NATL ACAD SCI USA, V106, P22157, DOI 10.1073/pnas.0906810106; Nogueira KMV, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0536-z; Virgilio S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161659; Vogel H.J., 1956, MICROB GENET B, V13, P42; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Xiao ZZ, 2005, ANAL BIOCHEM, V342, P176, DOI 10.1016/j.ab.2005.01.052	35	13	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0169796	10.1371/journal.pone.0169796	http://dx.doi.org/10.1371/journal.pone.0169796			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107376	Green Published, Green Submitted, gold			2022-12-26	WOS:000392405300043
J	Cunnion, KM; Krishna, NK; Pallera, HK; Pineros-Fernandez, A; Rivera, MG; Hair, PS; Lassiter, BP; Huyck, R; Clements, MA; Hood, AF; Rodeheaver, GT; Cottler, PS; Nadler, JL; Dobrian, AD				Cunnion, Kenji M.; Krishna, Neel K.; Pallera, Haree K.; Pineros-Fernandez, Angela; Rivera, Magdielis Gregory; Hair, Pamela S.; Lassiter, Brittany P.; Huyck, Ryan; Clements, Mary A.; Hood, Antoinette F.; Rodeheaver, George T.; Cottler, Patrick S.; Nadler, Jerry L.; Dobrian, Anca D.			Complement Activation and STAT4 Expression Are Associated with Early Inflammation in Diabetic Wounds	PLOS ONE			English	Article							INSULIN-RESISTANCE; SIGNAL TRANSDUCER; CELLS; BIOLOGY; INNATE; SYSTEM; MACROPHAGES; DYSFUNCTION; RESOLUTION; INDUCTION	Diabetic non-healing wounds are a major clinical problem. The mechanisms leading to poor wound healing in diabetes are multifactorial but unresolved inflammation may be a major contributing factor. The complement system (CS) is the most potent inflammatory cascade in humans and contributes to poor wound healing in animal models. Signal transducer and activator of transcription 4 (STAT4) is a transcription factor expressed in immune and adipose cells and contributes to upregulation of some inflammatory chemokines and cytokines. Persistent CS and STAT4 expression in diabetic wounds may thus contribute to chronic inflammation and delayed healing. The purpose of this study was to characterize CS and STAT4 in early diabetic wounds using db/db mice as a diabetic skin wound model. The CS was found to be activated early in the diabetic wounds as demonstrated by increased anaphylatoxin C5a in wound fluid and C3-fragment deposition by immunostaining. These changes were associated with a 76% increase in nucleated cells in the wounds of db/db mice vs. controls. The novel classical CS inhibitor, Peptide Inhibitor of Complement C1 (PIC1) reduced inflammation when added directly or saturated in an acellular skin scaffold, as reflected by reduced CS components and leukocyte infiltration. A significant increase in expression of STAT4 and the downstream macrophage chemokine CCL2 and its receptor CCR2 were also found in the early wounds of db/db mice compared to non-diabetic controls. These studies provide evidence for two new promising targets to reduce unresolved inflammation and to improve healing of diabetic skin wounds.	[Cunnion, Kenji M.; Krishna, Neel K.; Pallera, Haree K.; Rivera, Magdielis Gregory; Hair, Pamela S.] Eastern Virginia Med Sch, Dept Pediat, Norfolk, VA 23501 USA; [Cunnion, Kenji M.; Krishna, Neel K.] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA; [Cunnion, Kenji M.] Childrens Hosp Kings Daughters, Childrens Specialty Grp, Norfolk, VA USA; [Pineros-Fernandez, Angela; Rodeheaver, George T.; Cottler, Patrick S.] Univ Virginia, Dept Plast Surg, Charlottesville, VA USA; [Huyck, Ryan; Dobrian, Anca D.] Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23501 USA; [Clements, Mary A.; Hood, Antoinette F.] Eastern Virginia Med Sch, Dept Dermatol, Norfolk, VA 23501 USA; [Clements, Mary A.; Hood, Antoinette F.] Eastern Virginia Med Sch, Dept Pathol, Norfolk, VA 23501 USA; [Nadler, Jerry L.] Eastern Virginia Med Sch, Dept Internal Med, Strelitz Diabet Ctr, Norfolk, VA 23501 USA	Eastern Virginia Medical School; Eastern Virginia Medical School; University of Virginia; Eastern Virginia Medical School; Eastern Virginia Medical School; Eastern Virginia Medical School; Eastern Virginia Medical School	Cottler, PS (corresponding author), Univ Virginia, Dept Plast Surg, Charlottesville, VA USA.	cottlerp@virginia.edu		Pallera, Haree/0000-0002-4576-1626	Virginia Biosciences Health Research Corporation; National Institutes of Health, National Heart Lung and Blood Institute [R01HL112605]	Virginia Biosciences Health Research Corporation; National Institutes of Health, National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by a grant from the Virginia Biosciences Health Research Corporation, (Catalyst Grant) (www.vbhrc.com) to JLN. The studies were also supported in part by the National Institutes of Health, National Heart Lung and Blood Institute, #R01HL112605 (www.nhlbi.gov), to JLN and ADD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelman Y, 2015, ATHEROSCLEROSIS, V241, P211, DOI 10.1016/j.atherosclerosis.2015.01.027; Bannon P, 2013, DIS MODEL MECH, V6, P1434, DOI 10.1242/dmm.012237; Begieneman MPV, 2012, J BURN CARE RES, V33, P544, DOI 10.1097/BCR.0b013e31823bc2fc; Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x; Bolin K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084450; Cazander G, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/534291; Chang HC, 2009, BLOOD, V113, P5887, DOI 10.1182/blood-2008-09-179820; Daha NA, 2011, MOL IMMUNOL, V48, P1656, DOI 10.1016/j.molimm.2011.04.024; Dobrian AD, 2015, J ENDOCRINOL, V227, P13, DOI 10.1530/JOE-15-0098; Dobrian AD, 2013, DIABETES, V62, P4109, DOI 10.2337/db12-1275; Frank MM, 1975, DIS MON, P1; Gallagher KA, 2015, DIABETES, V64, P1420, DOI 10.2337/db14-0872; Good SR, 2009, J IMMUNOL, V183, P3839, DOI 10.4049/jimmunol.0901411; Hertle E, 2014, MOL IMMUNOL, V61, P135, DOI 10.1016/j.molimm.2014.06.031; Hill MJ, 2009, CLIN SCI, V116, P113, DOI 10.1042/CS20080050; Houreld NN, 2014, SCI WORLD J, DOI 10.1155/2014/398412; Imai Y, 2013, DIABETES OBES METAB, V15, P117, DOI 10.1111/dom.12161; Kaplan MH, 2005, IMMUNOL RES, V31, P231, DOI 10.1385/IR:31:3:231; Khanna S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009539; Kim SH, 2006, CLIN IMMUNOL, V118, P250, DOI 10.1016/j.clim.2003.10.002; Knudsen NH, 2013, DIABETES, V62, DOI 10.4049/jimmunol.0901411; Kohl J, 2006, ADV EXP MED BIOL, V586, P71; Kumar PS, 2015, MOL IMMUNOL, V67, P575, DOI 10.1016/j.molimm.2015.07.017; Lambris JD, 1999, IMMUNOL TODAY, V20, P207, DOI 10.1016/S0167-5699(98)01417-0; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Maskrey BH, 2011, ARTERIOSCL THROM VAS, V31, P1001, DOI 10.1161/ATVBAHA.110.213850; Mauriello CT, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/762051; Michaels J, 2007, WOUND REPAIR REGEN, V15, P665, DOI 10.1111/j.1524-475X.2007.00273.x; Pei H, 2006, AM J PHYSIOL-ENDOC M, V290, pE92, DOI 10.1152/ajpendo.00133.2005; Phieler J, 2013, SEMIN IMMUNOL, V25, P47, DOI 10.1016/j.smim.2013.04.003; Ploeger DTA, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-29; Rafail S, 2015, J IMMUNOL, V194, P1285, DOI 10.4049/jimmunol.1402354; Raman K, 2003, J IMMUNOL, V170, P3859, DOI 10.4049/jimmunol.170.7.3859; Riedemann NC, 2003, IMMUNITY, V19, P193, DOI 10.1016/S1074-7613(03)00206-1; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Sharp JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132446; Sharp JA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00406; Silva LM, 2015, HUM PATHOL, V46, P746, DOI 10.1016/j.humpath.2015.01.015; Sinno Hani, 2013, Plast Surg Int, V2013, P146764, DOI 10.1155/2013/146764; Stacey D Heath, 2013, Eplasty, V13, pe61; Suber F, 2007, P NATL ACAD SCI USA, V104, P3973, DOI 10.1073/pnas.0609026104; van de Goot F, 2009, J BURN CARE RES, V30, P274, DOI 10.1097/BCR.0b013e318198a252; Vlaicu SI, 2016, IMMUNOL RES, V64, P653, DOI 10.1007/s12026-015-8783-5; Wang Y, 2015, INT J BIOL SCI, V11, P448, DOI 10.7150/ijbs.11164; Weaver JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142735; Wetzler C, 2000, J INVEST DERMATOL, V115, P245, DOI 10.1046/j.1523-1747.2000.00029.x; Xu L, 2007, DIABETES CARE, V30, P378, DOI 10.2337/dc06-1383; Yang ZD, 2003, ANN NY ACAD SCI, V1005, P409, DOI 10.1196/annals.1288.069; Yang ZD, 2004, J AUTOIMMUN, V22, P191, DOI 10.1016/j.jaut.2003.08.006	49	15	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170500	10.1371/journal.pone.0170500	http://dx.doi.org/10.1371/journal.pone.0170500			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107529	gold, Green Published, Green Submitted			2022-12-26	WOS:000392405300149
J	Fernandez-Robredo, P; Selvam, S; Powner, MB; Sim, DA; Fruttiger, M				Fernandez-Robredo, Patricia; Selvam, Senthil; Powner, Michael B.; Sim, Dawn A.; Fruttiger, Marcus			Neuropilin 1 Involvement in Choroidal and Retinal Neovascularisation	PLOS ONE			English	Article							OXYGEN-INDUCED RETINOPATHY; ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; PATHOLOGICAL ANGIOGENESIS; SPROUTING ANGIOGENESIS; VASCULAR-DISEASE; VEGF; MODEL; NRP1; INHIBITION	Purpose Inhibiting VEGF is the gold standard treatment for neovascular age-related macular degeneration (AMD). It is also effective in preventing retinal oedema and neovascularisation (NV) in diabetic retinopathy (DR) and retinal vein occlusions (RVO). Neuropilin 1 (Nrp1) is a coreceptor for VEGF and many other growth factors, and therefore a possible alternative drug target in intra ocular neovascular disease. Here we assessed choroidal and retinal NV in an inducible, endothelial specific knock out model for Nrp1. Methods Crossing Nrp1 floxed mice with Pdgfb-CreERT2 mice produced tamoxifen-inducible, endothelial specific Nrp1 knock out mice (Nrp1(Delta EC)) and Cre-negative, control littermates. Crerecombinase activity was confirmed in the Ai3(RCL-EYFP) reporter strain. Animals were subjected to laser-induced CNV (532 nm) and spectral domain-optical coherence tomography (SD-OCT) was performed immediately after laser and at day 7. Fluorescein angiography (FA) evaluated leakage and postmortem lectin staining in flat mounted RPE/choroid complexes was also used to measure CNV. Furthermore, retinal neovascularisation in the oxygen induced retinopathy (OIR) model was assessed by immunohistochemistry in retinal flatmounts. Results In vivo FA, OCT and post-mortem lectin staining showed a statistically significant reduction in leakage (p<0.05), CNV volume (p<0.05) and CNV area (p<0.05) in the Nrp1(Delta EC) mice compared to their Cre-negative littermates. Also the OIR model showed reduced retinal NV in the mutant animals compared to wild types (p<0.001). Conclusion We have demonstrated reduced choroidal and retinal NV in animals that lack endothelial Nrp1, confirming a role of Nrp1 in those processes. Therefore, Nrp1 may be a promising drug target for neovascular diseases in the eye.	[Fernandez-Robredo, Patricia; Selvam, Senthil; Powner, Michael B.; Sim, Dawn A.; Fruttiger, Marcus] UCL, UCL Inst Ophthalmol, London, England; [Fernandez-Robredo, Patricia] Univ Navarra, Sch Med, Expt Ophthalmol Lab, Navarra Inst Hlth Res,IdiSNA, Pamplona, Spain; [Powner, Michael B.] City Univ London, Sch Hlth Sci, Div Optometry & Visual Sci, London, England; [Sim, Dawn A.] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr Ophthalmol, London, England	University of London; University College London; University of Navarra; City University London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Fruttiger, M (corresponding author), UCL, UCL Inst Ophthalmol, London, England.	m.fruttiger@ucl.ac.uk	Powner, Michael/CAG-7455-2022	Powner, Michael/0000-0003-4913-1004; Fruttiger, Marcus/0000-0002-6962-5485	European Union, 7th Framework Program [331855]; Fight for Sight [1389]; Wellcome Trust [099173/Z/12/Z]; National Institute for Health Research [ACF-2016-18-014] Funding Source: researchfish; Fight for Sight [1987, 1389/90] Funding Source: researchfish	European Union, 7th Framework Program(European Commission); Fight for Sight; Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Fight for Sight	PFR received an FP7-MC-IEF grant (331855) from the European Union, 7th Framework Program. The study was also partially funded by grant from Fight for Sight (1389) and used imaging equipment that was obtained by a multiuser equipment grant from the Wellcome Trust [099173/Z/12/Z].	Aspalter IM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8264; Campochiaro PA, 2012, OPHTHALMOLOGICA, V227, P30, DOI 10.1159/000337157; Claxton S, 2008, GENESIS, V46, P74, DOI 10.1002/dvg.20367; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Eklund L, 2013, EXP CELL RES, V319, P1271, DOI 10.1016/j.yexcr.2013.03.011; Evans IM, 2011, MOL CELL BIOL, V31, P1174, DOI 10.1128/MCB.00903-10; Fantin A, 2013, BLOOD, V121, P2352, DOI 10.1182/blood-2012-05-424713; Garcia-Layana A, 2009, OPHTHALMIC RES, V42, P205, DOI 10.1159/000232946; Gelfand MV, 2014, ELIFE, V3, DOI 10.7554/eLife.03720; Gerhardt H, 2004, DEV DYNAM, V231, P503, DOI 10.1002/dvdy.20148; Glinka Y, 2008, J LEUKOCYTE BIOL, V84, P302, DOI 10.1189/jlb.0208090; Gong Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122248; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Guthrie MJ, 2014, MICROVASC RES, V91, P1, DOI 10.1016/j.mvr.2013.11.005; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Herzog B, 2011, MOL BIOL CELL, V22, P2766, DOI 10.1091/mbc.E09-12-1061; Hirota S, 2015, DEVELOPMENT; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Jin Y, 2014, BIOCHEM SOC T, V42, P1576, DOI 10.1042/BST20140231; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Kim ES, 2002, P NATL ACAD SCI USA, V99, P11399, DOI 10.1073/pnas.172398399; Kwong T. Q., 2014, BIOMED RES INT, P1; Lang GE, 2012, OPHTHALMOLOGICA, V227, P21, DOI 10.1159/000337156; Lores-Motta L, 2015, PHARMACOGENET GENOMI; Mahmoud M, 2011, BIOCHEM SOC T, V39, P1659, DOI 10.1042/BST20110664; Miller JW, 2013, OPHTHALMOLOGY, V120, P106, DOI 10.1016/j.ophtha.2012.07.038; Murakami M, 2008, CARDIOVASC RES, V78, P223, DOI 10.1093/cvr/cvm086; Murga M, 2005, BLOOD, V105, P1992, DOI 10.1182/blood-2004-07-2598; Pieramici DJ, 2006, EXPERT OPIN BIOL TH, V6, P1237, DOI 10.1517/14712598.6.11.1237; Recalde S, 2011, INVEST OPHTH VIS SCI, V52, P7090, DOI 10.1167/iovs.11-7300; Sakurai A, 2012, CELL RES, V22, P441, DOI 10.1038/cr.2012.21; Scott A, 2010, EYE, V24, P416, DOI 10.1038/eye.2009.306; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Uniewicz KA, 2008, FRONT BIOSCI-LANDMRK, V13, P4339, DOI 10.2741/3008; Yang WJ, 2015, EMBO MOL MED, V7, P1267, DOI 10.15252/emmm.201404922; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; Zarranz-Ventura J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065434; Zhang XY, 2009, INT J BIOCHEM CELL B, V41, P2368, DOI 10.1016/j.biocel.2009.07.011	38	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0169865	10.1371/journal.pone.0169865	http://dx.doi.org/10.1371/journal.pone.0169865			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107458	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000392405300048
J	Guo, B; Wang, WJ; Zhao, ZH; Li, Q; Zhou, KY; Zhao, LY; Wang, LM; Yang, J; Huang, C				Guo, Bo; Wang, Wenjing; Zhao, Zhenghao; Li, Qian; Zhou, Kaiyue; Zhao, Lingyu; Wang, Lumin; Yang, Juan; Huang, Chen			Rab14 Act as Oncogene and Induce Proliferation of Gastric Cancer Cells via AKT Signaling Pathway	PLOS ONE			English	Article								Rab14 is a member of RAS oncogene family, and its dysfunction has been reported to be involved in various types of human cancer. However, its expression and function were still unclear in gastric cancer. The aim of this study was to investigate the function and mechanism of Rab14 in gastric cancer cell lines. Quantitative real-time PCR (qRT-PCR) was performed in 17 gastric adenocarcinoma tissues and 4 cell lines to detect the expression of Rab14. 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl-tetrazolium bromide (MTT), colony formation and flow cytometry assays were employed to determine the proliferative ability, cell cycle transition and apoptosis in vitro in BGC-823 or SGC-7901 cells. Western blot was performed to investigate the pathways and mechanism of Rab14 regulation. In this study, we show that Rab14 presents a significant up-regulated expression among the paired tissue samples and cell lines in gastric cancer. When we overexpressed Rab14 in SGC-7901 cells or silenced Rab14 in BGC-823 cells, we found that Rab14 could modify cell growth, cell cycle or apoptosis, which accompanied with an obvious regulation of CCND1, CDK2 and BAX involving in AKT signaling pathway. In conclusion, this study provides a new evidence on that Rab14 functions as a novel tumor oncogene and could be a potential therapeutic target in gastric cancer.	[Guo, Bo; Zhao, Zhenghao; Li, Qian; Zhao, Lingyu; Wang, Lumin; Yang, Juan; Huang, Chen] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Cell Biol & Genet, Xian, Shaanxi, Peoples R China; [Wang, Wenjing] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian, Shaanxi, Peoples R China; [Zhou, Kaiyue] Northwestern Univ, Weinberg Coll Arts & Sci, Program Plant Biol & Conservat Biol Sci, Evanston, IL USA; [Huang, Chen] Xi An Jiao Tong Univ, Coll Stomatol, Key Lab Shaanxi Prov Craniofacial Precis Med Res, Xian, Shaanxi, Peoples R China; [Huang, Chen] Xi An Jiao Tong Univ, Key Lab Environm & Genes Related Dis, Minist Educ China, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Northwestern University; Xi'an Jiaotong University; Ministry of Education, China; Xi'an Jiaotong University	Huang, C (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Cell Biol & Genet, Xian, Shaanxi, Peoples R China.; Huang, C (corresponding author), Xi An Jiao Tong Univ, Coll Stomatol, Key Lab Shaanxi Prov Craniofacial Precis Med Res, Xian, Shaanxi, Peoples R China.; Huang, C (corresponding author), Xi An Jiao Tong Univ, Key Lab Environm & Genes Related Dis, Minist Educ China, Xian, Shaanxi, Peoples R China.	hchen@mail.xjtu.edu.cn			Biomedical Sharing Platform Project of Xi'an Jiaotong University [2015FWPT-14]; Shaanxi Province Science and Technology Projects [2014D75]; National Natural Science Foundation of China [81660492]; China Postdoctoral Science Foundation [2016M602801]; Fundamental Research Funds for the Central Universities [0811/1191320073]	Biomedical Sharing Platform Project of Xi'an Jiaotong University; Shaanxi Province Science and Technology Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was funded by Biomedical Sharing Platform Project of Xi'an Jiaotong University (2015FWPT-14), Shaanxi Province Science and Technology Projects (2014D75), National Natural Science Foundation of China (81660492), China Postdoctoral Science Foundation (2016M602801), the Fundamental Research Funds for the Central Universities (0811/1191320073). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assaker G, 2010, P NATL ACAD SCI USA, V107, P22558, DOI 10.1073/pnas.1010795108; Beck A.T., 2005, ANXIETY DISORDERS PH; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; Cheng KW, 2005, CANCER RES, V65, P2516, DOI 10.1158/0008-5472.CAN-05-0573; Cho WJ, 2009, MOL CELLS, V28, P521, DOI 10.1007/s10059-009-0158-0; CORREA P, 1992, CANCER RES, V52, P6735; Ferlay J, 2014, INT J CANCER, V5, P359; Glodowski DR, 2007, MOL BIOL CELL, V18, P4387, DOI 10.1091/mbc.E07-05-0486; Hao NB, 2015, CANC LETT, V1, P57; He JY, 2015, INT J ONCOL, V47, P1725, DOI 10.3892/ijo.2015.3146; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; Ishikura S, 2008, ACTA PHYSIOL, V192, P61, DOI 10.1111/j.1748-1716.2007.01778.x; Kang MJ, 2008, GASTROENTEROLOGY, V135, P2030, DOI 10.1053/j.gastro.2008.08.009; Kawauchi T, 2010, NEURON, V67, P588, DOI 10.1016/j.neuron.2010.07.007; Kim SJ, 2016, ONCOGENE, V35, P251, DOI 10.1038/onc.2015.80; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Lock JG, 2005, MOL BIOL CELL, V16, P1744, DOI 10.1091/mbc.E04-10-0867; Maddika S, 2008, J CELL SCI, V121, P979, DOI 10.1242/jcs.009530; Motoyama K, 2010, INT J ONCOL, V36, P1089, DOI 10.3892/ijo_00000590; Rahman R, 2014, WORLD J GASTROENTERO, V20, P4483, DOI 10.3748/wjg.v20.i16.4483; Rosenfeld JL, 2002, RECEPTOR CHANNEL, V8, P87, DOI 10.1080/10606820212398; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shi R, 2014, ONCOL REP, V2, P812; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Sun JT, 2015, MOL MED REP, V11, P1400, DOI 10.3892/mmr.2014.2880; Tao L, 2009, CANC LETT, V2, P233; Toker A, 2012, ADV BIOL REGULATION, V1, P78; Tsuruta F, 2002, J BIOL CHEM, V277, P14040, DOI 10.1074/jbc.M108975200; Ulrich F, 2005, DEV CELL, V9, P555, DOI 10.1016/j.devcel.2005.08.011; Wanajo A, 2008, GASTROENTEROLOGY, V135, P580, DOI 10.1053/j.gastro.2008.05.041; Wang R, 2011, ONCOGENE, V30, P2644, DOI 10.1038/onc.2010.642; Wu AW, 2010, CHINESE J CANCER RES, V22, P167, DOI 10.1007/s11670-010-0167-8; Wu H, 2014, SCI WORLD J, DOI 10.1155/2014/237356; Zhang C, 2016, DEV MKT SCI, P6; Zhang HC, 2009, LIFE SCI J, V6, P71	35	33	33	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170620	10.1371/journal.pone.0170620	http://dx.doi.org/10.1371/journal.pone.0170620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107526	Green Submitted, Green Published, gold			2022-12-26	WOS:000392405300172
J	Sladecek, FXJ; Segar, ST; Lee, C; Wall, R; Konvicka, M				Sladecek, Frantisek Xaver Jiri; Segar, Simon Tristram; Lee, Colin; Wall, Richard; Konvicka, Martin			Temporal Segregation between Dung-Inhabiting Beetle and Fly Species	PLOS ONE			English	Article							COLEOPTERA SCARABAEIDAE; INTRAGUILD PREDATION; RESOURCE UTILIZATION; CATTLE DUNG; SEASONAL OCCURRENCE; COMMUNITY ECOLOGY; BURYING BEETLES; ASSEMBLY RULES; ALPINE MEADOW; COW-DUNG	The coexistence of ecologically similar species (i.e. species utilizing the same resource) is a major topic in ecology. Communities are assembled either through the biotic interactions of ecologically similar species, e.g. competition, or by the abiotic separation of species along gradients of environmental conditions. Here, we investigated the temporal segregation, succession and seasonality of dung-inhabiting Coleoptera and Diptera that utilize an identical resource in exactly the same way. The data were collected from two temperate pastures, one in the United Kingdom and the second in the Czech Republic. There was no evident temporal separation between ecologically similar coleopterous or dipterous taxa during succession. In contrast, these two orders were almost perfectly separated seasonally in both combined and site-specific datasets. Flies were most abundant in the summer, and beetles were more abundant in the spring and autumn. Ecologically similar beetles and flies also displayed seasonal separation in both combined and site-specific data. Analyses within sitespecific data sets revealed such a separation at both the order and species level. Season is therefore the main temporal axis separating ecologically similar species of dung-inhabiting insects in temperate habitats, while succession aggregates species that may have similar environmental tolerances (to e.g. dung moisture). This separation between ecologically similar taxa of beetles and flies may be attributable to either competition-based niche separation or to temperature tolerance-based habitat filtering, since flies have peak activity in warmer months while beetles have peak activity in cooler months.	[Sladecek, Frantisek Xaver Jiri; Segar, Simon Tristram; Konvicka, Martin] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Sladecek, Frantisek Xaver Jiri; Segar, Simon Tristram; Konvicka, Martin] Acad Sci Czech Republ, Ctr Biol, Inst Entomol, Ceske Budejovice, Czech Republic; [Lee, Colin; Wall, Richard] Univ Bristol, Sch Biol Sci, Bristol BS8 1TH, Avon, England	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of Bristol	Sladecek, FXJ (corresponding author), Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic.; Sladecek, FXJ (corresponding author), Acad Sci Czech Republ, Ctr Biol, Inst Entomol, Ceske Budejovice, Czech Republic.	franzsladecek@gmail.com	Sladecek, Frantisek Xaver/R-3206-2018; Konvicka, Martin/H-1446-2014; Sladecek, Frantisek Xaver Jiri/O-9595-2019; Segar, Simon/K-6783-2015	Sladecek, Frantisek Xaver/0000-0002-5480-5934; Sladecek, Frantisek Xaver Jiri/0000-0002-5480-5934; 	Institute of Entomology, Biology Centre of the Czech Academy of Science [RVO//:60077344]; Grant Agency of University of South Bohemia [152/2016/P]; University of Bristol, UK; Univ. of South Bohemia Postdoc project (EU Education for Competitiveness Operational Programme, the European Social Fund and the Czech State Budget) [CZ.1.07/2.3.00/30.0006]	Institute of Entomology, Biology Centre of the Czech Academy of Science; Grant Agency of University of South Bohemia; University of Bristol, UK; Univ. of South Bohemia Postdoc project (EU Education for Competitiveness Operational Programme, the European Social Fund and the Czech State Budget)	This work was supported by the Institute of Entomology, Biology Centre of the Czech Academy of Science (RVO//:60077344); Grant Agency of University of South Bohemia (152/2016/P); Studentship funding from the University of Bristol, UK; Simon T Segar acknowledges funding from and a Univ. of South Bohemia Postdoc project (reg.no. CZ.1.07/2.3.00/30.0006) (funded by the EU Education for Competitiveness Operational Programme, the European Social Fund and the Czech State Budget). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RA, 2006, J ZOOL, V270, P466, DOI 10.1111/j.1469-7998.2006.00152.x; ANDERSON RS, 1982, CAN J ZOOL, V60, P1314, DOI 10.1139/z82-178; Arellano G, 2016, OIKOS, V125, P326, DOI 10.1111/oik.02426; Arim M, 2004, ECOL LETT, V7, P557, DOI 10.1111/j.1461-0248.2004.00613.x; Balthasar V, 1963, MONOGRAPHIE SCARABAE, pI; BARTH D, 1994, ENVIRON ENTOMOL, V23, P571, DOI 10.1093/ee/23.3.571; Best RJ, 2014, ECOLOGY, V95, P775, DOI 10.1890/13-0163.1; Chao A, 2013, J INSECT BEHAV, V26, P525, DOI 10.1007/s10905-012-9364-2; Chazot N, 2014, AM NAT, V183, P26, DOI 10.1086/674100; CUMMING JM, 1993, ENTOMOL NEWS, V104, P93; DAVIS ALV, 1989, J ENTOMOL SOC S AFR, V52, P229; Davison J, 2016, SOIL BIOL BIOCHEM, V97, P63, DOI 10.1016/j.soilbio.2016.03.003; de Camargo NF, 2016, OECOLOGIA, V180, P313, DOI 10.1007/s00442-015-3363-x; DOWDING VM, 1967, PARASITOLOGY, V57, P371, DOI 10.1017/S0031182000072164; Drag L, 2015, BIOL J LINN SOC, V116, P911, DOI 10.1111/bij.12624; Emerson BC, 2008, TRENDS ECOL EVOL, V23, P619, DOI 10.1016/j.tree.2008.07.005; Errouissi F, 2011, ANN SOC ENTOMOL FR, V47, P402, DOI 10.1080/00379271.2011.10697734; Feer F, 2005, J TROP ECOL, V21, P21, DOI 10.1017/S0266467404002056; Finn JA, 2003, ECOL ENTOMOL, V28, P1, DOI 10.1046/j.1365-2311.2002.00487.x; Finn JA, 2001, OIKOS, V92, P363, DOI 10.1034/j.1600-0706.2001.920219.x; Fowler D, 2014, J ANIM ECOL, V83, P943, DOI 10.1111/1365-2656.12188; GALANTE E, 1995, ENVIRON ENTOMOL, V24, P1063, DOI 10.1093/ee/24.5.1063; Gassert F, 2013, J BIOGEOGR, V40, P1475, DOI 10.1111/jbi.12109; Gause G. F., 1934, STRUGGLE EXISTENCE; Gawaad A, 1976, Z ANGEW ENTOMOL, V80, P1; Gittings T, 1998, ECOGRAPHY, V21, P581, DOI 10.1111/j.1600-0587.1998.tb00550.x; Gittings T, 1997, ECOGRAPHY, V20, P55, DOI 10.1111/j.1600-0587.1997.tb00347.x; Gregor F, 2002, MUSCIDAE DIPTERA CE, P1; Halffter G., 1982, ECOLOGICAL EVOLUTIVE; Hammer O, 1941, VIDENSK MEDD DANSK N, V105, P1; HANSKI I, 1980, ANN ZOOL FENN, V17, P17; HANSKI I, 1980, OIKOS, V34, P311, DOI 10.2307/3544290; HANSKI I, 1977, OECOLOGIA, V28, P203, DOI 10.1007/BF00751601; Hirschberger P, 1996, ECOL ENTOMOL, V21, P352, DOI 10.1046/j.1365-2311.1996.t01-1-00008.x; Holt RD, 2007, ECOLOGY, V88, P2706, DOI 10.1890/06-1525.1; HOLTER P, 1982, OIKOS, V39, P213, DOI 10.2307/3544488; Hulcr J, 2005, EUR J ENTOMOL, V102, P655, DOI 10.14411/eje.2005.093; Jonsell M, 2004, ECOL ENTOMOL, V29, P697, DOI 10.1111/j.0307-6946.2004.00654.x; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; Kocarek P, 2003, EUR J SOIL BIOL, V39, P31, DOI 10.1016/S1164-5563(02)00007-9; KOSKELA H, 1977, ANN ZOOL FENN, V14, P204; Kraft NJB, 2015, FUNCT ECOL, V29, P592, DOI 10.1111/1365-2435.12345; LANDIN BENGT-OLOF, 1961, OPUSCULA ENT SUPPL, V19, P1; Lee CM, 2006, B ENTOMOL RES, V96, P315, DOI 10.1079/BER2006428; Lee C, 2006, J NAT HIST, V40, P1167, DOI 10.1080/00222930600822597; Leps J, 2003, MULTIVARIATE ANAL EC; Lhotsky B, 2016, J ECOL, V104, P507, DOI 10.1111/1365-2745.12532; Lohbeck M, 2014, FUNCT ECOL, V28, P1052, DOI 10.1111/1365-2435.12240; LUMARET JP, 1987, ACTA ZOOL MEX, V24, P1; Maass S, 2015, SOIL BIOL BIOCHEM, V85, P145, DOI 10.1016/j.soilbio.2015.03.005; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Maggi E, 2011, ECOLOGY, V92, P1399, DOI 10.1890/10-1323.1; Maire V, 2012, NEW PHYTOL, V196, P497, DOI 10.1111/j.1469-8137.2012.04287.x; Martin-Vega D, 2013, MED VET ENTOMOL, V27, P64, DOI 10.1111/j.1365-2915.2012.01028.x; Martinez-Sanchez A, 2000, MED VET ENTOMOL, V14, P56, DOI 10.1046/j.1365-2915.2000.00205.x; Masunga GS, 2006, MYCOL RES, V110, P1214, DOI 10.1016/j.mycres.2006.07.004; Merrick MJ, 2004, J EXP BIOL, V207, P723, DOI 10.1242/jeb.00807; Michel VT, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1229; Mohr Carl O., 1943, ECOL MONOGR, V13, P275, DOI 10.2307/1943223; Mouchet MA, 2013, OIKOS, V122, P247, DOI 10.1111/j.1600-0706.2012.20411.x; Mueller AK, 2016, J ANIM ECOL, V85, P774, DOI 10.1111/1365-2656.12493; Orledge GM, 2005, ECOL ENTOMOL, V30, P620, DOI 10.1111/j.0307-6946.2005.00727.x; Psarev A. M., 2001, Russian Entomological Journal, V10, P405; RIDSDILLSMITH TJ, 1986, ENTOMOL EXP APPL, V41, P83, DOI 10.1007/BF00343494; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; Skidmore P, 1985, BIOL MUSCIDAE WORLD; Sladecek FXJ, 2013, ACTA OECOL, V46, P17, DOI 10.1016/j.actao.2012.10.012; Sladecek FXJ, 2016, ENTOMOL SCI; Sowig P, 1997, ETHOL ECOL EVOL, V9, P241, DOI 10.1080/08927014.1997.9522884; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; Verdu JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033914; Villet M. H., 2011, Pest Technology, V5, P1; Wassmer T, 2014, COLEOPTS BULL, V68, P603, DOI 10.1649/072.068.0327; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Whipple SD, 2013, COLEOPTS BULL, V67, P257, DOI 10.1649/0010-065X-67.3.257; Wiescher PT, 2012, OECOLOGIA, V169, P1063, DOI 10.1007/s00442-012-2262-7; Wu XW, 2012, ANN ZOOL FENN, V49, P174, DOI 10.5735/086.049.0305; Wu XW, 2010, ECOSCIENCE, V17, P146, DOI 10.2980/17-2-3319	80	5	5	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170426	10.1371/journal.pone.0170426	http://dx.doi.org/10.1371/journal.pone.0170426			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107542	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000392405300133
J	Yogalingam, G; Lee, AR; Mackenzie, DS; Maures, TJ; Rafalko, A; Prill, H; Berguig, GY; Hague, C; Christianson, T; Bell, SM; LeBowitz, JH				Yogalingam, Gouri; Lee, Amanda R.; Mackenzie, Donald S.; Maures, Travis J.; Rafalko, Agnes; Prill, Heather; Berguig, Geoffrey Y.; Hague, Chuck; Christianson, Terri; Bell, Sean M.; LeBowitz, Jonathan H.			Cellular Uptake and Delivery of Myeloperoxidase to Lysosomes Promote Lipofuscin Degradation and Lysosomal Stress in Retinal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE 6-PHOSPHATE RECOGNITION; MACULAR DEGENERATION; PIGMENT EPITHELIUM; A2E; PRECURSOR; PATHOGENESIS; FIBROBLASTS; DISEASE; BINDING; MODEL	Neutrophil myeloperoxidase (MPO) catalyzes the H2O2-dependent oxidation of chloride anion to generate hypochlorous acid, a potent antimicrobial agent. Besides its well defined role in innate immunity, aberrant degranulation of neutrophils in several inflammatory diseases leads to redistribution of MPO to the extracellular space, where it can mediate tissue damage by promoting the oxidation of several additional substrates. Here, we demonstrate that mannose 6-phosphate receptor-mediated cellular uptake and delivery of MPO to lysosomes of retinal pigmented epithelial (RPE) cells acts to clear this harmful enzyme from the extracellular space, with lysosomal-delivered MPO exhibiting a half-life of 10 h. Lysosomal-targeted MPO exerts both cell-protective and cytotoxic functions. From a therapeutic standpoint, MPO catalyzes the in vitro degradation of N-retinylidene-N-retinylethanolamine, a toxic form of retinal lipofuscin that accumulates in RPE lysosomes and drives the pathogenesis of Stargardt macular degeneration. Furthermore, chronic cellular uptake and accumulation of MPO in lysosomes coincides with N-retinylidene-N-retinylethanolamine elimination in a cell-based model of macular degeneration. However, lysosomal-delivered MPO also disrupts lysosomal acidification in RPE cells, which coincides with nuclear translocation of the lysosomal stress-sensing transcription factor EB and, eventually, cell death. Based on these findings we predict that under periods of acute exposure, cellular uptake and lysosomal degradation of MPO mediates elimination of this harmful enzyme, whereas chronic exposure results in progressive accumulation of MPO in lysosomes. Lysosomal-accumulated MPO can be both cell-protective, by promoting the degradation of toxic retinal lipofuscin deposits, and cytotoxic, by triggering lysosomal stress and cell death.	[Lee, Amanda R.; Mackenzie, Donald S.; Maures, Travis J.; Rafalko, Agnes; Prill, Heather; Berguig, Geoffrey Y.; Hague, Chuck; Christianson, Terri; Bell, Sean M.; LeBowitz, Jonathan H.] BioMarin Pharmaceut Inc, Dept Res, San Rafael, CA 94901 USA	BioMarin Pharmaceutical Inc.	Yogalingam, G (corresponding author), BioMarin Pharmaceut Inc, Res Dept, Cell & Mol Biol Grp, 790 Lindaro St, San Rafael, CA 94901 USA.	gyogalingam@bmrn.com						Arafat SN, 2014, OPHTHALMOLOGY, V121, P79, DOI 10.1016/j.ophtha.2013.06.049; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Cardone M., 2008, PATHOGENETICS, V1, P6; Cieutat AM, 1998, BLOOD, V91, P1044, DOI 10.1182/blood.V91.3.1044.1044_1044_1058; Cukras CA, 2012, ARCH OPHTHALMOL-CHIC, V130, P171, DOI 10.1001/archophthalmol.2011.332; De S, 2002, J GEN PHYSIOL, V120, P147, DOI 10.1085/jgp.20028566; HASILIK A, 1984, EMBO J, V3, P2671, DOI 10.1002/j.1460-2075.1984.tb02192.x; Kennedy CJ, 1995, EYE, V9, P763, DOI 10.1038/eye.1995.192; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; LEMANSKY P, 1985, J BIOL CHEM, V260, P9023; McCormick S, 2012, ARCH BIOCHEM BIOPHYS, V527, P31, DOI 10.1016/j.abb.2012.07.013; Molday RS, 2007, J BIOENERG BIOMEMBR, V39, P507, DOI 10.1007/s10863-007-9118-6; Oberle C, 2010, CELL DEATH DIFFER, V17, P1167, DOI 10.1038/cdd.2009.214; OWADA M, 1982, BIOCHEM BIOPH RES CO, V105, P814, DOI 10.1016/0006-291X(82)91042-7; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Prokopowicz Z, 2012, ARCH IMMUNOL THER EX, V60, P43, DOI 10.1007/s00005-011-0156-8; Radu RA, 2011, J BIOL CHEM, V286, P18593, DOI 10.1074/jbc.M110.191866; Ray RS, 2016, NEUROSCI BIOBEHAV R, V68, P611, DOI 10.1016/j.neubiorev.2016.06.031; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Soubhye J, 2016, CURR MED CHEM, V23, P3975, DOI 10.2174/0929867323666160607111806; Sparrow JR, 2008, ADV EXP MED BIOL, V613, P393, DOI 10.1007/978-0-387-74904-4_46; Sparrow JR, 2010, METHODS MOL BIOL, V652, P315, DOI 10.1007/978-1-60327-325-1_18; Sparrow JR, 1999, INVEST OPHTH VIS SCI, V40, P2988; Sparrow JR, 2003, VISION RES, V43, P2983, DOI 10.1016/S0042-6989(03)00475-9; Van Antwerpen P, 2010, J BIOL CHEM, V285, P16351, DOI 10.1074/jbc.M109.089748; Vives-Bauza C, 2008, J BIOL CHEM, V283, P24770, DOI 10.1074/jbc.M800706200; Winkler BS, 1999, MOL VIS, V5; Wu YL, 2011, J AM CHEM SOC, V133, P849, DOI 10.1021/ja107195u; York SJ, 1999, J BIOL CHEM, V274, P1164, DOI 10.1074/jbc.274.2.1164	30	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4255	4265		10.1074/jbc.M116.739441	http://dx.doi.org/10.1074/jbc.M116.739441			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28115520	Green Published, hybrid			2022-12-26	WOS:000395837100023
J	El Khadir, M; Boukhris, SA; Benajah, DA; El Rhazi, K; Ibrahimi, SA; El Abkari, M; Harmouch, T; Nejjari, C; Mahmoud, M; Benlemlih, M; Bennani, B				El Khadir, Mounia; Boukhris, Samia Alaoui; Benajah, Dafr-Allah; El Rhazi, Karima; Ibrahimi, Sidi Adil; El Abkari, Mohamed; Harmouch, Taoufiq; Nejjari, Chakib; Mahmoud, Mustapha; Benlemlih, Mohamed; Bennani, Bahia			VacA and CagA Status as Biomarker of Two Opposite End Outcomes of Helicobacter pylori Infection (Gastric Cancer and Duodenal Ulcer) in a Moroccan Population	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; INTERMEDIATE REGION; BIOPSY SPECIMENS; GASTRODUODENAL DISEASES; PRENEOPLASTIC LESIONS; CLINICAL-RELEVANCE; GENE POLYMORPHISMS; GENOTYPES; STRAINS; PREVALENCE	Helicobacter pylori (H. pylori) infection induces inflammation of the gastric mucosa, which may progress to precancerous lesions leading to gastric cancer. Pathological determinism is associated to some virulence genes of the bacterium, notably the vacA and cagA genes. The present study aimed to determine the H. pylori genotypes distribution and their association with sex, age and gastric diseases in a Moroccan population. Gastric biopsy was taken from 1079 consenting patients. The specimens were processed by PCR to identify H. pylori and to determine the genotypic profile by PCR characterizing vacA s, vacA m and vacA i regions directly from biopsies H. pylori positives. VacA genotyping revealed the predominance of vacA m2 (53.2%), vacA s2 (52.9%) and vacA i2 (52%). The most virulent vacA alleles (s1, i1 and m1) are more predominant in men (47.3%, 41.9% and 46.1% respectively) than in women (38.3%, 33.3% and 37% respectively). However, the association between vacA genotypes and age did not reach a statistical significant value. Logistic regression analysis results show that vacA i1m1 and vacA i1m2 genotypes were strongly associated with the risk of GC, the Odds Ratio (95% confidence interval) was 29.73 [ 5.08-173.73] and 9.17 [ 2.06-40.82] respectively, while vacAs1/cagA+ seems to be a risk factor for DU since it is inversely associated with GC (OR was 0.13 [0.02-0.75]. The results of this study suggest that vacA i1 genotype independently to vacAm status may be of a clinical usefulness and will help to identify patients at a high risk of GC development.	[El Khadir, Mounia; Boukhris, Samia Alaoui; Bennani, Bahia] USMBA, Lab Microbiol & Biol Mol, Equipe Microorganismes Genom & Facteurs Oncogenes, FMPF, Fes, Morocco; [El Khadir, Mounia; Benlemlih, Mohamed] USMBA, Lab Biotechnol, Fac Sci Dhar El Mehraz, Fes, Morocco; [Benajah, Dafr-Allah; Ibrahimi, Sidi Adil; El Abkari, Mohamed] CHU Hassan II Fes, FMPF, Serv Hepatogastroenterol, Equipe Malad Appareil Digestif, Fes, Morocco; [Benajah, Dafr-Allah; Ibrahimi, Sidi Adil; El Abkari, Mohamed; Bennani, Bahia] USMBA, FMPF, Lab Pathol Humaine Biomed & Environm, Fes, Morocco; [El Rhazi, Karima; Nejjari, Chakib] USMBA, FMPF, Lab Epidemiol & Rech Clin, Fes, Morocco; [Harmouch, Taoufiq] CHU Hassan II, Serv Anat Pathol, Fes, Morocco; [Mahmoud, Mustapha] CHU Hassan II, Serv Bacteriol, Fes, Morocco	Sidi Mohamed Ben Abdellah University of Fez; Sidi Mohamed Ben Abdellah University of Fez; Hassan II University Hospital Center of Fez; Sidi Mohamed Ben Abdellah University of Fez; Sidi Mohamed Ben Abdellah University of Fez; Sidi Mohamed Ben Abdellah University of Fez; Hassan II University Hospital Center of Fez; Hassan II University Hospital Center of Fez	Bennani, B (corresponding author), USMBA, Lab Microbiol & Biol Mol, Equipe Microorganismes Genom & Facteurs Oncogenes, FMPF, Fes, Morocco.; Bennani, B (corresponding author), USMBA, FMPF, Lab Pathol Humaine Biomed & Environm, Fes, Morocco.	bahia.bennani@usmba.ac.ma		, bahia/0000-0002-5509-3991; EL KHADIR, Mounia/0000-0002-8426-5078; EL RHAZI, Karima/0000-0002-8135-9044	University Hospital Hassan II of Fez, Laboratory of Human Pathology, Biomedicine and Environment of the Faculty of Medicine and Pharmacy of Fez; Ministry of Higher Education, Scientific Research and Professional Training, Morocco; National Centre for Scientific and Technical Research (CNRST)	University Hospital Hassan II of Fez, Laboratory of Human Pathology, Biomedicine and Environment of the Faculty of Medicine and Pharmacy of Fez; Ministry of Higher Education, Scientific Research and Professional Training, Morocco; National Centre for Scientific and Technical Research (CNRST)	We would like to express our deep gratitude to the University Hospital Hassan II of Fez, Laboratory of Human Pathology, Biomedicine and Environment of the Faculty of Medicine and Pharmacy of Fez, Ministry of Higher Education, Scientific Research and Professional Training, Morocco and the National Centre for Scientific and Technical Research (CNRST) for the financial support of this study.	Boukhris SA, 2013, EUR J CLIN MICROBIOL, V32, P969, DOI 10.1007/s10096-013-1887-8; Alarcon T, 1999, FEMS IMMUNOL MED MIC, V24, P215, DOI 10.1016/S0928-8244(99)00029-2; Ashour AAR, 2002, FEMS IMMUNOL MED MIC, V33, P173, DOI 10.1111/j.1574-695X.2002.tb00588.x; Asrat D, 2004, J CLIN MICROBIOL, V42, P2682, DOI 10.1128/JCM.42.6.2682-2684.2004; ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; Basso D, 2008, GASTROENTEROLOGY, V135, P91, DOI 10.1053/j.gastro.2008.03.041; Belda S, 2012, CLIN MICROBIOL INFEC, V18, pE251, DOI 10.1111/j.1469-0691.2012.03884.x; Ben Mansour K, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-10; Bolek BK, 2007, DIAGN MICR INFEC DIS, V58, P67, DOI 10.1016/j.diagmicrobio.2006.12.001; Boquet P, 2012, TRENDS MICROBIOL, V20, P165, DOI 10.1016/j.tim.2012.01.008; Boukhris SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082646; Breurec S, 2012, CLIN MICROBIOL INFEC, V18, P153, DOI 10.1111/j.1469-0691.2011.03524.x; Chattopadhyay S, 2004, J CLIN MICROBIOL, V42, P2821, DOI 10.1128/JCM.42.6.2821-2824.2004; Chung C, 2010, J CLIN MICROBIOL, V48, P690, DOI 10.1128/JCM.01815-09; Danon SJ, 1998, HELICOBACTER, V3, P254, DOI 10.1046/j.1523-5378.1998.08010.x; Erzin Y, 2006, HELICOBACTER, V11, P574, DOI 10.1111/j.1523-5378.2006.00461.x; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Fasciana T, 2015, J MED MICROBIOL, V64, P1408, DOI 10.1099/jmm.0.000163; Ferreira RM, 2012, J CLIN MICROBIOL, V50, P3983, DOI 10.1128/JCM.02087-12; Ferreira RM, 2012, AM J GASTROENTEROL, V107, P145, DOI 10.1038/ajg.2011.389; Figueiredo C, 2001, SCAND J GASTROENTERO, V36, P128, DOI 10.1080/003655201750065861; Frenck RW, 2003, MICROBES INFECT, V5, P705, DOI 10.1016/S1286-4579(03)00112-6; Gangwer KA, 2010, J BACTERIOL, V192, P6126, DOI 10.1128/JB.01081-10; Gonzalez CA, 2011, AM J GASTROENTEROL, V106, P867, DOI 10.1038/ajg.2011.1; Hansson LE, 1996, NEW ENGL J MED, V335, P242, DOI 10.1056/NEJM199607253350404; Hussein N. R., 2015, New Microbes and New Infections, V6, P5, DOI 10.1016/j.nmni.2015.02.005; Hussein NR, 2008, J CLIN MICROBIOL, V46, P1774, DOI 10.1128/JCM.01737-07; Jones KR, 2011, J CLIN MICROBIOL, V49, P101, DOI 10.1128/JCM.01782-10; Karlsson A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-129; Kibria KMK, 2015, HELICOBACTER, V20, P397, DOI 10.1111/hel.12213; Kim JJ, 2003, HELICOBACTER, V8, P202, DOI 10.1046/j.1523-5378.2003.00145.x; Koehler CI, 2003, J CLIN PATHOL-MOL PA, V56, P36, DOI 10.1136/mp.56.1.36; Kumar S, 2008, DIAGN MICR INFEC DIS, V62, P366, DOI 10.1016/j.diagmicrobio.2008.07.014; LAGE AP, 1995, J CLIN MICROBIOL, V33, P2752, DOI 10.1128/JCM.33.10.2752-2756.1995; Lai YC, 2003, WORLD J GASTROENTERO, V9, P1537, DOI 10.3748/wjg.v9.i7.1537; Lehours P, 2004, INFECT IMMUN, V72, P880, DOI 10.1128/IAI.72.2.880-888.2004; Letley DP, 2003, J BIOL CHEM, V278, P26734, DOI 10.1074/jbc.M304071200; Lopez-Vidal Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003849; Markovska R, 2011, DIAGN MICR INFEC DIS, V71, P335, DOI 10.1016/j.diagmicrobio.2011.08.008; Miftahussurur M, 2015, PLOS ONE, V10; Mitonga LG, 2015, INT J HLTH SCI RES, V5, P436; Nguyen TL, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-114; Nimri LF, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-27; Ogiwara H, 2009, J CLIN MICROBIOL, V47, P3493, DOI 10.1128/JCM.00887-09; Ortiz-Princz D, 2010, MEM I OSWALDO CRUZ, V105, P331, DOI 10.1590/S0074-02762010000300016; Rhead JL, 2007, GASTROENTEROLOGY, V133, P926, DOI 10.1053/j.gastro.2007.06.056; Schmidt HMA, 2010, EUR J CLIN MICROBIOL, V29, P439, DOI 10.1007/s10096-010-0881-7; Scholte GHA, 2002, AM J GASTROENTEROL, V97, P1687, DOI 10.1111/j.1572-0241.2002.05775.x; Sgouras DN, 2009, J CLIN MICROBIOL, V47, P2426, DOI 10.1128/JCM.00159-09; Sugimoto M, 2009, EUR J CLIN MICROBIOL, V28, P1227, DOI 10.1007/s10096-009-0772-y; Sugimoto M, 2009, CLIN MICROBIOL INFEC, V15, P835, DOI 10.1111/j.1469-0691.2009.02769.x; Talarico S, 2009, J CLIN MICROBIOL, V47, P1680, DOI 10.1128/JCM.00273-09; van Doorn LJ, 1998, J CLIN MICROBIOL, V36, P2597, DOI 10.1128/JCM.36.9.2597-2603.1998; Yamaoka Y, 1999, GASTROENTEROLOGY, V117, P342, DOI 10.1053/gast.1999.0029900342; Yordanov D, 2012, DIAGN MICR INFEC DIS, V74, P253, DOI 10.1016/j.diagmicrobio.2012.07.008	56	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170616	10.1371/journal.pone.0170616	http://dx.doi.org/10.1371/journal.pone.0170616			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125638	Green Published, gold, Green Submitted			2022-12-26	WOS:000396176100084
J	Hu, W; Shao, XJ; Guo, DX; Hao, HR; Zhang, Y; Xia, MF; Gong, YY; Zhou, HW; Fan, YQ; Yu, WN				Hu, Wen; Shao, Xiaojuan; Guo, Dianxuan; Hao, Hairong; Zhang, Yong; Xia, Mingfeng; Gong, Yingyun; Zhou, Hongwen; Fan, Yunqing; Yu, Weinan			Relationship of Serum Betatrophin with Nonalcoholic Fatty Liver in a Chinese Population	PLOS ONE			English	Article							NONINVASIVE ASSESSMENT; LIPID-METABOLISM; DISEASE; STEATOHEPATITIS; ULTRASONOGRAPHY; EPIDEMIOLOGY; STEATOSIS; FIBROSIS; LIPASIN; GLUCOSE	Objective This study aimed to investigate the association of serum betatrophin with the status and progression of nonalcoholic fatty liver disease (NAFLD). Methods A total of 249 subjects who received ultrasonic examination of liver fat content (LFC) were recruited. Anthropometric and biochemical examinations were performed. Serum betatrophin was measured by ELISA. Results Compared with control group, serum betatrophin significantly increased in NAFLD group (P < 0.05). There was significant difference in serum betatrophin among control, low liver fat content (LLFC), and high liver fat content (HLFC) groups (P < 0.01). After adjustment for gender, age, BMI, FPG and HbA1c, the betatrophin positively correlated with LFC (r = 0.185, P < 0.01) and TG (r = 0.195, P < 0.01). Stepwise multiple regression analysis indicated serum betatrophin was independently related to LFC (P < 0.05). Multivariate logistic regression analysis revealed subjects in the highest tertile of serum betatrophin had higher odds of having NAFLD after adjustment for traditional NAFLD risk factors (OR = 2.88, 95% CI: 1.15-7.19) (P<0.05). Conclusion Serum betatrophin is an independent risk factor for NAFLD and potential non-invasive marker for its progression. Serum betatrophin may be helpful for the early diagnosis of NAFLD and improvement of its prognosis.	[Hu, Wen; Shao, Xiaojuan; Hao, Hairong; Zhang, Yong; Yu, Weinan] Xuzhou Med Coll, Huaian Hosp, Dept Endocrinol, Huaian, Jiangsu, Peoples R China; [Hu, Wen; Shao, Xiaojuan; Guo, Dianxuan; Hao, Hairong; Zhang, Yong; Fan, Yunqing; Yu, Weinan] Second Peoples Hosp, Huaian, Jiangsu, Peoples R China; [Guo, Dianxuan] Xuzhou Med Coll, Dept Geriatr, Huaian Hosp, Huaian, Jiangsu, Peoples R China; [Xia, Mingfeng] Fudan Univ, Zhongshan Hosp, Dept Endocrinol, Shanghai, Peoples R China; [Gong, Yingyun; Zhou, Hongwen] Nanjing Med Univ, Dept Endocrinol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Fan, Yunqing] Xuzhou Med Coll, Huaian Hosp, Dept Color Doppler Ultrasound, Huaian, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University; Fudan University; Nanjing Medical University; Xuzhou Medical University	Yu, WN (corresponding author), Xuzhou Med Coll, Huaian Hosp, Dept Endocrinol, Huaian, Jiangsu, Peoples R China.; Fan, YQ; Yu, WN (corresponding author), Second Peoples Hosp, Huaian, Jiangsu, Peoples R China.; Fan, YQ (corresponding author), Xuzhou Med Coll, Huaian Hosp, Dept Color Doppler Ultrasound, Huaian, Jiangsu, Peoples R China.	haeyfyq@163.com; hayuweinan@163.com	Xia, Ming-Feng/AAL-1403-2020	Xia, Ming-Feng/0000-0002-5650-0165; Gong, Yingyun/0000-0002-8570-6904	Bureau of Science and Technology of Huai'an City (CN) [HAS2014005]; Jiangsu Provincial Commission of Health and Family Planning (CN) [Z201317]	Bureau of Science and Technology of Huai'an City (CN); Jiangsu Provincial Commission of Health and Family Planning (CN)	Our work has been funded by Bureau of Science and Technology of Huai'an City (CN) - HAS2014005 and Jiangsu Provincial Commission of Health and Family Planning (CN) - Z201317.	Amarapurkar D N, 2000, J Assoc Physicians India, V48, P311; Angulo P, 2010, HEPATOLOGY, V51, P373, DOI 10.1002/hep.23521; Ballestri S, 2012, LIVER INT, V32, P1242, DOI 10.1111/j.1478-3231.2012.02804.x; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bellentani S, 2010, DIGEST DIS, V28, P155, DOI 10.1159/000282080; Cengiz M, 2016, EUR J GASTROEN HEPAT, V28, P57, DOI 10.1097/MEG.0000000000000502; Chalasani N, 2008, J HEPATOL, V48, P829, DOI 10.1016/j.jhep.2008.01.016; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Ebert T, 2014, J CLIN ENDOCR METAB, V99, pE2510, DOI 10.1210/jc.2013-4349; Edens MA, 2009, OBESITY, V17, P2239, DOI 10.1038/oby.2009.154; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Fu Z, 2014, SCI REPORTS, P4; Lee Y., 2016, SCI REPORTS, V6; Mazhar SM, 2009, CLIN GASTROENTEROL H, V7, P135, DOI 10.1016/j.cgh.2008.11.023; McCullough AJ, 2005, FATTY LIVER DIS NASH, P23, DOI DOI 10.1002/9780470987438.CH3; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; Ong Janus P, 2007, Clin Liver Dis, V11, P1, DOI 10.1016/j.cld.2007.02.009; Ramesh S, 2004, HEPATITIS C NONALCOH; Ren G, 2012, AM J PHYSIOL-ENDOC M, V303, pE334, DOI 10.1152/ajpendo.00084.2012; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Strauss S, 2007, AM J ROENTGENOL, V189, pW320, DOI 10.2214/AJR.07.2123; Arias-Loste MT, 2015, WORLD J GASTROENTERO, V21, P10662, DOI 10.3748/wjg.v21.i37.10662; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Wieckowska A, 2008, DIAGNOSIS NONALCOHOL; Xia MF, 2015, OBESITY, V23, P1929, DOI 10.1002/oby.21182; Xia MF, 2012, OBESITY, V20, P444, DOI 10.1038/oby.2011.302; Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008; Zhang R, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0133-8; Zhang R, 2012, BIOCHEM BIOPH RES CO, V424, P786, DOI 10.1016/j.bbrc.2012.07.038	29	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170758	10.1371/journal.pone.0170758	http://dx.doi.org/10.1371/journal.pone.0170758			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125672	gold, Green Published, Green Submitted			2022-12-26	WOS:000396176100060
J	Lorin, J; Guilland, JC; Stamboul, K; Guenancia, C; Cottin, Y; Rochette, L; Vergely, C; Zeller, M				Lorin, Julie; Guilland, Jean-Claude; Stamboul, Karim; Guenancia, Charles; Cottin, Yves; Rochette, Luc; Vergely, Catherine; Zeller, Marianne			Increased Symmetric Dimethylarginine Level Is Associated with Worse Hospital Outcomes through Altered Left Ventricular Ejection Fraction in Patients with Acute Myocardial Infarction	PLOS ONE			English	Article							ASYMMETRIC DIMETHYLARGININE; RENAL-FUNCTION; MORTALITY; PERFORMANCE; MARKER; IMPACT; ARTERY; RISK	Objectives We aimed to investigate whether SDMA-symmetric dimethylarginine -the symmetrical stereoisomer of ADMA-might be a marker of left ventricular function in AMI. Background Asymmetric dimethylarginine (ADMA) has been implicated in the prognosis after acute myocardial infarction (AMI) and heart failure (HF). Methods Cross sectional prospective study from 487 consecutive patients hospitalized <24 hours after AMI. Patients with HF on admission were excluded. Serum levels of ADMA, SDMA and L-arginine were determined using HPLC. Glomerular filtration rate (eGFR) was estimated based on creatinine levels. Outcomes were in-hospital severe HF, as defined by Killip class >2, and death. Results Patients were analysed based on SDMA tertiles. Sex, diabetes, dyslipidemia, and prior MI were similar for all tertiles. In contrast, age and hypertension increased across the tertiles (p<0.001). From the first to the last tertile, GRACE risk score was elevated while LVEF and eGFR was reduced. The rate of severe HF and death were gradually increased across the SDMA tertiles (from 0.6% to 7.4%, p = 0.006 and from 0.6% to 5.0%, p = 0.034, respectively). Backward logistic multivariate analysis showed that SDMA was an independent estimate of developing severe HF, even when adjusted for confounding (OR(95% CI): 8.2(3.0-22.5), p<0.001). Further, SDMA was associated with mortality, even after adjustment for GRACE risk score (OR(95%CI): 4.56(1.34-15.52), p = 0.015). Conclusions Our study showed for the first time that SDMA is associated with hospital outcomes, through altered LVEF and may have biological activity beyond renal function.	[Lorin, Julie; Guilland, Jean-Claude; Stamboul, Karim; Guenancia, Charles; Cottin, Yves; Rochette, Luc; Vergely, Catherine; Zeller, Marianne] Univ Bourgogne, Lab Cardiometabol Physiopathol & Pharmacol, INSERM UMR 866, UFR Sci Sante, Dijon, France; [Stamboul, Karim; Guenancia, Charles; Cottin, Yves] CHU Dijon, Serv Cardiol, Dijon, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; CHU Dijon Bourgogne	Zeller, M (corresponding author), Univ Bourgogne, Lab Cardiometabol Physiopathol & Pharmacol, INSERM UMR 866, UFR Sci Sante, Dijon, France.	marianne.zeller@u-bourgogne.fr	COTTIN, YVES/ABA-4622-2020; Vergely, Catherine/L-9534-2015; Guenancia, Charles/M-5558-2013	Vergely, Catherine/0000-0003-4009-776X; Guenancia, Charles/0000-0002-3554-7714; Rochette, Luc/0000-0001-9973-8803	University Hospital of Dijon; Association de Cardiologie de Bourgogne; Agence Regionale de Sante (ARS) de Bourgogne; French Ministry of Research; Institut National de la Sante et de la Recherche Medicale (INSERM); Federation Francaise de Cardiologie; Societe Francaise de Cardiologie; Regional Council of Burgundy	University Hospital of Dijon; Association de Cardiologie de Bourgogne; Agence Regionale de Sante (ARS) de Bourgogne(Region Bourgogne-Franche-Comte); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Federation Francaise de Cardiologie; Societe Francaise de Cardiologie; Regional Council of Burgundy(Region Bourgogne-Franche-Comte)	This work was supported by the University Hospital of Dijon, the Association de Cardiologie de Bourgogne, and by grants from the Agence Regionale de Sante (ARS) de Bourgogne, French Ministry of Research, Institut National de la Sante et de la Recherche Medicale (INSERM), Federation Francaise de Cardiologie, Societe Francaise de Cardiologie and from the Regional Council of Burgundy.	Bode-Boger SM, 2006, J AM SOC NEPHROL, V17, P1128, DOI 10.1681/ASN.2005101119; Brutsaert DL, 2003, PHYSIOL REV, V83, P59, DOI 10.1152/physrev.00017.2002; Cavalca V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048499; Closs EI, 1997, NITRIC OXIDE-BIOL CH, V1, P65, DOI 10.1006/niox.1996.0106; Duckelmann C, 2007, ARTERIOSCL THROM VAS, V27, P2037, DOI 10.1161/ATVBAHA.107.147595; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Gore MO, 2013, ARTERIOSCL THROM VAS, V33, P2682, DOI 10.1161/ATVBAHA.113.301219; Hoebers LPC, 2016, EUROINTERVENTION, V12, P423, DOI 10.4244/EIJV12I4A75; Ivanova M, 2010, CLIN CHIM ACTA, V411, P1632, DOI 10.1016/j.cca.2010.06.001; Kaye DM, 2002, CIRC RES, V91, P1198, DOI 10.1161/01.RES.0000047506.52381.90; Kielstein JT, 2006, NEPHROL DIAL TRANSPL, V21, P2446, DOI 10.1093/ndt/gfl292; Korandji C, 2007, CLIN BIOCHEM, V40, P66, DOI 10.1016/j.clinbiochem.2006.08.004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lorin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064796; Luneburg N, 2012, CLIN SCI, V122, P105, DOI 10.1042/CS20110013; Meinitzer A, 2011, CLIN CHEM, V57, P112, DOI 10.1373/clinchem.2010.150854; Moretti C, 2015, INT J CARDIOL, V179, P552, DOI 10.1016/j.ijcard.2014.10.035; Qi XL, 1999, CIRCULATION, V100, P1338, DOI 10.1161/01.CIR.100.12.1338; Ronden RA, 2012, AM J PHYSIOL-RENAL, V303, pF149, DOI 10.1152/ajprenal.00045.2012; Russo JJ, 2015, AM J CARDIOL, V115, P1005, DOI 10.1016/j.amjcard.2015.01.533; Schepers E, 2009, NEPHROL DIAL TRANSPL, V24, P1429, DOI 10.1093/ndt/gfn670; Schwedhelm E, 2011, CLIN CHEM LAB MED, V49, P1907, DOI 10.1515/CCLM.2011.679; Schwedhelm E, 2011, NAT REV NEPHROL, V7, P275, DOI 10.1038/nrneph.2011.31; Speer T, 2013, IMMUNITY, V38, P754, DOI 10.1016/j.immuni.2013.02.009; Tang WHW, 2008, EUR HEART J, V29, P2506, DOI 10.1093/eurheartj/ehn360; Teerlink T, 2009, PHARMACOL RES, V60, P448, DOI 10.1016/j.phrs.2009.08.002; Tojo A, 1997, KIDNEY INT, V52, P1593, DOI 10.1038/ki.1997.490; Usui M, 1998, LIFE SCI, V62, P2425, DOI 10.1016/S0024-3205(98)00225-2; von Haehling S, 2010, CLIN PHARMACOL THER, V88, P506, DOI 10.1038/clpt.2010.116; Zairis MN, 2012, HEART, V98, P860, DOI 10.1136/heartjnl-2011-301372; Zeller M, 2008, ARTERIOSCL THROM VAS, V28, P954, DOI 10.1161/ATVBAHA.108.162768	31	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0169979	10.1371/journal.pone.0169979	http://dx.doi.org/10.1371/journal.pone.0169979			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125604	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100132
J	Nesti, A; de Winkel, K; Bulthoff, HH				Nesti, Alessandro; de Winkel, Ksander; Buelthoff, Heinrich H.			Accumulation of Inertial Sensory Information in the Perception of Whole Body Yaw Rotation	PLOS ONE			English	Article							VISUAL-VESTIBULAR INTEGRATION; SELF-MOTION PERCEPTION; HUMAN DISCRIMINATION; DIFFUSION-MODELS; VELOCITY STORAGE; CUES; SENSITIVITY; OTOLITH; HUMANS; HEAD	While moving through the environment, our central nervous system accumulates sensory information over time to provide an estimate of our self-motion, allowing for completing crucial tasks such as maintaining balance. However, little is known on how the duration of the motion stimuli influences our performances in a self-motion discrimination task. Here we study the human ability to discriminate intensities of sinusoidal (0.5 Hz) self-rotations around the vertical axis (yaw) for four different stimulus durations (1, 2, 3 and 5s) in darkness. In a typical trial, participants experienced two consecutive rotations of equal duration and different peak amplitude, and reported the one perceived as stronger. For each stimulus duration, we determined the smallest detectable change in stimulus intensity (differential threshold) for a reference velocity of 15 deg/s. Results indicate that differential thresholds decrease with stimulus duration and asymptotically converge to a constant, positive value. This suggests that the central nervous system accumulates sensory information on self-motion over time, resulting in improved discrimination performances. Observed trends in differential thresholds are consistent with predictions based on a drift diffusion model with leaky integration of sensory evidence.	[Nesti, Alessandro; de Winkel, Ksander; Buelthoff, Heinrich H.] Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, Tubingen, Germany	Max Planck Society	Nesti, A; Bulthoff, HH (corresponding author), Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, Tubingen, Germany.	alessandro.nesti@tuebingen.mpg.de; heinrich.buelthoff@tuebingen.mpg.de	Bülthoff, Heinrich H/J-6579-2012; de Winkel, Ksander/ABE-5608-2020; Bülthoff, Heinrich/AAC-8818-2019	Bülthoff, Heinrich H/0000-0003-2568-0607; de Winkel, Ksander/0000-0003-0534-2723; 	Max Planck Society; German Research Foundation (DFG) [SFB/Transregio 161]	Max Planck Society(Max Planck SocietyFoundation CELLEX); German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by funds from the Max Planck Society. AN and HHB were further supported by the German Research Foundation (DFG) within project CO3 of SFB/Transregio 161.	Benson A. J., 1990, PERCEPTION CONTROL S, P145; BENSON AJ, 1989, AVIAT SPACE ENVIR MD, V60, P205; Bertolini G, 2011, J NEUROPHYSIOL, V105, P209, DOI 10.1152/jn.00154.2010; Bigler RS, 2011, 22 IAVSD S DYN VEH R, P1; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Bos JE, 2002, BIOL CYBERN, V86, P191, DOI 10.1007/s00422-001-0289-7; Buinhas S, 2013, AIAA MOD SIM TECHN C, P1; Butler JS, 2015, EXP BRAIN RES, V233, P587, DOI 10.1007/s00221-014-4136-1; Butler JS, 2011, SEEING PERCEIVING, V24, P453, DOI 10.1163/187847511X588070; Butler JS, 2010, J VISION, V10, DOI 10.1167/10.11.23; Coniglio AJ, 2014, JARO-J ASSOC RES OTO, V15, P305, DOI 10.1007/s10162-013-0438-4; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; de Winkel KN, 2013, EXP BRAIN RES, V231, P209, DOI 10.1007/s00221-013-3683-1; de Winkel KN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127104; de Winkel KN, 2010, J VISION, V10, DOI 10.1167/10.12.1; Drugowitsch J, 2014, ELIFE, V3, DOI 10.7554/eLife.03005; Fetsch CR, 2010, EUR J NEUROSCI, V31, P1721, DOI 10.1111/j.1460-9568.2010.07207.x; Gescheider GA, 1997, PSYCHOPHYSICS FUNDAM; Greig GL, 1988, 313 U TOR; Harris LR, 2000, EXP BRAIN RES, V135, P12, DOI 10.1007/s002210000504; Hosman R, 1978, LR265 TU DELFT; Kelly SP, 2013, J NEUROSCI, V33, P19434, DOI 10.1523/JNEUROSCI.3355-13.2013; Kent C, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00412; Kira S, 2015, NEURON, V85, P861, DOI 10.1016/j.neuron.2015.01.007; Li D, 2014, ENCY COMPUT NEUROSCI; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; MacNeilage PR, 2010, J NEUROSCI, V30, P9084, DOI 10.1523/JNEUROSCI.1304-10.2010; Mallery RM, 2010, EXP BRAIN RES, V204, P11, DOI 10.1007/s00221-010-2288-1; Merfeld DM, 2010, J VESTIBUL RES-EQUIL, V20, P71, DOI 10.3233/VES-2010-0347; Mittelstaedt ML, 2001, EXP BRAIN RES, V139, P318, DOI 10.1007/s002210100735; Naseri AR, 2012, EXP BRAIN RES, V218, P455, DOI 10.1007/s00221-012-3035-6; Nesti A, 2015, EXP BRAIN RES, V233, P3553, DOI 10.1007/s00221-015-4426-2; Nesti A, 2015, EXP BRAIN RES, V233, P861, DOI 10.1007/s00221-014-4161-0; Nesti A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094570; Nesti A, 2014, EXP BRAIN RES, V232, P303, DOI 10.1007/s00221-013-3741-8; Newman M.C., 2012, AIAA MOD SIM TECHN C; O'Connell RG, 2012, NAT NEUROSCI, V15, P1729, DOI 10.1038/nn.3248; Pretto P, 2015, RECENT PROG BRAIN CO, P153; Prsa M, 2012, J NEUROPHYSIOL, V108, P2282, DOI 10.1152/jn.00439.2012; Purcell BA, 2010, PSYCHOL REV, V117, P1113, DOI 10.1037/a0020311; Rabbitt RD, 2004, SPR HDB AUD, P153; Ratcliff R, 1999, PSYCHOL REV, V106, P261, DOI 10.1037/0033-295X.106.2.261; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Roditi RE, 2012, JARO-J ASSOC RES OTO, V13, P381, DOI 10.1007/s10162-012-0318-3; Sarkka S., 2013, BAYESIAN FILTERING S, P254; Soyka F, 2012, EXP BRAIN RES, V220, P89, DOI 10.1007/s00221-012-3120-x; Telban RJ, 2001, AIAA MOD SIM TECHN C; Voss A, 2013, EXP PSYCHOL, V60, P385, DOI 10.1027/1618-3169/a000218; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Zaichik LE, 1999, AIAA MODELING AND SIMULATION TECHNOLOGIES CONFERENCE, P512; Zupan LH, 2002, BIOL CYBERN, V86, P209, DOI 10.1007/s00422-001-0290-1	51	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170497	10.1371/journal.pone.0170497	http://dx.doi.org/10.1371/journal.pone.0170497			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7IT	28125681	Green Published, gold, Green Submitted			2022-12-26	WOS:000396176100099
J	Ropiak, HM; Lachmann, P; Ramsay, A; Green, RJ; Mueller-Harvey, I				Ropiak, Honorata M.; Lachmann, Peter; Ramsay, Aina; Green, Rebecca J.; Mueller-Harvey, Irene			Identification of Structural Features of Condensed Tannins That Affect Protein Aggregation	PLOS ONE			English	Article							BOVINE SERUM-ALBUMIN; ISOTHERMAL TITRATION CALORIMETRY; CIRCULAR-DICHROISM SPECTROSCOPY; SECONDARY STRUCTURE ANALYSES; ANTHELMINTIC ACTIVITY; HAEMONCHUS-CONTORTUS; TRANS-CINNAMALDEHYDE; ALPHA-AMYLASE; PROANTHOCYANIDINS; BINDING	A diverse panel of condensed tannins was used to resolve the confounding effects of size and subunit composition seen previously in tannin-protein interactions. Turbidimetry revealed that size in terms of mean degree of polymerisation (mDP) or average molecular weight (amw) was the most important tannin parameter. The smallest tannin with the relatively largest effect on protein aggregation had an mDP of similar to 7. The average size was significantly correlated with aggregation of bovine serum albumin, BSA (mDP: r = -0.916; amw: r = -0.925; p<0.01; df = 27), and gelatin (mDP: r = -0.961; amw: r = -0.981; p<0.01; df = 12). The procyanidin/prodelphinidin and cis-/trans-flavan-3-ol ratios gave no significant correlations. Tryptophan fluorescence quenching indicated that procyanidins and cis-flavan-3-ol units contributed most to the tannin interactions on the BSA surface and in the hydrophobic binding pocket (r = 0.677; p<0.05; df = 9 and r = 0.887; p<0.01; df = 9, respectively). Circular dichroism revealed that higher proportions of prodelphinidins decreased the apparent a-helix content (r = -0.941; p<0.01; df = 5) and increased the apparent beta-sheet content (r = 0.916; p<0.05; df = 5) of BSA.	[Ropiak, Honorata M.; Ramsay, Aina; Mueller-Harvey, Irene] Univ Reading, Sch Agr Policy & Dev, Chem & Biochem Lab, Reading, Berks, England; [Green, Rebecca J.] Univ Reading, Sch Chem Food & Pharm, Reading, Berks, England	University of Reading; University of Reading	Mueller-Harvey, I (corresponding author), Univ Reading, Sch Agr Policy & Dev, Chem & Biochem Lab, Reading, Berks, England.	h.m.ropiak@reading.ac.uk; i.mueller-harvey@reading.ac.uk		Green, Rebecca/0000-0001-6783-549X; mueller-harvey, irene/0000-0001-6613-072X	European Union (Marie Curie Initial Training Network) [PITN GA 2011 289377]	European Union (Marie Curie Initial Training Network)	HMR, AR and IMH acknowledge financial support from the European Union (Marie Curie Initial Training Network; PITN GA 2011 289377, "LegumePlus"). The funder provided support in the form of salaries for authors HMR and AR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Gader A, 2011, BIOINFORMATICS, V27, P1630, DOI 10.1093/bioinformatics/btr234; Bras NF, 2010, BIOCHEMISTRY-US, V49, P5097, DOI 10.1021/bi100410q; Cai X, 2015, FOOD CHEM, V174, P291, DOI 10.1016/j.foodchem.2014.10.131; Chamani J, 2010, J LUMIN, V130, P1160, DOI 10.1016/j.jlumin.2010.02.014; Chamani J, 2011, J PHARMACEUT BIOMED, V55, P114, DOI 10.1016/j.jpba.2010.12.029; Cheynier V, 2015, J AGR FOOD CHEM, V63, P7589, DOI 10.1021/acs.jafc.5b01173; Dancey C., 2004, STAT MATHS PSYCHOL U; de Freitas V, 2002, J SCI FOOD AGR, V82, P113, DOI 10.1002/jsfa.1016; de Freitas V, 2001, J AGR FOOD CHEM, V49, P940, DOI 10.1021/jf000981z; de la Iglesia R, 2010, BIOFACTORS, V36, P159, DOI 10.1002/biof.79; Desrues O, 2016, PARASITOLOGY, V143, P444, DOI 10.1017/S0031182015001912; Dinh NN, 2014, ANAL BIOCHEM, V464, P60, DOI 10.1016/j.ab.2014.07.011; Dobreva MA, 2012, 26 INT C POL 2012; Dobreva MA, 2014, J AGR FOOD CHEM, V62, P9186, DOI 10.1021/jf502174r; Dobreva MA, 2011, BIOMACROMOLECULES, V12, P710, DOI 10.1021/bm101341s; FETTERER RH, 1993, VET PARASITOL, V46, P103, DOI 10.1016/0304-4017(93)90051-N; Frazier RA, 2010, J PHARMACEUT BIOMED, V51, P490, DOI 10.1016/j.jpba.2009.05.035; Gospodarczyk W, 2014, J PHYS CHEM B, V118, P8652, DOI 10.1021/jp5047485; Green RJ, 1999, LANGMUIR, V15, P5102, DOI 10.1021/la981052t; HAGERMAN AE, 1978, J AGR FOOD CHEM, V26, P809, DOI 10.1021/jf60218a027; Hagerman AE, 2012, REC ADV POLYPHEN RES, V3, P71; Han B, 2003, J BIOMED MATER RES A, V65A, P118, DOI 10.1002/jbm.a.10460; Harbertson JF, 2014, FOOD CHEM, V160, P16, DOI 10.1016/j.foodchem.2014.03.026; Hoste H, 2015, VET PARASITOL, V212, P5, DOI 10.1016/j.vetpar.2015.06.026; KAPLAN LJ, 1971, BIOCHEMISTRY-US, V10, P630; Karonen M, 2007, PHYTOCHEM ANALYSIS, V18, P378, DOI 10.1002/pca.992; Kilmister RL, 2016, FOOD CHEM, V190, P173, DOI 10.1016/j.foodchem.2015.04.144; Kommuru DS, 2014, VET PARASITOL, V204, P191, DOI 10.1016/j.vetpar.2014.04.017; Kosinska A, 2011, EUR FOOD RES TECHNOL, V233, P213, DOI 10.1007/s00217-011-1506-9; Lakowicz JR, 1991, TOPICS FLUORESCENCE, V2, P277; Le Bourvellec C, 2012, CRIT REV FOOD SCI, V52, P213, DOI 10.1080/10408398.2010.499808; Li M, 2014, J AGR FOOD CHEM, V62, P3768, DOI 10.1021/jf500246m; Lorenz MM, 2014, J SCI FOOD AGR, V94, P963, DOI 10.1002/jsfa.6344; Maiti TK, 2006, PROTEINS, V64, P355, DOI 10.1002/prot.20995; Martinez-Ortiz-de-Montellano C, 2013, EXP PARASITOL, V133, P281, DOI 10.1016/j.exppara.2012.11.024; Mueller-Harvey I, 2006, J SCI FOOD AGR, V86, P2010, DOI 10.1002/jsfa.2577; Naumann HD, 2014, J PLANT INTERACT, V9, P212, DOI 10.1080/17429145.2013.811547; PAGE A, 2007, THE CUTICLE; Papadopoulou A, 2005, J AGR FOOD CHEM, V53, P158, DOI 10.1021/jf048693g; Poncet-Legrand C, 2006, FOOD HYDROCOLLOID, V20, P687, DOI 10.1016/j.foodhyd.2005.06.009; Quijada J, 2015, J AGR FOOD CHEM, V63, P6346, DOI 10.1021/acs.jafc.5b00831; Ramsay A, 2016, PHYTOCHEMISTRY, V122, P146, DOI 10.1016/j.phytochem.2015.12.005; Rawel HA, 2005, J AGR FOOD CHEM, V53, P4228, DOI 10.1021/jf0480290; Ropiak HM, 2016, J AGR FOOD CHEM, V64, P8795, DOI 10.1021/acs.jafc.6b03842; Ropiak HM, 2016, J PHARMACEUT BIOMED, V121, P225, DOI 10.1016/j.jpba.2015.12.034; Simon C, 2003, BIOCHEMISTRY-US, V42, P10385, DOI 10.1021/bi034354p; Soares S, 2007, J AGR FOOD CHEM, V55, P6726, DOI 10.1021/jf070905x; Soares S, 2016, J AGR FOOD CHEM, V64, P7823, DOI 10.1021/acs.jafc.6b02659; SOGAMI M, 1968, BIOCHEMISTRY-US, V7, P2172, DOI 10.1021/bi00846a020; Takeshita M, 2009, J BIOL CHEM, V284, P21165, DOI 10.1074/jbc.M109.004945; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Williams AR, 2016, RES VET SCI, V105, P209, DOI 10.1016/j.rvsc.2016.02.021; Williams AR, 2015, SCI REP-UK, V5, P1, DOI 10.1038/srep14791; Williams AR, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0518-2; Williams AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097053; Zeller WE, 2015, J AGR FOOD CHEM, V63, P1160, DOI 10.1021/jf504715p; Ziyarat FP, 2014, J BIOMOL STRUCT DYN, V32, P613, DOI 10.1080/07391102.2013.785919	58	38	39	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170768	10.1371/journal.pone.0170768	http://dx.doi.org/10.1371/journal.pone.0170768			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125657	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000396176100056
J	Chen, X; Siebourg-Polster, J; Wolf, D; Czech, C; Bonati, U; Fischer, D; Khwaja, O; Strahm, M				Chen, Xing; Siebourg-Polster, Juliane; Wolf, Detlef; Czech, Christian; Bonati, Ulrike; Fischer, Dirk; Khwaja, Omar; Strahm, Martin			Feasibility of Using Microsoft Kinect to Assess Upper Limb Movement in Type III Spinal Muscular Atrophy Patients	PLOS ONE			English	Article							FUNCTIONAL MOTOR SCALE; XBOX ONE KINECT; CONCURRENT VALIDITY; PARKINSONS-DISEASE; GAIT PARAMETERS; SMA PATIENTS; RELIABILITY; FATIGUE; DYSTROPHINOPATHY; VALIDATION	Although functional rating scales are being used increasingly as primary outcome measures in spinal muscular atrophy (SMA), sensitive and objective assessment of early-stage disease progression and drug efficacy remains challenging. We have developed a game based on the Microsoft Kinect sensor, specifically designed to measure active upper limb movement. An explorative study was conducted to determine the feasibility of this new tool in 18 ambulant SMA type III patients and 19 age- and gender-matched healthy controls. Upper limb movement was analysed elaborately through derived features such as elbow flexion and extension angles, arm lifting angle, velocity and acceleration. No significant differences were found in the active range of motion between ambulant SMA type III patients and controls. Hand velocity was found to be different but further validation is necessary. This study presents an important step in the process of designing and handling digital bio-markers as complementary outcome measures for clinical trials.	[Chen, Xing; Wolf, Detlef; Strahm, Martin] F Hoffmann La Roche Ltd, Roche Innovat Ctr Basel, Roche Pharmaceut Res & Early Dev Informat, Data Sci, Basel, Switzerland; [Siebourg-Polster, Juliane] F Hoffmann La Roche Ltd, Roche Innovat Ctr Basel, Roche Pharmaceut Res & Early Dev, Translat Technol & Bioinformat,Pharmaceut Sci, Basel, Switzerland; [Czech, Christian] F Hoffmann La Roche Ltd, Roche Innovat Ctr Basel, Roche Pharmaceut Res & Early Dev, Biomarker Expt Med,Neurosci, Basel, Switzerland; [Bonati, Ulrike; Fischer, Dirk] Univ Basel, Childrens Hosp, Div Neuropediat, Basel, Switzerland; [Bonati, Ulrike; Fischer, Dirk] Univ Basel Hosp, Dept Neurol, Basel, Switzerland; [Khwaja, Omar] F Hoffmann La Roche Ltd, Roche Innovat Ctr Basel, Roche Pharmaceut Res & Early Dev, Translat Med Neurosci & Rare Dis, Basel, Switzerland	Roche Holding; Roche Holding; Roche Holding; University of Basel; University of Basel; Roche Holding	Chen, X (corresponding author), F Hoffmann La Roche Ltd, Roche Innovat Ctr Basel, Roche Pharmaceut Res & Early Dev Informat, Data Sci, Basel, Switzerland.	xing.chen@roche.com	Bonati, Ulrike/P-4093-2017	Czech, Christian/0000-0001-7746-0134; Siebourg, Juliane/0000-0002-1759-3223	F. Hoffmann-La Roche	F. Hoffmann-La Roche(Hoffmann-La Roche)	The study was entirely funded by F. Hoffmann-La Roche. The funder provided support in the form of salaries for authors XC, JS, DW, CC, OK and MS, but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Berard C, 2005, NEUROMUSCULAR DISORD, V15, P463, DOI 10.1016/j.nmd.2005.03.004; Bonnechere B, 2014, TELEMED E-HEALTH, V20, P451, DOI 10.1089/tmj.2013.0247; Cano SJ, 2014, MUSCLE NERVE, V49, P422, DOI 10.1002/mus.23937; CARTER CT, 1995, AM J PHYS MED REHAB, V74, pS150, DOI 10.1097/00002060-199509001-00009; Clark RA, 2015, GAIT POSTURE, V42, P210, DOI 10.1016/j.gaitpost.2015.03.005; Finkel Richard S, 2008, Pediatr Phys Ther, V20, P242, DOI 10.1097/PEP.0b013e318181ae96; Galna B, 2014, GAIT POSTURE, V39, P1062, DOI 10.1016/j.gaitpost.2014.01.008; Georgios Th Papadopoulos AA, 2014, P MMM 2014 P 20 ANN, V8325, P473; Glanzman AM, 2010, NEUROMUSCULAR DISORD, V20, P155, DOI 10.1016/j.nmd.2009.11.014; Han JJ, 2015, MUSCLE NERVE, V52, P344, DOI 10.1002/mus.24567; Kolb SJ, 2015, NEUROL CLIN, V33, P831, DOI 10.1016/j.ncl.2015.07.004; Lowes LP, 2013, NEUROMUSCULAR DISORD, V23, P770, DOI 10.1016/j.nmd.2013.06.473; Lowes LP, 2015, MUSCLE NERVE, V52, P356, DOI 10.1002/mus.24557; LOWES LP, 2013, PLOS CURR, V5; Main M, 2003, EUR J PAEDIATR NEURO, V7, P155, DOI 10.1016/S1090-3798(03)00060-6; Mazzone E, 2014, NEUROMUSCULAR DISORD, V24, P347, DOI 10.1016/j.nmd.2014.01.003; Mazzone E, 2011, NEUROMUSCULAR DISORD, V21, P406, DOI 10.1016/j.nmd.2011.02.014; Mentiplay BF, 2015, J BIOMECH, V48, P2166, DOI 10.1016/j.jbiomech.2015.05.021; Mercuri E, 2008, Neuromuscul Disord, V18, P894, DOI 10.1016/j.nmd.2008.07.003; Mintal FA, 2015, STUD HEALTH TECHNOL, V217, P773, DOI 10.3233/978-1-61499-566-1-773; Mobini A, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0070-0; Montes J, 2010, NEUROLOGY, V74, P833, DOI 10.1212/WNL.0b013e3181d3e308; Montes J, 2015, MUSCLE NERVE, V52, P942, DOI 10.1002/mus.24670; Montes J, 2014, MUSCLE NERVE, V50, P34, DOI 10.1002/mus.24081; Motiian S, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0102-9; Nathan D, 2015, PLOS ONE, V10; Nelson L, 2006, NEUROMUSCULAR DISORD, V16, P374, DOI 10.1016/j.nmd.2006.03.005; O'Hagen JM, 2007, NEUROMUSCULAR DISORD, V17, P693, DOI 10.1016/j.nmd.2007.05.009; Palacios-Navarro G, 2015, J MED SYST, V39, DOI 10.1007/s10916-015-0289-0; Peeters K, 2014, BRAIN, V137, P2879, DOI 10.1093/brain/awu169; Rocha AP, 2014, IEEE ENG MED BIO, P3126, DOI 10.1109/EMBC.2014.6944285; Sivo S, 2015, NEUROMUSCULAR DISORD, V25, P212, DOI 10.1016/j.nmd.2014.11.008; Steffensen B, 2001, Physiother Res Int, V6, P119, DOI 10.1002/pri.221; Wang HY, 2004, ARCH PHYS MED REHAB, V85, P1689, DOI 10.1016/j.apmr.2004.01.043; Werlauff U, 2014, QUAL LIFE RES, V23, P1479, DOI 10.1007/s11136-013-0565-8; Xu X, 2015, GAIT POSTURE, V42, P145, DOI 10.1016/j.gaitpost.2015.05.002	36	13	13	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0170472	10.1371/journal.pone.0170472	http://dx.doi.org/10.1371/journal.pone.0170472			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122039	Green Published, gold, Green Submitted			2022-12-26	WOS:000396167300044
J	Liu, RL; Fan, TT; Geng, WW; Chen, YHH; Ruan, QG; Zhang, C				Liu, Ruiling; Fan, Tingting; Geng, Wenwen; Chen, Youhai H.; Ruan, Qingguo; Zhang, Cui			Negative Immune Regulator TIPE2 Promotes M2 Macrophage Differentiation through the Activation of PI3K-AKT Signaling Pathway	PLOS ONE			English	Article							NITRIC-OXIDE; POLARIZATION; INNATE; PROTEIN; ORCHESTRATION; EXPRESSION; PLASTICITY; HEALTH; CELLS; MODEL	Macrophages play important roles in the regulation of the innate and adaptive immune responses. Classically activated macrophages and alternatively activated macrophages are the two major forms of macrophages and have opposing functionalities. Tumor necrosis factor-alpha-induced protein 8-2 is expressed primarily by immune cells and negatively regulates type 1 innate and adaptive immune responses to maintain immune tolerance. While previous studies indicate that TIPE2 promotes M2 but inhibits M1 macrophage differentiation, the underlying molecular mechanism by which TIPE2 promotes M2 macrophage differentiation remains unclear. Our current study shows that TIPE2-deficient bone-marrow cells are defective in IL-4 induced M2 macrophage differentiation in vitro. Mechanistic studies revealed that TIPE2 promotes phosphoinositide metabolism and the activation of the downstream AKT signaling pathway, which in turn leads to the expression of markers specific for M2 macrophages. In addition, our results showed that Tipe2-deficiency does not affect the activation of the JAK-STAT6 signaling pathway that also plays an important role during M2 macrophage differentiation. Taken together, these results indicate that TIPE2 promotes M2 macrophage differentiation through the activation of PI3K-AKT signaling pathway, and may play an important role during the resolution of inflammation, parasite control, as well as tissue repair.	[Liu, Ruiling; Zhang, Cui] GuangDong Pharmaceut Univ, Guangzhou, Guangdong, Peoples R China; [Fan, Tingting; Geng, Wenwen; Ruan, Qingguo] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Biotechnol, Ctr Antibody Drug, Shenzhen, Peoples R China; [Chen, Youhai H.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Guangdong Pharmaceutical University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; University of Pennsylvania	Zhang, C (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Biotechnol, Ctr Antibody Drug, Shenzhen, Peoples R China.	qg.ruan@siat.ac.cn; ccuizhang@126.com	Chen, Youhai/AAJ-4031-2021	ruan, qingguo/0000-0001-9315-3716	National Natural Science Foundation of China [81471554, 81530027]; Shenzhen Municipal Science and Technology Innovation Committee [1110140040347265, JCYJ20140610151856705, JCYJ20150630114942263]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Municipal Science and Technology Innovation Committee	National Natural Science Foundation of China URL: http://www.nsfc.gov.cn/. Grant numbers: 81471554, 81530027. Author received the funding: QR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Shenzhen Municipal Science and Technology Innovation Committee. URL: http://www.szsti.gov.cn/ Grant number: 1110140040347265. Author received the funding: YHC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Shenzhen Municipal Science and Technology Innovation Committee URL: http://www.szsti.gov.cn/. Grant numbers: JCYJ20140610151856705, JCYJ20150630114942263 Author received the funding: QR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arranz A, 2012, P NATL ACAD SCI USA, V109, P9517, DOI 10.1073/pnas.1119038109; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Biswas SK, 2012, IMMUNOL RES, V53, P11, DOI 10.1007/s12026-012-8291-9; Biswas SK, 2012, CELL METAB, V15, P432, DOI 10.1016/j.cmet.2011.11.013; Bosca L, 2005, TOXICOLOGY, V208, P249, DOI 10.1016/j.tox.2004.11.035; Brombacher Frank, 2009, V531, P225, DOI 10.1007/978-1-59745-396-7_15; Byles V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3834; Caescu CI, 2015, BLOOD, V125, pE1, DOI 10.1182/blood-2014-10-608000; Cassetta L, 2011, THESCIENTIFICWORLDJO, V11, P2391, DOI 10.1100/2011/213962; Chen HH, 2011, CELL, V147, P436, DOI 10.1016/j.cell.2011.09.022; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Fayngerts SA, 2014, CANCER CELL, V26, P465, DOI 10.1016/j.ccr.2014.07.025; Gus-Brautbar Y, 2012, MOL CELL, V45, P610, DOI 10.1016/j.molcel.2012.01.006; Han JM, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00245; Hao YS, 2008, MOL CELL BIOL, V28, P2851, DOI 10.1128/MCB.01917-07; Jethwa N, 2015, J CELL SCI, V128, P3456, DOI 10.1242/jcs.172775; Kumar D, 2000, J BIOL CHEM, V275, P2973, DOI 10.1074/jbc.275.4.2973; Li F, 2016, CELL PHYSIOL BIOCHEM, V38, P330, DOI 10.1159/000438633; Locati M, 2013, ADV IMMUNOL, V120, P163, DOI 10.1016/B978-0-12-417028-5.00006-5; Lou YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096508; MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2009, BLOOD, V114, P3135, DOI 10.1182/blood-2009-07-231795; Marchetti V, 2011, SCI REP-UK, V1, DOI 10.1038/srep00076; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; McNelis JC, 2014, IMMUNITY, V41, P36, DOI 10.1016/j.immuni.2014.05.010; Mills CD, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00620; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Qin HW, 2010, J NEUROIMMUNOL, V228, P32; Ruan QG, 2011, J EXP MED, V208, P2321, DOI 10.1084/jem.20110462; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sun HH, 2008, CELL, V133, P415, DOI 10.1016/j.cell.2008.03.026; Sun HH, 2012, J IMMUNOL, V189, P2768, DOI 10.4049/jimmunol.1103477; Sun LP, 2011, EXP CELL RES, V317, P932, DOI 10.1016/j.yexcr.2011.01.025; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Van den Bossche J, 2012, J LEUKOCYTE BIOL, V91, P685, DOI 10.1189/jlb.0911453; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Wang ZJ, 2012, P NATL ACAD SCI USA, V109, P15413, DOI 10.1073/pnas.1204525109; Wilson HM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00357; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xu F, 2013, J INFECT DIS, V208, P528, DOI 10.1093/infdis/jit177; Yuan A, 2015, SCI REP, V5, P387; Zhang F, 2014, MOL CELL ENDOCRINOL, V382, P197, DOI 10.1016/j.mce.2013.09.020; Zhang GZ, 2010, MOL IMMUNOL, V47, P2435, DOI 10.1016/j.molimm.2010.06.016	48	26	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0170666	10.1371/journal.pone.0170666	http://dx.doi.org/10.1371/journal.pone.0170666			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122045	Green Published, gold, Green Submitted			2022-12-26	WOS:000396167300030
J	Rubbens, P; Props, R; Boon, N; Waegeman, W				Rubbens, Peter; Props, Ruben; Boon, Nico; Waegeman, Willem			Flow Cytometric Single-Cell Identification of Populations in Synthetic Bacterial Communities	PLOS ONE			English	Article							CLASSIFICATION; CONSORTIA; EVENNESS	Bacterial cells can be characterized in terms of their cell properties using flow cytometry. Flow cytometry is able to deliver multiparametric measurements of up to 50,000 cells per second. However, there has not yet been a thorough survey concerning the identification of the population to which bacterial single cells belong based on flow cytometry data. This paper not only aims to assess the quality of flow cytometry data when measuring bacterial populations, but also suggests an alternative approach for analyzing synthetic microbial communities. We created so-called in silico communities, which allow us to explore the possibilities of bacterial flow cytometry data using supervised machine learning techniques. We can identify single cells with an accuracy > 90% for more than half of the communities consisting out of two bacterial populations. In order to assess to what extent an in silico community is representative for its synthetic counterpart, we created so-called abundance gradients, a combination of synthetic ( i. e., in vitro) communities containing two bacterial populations in varying abundances. By showing that we are able to retrieve an abundance gradient using a combination of in silico communities and supervised machine learning tech-niques, we argue that in silico communities form a viable representation for synthetic bacte-rial communities, opening up new opportunities for the analysis of synthetic communities and bacterial flow cytometry data in general.	[Rubbens, Peter; Waegeman, Willem] Univ Ghent, Dept Math Modelling Stat & Bioinformat, KERMIT, Ghent, Belgium; [Props, Ruben; Boon, Nico] Univ Ghent, Ctr Microbial Technol & Ecol CMET, Ghent, Belgium	Ghent University; Ghent University	Rubbens, P (corresponding author), Univ Ghent, Dept Math Modelling Stat & Bioinformat, KERMIT, Ghent, Belgium.	Peter.Rubbens@UGent.be	Rubbens, Peter/O-4737-2016; Props, Ruben/AAV-4218-2020; Rubbens, Peter/GSE-0797-2022; Boon, Nico/B-4083-2011	Rubbens, Peter/0000-0001-5595-4758; Props, Ruben/0000-0003-4996-2596; Boon, Nico/0000-0002-7734-3103	Special Research Fund from Ghent University [BOFSTA2015000501, BOFDOC2015000601]; Belgian Nuclear Research Centre [SCK (7) CEN]; Ghent University; Hercules Foundation; Flemish Government department EWI	Special Research Fund from Ghent University; Belgian Nuclear Research Centre; Ghent University(Ghent University); Hercules Foundation; Flemish Government department EWI	PR is supported by the Special Research Fund (BOFSTA2015000501) from Ghent University. RP is supported by the Special Research Fund (BOFDOC2015000601) from Ghent University and the Belgian Nuclear Research Centre (SCK (7) CEN).; We thank Benjamin Buysschaert for discussing the ideas concerning the abundance gradients. Part of the computational resources (Stevin Supercomputer Infrastructure) and services used in this work were provided by the VSC (Flemish Supercomputer Center), funded by Ghent University, the Hercules Foundation and the Flemish Government department EWI.	Aly M., 2005, SURVEY ON MULTI CLAS; Ambriz-Avina V, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/461941; Bernard S, 2009, LECT NOTES COMPUT SC, V5519, P171, DOI 10.1007/978-3-642-02326-2_18; Boddy L, 2000, MAR ECOL PROG SER, V195, P47, DOI 10.3354/meps195047; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Davey Hazel M., 2003, Current Issues in Molecular Biology, V5, P9; Davey HM, 2010, CYTOM PART A, V77A, P3, DOI 10.1002/cyto.a.20835; Davey HM, 1999, CYTOMETRY, V35, P162, DOI 10.1002/(SICI)1097-0320(19990201)35:2<162::AID-CYTO8>3.0.CO;2-U; Davis BH, 2013, CYTOM PART B-CLIN CY, V84, P329, DOI [10.1002/cyto.b.21116, 10.1002/cytob.21116]; De Roy K, 2014, ENVIRON MICROBIOL, V16, P1472, DOI 10.1111/1462-2920.12343; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fernandes RL, 2011, BIOTECHNOL ADV, V29, P575, DOI 10.1016/j.biotechadv.2011.03.007; Fernandez-Delgado M, 2014, J MACH LEARN RES, V15, P3133; Grosskopf T, 2014, CURR OPIN MICROBIOL, V18, P72, DOI 10.1016/j.mib.2014.02.002; Hahne F, 2010, CYTOM PART A, V77A, P121, DOI 10.1002/cyto.a.20823; Hahne F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-106; Hammes FA, 2005, ENVIRON SCI TECHNOL, V39, P3289, DOI 10.1021/es048277c; Hammes F, 2008, WATER RES, V42, P269, DOI 10.1016/j.watres.2007.07.009; Hammes F, 2011, ADV BIOCHEM ENG BIOT, V124, P123, DOI 10.1007/10_2010_95; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hays SG, 2015, CURR OPIN BIOTECH, V36, P40, DOI 10.1016/j.copbio.2015.08.008; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; King N, 2015, CURR OPIN MICROBIOL, V25, pV, DOI 10.1016/j.mib.2015.06.006; Koch C, 2013, NAT PROTOC, V8, P190, DOI 10.1038/nprot.2012.149; McDougald D, 1998, FEMS MICROBIOL ECOL, V25, P1, DOI 10.1111/j.1574-6941.1998.tb00455.x; Mee MT, 2014, P NATL ACAD SCI USA, V111, pE2149, DOI 10.1073/pnas.1405641111; Minty JJ, 2013, P NATL ACAD SCI USA, V110, P14592, DOI 10.1073/pnas.1218447110; Muller S, 2010, FEMS MICROBIOL REV, V34, P554, DOI 10.1111/j.1574-6976.2010.00214.x; Nebe-Von-Caron G, 2009, CYTOM PART A, V75A, P86, DOI 10.1002/cyto.a.20696; Normolle DP, 2013, CYTOM PART A, V83A, P150, DOI 10.1002/cyto.a.22240; O'Neill K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003365; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pereira GC, 2011, EXPERT SYST APPL, V38, P9626, DOI 10.1016/j.eswa.2011.01.140; Prest EI, 2013, WATER RES, V47, P7131, DOI 10.1016/j.watres.2013.07.051; Rajwa B, 2008, CYTOM PART A, V73A, P369, DOI 10.1002/cyto.a.20515; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; RAO CR, 1948, J ROY STAT SOC B, V10, P159; Saleem M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2287; Song H, 2014, CHEM SOC REV, V43, P6954, DOI 10.1039/c4cs00114a; Spidlen J, 2012, CYTOM PART A, V81A, P727, DOI 10.1002/cyto.a.22106; Stewart EJ, 2012, J BACTERIOL, V194, P4151, DOI 10.1128/JB.00345-12; Strauber H, 2010, CYTOM PART A, V77A, P623, DOI 10.1002/cyto.a.20920; Toedling J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-282; Van Nevel S, 2013, J MICROBIOL METH, V94, P73, DOI 10.1016/j.mimet.2013.05.007; Vives-Rego J, 2003, J MICROBIOL METH, V53, P43, DOI 10.1016/S0167-7012(02)00219-1; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840; Xu L, 2011, BIORESOURCE TECHNOL, V102, P10065, DOI 10.1016/j.biortech.2011.08.067	49	26	26	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0169754	10.1371/journal.pone.0169754	http://dx.doi.org/10.1371/journal.pone.0169754			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122063	Green Published, Green Submitted, gold			2022-12-26	WOS:000396167300067
J	Triplette, M; Attia, EF; Akgun, KM; Hoo, GWS; Freiberg, MS; Butt, AA; Wongtrakool, C; Goetz, MB; Brown, ST; Graber, CJ; Huang, L; Crothers, K				Triplette, Matthew; Attia, Engi F.; Akgun, Kathleen M.; Hoo, Guy W. Soo; Freiberg, Matthew S.; Butt, Adeel A.; Wongtrakool, Cherry; Goetz, Matthew Bidwell; Brown, Sheldon T.; Graber, Christopher J.; Huang, Laurence; Crothers, Kristina			A Low Peripheral Blood CD4/CD8 Ratio Is Associated with Pulmonary Emphysema in HIV	PLOS ONE			English	Article							SPIROMETRY REFERENCE VALUES; T-CELL-ACTIVATION; ANTIRETROVIRAL THERAPY; DIFFUSING-CAPACITY; LYMPHOCYTE SUBSETS; INFECTED PATIENTS; CD4CD8 RATIO; SAMPLE; DISEASES; MARKER	Objectives The prevalence of emphysema is higher among HIV-infected (HIV+) individuals compared to HIV-uninfected persons. While greater tobacco use contributes, HIV-related effects on immunity likely confer additional risk. Low peripheral blood CD4+ to CD8+ T-lymphocyte (CD4/CD8) ratio may reflect chronic inflammation in HIV and may be a marker of chronic lung disease in this population. Therefore, we sought to determine whether the CD4/CD8 ratio was associated with chronic obstructive pulmonary disease (COPD), particularly the emphysema subtype, in a cohort of HIV+ subjects. Methods We performed a cross-sectional analysis of 190 HIV+ subjects enrolled in the Examinations of HIV Associated Lung Emphysema (EXHALE) study. Subjects underwent baseline laboratory assessments, pulmonary function testing and chest computed tomography (CT) analyzed for emphysema severity and distribution. We determined the association between CD4/CD8 ratio and emphysema, and the association between CD4/CD8 ratio and pulmonary function markers of COPD. Results Mild or greater emphysema (> 10% lung involvement) was present in 31% of subjects. Low CD4/CD8 ratio was associated with > 10% emphysema in multivariable models, adjusting for risk factors including smoking, current and nadir CD4 count and HIV RNA level. Those with CD4/CD8 ratio < 0.4 had 6.3 (1.1-39) times the odds of > 10% emphysema compared to those with a ratio > 1.0 in fully adjusted models. A low CD4/CD8 ratio was also associated with reduced diffusion capacity (DLCO). Conclusions A low CD4/CD8 ratio was associated with emphysema and low DLCO in HIV+ subjects, independent of other risk factors and clinical markers of HIV. The CD4/CD8 ratio may be a useful, clinically available, marker for risk of emphysema in HIV+ subjects in the antiretroviral therapy (ART) era.	[Triplette, Matthew; Attia, Engi F.; Crothers, Kristina] Univ Washington, Dept Med, Seattle, WA 98105 USA; [Akgun, Kathleen M.] Vet Affairs Connecticut Healthcare Syst, Dept Med, New Haven, CT USA; [Akgun, Kathleen M.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Hoo, Guy W. Soo; Goetz, Matthew Bidwell; Graber, Christopher J.] Vet Affairs Greater Los Angeles Healthcare Syst, Dept Med, Los Angeles, CA USA; [Hoo, Guy W. Soo; Goetz, Matthew Bidwell; Graber, Christopher J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Freiberg, Matthew S.] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Butt, Adeel A.] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Butt, Adeel A.] Hamad Healthcare Qual Inst & Med Corp, Doha, Qatar; [Wongtrakool, Cherry] Atlanta Vet Affairs Med Ctr, Dept Med, Atlanta, GA USA; [Wongtrakool, Cherry] Emory Univ, Sch Med, Dept Med, Atlanta, GA USA; [Brown, Sheldon T.] James J Peters Vet Affairs Med Ctr, Dept Med, New York, NY USA; [Brown, Sheldon T.] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Huang, Laurence] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Vanderbilt University; Cornell University; Hamad Medical Corporation; Hamad General Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Emory University; Icahn School of Medicine at Mount Sinai; University of California System; University of California San Francisco	Triplette, M (corresponding author), Univ Washington, Dept Med, Seattle, WA 98105 USA.	mtrip@uw.edu	Attia, Engi Farouk/J-7793-2019; Goetz, Matthew Bidwell/GPX-4090-2022; Huang, Laurence/AAE-1590-2019; Huang, Laurence/AAZ-7120-2021	Attia, Engi Farouk/0000-0002-5044-9602; Huang, Laurence/0000-0003-3888-2195; Crothers, Kristina/0000-0001-9702-0371; Goetz, Matthew/0000-0003-4542-992X	National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH) [R01 HL090342, 5R01HL126536, T32 HL007287-37, K24 HL087713]; National Institute on Alcohol Abuse and Alcoholism at NIH [U01 AA013566]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863, KL2TR001862] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007287, K24HL087713] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH); National Institute on Alcohol Abuse and Alcoholism at NIH; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH) [R01 HL090342 and 5R01HL126536 to Dr. Crothers, T32 HL007287-37 supporting Dr. Triplette under Drs. Robb Glenny and J. Randall Curtis, K24 HL087713 to Dr. Huang] and the National Institute on Alcohol Abuse and Alcoholism at NIH [U01 AA013566]. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini C, 2000, AM J RESP CRIT CARE, V162, P1466, DOI 10.1164/ajrccm.162.4.2003130; Attia EF, 2014, CHEST, V146, P1543, DOI 10.1378/chest.14-0543; Barnes PJ, 2014, CLIN CHEST MED, V35, P71, DOI 10.1016/j.ccm.2013.10.004; Battegay M, 2006, LANCET INFECT DIS, V6, P280, DOI 10.1016/S1473-3099(06)70463-7; Besutti G, 2015, HIV MED; Chen C, 2012, J CLIN LAB ANAL, V26, P109, DOI 10.1002/jcla.21490; Cotton DJ, 1996, MED CLIN N AM, V80, P549, DOI 10.1016/S0025-7125(05)70453-3; Crothers K, 2011, AM J RESP CRIT CARE, V183, P388, DOI 10.1164/rccm.201006-0836OC; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; DeJong JW, 1997, RESP MED, V91, P67, DOI 10.1016/S0954-6111(97)90070-6; Drummond MB, 2014, LANCET RESP MED, V2, P583, DOI 10.1016/S2213-2600(14)70017-7; GEVENOIS PA, 1995, AM J RESP CRIT CARE, V152, P653, DOI 10.1164/ajrccm.152.2.7633722; Gingo MR, 2013, CLIN CHEST MED, V34, P273, DOI 10.1016/j.ccm.2013.02.002; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2015, GLOBAL STRATEGY FOR; Guaraldi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109027; Gupta J, 2007, CLIN EXP IMMUNOL, V149, P463, DOI 10.1111/j.1365-2249.2007.03429.x; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hankinson JL, 2010, CHEST, V137, P138, DOI 10.1378/chest.09-0919; Justice AC, 2006, MED CARE, V44, pS13, DOI 10.1097/01.mlr.0000223741.02074.66; Kim WD, 2002, CHEST, V122, P437, DOI 10.1378/chest.122.2.437; KLEIN JS, 1992, RADIOLOGY, V182, P817, DOI 10.1148/radiology.182.3.1535900; Lim SC, 2011, YONSEI MED J, V52, P581, DOI 10.3349/ymj.2011.52.4.581; Lu W, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20052; MacNee William, 2005, Proc Am Thorac Soc, V2, P258, DOI 10.1513/pats.200504-045SR; MARGOLICK JB, 1995, NAT MED, V1, P674, DOI 10.1038/nm0795-674; Marion MS, 2001, CHEST, V120, P489, DOI 10.1378/chest.120.2.489; Milivojevic-Poleksic L, 2001, Respirology, V6, P247, DOI 10.1046/j.1440-1843.2001.00338.x; Mudd JC, 2014, CURR OPIN HIV AIDS, V9, P500, DOI 10.1097/COH.0000000000000086; Neas LM, 1996, AM J RESP CRIT CARE, V153, P656, DOI 10.1164/ajrccm.153.2.8564114; OShaughnessy TC, 1997, AM J RESP CRIT CARE, V155, P852, DOI 10.1164/ajrccm.155.3.9117016; PLATA F, 1987, NATURE, V328, P348, DOI 10.1038/328348a0; Popescu L, 2014, AM J RESP CRIT CARE, V190, P744, DOI 10.1164/rccm.201407-1226OC; Saeta M, 1999, AM J RESP CRIT CARE, V160, P711, DOI 10.1164/ajrccm.160.2.9812020; Sainz T, 2013, AIDS, V27, P1513, DOI 10.1097/QAD.0b013e32835faa72; Serrano-Villar S, 2014, HIV MED, V15, P40, DOI 10.1111/hiv.12081; Serrano-Villar S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004078; Serrano-Villar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085798; Serrano-Villar S, 2013, J INFECTION, V66, P57, DOI 10.1016/j.jinf.2012.09.013; Torti C, 2012, CLIN MICROBIOL INFEC, V18, P449, DOI 10.1111/j.1469-0691.2011.03650.x; Triplette M, 2016, J ACQUIR IMMUNE DEFI; Wikby A, 1998, MECH AGEING DEV, V102, P187, DOI 10.1016/S0047-6374(97)00151-6	41	35	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0170857	10.1371/journal.pone.0170857	http://dx.doi.org/10.1371/journal.pone.0170857			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122034	Green Published, Green Submitted, gold			2022-12-26	WOS:000396167300008
J	Leventakos, K; Tsiodras, S; Kelesidis, T; Kefala, M; Kottaridi, C; Spathis, A; Gouloumi, AR; Pouliakis, A; Pappas, A; Sioulas, V; Chrelias, C; Karakitsos, P; Panayiotides, I				Leventakos, Konstantinos; Tsiodras, Sotirios; Kelesidis, Theodore; Kefala, Maria; Kottaridi, Christine; Spathis, Aris; Gouloumi, Alina-Roxani; Pouliakis, Abraham; Pappas, Asimakis; Sioulas, Vasileios; Chrelias, Charalambos; Karakitsos, Petros; Panayiotides, Ioannis			gamma H2Ax Expression as a Potential Biomarker Differentiating between Low and High Grade Cervical Squamous Intraepithelial Lesions (SIL) and High Risk HPV Related SIL	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HISTONE H2AX PHOSPHORYLATION; DNA-DAMAGE; E7 ONCOPROTEINS; CANCER; REPAIR; E6; MECHANISMS; PATHWAY; WOMEN	Background gamma H2AX is a protein biomarker for double-stranded DNA breakage; its expression was studied in cervical squamous intraepithelial lesions and carcinomas. Methods Immunostaining for phospho-gamma H2AX was performed in sections from histologically confirmed cervical SIL and carcinomas, as well as from normal cervices used as controls. In total, 275 cases were included in the study: 112 low grade SIL (LGSIL), 99 high grade SIL (HGSIL), 24 squamous cell carcinoma (SCC), 12 adenocarcinoma and 28 cervical specimens with no essential lesions. Correlation of histological grading, high risk vs. low risk HPV virus presence, activated vs. non-activated status (by high risk HPV mRNA expression) and gamma H2AX expression in both basal and surface segments of the squamous epithelium was performed. Results Gradual increase of both basal and surface gamma H2AX expression was noted up from normal cervices to LGSIL harboring a low risk HPV type, to LGSIL harboring a high risk virus at a non-activated state (p<0.05). Thereafter, both basal and surface gamma H2AX expression dropped in LGSIL harboring a high risk virus at an activated state and in HGSIL. Conclusions gamma H2AX could serve as a potential biomarker discriminating between LGSIL and HGSIL, as well as between LGSIL harboring high risk HPV at an activated state.	[Leventakos, Konstantinos; Kefala, Maria; Gouloumi, Alina-Roxani; Panayiotides, Ioannis] Univ Athens, Univ Hosp Attikon, Sch Med, Dept Pathol 2, Athens, Greece; [Leventakos, Konstantinos; Tsiodras, Sotirios; Kelesidis, Theodore] Univ Athens, Univ Hosp Attikon, Sch Med, Dept Internal Med 4, Athens, Greece; [Kottaridi, Christine; Spathis, Aris; Pouliakis, Abraham; Karakitsos, Petros] Univ Athens, Univ Hosp Attikon, Sch Med, Dept Cytopathol, Athens, Greece; [Pappas, Asimakis; Sioulas, Vasileios; Chrelias, Charalambos] Univ Athens, Univ Hosp Attikon, Sch Med, Dept Obstet & Gynecol 3, Athens, Greece; [Leventakos, Konstantinos] Mayo Clin, Hematol Oncol, Rochester, MN USA	Athens Medical School; National & Kapodistrian University of Athens; University Hospital Attikon; Athens Medical School; National & Kapodistrian University of Athens; University Hospital Attikon; Athens Medical School; National & Kapodistrian University of Athens; University Hospital Attikon; Athens Medical School; National & Kapodistrian University of Athens; University Hospital Attikon; Mayo Clinic	Tsiodras, S (corresponding author), Univ Athens, Univ Hosp Attikon, Sch Med, Dept Internal Med 4, Athens, Greece.	tsiodras@med.uoa.gr	Kelesidis, Theodoros/AAE-1961-2020; TSIODRAS, SOTIRIOS/AAD-8273-2019; Spathis, Aris T/A-2442-2015; Pouliakis, Abraham/C-4809-2011	TSIODRAS, SOTIRIOS/0000-0002-0463-4321; Spathis, Aris T/0000-0001-8867-3661; Pouliakis, Abraham/0000-0002-0074-3619; Kottaridi, Christine/0000-0003-0979-3871; Kelesidis, Theodoros/0000-0002-8463-3811	NCATS NIH HHS [UL1 TR000124] Funding Source: Medline; NHLBI NIH HHS [R21 HL134444] Funding Source: Medline; NIAID NIH HHS [K08 AI108272] Funding Source: Medline	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bassing CH, 2004, CELL CYCLE, V3, P149; Bonner M, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.9; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bountris P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/341483; Carlson BC, 2013, J UROLOGY, V190, P399, DOI 10.1016/j.juro.2013.01.102; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Clark JL, 2016, HUM PATHOL, V55, P51, DOI 10.1016/j.humpath.2016.04.010; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Duensing S, 2002, CANCER RES, V62, P7075; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Jeong Y S, 2013, INT J DISTRIB SENS N, V2013, DOI DOI 10.1016/J.IJRMMS.2009.03.007; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Koliopoulos G, 2012, ACTA OBSTET GYN SCAN, V91, P794, DOI 10.1111/j.1600-0412.2012.01414.x; Limoli CL, 2002, P NATL ACAD SCI USA, V99, P233, DOI 10.1073/pnas.231611798; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mehta K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004763; Moody CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000605; Narimatsu R, 2005, AM J CLIN PATHOL, V123, P716, DOI 10.1309/FE70AVNY75TDDJUH; Park JW, 2014, RADIOTHER ONCOL, V113, P337, DOI 10.1016/j.radonc.2014.08.026; Pilch DR, 2003, BIOCHEM CELL BIOL, V81, P123, DOI 10.1139/o03-042; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sakakibara N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003321; Sedelnikova OA, 2003, CANCER BIOL THER, V2, P233; Spathis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049205; Stripp Barry R, 2008, Proc Am Thorac Soc, V5, P695, DOI 10.1513/pats.200801-011AW; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Tsiodras S, 2011, CLIN MICROBIOL INFEC, V17, P1185, DOI 10.1111/j.1469-0691.2011.03505.x; Turinetto V, 2015, NUCLEIC ACIDS RES, V43, P2489, DOI 10.1093/nar/gkv061; Voltaggio L, 2016, CA-CANCER J CLIN, V66, P408, DOI 10.3322/caac.21350; Yugawa T, 2009, REV MED VIROL, V19, P97, DOI 10.1002/rmv.605	33	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2017	12	1							e0170626	10.1371/journal.pone.0170626	http://dx.doi.org/10.1371/journal.pone.0170626			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7CU	28118377	gold, Green Published, Green Submitted			2022-12-26	WOS:000396160500020
J	Huang, JH; Ma, KP; Huang, JH				Huang, Jihong; Ma, Keping; Huang, Jianhua			Species Diversity Distribution Patterns of Chinese Endemic Seed Plants Based on Geographical Regions	PLOS ONE			English	Article							EAST-ASIA; BIODIVERSITY; HOTSPOTS	Based on a great number of literatures, we established the database about the Chinese endemic seed plants and analyzed the compositions, growth form, distribution and angiosperm original families of them within three big natural areas and seven natural regions. The results indicate that the above characters of Chinese endemic plants take on relative rule at the different geographical scales. Among the three big natural areas, Eastern Monsoon area has the highest endemic plants richness, whereas Northwest Dryness area is the lowest. For life forms, herbs dominate. In contrast, the proportion of herbs of Eastern Monsoon area is remarkable under other two areas. Correspondingly the proportions of trees and shrubs are substantially higher than other two. For angiosperm original families, the number is the highest in Eastern Monsoon area, and lowest in Northwest Dryness area. On the other hand, among the seven natural regions, the humid and subtropical zone in Central and Southern China has the highest endemic plants richness, whereas the humid, hemihumid region and temperate zone in Northeast China has the lowest. For life forms, the proportion of herbs tends to decrease from humid, hemi- humid region and temperate zone in Northeast China to humid and tropical zone in Southern China. Comparably, trees, shrubs and vines or lianas increase with the same directions. This fully represents these characters of Chinese endemic plants vary with latitudinal gradients. Furthermore, as to the number of endemic plants belonging to angiosperm original families, the number is the most in humid and subtropical zone in Center and Southern China, and tropical zone in Southern China in the next place. In contrast, the endemic plant of these two regions relatively is richer than that of The Qinghai-Tibet alpine and cold region. All above results sufficiently reflect that the Chinese endemic plants mainly distribute in Eastern Monsoon area, especially humid and subtropical zone in Center and Southern China and tropical zone in Southern China. Furthermore, the flora of Eastern Monsoon area, in particular humid and subtropical zone in Center and Southern China and tropical zone in Southern China, is more ancient and original than that of Northwest Dryness area and Qinghai- Tibet alpine and cold area.	[Huang, Jihong] Chinese Acad Forestry, Inst Forest Ecol Environm & Protect, State Forestry Adm, Key Lab Forest Ecol & Environm, Beijing, Peoples R China; [Huang, Jihong] Nanjing Forestry Univ, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing, Jiangsu, Peoples R China; [Ma, Keping] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Huang, Jianhua] Minzu Univ China, Sch Econ, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; Nanjing Forestry University; Chinese Academy of Sciences; Institute of Botany, CAS; Minzu University of China	Ma, KP (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	kpma@ibcas.ac.cn	Huang, Jihong/I-8860-2019	Huang, Jihong/0000-0001-7668-3010	National Nonprofit Institute Research Grant of the Chinese Academy of Forestry [CAFYBB2014MA005]; Chinese Academy of Forestry; National Natural Science Foundation of China [41471048]; National Natural Science Foundation of China; National Nonprofit Institute Research Grant of the Institute of Forest Ecology, Environmental and Protection, Chinese Academy of Forestry [CAFIFEEP2015602]; Institute of Forest Ecology, Environmental and Protection, Chinese Academy of Forestry	National Nonprofit Institute Research Grant of the Chinese Academy of Forestry; Chinese Academy of Forestry; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Nonprofit Institute Research Grant of the Institute of Forest Ecology, Environmental and Protection, Chinese Academy of Forestry; Institute of Forest Ecology, Environmental and Protection, Chinese Academy of Forestry	This work was supported by the National Nonprofit Institute Research Grant of the Chinese Academy of Forestry (Grant number: CAFYBB2014MA005; No URL); Full name of funding institution is Chinese Academy of Forestry; Author who received the funding is JH (Jihong); the National Natural Science Foundation of China (Grant number: 41471048; the URL: http://www.nsfc.gov.cn/); Full name of funding institution is National Natural Science Foundation of China; Author who received the funding is JH (Jihong); and the National Nonprofit Institute Research Grant of the Institute of Forest Ecology, Environmental and Protection, Chinese Academy of Forestry (Grant number: CAFIFEEP2015602; No URL); Full name of funding institution is Institute of Forest Ecology, Environmental and Protection, Chinese Academy of Forestry; Author who received the funding is JH (Jihong).	Albert CS, 1971, J INDIA BOTANICAL A, V50A, P215; Axelrod D., 1996, FLORISTIC CHARACTERI, P43; Chen C. D, 1998, BIODIVERSITY CHINA C; Editorial Committee of China's Physical Geography, 1983, CHIN PHYS GEOGR PHYT, V1; Editorial Committee of China's physical geography, 1985, CHIN PHYS GEOGR PAND; Editorial Committee of China's physical geography, 1980, CHIN PHYS GEOGR PHYS; Editorial Committee of Flora Reipublicae Popularis Sinicae, 1959, FLORA REIPUBLICAE PO; Environmental Systems Research Institute (ESRI), 2008, ARCGIS 9 3; FU L, 1993, BIODIVERSITY CHINA S, P31; Hsu J, 1984, CHANGES PALAEOENVIRO, P419; Huang J., 2014, DIVERSITY GEOGRAPHIC; Huang JH, 2011, J SYST EVOL, V49, P81, DOI 10.1111/j.1759-6831.2011.00119.x; Huang JH, 2016, BIOL CONSERV, V198, P104, DOI 10.1016/j.biocon.2016.04.007; Huang JH, 2012, DIVERS DISTRIB, V18, P673, DOI 10.1111/j.1472-4642.2011.00845.x; Jenkins M, 2003, SCIENCE, V302, P1175, DOI 10.1126/science.1088666; Latham Roger Earl, 1993, P294; Liu MG, 1998, ATLAS PHYS GEOGRAPHY; [马克平 Ma Keping], 2015, [生物多样性, Biodiversity Science], V23, P557; Ma Keping, 2015, Biodiversity Science, V23, P137, DOI 10.17520/biods.2015077; Ma Keping, 2013, Shengwu Duoyangxing, V21, P1, DOI 10.3724/SP.J.1003.2013.02024; [马克平 Ma Keping], 2012, [生物多样性, Biodiversity Science], V20, P535; McNeely J. A., 1990, Conserving the world's biological diversity.; Mittermeier RA, 1997, MEGADIVERSITY EARTHS; Mittermeier RA, 2005, HOTSPOTS REVISITED; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Qian H, 2002, AM J BOT, V89, P1818, DOI 10.3732/ajb.89.11.1818; Qian H, 2003, J BIOGEOGR, V30, P129, DOI 10.1046/j.1365-2699.2003.00807.x; R Core Team, 2015, R LANG ENV STAT COMP; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Tang ZY, 2006, FRONT ECOL ENVIRON, V4, P347, DOI 10.1890/1540-9295(2006)004[0347:BICM]2.0.CO;2; Wang GuoHong, 2003, Acta Prataculturae Sinica, V12, P41; Wang HS, 1992, FLORISTIC PLANT GEOG; Wang Lisong, 2015, Biodiversity Science, V23, P217, DOI 10.17520/biods.2015049; [王襄平 Wang Xiangping], 2004, [生物多样性, Chinese Biodiversity], V12, P206; Wu, 1980, VEGETATION CHINA; Wu Z.Y., 1994, FLORA CHINA; Wu Z. Y., 1983, PHYS GEOGRAPHY CHINA; Ying JS, 1994, ENDEMIC GENERA SEED; YING JS, 2001, BIODIVERSITY SCI, V9, P393, DOI DOI 10.17520/BI0DS.2001058; Zhang YB, 2008, BIODIVERS CONSERV, V17, P1783, DOI 10.1007/s10531-008-9384-6	41	6	9	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e170276	10.1371/journal.pone.0170276	http://dx.doi.org/10.1371/journal.pone.0170276			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114417	Green Published, Green Submitted, gold			2022-12-26	WOS:000396129000032
J	Yang, L; Sun, HX; Cao, YN; Xuan, BB; Fan, YC; Sheng, HM; Zhuang, WF				Yang, Li; Sun, Hanxiao; Cao, Yanan; Xuan, Binbin; Fan, Yingchao; Sheng, Huiming; Zhuang, Wenfang			GATA2 Inhibition Sensitizes Acute Myeloid Leukemia Cells to Chemotherapy	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; MYELODYSPLASTIC SYNDROME; TRANSCRIPTION FACTOR; EXPRESSION; DIFFERENTIATION; EVI-1; GENE; GENERATION; MUTATIONS; GEFITINIB	Drug resistance constitutes one of the main obstacles for clinical recovery of acute myeloid leukemia (AML) patients. Therefore, the treatment of AML requires new strategies, such as adding a third drug. To address whether GATA2 could act as a regulator of chemotherapy resistance in human leukemia cells, we observed KG1a cells and clinical patients' AML cells with a classic drug (Cerubidine) and Gefitinib. After utilizing chemotherapy, the expression of GATA2 and its target genes (EVI, SCL and WT1) in surviving AML cells and KG1a cells were significantly enhanced to double and quadrupled compared to its original level respectively. Furthermore, with continuous chemotherapeutics, AML cells with GATA2 knockdown or treated with GATA2 inhibitor (K1747) almost eliminated with dramatically reduced expression of WT1, SCL, EVI, and significantly increased apoptotic population. Therefore, we propose that reducing GATA2 expression or inhibition of its transcription activity can relieve the drug resistance of acute myeloid leukemia cells and it would be helpful for eliminating the leukemia cells in patients.	[Yang, Li] Shanghai Jiao Tong Univ, Sch Med, Tongren Hosp, Dept Hematol, Shanghai, Peoples R China; [Sun, Hanxiao; Cao, Yanan; Xuan, Binbin; Fan, Yingchao; Sheng, Huiming; Zhuang, Wenfang] Shanghai Jiao Tong Univ, Sch Med, Dept Lab Med, Tongren Hosp, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhuang, WF (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Lab Med, Tongren Hosp, Shanghai, Peoples R China.	poloshm@aliyun.com; czwf1991@163.com	sheng, huiming/GQZ-8569-2022; sheng, huiming/T-8439-2019	sheng, huiming/0000-0001-9382-3687	Shanghai Municipal Health Bureau Project [15ZR1437900]; Natural Science Research Project of Changning District [CNKW2014Z01]; Leading Disciplines of Medical Laboratory in Changning District [2012QZK01]; Tongren Hospital grant [TR201407, TRYJ201506]	Shanghai Municipal Health Bureau Project; Natural Science Research Project of Changning District; Leading Disciplines of Medical Laboratory in Changning District; Tongren Hospital grant	This work was supported by the Shanghai Municipal Health Bureau Project (15ZR1437900), Natural Science Research Project of Changning District (CNKW2014Z01), Leading Disciplines of Medical Laboratory in Changning District (2012QZK01) and Tongren Hospital grant (grant TR201407, TRYJ201506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; All authors were involved in the design, conduct and analyses of the study. Wenfang Zhuang for study design, technical assistance, lab management; Wenfang Zhuang, Li Yang, Yanan Cao, and Binbin Xuan for general experimental techniques; Li Yang and Hanxiao Sun for manuscript preparation; for general experimental techniques; Wenfang Zhuang and Huiming Sheng for final approval of the version to be published. We are grateful to Mr. Kai Zhang, Ms. Xiaohui Wu and Ms. Yu Hua for their excellent assistance. The authors thank Shanghai Tuzhu biotechnology, the Flow Cytometry Core, Light Microscopy Core, and the Animal Facility of the SLAG Company in Shanghai for the technical support. This work was supported by the Shanghai Municipal Health Bureau Project (15ZR1437900), Natural Science Research Project of Changning District (CNKW2014Z01), Leading Disciplines of Medical Laboratory in Changning District (2012QZK01) and Tongren Hospital grant (grant TR201407, TRYJ201506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boehrer S, 2008, BIOCHEM PHARMACOL, V76, P1417, DOI 10.1016/j.bcp.2008.05.024; Bruserud O, 2003, HAEMATOLOGICA, V88, P416; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Celton M, 2014, LEUKEMIA, V28, P1617, DOI 10.1038/leu.2014.67; Corces-Zimmerman MR, 2014, LEUKEMIA, V28, P2276, DOI 10.1038/leu.2014.211; Dang Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0846-3; de Pater E, 2013, J EXP MED, V210, P2843, DOI 10.1084/jem.20130751; DeAngelo DJ, 2014, LEUKEMIA RES, V38, P430, DOI 10.1016/j.leukres.2013.10.026; Ding YH, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0327-5; Dombret H, 2016, BLOOD, V127, P53, DOI 10.1182/blood-2015-08-604520; Furuhata A, 2009, LEUKEMIA, V23, P1270, DOI 10.1038/leu.2009.13; Gao X, 2013, J EXP MED, V210, P2833, DOI 10.1084/jem.20130733; Ghatpande S, 2002, BLOOD, V99, P2379, DOI 10.1182/blood.V99.7.2379; Gottgens B, 2002, EMBO J, V21, P3039, DOI 10.1093/emboj/cdf286; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; Greif PA, 2012, BLOOD, V120, P395, DOI 10.1182/blood-2012-01-403220; Guzman ML, 2002, P NATL ACAD SCI USA, V99, P16220, DOI 10.1073/pnas.252462599; HAASE D, 1995, BLOOD, V86, P2906; Huang Z, 2009, MOL CELL BIOL, V29, P5168, DOI 10.1128/MCB.00482-09; Kitajima K, 2006, BLOOD, V107, P1857, DOI 10.1182/blood-2005-06-2527; Kumar MS, 2012, CELL, V149, P642, DOI 10.1016/j.cell.2012.02.059; Lichtman MA, 2013, BLOOD CELL MOL DIS, V50, P119, DOI 10.1016/j.bcmd.2012.10.005; Luesink M, 2012, BLOOD, V120, P2064, DOI 10.1182/blood-2011-12-397083; MIWA H, 1992, LEUKEMIA, V6, P405; Perry JM, 2007, CELL, V129, P1045, DOI 10.1016/j.cell.2007.05.053; Rodrigues NP, 2012, INT J BIOCHEM CELL B, V44, P457, DOI 10.1016/j.biocel.2011.12.004; Sato T, 2008, CANCER SCI, V99, P1407, DOI 10.1111/j.1349-7006.2008.00842.x; She MR, 2012, CANCER LETT, V318, P173, DOI 10.1016/j.canlet.2011.12.017; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Takeshita M, 2008, LEUKEMIA, V22, P1241, DOI 10.1038/leu.2008.53; Tao JL, 2014, LEUKEMIA RES, V38, P714, DOI 10.1016/j.leukres.2014.03.018; Tipping AJ, 2009, BLOOD, V113, P2661, DOI 10.1182/blood-2008-06-161117; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; Vidal SJ, 2015, CANCER CELL, V27, P223, DOI 10.1016/j.ccell.2014.11.013	34	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170630	10.1371/journal.pone.0170630	http://dx.doi.org/10.1371/journal.pone.0170630			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114350	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129000080
J	Colzani, E; Cassini, A; Lewandowski, D; Mangen, MJJ; Plass, D; McDonald, SA; van Lier, A; Haagsma, JA; Maringhini, G; Pini, A; Kramarz, P; Kretzschmar, ME				Colzani, Edoardo; Cassini, Alessandro; Lewandowski, Daniel; Mangen, Marie-Josee J.; Plass, Dietrich; McDonald, Scott A.; van Lier, Alies; Haagsma, Juanita A.; Maringhini, Guido; Pini, Alessandro; Kramarz, Piotr; Kretzschmar, Mirjam E.			A Software Tool for Estimation of Burden of Infectious Diseases in Europe Using Incidence-Based Disability Adjusted Life Years	PLOS ONE			English	Article							COUNTRIES; MEASLES; UNION	The burden of disease framework facilitates the assessment of the health impact of diseases through the use of summary measures of population health such as Disability-Adjusted Life Years (DALYs). However, calculating, interpreting and communicating the results of studies using this methodology poses a challenge. The aim of the Burden of Communicable Disease in Europe (BCoDE) project is to summarize the impact of communicable disease in the European Union and European Economic Area Member States (EU/EEA MS). To meet this goal, a user-friendly software tool (BCoDE toolkit), was developed. This stand-alone application, written in C++, is open-access and freely available for download from the website of the European Centre for Disease Prevention and Control (ECDC). With the BCoDE toolkit, one can calculate DALYs by simply entering the age group-and sex-specific number of cases for one or more of selected sets of 32 communicable diseases (CDs) and 6 healthcare associated infections (HAIs). Disease progression models (i.e., outcome trees) for these communicable diseases were created following a thorough literature review of their disease progression pathway. The BCoDE toolkit runs Monte Carlo simulations of the input parameters and provides disease-specific results, including 95% uncertainty intervals, and permits comparisons between the different disease models entered. Results can be displayed as mean and median overall DALYs, DALYs per 100,000 population, and DALYs related to mortality vs. disability. Visualization options summarize complex epidemiological data, with the goal of improving communication and knowledge transfer for decision-making.	[Colzani, Edoardo; Cassini, Alessandro; Maringhini, Guido; Pini, Alessandro; Kramarz, Piotr] European Ctr Dis Prevent & Control ECDC, Solna, Sweden; [Cassini, Alessandro; Mangen, Marie-Josee J.; Kretzschmar, Mirjam E.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Lewandowski, Daniel] NextPage Software Daniel Lewandowski, Zielona Gora, Poland; [Mangen, Marie-Josee J.; McDonald, Scott A.; van Lier, Alies; Kretzschmar, Mirjam E.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [Plass, Dietrich] German Environm Agcy, Sect Exposure Assessment & Environm Hlth Indicato, Berlin, Germany; [Haagsma, Juanita A.] Univ Washington, IHME, Dept Global Hlth, Seattle, WA 98195 USA; [Haagsma, Juanita A.] Erasmus Univ, Erasmus Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands	European Centre for Disease Prevention & Control; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Erasmus University Rotterdam; Erasmus MC	Colzani, E; Cassini, A (corresponding author), European Ctr Dis Prevent & Control ECDC, Solna, Sweden.; Cassini, A (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	edoardo.colzani@ecdc.europa.eu; alessandro.cassini@ecdc.europa.eu	Cassini, Alessandro/A-5122-2019; Kramarz, Piotr/U-9442-2019	Cassini, Alessandro/0000-0002-7973-6445; Colzani, Edoardo/0000-0001-8105-5027; Kretzschmar, Mirjam/0000-0002-4394-7697	European Centre for Disease Prevention and Control (ECDC); European Commission [ECDC/2013/020]	European Centre for Disease Prevention and Control (ECDC); European Commission(European CommissionEuropean Commission Joint Research Centre)	The European Centre for Disease Prevention and Control (ECDC), a publicly funded technical agency of the European Commission, funded the development of the BCoDE toolkit software through the framework contract ECDC/2013/020 "Maintenance and further development of the BCoDE software tool" with NextPage Software Daniel Lewandowski. DL, self-employed at NextPage Software Daniel Lewandowski, developed the BCoDE toolkit software but did not have additional roles in the study design, data collection and analysis and decision to publish. He contributed to the preparation of the manuscript concerning the BCoDE toolkit software development technical description. The funder (ECDC) also provided support in the form of salaries for authors EC, AC and PK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abu Sin M, 2016, RES REPORT; [Anonymous], 2010, ACC HLTH HLTH CAR AP, V5; Cassini A, IMPACT INFECT UNPUB; Cassini A, PLOS MED UNPUB; Colzani E, 2014, VACCINE, V32, P1814, DOI 10.1016/j.vaccine.2014.01.094; Colzani E, 2015, COMMUNICATION; EFSA BIOHAZ Panel (EFSA Panel on Biological Hazards), 2015, SCI OP DEV RISK RANK, P3939; Gibbons CL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-147; Haagsma J.A., 2016, ESTIMATING BURDEN IN; Haagsma JA, 2015, POPULATION HLTH METR, V13; Haagsma JA, 2014, POPUL HEALTH METR, V12, DOI 10.1186/s12963-014-0020-2; Jagger C, 2008, LANCET, V372, P2124, DOI 10.1016/S0140-6736(08)61594-9; Kretzschmar M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001205; Kwong JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044103; Mangen MJJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079740; Mangen MJ, 2016, MICROBIAL R IN PRESS; Mathers CD, 2001, LANCET, V357, P1685, DOI 10.1016/S0140-6736(00)04824-8; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Plass D, 2014, EPIDEMIOL INFECT, V142, P2024, DOI 10.1017/S0950268813003312; Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8; van Lier A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153106	23	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170662	10.1371/journal.pone.0170662	http://dx.doi.org/10.1371/journal.pone.0170662			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107447	Green Published, gold, Green Submitted			2022-12-26	WOS:000392405300177
J	Lecendreux, M; Churlaud, G; Pitoiset, F; Regnault, A; Tran, TA; Liblau, R; Klatzmann, D; Rosenzwajg, M				Lecendreux, Michel; Churlaud, Guillaume; Pitoiset, Fabien; Regnault, Armelle; Tu Anh Tran; Liblau, Roland; Klatzmann, David; Rosenzwajg, Michelle			Narcolepsy Type 1 Is Associated with a Systemic Increase and Activation of Regulatory T Cells and with a Systemic Activation of Global T Cells	PLOS ONE			English	Article							HYPOCRETIN NEURONS; CONFER RISK; INFLUENZA; AUTOIMMUNITY; VACCINATION; CATAPLEXY; INFECTION; CHILDREN; LINK	Narcolepsy is a rare neurologic disorder characterized by excessive daytime sleepiness, cataplexy and disturbed nocturnal sleep patterns. Narcolepsy type 1 (NT1) has been shown to result from a selective loss of hypothalamic hypocretin-secreting neurons with patients typically showing low CSF-hypocretin levels (< 110 pg/ml). This specific loss of hypocretin and the strong association with the HLA-DQB1* 06: 02 allele led to the hypothesis that NT1 could be an immune-mediated pathology. Moreover, susceptibility to NT1 has recently been associated with several pathogens, particularly with influenza A H1N1 virus either through infection or vaccination. The goal of this study was to compare peripheral blood immune cell populations in recent onset pediatric NT1 subjects (post or non-post 2009-influenza A H1N1 vaccination) to healthy donors. We demonstrated an increased number of central memory CD4(+) T cells (CD62L(+) CD45RA(-)) associated to an activated phenotype (increase in CD69 and CD25 expression) in NT1 patients. Percentage and absolute count of regulatory T cells (Tregs) in NT1 patients were increased associated with an activated phenotype (increase in GITR and LAP expression), and of activated memory phenotype. Cytokine production by CD4(+) and CD8(+) T cells after activation was not modified in NT1 patients. In H1N1 vaccinated NT1 patients, absolute counts of CD3(+), CD8(+) T cells, and B cells were increased compared to non-vaccinated NT1 patients. These results support a global T cell activation in NT1 patients and thus support a T cell-mediated autoimmune origin of NT1, but do not demonstrate the pathological role of H1N1 prophylactic vaccination. They should prompt further studies of T cells, particularly of Tregs (such as suppression and proliferation antigen specific assays, and also T-cell receptor sequencing), in NT1.	[Lecendreux, Michel] CHU Robert Debre, AP HP, Pediat Sleep Ctr, Paris, France; [Lecendreux, Michel] CHU Robert Debre, Natl Reference Ctr Orphan Dis Narcolepsy Idiopath, Paris, France; [Lecendreux, Michel] Robert Debre Hosp, Pediat Sleep Disorders Ctr, Paris, France; [Churlaud, Guillaume; Pitoiset, Fabien; Klatzmann, David; Rosenzwajg, Michelle] Hop La Pitie Salpetriere, AP HP, Biotherapy CIC BTi, Paris, France; [Churlaud, Guillaume; Pitoiset, Fabien; Klatzmann, David; Rosenzwajg, Michelle] Hop La Pitie Salpetriere, AP HP, Inflammat Immunopathol Biotherapy Dept I2B, Paris, France; [Churlaud, Guillaume; Pitoiset, Fabien; Klatzmann, David; Rosenzwajg, Michelle] UPMC Univ Paris 06, Sorbonne Univ, UMRS 959, Immunol Immunopathol Immunotherapy I3, Paris, France; [Churlaud, Guillaume; Pitoiset, Fabien; Klatzmann, David; Rosenzwajg, Michelle] INSERM, UMR S 959, Immunol Immunopathol Immunotherapy I3, Paris, France; [Regnault, Armelle] Aviesan Inst Multi Organismes Immunol Hematol & P, Paris, France; [Tu Anh Tran] Ctr Hosp Univ Nimes, Dept Pediat, F-30029 Nimes 9, France; [Tu Anh Tran] INSERM U1012, Le Kremlin Bicetre, France; [Liblau, Roland] Univ Toulouse 3, INSERM UMR1043, CNRS UMR5282, Toulouse, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Nimes; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Rosenzwajg, M (corresponding author), Hop La Pitie Salpetriere, AP HP, Biotherapy CIC BTi, Paris, France.; Rosenzwajg, M (corresponding author), Hop La Pitie Salpetriere, AP HP, Inflammat Immunopathol Biotherapy Dept I2B, Paris, France.; Rosenzwajg, M (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, UMRS 959, Immunol Immunopathol Immunotherapy I3, Paris, France.; Rosenzwajg, M (corresponding author), INSERM, UMR S 959, Immunol Immunopathol Immunotherapy I3, Paris, France.	michelle.rosenzwajg@upmc.fr	Rosenzwajg, Michelle/AAF-6276-2019; REGNAULT, Armelle/G-4142-2011; Liblau, Roland/J-3530-2014	Rosenzwajg, Michelle/0000-0001-5312-6203; REGNAULT, Armelle/0000-0001-7286-9491; LIBLAU, Roland/0000-0001-5477-5475; TRAN, Tu-Anh/0000-0001-6587-1876; Pitoiset, Fabien/0000-0001-9950-4011; Klatzmann, David/0000-0002-0054-3422	Departement de la Recherche Clinique et du Developpement (Department of Clinical Research and Development, DRCD); Clinical Investigations center for biotherapies (CIC-BTi); Institut national de la sante et de la recherche medicale (National Institute for health and medical research, INSERM); French state funds - Agence nationale de la recherche (National Research Agency, ANR) [PHRC AOM07-138]; Investissements d'Avenir program [ANR-11-IDEX0004-02]	Departement de la Recherche Clinique et du Developpement (Department of Clinical Research and Development, DRCD); Clinical Investigations center for biotherapies (CIC-BTi); Institut national de la sante et de la recherche medicale (National Institute for health and medical research, INSERM); French state funds - Agence nationale de la recherche (National Research Agency, ANR)(French National Research Agency (ANR)); Investissements d'Avenir program(French National Research Agency (ANR))	This work was funded by the Departement de la Recherche Clinique et du Developpement (Department of Clinical Research and Development, DRCD), the Clinical Investigations center for biotherapies (CIC-BTi), the Institut national de la sante et de la recherche medicale (National Institute for health and medical research, INSERM) and French state funds managed by the Agence nationale de la recherche (National Research Agency, ANR) within the national research program (PHRC AOM07-138, Narcobank) and the Investissements d'Avenir program (ANR-11-IDEX0004-02).	Ahmed SS, 2014, J AUTOIMMUN, V50, P1, DOI 10.1016/j.jaut.2014.01.033; Ahmed SS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2354; Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Ambati A, 2015, J INTERN MED; Aran A, 2009, SLEEP, V32, P979, DOI 10.1093/sleep/32.8.979; Bergot AS, 2015, EUR J IMMUNOL, V45, P1524, DOI 10.1002/eji.201445269; Bovenschen HJ, 2006, DERMATOLOGY, V213, P111, DOI 10.1159/000093849; Boyle MJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005041; Brusko T, 2007, DIABETES, V56, P604, DOI 10.2337/db06-1248; Buckner JH, 2010, NAT REV IMMUNOL, V10, P849, DOI 10.1038/nri2889; Cao D, 2003, EUR J IMMUNOL, V33, P215, DOI 10.1002/immu.200390024; Carter ME, 2012, P NATL ACAD SCI USA, V109, pE2635, DOI 10.1073/pnas.1202526109; Chen YH, 2013, SLEEP MED, V14, P1272, DOI 10.1016/j.sleep.2013.04.030; Cvetkovic-Lopes V, 2010, J CLIN INVEST, V120, P713, DOI 10.1172/JCI41366; Dalal J, 2013, GENE DEV, V27, P565, DOI 10.1101/gad.207654.112; Dauvilliers Y, 2013, BRAIN, V136, P2486, DOI 10.1093/brain/awt187; De la Herran-Arita Alberto K, 2014, Sleep Disord, V2014, P792687, DOI 10.1155/2014/792687; Degn M, 2015, ANN N Y ACAD SCI; Duffy J, 2014, NEUROLOGY, V83, P1823, DOI 10.1212/WNL.0000000000000987; Faraco J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003270; Ferrando-Martinez S, 2014, J PEDIATR-US, V164, P882, DOI 10.1016/j.jpeds.2013.12.013; Fontana A, 2010, BRAIN, V133, P1300, DOI 10.1093/brain/awq086; Hallmayer J, 2009, NAT GENET, V41, P708, DOI 10.1038/ng.372; Han F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003880; Han F, 2013, ANN NEUROL, V73, P560, DOI 10.1002/ana.23799; Han F, 2011, ANN NEUROL, V70, P410, DOI 10.1002/ana.22587; Hinze-Selch D, 1998, NEUROLOGY, V50, P1149, DOI 10.1212/WNL.50.4.1149; Katzav A, 2013, J AUTOIMMUN, V45, P24, DOI 10.1016/j.jaut.2013.06.010; Kornum BR, 2011, NAT GENET, V43, P66, DOI 10.1038/ng.734; Kugelberg E, 2014, NAT REV IMMUNOL, V14, P66, DOI 10.1038/nri3609; Lecendreux M, 2015, J AUTOIMMUN, V60, P20, DOI 10.1016/j.jaut.2015.03.003; Libera DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021386; Liblau RS, 2015, LANCET NEUROL, V14, P318, DOI 10.1016/S1474-4422(14)70218-2; Liguori C, 2014, J SLEEP RES, V23, P420, DOI 10.1111/jsr.12130; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Long SA, 2011, J IMMUNOL, V187, P2061, DOI 10.4049/jimmunol.1003224; Long SA, 2010, DIABETES, V59, P407, DOI 10.2337/db09-0694; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; Miyagawa T, 2010, J HUM GENET, V55, P63, DOI 10.1038/jhg.2009.118; Mottonen M, 2005, CLIN EXP IMMUNOL, V140, P360, DOI 10.1111/j.1365-2249.2005.02754.x; Ollila HM, 2015, AM J HUM GENET, V96, P136, DOI 10.1016/j.ajhg.2014.12.010; Partinen M, 2014, LANCET NEUROL, V13, P600, DOI 10.1016/S1474-4422(14)70075-4; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Pizza F, 2014, SLEEP MED, V15, P262, DOI 10.1016/j.sleep.2013.09.021; Poli F, 2013, VACCINE, V31, P994, DOI 10.1016/j.vaccine.2012.12.014; Saadoun D, 2011, NEW ENGL J MED, V365, P2067, DOI 10.1056/NEJMoa1105143; Saariaho AH, 2015, J AUTOIMMUN, V63, P68, DOI 10.1016/j.jaut.2015.07.006; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Szakacs A, 2013, NEUROLOGY, V80, P1315, DOI 10.1212/WNL.0b013e31828ab26f; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; van Leeuwen MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068432; Vogel G, 2015, SCIENCE, V349, P17, DOI 10.1126/science.349.6243.17; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Yan KX, 2010, BRIT J DERMATOL, V163, P48, DOI 10.1111/j.1365-2133.2010.09742.x; Zhang L, 2010, CLIN IMMUNOL, V135, P108, DOI 10.1016/j.clim.2009.11.008	56	29	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0169836	10.1371/journal.pone.0169836	http://dx.doi.org/10.1371/journal.pone.0169836			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107375	Green Published, Green Submitted, gold			2022-12-26	WOS:000392405300046
J	Torremade, N; Bozic, M; Goltzman, D; Fernandez, E; Valdivielso, JM				Torremade, Noelia; Bozic, Milica; Goltzman, David; Fernandez, Elvira; Valdivielso, Jose M.			Effects of the Administration of 25(OH) Vitamin D3 in an Experimental Model of Chronic Kidney Disease in Animals Null for 1-Alpha-Hydroxylase	PLOS ONE			English	Article							VASCULAR CALCIFICATION; 1,25-DIHYDROXYVITAMIN D-3; INTESTINAL CALCIUM; CORONARY-ARTERIES; RECEPTOR-BINDING; TUBULAR CELLS; CA2+ CHANNEL; EXPRESSION; GENE; IDENTIFICATION	The final step in vitamin D activation is catalyzed by 1-alpha-hydroxylase (CYP27B1). Chronic kidney disease (CKD) is characterized by low levels of both 25(OH)D-3 and 1,25 (OH)(2)D-3 provoking secondary hyperparathyroidism (2HPT). Therefore, treatments with active or native vitamin D compounds are common in CKD to restore 25(OH)D-3 levels and also to decrease PTH. This study evaluates the dose of 25(OH)D-3 that restores parathyroid hormone (PTH) and calcium levels in a model of CKD in CYP27B1(-/-) mice. Furthermore, we compare the safety and efficacy of the same dose in CYP27B1(+/+) animals. The dose needed to decrease PTH levels in CYP27B1(-/-) mice with CKD was 50 ng/g. That dose restored blood calcium levels without modifying phosphate levels, and increased the expression of genes responsible for calcium absorption (TRPV5 and calbindinD-28K in the kidney, TRPV6 and calbindinD-9k in the intestine). The same dose of 25(OH)D-3 did not modify PTH in CYP27B1(+/+) animals with CKD. Blood calcium remained normal, while phosphate increased significantly. Blood levels of 25(OH)D-3 in CYP27B1(-/-) mice were extremely high compared to those in CYP27B1(+/+) animals. CYP27B1(+/+) animals with CKD showed increases in TRPV5, TRPV6, calbindinD-28K and calbindinD-9K, which were not further elevated with the treatment. Furthermore, CYP27B1(+/+) animals displayed an increase in vascular calcification. We conclude that the dose of 25(OH)D-3 effective in decreasing PTH levels in CYP27B1(-/-) mice with CKD, has a potentially toxic effect in CYP27B1(+/+) animals with CKD.	[Torremade, Noelia; Bozic, Milica; Fernandez, Elvira; Valdivielso, Jose M.] Univ Hosp Arnau De Vilanova, IRBLleida, REDinREN ISCIII, Vasc & Renal Translat Res Grp, Lleida, Spain; [Goltzman, David] McGill Univ, Ctr Hlth, Calcium Res Lab, Montreal, PQ, Canada; [Goltzman, David] McGill Univ, Dept Med, Montreal, PQ, Canada	McGill University; McGill University	Valdivielso, JM (corresponding author), Univ Hosp Arnau De Vilanova, IRBLleida, REDinREN ISCIII, Vasc & Renal Translat Res Grp, Lleida, Spain.	valdivielso@medicina.udl.es	Giráldez, Elvira Dolores Fernández/D-3358-2009; Valdivielso, Jose M/B-5673-2009; Bozic, Milica/B-7425-2009	Giráldez, Elvira Dolores Fernández/0000-0001-5236-1762; Valdivielso, Jose M/0000-0003-1343-0184; Bozic, Milica/0000-0002-6064-1446	Institute de Salud Carlos III [PS12/01770, RD12/0021/0026]	Institute de Salud Carlos III(Instituto de Salud Carlos III)	This work was supported by the Institute de Salud Carlos III PS12/01770, RD12/0021/0026. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaden Y, 1998, J AM SOC NEPHROL, V9, P1845; [Anonymous], 2003, AM J KIDNEY DIS S3, V42, pS1; [Anonymous], 2009, KIDNEY INTSUPPL, P1; Bozic M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136863; Bozic M, 2014, J HYPERTENS, V32, P1822, DOI 10.1097/HJH.0000000000000261; Bozic M, 2011, J AM SOC NEPHROL, V22, P1099, DOI 10.1681/ASN.2010070701; Brown AJ, 1999, AM J PHYSIOL-RENAL, V277, pF157, DOI 10.1152/ajprenal.1999.277.2.F157; Brown AJ, 2002, J LAB CLIN MED, V139, P279, DOI 10.1067/mlc.2002.122819; Cardus A, 2007, J BONE MINER RES, V22, P860, DOI 10.1359/JBMR.070305; CARLSSON A, 1954, ACTA PHYSIOL SCAND, V31, P301, DOI 10.1111/j.1748-1716.1954.tb01141.x; Cozzolino M, 2005, KIDNEY INT, V68, P429, DOI 10.1111/j.1523-1755.2005.00421.x; Craver L, 2007, NEPHROL DIAL TRANSPL, V22, P1171, DOI 10.1093/ndt/gfl718; DeLuca HF, 2011, ARCH BIOCHEM BIOPHYS, V505, P226, DOI 10.1016/j.abb.2010.10.012; FRASER DR, 1970, NATURE, V228, P764, DOI 10.1038/228764a0; GILL RK, 1993, P NATL ACAD SCI USA, V90, P2984, DOI 10.1073/pnas.90.7.2984; Glendenning P, 2000, ARCH BIOCHEM BIOPHYS, V380, P126, DOI 10.1006/abbi.2000.1908; Glendenning P, 2000, BIOCHEM BIOPH RES CO, V277, P722, DOI 10.1006/bbrc.2000.3745; Goodman WG, 2001, KIDNEY INT, V59, P1187, DOI 10.1046/j.1523-1755.2001.00605.x; Hoenderop JGJ, 2002, ANNU REV PHYSIOL, V64, P529, DOI 10.1146/annurev.physiol.64.081501.155921; Hoenderop JGJ, 1999, J BIOL CHEM, V274, P8375, DOI 10.1074/jbc.274.13.8375; Kendrick J, 2011, AM J KIDNEY DIS, V58, P826, DOI 10.1053/j.ajkd.2011.07.020; LI H, 1991, ENDOCRINOLOGY, V128, P2844, DOI 10.1210/endo-128-6-2844; Mazzaferro S, 2014, CURR VASC PHARMACOL, V12, P339, DOI 10.2174/15701611113119990024; Meyer MB, 2006, MOL ENDOCRINOL, V20, P1447, DOI 10.1210/me.2006-0031; Micheletti RG, 2008, MODERN PATHOL, V21, P1019, DOI 10.1038/modpathol.2008.89; Moslehi N, 2015, BRIT J NUTR, V114, P1360, DOI 10.1017/S0007114515003189; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; Nijenhuis T, 2003, J AM SOC NEPHROL, V14, P2731, DOI 10.1097/01.ASN.0000094081.78893.E8; Panda DK, 2001, P NATL ACAD SCI USA, V98, P7498, DOI 10.1073/pnas.131029498; PATEL SR, 1995, J CLIN INVEST, V96, P50, DOI 10.1172/JCI118061; Peng JB, 1999, J BIOL CHEM, V274, P22739, DOI 10.1074/jbc.274.32.22739; Pulskens WP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142510; Qiao JH, 2005, MAYO CLIN PROC, V80, P807; Rowling MJ, 2007, J NUTR, V137, P2608, DOI 10.1093/jn/137.12.2608; Slatopolsky E, 2002, KIDNEY INT, V62, P1277, DOI 10.1111/j.1523-1755.2002.kid573.x; Stubbs JR, 2007, J AM SOC NEPHROL, V18, P2116, DOI 10.1681/ASN.2006121385; TANAKA Y, 1974, SCIENCE, V183, P1198, DOI 10.1126/science.183.4130.1198; Torremade N, 2016, J BONE MINER RES, V31, P1865, DOI 10.1002/jbmr.2852	38	4	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170654	10.1371/journal.pone.0170654	http://dx.doi.org/10.1371/journal.pone.0170654			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107527	Green Published, Green Submitted, gold			2022-12-26	WOS:000392405300176
J	Bedwell, RM; Spielvogel, H; Bellido, D; Vitzthum, VJ				Bedwell, Rebecca M.; Spielvogel, Hilde; Bellido, Diva; Vitzthum, Virginia J.			Factors Influencing the Use of Biomedical Health Care by Rural Bolivian Anemic Women: Structural Barriers, Reproductive Status, Gender Roles, and Concepts of Anemia	PLOS ONE			English	Article							IRON-DEFICIENCY; FOLATE SUPPLEMENTATION; HIGH-ALTITUDES; DETERMINANTS; PREVALENCE; PREGNANCY; AGE	The persistently high prevalence of anemia in rural highland Bolivia argues for targeted iron supplementation. We evaluated the cultural, structural and behavioral factors that may facilitate or impede an anemic woman's decision to secure this biomedical treatment from a rural Bolivian health center. Methods Non-pregnant women from a rural town and its surrounding region were tested for anemia. During phase 1 ( n = 181), anemic women received a written recommendation for low-cost purchase of iron pills at the nearest health center. They were subsequently interviewed on their actions and experiences. Results Estimated anemia prevalence among these non-pregnant women was 50% higher than the national average. Despite holding conceptualizations of anemia generally aligned with biomedical concepts, only 40% of anemic women attempted to obtain iron supplements from the health center. Town residents were about twice as likely to attempt to purchase pills as outside-town residents. Town women who were concurrently breastfeeding and menstruating, considered anemia most serious for women, and considered family health the shared responsibility of spouses were most likely to decide to purchase iron pills. Age, education, or native language did not negatively influence this health care behavior. Conclusions Securing iron supplements involves individual trade-offs in the allocation of time, cost and effort. Nonetheless, suitably tailored programs can potentially harness local perceptions in the service of reducing anemia. Because of their comparatively high motivation to obtain iron supplements, targeting concurrently breastfeeding and menstruating women could have a positive cascade effect such that these women continue attending to their iron needs once they stop breastfeeding and if they become pregnant again. Because a sense of shared responsibility for family health appears to encourage women to attend to their own health, programs for women could involve their spouses. Complementing centralized availability, biomedical and traditional healers could distribute iron supplements on rotating visits to outlying areas and/or at highly attended weekly markets.	[Bedwell, Rebecca M.; Vitzthum, Virginia J.] Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA; [Bedwell, Rebecca M.; Vitzthum, Virginia J.] Indiana Univ, Kinsey Inst, Bloomington, IN 47405 USA; [Spielvogel, Hilde; Bellido, Diva] Inst Boliviano Biol Altura, La Paz, Bolivia; [Bedwell, Rebecca M.] Univ Arizona, Sch Anthropol, Tucson, AZ USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Universidad Mayor de San Andres; University of Arizona	Vitzthum, VJ (corresponding author), Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA.; Vitzthum, VJ (corresponding author), Indiana Univ, Kinsey Inst, Bloomington, IN 47405 USA.	vitzthum@indiana.edu		Vitzthum, Virginia J./0000-0002-6765-4557	U.S. National Science Foundation [SBR 9506107]; Office of the Vice Provost for Research, Indiana University, Bloomington	U.S. National Science Foundation(National Science Foundation (NSF)); Office of the Vice Provost for Research, Indiana University, Bloomington	This work was supported by the U.S. National Science Foundation (SBR 9506107) and the Office of the Vice Provost for Research, Indiana University, Bloomington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2011, FOOD RES INT, V44, P652, DOI 10.1016/j.foodres.2010.12.033; BASTIEN JW, 1985, AM ANTHROPOL, V87, P595, DOI 10.1525/aa.1985.87.3.02a00050; Beall CM, 2014, ANNU REV ANTHROPOL, V43, P251, DOI 10.1146/annurev-anthro-102313-030000; BENDER DE, 1993, SOC SCI MED, V37, P1345, DOI 10.1016/0277-9536(93)90164-Y; Berger J, 1997, NUTR REV, V55, P247, DOI 10.1111/j.1753-4887.1997.tb01612.x; Berti PR, 2014, REV PANAM SALUD PUBL, V36, P314; Bindon JR, 2002, SOC SCI MED, V54, P1299, DOI 10.1016/S0277-9536(01)00097-1; Blackwell D.L., 2014, VITAL HEALTH STAT 10, V260, P1; CIAES (The Center for Health Research Consultation and Education), 1991, 9 CIAES JOHN SNOW IN; Currie Dawn, 2003, Health Care Women Int, V24, P880, DOI 10.1080/07399330390244257; Dary O, 2007, NUTR ANEMIA, P315; Ejidokun OO, 2000, MIDWIFERY, V16, P89, DOI 10.1054/midw.1999.0196; GALLOWAY R, 1994, SOC SCI MED, V39, P381, DOI 10.1016/0277-9536(94)90135-X; Galloway R, 2002, SOC SCI MED, V55, P529, DOI 10.1016/S0277-9536(01)00185-X; Ghanekar J, 2002, INDIA FOOD NUTR B, V23, P65, DOI DOI 10.1177/156482650202300109; Gonzales GF, 2009, AM J PHYSIOL-REG I, V297, pR1477, DOI 10.1152/ajpregu.00275.2009; Horton S, 2003, FOOD POLICY, V28, P51, DOI 10.1016/S0306-9192(02)00070-2; Imhoff-Kunsch B, 2007, J NUTR, V137, P1017, DOI 10.1093/jn/137.4.1017; Jefferds MD, 2002, SOC SCI MED, V55, P1143, DOI 10.1016/S0277-9536(01)00254-4; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Leon-Velarde F, 2000, High Alt Med Biol, V1, P97; Mora JO, 2010, ANEMIA LATIN AM CARB; Mujica-Coopman MF, 2015, FOOD NUTR BULL, V36, pS119, DOI 10.1177/0379572115585775; Nagata JM, 2012, MATERN CHILD NUTR, V8, P1, DOI 10.1111/j.1740-8709.2011.00338.x; Sanghvi T., 2007, Food and Nutrition Bulletin, V28, pS182; Sullivan KM, 2008, TROP MED INT HEALTH, V13, P1267, DOI 10.1111/j.1365-3156.2008.02143.x; Vitzthum VJ, 2009, AM J HUM BIOL, V21, P762, DOI 10.1002/ajhb.20927; Vitzthum VJ, 2009, AM J HUM BIOL, V21, P548, DOI 10.1002/ajhb.20936; WHO (World Health Organization), 2000, REC METH DET HEM PAC; Woldemicael G, 2010, HEALTH CARE WOMEN IN, V31, P599, DOI 10.1080/07399331003599555; Young SL, 2005, MATERN CHILD NUTR, V1, P51, DOI 10.1111/j.1740-8709.2004.00002.x	31	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170475	10.1371/journal.pone.0170475	http://dx.doi.org/10.1371/journal.pone.0170475			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7IT	28125636	Green Published, gold, Green Submitted			2022-12-26	WOS:000396176100105
J	Camlin, NJ; McLaughlin, EA; Holt, JE				Camlin, Nicole J.; McLaughlin, Eileen A.; Holt, Janet E.			Kif4 Is Essential for Mouse Oocyte Meiosis	PLOS ONE			English	Article							KINESIN-LIKE PROTEIN; KINETOCHORE-MICROTUBULE ATTACHMENTS; PHOSPHORYLATION SITES; SPINDLE ORGANIZATION; CHROMOSOME ALIGNMENT; MITOTIC CHROMOSOMES; KLP3A; PROLIFERATION; ANEUPLOIDY; LENGTH	Progression through the meiotic cell cycle must be strictly regulated in oocytes to generate viable embryos and offspring. During mitosis, the kinesin motor protein Kif4 is indispensable for chromosome condensation and separation, midzone formation and cytokinesis. Additionally, the bioactivity of Kif4 is dependent on phosphorylation via Aurora Kinase B and Cdk1, which regulate Kif4 function throughout mitosis. Here, we examine the role of Kif4 in mammalian oocyte meiosis. Kif4 localized in the cytoplasm throughout meiosis I and II, but was also observed to have a dynamic subcellular distribution, associating with both microtubules and kinetochores at different stages of development. Co-localization and proximity ligation assays revealed that the kinetochore proteins, CENP-C and Ndc80, are potential Kif4 interacting proteins. Functional analysis of Kif4 in oocytes via antisense knock-down demonstrated that this protein was not essential for meiosis I completion. However, Kif4 depleted oocytes displayed enlarged polar bodies and abnormal metaphase II spindles, indicating an essential role for this protein for correct asymmetric cell division in meiosis I. Further investigation of the phosphoregulation of meiotic Kif4 revealed that Aurora Kinase and Cdk activity is critical for Kif4 kinetochore localization and interaction with Ndc80 and CENPC. Finally, Kif4 protein but not gene expression was found to be upregulated with age, suggesting a role for this protein in the decline of oocyte quality with age.	[Camlin, Nicole J.; McLaughlin, Eileen A.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW, Australia; [Camlin, Nicole J.; McLaughlin, Eileen A.; Holt, Janet E.] Univ Newcastle, Prior Res Ctr Reprod Sci, Callaghan, NSW, Australia; [McLaughlin, Eileen A.] Univ Auckland, Sch Biol Sci, Auckland, New Zealand; [Holt, Janet E.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia	University of Newcastle; University of Newcastle; University of Auckland; University of Newcastle	Camlin, NJ; McLaughlin, EA (corresponding author), Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW, Australia.; Camlin, NJ; McLaughlin, EA (corresponding author), Univ Newcastle, Prior Res Ctr Reprod Sci, Callaghan, NSW, Australia.; McLaughlin, EA (corresponding author), Univ Auckland, Sch Biol Sci, Auckland, New Zealand.	Nicole.Camlin@uon.edu.au; eileen.mclaughlin@auckland.ac.nz	McLaughlin, Eileen/AAF-5588-2021; McLaughlin, Eileen A/G-7620-2013	Camlin, Nicole/0000-0001-9673-6191; McLaughlin, Eileen/0000-0002-5837-3876	Australian Research Council (ARC) [DP110100418, DP120100946/DE120101242]; Australian Postgraduate award	Australian Research Council (ARC)(Australian Research Council); Australian Postgraduate award(Australian Government)	This work was supported by Australian Research Council (ARC) grants to E A McLaughlin (DP110100418) and J E Holt (DP120100946/DE120101242) and an Australian Postgraduate award to N J Camlin.	Adhikari D, 2012, HUM MOL GENET, V21, P2476, DOI 10.1093/hmg/dds061; Balboula AZ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004194; Bastos RN, 2014, J CELL BIOL, V207, P683, DOI 10.1083/jcb.201409129; Bastos RN, 2013, J CELL BIOL, V202, P605, DOI 10.1083/jcb.201301094; Bieling P, 2010, CURR BIOL, V20, P763, DOI 10.1016/j.cub.2010.02.067; Bringmann H, 2004, SCIENCE, V303, P1519, DOI 10.1126/science.1094838; Camlin NJ, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.135848; Castoldi M, 2006, MOL BIOL CELL, V17, P1451, DOI 10.1091/mbc.e05-04-0271; Cohen Y, 2014, HEMATOLOGY, V19, P286, DOI 10.1179/1607845413Y.0000000125; Davydenko O, 2013, J CELL BIOL, V202, P221, DOI 10.1083/jcb.201303019; Gao J, 2011, TUMOR BIOL, V32, P53, DOI 10.1007/s13277-010-0090-0; Gui LM, 2013, DEV CELL, V25, P43, DOI 10.1016/j.devcel.2013.02.008; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hassold T, 2007, HUM MOL GENET, V16, pR203, DOI 10.1093/hmg/ddm243; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Holt Janet E, 2013, Methods Mol Biol, V957, P91, DOI 10.1007/978-1-62703-191-2_6; Holt JE, 2011, DEVELOPMENT, V138, P905, DOI 10.1242/dev.059022; Hu CK, 2012, MOL BIOL CELL, V23, P1024, DOI 10.1091/mbc.E11-08-0721; Hu CK, 2011, CURR BIOL, V21, P815, DOI 10.1016/j.cub.2011.04.019; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kurasawa Y, 2004, ESSENTIAL ROLES KIF4; Kwon MS, 2007, MOL BIOL CELL, V18, P2155, DOI 10.1091/mbc.E07-01-0045; Lane SIR, 2010, REPRODUCTION, V140, P521, DOI 10.1530/REP-10-0223; Mazumdar M, 2004, J CELL BIOL, V166, P613, DOI 10.1083/jcb.200401142; Mazumdar M, 2006, CURR BIOL, V16, P1559, DOI 10.1016/j.cub.2006.06.029; Mazumdar M, 2011, NUCLEUS-AUSTIN, V2, P591, DOI 10.4161/nucl.2.6.18044; Mitchison TJ, 2013, MOL BIOL CELL, V24, P1559, DOI 10.1091/mbc.E12-12-0850; Morris EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091568; Page SL, 2005, GENETICS, V170, P1797, DOI 10.1534/genetics.105.041194; Pan H, 2008, DEV BIOL, V316, P397, DOI 10.1016/j.ydbio.2008.01.048; Patel J, 2016, BIOL OPEN, V5, P178, DOI 10.1242/bio.016394; Samejima K, 2012, J CELL BIOL, V199, P755, DOI 10.1083/jcb.201202155; Shomper M, 2014, CELL CYCLE, V13, P1171, DOI 10.4161/cc.28046; Shrestha S, 2012, MOL BIOL CELL, V23, P1196, DOI 10.1091/mbc.E11-12-1008; Sun SC, 2011, MICROSC MICROANAL, V17, P431, DOI 10.1017/S1431927611000274; Takahashi M, 2016, BIOMED RES-TOKYO, V37, P161, DOI 10.2220/biomedres.37.161; Tang A, 2016, CELL CYCLE; VERNOS I, 1995, CELL, V81, P117, DOI 10.1016/0092-8674(95)90376-3; Voets E, 2014, SCI REPORTS, V5, P14798; Wandke C, 2012, J CELL BIOL, V198, P847, DOI 10.1083/jcb.201110060; Wei XM, 2014, MOL BIOL REP, V41, P5089, DOI 10.1007/s11033-014-3374-4; Williams BC, 1997, DEVELOPMENT, V124, P2365; WILLIAMS BC, 1995, J CELL BIOL, V129, P709, DOI 10.1083/jcb.129.3.709; Wynne DJ, 2015, J CELL BIOL, V210, P899, DOI 10.1083/jcb.201506020; Xue Y, 2005, NUCLEIC ACIDS RES, V33, pW184, DOI 10.1093/nar/gki393; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094; Yoshida S, 2015, DEV CELL, V33, P589, DOI 10.1016/j.devcel.2015.04.020; Yun Y, 2014, CELL CYCLE, V13, P1938, DOI 10.4161/cc.28897; Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102; Zielinska AP, 2015, ELIFE, V4, DOI 10.7554/eLife.11389	51	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170650	10.1371/journal.pone.0170650	http://dx.doi.org/10.1371/journal.pone.0170650			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125646	gold, Green Published, Green Submitted			2022-12-26	WOS:000396176100080
J	Coker, DJ; Chaidez, V; Berumen, ML				Coker, Darren J.; Chaidez, Veronica; Berumen, Michael L.			Habitat Use and Spatial Variability of Hawkfishes with a Focus on Colour Polymorphism in Paracirrhites forsteri	PLOS ONE			English	Article							GREAT-BARRIER-REEF; FISH ASSEMBLAGES; SOCIAL-ORGANIZATION; COMMUNITY STRUCTURE; CORAL-REEFS; ECOLOGY; COVER; SPECIALIZATION; BIODIVERSITY; COMPLEXITY	Identifying relationships between fishes and their environment is an integral part of understanding coral reef ecosystems. However, this information is lacking for many species, particularly in understudied and remote regions. With coral reefs continuing to face environmental pressures, insight into abundance and distribution patterns along with resource use of fish communities will aid in advancing our ecological understanding and management processes. Based on ecological surveys of hawkfish assemblages ( Family: Cirrhitidae) in the Red Sea, we reveal distinct patterns in the distribution and abundance across the continental shelf, wave exposure, and with depth, particularly in the four colour morphs of Paracirrhites forsteri. Distinct patterns were observed among hawkfishes, with higher abundance of all species recorded on reefs farther from shore and on wave exposed reef zones. Cirrhitus spilotoceps was only recorded on the exposed crest, but unlike the other species, did not associate with live coral colonies. Overall, the most abundant species was P. forsteri. This species exploited a variety of habitats but showed an affinity for complex habitats provided by live and dead coral colonies. No difference in habitat use was observed among the four colour morphs, but distinct patterns were apparent in distribution and abundance with depth. This study suggests that in addition to P. forsteri exhibiting diverse colour morphologies, these various morphotypes appear to have corresponding ecological differences in the Red Sea. To better understand this, further studies are needed to identify what these differences extend to and the mechanisms involved.	[Coker, Darren J.; Chaidez, Veronica; Berumen, Michael L.] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Red Sea Res Ctr, Thuwal, Saudi Arabia	King Abdullah University of Science & Technology	Coker, DJ (corresponding author), King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Red Sea Res Ctr, Thuwal, Saudi Arabia.	darren.coker@kaust.edu.sa	; Berumen, Michael/F-7745-2011	Chaidez, Veronica/0000-0003-1340-5835; Berumen, Michael/0000-0003-2463-2742	King Abdullah University of Science and Technology	King Abdullah University of Science and Technology(King Abdullah University of Science & Technology)	Funding was provided by King Abdullah University of Science and Technology (baseline funding to MLB).	Adam TC, 2015, MAR ECOL PROG SER, V520, P1, DOI 10.3354/meps11170; Allen G.R., 2003, REEF FISH IDENTIFICA; BELL JD, 1984, MAR ECOL PROG SER, V15, P265, DOI 10.3354/meps015265; Berumen ML, 2013, CORAL REEFS, V32, P737, DOI 10.1007/s00338-013-1055-8; Brokovich E, 2008, MAR ECOL PROG SER, V371, P253, DOI 10.3354/meps07591; Brown J.L., 1970, ANNU REV ECOL SYST, V1, P239; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Chabanet P, 1997, CORAL REEFS, V16, P93, DOI 10.1007/s003380050063; Coker DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138136; Coker DJ, 2014, REV FISH BIOL FISHER, P1; Cole AJ, 2008, FISH FISH, V9, P286, DOI 10.1111/j.1467-2979.2008.00290.x; CONNELL SD, 1991, J EXP MAR BIOL ECOL, V151, P271, DOI 10.1016/0022-0981(91)90129-K; Cortesi F, 2015, CURR BIOL, V25, P949, DOI 10.1016/j.cub.2015.02.013; De Young C, 2008, HUMAN DIMENSIONS ECO; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; DeMartini EE, 2013, MAR ECOL PROG SER, V485, P165, DOI 10.3354/meps10306; DeMartini EE, 1996, COPEIA, P362, DOI 10.2307/1446852; DeMartini EE, 1996, B MAR SCI, V58, P826; DONALDSON TJ, 1990, JPN J ICHTHYOL, V36, P439, DOI 10.1007/BF02905464; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; FISHELSON L, 1971, MAR BIOL, V10, P113, DOI 10.1007/BF00354828; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Friedlander AM, 1998, J EXP MAR BIOL ECOL, V224, P1, DOI 10.1016/S0022-0981(97)00164-0; Friedlander AM, 2003, CORAL REEFS, V22, P291, DOI 10.1007/s00338-003-0317-2; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Gaither MR, 2013, ZOOTAXA, V3599, P189, DOI 10.11646/zootaxa.3599.2.5; Gardiner NM, 2010, CORAL REEFS, V29, P845, DOI 10.1007/s00338-010-0642-1; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Goatley CHR, 2016, MAR ECOL PROG SER, V544, P271, DOI 10.3354/meps11614; Graham NAJ, 2013, CORAL REEFS, V32, P315, DOI 10.1007/s00338-012-0984-y; HAMILTON WJ, 1971, ANIM BEHAV, V19, P357, DOI 10.1016/S0003-3472(71)80017-9; Hoey AS, 2013, CORAL REEFS, V32, P973, DOI 10.1007/s00338-013-1043-z; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jennings S, 1996, ENVIRON BIOL FISH, V46, P15, DOI 10.1007/BF00001693; Jones GP, 1998, AUST J ECOL, V23, P287, DOI 10.1111/j.1442-9993.1998.tb00733.x; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Kadota T, 2011, ENVIRON BIOL FISH, V92, P79, DOI 10.1007/s10641-011-9817-z; Kane C, 2009, ENVIRON BIOL FISH, V84, P1, DOI 10.1007/s10641-008-9377-z; Kuiter RH, 2006, WORLD ATLAS OF MARIN; Lawton RJ, 2012, ECOGRAPHY, V35, P566, DOI 10.1111/j.1600-0587.2011.07326.x; Leray M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058076; Manly B.F.J., 2002, RESOURCE SELECTION A; Masuda H, 1985, FISHES JAPANESE ARCH; Messmer V, 2005, ENVIRON BIOL FISH, V74, P175, DOI 10.1007/s10641-005-7430-8; Messmer V, 2011, ECOLOGY, V92, P2285, DOI 10.1890/11-0037.1; Miller J, 1981, SIMULTANEOUS STAT IN; Morris DW, 2003, OECOLOGIA, V136, P1, DOI 10.1007/s00442-003-1241-4; Munday PL, 1998, OCEANOGR MAR BIOL<D>, V36, P373; Munday PL, 2000, ENVIRON BIOL FISH, V58, P355, DOI 10.1023/A:1007689314926; Munday PL, 2003, OECOLOGIA, V137, P519, DOI 10.1007/s00442-003-1356-7; Munday PL, 1997, MAR ECOL PROG SER, V152, P227, DOI 10.3354/meps152227; NORMAN MD, 1984, OECOLOGIA, V61, P60, DOI 10.1007/BF00379090; Orpin AR, 2012, CONT SHELF RES, V47, P55, DOI 10.1016/j.csr.2012.06.013; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Pratchett MS, 2012, ECOL EVOL, V2, P2168, DOI 10.1002/ece3.321; Raitsos DE, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047984; Randall JE, 1997, FISHES GREAT BARRIER; RANDALL JOHN E., 1963, CARIBBEAN J SCI, V3, P31; ROSENZWEIG ML, 1991, AM NAT, V137, pS5, DOI 10.1086/285137; ROSS ST, 1986, COPEIA, P352, DOI 10.2307/1444996; SADOVY Y, 1995, ENVIRON BIOL FISH, V42, P143, DOI 10.1007/BF00001992; Schmitt RJ, 2009, ECOLOGY, V90, P2434, DOI 10.1890/08-1225.1; Thomson D. A, 2000, REEF FISHES SEA CORT; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Wismer S, 2009, MAR ECOL PROG SER, V376, P45, DOI 10.3354/meps07790	65	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0169079	10.1371/journal.pone.0169079	http://dx.doi.org/10.1371/journal.pone.0169079			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125589	Green Published, gold, Green Submitted			2022-12-26	WOS:000396176100146
J	Iwamoto, K; Uehara, Y; Inoue, Y; Taguchi, K; Muraoka, D; Ogo, N; Matsuno, K; Asai, A				Iwamoto, Kazunori; Uehara, Yutaka; Inoue, Yukie; Taguchi, Kyoko; Muraoka, Daisuke; Ogo, Naohisa; Matsuno, Kenji; Asai, Akira			Inhibition of STAT3 by Anticancer Drug Bendamustine	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; SIGNAL TRANSDUCERS; INDUCED APOPTOSIS; LYMPHOMA-CELLS; CANCER; ACTIVATORS; RITUXIMAB; TARGETS; DNA	Bendamustine (BENDA), which bears the bis(2-chloroethyl) amino moiety, is an alkylating agent that stops the growth of cancer cells by binding to DNA and interfering with its replication. However, the mechanism of action underlying its excellent clinical efficacy remains unclear. In this work, we report that BENDA inhibits signal transducer and activator of transcription 3 (STAT3). In an AlphaScreen-based biochemical assay using recombinant human STAT3, binding of STAT3-Src homology 2 (SH2) to the phosphotyrosine (pTyr, pY) peptide was inhibited by BENDA but not by the inactive metabolite dihydroxy bendamustine (HP2). When a single point mutation of C550A or C712A was introduced into recombinant human STAT3, its sensitivity to BENDA was substantially reduced, suggesting that these cysteine residues are important for BENDA to inhibit STAT3. Furthermore, BENDA suppressed the function of cellular STAT3 as a transcriptional activator in a human breast cancer cell line, MDA-MB-468, with constitutively activated STAT3. A competitive pull-down assay using biotinylated BENDA (Bio-BENDA) revealed that BENDA bound tightly to cellular STAT3, presumably through covalent bonds. Therefore, our results suggest that the anticancer effects of BENDA may be associated, at least in part, with its inhibitory effect on the SH2 domain of STAT3.	[Iwamoto, Kazunori; Uehara, Yutaka; Inoue, Yukie; Taguchi, Kyoko; Muraoka, Daisuke; Ogo, Naohisa; Matsuno, Kenji; Asai, Akira] Univ Shizuoka, Grad Sch Pharmaceut Sci, Ctr Drug Discovery, Shizuoka, Japan; [Matsuno, Kenji] Kogakuin Univ, Dept Chem & Life Sci, Hachioji, Tokyo, Japan	University of Shizuoka; Kogakuin University	Asai, A (corresponding author), Univ Shizuoka, Grad Sch Pharmaceut Sci, Ctr Drug Discovery, Shizuoka, Japan.	aasai@u-shizuoka-ken.ac.jp		MATSUNO, Kenji/0000-0003-0884-1333	 [23510281/26430166]		This work was supported by Grant-in-Aid for Scientific Research (C) 23510281/26430166. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beeharry N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040342; Bergmann MA, 2005, HAEMATOLOGICA, V90, P1357; Buettner R, 2002, CLIN CANCER RES, V8, P945; Buettner R, 2011, ACS CHEM BIOL, V6, P432, DOI 10.1021/cb100253e; Chow KU, 2003, BIOCHEM PHARMACOL, V66, P711, DOI 10.1016/S0006-2952(03)00410-6; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Debnath B, 2012, J MED CHEM, V55, P6645, DOI 10.1021/jm300207s; Desrivieres S, 2006, J MAMMARY GLAND BIOL, V11, P75, DOI 10.1007/s10911-006-9014-4; Don-Doncow N, 2014, J BIOL CHEM, V289, P15969, DOI 10.1074/jbc.M114.564252; Dubbelman AC, 2013, DRUGS R&D, V13, P17, DOI 10.1007/s40268-012-0001-5; Fields WR, 2001, TOXICOL SCI, V63, P107, DOI 10.1093/toxsci/63.1.107; Friedberg JW, 2008, J CLIN ONCOL, V26, P204, DOI 10.1200/JCO.2007.12.5070; HARTMANN M, 1972, BIOCHIM BIOPHYS ACTA, V287, P386, DOI 10.1016/0005-2787(72)90282-1; Haura EB, 2005, NAT CLIN PRACT ONCOL, V2, P315, DOI 10.1038/ncponc0195; Heidelberger S, 2013, BIOORG MED CHEM LETT, V23, P4719, DOI 10.1016/j.bmcl.2013.05.066; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Hu Y, 2014, APOPTOSIS, V19, P1627, DOI 10.1007/s10495-014-1030-z; Jatiani Shashidhar S, 2010, Genes Cancer, V1, P979, DOI 10.1177/1947601910397187; Klampfer L, 2006, CURR CANCER DRUG TAR, V6, P107, DOI 10.2174/156800906776056491; Knop S, 2005, HAEMATOLOGICA, V90, P1287; Konstantinov SM, 2002, J CANCER RES CLIN, V128, P271, DOI 10.1007/s00432-002-0331-8; Leoni LM, 2008, CLIN CANCER RES, V14, P309, DOI 10.1158/1078-0432.CCR-07-1061; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lin L, 2012, INT J CANCER, V130, P1459, DOI 10.1002/ijc.26152; Matsuno K, 2010, ACS MED CHEM LETT, V1, P371, DOI 10.1021/ml1000273; Nowak D, 2004, LEUKEMIA LYMPHOMA, V45, P1429, DOI 10.1080/1042819042000198858; Ponisch W, 2006, J CANCER RES CLIN, V132, P205, DOI 10.1007/s00432-005-0074-4; Rummel MJ, 2005, J CLIN ONCOL, V23, P3383, DOI 10.1200/JCO.2005.08.100; Schwanen C, 2002, LEUKEMIA, V16, P2096, DOI 10.1038/sj.leu.2402651; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Strumberg D, 1996, ANTI-CANCER DRUG, V7, P415, DOI 10.1097/00001813-199606000-00007; Takakuma K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071646; Taldone T, 2013, BEILSTEIN J ORG CHEM, V9, P544, DOI 10.3762/bjoc.9.60; Uehara Y, 2009, BIOCHEM BIOPH RES CO, V380, P627, DOI 10.1016/j.bbrc.2009.01.137; Watson CJ, 2008, SEMIN CELL DEV BIOL, V19, P401, DOI 10.1016/j.semcdb.2008.07.021; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yu XK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128406; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	39	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170709	10.1371/journal.pone.0170709	http://dx.doi.org/10.1371/journal.pone.0170709			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125678	gold, Green Published, Green Submitted			2022-12-26	WOS:000396176100070
J	Knowler, SP; Cross, C; Griffiths, S; McFadyen, AK; Jovanovik, J; Tauro, A; Kibar, Z; Driver, CJ; La Ragione, RM; Rusbridge, C				Knowler, Susan P.; Cross, Chloe; Griffiths, Sandra; McFadyen, Angus K.; Jovanovik, Jelena; Tauro, Anna; Kibar, Zoha; Driver, Colin J.; La Ragione, Roberto M.; Rusbridge, Clare			Use of Morphometric Mapping to Characterise Symptomatic Chiari-Like Malformation, Secondary Syringomyelia and Associated Brachycephaly in the Cavalier King Charles Spaniel	PLOS ONE			English	Article							CAUDAL CRANIAL FOSSA; CRANIOCERVICAL JUNCTION; CEREBROSPINAL-FLUID; DOGS; FEATURES; VOLUMES; CLOSURE; ANGLE; SIGNS	Objectives To characterise the symptomatic phenotype of Chiari-like malformation (CM), secondary syringomyelia (SM) and brachycephaly in the Cavalier King Charles Spaniel using morphometric measurements on mid-sagittal Magnetic Resonance images (MRI) of the brain and craniocervical junction. Methods This retrospective study, based on a previous quantitative analysis in the Griffon Bruxellois (GB), used 24 measurements taken on 130 T1-weighted MRI of hindbrain and cervical region. Associated brachycephaly was estimated using 26 measurements, including rostral forebrain flattening and olfactory lobe rotation, on 72 T2-weighted MRI of the whole brain. Both study cohorts were divided into three groups; Control, CM pain and SM and their morphometries compared with each other. Results Fourteen significant traits were identified in the hindbrain study and nine traits in the whole brain study, six of which were similar to the GB and suggest a common aetiology. The Control cohort had the most elliptical brain (p = 0.010), least olfactory bulb rotation (p = 0.003) and a protective angle (p = 0.004) compared to the other groups. The CM pain cohort had the greatest rostral forebrain flattening (p = 0.007), shortest basioccipital (p = 0.019), but a greater distance between the atlas and basioccipital (p = 0.002) which was protective for SM. The SM cohort had two conformation anomalies depending on the severity of craniocervical junction incongruities; i) the proximity of the dens (p < 0.001) ii) increased airorhynchy with a smaller, more ventrally rotated olfactory bulb (p < 0.001). Both generated 'concertina' flexures of the brain and craniocervical junction. Conclusion Morphometric mapping provides a diagnostic tool for quantifying symptomatic CM, secondary SM and their relationship with brachycephaly. It is hypothesized that CM pain is associated with increased brachycephaly and SM can result from different combinations of abnormalities of the forebrain, caudal fossa and craniocervical junction which compromise the neural parenchyma and impede cerebrospinal fluid flow.	[Knowler, Susan P.; Cross, Chloe; La Ragione, Roberto M.; Rusbridge, Clare] Univ Surrey, Fac Hlth & Med Sci, Sch Vet Med, Guildford, Surrey, England; [Griffiths, Sandra] Stone Lion Vet Hosp, Wimbledon, England; [McFadyen, Angus K.] Akm Stats, Glasgow, Lanark, Scotland; [Jovanovik, Jelena; Tauro, Anna; Driver, Colin J.; Rusbridge, Clare] Fitzpatrick Referrals, Godalming, Surrey, England; [Kibar, Zoha] CHU St Justine Res Ctr, Montreal, PQ, Canada; [Kibar, Zoha] Univ Montreal, Montreal, PQ, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal	Knowler, SP (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Sch Vet Med, Guildford, Surrey, England.	s.knowler@surrey.ac.uk	La Ragione, Roberto M/Q-9916-2017; Rusbridge, Clare/A-3794-2019; Rusbridge, Clare/K-6560-2019; Knowler, Susan P/AAL-4595-2021	La Ragione, Roberto M/0000-0001-5861-613X; Rusbridge, Clare/0000-0002-3366-2110; Rusbridge, Clare/0000-0002-3366-2110; Knowler, Susan P/0000-0001-8727-8440; Driver, Colin/0000-0001-5419-7513; McFadyen, Angus/0000-0003-3081-5780	Cavalier Matters Charity [1141674]; BSAVA Petsavers Millennium Award, Woodrow House, Quedgeley; Dogs Trust Charity [227523, SC037843]; Fitzpatrick Referrals Ltd; Goddard Veterinary Group; Ruperts Fund	Cavalier Matters Charity; BSAVA Petsavers Millennium Award, Woodrow House, Quedgeley; Dogs Trust Charity; Fitzpatrick Referrals Ltd; Goddard Veterinary Group; Ruperts Fund	Cavalier Matters Charity (http://www.cavaliermatters.org/) Reg No 1141674 funded SPKs doctoral research. CC was supported by the BSAVA Petsavers Millennium Award, Woodrow House, Quedgeley GL22AB http://www.petsavers.org.uk/ and, together with The Dogs Trust Charity https://www.dogstrust.org.uk/ Reg. No. 227523 & SC037843, contributed towards the cost of leasing the DICOM viewing software package MIMICS 14.12 Materialise (Technologielaan 15 3001 Leuven Belgium). Henny van/der Berg donated the photo morphing software Abrosoft FantaMorph. Ruperts Fund (www.rupertsfund.com) and For the Love of Ollie (www.fortheloveofollie.com) provided financial support for health screening. AKM is an independent statistical consultant operating professionally as a sole trader under the company name of akm-stats and did not receive any salary or other remittance for his contribution in this investigation. Fitzpatrick Referrals Ltd, provided support in the form of salaries and materials for authors CD, JJ, AT and CR and the Goddard Veterinary Group provided the salary for SG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannasch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009632; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; BVA/KC, 2012, CHIAR MALF SYR SCH C; Cappello R., 2007, AM COLL VET SURG, V36, P389; Carrera I, 2009, AM J VET RES, V70, P340, DOI 10.2460/ajvr.70.3.340; Cerda-Gonzalez S, 2015, J VET INTERN MED, V29, P882, DOI 10.1111/jvim.12605; Cerda-Gonzalez S, 2016, J VET INTERN MED; Cerda-Gonzalez S, 2009, VET RADIOL ULTRASOUN, V50, P467, DOI 10.1111/j.1740-8261.2009.01571.x; Cerda-Gonzalez S, 2009, VET RADIOL ULTRASOUN, V50, P264, DOI 10.1111/j.1740-8261.2009.01531.x; Cross HR, 2009, J SMALL ANIM PRACT, V50, P399, DOI 10.1111/j.1748-5827.2009.00799.x; D'Addario V, 2001, ULTRASOUND OBST GYN, V18, P146, DOI 10.1046/j.1469-0705.2001.00409.x; Driver CJ, 2013, VET J, V198, P551, DOI 10.1016/j.tvjl.2013.07.014; Driver CJ, 2013, VET J, V198, P88, DOI 10.1016/j.tvjl.2013.05.017; Driver CJ, 2010, VET REC, V167, P978, DOI 10.1136/vr.c4109; Driver CJ, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-215; Fenn J, 2013, VET J, V197, P896, DOI 10.1016/j.tvjl.2013.05.007; Flint G, 2014, SYRINGOMYELIA DISORD; Freeman AC, 2014, J VET INTERN MED, V28, P1551, DOI 10.1111/jvim.12421; Geiger M, 2016, ANAT REC, V299, P412, DOI 10.1002/ar.23313; Guyot L, 2006, SURG RADIOL ANAT, V28, P559, DOI 10.1007/s00276-006-0161-5; Harrison SJ, 2012, DIS MODEL MECH, V5, P351, DOI 10.1242/dmm.002873; Knowler SP, 2011, VET REC, V169, P681, DOI 10.1136/vr.100062; Knowler SP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151280; Knowler SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088120; LEEDS SE, 1989, LYMPHOLOGY, V22, P144; Lemay P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089816; Marino DJ, 2012, AM J VET RES, V73, P105, DOI 10.2460/ajvr.73.1.105; Martin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075335; Mitchell Thomas J, 2014, Canine Genet Epidemiol, V1, P9, DOI 10.1186/2052-6687-1-9; Parker JE, 2011, VET REC, V168, DOI 10.1136/vr.d1726; Plessas IN, 2008, VET REC, V171, P501; Roberts T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011946; Rusbridge C, 2009, J SMALL ANIM PRACT, V50, P386, DOI 10.1111/j.1748-5827.2009.00744.x; Rusbridge C, 2000, J AM ANIM HOSP ASSOC, V36, P34, DOI 10.5326/15473317-36-1-34; Rusbridge C., 2013, EUR J COMPANION, V23, P70, DOI DOI 10.1111/J.1748-5827.2008.00578.X; Rusbridge C, 2008, VET J, V175, P164, DOI 10.1016/j.tvjl.2006.12.007; Saito M, 2003, VET RADIOL ULTRASOUN, V44, P687, DOI 10.1111/j.1740-8261.2003.tb00532.x; Schmidt MJ, 2011, VET RADIOL ULTRASOUN, V52, P436, DOI 10.1111/j.1740-8261.2011.01825.x; Schmidt MJ, 2013, VET RADIOL ULTRASOUN, V54, P497, DOI 10.1111/vru.12072; Schmidt MJ, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-158; Shaw TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033660; Stockard Charles Rupert, 1941, GENETIC ENDOCRINE BA; Thofner MS, 2015, J VET INTERN MED, V29, P243, DOI 10.1111/jvim.12475; Trinh Q-H., 2010, 5 ANN CAN GEN EP STA; Trinh Q-U, 2011, 24 ANN S EUR SOC VET	45	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0170315	10.1371/journal.pone.0170315	http://dx.doi.org/10.1371/journal.pone.0170315			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122014	Green Published, gold			2022-12-26	WOS:000396167300046
J	Shi, X; Banerjee, S; Chen, L; Hilakivi-Clarke, L; Clarke, R; Xuan, JH				Shi, Xu; Banerjee, Sharmi; Chen, Li; Hilakivi-Clarke, Leena; Clarke, Robert; Xuan, Jianhua			CyNetSVM: A Cytoscape App for Cancer Biomarker Identification Using Network Constrained Support Vector Machines	PLOS ONE			English	Article							BREAST-CANCER; GENE	One of the important tasks in cancer research is to identify biomarkers and build classification models for clinical outcome prediction. In this paper, we develop a CyNetSVM software package, implemented in Java and integrated with Cytoscape as an app, to identify network biomarkers using network-constrained support vector machines (NetSVM). The Cytoscape app of NetSVM is specifically designed to improve the usability of NetSVM with the following enhancements: (1) user-friendly graphical user interface (GUI), (2) computationally efficient core program and (3) convenient network visualization capability. The CyNetSVM app has been used to analyze breast cancer data to identify network genes associated with breast cancer recurrence. The biological function of these network genes is enriched in signaling pathways associated with breast cancer progression, showing the effectiveness of CyNetSVM for cancer biomarker identification. The CyNetSVM package is available at Cytoscape App Store and http://sourceforge.net/projects/netsvmjava; a sample data set is also provided at source-forge.net.	[Shi, Xu; Banerjee, Sharmi; Xuan, Jianhua] Virginia Polytech Inst & State Univ, Dept Elect & Comp Engn, Arlington, VA 22203 USA; [Chen, Li] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Hilakivi-Clarke, Leena; Clarke, Robert] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC USA	Virginia Polytechnic Institute & State University; Johns Hopkins University; Georgetown University	Xuan, JH (corresponding author), Virginia Polytech Inst & State Univ, Dept Elect & Comp Engn, Arlington, VA 22203 USA.	xuan@vt.edu	Shi, Xu/E-6789-2019; Clarke, Robert/A-6485-2008	Shi, Xu/0000-0001-9130-9289; Clarke, Robert/0000-0002-9278-0854	National Institutes of Health [CA149653, CA164384, CA149147, CA184902]; Virginia Tech's Open Access Subvention Fund; NATIONAL CANCER INSTITUTE [P30CA051008, R01CA149653, U01CA184902] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Tech's Open Access Subvention Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (Grant numbers: CA149653, CA164384, CA149147 and CA184902); URL: http://www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Publication of this article was supported by Virginia Tech's Open Access Subvention Fund.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Chen L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks951; Chen L, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-161; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dittrich MT, 2008, BIOINFORMATICS, V24, pI223, DOI 10.1093/bioinformatics/btn161; Dougherty ER, 2012, BIOESSAYS, V34, P277, DOI 10.1002/bies.201200003; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Giltnane JM, 2014, DISCOVERY MED; Hanash S, 2004, NAT REV CANCER, V4, P638, DOI 10.1038/nrc1414; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Li CY, 2008, BIOINFORMATICS, V24, P1175, DOI 10.1093/bioinformatics/btn081; Loi S, 2010, P NATL ACAD SCI USA, V107, P10208, DOI 10.1073/pnas.0907011107; Niemitz E., 2013, NAT GENET, V45, P1273, DOI [10.1038/ng.2817, DOI 10.1038/NG.2817]; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Roy S. Saha, 2011, INT J BREAST CANC, V2012; Shi X, 2015, BIOINFORMATICS; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087	24	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0170482	10.1371/journal.pone.0170482	http://dx.doi.org/10.1371/journal.pone.0170482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122019	Green Published, Green Submitted, gold			2022-12-26	WOS:000396167300043
J	Wang, AP; Li, T; An, P; Yan, WH; Zheng, H; Wang, BA; Mu, YM				Wang, Anping; Li, Ting; An, Ping; Yan, Wenhua; Zheng, Hua; Wang, Baoan; Mu, Yiming			Exendin-4 Upregulates Adiponectin Level in Adipocytes via Sirt1/Foxo-1 Signaling Pathway	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; GLP-1 RECEPTOR AGONIST; INSULIN SENSITIVITY; LIPID-ACCUMULATION; MICE; EXPRESSION; PHYSIOLOGY; DIET	Glucagon-like peptide-1 (GLP-1) receptor plays an essential role in regulating glucose metabolism. GLP-1 receptor agonists have been widely used for treating diabetes and other insulin resistance-related diseases. However, mechanisms underlying the anti-diabetic effects of GLP-1 receptor agonists remain largely unknown. In this study, we investigated the effects of GLP-1 agonist exendin-4 on the expression of adiponectin, an insulin sensitizing hormone. We found that exendin-4 increased the expression and secretion of adiponectin both in vitro and in vivo. Our data showed that exendin-4 upregulated adiponectin expression at both mRNA and protein levels in adipocytes and adipose tissues. The effects of exendin-4 on adiponectin expression were dependent on the GLP-1 receptor. We further demonstrated important roles of Sirt1 and transcriptional factor Foxo-1 in mediating the function of exendin-4 in regulating adiponectin expression. Suppression of Sirt1 or Foxo-1 expression significantly impaired exendin-4-induced adiponectin expression. Consistently, exendin-4 up-regulated Sirt1 and Foxo-1 expression in vivo. Our work is the first study demonstrating the role of Sirt1/Foxo-1 in regulating the regulatory function of a GLP-1 receptor agonist in adiponectin expression both in vitro and in vivo. The results provide important information for the mechanism underlying the function of GLP-1R on improving insulin resistance and related diseases.	[Wang, Anping; Li, Ting; An, Ping; Yan, Wenhua; Zheng, Hua; Wang, Baoan; Mu, Yiming] Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Mu, YM (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing, Peoples R China.	muyiming@301hospital.com			National Natural Science Foundation of China [81471026]; Diabetes Doctors Foundation of China; Chinese Diabetes Doctors Funds	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Diabetes Doctors Foundation of China; Chinese Diabetes Doctors Funds	This work was supported by National Natural Science Foundation of China (Grant No#: 81471026, to A.W.) and Diabetes Doctors Foundation of China (to A.W.).; This work was supported by the National Natural Science Foundation of China (Grant No. 81471026, to A.W.) and The Chinese Diabetes Doctors Funds (to A.W.).	Arakawa M, 2009, BIOCHEM BIOPH RES CO, V390, P809, DOI 10.1016/j.bbrc.2009.10.054; Burmeister MA, 2012, AM J PHYSIOL-ENDOC M, V302, pE334, DOI 10.1152/ajpendo.00409.2011; Chung LTK, 2009, BIOCHEM BIOPH RES CO, V390, P613, DOI 10.1016/j.bbrc.2009.10.015; Dalle S, 2002, DIABETES, V51, P406, DOI 10.2337/diabetes.51.2.406; Dalle S, 2013, CELL SIGNAL, V25, P570, DOI 10.1016/j.cellsig.2012.11.009; Ding XK, 2006, HEPATOLOGY, V43, P173, DOI 10.1002/hep.21006; Fu YC, 2005, J LIPID RES, V46, P1369, DOI 10.1194/jlr.M400373-JLR200; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Idris I, 2002, BIOCHEM PHARMACOL, V63, P993, DOI 10.1016/S0006-2952(01)00924-8; Lee JS, 2013, MULTIMED TOOLS APPL, V67, P31, DOI 10.1007/s11042-012-1011-6; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Otabe S, 2007, AM J PHYSIOL-ENDOC M, V293, pE210, DOI 10.1152/ajpendo.00645.2006; Park CW, 2007, J AM SOC NEPHROL, V18, P1227, DOI 10.1681/ASN.2006070778; Park YJ, 2013, DIABETOLOGIA, V56, P508, DOI 10.1007/s00125-012-2802-z; Qiao LP, 2006, J BIOL CHEM, V281, P39915, DOI 10.1074/jbc.M607215200; Soleimanpour SA, 2010, J BIOL CHEM, V285, P40050, DOI 10.1074/jbc.M110.154955; Wang AP, 2011, J BIOL CHEM, V286, P60, DOI 10.1074/jbc.M110.188144; Weiss R, 2003, J CLIN ENDOCR METAB, V88, P2014, DOI 10.1210/jc.2002-021711; Yang WS, 2002, OBES RES, V10, P1104, DOI 10.1038/oby.2002.150	19	31	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0169469	10.1371/journal.pone.0169469	http://dx.doi.org/10.1371/journal.pone.0169469			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122026	gold, Green Published, Green Submitted			2022-12-26	WOS:000396167300076
J	Martino, FP; Miller, PG; Coomber, K; Hancock, L; Kypri, K				Martino, Florentine Petronella; Miller, Peter Graeme; Coomber, Kerri; Hancock, Linda; Kypri, Kypros			Analysis of Alcohol Industry Submissions against Marketing Regulation	PLOS ONE			English	Article							ADDICTION RESEARCH; ADVERTISING BANS; VESTED INTERESTS; TOBACCO; SCIENCE; POLICY; CONSUMPTION; DRINKING; IMPACT	A growing body of literature points to the role of vested interests as a barrier to the implementation of effective public health policies. Corporate political activity by the alcohol industry is commonly used to influence policy and regulation. It is important for policy makers to be able to critique alcohol industry claims opposed to improved alcohol marketing regulation. The Australian National Preventive Health Agency reviewed alcohol marketing regulations in 2012 and stakeholders were invited to comment on them. In this study we used thematic analysis to examine submissions from the Australian alcohol industry, based on a system previously developed in relation to tobacco industry corporate political activity. The results show that submissions were a direct lobbying tactic, making claims to government that were contrary to the evidence-base. Five main frames were identified, in which the alcohol industry claimed that increased regulation: (1) is unnecessary; (2) is not backed up by sufficient evidence; (3) will lead to unintended negative consequences; and (4) faces legal barriers to implementation; underpinned by the view (5) that the industry consists of socially responsible companies working toward reducing harmful drinking. In contrast with tobacco industry submissions on public policy, which often focused on legal and economic barriers, the Australian alcohol industry placed a heavier emphasis on notions of regulatory redundancy and insufficient evidence. This may reflect differences in where these industries sit on the 'regulatory pyramid', alcohol being less regulated than tobacco.	[Martino, Florentine Petronella; Miller, Peter Graeme; Coomber, Kerri] Deakin Univ, Sch Psychol, Fac Hlth, Geelong, Vic, Australia; [Hancock, Linda] Deakin Univ, Sch Humanities & Social Sci, Fac Arts & Educ, Melbourne, Vic, Australia; [Kypri, Kypros] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW, Australia; [Kypri, Kypros] Univ Otago, Dept Prevent & Social Med, Injury Prevent Res Unit, Dunedin, New Zealand	Deakin University; Deakin University; University of Newcastle; University of Otago	Miller, PG (corresponding author), Deakin Univ, Sch Psychol, Fac Hlth, Geelong, Vic, Australia.	petermiller.mail@gmail.com	hancock, linda/C-3183-2019	hancock, linda/0000-0003-2953-2353; Coomber, Kerri/0000-0001-6160-0235; Miller, Peter/0000-0002-6896-5437; Martino, Florentine/0000-0001-6718-5239	Australian Research Council [LP130100046]; Foundation for Alcohol Research and Education; Victorian Cancer Council; Australian Research Council; Australian National Health and Medical Research Council; NSW Government; National Drug Law Enforcement Research Fund; Cancer Council Victoria; Queensland government; Australian Drug Foundation; National Health & Medical Research Council Research Fellowship; Campaign for Fairer Gambling evaluating the Responsible Gambling Trust	Australian Research Council(Australian Research Council); Foundation for Alcohol Research and Education; Victorian Cancer Council(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NSW Government; National Drug Law Enforcement Research Fund; Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Queensland government; Australian Drug Foundation; National Health & Medical Research Council Research Fellowship; Campaign for Fairer Gambling evaluating the Responsible Gambling Trust	This work was supported by: Australian Research Council Linkage Grant (LP130100046) PM LH KK (http://www.arc.gov.au/linkage-projects); Foundation for Alcohol Research and Education (http://www.fare.org.au/) PM LH KK; Victorian Cancer Council (http://www.cancervic.org.au) PM LH KK. Peter Miller receives funding from Australian Research Council and Australian National Health and Medical Research Council, grants from NSW Government, National Drug Law Enforcement Research Fund, Foundation for Alcohol Research and Education, Cancer Council Victoria, Queensland government and Australian Drug Foundation, travel and related costs from Australasian Drug Strategy Conference. He has acted as a paid expert witness in legal proceedings on behalf of a licensed venue and a security firm. Kypros Kypri's contribution to this study is funded via a National Health & Medical Research Council Research Fellowship. Linda Hancock has received funding from the Australian Research Council in relation to this article. She has been an unpaid expert witness in relation to gambling-related inquiries in Victorian and Commonwealth government inquiries, the Australian Productivity Commission, the South Australian Coronial Court, and inquiries in New Zealand, Canada and the UK; and she is a member of the Singapore Government International Advisory Panel. She was appointed by the Governor in Council as Chair of the Victorian Gambling Research Panel (2000-2004) and was a member of the Ministerial Roundtable on Gambling. She was Director of Research for the UK Responsible Gambling Fund and participated in that role on various UK committees on the ESRC, MRC, DCMS and the Gambling Commission. She has conducted independent peer review of bookmaker research for the UK Department of Culture, Media and Sport (DCMS) and undertook research funded by the Campaign for Fairer Gambling evaluating the Responsible Gambling Trust funded research on fixed odds betting machines in bookmakers' shops (2014 and 2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAC, 2014, ANN REP 2013 ALC BEV; Alcohol Concern, 2014, CREAT CUST FIND NEW; Anderson P, 2009, ALCOHOL ALCOHOLISM, V44, P229, DOI 10.1093/alcalc/agn115; [Anonymous], 2012, J CURRENT ISSUES RES, DOI DOI 10.1080/10641734.2012.700800; [Anonymous], 2011, 2010 NAT DRUG STRAT; Argyriou E, 2011, INT J MANAG REV, V13, P431, DOI 10.1111/j.1468-2370.2011.00299.x; Australian Communications and Media Authority, 2007, CHILDR VIEW PATT COM; Australian National Preventive Health Agency, 2012, ALC ADV EFF CURR REG; Beauchamp D E, 1976, Inquiry, V13, P3; Benford RD, 2000, ANNU REV SOCIOL, V26, P611, DOI 10.1146/annurev.soc.26.1.611; Blecher E, 2008, J HEALTH ECON, V27, P930, DOI 10.1016/j.jhealeco.2008.02.010; Bond L, 2010, AUSTRALAS MED J, V3, P325, DOI 10.4066/AMJ.2010.363; Bosque-Prous M, 2014, ADDICTION, V109, P1634, DOI 10.1111/add.12562; Boyatzis R. E., 1998, TRANSFORMING QUALITA, DOI 10.1191/1478088706qp063oa; Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x; Casswell S, 2013, ADDICTION, V108, P680, DOI 10.1111/add.12011; Chapman S, 2003, BRIT MED J S3, V12; Davey M, 2015, GUARDIAN; Dorfman L, 2005, HEALTH EDUC BEHAV, V32, P320, DOI 10.1177/1090198105275046; Fischer Frank., 2003, REFRAMING PUBLIC POL; Fooks GJ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001076; GERHARDS J, 1995, SOC SCI INFORM, V34, P225, DOI 10.1177/053901895034002003; Grier SA, 2010, ANNU REV PUBL HEALTH, V31, P349, DOI 10.1146/annurev.publhealth.012809.103607; Hancock L., 2012, REGULATORY FAILURE C; Hawkins B, 2014, POLICY POLIT, V42, P55, DOI 10.1332/030557312X655468; Hawkins B, 2012, CRIT PUBLIC HEALTH, V22, P297, DOI 10.1080/09581596.2012.658027; Hillman AJ, 2004, J MANAGE, V30, P837, DOI 10.1016/j.jm.2004.06.003; IGCD, 2012, ANN REP 2011 2012; Ihlen O, 2008, INT J STRATEGIC COMM, V2, P1; Jasanoff S, 1996, LAW CONTEMP PROBL, V59, P95, DOI 10.2307/1192125; Jernigan DH, 2012, AM J PUBLIC HEALTH, V102, P80, DOI 10.2105/AJPH.2011.300269; Lovato C, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003439.pub2; Manning M, 2013, TRENDS ISS CRIME CRI, P1; Martino F., 2017, SUBMISSIONS ALCOHOL; Massoudi A., 2016, FINANCIAL TIMES; Meier PS, 2011, ADDICTION, V106, P466, DOI 10.1111/j.1360-0443.2010.03160.x; Miles M.B., 2014, QUALITATIVE DATA ANA, V3rd ed.; Miller PG, 2011, ADDICTION, V106, P1560, DOI 10.1111/j.1360-0443.2011.03499.x; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; Munro G, 2004, ADDICTION, V99, P1370, DOI 10.1111/j.1360-0443.2004.00811.x; Murray James A. H., 1933, OXFORD ENGLISH DICT; National Preventative Health Taskforce, 2009, AUSTR HEALTH COUNTR; Ong EK, 2001, AM J PUBLIC HEALTH, V91, P1749, DOI 10.2105/AJPH.91.11.1749; Pollay RW, 2002, TOB CONTROL, V11, pI18, DOI 10.1136/tc.11.suppl_1.i18; Quentin W, 2007, INT J PUBLIC HEALTH, V52, P295, DOI 10.1007/s00038-007-5131-0; Reeve B, 2015, 1534 SYDN LAW SCH, p[15, 34]; Rein M, 1977, USING SOCIAL RES PUB, P235; Rein M., 1994, FRAME REFLECTION RES; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; Rosenstock L, 2002, AM J PUBLIC HEALTH, V92, P14, DOI 10.2105/AJPH.92.1.14; Ross CS, 2014, ALCOHOL CLIN EXP RES, V38, P2234, DOI 10.1111/acer.12488; Samet JM, 2001, AM J PUBLIC HEALTH, V91, P1742, DOI 10.2105/AJPH.91.11.1742; Savell E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087389; Smith LA, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-51; Ulucanlar S, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001629; Van Gorp B, 2007, J COMMUN, V57, P60, DOI 10.1111/j.1460-2466.2006.00329.x; van Hulst M, 2016, AM REV PUBLIC ADM, V46, P92, DOI 10.1177/0275074014533142; Weishaar H, 2016, BMC PUBLIC HEALTH, V16, P1; Yach D, 2001, AM J PUBLIC HEALTH, V91, P1745, DOI 10.2105/AJPH.91.11.1745	59	36	36	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2017	12	1							e0170366	10.1371/journal.pone.0170366	http://dx.doi.org/10.1371/journal.pone.0170366			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7CU	28118411	Green Published, gold			2022-12-26	WOS:000396160500038
J	Sasse, A; de Vries, SJ; Schindler, CEM; de Beauchene, IC; Zacharias, M				Sasse, Alexander; de Vries, Sjoerd J.; Schindler, Christina E. M.; de Beauchene, Isaure Chauvot; Zacharias, Martin			Rapid Design of Knowledge-Based Scoring Potentials for Enrichment of Near-Native Geometries in Protein-Protein Docking	PLOS ONE			English	Article							REFINEMENT; PREDICTION; DESOLVATION; INTERFACE; COMPLEXES; SERVER	Protein-protein docking protocols aim to predict the structures of protein-protein complexes based on the structure of individual partners. Docking protocols usually include several steps of sampling, clustering, refinement and re-scoring. The scoring step is one of the bottlenecks in the performance of many state-of-the-art protocols. The performance of scoring functions depends on the quality of the generated structures and its coupling to the sampling algorithm. A tool kit, GRADSCOPT (GRid Accelerated Directly SCoring OPTimizing), was designed to allow rapid development and optimization of different knowledge-based scoring potentials for specific objectives in protein-protein docking. Different atomistic and coarse-grained potentials can be created by a grid-accelerated directly scoring dependent MonteCarlo annealing or by a linear regression optimization. We demonstrate that the scoring functions generated by our approach are similar to or even outperform state-of-the-art scoring functions for predicting near-native solutions. Of additional importance, we find that potentials specifically trained to identify the native bound complex perform rather poorly on identifying acceptable or medium quality (near-native) solutions. In contrast, atomistic long-range contact potentials can increase the average fraction of near-native poses by up to a factor 2.5 in the best scored 1% decoys (compared to existing scoring), emphasizing the need of specific docking potentials for different steps in the docking protocol.	[Sasse, Alexander; de Vries, Sjoerd J.; Schindler, Christina E. M.; de Beauchene, Isaure Chauvot; Zacharias, Martin] Tech Univ Munich, Phys Dept T38, James Franck Str, Garching, Germany	Technical University of Munich	Zacharias, M (corresponding author), Tech Univ Munich, Phys Dept T38, James Franck Str, Garching, Germany.	zacharias@tum.de			Deutsche Forschungsgemeinschaft; Center of Integrated Protein Science (CIPSM)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center of Integrated Protein Science (CIPSM)	This study was supported by Deutsche Forschungsgemeinschaft, Center of Integrated Protein Science (CIPSM) to Dr. Martin Zacharias. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Bahadur RP, 2008, CELL MOL LIFE SCI, V65, P1059, DOI 10.1007/s00018-007-7451-x; Basu S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161879; Cheng TMK, 2007, PROTEINS, V68, P503, DOI 10.1002/prot.21419; Chuang GY, 2008, BIOPHYS J, V95, P4217, DOI 10.1529/biophysj.108.135814; de Vries S, 2013, PROTEINS, V81, P2167, DOI 10.1002/prot.24400; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eisenberg D, 2000, NATURE, V405, P823, DOI 10.1038/35015694; Fiorucci S, 2010, PROTEINS, V78, P3131, DOI 10.1002/prot.22808; Geppert T, 2010, J COMPUT CHEM, V31, P1919, DOI 10.1002/jcc.21479; Huang SY, 2008, PROTEINS, V72, P557, DOI 10.1002/prot.21949; Huang SY, 2015, DRUG DISCOV TODAY, V20, P969, DOI 10.1016/j.drudis.2015.03.007; Hwang H, 2010, PROTEINS, V78, P3111, DOI 10.1002/prot.22830; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Liu SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-280; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Marczyk M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-101; Mashiach E, 2010, PROTEINS, V78, P1503, DOI 10.1002/prot.22668; Moal IH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-286; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pierce B, 2008, PROTEINS, V72, P270, DOI 10.1002/prot.21920; Pierce B, 2007, PROTEINS, V67, P1078, DOI 10.1002/prot.21373; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Pons C, 2011, J CHEM INF MODEL, V51, P370, DOI 10.1021/ci100353e; RICHMOND TJ, 1984, J MOL BIOL, V178, P63, DOI 10.1016/0022-2836(84)90231-6; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Schindler CEM, 2015, STRUCTURE, V23, P1507, DOI 10.1016/j.str.2015.05.021; Schindler CEM, 2015, PROTEINS, V83, P248, DOI 10.1002/prot.24728; Setny P, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-228; Setny P, 2011, NUCLEIC ACIDS RES, V39, P9118, DOI 10.1093/nar/gkr636; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; Tobi D, 2006, PROTEINS, V62, P970, DOI 10.1002/prot.20859; Tobi D, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-40; Torchala M, 2013, BIOINFORMATICS, V29, P807, DOI 10.1093/bioinformatics/btt038; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; Vajda S, 2013, PROTEINS, V81, P1874, DOI 10.1002/prot.24343; Vallat BK, 2009, PROTEINS, V76, P930, DOI 10.1002/prot.22401; van Dijk ADJ, 2006, BIOINFORMATICS, V22, P2340, DOI 10.1093/bioinformatics/btl395; Vangone A, 2015, ELIFE, V4, DOI 10.7554/eLife.07454; Vreven T, 2015, J MOL BIOL, V427, P3031, DOI 10.1016/j.jmb.2015.07.016; Zacharias M, 2003, PROTEIN SCI, V12, P1271, DOI 10.1110/ps.0239303; Zacharias M, 2010, CURR OPIN STRUC BIOL, V20, P180, DOI 10.1016/j.sbi.2010.02.001; Zhang C, 1997, J MOL BIOL, V267, P707, DOI 10.1006/jmbi.1996.0859	43	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2017	12	1							e0170625	10.1371/journal.pone.0170625	http://dx.doi.org/10.1371/journal.pone.0170625			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7CU	28118389	Green Submitted, gold, Green Published			2022-12-26	WOS:000396160500021
J	Tudela, R; Munoz-Moreno, E; Lopez-Gil, X; Soria, G				Tudela, Raul; Munoz-Moreno, Emma; Lopez-Gil, Xavier; Soria, Guadalupe			Effects of Orientation and Anisometry of Magnetic Resonance Imaging Acquisitions on Diffusion Tensor Imaging and Structural Connectomes	PLOS ONE			English	Article							PRINCIPAL EIGENVECTOR MEASUREMENTS; WHITE-MATTER; FRACTIONAL ANISOTROPY; FIBER TRACTOGRAPHY; MEAN DIFFUSIVITY; DISTORTION CORRECTION; VOXEL SIZE; RAT-BRAIN; MRI; DTI	Diffusion-weighted imaging (DWI) quantifies water molecule diffusion within tissues and is becoming an increasingly used technique. However, it is very challenging as correct quantification depends on many different factors, ranging from acquisition parameters to a long pipeline of image processing. In this work, we investigated the influence of voxel geometry on diffusion analysis, comparing different acquisition orientations as well as isometric and anisometric voxels. Diffusion-weighted images of one rat brain were acquired with four different voxel geometries (one isometric and three anisometric in different directions) and three different encoding orientations (coronal, axial and sagittal). Diffusion tensor scalar measurements, tractography and the brain structural connectome were analyzed for each of the 12 acquisitions. The acquisition direction with respect to the main magnetic field orientation affected the diffusion results. When the acquisition slice-encoding direction was not aligned with the main magnetic field, there were more artifacts and a lower signal-to-noise ratio that led to less anisotropic tensors (lower fractional anisotropic values), producing poorer quality results. The use of anisometric voxels generated statistically significant differences in the values of diffusion metrics in specific regions. It also elicited differences in tract reconstruction and in different graph metric values describing the brain networks. Our results highlight the importance of taking into account the geometric aspects of acquisitions, especially when comparing diffusion data acquired using different geometries.	[Tudela, Raul; Soria, Guadalupe] CIBER BBN, Barcelona, Spain; [Munoz-Moreno, Emma; Lopez-Gil, Xavier; Soria, Guadalupe] IDIBAPS, Expt MRI Unit 7T, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Tudela, R (corresponding author), CIBER BBN, Barcelona, Spain.	raul.tudela@ub.edu	Soria, Guadalupe/GXH-4792-2022; Muñoz-Moreno, Emma/ABD-6424-2021; Soria, Guadalupe/AAG-4658-2021; Tudela, Raúl/K-8261-2017; Muñoz-Moreno, Emma/A-2363-2016	Muñoz-Moreno, Emma/0000-0003-2104-7265; Soria, Guadalupe/0000-0002-8344-0479; Tudela, Raúl/0000-0001-5134-4784; Muñoz-Moreno, Emma/0000-0003-2104-7265; Lopez-Gil, Xavier/0000-0002-7468-6717	ISCIII-Subdireccion General de Evaluacion and European Regional Development Fund (ERDF); Fundacio La Marato de TV3 [201441 10]; European Regional Development Fund; Instituto de Salud Carlos III;  [PI14/00595]	ISCIII-Subdireccion General de Evaluacion and European Regional Development Fund (ERDF); Fundacio La Marato de TV3; European Regional Development Fund(European Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); 	This work has been funded by the project PI14/00595, integrated in the Plan Nacional I+D+I and co-funded by ISCIII-Subdireccion General de Evaluacion and European Regional Development Fund (ERDF); and by the Fundacio La Marato de TV3 (201441 10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CIBER-BBN is an initiative financed by the Instituto de Salud Carlos III with assistance from the European Regional Development Fund.	Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Asanuma T, 2008, J MAGN RESON IMAGING, V28, P566, DOI 10.1002/jmri.21473; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Barrio-Arranz G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137905; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Bisdas S, 2008, AM J NEURORADIOL, V29, P1128, DOI 10.3174/ajnr.A1044; Bonilha L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135247; Chahboune H, 2009, NEUROIMAGE, V47, P459, DOI 10.1016/j.neuroimage.2009.04.060; Chan RW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144328; Chen B, 2006, NEUROIMAGE, V30, P121, DOI 10.1016/j.neuroimage.2005.09.008; Chen NK, 2003, NEUROIMAGE, V19, P817, DOI 10.1016/S1053-8119(03)00091-0; Clare S, 2006, MAGN RESON MED, V55, P210, DOI 10.1002/mrm.20735; Clark CA, 2000, MAGN RESON MED, V44, P852, DOI 10.1002/1522-2594(200012)44:6<852::AID-MRM5>3.0.CO;2-A; Coupe P, 2008, IEEE T MED IMAGING, V27, P425, DOI 10.1109/TMI.2007.906087; Daianu M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145205; Delouche A, 2016, EUR J RADIOL, V85, P25, DOI 10.1016/j.ejrad.2015.11.004; Eixarch E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031497; Farquharson S, 2013, J NEUROSURG, V118, P1367, DOI 10.3171/2013.2.JNS121294; Farrell JAD, 2007, J MAGN RESON IMAGING, V26, P756, DOI 10.1002/jmri.21053; Figini M, 2015, MAGN RESON IMAGING, V33, P296, DOI 10.1016/j.mri.2014.11.001; Garyfallidis E, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00008; Griffa A, 2013, NEUROIMAGE, V80, P515, DOI 10.1016/j.neuroimage.2013.04.056; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Holland D, 2010, NEUROIMAGE, V50, P175, DOI 10.1016/j.neuroimage.2009.11.044; Horsfield MA, 2002, NMR BIOMED, V15, P570, DOI 10.1002/nbm.787; Hui ES, 2010, NEUROIMAGE, V49, P2366, DOI 10.1016/j.neuroimage.2009.10.022; Irfanoglu MO, 2015, NEUROIMAGE, V106, P284, DOI 10.1016/j.neuroimage.2014.11.042; Irfanoglu MO, 2012, NEUROIMAGE, V61, P275, DOI 10.1016/j.neuroimage.2012.02.054; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jezzard P, 1999, HUM BRAIN MAPP, V8, P80, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<80::AID-HBM2>3.0.CO;2-C; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Jones DK, 2004, MAGN RESON MED, V52, P979, DOI 10.1002/mrm.20283; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Jones DK., 2011, DIFFUSION MRI THEORY; Jones DK., 2011, TOP MAGN RESON IMAG, V21, P87; Kennis M, 2016, NEUROIMAGE-CLIN, V11, P539, DOI 10.1016/j.nicl.2016.03.022; Kim DJ, 2006, MAGN RESON IMAGING, V24, P1369, DOI 10.1016/j.mri.2006.07.014; Kochan M, 2015, INT J COMPUT ASS RAD, V10, P1405, DOI 10.1007/s11548-015-1253-7; Kumar BSH, 2014, NEUROSCIENCE, V275, P12, DOI 10.1016/j.neuroscience.2014.05.037; Landman BA, 2007, NEUROIMAGE, V36, P1123, DOI 10.1016/j.neuroimage.2007.02.056; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Le Bihan D, 2006, J MAGN RESON IMAGING, V24, P478, DOI 10.1002/jmri.20683; Liu H, 2001, NEUROIMAGE, V56, P280; Lopez-Gil X, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00167; Lowekamp BC, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00045; Mangin JF, 2002, MED IMAGE ANAL, V6, P191, DOI 10.1016/S1361-8415(02)00079-8; Melhem ER, 2000, AM J NEURORADIOL, V21, P1813; Metzler-Baddeley C, 2012, NEUROIMAGE, V59, P1394, DOI 10.1016/j.neuroimage.2011.08.043; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Mori S., 2008, INTRO DIFFUSION TENS; Mukherjee P, 2008, AM J NEURORADIOL, V29, P843, DOI 10.3174/ajnr.A1052; Ni H, 2006, AM J NEURORADIOL, V27, P1776; Ojemann JG, 1997, NEUROIMAGE, V6, P156, DOI 10.1006/nimg.1997.0289; Oouchi H, 2007, AM J NEURORADIOL, V28, P1102, DOI 10.3174/ajnr.A0488; Papadakis NG, 2000, MAGN RESON IMAGING, V18, P671, DOI 10.1016/S0730-725X(00)00151-X; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Poonawalla AH, 2004, J MAGN RESON IMAGING, V19, P489, DOI 10.1002/jmri.20020; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Santarelli X, 2010, MAGN RESON IMAGING, V28, P70, DOI 10.1016/j.mri.2009.05.046; Schwarz AJ, 2006, NEUROIMAGE, V32, P538, DOI 10.1016/j.neuroimage.2006.04.214; Soares JM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00031; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Sporns O, 2013, NEUROIMAGE, V80, P53, DOI 10.1016/j.neuroimage.2013.03.023; Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x; Takao H, 2011, NEUROIMAGE, V57, P958, DOI 10.1016/j.neuroimage.2011.05.019; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Vos SB, 2011, P INT SOC MAG RESON, V19; Vos SB, 2012, NEUROIMAGE, V59, P2208, DOI 10.1016/j.neuroimage.2011.09.086; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Wang S, 2009, MILD HYPOXIC ISCHEMI, V30, P1907; Zalsman G, 2016, WORLD J BIOL PSYCHIA; Zhan L, WORKSH COMP DIFF MRI, P216; Zhao C, 2016, NEURORADIOLOGY, V58, P607, DOI 10.1007/s00234-016-1660-7	77	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2017	12	1							e0170703	10.1371/journal.pone.0170703	http://dx.doi.org/10.1371/journal.pone.0170703			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7CU	28118397	gold, Green Published, Green Submitted			2022-12-26	WOS:000396160500010
J	Quinto-Mosquera, H; Moreno, F				Quinto-Mosquera, Harley; Moreno, Flavio			Net Primary Productivity and Edaphic Fertility in Two Pluvial Tropical Forests in the Choco Biogeographical Region of Colombia	PLOS ONE			English	Article							LEAF-LITTER DECOMPOSITION; FINE-ROOT DYNAMICS; RAIN-FOREST; PHOSPHORUS LIMITATION; NUTRIENT LIMITATION; TREE GROWTH; NITROGEN; AVAILABILITY; TERRESTRIAL; PATTERNS	The net primary productivity (NPP) of tropical forests is a key process of the carbon cycle and therefore for the mitigation of global climate change. It has been proposed that NPP is limited by the availability of soil nutrients in lowland tropical forests and that belowground NPP decreases as edaphic fertility increases. This hypothesis was evaluated in two localities (Opogodo and Pacurita) of the Choco Biogeographical region, one of the rainiest of the world, where the aboveground (litter and wood) and belowground (fine and coarse roots) components of NPP were measured. Fertility parameters (pH, nutrients, and texture) were also determined and related to NPP. Total NPP was similar between locations (23.7 vs. 24.2 t ha(-1) year for Opogodo and Pacurita, respectively). However, components of NPP showed differences: in Pacurita, with steeper topography, NPP of wood and coarse roots were higher; therefore, differences of topography and drainage between localities probably affected the NPP of wood. On the other hand, soils of Opogodo, where NPP of fine roots was higher, showed higher contents of sand, N+, and organic matter (OM). With the increase of pH, OM, N+, K, Mg, and sand, the NPP of leaves and fine roots as well as the percentage of NPP belowground also increased, which suggests NPP limitation by multiple nutrients. The increase of NPP belowground with the availability of edaphic nutrients evidenced a redistribution of the aboveground and belowground components of NPP with the increase of soil fertility in oligotrophic systems, probably as a mechanism to improve the capture of resources.	[Quinto-Mosquera, Harley] Univ Tecnol Choco Diego Luis Cordoba, Fac Ciencias Basicas, Programa Biol, Quibdo, Colombia; [Moreno, Flavio] Univ Nacl Colombia Sede Medellin, Fac Ciencias Agr, Dept Ciencias Forestales, Medellin, Colombia	Universidad Nacional de Colombia	Moreno, F (corresponding author), Univ Nacl Colombia Sede Medellin, Fac Ciencias Agr, Dept Ciencias Forestales, Medellin, Colombia.	fhmoreno@unal.edu.co		Quinto Mosquera, Harley/0000-0001-5989-4334	Departamento Administrativo de Ciencia, Tecnologia e Innovacion of Colombia COLCIENCIAS; Universidad Tecnologica del Choco "Diego Luis Cordoba"; Universidad Nacional de Colombia sede Medellin [1128-569-35113]	Departamento Administrativo de Ciencia, Tecnologia e Innovacion of Colombia COLCIENCIAS; Universidad Tecnologica del Choco "Diego Luis Cordoba"; Universidad Nacional de Colombia sede Medellin	This study was financed by the Departamento Administrativo de Ciencia, Tecnologia e Innovacion of Colombia COLCIENCIAS (http.//www.colciencias.gov.co), the Universidad Tecnologica del Choco "Diego Luis Cordoba" (http://www.utch.edu.co/portal/es), and the Universidad Nacional de Colombia sede Medellin (http://medellin.unal.edu.co) through the grant number 1128-569-35113. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Alvarez-Clare S, 2013, ECOLOGY, V94, P1540, DOI 10.1890/12-2128.1; Alvarez-Clare S, 2011, BIOTROPICA, V43, P433, DOI 10.1111/j.1744-7429.2010.00732.x; ARAGAO L. E. O. C., 2009, BIOGEOSCIENCES, V6, P2441, DOI [DOI 10.5194/BGD-6-2441-2009, DOI 10.5194/BG-6-2759-2009]; Austin AT, 1998, OECOLOGIA, V113, P519, DOI 10.1007/s004420050405; Baker TR, 2004, GLOBAL CHANGE BIOL, V10, P545, DOI 10.1111/j.1365-2486.2004.00751.x; Brown S., 1997, 134 UN FAO FOR; Chambers JQ, 2001, FOREST ECOL MANAG, V152, P73, DOI 10.1016/S0378-1127(00)00591-0; CHAPIN FS, 1986, AM NAT, V127, P48, DOI 10.1086/284466; Chave J, 2010, BIOGEOSCIENCES, V7, P43, DOI 10.5194/bg-7-43-2010; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Clark DA, 2001, ECOL APPL, V11, P356, DOI 10.1890/1051-0761(2001)011[0356:MNPPIF]2.0.CO;2; Clark DA, 2001, ECOL APPL, V11, P371, DOI 10.1890/1051-0761(2001)011[0371:NPPITF]2.0.CO;2; Cleveland CC, 2011, ECOL LETT, V14, P939, DOI 10.1111/j.1461-0248.2011.01658.x; CUEVAS E, 1988, OECOLOGIA, V76, P222, DOI 10.1007/BF00379956; FABERLANGENDOEN D, 1991, BIOTROPICA, V23, P2, DOI 10.2307/2388682; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Gardi C., 2014, ATLAS SUELOS AM LATI; Gentry A. H., 1993, FIELD GUIDE FAMILIES; Haase R, 1999, FOREST ECOL MANAG, V117, P129, DOI 10.1016/S0378-1127(98)00477-0; Hendricks JJ, 2006, J ECOL, V94, P40, DOI 10.1111/j.1365-2745.2005.01067.x; Hoshmand A. R, 1998, STAT METHODS ENV AGR; Instituto Geografico Aguston Codazzi, 2002, MAP SUEL COL; Jimenez EM, 2014, J GEOPHYS RES-BIOGEO, V119, P1820, DOI 10.1002/2014JG002653; Kaspari M, 2008, ECOL LETT, V11, P35, DOI 10.1111/j.1461-0248.2007.01124.x; Kochsiek A, 2013, PLANT ECOL, V214, P869, DOI 10.1007/s11258-013-0215-9; Kozlowski T.T., 1997, GROWTH CONTROL WOODY, P352; KOZLOWSKI TT, 1984, BIOSCIENCE, V34, P162, DOI 10.2307/1309751; Kozlowski TT, 1997, TREE PHYSL MONOGR, V1, P1, DOI [DOI 10.1093/TREEPHYS/17.7.490, 10.1093/treephys/17.7.490]; Landsberg J. J., 1996, USE REMOTE SENSING M, P273; Malhi Y, 2011, PHILOS T R SOC B, V366, P3225, DOI 10.1098/rstb.2011.0062; Martinez JO., 1993, COLOMBIA PACIFICO, VI; McCracken, 1981, GENESIS CLASIFICACIO; Metcalfe DB, 2008, PLANT SOIL, V311, P189, DOI 10.1007/s11104-008-9670-9; Mirmanto E, 1999, PHILOS T ROY SOC B, V354, P1825, DOI 10.1098/rstb.1999.0524; Mosquera HQ, 2014, REV ARVORE, V38, P1123, DOI 10.1590/S0100-67622014000600017; Murillo W, 2005, REV CLIMATOLOGIA, V5, P1; Nebel G, 2001, FOREST ECOL MANAG, V150, P93, DOI 10.1016/S0378-1127(00)00683-6; Osorio N. W, 2014, MANEJO NUTR SUELOS T; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Paoli GD, 2007, ECOSYSTEMS, V10, P503, DOI 10.1007/s10021-007-9042-y; Paoli GD, 2005, ECOLOGY, V86, P1548, DOI 10.1890/04-1126; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; Posada JM, 2011, OECOLOGIA, V165, P783, DOI 10.1007/s00442-010-1881-0; Poveda I. C., 2004, COLOMBIA DIVERSIDAD, P1; Quinto Mosquera Harley, 2011, Rev. Fac. Nac. Agron. Medellín, V64, P5917; Robinson D, 1999, P ROY SOC B-BIOL SCI, V266, P431, DOI 10.1098/rspb.1999.0656; Ruiz-Murcia J., 2010, CAMBIO CLIMATICO TEM; Saugier B., 2001, TERRESTRIAL GLOBAL P, P543, DOI [10.1016/B978-0-12-505290-0.X5000-5, DOI 10.1016/B978-012505290-0/50024-7]; Schuur EAG, 2003, ECOLOGY, V84, P1165, DOI 10.1890/0012-9658(2003)084[1165:PAGCRT]2.0.CO;2; Sierra CA, 2007, GLOBAL CHANGE BIOL, V13, P838, DOI 10.1111/j.1365-2486.2007.01336.x; Silver WL, 1999, BIOGEOCHEMISTRY, V44, P301, DOI 10.1007/BF00996995; Sundarapandian SM, 1999, FOREST ECOL MANAG, V123, P231, DOI 10.1016/S0378-1127(99)00062-6; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; VITOUSEK PM, 1986, ANNU REV ECOL SYST, V17, P137, DOI 10.1146/annurev.es.17.110186.001033; VITOUSEK PM, 1984, ECOLOGY, V65, P285, DOI 10.2307/1939481; West R., 1957, TIERRAS BAJAS PACIFI; Wieder WR, 2009, ECOLOGY, V90, P3333, DOI 10.1890/08-2294.1; Wright SJ, 2011, ECOLOGY, V92, P1616, DOI 10.1890/10-1558.1; Zhao MS, 2010, SCIENCE, V329, P940, DOI 10.1126/science.1189590	60	8	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0168211	10.1371/journal.pone.0168211	http://dx.doi.org/10.1371/journal.pone.0168211			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114418	Green Published, gold, Green Submitted			2022-12-26	WOS:000396129000002
J	Fu, YF; Li, PH; Cao, YM; Wang, N; Sun, P; Shi, Q; Ji, XC; Bao, HF; Li, D; Chen, YL; Bai, XW; Ma, XQ; Zhang, J; Lu, ZJ; Liu, ZX				Fu, Yuanfang; Li, Pinghua; Cao, Yimei; Wang, Na; Sun, Pu; Shi, Qian; Ji, Xincheng; Bao, Huifang; Li, Dong; Chen, Yingli; Bai, Xingwen; Ma, Xueqing; Zhang, Jing; Lu, Zengjun; Liu, Zaixin			Development of a Blocking ELISA Using a Monoclonal Antibody to a Dominant Epitope in Non-Structural Protein 3A of Foot-and-Mouth Disease Virus, as a Matching Test for a Negative-Marker Vaccine	PLOS ONE			English	Article							IMMUNOSORBENT-ASSAY ELISA; ANIMALS; CATTLE; INFECTION; 3B; DIFFERENTIATION; IDENTIFICATION; PEPTIDE	Foot-and-mouth disease (FMD) is a devastating animal disease. Strategies for differentiation of infected from vaccinated animals (DIVA) remain very important for controlling disease. Development of an epitope-deleted marker vaccine and accompanying diagnostic method will improve the efficiency of DIVA. Here, a monoclonal antibody (Mab) was found to recognize a conserved "AEKNPLE" epitope spanning amino acids 109-115 of non-structural protein (NSP) 3A of foot-and-mouth disease virus (FMDV; O/Tibet/CHA/99 strain), which could be deleted by a reverse-genetic procedure. In addition, a blocking ELISA was developed based on this Mab against NSP 3A, which could serve as a matching test for a negative-marker vaccine. The criterion of this blocking ELISA was determined by detecting panels of sera from different origins. The serum samples with a percentage inhibition (PI) equal or greater than 50% were considered to be from infected animals, and those with < 50% PI were considered to be from non-infected animals. This test showed similar performance when compared with other 2 blocking ELISAs based on an anti-NSP 3B Mab. This is the first report of the DIVA test for an NSP antibody based on an Mab against the conserved and predominant "AEKNPLE" epitope in NSP 3A of FMDV.	[Fu, Yuanfang; Li, Pinghua; Cao, Yimei; Wang, Na; Sun, Pu; Bao, Huifang; Li, Dong; Chen, Yingli; Bai, Xingwen; Ma, Xueqing; Zhang, Jing; Lu, Zengjun; Liu, Zaixin] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol,Minist Agr, Natl Foot & Mouth Dis Reference Lab,Key Lab Anim, Lanzhou, Gansu, Peoples R China; [Shi, Qian; Ji, Xincheng] Xinjiang Entry Exit Inspect & Quarantine Bur, Urumqi, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Lu, ZJ; Liu, ZX (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol,Minist Agr, Natl Foot & Mouth Dis Reference Lab,Key Lab Anim, Lanzhou, Gansu, Peoples R China.	luzengjun@caas.cn; liuzaixin@caas.cn	Li, Ping/GYV-4914-2022		General Bureau of Quality Supervision, Inspection, and Quarantine of the People's Republic of China [201410061]; Agricultural Biotechnology Research and Application Development Project of Gansu Province [GNSW-2015-26]	General Bureau of Quality Supervision, Inspection, and Quarantine of the People's Republic of China; Agricultural Biotechnology Research and Application Development Project of Gansu Province	This study was supported by a research grant for public welfare from the General Bureau of Quality Supervision, Inspection, and Quarantine of the People's Republic of China (grant no. 201410061) and Agricultural Biotechnology Research and Application Development Project of Gansu Province (Grant no. GNSW-2015-26).	Biswal JK, 2015, BIOLOGICALS, V43, P504, DOI 10.1016/j.biologicals.2015.07.004; Brocchi E, 2006, VACCINE, V24, P6966, DOI 10.1016/j.vaccine.2006.04.050; Clavijo A, 2004, VET J, V167, P9, DOI 10.1016/S1090-0233(03)00087-X; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Earley EM, 1985, J TISSUE CULT METHOD, V9, P129; Fu YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111737; Fu YF, 2011, J VIROL METHODS, V171, P234, DOI 10.1016/j.jviromet.2010.11.006; Gao MC, 2012, APPL MICROBIOL BIOT, V93, P1271, DOI 10.1007/s00253-011-3815-0; HAMBLIN C, 1987, EPIDEMIOL INFECT, V99, P733, DOI 10.1017/S0950268800066590; HAMBLIN C, 1986, J IMMUNOL METHODS, V93, P115, DOI 10.1016/0022-1759(86)90441-2; Hohlich BJ, 2003, J VIROL, V77, P8633, DOI 10.1128/JVI.77.16.8633-8639.2003; Jiang F., 2012, J QUANTITATIVE TECHN, V2012, P3; Li PH, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-51; Lu ZJ, 2007, VET MICROBIOL, V125, P157, DOI 10.1016/j.vetmic.2007.05.017; Lu ZJ, 2010, J VIROL METHODS, V170, P128, DOI 10.1016/j.jviromet.2010.09.016; Mason PW, 2003, VIRUS RES, V91, P9, DOI 10.1016/S0168-1702(02)00257-5; OIE, 2022, OFF DIS STAT AFR HOR; Pacheco JM, 2003, J VIROL, V77, P13017, DOI 10.1128/JVI.77.24.13017-13027.2003; Paton DJ, 2006, VACCINE, V24, P6503, DOI 10.1016/j.vaccine.2006.06.032; Shen F, 1999, VACCINE, V17, P3039, DOI 10.1016/S0264-410X(99)00148-6; Uddowla S, 2012, J VIROL, V86, P11675, DOI 10.1128/JVI.01254-12; Yang M, 2007, J IMMUNOL METHODS, V321, P174, DOI 10.1016/j.jim.2007.01.016	22	10	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170560	10.1371/journal.pone.0170560	http://dx.doi.org/10.1371/journal.pone.0170560			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107470	Green Published, Green Submitted, gold			2022-12-26	WOS:000392405300164
J	Mandalakas, AM; Ngo, K; Ustero, PA; Golin, R; Anabwani, F; Mzileni, B; Sikhondze, W; Stevens, R				Mandalakas, Anna Maria; Ngo, Katherine; Ustero, Pilar Alonso; Golin, Rachel; Anabwani, Florence; Mzileni, Bulisile; Sikhondze, Welile; Stevens, Robert			BUTIMBA: Intensifying the Hunt for Child TB in Swaziland through Household Contact Tracing	PLOS ONE			English	Article							ISONIAZID PREVENTIVE THERAPY; TUBERCULOSIS INFECTION; PULMONARY TUBERCULOSIS; ACTIVE TUBERCULOSIS; INCOME COUNTRIES; HIV CARE; METAANALYSIS; CHALLENGES; COMMUNITY; DELIVERY	Background Limited data exists to inform contact tracing guidelines in children and HIV-affected populations. We evaluated the yield and additionality of household contact and source case investigations in Swaziland, a TB/HIV high-burden setting, while prioritizing identification of childhood TB. Methods In partnership with 7 local TB clinics, we implemented standardized contact tracing of index cases (IC) receiving TB treatment. Prioritizing child contacts and HIV-affected households, screening officers screened contacts for TB symptoms and to identify risk factors associated with TB. We ascertained factors moderating the yield of contact tracing and measured the impact of our program by additional notifications. Results From March 2013 to November 2015, 3,258 ICs (54% bacteriologically confirmed; 70% HIV-infected; 85% adults) were enrolled leading to evaluation of 12,175 contacts (median age 18 years, IQR 24 +/- 42; 45% children; 9% HIV-infected). Among contacts, 196 TB cases (56% bacteriologically confirmed) were diagnosed resulting in a program yield of 1.6% for all forms of TB. The number needed to screen (NNS) to identify a bacteriologically confirmed TB case or all forms TB case traced from a child IC < 5 years was respectively 62% and 40% greater than the NNS for tracing from an adult IC. In year one, we demonstrated a 32% increase in detection of bacteriologically confirmed child TB. Contacts were more likely to have TB if < 5 years (OR = 2.0), HIV-infected (OR = 4.9), reporting >= 1 TB symptoms (OR = 7.7), and sharing a bed (OR = 1.7) or home (OR = 1.4) with the IC. There was a 1.4 fold increased chance of detecting a TB case in households known to be HIV-affected. Conclusion Contact tracing prioritizing children is not only feasible in a TB/HIV high-burden setting but contributes to overall case detection. Our findings support WHO guidelines prioritizing contact tracing among children and HIV-infected populations while highlighting potential to integrate TB and HIV case finding.	[Mandalakas, Anna Maria; Ngo, Katherine; Ustero, Pilar Alonso; Golin, Rachel; Mzileni, Bulisile] Texas Childrens Hosp, Baylor Coll Med, Global TB Program, Sect Global & Immigrant Hlth,Dept Pediat, Houston, TX 77030 USA; [Anabwani, Florence; Mzileni, Bulisile] Baylor Coll Med Childrens Fdn Swaziland, Mbabane, Swaziland; [Sikhondze, Welile] Swaziland Natl TB Control Program, Mbabane, Swaziland; [Stevens, Robert] Mott McDonald, London, England	Baylor College of Medicine	Mandalakas, AM (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Global TB Program, Sect Global & Immigrant Hlth,Dept Pediat, Houston, TX 77030 USA.	anna.mandalakas@bcm.edu			TB REACH Initiative of the Stop TB Partnership (Global Affairs Canada); Baylor College of Medicine's Children's Foundation Swaziland	TB REACH Initiative of the Stop TB Partnership (Global Affairs Canada); Baylor College of Medicine's Children's Foundation Swaziland	This project was supported by the TB REACH Initiative of the Stop TB Partnership (through a grant from Global Affairs Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The primary grant recipient was the Baylor College of Medicine's Children's Foundation Swaziland (Program Director PAU). Mott MacDonald was contracted by the Stop TB Partnership to provide independent monitoring and evaluation of TB REACH projects. It contributed professional services and opinion independently of the funder (principally Global Affairs Canada), Stop TB Partnership and the grantee.	[Anonymous], 2011, GUID INT TUB CAS FIN; Ayles HM, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-63; Blok L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119822; Blok L, 2014, INT HEALTH, V6, P181, DOI 10.1093/inthealth/ihu055; Creswell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094465; Creswell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093858; Creswell J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-2; Elden S, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-118; ELLIOTT AM, 1993, AIDS, V7, P981, DOI 10.1097/00002030-199307000-00012; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; Hall C, 2015, TROP MED INT HEALTH, V20, P730, DOI 10.1111/tmi.12479; Haumba S, 2015, PUBLIC HEALTH ACTION, V5, P103, DOI 10.5588/pha.15.0008; Jaganath D, 2013, CLIN INFECT DIS, V57, P1685, DOI 10.1093/cid/cit645; Joint United Nations Programme on HIV/AIDS, 2014, FAST TRACK ENDING AI; Joshi B, 2015, PUBLIC HEALTH ACTION, V5, P93, DOI 10.5588/pha.15.0004; Kenyon TA, 2002, INT J TUBERC LUNG D, V6, P843; Kliner M, 2013, PUBLIC HEALTH ACTION, V3, P299, DOI 10.5588/pha.13.0070; Lala SG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137518; Loredo C, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-133; Lorent N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130179; Mandalakas AM, 2015, AM J RESP CRIT CARE, V191, P820, DOI 10.1164/rccm.201406-1165OC; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Organization WH, 2016, GLOBAL TUBERCULOSIS; Oxlade O, 2007, INT J TUBERC LUNG D, V11, P16; PEPFAR, 2014, PEPFAR 3 0 CONTR EP, DOI [10.1164/rccm.201406-1165OC, DOI 10.1164/RCCM.201406-1165OC]; Pothukuchi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022500; Prasad BM, 2016, PUBLIC HEALTH ACTION, V6, P15, DOI 10.5588/pha.15.0035; Puryear S, 2013, INT J TUBERC LUNG D, V17, P1049, DOI 10.5588/ijtld.12.0933; Russell GK, 2013, INT J TUBERC LUNG D, V17, P1518, DOI 10.5588/ijtld.13.0238; Saunders RP, 2005, HEALTH PROMOT PRACT, V6, P134, DOI 10.1177/1524839904273387; Skinner D, 2013, PUBLIC HEALTH ACTION, V3, P191, DOI 10.5588/pha.13.0010; Skinner D, 2013, INT J TUBERC LUNG D, V17, P175, DOI 10.5588/ijtld.12.0230; Turashvili M, 2014, DECENTRALISATION HIV, DOI [10.1186/1471-2334-14-2, DOI 10.1186/1471-2334-14-2]; (UNAIDS) JUNPoHA, 2014, 90 90 90 AMB TREATM; Van Wyk SS, 2010, INT J TUBERC LUNG D, V14, P650; World Health Organization, 2012, REC INV CONT PERS IN; Yassin MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063174	38	15	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0169769	10.1371/journal.pone.0169769	http://dx.doi.org/10.1371/journal.pone.0169769			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107473	Green Published, gold			2022-12-26	WOS:000392405300042
J	Robertson, AH; Lariviere, C; Leduc, CR; McGillis, Z; Eger, T; Godwin, A; Lariviere, M; Dorman, SC				Robertson, A. H.; Lariviere, C.; Leduc, C. R.; McGillis, Z.; Eger, T.; Godwin, A.; Lariviere, M.; Dorman, S. C.			Novel Tools in Determining the Physiological Demands and Nutritional Practices of Ontario FireRangers during Fire Deployments	PLOS ONE			English	Article							TOTAL-ENERGY EXPENDITURE; CARBOHYDRATE INGESTION; PHYSICAL-ACTIVITY; FOOD-INTAKE; SLEEP; RECOVERY; EXERCISE; TIME; IDENTIFICATION; PHOTOGRAPHY	Introduction The seasonal profession of wildland fire fighting in Canada requires individuals to work in harsh environmental conditions that are physically demanding. The purpose of this study was to use novel technologies to evaluate the physiological demands and nutritional practices of Canadian FireRangers during fire deployments. Methods Participants (n = 21) from a northern Ontario Fire Base volunteered for this study and data collection occurred during the 2014 fire season and included Initial Attack (IA), Project Fire (P), and Fire Base (B) deployments. Deployment-specific energy demands and physiological responses were measured using heart-rate variability (HRV) monitoring devices (Zephyr BioHarness3 units). Food consumption behaviour and nutrient quantity and quality were captured using audio-video food logs on iPod Touches and analyzed by NutriBase Pro 11 software. Results Insufficient kilocalories were consumed relative to expenditure for all deployment types. Average daily kilocalories consumed: IA: 3758 (80% consumption rate); P: 2945 +/- 888.8; B: 2433 +/- 570.8. Average daily kilocalorie expenditure: IA: 4538 +/- 106.3; P: 4012 +/- 1164.8; B: 2842 +/- 649.9. The Average Macronutrient Distribution Range (AMDR) for protein was acceptable: 22-25% (across deployment types). Whereas the AMDR for fat and carbohydrates were high: 40-50%; and low: 27-37% respectively, across deployment types. Conclusions This study is the first to use the described methodology to simultaneously evaluate energy expenditures and nutritional practices in an occupational setting. The results support the use of HRV monitoring and video-food capture, in occupational field settings, to assess demands. FireRangers expended the most energy during IA, and the least during B deployments. These results indicate the need to develop strategies centered on maintaining physical fitness and improving food practices.	[Robertson, A. H.; Lariviere, C.; Leduc, C. R.; McGillis, Z.; Eger, T.; Godwin, A.; Lariviere, M.; Dorman, S. C.] Laurentian Univ, CROSH, Sudbury, ON, Canada; [Robertson, A. H.; Lariviere, C.; Leduc, C. R.; McGillis, Z.; Eger, T.; Godwin, A.; Lariviere, M.; Dorman, S. C.] Laurentian Univ, Sch Human Kinet, Sudbury, ON, Canada	Laurentian University; Laurentian University	Robertson, AH (corresponding author), Laurentian Univ, CROSH, Sudbury, ON, Canada.; Robertson, AH (corresponding author), Laurentian Univ, Sch Human Kinet, Sudbury, ON, Canada.	Arobertson2@laurentian.ca	Leduc, Caleb/AAS-7163-2020	Leduc, Caleb/0000-0003-1140-0184	Ministry of Labour - Bridging the Gap [12104]; Ministry of Labour and their Bridging the Gap program [12104]	Ministry of Labour - Bridging the Gap; Ministry of Labour and their Bridging the Gap program	This work was supported by Ministry of Labour - Bridging the Gap (12104). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research team would like to thank the Ministry of Natural Resources and Forestry, Bill Cole, Ted Shannon, and all of the participating FireRangers for all of their efforts and ongoing support with this research. The research team would also like to thank the Ministry of Labour and their Bridging the Gap program (Grant # 12104) that has supported this research.	Achten J, 2003, SPORTS MED, V33, P517, DOI 10.2165/00007256-200333070-00004; ActiGraph, 2015, ACTISLEEP MON; AFFES, 2015, FOR FIR AV FOR FIR E; Ainslie PN, 2003, SPORTS MED, V33, P683, DOI 10.2165/00007256-200333090-00004; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; [Anonymous], 2000, MED SCI SPORT EXER, V32, P2130; [Anonymous], 2014, STRESS REC AN METH B; Barregard L, 2008, OCCUP ENVIRON MED, V65, P319, DOI 10.1136/oem.2006.032458; BELOW PR, 1995, MED SCI SPORT EXER, V27, P200; Berardi JM, 2006, MED SCI SPORT EXER, V38, P1106, DOI 10.1249/01.mss.0000222826.49358.f3; Bird SP, 2006, NUTRITION, V22, P367, DOI 10.1016/j.nut.2005.11.005; Carter JM, 2004, MED SCI SPORT EXER, V36, P2107, DOI 10.1249/01.MSS.0000147585.65709.6F; CCOHS, 2012, FATIGUE; Charkoudian N, 2009, MAYO CLIN PROC, V84, P822, DOI 10.1016/S0025-6196(11)60492-8; Cuddy JS, 2007, MED SCI SPORT EXER, V39, P1004, DOI 10.1249/mss.0b013e318040b2fb; Dhurandhar N. V., 2014, INT J OBESITY; Dorman S. C., 2013, ICAN: Infant, Child & Adolescent Nutrition, V5, P78, DOI 10.1177/1941406413476547; Ebine N, 2002, J SPORT SCI, V20, P391, DOI 10.1080/026404102317366645; Firstbeat Technologies Ltd, 2005, AN ENERGY EXPENDITUR; Firstbeat Technologies Ltd, 2005, EPOC BAS TRAIN EFF A; Friedl KE, 1997, ANNU REV NUTR, V17, P51, DOI 10.1146/annurev.nutr.17.1.51; Gauthier AP, 2013, J NUTR EDUC BEHAV, V45, P708, DOI 10.1016/j.jneb.2013.05.005; GERSOVITZ M, 1978, J AM DIET ASSOC, V73, P48; Geurts SAE, 2006, SCAND J WORK ENV HEA, V32, P482, DOI 10.5271/sjweh.1053; Health Canada, 2014, EST EN REQ CAN FOOD; Health Canada, 2006, DIET REF INT TABL NU; Health Canada, 2011, EAT WELL CAN FOOD GU; Heil DP, 2002, APPL ERGON, V33, P405, DOI 10.1016/S0003-6870(02)00042-X; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hoyt RW, 2006, CURR OPIN CLIN NUTR, V9, P685, DOI 10.1097/01.mco.0000247472.72155.7c; Illner AK, 2012, INT J EPIDEMIOL, V41, P1187, DOI 10.1093/ije/dys105; Institute of Medicine, 2005, DIET REF INT EN CARB; Iron Disorders Institute, 2009, IR OUT BAL MEN; Jeukendrup AE, 2004, NUTRITION, V20, P669, DOI 10.1016/j.nut.2004.04.017; Lukaski HC, 2004, NUTRITION, V20, P632, DOI 10.1016/j.nut.2004.04.001; Martin CK, 2014, J HUM NUTR DIET, V27, P72, DOI 10.1111/jhn.12014; Martin CK, 2009, BRIT J NUTR, V101, P446, DOI 10.1017/S0007114508027438; Montain SJ, 2008, MED SCI SPORT EXER, V40, P1970, DOI 10.1249/MSS.0b013e31817f4d58; Montgomery PG, 2009, J STRENGTH COND RES, V23, P1489, DOI 10.1519/JSC.0b013e3181a39277; National Strength and Conditioning Association, 2011, NSCAS GUID SPORT EX; Nehlsen-Cannarella SL, 1985, J APPL PHYSIOL, V82, P1662; Nieman DC, 2004, J APPL PHYSIOL, V96, P1292, DOI 10.1152/japplphysiol.01064.2003; Nindl BC, 1997, INT J SPORTS MED, V18, P317, DOI 10.1055/s-2007-972640; Palmer C, 2005, 8 INT WILDLAND FIREF; Phillips M, 2012, APPL ERGON, V43, P435, DOI 10.1016/j.apergo.2011.06.018; Volp ACP, 2011, NUTR HOSP, V26, P430, DOI [10.3305/nh.2011.26.3.5181, 10.1590/S0212-16112011000300002]; Rahman I, 2006, EUR J PHARMACOL, V533, P222, DOI 10.1016/j.ejphar.2005.12.087; REILLY T, 1979, ERGONOMICS, V22, P541, DOI 10.1080/00140137908924638; Robertson AH., 2015, INT J HUMAN MOV SPOR, V3, P19, DOI [10.13189/saj.2015.030203, DOI 10.13189/SAJ.2015.030203]; Rodriguez-Marroyo JA, 2011, ERGONOMICS, V54, P1101, DOI 10.1080/00140139.2011.611895; Ruby BC, 2002, MED SCI SPORT EXER, V34, P1048, DOI 10.1097/00005768-200206000-00023; Sadeh A, 2002, SLEEP MED REV, V6, P113, DOI 10.1053/smrv.2001.0182; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; Saunders MJ, 2004, MED SCI SPORT EXER, V36, P1233, DOI 10.1249/01.MSS.0000132377.66177.9F; SCHOELLER DA, 1995, METABOLISM, V44, P18, DOI 10.1016/0026-0495(95)90204-X; SCHOELLER DA, 1990, NUTR REV, V48, P373, DOI 10.1111/j.1753-4887.1990.tb02882.x; Statistics Canada, 2004, OV CAN EAT HAB NUTR; Swaen GMH, 2003, OCCUP ENVIRON MED, V60, P88; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Tharion WJ, 2005, APPETITE, V44, P47, DOI 10.1016/j.appet.2003.11.010; Vina J, 2000, IUBMB LIFE, V50, P271, DOI 10.1080/15216540051080994; Vincent G, 2015, ERGONOMICS, V14, P1; Vincent G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115329; Vincent GE, 2016, ERGONOMICS, V59, P932, DOI 10.1080/00140139.2015.1105389; Vogt S, 2005, INT J SPORTS MED, V26, P701, DOI 10.1055/s-2004-830438; Williamson DA, 2003, J AM DIET ASSOC, V103, P1139, DOI 10.1016/S0002-8223(03)00974-X; Yang YJ, 2010, NUTR RES PRACT, V4, P142, DOI 10.4162/nrp.2010.4.2.142; Zephyr, 2015, BIOHARNESS3	69	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0169390	10.1371/journal.pone.0169390	http://dx.doi.org/10.1371/journal.pone.0169390			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI3QC	28107380	Green Published, gold, Green Submitted			2022-12-26	WOS:000392405300025
J	Spiller, CM; Wilhelm, D; Jans, DA; Bowles, J; Koopman, P				Spiller, Cassy M.; Wilhelm, Dagmar; Jans, David A.; Bowles, Josephine; Koopman, Peter			Mice Lacking Hbp1 Function Are Viable and Fertile	PLOS ONE			English	Article							BOX TRANSCRIPTIONAL REPRESSOR; PRIMORDIAL GERM-CELLS; IN-VIVO; PROLIFERATION; GENE; MIGRATION; ARREST; DIFFERENTIATION; DEREGULATION; DEFICIENCY	Fetal germ cell development is tightly regulated by the somatic cell environment, and is characterised by cell cycle states that differ between XY and XX gonads. In the testis, gonocytes enter G1/G0 arrest from 12.5 days post coitum (dpc) in mice and maintain cell cycle arrest until after birth. Failure to correctly maintain G1/G0 arrest can result in loss of germ cells or, conversely, germ cell tumours. High mobility group box containing transcription factor 1 (HBP1) is a transcription factor that was previously identified in fetal male germ cells at the time of embryonic cell cycle arrest. In somatic cells, HBP1 is classified as a tumour suppressor protein, known to regulate proliferation and senescence. We therefore investigated the possible role of HBP1 in the initiation and maintenance of fetal germ cell G1/G0 arrest using the mouse model. We identified two splice variants of Hbp1, both of which are expressed in XY and XX fetal gonads, but only one of which is localised to the nucleus in in vitro assays. To investigate Hbp1 loss of function, we used embryonic stem (ES) cells carrying a Genetrap mutation for Hbp1 to generate mice lacking Hbp1 function. We found that Hbp1-genetrap mouse mutant germ cells proliferated correctly throughout development, and adult males were viable and fertile. Multiple Hbp1-LacZ reporter mouse lines were generated, unexpectedly revealing Hbp1 embryonic expression in hair follicles, eye and limbs. Lastly, in a model of defective germ cell G1/G0 arrest, the Rb1-knockout model, we found no evidence for Hbp1 mis-regulation, suggesting that the reported RB1-HBP1 interaction is not critical in the germline, despite co-expression.	[Spiller, Cassy M.; Wilhelm, Dagmar; Koopman, Peter] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Jans, David A.] Monash Univ, Sch Biomed Sci, Clayton, Vic, Australia; [Spiller, Cassy M.; Bowles, Josephine] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Wilhelm, Dagmar] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic, Australia	University of Queensland; Monash University; University of Queensland; University of Melbourne	Spiller, CM (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	c.spiller@uq.edu.au	Bowles, Josephine/AAG-4903-2020; Wilhelm, Dagmar/B-6915-2009; Koopman, Peter A/C-9416-2009; Spiller, Cassy/C-2779-2013	Bowles, Josephine/0000-0003-2867-7438; Wilhelm, Dagmar/0000-0002-7757-4075; Koopman, Peter A/0000-0001-6939-0914; Jans, David/0000-0001-5115-4745; Spiller, Cassy/0000-0002-1343-8269	Australian Research Council Centre of Excellence in Biotechnology and Development [CE0348239]; National Health and Medical Research Council of Australia [APP1109405]	Australian Research Council Centre of Excellence in Biotechnology and Development(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Support was provided by the Australian Research Council Centre of Excellence in Biotechnology and Development (CE0348239) and the National Health and Medical Research Council of Australia Project Grant (APP1109405).	Almstrup K, 2007, INT J ANDROL, V30, P292, DOI 10.1111/j.1365-2605.2007.00758.x; Bartkova J, 2003, APMIS, V111, P252, DOI 10.1034/j.1600-0463.2003.1110129.x; Bartkova J, 2003, J PATHOL, V200, P149, DOI 10.1002/path.1353; Beverdam A, 2003, CYTOGENET GENOME RES, V101, P242, DOI 10.1159/000074344; Bewley CA, 1998, ANNU REV BIOPH BIOM, V27, P105, DOI 10.1146/annurev.biophys.27.1.105; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Bowles J, 2010, DEV CELL, V19, P440, DOI 10.1016/j.devcel.2010.08.010; Brennan Jane, 2008, V461, P133, DOI 10.1007/978-1-60327-483-8_9; BUEHR M, 1993, DEV DYNAM, V198, P182, DOI 10.1002/aja.1001980304; Dong Z, 2016, CELL DEATH DIFFER; Forwood JK, 2001, J BIOL CHEM, V276, P46575, DOI 10.1074/jbc.M101668200; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hargrave Murray, 2006, Methods Mol Biol, V326, P103; HILSCHER W, 1974, Verhandlungen der Anatomischen Gesellschaft, V68, P39; Hoei-Hansen CE, 2005, HISTOPATHOLOGY, V47, P48, DOI 10.1111/j.1365-2559.2005.02182.x; Hogan B, 1994, MANIPULATING MOUSE E; Jorgensen A, 2013, J PATHOL, V229, P588, DOI 10.1002/path.4154; Kimura T, 2003, DEVELOPMENT, V130, P1691, DOI 10.1242/dev.00392; KOTHARY R, 1989, DEVELOPMENT, V105, P707; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lavender P, 1997, ONCOGENE, V14, P2721, DOI 10.1038/sj.onc.1201243; Lin YF, 2005, DEV BIOL, V288, P309, DOI 10.1016/j.ydbio.2005.06.032; Martineau J, 1997, CURR BIOL, V7, P958, DOI 10.1016/S0960-9822(06)00415-5; McLaren A, 1984, Symp Soc Exp Biol, V38, P7; NOGUCHI T, 1985, JNCI-J NATL CANCER I, V75, P385; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; Schilham MW, 1998, J IMMUNOL, V161, P3984; Shih HH, 1998, MOL CELL BIOL, V18, P4732, DOI 10.1128/MCB.18.8.4732; Shih HH, 2001, MOL CELL BIOL, V21, P5723, DOI 10.1128/MCB.21.17.5723-5732.2001; Smith JM, 2004, DEV DYNAM, V230, P366, DOI 10.1002/dvdy.20053; Spiller CM, 2010, BIOL REPROD, V82, P433, DOI 10.1095/biolreprod.109.078691; TAM PPL, 1981, J EMBRYOL EXP MORPH, V64, P133; Tevosian SG, 1997, GENE DEV, V11, P383, DOI 10.1101/gad.11.3.383; Tonks ID, 2005, PIGM CELL RES, V18, P252, DOI 10.1111/j.1600-0749.2005.00245.x; Western PS, 2008, STEM CELLS, V26, P339, DOI 10.1634/stemcells.2007-0622; Wilhelm D, 2005, DEV BIOL, V287, P111, DOI 10.1016/j.ydbio.2005.08.039; Yee AS, 2004, GENE, V336, P1, DOI 10.1016/j.gene.2004.04.004	38	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170576	10.1371/journal.pone.0170576	http://dx.doi.org/10.1371/journal.pone.0170576			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107452	Green Published, gold			2022-12-26	WOS:000392405300168
J	Liu-Chittenden, Y; Jain, M; Gaskins, K; Wang, S; Merino, MJ; Kotian, S; Gara, SK; Davis, S; Zhang, L; Kebebew, E				Liu-Chittenden, Y.; Jain, M.; Gaskins, K.; Wang, S.; Merino, M. J.; Kotian, S.; Gara, S. Kumar; Davis, S.; Zhang, L.; Kebebew, E.			RARRES2 functions as a tumor suppressor by promoting beta-catenin phosphorylation/degradation and inhibiting p38 phosphorylation in adrenocortical carcinoma	ONCOGENE			English	Article							DENDRITIC CELLS; CANCER-THERAPY; HUMAN BLOOD; CHEMERIN; EXPRESSION; ACTIVATION; PATHWAY; CLASSIFICATION; INFLAMMATION; METABOLISM	Tumor suppressor genes and the immune system are critical players in inhibiting cancer initiation and/or progression. However, little is known about whether a tumor suppressor gene can function through both immune-dependent and - independent mechanisms. Retinoic acid receptor responder 2 (RARRES2) is transcriptionally downregulated in multiple cancer types. Previous studies suggested that it can serve as an immune-dependent tumor suppressor by acting as a chemoattractant to recruit anticancer immune cells expressing its receptor, the chemerin chemokine receptor 1 (CMKLR1), to sites of tumor. In this study, we investigated the role of RARRES2 in adrenocortical carcinoma (ACC), a rare lethal malignancy in which aberrant Wnt/beta-catenin signaling is frequently detected. We show that RARRES2 expression is downregulated in ACC as compared with normal and benign adrenocortical tissues, which is a result of CpG hypermethylation. Despite minimal CMKLR1 expression and lack of phenotypic tumor-suppressive effect with exogenous RARRES2 treatment, RARRES2 overexpression in ACC cell lines not only reduced cell proliferation, cell invasion and tumorigenicity in vitro, but also inhibited tumor growth in vivo in two immunodeficient mouse xenograft models. Mechanistically, RARRES2 overexpression in ACC cells inhibited Wnt/beta-catenin pathway activity by promoting beta-catenin phosphorylation and degradation, it also inhibited the phosphorylation of p38 mitogen-activated protein kinase. Thus our study identifies RARRES2 as a novel tumor suppressor for ACC, which can function through an immune-independent mechanism.	[Liu-Chittenden, Y.; Jain, M.; Gaskins, K.; Wang, S.; Kotian, S.; Gara, S. Kumar; Zhang, L.; Kebebew, E.] NCI, NIH, Endocrine Oncol Branch, 10 Ctr Dr,Room 4-5952, Bethesda, MD 20892 USA; [Merino, M. J.] NCI, NIH, Pathol Lab, Bethesda, MD 20892 USA; [Davis, S.] NIH, Ctr Canc Res, Canc Genet Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kebebew, E (corresponding author), NCI, NIH, Endocrine Oncol Branch, 10 Ctr Dr,Room 4-5952, Bethesda, MD 20892 USA.	kebebewe@mail.nih.gov	Gara, Sudheer Kumar/E-8084-2016; Davis, Sean/AAD-1801-2021; Kotian, Shweta/GMX-3418-2022	Davis, Sean/0000-0002-8991-6458; Liu, Yi/0000-0001-6357-5360	intramural research program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health [1ZIABC01127506]; NATIONAL CANCER INSTITUTE [ZIABC011275] Funding Source: NIH RePORTER	intramural research program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the intramural research program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health (1ZIABC01127506). Supported by the intramural research program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health (1ZIABC01127506).	Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Bilimoria KY, 2008, CANCER, V113, P3130, DOI 10.1002/cncr.23886; Bondue B, 2011, CYTOKINE GROWTH F R, V22, P331, DOI 10.1016/j.cytogfr.2011.11.004; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Chiacchiera F, 2012, CANCER LETT, V324, P98, DOI 10.1016/j.canlet.2012.05.006; de Reynies A, 2009, J CLIN ONCOL, V27, P1108, DOI 10.1200/JCO.2008.18.5678; Ernst MC, 2010, TRENDS ENDOCRIN MET, V21, P660, DOI 10.1016/j.tem.2010.08.001; Fassnacht M, 2013, J CLIN ENDOCR METAB, V98, P4551, DOI 10.1210/jc.2013-3020; Fassnacht M, 2009, BEST PRACT RES CL EN, V23, P273, DOI 10.1016/j.beem.2008.10.008; Fernandez-Ranvier GG, 2008, ARCH SURG-CHICAGO, V143, P841, DOI 10.1001/archsurg.143.9.841; Finn OJ, 2012, ANN ONCOL, V23, P6, DOI 10.1093/annonc/mds256; Gaujoux S, 2011, CLIN CANCER RES, V17, P328, DOI 10.1158/1078-0432.CCR-10-2006; Giordano TJ, 2009, CLIN CANCER RES, V15, P668, DOI 10.1158/1078-0432.CCR-08-1067; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Grossi V, 2014, WORLD J GASTROENTERO, V20, P9744, DOI 10.3748/wjg.v20.i29.9744; Igea A, 2015, CANCER RES, V75, P3997, DOI 10.1158/0008-5472.CAN-15-0173; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Kerkhofs TMA, 2013, EUR J CANCER, V49, P2579, DOI 10.1016/j.ejca.2013.02.034; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Lin W, 2011, CLIN LAB, V57, P879; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Pachynski RK, 2012, J EXP MED, V209, P1427, DOI 10.1084/jem.20112124; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Rechache NS, 2012, J CLIN ENDOCR METAB, V97, pE1004, DOI 10.1210/jc.2011-3298; Salomon A, 2015, ONCOTARGET, V6, P11421, DOI 10.18632/oncotarget.3222; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Tissier F, 2005, CANCER RES, V65, P7622, DOI 10.1158/0008-5472.CAN-05-0593; Velazquez-Fernandez D, 2005, SURGERY, V138, P1087, DOI 10.1016/j.surg.2005.09.031; Vermi W, 2005, J EXP MED, V201, P509, DOI 10.1084/jem.20041310; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wittamer V, 2005, J IMMUNOL, V175, P487, DOI 10.4049/jimmunol.175.1.487; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Zabel BA, 2005, J IMMUNOL, V174, P244, DOI 10.4049/jimmunol.174.1.244; Zabel BA, 2008, J EXP MED, V205, P2207, DOI 10.1084/jem.20080300; Zheng Y, 2008, EUR J DERMATOL, V18, P638, DOI 10.1684/ejd.2008.0511	38	30	30	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 22	2017	36	25					3541	3552		10.1038/onc.2016.497	http://dx.doi.org/10.1038/onc.2016.497			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY3NL	28114280	Green Accepted			2022-12-26	WOS:000403878600004
J	Cheng, XY; Yamauchi, J; Lee, S; Zhang, T; Gong, ZW; Muzumdar, R; Qu, S; Dong, HH				Cheng, Xiaoyun; Yamauchi, Jun; Lee, Sojin; Zhang, Ting; Gong, Zhenwei; Muzumdar, Radhika; Qu, Shen; Dong, H. Henry			APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apolipoprotein; lipid metabolism; liver; obesity; triglyceride; Apolipoprotein C3; Hypertriglyceridemia; Nonalcoholic fatty liver disease; Steatosis; Triglyceride metabolism	APOLIPOPROTEIN-C-III; LOW-DENSITY LIPOPROTEINS; TRIGLYCERIDE-RICH LIPOPROTEINS; INSULIN-RESISTANCE; TRANSGENIC MICE; LIPASE ACTIVITY; LIPID PROFILE; PNPLA3 I148M; GENE; PLASMA	Nonalcoholic fatty liver disease (NAFLD), characterized by excessive fat accumulation in liver, is prevalent in obesity. Genetic factors that link obesity to NAFLD remain obscure. Apolipoprotein C3 (APOC3) is a lipid-binding protein with a pivotal role in triglyceride metabolism. Humans with APOC3 gain-of-function mutations and mice with APOC3 overproduction are associated with hypertriglyceridemia. Nonetheless, it remains controversial whether APOC3 is culpable for diet-induced NAFLD. To address this fundamental issue, we fed APOC3-transgenic and wild-type littermates a high fructose diet or high fat diet, followed by determination of the effect of APOC3 on hepatic lipid metabolism and inflammation and the progression of NAFLD. To gain mechanistic insight into NAFLD, we determined the impact of APOC3 on hepatic triglyceride synthesis and secretion versus fatty acid oxidation. APOC3-transgenic mice were hypertriglyceridemic, culminating in marked elevation of triglycerides, cholesterols, and non-esterified fatty acids in plasma. Despite the prevailing hypertriglyceridemia, APOC3-transgenic mice, relative to wild-type littermates, had similar weight gain and hepatic lipid content without alterations in hepatic expression of key genes involved in triglyceride synthesis and secretion and fatty acid oxidation. APOC3-transgenic and wild-type mice had similar Kupffer cell content without alterations in hepatic expression of pro- and anti-inflammatory cytokines. APOC3 neither exacerbated diet-induced adiposity nor aggravated the degree of steatosis in high fructose or high fat-fed APOC3-transgenic mice. These effects ensued independently of weight gain even after 10-month high fat feeding. We concluded that APOC3, whose dysregulation is liable for hypertriglyceridemia, is not a predisposing factor for linking overnutrition to NAFLD in obesity.	[Cheng, Xiaoyun; Qu, Shen] Tongji Univ, Sch Med, Dept Endocrinol & Metab, Shanghai Peoples Hosp 10, Shanghai 200072, Peoples R China; [Cheng, Xiaoyun; Yamauchi, Jun; Lee, Sojin; Zhang, Ting; Gong, Zhenwei; Muzumdar, Radhika; Dong, H. Henry] Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh UPMC, Dept Pediat,Div Endocrinol & Diabet, Pittsburgh, PA 15224 USA	Tongji University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Qu, S (corresponding author), Tongji Univ, Sch Med, Dept Endocrinol & Metab, Shanghai Peoples Hosp 10, Shanghai 200072, Peoples R China.; Dong, HH (corresponding author), Childrens Hosp Pittsburgh UPMC, Rangos Res Ctr, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	qushencn@hotmail.com; dongh@pitt.edu	Cheng, Xiaoyun/HDM-5535-2022	Dong, H. Henry/0000-0003-0279-5241	National Institutes of Health [R01 DK098437]; Fundamental Research Funds for the Central Universities and National Science Foundation, China [81570782]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundamental Research Funds for the Central Universities and National Science Foundation, China; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health Grant R01 DK098437. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by the Fundamental Research Funds for the Central Universities and National Science Foundation Grant 81570782, China.	AALTOSETALA K, 1992, J CLIN INVEST, V90, P1889, DOI 10.1172/JCI116066; Altomonte J, 2004, J CLIN INVEST, V114, P1493, DOI 10.1172/JCI200419992; Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; Brunt EM, 2010, NAT REV GASTRO HEPAT, V7, P195, DOI 10.1038/nrgastro.2010.21; Burgert TS, 2006, J CLIN ENDOCR METAB, V91, P4287, DOI 10.1210/jc.2006-1010; Chan DC, 2006, ARTERIOSCL THROM VAS, V26, P590, DOI 10.1161/01.ATV.0000203519.25116.54; CHEN M, 1994, J LIPID RES, V35, P1918; Cohn JS, 2004, J CLIN ENDOCR METAB, V89, P3949, DOI 10.1210/jc.2003-032056; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Duivenvoorden I, 2005, DIABETES, V54, P664, DOI 10.2337/diabetes.54.3.664; Dunn Winston, 2008, Curr Gastroenterol Rep, V10, P67, DOI 10.1007/s11894-008-0011-1; Ebara T, 1997, J CLIN INVEST, V99, P2672, DOI 10.1172/JCI119456; Fan Y, 2009, J BIOL CHEM, V284, P19937, DOI 10.1074/jbc.M109.014308; Gaudet D, 2014, NEW ENGL J MED, V371, P2200, DOI 10.1056/NEJMoa1400284; Gerritsen G, 2005, J LIPID RES, V46, P1466, DOI 10.1194/jlr.M400479-JLR200; Ginsberg HN, 2009, J LIPID RES, V50, pS162, DOI 10.1194/jlr.R800090-JLR200; Gordts PLSM, 2016, J CLIN INVEST, V126, P2855, DOI 10.1172/JCI86610; Graham MJ, 2013, CIRC RES, V112, P1479, DOI 10.1161/CIRCRESAHA.111.300367; Hegele RA, 1997, ARTERIOSCL THROM VAS, V17, P2753, DOI 10.1161/01.ATV.17.11.2753; ITO Y, 1990, SCIENCE, V249, P790, DOI 10.1126/science.2167514; Jong MC, 1999, ARTERIOSCL THROM VAS, V19, P472, DOI 10.1161/01.ATV.19.3.472; Jong MC, 2001, J LIPID RES, V42, P1578; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; Kamagate A, 2008, J CLIN INVEST, V118, P2347, DOI [10.1172/JCI32914, 10.1172/JC132914]; Khetarpal SA, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-016-0609-y; KINNUNEN PKJ, 1976, FEBS LETT, V65, P354, DOI 10.1016/0014-5793(76)80145-7; Kozlitina J, 2011, HEPATOLOGY, V53, P467, DOI 10.1002/hep.24072; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Le KA, 2009, AM J CLIN NUTR, V89, P1760, DOI 10.3945/ajcn.2008.27336; Lee HY, 2011, HEPATOLOGY, V54, P1650, DOI 10.1002/hep.24571; Lerret SM, 2008, GASTROENTEROL NURS, V31, P115, DOI 10.1097/01.SGA.0000316530.31366.6e; Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41; Liu YZ, 2016, J BIOL CHEM, V291, P14695, DOI 10.1074/jbc.M115.707885; MAEDA N, 1994, J BIOL CHEM, V269, P23610; Mann CJ, 1997, J BIOL CHEM, V272, P31348, DOI 10.1074/jbc.272.50.31348; MCCONATHY WJ, 1992, J LIPID RES, V33, P995; Niu TH, 2014, WORLD J GASTROENTERO, V20, P3655, DOI 10.3748/wjg.v20.i13.3655; Nobili V, 2009, WORLD J GASTROENTERO, V15, P6017, DOI 10.3748/wjg.15.6017; Norata GD, 2015, TRENDS PHARMACOL SCI, V36, P675, DOI 10.1016/j.tips.2015.07.001; Nugent C, 2007, NAT CLIN PRACT GASTR, V4, P432, DOI 10.1038/ncpgasthep0879; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Petersen KF, 2010, NEW ENGL J MED, V362, P1082, DOI 10.1056/NEJMoa0907295; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Qin W, 2011, J BIOL CHEM, V286, P27769, DOI 10.1074/jbc.M110.203679; Qu S, 2007, J LIPID RES, V48, P1476, DOI 10.1194/jlr.M600498-JLR200; Qu S, 2007, AM J PHYSIOL-ENDOC M, V292, pE421, DOI 10.1152/ajpendo.00157.2006; QUARFORDT SH, 1982, J BIOL CHEM, V257, P4642; Samuel VT, 2011, TRENDS ENDOCRIN MET, V22, P60, DOI 10.1016/j.tem.2010.10.003; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Sentinelli F, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-93; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Sundaram M, 2010, J LIPID RES, V51, P1524, DOI 10.1194/jlr.M005108; Talmud PJ, 1997, CURR OPIN LIPIDOL, V8, P154, DOI 10.1097/00041433-199706000-00005; Taskinen MR, 2011, ARTERIOSCL THROM VAS, V31, P2144, DOI 10.1161/ATVBAHA.111.224808; Torres DM, 2008, GASTROENTEROLOGY, V134, P1682, DOI 10.1053/j.gastro.2008.02.077; Valenti L, 2011, J HEPATOL, V55, P1409, DOI 10.1016/j.jhep.2011.03.035; Verrijken A, 2013, OBESITY, V21, P2138, DOI 10.1002/oby.20366; Vuppalanchi R, 2009, HEPATOLOGY, V49, P306, DOI 10.1002/hep.22603; WANG CS, 1985, J CLIN INVEST, V75, P384, DOI 10.1172/JCI111711; Waterworth DM, 2000, J LIPID RES, V41, P1103; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Yao Zemin, 2012, Cardiovascular & Hematological Disorders - Drug Targets, V12, P133; Zampino R, 2013, J VIRAL HEPATITIS, V20, P517, DOI 10.1111/jvh.12053; Zhang HY, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.23100; Zhang LH, 2008, METABOLISM, V57, P1115, DOI 10.1016/j.metabol.2008.03.017; Zhang T, 2016, ENDOCRINOLOGY, V157, P1055, DOI 10.1210/en.2015-1852	66	10	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3692	3705		10.1074/jbc.M116.765917	http://dx.doi.org/10.1074/jbc.M116.765917			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28115523	Green Published, hybrid			2022-12-26	WOS:000395542500013
J	Bolten, M; Vahlensieck, C; Lipp, C; Leibundgut, M; Ban, N; Weber-Ban, E				Bolten, Marcel; Vahlensieck, Christian; Lipp, Colette; Leibundgut, Marc; Ban, Nenad; Weber-Ban, Eilika			Depupylase Dop Requires Inorganic Phosphate in the Active Site for Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-LIKE PROTEIN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ENZYME; PUP; SYNTHETASE; PATHWAY; COMPLEX	Analogous to eukaryotic ubiquitination, proteins in actino-bacteria can be post-translationally modified in a process referred to as pupylation, the covalent attachment of prokaryotic ubiquitin-like protein Pup to lysine side chains of the target protein via an isopeptide bond. As in eukaryotes, an opposing activity counteracts the modification by specific cleavage of the isopeptide bond formed with Pup. However, the enzymes involved in pupylation and depupylation have evolved independently of ubiquitination and are related to the family of ATP-binding and hydrolyzing carboxylate-amine ligases of the glutamine synthetase type. Furthermore, the Pup ligase PafA and the depupylase Dop share close structural and sequence homology and have a common evolutionary history despite catalyzing opposing reactions. Here, we investigate the role played by the nucleotide in the active site of the depupylase Dop using a combination of biochemical experiments and X-ray crystallographic studies. We show that, although Dop does not turn over ATP stoichiometrically with substrate, the active site nucleotide species in Dop is ADP and inorganic phosphate rather than ATP, and that non-hydrolyzable analogs of ATP cannot support the enzymatic reaction. This finding suggests that the catalytic mechanism is more similar to the mechanism of the ligase PafA than previously thought and likely involves the transient formation of a phosphorylated Pup-intermediate. Evidence is presented for a mechanism where the inorganic phosphate acts as the nucleophilic species in amide bond cleavage and implications for Dop function are discussed.	[Bolten, Marcel; Vahlensieck, Christian; Lipp, Colette; Leibundgut, Marc; Ban, Nenad; Weber-Ban, Eilika] Swiss Fed Inst Technol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Weber-Ban, E (corresponding author), Otto Stern Weg 5, CH-8093 Zurich, Switzerland.	eilika@mol.biol.ethz.ch		Bolten, Marcel/0000-0002-3808-2481; Vahlensieck, Christian/0000-0002-7716-6469; Weber-Ban, Eilika/0000-0002-5773-9274	Swiss Light Source (SLS, Paul Scherrer Institut, Villigen, Switzerland) [X06SA]	Swiss Light Source (SLS, Paul Scherrer Institut, Villigen, Switzerland)	We thank B. Blattmann and C. Stutz-Ducommun for support with initial screening and acknowledge the staff of X06SA at the Swiss Light Source (SLS, Paul Scherrer Institut, Villigen, Switzerland) for support with data collection.	Abbott JJ, 2001, J BIOL CHEM, V276, P42099, DOI 10.1074/jbc.M104672200; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALBE KR, 1990, J THEOR BIOL, V143, P163, DOI 10.1016/S0022-5193(05)80266-8; Barandun J, 2013, J AM CHEM SOC, V135, P6794, DOI 10.1021/ja4024012; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Biterova EI, 2010, J BIOL CHEM, V285, P14459, DOI 10.1074/jbc.M110.104802; Burns KE, 2012, J BIOL CHEM, V287, P37522, DOI 10.1074/jbc.M112.384784; Burns KE, 2010, MOL CELL, V39, P821, DOI 10.1016/j.molcel.2010.07.019; Burns KE, 2010, J BACTERIOL, V192, P2933, DOI 10.1128/JB.01639-09; Burns KE, 2009, J BIOL CHEM, V284, P3069, DOI 10.1074/jbc.M808032200; Bystrom CE, 1997, BIOORG MED CHEM LETT, V7, P2613, DOI 10.1016/S0960-894X(97)10051-8; Cerda-Maira FA, 2010, MOL MICROBIOL, V77, P1123, DOI 10.1111/j.1365-2958.2010.07276.x; Chen B, 2009, FEBS J, V276, P807, DOI 10.1111/j.1742-4658.2008.06825.x; Eisenberg D, 2000, BBA-PROTEIN STRUCT M, V1477, P122, DOI 10.1016/S0167-4838(99)00270-8; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Guth E, 2011, J BIOL CHEM, V286, P4412, DOI 10.1074/jbc.M110.189282; Hecht N, 2015, ANAL BIOCHEM, V485, P97, DOI 10.1016/j.ab.2015.06.019; Hibi T, 2004, P NATL ACAD SCI USA, V101, P15052, DOI 10.1073/pnas.0403277101; Hothorn M, 2006, J BIOL CHEM, V281, P27557, DOI 10.1074/jbc.M602770200; Imkamp F, 2010, EMBO REP, V11, P791, DOI 10.1038/embor.2010.119; Iyer LM, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-45; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krajewski WW, 2005, P NATL ACAD SCI USA, V102, P10499, DOI 10.1073/pnas.0502248102; Lazar I., 2010, GELANALYZER 2010A; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Ozcelik D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2009; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Rasband W, 1997, IMAGEJ VERSION 1 48; Samanovic Marie I, 2013, Subcell Biochem, V66, P267, DOI 10.1007/978-94-007-5940-4_10; Schrodinger LLC., 2015, PYMOL MOL GRAPHICS S; Striebel F, 2010, EMBO J, V29, P1262, DOI 10.1038/emboj.2010.23; Striebel F, 2009, NAT STRUCT MOL BIOL, V16, P647, DOI 10.1038/nsmb.1597; Sutter M, 2010, J AM CHEM SOC, V132, P5610, DOI 10.1021/ja910546x; Sutter M, 2009, FEBS LETT, V583, P3151, DOI 10.1016/j.febslet.2009.09.020; Tran QH, 1998, EUR J BIOCHEM, V251, P538, DOI 10.1046/j.1432-1327.1998.2510538.x; Yaginuma H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06522	38	13	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4044	4053		10.1074/jbc.M116.755645	http://dx.doi.org/10.1074/jbc.M116.755645			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28119453	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000395837100008
J	Barauna, RA; Ramos, RTJ; Veras, AAO; Pinheiro, KC; Benevides, LJ; Viana, MVC; Guimaraes, LC; Edman, JM; Spier, SJ; Azevedo, V; Silva, A				Barauna, Rafael A.; Ramos, Rommel T. J.; Veras, Adonney A. O.; Pinheiro, Kenny C.; Benevides, Leandro J.; Viana, Marcus V. C.; Guimaraes, Luis C.; Edman, Judy M.; Spier, Sharon J.; Azevedo, Vasco; Silva, Artur			Assessing the Genotypic Differences between Strains of Corynebacterium pseudotuberculosis biovar equi through Comparative Genomics	PLOS ONE			English	Article							PIGEON FEVER; PAN-GENOME; SEQUENCE; INFECTION; HORSES; TOOL; VISUALIZATION; NETWORKS; INSIGHTS; ARTEMIS	Seven genomes of Corynebacterium pseudotuberculosis biovar equi were sequenced on the Ion Torrent PGM platform, generating high-quality scaffolds over 2.35 Mbp. This bacterium is the causative agent of disease known as "pigeon fever" which commonly affects horses worldwide. The pangenome of biovar equi was calculated and two phylogenomic approaches were used to identify clustering patterns within Corynebacterium genus. Furthermore, other comparative analyses were performed including the prediction of genomic islands and prophages, and SNP-based phylogeny. In the phylogenomic tree, C. pseudotuberculosis was divided into two distinct clades, one formed by nitrate non-reducing species (biovar ovis) and another formed by nitrate-reducing species (biovar equi). In the latter group, the strains isolated from California were more related to each other, while the strains CIP 52.97 and 1/06-A formed the outermost clade of the biovar equi. A total of 1,355 core genes were identified, corresponding to 42.5% of the pangenome. This pangenome has one of the smallest core genomes described in the literature, suggesting a high genetic variability of biovar equi of C. pseudotuberculosis. The analysis of the similarity between the resistance islands identified a higher proximity between the strains that caused more severe infectious conditions (infection in the internal organs). Pathogenicity islands were largely conserved between strains. Several genes that modulate the pathogenicity of C. pseudotuberculosis were described including peptidases, recombination enzymes, micoside synthesis enzymes, bacteriocins with antimicrobial activity and several others. Finally, no genotypic differences were observed between the strains that caused the three different types of infection (external abscess formation, infection with abscess formation in the internal organs, and ulcerative lymphangitis). Instead, it was noted that there is a higher phenetic correlation between strains isolated at California compared to the other strains. Additionally, high variability of resistance islands suggests gene acquisition through several events of horizontal gene transfer.	[Barauna, Rafael A.; Ramos, Rommel T. J.; Veras, Adonney A. O.; Pinheiro, Kenny C.; Guimaraes, Luis C.; Silva, Artur] Fed Univ Para, Inst Biol Sci, Ctr Genom & Syst Biol, Lab Genom & Bioinformat, Belem, Para, Brazil; [Benevides, Leandro J.; Viana, Marcus V. C.; Azevedo, Vasco] Univ Fed Minas Gerais, Inst Biol Sci, Lab Cellular & Mol Genet, Belo Horizonte, MG, Brazil; [Edman, Judy M.; Spier, Sharon J.] Univ Calif Davis, Dept Med & Epidemiol, Sch Vet Med, Davis, CA 95616 USA	Universidade Federal do Para; Universidade Federal de Minas Gerais; University of California System; University of California Davis	Barauna, RA (corresponding author), Fed Univ Para, Inst Biol Sci, Ctr Genom & Syst Biol, Lab Genom & Bioinformat, Belem, Para, Brazil.	rabarauna@ufpa.br	Ramos, Rommel Thiago Juca/L-9329-2013; Luiz Silva, Artur da Costa da/AAI-3516-2021; Azevedo, Vasco A.C/F-4315-2011; Veras, Adonney Allan de Oliveira/AAK-6488-2020; Guimarães, Luis/T-7186-2019; Azevedo, Vasco/B-1556-2019; Guimaraes, Luis Carlos/J-5689-2015	Ramos, Rommel Thiago Juca/0000-0002-8032-1474; Luiz Silva, Artur da Costa da/0000-0002-4082-1132; Azevedo, Vasco A.C/0000-0002-4775-2280; Veras, Adonney Allan de Oliveira/0000-0002-7227-0590; Azevedo, Vasco/0000-0002-4775-2280; Canario Viana, Marcus Vinicius/0000-0002-7017-6437; Guimaraes, Luis Carlos/0000-0002-7147-9448	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039107; Aleman M, 1996, J AM VET MED ASSOC, V209, P804; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Almeida S, 2016, STAND GENOMIC SCI, V11, DOI 10.1186/s40793-016-0149-7; Araujo CLD, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00176-16; Azad AK, 1996, P NATL ACAD SCI USA, V93, P4787, DOI 10.1073/pnas.93.10.4787; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Barauna RA, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00977-14; BIBERSTEIN EL, 1971, VET REC, V89, P691, DOI 10.1136/vr.89.26.691; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Boysen C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140666; Britz E, 2014, VET J, V200, P282, DOI 10.1016/j.tvjl.2014.03.009; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cavalcante ALQ, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01385-15; Cerdeira LT, 2011, J BACTERIOL, V193, P7025, DOI 10.1128/JB.06293-11; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Deng XY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-500; Doherr MG, 1998, PREV VET MED, V35, P229, DOI 10.1016/S0167-5877(98)00071-3; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; Gorminet M, 2001, MOL MICROBIOL, V40, P963; Grabowska M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14833; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Hall K, 2001, J EQUINE VET SCI, V21, P284, DOI 10.1016/S0737-0806(01)70058-5; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kilcoyne I, 2014, JAVMA-J AM VET MED A, V245, P309, DOI 10.2460/javma.245.3.309; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; McMullan G, 2004, BIOCHEM SOC T, V32, P214, DOI 10.1042/BST0320214; Pacheco LGC, 2007, J MED MICROBIOL, V56, P480, DOI 10.1099/jmm.0.46997-0; Parret AHA, 2002, TRENDS MICROBIOL, V10, P107, DOI 10.1016/S0966-842X(02)02307-7; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Rhodes DM, 2015, J VET INTERN MED, V29, P327, DOI 10.1111/jvim.12534; Rissman AI, 2009, BIOINFORMATICS, V25, P2071, DOI 10.1093/bioinformatics/btp356; RUIMY R, 1995, INT J SYST BACTERIOL, V45, P740, DOI 10.1099/00207713-45-4-740; Sahl JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054287; Santos AR, 2013, GENET MOL RES, V12, P2982, DOI 10.4238/2013.August.16.2; Silva A, 2012, J BACTERIOL, V194, P6663, DOI 10.1128/JB.01782-12; Silva A, 2011, J BACTERIOL, V193, P323, DOI 10.1128/JB.01211-10; Soares SC, 2015, J BIOTECHNOL; Soares SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053818; Spier SJ, 2012, VET REC, V170, DOI 10.1136/vr.100543; Spier SJ, 2004, AM J VET RES, V65, P829, DOI 10.2460/ajvr.2004.65.829; Sutherland SS, 1996, VET MICROBIOL, V49, P1, DOI 10.1016/0378-1135(95)00146-8; Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x; Szonyi B, 2014, J EQUINE VET SCI, V34, P281, DOI 10.1016/j.jevs.2013.06.006; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Trost E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-728; Veltri D, 2016, NUCLEIC ACIDS RES, V44, pW41, DOI 10.1093/nar/gkw330; Wang CH, 2005, INFECT IMMUN, V73, P2881, DOI 10.1128/IAI.73.5.2881-2890.2005; Yeruham I, 1996, VET QUART, V18, P87, DOI 10.1080/01652176.1996.9694623; Zhao YB, 2012, BIOINFORMATICS, V28, P416, DOI 10.1093/bioinformatics/btr655; Zhou Y, 2011, NUCL ACIDS RES	53	11	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170676	10.1371/journal.pone.0170676	http://dx.doi.org/10.1371/journal.pone.0170676			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125655	gold, Green Published			2022-12-26	WOS:000396176100076
J	Rubio-Escudero, C; Valverde-Fernandez, J; Nepomuceno-Chamorro, I; Pontes-Balanza, B; Hernandez-Mendoza, Y; Rodriguez-Herrera, A				Rubio-Escudero, Cristina; Valverde-Fernandez, Justo; Nepomuceno-Chamorro, Isabel; Pontes-Balanza, Beatriz; Hernandez-Mendoza, Yoedusvany; Rodriguez-Herrera, Alfonso			Data Mining Techniques Applied to Hydrogen Lactose Breath Test	PLOS ONE			English	Article								In this work, we present the results of applying data mining techniques to hydrogen breath test data. Disposal of H2 gas is of utmost relevance to maintain efficient microbial fermentation processes. Objectives Analyze a set of data of hydrogen breath tests by use of data mining tools. Identify new patterns of H-2 production. Methods Hydrogen breath tests data sets as well as k-means clustering as the data mining technique to a dataset of 2571 patients. Results Six different patterns have been extracted upon analysis of the hydrogen breath test data. We have also shown the relevance of each of the samples taken throughout the test. Conclusions Analysis of the hydrogen breath test data sets using data mining techniques has identified new patterns of hydrogen generation upon lactose absorption. We can see the potential of application of data mining techniques to clinical data sets. These results offer promising data for future research on the relations between gut microbiota produced hydrogen and its link to clinical symptoms.	[Rubio-Escudero, Cristina; Nepomuceno-Chamorro, Isabel; Pontes-Balanza, Beatriz] Univ Seville, Dept Comp Languages & Syst, Seville, Spain; [Valverde-Fernandez, Justo; Rodriguez-Herrera, Alfonso] Hispalense Pediat Inst, Seville, Spain; [Hernandez-Mendoza, Yoedusvany] Univ Ciego de Avila, Dept Networks, Ciego De Avila, Cuba	University of Sevilla; University of Ciego de Avila	Rubio-Escudero, C (corresponding author), Univ Seville, Dept Comp Languages & Syst, Seville, Spain.	crubioescudero@us.es	Rubio-Escudero, Cristina/M-8308-2019; Nepomuceno-Chamorro, Isabel A./G-4037-2010	Nepomuceno-Chamorro, Isabel A./0000-0002-4255-7160	Spanish Ministry of Science and Technology [TIN2014-55894- C2-1-R]; Junta de Andalucia's project [TIC-7528]	Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia's project(Junta de Andalucia)	The authors want to thank the financial support given by the Spanish Ministry of Science and Technology project TIN2014-55894- C2-1-R. This work has also been funded by Junta de Andalucia's project TIC-7528. The authors want to thank technical support from System's Department of Institute Hispalense de Pediatria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Arthur D., 2007, P 18 ANN ACMS S, P1027, DOI DOI 10.1145/1283383.1283494; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Di Rienzo T, 2013, EUR REV MED PHARMACO, V17, P18; Dunn J.C., 1974, J CYBERNETICS, V4, P95, DOI 10.1080/01969727408546059; Eisenmann A, 2008, J BREATH RES, V2, DOI 10.1088/1752-7155/2/4/046002; Fayyad U, 1996, AI MAG, V17, P37; Gasbarrini A, 2009, ALIMENT PHARM THER, V29, P1, DOI 10.1111/j.1365-2036.2009.03951.x; Ghoshal UC, 2011, J NEUROGASTROENTEROL, V17, P312, DOI 10.5056/jnm.2011.17.3.312; Han J., 2006, DATA MINING CONCEPTS, DOI 10.1016/C2009-0-61819-5; Hartigan J., 1975, CLUSTERING ALGORITHM; Iavindrasana J, 2009, Yearb Med Inform, P121; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Maier L, 2013, CELL HOST MICROBE, V14, P641, DOI 10.1016/j.chom.2013.11.002; Martinez-Alvarez F, 2011, IEEE T KNOWL DATA EN, V23, P1230, DOI 10.1109/TKDE.2010.227; Nava GM, 2012, ISME J, V6, P57, DOI 10.1038/ismej.2011.90; NEWMAN A, 1974, GUT, V15, P308, DOI 10.1136/gut.15.4.308; Oquendo MA, 2012, MOL PSYCHIATR, V17, P956, DOI 10.1038/mp.2011.173; Romagnuolo J, 2002, AM J GASTROENTEROL, V97, P1113, DOI 10.1111/j.1572-0241.2002.05664.x; SilPeter J, 1987, J COMPUT APPL MATH, V20, P53; Simren M, 2006, GUT, V55, P297, DOI 10.1136/gut.2005.075127; Singh Sudha B, 2015, Microorganisms, V3, P866, DOI 10.3390/microorganisms3040866; Szilagyi A, 2007, CLIN GASTROENTEROL H, V5, P192, DOI 10.1016/j.cgh.2006.06.009; Thevenot EA, 2015, J PROTEOME RES, V14, P3322, DOI 10.1021/acs.jproteome.5b00354; Thomas AO, 2015, J ALLERGY CLIN IMMUN, V136, P282, DOI 10.1016/j.jaci.2014.12.1927; Van Berkel JJBN, 2008, J CHROMATOGR B, V861, P101, DOI 10.1016/j.jchromb.2007.11.008; Vandenplas Y, 2015, ASIA PAC J CLIN NUTR, V24, pS9, DOI 10.6133/apjcn.2015.24.s1.02; Xu R, 2005, IEEE T NEURAL NETWOR, V16, P645, DOI 10.1109/TNN.2005.845141	31	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170385	10.1371/journal.pone.0170385	http://dx.doi.org/10.1371/journal.pone.0170385			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125620	Green Published, Green Submitted, gold			2022-12-26	WOS:000396176100114
J	Secore, S; Wang, S; Doughtry, J; Xie, JF; Miezeiewski, M; Rustandi, RR; Horton, M; Xoconostle, R; Wang, B; Lancaster, C; Kristopeit, A; Wang, SC; Christanti, S; Vitelli, S; Gentile, MP; Goerke, A; Skinner, J; Strable, E; Thiriot, DS; Bodmer, JL; Heinrichs, JH				Secore, Susan; Wang, Su; Doughtry, Julie; Xie, Jinfu; Miezeiewski, Matt; Rustandi, Richard R.; Horton, Melanie; Xoconostle, Rachel; Wang, Bei; Lancaster, Catherine; Kristopeit, Adam; Wang, Sheng-Ching; Christanti, Sianny; Vitelli, Salvatore; Gentile, Marie-Pierre; Goerke, Aaron; Skinner, Julie; Strable, Erica; Thiriot, David S.; Bodmer, Jean-Luc; Heinrichs, Jon H.			Development of a Novel Vaccine Containing Binary Toxin for the Prevention of Clostridium difficile Disease with Enhanced Efficacy against NAP1 Strains	PLOS ONE			English	Article							MEASURE NEUTRALIZING ANTIBODIES; ADP-RIBOSYLTRANSFERASE; ENZYMATIC COMPONENT; CLINICAL-FEATURES; TOXOID VACCINE; EPIDEMIC; ACTIN; OPTIMIZATION; INFECTIONS; GUIDELINES	Clostridium difficile infections (CDI) are a leading cause of nosocomial diarrhea in the developed world. The main virulence factors of the bacterium are the large clostridial toxins (LCTs), TcdA and TcdB, which are largely responsible for the symptoms of the disease. Recent outbreaks of CDI have been associated with the emergence of hypervirulent strains, such as NAP1/BI/027, many strains of which also produce a third toxin, binary toxin (CDTa and CDTb). These hypervirulent strains have been associated with increased morbidity and higher mortality. Here we present pre-clinical data describing a novel tetravalent vaccine composed of attenuated forms of TcdA, TcdB and binary toxin components CDTa and CDTb. We demonstrate, using the Syrian golden hamster model of CDI, that the inclusion of binary toxin components CDTa and CDTb significantly improves the efficacy of the vaccine against challenge with NAP1 strains in comparison to vaccines containing only TcdA and TcdB antigens, while providing comparable efficacy against challenge with the prototypic, non-epidemic strain VPI10463. This combination vaccine elicits high neutralizing antibody titers against TcdA, TcdB and binary toxin in both hamsters and rhesus macaques. Finally we present data that binary toxin alone can act as a virulence factor in animal models. Taken together, these data strongly support the inclusion of binary toxin in a vaccine against CDI to provide enhanced protection from epidemic strains of C. difficile.	[Secore, Susan; Wang, Su; Doughtry, Julie; Xie, Jinfu; Horton, Melanie; Xoconostle, Rachel; Skinner, Julie; Bodmer, Jean-Luc; Heinrichs, Jon H.] Merck & Co Inc, Vaccine Basic Res, Merck Res Labs, West Point, PA USA; [Miezeiewski, Matt] Eurofins Labs, Lancaster, PA USA; [Rustandi, Richard R.; Lancaster, Catherine] Merck & Co Inc, Vaccine Analyt Dev, Merck Res Labs, West Point, PA USA; [Wang, Bei; Thiriot, David S.] Merck & Co Inc, Vaccine Drug Prod Dev, Merck Res Labs, West Point, PA USA; [Kristopeit, Adam; Wang, Sheng-Ching; Christanti, Sianny; Gentile, Marie-Pierre; Goerke, Aaron] Merck & Co Inc, Vaccine Proc Dev, Merck Res Labs, West Point, PA USA; [Wang, Su] Meso Scale Diagnost, Dept Clin Biodef, Gaithersburg, MD USA; [Doughtry, Julie] Bristol Myers Squibb, Translat Res & Dev, Princeton, NJ USA; [Miezeiewski, Matt] Janssen Res & Dev, Dept Large Mol Analyt Dev, Malvern, PA USA; [Xoconostle, Rachel] Merck & Co Inc, Proc Dev & Analyt, Durham, NC USA; [Gentile, Marie-Pierre; Goerke, Aaron] Genentech Inc, Dept Global Biol Mfg Sci & Technol, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA; [Bodmer, Jean-Luc] Seres Therapeut Inc, CMC Analyt Dev & QC, Cambridge, MA USA; [Heinrichs, Jon H.] Sanofi Pasteur, Global Project Leadership, Swiftwater, PA USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company; Bristol-Myers Squibb; Merck & Company; Roche Holding; Genentech; Sanofi-Aventis	Secore, S (corresponding author), Merck & Co Inc, Vaccine Basic Res, Merck Res Labs, West Point, PA USA.	susan_secore1@merck.com		Horton, Melanie/0000-0003-4996-9042	Merck and Co., Inc.	Merck and Co., Inc.(Merck & Company)	The research was fully funded by Merck and Co., Inc. The funder provided support in the form of salaries for authors SS, SW, JD, JX, RRR, MH, RX, BW, CL, AK, SCW, SC, SV, MPG, AG, JS, ES, DST, JLB, and JHH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aboudola S, 2003, INFECT IMMUN, V71, P1608, DOI 10.1128/IAI.71.3.1608-1610.2003; Akerlund T, 2008, J CLIN MICROBIOL, V46, P1530, DOI 10.1128/JCM.01964-07; Anosova NG, 2013, J MED MICROBIOL, V62, P1394, DOI 10.1099/jmm.0.056796-0; Bacci S, 2011, EMERG INFECT DIS, V17, P976, DOI [10.3201/eid1706.101483, 10.3201/eid/1706.101483]; Barbut F, 2005, J MED MICROBIOL, V54, P181, DOI 10.1099/jmm.0.45804-0; Barbut F, 2007, INFECT CONT HOSP EP, V28, P131, DOI 10.1086/511794; Bassetti M, 2012, EXPERT REV ANTI-INFE, V10, P1405, DOI [10.1586/ERI.12.135, 10.1586/eri.12.135]; Boquet P, 1998, CURR OPIN MICROBIOL, V1, P66, DOI 10.1016/S1369-5274(98)80144-6; Busch C, 2000, J BIOL CHEM, V275, P13228, DOI 10.1074/jbc.275.18.13228; Busch C, 1998, J BIOL CHEM, V273, P19566, DOI 10.1074/jbc.273.31.19566; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Donald RGK, 2013, MICROBIOL-SGM, V159, P1254, DOI 10.1099/mic.0.066712-0; Drudy D, 2007, EMERG INFECT DIS, V13, P504, DOI 10.3201/eid1303.060771; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Egerer M, 2009, J BIOL CHEM, V284, P3389, DOI 10.1074/jbc.M806002200; Foglia G, 2012, VACCINE, V30, P4307, DOI 10.1016/j.vaccine.2012.01.056; Gerding DN, 2014, GUT MICROBES, V5, P15, DOI 10.4161/gmic.26854; Gerhard R, 2008, J MED MICROBIOL, V57, P765, DOI 10.1099/jmm.0.47769-0; Geric B, 2006, J INFECT DIS, V193, P1143, DOI 10.1086/501368; Geric B, 2003, J CLIN MICROBIOL, V41, P5227, DOI 10.1128/JCM.41.11.5227-5232.2003; Goldenberg SD, 2011, J INFECTION, V62, P355, DOI 10.1016/j.jinf.2011.03.001; Goncalves C, 2004, J CLIN MICROBIOL, V42, P1933, DOI 10.1128/JCM.42.5.1933-1939.2004; Gulke I, 2001, INFECT IMMUN, V69, P6004, DOI 10.1128/IAI.69.10.6004-6011.2001; Heinrichs JH, 2014, SEMIN COLON RECTAL S, V25, P153, DOI 10.1053/j.scrs.2014.05.011; Hippenstiel S, 2002, AM J PHYSIOL-LUNG C, V283, pL830, DOI 10.1152/ajplung.00467.2001; Jank T, 2007, J BIOL CHEM, V282, P35222, DOI 10.1074/jbc.M703138200; Kotloff KL, 2001, INFECT IMMUN, V69, P988, DOI 10.1128/IAI.69.2.988-995.2001; Kuehne SA, 2014, J INFECT DIS, V209, P83, DOI 10.1093/infdis/jit426; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; Martirosian Gayane, 2004, Polish Journal of Microbiology, V53, P197; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; McEllistrem MC, 2005, CLIN INFECT DIS, V40, P265, DOI 10.1086/427113; Miller BA, 2011, INFECT CONT HOSP EP, V32, P387, DOI 10.1086/659156; Miller M, 2010, CLIN INFECT DIS, V50, P194, DOI 10.1086/649213; Nagahama M, 2000, J BACTERIOL, V182, P2096, DOI 10.1128/JB.182.8.2096-2103.2000; Pruitt RN, 2009, J BIOL CHEM, V284, P21934, DOI 10.1074/jbc.M109.018929; Schwan C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000626; Siddiqui F, 2012, J INFECT DIS, V80, P2678; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; Spyres LM, 2003, INFECT IMMUN, V71, P3294, DOI 10.1128/IAI.71.6.3294-3301.2003; Stewart DB, 2013, J GASTROINTEST SURG, V17, P118, DOI 10.1007/s11605-012-2056-6; Stubbs S, 2000, FEMS MICROBIOL LETT, V186, P307, DOI 10.1016/S0378-1097(00)00162-2; Sundriyal A, 2009, J BIOL CHEM, V284, P28713, DOI 10.1074/jbc.M109.043018; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; Teichert M, 2006, INFECT IMMUN, V74, P6006, DOI 10.1128/IAI.00545-06; VANDEKERCKHOVE J, 1987, FEBS LETT, V225, P48, DOI 10.1016/0014-5793(87)81129-8; VANDEKERCKHOVE J, 1988, J BIOL CHEM, V263, P696; Walk ST, 2012, CLIN INFECT DIS, V55, P1661, DOI 10.1093/cid/cis786; Wang HY, 2012, INFECT IMMUN, V80, P2678, DOI 10.1128/IAI.00215-12; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Wilson V, 2010, CLIN INFECT DIS, V50, pE77, DOI 10.1086/653012; Xie JF, 2014, CLIN VACCINE IMMUNOL, V21, P689, DOI 10.1128/CVI.00038-14; Xie JF, 2013, CLIN VACCINE IMMUNOL, V20, P517, DOI 10.1128/CVI.00549-12	54	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170640	10.1371/journal.pone.0170640	http://dx.doi.org/10.1371/journal.pone.0170640			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125650	gold, Green Submitted, Green Published			2022-12-26	WOS:000396176100082
J	Casal, ML; Wang, P; Mauldin, EA; Lin, G; Henthorn, PS				Casal, Margret L.; Wang, Ping; Mauldin, Elizabeth A.; Lin, Gloria; Henthorn, Paula S.			A Defect in NIPAL4 Is Associated with Autosomal Recessive Congenital Ichthyosis in American Bulldogs	PLOS ONE			English	Article							MUTATIONS; FAMILY	Autosomal recessive congenital ichthyosis in the American bulldog is characterized by generalized scaling and erythema with adherent scale on the glabrous skin. We had previously linked this disorder to NIPAL4, which encodes the protein ichthyin. Sequencing of NIPAL4 revealed a homozygous single base deletion (CanFam3.1 canine reference genome sequence NC_06586.3 g.52737379del), the 157th base (cytosine) in exon 6 of NIPAL4 as the most likely causative variant in affected dogs. This frameshift deletion results in a premature stop codon producing a truncated and defective NIPAL4 (ichthyin) protein of 248 amino acids instead of the wild-type length of 404. Obligate carriers were confirmed to be heterozygous for this variant, and 150 clinically non-affected dogs of other breeds were homozygous for the wild-type gene. Among 800 American bulldogs tested, 34% of clinically healthy dogs were discovered to be heterozygous for the defective allele. More importantly, the development of this canine model of autosomal recessive congenital ichthyosis will provide insight into the development of new treatments across species.	[Casal, Margret L.; Wang, Ping; Lin, Gloria; Henthorn, Paula S.] Univ Penn, Sch Vet Med, Dept Clin Studies, Med Genet Sect, Philadelphia, PA 19104 USA; [Mauldin, Elizabeth A.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Casal, ML (corresponding author), Univ Penn, Sch Vet Med, Dept Clin Studies, Med Genet Sect, Philadelphia, PA 19104 USA.	casalml@vet.upenn.edu			National Institutes of Health [NIH OD010939]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR002512] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010939] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health-Office of the Director-NIH OD010939. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MLC and PSH are co-investigators on this grant and materials for this project were provided through this grant.	Aken BL, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw093; Akiyama M, 2011, NAGOYA J MED SCI, V73, P79; Alavi A, 2012, J DERMATOL, V39, P375, DOI 10.1111/j.1346-8138.2011.01412.x; Bygum A, 2016, ACTA DERM VENEREOL; Credille KM, 2009, BRIT J DERMATOL, V161, P265, DOI 10.1111/j.1365-2133.2009.09161.x; Credille KM, 2005, BRIT J DERMATOL, V153, P51, DOI 10.1111/j.1365-2133.2005.06735.x; Dahlqvist J, 2007, J MED GENET, V44, P615, DOI 10.1136/jmg.2007.050542; Grall A, 2012, NAT GENET, V44, P140, DOI 10.1038/ng.1056; Hoeppner MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091172; Hoffmann A, 2016, VET PATHOL, V53, P614, DOI 10.1177/0300985815595516; Lefevre C, 2004, HUM MOL GENET, V13, P2473, DOI 10.1093/hmg/ddh263; Lewis DT, 1998, VET DERMATOL, V9, P111, DOI 10.1046/j.1365-3164.1998.00070.x; Maier D, 2016, CLIN EXP DERMATOL, V41, P279, DOI 10.1111/ced.12740; Mauldin EA, 2008, VET PATHOL, V45, P174, DOI 10.1354/vp.45-2-174; Mauldin EA, 2015, VET PATHOL, V52, P654, DOI 10.1177/0300985814551425; Mauldin EA, 2013, VET CLIN N AM-SMALL, V43, P89, DOI 10.1016/j.cvsm.2012.09.005; Metzger J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141514; Milstone LM, 2012, ARCH DERMATOL, V148, P1080, DOI 10.1001/archdermatol.2012.1702; Richard G, 2011, GENEREVIEWS R; Sugiura K, 2015, J DERMATOL SCI, V79, P4, DOI 10.1016/j.jdermsci.2015.04.009; Takeichi T, 2016, J DERMATOL, V43, P242, DOI 10.1111/1346-8138.13243	21	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0170708	10.1371/journal.pone.0170708	http://dx.doi.org/10.1371/journal.pone.0170708			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122049	Green Published, Green Submitted, gold			2022-12-26	WOS:000396167300026
J	Silva, RMD; Stafuzza, NB; Fragomeni, BD; de Camargo, GMF; Ceacero, TM; Cyrillo, JNDG; Baldi, F; Boligon, AA; Mercadante, MEZ; Lourenco, DL; Misztal, I; de Albuquerque, LG				de Oliveira Silva, Rafael Medeiros; Stafuzza, Nedenia Bonvino; Fragomeni, Breno de Oliveira; Ferreira de Camargo, Gregorio Miguel; Ceacero, Thais Matos; dos Santos Goncalves Cyrillo, Joslaine Noely; Baldi, Fernando; Boligon, Arione Augusti; Zerlotti Mercadante, Maria Eugenia; Lourenco, Daniela Lino; Misztal, Ignacy; de Albuquerque, Lucia Galvao			Genome-Wide Association Study for Carcass Traits in an Experimental Nelore Cattle Population	PLOS ONE			English	Article							MAPPING INCLUDING PHENOTYPES; BOS-INDICUS; BROILER CHICKEN; FEED-INTAKE; VARIANTS; WEIGHT; HEIGHT; GROWTH; GENES; XKR4	The purpose of this study was to identify genomic regions associated with carcass traits in an experimental Nelore cattle population. The studied data set contained 2,306 ultrasound records for longissimus muscle area (LMA), 1,832 for backfat thickness (BF), and 1,830 for rump fat thickness (RF). A high-density SNP panel (BovineHD BeadChip assay 700k, Illumina Inc., San Diego, CA) was used for genotyping. After genomic data quality control, 437,197 SNPs from 761 animals were available, of which 721 had phenotypes for LMA, 669 for BF, and 718 for RF. The SNP solutions were estimated using a single-step genomic BLUP approach (ssGWAS), which calculated the variance for windows of 50 consecutive SNPs and the regions that accounted for more than 0.5% of the additive genetic variance were used to search for candidate genes. The results indicated that 12, 18, and 15 different windows were associated to LMA, BF, and RF, respectively. Confirming the polygenic nature of the studied traits, 43, 65, and 53 genes were found in those associated windows, respectively for LMA, BF, and RF. Among the candidate genes, some of them, which already had their functions associated with the expression of energy metabolism, were found associated with fat deposition in this study. In addition, ALKBH3 and HSD17B12 genes, which are related in fibroblast death and metabolism of steroids, were found associated with LMA. The results presented here should help to better understand the genetic and physiologic mechanism regulating the muscle tissue deposition and subcutaneous fat cover expression of Zebu animals. The identification of candidate genes should contribute for Zebu breeding programs in order to consider carcass traits as selection criteria in their genetic evaluation.	[de Oliveira Silva, Rafael Medeiros; Stafuzza, Nedenia Bonvino; Ferreira de Camargo, Gregorio Miguel; Baldi, Fernando; de Albuquerque, Lucia Galvao] Sao Paulo State Univ, Sch Agr & Veterinarian Sci, FCAV UNESP, Dept Anim Sci, Jaboticabal, SP, Brazil; [Fragomeni, Breno de Oliveira; Lourenco, Daniela Lino; Misztal, Ignacy] Univ Georgia, Dept Anim & Dairy Sci, Athens, GA 30602 USA; [Ceacero, Thais Matos; dos Santos Goncalves Cyrillo, Joslaine Noely; Zerlotti Mercadante, Maria Eugenia] Inst Anim Sci, APTA Ctr Beef Cattle, Sertaozinho, SP, Brazil; [Boligon, Arione Augusti] Univ Fed Pelotas, Dept Anim Sci, Pelotas, RS, Brazil	Universidade Estadual Paulista; University System of Georgia; University of Georgia; Universidade Federal de Pelotas	de Albuquerque, LG (corresponding author), Sao Paulo State Univ, Sch Agr & Veterinarian Sci, FCAV UNESP, Dept Anim Sci, Jaboticabal, SP, Brazil.	lgalb@fcav.unesp.br	Mercadante, Maria Eugenia/C-9536-2012; Stafuzza, Nedenia Bonvino/M-9224-2019; Baldi, Fernando/E-5492-2012; Camargo, Gregorio M. F./J-9511-2016; Stafuzza, Nedenia B./C-4419-2013; Cyrillo, Joslaine/S-2637-2019; Albuquerque, Lucia/A-7402-2013	Mercadante, Maria Eugenia/0000-0002-1218-5378; Stafuzza, Nedenia Bonvino/0000-0001-6432-2330; Baldi, Fernando/0000-0003-4094-2011; Stafuzza, Nedenia B./0000-0001-6432-2330; Cyrillo, Joslaine/0000-0002-4390-630X; Albuquerque, Lucia/0000-0002-2030-7590; de Camargo, Gregorio Miguel Ferreira/0000-0002-8736-5576	FUNDACAO DE AMPARO A PESQUISA DO ESTADO DE SAO PAULO, FAPESP [2009/16118-5]; FAPESP [2013/01228-5]	FUNDACAO DE AMPARO A PESQUISA DO ESTADO DE SAO PAULO, FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FUNDACAO DE AMPARO A PESQUISA DO ESTADO DE SAO PAULO, FAPESP grant number 2009/16118-5, and FAPESP grant number 2013/01228-5.	Aguilar I, 2010, J DAIRY SCI, V93, P743, DOI 10.3168/jds.2009-2730; Albrecht E, 2011, ARCH TIERZUCHT, V54, P147, DOI 10.5194/aab-54-147-2011; [Anonymous], 2007, REV FZVA; Bastin BC, 2014, ANIM GENET, V45, P439, DOI 10.1111/age.12134; Bergen R, 2005, CAN J ANIM SCI, V85, P463, DOI 10.4141/A05-013; BOGGS D. L., 1990, LIVE ANIMAL CARCASS; Caetano SL, 2013, LIVEST SCI, V155, P1, DOI 10.1016/j.livsci.2013.04.004; Ceacero TM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161366; CROUSE JD, 1989, J ANIM SCI, V67, P2661; Douglas T, 2006, BIOMACROMOLECULES, V7, P2388, DOI 10.1021/bm0603746; Fortes MRS, 2013, ANDROLOGY-US, V1, P644, DOI 10.1111/j.2047-2927.2013.00101.x; Fragomeni BD, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00332; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hamoud N, 2014, P NATL ACAD SCI USA, V111, P3745, DOI 10.1073/pnas.1313886111; HEDRICK HB, 1983, J ANIM SCI, V57, P1316, DOI 10.2527/jas1983.5751316x; Jeff JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086931; Jiao S, 2014, J ANIM SCI, V92, P2846, DOI 10.2527/jas.2014-7337; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; Kitamura T, 2013, BBA-MOL CELL BIOL L, V1831, P1395, DOI 10.1016/j.bbalip.2013.05.007; Lee SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074677; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Li MZ, 2012, INT J BIOL SCI, V8, P831, DOI 10.7150/ijbs.4493; Liefke R, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0180-0; Lindholm-Perry AK, 2012, ANIM GENET, V43, P216, DOI 10.1111/j.1365-2052.2011.02232.x; Lu D, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-80; Magalhaes AFB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157845; Malheiros JM, 2015, B IND ANIM, V72, P341, DOI 10.17523/bia.v72n4p341; Misztal I., 2002, P 7 WORLD C GEN APPL, V28, P7; Moreira FB, 2003, BRAZ ARCH BIOL TECHN, V46, P609, DOI 10.1590/S1516-89132003000400016; Nay SL, 2012, DNA REPAIR, V11, P502, DOI 10.1016/j.dnarep.2012.02.005; Neto LRP, 2012, ANIM GENET, V43, P785, DOI 10.1111/j.1365-2052.2012.02330.x; Nishimura S, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-40; OConnor SF, 1997, J ANIM SCI, V75, P1822; Oliva K, 2013, J ENDOCRINOL, V218, P165, DOI 10.1530/JOE-13-0010; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pryce JE, 2014, ANIMAL, V8, P1, DOI 10.1017/S1751731113001687; Saez ME, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-1; Santana MHA, 2012, LIVEST SCI, V145, P252, DOI 10.1016/j.livsci.2012.02.012; Sharma A, 2014, ANIM GENET, V45, P863, DOI 10.1111/age.12204; Sohle J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031193; STAM P, 1980, GENET RES, V35, P131, DOI 10.1017/S0016672300014002; Utsunomiya YT, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-52; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Visus C, 2011, CANCER IMMUNOL IMMUN, V60, P919, DOI 10.1007/s00262-011-1001-y; Wang H, 2012, GENET RES, V94, P73, DOI 10.1017/S0016672312000274; Wang HY, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00134; WANG P, 2014, SCI WORLD J, V2014, P1, DOI DOI 10.1155/2014/562797; Zhang H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-704	49	49	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2017	12	1							e0169860	10.1371/journal.pone.0169860	http://dx.doi.org/10.1371/journal.pone.0169860			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7CU	28118362	Green Submitted, Green Published, gold			2022-12-26	WOS:000396160500045
J	Dillon, MP; Fortington, LV; Akram, M; Erbas, B; Kohler, F				Dillon, Michael P.; Fortington, Lauren V.; Akram, Muhammad; Erbas, Bircan; Kohler, Friedbert			Geographic Variation of the Incidence Rate of Lower Limb Amputation in Australia from 2007-12	PLOS ONE			English	Article							LOWER-EXTREMITY AMPUTATIONS; HEALTH-CARE COSTS; WESTERN-AUSTRALIA; PEOPLE	In Australia, little is known about how the incidence rate (IR) of lower limb amputation (LLA) varies across the country. While studies in other economically developed countries have shown considerable geographic variation in the IR-LLA, mostly these have not considered whether the effect of common risk factors are the same across regions. Mapping variation of the IR-LLA, and the effect of common risk factors, is an important first step to focus research into areas of greatest need and support the development of regional specific hypotheses for in-depth examination. The aim of this study was to describe the geographic variation in the IR-LLA across Australia and understand whether the effect of common risk factors was the same across regions. Using hospital episode data from the Australian National Hospital Morbidity database and Australian Bureau of Statistics, the all-cause crude and age-standardised IR-LLA in males and females were calculated for the nation and each state and territory. Generalised Linear Models were developed to understand which factors influenced geographic variation in the crude IR-LLA. While the crude and age-standardised IR-LLA in males and females were similar in most states and territories, they were higher in the Northern Territory. The effect of older age, being male and the presence of type 2 diabetes was associated with an increase of IR-LLA in most states and territories. In the Northern Territory, the younger age at amputation confounded the effect of sex and type 2 diabetes. There are likely to be many factors not included in this investigation, such as Indigenous status, that may explain part of the variation in the IR-LLA not captured in our models. Further research is needed to identify regional-and population-specific factors that could be modified to reduce the IR-LLA in all states and territories of Australia.	[Dillon, Michael P.] La Trobe Univ, Sch Allied Hlth, Bundoora, Vic, Australia; [Fortington, Lauren V.] Federat Univ, Australian Collaborat Res Injury Sports & Its Pre, Ballarat, Vic, Australia; [Akram, Muhammad] Australian Catholic Univ, Australian Ctr Hlth & Social Res, Melbourne, Vic, Australia; [Erbas, Bircan] La Trobe Univ, Sch Psychol & Publ Hlth, Bundoora, Vic, Australia; [Kohler, Friedbert] Braeside Hosp, Rehabil Med, Prairiewood, NSW, Australia; [Kohler, Friedbert] Univ New South Wales, Fac Med, Kensington, NSW, Australia	La Trobe University; Federation University Australia; Australian Catholic University; La Trobe University; University of New South Wales Sydney	Dillon, MP (corresponding author), La Trobe Univ, Sch Allied Hlth, Bundoora, Vic, Australia.	michael.dillon@latrobe.edu.au	Fortington, Lauren/E-9002-2015	Fortington, Lauren/0000-0003-2760-9249; Dillon, Michael/0000-0003-3614-7787	APC Prosthetics Pty Ltd., New South Wales. Australia	APC Prosthetics Pty Ltd., New South Wales. Australia	This research was funded by APC Prosthetics Pty Ltd., New South Wales. Australia http://apcprosthetics.com.au/ Funds were awarded to MD, FK and BE. The funder had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	[Anonymous], 2011, END STAG KIDN DIS AU; Australian Bureau of Statistics, 2013, AUSTR DEM STAT; Australian Bureau of Statistics, 2012, AUSTR DEM STAT; Australian Bureau of Statistics, 2008, POP DISTR AB TORR ST; Australian Indigenous HealthInfoNet, 2016, OVER AUSTR AB TORR S; Australian Institute of Health and Welfare, 2014, INC INS TREAT DIAB A; Australian Institute of Health and Welfare, 2010, NAT HLTH DAT DICT VE; Australian Institute of Health and Welfare, 2012, HOSPITALS; Australian Institute of Health and Welfare, 2012, PROC DAT CUB; Australian Institute of Health & Welfare, 2012, NAT HOSP MORB DAT; Department of Prime Minister and Cabinet, 2014, AB TORR STRAIT ISL H; Dillingham TR, 2005, ARCH PHYS MED REHAB, V86, P480, DOI 10.1016/j.apmr.2004.06.072; Dillon MP, 2014, PROSTHET ORTHOT INT, V38, P122, DOI 10.1177/0309364613490441; Goodney PP, 2012, CIRC-CARDIOVASC QUAL, V5, P94, DOI 10.1161/CIRCOUTCOMES.111.962233; Gordois A, 2003, DIABETES CARE, V26, P1790, DOI 10.2337/diacare.26.6.1790; Holman N, 2012, DIABETOLOGIA, V55, P1919, DOI 10.1007/s00125-012-2468-6; Jeffcoate WJ, 2004, DIABETOLOGIA, V47, P2051, DOI 10.1007/s00125-004-1584-3; Jeffcoate WJ, 2005, ACTA CHIRURG BELGICA, V105, P104; Jones WS, 2012, J AM COLL CARDIOL, V60, P2230, DOI 10.1016/j.jacc.2012.08.983; Kaminski MR, NEPHROLOGY DIALYSIS, V30, p[2, 1747]; Kurowski JR, 2015, DIABETES RES CLIN PR, V108, P280, DOI 10.1016/j.diabres.2015.02.008; Lavery LA, 2015, INT WOUND J, V12, P523, DOI 10.1111/iwj.12146; Lazzarini PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130609; Lazzarini PA, 2012, J FOOT ANKLE RES, V5, DOI 10.1186/1757-1146-5-12; Margolis DJ, 2013, MED CLIN N AM, V97, P791, DOI 10.1016/j.mcna.2013.03.008; Margolis DJ, 2011, DIABETES CARE, V34, P2363, DOI 10.2337/dc11-0807; Moxey PW, 2010, BRIT J SURG, V97, P1348, DOI 10.1002/bjs.7092; National Aboriginal Community Controlled Health Organisation Royal Australian College General Practitioners, 2005, NAT GUID PREV HLTH A; National Aboriginal Community Controlled Health Organisation Royal Australian College General Practitioners Chronic Disease Alliance of Non-Government Organisations, 2005, EV BAS PREV HLTH ASS; NHMRC, 2011, NATL EVIDENCE BASED; Norman PE, 2010, MED J AUSTRALIA, V192, P421, DOI 10.5694/j.1326-5377.2010.tb03571.x; O'Rourke SR, 2012, AUST HEALTH REV, V36, P105, DOI 10.1071/AH10969; Peacock JM, 2011, PREV CHRONIC DIS, V8; Ray JA, 2005, CURR MED RES OPIN, V21, P1617, DOI 10.1185/030079905X65349; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Sambamoorthi U, 2006, MED CARE, V44, P779, DOI 10.1097/01.mlr.0000218793.74558.0e; Singh H, 2015, AUSTRALASIAN EPIDEMI, V22, P32; Stevens CD, 2014, HEALTH AFFAIR, V33, P1383, DOI 10.1377/hlthaff.2014.0148; vanHoutum WH, 1996, DIABETES RES CLIN PR, V31, P125, DOI 10.1016/0168-8227(96)01199-0; Wrobel JS, 2001, DIABETES CARE, V24, P860, DOI 10.2337/diacare.24.5.860	40	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2017	12	1							e0170705	10.1371/journal.pone.0170705	http://dx.doi.org/10.1371/journal.pone.0170705			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7CU	28118408	Green Published, gold			2022-12-26	WOS:000396160500009
J	Liu, YC; Lee, YD; Wang, HL; Liao, KH; Chen, KB; Poon, KS; Pan, YL; Lai, TWT				Liu, Yu-Cheng; Lee, Yu-Da; Wang, Hwai-Lee; Liao, Kate Hsiurong; Chen, Kuen-Bao; Poon, Kin-Shing; Pan, Yu-Ling; Lai, Ted Weita			Anesthesia-Induced Hypothermia Attenuates Early-Phase Blood-Brain Barrier Disruption but Not Infarct Volume following Cerebral Ischemia	PLOS ONE			English	Article							TRANSIENT FOCAL ISCHEMIA; ARTERY OCCLUSION; THERAPEUTIC HYPOTHERMIA; NEURONAL INJURIES; STROKE RESEARCH; PERMEABILITY; RAT; ISOFLURANE; NEUROPROTECTION; EXPRESSION	Blood-brain barrier (BBB) disruption is thought to facilitate the development of cerebral infarction after a stroke. In a typical stroke model (such as the one used in this study), the early phase of BBB disruption reaches a peak 6 h post-ischemia and largely recovers after 8-24 h, whereas the late phase of BBB disruption begins 48-58 h post-ischemia. Because cerebral infarct develops within 24 h after the onset of ischemia, and several therapeutic agents have been shown to reduce the infarct volume when administered at 6 h post-ischemia, we hypothesized that attenuating BBB disruption at its peak (6 h post-ischemia) can also decrease the infarct volume measured at 24 h. We used a mouse stroke model obtained by combining 120 min of distal middle cerebral arterial occlusion (dMCAo) with ipsilateral common carotid arterial occlusion (CCAo). This model produced the most reliable BBB disruption and cerebral infarction compared to other models characterized by a shorter duration of ischemia or obtained with dMCAO or CCAo alone. The BBB permeability was measured by quantifying Evans blue dye (EBD) extravasation, as this tracer has been shown to be more sensitive for the detection of early-phase BBB disruption compared to other intravascular tracers that are more appropriate for detecting late-phase BBB disruption. We showed that a 1 h-long treatment with isoflurane-anesthesia induced marked hypothermia and attenuated the peak of BBB disruption when administered 6 h after the onset of dMCAo/CCAo-induced ischemia. We also demonstrated that the inhibitory effect of isoflurane was hypothermia-dependent because the same treatment had no effect on ischemic BBB disruption when the mouse body temperature was maintained at 37 degrees C. Importantly, inhibiting the peak of BBB disruption by hypothermia had no effect on the volume of brain infarct 24 h post-ischemia. In conclusion, inhibiting the peak of BBB disruption is not an effective neuroprotective strategy, especially in comparison to the inhibitors of the neuronal death signaling cascade; these, in fact, can attenuate the infarct volume measured at 24 h post-ischemia when administered at 6 h in our same stroke model.	[Liu, Yu-Cheng; Lee, Yu-Da; Wang, Hwai-Lee; Liao, Kate Hsiurong; Chen, Kuen-Bao; Poon, Kin-Shing; Pan, Yu-Ling; Lai, Ted Weita] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Liu, Yu-Cheng; Liao, Kate Hsiurong; Chen, Kuen-Bao; Poon, Kin-Shing] China Med Univ Hosp, Dept Anesthesiol, Taichung, Taiwan; [Lai, Ted Weita] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Lai, Ted Weita] China Med Univ Hosp, Translat Med Res Ctr, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Lai, TWT (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan.; Lai, TWT (corresponding author), China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan.; Lai, TWT (corresponding author), China Med Univ Hosp, Translat Med Res Ctr, Taichung, Taiwan.	ted.weita@me.com	Lai, Ted Weita/E-9392-2016	Lai, Ted Weita/0000-0002-6229-4134	China Medical University Hospital [DMR-102-062]; Taiwan Ministry of Science and Technology [MOST105-2320-B-039-007]; National Health Research Institutes [NHRI-EX105-10412NC]	China Medical University Hospital; Taiwan Ministry of Science and Technology; National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan)	This study was supported by research grants from the China Medical University Hospital (DMR-102-062), the Taiwan Ministry of Science and Technology (MOST105-2320-B-039-007), and the National Health Research Institutes (NHRI-EX105-10412NC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albayrak S, 1997, ACTA NEUROPATHOL, V94, P158, DOI 10.1007/s004010050688; Altay O, 2012, STROKE, V43, P2513, DOI 10.1161/STROKEAHA.112.661728; Aoki T, 2002, STROKE, V33, P2711, DOI 10.1161/01.STR.0000033932.34467.97; Barone FC, 1997, NEUROSCI BIOBEHAV R, V21, P31, DOI 10.1016/0149-7634(95)00080-1; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Broderick JP, 2002, CIRCULATION, V106, P1736, DOI 10.1161/01.CIR.0000030407.10591.35; CHEN ST, 1986, STROKE, V17, P738, DOI 10.1161/01.STR.17.4.738; Cheng CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23882; CHI OZ, 1992, ANESTH ANALG, V75, P31; CHI OZ, 1992, ANESTHESIOLOGY, V76, P426, DOI 10.1097/00000542-199203000-00016; DIETRICH WD, 1990, J NEUROPATH EXP NEUR, V49, P486, DOI 10.1097/00005072-199009000-00004; Dirnagl U, 2013, STROKE, V44, P1754, DOI 10.1161/STROKEAHA.113.000734; Fernandez-Lopez D, 2012, J NEUROSCI, V32, P9588, DOI 10.1523/JNEUROSCI.5977-11.2012; FISCHER S, 1995, ANESTHESIOLOGY, V82, P451, DOI 10.1097/00000542-199502000-00015; Haley M. J., 2016, J CEREB BLOOD FLOW M; Hemmen TM, 2007, STROKE, V38, P794, DOI 10.1161/01.STR.0000247920.15708.fa; Hemmen TM, 2009, J NEUROTRAUM, V26, P387, DOI 10.1089/neu.2008.0574; Jackman K, 2013, J NEUROSCI, V33, P19579, DOI 10.1523/JNEUROSCI.4318-13.2013; Knowland D, 2014, NEURON, V82, P603, DOI 10.1016/j.neuron.2014.03.003; Krieger DW, 2004, STROKE, V35, P1482, DOI 10.1161/01.STR.0000126118.44249.5c; Krueger M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056419; Kuntz M, 2014, J CEREBR BLOOD F MET, V34, P95, DOI 10.1038/jcbfm.2013.169; KUROIWA T, 1985, ACTA NEUROPATHOL, V68, P122, DOI 10.1007/BF00688633; Lai TW, 2014, PROG NEUROBIOL, V115, P157, DOI 10.1016/j.pneurobio.2013.11.006; Liu YT, 2000, BRAIN RES, V862, P111, DOI 10.1016/S0006-8993(00)02078-3; MORIKAWA E, 1992, J CEREBR BLOOD F MET, V12, P380, DOI 10.1038/jcbfm.1992.55; OLSSON Y, 1971, ACTA NEUROPATHOL, V18, P89, DOI 10.1007/BF00687597; Redel A, 2009, EXP BIOL MED, V234, P1186, DOI 10.3181/0902-RM-58; SAIJA A, 1989, NEUROPHARMACOLOGY, V28, P997, DOI 10.1016/0028-3908(89)90202-5; Schindler S., 2016, MED RES ARCH, V4, P1; Schwab S, 1998, STROKE, V29, P2461, DOI 10.1161/01.STR.29.12.2461; Shi YJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10523; Shi YJ, 2016, TRANSL STROKE RES, V7, P89, DOI 10.1007/s12975-016-0447-9; STEWART PA, 1988, BRAIN RES, V443, P12, DOI 10.1016/0006-8993(88)91593-4; Taghibiglou C, 2009, NAT MED, V15, P1399, DOI 10.1038/nm.2064; Tetrault S, 2008, EUR J NEUROSCI, V28, P1330, DOI 10.1111/j.1460-9568.2008.06443.x; Wang HL, 2014, SCI REP-UK, V4, DOI 10.1038/srep06588; Whittington RA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01388; Wu TC, 2013, LANCET NEUROL, V12, P275, DOI 10.1016/S1474-4422(13)70013-9; Xie ZC, 2008, ANN NEUROL, V64, P618, DOI 10.1002/ana.21548; Yen LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068595; Yenari MA, 2010, STROKE, V41, pS72, DOI 10.1161/STROKEAHA.110.595371; Zhang S, 2013, J NEUROSCI, V33, P7997, DOI 10.1523/JNEUROSCI.5661-12.2013; Zhou Y, 2014, PHYTOMEDICINE, V21, P998, DOI 10.1016/j.phymed.2013.12.005	45	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2017	12	1							e0170682	10.1371/journal.pone.0170682	http://dx.doi.org/10.1371/journal.pone.0170682			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7CU	28118390	Green Published, Green Submitted, gold			2022-12-26	WOS:000396160500015
J	Arnaiz-Villena, A; Palacio-Gruber, J; Muniz, E; Campos, C; Alonso-Rubio, J; Gomez-Casado, E; Salih, SF; Martin-Villa, M; Al-Qadi, R				Arnaiz-Villena, Antonio; Palacio-Gruber, Jose; Muniz, Ester; Campos, Cristina; Alonso-Rubio, Javier; Gomez-Casado, Eduardo; Salih, Shadallah Fareq; Martin-Villa, Manuel; Al-Qadi, Rawand			Genetic HLA Study of Kurds in Iraq, Iran and Tbilisi (Caucasus, Georgia): Relatedness and Medical Implications	PLOS ONE			English	Article							CLASS-I; HAPLOTYPE FREQUENCIES; ALLELE FREQUENCIES; POPULATION; POLYMORPHISM; ORIGIN; MOROCCAN; SPAIN; DIVERSITY; ASHKENAZI	Kurds from Iraq (Dohuk and Erbil Area, North Iraq) have been analyzed for HLA genes. Their HLA genetic profile has been compared with that of other Kurd groups from Iran and Tbilisi (Georgia, Caucasus) and also Worldwide populations. A total of 7,746 HLA chromosomes have been used. Genetic distances, NJ dendrograms and correspondence analyses have been carried out. Haplotype HLA-B*52-DRB1*15 is present in all three analyzed Kurd populations. HLA-A*02-B*51-DRB1*11 is present in Iraq and Georgia Kurds. Haplotypes common to Iran and Iraq Kurds are HLA DRB1*11-DQB1*03, HLA DRB1*03-DQB1*02 and others in a lower frequency. Our HLA study conclusions are that Kurds most probably belong to an ancient Mediterranean/MiddleEast/Caucasian genetic substratum and that present results and those previously obtained by us in Kurds may be useful for Medicine in future Kurd transplantation programs, HLA Epidemiology (HLA linked diseases) and Pharmacogenomics (HLA-associated drug side effects) and also for Anthropology. It is discussed that one of the most ancient Kurd ancestor groups is in Hurrians (2,000 years BC).	[Arnaiz-Villena, Antonio; Palacio-Gruber, Jose; Muniz, Ester; Campos, Cristina; Alonso-Rubio, Javier; Martin-Villa, Manuel] Univ Complutense, Sch Med, Madrid Reg Blood Ctr, Dept Immunol, Madrid, Spain; [Gomez-Casado, Eduardo] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Inmunol Anim, Autopista A6, Madrid, Spain; [Salih, Shadallah Fareq; Al-Qadi, Rawand] Dohuk Specialized Lab Ctr, HLA Typing Dept, Dohuk, Iraq	Complutense University of Madrid; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Arnaiz-Villena, A (corresponding author), Univ Complutense, Sch Med, Madrid Reg Blood Ctr, Dept Immunol, Madrid, Spain.	arnaizantonio@gmail.com	Martin-Villa, Jose M. M/F-9234-2013; Gomez-Casado, Eduardo/G-5502-2010; Al-Qadi, Rawand A/K-9778-2013; Martin-Villa, Jose M./K-2522-2019; Juárez, Ignacio/B-9242-2019	Martin-Villa, Jose M. M/0000-0002-2436-8585; Gomez-Casado, Eduardo/0000-0001-6904-1300; Martin-Villa, Jose M./0000-0002-2436-8585; Juárez, Ignacio/0000-0002-9865-3063; Al-Qadi, Rawand/0000-0001-7772-4195	Spanish Ministry of Health and Economy [PI11/00807, PI14/01067]; European FEDER funds; Mutua Madrilena Automovilista grants	Spanish Ministry of Health and Economy; European FEDER funds(European Commission); Mutua Madrilena Automovilista grants	This work was supported in part by Grants from the Spanish Ministry of Health and Economy (PI11/00807 and PI14/01067), European FEDER funds and three different Mutua Madrilena Automovilista grants.	Amirzargar A., 2015, OPEN MED J, V2, P43; [Anonymous], 2013, INS PESTS POT GLOB, DOI DOI 10.1016/B978-0-12-386895-4.00005-3; Arnaiz-Villena A, 1999, TISSUE ANTIGENS, V53, P213, DOI 10.1034/j.1399-0039.1999.530301.x; Arnaiz-Villena A, 2003, HUM BIOL, V75, P375, DOI 10.1353/hub.2003.0040; Arnaiz-Villena A, 2002, TISSUE ANTIGENS, V60, P111, DOI 10.1034/j.1399-0039.2002.600201.x; Arnaiz-Villena A, 2009, INT J IMMUNOGENET, V36, P9, DOI 10.1111/j.1744-313X.2008.00813.x; Arnaiz-Villena A, 2001, TISSUE ANTIGENS, V57, P308, DOI 10.1034/j.1399-0039.2001.057004308.x; Arnaiz-Villena A, 2001, TISSUE ANTIGENS, V57, P118, DOI 10.1034/j.1399-0039.2001.057002118.x; Arnaiz-Villena A, 2000, PREHISTORIC IBERIA: GENETICS, ANTHROPOLOGY, AND LINGUISTICS, P205; Arnaiz-Villena A., 2009, OPEN IMMUNOL J, V2, P59, DOI DOI 10.2174/1874226200902010059; Arnaiz-Villena A, 2001, ORIGIN PALESTINIANS; ARNAIZVILLENA A, 1995, HUM IMMUNOL, V43, P259, DOI 10.1016/0198-8859(95)00024-X; Ashouri E, 2016, HLA, V88, P87, DOI 10.1111/tan.12852; Becquemont L, 2010, PHARMACOGENOMICS, V11, P277, DOI [10.2217/pgs.10.38, 10.2217/PGS.10.38]; Central Intelligence Agency, 2015, WORLD FACTBOOK; Clayton J, 1997, GENETIC DIVERSITY HL, P665; Farjadian S, 2007, INT J IMMUNOGENET, V34, P457, DOI 10.1111/j.1744-313X.2007.00723.x; Farjadian S, 2004, TISSUE ANTIGENS, V64, P581, DOI 10.1111/j.1399-0039.2004.00302.x; Gomez-Casado E, 2000, TISSUE ANTIGENS, V55, P239, DOI 10.1034/j.1399-0039.2000.550307.x; Gonzalez-Galarza FF, 2015, NUCLEIC ACIDS RES, V43, pD784, DOI 10.1093/nar/gku1166; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Grahovac B, 1998, HUM GENET, V102, P27, DOI 10.1007/s004390050650; Grugni V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041252; Gunther M. M., 2011, HIST DICT KURDS; Hennerbichler F., 2012, ADV ANTHR, V2, P64, DOI [10.4236/aa.2012.22008, DOI 10.4236/AA.2012.22008]; Izaabel H, 1998, TISSUE ANTIGENS, V51, P106, DOI 10.1111/j.1399-0039.1998.tb02954.x; Jouve M. A., 1989, BALENCIAGA; Kapustin S, 1999, TISSUE ANTIGENS, V54, P517, DOI 10.1034/j.1399-0039.1999.540509.x; Longas J, 2012, MOL BIOL REP, V39, P1387, DOI 10.1007/s11033-011-0873-4; Martinez-Laso J, 2001, ANN HUM GENET, V65, P245, DOI 10.1017/S0003480001008624; MartinezLaso J, 1996, TISSUE ANTIGENS, V47, P63, DOI 10.1111/j.1399-0039.1996.tb02515.x; MARTINEZLASO J, 1995, TISSUE ANTIGENS, V45, P237, DOI 10.1111/j.1399-0039.1995.tb02446.x; Nasidze I, 2005, ANN HUM GENET, V69, P401, DOI 10.1046/j.1529-8817.2005.00174.x; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; Pingel J, 2013, HUM IMMUNOL, V74, P330, DOI 10.1016/j.humimm.2012.10.029; Rendine S, 2012, HUM IMMUNOL, V73, P399, DOI 10.1016/j.humimm.2012.01.005; Rey D., 2014, IMMUNOL INVEST; Rey D, 2013, MOL BIOL REP, V40, P5523, DOI 10.1007/s11033-013-2651-y; ROITBERGTAMBUR A, 1995, TISSUE ANTIGENS, V46, P104, DOI 10.1111/j.1399-0039.1995.tb02485.x; RUHLEN M, 1987, GUIDE WORLDS LANGUAG, V1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanchez-Velasco P, 2003, TISSUE ANTIGENS, V61, P384, DOI 10.1034/j.1399-0039.2003.00041.x; Sanchez-Velasco P, 2001, TISSUE ANTIGENS, V58, P223, DOI 10.1034/j.1399-0039.2001.580402.x; Sanchez-Velasco P, 1999, TISSUE ANTIGENS, V53, P65, DOI 10.1034/j.1399-0039.1999.530107.x; Sasazuki T., 1992, HLA 1991, P76; Sellier J., 1993, ATLAS PEUPLES ORIENT; Shahsavar F, 2017, GENOM DATA, V11, P3, DOI 10.1016/j.gdata.2016.11.012; Sulcebe G., 2009, INT J IMMUNOGENETICS; Uinuk-ool TS, 2002, HUM GENET, V110, P209, DOI 10.1007/s00439-001-0668-0; Young FW, 1996, STAT COMPUTING ENV S, ps207	53	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0169929	10.1371/journal.pone.0169929	http://dx.doi.org/10.1371/journal.pone.0169929			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114347	Green Published, Green Submitted, gold			2022-12-26	WOS:000396129000016
J	Etchegaray-Morales, I; Mendez-Martinez, S; Jimenez-Hernandez, C; Mendoza-Pinto, C; Alonso-Garcia, NE; Montiel-Jarquin, A; Lopez-Colombo, A; Garcia-Villasenor, A; Cardiel, MH; Garcia-Carrasco, M				Etchegaray-Morales, I.; Mendez-Martinez, S.; Jimenez-Hernandez, C.; Mendoza-Pinto, C.; Alonso-Garcia, N. E.; Montiel-Jarquin, A.; Lopez-Colombo, A.; Garcia-Villasenor, A.; Cardiel, M. H.; Garcia-Carrasco, M.			Factors Associated with Health-Related Quality of Life in Mexican Lupus Patients Using the LupusQol	PLOS ONE			English	Article							DISEASE-ACTIVITY; PSYCHIATRIC-DISORDERS; RHEUMATOID-ARTHRITIS; ERYTHEMATOSUS; FIBROMYALGIA; VALIDATION; DEPRESSION; DAMAGE; CLASSIFICATION; PREVALENCE	Introduction Health-related quality of life (HRQOL) is affected by numerous clinical variables, including disease activity, damage, fibromyalgia, depression and anxiety. However, these associations have not yet been described in Mexican patients with systemic lupus erythematosus (SLE). Objective To evaluate the relationship between disease activity, damage, depression and fibromyalgia and HRQOL measured by the LupusQoL-instrument in Mexican patients with SLE. Methods A cross-sectional study was conducted in women fulfilling the 1997 ACR classification criteria for SLE. HRQOL was evaluated using a disease-specific instrument for SLE, the Lupus-QoL (validated for the Spanish-speaking population). Patients were evaluated clinically to determine the degree of disease activity and damage using the Mexican Systemic Lupus Erythematosus Disease Activity Index (Mex-SLEDAI) and Systemic Lupus International Collaborating Clinics-Damage Index (SLICC), respectively. Fibromyalgia and depression were assessed using the ACR criteria and the CES-D scale, respectively. The relationship between HRQOL and these variables was measured using Spearman's rank correlation coefficient and linear regression analysis. Results A total of 138 women with SLE, age 40.3 +/- 11 years, disease duration 8.8 +/- 6.4 years, with disease activity in 51.4%, depression in 50%, damage in 43% and fibromyalgia in 19.6% were included. Poorer HRQOL correlated with depression (r = -0.61; p<0.005), fibromyalgia (r = -0.42; p<0.005), disease activity (r = -0.37; p < 0.005) and damage (r = -0.31; p < 0.005). In the multivariate linear regression analysis, damage (beta= -3.756, p < 0.005), fibromyalgia (beta = -0.920, p< 0.005), depression (beta = -0.911, p<0.005) and disease activity (beta = -0.911, p<0.005) were associated with poor HRQOL. Conclusion SLE disease activity, damage, fibromyalgia and depression were associated with poor HRQOL in our sample of Mexican SLE patients.	[Etchegaray-Morales, I.] Univ Autonoma Puebla, Sch Med, Physiotherapy Program, Puebla, Mexico; [Etchegaray-Morales, I.; Mendez-Martinez, S.; Jimenez-Hernandez, C.; Mendoza-Pinto, C.; Garcia-Carrasco, M.] Inst Mexicano Seguro Social, Reg Gen Hosp 36, System Autoimmune Dis Res Unit, Puebla 72570, Mexico; [Mendez-Martinez, S.] Inst Mexicano Seguro Social, Puebla Res Coordinat, Puebla, Mexico; [Mendoza-Pinto, C.; Garcia-Carrasco, M.] Benemerita Univ Autonoma Puebla, Dept Rheumatol, Puebla, Mexico; [Alonso-Garcia, N. E.] Benemerita Univ Autonoma Puebla, Sch Med, Dept Psychol, Puebla, Mexico; [Montiel-Jarquin, A.] Traumatol & Orthopaed Hosp, Inst Mexicano Seguro Social, Div Hlth Res, Highly Specialized Med Unit, Puebla, Mexico; [Lopez-Colombo, A.] Special Hosp Puebla, Inst Mexicano Seguro Social, Highly Specialized Med Unit, Puebla, Mexico; [Garcia-Villasenor, A.] Univ Americas Puebla, Sch Med, Cholula, Mexico; [Cardiel, M. H.] Clin Res Ctr Morelia, Morelia, Michoacan, Mexico; [Garcia-Carrasco, M.] Benemerita Univ Autonoma Puebla, Dept Immunol, Puebla, Mexico	Benemerita Universidad Autonoma de Puebla; Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social; Benemerita Universidad Autonoma de Puebla; Benemerita Universidad Autonoma de Puebla; Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social; Universidad Americas Puebla (UDLAP); Benemerita Universidad Autonoma de Puebla	Garcia-Carrasco, M (corresponding author), Inst Mexicano Seguro Social, Reg Gen Hosp 36, System Autoimmune Dis Res Unit, Puebla 72570, Mexico.; Garcia-Carrasco, M (corresponding author), Benemerita Univ Autonoma Puebla, Dept Rheumatol, Puebla, Mexico.; Garcia-Carrasco, M (corresponding author), Benemerita Univ Autonoma Puebla, Dept Immunol, Puebla, Mexico.	mgc30591@yahoo.com	Carrasco, Mario García/AAU-5477-2021; Montiel-Jarquin, Alvaro/R-3773-2017	JIMENEZ, CESAR/0000-0003-2455-2048; Montiel-Jarquin, Alvaro/0000-0003-0531-9611; Etchegaray Morales, Ivet/0000-0002-5857-4299; Mendez, Socorro/0000-0001-7463-0580				Araujo AL, 2015, REV BRAS REUMATOL, V55, P37, DOI [10.1016/j.rbr.2014.08.004, DOI 10.1016/J.RBR.2014.08.004]; Buskila D, 2003, CLIN REV ALLERG IMMU, V25, P25, DOI 10.1385/CRIAI:25:1:25; Camtbell R, 2008, ARTHRIT RHEUM-ARTHR, V59, P458, DOI 10.1002/art.23539; Carter EE, 2016, NAT REV RHE IN PRESS; Chaiamnuay S, 2010, J MED ASS THAI S6, V93, P125; Choi ST, 2012, CLIN EXP RHEUMATOL, V30, P665; Conti F, 2016, LUPUS IN PRESS; Da Costa D, 2005, ARTHRIT RHEUM-ARTHR, V53, P272, DOI 10.1002/art.21069; Devilliers H, 2012, RHEUMATOLOGY, V51, P1906, DOI 10.1093/rheumatology/kes165; Dua AB, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0380-9; Duarte C, 2010, ACTA REUMATOL PORT, V35, P30; Galarza-Maldonado C, 2010, AUTOIMMUN REV, V10, P108, DOI 10.1016/j.autrev.2010.08.012; Gao CC, 2016, LUPUS IN PRESS; Garcia-Carrasco M, 2012, LUPUS, V21, P1219, DOI 10.1177/0961203312456749; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Gonzalez-Rodriguez V, 2010, MED CLIN-BARCELONA, V134, P13, DOI 10.1016/j.medcli.2009.04.045; GUZMAN J, 1992, J RHEUMATOL, V19, P1551; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hyphantis T, 2011, LUPUS, V20, P893, DOI 10.1177/0961203311398264; Jolly M, 2010, J RHEUMATOL, V37, P1828, DOI 10.3899/jrheum.091443; Kulczycka L, 2010, J EUR ACAD DERMATOL, V24, P38, DOI 10.1111/j.1468-3083.2009.03348.x; Kuriya B, 2008, ARTHRIT RHEUM-ARTHR, V59, P181, DOI 10.1002/art.23339; Lewinsohn PM, 1997, PSYCHOL AGING, V12, P277, DOI 10.1037/0882-7974.12.2.277; Macedo EA, 2016, LUPUS IN PRESS; McElhone K, 2006, LUPUS, V15, P633, DOI 10.1177/0961203306071710; McElhone K, 2007, ARTHRIT RHEUM-ARTHR, V57, P972, DOI 10.1002/art.22881; McElhone K, 2010, J RHEUMATOL, V37, P2273, DOI 10.3899/jrheum.091277; Mok CC, 2013, ARTHRITIS RHEUM-US, V65, P2154, DOI 10.1002/art.38006; Mok CC, 2016, CLIN EXP RH IN PRESS; Mok MY, 2010, LUPUS, V19, P1384, DOI 10.1177/0961203310375832; Pettersson S, 2012, SCAND J RHEUMATOL, V41, P383, DOI 10.3109/03009742.2012.677857; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ramos-Remus C, 2014, RHEUMATOL INT, V34, P1743, DOI 10.1007/s00296-014-3044-9; Schmeding A, 2013, BEST PRACT RES CL RH, V27, P363, DOI 10.1016/j.berh.2013.07.009; Shen B, 2014, CLIN EXP RHEUMATOL, V32, P101; Staud Roland, 2006, Curr Rheumatol Rep, V8, P430, DOI 10.1007/s11926-006-0037-z; Tamayo T, 2010, LUPUS, V19, P1606, DOI 10.1177/0961203310377090; Toloza Sergio M A, 2010, Curr Rheumatol Rep, V12, P237, DOI 10.1007/s11926-010-0110-5; Torrente-Segarra V, 2010, CLIN EXP RHEUMATOL, V28, pS22; Touma Z, 2011, J RHEUMATOL, V38, P1898, DOI 10.3899/jrheum.110007; Valencia-Flores M, 2004, LUPUS, V13, P4, DOI 10.1191/0961203304lu480oa; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2010, J RHEUMATOL, V37, P305, DOI 10.3899/jrheum.090781; Yilmaz-Oner S, 2015, CLIN EXP RHEUMATOL, V33, P360; Zhu LW, 2010, CLIN RHEUMATOL, V29, P1413, DOI 10.1007/s10067-010-1477-4	45	24	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170209	10.1371/journal.pone.0170209	http://dx.doi.org/10.1371/journal.pone.0170209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114336	Green Submitted, Green Published, gold			2022-12-26	WOS:000396129000025
J	Sawada, Y; Hangai, M; Ishikawa, M; Yoshitomi, T				Sawada, Yu; Hangai, Masanori; Ishikawa, Makoto; Yoshitomi, Takeshi			Association of Myopic Deformation of Optic Disc with Visual Field Progression in Paired Eyes with Open-Angle Glaucoma	PLOS ONE			English	Article							NORMAL-TENSION GLAUCOMA; NERVE HEAD BIOMECHANICS; INTRAOCULAR-PRESSURE; BETA-ZONE; PARAPAPILLARY ATROPHY; PERIPAPILLARY ATROPHY; RISK-FACTOR; MICROSTRUCTURE; DAMAGE; METAANALYSIS	Purpose The influence of myopia on glaucoma progression remains unknown, possibly because of the multifactorial nature of glaucoma and difficulty in assessing a solo contribution of myopia. The purpose of this study is to investigate the association of myopia with visual field (VF) progression in glaucoma using a paired-eye design to minimize the influence of confounding systemic factors that are diverse among individuals. Methods This retrospective study evaluated 144 eyes of 72 subjects with open-angle glaucoma, with similar intra-ocular pressure between paired eyes, spherical equivalent (SE) <= -2 diopter (D), and axial length >= 24 mm. Paired eyes with faster and slower VF progression were grouped separately, according to the global VF progression rate assessed by automated pointwise linear regression analysis. The SE, axial length, tilt ratio and torsion angle of optic discs, Bruch's membrane (BM) opening area, and gamma zone parapapillary atrophy (PPA) width were compared between the two groups. Factors associated with faster VF progression were determined by logistic regression analysis. Results The mean follow-up duration was 8.9 +/- 4.4 years. The mean value of SE and axial length were -6.31 +/- 1.88 D and 26.05 +/- 1.12 mm, respectively. The mean global visual field progression rate was -0.32 +/- 0.38 dB/y. Tilt ratio, BM opening area, and gamma zone PPA width were significantly greater in the eyes with faster VF progression than those with slower progression. In multivariate analysis, these factors were significantly associated with faster VF progression (all P < 0.05), while SE and axial length were not associated with it. Conclusion In myopic glaucoma subjects, tilt of the optic disc and temporal shifting and enlargement of the BM opening were associated with faster rate of VF progression between paired eyes. This suggests that myopia influences VF progression in glaucomatous eyes via optic disc deformations rather than via refractive error itself.	[Sawada, Yu; Ishikawa, Makoto; Yoshitomi, Takeshi] Akita Univ, Grad Sch Med, Dept Ophthalmol, Akita, Japan; [Hangai, Masanori] Saitama Med Univ, Dept Ophthalmol, Saitama, Japan	Akita University; Saitama Medical University	Sawada, Y (corresponding author), Akita Univ, Grad Sch Med, Dept Ophthalmol, Akita, Japan.	sawadayu@doc.med.akita-u.ac.jp		Ishikawa, Makoto/0000-0002-1808-1799				Anderson DR, 2003, AM J OPHTHALMOL, V136, P820, DOI 10.1016/S0002-9394(03)00478-1; CARTWRIGHT MJ, 1988, ARCH OPHTHALMOL-CHIC, V106, P898; Charlson ME, 2014, OPHTHALMOLOGY, V121, P2004, DOI 10.1016/j.ophtha.2014.04.016; Chihara E, 1997, OPHTHALMOLOGICA, V211, P66, DOI 10.1159/000310760; Choi JA, 2014, JAMA OPHTHALMOL, V132, P1068, DOI 10.1001/jamaophthalmol.2014.1056; CRICHTON A, 1989, OPHTHALMOLOGY, V96, P1312; Dai Y, 2013, INVEST OPHTH VIS SCI, V54, P2013, DOI 10.1167/iovs.12-11255; De Moraes CGV, 2009, ARCH OPHTHALMOL-CHIC, V127, P1129, DOI 10.1001/archophthalmol.2009.165; Drance S, 2001, AM J OPHTHALMOL, V131, P699, DOI 10.1016/S0002-9394(01)00964-3; ELMASSRI A, 1971, BRIT J OPHTHALMOL, V55, P12, DOI 10.1136/bjo.55.1.12; Ernest PJ, 2013, OPHTHALMOLOGY, V120, P512, DOI 10.1016/j.ophtha.2012.09.005; Girard MJA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3113682; Hayashi K, 2012, INVEST OPHTH VIS SCI, V53, P1499, DOI 10.1167/iovs.11-8572; Jonas JB, 2004, INVEST OPHTH VIS SCI, V45, P2660, DOI 10.1167/iovs.03-1363; Jonas JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047237; Jonas JB, 2011, AM J OPHTHALMOL, V152, P1021, DOI 10.1016/j.ajo.2011.05.006; Jonas JB, 2010, ACTA OPHTHALMOL, V88, pe317, DOI 10.1111/j.1755-3768.2010.02022.x; Kim YW, 2014, OPHTHALMOLOGY, V121, P1341, DOI 10.1016/j.ophtha.2014.01.008; Lee JY, 2015, INVEST OPHTH VIS SCI, V56, P1775, DOI 10.1167/iovs.14-16002; Lee JE, 2015, INVEST OPHTH VIS SCI, V56, P6925, DOI 10.1167/iovs.15-17892; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Leung DYL, 2009, OPHTHALMOLOGY, V116, P1250, DOI 10.1016/j.ophtha.2009.02.003; Marcus MW, 2011, OPHTHALMOLOGY, V118, P1989, DOI 10.1016/j.ophtha.2011.03.012; Mitchell P, 1999, OPHTHALMOLOGY, V106, P2010, DOI 10.1016/S0161-6420(99)90416-5; Murata K, 2002, MED STAT EVIDENCE BA; Nicolela MT, 1996, AM J OPHTHALMOL, V121, P502, DOI 10.1016/S0002-9394(14)75424-8; Norman RE, 2011, EXP EYE RES, V93, P4, DOI 10.1016/j.exer.2010.09.014; Nouri-Mahdavi K, 2004, OPHTHALMOLOGY, V111, P1627, DOI 10.1016/j.ophtha.2004.02.017; OhnoMatsui K, 1997, AM J OPHTHALMOL, V123, P494, DOI 10.1016/S0002-9394(14)70175-8; Park HYL, 2012, OPHTHALMOLOGY, V119, P1844, DOI 10.1016/j.ophtha.2012.03.006; QUIGLEY HA, 1983, AM J OPHTHALMOL, V95, P673, DOI 10.1016/0002-9394(83)90389-6; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; Samarawickrama C, 2011, OPHTHALMOLOGY, V118, P2050, DOI 10.1016/j.ophtha.2011.02.040; Sawada Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161961; Sigal IA, 2005, INVEST OPHTH VIS SCI, V46, P4189, DOI 10.1167/iovs.05-0541; Sigal IA, 2007, EXP EYE RES, V85, P312, DOI 10.1016/j.exer.2007.05.005; Sohn SW, 2010, AM J OPHTHALMOL, V149, P831, DOI 10.1016/j.ajo.2009.12.033; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Sung MS, 2016, OPHTHALMOLOGY, V123, P1484, DOI 10.1016/j.ophtha.2016.03.040; Tay E, 2005, AM J OPHTHALMOL, V139, P247, DOI 10.1016/j.ajo.2004.08.076; Yamada H, 2016, OPHTHALMOLOGY, V123, P542, DOI 10.1016/j.ophtha.2015.10.061; Zhao D, 2015, OPHTHALMOLOGY, V122, P72, DOI 10.1016/j.ophtha.2014.07.051	42	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170733	10.1371/journal.pone.0170733	http://dx.doi.org/10.1371/journal.pone.0170733			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114308	Green Published, Green Submitted, gold			2022-12-26	WOS:000396129000091
J	Young, MF; Nguyen, PH; Addo, OY; Pham, H; Nguyen, S; Martorell, R; Ramakrishnan, U				Young, Melissa F.; Nguyen, Phuong Hong; Addo, O. Yaw; Pham, Hoa; Nguyen, Son; Martorell, Reynaldo; Ramakrishnan, Usha			Timing of Gestational Weight Gain on Fetal Growth and Infant Size at Birth in Vietnam	PLOS ONE			English	Article							MATERNAL NUTRITIONAL-STATUS; INTERNATIONAL STANDARDS; PREGNANCY; LENGTH; PATTERNS; INCOME; WOMEN; AGE	Objective To examine the importance of timing of gestational weight gain during three time periods: 1: <= 20 weeks gestation), 2: 21-29 weeks) and 3: >= 30 weeks) on fetal growth and infant birth size. Methods Study uses secondary data from the PRECONCEPT randomized controlled trial in Thai Nguyen province, Vietnam (n = 1436). Prospective data were collected on women starting pre-pregnancy through delivery. Maternal conditional weight gain (CWG) was defined as window-specific weight gains, uncorrelated with pre-pregnancy body mass index and all prior body weights. Fetal biometry, was assessed by ultrasound measurements of head and abdomen circumferences, biparietal diameter, and femoral length throughout pregnancy. Birth size outcomes included weight and length, and head, abdomen and mid upper arm circumferences as well as small for gestational age (SGA). Adjusted generalized linear and logistic models were used to examine associations. Results Overall, three-quarters of women gained below the Institute of Medicine guidelines, and these women were 2.5 times more likely to give birth to a SGA infant. Maternal CWG in the first window (<= 20 weeks), followed by 21-29 weeks, had the greatest association on all parameters of fetal growth (except abdomen circumference) and infant size at birth. For birth weight, a 1 SD increase CWG in the first 20 weeks had 3 times the influence compared to later CWG (>= 30 weeks) (111 g vs. 39 g) and was associated with a 43% reduction in SGA risk (OR (95% CI): 0.57 (0.46-0.70). Conclusion There is a need to target women before or early in pregnancy to ensure adequate nutrition to maximize impact on fetal growth and birth size.	[Young, Melissa F.; Addo, O. Yaw; Martorell, Reynaldo; Ramakrishnan, Usha] Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Nguyen, Phuong Hong; Pham, Hoa; Nguyen, Son] Thai Nguyen Univ Pharm & Med, Thai Nguyen, Vietnam; [Nguyen, Phuong Hong] Int Food Policy Res Inst, Washington, DC USA	Emory University; Thai Nguyen University; CGIAR; International Food Policy Research Institute (IFPRI)	Young, MF (corresponding author), Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.	melissa.young@emory.edu	Martorell, Reynaldo/I-2539-2012	Addo, O.Yaw/0000-0003-1269-759X	Thrasher Research Fund (Early Career Award) [12281]; Micronutrient Initiative; Mathile Institute for Advancement of Human Nutrition; Thrasher Research fund; Mathile Institute for the Advancement of Human Nutrition	Thrasher Research Fund (Early Career Award); Micronutrient Initiative; Mathile Institute for Advancement of Human Nutrition; Thrasher Research fund; Mathile Institute for the Advancement of Human Nutrition	This work was supported by the Thrasher Research Fund (Early Career Award, MY; 12281; https://www.thrasherresearch.org/) Micronutrient Initiative (UR;www.micronutrient.org/) & the Mathile Institute for Advancement of Human Nutrition (UR; mathileinstitute.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this research was provided by the Thrasher Research fund, Mathile Institute for the Advancement of Human Nutrition and the Micronutrient Initiative.	ABRAMS B, 1995, OBSTET GYNECOL, V86, P163, DOI 10.1016/0029-7844(95)00118-B; Abu-Saad K, 2010, EPIDEMIOL REV, V32, P5, DOI 10.1093/epirev/mxq001; Adair LS, 2013, LANCET, V382, P525, DOI 10.1016/S0140-6736(13)60103-8; Ay L, 2009, BJOG-INT J OBSTET GY, V116, P953, DOI 10.1111/j.1471-0528.2009.02143.x; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Brown JE, 2002, AM J CLIN NUTR, V76, P205, DOI 10.1093/ajcn/76.1.205; CHITTY LS, 1994, BRIT J OBSTET GYNAEC, V101, P125, DOI 10.1111/j.1471-0528.1994.tb13077.x; Davenport MH, 2013, OBSTET GYNECOL, V122, P255, DOI 10.1097/AOG.0b013e31829a3b86; Deputy NP, 2015, SOC PED PER EP RES A; Gwatkin D R, 2007, Niger J Clin Pract, V10, P272; Hickey CA, 1996, OBSTET GYNECOL, V88, P490, DOI 10.1016/0029-7844(96)00262-1; Institute of Medicine, 2009, WEIGHT GAIN PREGNANC; Karachaliou M, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.12.038; Li RW, 1998, AM J HUM BIOL, V10, P529, DOI 10.1002/(SICI)1520-6300(1998)10:4<529::AID-AJHB13>3.0.CO;2-A; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Margerison-Zilko CE, 2012, MATERN CHILD HLTH J, V16, P1215, DOI 10.1007/s10995-011-0846-1; Meire HB, 1995, BASIC ULTRASOUND; Misra VK, 2010, J MATERN-FETAL NEO M, V23, P842, DOI 10.3109/14767050903387037; Neufeld L, 1999, AM J HUM BIOL, V11, P627, DOI 10.1002/(SICI)1520-6300(199909/10)11:5<627::AID-AJHB6>3.0.CO;2-X; Neufeld LM, 2004, AM J CLIN NUTR, V79, P646; Neufeld LM, 2006, PAEDIATR PERINAT EP, V20, P290, DOI 10.1111/j.1365-3016.2006.00741.x; Nguyen PH, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-898; OBRIEN GD, 1981, AM J OBSTET GYNECOL, V141, P833, DOI 10.1016/0002-9378(81)90713-4; Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2; Nguyen PH, 2016, PAEDIATR PERINAT EP, V30, P256, DOI 10.1111/ppe.12276; Raje L, 2012, J DEV ORIG HLTH DIS, V3, P387, DOI 10.1017/S2040174412000335; SCHOLL TO, 1990, OBSTET GYNECOL, V75, P948; Siega-Riz AM, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.07.002; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Young MF, 2015, EUR J OBSTET GYN R B, V194, P223, DOI 10.1016/j.ejogrb.2015.09.018	32	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170192	10.1371/journal.pone.0170192	http://dx.doi.org/10.1371/journal.pone.0170192			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114316	Green Submitted, gold, Green Published			2022-12-26	WOS:000396129000024
J	Dufresnes, C; Jan, C; Bienert, F; Goudet, J; Fumagalli, L				Dufresnes, Christophe; Jan, Catherine; Bienert, Friederike; Goudet, Jerome; Fumagalli, Luca			Broad-Scale Genetic Diversity of Cannabis for Forensic Applications	PLOS ONE			English	Article							POPULATION-STRUCTURE; SATIVA L; NOMENCLATURE PROPOSAL; SNPSTR HAPLOTYPES; MULTIPLEX SYSTEM; MARIJUANA; MARKERS; PLANTS; IDENTIFICATION; CANNABACEAE	Cannabis (hemp and marijuana) is an iconic yet controversial crop. On the one hand, it represents a growing market for pharmaceutical and agricultural sectors. On the other hand, plants synthesizing the psychoactive THC produce the most widespread illicit drug in the world. Yet, the difficulty to reliably distinguish between Cannabis varieties based on morphological or biochemical criteria impedes the development of promising industrial programs and hinders the fight against narcotrafficking. Genetics offers an appropriate alternative to characterize drug vs. non-drug Cannabis. However, forensic applications require rapid and affordable genotyping of informative and reliable molecular markers for which a broad-scale reference database, representing both intra-and inter-variety variation, is available. Here we provide such a resource for Cannabis, by genotyping 13 microsatellite loci (STRs) in 1 324 samples selected specifically for fibre (24 hemp varieties) and drug (15 marijuana varieties) production. We showed that these loci are sufficient to capture most of the genomewide diversity patterns recently revealed by NGS data. We recovered strong genetic structure between marijuana and hemp and demonstrated that anonymous samples can be confidently assigned to either plant types. Fibres appear genetically homogeneous whereas drugs show low (often clonal) diversity within varieties, but very high genetic differentiation between them, likely resulting from breeding practices. Based on an additional test dataset including samples from 41 local police seizures, we showed that the genetic signature of marijuana cultivars could be used to trace crime scene evidence. To date, our study provides the most comprehensive genetic resource for Cannabis forensics worldwide.	[Dufresnes, Christophe; Bienert, Friederike; Fumagalli, Luca] Univ Lausanne, Dept Ecol & Evolut, Lab Conservat Biol, Biophore Bldg, Lausanne, Switzerland; [Jan, Catherine; Goudet, Jerome; Fumagalli, Luca] Ctr Univ Romand Med Legale, Chemin Vuillette 4, Lausanne, Switzerland; [Goudet, Jerome] Univ Lausanne, Dept Ecol & Evolut, Biophore Bldg, Lausanne, Switzerland	University of Lausanne; University of Lausanne	Fumagalli, L (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Lab Conservat Biol, Biophore Bldg, Lausanne, Switzerland.; Fumagalli, L (corresponding author), Ctr Univ Romand Med Legale, Chemin Vuillette 4, Lausanne, Switzerland.	Luca.Fumagalli@unil.ch	Dufresnes, Christophe/U-1387-2019	Fumagalli, Luca/0000-0002-6648-2570; Goudet, Jerome/0000-0002-5318-7601	Swiss National Science Foundation (SNSF) [31003A_130234]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	This work was supported by Swiss National Science Foundation (SNSF). Grant number 31003A_130234 to LF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alghanim HJ, 2003, ANAL BIOANAL CHEM, V376, P1225, DOI 10.1007/s00216-003-1984-0; Anderson P, 2006, DRUG ALCOHOL REV, V25, P489, DOI 10.1080/09595230600944446; BAKER PB, 1982, B NARCOTICS, V34, P27; Cabezudo B, 1997, ATMOS ENVIRON, V31, P3323, DOI 10.1016/S1352-2310(97)00161-1; Chandra S, 2011, PLANTA MED, V77-P_5; Clarke RC, 2013, CANNABIS: EVOLUTION AND ETHNOBOTANY, P1; Coyle HM, 2003, CROAT MED J, V44, P315; de Meijer E, 2014, CHEM PHENOTYPES CHEM, P89; de Meijer EPM, 2003, GENETICS, V163, P335; DEMEIJER EPM, 1992, EUPHYTICA, V62, P201, DOI 10.1007/BF00041754; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Gao C, 2012, PLOS ONE, V9; Gilmore S, 2003, FORENSIC SCI INT, V131, P65, DOI 10.1016/S0379-0738(02)00397-3; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guerriero G, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.00019, 10.3389/fpls.2016.00463]; Hillig KW, 2005, GENET RESOUR CROP EV, V52, P161, DOI 10.1007/s10722-003-4452-y; Hillig KW, 2004, AM J BOT, V91, P966, DOI 10.3732/ajb.91.6.966; Houston R, 2016, INT J LEGAL MED, V130, P635, DOI 10.1007/s00414-015-1296-x; Howard C, 2008, J FORENSIC SCI, V53, P1061, DOI 10.1111/j.1556-4029.2008.00792.x; Howard C, 2009, J FORENSIC SCI, V54, P556, DOI 10.1111/j.1556-4029.2009.01014.x; Hsieh HM, 2003, FORENSIC SCI INT, V131, P53, DOI 10.1016/S0379-0738(02)00395-X; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kohnemann S, 2012, INT J LEGAL MED, V126, P601, DOI 10.1007/s00414-012-0706-6; McKernan KJ, 2015, BIORXIV; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piluzza G, 2013, GENET RESOUR CROP EV, V60, P2331, DOI 10.1007/s10722-013-0001-5; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Presinszka M, 2015, MENDELNET 2015, P434; Pritchard JK, 2000, GENETICS, V155, P945; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; ROWAN MG, 1977, J PHARM PHARMACOL, V29, P491, DOI 10.1111/j.2042-7158.1977.tb11375.x; Sawler J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133292; SMALL E, 1976, TAXON, V25, P405, DOI 10.2307/1220524; Small E, 2015, BOT REV, V81, P189, DOI 10.1007/s12229-015-9157-3; Staginnus C, 2014, J FORENSIC SCI, V59, P919, DOI 10.1111/1556-4029.12448; Tipparat P, 2012, FORENSIC SCI INT, V215, P164, DOI 10.1016/j.forsciint.2011.05.006; United Nations Office on Drugs and Crime, UN PUBLICATION SALES; Valverde L, 2014, FORENSIC SCI INT-GEN, V13, P185, DOI 10.1016/j.fsigen.2014.08.002; Valverde L, 2014, FORENSIC SCI INT-GEN, V9, P61, DOI 10.1016/j.fsigen.2013.11.001; van Bakel H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r102; Weiblen GD, 2015, NEW PHYTOL, V208, P1241, DOI 10.1111/nph.13562; Welling MT, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01113; Welling MT, 2016, EUPHYTICA, V208, P463, DOI 10.1007/s10681-015-1585-y	47	27	27	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170522	10.1371/journal.pone.0170522	http://dx.doi.org/10.1371/journal.pone.0170522			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107530	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000392405300154
J	Erudaitius, D; Huang, A; Kazmi, S; Buettner, GR; Rodgers, VGJ				Erudaitius, Dieanira; Huang, Andrew; Kazmi, Sarah; Buettner, Garry R.; Rodgers, Victor G. J.			Peroxiporin Expression Is an Important Factor for Cancer Cell Susceptibility to Therapeutic H2O2: Implications for Pharmacological Ascorbate Therapy	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; PANCREATIC-CANCER; INDUCED CYTOTOXICITY; IN-VIVO; CATALYTIC METALS; TUMOR-CELLS; VITAMIN-C; ACID; GEMCITABINE; AQUAPORINS	Cancer cell toxicity to therapeutic H2O2 varies widely depending on cell type. Interestingly, it has been observed that different cancer cell types have varying peroxiporin expression. We hypothesize that variation in peroxiporin expression can alter cell susceptibility to therapeutic H2O2 concentrations. Here, we silence peroxiporin aquaporin-3 (AQP3) on the pancreatic cancer cell line MIA PaCa-2 and compare clonogenic survival response to the wild-type. The results showed a significantly higher surviving fraction in the clonogenic response for siAQP3 MIA PaCa-2 cells at therapeutic H2O2 doses (P < 0.05). These results suggest that peroxiporin expression is significant in modulating the susceptibility of cancer cells to ascorbate therapy.	[Erudaitius, Dieanira; Kazmi, Sarah; Rodgers, Victor G. J.] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA; [Huang, Andrew] Univ Calif Riverside, Dept Neurosci, Riverside, CA 92521 USA; [Buettner, Garry R.] Univ Iowa, Coll Med, Dept Radiat Oncol, Free Radical & Radiat Biol, Iowa City, IA USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of Iowa	Rodgers, VGJ (corresponding author), Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA.	victor.rodgers@ucr.edu	Rodgers, Victor G. J./AAF-3838-2021; Rodgers, Victor G/G-3652-2016	Rodgers, Victor G. J./0000-0002-1857-8025; Rodgers, Victor G/0000-0002-1857-8025; Buettner, Garry/0000-0002-5594-1903; Huang, Andrew/0000-0001-5130-5910	NATIONAL CANCER INSTITUTE [P30CA086862, R01CA169046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA169046, P30 CA086862] Funding Source: Medline; NIEHS NIH HHS [P30 ES005605] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Almasalmeh A, 2014, FEBS J, V281, P647, DOI 10.1111/febs.12653; BENADE L, 1969, ONCOLOGY-BASEL, V23, P33, DOI 10.1159/000224465; BUETTNER GR, 1988, J BIOCHEM BIOPH METH, V16, P27, DOI 10.1016/0165-022X(88)90100-5; Buettner GR, 1996, RADIAT RES, V145, P532, DOI 10.2307/3579271; Castro ML, 2014, FREE RADICAL BIO MED, V74, P200, DOI 10.1016/j.freeradbiomed.2014.06.022; Chen P, 2012, ANTI-CANCER DRUG, V23, P437, DOI 10.1097/CAD.0b013e32834fd01f; Chen Q, 2005, P NATL ACAD SCI USA, V102, P13604, DOI 10.1073/pnas.0506390102; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; Chen Q, 2007, P NATL ACAD SCI USA, V104, P8749, DOI 10.1073/pnas.0702854104; Cieslak JA, 2015, CURR PHARM BIOTECHNO, V16, P759, DOI 10.2174/138920101609150715135921; Cieslak JA, 2015, FREE RADICAL BIO MED, V83, P227, DOI 10.1016/j.freeradbiomed.2015.02.018; Doskey CM, 2016, REDOX BIOL, V10, P274, DOI 10.1016/j.redox.2016.10.010; Doskey CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132572; Du J, 2015, CANCER RES, V75, P3314, DOI 10.1158/0008-5472.CAN-14-1707; Du J, 2015, FREE RADICAL BIO MED, V84, P289, DOI 10.1016/j.freeradbiomed.2015.03.033; Du J, 2013, MOL CARCINOGEN, V52, P555, DOI 10.1002/mc.21891; Du J, 2012, BBA-REV CANCER, V1826, P443, DOI 10.1016/j.bbcan.2012.06.003; Du JA, 2010, CLIN CANCER RES, V16, P509, DOI 10.1158/1078-0432.CCR-09-1713; Espey MG, 2011, FREE RADICAL BIO MED, V50, P1610, DOI 10.1016/j.freeradbiomed.2011.03.007; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Frei B, 2008, P NATL ACAD SCI USA, V105, P11037, DOI 10.1073/pnas.0806433105; Halliwell B, 1999, TRENDS BIOCHEM SCI, V24, P255, DOI 10.1016/S0968-0004(99)01418-8; Herst PM, 2012, FREE RADICAL BIO MED, V52, P1486, DOI 10.1016/j.freeradbiomed.2012.01.021; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Klingelhoeffer C, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-61; Low FM, 2007, BLOOD, V109, P2611, DOI 10.1182/blood-2006-09-048728; Ma Y, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007154; Munshi A, 2005, METH MOLEC MED, V110, P21; Ng CF, 2007, FREE RADICAL RES, V41, P1201, DOI 10.1080/10715760701625075; Olney KE, 2013, FREE RADICAL RES, V47, P154, DOI 10.3109/10715762.2012.755263; Ranzato E, 2011, AM J RESP CELL MOL, V44, P108, DOI 10.1165/rcmb.2009-0340OC; Rawal M, 2013, CANCER RES, V73, P5232, DOI 10.1158/0008-5472.CAN-13-0470; Sasaki K, 1998, BBA-GEN SUBJECTS, V1380, P275, DOI 10.1016/S0304-4165(97)00152-9; Sestili P, 1996, J PHARMACOL EXP THER, V277, P1719; Shatzer AN, 2013, LEUKEMIA LYMPHOMA, V54, P1069, DOI 10.3109/10428194.2012.739686; Sies H, 2014, J BIOL CHEM, V289, P8735, DOI 10.1074/jbc.R113.544635; Tian JQ, 2010, CANCER BIOTHER RADIO, V25, P439, DOI 10.1089/cbr.2009.0756; Trigueros-Motos L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-434; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Verkman AS, 2008, J MOL MED, V86, P523, DOI 10.1007/s00109-008-0303-9; Wagner BA, 2013, REDOX BIOL, V1, P210, DOI 10.1016/j.redox.2013.01.011; Welsh JL, 2013, CANCER CHEMOTH PHARM, V71, P765, DOI 10.1007/s00280-013-2070-8; Wu B, 2007, CELL MOL LIFE SCI, V64, P2413, DOI 10.1007/s00018-007-7163-2	43	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170442	10.1371/journal.pone.0170442	http://dx.doi.org/10.1371/journal.pone.0170442			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107421	Green Published, gold			2022-12-26	WOS:000392405300136
J	Perichon, B; Szili, N; du Merle, L; Rosinski-Chupin, I; Gominet, M; Bellais, S; Poyart, C; Trieu-Cuot, P; Dramsi, S				Perichon, Bruno; Szili, Noemi; du Merle, Laurence; Rosinski-Chupin, Isabelle; Gominet, Myriam; Bellais, Samuel; Poyart, Claire; Trieu-Cuot, Patrick; Dramsi, Shaynoor			Regulation of PI-2b Pilus Expression in Hypervirulent Streptococcus agalactiae ST-17 BM110	PLOS ONE			English	Article							GROUP-B STREPTOCOCCUS; RNA-SEQ; IDENTIFICATION; VIRULENCE; DISEASE; DIVERSITY; ISLANDS; SYSTEM	The widely spread Streptococcus agalactiae (also known as Group B Streptococcus, GBS) "hypervirulent" ST17 clone is strongly associated with neonatal meningitis. The PI-2b locus is mainly found in ST17 strains but is also present in a few non ST17 human isolates such as the ST-7 prototype strain A909. Here, we analysed the expression of the PI-2b pilus in the ST17 strain BM110 as compared to the non ST17 A909. Comparative genome analyses revealed the presence of a 43-base pair (bp) hairpin-like structure in the upstream region of PI-2b operon in all 26 ST17 genomes, which was absent in the 8 non-ST17 strains carrying the PI-2b locus. Deletion of this 43-bp sequence in strain BM110 resulted in a 3-to 5-fold increased transcription of PI-2b. Characterization of PI-2b promoter region in A909 and BM110 strains was carried out by RNAseq, primer extension, qRT-PCR and transcriptional fusions with gfp as reporter gene. Our results indicate the presence of a single promoter (Ppi2b) with a transcriptional start site (TSS) mapped 37 bases upstream of the start codon of the first PI-2b gene. The large operon of 16 genes located upstream of PI-2b codes for the group B carbohydrate (also known as antigen B), a major constituent of the bacterial cell wall. We showed that the hairpin sequence located between antigen B and PI-2b operons is a transcriptional terminator. In A909, increased expression of PI-2b probably results from read-through transcription from antigen B operon. In addition, we showed that an extended 5' promoter region is required for maximal transcription of gfp as a reporter gene in S. agalactiae from Ppi2b promoter. Gene reporter assays performed in Lactococcus lactis strain NZ9000, a related non-pathogenic Gram-positive species, revealed that GBS-specific regulatory factors are required to drive PI-2b transcription. PI-2b expression is up-regulated in the BM110 Delta covR mutant as compared to the parental BM110 strain, but this effect is probably indirect. Collectively, our results indicate that PI-2b expression is regulated in GBS ST17 strains, which may confer a selective advantage in the human host either by reducing host immune responses and/or increasing their dissemination potential.	[Perichon, Bruno; Szili, Noemi; du Merle, Laurence; Gominet, Myriam; Trieu-Cuot, Patrick; Dramsi, Shaynoor] Inst Pasteur, Biol Gram Posit Pathogens Unit, Paris, France; [Perichon, Bruno; Szili, Noemi; du Merle, Laurence; Gominet, Myriam; Trieu-Cuot, Patrick; Dramsi, Shaynoor] CNRS, ERL3526, Paris, France; [Rosinski-Chupin, Isabelle] Inst Pasteur, Unite Ecol & Evolut Resistance Antibiot, Paris, France; [Bellais, Samuel; Poyart, Claire] CNRS UMR, Inserm 1016, Inst Cochin, Equipe Barrieres & Pathogenes, Paris, France; [Bellais, Samuel; Poyart, Claire] Hop Univ Paris Ctr, AP HP, Site Cochin, Paris, France; [Poyart, Claire] Hop Univ Paris Ctr, AP HP, CNR Streptocoques, Site Cochin, Paris, France; [Poyart, Claire] DHU Risques & Grossesse, AP HP, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP)	Dramsi, S (corresponding author), Inst Pasteur, Biol Gram Posit Pathogens Unit, Paris, France.; Dramsi, S (corresponding author), CNRS, ERL3526, Paris, France.	shaynoor.dramsi@pasteur.fr	POYART, Claire/P-4225-2017	POYART, Claire/0000-0003-2158-6293; TRIEU-CUOT, Patrick/0000-0002-2768-9587	Conseil Regional d'Ile-de-France [DIM130065]; DIM Malinf	Conseil Regional d'Ile-de-France(Region Ile-de-France); DIM Malinf	This work was supported by the DIM Malinf from the Conseil Regional d'Ile-de-France (Grant DIM130065) to CP and SD. NS was recipient of a doctoral fellowship from the DIM Malinf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brochet M, 2006, MICROBES INFECT, V8, P1227, DOI 10.1016/j.micinf.2005.11.010; Campisi E, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01265; Chattopadhyay D, 2011, MICROBES INFECT, V13, P369, DOI 10.1016/j.micinf.2010.12.009; Cozzi R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125875; Da Cunha V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5544; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Jiang SM, 2012, J BACTERIOL, V194, P2479, DOI 10.1128/JB.00202-12; Jiang SM, 2005, J BACTERIOL, V187, P1105, DOI 10.1128/JB.187.3.1105-1113.2005; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Lamy MC, 2004, MOL MICROBIOL, V54, P1250, DOI 10.1111/j.1365-2958.2004.04365.x; Lazzarin M, 2015, FASEB J, V29, P4629, DOI 10.1096/fj.15-272500; Lembo A, 2010, MOL MICROBIOL, V77, P431, DOI 10.1111/j.1365-2958.2010.07215.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madzivhandila M, 2013, J MED MICROBIOL, V62, P249, DOI 10.1099/jmm.0.052951-0; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; MUSSER JM, 1989, P NATL ACAD SCI USA, V86, P4731, DOI 10.1073/pnas.86.12.4731; Parker RE, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0704-9; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; Poyart C, 2008, EMERG INFECT DIS, V14, P1647, DOI 10.3201/eid1410.080185; Rinaudo CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009216; Rosini R, 2006, MOL MICROBIOL, V61, P126, DOI 10.1111/j.1365-2958.2006.05225.x; Rosinski-Chupin I, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1583-4; Rosinski-Chupin I, 2014, METHOD ENZYMOL, V549, P3, DOI 10.1016/B978-0-12-801122-5.00001-5; Six A, 2015, MOL MICROBIOL, V97, P1209, DOI 10.1111/mmi.13097; Springman AC, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-159; Sutcliffe IC, 2008, MICROBIOL-SGM, V154, P1354, DOI 10.1099/mic.0.2007/014522-0; Tazi A, 2010, J EXP MED, V207, P2313, DOI 10.1084/jem.20092594; Teatero S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20047; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017	29	14	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0169840	10.1371/journal.pone.0169840	http://dx.doi.org/10.1371/journal.pone.0169840			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107386	gold, Green Published, Green Submitted			2022-12-26	WOS:000392405300047
J	Prockow, M; Strzala, T; Kuznik-Kowalska, E; Prockow, J; Mackiewicz, P				Prockow, Malgorzata; Strzala, Tomasz; Kuznik-Kowalska, Elzbieta; Prockow, Jaroslaw; Mackiewicz, Pawel			Ongoing Speciation and Gene Flow between Taxonomically Challenging Trochulus Species Complex (Gastropoda: Hygromiidae)	PLOS ONE			English	Article							PULMONATA HYGROMIIDAE; POPULATION-STRUCTURE; LAND SNAILS; DELIMITATION; DIVERGENCE; DIFFERENTIATION; INFERENCE; EVOLUTION; MICROSATELLITES; PHYLOGENETICS	Geographical isolation, selection and genetic drift can cause the geographical diversification of populations and lead to speciation. Land snail species in the genus Trochulus show overlaps in geographical ranges as well as in morphology, but genetic data do not always support the species-level taxonomy based on morphological characters. Such a group offers an excellent opportunity to explore the processes involved. We have addressed the problem by determining the status of the restricted endemic T. graminicola within the larger context of Trochulus taxonomy. We used an integrated approach based on morphological features, ecological preferences and two molecular markers: mitochondrial COI sequences and microsatellites. Comparison of these results demonstrated: (i) conchological distinction of T. striolatus and T. sericeus; (ii) anatomical, ecological and genetic differentiation of T. graminicola and (iii) concordance between morphological characters and mtDNA markers in T. striolatus. Moreover, our data showed an intricate evolutionary history within the genus Trochulus, which can be best explained by: (i) recent or ongoing gene flow between taxa or (ii) their large ancestral polymorphism. Both of these hypotheses suggest that diversification within this group of snails has occurred relatively recently. The mismatches between species defined on morphology and on molecular genetics indicate the complexity of the processes involved in the diversification of this genus.	[Prockow, Malgorzata] Univ Wroclaw, Museum Nat Hist, Wroclaw, Poland; [Strzala, Tomasz] Wroclaw Univ Environm & Life Sci, Fac Biol & Anim Sci, Dept Genet, Wroclaw, Poland; [Kuznik-Kowalska, Elzbieta] Wroclaw Univ Environm & Life Sci, Inst Biol, Dept Invertebrate Systemat & Ecol, Wroclaw, Poland; [Prockow, Jaroslaw] Wroclaw Univ Environm & Life Sci, Inst Biol, Dept Plant Biol, Wroclaw, Poland; [Mackiewicz, Pawel] Univ Wroclaw, Fac Biotechnol, Dept Genom, Wroclaw, Poland	University of Wroclaw; Wroclaw University of Environmental & Life Sciences; Wroclaw University of Environmental & Life Sciences; Wroclaw University of Environmental & Life Sciences; University of Wroclaw	Prockow, M (corresponding author), Univ Wroclaw, Museum Nat Hist, Wroclaw, Poland.	malgorzata.prockow@uwr.edu.pl	Proćków, Jarosław/B-4832-2017; Kowalska, Elżbieta Kuźnik/B-6223-2017; Kuźnik-Kowalska, Elżbieta/ABC-8949-2020; Strzała, Tomasz/P-3357-2019	Proćków, Jarosław/0000-0003-4100-3438; Kowalska, Elżbieta Kuźnik/0000-0002-5509-0336; Kuźnik-Kowalska, Elżbieta/0000-0002-5509-0336; Strzała, Tomasz/0000-0002-7761-1630; Prockow, Malgorzata/0000-0003-2240-7306; Mackiewicz, Pawel/0000-0003-4855-497X	National Science Centre, Poland (Narodowe Centrum Nauki, Polska) [2016/21/B/NZ8/03022]; KNOW Consortium, Faculty of Biotechnology, University of Wroctaw	National Science Centre, Poland (Narodowe Centrum Nauki, Polska); KNOW Consortium, Faculty of Biotechnology, University of Wroctaw	This work was supported by the National Science Centre, Poland (Narodowe Centrum Nauki, Polska) under Grant number 2016/21/B/NZ8/03022. The publication fee was funded by the KNOW Consortium, Faculty of Biotechnology, University of Wroctaw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud JF, 2004, BIOL J LINN SOC, V82, P89, DOI 10.1111/j.1095-8312.2004.00320.x; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Cruzan MB, 2000, TRENDS ECOL EVOL, V15, P491, DOI 10.1016/S0169-5347(00)01998-4; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Davison A, 2009, MOL ECOL RESOUR, V9, P1092, DOI 10.1111/j.1755-0998.2009.02559.x; de Queiroz K, 2005, BIOESSAYS, V27, P1263, DOI 10.1002/bies.20325; Depraz A, 2008, MOL ECOL, V17, P2449, DOI 10.1111/j.1365-294X.2008.03760.x; Depraz A, 2008, MOL ECOL RESOUR, V8, P704, DOI 10.1111/j.1471-8286.2007.02055.x; Depraz A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-171; Dowle EJ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0216-x; Duda M, 2014, J MOLLUS STUD, V80, P371, DOI 10.1093/mollus/eyu023; Duda M, 2011, J MOLLUS STUD, V77, P30, DOI 10.1093/mollus/eyq037; Duda M, 2010, ECO MONT, V2, P5, DOI 10.1553/eco.mont-2-2s5; Duminil J, 2006, MOL ECOL, V15, P3505, DOI 10.1111/j.1365-294X.2006.03040.x; Duminil J, 2012, MOL PHYLOGENET EVOL, V62, P275, DOI 10.1016/j.ympev.2011.09.020; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ehrmann P., 1933, Die Tierwelt Mitteleuropas, V2, P1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ezard T., SPLITS SPECIES LIMIT; Falkner G., 1982, Mitteilungen der Deutschen Malakozoologischen Gesellschaft, V3, P30; FALKNER G, 1973, Archiv fuer Molluskenkunde, V103, P209; Falkner G, 1990, WEICHTIERE EUROPAISC, P112; Falush D, 2003, GENETICS, V164, P1567; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; de Leon LF, 2010, PHILOS T R SOC B, V365, P1041, DOI 10.1098/rstb.2009.0314; Fontaneto D, 2015, MAR BIODIVERS, V45, P433, DOI 10.1007/s12526-015-0319-7; GERMAIN LOUIS, 1929, ARCH MUS HIST NAT LYON, V13, P1; Gluckert G, 1987, GEOGR HELV, V2, P93, DOI DOI 10.5194/GH-42-93-1987; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hoshino AA, 2012, GENETIC DIVERSITY IN MICROORGANISMS, P149; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Huelsenbeck JP, 2004, MOL BIOL EVOL, V21, P1123, DOI 10.1093/molbev/msh123; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Kekkonen M, 2014, MOL ECOL RESOUR, V14, P706, DOI 10.1111/1755-0998.12233; Kerney MP, 1983, LANDSCHNECKEN NORD M; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Kruckenhauser L, 2014, ZOOL SCR, V43, P273, DOI 10.1111/zsc.12046; Lartillot N, 2013, SYST BIOL, V62, P611, DOI 10.1093/sysbio/syt022; Locard A, 1895, ANN SOC AGR SCI IND, V7, P137; Locard A, 1888, ANN SOC LINNEENNE LY, V34, P309; Locard A, 1896, ANN SOC AGR SCI IND, V7, P5; Mila B, 2009, MOL ECOL, V18, P2979, DOI 10.1111/j.1365-294X.2009.04251.x; Miralles A, 2013, PLOS ONE, P8; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Oberdorfer E, 1992, SUDDEUTSCHE PFLANZEN, VIV; Oberdorfer E., 1994, PFLANZENSOZIOLOGISCH; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paul C.R.C., 1967, J CONCHOL, V28, P301; Pfenninger M, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-59; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Pfenninger Markus, 2005, Archiv fuer Molluskenkunde, V134, P261; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Pritchard JK, 2000, GENETICS, V155, P945; PRockow M, 1758, CURR ZOOL; Prockow M, 2014, SYST BIODIVERS, V12, P366, DOI 10.1080/14772000.2014.925986; Prockow M, 2013, ZOOL J LINN SOC-LOND, V169, P124, DOI 10.1111/zoj.12048; Prockow Malgorzata, 2009, Folia Malacologica, V17, P101; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Purty R.S., 2016, AUSTIN J BIOTECHNOL, V3, P1059; R Core Team, 2021, R LANGUAGE ENV STAT; Rannala B, 2015, CURR ZOOL, V61, P846, DOI 10.1093/czoolo/61.5.846; Rodriguez-Gomez F, 2013, J BIOGEOGR, V40, P1360, DOI 10.1111/jbi.12093; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sauer J, 2012, CLADISTICS, V28, P300, DOI 10.1111/j.1096-0031.2011.00382.x; Schweiger O, 2004, MOL ECOL, V13, P3645, DOI 10.1111/j.1365-294X.2004.02357.x; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Shirley MH, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2483; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; Stride AH, 1959, GEOL MAG, V96, P33, DOI DOI 10.1017/S0016756800059197; Supple MA, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0486-y; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Turini FG, 2014, TAXON, V63, P329, DOI 10.12705/632.36; Turner H., 1998, FAUNA HELVETICA, V2; Ursenbacher S, 2010, CONSERV GENET, V11, P1265, DOI 10.1007/s10592-009-9956-3; van der Horst D., 1978, MITTEILUNGEN ZOOL GE, V3, P125; Vanhaecke D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032939; Welter-Schultes F.W., 2012, pA1; Willis SC, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-96; Ziemi Klodzkiej i gor przyleglych, 1964, TOW PRZVI NAUK WYDZ, V29, P1	85	10	10	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170460	10.1371/journal.pone.0170460	http://dx.doi.org/10.1371/journal.pone.0170460			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107432	gold, Green Published, Green Submitted			2022-12-26	WOS:000392405300139
J	Sun, HL; Wang, NJ; Nie, XM; Zhao, L; Li, Q; Cang, Z; Chen, C; Lu, M; Cheng, J; Zhai, HL; Xia, FZ; Ye, L; Lu, YL				Sun, Honglin; Wang, Ningjian; Nie, Xiaomin; Zhao, Li; Li, Qin; Cang, Zhen; Chen, Chi; Lu, Meng; Cheng, Jing; Zhai, Hualing; Xia, Fangzhen; Ye, Lin; Lu, Yingli			Lead Exposure Induces Weight Gain in Adult Rats, Accompanied by DNA Hypermethylation	PLOS ONE			English	Article							GENOME-WIDE EXPRESSION; HIGH-FAT DIET; ALZHEIMERS-DISEASE; HUMAN LIVER; METHYLATION; LEVEL; MICE; ASSOCIATION; CHILDREN; OBESITY	Objective Previous studies have revealed the association of lead (Pb) exposure with obesity. DNA methylation alteration has been suggested to be one of the regulatory mechanisms of obesity. We aimed to explore whether Pb exposure is related with weight gain and DNA methylation alteration. Methods Male adult 8 week Wistar rats were divided into 5 groups: the normal chow diet (NCD); the NCD+0.05%Pb; the NCD+0.15%Pb; the NCD+0.45% Pb and the high fat diet. Rats were exposed to different dosages of Pb through drinking water for 21 weeks. Body weight, fasted blood glucose level, fasted insulin level, homeostasis assessment of insulin resistance (HOMA-IR) index and lipid profile were detected. Intra-peritoneal glucose tolerance test (IPGTT) was constructed to evaluate the glucose tolerance. Lipid accumulation of liver was detected and liver DNA underwent whole genome bisulfite sequencing. Results The NCD+0.05% Pb group had significantly greater weight, HOMA-IR and triglycerides, and lower glucose intolerance than the NCD group (P <0.05). This group also showed hepatic lipid accumulation. These metabolic changes were not observed in the other two Pb dosage groups. Furthermore, DNA hypermethylation extended along pathways related to glucose and lipid metabolism in NCD+0.05% Pb group. Conclusion Pb exposure resulted in dose-specific weight gain in adult Wistar rats, accompanied by alteration of DNA methylation.	[Ye, Lin; Lu, Yingli] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Inst, Shanghai, Peoples R China; Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Endocrinol & Metab, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Ye, L; Lu, YL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Inst, Shanghai, Peoples R China.	luyingli2008@126.com; yelin3@medmail.com.cn	Sun, Honglin/AAC-8053-2021		National Natural Science Foundation of China [81270885, 81070677, 81300653]; Clinical Potential Subject Construction of Shanghai Jiaotong University School of Medicine; Ministry of Science and Technology in China [2012CB524906]; Science and Technology Commission of Shanghai Municipality [14495810700, 12XD1403100, 16410723200]; Three-year Action Plan for Public Health System Construction in Shanghai by Shanghai Municipal Commission of Health and Family Planning	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Clinical Potential Subject Construction of Shanghai Jiaotong University School of Medicine; Ministry of Science and Technology in China(Ministry of Science and Technology, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Three-year Action Plan for Public Health System Construction in Shanghai by Shanghai Municipal Commission of Health and Family Planning	Support was provided by: National Natural Science Foundation of China (81270885, 81070677, and 81300653): [role in study design]; Clinical Potential Subject Construction of Shanghai Jiaotong University School of Medicine (2014): [rle in animal model creation]; Ministry of Science and Technology in China (2012CB524906): [role in data collection and analysis]; Science and Technology Commission of Shanghai Municipality (14495810700, 12XD1403100,16410723200): [role in decision to publish and preparation of the manuscript]; Three-year Action Plan for Public Health System Construction in Shanghai by Shanghai Municipal Commission of Health and Family Planning 2015-2017 (to YL).	Afeiche M, 2011, ENVIRON HEALTH PERSP, V119, P1436, DOI 10.1289/ehp.1003184; Alashwal H, 2012, NEUROTOXICOLOGY, V33, P1450, DOI 10.1016/j.neuro.2012.06.008; Beier EE, 2015, ENVIRON HEALTH PERSP, V123, P935, DOI 10.1289/ehp.1408581; Bihaqi SW, 2011, J ALZHEIMERS DIS, V27, P819, DOI 10.3233/JAD-2011-111013; Chang XX, 2010, J LIPID RES, V51, P2504, DOI 10.1194/jlr.M001958; Cory-Slechta DA, 2004, ENVIRON HEALTH PERSP, V112, P717, DOI 10.1289/ehp.6481; Dosunmu R, 2012, MECH AGEING DEV, V133, P435, DOI 10.1016/j.mad.2012.05.003; Faulk C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104273; Faulk C, 2014, EPIGENETICS-US, V9, P934, DOI 10.4161/epi.29024; Faulk C, 2013, EPIGENOMICS-UK, V5, P487, DOI 10.2217/epi.13.49; GonzalezCossio T, 1997, PEDIATRICS, V100, P856, DOI 10.1542/peds.100.5.856; Grun F, 2006, ENDOCRINOLOGY, V147, pS50, DOI 10.1210/en.2005-1129; Gump BB, 2008, ENVIRON HEALTH PERSP, V116, P249, DOI 10.1289/ehp.10391; Hauser R, 2008, ENVIRON HEALTH PERSP, V116, P976, DOI 10.1289/ehp.10516; Holliday R, 2006, EPIGENETICS-US, V1, P76, DOI 10.4161/epi.1.2.2762; Horvath S, 2014, P NATL ACAD SCI USA, V111, P15538, DOI 10.1073/pnas.1412759111; Hou LF, 2012, INT J EPIDEMIOL, V41, P79, DOI 10.1093/ije/dyr154; Iavicoli I, 2004, REPROD TOXICOL, V19, P35, DOI 10.1016/j.reprotox.2004.06.013; KIM R, 1995, ENVIRON HEALTH PERSP, V103, P952, DOI 10.2307/3432741; Kirchner H, 2016, MOL METAB, V5, P171, DOI 10.1016/j.molmet.2015.12.004; Leasure JL, 2008, ENVIRON HEALTH PERSP, V116, P355, DOI 10.1289/ehp.10862; Lee JH, 2014, NUTRIENTS, V6, P3303, DOI 10.3390/nu6083303; Li CP, 2013, CLIN TOXICOL, V51, P225, DOI 10.3109/15563650.2013.782410; Masoud AM, 2016, J ALZHEIMERS DIS, V51, P1257, DOI 10.3233/JAD-151018; Mostafalou S, 2015, ENVIRON TOXICOL PHAR, V39, P16, DOI 10.1016/j.etap.2014.11.001; Myers JP, 2009, ENVIRON HEALTH PERSP, V117, P1652, DOI 10.1289/ehp.0900887; Nilsson E, 2015, J CLIN ENDOCR METAB, V100, pE1491, DOI 10.1210/jc.2015-3204; Nye MD, 2015, TOXICOL IN VITRO, V29, P544, DOI 10.1016/j.tiv.2015.01.002; Padilla MA, 2010, INT J ENV RES PUB HE, V7, P3332, DOI 10.3390/ijerph7093332; Ronco AM, 2010, BIOL TRACE ELEM RES, V136, P269, DOI 10.1007/s12011-009-8546-z; Rossi-George A, 2009, TOXICOL APPL PHARM, V234, P117, DOI 10.1016/j.taap.2008.10.003; Schneider JS, 2013, TOXICOL LETT, V217, P75, DOI 10.1016/j.toxlet.2012.12.004; Scinicariello F, 2013, TOXICOL APPL PHARM, V273, P516, DOI 10.1016/j.taap.2013.09.022; Sen A, 2015, SCI REP-UK, V5, DOI 10.1038/srep14466; Wang N, 2015, SCI REPORTS, V5; Wright RO, 2010, ENVIRON HEALTH PERSP, V118, P790, DOI 10.1289/ehp.0901429	36	31	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0169958	10.1371/journal.pone.0169958	http://dx.doi.org/10.1371/journal.pone.0169958			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107465	Green Submitted, gold, Green Published			2022-12-26	WOS:000392405300056
J	Zhou, J; Wang, S; Qi, Q; Yang, XY; Zhu, ED; Yuan, HR; Li, XM; Liu, Y; Li, XX; Wang, BL				Zhou, Jie; Wang, Shan; Qi, Qi; Yang, Xiaoyue; Zhu, Endong; Yuan, Hairui; Li, Xuemei; Liu, Ying; Li, Xiaoxia; Wang, Baoli			Nuclear factor I-C reciprocally regulates adipocyte and osteoblast differentiation via control of canonical Wnt signaling	FASEB JOURNAL			English	Article						adipogenesis; osteogenesis; Wnt/b; catenin; Lrp5	TOOTH ROOT DEVELOPMENT; MESENCHYMAL STEM-CELLS; OSTEOGENIC DIFFERENTIATION; BETA-CATENIN; ODONTOBLAST DIFFERENTIATION; BRAIN-DEVELOPMENT; GENE-EXPRESSION; ADIPOSE-TISSUE; BONE-FORMATION; C/EBP-ALPHA	Nuclear factor I-C (NFIC) has recently been identified as an important player in osteogenesis and bone homeostasis in vivo. However, the molecular mechanisms involved have yet to be defined. In the current study, Nfic expression was altered in primary marrow stromal cells and established progenitor lines after adipogenic and osteogenic treatment. Overexpression of Nfic in stromal cells ST2, mesenchymal cells C3H10T1/2, and primary marrow stromal cells inhibited adipogenic differentiation, whereas it promoted osteogenic differentiation. Conversely, silencing of endogenous Nfic in the cell lines enhanced adipogenic differentiation, whereas it blocked osteogenic differentiation. Mechanism investigations revealed that Nfic overexpression promoted nuclear translocation of beta-catenin and increased nuclear protein levels of b-catenin and transcription factor 7-like 2 (TCF7L2). Promoter studies and the chromatin immunoprecipitation (ChIP) assay revealed that NFIC directly binds to the promoter of low-density lipoprotein receptor-related protein 5 (Lrp5) and thereafter transactivates the promoter. Finally, inactivation of canonical Wnt signaling in ST2 attenuated the inhibition of adipogenic differentiation and stimulation of osteogenic differentiation by NFIC. Our study suggests that NFIC balances adipogenic and osteogenic differentiation from progenitor cells through controlling canonical Wnt signaling and highlights the potential of NFIC as a target for new therapies to control metabolic disorders like osteoporosis and obesity.-Zhou, J., Wang, S., Qi, Q., Yang, X., Zhu, E., Yuan, H., Li, X., Liu, Y., Li, X., Wang, B. Nuclear factor I-C reciprocally regulates adipocyte and osteoblast differentiation via control of canonical Wnt signaling.	[Zhou, Jie; Qi, Qi; Zhu, Endong; Yuan, Hairui; Li, Xuemei; Wang, Baoli] Tianjin Med Univ, Tianjin Key Lab Metab Dis, Minist Hlth, Key Lab Hormones & Dev, Tianjin, Peoples R China; [Zhou, Jie; Wang, Baoli] Tianjin Med Univ, Collaborat Innovat Ctr Metab Dis 2011, Metab Dis Hosp, Tianjin, Peoples R China; [Zhou, Jie; Wang, Baoli] Tianjin Med Univ, Inst Endocrinol, Tianjin, Peoples R China; [Wang, Shan; Li, Xiaoxia] Tianjin Med Univ, Coll Basic Med Sci, Tianjin, Peoples R China; [Yang, Xiaoyue; Liu, Ying] Tianjin Med Univ, Stomatol Hosp, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Wang, BL (corresponding author), Tianjin Med Univ, 22 Qi Xiang Tai Rd,Box 126, Tianjin 300070, Tianjin, Peoples R China.	blwang@tmu.edu.cn			Natural Science Foundation of China [81672116, 81472040, 81271977, 81101596, 81501846]; Key Laboratory of Hormones and Development, Ministry of Health	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Hormones and Development, Ministry of Health	This work was supported by Natural Science Foundation of China Grants 81672116, 81472040, and 81271977 (to B.W.), Grant 81101596 (to X.L.), and Grant 81501846 (to E.Z.); and by an Open Grant from the Key Laboratory of Hormones and Development, Ministry of Health. The authors declare no conflicts of interest.	Abdallah BM, 2015, BONE, V70, P28, DOI 10.1016/j.bone.2014.07.028; Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Bennett CN, 2007, J BONE MINER RES, V22, P1924, DOI 10.1359/JBMR.070810; Cai T, 2016, EXP CELL RES, V345, P206, DOI 10.1016/j.yexcr.2016.06.007; Campbell CE, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-52; Cheng HC, 2011, ACTA BIOCH BIOPH SIN, V43, P204, DOI 10.1093/abbs/gmq130; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Driller K, 2007, MOL CELL BIOL, V27, P3855, DOI 10.1128/MCB.02293-06; Felber K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144982; FREYTAG SO, 1994, GENE DEV, V8, P1654, DOI 10.1101/gad.8.14.1654; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Guan XH, 2015, STEM CELLS, V33, P1589, DOI 10.1002/stem.1947; Harris L, 2015, DEV DYNAM, V244, P227, DOI 10.1002/dvdy.24182; He W, 2014, J DENT RES, V93, P496, DOI 10.1177/0022034514525200; Heng YHE, 2014, CEREB CORTEX, V24, P261, DOI 10.1093/cercor/bhs307; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Karasik D, 2016, NAT REV RHEUMATOL, V12, P323, DOI 10.1038/nrrheum.2016.48; Kennell JA, 2005, J BIOL CHEM, V280, P24004, DOI 10.1074/jbc.M501080200; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Kook SH, 2015, MOL CELL BIOCHEM, V402, P213, DOI 10.1007/s11010-015-2329-y; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Lee DS, 2014, STEM CELLS, V32, P2467, DOI 10.1002/stem.1733; Lee DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029160; Lee DS, 2009, J BIOL CHEM, V284, P17293, DOI 10.1074/jbc.M109.009084; Linhart HG, 2001, P NATL ACAD SCI USA, V98, P12532, DOI 10.1073/pnas.211416898; Liu Y, 2015, DEVELOPMENT, V142, P3374, DOI 10.1242/dev.127068; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDonald BT, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007880; Mason S, 2009, MOL NEUROBIOL, V39, P10, DOI 10.1007/s12035-008-8048-6; Miclea RL, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-26; Nemoto E, 2016, J PERIODONTAL RES, V51, P164, DOI 10.1111/jre.12294; Oh HJ, 2012, J CELL BIOCHEM, V113, P877, DOI 10.1002/jcb.23421; Pignolo RJ, 2015, APPL CLIN GENET, V8, P37, DOI 10.2147/TACG.S51064; Pjanic M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-181; Plachez C, 2012, J COMP NEUROL, V520, P3135, DOI 10.1002/cne.23081; Rudnicki MA, 2015, BONE, V80, P60, DOI 10.1016/j.bone.2015.02.009; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; Smink JJ, 2012, GENE, V497, P10, DOI 10.1016/j.gene.2012.01.043; Steele-Perkins G, 2005, MOL CELL BIOL, V25, P685, DOI 10.1128/MCB.25.2.685-698.2005; Steele-Perkins G, 2003, MOL CELL BIOL, V23, P1075, DOI 10.1128/MCB.23.3.1075-1084.2003; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Wang J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.356; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Wang YP, 2014, FRONT BIOSCI-LANDMRK, V19, P379, DOI 10.2741/4214; Wong YW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r72; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Zhang JF, 2004, P NATL ACAD SCI USA, V101, P10703, DOI 10.1073/pnas.0403652101; Zhao M, 2004, J BIOL CHEM, V279, P12854, DOI 10.1074/jbc.M313294200	50	27	27	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1939	1952		10.1096/fj.201600975RR	http://dx.doi.org/10.1096/fj.201600975RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28122918				2022-12-26	WOS:000399195500016
J	Nagao, H; Nishizawa, H; Bamba, T; Nakayama, Y; Isozumi, N; Nagamori, S; Kanai, Y; Tanaka, Y; Kita, S; Fukuda, S; Funahashi, T; Maeda, N; Fukusaki, E; Shimomura, I				Nagao, Hirofumi; Nishizawa, Hitoshi; Bamba, Takeshi; Nakayama, Yasumune; Isozumi, Noriyoshi; Nagamori, Shushi; Kanai, Yoshikatsu; Tanaka, Yoshimitsu; Kita, Shunbun; Fukuda, Shiro; Funahashi, Tohru; Maeda, Norikazu; Fukusaki, Eiichiro; Shimomura, Iichiro			Increased Dynamics of Tricarboxylic Acid Cycle and Glutamate Synthesis in Obese Adipose Tissue IN VIVO METABOLIC TURNOVER ANALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; ASPARTATE TRANSPORTER; ADIPONECTIN LEVELS; VISCERAL FAT; RAT-BRAIN; EXPRESSION; PLASMA; CELLS; CLONING; MICE	Obesity is closely associated with various metabolic disorders. However, little is known about abnormalities in the metabolic change of obese adipose tissue. Here we use static metabolic analysis and in vivo metabolic turnover analysis to assess metabolic dynamics in obese mice. The static metabolic analyses showed that glutamate and constitutive metabolites of the TCA cycle were increased in the white adipose tissue (WAT) of ob/ob and diet-induced obesity mice but not in the liver or skeletal muscle of these obese mice. Moreover, in vivo metabolic turnover analyses demonstrated that these glucose-derived metabolites were dynamically and specifically produced in obese WAT compared with lean WAT. Glutamate rise in obese WAT was associated with down-regulation of glutamate aspartate transporter (GLAST), a major glutamate transporter for adipocytes, and low uptake of glutamate into adipose tissue. In adipocytes, glutamate treatment reduced adiponectin secretion and insulin-mediated glucose uptake and phosphorylation of Akt. These data suggest that a high intra-adipocyte glutamate level potentially relates to adipocyte dysfunction in obesity. This study provides novel insights into metabolic dysfunction in obesity through comprehensive application of in vivo metabolic turnover analysis in two obese animal models.	[Tanaka, Yoshimitsu; Kita, Shunbun; Fukuda, Shiro; Funahashi, Tohru; Maeda, Norikazu; Shimomura, Iichiro] Osaka Univ, Grad Sch Engn, Dept Metab Med, 2-2-B5, Suita, Osaka 5650871, Japan; [Isozumi, Noriyoshi; Nagamori, Shushi; Kanai, Yoshikatsu] Osaka Univ, Grad Sch Engn, Dept Biosyst Pharmacol, Suita, Osaka 5650871, Japan; [Kita, Shunbun; Funahashi, Tohru; Maeda, Norikazu] Osaka Univ, Grad Sch Med, Dept Metab & Atherosclerosis, Suita, Osaka 5650871, Japan; [Bamba, Takeshi; Nakayama, Yasumune; Fukusaki, Eiichiro] Osaka Univ, Grad Sch Med, Dept Biotechnol, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University; Osaka University	Nishizawa, H (corresponding author), Osaka Univ, Grad Sch Engn, Dept Metab Med, 2-2-B5, Suita, Osaka 5650871, Japan.	hitoshin1127@endmet.med.osaka-u.ac.jp	Nagamori, Shushi/P-4530-2018; Nakayama, Yasumune/H-2982-2019	Nagamori, Shushi/0000-0003-0203-2754; Nakayama, Yasumune/0000-0002-6810-4354	Ministry of Education, Culture, Sports, Science, and Technology of Japan [25136714, 26293221, 15K09412]; Core Research for Evolutional Science and Technology (CREST) program of Japan Science and Technology Agency (JST); Kowa Co. Ltd.	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (CREST) program of Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Kowa Co. Ltd.	This work was supported in part by Grant-in-Aid for Scientific Research (C) 15K09412 (to H.Nishizawa), Grant-in-Aid for Scientific Research (B) 26293221 (to T.F.), Grant-in-Aid for Scientific Research Innovative Areas " HD Physiology" 25136714 (to S.N.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and Core Research for Evolutional Science and Technology (CREST) program of Japan Science and Technology Agency (JST) (to E.F and I.S.). S.K., T.F., and N. M. are members of the Department of Metabolism and Atherosclerosis, a sponsored course endowed by Kowa Co. Ltd. The company has a scientific officer who oversees the program.	Abrahamsen B, 2013, J NEUROSCI, V33, P1068, DOI 10.1523/JNEUROSCI.3396-12.2013; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163; CONRADT M, 1995, EUR J BIOCHEM, V229, P682, DOI 10.1111/j.1432-1033.1995.tb20514.x; Cummins TD, 2014, AM J PHYSIOL-ENDOC M, V307, pE262, DOI 10.1152/ajpendo.00271.2013; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Drolet R, 2008, INT J OBESITY, V32, P283, DOI 10.1038/sj.ijo.0803708; Fendt SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3236; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; FREDERICH RC, 1992, HYPERTENSION, V19, P339, DOI 10.1161/01.HYP.19.4.339; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gheni G, 2014, CELL REP, V9, P661, DOI 10.1016/j.celrep.2014.09.030; Giesbertz P, 2015, DIABETOLOGIA, V58, P2133, DOI 10.1007/s00125-015-3656-y; Harada K, 2006, BIOTECHNOL PROGR, V22, P1003, DOI 10.1021/bp060139z; Hashim Z, 2014, J CHROMATOGR B, V966, P83, DOI 10.1016/j.jchromb.2014.05.041; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Kitata RB, 2015, J PROTEOME RES, V14, P3658, DOI 10.1021/acs.jproteome.5b00477; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maeda N, 2004, P NATL ACAD SCI USA, V101, P17801, DOI 10.1073/pnas.0406230101; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Masuda T, 2008, J PROTEOME RES, V7, P731, DOI 10.1021/pr700658q; Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mittelman SD, 2002, DIABETES, V51, P755, DOI 10.2337/diabetes.51.3.755; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Nakagawa Y, 2011, J ATHEROSCLER THROMB, V18, P240, DOI 10.5551/jat.6593; Nakamura H, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.32; Nakayama Y, 2014, J BIOSCI BIOENG, V118, P350, DOI 10.1016/j.jbiosc.2014.02.014; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Overmyer KA, 2015, CELL METAB, V21, P468, DOI 10.1016/j.cmet.2015.02.007; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; SCHULTE S, 1995, EUR J BIOCHEM, V233, P947, DOI 10.1111/j.1432-1033.1995.947_3.x; Sekimoto R, 2012, BIOCHEM BIOPH RES CO, V419, P782, DOI 10.1016/j.bbrc.2012.02.102; She PX, 2007, AM J PHYSIOL-ENDOC M, V293, pE1552, DOI 10.1152/ajpendo.00134.2007; She PX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059443; Shimizu R, 2015, SCI REP-UK, V5, DOI 10.1038/srep11617; Shimomura I, 1996, NAT MED, V2, P800, DOI 10.1038/nm0796-800; SMITH U, 1979, EUR J CLIN INVEST, V9, P327, DOI 10.1111/j.1365-2362.1979.tb00892.x; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; Tsugawa H, 2011, J BIOSCI BIOENG, V112, P292, DOI 10.1016/j.jbiosc.2011.05.001; Tsushima Y, 2013, J BIOL CHEM, V288, P27138, DOI 10.1074/jbc.M113.485094; Uetsuka S, 2015, EUR J NEUROSCI, V42, P1984, DOI 10.1111/ejn.12973; UtsunomiyaTate N, 1996, J BIOL CHEM, V271, P14883, DOI 10.1074/jbc.271.25.14883; Varma V, 2015, METABOLOMICS, V11, P529, DOI 10.1007/s11306-014-0716-0; Yamakado M, 2012, CLIN OBES, V2, P29, DOI 10.1111/j.1758-8111.2012.00039.x; Zeve D, 2009, CELL STEM CELL, V5, P472, DOI 10.1016/j.stem.2009.10.014	54	26	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4469	4483		10.1074/jbc.M116.770172	http://dx.doi.org/10.1074/jbc.M116.770172			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28119455	Green Published, hybrid			2022-12-26	WOS:000397585100008
J	Caudell, MA; Quinlan, MB; Subbiah, M; Call, DR; Roulette, CJ; Roulette, JW; Roth, A; Matthews, L; Quinlan, RJ				Caudell, Mark A.; Quinlan, Marsha B.; Subbiah, Murugan; Call, Douglas R.; Roulette, Casey J.; Roulette, Jennifer W.; Roth, Adam; Matthews, Louise; Quinlan, Robert J.			Antimicrobial Use and Veterinary Care among Agro-Pastoralists in Northern Tanzania	PLOS ONE			English	Article							ANTIBIOTIC USE; RESISTANCE; FOOD; PASTORALISTS; PERSPECTIVE; RESILIENCE; KNOWLEDGE; WORLDWIDE; FARMERS; ARUSHA	Frequent and unregulated use of antimicrobials (AM) in livestock requires public health attention as a likely selection pressure for resistant bacteria. Studies among small-holders, who own a large percentage of the world's livestock, are vital for understanding how practices involving AM use might influence resistance. We present a cultural-ecological mixedmethods analysis to explore sectors of veterinary care, loosely regulated AM use, and human exposure to AMs through meat and milk consumption across three rural to periurban Tanzanian ethnic groups (N = 415 households). Reported use of self-administered AMs varied by ethnic group (Maasai: 74%, Arusha: 21%, Chagga: 1%) as did consultation with professional veterinarians (Maasai: 36%, Arusha: 45%, Chagga: 96%) and observation of withdrawal of meat and milk from consumption during and following AM treatment (Maasai: 7%, Arusha: 72%, Chagga: 96%). The antibiotic oxytetracycline was by far the most common AM in this sample. Within ethnic groups, herd composition differences, particularly size of small-stock and cattle herds, were most strongly associated with differences in lay AM use. Among the Arusha, proxies for urbanization, including owning transportation and reliance on "zero-grazing" herds had the strongest positive associations with veterinarian consultation, while distance to urban centers was negatively associated. For Maasai, consultation was negatively associated with use of traditional healers or veterinary drug-shops. Observation of withdrawal was most strongly associated with owning technology among Maasai while Arusha observance displayed seasonal differences. This "One-Health" analysis suggests that livelihood and cultural niche factors, through their association with practices in smallholder populations, provide insight into the selection pressures that may contribute to the evolution and dissemination of antimicrobial resistance.	[Caudell, Mark A.; Quinlan, Marsha B.; Subbiah, Murugan; Call, Douglas R.; Quinlan, Robert J.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Caudell, Mark A.; Quinlan, Marsha B.; Roulette, Jennifer W.; Quinlan, Robert J.] Washington State Univ, Dept Anthropol, Pullman, WA 99164 USA; [Roulette, Casey J.] San Diego State Univ, Dept Anthropol, San Diego, CA 92182 USA; [Roth, Adam] Washington State Univ, Dept Sociol, Pullman, WA 99164 USA; [Matthews, Louise] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland	Washington State University; Washington State University; California State University System; San Diego State University; Washington State University; University of Glasgow	Quinlan, RJ (corresponding author), Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.; Quinlan, RJ (corresponding author), Washington State Univ, Dept Anthropol, Pullman, WA 99164 USA.	rquinlan@wsu.edu	Roulette, Casey J/HGB-9551-2022	Roulette, Jennifer/0000-0002-4362-4927; Quinlan, Marsha/0000-0002-9311-9494	National Science Foundation: Ecology and Evolution of Infectious Diseases [DEB1216040]; BBRSC [BB/K01126X/1]; BBSRC [BB/P004202/1, BB/K01126X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/P004202/1, 1371607, BB/K01126X/1, 1096845] Funding Source: researchfish	National Science Foundation: Ecology and Evolution of Infectious Diseases; BBRSC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	National Science Foundation: Ecology and Evolution of Infectious Diseases: DEB1216040 DRC, RJQ, MBQ, LM https://urldefense.proofpoint.com/v2/url?u=http-3A_www.nsf.gov_funding_com/v2/url?u=http-3A_www.nsf.gov_funding_pgm-5Fsumm.jsp-3Fpims-5Fid-3D5269&d=DgIGaQ&c=C3yme8gMkxg_ihJNXSO6ZyWk4EJm8LdrrvxQb-Je7sw&r=_jmO53oaugwTxQtMBRzTrg&m=dm11xz98owEqtCiC4GSdhnMeD-iwt6WCLXOOW42_MCQ&s=s4bsaZlglhMdSoGxRKCX6s6HRTv3mvGFdsnDAk01QoU&e-. BBRSC grant BB/K01126X/1.	Ahmed H, 201617 WASH STAT U S; [Anonymous], 2011, RES METHODS ANTHR; ANYINAM C, 1987, SOC SCI MED, V25, P803, DOI 10.1016/0277-9536(87)90038-4; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Campbell DJ, 2004, COMPARING KENYAN TAN; Carlet J, 2012, ANTIMICROB RESIST IN, V1, DOI 10.1186/2047-2994-1-11; Caudell M, 2015, SOC NETWORKS, V40, P34, DOI 10.1016/j.socnet.2014.07.003; Colquhoun D, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140216; Darwish WS, 2013, JPN J VET RES, V61, pS13; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Eltayb A, 2012, ZOONOSES PUBLIC HLTH, V59, P330, DOI 10.1111/j.1863-2378.2012.01458.x; FAO, 2013, WORLD AGR 2015 2030; Fratkin E., 2001, AFR STUD REV, V44, P1, DOI [10.2307/525591, DOI 10.2307/525591]; Fratkin E., 2011, LAIBON; Galvin KA, 2009, ANNU REV ANTHROPOL, V38, P185, DOI 10.1146/annurev-anthro-091908-164442; Graeub BE, WORLD DEV; Helman CG, 2007, CULTURE HLTH ILLNESS; Hodgson Dorothy., 2001, ONCE INTREPID WARRIO, P48; Kioko J, 2015, VET WORLD, V8, P755, DOI 10.14202/vetworld.2015.755-762; Kleinman A., 1981, PATIENTS HEALERS CON; Landers TF, 2012, PUBLIC HEALTH REP, V127, P4, DOI 10.1177/003335491212700103; Leslie P, 2013, CURR ANTHROPOL, V54, P114, DOI 10.1086/669563; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; McCabe JT, 2010, HUM ECOL, V38, P322, DOI 10.1007/s10745-010-9312-8; McCabe J. Terrence, 2004, CATTLE BRING US OUR; McCorkle C. M., 1992, Africa (London), V62, P59, DOI 10.2307/1160064; McCorkle C. M., 1995, Agriculture and Human Values, V12, P52, DOI 10.1007/BF02217297; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Norval RAI., 1992, EPIDEMIOLOGY THEILER; Omulo S, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-014-0041-4; Palmer GH, 2013, ANTIMICROBIAL RESIST; Quinlan RJ, 2016, ETHNOBIOL LETT, V7, P76; Quinlan RJ, 2015, J ETHNOBIOL, V35, P314, DOI 10.2993/etbi-35-02-314-336.1; Redding LE, 2014, PREV VET MED, V113, P88, DOI 10.1016/j.prevetmed.2013.10.012; Roderick S, 2000, TROP ANIM HEALTH PRO, V32, P361, DOI 10.1023/A:1005277518352; Roth EA, 2005, PASTORALISTS SETTLE; Roulette C, MAASAI DIETARY ADDIT; Rugumisa B. T., 2016, African Journal of Microbiology Research, V10, P1422; Rugumisa BT, 2016, J FOOD PROTECT, V79, P1424, DOI 10.4315/0362-028X.JFP-15-584; Sarmah AK, 2006, CHEMOSPHERE, V65, P725, DOI 10.1016/j.chemosphere.2006.03.026; Sato A, 2012, SOC SCI MED, V75, P1450, DOI 10.1016/j.socscimed.2012.05.032; Silbergeld EK, 2008, ANNU REV PUBL HEALTH, V29, P151, DOI 10.1146/annurev.publhealth.29.020907.090904; SPEAR T, 1992, INT J AFR HIST STUD, V25, P481, DOI 10.2307/219022; Spear Thomas, 1997, MOUNTAIN FARMERS MOR; Stahl K.M., 1964, HIST CHAGGA PEOPLE K; Steinfeld H, 2004, VET PARASITOL, V125, P19, DOI 10.1016/j.vetpar.2004.05.003; Thumbi SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120761; Turnidge J, 2005, LANCET, V365, P548; Wasserstein RL, 2016, AM STAT	49	59	59	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170328	10.1371/journal.pone.0170328	http://dx.doi.org/10.1371/journal.pone.0170328			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7IT	28125722	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000396176100118
J	Ma, C; Pi, CC; Yang, Y; Lin, L; Shi, YG; Li, Y; Li, YL; He, X				Ma, Cao; Pi, Chenchen; Yang, Yue; Lin, Lin; Shi, Yingai; Li, Yan; Li, Yulin; He, Xu			Nampt Expression Decreases Age-Related Senescence in Rat Bone Marrow Mesenchymal Stem Cells by Targeting Sirt1	PLOS ONE			English	Article							NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; DNA-DAMAGE; CELLULAR SENESCENCE; BETA-GALACTOSIDASE; IN-VIVO; OXIDATIVE STRESS; NAD BIOSYNTHESIS; LIFE-SPAN; TELOMERASE; METABOLISM	Senescence restricts the development of applications involving mesenchymal stem cells (MSCs) in research fields, such as tissue engineering, and stem cell therapeutic strategies. Understanding the mechanisms underlying natural aging processes may contribute to the development of novel approaches to preventing age-related diseases or slowing individual aging processes. Nampt is a rate-limiting NAD biosynthetic enzyme that plays critical roles in energy metabolism, cell senescence and maintaining life spans. However, it remains unknown whether Nampt influences stem cell senescence. In this study, the function of Nampt was investigated using a rat model of natural aging. Our data show that Nampt expression was significantly lower in MSCs obtained from aged rats than in those obtained from young rats during physiological aging. Reducing the level of Nampt in aged MSCs resulted in lower intracellular concentrations of NAD+ and downregulated Sirt1 expression and activity. After the Nampt inhibitor FK866 was added, young MSCs were induced to become aged cells. The enhanced senescence was correlated with NAD+ depletion and Sirt1 activity attenuation. In addition, Nampt overexpression attenuated cell senescence in aged MSCs. Our findings provide a new explanation for the mechanisms underlying stem cell senescence and a novel target for delaying stem cell senescence and preventing and treating age-related diseases.	[Ma, Cao; Pi, Chenchen; Yang, Yue; Lin, Lin; Shi, Yingai; Li, Yulin; He, Xu] Jilin Univ, Coll Basic Med Sci, Minist Educ, Key Lab Pathobiol, Changchun, Peoples R China; [Ma, Cao] Southeast Univ, Sch Med, Zhongda Hosp, Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Li, Yan] Sahlgrens Univ Hosp, CARE, Molndal, Sweden	Jilin University; Southeast University - China; Sahlgrenska University Hospital	He, X (corresponding author), Jilin Univ, Coll Basic Med Sci, Minist Educ, Key Lab Pathobiol, Changchun, Peoples R China.	hexu@jlu.edu.cn		Pi, Chenchen/0000-0002-5177-4108	National Natural Science Foundation of China [81571370]; Jilin Provincial Science and Technology Projects [20150414029GH, 20130101130JC]; Norman Bethune Program of Jilin University [2012204]; Science and Technology Projects of the Education Department of Jilin Province [447]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin Provincial Science and Technology Projects; Norman Bethune Program of Jilin University; Science and Technology Projects of the Education Department of Jilin Province	This study was supported by National Natural Science Foundation of China (81571370, to XH), Jilin Provincial Science and Technology Projects (20150414029GH and 20130101130JC, to XH), Norman Bethune Program of Jilin University (2012204, to XH), and Science and Technology Projects of the Education Department of Jilin Province (Code (2016) 447, to XH). The funders had roles in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016; Boyette LB, 2014, J CLIN MED, V3, P88, DOI 10.3390/jcm3010088; Chen HQ, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00103; Choudhery MS, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-8; de Lapuente J, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00180; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dobbin MM, 2013, NAT NEUROSCI, V16, P1008, DOI 10.1038/nn.3460; Droge W, 2003, ADV EXP MED BIOL, V543, P191; El-Fadaly AB, 2014, ANN ANAT, V196, P336, DOI 10.1016/j.aanat.2014.06.005; Feng XM, 2014, MECH AGEING DEV, V141, P46, DOI 10.1016/j.mad.2014.09.004; Gruber HE, 2007, SPINE, V32, P321, DOI 10.1097/01.brs.0000253960.57051.de; Huang PX, 2015, ONCOTARGET, V6, P10812, DOI 10.18632/oncotarget.3580; Imai S, 2013, DIABETES OBES METAB, V15, P26, DOI 10.1111/dom.12171; Imai S, 2011, FEBS LETT, V585, P1657, DOI 10.1016/j.febslet.2011.04.060; Imai SI, 2010, PHARMACOL RES, V62, P42, DOI 10.1016/j.phrs.2010.01.006; Imai SI, 2010, BBA-PROTEINS PROTEOM, V1804, P1584, DOI 10.1016/j.bbapap.2009.10.024; Imai S, 2009, CURR PHARM DESIGN, V15, P20, DOI 10.2174/138161209787185814; Koltai E, 2010, MECH AGEING DEV, V131, P21, DOI 10.1016/j.mad.2009.11.002; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Nakamura AJ, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-6; Naylor RM, 2013, CLIN PHARMACOL THER, V93, P105, DOI 10.1038/clpt.2012.193; Oh J, 2014, NAT MED, V20, P870, DOI 10.1038/nm.3651; Palacios JA, 2010, J CELL BIOL, V191, P1299, DOI 10.1083/jcb.201005160; PREISS J, 1957, J BIOL CHEM, V225, P759; Rehan L, 2014, LIFE SCI, V105, P1, DOI 10.1016/j.lfs.2014.03.015; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Serakinci N, 2008, BIOCHIMIE, V90, P33, DOI 10.1016/j.biochi.2007.09.005; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Sikora E, 2011, AGEING RES REV, V10, P146, DOI 10.1016/j.arr.2010.10.002; Song J, 2014, J GERONTOL A-BIOL, V69, P44, DOI 10.1093/gerona/glt122; Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Takeuchi S, 2010, CANCER RES, V70, P9381, DOI 10.1158/0008-5472.CAN-10-0801; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200; Zeng Y, 2015, BIOCHEM BIOPH RES CO, V468, P167, DOI 10.1016/j.bbrc.2015.10.139; Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693; Zhou D, 2015, MED SCI MONITOR, V21, P3728, DOI 10.12659/MSM.895596; Zvereva MI, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1563, DOI 10.1134/S0006297910130055	41	39	40	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170930	10.1371/journal.pone.0170930	http://dx.doi.org/10.1371/journal.pone.0170930			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125705	Green Submitted, Green Published, gold			2022-12-26	WOS:000396176100022
J	Domenech, F; Tomas, J; Cespo-Picazo, JL; Garcia-Parraga, D; Raga, JA; Aznar, FJ				Domenech, Francesc; Tomas, Jesus; Luis Cespo-Picazo, Jose; Garcia-Parraga, Daniel; Antonio Raga, Juan; Javier Aznar, Francisco			To Swim or Not to Swim: Potential Transmission of Balaenophilus manatorum (Copepoda: Harpacticoida) in Marine Turtles	PLOS ONE			English	Article							CARETTA-CARETTA; SEA-TURTLES; TORRES; LALANA; ORTIZ; HISTORIES; CRUSTACEA; EPIBIONT; DIET	Species of Balaenophilus are the only harpacticoid copepods that exhibit a widespread, obligate association with vertebrates, i.e., B. unisetus with whales and B. manatorum with marine turtles and manatees. In the western Mediterranean, juveniles of the loggerhead sea turtle, Caretta caretta are the only available hosts for B. manatorum, which has been found occurring at high prevalence (> 80%) on them. A key question is how these epibionts are transmitted from host to host. We investigated this issue based on experiments with live specimens of B. manatorum that were cultured with turtle skin. Specimens were obtained from head-started hatchlings of C. caretta from the western Mediterranean. Hatched nauplii crawled only on rough substrates and lacked the ability to swim. Only copepodites IV and V, and adults, were able to perform directional swimming. Legs 2, 3 and 4 played a major role in swimming and were only well-developed in these stages. Nauplii reared in wells with turtle skin readily fed on this item. Late copepodites and adults also fed on turtle skin but did not consume other potential food items such as fish skin, baleen plates or planktonic algae. Evidences suggest that the transmission of B. manatorum should rely on hosts' bodily contacts and/or swimming of late developmental stages between spatially close hosts. The possibility of long-ranged dispersal is unlikely for two reasons. First, all developmental stages seem to depend on turtle skin as a food resource. Second, the average clutch size of ovigerous females was small (< 70 eggs) for free-living phases to successfully contact turtles that occur at very low densities (< 0.6 turtles.km(-2)) in the western Mediterranean. The high prevalence of B. manatorum in loggerhead turtles in this area raises the question whether these turtles have contacts, or tend to closely aggregate, more than is currently believed.	[Domenech, Francesc; Tomas, Jesus; Antonio Raga, Juan; Javier Aznar, Francisco] Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Marine Zool Unit, Valencia, Spain; [Luis Cespo-Picazo, Jose; Garcia-Parraga, Daniel] Dept Biol, Vet Serv, Oceanog, Valencia, Spain	University of Valencia	Domenech, F (corresponding author), Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Marine Zool Unit, Valencia, Spain.	francesc.domenech@uv.es	Raga, Juan Antonio/L-7669-2014; Aznar, Francisco Javier/S-3427-2018; Tomás, Jesús/AAA-4561-2019	Raga, Juan Antonio/0000-0003-2687-2539; Aznar, Francisco Javier/0000-0002-1316-1175; Garcia Parraga, Daniel/0000-0002-3335-5831; Crespo Picazo, Jose Luis/0000-0002-5216-044X; Tomas, Jesus/0000-0003-0120-7006	Generalitat Valenciana, Spain [PROMETEOII/2015/018]; Ministry of Economy and Competitiveness, Spain [AGL2015-68405-R]; University of Valencia, Spain [UV-INV-PREDOC15-265927]; Wildlife Service; Conselleria d'Agricultura, Medi Ambient, Canvi Climatic i Desenvolupament Rural of the Generalitat Valenciana; Conselleria d'Educacio, Investigacio, Cultura i Esport of the Generalitat Valenciana [PROMETEOII/2015/018]; Ministerio de Economia y Competitividad of Spain [AGL2015-68405-R]; Universitat de Valencia [UV-INV-PREDOC15-265927]	Generalitat Valenciana, Spain(Center for Forestry Research & Experimentation (CIEF)); Ministry of Economy and Competitiveness, Spain(Spanish Government); University of Valencia, Spain; Wildlife Service; Conselleria d'Agricultura, Medi Ambient, Canvi Climatic i Desenvolupament Rural of the Generalitat Valenciana; Conselleria d'Educacio, Investigacio, Cultura i Esport of the Generalitat Valenciana; Ministerio de Economia y Competitividad of Spain(Spanish Government); Universitat de Valencia	This work was supported by Project PROMETEOII/2015/018 from the Generalitat Valenciana, Spain (http://www.ceice.gva.es/poci/es/14_PROMETEOII.htm): funding for contributed reagents/materials/analysis tools; by Project AGL2015-68405-R (MINECO/FEDER) from the Ministry of Economy and Competitiveness, Spain (http://www.idi.mineco.gob.es/portal/site/MICINN/menuitem.d20caeda35a0c5dc7c68b11001432ea0/?vgnextoid=33f85656ecfee310VgnVCM1000001d04140aRCRD): funding for contributed reagents/materials/analysis tools; and by Predoc grant UV-INV-PREDOC15-265927 from the University of Valencia, Spain (http://www.uv.es/uvweb/servei-investigacio/ca/servei-investigacio-1285906397400.html): supporting doctoral formation of FD.; We thank the Wildlife Service and the Conselleria d'Agricultura, Medi Ambient, Canvi Climatic i Desenvolupament Rural of the Generalitat Valenciana for logistic and financial support. Additional financial support was given by: (1) the project PROMETEOII/2015/018 of the Conselleria d'Educacio, Investigacio, Cultura i Esport of the Generalitat Valenciana and (2) the project AGL2015-68405-R (MINECO/FEDER) of the Ministerio de Economia y Competitividad of Spain. We also thank the Universitat de Valencia for supporting F. Domenech with a predoctoral grant UV-INV-PREDOC15-265927. Finally, we thank the staff of the Marine Zoology Unit and the Oceanografic aquarium of Valencia for assistance during the survey. The constructive criticism of two anonymous referees is greatly appreciated.	Badillo FJ, 2007, MAR BIOL, V151, P751, DOI 10.1007/s00227-006-0521-z; Baeza J.A., 2015, LIFESTYLES FEEDING B, V2, P163; Bannister J. L., 1966, Crustaceana, V10, P296, DOI 10.1163/156854066X00199; Boxshall GA, 2004, INTRO COPEPOD DIVERS, P966; Clusa M, 2014, MAR BIOL, V161, P509, DOI 10.1007/s00227-013-2353-y; Dahms HU, 2004, J NAT HIST, V38, P1725, DOI 10.1080/0022293031000156321; de Segura AG, 2006, ANIM CONSERV, V9, P199, DOI 10.1111/j.1469-1795.2005.00014.x; Domenech F, 2015, J MAR BIOL ASSOC UK, V95, P851, DOI 10.1017/S0025315414001520; Frost B. W., 1967, Crustaceana, V12, P133, DOI 10.1163/156854067X00549; Harper JY, 2005, ZOO BIOL, V24, P135, DOI 10.1002/zoo.20044; Hays GC, 2002, MAR BIOL, V141, P985, DOI 10.1007/s00227-002-0885-7; Heppell SS, 1996, ECOL APPL, V6, P556, DOI 10.2307/2269391; Hopkins-Murphy SR, 2003, LOGGERHEAD SEA TURTL, P79; HUMES ARTHUR G., 1964, BULL MAR SCI GULF CARIBBEAN, V14, P517; Aznar FJ, 2010, J PARASITOL, V96, P299, DOI 10.1645/GE-2246.1; Kaliszewska ZA, 2005, MOL ECOL, V14, P3439, DOI 10.1111/j.1365-294X.2005.02664.x; Knuckey RM, 2005, AQUACULTURE, V249, P339, DOI 10.1016/j.aquaculture.2005.02.053; Koski M, 1998, MAR ECOL PROG SER, V170, P169, DOI 10.3354/meps170169; Lazo-Wasem Eric A., 2007, Bulletin of the Peabody Museum of Natural History, V48, P153, DOI 10.3374/0079-032X(2007)48[153:NROTMT]2.0.CO;2; Lee PLM, 2004, P NATL ACAD SCI USA, V101, P6530, DOI 10.1073/pnas.0307982101; Musick John A., 1997, P137; Nogata Y, 2006, BIOL LETTERS, V2, P92, DOI 10.1098/rsbl.2005.0409; Ogawa K, 1997, ZOOL SCI, V14, P691, DOI 10.2108/zsj.14.691; Olafsson E, 2001, HYDROBIOLOGIA, V453, P189, DOI 10.1023/A:1013196724039; Ortiz Manuel, 1992, Revista de Investigaciones Marinas, V13, P117; PALMER MA, 1988, MAR ECOL PROG SER, V48, P81, DOI 10.3354/meps048081; POULIN R, 1995, EVOLUTION, V49, P325, DOI 10.2307/2410343; PROVANCHA J A, 1991, Florida Scientist, V54, P87; RAGA J A, 1986, Investigacion Pesquera (Barcelona), V50, P489; Rasband WS, 2016, IMAGE J, V5, P19; Reiczigel J, 2003, STAT MED, V22, P611, DOI 10.1002/sim.1320; Reiczigel J, 2005, QUANTITATIVE PARASIT, V5, P19; Rowntree VJ, 1996, CAN J ZOOL, V74, P103, DOI 10.1139/z96-014; Rozsa L, 2000, J PARASITOL, V86, P228, DOI 10.1645/0022-3395(2000)086[0228:QPISOH]2.0.CO;2; Schofield G., 2006, ENDANGER SPECIES RES, V2, P71, DOI [DOI 10.3354/ESR002071, 110.3354/esr002071]; Schofield G, 2007, MAR ECOL PROG SER, V336, P267, DOI 10.3354/meps336267; Sewell R. B. S., 1949, SCI REPORTS, V9, P17; Suarez-Morales E, 2010, J NAT HIST, V44, P847, DOI 10.1080/00222931003615711; Suarez-Morales E, 2009, COMP PARASITOL, V76, P84, DOI 10.1654/4351.1; Takano-Lee M, 2005, INT J DERMATOL, V44, P811, DOI 10.1111/j.1365-4632.2005.02418.x; Vervoort W., 1961, Crustaceana, V3, P70, DOI 10.1163/156854061X00545; WALTERS K, 1994, MAR ECOL PROG SER, V108, P237, DOI 10.3354/meps108237; Whitehead H, 2000, CETACEAN SOCIETIES, P65; ZWERNER DE, 1967, T AM MICROSC SOC, V86, P152, DOI 10.2307/3224682	44	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170789	10.1371/journal.pone.0170789	http://dx.doi.org/10.1371/journal.pone.0170789			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114412	Green Submitted, Green Published, gold			2022-12-26	WOS:000396129000095
J	St Clair, JB; Detanico, T; Aviszus, K; Kirchenbaum, GA; Christie, M; Carpenter, JF; Wysocki, LJ				St Clair, J. Benjamin; Detanico, Thiago; Aviszus, Katja; Kirchenbaum, Greg A.; Christie, Merry; Carpenter, John F.; Wysocki, Lawrence J.			Immunogenicity of Isogenic IgG in Aggregates and Immune Complexes	PLOS ONE			English	Article							T-CELL EPITOPES; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; COMPLEMENT-DEPENDENT TRANSPORT; IMMUNOGLOBULIN VARIABLE-REGION; ANTIGEN-ANTIBODY COMPLEXES; B-CELLS; MONOCLONAL-ANTIBODY; IN-VIVO; IMMUNOLOGICAL-UNRESPONSIVENESS; THERAPEUTIC ANTIBODIES	A paradox in monoclonal antibody (mAb) therapy is that despite the well-documented tolerogenic properties of deaggregated IgG, most therapeutic IgG mAb induce anti-mAb responses. To analyze CD4 T cell reactions against IgG in various physical states, we developed an adoptive transfer model using CD4+ T cells specific for a VK region-derived peptide in the hapten-specific IgG mAb 36-71. We found that heat-aggregated or immune complexes (IC) of mAb 36-71 elicited anti-idiotypic (anti-Id) antibodies, while the deaggregated form was tolerogenic. All 3 forms of mAb 36-71 induced proliferation of cognate CD4+ T cells, but the aggregated and immune complex forms drove more division cycles and induced T follicular helper cells (T-FH) development more effectively than did the deaggregated form. These responses occurred despite no adjuvant and no or only trace levels of endotoxin in the preparations. Physical analyses revealed large differences in micron-and nanometer-sized particles between the aggregated and IC forms. These differences may be functionally relevant, as CD4+ T cell proliferation to aggregated, but not IC mAb 36-71, was nearly ablated upon peritoneal injection of B cell-depleting antibody. Our results imply that, in addition to denatured aggregates, immune complexes formed in vivo between therapeutic mAb and their intended targets can be immunogenic.	[St Clair, J. Benjamin; Detanico, Thiago; Aviszus, Katja; Wysocki, Lawrence J.] Natl Jewish Hlth, Dept Biomed Res, Denver, CO 80206 USA; [St Clair, J. Benjamin] Univ Colorado, Sch Med, Med Scientist Training Program, Denver, CO USA; [St Clair, J. Benjamin; Detanico, Thiago; Aviszus, Katja; Kirchenbaum, Greg A.] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO USA; [St Clair, J. Benjamin; Detanico, Thiago; Aviszus, Katja; Kirchenbaum, Greg A.] Univ Colorado, Sch Med, Denver, CO USA; [Christie, Merry; Carpenter, John F.] Univ Colorado Denver, Dept Pharmaceut Sci, Anschutz Med Campus, Aurora, CO USA; [Kirchenbaum, Greg A.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA USA; [Christie, Merry] US FDA, Off Biotechnol Prod, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Wysocki, Lawrence J.] Univ Colorado, Sch Med, Dept Immunol, Denver, CO 80204 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University System of Georgia; University of Georgia; US Food & Drug Administration (FDA); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Wysocki, LJ (corresponding author), Natl Jewish Hlth, Dept Biomed Res, Denver, CO 80206 USA.	wysockil@njhealth.org		Kirchenbaum, Greg/0000-0001-6463-7623	National Institutes of Health/National Institute of Allergy and Infectious Disease [R01AI033613, R21AI121980, R03AI088408]; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [F30DK091102]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI121980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008497] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by National Institutes of Health/National Institute of Allergy and Infectious Disease: R01AI033613 (LJW) R21AI121980 (LJW), R03AI088408 (LJW) and National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases F30DK091102 (JBS).	Aarden L, 2008, CURR OPIN IMMUNOL, V20, P431, DOI 10.1016/j.coi.2008.06.011; AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Anthony RM, 2010, J CLIN IMMUNOL, V30, pS9, DOI 10.1007/s10875-010-9405-6; Anthony RM, 2008, P NATL ACAD SCI USA, V105, P19571, DOI 10.1073/pnas.0810163105; Baker Matthew P, 2010, Self Nonself, V1, P314, DOI 10.4161/self.1.4.13904; Barnard JG, 2011, J PHARM SCI-US, V100, P492, DOI 10.1002/jps.22305; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Benschop RJ, 2001, IMMUNITY, V14, P33, DOI 10.1016/S1074-7613(01)00087-5; BOGEN B, 1985, EUR J IMMUNOL, V15, P278, DOI 10.1002/eji.1830150313; BOGEN B, 1986, EUR J IMMUNOL, V16, P1373, DOI 10.1002/eji.1830161110; BOGEN B, 1983, EUR J IMMUNOL, V13, P353, DOI 10.1002/eji.1830130502; Buss NAPS, 2012, CURR OPIN PHARMACOL, V12, P615, DOI 10.1016/j.coph.2012.08.001; Carpenter J, 2010, BIOL J INT ASS B SEP, P602; Carpenter JF, 2009, J PHARM SCI-US, V98, P1201, DOI 10.1002/jps.21530; Chen DY, 2014, ANN RHEUMATIC DIS; CHILLER JM, 1971, SCIENCE, V171, P813, DOI 10.1126/science.171.3973.813; CHILLER JM, 1970, P NATL ACAD SCI USA, V65, P551, DOI 10.1073/pnas.65.3.551; Christie M, 2014, J PHARM SCI-US, V103, P128, DOI 10.1002/jps.23794; De Groot AS, 2007, TRENDS IMMUNOL, V28, P482, DOI 10.1016/j.it.2007.07.011; Detanico T, 2011, J IMMUNOL, V187, P82, DOI 10.4049/jimmunol.1002287; Divekar RD, 2011, J IMMUNOL, V187, P3979, DOI 10.4049/jimmunol.1100531; DRESSER DW, 1961, NATURE, V191, P1169, DOI 10.1038/1911169a0; DRESSER DW, 1962, IMMUNOLOGY, V5, P378; DRESSER DW, 1961, IMMUNOLOGY, V4, P13; Eidem JK, 2000, J IMMUNOL METHODS, V245, P119, DOI 10.1016/S0022-1759(00)00274-X; Eyerman MC, 1996, J IMMUNOL, V157, P1037; EYERMAN MC, 1994, J IMMUNOL, V152, P1569; Filipe V, 2014, PHARM RES-DORDR, V31, P216, DOI 10.1007/s11095-013-1154-9; Filipe V, 2012, MABS-AUSTIN, V4, P740, DOI 10.4161/mabs.22066; Gilliland LK, 1999, J IMMUNOL, V162, P3663; Gonzalez SF, 2010, J IMMUNOL, V185, P2659, DOI 10.4049/jimmunol.1000522; Gonzalez SF, 2010, NAT IMMUNOL, V11, P427, DOI 10.1038/ni.1856; Guo WZ, 2005, J IMMUNOL, V175, P2184, DOI 10.4049/jimmunol.175.4.2184; Harwood Naomi E, 2010, F1000 Biol Rep, V2, P87, DOI 10.3410/B2-87; Heiser RA, 2011, J IMMUNOL, V187, P212, DOI 10.4049/jimmunol.1002328; ISHIZAKA K, 1959, J EXP MED, V109, P127, DOI 10.1084/jem.109.2.127; ISHIZAKA K, 1959, J IMMUNOL, V83, P105; Jain R, 2008, J EXP MED, V205, P207, DOI 10.1084/jem.20071878; JANEWAY CA, 1973, EUR J IMMUNOL, V3, P340, DOI 10.1002/eji.1830030605; Jefferis R, 2011, MABS-AUSTIN, V3, P503, DOI 10.4161/mabs.3.6.17611; JORGENSEN T, 1983, J EXP MED, V158, P2183, DOI 10.1084/jem.158.6.2183; Joubert MK, 2012, J BIOL CHEM, V287, P25266, DOI 10.1074/jbc.M111.330902; Joubert MK, 2011, J BIOL CHEM, V286, P25118, DOI 10.1074/jbc.M110.160457; KUSSIE PH, 1994, J IMMUNOL, V152, P146; Legge KL, 1998, J IMMUNOL, V161, P106; Legge KL, 1997, J EXP MED, V185, P1043, DOI 10.1084/jem.185.6.1043; Legge KL, 2002, J EXP MED, V196, P217, DOI 10.1084/jem.20011061; Lopez-Requena A, 2007, MOL IMMUNOL, V44, P3076, DOI 10.1016/j.molimm.2007.01.005; Lund E, 2001, Int Rev Immunol, V20, P647, DOI 10.3109/08830180109045583; Lunde E, 1997, MOL IMMUNOL, V34, P1167, DOI 10.1016/S0161-5890(97)00143-0; Lunde E, 2002, J IMMUNOL, V168, P2154, DOI 10.4049/jimmunol.168.5.2154; Lunde E, 2001, BIOMOL ENG, V18, P109, DOI 10.1016/S1389-0344(01)00091-0; Lunde E, 2003, MOL IMMUNOL, V34, P1167; Maini RN, 1998, ARTHRITIS RHEUM, V41, P1552, DOI 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W; MARSHAKROTHSTEIN A, 1980, J IMMUNOL, V125, P1987; MARSHAKROTHSTEIN A, 1980, P NATL ACAD SCI-BIOL, V77, P1120, DOI 10.1073/pnas.77.2.1120; Merrell KT, 2006, IMMUNITY, V25, P953, DOI 10.1016/j.immuni.2006.10.017; Moss AC, 2013, ALIMENT PHARM THER, V38, P1188, DOI 10.1111/apt.12507; Munthe LA, 1999, EUR J IMMUNOL, V29, P4043, DOI 10.1002/(SICI)1521-4141(199912)29:12<4043::AID-IMMU4043>3.0.CO;2-E; Munthe LA, 2005, J IMMUNOL, V175, P2391, DOI 10.4049/jimmunol.175.4.2391; Munthe LA, 2004, J IMMUNOL, V172, P7476, DOI 10.4049/jimmunol.172.12.7476; Nimmerjahn F, 2010, IMMUNOL REV, V236, P265, DOI 10.1111/j.1600-065X.2010.00910.x; Oliver AM, 1999, HYBRIDOMA, V18, P113, DOI 10.1089/hyb.1999.18.113; Phan TG, 2009, IMMUNE COMPLEX RELAY, V10, P787; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Phillips WJ, 2005, INT REV IMMUNOL, V24, P501, DOI 10.1080/08830180500379648; Presta LG, 2008, CURR OPIN IMMUNOL, V20, P460, DOI 10.1016/j.coi.2008.06.012; Maneiro JR, 2013, JAMA INTERN MED, V173, P1416, DOI 10.1001/jamainternmed.2013.7430; RAO A, 1984, J EXP MED, V159, P479, DOI 10.1084/jem.159.2.479; Rasmussen IB, 2001, P NATL ACAD SCI USA, V98, P10296, DOI 10.1073/pnas.181336898; Reichardt V L, 1997, Biol Blood Marrow Transplant, V3, P157; Reitan SK, 2002, P NATL ACAD SCI USA, V99, P7588, DOI 10.1073/pnas.052150899; Reitan SK, 2001, EUR J IMMUNOL, V31, P2143, DOI 10.1002/1521-4141(200107)31:7<2143::AID-IMMU2143>3.0.CO;2-1; REITAN SK, 1995, EUR J IMMUNOL, V25, P1601, DOI 10.1002/eji.1830250620; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; Rosenberg AS, 2006, AAPS J, V8, pE501, DOI 10.1208/aapsj080359; Scott DW, 2010, ANN RHEUM DIS, V69, P72, DOI 10.1136/ard.2009.117564; Shomali M, 2014, J PHARM SCI-US, V103, P78, DOI 10.1002/jps.23772; Snyder CM, 2004, J EXP MED, V200, P1, DOI 10.1084/jem.20031234; Somerfield J, 2010, J IMMUNOL, V185, P763, DOI 10.4049/jimmunol.1000422; van Schouwenburg PA, 2010, J IMMUNOL METHODS, V362, P82, DOI 10.1016/j.jim.2010.09.005; Wan XX, 2014, IMMUNOTHERAPY-UK, V6, P155, DOI [10.2217/IMT.13.172, 10.2217/imt.13.172]; WEIGLE WO, 1971, CLIN EXP IMMUNOL, V9, P437; YOUNG NS, 1972, J CLIN INVEST, V51, P1790, DOI 10.1172/JCI106980; Yu P, 2005, J IMMUNOL, V174, P6772, DOI 10.4049/jimmunol.174.11.6772; ZAGHOUANI H, 1993, SCIENCE, V259, P224, DOI 10.1126/science.7678469; Zaghouani H, 1993, Int Rev Immunol, V10, P265, DOI 10.3109/08830189309061701	87	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170556	10.1371/journal.pone.0170556	http://dx.doi.org/10.1371/journal.pone.0170556			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114383	Green Published, Green Submitted, gold			2022-12-26	WOS:000396129000067
J	Ji, J; Hedelin, A; Malmlof, M; Kessler, V; Seisenbaeva, G; Gerde, P; Palmberg, L				Ji, Jie; Hedelin, Anna; Malmlof, Maria; Kessler, Vadim; Seisenbaeva, Gulaim; Gerde, Per; Palmberg, Lena			Development of Combining of Human Bronchial Mucosa Models with XposeALI (R) for Exposure of Air Pollution Nanoparticles	PLOS ONE			English	Article							LIQUID INTERFACE; EPITHELIAL-CELLS; INHALATION EXPOSURES; IN-VITRO; LUNG; EXACERBATION; PARTICLES; PALLADIUM; STATEMENT; POWDER	Background Exposure to agents via inhalation is of great concerns both in workplace environment and in the daily contact with particles in the ambient air. Reliable human airway exposure systems will most likely replace animal experiment in future toxicity assessment studies of inhaled agents. Methods In this study, we successfully established a combination of an exposure system (XposeALI) with 3D models mimicking both healthy and chronic bronchitis-like mucosa by co-culturing human primary bronchial epithelial cells (PBEC) and fibroblast at air-liquid interface (ALI). Light-, confocal microscopy, scanning-and transmission electron microscopy, transepithelial electrical resistance (TEER) measurement and RT-PCR were performed to identify how the PBEC differentiated under ALI culture condition. Both models were exposed to palladium (Pd) nanoparticles which sized 6 - 10 nm, analogous to those released from modern car catalysts, at three different concentrations utilizing the XposeALI module of the PreciseInhale (R) exposure system. Results Exposing the 3D models to Pd nanoparticles induced increased secretion of IL-8, yet the chronic bronchitis-like model released significantly more IL-8 than the normal model. The levels of IL-8 in basal medium (BM) and apical lavage medium (AM) were in the same ranges, but the secretion of MMP-9 was significantly higher in the AM compared to the BM. Conclusion This combination of relevant human bronchial mucosa models and sophisticated exposure system can mimic in vivo conditions and serve as a useful alternative animal testing tool	[Ji, Jie; Hedelin, Anna; Palmberg, Lena] Karolinska Inst, Inst Environm Med, Lung & Airway Res, Stockholm, Sweden; [Malmlof, Maria; Gerde, Per] Inhalat Sci Sweden AB, Stockholm, Sweden; [Malmlof, Maria; Gerde, Per] Karolinska Inst, Inst Environm Med, Expt Asthma & Allergy Res, Stockholm, Sweden; [Kessler, Vadim; Seisenbaeva, Gulaim] Swedish Univ Agr Sci, SLU, Dept Chem & Biotechnol, Inorgan Bionanotechnol Unit, Uppsala, Sweden	Karolinska Institutet; Karolinska Institutet; Swedish University of Agricultural Sciences	Ji, J (corresponding author), Karolinska Inst, Inst Environm Med, Lung & Airway Res, Stockholm, Sweden.	jie.ji@ki.se	Seisenbaeva, Gulaim/Y-8024-2019; JI, JIE/H-2394-2017; Kessler, Vadim G/C-5012-2017	Seisenbaeva, Gulaim/0000-0003-0072-6082; JI, JIE/0000-0002-0280-5801; Kessler, Vadim G/0000-0001-7570-2814	Swedish Fund for Research without Animal Experiments [22/10, 40/11, F35/12, F25/13, F34-14, F36/15]; Swedish Research Council [521-2010-2801, 2014-02767]; Swedish Heart-lung Foundation [20100180, 20120376, 20120818, 20150328, 20150329, 20150330]; Karolinska Insitutet	Swedish Fund for Research without Animal Experiments; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-lung Foundation(Swedish Heart-Lung Foundation); Karolinska Insitutet	Support was provided to: LP by the Swedish Fund for Research without Animal Experiments (grant no. 22/10, 40/11, F35/12, F25/13, F34-14 and F36/15); LP, VK, PG by: Swedish Research Council (grant no. 521-2010-2801 and 2014-02767); LP by the Swedish Heart-lung Foundation (grant no. 20100180, 20120376, 20120818, 20150328, 20150329 and 20150330); and LP by the Karolinska Insitutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atherton HC, 2003, AM J PHYSIOL-LUNG C, V285, pL730, DOI 10.1152/ajplung.00089.2003; Atkinson JJ, 2003, AM J RESP CELL MOL, V28, P12, DOI 10.1165/rcmb.2002-0166TR; Atkinson RW, 2001, AM J RESP CRIT CARE, V164, P1860, DOI 10.1164/ajrccm.164.10.2010138; Aufderheide M, 2004, EXP TOXICOL PATHOL, V55, P451, DOI 10.1078/0940-2993-00348; Aufderheide M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/734137; Bitterle E, 2006, CHEMOSPHERE, V65, P1784, DOI 10.1016/j.chemosphere.2006.04.035; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Eisner MD, 2010, AM J RESP CRIT CARE, V182, P693, DOI 10.1164/rccm.200811-1757ST; Geiser M, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-2; Gerde P, 2004, INHAL TOXICOL, V16, P45, DOI 10.1080/08958370490258381; Hurst JR, 2011, AM J RESP CRIT CARE, V184, P625, DOI 10.1164/rccm.201106-1136ED; Ji J, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0104-3; Kanitsar K, 2003, J ANAL ATOM SPECTROM, V18, P239, DOI 10.1039/b212218a; Larsson K, 1998, EUR RESPIR J, V12, P825, DOI 10.1183/09031936.98.12040825; Lenz AG, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-32; Mathis C, 2013, AM J PHYSIOL-LUNG C, V304, pL489, DOI 10.1152/ajplung.00181.2012; Monteiller C, 2007, OCCUP ENVIRON MED, V64, P609, DOI 10.1136/oem.2005.024802; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Rauch S, 2005, ENVIRON SCI TECHNOL, V39, P8156, DOI 10.1021/es050784m; Schamberger AC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08163; Scheffler S, 2015, INT J ENV RES PUB HE, V12, P12466, DOI 10.3390/ijerph121012466; Selg E, 2013, J AEROSOL MED PULM D, V26, P181, DOI 10.1089/jamp.2012.0971; Sint T, 2008, INHAL TOXICOL, V20, P25, DOI [10.1080/08958370701758759, 10.1080/08958370701758759 ]; Stan MS, 2015, FEBS J, V282, P2914, DOI 10.1111/febs.13330; Wilkinson KE, 2011, ACS NANO, V5, P5312, DOI 10.1021/nn1032664; Yoshisue H, 2004, BIOSCI BIOTECH BIOCH, V68, P2024, DOI 10.1271/bbb.68.2024; Zhen GH, 2007, AM J RESP CELL MOL, V36, P244, DOI 10.1165/rcmb.2006-0180OC	28	28	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170428	10.1371/journal.pone.0170428	http://dx.doi.org/10.1371/journal.pone.0170428			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107509	Green Published, gold, Green Submitted			2022-12-26	WOS:000392405300134
J	Leong, DP; McKee, M; Yusuf, S				Leong, Darryl P.; McKee, Martin; Yusuf, Salim		PURE Investigators	Population Muscle Strength Predicts Olympic Medal Tallies: Evidence from 20 Countries in the PURE Prospective Cohort Study	PLOS ONE			English	Article								Background National sporting achievement at the Olympic Games is important for national pride and prestige, and to promote participation in sport. Summer Olympic Games medal tallies have been associated with national wealth, and also social development and healthcare expenditure. It is uncertain however, how these socioeconomic factors translate into Olympic success. The objective of this study was therefore to examine the relationship between population muscle strength and Olympic medal tallies. Methods and Results This study of handgrip strength represents a cross-sectional analysis of the Prospective Urban Rural Epidemiology (PURE) study, which is an ongoing population cohort study of individuals from high-, middle-, and low-income countries. Within participating countries, households from both urban and rural communities were invited to participate using a sampling strategy intended to yield a sample that was representative of the community. Households were eligible if at least one member was aged 35 +/- 70 years and if they intended living at the same address for a further four years. A total of 152,610 participants from these households, located in 21 countries, were included in this analysis. Handgrip strength was measured using a Jamar dynanometer. Olympic medal tallies were made over the five most recent Summer Games. There was a significant positive association between national population grip strength (GS) and medal tally that persisted after adjustment for sex, age, height, average daily caloric intake and GDP (total and per capita). For every 1kg increase in population GS, the medal tally increased by 36% (95% CI 13 +/- 65%, p = 0.001) after adjustment. Among countries that won at least one medal over the four most recent Summer Olympic Games, there was a close linear relationship between adjusted GS and the natural logarithm of the per capita medal tally (adjusted r = 0.74, p = 0.002). Conclusions Population muscle strength may be an important determinant of Summer Olympic Games medal success. Further research is needed to understand whether population muscle strength is modifiable, and whether this can improve Olympic medal success. Extreme outcomes may reflect the average attributes of the population from which the individual experiencing the extreme outcome is drawn.	[Leong, Darryl P.; Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Leong, Darryl P.; Yusuf, Salim] Hamilton Hlth Sci, Hamilton, ON, Canada; [McKee, Martin] London Sch Hyg & Trop Med, London, England	McMaster University; Population Health Research Institute; McMaster University; University of London; London School of Hygiene & Tropical Medicine	Leong, DP (corresponding author), McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada.; Leong, DP (corresponding author), Hamilton Hlth Sci, Hamilton, ON, Canada.	leongd@phri.ca	McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; Yusuf, Salim/0000-0003-4776-5601	Population Health Research Institute; Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario; AstraZeneca [Sweden and Canada]; Sanofi-Aventis [France and Canada]; Boehringer Ingelheim [Germany and Canada]; Servier; GlaxoSmithKline; Novartis; King Pharma; Bangladesh Independent University; Mitra and Associates in Bangladesh; Unilever Health Institute in Brazil; Public Health Agency of Canada; Champlain Cardiovascular Disease Prevention Network in Canada; Universidad de la Frontera in Chile; National Center for Cardiovascular Diseases in China; Colciencias in Colombia [6566-04-18062]; Indian Council of Medical Research in India; Ministry of Science, Technology and Innovation of Malaysia [07-05-IFN-MEB010]; Universiti Teknologi MARA; Universiti Kebangsaan Malaysia in Malaysia [UKM-Hejim-Komuniti-15-2010]; Polish Ministry of Science and Higher Education [290/W-PURE/2008/0]; Wroclaw Medical University in Poland; North-West University, South Africa; Netherlands Programme for Alternative Development (SANPAD); National Research Foundation; Medical Research Council of South Africa; South Africa Sugar Association (SASA); Faculty of Community and Health Sciences (UWC) in South Africa; Swedish Council for Working Life and Social Research; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; Swedish Heart and Lung Foundation; Swedish Research Council; Swedish State under LUA (LskarUtbildningsAvtalet) agreement; Vastra Gotaland Region (FOUU) in Sweden; Metabolic Syndrome Society; Astra Zeneca; Sanofi-Aventis in Turkey; Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences, Dubai Health Authority, Dubai, in the United Arab Emirates; Michael G. DeGroote Fellowship Award, McMaster University; E.J. Moran Campbell Career Research Award, McMaster University; Marion Burke Chair of the Heart and Stroke foundation of Canada	Population Health Research Institute; Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of OntarioCanadian Institutes of Health Research (CIHR)); AstraZeneca [Sweden and Canada](AstraZeneca); Sanofi-Aventis [France and Canada]; Boehringer Ingelheim [Germany and Canada](Boehringer Ingelheim); Servier(Servier); GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); King Pharma; Bangladesh Independent University; Mitra and Associates in Bangladesh; Unilever Health Institute in Brazil(Unilever); Public Health Agency of Canada; Champlain Cardiovascular Disease Prevention Network in Canada; Universidad de la Frontera in Chile; National Center for Cardiovascular Diseases in China; Colciencias in Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Indian Council of Medical Research in India; Ministry of Science, Technology and Innovation of Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Universiti Teknologi MARA; Universiti Kebangsaan Malaysia in Malaysia; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Wroclaw Medical University in Poland; North-West University, South Africa; Netherlands Programme for Alternative Development (SANPAD); National Research Foundation; Medical Research Council of South Africa(South African Medical Research Council); South Africa Sugar Association (SASA); Faculty of Community and Health Sciences (UWC) in South Africa; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish State under LUA (LskarUtbildningsAvtalet) agreement; Vastra Gotaland Region (FOUU) in Sweden; Metabolic Syndrome Society; Astra Zeneca(AstraZeneca); Sanofi-Aventis in Turkey; Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences, Dubai Health Authority, Dubai, in the United Arab Emirates; Michael G. DeGroote Fellowship Award, McMaster University; E.J. Moran Campbell Career Research Award, McMaster University; Marion Burke Chair of the Heart and Stroke foundation of Canada	The main PURE study and its components are funded by the Population Health Research Institute, the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, and through unrestricted grants from several pharmaceutical companies (major contributions from AstraZeneca [Sweden and Canada], Sanofi-Aventis [France and Canada], Boehringer Ingelheim [Germany and Canada], Servier, and GlaxoSmithKline), and additional contributions from Novartis and King Pharma and from various national or local organisations in participating countries. These contributions were from the Bangladesh Independent University and Mitra and Associates in Bangladesh; Unilever Health Institute in Brazil; Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network in Canada; Universidad de la Frontera in Chile; National Center for Cardiovascular Diseases in China; Colciencias in Colombia (grant number 6566-04-18062); Indian Council of Medical Research in India; Ministry of Science, Technology and Innovation of Malaysia (grant number 07-05-IFN-MEB010) and Universiti Teknologi MARA, Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010) in Malaysia; Polish Ministry of Science and Higher Education (grant number 290/W-PURE/2008/0) and Wroclaw Medical University in Poland; The North-West University, South Africa and Netherlands Programme for Alternative Development (SANPAD), National Research Foundation, Medical Research Council of South Africa, The South Africa Sugar Association (SASA), and Faculty of Community and Health Sciences (UWC) in South Africa; Swedish Council for Working Life and Social Research, Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, Swedish Heart and Lung Foundation, Swedish Research Council, Grant from the Swedish State under LUA (LskarUtbildningsAvtalet) agreement, and grant from the Vastra Gotaland Region (FOUU) in Sweden; Metabolic Syndrome Society, Astra Zeneca, and Sanofi-Aventis in Turkey; Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences, Dubai Health Authority, Dubai, in the United Arab Emirates. Study funders played no role in the study design, or the collection, analysis, or interpretation of data. Dr. Leong is supported by the Michael G. DeGroote Fellowship Award, McMaster University, and the E.J. Moran Campbell Career Research Award, McMaster University. Dr. Yusuf is funded by the Marion Burke Chair of the Heart and Stroke foundation of Canada.	Aspenes ST, 2012, SPORTS MED, V42, P527, DOI 10.2165/11630760-000000000-00000; Bernard AB, 2004, REV ECON STAT, V86, P413, DOI 10.1162/003465304774201824; Berthelot G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008800; Beunen G, 2006, BRIT J SPORT MED, V40, P822, DOI 10.1136/bjsm.2006.029116; Bleeker GB, 2004, J CARDIOVASC ELECTR, V15, P544, DOI 10.1046/j.1540-8167.2004.03604.x; Corsi DJ, 2013, AM HEART J, V166, P636, DOI 10.1016/j.ahj.2013.04.019; Desgorces FD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003653; Green M., 2007, International Journal of the History of Sport, V24, P921, DOI 10.1080/09523360701311810; Johnson DKN, 2004, SOC SCI QUART, V85, P974, DOI 10.1111/j.0038-4941.2004.00254.x; Krishna A., 2008, Economic and Political Weekly, V43, P143; Larsen HB, 2003, COMP BIOCHEM PHYS A, V136, P161, DOI 10.1016/S1095-6433(03)00227-7; Leong DP, 2015, LANCET, V386, P266, DOI 10.1016/S0140-6736(14)62000-6; Lillis K, 2012, RUNNING BLACK GOLD 5; Lombardo MP, 2014, PEERJ, V2, DOI 10.7717/peerj.445; Lui HK, 2008, PAC ECON REV, V13, P1, DOI 10.1111/j.1468-0106.2007.00386.x; Luschen G., 1967, J INT SOC SPORTS, V2, P127, DOI [10.1177/101269026700200109, DOI 10.1177/101269026700200109]; Majumdar Boria, 2010, INDIA OLYMPICS; Moosa I.A., 2004, AUST ECON PAP, V43, P288, DOI [10.1111/j.1467-8454.2004.00231.x, DOI 10.1111/J.1467-8454.2004.00231.X]; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; Timmons JA, 2010, J APPL PHYSIOL, V108, P1487, DOI 10.1152/japplphysiol.01295.2009; Van Tuyckom C, 2012, QUAL QUANT, V46, P189, DOI 10.1007/s11135-010-9351-7; Vaz M, 1996, BRIT J NUTR, V76, P9, DOI 10.1079/BJN19960005	22	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0169821	10.1371/journal.pone.0169821	http://dx.doi.org/10.1371/journal.pone.0169821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI3QC	28107362	Green Submitted, Green Published, gold			2022-12-26	WOS:000392405300045
J	Roth-Monzon, AJ; Scott, LE; Camargo, AA; Clark, EI; Schott, EE; Johnson, JB				Roth-Monzon, Andrea J.; Scott, Laura E.; Camargo, Ashley A.; Clark, Eliza I.; Schott, Eric E.; Johnson, Jerald B.			Sympatry Predicts Spot Pigmentation Patterns and Female Association Behavior in the Livebearing Fish Poeciliopsis baenschi	PLOS ONE			English	Article							REPRODUCTIVE CHARACTER DISPLACEMENT; MALE MATING SUCCESS; MATE CHOICE; SEXUAL-HARASSMENT; INSEMINATION SUCCESS; COLOR PATTERNS; LIFE-HISTORY; EVOLUTION; MOSQUITOFISH; RECOGNITION	In this study, we explored the possibility that differences in pigmentation patterns among populations of the fish Poeciliopsis baenschi were associated with the presence or absence of the closely related species P. turneri. If reproductive character displacement is responsible, spotting patterns in these two species should diverge in sympatry, but not allopatry. We predicted that female P. baenschi from sympatric sites should show a preference for associating with conspecifics vs. heterospecific males, but females from allopatric sites should show no such preferences. To evaluate these predictions, we compared spotting patterns and female association behaviors in populations of P. baenschi from Central Mexico. We found that both of our predictions were supported. Poeciliopsis baenschi that co-occured with P. turneri had spotting patterns significantly different than their counterparts from allopatric sites. Using a simultaneous choice test of video presentations of males, we also found that female P. baenschi from populations that co-occured with P. turneri spent significantly more time with males of their own species than with P. turneri males. In contrast, females from allopatric populations of P. baenschi showed no differences in the amount of time they spent with either conspecific or heterospecific males. Together, our results are consistent with the hypothesis that reproductive character displacement may be responsible for behavioral and spotting pattern differences in these populations of P. baenschi.	[Roth-Monzon, Andrea J.; Scott, Laura E.; Camargo, Ashley A.; Clark, Eliza I.; Schott, Eric E.; Johnson, Jerald B.] Brigham Young Univ, Dept Biol, Evolutionary Ecol Labs, Provo, UT 84602 USA; [Johnson, Jerald B.] Brigham Young Univ, Monte L Bean Life Sci Museum, Provo, UT 84602 USA	Brigham Young University; Brigham Young University	Roth-Monzon, AJ (corresponding author), Brigham Young Univ, Dept Biol, Evolutionary Ecol Labs, Provo, UT 84602 USA.	rothmonzon@gmail.com	Johnson, Jerald/AAN-5574-2020	Clark, Eliza/0000-0001-9693-2045	Brigham Young University; Consejo Nacional de Ciencia y Tecnologia, Mexico; Brigham Young University High Impact Doctoral Research Award (HIDRA)	Brigham Young University; Consejo Nacional de Ciencia y Tecnologia, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Brigham Young University High Impact Doctoral Research Award (HIDRA)	This work was funded by a Mentoring Environment Grant and the Roger and Victoria Sant Educational Endowment for a Sustainable Environment Grant to JBJ from Brigham Young University. AJRM is supported by fellowships from Consejo Nacional de Ciencia y Tecnologia, Mexico and a Brigham Young University High Impact Doctoral Research Award (HIDRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; J. J. Zuniga-Vega helped secure permits and logistical support during fieldwork. We thank K. Stilson for his help with spot quantification. M. Belk and two anonymous reviewers read the manuscript and provided helpful feedback. This work was funded by a Mentoring Environment Grant and a grant from the Roger and Victoria Sant Educational Endowment for a Sustainable Environment at Brigham Young University to JBJ. AJRM is supported by fellowships from Consejo Nacional de Ciencia y Tecnologia, Mexico and a Brigham Young University High Impact Doctoral Research Award (HIDRA).	Arnold ML, 2010, TRENDS ECOL EVOL, V25, P530, DOI 10.1016/j.tree.2010.06.005; Bacquet PMB, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2734; Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; Basolo AL, 2004, ANIM BEHAV, V68, P75, DOI 10.1016/j.anbehav.2003.07.019; Bastiaans E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093197; Bisazza A, 2001, BEHAV ECOL, V12, P59, DOI 10.1093/oxfordjournals.beheco.a000379; Booksmythe I, 2013, ANIM BEHAV, V85, P371, DOI 10.1016/j.anbehav.2012.11.009; BROWN WL, 1956, SYST ZOOL, V5, P49, DOI 10.2307/2411924; Burke JM, 2001, ANNU REV GENET, V35, P31, DOI 10.1146/annurev.genet.35.102401.085719; Campbell DLM, 2009, BEHAV PROCESS, V80, P90, DOI 10.1016/j.beproc.2008.10.007; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; Chek AA, 2003, ECOL LETT, V6, P235, DOI 10.1046/j.1461-0248.2003.00420.x; CLUTTONBROCK TH, 1995, ANIM BEHAV, V49, P1345, DOI 10.1006/anbe.1995.0166; Cohen J.E., 1988, STAT POWER ANAL BEHA; Culumber ZW, 2014, ETHOLOGY, V120, P1090, DOI 10.1111/eth.12282; Culumber ZW, 2014, AM NAT, V184, P225, DOI 10.1086/677033; Cummings ME, 2008, P ROY SOC B-BIOL SCI, V275, P393, DOI 10.1098/rspb.2007.1454; Dyer KA, 2014, EVOLUTION, V68, P1163, DOI 10.1111/evo.12335; ENDLER JA, 1983, ENVIRON BIOL FISH, V9, P173, DOI 10.1007/BF00690861; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; ENDLER JA, 1987, ANIM BEHAV, V35, P1376, DOI 10.1016/S0003-3472(87)80010-6; Engeszer RE, 2008, P NATL ACAD SCI USA, V105, P929, DOI 10.1073/pnas.0708778105; Fernandez AA, 2008, P NATL ACAD SCI USA, V105, P13503, DOI 10.1073/pnas.0803851105; Fisher HS, 2009, ANIM BEHAV, V78, P265, DOI 10.1016/j.anbehav.2009.02.029; Franck Dierk, 2003, Acta Ethologica, V5, P75, DOI 10.1007/s10211-002-0072-3; Franz M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-323; Gabor CR, 2001, P ROY SOC B-BIOL SCI, V268, P1063, DOI 10.1098/rspb.2001.1626; Gavrilets S, 2001, P ROY SOC B-BIOL SCI, V268, P531, DOI 10.1098/rspb.2000.1382; GERHARDT HC, 1994, ANIM BEHAV, V47, P959, DOI 10.1006/anbe.1994.1127; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; Grether GF, 2001, P ROY SOC B-BIOL SCI, V268, P1245, DOI 10.1098/rspb.2001.1624; Groning J, 2008, Q REV BIOL, V83, P257, DOI 10.1086/590510; Head ML, 2015, ECOL EVOL, V5, P4999, DOI 10.1002/ece3.1775; Head ML, 2015, ANIM BEHAV, V103, P99, DOI 10.1016/j.anbehav.2015.02.011; Heubel KU, 2008, BEHAV ECOL SOCIOBIOL, V62, P1689, DOI 10.1007/s00265-008-0597-1; Hobel G, 2003, EVOLUTION, V57, P894; Horth L, 2004, J EVOLUTION BIOL, V17, P672, DOI 10.1111/j.1420-9101.2004.00710.x; HUGHES AL, 1985, BEHAV ECOL SOCIOBIOL, V17, P271, DOI 10.1007/BF00300146; Ingley SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090274; Johnson JB, 2002, OIKOS, V96, P82, DOI 10.1034/j.1600-0706.2002.960109.x; Johnson JB, 2003, BEHAV ECOL, V14, P619, DOI 10.1093/beheco/arg046; Kahn AT, 2012, BIOL LETT, V11, P1; KATZIR G, 1981, ANIM BEHAV, V29, P842, DOI 10.1016/S0003-3472(81)80019-X; Kirschel ANG, 2009, P NATL ACAD SCI USA, V106, P8256, DOI 10.1073/pnas.0810124106; Kodric-Brown A, 2001, BEHAV ECOL SOCIOBIOL, V50, P346, DOI 10.1007/s002650100374; KODRICBROWN A, 1993, BEHAV ECOL SOCIOBIOL, V32, P415, DOI 10.1007/BF00168825; KODRICBROWN A, 1989, BEHAV ECOL SOCIOBIOL, V25, P393, DOI 10.1007/BF00300185; Kohler A, 2011, BEHAV ECOL SOCIOBIOL, V65, P1513, DOI 10.1007/s00265-011-1161-y; Kozak HL, 2008, BEHAV ECOL, V19, P463, DOI 10.1093/beheco/arm139; Langerhans BR, 2006, AM NAT, V164, P335; Langerhans RB, 2004, EVOLUTION, V58, P2305, DOI 10.1111/j.0014-3820.2004.tb01605.x; Lemmon EM, 2009, EVOLUTION, V63, P1155, DOI 10.1111/j.1558-5646.2009.00650.x; Louviere JJ, 2000, STATED CHOICE METHOD, P34, DOI DOI 10.1017/CBO9780511753831.003; Lynch KS, 2012, GENES BRAIN BEHAV, V11, P222, DOI 10.1111/j.1601-183X.2011.00742.x; LYONS J, 1990, SOUTHWEST NAT, V35, P32, DOI 10.2307/3671983; MACARTHUR RH, 1964, P NATL ACAD SCI USA, V51, P1207, DOI 10.1073/pnas.51.6.1207; MAGURRAN AE, 1994, P ROY SOC B-BIOL SCI, V258, P89, DOI 10.1098/rspb.1994.0147; Magurran AE., 2010, ECOLOGY EVOLUTION PO; Makowicz AM, 2013, ANIM BEHAV, V85, P569, DOI 10.1016/j.anbehav.2012.12.016; Mateos M, 2005, J BIOGEOGR, V32, P775, DOI 10.1111/j.1365-2699.2005.01236.x; Mateos M, 2005, J HERED, V96, P32, DOI 10.1093/jhered/esi010; Mateos M, 2002, EVOLUTION, V56, P972; MORRIS MR, 1995, BEHAV ECOL, V6, P274, DOI 10.1093/beheco/6.3.274; Morris MR, 1996, ANIM BEHAV, V52, P1017, DOI 10.1006/anbe.1996.0249; Noor MAF, 1999, HEREDITY, V83, P503, DOI 10.1038/sj.hdy.6886320; NORRIS S. M., 2005, FRESHWATER FISHES ME; Olson VA, 1998, TRENDS ECOL EVOL, V13, P510, DOI 10.1016/S0169-5347(98)01484-0; Ortiz-Barrientos D, 2009, ANN NY ACAD SCI, V1168, P156, DOI 10.1111/j.1749-6632.2009.04919.x; Pfennig DW, 2010, AM NAT, V176, pS26, DOI 10.1086/657056; Pfennig KS, 2009, Q REV BIOL, V84, P253, DOI 10.1086/605079; Pilastro A, 2003, ANIM BEHAV, V65, P1161, DOI 10.1006/anbe.2003.2118; Pillay N, 2012, BEHAV PROCESS, V91, P223, DOI 10.1016/j.beproc.2012.08.006; PREHN LM, 1969, CAN J GENET CYTOL, V11, P880, DOI 10.1139/g69-103; Ptacek MB, 1997, EVOLUTION, V51, P1217, DOI 10.1111/j.1558-5646.1997.tb03969.x; R Core Development Team, 2010, R LANG ENV STAT COMP; Rafferty NE, 2006, BEHAV ECOL, V17, P965, DOI 10.1093/beheco/arl030; Reznick D, 2001, AM NAT, V157, P126, DOI 10.1086/318627; Richards-Zawacki CL, 2011, EVOLUTION, V65, P259, DOI 10.1111/j.1558-5646.2010.01124.x; Rosenthal GG, 1999, ENVIRON BIOL FISH, V56, P307, DOI 10.1023/A:1007597604793; Rundle HD, 1998, EVOLUTION, V52, P200, DOI 10.1111/j.1558-5646.1998.tb05153.x; Schlupp I, 2001, BEHAVIOUR, V138, P277, DOI 10.1163/15685390151074438; Schlupp I, 2010, BEHAV ECOL SOCIOBIOL, V64, P1849, DOI 10.1007/s00265-010-0996-y; SCHLUTER D, 1993, TRENDS ECOL EVOL, V8, P197, DOI 10.1016/0169-5347(93)90098-A; SCHLUTER D, 1988, AM NAT, V131, P799, DOI 10.1086/284823; Scott LE, 2010, BIOL J LINN SOC, V100, P608, DOI 10.1111/j.1095-8312.2010.01452.x; Seddon N, 2010, P ROY SOC B-BIOL SCI, V277, P2475, DOI 10.1098/rspb.2010.0210; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; Servedio MR, 2004, PLOS BIOL, V2, P2032, DOI 10.1371/journal.pbio.0020420; SLATKIN M, 1980, ECOLOGY, V61, P163, DOI 10.2307/1937166; Soltis J, 1997, ANIM BEHAV, V54, P725, DOI 10.1006/anbe.1997.0567; Williams TH, 2010, ETHOLOGY, V116, P1038, DOI 10.1111/j.1439-0310.2010.01816.x; Wong BBM, 2005, ETHOLOGY, V111, P179, DOI 10.1111/j.1439-0310.2004.01044.x; Yamaguchi R, 2013, EVOL ECOL RES, V15, P25	94	2	2	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170326	10.1371/journal.pone.0170326	http://dx.doi.org/10.1371/journal.pone.0170326			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI3QC	28107407	gold, Green Published, Green Submitted			2022-12-26	WOS:000392405300110
J	Leveque, M; Simonin-Le Jeune, K; Jouneau, S; Moulis, S; Desrues, B; Belleguic, C; Brinchault, G; Le Trionnaire, S; Gangneux, JP; Dimanche-Boitrel, MT; Martin-Chouly, C				Leveque, Manuella; Simonin-Le Jeune, Karin; Jouneau, Stephane; Moulis, Solenn; Desrues, Benoit; Belleguic, Chantal; Brinchault, Graziella; Le Trionnaire, Sophie; Gangneux, Jean-Pierre; Dimanche-Boitrel, Marie-Therese; Martin-Chouly, Corinne			Soluble CD14 acts as a DAMP in human macrophages: origin and involvement in inflammatory cytokine/chemokine production	FASEB JOURNAL			English	Article						inflammation; cystic fibrosis; NF-kappa B; inflammasome	LPS-BINDING-PROTEIN; NECROSIS-FACTOR-ALPHA; HUMAN MONOCYTES; LIPOPOLYSACCHARIDE RECEPTOR; IMMUNE-RESPONSES; CYSTIC-FIBROSIS; DIFFERENTIATION ANTIGEN; CEREBROSPINAL-FLUID; MEMBRANE CD14; CELL-SURFACE	The innate immune system is able to detect bacterial LPS through the pattern recognition receptor CD14, which delivers LPS to various TLR signaling complexes that subsequently induce intracellular proinflammatory signaling cascades. In a previous study, we showed the overproduction of the soluble form of CD14 (sCD14) by macrophages from patients with cystic fibrosis (CF). CF is an autosomal recessive disorder that is caused by mutations in the gene that encodes the CFTR protein and is characterized by persistent inflammation. Macrophages play a significant role in the initial stages of this disease due to their inability to act as suppressor cells, leading to chronic inflammation in CF. In this work, we investigated the origin of sCD14 by human macrophages and studied the effect of sCD14 on the production of inflammatory cytokine/chemokine. Our data indicate that sCD14 stimulate proinflammatory cytokine/chemokine production in a manner that is independent of LPS but dependent on the TLR-4/CD14 membrane complex, NF-kappa B, and the inflammasome. Therefore, sCD14, overproduced by CF macrophages, originates primarily from the endocytosis/exocytosis process and should be considered to be a danger associated molecular pattern. This elucidation of the origin and inflammation-induced mechanisms associated with sCD14 contributes to our understanding of maintained tissue inflammation.-Lev eque, M., Simonin-Le Jeune, K., Jouneau, S., Moulis, S., Desrues, B., Belleguic, C., Brinchault, G., Le Trionnaire, S., Gangneux, J.-P., DimancheBoitrel, M.-T., Martin-Chouly, C. Soluble CD14 acts as aDAMPin human macrophages: origin and involvement in inflammatory cytokine/chemokine production.	[Leveque, Manuella; Simonin-Le Jeune, Karin; Moulis, Solenn; Le Trionnaire, Sophie; Dimanche-Boitrel, Marie-Therese; Martin-Chouly, Corinne] INSERM, Unite 1085, Res Inst Environm & Occupat Hlth IRSET, Stress Membrane & Signaling Team, Rennes, France; [Jouneau, Stephane] INSERM, Unite 1085, Res Inst Environm & Occupat Hlth IRSET, Chem Contaminant Immun & Inflammat Team, Rennes, France; [Leveque, Manuella; Simonin-Le Jeune, Karin; Jouneau, Stephane; Moulis, Solenn; Desrues, Benoit; Le Trionnaire, Sophie; Gangneux, Jean-Pierre; Dimanche-Boitrel, Marie-Therese; Martin-Chouly, Corinne] Univ Rennes 1, Unit Mixte Serv Biosit 3480, Rennes, France; [Jouneau, Stephane; Desrues, Benoit; Belleguic, Chantal; Brinchault, Graziella; Gangneux, Jean-Pierre] Ctr Hosp Univ Rennes, Ctr Ressource & Competences Mucoviscidose, Rennes, France; [Desrues, Benoit] INSERM, Unite 1242, Ctr Eugene Marquis, Chem Oncogenesis Stress & Signaling, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CHU Rennes; Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Eugene Marquis	Martin-Chouly, C (corresponding author), 2 Ave Pr Leon Bernard, F-35043 Rennes, France.	corinne.chouly@univ-rennes1.fr	Dimanche-Boitrel, Marie-Therese M/I-4642-2015; Jouneau, Stephane/K-9956-2015; MARTIN-CHOULY, Corinne AE/K-4288-2015; Gangneux, Jean-Pierre/J-2960-2015	Gangneux, Jean-Pierre/0000-0002-4974-5607; MARTIN-CHOULY, corinne/0000-0001-7493-0612; Dimanche-Boitrel, Marie-Therese/0000-0002-8038-7780; Leveque, Manuella/0000-0001-6642-0372	Cystic Fibrosis French Foundation "Vaincre La Mucoviscidose" [RF20130500807]	Cystic Fibrosis French Foundation "Vaincre La Mucoviscidose"	This work was supported by Grant RF20130500807 from the Cystic Fibrosis French Foundation "Vaincre La Mucoviscidose." The authors thank secretary Laurence Hiard and the nurses Marie-Therese Jousseaume and Isabelle Berhault at the Centre de Ressources et de Competences pour la Mucoviscidose (Rennes University Hospital).	Arai Y, 2015, J INFECT CHEMOTHER, V21, P564, DOI 10.1016/j.jiac.2015.04.011; BAZIL V, 1989, MOL IMMUNOL, V26, P657, DOI 10.1016/0161-5890(89)90048-5; BAZIL V, 1986, EUR J IMMUNOL, V16, P1583, DOI 10.1002/eji.1830161218; BAZIL V, 1991, J IMMUNOL, V147, P1567; BUFLER P, 1995, EUR J IMMUNOL, V25, P604, DOI 10.1002/eji.1830250244; Cifani N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071717; Coyne CP, 2002, J ENDOTOXIN RES, V8, P273, DOI 10.1179/096805102125000489; Del Porto P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019970; DENTENER MA, 1993, J IMMUNOL, V150, P2885; Dessing MC, 2007, AM J RESP CRIT CARE, V175, P604, DOI 10.1164/rccm.200606-824OC; Douglas TA, 2009, EUR RESPIR J, V33, P305, DOI 10.1183/09031936.00043108; DURIEUX JJ, 1994, EUR J IMMUNOL, V24, P2006, DOI 10.1002/eji.1830240911; Egerer K, 2000, LUPUS, V9, P614, DOI 10.1191/096120300678828749; Eickmeier O, 2010, CYTOKINE, V50, P152, DOI 10.1016/j.cyto.2010.02.004; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Frey T, 2007, MOL MED, V13, P592, DOI 10.2119/2007-00054.Frey; GEGNER JA, 1995, J BIOL CHEM, V270, P5320, DOI 10.1074/jbc.270.10.5320; HAZIOT A, 1988, J IMMUNOL, V141, P547; HAZIOT A, 1994, J IMMUNOL, V152, P5868; Ikonen E, 2001, CURR OPIN CELL BIOL, V13, P470, DOI 10.1016/S0955-0674(00)00238-6; Jersmann HPA, 2005, IMMUNOL CELL BIOL, V83, P462, DOI 10.1111/j.1440-1711.2005.01370.x; Kirkland TN, 1998, PROG CLIN BIOL RES, V397, P79; LABETA MO, 1993, EUR J IMMUNOL, V23, P2144, DOI 10.1002/eji.1830230915; Le-Barillec K, 1999, J CLIN INVEST, V103, P1039, DOI 10.1172/JCI5779; Lin B, 2000, J INFECT DIS, V181, P1185, DOI 10.1086/315357; Marcos V, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-32; MARTIN TR, 1994, CHEST, V105, pS55, DOI 10.1378/chest.105.3.55S; Martin-Chouly CAE, 2004, LIFE SCI, V75, P823, DOI 10.1016/j.lfs.2004.01.021; MILLER SG, 1992, J CELL BIOL, V118, P267, DOI 10.1083/jcb.118.2.267; Miwako I, 2001, J CELL SCI, V114, P1765; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Nockher WA, 1999, J NEUROIMMUNOL, V101, P161, DOI 10.1016/S0165-5728(99)00141-1; Opal SM, 1999, J INFECT DIS, V180, P1584, DOI 10.1086/315093; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; PUGIN J, 1994, IMMUNITY, V1, P509, DOI 10.1016/1074-7613(94)90093-0; Ratner D, 2012, AM J RESP CELL MOL, V46, P715, DOI 10.1165/rcmb.2011-0399RT; Salomao R, 2012, SHOCK, V38, P227, DOI 10.1097/SHK.0b013e318262c4b0; Schiff DE, 1997, J LEUKOCYTE BIOL, V62, P786, DOI 10.1002/jlb.62.6.786; Schmitz G, 2002, CURR OPIN LIPIDOL, V13, P513, DOI 10.1097/00041433-200210000-00007; SCHUETT C, 1991, Allergie und Immunologie (Leipzig), V37, P159; Schutt C, 1999, INT J BIOCHEM CELL B, V31, P545, DOI 10.1016/S1357-2725(98)00153-8; SIMMONS DL, 1989, BLOOD, V73, P284; Simonin-Le Jeune K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075667; Stelter F, 1996, EUR J BIOCHEM, V236, P457, DOI 10.1111/j.1432-1033.1996.00457.x; Tang A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037689; Tapping RI, 2000, CHEM IMMUNOL, V74, P108; Thieblemont N, 1999, J EXP MED, V190, P523, DOI 10.1084/jem.190.4.523; Vaincre la Mucoviscidose, 2019, BILAN DONNEES; van Grevenynghe J, 2003, J IMMUNOL, V170, P2374, DOI 10.4049/jimmunol.170.5.2374; WRIGHT SD, 1995, J IMMUNOL, V155, P6; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yu B, 1997, J CLIN INVEST, V99, P315, DOI 10.1172/JCI119160; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007	53	29	31	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1891	1902		10.1096/fj.201600772R	http://dx.doi.org/10.1096/fj.201600772R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28122919	Green Submitted			2022-12-26	WOS:000399195500012
J	Hao, JL; Lou, Q; Wei, QQ; Mei, SQ; Li, L; Wu, GY; Mi, QS; Mei, CL; Dong, Z				Hao, Jielu; Lou, Qiang; Wei, Qingqing; Mei, Shuqin; Li, Lin; Wu, Guangyu; Mi, Qing-Sheng; Mei, Changlin; Dong, Zheng			MicroRNA-375 Is Induced in Cisplatin Nephrotoxicity to Repress Hepatocyte Nuclear Factor 1-beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ACUTE KIDNEY INJURY; TRANSCRIPTION FACTORS; CELL APOPTOSIS; P53; DISEASES; MECHANISMS; TARGETS; CANCER; ROLES	Nephrotoxicity is a major adverse effect of cisplatin-mediated chemotherapy in cancer patients. The pathogenesis of cisplatininduced nephrotoxicity remains largely unclear, making it difficult to design effective renoprotective approaches. Here, we have examined the role of microRNAs (miRNAs) in cisplatininduced nephrotoxicity. We show that cisplatin nephrotoxicity was not affected by overall depletion of both beneficial and detrimental miRNAs from kidney proximal tubular cells in mice in which the miRNA-generating enzyme Dicer had been conditionally knocked out. To identify miRNAs involved in cisplatin nephrotoxicity, we used microarray analysis to profile miRNA expression and identified 47 up-regulated microRNAs and 20 down-regulated microRNAs in kidney cortical tissues. One upregulated miRNA was miR-375, whose expression was also induced in cisplatin-treated renal tubular cells. Interestingly, inhibition of miR-375 decreased cisplatin-induced apoptosis, suggesting that miR-375 is a cell-damaging or pro-apoptotic agent. Blockade of P53 or NF-kappa B attenuated cisplatin-induced miR-375 expression, supporting a role of P53 and NF-kappa B in miR-375 induction. We also identified hepatocyte nuclear factor 1 homeobox B(HNF-1 beta) as a key downstream target of miR-375. Of note, we further demonstrated that HNF-1 beta protected renal cells against cisplatin-induced apoptosis. Together, these results suggest that upon cisplatin exposure, P53 and NF-kappa B collaboratively induce miR-375 expression, which, in turn, represses HNF-1 beta activity, resulting in renal tubular cell apoptosis and nephrotoxicity.	[Hao, Jielu; Mei, Shuqin; Li, Lin; Mei, Changlin] Second Mil Med Univ, Changzheng Hosp, Dept Nephrol, Shanghai 200003, Peoples R China; [Lou, Qiang] Henan Univ, Sch Med, Antibody Drug Engn Lab Henan Prov, Kaifeng 475004, Henan, Peoples R China; [Hao, Jielu; Lou, Qiang; Wei, Qingqing; Mei, Shuqin; Li, Lin; Dong, Zheng] Augusta Univ, Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA 30912 USA; [Wu, Guangyu] Augusta Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Wu, Guangyu] Charlie Norwood Vet Affairs Med Ctr, Augusta, GA 30912 USA; [Mi, Qing-Sheng] Henry Ford Hlth Syst, Dept Dermatol & Internal Med, Detroit, MI 48202 USA; [Dong, Zheng] Cent S Univ, Xiangya Hosp 2, Dept Nephrol, Changsha 410011, Hunan, Peoples R China	Naval Medical University; Henan University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Henry Ford Health System; Henry Ford Hospital; Central South University	Mei, CL (corresponding author), 415 Fengyang Rd, Shanghai, Peoples R China.; Dong, Z (corresponding author), 1459 Laney Walker Blvd, Augusta, GA 30912 USA.	chlmei1954@126.com; zdong@augusta.edu		Hao, Jielu/0000-0002-0760-745X	National Natural Science Foundation of China [81430017, 31371172]; Major Fundamental Research Program of Shanghai Committee of Science and Technology [12DJ1400300]; Key Projects in the National Science & Technology Pillar Program in the Twelfth Five-year Plan Period Grant [2011BAI10B07]; American Heart Association [12SDG8270002]; National Institutes of Health [5R01DK058831, 2R01DK087843]; Department of Veterans Administration [5I01BX000319]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087843, R01DK058831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118915] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000319] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Fundamental Research Program of Shanghai Committee of Science and Technology; Key Projects in the National Science & Technology Pillar Program in the Twelfth Five-year Plan Period Grant; American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Administration; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by National Natural Science Foundation of China Grants 81430017 and 31371172, Major Fundamental Research Program of Shanghai Committee of Science and Technology Grant 12DJ1400300, the Key Projects in the National Science & Technology Pillar Program in the Twelfth Five-year Plan Period Grant 2011BAI10B07, American Heart Association Grant 12SDG8270002, National Institutes of Health Grants 5R01DK058831 and 2R01DK087843, and Department of Veterans Administration Grant 5I01BX000319. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Badal SS, 2015, PEDIATR NEPHROL, V30, P727, DOI 10.1007/s00467-014-2867-7; Bhatt K, 2016, AM J PHYSIOL-RENAL, V310, pF109, DOI 10.1152/ajprenal.00387.2015; Bhatt K, 2015, J AM SOC NEPHROL, V26, P1588, DOI 10.1681/ASN.2014050463; Bhatt K, 2011, AM J PHYSIOL-RENAL, V300, pF602, DOI 10.1152/ajprenal.00727.2010; Bhatt K, 2010, MOL MED, V16, P409, DOI 10.2119/molmed.2010.00002; Cepeda V, 2007, ANTI-CANCER AGENT ME, V7, P3, DOI 10.2174/187152007779314044; Chen JZ, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.09.39; Chung ACK, 2013, INT J NEPHROL RENOV, V6, P169, DOI 10.2147/IJNRD.S37885; Clissold RL, 2015, NAT REV NEPHROL, V11, P102, DOI 10.1038/nrneph.2014.232; Deng QP, 2014, J MOL CELL BIOL, V6, P198, DOI 10.1093/jmcb/mju017; Faguer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063585; Finkel M., 2014, PEDIAT NEPHROLOGY, V29, P2421; Gong ZJ, 2016, TUMOR BIOL, V37, P3683, DOI 10.1007/s13277-015-4156-x; dos Santos NAG, 2012, ARCH TOXICOL, V86, P1233, DOI 10.1007/s00204-012-0821-7; Gurova KV, 2005, P NATL ACAD SCI USA, V102, P17448, DOI 10.1073/pnas.0508888102; Igarashi P, 2005, KIDNEY INT, V68, P1944, DOI 10.1111/j.1523-1755.2005.00625.x; Jiang M, 2006, ONCOGENE, V25, P4056, DOI 10.1038/sj.onc.1209440; Jiang M, 2004, AM J PHYSIOL-RENAL, V287, pF1140, DOI 10.1152/ajprenal.00262.2004; Jiang M, 2008, J PHARMACOL EXP THER, V327, P300, DOI 10.1124/jpet.108.139162; Kanki M, 2014, TOXICOLOGY, V324, P158, DOI 10.1016/j.tox.2014.05.004; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Launay-Vacher V, 2008, CANCER CHEMOTH PHARM, V61, P903, DOI 10.1007/s00280-008-0711-0; Li JC, 2015, SCI REP-UK, V5, DOI 10.1038/srep16422; Limaye PB, 2008, LAB INVEST, V88, P865, DOI 10.1038/labinvest.2008.56; Lorenzen JM, 2011, NAT REV NEPHROL, V7, P286, DOI 10.1038/nrneph.2011.26; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Miller RP, 2010, TOXINS, V2, P2490, DOI 10.3390/toxins2112490; Naylor RW, 2014, PEDIATR NEPHROL, V29, P659, DOI 10.1007/s00467-013-2662-x; Ozkok A, 2016, TOXICOL LETT, V240, P105, DOI 10.1016/j.toxlet.2015.10.028; Ozkok A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/967826; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; Pavkovic M, 2016, TOXICOL SCI, V152, P205, DOI 10.1093/toxsci/kfw077; Pavkovic M, 2014, TOXICOLOGY, V324, P147, DOI 10.1016/j.tox.2014.05.005; Pellegrini KL, 2014, TOXICOL SCI, V141, P484, DOI 10.1093/toxsci/kfu143; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Podolin PL, 2005, J PHARMACOL EXP THER, V312, P373, DOI 10.1124/jpet.104.074484; Shang YL, 2016, ONCOTARGET, V7, P538, DOI 10.18632/oncotarget.6374; Thomas H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh144; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wei QQ, 2007, AM J PHYSIOL-RENAL, V293, pF1282, DOI 10.1152/ajprenal.00230.2007; Wei QQ, 2016, J AM SOC NEPHROL, V27, P2784, DOI 10.1681/ASN.2015080870; Wei QQ, 2013, IUBMB LIFE, V65, P602, DOI 10.1002/iub.1174; Wei QQ, 2010, J AM SOC NEPHROL, V21, P756, DOI 10.1681/ASN.2009070718; Woost PG, 1996, KIDNEY INT, V50, P125, DOI 10.1038/ki.1996.295; Yang T, 2016, THERANOSTICS, V6, P142, DOI 10.7150/thno.13130; Yuan Y, 2015, ADV EXP MED BIOL, V887, P157, DOI 10.1007/978-3-319-22380-3_9; Zhang DS, 2014, J AM SOC NEPHROL, V25, P2278, DOI 10.1681/ASN.2013080902	47	33	33	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4571	4582		10.1074/jbc.M116.754929	http://dx.doi.org/10.1074/jbc.M116.754929			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28119452	hybrid, Green Published			2022-12-26	WOS:000397585100015
J	Paczkowski, JE; Mukherjee, S; McCready, AR; Cong, JP; Aquino, CJ; Kim, H; Henke, BR; Smith, CD; Bassler, BL				Paczkowski, Jon E.; Mukherjee, Sampriti; McCready, Amelia R.; Cong, Jian-Ping; Aquino, Christopher J.; Kim, Hahn; Henke, Brad R.; Smith, Chari D.; Bassler, Bonnie L.			Flavonoids Suppress Pseudomonas aeruginosa Virulence through Allosteric Inhibition of Quorum-sensing Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATOR; HALOGENATED FURANONES; GENE-EXPRESSION; PROTEIN; SIGNAL; LASR; NODULATION; BINDING; RESISTANCE; REGULATOR	Quorum sensing is a process of cell-cell communication that bacteria use to regulate collective behaviors. Quorum sensing depends on the production, detection, and group-wide response to extracellular signal molecules called auto inducers. In many bacterial species, quorum sensing controls virulence factor production. Thus, disrupting quorum sensing is considered a promising strategy to combat bacterial pathogenicity. Several members of a family of naturally produced plant metabolites called flavonoids inhibit Pseudomonas aeruginosa biofilm formation by an unknown mechanism. Here, we explore this family of molecules further, and we demonstrate that flavonoids specifically inhibit quorum sensing via antagonism of the autoinducer-binding receptors, LasR and RhlR. Structure-activity relationship analyses demonstrate that the presence of two hydroxyl moieties in the flavone A-ring backbone are essential for potent inhibition of LasR/RhlR. Biochemical analyses reveal that the flavonoids function non-competitively to prevent LasR/RhlR DNA binding. Administration of the flavonoids to P. aeruginosa alters transcription of quorum sensing-controlled target promoters and suppresses virulence factor production, confirming their potential as anti-infectives that do not function by traditional bacteriocidal or bacteriostatic mechanisms.	[Paczkowski, Jon E.; Mukherjee, Sampriti; McCready, Amelia R.; Cong, Jian-Ping; Smith, Chari D.; Bassler, Bonnie L.] Princeton Univ, Small Mol Screening Ctr, Dept Mol Biol, Princeton, NJ 08544 USA; [Kim, Hahn] Princeton Univ, Small Mol Screening Ctr, Dept Chem, Princeton, NJ 08544 USA; [Aquino, Christopher J.] CJA MedChem, Hillsborough, NC 27278 USA; [Henke, Brad R.] LLC, Opti Mol Consulting, Cary, NC 27513 USA; [Bassler, Bonnie L.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Princeton University; Princeton University; Howard Hughes Medical Institute	Bassler, BL (corresponding author), Princeton Univ, Dept Mol Biol, Lewis Thomas Labs 329, Princeton, NJ 08544 USA.	bbassler@princeton.edu		McCready, Amelia/0000-0001-6176-4432; Mukherjee, Sampriti/0000-0002-5509-8776; Bassler, Bonnie/0000-0002-0043-746X	Howard Hughes Medical Institute; National Institutes of Health Grant [2R37GM065859]; National Science Foundation Grant [MCB-0948112]; Jane Coffin Childs Memorial Fund; Life Science Research Foundation Postdoctoral Fellowship through the Gordon and Betty Moore Foundation [GBMF2550.06]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007388, R01GM065859, R37GM065859] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0948112] Funding Source: National Science Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Grant(National Science Foundation (NSF)); Jane Coffin Childs Memorial Fund; Life Science Research Foundation Postdoctoral Fellowship through the Gordon and Betty Moore Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Howard Hughes Medical Institute, National Institutes of Health Grant 2R37GM065859, National Science Foundation Grant MCB-0948112 (to B.L.B.), a Jane Coffin Childs Memorial Fund for Biomedical Research Postdoctoral Fellowship (to J.E.P.), and a Life Science Research Foundation Postdoctoral Fellowship through the Gordon and Betty Moore Foundation through Grant GBMF2550.06 (to S.M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alguel Y, 2007, J MOL BIOL, V369, P829, DOI 10.1016/j.jmb.2007.03.062; Attila C, 2008, MICROB BIOTECHNOL, V1, P17, DOI 10.1111/j.1751-7915.2007.00002.x; Begum AA, 2001, J EXP BOT, V52, P1537, DOI 10.1093/jexbot/52.360.1537; Bjarnsholt T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010115; Bodini SF, 2009, LETT APPL MICROBIOL, V49, P551, DOI 10.1111/j.1472-765X.2009.02704.x; Chen GZ, 2011, MOL CELL, V42, P199, DOI 10.1016/j.molcel.2011.04.003; Cushnie TPT, 2011, INT J ANTIMICROB AG, V38, P99, DOI 10.1016/j.ijantimicag.2011.02.014; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Dholvitayakhun A, 2012, NAT PROD RES, V26, P356, DOI 10.1080/14786419.2010.545777; GAMBELLO MJ, 1993, INFECT IMMUN, V61, P1180, DOI 10.1128/IAI.61.4.1180-1184.1993; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hassan S, 2012, J EXP BOT, V63, P3429, DOI 10.1093/jxb/err430; Hoyland-Kroghsbo NM, 2017, P NATL ACAD SCI USA, V114, P131, DOI 10.1073/pnas.1617415113; Kiratisin P, 2002, J BACTERIOL, V184, P4912, DOI 10.1128/JB.184.17.4912-4919.2002; Koch B, 2005, MICROBIOL-SGM, V151, P3589, DOI 10.1099/mic.0.27954-0; Kumar S, 2013, SCI WORLD J, DOI 10.1155/2013/162750; LaSarre B, 2013, MICROBIOL MOL BIOL R, V77, P73, DOI 10.1128/MMBR.00046-12; Manefield M, 1999, MICROBIOL-SGM, V145, P283, DOI 10.1099/13500872-145-2-283; Manefield M, 2002, MICROBIOL-SGM, V148, P1119, DOI 10.1099/00221287-148-4-1119; Mathesius U, 2003, P NATL ACAD SCI USA, V100, P1444, DOI 10.1073/pnas.262672599; Muh U, 2006, P NATL ACAD SCI USA, V103, P16948, DOI 10.1073/pnas.0608348103; Muh U, 2006, ANTIMICROB AGENTS CH, V50, P3674, DOI 10.1128/AAC.00665-06; Nazzaro F, 2013, INT J MOL SCI, V14, P12607, DOI 10.3390/ijms140612607; Ng WL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002767; Novak K, 2002, J EXP BOT, V53, P1735, DOI 10.1093/jxb/erf016; O'Loughlin CT, 2013, P NATL ACAD SCI USA, V110, P17981, DOI 10.1073/pnas.1316981110; Ouyang J, 2016, J APPL MICROBIOL, V120, P966, DOI 10.1111/jam.13073; Papenfort K, 2016, NAT REV MICROBIOL, V14, P576, DOI 10.1038/nrmicro.2016.89; PEARSON JP, 1995, P NATL ACAD SCI USA, V92, P1490, DOI 10.1073/pnas.92.5.1490; PETERS NK, 1986, SCIENCE, V233, P977, DOI 10.1126/science.3738520; Pinto UM, 2009, MOL MICROBIOL, V73, P32, DOI 10.1111/j.1365-2958.2009.06730.x; Rahme LG, 1997, P NATL ACAD SCI USA, V94, P13245, DOI 10.1073/pnas.94.24.13245; Raj U, 2017, J BIOMOL STRUCT DYN, V35, P2351, DOI 10.1080/07391102.2016.1217276; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; Rosier A, 2016, PLANT MOL BIOL, V90, P537, DOI 10.1007/s11103-016-0433-3; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Sato Y, 2004, ANTIMICROB AGENTS CH, V48, P1357, DOI 10.1128/AAC.48.4.1357-1360.2004; Schaefer AL, 2008, NATURE, V454, P595, DOI 10.1038/nature07088; Schuster M, 2004, P NATL ACAD SCI USA, V101, P15833, DOI 10.1073/pnas.0407229101; Seyedi SS, 2016, SCI REP-UK, V6, DOI 10.1038/srep24027; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/NMETH.2413, 10.1038/nmeth.2413]; Smith RS, 2003, J CLIN INVEST, V112, P1460, DOI 10.1172/JCI200320364; Storey DG, 1998, INFECT IMMUN, V66, P2521, DOI 10.1128/IAI.66.6.2521-2528.1998; Swem LR, 2008, CELL, V134, P461, DOI 10.1016/j.cell.2008.06.023; Swem LR, 2009, MOL CELL, V35, P143, DOI 10.1016/j.molcel.2009.05.029; Tsitsanou KE, 2013, FOOD CHEM TOXICOL, V61, P14, DOI 10.1016/j.fct.2012.12.030; Vandeputte OM, 2011, MICROBIOL-SGM, V157, P2120, DOI 10.1099/mic.0.049338-0; Vasavi HS, 2014, MICROBIOL IMMUNOL, V58, P286, DOI 10.1111/1348-0421.12150; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Welsh MA, 2016, CELL CHEM BIOL, V23, P361, DOI 10.1016/j.chembiol.2016.01.006; Welsh MA, 2015, J AM CHEM SOC, V137, P1510, DOI 10.1021/ja5110798; WINSON MK, 1995, P NATL ACAD SCI USA, V92, P9427, DOI 10.1073/pnas.92.20.9427; Zakhari JS, 2011, J AM CHEM SOC, V133, P3840, DOI 10.1021/ja111138y; Zhang RG, 2002, NATURE, V417, P971, DOI 10.1038/nature00833; Zhu J, 1998, J BACTERIOL, V180, P5398, DOI 10.1128/JB.180.20.5398-5405.1998; Zhu J, 2001, P NATL ACAD SCI USA, V98, P1507, DOI 10.1073/pnas.98.4.1507; Zou YZ, 2009, CHEM BIOL, V16, P961, DOI 10.1016/j.chembiol.2009.09.001	59	117	125	4	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4064	4076		10.1074/jbc.M116.770552	http://dx.doi.org/10.1074/jbc.M116.770552			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28119451	Green Published, hybrid			2022-12-26	WOS:000395837100010
J	Srikumar, A; Krishna, PS; Sivaramakrishna, D; Kopfmann, S; Hess, WR; Swamy, MJ; Lin-Chao, S; Prakash, JSS				Srikumar, Afshan; Krishna, Pilla Sankara; Sivaramakrishna, Dokku; Kopfmann, Stefan; Hess, Wolfgang R.; Swamy, Musti J.; Lin-Chao, Sue; Prakash, Jogadhenu S. S.			The Ssl2245-Sll1130 Toxin-Antitoxin System Mediates Heat-induced Programmed Cell Death in Synechocystis sp PCC6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MARINE CYANOBACTERIUM; BIOFILM FORMATION; MOLTEN GLOBULE; PLASMID; GENES; MAINTENANCE; MECHANISMS; REGULATOR; BINDING	Twoputative heat-responsive genes, ssl2245 and sll1130, constitute an operon that also has characteristics of a toxin-antitoxin system, thus joining several enigmatic features. Closely related orthologs of Ssl2245 and Sll1130 exist in widely different bacteria, which thrive under environments with large fluctuations in temperature and salinity, among which some are thermo-epilithic biofilm-forming cyanobacteria. Transcriptome analyses revealed that the clustered regularly interspaced short palindromic repeats (CRISPR) genes as well as several hypothetical genes were commonly up-regulated in Delta ssl2245 and Delta sll1130 mutants. Genes coding for heat shock proteins and pilins were also induced in Delta sll1130. We observed that the majority of cells in a Delta sll1130 mutant strain remained unicellular and viable after prolonged incubation at high temperature (50 degrees C). In contrast, the wild type formed large cell clumps of dead and live cells, indicating the attempt to form biofilms under harsh conditions. Furthermore, we observed that Sll1130 is a heat-stable ribonuclease whose activity was inhibited by Ssl2245 at optimal temperatures but not at high temperatures. In addition, we demonstrated that Ssl2245 is physically associated with Sll1130 by electrostatic interactions, thereby inhibiting its activity at optimal growth temperature. This association is lost upon exposure to heat, leaving Sll1130 to exhibit its ribonuclease activity. Thus, the activation of Sll1130 leads to the degradation of cellular RNA and thereby heat-induced programmed cell death that in turn supports the formation of a more resistant biofilm for the surviving cells. Wesuggest to designate Ssl2245 and Sll1130 as MazE and MazF, respectively.	[Srikumar, Afshan; Krishna, Pilla Sankara; Prakash, Jogadhenu S. S.] Univ Hyderabad, Sch Life Sci, Dept Biotechnol & Bioinformat, Hyderabad 500046, Andhra Pradesh, India; [Sivaramakrishna, Dokku; Swamy, Musti J.] Univ Hyderabad, Sch Chem, Hyderabad 500046, Andhra Pradesh, India; [Kopfmann, Stefan; Hess, Wolfgang R.] Univ Freiburg, Fac Biol, Genet & Expt Bioinformat, D-79104 Freiburg, Germany; [Lin-Chao, Sue] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; [Krishna, Pilla Sankara] Uppsala Univ, Dept Chem, Angstrom Lab, Mol Biomimet, S-75236 Uppsala, Sweden	University of Hyderabad; University of Hyderabad; University of Freiburg; Academia Sinica - Taiwan; Uppsala University	Prakash, JSS (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biotechnol & Bioinformat, Hyderabad 500046, Andhra Pradesh, India.	syamsunderp@yahoo.com	Lin-Chao, Sue/AAZ-8246-2021; Lin-Chao, Sue/AGI-2030-2022; Swamy, Musti/B-9418-2009	Lin-Chao, Sue/0000-0002-8415-9304; Lin-Chao, Sue/0000-0002-8415-9304; Swamy, Musti/0000-0002-3108-3633; Dokku, Sivaramakrishna/0000-0002-1256-8096; Hess, Wolfgang/0000-0002-5340-3423	University Grants Commission (India)	University Grants Commission (India)(University Grants Commission, India)	We acknowledge the Department of Biotechnology-Centre for Research and Education in Biology and Biotechnology program of the School of Life Sciences, University of Hyderabad for providing genomics facility. We acknowledge Taiwan International Graduate Program, Academia Sinica, Taiwan for the summer internship to A. S. The MicroCal VP-ITC and VP-DSC equipment used in this study were obtained from the funds made available to the University of Hyderabad through the Universities with Potential for Excellence program of the University Grants Commission (India). We acknowledge the University Grants Commission (India) for support through the Centre for Advanced Studies program to the School of Chemistry.	Allocati N, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.570; Arai M, 2000, ADV PROTEIN CHEM, V53, P209; Bar-Zeev E, 2013, ISME J, V7, P2340, DOI 10.1038/ismej.2013.121; Berman-Frank I, 2004, LIMNOL OCEANOGR, V49, P997, DOI 10.4319/lo.2004.49.4.0997; Chan WT, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00009; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Claessen D, 2014, NAT REV MICROBIOL, V12, P115, DOI 10.1038/nrmicro3178; de Laureto PP, 2002, PROTEINS, V49, P385, DOI 10.1002/prot.10234; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Foster JS, 2009, ISME J, V3, P573, DOI 10.1038/ismej.2008.129; Gotfredsen M, 1998, MOL MICROBIOL, V29, P1065, DOI 10.1046/j.1365-2958.1998.00993.x; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Hazan R, 2004, MOL GENET GENOMICS, V272, P227, DOI 10.1007/s00438-004-1048-y; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; Hosoya-Matsuda N, 2005, J BIOL CHEM, V280, P840, DOI 10.1074/jbc.M411493200; Hu Ming-Xi, 2010, Int J Microbiol, V2010, P781430, DOI 10.1155/2010/781430; Hu Y, 2012, ENVIRON MICROBIOL, V14, P669, DOI 10.1111/j.1462-2920.2011.02618.x; Johnson LR, 2008, J THEOR BIOL, V251, P24, DOI 10.1016/j.jtbi.2007.10.039; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kavitha M, 2010, BIOCHIMIE, V92, P58, DOI 10.1016/j.biochi.2009.09.009; Kim Y, 2010, ENVIRON MICROBIOL, V12, P1105, DOI 10.1111/j.1462-2920.2009.02147.x; Klemencic M, 2016, CURR GENET, V62, P669, DOI 10.1007/s00294-016-0582-6; Kopf M, 2014, DNA RES, V21, P527, DOI 10.1093/dnares/dsu018; Kopfmann S, 2013, J BIOL CHEM, V288, P7399, DOI 10.1074/jbc.M112.434100; Krishna PS, 2013, BIOCHEM J, V449, P751, DOI 10.1042/BJ20120928; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lewis K, 2008, CURR TOP MICROBIOL, V322, P107; Maisonneuve E, 2014, CELL, V157, P539, DOI 10.1016/j.cell.2014.02.050; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; MASUDA YJ, 1993, J BACTERIOL, V175, P6850, DOI 10.1128/jb.175.21.6850-6856.1993; Narahari A, 2011, J PHYS CHEM B, V115, P4110, DOI 10.1021/jp110468n; Ning DG, 2011, CURR MICROBIOL, V63, P496, DOI 10.1007/s00284-011-0011-5; OGURA T, 1983, CELL, V32, P351, DOI 10.1016/0092-8674(83)90454-3; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pandey V., 2013, INT J CURR MICROBIOL, V2, P519; Prakash JSS, 2010, MICROBIOL-SGM, V156, P442, DOI 10.1099/mic.0.031823-0; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; Sabart M, 2013, ENV MICROBIOL REP, V5, P747, DOI 10.1111/1758-2229.12077; Sat B, 2001, J BACTERIOL, V183, P2041, DOI 10.1128/JB.183.6.2041-2045.2001; Scholz I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056470; Schuster CF, 2013, FEMS MICROBIOL LETT, V340, P73, DOI 10.1111/1574-6968.12074; Soo VWC, 2013, SCI REP-UK, V3, DOI 10.1038/srep03186; Spungin D, 2016, BIOGEOSCIENCES, V13, P4187, DOI 10.5194/bg-13-4187-2016; Stazic D, 2011, NUCLEIC ACIDS RES, V39, P4890, DOI 10.1093/nar/gkr037; Tanouchi Y, 2013, TRENDS MICROBIOL, V21, P265, DOI 10.1016/j.tim.2013.04.001; Tseng YT, 2015, J BIOL CHEM, V290, P29953, DOI 10.1074/jbc.M115.691881; WALSBY AE, 1983, PROC R SOC SER B-BIO, V217, P417, DOI 10.1098/rspb.1983.0019; Wen YR, 2014, PATHOG DIS, V70, P240, DOI 10.1111/2049-632X.12145; Westra ER, 2010, MOL MICROBIOL, V77, P1380, DOI 10.1111/j.1365-2958.2010.07315.x; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Zorzini V, 2015, NUCLEIC ACIDS RES, V43, P1241, DOI 10.1093/nar/gku1352	53	11	11	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4222	4234		10.1074/jbc.M116.748178	http://dx.doi.org/10.1074/jbc.M116.748178			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28104802	Green Published, hybrid			2022-12-26	WOS:000395837100020
J	Aukema, JE; Pricope, NG; Husak, GJ; Lopez-Carr, D				Aukema, Juliann E.; Pricope, Narcisa G.; Husak, Gregory J.; Lopez-Carr, David			Biodiversity Areas under Threat: Overlap of Climate Change and Population Pressures on the World's Biodiversity Priorities	PLOS ONE			English	Article							LAND-USE CHANGE; MANGROVE FORESTS; GLOBAL 200; CONSERVATION; DEFORESTATION; VULNERABILITY; IMPACT; FUTURE; CARBON; LIVELIHOODS	Humans and the ecosystem services they depend on are threatened by climate change. Places with high or growing human population as well as increasing climate variability, have a reduced ability to provide ecosystem services just as the need for these services is most critical. A spiral of vulnerability and ecosystem degradation often ensues in such places. We apply different global conservation schemes as proxies to examine the spatial relation between wet season precipitation, population change over three decades, and natural resource conservation. We pose two research questions: 1) Where are biodiversity and ecosystem services vulnerable to the combined effects of climate change and population growth? 2) Where are human populations vulnerable to degraded ecosystem services? Results suggest that globally only about 20% of the area between 50 degrees latitude North and South has experienced significant change-largely wetting-in wet season precipitation. Approximately 40% of rangelands and 30% of rainfed agriculture lands have experienced significant precipitation changes, with important implications for food security. Over recent decades a number of critical conservation areas experienced high population growth concurrent with significant wetting or drying (e.g. the Horn of Africa, Himalaya, Western Ghats, and Sri Lanka), posing challenges not only for human adaptation but also to the protection and sustenance of biodiversity and ecosystem services. Identifying areas of climate and population risk and their overlap with conservation priorities can help to target activities and resources that promote biodiversity and ecosystem services while improving human well-being.	[Aukema, Juliann E.] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; [Pricope, Narcisa G.] Univ North Carolina Wilmington, Dept Earth & Ocean Sci, Wilmington, NC USA; [Husak, Gregory J.; Lopez-Carr, David] Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA; [Aukema, Juliann E.] US Agcy Int Dev, Global Climate Change Off, Washington, DC 20523 USA	National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; University of North Carolina; University of North Carolina Wilmington; University of California System; University of California Santa Barbara; United States Agency for International Development (USAID)	Aukema, JE (corresponding author), Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA.; Aukema, JE (corresponding author), US Agcy Int Dev, Global Climate Change Off, Washington, DC 20523 USA.	jaukema@alumni.brown.edu	PRICOPE, NARCISA/D-7123-2015	PRICOPE, NARCISA/0000-0002-6591-7237	David and Lucile Packard Foundation; USGS	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); USGS(United States Geological Survey)	The Climate Hazards Group InfraRed Precipitation with Stations development process was carried out through U.S. Geological Survey (USGS) cooperative agreement #G09AC000001 and #G14AC00042. JEA was supported by a grant to NCEAS from The David and Lucile Packard Foundation. The two grants from USGS supported the creation of the CHIRPS dataset, and the customized trend analysis that supported this paper. While these grants provided the resources for the above activities, the influence of USGS in these activities was minimal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aide TM, 2013, BIOTROPICA, V45, P262, DOI 10.1111/j.1744-7429.2012.00908.x; Biazin B, 2013, AGR ECOSYST ENVIRON, V164, P100, DOI 10.1016/j.agee.2012.09.012; Boisier JP, 2015, NAT CLIM CHANGE, V5, P656, DOI [10.1038/NCLIMATE2658, 10.1038/nclimate2658]; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Carr D, 2009, PROG HUM GEOG, V33, P355, DOI 10.1177/0309132508096031; Center for International Earth Science Information Network (CIESIN) Food and Agriculture Organization of the United Nations (FAO) and Centro Internacional de Agricultura Tropical (CIAT), 2005, GRIDD POP WORLD VERS; Dale VH, 1997, ECOL APPL, V7, P753, DOI 10.1890/1051-0761(1997)007[0753:TRBLUC]2.0.CO;2; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; Dobrovolski R, 2011, BIODIVERS CONSERV, V20, P2445, DOI 10.1007/s10531-011-9997-z; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; Dong BW, 2015, NAT CLIM CHANGE, V5, P757, DOI [10.1038/nclimate2664, 10.1038/NCLIMATE2664]; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Fernandes K, 2015, GEOPHYS RES LETT, V42; Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Funk CC, 2014, US GEOLOGICAL SURVEY, V832, P4; Funk C, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.50; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Giri C, 2011, GLOBAL ECOL BIOGEOGR, V20, P154, DOI 10.1111/j.1466-8238.2010.00584.x; Heubes J, 2013, J ARID ENVIRON, V96, P48, DOI 10.1016/j.jaridenv.2013.04.008; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Hof C, 2011, GLOBAL CHANGE BIOL, V17, P2987, DOI 10.1111/j.1365-2486.2011.02418.x; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Husak GJ, 2007, INT J CLIMATOL, V27, P935, DOI 10.1002/joc.1441; Jankowska MM, 2012, APPL GEOGR, V33, P4, DOI 10.1016/j.apgeog.2011.08.009; Koziell I., 2001, LIVING BIODIVERSITY; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Laurance WF, 2014, TRENDS ECOL EVOL, V29, P107, DOI 10.1016/j.tree.2013.12.001; Lawler JJ, 2013, ECOL LETT, V16, P1014, DOI 10.1111/ele.12132; Lopez-Carr D, 2013, ENVIRONMENT, V55, P3, DOI 10.1080/00139157.2013.748385; MCKEE TB, 1993, P 8 C APPL CLIM AN C; Mittermeier R. A., 1999, CHELONIAN CONSERV BI; Morand P, 2012, CLIMATIC CHANGE, V115, P463, DOI 10.1007/s10584-012-0492-7; Moreland S., 2012, MODELING CLIMATE CHA; Moritz C, 2013, SCIENCE, V341, P504, DOI 10.1126/science.1237190; Mwampamba TH, 2007, ENERG POLICY, V35, P4221, DOI 10.1016/j.enpol.2007.02.010; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; O'Neill BC, 2010, P NATL ACAD SCI USA, V107, P17521, DOI 10.1073/pnas.1004581107; OJIMA DS, 1994, BIOSCIENCE, V44, P300, DOI 10.2307/1312379; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Paavola J, 2008, ENVIRON SCI POLICY, V11, P642, DOI 10.1016/j.envsci.2008.06.002; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Patz JA, 2006, ANN TROP MED PARASIT, V100, P535, DOI 10.1179/136485906X97426; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Pricope NG, 2013, GLOBAL ENVIRON CHANG, V23, P1525, DOI 10.1016/j.gloenvcha.2013.10.002; Rangel TFLVB, 2007, APPL GEOGR, V27, P14, DOI 10.1016/j.apgeog.2006.09.009; Samson J, 2011, GLOBAL ECOL BIOGEOGR, V20, P532, DOI 10.1111/j.1466-8238.2010.00632.x; Sayer J, 2013, P NATL ACAD SCI USA, V110, P8345, DOI 10.1073/pnas.1208054110; Schlenker W, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014010; Searchinger TD, 2015, NAT CLIM CHANGE, V5, P481, DOI [10.1038/nclimate2584, 10.1038/NCLIMATE2584]; Secchi S, 2009, ENVIRON MANAGE, V44, P732, DOI 10.1007/s00267-009-9365-x; Shackleton C, 2004, S AFR J SCI, V100, P658; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tingley MW, 2012, GLOBAL CHANGE BIOL, V18, P3279, DOI 10.1111/j.1365-2486.2012.02784.x; Travis JMJ, 2003, P ROY SOC B-BIOL SCI, V270, P467, DOI 10.1098/rspb.2002.2246; Tsegaye D, 2010, AGR ECOSYST ENVIRON, V139, P174, DOI 10.1016/j.agee.2010.07.017; VALIELA I, 2001, BIOSCIENCE, V51, P807, DOI DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2; Webb EL, 2014, GLOBAL ENVIRON CHANG, V24, P321, DOI 10.1016/j.gloenvcha.2013.10.007; Weeks ES, 2013, ENVIRON CONSERV, V40, P84, DOI 10.1017/S0376892912000343; Wheeler T, 2013, SCIENCE, V341, P508, DOI 10.1126/science.1239402; Wilcove DS, 2010, BIODIVERS CONSERV, V19, P999, DOI 10.1007/s10531-009-9760-x; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Wright CK, 2013, P NATL ACAD SCI USA, V110, P4134, DOI 10.1073/pnas.1215404110; Zak MR, 2004, BIOL CONSERV, V120, P589, DOI 10.1016/j.biocon.2004.03.034; Zhou LM, 2014, NATURE, V509, P86, DOI 10.1038/nature13265	69	24	24	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170615	10.1371/journal.pone.0170615	http://dx.doi.org/10.1371/journal.pone.0170615			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7IT	28125659	Green Published, gold, Green Submitted			2022-12-26	WOS:000396176100085
J	Bonfiglio, T; Olivero, G; Merega, E; Di Prisco, S; Padolecchia, C; Grilli, M; Milanese, M; Mannelli, LD; Ghelardini, C; Bonanno, G; Marchi, M; Pittaluga, A				Bonfiglio, Tommaso; Olivero, Guendalina; Merega, Elisa; Di Prisco, Silvia; Padolecchia, Cristina; Grilli, Massimo; Milanese, Marco; Mannelli, Lorenzo Di Cesare; Ghelardini, Carla; Bonanno, Giambattista; Marchi, Mario; Pittaluga, Anna			Prophylactic versus Therapeutic Fingolimod: Restoration of Presynaptic Defects in Mice Suffering from Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; GLUTAMATE RELEASE; ANIMAL-MODEL; CORTEX SYNAPTOSOMES; FTY720 FINGOLIMOD; NMDA RECEPTORS; FRONTAL-CORTEX; RATS; SPHINGOSINE-1-PHOSPHATE; SYSTEM	Fingolimod, the first oral, disease-modifying therapy for MS, has been recently proposed to modulate glutamate transmission in the central nervous system (CNS) of mice suffering from Experimental Autoimmune Encephalomyelitis (EAE) and in MS patients. Our study aims at investigating whether oral fingolimod recovers presynaptic defects that occur at different stages of disease in the CNS of EAE mice. In vivo prophylactic (0.3 mg/kg for 14 days, from the 7 th day post immunization, d.p.i, the drug dissolved in the drinking water) fingolimod significantly reduced the clinical symptoms and the anxiety-related behaviour in EAE mice. Spinal cord inflammation, demyelination and glial cell activation are markers of EAE progression. These signs were ameliorated following oral fingolimod administration. Glutamate exocytosis was shown to be impaired in cortical and spinal cord terminals isolated from EAE mice at 21 +/- 1 d.p.i., while GABA alteration emerged only at the spinal cord level. Prophylactic fingolimod recovered these presynaptic defects, restoring altered glutamate and GABA release efficiency. The beneficial effect occurred in a dose-dependent, region-specific manner, since lower (0.1-0.03 mg/kg) doses restored, although to a different extent, synaptic defects in cortical but not spinal cord terminals. A delayed reduction of glutamate, but not of GABA, exocytosis was observed in hippocampal terminals of EAE mice at 35 d.p.i. Therapeutic (0.3 mg/kg, from 21 d.p.i. for 14 days) fingolimod restored glutamate exocytosis in the cortex and in the hippocampus of EAE mice at 35 +/- 1 d.p.i. but not in the spinal cord, where also GABAergic defects remained unmodified. These results improve our knowledge of the molecular events accounting for the beneficial effects elicited by fingolimod in demyelinating disorders.	[Bonfiglio, Tommaso; Olivero, Guendalina; Merega, Elisa; Di Prisco, Silvia; Padolecchia, Cristina; Grilli, Massimo; Milanese, Marco; Bonanno, Giambattista; Marchi, Mario; Pittaluga, Anna] Univ Genoa, Dept Pharm, Pharmacol & Toxicol Sect, Sch Med & Pharmaceut Sci, Genoa, Italy; [Grilli, Massimo; Milanese, Marco; Bonanno, Giambattista; Marchi, Mario; Pittaluga, Anna] Univ Genoa, Ctr Excellence Biomed Res, Genoa, Italy; [Mannelli, Lorenzo Di Cesare; Ghelardini, Carla] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth, Neurofarba Pharmacol & Toxicol Sect, Florence, Italy	University of Genoa; University of Genoa; University of Florence	Pittaluga, A (corresponding author), Univ Genoa, Dept Pharm, Pharmacol & Toxicol Sect, Sch Med & Pharmaceut Sci, Genoa, Italy.; Pittaluga, A (corresponding author), Univ Genoa, Ctr Excellence Biomed Res, Genoa, Italy.	pittalug@difar.unige.it	Milanese, Marco/AAB-2238-2021; Bonfiglio, Tommaso/AAB-2579-2019; Grilli, Massimo/C-4217-2008; Bonanno, Giambattista/C-5856-2008; Olivero, Guendalina/AAL-7489-2020; Milanese, Marco/C-4444-2013; Di Cesare Mannelli, Lorenzo/A-1641-2015	Milanese, Marco/0000-0003-3384-0666; Grilli, Massimo/0000-0003-1046-7897; Milanese, Marco/0000-0003-3384-0666; Olivero, Guendalina/0000-0001-8571-3736; Di Cesare Mannelli, Lorenzo/0000-0001-8374-4432; GHELARDINI, CARLA/0000-0001-9856-8144; Bonanno, Giambattista/0000-0003-3744-5786	Novartis Pharma [PO 3900006436]	Novartis Pharma	AP was recipient of a grant from Novartis Pharma (PO 3900006436). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Vilcaes AA, 2009, J NEUROCHEM, V108, P881, DOI 10.1111/j.1471-4159.2008.05809.x; Batista S, 2012, J NEUROL, V259, P139, DOI 10.1007/s00415-011-6147-1; Brinkmann V, 2004, AM J TRANSPLANT, V4, P1019, DOI 10.1111/j.1600-6143.2004.00476.x; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Brinkmann V, 2009, BRIT J PHARMACOL, V158, P1173, DOI 10.1111/j.1476-5381.2009.00451.x; Camoletto PG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005310; Centonze D, 2009, J NEUROSCI, V29, P3442, DOI 10.1523/JNEUROSCI.5804-08.2009; Chanaday NL, 2016, NEUROSCIENCE, V314, P160, DOI 10.1016/j.neuroscience.2015.11.060; Chiba K, 2011, INT IMMUNOPHARMACOL, V11, P366, DOI 10.1016/j.intimp.2010.10.005; Chiba S, 2012, PROG NEURO-PSYCHOPH, V39, P112, DOI 10.1016/j.pnpbp.2012.05.018; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Cid MP, 2011, NEUROSCIENCE, V189, P337, DOI 10.1016/j.neuroscience.2011.05.005; Darios F, 2009, NEURON, V62, P683, DOI 10.1016/j.neuron.2009.04.024; de Bruin NMWJ, 2016, BEHAV BRAIN RES, V300, P160, DOI 10.1016/j.bbr.2015.12.006; Demakova E. V., 2003, Klinicheskaya Laboratornaya Diagnostika, P15; Di Prisco S, 2016, J NEUROIMMUNE PHARM, V11, P645, DOI 10.1007/s11481-016-9677-6; Di Prisco S, 2016, BRIT J PHARMACOL, V173, P1465, DOI 10.1111/bph.13442; Di Prisco S, 2014, SYNAPSE, V68, P529, DOI 10.1002/syn.21774; Di Prisco S, 2014, BRIT J PHARMACOL, V171, P2457, DOI 10.1111/bph.12631; Di Prisco S, 2013, NEUROPHARMACOLOGY, V75, P337, DOI 10.1016/j.neuropharm.2013.07.037; Di Prisco S, 2012, J NEUROCHEM, V121, P428, DOI 10.1111/j.1471-4159.2012.07720.x; Eltayeb S, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-14; Errede M, 2012, J NEUROPATH EXP NEUR, V71, P840, DOI 10.1097/NEN.0b013e31826ac110; Furlan R, 2005, J NEUROIMMUNOL, V165, P192, DOI 10.1016/j.jneuroim.2005.04.012; Gillingwater TH, 2012, BRIT J PHARMACOL, V165, P858, DOI 10.1111/j.1476-5381.2011.01612.x; GODISKA R, 1995, J NEUROIMMUNOL, V58, P167, DOI 10.1016/0165-5728(95)00008-P; GOTTESFELD Z, 1976, J NEUROCHEM, V27, P695, DOI 10.1111/j.1471-4159.1976.tb10396.x; Grilli M, 2012, NEUROPHARMACOLOGY, V63, P916, DOI 10.1016/j.neuropharm.2012.06.049; Grilli M, 2009, J NEUROCHEM, V110, P1598, DOI 10.1111/j.1471-4159.2009.06265.x; Groom AJ, 2003, ANN NY ACAD SCI, V993, P229, DOI 10.1111/j.1749-6632.2003.tb07533.x; Haji N, 2012, EXP NEUROL, V237, P296, DOI 10.1016/j.expneurol.2012.07.010; Hou HQ, 2016, INT IMMUNOPHARMACOL, V30, P171, DOI 10.1016/j.intimp.2015.11.024; Kajimoto T, 2007, MOL CELL BIOL, V27, P3429, DOI 10.1128/MCB.01465-06; Landi D, 2015, CLIN NEUROPHYSIOL, V126, P165, DOI 10.1016/j.clinph.2014.05.031; Lanz M, 2007, J NEUROL, V254, P43, DOI 10.1007/s00415-007-2011-8; Luccini E, 2007, J NEUROSCI RES, V85, P3657, DOI 10.1002/jnr.21446; Mandolesi G, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2015.222; Mangiardi M, 2011, BRAIN PATHOL, V21, P263, DOI 10.1111/j.1750-3639.2010.00444.x; Mannelli LD, 2013, J PAIN, V14, P1585, DOI 10.1016/j.jpain.2013.08.002; Musante V, 2011, J NEUROCHEM, V117, P516, DOI 10.1111/j.1471-4159.2011.07223.x; Nistico R, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0162; Novkovic T, 2015, NEUROSCIENCE, V309, P100, DOI 10.1016/j.neuroscience.2015.03.008; Okada T, 2009, CELL SIGNAL, V21, P7, DOI 10.1016/j.cellsig.2008.07.011; Olechowski CJ, 2013, EXP NEUROL, V241, P113, DOI 10.1016/j.expneurol.2012.12.012; Orlando R, 2014, NEUROPHARMACOLOGY, V86, P133, DOI 10.1016/j.neuropharm.2014.07.009; Peruga I, 2011, BEHAV BRAIN RES, V220, P20, DOI 10.1016/j.bbr.2011.01.018; Pittaluga A, 2007, NEUROPHARMACOLOGY, V53, P27, DOI 10.1016/j.neuropharm.2007.04.006; Polak PE, 2005, J NEUROIMMUNOL, V168, P65, DOI 10.1016/j.jneuroim.2005.07.006; RAITERI M, 1974, EUR J PHARMACOL, V25, P411, DOI 10.1016/0014-2999(74)90272-6; Riganti L, 2016, J NEUROSCI, V36, P4624, DOI 10.1523/JNEUROSCI.3588-15.2016; Rossi S, 2012, BRIT J PHARMACOL, V165, P861, DOI 10.1111/j.1476-5381.2011.01579.x; Rossi S, 2011, BRAIN BEHAV IMMUN, V25, P947, DOI 10.1016/j.bbi.2010.10.004; Ruffini F, 2013, MULT SCLER J, V19, P1084, DOI 10.1177/1352458512469698; Sarchielli P, 2003, ARCH NEUROL-CHICAGO, V60, P1082, DOI 10.1001/archneur.60.8.1082; Schaier M, 2009, AM J PHYSIOL-RENAL, V297, pF769, DOI 10.1152/ajprenal.90530.2008; SCHIFFER RB, 1990, AM J PSYCHIAT, V147, P1493; Schwartz M, 2003, TRENDS NEUROSCI, V26, P297, DOI 10.1016/S0166-2236(03)00126-7; Sheridan GK, 2014, SCI REP-UK, V4, DOI 10.1038/srep05051; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Storch MK, 1998, BRAIN PATHOL, V8, P681, DOI 10.1111/j.1750-3639.1998.tb00194.x; Sulkowski G, 2009, FOLIA NEUROPATHOL, V47, P329; Summa M, 2013, NEUROPHARMACOLOGY, V66, P215, DOI 10.1016/j.neuropharm.2012.04.020; Sun JJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14235; Trkov S, 2012, GLIA, V60, P1406, DOI 10.1002/glia.22361; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; Zhang J, 2015, NEUROBIOL DIS, V76, P57, DOI 10.1016/j.nbd.2015.01.006	66	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e170825	10.1371/journal.pone.0170825	http://dx.doi.org/10.1371/journal.pone.0170825			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125677	Green Published, gold, Green Submitted			2022-12-26	WOS:000396176100040
J	Hwang, IS; Lin, YT; Huang, WM; Yang, ZR; Hu, CL; Chen, YC				Hwang, Ing-Shiou; Lin, Yen-Ting; Huang, Wei-Min; Yang, Zong-Ru; Hu, Chia-Ling; Chen, Yi-Ching			Alterations in Neural Control of Constant Isometric Contraction with the Size of Error Feedback	PLOS ONE			English	Article							COMMON SYNAPTIC INPUT; HUMAN MOTOR UNITS; MEDIAL FRONTAL-CORTEX; SURFACE EMG SIGNALS; FORCE VARIABILITY; MANUAL TRACKING; DISCHARGE RATE; MUSCLE FORCE; RANGE; DECOMPOSITION	Discharge patterns from a population of motor units (MUs) were estimated with multi-channel surface electromyogram and signal processing techniques to investigate parametric differences in low-frequency force fluctuations, MU discharges, and force-discharge relation during static force-tracking with varying sizes of execution error presented via visual feedback. Fourteen healthy adults produced isometric force at 10% of maximal voluntary contraction through index abduction under three visual conditions that scaled execution errors with different amplification factors. Error-augmentation feedback that used a high amplification factor (HAF) to potentiate visualized error size resulted in higher sample entropy, mean frequency, ratio of high-frequency components, and spectral dispersion of force fluctuations than those of error-reducing feedback using a low amplification factor (LAF). In the HAF condition, MUs with relatively high recruitment thresholds in the dorsal interosseous muscle exhibited a larger coefficient of variation for inter-spike intervals and a greater spectral peak of the pooled MU coherence at 13-35 Hz than did those in the LAF condition. Manipulation of the size of error feedback altered the force-discharge relation, which was characterized with non-linear approaches such as mutual information and cross sample entropy. The association of force fluctuations and global discharge trace decreased with increasing error amplification factor. Our findings provide direct neurophysiological evidence that favors motor training using error-augmentation feedback. Amplification of the visualized error size of visual feedback could enrich force gradation strategies during static force-tracking, pertaining to selective increases in the discharge variability of higher-threshold MUs that receive greater common oscillatory inputs in the beta-band.	[Hwang, Ing-Shiou; Yang, Zong-Ru] Natl Cheng Kung Univ, Inst Allied Hlth Sci, Coll Med, Tainan, Taiwan; [Hwang, Ing-Shiou; Hu, Chia-Ling] Natl Cheng Kung Univ, Dept Phys Therapy, Coll Med, Tainan, Taiwan; [Lin, Yen-Ting] Asian Univ, Phys Educ Off, Taichung, Taiwan; [Huang, Wei-Min] Natl Chung Cheng Univ, Dept Management Informat Syst, Chiayi, Taiwan; [Chen, Yi-Ching] Chung Shan Med Univ, Sch Phys Therapy, Coll Med Sci & Technol, Taichung, Taiwan; [Chen, Yi-Ching] Chung Shan Med Univ Hosp, Physical Therapy Room, Taichung, Taiwan	National Cheng Kung University; National Cheng Kung University; Asia University Taiwan; National Chung Cheng University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Chen, YC (corresponding author), Chung Shan Med Univ, Sch Phys Therapy, Coll Med Sci & Technol, Taichung, Taiwan.; Chen, YC (corresponding author), Chung Shan Med Univ Hosp, Physical Therapy Room, Taichung, Taiwan.	yiching@csmu.edu.tw			Ministry of Science and Technology, Taiwan, R.O.C. [MOST 103-2410-H-040-010-MY2, MOST 104-2314-B-006-016-MY3]	Ministry of Science and Technology, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This research was supported by a grant from the Ministry of Science and Technology, Taiwan, R.O.C. (https://www.most.gov.tw/), under Grant No. MOST 103-2410-H-040-010-MY2 and MOST 104-2314-B-006-016-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi F, 2014, NEUROREHAB NEURAL RE, V28, P120, DOI 10.1177/1545968313498649; Adam A, 1998, J NEUROPHYSIOL, V80, P1373, DOI 10.1152/jn.1998.80.3.1373; Amjad AM, 1997, J NEUROSCI METH, V73, P69, DOI 10.1016/S0165-0270(96)02214-5; Baker SN, 2003, J NEUROPHYSIOL, V89, P1941, DOI 10.1152/jn.00832.2002; Baweja HS, 2010, EUR J APPL PHYSIOL, V108, P935, DOI 10.1007/s00421-009-1301-5; Casellato C, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-46; Castronovo AM, 2015, J APPL PHYSIOL, V119, P1337, DOI 10.1152/japplphysiol.00255.2015; Chen YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074273; Contessa P, 2013, J NEUROPHYSIOL, V109, P1548, DOI 10.1152/jn.00237.2012; Coombes SA, 2011, NEUROIMAGE, V54, P2226, DOI 10.1016/j.neuroimage.2010.10.003; Coombes SA, 2010, J NEUROPHYSIOL, V103, P2114, DOI 10.1152/jn.00920.2009; Day SJ, 2001, J NEUROPHYSIOL, V86, P2144, DOI 10.1152/jn.2001.86.5.2144; De Luca CJ, 2006, J NEUROPHYSIOL, V96, P1646, DOI 10.1152/jn.00009.2006; De Luca CJ, 2014, J NEUROPHYSIOL, V112, P962, DOI 10.1152/jn.00619.2013; De Luca CJ, 2011, J NEUROPHYSIOL, V105, P983, DOI 10.1152/jn.01060.2010; DE LUCA CJ, 1982, J PHYSIOL-LONDON, V329, P129, DOI 10.1113/jphysiol.1982.sp014294; Dideriksen JL, 2012, J NEUROPHYSIOL, V107, P3357, DOI 10.1152/jn.00938.2011; Emken JL, 2005, IEEE T NEUR SYS REH, V13, P33, DOI 10.1109/TNSRE.2004.843173; Farina D, 2016, PHYSIOLOGY, V31, P83, DOI 10.1152/physiol.00040.2015; Farina D, 2015, EXERC SPORT SCI REV, V43, P23, DOI 10.1249/JES.0000000000000032; Farina Dario, 2012, IEEE Rev Biomed Eng, V5, P3, DOI 10.1109/RBME.2012.2183586; Farina D, 2012, J NEUROPHYSIOL, V107, P958, DOI 10.1152/jn.00304.2011; Fox EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055970; Gallego JA, 2015, J NEUROSCI, V35, P8925, DOI 10.1523/JNEUROSCI.0106-15.2015; Gehring WJ, 2001, J NEUROSCI, V21, P9430, DOI 10.1523/JNEUROSCI.21-23-09430.2001; Hong SL, 2008, EXP BRAIN RES, V189, P61, DOI 10.1007/s00221-008-1403-z; Hu XG, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/2/026015; Hu XG, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-99; Hu XG, 2013, J NEUROPHYSIOL, V110, P1205, DOI 10.1152/jn.00301.2012; Hu XG, 2011, EXP BRAIN RES, V212, P497, DOI 10.1007/s00221-011-2760-6; Jordan K, 2013, EXP PHYSIOL, V98, P546, DOI 10.1113/expphysiol.2012.067975; Kobayashi H, 2014, SCAND J MED SCI SPOR, V24, P98, DOI 10.1111/j.1600-0838.2012.01460.x; Kristeva R, 2007, NEUROIMAGE, V36, P785, DOI 10.1016/j.neuroimage.2007.03.025; Kristeva-Feige R, 2002, CLIN NEUROPHYSIOL, V113, P124, DOI 10.1016/S1388-2457(01)00722-2; Kuznetsov NA, 2010, NEUROSCI LETT, V470, P121, DOI 10.1016/j.neulet.2009.12.068; Laine CM, 2014, ACTA PHYSIOL, V211, P229, DOI 10.1111/apha.12255; Lin YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085578; Luu P, 2000, J NEUROSCI, V20, P464, DOI 10.1523/JNEUROSCI.20-01-00464.2000; Marmon AR, 2011, MED SCI SPORT EXER, V43, P560, DOI 10.1249/MSS.0b013e3181f3f3ab; Matthews PBC, 1996, J PHYSIOL-LONDON, V492, P597, DOI 10.1113/jphysiol.1996.sp021332; MIALL RC, 1986, BEHAV BRAIN RES, V20, P185, DOI 10.1016/0166-4328(86)90003-3; Moon H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109202; Moritz CT, 2005, J NEUROPHYSIOL, V93, P2449, DOI 10.1152/jn.01122.2004; NAVAS F, 1968, BIOPHYS J, V8, P252, DOI 10.1016/S0006-3495(68)86488-4; Nawab SH, 2010, CLIN NEUROPHYSIOL, V121, P1602, DOI 10.1016/j.clinph.2009.11.092; Negro F, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/2/026027; Negro F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044894; Negro F, 2009, J PHYSIOL-LONDON, V587, P5925, DOI 10.1113/jphysiol.2009.178509; Ofori E, 2010, EXP BRAIN RES, V203, P299, DOI 10.1007/s00221-010-2229-z; Pasalar S, 2005, EXP BRAIN RES, V163, P214, DOI 10.1007/s00221-004-2169-6; Patton JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0046466; Perez MA, 2006, J PHYSIOL-LONDON, V573, P843, DOI 10.1113/jphysiol.2006.105361; Prodoehl J, 2010, EXP BRAIN RES, V200, P67, DOI 10.1007/s00221-009-1966-3; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rosenbaum R, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00058; Slifkin AB, 2000, J NEUROPHYSIOL, V84, P1708, DOI 10.1152/jn.2000.84.4.1708; Sosnoff JJ, 2006, EXP BRAIN RES, V170, P423, DOI 10.1007/s00221-005-0225-5; Tracy BL, 2007, HUM MOVEMENT SCI, V26, P796, DOI 10.1016/j.humov.2007.07.001; Vaillancourt DE, 2006, EXP BRAIN RES, V173, P742, DOI 10.1007/s00221-006-0454-2; Vaillancourt DE, 2003, J APPL PHYSIOL, V94, P903, DOI 10.1152/japplphysiol.00166.2002; Vaillancourt DE, 2002, CLIN NEUROPHYSIOL, V113, P1325, DOI 10.1016/S1388-2457(02)00167-0; Witte M, 2007, EUR J NEUROSCI, V26, P3564, DOI 10.1111/j.1460-9568.2007.05942.x	62	13	13	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170824	10.1371/journal.pone.0170824	http://dx.doi.org/10.1371/journal.pone.0170824			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125658	Green Submitted, Green Published, gold			2022-12-26	WOS:000396176100041
J	Lagrutta, LC; Montero-Villegas, S; Layerenza, JP; Sisti, MS; de Bravo, MMG; Ves-Losada, A				Lagrutta, Lucia C.; Montero-Villegas, Sandra; Layerenza, Juan P.; Sisti, Martin S.; Garcia de Bravo, Margarita M.; Ves-Losada, Ana			Reversible Nuclear-Lipid-Droplet Morphology Induced by Oleic Acid: A Link to Cellular-Lipid Metabolism	PLOS ONE			English	Article							ACYL-COA SYNTHETASE; FATTY-ACIDS; PHOSPHATIDYLCHOLINE SYNTHESIS; CYTIDYLYLTRANSFERASE-ALPHA; HUMAN HEPATOCYTE; GROWTH; PROTEINS; LIVER; ACCUMULATION; CELLS	Neutral lipids-involved in many cellular processes D are stored as lipid droplets (LD), those mainly cytosolic (cLD) along with a small nuclear population (nLD). nLD could be involved in nuclear-lipid homeostasis serving as an endonuclear buffering system that would provide or incorporate lipids and proteins involved in signalling pathways as transcription factors and as enzymes of lipid metabolism and nuclear processes. Our aim was to determine if nLD constituted a dynamic domain. Oleic-acid (OA) added to rat hepatocytes or HepG2 cells in culture produced cellular-phenotypic LD modifications: increases in TAG, CE, C, and PL content and in cLD and nLD numbers and sizes. LD increments were reversed on exclusion of OA and were prevented by inhibition of acyl-CoA synthetase (with Triacsin C) and thus lipid biosynthesis. Under all conditions, nLD corresponded to a small population (2-10%) of total cellular LD. The anabolism triggered by OA, involving morphologic and size changes within the cLD and nLD populations, was reversed by a net balance of catabolism, upon eliminating OA. These catabolic processes included lipolysis and the mobilization of hydrolyzed FA from the LD to cytosolic-oxidation sites. These results would imply that nLD are actively involved in nuclear processes that include lipids. In conclusion, nLD are a dynamic nuclear domain since they are modified by OA through a reversible mechanism in combination with cLD; this process involves acyl-CoA-synthetase activity; ongoing TAG, CE, and PL biosynthesis. Thus, liver nLD and cLD are both dynamic cellular organelles.	[Lagrutta, Lucia C.; Montero-Villegas, Sandra; Layerenza, Juan P.; Sisti, Martin S.; Garcia de Bravo, Margarita M.; Ves-Losada, Ana] Inst Invest Bioqum La Plata Prof Doctor Rodolf R, La Plata, Buenos Aires, Argentina; [Garcia de Bravo, Margarita M.] Univ Nacl La Plata, Catedra Biol, Fac Ciencias Med, La Plata, Buenos Aires, Argentina; [Ves-Losada, Ana] Univ Nacl La Plata, Dept Ciencias Biol, Fac Ciencias Exactas, La Plata, Buenos Aires, Argentina	National University of La Plata; National University of La Plata	Ves-Losada, A (corresponding author), Inst Invest Bioqum La Plata Prof Doctor Rodolf R, La Plata, Buenos Aires, Argentina.; Ves-Losada, A (corresponding author), Univ Nacl La Plata, Dept Ciencias Biol, Fac Ciencias Exactas, La Plata, Buenos Aires, Argentina.	avlosada@biol.unlp.edu.ar		Sisti, Martin Sebastian/0000-0003-2561-3324	PICT (Proyecto de Investigacion Cientifica y Tecnologica (Argentina)) [00762]; CONICET PIP [11220100100037]; UNP [11/M149, 11/M177]	PICT (Proyecto de Investigacion Cientifica y Tecnologica (Argentina)); CONICET PIP(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UNP	Support was provided by PICT (Proyecto de Investigacion Cientifica y Tecnologica (Argentina)) 2007 Tipo A No 00762; CONICET PIP 2013 No11220100100037; and UNP 2010-2013, 11/M149; UNP 2014-2017, 11/M177 (UNLP: Universidad Nacional de La Plata (Argentina)).	Aitchison AJ, 2015, MOL BIOL CELL, V26, P2927, DOI 10.1091/mbc.E15-03-0159; Alvarez HM, 2016, BIOCHIMIE, V120, P28, DOI 10.1016/j.biochi.2015.08.016; Barneda D, 2013, BBA-MOL CELL BIOL L, V1831, P924, DOI 10.1016/j.bbalip.2013.01.015; Bi JF, 2012, J CELL SCI, V125, P3568, DOI 10.1242/jcs.101329; Boschi F, 2015, EXP CELL RES, V336, P253, DOI 10.1016/j.yexcr.2015.06.001; Caire-Brandli I, 2014, INFECT IMMUN, V82, P476, DOI 10.1128/IAI.01196-13; Choudhary V, 2015, J CELL BIOL, V211, P261, DOI 10.1083/jcb.201505067; Crespo R, 2013, BIOCHEM CELL BIOL, V91, P131, DOI 10.1139/bcb-2012-0076; Ding YF, 2012, J LIPID RES, V53, P399, DOI 10.1194/jlr.M021899; Dundr M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000711; Farese RV, 2016, J CELL BIOL, V212, P7, DOI 10.1083/jcb.201512056; Farooqui AA, 2005, REPROD NUTR DEV, V45, P613, DOI 10.1051/rnd:2005049; Favale NO, 2010, BBA-MOL CELL BIOL L, V1801, P1184, DOI 10.1016/j.bbalip.2010.07.003; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fujimoto Y, 2007, J LIPID RES, V48, P1280, DOI 10.1194/jlr.M700050-JLR200; Fujimoto Y, 2006, BIOL PHARM BULL, V29, P2174, DOI 10.1248/bpb.29.2174; Gaveglio VL, 2013, FEBS LETT, V587, P950, DOI 10.1016/j.febslet.2013.01.074; Gehrig K, 2008, MOL BIOL CELL, V19, P237, DOI 10.1091/mbc.E07-02-0179; Georgiadi A, 2012, ADV NUTR, V3, P127, DOI 10.3945/an.111.001602; GIBBONS GF, 1994, J LIPID RES, V35, P1801; GIBBONS GF, 1992, BIOCHEM J, V287, P749, DOI 10.1042/bj2870749; Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142; Green CJ, 2015, AM J PHYSIOL-ENDOC M, V308, pE1, DOI 10.1152/ajpendo.00192.2014; HILLMAN N, 1975, J EMBRYOL EXP MORPH, V33, P685; Igal RA, 1997, BIOCHEM J, V324, P529, DOI 10.1042/bj3240529; Iglesias NG, 2015, TRAFFIC, V16, P962, DOI 10.1111/tra.12305; Kory N, 2015, DEV CELL, V34, P351, DOI 10.1016/j.devcel.2015.06.007; Layerenza JP, 2013, BBA-MOL CELL BIOL L, V1831, P327, DOI 10.1016/j.bbalip.2012.10.005; Le Lay S, 2015, ADIPOCYTE, V4, P158, DOI 10.4161/21623945.2014.973774; Liefhebber JMP, 2014, J BIOL CHEM, V289, P21276, DOI 10.1074/jbc.M114.582999; Mao YTS, 2011, TRENDS GENET, V27, P295, DOI 10.1016/j.tig.2011.05.006; Marcinkiewicz A, 2006, J BIOL CHEM, V281, P11901, DOI 10.1074/jbc.M600171200; Mate SM, 2007, LIPIDS, V42, P589, DOI 10.1007/s11745-007-3063-3; Muoio DM, 2000, AM J PHYSIOL-ENDOC M, V279, pE1366, DOI 10.1152/ajpendo.2000.279.6.E1366; Ohsaki Y, 2016, J CELL BIOL, V212, P29, DOI 10.1083/jcb.201507122; Opie EL, 1944, J EXP MED, V80, P231, DOI 10.1084/jem.80.3.231; Paar M, 2012, J BIOL CHEM, V287, P11164, DOI 10.1074/jbc.M111.316794; Sahini N, 2014, PROG LIPID RES, V54, P86, DOI 10.1016/j.plipres.2014.02.002; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Somwar R, 2011, FEBS LETT, V585, P1946, DOI 10.1016/j.febslet.2011.05.016; Uzbekov Rustem, 2013, BMC Res Notes, V6, P386, DOI 10.1186/1756-0500-6-386; VesLosada A, 1996, MOL CELL BIOCHEM, V159, P1; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Wang L, 2013, SCI REP-UK, V3, DOI 10.1038/srep02174; Welte MA, 2015, CURR BIOL, V25, pR470, DOI 10.1016/j.cub.2015.04.004; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Wolins NE, 2001, J BIOL CHEM, V276, P5101, DOI 10.1074/jbc.M006775200; Xu WY, 2016, J BIOL CHEM, V291, P4282, DOI 10.1074/jbc.M115.701094; Zhao Jing, 2013, ISRN Neurosci, V2013, P579216, DOI 10.1155/2013/579216	49	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2017	12	1							e0170608	10.1371/journal.pone.0170608	http://dx.doi.org/10.1371/journal.pone.0170608			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7IT	28125673	gold, Green Published, Green Submitted			2022-12-26	WOS:000396176100087
J	Bonaldo, RM; Pires, MM; Guimaraes, PR; Hoey, AS; Hay, ME				Bonaldo, Roberta M.; Pires, Mathias M.; Guimaraes Junior, Paulo Roberto; Hoey, Andrew S.; Hay, Mark E.			Small Marine Protected Areas in Fiji Provide Refuge for Reef Fish Assemblages, Feeding Groups, and Corals	PLOS ONE			English	Article							GREAT-BARRIER-REEF; HOME-RANGE SIZE; BIODIVERSITY CONSERVATION; HABITAT UTILIZATION; ECOSYSTEM FUNCTION; MOVEMENT PATTERNS; PREDATORY FISH; REMOTE VIDEO; PHASE-SHIFTS; RESERVES	The establishment of no-take marine protected areas (MPAs) on coral reefs is a common management strategy for conserving the diversity, abundance, and biomass of reef organisms. Generally, well-managed and enforced MPAs can increase or maintain the diversity and function of the enclosed coral reef, with some of the benefits extending to adjacent nonprotected reefs. A fundamental question in coral reef conservation is whether these benefits arise within small MPAs (< 1 km(2)), because larval input of reef organisms is largely decoupled from local adult reproduction. We examined the structure of fish assemblages, composition of fish feeding groups, benthic cover, and key ecosystem processes (grazing, macroalgal browsing, and coral replenishment) in three small (0.5-0.8 km(2)) no-take MPAs and adjacent areas where fisheries are allowed (non-MPAs) on coral reefs in Fiji. The MPAs exhibited greater species richness, density, and biomass of fishes than non-MPAs. Furthermore, MPAs contained a greater abundance and biomass of grazing herbivores and piscivores as well as a greater abundance of cleaners than fished areas. We also found differences in fish associations when foraging, with feeding groups being generally more diverse and having greater biomass within MPAs than adjacent non-MPAs. Grazing by parrotfishes was 3-6 times greater, and macroalgal browsing was 3-5 times greater in MPAs than in non-MPAs. On average, MPAs had 260-280% as much coral cover and only 5-25% as much macroalgal cover as their paired non-MPA sites. Finally, two of the three MPAs had three-fold more coral recruits than adjacent non-MPAs. The results of this study indicate that small MPAs benefit not only populations of reef fishes, but also enhance ecosystem processes that are critical to reef resilience within the MPAs.	[Bonaldo, Roberta M.; Pires, Mathias M.; Guimaraes Junior, Paulo Roberto] Univ Sao Paulo, Inst Biociencias, Dept Ecol, Sao Paulo, SP, Brazil; [Bonaldo, Roberta M.; Hay, Mark E.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Bonaldo, Roberta M.; Hay, Mark E.] Georgia Inst Technol, Aquat Chem Ecol Ctr, Atlanta, GA 30332 USA; [Hoey, Andrew S.] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia	Universidade de Sao Paulo; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; James Cook University	Bonaldo, RM (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Ecol, Sao Paulo, SP, Brazil.	robertabonaldo@usp.br	Hoey, Andrew S/B-5457-2015; Guimaraes, Paulo R./E-1915-2016; Hay, Mark E/D-9752-2011; Pires, Mathias/I-4489-2012	Guimaraes, Paulo R./0000-0001-9161-8305; Hay, Mark E/0000-0002-6130-9349; Pires, Mathias/0000-0003-2500-4748; Hoey, Andrew/0000-0002-4261-5594	National Science Foundation [OCE-0929119]; National Institutes of Health - International Cooperative Biodiversity Group grant [U01-TW007401]; Teasley Endowment; Fundacao de Apoio a Pesquisa no Estado de Sao Paulo (FAPESP) [2012/24432-4, 2009/54567-6, 2009/54422-8]; FOGARTY INTERNATIONAL CENTER [U19TW007401] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health - International Cooperative Biodiversity Group grant; Teasley Endowment; Fundacao de Apoio a Pesquisa no Estado de Sao Paulo (FAPESP); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by National Science Foundation grant OCE-0929119 (MEH), National Institutes of Health - International Cooperative Biodiversity Group grant U01-TW007401 (MEH), Teasley Endowment (to MEH), Fundacao de Apoio a Pesquisa no Estado de Sao Paulo (FAPESP; grants 2012/24432-4 to R.M.B., 2009/54567-6 to M.P.P., and 2009/54422-8 to P. R.G.J.).	Allison GW, 1998, ECOL APPL, V8, pS79, DOI 10.1890/1051-0761(1998)8[S79:MRANBN]2.0.CO;2; Baird AH, 2006, CORAL REEFS, V25, P73, DOI 10.1007/s00338-005-0072-7; Beissinger SR, 1997, BEHAV APPROACHES CON, P3; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Bonaldo RM, 2011, CORAL REEFS, V30, P381, DOI 10.1007/s00338-010-0704-4; Bonaldo RM, 2008, MAR ECOL PROG SER, V360, P237, DOI 10.3354/meps07413; Bonaldo RM, 2014, OCEANOGR MAR BIOL, V52, P81; Bonaldo RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085786; Bonaldo RM, 2009, MAR BIOL, V156, P771, DOI 10.1007/s00227-009-1129-x; Brandl SJ, 2014, OCEANOGR MAR BIOL, V52, P1; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; CHOAT JH, 1993, MAR BIOL, V117, P205, DOI 10.1007/BF00345664; Chong-Seng KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042167; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Clements C, 2012, MAR ECOL PROG SER, V449, P233, DOI 10.3354/meps09554; Clemmons Janine R., 1997, P3; Coker DJ, 2014, REV FISH BIOL FISHER, V24, P89, DOI 10.1007/s11160-013-9319-5; Cole AJ, 2011, CORAL REEFS, V30, P85, DOI 10.1007/s00338-010-0674-6; Cole AJ, 2008, FISH FISH, V9, P286, DOI 10.1111/j.1467-2979.2008.00290.x; Costello MJ, 2015, TRENDS ECOL EVOL, V30, P507, DOI 10.1016/j.tree.2015.06.011; Dell C, 2015, MAR ECOL PROG SER, V540, P227, DOI 10.3354/meps11487; Dell CLA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155049; Dixson DL, 2014, SCIENCE, V345, P892, DOI 10.1126/science.1255057; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Feary DA, 2011, CONSERV BIOL, V25, P341, DOI 10.1111/j.1523-1739.2010.01613.x; FOSTER SA, 1985, OECOLOGIA, V67, P499, DOI 10.1007/BF00790020; FOSTER SA, 1985, ANIM BEHAV, V33, P782, DOI 10.1016/S0003-3472(85)80011-7; Fox RJ, 2008, CORAL REEFS, V27, P605, DOI 10.1007/s00338-008-0359-6; Francini-Filho RB, 2008, FISH RES, V93, P346, DOI 10.1016/j.fishres.2008.06.011; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Goatley CHR, 2016, ECOL SOC, V21, DOI 10.5751/ES-08334-210129; Goatley CHR, 2012, BIOL LETTERS, V8, P1016, DOI 10.1098/rsbl.2012.0770; Govan H., 2009, SPC TRAD MAR RESOUR, V25, P16; Green AL, 2009, IUCN WORKING GROUP C; Green AL, 2015, BIOL REV, V90, P1215, DOI 10.1111/brv.12155; Guimaraes PR, 2007, J THEOR BIOL, V245, P784, DOI 10.1016/j.jtbi.2006.12.001; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Halpern BS, 2003, ECOL APPL, V13, pS117; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; Hamilton RJ, 2012, BIOL CONSERV, V145, P246, DOI 10.1016/j.biocon.2011.11.020; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Hoey AS, 2010, CORAL REEFS, V29, P499, DOI 10.1007/s00338-010-0605-6; Hoey AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025824; Hoey AS, 2011, ECOL LETT, V14, P267, DOI 10.1111/j.1461-0248.2010.01581.x; Hoey AS, 2009, ECOSYSTEMS, V12, P1316, DOI 10.1007/s10021-009-9291-z; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jackson JBC, 2001, P NATL ACAD SCI USA, V98, P5411, DOI 10.1073/pnas.091092898; Januchowski-Hartley FA, 2013, ECOL LETT, V16, P321; Januchowski-Hartley FA, 2014, AQUAT CONSERV, V24, P777, DOI 10.1002/aqc.2388; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Jones G.P., 1991, P156; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Jupiter SD, 2012, CORAL REEFS, V31, P321, DOI 10.1007/s00338-012-0888-x; Katsanevakis S, 2012, AQUAT BIOL, V16, P31, DOI 10.3354/ab00426; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Krause J, 2002, LIVING GROUPS; Kulbicki M, 1998, J EXP MAR BIOL ECOL, V222, P11, DOI 10.1016/S0022-0981(97)00133-0; Lawson GL, 1999, ENVIRON BIOL FISH, V54, P19, DOI 10.1023/A:1007477527663; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Lima SL, 1998, ADV STUD BEHAV, V27, P215; Longo GO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127176; Longo GO, 2012, J FISH BIOL, V81, P1773, DOI 10.1111/j.1095-8649.2012.03441.x; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lukoschek V., 2000, P 9 INT COR REEF S B, V1, P467; Madin EMP, 2010, ECOLOGY, V91, P3563, DOI 10.1890/09-2174.1; Manor R, 2003, ECOL APPL, V13, P1830, DOI 10.1890/01-5354; McClanahan TR, 2011, P NATL ACAD SCI USA, V108, P17230, DOI 10.1073/pnas.1106861108; McClanahan TR, 2009, MAR ECOL PROG SER, V396, P99, DOI 10.3354/meps08279; McClanahan TR, 2006, CURR BIOL, V16, P1408, DOI 10.1016/j.cub.2006.05.062; McClanahan TR, 2001, ECOL APPL, V11, P559, DOI 10.2307/3060909; McClanahan TR, 2011, KENYA AQUAT CONSERV, V21, P186; Meyer CG, 2000, ENVIRON BIOL FISH, V59, P235, DOI 10.1023/A:1007664813814; Meyer CG, 2005, ENVIRON BIOL FISH, V73, P201, DOI 10.1007/s10641-005-0559-7; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Nash KL, 2015, OECOLOGIA, V177, P73, DOI 10.1007/s00442-014-3152-y; NEILL SRS, 1974, J ZOOL, V172, P549, DOI 10.1111/j.1469-7998.1974.tb04385.x; Nowlis Joshua Sladek, 2005, P280; Ohgushi T, 2012, TRAIT MEDIATED INDIR; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; PAUL VJ, 1986, MAR ECOL PROG SER, V33, P255, DOI 10.3354/meps033255; PITCHER TJ, 1982, BEHAV ECOL SOCIOBIOL, V10, P149, DOI 10.1007/BF00300175; Pitcher TJ., 1993, Behaviour of teleost fishes, P363, DOI 10.1007/978-94-011-1578-0_12; POLUNIN NVC, 1993, MAR ECOL PROG SER, V100, P167, DOI 10.3354/meps100167; Rasher DB, 2013, ECOLOGY, V94, P1347, DOI 10.1890/12-0389.1; Rasher DB, 2012, OECOLOGIA, V169, P187, DOI 10.1007/s00442-011-2174-y; RDC T, 2008, LANG ENV STAT COMP 3; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Roberts C.M., 2001, CONSERV PRACT, V2, P10, DOI [DOI 10.1111/J.1526-4629.2001.TB00012.X, 10.1111/j.1526-4629.2001.tb00012.x]; Roberts CM, 1997, CORAL REEFS, V16, P150, DOI 10.1007/BF03257480; Russ Garry R., 2002, P421, DOI 10.1016/B978-012615185-5/50024-4; Russ GR, 2005, MAR ECOL PROG SER, V292, P1, DOI 10.3354/meps292001; Russ GR, 2004, OECOLOGIA, V138, P622, DOI 10.1007/s00442-003-1456-4; Russ GR, 1996, ECOL APPL, V6, P947, DOI 10.2307/2269497; Simpson S., 2010, CASE STUDY KOROLEVU; SINCLAIR ARE, 1975, J ANIM ECOL, V44, P497, DOI 10.2307/3608; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Stockwell B, 2009, MAR ECOL PROG SER, V389, P1, DOI 10.3354/meps08150; Terborgh J., 2010, TROPHIC CASCADES PRE; Titlyanov EA, 2007, J EXP MAR BIOL ECOL, V342, P282, DOI 10.1016/j.jembe.2006.11.007; TREMBLAY D, 1979, NAT CANADIEN, V106, P411; Welsh JQ, 2012, CORAL REEFS, V31, P55, DOI 10.1007/s00338-011-0813-8; Wilson SK, 2003, OCEANOGR MAR BIOL, V41, P279; Zemke-White WL, 2002, MAR BIOL, V141, P571, DOI 10.1007/s00227-002-0849-y	110	46	46	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e170638	10.1371/journal.pone.0170638	http://dx.doi.org/10.1371/journal.pone.0170638			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122006	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000396167300033
J	Nakamura, TY; Nakao, S; Nakajo, Y; Takahashi, JC; Wakabayashi, S; Yanamoto, H				Nakamura, Tomoe Y.; Nakao, Shu; Nakajo, Yukako; Takahashi, Jun C.; Wakabayashi, Shigeo; Yanamoto, Hiroji			Possible Signaling Pathways Mediating Neuronal Calcium Sensor-1-Dependent Spatial Learning and Memory in Mice	PLOS ONE			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; ACTIVATOR PROTEIN; SECRETION 2; SENSOR-1; BDNF; BRAIN; NCS-1; SURVIVAL; ASSOCIATION	Intracellular Ca2+ signaling regulates diverse functions of the nervous system. Many of these neuronal functions, including learning and memory, are regulated by neuronal calcium sensor-1 (NCS-1). However, the pathways by which NCS-1 regulates these functions remain poorly understood. Consistent with the findings of previous reports, we revealed that NCS-1 deficient (Ncs1(-/-)) mice exhibit impaired spatial learning and memory function in the Morris water maze test, although there was little change in their exercise activity, as determined via treadmill-analysis. Expression of brain-derived neurotrophic factor (BDNF; a key regulator of memory function) and dopamine was significantly reduced in the Ncs1(-/-) mouse brain, without changes in the levels of glial cell-line derived neurotrophic factor or nerve growth factor. Although there were no gross structural abnormalities in the hippocampi of Ncs1(-/-) mice, electron microscopy analysis revealed that the density of large dense core vesicles in CA1 presynaptic neurons, which release BDNF and dopamine, was decreased. Phosphorylation of Ca2+/calmodulin-dependent protein kinase II-alpha (CaMKII-alpha, which is known to trigger long-term potentiation and increase BDNF levels, was significantly reduced in the Ncs1(-/-) mouse brain. Furthermore, high voltage electric potential stimulation, which increases the levels of BDNF and promotes spatial learning, significantly increased the levels of NCS-1 concomitant with phosphorylated CaMKII-alpha in the hippocampus; suggesting a close relationship between NCS-1 and CaMKII-alpha. Our findings indicate that NCS-1 may regulate spatial learning and memory function at least in part through activation of CaMKII-alpha signaling, which may directly or indirectly increase BDNF production.	[Nakamura, Tomoe Y.; Nakao, Shu; Wakabayashi, Shigeo] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Mol Physiol, Suita, Osaka, Japan; [Nakajo, Yukako; Yanamoto, Hiroji] Natl Cerebral & Cardiovasc Ctr, Res Inst, Lab Neurol & Neurosurg, Suita, Osaka, Japan; [Takahashi, Jun C.] Natl Cerebral & Cardiovasc Ctr Hosp, Dept Neurosurg, Suita, Osaka, Japan; [Nakao, Shu] Univ Manchester, Inst Cardiovasc Sci, Manchester, Lancs, England; [Wakabayashi, Shigeo] Osaka Med Coll, Dept Pharmacol, Takatsuki, Osaka, Japan	National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan; University of Manchester; Osaka Medical College	Nakamura, TY (corresponding author), Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Mol Physiol, Suita, Osaka, Japan.	tomoen@ri.ncvc.go.jp	yanamoto, hiroji/ABB-3923-2020; Nakao, Shu/L-1796-2019; Yanamoto, Hiroji/ABF-7320-2020	Nakao, Shu/0000-0001-8990-1179; 	JSPS KAKENHI [JP24590293, JP26460312, JP25860174]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant Number JP24590293, JSPS KAKENHI (https://www.jsps.go.jp/english/e-grants/index.html) obtained by T.Y.N.; Grant Number JP26460312, JSPS KAKENHI (https://www.jsps.go.jp/english/e-grants/index.html) obtained by S.W.; Grant Number JP25860174, JSPS KAKENHI (https://www.jsps.go.jp/english/e-grants/index.html) obtained by S.N.	Bekinschtein P, 2008, NEUROSCIENTIST, V14, P147, DOI 10.1177/1073858407305850; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Boehmerle W, 2007, P NATL ACAD SCI USA, V104, P11103, DOI 10.1073/pnas.0701546104; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Dason JS, 2009, J CELL SCI, V122, P4109, DOI 10.1242/jcs.055095; de Rezende VB, 2014, PHYSIOL BEHAV, V130, P91, DOI 10.1016/j.physbeh.2014.03.005; Finkbeiner S, 2000, CELL MOL LIFE SCI, V57, P394, DOI 10.1007/PL00000701; Genin A, 2001, NEUROSCIENCE, V106, P571, DOI 10.1016/S0306-4522(01)00301-3; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Gomez M, 2001, NEURON, V30, P241, DOI 10.1016/S0896-6273(01)00276-8; Gorski JA, 2003, NEUROSCIENCE, V121, P341, DOI 10.1016/S0306-4522(03)00426-3; Hasbi A, 2009, P NATL ACAD SCI USA, V106, P21377, DOI 10.1073/pnas.0903676106; Jo J, 2008, NEURON, V60, P1095, DOI 10.1016/j.neuron.2008.10.050; Kabbani N, 2002, J NEUROSCI, V22, P8476; Koh PO, 2003, P NATL ACAD SCI USA, V100, P313, DOI 10.1073/pnas.232693499; Koizumi S, 2002, J BIOL CHEM, V277, P30315, DOI 10.1074/jbc.M201132200; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Li L, 2003, AM J PATHOL, V163, P2155, DOI 10.1016/S0002-9440(10)63572-9; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; MATTSON MP, 1993, ANN NY ACAD SCI, V679, P1, DOI 10.1111/j.1749-6632.1993.tb18285.x; Multani PK, 2012, NEUROSCI LETT, V531, P46, DOI 10.1016/j.neulet.2012.09.014; Mun HS, 2015, SCI REP-UK, V5, DOI 10.1038/srep17697; Nakajo Y, 2008, BRAIN RES, V1241, P103, DOI 10.1016/j.brainres.2008.08.080; Nakamura TY, 2011, CIRC RES, V109, P512, DOI 10.1161/CIRCRESAHA.111.248864; Nakamura TY, 2006, J CELL BIOL, V172, P1081, DOI 10.1083/jcb.200508156; Nakamura TY, 2001, P NATL ACAD SCI USA, V98, P12808, DOI 10.1073/pnas.221168498; Nakao S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125050; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Ng E, 2016, BEHAV BRAIN RES, V301, P213, DOI 10.1016/j.bbr.2015.12.037; Ninan I, 2004, NEURON, V42, P129, DOI 10.1016/S0896-6273(04)00143-6; Oikawa K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-45; Olafsson P, 1997, MOL BRAIN RES, V44, P73, DOI 10.1016/S0169-328X(96)00188-X; Perez-Garcia MJ, 2004, J BIOL CHEM, V279, P6132, DOI 10.1074/jbc.M308367200; Saab BJ, 2009, NEURON, V63, P643, DOI 10.1016/j.neuron.2009.08.014; Sadakata T, 2010, NEUROSCI RES, V67, P197, DOI 10.1016/j.neures.2010.03.006; Sanhueza M, 2011, J NEUROSCI, V31, P9170, DOI 10.1523/JNEUROSCI.1250-11.2011; Schmidt U, 1996, NEUROSCIENCE, V74, P453, DOI 10.1016/0306-4522(96)00201-1; Shinoda Y, 2011, P NATL ACAD SCI USA, V108, P373, DOI 10.1073/pnas.1012220108; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Sippy T, 2003, NAT NEUROSCI, V6, P1031, DOI 10.1038/nn1117; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Tsujimoto T, 2002, SCIENCE, V295, P2276, DOI 10.1126/science.1068278; Yanamoto H, 2008, BRAIN RES, V1212, P79, DOI 10.1016/j.brainres.2008.03.011	47	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2017	12	1							e0170829	10.1371/journal.pone.0170829	http://dx.doi.org/10.1371/journal.pone.0170829			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7FK	28122057	gold, Green Submitted, Green Published			2022-12-26	WOS:000396167300013
J	Spieker, J; Mudersbach, T; Vogel-Hopker, A; Layer, PG				Spieker, Janine; Mudersbach, Thomas; Vogel-Hoepker, Astrid; Layer, Paul G.			Endochondral Ossification Is Accelerated in Cholinesterase-Deficient Mice and in Avian Mesenchymal Micromass Cultures	PLOS ONE			English	Article							ACETYLCHOLINESTERASE KNOCKOUT MOUSE; IN-VITRO MODEL; BONE-FORMATION; OSTEOBLAST DIFFERENTIATION; CELL-PROLIFERATION; INDIAN-HEDGEHOG; CHICK-EMBRYO; HYPERTROPHIC CHONDROCYTES; CHOLINERGIC SYSTEM; LIMB BUD	Most components of the cholinergic system are detected in skeletogenic cell types in vitro, yet the function of this system in skeletogenesis remains unclear. Here, we analyzed endochondral ossification in mutant murine fetuses, in which genes of the rate-limiting cholinergic enzymes acetyl-(AChE), or butyrylcholinesterase (BChE), or both were deleted (called here A(-)B(+), A(+)B(-), A(-)B(-), respectively). In all mutant embryos bone growth and cartilage remodeling into mineralizing bone were accelerated, as revealed by Alcian blue (A-blu) and Alizarin red (A-red) staining. In A(+)B(-) and A(-)B(-) onset of mineralization was observed before E13.5, about 2 days earlier than in wild type and A(-)B(+) mice. In all mutants between E18.5 to birth A-blu staining disappeared from epiphyses prematurely. Instead, A-blu(+) cells were dislocated into diaphyses, most pronounced so in A(-)B(-) mutants, indicating additive effects of both missing ChEs in A(-)B(-) mutant mice. The remodeling effects were supported by in situ hybridization (ISH) experiments performed on cryosections from A(-)B(-) mice, in which Ihh, Runx2, MMP13, ALP, Col-II and Col-X were considerably decreased, or had disappeared between E18.5 and P0. With a second approach, we applied an improved in vitro micromass model from chicken limb buds that allowed histological distinction between areas of cartilage, apoptosis and mineralization. When treated with the AChE inhibitor BW284c51, or with nicotine, there was decrease in cartilage and accelerated mineralization, suggesting that these effects were mediated through nicotinic receptors (alpha 7-nAChR). We conclude that due to absence of either one or both cholinesterases in KO mice, or inhibition of AChE in chicken micromass cultures, there is increase in cholinergic signalling, which leads to increased chondroblast production and premature mineralization, at the expense of incomplete chondrogenic differentiation. This emphasizes the importance of cholinergic signalling in cartilage and bone formation.	[Spieker, Janine; Mudersbach, Thomas; Vogel-Hoepker, Astrid; Layer, Paul G.] Tech Univ Darmstadt, Dev Biol & Neurogenet, Schnittspahnstr 13, Darmstadt, Germany	Technical University of Darmstadt	Layer, PG (corresponding author), Tech Univ Darmstadt, Dev Biol & Neurogenet, Schnittspahnstr 13, Darmstadt, Germany.	layer@bio.tu-darmstadt.de						AHRENS PB, 1977, DEV BIOL, V60, P69, DOI 10.1016/0012-1606(77)90110-5; ALBER R, 1994, ANAT EMBRYOL, V190, P429; Ballock R. Tracy, 2003, Birth Defects Research, V69, P123, DOI 10.1002/bdrc.10014; Bobick BE, 2009, BIRTH DEFECTS RES C, V87, P351, DOI 10.1002/bdrc.20167; Campoy FJ, 2016, CHEM BIOL INTERACT; Carlevaro MF, 1997, J CELL BIOL, V136, P1375, DOI 10.1083/jcb.136.6.1375; Chinnadurai RK, 2015, ARCH BIOCHEM BIOPHYS, V580, P1, DOI 10.1016/j.abb.2015.06.002; Compston JE, 1999, LANCET, V354, P1791, DOI 10.1016/S0140-6736(99)04466-9; Dhein S, 2015, J CARDIOVASC PHARM, V65, P508, DOI 10.1097/FJC.0000000000000221; Duysen EG, 2002, DEV BRAIN RES, V137, P43, DOI 10.1016/S0165-3806(02)00367-X; Eimar H, 2013, J MUSCULOSKEL NEURON, V13, P454; Eimar H, 2013, J MUSCULOSKEL NEURON, V13, P124; En-Nosse M, 2009, CELL TISSUE RES, V338, P203, DOI 10.1007/s00441-009-0871-1; Forsgren S, 2012, LIFE SCI, V91, P1043, DOI 10.1016/j.lfs.2012.03.028; GALOTTO M, 1994, J BONE MINER RES, V9, P1239; Genever PG, 1999, BONE, V24, P297, DOI 10.1016/S8756-3282(98)00187-2; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Grando SA, 2015, INT IMMUNOPHARMACOL, V29, P1, DOI 10.1016/j.intimp.2015.08.023; Grisaru D, 1999, MOL CELL BIOL, V19, P788; Grisaru D, 1999, EUR J BIOCHEM, V264, P672, DOI 10.1046/j.1432-1327.1999.00693.x; Horton WA, 2007, LANCET, V370, P162, DOI 10.1016/S0140-6736(07)61090-3; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Inkson CA, 2004, BONE, V35, P819, DOI 10.1016/j.bone.2004.05.026; Johnson G, 2009, J MOL RECOGNIT, V22, P188, DOI 10.1002/jmr.931; Kakinuma Y, 2010, J MOL CELL CARDIOL, V48, P680, DOI 10.1016/j.yjmcc.2009.11.010; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; Kauschke V, 2014, MED SCI MONITOR, V20, P869, DOI 10.12659/MSM.890217; Kawakita A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003945; Kini U., 2012, RADIONUCLIDE HYBRID, P29, DOI [10.1007/978-3-642-02400-9_2, DOI 10.1007/978-3-642-02400-9_2]; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Laurie LE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150263; Layer PG, 2013, CHEM-BIOL INTERACT, V203, P269, DOI 10.1016/j.cbi.2012.09.014; LAYER PG, 1993, CELL TISSUE RES, V273, P219, DOI 10.1007/BF00312823; LAYER PG, 1995, PROG HISTOCHEM CYTOC, V29, P1; Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048; Li B, 2000, J NEUROCHEM, V75, P1320, DOI 10.1046/j.1471-4159.2000.751320.x; Li B, 2006, J MOL NEUROSCI, V30, P193, DOI 10.1385/JMN:30:1:193; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; Linder CH, 2014, BONE ABSTRACTS, V3, P51; Liu PS, 2011, EUR J PHARMACOL, V650, P34, DOI 10.1016/j.ejphar.2010.09.031; Liu YH, 2015, MOL MED REP, V11, P4121, DOI 10.3892/mmr.2015.3307; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; MATTOT V, 1995, J CELL SCI, V108, P529; Mello MA, 1999, IN VITRO CELL DEV-AN, V35, P262; Minina E, 2001, DEVELOPMENT, V128, P4523; Miyazaki R, 2012, CLIN SCI, V123, P241, DOI 10.1042/CS20110633; MUNDLOS S, 1994, DEV DYNAM, V199, P241, DOI 10.1002/aja.1001990308; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nelson E, 1999, HUM EXP TOXICOL, V18, P252, DOI 10.1191/096032799678840002; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Park J, 2015, BIOL OPEN, V4, P608, DOI 10.1242/bio.201411031; Pegan K, 2010, CHEM-BIOL INTERACT, V187, P96, DOI 10.1016/j.cbi.2010.03.034; Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068; REICH A, 1983, HISTOCHEMISTRY, V78, P383, DOI 10.1007/BF00496624; Reissmann E, 1996, DEVELOPMENT, V122, P2079; Richette P, 2008, JOINT BONE SPINE, V75, P125, DOI 10.1016/j.jbspin.2007.06.007; Roach HI, 1999, HISTOCHEM J, V31, P53, DOI 10.1023/A:1003519104980; ROACH HI, 1995, J CELL BIOL, V131, P483, DOI 10.1083/jcb.131.2.483; Robitzki A, 1998, J NEUROCHEM, V71, P1413; Rothem DE, 2009, J BONE MINER METAB, V27, P555, DOI 10.1007/s00774-009-0075-5; Sato T, 2010, FEBS LETT, V584, P817, DOI 10.1016/j.febslet.2010.01.001; Schaal C, 2014, MOL CANCER RES, V12, P14, DOI 10.1158/1541-7786.MCR-13-0541; Scholl FG, 2003, TRENDS NEUROSCI, V26, P618, DOI 10.1016/j.tins.2003.09.004; Sharma KV, 1998, J NEUROSCI RES, V53, P454, DOI 10.1002/(SICI)1097-4547(19980815)53:4<454::AID-JNR7>3.3.CO;2-E; Silman I, 2005, CURR OPIN PHARMACOL, V5, P293, DOI 10.1016/j.coph.2005.01.014; Sloan A, 2010, SURG-J R COLL SURG E, V8, P111, DOI 10.1016/j.surge.2009.10.014; Spieker J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161675; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Weitnauer E, 1999, J PROTEIN CHEM, V18, P205, DOI 10.1023/A:1020632207361; WILLBOLD E, 1994, EUR J CELL BIOL, V64, P192; Xie J, 2011, APPL ENVIRON MICROB, V2011, P3, DOI DOI 10.1093/JMCB/MJQ047; Xie WH, 1999, CHEM-BIOL INTERACT, V119, P289, DOI 10.1016/S0009-2797(99)00039-3; Xu ML, 2016, CHEM BIOL INTERACT; YAMADA Y, 1991, J CRAN GENET DEV BIO, V11, P350; Yamagiwa H, 1999, BONE, V25, P197, DOI 10.1016/S8756-3282(99)00157-X; Yang Q, 2011, J BONE MINER RES, V26, P1188, DOI 10.1002/jbmr.337; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Zhang XJ, 2002, CELL DEATH DIFFER, V9, P790, DOI 10.1038/sj.cdd.4401034; Zhang XJ, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00040	80	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2017	12	1							e0170252	10.1371/journal.pone.0170252	http://dx.doi.org/10.1371/journal.pone.0170252			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7CU	28118357	gold, Green Published			2022-12-26	WOS:000396160500040
J	Rahman, AE; Iqbal, A; Hoque, DME; Moinuddin, M; Bin Zaman, S; Rahman, QSU; Begum, T; Chowdhury, AI; Haider, R; El Arifeen, S; Kissoon, N; Larson, CP				Rahman, Ahmed Ehsanur; Iqbal, Afrin; Hoque, D. M. Emdadul; Moinuddin, Md.; Bin Zaman, Sojib; Rahman, Qazi Sadeq-ur; Begum, Tahmina; Chowdhury, Atique Iqbal; Haider, Rafiqul; El Arifeen, Shams; Kissoon, Niranjan; Larson, Charles P.			Managing Neonatal and Early Childhood Syndromic Sepsis in Sub-District Hospitals in Resource Poor Settings: Improvement in Quality of Care through Introduction of a Package of Interventions in Rural Bangladesh	PLOS ONE			English	Article							INJECTABLE PROCAINE BENZYLPENICILLIN; DEVELOPING-COUNTRY; YOUNG INFANTS; BACTERIAL-INFECTIONS; SYLHET DISTRICT; CLINICAL SIGNS; OPEN-LABEL; ANTIBIOTICS; GENTAMICIN; STRATEGIES	Introduction Sepsis is dysregulated systemic inflammatory response which can lead to tissue damage, organ failure, and death. With an estimated 30 million cases per year, it is a global public health concern. Severe infections leading to sepsis account for more than half of all under five deaths and around one quarter of all neonatal deaths annually. Most of these deaths occur in low and middle income countries and could be averted by rapid assessment and appropriate treatment. Evidence suggests that service provision and quality of care pertaining to sepsis management in resource poor settings can be improved significantly with minimum resource allocation and investments. Cognizant of the stark realities, a project titled 'Interrupting Pathways to Sepsis Initiative' (IPSI) introduced a package of interventions for improving quality of care pertaining to sepsis management at 2 sub-district level public hospitals in rural Bangladesh. We present here the quality improvement process and achievements regarding some fundamental steps of sepsis management which include rapid identification and admission, followed by assessment for hypoxemia, hypoglycaemia and hypothermia, immediate resuscitation when required and early administration of parenteral broad spectrum antibiotics. Materials and Method Key components of the intervention package include identification of structural and functional gaps through a baseline environmental scan, capacity development on protocolized management through training and supportive supervision by onsite 'Program Coaches', facilitating triage and rapid transfer of patients through 'Welcoming Persons' and enabling rapid treatment through 'Task Shifting' from on-call physicians to on-duty paramedics in the emergency department and on-call physicians to on-duty nurses in the inpatient department. Results From August, 2013 to March, 2015, 1,262 under-5 children were identified as syndromic sepsis in the emergency departments; of which 82% were admitted. More neonates (30%) were referred to higher level facilities than post-neonates (6%) (p<0.05). Immediately after admission, around 99% were assessed for hypoxemia, hypoglycaemia and hypothermia. Around 21% were hypoxemic (neonate-37%, post-neonate-18%, p<0.05), among which 94% received immediate oxygenation. Vascular access was established in 78% cases and 85% received recommended broad spectrum antibiotics parenterally within 1 hour of admission. There was significant improvement in the rate of establishing vascular access and choice of recommended first line parenteral antibiotic over time. After arrival in the emergency department, the median time taken for identification of syndromic sepsis and completion of admission procedure was 6 minutes. The median time taken for completion of assessment for complications was 15 minutes and administration of first dose of broad spectrum antibiotics was 35 minutes. There were only 3 inpatient deaths during the reporting period. Discussion and Conclusion Needs based health systems strengthening, supportive-supervision and task shifting can improve the quality and timeliness of in-patient management of syndromic sepsis in resource limited settings.	[Rahman, Ahmed Ehsanur; Iqbal, Afrin; Hoque, D. M. Emdadul; Moinuddin, Md.; Bin Zaman, Sojib; Rahman, Qazi Sadeq-ur; Begum, Tahmina; Chowdhury, Atique Iqbal; Haider, Rafiqul; El Arifeen, Shams] Int Ctr Diarrhoeal Dis Res, Maternal & Child Hlth Div, Dhaka, Bangladesh; [Kissoon, Niranjan; Larson, Charles P.] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada	International Centre for Diarrhoeal Disease Research (ICDDR); University of British Columbia	Rahman, AE (corresponding author), Int Ctr Diarrhoeal Dis Res, Maternal & Child Hlth Div, Dhaka, Bangladesh.	ehsanur@icddrb.org	Hoque, Dewan Md. Emdadul/J-1999-2019; Begum, Tahmina/AAD-5258-2021; Moinuddin, Mohammed/AAP-4454-2021; Rahman, Ahmed Ehsanur/ABC-5318-2021; Hoque, Dewan/O-3606-2015; Kissoon, Niranjan/AAC-6140-2021; Haider, Rafiqul/A-4236-2016	Hoque, Dewan Md. Emdadul/0000-0001-8219-9196; Begum, Tahmina/0000-0001-8106-2454; Moinuddin, Mohammed/0000-0001-9364-390X; Hoque, Dewan/0000-0001-8219-9196; Zaman, Sojib Bin/0000-0002-3043-7954; Kissoon, Niranjan/0000-0001-8847-9973; Arifeen, Shams/0000-0002-5372-5932; Haider, Rafiqul/0000-0002-7864-3319	Global Affairs Canada Trade and Developments MUSKOKA Initiative on Maternal, Newborn and Child Health (MNCH) [S065353001]	Global Affairs Canada Trade and Developments MUSKOKA Initiative on Maternal, Newborn and Child Health (MNCH)	This study was a component of the project titled "Interrupting Pathways to Maternal, Newborn and Early Childhood Sepsis Initiative" (IPSI) (project number S065353001) that was funded by Global Affairs Canada Trade and Developments MUSKOKA Initiative on Maternal, Newborn and Child Health (MNCH), received by Dr. Charles Larson, url http://www.international.gc.ca/. The funders had no role in study design, data collection, analysis and writing the manuscript.	Ahmed S, 2001, J TROP PEDIATRICS, V47, P98, DOI 10.1093/tropej/47.2.98; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Anwar I, 2009, J HEALTH POPUL NUTR, V27, P139, DOI 10.3329/jhpn.v27i2.3327; Arifeen SE, 2005, B WORLD HEALTH ORGAN, V83, P260; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Baqui AH, 2015, LANCET GLOB HEALTH, V3, pE279, DOI 10.1016/S2214-109X(14)70347-X; Bhandari N, 1996, LANCET, V347, P1774, DOI 10.1016/S0140-6736(96)90856-9; Bhutta ZA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009636; Bhutta ZA, 2009, PEDIATR INFECT DIS J, V28, pS22, DOI 10.1097/INF.0b013e31819588ac; Chisti MJ, 2015, LANCET, V386, P1057, DOI 10.1016/S0140-6736(15)60249-5; Chowdhury Sameena, 2009, Bangladesh Med Res Counc Bull, V35, P53; Cruz AT, 2011, PEDIATRICS, V127, pE758, DOI 10.1542/peds.2010-2895; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Darmstadt GL, 2006, J HEALTH POPUL NUTR, V24, P380; Darmstadt Gary L, 2005, J Perinatol, V25, P331, DOI 10.1038/sj.jp.7211283; Darmstadt GL, 2009, PEDIATR INFECT DIS J, V28, pS31, DOI 10.1097/INF.0b013e3181958794; Darmstadt GL, 2009, PEDIATR INFECT DIS J, V28, pS37, DOI 10.1097/INF.0b013e31819588c3; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Edmond K, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000213; Fleischmann C., 2015, CRIT CARE, V19, pP21, DOI [10.1186/cc14101, DOI 10.1186/CC14101]; Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC; Geldsetzer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093427; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Hoque DME, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-197; Kissoon N, 2016, JAMA PEDIATR, V170, P107, DOI 10.1001/jamapediatrics.2015.3241; Kissoon N, 2015, J INFECTION, V71, pS36, DOI 10.1016/j.jinf.2015.04.017; Kissoon N, 2015, J INFECTION, V71, pS21, DOI 10.1016/j.jinf.2015.04.016; Kissoon N, 2011, PEDIATR CRIT CARE ME, V12, P494, DOI 10.1097/PCC.0b013e318207096c; Koyamaibole L, 2006, J TROP PEDIATRICS, V52, P249, DOI 10.1093/tropej/fmi109; Kuensting LL, 2009, J EMERG NURS, V35, P419, DOI 10.1016/j.jen.2009.01.014; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Larsen GY, 2011, PEDIATRICS; Lee JW, 2003, LANCET, V362, P2083, DOI 10.1016/S0140-6736(03)15107-0; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Martin S, 2014, ARCH DIS CHILD-FETAL, V99, pF495, DOI 10.1136/archdischild-2013-305519; Ministry of Health and Family Welfare Bangladesh, 2009, NAT NEON HLTH STRAT; NIPORT Mitra and Associates and ICF International, 2013, BANGL DEM HLTH SURV; Oza S, 2015, B WORLD HEALTH ORGAN, V93, P19, DOI 10.2471/BLT.14.139790; PARSONS HM, 1974, SCIENCE, V183, P922, DOI 10.1126/science.183.4128.922; Paul R, 2014, PEDIATRICS, V133, pE1358, DOI 10.1542/peds.2013-3871; Paul R, 2012, PEDIATRICS, V130, pE273, DOI 10.1542/peds.2012-0094; Paxton JH, 2008, ANN EMERG MED, V52, pS58, DOI 10.1016/j.annemergmed.2008.06.119; Qazi SA, 2009, PEDIATR INFECT DIS J, V28, pS1, DOI 10.1097/INF.0b013e31819587a9; Riviello ED, 2015, LANCET INFECT DIS, V15, P501, DOI 10.1016/S1473-3099(15)70148-9; Sabri A, 2013, BIO-MED MATER ENG, V23, P93, DOI 10.3233/BME-120735; Sandberg J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097253; Seale AC, 2014, LANCET INFECT DIS, V14, P731, DOI 10.1016/S1473-3099(14)70804-7; Syed U, 2008, J PERINATOL, V28, pS9, DOI 10.1038/jp.2008.165; Taylor MJ, 2014, BMJ QUAL SAF, V23, P290, DOI 10.1136/bmjqs-2013-001862; Thaver D, 2009, PEDIATR INFECT DIS J, V28, pS3, DOI 10.1097/INF.0b013e3181958755; Tshefu A, 2015, LANCET, V385, P1767, DOI 10.1016/S0140-6736(14)62284-4; Victora CG, 2005, HEALTH POLICY PLANN, V20, pI18, DOI 10.1093/heapol/czi050; Wickstrom G, 2000, SCAND J WORK ENV HEA, V26, P363, DOI 10.5271/sjweh.555; Winch PJ, 2005, LANCET, V366, P478, DOI 10.1016/S0140-6736(05)66836-5; Witting MD, 2012, J EMERG MED, V42, P483, DOI 10.1016/j.jemermed.2011.07.030; World Health Organization, 2000, MAN CHILD SER INF SE; World Health Organization, 2015, GUID MAN POSS SER BA; World Health Organization, 2011, POCK BOOK HOSP CAR C	60	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170267	10.1371/journal.pone.0170267	http://dx.doi.org/10.1371/journal.pone.0170267			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114415	gold, Green Published, Green Submitted			2022-12-26	WOS:000396129000030
J	Conigliaro, P; Ciccacci, C; Politi, C; Triggianese, P; Rufini, S; Kroegler, B; Perricone, C; Latini, A; Novelli, G; Borgiani, P; Perricone, R				Conigliaro, Paola; Ciccacci, Cinzia; Politi, Cristina; Triggianese, Paola; Rufini, Sara; Kroegler, Barbara; Perricone, Carlo; Latini, Andrea; Novelli, Giuseppe; Borgiani, Paola; Perricone, Roberto			Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 Genes Are Associated with the Response to TNF Inhibitors in Patients with Rheumatoid Arthritis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PSORIATIC-ARTHRITIS; AMERICAN-COLLEGE; NECROSIS-FACTOR; SUSCEPTIBILITY; METAANALYSIS; PREDICTORS; REMISSION; MECHANISMS	Objective Rheumatoid Arthritis (RA) is a progressive autoimmune disease characterized by chronic joint inflammation and structural damage. Remission or at least low disease activity (LDA) represent potentially desirable goals of RA treatment. Single nucleotide polymorphisms (SNPs) in several genes might be useful for prediction of response to therapy. We aimed at exploring 4 SNPs in candidate genes (STAT4, PTPN2, PSORS1C1 and TRAF3IP2) in order to investigate their potential role in the response to therapy with tumor necrosis factor inhibitors (TNF-i) in RA patients. Methods In 171 RA patients we investigated the following SNPs: rs7574865 (STAT4), rs2233945 (PSORS1C1), rs7234029 (PTPN2) and rs33980500 (TRAF3IP2). Remission, LDA, and EULAR response were registered at 6 months and 2 years after initiation of first line TNF-i [ Adalimumab (ADA) and Etanercept (ETN)]. Results STAT4 variant allele was associated with the absence of a good/moderate EULAR response at 2 years of treatment in the whole RA group and in ETN treated patients. The PTPN2 SNP was associated with no good/moderate EULAR response at 6 months in ADA treated patients. Patients carrying PSORS1C1 variant allele did not reach LDA at 6 months in both the whole RA group and ETN treated patients. TRAF3IP2 variant allele was associated with the lack of LDA and remission achievement at 6 months in all RA cohort while an association with no EULAR response at 2 years of treatment occurred only in ETN treated patients. Conclusions For the first time, we reported that SNPs in STAT4, PTPN2, PSORS1C1, and TRAF3IP2 are associated with response to TNF-i treatment in RA patients; however, these findings should be validated in a larger population.	[Conigliaro, Paola; Triggianese, Paola; Kroegler, Barbara; Perricone, Roberto] Univ Roma Tor Vergata, Dept Med Sistemi, Clin Rheumatol Allergol & Clin Immunol, Rome, Italy; [Ciccacci, Cinzia; Politi, Cristina; Rufini, Sara; Latini, Andrea; Novelli, Giuseppe; Borgiani, Paola] Univ Roma Tor Vergata, Genet Sect, Dept Biomed & Prevent, Rome, Italy; [Perricone, Carlo] Sapienza Univ Roma, Dipartimento Med Interna & Specialita Med, Reumatol, Rome, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata; Sapienza University Rome	Triggianese, P (corresponding author), Univ Roma Tor Vergata, Dept Med Sistemi, Clin Rheumatol Allergol & Clin Immunol, Rome, Italy.	triggianese@med.uniroma2.it	Novelli, Giuseppe/T-8822-2019; Novelli, Giuseppe/A-5195-2013; Novelli, Giuseppe/GQB-3329-2022; Ciccacci, Cinzia/Z-6114-2019	Novelli, Giuseppe/0000-0002-7781-602X; Novelli, Giuseppe/0000-0002-7781-602X; Perricone, Carlo/0000-0003-4771-6981; Ciccacci, Cinzia/0000-0002-3995-7032; Perricone, Roberto/0000-0002-2368-9766; Latini, Andrea/0000-0002-5350-7361				Acosta-Colman I, 2013, PHARMACOGENOMICS, V14, P727, DOI [10.2217/PGS.13.60, 10.2217/pgs.13.60]; Aerts NE, 2010, CLIN EXP RHEUMATOL, V28, P208; Alessandri C, 2009, ANN NY ACAD SCI, V1173, P52, DOI 10.1111/j.1749-6632.2009.04806.x; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Antiga E, 2012, J CLIN IMMUNOL, V32, P1221, DOI 10.1007/s10875-012-9716-x; Aradi B, 2015, ARTHRITIS RHEUMATOL, V67, P2624, DOI 10.1002/art.39256; Canhao H, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/490295; Chimenti MS, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.246; Ciccacci C, 2016, CLIN EXP IMMUNOL, V186, P157, DOI 10.1111/cei.12831; Ciccacci C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111991; Ciccacci C, 2013, J CROHNS COLITIS, V7, P44, DOI 10.1016/j.crohns.2012.02.020; Combe Bernard, 2009, Best Pract Res Clin Rheumatol, V23, P59, DOI 10.1016/j.berh.2008.11.006; Conigliaro P, 2016, AUTOIMMUN REV, V15, P673, DOI 10.1016/j.autrev.2016.03.003; Conigliaro P, 2014, CLIN EXP IMMUNOL, V177, P234, DOI 10.1111/cei.12335; Conigliaro P, 2016, J INT MED RES, V44, P90, DOI 10.1177/0300060515593262; Cuppen BVJ, 2016, RHEUMATOLOGY, V55, P826, DOI 10.1093/rheumatology/kev421; Cush JJ, 2007, J RHEUMATOL, V34, P1; Daien CI, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/386148; Doyle MS, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4071; Elshazli R, 2015, IMMUNOBIOLOGY, V220, P1012, DOI 10.1016/j.imbio.2015.04.003; Frucht DM, 2000, J IMMUNOL, V164, P4659, DOI 10.4049/jimmunol.164.9.4659; Furst DE, 2006, SEMIN ARTHRITIS RHEU, V36, P159, DOI 10.1016/j.semarthrit.2006.02.001; Glas J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033682; Gottenberg JE, 2012, ANN RHEUM DIS, V71, P1815, DOI 10.1136/annrheumdis-2011-201109; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Morales-Lara MJ, 2012, JOINT BONE SPINE, V79, P591, DOI 10.1016/j.jbspin.2012.02.003; Katchamart W, 2010, ARTHRIT CARE RES, V62, P1128, DOI 10.1002/acr.20188; Korman BD, 2008, CURR ALLERGY ASTHM R, V8, P398, DOI 10.1007/s11882-008-0077-8; Lamana A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142683; Liu Y, 2016, ARTHRITIS CARE RES; Moon YM, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4089; Mourao AF, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/706515; Nabi G, 2016, AUTOIMMUNITY, V49, P197, DOI 10.3109/08916934.2015.1134514; Oliver J, 2015, BIOMARK MED, V9, P499, DOI 10.2217/bmm.15.18; Patakas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049715; Perricone C, 2013, IMMUNOGENETICS, V65, P703, DOI 10.1007/s00251-013-0717-6; Plant D, 2012, ARTHRITIS RHEUM-US, V64, P665, DOI 10.1002/art.33381; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Prajapati R, 2011, PHARMACOGENOMICS, V12, P1571, DOI [10.2217/PGS.11.114, 10.2217/pgs.11.114]; Prieto-Perez R, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020225; Quintana-Duque MA, 2016, CLIN RHEUMATOL, V35, P1463, DOI 10.1007/s10067-016-3246-5; Scott IC, 2015, J RHEUMATOL, V42, P1131, DOI 10.3899/jrheum.141211; Scrivo R, 2015, CLIN EXP IMMUNOL, V179, P300, DOI 10.1111/cei.12449; Sieberts SK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12460; Smolen JS, 2016, ANN RHEUM DIS, V75, P3, DOI 10.1136/annrheumdis-2015-207524; Smolen JS, 2016, LANCET, V388, P2023, DOI 10.1016/S0140-6736(16)30173-8; Smolen JS, 2003, RHEUMATOLOGY, V42, P244, DOI 10.1093/rheumatology/keg072; Sode J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139781; Solus JF, 2015, CLIN RHEUMATOL, V34, P1375, DOI 10.1007/s10067-015-2881-6; Stuart PE, 2015, AM J HUM GENET, V97, P816, DOI 10.1016/j.ajhg.2015.10.019; Sun HJ, 2013, IMMUNOL LETT, V153, P9, DOI 10.1016/j.imlet.2013.06.001; Tong Q, 2013, PHARMACOGENOMICS, V14, P1691, DOI 10.2217/pgs.13.146; Urabe S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/416838; van Nies JAB, 2015, ANN RHEUM DIS, V74, P806, DOI 10.1136/annrheumdis-2014-206047; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Wallman JK, 2016, J RHEUMATOL, V43, P1292, DOI 10.3899/jrheum.150617; Zervou MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074375	57	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0169956	10.1371/journal.pone.0169956	http://dx.doi.org/10.1371/journal.pone.0169956			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107378	Green Published, gold, Green Submitted			2022-12-26	WOS:000392405300055
J	Duarte, C; Matos, M; Stubbs, RJ; Gale, C; Morris, L; Gouveia, JP; Gilbert, P				Duarte, Cristiana; Matos, Marcela; Stubbs, R. James; Gale, Corinne; Morris, Liam; Gouveia, Jose Pinto; Gilbert, Paul			The Impact of Shame, Self-Criticism and Social Rank on Eating Behaviours in Overweight and Obese Women Participating in a Weight Management Programme	PLOS ONE			English	Article							DEPRESSIVE SYMPTOMS; EMOTION REGULATION; BODY-IMAGE; EXPLORATION; STIGMA; LIKING; FOOD; INTERVENTIONS; HEALTHY; FORMS	Recent research has suggested that obesity is a stigmatised condition. Concerns with personal inferiority (social rank), shame and self-criticism may impact on weight management behaviours. The current study examined associations between social comparison (shame, self-criticism), negative affect and eating behaviours in women attending a community based weight management programme focused on behaviour change. 2,236 participants of the programme completed an online survey using measures of shame, self-criticism, social comparison, and weight-related affect, which were adapted to specifically address eating behaviour, weight and body shape perceptions. Correlation analyses showed that shame, self-criticism and social comparison were associated with negative affect. All of these variables were related to eating regulation and weight control (p < 0.001). Path analysis revealed that the association of shame, hated-self, and low self-reassurance on disinhibition and susceptibility to hunger was fully mediated by weight-related negative affect, even when controlling for the effect of depressive symptoms (p < 0.050 to p < 0.010). In addition, feelings of inadequacy and unfavourable social comparisons were associated with higher disinhibition and susceptibility to hunger, partially mediated through weight-related negative affect (p = 0.001). These variables were negatively associated with extent of weight loss during programme attendance prior to the survey, while self-reassurance and positive social comparisons were positively associated with the extent of weight loss prior to the survey (p <.050). Shame, self-criticism, and perceptions of inferiority may play a significant role in self-regulation of eating behaviour in overweight people trying to manage their weight.	[Duarte, Cristiana; Matos, Marcela; Gouveia, Jose Pinto] Univ Coimbra, Cognit & Behav Ctr Res & Intervent, Rua Colegio Novo, Coimbra, Portugal; [Stubbs, R. James] Univ Derby, Coll Life & Nat Sci, Derby, England; [Stubbs, R. James; Morris, Liam] Slimming World, Nutr & Res Dept, Alfreton, Derby, England; [Gale, Corinne; Gilbert, Paul] Kingsway Hosp, Mental Hlth Res Unit, Derby, England; [Stubbs, R. James] Univ Leeds, Fac Med & Hlth, Sch Psychol, Leeds, W Yorkshire, England	Universidade de Coimbra; University of Derby; University of Leeds	Stubbs, RJ (corresponding author), Univ Derby, Coll Life & Nat Sci, Derby, England.; Stubbs, RJ (corresponding author), Slimming World, Nutr & Res Dept, Alfreton, Derby, England.; Stubbs, RJ (corresponding author), Univ Leeds, Fac Med & Hlth, Sch Psychol, Leeds, W Yorkshire, England.	r.j.stubbs@leeds.ac.uk	Matos, Marcela/H-8563-2018; Stubbs, R James/AAH-4739-2021	Matos, Marcela/0000-0001-7320-7107; Stubbs, R James/0000-0002-0843-9064; Pinto-Gouveia, Jose/0000-0002-4505-8367; Duarte, Cristiana/0000-0002-6566-273X; Gale, Corinne/0000-0002-8657-7446; Gilbert, paul/0000-0001-8431-9892	FCT (Portuguese Foundation for Science and Technology) [SFRH/BD/76858/2011]; Slimming World UK	FCT (Portuguese Foundation for Science and Technology)(Portuguese Foundation for Science and Technology); Slimming World UK	Research by the first author (Cristiana Duarte) is supported by a Ph.D. Grant (SFRH/BD/76858/2011), sponsored by FCT (Portuguese Foundation for Science and Technology). This study was funded by grant-in-aid of research from Slimming World UK to the University of Derby. Slimming World UK funded this project and contributed staff and resources to data extraction and collation. Slimming World employee RJS was involved in the design of the study, analysis, preparation of the manuscript and decision to publish. RJS has since moved the the University of Leeds and currently acts as a University consultant to Slimming World. Slimming World employee LM was involved in the preparation of the manuscript and decision to publish. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	ALLAN S, 1994, PERS INDIV DIFFER, V17, P719, DOI 10.1016/0191-8869(94)90150-3; ALLAN S, 1995, PERS INDIV DIFFER, V19, P293, DOI 10.1016/0191-8869(95)00086-L; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Benjamin RM, 2010, PUBLIC HEALTH REP, V125, P514, DOI 10.1177/003335491012500402; Branca F., 2007, CHALLENGE OBESITY WH; Byrne B.M., 2010, STRUCTURAL EQUATION, V396, P7384; Cohen DA, 2012, OBES REV, V13, P766, DOI 10.1111/j.1467-789X.2012.01001.x; Cohen J., 2013, APPL MULTIPLE CORREL, DOI DOI 10.4324/9780203774441; Conradt M, 2008, J CLIN PSYCHOL, V64, P1129, DOI 10.1002/jclp.20501; Dombrowski SU, 2010, OBESITY FACTS, V3, P377, DOI 10.1159/000323076; Duarte C., 2015, CLIN PSYCHOL PSYCHOT; Duarte C, 2015, CLIN PSYCHOL PSYCHOT, V22, P656, DOI 10.1002/cpp.1925; Duarte C, 2014, EAT BEHAV, V15, P638, DOI 10.1016/j.eatbeh.2014.08.025; Dunkley DM, 2007, BEHAV RES THER, V45, P139, DOI 10.1016/j.brat.2006.01.017; Ferreira C, 2013, CLIN PSYCHOL PSYCHOT, V20, P55, DOI 10.1002/cpp.769; Finlayson G, 2008, APPETITE, V50, P120, DOI 10.1016/j.appet.2007.06.007; Finlayson G, 2007, NEUROSCI BIOBEHAV R, V31, P987, DOI 10.1016/j.neubiorev.2007.03.004; Gee A, 2003, Eat Weight Disord, V8, P72; Gilbert P, 2004, BRIT J CLIN PSYCHOL, V43, P31, DOI 10.1348/014466504772812959; GOSS K, 1994, PERS INDIV DIFFER, V17, P713, DOI 10.1016/0191-8869(94)90149-X; Goverment H., 2010, HLTH LIV HLTH PEOPL; Grabhorn M, 2006, CLIN PSYCHOL PSYCHOT, V13, P12, DOI 10.1002/cpp.463; Gratz KL, 2004, J PSYCHOPATHOL BEHAV, V26, P41, DOI 10.1023/B:JOBA.0000007455.08539.94; GREENO CG, 1994, PSYCHOL BULL, V115, P444, DOI 10.1037/0033-2909.115.3.444; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; HEATHERTON TF, 1991, PSYCHOL BULL, V110, P86, DOI 10.1037/0033-2909.110.1.86; Herman C. P., 1980, OBESITY, P208; Jambekar SA, 2003, OBES RES, V11, P571, DOI 10.1038/oby.2003.80; Kelly AC, 2013, BRIT J CLIN PSYCHOL, V52, P148, DOI 10.1111/bjc.12006; Kim S, 2011, PSYCHOL BULL, V137, P68, DOI 10.1037/a0021466; Kline R.B., 2005, PRINCIPLES PRACTICE, V2, DOI DOI 10.1038/156278A0; Koole S, 2009, COGNITION EMOTION, V23, P4, DOI 10.1080/02699930802619031; LAHTEENMAKI L, 1995, PHYSIOL BEHAV, V57, P81, DOI 10.1016/0031-9384(94)00210-V; Latner JD, 2008, INT J OBESITY, V32, P1145, DOI 10.1038/ijo.2008.53; Lemmens SG, 2011, PHYSIOL BEHAV, V103, P157, DOI 10.1016/j.physbeh.2011.01.009; LICHTMAN SW, 1992, NEW ENGL J MED, V327, P1893, DOI 10.1056/NEJM199212313272701; Lillis J, 2014, J CONTEXTUAL BEHAV S, V3, P1, DOI 10.1010/j.jcbs.2013.11.005; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; McPherson K, 2007, TACKLING OBESITIES F; Michie S, 2009, HEALTH PSYCHOL, V28, P690, DOI 10.1037/a0016136; Mueller R. O., 2008, BEST PRACTICES QUANT, P488, DOI [DOI 10.4135/9781412995627.D38, 10.4135/9781412995627.D38]; National Institute for HealthandClinical Excellence, 2006, OB PREV ID ASS MAN O; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; O'Reilly GA, 2014, OBES REV, V15, P453, DOI 10.1111/obr.12156; Pinto-Gouveia J, 2014, CLIN PSYCHOL PSYCHOT, V21, P154, DOI 10.1002/cpp.1820; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Schafer MH, 2011, SOC PSYCHOL QUART, V74, P76, DOI 10.1177/0190272511398197; Silva MN, 2011, MED SCI SPORT EXER, V43, P728, DOI 10.1249/MSS.0b013e3181f3818f; Steele AL, 2011, INT J EAT DISORDER, V44, P459, DOI 10.1002/eat.20817; Stubbs J, 2010, NUTR BULL, V35, P113, DOI 10.1111/j.1467-3010.2010.01827.x; Stubbs RJ, 2013, NUTR BULL, V38, P5, DOI 10.1111/nbu.12002; Stubbs RJ, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2225-0; Stubbs RJ, 2011, OBESITY FACTS, V4, P113, DOI 10.1159/000327249; Stubbs RJ., 2012, OBESITY WEIGHT MANAG; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Swan S, 2003, BRIT J CLIN PSYCHOL, V42, P367, DOI 10.1348/014466503322528919; Swanton K., 2007, LIGHTENING LOAD TACK; Swinburn B, 2002, Obes Rev, V3, P289; Swinburn B, 2004, BMJ-BRIT MED J, V329, P736, DOI 10.1136/bmj.329.7468.736; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Teixeira PJ, 2005, OBES REV, V6, P43, DOI 10.1111/j.1467-789X.2005.00166.x; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; World Healht Organisation, 1998, OB PREV MAN GLOB EP; World Health Organization, 2013, METH SUMM COUNTR PRO; Wright KB, 2005, J COMPUT-MEDIAT COMM, V10	65	32	34	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0167571	10.1371/journal.pone.0167571	http://dx.doi.org/10.1371/journal.pone.0167571			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI3QC	28107449	Green Published, gold, Green Accepted			2022-12-26	WOS:000392405300005
J	Martin, C; Waghela, SD; Lokhandwala, S; Ambrus, A; Bray, J; Vuong, C; Vinodkumar, V; Dominowski, PJ; Rai, S; Mwangi, D; Foss, DL; Mwangi, W				Martin, Cameron; Waghela, Suryakant D.; Lokhandwala, Shehnaz; Ambrus, Andy; Bray, Jocelyn; Vuong, Christina; Vinodkumar, Vanitha; Dominowski, Paul J.; Rai, Sharath; Mwangi, Duncan; Foss, Dennis L.; Mwangi, Waithaka			Characterization of a Broadly Reactive Anti-CD40 Agonistic Monoclonal Antibody for Potential Use as an Adjuvant	PLOS ONE			English	Article							MHC CLASS-II; MATURING DENDRITIC CELLS; CD4(+) T-CELLS; IN-VIVO; NITRIC-OXIDE; CD40 LIGAND; ANTIGEN PRESENTATION; TUMOR-ANTIGEN; B-CELLS; ACTIVATION	Lack of safe and effective adjuvants is a major hindrance to the development of efficacious vaccines. Signaling via CD40 pathway leads to enhanced antigen processing and presentation, nitric oxide expression, pro-inflammatory cytokine expression by antigen presenting cells, and stimulation of B-cells to undergo somatic hypermutation, immunoglobulin class switching, and proliferation. Agonistic anti-CD40 antibodies have shown promising adjuvant qualities in human and mouse vaccine studies. An anti-CD40 monoclonal antibody (mAb), designated 2E4E4, was identified and shown to have strong agonistic effects on primary cells from multiple livestock species. The mAb recognize swine, bovine, caprine, and ovine CD40, and evoked 25-fold or greater proliferation of peripheral blood mononuclear cells (PBMCs) from these species relative to cells incubated with an isotype control (p< 0.001). In addition, the mAb induced significant nitric oxide (p< 0.0001) release by bovine macrophages. Furthermore, the mAb upregulated the expression of MHC-II by PBMCs, and stimulated significant (p< 0.0001) IL-1 alpha, IL6, IL-8, and TNF-alpha expression by PBMCs. These results suggest that the mAb 2E4E4 can target and stimulate cells from multiple livestock species and thus, it is a potential candidate for adjuvant development. This is the first study to report an antiswine CD40 agonistic mAb that is also broadly reactive against multiple species.	[Martin, Cameron; Waghela, Suryakant D.; Lokhandwala, Shehnaz; Ambrus, Andy; Bray, Jocelyn; Vuong, Christina; Vinodkumar, Vanitha; Mwangi, Waithaka] Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Dominowski, Paul J.; Rai, Sharath; Mwangi, Duncan; Foss, Dennis L.] Zoetis, Kalamazoo, MI USA	Texas A&M University System; Texas A&M University College Station; Zoetis	Mwangi, W (corresponding author), Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX 77843 USA.	wmwangi@vet.k-state.edu		Vuong, Christine/0000-0001-8663-6816; Martin, Cameron/0000-0003-0824-3106; Lokhandwala, Shehnaz/0000-0002-0873-8611				Akunda JK, 2001, AM J VET RES, V62, P1040, DOI 10.2460/ajvr.2001.62.1040; Anderson HA, 2000, NAT IMMUNOL, V1, P156, DOI 10.1038/77842; ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G; Bajor DL, 2014, CANCER IMMUNOL RES, V2, P1051, DOI 10.1158/2326-6066.CIR-14-0154; Bajor DL, 2015, AACR 106 ANN M PHIL; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; Banchereau J, 1995, ADV EXP MED BIOL, V378, P79; Barr TA, 2003, IMMUNOLOGY, V109, P87, DOI 10.1046/j.1365-2567.2003.01634.x; Barr TA, 2001, IMMUNOLOGY, V102, P39, DOI 10.1046/j.1365-2567.2001.01148.x; Bishop DGA, 2009, SEMIN IMMUNOL, DOI [10.1046/j.1365-2567.2003.01634.x, DOI 10.1046/J.1365-2567.2003.01634.X]; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; CLARK EA, 1986, P NATL ACAD SCI USA, V83, P4494, DOI 10.1073/pnas.83.12.4494; DEMOTZ S, 1990, SCIENCE, V249, P1028, DOI 10.1126/science.2118680; Diehl S, 2002, J EXP MED, V196, P39, DOI 10.1084/jem.20020026; Fanslow W C, 1994, Semin Immunol, V6, P267, DOI 10.1006/smim.1994.1035; Fournel S, 2005, NAT CHEM BIOL, V1, P377, DOI 10.1038/nchembio746; FOY TM, 1993, J EXP MED, V178, P1567, DOI 10.1084/jem.178.5.1567; FRIES KM, 1995, CLIN IMMUNOL IMMUNOP, V77, P42, DOI 10.1016/0090-1229(95)90135-3; Fujii SI, 2004, J EXP MED, V199, P1607, DOI 10.1084/jem.20040317; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; GALY AHM, 1992, J IMMUNOL, V149, P775; Gladue RP, 2011, CANCER IMMUNOL IMMUN, V60, P1009, DOI 10.1007/s00262-011-1014-6; Grewal IS, 1996, IMMUNOL TODAY, V17, P410, DOI 10.1016/0167-5699(96)10030-X; Grow SI, 2005, ANN NY ACAD SCI, P1049; Haase C, 2004, SCAND J IMMUNOL, V59, P237, DOI 10.1111/j.0300-9475.2004.01390.x; HARDING CV, 1990, NATURE, V346, P574, DOI 10.1038/346574a0; Hatzifoti C, 2007, IMMUNOLOGY, V122, P98, DOI 10.1111/j.1365-2567.2007.02617.x; Hill SC, 2005, J IMMUNOL, V174, P41, DOI 10.4049/jimmunol.174.1.41; Hope JC, 2005, J IMMUNOL METHODS, V301, P114, DOI 10.1016/j.jim.2005.04.010; Hopkins RF, 2012, METHODS MOL BIOL, V801, P251, DOI 10.1007/978-1-61779-352-3_16; Huang HI, 2004, INT J CANCER, V108, P696, DOI 10.1002/ijc.11612; Hurst SM, 2001, IMMUNITY, V14, P705, DOI 10.1016/S1074-7613(01)00151-0; Koch F, 1996, J EXP MED, V184, P741, DOI 10.1084/jem.184.2.741; Kracker Sven, 2004, Methods Mol Biol, V271, P149; Mast J, 1998, VET IMMUNOL IMMUNOP, V61, P343, DOI 10.1016/S0165-2427(97)00152-9; Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002; Mwangi W, 2005, J LEUKOCYTE BIOL, V78, P401, DOI 10.1189/jlb.1204722; Noelle RJ, 1996, IMMUNITY, V4, P415, DOI 10.1016/S1074-7613(00)80408-2; NOELLE RJ, 1992, IMMUNOL TODAY, V13, P431, DOI 10.1016/0167-5699(92)90068-I; Nowak AK, 2015, ANN ONCOL, V26, P2483, DOI 10.1093/annonc/mdv387; Pampusch MS, 1998, VET IMMUNOL IMMUNOP, V61, P279, DOI 10.1016/S0165-2427(97)00139-6; PAULIE S, 1985, CANCER IMMUNOL IMMUN, V20, P23; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; SCHINDLER R, 1990, BLOOD, V75, P40; Serra P, 2003, IMMUNITY, V19, P877, DOI 10.1016/S1074-7613(03)00327-3; Shoda LKM, 1999, J INTERF CYTOK RES, V19, P1169, DOI 10.1089/107999099313118; Staveley-O'Carroll K, 2003, J IMMUNOL, V171, P697, DOI 10.4049/jimmunol.171.2.697; Vonderheide RH, 2007, J CLIN ONCOL, V25, P876, DOI 10.1200/JCO.2006.08.3311; WHITELAND JL, 1995, J HISTOCHEM CYTOCHEM, V43, P313, DOI 10.1177/43.3.7868861; Wu WD, 2009, BIOCHEM BIOPH RES CO, V379, P573, DOI 10.1016/j.bbrc.2008.12.082; Zelnickova P, 2008, NITRIC OXIDE-BIOL CH, V19, P36, DOI 10.1016/j.niox.2008.04.001	51	2	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170504	10.1371/journal.pone.0170504	http://dx.doi.org/10.1371/journal.pone.0170504			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107431	gold, Green Published, Green Submitted			2022-12-26	WOS:000392405300151
J	Sutton, MY; Gray, SC; Elmore, K; Gaul, Z				Sutton, Madeline Y.; Gray, Simone C.; Elmore, Kim; Gaul, Zaneta			Social Determinants of HIV Disparities in the Southern United States and in Counties with Historically Black Colleges and Universities (HBCUs), 2013-2014	PLOS ONE			English	Article							HEALTH; COMMUNITY; PREVENTION; OUTCOMES; DEVELOP	HIV infection disproportionately affects Blacks in the southern United States (U.S.), a region where legal policies that may unintentionally impede earlier HIV detection and treatment are prevalent. Historically Black Colleges and Universities (HBCUs) have historically facilitated social change in communities of color and have been underexplored as partners for HIV prevention. We describe geographic and social determinants of health (SDH) in the southern U.S. to inform potential HBCU-public health partnerships that might improve HIV health equity. We evaluated the relationship between county-level HIV prevalences (2013), HBCU geographic coordinates, and SDH variables in the southern counties with HBCUs. U.S. Census-derived SDH variables included race/ethnicity (i.e., Black, White, Hispanic), unemployment, female head of household, poverty, percent owner-occupied housing units, urbanicity, and primary care provider rates. Associations were assessed using bivariate and multivariable linear regression. Of 104 HBCUs in the contiguous U.S., 100 (96%) were located in 69 southern counties with average Black populations of 40% and an average HIV prevalence of 615. 5 per 100,000, over two times the national rate (295.1 per 100,000). In bivariable analyses, higher HIV rates in these counties were associated with higher percent Black population, unemployment, female head of household, poverty, fewer owner-occupied housing units, and greater urbanicity (p < 0.05). In multivariable analyses, counties with higher HIV rates had higher percentages of Blacks, greater urbanicity, fewer owner-occupied housing units, and more female heads of households (p < 0.05). The southern U.S. is disproportionately affected by HIV, and many HBCUs are located in affected southern counties. HBCUs may be important public health partners for helping to develop structural interventions that strengthen HIV policies in support of health equity in these southern, mostly urban counties.	[Sutton, Madeline Y.; Gray, Simone C.; Elmore, Kim; Gaul, Zaneta] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA; [Gaul, Zaneta] ICF, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Sutton, MY (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA.	msutton@cdc.gov			ICF	ICF	ICF is the employer of one of the coauthors (ZG). ICF provided support in the form of salaries for author (ZG), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section.	Adimora AA, 2006, SEX TRANSM DIS, V33, pS39, DOI 10.1097/01.olq.0000228298.07826.68; Adimora AA, 2014, AIDS, V28, P1393, DOI 10.1097/QAD.0000000000000225; Adimora AA, 2014, JAIDS-J ACQ IMM DEF, V65, P99, DOI 10.1097/QAI.0b013e3182a9c22a; AIDS.gov Conversations on the National HIV/AIDS Strategy, 2012, HISTR BLACK COLL UN; [Anonymous], 2014, HIV SURV REP; [Anonymous], 2015, WHAT THEYRE SAYING R; Baptiste DR, 2005, BEHAV MODIF, V29, P370, DOI 10.1177/0145445504272602; Braveman P, 2014, PUBLIC HEALTH REP, V129, P19, DOI 10.1177/00333549141291S206; Braveman PA, 2011, AM J PUBLIC HEALTH, V101, pS149, DOI 10.2105/AJPH.2010.300062; Brown M.C., 2001, PEABODY J EDUC, V76, P31, DOI [10.1207/S15327930PJE7601_03, DOI 10.1207/S15327930PJE7601_03]; Buot MLG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091711; Carey TS, 2005, ACAD MED, V80, P1039, DOI 10.1097/00001888-200511000-00012; Centers for Disease Control and Prevention, 2010, DIST PUBL HLTH RES P; Corbie-Smith G, 2011, HEALTH PROMOT PRACT, V12, P293, DOI 10.1177/1524839909348766; Dean HD, 2010, PUBLIC HEALTH REP, V125, P1, DOI 10.1177/00333549101250S401; Duffus WA, 2014, AM J PREV MED, V47, pS368, DOI 10.1016/j.amepre.2014.07.028; Duncan A., HBCU VALUE PROPOSITI; Ford O, 2007, THESIS; Free MCG, 2006, UTILIZING STUDENT OR; Fuchs J, 2016, AIDS BEHAV; Gasman M., 2014, TEXAS ED REV, V2, P75; Gasman M., CHANGING FACE HIS BL; Gasman M., 2009, HIST BLACK COLLEGES; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jaeger A.J., 2013, J AFRICAN AM MALES E, V4, P124; Kreuter MW, 2011, AM J PUBLIC HEALTH, V101, pS188, DOI 10.2105/AJPH.2011.300122; Lee JM, 201301 APLU OFF ACC; Meditz AL, 2011, J INFECT DIS, V203, P442, DOI 10.1093/infdis/jiq085; Noonan A, 2013, AM J PUBLIC HEALTH, V103, P412, DOI 10.2105/AJPH.2012.300726; Obama President Barack, 2020 VISION ADDRESSI; Ofili EO, 2013, CTS-CLIN TRANSL SCI, V6, P435, DOI 10.1111/cts.12118; Reif S, 2015, J COMMUN HEALTH, V40, P642, DOI 10.1007/s10900-014-9979-7; Rosenberg Eli Samuel, 2016, JMIR Public Health Surveill, V2, pe22, DOI 10.2196/publichealth.5684; Song RG, 2012, JP J BIOSTAT, V7, P1; Southern HIV/AIDS Strategy Initiative, HIV AIDS CAR PREV IN; Southern HIV/AIDS Strategy Initiative, MED EXP S; Sullivan PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090514; The Black AIDS Institute, HBCU STUD LEAD PLEDG; The Office of National AIDS Policy, NAT HIV AIDS STRAT U; The White House, 2010, EX 13532 D PROM EXC; THOMAS SB, 1991, AM J PUBLIC HEALTH, V81, P1498, DOI 10.2105/AJPH.81.11.1498; United States Census Bureau, ANN EST RES POP APR; Upton R, ROLE HIST BLACK COLL; US Census Bureau, AM COMMUNITY SURVEY; Whetten K, 2006, AM J PUBLIC HEALTH, V96, P716, DOI 10.2105/AJPH.2005.063255; Zhang S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096148	46	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170714	10.1371/journal.pone.0170714	http://dx.doi.org/10.1371/journal.pone.0170714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI3QC	28107532	Green Published, Green Submitted, gold			2022-12-26	WOS:000392405300179
J	Burley, DT; Gray, NS; Snowden, RJ				Burley, Daniel T.; Gray, Nicola S.; Snowden, Robert J.			As Far as the Eye Can See: Relationship between Psychopathic Traits and Pupil Response to Affective Stimuli	PLOS ONE			English	Article							ANTISOCIAL PERSONALITY-DISORDER; TRIARCHIC CONCEPTUALIZATION; STARTLE REFLEX; CRIMINAL PSYCHOPATHS; FACIAL EXPRESSIONS; GENDER-DIFFERENCES; EMOTIONAL REACTIVITY; RECOGNITION DEFICITS; FEARFUL EXPRESSIONS; AMYGDALA RESPONSE	Psychopathic individuals show a range of affective processing deficits, typically associated with the interpersonal/affective component of psychopathy. However, previous research has been inconsistent as to whether psychopathy, within both offender and community populations, is associated with deficient autonomic responses to the simple presentation of affective stimuli. Changes in pupil diameter occur in response to emotionally arousing stimuli and can be used as an objective indicator of physiological reactivity to emotion. This study used pupillometry to explore whether psychopathic traits within a community sample were associated with hypo-responsivity to the affective content of stimuli. Pupil activity was recorded for 102 adult (52 female) community participants in response to affective (both negative and positive affect) and affectively neutral stimuli, that included images of scenes, static facial expressions, dynamic facial expressions and sound-clips. Psychopathic traits were measured using the Triarchic Psychopathy Measure. Pupil diameter was larger in response to negative stimuli, but comparable pupil size was demonstrated across pleasant and neutral stimuli. A linear relationship between subjective arousal and pupil diameter was found in response to sound-clips, but was not evident in response to scenes. Contrary to predictions, psychopathy was unrelated to emotional modulation of pupil diameter across all stimuli. The findings were the same when participant gender was considered. This suggests that psychopathy within a community sample is not associated with autonomic hypo-responsivity to affective stimuli, and this effect is discussed in relation to later defensive/appetitive mobilisation deficits.	[Burley, Daniel T.; Snowden, Robert J.] Cardiff Univ, Sch Psychol, Cardiff, S Glam, Wales; [Gray, Nicola S.] Swansea Univ, Dept Psychol, Coll Human & Hlth Sci, Swansea, W Glam, Wales; [Gray, Nicola S.] Abertawe Bromorgannwg Univ Hlth Board, Swansea, W Glam, Wales	Cardiff University; Swansea University	Burley, DT; Snowden, RJ (corresponding author), Cardiff Univ, Sch Psychol, Cardiff, S Glam, Wales.	BurleyD2@Cardiff.ac.uk; Snowden@Cardiff.ac.uk		Gray, Nicola Susan/0000-0003-3849-8118	Wellcome Trust; ISSF Seedcorn Grant [504181]; School of Psychology at Cardiff University	Wellcome Trust(Wellcome TrustEuropean Commission); ISSF Seedcorn Grant; School of Psychology at Cardiff University	The current research was funded by the Wellcome Trust (http://wellcome.ac.uk/). The funding was an ISSF Seedcorn Grant (504181) awarded to Professor Snowden (42,189) pound. Additionally, Daniel T. Burley received funding from the School of Psychology at Cardiff University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 1999, NEUROPSYCHOLOGIA, V37, P1111, DOI 10.1016/S0028-3932(99)00039-1; ADOLPHS R, 1995, J NEUROSCI, V15, P5879; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Aguinis H., 2004, REGRESSION ANAL CATE; APPLEGATE CD, 1983, PHYSIOL BEHAV, V31, P353, DOI 10.1016/0031-9384(83)90201-9; Arriaga P, 2015, PSYCHOL VIOLENCE, V5, P199, DOI 10.1037/a0037260; Babiker A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01921; Barbur JL, 2004, THE VISUAL NEUROSCIE, P641; Barke A, 2012, J BEHAV THER EXP PSY, V43, P565, DOI 10.1016/j.jbtep.2011.07.006; Baskin-Sommers AR, 2011, PSYCHOL SCI, V22, P226, DOI 10.1177/0956797610396227; Bate C, 2014, J FORENSIC PSYCHI PS, V25, P600, DOI 10.1080/14789949.2014.943798; Benning SD, 2005, PSYCHOPHYSIOLOGY, V42, P753, DOI 10.1111/j.1469-8986.2005.00353.x; Bianchin M, 2012, PHYSIOL BEHAV, V105, P925, DOI 10.1016/j.physbeh.2011.10.031; Birbaumer N, 2005, ARCH GEN PSYCHIAT, V62, P799, DOI 10.1001/archpsyc.62.7.799; Blagov P. S., 2016, J PERS DISORD, V29, P182, DOI DOI 10.1521/PEDI_; Blair KS, 2006, BIOL PSYCHOL, V73, P114, DOI 10.1016/j.biopsycho.2005.12.006; Blair RJR, 1999, PERS INDIV DIFFER, V27, P135, DOI 10.1016/S0191-8869(98)00231-1; Blair RJR, 2004, PERS INDIV DIFFER, V37, P1111, DOI 10.1016/j.paid.2003.10.008; Blair RJR, 2001, J ABNORM CHILD PSYCH, V29, P491, DOI 10.1023/A:1012225108281; Blair RJR, 1997, PSYCHOPHYSIOLOGY, V34, P192; Bowen KL, 2014, J PSYCHOPATHOL BEHAV, V36, P60, DOI 10.1007/s10862-013-9368-z; Bradley M. M., 2007, B3 U FLOR; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Bradley MM, 2015, PSYCHOPHYSIOLOGY, V52, P1186, DOI 10.1111/psyp.12442; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; Bradley MM, 2001, EMOTION, V1, P300, DOI 10.1037//1528-3542.1.3.300; Bradley MM, 2009, PSYCHOPHYSIOLOGY, V46, P1, DOI 10.1111/j.1469-8986.2008.00702.x; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Brook M, 2013, CLIN PSYCHOL REV, V33, P979, DOI 10.1016/j.cpr.2013.07.008; Burkhouse KL, 2015, J ABNORM PSYCHOL, V124, P498, DOI 10.1037/abn0000072; Calder AJ, 1996, COGNITIVE NEUROPSYCH, V13, P699, DOI 10.1080/026432996381890; Canli T, 2002, SCIENCE, V296, P2191, DOI 10.1126/science.1068749; Codispoti M, 2008, INT J PSYCHOPHYSIOL, V69, P90, DOI 10.1016/j.ijpsycho.2008.03.004; Coid J, 2008, SOC PSYCH PSYCH EPID, V43, P773, DOI 10.1007/s00127-008-0363-8; Coid J, 2009, INT J LAW PSYCHIAT, V32, P134, DOI 10.1016/j.ijlp.2009.02.008; Coid J, 2009, INT J LAW PSYCHIAT, V32, P65, DOI 10.1016/j.ijlp.2009.01.002; Contreras-Rodriguez O, 2014, SOC COGN AFFECT NEUR, V9, P505, DOI 10.1093/scan/nst014; Craig RL, 2013, PERS INDIV DIFFER, V55, P345, DOI 10.1016/j.paid.2013.03.012; Dawel A, 2012, NEUROSCI BIOBEHAV R, V36, P2288, DOI 10.1016/j.neubiorev.2012.08.006; Decety J, 2013, JAMA PSYCHIAT, V70, P638, DOI 10.1001/jamapsychiatry.2013.27; Dietz J, 2011, NEUROPSYCHOLOGIA, V49, P3247, DOI 10.1016/j.neuropsychologia.2011.07.029; Dolan M, 2006, PSYCHOL MED, V36, P1563, DOI 10.1017/S0033291706008634; Dolan MC, 2009, BIOL PSYCHIAT, V66, P570, DOI 10.1016/j.biopsych.2009.03.019; Drislane LE, 2014, PSYCHOL ASSESSMENT, V26, P350, DOI 10.1037/a0035152; Duque A, 2014, COGNITION EMOTION, V28, P1347, DOI 10.1080/02699931.2014.881327; Edens JF, 2006, J ABNORM PSYCHOL, V115, P131, DOI 10.1037/0021-843X.115.1.131; Esteller A, 2016, BIOL PSYCHOL, V117, P131, DOI 10.1016/j.biopsycho.2016.03.012; Farzin F, 2009, J AUTISM DEV DISORD, V39, P946, DOI 10.1007/s10803-009-0744-1; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Flor H, 2002, PSYCHOPHYSIOLOGY, V39, P505, DOI 10.1017/S0048577202394046; Forouzan E, 2005, BEHAV SCI LAW, V23, P765, DOI 10.1002/bsl.669; Fridlund AJ, 2014, HUMAN FACIAL EXPRESS; Geangu E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027132; Gloor P., 1997, TEMPORAL LOBE LIMBIC; Guay JP, 2007, J ABNORM PSYCHOL, V116, P701, DOI 10.1037/0021-843X.116.4.701; Hamann SB, 1996, NATURE, V379, P497, DOI 10.1038/379497a0; Han T, 2012, SOC COGN AFFECT NEUR, V7, P958, DOI 10.1093/scan/nsr068; Hare RD., 2003, MANUAL REVISED PSYCH, V2; Harenski CL, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00741; Harenski CL, 2009, COGN AFFECT BEHAV NE, V9, P1, DOI 10.3758/CABN.9.1.1; Hastings ME, 2008, PERS INDIV DIFFER, V44, P1474, DOI 10.1016/j.paid.2008.01.004; Henderson RR, 2014, PSYCHOPHYSIOLOGY, V51, P815, DOI 10.1111/psyp.12236; Herpertz SC, 2001, ARCH GEN PSYCHIAT, V58, P737, DOI 10.1001/archpsyc.58.8.737; Hyde LW, 2014, J ABNORM PSYCHOL, V123, P214, DOI 10.1037/a0035467; Ishikawa SS, 2001, J ABNORM PSYCHOL, V110, P423, DOI 10.1037/0021-843X.110.3.423; Jin AB, 2015, INT J PSYCHOPHYSIOL, V97, P66, DOI 10.1016/j.ijpsycho.2015.04.014; Justus AN, 2007, PERS INDIV DIFFER, V43, P2057, DOI 10.1016/j.paid.2007.06.020; Kiehl KA, 2001, BIOL PSYCHIAT, V50, P677, DOI 10.1016/S0006-3223(01)01222-7; Kosson DS, 2006, J ABNORM PSYCHOL, V115, P798, DOI 10.1037/0021-843X.115.4.798; Kret ME, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00810; Kuchinke L, 2011, NEUROPSYCHOLOGIA, V49, P331, DOI 10.1016/j.neuropsychologia.2010.12.026; Lang P.J., 2008, A8 U FLOR; Lang PJ, 2010, BIOL PSYCHOL, V84, P437, DOI 10.1016/j.biopsycho.2009.10.007; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; Larson CL, 2013, COGN AFFECT BEHAV NE, V13, P757, DOI 10.3758/s13415-013-0172-8; Lee BT, 2008, PROG NEURO-PSYCHOPH, V32, P778, DOI 10.1016/j.pnpbp.2007.12.009; Lemaire M, 2014, PSYCHIAT RES, V220, P294, DOI 10.1016/j.psychres.2014.07.002; Leppanen JM, 2007, BRAIN RES, V1166, P103, DOI 10.1016/j.brainres.2007.06.060; LEVENSON RW, 1992, PSYCHOL SCI, V3, P23, DOI 10.1111/j.1467-9280.1992.tb00251.x; Levenston GK, 2000, J ABNORM PSYCHOL, V109, P373, DOI 10.1037//0021-843X.109.3.373; Lilienfeld S, 2005, PPI R PROFESSIONAL M; Lilienfeld SO, 2015, META ANALYTIC RELATI; Lopez R, 2013, PSYCHOPHYSIOLOGY, V50, P210, DOI 10.1111/j.1469-8986.2012.01493.x; Lorber MF, 2004, PSYCHOL BULL, V130, P531, DOI 10.1037/0033-2909.130.4.531; Marcus DK, 2006, PSYCHOL MED, V36, P1571, DOI 10.1017/S0033291706008245; Marion BE, 2013, LAW HUMAN BEHAV, V37, P219, DOI 10.1037/lhb0000008; Medina AL, 2016, INTERNATIONAL JOURNA; Meffert H, 2013, BRAIN, V136, P2550, DOI 10.1093/brain/awt190; Mier D, 2014, WORLD J BIOL PSYCHIA, V15, P479, DOI 10.3109/15622975.2014.902541; Mitchell DGV, 2006, J ABNORM PSYCHOL, V115, P559, DOI 10.1037/0021-843X.115.3.559; Morris J, 1996, NATURE, V384, P325, DOI 10.1038/384325b0; Morrison SE, 2010, CURR OPIN NEUROBIOL, V20, P221, DOI 10.1016/j.conb.2010.02.007; Most SB, 2007, COGNITION EMOTION, V21, P964, DOI 10.1080/02699930600959340; MOULDEN B, 1990, PERCEPTION, V19, P79, DOI 10.1068/p190079; Muller JL, 2003, BIOL PSYCHIAT, V54, P152, DOI 10.1016/S0006-3223(02)01749-3; Murrie DC, 2007, J CHILD PSYCHOL PSYC, V48, P714, DOI 10.1111/j.1469-7610.2007.01734.x; Neumann CS, 2008, J CONSULT CLIN PSYCH, V76, P893, DOI 10.1037/0022-006X.76.5.893; Newman JP, 2010, BIOL PSYCHIAT, V67, P66, DOI 10.1016/j.biopsych.2009.07.035; Nuske HJ, 2014, BIOL PSYCHOL, V101, P24, DOI 10.1016/j.biopsycho.2014.07.003; OGLOFF JRP, 1990, CRIM JUSTICE BEHAV, V17, P231, DOI 10.1177/0093854890017002006; Partala T, 2003, INT J HUM-COMPUT ST, V59, P185, DOI 10.1016/S1071-5819(03)00017-X; Pastor MC, 2003, PSYCHOPHYSIOLOGY, V40, P934, DOI 10.1111/1469-8986.00111; Patrick C.J., 2010, TRIARCHIC PSYCHOPATH; Patrick CJ, 2015, J PERS, V83, P627, DOI 10.1111/jopy.12119; Patrick CJ, 2009, DEV PSYCHOPATHOL, V21, P913, DOI 10.1017/S0954579409000492; PATRICK CJ, 1993, J ABNORM PSYCHOL, V102, P82, DOI 10.1037/0021-843X.102.1.82; Pham TH, 2000, ENCEPHALE, V26, P45; Posamentier MT, 2003, NEUROPSYCHOL REV, V13, P113, DOI 10.1023/A:1025519712569; Poy R, 2014, PSYCHOL ASSESSMENT, V26, P69, DOI 10.1037/a0034642; Prehn K, 2013, PSYCHOPHYSIOLOGY, V50, P528, DOI 10.1111/psyp.12042; Prehn K, 2013, SOC NEUROSCI-UK, V8, P136, DOI 10.1080/17470919.2012.686923; Pujol J, 2012, SOC COGN AFFECT NEUR, V7, P917, DOI 10.1093/scan/nsr075; Ragsdale KA, 2013, PSYCHIAT RES, V210, P1000, DOI 10.1016/j.psychres.2013.07.027; Recio G, 2011, BRAIN RES, V1376, P66, DOI 10.1016/j.brainres.2010.12.041; Rilling JK, 2007, BIOL PSYCHIAT, V61, P1260, DOI 10.1016/j.biopsych.2006.07.021; Rymarczyk K, 2011, INT J PSYCHOPHYSIOL, V79, P330, DOI 10.1016/j.ijpsycho.2010.11.001; Sarlo M, 2005, BIOL PSYCHOL, V70, P188, DOI 10.1016/j.biopsycho.2005.01.005; Sato W, 2008, INT J PSYCHOPHYSIOL, V70, P70, DOI 10.1016/j.ijpsycho.2008.06.001; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Sellbom M, 2013, J ABNORM PSYCHOL, V122, P208, DOI 10.1037/a0029306; Sepeta L, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-17; Siegle GJ, 2003, NEUROIMAGE, V20, P114, DOI 10.1016/S1053-8119(03)00298-2; Siegle GJ, 2007, BIOL PSYCHIAT, V61, P198, DOI 10.1016/j.biopsych.2006.05.048; Siegle GJ, 2011, BIOL PSYCHIAT, V69, P726, DOI 10.1016/j.biopsych.2010.12.041; Simons RF, 1999, PSYCHOPHYSIOLOGY, V36, P619, DOI 10.1017/S0048577299980976; Snowden RJ., 2016, PSYCHOPHYSIOLOGY; Somerville LH, 2004, BIOL PSYCHIAT, V55, P897, DOI 10.1016/j.biopsych.2004.01.007; Stanley JH, 2013, J PERS ASSESS, V95, P343, DOI 10.1080/00223891.2012.735302; Steidtmann D, 2010, COGNITION EMOTION, V24, P480, DOI 10.1080/02699930902738897; Steinhauer SR, 2004, INT J PSYCHOPHYSIOL, V52, P77, DOI 10.1016/j.ijpsycho.2003.12.005; Stevenson RA, 2008, BEHAV RES METHODS, V40, P315, DOI 10.3758/BRM.40.1.315; Strickland CM, 2013, ASSESSMENT, V20, P327, DOI 10.1177/1073191113486691; Sutton SK, 2002, J ABNORM PSYCHOL, V111, P610, DOI 10.1037//0021-843X.111.4.610; Thomas KM, 2001, BIOL PSYCHIAT, V49, P309, DOI 10.1016/S0006-3223(00)01066-0; Tukey JW, 1977, EXPLORATORY DATA ANA; URSIN H, 1960, ELECTROEN CLIN NEURO, V12, P1, DOI 10.1016/0013-4694(60)90058-4; Vaidyanathan U, 2011, J ABNORM PSYCHOL, V120, P253, DOI 10.1037/a0021224; van der Schalk J, 2011, EMOTION, V11, P907, DOI 10.1037/a0023853; Vanman EJ, 2003, PERS INDIV DIFFER, V35, P2007, DOI 10.1016/S0191-8869(03)00052-7; VANSTEENBERGEN H, 2011, FRONT PSYCHOL, V2, P1; Venables NC, 2014, PSYCHOL MED, V44, P1005, DOI 10.1017/S003329171300161X; Verona E, 2004, J ABNORM PSYCHOL, V113, P99, DOI 10.1037/0021-843X.113.1.99; WALLBOTT HG, 1993, EUR J SOC PSYCHOL, V23, P427, DOI 10.1002/ejsp.2420230408; WALLIN BG, 1981, PSYCHOPHYSIOLOGY, V18, P470, DOI 10.1111/j.1469-8986.1981.tb02483.x; Walters GD, 2007, ASSESSMENT, V14, P270, DOI 10.1177/1073191107299594; Wang P, 2012, J ABNORM CHILD PSYCH, V40, P759, DOI 10.1007/s10802-011-9606-3; Weinberg A, 2010, EMOTION, V10, P767, DOI 10.1037/a0020242; Weyers P, 2006, PSYCHOPHYSIOLOGY, V43, P450, DOI 10.1111/j.1469-8986.2006.00451.x; White TL, 1999, J PERS SOC PSYCHOL, V77, P863, DOI 10.1037/0022-3514.77.4.863; WILLIAMSON S, 1991, PSYCHOPHYSIOLOGY, V28, P260, DOI 10.1111/j.1469-8986.1991.tb02192.x; Wilson K, 2011, CRIM JUSTICE BEHAV, V38, P659, DOI 10.1177/0093854811404120; Wrase J, 2003, NEUROSCI LETT, V348, P41, DOI 10.1016/S0304-3940(03)00565-2; Zimak EH, 2014, J PSYCHOPATHOL BEHAV, V36, P542, DOI 10.1007/s10862-014-9430-5	154	21	21	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2017	12	1							e0167436	10.1371/journal.pone.0167436	http://dx.doi.org/10.1371/journal.pone.0167436			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7CU	28118366	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000396160500054
J	Guerrero, J; Oliver, G; Valero, O				Guerrero, Jose; Oliver, Gabriel; Valero, Oscar			Multi-Robot Coalitions Formation with Deadlines: Complexity Analysis and Solutions	PLOS ONE			English	Article							TASK ALLOCATION; ALGORITHMS; ASSIGNMENT	Multi-robot task allocation is one of the main problems to address in order to design a multi-robot system, very especially when robots form coalitions that must carry out tasks before a deadline. A lot of factors affect the performance of these systems and among them, this paper is focused on the physical interference effect, produced when two or more robots want to access the same point simultaneously. To our best knowledge, this paper presents the first formal description of multi-robot task allocation that includes a model of interference. Thanks to this description, the complexity of the allocation problem is analyzed. Moreover, the main contribution of this paper is to provide the conditions under which the optimal solution of the aforementioned allocation problem can be obtained solving an integer linear problem. The optimal results are compared to previous allocation algorithms already proposed by the first two authors of this paper and with a new method proposed in this paper. The results obtained show how the new task allocation algorithms reach up more than an 80% of the median of the optimal solution, outperforming previous auction algorithms with a huge reduction of the execution time.	[Guerrero, Jose; Oliver, Gabriel; Valero, Oscar] Univ Balearic Isl, Dept Math & Comp Sci, Palma De Mallorca, Illes Balears, Spain	Universitat de les Illes Balears	Guerrero, J (corresponding author), Univ Balearic Isl, Dept Math & Comp Sci, Palma De Mallorca, Illes Balears, Spain.	jose.guerrero@uib.es	Oliver-Codina, Gabriel/J-7749-2013; Guerrero, José/L-1876-2014; Valero, Oscar/L-1874-2014	Oliver-Codina, Gabriel/0000-0001-6910-1940; Guerrero, José/0000-0002-4772-6568; Valero, Oscar/0000-0003-4710-1338	FEDER;  [DPI2014-57746-C03-2-R]	FEDER(European Commission); 	This work has been partially supported by project DPI2014-57746-C03-2-R and FEDER funds.	Agarwal M, 2014, EXPERT SYST APPL, V41, P3736, DOI 10.1016/j.eswa.2013.11.044; Alan F. T., 2009, ENCY COMPLEXITY SYST, P3682, DOI 10.1007/978-0-387-30440-3_217; BALAS E, 1976, SIAM REV, V18, P710, DOI 10.1137/1018115; Balas E, 2008, J SCHEDULING, V11, P253, DOI 10.1007/s10951-008-0067-7; Bayram H, 2015, SPRINGER TRAC ADV RO, V107, P37, DOI 10.1007/978-3-319-16595-0_3; Campbell A, 2008, P 10 ANN C GEN EV CO, P201; Cao YU, 1997, AUTON ROBOT, V4, P7, DOI 10.1023/A:1008855018923; Chen D.S., 2010, APPL INTEGER PROGRAM; Chinneck JW, 2015, PRACTICAL OPTIMIZATI; Dahl TS, 2009, ROBOT AUTON SYST, V57, P674, DOI 10.1016/j.robot.2008.12.001; Dawson S, 2011, INTELLIGENT CONTROL, V2, P133, DOI [10.4236/ica.2011.22016, DOI 10.4236/ICA.2011.22016]; Ducatelle F, 2009, IDSIA0109; Fang Tang, 2005, 2005 IEEE/RSJ International Conference on Intelligent Robots and Systems, P2606; GAREY MR, 1978, J ACM, V25, P499, DOI 10.1145/322077.322090; Gendreau M, 2010, 201004 CIRRELT INT R; Gerkey BP, 2004, INT J ROBOT RES, V23, P939, DOI 10.1177/0278364904045564; Gerkey BP, 2003, PROCEEDINGS OF THE 11TH INTERNATIONAL CONFERENCE ON ADVANCED ROBOTICS 2003, VOL 1-3, P317; Gerkey BP, 2003, MULTIROBOT TASK ALLO; Guerrero J., 2016, ROBOTICS YOUTUBE CHA; Guerrero J, 2006, DIS 2006: IEEE WORKSHOP ON DISTRIBUTED INTELLIGENT SYSTEMS: COLLECTIVE INTELLIGENCE AND ITS APPLICATIONS, PROCEEDINGS, P19; Guerrero J, 2012, ROBOT AUTON SYST, V60, P1295, DOI 10.1016/j.robot.2012.06.004; Jones E. G., 2007, P IEEE RSJ INT C INT, P2308, DOI DOI 10.1109/IROS.2007.4399534; Jones EG, 2009, ROBOTICS SCI SYSTEMS; Khaluf Y, 2016, SOFT COMPUT, V20, P37, DOI 10.1007/s00500-015-1958-0; Koes Mary, 2005, AAAI, V5, P1292; Lemaire T, 2004, IEEE INT CONF ROBOT, P3622, DOI 10.1109/ROBOT.2004.1308816; Lerman K, 2002, AUTON ROBOT, V13, P127, DOI 10.1023/A:1019633424543; Lingli Yu, 2009, Proceedings of the 2009 Fifth International Conference on Natural Computation (ICNC 2009), P583, DOI 10.1109/ICNC.2009.15; Low KH, 2004, PROCEEDING OF THE NINETEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND THE SIXTEENTH CONFERENCE ON INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE, P28; Luo LZ, 2015, IEEE T AUTOM SCI ENG, V12, P876, DOI 10.1109/TASE.2015.2438032; Melvin J, 2007, 2007 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-9, P2338; Nam C, 2014, IEEE INT CONF ROBOT, P2158, DOI 10.1109/ICRA.2014.6907156; Nunes E, 2016, 16007 TR U MINN; Nunes E, 2012, INT C AUT AG MULT SY, V3, P1211; Paquet S., 2006, DISTRIBUTED DECISION; Pini G, 2009, ICINCO 2009: PROCEEDINGS OF THE 6TH INTERNATIONAL CONFERENCE ON INFORMATICS IN CONTROL, AUTOMATION AND ROBOTICS, VOL 2, P52; Rosenfeld A, 2006, COORDINATION OF LARGE-SCALE MULTIAGENT SYSTEMS, P27, DOI 10.1007/0-387-27972-5_2; Rubenstein M., 2013, P 2013 INT C AUT AG, P47, DOI DOI 10.5555/2484920.2484932; Rubenstein M, 2014, SCIENCE, V345, P795, DOI 10.1126/science.1254295; Sellner B, 2008, IEEE INT CONF ROBOT, P1365, DOI 10.1109/ROBOT.2008.4543393; Service T, 2010, COALITION FORMATION; Shehory O, 1998, ARTIF INTELL, V101, P165, DOI 10.1016/S0004-3702(98)00045-9; SMITH RG, 1980, IEEE T COMPUT, V29, P1104, DOI 10.1109/TC.1980.1675516; Smith SL, 2009, SYST CONTROL LETT, V58, P709, DOI 10.1016/j.sysconle.2009.07.001; Thamilselvan R, 2009, INT J COMPUTER SCI I, V2, P134; Vaughan R. T., 2008, ARTIF LIFE, P337; Vig L, 2006, MULTIROBOT COALITION; Vig L, 2006, DISTRIBUTED AUTONOMOUS ROBOTIC SYSTEMS 7, P227, DOI 10.1007/4-431-35881-1_23; Vygen J, 2011, COMBINATORIAL OPTIMI	50	11	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2017	12	1							e0170659	10.1371/journal.pone.0170659	http://dx.doi.org/10.1371/journal.pone.0170659			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7CU	28118384	gold, Green Published, Green Submitted			2022-12-26	WOS:000396160500017
J	Forss, J; Lindh, MV; Pinhassi, J; Welander, U				Forss, Jorgen; Lindh, Markus V.; Pinhassi, Jarone; Welander, Ulrika			Microbial Biotreatment of Actual Textile Wastewater in a Continuous Sequential Rice Husk Biofilter and the Microbial Community Involved	PLOS ONE			English	Article							AZO DYES; AROMATIC-AMINES; DEGRADATION; IDENTIFICATION; EFFLUENT; DECOLORIZATION; BIODEGRADATION; BIOREMEDIATION; AZOREDUCTASE; REDUCTION	Textile dying processes often pollute wastewater with recalcitrant azo and anthraquinone dyes. Yet, there is little development of effective and affordable degradation systems for textile wastewater applicable in countries where water technologies remain poor. We determined biodegradation of actual textile wastewater in biofilters containing rice husks by spectrophotometry and liquid chromatography mass spectrometry. The indigenous micro flora from the rice husks consistently performed >90% decolorization at a hydraulic retention time of 67 h. Analysis of microbial community composition of bacterial 16S rRNA genes and fungal internal transcribed spacer (ITS) gene fragments in the biofilters revealed a bacterial consortium known to carry azoreductase genes, such as Dysgonomonas, and Pseudomonas and the presence of fungal phylotypes such as Gibberella and Fusarium. Our findings emphasize that rice husk biofilters support a microbial community of both bacteria and fungi with key features for biodegradation of actual textile wastewater. These results suggest that microbial processes can substantially contribute to efficient and reliable degradation of actual textile wastewater. Thus, development of biodegradation systems holds promise for application of affordable wastewater treatment in polluted environments.	[Forss, Jorgen; Welander, Ulrika] Linnaeus Univ, Fac Technol, Vaxjo, Sweden; [Lindh, Markus V.; Pinhassi, Jarone] Linnaeus Univ, Ctr Ecol & Evolut Microbial Model Syst, Kalmar, Sweden	Linnaeus University; Linnaeus University	Forss, J (corresponding author), Linnaeus Univ, Fac Technol, Vaxjo, Sweden.	jorgen.forss@lnu.se		Forss, Jorgen/0000-0001-8179-1446	Swedish International Development Cooperation Agency-Sida; Swedish Association of Graduate Engineers; Swedish Research Council Formas	Swedish International Development Cooperation Agency-Sida; Swedish Association of Graduate Engineers; Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	This work was supported by Swedish International Development Cooperation Agency-Sida; The Swedish Association of Graduate Engineers; The Swedish Research Council Formas.	Alvarez MS, 2015, BIORESOURCE TECHNOL, V198, P181, DOI 10.1016/j.biortech.2015.08.125; Ang TN, 2012, BIORESOUR TECHNOL; Angelova B, 2008, BIODEGRADATION, V19, P387, DOI 10.1007/s10532-007-9144-4; Bisschops I, 2003, ENVIRON TECHNOL, V24, P1399, DOI 10.1080/09593330309385684; Brede C, 2003, J CHROMATOGR A, V983, P35, DOI 10.1016/S0021-9673(02)01652-7; Cervantes FJ, 2011, REV ENVIRON SCI BIO, V10, P125, DOI 10.1007/s11157-011-9228-9; Chen HZ, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-13; Dafale N, 2010, ENVIRON REV, V18, P21, DOI 10.1139/A10-001; Dey S., 2015, RESOURCES ENV, V5, P15, DOI [10.5923/j.re.20150501.03, DOI 10.5923/J.RE.20150501.03]; Forss J, 2013, BIORESOURCE TECHNOL, V130, P681, DOI 10.1016/j.biortech.2012.12.097; Franca RDG, 2015, WATER RES, V85, P327, DOI 10.1016/j.watres.2015.08.043; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Griekspoor A, 2012, 4PEAKS; GROENEWEGEN PEJ, 1992, J GEN MICROBIOL, V138, P1599, DOI 10.1099/00221287-138-8-1599; Khalid A, 2012, APPL MICROBIOL BIOT, V96, P1599, DOI 10.1007/s00253-012-3877-7; Kobya M, 2016, CHEM ENG PROCESS, V101, P87, DOI 10.1016/j.cep.2015.11.012; Kudlich M, 1996, APPL MICROBIOL BIOT, V46, P597, DOI 10.1007/s002530050867; Leite GM, 2012, J MICROBIOL METH, V88, P413, DOI 10.1016/j.mimet.2012.01.011; Ling YF, 2016, CHEM ENG J, V286, P571, DOI 10.1016/j.cej.2015.10.104; Loick N, 2009, CRIT REV ENV SCI TEC, V39, P271, DOI 10.1080/10643380701413682; Lotito AM, 2012, INT BIODETER BIODEGR, V69, P62, DOI 10.1016/j.ibiod.2012.01.004; Madigan MT, 2009, BROCK BIOL MICROORGA; Makarenko AA, 2005, APPL BIOCHEM MICRO+, V41, P457, DOI 10.1007/s10438-005-0081-x; Mansaray KG, 1997, ENERG SOURCE, V19, P989, DOI 10.1080/00908319708908904; MEMBRE JM, 1994, APPL ENVIRON MICROB, V60, P2017; Michielse CB, 2012, MOL PLANT PATHOL, V13, P1089, DOI 10.1111/j.1364-3703.2012.00818.x; Morrison JM, 2012, ANAEROBE, V18, P229, DOI 10.1016/j.anaerobe.2011.12.006; Muthukani C, 2015, J IND POLLUTION CONT, V31, P83; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Muyzer G, 1998, DENATURING GRADIENT; Pandey A, 2007, INT BIODETER BIODEGR, V59, P73, DOI 10.1016/j.ibiod.2006.08.006; Punzi M, 2015, CHEM ENG J, V270, P290, DOI 10.1016/j.cej.2015.02.042; Rafii F, 1995, ENVIRON HEALTH PERSP, V103, P17, DOI 10.2307/3432471; Rafin C, 2006, NEW FRONTIERS ENV RE; Riemann L, 2000, APPL ENVIRON MICROB, V66, P578, DOI 10.1128/AEM.66.2.578-587.2000; Alaejos MS, 2008, J CHROMATOGR B, V862, P15, DOI 10.1016/j.jchromb.2007.11.040; Saratale RG, 2011, J TAIWAN INST CHEM E, V42, P138, DOI 10.1016/j.jtice.2010.06.006; Sarti A, 2010, PROCESS BIOCHEM, V45, P164, DOI 10.1016/j.procbio.2009.09.002; Savin II, 2008, ENVIRON ENG MANAG J, V7, P859, DOI 10.30638/eemj.2008.113; Singh Davinder, 2013, International Journal of Environmental Sciences, V3, P1271, DOI 10.6088/ijes.2013030400006; Singh P, 2010, REV ENVIRON SCI BIO, V9, P141, DOI 10.1007/s11157-010-9200-0; Sipma J, 2010, CRIT REV ENV SCI TEC, V40, P147, DOI 10.1080/10643380802039329; Solis M, 2012, PROCESS BIOCH; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Verhagen P, 2011, APPL ENV MICROBIOL, V77; Vijayalakshmidevi SR, 2015, ECOTOX ENVIRON SAFE, V114, P23, DOI 10.1016/j.ecoenv.2014.09.039; Visser M, 2013, COMPLETE GENOME SEQU; Viswanath Buddolla, 2014, Enzyme Res, V2014, P163242, DOI 10.1155/2014/163242; Watanabe K, 2009, CURR OPIN BIOTECH, V20, P633, DOI 10.1016/j.copbio.2009.09.006; Weissbrodt DG, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00332; Wesenberg D, 2003, BIOTECHNOL ADV, V22, P161, DOI 10.1016/j.biotechadv.2003.08.011; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Yang QX, 2012, BIORESOURCE TECHNOL, V117, P155, DOI 10.1016/j.biortech.2012.04.059; Yoon JH, 2007, INT J SYST EVOL MICR, V57, P1188, DOI 10.1099/ijs.0.64901-0; Zhang MM, 2010, BIORESOURCE TECHNOL, V101, P2651, DOI 10.1016/j.biortech.2009.10.070	56	30	30	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170562	10.1371/journal.pone.0170562	http://dx.doi.org/10.1371/journal.pone.0170562			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QR	28114377	Green Published, Green Submitted, gold			2022-12-26	WOS:000396129000068
J	Waltzman, D; Soman, S; Hantke, NC; Fairchild, JK; Kinoshita, LM; Wintermark, M; Ashford, JW; Yesavage, J; Williams, L; Adamson, MM; Furst, AJ				Waltzman, Dana; Soman, Salil; Hantke, Nathan C.; Fairchild, J. Kaci; Kinoshita, Lisa M.; Wintermark, Max; Ashford, J. Wesson; Yesavage, Jerome; Williams, Leanne; Adamson, Maheen M.; Furst, Ansgar J.			Altered Microstructural Caudate Integrity in Posttraumatic Stress Disorder but Not Traumatic Brain Injury	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS PATIENTS; REDUCED CORTICAL THICKNESS; MILD COGNITIVE IMPAIRMENT; DIFFUSION TENSOR; HIPPOCAMPAL VOLUME; MEMORY PERFORMANCE; BLOOD-FLOW; PTSD; ROBUST; MRI	Objective Given the high prevalence and comorbidity of combat-related PTSD and TBI in Veterans, it is often difficult to disentangle the contributions of each disorder. Examining these pathologies separately may help to understand the neurobiological basis of memory impairment in PTSD and TBI independently of each other. Thus, we investigated whether a) PTSD and TBI are characterized by subcortical structural abnormalities by examining diffusion tensor imaging (DTI) metrics and volume and b) if these abnormalities were specific to PTSD versus TBI. Method We investigated whether individuals with PTSD or TBI display subcortical structural abnormalities in memory regions by examining DTI metrics and volume of the hippocampus and caudate in three groups of Veterans: Veterans with PTSD, Veterans with TBI, and Veterans with neither PTSD nor TBI (Veteran controls). Results While our results demonstrated no macrostructural differences among the groups in these regions, there were significant alterations in microstructural DTI indices in the caudate for the PTSD group but not the TBI group compared to Veteran controls. Conclusions The result of increased mean, radial, and axial diffusivity, and decreased fractional anisotropy in the caudate in absence of significant volume atrophy in the PTSD group suggests the presence of subtle abnormalities evident only at a microstructural level. The caudate is thought to play a role in the physiopathology of PTSD, and the habit-like behavioral features of the disorder could be due to striatal-dependent habit learning mechanisms. Thus, DTI appears to be a vital tool to investigate subcortical pathology, greatly enhancing the ability to detect subtle brain changes in complex disorders.	[Waltzman, Dana; Hantke, Nathan C.; Fairchild, J. Kaci; Ashford, J. Wesson; Yesavage, Jerome; Williams, Leanne; Furst, Ansgar J.] VAPAHCS, WRIISC, Palo Alto, CA 94304 USA; [Waltzman, Dana; Hantke, Nathan C.; Fairchild, J. Kaci; Kinoshita, Lisa M.; Ashford, J. Wesson; Yesavage, Jerome; Williams, Leanne; Adamson, Maheen M.; Furst, Ansgar J.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA; [Soman, Salil] Harvard Univ, Dept Radiol, Cambridge, MA 02138 USA; [Hantke, Nathan C.; Fairchild, J. Kaci] VAPAHCS, Sierra Pacific Mental Illness Res Educ & Clin Ctr, Palo Alto, CA USA; [Kinoshita, Lisa M.] VAPAHCS, Psychol Serv, Palo Alto, CA USA; [Wintermark, Max] Stanford Univ, Sch Med, Dept Radiol, Palo Alto, CA 94304 USA; [Wintermark, Max; Furst, Ansgar J.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Palo Alto, CA 94304 USA; [Adamson, Maheen M.] VAPAHCS, DVBIC, Palo Alto, CA USA; [Waltzman, Dana] Vet Affairs Palo Alto Hlth Care Syst, MC 151Y, Palo Alto, CA 94304 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Harvard University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Waltzman, D (corresponding author), VAPAHCS, WRIISC, Palo Alto, CA 94304 USA.; Waltzman, D (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA.; Waltzman, D (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, MC 151Y, Palo Alto, CA 94304 USA.	dana2@stanford.edu	Ashford, J. Wesson/D-3929-2009; Williams, Leanne/GLU-4975-2022	Williams, Leanne/0000-0001-9987-7360; Adamson, Maheen/0000-0002-1534-4063; Soman, Salil/0000-0002-5887-0717	Department of Veterans Affairs, Office of Public Health, WRIISC Fellowship program	Department of Veterans Affairs, Office of Public Health, WRIISC Fellowship program(US Department of Veterans Affairs)	Work for this article was supported by the Department of Veterans Affairs, Office of Public Health, WRIISC Fellowship program.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Andersson JLR, 2007, NONLINEAR OPTIMISATI; Andersson JLR, 2007, TRO7JA2 FMRIB; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bockhorst KH, 2008, J NEUROSCI RES, V86, P1520, DOI 10.1002/jnr.21607; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bozzali M, 2002, AM J NEURORADIOL, V23, P985; Bremner JD, 2006, ANN NY ACAD SCI, V1071, P80, DOI 10.1196/annals.1364.008; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; Cavallari M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101199; Caverzasi E, 2014, NEUROIMAGE-CLIN, V4, P426, DOI 10.1016/j.nicl.2014.01.011; Ciccarelli O, 2001, NEUROLOGY, V56, P926, DOI 10.1212/WNL.56.7.926; Corbo V, 2014, PSYCHIAT RES-NEUROIM, V223, P53, DOI 10.1016/j.pscychresns.2014.04.013; Dickerson KC, 2011, NEUROIMAGE, V55, P266, DOI 10.1016/j.neuroimage.2010.10.080; Doshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118061; Fani N, 2012, NEUROPSYCHOPHARMACOL, V37, P2740, DOI 10.1038/npp.2012.146; Fellgiebel A, 2004, DEMENT GERIATR COGN, V18, P101, DOI 10.1159/000077817; Fjell AM, 2016, CEREB CORTEX, V26, P1272, DOI 10.1093/cercor/bhv102; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; Geuze E, 2007, ARCH GEN PSYCHIAT, V64, P76, DOI 10.1001/archpsyc.64.1.76; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Golier JA, 2005, PSYCHIAT RES-NEUROIM, V139, P53, DOI 10.1016/j.pscychresns.2005.02.007; Goodman J, 2012, REV NEUROSCIENCE, V23, P627, DOI 10.1515/revneuro-2012-0049; Hannoun S, 2012, AM J NEURORADIOL, V33, P1363, DOI 10.3174/ajnr.A2983; Hasan KM, 2012, J NEUROL SCI, V313, P99, DOI 10.1016/j.jns.2011.09.015; Hasan KM, 2011, J NEUROSCI, V31, P16826, DOI 10.1523/JNEUROSCI.4184-11.2011; Hasan KM, 2009, J MAGN RESON IMAGING, V29, P70, DOI 10.1002/jmri.21648; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Herringa R, 2012, PSYCHIAT RES-NEUROIM, V203, P139, DOI 10.1016/j.pscychresns.2012.02.005; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jernigan TL, 2001, NEUROBIOL AGING, V22, P581, DOI 10.1016/S0197-4580(01)00217-2; Johnsen GE, 2008, J AFFECT DISORDERS, V111, P74, DOI 10.1016/j.jad.2008.02.007; Kantarci K, 2002, DEMENT GERIATR COGN, V14, P198, DOI 10.1159/000066021; KOTAPKA MJ, 1993, NEUROPATH APPL NEURO, V19, P128, DOI 10.1111/j.1365-2990.1993.tb00417.x; Layton B, 2002, J NEUROPSYCH CLIN N, V14, P254, DOI 10.1176/appi.neuropsych.14.3.254; Lindauer RJL, 2004, BIOL PSYCHIAT, V56, P853, DOI 10.1016/j.biopsych.2004.08.003; Lindemer ER, 2013, NEUROIMAGE-CLIN, V2, P601, DOI 10.1016/j.nicl.2013.04.009; Linnman C, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-8; Lucey JV, 1997, BRIT J PSYCHIAT, V171, P346, DOI 10.1192/bjp.171.4.346; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Mueller SG, 2007, PSYCHIAT RES, V234, P194; Nardo D, 2011, PSYCHOL MED, V41, P2549, DOI 10.1017/S0033291711000912; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Newsome MR, 2015, NEUROIMAGE-CLIN, V8, P543, DOI 10.1016/j.nicl.2015.04.024; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Pederson CL, 2004, J TRAUMA STRESS, V17, P37, DOI 10.1023/B:JOTS.0000014674.84517.46; Piras F, 2010, NEUROSCIENCE, V171, P496, DOI 10.1016/j.neuroscience.2010.09.006; Poldrack RA, 2001, NATURE, V414, P546, DOI 10.1038/35107080; Primus EA, 1997, BRAIN INJURY, V11, P577; Randolph C., 1998, REPEATABLE BATTERY A; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Reitan RM, 1985, HALSTEAD REITAN NEUR; Richardson LK, 2010, AUST NZ J PSYCHIAT, V44, P4, DOI 10.3109/00048670903393597; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Sanjuan PM, 2013, PSYCHIAT RES-NEUROIM, V214, P260, DOI 10.1016/j.pscychresns.2013.09.002; Shah S, 2012, BRAIN INJURY, V26, P201, DOI 10.3109/02699052.2012.654591; Shandera-Ochsner AL, 2013, CLIN NEUROPSYCHOL, V27, P881, DOI 10.1080/13854046.2013.802017; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2001, J COMPUT ASSIST TOMO, V25, P466, DOI 10.1097/00004728-200105000-00022; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Spoletini I, 2011, SCHIZOPHRENIA BULL, V37, P118, DOI 10.1093/schbul/sbp058; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; Tanelian T, 2008, INVISIBLE WOUNDS WAR; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Vasterling JJ, 2009, J INT NEUROPSYCH SOC, V15, P826, DOI 10.1017/S1355617709990683; Villarreal G, 2002, BIOL PSYCHIAT, V52, P119, DOI 10.1016/S0006-3223(02)01359-8; Vrenken H, 2006, J MAGN RESON IMAGING, V23, P628, DOI 10.1002/jmri.20564; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wechsler D., 2008, WECHSLER ADULTS INTE; Wechsler D., 2001, WECHSLER TEST ADULT; Woods AS, 2013, ACS CHEM NEUROSCI, V4, P594, DOI 10.1021/cn300216h; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Ziyan U, 2008, LECT NOTES COMPUT SC, V5241, P279, DOI 10.1007/978-3-540-85988-8_34	84	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2017	12	1							e0170564	10.1371/journal.pone.0170564	http://dx.doi.org/10.1371/journal.pone.0170564			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6QR	28114393	Green Published, Green Submitted, gold			2022-12-26	WOS:000396129000069
J	Deroualle, D; Toupet, M; van Nechel, C; Duquesne, U; Hautefort, C; Lopez, C				Deroualle, Diane; Toupet, Michel; van Nechel, Christian; Duquesne, Ulla; Hautefort, Charlotte; Lopez, Christophe			Anchoring the Self to the Body in Bilateral Vestibular Failure	PLOS ONE			English	Article							PERSPECTIVE-TAKING; DEPERSONALISATION/DEREALISATION SYMPTOMS; MULTISENSORY MECHANISMS; CUTANEOUS PATTERNS; SEX-DIFFERENCES; ORIENTATION; LOCATION; CORTEX; DEPERSONALIZATION; INTERFERENCE	Recent findings suggest that vestibular information plays a significant role in anchoring the self to the body. Out-of-body experiences of neurological origin are frequently associated with vestibular sensations, and galvanic vestibular stimulation in healthy participants anchors the self to the body. Here, we provide the first objective measures of anchoring the self to the body in chronic bilateral vestibular failure (BVF). We compared 23 patients with idiopathic BVF to 23 healthy participants in a series of experiments addressing several aspects of visuo-spatial perspective taking and embodiment. In Experiment 1, participants were involved in a virtual "dot-counting task" from their own perspective or the perspective of a distant avatar, to measure implicit and explicit perspective taking, respectively. In both groups, response times increased similarly when the avatar's and participant's viewpoint differed, for both implicit and explicit perspective taking. In Experiment 2, participants named ambiguous letters (such as "b" or "q") traced on their forehead that could be perceived from an internal or external perspective. The frequency of perceiving ambiguous letters from an internal perspective was similar in both groups. In Experiment 3, participants completed a questionnaire measuring the experienced self/body and self/environment "closeness". Both groups reported a similar embodied experience. Altogether, our data show that idiopathic BVF does not change implicit and explicit perspective taking nor subjective anchoring of the self to the body. Our negative findings offer insight into the multisensory mechanisms of embodiment. Only acute peripheral vestibular disorders and neurological disorders in vestibular brain areas (characterized by strong multisensory conflicts) may evoke disembodied experiences.	[Deroualle, Diane; Lopez, Christophe] Aix Marseille Univ, CNRS, LNIA, FR3C, Marseille, France; [Toupet, Michel; van Nechel, Christian; Duquesne, Ulla; Hautefort, Charlotte] IRON, Paris, France; [Toupet, Michel] Ctr Explorat Fonct Otoneurol, Paris, France; [van Nechel, Christian; Duquesne, Ulla] CHU Brugmann, Unite Troubles Equilibre & Vertiges, Brussels, Belgium; [van Nechel, Christian] CHU Erasme, Unite Neuroophtalmol, Brussels, Belgium; [van Nechel, Christian; Duquesne, Ulla] Clin Vertiges, Brussels, Belgium; [Hautefort, Charlotte] Hop Lariboisiere, Serv ORL, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Universite Libre de Bruxelles; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Lopez, C (corresponding author), Aix Marseille Univ, CNRS, LNIA, FR3C, Marseille, France.	christophe.lopez@univ-amu.fr	Lopez, Christophe/AAJ-6155-2020; Lopez, Christophe/ABG-6263-2020	Lopez, Christophe/0000-0001-9298-2969; 	VolkswagenStiftung [89434]	VolkswagenStiftung(Volkswagen)	CL's research is supported by a grant from the VolkswagenStiftung (Grant no. 89434: "Finding Perspective: Determining the embodiment of perspectival experience"). The sponsor was not involved in the study design, collection, analysis, and interpretation of data, writing the report and in the decision to submit the manuscript for publication.	Arnold G, 2016, COGNITION, V148, P27, DOI 10.1016/j.cognition.2015.12.006; ARON A, 1992, J PERS SOC PSYCHOL, V63, P596, DOI 10.1037/0022-3514.63.4.596; Aspell JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006488; Bessot N, 2012, GAIT POSTURE, V36, P319, DOI 10.1016/j.gaitpost.2012.02.021; Blanke O, 2005, BRAIN RES REV, V50, P184, DOI 10.1016/j.brainresrev.2005.05.008; Blanke O, 2004, BRAIN, V127, P243, DOI 10.1093/brain/awh040; Blanke O, 2014, CURR BIOL, V24, P2681, DOI 10.1016/j.cub.2014.09.049; Blanke O, 2012, NAT REV NEUROSCI, V13, P556, DOI 10.1038/nrn3292; Blanke O, 2009, NEUROLOGY OF CONSCIOUSNESS: COGNITIVE NEUROSCIENCE AND NEUROPATHOLOGY, P303, DOI 10.1016/B978-0-12-374168-4.00023-X; Bonnier P., 1905, REV NEUROL, V13, P605, DOI [10.1016/j.yebeh.2009.09.020, DOI 10.1016/J.YEBEH.2009.09.020]; Bronstein AM, 1996, NEUROLOGY, V47, P651, DOI 10.1212/WNL.47.3.651; Butler T, 2006, NEUROIMAGE, V32, P445, DOI 10.1016/j.neuroimage.2006.03.030; Candidi M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00783; Capozzi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114210; Claparede E, 1924, ARCH PSYCHOLOGIE, V19, P172; CORCORAN DWJ, 1977, PERCEPTION, V6, P249, DOI 10.1068/p060247; Cox BJ, 2002, DEPRESS ANXIETY, V15, P172, DOI 10.1002/da.10051; Demougeot L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026764; Deroualle D, 2015, NEUROPHYSIOL CLIN NE, V45, P400; Deroualle D, 2015, NEUROPSYCHOLOGIA, V79, P175, DOI 10.1016/j.neuropsychologia.2015.08.022; Dieguez S, ANN PHYS REHABIL MED; Dieterich M, 2003, CEREB CORTEX, V13, P994, DOI 10.1093/cercor/13.9.994; Ehrsson HH, 2007, SCIENCE, V317, P1048, DOI 10.1126/science.1142175; Fanelli D., 2010, PLOS ONE, V5; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ferre ER, 2014, PSYCHOL SCI, V25, P2106, DOI 10.1177/0956797614547917; Furlanetto T, 2016, J EXP PSYCHOL HUMAN, V42, P158, DOI 10.1037/xhp0000138; Furlanetto T, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00455; Grabherr L, 2011, EXP BRAIN RES, V209, P205, DOI 10.1007/s00221-011-2535-0; GRIGSBY JP, 1989, PSYCHOL REP, V64, P527, DOI 10.2466/pr0.1989.64.2.527; Guterstam A, 2015, CURR BIOL, V25, P1416, DOI 10.1016/j.cub.2015.03.059; Guterstam A, 2012, CONSCIOUS COGN, V21, P1037, DOI 10.1016/j.concog.2012.01.018; Heed T, 2010, CURR BIOL, V20, P1345, DOI 10.1016/j.cub.2010.05.068; Heydrich L, 2013, BRAIN, V136, P790, DOI 10.1093/brain/aws364; Heydrich L, 2011, EPILEPSY BEHAV, V20, P583, DOI 10.1016/j.yebeh.2011.01.008; Honrubia V., 2001, CLIN NEUROPHYSIOLOGY; Hugdahl K, 2006, NEUROPSYCHOLOGIA, V44, P1575, DOI 10.1016/j.neuropsychologia.2006.01.026; Ionta S, 2011, NEURON, V70, P363, DOI 10.1016/j.neuron.2011.03.009; Janzen J, 2008, NEUROIMAGE, V42, P1508, DOI 10.1016/j.neuroimage.2008.06.026; Jauregui-Renaud K, 2008, J NEUROL NEUROSUR PS, V79, P276, DOI 10.1136/jnnp.2007.122119; Jauregui-Renaud K, 2008, J VESTIBUL RES-EQUIL, V18, P129; Kahane P, 2003, ANN NEUROL, V54, P615, DOI 10.1002/ana.10726; Kaliuzhna M, 2015, MULTISENS RES, V28, P613, DOI 10.1163/22134808-00002506; Kapoula Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066652; Kessler K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0388; Kessler K, 2012, SPAT COGN COMPUT, V12, P133, DOI 10.1080/13875868.2011.634533; Kolev OI, 2014, BEHAV NEUROL, V2014, DOI 10.1155/2014/847054; Landes D., 2012, PHENOMENOLOGY PERCEP; Lenggenhager B., 2015, OPEN MIND, P1, DOI [10.5167/uzh-139675, DOI 10.5167/UZH-139675]; Lenggenhager B, 2009, CONSCIOUS COGN, V18, P110, DOI 10.1016/j.concog.2008.11.003; Lopez C, 2008, NEUROPHYSIOL CLIN, V38, P149, DOI 10.1016/j.neucli.2007.12.006; Lopez C, 2014, NEUROPHYSIOL CLIN NE, V44, P494; Lopez C, 2016, CURR OPIN NEUROL, V29, P74, DOI 10.1097/WCO.0000000000000286; Lopez C, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00091; Lopez C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048293; Lopez C, 2011, BRAIN RES REV, V67, P119, DOI 10.1016/j.brainresrev.2010.12.002; MacDougall HG, 2009, NEUROLOGY, V73, P1134, DOI 10.1212/WNL.0b013e3181bacf85; Matosin N, 2014, DIS MODEL MECH, V7, P171, DOI 10.1242/dmm.015123; Mattan B, 2014, J EXP PSYCHOL LEARN; Mattan BD, 2006, Q J EXP PSYCHOL, V2016, P1; Mazzarella E, 2012, Q J EXP PSYCHOL, V65, P2447, DOI 10.1080/17470218.2012.697905; McGarvie LA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00154; Mohr C, 2010, BRIT J PSYCHOL, V101, P277, DOI 10.1348/000712609X457450; NATSOULAS T, 1964, AM J PSYCHOL, V77, P281, DOI 10.2307/1420136; NATSOULAS T, 1966, J PERS SOC PSYCHOL, V3, P190, DOI 10.1037/h0022815; Nielsen M.K., 2015, Q J EXP PSYCHOL, V2006, P1; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PARSONS LM, 1987, J EXP PSYCHOL HUMAN, V13, P488, DOI 10.1037/0096-1523.13.3.488; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Peruch P, 2011, NEUROPSYCHOLOGIA, V49, P3136, DOI 10.1016/j.neuropsychologia.2011.07.026; Pfeiffer C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061751; Qureshi AW, 2010, COGNITION, V117, P230, DOI 10.1016/j.cognition.2010.08.003; Ramsey R, 2013, J COGNITIVE NEUROSCI, V25, P670, DOI 10.1162/jocn_a_00345; Rosengren SM, 2005, CLIN NEUROPHYSIOL, V116, P1938, DOI 10.1016/j.clinph.2005.03.019; Saj A, 2013, CORTEX, V49, P1219, DOI 10.1016/j.cortex.2012.05.019; Samson D, 2010, J EXP PSYCHOL HUMAN, V36, P1255, DOI 10.1037/a0018729; Sang FYP, 2006, J NEUROL NEUROSUR PS, V77, P760, DOI 10.1136/jnnp.2005.075473; Santiesteban I, 2014, J EXP PSYCHOL HUMAN, V40, P929, DOI 10.1037/a0035175; Schilder P., 1936, J NERV MENT DIS, V83, P227, DOI [10.1097/00005053-193602000-00051, DOI 10.1097/00005053-193602000-00051]; SEKIYAMA K, 1991, PERCEPT PSYCHOPHYS, V49, P481, DOI 10.3758/BF03212182; Skworzoff K, 1931, Z GESAMTE NEUROL PSY, V133, P762, DOI 10.1007/BF02909953; Spence C, 2010, ADVANCES IN HAPTICS, P47; Starmans C, 2012, COGNITION, V123, P313, DOI 10.1016/j.cognition.2012.02.002; Surtees ADR, 2012, CHILD DEV, V83, P452, DOI 10.1111/j.1467-8624.2011.01730.x; Todd AR, 2015, J EXP PSYCHOL GEN, V144, P374, DOI 10.1037/xge0000048; Toupet M, 2014, AUDIOL NEURO-OTOL, V19, P248, DOI 10.1159/000360266; Tversky B, 2009, COGNITION, V110, P124, DOI 10.1016/j.cognition.2008.10.008; Welgampola MS, 2005, NEUROLOGY, V64, P1682, DOI 10.1212/01.WNL.0000161876.20552.AA	88	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170488	10.1371/journal.pone.0170488	http://dx.doi.org/10.1371/journal.pone.0170488			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI3QC	28107424	Green Submitted, Green Published, gold			2022-12-26	WOS:000392405300145
J	Hasenour, CM; Ridley, DE; James, FD; Hughey, CC; Donahue, P; Viollet, B; Foretz, M; Young, JD; Wasserman, DH				Hasenour, Clinton M.; Ridley, D. Emerson; James, Freyja D.; Hughey, Curtis C.; Donahue, Patrick; Viollet, Benoit; Foretz, Marc; Young, Jamey D.; Wasserman, David H.			Liver AMP-Activated Protein Kinase Is Unnecessary for Gluconeogenesis but Protects Energy State during Nutrient Deprivation	PLOS ONE			English	Article							ACID CYCLE ACTIVITY; CYTOSOLIC PHOSPHOENOLPYRUVATE CARBOXYKINASE; INHIBITS HEPATIC GLUCONEOGENESIS; SKELETAL-MUSCLE; MITOCHONDRIAL METABOLISM; INSULIN-RESISTANCE; GLUCOSE-PRODUCTION; FATTY LIVER; IN-VIVO; MUSCULAR WORK	AMPK is an energy sensor that protects cellular energy state by attenuating anabolic and promoting catabolic processes. AMPK signaling is purported to regulate hepatic gluconeogenesis and substrate oxidation; coordination of these processes is vital during nutrient deprivation or pathogenic during overnutrition. Here we directly test hepatic AMPK function in regulating metabolic fluxes that converge to produce glucose and energy in vivo. Flux analysis was applied in mice with a liver-specific deletion of AMPK (L-KO) or floxed control litter mates to assess rates of hepatic glucose producing and citric acid cycle (CAC) fluxes. Fluxes were assessed in short and longterm fasted mice; the latter condition is a nutrient stressor that increases liver AMP/ATP. The flux circuit connecting anaplerosis with gluconeogenesis from the CAC was unaffected by hepatic AMPK deletion in short and long term fasting. Nevertheless, depletion of hepatic ATP was exacerbated in L-KO mice, corresponding to a relative elevation in citrate synthase flux and accumulation of branched-chain amino acid-related metabolites. L-KO mice also had a physiological reduction in flux from glycogen to G6P. These results demonstrate AMPK is unnecessary for maintaining gluconeogenic flux from the CAC yet is critical for stabilizing liver energy state during nutrient deprivation.	[Hasenour, Clinton M.; Ridley, D. Emerson; Hughey, Curtis C.; Donahue, Patrick; Young, Jamey D.; Wasserman, David H.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37235 USA; [James, Freyja D.; Wasserman, David H.] Vanderbilt Univ, Mouse Metab Phenotyping Ctr, Nashville, TN 37235 USA; [Viollet, Benoit; Foretz, Marc] INSERM, Inst Cochin, U1016, Paris, France; [Viollet, Benoit; Foretz, Marc] CNRS, UMR 8104, Paris, France; [Viollet, Benoit; Foretz, Marc] Univ Paris 05, Sorborne Paris Cite, Paris, France; [Young, Jamey D.] Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN 37235 USA	Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Vanderbilt University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Vanderbilt University	Wasserman, DH (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37235 USA.; Wasserman, DH (corresponding author), Vanderbilt Univ, Mouse Metab Phenotyping Ctr, Nashville, TN 37235 USA.	david.wasserman@vanderbilt.edu	Viollet, Benoit/N-2397-2019; Young, Jamey/A-5857-2012; Viollet, Benoit/O-6927-2017; FORETZ, Marc/O-7334-2017	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; FORETZ, Marc/0000-0001-7017-9032	National Institute of Diabetes and Digestive and Kidney Diseases [DK050277, DK059637, DK07563, DK020593]; Canadian Diabetes Association [PF-3-14-4687-CH]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK106348, T32DK101003] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Canadian Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases through grant numbers DK050277, DK059637, DK07563 and DK020593. This work was also supported by the Canadian Diabetes Association through grant PF-3-14-4687-CH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreelli F, 2006, ENDOCRINOLOGY, V147, P2432, DOI 10.1210/en.2005-0898; Antoniewicz MR, 2006, METAB ENG, V8, P324, DOI 10.1016/j.ymben.2006.01.004; Antoniewicz MR, 2011, ANAL CHEM, V83, P3211, DOI 10.1021/ac200012p; Atkinson D E, 1976, Biochem Soc Symp, P205; Ayala JE, 2006, DIABETES, V55, P390, DOI 10.2337/diabetes.55.02.06.db05-0686; BEYLOT M, 1995, J BIOL CHEM, V270, P1509, DOI 10.1074/jbc.270.4.1509; Bultot L, 2012, BIOCHEM J, V443, P193, DOI 10.1042/BJ20112026; Burgess SC, 2005, AM J PHYSIOL-ENDOC M, V289, pE53, DOI 10.1152/ajpendo.00601.2004; Burgess SC, 2004, J BIOL CHEM, V279, P48941, DOI 10.1074/jbc.M407120200; Burgess SC, 2007, CELL METAB, V5, P313, DOI 10.1016/j.cmet.2007.03.004; Burgess SC, 2006, J BIOL CHEM, V281, P19000, DOI 10.1074/jbc.M600050200; Camacho RC, 2006, AM J PHYSIOL-ENDOC M, V290, pE405, DOI 10.1152/ajpendo.00385.2005; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2; CHAN TM, 1976, ANAL BIOCHEM, V71, P96, DOI 10.1016/0003-2697(76)90014-2; Cortez-Pinto H, 1999, JAMA-J AM MED ASSOC, V282, P1659, DOI 10.1001/jama.282.17.1659; DOHM GL, 1983, BIOCHEM J, V212, P633, DOI 10.1042/bj2120633; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; Guigas B, 2007, BIOCHEM J, V404, P499, DOI 10.1042/BJ20070105; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hasenour CM, 2015, AM J PHYSIOL-ENDOC M, V309, pE191, DOI 10.1152/ajpendo.00003.2015; Hasenour CM, 2014, J BIOL CHEM, V289, P5950, DOI 10.1074/jbc.M113.528232; Hasenour CM, 2013, MOL CELL ENDOCRINOL, V366, P152, DOI 10.1016/j.mce.2012.06.018; Hong YH, 2003, J BIOL CHEM, V278, P27495, DOI 10.1074/jbc.M304112200; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jensen TL, 2013, LAB ANIM-UK, V47, P225, DOI 10.1177/0023677213501659; KATZ J, 1993, J BIOL CHEM, V268, P25509; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; KREBS H, 1964, PROC R SOC SER B-BIO, V159, P545, DOI 10.1098/rspb.1964.0019; Krishna MG, 2000, AM J PHYSIOL-ENDOC M, V279, pE638, DOI 10.1152/ajpendo.2000.279.3.E638; Kucejova B, 2011, ONCOGENE, V30, P2147, DOI 10.1038/onc.2010.587; Kucejova B, 2016, CELL REP, V16, P508, DOI 10.1016/j.celrep.2016.06.006; Lantier L, 2014, FASEB J, V28, P3211, DOI 10.1096/fj.14-250449; Large V, 1999, DIABETES, V48, P1251, DOI 10.2337/diabetes.48.6.1251; Leclerc I, 2001, DIABETES, V50, P1515, DOI 10.2337/diabetes.50.7.1515; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; MAGNUSSON I, 1991, J BIOL CHEM, V266, P6975; Makowski L, 2009, FASEB J, V23, P586, DOI 10.1096/fj.08-119420; Michalik L, 2004, NAT REV CANCER, V4, P61, DOI 10.1038/nrc1254; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; Patel K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5535; Perry RJ, 2016, J BIOL CHEM, V291, P12161, DOI 10.1074/jbc.M116.720631; PETERSEN KF, 1994, AM J PHYSIOL, V267, pE273, DOI 10.1152/ajpendo.1994.267.2.E273; Previs SF, 2015, AM J PHYSIOL-ENDOC M, V309, pE727, DOI 10.1152/ajpendo.00216.2015; Satapati S, 2015, J CLIN INVEST, V125, P4447, DOI 10.1172/JCI82204; Satapati S, 2012, J LIPID RES, V53, P1080, DOI 10.1194/jlr.M023382; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; She PX, 2003, DIABETES, V52, P1649, DOI 10.2337/diabetes.52.7.1649; START C, 1968, BIOCHEM J, V107, P411, DOI 10.1042/bj1070411; Steinberg GR, 2010, J BIOL CHEM, V285, P37198, DOI 10.1074/jbc.M110.102434; Sunny NE, 2010, AM J PHYSIOL-ENDOC M, V298, pE1226, DOI 10.1152/ajpendo.00033.2010; Szendroedi J, 2009, HEPATOLOGY, V50, P1079, DOI 10.1002/hep.23093; WASSERMAN DH, 1988, AM J PHYSIOL, V254, pE518, DOI 10.1152/ajpendo.1988.254.4.E518; WASSERMAN DH, 1991, AM J PHYSIOL, V260, pE811, DOI 10.1152/ajpendo.1991.260.6.E811; WASSERMAN DH, 1989, DIABETES, V38, P799, DOI 10.2337/diabetes.38.6.799; Young JD, 2014, BIOINFORMATICS, V30, P1333, DOI 10.1093/bioinformatics/btu015; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	70	16	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170382	10.1371/journal.pone.0170382	http://dx.doi.org/10.1371/journal.pone.0170382			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107516	gold, Green Published, Green Submitted			2022-12-26	WOS:000392405300122
J	Karsakov, A; Bartlett, T; Ryblov, A; Meyerov, I; Ivanchenko, M; Zaikin, A				Karsakov, Alexander; Bartlett, Thomas; Ryblov, Artem; Meyerov, Iosif; Ivanchenko, Mikhail; Zaikin, Alexey			Parenclitic Network Analysis of Methylation Data for Cancer Identification	PLOS ONE			English	Article							VARIABILITY; RISK	We make use of ideas from the theory of complex networks to implement a machine learning classification of human DNA methylation data, that carry signatures of cancer development. The data were obtained from patients with various kinds of cancers and represented as parenclictic networks, wherein nodes correspond to genes, and edges are weighted according to pairwise variation from control group subjects. We demonstrate that for the 10 types of cancer under study, it is possible to obtain a high performance of binary classification between cancer-positive and negative samples based on network measures. Remarkably, an accuracy as high as 93-99% is achieved with only 12 network topology indices, in a dramatic reduction of complexity from the original 15295 gene methylation levels. Moreover, it was found that the parenclictic networks are scale-free in cancer-negative subjects, and deviate from the power-law node degree distribution in cancer. The node centrality ranking and arising modular structure could provide insights into the systems biology of cancer.	[Karsakov, Alexander; Ryblov, Artem; Ivanchenko, Mikhail; Zaikin, Alexey] Lobachevsky State Univ Nizhny Novgorod, Dept Appl Math, Nizhnii Novgorod, Russia; [Karsakov, Alexander; Ryblov, Artem; Ivanchenko, Mikhail; Zaikin, Alexey] Lobachevsky State Univ Nizhny Novgorod, Ctr Bioinformat, Nizhnii Novgorod, Russia; [Bartlett, Thomas; Zaikin, Alexey] UCL, Inst Womens Hlth, London, England; [Bartlett, Thomas; Zaikin, Alexey] UCL, Dept Math, London, England; [Meyerov, Iosif] Lobachevsky State Univ Nizhny Novgorod, Dept Math Software & High Performance Comp, Nizhnii Novgorod, Russia	Lobachevsky State University of Nizhni Novgorod; Lobachevsky State University of Nizhni Novgorod; University of London; University College London; University of London; University College London; Lobachevsky State University of Nizhni Novgorod	Zaikin, A (corresponding author), Lobachevsky State Univ Nizhny Novgorod, Dept Appl Math, Nizhnii Novgorod, Russia.; Zaikin, A (corresponding author), Lobachevsky State Univ Nizhny Novgorod, Ctr Bioinformat, Nizhnii Novgorod, Russia.; Zaikin, A (corresponding author), UCL, Inst Womens Hlth, London, England.; Zaikin, A (corresponding author), UCL, Dept Math, London, England.	alexey.zaikin@ucl.ac.uk	Meyerov, Iosif B/O-2831-2013; Zaikin, Alexey/T-7171-2019; Ivanchenko, Mikhail/AGE-5444-2022; Zaikin, Alexey/K-6581-2017; Ivanchenko, Mikhail V/J-7045-2013	Meyerov, Iosif B/0000-0001-6905-2050; Zaikin, Alexey/0000-0001-7540-1130; Zaikin, Alexey/0000-0001-7540-1130; Ivanchenko, Mikhail V/0000-0002-1903-7423	Russian Foundation for Basic Research [14-04-01202]; Russian Ministry of Education and Science [218]; Russian Science Foundation [14-12-00811]; MRC [MR/P014070/1] Funding Source: UKRI	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); Russian Science Foundation(Russian Science Foundation (RSF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors acknowledge Russian Foundation for Basic Research, grant No. 14-04-01202 and Russian Ministry of Education and Science, agreement from 20.07.2015 according to Russian Government Statement No. 218 (A.R., I.M., A.Z.). M.I. acknowledges support of Russian Science Foundation grant No. 14-12-00811 (network statistics analysis). Computations were carried out on the Lobachevsky University supercomputer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Bartlett TE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084573; Bartlett TE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068285; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Collins FS, 2007, SCI AM, V296, P50, DOI 10.1038/scientificamerican0307-50; Cooney CA, 2007, DIS MARKERS, V23, P121, DOI 10.1155/2007/394034; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Huberty C, 2005, MAHALANOBIS DISTANCE; Jaffe AE, 2012, BIOSTATISTICS, V13, P166, DOI 10.1093/biostatistics/kxr013; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Teschendorff AE, 2012, GENOME MED, V4, DOI 10.1186/gm323; Teschendorff AE, 2012, BIOINFORMATICS, V28, P1487, DOI 10.1093/bioinformatics/bts170; Zanin M, 2011, CHAOS, V21, DOI 10.1063/1.3608126; Zanin M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05112	19	12	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0169661	10.1371/journal.pone.0169661	http://dx.doi.org/10.1371/journal.pone.0169661			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107365	Green Published, gold, Green Submitted			2022-12-26	WOS:000392405300035
J	Sugino, K; Kobayashi, M; Nakamura, Y; Gocho, K; Ishida, F; Isobe, K; Shiraga, N; Homma, S				Sugino, Keishi; Kobayashi, Masahiro; Nakamura, Yasuhiko; Gocho, Kyoko; Ishida, Fumiaki; Isobe, Kazutoshi; Shiraga, Nobuyuki; Homma, Sakae			Xenon-Enhanced Dual-Energy CT Imaging in Combined Pulmonary Fibrosis and Emphysema	PLOS ONE			English	Article							CLINICAL CHARACTERISTICS; VITAL-CAPACITY; VENTILATION	Background Little has been reported on the feasibility of xenon-enhanced dual-energy computed tomography (Xe-DECT) in the visual and quantitative analysis of combined pulmonary fibrosis and emphysema (CPFE). Objectives We compared CPFE with idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD), as well as correlation with parameters of pulmonary function tests (PFTs). Methods Studied in 3 groups were 25 patients with CPFE, 25 with IPF without emphysema (IPF alone), 30 with COPD. Xe-DECT of the patients' entire thorax was taken from apex to base after a patient's single deep inspiration of 35% stable nonradioactive xenon. The differences in several parameters of PFTs and percentage of areas enhanced by xenon between 3 groups were compared and analyzed retrospectively. Results The percentage of areas enhanced by xenon in both lungs were calculated as CPFE/IPF alone/COPD = 72.2 +/- 15.1% /82.2 +/- 14.7% /45.2 +/- 23.2%, respectively. In the entire patients, the percentage of areas enhanced by xenon showed significantly a positive correlation with FEV1/FVC (R = 0.558, P < 0.0001) and %FEV1, (R = 0.528, P < 0.0001) and a negative correlation with %RV (R = -0.594, P < 0.0001) and RV/TLC (R = -0.579, P < 0.0001). The percentage of areas enhanced by xenon in patients with CPFE showed significantly a negative correlation with RV/TLC (R = -0.529, P = 0.007). Xenon enhancement of CPFE indicated 3 different patterns such as upper predominant, diffuse, and multifocal defect. The percentage of areas enhanced by xenon in upper predominant defect pattern was significantly higher than that in diffuse defect and multifocal defect pattern among these 3 different patterns in CPFE. Conclusion The percentage of areas enhanced by xenon demonstrated strong correlations with obstructive ventilation impairment. Therefore, we conclude that Xe-DECT may be useful for distinguishing emphysema lesion from fibrotic lesion in CPFE.	[Sugino, Keishi; Nakamura, Yasuhiko; Gocho, Kyoko; Ishida, Fumiaki; Isobe, Kazutoshi; Homma, Sakae] Toho Univ, Omori Med Ctr, Dept Resp Med, Ota Ku, 6-11-1 Omori Nishi, Tokyo, Japan; [Kobayashi, Masahiro; Shiraga, Nobuyuki] Toho Univ, Omori Med Ctr, Dept Diagnost Radiol, Ota Ku, 6-11-1 Omori Nishi, Tokyo, Japan	Toho University; Toho University	Sugino, K (corresponding author), Toho Univ, Omori Med Ctr, Dept Resp Med, Ota Ku, 6-11-1 Omori Nishi, Tokyo, Japan.	ks142129_ikusou@ybb.ne.jp		Sugino, Keishi/0000-0003-3688-6782	JSPS KAKENHI [24591791]; Toho University [23-18]; Japanese Ministry of Health, Labor and Welfare; Japan Agency for Medical Research and development, AMED	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Toho University(Toho University); Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED))	This study was supported by JSPS KAKENHI Grant Number 24591791 and Toho University project grant (#23-18). This study was partially supported by a grant-in-aid for interstitial lung diseases from the Japanese Ministry of Health, Labor and Welfare and the Practical Research Project for Rare Intractable Diseases from Japan Agency for Medical Research and development, AMED.	Akagi T, 2009, RESP MED, V103, P1209, DOI 10.1016/j.rmed.2009.02.001; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Chae EJ, 2010, INVEST RADIOL, V45, P354, DOI 10.1097/RLI.0b013e3181dfdae0; Cottin V, 2005, EUR RESPIR J, V26, P586, DOI 10.1183/09031936.05.00021005; Goo HW, 2010, PEDIATR RADIOL, V40, P1490, DOI 10.1007/s00247-010-1645-3; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Hoag JB, 2007, ACAD RADIOL, V14, P81, DOI 10.1016/j.acra.2006.10.012; Honda N, 2012, RADIOLOGY, V262, P262, DOI 10.1148/radiol.11110569; Kang MJ, 2010, RADIOGRAPHICS, V30, P685, DOI 10.1148/rg.303095101; Kitaguchi Y, 2010, RESPIROLOGY, V15, P265, DOI 10.1111/j.1440-1843.2009.01676.x; Kong X, 2014, AM J ROENTGENOL, V202, P309, DOI 10.2214/AJR.13.11191; Lu GM, 2012, AM J ROENTGENOL, V199, pS40, DOI 10.2214/AJR.12.9112; Park EA, 2010, RADIOLOGY, V256, P985, DOI 10.1148/radiol.10091502; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Ryerson CJ, 2013, CHEST, V144, P234, DOI 10.1378/chest.12-2403; Sugino K, 2014, RESPIROLOGY, V19, P239, DOI 10.1111/resp.12207; Zou KH, 2003, RADIOLOGY, V227, P617, DOI 10.1148/radiol.2273011499	18	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170289	10.1371/journal.pone.0170289	http://dx.doi.org/10.1371/journal.pone.0170289			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107411	Green Submitted, gold, Green Published			2022-12-26	WOS:000392405300100
J	Zhang, QL; Wang, DL; Zhang, MY; Zhao, YL; Yu, ZG				Zhang, Qili; Wang, Danlin; Zhang, Meiyan; Zhao, Yunli; Yu, Zhiguo			Studies on New Activities of Enantiomers of 2-(2-Hydroxypropanamido) Benzoic Acid: Antiplatelet Aggregation and Antithrombosis	PLOS ONE			English	Article							FERRIC-CHLORIDE; EXPERIMENTAL THROMBOSIS; PLATELET-AGGREGATION; RAT MODEL; ATHEROTHROMBOSIS; COAGULATION; MECHANISMS; RECEPTORS; EXTRACT; DISEASE	R-/S-2-(2-Hydroxypropanamido) benzoic acid (R-/S-HPABA), a marine-derived antiinflammatory drug, however, the antiplatelet and antithrombotic effects have not been investigated. In this paper, the in vitro antiplatelet activities and in vivo antithrombotic effects of R-/S-HPABA were investigated, for the first time. The effects of R-/S-HPABA on platelet aggregation induced by adenosine diphosphate (ADP), collagen (COLL) and arachidonic acid (AA) were evaluated. In addition, the in vivo bleeding time, clotting time, collagen-epinephrine induced pulmonary thrombosis and common carotid artery thrombosis were also investigated in rats. R-/S-HPABA significantly inhibited ADP, COLL and AA induced platelet aggregation in rabbit platelet rich plasma in vitro compared with control group, to a degree similar to that of aspirin. Besides, R-/S-HPABA prolonged bleeding time and clotting time as well as increased the recovery rate obviously in pulmonary thrombosis. Moreover, the level of thromboxane B-2 (TXB2) was decreased while the production of 6-keto-prostaglandin F1 alpha (6-keto-PGF1 alpha) was increased markedly by R-/S-HPABA. Furthermore, R-/S-HPABA reduced carotid artery thrombosis weight. These results illustrated that R-/S-HPABA could be a potent antiplatelet aggregation and antithrombotic agent.	[Zhang, Qili; Wang, Danlin; Zhang, Meiyan; Zhao, Yunli; Yu, Zhiguo] Shenyang Pharmaceut Univ, Sch Pharm, Shenyang, Peoples R China	Shenyang Pharmaceutical University	Zhao, YL; Yu, ZG (corresponding author), Shenyang Pharmaceut Univ, Sch Pharm, Shenyang, Peoples R China.	yunli76@163.com; zhiguo-yu@163.com						Bhatt DL, 2003, NAT REV DRUG DISCOV, V2, P15, DOI 10.1038/nrd985; Boos CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P328, DOI 10.2741/1800; BORN GVR, 1962, NATURE, V194, P927, DOI 10.1038/194927b0; BULT H, 1988, BRIT J PHARMACOL, V93, P791, DOI 10.1111/j.1476-5381.1988.tb11464.x; Chakrabarti Ranjan, 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P175; Couture L, 2013, J PHARMACOL TOX MET, V67, P91, DOI 10.1016/j.vascn.2012.11.003; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Du H, 2007, THROMB RES, V121, P419, DOI 10.1016/j.thromres.2007.05.001; FRUCHTMAN S, 1986, J AM COLL CARDIOL, V8, pB159, DOI 10.1016/S0735-1097(86)80017-1; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Furie B, 2006, BLOOD CELL MOL DIS, V36, P177, DOI 10.1016/j.bcmd.2005.12.018; Gu Y., 1991, CHINESE PHARMACOL B, V7, P317; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Hoppensteadt DA, 2008, SEMIN RESP CRIT CARE, V29, P90, DOI 10.1055/s-2008-1047567; Jin YR, 2004, VASC PHARMACOL, V41, P35, DOI 10.1016/j.vph.2004.04.001; Kim M, 2014, BIOMOL THER, V22, P254, DOI 10.4062/biomolther.2014.008; Kim TH, 2016, J ETHNOPHARMACOL, V178, P172, DOI 10.1016/j.jep.2015.11.040; Kunapuli SP, 2003, CURR OPIN PHARMACOL, V3, P175, DOI 10.1016/S1471-4892(03)00007-9; KURZ KD, 1990, THROMB RES, V60, P269, DOI 10.1016/0049-3848(90)90106-M; Kwon SU, 2016, BLOOD COAGUL FIBRIN, V27, P141, DOI 10.1097/MBC.0000000000000394; Levi M, 2008, SEMIN THROMB HEMOST, V34, P742, DOI 10.1055/s-0029-1145256; Li YKM, 1991, PHARMARCOLOGICAL EXP; Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878; Meng L, 2008, HEART, V94, P777, DOI 10.1136/hrt.2007.117382; Nesheim M, 2003, CHEST, V124, p33S, DOI 10.1378/chest.124.3_suppl.33S; Pearson TA, 1997, AM J CLIN NUTR, V65, P1674; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Seo EJ, 2011, J ETHNOPHARMACOL, V135, P48, DOI 10.1016/j.jep.2011.02.025; Song Yang, 2011, Chinese Journal of Natural Medicines, V9, P141, DOI 10.3724/SP.J.1009.2011.00141; UMETSU T, 1978, THROMB HAEMOSTASIS, V39, P74; Varga-Szabo D, 2008, ARTERIOSCL THROM VAS, V28, P403, DOI 10.1161/ATVBAHA.107.150474; Wang JJ, 2014, CHEM NAT COMPD+, V50, P405, DOI 10.1007/s10600-014-0971-3; Wang QC, 1993, J CLIN PHARMACOL, V8, P228; Wang X, 2006, J THROMB HAEMOST, V4, P403, DOI 10.1111/j.1538-7836.2006.01703.x; Wonhwa Lee, 2015, Journal of Functional Foods, V17, P388, DOI 10.1016/j.jff.2015.05.037; Yu ZG, Patent No. [Z L 201210541957. 8, 2012105419578]; Zhou Q., 2006, J SHENYANG PHARM U, V23, P162	38	4	4	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2017	12	1							e0170334	10.1371/journal.pone.0170334	http://dx.doi.org/10.1371/journal.pone.0170334			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI3QC	28107496	Green Published, gold, Green Submitted			2022-12-26	WOS:000392405300112
